PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Vishnivetskiy, SA; Gimenez, LE; Francis, DJ; Hanson, SM; Hubbell, WL; Klug, CS; Gurevich, VV				Vishnivetskiy, Sergey A.; Gimenez, Luis E.; Francis, Derek J.; Hanson, Susan M.; Hubbell, Wayne L.; Klug, Candice S.; Gurevich, Vsevolod V.			Few Residues within an Extensive Binding Interface Drive Receptor Interaction and Determine the Specificity of Arrestin Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCARINIC ACETYLCHOLINE-RECEPTOR; 3RD INTRACELLULAR LOOP; VISUAL ARRESTIN; BETA-ARRESTIN; CRYSTAL-STRUCTURE; COUPLED RECEPTORS; PHOSPHORYLATION-RECOGNITION; FLUORESCENT PROTEIN; CLATHRIN ADAPTER; 48-KDA PROTEIN	Arrestins bind active phosphorylated forms of Gprotein-coupled receptors, terminating G protein activation, orchestrating receptor trafficking, and redirecting signaling to alternative pathways. Visual arrestin-1 preferentially binds rhodopsin, whereas the two non-visual arrestins interact with hundreds of G protein-coupled receptor subtypes. Here we show that an extensive surface on the concave side of both arrestin-2 domains is involved in receptor binding. We also identified a small number of residues on the receptor binding surface of the N- and C-domains that largely determine the receptor specificity of arrestins. We show that alanine substitution of these residues blocks the binding of arrestin-1 to rhodopsin in vitro and of arrestin-2 and -3 to beta 2-adrenergic, M2 muscarinic cholinergic, and D2 dopamine receptors in intact cells, suggesting that these elements critically contribute to the energy of the interaction. Thus, in contrast to arrestin-1, where direct phosphate binding is crucial, the interaction of non-visual arrestins with their cognate receptors depends to a lesser extent on phosphate binding and more on the binding to non-phosphorylated receptor elements.	[Hubbell, Wayne L.] Univ Calif Los Angeles, Jules Stein Eye Inst, Los Angeles, CA 90095 USA; [Hubbell, Wayne L.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Francis, Derek J.; Klug, Candice S.] Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA; [Vishnivetskiy, Sergey A.; Gimenez, Luis E.; Hanson, Susan M.; Gurevich, Vsevolod V.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Medical College of Wisconsin; Vanderbilt University	Hubbell, WL (corresponding author), Univ Calif Los Angeles, Jules Stein Eye Inst, Los Angeles, CA 90095 USA.	hubbellw@jsei.ucla.edu; candice@mcw.edu; vsevolod.gurevich@vanderbilt.edu	Gimenez, Luis E Diaz/D-9291-2011; Gurevich, Vsevolod/A-3236-2008; Vishnivetskiy, Sergey/AAJ-8661-2020	Gurevich, Vsevolod/0000-0002-3950-5351; Diaz Gimenez, Luis Eduardo/0000-0002-0110-2135	National Institutes of Health [GM081756, GM077561, EY011500, GM070642, EY005216]; Jules Stein Professorship Endowment; NATIONAL EYE INSTITUTE [P30EY000331, R01EY011500, R37EY005216, R01EY005216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070642, R01GM077561, R56GM070642, R01GM081756] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jules Stein Professorship Endowment; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM081756, GM077561, EY011500 (to V. V. G.), GM070642 (to C. S. K.), and EY005216 (to W. L. H.). This work was also supported by the Jules Stein Professorship Endowment (to W. L. H.).	ATTRAMADAL H, 1992, J BIOL CHEM, V267, P17882; Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; Bayburt TH, 2011, J BIOL CHEM, V286, P1420, DOI 10.1074/jbc.M110.151043; Celver J, 2002, J BIOL CHEM, V277, P9043, DOI 10.1074/jbc.M107400200; Columbus L, 2002, TRENDS BIOCHEM SCI, V27, P288, DOI 10.1016/S0968-0004(02)02095-9; Crane JM, 2005, J MOL BIOL, V353, P295, DOI 10.1016/j.jmb.2005.08.022; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Dinculescu A, 2002, J BIOL CHEM, V277, P11703, DOI 10.1074/jbc.M111833200; Fotiadis D, 2006, CURR OPIN STRUC BIOL, V16, P252, DOI 10.1016/j.sbi.2006.03.013; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Gurevich EV, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-236; Gurevich EV, 2004, J NEUROCHEM, V91, P1404, DOI 10.1111/j.1471-4159.2004.02830.x; Gurevich EV, 2002, NEUROSCIENCE, V109, P421, DOI 10.1016/S0306-4522(01)00511-5; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Gurevich VV, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001444; Gurevich Vsevolod V., 2008, P55; GUREVICH VV, 1992, J BIOL CHEM, V267, P21919; GUREVICH VV, 1993, J BIOL CHEM, V268, P11628; Gurevich VV, 2000, METHOD ENZYMOL, V315, P422; GUREVICH VV, 1993, J BIOL CHEM, V268, P16879; Gurevich VV, 2004, TRENDS PHARMACOL SCI, V25, P105, DOI 10.1016/j.tips.2003.12.008; Gurevich VV, 1997, J BIOL CHEM, V272, P28849, DOI 10.1074/jbc.272.46.28849; Gurevich VV, 1996, METHOD ENZYMOL, V275, P382; GUREVICH VV, 1995, J BIOL CHEM, V270, P720, DOI 10.1074/jbc.270.2.720; Gurevich VV, 1997, MOL PHARMACOL, V51, P161, DOI 10.1124/mol.51.1.161; Gurevich VV, 1998, J BIOL CHEM, V273, P15501, DOI 10.1074/jbc.273.25.15501; GUREVICH VV, 1995, J BIOL CHEM, V270, P6010, DOI 10.1074/jbc.270.11.6010; Han M, 2001, STRUCTURE, V9, P869, DOI 10.1016/S0969-2126(01)00644-X; Hanson SM, 2006, J BIOL CHEM, V281, P9765, DOI 10.1074/jbc.M510738200; Hanson SM, 2006, J BIOL CHEM, V281, P3458, DOI 10.1074/jbc.M512148200; Hanson SM, 2006, P NATL ACAD SCI USA, V103, P4900, DOI 10.1073/pnas.0600733103; Hanson SM, 2008, STRUCTURE, V16, P924, DOI 10.1016/j.str.2008.03.006; Hanson SM, 2008, BIOCHEMISTRY-US, V47, P1070, DOI 10.1021/bi7021359; Hanson SM, 2007, J MOL BIOL, V368, P375, DOI 10.1016/j.jmb.2007.02.053; Hanson SM, 2007, EMBO J, V26, P1726, DOI 10.1038/sj.emboj.7601614; Hanson SM, 2007, P NATL ACAD SCI USA, V104, P3125, DOI 10.1073/pnas.0610886104; Hirsch JA, 1999, CELL, V97, P257, DOI 10.1016/S0092-8674(00)80735-7; Hubbell WL, 1998, CURR OPIN STRUC BIOL, V8, P649, DOI 10.1016/S0959-440X(98)80158-9; Imamoto Y, 2003, BIOPHYS J, V85, P1186, DOI 10.1016/S0006-3495(03)74554-8; Kang DS, 2009, J BIOL CHEM, V284, P29860, DOI 10.1074/jbc.M109.023366; Kim M, 2011, BIOCHEMISTRY-US, V50, P2235, DOI 10.1021/bi1018607; Kim OJ, 2004, J BIOL CHEM, V279, P7999, DOI 10.1074/jbc.M308281200; Kim YM, 2002, J BIOL CHEM, V277, P16340, DOI 10.1074/jbc.M200678200; Kishi H, 2002, J BIOL CHEM, V277, P21939, DOI 10.1074/jbc.M110894200; Klewe IV, 2008, NEUROPHARMACOLOGY, V54, P1215, DOI 10.1016/j.neuropharm.2008.03.015; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Kovoor A, 1999, J BIOL CHEM, V274, P6831, DOI 10.1074/jbc.274.11.6831; Krupnick JG, 1997, J BIOL CHEM, V272, P18125, DOI 10.1074/jbc.272.29.18125; Kuravi S, 2010, BIOPHYS J, V98, P2391, DOI 10.1016/j.bpj.2010.02.004; Kusnetzow AK, 2006, BIOCHEMISTRY-US, V45, P5538, DOI 10.1021/bi060101v; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Lee KB, 2000, J BIOL CHEM, V275, P9284, DOI 10.1074/jbc.275.13.9284; Loening AM, 2006, PROTEIN ENG DES SEL, V19, P391, DOI 10.1093/protein/gzl023; LOHSE MJ, 1992, J BIOL CHEM, V267, P8558; Mendez A, 2000, NEURON, V28, P153, DOI 10.1016/S0896-6273(00)00093-3; Milano SK, 2002, BIOCHEMISTRY-US, V41, P3321, DOI 10.1021/bi015905j; Mukherjee S, 1999, J BIOL CHEM, V274, P12984, DOI 10.1074/jbc.274.19.12984; Mukherjee S, 2002, J BIOL CHEM, V277, P17916, DOI 10.1074/jbc.M110479200; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Namkung Y, 2009, J BIOL CHEM, V284, P34103, DOI 10.1074/jbc.M109.055707; Namkung Y, 2009, J BIOL CHEM, V284, P15038, DOI 10.1074/jbc.M900388200; Nikonov SS, 2008, NEURON, V59, P462, DOI 10.1016/j.neuron.2008.06.011; OHGURO H, 1994, PROTEIN SCI, V3, P2428, DOI 10.1002/pro.5560031226; PalsRylaarsdam R, 1997, J BIOL CHEM, V272, P23682, DOI 10.1074/jbc.272.38.23682; Pan L, 2003, J BIOL CHEM, V278, P11623, DOI 10.1074/jbc.M209532200; Pulvermuller A, 2000, J BIOL CHEM, V275, P37679, DOI 10.1074/jbc.M006776200; Pulvermuller A, 1997, BIOCHEMISTRY-US, V36, P9253, DOI 10.1021/bi970772g; Satoh AK, 2010, NEURON, V67, P997, DOI 10.1016/j.neuron.2010.08.024; SCHLEICHER A, 1989, BIOCHEMISTRY-US, V28, P1770, DOI 10.1021/bi00430a052; Schoneberg T, 2004, PHARMACOL THERAPEUT, V104, P173, DOI 10.1016/j.pharmthera.2004.08.008; Schubert C, 1999, J BIOL CHEM, V274, P21186, DOI 10.1074/jbc.274.30.21186; SHINOHARA T, 1987, P NATL ACAD SCI USA, V84, P6975, DOI 10.1073/pnas.84.20.6975; Smith WC, 2000, INVEST OPHTH VIS SCI, V41, P2445; Song X, 2011, NEUROSCIENCE, V174, P37, DOI 10.1016/j.neuroscience.2010.11.009; Song XF, 2006, J BIOL CHEM, V281, P21491, DOI 10.1074/jbc.M603659200; Song X, 2007, J NEUROCHEM, V103, P1053, DOI 10.1111/j.1471-4159.2007.04842.x; Song X, 2009, CURR BIOL, V19, P700, DOI 10.1016/j.cub.2009.02.065; STERNEMARR R, 1993, J BIOL CHEM, V268, P15640; Sutton RB, 2005, J MOL BIOL, V354, P1069, DOI 10.1016/j.jmb.2005.10.023; Tsukamoto H, 2010, J MOL BIOL, V399, P501, DOI 10.1016/j.jmb.2010.04.029; Vishnivetskiy SA, 2004, J BIOL CHEM, V279, P1262, DOI 10.1074/jbc.M308834200; Vishnivetskiy SA, 2002, J BIOL CHEM, V277, P43961, DOI 10.1074/jbc.M206951200; Vishnivetskiy SA, 2000, J BIOL CHEM, V275, P41049, DOI 10.1074/jbc.M007159200; Vishnivetskiy SA, 2007, J BIOL CHEM, V282, P32075, DOI 10.1074/jbc.M706057200; Vishnivetskiy SA, 2010, J MOL BIOL, V395, P42, DOI 10.1016/j.jmb.2009.10.058; Vishnivetskiy SK, 1999, J BIOL CHEM, V274, P11451, DOI 10.1074/jbc.274.17.11451; Walther C, 2010, J BIOL CHEM, V285, P41578, DOI 10.1074/jbc.M110.162156; Whistler JL, 2001, J BIOL CHEM, V276, P34331, DOI 10.1074/jbc.M104627200; WILDEN U, 1986, P NATL ACAD SCI USA, V83, P1174, DOI 10.1073/pnas.83.5.1174; Wu N, 2006, J MOL BIOL, V364, P955, DOI 10.1016/j.jmb.2006.09.075; Zhan XZ, 2011, J MOL BIOL, V406, P467, DOI 10.1016/j.jmb.2010.12.034; Zhang LR, 1997, J BIOL CHEM, V272, P14762, DOI 10.1074/jbc.272.23.14762; Zhuang TD, 2010, BIOCHEMISTRY-US, V49, P10473, DOI 10.1021/bi101596g	93	75	75	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24288	24299		10.1074/jbc.M110.213835	http://dx.doi.org/10.1074/jbc.M110.213835			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21471193	Green Published, hybrid			2022-12-25	WOS:000292294900070
J	Nagele, V; Heesemann, J; Schielke, S; Jimenez-Soto, LF; Kurzai, O; Ackermann, N				Naegele, Virginie; Heesemann, Juergen; Schielke, Stephanie; Jimenez-Soto, Luisa F.; Kurzai, Oliver; Ackermann, Nikolaus			Neisseria meningitidis Adhesin NadA Targets beta 1 Integrins FUNCTIONAL SIMILARITY TO YERSINIA INVASIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOST RECEPTOR RECOGNITION; OUTER-MEMBRANE PROTEINS; HUMAN DENDRITIC-CELLS; EPITHELIAL-CELLS; ESCHERICHIA-COLI; MUCOSAL IMMUNITY; COLLAGEN-BINDING; LYMPHOID-TISSUE; III SECRETION; YADA PROTEIN	Meningococci are facultative-pathogenic bacteria endowed with a set of adhesins allowing colonization of the human upper respiratory tract, leading to fulminant meningitis and septicemia. The Neisseria adhesin NadA was identified in about 50% of N. meningitidis isolates and is closely related to the Yersinia adhesin YadA, the prototype of the oligomeric coiled-coil adhesin (Oca) family. NadA is known to be involved in cell adhesion, invasion, and induction of proinflammatory cytokines. Because of the enormous diversity of neisserial cell adhesins the analysis of the specific contribution of NadA in meningococcal host interactions is limited. Therefore, we used a non-invasive Y. enterocolitica mutant as carrier to study the role of NadA in host cell interaction. NadA was shown to be efficiently produced and localized in its oligomeric form on the bacterial surface of Y. enterocolitica. Additionally, NadA mediated a beta 1 integrin-dependent adherence with subsequent internalization of yersiniae by a beta 1 integrin-positive cell line. Using recombinant NadA(24-210) protein and human and murine beta 1 integrin-expressing cell lines we could demonstrate the role of the beta 1 integrin subunit as putative receptor for NadA. Subsequent inhibition assays revealed specific interaction of NadA(24-210) with the human beta 1 integrin subunit. Cumulatively, these results indicate that Y. enterocolitica is a suitable toolbox system for analysis of the adhesive properties of NadA, revealing strong evidence that beta 1 integrins are important receptors for NadA. Thus, this study demonstrated for the first time a direct interaction between the Oca-family member NadA and human beta 1 integrins.	[Naegele, Virginie; Heesemann, Juergen; Jimenez-Soto, Luisa F.; Ackermann, Nikolaus] Univ Munich, Max von Pettenkofer Inst Hyg & Med Microbiol, D-80336 Munich, Germany; [Schielke, Stephanie; Kurzai, Oliver] Univ Wurzburg, Inst Hyg & Microbiol, D-97080 Wurzburg, Germany; [Kurzai, Oliver] Univ Jena, Sept Res Ctr, D-07745 Jena, Germany	University of Munich; University of Wurzburg; Friedrich Schiller University of Jena	Ackermann, N (corresponding author), Univ Munich, Max von Pettenkofer Inst Hyg & Med Microbiol, Pettenkoferstr 9A, D-80336 Munich, Germany.	ackermann@mvp.uni-muenchen.de		Kurzai, Oliver/0000-0002-7277-2646; Dille, Stephanie/0000-0002-7712-6002; Dille, Stephanie/0000-0001-9465-8345	Friedrich-Baur-Stiftung; Munich Centre for Integrated Protein Science (CIPSM); German Research Foundation (DFG) [SFB594, SFB479]	Friedrich-Baur-Stiftung; Munich Centre for Integrated Protein Science (CIPSM); German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the Friedrich-Baur-Stiftung, the Munich Centre for Integrated Protein Science (CIPSM) and by the German Research Foundation (DFG) Grant SFB594. This work was also supported in part by the DFG Grant SFB479 (to O. K.).	Ackermann N, 2008, J BACTERIOL, V190, P5031, DOI 10.1128/JB.00161-08; Capecchi B, 2005, MOL MICROBIOL, V55, P687, DOI 10.1111/j.1365-2958.2004.04423.x; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; Comanducci M, 2004, INFECT IMMUN, V72, P4217, DOI 10.1128/IAI.72.7.4217-4223.2004; Comanducci M, 2002, J EXP MED, V195, P1445, DOI 10.1084/jem.20020407; Cornelis GR, 2002, J CELL BIOL, V158, P401, DOI 10.1083/jcb.200205077; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Corr SC, 2008, FEMS IMMUNOL MED MIC, V52, P2, DOI 10.1111/j.1574-695X.2007.00359.x; Cotter SE, 2005, TRENDS MICROBIOL, V13, P199, DOI 10.1016/j.tim.2005.03.004; El Tahir Y, 2000, MOL MICROBIOL, V37, P192, DOI 10.1046/j.1365-2958.2000.01992.x; Elias J, 2007, J CLIN MICROBIOL, V45, P159, DOI 10.1128/JCM.01322-06; Franzoso S, 2008, J LEUKOCYTE BIOL, V83, P1100, DOI 10.1189/jlb.1207810; Gimond C, 1999, J CELL BIOL, V147, P1325, DOI 10.1083/jcb.147.6.1325; Grassl GA, 2003, CELL MICROBIOL, V5, P957, DOI 10.1046/j.1462-5822.2003.00339.x; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hauck CR, 2003, CURR OPIN MICROBIOL, V6, P43, DOI 10.1016/S1369-5274(03)00004-3; Heesemann J, 2006, CURR OPIN MICROBIOL, V9, P55, DOI 10.1016/j.mib.2005.10.018; HEESEMANN J, 1983, J INFECT DIS, V147, P107, DOI 10.1093/infdis/147.1.107; Heise T, 2006, P NATL ACAD SCI USA, V103, P3375, DOI 10.1073/pnas.0507749103; Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004; Heritage PL, 1997, AM J RESP CRIT CARE, V156, P1256, DOI 10.1164/ajrccm.156.4.97-03017; Hoiczyk E, 2000, EMBO J, V19, P5989, DOI 10.1093/emboj/19.22.5989; Isberg RR, 2000, MICROBES INFECT, V2, P793, DOI 10.1016/S1286-4579(00)90364-2; ISBERG RR, 1990, CELL, V60, P861, DOI 10.1016/0092-8674(90)90099-Z; Kiyono H, 2004, NAT REV IMMUNOL, V4, P699, DOI 10.1038/nri1439; Kolb-Maurer A, 2001, INFECT IMMUN, V69, P6912, DOI 10.1128/IAI.69.11.6912-6922.2001; Kuespert K, 2007, J MICROBIOL METH, V68, P478, DOI 10.1016/j.mimet.2006.10.003; Kuespert K, 2006, CURR OPIN CELL BIOL, V18, P565, DOI 10.1016/j.ceb.2006.08.008; Kuespert Katharina, 2009, V470, P57, DOI 10.1007/978-1-59745-204-5_5; KUPSCH EM, 1993, EMBO J, V12, P641, DOI 10.1002/j.1460-2075.1993.tb05697.x; Kurzai O, 2005, CELL MICROBIOL, V7, P1319, DOI 10.1111/j.1462-5822.2005.00559.x; Linke D, 2006, TRENDS MICROBIOL, V14, P264, DOI 10.1016/j.tim.2006.04.005; MACK D, 1994, MED MICROBIOL IMMUN, V183, P217; Mazzon C, 2007, J IMMUNOL, V179, P3904, DOI 10.4049/jimmunol.179.6.3904; MCNEIL G, 1994, MICROB PATHOGENESIS, V16, P153, DOI 10.1006/mpat.1994.1016; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Park HS, 2003, J IMMUNOL, V171, P2532, DOI 10.4049/jimmunol.171.5.2532; Roggenkamp A, 2003, J BACTERIOL, V185, P3735, DOI 10.1128/JB.185.13.3735-3744.2003; ROGGENKAMP A, 1995, MOL MICROBIOL, V16, P1207, DOI 10.1111/j.1365-2958.1995.tb02343.x; Ruckdeschel K, 1996, INFECT IMMUN, V64, P724, DOI 10.1128/IAI.64.3.724-733.1996; Schubert S, 2004, INT J MED MICROBIOL, V294, P83, DOI 10.1016/j.ijmm.2004.06.026; Schulte R, 2000, FASEB J, V14, P1471, DOI 10.1096/fj.14.11.1471; TAMM A, 1993, MOL MICROBIOL, V10, P995, DOI 10.1111/j.1365-2958.1993.tb00971.x; VIRJI M, 1994, MOL MICROBIOL, V14, P173, DOI 10.1111/j.1365-2958.1994.tb01277.x; Virji M, 2009, NAT REV MICROBIOL, V7, P274, DOI 10.1038/nrmicro2097; Wiedemann A, 2001, CELL MICROBIOL, V3, P693, DOI 10.1046/j.1462-5822.2001.00149.x; Wong KW, 2005, PLOS PATHOG, V1, P125, DOI 10.1371/journal.ppat.0010016; Wong KW, 2005, CURR OPIN MICROBIOL, V8, P4, DOI 10.1016/j.mib.2004.12.009; WOOD WB, 1966, J MOL BIOL, V16, P118, DOI 10.1016/S0022-2836(66)80267-X; Wu YL, 2007, NAT PROTOC, V2, P3278, DOI 10.1038/nprot.2007.459	50	33	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20536	20546		10.1074/jbc.M110.188326	http://dx.doi.org/10.1074/jbc.M110.188326			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21471204	Green Published, hybrid			2022-12-25	WOS:000291267600040
J	Hrdinka, M; Draber, P; Stepanek, O; Ormsby, T; Otahal, P; Angelisova, P; Brdicka, T; Paces, J; Horejsi, V; Drbal, K				Hrdinka, Matous; Draber, Peter; Stepanek, Ondrej; Ormsby, Tereza; Otahal, Pavel; Angelisova, Pavla; Brdicka, Tomas; Paces, Jan; Horejsi, Vaclav; Drbal, Karel			PRR7 Is a Transmembrane Adaptor Protein Expressed in Activated T Cells Involved in Regulation of T Cell Receptor Signaling and Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PHOSPHORYLATION; MEMBRANE MICRODOMAINS; B-CELL; LAT; BINDS; IDENTIFICATION; LYMPHOCYTES; MOLECULE; PROMOTER; FAMILIES	Transmembrane adaptor proteins (TRAPs) are important organizers and regulators of immunoreceptor-mediated signaling. A bioinformatic search revealed several potential novel TRAPs, including a highly conserved protein, proline rich 7 (PRR7), previously described as a component of the PSD-95/N-methyl-D-aspartate receptor protein complex in postsynaptic densities (PSD) of rat neurons. Our data demonstrate that PRR7 is weakly expressed in other tissues but is readily up-regulated in activated human peripheral blood lymphocytes. Transient overexpression of PRR7 in Jurkat T cell line led to gradual apoptotic death dependent on the WW domain binding motif surrounding Tyr-166 in the intracellular part of PRR7. To circumvent the pro-apoptotic effect of PRR7, we generated Jurkat clones with inducible expression of PRR7 (J-iPRR7). In these cells acute induction of PRR7 expression had a dual effect. It resulted in up-regulation of the transcription factor c-Jun and the activation marker CD69 as well as enhanced production of IL-2 after phorbol 12-myristate 13-acetate (PMA) and ionomycin treatment. On the other hand, expression of PRR7 inhibited general tyrosine phosphorylation and calcium influx after T cell receptor cross-linking by antibodies. Moreover, we found PRR7 constitutively tyrosine-phosphorylated and associated with Src. Collectively, these data indicate that PRR7 is a potential regulator of signaling and apoptosis in activated T cells.	[Hrdinka, Matous; Draber, Peter; Stepanek, Ondrej; Ormsby, Tereza; Otahal, Pavel; Angelisova, Pavla; Brdicka, Tomas; Paces, Jan; Horejsi, Vaclav; Drbal, Karel] Acad Sci Czech Republic, Inst Mol Genet, CR-14220 Prague 4, Czech Republic	Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences	Drbal, K (corresponding author), Videnska 1083, CZ-14220 Prague 4, Czech Republic.	drbal@img.cas.cz	Draber, Peter/G-3141-2014; Hrdinka, Matous/B-9187-2011; Stepanek, Ondrej/F-8882-2013; Pačes, Jan/C-8851-2009; Horejsi, Vaclav/G-3113-2014; Brdicka, Tomas/G-6205-2014; Otahal, Pavel/G-3153-2014; Angelisova, Pavla/G-3131-2014; Ormsby, Tereza/O-3854-2018; Stepanek, Ondrej/AAG-3180-2020; Drbal, Karel/G-9329-2011	Draber, Peter/0000-0001-8658-4614; Hrdinka, Matous/0000-0002-2981-2825; Stepanek, Ondrej/0000-0002-2735-3311; Pačes, Jan/0000-0003-3059-6127; Horejsi, Vaclav/0000-0003-4925-0142; Brdicka, Tomas/0000-0002-1560-4398; Ormsby, Tereza/0000-0002-2953-9208; Stepanek, Ondrej/0000-0002-2735-3311; Drbal, Karel/0000-0003-4450-4625; Otahal, Pavel/0000-0002-5513-4159	Academy of Sciences of the Czech Republic [AV0Z50520514]; GACR [MEM/09/E011]; Center of Molecular and Cellular Immunology (Ministry of Education, Youth, and Sports of the Czech Republic) [1M0506]; Faculty of Science, Charles University in Prague	Academy of Sciences of the Czech Republic(Czech Academy of Sciences); GACR(Grant Agency of the Czech Republic); Center of Molecular and Cellular Immunology (Ministry of Education, Youth, and Sports of the Czech Republic)(Ministry of Education, Youth & Sports - Czech Republic); Faculty of Science, Charles University in Prague	This work was supported in part by Academy of Sciences of the Czech Republic Project AV0Z50520514, GACR (Project MEM/09/E011), and by the Center of Molecular and Cellular Immunology (Project 1M0506, Ministry of Education, Youth, and Sports of the Czech Republic).; Supported in part by the Faculty of Science, Charles University in Prague.	Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Brannetti B, 2003, NUCLEIC ACIDS RES, V31, P3709, DOI 10.1093/nar/gkg592; Brdicka T, 2002, J EXP MED, V196, P1617, DOI 10.1084/jem.20021405; Brdicka T, 2000, J EXP MED, V191, P1591, DOI 10.1084/jem.191.9.1591; Brdicka T, 1998, BIOCHEM BIOPH RES CO, V248, P356, DOI 10.1006/bbrc.1998.8857; Brdickova N, 2003, J EXP MED, V198, P1453, DOI 10.1084/jem.20031484; Bruyns E, 1998, J EXP MED, V188, P561, DOI 10.1084/jem.188.3.561; Castellanos MD, 1997, J IMMUNOL, V159, P5463; CHEN HI, 1995, P NATL ACAD SCI USA, V92, P7819, DOI 10.1073/pnas.92.17.7819; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; FRASER JD, 1989, P NATL ACAD SCI USA, V86, P7133, DOI 10.1073/pnas.86.18.7133; Fuller DM, 2009, IMMUNOL REV, V232, P72, DOI 10.1111/j.1600-065X.2009.00828.x; Gao M, 2004, SCIENCE, V306, P271, DOI 10.1126/science.1099414; Hobbs S, 1998, BIOCHEM BIOPH RES CO, V252, P368, DOI 10.1006/bbrc.1998.9646; Horejsi V, 2004, IMMUNOL LETT, V92, P43, DOI 10.1016/j.imlet.2003.10.013; Horejsi V, 2010, FEBS J, V277, P4383, DOI 10.1111/j.1742-4658.2010.07831.x; Hur EM, 2003, J EXP MED, V198, P1463, DOI 10.1084/jem.20030232; JADOT M, 1992, J BIOL CHEM, V267, P11069; JAIN J, 1992, J IMMUNOL, V148, P1240; Janssen E, 2003, NAT IMMUNOL, V4, P117, DOI 10.1038/ni882; Kawabuchi M, 2000, NATURE, V404, P999, DOI 10.1038/35010121; Koelsch U, 2008, J IMMUNOL, V181, P5930, DOI 10.4049/jimmunol.181.9.5930; Krammer PH, 2007, NAT REV IMMUNOL, V7, P532, DOI 10.1038/nri2115; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lessard J, 2007, PROSTATE, V67, P808, DOI 10.1002/pros.20559; Liu Y, 2008, J LEUKOCYTE BIOL, V84, P842, DOI 10.1189/jlb.0208087; Marie-Cardine A, 1999, J EXP MED, V189, P1181, DOI 10.1084/jem.189.8.1181; Murata Y, 2005, BIOCHEM BIOPH RES CO, V327, P183, DOI 10.1016/j.bbrc.2004.11.154; Otahal P, 2010, J IMMUNOL, V184, P3689, DOI 10.4049/jimmunol.0902075; QIAO L, 1991, GASTROENTEROLOGY, V101, P1529, DOI 10.1016/0016-5085(91)90388-2; Roose JP, 2007, MOL CELL BIOL, V27, P2732, DOI 10.1128/MCB.01882-06; Round JL, 2005, J EXP MED, V201, P419, DOI 10.1084/jem.20041428; Saras J, 1996, TRENDS BIOCHEM SCI, V21, P455, DOI 10.1016/S0968-0004(96)30044-3; Simeoni L, 2004, CURR OPIN IMMUNOL, V16, P304, DOI 10.1016/j.coi.2004.03.001; Wan J, 2007, NAT PROTOC, V2, P1573, DOI 10.1038/nprot.2007.225; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8; Zhu MH, 2002, J BIOL CHEM, V277, P46151, DOI 10.1074/jbc.M208946200	37	11	14	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19617	19629		10.1074/jbc.M110.175117	http://dx.doi.org/10.1074/jbc.M110.175117			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21460222	hybrid, Green Published			2022-12-25	WOS:000291027700045
J	Wang, LX; Nomura, M; Goto, Y; Tanaka, K; Sakamoto, R; Abe, I; Sakamoto, S; Shibata, A; Enciso, PLM; Adachi, M; Ohnaka, K; Kawate, H; Takayanagi, R				Wang, Lixiang; Nomura, Masatoshi; Goto, Yutaka; Tanaka, Kimitaka; Sakamoto, Ryuichi; Abe, Ichiro; Sakamoto, Shohei; Shibata, Atsushi; Enciso, Patricio L. M.; Adachi, Masahiro; Ohnaka, Keizo; Kawate, Hisaya; Takayanagi, Ryoichi			Smad2 Protein Disruption in the Central Nervous System Leads to Aberrant Cerebellar Development and Early Postnatal Ataxia in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-BETA-S; GROWTH-FACTOR; TRANSFORMING GROWTH-FACTOR-BETA-1; PROGRESSIVE CEREBELLAR; ALZHEIMERS-DISEASE; GRANULE NEURONS; IN-VITRO; EXPRESSION; RAT; PROLIFERATION	Smad2 is a critical mediator of TGF-beta signals that are known to play an important role in a wide range of biological processes in various cell types. Its role in the development of the CNS, however, is largely unknown. Mice lacking Smad2 in the CNS (Smad2-CNS-KO) were generated by a Cre-loxP approach. These mice exhibited behavioral abnormalities in motor coordination from an early postnatal stage and mortality at approximately 3 weeks of age, suggestive of severe cerebellar dysfunction. Gross observation of Smad2-CNS-KO cerebella demonstrated aberrant foliations in lobule IX and X. Further analyses revealed increased apoptotic cell death, delayed migration and maturation of granule cells, and retardation of dendritic arborization of Purkinje cells. These findings indicate that Smad2 plays a key role in cerebellar development and motor function control.	[Wang, Lixiang; Nomura, Masatoshi; Goto, Yutaka; Tanaka, Kimitaka; Sakamoto, Ryuichi; Abe, Ichiro; Sakamoto, Shohei; Shibata, Atsushi; Enciso, Patricio L. M.; Adachi, Masahiro; Ohnaka, Keizo; Kawate, Hisaya; Takayanagi, Ryoichi] Kyushu Univ, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Higashi Ku, Fukuoka 8128582, Japan	Kyushu University	Nomura, M (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Higashi Ku, Maidashi 3-1-1, Fukuoka 8128582, Japan.	nomura@med.kyushu-u.ac.jp	Tanaka, Kimitaka/AAN-1479-2021	Tanaka, Kimitaka/0000-0001-9899-4581; Shibata, Atsushi/0000-0003-4521-8962	Ministry of Education, Science, Sports, and Culture (Japan)	Ministry of Education, Science, Sports, and Culture (Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant-in-aid for Scientific Research from the Ministry of Education, Science, Sports, and Culture (Japan).	Abe K, 1996, BRAIN RES, V723, P206, DOI 10.1016/0006-8993(96)00253-3; ALTMAN J, 1990, J COMP NEUROL, V301, P365, DOI 10.1002/cne.903010304; ALTMAN J, 1972, J COMP NEUROL, V145, P399, DOI 10.1002/cne.901450402; Bottner M, 2000, J NEUROCHEM, V75, P2227, DOI 10.1046/j.1471-4159.2000.0752227.x; Brionne TC, 2003, NEURON, V40, P1133, DOI 10.1016/S0896-6273(03)00766-9; Brown KA, 2007, J CELL BIOCHEM, V101, P9, DOI 10.1002/jcb.21255; Cameron HA, 1998, J NEUROBIOL, V36, P287, DOI 10.1002/(SICI)1097-4695(199808)36:2<287::AID-NEU13>3.0.CO;2-B; Chalmers KA, 2007, J NEUROPATH EXP NEUR, V66, P1019, DOI 10.1097/nen.0b013e31815885ad; Chalmers KA, 2007, J NEUROPATH EXP NEUR, V66, P158, DOI 10.1097/nen.0b013e3180303b93; Clark HB, 1997, J NEUROSCI, V17, P7385; CONSTAM DB, 1994, EUR J NEUROSCI, V6, P766, DOI 10.1111/j.1460-9568.1994.tb00988.x; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Dunn NR, 2005, GENE DEV, V19, P152, DOI 10.1101/gad.1243205; Elvers M, 2005, MECH DEVELOP, V122, P587, DOI 10.1016/j.mod.2004.10.012; FLANDERS KC, 1991, DEVELOPMENT, V113, P183; Goldowitz D, 1998, TRENDS NEUROSCI, V21, P375, DOI 10.1016/S0166-2236(98)01313-7; HATTEN ME, 1995, ANNU REV NEUROSCI, V18, P385, DOI 10.1146/annurev.ne.18.030195.002125; Heyer J, 1999, P NATL ACAD SCI USA, V96, P12595, DOI 10.1073/pnas.96.22.12595; LABOURDETTE G, 1990, J CELL PHYSIOL, V144, P473, DOI 10.1002/jcp.1041440315; Lee HG, 2006, J NEUROSCI RES, V84, P1856, DOI 10.1002/jnr.21072; Lu J, 2005, DEVELOPMENT, V132, P3231, DOI 10.1242/dev.01893; Luo J, 2006, P NATL ACAD SCI USA, V103, P18326, DOI 10.1073/pnas.0605077103; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Nomura M, 1998, NATURE, V393, P786, DOI 10.1038/31693; Oliver PL, 2007, BEHAV BRAIN RES, V181, P239, DOI 10.1016/j.bbr.2007.04.012; Rubino FA, 2002, NEUROLOGIST, V8, P254, DOI 10.1097/00127893-200207000-00005; SCHLESSINGER AR, 1975, J COMP NEUROL, V159, P149, DOI 10.1002/cne.901590202; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; SHOLL DA, 1953, J ANAT, V87, P387; Simon D, 2004, J NEUROSCI, V24, P1987, DOI 10.1523/JNEUROSCI.4549-03.2004; Stegmuller J, 2008, J NEUROSCI, V28, P1961, DOI 10.1523/JNEUROSCI.3061-07.2008; Takayama C, 2004, DEV BRAIN RES, V148, P169, DOI 10.1016/j.devbrainres.2003.11.007; Tanaka M, 2005, NEUROSCI LETT, V390, P182, DOI 10.1016/j.neulet.2005.08.017; Taroni F, 2004, NAT REV NEUROSCI, V5, P641, DOI 10.1038/nrn1474; TORUDELBAUFFE D, 1990, J NEUROCHEM, V54, P1056, DOI 10.1111/j.1471-4159.1990.tb02357.x; Ueberham U, 2006, EUR J NEUROSCI, V24, P2327, DOI 10.1111/j.1460-9568.2006.05109.x; Ueberham U, 2009, INT J DEV NEUROSCI, V27, P501, DOI 10.1016/j.ijdevneu.2009.04.001; Unsicker K, 2000, EUR J BIOCHEM, V267, P6972, DOI 10.1046/j.1432-1327.2000.01824.x; Voogd J, 1998, TRENDS NEUROSCI, V21, P370, DOI 10.1016/S0166-2236(98)01318-6; Waldrip WR, 1998, CELL, V92, P797, DOI 10.1016/S0092-8674(00)81407-5; Weinstein M, 2000, CYTOKINE GROWTH F R, V11, P49, DOI 10.1016/S1359-6101(99)00028-3; Weinstein M, 1998, P NATL ACAD SCI USA, V95, P9378, DOI 10.1073/pnas.95.16.9378; Weyer A, 2003, J NEUROSCI RES, V73, P400, DOI 10.1002/jnr.10655; Xing Y, 2010, J NEUROCHEM, V115, P1486, DOI 10.1111/j.1471-4159.2010.07053.x; Yagi K, 1999, J BIOL CHEM, V274, P703, DOI 10.1074/jbc.274.2.703; Zhou YX, 2003, J BIOL CHEM, V278, P42313, DOI 10.1074/jbc.M308287200	47	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18766	18774		10.1074/jbc.M111.223271	http://dx.doi.org/10.1074/jbc.M111.223271			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21464123	Green Published, hybrid			2022-12-25	WOS:000290785700049
J	Rock, K; Grandoch, M; Majora, M; Krutmann, J; Fischer, JW				Roeck, Katharina; Grandoch, Maria; Majora, Marc; Krutmann, Jean; Fischer, Jens W.			Collagen Fragments Inhibit Hyaluronan Synthesis in Skin Fibroblasts in Response to Ultraviolet B (UVB) NEW INSIGHTS INTO MECHANISMS OF MATRIX REMODELING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; SMOOTH-MUSCLE-CELLS; BREAST-CANCER CELLS; NUCLEAR TRANSLOCATION; PROCOLLAGEN SYNTHESIS; DISACCHARIDE ANALYSIS; EXTRACELLULAR-MATRIX; ACTIN CYTOSKELETON; FOCAL ADHESIONS; RETINOIC ACID	UVB irradiation causes characteristic features of skin aging including remodeling of the dermal extracellular matrix. A key feature during this process is the up-regulation of matrix metalloproteinases and cleavage of collagen. Hyaluronic acid (HA), a major component of the dermal matrix, decreases after chronic UVB exposure. However, the factors that govern the decline of HA synthesis during the course of actinic aging are largely unknown. The aim of the present study was to explore whether collagen degradation causes inhibition of HA synthesis in human skin fibroblasts. After treatment of fibroblasts with collagen fragments (CF) in vitro, resolution of the actin cytoskeleton and inhibition of HA secretion occurred because of specific down-regulation of hyaluronan synthase 2 (HAS2) expression. The alpha(v)beta(3)-agonist, RGDS, latrunculin A, and an inhibitor of Rho-activated kinase inhibited HAS2 expression. Conversely, blocking antibodies to alpha(v)beta(3) abolished the down-regulation of HAS2 and the cytoskeletal effects. Furthermore, inhibition of cofilin phosphorylation in response to CF was prevented by alpha(v)beta(3)-blocking antibodies. The key role of ERK signaling was shown by reduced nuclear accumulation of phosphoERK and of ELK-1 phosphorylation in response to CF. In addition, the ERK inhibitor PD98059 reduced HAS2 expression. Also, UVB irradiation of fibroblasts caused down-regulation of HAS2, which was sensitive to matrix metalloproteinase inhibitors and to alpha(v)beta(3)-blocking antibodies. In conclusion, these data suggest that CF activate alpha(v)beta(3)-integrins and in turn inhibit Rho kinase (ROCK) signaling and nuclear translocation of phosphoERK, resulting in reduced HAS2 expression. Therefore, a novel mechanism is presented how proteolytic collagen cleavage may inhibit HA synthesis in dermal fibroblasts during extrinsic skin aging.	[Fischer, Jens W.] Univ Dusseldorf, Univ Klinikum Dusseldorf, Inst Pharmakol & Klin Pharmakol, D-40225 Dusseldorf, Germany; [Majora, Marc; Krutmann, Jean] Univ Dusseldorf, IUF Leibniz Inst Environm Med, D-40221 Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Heinrich Heine University Dusseldorf; Leibniz Institut fur Umweltmedizinische Forschung (IUF)	Fischer, JW (corresponding author), Univ Dusseldorf, Univ Klinikum Dusseldorf, Inst Pharmakol & Klin Pharmakol, Moorenstr 5, D-40225 Dusseldorf, Germany.	jens.fischer@uni-duesseldorf.de			Deutsche Forschungsgemeinschaft (DFG) Collaborative Research Center (SFB) [TP C6, TP C1]	Deutsche Forschungsgemeinschaft (DFG) Collaborative Research Center (SFB)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) Collaborative Research Center (SFB) 728 (Grants TP C6 and TP C1).	Ahmed M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-101; Aplin AE, 2001, J CELL BIOL, V153, P273, DOI 10.1083/jcb.153.2.273; Averbeck M, 2007, J INVEST DERMATOL, V127, P687, DOI 10.1038/sj.jid.5700614; Billinghurst RC, 1997, J CLIN INVEST, V99, P1534, DOI 10.1172/JCI119316; BRULS WAG, 1984, PHOTOCHEM PHOTOBIOL, V39, P63, DOI 10.1111/j.1751-1097.1984.tb03405.x; Brunet A, 1999, EMBO J, V18, P664, DOI 10.1093/emboj/18.3.664; Carragher NO, 1999, J CELL BIOL, V147, P619, DOI 10.1083/jcb.147.3.619; Chen J, 2001, J BIOL CHEM, V276, P47901, DOI 10.1074/jbc.M107574200; Dai G, 2007, AM J PATHOL, V171, P1451, DOI 10.2353/ajpath.2007.070136; Danen EHJ, 2002, J CELL BIOL, V159, P1071, DOI 10.1083/jcb.200205014; DAVIS GE, 1992, BIOCHEM BIOPH RES CO, V182, P1025, DOI 10.1016/0006-291X(92)91834-D; Day AJ, 2002, J BIOL CHEM, V277, P4585, DOI 10.1074/jbc.R100036200; de la Motte CA, 2003, AM J PATHOL, V163, P121, DOI 10.1016/S0002-9440(10)63636-X; DEOLIVEIRA CA, 1988, LIFE SCI, V43, P1825, DOI 10.1016/0024-3205(88)90282-2; Evanko SP, 1999, ARTERIOSCL THROM VAS, V19, P1004, DOI 10.1161/01.ATV.19.4.1004; Fisher GJ, 1996, NATURE, V379, P335, DOI 10.1038/379335a0; Fisher GJ, 1997, NEW ENGL J MED, V337, P1419, DOI 10.1056/NEJM199711133372003; Fligiel SEG, 2003, J INVEST DERMATOL, V120, P842, DOI 10.1046/j.1523-1747.2003.12148.x; GRIFFITHS CEM, 1993, NEW ENGL J MED, V329, P530, DOI 10.1056/NEJM199308193290803; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085; Itano N, 1996, BIOCHEM BIOPH RES CO, V222, P816, DOI 10.1006/bbrc.1996.0827; Kawamura S, 2003, J BIOL CHEM, V278, P31111, DOI 10.1074/jbc.M300725200; Lee DY, 2008, J BONE MINER RES, V23, P1140, DOI 10.1359/JBMR.080302; Lipinski KV, 2006, CARDIOVASC RES, V69, P697, DOI 10.1016/j.cardiores.2005.08.005; Liu YL, 2004, CIRC RES, V95, P579, DOI 10.1161/01.RES.0000141428.53262.a4; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Majora M, 2009, AM J PATHOL, V175, P1019, DOI 10.2353/ajpath.2009.080832; Makkonen KM, 2009, J BIOL CHEM, V284, P18270, DOI 10.1074/jbc.M109.012492; Manuskiatti W, 1996, INT J DERMATOL, V35, P539, DOI 10.1111/j.1365-4362.1996.tb03650.x; Marchand-Brynaert J, 1999, BIOMATERIALS, V20, P1773, DOI 10.1016/S0142-9612(99)00072-1; Margelin D, 1996, J INVEST DERMATOL, V106, P505, DOI 10.1111/1523-1747.ep12343819; Masiero L, 1999, J CELL SCI, V112, P3205; MONTGOMERY AMP, 1994, P NATL ACAD SCI USA, V91, P8856, DOI 10.1073/pnas.91.19.8856; MOON A, 1995, MOL BIOL CELL, V6, P1423, DOI 10.1091/mbc.6.11.1423; Narumiya S, 1997, FEBS LETT, V410, P68, DOI 10.1016/S0014-5793(97)00317-7; Ortega-Velazquez R, 2003, FASEB J, V17, P1529, DOI 10.1096/fj.02-0785fje; Pouyssegur J, 2002, BIOCHEM PHARMACOL, V64, P755, DOI 10.1016/S0006-2952(02)01135-8; Putnam AJ, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-10; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Stuhlmeier KM, 2004, J BIOL CHEM, V279, P8753, DOI 10.1074/jbc.M303945200; Takahashi Y, 1996, J DERMATOL SCI, V11, P129, DOI 10.1016/0923-1811(95)00430-0; TAKAHASHI Y, 1995, J DERMATOL SCI, V10, P139, DOI 10.1016/0923-1811(95)00396-A; Tammi RH, 2009, J INVEST DERMATOL, V129, P1858, DOI 10.1038/jid.2009.91; Toole BP, 2002, J BIOL CHEM, V277, P4593, DOI 10.1074/jbc.R100039200; Twarock S, 2010, J BIOL CHEM, V285, P23274, DOI 10.1074/jbc.M109.093146; van Leeuwen FN, 2003, BIOCHEM SOC T, V31, P1209; Varani J, 2004, J INVEST DERMATOL, V122, P1471, DOI 10.1111/j.0022-202X.2004.22614.x; Varani J, 2002, J INVEST DERMATOL, V119, P122, DOI 10.1046/j.1523-1747.2002.01810.x; Varani J, 2001, AM J PATHOL, V158, P931, DOI 10.1016/S0002-9440(10)64040-0; Varani J, 2000, J INVEST DERMATOL, V114, P480, DOI 10.1046/j.1523-1747.2000.00902.x; Lipinski KV, 2006, CIRC RES, V98, P1490, DOI 10.1161/01.RES.0000229267.77982.0d; Weber AA, 2002, BRIT J HAEMATOL, V117, P424, DOI 10.1046/j.1365-2141.2002.03423.x; White DP, 2007, J CELL BIOL, V177, P515, DOI 10.1083/jcb.200609004; Wiggin GR, 2002, MOL CELL BIOL, V22, P2871, DOI 10.1128/MCB.22.8.2871-2881.2002; Wilkinson TS, 2004, AM J RESP CELL MOL, V31, P92, DOI 10.1165/rcmb.2003-0380OC; YONEDA M, 1988, J CELL SCI, V90, P265	57	64	67	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					18268	18276		10.1074/jbc.M110.201665	http://dx.doi.org/10.1074/jbc.M110.201665			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454612	hybrid, Green Published			2022-12-25	WOS:000290585200087
J	Ding, SY; Nkobena, A; Kraft, CA; Markwardt, ML; Rizzo, MA				Ding, Shi-Ying; Nkobena, Andongfac; Kraft, Catherine A.; Markwardt, Michele L.; Rizzo, Mark A.			Glucagon-like Peptide 1 Stimulates Post-translational Activation of Glucokinase in Pancreatic beta Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE; INSULIN-SECRETION; S-NITROSYLATION; GLUCOSE; RECEPTOR; INTERNALIZATION; HYPOGLYCEMIA; MUTATIONS; DYNAMICS; CA2+	Glucagon-like peptide 1 (GLP-1) potentiates glucose-stimulated insulin secretion from pancreatic beta cells, yet does not directly stimulate secretion. The mechanisms underlying this phenomenon are incompletely understood. Here, we report that GLP-1 augments glucose-dependent rises in NAD(P)H autofluorescence in both beta TC3 insulinoma cells and islets in a manner consistent with post-translational activation of glucokinase (GCK). GLP-1 treatment increased GCK activity and enhanced GCK S-nitrosylation in beta TC3 cells. A 2-fold increase in S-nitrosylated GCK was also observed in mouse islets. Furthermore, GLP-1 activated a FRET-based GCK reporter in living cells. Activation of this reporter was sensitive to inhibition of nitricoxide synthase (NOS), and incorporating the S-nitrosylation-blocking V367M mutation into this sensor prevented activation by GLP-1. GLP-1 potentiation of the glucose-dependent increase in islet NAD(P)H autofluorescence was also sensitive to a NOS inhibitor, whereas NOS inhibition did not affect the response to glucose alone. Expression of the GCK(V367M) mutant also blocked GLP-1 potentiation of the NAD(P) H response to glucose in beta TC3 cells, but did not significantly affect metabolism of glucose in the absence of GLP-1. Co-expression of WT or mutant GCK proteins with a sensor for insulin secretory granule fusion also revealed that blockade of post-translational GCK S-nitrosylation diminished the effects of GLP-1 on granule exocytosis by similar to 40% in beta TC3 cells. These results suggest that post-translational activation of GCK is an important mechanism for mediating the insulinotropic effects of GLP-1.	[Ding, Shi-Ying; Nkobena, Andongfac; Kraft, Catherine A.; Markwardt, Michele L.; Rizzo, Mark A.] Univ Maryland, Dept Physiol, Sch Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Rizzo, MA (corresponding author), 660 W Redwood St,HH 525B, Baltimore, MD 21201 USA.	mrizz001@umaryland.edu			National Institutes of Health [R21-DK067415, R01-DK077140, DK077140-02S1, P60-DK079637, P30-DK072488]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK079637, R21DK067415, P30DK072488, R01DK077140, P30DK079637] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R21-DK067415, R01-DK077140, and DK077140-02S1 (to M. A. R.) and P60-DK079637 and P30-DK072488.	Arden C, 2007, DIABETES, V56, P1773, DOI 10.2337/db06-1151; AXELROD D, 1981, J CELL BIOL, V89, P141, DOI 10.1083/jcb.89.1.141; Bennett BD, 1996, J BIOL CHEM, V271, P3647; Bertram R, 2007, AM J PHYSIOL-ENDOC M, V293, pE890, DOI 10.1152/ajpendo.00359.2007; DALESSIO DA, 1989, DIABETES, V38, P1534, DOI 10.2337/diabetes.38.12.1534; Davis EA, 1999, DIABETOLOGIA, V42, P1175, DOI 10.1007/s001250051289; Ding SY, 2010, MOL ENDOCRINOL, V24, P171, DOI 10.1210/me.2009-0138; GERMAN MS, 1993, P NATL ACAD SCI USA, V90, P1781, DOI 10.1073/pnas.90.5.1781; Gloyn AL, 2004, FRONT DIABETES, V16, P92; Gloyn AL, 2003, DIABETES, V52, P2433, DOI 10.2337/diabetes.52.9.2433; GOKE R, 1993, RES EXP MED, V193, P97, DOI 10.1007/BF02576216; Hao M, 2007, DIABETES, V56, P2328, DOI 10.2337/db07-0056; Henningsson R, 2002, AM J PHYSIOL-CELL PH, V283, pC296, DOI 10.1152/ajpcell.00537.2001; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Kaneko Y, 2003, AM J PHYSIOL-CELL PH, V284, pC1215, DOI 10.1152/ajpcell.00223.2002; Kang GX, 2008, J PHYSIOL-LONDON, V586, P1307, DOI 10.1113/jphysiol.2007.143818; Kwan EP, 2005, DIABETES, V54, P2734, DOI 10.2337/diabetes.54.9.2734; Lajoix AD, 2001, DIABETES, V50, P1311, DOI 10.2337/diabetes.50.6.1311; Light PE, 2002, MOL ENDOCRINOL, V16, P2135, DOI 10.1210/me.2002-0084; Matschinsky FM, 1998, DIABETES, V47, P307, DOI 10.2337/diabetes.47.3.307; Matschinsky FM, 2002, DIABETES, V51, pS394, DOI 10.2337/diabetes.51.2007.S394; Mayevsky A, 2007, AM J PHYSIOL-CELL PH, V292, pC615, DOI 10.1152/ajpcell.00249.2006; MEGLASSON MD, 1983, P NATL ACAD SCI-BIOL, V80, P85, DOI 10.1073/pnas.80.1.85; Mica OI, 2004, BIOCHEM J, V381, P13, DOI 10.1042/BJ20040434; Michael DJ, 2007, DIABETES, V56, P1277, DOI 10.2337/db06-0367; Michael DJ, 2004, BIOPHYS J, V87, pL3, DOI 10.1529/biophysj.104.052175; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Patterson GH, 2000, P NATL ACAD SCI USA, V97, P5203, DOI 10.1073/pnas.090098797; Peyot ML, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006221; Rizzo MA, 2003, J CELL BIOL, V161, P243, DOI 10.1083/jcb.200301063; Rizzo MA, 2002, J BIOL CHEM, V277, P34168, DOI 10.1074/jbc.M112478200; Rocheleau JV, 2006, PLOS BIOL, V4, P221, DOI 10.1371/journal.pbio.0040026; Salehi A, 1996, AM J PHYSIOL-CELL PH, V270, pC1634, DOI 10.1152/ajpcell.1996.270.6.C1634; Shibasaki T, 2007, P NATL ACAD SCI USA, V104, P19333, DOI 10.1073/pnas.0707054104; Smukler SR, 2002, DIABETES, V51, P3450, DOI 10.2337/diabetes.51.12.3450; Stubbs M, 2000, DIABETES, V49, P2048, DOI 10.2337/diabetes.49.12.2048; Tiedge M, 2000, ARCH BIOCHEM BIOPHYS, V375, P251, DOI 10.1006/abbi.1999.1666; Tsuboi T, 2003, BIOCHEM J, V369, P287, DOI 10.1042/BJ20021288; Vazquez P, 2005, J ENDOCRINOL, V186, P221, DOI 10.1677/joe.1.06179; Velho G, 1997, DIABETOLOGIA, V40, P217, DOI 10.1007/s001250050666; Wang HY, 1997, P NATL ACAD SCI USA, V94, P4372, DOI 10.1073/pnas.94.9.4372; WEIR GC, 1989, DIABETES, V38, P338, DOI 10.2337/diabetes.38.3.338; WIDMANN C, 1995, BIOCHEM J, V310, P203, DOI 10.1042/bj3100203; Widmann C, 1997, MOL ENDOCRINOL, V11, P1094, DOI 10.1210/me.11.8.1094	44	29	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16768	16774		10.1074/jbc.M110.192799	http://dx.doi.org/10.1074/jbc.M110.192799			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454584	Green Published, hybrid			2022-12-25	WOS:000290301900025
J	Koumanov, F; Richardson, JD; Murrow, BA; Holman, GD				Koumanov, Francoise; Richardson, Judith D.; Murrow, Beverley A.; Holman, Geoffrey D.			AS160 Phosphotyrosine-binding Domain Constructs Inhibit Insulin-stimulated GLUT4 Vesicle Fusion with the Plasma Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT ADIPOSE-CELLS; AKT SUBSTRATE; SKELETAL-MUSCLE; TRANSLOCATION; PROTEIN; PHOSPHORYLATION; TBC1D1; MUTATION; AS160/TBC1D4; TRAFFICKING	AS160 (TBC1D4) is a known Akt substrate that is phosphorylated downstream of insulin action and that leads to regulated traffic of GLUT4. As GLUT4 vesicle fusion with the plasma membrane is a highly regulated step in GLUT4 traffic, we investigated whether AS160 and 14-3-3 interactions are involved in this process. Fusion was inhibited by a human truncated AS160 variant that encompasses the first N-terminal phosphotyrosine-binding (PTB) domain, by either of the two N-terminal PTB domains, and by a tandem construct of both PTB domains of rat AS160. We also found that in vitro GLUT4 vesicle fusion was strongly inhibited by the 14-3-3-quenching inhibitors R18 and fusicoccin. To investigate the mode of interaction of AS160 and 14-3-3, we examined insulin-dependent increases in the levels of these proteins on GLUT4 vesicles. 14-3-3 gamma was enriched on insulin-stimulated vesicles, and its binding to AS160 on GLUT4 vesicles was inhibited by the AS160 tandem PTB domain construct. These data suggest a model for PTB domain action on GLUT4 vesicle fusion in which these constructs inhibit insulin-stimulated 14-3-3 gamma interaction with AS160 rather than AS160 phosphorylation.	[Koumanov, Francoise; Richardson, Judith D.; Murrow, Beverley A.; Holman, Geoffrey D.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	University of Bath	Holman, GD (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	g.d.holman@bath.ac.uk	Koumanov, Francoise/AAV-7654-2020	Koumanov, Francoise/0000-0002-9029-3390; Holman, Geoffrey/0000-0001-7045-1358	Wellcome Trust; Diabetes UK; MRC [G9225018] Funding Source: UKRI; British Heart Foundation [PG/11/52/28989] Funding Source: researchfish; Medical Research Council [G9225018] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Diabetes UK(Diabetes UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Wellcome Trust and Diabetes UK.	Al-Hasani H, 1998, J BIOL CHEM, V273, P17504, DOI 10.1074/jbc.273.28.17504; Bai L, 2007, CELL METAB, V5, P47, DOI 10.1016/j.cmet.2006.11.013; Bose A, 2004, MOL CELL BIOL, V24, P5447, DOI 10.1128/MCB.24.12.5447-5458.2004; Bruss MD, 2005, DIABETES, V54, P41, DOI 10.2337/diabetes.54.1.41; Chadt A, 2008, NAT GENET, V40, P1354, DOI 10.1038/ng.244; Chen SA, 2008, BIOCHEM J, V409, P449, DOI 10.1042/BJ20071114; Chen SA, 2011, CELL METAB, V13, P68, DOI 10.1016/j.cmet.2010.12.005; Dash S, 2010, DIABETOLOGIA, V53, P1239, DOI 10.1007/s00125-010-1724-x; Dash S, 2009, P NATL ACAD SCI USA, V106, P9350, DOI 10.1073/pnas.0900909106; Eguez L, 2005, CELL METAB, V2, P263, DOI 10.1016/j.cmet.2005.09.005; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Geraghty KM, 2007, BIOCHEM J, V407, P231, DOI 10.1042/BJ20070649; Gonzalez E, 2006, MOL BIOL CELL, V17, P4484, DOI 10.1091/mbc.E06-07-0585; Huang SH, 2007, MOL CELL BIOL, V27, P3456, DOI 10.1128/MCB.01719-06; Jiang L, 2008, J BIOL CHEM, V283, P8508, DOI 10.1074/jbc.M708688200; Kane S, 2002, J BIOL CHEM, V277, P22115, DOI 10.1074/jbc.C200198200; Karlsson HKR, 2005, DIABETES, V54, P1692, DOI 10.2337/diabetes.54.6.1692; Koumanov F, 2005, CELL METAB, V2, P179, DOI 10.1016/j.cmet.2005.08.007; Larance M, 2005, J BIOL CHEM, V280, P37803, DOI 10.1074/jbc.M503897200; Liang SF, 2009, ELECTROPHORESIS, V30, P4152, DOI 10.1002/elps.200900249; Lizunov VA, 2005, J CELL BIOL, V169, P481, DOI 10.1083/jcb.200412069; Meyre D, 2008, HUM MOL GENET, V17, P1798, DOI 10.1093/hmg/ddn070; Miinea CP, 2005, BIOCHEM J, V391, P87, DOI 10.1042/BJ20050887; Moorhead G, 1996, CURR BIOL, V6, P1104, DOI 10.1016/S0960-9822(02)70677-5; Peck GR, 2006, MOL ENDOCRINOL, V20, P2576, DOI 10.1210/me.2005-0476; QUON MJ, 1994, P NATL ACAD SCI USA, V91, P5587, DOI 10.1073/pnas.91.12.5587; Ramm G, 2006, J BIOL CHEM, V281, P29174, DOI 10.1074/jbc.M603274200; Rozen S, 2000, Methods Mol Biol, V132, P365; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Rubio MP, 2004, BIOCHEM J, V379, P395, DOI 10.1042/bj20031797; Sakamoto K, 2008, AM J PHYSIOL-ENDOC M, V295, pE29, DOI 10.1152/ajpendo.90331.2008; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Sano H, 2008, BIOCHEM J, V411, P89, DOI 10.1042/BJ20071318; Sano H, 2007, CELL METAB, V5, P293, DOI 10.1016/j.cmet.2007.03.001; SATOH S, 1993, J BIOL CHEM, V268, P17820; SIMPSON IA, 1983, BIOCHIM BIOPHYS ACTA, V763, P393, DOI 10.1016/0167-4889(83)90101-5; Somwar R, 2001, J BIOL CHEM, V276, P46079, DOI 10.1074/jbc.M109093200; Stenkula KG, 2010, CELL METAB, V12, P250, DOI 10.1016/j.cmet.2010.08.005; Stockli J, 2008, MOL ENDOCRINOL, V22, P2703, DOI 10.1210/me.2008-0111; Stone S, 2006, HUM MOL GENET, V15, P2709, DOI 10.1093/hmg/ddl204; Yip MF, 2008, CELL METAB, V8, P384, DOI 10.1016/j.cmet.2008.09.011; Zeigerer A, 2004, MOL BIOL CELL, V15, P4406, DOI 10.1091/mbc.e04-04-0333	42	26	26	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16574	16582		10.1074/jbc.M111.226092	http://dx.doi.org/10.1074/jbc.M111.226092			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454690	hybrid, Green Published			2022-12-25	WOS:000290301900006
J	Liu, JL; Vitorin, JFE; Weintraub, ST; Gu, SM; Shi, Q; Burt, JM; Jiang, JX				Liu, Jialu; Vitorin, Jose F. Ek; Weintraub, Susan T.; Gu, Sumin; Shi, Qian; Burt, Janis M.; Jiang, Jean X.			Phosphorylation of Connexin 50 by Protein Kinase A Enhances Gap Junction and Hemichannel Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LENS-FIBER CONNEXINS; CARBOXYL-TERMINAL DOMAIN; CYCLIC-AMP; INTERCELLULAR COMMUNICATION; VOLTAGE-DEPENDENCE; MEDIATED PHOSPHORYLATION; CELLULAR-DISTRIBUTION; CHANNELS; CELLS; SELECTIVITY	Phosphorylation of connexins is an important mechanism regulating gap junction channels. However, the role(s) of connexin (Cx) phosphorylation in vivo are largely unknown. Here, we showed by mass spectrometry that Ser-395 in the C terminus of chicken Cx50 was phosphorylated in the lens. Ser-395 is located within a PKA consensus site. Analyses of Cx50 phosphorylation by two-dimensional thin layer chromatography tryptic phosphopeptide profiles suggested that Ser-395 was targeted by PKA in vivo. PKA activation increased both gap junction dye coupling and hemichannel dye uptake in a manner not involving increases in total Cx50 expression or relocation to the cell surface or gap junctional plaques. Single channel recordings indicated PKA enhanced transitions between the closed and similar to 200-pS open state while simultaneously reducing transitions between this open state and a similar to 65-pS subconductance state. The mutation of Ser-395 to alanine significantly attenuated PKA-induced increases in dye coupling and uptake by Cx50. However, channel records indicated that phosphorylation at this site was unnecessary for enhanced transitions between the closed and similar to 200-pS conductance state. Together, these results suggest that Cx50 is phosphorylated in vivo by PKA at Ser-395 and that this event, although unnecessary for PKA-induced alterations in channel conductance, promotes increased dye permeability of Cx50 channels, which plays an important role in metabolic coupling and transport in lens fibers.	[Liu, Jialu; Weintraub, Susan T.; Gu, Sumin; Shi, Qian; Jiang, Jean X.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Vitorin, Jose F. Ek; Burt, Janis M.] Univ Arizona, Dept Physiol, Tucson, AZ 85724 USA	University of Texas System; University of Texas Health San Antonio; University of Arizona	Jiang, JX (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	jiangj@uthscsa.edu	Shi, Qian/C-5962-2013; Ek-Vitorin, Jose F./AAF-8533-2020	Jiang, Jean/0000-0002-2185-5716	National Institutes of Health [EY012085]; Welch Foundation [AQ-1507]; NATIONAL EYE INSTITUTE [R29EY012085, R01EY012085] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant EY012085 (to J. X. J.). This work was also supported by Welch Foundation Grant AQ-1507 (to J. X. J.).	Anumonwo JMB, 2001, CIRC RES, V88, P666, DOI 10.1161/hh0701.088833; ATKINSON MM, 1995, J CELL SCI, V108, P3079; Banks EA, 2009, J CELL SCI, V122, P378, DOI 10.1242/jcs.034124; Bao L, 2004, AM J PHYSIOL-CELL PH, V287, pC1389, DOI 10.1152/ajpcell.00220.2004; Berthoud VM, 1997, EUR J BIOCHEM, V244, P89, DOI 10.1111/j.1432-1033.1997.00089.x; Burghardt RC, 1995, J MEMBRANE BIOL, V148, P243; Cheng HL, 2001, J MEMBRANE BIOL, V181, P21, DOI 10.1007/s0023200100055; Cheng HL, 1999, EUR J BIOCHEM, V263, P276, DOI 10.1046/j.1432-1327.1999.00502.x; Cherian PP, 2005, MOL BIOL CELL, V16, P3100, DOI 10.1091/mbc.E04-10-0912; Cruciani V, 2002, BIOL CELL, V94, P433, DOI 10.1016/S0248-4900(02)00014-X; Daniels GM, 1998, METHOD ENZYMOL, V296, P307; DeRosa AM, 2009, EXP CELL RES, V315, P1063, DOI 10.1016/j.yexcr.2009.01.017; DONALDSON PJ, 1995, AM J PHYSIOL-CELL PH, V269, pC590, DOI 10.1152/ajpcell.1995.269.3.C590; Ebihara L, 1999, BIOPHYS J, V76, P198, DOI 10.1016/S0006-3495(99)77189-4; Ek-Vitorin JF, 2006, CIRC RES, V98, P1498, DOI 10.1161/01.RES.0000227572.45891.2c; ELFOULY MH, 1987, EXP CELL RES, V168, P422, DOI 10.1016/0014-4827(87)90014-0; Gong X, 2007, J MEMBRANE BIOL, V218, P9, DOI 10.1007/s00232-007-9033-0; Goodenough DA, 2003, NAT REV MOL CELL BIO, V4, P285, DOI 10.1038/nrm1072; Heyman NS, 2008, BIOPHYS J, V94, P840, DOI 10.1529/biophysj.107.115634; Heyman NS, 2009, AM J PHYSIOL-HEART C, V297, pH450, DOI 10.1152/ajpheart.00287.2009; HUR KC, 1989, BIOCHIM BIOPHYS ACTA, V1010, P56; Jiang JX, 1998, EUR J BIOCHEM, V255, P37, DOI 10.1046/j.1432-1327.1998.2550037.x; JIANG JX, 1994, MOL BIOL CELL, V5, P363, DOI 10.1091/mbc.5.3.363; Jiang JX, 2001, METH MOL B, V154, P159; Lampe PD, 2004, INT J BIOCHEM CELL B, V36, P1171, DOI 10.1016/S1357-2725(03)00264-4; Mathias RT, 2007, J MEMBRANE BIOL, V216, P1, DOI 10.1007/s00232-007-9019-y; Mese G, 2007, J INVEST DERMATOL, V127, P2516, DOI 10.1038/sj.jid.5700770; Mitropoulou G, 2003, J NEUROSCI RES, V72, P147, DOI 10.1002/jnr.10572; Moreno AP, 2002, CIRC RES, V90, P450, DOI 10.1161/hh0402.105667; MUSIL LS, 1991, J CELL BIOL, V115, P1357, DOI 10.1083/jcb.115.5.1357; Ouyang XS, 2005, MOL BRAIN RES, V135, P1, DOI 10.1016/j.molbrainres.2004.10.045; Paulson AF, 2000, J CELL SCI, V113, P3037; Shah MM, 2002, MOL CELL BIOCHEM, V238, P57, DOI 10.1023/A:1019902920693; Shearer D, 2008, INVEST OPHTH VIS SCI, V49, P1553, DOI 10.1167/iovs.07-1193; Shibayama J, 2006, BIOPHYS J, V91, P4054, DOI 10.1529/biophysj.106.085787; Solan JL, 2005, BBA-BIOMEMBRANES, V1711, P154, DOI 10.1016/j.bbamem.2004.09.013; Solan JL, 2009, BIOCHEM J, V419, P261, DOI 10.1042/BJ20082319; Srinivas M, 1999, J PHYSIOL-LONDON, V517, P673, DOI 10.1111/j.1469-7793.1999.0673s.x; Stergiopoulos K, 1999, CIRC RES, V84, P1144, DOI 10.1161/01.RES.84.10.1144; TenBroek EM, 2001, J CELL BIOL, V155, P1307, DOI 10.1083/jcb.200102017; Tong JJ, 2006, BIOPHYS J, V91, P2142, DOI 10.1529/biophysj.106.082859; Urschel S, 2006, J BIOL CHEM, V281, P33163, DOI 10.1074/jbc.M606396200; Wang Z, 2009, EXP EYE RES, V89, P898, DOI 10.1016/j.exer.2009.07.015; White TW, 2007, INVEST OPHTH VIS SCI, V48, P5630, DOI 10.1167/iovs.06-1540; Xu X, 2002, J MEMBRANE BIOL, V186, P101, DOI 10.1007/s00232-001-0139-5; Yin XY, 2000, J BIOL CHEM, V275, P6850, DOI 10.1074/jbc.275.10.6850; Yin XY, 2001, J BIOL CHEM, V276, P34567, DOI 10.1074/jbc.M106073200	47	34	34	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16914	16928		10.1074/jbc.M111.218735	http://dx.doi.org/10.1074/jbc.M111.218735			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454606	Green Published, hybrid			2022-12-25	WOS:000290301900041
J	Mosialou, I; Krasagakis, K; Kardassis, D				Mosialou, Ioanna; Krasagakis, Konstantin; Kardassis, Dimitris			Opposite Regulation of the Human Apolipoprotein M Gene by Hepatocyte Nuclear Factor 1 and Jun Transcription Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; PROTEIN-KINASE-C; CORONARY-HEART-DISEASE; ACUTE-PHASE RESPONSE; CHOLESTEROL EFFLUX; HDL METABOLISM; THERAPEUTIC TARGETS; LIPID OXIDATION; SIGNAL PEPTIDE; II GENE	HDL is a negative risk factor for atherosclerosis because of its multiple atheroprotective functions. Inflammation converts HDL particles from anti-atherogenic to pro-atherogenic, and this transformation is associated with changes in HDL structure and composition. Apolipoprotein M (apoM) has been recently shown to play a role in the maturation of HDL in plasma and to protect from atherosclerosis. ApoM gene is expressed primarily in the liver and kidney and is down-regulated by pro-inflammatory signals. We now show that the human apoM promoter harbors a dual specificity regulatory element in the proximal region that binds hepatocyte nuclear factor 1 (HNF-1) and members of the AP-1 family of pro-inflammatory transcription factors (c-Jun and JunB). Overexpression of c-Jun or JunB repressed both the basal and the HNF-1-mediated transactivation of the human apoM promoter. Treatment of HepG2 cells with potent inflammation-inducing phorbol esters or overexpression of PKC alpha was associated with a marked inhibition of apoM gene expression in a c-Jun/JunB-dependent manner. We provide evidence for a novel mechanism of inflammation-induced transcriptional repression that is based on the competition between HNF-1 and Jun proteins for binding to the same regulatory region. A similar mechanism accounts for the down-regulation of the liver-specific apolipoprotein A-II gene by Jun factors. Our studies provide novel insights on the mechanisms that control the expression of liver-specific apolipoprotein genes during inflammation and could affect the maturation and the functionality of HDL particles.	[Mosialou, Ioanna; Kardassis, Dimitris] Univ Crete, Sch Med, Dept Basic Sci, Iraklion 71003, Greece; [Krasagakis, Konstantin] Univ Crete, Sch Med, Dept Internal Med, Iraklion 71003, Greece; [Kardassis, Dimitris] Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion 71003, Greece	University of Crete; University of Crete; Foundation for Research & Technology - Hellas (FORTH)	Kardassis, D (corresponding author), Univ Crete, Sch Med, Dept Basic Sci, Iraklion 71003, Greece.	kardasis@imbb.forth.gr			Greek Ministry of Development; General Secretariat for Research and Technology [PENED03-780]; COST [BM0904]	Greek Ministry of Development; General Secretariat for Research and Technology(Greek Ministry of Development-GSRT); COST(European Cooperation in Science and Technology (COST))	This work was supported by Greek Ministry of Development, General Secretariat for Research and Technology Grant PENED03-780 and COST Action Grant BM0904 (to D. K.).	ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Ansell BJ, 2003, CIRCULATION, V108, P2751, DOI 10.1161/01.CIR.0000103624.14436.4B; Axler O, 2008, FEBS LETT, V582, P826, DOI 10.1016/j.febslet.2008.02.007; Barter PJ, 2004, CIRC RES, V95, P764, DOI 10.1161/01.RES.0000146094.59640.13; Barter PJ, 1996, ATHEROSCLEROSIS, V121, P1, DOI 10.1016/0021-9150(95)05675-0; BENGAL E, 1992, CELL, V68, P507, DOI 10.1016/0092-8674(92)90187-H; CABANA VG, 1989, J LIPID RES, V30, P39; CARDOT P, 1993, BIOCHEMISTRY-US, V32, P9080, DOI 10.1021/bi00086a013; CARDOT P, 1991, J BIOL CHEM, V266, P24460; CASTELLI WP, 1986, JAMA-J AM MED ASSOC, V256, P2835, DOI 10.1001/jama.256.20.2835; Chinenov Y, 2001, ONCOGENE, V20, P2438, DOI 10.1038/sj.onc.1204385; Christoffersen C, 2008, J BIOL CHEM, V283, P18765, DOI 10.1074/jbc.M800695200; Christoffersen C, 2008, J BIOL CHEM, V283, P1839, DOI 10.1074/jbc.M704576200; Christoffersen C, 2006, J LIPID RES, V47, P1833, DOI 10.1194/jlr.M600055-JLR200; Churchill E, 2008, ANNU REV PHARMACOL, V48, P569, DOI 10.1146/annurev.pharmtox.48.121806.154902; Dahlback B, 2009, CELL MOL LIFE SCI, V66, P559, DOI 10.1007/s00018-009-8764-8; Davidson MH, 2007, AM J CARDIOL, V100, p32N, DOI 10.1016/j.amjcard.2007.08.011; Deakin JE, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-281; DISTEL RJ, 1987, CELL, V49, P835, DOI 10.1016/0092-8674(87)90621-0; Feingold KR, 2008, ATHEROSCLEROSIS, V199, P19, DOI 10.1016/j.atherosclerosis.2007.10.007; Hadzopoulou-Cladaras M, 1998, BIOCHEMISTRY-US, V37, P14078, DOI 10.1021/bi9804176; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; HOWCROFT TK, 1993, EMBO J, V12, P3163, DOI 10.1002/j.1460-2075.1993.tb05985.x; Hu YW, 2010, BBA-MOL CELL BIOL L, V1801, P100, DOI 10.1016/j.bbalip.2009.10.013; Khovidhunkit W, 2004, J LIPID RES, V45, P1169, DOI 10.1194/jlr.R300019-JLR200; Kontush A, 2006, PHARMACOL REV, V58, P342, DOI 10.1124/pr.58.3.1; Koutsodontis G, 2004, ONCOGENE, V23, P9190, DOI 10.1038/sj.onc.1208141; Lewis GF, 2005, CIRC RES, V96, P1221, DOI 10.1161/01.RES.0000170946.56981.5c; LI L, 1992, GENE DEV, V6, P676, DOI 10.1101/gad.6.4.676; Li Q, 1999, J BIOL CHEM, V274, P3764, DOI 10.1074/jbc.274.6.3764; LI Q, 1994, J BIOL CHEM, V269, P17508; Lopez-Bergami P, 2005, MOL CELL, V19, P309, DOI 10.1016/j.molcel.2005.06.025; LUCIBELLO FC, 1989, CELL, V59, P999, DOI 10.1016/0092-8674(89)90756-3; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Memon RA, 2001, J BIOL CHEM, V276, P30118, DOI 10.1074/jbc.M102516200; MILLER GJ, 1975, LANCET, V1, P16; Mineo C, 2006, CIRC RES, V98, P1352, DOI 10.1161/01.RES.0000225982.01988.93; Mosialou I, 2010, J BIOL CHEM, V285, P30719, DOI 10.1074/jbc.M110.131771; Nielsen LB, 2009, TRENDS ENDOCRIN MET, V20, P66, DOI 10.1016/j.tem.2008.11.003; Nikolaidou-Neokosmidou V, 2006, BIOCHEM J, V398, P439, DOI 10.1042/BJ20060169; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; PESTELL RG, 1994, J BIOL CHEM, V269, P31090; Richter S, 2003, DIABETES, V52, P2989, DOI 10.2337/diabetes.52.12.2989; SASSONECORSI P, 1988, NATURE, V334, P314, DOI 10.1038/334314a0; SCHULE R, 1990, CELL, V61, P497, DOI 10.1016/0092-8674(90)90531-I; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Singh IM, 2007, JAMA-J AM MED ASSOC, V298, P786, DOI 10.1001/jama.298.7.786; Tall AR, 2008, J INTERN MED, V263, P256, DOI 10.1111/j.1365-2796.2007.01898.x; Tall AR, 2008, CELL METAB, V7, P365, DOI 10.1016/j.cmet.2008.03.001; Vasilaki E, 2010, FASEB J, V24, P891, DOI 10.1096/fj.09-134742; Venteclef N, 2008, J BIOL CHEM, V283, P3694, DOI 10.1074/jbc.M706382200; von Eckardstein A, 2005, CURR OPIN CLIN NUTR, V8, P147, DOI 10.1097/00075197-200503000-00007; Watts GF, 2008, CURR OPIN LIPIDOL, V19, P395, DOI 10.1097/MOL.0b013e328306596d; Wolfrum C, 2005, NAT MED, V11, P418, DOI 10.1038/nm1211; Wolfrum C, 2008, J BIOL CHEM, V283, P16940, DOI 10.1074/jbc.M801930200; Xu N, 1999, J BIOL CHEM, V274, P31286, DOI 10.1074/jbc.274.44.31286; Zannis VI, 2006, J MOL MED, V84, P276, DOI 10.1007/s00109-005-0030-4; ZANNIS VI, 1993, ADV HUM GENET, V21, P145; Zannis VI., 2004, MOL MECH ATHEROSCLER, V8, P111; Zhang XY, 2003, ACTA HISTOCHEM, V105, P67, DOI 10.1078/0065-1281-00687	61	14	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17259	17269		10.1074/jbc.M110.200659	http://dx.doi.org/10.1074/jbc.M110.200659			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454713	Green Published, hybrid			2022-12-25	WOS:000290301900074
J	Nishikori, S; Esaki, M; Yamanaka, K; Sugimoto, S; Ogura, T				Nishikori, Shingo; Esaki, Masatoshi; Yamanaka, Kunitoshi; Sugimoto, Shinya; Ogura, Teru			Positive Cooperativity of the p97 AAA ATPase Is Critical for Essential Functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; CAENORHABDITIS-ELEGANS; MEMBRANE-FUSION; PROTEIN VCP; ER; HYDROLYSIS; P97/VCP; BINDING; CYCLE	p97 is composed of two conserved AAA (ATPases associated with diverse cellular activities) domains, which form a tandem hexameric ring. We characterized the ATP hydrolysis mechanism of CDC-48.1, a p97 homolog of Caenorhabditis elegans. The ATPase activity of the N-terminal AAA domain was very low at physiological temperature, whereas the C-terminal AAA domain showed high ATPase activity in a coordinated fashion with positive cooperativity. The cooperativity and coordination are generated by different mechanisms because a noncooperative mutant still showed the coordination. Interestingly, the growth speed of yeast cells strongly related to the positive cooperativity rather than the ATPase activity itself, suggesting that the positive cooperativity is critical for the essential functions of p97.	[Nishikori, Shingo; Esaki, Masatoshi; Yamanaka, Kunitoshi; Sugimoto, Shinya; Ogura, Teru] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Mol Cell Biol, Kumamoto 8600811, Japan	Kumamoto University	Ogura, T (corresponding author), Kumamoto Univ, Inst Mol Embryol & Genet, Dept Mol Cell Biol, 2-2-1 Honjo, Kumamoto 8600811, Japan.	ogura@gpo.kumamoto-u.ac.jp	Esaki, Masatoshi/L-6591-2017; Esaki, Masatoshi/ABS-6645-2022	Sugimoto, Shinya/0000-0002-3114-8513; Ogura, Teru/0000-0003-3784-0970	Japan Society for the Promotion of Science; Ministry of Education, Culture, Science, Sports and Technology of Japan; Japan Science and Technology Agency; Grants-in-Aid for Scientific Research [23590521] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Science, Sports and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid from the Japan Society for the Promotion of Science, the Ministry of Education, Culture, Science, Sports and Technology of Japan, and the Core Research for Evolutional Science and Technology program by the Japan Science and Technology Agency.	Ammelburg M, 2006, J STRUCT BIOL, V156, P2, DOI 10.1016/j.jsb.2006.05.002; Augustin S, 2009, MOL CELL, V35, P574, DOI 10.1016/j.molcel.2009.07.018; Braun S, 2002, EMBO J, V21, P615, DOI 10.1093/emboj/21.4.615; Briggs LC, 2008, J BIOL CHEM, V283, P13745, DOI 10.1074/jbc.M709632200; CHAN KM, 1986, ANAL BIOCHEM, V157, P375, DOI 10.1016/0003-2697(86)90640-8; Davies JM, 2008, STRUCTURE, V16, P715, DOI 10.1016/j.str.2008.02.010; Davies JM, 2005, STRUCTURE, V13, P183, DOI 10.1016/j.str.2004.11.014; DeLaBarre B, 2005, J MOL BIOL, V347, P437, DOI 10.1016/j.jmb.2005.01.060; DeLaBarre B, 2006, MOL CELL, V22, P451, DOI 10.1016/j.molcel.2006.03.036; Esaki M, 2010, BIOCHEM CELL BIOL, V88, P109, DOI [10.1139/o09-116, 10.1139/O09-116]; Hetzer M, 2001, NAT CELL BIOL, V3, P1086, DOI 10.1038/ncb1201-1086; HUANG TG, 1994, J BIOL CHEM, V269, P16502; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Kobayashi T, 2002, J BIOL CHEM, V277, P47358, DOI 10.1074/jbc.M207783200; LATTERICH M, 1995, CELL, V82, P885, DOI 10.1016/0092-8674(95)90268-6; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P139, DOI 10.1038/nsmb.1380; Nishikori S, 2008, GENES CELLS, V13, P827, DOI 10.1111/j.1365-2443.2008.01214.x; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Patel SK, 1998, CELL, V92, P611, DOI 10.1016/S0092-8674(00)81129-0; Pye VE, 2006, J STRUCT BIOL, V156, P12, DOI 10.1016/j.jsb.2006.03.003; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Roy L, 2000, MOL BIOL CELL, V11, P2529, DOI 10.1091/mbc.11.8.2529; Sasagawa Y, 2007, BIOCHEM BIOPH RES CO, V358, P920, DOI 10.1016/j.bbrc.2007.05.022; Song CC, 2003, J BIOL CHEM, V278, P3648, DOI 10.1074/jbc.M208422200; Sugimoto S, 2010, J BIOL CHEM, V285, P6648, DOI 10.1074/jbc.M109.080739; Wang Q, 2004, J STRUCT BIOL, V146, P44, DOI 10.1016/j.jsb.2003.11.014; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509; Zalk R, 2003, BIOCHEM J, V374, P473, DOI 10.1042/BJ20030219	30	38	40	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.201400	http://dx.doi.org/10.1074/jbc.M110.201400			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454554	hybrid, Green Published			2022-12-25	WOS:000290022800022
J	Sharma, P; Dube, D; Singh, A; Mishra, B; Singh, N; Sinha, M; Dey, S; Kaur, P; Mitra, DK; Sharma, S; Singh, TP				Sharma, Pradeep; Dube, Divya; Singh, Amar; Mishra, Biswajit; Singh, Nagendra; Sinha, Mau; Dey, Sharmistha; Kaur, Punit; Mitra, Dipendra K.; Sharma, Sujata; Singh, Tej P.			Structural Basis of Recognition of Pathogen-associated Molecular Patterns and Inhibition of Proinflammatory Cytokines by Camel Peptidoglycan Recognition Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; LIPOTEICHOIC ACID; INFECTION; IMMUNITY; SEPSIS; LPS	Peptidoglycan recognition proteins (PGRPs) are involved in the recognition of pathogen-associated molecular patterns. The well known pathogen-associated molecular patterns include LPS from Gram-negative bacteria and lipoteichoic acid (LTA) from Gram-positive bacteria. In this work, the crystal structures of two complexes of the short form of camel PGRP (CPGRP-S) with LPS and LTA determined at 1.7- and 2.1-angstrom resolutions, respectively, are reported. Both compounds were held firmly inside the complex formed with four CPGRP-S molecules designated A, B, C, and D. The binding cleft is located at the interface of molecules C and D, which is extendable to the interface of molecules A and C. The interface of molecules A and B is tightly packed, whereas that of molecules B and D forms a wide channel. The hydrophilic moieties of these compounds occupy a common region, whereas hydrophobic chains interact with distinct regions in the binding site. The binding studies showed that CPGRP-S binds to LPS and LTA with affinities of 1.6 x 10(-9) and 2.4 x 10(-8) M, respectively. The flow cytometric studies showed that both LPS- and LTA-induced expression of the pro-inflammatory cytokines TNF-alpha and IL-6 was inhibited by CPGRP-S. The results of animal studies using mouse models indicated that both LPS- and LTA-induced mortality rates decreased drastically when CPGRP-S was administered. The recognition of both LPS and LTA, their high binding affinities for CPGRP-S, the significant decrease in the production of LPS- and LTA-induced TNF-alpha and IL-6, and the drastic reduction in the mortality rates in mice by CPGRP-S indicate its useful properties as an antibiotic agent.	[Sharma, Pradeep; Dube, Divya; Mishra, Biswajit; Singh, Nagendra; Sinha, Mau; Dey, Sharmistha; Kaur, Punit; Sharma, Sujata; Singh, Tej P.] All India Inst Med Sci, Dept Biophys, New Delhi 110029, India; [Singh, Amar; Mitra, Dipendra K.] All India Inst Med Sci, Dept Transplantat Immunol & Immunogenet, New Delhi 110029, India	All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi	Singh, TP (corresponding author), All India Inst Med Sci, Dept Biophys, New Delhi 110029, India.	tpsingh.aiims@gmail.com		SINHA, MAU/0000-0003-3011-9160; Singh, Nagendra/0000-0003-0419-0684	Department of Science and Technology, Ministry of Science and Technology, Government of India (New Delhi); Council of Scientific and Industrial Research (CSIR; New Delhi); International Center for Diffraction Data (ICDD); Department of Biotechnology; Department of Biotechnology, Ministry of Science and Technology, Government of India (New Delhi)	Department of Science and Technology, Ministry of Science and Technology, Government of India (New Delhi)(Department of Science & Technology (India)); Council of Scientific and Industrial Research (CSIR; New Delhi)(Council of Scientific & Industrial Research (CSIR) - India); International Center for Diffraction Data (ICDD); Department of Biotechnology; Department of Biotechnology, Ministry of Science and Technology, Government of India (New Delhi)(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India)	This work was supported by the Departments of Science and Technology and Biotechnology, Ministry of Science and Technology, Government of India (New Delhi).; Recipient of fellowships from the Council of Scientific and Industrial Research (CSIR; New Delhi) and the International Center for Diffraction Data (ICDD).; Supported by a Distinguished Biotechnology Research Professorship grant from the Department of Biotechnology.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Chang CI, 2006, SCIENCE, V311, P1761, DOI 10.1126/science.1123056; Charland M. B., 1995, SIGMAPLOT SCI VERS 8; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Ginsburg I, 2002, LANCET INFECT DIS, V2, P171, DOI 10.1016/S1473-3099(02)00226-8; Guan RJ, 2006, PROTEIN SCI, V15, P1199, DOI 10.1110/ps.062077606; Guan RJ, 2005, J MOL BIOL, V347, P683, DOI 10.1016/j.jmb.2005.01.070; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Hu YJ, 2010, PROTEIN J, V29, P234, DOI 10.1007/s10930-010-9244-6; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kappeler SR, 2004, J DAIRY SCI, V87, P2660, DOI 10.3168/jds.S0022-0302(04)73392-5; Kim MS, 2003, NAT IMMUNOL, V4, P787, DOI 10.1038/ni952; KINI RM, 1995, BIOCHEM BIOPH RES CO, V212, P1115, DOI 10.1006/bbrc.1995.2084; Kitaigorodskii A. I., 1955, ORGANIC CHEM CRYSTAL; Komai-Koma M, 2009, EUR J IMMUNOL, V39, P1564, DOI 10.1002/eji.200838866; Lim JH, 2006, J BIOL CHEM, V281, P8286, DOI 10.1074/jbc.M513030200; Lu XF, 2006, J BIOL CHEM, V281, P5895, DOI 10.1074/jbc.M511631200; Medzhitov R, 1998, CURR OPIN IMMUNOL, V10, P12, DOI 10.1016/S0952-7915(98)80024-1; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pauling L., 1960, NATURE CHEM BOND; RAETZ CRH, 1990, ANNU REV BIOCHEM, V59, P129, DOI 10.1146/annurev.bi.59.070190.001021; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Reiser JB, 2004, J MOL BIOL, V340, P909, DOI 10.1016/j.jmb.2004.04.077; Sarrias MR, 2007, P NATL ACAD SCI USA, V104, P11724, DOI 10.1073/pnas.0702815104; Sharma P, 2008, J MOL BIOL, V378, P923, DOI 10.1016/j.jmb.2008.03.018; Wang JE, 2003, SHOCK, V20, P402, DOI 10.1097/01.shk.0000092268.01859.0d; Zhang YO, 2005, BBA-PROTEINS PROTEOM, V1752, P34, DOI 10.1016/j.bbapap.2005.07.001	31	31	35	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M111.228163	http://dx.doi.org/10.1074/jbc.M111.228163			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454594	hybrid, Green Published			2022-12-25	WOS:000290022800060
J	Franck, C; Maskarinec, SA; Tirrell, DA; Ravichandran, G				Franck, Christian; Maskarinec, Stacey A.; Tirrell, David A.; Ravichandran, Guruswami			Three-Dimensional Traction Force Microscopy: A New Tool for Quantifying Cell-Matrix Interactions	PLOS ONE			English	Article							DIGITAL VOLUME CORRELATION; FOCAL ADHESIONS; LOCOMOTING CELLS; SUBSTRATE; ELASTICITY; MIGRATION; MOVEMENT; STRESSES; PHYSICS	The interactions between biochemical processes and mechanical signaling play important roles during various cellular processes such as wound healing, embryogenesis, metastasis, and cell migration. While traditional traction force measurements have provided quantitative information about cell matrix interactions in two dimensions, recent studies have shown significant differences in the behavior and morphology of cells when placed in three-dimensional environments. Hence new quantitative experimental techniques are needed to accurately determine cell traction forces in three dimensions. Recently, two approaches both based on laser scanning confocal microscopy have emerged to address this need. This study highlights the details, implementation and advantages of such a three-dimensional imaging methodology with the capability to compute cellular traction forces dynamically during cell migration and locomotion. An application of this newly developed three-dimensional traction force microscopy (3D TFM) technique to single cell migration studies of 3T3 fibroblasts is presented to show that this methodology offers a new quantitative vantage point to investigate the three-dimensional nature of cell-ECM interactions.	[Franck, Christian] Brown Univ, Sch Engn, Providence, RI 02912 USA; [Maskarinec, Stacey A.; Tirrell, David A.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Ravichandran, Guruswami] CALTECH, Div Engn & Appl Sci, Pasadena, CA 91125 USA	Brown University; California Institute of Technology; California Institute of Technology	Franck, C (corresponding author), Brown Univ, Sch Engn, Providence, RI 02912 USA.	franck@brown.edu	Franck, Christian/C-6077-2012	Franck, Christian/0000-0002-2347-620X; Maskarinec, Stacey/0000-0002-1716-8374	National Science Foundation (DMR) through the Center for Science and Engineering of Materials (CSEM) at the California Institute of Technology [0520565]; National Institutes of Health	National Science Foundation (DMR) through the Center for Science and Engineering of Materials (CSEM) at the California Institute of Technology(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Science Foundation (DMR \# 0520565) through the Center for Science and Engineering of Materials (CSEM) at the California Institute of Technology. S. A. M. had additional support from a predoctoral National Research Service Award fellowship from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananthakrishnan R, 2007, INT J BIOL SCI, V3, P303; Bay BK, 2008, J STRAIN ANAL ENG, V43, P745, DOI 10.1243/03093247JSA436; Bay BK, 1999, EXP MECH, V39, P217, DOI 10.1007/BF02323555; Butler JP, 2002, AM J PHYSIOL-CELL PH, V282, pC595, DOI 10.1152/ajpcell.00270.2001; Buxboim A, 2010, J CELL SCI, V123, P297, DOI 10.1242/jcs.041186; CHEN DJ, 1993, APPL OPTICS, V32, P1839, DOI 10.1364/AO.32.001839; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; del Alamo JC, 2007, P NATL ACAD SCI USA, V104, P13343, DOI 10.1073/pnas.0705815104; Dembo M, 1996, BIOPHYS J, V70, P2008, DOI 10.1016/S0006-3495(96)79767-9; Dembo M, 1999, BIOPHYS J, V76, P2307, DOI 10.1016/S0006-3495(99)77386-8; di Scalea FL, 1998, EXP MECH, V38, P55, DOI 10.1007/BF02321268; Even-Ram S, 2005, CURR OPIN CELL BIOL, V17, P524, DOI 10.1016/j.ceb.2005.08.015; Franck C, 2007, EXP MECH, V47, P427, DOI 10.1007/s11340-007-9037-9; FRANCK C, 2008, THESIS CALTECH; Fung YC., 1993, 1 COURSE CONTINUUM M, V3rd ed.; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Gjorevski N, 2010, INTEGR BIOL-UK, V2, P424, DOI 10.1039/c0ib00040j; HARRIS AK, 1980, SCIENCE, V208, P177, DOI 10.1126/science.6987736; Hur SS, 2009, CELL MOL BIOENG, V2, P425, DOI 10.1007/s12195-009-0082-6; Ingber DE, 2008, SEMIN CANCER BIOL, V18, P356, DOI 10.1016/j.semcancer.2008.03.016; Landau LD, 1986, THEORY ELASTICITY, DOI 10.1016/C2009-0-25521-8; LEE J, 1994, J CELL BIOL, V127, P1957, DOI 10.1083/jcb.127.6.1957; Legant WR, 2010, NAT METHODS, V7, P969, DOI 10.1038/NMETH.1531; Levental I, 2007, SOFT MATTER, V3, P299, DOI 10.1039/b610522j; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Maloney JM, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.041923; Maskarinec SA, 2009, P NATL ACAD SCI USA, V106, P22108, DOI 10.1073/pnas.0904565106; Merkel R, 2007, BIOPHYS J, V93, P3314, DOI 10.1529/biophysj.107.111328; OLIVER T, 1995, CELL MOTIL CYTOSKEL, V31, P225, DOI 10.1002/cm.970310306; Paszek MJ, 2004, J MAMMARY GLAND BIOL, V9, P325, DOI 10.1007/s10911-004-1404-x; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Reinhart-King CA, 2003, LANGMUIR, V19, P1573, DOI 10.1021/la026142j; ROEDER B, 2004, T ASME, V126, P669; Sabass B, 2008, BIOPHYS J, V94, P207, DOI 10.1529/biophysj.107.113670; Safran SA, 2005, PHYSICA A, V352, P171, DOI 10.1016/j.physa.2004.12.035; Schwarz US, 2003, MAT SCI ENG C-BIO S, V23, P387, DOI 10.1016/S0928-4931(02)00309-0; Schwarz US, 2002, BIOPHYS J, V83, P1380, DOI 10.1016/S0006-3495(02)73909-X; Takita K, 2003, IEICE T FUND ELECTR, VE86A, P1925; Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100; Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361; Wang JHC, 2007, BIOMECH MODEL MECHAN, V6, P361, DOI 10.1007/s10237-006-0068-4; WARD M, 1994, BIOPHYS J, V6, P2522; WARD MD, 1993, BIOPHYS J, V64, P936, DOI 10.1016/S0006-3495(93)81456-5; YANG JT, 1995, DEVELOPMENT, V121, P549; Zaman MH, 2005, BIOPHYS J, V89, P1389, DOI 10.1529/biophysj.105.060723	46	202	206	3	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e17833	10.1371/journal.pone.0017833	http://dx.doi.org/10.1371/journal.pone.0017833			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21468318	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000289054600018
J	Amsalem, E; Hefetz, A				Amsalem, Etya; Hefetz, Abraham			The Effect of Group Size on the Interplay between Dominance and Reproduction in Bombus terrestris	PLOS ONE			English	Article							DIVISION-OF-LABOR; WORKER REPRODUCTION; OVARIAN DEVELOPMENT; JUVENILE-HORMONE; HIERARCHY LENGTH; COLONY SIZE; CONFLICT; BEHAVIOR; HYMENOPTERA; ASSOCIATIONS	Social insects provide good model systems for testing trade-offs in decision-making because of their marked reproductive skew and the dilemma workers face when to reproduce. Attaining reproductive skew requires energy investment in aggression or fertility signaling, creating a trade-off between reproduction and dominance. This may be density-dependent because the cost of achieving dominance may be higher in larger groups. We investigated the effect of group-size in B. terrestris queenless workers on two major reproduction-dominance correlates: between-worker aggression, and pheromone production, aiming at mimicking decision-making during the transition of worker behavior from cooperation and sterility to aggressive reproductive competition in whole colonies. Despite the competition, reproductive division of labor in colonies can be maintained even during this phase through the production of a sterility signal by sterile workers that has an appeasement effect on dominant nestmates. Worker-worker aggression, ovary activation, and production of sterility-appeasement signals may therefore constitute components of a trade-off affecting worker reproduction decisions. By constructing queenless groups of different size and measuring how this affected the parameters above, we found that in all groups aggression was not evenly distributed with the alpha-worker performing most of the aggressive acts. Moreover, aggression by the alpha-worker increased proportionally with group-size. However, while in small groups the alpha-worker monopolized reproduction, in larger groups several workers shared reproduction, creating two worker groups: reproductives and helpers. It appears that despite the increase of aggression, this was evidently not sufficient for the alpha-worker to monopolize reproduction. If we compare the alpha-worker to the queen in full-sized colonies it can be hypothesized that worker reproduction in B. terrestris colonies starts due to a gradual increase in the worker population and the queen's inability to physically inhibit worker oviposition. This may shift the trade-off between cost and benefit of worker reproduction and trigger the competition phase.	[Amsalem, Etya; Hefetz, Abraham] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Zool, Ramat Aviv, Israel	Tel Aviv University	Amsalem, E (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Zool, Ramat Aviv, Israel.	amsaleme@post.tau.ac.il	Hefetz, Abraham/I-3853-2015		Israel Science Foundation (ISF) [535/08]	Israel Science Foundation (ISF)(Israel Science Foundation)	The work was supported by a grant from The Israel Science Foundation founded by the Israel Academy of Sciences (ISF grant no. 535/08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaux C, 2004, INSECT SOC, V51, P287, DOI 10.1007/s00040-004-0741-5; Alaux C, 2005, BEHAV ECOL SOCIOBIOL, V59, P270, DOI 10.1007/s00265-005-0035-6; Alaux C, 2006, BEHAV ECOL SOCIOBIOL, V60, P439, DOI 10.1007/s00265-006-0184-2; Amsalem E, 2010, BEHAV ECOL SOCIOBIOL, V64, P1685, DOI 10.1007/s00265-010-0982-4; Amsalem E, 2009, P R SOC B, V276, P1295, DOI 10.1098/rspb.2008.1688; Bloch G, 1999, BEHAV ECOL SOCIOBIOL, V45, P125, DOI 10.1007/s002650050546; Bloch G, 1996, PHYSIOL ENTOMOL, V21, P257, DOI 10.1111/j.1365-3032.1996.tb00863.x; Bloch G, 1999, P ROY SOC B-BIOL SCI, V266, P2465, DOI 10.1098/rspb.1999.0947; Bloch G, 2000, J COMP PHYSIOL A, V186, P261, DOI 10.1007/s003590050426; Bloch G, 2000, J INSECT PHYSIOL, V46, P47, DOI 10.1016/S0022-1910(99)00101-8; Bortolotti L, 2001, ENTOMOL EXP APPL, V101, P143, DOI 10.1023/A:1019234709744; Bourke AFG, 1999, J EVOLUTION BIOL, V12, P245, DOI 10.1046/j.1420-9101.1999.00028.x; Bourke AFG, 2001, P ROY SOC B-BIOL SCI, V268, P347, DOI 10.1098/rspb.2000.1381; BULMER MG, 1983, AM NAT, V121, P540, DOI 10.1086/284081; Cant MA, 2000, AM NAT, V155, P406, DOI 10.1086/303328; Cant MA, 2006, AM NAT, V167, P837, DOI 10.1086/503445; Cant MA, 2006, BEHAV ECOL, V17, P560, DOI 10.1093/beheco/arj065; Cnaani J, 2002, INSECT SOC, V49, P164, DOI 10.1007/s00040-002-8297-8; Cnaani J, 2007, ENTOMOL GEN, V29, P305; Cumber R. A., 1949, Transactions of the Royal Entomological Society of London, V100, P1; DUCHATEAU MJ, 1989, J ETHOL, V7, P141, DOI 10.1007/BF02350036; DUCHATEAU MJ, 1989, ENTOMOL EXP APPL, V51, P199, DOI 10.1007/BF00347883; Duchateau MJ, 2004, BEHAV ECOL, V15, P71, DOI 10.1093/beheco/arg087; DUCHATEAU MJ, 1988, BEHAVIOUR, V107, P186, DOI 10.1163/156853988X00340; Fanelli D, 2008, ANIM BEHAV, V75, P879, DOI 10.1016/j.anbehav.2007.07.009; Field J, 1998, AM NAT, V151, P545, DOI 10.1086/286140; FREE J.B, 1958, BEHAVIOUR, V12, P233, DOI 10.1163/156853957X00128; Geva S, 2005, J INSECT PHYSIOL, V51, P811, DOI 10.1016/j.jinsphys.2005.03.009; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Heinze J, 2008, NATURWISSENSCHAFTEN, V95, P757, DOI 10.1007/s00114-008-0375-y; Hsu YY, 2006, BIOL REV, V81, P33, DOI 10.1017/S146479310500686X; MICHENER CD, 1974, SOCIAL BEHAV BEES; Molet M, 2005, INSECT SOC, V52, P247, DOI 10.1007/s00040-005-0801-5; Monnin T, 2003, BEHAV ECOL SOCIOBIOL, V54, P71, DOI 10.1007/s00265-003-0600-9; Monnin T, 1999, BEHAV ECOL SOCIOBIOL, V46, P413, DOI 10.1007/s002650050637; OWEN RE, 1982, BEHAV ECOL SOCIOBIOL, V11, P91, DOI 10.1007/BF00300097; Ratnieks FLW, 2006, ANNU REV ENTOMOL, V51, P581, DOI 10.1146/annurev.ento.51.110104.151003; Reeve HK, 2001, ANNU REV ENTOMOL, V46, P347, DOI 10.1146/annurev.ento.46.1.347; Reeve HK, 2000, AM NAT, V155, P365, DOI 10.1086/303322; ROSELER PF, 1981, EXPERIENTIA, V37, P348, DOI 10.1007/BF01959856; Seppa P, 2002, BEHAV ECOL, V13, P531, DOI 10.1093/beheco/13.4.531; Stearns S.C., 1992, pi; VANDERBLOM J, 1986, BEHAVIOUR, V97, P37, DOI 10.1163/156853986X00306; VANDOORN A, 1989, PHYSIOL ENTOMOL, V14, P211, DOI 10.1111/j.1365-3032.1989.tb00954.x; VANDOORN A, 1987, NETH J ZOOL, V37, P255, DOI 10.1163/002829687X00080; VANDOORN A, 1986, INSECT SOC, V33, P3, DOI 10.1007/BF02224031; VANHONK CGJ, 1981, BEHAV ECOL SOCIOBIOL, V9, P9, DOI 10.1007/BF00299847; [No title captured]	48	44	44	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e18238	10.1371/journal.pone.0018238	http://dx.doi.org/10.1371/journal.pone.0018238			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464893	Green Submitted, Green Published, gold			2022-12-25	WOS:000289053800031
J	Gunapala, KM; Gallardo, CM; Hsu, CT; Steele, AD				Gunapala, Keith M.; Gallardo, Christian M.; Hsu, Cynthia T.; Steele, Andrew D.			Single Gene Deletions of Orexin, Leptin, Neuropeptide Y, and Ghrelin Do Not Appreciably Alter Food Anticipatory Activity in Mice	PLOS ONE			English	Article							ENTRAINED CIRCADIAN-RHYTHMS; BODY-WEIGHT; ZUCKER RAT; DROSOPHILA-MELANOGASTER; SUPRACHIASMATIC NUCLEI; GLUCOSE-HOMEOSTASIS; ENERGY HOMEOSTASIS; ARCUATE NUCLEUS; DEFICIENT MICE; MUTANT MICE	Timing activity to match resource availability is a widely conserved ability in nature. Scheduled feeding of a limited amount of food induces increased activity prior to feeding time in animals as diverse as fish and rodents. Typically, food anticipatory activity (FAA) involves temporally restricting unlimited food access (RF) to several hours in the middle of the light cycle, which is a time of day when rodents are not normally active. We compared this model to calorie restriction (CR), giving the mice 60% of their normal daily calorie intake at the same time each day. Measurement of body temperature and home cage behaviors suggests that the RF and CR models are very similar but CR has the advantage of a clearly defined food intake and more stable mean body temperature. Using the CR model, we then attempted to verify the published result that orexin deletion diminishes food anticipatory activity (FAA) but observed little to no diminution in the response to CR and, surprisingly, that orexin KO mice are refractory to body weight loss on a CR diet. Next we tested the orexigenic neuropeptide Y (NPY) and ghrelin and the anorexigenic hormone, leptin, using mouse mutants. NPY deletion did not alter the behavior or physiological response to CR. Leptin deletion impaired FAA in terms of some activity measures, such as walking and rearing, but did not substantially diminish hanging behavior preceding feeding time, suggesting that leptin knockout mice do anticipate daily meal time but do not manifest the full spectrum of activities that typify FAA. Ghrelin knockout mice do not have impaired FAA on a CR diet. Collectively, these results suggest that the individual hormones and neuropepetides tested do not regulate FAA by acting individually but this does not rule out the possibility of their concerted action in mediating FAA.	[Gunapala, Keith M.; Gallardo, Christian M.; Hsu, Cynthia T.; Steele, Andrew D.] CALTECH, Div Biol, Broad Fellows Program Brain Circuitry, Pasadena, CA 91125 USA	California Institute of Technology	Gunapala, KM (corresponding author), CALTECH, Div Biol, Broad Fellows Program Brain Circuitry, Pasadena, CA 91125 USA.	steelea@caltech.edu		Gallardo, Christian/0000-0001-5702-0852	Broad Fellow Program in Brain Circuitry at Caltech; Ellison Medical Foundation; Klarman Family Foundation	Broad Fellow Program in Brain Circuitry at Caltech; Ellison Medical Foundation(Lawrence Ellison Foundation); Klarman Family Foundation	These studies were funded by the Broad Fellow Program in Brain Circuitry at Caltech, the Ellison Medical Foundation, and the Klarman Family Foundation Grants Program in Eating Disorders Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama M, 2004, EUR J NEUROSCI, V20, P3054, DOI 10.1111/j.1460-9568.2004.03749.x; Antle MC, 2009, EUR J NEUROSCI, V30, P1643, DOI 10.1111/j.1460-9568.2009.06959.x; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; BARGIELLO TA, 1984, NATURE, V312, P752, DOI 10.1038/312752a0; Blum ID, 2009, NEUROSCIENCE, V164, P351, DOI 10.1016/j.neuroscience.2009.08.009; Challet E, 2009, EUR J NEUROSCI, V30, P1676, DOI 10.1111/j.1460-9568.2009.06962.x; CHOI DL, NEUROSCIENCE, V167, P11; Clark EL, 2009, NEUROSCIENCE, V161, P970, DOI 10.1016/j.neuroscience.2009.04.007; Coppari R, 2005, CELL METAB, V1, P63, DOI 10.1016/j.cmet.2004.12.004; Dhillon H, 2006, NEURON, V49, P191, DOI 10.1016/j.neuron.2005.12.021; Dudley CA, 2003, SCIENCE, V301, P379, DOI 10.1126/science.1082795; Elmquist JK, 2005, J COMP NEUROL, V493, P63, DOI 10.1002/cne.20786; Feillet CA, 2006, CURR BIOL, V16, P2016, DOI 10.1016/j.cub.2006.08.053; Goulding EH, 2008, P NATL ACAD SCI USA, V105, P20575, DOI 10.1073/pnas.0809053106; Hastings MH, 2004, J BIOL RHYTHM, V19, P400, DOI 10.1177/0748730404268786; Hillebrand JJG, 2005, BIOL PSYCHIAT, V58, P165, DOI 10.1016/j.biopsych.2005.03.011; Hsu CT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012903; Hsu JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011802; Iida M, 1996, BIOCHEM BIOPH RES CO, V224, P597, DOI 10.1006/bbrc.1996.1070; Iijima M, 2005, NEUROSCI RES, V52, P166, DOI 10.1016/j.neures.2005.03.003; Jackson WS, 2009, NEURON, V63, P438, DOI 10.1016/j.neuron.2009.07.026; Kaur S, 2008, BRAIN RES, V1205, P47, DOI 10.1016/j.brainres.2008.02.026; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; LeSauter J, 2009, P NATL ACAD SCI USA, V106, P13582, DOI 10.1073/pnas.0906426106; Marchant EG, 1997, BRAIN RES, V765, P273, DOI 10.1016/S0006-8993(97)00571-4; Mercer JG, 1996, J NEUROENDOCRINOL, V8, P733, DOI 10.1046/j.1365-2826.1996.05161.x; MISTLBERGER RE, 1992, BEHAV NEUROSCI, V106, P192, DOI 10.1037/0735-7044.106.1.192; Mistlberger RE, 2003, BRAIN RES, V980, P161, DOI 10.1016/S0006-8993(03)02755-0; Mistlberger RE, 1999, PHYSIOL BEHAV, V66, P329, DOI 10.1016/S0031-9384(98)00311-4; Mistlberger RE, 1998, APPETITE, V30, P255, DOI 10.1006/appe.1997.0134; Moon BC, 1997, GENOMICS, V42, P152, DOI 10.1006/geno.1997.4701; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Pendergast JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004860; Phillips MS, 1996, NAT GENET, V13, P18, DOI 10.1038/ng0596-18; Pitts SN, 2003, AM J PHYSIOL-REG I, V285, pR57, DOI 10.1152/ajpregu.00023.2003; Qian S, 2002, MOL CELL BIOL, V22, P5027, DOI 10.1128/MCB.22.14.5027-5035.2002; Schwartz MW, 1996, DIABETES, V45, P531, DOI 10.2337/diabetes.45.4.531; Seeley RJ, 1996, HORM METAB RES, V28, P664, DOI 10.1055/s-2007-979874; Seoane LM, 2003, ENDOCRINOLOGY, V144, P544, DOI 10.1210/en.2002-220795; STANLEY BG, 1993, BRAIN RES, V604, P304; STANLEY BG, 1993, PEPTIDES, V14, P475, DOI 10.1016/0196-9781(93)90135-4; Steele AD, 2007, P NATL ACAD SCI USA, V104, P1983, DOI 10.1073/pnas.0610779104; STEPHAN FK, 1979, BEHAV NEURAL BIOL, V25, P545, DOI 10.1016/S0163-1047(79)90332-7; STEPHENS TW, 1995, NATURE, V377, P530, DOI 10.1038/377530a0; Storch KF, 2009, P NATL ACAD SCI USA, V106, P6808, DOI 10.1073/pnas.0902063106; Sun YX, 2003, MOL CELL BIOL, V23, P7973, DOI 10.1128/MCB.23.22.7973-7981.2003; Sutton GM, 2008, J NEUROSCI, V28, P12946, DOI 10.1523/JNEUROSCI.3615-08.2008; Szentirmai E, 2010, AM J PHYSIOL-REG I, V298, pR467, DOI 10.1152/ajpregu.00557.2009; Tomaszuk A, 1996, HORM RES, V46, P53, DOI 10.1159/000184996; Verhagen LA, 2010, EUR NEUROPSYCHOPHARM; White BD, 1997, P SOC EXP BIOL MED, V214, P222, DOI 10.3181/00379727-214-44090; Wortley KE, 2004, P NATL ACAD SCI USA, V101, P8227, DOI 10.1073/pnas.0402763101; Yamanaka A, 2003, NEURON, V38, P701, DOI 10.1016/S0896-6273(03)00331-3; ZEHRING WA, 1984, CELL, V39, P369, DOI 10.1016/0092-8674(84)90015-1	54	45	47	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e18377	10.1371/journal.pone.0018377	http://dx.doi.org/10.1371/journal.pone.0018377			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464907	gold, Green Submitted, Green Accepted, Green Published			2022-12-25	WOS:000289053800045
J	Montoto, LG; Magana, C; Tourmente, M; Martin-Coello, J; Crespo, C; Luque-Larena, JJ; Gomendio, M; Roldan, ERS				Gomez Montoto, Laura; Magana, Concepcion; Tourmente, Maximiliano; Martin-Coello, Juan; Crespo, Cristina; Jose Luque-Larena, Juan; Gomendio, Montserrat; Roldan, Eduardo R. S.			Sperm Competition, Sperm Numbers and Sperm Quality in Muroid Rodents	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; TESTIS SIZE; CYTOCHROME-B; PRIMARY DETERMINANT; EJACULATE QUALITY; SEXUAL SELECTION; MALE-FERTILITY; IN-VIVO; EVOLUTION; SPERMATOZOA	Sperm competition favors increases in relative testes mass and production efficiency, and changes in sperm phenotype that result in faster swimming speeds. However, little is known about its effects on traits that contribute to determine the quality of a whole ejaculate (i.e., proportion of motile, viable, morphologically normal and acrosome intact sperm) and that are key determinants of fertilization success. Two competing hypotheses lead to alternative predictions: (a) sperm quantity and quality traits co-evolve under sperm competition because they play complementary roles in determining ejaculate's competitive ability, or (b) energetic constraints force trade-offs between traits depending on their relevance in providing a competitive advantage. We examined relationships between sperm competition levels, sperm quantity, and traits that determine ejaculate quality, in a comparative study of 18 rodent species using phylogenetically controlled analyses. Total sperm numbers were positively correlated to proportions of normal sperm, acrosome integrity and motile sperm; the latter three were also significantly related among themselves, suggesting no trade-offs between traits. In addition, testes mass corrected for body mass (i.e., relative testes mass), showed a strong association with sperm numbers, and positive significant associations with all sperm traits that determine ejaculate quality with the exception of live sperm. An "overall sperm quality" parameter obtained by principal component analysis (which explained 85% of the variance) was more strongly associated with relative testes mass than any individual quality trait. Overall sperm quality was as strongly associated with relative testes mass as sperm numbers. Thus, sperm quality traits improve under sperm competition in an integrated manner suggesting that a combination of all traits is what makes ejaculates more competitive. In evolutionary terms this implies that a complex network of genetic and developmental pathways underlying processes of sperm formation, maturation, transport in the female reproductive tract, and preparation for fertilization must all evolve in concert.	[Gomez Montoto, Laura; Magana, Concepcion; Tourmente, Maximiliano; Martin-Coello, Juan; Crespo, Cristina; Gomendio, Montserrat; Roldan, Eduardo R. S.] CSIC, Museo Nacl Ciencias Nat, Reprod Ecol & Biol Grp, E-28006 Madrid, Spain; [Jose Luque-Larena, Juan] Univ Valladolid, Dept Ciencias Agroforest ETS Ingn Agr, Area Zool, Palencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Universidad de Valladolid	Montoto, LG (corresponding author), CSIC, Museo Nacl Ciencias Nat, Reprod Ecol & Biol Grp, E-28006 Madrid, Spain.	roldane@mncn.csic.es	Roldan, Eduardo R.S./M-7947-2014; Luque-Larena, Juan Jose/D-6454-2014; Tourmente, Maximiliano/I-2852-2019	Roldan, Eduardo R.S./0000-0002-7545-4248; Luque-Larena, Juan Jose/0000-0001-6425-637X; Tourmente, Maximiliano/0000-0002-5833-9117	Spanish Ministry of Science and Innovation; Spanish Ministry of Education and Science; Spanish Ministry of Education	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Education and Science(Spanish Government); Spanish Ministry of Education(Spanish Government)	This work was supported by the Spanish Ministry of Science and Innovation. L. G. M. and J.M.C. were supported by predoctoral studentships from the Spanish Ministry of Education and Science. M. T. is a postdoctoral researcher funded by the Programa Nacional de Movilidad de Recursos Humanos de Investigacion of the Spanish Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2005, J ZOOL, V267, P135, DOI 10.1017/S0952836905007284; Anderson MJ, 2002, NATURE, V416, P496, DOI 10.1038/416496a; Bannikova AA, 2010, BIOL J LINN SOC, V99, P595, DOI 10.1111/j.1095-8312.2009.01378.x; BARTKE A, 1972, J HERED, V63, P172, DOI 10.1093/oxfordjournals.jhered.a108263; Birkhead TR, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P1; Birkhead TR, 1999, P ROY SOC B-BIOL SCI, V266, P1759, DOI 10.1098/rspb.1999.0843; BIRKHEAD TR, 1998, SPERM COMPETITION SE, P826; Birkhead TR, 1992, SPERM COMPETITION BI; BRISKIE JV, 1992, P ROY SOC B-BIOL SCI, V247, P89, DOI 10.1098/rspb.1992.0013; Buzan EV, 2008, BIOL J LINN SOC, V94, P825, DOI 10.1111/j.1095-8312.2008.01024.x; CUMMINS JM, 1982, GAMETE RES, V5, P239, DOI 10.1002/mrd.1120050304; CUMMINS JM, 1986, GAMETE RES, V15, P187, DOI 10.1002/mrd.1120150302; CUMMINS JM, 1985, J REPROD FERTIL, V75, P153, DOI 10.1530/jrf.0.0750153; DEWSBURY DA, 1982, AM NAT, V119, P601, DOI 10.1086/283938; Firman RC, 2010, EVOLUTION, V64, P1245, DOI 10.1111/j.1558-5646.2009.00894.x; Fitzpatrick JL, 2009, P NATL ACAD SCI USA, V106, P1128, DOI 10.1073/pnas.0809990106; Florman HM, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P55; Foote RH, 2003, ANIM REPROD SCI, V75, P119, DOI 10.1016/S0378-4320(02)00233-6; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Froman DP, 1999, BIOL REPROD, V61, P400, DOI 10.1095/biolreprod61.2.400; Gage MJG, 2004, CURR BIOL, V14, P44, DOI 10.1016/j.cub.2003.12.028; Gage MJG, 2003, P ROY SOC B-BIOL SCI, V270, P625, DOI 10.1098/rspb.2002.2258; Gage MJG, 2002, J FISH BIOL, V61, P1528, DOI [10.1006/jfbi.2002.2171, 10.1111/j.1095-8649.2002.tb02495.x]; Gage MJG, 1998, J FISH BIOL, V53, P835, DOI 10.1111/j.1095-8649.1998.tb01836.x; Garcia-Gonzalez F, 2005, CURR BIOL, V15, P271, DOI 10.1016/j.cub.2005.01.032; GARRETT C, 2007, SPERMATOLOGY, P357; Golas A, 2008, INT J DEV BIOL, V52, P287, DOI 10.1387/ijdb.072333ag; GOMENDIO M, 1991, P ROY SOC B-BIOL SCI, V243, P181, DOI 10.1098/rspb.1991.0029; Gomendio M, 2000, P ROY SOC B-BIOL SCI, V267, P875, DOI 10.1098/rspb.2000.1084; Gomendio M, 2008, INT J DEV BIOL, V52, P439, DOI 10.1387/ijdb.082595mg; Gomendio M, 2006, P NATL ACAD SCI USA, V103, P15113, DOI 10.1073/pnas.0605795103; Gomenido Montserrat, 1998, P667, DOI 10.1016/B978-012100543-6/50041-6; Gotoh H, 2010, REPROD FERT DEVELOP, V22, P1066, DOI 10.1071/RD09295; HARCOURT AH, 1981, NATURE, V293, P55, DOI 10.1038/293055a0; Hosken DJ, 1997, P ROY SOC B-BIOL SCI, V264, P385, DOI 10.1098/rspb.1997.0055; Hosken DJ, 2001, ECOL LETT, V4, P10, DOI 10.1046/j.1461-0248.2001.00198.x; HOWARD J, 1991, J ANDROL, V12, P36; Hunter FM, 2002, CURR BIOL, V12, P121, DOI 10.1016/S0960-9822(01)00647-9; Immler S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000170; Jaarola M, 2004, MOL PHYLOGENET EVOL, V33, P647, DOI 10.1016/j.ympev.2004.07.015; JENNIONS MD, 1993, BIOL J LINN SOC, V50, P211; Jurewicz J, 2009, INT J OCCUP MED ENV, V22, P305, DOI 10.2478/v10001-009-0036-1; KENAGY GJ, 1986, J MAMMAL, V67, P1, DOI 10.2307/1380997; KOT MC, 1987, GAMETE RES, V18, P57, DOI 10.1002/mrd.1120180107; KRZANOWSKA H, 1974, J REPROD FERTIL, V38, P81, DOI 10.1530/jrf.0.0380081; Larson JL, 1999, MOL REPROD DEV, V52, P445, DOI 10.1002/(SICI)1098-2795(199904)52:4&lt;445::AID-MRD14&gt;3.0.CO;2-6; Lessells CM, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P43, DOI 10.1016/B978-0-12-372568-4.00002-1; Levitan DR, 2000, P ROY SOC B-BIOL SCI, V267, P531, DOI 10.1098/rspb.2000.1032; Lupold S, 2009, EVOLUTION, V63, P391, DOI 10.1111/j.1558-5646.2008.00571.x; Lundrigan BL, 2002, SYST BIOL, V51, P410, DOI 10.1080/10635150290069878; Malo AF, 2005, BIOL REPROD, V72, P822, DOI 10.1095/biolreprod.104.036368; Malo AF, 2005, P ROY SOC B-BIOL SCI, V272, P149, DOI 10.1098/rspb.2004.2933; Martin Y, 2000, MOL PHYLOGENET EVOL, V16, P37, DOI 10.1006/mpev.1999.0760; Martin-Coello J, 2009, P ROY SOC B-BIOL SCI, V276, P2427, DOI 10.1098/rspb.2009.0257; MOLLER AP, 1989, FUNCT ECOL, V3, P91, DOI 10.2307/2389679; MOLLER AP, 1988, J HUM EVOL, V17, P479, DOI 10.1016/0047-2484(88)90037-1; Moore H, 2002, NATURE, V418, P174, DOI 10.1038/nature00832; Moore PJ, 2004, EVOLUTION, V58, P1773, DOI 10.1111/j.0014-3820.2004.tb00460.x; NAKATSURU K, 1982, SCIENCE, V216, P753, DOI 10.1126/science.216.4547.753; Olsson M, 1997, P ROY SOC B-BIOL SCI, V264, P455, DOI 10.1098/rspb.1997.0065; Pagel M., 1991, COMP METHOD EVOLUTIO, P248; PARKER GA, 1982, J THEOR BIOL, V96, P281, DOI 10.1016/0022-5193(82)90225-9; PARKER GA, 1993, P ROY SOC B-BIOL SCI, V253, P245, DOI 10.1098/rspb.1993.0110; PARKER GA, 1993, P ROY SOC B-BIOL SCI, V253, P255, DOI 10.1098/rspb.1993.0111; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; PARKER GA, 2010, BIOL REV IN PRESS; Pfunder M, 2004, MOL ECOL, V13, P1277, DOI 10.1111/j.1365-294X.2004.02126.x; Pitnick S, 1996, AM NAT, V148, P57, DOI 10.1086/285911; Pitnick S, 2001, P ROY SOC B-BIOL SCI, V268, P1071, DOI 10.1098/rspb.2001.1621; Pitnick S, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P247, DOI 10.1016/B978-0-12-372568-4.00007-0; Pizzari T, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P207, DOI 10.1016/B978-0-12-372568-4.00006-9; Pukazhenthi BS, 2006, THERIOGENOLOGY, V66, P112, DOI 10.1016/j.theriogenology.2006.03.020; PURSEL VG, 1972, J ANIM SCI, V34, P278; Robinson M, 1997, MOL PHYLOGENET EVOL, V8, P423, DOI 10.1006/mpev.1997.0424; Robovsky J, 2008, ZOOL SCR, V37, P571, DOI 10.1111/j.1463-6409.2008.00342.x; ROLDAN ERS, 1992, BIOL REV, V67, P551, DOI 10.1111/j.1469-185X.1992.tb01193.x; Scott MA, 2000, ANIM REPROD SCI, V60, P337, DOI 10.1016/S0378-4320(00)00130-5; SHI QX, 1995, BIOL REPROD, V52, P540, DOI 10.1095/biolreprod52.3.540; Simmons L. W., 2001, MG BEH ECOL; SMITH TT, 1990, BIOL REPROD, V42, P450, DOI 10.1095/biolreprod42.3.450; Soulsbury CD, 2010, PLOS ONE, V5, pA152, DOI 10.1371/journal.pone.0009581; Stockley P, 1997, AM NAT, V149, P933, DOI 10.1086/286031; Suarez S.S., 1990, P111; Suarez SS, 2008, INT J DEV BIOL, V52, P455, DOI 10.1387/ijdb.072527ss; Suzuki H, 2004, MOL PHYLOGENET EVOL, V33, P626, DOI 10.1016/j.ympev.2004.08.003; TAMULI MK, 1994, ANIM REPROD SCI, V35, P247, DOI 10.1016/0378-4320(94)90040-X; TANNENBAUM LV, 2010, ARCH ENV CONTAM TOXI, V60, P173; Tomkins JL, 2002, ANIM BEHAV, V63, P1009, DOI 10.1006/anbe.2001.1994; Tougard C, 2008, BIOL J LINN SOC, V93, P309, DOI 10.1111/j.1095-8312.2007.00926.x; Tourmente M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-12	90	87	88	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e18173	10.1371/journal.pone.0018173	http://dx.doi.org/10.1371/journal.pone.0018173			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464956	Green Submitted, gold, Green Published			2022-12-25	WOS:000288813900046
J	Palmer, SM; Flake, GP; Kelly, FL; Zhang, HL; Nugent, JL; Kirby, PJ; Foley, JF; Gwinn, WM; Morgan, DL				Palmer, Scott M.; Flake, Gordon P.; Kelly, Fran L.; Zhang, Helen L.; Nugent, Julia L.; Kirby, Patrick J.; Foley, Julie F.; Gwinn, William M.; Morgan, Dan L.			Severe Airway Epithelial Injury, Aberrant Repair and Bronchiolitis Obliterans Develops after Diacetyl Instillation in Rats	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; SECRETORY PROTEIN CC16; LUNG TRANSPLANTATION; BASEMENT-MEMBRANE; DECREASED SERUM; WORKERS; TENASCIN; UPDATE; ASTHMA; PLANT	Background: Bronchiolitis obliterans (BO) is a fibrotic lung disease that occurs in a variety of clinical settings, including toxin exposures, autoimmunity and lung or bone marrow transplant. Despite its increasing clinical importance, little is known regarding the underlying disease mechanisms due to a lack of adequate small animal BO models. Recent epidemiological studies have implicated exposure to diacetyl (DA), a volatile component of artificial butter flavoring, as a cause of BO in otherwise healthy factory workers. Our overall hypothesis is that DA induces severe epithelial injury and aberrant repair that leads to the development of BO. Therefore, the objectives of this study were 1) to determine if DA, delivered by intratracheal instillation (ITI), would lead to the development of BO in rats and 2) to characterize epithelial regeneration and matrix repair after ITI of DA. Methods and Main Results: Male Sprague-Dawley rats were treated with a single dose of DA (125 mg/kg) or sterile water (vehicle control) by ITI. Instilled DA resulted in airway specific injury, followed by rapid epithelial regeneration, and extensive intraluminal airway fibrosis characteristic of BO. Increased airway resistance and lung fluid neutrophilia occurred with the development of BO, similar to human disease. Despite rapid epithelial regeneration after DA treatment, expression of the normal phenotypic markers, Clara cell secretory protein and acetylated tubulin, were diminished. In contrast, expression of the matrix component Tenascin C was significantly increased, particularly evident within the BO lesions. Conclusions: We have established that ITI of DA results in BO, creating a novel chemical-induced animal model that replicates histological, biological and physiological features of the human disease. Furthermore, we demonstrate that dysregulated epithelial repair and excessive matrix Tenacin C deposition occur in BO, providing new insights into potential disease mechanisms and therapeutic targets.	[Palmer, Scott M.; Kelly, Fran L.; Zhang, Helen L.; Nugent, Julia L.] Duke Univ, Med Ctr, Div Pulm & Crit Care Med, Durham, NC 27706 USA; [Flake, Gordon P.; Kirby, Patrick J.; Foley, Julie F.; Gwinn, William M.; Morgan, Dan L.] NIEHS, Res Triangle Pk, NC 27709 USA	Duke University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Palmer, SM (corresponding author), Duke Univ, Med Ctr, Div Pulm & Crit Care Med, Durham, NC 27706 USA.	palme002@mc.duke.edu		Palmer, Scott/0000-0002-1370-3771	U.S. National Institutes of Health at the National Institute of Environmental Health Sciences (NIEHS); National Heart Lung Blood Institute [HL91140-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL091140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101578, ZIGES102505, ZIAES101865] Funding Source: NIH RePORTER	U.S. National Institutes of Health at the National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Heart Lung Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was funded the U.S. National Institutes of Health through Intramural Research grants to DLM at the National Institute of Environmental Health Sciences (NIEHS) and SMP from National Heart Lung Blood Institute (grant HL91140-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afessa B, 2001, BONE MARROW TRANSPL, V28, P425, DOI 10.1038/sj.bmt.1703142; Agostini Carlo, 2006, Proc Am Thorac Soc, V3, P357, DOI 10.1513/pats.200601-010TK; Akpinar-Elci M, 2005, CHEST, V128, P991, DOI 10.1378/chest.128.2.991; Akpinar-Elci M, 2004, EUR RESPIR J, V24, P298, DOI 10.1183/09031936.04.00013903; Antonov J, 2005, LAB INVEST, V85, P1040, DOI 10.1038/labinvest.3700303; Appel JZ, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-87; Chan A, 2004, CURR OPIN PULM MED, V10, P133, DOI 10.1097/00063198-200403000-00008; Chen Huaiyong, 2009, Proc Am Thorac Soc, V6, P602, DOI 10.1513/pats.200907-078RM; Costa CLB, 2005, RESPIRATION, V72, P642, DOI 10.1159/000087363; Estenne M, 2002, J HEART LUNG TRANSPL, V21, P297, DOI 10.1016/S1053-2498(02)00398-4; Glaab T, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-63; Hubbs AF, 2008, TOXICOL PATHOL, V36, P330, DOI 10.1177/0192623307312694; Karjalainen EM, 2003, RESP MED, V97, P1045, DOI 10.1016/S0954-6111(03)00136-7; KIM TJ, AM J IND MED, V53, P857; Kreiss K, 2002, NEW ENGL J MED, V347, P330, DOI 10.1056/NEJMoa020300; Laitinen A, 1997, AM J RESP CRIT CARE, V156, P951, DOI 10.1164/ajrccm.156.3.9610084; Lockey JE, 2009, EUR RESPIR J, V34, P63, DOI 10.1183/09031936.00050808; Mattsson J, 2005, TRANSPLANTATION, V79, P1411, DOI 10.1097/01.TP.0000158354.39635.AB; McDyer John F, 2007, Proc Am Thorac Soc, V4, P37, DOI 10.1513/pats.200605-107JG; Morgan DL, 2008, TOXICOL SCI, V103, P169, DOI 10.1093/toxsci/kfn016; Morris JB, 2009, TOXICOL SCI, V108, P173, DOI 10.1093/toxsci/kfn222; Nakahara H, 2006, EUR J IMMUNOL, V36, P3334, DOI 10.1002/eji.200636271; Nord M, 2002, TRANSPLANTATION, V73, P1264, DOI 10.1097/00007890-200204270-00013; Ryu JH, 2003, AM J RESP CRIT CARE, V168, P1277, DOI 10.1164/rccm.200301-053SO; Snyder JC, 2009, AM J RESP CELL MOL, V40, P633, DOI 10.1165/rcmb.2008-0334OC; van Rooy FGBGJ, 2007, AM J RESP CRIT CARE, V176, P498, DOI 10.1164/rccm.200611-1620OC; Vanaudenaerde BM, 2008, EUR RESPIR J, V32, P832, DOI 10.1183/09031936.00134307; Verleden GM, 2009, TRANSPL INT, V22, P771, DOI 10.1111/j.1432-2277.2009.00872.x	28	63	68	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e17644	10.1371/journal.pone.0017644	http://dx.doi.org/10.1371/journal.pone.0017644			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464978	Green Published, Green Submitted, gold			2022-12-25	WOS:000288813900004
J	von Kleist, M; Menz, S; Stocker, H; Arasteh, K; Schutte, C; Huisinga, W				von Kleist, Max; Menz, Stephan; Stocker, Hartmut; Arasteh, Keikawus; Schuette, Christof; Huisinga, Wilhelm			HIV Quasispecies Dynamics during Pro-Active Treatment Switching: Impact on Multi-Drug Resistance and Resistance Archiving in Latent Reservoirs	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CD4(+) T-CELLS; COMBINATION ANTIRETROVIRAL THERAPY; RANDOMIZED CONTROLLED-TRIAL; IN-VIVO; TREATMENT-NAIVE; REVERSE-TRANSCRIPTASE; VIRAL SUPPRESSION; DRUG REGIMENS; INFECTION	The human immunodeficiency virus (HIV) can be suppressed by highly active anti-retroviral therapy (HAART) in the majority of infected patients. Nevertheless, treatment interruptions inevitably result in viral rebounds from persistent, latently infected cells, necessitating lifelong treatment. Virological failure due to resistance development is a frequent event and the major threat to treatment success. Currently, it is recommended to change treatment after the confirmation of virological failure. However, at the moment virological failure is detected, drug resistant mutants already replicate in great numbers. They infect numerous cells, many of which will turn into latently infected cells. This pool of cells represents an archive of resistance, which has the potential of limiting future treatment options. The objective of this study was to design a treatment strategy for treatment-naive patients that decreases the likelihood of early treatment failure and preserves future treatment options. We propose to apply a single, pro-active treatment switch, following a period of treatment with an induction regimen. The main goal of the induction regimen is to decrease the abundance of randomly generated mutants that confer resistance to the maintenance regimen, thereby increasing subsequent treatment success. Treatment is switched before the overgrowth and archiving of mutant strains that carry resistance against the induction regimen and would limit its future re-use. In silico modelling shows that an optimal trade-off is achieved by switching treatment at & 80 days after the initiation of antiviral therapy. Evaluation of the proposed treatment strategy demonstrated significant improvements in terms of resistance archiving and virological response, as compared to conventional HAART. While continuous pro-active treatment alternation improved the clinical outcome in a randomized trial, our results indicate that a similar improvement might also be reached after a single pro-active treatment switch. The clinical validity of this finding, however, remains to be shown by a corresponding trial.	[von Kleist, Max; Menz, Stephan; Schuette, Christof] Free Univ Berlin, Dept Math & Comp Sci, Berlin, Germany; [Stocker, Hartmut; Arasteh, Keikawus] Vivantes Auguste Viktoria Klinikum, Dept Gastroenterol & Infect Dis, Berlin, Germany; [Huisinga, Wilhelm] Natl Univ Ireland, Hamilton Inst, Maynooth, Kildare, Ireland; [Huisinga, Wilhelm] Univ Potsdam, Inst Math, Potsdam, Germany	Free University of Berlin; Maynooth University; University of Potsdam	von Kleist, M (corresponding author), Free Univ Berlin, Dept Math & Comp Sci, Berlin, Germany.	vkleist@zedat.fu-berlin.de	von Kleist, Max/K-3023-2016; Stoecker, Horst/F-8382-2012	von Kleist, Max/0000-0001-6587-6394; Stoecker, Horst/0000-0002-3282-3664	BMBF; DFG	BMBF(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG))	MvK acknowledges financial support by BMBF funding. SM acknowledges financial support by DFG funding, provided through the Dahlem Research School of Freie Universitat Berlin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALFONSI A, 2005, ESAIM P, V14, P1, DOI DOI 10.1051/PROC:2005001; Archer J, 2009, AIDS, V23, P1209, DOI 10.1097/QAD.0b013e32832b4399; Arora P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000305; Bartlett JA, 2002, J ACQ IMMUN DEF SYND, V29, pS2, DOI 10.1097/00126334-200202011-00002; Blankson JN, 2000, J INFECT DIS, V182, P1636, DOI 10.1086/317615; Blumberg HM, 2005, JAMA-J AM MED ASSOC, V293, P2776, DOI 10.1001/jama.293.22.2776; Callaway DS, 2002, B MATH BIOL, V64, P29, DOI 10.1006/bulm.2001.0266; Carr A, 2003, NAT REV DRUG DISCOV, V2, P624, DOI 10.1038/nrd1151; Carter CC, 2010, NAT MED, V16, P446, DOI 10.1038/nm.2109; Catanzaro Linda M, 2004, Curr HIV/AIDS Rep, V1, P89, DOI 10.1007/s11904-004-0013-z; Chun TW, 2007, J INFECT DIS, V195, P1762, DOI 10.1086/518250; CHUN TW, 1995, NAT MED, V1, P1284, DOI 10.1038/nm1295-1284; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Clavel F, 2004, NEW ENGL J MED, V350, P1023, DOI 10.1056/NEJM2ra025195; Clavel Francois, 2009, Eur J Med Res, V14 Suppl 3, P47; COFFIN J, 2006, 13 C RETR OPP INF 5; Coovadia A, 2010, JAMA-J AM MED ASSOC, V304, P1082, DOI 10.1001/jama.2010.1278; Curlin ME, 2007, PLOS COMPUT BIOL, V3, P1239, DOI 10.1371/journal.pcbi.0030133; D'Amato RM, 1998, ANTIVIR THER, V3, P147; DeJesus E, 2006, JAIDS-J ACQ IMM DEF, V43, P1, DOI 10.1097/01.qai.0000233308.82860.2f; Eriksson N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000074; Fabbiani M, 2009, J ANTIMICROB CHEMOTH, V64, P109, DOI 10.1093/jac/dkp132; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Fondere JM, 2004, J CLIN VIROL, V29, P33, DOI 10.1016/S1386-6532(03)00083-0; Ghosn J, 2006, AIDS, V20, P159, DOI 10.1097/01.aids.0000199820.47703.a0; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Horstkotte D, 2004, EUR HEART J, V25, P267, DOI 10.1016/j.ehj.2003.11.008; Ji HZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009263; KLOPFENSTEIN RW, 1971, RCA REV, V32, P447; Koelsch KK, 2008, J INFECT DIS, V197, P411, DOI 10.1086/525283; Lambotte O, 2004, AIDS, V18, P1147, DOI 10.1097/00002030-200405210-00008; Lassen KG, 2006, PLOS PATHOG, V2, P650, DOI 10.1371/journal.ppat.0020068; Lennox JL, 2010, JAIDS-J ACQ IMM DEF, V55, P39, DOI 10.1097/QAI.0b013e3181da1287; Lennox JL, 2009, LANCET, V374, P796, DOI 10.1016/S0140-6736(09)60918-1; MANSKY LM, 1995, J VIROL, V69, P5087, DOI 10.1128/JVI.69.8.5087-5094.1995; Markowitz M, 2003, J VIROL, V77, P5037, DOI 10.1128/JVI.77.8.5037-5038.2003; Martinez-Picado J, 2003, ANN INTERN MED, V139, P81, DOI 10.7326/0003-4819-139-2-200307150-00007; Martinez-Picado J, 2008, VIRUS RES, V134, P104, DOI 10.1016/j.virusres.2007.12.021; Murray JM, 2007, AIDS, V21, P2315, DOI 10.1097/QAD.0b013e3282f12377; Negredo E, 2004, ANTIVIR THER, V9, P889; Nijhuis M, 1999, AIDS, V13, P2349, DOI 10.1097/00002030-199912030-00006; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; Pierson T, 2000, ANNU REV IMMUNOL, V18, P665, DOI 10.1146/annurev.immunol.18.1.665; Pierson TC, 2002, J VIROL, V76, P8518, DOI 10.1128/JVI.76.17.8518-8513.2002; Ramratnam B, 2000, NAT MED, V6, P82, DOI 10.1038/71577; Ramratnam B, 1999, LANCET, V354, P1782, DOI 10.1016/S0140-6736(99)02035-8; Reekie J, 2010, HIV MED, V11, P469, DOI 10.1111/j.1468-1293.2009.00816.x; Ribeiro RM, 1998, AIDS, V12, P461, DOI 10.1097/00002030-199805000-00006; Richman DD, 2000, ANTIVIR THER, V5, P27; Riddler SA, 2008, NEW ENGL J MED, V358, P2095, DOI 10.1056/NEJMoa074609; Sedaghat AR, 2008, P NATL ACAD SCI USA, V105, P4832, DOI 10.1073/pnas.0711372105; Sedaghat AR, 2009, ANTIVIR THER, V14, P263; Shampine LF, 1997, SIAM J SCI COMPUT, V18, P1, DOI 10.1137/S1064827594276424; Sherr L, 2007, INT J STD AIDS, V18, P700, DOI 10.1258/095646207782193821; Siliciano JD, 2004, J ANTIMICROB CHEMOTH, V54, P6, DOI 10.1093/jac/dkh292; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Smith RJ, 2010, SCIENCE, V327, P697, DOI 10.1126/science.1180556; US Department of Health and Human Services US Food and Drug Administration Center for Drug Evaluation and Research Center for Biologics Evaluation and Research Center for Devices and Radiological Health, 2009, PAN ANT GUID AD AD G, P1; von Kleist M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000720; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; Weinberger LS, 2005, CELL, V122, P169, DOI 10.1016/j.cell.2005.06.006; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Zhang LQ, 1999, NEW ENGL J MED, V340, P1605, DOI 10.1056/NEJM199905273402101; Zhou Y, 2005, J VIROL, V79, P2199, DOI 10.1128/JVI.79.4.2199-2210.2005; Zimmerli W, 2003, INFECTION, V31, P99, DOI 10.1007/s15010-002-3079-9	69	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2011	6	3							e18204	10.1371/journal.pone.0018204	http://dx.doi.org/10.1371/journal.pone.0018204			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740RG	21455303	Green Submitted, Green Published, gold			2022-12-25	WOS:000288811500028
J	Mermel, LA; Machan, JT; Parenteau, S				Mermel, Leonard A.; Machan, Jason T.; Parenteau, Stephen			Seasonality of MRSA Infections	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS INFECTIONS; GENERAL-PRACTICE; IMPETIGO; CARRIAGE; 3-YEAR	Using MRSA isolates submitted to our hospital microbiology laboratory January 2001-March 2010 and the number of our emergency department (ED) visits, quarterly community-associated (CA) and hospital-associated (HA) MRSA infections were modeled using Poisson regressions. For pediatric patients, approximately 1.85x (95% CI 1.45x-2.36x, adj. p < 0.0001) as many CA-MRSA infections per ED visit occurred in the second two quarters as occurred in the first two quarters. For adult patients, 1.14x (95% CI 1.01x-1.29x, adj. p = 0.03) as many infections per ED visit occurred in the second two quarters as in the first two quarters. Approximately 2.94x (95% CI 1.39x-6.21x, adj. p = 0.015) as many HA-MRSA infections per hospital admission occurred in the second two quarters as occurred in the first two quarters for pediatric patients. No seasonal variation was observed among adult HA-MRSA infections per hospital admission. We demonstrated seasonality of MRSA infections and provide a summary table of similar observations in other studies.	[Mermel, Leonard A.; Parenteau, Stephen] Rhode Isl Hosp, Dept Epidemiol & Infect Control, Providence, RI 02903 USA; [Mermel, Leonard A.] Brown Univ, Dept Med, Warren Alpert Med Sch, Providence, RI 02912 USA; [Machan, Jason T.] Brown Univ, Dept Orthopaed, Warren Alpert Med Sch, Providence, RI USA; [Machan, Jason T.] Brown Univ, Dept Surg, Warren Alpert Med Sch, Providence, RI 02912 USA	Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Brown University; Brown University	Mermel, LA (corresponding author), Rhode Isl Hosp, Dept Epidemiol & Infect Control, Providence, RI 02903 USA.	lmermel@lifespan.org	Mermel, Leonard/Z-1475-2019; Machan, Jason/D-3897-2013	Machan, Jason/0000-0003-2048-4914				Bassetti S, 2005, INFECT CONT HOSP EP, V26, P196, DOI 10.1086/502526; Chi Chih-Yu, 2004, J Microbiol Immunol Infect, V37, P16; Cluff L E, 1968, Trans Am Clin Climatol Assoc, V79, P205; Dailiana ZH, 2008, MED SCI MONITOR, V14, pCR511; Dietrich DW, 2004, PEDIATRICS, V113, pE347, DOI 10.1542/peds.113.4.e347; DILLON HC, 1968, AM J DIS CHILD, V115, P530, DOI 10.1001/archpedi.1968.02100010532002; EHRENKRANTZ NJ, 1964, NEW ENGL J MED, V271, P225, DOI 10.1056/NEJM196407302710503; ELEGBE IA, 1983, J ROY SOC HEALTH, V103, P118, DOI 10.1177/146642408310300308; Elliot AJ, 2006, FAM PRACT, V23, P490, DOI 10.1093/fampra/cml042; Grassly NC, 2006, P ROY SOC B-BIOL SCI, V273, P2541, DOI 10.1098/rspb.2006.3604; Harrison LM, 1999, FEMS IMMUNOL MED MIC, V25, P19, DOI 10.1111/j.1574-695X.1999.tb01323.x; Kaimal S, 2009, INT J DERMATOL, V48, P1082, DOI 10.1111/j.1365-4632.2009.04156.x; Kakar Nirupama, 1999, Journal of Dermatology (Tokyo), V26, P288; Kaplan SL, 2005, CLIN INFECT DIS, V40, P1785, DOI 10.1086/430312; Koning S, 2006, BRIT J DERMATOL, V154, P239, DOI 10.1111/j.1365-2133.2005.06766.x; KRISTENSEN JK, 1991, INT J DERMATOL, V30, P699, DOI 10.1111/j.1365-4362.1991.tb02612.x; Levy RM, 2005, CLIN MICROBIOL INFEC, V11, P153, DOI 10.1111/j.1469-0691.2004.01042.x; Loffeld A, 2005, CLIN EXP DERMATOL, V30, P512, DOI 10.1111/j.1365-2230.2005.01847.x; Luby S, 2002, AM J TROP MED HYG, V67, P430, DOI 10.4269/ajtmh.2002.67.430; Monnet DL, 2004, EMERG INFECT DIS, V10, P1432, DOI 10.3201/eid1008.020694; Morin CA, 2001, J INFECT DIS, V184, P1029, DOI 10.1086/323459; Morrison-Rodriguez SM, 2010, EPIDEMIOL INFECT, V138, P721, DOI 10.1017/S0950268810000142; NOBLE WC, 1967, J HYG-CAMB, V65, P567, DOI 10.1017/S002217240004609X; Perencevich EN, 2008, INFECT CONT HOSP EP, V29, P1124, DOI 10.1086/592698; ROGERS M, 1987, MED J AUSTRALIA, V147, P63, DOI 10.5694/j.1326-5377.1987.tb133260.x; Sdougkos G, 2008, CLIN MICROBIOL INFEC, V14, P995, DOI 10.1111/j.1469-0691.2008.02064.x; SINGH G, 1973, DERMATOLOGICA, V147, P342, DOI 10.1159/000251891; Skinner D, 1941, ARCH INTERN MED, V68, P851, DOI 10.1001/archinte.1941.00200110003001; Solberg C O, 1965, Acta Med Scand Suppl, V436, P1; Szczesiul JM, 2007, PEDIATR INFECT DIS J, V26, P852, DOI 10.1097/INF.0b013e318124aa5c; TAPLIN D, 1965, ARCH ENVIRON HEALTH, V11, P546, DOI 10.1080/00039896.1965.10664255; Tveten Y, 2002, J ANTIMICROB CHEMOTH, V50, P873, DOI 10.1093/jac/dkf217; Van De Griend P, 2009, EMERG INFECT DIS, V15, P1582, DOI 10.3201/eid1510.080877; WHITE A, 1961, J LAB CLIN MED, V58, P273; Wiersma P, 2009, EPIDEMIOL INFECT, V137, P1674, DOI 10.1017/S0950268809002490	35	46	47	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e17925	10.1371/journal.pone.0017925	http://dx.doi.org/10.1371/journal.pone.0017925			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21468350	Green Submitted, Green Published, gold			2022-12-25	WOS:000288810500022
J	Cailotto, F; Reboul, P; Sebillaud, S; Netter, P; Jouzeau, JY; Bianchi, A				Cailotto, Frederic; Reboul, Pascal; Sebillaud, Sylvie; Netter, Patrick; Jouzeau, Jean-Yves; Bianchi, Arnaud			Calcium Input Potentiates the Transforming Growth Factor (TGF)-beta 1-dependent Signaling to Promote the Export of Inorganic Pyrophosphate by Articular Chondrocyte	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIHYDRATE DEPOSITION DISEASE; PRIMARY HYPERPARATHYROIDISM; MAP KINASE; PARATHYROID-HORMONE; GENE-EXPRESSION; CA2+ INFLUX; FACTOR-BETA; PROTEIN; CELLS; SP1	Transforming growth factor (TGF)-beta 1 stimulates extracellular PPi (ePP(i)) generation and promotes chondrocalcinosis, which also occurs secondary to hyperparathyroidism-induced hypercalcemia. We previously demonstrated that ANK was upregulated by TGF-beta 1 activation of ERK1/2 and Ca2+-dependent protein kinase C (PKC alpha). Thus, we investigated mechanisms by which calcium could affect ePP(i) metabolism, especially its main regulating proteins ANK and PC-1 (plasma cell membrane glycoprotein-1). We stimulated articular chondrocytes with TGF-beta 1 under extracellular (eCa(2+)) or cytosolic Ca2+ (cCa(2+)) modulations. We studied ANK, PC-1 expression (quantitative RT-PCR, Western blotting), ePP(i) levels (radiometric assay), and cCa(2+) input (fluorescent probe). Voltage-operated Ca2+-channels (VOC) and signaling pathways involved were investigated with selective inhibitors. Finally, Ank promoter activity was evaluated (gene reporter). TGF-beta 1 elevated cCa(2+) and ePP(i) levels (by up-regulating Ank and PC-1 mRNA/proteins) in an eCa(2+) dose-dependent manner. TGF-beta 1 effects were suppressed by cCa(2+) chelation or L- and T-VOC blockade while being mostly reproduced by ionomycin. In the same experimental conditions, the activation of Ras, the phosphorylation of ERK1/2 and PKC alpha, and the stimulation of Ank promoter activity were affected similarly. Activation of SP1 (specific protein 1) and ELK-1 (Ets-like protein-1) transcription factors supported the regulatory role of Ca2+. SP1 or ELK-1 overexpression or blockade experiments demonstrated a major contribution of ELK-1, which acted synergistically with SP1 to activate Ank promoter in response to TGF-beta 1. TGF-beta 1 promotes input of eCa(2+) through opening of L- and T-VOCs, to potentiate ERK1/2 and PKC alpha signaling cascades, resulting in an enhanced activation of Ank promoter and ePP(i) production in chondrocyte.	[Cailotto, Frederic; Reboul, Pascal; Sebillaud, Sylvie; Netter, Patrick; Jouzeau, Jean-Yves; Bianchi, Arnaud] Nancy Univ, CNRS, UMR 7561,Fac Med, Lab Physiopathol Pharmacol & Ingn Articularies, F-54505 Vandoeuvre Les Nancy, France	Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine	Cailotto, F (corresponding author), Nancy Univ, CNRS, UMR 7561,Fac Med, Lab Physiopathol Pharmacol & Ingn Articularies, Ave Foret Haye,BP184, F-54505 Vandoeuvre Les Nancy, France.	frederic.cailotto@hotmail.fr; arnaud.bianchi@medecine.uhp-nancy.fr	bianchi, arnaud/AAY-7059-2021; REBOUL, Pascal/ABA-3774-2021	bianchi, arnaud/0000-0003-4925-5269; REBOUL, Pascal/0000-0003-3546-2152; Cailotto, Frederic/0000-0002-4941-9238	University Hospital of Nancy; Fondation pour la Recherche Medicale; Region Lorraine; Conseil General [54]; Communaute Urbaine du Grand Nancy	University Hospital of Nancy; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Region Lorraine(Region Grand-Est); Conseil General; Communaute Urbaine du Grand Nancy(Region Grand-Est)	This work was supported by grants (Contrat de Programme de Recherche Clinique (CPRC)/Programmes Hospitaliers de Recherche Clinique (PHRC)) from the University Hospital of Nancy, the Fondation pour la Recherche Medicale, the Region Lorraine, the Conseil General 54, and the Communaute Urbaine du Grand Nancy.	BARDIN T, 1988, REV RHUM, V55, P511; Barre L, 2006, FASEB J, V20, P1692, DOI 10.1096/fj.05-5073fje; Bhogal R, 2008, INT REV IMMUNOL, V27, P472, DOI 10.1080/08830180802430974; Cailotto F, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2330; Cailotto F, 2010, J BIOL CHEM, V285, P10572, DOI 10.1074/jbc.M109.050534; Chang YH, 1999, ENDOCRINOLOGY, V140, P5883, DOI 10.1210/en.140.12.5883; DODDS WJ, 1968, AMER J ROENTGENOL RA, V104, P884, DOI 10.2214/ajr.104.4.884; FARNSWORTH CL, 1995, NATURE, V376, P524, DOI 10.1038/376524a0; Gee KR, 2000, CELL CALCIUM, V27, P97, DOI 10.1054/ceca.1999.0095; Hamade T, 2010, BIO-MED MATER ENG, V20, P209, DOI 10.3233/BME-2010-0634; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Hiyama A, 2010, J BONE MINER RES, V25, P1179, DOI 10.1359/jbmr.091202; Ho AM, 2000, SCIENCE, V289, P265, DOI 10.1126/science.289.5477.265; Julien M, 2007, ENDOCRINOLOGY, V148, P530, DOI 10.1210/en.2006-0763; KORTENJANN M, 1994, MOL CELL BIOL, V14, P4815, DOI 10.1128/MCB.14.7.4815; Kudirka JC, 2007, J CELL PHYSIOL, V213, P54, DOI 10.1002/jcp.21087; KUETTNER KE, 1982, J CELL BIOL, V93, P743, DOI 10.1083/jcb.93.3.743; Kumar A, 1997, J LIPID RES, V38, P2240; Lee JH, 1999, BIOPHYS J, V77, P3034, DOI 10.1016/S0006-3495(99)77134-1; MCGILL PE, 1984, SCAND J RHEUMATOL, V13, P56, DOI 10.3109/03009748409102668; McGowan TA, 2002, AM J PHYSIOL-RENAL, V282, pF910, DOI 10.1152/ajprenal.00252.2001; Merchant JL, 1999, BIOCHEM BIOPH RES CO, V254, P454, DOI 10.1006/bbrc.1998.9964; Messa P, 2008, EXPERT OPIN DRUG MET, V4, P1551, DOI [10.1517/17425250802587017, 10.1517/17425250802587017 ]; Momberger TS, 2006, MATRIX BIOL, V25, P306, DOI 10.1016/j.matbio.2006.01.008; Moussaud S, 2009, CELL PHYSIOL BIOCHEM, V24, P141, DOI 10.1159/000233240; MULDOON LL, 1988, J BIOL CHEM, V263, P18834; Nakatani S, 2006, BIOCHEM BIOPH RES CO, V348, P1157, DOI 10.1016/j.bbrc.2006.07.180; Oca P, 2010, J CELL PHYSIOL, V224, P540, DOI 10.1002/jcp.22155; OYAJOBI BO, 1994, J BONE MINER RES, V9, P1259; Pawlotsky Y, 2008, J RHEUMATOL, V35, P315; PFEILSCHIFTER J, 1995, J CLIN INVEST, V96, P767, DOI 10.1172/JCI118121; Ponce A, 2006, CELL PHYSIOL BIOCHEM, V18, P35, DOI 10.1159/000095134; Punzi L, 2003, J RHEUMATOL, V30, P420; Qureshi HY, 2005, J CELL PHYSIOL, V203, P345, DOI 10.1002/jcp.20228; REES JA, 1988, ANN RHEUM DIS, V47, P747, DOI 10.1136/ard.47.9.747; ROSEN LB, 1994, NEURON, V12, P1207, DOI 10.1016/0896-6273(94)90438-3; ROSENTHAL AK, 1993, ARTHRITIS RHEUM, V36, P539, DOI 10.1002/art.1780360415; RYAN LM, 1986, J CLIN INVEST, V77, P1689, DOI 10.1172/JCI112487; Sanchez JC, 2003, GEN PHYSIOL BIOPHYS, V22, P487; Scherle PA, 1997, BIOCHEM BIOPH RES CO, V230, P573, DOI 10.1006/bbrc.1996.5985; Secondo A, 2000, MOL PHARMACOL, V58, P1115, DOI 10.1124/mol.58.5.1115; Shao Y, 2005, DEV DYNAM, V234, P54, DOI 10.1002/dvdy.20517; STOECKLIN G, 1994, J BIOL CHEM, V269, P28591; TERKELTAUB R, 1994, ARTHRITIS RHEUM, V37, P934, DOI 10.1002/art.1780370624; Tsai EY, 2000, MOL CELL BIOL, V20, P6084, DOI 10.1128/MCB.20.16.6084-6094.2000; Tuli R, 2002, ANN NY ACAD SCI, V961, P172, DOI 10.1111/j.1749-6632.2002.tb03077.x; Volpe A, 2009, JOINT BONE SPINE, V76, P708, DOI 10.1016/j.jbspin.2009.02.001; Wittrant Y, 2009, BIOCHEM BIOPH RES CO, V381, P259, DOI 10.1016/j.bbrc.2009.02.034; Xu J, 2009, OSTEOARTHR CARTILAGE, V17, P397, DOI 10.1016/j.joca.2008.07.001; Yellowley CE, 1999, J CELL PHYSIOL, V180, P402, DOI 10.1002/(SICI)1097-4652(199909)180:3<402::AID-JCP11>3.0.CO;2-4; Yosimichi G, 2001, EUR J BIOCHEM, V268, P6058, DOI 10.1046/j.0014-2956.2001.02553.x; Zhang W, 2000, J BIOL CHEM, V275, P39237, DOI 10.1074/jbc.M003339200; ZHU Z, 1995, EUR J CLIN INVEST, V25, P317, DOI 10.1111/j.1365-2362.1995.tb01708.x; Zuscik MJ, 1997, BIOCHEM BIOPH RES CO, V234, P432, DOI 10.1006/bbrc.1997.6661	54	12	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19215	19228		10.1074/jbc.M110.175448	http://dx.doi.org/10.1074/jbc.M110.175448			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21471198	Green Published, hybrid			2022-12-25	WOS:000291027700004
J	Diaz, A; Martinez-Pons, C; Fita, I; Ferrer, JC; Guinovart, JJ				Diaz, Adelaida; Martinez-Pons, Carlos; Fita, Ignacio; Ferrer, Juan C.; Guinovart, Joan J.			Processivity and Subcellular Localization of Glycogen Synthase Depend on a Non-catalytic High Affinity Glycogen-binding Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; PROTEIN; DEGRADATION; MECHANISM; DISEASE; GLUCOSE; LAFORA; DOMAIN	Glycogen synthase, a central enzyme in glucose metabolism, catalyzes the successive addition of alpha-1,4-linked glucose residues to the non-reducing end of a growing glycogen molecule. A non-catalytic glycogen-binding site, identified by x-ray crystallography on the surface of the glycogen synthase from the archaeon Pyrococcus abyssi, has been found to be functionally conserved in the eukaryotic enzymes. The disruption of this binding site in both the archaeal and the human muscle glycogen synthases has a large impact when glycogen is the acceptor substrate. Instead, the catalytic efficiency remains essentially unchanged when small oligosaccharides are used as substrates. Mutants of the human muscle enzyme with reduced affinity for glycogen also show an altered intracellular distribution and a marked decrease in their capacity to drive glycogen accumulation in vivo. The presence of a high affinity glycogen-binding site away from the active center explains not only the long-recognized strong binding of glycogen synthase to glycogen but also the processivity and the intracellular localization of the enzyme. These observations demonstrate that the glycogen-binding site is a critical regulatory element responsible for the in vivo catalytic efficiency of GS.	[Diaz, Adelaida; Martinez-Pons, Carlos; Fita, Ignacio; Guinovart, Joan J.] CSIC, Inst Res Biomed, E-08028 Barcelona, Spain; [Fita, Ignacio] CSIC, Inst Biol Mol Barcelona, E-08028 Barcelona, Spain; [Ferrer, Juan C.; Guinovart, Joan J.] Univ Barcelona, Dept Bioquim & Biol Mol, E-08028 Barcelona, Spain; [Diaz, Adelaida; Martinez-Pons, Carlos; Guinovart, Joan J.] CIBER Diabet & Enfermedades Metab, Barcelona 08017, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM	Guinovart, JJ (corresponding author), Baldiri & Reixac 10, Barcelona 08028, Spain.	guinovart@irbbarcelona.org	Fita, Ignasi/R-4515-2019; Ferrer, Joan C./AAP-2145-2021	Fita, Ignasi/0000-0002-7521-2679; Diaz-Vilchis, Adelaida/0000-0001-5891-1470; Ferrer, Joan C./0000-0003-1212-5161	Direccion General de Investigacion, Ministerio de Ciencia y Tecnologia, Spain [BFU2009-09268, CTQ2006-00743, BFU2008-00769]; Generalitat de Catalunya [2009SGR-1176]; Fundacion Marcelino Botin; CIBER de Diabetes y Enfermedades Metabolicas Asociadas; Ministerio de Ciencia e Innovacion; Juan de la Cierva [JCI-2006-4024-4021]; Ministerio de Educacion [AP2005-3078]	Direccion General de Investigacion, Ministerio de Ciencia y Tecnologia, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Fundacion Marcelino Botin; CIBER de Diabetes y Enfermedades Metabolicas Asociadas; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Juan de la Cierva(Instituto de Salud Carlos III); Ministerio de Educacion	This work was supported by the Direccion General de Investigacion, Ministerio de Ciencia y Tecnologia, Spain Grants BFU2009-09268 (to I. F.), CTQ2006-00743 (to J. C. F.), and BFU2008-00769 (to J. J. G.), a grant from the Generalitat de Catalunya AGAUR 2009SGR-1176 (to J. J. G.), a grant from the Fundacion Marcelino Botin, and the CIBER de Diabetes y Enfermedades Metabolicas Asociadas.; Recipient of a postdoctoral fellowship from the Ministerio de Ciencia e Innovacion and currently JCI-2006-4024-4021 Juan de la Cierva.; Recipient of Predoctoral Fellowship AP2005-3078 from the Ministerio de Educacion.	[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Baba O, 1993, Kokubyo Gakkai Zasshi, V60, P264; Baskaran S, 2010, P NATL ACAD SCI USA, V107, P17563, DOI 10.1073/pnas.1006340107; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buschiazzo A, 2004, EMBO J, V23, P3196, DOI 10.1038/sj.emboj.7600324; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cheng A, 2007, GENE DEV, V21, P2399, DOI 10.1101/gad.1553207; Cid E, 2005, FEBS J, V272, P3197, DOI 10.1111/j.1742-4658.2005.04738.x; Cid E, 2002, FEBS LETT, V528, P5, DOI 10.1016/S0014-5793(02)03313-6; Cohen PTW, 2002, J CELL SCI, V115, P241; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferrer JC, 1997, FEBS LETT, V415, P249, DOI 10.1016/S0014-5793(97)01136-8; Gloeckner CJ, 2007, PROTEOMICS, V7, P4228, DOI 10.1002/pmic.200700038; Guillen D, 2010, APPL MICROBIOL BIOT, V85, P1241, DOI 10.1007/s00253-009-2331-y; Horcajada C, 2006, J BIOL CHEM, V281, P2923, DOI 10.1074/jbc.M507394200; Horcajada C, 2003, ACTA CRYSTALLOGR D, V59, P2322, DOI 10.1107/S0907444903021279; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; McBride A, 2009, CELL METAB, V9, P23, DOI 10.1016/j.cmet.2008.11.008; MELENDEZHEVIA E, 1993, BIOCHEM J, V295, P477, DOI 10.1042/bj2950477; NEWGARD CB, 1983, J BIOL CHEM, V258, P8046; Phair RD, 2004, METHOD ENZYMOL, V375, P393; Pinotsis N, 2003, PROTEIN SCI, V12, P1914, DOI 10.1110/ps.03149503; Qing GL, 2004, NAT BIOTECHNOL, V22, P877, DOI 10.1038/nbt984; Sheng F, 2009, BIOCHEMISTRY-US, V48, P10089, DOI 10.1021/bi900916t; Sheng F, 2009, J BIOL CHEM, V284, P17796, DOI 10.1074/jbc.M809804200; SKURAT AV, 1994, J BIOL CHEM, V269, P25534; Stapleton D, 2010, PROTEOMICS, V10, P2320, DOI 10.1002/pmic.200900628; TAKEDA Y, 1975, J BIOL CHEM, V250, P8943; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; THOMAS JA, 1968, ANAL BIOCHEM, V25, P486, DOI 10.1016/0003-2697(68)90127-9; Vilchez D, 2007, NAT NEUROSCI, V10, P1407, DOI 10.1038/nn1998; Wang JY, 2002, J BIOL CHEM, V277, P2377, DOI 10.1074/jbc.C100686200; Wilson WA, 2010, CAN J MICROBIOL, V56, P408, DOI [10.1139/W10-027, 10.1139/w10-027]; Worby CA, 2008, J BIOL CHEM, V283, P4069, DOI 10.1074/jbc.M708712200	35	19	19	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18505	18514		10.1074/jbc.M111.236109	http://dx.doi.org/10.1074/jbc.M111.236109			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21464127	hybrid, Green Published			2022-12-25	WOS:000290785700023
J	de Oliveira, AL; Gallo, M; Pazzagli, L; Benedetti, CE; Cappugi, G; Scala, A; Pantera, B; Spisni, A; Pertinhez, TA; Cicero, DO				de Oliveira, Aline L.; Gallo, Mariana; Pazzagli, Luigia; Benedetti, Celso E.; Cappugi, Gianni; Scala, Aniello; Pantera, Barbara; Spisni, Alberto; Pertinhez, Thelma A.; Cicero, Daniel O.			The Structure of the Elicitor Cerato-platanin (CP), the First Member of the CP Fungal Protein Family, Reveals a Double psi beta-Barrel Fold and Carbohydrate Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESIDUAL DIPOLAR COUPLINGS; RESONANCE ASSIGNMENTS; PHYTOTOXIC PROTEIN; BIOCHEMICAL-CHARACTERIZATION; SYSTEMIC RESISTANCE; MAGNAPORTHE-GRISEA; CRYSTAL-STRUCTURE; SECRETED PROTEIN; SH3 DOMAIN; SEQUENCE	Cerato-platanin (CP) is a secretion protein produced by the fungal pathogen Ceratocystis platani, the causal agent of the plane canker disease and the first member of the CP family. CP is considered a pathogen-associated molecular pattern because it induces various defense responses in the host, including production of phytoalexins and cell death. Although much is known about the properties of CP and related proteins as elicitors of plant defense mechanisms, its biochemical activity and host target(s) remain elusive. Here, we present the three-dimensional structure of CP. The protein, which exhibits a remarkable pH and thermal stability, has a double psi beta-barrel fold quite similar to those found in expansins, endoglucanases, and the plant defense protein barwin. Interestingly, although CP lacks lytic activity against a variety of carbohydrates, it binds oligosaccharides. We identified the CP region responsible for binding as a shallow surface located at one side of the beta-barrel. Chemical shift perturbation of the protein amide protons, induced by oligo-N-acetylglucosamines of various size, showed that all the residues involved in oligosaccharide binding are conserved among the members of the CP family. Overall, the results suggest that CP might be involved in polysaccharide recognition and that the double psi beta-barrel fold is widespread in distantly related organisms, where it is often involved in host-microbe interactions.	[Spisni, Alberto; Pertinhez, Thelma A.] Univ Parma, Dept Expt Med, I-43125 Parma, Italy; [de Oliveira, Aline L.; Benedetti, Celso E.] Natl Lab Biosci, BR-13083100 Campinas, SP, Brazil; [Gallo, Mariana; Cicero, Daniel O.] Univ Roma Tor Vergata, Dept Chem Sci & Technol, I-00133 Rome, Italy; [Pazzagli, Luigia; Cappugi, Gianni; Pantera, Barbara] Univ Florence, Dept Biochem Sci, I-50134 Florence, Italy; [Scala, Aniello] Univ Florence, Dept Agr Biotechnol, I-50134 Florence, Italy	University of Parma; University of Rome Tor Vergata; University of Florence; University of Florence	Spisni, A (corresponding author), Univ Parma, Dept Expt Med, Via Volturno 39, I-43125 Parma, Italy.	alberto.spisni@unipr.it; cicero@scienze.uniroma2.it	Oliveira, Aline L/D-2953-2012; Cicero, Daniel/AAV-5203-2021; Spisni, Alberto/AAY-7778-2020; Citros, Inct/I-2442-2013	Oliveira, Aline L/0000-0002-6928-078X; Benedetti, Celso/0000-0002-4602-0256; Gallo, Mariana/0000-0002-0022-4499	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [99/11030-9, TAP 00/02026-7, Smolbnet 00/10266-8]; Ministero dell'Istruzione dell'Universita e della Ricerca (MIUR) [20050717.5-002]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [BEX3666/05-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Ministero dell'Istruzione dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported in part by grants from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (NMR Project 99/11030-9, TAP 00/02026-7, Smolbnet 00/10266-8) and from the Ministero dell'Istruzione dell'Universita e della Ricerca (MIUR) (PRIN 2005 20050717.5-002). Some of the CD and NMR experiments were carried out using equipment at the Centro Interfacolta Misure, University of Parma.; Supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) Fellowship 03/12418-8 and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) Fellowship BEX3666/05-0. Present address: Inst. de Quimica, Universidade Federal de Goias, 74001-970 Goiania, Brazil.	Bent AF, 2007, ANNU REV PHYTOPATHOL, V45, P399, DOI 10.1146/annurev.phyto.45.062806.094427; Bernardi R., 2011, FOREST PATH IN PRESS, V41; Blackburn NT, 2001, J MOL EVOL, V52, P78, DOI 10.1007/s002390010136; Boddi S, 2004, FEMS MICROBIOL LETT, V233, P341, DOI [10.1016/j.femsle.2004.03.001, 10.1111/j.1574-6968.2004.tb09501.x]; Boller T, 2009, SCIENCE, V324, P742, DOI 10.1126/science.1171647; Carresi L, 2006, PROTEIN EXPRES PURIF, V49, P159, DOI 10.1016/j.pep.2006.07.006; Castillo RM, 1999, STRUCTURE, V7, P227, DOI 10.1016/S0969-2126(99)80028-8; CERVONE F, 1989, PLANT PHYSIOL, V90, P542, DOI 10.1104/pp.90.2.542; Cicero DO, 2006, J MAGN RESON, V180, P222, DOI 10.1016/j.jmr.2006.02.016; Clore GM, 1999, J AM CHEM SOC, V121, P9008, DOI 10.1021/ja991789k; Comparini C, 2009, APPL MICROBIOL BIOT, V84, P309, DOI 10.1007/s00253-009-1998-4; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Davies GJ, 1995, BIOCHEMISTRY-US, V34, P16210, DOI 10.1021/bi00049a037; de Jonge R, 2010, SCIENCE, V329, P953, DOI 10.1126/science.1190859; de Wit PJGM, 2007, CELL MOL LIFE SCI, V64, P2726, DOI 10.1007/s00018-007-7284-7; de Wit PJGM, 2009, MOL PLANT PATHOL, V10, P735, DOI 10.1111/j.1364-3703.2009.00591.x; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Djonovic S, 2007, PLANT PHYSIOL, V145, P875, DOI 10.1104/pp.107.103689; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Eliseo T, 2007, BIOCHEMISTRY-US, V46, P12557, DOI 10.1021/bi7013085; Eriksson J, 2005, J COLLOID INTERF SCI, V285, P94, DOI 10.1016/j.jcis.2004.10.042; Fontana F, 2008, J PLANT PATHOL, V90, P295; GILKES NR, 1991, MICROBIOL REV, V55, P303, DOI 10.1128/MMBR.55.2.303-315.1991; Grzesiek S, 1996, NAT STRUCT BIOL, V3, P340, DOI 10.1038/nsb0496-340; Gueguen Y, 1997, J BIOL CHEM, V272, P31258, DOI 10.1074/jbc.272.50.31258; Hematy K, 2009, CURR OPIN PLANT BIOL, V12, P406, DOI 10.1016/j.pbi.2009.06.007; Henrissat B, 1996, BIOCHEM J, V316, P695, DOI 10.1042/bj3160695; Hirvonen M, 2003, J MOL BIOL, V329, P403, DOI 10.1016/S0022-2836(03)00467-4; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Hseu YC, 2005, INT IMMUNOPHARMACOL, V5, P1914, DOI 10.1016/j.intimp.2005.06.013; Jeong JS, 2007, FEMS MICROBIOL LETT, V273, P157, DOI 10.1111/j.1574-6968.2007.00796.x; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Jones JA, 1997, J BIOMOL NMR, V10, P199, DOI 10.1023/A:1018304117895; Juge N, 2006, TRENDS PLANT SCI, V11, P359, DOI 10.1016/j.tplants.2006.05.006; Kerff F, 2008, P NATL ACAD SCI USA, V105, P16876, DOI 10.1073/pnas.0809382105; Kim YT, 2010, MOL BIOL REP, V37, P717, DOI 10.1007/s11033-009-9570-y; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee CG, 2008, CURR OPIN IMMUNOL, V20, P684, DOI 10.1016/j.coi.2008.10.002; Losonczi JA, 1999, J MAGN RESON, V138, P334, DOI 10.1006/jmre.1999.1754; LUDVIGSEN S, 1992, BIOCHEMISTRY-US, V31, P8783, DOI 10.1021/bi00152a014; McFeeters R, 2005, J BIOMOL NMR, V31, P35, DOI 10.1007/s10858-004-6057-y; MUHANDIRAM DR, 1993, J MAGN RESON SER B, V102, P317, DOI 10.1006/jmrb.1993.1102; Oliveira AL, 2006, J BIOMOL NMR, V36, P50, DOI 10.1007/s10858-006-9023-z; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; PAN SC, 1995, INFECT IMMUN, V63, P3994, DOI 10.1128/IAI.63.10.3994-4002.1995; Pazzagli L, 1999, J BIOL CHEM, V274, P24959, DOI 10.1074/jbc.274.35.24959; Pazzagli L, 2006, CELL BIOCHEM BIOPHYS, V44, P512, DOI 10.1385/CBB:44:3:512; Pazzagli L, 2009, BBA-GEN SUBJECTS, V1790, P1334, DOI 10.1016/j.bbagen.2009.07.014; Pitzschke A, 2009, CURR OPIN PLANT BIOL, V12, P421, DOI 10.1016/j.pbi.2009.06.008; Powell AJ, 2006, J MOL BIOL, V359, P122, DOI 10.1016/j.jmb.2006.03.023; Rementeria Aitor, 2005, Revista Iberoamericana de Micologia, V22, P1, DOI 10.1016/S1130-1406(05)70001-2; Sampedro J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-242; Scala A, 2004, J PLANT PATHOL, V86, P27; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Seidl V, 2006, FEBS J, V273, P4346, DOI 10.1111/j.1742-4658.2006.05435.x; Svozilova Z, 2009, ANAL BIOCHEM, V390, P115, DOI 10.1016/j.ab.2009.04.012; Vargas WA, 2008, J BIOL CHEM, V283, P19804, DOI 10.1074/jbc.M802724200; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Waldeck AR, 1997, PROG NUCL MAG RES SP, V30, P39, DOI 10.1016/S0079-6565(96)01034-5; Wang YX, 1998, J AM CHEM SOC, V120, P7385, DOI 10.1021/ja980862o; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q; Wilson LM, 2002, MOL PLANT PATHOL, V3, P487, DOI 10.1046/j.1364-3703.2002.00144.x; Wood T.M., 1988, METHOD ENZYMOL, P87, DOI DOI 10.1016/0076-6879(88)60109-1; Yang YY, 2009, PLANT BIOTECHNOL J, V7, P763, DOI 10.1111/j.1467-7652.2009.00442.x; YORK WS, 1986, METHOD ENZYMOL, V118, P3; Zaparoli G, 2009, MYCOL RES, V113, P61, DOI 10.1016/j.mycres.2008.08.004; ZHANG OW, 1994, J BIOMOL NMR, V4, P845, DOI 10.1007/BF00398413; Zipfel C, 2009, CURR OPIN PLANT BIOL, V12, P414, DOI 10.1016/j.pbi.2009.06.003; Zweckstetter M, 2000, J AM CHEM SOC, V122, P3791, DOI 10.1021/ja0000908	69	78	78	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17560	17568		10.1074/jbc.M111.223644	http://dx.doi.org/10.1074/jbc.M111.223644			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454637	Green Published, hybrid			2022-12-25	WOS:000290585200018
J	Yan, WS; Zhang, YH; Zhang, J; Liu, S; Cho, SJ; Chen, XB				Yan, Wensheng; Zhang, Yanhong; Zhang, Jin; Liu, Shou; Cho, Seong Jun; Chen, Xinbin			Mutant p53 Protein Is Targeted by Arsenic for Degradation and Plays a Role in Arsenic-mediated Growth Suppression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; LI-FRAUMENI-SYNDROME; GENE-EXPRESSION; INDUCED APOPTOSIS; OXIDATIVE STRESS; TP53 MUTATIONS; NUCLEAR EXPORT; HUMAN CANCERS; CORE DOMAIN; CELL LINES	p53 is frequently mutated in tumor cells, and mutant p53 is often highly expressed due to its increased half-life. Thus, targeting mutant p53 for degradation might be explored as a therapeutic strategy to manage tumors that are addicted to mutant p53 for survival. Arsenic trioxide, a drug for patients with acute promyelocytic leukemia, is found to target and degrade a class of proteins with high levels of cysteine residues and vicinal thiol groups, such as promyelocytic leukemia protein (PML) and PML-retinoic acid receptor alpha fusion protein. Interestingly, wild type p53 is accumulated in cells treated with arsenic compounds, presumably due to arsenic-induced oxidative stresses. In this study, we found that wild type p53 is induced by arsenic trioxide in tumor cells, consistent with published studies. In contrast, we found that arsenic compounds degrade both endogenous and ectopically expressed mutant p53 in time-and dose-dependent manners. We also found that arsenic trioxide decreases the stability of mutant p53 protein through a proteasomal pathway, and blockage of mutant p53 nuclear export can alleviate the arsenic-induced mutant p53 degradation. Furthermore, we found that knockdown of endogenous mutant p53 sensitizes, whereas ectopic expression of mutant p53 desensitizes, tumor cells to arsenic treatment. Taken together, we found that mutant p53 is a target of arsenic compounds, which provides an insight into exploring arsenic compound-based therapy for tumors harboring a mutant p53.	[Yan, Wensheng; Zhang, Yanhong; Zhang, Jin; Liu, Shou; Cho, Seong Jun; Chen, Xinbin] Univ Calif Davis, Comparat Oncol Lab, Davis, CA 95616 USA	University of California System; University of California Davis	Chen, XB (corresponding author), Univ Calif Davis, Comparat Oncol Lab, Davis, CA 95616 USA.	xbchen@ucdavis.edu	liu, shou/C-5406-2015; qiao, zhixin/I-3408-2012; Cho, Seong-Jun/P-2491-2019		National Institutes of Health [R01CA121137]; NATIONAL CANCER INSTITUTE [P30CA093373, R01CA121137] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA121137.	Bergamaschi D, 2003, CANCER CELL, V3, P387, DOI 10.1016/S1535-6108(03)00079-5; Bossi G, 2006, ONCOGENE, V25, P304, DOI 10.1038/sj.onc.1209026; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Carney DA, 2008, LEUKEMIA LYMPHOMA, V49, P1846, DOI 10.1080/10428190802464745; Carter S, 2007, NAT CELL BIOL, V9, P428, DOI 10.1038/ncb1562; Cheng YH, 2006, ARCH TOXICOL, V80, P310, DOI 10.1007/s00204-005-0045-1; DeYoung MP, 2007, ONCOGENE, V26, P5169, DOI 10.1038/sj.onc.1210337; Di Como CJ, 1999, MOL CELL BIOL, V19, P1438; Frazier MW, 1998, MOL CELL BIOL, V18, P3735, DOI 10.1128/MCB.18.7.3735; Freedman DA, 1998, MOL CELL BIOL, V18, P7288, DOI 10.1128/MCB.18.12.7288; Gaiddon C, 2001, MOL CELL BIOL, V21, P1874, DOI 10.1128/MCB.21.5.1874-1887.2001; Haupt S, 2009, CANCER RES, V69, P4818, DOI 10.1158/0008-5472.CAN-08-4010; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Ichimiya S, 1999, ONCOGENE, V18, P1061, DOI 10.1038/sj.onc.1202390; Ishitsuka K, 2000, LEUKEMIA LYMPHOMA, V37, P649, DOI 10.3109/10428190009058521; Jeanne M, 2010, CANCER CELL, V18, P88, DOI 10.1016/j.ccr.2010.06.003; Jiang XH, 2001, INT J CANCER, V91, P173, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1039>3.0.CO;2-D; Jing YK, 1999, BLOOD, V94, P2102, DOI 10.1182/blood.V94.6.2102; Kim J, 2010, P NATL ACAD SCI USA, V107, P13432, DOI 10.1073/pnas.1006822107; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Lambert JMR, 2009, CANCER CELL, V15, P376, DOI 10.1016/j.ccr.2009.03.003; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Lee JH, 2008, J BIOL CHEM, V283, P19826, DOI 10.1074/jbc.M706201200; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Li Y, 2007, ONCOGENE, V26, P2220, DOI 10.1038/sj.onc.1210311; Lukashchuk N, 2007, MOL CELL BIOL, V27, P8284, DOI 10.1128/MCB.00050-07; Lundgren K, 1997, GENE DEV, V11, P714, DOI 10.1101/gad.11.6.714; Mann KK, 2008, MOL CANCER THER, V7, P1680, DOI 10.1158/1535-7163.MCT-07-2164; Miller WH, 2002, CANCER RES, V62, P3893; Moll UM, 2004, MOL CANCER RES, V2, P371; Momand J, 1998, NUCLEIC ACIDS RES, V26, P3453, DOI 10.1093/nar/26.15.3453; Morton JP, 2010, P NATL ACAD SCI USA, V107, P246, DOI 10.1073/pnas.0908428107; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; Pelicano H, 2003, J BIOL CHEM, V278, P37832, DOI 10.1074/jbc.M301546200; Peng YH, 2001, J BIOL CHEM, V276, P40583, DOI 10.1074/jbc.M102817200; Petitjean A, 2007, ONCOGENE, V26, P2157, DOI 10.1038/sj.onc.1210302; Platanias LC, 2009, J BIOL CHEM, V284, P18583, DOI 10.1074/jbc.R900003200; Poeta ML, 2007, NEW ENGL J MED, V357, P2552, DOI 10.1056/NEJMoa073770; Rollig C, 2009, CANCER TREAT REV, V35, P425, DOI 10.1016/j.ctrv.2009.04.007; Sakurai Teruaki, 2006, Environmental Sciences, V13, P101; Schmidt D, 2002, P NATL ACAD SCI USA, V99, P2872, DOI 10.1073/pnas.052559499; Scian MJ, 2005, MOL CELL BIOL, V25, P10097, DOI 10.1128/MCB.25.22.10097-10110.2005; Shackelford D, 2006, CANCER RES, V66, P11360, DOI 10.1158/0008-5472.CAN-06-1774; Shen L, 2000, J BIOL REG HOMEOS AG, V14, P116; Shen Y, 2001, LEUKEMIA, V15, P735, DOI 10.1038/sj.leu.2402106; Strano S, 2002, J BIOL CHEM, V277, P18817, DOI 10.1074/jbc.M201405200; Strano S, 2000, J BIOL CHEM, V275, P29503, DOI 10.1074/jbc.M003360200; Terzian T, 2008, GENE DEV, V22, P1337, DOI 10.1101/gad.1662908; Tomasini R, 2008, GENE DEV, V22, P2677, DOI 10.1101/gad.1695308; Weger S, 2005, FEBS LETT, V579, P5007, DOI 10.1016/j.febslet.2005.07.088; Wu XS, 2010, CANCER BIOL THER, V10, P1202, DOI 10.4161/cbt.10.11.13669; Yan WS, 2008, CANCER RES, V68, P6789, DOI 10.1158/0008-5472.CAN-08-0810; Yan WS, 2010, J BIOL CHEM, V285, P14229, DOI 10.1074/jbc.M109.097253; Yan WS, 2009, J BIOL CHEM, V284, P12178, DOI 10.1074/jbc.M900994200; Yan WS, 2006, J BIOL CHEM, V281, P7856, DOI 10.1074/jbc.M512655200; Zalcenstein A, 2003, ONCOGENE, V22, P5667, DOI 10.1038/sj.onc.1206724; Zhang QY, 2009, P NATL ACAD SCI USA, V106, P3378, DOI 10.1073/pnas.0813142106; Zhang TD, 2001, ONCOGENE, V20, P7146, DOI 10.1038/sj.onc.1204762; Zhang XW, 2010, SCIENCE, V328, P240, DOI 10.1126/science.1183424	62	45	49	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17478	17486		10.1074/jbc.M111.231639	http://dx.doi.org/10.1074/jbc.M111.231639			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454520	Green Published, hybrid			2022-12-25	WOS:000290585200009
J	Giddings, LA; Liscombe, DK; Hamilton, JP; Childs, KL; DellaPenna, D; Buell, CR; O'Connor, SE				Giddings, Lesley-Ann; Liscombe, David K.; Hamilton, John P.; Childs, Kevin L.; DellaPenna, Dean; Buell, C. Robin; O'Connor, Sarah E.			A Stereoselective Hydroxylation Step of Alkaloid Biosynthesis by a Unique Cytochrome P450 in Catharanthus roseus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MADAGASCAR PERIWINKLE; TABERSONINE; ENZYME; EXPRESSION; CULTURES; CHEMISTRY; GENES; YEAST	Plant cytochrome P450s are involved in the production of over a hundred thousand metabolites such as alkaloids, terpenoids, and phenylpropanoids. Although cytochrome P450 genes constitute one of the largest superfamilies in plants, many of the catalytic functions of the enzymes they encode remain unknown. Here, we report the identification and functional characterization of a cytochrome P450 gene in a new subfamily of CYP71, CYP71BJ1, involved in alkaloid biosynthesis. Co-expression analysis of putative cytochrome P450 genes in the Catharanthus roseus transcriptome identified candidate genes with expression profiles similar to known terpene indole alkaloid biosynthetic genes. Screening of these candidate genes by functional expression in Saccharomyces cerevisiae yielded a unique P450-dependent enzyme that stereoselectively hydroxylates the alkaloids tabersonine and lochnericine at the 19-position of the aspidosperma-type alkaloid scaffold. Tabersonine, which can be converted to either vindoline or 19-O-acetylhorhammericine, represents a branch point in alkaloid biosynthesis. The discovery of CYP71BJ1, which forms part of the pathway leading to 19-O-acetylhorhammericine, will help illuminate how this branch point is controlled in C. roseus.	[Giddings, Lesley-Ann; Liscombe, David K.; O'Connor, Sarah E.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Hamilton, John P.; Childs, Kevin L.; Buell, C. Robin] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [DellaPenna, Dean] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	Massachusetts Institute of Technology (MIT); Michigan State University; Michigan State University	O'Connor, SE (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.	soc@mit.edu	O'Connor, Sarah Ellen/X-2893-2019; Hamilton, John P/G-1379-2016; O'Connor, Sarah/O-5850-2016; Childs, Kevin/C-9513-2014	Hamilton, John P/0000-0002-8682-5526; Giddings, Lesley-Ann/0000-0003-1089-1276; Buell, C Robin/0000-0002-6727-4677; O'Connor, Sarah/0000-0003-0356-6213; Childs, Kevin/0000-0002-3680-062X	National Institutes of Health [GM074820, RC2GM092521, 1S10RR13886-01]; National Science Foundation; Ford Foundation; Natural Sciences and Engineering Research Council of Canada; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR013886] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC2GM092521, R01GM074820] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Ford Foundation; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by grants from the National Institutes of Health (GM074820 and RC2GM092521). Funding for the MIT-DCIF Avance (DPX) 400 MHz NMR spectrometer was provided by the National Institutes of Health (Award 1S10RR13886-01).; Supported by fellowships from National Science Foundation and the Ford Foundation.; Recipient of a Natural Sciences and Engineering Research Council of Canada Postdoctoral Fellowship.	ABRAHAM DJ, 1969, J ORG CHEM, V34, P1575, DOI 10.1021/jo01258a009; Collu G, 2001, FEBS LETT, V508, P215, DOI 10.1016/S0014-5793(01)03045-9; Ehlting J, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-47; Facchini PJ, 2008, PLANT J, V54, P763, DOI 10.1111/j.1365-313X.2008.03438.x; FURUYA T, 1992, PHYTOCHEMISTRY, V31, P3065, DOI 10.1016/0031-9422(92)83447-7; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Hisiger Steve, 2007, Phytochemistry Reviews, V6, P207, DOI 10.1007/s11101-006-9036-y; HOTZE M, 1995, FEBS LETT, V374, P345, DOI 10.1016/0014-5793(95)01141-Z; Irmler S, 2000, PLANT J, V24, P797, DOI 10.1046/j.1365-313x.2000.00922.x; Jensen K, 2010, PHYTOCHEMISTRY, V71, P132, DOI 10.1016/j.phytochem.2009.10.017; Kaltenbach M, 1999, PLANT J, V19, P183, DOI 10.1046/j.1365-313X.1999.00524.x; KOHL W, 1981, Z NATURFORSCH B, V36, P1153; KUTNEY JP, 1980, PHYTOCHEMISTRY, V19, P2589, DOI 10.1016/S0031-9422(00)83924-2; Laflamme P, 2001, PLANT PHYSIOL, V125, P189, DOI 10.1104/pp.125.1.189; LANGLOIS N, 1979, J ORG CHEM, V44, P2468, DOI 10.1021/jo01328a028; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Liscombe DK, 2010, P NATL ACAD SCI USA, V107, P18793, DOI 10.1073/pnas.1009003107; Matsuno M, 2009, SCIENCE, V325, P1688, DOI 10.1126/science.1174095; Mizutani M, 2010, ANNU REV PLANT BIOL, V61, P291, DOI 10.1146/annurev-arplant-042809-112305; Morgan JA, 1999, PHYTOCHEMISTRY, V51, P61, DOI 10.1016/S0031-9422(98)00585-8; Nelson DR, 2004, PLANT PHYSIOL, V135, P756, DOI 10.1104/pp.104.039826; NIELSEN KA, 2005, CYTOCHROME P450 STRU, P553; O'Connor SE, 2006, NAT PROD REP, V23, P532, DOI 10.1039/b512615k; Pompon D, 1996, METHOD ENZYMOL, V272, P51, DOI 10.1016/S0076-6879(96)72008-6; Rodriguez S, 2003, PHYTOCHEMISTRY, V64, P401, DOI 10.1016/S0031-9422(03)00269-3; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schroder G, 1999, FEBS LETT, V458, P97, DOI 10.1016/S0014-5793(99)01138-2; Shanks JV, 1998, BIOTECHNOL BIOENG, V58, P333, DOI 10.1002/(SICI)1097-0290(19980420)58:2/3&lt;333::AID-BIT35&gt;3.0.CO;2-A; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	29	91	94	2	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16751	16757		10.1074/jbc.M111.225383	http://dx.doi.org/10.1074/jbc.M111.225383			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454651	Green Published, hybrid			2022-12-25	WOS:000290301900023
J	Giralt, A; Hondares, E; Villena, JA; Ribas, F; Diaz-Delfin, J; Giralt, M; Iglesias, R; Villarroya, F				Giralt, Albert; Hondares, Elayne; Villena, Josep A.; Ribas, Francesc; Diaz-Delfin, Julieta; Giralt, Marta; Iglesias, Roser; Villarroya, Francesc			Peroxisome Proliferator-activated Receptor-gamma Coactivator-1 alpha Controls Transcription of the Sirt3 Gene, an Essential Component of the Thermogenic Brown Adipocyte Phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSINE ACETYLATION; EXPRESSION; HOMOLOG; ALPHA; FAT; DIFFERENTIATION; MITOCHONDRIA; METABOLISM; SIRTUINS; DEACETYLASE	Sirt3 (silent mating type information regulation 2, homolog 3), a member of the sirtuin family of protein deacetylases with multiple actions on metabolism and gene expression is expressed in association with brown adipocyte differentiation. Using Sirt3-null brown adipocytes, we determined that Sirt3 is required for an appropriate responsiveness of cells to noradrenergic, cAMP-mediated activation of the expression of brown adipose tissue thermogenic genes. The transcriptional coactivator Pgc-1 alpha (peroxisome proliferator-activated receptor-gamma coactivator-1 alpha) induced Sirt3 gene expression in white adipocytes and embryonic fibroblasts as part of its overall induction of a brown adipose tissue-specific pattern of gene expression. In cells lacking Sirt3, Pgc-1 alpha failed to fully induce the expression of brown fat-specific thermogenic genes. Pgc-1 alpha activates Sirt3 gene transcription through coactivation of the orphan nuclear receptor Err (estrogen-related receptor)-alpha, which bound the proximal Sirt3 gene promoter region. Err alpha knockdown assays indicated that Err alpha is required for full induction of Sirt3 gene expression in response to Pgc-1 alpha. The present results indicate that Pgc-1 alpha controls Sirt3 gene expression and this action is an essential component of the overall mechanisms by which Pgc-1 alpha induces the full acquisition of a brown adipocyte differentiated phenotype.	[Giralt, Albert; Hondares, Elayne; Ribas, Francesc; Diaz-Delfin, Julieta; Giralt, Marta; Iglesias, Roser; Villarroya, Francesc] Univ Barcelona, IBUB, Dept Bioquim & Biol Mol, E-08028 Barcelona, Spain; [Giralt, Albert; Hondares, Elayne; Ribas, Francesc; Diaz-Delfin, Julieta; Giralt, Marta; Iglesias, Roser; Villarroya, Francesc] CIBER Fisiopatol Obesidad & Nutr, Barcelona 08028, Spain; [Villena, Josep A.] Inst Recerca Vall Hebron, Barcelona 08035, Spain	University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR)	Villarroya, F (corresponding author), Univ Barcelona, IBUB, Dept Bioquim & Biol Mol, Avda Diagonal 645, E-08028 Barcelona, Spain.	fvillarroya@ub.edu	Villarroya, Francesc/K-4357-2014; Aulinas, Francesc Ribas/B-7677-2018; Villena, Josep A/H-1597-2015; Giralt, Albert/M-7672-2015; Iglesias, Roser/C-5561-2017; Giralt, Marta/A-4756-2013	Aulinas, Francesc Ribas/0000-0001-7672-4775; Giralt, Albert/0000-0001-5334-0963; Iglesias, Roser/0000-0002-7107-8097; Giralt, Marta/0000-0001-7968-4190; Villarroya, Francesc/0000-0003-1266-9142; Giralt, Albert/0000-0003-4498-063X; Villena, Josep A/0000-0002-2200-2985	Ministerio de Ciencia e Innovacion, Spain [SAF2008-01896]; Generalitat de Catalunya [2009SGR-284]	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya)	The work was supported by Grant SAF2008-01896 from the Ministerio de Ciencia e Innovacion, Spain, and Grant 2009SGR-284 from the Generalitat de Catalunya.	Bao JJ, 2010, CELL MOL LIFE SCI, V67, P3073, DOI 10.1007/s00018-010-0402-y; Bellizzi D, 2005, GENOMICS, V85, P258, DOI 10.1016/j.ygeno.2004.11.003; Bellizzi D, 2007, GENOMICS, V89, P143, DOI 10.1016/j.ygeno.2006.09.004; Busch BB, 2004, J MED CHEM, V47, P5593, DOI 10.1021/jm049334f; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Carmona MC, 2005, BIOCHEM J, V389, P47, DOI 10.1042/BJ20050009; Debevec D, 2007, MOL ENDOCRINOL, V21, P1581, DOI 10.1210/me.2007-0103; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Hansen JB, 2004, P NATL ACAD SCI USA, V101, P4112, DOI 10.1073/pnas.0301964101; Herzog B, 2006, J BIOL CHEM, V281, P99, DOI 10.1074/jbc.M509276200; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Hondares E, 2006, ENDOCRINOLOGY, V147, P2829, DOI 10.1210/en.2006-0070; Huang JY, 2010, BBA-PROTEINS PROTEOM, V1804, P1645, DOI 10.1016/j.bbapap.2009.12.021; Jacobs KM, 2008, INT J BIOL SCI, V4, P291; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; KLAUS S, 1994, J CELL SCI, V107, P313; Kong XX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011707; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Mercader J, 2010, OBESITY, V18, P655, DOI 10.1038/oby.2009.330; Pillai VB, 2010, J BIOL CHEM, V285, P3133, DOI 10.1074/jbc.M109.077271; Rose G, 2003, EXP GERONTOL, V38, P1065, DOI 10.1016/S0531-5565(03)00209-2; Scher MB, 2007, GENE DEV, V21, P920, DOI 10.1101/gad.1527307; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Shi T, 2005, J BIOL CHEM, V280, P13560, DOI 10.1074/jbc.M414670200; Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162; Tiraby C, 2003, J BIOL CHEM, V278, P33370, DOI 10.1074/jbc.M305235200; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Villarroya F, 2009, J PHYSIOL SCI, V59, P279; Villena JA, 2007, P NATL ACAD SCI USA, V104, P1418, DOI 10.1073/pnas.0607696104; Wabitsch M, 2001, INT J OBESITY, V25, P8, DOI 10.1038/sj.ijo.0801520	32	153	165	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16958	16966		10.1074/jbc.M110.202390	http://dx.doi.org/10.1074/jbc.M110.202390			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454513	hybrid, Green Published			2022-12-25	WOS:000290301900045
J	Komori, T; Nakamura, T; Matsunaga, I; Morita, D; Hattori, Y; Kuwata, H; Fujiwara, N; Hiromatsu, K; Harashima, H; Sugita, M				Komori, Takaya; Nakamura, Takashi; Matsunaga, Isamu; Morita, Daisuke; Hattori, Yuki; Kuwata, Hirotaka; Fujiwara, Nagatoshi; Hiromatsu, Kenji; Harashima, Hideyoshi; Sugita, Masahiko			A Microbial Glycolipid Functions as a New Class of Target Antigen for Delayed-type Hypersensitivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYCOBACTERIUM-TUBERCULOSIS INFECTION; OCTAARGININE-MODIFIED LIPOSOMES; T-CELL RECOGNITION; LIPID ANTIGENS; INTRACELLULAR TRAFFICKING; ENDOPLASMIC-RETICULUM; PRESENTING MOLECULES; IMMUNE-RESPONSES; CD1 MOLECULES; GUINEA-PIGS	Delayed-type hypersensitivity (DTH) is marked by high levels of protein antigen-specific T cell responses in sensitized individuals. Recent evidence has revealed a distinct pathway for T cell immunity directed against glycolipid antigens, but DTH to this class of antigen has been undetermined and difficult to prove due to their insolubility in aqueous solutions. Here, glucose monomycolate (GMM), a highly hydrophobic glycolipid of the cell wall of mycobacteria, was dispersed in aqueous solutions in the form of octaarginine-modified liposomes and tested for its ability to elicit cutaneous DTH responses in bacillus Calmette-Guerin (BCG)-immunized guinea pigs. After an intradermal challenge with the GMM liposome, a significant skin induration was observed in BCG-immunized, but not mock-treated, animals. The skin reaction peaked at around 2 days with local infiltration by mononuclear cells, and therefore, the response shared basic features with the classical DTH to protein antigens. Lymph node T cells from BCG-immunized guinea pigs specifically increased IFN-gamma transcription in response to the GMM liposome, and this response was completely blocked by antibodies to CD1 lipid antigen-presenting molecules. Finally, whereas the T cells increased transcription of both T helper (Th) 1-type (IFN-gamma and TNF-alpha) and Th2-type (IL-5 and IL-10) cytokines in response to the purified protein derivative or tuberculin, their GMM-specific response was skewed to Th1-type cytokine production known to be critical for protection against tuberculosis. Thus, our study reveals a novel form of DTH with medical implications.	[Komori, Takaya; Matsunaga, Isamu; Morita, Daisuke; Hattori, Yuki; Kuwata, Hirotaka; Sugita, Masahiko] Kyoto Univ, Inst Virus Res, Lab Cell Regulat, Kyoto 6068507, Japan; [Komori, Takaya; Matsunaga, Isamu; Morita, Daisuke; Hattori, Yuki; Sugita, Masahiko] Grad Sch Biostudies, Lab Cell Regulat & Mol Network, Kyoto 6068507, Japan; [Nakamura, Takashi; Harashima, Hideyoshi] Hokkaido Univ, Fac Pharmaceut Sci, Sapporo, Hokkaido 0600812, Japan; [Fujiwara, Nagatoshi] Osaka City Univ, Grad Sch Med, Dept Bacteriol, Osaka 5458585, Japan; [Hiromatsu, Kenji] Fukuoka Univ, Fac Med, Dept Microbiol & Immunol, Fukuoka 8140180, Japan	Kyoto University; Hokkaido University; Osaka Metropolitan University; Fukuoka University	Sugita, M (corresponding author), 53 Kawahara Cho,Sakyo Ku, Kyoto 6068507, Japan.	msugita@virus.kyoto-u.ac.jp	Komori, Takaya/AAW-7731-2021; Harashima, Hideyoshi/D-8390-2012; Kuwata, Hiro/N-2023-2019; Hattori, Yuki/AAW-2061-2021; Nakamura, Takashi/F-4419-2016	Kuwata, Hiro/0000-0002-5023-1777; Nakamura, Takashi/0000-0001-9019-1426; Hattori, Yuki/0000-0001-6576-0121; Sugita, Masahiko/0000-0001-5511-1304	Ministry of Education, Culture, Sports, Science, and Technology; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology (grant-in-aid for Scientific Research on Priority Areas) and from the Japan Society for the Promotion of Science (grant-in-aid for Scientific Research (B) (to M. S.)).	Batuwangala T, 2004, J IMMUNOL, V172, P2382, DOI 10.4049/jimmunol.172.4.2382; Behar SM, 2007, CURR TOP MICROBIOL, V314, P215; Dascher CC, 2003, INT IMMUNOL, V15, P915, DOI 10.1093/intimm/dxg091; Grant EP, 1999, J EXP MED, V189, P195, DOI 10.1084/jem.189.1.195; Hiromatsu K, 2002, J IMMUNOL, V169, P330, DOI 10.4049/jimmunol.169.1.330; Hiromatsu K, 2002, IMMUNOLOGY, V106, P159, DOI 10.1046/j.1365-2567.2002.01422.x; HOCHSTENBACH F, 1992, P NATL ACAD SCI USA, V89, P4734, DOI 10.1073/pnas.89.10.4734; Homhuan A, 2009, J CONTROL RELEASE, V136, P79, DOI 10.1016/j.jconrel.2009.01.004; Ishikawa E, 2009, J EXP MED, V206, P2879, DOI 10.1084/jem.20091750; Kawashima T, 2003, J IMMUNOL, V170, P5345, DOI 10.4049/jimmunol.170.11.5345; Khalil IA, 2006, J BIOL CHEM, V281, P3544, DOI 10.1074/jbc.M503202200; Kobayashi K, 2001, MICROSC RES TECHNIQ, V53, P241, DOI 10.1002/jemt.1090; Matsunaga I, 2004, J EXP MED, V200, P1559, DOI 10.1084/jem.20041429; Matsunaga I, 2008, J BIOL CHEM, V283, P28835, DOI 10.1074/jbc.M805776200; Moody DB, 2000, J EXP MED, V192, P965, DOI 10.1084/jem.192.7.965; Moody DB, 2000, NATURE, V404, P884, DOI 10.1038/35009119; Moody DB, 1997, SCIENCE, V278, P283, DOI 10.1126/science.278.5336.283; Morita D, 2008, BIOCHEM BIOPH RES CO, V377, P889, DOI 10.1016/j.bbrc.2008.10.075; Nakamura T, 2008, MOL THER, V16, P1507, DOI 10.1038/mt.2008.122; Nakao H, 2009, J BIOCHEM, V146, P659, DOI 10.1093/jb/mvp113; North RJ, 2004, ANNU REV IMMUNOL, V22, P599, DOI 10.1146/annurev.immunol.22.012703.104635; Orme IM, 1999, IMMUNOL TODAY, V20, P307, DOI 10.1016/S0167-5699(98)01438-8; Otsuka A, 2008, J IMMUNOL, V181, P8528, DOI 10.4049/jimmunol.181.12.8528; PORCELLI SA, 1995, ADV IMMUNOL, V59, P1, DOI 10.1016/S0065-2776(08)60629-X; Rosat JP, 1999, J IMMUNOL, V162, P366; Ryll R, 2001, MICROBIOL IMMUNOL, V45, P801, DOI 10.1111/j.1348-0421.2001.tb01319.x; Stenger S, 1998, SCIENCE, V282, P121, DOI 10.1126/science.282.5386.121; Stenger S, 1997, SCIENCE, V276, P1684, DOI 10.1126/science.276.5319.1684; Sugita M, 2000, P NATL ACAD SCI USA, V97, P8445, DOI 10.1073/pnas.150236797; Sugita M, 1999, IMMUNITY, V11, P743, DOI 10.1016/S1074-7613(00)80148-X; Sugita M, 1997, J IMMUNOL, V159, P2358; Sugita M, 1996, SCIENCE, V273, P349, DOI 10.1126/science.273.5273.349; Sugita M, 2002, IMMUNITY, V16, P697, DOI 10.1016/S1074-7613(02)00311-4; Ulrichs T, 2003, INFECT IMMUN, V71, P3076, DOI 10.1128/IAI.71.6.3076-3087.2003; Van Rhijn I, 2009, EUR J IMMUNOL, V39, P3031, DOI 10.1002/eji.200939619; Watanabe Y, 2006, VACCINE, V24, P5700, DOI 10.1016/j.vaccine.2006.04.049	36	28	31	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16800	16806		10.1074/jbc.M110.217224	http://dx.doi.org/10.1074/jbc.M110.217224			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454504	Green Published, hybrid			2022-12-25	WOS:000290301900029
J	Rambhadran, A; Gonzalez, J; Jayaraman, V				Rambhadran, Anu; Gonzalez, Jennifer; Jayaraman, Vasanthi			Conformational Changes at the Agonist Binding Domain of the N-Methyl-D-Aspartic Acid Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IONOTROPIC GLUTAMATE-RECEPTOR; LIGAND-PROTEIN INTERACTIONS; CRYSTAL-STRUCTURES; NMR-SPECTROSCOPY; NMDA RECEPTORS; AMPA RECEPTORS; CORE; ACTIVATION; MECHANISM; SUBUNIT	The conformational changes in the agonist binding domain of the glycine-binding GluN1 and glutamate-binding GluN2A subunits of the N-methyl D-aspartic acid receptor upon binding agonists of varying efficacy have been investigated by luminescence resonance energy transfer (LRET) measurements. The LRET-based distances indicate a cleft closure conformational change at the GluN1 subunit upon binding agonists; however, no significant changes in the cleft closure are observed between partial and full agonists. This is consistent with the previously reported crystal structures for the isolated agonist binding domain of this receptor. Additionally, the LRET-based distances show that the agonist binding domain of the glutamate-binding GluN2A subunit exhibits a graded cleft closure with the extent of cleft closure being proportional to the extent of activation, indicating that the mechanism of activation in this subunit is similar to that of the glutamate binding alpha-amino-5-methyl-3-hydroxy-4-isoxazole propionate and kainate subtypes of the ionotropic glutamate receptors.	[Rambhadran, Anu; Gonzalez, Jennifer; Jayaraman, Vasanthi] Univ Texas Hlth Sci Ctr, Dept Biochem & Mol Biol, Ctr Membrane Biol, Grad Sch Biomed Sci, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Jayaraman, V (corresponding author), Univ Texas Hlth Sci Ctr, Dept Biochem & Mol Biol, Ctr Membrane Biol, Grad Sch Biomed Sci, MSB 6-174,6431 Fannin St, Houston, TX 77030 USA.	vasanthi.jayaraman@uth.tmc.edu			National Institutes of Health [R01GM073102, GM082023-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073102, F31GM082023] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM073102.; Supported by National Institutes of Health Grant GM082023-01 through the NRSA. Present address: Baylor College of Medicine, Houston, TX 77030.	Ahmed AH, 2007, J BIOL CHEM, V282, P12773, DOI 10.1074/jbc.M610077200; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 2006, CELL, V127, P85, DOI 10.1016/j.cell.2006.08.037; BENVENISTE M, 1991, BIOPHYS J, V59, P560, DOI 10.1016/S0006-3495(91)82272-X; Cheng Q, 2005, NAT CHEM BIOL, V1, P329, DOI 10.1038/nchembio738; Cheng Q, 2004, J BIOL CHEM, V279, P26346, DOI 10.1074/jbc.M403111200; Cheng Q, 2002, BIOCHEMISTRY-US, V41, P1602, DOI 10.1021/bi015729e; CLEMENTS JD, 1991, NEURON, V7, P605, DOI 10.1016/0896-6273(91)90373-8; Deming D, 2003, J BIOL CHEM, V278, P17589, DOI 10.1074/jbc.C300105200; Du M, 2005, J BIOL CHEM, V280, P8633, DOI 10.1074/jbc.C400590200; Erreger K, 2007, MOL PHARMACOL, V72, P907, DOI 10.1124/mol.107.037333; Fenwick MK, 2008, J MOL BIOL, V378, P673, DOI 10.1016/j.jmb.2008.03.012; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Furukawa H, 2003, EMBO J, V22, P2873, DOI 10.1093/emboj/cdg303; Gonzalez J, 2008, BIOCHEMISTRY-US, V47, P10027, DOI 10.1021/bi800690b; Inanobe A, 2005, NEURON, V47, P71, DOI 10.1016/j.neuron.2005.05.022; Jayaraman V, 2000, BIOCHEMISTRY-US, V39, P8693, DOI 10.1021/bi000892f; Jayaraman V, 2004, METHOD ENZYMOL, V380, P170; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; Landes CF, 2011, NAT CHEM BIOL, V7, P168, DOI 10.1038/NCHEMBIO.523; Madden DR, 2004, BIOCHEMISTRY-US, V43, P15838, DOI 10.1021/bi048447y; Madden DR, 2001, J BIOL CHEM, V276, P37821; Maltsev AS, 2008, BIOCHEMISTRY-US, V47, P10600, DOI 10.1021/bi800843c; Maltsev AS, 2010, J BIOL CHEM, V285, P10154, DOI 10.1074/jbc.M109.088641; Mankiewicz KA, 2007, BRAZ J MED BIOL RES, V40, P1419, DOI 10.1590/S0100-879X2007001100001; Mankiewicz KA, 2008, BIOCHEMISTRY-US, V47, P398, DOI 10.1021/bi702004b; Mankiewicz KA, 2007, BIOCHEMISTRY-US, V46, P1343, DOI 10.1021/bi062270l; Mayer ML, 2005, NEURON, V45, P539, DOI 10.1016/j.neuron.2005.01.031; Mayer ML, 2006, J NEUROSCI, V26, P2852, DOI 10.1523/JNEUROSCI.0123-06.2005; Mayer ML, 2004, ANNU REV PHYSIOL, V66, P161, DOI 10.1146/annurev.physiol.66.050802.084104; McFeeters RL, 2004, FASEB J, V18, P428, DOI 10.1096/fj.03-0873rev; McFeeters RL, 2002, BIOCHEMISTRY-US, V41, P10472, DOI 10.1021/bi026010p; Nanao MH, 2005, P NATL ACAD SCI USA, V102, P1708, DOI 10.1073/pnas.0409573102; Naur P, 2005, FEBS LETT, V579, P1154, DOI 10.1016/j.febslet.2005.01.012; Ramanoudjame G, 2006, P NATL ACAD SCI USA, V103, P10473, DOI 10.1073/pnas.0603225103; Rambhadran A, 2010, J BIOL CHEM, V285, P15296, DOI 10.1074/jbc.M109.085035; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a	38	23	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16953	16957		10.1074/jbc.M111.224576	http://dx.doi.org/10.1074/jbc.M111.224576			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454656	hybrid, Green Published			2022-12-25	WOS:000290301900044
J	Sano, H; Peck, GR; Kettenbach, AN; Gerber, SA; Lienhard, GE				Sano, Hiroyuki; Peck, Grantley R.; Kettenbach, Arminja N.; Gerber, Scott A.; Lienhard, Gustav E.			Insulin-stimulated GLUT4 Protein Translocation in Adipocytes Requires the Rab10 Guanine Nucleotide Exchange Factor Dennd4C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATED MEMBRANE AMINOPEPTIDASE; GTPASE-ACTIVATING-PROTEIN; EXOCYST COMPLEX; MUSCLE; DOMAIN; CELLS; AS160	Insulin-stimulated translocation of the glucose transporter GLUT4 to the cell surface in fat and muscle cells is the basis for insulin-stimulated glucose transport. Studies in adipocytes strongly support the following molecular mechanism for this process. Insulin-elicited phosphorylation of the GTPase-activating protein TBC1D4 (AS160) suppresses its activity toward Rab10 and thereby leads to an increase in the GTP-bound form of Rab10, which in turn triggers movement of vesicles containing GLUT4 to the plasma membrane and their fusion with the membrane. This process is expected to require the participation of a guanine nucleotide exchange factor (GEF) to generate the GTP-bound form of Rab10, but this GEF has not hitherto been identified. The present study identifies Dennd4C, a recently described GEF for Rab10, as the primary GEF required for GLUT4 translocation. Knockdown of Dennd4C markedly inhibited GLUT4 translocation, and ectopic expression of Dennd4C slightly stimulated it. Dennd4C was found in isolated GLUT4 vesicles. This study thus identifies another key component in the machinery of GLUT4 translocation. Moreover, it provides a potential explanation for the moderate association of a variant in the Dennd4C gene with type 2 diabetes.	[Sano, Hiroyuki; Peck, Grantley R.; Lienhard, Gustav E.] Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA; [Kettenbach, Arminja N.; Gerber, Scott A.] Dartmouth Med Sch, Dept Genet, Lebanon, NH 03756 USA; [Kettenbach, Arminja N.; Gerber, Scott A.] Dartmouth Med Sch, Norris Cotton Canc Ctr, Lebanon, NH 03756 USA	Dartmouth College; Dartmouth College; Dartmouth College; Norris Cotton Cancer Center	Lienhard, GE (corresponding author), Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA.	gustav.e.lienhard@dartmouth.edu	Peck, Grantley/H-2318-2013	Gerber, Scott/0000-0002-2964-5051; Kettenbach, Arminja/0000-0003-3979-4576	National Institutes of Health [DK25336]; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK025336, R01DK025336, R55DK025336] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK25336 (to G. E. L.).	Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Babbey CM, 2010, AM J PHYSIOL-RENAL, V299, pF495, DOI 10.1152/ajprenal.00198.2010; Eguez L, 2005, CELL METAB, V2, P263, DOI 10.1016/j.cmet.2005.09.005; Hattula K, 2002, MOL BIOL CELL, V13, P3268, DOI 10.1091/mbc.E02-03-0143; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Inoue M, 2006, MOL BIOL CELL, V17, P2303, DOI 10.1091/mbc.E06-01-0030; Ishikura S, 2008, AM J PHYSIOL-CELL PH, V295, pC1016, DOI 10.1152/ajpcell.00277.2008; Jedrychowski MP, 2010, J BIOL CHEM, V285, P104, DOI 10.1074/jbc.M109.040428; Jiang ZY, 2003, P NATL ACAD SCI USA, V100, P7569, DOI 10.1073/pnas.1332633100; Johnson AD, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-6; KELLER SR, 1995, J BIOL CHEM, V270, P23612, DOI 10.1074/jbc.270.40.23612; Kuroda TS, 2002, J BIOL CHEM, V277, P9212, DOI 10.1074/jbc.M112414200; Larance M, 2005, J BIOL CHEM, V280, P37803, DOI 10.1074/jbc.M503897200; Lyons PD, 2009, BIOSCIENCE REP, V29, P229, DOI 10.1042/BSR20080162; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Muretta JM, 2008, J BIOL CHEM, V283, P311, DOI 10.1074/jbc.M705756200; Pimienta Genaro, 2009, V527, P107, DOI 10.1007/978-1-60327-834-8_9; Ross SA, 1996, J BIOL CHEM, V271, P3328, DOI 10.1074/jbc.271.6.3328; Sakamoto K, 2008, AM J PHYSIOL-ENDOC M, V295, pE29, DOI 10.1152/ajpendo.90331.2008; Sano H, 2008, BIOCHEM J, V411, P89, DOI 10.1042/BJ20071318; Sano H, 2007, CELL METAB, V5, P293, DOI 10.1016/j.cmet.2007.03.001; Yoshimura S, 2010, J CELL BIOL, V191, P367, DOI 10.1083/jcb.201008051; Yoshizaki T, 2007, MOL CELL BIOL, V27, P5172, DOI 10.1128/MCB.02298-06; Zaid H, 2008, BIOCHEM J, V413, P201, DOI 10.1042/BJ20080723	24	51	55	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16541	16545		10.1074/jbc.C111.228908	http://dx.doi.org/10.1074/jbc.C111.228908			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454697	Green Published, hybrid			2022-12-25	WOS:000290301900002
J	Moghekar, A; Rao, S; Li, M; Ruben, D; Mammen, A; Tang, XP; O'Brien, RJ				Moghekar, Abhay; Rao, Sneha; Li, Ming; Ruben, Dawn; Mammen, Andrew; Tang, Xiaopei; O'Brien, Richard J.			Large Quantities of A beta Peptide Are Constitutively Released during Amyloid Precursor Protein Metabolism in Vivo and in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREBRAL-BLOOD-FLOW; INTERNAL CAROTID-ARTERY; SYNAPTIC NMDA RECEPTORS; ALZHEIMERS-DISEASE; AXONAL-TRANSPORT; SPINAL NEURONS; HEALTHY-ADULTS; BRAIN; ACCUMULATION; PATHOGENESIS	The metabolism of the amyloid precursor protein (APP) has been extensively investigated because its processing generates the amyloid-beta-peptide (A beta), which is a likely cause of Alzheimer disease. Much prior research has focused on APP processing using transgenic constructs and heterologous cell lines. Work to date in native neuronal cultures suggests that A beta is produced in very large amounts. We sought to investigate APP metabolism and A beta production simultaneously under more physiological conditions in vivo and in vitro using cultured rat cortical neurons and live pigs. We found in cultured neurons that both APP and A beta are secreted rapidly and at extremely high rates into the extracellular space (2-4 molecules/neuron/s for A beta). Little APP is degraded outside of the pathway that leads to extracellular release. Two metabolic pools of APP are identified, one that is metabolized extremely rapidly (t(1/2) = 2.2 h), and another, surface pool, composed of both synaptic and extrasynaptic elements, that turns over very slowly. A beta release and accumulation in the extracellular medium can be accounted for stoichiometrically by the extracellular release of beta-cleaved forms of the APP ecto-domain. Two beta-cleavages of APP occur for every beta-cleavage. Consistent with the results seen in cultured neurons, an extremely high rate of A beta production and secretion from the brain was seen in juvenile pigs. In summary, our experiments show an enormous and rapid production and extracellular release of A beta and the soluble APP ectodomain. A small, slowly metabolized, surface pool of full-length APP is also identified.	[Moghekar, Abhay; Rao, Sneha; Li, Ming; Mammen, Andrew; Tang, Xiaopei; O'Brien, Richard J.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Ruben, Dawn] Johns Hopkins Univ, Sch Med, Dept Comparat Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	O'Brien, RJ (corresponding author), Johns Hopkins Bayview Med Ctr, Mason Lord Ctr Tower,Rm 5100,5200 Eastern Ave, Baltimore, MD 21224 USA.	robrien@jhmi.edu	Mammen, Andrew/AAF-2885-2021; Rao, Sneha/AAE-1503-2020	Rao, Sneha/0000-0003-2147-3248	National Institutes of Health [P50 AG05146]; NIA; Burroughs Wellcome Fund for Translational Research; NATIONAL INSTITUTE ON AGING [P50AG005146] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Burroughs Wellcome Fund for Translational Research(Burroughs Wellcome Fund); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant P50 AG05146 from the NIA and the Burroughs Wellcome Fund for Translational Research.	Beck M, 2000, NEUROSCIENCE, V95, P243; Braitenberg V, 2001, J COMPUT NEUROSCI, V10, P71, DOI 10.1023/A:1008920127052; Cirrito JR, 2008, NEURON, V58, P42, DOI 10.1016/j.neuron.2008.02.003; Cook DG, 1997, NAT MED, V3, P1021, DOI 10.1038/nm0997-1021; Deane R, 2007, CURR ALZHEIMER RES, V4, P191, DOI 10.2174/156720507780362245; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HILBICH C, 1993, J BIOL CHEM, V268, P26571; Hoe HS, 2009, J BIOL CHEM, V284, P8495, DOI 10.1074/jbc.M900141200; Kamal A, 2001, NATURE, V414, P643, DOI 10.1038/414643a; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kienlen-Campard P, 2002, J BIOL CHEM, V277, P15666, DOI 10.1074/jbc.M200887200; Lazarov O, 2005, J NEUROSCI, V25, P2386, DOI 10.1523/JNEUROSCI.3089-04.2005; Mammen AL, 1997, J NEUROSCI, V17, P7351; MarquezSterling NR, 1997, J NEUROSCI, V17, P140, DOI 10.1523/JNEUROSCI.17-01-00140.1997; Meadow W, 1999, PEDIATR RES, V45, P324, DOI 10.1203/00006450-199903000-00006; Mi RF, 2004, NEURON, V44, P335, DOI 10.1016/j.neuron.2004.09.029; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Oh ES, 2009, NEUROBIOL AGING, V30, P1238, DOI 10.1016/j.neurobiolaging.2007.12.024; Rosen KM, 2007, MOL CELL NEUROSCI, V34, P578, DOI 10.1016/j.mcn.2006.12.008; Scheel P, 2000, STROKE, V31, P147, DOI 10.1161/01.STR.31.1.147; SCHONING M, 1994, STROKE, V25, P17, DOI 10.1161/01.STR.25.1.17; Selkoe DJ, 2001, NEURON, V32, P177, DOI 10.1016/S0896-6273(01)00475-5; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; Shepherd C, 2009, ACTA NEUROPATHOL, V118, P37, DOI 10.1007/s00401-009-0521-4; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; Small SA, 2006, NEURON, V52, P15, DOI 10.1016/j.neuron.2006.09.001; Soustiel JF, 2003, STROKE, V34, P1876, DOI 10.1161/01.STR.0000080942.32331.39; Storey E, 1999, EUR J NEUROSCI, V11, P1779, DOI 10.1046/j.1460-9568.1999.00599.x; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Turner PR, 2003, PROG NEUROBIOL, V70, P1, DOI 10.1016/S0301-0082(03)00089-3; VANGOOL WA, 1994, NEUROSCI LETT, V172, P122, DOI 10.1016/0304-3940(94)90677-7; WildBode C, 1997, J BIOL CHEM, V272, P16085, DOI 10.1074/jbc.272.26.16085	34	22	22	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.191262	http://dx.doi.org/10.1074/jbc.M110.191262			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454701	Green Published, hybrid			2022-12-25	WOS:000290022800039
J	Sengupta, S; Ulasov, IV; Thaci, B; Ahmed, AU; Lesniak, MS				Sengupta, Sadhak; Ulasov, Ilya V.; Thaci, Bart; Ahmed, Atique U.; Lesniak, Maciej S.			Enhanced Transduction and Replication of RGD-Fiber Modified Adenovirus in Primary T Cells	PLOS ONE			English	Article							MEDIATED GENE DELIVERY; COXSACKIE B VIRUSES; ONCOLYTIC ADENOVIRUS; DENDRITIC CELLS; IN-VIVO; INTRACRANIAL GLIOMA; MALIGNANT GLIOMA; NATURAL-KILLER; LYMPHOCYTES; VECTORS	Background: Adenoviruses are often used as vehicles to mediate gene delivery for therapeutic purposes, but their research scope in hematological cells remains limited due to a narrow choice of host cells that express the adenoviral receptor (CAR). T cells, which are attractive targets for gene therapy of numerous diseases, remain resistant to adenoviral infection because of the absence of CAR expression. Here, we demonstrate that this resistance can be overcome when murine or human T cells are transduced with an adenovirus incorporating the RGD-fiber modification (Ad-RGD). Methodology/Principal Finding: A luciferase-expressing replication-deficient Ad-RGD infected 3-fold higher number of activated primary T cells than an adenovirus lacking the RGD-fiber modification in vitro. Infection with replication-competent Ad-RGD virus also caused increased cell cycling, higher E1A copy number and enriched hexon antigen expression in both human and murine T cells. Transduction with oncolytic Ad-RGD also resulted in higher titers of progeny virus and enhanced the killing of T cells. In vivo, 35-45% of splenic T cells were transduced by Ad-RGD. Conclusions: Collectively, our results prove that a fiber modified Ad-RGD successfully transduces and replicates in primary T cells of both murine and human origin.	[Sengupta, Sadhak; Ulasov, Ilya V.; Thaci, Bart; Ahmed, Atique U.; Lesniak, Maciej S.] Univ Chicago, Brain Tumor Ctr, Chicago, IL 60637 USA	University of Chicago	Sengupta, S (corresponding author), Univ Chicago, Brain Tumor Ctr, Chicago, IL 60637 USA.	mlesniak@surgery.bsd.uchicago.edu	Ulasov, Ilya/A-2352-2014; Sengupta, Sadhak/D-2526-2009	Ulasov, Ilya/0000-0002-0818-0363; Thaci, Bart/0000-0001-5392-7174	NCI [R01CA122930, R01CA138587]; National Institute of Neurological Disorders and Stroke [U01NS069997]; American Cancer Society [RSG-07-276-01-MGO]; NATIONAL CANCER INSTITUTE [R01CA122930, R01CA138587] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS069997] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the NCI (R01CA122930, R01CA138587), the National Institute of Neurological Disorders and Stroke (U01NS069997), and the American Cancer Society (RSG-07-276-01-MGO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe J, 1996, BIOCHEM BIOPH RES CO, V218, P164, DOI 10.1006/bbrc.1996.0029; Ahmed AU, 2010, MOL THER, V18, P1846, DOI 10.1038/mt.2010.131; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Bergelson JM, 1998, J VIROL, V72, P415, DOI 10.1128/JVI.72.1.415-419.1998; Bobisse S, 2009, CANCER RES, V69, P9385, DOI 10.1158/0008-5472.CAN-09-0494; Chen Z, 2002, J IMMUNOL METHODS, V260, P79, DOI 10.1016/S0022-1759(01)00521-X; Colin L, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-111; Coughlan L, 2009, J VIROL, V83, P6416, DOI 10.1128/JVI.00445-09; Di Nicola M, 1999, HUM GENE THER, V10, P1875; Dmitriev I, 1998, J VIROL, V72, P9706, DOI 10.1128/JVI.72.12.9706-9713.1998; Evans J. D., 2002, ADENOVIRAL VECTORS G, P39; Fueyo J, 2000, ONCOGENE, V19, P2, DOI 10.1038/sj.onc.1203251; Garnett CT, 2002, J VIROL, V76, P10608, DOI 10.1128/JVI.76.21.10608-10616.2002; Harui A, 2006, J IMMUNOL METHODS, V312, P94, DOI 10.1016/j.jim.2006.02.014; Harui A, 2006, J LEUKOCYTE BIOL, V79, P1271, DOI 10.1189/jlb.1105694; HUANG SA, 1995, J VIROL, V69, P2257, DOI 10.1128/JVI.69.4.2257-2263.1995; Hurez Vincent, 2002, BMC Immunol, V3, P4, DOI 10.1186/1471-2172-3-4; Kennedy-Nasser AA, 2007, CURR OPIN HEMATOL, V14, P616, DOI 10.1097/MOH.0b013e3282ef615a; Lecoeur H, 1997, J IMMUNOL METHODS, V209, P111, DOI 10.1016/S0022-1759(97)00138-5; Liu YZ, 2004, HUM GENE THER, V15, P637, DOI 10.1089/1043034041361181; McNees AL, 2004, J VIROL, V78, P6955, DOI 10.1128/JVI.78.13.6955-6966.2004; Miller G, 2002, CANCER RES, V62, P5260; NAKAMURA Y, 1994, CANCER RES, V54, P5757; Nandi S, 2009, J GENE MED, V11, P1005, DOI 10.1002/jgm.1385; Nevins JR, 1997, METHOD ENZYMOL, V283, P205; Okada N, 2005, CANCER GENE THER, V12, P72, DOI 10.1038/sj.cgt.7700772; Okada N, 2003, CANCER GENE THER, V10, P421, DOI 10.1038/sj.cgt.7700586; Rein DT, 2004, INT J CANCER, V111, P698, DOI 10.1002/ijc.20295; Schmidt MR, 2000, J IMMUNOL, V165, P4112, DOI 10.4049/jimmunol.165.7.4112; Schroers R, 2004, EXP HEMATOL, V32, P536, DOI 10.1016/j.exphem.2004.03.010; Sengupta S, 2005, IMMUNOBIOLOGY, V210, P647, DOI 10.1016/j.imbio.2005.06.003; Sengupta S, 2007, J IMMUNOL, V178, P6083, DOI 10.4049/jimmunol.178.10.6083; Sonabend AM, 2009, CANCER GENE THER, V16, P362, DOI 10.1038/cgt.2008.80; Sonabend AM, 2008, STEM CELLS, V26, P831, DOI 10.1634/stemcells.2007-0758; Tekant Y, 2005, SURGERY, V137, P527, DOI 10.1016/j.surg.2004.12.014; Tomko RP, 1997, P NATL ACAD SCI USA, V94, P3352, DOI 10.1073/pnas.94.7.3352; Tyler MA, 2006, MOL CANCER THER, V5, P2408, DOI 10.1158/1535-7163.MCT-06-0187; Ulasov IV, 2007, HUM GENE THER, V18, P589, DOI 10.1089/hum.2007.002; Vera JF, 2009, CURR GENE THER, V9, P396, DOI 10.2174/156652309789753338; Wattel E, 1996, LEUKEMIA, V10, P171; Wickham TJ, 1997, J VIROL, V71, P7663, DOI 10.1128/JVI.71.10.7663-7669.1997; WICKHAM TJ, 1993, CELL, V73, P309, DOI 10.1016/0092-8674(93)90231-E; Wu HJ, 2002, HUM GENE THER, V13, P1647, DOI 10.1089/10430340260201734; YANG YP, 1995, J IMMUNOL, V155, P2564; Ye Z, 2007, CANCER GENE THER, V14, P661, DOI 10.1038/sj.cgt.7701039; Yotnda P, 2004, BLOOD, V104, P2272, DOI 10.1182/blood-2003-11-3803; Zhang YG, 2010, J VIROL, V84, P8799, DOI 10.1128/JVI.00562-10; Zheng S, 2007, J GENE MED, V9, P151, DOI 10.1002/jgm.1008	48	12	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e18091	10.1371/journal.pone.0018091	http://dx.doi.org/10.1371/journal.pone.0018091			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464908	Green Published, gold, Green Submitted			2022-12-25	WOS:000289053800023
J	Wyatt, CM; Shi, QH; Novak, JE; Hoover, DR; Szczech, L; Mugabo, JS; Binagwaho, A; Cohen, M; Mutimura, E; Anastos, K				Wyatt, Christina M.; Shi, Qiuhu; Novak, James E.; Hoover, Donald R.; Szczech, Lynda; Mugabo, Jules Semahore; Binagwaho, Agnes; Cohen, Mardge; Mutimura, Eugene; Anastos, Kathryn			Prevalence of Kidney Disease in HIV-Infected and Uninfected Rwandan Women	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; STAGE RENAL-DISEASE; ANTIRETROVIRAL THERAPY; SEROPOSITIVE PATIENTS; AFRICAN-AMERICANS; SERUM CREATININE; COCKCROFT-GAULT; RISK-FACTORS; ADULTS; ASSOCIATION	Background: In the United States, HIV-related kidney disease disproportionately affects individuals of African descent; however, there are few estimates of kidney disease prevalence in Africa. We evaluated the prevalence of kidney disease among HIV-infected and uninfected Rwandan women. Methods: The Rwandan Women's Interassociation Study and Assessment prospectively enrolled 936 women. Associations with estimated glomerular filtration rate (eGFR)<60 mL/min/1.73 m(2) and proteinuria were assessed in separate logistic regression models. Results: Among 891 non-pregnant women with available data, 2.4% had an eGFR<60 mL/min/1.73 m(2) (calculated by the Modification of Diet in Renal Disease equation, MDRD eGFR) and 8.7% had proteinuria >= 1+. The prevalence of decreased eGFR varied markedly depending on the estimating method used, with the highest prevalence by Cockcroft-Gault. Regardless of the method used to estimate GFR, the proportion with decreased eGFR or proteinuria did not differ significantly between HIV-infected and -uninfected women in unadjusted analysis. After adjusting for age and blood pressure, HIV infection was associated with significantly higher odds of decreased MDRD eGFR but not proteinuria. Conclusion: In a well-characterized cohort of Rwandan women, HIV infection was associated with decreased MDRD eGFR. The prevalence of decreased eGFR among HIV-infected women in our study was lower than that previously reported in African-Americans and in other Central and East African HIV populations, although there was substantial variability depending on the equation used to estimate GFR. Future studies are needed to optimize GFR estimates and to determine the impact of antiretroviral therapy on kidney disease in this population.	[Wyatt, Christina M.] Mt Sinai Sch Med, New York, NY 10029 USA; [Shi, Qiuhu] New York Med Coll, Sch Publ Hlth, Valhalla, NY 10595 USA; [Novak, James E.] Henry Ford Hlth Syst, Detroit, MI USA; [Hoover, Donald R.] Rutgers State Univ, New Brunswick, NJ 08903 USA; [Szczech, Lynda] Duke Univ, Med Ctr, Dept Med, Div Nephrol, Durham, NC 27710 USA; [Mugabo, Jules Semahore] Univ Maryland, Inst Human Virol, Baltimore, MD 21201 USA; [Binagwaho, Agnes] Minist Hlth, Kigali, Rwanda; [Binagwaho, Agnes] Harvard Univ, Sch Med, Boston, MA USA; [Cohen, Mardge] Cook Cty Bur Hlth Serv, CORE Ctr, Chicago, IL USA; [Mutimura, Eugene] Womens Equ Access Care & Treatment, Kigali, Rwanda; [Anastos, Kathryn] Montefiore Med Ctr, Bronx, NY 10467 USA; [Anastos, Kathryn] Albert Einstein Coll Med, Bronx, NY 10467 USA	Icahn School of Medicine at Mount Sinai; New York Medical College; Henry Ford Health System; Henry Ford Hospital; Rutgers State University New Brunswick; Duke University; University System of Maryland; University of Maryland Baltimore; Harvard University; Harvard Medical School; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Wyatt, CM (corresponding author), Mt Sinai Sch Med, New York, NY 10029 USA.	kanastos@verizon.net			National Institute of Allergy and Infectious Diseases [UO1-AI-35004]; Fogarty International Center [NIH D43-TW001403]; National Institutes of Health [NIH AI-51519]; National Institute of Diabetes and Digestive and Kidney Disease [DK54615]; Chicago WIHS [U01-AI-34993]; National Institute of Diabetes and Digestive and Kidney Diseases [K23DK077568]; FOGARTY INTERNATIONAL CENTER [D43TW001403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI051519, U01AI035004, U01AI034993, K22AI134993] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054615, K23DK077568] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Chicago WIHS; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by supplements from the National Institute of Allergy and Infectious Diseases to the Bronx/Manhattan Women's Interagency HIV Study (WIHS), which is funded by the National Institute of Allergy and Infectious Diseases (UO1-AI-35004). This work was also supported in part by the AIDS International Training and Research Program (Fogarty International Center, NIH D43-TW001403) and the Center for AIDS Research of the Albert Einstein College of Medicine and Montefiore Medical Center funded by the National Institutes of Health (NIH AI-51519) and by the National Institute of Diabetes and Digestive and Kidney Disease (DK54615), and the Chicago WIHS (U01-AI-34993). CMW is supported by a career development award from the National Institute of Diabetes and Digestive and Kidney Diseases (K23DK077568). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, PAT MON GUID HIV CAR; Arendse CG, 2010, KIDNEY INT, V78, P239, DOI 10.1038/ki.2010.155; Choi AI, 2007, J AM SOC NEPHROL, V18, P2968, DOI 10.1681/ASN.2007040402; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Eastwood JB, 2010, NEPHROL DIAL TRANSPL, V25, P2178, DOI 10.1093/ndt/gfp765; Emem CP, 2008, NEPHROL DIAL TRANSPL, V23, P741, DOI 10.1093/ndt/gfm836; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Gupta SK, 2005, CLIN INFECT DIS, V40, P1559, DOI 10.1086/430257; Han TM, 2006, KIDNEY INT, V69, P2243, DOI 10.1038/sj.ki.5000339; Kao WHL, 2008, NAT GENET, V40, P1185, DOI 10.1038/ng.232; Kopp JB, 2008, NAT GENET, V40, P1175, DOI 10.1038/ng.226; Kotler Donald P., 1996, American Journal of Clinical Nutrition, V64, p489S, DOI 10.1093/ajcn/64.3.489S; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lucas GM, 2008, J INFECT DIS, V197, P1548, DOI 10.1086/587994; Lucas GM, 2010, JAIDS-J ACQ IMM DEF, V55, P491, DOI 10.1097/QAI.0b013e3181e8d5a8; Mugyenyi P, 2010, LANCET, V375, P123, DOI 10.1016/S0140-6736(09)62067-5; Mulenga LB, 2008, AIDS, V22, P1821, DOI 10.1097/QAD.0b013e328307a051; Peters PJ, 2008, KIDNEY INT, V74, P925, DOI 10.1038/ki.2008.305; Reid A, 2008, CLIN INFECT DIS, V46, P1271, DOI 10.1086/533468; Stohr W, 2008, ANTIVIR THER, V13, P761; Szczech LA, 2004, CLIN INFECT DIS, V39, P1199, DOI 10.1086/424013; UNAIDS and WHO, 2008, UNAIDS WHO AIDS EP U; van Deventer HE, 2008, CLIN CHEM, V54, P1197, DOI 10.1373/clinchem.2007.099085; Wools-Kaloustian K, 2007, NEPHROL DIAL TRANSPL, V22, P2208, DOI 10.1093/ndt/gfm223; Wyatt CM, 2007, AIDS, V21, P2101, DOI 10.1097/QAD.0b013e3282ef1bb4; Wyatt CM, 2010, JAIDS-J ACQ IMM DEF, V55, P73, DOI 10.1097/QAI.0b013e3181cc1070; WYATT CM, 2011, ANTIVIR THE IN PRESS	28	21	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e18352	10.1371/journal.pone.0018352	http://dx.doi.org/10.1371/journal.pone.0018352			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464937	Green Submitted, gold, Green Published			2022-12-25	WOS:000289053800043
J	Zhang, L; Valdez, JM; Zhang, BY; Wei, L; Chang, JA; Xin, L				Zhang, Li; Valdez, Joseph M.; Zhang, Boyu; Wei, Lei; Chang, Jiang; Xin, Li			ROCK Inhibitor Y-27632 Suppresses Dissociation-Induced Apoptosis of Murine Prostate Stem/Progenitor Cells and Increases Their Cloning Efficiency	PLOS ONE			English	Article							STEM-CELLS; PTEN; PHOSPHORYLATION; SUBPOPULATION; SURVIVAL; DELETION; ISOFORM; KINASES; ACTS; RHOA	Activation of the RhoA/ROCK signaling pathway has been shown to contribute to dissociation-induced apoptosis of embryonic and neural stem cells. We previously demonstrated that approximately 1 out of 40 Lin(-)Sca-1(+)CD49f(high) (LSC) prostate basal epithelial cells possess the capacities of stem cells for self-renewal and multi-lineage differentiation. We show here that treating LSC cells with the ROCK kinase inhibitor Y-27632 increases their cloning efficiency by 8 fold in an in vitro prostate colony assay. Y-27632 treatment allows prostate colony cells to replate efficiently, which does not occur otherwise. Y-27632 also increases the cloning efficiency of prostate stem cells in a prostate sphere assay and a dissociated prostate cell regeneration assay. The increased cloning efficiency is due to the suppression of the dissociation-induced, RhoA/ROCK activation-mediated apoptosis of prostate stem cells. Dissociation of prostate epithelial cells from extracellular matrix increases PTEN activity and attenuates AKT activity. Y-27632 treatment alone is sufficient to suppress cell dissociation-induced activation of PTEN activity. However, this does not contribute to the increased cloning efficiency, because Y-27632 treatment increases the sphere-forming unit of wild type and Pten null prostate cells to a similar extent. Finally, knocking down expression of both ROCK kinases slightly increases the replating efficiency of prostate colony cells, corroborating that they play a major role in the Y-27632 mediated increase in cloning efficiency. Our study implies that the numbers of prostate cells with stem/progenitor activity may be underestimated based on currently employed assays, supports that dissociation-induced apoptosis is a common feature of embryonic and somatic stem cells with an epithelial phenotype, and highlights the significance of environmental cues for the maintenance of stem cells.	[Zhang, Li; Valdez, Joseph M.; Zhang, Boyu; Xin, Li] Baylor Coll Med, Dept Mol & Cell Biol, Houston, TX 77030 USA; [Wei, Lei] Indiana Univ, Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Chang, Jiang] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX USA; [Xin, Li] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Xin, Li] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Indiana University System; Indiana University-Purdue University Indianapolis; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Baylor College of Medicine; Baylor College of Medicine	Zhang, L (corresponding author), Baylor Coll Med, Dept Mol & Cell Biol, Houston, TX 77030 USA.	xin@bcm.edu		Chang, Jiang/0000-0003-3707-7557	NIH [CA125937, CA141497, HL102314]; Baylor College of Medicine; NATIONAL CANCER INSTITUTE [R00CA125937, U01CA141497] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K02HL098956, R01HL102314, R21HL094844, P01HL085098] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Baylor College of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH CA125937, NIH CA141497, NIH HL102314, and a Junior Faculty Seed Award from the Baylor College of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate-Shen C, 2000, GENE DEV, V14, P2410, DOI 10.1101/gad.819500; Al-Khouri AM, 2005, J BIOL CHEM, V280, P35195, DOI 10.1074/jbc.M503045200; Burger PE, 2005, P NATL ACAD SCI USA, V102, P7180, DOI 10.1073/pnas.0502761102; Chang J, 2006, P NATL ACAD SCI USA, V103, P14495, DOI 10.1073/pnas.0601911103; Chapman S, 2010, J CLIN INVEST, V120, P2619, DOI 10.1172/JCI42297; CHEN G, CELL STEM CELL, V7, P240; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; GOLDSTEIN AS, 2008, P NATL ACAD SCI US; Groszer M, 2006, P NATL ACAD SCI USA, V103, P111, DOI 10.1073/pnas.0509939103; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Hudson DL, 2000, LAB INVEST, V80, P1243, DOI 10.1038/labinvest.3780132; Hudson DL, 2001, J HISTOCHEM CYTOCHEM, V49, P271, DOI 10.1177/002215540104900214; Korkaya H, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000121; Koyanagi M, 2008, J NEUROSCI RES, V86, P270, DOI 10.1002/jnr.21502; Krawetz RJ, 2009, BIOESSAYS, V31, P336, DOI 10.1002/bies.200800157; Lawson DA, 2007, P NATL ACAD SCI USA, V104, P181, DOI 10.1073/pnas.0609684104; Li Z, 2005, NAT CELL BIOL, V7, P399, DOI 10.1038/ncb1236; Litvinov IV, 2006, CANCER RES, V66, P8598, DOI 10.1158/0008-5472.CAN-06-1228; Lukacs RU, 2010, NAT PROTOC, V5, P702, DOI 10.1038/nprot.2010.11; Man JH, 2010, J CLIN INVEST, V120, P2829, DOI 10.1172/JCI42542; Matusik RJ, 2008, DIFFERENTIATION, V76, P682, DOI 10.1111/j.1432-0436.2008.00276.x; Min J, 2010, NAT MED, V16, P286, DOI 10.1038/nm.2100; Ming XF, 2002, MOL CELL BIOL, V22, P8467, DOI 10.1128/MCB.22.24.8467-8477.2002; Mulholland DJ, 2009, CANCER RES, V69, P8555, DOI 10.1158/0008-5472.CAN-08-4673; Nakaya Y, 2008, NAT CELL BIOL, V10, P765, DOI 10.1038/ncb1739; Ohgushi M, 2010, CELL STEM CELL, V7, P225, DOI 10.1016/j.stem.2010.06.018; Olson MF, 2008, CURR OPIN CELL BIOL, V20, P242, DOI 10.1016/j.ceb.2008.01.002; Papakonstanti EA, 2007, EMBO J, V26, P3050, DOI 10.1038/sj.emboj.7601763; Pelosi M, 2007, MOL CELL BIOL, V27, P6163, DOI 10.1128/MCB.01735-06; Pertz O, 2010, J CELL SCI, V123, P1841, DOI 10.1242/jcs.064345; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Sanchez T, 2005, P NATL ACAD SCI USA, V102, P4312, DOI 10.1073/pnas.0409784102; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Sawicki JA, 2002, PROSTATE, V50, P46, DOI 10.1002/pros.10031; TERUNUMA A, TISSUE ENG A, V16, P1363; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Uzgare AR, 2004, CANCER RES, V64, P6190, DOI 10.1158/0008-5472.CAN-04-0968; Vazquez F, 2006, P NATL ACAD SCI USA, V103, P3633, DOI 10.1073/pnas.0510570103; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Vazquez F, 2001, J BIOL CHEM, V276, P48627, DOI 10.1074/jbc.C100556200; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang SY, 2006, P NATL ACAD SCI USA, V103, P1480, DOI 10.1073/pnas.0510652103; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; XIE D, P NATL ACAD SCI US, V107, P2485; Xin L, 2005, P NATL ACAD SCI USA, V102, P6942, DOI 10.1073/pnas.0502320102; Xin L, 2003, P NATL ACAD SCI USA, V100, P11896, DOI 10.1073/pnas.1734139100; Xin L, 2007, STEM CELLS, V25, P2760, DOI 10.1634/stemcells.2007-0355; Zhang YM, 2006, FASEB J, V20, P916, DOI 10.1096/fj.05-5129com	49	67	74	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e18271	10.1371/journal.pone.0018271	http://dx.doi.org/10.1371/journal.pone.0018271			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464902	gold, Green Submitted, Green Published			2022-12-25	WOS:000289053800035
J	Ding, H; Tsai, CG; Zhou, F; Buchy, P; Deubel, V; Zhou, P				Ding, Heng; Tsai, Cheguo; Zhou, Fan; Buchy, Philippe; Deubel, Vincent; Zhou, Paul			Heterosubtypic Antibody Response Elicited with Seasonal Influenza Vaccine Correlates Partial Protection against Highly Pathogenic H5N1 Virus	PLOS ONE			English	Article							AVIAN INFLUENZA; A H5N1; CROSS-PROTECTION; GENE DELIVERY; T-CELLS; INFECTION; IMMUNITY; INDUCTION	Background: The spread of highly pathogenic avian influenza (HPAI) H5N1 virus in human remains a global health concern. Heterosubtypic antibody response between seasonal influenza vaccine and potential pandemic influenza virus has important implications for public health. Previous studies by Corti et al. and by Gioia et al. demonstrate that heterosubtypic neutralizing antibodies against the highly pathogenic H5N1 virus can be elicited with a seasonal influenza vaccine in humans. However, whether such response offers immune protection against highly pathogenic H5N1 virus remained to be determined. Methodology/Principal Findings: In this study, using a sensitive influenza HA (hemagglutinin) and NA (neuraminidase) pseudotype-based neutralization (PN) assay we first confirmed that low levels of heterosubtypic neutralizing antibody response against H5N1 virus were indeed elicited with seasonal influenza vaccine in humans. We then immunized mice with the seasonal influenza vaccine and challenged them with lethal doses of highly pathogenic H5N1 virus. As controls, we immunized mice with homosubtypic H5N1 virus like particles (VLP) or PBS and challenged them with the same H5N1 virus. Here we show that low levels of heterosubtypic neutralizing antibody response were elicited with seasonal influenza vaccine in mice, which were significantly higher than those in PBS control. Among them 2 out of 27 whose immune sera exhibited similar levels of neutralizing antibody response as VLP controls actually survived from highly pathogenic H5N1 virus challenge. Conclusions/Significance: Therefore, we conclude that low levels of heterosubtypic neutralizing antibody response are indeed elicited with seasonal influenza vaccine in humans and mice and at certain levels such response offers immune protection against severity of H5N1 virus infection.	[Ding, Heng; Tsai, Cheguo; Zhou, Fan; Zhou, Paul] Chinese Acad Sci, Unit Antiviral Immun & Genet Therapy, Key Lab Mol Virol & Immunol, Inst Pasteur Shanghai, Shanghai, Peoples R China; [Buchy, Philippe; Deubel, Vincent] Inst Pasteur Cambodia, Phnom Penh, Cambodia	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia	Ding, H (corresponding author), Chinese Acad Sci, Unit Antiviral Immun & Genet Therapy, Key Lab Mol Virol & Immunol, Inst Pasteur Shanghai, Shanghai, Peoples R China.	blzhou@sibs.ac.cn	Cai, Cheguo/K-3747-2019	BUCHY, Philippe/0000-0003-1372-3008; Zhou, Fan/0000-0001-9918-3422	French Ministry of Health; Chinese National Science Foundation [30671922]; National Science and Technology Major Projects [2008ZX10001-010, 2009ZX10004-105, 2009ZX10004-016]; Li Kai-Shing Foundation of Hong Kong	French Ministry of Health; Chinese National Science Foundation(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Projects; Li Kai-Shing Foundation of Hong Kong	This work was supported by research grants from the French Ministry of Health, the Chinese National Science Foundation (#30671922), National Science and Technology Major Projects (#2008ZX10001-010, #2009ZX10004-105, #2009ZX10004-016), and the Li Kai-Shing Foundation of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsharifi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005336; BIDDISON WE, 1979, J IMMUNOL, V122, P660; Boon ACM, 2004, J IMMUNOL, V172, P2453, DOI 10.4049/jimmunol.172.4.2453; Buchy P, 2007, J CLIN VIROL, V39, P164, DOI 10.1016/j.jcv.2007.04.010; Bui HH, 2007, P NATL ACAD SCI USA, V104, P246, DOI 10.1073/pnas.0609330104; Cheng X, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004436; Corti D, 2010, J CLIN INVEST, V120, P1663, DOI 10.1172/JCI41902; Couch RB, 2008, VACCINE, V26, pD5, DOI 10.1016/j.vaccine.2008.05.076; Cox NJ, 2000, ANNU REV MED, V51, P407, DOI 10.1146/annurev.med.51.1.407; Garcia JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007918; Gillim-Ross L, 2007, PLOS MED, V4, P226, DOI 10.1371/journal.pmed.0040091; Gioia C, 2008, EMERG INFECT DIS, V14, P121, DOI 10.3201/eid1401.061283; Ichinohe T, 2007, J INFECT DIS, V196, P1313, DOI 10.1086/521304; Jameson J, 1998, J VIROL, V72, P8682, DOI 10.1128/JVI.72.11.8682-8689.1998; Kositanont U, 2010, VIRAL IMMUNOL, V23, P329, DOI 10.1089/vim.2009.0082; Kreijtz JHCM, 2009, VACCINE, V27, P4983, DOI 10.1016/j.vaccine.2009.05.079; Lee LYH, 2008, J CLIN INVEST, V118, P3478, DOI 10.1172/JCI32460; MCMICHAEL AJ, 1978, EUR J IMMUNOL, V8, P705, DOI 10.1002/eji.1830081007; Monto AS, 2009, EXPERT REV VACCINES, V8, P383, DOI [10.1586/erv.09.9, 10.1586/ERV.09.9]; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; REED L. J., 1938, AMER JOUR HYG, V27, P493; Sandbulte MR, 2007, PLOS MED, V4, P265, DOI 10.1371/journal.pmed.0040059; Seo SH, 2001, J VIROL, V75, P2516, DOI 10.1128/JVI.75.6.2516-2525.2001; Tang JW, 2008, J MED VIROL, V80, P1992, DOI 10.1002/jmv.21321; Tsai CG, 2009, VACCINE, V27, P6777, DOI 10.1016/j.vaccine.2009.08.056; Tumpey TM, 2001, J VIROL, V75, P5141, DOI 10.1128/JVI.75.11.5141-5150.2001; van Maurik A, 2010, VACCINE, V28, P1778, DOI 10.1016/j.vaccine.2009.12.008; World Health Organization, CUM NUMB CONF HUM CA; Zhou BP, 2007, NEW ENGL J MED, V357, P1450, DOI 10.1056/NEJMc070359; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	31	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e17821	10.1371/journal.pone.0017821	http://dx.doi.org/10.1371/journal.pone.0017821			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464977	Green Published, gold			2022-12-25	WOS:000288813900011
J	Toldo, S; Bogaard, HJ; Van Tassell, BW; Mezzaroma, E; Seropian, IM; Robati, R; Salloum, FN; Voelkel, NF; Abbate, A				Toldo, Stefano; Bogaard, Herman J.; Van Tassell, Benjamin W.; Mezzaroma, Eleonora; Seropian, Ignacio M.; Robati, Roshanak; Salloum, Fadi N.; Voelkel, Norbert F.; Abbate, Antonio			Right Ventricular Dysfunction following Acute Myocardial Infarction in the Absence of Pulmonary Hypertension in the Mouse	PLOS ONE			English	Article							HEART-FAILURE; APOPTOSIS	Background: Cardiac remodelling after AMI is characterized by molecular and cellular mechanisms involving both the ischemic and non-ischemic myocardium. The extent of right ventricular (RV) dilatation and dysfunction and its relation to pulmonary hypertension (PH) following AMI are unknown. The aim of the current study was to evaluate changes in dimensions and function of the RV following acute myocardial infarction (AMI) involving the left ventricle (LV). Methods: We assessed changes in RV dimensions and function 1 week following experimental AMI involving the LV free wall in 10 mice and assessed for LV and RV dimensions and function and for the presence and degree of PH. Results: RV fractional area change and tricuspidal annular plane systolic excursion significantly declined by 33% (P = 0.021) and 28% (P = 0.001) respectively. Right ventricular systolic pressure measured invasively in the mouse was within the normal values and unchanged following AMI. Conclusion: AMI involving the LV and sparing the RV induces a significant acute decline in RV systolic function in the absence of pulmonary hypertension in the mouse indicating that RV dysfunction developed independent of changes in RV afterload.	[Toldo, Stefano] Virginia Commonwealth Univ, VCU Pauley Heart Ctr, Richmond, VA 23284 USA; Virginia Commonwealth Univ, Victoria Johnson Res Ctr, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University	Toldo, S (corresponding author), Virginia Commonwealth Univ, VCU Pauley Heart Ctr, Richmond, VA 23284 USA.	abbatea@yahoo.com	Salloum, Fadi N/C-2391-2008; Abbate, Antonio/E-3405-2014; Abbate, Antonio/G-8805-2016	Salloum, Fadi N/0000-0002-8947-9315; Abbate, Antonio/0000-0002-1930-785X; Seropian, Ignacio Miguel/0000-0002-6823-4001; Bogaard, Harm Jan/0000-0001-5371-0346; Toldo, Stefano/0000-0002-1588-4019	VCU Pauley Heart Center; Victoria Johnson Research Laboratories; American Heart Association; institutional NIH [1KL2RR031989-01]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000058, KL2TR000057] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR031989] Funding Source: NIH RePORTER	VCU Pauley Heart Center; Victoria Johnson Research Laboratories; American Heart Association(American Heart Association); institutional NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The study was supported by funds deriving from the VCU Pauley Heart Center and Victoria Johnson Research Laboratories, and in part by an American Heart Association Beginning Grant in Aid to Dr. Abbate. Dr. Van Tassell is supported by an institutional NIH 1KL2RR031989-01 grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate A, 2008, AM J CARDIOL, V102, P658, DOI 10.1016/j.amjcard.2008.05.007; Abbate A, 2008, CIRCULATION, V117, P2670, DOI 10.1161/CIRCULATIONAHA.107.740233; Anavekar NS, 2008, AM J CARDIOL, V101, P607, DOI 10.1016/j.amjcard.2007.09.115; ANTONI ML, 2010, CIRC CARDIOVASC IMAG; ANVERSA P, 1991, AM J CARDIOL, V68, P7; BAKOS AUGUSTUS C. P., 1950, CIRCULATION, V1, P724; Bussani R, 2003, J CLIN PATHOL, V56, P672, DOI 10.1136/jcp.56.9.672; Daniels MCG, 2001, AM J PHYSIOL-HEART C, V281, pH2150, DOI 10.1152/ajpheart.2001.281.5.H2150; DISALVO TG, 1995, J AM COLL CARDIOL, V25, P1143, DOI 10.1016/0735-1097(94)00511-N; Gardin JM, 2002, J AM SOC ECHOCARDIOG, V15, P275, DOI 10.1067/mje.2002.121536; Haddad F, 2008, CIRCULATION, V117, P1436, DOI 10.1161/CIRCULATIONAHA.107.653576; Larose E, 2007, J AM COLL CARDIOL, V49, P855, DOI 10.1016/j.jacc.2006.10.056; OAKLEY C, 1988, AM J CARDIOL, V62, pA14, DOI 10.1016/S0002-9149(88)80079-1; Patten RD, 1998, AM J PHYSIOL-HEART C, V274, pH1812, DOI 10.1152/ajpheart.1998.274.5.H1812; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; Quaife RA, 1998, AM J CARDIOL, V81, P247, DOI 10.1016/S0002-9149(97)00874-6; SANTAMORE WP, 1976, J APPL PHYSIOL, V41, P925, DOI 10.1152/jappl.1976.41.6.925; Voelkel NF, 2006, CIRCULATION, V114, P1883, DOI 10.1161/CIRCULATIONAHA.106.632208; Zornoff LAM, 2002, J AM COLL CARDIOL, V39, P1450, DOI 10.1016/S0735-1097(02)01804-1	19	29	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2011	6	3							e18102	10.1371/journal.pone.0018102	http://dx.doi.org/10.1371/journal.pone.0018102			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740RG	21455304	Green Published, Green Submitted, gold			2022-12-25	WOS:000288811500021
J	Xiang, X; Zhuang, X; Ju, S; Zhang, S; Jiang, H; Mu, J; Zhang, L; Miller, D; Grizzle, W; Zhang, HG				Xiang, X.; Zhuang, X.; Ju, S.; Zhang, S.; Jiang, H.; Mu, J.; Zhang, L.; Miller, D.; Grizzle, W.; Zhang, H-G			miR-155 promotes macroscopic tumor formation yet inhibits tumor dissemination from mammary fat pads to the lung by preventing EMT	ONCOGENE			English	Article						miR-155; tumor metastasis; epithelial-to-mesenchymal transition	EPITHELIAL-MESENCHYMAL TRANSITION; BREAST-CANCER; E-CADHERIN; GENE-EXPRESSION; BHLH FACTORS; CELL; MICRORNA-155; METASTASIS; GROWTH; PROGRESSION	A micro-RNA, miR-155, is overexpressed in many types of cancer cells, including breast cancer, and its role(s) in tumor metastasis has been studied on a very limited basis. Tumor metastasis is a multi-step process with the last step in the process being formation of macroscopic tumor in organs distant from the primary tumor site. This step is the least studied. Here, we report that stable expression of miR-155 in 4T1 breast tumor cells reduces significantly the aggressiveness of tumor cell dissemination as a result of preventing epithelial-to-mesenchymal transition (EMT) of tumor cells in vivo. Further, miR-155 directly suppresses the expression of the transcription factor TCF4, which is an important regulator of EMT. However, when tumor cells are injected directly into the bloodstream, miR-155 remarkably promotes macroscopic tumor formation in the lung. Analysis of gene expression profiling identified a group of genes that are associated with promoting macroscopic tumor formation in the lung. Importantly, most of these genes are overexpressed in epithelial cells. Our findings provide new insight into how miR-155 modulates the development of tumor metastasis. This study suggests that the location of tumor cells overexpressing miR-155 is a critical factor: in mammary fat pads miR-155 prevents tumor dissemination; whereas in the lung miR-155 apparently maintains the epithelial phenotype of tumor cells that is critical for macroscopic tumor formation. Oncogene (2011) 30, 3440-3453; doi:10.1038/onc.2011.54; published online 4 April 2011	[Xiang, X.; Zhuang, X.; Ju, S.; Jiang, H.; Mu, J.; Zhang, L.; Miller, D.; Zhang, H-G] Univ Louisville, James Graham Brown Canc Ctr, Dept Microbiol & Immunol, Louisville, KY 40202 USA; [Zhang, S.; Grizzle, W.] Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA; [Zhang, H-G] Louisville Vet Adm Med Ctr, Louisville, KY USA	University of Louisville; University of Alabama System; University of Alabama Birmingham	Xiang, X (corresponding author), Univ Louisville, Brown Canc Ctr, 505 Hancock St,CTRB 309, Louisville, KY 40202 USA.	x0xian02@louisville.edu; H0Zhan17@louisvile.edu			National Institutes of Health (NIH) [RO1CA137037, R01AT004294, RO1CA107181, RO1CA116092]; Louisville Veterans Administration Medical Center (VAMC); Susan G Komen Breast Cancer Foundation; NATIONAL CANCER INSTITUTE [R01CA107181, R01CA116092, R01CA137037] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT004294] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louisville Veterans Administration Medical Center (VAMC); Susan G Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	We thank Dr David L Turner for providing plasmid UAS-luc-miR-155as, Dr David P Bartel for MDH1-PGK-GFP-miR-223 plasmid and Dr Jeffrey Schlom for the AT-3 breast tumor cell line. This work was supported by grants from the National Institutes of Health (NIH) (RO1CA137037, R01AT004294, RO1CA107181 and RO1CA116092), the Louisville Veterans Administration Medical Center (VAMC) Merit Review Grants (H-G Z) and a grant from the Susan G Komen Breast Cancer Foundation. We thank Dr Jerald Ainsworth for editorial assistance.	Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Aokage K, 2011, INT J CANCER, V128, P1585, DOI 10.1002/ijc.25500; Bukholm IK, 2000, J PATHOL, V190, P15; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Cheng CW, 2001, ONCOGENE, V20, P3814, DOI 10.1038/sj.onc.1204505; Chung KH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl143; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Gallardo E, 2009, CARCINOGENESIS, V30, P1903, DOI 10.1093/carcin/bgp219; Gibbons DL, 2009, GENE DEV, V23, P2140, DOI 10.1101/gad.1820209; Grizzle WE, 2002, INT J CANCER, V101, P270, DOI 10.1002/ijc.10606; Han HJ, 2008, NATURE, V452, P187, DOI 10.1038/nature06781; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Iorns E, 2010, JNCI-J NATL CANCER I, V102, P1284, DOI 10.1093/jnci/djq243; Jiang SA, 2010, CANCER RES, V70, P3119, DOI 10.1158/0008-5472.CAN-09-4250; Johnson MH, 2009, ANNU REV CELL DEV BI, V25, P483, DOI 10.1146/annurev.cellbio.042308.113348; Katoh M, 2005, INT J ONCOL, V27, P1677; Kong W, 2008, MOL CELL BIOL, V28, P6773, DOI 10.1128/MCB.00941-08; Kong W, 2010, J BIOL CHEM, V285, P17869, DOI 10.1074/jbc.M110.101055; Li JS, 2009, CLIN CANCER RES, V15, P3998, DOI 10.1158/1078-0432.CCR-08-3053; Logullo AF, 2010, ONCOL REP, V23, P313, DOI 10.3892/or_00000638; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Nakaya Y, 2004, DEV CELL, V7, P425, DOI 10.1016/j.devcel.2004.08.003; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; PULASKI BA, 2001, CURRENT PROTOCOLS IM, V4, pCH20; Ryu JK, 2010, PANCREATOLOGY, V10, P66, DOI 10.1159/000231984; Sobrado VR, 2009, J CELL SCI, V122, P1014, DOI 10.1242/jcs.028241; Soltermann A, 2008, CLIN CANCER RES, V14, P7430, DOI 10.1158/1078-0432.CCR-08-0935; Stewart TJ, 2007, J IMMUNOL, V179, P2851, DOI 10.4049/jimmunol.179.5.2851; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thompson EW, 2008, CLIN EXP METASTAS, V25, P591, DOI 10.1007/s10585-008-9189-8; Tsuji T, 2009, CANCER RES, V69, P7135, DOI 10.1158/0008-5472.CAN-09-1618; Tsuji T, 2008, CANCER RES, V68, P10377, DOI 10.1158/0008-5472.CAN-08-1444; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang B, 2009, HEPATOLOGY, V50, P1152, DOI 10.1002/hep.23100; Wells A, 2008, CLIN EXP METASTAS, V25, P621, DOI 10.1007/s10585-008-9167-1; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047	44	79	90	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	AUG	2011	30	31					3440	3453		10.1038/onc.2011.54	http://dx.doi.org/10.1038/onc.2011.54			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	802KA	21460854	Green Accepted			2022-12-25	WOS:000293508100005
J	Stalnaker, SH; Aoki, K; Lim, JM; Porterfield, M; Liu, MA; Satz, JS; Buskirk, S; Xiong, YF; Zhang, P; Campbell, KP; Hu, HY; Live, D; Tiemeyer, M; Wells, L				Stalnaker, Stephanie H.; Aoki, Kazuhiro; Lim, Jae-Min; Porterfield, Mindy; Liu, Mian; Satz, Jakob S.; Buskirk, Sean; Xiong, Yufang; Zhang, Peng; Campbell, Kevin P.; Hu, Huaiyu; Live, David; Tiemeyer, Michael; Wells, Lance			Glycomic Analyses of Mouse Models of Congenital Muscular Dystrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-DYSTROGLYCAN; ABNORMAL GLYCOSYLATION; GLYCOPROTEIN COMPLEX; MUTATIONS; LAMININ; GLYCANS; BINDING; POMT1; FORM; H-1	Dystroglycanopathies are a subset of congenital muscular dystrophies wherein alpha-dystroglycan (alpha-DG) is hypoglycosylated. alpha-DG is an extensively O-glycosylated extracellular matrix-binding protein and a key component of the dystrophinglycoprotein complex. Previous studies have shown alpha-DG to be post-translationally modified by both O-GalNAc-and O-mannose-initiated glycan structures. Mutations in defined or putative glycosyltransferase genes involved in O-mannosylation are associated with a loss of ligand-binding activity of alpha-DG and are causal for various forms of congenital muscular dystrophy. In this study, we sought to perform glycomic analysis on brain O-linked glycan structures released from proteins of three different knock-out mouse models associated with O-mannosylation (POMGnT1, LARGE (Myd), and DAG1(-/-)). Using mass spectrometry approaches, we were able to identify nine O-mannose-initiated and 25 O-GalNAc-initiated glycan structures in wild-type littermate control mouse brains. Through our analysis, we were able to confirm that POMGnT1 is essential for the extension of all observed O-mannose glycan structures with beta 1,2-linked GlcNAc. Loss of LARGE expression in the Myd mouse had no observable effect on the O-mannose-initiated glycan structures characterized here. Interestingly, we also determined that similar amounts of O-mannose-initiated glycan structures are present on brain proteins from alpha-DG-lacking mice (DAG1) compared with wild-type mice, indicating that there must be additional proteins that are O-mannosylated in the mammalian brain. Our findings illustrate that classical beta 1,2-elongation and beta 1,6-GlcNAc branching of O-mannose glycan structures are dependent upon the POMGnT1 enzyme and that O-mannosylation is not limited solely to alpha-DG in the brain.	[Stalnaker, Stephanie H.; Aoki, Kazuhiro; Lim, Jae-Min; Porterfield, Mindy; Liu, Mian; Buskirk, Sean; Live, David; Tiemeyer, Michael; Wells, Lance] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Satz, Jakob S.; Campbell, Kevin P.] Howard Hughes Med Inst, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Xiong, Yufang; Zhang, Peng; Hu, Huaiyu] SUNY Upstate Med Univ, Syracuse, NY 13210 USA	University System of Georgia; University of Georgia; Howard Hughes Medical Institute; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Wells, L (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA.	lwells@ccrc.uga.edu	Buskirk, Sean/AAM-1228-2021; Wells, Lance/H-3118-2013; Aoki, Kazuhiro/H-8283-2014	Buskirk, Sean/0000-0003-1213-8130; Aoki, Kazuhiro/0000-0003-0029-4291; Campbell, Kevin/0000-0003-2066-5889; Wells, Lance/0000-0003-4956-5363	National Institutes of Health [HD060458, NS066582]; Muscular Dystrophy Association; National Center for Research Resources Center [P41RR018502]; Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center [1U54NS053672]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD060458] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066582, U54NS053672] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); National Center for Research Resources Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center(Ohio State University); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants HD060458 and NS066582 (to H. H.). This work was also supported by the Muscular Dystrophy Association (to L. W.), National Center for Research Resources Center Grant P41RR018502 (to L. W. and M. T.), and Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center Grant 1U54NS053672 (to K. P. C.).	Alvarez-Manilla G, 2010, GLYCOBIOLOGY, V20, P166, DOI 10.1093/glycob/cwp158; Aoki K, 2008, J BIOL CHEM, V283, P30385, DOI 10.1074/jbc.M804925200; Aoki K, 2007, J BIOL CHEM, V282, P9127, DOI 10.1074/jbc.M606711200; Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; BAX A, 1986, J AM CHEM SOC, V108, P2093, DOI 10.1021/ja00268a061; Beltran-Valero de Bernabe D, 2002, AM J HUM GENET, V71, P1033, DOI 10.1086/342975; Brockington M, 2001, AM J HUM GENET, V69, P1198, DOI 10.1086/324412; Bubb WA, 2003, CONCEPT MAGN RESON A, V19A, P1, DOI 10.1002/cmr.a.10080; Cao W, 1998, SCIENCE, V282, P2079, DOI 10.1126/science.282.5396.2079; Chai WG, 1999, EUR J BIOCHEM, V263, P879, DOI 10.1046/j.1432-1327.1999.00572.x; Chiba A, 1997, J BIOL CHEM, V272, P2156; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; Combs AC, 2005, BIOCHEM J, V390, P303, DOI 10.1042/BJ20050375; Endo T, 1999, BBA-GEN SUBJECTS, V1473, P237, DOI 10.1016/S0304-4165(99)00182-8; Endo Tamao, 2006, V347, P43; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; Jimenez-Mallebrera C, 2005, CELL MOL LIFE SCI, V62, P809, DOI 10.1007/s00018-004-4510-4; Kanagawa M, 2004, CELL, V117, P953, DOI 10.1016/j.cell.2004.06.003; Kobayashi K, 1998, NATURE, V394, P388, DOI 10.1038/28653; Lisi MT, 2007, BBA-MOL BASIS DIS, V1772, P159, DOI 10.1016/j.bbadis.2006.09.006; Liu JM, 2006, MECH DEVELOP, V123, P228, DOI 10.1016/j.mod.2005.12.003; Longman C, 2003, HUM MOL GENET, V12, P2853, DOI 10.1093/hmg/ddg307; Manya H, 2004, P NATL ACAD SCI USA, V101, P500, DOI 10.1073/pnas.0307228101; Martin PT, 2007, CURR MOL MED, V7, P417, DOI 10.2174/156652407780831601; Michele DE, 2003, J BIOL CHEM, V278, P15457, DOI 10.1074/jbc.R200031200; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Moore SA, 2002, NATURE, V418, P422, DOI 10.1038/nature00838; Nakamura N, 2010, GLYCOBIOLOGY, V20, P381, DOI 10.1093/glycob/cwp189; PODLASEK CA, 1995, J AM CHEM SOC, V117, P8635, DOI 10.1021/ja00138a020; Spiropoulou CF, 2002, J VIROL, V76, P5140, DOI 10.1128/JVI.76.10.5140-5146.2002; Stalnaker SH, 2010, J BIOL CHEM, V285, P24882, DOI 10.1074/jbc.M110.126474; Sutton-Smith M, 2002, BIOCHEM SOC SYMP, V69, P105; van Reeuwijk J, 2005, J MED GENET, V42, P907, DOI 10.1136/jmg.2005.031963; Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3; Yoshida-Moriguchi T, 2010, SCIENCE, V327, P88, DOI 10.1126/science.1180512	37	59	59	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21180	21190		10.1074/jbc.M110.203281	http://dx.doi.org/10.1074/jbc.M110.203281			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21460210	hybrid, Green Published			2022-12-25	WOS:000291464700018
J	Zamborlini, A; Coiffic, A; Beauclair, G; Delelis, O; Paris, J; Koh, Y; Magne, F; Giron, ML; Tobaly-Tapiero, J; Deprez, E; Emiliani, S; Engelman, A; de The, H; Saib, A				Zamborlini, Alessia; Coiffic, Audrey; Beauclair, Guillaume; Delelis, Olivier; Paris, Joris; Koh, Yashuiro; Magne, Fabian; Giron, Marie-Lou; Tobaly-Tapiero, Joelle; Deprez, Eric; Emiliani, Stephane; Engelman, Alan; de The, Hugues; Saib, Ali			Impairment of Human Immunodeficiency Virus Type-1 Integrase SUMOylation Correlates with an Early Replication Defect	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIV-1 INTEGRASE; REVERSE-TRANSCRIPTASE; DNA-BINDING; IN-VITRO; NONDIVIDING CELLS; VIRAL INTEGRATION; SUMO MODIFICATION; GENE-EXPRESSION; TERMINAL DOMAIN; RETROVIRAL DNA	HIV-1 integrase (IN) orchestrates the integration of the reverse transcribed viral cDNA into the host cell genome and participates also in other steps of HIV-1 replication. Cellular and viral factors assist IN in performing its multiple functions, and post-translational modifications contribute to modulate its activities. Here, we show that HIV-1 IN is modified by SUMO proteins and that phylogenetically conserved SUMOylation consensus motifs represent major SUMO acceptor sites. Viruses harboring SUMOylation site IN mutants displayed a replication defect that was mapped during the early stages of infection, before integration but after reverse transcription. Because SUMOylation-defective IN mutants retained WT catalytic activity, we hypothesize that SUMOylation might regulate the affinity of IN for co-factors, contributing to efficient HIV-1 replication.	[Zamborlini, Alessia; Coiffic, Audrey; Beauclair, Guillaume; Paris, Joris; Magne, Fabian; Giron, Marie-Lou; Tobaly-Tapiero, Joelle; de The, Hugues; Saib, Ali] Univ Paris 07, CNRS, INSERM, Inst Univ Hematol,UMR7212,U944, F-75475 Paris, France; [Zamborlini, Alessia; Magne, Fabian; Saib, Ali] Conservatoire Arts & Metiers, Paris, France; [Delelis, Olivier; Deprez, Eric] Ecole Normale Super, Lab Biotechnol & Pharmacol Genet Appl, CNRS, UMR8113, F-94235 Cachan, France; [Emiliani, Stephane] Univ Paris 05, INSERM, CNRS, Inst Cochin,U1016,UMR8104, F-75014 Paris, France; [Koh, Yashuiro; Engelman, Alan] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02215 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; heSam Universite; Conservatoire National Arts & Metiers (CNAM); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Harvard University; Dana-Farber Cancer Institute	Saib, A (corresponding author), Univ Paris 07, CNRS, INSERM, Inst Univ Hematol,UMR7212,U944, F-75475 Paris, France.	ali.saib@cnam.fr	Guillaume, Beauclair/ABF-6429-2020; Zamborlini, Alessia/ABE-2256-2021; Magne, Fabien/F-1393-2014	Guillaume, Beauclair/0000-0001-5323-5987; Zamborlini, Alessia/0000-0002-8902-1996; Magne, Fabien/0000-0002-8210-4561; Tobaly-Tapiero, Joelle/0000-0001-6318-8627	National Institutes of Health [AI052014]; Agence Nationale pour la Recherche sur le SIDA et les Hepatites Virales (ANRS); Sidaction; French Research Ministry; Mitsubishi Pharma Foundation; Conseil Regional d'Ile de France; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052014, P30AI060354] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agence Nationale pour la Recherche sur le SIDA et les Hepatites Virales (ANRS)(ANRSFrench National Research Agency (ANR)); Sidaction; French Research Ministry(Ministry of Research, France); Mitsubishi Pharma Foundation; Conseil Regional d'Ile de France(Region Ile-de-France); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI052014 (to A. E.). This work was also supported by Sidaction and by Agence Nationale pour la Recherche sur le SIDA et les Hepatites Virales (ANRS).; Supported by the French Research Ministry.; Supported by the Mitsubishi Pharma Foundation.; We thank D. Gabuzda, R. Niedenthal, F. Mammano, R. Hay, and D. Trono for reagents; P. Lesage, S. Basmaciogullari, V. Lallemand-Breitenbach, and M. Benkirane for discussion and critical reading of the manuscript; and F. Lacoste for informatics supplies. We thank N. Setterblad and C. Doliger at the Imagery and Cell Sorting Department of the Institut Universitaire d'Hematologie-Hopital St-Louis IFR105 (supported by grants from the Conseil Regional d'Ile de France and the French Research Ministry) for technical assistance.	Al-Mawsawi LQ, 2007, TRENDS PHARMACOL SCI, V28, P526, DOI 10.1016/j.tips.2007.09.005; ALLOUCH A, 2009, AMINO ACIDS IN PRESS; Ayaydin F, 2004, MOL BIOL CELL, V15, P5208, DOI 10.1091/mbc.E04-07-0589; Boggio R, 2006, CURR OPIN MICROBIOL, V9, P430, DOI 10.1016/j.mib.2006.06.008; BOWERMAN B, 1989, GENE DEV, V3, P469, DOI 10.1101/gad.3.4.469; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Briones MS, 2010, J VIROL, V84, P5181, DOI 10.1128/JVI.02382-09; Brussel A, 2004, J VIROL, V78, P11263, DOI 10.1128/JVI.78.20.11263-11271.2004; Bukovsky A, 1996, J VIROL, V70, P6820, DOI 10.1128/JVI.70.10.6820-6825.1996; Cannon PM, 1996, J VIROL, V70, P651, DOI 10.1128/JVI.70.1.651-657.1996; Carayon K, 2010, NUCLEIC ACIDS RES, V38, P3692, DOI 10.1093/nar/gkq087; Carteau S, 1999, J VIROL, V73, P6670, DOI 10.1128/JVI.73.8.6670-6679.1999; Ceccherini-Silberstein F, 2009, AIDS REV, V11, P17; Cereseto A, 2005, EMBO J, V24, P3070, DOI 10.1038/sj.emboj.7600770; Chen JCH, 2000, P NATL ACAD SCI USA, V97, P8233, DOI 10.1073/pnas.150220297; Cherepanov P, 2005, NAT STRUCT MOL BIOL, V12, P526, DOI 10.1038/nsmb937; Cherepanov P, 2000, FASEB J, V14, P1389, DOI 10.1096/fj.14.10.1389; Craigie R, 2001, J BIOL CHEM, V276, P23213, DOI 10.1074/jbc.R100027200; CRAIGIE R, 1990, CELL, V62, P829, DOI 10.1016/0092-8674(90)90126-Y; Devroe E, 2003, J CELL SCI, V116, P4401, DOI 10.1242/jcs.00747; Eladad S, 2005, HUM MOL GENET, V14, P1351, DOI 10.1093/hmg/ddi145; Emiliani S, 2005, J BIOL CHEM, V280, P25517, DOI 10.1074/jbc.M501378200; Engelman A, 1999, ADV VIRUS RES, V52, P411, DOI 10.1016/S0065-3527(08)60309-7; ENGELMAN A, 1995, J VIROL, V69, P2729, DOI 10.1128/JVI.69.5.2729-2736.1995; Esposito D, 1999, ADV VIRUS RES, V52, P319, DOI 10.1016/S0065-3527(08)60304-8; Gallay P, 1997, P NATL ACAD SCI USA, V94, P9825, DOI 10.1073/pnas.94.18.9825; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gervaix A, 1997, P NATL ACAD SCI USA, V94, P4653, DOI 10.1073/pnas.94.9.4653; GOFF SP, 2001, FIELDS VIROLOGY, P1871; Gurer C, 2005, J VIROL, V79, P910, DOI 10.1128/JVI.79.2.910-917.2005; He JL, 1997, NATURE, V385, P645, DOI 10.1038/385645a0; Hehl EA, 2004, J VIROL, V78, P5056, DOI 10.1128/JVI.78.10.5056-5067.2004; Hindmarsh P, 1999, ADV VIRUS RES, V52, P397, DOI 10.1016/S0065-3527(08)60308-5; Ikeda T, 2004, J VIROL, V78, P11563, DOI 10.1128/JVI.78.21.11563-11573.2004; Jaber T, 2009, J VIROL, V83, P10448, DOI 10.1128/JVI.00237-09; KATZ RA, 1990, CELL, V63, P87, DOI 10.1016/0092-8674(90)90290-U; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; KUIKEN CL, 2002, HIV SEQUENCE COMPEND; Leavitt AD, 1996, J VIROL, V70, P721, DOI 10.1128/JVI.70.2.721-728.1996; Leh H, 2000, BIOCHEMISTRY-US, V39, P9285, DOI 10.1021/bi000398b; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Liu HM, 1997, J VIROL, V71, P7704, DOI 10.1128/JVI.71.10.7704-7710.1997; Llano M, 2006, SCIENCE, V314, P461, DOI 10.1126/science.1132319; Lu R, 2005, J VIROL, V79, P2493, DOI 10.1128/JVI.79.4.2493-2505.2005; Manganaro L, 2010, NAT MED, V16, P329, DOI 10.1038/nm.2102; Martinez NW, 2008, J VIROL, V82, P9937, DOI 10.1128/JVI.00819-08; Matic I, 2010, MOL CELL, V39, P641, DOI 10.1016/j.molcel.2010.07.026; Mousnier A, 2007, P NATL ACAD SCI USA, V104, P13615, DOI 10.1073/pnas.0705162104; Mulder LCF, 2000, J BIOL CHEM, V275, P29749, DOI 10.1074/jbc.M004670200; Petit C, 1999, J VIROL, V73, P5079, DOI 10.1128/JVI.73.6.5079-5088.1999; Quillent C, 1996, VIROLOGY, V219, P29, DOI 10.1006/viro.1996.0219; Rhee SY, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-74; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; SHIN CG, 1994, J VIROL, V68, P1633, DOI 10.1128/JVI.68.3.1633-1642.1994; Shun MC, 2007, GENE DEV, V21, P1767, DOI 10.1101/gad.1565107; Swanson CM, 2008, CELL, V133, DOI 10.1016/j.cell.2008.05.005; Tasara T, 2001, FEBS LETT, V507, P39, DOI 10.1016/S0014-5793(01)02945-3; Terreni M, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-18; Topper M, 2007, J VIROL, V81, P3012, DOI 10.1128/JVI.02257-06; Tsurutani N, 2000, J VIROL, V74, P4795, DOI 10.1128/JVI.74.10.4795-4806.2000; Vandegraaff Nick, 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S1462399407000257; Wang JY, 2001, EMBO J, V20, P7333, DOI 10.1093/emboj/20.24.7333; Weldon RA, 2003, VIROLOGY, V314, P62, DOI 10.1016/S0042-6822(03)00348-9; Wilson VG, 2001, VIRUS RES, V81, P17, DOI 10.1016/S0168-1702(01)00365-3; Wu XY, 1999, J VIROL, V73, P2126, DOI 10.1128/JVI.73.3.2126-2135.1999; Xue Y, 2006, NUCLEIC ACIDS RES, V34, pW254, DOI 10.1093/nar/gkl207; Yoder KE, 2000, J VIROL, V74, P11191, DOI 10.1128/JVI.74.23.11191-11200.2000; Yueh A, 2006, J VIROL, V80, P342, DOI 10.1128/JVI.80.1.342-352.2006; Zhu K, 2004, J VIROL, V78, P5045, DOI 10.1128/JVI.78.10.5045-5055.2004	70	48	48	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					21013	21022		10.1074/jbc.M110.189274	http://dx.doi.org/10.1074/jbc.M110.189274			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21454548	Green Published, hybrid			2022-12-25	WOS:000291267600085
J	Dai, YF; Walker, SA; de Vet, E; Cook, S; Welch, HCE; Lockyer, PJ				Dai, Yanfeng; Walker, Simon A.; de Vet, Edwin; Cook, Simon; Welch, Heidi C. E.; Lockyer, Peter J.			Ca2+-dependent Monomer and Dimer Formation Switches CAPRI Protein between Ras GTPase-activating Protein (GAP) and RapGAP Activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARGININE-FINGER; FLUORESCENCE COMPLEMENTATION; CELL-PROLIFERATION; CA2+ OSCILLATIONS; C2 DOMAIN; KINASE-II; FAMILY; RAP1; COMPLEX; IDENTIFICATION	CAPRI is a member of the GAP1 family of GTPase-activating proteins (GAPs) for small G proteins. It is known to function as an amplitude sensor for intracellular Ca2+ levels stimulated by extracellular signals and has a catalytic domain with dual RasGAP and RapGAP activities. Here, we have investigated the mechanism that switches CAPRI between its two GAP activities. We demonstrate that CAPRI forms homodimers in vitro and in vivo in a Ca2+-dependent manner. The site required for dimerization was pinpointed by deletion and point mutations to a helix motif that forms a hydrophobic face in the extreme C-terminal tail of the CAPRI protein. Deletion of this helix motif abolished dimer formation but did not affect translocation of CAPRI to the plasma membrane upon cell stimulation with histamine. We found that dimeric and monomeric CAPRI coexist in cells and that the ratio of dimeric to monomeric CAPRI increases upon cell stimulation with histamine. Free Ca2+ at physiologically relevant concentrations was both necessary and sufficient for dimer formation. Importantly, the monomeric and dimeric forms of CAPRI exhibited differential GAP activities in vivo; the wild-type form of CAPRI had stronger RapGAP activity than RasGAP activity, whereas a monomeric CAPRI mutant showed stronger RasGAP than RapGAP activity. These results demonstrate that CAPRI switches between its dual GAP roles by forming monomers or homodimers through a process regulated by Ca2+. We propose that Ca2+-dependent dimerization of CAPRI may serve to coordinate Ras and Rap1 signaling pathways.	[Dai, Yanfeng; Walker, Simon A.; de Vet, Edwin; Cook, Simon; Lockyer, Peter J.] Babraham Inst, Mol Signalling Lab, Cambridge CB22 3AT, England; [Dai, Yanfeng; Welch, Heidi C. E.] Babraham Inst, Inositide Lab, Cambridge CB22 3AT, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Dai, YF (corresponding author), Inner Mongolia Univ, Coll Life Sci, Hohhot 010021, Peoples R China.	yfdai9698@gmail.com		Welch, Heidi/0000-0001-7865-7000; Dai, Yanfeng/0000-0002-6151-2654; dai, dai yan feng/0000-0001-7147-1748; Walker, Simon/0000-0001-9185-4922	Biotechnology and Biological Sciences Research Council [C20001, BBS/E/B/0000C231, BBS/E/B/0000C199, BBS/E/B/0000M090, BBS/E/B/0000C197] Funding Source: Medline; BBSRC [BBS/E/B/0000C231] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Ahmadian MR, 1997, NAT STRUCT BIOL, V4, P686, DOI 10.1038/nsb0997-686; Bernards A, 2003, BBA-REV CANCER, V1603, P47, DOI 10.1016/S0304-419X(02)00082-3; Bivona TG, 2003, NATURE, V424, P694, DOI 10.1038/nature01806; Bootman MD, 2001, SEMIN CELL DEV BIOL, V12, P3, DOI 10.1006/scdb.2000.0211; Brinkmann T, 2002, J BIOL CHEM, V277, P12525, DOI 10.1074/jbc.M109176200; Chakrabarti PP, 2004, J BIOL CHEM, V279, P46226, DOI 10.1074/jbc.M405603200; Cook SJ, 2006, CELL CALCIUM, V39, P101, DOI 10.1016/j.ceca.2005.10.014; COOK SJ, 1993, EMBO J, V12, P3475, DOI 10.1002/j.1460-2075.1993.tb06022.x; Cullen PJ, 2006, CURR OPIN CELL BIOL, V18, P157, DOI 10.1016/j.ceb.2006.02.012; CULLEN PJ, 1995, NATURE, V376, P527, DOI 10.1038/376527a0; Daumke O, 2004, NATURE, V429, P197, DOI 10.1038/nature02505; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; Dote H, 2004, CLIN CANCER RES, V10, P2082, DOI 10.1158/1078-0432.CCR-03-0236; Hames BD., 1990, GEL ELECTROPHORESIS, P1; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Hu CD, 2003, NAT BIOTECHNOL, V21, P539, DOI 10.1038/nbt816; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Kim JH, 2003, J NEUROSCI, V23, P1119; Kinashi T, 2005, NAT REV IMMUNOL, V5, P546, DOI 10.1038/nri1646; KITAYAMA H, 1989, CELL, V56, P77, DOI 10.1016/0092-8674(89)90985-9; Kooistra MRH, 2007, J CELL SCI, V120, P17, DOI 10.1242/jcs.03306; Kupzig S, 2006, J BIOL CHEM, V281, P9891, DOI 10.1074/jbc.M512802200; Kupzig S, 2009, MOL CELL BIOL, V29, P3929, DOI 10.1128/MCB.00427-09; Liu Q, 2005, J CELL BIOL, V170, P183, DOI 10.1083/jcb.200504167; Lockyer PJ, 2001, CURR BIOL, V11, P981, DOI 10.1016/S0960-9822(01)00261-5; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; Oh JS, 2004, J BIOL CHEM, V279, P17980, DOI 10.1074/jbc.M314109200; Ohba Y, 2001, EMBO J, V20, P3333, DOI 10.1093/emboj/20.13.3333; Pena V, 2008, EMBO REP, V9, P350, DOI 10.1038/embor.2008.20; Raaijmakers JH, 2009, J BIOL CHEM, V284, P10995, DOI 10.1074/jbc.R800061200; Roderick HL, 2008, NAT REV CANCER, V8, P361, DOI 10.1038/nrc2374; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Scheffzek K, 1996, NATURE, V384, P591, DOI 10.1038/384591a0; Scrima A, 2008, EMBO J, V27, P1145, DOI 10.1038/emboj.2008.30; Sot B, 2010, EMBO J, V29, P1205, DOI 10.1038/emboj.2010.20; Stork PJS, 2003, TRENDS BIOCHEM SCI, V28, P267, DOI 10.1016/S0968-0004(03)00087-2; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Walker SA, 2004, EMBO J, V23, P1749, DOI 10.1038/sj.emboj.7600197; Westbrook TF, 2005, CELL, V121, P837, DOI 10.1016/j.cell.2005.03.033; Yarwood S, 2006, BIOCHEM SOC T, V34, P846, DOI 10.1042/BST0340846; Zhang J, 2005, NAT IMMUNOL, V6, P911, DOI 10.1038/ni1232	41	19	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19905	19916		10.1074/jbc.M110.201301	http://dx.doi.org/10.1074/jbc.M110.201301			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21460216	Green Published, hybrid			2022-12-25	WOS:000291027700070
J	Campbell, GR; Spector, SA				Campbell, Grant R.; Spector, Stephen A.			Hormonally Active Vitamin D3 (1 alpha,25-Dihydroxycholecalciferol) Triggers Autophagy in Human Macrophages That Inhibits HIV-1 Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CD4(+) T-CELLS; PHOSPHATIDYLINOSITOL 3-KINASE; ANTIRETROVIRAL THERAPY; HIGHER EUKARYOTES; DOWN-REGULATION; LEUKEMIA CELLS; D DEFICIENCY; ASSOCIATION; REPLICATION	Autophagy is a self-digestion pathway essential for maintaining cellular homeostasis and cell survival and for degrading intracellular pathogens. Human immunodeficiency virus-1 (HIV-1) may utilize autophagy for replication as the autophagy-related protein-7 (ATG-7), microtubule-associated protein 1 light chain 3, ATG-12, and ATG-16L2 are required for productive HIV-1 infection; however, the effects of autophagy induction on HIV-1 infection are unknown. HIV-1-infected individuals have lower levels of 1 alpha,25-dihydroxycholecalciferol, the hormonally active form of vitamin D, than uninfected individuals. with the lowest concentrations found in persons with AIDS. Using human macrophages and RNA interference for ATG-5 and Beclin-1 and chemical inhibition of phosphatidylinositol 3-kinase, we have found that physiologically relevant concentrations of 1 alpha,25-dihydroxycholecalciferol induce autophagy in human macrophages through a phosphatidylinositol 3-kinase-, ATG-5-, and Beclin-1-dependent mechanism that significantly inhibits HIV-1 replication in a dose-dependent manner. We also show that the inhibition of basal autophagy inhibits HIV-1 replication. Furthermore, although 1 alpha,25-dihydroxycholecalciferol induces the secretion of human cathelicidin, at the concentrations produced in vitro, cathelicidin does not trigger autophagy. Our findings support an important role for autophagy during HIV-1 infection and provide new insights into novel approaches to prevent and treat HIV-1 infection and related opportunistic infections.	[Campbell, Grant R.; Spector, Stephen A.] Univ Calif San Diego, Dept Pediat, Div Infect Dis, La Jolla, CA 92093 USA; [Spector, Stephen A.] Rady Childrens Hosp, San Diego, CA 92123 USA	University of California System; University of California San Diego; Rady Childrens Hospital San Diego	Spector, SA (corresponding author), Univ Calif San Diego, Dept Pediat, Div Infect Dis, 9500 Gilman Dr, La Jolla, CA 92093 USA.	saspector@ucsd.edu	Campbell, Grant/C-9018-2011	Campbell, Grant/0000-0003-3927-1994	National Institutes of Health (NIAID) [AI084573, AI068632]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI084573, U01AI068632, UM1AI068632] Funding Source: NIH RePORTER	National Institutes of Health (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI084573 and AI068632 (NIAID; to the International Maternal Pediatric Adolescent AIDS Clinical Trials Group).	Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bergman P, 2007, CURR HIV RES, V5, P410; Blanchet FP, 2010, IMMUNITY, V32, P654, DOI 10.1016/j.immuni.2010.04.011; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Brady NR, 2007, FEBS J, V274, P3184, DOI 10.1111/j.1742-4658.2007.05849.x; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; CAMPBELL GR, 2011, AIDS RES HU IN PRESS; Campbell GR, 2008, J BIOL CHEM, V283, P30745, DOI 10.1074/jbc.M804112200; Campbell GR, 2010, J BIOL CHEM, V285, P1681, DOI 10.1074/jbc.M109.049957; de Luis D A, 2002, Nutr Hosp, V17, P285; Delgado MA, 2008, EMBO J, V27, P1110, DOI 10.1038/emboj.2008.31; DeMasters G, 2006, MOL CANCER THER, V5, P2786, DOI 10.1158/1535-7163.MCT-06-0316; Denek M, 2007, J CELL BIOL, V177, P329, DOI 10.1083/jcb.200609050; Denizot M, 2008, AUTOPHAGY, V4, P998, DOI 10.4161/auto.6880; Di Benedetto F, 2010, TRANSPLANTATION, V89, P733, DOI 10.1097/TP.0b013e3181c7dcc0; Dixon WJ, 1983, INTRO STAT ANAL, P92; Eng KE, 2010, AUTOPHAGY, V6, P634, DOI 10.4161/auto.6.5.12112; Espert L, 2006, M S-MED SCI, V22, P677, DOI 10.1051/medsci/20062289677; Espert L, 2006, J CLIN INVEST, V116, P2161, DOI 10.1172/JCI26185; Espert L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005787; FEDERIGHI ET, 1959, J AM STAT ASSOC, V54, P683, DOI 10.2307/2282546; Francois F, 2003, J VIROL, V77, P2539, DOI 10.1128/JVI.77.4.2539-2549.2003; Galluzzi L, 2009, CELL DEATH DIFFER, V16, P1093, DOI 10.1038/cdd.2009.44; GARTNER S, 1986, SCIENCE, V233, P215, DOI 10.1126/science.3014648; Hagenau T, 2009, OSTEOPOROSIS INT, V20, P133, DOI 10.1007/s00198-008-0626-y; HARRIS J, 2009, CURR PROTOC IMMUNOL, pCH14; HAUG C, 1994, J INFECT DIS, V169, P889, DOI 10.1093/infdis/169.4.889; Haug CJ, 1998, J CLIN ENDOCR METAB, V83, P3832, DOI 10.1210/jc.83.11.3832; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Heredia A, 2003, P NATL ACAD SCI USA, V100, P10411, DOI 10.1073/pnas.1834278100; Hoyer-Hansen M, 2005, CELL DEATH DIFFER, V12, P1297, DOI 10.1038/sj.cdd.4401651; JAPOUR AJ, 1993, ANTIMICROB AGENTS CH, V37, P1095, DOI 10.1128/AAC.37.5.1095; Joint United Nations Programme on HIV/AIDS, 2008, REP GLOB HIV AIDS EP; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kyei GB, 2009, J CELL BIOL, V186, P255, DOI 10.1083/jcb.200903070; Levinson P, 2009, AIDS, V23, P309, DOI 10.1097/QAD.0b013e328321809c; Martineau AR, 2007, J STEROID BIOCHEM, V103, P793, DOI 10.1016/j.jsbmb.2006.12.052; Mehta S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008770; Mehta S, 2009, J INFECT DIS, V200, P1022, DOI 10.1086/605699; Mercalli A, 2006, AM J TRANSPLANT, V6, P1331, DOI 10.1111/j.1600-6143.2006.01332.x; Misse D, 2005, AIDS, V19, P897, DOI 10.1097/01.aids.0000171403.07995.92; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mueller NJ, 2010, AIDS, V24, P1127, DOI 10.1097/QAD.0b013e328337b161; Pathak S, 2009, SCAND J IMMUNOL, V70, P264, DOI 10.1111/j.1365-3083.2009.02299.x; Pelchen-Matthews A, 2003, J CELL BIOL, V162, P443, DOI 10.1083/jcb.200304008; Pepper C, 2003, BLOOD, V101, P2454, DOI 10.1182/blood-2002-07-1984; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Popovic M., 1988, RETROVIRUSES HUMAN A, P21; Roy J, 2002, ANTIMICROB AGENTS CH, V46, P3447, DOI 10.1128/AAC.46.11.3447-3455.2002; Sly LM, 2001, J BIOL CHEM, V276, P35482, DOI 10.1074/jbc.M102876200; Teichmann J, 2003, J INFECTION, V46, P221, DOI 10.1053/jinf.2002.1109; Teichmann J, 2000, METABOLISM, V49, P1134, DOI 10.1053/meta.2000.8609; Trump DL, 2006, CANCER-AM CANCER SOC, V106, P2136, DOI 10.1002/cncr.21890; Wang JR, 2008, J BIOL CHEM, V283, P25596, DOI 10.1074/jbc.M801716200; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; Welz T, 2010, AIDS, V24, P1923, DOI 10.1097/QAD.0b013e32833c3281; Wu YT, 2010, J BIOL CHEM, V285, P10850, DOI 10.1074/jbc.M109.080796; Yuk JM, 2009, CELL HOST MICROBE, V6, P231, DOI 10.1016/j.chom.2009.08.004; Zhou DJ, 2008, AIDS, V22, P695, DOI 10.1097/QAD.0b013e3282f4a836	60	122	124	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18890	18902		10.1074/jbc.M110.206110	http://dx.doi.org/10.1074/jbc.M110.206110			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21454634	Green Published, hybrid			2022-12-25	WOS:000290785700061
J	Droescher, M; Begitt, A; Marg, A; Zacharias, M; Vinkemeier, U				Droescher, Mathias; Begitt, Andreas; Marg, Andreas; Zacharias, Martin; Vinkemeier, Uwe			Cytokine-induced Paracrystals Prolong the Activity of Signal Transducers and Activators of Transcription (STAT) and Provide a Model for the Regulation of Protein Solubility by Small Ubiquitin-like Modifier (SUMO)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING; TYROSINE-PHOSPHATASE; NUCLEAR ACCUMULATION; GENE ACTIVATION; SUMOYLATION; DOMAIN; DIMERIZATION; DIMERS; PHOSPHOTYROSINE; INACTIVATION	The biological effects of cytokines are mediated by STAT proteins, a family of dimeric transcription factors. In order to elicit transcriptional activity, the STATs require activation by phosphorylation of a single tyrosine residue. Our experiments revealed that fully tyrosine-phosphorylated STAT dimers polymerize via Tyr(P)-Src homology 2 domain interactions and assemble into paracrystalline arrays in the nucleus of cytokine-stimulated cells. Paracrystals are demonstrated to be dynamic reservoirs that protect STATs from dephosphorylation. Activated STAT3 forms such paracrystals in acute phase liver cells. Activated STAT1, in contrast, does not normally form paracrystals. By reversing the abilities of STAT1 and STAT3 to be sumoylated, we show that this is due to the unique ability of STAT1 among the STATs to conjugate to small ubiquitin-like modifier (SUMO). Sumoylation had one direct effect; it obstructed proximal tyrosine phosphorylation, which led to semiphosphorylated STAT dimers. These competed with their fully phosphorylated counterparts and interfered with their polymerization into paracrystals. Consequently, sumoylation, by preventing paracrystal formation, profoundly curtailed signal duration and reporter gene activation in response to cytokine stimulation of cells. The study thus identifies polymerization of activated STAT transcription factors as a positive regulatory mechanism in cytokine signaling. It provides a unifying explanation for the different subnuclear distributions of STAT transcription factors and reconciles the conflicting results as to the role of SUMO modification in STAT1 functioning. We present a generally applicable system in which protein solubility is maintained by a disproportionately small SUMO-modified fraction, whereby modification by SUMO partially prevents formation of polymerization interfaces, thus generating competitive polymerization inhibitors.	[Droescher, Mathias; Begitt, Andreas; Vinkemeier, Uwe] Univ Nottingham, Sch Med, Sch Biomed Sci, Nottingham NG7 2UH, England; [Marg, Andreas] Charite Univ Med Berlin, Expt & Clin Res Ctr, D-10117 Berlin, Germany; [Zacharias, Martin] Tech Univ Munich, Lehrstuhl Mol Dynam, D-80333 Munich, Germany	University of Nottingham; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Technical University of Munich	Vinkemeier, U (corresponding author), Queens Med Ctr, Clifton Blvd, Nottingham NG7 2UH, England.	uwe.vinkemeier@nottingham.ac.uk		Vinkemeier, Uwe/0000-0001-6924-1783	Deutsche Forschungsgemeinschaft (DFG) [KFO 192, VI 218/4, 218/5]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (DFG; KFO 192) Grants VI 218/4 and 218/5 (to U. V.).	Bartlett NW, 2004, J GEN VIROL, V85, P1401, DOI 10.1099/vir.0.79980-0; Begitt A, 2000, P NATL ACAD SCI USA, V97, P10418, DOI 10.1073/pnas.190318397; Bossis G, 2006, MOL CELL, V21, P349, DOI 10.1016/j.molcel.2005.12.019; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chen XM, 1998, CELL, V93, P827, DOI 10.1016/S0092-8674(00)81443-9; Eaton W A, 1990, Adv Protein Chem, V40, P63, DOI 10.1016/S0065-3233(08)60287-9; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gupta S, 1996, EMBO J, V15, P1075, DOI 10.1002/j.1460-2075.1996.tb00445.x; Haspel RL, 1996, EMBO J, V15, P6262, DOI 10.1002/j.1460-2075.1996.tb01016.x; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Herrington J, 1999, J BIOL CHEM, V274, P5138, DOI 10.1074/jbc.274.8.5138; Herrmann A, 2004, J CELL SCI, V117, P339, DOI 10.1242/jcs.00833; Jakobs A, 2007, NAT METHODS, V4, P245, DOI 10.1038/NMETH1006; Kaminsky R, 2009, DEV CELL, V17, P724, DOI 10.1016/j.devcel.2009.10.005; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Lillemeier BF, 2001, EMBO J, V20, P2508, DOI 10.1093/emboj/20.10.2508; Lodige I, 2005, J BIOL CHEM, V280, P43087, DOI 10.1074/jbc.M509180200; Lorenz D, 2003, EMBO REP, V4, P88, DOI 10.1038/sj.embor.embor711; Mao X, 2005, MOL CELL, V17, P761, DOI 10.1016/j.molcel.2005.02.021; Marg A, 2008, CYTOM PART A, V73A, P1128, DOI 10.1002/cyto.a.20635; Matsui T, 2002, J BIOL CHEM, V277, P36167, DOI 10.1074/jbc.M203184200; Mertens C, 2006, GENE DEV, V20, P3372, DOI 10.1101/gad.1485406; Meyer T, 2002, EMBO J, V21, P344, DOI 10.1093/emboj/21.3.344; Meyer T, 2003, GENE DEV, V17, P1992, DOI 10.1101/gad.268003; Misteli T, 2001, J CELL BIOL, V155, P181, DOI 10.1083/jcb.200108110; Ota N, 2004, NAT IMMUNOL, V5, P208, DOI 10.1038/ni1032; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Ray S, 2005, GASTROENTEROLOGY, V129, P1616, DOI 10.1053/j.gastro.2005.07.055; Rogers RS, 2003, J BIOL CHEM, V278, P30091, DOI 10.1074/jbc.M301344200; Roingeard P, 2008, BIOL CELL, V100, P491, DOI 10.1042/BC20070173; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; SHUAI K, 1993, SCIENCE, V261, P1744, DOI 10.1126/science.7690989; Soler-Lopez M, 2004, MOL CELL, V13, P791, DOI 10.1016/S1097-2765(04)00130-3; Song L, 2006, BLOOD, V108, P3237, DOI 10.1182/blood-2006-04-020271; ten Hoeve J, 2002, MOL CELL BIOL, V22, P5662, DOI 10.1128/MCB.22.16.5662-5668.2002; Tonozuka Y, 2004, BLOOD, V104, P3550, DOI 10.1182/blood-2004-03-1066; Truchet S, 2004, BIOL REPROD, V71, P1330, DOI 10.1095/biolreprod.104.029405; Ungureanu D, 2005, BLOOD, V106, P224, DOI 10.1182/blood-2004-11-4514; Ungureanu D, 2003, BLOOD, V102, P3311, DOI 10.1182/blood-2002-12-3816; Vinkemeier U, 1996, EMBO J, V15, P5616, DOI 10.1002/j.1460-2075.1996.tb00946.x; Wang Y, 2006, FASEB J, V20, P1641, DOI 10.1096/fj.06-6051com; Wenta N, 2008, P NATL ACAD SCI USA, V105, P9238, DOI 10.1073/pnas.0802130105; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166; Zimnik S, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp020	46	39	40	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18731	18746		10.1074/jbc.M111.235978	http://dx.doi.org/10.1074/jbc.M111.235978			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21460228	Green Published, hybrid			2022-12-25	WOS:000290785700046
J	Yu, XF; Yi, HF; Guo, CQ; Zuo, DM; Wang, YP; Kim, HL; Subjeck, JR; Wang, XY				Yu, Xiaofei; Yi, Huanfa; Guo, Chunqing; Zuo, Daming; Wang, Yanping; Kim, Hyung L.; Subjeck, John R.; Wang, Xiang-Yang			Pattern Recognition Scavenger Receptor CD204 Attenuates Toll-like Receptor 4-induced NF-kappa B Activation by Directly Inhibiting Ubiquitination of Tumor Necrosis Factor (TNF) Receptor-associated Factor 6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNATE IMMUNITY; MACROPHAGES; RESPONSES; PROTEINS; KINASE; CELLS; EXPRESSION; INDUCTION; INFECTION; PATHWAY	The collaboration and cross-talk between different classes of innate pattern recognition receptors are crucial for a well coordinated inflammatory response and host defense. Here we report a previously unrecognized role of scavenger receptor A (SRA; also known as CD204) as a signaling regulator in the context of Toll-like receptor 4 (TLR4) activation. We show that SRA/CD204 deficiency leads to greater sensitivity to LPS-induced endotoxic shock. SRA/CD204 down-regulates inflammatory gene expression in dendritic cells by suppressing TLR4-induced activation of the transcription factor NF-kappa B. For the first time, we demonstrate that SRA/CD204 executes its regulatory functions by directly interacting with the TRAF-C domain of TNF receptor-associated factor 6 (TRAF6), resulting in inhibition of TRAF6 dimerization and ubiquitination. The attenuation of NF-kappa B activity by SRA/CD204 is independent of its ligand-binding domain, indicating that the signaling-regulatory feature of SRA/CD204 can be uncoupled from its conventional endocytic functions. Collectively, we have identified the molecular linkage between SRA/CD204 and the TLR4 signaling pathways, and our results reveal a novel mechanism by which a non-TLR pattern recognition receptor restricts TLR4 activation and consequent inflammatory response.	[Yu, Xiaofei; Yi, Huanfa; Guo, Chunqing; Zuo, Daming; Wang, Xiang-Yang] Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA 23298 USA; [Yu, Xiaofei; Yi, Huanfa; Guo, Chunqing; Zuo, Daming; Wang, Xiang-Yang] Virginia Commonwealth Univ, Inst Mol Med, Richmond, VA 23298 USA; [Yu, Xiaofei; Yi, Huanfa; Guo, Chunqing; Zuo, Daming; Wang, Xiang-Yang] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA 23298 USA; [Wang, Yanping; Kim, Hyung L.] Cedars Sinai Med Ctr, Dept Surg, Los Angeles, CA 90048 USA; [Subjeck, John R.] Roswell Pk Canc Inst, Dept Cellar Stress Biol, Buffalo, NY 14263 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Cedars Sinai Medical Center; Roswell Park Cancer Institute	Wang, XY (corresponding author), Virginia Commonwealth Univ, Dept Human & Mol Genet, Med Coll Virginia Campus, Richmond, VA 23298 USA.	xywang@vcu.edu	GUO, CHUNQING/F-4524-2014; Yu, Xiaofei/N-7860-2013; Zuo, Daming/AAO-8461-2021; Yu, Xiaofei/C-2893-2014; Kim, Hyung/F-5129-2017	Yu, Xiaofei/0000-0003-3119-4920; Yu, Xiaofei/0000-0002-4944-1865; Kim, Hyung/0000-0003-2085-6140	National Institutes of Health (NIH) [CA129111, CA154708, CA099362]; NIH Cancer Center; American Cancer Society [RSG-08-187-01-LIB]; Harrison Endowed Scholarship; NATIONAL CANCER INSTITUTE [R01CA154708, R01CA129111] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Harrison Endowed Scholarship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grants CA129111, CA154708 (to X.-Y. W.) and CA099362 (to J. S.) and an NIH Cancer Center Support Grant to the Massey Cancer Center, Virginia Commonwealth University. This work was also supported by American Cancer Society Grant RSG-08-187-01-LIB (to X.-Y. W.) and a Harrison Endowed Scholarship (to X.-Y. W.).	Amiel E, 2009, INFECT IMMUN, V77, P4567, DOI 10.1128/IAI.00727-09; Andreakos E, 2006, P NATL ACAD SCI USA, V103, P14459, DOI 10.1073/pnas.0603493103; Areschoug T, 2009, CELL MICROBIOL, V11, P1160, DOI 10.1111/j.1462-5822.2009.01326.x; Choudhury A, 2002, J CLIN INVEST, V109, P1541, DOI 10.1172/JCI200215420; Cotena A, 2004, J IMMUNOL, V173, P6427, DOI 10.4049/jimmunol.173.10.6427; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; DeWitte-Orr SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000829; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Haworth R, 1997, J EXP MED, V186, P1431, DOI 10.1084/jem.186.9.1431; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Hollifield M, 2007, INFECT IMMUN, V75, P3999, DOI 10.1128/IAI.00393-07; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; Jeannin P, 2005, IMMUNITY, V22, P551, DOI 10.1016/j.immuni.2005.03.008; Jozefowski S, 2005, J IMMUNOL, V175, P8032, DOI 10.4049/jimmunol.175.12.8032; Jozefowski S, 2004, J LEUKOCYTE BIOL, V76, P1066, DOI 10.1189/jlb.0504270; Jozefowski S, 2006, J LEUKOCYTE BIOL, V80, P870, DOI 10.1189/jlb.0705357; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Li QA, 2006, MOL CELL BIOL, V26, P140, DOI 10.1128/MCB.26.1.140-154.2006; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Lind EF, 2008, J IMMUNOL, V181, P354, DOI 10.4049/jimmunol.181.1.354; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Moore F, 2007, J IMMUNOL, V178, P1301, DOI 10.4049/jimmunol.178.3.1301; Murphy JE, 2005, ATHEROSCLEROSIS, V182, P1, DOI 10.1016/j.atherosclerosis.2005.03.036; Park J, 2003, BIOCHEMISTRY-US, V42, P14893, DOI 10.1021/bi030122e; Platt N, 2001, J CLIN INVEST, V108, P649, DOI 10.1172/JCI200113903; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Seimon TA, 2006, P NATL ACAD SCI USA, V103, P19794, DOI 10.1073/pnas.0609671104; Sly LM, 2004, IMMUNITY, V21, P227, DOI 10.1016/j.immuni.2004.07.010; Suzuki H, 1997, NATURE, V386, P292, DOI 10.1038/386292a0; Thomas CA, 2000, J EXP MED, V191, P147, DOI 10.1084/jem.191.1.147; Van Amersfoort ES, 2003, CLIN MICROBIOL REV, V16, P379, DOI 10.1128/CMR.16.3.379-414.2003; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Yi HF, 2009, BLOOD, V113, P5819, DOI 10.1182/blood-2008-11-190033	36	66	68	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18795	18806		10.1074/jbc.M111.224345	http://dx.doi.org/10.1074/jbc.M111.224345			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21460221	Green Published, hybrid			2022-12-25	WOS:000290785700052
J	Jagannathan, I; Pepenella, S; Hayes, JJ				Jagannathan, Indu; Pepenella, Sharon; Hayes, Jeffrey J.			Activity of FEN1 Endonuclease on Nucleosome Substrates Is Dependent upon DNA Sequence but Not Flap Orientation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; HISTONE OCTAMER; CORE PARTICLES; CHROMATIN; COMPLEX; REPLICATION; MECHANISM; BINDING; URACIL; RNA	We demonstrated previously that human FEN1 endonuclease, an enzyme involved in excising single-stranded DNA flaps that arise during Okazaki fragment processing and base excision repair, cleaves model flap substrates assembled into nucleosomes. Here we explore the effect of flap orientation with respect to the surface of the histone octamer on nucleosome structure and FEN1 activity in vitro. We find that orienting the flap substrate toward the histone octamer does not significantly alter the rotational orientation of two different nucleosome positioning sequences on the surface of the histone octamer but does cause minor perturbation of nucleosome structure. Surprisingly, flaps oriented toward the nucleosome surface are accessible to FEN1 cleavage in nucleosomes containing the Xenopus 5S positioning sequence. In contrast, neither flaps oriented toward nor away from the nucleosome surface are cleaved by the enzyme in nucleosomes containing the high-affinity 601 nucleosome positioning sequence. The data are consistent with a model in which sequence-dependent motility of DNA on the nucleosome is a major determinant of FEN1 activity. The implications of these findings for the activity of FEN1 in vivo are discussed.	[Hayes, Jeffrey J.] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA	University of Rochester	Hayes, JJ (corresponding author), Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA.	Jeffrey_Hayes@urmc.rochester.edu			National Institutes of Health [RO1GM52426]; American Cancer Society [RPG GMC-99742]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM068411, R01GM052426] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1GM52426. This work was also supported by American Cancer Society Grant RPG GMC-99742.	Aoyagi S, 2003, J BIOL CHEM, V278, P30562, DOI 10.1074/jbc.M304148200; Aoyagi S, 2002, MOL CELL BIOL, V22, P3653, DOI 10.1128/MCB.22.11.3653-3662.2002; Beard BC, 2005, DNA REPAIR, V4, P203, DOI 10.1016/j.dnarep.2004.09.011; Beard BC, 2003, P NATL ACAD SCI USA, V100, P7465, DOI 10.1073/pnas.1330328100; Bornarth CJ, 1999, BIOCHEMISTRY-US, V38, P13347, DOI 10.1021/bi991321u; Chafin DR, 2000, EMBO J, V19, P5492, DOI 10.1093/emboj/19.20.5492; Cole HA, 2010, J BIOL CHEM, V285, P2876, DOI 10.1074/jbc.M109.073544; CUSICK ME, 1983, BIOCHEMISTRY-US, V22, P3873, DOI 10.1021/bi00285a024; Edayathumangalam RS, 2005, J MOL BIOL, V345, P103, DOI 10.1016/j.jmb.2004.10.012; Gong F, 2008, CELL CYCLE, V7, P1067, DOI 10.4161/cc.7.8.5647; Gong F, 2006, NAT STRUCT MOL BIOL, V13, P902, DOI 10.1038/nsmb1152; HAYES JJ, 1990, P NATL ACAD SCI USA, V87, P7405, DOI 10.1073/pnas.87.19.7405; Henricksen LA, 1998, LEUKEMIA RES, V22, P1, DOI 10.1016/S0145-2126(97)00113-6; Hosfield DJ, 1998, CELL, V95, P135, DOI 10.1016/S0092-8674(00)81789-4; Huggins CF, 2002, MOL CELL, V10, P1201, DOI 10.1016/S1097-2765(02)00736-0; Ishlbashi T, 2008, MOL CELL BIOL, V28, P4734, DOI 10.1128/MCB.00588-08; Kao KI, 2002, J BIOL CHEM, V277, P14379, DOI 10.1074/jbc.M110662200; Kassabov SR, 2002, MOL CELL BIOL, V22, P7524, DOI 10.1128/MCB.22.21.7524-7534.2002; Kucherlapati M, 2002, P NATL ACAD SCI USA, V99, P9924, DOI 10.1073/pnas.152321699; Kulaeva OI, 2009, NAT STRUCT MOL BIOL, V16, P1272, DOI 10.1038/nsmb.1689; Larsen E, 2003, MOL CELL BIOL, V23, P5346, DOI 10.1128/MCB.23.15.5346-5353.2003; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Lowary PT, 1997, P NATL ACAD SCI USA, V94, P1183, DOI 10.1073/pnas.94.4.1183; Matsuzaki Y, 2002, NUCLEIC ACIDS RES, V30, P3273, DOI 10.1093/nar/gkf440; Murante RS, 1995, J BIOL CHEM, V270, P30377, DOI 10.1074/jbc.270.51.30377; Nilsen H, 2002, EMBO J, V21, P5943, DOI 10.1093/emboj/cdf581; Ong MS, 2007, J MOL BIOL, V368, P1067, DOI 10.1016/j.jmb.2007.02.062; Peterson CL, 2004, GENE DEV, V18, P602, DOI 10.1101/gad.1182704; POLACH KJ, 1995, J MOL BIOL, V254, P130, DOI 10.1006/jmbi.1995.0606; Prasad A, 2007, MOL CELL BIOL, V27, P8442, DOI 10.1128/MCB.00791-07; Qiu JZ, 1999, J BIOL CHEM, V274, P17893, DOI 10.1074/jbc.274.25.17893; RHODES D, 1985, EMBO J, V4, P3473, DOI 10.1002/j.1460-2075.1985.tb04106.x; ROBINS P, 1994, J BIOL CHEM, V269, P28535; Suto RK, 2003, J MOL BIOL, V326, P371, DOI 10.1016/S0022-2836(02)01407-9; Thiriet C, 1998, J BIOL CHEM, V273, P21352, DOI 10.1074/jbc.273.33.21352; Yang ZY, 2007, J BIOL CHEM, V282, P7930, DOI 10.1074/jbc.M610584200	37	4	5	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17521	17529		10.1074/jbc.M111.229658	http://dx.doi.org/10.1074/jbc.M111.229658			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454907	Green Published, hybrid			2022-12-25	WOS:000290585200014
J	Zi, M; Kimura, TE; Liu, W; Jin, JW; Higham, J; Kharche, S; Hao, GL; Shi, Y; Shen, WJ; Prehar, S; Mironov, A; Neyses, L; Bierhuizen, MFA; Boyett, MR; Zhang, HG; Lei, M; Cartwright, EJ; Wang, X				Zi, Min; Kimura, Tomomi E.; Liu, Wei; Jin, Jiawei; Higham, Jonathan; Kharche, Sanjay; Hao, Guoliang; Shi, Ying; Shen, Weijian; Prehar, Sukhpal; Mironov, Aleksandr; Neyses, Ludwig; Bierhuizen, Marti F. A.; Boyett, Mark R.; Zhang, Henggui; Lei, Ming; Cartwright, Elizabeth J.; Wang, Xin			Mitogen-activated Protein Kinase Kinase 4 Deficiency in Cardiomyocytes Causes Connexin 43 Reduction and Couples Hypertrophic Signals to Ventricular Arrhythmogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEONATAL-RAT CARDIOMYOCYTES; CARDIAC MYOCYTES; HEART-FAILURE; GAP-JUNCTIONS; TRANSMURAL DISPERSION; CONDUCTION-VELOCITY; INDUCED DELETION; CELL-CELL; IN-VIVO; EXPRESSION		[Kimura, Tomomi E.; Liu, Wei; Jin, Jiawei; Mironov, Aleksandr; Wang, Xin] Univ Manchester, Fac Life Sci, Manchester M13 9NT, Lancs, England; [Zi, Min; Hao, Guoliang; Shi, Ying; Prehar, Sukhpal; Neyses, Ludwig; Boyett, Mark R.; Lei, Ming; Cartwright, Elizabeth J.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester M13 9NT, Lancs, England; [Higham, Jonathan; Kharche, Sanjay; Shen, Weijian; Zhang, Henggui] Univ Manchester, Sch Phys & Astron, Manchester M13 9NT, Lancs, England; [Bierhuizen, Marti F. A.] Univ Med Ctr Utrecht, Dept Med Physiol, Div Heart & Lungs, NL-3584 CM Utrecht, Netherlands	University of Manchester; University of Manchester; University of Manchester; Utrecht University; Utrecht University Medical Center	Wang, X (corresponding author), Univ Manchester, Fac Life Sci, CTF Bldg,46 Grafton St, Manchester M13 9NT, Lancs, England.	xin.wang@manchester.ac.uk	Neyses, Ludwig/AGY-7446-2022; Kharche, Sanjay Ram/I-2130-2014; jin, jiawei/AAJ-7378-2021; Zhang, Henggui/AAM-1043-2020; Zhang, Henggui/D-6712-2011	Kharche, Sanjay Ram/0000-0002-2634-4894; Liu, Wei/0000-0003-1592-6693; Higham, Jonathan/0000-0002-9779-9968; Mironov, Aleksandr/0000-0002-1497-328X; Cartwright, Elizabeth/0000-0002-6836-7795; , Jiawei Jin/0000-0001-5598-6039; Boyett, Mark/0000-0003-3931-2020; Prehar, Sukhpal/0000-0002-4334-7931	British Heart Foundation [PG/07/055/23144, PG/09/052/27833]; MRC [G0802004] Funding Source: UKRI; Medical Research Council [G0802004] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by British Heart Foundation Grants PG/07/055/23144 (to X. W. and E.J.C.) and PG/09/052/27833 (to X. W., E.J.C. and M. L.).	Ai ZW, 2000, J CLIN INVEST, V105, P161, DOI 10.1172/JCI7798; Antzelevitch C, 2001, CARDIOVASC RES, V50, P426, DOI 10.1016/S0008-6363(01)00285-1; Boogerd KJ, 2008, CARDIOVASC RES, V78, P485, DOI 10.1093/cvr/cvn049; Brancho D, 2003, GENE DEV, V17, P1969, DOI 10.1101/gad.1107303; Cameron SJ, 2003, J BIOL CHEM, V278, P18682, DOI 10.1074/jbc.M213283200; Danik SB, 2004, CIRC RES, V95, P1035, DOI 10.1161/01.RES.0000148664.33695.2a; Dupont E, 2001, J MOL CELL CARDIOL, V33, P359, DOI 10.1006/jmcc.2000.1308; Gutstein DE, 2003, AM J PHYSIOL-HEART C, V285, pH1091, DOI 10.1152/ajpheart.00100.2003; Gutstein DE, 2001, CIRCULATION, V104, P1194, DOI 10.1161/hc3601.093990; Gutstein DE, 2001, CIRC RES, V88, P333, DOI 10.1161/01.RES.88.3.333; Kleber AG, 2004, PHYSIOL REV, V84, P431, DOI 10.1152/physrev.00025.2003; Kostetskii I, 2005, CIRC RES, V96, P346, DOI 10.1161/01.RES.0000156274.72390.2c; Laird DW, 2005, BBA-BIOMEMBRANES, V1711, P172, DOI 10.1016/j.bbamem.2004.09.009; Lampe PD, 2006, J CELL SCI, V119, P3435, DOI 10.1242/jcs.03089; Li JF, 2005, CIRC RES, V97, P474, DOI 10.1161/01.RES.0000181132.11393.18; Liu W, 2009, CIRC RES, V104, P905, DOI 10.1161/CIRCRESAHA.108.188292; Maass K, 2007, CIRC RES, V101, P1283, DOI 10.1161/CIRCRESAHA.107.162818; Matsushita T, 1999, CIRC RES, V85, P1046; McKoy G, 2000, LANCET, V355, P2119, DOI 10.1016/S0140-6736(00)02379-5; Mitchell JA, 2005, ENDOCRINOLOGY, V146, P2048, DOI 10.1210/en.2004-1066; Ogawa T, 2004, J CELL SCI, V117, P2087, DOI 10.1242/jcs.01056; PETERS NS, 1993, CIRCULATION, V88, P864, DOI 10.1161/01.CIR.88.3.864; Petrich BG, 2004, J BIOL CHEM, V279, P15330, DOI 10.1074/jbc.M314142200; Petrich BG, 2002, CIRC RES, V91, P640, DOI 10.1161/01.RES.0000035854.11082.01; Saffitz JE, 2005, ANN NY ACAD SCI, V1047, P336, DOI 10.1196/annals.1341.030; Saffitz JE, 2004, CIRC RES, V94, P585, DOI 10.1161/01.RES.0000121575.34653.50; Salameh A, 2004, EUR J PHARMACOL, V503, P9, DOI 10.1016/j.ejphar.2004.09.024; Severs NJ, 2008, CARDIOVASC RES, V80, P9, DOI 10.1093/cvr/cvn133; Shyu KG, 2004, CARDIOVASC RES, V63, P98, DOI 10.1016/j.cardiores.2004.02.018; Teunissen BEJ, 2003, GENE, V322, P123, DOI 10.1016/j.gene.2003.08.011; Tournier C, 1997, P NATL ACAD SCI USA, V94, P7337, DOI 10.1073/pnas.94.14.7337; Toyofuku T, 1998, J BIOL CHEM, V273, P12725, DOI 10.1074/jbc.273.21.12725; van Rijen HVM, 2004, CIRCULATION, V109, P1048, DOI 10.1161/01.CIR.0000117402.70689.75; Wang X, 2007, MOL CELL BIOL, V27, P7935, DOI 10.1128/MCB.00226-07; Wang X, 2007, BBA-MOL CELL RES, V1773, P1349, DOI 10.1016/j.bbamcr.2006.10.016; Wiegerinck RF, 2006, CIRCULATION, V113, P806, DOI 10.1161/CIRCULATIONAHA.105.565804; Wiegerinck RF, 2008, HEART RHYTHM, V5, P1178, DOI 10.1016/j.hrthm.2008.04.026	37	11	11	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17821	17830		10.1074/jbc.M111.228791	http://dx.doi.org/10.1074/jbc.M111.228791			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454599	hybrid, Green Published			2022-12-25	WOS:000290585200045
J	Barr, I; Smith, AT; Senturia, R; Chen, YQ; Scheidemantle, BD; Burstyn, JN; Guo, F				Barr, Ian; Smith, Aaron T.; Senturia, Rachel; Chen, Yanqiu; Scheidemantle, Brooke D.; Burstyn, Judith N.; Guo, Feng			DiGeorge Critical Region 8 (DGCR8) Is a Double-cysteine-ligated Heme Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOGENOUS THIOLATE LIGATION; FERRIC CHLOROPEROXIDASE; MICROPROCESSOR COMPLEX; REGULATORY MOTIFS; ACTIVE-SITE; BINDING; BIOGENESIS; MICRORNAS; OXYGENASE-2; MECHANISM	All known heme-thiolate proteins ligate the heme iron using one cysteine side chain. We previously found that DiGeorge Critical Region 8 (DGCR8), an essential microRNA processing factor, associates with heme of unknown redox state when over-expressed in Escherichia coli. On the basis of the similarity of the 450-nm Soret absorption peak of the DGCR8-heme complex to that of cytochrome P450 containing ferrous heme with CO bound, we identified cysteine 352 as a probable axial ligand in DGCR8. Here we further characterize the DGCR8-heme interaction using biochemical and spectroscopic methods. The DGCR8-heme complex is highly stable, with a half-life exceeding 4 days. Mutation of the conserved proline 351 to an alanine increases the rate of heme dissociation and allows the DGCR8-heme complex to be reconstituted biochemically. Surprisingly, DGCR8 binds ferric heme without CO to generate a hyperporphyrin spectrum. The electronic absorption, magnetic circular dichroism, and electron paramagnetic resonance spectra of the DGCR8-heme complex suggest a ferric heme bearing two cysteine ligands. This model was further confirmed using selenomethionine-substituted DGCR8 and mercury titration. DGCR8 is the first example of a heme-binding protein with two endogenous cysteine side chains serving as axial ligands. We further show that native DGCR8 binds heme when expressed in eukaryotic cells. This study provides a chemical basis for understanding the function of the DGCR8-heme interaction in microRNA maturation.	[Smith, Aaron T.; Burstyn, Judith N.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA; [Barr, Ian; Senturia, Rachel; Chen, Yanqiu; Scheidemantle, Brooke D.; Guo, Feng] Univ Calif Los Angeles, Inst Mol Biol, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA	University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Burstyn, JN (corresponding author), 1101 Univ Ave, Madison, WI 53706 USA.	burstyn@chem.wisc.edu; fguo@mbi.ucla.edu		Barr, Ian/0000-0002-7351-418X; Barr, Ian/0000-0003-1805-1415; Burstyn, Judith/0000-0003-3245-5563; Smith, Aaron/0000-0002-9332-8683	National Institutes of Health [GM080563, HL065217]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065217] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080563] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project is supported, in whole or in part, by National Institutes of Health Grants GM080563 (to F. G.) and HL065217 (to J. N. B.).	BLUMBERG WE, 1971, ADV CHEM, V100, P271; DAWSON JH, 1988, SCIENCE, V240, P433, DOI 10.1126/science.3358128; DAWSON JH, 1987, CHEM REV, V87, P1255, DOI 10.1021/cr00081a015; de Montellano PRO, 2000, CURR OPIN CHEM BIOL, V4, P221; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Derbyshire Emily R., 2009, V191, P17, DOI 10.1007/978-3-540-68964-5_2; Faller M, 2010, RNA, V16, P1570, DOI 10.1261/rna.2111310; Faller M, 2008, BBA-GENE REGUL MECH, V1779, P663, DOI 10.1016/j.bbagrm.2008.08.005; Faller M, 2007, NAT STRUCT MOL BIOL, V14, P23, DOI 10.1038/nsmb1182; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gilles-Gonzalez MA, 2005, J INORG BIOCHEM, V99, P1, DOI 10.1016/j.jinorgbio.2004.11.006; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Gupta N, 2011, J BIOL CHEM, V286, P4392, DOI 10.1074/jbc.M110.193466; Han J, 2009, CELL, V136, P75, DOI 10.1016/j.cell.2008.10.053; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; HARGROVE MS, 1994, J BIOL CHEM, V269, P4207; Hargrove MS, 1996, BIOCHEMISTRY-US, V35, P11293, DOI 10.1021/bi960371l; HARGROVE MS, 1994, BIOCHEMISTRY-US, V33, P11767, DOI 10.1021/bi00205a012; Igarashi J, 2008, J BIOL CHEM, V283, P18782, DOI 10.1074/jbc.M801400200; Igarashi J, 2008, ACTA CHIM SLOV, V55, P67; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Low DW, 2001, P NATL ACAD SCI USA, V98, P6554, DOI 10.1073/pnas.121178598; McCoubrey WK, 1997, J BIOL CHEM, V272, P12568, DOI 10.1074/jbc.272.19.12568; Omura T, 2005, BIOCHEM BIOPH RES CO, V338, P404, DOI 10.1016/j.bbrc.2005.08.267; Ortiz de Montellano P.R., 2004, CYTOCHROME P450 STRU, V3rd; Paoli M, 2002, DNA CELL BIOL, V21, P271, DOI 10.1089/104454902753759690; Perutz MF, 1998, ANNU REV BIOPH BIOM, V27, P1, DOI 10.1146/annurev.biophys.27.1.1; Rousseau DL, 2005, J INORG BIOCHEM, V99, P306, DOI 10.1016/j.jinorgbio.2004.11.007; RUF HH, 1977, J AM CHEM SOC, V99, P5499, DOI 10.1021/ja00458a054; Senturia R, 2010, PROTEIN SCI, V19, P1354, DOI 10.1002/pro.414; SONO M, 1982, J BIOL CHEM, V257, P8308; SONO M, 1985, INORG CHEM, V24, P4339, DOI 10.1021/ic00219a028; SONO M, 1984, J BIOL CHEM, V259, P13209; SONO M, 1991, BIOCHIM BIOPHYS ACTA, V1078, P351, DOI 10.1016/0167-4838(91)90156-T; STERN JO, 1974, J BIOL CHEM, V249, P7495; Udit AK, 2005, BIOCHEM BIOPH RES CO, V338, P470, DOI 10.1016/j.bbrc.2005.08.087; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; WALLACE CJA, 1992, J BIOL CHEM, V267, P3852; Yi L, 2007, J BIOL CHEM, V282, P21056, DOI 10.1074/jbc.M700664200; YU CA, 1974, J BIOL CHEM, V249, P94; ZHANG L, 1995, EMBO J, V14, P313, DOI 10.1002/j.1460-2075.1995.tb07005.x	43	49	50	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16716	16725		10.1074/jbc.M110.180844	http://dx.doi.org/10.1074/jbc.M110.180844			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454614	Green Published, hybrid			2022-12-25	WOS:000290301900019
J	Li, Y; Tu, CK; Wang, H; Silverman, DN; Frost, SC				Li, Ying; Tu, Chingkuang; Wang, Hai; Silverman, David N.; Frost, Susan C.			Catalysis and pH Control by Membrane-associated Carbonic Anhydrase IX in MDA-MB-231 Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RED-BLOOD-CELLS; INTRACELLULAR PH; O-18 EXCHANGE; ISOZYME-IX; PROTON-TRANSFER; MN/CA IX; CA-IX; EXPRESSION; HYPOXIA; INHIBITORS	Carbonic anhydrase IX (CAIX) is a membrane-bound, tumor-related enzyme whose expression is often considered a marker for hypoxia, an indicator of poor prognosis in the majority of cancer patients, and is associated with acidification of the tumor microenvironment. Here, we describe for the first time the catalytic properties of native CAIX in MDA-MB-231 breast cancer cells that exhibit hypoxia-inducible CAIX expression. Using O-18 exchange measured by membrane inlet mass spectrometry, we determined catalytic activity in membrane ghosts and intact cells. Exofacial carbonic anhydrase activity increases with exposure to hypoxia, an activity which is suppressed by impermeant sulfonamide CA inhibitors. Inhibition by sulfonamide inhibitors is not sensitive to reoxygenation. CAIX activity in intact cells increases in response to reduced pH. Data from membrane ghosts show that the increase in activity at reduced pH is largely due to an increase in the dehydration reaction. In addition, the kinetic constants of CAIX in membrane ghosts are very similar to our previous measurements for purified, recombinant, truncated forms. Hence, the activity of CAIX is not affected by the proteoglycan extension or membrane environment. These activities were measured at a total concentration for all CO2 species at 25 mM and close to chemical equilibrium, conditions which approximate the physiological extracellular environment. Our data suggest that CAIX is particularly well suited to maintain the extracellular pH at a value that favors the survival fitness of tumor cells.	[Li, Ying; Wang, Hai; Frost, Susan C.] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Tu, Chingkuang; Silverman, David N.] Univ Florida, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Frost, SC (corresponding author), Univ Florida, Dept Biochem & Mol Biol, Box 100245,1600 SW Archer Rd, Gainesville, FL 32610 USA.	sfrost@ufl.edu			National Institutes of Health [DK45035, GM25254]; Department of Defense [BC073020]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025254] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK45035 (to S. C. F.) and GM25254 (to D. N. S.). This work was also supported by Department of Defense Grant BC073020 (to S. C. F.).	Alterio V, 2009, P NATL ACAD SCI USA, V106, P16233, DOI 10.1073/pnas.0908301106; Alterio V, 2006, J AM CHEM SOC, V128, P8329, DOI 10.1021/ja061574s; Cairns R, 2006, MOL CANCER RES, V4, P61, DOI 10.1158/1541-7786.MCR-06-0002; Cecchi A, 2005, J MED CHEM, V48, P4834, DOI 10.1021/jm0501073; Chiche J, 2009, CANCER RES, V69, P358, DOI 10.1158/0008-5472.CAN-08-2470; Delacruz J, 2010, ANAL BIOCHEM, V403, P74, DOI 10.1016/j.ab.2010.04.019; Dubois L, 2007, RADIOTHER ONCOL, V83, P367, DOI 10.1016/j.radonc.2007.04.018; Dubois L, 2009, RADIOTHER ONCOL, V92, P423, DOI 10.1016/j.radonc.2009.06.019; Endeward V, 2009, J PHYSIOL-LONDON, V587, P1153, DOI 10.1113/jphysiol.2008.165027; Fisher SZ, 2007, BIOCHEMISTRY-US, V46, P3803, DOI 10.1021/bi602620k; Generali D, 2006, ENDOCR-RELAT CANCER, V13, P921, DOI 10.1677/erc.1.01216; Gillies RJ, 2007, J BIOENERG BIOMEMBR, V39, P251, DOI 10.1007/s10863-007-9085-y; Helmlinger G, 1997, NAT MED, V3, P177, DOI 10.1038/nm0297-177; Hilvo M, 2008, J BIOL CHEM, V283, P27799, DOI 10.1074/jbc.M800938200; ITADA N, 1977, J BIOL CHEM, V252, P3881; Koukourakis MI, 2006, CANCER RES, V66, P632, DOI 10.1158/0008-5472.CAN-05-3260; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI Y, 2010, BIOCHIM BIOPHYS ACTA, V1813, P159; Li Y, 2009, CANCER INVEST, V27, P613, DOI 10.1080/07357900802653464; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; McMurtrie HL, 2004, J ENZYM INHIB MED CH, V19, P231, DOI 10.1080/14756360410001704443; Opavsky R, 1996, GENOMICS, V33, P480, DOI 10.1006/geno.1996.0223; PASTOREK J, 1994, ONCOGENE, V9, P2877; Pastorekova S, 2004, CRC ENZYM INHIB SER, P255; PASTOREKOVA S, 1992, VIROLOGY, V187, P620, DOI 10.1016/0042-6822(92)90464-Z; Pastorekova S, 1997, GASTROENTEROLOGY, V112, P398, DOI 10.1053/gast.1997.v112.pm9024293; Potter C, 2004, CELL CYCLE, V3, P164; Potter CPS, 2003, BRIT J CANCER, V89, P2, DOI 10.1038/sj.bjc.6600936; Rafajova M, 2004, INT J ONCOL, V24, P995; Robertson N, 2004, CANCER RES, V64, P6160, DOI 10.1158/0008-5472.CAN-03-2224; Saarnio J, 1998, J HISTOCHEM CYTOCHEM, V46, P497, DOI 10.1177/002215549804600409; Sennoune SR, 2004, AM J PHYSIOL-CELL PH, V286, pC1443, DOI 10.1152/ajpcell.00407.2003; SILVERMAN DN, 1982, METHOD ENZYMOL, V87, P732; SIMONSSON I, 1979, EUR J BIOCHEM, V93, P409, DOI 10.1111/j.1432-1033.1979.tb12837.x; SLY WS, 1995, ANNU REV BIOCHEM, V64, P375, DOI 10.1146/annurev.bi.64.070195.002111; Smallbone K, 2007, J THEOR BIOL, V244, P703, DOI 10.1016/j.jtbi.2006.09.010; Span PN, 2003, BRIT J CANCER, V89, P271, DOI 10.1038/sj.bjc.6601122; Stockwin LH, 2006, J PROTEOME RES, V5, P2996, DOI 10.1021/pr0601739; Supuran CT, 2008, NAT REV DRUG DISCOV, V7, P168, DOI 10.1038/nrd2467; Svastova E, 2003, EXP CELL RES, V290, P332, DOI 10.1016/S0014-4827(03)00351-3; Svastova E, 2004, FEBS LETT, V577, P439, DOI 10.1016/j.febslet.2004.10.043; Swietach P, 2008, J BIOL CHEM, V283, P20473, DOI 10.1074/jbc.M801330200; Swietach P, 2007, CANCER METAST REV, V26, P299, DOI 10.1007/s10555-007-9064-0; Swietach P, 2009, J BIOL CHEM, V284, P20299, DOI 10.1074/jbc.M109.006478; Tan EY, 2009, BRIT J CANCER, V100, P405, DOI 10.1038/sj.bjc.6604844; TU C, 1978, J BIOL CHEM, V253, P8178; Tu C, 2007, FREE RADICAL BIO MED, V43, P1453, DOI 10.1016/j.freeradbiomed.2007.07.026; Wingo T, 2001, BIOCHEM BIOPH RES CO, V288, P666, DOI 10.1006/bbrc.2001.5824; Wykoff CC, 2001, AM J PATHOL, V158, P1011, DOI 10.1016/S0002-9440(10)64048-5; [No title captured]	50	39	39	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.188524	http://dx.doi.org/10.1074/jbc.M110.188524			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454639	Green Published, hybrid			2022-12-25	WOS:000290022800019
J	Nevzorov, IA; Nikolaeva, OP; Kainov, YA; Redwood, CS; Levitsky, DI				Nevzorov, Ilya A.; Nikolaeva, Olga P.; Kainov, Yaroslav A.; Redwood, Charles S.; Levitsky, Dmitrii I.			Conserved Noncanonical Residue Gly-126 Confers Instability to the Middle Part of the Tropomyosin Molecule	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE THIN-FILAMENTS; HELICAL COILED-COILS; ALPHA-TROPOMYOSIN; MYOSIN SUBFRAGMENT-1; LABELED TROPOMYOSIN; ACTIN; PROTEIN; BINDING; REGION; FLEXIBILITY	Tropomyosin (Tm) is a two-stranded alpha-helical coiled-coil protein with a well established role in regulation of actin cytoskeleton and muscle contraction. It is believed that many Tm functions are enabled by its flexibility whose nature has not been completely understood. We hypothesized that the well conserved non-canonical residue Gly-126 causes local destabilization of Tm. To test this, we substituted Gly-126 in skeletal muscle alpha-Tm either with an Ala residue, which should stabilize the Tm alpha-helix, or with an Arg residue, which is expected to stabilize both alpha-helix and coiled-coil structure of Tm. We have shown that both mutations dramatically reduce the rate of Tm proteolysis by trypsin at Asp-133. Differential scanning calorimetry was used for detailed investigation of thermal unfolding of the Tm mutants, both free in solution and bound to F-actin. It was shown that a significant part of wild type Tm unfolds in a non-cooperative manner at low temperature, and both mutations confer cooperativity to this part of the Tm molecule. The size of the flexible middle part of Tm is estimated to be 60-70 amino acid residues, about a quarter of the Tm molecule. Thus, our results show that flexibility is unevenly distributed in the Tm molecule and achieves the highest extent in its middle part. We conclude that the highly conserved Gly-126, acting in concert with the previously identified non-canonical Asp-137, destabilizes the middle part of Tm, resulting in a more flexible region that is important for Tm function.	[Nevzorov, Ilya A.; Levitsky, Dmitrii I.] Russian Acad Sci, AN Bach Inst Biochem, Moscow 119071, Russia; [Nevzorov, Ilya A.] Moscow MV Lomonosov State Univ, Sch Biol, Dept Biochem, Moscow 119992, Russia; [Nikolaeva, Olga P.; Levitsky, Dmitrii I.] Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow 119992, Russia; [Kainov, Yaroslav A.] NN Blokhin Canc Res Ctr, Inst Carcinogenesis, Oncogene Regulat Dept, Moscow 115478, Russia; [Redwood, Charles S.] Univ Oxford, Dept Cardiovasc Med, Oxford OX3 7BN, England	Research Center of Biotechnology RAS; Russian Academy of Sciences; Lomonosov Moscow State University; Lomonosov Moscow State University; N.N. Blokhin Russian Cancer Research Center; University of Oxford	Levitsky, DI (corresponding author), Russian Acad Sci, AN Bach Inst Biochem, Leninsky Prospect 33, Moscow 119071, Russia.	Levitsky@inbi.ras.ru		Kainov, Yaroslav/0000-0003-0664-9102	Russian Foundation for Basic Research [09-04-00339, 09-04-00266]; Russian Academy of Sciences; Russian Federation [MK 2965.2009.4]; Muscular Dystrophy Campaign	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Academy of Sciences(Russian Academy of Sciences); Russian Federation(Russian Federation); Muscular Dystrophy Campaign(Muscular Dystrophy AssociationEuropean Commission)	This work was supported by Russian Foundation for Basic Research Grants 09-04-00339 (to I. A. N. and O. P. N.) and 09-04-00266 (to D. I. L.), the Program "Molecular and Cell Biology" of the Russian Academy of Sciences (to D. I. L.), Grant MK 2965.2009.4 of the President of the Russian Federation (to I. A. N.), and the Muscular Dystrophy Campaign (to C. S. R.).	Brown JH, 2005, P NATL ACAD SCI USA, V102, P18878, DOI 10.1073/pnas.0509269102; Brown JH, 1996, PROTEINS, V26, P134; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; Dragan AI, 2002, J MOL BIOL, V321, P891, DOI 10.1016/S0022-2836(02)00699-X; GORDON ANI, 2000, Regnir M Physioi Ics, V80, P924; GREASER ML, 1971, J BIOL CHEM, V246, P4226; Greenfield NJ, 1995, BIOCHEMISTRY-US, V34, P16797, DOI 10.1021/bi00051a030; Hitchcock-DeGregori SE, 2010, J STRUCT BIOL, V170, P319, DOI 10.1016/j.jsb.2009.12.013; Hitchcock-DeGregori SE, 2002, BIOCHEMISTRY-US, V41, P15036, DOI 10.1021/bi026519k; Hodges RS, 2009, J MOL BIOL, V392, P747, DOI 10.1016/j.jmb.2009.07.039; HODGES RS, 1981, J BIOL CHEM, V256, P1214; Holmes KC, 2008, J MUSCLE RES CELL M, V29, P213, DOI 10.1007/s10974-008-9157-6; ISHII Y, 1985, BIOCHEMISTRY-US, V24, P6631, DOI 10.1021/bi00344a050; ISHII Y, 1990, BIOCHEMISTRY-US, V29, P1160, DOI 10.1021/bi00457a010; Kazakov AS, 2009, BIOPHYS CHEM, V145, P79, DOI 10.1016/j.bpc.2009.09.003; Kremneva E, 2006, FEBS J, V273, P588, DOI 10.1111/j.1742-4658.2005.05092.x; Kremneva E, 2004, BIOPHYS J, V87, P3922, DOI 10.1529/biophysj.104.048793; Levitsky D. I., 2004, The nature of biological systems as revealed by thermal methods, P127; Li XC, 2010, J MOL BIOL, V395, P327, DOI 10.1016/j.jmb.2009.10.060; Makhatadze GI, 1995, ADV PROTEIN CHEM, V47, P307, DOI 10.1016/S0065-3233(08)60548-3; Mason JM, 2004, CHEMBIOCHEM, V5, P170, DOI 10.1002/cbic.200300781; Maytum R, 1999, BIOCHEMISTRY-US, V38, P1102, DOI 10.1021/bi981603e; MCKILLOP DFA, 1993, BIOPHYS J, V65, P693, DOI 10.1016/S0006-3495(93)81110-X; Mirza M, 2007, J BIOL CHEM, V282, P13487, DOI 10.1074/jbc.M701071200; MONTEIRO PB, 1994, J BIOL CHEM, V269, P10461; Nevzorov I, 2008, J MUSCLE RES CELL M, V29, P173, DOI 10.1007/s10974-009-9171-3; PANUSZ HT, 1970, ANAL BIOCHEM, V35, P494, DOI 10.1016/0003-2697(70)90212-5; PATO MD, 1981, J BIOL CHEM, V256, P593; Permyakoy SE, 2008, PROTEINS, V72, P822, DOI 10.1002/prot.21974; Privalov P L, 1986, Methods Enzymol, V131, P4; Sakuma A, 2006, BIOCHEMISTRY-US, V45, P9550, DOI 10.1021/bi060963w; Singh A, 2006, STRUCTURE, V14, P43, DOI 10.1016/j.str.2005.09.016; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; STURTEVANT JM, 1991, BIOPOLYMERS, V31, P489, DOI 10.1002/bip.360310504; Sumida JP, 2008, J BIOL CHEM, V283, P6728, DOI 10.1074/jbc.M707485200; UENO H, 1984, BIOCHEMISTRY-US, V23, P4791, DOI 10.1021/bi00315a040; WAY M, 1990, EMBO J, V9, P4103, DOI 10.1002/j.1460-2075.1990.tb07632.x; WEEDS AG, 1975, NATURE, V257, P54, DOI 10.1038/257054a0; WILLIAMS DL, 1981, BIOCHEMISTRY-US, V20, P3856, DOI 10.1021/bi00516a029	40	30	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.209353	http://dx.doi.org/10.1074/jbc.M110.209353			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454502	Green Published, hybrid			2022-12-25	WOS:000290022800016
J	Song, WZ; Du, YZ; Liu, ZQ; Luo, NG; Turkov, M; Gordon, D; Gurevitz, M; Goldin, AL; Dong, K				Song, Weizhong; Du, Yuzhe; Liu, Zhiqi; Luo, Ningguang; Turkov, Michael; Gordon, Dalia; Gurevitz, Michael; Goldin, Alan L.; Dong, Ke			Substitutions in the Domain III Voltage-sensing Module Enhance the Sensitivity of an Insect Sodium Channel to a Scorpion beta-Toxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-MECHANISMS; MEMBRANE-PROTEIN; SENSOR; SPECIFICITY; MODULATION; EXPRESSION; TIPE; LOOP	Scorpion beta-toxins bind to the extracellular regions of the voltage-sensing module of domain II and to the pore module of domain III in voltage-gated sodium channels and enhance channel activation by trapping and stabilizing the voltage sensor of domain II in its activated state. We investigated the interaction of a highly potent insect-selective scorpion depressant beta-toxin, Lqh-dprIT(3), from Leiurus quinquestriatus hebraeus with insect sodium channels from Blattella germanica (BgNa(v)). Like other scorpion beta-toxins, Lqh-dprIT(3) shifts the voltage dependence of activation of BgNa(v) channels expressed in Xenopus oocytes to more negative membrane potentials but only after strong depolarizing prepulses. Notably, among 10 BgNa(v) splice variants tested for their sensitivity to the toxin, only BgNa(v)1-1 was hypersensitive due to an L1285P substitution in IIIS1 resulting from a U-to-C RNA-editing event. Furthermore, charge reversal of a negatively charged residue (E1290K) at the extracellular end of IIIS1 and the two innermost positively charged residues (R4E and R5E) in IIIS4 also increased the channel sensitivity to Lqh-dprIT(3). Besides enhancement of toxin sensitivity, the R4E substitution caused an additional 20-mV negative shift in the voltage dependence of activation of toxin-modified channels, inducing a unique toxin-modified state. Our findings provide the first direct evidence for the involvement of the domain III voltage-sensing module in the action of scorpion beta-toxins. This hypersensitivity most likely reflects an increase in IIS4 trapping via allosteric mechanisms, suggesting coupling between the voltage sensors in neighboring domains during channel activation.	[Song, Weizhong; Du, Yuzhe; Liu, Zhiqi; Luo, Ningguang; Dong, Ke] Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA; [Song, Weizhong; Du, Yuzhe; Liu, Zhiqi; Luo, Ningguang; Dong, Ke] Michigan State Univ, Genet Program, E Lansing, MI 48824 USA; [Song, Weizhong; Du, Yuzhe; Liu, Zhiqi; Luo, Ningguang; Dong, Ke] Michigan State Univ, Neurosci Program, E Lansing, MI 48824 USA; [Turkov, Michael; Gordon, Dalia; Gurevitz, Michael] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Plant Mol Biol & Ecol, IL-69978 Tel Aviv, Israel; [Goldin, Alan L.] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA	Michigan State University; Michigan State University; Michigan State University; Tel Aviv University; University of California System; University of California Irvine	Dong, K (corresponding author), Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA.	dongk@msu.edu	Goldin, Alan/A-8385-2015	Goldin, Alan/0000-0001-7159-0288	National Institutes of Health [GM057440]; United States-Israel Binational Agricultural Research and Development Grant [IS-4066-07]; National Science Foundation [IBN 9808156]; Israeli Science Foundation [107/08]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057440] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States-Israel Binational Agricultural Research and Development Grant; National Science Foundation(National Science Foundation (NSF)); Israeli Science Foundation(Israel Science Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM057440 (to K. D.). This work was also supported by United States-Israel Binational Agricultural Research and Development Grant IS-4066-07 (to D. G., M. G., and K. D.), National Science Foundation Grant IBN 9808156 (to K. D.), and Israeli Science Foundation Grant 107/08 (to M. G. and D. G.).	ARMSTRONG CM, 1977, J GEN PHYSIOL, V70, P567, DOI 10.1085/jgp.70.5.567; Campos FV, 2007, J GEN PHYSIOL, V130, P257, DOI 10.1085/jgp.200609719; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; CATTERALL WA, 1992, PHYSIOL REV, V72, pS15, DOI 10.1152/physrev.1992.72.suppl_4.S15; Cestele S, 1998, NEURON, V21, P919, DOI 10.1016/S0896-6273(00)80606-6; Cestele S, 2001, J GEN PHYSIOL, V118, P291, DOI 10.1085/jgp.118.3.291; Cestele S, 2000, BIOCHIMIE, V82, P883, DOI 10.1016/S0300-9084(00)01174-3; Cestele S, 2006, J BIOL CHEM, V281, P21332, DOI 10.1074/jbc.M603814200; Chanda B, 2004, J GEN PHYSIOL, V123, P217, DOI 10.1085/jgp.200308971; Cohen L, 2005, J BIOL CHEM, V280, P5045, DOI 10.1074/jbc.M408427200; Cohen L, 2007, J BIOL CHEM, V282, P29424, DOI 10.1074/jbc.M704651200; Dong K., 2010, INSECT PHARM CHANNEL, P25; Dong Ke, 2007, Invertebrate Neuroscience, V7, P17, DOI 10.1007/s10158-006-0036-9; FENG GP, 1995, CELL, V82, P1001, DOI 10.1016/0092-8674(95)90279-1; Goldin AL, 1999, ANN NY ACAD SCI, V868, P38, DOI 10.1111/j.1749-6632.1999.tb11272.x; Goldin AL, 2000, NEURON, V28, P365, DOI 10.1016/S0896-6273(00)00116-1; Gordon D, 1997, TOXINS SIGNAL TRANSD, P119; Gordon Dalia, 1997, Invertebrate Neuroscience, V3, P103, DOI 10.1007/BF02480365; Gordon D, 2007, TOXICON, V49, P452, DOI 10.1016/j.toxicon.2006.11.016; Gurevitz M, 2007, TOXICON, V49, P473, DOI 10.1016/j.toxicon.2006.11.015; HODGKIN AL, 1952, COLD SPRING HARB SYM, V17, P43, DOI 10.1101/SQB.1952.017.01.007; Leipold E, 2006, MOL PHARMACOL, V70, P340, DOI 10.1124/mol.106.024034; Marcotte P, 1997, CIRC RES, V80, P363, DOI 10.1161/01.RES.80.3.363; MARTINEAUCLAIRE MF, 1995, HDN NEUROTOXICOLOGY; Nicholson GM, 2007, TOXICON, V49, P490, DOI 10.1016/j.toxicon.2006.11.027; SODERLUND DM, 2010, SODIUM CHANNELS; Song WZ, 2004, J BIOL CHEM, V279, P32554, DOI 10.1074/jbc.M402392200; Strugatsky D, 2005, BIOCHEMISTRY-US, V44, P9179, DOI 10.1021/bi050235t; Tan JG, 2005, MOL PHARMACOL, V67, P513, DOI 10.1124/mol.104.006205; Tan JG, 2002, J NEUROSCI, V22, P5300; Terlau H, 2004, PHYSIOL REV, V84, P41, DOI 10.1152/physrev.00020.2003; Tsushima RG, 1999, PFLUG ARCH EUR J PHY, V437, P661, DOI 10.1007/s004240050830; Warmke JW, 1997, J GEN PHYSIOL, V110, P119, DOI 10.1085/jgp.110.2.119	33	18	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.217000	http://dx.doi.org/10.1074/jbc.M110.217000			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454658	hybrid, Green Published			2022-12-25	WOS:000290022800018
J	Tran, H; Gourrier, N; Lemercier-Neuillet, C; Dhaenens, CM; Vautrin, A; Fernandez-Gomez, FJ; Arandel, L; Carpentier, C; Obriot, H; Eddarkaoui, S; Delattre, L; Van Brussels, E; Holt, I; Morris, GE; Sablonniere, B; Buee, L; Charlet-Berguerand, N; Schraen-Maschke, S; Furling, D; Behm-Ansmant, I; Branlant, C; Caillet-Boudin, ML; Sergeant, N				Tran, Helene; Gourrier, Nathalie; Lemercier-Neuillet, Camille; Dhaenens, Claire-Marie; Vautrin, Audrey; Fernandez-Gomez, Francisco Jose; Arandel, Ludovic; Carpentier, Celine; Obriot, Helene; Eddarkaoui, Sabiha; Delattre, Lucie; Van Brussels, Edwige; Holt, Ian; Morris, Glenn E.; Sablonniere, Bernard; Buee, Luc; Charlet-Berguerand, Nicolas; Schraen-Maschke, Susanna; Furling, Denis; Behm-Ansmant, Isabelle; Branlant, Christiane; Caillet-Boudin, Marie-Laure; Sergeant, Nicolas			Analysis of Exonic Regions Involved in Nuclear Localization, Splicing Activity, and Dimerization of Muscleblind-like-1 Isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPANDED-REPEAT TRANSCRIPTS; CARDIAC TROPONIN-T; PRE-MESSENGER-RNA; MYOTONIC-DYSTROPHY; CUG REPEATS; IN-VIVO; PROTEINS; MBNL1; GENE; DROSOPHILA	Muscleblind-like-1 (MBNL1) is a splicing regulatory factor controlling the fetal-to-adult alternative splicing transitions during vertebrate muscle development. Its capture by nuclear CUG expansions is one major cause for type 1 myotonic dystrophy (DM1). Alternative splicing produces MBNL1 isoforms that differ by the presence or absence of the exonic regions 3, 5, and 7. To understand better their respective roles and the consequences of the deregulation of their expression in DM1, here we studied the respective roles of MBNL1 alternative and constitutive exons. By combining genetics, molecular and cellular approaches, we found that (i) the exon 5 and 6 regions are both needed to control the nuclear localization of MBNL1; (ii) the exon 3 region strongly enhances the affinity of MBNL1 for its pre-mRNA target sites; (iii) the exon 3 and 6 regions are both required for the splicing regulatory activity, and this function is not enhanced by an exclusive nuclear localization of MBNL1; and finally (iv) the exon 7 region enhances MBNL1-MBNL1 dimerization properties. Consequently, the abnormally high inclusion of the exon 5 and 7 regions in DM1 is expected to enhance the potential of MBNL1 of being sequestered with nuclear CUG expansions, which provides new insight into DM1 pathophysiology.	[Gourrier, Nathalie; Vautrin, Audrey; Behm-Ansmant, Isabelle; Branlant, Christiane] Nancy Univ, Lab Lab ARN Ribonucl Particles Maturat Struct Fun, Unite Mixte Rech 7214, CNRS,Fac Sci, F-54506 Vandoeuvre Les Nancy, France; [Sergeant, Nicolas] Univ Lille Nord France, INSERM, U837, USDL,IMPRT, F-59045 Lille, France; [Tran, Helene; Dhaenens, Claire-Marie; Fernandez-Gomez, Francisco Jose; Carpentier, Celine; Obriot, Helene; Eddarkaoui, Sabiha; Delattre, Lucie; Van Brussels, Edwige; Sablonniere, Bernard; Buee, Luc; Schraen-Maschke, Susanna; Caillet-Boudin, Marie-Laure; Sergeant, Nicolas] Univ Lille 2, Univ Lille Nord France, Inst Predict Med & Therapeut Res, Fac Med,Jean Pierre Aubert Res Ctr, F-59045 Lille, France; [Lemercier-Neuillet, Camille; Furling, Denis] Univ Paris 06, Unite Mixte 76, Inst Myol, F-75013 Paris, France; [Lemercier-Neuillet, Camille; Arandel, Ludovic; Furling, Denis] CNRS, Unite Mixte Rech 7215, F-75013 Paris, France; [Lemercier-Neuillet, Camille; Arandel, Ludovic; Furling, Denis] INSERM, U974, F-75013 Paris, France; [Charlet-Berguerand, Nicolas] IGBMC, F-67404 Illkirch Graffenstaden, France; [Holt, Ian; Morris, Glenn E.] Robert Jones & Agnes Hunt Orthopaed Hosp, Wolfson Ctr Inherited Neuromuscular Dis, Owestry, England; [Holt, Ian; Morris, Glenn E.] Keele Univ, Inst Sci & Technol Med, Keele, Staffs, England	Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Keele University	Branlant, C (corresponding author), Nancy Univ, Lab Lab ARN Ribonucl Particles Maturat Struct Fun, Unite Mixte Rech 7214, CNRS,Fac Sci, BP 70239, F-54506 Vandoeuvre Les Nancy, France.	christiane.branlant@maem.uhp-nancy.fr; nicolas.sergeant@inserm.fr	Charlet-Berguerand, Nicolas/GZM-6636-2022; Furling, Denis/M-2346-2017; Sergeant, Nicolas/O-5467-2017; BEHM-ANSMANT, Isabelle/B-1406-2012; Charlet-Berguerand, Nicolas/I-6727-2016; Fernández-Gómez, Francisco José/GOP-0463-2022; BUEE, Luc/B-3126-2010	Charlet-Berguerand, Nicolas/0000-0002-4423-4920; Furling, Denis/0000-0001-7912-4409; Sergeant, Nicolas/0000-0003-1448-124X; Charlet-Berguerand, Nicolas/0000-0002-4423-4920; BUEE, Luc/0000-0002-6261-4230; Behm-Ansmant, Isabelle/0000-0001-8909-0660; SCHRAEN, Susanna/0000-0002-7247-4809; Branlant, Christiane/0000-0003-4728-5499; Fernandez-Gomez, Francisco Jose/0000-0002-7891-8634	Association Francaise contre les Myopathies [14269, 15047]; Agence Nationale de Recherche Neuro-SplicedeTau BLAN [1114 01]; EU [FP6]; Centre National de la Recherche Scientifique; Institut National pour la Sante et la Recherche Medicale; French Ministry for Youth, National Education and Research; Lorraine Region	Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Agence Nationale de Recherche Neuro-SplicedeTau BLAN(French National Research Agency (ANR)); EU(European Commission); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National pour la Sante et la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); French Ministry for Youth, National Education and Research; Lorraine Region(Region Grand-Est)	This work was supported by the Association Francaise contre les Myopathies Grants 14269 and 15047, the Agence Nationale de Recherche Neuro-SplicedeTau BLAN 1114 01, the EURASNET EU Contract FP6, life sciences, genomics and biotechnology for health, the Centre National de la Recherche Scientifique, the Institut National pour la Sante et la Recherche Medicale, the French Ministry for Youth, National Education and Research, and the Lorraine Region.	Adereth Y, 2005, NAT CELL BIOL, V7, P1240, DOI 10.1038/ncb1335; Artero R, 1998, DEV BIOL, V195, P131, DOI 10.1006/dbio.1997.8833; Begemann G, 1997, DEVELOPMENT, V124, P4321; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; BROOK, 1992, CELL, V69, P385; Cooper TA, 1998, MOL CELL BIOL, V18, P4519, DOI 10.1128/MCB.18.8.4519; Dhaenens CM, 2008, EXP NEUROL, V210, P467, DOI 10.1016/j.expneurol.2007.11.020; Du HQ, 2010, NAT STRUCT MOL BIOL, V17, P187, DOI 10.1038/nsmb.1720; EDOM F, 1994, DEV BIOL, V164, P219, DOI 10.1006/dbio.1994.1193; Fardaei M, 2002, HUM MOL GENET, V11, P805, DOI 10.1093/hmg/11.7.805; Fardaei M, 2001, NUCLEIC ACIDS RES, V29, P2766, DOI 10.1093/nar/29.13.2766; Fernandez-Costa JM, 2010, MOL CELLS, V30, P65, DOI 10.1007/s10059-010-0089-9; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; Goers ES, 2010, NUCLEIC ACIDS RES, V38, P2467, DOI 10.1093/nar/gkp1209; Ho TH, 2004, EMBO J, V23, P3103, DOI 10.1038/sj.emboj.7600300; Holt I, 2007, GENES CELLS, V12, P1035, DOI 10.1111/j.1365-2443.2007.01112.x; Holt I, 2009, AM J PATHOL, V174, P216, DOI 10.2353/ajpath.2009.080520; Kalsotra A, 2008, P NATL ACAD SCI USA, V105, P20333, DOI 10.1073/pnas.0809045105; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; Kino Y, 2004, HUM MOL GENET, V13, P495, DOI 10.1093/hmg/ddh056; Kosaki A, 1998, J BIOL CHEM, V273, P10331, DOI 10.1074/jbc.273.17.10331; Lee JE, 2009, BIOCHEM SOC T, V37, P1281, DOI 10.1042/BST0371281; Lin XY, 2006, HUM MOL GENET, V15, P2087, DOI 10.1093/hmg/ddl132; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; Mooers BHM, 2005, P NATL ACAD SCI USA, V102, P16626, DOI 10.1073/pnas.0505873102; Onishi H, 2008, J NEUROSCI RES, V86, P1994, DOI 10.1002/jnr.21655; Osborne RJ, 2009, HUM MOL GENET, V18, P1471, DOI 10.1093/hmg/ddp058; Pascual M, 2006, DIFFERENTIATION, V74, P65, DOI 10.1111/j.1432-0436.2006.00060.x; Ranum LPW, 2006, ANNU REV NEUROSCI, V29, P259, DOI 10.1146/annurev.neuro.29.051605.113014; Sen S, 2010, J BIOL CHEM, V285, P25426, DOI 10.1074/jbc.M109.095224; Taneja KL, 1998, BIOTECHNIQUES, V24, P472, DOI 10.2144/98243rr02; Teplova M, 2008, NAT STRUCT MOL BIOL, V15, P1343, DOI 10.1038/nsmb.1519; Terenzi F, 2010, RNA BIOL, V7, P43, DOI 10.4161/rna.7.1.10401; Warf MB, 2007, RNA, V13, P2238, DOI 10.1261/rna.610607; Warf MB, 2009, P NATL ACAD SCI USA, V106, P9203, DOI 10.1073/pnas.0900342106; Yuan Y, 2007, NUCLEIC ACIDS RES, V35, P5474, DOI 10.1093/nar/gkm601	37	42	46	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.194928	http://dx.doi.org/10.1074/jbc.M110.194928			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454535	Green Published, hybrid			2022-12-25	WOS:000290022800081
J	Buch, PK; Mihelec, M; Cottrill, P; Wilkie, SE; Pearson, RA; Duran, Y; West, EL; Michaelides, M; Ali, RR; Hunt, DM				Buch, Prateek K.; Mihelec, Marija; Cottrill, Phillippa; Wilkie, Susan E.; Pearson, Rachael A.; Duran, Yanai; West, Emma L.; Michaelides, Michel; Ali, Robin R.; Hunt, David M.			Dominant Cone-Rod Dystrophy: A Mouse Model Generated by Gene Targeting of the GCAP1/Guca1a Gene	PLOS ONE			English	Article							CYCLASE-ACTIVATING PROTEIN-1; CALCIUM-CHANNEL BLOCKER; D-CIS-DILTIAZEM; GUANYLYL CYCLASE; RETINAL DEGENERATION; RETINITIS-PIGMENTOSA; PHOTORECEPTOR RESCUE; DEPENDENT CHANNEL; RECOVERY KINETICS; PROGRESSIVE CONE	Cone dystrophy 3 (COD3) is a severe dominantly inherited retinal degeneration caused by missense mutations in GUCA1A, the gene encoding Guanylate Cyclase Activating Protein 1 (GCAP1). The role of GCAP1 in controlling cyclic nucleotide levels in photoreceptors has largely been elucidated using knock-out mice, but the disease pathology in these mice cannot be extrapolated directly to COD3 as this involves altered, rather than loss of, GCAP1 function. Therefore, in order to evaluate the pathology of this dominant disorder, we have introduced a point mutation into the murine Guca1a gene that causes an E155G amino acid substitution; this is one of the disease-causing mutations found in COD3 patients. Disease progression in this novel mouse model of cone dystrophy was determined by a variety of techniques including electroretinography (ERG), retinal histology, immunohistochemistry and measurement of cGMP levels. It was established that although retinal development was normal up to 3 months of age, there was a subsequent progressive decline in retinal function, with a far greater alteration in cone than rod responses, associated with a corresponding loss of photoreceptors. In addition, we have demonstrated that accumulation of cyclic GMP precedes the observed retinal degeneration and is likely to contribute to the disease mechanism. Importantly, this knock-in mutant mouse has many features in common with the human disease, thereby making it an excellent model to further probe disease pathogenesis and investigate therapeutic interventions.	[Buch, Prateek K.; Mihelec, Marija; Cottrill, Phillippa; Wilkie, Susan E.; Pearson, Rachael A.; Duran, Yanai; West, Emma L.; Michaelides, Michel; Ali, Robin R.; Hunt, David M.] UCL, Inst Ophthalmol, London, England; [Hunt, David M.] Univ Western Australia, Sch Anim Biol, Perth, WA 6009, Australia	University of London; University College London; University of Western Australia	Buch, PK (corresponding author), UCL, Inst Ophthalmol, London, England.	r.ali@ucl.ac.uk; david.hunt@uwa.edu.au	Pearson, Rachael/Y-3339-2018; Hunt, David M/K-6024-2012; West, Emma L/C-5252-2013	Pearson, Rachael/0000-0002-1107-1969; Hunt, David M/0000-0002-9264-3948; Ali, Robin/0000-0003-3126-6517; West, Emma/0000-0002-7006-3686	UK Medical Research Council; Wellcome Trust; Fight for Sight UK; Foundation Fighting Blindness USA; Royal Society; National Institute for Health Research USA; Biomedical Research Centre for Ophthalmology at Moorfields Eye Hospital; Moorfields Special Trustees; UCL Institute of Ophthalmology; Medical Research Council [G0801004] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10130] Funding Source: researchfish; MRC [G0801004] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Fight for Sight UK; Foundation Fighting Blindness USA; Royal Society(Royal Society of London); National Institute for Health Research USA; Biomedical Research Centre for Ophthalmology at Moorfields Eye Hospital; Moorfields Special Trustees; UCL Institute of Ophthalmology; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by grants from the UK Medical Research Council (Hunt and Ali), the Wellcome Trust (Hunt), Fight for Sight UK (Ali), Foundation Fighting Blindness USA (Hunt), the Royal Society (Pearson) and the National Institute for Health Research USA (Ali and Michaelides). The authors also acknowledge support from the Biomedical Research Centre for Ophthalmology at Moorfields Eye Hospital, Moorfields Special Trustees and UCL Institute of Ophthalmology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali RR, 2000, NAT GENET, V25, P306, DOI 10.1038/77068; BIRCH DG, 1995, INVEST OPHTH VIS SCI, V36, P1603; Burns ME, 2002, NEURON, V36, P81, DOI 10.1016/S0896-6273(02)00911-X; Chang B, 2007, VISION RES, V47, P624, DOI 10.1016/j.visres.2006.11.020; COOK NJ, 1987, P NATL ACAD SCI USA, V84, P585, DOI 10.1073/pnas.84.2.585; Cuenca N, 1998, INVEST OPHTH VIS SCI, V39, P1243; DIZHOOR AM, 1994, NEURON, V12, P1345, DOI 10.1016/0896-6273(94)90449-9; FARBER DB, 1976, J CYCLIC NUCL PROT, V2, P139; Frasson M, 1999, NAT MED, V5, P1183, DOI 10.1038/13508; GORCZYCA WA, 1995, J BIOL CHEM, V270, P22029, DOI 10.1074/jbc.270.37.22029; HANKE W, 1988, P NATL ACAD SCI USA, V85, P94, DOI 10.1073/pnas.85.1.94; He LH, 2000, J BIOL CHEM, V275, P12175, DOI 10.1074/jbc.275.16.12175; Hetling JR, 1999, J PHYSIOL-LONDON, V516, P593, DOI 10.1111/j.1469-7793.1999.0593v.x; Howes K, 1998, INVEST OPHTH VIS SCI, V39, P867; Howes KA, 2002, EMBO J, V21, P1545, DOI 10.1093/emboj/21.7.1545; Humphries MM, 1997, NAT GENET, V15, P216, DOI 10.1038/ng0297-216; Hunt DM, 2010, MOL CELL BIOCHEM, V334, P157, DOI 10.1007/s11010-009-0331-y; Jiang L, 2005, MOL VIS, V11, P143; Jiang L, 2008, VISION RES, V48, P2425, DOI 10.1016/j.visres.2008.07.016; Kachi S, 1999, EXP EYE RES, V68, P465, DOI 10.1006/exer.1998.0629; Kitiratschky VBD, 2009, HUM MUTAT, V30, pE782, DOI 10.1002/humu.21055; LaVail MM, 1998, INVEST OPHTH VIS SCI, V39, P592; Lyubarsky A, 2001, MOL VIS, V7, P71; Lyubarsky AL, 2000, J NEUROSCI, V20, P2209; Lyubarsky AL, 1996, J NEUROSCI, V16, P563, DOI 10.1523/jneurosci.16-02-00563.1996; Lyubarsky AL, 1999, J NEUROSCI, V19, P442, DOI 10.1523/JNEUROSCI.19-01-00442.1999; Mendez A, 2001, P NATL ACAD SCI USA, V98, P9948, DOI 10.1073/pnas.171308998; Michaelides M, 2005, OPHTHALMOLOGY, V112, P1442, DOI 10.1016/j.ophtha.2005.02.024; Michaelides M, 2006, SURV OPHTHALMOL, V51, P232, DOI 10.1016/j.survophthal.2006.02.007; Naash MI, 2004, J COMP NEUROL, V478, P149, DOI 10.1002/cne.20283; Nishiguchi KM, 2004, INVEST OPHTH VIS SCI, V45, P3863, DOI 10.1167/iovs.04-0590; Olshevskaya EV, 2004, J NEUROSCI, V24, P6078, DOI 10.1523/JNEUROSCI.0963-04.2004; OttoBruc A, 1997, P NATL ACAD SCI USA, V94, P4727, DOI 10.1073/pnas.94.9.4727; Pawlyk BS, 2002, INVEST OPHTH VIS SCI, V43, P1912; Payne AM, 1998, HUM MOL GENET, V7, P273, DOI 10.1093/hmg/7.2.273; Pearce-Kelling SE, 2001, MOL VIS, V7, P42; Pennesi ME, 2003, P NATL ACAD SCI USA, V100, P6783, DOI 10.1073/pnas.1130102100; Pepperberg DR, 1996, J OPT SOC AM A, V13, P586, DOI 10.1364/JOSAA.13.000586; Pepperberg DR, 2000, METHOD ENZYMOL, V316, P202; Pepperberg DR, 1997, VISUAL NEUROSCI, V14, P73, DOI 10.1017/S0952523800008774; Samardzija M, 2008, HUM MOL GENET, V17, P281, DOI 10.1093/hmg/ddm304; Small KW, 1996, AM J OPHTHALMOL, V121, P1; Sokal I, 1998, MOL CELL, V2, P129, DOI 10.1016/S1097-2765(00)80121-5; Sokal I, 2005, INVEST OPHTH VIS SCI, V46, P1124, DOI 10.1167/iovs.04-1431; Tan MH, 2009, HUM MOL GENET, V18, P2099, DOI 10.1093/hmg/ddp133; Tsang SH, 1996, SCIENCE, V272, P1026, DOI 10.1126/science.272.5264.1026; van de Pavert SA, 2007, J NEUROSCI, V27, P564, DOI 10.1523/JNEUROSCI.3496-06.2007; Vasireddy V, 2006, INVEST OPHTH VIS SCI, V47, P4558, DOI 10.1167/iovs.06-0353; Wilkie SE, 2001, AM J HUM GENET, V69, P471, DOI 10.1086/323265; Yang RB, 1999, J NEUROSCI, V19, P5889, DOI 10.1523/JNEUROSCI.19-14-05889.1999	50	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e18089	10.1371/journal.pone.0018089	http://dx.doi.org/10.1371/journal.pone.0018089			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464903	Green Published, Green Submitted, gold			2022-12-25	WOS:000289053800022
J	Goncalves-Pimentel, C; Rita, G; Jozsef, M; Sanchez-Soriano, N; Prokop, A				Goncalves-Pimentel, Catarina; Rita Gombos; Jozsef Mihaly; Sanchez-Soriano, Natalia; Prokop, Andreas			Dissecting Regulatory Networks of Filopodia Formation in a Drosophila Growth Cone Model	PLOS ONE			English	Article							VASODILATOR-STIMULATED PHOSPHOPROTEIN; ABL TYROSINE KINASE; ARP2/3 COMPLEX; AXON GUIDANCE; ACTIN; PROFILIN; ROLES; MUTATIONS; MECHANISM; PROTEIN	F-actin networks are important structural determinants of cell shape and morphogenesis. They are regulated through a number of actin-binding proteins. The function of many of these proteins is well understood, but very little is known about how they cooperate and integrate their activities in cellular contexts. Here, we have focussed on the cellular roles of actin regulators in controlling filopodial dynamics. Filopodia are needle-shaped, actin-driven cell protrusions with characteristic features that are well conserved amongst vertebrates and invertebrates. However, existing models of filopodia formation are still incomplete and controversial, pieced together from a wide range of different organisms and cell types. Therefore, we used embryonic Drosophila primary neurons as one consistent cellular model to study filopodia regulation. Our data for loss-of-function of capping proteins, enabled, different Arp2/3 complex components, the formin DAAM and profilin reveal characteristic changes in filopodia number and length, providing a promising starting point to study their functional relationships in the cellular context. Furthermore, the results are consistent with effects reported for the respective vertebrate homologues, demonstrating the conserved nature of our Drosophila model system. Using combinatorial genetics, we demonstrate that different classes of nucleators cooperate in filopodia formation. In the absence of Arp2/3 or DAAM filopodia numbers are reduced, in their combined absence filopodia are eliminated, and in genetic assays they display strong functional interactions with regard to filopodia formation. The two nucleators also genetically interact with enabled, but not with profilin. In contrast, enabled shows strong genetic interaction with profilin, although loss of profilin alone does not affect filopodia numbers. Our genetic data support a model in which Arp2/ 3 and DAAM cooperate in a common mechanism of filopodia formation that essentially depends on enabled, and is regulated through profilin activity at different steps.	[Goncalves-Pimentel, Catarina; Sanchez-Soriano, Natalia; Prokop, Andreas] Wellcome Trust Ctr Cell Matrix Res, Fac Life Sci, Manchester, Lancs, England; [Goncalves-Pimentel, Catarina] Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Rita Gombos; Jozsef Mihaly] Hungarian Acad Sci, Inst Genet, Biol Res Ctr, Szeged, Hungary	University of Manchester; Universidade de Coimbra; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center	Goncalves-Pimentel, C (corresponding author), Wellcome Trust Ctr Cell Matrix Res, Fac Life Sci, Manchester, Lancs, England.	NSanchez@manchester.ac.uk; Andreas.Prokop@manchester.ac.uk	Gonçalves-Pimentel, Catarina/E-6277-2013; Pimentel, Catarina/I-6095-2015	Gonçalves-Pimentel, Catarina/0000-0003-1181-3907; Pimentel, Catarina/0000-0003-1181-3907; Mihaly, Jozsef/0000-0003-3399-2424; Sanchez-Soriano, Natalia/0000-0002-6667-2817; Prokop, Andreas/0000-0001-8482-3298	Wellcome Trust [087742/Z/08/Z]; NSS [077748/Z/05/Z, 092403/Z/10/Z]; Hungarian Scientific Research Foundation (OTKA) [K82039]; Fundacao para a Ciencia e a Tecnologia [SFRH/BD/15891/2005]; Hungarian Academy of Sciences; BBSRC; University of Manchester	Wellcome Trust(Wellcome TrustEuropean Commission); NSS; Hungarian Scientific Research Foundation (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Hungarian Academy of Sciences(Hungarian Academy of Sciences); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Manchester	This work was funded through grants by the Wellcome Trust to AP and NSS (077748/Z/05/Z and 092403/Z/10/Z), a support from the Hungarian Scientific Research Foundation (OTKA grant K82039) to JM, a studentship from the Fundacao para a Ciencia e a Tecnologia to CGP (SFRH/BD/15891/2005), and a studentship from the Hungarian Academy of Sciences to RG. The Bioimaging Facility used for live imaging is supported by grants from the BBSRC, The Wellcome Trust and the University of Manchester Strategic Fund. The Drosophila core facility is supported by grants of the Wellcome Trust (087742/Z/08/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern-Djamali SM, 1999, P NATL ACAD SCI USA, V96, P4977, DOI 10.1073/pnas.96.9.4977; Ahern-Djamali SM, 1998, MOL BIOL CELL, V9, P2157, DOI 10.1091/mbc.9.8.2157; Alves-Silva J, 2008, MOL BIOL CELL, V19, P4287, DOI 10.1091/mbc.E08-02-0182; Barko S, 2010, J BIOL CHEM, V285, P13154, DOI 10.1074/jbc.M109.093914; Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Bear JE, 2009, J CELL SCI, V122, P1947, DOI 10.1242/jcs.038125; Block J, 2008, J MICROSC-OXFORD, V231, P506, DOI 10.1111/j.1365-2818.2008.02063.x; Bottenberg W, 2009, MECH DEVELOP, V126, P489, DOI 10.1016/j.mod.2009.04.004; Budnik V, 2006, INT REV NEUROBIOL, V75, P323, DOI 10.1016/S0074-7742(06)75015-2; Campos-Ortega J, 1997, EMBRYONIC DEV DROSOP; Chang C, 2006, CURR BIOL, V16, P854, DOI 10.1016/j.cub.2006.03.083; Chesarone MA, 2009, CURR OPIN CELL BIOL, V21, P28, DOI 10.1016/j.ceb.2008.12.001; Cooper JA, 2008, INT REV CEL MOL BIO, V267, P183, DOI 10.1016/S1937-6448(08)00604-7; Delalle I, 2005, GENETICS, V171, P1757, DOI 10.1534/genetics.105.049213; Dent EW, 2007, NAT CELL BIOL, V9, P1347, DOI 10.1038/ncb1654; DUBENDORFER A, 1980, INVERTEBRATE SYSTEMS, P169; Dwivedy A, 2007, DEVELOPMENT, V134, P2137, DOI 10.1242/dev.002345; FAIX J, 2009, INT J BIOCHEM CELL B, DOI DOI 10.1016/J.BIOCEL.2009.1002.1012; Gates J, 2007, DEVELOPMENT, V134, P2027, DOI 10.1242/dev.02849; Gates J, 2009, DEV BIOL, V333, P90, DOI 10.1016/j.ydbio.2009.06.030; GERTLER FB, 1995, GENE DEV, V9, P521, DOI 10.1101/gad.9.5.521; Gournier H, 2001, MOL CELL, V8, P1041, DOI 10.1016/S1097-2765(01)00393-8; GUPTON SL, 2007, SCI STKE, pRE5, DOI DOI 10.1126/STKE.4002007RE5; Hansen SD, 2010, J CELL BIOL, V191, P571, DOI 10.1083/jcb.201003014; HOMEM CC, 2009, MOL BIOL CELL; Hudson AM, 2002, J CELL BIOL, V156, P677, DOI 10.1083/jcb.200109065; Insall RH, 2009, DEV CELL, V17, P310, DOI 10.1016/j.devcel.2009.08.012; Korobova F, 2008, MOL BIOL CELL, V19, P1561, DOI 10.1091/mbc.E07-09-0964; Kuppers B, 2003, J NEUROCHEM, V84, P939, DOI 10.1046/j.1471-4159.2003.01554.x; Kuppers-Munther B, 2004, DEV BIOL, V269, P459, DOI 10.1016/j.ydbio.2004.01.038; Lanier LM, 1999, NEURON, V22, P313, DOI 10.1016/S0896-6273(00)81092-2; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Lowery LA, 2009, NAT REV MOL CELL BIO, V10, P332, DOI 10.1038/nrm2679; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; Matusek T, 2006, DEVELOPMENT, V133, P957, DOI 10.1242/dev.02266; Matusek T, 2008, J NEUROSCI, V28, P13310, DOI 10.1523/JNEUROSCI.2727-08.2008; Mejillano MR, 2004, CELL, V118, P363, DOI 10.1016/j.cell.2004.07.019; MELLOR H, 2009, BIOCHIM BIOPHYS ACTA, DOI DOI 10.1016/J.BBAMCR.2008.1012.1018; Ng JL, 2004, NEURON, V44, P779, DOI 10.1016/j.neuron.2004.11.014; Okada K, 2010, J CELL BIOL, V189, P1087, DOI 10.1083/jcb.201001016; Ono S, 2007, INT REV CYTOL, V258, P1, DOI 10.1016/S0074-7696(07)58001-0; Paul AS, 2009, CELL MOTIL CYTOSKEL, V66, P606, DOI 10.1002/cm.20379; PROKOP A, 2011, MAKING UNMA IN PRESS; Sanchez-Soriano N, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-9; Sanchez-Soriano N, 2010, DEV NEUROBIOL, V70, P58, DOI 10.1002/dneu.20762; Sanchez-Soriano N, 2009, J CELL SCI, V122, P2534, DOI 10.1242/jcs.046268; Schenck A, 2004, DEV BIOL, V274, P260, DOI 10.1016/j.ydbio.2004.07.009; Schirenbeck A, 2006, P NATL ACAD SCI USA, V103, P7694, DOI 10.1073/pnas.0511243103; SCHNEIDER I, 1964, J EXP ZOOL, V156, P91, DOI 10.1002/jez.1401560107; Svitkina TM, 2003, J CELL BIOL, V160, P409, DOI 10.1083/jcb.200210174; VERHEYEN EM, 1994, DEVELOPMENT, V120, P717; Vignjevic D, 2006, J CELL BIOL, V174, P863, DOI 10.1083/jcb.200603013; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Wills Z, 1999, NEURON, V22, P291, DOI 10.1016/S0896-6273(00)81090-9; Witke W, 2004, TRENDS CELL BIOL, V14, P461, DOI 10.1016/j.tcb.2004.07.003; Yang C, 2007, PLOS BIOL, V5, P2624, DOI 10.1371/journal.pbio.0050317; Yarmola EG, 2006, TRENDS BIOCHEM SCI, V31, P197, DOI 10.1016/j.tibs.2006.02.006	57	30	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e18340	10.1371/journal.pone.0018340	http://dx.doi.org/10.1371/journal.pone.0018340			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464901	Green Published, Green Submitted, gold			2022-12-25	WOS:000289053800042
J	Irish, J; Blair, S; Carter, DA				Irish, Julie; Blair, Shona; Carter, Dee A.			The Antibacterial Activity of Honey Derived from Australian Flora	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; GLUCOSE-OXIDASE; STRAINS; IDENTIFICATION; METHYLGLYOXAL; SENSITIVITY; INHIBINE; ORIGIN	Chronic wound infections and antibiotic resistance are driving interest in antimicrobial treatments that have generally been considered complementary, including antimicrobially active honey. Australia has unique native flora and produces honey with a wide range of different physicochemical properties. In this study we surveyed 477 honey samples, derived from native and exotic plants from various regions of Australia, for their antibacterial activity using an established screening protocol. A level of activity considered potentially therapeutically useful was found in 274 (57%) of the honey samples, with exceptional activity seen in samples derived from marri (Corymbia calophylla), jarrah (Eucalyptus marginata) and jellybush (Leptospermum polygalifolium). In most cases the antibacterial activity was attributable to hydrogen peroxide produced by the bee-derived enzyme glucose oxidase. Non-hydrogen peroxide activity was detected in 80 (16.8%) samples, and was most consistently seen in honey produced from Leptospermum spp. Testing over time found the hydrogen peroxide-dependent activity in honey decreased, in some cases by 100%, and this activity was more stable at 4 degrees C than at 25 degrees C. In contrast, the non-hydrogen peroxide activity of Leptospermum honey samples increased, and this was greatest in samples stored at 25 degrees C. The stability of non-peroxide activity from other honeys was more variable, suggesting this activity may have a different cause. We conclude that many Australian honeys have clinical potential, and that further studies into the composition and stability of their active constituents are warranted.	[Irish, Julie; Blair, Shona; Carter, Dee A.] Univ Sydney, Sch Mol Biosci, Camperdown, NSW, Australia	University of Sydney	Irish, J (corresponding author), Univ Sydney, Sch Mol Biosci, Camperdown, NSW, Australia.	dee.carter@sydney.edu.au	Carter, Dee/C-1331-2010	Carter, Dee/0000-0002-4638-0059; Blair, Shona/0000-0002-4425-6775	Rural Industries Research and Development Corporation grant [US-128A]; Australian Postgraduate Award	Rural Industries Research and Development Corporation grant(Rural Industries R&D Corp); Australian Postgraduate Award(Australian Government)	This project was financially supported by a Rural Industries Research and Development Corporation grant (Project No. US-128A), and an Australian Postgraduate Award to JI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CJ, 2008, CARBOHYD RES, V343, P651, DOI 10.1016/j.carres.2007.12.011; Adams CJ, 2009, CARBOHYD RES, V344, P1050, DOI 10.1016/j.carres.2009.03.020; Allen K.L., 1991, APIACTA, V26, P114, DOI [10.1080/ 0005772X.1992.11099118, DOI 10.1080/0005772X.1992.11099118]; ALLEN KL, 1991, J PHARM PHARMACOL, V43, P817, DOI 10.1111/j.2042-7158.1991.tb03186.x; Allen KL, 1997, NEW ZEAL J AGR RES, V40, P537, DOI 10.1080/00288233.1997.9513276; *AUSTR NAT BOT GAR, 2008, AUSTR PLANT COMM NAM; Bang LM, 2003, J ALTERN COMPLEM MED, V9, P267, DOI 10.1089/10755530360623383; Blair SE, 2009, EUR J CLIN MICROBIOL, V28, P1199, DOI 10.1007/s10096-009-0763-z; Brady N, 2004, J APICULT RES, V43, P47, DOI 10.1080/00218839.2004.11101109; Brady N. F., 1996, Pharmaceutical Sciences, V2, P471; Brooker M.I.H., 2001, FIELD GUIDE EUCALYPT, VII; Brooker M.I.H., 2006, FIELD GUIDE EUCALYPT, V1; Brooker MIH, 2004, FIELD GUIDE EUCALYPT, V3; Cabrera L, 2006, REV CIENT-FAC CIEN V, V16, P556; Castro-Vazquez L, 2008, J AGR FOOD CHEM, V56, P1999, DOI 10.1021/jf072227k; Clemson A.A., 1985, HONEY POLLEN FLORA; Cooper R, 1999, J Wound Care, V8, P161; Cooper RA, 2000, LETT APPL MICROBIOL, V31, P20, DOI 10.1046/j.1472-765x.2000.00756.x; Cooper RA, 2002, J APPL MICROBIOL, V93, P857, DOI 10.1046/j.1365-2672.2002.01761.x; Cooper RA, 2002, J BURN CARE REHABIL, V23, P366, DOI 10.1097/00004630-200211000-00002; Cooper RA, 1999, J ROY SOC MED, V92, P283, DOI 10.1177/014107689909200604; COOPER RA, 2009, COMP MED GRADE HONEY; *CTR PLANT BIOD RE, 2008, AUSTR PLANT NAM IND; *CTR PLANT BIOD RE, 2008, AUSTR VIRT HERB MAP; Dag A, 2003, APIDOLOGIE, V34, P299, DOI 10.1051/apido:2003022; Flores MJ, 2002, MOL MICROBIOL, V44, P783, DOI 10.1046/j.1365-2958.2002.02913.x; French VM, 2005, J ANTIMICROB CHEMOTH, V56, P228, DOI 10.1093/jac/dki193; Gallardo-Chacon JJ, 2008, J APICULT RES, V47, P131, DOI 10.1080/00218839.2008.11101439; Henriques A, 2005, J APICULT RES, V44, P119, DOI 10.1080/00218839.2005.11101161; Irish J, 2006, MED MYCOL, V44, P289, DOI 10.1080/13693780500417037; Janmaat AF, 2000, BEHAV ECOL SOCIOBIOL, V47, P171, DOI 10.1007/s002650050008; Kwakman PHS, 2010, FASEB J, V24, P2576, DOI 10.1096/fj.09-150789; Mattila HR, 2006, ENVIRON ENTOMOL, V35, P708, DOI 10.1603/0046-225X-35.3.708; Mavric E, 2008, MOL NUTR FOOD RES, V52, P483, DOI 10.1002/mnfr.200700282; MOLAN PC, 1988, J APICULT RES, V27, P252, DOI 10.1080/00218839.1988.11100811; MOLAN PC, 1988, J APICULT RES, V27, P62, DOI 10.1080/00218839.1988.11100783; Molan PC, 1996, J PHARM PHARMACOL, V48, P1206, DOI 10.1111/j.2042-7158.1996.tb03922.x; MOLAN PC, 1992, BEE WORLD, V73, P5, DOI 10.1080/0005772X.1992.11099109; Mundo MA, 2004, INT J FOOD MICROBIOL, V97, P1, DOI 10.1016/j.ijfoodmicro.2004.03.025; Ohashi K, 1999, EUR J BIOCHEM, V265, P127, DOI 10.1046/j.1432-1327.1999.00696.x; Price JN, 2006, ECOGRAPHY, V29, P623, DOI 10.1111/j.0906-7590.2006.04645.x; SOMERVILLE DC, 2008, RURAL IND RES DEV CO, V8060; Stephens JM, 2010, FOOD CHEM, V120, P78, DOI 10.1016/j.foodchem.2009.09.074; WHITE JW, 1963, BIOCHIM BIOPHYS ACTA, V73, P57; WHITE JW, 1964, J FOOD SCI, V29, P819, DOI 10.1111/j.1365-2621.1964.tb00455.x; Yang XL, 2005, P NATL ACAD SCI USA, V102, P7470, DOI 10.1073/pnas.0501860102	46	131	137	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e18229	10.1371/journal.pone.0018229	http://dx.doi.org/10.1371/journal.pone.0018229			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464891	Green Submitted, gold, Green Published			2022-12-25	WOS:000289053800030
J	Ahlehoff, O; Gislason, GH; Lindhardsen, J; Charlot, MG; Jorgensen, CH; Olesen, JB; Bretler, DM; Skov, L; Torp-Pedersen, C; Hansen, PR				Ahlehoff, Ole; Gislason, Gunnar Hilmar; Lindhardsen, Jesper; Charlot, Mette Gitz; Jorgensen, Casper Haslund; Olesen, Jonas Bjerring; Bretler, Ditte-Marie; Skov, Lone; Torp-Pedersen, Christian; Hansen, Peter Riis			Psoriasis Carries an Increased Risk of Venous Thromboembolism: A Danish Nationwide Cohort Study	PLOS ONE			English	Article							CORONARY-ARTERY; CARDIOVASCULAR MORTALITY; PLATELET ACTIVATION; VASCULAR-DISEASES; ATHEROSCLEROSIS; INFLAMMATION; MECHANISMS; CANCER	Background: Psoriasis is an immunoinflammatory disease associated with cardiovascular risk factors, atherothrombotic events, and hypercoagulability. Venous thromboembolism (VTE) is potentially lethal and shares risk factors with psoriasis, but the risk of VTE associated with psoriasis is unknown. The present study investigated the potential association between psoriasis and VTE. Methods and Findings: Information from nationwide prospectively recorded registers of hospitalization, drug dispensing from pharmacies, socio-economic data, and causes of death was linked on an individual level. In an unselected nationwide cohort, we used multivariate Poisson regression models controlling for age, gender, comorbidity, concomitant medication, socio-economic data, and calendar year, to assess the risk of VTE associated with psoriasis. A total of 35,138 patients with mild and 3,526 patients with severe psoriasis were identified and compared with 4,126,075 controls. Patients with psoriasis had higher incidence rates per 1000 person-years of VTE than controls (1.29, 1.92, and 3.20 for controls, mild psoriasis, and severe psoriasis, respectively). The rate ratio (RR) of VTE was elevated in all patients with psoriasis with RR 1.35 (95% confidence interval [CI] 1.21-1.49) and RR 2.06 (CI 1.63-2.61) for mild and severe psoriasis, respectively. Exclusion of patients with malignancies, and censoring of patients undergoing surgery did not alter the results. Conclusion: This nationwide cohort study indicates that patients with psoriasis are at increased risk of VTE. The risk was highest in young patients with severe psoriasis. Physicians should be aware that patients with psoriasis may be at increased risk of both venous and arterial thromboembolic events.	[Ahlehoff, Ole; Gislason, Gunnar Hilmar; Lindhardsen, Jesper; Charlot, Mette Gitz; Jorgensen, Casper Haslund; Olesen, Jonas Bjerring; Bretler, Ditte-Marie; Torp-Pedersen, Christian; Hansen, Peter Riis] Univ Copenhagen, Gentofte Hosp, Dept Cardiol, Hellerup, Denmark; [Skov, Lone] Univ Copenhagen, Gentofte Hosp, Dept Dermatol, Hellerup, Denmark; [Skov, Lone; Torp-Pedersen, Christian] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen	Ahlehoff, O (corresponding author), Univ Copenhagen, Gentofte Hosp, Dept Cardiol, Hellerup, Denmark.	olahha01@geh.regionh.dk	Skov, Lone/W-3575-2018; Gislason, Gunnar/B-7561-2009; Hansen, Peter Riis/AAR-7659-2020	Gislason, Gunnar/0000-0002-0548-402X; Hansen, Peter Riis/0000-0002-9056-535X; Skov, Lone/0000-0002-4784-9680	Department of Cardiology, Copenhagen University Hospital Gentofte	Department of Cardiology, Copenhagen University Hospital Gentofte	The study was supported by the Department of Cardiology, Copenhagen University Hospital Gentofte. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlehoff O, 2011, J INTERN MED, V270, P147, DOI 10.1111/j.1365-2796.2010.02310.x; Alexandroff AB, 2009, BRIT J DERMATOL, V161, P1, DOI 10.1111/j.1365-2133.2009.09281.x; BERRETTINI M, 1985, THROMB HAEMOSTASIS, V53, P195; Brauchli YB, 2009, J INVEST DERMATOL, V129, P2604, DOI 10.1038/jid.2009.113; Friedewald VE, 2008, AM J CARDIOL, V102, P1631, DOI 10.1016/j.amjcard.2008.10.004; Gelfand JM, 2007, ARCH DERMATOL, V143, P1493, DOI 10.1001/archderm.143.12.1493; Gelfand JM, 2006, JAMA-J AM MED ASSOC, V296, P1735, DOI 10.1001/jama.296.14.1735; Gelfand JM, 2009, J INVEST DERMATOL, V129, P2411, DOI 10.1038/jid.2009.112; Gisondi P, 2009, SEMIN THROMB HEMOST, V35, P313, DOI 10.1055/s-0029-1222610; Goldhaber SZ, 2010, J AM COLL CARDIOL, V56, P1, DOI 10.1016/j.jacc.2010.01.057; Grainge MJ, 2010, LANCET, V375, P657, DOI 10.1016/S0140-6736(09)61963-2; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Holst AG, 2010, CIRCULATION, V121, P1896, DOI 10.1161/CIRCULATIONAHA.109.921460; Karabudak O, 2008, ACTA DERM-VENEREOL, V88, P337, DOI 10.2340/00015555-0456; Kimball AB, 2008, DERMATOLOGY, V217, P27, DOI 10.1159/000121333; LIPPI G, 2010, CLIN CHEM LAB MED; Mallbris L, 2004, EUR J EPIDEMIOL, V19, P225, DOI 10.1023/B:EJEP.0000020447.59150.f9; MCDONALD CJ, 1978, BRIT J DERMATOL, V99, P469, DOI 10.1111/j.1365-2133.1978.tb02012.x; Mehta NN, 2010, EUR HEART J, V31, P1000, DOI 10.1093/eurheartj/ehp567; Menter A, 2007, LANCET, V370, P272, DOI 10.1016/S0140-6736(07)61129-5; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Nuttall M, 2006, J CLIN EPIDEMIOL, V59, P265, DOI 10.1016/j.jclinepi.2005.07.015; Prodanovich S, 2009, ARCH DERMATOL, V145, P700, DOI 10.1001/archdermatol.2009.94; Prodanowich S, 2005, J AM ACAD DERMATOL, V52, P262, DOI 10.1016/j.jaad.2004.06.017; SALEH T, 2010, CLIN APPL THROMB HEM; Severinsen MT, 2010, J CLIN EPIDEMIOL, V63, P223, DOI 10.1016/j.jclinepi.2009.03.018; Shirinsky IV, 2007, J AM ACAD DERMATOL, V57, P529, DOI 10.1016/j.jaad.2007.05.040; Sorensen HT, 2007, LANCET, V370, P1773, DOI 10.1016/S0140-6736(07)61745-0; Squizzato A, 2010, EUR HEART J, V31, P1248, DOI 10.1093/eurheartj/ehp556; Tamagawa-Mineoka R, 2010, J AM ACAD DERMATOL, V62, P621, DOI 10.1016/j.jaad.2009.06.053; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wakkee M, 2007, ATHEROSCLEROSIS, V190, P1, DOI 10.1016/j.atherosclerosis.2006.07.011; Zacho J, 2010, ARTERIOSCL THROM VAS, V30, P1672, DOI 10.1161/ATVBAHA.109.198473	33	72	72	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e18125	10.1371/journal.pone.0018125	http://dx.doi.org/10.1371/journal.pone.0018125			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464995	Green Published, Green Submitted, gold			2022-12-25	WOS:000288813900042
J	Liebau, S; Steinestel, J; Linta, L; Kleger, A; Storch, A; Schoen, M; Steinestel, K; Proepper, C; Bockmann, J; Schmeisser, MJ; Boeckers, TM				Liebau, Stefan; Steinestel, Julie; Linta, Leonhard; Kleger, Alexander; Storch, Alexander; Schoen, Michael; Steinestel, Konrad; Proepper, Christian; Bockmann, Juergen; Schmeisser, Michael J.; Boeckers, Tobias M.			An SK3 Channel/nWASP/Abi-1 Complex Is Involved in Early Neurogenesis	PLOS ONE			English	Article							CA2+-ACTIVATED K+ CHANNELS; ACTIVATED POTASSIUM CHANNEL; NEURAL STEM-CELLS; SMALL-CONDUCTANCE; INTERMEDIATE-CONDUCTANCE; DENDRITIC SPINES; POSTSYNAPTIC DENSITY; N-WASP; FUNCTIONAL EXPRESSION; EXCITATORY SYNAPSES	Background: The stabilization or regulated reorganization of the actin cytoskeleton is essential for cellular structure and function. Recently, we could show that the activation of the SK3-channel that represents the predominant SK-channel in neural stem cells, leads to a rapid local outgrowth of long filopodial processes. This observation indicates that the rearrangement of the actin based cytoskeleton via membrane bound SK3-channels might selectively be controlled in defined micro compartments of the cell. Principal Findings: We found two important proteins for cytoskeletal rearrangement, the Abelson interacting protein 1, Abi-1 and the neural Wiskott Aldrich Syndrome Protein, nWASP, to be in complex with SK3-channels in neural stem cells (NSCs). Moreover, this interaction is also found in spines and postsynaptic compartments of developing primary hippocampal neurons and regulates neurite outgrowth during early phases of differentiation. Overexpression of the proteins or pharmacological activation of SK3 channels induces obvious structural changes in NSCs and hippocampal neurons. In both neuronal cell systems SK3 channels and nWASP act synergistic by strongly inducing filopodial outgrowth while Abi-1 behaves antagonistic to its interaction partners. Conclusions: Our results give good evidence for a functional interplay of a trimeric complex that transforms incoming signals via SK3-channel activation into the local rearrangement of the cytoskeleton in early steps of neuronal differentiation involving nWASP and Abi-1 actin binding proteins.	[Liebau, Stefan; Steinestel, Julie; Linta, Leonhard; Schoen, Michael; Steinestel, Konrad; Proepper, Christian; Bockmann, Juergen; Schmeisser, Michael J.; Boeckers, Tobias M.] Univ Ulm, Inst Anat & Cell Biol, Ulm, Germany; [Kleger, Alexander] Univ Ulm, Dept Internal Med 1, D-7900 Ulm, Germany; [Kleger, Alexander] Inst Mol Med, Ulm, Germany; [Kleger, Alexander] Max Planck Res Grp Stem Cell Aging, Ulm, Germany; [Storch, Alexander] Tech Univ Dresden, Dept Neurol, D-8027 Dresden, Germany; [Storch, Alexander] Tech Univ Dresden, CRTD, D-8027 Dresden, Germany	Ulm University; Ulm University; Max Planck Society; Technische Universitat Dresden; Technische Universitat Dresden	Liebau, S (corresponding author), Univ Ulm, Inst Anat & Cell Biol, Ulm, Germany.	tobias.boeckers@uni-ulm.de	Liebau, Stefan/C-3374-2015; Schmeisser, Michael/S-6347-2019	Liebau, Stefan/0000-0003-0721-8187; Kleger, Alexander/0000-0003-0592-5232; Steinestel, Konrad/0000-0002-6549-9848	Deutsche Forschungsgemeinschaft (DFG) [BO1718/3-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The study was supported by the Deutsche Forschungsgemeinschaft (DFG) URL: www.dfg.de (BO1718/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes AP, 2009, ANNU REV NEUROSCI, V32, P347, DOI 10.1146/annurev.neuro.31.060407.125536; Boeckers TM, 2005, J NEUROCHEM, V92, P519, DOI 10.1111/j.1471-4159.2004.02910.x; Boeckers TM, 1999, J NEUROSCI, V19, P6506; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; CHICCHI GG, 1988, J BIOL CHEM, V263, P10192; DesMarais V, 2009, CELL MOTIL CYTOSKEL, V66, P303, DOI 10.1002/cm.20361; El-Hussein AE, 2000, SCIENCE, V290, P1364; Espinosa L, 2002, J CELL SCI, V115, P3837, DOI 10.1242/jcs.00062; Gavrilova-Ruch O, 2002, J MEMBRANE BIOL, V188, P137, DOI 10.1007/s00232-001-0181-3; GilPerotin S, 2009, ADV ANAT EMBRYOL CEL, V203, P1, DOI 10.1007/978-3-540-88719-5; GILPEROTIN S, 2009, ANAT EMBRYOL CELL BI, V203, pR9; Guan JQ, 2005, BIOCHEMISTRY-US, V44, P3166, DOI 10.1021/bi048021j; Hartig SM, 2009, J CELL SCI, V122, P2283, DOI 10.1242/jcs.041343; Hofer SB, 2010, CURR BIOL, V20, pR157, DOI 10.1016/j.cub.2009.12.040; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Howard J, 2009, ANNU REV BIOPHYS, V38, P217, DOI 10.1146/annurcv.biophys.050708.133732; Ichigotani Y, 2002, INT J MOL MED, V9, P591; Innocenti M, 2002, J CELL BIOL, V156, P125, DOI 10.1083/jcb.200108035; Insall RH, 2009, DEV CELL, V17, P310, DOI 10.1016/j.devcel.2009.08.012; Ishii TM, 1997, P NATL ACAD SCI USA, V94, P11651, DOI 10.1073/pnas.94.21.11651; Jager H, 2004, TOXICON, V43, P951, DOI 10.1016/j.toxicon.2004.03.025; Jager H, 2004, MOL PHARMACOL, V65, P630, DOI 10.1124/mol.65.3.630; Jensen BS, 2001, CURR DRUG TARGETS, V2, P401, DOI 10.2174/1389450013348173; Ji HF, 2009, EUR J NEUROSCI, V29, P1883, DOI 10.1111/j.1460-9568.2009.06735.x; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Kleger A, 2010, CIRCULATION, V122, P1823, DOI 10.1161/CIRCULATIONAHA.110.971721; Lauritzen I, 2005, EMBO REP, V6, P642, DOI 10.1038/sj.embor.7400449; Lee S. H., 2010, MOL CELLS, V29, P311, DOI DOI 10.1007/s10059-010-0053-8; Liebau S, 2007, STEM CELLS, V25, P1720, DOI 10.1634/stemcells.2006-0823; Liebau S, 2007, J NEUROCHEM, V101, P1338, DOI 10.1111/j.1471-4159.2006.04437.x; Liebau S, 2009, BIOCHEM BIOPH RES CO, V385, P460, DOI 10.1016/j.bbrc.2009.05.098; Lujan R, 2009, NAT REV NEUROSCI, V10, P475, DOI 10.1038/nrn2668; Mattson MP, 1999, J NEUROSCI RES, V57, P577, DOI 10.1002/(SICI)1097-4547(19990901)57:5<577::AID-JNR1>3.0.CO;2-H; Maurer Martin H, 2003, Proteome Sci, V1, P4, DOI 10.1186/1477-5956-1-4; Maurer MH, 2004, NEUROCHEM RES, V29, P1129, DOI 10.1023/B:NERE.0000023600.25994.11; Mejillano MR, 2004, CELL, V118, P363, DOI 10.1016/j.cell.2004.07.019; Ngo-Anh TJ, 2005, NAT NEUROSCI, V8, P642, DOI 10.1038/nn1449; Obermair GJ, 2003, EUR J NEUROSCI, V17, P721, DOI 10.1046/j.1460-9568.2003.02488.x; Padrick SB, 2010, ANNU REV BIOCHEM, V79, P707, DOI 10.1146/annurev.biochem.77.060407.135452; Pedarzani P, 2008, CELL MOL LIFE SCI, V65, P3196, DOI 10.1007/s00018-008-8216-x; Pedarzani P, 2001, J BIOL CHEM, V276, P9762, DOI 10.1074/jbc.M010001200; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Portera-Cailliau C, 2003, J NEUROSCI, V23, P7129, DOI 10.1523/JNEUROSCI.23-18-07129.2003; Proepper C, 2007, EMBO J, V26, P1397, DOI 10.1038/sj.emboj.7601569; Sah P, 2002, PROG NEUROBIOL, V66, P345, DOI 10.1016/S0301-0082(02)00004-7; Sailer CA, 2004, MOL CELL NEUROSCI, V26, P458, DOI 10.1016/j.mcn.2004.03.002; Sailer CA, 2002, J NEUROSCI, V22, P9698; Sarpal D, 2004, SYNAPSE, V53, P104, DOI 10.1002/syn.20042; Schmeisser MJ, 2009, J BIOL CHEM, V284, P29146, DOI 10.1074/jbc.M109.020628; Schwab A, 1999, CELL PHYSIOL BIOCHEM, V9, P126, DOI 10.1159/000016309; Sekerkova G, 2007, NEUROSCIENCE, V145, P116, DOI 10.1016/j.neuroscience.2006.11.061; Sekino Y, 2007, NEUROCHEM INT, V51, P92, DOI 10.1016/j.neuint.2007.04.029; Shao DM, 2009, INT J BIOCHEM CELL B, V41, P1471, DOI 10.1016/j.biocel.2009.01.016; Stocker M, 2000, MOL CELL NEUROSCI, V15, P476, DOI 10.1006/mcne.2000.0842; Strassmaier T, 2005, J BIOL CHEM, V280, P21231, DOI 10.1074/jbc.M413125200; Suzuki T, 1999, BRAIN RES, V840, P36, DOI 10.1016/S0006-8993(99)01762-X; Takenawa T, 2001, J CELL SCI, V114, P1801; Tani K, 2003, J BIOL CHEM, V278, P21685, DOI 10.1074/jbc.M301447200; Tao R, 2008, AM J PHYSIOL-CELL PH, V295, pC1409, DOI 10.1152/ajpcell.00268.2008; Tzounopoulos T, 2003, NEUROSCIENTIST, V9, P434, DOI 10.1177/1073858403259282; Vick KA, 2010, NEUROPHARMACOLOGY, V58, P650, DOI 10.1016/j.neuropharm.2009.11.008; Wegner AM, 2008, J BIOL CHEM, V283, P15912, DOI 10.1074/jbc.M801555200; Wolfart J, 2001, J NEUROSCI, V21, P3443, DOI 10.1523/JNEUROSCI.21-10-03443.2001; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758	65	40	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e18148	10.1371/journal.pone.0018148	http://dx.doi.org/10.1371/journal.pone.0018148			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464958	Green Submitted, gold, Green Published			2022-12-25	WOS:000288813900043
J	Nandagopal, S; Wu, D; Lin, F				Nandagopal, Saravanan; Wu, Dan; Lin, Francis			Combinatorial Guidance by CCR7 Ligands for T Lymphocytes Migration in Co-Existing Chemokine Fields	PLOS ONE			English	Article							IN-VIVO; LYMPHOID NEOGENESIS; NEURONAL MIGRATION; ACTIVE MOVEMENT; CELL CHEMOTAXIS; DENDRITIC CELLS; CCL21; EXPRESSION; INFLAMMATION; GRADIENTS	Chemokines mediate the trafficking and positioning of lymphocytes in lymphoid tissues that is crucial for immune surveillance and immune responses. In particular, a CCR7 ligand, CCL21, plays important roles in recruiting T cells to secondary lymphoid tissues (SLT). Furthermore, CCL21 together with another CCR7 ligand, CCL19, direct the navigation and compartmentation of T cells within SLT. However, the distinct roles of these two chemokines for regulating cell trafficking and positioning are not clear. In this study, we explore the effect of co-existing CCL19 and CCL21 concentration fields on guiding T cell migration. Using microfluidic devices that can configure single and superimposed chemokine fields we show that under physiological gradient conditions, human peripheral blood T cells chemotax to CCL21 but not CCL19. Furthermore, T cells migrate away from the CCL19 gradient in a uniform background of CCL21. This repulsive migratory response is predicted by mathematical modeling based on the competition of CCL19 and CCL21 for CCR7 signaling and the differential ability of the two chemokines for desensitizing CCR7. These results suggest a new combinatorial guiding mechanism by CCL19 and CCL21 for the migration and trafficking of CCR7 expressing leukocytes.	[Nandagopal, Saravanan; Wu, Dan; Lin, Francis] Univ Manitoba, Dept Phys & Astron, Winnipeg, MB, Canada; [Nandagopal, Saravanan; Lin, Francis] Univ Manitoba, Dept Biosyst Engn, Winnipeg, MB, Canada; [Lin, Francis] Univ Manitoba, Dept Biol Sci, Winnipeg, MB, Canada; [Lin, Francis] Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba; University of Manitoba; University of Manitoba	Nandagopal, S (corresponding author), Univ Manitoba, Dept Phys & Astron, Winnipeg, MB, Canada.	flin@physics.umanitoba.ca		Lin, Francis/0000-0003-1736-193X; Andalur Nandagopal, Saravanan/0000-0002-1787-3356	Natural Sciences and Engineering Research Council of Canada (NSERC); Manitoba Health Research Council (MHRC); University of Manitoba	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Manitoba Health Research Council (MHRC); University of Manitoba	This study is supported by grants from Natural Sciences and Engineering Research Council of Canada (NSERC), Manitoba Health Research Council (MHRC) and the University of Manitoba. The authors would like to acknowledge the products and services provided by CMC Microsystems (www.cmc.ca) that facilitated this research. CMC is a non-profit corporation funded by NSERC, with matching contributions from industries. S.N. thanks MHRC for a fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayala R, 2007, CELL, V128, P29, DOI 10.1016/j.cell.2006.12.021; BEHAR TN, 1994, J NEUROSCI, V14, P29; Britschgi MR, 2010, EUR J IMMUNOL, V40, P1266, DOI 10.1002/eji.200939921; Britschgi MR, 2008, J IMMUNOL, V181, P7681, DOI 10.4049/jimmunol.181.11.7681; Brown MN, 2010, J IMMUNOL, V185, P4873, DOI 10.4049/jimmunol.1000676; Carlsen HS, 2005, BLOOD, V106, P444, DOI 10.1182/blood-2004-11-4353; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Debes GF, 2005, NAT IMMUNOL, V6, P889, DOI 10.1038/ni1238; Dekker LV, 2000, SCIENCE, V287, P982, DOI 10.1126/science.287.5455.982; Dustin ML, 2008, IMMUNITY, V28, P15, DOI 10.1016/j.immuni.2008.01.001; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Foxman EF, 1997, J CELL BIOL, V139, P1349, DOI 10.1083/jcb.139.5.1349; Foxman EF, 1999, J CELL BIOL, V147, P577, DOI 10.1083/jcb.147.3.577; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; Hatten ME, 2002, SCIENCE, V297, P1660, DOI 10.1126/science.1074572; Knapp DM, 1999, EXP CELL RES, V247, P543, DOI 10.1006/excr.1998.4364; Kohout TA, 2004, J BIOL CHEM, V279, P23214, DOI 10.1074/jbc.M402125200; Kunkel EJ, 2003, NAT REV IMMUNOL, V3, P822, DOI 10.1038/nri1203; Kunkel EJ, 2002, IMMUNITY, V16, P1, DOI 10.1016/S1074-7613(01)00261-8; LAUFFENBURGER DA, 1981, J IMMUNOL METHODS, V40, P45, DOI 10.1016/0022-1759(81)90079-X; LAUFFENBURGER DA, 1982, CELL BIOPHYS, V4, P177, DOI 10.1007/BF02918312; Lin F, 2008, J IMMUNOL, V181, P2465, DOI 10.4049/jimmunol.181.4.2465; Lin F, 2006, LAB CHIP, V6, P1462, DOI 10.1039/b607071j; Lin F, 2008, J IMMUNOL, V181, P8335, DOI 10.4049/jimmunol.181.12.8335; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Luther SA, 2000, P NATL ACAD SCI USA, V97, P12694, DOI 10.1073/pnas.97.23.12694; Luther SA, 2002, J IMMUNOL, V169, P424, DOI 10.4049/jimmunol.169.1.424; Manzo A, 2007, AM J PATHOL, V171, P1549, DOI 10.2353/ajpath.2007.061275; Mathias JR, 2006, J LEUKOCYTE BIOL, V80, P1281, DOI 10.1189/jlb.0506346; Miller MJ, 2003, P NATL ACAD SCI USA, V100, P2604, DOI 10.1073/pnas.2628040100; Ngo VN, 1998, J EXP MED, V188, P181, DOI 10.1084/jem.188.1.181; Otero C, 2006, J IMMUNOL, V177, P2314, DOI 10.4049/jimmunol.177.4.2314; Ott TR, 2006, BIOCHEM BIOPH RES CO, V348, P1089, DOI 10.1016/j.bbrc.2006.07.165; Poznansky MC, 2002, J CLIN INVEST, V109, P1101, DOI 10.1172/JCI200213853; Raffaghello L, 2009, J LEUKOCYTE BIOL, V86, P1271, DOI 10.1189/jlb.0409283; Schumann K, 2010, IMMUNITY, V32, P703, DOI 10.1016/j.immuni.2010.04.017; Shankaran H, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-48; Tharp WG, 2006, J LEUKOCYTE BIOL, V79, P539, DOI 10.1189/jlb.0905516; TRANQUILLO RT, 1988, J CELL BIOL, V106, P303, DOI 10.1083/jcb.106.2.303; Vianello F, 2005, J MOL MED, V83, P752, DOI 10.1007/s00109-005-0675-z; Weninger W, 2003, SEMIN IMMUNOL, V15, P257, DOI 10.1016/j.smim.2003.08.007; Worbs T, 2007, J EXP MED, V204, P489, DOI 10.1084/jem.20061706	43	52	54	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e18183	10.1371/journal.pone.0018183	http://dx.doi.org/10.1371/journal.pone.0018183			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464944	Green Published, gold, Green Submitted			2022-12-25	WOS:000288813900048
J	Morris, MJ; Liu, D; Weaver, LM; Board, PG; Casarotto, MG				Morris, Melanie J.; Liu, Dan; Weaver, Llara M.; Board, Philip G.; Casarotto, Marco G.			A Structural Basis for Cellular Uptake of GST-Fold Proteins	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; CRYSTAL-STRUCTURE; CHANNEL; PORE; MEMBRANES; TOXIN; CELLS; INTERMEDIATE; EXPRESSION; STABILITY	It has recently emerged that glutathione transferase enzymes (GSTs) and other structurally related molecules can be translocated from the external medium into many different cell types. In this study we aim to explore in detail, the structural features that govern cell translocation and by dissecting the human GST enzyme GSTM2-2 we quantatively demonstrate that the alpha-helical C-terminal domain (GST-C) is responsible for this property. Attempts to further examine the constituent helices within GST-C resulted in a reduction in cell translocation efficiency, indicating that the intrinsic GST-C domain structure is necessary for maximal cell translocation capacity. In particular, it was noted that the alpha-6 helix of GST-C plays a stabilising role in the fold of this domain. By destabilising the conformation of GST-C, an increase in cell translocation efficiency of up to similar to 2-fold was observed. The structural stability profiles of these protein constructs have been investigated by circular dichroism and differential scanning fluorimetry measurements and found to impact upon their cell translocation efficiency. These experiments suggest that the globular, helical domain in the 'GST-fold' structural motif plays a role in influencing cellular uptake, and that changes that affect the conformational stability of GST-C can significantly influence cell translocation efficiency.	[Morris, Melanie J.; Liu, Dan; Weaver, Llara M.; Board, Philip G.; Casarotto, Marco G.] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia	Australian National University; John Curtin School of Medical Research	Morris, MJ (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia.	Marco.Casarotto@anu.edu.au	Casarotto, Marco/D-8704-2011	Casarotto, Marco/0000-0002-0571-7671	Australian Research Council [DP0558315]	Australian Research Council(Australian Research Council)	This work was supported by Grant DP0558315 Australian Research Council (http://www.arc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Branden C., 1999, INTRO PROTEIN STRUCT; Catanzariti AM, 2004, PROTEIN SCI, V13, P1331, DOI 10.1110/ps.04618904; CHOE S, 1992, NATURE, V357, P216, DOI 10.1038/357216a0; Cromer BA, 2002, EUR BIOPHYS J BIOPHY, V31, P356, DOI 10.1007/s00249-002-0219-1; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Dulhunty A, 2001, J BIOL CHEM, V276, P3319, DOI 10.1074/jbc.M007874200; Elkins P, 1997, STRUCTURE, V5, P443, DOI 10.1016/S0969-2126(97)00200-1; Elmquist A, 2001, EXP CELL RES, V269, P237, DOI 10.1006/excr.2001.5316; Gonzalez MR, 2008, CELL MOL LIFE SCI, V65, P493, DOI 10.1007/s00018-007-7434-y; Grimsley JK, 1997, BIOCHEMISTRY-US, V36, P14366, DOI 10.1021/bi971596e; Hayes JD, 1999, FREE RADICAL RES, V31, P273, DOI 10.1080/10715769900300851; Knubovets T, 1999, P NATL ACAD SCI USA, V96, P1262, DOI 10.1073/pnas.96.4.1262; Lakey JH, 2001, CURR TOP MICROBIOL, V257, P131; Le Trong I, 2002, PROTEINS, V48, P618, DOI 10.1002/prot.10162; Mannervik B, 2005, METHOD ENZYMOL, V401, P1, DOI 10.1016/S0076-6879(05)01001-3; Minn AJ, 1997, NATURE, V385, P353, DOI 10.1038/385353a0; Morris MJ, 2009, BBA-BIOMEMBRANES, V1788, P676, DOI 10.1016/j.bbamem.2008.10.018; Namiki S, 2003, BIOCHEM BIOPH RES CO, V305, P592, DOI 10.1016/S0006-291X(03)00807-6; NEET KE, 1994, PROTEIN SCI, V3, P2167, DOI 10.1002/pro.5560031202; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; ORLANDI PA, 1993, J BIOL CHEM, V268, P12010; Parker MW, 2005, PROG BIOPHYS MOL BIO, V88, P91, DOI 10.1016/j.pbiomolbio.2004.01.009; ROSS VL, 1993, BIOCHEM J, V294, P373, DOI 10.1042/bj2940373; Schendel SL, 1997, P NATL ACAD SCI USA, V94, P5113, DOI 10.1073/pnas.94.10.5113; Schendel SL, 1998, CELL DEATH DIFFER, V5, P372, DOI 10.1038/sj.cdd.4400365; Shield AJ, 2006, BIOCHEM BIOPH RES CO, V347, P859, DOI 10.1016/j.bbrc.2006.06.189; Szpikowska BK, 1996, ARCH BIOCHEM BIOPHYS, V335, P173, DOI 10.1006/abbi.1996.0495; Tetlow N, 2004, PHARMACOGENETICS, V14, P359, DOI 10.1097/00008571-200406000-00005; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; WEST MA, 1989, J CELL BIOL, V109, P2731, DOI 10.1083/jcb.109.6.2731; Zhou HN, 2011, J BIOL CHEM, V286, P4271, DOI 10.1074/jbc.M110.197822	32	9	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2011	6	3							e17864	10.1371/journal.pone.0017864	http://dx.doi.org/10.1371/journal.pone.0017864			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740RG	21455499	Green Published, gold			2022-12-25	WOS:000288811500011
J	Elsawa, SF; Almada, LL; Ziesmer, SC; Novak, AJ; Witzig, TE; Ansell, SM; Fernandez-Zapico, ME				Elsawa, Sherine F.; Almada, Luciana L.; Ziesmer, Steven C.; Novak, Anne J.; Witzig, Thomas E.; Ansell, Stephen M.; Fernandez-Zapico, Martin E.			GLI2 Transcription Factor Mediates Cytokine Cross-talk in the Tumor Microenvironment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEDGEHOG SIGNALING PATHWAY; MESENCHYMAL STROMAL CELLS; SCID-HU MICE; MYELOMA CELLS; MULTIPLE-MYELOMA; IN-VIVO; WALDENSTROMS MACROGLOBULINEMIA; CANCER CELLS; IMMUNOGLOBULIN SECRETION; THERAPEUTIC TARGET	Tumor cells interact with their surrounding microenvironment to survive and persist within the host. Cytokines play a key role in regulating this crosstalk between malignant cells and surrounding cells in the microenvironment. Although this phenomenon is clearly established, the molecular mechanisms mediating this cellular event remain elusive. Here, using as a model bone marrow stromal cells, we describe a novel signaling mechanism initiated by CCL5 in these cells leading to up-regulation of immunoglobulin secretion by malignant B cells. CCL5 increases IL-6 expression and secretion in bone marrow stromal cells. IL-6 in turn induces Ig secretion by malignant B cells. Analysis of the mechanism reveals that CCL5 signaling induces GLI2 through a PI3K-AKT-I kappa B alpha-p65 pathway and requires GLI2 transcriptional activity to modulate IL-6 expression and Ig secretion in vitro and in vivo. Together, these results identify a novel signaling pathway mediating the stromal-cancer cell interactions, leading to increased Ig production by malignant cells.	[Elsawa, Sherine F.; Almada, Luciana L.; Fernandez-Zapico, Martin E.] Mayo Clin, Schulze Ctr Novel Therapeut, Div Oncol Res, Rochester, MN 55905 USA; [Ziesmer, Steven C.; Novak, Anne J.; Witzig, Thomas E.; Ansell, Stephen M.] Mayo Clin, Div Hematol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Fernandez-Zapico, ME (corresponding author), Mayo Clin, Schulze Ctr Novel Therapeut, Div Oncol Res, Rochester, MN 55905 USA.	fernandezzapico.martin@mayo.edu		Elsawa, Sherine/0000-0002-3917-3078	National Institutes of Health [T32 HL67742, CA92104, CA97274]; International Waldenstrom's Macroglobulinemia Foundation; Predolin Foundation; Schulze Center for Novel Therapeutics; Mayo Clinic Cancer Center; Mayo Clinic Pancreatic [P50 CA102701]; Mayo Clinic Center for Cell Signaling in Gastroenterology [P30 DK084567]; Mayo/Iowa Lymphoma [P50 CA097274]; Leukemia and Lymphoma Society; NATIONAL CANCER INSTITUTE [P50CA102701, P50CA097274, R01CA092104] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL067742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK084567] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Waldenstrom's Macroglobulinemia Foundation; Predolin Foundation; Schulze Center for Novel Therapeutics; Mayo Clinic Cancer Center; Mayo Clinic Pancreatic; Mayo Clinic Center for Cell Signaling in Gastroenterology; Mayo/Iowa Lymphoma; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants T32 HL67742 (to S. F. E.), CA92104, and CA97274. This work was also supported by a grant from the International Waldenstrom's Macroglobulinemia Foundation (to S. M. A.) and the Predolin Foundation (to T. E. W.) M. E. F.-Z. was supported by the Schulze Center for Novel Therapeutics, the Mayo Clinic Cancer Center, Mayo Clinic Pancreatic SPORE Grant P50 CA102701, Mayo Clinic Center for Cell Signaling in Gastroenterology Grant P30 DK084567, Mayo/Iowa Lymphoma SPORE Grant P50 CA097274, and the Leukemia and Lymphoma Society Translational Research Program.	Akira S, 1992, Semin Cancer Biol, V3, P17; Altaba AR, 2003, CURR OPIN GENET DEV, V13, P513, DOI 10.1016/j.gde.2003.08.005; Arendt BK, 2002, LEUKEMIA, V16, P2142, DOI 10.1038/sj.leu.2402714; Badache A, 2001, CANCER RES, V61, P383; Berghuis D, 2011, J PATHOL, V223, P347, DOI 10.1002/path.2819; Bergsagel FL, 2008, BLOOD, V112, P917, DOI 10.1182/blood-2008-05-154831; Bryant VL, 2007, J IMMUNOL, V179, P8180, DOI 10.4049/jimmunol.179.12.8180; Burger JA, 2000, BLOOD, V96, P2655; Burger JA, 2009, BLOOD, V114, P3367, DOI 10.1182/blood-2009-06-225326; Chauhan D, 2009, CANCER CELL, V16, P309, DOI 10.1016/j.ccr.2009.08.019; Chen M, 2009, CELL CYCLE, V8, P149, DOI 10.4161/cc.8.1.7532; di Magliano MP, 2006, GENE DEV, V20, P3161, DOI 10.1101/gad.1470806; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; Drexler HG, 2008, LEUKEMIA RES, V32, P1669, DOI 10.1016/j.leukres.2008.04.016; Eliopoulos N, 2010, AM J PHYSIOL-RENAL, V299, pF1288, DOI 10.1152/ajprenal.00671.2009; Elsawa SF, 2009, CLIN LYMPHOMA MYELOM, V9, P43, DOI 10.3816/CLM.2009.n.010; Fernandez-Zapico ME, 2005, CANCER CELL, V7, P39, DOI 10.1016/j.ccr.2004.11.024; Forst B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010374; French JD, 2003, J IMMUNOL, V170, P3717, DOI 10.4049/jimmunol.170.7.3717; French JD, 2002, LEUKEMIA, V16, P1189, DOI 10.1038/sj.leu.2402516; GARTNER S, 1980, P NATL ACAD SCI-BIOL, V77, P4756, DOI 10.1073/pnas.77.8.4756; GOLDSTEIN H, 1993, J IMMUNOL, V151, P6701; Gunn WG, 2006, STEM CELLS, V24, P986, DOI 10.1634/stemcells.2005-0220; Hegde GV, 2008, MOL CANCER RES, V6, P1928, DOI 10.1158/1541-7786.MCR-08-0142; Hideshima T, 2009, BLOOD, V113, P5228, DOI 10.1182/blood-2008-06-161505; HIRANO T, 1991, INT J CELL CLONING, V9, P166, DOI 10.1002/stem.5530090303; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Jiang J, 2006, CELL CYCLE, V5, P2457, DOI 10.4161/cc.5.21.3406; Kishimoto T, 2005, ANNU REV IMMUNOL, V23, P1, DOI 10.1146/annurev.immunol.23.021704.115806; KISHIMOTO T, 1989, BLOOD, V74, P1, DOI 10.1182/blood.V74.1.1.1; Lagneaux L, 1998, BLOOD, V91, P2387, DOI 10.1182/blood.V91.7.2387.2387_2387_2396; Laner-Plamberger S, 2009, ONCOGENE, V28, P1639, DOI 10.1038/onc.2009.10; Lau J, 2006, CELL MOL LIFE SCI, V63, P642, DOI 10.1007/s00018-005-5357-z; Lauth M, 2007, CELL CYCLE, V6, P2458, DOI 10.4161/cc.6.20.4808; Leleu X, 2007, BLOOD, V110, P4417, DOI 10.1182/blood-2007-05-092098; Li J, 2011, MOL THER, V19, P650, DOI 10.1038/mt.2010.312; Lis R, 2011, INT J CANCER, V128, P715, DOI 10.1002/ijc.25619; Lu C, 1996, CLIN CANCER RES, V2, P1417; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; Mill P, 2003, GENE DEV, V17, P282, DOI 10.1101/gad.1038103; Mishra P, 2011, J LEUKOCYTE BIOL, V89, P31, DOI 10.1189/jlb.0310182; Mitsiades CS, 2004, CANCER CELL, V6, P439, DOI 10.1016/j.ccr.2004.10.020; Moreau AS, 2007, BLOOD, V109, P4964, DOI 10.1182/blood-2006-10-054577; Mullor JL, 2002, TRENDS CELL BIOL, V12, P562, DOI 10.1016/S0962-8924(02)02405-4; Podar K, 2009, LEUKEMIA, V23, P10, DOI 10.1038/leu.2008.259; Rohatgi R, 2007, NAT CELL BIOL, V9, P1005, DOI 10.1038/ncb435; Ruiz i Altaba A, 2007, TRENDS CELL BIOL, V17, P438, DOI 10.1016/j.tcb.2007.06.007; Santos DD, 2007, EXP HEMATOL, V35, P1366, DOI 10.1016/j.exphem.2007.05.022; Schnidar H, 2009, CANCER RES, V69, P1284, DOI 10.1158/0008-5472.CAN-08-2331; Secchiero P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011140; Seshi B, 2000, BLOOD CELL MOL DIS, V26, P234, DOI 10.1006/bcmd.2000.0301; Sheng H, 2002, CANCER RES, V62, P5308; Shiao RT, 1996, LEUKEMIA LYMPHOMA, V21, P293, DOI 10.3109/10428199209067610; TAKAHASHI S, 1995, ENDOCRINOLOGY, V136, P1441, DOI 10.1210/en.136.4.1441; Tredan O, 2007, J NATL CANCER I, V99, P1441, DOI 10.1093/jnci/djm135; Villanueva J, 2008, CURR ONCOL REP, V10, P439, DOI 10.1007/s11912-008-0067-y; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Xie KP, 2003, CANCER CELL, V4, P245, DOI 10.1016/S1535-6108(03)00246-0; Yaccoby S, 1998, BLOOD, V92, P2908, DOI 10.1182/blood.V92.8.2908.420a32_2908_2913; Yanez R, 2010, EXP CELL RES, V316, P3109, DOI 10.1016/j.yexcr.2010.08.008; Zardawi SJ, 2009, HISTOL HISTOPATHOL, V24, P385, DOI 10.14670/HH-24.385	61	31	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21524	21534		10.1074/jbc.M111.234146	http://dx.doi.org/10.1074/jbc.M111.234146			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21454528	Green Published, hybrid			2022-12-25	WOS:000291464700050
J	Tarallo, V; Lepore, L; Marcellini, M; Dal Piaz, F; Tudisco, L; Ponticelli, S; Lund, FW; Roepstorff, P; Orlandi, A; Pisano, C; De Tommasi, N; De Falco, S				Tarallo, Valeria; Lepore, Laura; Marcellini, Marcella; Dal Piaz, Fabrizio; Tudisco, Laura; Ponticelli, Salvatore; Lund, Frederik Wendelboe; Roepstorff, Peter; Orlandi, Augusto; Pisano, Claudio; De Tommasi, Nunziatina; De Falco, Sandro			The Biflavonoid Amentoflavone Inhibits Neovascularization Preventing the Activity of Proangiogenic Vascular Endothelial Growth Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER CHEMOPREVENTION; MACULAR DEGENERATION; TUMOR ANGIOGENESIS; FACTOR RECEPTOR-1; CRYSTAL-STRUCTURE; VEGF FAMILY; PATHWAYS; APIGENIN; THERAPY; PROTEIN	The proangiogenic members of VEGF family and related receptors play a central role in the modulation of pathological angiogenesis. Recent insights indicate that, due to the strict biochemical and functional relationship between VEGFs and related receptors, the development of a new generation of agents able to target contemporarily more than one member of VEGFs might amplify the antiangiogenic response representing an advantage in term of therapeutic outcome. To identify molecules that are able to prevent the interaction of VEGFs with related receptors, we have screened small molecule collections consisting of > 100 plant extracts. Here, we report the isolation and identification from an extract of the Malian plant Chrozophora senegalensis of the biflavonoid amentoflavone as an antiangiogenic bioactive molecule. Amentoflavone can to bind VEGFs preventing the interaction and phosphorylation of VEGF receptor 1 and 2 (VEGFR-1, VEGFR-2) and to inhibit endothelial cell migration and capillary-like tube formation induced by VEGF-A or placental growth factor 1 (PlGF-1) at low mu M concentration. In vivo, amentoflavone is able to inhibit VEGF-A-induced chorioallantoic membrane neovascularization as well as tumor growth and associated neovascularization, as assessed in orthotropic melanoma and xenograft colon carcinoma models. In addition structural studies performed on the amentoflavone. PlGF-1 complex have provided evidence that this biflavonoid effectively interacts with the growth factor area crucial for VEGFR-1 receptor recognition. In conclusion, our results demonstrate that amentoflavone represents an interesting new antiangiogenic molecule that is able to prevent the activity of proangiogenic VEGF family members and that the biflavonoid structure is a new chemical scaffold to develop powerful new antiangiogenic molecules.	[Lepore, Laura; Dal Piaz, Fabrizio; De Tommasi, Nunziatina] Univ Salerno, Dept Pharmaceut Sci, I-84084 Salerno, Italy; [Tarallo, Valeria; Tudisco, Laura; Ponticelli, Salvatore; De Falco, Sandro] CNR, Angiogenesis Lab, Inst Genet & Biophys Adriano Buzzati Traverso, I-80131 Naples, Italy; [Tarallo, Valeria; Tudisco, Laura; Ponticelli, Salvatore; De Falco, Sandro] Inst Genet & Biophys, Stem Cell Fate Lab, I-80131 Naples, Italy; [Marcellini, Marcella; Pisano, Claudio] Sigma Tau Pharmaceut Co, Ind Farmaceut Riunite, Res & Dev Oncol Area, I-00040 Rome, Italy; [Lund, Frederik Wendelboe; Roepstorff, Peter] Univ So Denmark, Dept Biochem & Mol Biol, DK-5230 Odense, Denmark; [Orlandi, Augusto] Univ Roma Tor Vergata, Dept Biopathol & Image Diagnost, Inst Pathol Anat, I-00133 Rome, Italy	University of Salerno; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Leadiant Biosciences; University of Southern Denmark; University of Rome Tor Vergata	Dal Piaz, F (corresponding author), Univ Salerno, Dept Pharmaceut Sci, I-84084 Salerno, Italy.	fdalpiaz@unisa.it; defalco@igb.cnr.it	Orlandi, Augusto/AHE-8753-2022; Dal Piaz, Fabrizio/D-1843-2010; De Falco, Sandro/P-6724-2015; De Tommasi, Nunziatina/A-7768-2011	Dal Piaz, Fabrizio/0000-0002-8643-5018; De Tommasi, Nunziatina/0000-0003-1707-4156; De Falco, Sandro/0000-0002-6501-1697; orlandi, augusto/0000-0001-7202-5854; Tarallo, Valeria/0000-0002-6920-4402; Lund, Frederik Wendelboe/0000-0002-8261-0309; pisano, claudio/0000-0001-8624-2980	Associazione Italiana Ricerca sul Cancro [4840]; Telethon Italy [GGP08062]	Associazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Telethon Italy(Fondazione Telethon)	This work was supported by Associazione Italiana Ricerca sul Cancro Grant 4840 and Telethon Italy Grant GGP08062 (to S. D. F).	Albini A, 2007, CLIN CANCER RES, V13, P4320, DOI 10.1158/1078-0432.CCR-07-0069; Cao YH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.259re1; Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; CHOLBI MR, 1991, EXPERIENTIA, V47, P195, DOI 10.1007/BF01945426; Christinger HW, 2004, J BIOL CHEM, V279, P10382, DOI 10.1074/jbc.M313237200; Clauss M, 1996, J BIOL CHEM, V271, P17629, DOI 10.1074/jbc.271.30.17629; Dal Piaz F, 2009, J MED CHEM, V52, P3814, DOI 10.1021/jm801637f; De Falco S, 2002, TRENDS CARDIOVAS MED, V12, P241, DOI 10.1016/S1050-1738(02)00168-8; Ellis LM, 2008, NAT REV CANCER, V8, P579, DOI 10.1038/nrc2403; Errico M, 2004, J BIOL CHEM, V279, P43929, DOI 10.1074/jbc.M401418200; Fang J, 2005, FASEB J, V19, P342, DOI 10.1096/fj.04-2175com; Ferrara N, 2005, BIOCHEM BIOPH RES CO, V333, P328, DOI 10.1016/j.bbrc.2005.05.132; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Fischer C, 2007, CELL, V131, P463, DOI 10.1016/j.cell.2007.08.038; Fischer C, 2008, NAT REV CANCER, V8, P942, DOI 10.1038/nrc2524; Gigante B, 2006, FASEB J, V20, P970, DOI 10.1096/fj.05-4481fje; Gillet A, 2005, STRUCTURE, V13, P483, DOI 10.1016/j.str.2005.01.009; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; Guruvayoorappan C, 2008, BIOCHEMISTRY-MOSCOW+, V73, P209, DOI 10.1134/S0006297908020132; Iyer S, 2001, J BIOL CHEM, V276, P12153, DOI 10.1074/jbc.M008055200; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kim HK, 1998, ARCH PHARM RES, V21, P406, DOI 10.1007/BF02974634; Kim HP, 2008, ARCH PHARM RES, V31, P265, DOI 10.1007/s12272-001-1151-3; Lengauer T, 1996, CURR OPIN STRUC BIOL, V6, P402, DOI 10.1016/S0959-440X(96)80061-3; Lin YM, 1999, PLANTA MED, V65, P120, DOI 10.1055/s-1999-13971; Luttun A, 2002, NAT MED, V8, P831, DOI 10.1038/nm731; Ma SC, 2001, BIOL PHARM BULL, V24, P311, DOI 10.1248/bpb.24.311; MAGLIONE D, 1993, ONCOGENE, V8, P925; Marcellini M, 2006, AM J PATHOL, V169, P643, DOI 10.2353/ajpath.2006.051041; Newman DJ, 2003, J NAT PROD, V66, P1022, DOI 10.1021/np030096l; Osada M, 2004, FEBS LETT, V575, P59, DOI 10.1016/j.febslet.2004.08.036; Patel D, 2007, INT J ONCOL, V30, P233; Ponticelli S, 2008, PLANTA MED, V74, P401, DOI 10.1055/s-2008-1034346; Ponticelli S, 2008, J BIOL CHEM, V283, P34250, DOI 10.1074/jbc.M806607200; Rakic JM, 2003, INVEST OPHTH VIS SCI, V44, P3186, DOI 10.1167/iovs.02-1092; Ramos S, 2008, MOL NUTR FOOD RES, V52, P507, DOI 10.1002/mnfr.200700326; Renzone Giovanni, 2007, Current Proteomics, V4, P1; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Sawano A, 2001, BLOOD, V97, P785, DOI 10.1182/blood.V97.3.785; Tarallo V, 2010, CANCER RES, V70, P1804, DOI 10.1158/0008-5472.CAN-09-2609; Van de Veire S, 2010, CELL, V141, P178, DOI 10.1016/j.cell.2010.02.039; van Dijk ADJ, 2005, FEBS J, V272, P293, DOI 10.1111/j.1742-4658.2004.04473.x; Wu Y, 2006, CLIN CANCER RES, V12, P6573, DOI 10.1158/1078-0432.CCR-06-0831; Yang CS, 2001, ANNU REV NUTR, V21, P381, DOI 10.1146/annurev.nutr.21.1.381	45	32	33	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19641	19651		10.1074/jbc.M110.186239	http://dx.doi.org/10.1074/jbc.M110.186239			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21471210	Green Published, hybrid			2022-12-25	WOS:000291027700047
J	Tominaga, T; Abe, H; Ueda, O; Goto, C; Nakahara, K; Murakami, T; Matsubara, T; Mima, A; Nagai, K; Araoka, T; Kishi, S; Fukushima, N; Jishage, K; Doi, T				Tominaga, Tatsuya; Abe, Hideharu; Ueda, Otoya; Goto, Chisato; Nakahara, Kunihiko; Murakami, Taichi; Matsubara, Takeshi; Mima, Akira; Nagai, Kojiro; Araoka, Toshikazu; Kishi, Seiji; Fukushima, Naoshi; Jishage, Kou-ichi; Doi, Toshio			Activation of Bone Morphogenetic Protein 4 Signaling Leads to Glomerulosclerosis That Mimics Diabetic Nephropathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCATION END-PRODUCTS; MESANGIAL MATRIX EXPANSION; GROWTH-FACTOR-BETA; GLOMERULAR BASEMENT-MEMBRANE; GENE-EXPRESSION; ANGIOTENSIN-II; IV COLLAGEN; RECEPTOR; MOUSE; CELLS	Diabetic nephropathy (DN) is the most common cause of chronic kidney disease. We have previously reported that Smad1 transcriptionally regulates the expression of extracellular matrix (ECM) proteins in DN. However, little is known about the regulatory mechanisms that induce and activate Smad1. Here, bone morphogenetic protein 4 (Bmp4) was found to up-regulate the expression of Smad1 in mesangial cells and subsequently to phosphorylate Smad1 downstream of the advanced glycation end product-receptor for advanced glycation end product signaling pathway. Moreover, Bmp4 utilized Alk3 and affected the activation of Smad1 and Col4 expressions in mesangial cells. In the diabetic mouse, Bmp4 was remarkably activated in the glomeruli, and the mesangial area was expanded. To elucidate the direct function of Bmp4 action in the kidneys, we generated transgenic mice inducible for the expression of Bmp4. Tamoxifen treatment dramatically induced the expression of Bmp4, especially in the glomeruli of the mice. Notably, in the nondiabetic condition, the mice exhibited not only an expansion of the mesangial area and thickening of the basement membrane but also remarkable albuminuria, which are consistent with the distinct glomerular injuries in DN. ECM protein overexpression and activation of Smad1 in the glomeruli were also observed in the mice. The mesangial expansion in the mice was significantly correlated with albuminuria. Furthermore, the heterozygous Bmp4 knock-out mice inhibited the glomerular injuries compared with wild type mice in diabetic conditions. Here, we show that BMP4 may act as an upstream regulatory molecule for the process of ECM accumulation in DN and thereby reveals a new aspect of the molecular mechanisms involved in DN.	[Tominaga, Tatsuya; Abe, Hideharu; Murakami, Taichi; Mima, Akira; Nagai, Kojiro; Araoka, Toshikazu; Kishi, Seiji; Doi, Toshio] Univ Tokushima, Hlth Biosci Inst, Grad Sch Med, Dept Nephrol, Tokushima 7708503, Japan; [Ueda, Otoya; Goto, Chisato; Jishage, Kou-ichi] Chugai Res Inst Med Sci Inc, Shizuoka 4128513, Japan; [Nakahara, Kunihiko] Hubit Genomix Inc, Tokyo 1020092, Japan; [Fukushima, Naoshi] Chugai Pharmaceut Co Ltd, Tokyo 1030092, Japan; [Matsubara, Takeshi] Kyoto Univ, Grad Sch Med, Dept Nephrol, Kyoto 6068507, Japan	Tokushima University; Chugai Pharmaceutical Co., Ltd.; Chugai Research Institute for Medical Science, Inc.; Chugai Pharmaceutical Co., Ltd.; Roche Holding; Kyoto University	Doi, T (corresponding author), Univ Tokushima, Hlth Biosci Inst, Grad Sch Med, Dept Nephrol, Tokushima 7708503, Japan.	doi@clin.med.tokushima-u.ac.jp			Japan Society for the Promotion of Science [21591033, 19590973, 22390169]; Japan Science and Technology Agency [AS2115050G]; Mitsui Sumitomo Welfare Foundation; Kidney Foundation of Japan [JKFB09-41]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Mitsui Sumitomo Welfare Foundation; Kidney Foundation of Japan	This work was supported by Grants-in-aid for Scientific Research of the Japan Society for the Promotion of Science 21591033, 19590973, and 22390169, Japan Science and Technology Agency Grant AS2115050G, the Mitsui Sumitomo Welfare Foundation, and The Kidney Foundation of Japan Grant JKFB09-41.	Abe H, 2004, J BIOL CHEM, V279, P14201, DOI 10.1074/jbc.M310427200; Akagi Y, 1997, KIDNEY INT, V51, P1265, DOI 10.1038/ki.1997.172; [Anonymous], 1993, NEW ENGL J MED, V329, P977; BEISSWENGER PJ, 1970, SCIENCE, V168, P596, DOI 10.1126/science.168.3931.596; Bohlender JM, 2005, AM J PHYSIOL-RENAL, V289, pF645, DOI 10.1152/ajprenal.00398.2004; DAVIES M, 1994, KIDNEY INT, V45, P320, DOI 10.1038/ki.1994.41; DOI T, 1992, P NATL ACAD SCI USA, V89, P2873, DOI 10.1073/pnas.89.7.2873; Fogo AB, 2000, AM J KIDNEY DIS, V35, P179, DOI 10.1016/S0272-6386(00)70324-6; Fujimoto M, 2003, BIOCHEM BIOPH RES CO, V305, P1002, DOI 10.1016/S0006-291X(03)00885-4; Fukami K, 2004, KIDNEY INT, V66, P2137, DOI 10.1111/j.1523-1755.2004.66004.x; HASSLACHER C, 1984, DIABETOLOGIA, V26, P150; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Huang SX, 2000, GENE, V258, P43, DOI 10.1016/S0378-1119(00)00396-6; Iehara N, 1996, KIDNEY INT, V50, P1166, DOI 10.1038/ki.1996.424; Kanwar YS, 2008, EXP BIOL MED, V233, P4, DOI 10.3181/0705-MR-134; KANWAR YS, 1983, P NATL ACAD SCI-BIOL, V80, P2272, DOI 10.1073/pnas.80.8.2272; Lander HM, 1997, J BIOL CHEM, V272, P17810, DOI 10.1074/jbc.272.28.17810; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; Mason RM, 2003, J AM SOC NEPHROL, V14, P1358, DOI 10.1097/01.ASN.0000065640.77499.D7; Massague Joan, 1994, Trends in Cell Biology, V4, P172, DOI 10.1016/0962-8924(94)90202-X; Matsubara T, 2006, LAB INVEST, V86, P357, DOI 10.1038/labinvest.3700400; McCauley DW, 2004, EVOL DEV, V6, P411, DOI 10.1111/j.1525-142X.2004.04054.x; Mima A, 2008, DIABETES, V57, P1712, DOI 10.2337/db07-1726; Miyazaki Y, 2006, BIOCHEM BIOPH RES CO, V340, P681, DOI 10.1016/j.bbrc.2005.12.055; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Myint KM, 2006, DIABETES, V55, P2510, DOI 10.2337/db06-0221; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ohashi S, 2004, J BIOL CHEM, V279, P19816, DOI 10.1074/jbc.M310428200; PIRART J, 1977, DIABETES METAB, V3, P245; SANDERSON N, 1995, P NATL ACAD SCI USA, V92, P2572, DOI 10.1073/pnas.92.7.2572; Sato M, 2003, J CLIN INVEST, V112, P1486, DOI 10.1172/JCI200319270; SCHERRER LC, 1993, BIOCHEMISTRY-US, V32, P5381, DOI 10.1021/bi00071a013; Takahashi T, 2005, J BIOL CHEM, V280, P7100, DOI 10.1074/jbc.M411064200; TENDIJKE P, 1994, SCIENCE, V264, P101, DOI 10.1126/science.8140412; Verrou C, 1999, BIOL CHEM, V380, P1435, DOI 10.1515/BC.1999.184; Wang XM, 2008, NATURE, V455, P72, DOI 10.1038/nature07214; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Yamagishi S, 2002, J BIOL CHEM, V277, P20309, DOI 10.1074/jbc.M202634200; Yamamoto Y, 2005, ANN NY ACAD SCI, V1043, P562, DOI 10.1196/annals.1333.064; Yamamoto Y, 2001, J CLIN INVEST, V108, P261, DOI 10.1172/JCI11771; YANG CW, 1994, P NATL ACAD SCI USA, V91, P9436, DOI 10.1073/pnas.91.20.9436; Yang YL, 2009, ENDOCRINOLOGY, V150, P727, DOI 10.1210/en.2008-0090; Zhang Y, 1996, NUCLEIC ACIDS RES, V24, P543, DOI 10.1093/nar/24.4.543; Zhou GH, 2004, AM J PATHOL, V165, P2033, DOI 10.1016/S0002-9440(10)63254-3; Ziyadeh FN, 2000, P NATL ACAD SCI USA, V97, P8015, DOI 10.1073/pnas.120055097	49	46	47	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					20109	20116		10.1074/jbc.M110.179382	http://dx.doi.org/10.1074/jbc.M110.179382			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21471216	Green Published, hybrid			2022-12-25	WOS:000291027700087
J	Back, JH; Rezvani, HR; Zhu, YC; Guyonnet-Duperat, V; Athar, M; Ratner, D; Kim, AL				Back, Jung Ho; Rezvani, Hamid Reza; Zhu, Yucui; Guyonnet-Duperat, Veronique; Athar, Mohammad; Ratner, Desiree; Kim, Arianna L.			Cancer Cell Survival Following DNA Damage-mediated Premature Senescence Is Regulated by Mammalian Target of Rapamycin (mTOR)-dependent Inhibition of Sirtuin 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHORYLATION; CHEMOTHERAPY; ARREST; PRAS40; STRESS; TRANSLATION; PROOXIDANT; INDUCTION; SUBSTRATE; PATHWAY	DNA-damaging agents can induce premature senescence in cancer cells, which contributes to the static effects of cancer. However, senescent cancer cells may re-enter the cell cycle and lead to tumor relapse. Understanding the mechanisms that control the viability of senescent cells may be helpful in eliminating these cells before they can regrow. Treating human squamous cell carcinoma (SCC) cells with the anti-cancer compounds, resveratrol and doxorubicin, triggered p53-independent premature senescence by invoking oxidative stress-mediated DNA damage. This process involved the mTOR-dependent phosphorylation of SIRT1 at serine 47, resulting in the inhibition of the deacetylase activity of SIRT1. SIRT1 phosphorylation caused concomitant increases in p65/RelA NF-kappa B acetylation and the expression of an anti-apoptotic Bfl-1/A1. SIRT1 physically interacts with the mTOR-Raptor complex, and a single amino acid substitution in the TOS (TOR signaling) motif in the SIRT1 prevented Ser-47 phosphorylation and Bfl-1/A1 induction. The pharmacologic and genetic inhibition of mTOR, unphosphorylatable S47A, or F474A TOS mutants restored SIRT1 deacetylase activity, blocked Bfl-1/A1 induction, and sensitized prematurely senescent SCC cells for apoptosis. We further show that the treatment of UVB-induced SCCs with doxorubicin transiently stabilized tumor growth but was followed by tumor regrowth upon drug removal in p53(+/-)/SKH-1 mice. The subsequent treatment of stabilized SCCs with rapamycin decreased tumor size and induced caspase-3 activation. These results demonstrate that the inhibition of SIRT1 by mTOR fosters survival of DNA damage-induced prematurely senescent SCC cells via Bfl-1/A1 in the absence of functional p53.	[Back, Jung Ho; Zhu, Yucui; Ratner, Desiree; Kim, Arianna L.] Columbia Univ, Med Ctr, Dept Dermatol, New York, NY 10032 USA; [Rezvani, Hamid Reza] Inserm 1035, F-33076 Bordeaux, France; [Rezvani, Hamid Reza; Guyonnet-Duperat, Veronique] Univ Bordeaux Segalen, SFR TransBioMed, F-33076 Bordeaux, France; [Athar, Mohammad] Univ Alabama Birmingham, Dept Dermatol, Birmingham, AL 35205 USA	Columbia University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; University of Alabama System; University of Alabama Birmingham	Kim, AL (corresponding author), 1150 St Nicholas St 318A, New York, NY 10032 USA.	ak309@columbia.edu	Rezvani, Hamid Reza/G-3734-2013	Rezvani, Hamid Reza/0000-0001-8067-1338; Ratner, Desiree/0000-0002-1217-1929	National Institutes of Health [R01 ES015323, K01-AR048582, R03 CA125855]; Irving Scholar Award; Skin Cancer Foundation; NATIONAL CANCER INSTITUTE [R01CA138998, R03CA125855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR048582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015323] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irving Scholar Award; Skin Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 ES015323 (to M. A.) and K01-AR048582 and R03 CA125855 (to A. L. K.). This work was also supported by an Irving Scholar Award and Skin Cancer Foundation grant (to A. L. K.).	Ami AS, 2006, FEBS LETT, V580, P533, DOI 10.1016/j.febslet.2005.12.059; Ansieau S, 2008, CANCER CELL, V14, P79, DOI 10.1016/j.ccr.2008.06.005; Bachmann RA, 2006, J BIOL CHEM, V281, P7357, DOI 10.1074/jbc.M512218200; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Bernardi R, 2006, NATURE, V442, P779, DOI 10.1038/nature05029; Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028; Campisi J, 2005, SCIENCE, V309, P886, DOI 10.1126/science.1116801; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Dunlop EA, 2009, CELL SIGNAL, V21, P1073, DOI 10.1016/j.cellsig.2009.02.024; Elmore LW, 2005, CLIN CANCER RES, V11, P2637, DOI 10.1158/1078-0432.CCR-04-1462; Evan GI, 2009, CURR OPIN GENET DEV, V19, P25, DOI 10.1016/j.gde.2008.11.009; Fonseca BD, 2007, J BIOL CHEM, V282, P24514, DOI 10.1074/jbc.M704406200; Ford J, 2008, CELL CYCLE, V7, P3091, DOI 10.4161/cc.7.19.6799; Galati G, 2002, TOXICOLOGY, V177, P91, DOI 10.1016/S0300-483X(02)00198-1; Gary RK, 2005, ANAL BIOCHEM, V343, P329, DOI 10.1016/j.ab.2005.06.003; Gewirtz DA, 2008, BIOCHEM PHARMACOL, V76, P947, DOI 10.1016/j.bcp.2008.06.024; Guo XM, 2010, J BIOL CHEM, V285, P13223, DOI 10.1074/jbc.M110.102574; Jacobs JJL, 2005, CELL CYCLE, V4, P1364, DOI 10.4161/cc.4.10.2104; Kim AL, 2002, J INVEST DERMATOL, V118, P818, DOI 10.1046/j.1523-1747.2002.01734.x; Kim AL, 2006, EXP DERMATOL, V15, P538, DOI 10.1111/j.1600-0625.2006.00445.x; Kim H, 2005, ONCOGENE, V24, P1252, DOI 10.1038/sj.onc.1208282; Kim JE, 2000, P NATL ACAD SCI USA, V97, P14340, DOI 10.1073/pnas.011511898; Kim KH, 2011, J INVEST DERMATOL, V131, P195, DOI 10.1038/jid.2010.250; Ling YH, 2000, ANTICANCER RES, V20, P693; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Macip S, 2006, ONCOGENE, V25, P6037, DOI 10.1038/sj.onc.1209629; Murias M, 2005, BIOCHEM PHARMACOL, V69, P903, DOI 10.1016/j.bcp.2004.12.001; Nasrin N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008414; Oshiro N, 2007, J BIOL CHEM, V282, P20329, DOI 10.1074/jbc.M702636200; Ota H, 2009, J AM COLL CARDIOL, V53, P2298, DOI 10.1016/j.jacc.2009.01.072; Paglin S, 2005, CANCER RES, V65, P11061, DOI 10.1158/0008-5472.CAN-05-1083; Rezvani HR, 2011, J CLIN INVEST, V121, P195, DOI 10.1172/JCI40087; Roberson RS, 2005, CANCER RES, V65, P2795, DOI 10.1158/0008-5472.CAN-04-1270; Roninson IB, 2003, CANCER RES, V63, P2705; Saretzki G, 2010, CURR PHARM DESIGN, V16, P79, DOI 10.2174/138161210789941874; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; te Poele RH, 2002, CANCER RES, V62, P1876; Tyagi A, 2005, CARCINOGENESIS, V26, P1978, DOI 10.1093/carcin/bgi165; van Kranen HJ, 2005, MUTAT RES-FUND MOL M, V571, P81, DOI 10.1016/j.mrfmmm.2004.07.018; Wang CY, 1999, MOL CELL BIOL, V19, P5923; Wang LF, 2007, J BIOL CHEM, V282, P20036, DOI 10.1074/jbc.M702376200; Wang Q, 2011, INT J CANCER, V128, P1546, DOI 10.1002/ijc.25482; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yip CK, 2010, MOL CELL, V38, P768, DOI 10.1016/j.molcel.2010.05.017	46	54	56	0	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					19100	19108		10.1074/jbc.M111.240598	http://dx.doi.org/10.1074/jbc.M111.240598			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21471201	Green Published, hybrid			2022-12-25	WOS:000290785700079
J	Bei, L; Huang, WQ; Wang, H; Shah, C; Horvath, E; Eklund, E				Bei, Ling; Huang, Weiqi; Wang, Hao; Shah, Chirag; Horvath, Elizabeth; Eklund, Elizabeth			HoxA10 Activates CDX4 Transcription and Cdx4 Activates HOXA10 Transcription in Myeloid Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE-MARROW-CELLS; HUMAN HEMATOPOIETIC-CELLS; GENE-EXPRESSION; HOMEOBOX GENE; DNA-BINDING; IN-VITRO; DIRECT TARGET; STEM-CELLS; LEUKEMIA; MLL	HoxA10 is a homeodomain transcription factor that influences a number of developmental processes, including hematopoiesis. During definitive hematopoiesis, expression of HoxA10 is maximal in committed myeloid progenitor cells and decreases as differentiation proceeds. Aberrantly increased expression of HoxA10 was found in bone marrow cells in a poor prognosis subset of human acute myeloid leukemia (AML). Consistent with this, AML developed in mice transplanted with HoxA10-overexpressing bone marrow. However, relatively few target genes have been identified that explain the role of HoxA10 in leukemogenesis. In the current study, we identified CDX4 as a HoxA10 target gene. Cdx4 is a homeodomain transcription factor that was also implicated in myeloid leukemogenesis. Although relatively few Cdx4 target genes have been identified, Cdx4 was known to influence HOX gene transcription. We identified a HoxA10-binding cis element in the CDX4 promoter that activated transcription. We also identified a Cdx4-binding cis element that activated the HOXA10 promoter. Therefore, increased Cdx4 expression in HoxA10-overexpressing cells augmented transcription of the endogenous HOXA10 gene. Increased endogenous HoxA10 in these cells induced additional CDX4 transcription. We found that Cdx4 influenced transcription of HoxA10 target genes in a HoxA10-dependent manner. Similarly, HoxA10 influenced transcription of HOX genes in a Cdx4-dependent manner. We previously found that HoxA10-overexpressing myeloid progenitors were hypersensitive to a variety of cytokines. In the current studies, we found that Cdx4 knockdown decreased cytokine hypersensitivity of HoxA10-overexpressing cells. Therefore, these studies identified a positive feedback relationship between HoxA10 and Cdx4, which potentially amplified the contribution of either transcription factor to the pathogenesis of AML.	[Bei, Ling; Huang, Weiqi; Wang, Hao; Shah, Chirag; Horvath, Elizabeth; Eklund, Elizabeth] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Bei, Ling; Huang, Weiqi; Wang, Hao; Shah, Chirag; Horvath, Elizabeth; Eklund, Elizabeth] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Bei, Ling; Huang, Weiqi; Horvath, Elizabeth; Eklund, Elizabeth] Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60612 USA	Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Eklund, E (corresponding author), Northwestern Univ, Feinberg Sch Med, 303 E Super St,Lurie 5-105, Chicago, IL 60611 USA.	e-eklund@northwestern.edu	Shah, Chirag/C-6770-2011	Wang, Hao/0000-0003-2131-0377	National Institutes of Health [R01-HL87717]; Veterans Affairs Merit Review; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087717] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Review(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-HL87717 (to E. E.). This work was also supported by a Veterans Affairs Merit Review (to E. E.).	ACAMPORA D, 1989, NUCLEIC ACIDS RES, V17, P10385, DOI 10.1093/nar/17.24.10385; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Bansal D, 2006, P NATL ACAD SCI USA, V103, P16924, DOI 10.1073/pnas.0604579103; Bei L, 2007, J BIOL CHEM, V282, P16846, DOI 10.1074/jbc.M609744200; Bjornsson JM, 2001, BLOOD, V98, P3301, DOI 10.1182/blood.V98.12.3301; Buske C, 2001, BLOOD, V97, P2286, DOI 10.1182/blood.V97.8.2286; Calvo KR, 2000, MOL CELL BIOL, V20, P3274, DOI 10.1128/MCB.20.9.3274-3285.2000; Camos M, 2006, CANCER RES, V66, P6947, DOI 10.1158/0008-5472.CAN-05-4601; Davidson AJ, 2003, NATURE, V425, P300, DOI 10.1038/nature01973; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dubchak I, 2000, GENOME RES, V10, P1304, DOI 10.1101/gr.142200; Eklund EA, 1998, J BIOL CHEM, V273, P13957, DOI 10.1074/jbc.273.22.13957; Eklund EA, 2002, J BIOL CHEM, V277, P36878, DOI 10.1074/jbc.M203917200; Eklund EA, 2000, J BIOL CHEM, V275, P20117, DOI 10.1074/jbc.M907915199; Ernst P, 2004, CURR BIOL, V14, P2063, DOI 10.1016/j.cub.2004.11.012; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Guenther MG, 2005, P NATL ACAD SCI USA, V102, P8603, DOI 10.1073/pnas.0503072102; Horton SJ, 2005, CANCER RES, V65, P9245, DOI 10.1158/0008-5472.CAN-05-1691; Hu YL, 2007, BLOOD, V109, P4732, DOI 10.1182/blood-2006-08-043356; Huang WQ, 2008, J BIOL CHEM, V283, P7921, DOI 10.1074/jbc.M706710200; Kawagoe H, 1999, LEUKEMIA, V13, P687, DOI 10.1038/sj.leu.2401410; KOO S, 2011, HAEMATOLOGI IN PRESS; Kroon E, 1998, EMBO J, V17, P3714, DOI 10.1093/emboj/17.13.3714; LARRICK JW, 1980, J IMMUNOL, V125, P6; Lawrence HJ, 1997, BLOOD, V89, P1922, DOI 10.1182/blood.V89.6.1922; LAWRENCE HJ, 1995, EXP HEMATOL, V23, P1160; Lengerke C, 2009, ANN NY ACAD SCI, V1176, P219, DOI 10.1111/j.1749-6632.2009.04606.x; Lindsey S, 2005, J IMMUNOL, V175, P5269, DOI 10.4049/jimmunol.175.8.5269; Loots GG, 2002, GENOME RES, V12, P832, DOI 10.1101/gr.225502; LOWNEY P, 1991, NUCLEIC ACIDS RES, V19, P3443, DOI 10.1093/nar/19.12.3443; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Oberley MJ, 2003, METHOD ENZYMOL, V371, P577; Pilon N, 2006, DEV BIOL, V289, P55, DOI 10.1016/j.ydbio.2005.10.005; SATOKATA I, 1995, NATURE, V374, P460, DOI 10.1038/374460a0; SAUVAGEAU G, 1994, P NATL ACAD SCI USA, V91, P12223, DOI 10.1073/pnas.91.25.12223; SAUVAGEAU G, 1995, GENE DEV, V9, P1753, DOI 10.1101/gad.9.14.1753; Shah CA, 2011, J BIOL CHEM, V286, P3161, DOI 10.1074/jbc.M110.183251; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466, DOI 10.1128/MCB.8.1.466; Thorsteinsdottir U, 2002, BLOOD, V99, P121, DOI 10.1182/blood.V99.1.121; Thorsteinsdottir U, 2001, MOL CELL BIOL, V21, P224, DOI 10.1128/MCB.21.1.224-234.2001; Wang H, 2007, J BIOL CHEM, V282, P16164, DOI 10.1074/jbc.M610556200; Wang H, 2009, J BIOL CHEM, V284, P2549, DOI 10.1074/jbc.M804704200; Wang Y, 2005, P NATL ACAD SCI USA, V102, P19081, DOI 10.1073/pnas.0506127102; Zhu CL, 2004, J BIOL CHEM, V279, P50874, DOI 10.1074/jbc.M405736200	45	19	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					19047	19064		10.1074/jbc.M110.213983	http://dx.doi.org/10.1074/jbc.M110.213983			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21471217	Green Published, hybrid			2022-12-25	WOS:000290785700075
J	Cottrell, JW; Scott, LG; Fedor, MJ				Cottrell, Joseph W.; Scott, Lincoln G.; Fedor, Martha J.			The pH Dependence of Hairpin Ribozyme Catalysis Reflects Ionization of an Active Site Adenine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID-BASE CATALYSIS; TERTIARY STRUCTURE; PROTON BINDING; IMINO GROUP; RNA; PK(A); FLUORESCENCE; MECHANISM; CLEAVAGE; LINKAGE	Understanding how self-cleaving ribozymes mediate catalysis is crucial in light of compelling evidence that human and bacterial gene expression can be regulated through RNA self-cleavage. The hairpin ribozyme catalyzes reversible phosphodiester bond cleavage through a mechanism that does not require divalent metal cations. Previous structural and biochemical evidence implicated the amidine group of an active site adenosine, A38, in a pH-dependent step in catalysis. We developed a way to determine microscopic pK(a) values in active ribozymes based on the pH-dependent fluorescence of 8-azaadenosine (8azaA). We compared the microscopic pKa for ionization of 8azaA at position 38 with the apparent pK(a) for the self-cleavage reaction in a fully functional hairpin ribozyme with a unique 8azaA at position 38. Microscopic and apparent pK(a) values were virtually the same, evidence that A38 protonation accounts for the decrease in catalytic activity with decreasing pH. These results implicate the neutral unprotonated form of A38 in a transition state that involves formation of the 5'-oxygen-phosphorus bond.	[Cottrell, Joseph W.; Fedor, Martha J.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Cottrell, Joseph W.; Fedor, Martha J.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Cottrell, Joseph W.; Fedor, Martha J.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Scott, Lincoln G.] Cassia LLC, San Diego, CA 92109 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Fedor, MJ (corresponding author), Scripps Res Inst, Dept Physiol Chem, MB35,10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	mfedor@scripps.edu			National Institutes of Health [R01 GM046422]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046422] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM046422 (to M.J.F.).	Bevilacqua PC, 2005, BIOCHEM SOC T, V33, P466, DOI 10.1042/BST0330466; Bevilacqua PC, 2004, BIOPOLYMERS, V73, P90, DOI 10.1002/bip.10519; Bevilacqua PC, 2003, BIOCHEMISTRY-US, V42, P2259, DOI 10.1021/bi027273m; Bevilacqua PC, 2006, CURR OPIN CHEM BIOL, V10, P455, DOI 10.1016/j.cbpa.2006.08.014; Cai ZP, 1996, BIOCHEMISTRY-US, V35, P6026, DOI 10.1021/bi952985g; Chen JH, 2009, BIOCHEMISTRY-US, V48, P1498, DOI 10.1021/bi8020108; CLAUWAERT J, 1968, Z NATURFORSCH PT B, VB 23, P25, DOI 10.1515/znb-1968-0105; Da Costa CP, 2007, J AM CHEM SOC, V129, P3426, DOI 10.1021/ja067699e; Ditzler MA, 2009, RNA, V15, P560, DOI 10.1261/rna.1416709; Fedor MJ, 2009, ANNU REV BIOPHYS, V38, P271, DOI 10.1146/annurev.biophys.050708.133710; Fedor MJ, 1999, BIOCHEMISTRY-US, V38, P11040, DOI 10.1021/bi991069q; Gong B, 2007, J AM CHEM SOC, V129, P13335, DOI 10.1021/Ja0743893; Gong B, 2009, BIOCHEMISTRY-US, V48, P11961, DOI 10.1021/bi901091v; Gong B, 2009, METHODS, V49, P101, DOI 10.1016/j.ymeth.2009.04.016; Guo M, 2009, J AM CHEM SOC, V131, P12908, DOI 10.1021/ja9060883; Hampel A, 1997, CHEM BIOL, V4, P513, DOI 10.1016/S1074-5521(97)90323-9; Jean JM, 2001, P NATL ACAD SCI USA, V98, P37, DOI 10.1073/pnas.011442198; Jencks W. P., 1969, CATALYSIS CHEM ENZYM, P163; Kochetkov N. K., 1971, ORGANIC CHEM NUCL AC, P148; Kuzmin YI, 2005, J MOL BIOL, V349, P989, DOI 10.1016/j.jmb.2005.04.005; Kuzmin YI, 2004, J MOL BIOL, V340, P233, DOI 10.1016/j.jmb.2004.04.067; Lebruska LL, 2002, CHEM BIOL, V9, P465, DOI 10.1016/S1074-5521(02)00130-8; Liu L, 2009, NAT CHEM BIOL, V5, P351, DOI 10.1038/nchembio.156; Luptak A, 2001, J AM CHEM SOC, V123, P8447, DOI 10.1021/ja016091x; Millar DP, 1996, CURR OPIN STRUC BIOL, V6, P322, DOI 10.1016/S0959-440X(96)80050-9; MILLIGAN JF, 1989, METHOD ENZYMOL, V180, P51; Mlynsky V, 2010, J PHYS CHEM B, V114, P6642, DOI 10.1021/jp1001258; Moody EM, 2005, RNA, V11, P157, DOI 10.1261/rna.7177505; Murray JB, 1998, CHEM BIOL, V5, P587, DOI 10.1016/S1074-5521(98)90116-8; Nam K, 2008, RNA, V14, P1501, DOI 10.1261/rna.863108; Nesbitt S, 1997, CHEM BIOL, V4, P619, DOI 10.1016/S1074-5521(97)90247-7; Nesbitt SM, 1999, J MOL BIOL, V286, P1009, DOI 10.1006/jmbi.1999.2543; Pinard R, 1999, BIOCHEMISTRY-US, V38, P16035, DOI 10.1021/bi992024s; PUGLISI JD, 1990, BIOCHEMISTRY-US, V29, P4215, DOI 10.1021/bi00469a026; Raines RT, 1998, CHEM REV, V98, P1045, DOI 10.1021/cr960427h; Ravindranathan S, 2000, BIOCHEMISTRY-US, V39, P16026, DOI 10.1021/bi001976r; Rogstad KN, 2003, CHEM RES TOXICOL, V16, P1455, DOI 10.1021/tx034068e; Rupert PB, 2002, SCIENCE, V298, P1421, DOI 10.1126/science.1076093; Rupert PB, 2001, NATURE, V410, P780, DOI 10.1038/35071009; Ryder SP, 1999, J MOL BIOL, V291, P295, DOI 10.1006/jmbi.1999.2959; Ryder SP, 2001, RNA, V7, P1454; Saenger W., 1984, PRINCIPLES NUCL ACID, P107; Shih IH, 2002, ANNU REV BIOCHEM, V71, P887, DOI 10.1146/annurev.biochem.71.110601.135349; Siwkowski A, 1997, BIOCHEMISTRY-US, V36, P3930, DOI 10.1021/bi9628735; Spitale RC, 2009, J AM CHEM SOC, V131, P6093, DOI 10.1021/ja900450h; Suydam IT, 2010, BIOCHEMISTRY-US, V49, P3723, DOI 10.1021/bi100234v; Tang CL, 2007, J MOL BIOL, V366, P1475, DOI 10.1016/j.jmb.2006.12.001; Tolman RC, 1938, PRINCIPLES STAT MECH; Torelli AT, 2007, RNA, V13, P1052, DOI 10.1261/rna.510807; UHLENBECK OC, 1977, NUCLEIC ACIDS RES, V4, P85, DOI 10.1093/nar/4.1.85; Wadkins TS, 2001, J MOL BIOL, V305, P1045, DOI 10.1006/jmbi.2000.4368; Walter NG, 1999, NAT STRUCT BIOL, V6, P544; WARD DC, 1969, J BIOL CHEM, V244, P1228; Wierzchowski J, 1996, BBA-GEN SUBJECTS, V1290, P9, DOI 10.1016/0304-4165(95)00181-6; Yadava RS, 2001, J MOL BIOL, V309, P893, DOI 10.1006/jmbi.2001.4713; Young KJ, 1997, NUCLEIC ACIDS RES, V25, P3760, DOI 10.1093/nar/25.19.3760	56	31	31	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17658	17664		10.1074/jbc.M111.234906	http://dx.doi.org/10.1074/jbc.M111.234906			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454684	Green Published, hybrid			2022-12-25	WOS:000290585200029
J	Huebner, EA; Kim, BG; Duffy, PJ; Brown, RH; Strittmatter, SM				Huebner, Eric A.; Kim, Byung G.; Duffy, Philip J.; Brown, Rebecca H.; Strittmatter, Stephen M.			A Multi-domain Fragment of Nogo-A Protein Is a Potent Inhibitor of Cortical Axon Regeneration via Nogo Receptor 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYELIN-ASSOCIATED GLYCOPROTEIN; SPINAL-CORD-INJURY; FUNCTIONAL RECOVERY; DEFICIENT MICE; GROWTH; LIMITS; ACTIVATION; PLASTICITY; COMPLEXES; TRAUMA	Nogo-A limits axon regeneration and functional recovery after central nervous system injury in adult mammals. Three regions of Nogo-A (Nogo-A-24, Nogo-66, and Nogo-C39) interact with the neuronal Nogo-66 receptor 1 (NgR1). Nogo-66 also interacts with a structurally unrelated cell surface receptor, paired immunoglobulin-like receptor (PirB). We show here that the other two NgR1-interacting domains, Nogo-A-24 and Nogo-C39, also bind to PirB with high affinity. A purified 22-kDa protein containing all three NgR1- and PirB-interacting domains (Nogo-22) is a substantially more potent growth cone-collapsing molecule than Nogo-66 for chick dorsal root ganglion neurons and mature cortical neurons. Moreover, Nogo-22 inhibits axon regeneration of mature cortical neurons in vitro more potently than does Nogo-66. Although all three NgR1-interacting domains of Nogo-A also interact with PirB, expression of PirB in mature cortical cultures is nearly undetectable. Consistent with a relatively minor role for PirB in mature cortical neurons, Nogo-22 inhibition of axon regeneration is abolished by genetic deletion of NgR1. Thus, NgR1 is the predominant receptor for Nogo-22 in regenerating cortical neurons.	[Huebner, Eric A.; Kim, Byung G.; Duffy, Philip J.; Brown, Rebecca H.; Strittmatter, Stephen M.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06536 USA; [Huebner, Eric A.; Kim, Byung G.; Duffy, Philip J.; Brown, Rebecca H.; Strittmatter, Stephen M.] Yale Univ, Sch Med, Program Cellular Neurosci Neurodegenerat & Repair, New Haven, CT 06536 USA; [Kim, Byung G.] Ajou Univ, Sch Med, Dept Neurol, Suwon 443749, South Korea; [Kim, Byung G.] Ajou Univ, Sch Med, Brain Dis Res Ctr, Inst Med Sci, Suwon 443749, South Korea	Yale University; Yale University; Ajou University; Ajou University	Strittmatter, SM (corresponding author), Yale Univ, Sch Med, Dept Neurol, 333 Cedar St, New Haven, CT 06536 USA.	stephen.strittmatter@yale.edu	Kim, Byung Gon/L-6884-2019; Strittmatter, Stephen/F-5739-2011	Kim, Byung Gon/0000-0003-2233-9569; Strittmatter, Stephen/0000-0001-8188-3092	National Institutes of Health [MSTP TG T32GM07205, R01NS42304, R01NS39962, R01NS33020]; Falk Medical Research Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033020, R01NS039962, R01NS042304, R37NS033020] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Falk Medical Research Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants MSTP TG T32GM07205 (to E. A. H.) and R01NS42304, R01NS39962, and R01NS33020 (to S. M. S.). This work was also supported by the Falk Medical Research Trust (to S. M. S.). S. M. S. is a cofounder of Axerion Therapeutics, which seeks to develop PrP- and NgR-based therapeutics.	Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; Cafferty WBJ, 2007, NEURON, V54, P195, DOI 10.1016/j.neuron.2007.04.005; Cafferty WBJ, 2006, J NEUROSCI, V26, P12242, DOI 10.1523/JNEUROSCI.3827-06.2006; Cafferty WBJ, 2010, J NEUROSCI, V30, P6825, DOI 10.1523/JNEUROSCI.6239-09.2010; Chivatakarn O, 2007, J NEUROSCI, V27, P7117, DOI 10.1523/JNEUROSCI.1541-07.2007; Duffy P, 2009, J NEUROSCI, V29, P15266, DOI 10.1523/JNEUROSCI.4650-09.2009; Fournier AE, 2003, J NEUROSCI, V23, P1416, DOI 10.1523/JNEUROSCI.23-04-01416.2003; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a; Hu FH, 2008, J NEUROSCI, V28, P1262, DOI 10.1523/JNEUROSCI.1068-07.2008; Hu FH, 2005, J NEUROSCI, V25, P5298, DOI 10.1523/JNEUROSCI.5235-04.2005; Huebner EA, 2009, RESULTS PROBL CELL D, V48, P339, DOI 10.1007/400_2009_19; Kim JE, 2003, NEURON, V38, P187, DOI 10.1016/S0896-6273(03)00147-8; Kim JE, 2004, NEURON, V44, P439, DOI 10.1016/j.neuron.2004.10.015; Lauren J, 2007, J BIOL CHEM, V282, P5715, DOI 10.1074/jbc.M609797200; Lee JK, 2010, NEURON, V66, P663, DOI 10.1016/j.neuron.2010.05.002; Li SX, 2003, J NEUROSCI, V23, P4219; Liebscher T, 2005, ANN NEUROL, V58, P706, DOI 10.1002/ana.20627; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; Munitz A, 2008, BLOOD, V111, P5694, DOI 10.1182/blood-2007-12-126748; Nakamura Y, 2011, J BIOL CHEM, V286, P1876, DOI 10.1074/jbc.M110.163493; Niederost B, 2002, J NEUROSCI, V22, P10368; Omoto S, 2010, J NEUROSCI, V30, P13045, DOI 10.1523/JNEUROSCI.3228-10.2010; Seymour AB, 2005, J CEREBR BLOOD F MET, V25, P1366, DOI 10.1038/sj.jcbfm.9600134; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Uehara T, 2001, J CLIN INVEST, V108, P1041, DOI 10.1172/JCI200112195; Wang XX, 2002, J NEUROSCI, V22, P5505; Zheng BH, 2003, NEURON, V38, P213, DOI 10.1016/S0896-6273(03)00225-3	28	49	54	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					18026	18036		10.1074/jbc.M110.208108	http://dx.doi.org/10.1074/jbc.M110.208108			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454605	Green Published, hybrid			2022-12-25	WOS:000290585200064
J	Coleman, JA; Molday, RS				Coleman, Jonathan A.; Molday, Robert S.			Critical Role of the beta-Subunit CDC50A in the Stable Expression, Assembly, Subcellular Localization, and Lipid Transport Activity of the P-4-ATPase ATP8A2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-TYPE ATPASE; PLASMA-MEMBRANE; PHOSPHATIDYLSERINE ASYMMETRY; TRANSLOCASE ACTIVITY; GLYCOSYLATION SITES; PROTEIN-TRANSPORT; FLIPPASE ACTIVITY; DRS2P; YEAST; IDENTIFICATION	P-4-ATPases have been implicated in the transport of lipids across cellular membranes. Some P-4-ATPases are known to associate with members of the CDC50 protein family. Previously, we have shown that the P-4-ATPase ATP8A2 purified from photoreceptor membranes and reconstituted into liposomes catalyzes the active transport of phosphatidylserine across membranes. However, it was unclear whether ATP8A2 functioned alone or as a complex with a CDC50 protein. Here, we show by mass spectrometry and Western blotting using newly generated anti-CDC50A antibodies that CDC50A is associated with ATP8A2 purified from photoreceptor membranes. ATP8A2 expressed in HEK293T cells assembles with endogenous or expressed CDC50A, but not CDC50B, to generate a heteromeric complex that actively transports phosphatidylserine and to a lesser extent phosphatidylethanolamine across membranes. Chimera CDC50 proteins in which various domains of CDC50B were replaced with the corresponding domains of CDC50A were used to identify domains important in the formation of a functional ATP8A2-CDC50 complex. These studies indicate that both the transmembrane and exocytoplasmic domains of CDC50A are required to generate a functionally active complex. The N-terminal cytoplasmic domain of CDC50A appears to play a direct role in the reaction cycle. Mutagenesis studies further indicate that the N-linked oligosaccharide chains of CDC50A are required for stable expression of an active ATP8A2-CDC50A lipid transport complex. Together, our studies indicate that CDC50A is the beta-subunit of ATP8A2 and is crucial for the correct folding, stable expression, export from endoplasmic reticulum, and phosphatidylserine flippase activity of ATP8A2.	[Coleman, Jonathan A.; Molday, Robert S.] Univ British Columbia, Dept Biochem & Mol Biol, Ctr Macular Res, Vancouver, BC V6T 1Z3, Canada; [Molday, Robert S.] Univ British Columbia, Dept Ophthalmol & Visual Sci, Ctr Macular Res, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia	Molday, RS (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Ctr Macular Res, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	molday@interchange.ubc.ca		Coleman, Jonathan/0000-0003-0001-6195	Canadian Institutes of Health [MOP-106667]; University of British Columbia; National Sciences and Engineering Council	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); University of British Columbia; National Sciences and Engineering Council	This work was supported by Canadian Institutes of Health Research Grant MOP-106667.; Supported by a University of British Columbia and National Sciences and Engineering Council predoctoral studentship.	Abe K, 2009, EMBO J, V28, P1637, DOI 10.1038/emboj.2009.102; Alder-Baerens N, 2006, MOL BIOL CELL, V17, P1632, DOI 10.1091/mbc.E05-10-0912; Bryde S, 2010, J BIOL CHEM, V285, P40562, DOI 10.1074/jbc.M110.139543; Bull LN, 1998, NAT GENET, V18, P219, DOI 10.1038/ng0398-219; Bungert S, 2001, J BIOL CHEM, V276, P23539, DOI 10.1074/jbc.M101902200; Cacciagli P, 2010, EUR J HUM GENET, V18, P1360, DOI 10.1038/ejhg.2010.126; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Chen S, 2006, TRAFFIC, V7, P1503, DOI 10.1111/j.1600-0854.2006.00485.x; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Coleman JA, 2009, J BIOL CHEM, V284, P32670, DOI 10.1074/jbc.M109.047415; Darland-Ransom M, 2008, SCIENCE, V320, P528, DOI 10.1126/science.1155847; DOI T, 1990, P NATL ACAD SCI USA, V87, P4991, DOI 10.1073/pnas.87.13.4991; Folmer DE, 2009, BBA-MOL CELL BIOL L, V1791, P628, DOI 10.1016/j.bbalip.2009.02.008; GONZALEZROMO P, 1992, ANAL BIOCHEM, V200, P235, DOI 10.1016/0003-2697(92)90458-J; Gupta Ramneek, 2002, Pac Symp Biocomput, P310; Hasler U, 2001, J BIOL CHEM, V276, P16356, DOI 10.1074/jbc.M008778200; Hasler U, 1998, J BIOL CHEM, V273, P30826, DOI 10.1074/jbc.273.46.30826; JAUNIN P, 1993, J CELL BIOL, V123, P1751, DOI 10.1083/jcb.123.6.1751; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Katoh Y, 2004, ONCOL REP, V12, P939; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kwok MCM, 2008, MOL CELL PROTEOMICS, V7, P1053, DOI 10.1074/mcp.M700571-MCP200; Lenoir G, 2009, J BIOL CHEM, V284, P17956, DOI 10.1074/jbc.M109.013722; Lopez-Marques RL, 2010, MOL BIOL CELL, V21, P791, DOI 10.1091/mbc.E09-08-0656; MACKENZIE D, 1982, J BIOL CHEM, V257, P7100; MCINTYRE JC, 1991, BIOCHEMISTRY-US, V30, P11819, DOI 10.1021/bi00115a012; Meguro M, 2001, NAT GENET, V28, P19, DOI 10.1038/ng0501-19; MOLDAY LL, 1990, J BIOL CHEM, V265, P18690; Muthusamy BP, 2009, BBA-MOL CELL BIOL L, V1791, P612, DOI 10.1016/j.bbalip.2009.03.004; Natarajan P, 2004, P NATL ACAD SCI USA, V101, P10614, DOI 10.1073/pnas.0404146101; Osada N, 2007, GENE, V392, P151, DOI 10.1016/j.gene.2006.11.021; PAPERMASTER DS, 1974, BIOCHEMISTRY-US, V13, P2438, DOI 10.1021/bi00708a031; Paulusma CC, 2008, HEPATOLOGY, V47, P268, DOI 10.1002/hep.21950; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Poulsen LR, 2008, PLANT CELL, V20, P658, DOI 10.1105/tpc.107.054767; Puts CF, 2009, BBA-MOL CELL BIOL L, V1791, P603, DOI 10.1016/j.bbalip.2009.02.005; Romsicki Y, 2001, BIOCHEMISTRY-US, V40, P6937, DOI 10.1021/bi0024456; Saito K, 2004, MOL BIOL CELL, V15, P3418, DOI 10.1091/mbc.E03-11-0829; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Stapelbroek JM, 2009, P NATL ACAD SCI USA, V106, P9709, DOI 10.1073/pnas.0807919106; van der Velden LM, 2010, J BIOL CHEM, V285, P40088, DOI 10.1074/jbc.M110.139006; Wang L, 2004, DEV BIOL, V267, P203, DOI 10.1016/j.ydbio.2003.11.004; Xu P, 2007, ACTA BIOCH BIOPH SIN, V39, P739, DOI 10.1111/j.1745-7270.2007.00342.x; Zhou XM, 2009, P NATL ACAD SCI USA, V106, P16586, DOI 10.1073/pnas.0904293106	44	89	94	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17205	17216		10.1074/jbc.M111.229419	http://dx.doi.org/10.1074/jbc.M111.229419			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454556	Green Published, hybrid			2022-12-25	WOS:000290301900069
J	Kong, SY; Kim, SJ; Sandal, B; Lee, SM; Gao, BX; Zhang, DD; Fang, DY				Kong, Sinyi; Kim, Seung-Jae; Sandal, Barry; Lee, Sang-Myeong; Gao, Beixue; Zhang, Donna D.; Fang, Deyu			The Type III Histone Deacetylase Sirt1 Protein Suppresses p300-mediated Histone H3 Lysine 56 Acetylation at Bclaf1 Promoter to Inhibit T Cell Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; DNA-DAMAGE; TRANSCRIPTIONAL REPRESSOR; APOPTOTIC RESPONSE; H3K56 ACETYLATION; GENE-EXPRESSION; STABILITY; BINDING; BTF; DEGRADATION	The NAD-dependent histone deacetylase Sirt1 is a negative regulator of T cell activation. Here we report that Sirt1 inhibits T cell activation by suppressing the transcription of Bcl2-associated factor 1 (Bclaf1), a protein required for T cell activation. Sirt1-null T cells have increased acetylation of the histone 3 lysine 56 residue (H3K56) at the bclaf1 promoter, as well as increasing Bclaf1 transcription. Sirt1 binds to bclaf1 promoter upon T cell receptor (TCR)/CD28 stimulation by forming a complex with histone acetyltransferase p300 and NF-kappa B transcription factor Rel-A. The recruitment of Sirt1, but not p300, requires Rel-A because blocking Rel-A nuclear translocation in T cells and siRNA-mediated knockdown of Rel-A can inhibit Sirt1 binding to bclaf1 promoter. Although knockdown of either p300 or GCN5 partially suppressed global H3K56 acetylation, only p300 knockdown specifically attenuated H3K56 acetylation at the bclaf1 promoter. Lastly, knockdown of Bclaf1 suppresses the hyperactivation observed in Sirt1(-/-) T cells, indicated by less IL-2 production in CD4(+) T cells and reduced proliferation. Therefore, Sirt1 negatively regulates T cell activation via H3K56 deacetylation at the promoter region to inhibit transcription of Bclaf1.	[Kong, Sinyi; Kim, Seung-Jae; Sandal, Barry; Lee, Sang-Myeong; Gao, Beixue; Fang, Deyu] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA; [Zhang, Donna D.] Univ Arizona, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA	Northwestern University; Feinberg School of Medicine; University of Arizona	Fang, DY (corresponding author), Northwestern Univ, Dept Pathol, Feinberg Sch Med, 303 E Chicago Ave, Chicago, IL 60611 USA.	FangD@Northwestern.edu	Zhang, Donna/B-1015-2012; Fang, Deyu/I-7245-2013	Fang, Deyu/0000-0002-4211-2751	NIAID NIH HHS [R01 AI079056, R01AI079056] Funding Source: Medline; NIA NIH HHS [R21 AG028493, R21AG028493] Funding Source: Medline; NIDDK NIH HHS [DP2 DK083050, DK083050] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP2DK083050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG028493] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Atanassov BS, 2009, MOL CELL, V35, P352, DOI 10.1016/j.molcel.2009.06.015; BRACHMANN CB, 1995, GENE DEV, V9, P2888, DOI 10.1101/gad.9.23.2888; Bracken CP, 2008, CANCER RES, V68, P7621, DOI 10.1158/0008-5472.CAN-08-1217; Chen A, 2009, MOL CELL BIOL, V29, P5348, DOI 10.1128/MCB.00407-09; COHN RH, 1979, CELL, V18, P855, DOI 10.1016/0092-8674(79)90137-5; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; Gao BX, 2006, J BIOL CHEM, V281, P29711, DOI 10.1074/jbc.M604596200; Gillum M. P., 2010, TRENDS MOL IN PRESS; Gratchev A, 2008, J IMMUNOL, V180, P6553, DOI 10.4049/jimmunol.180.10.6553; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Haraguchi T, 2004, EUR J BIOCHEM, V271, P1035, DOI 10.1111/j.1432-1033.2004.04007.x; Hebert C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r51; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Johnson CA, 1998, NUCLEIC ACIDS RES, V26, P994, DOI 10.1093/nar/26.4.994; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kasof GM, 1999, MOL CELL BIOL, V19, P4390; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Kwon HS, 2008, CELL HOST MICROBE, V3, P158, DOI 10.1016/j.chom.2008.02.002; Lee KM, 2010, NUCLEIC ACIDS RES, V38, P3340, DOI 10.1093/nar/gkq017; Lee SM, 2008, BLOOD, V111, P3599, DOI 10.1182/blood-2007-09-115014; Liu H, 2007, MOL CELL BIOL, V27, P8480, DOI 10.1128/MCB.01126-07; Maas NL, 2006, MOL CELL, V23, P109, DOI 10.1016/j.molcel.2006.06.006; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; McPherson JP, 2009, CELL DEATH DIFFER, V16, P331, DOI 10.1038/cdd.2008.167; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Schneider J, 2006, J BIOL CHEM, V281, P37270, DOI 10.1074/jbc.C600265200; Schug TT, 2010, MOL CELL BIOL, V30, P4712, DOI 10.1128/MCB.00657-10; Sellers WR, 1998, GENE DEV, V12, P95, DOI 10.1101/gad.12.1.95; Sequeira J, 2008, EXP CELL RES, V314, P3069, DOI 10.1016/j.yexcr.2008.07.011; SHORE D, 1984, EMBO J, V3, P2817, DOI 10.1002/j.1460-2075.1984.tb02214.x; Silvestre R, 2009, IMMUNOLOGY, V128, P484, DOI 10.1111/j.1365-2567.2009.03132.x; Tang Y, 2008, NAT STRUCT MOL BIOL, V15, P738, DOI 10.1038/nsmb.1448; Thaminy S, 2007, J BIOL CHEM, V282, P37805, DOI 10.1074/jbc.M706384200; Vempati RK, 2010, J BIOL CHEM, V285, P28553, DOI 10.1074/jbc.M110.149393; Wang CG, 2006, NAT CELL BIOL, V8, P1025, DOI 10.1038/ncb1468; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yuan J, 2009, CELL CYCLE, V8, P1747, DOI 10.4161/cc.8.11.8620; Zhang JN, 2009, J CLIN INVEST, V119, P3048, DOI 10.1172/JCI38902; Ziegelbauer JM, 2009, NAT GENET, V41, P130, DOI 10.1038/ng.266	39	71	74	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16967	16975		10.1074/jbc.M111.218206	http://dx.doi.org/10.1074/jbc.M111.218206			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454709	hybrid, Green Published			2022-12-25	WOS:000290301900046
J	Wheeler, LJ; Mathews, CK				Wheeler, Linda J.; Mathews, Christopher K.			Nucleoside Triphosphate Pool Asymmetry in Mammalian Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA PRECURSOR ASYMMETRIES; REPLICATION FIDELITY; SYNTHETIC OLIGONUCLEOTIDES; RAT-LIVER; NUCLEOTIDES; ATP	Our laboratory has reported that deoxyribonucleoside triphosphate (dNTP) pools in rat tissue mitochondria are highly asymmetric, with dGTP predominating, and that the imbalance probably contributes toward the high spontaneous mutation rate of the mitochondrial genome. Ferraro et al. (Ferraro, P., Nicolosi, L., Bernardi, P., Reichard, P., and Bianchi, V. (2006) Proc. Natl. Acad. Sci. U.S.A. 103, 18586-18591) have challenged these findings, based upon their studies of mouse liver mitochondria. Moreover, they have identified a potential artifact in the DNA polymerase-based assay for dNTPs, based upon overestimation of dGTP when GTP levels in extracts are much higher than dGTP levels. We measured ribonucleoside triphosphate (rNTP) pools in rat mitochondrial extracts and found that GTP pools exceed dGTP pools by 50-fold or less, not enough to interfere with the dGTP assay. Analysis of dNTP pools in state 3 mitochondria, after incubation with ADP and oxidizable substrates, gave similar results. We confirmed our earlier finding that rat mitochondrial dNTP pools are highly asymmetric. dNTP pools in cytosolic extracts are uniformly low, suggesting that the dNTP pool asymmetry arises within the mitochondrion. Moreover, we found rat tissue rNTP pools to be even more highly asymmetric, with ATP, for example, at least 2 orders of magnitude more abundant than CTP in liver extracts. This finding raises the possibility that transcription of the mitochondrial genome is more error-prone than transcription in the nucleus.	[Wheeler, Linda J.; Mathews, Christopher K.] Oregon State Univ, Dept Biochem, Corvallis, OR 97331 USA	Oregon State University	Mathews, CK (corresponding author), Oregon State Univ, Dept Biochem, 2011 Agr & Life Sci Bldg, Corvallis, OR 97331 USA.	mathewsc@onid.orst.edu			National Institutes of Health [R01 GM073744]; Army Research Office [55953-LS]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073744] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Army Research Office; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM073744. This work was also supported by Army Research Office Grant 55953-LS.	Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200; Enriquez JA, 1996, EUR J BIOCHEM, V237, P601, DOI 10.1111/j.1432-1033.1996.0601p.x; ENRIQUEZ JA, 1994, NUCLEIC ACIDS RES, V22, P1861, DOI 10.1093/nar/22.10.1861; Ferraro P, 2006, P NATL ACAD SCI USA, V103, P18586, DOI 10.1073/pnas.0609020103; Ferraro P, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1141; HAMMAN HC, 1983, ARCH BIOCHEM BIOPHYS, V223, P85, DOI 10.1016/0003-9861(83)90574-X; Kamiya H, 2003, NUCLEIC ACIDS RES, V31, P517, DOI 10.1093/nar/gkg137; Martomo SA, 2002, MUTAT RES-FUND MOL M, V499, P197, DOI 10.1016/S0027-5107(01)00283-4; Mathews CK, 2006, FASEB J, V20, P1300, DOI 10.1096/fj.06-5730rev; Mathews CK, 2009, METHODS MOL BIOL, V554, P371, DOI 10.1007/978-1-59745-521-3_22; MATHEWS CK, 1992, BIOESSAYS, V14, P295, DOI 10.1002/bies.950140502; Pursell ZF, 2008, NUCLEIC ACIDS RES, V36, P2174, DOI 10.1093/nar/gkn062; SCHWENKE WD, 1981, BIOCHEM J, V200, P405, DOI 10.1042/bj2000405; SHERMAN PA, 1989, ANAL BIOCHEM, V180, P222, DOI 10.1016/0003-2697(89)90420-X; Song SW, 2005, P NATL ACAD SCI USA, V102, P4990, DOI 10.1073/pnas.0500253102; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361	16	28	29	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16992	16996		10.1074/jbc.M111.236968	http://dx.doi.org/10.1074/jbc.M111.236968			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454602	Green Published, hybrid			2022-12-25	WOS:000290301900049
J	Miller, EH; Harrison, JS; Radoshitzky, SR; Higgins, CD; Chi, XL; Dong, L; Kuhn, JH; Bavari, S; Lai, JR; Chandran, K				Miller, Emily Happy; Harrison, Joseph S.; Radoshitzky, Sheli R.; Higgins, Chelsea D.; Chi, Xiaoli; Dong, Lian; Kuhn, Jens H.; Bavari, Sina; Lai, Jonathan R.; Chandran, Kartik			Inhibition of Ebola Virus Entry by a C-peptide Targeted to Endosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRAL MEMBRANE-FUSION; HUMAN-IMMUNODEFICIENCY-VIRUS; ENVELOPE GLYCOPROTEIN; RECEPTOR-BINDING; AVIAN-SARCOMA; COILED-COIL; TYPE-1 GP41; INFECTION; MECHANISMS; PROTEINS	Ebola virus (EboV) and Marburg virus (MarV) (filoviruses) are the causative agents of severe hemorrhagic fever. Infection begins with uptake of particles into cellular endosomes, where the viral envelope glycoprotein (GP) catalyzes fusion between the viral and host cell membranes. This fusion event is thought to involve conformational rearrangements of the transmembrane subunit (GP2) of the envelope spike that ultimately result in formation of a six-helix bundle by the N- and C-terminal heptad repeat (NHR and CHR, respectively) regions of GP2. Infection by other viruses employing similar viral entry mechanisms (such as HIV-1 and severe acute respiratory syndrome coronavirus) can be inhibited with synthetic peptides corresponding to the native CHR sequence ("C-peptides"). However, previously reported EboV C-peptides have shown weak or insignificant antiviral activity. To determine whether the activity of a C-peptide could be improved by increasing its intracellular concentration, we prepared an EboV C-peptide conjugated to the arginine-rich sequence from HIV-1 Tat, which is known to accumulate in endosomes. We found that this peptide specifically inhibited viral entry mediated by filovirus GP proteins and infection by authentic filoviruses. We determined that antiviral activity was dependent on both the Tat sequence and the native EboV CHR sequence. Mechanistic studies suggested that the peptide acts by blocking a membrane fusion intermediate.	[Harrison, Joseph S.; Higgins, Chelsea D.; Lai, Jonathan R.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Miller, Emily Happy; Chandran, Kartik] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA; [Radoshitzky, Sheli R.; Chi, Xiaoli; Dong, Lian; Bavari, Sina] USA, Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA; [Kuhn, Jens H.] NIAID, Integrated Res Facil Ft Detrick, NIH, Frederick, MD 21702 USA; [Kuhn, Jens H.] Tunnell Consulting Inc, King Of Prussia, PA 19406 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Lai, JR (corresponding author), Albert Einstein Coll Med, Dept Biochem, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	jon.lai@einstein.yu.edu; kartik.chandran@einstein.yu.edu	Radoshitzky, Sheli/L-8410-2019; Kuhn, Jens H./B-7615-2011; Bavari, Sina/L-3642-2019; Radoshitzky, Sheli S/F-2766-2019	Radoshitzky, Sheli/0000-0001-8976-8056; Kuhn, Jens H./0000-0002-7800-6045; Bavari, Sina/0000-0001-8424-5635; Miller, Emily/0000-0002-0640-5653; Harrison, Joseph/0000-0002-2118-6524	National Institutes of Health [R01 AI088027, R01 AI090249]; Albert Einstein College of Medicine; Arnold and Mabel Beckman Foundation; Joint Science and Technology Office Transformational Medical Technologies [TMTI0048_09_RD_T]; Defense Threat Reduction Agency [4.10022_08_RD_B]; NIAID [HHSN272200200016I]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI090249, R01AI088027] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Albert Einstein College of Medicine; Arnold and Mabel Beckman Foundation; Joint Science and Technology Office Transformational Medical Technologies; Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI088027 (to K. C.) and R01 AI090249 (to J. R. L.). This work was also supported by the Albert Einstein College of Medicine, the Arnold and Mabel Beckman Foundation Young Investigators Program (to J. R. L.), and Joint Science and Technology Office Transformational Medical Technologies Proposal TMTI0048_09_RD_T and Defense Threat Reduction Agency Proposal 4.10022_08_RD_B (to S. B.). J. H. K. performed this work as an employee of Tunnell Consulting, Inc., a subcontractor to Battelle Memorial Institute under its prime contract with NIAID, under Contract No. HHSN272200200016I.	Akkarawongsa R, 2008, ANTIMICROB AGENTS CH, V52, P2120, DOI 10.1128/AAC.01424-07; Brindley MA, 2007, J VIROL, V81, P7702, DOI 10.1128/JVI.02433-06; Chan DC, 1998, P NATL ACAD SCI USA, V95, P15613, DOI 10.1073/pnas.95.26.15613; Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656; Dube D, 2009, J VIROL, V83, P2883, DOI 10.1128/JVI.01956-08; Earp LJ, 2005, CURR TOP MICROBIOL, V285, P25; Earp LJ, 2003, J VIROL, V77, P3058, DOI 10.1128/JVI.77.5.3058-3066.2003; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8; Furuta RA, 1998, NAT STRUCT BIOL, V5, P276, DOI 10.1038/nsb0498-276; Gallaher WR, 1996, CELL, V85, P477, DOI 10.1016/S0092-8674(00)81248-9; Gump JM, 2007, TRENDS MOL MED, V13, P443, DOI 10.1016/j.molmed.2007.08.002; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Heinrich BS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000958; HOOD CL, J VIROL, V84, P2972; Ingallinella P, 2009, P NATL ACAD SCI USA, V106, P5801, DOI 10.1073/pnas.0901007106; Ito H, 1999, J VIROL, V73, P8907, DOI 10.1128/JVI.73.10.8907-8912.1999; Jeffers SA, 2002, J VIROL, V76, P12463, DOI 10.1128/JVI.76.24.12463-12472.2002; Kaletsky RL, 2007, J VIROL, V81, P13378, DOI 10.1128/JVI.01170-07; Kuhn JH, 2006, J BIOL CHEM, V281, P15951, DOI 10.1074/jbc.M601796200; Kuhn JH, 2010, ARCH VIROL, V155, P2083, DOI 10.1007/s00705-010-0814-x; Kuhn Jens H, 2008, Arch Virol Suppl, V20, P13; Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082; Lee JE, 2009, FUTURE VIROL, V4, P621, DOI 10.2217/FVL.09.56; Lin G, 2003, J VIROL, V77, P1337, DOI 10.1128/JVI.77.2.1337-1346.2003; Malashkevich VN, 1999, P NATL ACAD SCI USA, V96, P2662, DOI 10.1073/pnas.96.6.2662; Manicassamy B, 2005, J VIROL, V79, P4793, DOI 10.1128/JVI.79.8.4793-4805.2005; Mitchell DJ, 2000, J PEPT RES, V56, P318, DOI 10.1034/j.1399-3011.2000.00723.x; Netter RC, 2004, J VIROL, V78, P13430, DOI 10.1128/JVI.78.24.13430-13439.2004; Porotto M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001168; Porotto M, 2010, J VIROL, V84, P6760, DOI 10.1128/JVI.00135-10; Richard JP, 2005, J BIOL CHEM, V280, P15300, DOI 10.1074/jbc.M401604200; Russell CJ, 2001, EMBO J, V20, P4024, DOI 10.1093/emboj/20.15.4024; Saeed MF, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001110; Schornberg K, 2006, J VIROL, V80, P4174, DOI 10.1128/JVI.80.8.4174-4178.2006; Smith JG, 2004, J VIROL, V78, P1403, DOI 10.1128/JVI.78.3.1403-1410.2004; Takada A, 2004, J VIROL, V78, P2943, DOI 10.1128/JVI.78.6.2943-2947.2004; Takada A, 1997, P NATL ACAD SCI USA, V94, P14764, DOI 10.1073/pnas.94.26.14764; Ujike M, 2008, J VIROL, V82, P588, DOI 10.1128/JVI.01697-07; Volchkov VE, 1998, P NATL ACAD SCI USA, V95, P5762, DOI 10.1073/pnas.95.10.5762; Watanabe S, 2000, J VIROL, V74, P10194, DOI 10.1128/JVI.74.21.10194-10201.2000; Weissenhorn W, 1998, MOL CELL, V2, P605, DOI 10.1016/S1097-2765(00)80159-8; Wexler-Cohen Y, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000509; White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]; WILD CT, 1994, P NATL ACAD SCI USA, V91, P9770, DOI 10.1073/pnas.91.21.9770; Wong AC, 2010, J VIROL, V84, P163, DOI 10.1128/JVI.01832-09; Wool-Lewis RJ, 1999, J VIROL, V73, P1419, DOI 10.1128/JVI.73.2.1419-1426.1999; Wool-Lewis RJ, 1998, J VIROL, V72, P3155, DOI 10.1128/JVI.72.4.3155-3160.1998	48	54	58	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.207084	http://dx.doi.org/10.1074/jbc.M110.207084			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454542	Green Published, hybrid			2022-12-25	WOS:000290022800026
J	Reichau, S; Jiao, WT; Walker, SR; Hutton, RD; Baker, EN; Parker, EJ				Reichau, Sebastian; Jiao, Wanting; Walker, Scott R.; Hutton, Richard D.; Baker, Edward N.; Parker, Emily J.			Potent Inhibitors of a Shikimate Pathway Enzyme from Mycobacterium tuberculosis COMBINING MECHANISM- AND MODELING-BASED DESIGN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-DEOXY-D-ARABINO-HEPTULOSONATE 7-PHOSPHATE SYNTHASE; AMINO-ACID BIOSYNTHESIS; KDO8P SYNTHASE; CRYSTAL-STRUCTURE; PURIFICATION; PRODRUGS; COMPLEX; CRYSTALLOGRAPHY; SYNTHETASE; PHOSPHATES	Tuberculosis remains a serious global health threat, with the emergence of multidrug-resistant strains highlighting the urgent need for novel antituberculosis drugs. The enzyme 3-deoxy-D-arabino-heptulosonate 7-phosphate synthase (DAH7PS) catalyzes the first step of the shikimate pathway for the biosynthesis of aromatic compounds. This pathway has been shown to be essential in Mycobacterium tuberculosis, the pathogen responsible for tuberculosis. DAH7PS catalyzes a condensation reaction between P-enolpyruvate and erythrose 4-phosphate to give 3-deoxy-D-arabino-heptulosonate 7-phosphate. The enzyme reaction mechanism is proposed to include a tetrahedral intermediate, which is formed by attack of an active site water on the central carbon of P-enolpyruvate during the course of the reaction. Molecular modeling of this intermediate into the active site reported in this study shows a configurational preference consistent with water attack from the re face of P-enolpyruvate. Based on this model, we designed and synthesized an inhibitor of DAH7PS that mimics this reaction intermediate. Both enantiomers of this intermediate mimic were potent inhibitors of M. tuberculosis DAH7PS, with inhibitory constants in the nanomolar range. The crystal structure of the DAH7PS-inhibitor complex was solved to 2.35 angstrom. Both the position of the inhibitor and the conformational changes of active site residues observed in this structure correspond closely to the predictions from the intermediate modeling. This structure also identifies a water molecule that is located in the appropriate position to attack the re face of P-enolpyruvate during the course of the reaction, allowing the catalytic mechanism for this enzyme to be clearly defined.	[Parker, Emily J.] Univ Canterbury, Dept Chem, Christchurch 8140, New Zealand; Univ Canterbury, Biomol Interact Ctr, Christchurch 8140, New Zealand; [Baker, Edward N.] Univ Auckland, Sch Biol Sci, Auckland 1010, New Zealand; [Baker, Edward N.] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland 1010, New Zealand	University of Canterbury; University of Canterbury; University of Auckland; University of Auckland	Parker, EJ (corresponding author), Univ Canterbury, Dept Chem, Private Bag 4800, Christchurch 8140, New Zealand.	emily.parker@canterbury.ac.nz	Reichau, Sebastian/C-2525-2016; Jiao, Wanting/I-3159-2019	Jiao, Wanting/0000-0002-0234-7206; Parker, Emily/0000-0002-9571-9987; Baker, Edward/0000-0003-2456-7661; Reichau, Sebastian/0000-0003-1370-8991	Maurice Wilkins Centre for Molecular Biodiscovery; University of Canterbury; New Zealand International Doctoral Research Scholarship (NZIDRS); New Zealand Tertiary Education Commission; International Synchrotron Access Program (ISAP)	Maurice Wilkins Centre for Molecular Biodiscovery; University of Canterbury; New Zealand International Doctoral Research Scholarship (NZIDRS); New Zealand Tertiary Education Commission; International Synchrotron Access Program (ISAP)	This research was funded in part by the Maurice Wilkins Centre for Molecular Biodiscovery.; Supported by a University of Canterbury Doctoral Scholarship and a New Zealand International Doctoral Research Scholarship (NZIDRS).; Supported by a New Zealand Tertiary Education Commission Top Achiever Doctoral Scholarship.; This research was undertaken on the MX2 beamline at the Australian Synchrotron, Victoria, Australia (48). We acknowledge travel funding provided by the International Synchrotron Access Program (ISAP) managed by the Australian Synchrotron and the New Zealand Synchrotron Group.	Ahn M, 2005, ORG BIOMOL CHEM, V3, P4046, DOI 10.1039/b511661a; [Anonymous], 2005, MAESTR VERS 7 5; [Anonymous], 2005, MACROMODEL VERS 9 1; [Anonymous], 2005, SCHROD SUIT 2006 IND; [Anonymous], 2005, GLID VERS 4 0; Armarego W.L.F., 2003, PURIFICATION LAB CHE; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barry CE, 2010, CURR OPIN CHEM BIOL, V14, P456, DOI 10.1016/j.cbpa.2010.04.008; BENTLEY R, 1990, CRIT REV BIOCHEM MOL, V25, P307, DOI 10.3109/10409239009090615; Campbell SA, 2004, INT J PARASITOL, V34, P5, DOI 10.1016/j.ijpara.2003.10.006; DELEO AB, 1973, J BIOL CHEM, V248, P2344; DESS DB, 1991, J AM CHEM SOC, V113, P7277, DOI 10.1021/ja00019a027; Friis GJ, 1996, EUR J PHARM SCI, V4, P49, DOI 10.1016/0928-0987(95)00031-3; Grison C, 2005, CARBOHYD RES, V340, P529, DOI 10.1016/j.carres.2004.11.019; Grison C, 2000, TETRAHEDRON LETT, V41, P6571, DOI 10.1016/S0040-4039(00)01053-4; Hartmann M, 2003, P NATL ACAD SCI USA, V100, P862, DOI 10.1073/pnas.0337566100; Hecker SJ, 2008, J MED CHEM, V51, P2328, DOI 10.1021/jm701260b; IRELAND RE, 1993, J ORG CHEM, V58, P2899, DOI 10.1021/jo00062a040; Kona F, 2007, BIOCHEMISTRY-US, V46, P4532, DOI 10.1021/bi6024879; Kona F, 2009, BIOCHEMISTRY-US, V48, P3610, DOI 10.1021/bi801955h; Konig V, 2004, J MOL BIOL, V337, P675, DOI 10.1016/j.jmb.2004.01.055; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Meya DB, 2007, J INTERN MED, V261, P309, DOI 10.1111/j.1365-2796.2007.01795.x; Parish T, 2002, MICROBIOL-SGM, V148, P3069, DOI 10.1099/00221287-148-10-3069; Petit Y, 1998, ORG SYNTH, V75, P37; RAY PH, 1980, J BACTERIOL, V141, P635, DOI 10.1128/JB.141.2.635-644.1980; Roberts F, 1998, NATURE, V393, P801, DOI 10.1038/31723; Sasso S, 2009, EMBO J, V28, P2128, DOI 10.1038/emboj.2009.165; Schofield LR, 2005, BIOCHEMISTRY-US, V44, P11950, DOI 10.1021/bi050577z; Schonbrunn E, 2001, P NATL ACAD SCI USA, V98, P1376, DOI 10.1073/pnas.98.4.1376; SCHONER R, 1976, J BIOL CHEM, V251, P5440; Schultz C, 2003, BIOORGAN MED CHEM, V11, P885, DOI 10.1016/S0968-0896(02)00552-7; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sharma SK, 2006, CHEST, V130, P261, DOI [10.1378/chest.130.1.261, 10.1016/S0012-3692(15)50981-1]; Shumilin IA, 2004, J MOL BIOL, V341, P455, DOI 10.1016/j.jmb.2004.05.077; Shumilin IA, 2003, BIOCHEMISTRY-US, V42, P3766, DOI 10.1021/bi027257p; Sikorski JA, 1997, ACCOUNTS CHEM RES, V30, P2, DOI 10.1021/ar950122+; Wagner T, 2000, J MOL BIOL, V301, P389, DOI 10.1006/jmbi.2000.3957; Walker SR, 2011, BIOORG MED CHEM LETT, V21, P5092, DOI 10.1016/j.bmcl.2011.03.071; Walker SR, 2009, ORG BIOMOL CHEM, V7, P3031, DOI 10.1039/b909241b; Walker SR, 2006, BIOORG MED CHEM LETT, V16, P2951, DOI 10.1016/j.bmcl.2006.02.073; Wang J, 2001, BIOCHEMISTRY-US, V40, P15676, DOI 10.1021/bi015568e; Webby CJ, 2010, J BIOL CHEM, V285, P30567, DOI 10.1074/jbc.M110.111856; Webby CJ, 2005, J MOL BIOL, V354, P927, DOI 10.1016/j.jmb.2005.09.093; Webby CJ, 2005, ACTA CRYSTALLOGR F, V61, P403, DOI 10.1107/S1744309105007931; Webby CJ, 2005, BIOCHEM J, V390, P223, DOI 10.1042/BJ20050259; WHO, 2009, GLOB TUB CONTR EP ST, P6; Williamson RM, 2005, BIOORG MED CHEM LETT, V15, P2339, DOI 10.1016/j.bmcl.2005.02.080	49	36	37	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.211649	http://dx.doi.org/10.1074/jbc.M110.211649			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454647	hybrid, Green Published			2022-12-25	WOS:000290022800059
J	Melendez, J; Stengel, K; Zhou, X; Chauhan, BK; Debidda, M; Andreassen, P; Lang, RA; Zheng, Y				Melendez, Jaime; Stengel, Kristy; Zhou, Xuan; Chauhan, Bharesh K.; Debidda, Marcella; Andreassen, Paul; Lang, Richard A.; Zheng, Yi			RhoA GTPase Is Dispensable for Actomyosin Regulation but Is Essential for Mitosis in Primary Mouse Embryonic Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN STRESS FIBERS; CITRON-KINASE; FAMILY GTPASES; TRANSFORMED-CELLS; CONTRACTILE RING; MAMMALIAN-CELLS; BINDING PROTEIN; CLEAVAGE FURROW; CDC42 GTPASES; DNA-DAMAGE	RhoA, the founding member of mammalian Rho GTPase family, is thought to be essential for actomyosin regulation. To date, the physiologic function of RhoA in mammalian cell regulation has yet to be determined genetically. Here we have created RhoA conditional knock-out mice. Mouse embryonic fibroblasts deleted of RhoA showed no significant change in actin stress fiber or focal adhesion complex formation in response to serum or LPA, nor any detectable change in Rho-kinase signaling activity. Concomitant knock-out or knockdown of RhoB and RhoC in the RhoA(-/-) cells resulted in a loss of actin stress fiber and focal adhesion similar to that of C3 toxin treatment. Proliferation of RhoA(-/-) cells was impaired due to a complete cell cycle block during mitosis, an effect that is associated with defective cytokinesis and chromosome segregation and can be readily rescued by exogenous expression of RhoA. Furthermore, RhoA deletion did not affect the transcriptional activity of Stat3, NF kappa B, or serum response factor, nor the expression of the cell division kinase inhibitor p21(Cip)1 or p27(Kip1). These genetic results demonstrate that in primary mouse embryonic fibroblasts, RhoA is uniquely required for cell mitosis but is redundant with related RhoB and RhoC GTPases in actomyosin regulation.	[Melendez, Jaime; Stengel, Kristy; Zhou, Xuan; Debidda, Marcella; Andreassen, Paul; Zheng, Yi] Univ Cincinnati, Childrens Hosp Res Fdn, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA; [Chauhan, Bharesh K.; Lang, Richard A.] Univ Cincinnati, Childrens Hosp Res Fdn, Div Dev Biol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati	Zheng, Y (corresponding author), Childrens Hosp, Med Ctr, Div Expt Hematol & Canc Biol, 3333 Brunet Ave, Cincinnati, OH 45229 USA.	yi.zheng@cchmc.org	Lang, Richard/E-5578-2011; Zheng, Yi/J-7235-2015	Zheng, Yi/0000-0001-7089-6074; Lang, Richard/0000-0002-5212-254X; Chauhan, Bharesh/0000-0002-6429-9190; Stengel, Kristy/0000-0002-8330-5744; Melendez Rojel, Jaime/0000-0003-4711-864X	National Institutes of Health [R01 CA150547, R01 HL085362, P30 DK090971]; NATIONAL CANCER INSTITUTE [R01CA150547] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085362] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK090971] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA150547, R01 HL085362, and P30 DK090971 (to Y.Z.).	Andreassen PR, 2001, CANCER RES, V61, P7660; Andreassen PR, 2001, MOL BIOL CELL, V12, P1315, DOI 10.1091/mbc.12.5.1315; Aznar S, 2001, MOL BIOL CELL, V12, P3282, DOI 10.1091/mbc.12.10.3282; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Bustelo XR, 2007, BIOESSAYS, V29, P356, DOI 10.1002/bies.20558; Croft DR, 2006, MOL CELL BIOL, V26, P4612, DOI 10.1128/MCB.02061-05; Di Cunto F, 2000, NEURON, V28, P115, DOI 10.1016/S0896-6273(00)00090-8; Eda M, 2001, J CELL SCI, V114, P3273; Eggert US, 2006, ANNU REV BIOCHEM, V75, P543, DOI 10.1146/annurev.biochem.74.082803.133425; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fritz G, 1997, J BIOL CHEM, V272, P30637, DOI 10.1074/jbc.272.49.30637; Gampel A, 1999, CURR BIOL, V9, P955, DOI 10.1016/S0960-9822(99)80422-9; Gruneberg U, 2006, J CELL BIOL, V172, P363, DOI 10.1083/jcb.200511061; Guo FK, 2006, J BIOL CHEM, V281, P18652, DOI 10.1074/jbc.M603508200; Hakem A, 2005, GENE DEV, V19, P1974, DOI 10.1101/gad.1310805; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Jackson B, 2011, MOL BIOL CELL, V22, P593, DOI 10.1091/mbc.E09-10-0859; Jantsch-Plunger V, 2000, J CELL BIOL, V149, P1391, DOI 10.1083/jcb.149.7.1391; Just I, 2001, INT J MED MICROBIOL, V291, P243, DOI 10.1078/1438-4221-00127; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Kamijo K, 2006, MOL BIOL CELL, V17, P43, DOI 10.1091/mbc.e05-06-0569; Kosako H, 2000, ONCOGENE, V19, P6059, DOI 10.1038/sj.onc.1203987; KOZMA R, 1995, MOL CELL BIOL, V15, P1942; Liu AX, 2001, P NATL ACAD SCI USA, V98, P6192, DOI 10.1073/pnas.111137198; Liu AX, 2001, MOL CELL BIOL, V21, P6906, DOI 10.1128/MCB.21.20.6906-6912.2001; Lohez OD, 2003, J CELL BIOL, V161, P67, DOI 10.1083/jcb.200208140; Madaule P, 1998, NATURE, V394, P491, DOI 10.1038/28873; Mammoto A, 2004, J BIOL CHEM, V279, P26323, DOI 10.1074/jbc.M402725200; Meraldi P, 2004, DEV CELL, V7, P45, DOI 10.1016/j.devcel.2004.06.006; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Montaner S, 1998, J BIOL CHEM, V273, P12779, DOI 10.1074/jbc.273.21.12779; Narumiya S, 2006, CURR OPIN CELL BIOL, V18, P199, DOI 10.1016/j.ceb.2006.02.002; Niiya F, 2006, ONCOGENE, V25, P827, DOI 10.1038/sj.onc.1209124; Nishimura Y, 2006, J CELL SCI, V119, P104, DOI 10.1242/jcs.02737; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; Olson MF, 1998, NATURE, V394, P295, DOI 10.1038/28425; Perona R, 1997, GENE DEV, V11, P463, DOI 10.1101/gad.11.4.463; Piekny A, 2005, TRENDS CELL BIOL, V15, P651, DOI 10.1016/j.tcb.2005.10.006; Ridley AJ, 2001, J CELL SCI, V114, P2713; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Rosario CO, 2010, P NATL ACAD SCI USA, V107, P6888, DOI 10.1073/pnas.0910941107; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084; Wang L, 2003, J BIOL CHEM, V278, P44617, DOI 10.1074/jbc.M308929200; Watanabe S, 2008, MOL BIOL CELL, V19, P2328, DOI 10.1091/mbc.E07-10-1086; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; Werner M, 2008, BIOCHEM SOC T, V36, P371, DOI 10.1042/BST0360371; Yang L, 2006, MOL BIOL CELL, V17, P4675, DOI 10.1091/mbc.E06-05-0466	51	51	51	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15132	15137		10.1074/jbc.C111.229336	http://dx.doi.org/10.1074/jbc.C111.229336			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21454503	hybrid, Green Published			2022-12-25	WOS:000289788300044
J	Ananiadou, S; Sullivan, D; Black, W; Levow, GA; Gillespie, JJ; Mao, CH; Pyysalo, S; Kolluru, B; Tsujii, J; Sobral, B				Ananiadou, Sophia; Sullivan, Dan; Black, William; Levow, Gina-Anne; Gillespie, Joseph J.; Mao, Chunhong; Pyysalo, Sampo; Kolluru, BalaKrishna; Tsujii, Junichi; Sobral, Bruno			Named Entity Recognition for Bacterial Type IV Secretion Systems	PLOS ONE			English	Article							LEGIONELLA-PNEUMOPHILA; CONJUGATION; ONTOLOGY; DNA	Research on specialized biological systems is often hampered by a lack of consistent terminology, especially across species. In bacterial Type IV secretion systems genes within one set of orthologs may have over a dozen different names. Classifying research publications based on biological processes, cellular components, molecular functions, and microorganism species should improve the precision and recall of literature searches allowing researchers to keep up with the exponentially growing literature, through resources such as the Pathosystems Resource Integration Center (PATRIC, patricbrc.org). We developed named entity recognition (NER) tools for four entities related to Type IV secretion systems: 1) bacteria names, 2) biological processes, 3) molecular functions, and 4) cellular components. These four entities are important to pathogenesis and virulence research but have received less attention than other entities, e. g., genes and proteins. Based on an annotated corpus, large domain terminological resources, and machine learning techniques, we developed recognizers for these entities. High accuracy rates (>80%) are achieved for bacteria, biological processes, and molecular function. Contrastive experiments highlighted the effectiveness of alternate recognition strategies; results of term extraction on contrasting document sets demonstrated the utility of these classes for identifying T4SS-related documents.	[Ananiadou, Sophia; Levow, Gina-Anne; Kolluru, BalaKrishna; Tsujii, Junichi] Univ Manchester, Sch Comp Sci, Manchester, Lancs, England; [Ananiadou, Sophia; Black, William; Kolluru, BalaKrishna; Tsujii, Junichi] Univ Manchester, Manchester Interdisciplinary Bioctr, Natl Ctr Text Min, Manchester, Lancs, England; [Sullivan, Dan; Gillespie, Joseph J.; Mao, Chunhong; Sobral, Bruno] Virginia Tech, Virginia Bioinformat Inst, Blacksburg, VA USA; [Pyysalo, Sampo; Tsujii, Junichi] Univ Tokyo, Dept Comp Sci, Sch Informat Sci & Technol, Tokyo, Japan	University of Manchester; University of Manchester; Virginia Polytechnic Institute & State University; University of Tokyo	Ananiadou, S (corresponding author), Univ Manchester, Sch Comp Sci, Manchester, Lancs, England.	dsulliva@vbi.vt.edu	Sobral, Bruno/GVU-7637-2022	Sobral, Bruno/0000-0003-3908-577X; Gillespie, Joseph/0000-0002-5447-7264	National Institutes of Health [HHSN272200900040C, HHSN266200400035C]; Biotechnology and Biological Sciences Research Council [BBS/B/13640, BB/F006039/1]; BBSRC [BB/G53025X/1, BB/F006039/1, BB/G013160/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G53025X/1, BB/G013160/1] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This was supported by the National Institutes of Health (http://www.nih.gov/) [grant numbers HHSN272200900040C and HHSN266200400035C] to BWSS. Sophia Ananiadou and Gina-Anne Levow acknowledge support by the Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk/) through grant numbers BBS/B/13640, BB/F006039/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Martinez CE, 2009, MICROBIOL MOL BIOL R, V73, P775, DOI 10.1128/MMBR.00023-09; Ananiadou S, 2006, TRENDS BIOTECHNOL, V24, P571, DOI 10.1016/j.tibtech.2006.10.002; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Cascales E, 2003, NAT REV MICROBIOL, V1, P137, DOI 10.1038/nrmicro753; Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630; Collier N, 2006, LANG RESOUR EVAL, V40, P405, DOI 10.1007/s10579-007-9019-7; Collier N, 2008, BIOINFORMATICS, V24, P2940, DOI 10.1093/bioinformatics/btn534; CONWAY M, 2008, P 3 INT S SEM MIN BI; Doms A, 2005, NUCLEIC ACIDS RES, V33, pW783, DOI 10.1093/nar/gki470; Ensminger AW, 2009, CURR OPIN MICROBIOL, V12, P67, DOI 10.1016/j.mib.2008.12.004; Finkel J, 2004, P JOINT WORKSH NAT L, P88; Frantzi K., 2000, INT J DIGITAL LIB, V3, P117, DOI DOI 10.1007/S007999900023; Fronzes R, 2009, NAT REV MICROBIOL, V7, P703, DOI 10.1038/nrmicro2218; Gillespie JJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004833; Gillespie JJ, 2010, INFECT IMMUN, V78, P1809, DOI 10.1128/IAI.01384-09; GUYON P, 1980, P NATL ACAD SCI-BIOL, V77, P2693, DOI 10.1073/pnas.77.5.2693; Hamilton HL, 2005, MOL MICROBIOL, V55, P1704, DOI 10.1111/j.1365-2958.2005.04521.x; Hirschman L, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S1-S1; Jin Y, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-492; Jones KM, 2007, J BACTERIOL, V189, P2133, DOI 10.1128/JB.00116-06; Juhas M, 2007, J BACTERIOL, V189, P761, DOI 10.1128/JB.01327-06; KAWAZOE A, 2006, P INT WORKSH BIOM ON, P77; KORVES T, 2009, CONTROLLED VOCABULAR, P279; Kutter S, 2008, J BACTERIOL, V190, P2161, DOI 10.1128/JB.01341-07; LAFFERTY, 2001, P 18 INT C MACH LEAR; Lawley TD, 2003, FEMS MICROBIOL LETT, V224, P1, DOI 10.1016/S0378-1097(03)00430-0; Lee KJ, 2004, J BIOMED INFORM, V37, P436, DOI 10.1016/j.jbi.2004.08.012; Leser U, 2005, BRIEF BIOINFORM, V6, P357, DOI 10.1093/bib/6.4.357; Li LS, 2009, COMPUT BIOL CHEM, V33, P334, DOI 10.1016/j.compbiolchem.2009.07.004; Miyao Y, 2006, COLING/ACL 2006, VOLS 1 AND 2, PROCEEDINGS OF THE CONFERENCE, P1017; Nenadic G., 2004, COLING 2004 P 20 INT, P604; Okanohara D, 2006, COLING/ACL 2006, VOLS 1 AND 2, PROCEEDINGS OF THE CONFERENCE, P465; OKAZAKI N, 2008, P C EMP METH NAT LAN, P447; Okazaki N, 2006, BIOINFORMATICS, V22, P3089, DOI 10.1093/bioinformatics/btl534; PYYSALO TOS, 2010, P 2010 WORKSH BIOM N, P132; SANG EFT, 2000, P CONLL 2000 LLL 200; SASAKI Y, 2008, MAKE MOST NE DICT ST, P63; SCHROEDER GN, J BACTERIOL JB; Segal G, 2005, FEMS MICROBIOL REV, V29, P65, DOI 10.1016/j.femsre.2004.07.001; Tsuruoka, 2004, P INT JOINT WORKSH N, P70, DOI DOI 10.3115/1567594.1567610; TSURUOKA JIT, 2009, EACL 2009 12 C EUR C, P790; Tsuruoka Y, 2005, LECT NOTES COMPUT SC, V3746, P382; TSURUOKA Y, 2006, GENIA TAGGER 3 0; Tsuruoka Y, 2007, BIOINFORMATICS, V23, P2768, DOI 10.1093/bioinformatics/btm393; Wilbur J., 2007, P 2 BIOCREATIVE CHAL, P7; Zupan J, 2000, PLANT J, V23, P11, DOI 10.1046/j.1365-313x.2000.00808.x	46	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e14780	10.1371/journal.pone.0014780	http://dx.doi.org/10.1371/journal.pone.0014780			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21468321	gold, Green Published, Green Submitted			2022-12-25	WOS:000289054600002
J	Dewaard, JR; Hebert, PDN; Humble, LM				deWaard, Jeremy R.; Hebert, Paul D. N.; Humble, Leland M.			A Comprehensive DNA Barcode Library for the Looper Moths (Lepidoptera: Geometridae) of British Columbia, Canada	PLOS ONE			English	Article							IDENTIFICATION; LIFE; DIVERSITY; DIPTERA; GENUS	Background: The construction of comprehensive reference libraries is essential to foster the development of DNA barcoding as a tool for monitoring biodiversity and detecting invasive species. The looper moths of British Columbia (BC), Canada present a challenging case for species discrimination via DNA barcoding due to their considerable diversity and limited taxonomic maturity. Methodology/Principal Findings: By analyzing specimens held in national and regional natural history collections, we assemble barcode records from representatives of 400 species from BC and surrounding provinces, territories and states. Sequence variation in the barcode region unambiguously discriminates over 93% of these 400 geometrid species. However, a final estimate of resolution success awaits detailed taxonomic analysis of 48 species where patterns of barcode variation suggest cases of cryptic species, unrecognized synonymy as well as young species. Conclusions/Significance: A catalog of these taxa meriting further taxonomic investigation is presented as well as the supplemental information needed to facilitate these investigations.	[deWaard, Jeremy R.; Humble, Leland M.] Univ British Columbia, Dept Forest Sci, Vancouver, BC V6T 1W5, Canada; [deWaard, Jeremy R.] Royal British Columbia Museum, Victoria, BC, Canada; [Hebert, Paul D. N.] Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada; [Humble, Leland M.] Nat Resources Canada, Canadian Forest Serv, Victoria, BC, Canada	University of British Columbia; University of Guelph; Natural Resources Canada; Canadian Forest Service	Dewaard, JR (corresponding author), Univ British Columbia, Dept Forest Sci, Vancouver, BC V6T 1W5, Canada.	jdewaard@interchange.ubc.ca	deWaard, Jeremy R/G-8112-2014; Hebert, Paul DN/C-4161-2013	Hebert, Paul DN/0000-0002-3081-6700	Forest Investment Account - Forest Science Program Student Grant; NSERC; Canadian Barcode of Life Network through funding from Genome Canada through the Ontario Genomics Institute	Forest Investment Account - Forest Science Program Student Grant; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Barcode of Life Network through funding from Genome Canada through the Ontario Genomics Institute	Funding was provided by a Forest Investment Account - Forest Science Program Student Grant and an NSERC Graduate Scholarship (to JRD) and by the Canadian Barcode of Life Network through funding from Genome Canada through the Ontario Genomics Institute and from NSERC (to LMH and PDNH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong KF, 2005, PHILOS T R SOC B, V360, P1813, DOI 10.1098/rstb.2005.1713; Barrett RDH, 2005, CAN J ZOOL, V83, P481, DOI 10.1139/Z05-024; Bolte K. B., 1990, Memoirs of the Entomological Society of Canada; Cywinska A, 2006, MED VET ENTOMOL, V20, P413, DOI 10.1111/j.1365-2915.2006.00653.x; deWaard JR, 2009, BIODIVERS CONSERV, V18, P3825, DOI 10.1007/s10531-009-9682-7; DeWaard Jeremy R., 2008, V410, P275; Doak P, 2000, ECOLOGY, V81, P1828, DOI 10.1890/0012-9658(2000)081[1828:PCORDF]2.0.CO;2; Elias-Gutierrez M, 2008, HIDROBIOLOGICA, V18, P63; Ferguson D.C., 1983, CHECK LIST LEPIDOPTE, p88 ; Ferguson DC, 2008, MOTHS AM N MEXICO; Ferris CD, 2010, ZOOTAXA, P1; Foottit RG, 2008, MOL ECOL RESOUR, V8, P1189, DOI 10.1111/j.1755-0998.2008.02297.x; Gibbs J, 2009, ZOOTAXA, P1; Hajibabaei M, 2005, PHILOS T R SOC B, V360, P1959, DOI 10.1098/rstb.2005.1727; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hausmann A, 2009, ZOOTAXA, P1; Hebert PDN, 2010, BIOL LETTERS, V6, P359, DOI 10.1098/rsbl.2009.0848; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hogg ID, 2004, CAN J ZOOL, V82, P749, DOI [10.1139/z04-041, 10.1139/Z04-041]; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; Huemer P, 2009, ZOOTAXA, P1; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Janzen DH, 2005, PHILOS T R SOC B, V360, P1835, DOI 10.1098/rstb.2005.1715; Kerr KCR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004379; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Locke SA, 2010, INT J PARASITOL, V40, P333, DOI 10.1016/j.ijpara.2009.08.012; Lukhtanov VA, 2009, MOL ECOL RESOUR, V9, P1302, DOI 10.1111/j.1755-0998.2009.02577.x; Marshall I.B., 1999, NATL ECOLOGICAL FRAM; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Miller SE, 2007, P NATL ACAD SCI USA, V104, P4775, DOI 10.1073/pnas.0700466104; Mitchell A, 2008, AUST J ENTOMOL, V47, P169, DOI 10.1111/j.1440-6055.2008.00645.x; Nieminen M, 1996, OECOLOGIA, V108, P643, DOI 10.1007/BF00329038; Packer L, 2009, MOL ECOL RESOUR, V9, P42, DOI 10.1111/j.1755-0998.2009.02631.x; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Penev L, 2008, ZOOKEYS, P1, DOI 10.3897/zookeys.1.11; Pohl GR, 2010, ZOOKEYS, P1; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Regier JC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-280; Rivera J, 2009, MOL ECOL RESOUR, V9, P224, DOI 10.1111/j.1755-0998.2009.02648.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Savolainen V, 2005, PHILOS T R SOC B, V360, P1805, DOI 10.1098/rstb.2005.1730; Scoble M, ONLINE LIST VALID AV; Scoble MJ, 1992, LEPIDOPTERA FORM FUN; Smith MA, 2008, P NATL ACAD SCI USA, V105, P12359, DOI 10.1073/pnas.0805319105; Smith MA, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-31; Smith MA, 2006, P NATL ACAD SCI USA, V103, P3657, DOI 10.1073/pnas.0511318103; Smith MA, 2005, PHILOS T R SOC B, V360, P1825, DOI 10.1098/rstb.2005.1714; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TOMON TT, 2007, REVISION GENUS PROBO; Vogler AP, 2007, J ZOOL SYST EVOL RES, V45, P1, DOI 10.1111/j.1439-0469.2006.00384.x; Waugh J, 2007, BIOESSAYS, V29, P188, DOI 10.1002/bies.20529; Wilson A. D., 2010, Journal of Entomology, V7, P60, DOI 10.3923/je.2010.60.79; Witt JDS, 2006, MOL ECOL, V15, P3073, DOI 10.1111/j.1365-294X.2006.02999.x; Zhou X, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-30	54	45	46	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e18290	10.1371/journal.pone.0018290	http://dx.doi.org/10.1371/journal.pone.0018290			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464900	Green Submitted, gold, Green Published			2022-12-25	WOS:000289053800038
J	Kerr, SC; Azzouz, N; Fuchs, SM; Collart, MA; Strahl, BD; Corbett, AH; Laribee, RN				Kerr, Shana C.; Azzouz, Nowel; Fuchs, Stephen M.; Collart, Martine A.; Strahl, Brian D.; Corbett, Anita H.; Laribee, R. Nicholas			The Ccr4-Not Complex Interacts with the mRNA Export Machinery	PLOS ONE			English	Article							NUCLEAR-PORE COMPLEX; SACCHAROMYCES-CEREVISIAE; BINDING PROTEIN; ARGININE METHYLATION; GENE-EXPRESSION; POLY(A) RNA; IN-VIVO; TRANSCRIPTION FACTOR; HISTONE METHYLATION; STATISTICAL-MODEL	Background: The Ccr4-Not complex is a key eukaryotic regulator of gene transcription and cytoplasmic mRNA degradation. Whether this complex also affects aspects of post-transcriptional gene regulation, such as mRNA export, remains largely unexplored. Human Caf1 (hCaf1), a Ccr4-Not complex member, interacts with and regulates the arginine methyltransferase PRMT1, whose targets include RNA binding proteins involved in mRNA export. However, the functional significance of this regulation is poorly understood. Methodology/Principal Findings: Here we demonstrate using co-immunoprecipitation approaches that Ccr4-Not subunits interact with Hmt1, the budding yeast ortholog of PRMT1. Furthermore, using genetic and biochemical approaches, we demonstrate that Ccr4-Not physically and functionally interacts with the heterogenous nuclear ribonucleoproteins (hnRNPs) Nab2 and Hrp1, and that the physical association depends on Hmt1 methyltransferase activity. Using mass spectrometry, co-immunoprecipitation and genetic approaches, we also uncover physical and functional interactions between Ccr4-Not subunits and components of the nuclear pore complex (NPC) and we provide evidence that these interactions impact mRNA export. Conclusions/Significance: Taken together, our findings suggest that Ccr4-Not has previously unrealized functional connections to the mRNA processing/export pathway that are likely important for its role in gene expression. These results shed further insight into the biological functions of Ccr4-Not and suggest that this complex is involved in all aspects of mRNA biogenesis, from the regulation of transcription to mRNA export and turnover.	[Kerr, Shana C.] Emory Univ, Sch Med, Dept Biochem, Cell & Dev Biol Grad Program, Atlanta, GA 30322 USA; [Azzouz, Nowel; Collart, Martine A.] Univ Geneva, Sch Med, Dept Microbiol & Mol Med, CH-1211 Geneva, Switzerland; [Fuchs, Stephen M.; Strahl, Brian D.] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Laribee, R. Nicholas] Univ Tennessee, Hlth Sci Ctr, Dept Pathol & Lab Med, Memphis, TN USA; [Laribee, R. Nicholas] Univ Tennessee, Hlth Sci Ctr, Ctr Canc Res, Memphis, TN USA	Emory University; University of Geneva; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Kerr, SC (corresponding author), Emory Univ, Sch Med, Dept Biochem, Cell & Dev Biol Grad Program, Atlanta, GA 30322 USA.	rlaribee@uthsc.edu	Strahl, Brian/C-7601-2012; Fuchs, Stephen/I-7251-2012; Corbett, Anita/AAH-6106-2021	Strahl, Brian/0000-0002-4947-6259; Corbett, Anita/0000-0002-0461-6895; Collart, Martine/0000-0001-6955-1773; Laribee, R. Nicholas/0000-0003-4519-4470; Fuchs, Stephen/0000-0001-7261-9214	National Institutes of Health [GM58728, GM068088]; Swiss National Science Foundation [3100A0-120419/1]; University of Tennessee; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008367, R01GM068088, R01GM058728, F32GM080896] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Tennessee; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funding from the National Institutes of Health grants GM58728 (to AHC) and GM068088 (to BDS), Swiss National Science Foundation grant 3100A0-120419/1 (to MAC), and start-up funding from the University of Tennessee (to RNL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams A, 1997, METHODS YEAST GENETI; Aguilera A, 2005, CURR OPIN CELL BIOL, V17, P242, DOI 10.1016/j.ceb.2005.03.001; Ahmed S, 2007, TRENDS GENET, V23, P396, DOI 10.1016/j.tig.2007.05.009; Aitchison JD, 1995, J CELL BIOL, V131, P1659, DOI 10.1083/jcb.131.6.1659; Albert TK, 2002, EMBO J, V21, P355, DOI 10.1093/emboj/21.3.355; Azzouz N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006760; Azzouz N, 2009, RNA, V15, P377, DOI 10.1261/rna.1348209; Belanger KD, 2005, GENETICS, V171, P935, DOI 10.1534/genetics.104.036319; Benson JD, 1998, EMBO J, V17, P6714, DOI 10.1093/emboj/17.22.6714; BLOBEL G, 1985, P NATL ACAD SCI USA, V82, P8527, DOI 10.1073/pnas.82.24.8527; BOGERD AM, 1994, J CELL BIOL, V127, P319, DOI 10.1083/jcb.127.2.319; Carmody SR, 2009, J CELL SCI, V122, P1933, DOI 10.1242/jcs.041236; Chang MP, 1999, MOL CELL BIOL, V19, P1056; Chavez S, 2000, EMBO J, V19, P5824, DOI 10.1093/emboj/19.21.5824; Chen JJ, 2002, EMBO J, V21, P1414, DOI 10.1093/emboj/21.6.1414; Clery A, 2008, CURR OPIN STRUC BIOL, V18, P290, DOI 10.1016/j.sbi.2008.04.002; Collart MA, 2003, GENE, V313, P1, DOI 10.1016/S0378-1119(03)00672-3; COLLART MA, 2004, PROGR NUCL ACID RES; Cui Y, 2008, MOL GENET GENOMICS, V279, P323, DOI 10.1007/s00438-007-0314-1; Deluen C, 2002, MOL CELL BIOL, V22, P6735, DOI 10.1128/MCB.22.19.6735-6749.2002; Dermody JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003273; Dilworth DJ, 2001, J CELL BIOL, V153, P1465, DOI 10.1083/jcb.153.7.1465; DOYE V, 1994, EMBO J, V13, P6062, DOI 10.1002/j.1460-2075.1994.tb06953.x; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; Duncan K, 2000, CURR BIOL, V10, P687, DOI 10.1016/S0960-9822(00)00527-3; Erkmann JA, 2004, EXP CELL RES, V296, P12, DOI 10.1016/j.yexcr.2004.03.015; FABRE E, 1994, CELL, V78, P275, DOI 10.1016/0092-8674(94)90297-6; Feuerbach F, 2002, NAT CELL BIOL, V4, P214, DOI 10.1038/ncb756; Galy V, 2004, CELL, V116, P63, DOI 10.1016/S0092-8674(03)01026-2; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Green DM, 2003, P NATL ACAD SCI USA, V100, P1010, DOI 10.1073/pnas.0336594100; Green DM, 2002, J BIOL CHEM, V277, P7752, DOI 10.1074/jbc.M110053200; Gwizdek C, 2006, P NATL ACAD SCI USA, V103, P16376, DOI 10.1073/pnas.0607941103; Heath CV, 1995, J CELL BIOL, V131, P1677, DOI 10.1083/jcb.131.6.1677; Hector RE, 2002, EMBO J, V21, P1800, DOI 10.1093/emboj/21.7.1800; Henry MF, 1996, MOL CELL BIOL, V16, P3668; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kelly SM, 2007, P NATL ACAD SCI USA, V104, P12306, DOI 10.1073/pnas.0701244104; Kessler MM, 1997, GENE DEV, V11, P2545, DOI 10.1101/gad.11.19.2545; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; Kress TL, 2008, MOL CELL, V32, P727, DOI 10.1016/j.molcel.2008.11.013; Lange A, 2008, J BIOL CHEM, V283, P12926, DOI 10.1074/jbc.M800898200; Laribee RN, 2007, P NATL ACAD SCI USA, V104, P5836, DOI 10.1073/pnas.0607996104; Lau NC, 2009, BIOCHEM J, V422, P443, DOI 10.1042/BJ20090500; Lee MS, 1996, GENE DEV, V10, P1233, DOI 10.1101/gad.10.10.1233; Lemaire M, 2000, J BIOL CHEM, V275, P26925; Lenssen E, 2007, EUKARYOT CELL, V6, P2251, DOI 10.1128/EC.00327-06; Lim RYH, 2008, HISTOCHEM CELL BIOL, V129, P105, DOI 10.1007/s00418-007-0371-x; LOEB JDJ, 1995, P NATL ACAD SCI USA, V92, P7647, DOI 10.1073/pnas.92.17.7647; Marfatia KA, 2003, J BIOL CHEM, V278, P6731, DOI 10.1074/jbc.M207571200; McBride AE, 2000, J BIOL CHEM, V275, P3128, DOI 10.1074/jbc.275.5.3128; Mersman DP, 2009, GENE DEV, V23, P951, DOI 10.1101/gad.1769209; Mulder KW, 2007, GENETICS, V176, P181, DOI 10.1534/genetics.106.060640; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Panasenko O, 2006, J BIOL CHEM, V281, P31389, DOI 10.1074/jbc.M604986200; Pulliam KF, 2009, GENETICS, V181, P105, DOI 10.1534/genetics.108.097303; Robin-Lespinasse Y, 2007, J CELL SCI, V120, P638, DOI 10.1242/jcs.03357; Rodriguez MS, 2004, BIOL CELL, V96, P639, DOI 10.1016/j.biolcel.2004.04.014; Rodriguez MS, 2003, TRAFFIC, V4, P566, DOI 10.1034/j.1600-0854.2003.00115.x; Sambrook J., 2002, MOL CLONING LAB MANU; Shen EC, 1998, GENE DEV, V12, P679, DOI 10.1101/gad.12.5.679; Siebel CW, 1996, P NATL ACAD SCI USA, V93, P13641, DOI 10.1073/pnas.93.24.13641; SIKORSKI RS, 1989, GENETICS, V122, P19; Singh RK, 2009, NAT CELL BIOL, V11, P925, DOI 10.1038/ncb1903; SINGLETON DR, 1995, J CELL SCI, V108, P265; Snay-Hodge CA, 1998, EMBO J, V17, P2663, DOI 10.1093/emboj/17.9.2663; Strambio-de-Castillia C, 1999, J CELL BIOL, V144, P839, DOI 10.1083/jcb.144.5.839; Strasser K, 2002, NATURE, V417, P304, DOI 10.1038/nature746; Strasser K, 2000, EMBO J, V19, P410, DOI 10.1093/emboj/19.3.410; Strawn LA, 2001, J BIOL CHEM, V276, P6445, DOI 10.1074/jbc.M008311200; Suntharalingam M, 2003, DEV CELL, V4, P775, DOI 10.1016/S1534-5807(03)00162-X; Swanson MJ, 2003, MOL CELL BIOL, V23, P2800, DOI 10.1128/MCB.23.8.2800-2820.2003; Taura T, 1998, P NATL ACAD SCI USA, V95, P7427, DOI 10.1073/pnas.95.13.7427; Terry LJ, 2007, J CELL BIOL, V178, P1121, DOI 10.1083/jcb.200704174; Thomas D, 1997, MICROBIOL MOL BIOL R, V61, P503, DOI 10.1128/.61.4.503-532.1997; Tran EJ, 2007, MOL CELL, V28, P850, DOI 10.1016/j.molcel.2007.09.019; Tseng SSL, 1998, EMBO J, V17, P2651, DOI 10.1093/emboj/17.9.2651; Tucker M, 2001, CELL, V104, P377, DOI 10.1016/S0092-8674(01)00225-2; Vinciguerra P, 2004, CURR OPIN CELL BIOL, V16, P285, DOI 10.1016/j.ceb.2004.03.013; Vinciguerra P, 2005, EMBO J, V24, P813, DOI 10.1038/sj.emboj.7600527; Viswanathan P, 2004, J BIOL CHEM, V279, P23988, DOI 10.1074/jbc.M402803200; WENTE SR, 1993, J CELL BIOL, V123, P275, DOI 10.1083/jcb.123.2.275; Wilmes GM, 2008, MOL CELL, V32, P735, DOI 10.1016/j.molcel.2008.11.012; WILSON SM, 1994, J CELL BIOL, V127, P1173, DOI 10.1083/jcb.127.5.1173; WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107; Wong DH, 1997, MOL CELL BIOL, V17, P3755, DOI 10.1128/MCB.17.7.3755; Xu C, 2003, RNA, V9, P746, DOI 10.1261/rna.5020803; Yan C, 1998, EMBO J, V17, P7416, DOI 10.1093/emboj/17.24.7416	90	36	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e18302	10.1371/journal.pone.0018302	http://dx.doi.org/10.1371/journal.pone.0018302			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464899	gold, Green Published, Green Submitted			2022-12-25	WOS:000289053800039
J	Kuzmova, E; Bartos, L; Kotrba, R; Bubenik, GA				Kuzmova, Erika; Bartos, Ludek; Kotrba, Radim; Bubenik, George A.			Effect of Different Factors on Proliferation of Antler Cells, Cultured In Vitro	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; BONE-MARROW; DEER ANTLERS; IGF-I; GROWTH; TESTOSTERONE; REGENERATION; EXPRESSION; CHONDROCYTES	Antlers as a potential model for bone growth and development have become an object of rising interest. To elucidate processes explaining how antler growth is regulated, in vitro cultures have been established. However, until now, there has been no standard method to cultivate antler cells and in vitro results are often opposite to those reported in vivo. In addition, many factors which are often not taken into account under in vitro conditions may play an important role in the development of antler cells. In this study we investigated the effects of the antler growth stage, the male individuality, passaged versus primary cultures and the effect of foetal calf serum concentrations on proliferative potential of mixed antler cell cultures in vitro, derived from regenerating antlers of red deer males (Cervus elaphus). The proliferation potential of antler cells was measured by incorporation of H-3 thymidine. Our results demonstrate that there is no significant effect of the antler growth stage, whereas male individuality and all other examined factors significantly affected antler cell proliferation. Furthermore, our results suggest that primary cultures may better represent in vivo conditions and processes occurring in regenerating antlers. In conclusion, before all main factors affecting antler cell proliferation in vitro will be satisfactorily investigated, results of in vitro studies focused on hormonal regulation of antler growth should be taken with extreme caution.	[Kuzmova, Erika; Bartos, Ludek; Kotrba, Radim] Inst Anim Sci, Dept Ethol, Prague, Czech Republic; [Kuzmova, Erika] Charles Univ Prague, Dept Ecol, Prague, Czech Republic; [Bubenik, George A.] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada	Czech Research Institute of Animal Science; Charles University Prague; University of Guelph	Kuzmova, E (corresponding author), Inst Anim Sci, Dept Ethol, Prague, Czech Republic.	kuzmovae@gmail.com	Kužmová, Erika/H-1520-2014	Kuzmova, Erika/0000-0002-0728-9578; Kotrba, Radim/0000-0001-5009-8454	Czech Science Foundation [523/08/0808]; Ministry of Agriculture of the Czech Republic [MZe 00027014020002701404]	Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Agriculture of the Czech Republic(Ministry of Agriculture, Czech Republic)	This study was supported by the Czech Science Foundation (grant number 523/08/0808) and the Ministry of Agriculture of the Czech Republic (grant number MZe 00027014020002701404). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen SP, 2002, DEV BIOL, V251, P409, DOI 10.1006/dbio.2002.0816; BARTOS L, 1987, ACTA THERIOL, V32, P403, DOI 10.4098/AT.arch.87-28; Bartos L, 1997, CAN J ZOOL, V75, P1934, DOI 10.1139/z97-823; Bartos L, 2000, J ENDOCRINOL, V164, P87, DOI 10.1677/joe.0.1640087; Bartos L., 2004, ANTLER SCI PRODUCT T, P45; Bartos L, 2009, BONE, V44, P691, DOI 10.1016/j.bone.2008.12.004; Beales MP, 1999, INVEST OPHTH VIS SCI, V40, P1658; Berg DK, 2007, BIOL REPROD, V77, P384, DOI 10.1095/biolreprod.106.058172; Cegielski M, 2006, B VET I PULAWY, V50, P247; Ciapetti G, 2006, BIOMATERIALS, V27, P6150, DOI 10.1016/j.biomaterials.2006.08.025; Ciba P, 2009, ANN ANAT, V191, P94, DOI 10.1016/j.aanat.2008.07.012; Colitti M, 2005, J ANAT, V207, P339, DOI 10.1111/j.1469-7580.2005.00464.x; Faucheux C, 2001, J EXP BIOL, V204, P443; Hiorns LR, 2004, BRIT J CANCER, V90, P476, DOI 10.1038/sj.bjc.6601405; Itaya T, 2009, J PERIODONTAL RES, V44, P425, DOI 10.1111/j.1600-0765.2008.01137.x; Kierdorf U, 2007, J MORPHOL, V268, P726, DOI 10.1002/jmor.10546; Kierdorf U, 2009, SEMIN CELL DEV BIOL, V20, P535, DOI 10.1016/j.semcdb.2008.11.011; KUZMOVA E, 2011, ANIM PROD S IN PRESS; Le Blanc K, 2005, CYTOTHERAPY, V7, P36, DOI 10.1080/14653240510018118; Li C, 2001, GEN COMP ENDOCR, V124, P75, DOI 10.1006/gcen.2001.7681; Li CY, 2007, CELL TISSUE RES, V328, P65, DOI 10.1007/s00441-006-0333-y; Li CY, 2001, ANAT EMBRYOL, V204, P375, DOI 10.1007/s004290100204; Li CY, 1999, J EXP ZOOL, V284, P82, DOI 10.1002/(SICI)1097-010X(19990615)284:1&lt;82::AID-JEZ11&gt;3.0.CO;2-K; Lutz MB, 2007, IMMUNOBIOLOGY, V212, P855, DOI 10.1016/j.imbio.2007.09.001; Matich J, 2003, CELL BIOL INT, V27, P625, DOI 10.1016/S1065-6995(03)00118-5; MUIR PD, 1987, NEW ZEAL J AGR RES, V30, P305; Patel M, 2009, ARCH ORAL BIOL, V54, P898, DOI 10.1016/j.archoralbio.2009.06.008; Pochampally RR, 2004, BLOOD, V103, P1647, DOI 10.1182/blood-2003-06-1967; Pradel W, 2008, J PHYSIOL PHARMACOL, V59, P47; Price J, 2005, CURR TOP DEV BIOL, V67, P1, DOI 10.1016/S0070-2153(05)67001-9; Price JS, 2005, J ANAT, V207, P603, DOI 10.1111/j.1469-7580.2005.00478.x; Rhodes NP, 2004, J MATER SCI-MATER M, V15, P397, DOI 10.1023/B:JMSM.0000021109.21807.f0; Riekstina U, 2008, CYTOTECHNOLOGY, V58, P153, DOI 10.1007/s10616-009-9183-2; Rolf HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002064; ROLF HJ, 2006, OSTEOLOGY, V15, P245; SADIGHI M, 1994, J ENDOCRINOL, V143, P461, DOI 10.1677/joe.0.1430461; Sadighi M, 2001, GROWTH HORM IGF RES, V11, P240, DOI 10.1054/ghir.2001.0232; Solchaga LA, 1999, CELL TRANSPLANT, V8, P511, DOI 10.1177/096368979900800506; Thibeault SL, 2002, ANN OTO RHINOL LARYN, V111, P8, DOI 10.1177/000348940211100102; Uchida K, 2007, J ORTHOP SCI, V12, P484, DOI 10.1007/s00776-007-1159-5; Vackova I, 2003, ANIM REPROD SCI, V77, P235, DOI 10.1016/S0378-4320(03)00034-4; Werren C, 2008, PFERDEHEILKUNDE, V24, P193; Yokoyama M, 2008, J BIOSCI BIOENG, V106, P46, DOI 10.1263/jbb.106.46	43	8	9	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e18053	10.1371/journal.pone.0018053	http://dx.doi.org/10.1371/journal.pone.0018053			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464927	Green Submitted, Green Published, gold			2022-12-25	WOS:000289053800017
J	Mays, CE; Yeom, J; Kang, HE; Bian, JF; Khaychuk, V; Kim, Y; Bartz, JC; Telling, GC; Ryou, C				Mays, Charles E.; Yeom, Jihyun; Kang, Hae-Eun; Bian, Jifeng; Khaychuk, Vadim; Kim, Younghwan; Bartz, Jason C.; Telling, Glenn C.; Ryou, Chongsuk			In Vitro Amplification of Misfolded Prion Protein Using Lysate of Cultured Cells	PLOS ONE			English	Article							CYCLIC AMPLIFICATION; PRPSC; CONVERSION; STRAINS; LINE; NEUROBLASTOMA; INFECTIVITY; PROPAGATION; GENERATION; COMPLEXES	Protein misfolding cyclic amplification (PMCA) recapitulates the prion protein (PrP) conversion process under cell-free conditions. PMCA was initially established with brain material and then with further simplified constituents such as partially purified and recombinant PrP. However, availability of brain material from some species or brain material from animals with certain mutations or polymorphisms within the PrP gene is often limited. Moreover, preparation of native PrP from mammalian cells and tissues, as well as recombinant PrP from bacterial cells, involves time-consuming purification steps. To establish a convenient and versatile PMCA procedure unrestricted to the availability of substrate sources, we attempted to conduct PMCA with the lysate of cells that express cellular PrP (PrPC). PrPSc was efficiently amplified with lysate of rabbit kidney epithelial RK13 cells stably transfected with the mouse or Syrian hamster PrP gene. Furthermore, PMCA was also successful with lysate of other established cell lines of neuronal or non-neuronal origins. Together with the data showing that the abundance of PrPC in cell lysate was a critical factor to drive efficient PrPSc amplification, our results demonstrate that cell lysate in which PrPC is present abundantly serves as an excellent substrate source for PMCA.	[Mays, Charles E.; Khaychuk, Vadim; Telling, Glenn C.; Ryou, Chongsuk] Univ Kentucky, Coll Med, Dept Microbiol Mol Genet & Immunol, Lexington, KY USA; [Yeom, Jihyun; Kang, Hae-Eun; Bian, Jifeng; Kim, Younghwan; Telling, Glenn C.; Ryou, Chongsuk] Univ Kentucky, Coll Med, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Bartz, Jason C.] Creighton Univ, Dept Med Microbiol & Immunol, Omaha, NE 68178 USA	University of Kentucky; University of Kentucky; Creighton University	Mays, CE (corresponding author), Univ Alberta, Ctr Prions & Prot Folding Dis, Edmonton, AB, Canada.	cryou2@email.uky.edu	Bian, Jifeng/AAE-6262-2019; Telling, Glenn C/G-1217-2019	Bian, Jifeng/0000-0001-6838-9938; Telling, Glenn C/0000-0002-6294-1805; Bartz, Jason/0000-0003-4081-7886	Sanders-Brown Center on Aging; Department of Microbiology, Immunology, and Molecular Genetics, University of Kentucky College of Medicine	Sanders-Brown Center on Aging; Department of Microbiology, Immunology, and Molecular Genetics, University of Kentucky College of Medicine	This work was supported in part by funds from the Sanders-Brown Center on Aging and the Department of Microbiology, Immunology, and Molecular Genetics, University of Kentucky College of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abid K, 2010, FEBS LETT, V584, P2409, DOI 10.1016/j.febslet.2010.04.040; Atarashi R, 2007, NAT METHODS, V4, P645, DOI 10.1038/NMETH1066; BALKEMABUSCHMAN.A, 2010, J GEN VIROL, DOI DOI 10.1099/VIR.1090.025387-025380; Barria MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000421; BEALE AJ, 1963, LANCET, V2, P640; BESSEN RA, 1992, J GEN VIROL, V73, P329, DOI 10.1099/0022-1317-73-2-329; Bian JF, 2010, J VIROL, V84, P8322, DOI 10.1128/JVI.00633-10; Birkett CR, 2001, EMBO J, V20, P3351, DOI 10.1093/emboj/20.13.3351; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Castilla J, 2005, NAT MED, V11, P982, DOI 10.1038/nm1286; Castilla J, 2008, CELL, V134, P757, DOI 10.1016/j.cell.2008.07.030; Castilla J, 2006, METHOD ENZYMOL, V412, P3, DOI 10.1016/s0076-6879(06)12001-7; Courageot MP, 2008, J GEN VIROL, V89, P341, DOI 10.1099/vir.0.83344-0; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Deleault NR, 2010, BIOCHEMISTRY-US, V49, P3928, DOI 10.1021/bi100370b; Deleault NR, 2005, J BIOL CHEM, V280, P26873, DOI 10.1074/jbc.M503973200; Deleault NR, 2003, NATURE, V425, P717, DOI 10.1038/nature01979; Geoghegan JC, 2007, J BIOL CHEM, V282, P36341, DOI 10.1074/jbc.M704447200; Geoghegan JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000535; Gonzalez-Romero D, 2008, FEBS LETT, V582, P3161, DOI 10.1016/j.febslet.2008.08.003; GORODINSKY A, 1995, J CELL BIOL, V129, P619, DOI 10.1083/jcb.129.3.619; Graham JF, 2010, J BIOL CHEM, V285, P9868, DOI 10.1074/jbc.M109.093484; Green KM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000139; Haley NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007990; JAINCHIL.JL, 1969, J VIROL, V4, P549, DOI 10.1128/JVI.4.5.549-553.1969; Jones M, 2007, J PATHOL, V213, P21, DOI 10.1002/path.2204; Jones M, 2009, TRANSFUSION, V49, P376, DOI 10.1111/j.1537-2995.2008.01954.x; Kim JI, 2010, J BIOL CHEM, V285, P14083, DOI 10.1074/jbc.C110.113464; Kim JI, 2009, FEBS LETT, V583, P3671, DOI 10.1016/j.febslet.2009.10.049; Kim NH, 2005, FASEB J, V19, P783, DOI 10.1096/fj.04-2117fje; KLEBE RJ, 1969, J CELL BIOL, V43, pA69; Kurt TD, 2007, J VIROL, V81, P9605, DOI 10.1128/JVI.00635-07; Kurt TD, 2009, VIROLOGY, V387, P235, DOI 10.1016/j.virol.2009.02.025; Kuwahara C, 1999, NATURE, V400, P225, DOI 10.1038/22241; Leblanc P, 2006, EMBO J, V25, P2674, DOI 10.1038/sj.emboj.7601162; Lucassen R, 2003, BIOCHEMISTRY-US, V42, P4127, DOI 10.1021/bi027218d; Mays CE, 2008, BRAIN RES, V1208, P170, DOI 10.1016/j.brainres.2008.02.103; Mays CE, 2010, FASEB J, V24, P5102, DOI 10.1096/fj.10-163600; Mays CE, 2009, BIOCHEM BIOPH RES CO, V388, P306, DOI 10.1016/j.bbrc.2009.07.163; Meyerett C, 2008, VIROLOGY, V382, P267, DOI 10.1016/j.virol.2008.09.023; Murayama Y, 2007, NEUROSCI LETT, V413, P270, DOI 10.1016/j.neulet.2006.11.056; Murayama Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013152; Naslavsky N, 1997, J BIOL CHEM, V272, P6324, DOI 10.1074/jbc.272.10.6324; Nishina K, 2004, BIOCHEMISTRY-US, V43, P2613, DOI 10.1021/bi035889l; Nishina KA, 2006, BIOCHEMISTRY-US, V45, P14129, DOI 10.1021/bi061526k; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rubenstein R, 2010, J GEN VIROL, V91, P1883, DOI 10.1099/vir.0.020164-0; Ryou Chongsuk, 2008, Int J Med Sci, V5, P347; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Saborio GP, 1999, BIOCHEM BIOPH RES CO, V258, P470, DOI 10.1006/bbrc.1999.0660; Shi S, 2009, VIRUS RES, V141, P26, DOI 10.1016/j.virusres.2008.12.010; Shikiya RA, 2010, J VIROL, V84, P5706, DOI 10.1128/JVI.00243-10; Soto C, 2005, FEBS LETT, V579, P638, DOI 10.1016/j.febslet.2004.12.035; STAHL N, 1990, BIOCHEMISTRY-US, V29, P5405, DOI 10.1021/bi00474a028; Tattum MH, 2010, TRANSFUSION, V50, P996, DOI 10.1111/j.1537-2995.2010.02595.x; Thorne L, 2008, J GEN VIROL, V89, P3177, DOI 10.1099/vir.0.2008/004226-0; Vey M, 1996, P NATL ACAD SCI USA, V93, P14945, DOI 10.1073/pnas.93.25.14945; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Weber P, 2007, VET MICROBIOL, V123, P346, DOI 10.1016/j.vetmic.2007.04.004; Yanai A, 1999, FEBS LETT, V460, P11, DOI 10.1016/S0014-5793(99)01316-2	61	19	19	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e18047	10.1371/journal.pone.0018047	http://dx.doi.org/10.1371/journal.pone.0018047			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464935	Green Published, Green Submitted, gold			2022-12-25	WOS:000289053800015
J	Catanzaro, D; Labbe, M; Porretta, L				Catanzaro, Daniele; Labbe, Martine; Porretta, Luciano			A Class Representative Model for Pure Parsimony Haplotyping under Uncertain Data	PLOS ONE			English	Article							GENE; SUSCEPTIBILITY; INFERENCE; RISK; POPULATIONS; ASSOCIATION; ALGORITHMS; COMPLEXITY; MUTATION	The Pure Parsimony Haplotyping (PPH) problem is a NP-hard combinatorial optimization problem that consists of finding the minimum number of haplotypes necessary to explain a given set of genotypes. PPH has attracted more and more attention in recent years due to its importance in analysis of many fine-scale genetic data. Its application fields range from mapping complex disease genes to inferring population histories, passing through designing drugs, functional genomics and pharmacogenetics. In this article we investigate, for the first time, a recent version of PPH called the Pure Parsimony Haplotype problem under Uncertain Data (PPH-UD). This version mainly arises when the input genotypes are not accurate, i.e., when some single nucleotide polymorphisms are missing or affected by errors. We propose an exact approach to solution of PPH-UD based on an extended version of Catanzaro et al. [1] class representative model for PPH, currently the state-of-the-art integer programming model for PPH. The model is efficient, accurate, compact, polynomial-sized, easy to implement, solvable with any solver for mixed integer programming, and usable in all those cases for which the parsimony criterion is well suited for haplotype estimation.	[Catanzaro, Daniele; Labbe, Martine; Porretta, Luciano] Univ Libre Bruxelles, Dept Comp Sci, Brussels, Belgium	Universite Libre de Bruxelles	Catanzaro, D (corresponding author), Univ Libre Bruxelles, Dept Comp Sci, CP 210-01, Brussels, Belgium.	dacatanz@ulb.ac.be	Catanzaro, Daniele/L-2486-2017	Catanzaro, Daniele/0000-0001-9427-1562; Labbe, Martine/0000-0001-7471-2308	Belgian National Fund for Scientific Research; Belgian American Education Foundation; Communaute Francaise de Belgique | Actions de Recherche Concertees (ARC); Ministerio de Ciencia e Innovacion [MTM2009-14039-C06]	Belgian National Fund for Scientific Research(Fonds de la Recherche Scientifique - FNRS); Belgian American Education Foundation; Communaute Francaise de Belgique | Actions de Recherche Concertees (ARC); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	DC acknowledges support from the Belgian National Fund for Scientific Research (F.N.R.S.), of which he is Charge de Recherches and from the Belgian American Education Foundation (B. A. E. F.). DC and ML also acknowledge support from Communaute Francaise de Belgique | Actions de Recherche Concertees (ARC). ML acknowledges support from "Ministerio de Ciencia e Innovacion" through the research project MTM2009-14039-C06. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; BELL GI, 1984, DIABETES, V33, P176, DOI 10.2337/diabetes.33.2.176; Brown DG, 2006, IEEE ACM T COMPUT BI, V3, P141, DOI 10.1109/TCBB.2006.24; Catanzaro D, 2010, HUMAN IMMUN IN PRESS; Catanzaro D, 2009, INT T OPER RES, V16, P561, DOI 10.1111/j.1475-3995.2009.00716.x; Catanzaro D, 2010, INFORMS J COMPUT, V22, P195, DOI 10.1287/ijoc.1090.0333; Clark VJ, 2001, HUM GENET, V108, P484, DOI 10.1007/s004390100512; Dahlback B, 1997, THROMB HAEMOSTASIS, V78, P483; Deeb SS, 1998, NAT GENET, V20, P284, DOI 10.1038/3099; DORMAN JS, 1990, P NATL ACAD SCI USA, V87, P7370, DOI 10.1073/pnas.87.19.7370; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Gusfield D, 2003, LECT NOTES COMPUT SC, V2676, P144; Gusfield D, 2001, J COMPUT BIOL, V8, P305, DOI 10.1089/10665270152530863; Halldorsson BV, 2003, LECT NOTE COMPUTER S, V2731; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Lancia G, 2006, OPER RES LETT, V34, P289, DOI 10.1016/j.orl.2005.05.007; Lancia G, 2004, INFORMS J COMPUT, V16, P348, DOI 10.1287/ijoc.1040.0085; LI WH, 1991, GENETICS, V129, P513; Lu X, 2003, GENOME RES, V13, P2112, DOI 10.1101/gr.586803; Marchini J, 2006, AM J HUM GENET, V78, P437, DOI 10.1086/500808; Nistico L, 1996, HUM MOL GENET, V5, P1075, DOI 10.1093/hmg/5.7.1075; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; Pennacchio LA, 2001, SCIENCE, V294, P169, DOI 10.1126/science.1064852; Rioux JD, 2001, NAT GENET, V29, P223, DOI 10.1038/ng1001-223; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Strittmatter WJ, 1996, ANNU REV NEUROSCI, V19, P53, DOI 10.1146/annurev.ne.19.030196.000413; Van Eerdewegh P, 2002, NATURE, V418, P426, DOI 10.1038/nature00878; Wang LS, 2003, BIOINFORMATICS, V19, P1773, DOI 10.1093/bioinformatics/btg239; Zhang XS, 2006, CURR BIOINFORM, V1, P105, DOI 10.2174/157489306775330570	33	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e17937	10.1371/journal.pone.0017937	http://dx.doi.org/10.1371/journal.pone.0017937			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464966	gold, Green Submitted, Green Published			2022-12-25	WOS:000288813900021
J	Holder, BP; Simon, P; Liao, LE; Abed, Y; Bouhy, X; Beauchemin, CAA; Boivin, G				Holder, Benjamin P.; Simon, Philippe; Liao, Laura E.; Abed, Yacine; Bouhy, Xavier; Beauchemin, Catherine A. A.; Boivin, Guy			Assessing the In Vitro Fitness of an Oseltamivir-Resistant Seasonal A/H1N1 Influenza Strain Using a Mathematical Model	PLOS ONE			English	Article							A VIRUS-INFECTION; NEURAMINIDASE INHIBITOR; VIRAL DYNAMICS; H274Y MUTATION; NS1 PROTEIN; H1N1 VIRUS; MDCK CELLS; VIVO; REPLICATION; APOPTOSIS	In 2007, the A/Brisbane/59/2007 (H1N1) seasonal influenza virus strain acquired the oseltamivir-resistance mutation H275Y in its neuraminidase (NA) gene. Although previous studies had demonstrated that this mutation impaired the replication capacity of the influenza virus in vitro and in vivo, the A/Brisbane/59/2007 H275Y oseltamivir-resistant mutant completely out-competed the wild-type (WT) strain and was, in the 2008-2009 influenza season, the primary A/H1N1 circulating strain. Using a combination of plaque and viral yield assays, and a simple mathematical model, approximate values were extracted for two basic viral kinetics parameters of the in vitro infection. In the ST6GalI-MDCK cell line, the latent infection period (i.e., the time for a newly infected cell to start releasing virions) was found to be 1-3 h for the WT strain and more than 7 h for the H275Y mutant. The infecting time (i.e., the time for a single infectious cell to cause the infection of another one) was between 30 and 80 min for the WT, and less than 5 min for the H275Y mutant. Single-cycle viral yield experiments have provided qualitative confirmation of these findings. These results, though preliminary, suggest that the increased fitness success of the A/Brisbane/59/2007 H275Y mutant may be due to increased infectivity compensating for an impaired or delayed viral release, and are consistent with recent evidence for the mechanistic origins of fitness reduction and recovery in NA expression. The method applied here can reconcile seemingly contradictory results from the plaque and yield assays as two complementary views of replication kinetics, with both required to fully capture a strain's fitness.	[Holder, Benjamin P.; Liao, Laura E.; Beauchemin, Catherine A. A.] Ryerson Univ, Dept Phys, Toronto, ON, Canada; [Simon, Philippe; Abed, Yacine; Bouhy, Xavier; Boivin, Guy] CHUQ CHUL, Infect Dis Res Ctr, Quebec City, PQ, Canada; [Simon, Philippe; Abed, Yacine; Bouhy, Xavier; Boivin, Guy] Univ Laval, Quebec City, PQ, Canada	Toronto Metropolitan University; Laval University; Laval University	Holder, BP (corresponding author), Ryerson Univ, Dept Phys, Toronto, ON, Canada.	cbeau@ryerson.ca; Guy.Boivin@crchul.ulaval.ca	Beauchemin, Catherine AA/G-4619-2011; SIMON, Philippe/GXZ-4688-2022	Beauchemin, Catherine AA/0000-0003-0599-0069; Liao, Laura/0000-0001-6069-2633; Boivin, Guy/0000-0003-3027-4662	Canadian Institutes for Health Research [86937]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported by a grant from the Canadian Institutes for Health Research [www.cihr-irsc.gc.ca; funding reference number 86937] (GB and CAAB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed Y, 2004, ANTIVIR THER, V9, P577; Aoki FY, 2007, ANTIVIR THER, V12, P603; Baccam P, 2006, J VIROL, V80, P7590, DOI 10.1128/JVI.01623-05; Baz M, 2006, CLIN INFECT DIS, V43, P1555, DOI 10.1086/508777; Baz M, 2010, J INFECT DIS, V201, P740, DOI 10.1086/650464; Beauchemin CAA, 2008, J THEOR BIOL, V254, P439, DOI 10.1016/j.jtbi.2008.05.031; Bloom JD, 2010, SCIENCE, V328, P1272, DOI 10.1126/science.1187816; BOCHAROV GA, 1994, J THEOR BIOL, V167, P323, DOI 10.1006/jtbi.1994.1074; Carr J, 2000, ANTIVIR RES, V46, pA59; Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; Collin N, 2009, VACCINE, V27, P5184, DOI 10.1016/j.vaccine.2009.06.034; Collins PJ, 2008, NATURE, V453, P1258, DOI 10.1038/nature06956; Correia V, 2010, ANTIVIR RES, V86, P128, DOI 10.1016/j.antiviral.2010.01.002; Dharan NJ, 2009, JAMA-J AM MED ASSOC, V301, P1034, DOI 10.1001/jama.2009.294; Doceul V, 2010, SCIENCE, V327, P873, DOI 10.1126/science.1183173; DULBECCO R, 1954, J EXP MED, V99, P167, DOI 10.1084/jem.99.2.167; DULBECCO R, 1952, P NATL ACAD SCI USA, V38, P747, DOI 10.1073/pnas.38.8.747; Efron B., 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815; Fort J, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.178101; GAUSH CR, 1968, APPL MICROBIOL, V16, P588, DOI 10.1128/AEM.16.4.588-594.1968; Gubareva LV, 2000, LANCET, V355, P827, DOI 10.1016/S0140-6736(99)11433-8; Handel A, 2010, J R SOC INTERFACE, V7, P35, DOI 10.1098/rsif.2009.0067; Hatakeyama S, 2005, J CLIN MICROBIOL, V43, P4139, DOI 10.1128/JCM.43.8.4139-4146.2005; Hayden FG, 1996, ANTIVIRAL DRUG RESIS, P59; HERLOCHER M, 2002, ANTIVIR RES, V55, P307; Herlocher ML, 2004, J INFECT DIS, V190, P1627, DOI 10.1086/424572; Herzog P, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-138; HINSHAW VS, 1994, J VIROL, V68, P3667, DOI 10.1128/JVI.68.6.3667-3673.1994; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; HOLDER BP, 2011, BMC PUBLIC IN PRESS; HOLDER BP, 2011, AUTOIMMUNIT IN PRESS; HUANG AS, 1970, NATURE, V226, P325, DOI 10.1038/226325a0; Hurt AC, 2010, J VIROL, V84, P9427, DOI 10.1128/JVI.00373-10; Ives JAL, 2002, ANTIVIR RES, V55, P307, DOI 10.1016/S0166-3542(02)00053-0; KAVERIN NV, 1995, J VIROL, V69, P2700, DOI 10.1128/JVI.69.4.2700-2703.1995; KOCH AL, 1964, J THEOR BIOL, V6, P413, DOI 10.1016/0022-5193(64)90056-6; Lackenby A, 2008, CURR OPIN INFECT DIS, V21, P626, DOI 10.1097/QCO.0b013e3283199797; Marcus PI, 2009, J VIROL, V83, P8122, DOI 10.1128/JVI.02680-08; Marriott AC, 2010, REV MED VIROL, V20, P51, DOI 10.1002/rmv.641; Matrosovich M, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-63; MCCASKILL J, 1991, BIOPHYS J, V61, P1540; Min JY, 2006, P NATL ACAD SCI USA, V103, P7100, DOI 10.1073/pnas.0602184103; Mohler L, 2005, BIOTECHNOL BIOENG, V90, P46, DOI 10.1002/bit.20363; Moscona A, 2009, NEW ENGL J MED, V360, P953, DOI 10.1056/NEJMp0900648; Mossong J, 2009, ANTIVIR RES, V84, P91, DOI 10.1016/j.antiviral.2009.08.001; NAGAI T, 1995, ANTIVIR RES, V26, P11, DOI 10.1016/0166-3542(94)00062-D; Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103; Noah JW, 2007, ANTIVIR RES, V73, P50, DOI 10.1016/j.antiviral.2006.07.006; Nowak MA, 1996, P NATL ACAD SCI USA, V93, P4398, DOI 10.1073/pnas.93.9.4398; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; POTIER M, 1979, ANAL BIOCHEM, V94, P287, DOI 10.1016/0003-2697(79)90362-2; Rameix-Welti MA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000103; Rasband W., 2006, IMAGEJ; Schirmer P, 2009, EXPERT OPIN DRUG SAF, V8, P357, DOI [10.1517/14740330902840519 , 10.1517/14740330902840519]; Sidorenko Y, 2004, BIOTECHNOL BIOENG, V88, P1, DOI 10.1002/bit.20096; Sieuwerts S, 2008, LETT APPL MICROBIOL, V47, P275, DOI 10.1111/j.1472-765X.2008.02417.x; SIMON P, 2010, J CLIN MICROBIOL; Smith AM, 2010, J MATH BIOL, V60, P711, DOI 10.1007/s00285-009-0281-8; TAKIZAWA T, 1993, J GEN VIROL, V74, P2347, DOI 10.1099/0022-1317-74-11-2347; Triana-Baltzer GB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007838; VANKLEY A, 2003, ADV BIOCH PROTEIN PR; von Itzstein M, 2007, NAT REV DRUG DISCOV, V6, P967, DOI 10.1038/nrd2400; Wagner R, 2002, REV MED VIROL, V12, P159, DOI 10.1002/rmv.352; Wu HL, 2008, B MATH BIOL, V70, P785, DOI 10.1007/s11538-007-9279-9; Yen HL, 2005, ANTIMICROB AGENTS CH, V49, P4075, DOI 10.1128/AAC.49.10.4075-4084.2005; Yen HL, 2007, J VIROL, V81, P12418, DOI 10.1128/JVI.01067-07; Zaraket H, 2010, J CLIN MICROBIOL, V48, P1085, DOI 10.1128/JCM.01532-09; Zhirnov OP, 2002, J VIROL, V76, P1617, DOI 10.1128/JVI.76.4.1617-1625.2002	69	38	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2011	6	3							e14767	10.1371/journal.pone.0014767	http://dx.doi.org/10.1371/journal.pone.0014767			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740RG	21455300	Green Submitted, Green Published, gold			2022-12-25	WOS:000288811500001
J	Ismail, Y; McCormick, S; Hijri, M				Ismail, Youssef; McCormick, Susan; Hijri, Mohamed			A Fungal Symbiont of Plant-Roots Modulates Mycotoxin Gene Expression in the Pathogen Fusarium sambucinum	PLOS ONE			English	Article							GLOMUS-INTRARADICES; HEAD BLIGHT; TRICHOTHECENE 3-O-ACETYLTRANSFERASE; SECONDARY METABOLISM; SPOROTRICHIOIDES; BIOSYNTHESIS; GRAMINEARUM; VOLATILES; GROWTH; TRI101	Fusarium trichothecenes are fungal toxins that cause disease on infected plants and, more importantly, health problems for humans and animals that consume infected fruits or vegetables. Unfortunately, there are few methods for controlling mycotoxin production by fungal pathogens. In this study, we isolated and characterized sixteen Fusarium strains from naturally infected potato plants in the field. Pathogenicity tests were carried out in the greenhouse to evaluate the virulence of the strains on potato plants as well as their trichothecene production capacity, and the most aggressive strain was selected for further studies. This strain, identified as F. sambucinum, was used to determine if trichothecene gene expression was affected by the symbiotic Arbuscular mycorrhizal fungus (AMF) Glomus irregulare. AMF form symbioses with plant roots, in particular by improving their mineral nutrient uptake and protecting plants against soil-borne pathogens. We found that that G. irregulare significantly inhibits F. sambucinum growth. We also found, using RT-PCR assays to assess the relative expression of trichothecene genes, that in the presence of the AMF G. irregulare, F. sambucinum genes TRI5 and TRI6 were up-regulated, while TRI4, TRI13 and TRI101 were down-regulated. We conclude that AMF can modulate mycotoxin gene expression by a plant fungal pathogen. This previously undescribed effect may be an important mechanism for biological control and has fascinating implications for advancing our knowledge of plant-microbe interactions and controlling plant pathogens.	[Ismail, Youssef; Hijri, Mohamed] Univ Montreal, Dept Sci Biol, Inst Rech Biol Vegetale, Montreal, PQ H3C 3J7, Canada; [Ismail, Youssef] Desert Res Ctr, Dept Plant Protect, Plant Pathol Unit, Cairo, Egypt; [McCormick, Susan] USDA, Bacterial Foodborne Pathogens & Mycol Res Unit, NCAUR, Peoria, IL USA	Universite de Montreal; Egyptian Knowledge Bank (EKB); Desert Research Center (DRC); United States Department of Agriculture (USDA)	Ismail, Y (corresponding author), Univ Montreal, Dept Sci Biol, Inst Rech Biol Vegetale, CP 6128, Montreal, PQ H3C 3J7, Canada.	Mohamed.Hijri@umontreal.ca	Hijri, Mohamed/ABC-5969-2021; Hijri, Mohamed/AAL-5737-2021	Hijri, Mohamed/0000-0001-6112-8372; McCormick, Susan/0000-0002-7824-6372	NSERC; Ministry of Higher Education of Egypt	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ministry of Higher Education of Egypt(Ministry of Higher Education & Scientific Research (MHESR))	This research is supported by an NSERC Discovery grant to MH. YI received a grant and scholarship from the Ministry of Higher Education of Egypt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander NJ, 2008, CAN J MICROBIOL, V54, P1023, DOI 10.1139/W08-100; Angelard C, 2010, CURR BIOL, V20, P1216, DOI 10.1016/j.cub.2010.05.031; AYERS G. W., 1956, American Potato Journal, V33, P1, DOI 10.1007/BF02846537; Boon E, 2010, J EVOLUTION BIOL, V23, P1519, DOI 10.1111/j.1420-9101.2010.02019.x; Brown DW, 2002, FUNGAL GENET BIOL, V36, P224, DOI 10.1016/S1087-1845(02)00021-X; Calvo AM, 2002, MICROBIOL MOL BIOL R, V66, P447, DOI 10.1128/MMBR.66.3.447-459.2002; Choudhary DK, 2008, CURR SCI INDIA, V94, P595; Cooney JM, 2001, J AGR FOOD CHEM, V49, P522, DOI 10.1021/jf0006372; Desjardins AE, 1997, MOL PLANT MICROBE IN, V10, P147, DOI 10.1094/MPMI.1997.10.2.147; Edwards SG, 2001, APPL ENVIRON MICROB, V67, P1575, DOI 10.1128/AEM.67.4.1575-1580.2001; Filion M, 1999, NEW PHYTOL, V141, P525, DOI 10.1046/j.1469-8137.1999.00366.x; Garvey GS, 2008, J BIOL CHEM, V283, P1660, DOI 10.1074/jbc.M705752200; Hijri M, 2005, NATURE, V433, P160, DOI 10.1038/nature03069; Hijri M, 2004, FUNGAL GENET BIOL, V41, P253, DOI 10.1016/j.fgb.2003.10.011; Hijri M, 2007, FUNGAL GENET BIOL, V44, P1380, DOI 10.1016/j.fgb.2007.03.004; Keller NP, 2005, NAT REV MICROBIOL, V3, P937, DOI 10.1038/nrmicro1286; Lecomte J, 2011, FEMS MICROBIOL LETT, V317, P43, DOI 10.1111/j.1574-6968.2011.02209.x; Leslie J F, 2006, Mycotoxin Res, V22, P73, DOI 10.1007/BF02956766; Lioussanne L, 2009, MYCORRHIZA, V19, P443, DOI 10.1007/s00572-009-0257-y; McCormick SP, 2010, APPL ENVIRON MICROB, V76, P136, DOI 10.1128/AEM.02017-09; McCormick SP, 1999, APPL ENVIRON MICROB, V65, P5252; MILLER JD, 1986, CAN J BOT, V64, P1, DOI 10.1139/b86-001; Nielsen Carina, 2009, Mycotoxin Res, V25, P77, DOI 10.1007/s12550-009-0011-5; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Piesik D, 2007, J PHYTOPATHOL, V155, P488, DOI 10.1111/j.1439-0434.2007.01266.x; Pirgozliev SR, 2003, EUR J PLANT PATHOL, V109, P731, DOI 10.1023/A:1026034509247; PROCTOR RH, 1995, APPL ENVIRON MICROB, V61, P1923, DOI 10.1128/AEM.61.5.1923-1930.1995; Proctor RH, 2009, MOL MICROBIOL, V74, P1128, DOI 10.1111/j.1365-2958.2009.06927.x; Roze LV, 2007, APPL ENVIRON MICROB, V73, P7268, DOI 10.1128/AEM.00801-07; Seo JA, 2001, FUNGAL GENET BIOL, V34, P155, DOI 10.1006/fgbi.2001.1299; St-Arnaud M., 2007, MYCORRHIZAE CROP PRO, P67; STARNAUD M, 1995, MYCORRHIZA, V5, P431, DOI 10.1007/s005720050093; TURNER WB, 1975, INT J ENVIRON STUD, V8, P159, DOI 10.1080/00207237508709727; Ward TJ, 2002, P NATL ACAD SCI USA, V99, P9278, DOI 10.1073/pnas.142307199	34	30	30	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2011	6	3							e17990	10.1371/journal.pone.0017990	http://dx.doi.org/10.1371/journal.pone.0017990			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740RG	21455305	Green Published, gold, Green Submitted			2022-12-25	WOS:000288811500017
J	Su, Y; Wagner, ER; Luo, Q; Huang, J; Chen, L; He, BC; Zuo, GW; Shi, Q; Zhang, BQ; Zhu, G; Bi, Y; Luo, J; Luo, X; Kim, SH; Shen, J; Rastegar, F; Huang, E; Gao, Y; Gao, JL; Yang, K; Wietholt, C; Li, M; Qin, J; Haydon, RC; He, TC; Luu, HH				Su, Y.; Wagner, E. R.; Luo, Q.; Huang, J.; Chen, L.; He, B-C; Zuo, G-W; Shi, Q.; Zhang, B-Q; Zhu, G.; Bi, Y.; Luo, J.; Luo, X.; Kim, S. H.; Shen, J.; Rastegar, F.; Huang, E.; Gao, Y.; Gao, J-L; Yang, K.; Wietholt, C.; Li, M.; Qin, J.; Haydon, R. C.; He, T-C; Luu, H. H.			Insulin-like growth factor binding protein 5 suppresses tumor growth and metastasis of human osteosarcoma	ONCOGENE			English	Article						osteosarcoma; tumorigenesis; metastasis; IGFBP5; animal model	MESENCHYMAL STEM-CELLS; BREAST-CANCER CELLS; OSTEOBLAST DIFFERENTIATION; RECOMBINANT ADENOVIRUSES; CLEAR-CELL; IN-VIVO; EXPRESSION; INHIBITOR; IGFBP-5; SYSTEM	Osteosarcoma (OS) is the most common primary malignancy of bone. There is a critical need to identify the events that lead to the poorly understood mechanism of OS development and metastasis. The goal of this investigation is to identify and characterize a novel marker of OS progression. We have established and characterized a highly metastatic OS subline that is derived from the less metastatic human MG63 line through serial passages in nude mice via intratibial injections. Microarray analysis of the parental MG63, the highly metastatic MG63.2 subline, as well as the corresponding primary tumors and pulmonary metastases revealed insulin-like growth factor binding protein 5 (IGFBP5) to be one of the significantly downregulated genes in the metastatic subline. Confirmatory quantitative RT-PCR on 20 genes of interest demonstrated IGFBP5 to be the most differentially expressed and was therefore chosen to be one of the genes for further investigation. Adenoviral mediated overexpression and knockdown of IGFBP5 in the MG63 and MG63.2 cell lines, as well as other OS lines (143B and MNNG/HOS) that are independent of our MG63 lines, were employed to examine the role of IGFBP5. We found that overexpression of IGFBP5 inhibited in vitro cell proliferation, migration and invasion of OS cells. Additionally, IGFBP5 overexpression promoted apoptosis and cell cycle arrest in the G1 phase. In an orthotopic xenograft animal model, overexpression of IGFBP5 inhibited OS tumor growth and pulmonary metastases. Conversely, siRNA-mediated knockdown of IGFBP5 promoted OS tumor growth and pulmonary metastases in vivo. Immunohistochemical staining of patient-matched primary and metastatic OS samples demonstrated decreased IGFBP5 expression in the metastases. These results suggest 1) a role for IGFBP5 as a novel marker that has an important role in the pathogenesis of OS, and 2) that the loss of IGFBP5 function may contribute to more metastatic phenotypes in OS. Oncogene (2011) 30, 3907-3917; doi:10.1038/onc.2011.97; published online 4 April 2011	[Luu, H. H.] Univ Chicago, Suzanne Berman Oncol Lab, Dept Surg, Med Ctr, Chicago, IL 60637 USA; [Su, Y.; Luo, Q.; Zhu, G.; Bi, Y.; Li, M.; Qin, J.; He, T-C] Chongqing Med Univ, Stem Cell Biol & Therapy Lab, Childrens Hosp, Chongqing, Peoples R China; [Su, Y.; Luo, Q.; Huang, J.; Chen, L.; He, B-C; Zuo, G-W; Shi, Q.; Zhang, B-Q; Zhu, G.; Bi, Y.; Luo, J.; Luo, X.; Li, M.; Qin, J.; He, T-C] Chinese Minist Educ, Key Lab Diagnost Med, Chongqing, Peoples R China; [Su, Y.; Luo, Q.; Huang, J.; Chen, L.; He, B-C; Zuo, G-W; Shi, Q.; Zhang, B-Q; Zhu, G.; Bi, Y.; Luo, J.; Luo, X.; Li, M.; Qin, J.; He, T-C] Chongqing Med Univ, Affiliated Hosp, Chongqing, Peoples R China; [Huang, E.] Chongqing Univ, Sch Bioengn, Chongqing, Peoples R China; [Gao, Y.] Shanghai Jiatong Univ, Dept Geriatr, Xinhua Hosp, Shanghai, Peoples R China; [Yang, K.] Third Mil Med Univ, Dept Cell Biol, Chongqing, Peoples R China; [Wietholt, C.] Univ Chicago, Dept Radiol, Med Ctr, Chicago, IL 60637 USA	University of Chicago; University of Chicago Medical Center; Chongqing Medical University; Chongqing Medical University; Chongqing University; Shanghai Jiao Tong University; Army Medical University; University of Chicago; University of Chicago Medical Center	Luu, HH (corresponding author), Univ Chicago, Suzanne Berman Oncol Lab, Dept Surg, Med Ctr, 5841 S Maryland Ave,MC3079, Chicago, IL 60637 USA.	hluu@surgery.bsd.uchicago.edu		Wagner, Eric/0000-0001-9241-5702	American Cancer Society; Brinson Foundation; National Institute of Health; Orthopaedic Research and Education Foundation; Natural Science Foundation of China [81001197]; Ministry of Science and Technology of China [2011CB707906]	American Cancer Society(American Cancer Society); Brinson Foundation; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Orthopaedic Research and Education Foundation; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	We thank Dr Xinmin Li, PhD (Director of The UCLA Clinical Microarray Core) for his help with the microarray and cluster analysis. We also sincerely thank Dr Anthony Montag, Leslie Martin and Guarav Luther for the creation of the tissue array. We also thank Dr Theodore Karrison for help with the statistical analysis. This work was supported in part by research grants from The American Cancer Society (HHL and TCH), the Brinson Foundation (HHL, TCH, RCH), The National Institute of Health (HHL, TCH, RCH), the Orthopaedic Research and Education Foundation (HHL, RCH), the Natural Science Foundation of China (#81001197 to YS), and the 973 Program of the Ministry of Science and Technology of China (#2011CB707906 to JL and TCH).	Akkiprik M, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2116; Amaar YG, 2002, J BIOL CHEM, V277, P12053, DOI 10.1074/jbc.M110872200; Avnet S, 2009, CANCER RES, V69, P2443, DOI 10.1158/0008-5472.CAN-08-2645; Butt AJ, 2005, ENDOCRINOLOGY, V146, P3113, DOI 10.1210/en.2004-1408; Butt AJ, 2003, J BIOL CHEM, V278, P29676, DOI 10.1074/jbc.M301965200; Cheung C, 2005, INT J UROL, V12, P17, DOI 10.1111/j.1442-2042.2004.00993.x; DAVIS AM, 1994, J CLIN ONCOL, V12, P423, DOI 10.1200/JCO.1994.12.2.423; Fuchs B, 2002, CLIN ORTHOP RELAT R, P40; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Kang Q, 2004, GENE THER, V11, P1312, DOI 10.1038/sj.gt.3302298; Kang Q, 2009, STEM CELLS DEV, V18, P545, DOI 10.1089/scd.2008.0130; Kaste SC, 1999, CANCER-AM CANCER SOC, V86, P1602, DOI 10.1002/(SICI)1097-0142(19991015)86:8<1602::AID-CNCR31>3.0.CO;2-R; Letson G D, 2001, Cancer Control, V8, P239; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Luo Q, 2004, J BIOL CHEM, V279, P55958, DOI 10.1074/jbc.M407810200; Luo Q, 2007, GENE, V395, P160, DOI 10.1016/j.gene.2007.02.030; Luo XJ, 2008, CLIN ORTHOP RELAT R, V466, P2060, DOI 10.1007/s11999-008-0361-x; Luu HH, 2005, CANCER LETT, V229, P135, DOI 10.1016/j.canlet.2005.02.015; Luu HH, 2005, CLIN EXP METASTAS, V22, P319, DOI 10.1007/s10585-005-0365-9; Luu HH, 1998, CANCER RES, V58, P3561; Manara MC, 2007, CLIN CANCER RES, V13, P1322, DOI 10.1158/1078-0432.CCR-06-1518; Mankin HJ, 2004, CLIN ORTHOP RELAT R, P286, DOI 10.1097/01.blo.0000145991.65770.e6; Mukherjee A, 2007, GROWTH HORM IGF RES, V17, P179, DOI 10.1016/j.ghir.2007.01.005; Peng Y, 2004, J BIOL CHEM, V279, P32941, DOI 10.1074/jbc.M403344200; Ragland BD, 2002, LAB INVEST, V82, P365, DOI 10.1038/labinvest.3780431; Rosenzweig SA, 2004, GROWTH HORM IGF RES, V14, P329, DOI 10.1016/j.ghir.2004.02.003; Schedlich LJ, 2000, J BIOL CHEM, V275, P23462, DOI 10.1074/jbc.M002208200; Schneider MR, 2002, J ENDOCRINOL, V172, P423, DOI 10.1677/joe.0.1720423; Schneider MR, 2001, BIOCHEM BIOPH RES CO, V288, P435, DOI 10.1006/bbrc.2001.5785; Sharff KA, 2009, J BIOL CHEM, V284, P649, DOI 10.1074/jbc.M806389200; Song H, 2001, J MOL ENDOCRINOL, V26, P229, DOI 10.1677/jme.0.0260229; Stolf BS, 2003, CANCER LETT, V191, P193, DOI 10.1016/S0304-3835(02)00679-1; Su YX, 2009, CLIN EXP METASTAS, V26, P599, DOI 10.1007/s10585-009-9259-6; Takahash M, 2005, INT J ONCOL, V26, P923; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang HM, 2006, MODERN PATHOL, V19, P1149, DOI 10.1038/modpathol.3800637; Whelan JS, 1997, EUR J CANCER, V33, P1611, DOI 10.1016/S0959-8049(97)00251-7; Xu C, 2007, PROSTATE, V67, P1621, DOI 10.1002/pros.20655; Yonemoto T, 1998, CLIN ORTHOP RELAT R, P194	39	109	111	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP	2011	30	37					3907	3917		10.1038/onc.2011.97	http://dx.doi.org/10.1038/onc.2011.97			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	820FG	21460855				2022-12-25	WOS:000294890400001
J	Shahzad-ul-Hussan, S; Gustchina, E; Ghirlando, R; Clore, GM; Bewley, CA				Shahzad-ul-Hussan, Syed; Gustchina, Elena; Ghirlando, Rodolfo; Clore, G. Marius; Bewley, Carole A.			Solution Structure of the Monovalent Lectin Microvirin in Complex with Man alpha(1-2)Man Provides a Basis for Anti-HIV Activity with Low Toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYANOVIRIN-N; OLIGOSACCHARIDE STRUCTURES; SEDIMENTATION EQUILIBRIUM; MICROCYSTIS-AERUGINOSA; INACTIVATING PROTEIN; BACKBONE DYNAMICS; NMR-SPECTROSCOPY; VIRUS; BINDING; FUSION	Lectins that bind surface envelope glycoprotein gp120 of HIV with high avidity can potently inhibit viral entry. Yet properties such as multivalency that facilitate strong interactions can also cause nonspecific binding and toxicity. The cyanobacterial lectin microvirin (MVN) is unusual as it potently inhibits HIV-1 with negligible toxicity compared with cyanovirin-N (CVN), its well studied antiviral homolog. To understand the structural and mechanistic basis for these differences, we solved the solution structure of MVN free and in complex with its ligand Man alpha(1-2)Man, and we compared specificity and time windows of inhibition with CVN and Man alpha(1-2)Man-specific mAb 2G12. We show by NMR and analytical ultracentrifugation that MVN is monomeric in solution, and we demonstrate by NMR that Man alpha(1-2)Man-terminating carbohydrates interact with a single carbohydrate-binding site. Synchronized infectivity assays show that 2G12, MVN, and CVN inhibit entry with distinct kinetics. Despite shared specificity for Man alpha(12) Man termini, combinations of the inhibitors are synergistic suggesting they recognize discrete glycans and/or dynamic glycan conformations on gp120. Entry assays employing amphotropic viruses show that MVN is inactive, whereas CVN potently inhibits both. In addition to demonstrating that HIV-1 can be inhibited through monovalent interactions, given the similarity of the carbohydrate-binding site common to MVN and CVN, these data suggest that gp120 behaves as a clustered glycan epitope and that multivalent-protein interactions achievable with CVN but not MVN are required for inhibition of some viruses.	[Shahzad-ul-Hussan, Syed; Bewley, Carole A.] NIDDK, Bioorgan Chem Lab, NIH, Bethesda, MD 20892 USA; [Gustchina, Elena; Clore, G. Marius] NIDDK, Chem Phys Lab, NIH, Bethesda, MD 20892 USA; [Ghirlando, Rodolfo] NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Bewley, CA (corresponding author), 8 Ctr Dr, Bethesda, MD 20892 USA.	caroleb@mail.nih.gov	Clore, G Marius/L-2546-2018; Clore, G. Marius/A-3511-2008; Ghirlando, Rodolfo/A-8880-2009	Clore, G Marius/0000-0003-3809-1027; Clore, G. Marius/0000-0003-3809-1027; Bewley, Carole/0000-0003-2203-0852	National Institutes of Health (NIDDK); Intramural AIDS Targeted Antiviral Program of the Office of the Director; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK033007, ZIADK029038, ZIADK032103, ZIADK029023] Funding Source: NIH RePORTER	National Institutes of Health (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural AIDS Targeted Antiviral Program of the Office of the Director; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program (NIDDK) and the Intramural AIDS Targeted Antiviral Program of the Office of the Director (to C. A. B. and G. M. C.).	Balzarini J, 2007, NAT REV MICROBIOL, V5, P583, DOI 10.1038/nrmicro1707; Bernardi A, 2004, CARBOHYD RES, V339, P967, DOI 10.1016/j.carres.2003.11.013; Bewley CA, 2004, J MOL BIOL, V339, P901, DOI 10.1016/j.jmb.2004.04.019; Bewley CA, 2001, STRUCTURE, V9, P931, DOI 10.1016/S0969-2126(01)00653-0; Bewley CA, 2002, J MOL BIOL, V322, P881, DOI 10.1016/S0022-2836(02)00842-2; Bewley CA, 1998, NAT STRUCT BIOL, V5, P571, DOI 10.1038/828; Bewley CA, 2001, J AM CHEM SOC, V123, P3892, DOI 10.1021/ja004040e; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Brewer CF, 2002, CURR OPIN STRUC BIOL, V12, P616, DOI 10.1016/S0959-440X(02)00364-0; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Chan DC, 1998, P NATL ACAD SCI USA, V95, P15613, DOI 10.1073/pnas.95.26.15613; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; CHOU TC, 1981, EUR J BIOCHEM, V115, P207, DOI 10.1111/j.1432-1033.1981.tb06218.x; Clore GM, 1998, J MAGN RESON, V133, P216, DOI 10.1006/jmre.1998.1419; CLORE GM, 1990, BIOCHEMISTRY-US, V29, P7387, DOI 10.1021/bi00484a006; Clore GM, 1999, J AM CHEM SOC, V121, P9008, DOI 10.1021/ja991789k; Cole JL, 2008, METHOD CELL BIOL, V84, P143, DOI 10.1016/S0091-679X(07)84006-4; CREIGHTON TE, 1979, J MOL BIOL, V129, P235, DOI 10.1016/0022-2836(79)90279-1; Dam TK, 2008, BIOCHEMISTRY-US, V47, P8470, DOI 10.1021/bi801208b; Dam TK, 2009, BIOCHEMISTRY-US, V48, P3822, DOI 10.1021/bi9002919; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Folkers GK, 2010, JAMA-J AM MED ASSOC, V304, P350, DOI 10.1001/jama.2010.957; Gallo SA, 2004, BIOCHEMISTRY-US, V43, P8230, DOI 10.1021/bi049957v; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; Gustchina E, 2007, J VIROL, V81, P12946, DOI 10.1128/JVI.01260-07; Gustchina E, 2006, J MOL BIOL, V364, P283, DOI 10.1016/j.jmb.2006.09.017; Helle F, 2006, J BIOL CHEM, V281, P25177, DOI 10.1074/jbc.M602431200; Huskens D, 2010, J BIOL CHEM, V285, P24845, DOI 10.1074/jbc.M110.128546; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Kehr JC, 2006, MOL MICROBIOL, V59, P893, DOI 10.1111/j.1365-2958.2005.05001.x; Kiessling LL, 1996, CHEM BIOL, V3, P71, DOI 10.1016/S1074-5521(96)90280-X; Kitov PI, 2000, NATURE, V403, P669, DOI 10.1038/35001095; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE YC, 1995, ACCOUNTS CHEM RES, V28, P7; Lehotzky RE, 2010, P NATL ACAD SCI USA, V107, P7722, DOI 10.1073/pnas.0909449107; LEONARD CK, 1990, J BIOL CHEM, V265, P10373; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; MIZUOCHI T, 1990, J BIOL CHEM, V265, P8519; Mori T, 2005, J BIOL CHEM, V280, P9345, DOI 10.1074/jbc.M411122200; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; O'Keefe BR, 2009, P NATL ACAD SCI USA, V106, P6099, DOI 10.1073/pnas.0901506106; O'Keefe BR, 2003, ANTIMICROB AGENTS CH, V47, P2518, DOI 10.1128/AAC.47.8.2518-2525.2003; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Percudani R, 2005, PROTEINS, V60, P670, DOI 10.1002/prot.20543; POLONOFF E, 1982, J BIOL CHEM, V257, P4023; Reeves JD, 2002, P NATL ACAD SCI USA, V99, P16249, DOI 10.1073/pnas.252469399; ROBERTSON JS, 1982, J GEN VIROL, V58, P13, DOI 10.1099/0022-1317-58-1-13; Ruckert M, 2000, J AM CHEM SOC, V122, P7793, DOI 10.1021/ja001068h; Scanlan CN, 2007, NATURE, V446, P1038, DOI 10.1038/nature05818; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Schwieters CD, 2001, J MAGN RESON, V152, P288, DOI 10.1006/jmre.2001.2413; Shahzad-Ul-Hussan S, 2009, J AM CHEM SOC, V131, P16500, DOI 10.1021/ja905929c; Sharon N, 2004, GLYCOBIOLOGY, V14, p53R, DOI 10.1093/glycob/cwh122; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Taiwo B, 2010, J ANTIMICROB CHEMOTH, V65, P1100, DOI 10.1093/jac/dkq096; Tanaka H, 2009, P NATL ACAD SCI USA, V106, P15633, DOI 10.1073/pnas.0907572106; Tiwari V, 2009, ANTIVIR RES, V84, P67, DOI 10.1016/j.antiviral.2009.07.014; Tsai CC, 2004, AIDS RES HUM RETROV, V20, P11, DOI 10.1089/088922204322749459; YEH JC, 1993, BIOCHEMISTRY-US, V32, P11087, DOI 10.1021/bi00092a019	60	65	68	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20788	20796		10.1074/jbc.M111.232678	http://dx.doi.org/10.1074/jbc.M111.232678			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21471192	Green Published, hybrid			2022-12-25	WOS:000291267600064
J	Foley, JH; Cook, PF; Nesheim, ME				Foley, Jonathan H.; Cook, Paul F.; Nesheim, Michael E.			Kinetics of Activated Thrombin-activatable Fibrinolysis Inhibitor (TAFIa)-catalyzed Cleavage of C-terminal Lysine Residues of Fibrin Degradation Products and Removal of Plasminogen-binding Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA PROCARBOXYPEPTIDASE B; THERMAL-STABILITY; TAFI; MECHANISM; ZYMOGEN; CARBOXYPEPTIDASE; THRESHOLD; VARIANTS; RESPECT; SYSTEM	Partial digestion of fibrin by plasmin exposes C-terminal lysine residues, which comprise new binding sites for both plasminogen and tissue-type plasminogen activator (tPA). This binding increases the catalytic efficiency of plasminogen activation by 3000-fold compared with tPA alone. The activated thrombin-activatable fibrinolysis inhibitor (TAFIa) attenuates fibrinolysis by removing these residues, which causes a 97% reduction in tPA catalytic efficiency. The aim of this study was to determine the kinetics of TAFIa-catalyzed lysine cleavage from fibrin degradation products and the kinetics of loss of plasminogen-binding sites. We show that the k(cat) and K-m of Glu(1)-plasminogen (Glu-Pg)-binding site removal are 2.34 s(-1) and 142.6 nM, respectively, implying a catalytic efficiency of 16.21 mu M-1 s(-1). The corresponding values of Lys(77)/Lys(78)-plasminogen (Lys-Pg)-binding site removal are 0.89 s(-1) and 96 nM implying a catalytic efficiency of 9.23 mu M-1 s(-1). These catalytic efficiencies of plasminogen-binding site removal by TAFIa are the highest of any TAFIa-catalyzed reaction with a biological substrate reported to date and suggest that plasmin-modified fibrin is a primary physiological substrate for TAFIa. We also show that the catalytic efficiency of cleavage of all C-terminal lysine residues, whether they are involved in plasminogen binding or not, is 1.10 mu M-1 s(-1). Interestingly, this value increases to 3.85 mu M-1 s(-1) in the presence of Glu-Pg. These changes are due to a decrease in K-m. This suggests that an interaction between TAFIa and plasminogen comprises a component of the reaction mechanism, the plausibility of which was established by showing that TAFIa binds both Glu-Pg and Lys-Pg.	[Foley, Jonathan H.; Nesheim, Michael E.] Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada; [Nesheim, Michael E.] Queens Univ, Dept Med, Kingston, ON K7L 3N6, Canada; [Cook, Paul F.] Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA	Queens University - Canada; Queens University - Canada; University of Oklahoma System; University of Oklahoma - Norman	Nesheim, ME (corresponding author), Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada.	nesheimm@queensu.ca		Foley, Jonathan/0000-0002-4593-0469	National Institutes of Health [HL46703]; Heart and Stroke Foundation of Ontario [T5575]; Heart and Stroke Foundation of Canada; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL046703] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL46703 (Project 4; to M. E. N.). This work was also supported by Heart and Stroke Foundation of Ontario Grant T5575.; Supported by a doctoral fellowship from the Heart and Stroke Foundation of Canada.	Bajzar L, 1996, J BIOL CHEM, V271, P16603, DOI 10.1074/jbc.271.28.16603; BAJZAR L, 1995, J BIOL CHEM, V270, P14477, DOI 10.1074/jbc.270.24.14477; Boffa MB, 1998, J BIOL CHEM, V273, P2127, DOI 10.1074/jbc.273.4.2127; Collen D, 1999, THROMB HAEMOSTASIS, V82, P259; Foley JH, 2008, J BIOL CHEM, V283, P8863, DOI 10.1074/jbc.M800127200; FREDENBURGH JC, 1992, J BIOL CHEM, V267, P26150; Horrevoets AJG, 1997, J BIOL CHEM, V272, P2183; Horrevoets AJG, 1997, J BIOL CHEM, V272, P2176; Jia ZC, 2008, BLOOD, V112, P2597, DOI 10.1182/blood-2008-07-167734; Kim PYG, 2008, ANAL BIOCHEM, V372, P32, DOI 10.1016/j.ab.2007.09.034; Leurs J, 2004, J THROMB HAEMOST, V2, P416, DOI 10.1111/j.1538-7836.2004.00605.x; Mao SS, 1999, J BIOL CHEM, V274, P35046, DOI 10.1074/jbc.274.49.35046; Marx PF, 2008, BLOOD, V112, P2803, DOI 10.1182/blood-2008-03-146001; Morser J, 2010, J THROMB HAEMOST, V8, P868, DOI 10.1111/j.1538-7836.2010.03787.x; Myles T, 2003, J BIOL CHEM, V278, P51059, DOI 10.1074/jbc.M306977200; Neill EKT, 2004, ANAL BIOCHEM, V330, P332, DOI 10.1016/j.ab.2004.04.007; Schneider M, 2002, J BIOL CHEM, V277, P1021, DOI 10.1074/jbc.M104444200; TAN AK, 1995, BIOCHEMISTRY-US, V34, P5811, DOI 10.1021/bi00017a012; Valnickova Z, 2007, J BIOL CHEM, V282, P3066, DOI 10.1074/jbc.M606559200; Walker JB, 1999, J BIOL CHEM, V274, P5201, DOI 10.1074/jbc.274.8.5201; Walker JB, 2004, J BIOL CHEM, V279, P27896, DOI 10.1074/jbc.M401027200; Wang W, 1998, J BIOL CHEM, V273, P27176, DOI 10.1074/jbc.273.42.27176; WYMAN J, 1964, ADV PROTEIN CHEM, V19, P223, DOI 10.1016/S0065-3233(08)60190-4; Xu HY, 2006, BIOCHEMISTRY-US, V45, P12156, DOI 10.1021/bi0610808	24	21	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19280	19286		10.1074/jbc.M110.215061	http://dx.doi.org/10.1074/jbc.M110.215061			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21467042	hybrid, Green Published			2022-12-25	WOS:000291027700010
J	Hasegawa, H; Wendling, J; He, F; Trilisky, E; Stevenson, R; Franey, H; Kinderman, F; Li, G; Piedmonte, DM; Osslund, T; Shen, M; Ketchem, RR				Hasegawa, Haruki; Wendling, John; He, Feng; Trilisky, Egor; Stevenson, Riki; Franey, Heather; Kinderman, Francis; Li, Gary; Piedmonte, Deirdre Murphy; Osslund, Timothy; Shen, Min; Ketchem, Randal R.			In Vivo Crystallization of Human IgG in the Endoplasmic Reticulum of Engineered Chinese Hamster Ovary (CHO) Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUALITY-CONTROL; RECOMBINANT PROTEINS; SECRETORY PATHWAY; INCLUSION-BODIES; MESSENGER-RNA; HIGH-LEVEL; ER STRESS; EXPRESSION; TRANSGENE; FACTORIES	Protein synthesis and secretion are essential to cellular life. Although secretory activities may vary in different cell types, what determines the maximum secretory capacity is inherently difficult to study. Increasing protein synthesis until reaching the limit of secretory capacity is one strategy to address this key issue. Under highly optimized growth conditions, recombinant CHO cells engineered to produce a model human IgG clone started housing rod-shaped crystals in the endoplasmic reticulum (ER) lumen. The intra-ER crystal growth was accompanied by cell enlargement and multinucleation and continued until crystals outgrew cell size to breach membrane integrity. The intra-ER crystals were composed of correctly folded, endoglycosidase H-sensitive IgG. Crystallizing propensity was due to the intrinsic physicochemical properties of the model IgG, and the crystallization was reproduced in vitro by exposing a high concentration of IgG to a near neutral pH. The striking cellular phenotype implicated the efficiency of IgG protein synthesis and oxidative folding exceeded the capacity of ER export machinery. As a result, export-ready IgG accumulated progressively in the ER lumen until a threshold concentration was reached to nucleate crystals. Using an in vivo system that reports accumulation of correctly folded IgG, we showed that the ER-toGolgi transport steps became rate-limiting in cells with high secretory activity.	[Hasegawa, Haruki; Shen, Min; Ketchem, Randal R.] Amgen Inc, Dept Prot Sci, Seattle, WA 98119 USA; [Wendling, John] Amgen Inc, Dept Cell Sci & Technol, Seattle, WA 98119 USA; [He, Feng] Amgen Inc, Dept Formulat & Analyt Resources, Seattle, WA 98119 USA; [Trilisky, Egor] Amgen Inc, Dept Purificat Proc Dev, Seattle, WA 98119 USA; [Stevenson, Riki; Franey, Heather; Kinderman, Francis; Li, Gary; Piedmonte, Deirdre Murphy] Amgen Inc, Dept Formulat & Analyt Resources, Thousand Oaks, CA 91320 USA; [Osslund, Timothy] Amgen Inc, Dept Analyt & Formulat Sci, Thousand Oaks, CA 91320 USA	Amgen; Amgen; Amgen; Amgen; Amgen; Amgen	Hasegawa, H (corresponding author), Amgen Inc, Dept Prot Sci, 1201 Amgen Court W, Seattle, WA 98119 USA.	harukih@amgen.com	Ketchem, Randal R/K-2258-2017; Ketchem, Randal/AAB-4372-2020	Ketchem, Randal R/0000-0002-7821-2682; Ketchem, Randal/0000-0002-7821-2682; Hasegawa, Haruki/0000-0002-3464-4715				Aldrich TL, 1998, CYTOTECHNOLOGY, V28, P9, DOI 10.1023/A:1008048807588; Alete DE, 2005, PROTEOMICS, V5, P4689, DOI 10.1002/pmic.200500019; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arvan P, 2002, TRAFFIC, V3, P771, DOI 10.1034/j.1600-0854.2002.31102.x; Barnes LM, 2006, CURR OPIN BIOTECH, V17, P381, DOI 10.1016/j.copbio.2006.06.005; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Brewer JW, 2005, NAT IMMUNOL, V6, P23, DOI 10.1038/ni1149; Carrio MM, 2002, J BIOTECHNOL, V96, P3, DOI 10.1016/S0168-1656(02)00032-9; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; Dinnis DM, 2005, BIOTECHNOL BIOENG, V91, P180, DOI 10.1002/bit.20499; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Durocher Y, 2009, CURR OPIN BIOTECH, V20, P700, DOI 10.1016/j.copbio.2009.10.008; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; GIPSON IK, 1975, INVEST OPHTH VISUAL, V14, P937; Hand DB, 1935, J GEN PHYSIOL, V18, P847, DOI 10.1085/jgp.18.6.847; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Hawi SR, 1997, J LIPID RES, V38, P1591; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; He F, 2010, J PHARM SCI-US, V99, P1707, DOI 10.1002/jps.21955; Jenkins N, 2008, MOL BIOTECHNOL, V39, P113, DOI 10.1007/s12033-008-9049-4; Jenkins N, 2009, BIOTECHNOL APPL BIOC, V53, P73, DOI 10.1042/BA20080258; KABAT EA, 1977, J BIOL CHEM, V252, P6609; Kantardjieff KA, 2004, BIOINFORMATICS, V20, P2162, DOI 10.1093/bioinformatics/bth066; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Lee J, 2007, BIOTECHNOL LETT, V29, P1797, DOI 10.1007/s10529-007-9490-7; Lucas BK, 1996, NUCLEIC ACIDS RES, V24, P1774, DOI 10.1093/nar/24.9.1774; Mariati, 2010, PROTEIN EXPRES PURIF, V69, P9, DOI 10.1016/j.pep.2009.08.010; Markossian KA, 2004, BIOCHEMISTRY-MOSCOW+, V69, P971, DOI 10.1023/B:BIRY.0000043539.07961.4c; Muller D, 2008, TRENDS BIOTECHNOL, V26, P359, DOI 10.1016/j.tibtech.2008.03.010; O'Callaghan Peter M., 2008, Briefings in Functional Genomics & Proteomics, V7, P95, DOI 10.1093/bfgp/eln012; Ortsater H, 2007, MOL CELL ENDOCRINOL, V277, P1, DOI 10.1016/j.mce.2007.06.006; Paroutis P, 2004, PHYSIOLOGY, V19, P207, DOI 10.1152/physiol.00005.2004; Peng RW, 2010, METAB ENG, V12, P18, DOI 10.1016/j.ymben.2009.08.007; Pilbrough W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008432; Rasmussen B, 1998, CYTOTECHNOLOGY, V28, P31, DOI 10.1023/A:1008052908496; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Shukla AA, 2010, TRENDS BIOTECHNOL, V28, P253, DOI 10.1016/j.tibtech.2010.02.001; Sitia R, 2003, NATURE, V426, P891, DOI 10.1038/nature02262; Tagliavacca L, 2003, BIOL CHEM, V384, P1273, DOI 10.1515/BC.2003.141; Tigges M, 2006, METAB ENG, V8, P264, DOI 10.1016/j.ymben.2006.01.006; Vitale A, 2004, PLANT PHYSIOL, V136, P3420, DOI 10.1104/pp.104.050351; Wang TY, 2008, CELL BIOL INT, V32, P1279, DOI 10.1016/j.cellbi.2008.07.014; Williams S, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-17; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2006, J CELL BIOL, V172, P565, DOI 10.1083/jcb.200508145	48	51	52	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19917	19931		10.1074/jbc.M110.204362	http://dx.doi.org/10.1074/jbc.M110.204362			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21464137	Green Published, hybrid			2022-12-25	WOS:000291027700071
J	Ruiz-Garcia, A; Monsalve, E; Novellasdemunt, L; Navarro-Sabate, A; Manzano, A; Rivero, S; Castrillo, A; Casado, M; Laborda, J; Bartrons, R; Diaz-Guerra, MJM				Ruiz-Garcia, Almudena; Monsalve, Eva; Novellasdemunt, Laura; Navarro-Sabate, Aurea; Manzano, Anna; Rivero, Samuel; Castrillo, Antonio; Casado, Marta; Laborda, Jorge; Bartrons, Ramon; Diaz-Guerra, Maria Jose M.			Cooperation of Adenosine with Macrophage Toll-4 Receptor Agonists Leads to Increased Glycolytic Flux through the Enhanced Expression of PFKFB3 Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; ACTIVATED PROTEIN-KINASE; TUMOR-NECROSIS-FACTOR; UP-REGULATION; TRANSCRIPTION FACTOR; FACTOR INDUCTION; IMMUNE-RESPONSE; NITRIC-OXIDE; C/EBP-DELTA	Macrophages activated through Toll receptor triggering increase the expression of the A(2A) and A(2B) adenosine receptors. In this study, we show that adenosine receptor activation enhances LPS-induced pfkfb3 expression, resulting in an increase of the key glycolytic allosteric regulator fructose 2,6-bisphosphate and the glycolytic flux. Using shRNA and differential expression of A(2A) and A(2B) receptors, we demonstrate that the A(2A) receptor mediates, in part, the induction of pfkfb3 by LPS, whereas the A(2B) receptor, with lower adenosine affinity, cooperates when high adenosine levels are present. pfkfb3 promoter sequence deletion analysis, site-directed mutagenesis, and inhibition by shRNAs demonstrated that HIF1 alpha is a key transcription factor driving pfkfb3 expression following macrophage activation by LPS, whereas synergic induction of pfkfb3 expression observed with the A(2) receptor agonists seems to depend on Sp1 activity. Furthermore, levels of phospho-AMP kinase also increase, arguing for increased PFKFB3 activity by phosphorylation in long term LPS-activated macrophages. Taken together, our results show that, in macrophages, endogenously generated adenosine cooperates with bacterial components to increase PFKFB3 isozyme activity, resulting in greater fructose 2,6-bisphosphate accumulation. This process enhances the glycolytic flux and favors ATP generation helping to develop and maintain the long term defensive and reparative functions of the macrophages.	[Ruiz-Garcia, Almudena; Monsalve, Eva; Rivero, Samuel; Laborda, Jorge; Diaz-Guerra, Maria Jose M.] Ctr Reg Invest Biomed, Fac Med, E-02006 Albacete, Spain; [Novellasdemunt, Laura; Navarro-Sabate, Aurea; Manzano, Anna; Bartrons, Ramon] Univ Barcelona, Unitat Bioquim & Biol Mol, Dept Ciences Fisiol 2, Inst Invest Biomed Bellvitge, E-08907 Lhospitalet De Llobregat, Spain; [Castrillo, Antonio] Univ Las Palmas, Fac Med, ULPGC, Las Palmas Gran Canaria 35016, Spain; [Casado, Marta] Inst Biomed Valencia, Valencia 46010, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Universidad de Las Palmas de Gran Canaria; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV)	Diaz-Guerra, MJM (corresponding author), Ctr Reg Invest Biomed, Fac Med, Av Almansa 14, E-02006 Albacete, Spain.	MariaJose.Martinez@uclm.es	Laborda, Jorge/L-5726-2014; Ruiz-García, Almudena/ABA-1492-2021; Manzano, Anna/ABG-3422-2020; Monsalve Argandona, Eva Maria/F-7156-2015; Navarro-Sabate, Aurea/K-6329-2018; Casado Pinna, Marta/L-2078-2014	Laborda, Jorge/0000-0002-9210-838X; Manzano, Anna/0000-0002-9106-3132; Monsalve Argandona, Eva Maria/0000-0003-4933-4602; Novellasdemunt Vilaseca, Laura/0000-0003-1590-9842; Navarro-Sabate, Aurea/0000-0002-8286-9732; Rivero Hinojosa, Samuel/0000-0002-3595-8273; Casado Pinna, Marta/0000-0001-6457-4650; Martinez Diaz-Guerra, Maria Jose/0000-0003-3843-3912; Bartrons, Ramon/0000-0001-9349-5847	Ministerio de Sanidad y Consumo [PI060449]; Ministerio de Ciencia e Innovacion [BFU 2009-07380]; Consejeria de Sanidad [SAN06-015]; Consejeria de Educacion y Ciencia, Junta de Comunidades de Castilla-La Mancha, Spain [PII1/09-0211-7101]	Ministerio de Sanidad y Consumo(Instituto de Salud Carlos III); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Consejeria de Sanidad; Consejeria de Educacion y Ciencia, Junta de Comunidades de Castilla-La Mancha, Spain(Junta de Comunidades de Castilla-La Mancha)	This work was supported by Grant PI060449 from the Ministerio de Sanidad y Consumo, Grant BFU 2009-07380 from Ministerio de Ciencia e Innovacion, Grant SAN06-015 from Consejeria de Sanidad, and Grant PII1/09-0211-7101 from the Consejeria de Educacion y Ciencia, Junta de Comunidades de Castilla-La Mancha, Spain.	Akira S, 1997, ADV IMMUNOL, V65, P1, DOI 10.1016/S0065-2776(08)60740-3; Almeida A, 2004, NAT CELL BIOL, V6, P45, DOI 10.1038/ncb1080; Atsumi T, 2002, CANCER RES, V62, P5881; Bando H, 2005, CLIN CANCER RES, V11, P5784, DOI 10.1158/1078-0432.CCR-05-0149; Blouin CC, 2004, BLOOD, V103, P1124, DOI 10.1182/blood-2003-07-2427; Castrillo A, 2003, MOL CELL, V12, P805, DOI 10.1016/S1097-2765(03)00384-8; Chesney J, 1999, P NATL ACAD SCI USA, V96, P3047, DOI 10.1073/pnas.96.6.3047; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; CRONSTEIN BN, 1994, J APPL PHYSIOL, V76, P5, DOI 10.1152/jappl.1994.76.1.5; Csoka B, 2007, BLOOD, V110, P2685, DOI 10.1182/blood-2007-01-065870; De Ponti C, 2007, J LEUKOCYTE BIOL, V82, P392, DOI 10.1189/jlb.0107060; Duran J, 2009, FEBS J, V276, P4555, DOI 10.1111/j.1742-4658.2009.07161.x; Escoll P, 2003, BIOCHEM BIOPH RES CO, V311, P465, DOI 10.1016/j.bbrc.2003.10.019; Gilroy DW, 2004, NAT REV DRUG DISCOV, V3, P401, DOI 10.1038/nrd1383; Hasko G, 2004, TRENDS IMMUNOL, V25, P33, DOI 10.1016/j.it.2003.11.003; Hasko G, 2008, J LEUKOCYTE BIOL, V83, P447, DOI 10.1189/jlb.0607359; Hasko G, 2008, NAT REV DRUG DISCOV, V7, P759, DOI 10.1038/nrd2638; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; HOHORST HJ, 1965, ANN NY ACAD SCI, V119, P974, DOI 10.1111/j.1749-6632.1965.tb47456.x; Jones RG, 2007, IMMUNITY, V27, P173, DOI 10.1016/j.immuni.2007.07.008; Jung YJ, 2003, FASEB J, V17, P2115, DOI 10.1096/fj.03-0329fje; Jung YJ, 2003, BIOCHEM J, V370, P1011, DOI 10.1042/BJ20021279; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kawaguchi T, 2001, J BIOL CHEM, V276, P28554, DOI 10.1074/jbc.M101396200; KAY NE, 1980, J RETICULOENDOTH SOC, V28, P367; Kempf VAJ, 2005, CIRCULATION, V111, P1054, DOI 10.1161/01.CIR.0000155608.07691.B7; Kempner W, 1939, J CLIN INVEST, V18, P291, DOI 10.1172/JCI101045; Khoa ND, 2001, J IMMUNOL, V167, P4026, DOI 10.4049/jimmunol.167.7.4026; Krebs H A, 1972, Essays Biochem, V8, P1; Litvak V, 2009, NAT IMMUNOL, V10, P437, DOI 10.1038/ni.1721; Liu YW, 2007, CELL MOL LIFE SCI, V64, P3282, DOI 10.1007/s00018-007-7375-5; Liu YW, 2006, CELL SIGNAL, V18, P1492, DOI 10.1016/j.cellsig.2005.12.001; Lukashev D, 2004, J IMMUNOL, V173, P21, DOI 10.4049/jimmunol.173.1.21; Marsin AS, 2002, J BIOL CHEM, V277, P30778, DOI 10.1074/jbc.M205213200; Minchenko A, 2002, J BIOL CHEM, V277, P6183, DOI 10.1074/jbc.M110978200; Murdoch C, 2005, J IMMUNOL, V175, P6257, DOI 10.4049/jimmunol.175.10.6257; Murphree LJ, 2005, BIOCHEM J, V391, P575, DOI 10.1042/BJ20050888; NATSUKA S, 1992, BLOOD, V79, P460; Navarro-Sabate A, 2001, GENE, V264, P131, DOI 10.1016/S0378-1119(00)00591-6; Nemeth ZH, 2003, BIOCHEM BIOPH RES CO, V312, P883, DOI 10.1016/j.bbrc.2003.11.006; Obach M, 2004, J BIOL CHEM, V279, P53562, DOI 10.1074/jbc.M406096200; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; Okar DO, 2001, TRENDS BIOCHEM SCI, V26, P30, DOI 10.1016/S0968-0004(00)01699-6; Page EL, 2002, J BIOL CHEM, V277, P48403, DOI 10.1074/jbc.M209114200; PILKIS SJ, 1995, ANNU REV BIOCHEM, V64, P799, DOI 10.1146/annurev.bi.64.070195.004055; Pinhal-Enfield G, 2003, AM J PATHOL, V163, P711, DOI 10.1016/S0002-9440(10)63698-X; Ramanathan M, 2007, MOL BIOL CELL, V18, P14, DOI 10.1091/mbc.E06-07-0596; Riera L, 2003, FEBS LETT, V550, P23, DOI 10.1016/S0014-5793(03)00808-1; Riera L, 2002, BBA-MOL CELL RES, V1589, P89, DOI 10.1016/S0167-4889(02)00169-6; Rodriguez-Prados JC, 2010, J IMMUNOL, V185, P605, DOI 10.4049/jimmunol.0901698; Sandau KB, 2001, J BIOL CHEM, V276, P39805, DOI 10.1074/jbc.M107689200; Sitkovsky M, 2005, NAT REV IMMUNOL, V5, P712, DOI 10.1038/nri1685; Sitkovsky MV, 2005, TRENDS IMMUNOL, V26, P299, DOI 10.1016/j.it.2005.04.004; Sitkovsky MV, 2004, ANNU REV IMMUNOL, V22, P657, DOI 10.1146/annurev.immunol.22.012703.104731; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tan NY, 2009, MOL CELL BIOL, V29, P2483, DOI 10.1128/MCB.01828-08; Turner L, 1999, EUR J IMMUNOL, V29, P2280, DOI 10.1002/(SICI)1521-4141(199907)29:07<2280::AID-IMMU2280>3.0.CO;2-C; Uematsu S, 2007, J IMMUNOL, V179, P5378, DOI 10.4049/jimmunol.179.8.5378; VANSCHAFTINGEN E, 1982, EUR J BIOCHEM, V129, P191; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011; Wu Z, 2005, MOL CELL BIOL, V25, P9741, DOI 10.1128/MCB.25.22.9741-9752.2005; Yeamans C, 2007, BLOOD, V110, P3136, DOI 10.1182/blood-2007-03-080291; Zheng XL, 2001, J BIOL CHEM, V276, P13822, DOI 10.1074/jbc.M011031200; Zheng XL, 2000, J BIOL CHEM, V275, P31747, DOI 10.1074/jbc.M000621200	64	54	55	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19247	19258		10.1074/jbc.M110.190298	http://dx.doi.org/10.1074/jbc.M110.190298			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21464136	Green Published, hybrid			2022-12-25	WOS:000291027700007
J	Wu, EY; Beese, LS				Wu, Eugene Y.; Beese, Lorena S.			The Structure of a High Fidelity DNA Polymerase Bound to a Mismatched Nucleotide Reveals an "Ajar" Intermediate Conformation in the Nucleotide Selection Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I KLENOW FRAGMENT; CRYSTAL-STRUCTURE; TERNARY COMPLEXES; ACTIVE-SITE; REPLICATION; FAMILY; BYPASS; BETA	To achieve accurate DNA synthesis, DNA polymerases must rapidly sample and discriminate against incorrect nucleotides. Here we report the crystal structure of a high fidelity DNA polymerase I bound to DNA primer-template caught in the act of binding a mismatched (dG: dTTP) nucleoside triphosphate. The polymerase adopts a conformation in between the previously established "open" and "closed" states. In this "ajar" conformation, the template base has moved into the insertion site but misaligns an incorrect nucleotide relative to the primer terminus. The displacement of a conserved active site tyrosine in the insertion site by the template base is accommodated by a distinctive kink in the polymerase O helix, resulting in a partially open ternary complex. We suggest that the ajar conformation allows the template to probe incoming nucleotides for complementarity before closure of the enzyme around the substrate. Based on solution fluorescence, kinetics, and crystallographic analyses of wild-type and mutant polymerases reported here, we present a three-state reaction pathway in which nucleotides either pass through this intermediate conformation to the closed conformation and catalysis or are misaligned within the intermediate, leading to destabilization of the closed conformation.	[Wu, Eugene Y.; Beese, Lorena S.] DUMC, Dept Biochem, Durham, NC 27710 USA	Duke University	Beese, LS (corresponding author), DUMC, Dept Biochem, Box 3711, Durham, NC 27710 USA.	lb12@duke.edu	Wu, Eugene Y/K-5677-2015; Classen, Scott/AAY-8176-2020	Wu, Eugene Y/0000-0002-5189-7036; 	National Institutes of Health [5 P01 CA92584, R01 GM91487]; NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM091487] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 5 P01 CA92584 and R01 GM91487 (to L. S. B.).	Arana ME, 2008, NUCLEIC ACIDS RES, V36, P3847, DOI 10.1093/nar/gkn310; Astatke M, 1998, J MOL BIOL, V278, P147, DOI 10.1006/jmbi.1998.1672; Batra VK, 2008, MOL CELL, V30, P315, DOI 10.1016/j.molcel.2008.02.025; Bell JB, 1997, J BIOL CHEM, V272, P7345, DOI 10.1074/jbc.272.11.7345; Bermek O, 2011, J BIOL CHEM, V286, P3755, DOI 10.1074/jbc.M110.167593; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Doublie S, 1999, STRUCTURE, V7, pR31, DOI 10.1016/S0969-2126(99)80017-3; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Florian J, 2005, P NATL ACAD SCI USA, V102, P6819, DOI 10.1073/pnas.0408173102; Franklin MC, 2001, CELL, V105, P657, DOI 10.1016/S0092-8674(01)00367-1; Gerstein M, 2001, INT TABLES CRYSTALLO, V22, P531; Golosov AA, 2010, STRUCTURE, V18, P83, DOI 10.1016/j.str.2009.10.014; Goodman MF, 1997, P NATL ACAD SCI USA, V94, P10493, DOI 10.1073/pnas.94.20.10493; Johnson SJ, 2003, P NATL ACAD SCI USA, V100, P3895, DOI 10.1073/pnas.0630532100; Joyce CM, 2008, BIOCHEMISTRY-US, V47, P6103, DOI 10.1021/bi7021848; Joyce CM, 2004, BIOCHEMISTRY-US, V43, P14317, DOI 10.1021/bi048422z; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kiefer JR, 1997, STRUCTURE, V5, P95, DOI 10.1016/S0969-2126(97)00169-X; Kunkel TA, 2004, J BIOL CHEM, V279, P16895, DOI 10.1074/jbc.R400006200; Li Y, 1998, PROTEIN SCI, V7, P1116, DOI 10.1002/pro.5560070505; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; Ling H, 2001, CELL, V107, P91, DOI 10.1016/S0092-8674(01)00515-3; Longley MJ, 2001, J BIOL CHEM, V276, P38555, DOI 10.1074/jbc.M105230200; Maga G, 2002, J MOL BIOL, V319, P359, DOI 10.1016/S0022-2836(02)00325-X; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minnick DT, 1999, J BIOL CHEM, V274, P3067, DOI 10.1074/jbc.274.5.3067; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; PELLETIER H, 1994, SCIENCE, V264, P1891, DOI 10.1126/science.7516580; Purohit V, 2003, BIOCHEMISTRY-US, V42, P10200, DOI 10.1021/bi0341206; Rothwell PJ, 2007, J BIOL CHEM, V282, P28884, DOI 10.1074/jbc.M704824200; Rothwell PJ, 2005, MOL CELL, V19, P345, DOI 10.1016/j.molcel.2005.06.032; Santoso Y, 2010, P NATL ACAD SCI USA, V107, P715, DOI 10.1073/pnas.0910909107; Steitz TA, 1998, NATURE, V391, P231, DOI 10.1038/34542; TABOR S, 1995, P NATL ACAD SCI USA, V92, P6339, DOI 10.1073/pnas.92.14.6339; Takata K, 2006, J BIOL CHEM, V281, P23445, DOI 10.1074/jbc.M604317200; Tsai YC, 2006, BIOCHEMISTRY-US, V45, P9675, DOI 10.1021/bi060993z; Vaisman A, 2005, EMBO J, V24, P2957, DOI 10.1038/sj.emboj.7600786; Warren JJ, 2006, P NATL ACAD SCI USA, V103, P19701, DOI 10.1073/pnas.0609580103	40	77	78	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19758	19767		10.1074/jbc.M110.191130	http://dx.doi.org/10.1074/jbc.M110.191130			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21454515	Green Published, hybrid			2022-12-25	WOS:000291027700058
J	Fukuda, T; Hashimoto, H; Okayasu, N; Kameyama, A; Onogi, H; Nakagawasai, O; Nakazawa, T; Kurosawa, T; Hao, Y; Isaji, T; Tadano, T; Narimatsu, H; Taniguchi, N; Gu, JG				Fukuda, Tomohiko; Hashimoto, Hirokazu; Okayasu, Natsumi; Kameyama, Akihiko; Onogi, Hiroshi; Nakagawasai, Osamu; Nakazawa, Takahiro; Kurosawa, Tomoyo; Hao, Yan; Isaji, Tomoya; Tadano, Takeshi; Narimatsu, Hisashi; Taniguchi, Naoyuki; Gu, Jianguo			alpha 1,6-Fucosyltransferase-deficient Mice Exhibit Multiple Behavioral Abnormalities Associated with a Schizophrenia-like Phenotype IMPORTANCE OF THE BALANCE BETWEEN THE DOPAMINE AND SEROTONIN SYSTEMS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEFICIENT GLYCOPROTEIN-SYNDROME; PREPULSE INHIBITION; LOCOMOTOR-ACTIVITY; GDP-FUCOSE; N-GLYCANS; ALPHA-3-BETA-1 INTEGRIN; CORE FUCOSYLATION; FRONTAL-CORTEX; EXPRESSION; LACKING	Previously, we reported that alpha 1,6-fucosyltransferase (Fut8)-deficient (Fut8(-/-)) mice exhibit emphysema-like changes in the lung and severe growth retardation due to dysregulation of TGF-beta 1 and EGF receptors and to abnormal integrin activation, respectively. To study the role of alpha 1,6-fucosylation in brain tissue where Fut8 is highly expressed, we examined Fut8(-/-) mice using a combination of neurological and behavioral tests. Fut8(-/-) mice exhibited multiple behavioral abnormalities consistent with a schizophrenia-like phenotype. Fut8(-/-) mice displayed increased locomotion compared with wild-type (Fut8(+/+)) and heterozygous (Fut8(-/-)) mice. In particular, Fut8(-/-) mice showed strenuous hopping behavior in a novel environment. Working memory performance was impaired in Fut8(-/-) mice as evidenced by the Y-maze tests. Furthermore, Fut8(-/-) mice showed prepulse inhibition (PPI) deficiency. Intriguingly, although there was no significant difference between Fut8(+/+) and Fut8(+/-) mice in the PPI test under normal conditions, Fut8(+/-) mice showed impaired PPI after exposure to a restraint stress. This result suggests that reduced expression of Fut8 is a plausible cause of schizophrenia and related disorders. The levels of serotonin metabolites were significantly decreased in both the striatum and nucleus accumbens of the Fut8(-/-) mice. Likewise, treatment with haloperidol, which is an antipsychotic drug that antagonizes dopaminergic and serotonergic receptors, significantly reduced hopping behaviors. The present study is the first to clearly demonstrate that alpha 1,6-fucosylation plays an important role in the brain, and that it might be related to schizophrenia-like behaviors. Thus, the results of the present study provide new insights into the underlying mechanisms responsible for schizophrenia and related disorders.	[Fukuda, Tomohiko; Hashimoto, Hirokazu; Okayasu, Natsumi; Kurosawa, Tomoyo; Hao, Yan; Isaji, Tomoya; Gu, Jianguo] Tohoku Pharmaceut Univ, Div Regulatory Glycobiol, Aoba Ku, Sendai, Miyagi 9818558, Japan; [Onogi, Hiroshi; Nakagawasai, Osamu; Tadano, Takeshi] Tohoku Pharmaceut Univ, Dept Pharmacol, Aoba Ku, Sendai, Miyagi 9818558, Japan; [Nakazawa, Takahiro] Tohoku Pharmaceut Univ, Dept Nat Prod Chem, Aoba Ku, Sendai, Miyagi 9818558, Japan; [Kameyama, Akihiko; Narimatsu, Hisashi] Natl Inst Adv Ind Sci & Technol, Res Ctr Med Glycosci, Open Space Lab C2, Tsukuba, Ibaraki 3058568, Japan; [Taniguchi, Naoyuki] Osaka Univ, Inst Sci & Ind Res, Dept Dis Glyc, Osaka 5670047, Japan; [Taniguchi, Naoyuki] RIKEN, Adv Sci Inst, Dis Glyc Team, Wako, Saitama 3510198, Japan	Tohoku Medical & Pharmaceutical University; Tohoku Medical & Pharmaceutical University; Tohoku Medical & Pharmaceutical University; National Institute of Advanced Industrial Science & Technology (AIST); Osaka University; RIKEN	Gu, JG (corresponding author), Tohoku Pharmaceut Univ, Div Regulatory Glycobiol, Aoba Ku, 4-4-1 Komatsusima, Sendai, Miyagi 9818558, Japan.	jgu@tohoku-pharm.ac.jp	Gu, Jianguo/ABC-9257-2020; Taniguchi, Naoyuki/I-4182-2014; Isaji, Tomoya/ABC-9285-2021; Nakagawasai, Osamu/AAB-4201-2022; Narimatsu, Hisashi/M-4757-2018; Kameyama, Akihiko/A-9641-2008; Taniguchi, Naoyuki/A-7086-2016	Taniguchi, Naoyuki/0000-0001-5889-5968; Nakagawasai, Osamu/0000-0002-4061-0802; Narimatsu, Hisashi/0000-0002-8402-133X; Kameyama, Akihiko/0000-0002-8229-4449; 	Japan Society for the Promotion of Science [21370059, 22590071]; Ministry of Education, Culture, Sports, Science and Technology of Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Scientific Research Grants-in-aid 21370059 (to J. G.) and 22590071 (to T. F.) from the Japan Society for the Promotion of Science and the Academic Frontier Project for Private Universities from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; Cai GQ, 2005, FEBS J, V272, P1625, DOI 10.1111/j.1742-4658.2005.04595.x; CARLSON JN, 1991, BRAIN RES, V550, P313, DOI 10.1016/0006-8993(91)91333-V; Caspi A, 2005, BIOL PSYCHIAT, V57, P1117, DOI 10.1016/j.biopsych.2005.01.026; Druhan JP, 1996, SYNAPSE, V24, P135, DOI 10.1002/(SICI)1098-2396(199610)24:2<135::AID-SYN5>3.0.CO;2-G; Dulabon L, 2000, NEURON, V27, P33, DOI 10.1016/S0896-6273(00)00007-6; Freedman R, 2003, NEW ENGL J MED, V349, P1738, DOI 10.1056/NEJMra035458; Furukawa JI, 2008, ANAL CHEM, V80, P1094, DOI 10.1021/ac702124d; Gainetdinov RR, 1999, SCIENCE, V283, P397, DOI 10.1126/science.283.5400.397; Garnock-Jones Karly P, 2009, Paediatr Drugs, V11, P203, DOI 10.2165/00148581-200911030-00005; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Halberstadt AL, 2009, NEUROPSYCHOPHARMACOL, V34, P1958, DOI 10.1038/npp.2009.29; Hashimoto H, 2001, P NATL ACAD SCI USA, V98, P13355, DOI 10.1073/pnas.231094498; Hidalgo A, 2003, BLOOD, V101, P1705, DOI 10.1182/blood-2002-09-2840; Hikida T, 2007, P NATL ACAD SCI USA, V104, P14501, DOI 10.1073/pnas.0704774104; Hyman SE, 2000, B WORLD HEALTH ORGAN, V78, P455; IOFFE E, 1994, P NATL ACAD SCI USA, V91, P728, DOI 10.1073/pnas.91.2.728; Ishii A, 2007, GLYCOBIOLOGY, V17, P261, DOI 10.1093/glycob/cwl076; JAEKEN J, 1994, ARCH DIS CHILD, V71, P123, DOI 10.1136/adc.71.2.123; Kapur S, 2000, NEUROPSYCHOPHARMACOL, V23, P595, DOI 10.1016/S0893-133X(00)00139-1; KAROUM F, 1992, BRIT J PHARMACOL, V105, P703, DOI 10.1111/j.1476-5381.1992.tb09042.x; KITAICHI K, 1994, JPN J PHARMACOL, V66, P181, DOI 10.1254/jjp.66.181; Kopelowicz A, 2006, SCHIZOPHRENIA BULL, V32, pS12, DOI 10.1093/schbul/sbl023; Kumari V, 2008, CORTEX, V44, P1206, DOI 10.1016/j.cortex.2007.11.007; Lewis DA, 2009, J CLIN INVEST, V119, P706, DOI 10.1172/JCI37335; Lubke T, 1999, J BIOL CHEM, V274, P25986, DOI 10.1074/jbc.274.37.25986; Lubke T, 2001, NAT GENET, V28, P73, DOI 10.1038/ng0501-73; Ludewig K, 2003, BIOL PSYCHIAT, V54, P121, DOI 10.1016/S0006-3223(02)01925-X; Marquardt T, 1999, J PEDIATR-US, V134, P681, DOI 10.1016/S0022-3476(99)70281-7; Marquardt T, 1999, BLOOD, V94, P3976, DOI 10.1182/blood.V94.12.3976.424k06_3976_3985; Matsumura K, 2007, J BIOL CHEM, V282, P15700, DOI 10.1074/jbc.M701195200; Miyakawa T, 2003, P NATL ACAD SCI USA, V100, P8987, DOI 10.1073/pnas.1432926100; Miyoshi E, 1999, BBA-GEN SUBJECTS, V1473, P9, DOI 10.1016/S0304-4165(99)00166-X; Mohn AR, 1999, CELL, V98, P427, DOI 10.1016/S0092-8674(00)81972-8; Moy SS, 2006, BRAIN RES, V1089, P186, DOI 10.1016/j.brainres.2006.03.073; Nakagawasai O, 2009, LIFE SCI, V84, P512, DOI 10.1016/j.lfs.2009.01.009; Nakakita S, 2005, J BIOCHEM, V138, P277, DOI 10.1093/jb/mvi125; Nakazawa T, 2003, BIOL PHARM BULL, V26, P474, DOI 10.1248/bpb.26.474; Nicodemus KK, 2008, MOL PSYCHIATR, V13, P873, DOI 10.1038/sj.mp.4002153; Noda K, 2003, CANCER RES, V63, P6282; Ozaslan D, 2003, J BIOL CHEM, V278, P43991, DOI 10.1074/jbc.M306360200; Patil ST, 2007, NAT MED, V13, P1102, DOI 10.1038/nm1632; Pierce RC, 1997, PSYCHOPHARMACOLOGY, V133, P188, DOI 10.1007/s002130050390; Piskulic D, 2007, PSYCHIAT RES, V150, P111, DOI 10.1016/j.psychres.2006.03.018; Pletnikov MV, 2008, MOL PSYCHIATR, V13, P173, DOI [10.1038/sj.mp.4002079, 10.1038/sj.mp.4002144]; Ross CA, 2006, NEURON, V52, P139, DOI 10.1016/j.neuron.2006.09.015; Roth BL, 2004, NAT REV DRUG DISCOV, V3, P353, DOI 10.1038/nrd1346; SAUDOU F, 1994, SCIENCE, V265, P1875, DOI 10.1126/science.8091214; Seeman P, 2009, J PSYCHIATR NEUROSCI, V34, P143; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; SHIMIZU H, 1993, J BIOCHEM-TOKYO, V114, P334, DOI 10.1093/oxfordjournals.jbchem.a124177; Shinkawa T, 2003, J BIOL CHEM, V278, P3466, DOI 10.1074/jbc.M210665200; Sitges M, 1998, EUR NEUROPSYCHOPHARM, V8, P105, DOI 10.1016/S0924-977X(97)00053-9; Soleimani L, 2008, GENES BRAIN BEHAV, V7, P334, DOI 10.1111/j.1601-183X.2007.00358.x; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Uozumi N, 1996, J BIOL CHEM, V271, P27810, DOI 10.1074/jbc.271.44.27810; van den Buuse M, 2009, INT J NEUROPSYCHOPH, V12, P1383, DOI 10.1017/S1461145709000388; Wang XC, 2005, P NATL ACAD SCI USA, V102, P15791, DOI 10.1073/pnas.0507375102; Wang XC, 2006, J BIOL CHEM, V281, P2572, DOI 10.1074/jbc.M510893200; Wang XC, 2009, J BIOCHEM, V145, P643, DOI 10.1093/jb/mvp022; Wang Y, 2001, GLYCOBIOLOGY, V11, P1051, DOI 10.1093/glycob/11.12.1051; WILSON JR, 1976, BIOCHEM BIOPH RES CO, V72, P909, DOI 10.1016/S0006-291X(76)80218-5; Ye ZY, 2004, GLYCOBIOLOGY, V14, P547, DOI 10.1093/glycob/cwh069; Zhao YY, 2006, J BIOL CHEM, V281, P38343, DOI 10.1074/jbc.M608764200	64	55	56	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18434	18443		10.1074/jbc.M110.172536	http://dx.doi.org/10.1074/jbc.M110.172536			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21471224	Green Published, hybrid			2022-12-25	WOS:000290785700016
J	Hernandez-Varas, P; Colo, GP; Bartolome, RA; Paterson, A; Medrano-Fernandez, I; Arellano-Sanchez, N; Cabanas, C; Sanchez-Mateos, P; Lafuente, EM; Boussiotis, VA; Stromblad, S; Teixido, J				Hernandez-Varas, Pablo; Colo, Georgina P.; Bartolome, Ruben A.; Paterson, Andrew; Medrano-Fernandez, Iria; Arellano-Sanchez, Nohem; Cabanas, Carlos; Sanchez-Mateos, Paloma; Lafuente, Esther M.; Boussiotis, Vassiliki A.; Stromblad, Staffan; Teixido, Joaquin			Rap1-GTP-interacting Adaptor Molecule (RIAM) Protein Controls Invasion and Growth of Melanoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX-METALLOPROTEINASE; INTEGRIN ACTIVATION; MIGRATION; ADHESION; RAP1; METASTASIS; MYOSIN; PROLIFERATION; INACTIVATION; RECEPTORS	The Mig-10/RIAM/lamellipodin (MRL) family member Rap1-GTP-interacting adaptor molecule (RIAM) interacts with active Rap1, a small GTPase that is frequently activated in tumors such as melanoma and prostate cancer. We show here that RIAM is expressed in metastatic human melanoma cells and that both RIAM and Rap1 are required for BLM melanoma cell invasion. RIAM silencing in melanoma cells led to inhibition of tumor growth and to delayed metastasis in a severe combined immunodeficiency xenograft model. Defective invasion of RIAM-silenced melanoma cells arose from impairment in persistent cell migration directionality, which was associated with deficient activation of a Vav2-RhoA-ROCK-myosin light chain pathway. Expression of constitutively active Vav2 and RhoA in cells depleted for RIAM partially rescued their invasion, indicating that Vav2 and RhoA mediate RIAM function. These results suggest that inhibition of cell invasion in RIAM-silenced melanoma cells is likely based on altered cell contractility and cell polarization. Furthermore, we show that RIAM depletion reduces beta 1 integrin-dependent melanoma cell adhesion, which correlates with decreased activation of both Erk1/2 MAPK and phosphatidylinositol 3-kinase, two central molecules controlling cell growth and cell survival. In addition to causing inhibition of cell proliferation, RIAM silencing led to higher susceptibility to cell apoptosis. Together, these data suggest that defective activation of these kinases in RIAM-silenced cells could account for inhibition of melanoma cell growth and that RIAM might contribute to the dissemination of melanoma cells.	[Hernandez-Varas, Pablo; Colo, Georgina P.; Bartolome, Ruben A.; Arellano-Sanchez, Nohem; Teixido, Joaquin] Ctr Invest Biol, Dept Cellular & Mol Med, Madrid 28040, Spain; [Paterson, Andrew; Stromblad, Staffan] Karolinska Inst, Dept Biosci & Nutr, Ctr Biosci, SE-14183 Huddinge, Sweden; [Medrano-Fernandez, Iria; Lafuente, Esther M.] Univ Complutense Madrid, Fac Med, Dept Microbiol, Madrid 28041, Spain; [Medrano-Fernandez, Iria; Lafuente, Esther M.] Univ Complutense Madrid, Inst Invest Hosp 12 Octubre, Madrid 28041, Spain; [Cabanas, Carlos] Univ Autonoma Madrid, Ctr Biol Mol, E-28049 Madrid, Spain; [Sanchez-Mateos, Paloma] Hosp Univ Gregorio Maranon, Serv Inmunooncol, Madrid 28007, Spain; [Boussiotis, Vassiliki A.] Harvard Univ, Sch Med, Div Hematol & Oncol, Dept Med, Boston, MA 02115 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Karolinska Institutet; Complutense University of Madrid; Complutense University of Madrid; Hospital Universitario 12 de Octubre; Autonomous University of Madrid; General University Gregorio Maranon Hospital; Harvard University; Harvard Medical School	Teixido, J (corresponding author), Ctr Invest Biol, Dept Cellular & Mol Med, Madrid 28040, Spain.	joaquint@cib.csic.es	CABAÑAS, CARLOS/J-4595-2012; Lafuente, Esther M/K-5684-2014; Sánchez, Nohemí Arellano/K-1210-2014; Teixidó, Joaquin/J-8543-2014; Medraño-Fernandez, Iria/AAN-4357-2020; Sanchez-Mateos, Paloma/E-8931-2013; LAFUENTE, ESTHER M/AAA-3149-2019; Bartolome, Ruben A/M-1873-2014	CABAÑAS, CARLOS/0000-0002-8767-060X; Lafuente, Esther M/0000-0001-8466-1022; Medraño-Fernandez, Iria/0000-0002-7956-9915; Bartolome, Ruben A/0000-0002-3292-1491; Stromblad, Staffan/0000-0002-1236-6339; Hernandez-Varas, Pablo/0000-0001-8664-9203; Sanchez-Mateos, Paloma/0000-0001-6589-4445	Ministerio de Ciencia e Innovacion [SAF2008-00479, SAF2007-60578, CCG08-UCM/SAL-4259, RETICS RD06/0020/0011, BFU2007-66443]; Fundacion Ramon Areces; EU; European Union [HEALTH-2007-201862]; Swedish Cancer Society; Swedish Research Council [2RO1 AI43552]; Fundacion de Investigacion Cientifica de la Asociacion Espanola Contra el Cancer; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043552] Funding Source: NIH RePORTER	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fundacion Ramon Areces; EU(European Commission); European Union(European Commission); Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Fundacion de Investigacion Cientifica de la Asociacion Espanola Contra el Cancer; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Grants SAF2008-00479 from the Ministerio de Ciencia e Innovacion (to J. T.), Grants SAF2007-60578 and CCG08-UCM/SAL-4259 from the Ministerio de Ciencia e Innovacion (to E. M. L.), Grant RETICS RD06/0020/0011 from the Ministerio de Ciencia e Innovacion (to J. T.), Grant BFU2007-66443 from the Ministerio de Ciencia e Innovacion (to C. C.), a 2006 Grant from the Fundacion Ramon Areces (to P. S.-M.), Grant EU-FP7-MetaFight, European Union HEALTH-2007-201862 (to J. T. and S. S.), a grant from the Swedish Cancer Society and the Swedish Research Council (to S. S.), Grant 2RO1 AI43552 (to V. A. B.), and by a grant from the Fundacion de Investigacion Cientifica de la Asociacion Espanola Contra el Cancer (to R. A. B.).	Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Arthur WT, 2004, J CELL BIOL, V167, P111, DOI 10.1083/jcb.200404068; Assoian RK, 2008, TRENDS CELL BIOL, V18, P347, DOI 10.1016/j.tcb.2008.05.002; Bailey CL, 2009, CANCER RES, V69, P4962, DOI 10.1158/0008-5472.CAN-08-4269; Bao WJ, 2004, J CELL BIOL, V167, P745, DOI 10.1083/jcb.200404018; Bartolome RA, 2006, CANCER RES, V66, P248, DOI 10.1158/0008-5472.CAN-05-2489; Bartolome RA, 2004, CANCER RES, V64, P2534, DOI 10.1158/0008-5472.CAN-03-3398; Bartolome RA, 2008, CANCER RES, V68, P8221, DOI 10.1158/0008-5472.CAN-08-0561; Bartolome RA, 2009, AM J PATHOL, V174, P602, DOI 10.2353/ajpath.2009.080636; Boettner B, 2009, CURR OPIN CELL BIOL, V21, P684, DOI 10.1016/j.ceb.2009.06.004; Bos JL, 2005, CURR OPIN CELL BIOL, V17, P123, DOI 10.1016/j.ceb.2005.02.009; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Bustelo XR, 2000, MOL CELL BIOL, V20, P1461, DOI 10.1128/MCB.20.5.1461-1477.2000; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; CIFONE MA, 1980, P NATL ACAD SCI-BIOL, V77, P1039, DOI 10.1073/pnas.77.2.1039; Gao L, 2006, CANCER RES, V66, P7880, DOI 10.1158/0008-5472.CAN-06-0254; Garcia-Bernal D, 2009, IMMUNITY, V31, P953, DOI 10.1016/j.immuni.2009.09.021; Go RS, 1999, J CLIN ONCOL, V17, P409, DOI 10.1200/JCO.1999.17.1.409; Gomes ER, 2005, CELL, V121, P451, DOI 10.1016/j.cell.2005.02.022; Lafuente EM, 2004, DEV CELL, V7, P585, DOI 10.1016/j.devcel.2004.07.021; Lee HS, 2009, J BIOL CHEM, V284, P5119, DOI 10.1074/jbc.M807117200; Lim J, 2010, J CELL BIOCHEM, V111, P999, DOI 10.1002/jcb.22788; Lyulcheva E, 2008, DEV CELL, V15, P680, DOI 10.1016/j.devcel.2008.09.020; Menasche G, 2007, MOL CELL BIOL, V27, P4070, DOI 10.1128/MCB.02011-06; Molina-Ortiz I, 2009, J BIOL CHEM, V284, P15147, DOI 10.1074/jbc.M807834200; MONTGOMERY AMP, 1994, P NATL ACAD SCI USA, V91, P8856, DOI 10.1073/pnas.91.19.8856; Patsoukis N, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000409; Raaijmakers JH, 2009, J BIOL CHEM, V284, P10995, DOI 10.1074/jbc.R800061200; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Robledo MM, 2001, J BIOL CHEM, V276, P45098, DOI 10.1074/jbc.M106912200; Schwartz MA, 2001, J CELL SCI, V114, P2553; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Ticchioni M, 2002, BLOOD, V99, P3111, DOI 10.1182/blood.V99.9.3111; Turner M, 2002, NAT REV IMMUNOL, V2, P476, DOI 10.1038/nri840; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Watanabe N, 2008, J CELL BIOL, V181, P1211, DOI 10.1083/jcb.200803094; YEDNOCK TA, 1995, J BIOL CHEM, V270, P28740, DOI 10.1074/jbc.270.48.28740	38	29	30	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18492	18504		10.1074/jbc.M110.189811	http://dx.doi.org/10.1074/jbc.M110.189811			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21454517	Green Published, hybrid			2022-12-25	WOS:000290785700022
J	Mahawar, M; Tran, V; Sharp, JS; Maier, RJ				Mahawar, Manish; ViLinh Tran; Sharp, Joshua S.; Maier, Robert J.			Synergistic Roles of Helicobacter pylori Methionine Sulfoxide Reductase and GroEL in Repairing Oxidant-damaged Catalase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOCHLOROUS ACID; OXIDATIVE STRESS; BIOLOGICAL FUNCTION; ESCHERICHIA-COLI; AMINO-ACIDS; PROTEINS; INACTIVATION; EXPRESSION; NITRATION; CHAPERONE	Hypochlorous acid (HOCl) produced via the enzyme myeloperoxidase is a major antibacterial oxidant produced by neutrophils, and Met residues are considered primary amino acid targets of HOCl damage via conversion to Met sulfoxide. Met sulfoxide can be repaired back to Met by methionine sulfoxide reductase (Msr). Catalase is an important antioxidant enzyme; we show it constitutes 4-5% of the total Helicobacter pylori protein levels. msr and katA strains were about 14- and 4-fold, respectively, more susceptible than the parent to killing by the neutrophil cell line HL-60 cells. Catalase activity of an msr strain was much more reduced by HOCl exposure than for the parental strain. Treatment of pure catalase with HOCl caused oxidation of specific MS-identified Met residues, as well as structural changes and activity loss depending on the oxidant dose. Treatment of catalase with HOCl at a level to limit structural perturbation (at a catalase/HOCl molar ratio of 1:60) resulted in oxidation of six identified Met residues. Msr repaired these residues in an in vitro reconstituted system, but no enzyme activity could be recovered. However, addition of GroEL to the Msr repair mixture significantly enhanced catalase activity recovery. Neutrophils produce large amounts of HOCl at inflammation sites, and bacterial catalase may be a prime target of the host inflammatory response; at high concentrations of HOCl (1:100), we observed loss of catalase secondary structure, oligomerization, and carbonylation. The same HOCl-sensitive Met residue oxidation targets in catalase were detected using chloramine-T as a milder oxidant.	[Mahawar, Manish; Maier, Robert J.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; [ViLinh Tran; Sharp, Joshua S.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Maier, RJ (corresponding author), Univ Georgia, Dept Microbiol, 805 Biol Sci Bldg, Athens, GA 30602 USA.	rmaier@uga.edu			National Institutes of Health [RO1 AI077569]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR005351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077569] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103390] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 AI077569.	Abulimiti A, 2003, BIOCHEM BIOPH RES CO, V305, P87, DOI 10.1016/S0006-291X(03)00685-5; Alamuri P, 2004, MOL MICROBIOL, V53, P1397, DOI 10.1111/j.1365-2958.2004.04190.x; Alamuri P, 2006, J BACTERIOL, V188, P5839, DOI 10.1128/JB.00430-06; Algood HMS, 2006, CLIN MICROBIOL REV, V19, P597, DOI 10.1128/CMR.00006-06; Alvarez B, 2003, AMINO ACIDS, V25, P295, DOI 10.1007/s00726-003-0018-8; Basu M, 2004, HELICOBACTER, V9, P211, DOI 10.1111/j.1083-4389.2004.00226.x; Berlett BS, 1998, P NATL ACAD SCI USA, V95, P2784, DOI 10.1073/pnas.95.6.2784; Bonini MG, 2007, FREE RADICAL BIO MED, V42, P530, DOI 10.1016/j.freeradbiomed.2006.11.019; Boschi-Muller S, 2008, ARCH BIOCHEM BIOPHYS, V474, P266, DOI 10.1016/j.abb.2008.02.007; Brennan LA, 2009, BBA-GEN SUBJECTS, V1790, P1665, DOI 10.1016/j.bbagen.2009.08.011; Cao G, 2010, J BIOL CHEM, V285, P26081, DOI 10.1074/jbc.M110.103655; Chao CC, 1997, P NATL ACAD SCI USA, V94, P2969, DOI 10.1073/pnas.94.7.2969; Chapman ALP, 2003, BIOCHEM J, V375, P33, DOI 10.1042/BJ20030685; Ezraty B, 2005, BBA-PROTEINS PROTEOM, V1703, P221, DOI 10.1016/j.bbapap.2004.08.017; Ezraty B, 2004, EMBO J, V23, P1868, DOI 10.1038/sj.emboj.7600172; Georgopoulos C, 2006, GENETICS, V174, P1699, DOI 10.1534/genetics.104.68262; Grimaud R, 2001, J BIOL CHEM, V276, P48915, DOI 10.1074/jbc.M105509200; Handa O, 2010, INFLAMM RES, V59, P997, DOI 10.1007/s00011-010-0245-x; HARLOW E, 1988, ANTIBODIES LAB MANUA, P598; Harris AG, 2003, MICROBIOL-SGM, V149, P665, DOI 10.1099/mic.0.26012-0; Hawkins CL, 2005, CHEM RES TOXICOL, V18, P1600, DOI 10.1021/tx050207b; Hawkins CL, 2003, AMINO ACIDS, V25, P259, DOI 10.1007/s00726-003-0016-x; HAZELL SL, 1991, J GEN MICROBIOL, V137, P57, DOI 10.1099/00221287-137-1-57; Hook DWA, 1997, EUR J BIOCHEM, V247, P380, DOI 10.1111/j.1432-1033.1997.00380.x; Hope HR, 2000, PROTEIN EXPRES PURIF, V18, P269, DOI 10.1006/prep.1999.1197; HUGHES MN, 1968, J CHEM SOC A, P450, DOI 10.1039/j19680000450; Khor HK, 2004, J BIOL CHEM, V279, P19486, DOI 10.1074/jbc.M310045200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lancellotti S, 2010, FREE RADICAL BIO MED, V48, P446, DOI 10.1016/j.freeradbiomed.2009.11.020; Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036; Loewen PC, 2004, BIOCHEMISTRY-US, V43, P3089, DOI 10.1021/bi035663i; Lowther WT, 2002, NAT STRUCT BIOL, V9, P348, DOI 10.1038/nsb783; Lund PA, 2009, FEMS MICROBIOL REV, V33, P785, DOI 10.1111/j.1574-6976.2009.00178.x; Luo S, 2009, FASEB J, V23, P464, DOI 10.1096/fj.08-118414; McLean S, 2010, J BIOL CHEM, V285, P20724, DOI 10.1074/jbc.M109.085506; Melkani GC, 2002, BIOCHEM BIOPH RES CO, V294, P893, DOI 10.1016/S0006-291X(02)00575-2; Mondal P, 2008, PROTEIN PEPTIDE LETT, V15, P1075, DOI 10.2174/092986608786071058; MORRIS JC, 1966, J PHYS CHEM-US, V70, P3798, DOI 10.1021/j100884a007; Moskovitz J, 2005, BBA-PROTEINS PROTEOM, V1703, P213, DOI 10.1016/j.bbapap.2004.09.003; Ramarao N, 2000, MOL MICROBIOL, V38, P103, DOI 10.1046/j.1365-2958.2000.02114.x; Rosen H, 2009, P NATL ACAD SCI USA, V106, P18686, DOI 10.1073/pnas.0909464106; Sharp JS, 2006, BIOCHEMISTRY-US, V45, P6260, DOI 10.1021/bi060470r; Su Z, 2007, BIOCHEM PHARMACOL, V74, P702, DOI 10.1016/j.bcp.2007.06.002; Tanaka M, 2007, P NATL ACAD SCI USA, V104, P66, DOI 10.1073/pnas.0609737104; Tien M, 1999, P NATL ACAD SCI USA, V96, P7809, DOI 10.1073/pnas.96.14.7809; Tsvetkov PO, 2005, BIOCHIMIE, V87, P473, DOI 10.1016/j.biochi.2004.11.020; Venkatesh S, 2007, RAPID COMMUN MASS SP, V21, P3927, DOI 10.1002/rcm.3291; VOGT W, 1995, FREE RADICAL BIO MED, V18, P93, DOI 10.1016/0891-5849(94)00158-G; Wang G, 2005, FREE RADICAL RES, V39, P1183, DOI 10.1080/10715760500194018; Wang G, 2004, J BIOL CHEM, V279, P51908, DOI 10.1074/jbc.M408450200; Wang G, 2006, MOL MICROBIOL, V61, P847, DOI 10.1111/j.1365-2958.2006.05302.x; Wang G, 2010, INFECT IMMUN, V78, P4660, DOI 10.1128/IAI.00307-10; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; Weissbach H, 2002, ARCH BIOCHEM BIOPHYS, V397, P172, DOI 10.1006/abbi.2001.2664; Winter J, 2008, CELL, V135, P691, DOI 10.1016/j.cell.2008.09.024; Wong YQ, 2010, P NATL ACAD SCI USA, V107, P1977, DOI 10.1073/pnas.0910136107	56	49	51	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					19159	19169		10.1074/jbc.M111.223677	http://dx.doi.org/10.1074/jbc.M111.223677			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21460217	Green Published, hybrid			2022-12-25	WOS:000290785700085
J	Yang, SY; Xu, HY; Yu, SB; Cao, HL; Fan, J; Ge, CX; Fransceschi, RT; Dong, HH; Xiao, GZ				Yang, Shengyong; Xu, Haiyan; Yu, Shibing; Cao, Huiling; Fan, Jie; Ge, Chunxi; Fransceschi, Renny T.; Dong, Henry H.; Xiao, Guozhi			Foxo1 Mediates Insulin-like Growth Factor 1 (IGF1)/Insulin Regulation of Osteocalcin Expression by Antagonizing Runx2 in Osteoblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATING TRANSCRIPTION FACTOR-4; MARROW STROMAL CELLS; GENE-EXPRESSION; PARATHYROID-HORMONE; SIGNALING PATHWAYS; BONE-FORMATION; CLEIDOCRANIAL DYSPLASIA; IN-VIVO; DEPENDENT ACTIVATION; SKELETAL DEVELOPMENT	In this study, we determined the molecular mechanisms whereby forkhead transcription factor Foxo1, a key downstream signaling molecule of insulin-like growth factor 1 (IGF1)/insulin actions, regulates Runx2 activity and expression of the mouse osteocalcin gene 2 (Bglap2) in osteoblasts in vitro. We showed that Foxo1 inhibited Runx2-dependent transcriptional activity and osteocalc in mRNA expression and Bglap2 promoter activity in MC-4 preosteoblasts. Co-immunoprecipitation assay showed that Foxo1 physically interacted with Runx2 via its C-terminal region in osteoblasts or when co-expressed in COS-7 cells. Electrophoretic mobility shift assay demonstrated that Foxo1 suppressed Runx2 binding to its cognate site within the Bglap2 promoter. IGF1 and insulin prevented Foxo1 from inhibiting Runx2 activity by promoting Foxo1 phosphorylation and nuclear exclusion. In contrast, a neutralizing anti-IGF1 antibody decreased Runx2 activity and osteocalcin expression in osteoblasts. Chromatin immunoprecipitation assay revealed that IGF1 increased Runx2 interaction with a chromatin fragment of the proximal Bglap2 promoter in a PI3K/AKT-dependent manner. Conversely, knockdown of Foxo1 increased Runx2 interaction with the promoter. This study establishes that Foxo1 is a novel negative regulator of osteoblast-specific transcription factor Runx2 and modulates IGF1/insulin-dependent regulation of osteocalcin expression in osteoblasts.	[Yang, Shengyong; Yu, Shibing; Cao, Huiling; Xiao, Guozhi] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15240 USA; [Yang, Shengyong] Chongqing Med Univ, Dept Biochem & Mol Biol, Chongqing 400016, Peoples R China; [Xu, Haiyan] Rhode Isl Hosp, Brown Med Sch, Hallett Ctr Diabet & Endocrinol, Providence, RI 02901 USA; [Fan, Jie] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA 15240 USA; [Ge, Chunxi; Fransceschi, Renny T.] Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA; [Fransceschi, Renny T.] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Dong, Henry H.] Univ Pittsburgh, Childrens Hosp Pittsburgh, Dept Pediat, Pittsburgh, PA 15240 USA; [Xiao, Guozhi] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Chongqing Medical University; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Nankai University	Xiao, GZ (corresponding author), VA Pittsburgh Healthcare Syst, Rm 2E-107,151-U, Pittsburgh, PA 15240 USA.	xiaog@upmc.edu	YU, SHIBING/B-7648-2012	Dong, H. Henry/0000-0003-0279-5241	National Institutes of Health [DK072230, AR059647, DK066301]; Department of Defense [W81XWH-07-1-0160]; Chinese Ministry of Science and Technology [2009CB918902]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072230, R01DK066301] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK072230, AR059647, and DK066301 and by Department of Defense Grant W81XWH-07-1-0160 and by Chinese Ministry of Science and Technology Grant 2009CB918902.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Arden KC, 2004, MOL CELL, V14, P416, DOI 10.1016/S1097-2765(04)00213-8; Asada S, 2007, CELL SIGNAL, V19, P519, DOI 10.1016/j.cellsig.2006.08.015; Aslam F, 1999, ENDOCRINOLOGY, V140, P63, DOI 10.1210/en.140.1.63; Banerjee C, 1996, P NATL ACAD SCI USA, V93, P4968, DOI 10.1073/pnas.93.10.4968; Banerjee C, 1997, J CELL BIOCHEM, V66, P1, DOI 10.1002/(SICI)1097-4644(19970701)66:1<1::AID-JCB1>3.0.CO;2-V; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Benson MD, 2000, J BIOL CHEM, V275, P13907, DOI 10.1074/jbc.275.18.13907; BENSON MD, 1998, J BONE MINER RES  S1, V12, pS277; Bialek P, 2004, DEV CELL, V6, P423, DOI 10.1016/S1534-5807(04)00058-9; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cao HL, 2010, J CLIN INVEST, V120, P2755, DOI 10.1172/JCI42106; D'Alonzo RC, 2002, J BIOL CHEM, V277, P24788, DOI 10.1074/jbc.M202604200; Dong XC, 2008, CELL METAB, V8, P65, DOI 10.1016/j.cmet.2008.06.006; DUCY P, 1995, MOL CELL BIOL, V15, P1858; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003; Frendo JL, 1998, J BIOL CHEM, V273, P30509, DOI 10.1074/jbc.273.46.30509; Fulzele K, 2010, CELL, V142, P309, DOI 10.1016/j.cell.2010.06.002; Ge CX, 2007, J CELL BIOL, V176, P709, DOI 10.1083/jcb.200610046; Ge CX, 2009, J BIOL CHEM, V284, P32533, DOI 10.1074/jbc.M109.040980; Gilbert L, 2002, J BIOL CHEM, V277, P2695, DOI 10.1074/jbc.M106339200; Hess J, 2001, J BIOL CHEM, V276, P20029, DOI 10.1074/jbc.M010601200; Hurley MM, 1999, J BONE MINER RES, V14, P776, DOI 10.1359/jbmr.1999.14.5.776; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Javed A, 2000, J CELL SCI, V113, P2221; Jiang D, 2004, J BIOL CHEM, V279, P5329, DOI 10.1074/jbc.M311547200; Kahler RA, 2003, J BIOL CHEM, V278, P11937, DOI 10.1074/jbc.M211443200; Kamagate A, 2008, J CLIN INVEST, V118, P2347, DOI [10.1172/JCI32914, 10.1172/JC132914]; Kim S, 2003, GENE DEV, V17, P1979, DOI 10.1101/gad.1119303; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kundu M, 2002, NAT GENET, V32, P639, DOI 10.1038/ng1050; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; McLarrent FW, 2001, J BIOL CHEM, V276, P1578, DOI 10.1074/jbc.M007629200; Miller J, 2002, NAT GENET, V32, P645, DOI 10.1038/ng1049; Montero A, 2000, J CLIN INVEST, V105, P1085, DOI 10.1172/JCI8641; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Qiao M, 2004, J BIOL CHEM, V279, P42709, DOI 10.1074/jbc.M404480200; Rached MT, 2010, J CLIN INVEST, V120, P357, DOI 10.1172/JCI39901; Selvamurugan N, 1998, J BIOL CHEM, V273, P10647, DOI 10.1074/jbc.273.17.10647; Thomas DM, 2001, MOL CELL, V8, P303, DOI 10.1016/S1097-2765(01)00327-6; Van der Heide LP, 2005, BIOCHEM J, V391, P623, DOI 10.1042/BJ20050525; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; Wang D, 1999, J BONE MINER RES, V14, P893, DOI 10.1359/jbmr.1999.14.6.893; Wu ZD, 2010, J CLIN INVEST, V120, P3901, DOI 10.1172/JCI43250; Xiao GZ, 1998, J BIOL CHEM, V273, P32988, DOI 10.1074/jbc.273.49.32988; Xiao GZ, 1997, MOL ENDOCRINOL, V11, P1103, DOI 10.1210/me.11.8.1103; Xiao GZ, 2000, J BIOL CHEM, V275, P4453, DOI 10.1074/jbc.275.6.4453; Xiao GZ, 2002, J BIOL CHEM, V277, P36181, DOI 10.1074/JBC.m206057200; Xiao GZ, 2002, J BONE MINER RES, V17, P101, DOI 10.1359/jbmr.2002.17.1.101; Xiao GZ, 2005, J BIOL CHEM, V280, P30689, DOI 10.1074/jbc.M500750200; Yakar S, 2002, J CLIN INVEST, V110, P771, DOI 10.1172/JCI200215463; Yang SY, 2003, J BONE MINER RES, V18, P705, DOI 10.1359/jbmr.2003.18.4.705; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Yoshida CA, 2002, NAT GENET, V32, P633, DOI 10.1038/ng1015; Yoshizawa T, 2009, J CLIN INVEST, V119, P2807, DOI 10.1172/JCI39366; Yu SB, 2008, ENDOCRINOLOGY, V149, P1960, DOI 10.1210/en.2007-1573; Yu SB, 2008, J BIOL CHEM, V283, P5542, DOI 10.1074/jbc.M705653200; Yu SB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007583; Zhang X, 2002, BIOCHEM BIOPH RES CO, V290, P526, DOI 10.1006/bbrc.2001.6217; Zhang XY, 2008, J CELL BIOCHEM, V105, P885, DOI 10.1002/jcb.21888; Zhang YW, 2000, P NATL ACAD SCI USA, V97, P10549, DOI 10.1073/pnas.180309597	65	55	62	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					19149	19158		10.1074/jbc.M110.197905	http://dx.doi.org/10.1074/jbc.M110.197905			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21471200	hybrid, Green Published			2022-12-25	WOS:000290785700084
J	Alvarez, F; Munoz, F; Schilcher, P; Imhof, A; Almouzni, G; Loyola, A				Alvarez, Francisca; Munoz, Francisca; Schilcher, Pierre; Imhof, Axel; Almouzni, Genevieve; Loyola, Alejandra			Sequential Establishment of Marks on Soluble Histones H3 and H4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAPERONE; ACETYLATION; DEPOSITION; COMPLEX; IMPORT; DAXX	Much progress has been made concerning histone function in the nucleus; however, following their synthesis, how their marking and subcellular traffic king are regulated remains to be explored. To gain an insight into these issues, we focused on soluble histones and analyzed endogenous and tagged H3 histones in parallel. We distinguished six complexes that we could place to account for maturation events occurring on histones H3 and H4 from their synthesis onward. In each complex, a different set of chaperones is involved, and we found specific post-translational modifications. Interestingly, we revealed that histones H3 and H4 are transiently poly-(ADP-ribosylated). The impact of these marks in histone metabolism proved to be important as we found that acetylation of lysines 5 and 12 on histone H4 stimulated its nuclear translocation. Furthermore, we showed that, depending on particular histone H3 modifications, the balance in the presence of the different translocation complexes changes. Therefore, our results enabled us to propose a regulatory means of these marks for controlling cytoplasmic/nuclear shuttling and the establishment of early modification patterns.	[Alvarez, Francisca; Munoz, Francisca; Loyola, Alejandra] Fdn Ciencia Vida, Santiago 7780272, Chile; [Schilcher, Pierre; Imhof, Axel] Munich Ctr Integrated Prot Sci, D-80336 Munich, Germany; [Schilcher, Pierre; Imhof, Axel] Adolf Butenandt Inst, D-80336 Munich, Germany; [Almouzni, Genevieve] Inst Curie, CNRS, UMR 218, F-75248 Paris, France; [Loyola, Alejandra] Univ San Sebastian, Santiago, Chile	University of Munich; University of Munich; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Universidad San Sebastian	Loyola, A (corresponding author), Avda Zanartu 1482, Santiago, Chile.	alejandra.loyola@bionova.cl	Imhof, Axel/AAU-5313-2021; Almouzni, Genevieve/ABG-1029-2021; Loyola, Maria Alejandra/A-2613-2013; Loyola, Alejandra/ABE-8337-2020	Imhof, Axel/0000-0003-2993-8249; Almouzni, Genevieve/0000-0001-5570-0723; 	Fondo Nacional de Desarrollo Cientifico y Tecnologico [1090270]; Basal Project [PFB16]; Iniciativa Cientifica Milenio-Millenium Institute of Fundamental Applied Biology; Institut Curie/CNRS	Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Basal Project(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/BASAL); Iniciativa Cientifica Milenio-Millenium Institute of Fundamental Applied Biology; Institut Curie/CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by Fondo Nacional de Desarrollo Cientifico y Tecnologico Grant 1090270, Basal Project PFB16, and the Iniciativa Cientifica Milenio-Millenium Institute of Fundamental Applied Biology (to A. L.) and by grants from the Institut Curie/CNRS (to G. A.).	ADAM SA, 1990, J CELL BIOL, V111, P807, DOI 10.1083/jcb.111.3.807; Campos EI, 2010, NAT STRUCT MOL BIOL, V17, P1343, DOI 10.1038/nsmb.1911; Campos EI, 2010, GENE DEV, V24, P1334, DOI 10.1101/gad.1946810; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Corpet A, 2011, EMBO J, V30, P480, DOI 10.1038/emboj.2010.335; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Drane P, 2010, GENE DEV, V24, P1253, DOI 10.1101/gad.566910; Groth A, 2005, MOL CELL, V17, P301, DOI 10.1016/j.molcel.2004.12.018; He HSHS, 2010, NAT GENET, V42, P343, DOI 10.1038/ng.545; Jasencakova Z, 2010, MOL CELL, V37, P736, DOI 10.1016/j.molcel.2010.01.033; KORNBERG RD, 1974, SCIENCE, V184, P868, DOI 10.1126/science.184.4139.868; Lewis PW, 2010, P NATL ACAD SCI USA, V107, P14075, DOI 10.1073/pnas.1008850107; Loyola A, 2007, TRENDS BIOCHEM SCI, V32, P425, DOI 10.1016/j.tibs.2007.08.004; Loyola A, 2006, MOL CELL, V24, P309, DOI 10.1016/j.molcel.2006.08.019; Loyola A, 2009, EMBO REP, V10, P769, DOI 10.1038/embor.2009.90; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; McKittrick E, 2004, P NATL ACAD SCI USA, V101, P1525, DOI 10.1073/pnas.0308092100; Mosammaparast N, 2002, J BIOL CHEM, V277, P862, DOI 10.1074/jbc.M106845200; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Schiltz RL, 1999, J BIOL CHEM, V274, P1189, DOI 10.1074/jbc.274.3.1189; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; SOBEL RE, 1995, P NATL ACAD SCI USA, V92, P1237, DOI 10.1073/pnas.92.4.1237; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Tang Y, 2006, NAT STRUCT MOL BIOL, V13, P921, DOI 10.1038/nsmb1147; Walde S, 2010, TRENDS CELL BIOL, V20, P461, DOI 10.1016/j.tcb.2010.05.001	25	80	80	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17714	17721		10.1074/jbc.M111.223453	http://dx.doi.org/10.1074/jbc.M111.223453			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454524	Green Published, hybrid			2022-12-25	WOS:000290585200035
J	Ingraham, CA; Park, GC; Makarenkova, HP; Crossin, KL				Ingraham, Christopher A.; Park, Gabriel C.; Makarenkova, Helen P.; Crossin, Kathryn L.			Matrix Metalloproteinase (MMP)-9 Induced by Wnt Signaling Increases the Proliferation and Migration of Embryonic Neural Stem Cells at Low O-2 Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; HIGH-ALTITUDE ADAPTATION; CENTRAL-NERVOUS-SYSTEM; MTT ASSAY; COLORIMETRIC ASSAY; PROGENITOR CELLS; OXYGEN-TENSION; ENHANCES PROLIFERATION; STEM/PROGENITOR CELLS	Recent studies have shown that various neural and embryonic stem cells cultured in 1-8% oxygen (O-2), levels lower than those typically used in cell culture (20.9%), displayed increased rates of proliferation; however, the molecular mechanisms underlying these changes are largely undefined. In this study, using rigorously controlled O-2 levels, we found that neural stem cells (NSCs) from embryonic day 15 rat cortex increased their rate of proliferation and migration in 1% O-2 relative to 20% O-2 without changes in viability. We sought to identify molecular changes in NSCs grown in 1% O-2 that might account for these increases. In 1% O-2, levels of the hypoxia-inducible transcription factor HIF-1 alpha were transiently increased. Reduced adherence of NSCs in 1% O-2 to basement membrane-coated plates was observed, and quantitative RT-PCR analysis confirmed that the levels of mRNA for an assortment of cell adhesion and extracellular matrix molecules were altered. Most notable was a 5-fold increase in matrix metalloproteinase (MMP)-9 mRNA. Specific inhibition of MMP-9 activity, verified using a fluorescent substrate assay, prevented the increase in proliferation and migration in 1% O-2. The canonical Wnt pathway was recently shown to be activated in stem cells in low O-2 via HIF-1 alpha. Inhibition of Wnt signaling by DKK-1 also prevented the increase in proliferation, migration, and MMP-9 expression. Thus, MMP-9 is a key molecular effector, downstream of HIF-1 alpha and Wnt activation, responsible for increased rates of NSC proliferation and migration in 1% O-2.	[Ingraham, Christopher A.; Park, Gabriel C.; Makarenkova, Helen P.; Crossin, Kathryn L.] Scripps Res Inst, Dept Neurobiol, La Jolla, CA 92037 USA	Scripps Research Institute	Crossin, KL (corresponding author), Scripps Res Inst, Dept Neurobiol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	kcrossin@scripps.edu			National Institutes of Health [AR053163]; Department of Neurobiology, The Scripps Research Institute; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053163] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Neurobiology, The Scripps Research Institute; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by National Institutes of Health Grant AR053163 (to H. P. M.). This work was also supported by the Department of Neurobiology, The Scripps Research Institute.	Agrawal SM, 2008, SEMIN CELL DEV BIOL, V19, P42, DOI 10.1016/j.semcdb.2007.06.003; Ardi VC, 2009, J BIOL CHEM, V284, P25854, DOI 10.1074/jbc.M109.033472; Barkho BZ, 2008, STEM CELLS, V26, P3139, DOI 10.1634/stemcells.2008-0519; Bigham A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001116; Bjorklund M, 2005, BBA-REV CANCER, V1755, P37, DOI 10.1016/j.bbcan.2005.03.001; Blake SM, 2008, EMBO J, V27, P3069, DOI 10.1038/emboj.2008.223; Brahimi-Horn MC, 2011, CURR OPIN GENET DEV, V21, P67, DOI 10.1016/j.gde.2010.10.006; Candela ME, 2010, J CELL PHYSIOL, V224, P144, DOI 10.1002/jcp.22111; CARMICHAEL J, 1987, CANCER RES, V47, P936; Chen HL, 2007, STEM CELLS, V25, P2291, DOI 10.1634/stemcells.2006-0609; Chen X, 2010, NEUROSCIENCE, V165, P705, DOI 10.1016/j.neuroscience.2009.11.007; Cho A, 2002, CIRC RES, V91, P845, DOI 10.1161/01.RES.0000040420.17366.2E; Clarke L, 2009, STEM CELLS, V27, P1879, DOI 10.1002/stem.96; DIRKEN MNJ, 1948, Q J EXP PHYSIOL CMS, V34, P193, DOI 10.1113/expphysiol.1948.sp000929; Ema M, 1997, P NATL ACAD SCI USA, V94, P4273, DOI 10.1073/pnas.94.9.4273; Erecinska M, 2001, RESP PHYSIOL, V128, P263, DOI 10.1016/S0034-5687(01)00306-1; Ethell IM, 2007, J NEUROSCI RES, V85, P2813, DOI 10.1002/jnr.21273; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Fedi P, 1999, J BIOL CHEM, V274, P19465, DOI 10.1074/jbc.274.27.19465; GERLIER D, 1986, J IMMUNOL METHODS, V94, P57, DOI 10.1016/0022-1759(86)90215-2; Giese AK, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-94; Halliwell B, 2003, FEBS LETT, V540, P3, DOI 10.1016/S0014-5793(03)00235-7; Harms KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009767; Harrison JF, 2011, ANNU REV PHYSIOL, V73, P95, DOI 10.1146/annurev-physiol-012110-142155; HAYNES LW, 1988, MOL NEUROBIOL, V2, P263, DOI 10.1007/BF02935635; Hernandez-Guillamon M, 2009, J NEUROSCI RES, V87, P2115, DOI 10.1002/jnr.22034; Higgins S, 2009, ENDOCRINOLOGY, V150, P4044, DOI 10.1210/en.2008-1797; HOFFMAN CE, 1946, AM J PHYSIOL, V145, P685, DOI 10.1152/ajplegacy.1946.145.5.685; Horie N, 2008, CELL MOL NEUROBIOL, V28, P833, DOI 10.1007/s10571-007-9237-y; Horng CT, 2008, AVIAT SPACE ENVIR MD, V79, P666, DOI 10.3357/ASEM.2160.2008; JABBAR SAB, 1989, BRIT J CANCER, V60, P523, DOI 10.1038/bjc.1989.306; Jiang BH, 1996, AM J PHYSIOL-CELL PH, V271, pC1172, DOI 10.1152/ajpcell.1996.271.4.C1172; Kang SS, 2008, BRAIN RES, V1228, P20, DOI 10.1016/j.brainres.2008.06.056; Kenagy RD, 1997, CIRCULATION, V96, P3555; Kim DH, 2008, J NEUROSCI, V28, P208, DOI 10.1523/JNEUROSCI.3674-07.2008; Kim TS, 2008, J NEUROSCI RES, V86, P2353, DOI 10.1002/jnr.21687; Kresse H, 2001, J CELL PHYSIOL, V189, P266, DOI 10.1002/jcp.10030; Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107; Levin JI, 2001, BIOORG MED CHEM LETT, V11, P2189, DOI 10.1016/S0960-894X(01)00419-X; Li HG, 2009, J EXP ZOOL PART A, V311A, P134, DOI 10.1002/jez.510; Lin Q, 2008, GENE REGUL SYST BIO, V2, P43; Liu HQ, 2010, J NEUROPATH EXP NEUR, V69, P386, DOI 10.1097/NEN.0b013e3181d68d12; Loenarz C, 2011, EMBO REP, V12, P63, DOI 10.1038/embor.2010.170; Lu ZJ, 2010, FASEB J, V24, P1925, DOI 10.1096/fj.09-150573; Maxwell PH, 1997, P NATL ACAD SCI USA, V94, P8104, DOI 10.1073/pnas.94.15.8104; Mazumdar J, 2010, NAT CELL BIOL, V12, P1007, DOI 10.1038/ncb2102; Meng H, 2009, J BIOL CHEM, V284, P7866, DOI 10.1074/jbc.M803650200; Michaluk P, 2007, J BIOL CHEM, V282, P16036, DOI 10.1074/jbc.M700641200; MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016/0092-8674(93)90573-9; Millman JR, 2009, CURR OPIN ORGAN TRAN, V14, P694, DOI 10.1097/MOT.0b013e3283329d53; Milosevic J, 2009, NEUROTOX RES, V15, P367, DOI 10.1007/s12640-009-9043-z; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Newby D, 2005, PLACENTA, V26, P353, DOI 10.1016/j.placenta.2004.07.002; Noles SR, 2007, MOL CELL NEUROSCI, V35, P549, DOI 10.1016/j.mcn.2007.04.012; Novak A, 1999, CELL MOL LIFE SCI, V56, P523, DOI 10.1007/s000180050449; PAGLIACCI MC, 1993, EUR J CANCER, V29A, P1573, DOI 10.1016/0959-8049(93)90297-S; Panchision DM, 2009, J CELL PHYSIOL, V220, P562, DOI 10.1002/jcp.21812; Peng Y, 2011, MOL BIOL EVOL, V28, P1075, DOI 10.1093/molbev/msq290; Pistollato F, 2007, MOL CELL NEUROSCI, V35, P424, DOI 10.1016/j.mcn.2007.04.003; Rodrigues CAV, 2010, BIOTECHNOL BIOENG, V106, P260, DOI 10.1002/bit.22648; Rytkonen KT, 2011, EMBO REP, V12, P3, DOI 10.1038/embor.2010.192; Santilli G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008575; Shams I, 2004, P NATL ACAD SCI USA, V101, P9698, DOI 10.1073/pnas.0403540101; Shams Imad, 2005, FASEB J, V19, P307; Simon MC, 2008, NAT REV MOL CELL BIO, V9, P285, DOI 10.1038/nrm2354; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; SOLER RC, 1995, DEV BRAIN RES, V88, P37; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Storz JF, 2010, J EXP BIOL, V213, P4125, DOI 10.1242/jeb.048181; Studer L, 2000, J NEUROSCI, V20, P7377; Toledo EM, 2008, PROG NEUROBIOL, V86, P281, DOI 10.1016/j.pneurobio.2008.08.001; Tonti GA, 2009, INT J DEV BIOL, V53, P1, DOI 10.1387/ijdb.082573gt; Tsatmali M, 2005, BRAIN RES, V1040, P137, DOI 10.1016/j.brainres.2005.01.087; Tsatmali M, 2006, MOL CELL NEUROSCI, V33, P345, DOI 10.1016/j.mcn.2006.08.005; Tuuli MG, 2011, PLACENTA, V32, pS109, DOI 10.1016/j.placenta.2010.12.013; VANDELOOSDRECHT AA, 1994, J IMMUNOL METHODS, V174, P311, DOI 10.1016/0022-1759(94)90034-5; Vieira HLA, 2011, PROG NEUROBIOL, V93, P444, DOI 10.1016/j.pneurobio.2011.01.007; Vlodavsky I, 1996, CANCER METAST REV, V15, P177, DOI 10.1007/BF00437470; Wang L, 2006, J NEUROSCI, V26, P5996, DOI 10.1523/JNEUROSCI.5380-05.2006; Webster KA, 2003, J EXP BIOL, V206, P2911, DOI 10.1242/jeb.00516; Wenger RH, 1997, BIOL CHEM, V378, P609; Wexler EM, 2008, MOL PSYCHIATR, V13, P285, DOI 10.1038/sj.mp.4002093; Wu BB, 2007, IMMUNITY, V26, P227, DOI 10.1016/j.immuni.2006.12.007; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Yong VW, 2001, NAT REV NEUROSCI, V2, P502, DOI 10.1038/35081571; York JL, 1998, BIOTECHNIQUES, V25, P622, DOI 10.2144/98254st03; Zadori A, 2011, EXP NEUROL, V227, P136, DOI 10.1016/j.expneurol.2010.10.004; Zhang XB, 2001, CANCER RES, V61, P6050; Zhang X, 2007, J BIOL CHEM, V282, P10873, DOI 10.1074/jbc.M608856200; Zhang Y, 2007, J NEUROSCI, V27, P4499, DOI 10.1523/JNEUROSCI.0200-07.2007; Zhang ZD, 1996, BIOCHEM MOL BIOL INT, V38, P431; Zhao T, 2008, FEBS J, V275, P1824, DOI 10.1111/j.1742-4658.2008.06340.x; Zhou D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000490; Zhou D, 2009, PEDIATR RES, V66, P239, DOI 10.1203/PDR.0b013e3181b27275; Zhou L, 2006, NEURODEGENER DIS, V3, P50, DOI 10.1159/000092093	97	63	66	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17649	17657		10.1074/jbc.M111.229427	http://dx.doi.org/10.1074/jbc.M111.229427			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21460212	Green Published, hybrid			2022-12-25	WOS:000290585200028
J	Mirza, AM; Aguilar, HC; Zhu, QY; Mahon, PJ; Rota, PA; Lee, B; Iorio, RM				Mirza, Anne M.; Aguilar, Hector C.; Zhu, Qiyun; Mahon, Paul J.; Rota, Paul A.; Lee, Benhur; Iorio, Ronald M.			Triggering of the Newcastle Disease Virus Fusion Protein by a Chimeric Attachment Protein That Binds to Nipah Virus Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMAGGLUTININ-NEURAMINIDASE GLYCOPROTEIN; REPORTER GENE ACTIVATION; HENDRA-VIRUS; CELL-FUSION; MONOCLONAL-ANTIBODIES; HN PROTEIN; FUNCTIONAL INTERACTION; PARAMYXOVIRUS FUSION; MEMBRANE-FUSION; VIRAL ENTRY	The fusion (F) proteins of Newcastle disease virus (NDV) and Nipah virus (NiV) are both triggered by binding to receptors, mediated in both viruses by a second protein, the attachment protein. However, the hemagglutinin-neuraminidase (HN) attachment protein of NDV recognizes sialic acid receptors, whereas the NiV G attachment protein recognizes ephrinB2/B3 as receptors. Chimeric proteins composed of domains from the two attachment proteins have been evaluated for fusion-promoting activity with each F protein. Chimeras having NiV G-derived globular domains and NDV HN-derived stalks, transmembranes, and cytoplasmic tails are efficiently expressed, bind ephrinB2, and trigger NDV F to promote fusion in Vero cells. Thus, the NDV F protein can be triggered by binding to the NiV receptor, indicating that an aspect of the triggering cascade induced by the binding of HN to sialic acid is conserved in the binding of NiV G to ephrinB2. However, the fusion cascade for triggering NiV F by the G protein and that of triggering NDV F by the chimeras can be distinguished by differential exposure of a receptor-induced conformational epitope. The enhanced exposure of this epitope marks the triggering of NiV F by NiV G but not the triggering of NDV F by the chimeras. Thus, the triggering cascade for NiV G-F fusion may be more complex than that of NDV HN and F. This is consistent with the finding that reciprocal chimeras having NDV HN-derived heads and NiV G-derived stalks, transmembranes, and tails do not trigger either F protein for fusion, despite efficient cell surface expression and receptor binding.	[Mirza, Anne M.; Zhu, Qiyun; Mahon, Paul J.; Iorio, Ronald M.] Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst, Worcester, MA 01655 USA; [Iorio, Ronald M.] Univ Massachusetts, Sch Med, Program Immunol & Virol, Worcester, MA 01655 USA; [Aguilar, Hector C.; Lee, Benhur] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Rota, Paul A.] Ctr Dis Control & Prevent, Measles Mumps Rubella & Herpesvirus Lab Branch, Atlanta, GA 30333 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Centers for Disease Control & Prevention - USA	Iorio, RM (corresponding author), Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst, 55 Lake Ave N, Worcester, MA 01655 USA.	ronald.iorio@umassmed.edu	Pacific-Southwest, RCE/B-6155-2009; Aguilar, Hector/AAD-6663-2022; Lee, Benhur/A-8554-2016	Lee, Benhur/0000-0003-0760-1709	National Institutes of Health [AI49268]; Pacific Southwest Regional Center for Excellence in Biodefense and Emerging Infectious Diseases [U54 AI065359]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069317, U19AI057319, R01AI049268, U54AI065359, R56AI049268] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pacific Southwest Regional Center for Excellence in Biodefense and Emerging Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI49268 (to R. M. I.), a subproject of U19 Grant AI057319 (to the University of Massachusetts Center for Translational Research on Human Immunology and Biodefense), and AI069317 (to B. L.). This work was also supported by Subproject Award U54 AI065359 from the Pacific Southwest Regional Center for Excellence in Biodefense and Emerging Infectious Diseases.	Aguilar HC, 2007, J VIROL, V81, P4520, DOI 10.1128/JVI.02205-06; Aguilar HC, 2006, J VIROL, V80, P4878, DOI 10.1128/JVI.80.10.4878-4889.2006; Aguilar HC, 2009, J BIOL CHEM, V284, P1628, DOI 10.1074/jbc.M807469200; Bishop KA, 2007, J VIROL, V81, P5893, DOI 10.1128/JVI.02022-06; Bonaparte MI, 2005, P NATL ACAD SCI USA, V102, P10652, DOI 10.1073/pnas.0504887102; Bowden TA, 2008, NAT STRUCT MOL BIOL, V15, P567, DOI 10.1038/nsmb.1435; Bowden TA, 2010, BIOCHEM SOC T, V38, P1349, DOI 10.1042/BST0381349; Bukreyev A, 2008, CURR OPIN MOL THER, V10, P46; Connolly SA, 2009, J VIROL, V83, P10857, DOI 10.1128/JVI.01191-09; Corey EA, 2003, J VIROL, V77, P6913, DOI 10.1128/JVI.77.12.6913-6922.2003; Crennell S, 2000, NAT STRUCT BIOL, V7, P1068; DENG RT, 1995, VIROLOGY, V209, P457, DOI 10.1006/viro.1995.1278; Harcourt BH, 2000, VIROLOGY, V271, P334, DOI 10.1006/viro.2000.0340; IORIO RM, 1989, VIRUS RES, V13, P245, DOI 10.1016/0168-1702(89)90019-1; IORIO RM, 1991, J VIROL, V65, P4999, DOI 10.1128/JVI.65.9.4999-5006.1991; IORIO RM, 1986, J GEN VIROL, V67, P1393, DOI 10.1099/0022-1317-67-7-1393; IORIO RM, 1983, J VIROL, V48, P440, DOI 10.1128/JVI.48.2.440-450.1983; Iorio RM, 2009, FUTURE VIROL, V4, P335, DOI 10.2217/FVL.09.17; Lee JK, 2008, J BIOL CHEM, V283, P16561, DOI 10.1074/jbc.M801018200; Li JR, 2004, J VIROL, V78, P5299, DOI 10.1128/JVI.78.10.5299-5310.2004; Lorio RM, 2008, TRENDS MICROBIOL, V16, P135, DOI 10.1016/j.tim.2008.01.006; Lyles D. S., 2007, FIELDS VIROLOGY, V1, P1364; Mahon PJ, 2008, J VIROL, V82, P10386, DOI 10.1128/JVI.00581-08; MCGINNES LW, 1994, VIROLOGY, V200, P470, DOI 10.1006/viro.1994.1210; Melanson VR, 2006, J VIROL, V80, P623, DOI 10.1128/JVI.80.2.623-633.2006; Melanson VR, 2004, J VIROL, V78, P13053, DOI 10.1128/JVI.78.23.13053-13061.2004; MIRZA AM, 1994, J VIROL, V68, P5093, DOI 10.1128/JVI.68.8.5093-5099.1994; MIRZA AM, 1993, J BIOL CHEM, V268, P21425; MURRAY K, 1995, SCIENCE, V268, P94, DOI 10.1126/science.7701348; Negrete OA, 2005, NATURE, V436, P401, DOI 10.1038/nature03838; Negrete Oscar A, 2006, PLoS Pathog, V2, pe7; NUSSBAUM O, 1994, J VIROL, V68, P5411, DOI 10.1128/JVI.68.9.5411-5422.1994; Okuma K, 1999, VIROLOGY, V254, P235, DOI 10.1006/viro.1998.9530; Paal T, 2009, J VIROL, V83, P10480, DOI 10.1128/JVI.01195-09; Schirrmacher Volker, 2009, V542, P565, DOI 10.1007/978-1-59745-561-9_30; SHEEHAN JP, 1987, VIROLOGY, V161, P603, DOI 10.1016/0042-6822(87)90158-9; Smith EC, 2009, FEBS J, V276, P7217, DOI 10.1111/j.1742-4658.2009.07401.x; Tanabayashi K, 1996, J VIROL, V70, P6112, DOI 10.1128/JVI.70.9.6112-6118.1996; TSURUDOME M, 1995, VIROLOGY, V213, P190, DOI 10.1006/viro.1995.1559; Xu K, 2008, P NATL ACAD SCI USA, V105, P9953, DOI 10.1073/pnas.0804797105; Yu M, 1998, VIROLOGY, V251, P227, DOI 10.1006/viro.1998.9302; Zaitsev V, 2004, J VIROL, V78, P3733, DOI 10.1128/JVI.78.7.3733-3741.2004	42	27	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17851	17860		10.1074/jbc.M111.233965	http://dx.doi.org/10.1074/jbc.M111.233965			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21460213	hybrid, Green Published			2022-12-25	WOS:000290585200048
J	Yuan, BF; You, CJ; Andersen, N; Jiang, Y; Moriya, M; O'Connor, TR; Wang, YS				Yuan, Bifeng; You, Changjun; Andersen, Nisana; Jiang, Yong; Moriya, Masaaki; O'Connor, Timothy R.; Wang, Yinsheng			The Roles of DNA Polymerases kappa and iota in the Error-free Bypass of N-2-Carboxyalkyl-2 '-deoxyguanosine Lesions in Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XERODERMA-PIGMENTOSUM VARIANT; CALF THYMUS DNA; TRANSLESION SYNTHESIS; IN-VIVO; POL-KAPPA; ADDUCT; REPAIR; ETA; MUTAGENESIS; N-2-(1-CARBOXYETHYL)-2'-DEOXYGUANOSINE	To counteract the deleterious effects of DNA damage, cells are equipped with specialized polymerases to bypass DNA lesions. Previous biochemical studies revealed that DinB family DNA polymerases, including Escherichia coli DNA polymerase IV and human DNA polymerase kappa, efficiently incorporate the correct nucleotide opposite some N-2-modified 2'-deoxyguanosine derivatives. Herein, we used shuttle vector technology and demonstrated that deficiency in Polk or Poli in mouse embryonic fibroblast (MEF) cells resulted in elevated frequencies of G-->T and G-->A mutations at N-2-(1-carboxyethyl)-2'-deoxyguanosine (N-2-CEdG) and N-2-carboxymethyl-2'-deoxyguanosine (N-2-CMdG) sites. Steady-state kinetic measurements revealed that human DNA polymerase iota preferentially inserts the correct nucleotide, dCMP, opposite N-2-CEdG lesions. In contrast, no mutation was found after the N-2-CEdG-and N-2-CMdG-bearing plasmids were replicated in POLH-deficient human cells or Rev3-deficient MEF cells. Together, our results revealed that, in mammalian cells, both polymerases kappa and iota are necessary for the error-free bypass of N-2-CEdG and N-2-CMdG. However, in the absence of polymerase kappa or iota, other translesion synthesis polymerase(s) could incorporate nucleotide(s) opposite these lesions but would do so inaccurately.	[Yuan, Bifeng; You, Changjun; Andersen, Nisana; Wang, Yinsheng] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA; [Jiang, Yong; Wang, Yinsheng] Univ Calif Riverside, Environm Toxicol Grad Program, Riverside, CA 92521 USA; [Yuan, Bifeng] Wuhan Univ, Coll Chem & Mol Sci, Wuhan 430072, Peoples R China; [Moriya, Masaaki] SUNY Stony Brook, Dept Pharmacol Sci, Biol Chem Lab, Stony Brook, NY 11794 USA; [O'Connor, Timothy R.] City Hope Natl Med Ctr, Beckman Res Inst, Div Biol, Duarte, CA 91010 USA	University of California System; University of California Riverside; University of California System; University of California Riverside; Wuhan University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; City of Hope; Beckman Research Institute of City of Hope	Wang, YS (corresponding author), Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA.	yinsheng.wang@ucr.edu	Yuan, Bi-Feng/K-5803-2013	Yuan, Bi-Feng/0000-0001-5223-4659; You, Changjun/0000-0003-4301-2098; O'Connor, Timothy/0000-0001-5848-3592; Jiang, Yong/0000-0002-1198-1807	National Institutes of Health [R01 DK082779]; California Tobacco-related Disease Research Program [17RT-0109, 18DT-0009, 18XT-0073]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082779] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES018833] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Tobacco-related Disease Research Program(University of California System); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health Grant R01 DK082779 (to Y. W.). This work was also supported by the California Tobacco-related Disease Research Program Grants 17RT-0109 (to T. R. O.), 18DT-0009 (to N. A.), and 18XT-0073 (to Y. W.).	Avkin S, 2004, J BIOL CHEM, V279, P53298, DOI 10.1074/jbc.M409155200; Baker DJ, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702856200; Bi XH, 2005, J BIOL CHEM, V280, P22343, DOI 10.1074/jbc.M501562200; Bullock SK, 2001, CARCINOGENESIS, V22, P233, DOI 10.1093/carcin/22.2.233; Cao HC, 2007, J AM CHEM SOC, V129, P12123, DOI 10.1021/ja072130e; Choi JY, 2006, J BIOL CHEM, V281, P21062, DOI 10.1074/jbc.M602246200; Cleaver JE, 2005, NAT REV CANCER, V5, P564, DOI 10.1038/nrc1652; Creighton S, 1995, METHOD ENZYMOL, V262, P232; Delaney JC, 2006, METHOD ENZYMOL, V408, P1, DOI 10.1016/S0076-6879(06)08001-3; Delaney JC, 1999, CHEM BIOL, V6, P743, DOI 10.1016/S1074-5521(00)80021-6; Delaney JC, 2004, P NATL ACAD SCI USA, V101, P14051, DOI 10.1073/pnas.0403489101; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Friedberg EC, 2002, SCIENCE, V296, P1627, DOI 10.1126/science.1070236; Frischmann M, 2005, CHEM RES TOXICOL, V18, P1586, DOI 10.1021/tx0501278; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; Hong HZ, 2007, NUCLEIC ACIDS RES, V35, P7118, DOI 10.1093/nar/gkm851; Jarosz DF, 2006, NATURE, V439, P225, DOI 10.1038/nature04318; Johnson RE, 2000, NATURE, V406, P1015, DOI 10.1038/35023030; Johnson RE, 1999, SCIENCE, V283, P1001, DOI 10.1126/science.283.5404.1001; Johnson RE, 2000, J BIOL CHEM, V275, P7447, DOI 10.1074/jbc.275.11.7447; Lehmann AR, 2007, DNA REPAIR, V6, P891, DOI 10.1016/j.dnarep.2007.02.003; Levine RL, 2000, CANCER RES, V60, P4098; Li H, 2006, KIDNEY INT, V69, P388, DOI 10.1038/sj.ki.5000064; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lone S, 2007, MOL CELL, V25, P601, DOI 10.1016/j.molcel.2007.01.018; Marnett LJ, 2000, CARCINOGENESIS, V21, P361, DOI 10.1093/carcin/21.3.361; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; McDonald JP, 2003, J EXP MED, V198, P635, DOI 10.1084/jem.20030767; Ogi T, 2002, P NATL ACAD SCI USA, V99, P15548, DOI 10.1073/pnas.222377899; Ohmori H, 2004, ADV PROTEIN CHEM, V69, P265; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; Pence MG, 2009, J BIOL CHEM, V284, P1732, DOI 10.1074/jbc.M807296200; Pluskota-Karwatka D, 2008, BIOORG CHEM, V36, P57, DOI 10.1016/j.bioorg.2007.10.004; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Schneider M, 2004, CHEM RES TOXICOL, V17, P1385, DOI 10.1021/tx049929d; Wang HX, 2010, CHEM RES TOXICOL, V23, P74, DOI 10.1021/tx900286c; Wittschieben JP, 2006, CANCER RES, V66, P134, DOI 10.1158/0008-5472.CAN-05-2982; Wolfle WT, 2006, MOL CELL BIOL, V26, P381, DOI 10.1128/MCB.26.1.381-386.2006; Yang IY, 2002, CHEM RES TOXICOL, V15, P160, DOI 10.1021/tx010123c; Yasui M, 2004, BIOCHEMISTRY-US, V43, P15005, DOI 10.1021/bi048279+; Yoon JH, 2009, P NATL ACAD SCI USA, V106, P18219, DOI 10.1073/pnas.0910121106; Yuan BF, 2008, J BIOL CHEM, V283, P23665, DOI 10.1074/jbc.M804047200; Yuan BF, 2008, P NATL ACAD SCI USA, V105, P8679, DOI 10.1073/pnas.0711546105; Yuan BF, 2010, ACS CHEM BIOL, V5, P1021, DOI 10.1021/cb100214b; Zewail-Foote M, 2001, CHEM BIOL, V8, P1033, DOI 10.1016/S1074-5521(01)00071-0; Ziv O, 2009, P NATL ACAD SCI USA, V106, P11552, DOI 10.1073/pnas.0812548106	47	49	48	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17503	17511		10.1074/jbc.M111.232835	http://dx.doi.org/10.1074/jbc.M111.232835			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454642	Green Published, hybrid			2022-12-25	WOS:000290585200012
J	Coffin, SR; Hollis, T; Perrino, FW				Coffin, Stephanie R.; Hollis, Thomas; Perrino, Fred W.			Functional Consequences of the RNase H2A Subunit Mutations That Cause Aicardi-Goutieres Syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURES; DNA; TREX1; COMPLEX; YEAST; HII; SPECIFICITY; EXPRESSION; PROTEINS	Mutations in the three genes encoding the heterotrimeric RNase H2 complex cause Aicardi-Goutieres Syndrome (AGS). Our mouse RNase H2 structure revealed that the catalytic RNase H2A subunit interfaces mostly with the RNase H2C subunit that is intricately interwoven with the RNase H2B subunit. We mapped the positions of AGS-causing RNase H2A mutations using the mouse RNase H2 structure and proposed that these mutations cause varied effects on catalytic potential. To determine the functional consequences of these mutations, heterotrimeric human RNase H2 complexes containing the RNase H2A subunit mutations were prepared, and catalytic efficiencies and nucleic acid binding properties were compared with the wild-type (WT) complex. These analyses reveal a dramatic range of effects with mutations at conserved positions G37S, R186W, and R235Q, reducing enzymatic activities and substrate binding affinities by as much as a 1000-fold, whereas mutations at non-conserved positions R108W, N212I, F230L, T240M, and R291H reduced activities and binding modestly or not at all. All mutants purify as three-subunit complexes, further supporting the required heterotrimeric structure in eukaryotic RNase H2. These kinetic properties reveal varied functional consequences of AGS-causing mutations in the catalytic RNase H2A subunit and reflect the complex mechanisms of nuclease dysfunction that include catalytic deficiencies and altered protein-nucleic acid interactions relevant in AGS.	[Coffin, Stephanie R.; Hollis, Thomas; Perrino, Fred W.] Wake Forest Univ Hlth Sci, Dept Biochem, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest University School of Medicine	Perrino, FW (corresponding author), Wake Forest Univ Hlth Sci, Dept Biochem, Winston Salem, NC 27157 USA.	fperrino@wfubmc.edu	Pinheiro, Maísa/E-7424-2012		National Institutes of Health [GM069962, F32GM095290]; Alliance for Lupus Research [179222]; American Heart Association [10GRNT3650033]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069962, F32GM095290] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alliance for Lupus Research; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM069962 (to F. W. P.). This work was also supported by the Alliance for Lupus Research 179222 (to F. W. P.), American Heart Association Grant 10GRNT3650033 (to T.H.), and National Institutes of Health Postdoctoral Fellowship Award F32GM095290 (to S. R. C.).	AICARDI J, 1984, ANN NEUROL, V15, P49, DOI 10.1002/ana.410150109; Ayyagari R, 2003, J BIOL CHEM, V278, P1618, DOI 10.1074/jbc.M209801200; Cerritelli SM, 2009, FEBS J, V276, P1494, DOI 10.1111/j.1742-4658.2009.06908.x; Chon HG, 2009, NUCLEIC ACIDS RES, V37, P96, DOI 10.1093/nar/gkn913; Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Crow YJ, 2009, HUM MOL GENET, V18, pR130, DOI 10.1093/hmg/ddp293; de Silva U, 2007, J BIOL CHEM, V282, P10537, DOI 10.1074/jbc.M700039200; El Hage A, 2010, GENE DEV, V24, P1546, DOI 10.1101/gad.573310; Figiel M, 2011, J BIOL CHEM, V286, P10540, DOI 10.1074/jbc.M110.181974; Frank P, 1998, P NATL ACAD SCI USA, V95, P12872, DOI 10.1073/pnas.95.22.12872; Goutieres F, 1998, ANN NEUROL, V44, P900, DOI 10.1002/ana.410440608; Hoss M, 1999, EMBO J, V18, P3868, DOI 10.1093/emboj/18.13.3868; ITAYA M, 1990, P NATL ACAD SCI USA, V87, P8587, DOI 10.1073/pnas.87.21.8587; Jeong HS, 2004, NUCLEIC ACIDS RES, V32, P407, DOI 10.1093/nar/gkh209; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Lehtinen DA, 2008, J BIOL CHEM, V283, P31649, DOI 10.1074/jbc.M806155200; Lin YF, 2010, P NATL ACAD SCI USA, V107, P692, DOI 10.1073/pnas.0909740107; Mazur DJ, 1999, J BIOL CHEM, V274, P19655, DOI 10.1074/jbc.274.28.19655; Mazur DJ, 2001, J BIOL CHEM, V276, P14718, DOI 10.1074/jbc.M010051200; Mazur DJ, 2001, J BIOL CHEM, V276, P17022, DOI 10.1074/jbc.M100623200; McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P4949, DOI 10.1073/pnas.0914857107; Nowotny M, 2005, CELL, V121, P1005, DOI 10.1016/j.cell.2005.04.024; Perrino FW, 2009, J MOL MED-JMM, V87, P25, DOI 10.1007/s00109-008-0422-3; Qiu JZ, 1999, MOL CELL BIOL, V19, P8361, DOI 10.1128/mcb.19.12.8361; Reijns MAM, 2011, J BIOL CHEM, V286, P10530, DOI 10.1074/jbc.M110.177394; Rice G, 2007, AM J HUM GENET, V81, P713, DOI 10.1086/521373; Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373; Rohman MS, 2008, FEBS J, V275, P4836, DOI 10.1111/j.1742-4658.2008.06622.x; Rychlik MP, 2010, MOL CELL, V40, P658, DOI 10.1016/j.molcel.2010.11.001; Rydberg B, 2002, P NATL ACAD SCI USA, V99, P16654, DOI 10.1073/pnas.262591699; Shaban NM, 2010, J BIOL CHEM, V285, P3617, DOI 10.1074/jbc.M109.059048	32	28	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16984	16991		10.1074/jbc.M111.228833	http://dx.doi.org/10.1074/jbc.M111.228833			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454563	Green Published, hybrid			2022-12-25	WOS:000290301900048
J	Fasquelle, L; Scott, HS; Lenoir, M; Wang, J; Rebillard, G; Gaboyard, S; Venteo, S; Francois, F; Mausset-Bonnefont, AL; Antonarakis, SE; Neidhart, E; Chabbert, C; Puel, JL; Guipponi, M; Delprat, B				Fasquelle, Lydie; Scott, Hamish S.; Lenoir, Marc; Wang, Jing; Rebillard, Guy; Gaboyard, Sophie; Venteo, Stephanie; Francois, Florence; Mausset-Bonnefont, Anne-Laure; Antonarakis, Stylianos E.; Neidhart, Elizabeth; Chabbert, Christian; Puel, Jean-Luc; Guipponi, Michel; Delprat, Benjamin			Tmprss3, a Transmembrane Serine Protease Deficient in Human DFNB8/10 Deafness, Is Critical for Cochlear Hair Cell Survival at the Onset of Hearing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOSOMAL RECESSIVE DEAFNESS; EPITHELIAL SODIUM-CHANNEL; INNER-EAR; RAT; MOUSE; ACTIVATION; MUTATIONS; PROTEINS; DOMAIN	Mutations in the type II transmembrane serine protease 3 (TMPRSS3) gene cause non-syndromic autosomal recessive deafness (DFNB8/10), characterized by congenital or childhood onset bilateral profound hearing loss. In order to explore the physiopathology of TMPRSS3 related deafness, we have generated an ethyl-nitrosourea-induced mutant mouse carrying a protein-truncating nonsense mutation in Tmprss3 (Y260X) and characterized the functional and histological consequences of Tmprss3 deficiency. Auditory brainstem response revealed that wild type and heterozygous mice have normal hearing thresholds up to 5 months of age, whereas Tmprss3(Y260X) homozygous mutant mice exhibit severe deafness. Histological examination showed degeneration of the organ of Corti in adult mutant mice. Cochlear hair cell degeneration starts at the onset of hearing, postnatal day 12, in the basal turn and progresses very rapidly toward the apex, reaching completion within 2 days. Given that auditory and vestibular deficits often co-exist, we evaluated the balancing abilities of Tmprss3(Y260X) mice by using rotating rod and vestibular behavioral tests. Tmprss3(Y260X) mice effectively displayed mild vestibular syndrome that correlated histologically with a slow degeneration of saccular hair cells. In situ hybridization in the developing inner ear showed that Tmprss3 mRNA is localized in sensory hair cells in the cochlea and the vestibule. Our results show that Tmprss3 acts as a permissive factor for cochlear hair cells survival and activation at the onset of hearing and is required for saccular hair cell survival. This mouse model will certainly help to decipher the molecular mechanisms underlying DFNB8/10 deafness and cochlear function.	[Scott, Hamish S.] SA Pathol, Dept Mol Pathol, Ctr Canc Biol, Adelaide, SA 5000, Australia; [Fasquelle, Lydie; Lenoir, Marc; Wang, Jing; Rebillard, Guy; Gaboyard, Sophie; Venteo, Stephanie; Francois, Florence; Mausset-Bonnefont, Anne-Laure; Chabbert, Christian; Puel, Jean-Luc; Delprat, Benjamin] Hop St Eloi, INSERM, U 583, Inst Neurosci, F-34091 Montpellier, France; [Fasquelle, Lydie; Lenoir, Marc; Wang, Jing; Rebillard, Guy; Gaboyard, Sophie; Venteo, Stephanie; Francois, Florence; Mausset-Bonnefont, Anne-Laure; Chabbert, Christian; Puel, Jean-Luc; Delprat, Benjamin] Univ Montpellier, F-34091 Montpellier, France; [Fasquelle, Lydie; Antonarakis, Stylianos E.; Neidhart, Elizabeth; Guipponi, Michel] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva 4, Switzerland; [Fasquelle, Lydie; Antonarakis, Stylianos E.; Neidhart, Elizabeth; Guipponi, Michel] Univ Hosp Geneva, CH-1211 Geneva 4, Switzerland; [Scott, Hamish S.] Univ Adelaide, Sch Med, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia	Centre for Cancer Biology; SA Pathology; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; University of Geneva; University of Geneva; University of Adelaide	Scott, HS (corresponding author), SA Pathol, Dept Mol Pathol, Ctr Canc Biol, Box 14 Rundle Mall PO, Adelaide, SA 5000, Australia.	hamish.scott@health.sa.gov.au; jean-luc.puel@inserm.fr	Scott, Hamish/B-2122-2009; Bonnefont, Anne-Laure/AAB-5022-2020; Delprat, Benjamin/O-3791-2018; Antonarakis, Stylianos E/N-8866-2014	Scott, Hamish/0000-0002-5813-631X; Bonnefont, Anne-Laure/0000-0003-4119-1475; Antonarakis, Stylianos E/0000-0001-8907-5823; Delprat, Benjamin/0000-0002-2457-6923; Gaboyard-Niay, Sophie/0000-0001-8256-8692; CHABBERT, CHRISTIAN/0000-0003-3932-0223; Puel, jean-luc/0000-0002-3772-5190	Swiss National Science Foundation [3100A0-114077-1]; National Health and Medical Research Council of Australia [257501, 215305, 71601, 461204]; Region Languedoc-Roussillon (Chercheur d'Avenir)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Region Languedoc-Roussillon (Chercheur d'Avenir)(Region Occitanie)	This work was supported Swiss National Science Foundation Grant 3100A0-114077-1 (to M. G.); National Health and Medical Research Council of Australia Grants 257501, 215305, 71601, and 461204 (to H. S. S.); and a grant from the Region Languedoc-Roussillon (Chercheur d'Avenir) (to B. D.).	Ahmed Zubair M, 2004, BMC Med Genet, V5, P24, DOI 10.1186/1471-2350-5-24; Altamura S, 2010, BIOCHEM J, V431, P363, DOI 10.1042/BJ20100668; ARAN JM, 1982, ACTA OTO-LARYNGOL, P1, DOI 10.3109/00016488209108895; Behrens M, 2004, CELL MOL LIFE SCI, V61, P2866, DOI 10.1007/s00018-004-4263-0; Beraneck M, 2008, J NEUROPHYSIOL, V100, P945, DOI 10.1152/jn.90319.2008; Boadas-Vaello P, 2005, TOXICOL SCI, V88, P456, DOI 10.1093/toxsci/kfi314; Bourane S, 2009, NEURON, V64, P857, DOI 10.1016/j.neuron.2009.12.004; Brugeaud A, 2007, J NEUROSCI, V27, P3503, DOI 10.1523/JNEUROSCI.5185-06.2007; Bugge TH, 2009, J BIOL CHEM, V284, P23177, DOI 10.1074/jbc.R109.021006; Couloigner V, 2001, AM J PHYSIOL-RENAL, V280, pF214, DOI 10.1152/ajprenal.2001.280.2.F214; Desai SS, 2005, J NEUROPHYSIOL, V93, P251, DOI 10.1152/jn.00746.2003; Geleoc GSG, 2003, NAT NEUROSCI, V6, P1019, DOI 10.1038/nn1120; Grunder S, 2001, EUR J NEUROSCI, V13, P641, DOI 10.1046/j.1460-9568.2001.01426.x; Guipponi M, 2002, HUM MOL GENET, V11, P2829, DOI 10.1093/hmg/11.23.2829; Guipponi M, 2008, HUM MUTAT, V29, P130, DOI 10.1002/humu.20617; Guipponi M, 2007, AM J PATHOL, V171, P608, DOI 10.2353/ajpath.2007.070068; KRAUS HJ, 1981, HEARING RES, V4, P89, DOI 10.1016/0378-5955(81)90038-1; Ladrech S, 2004, J COMP NEUROL, V477, P149, DOI 10.1002/cne.20252; Lee YJ, 2003, J MED GENET, V40, P629, DOI 10.1136/jmg.40.8.629; Masmoudi S, 2001, HUM MUTAT, V18, P101, DOI 10.1002/humu.1159; Ou HC, 2000, HEARING RES, V145, P123, DOI 10.1016/S0378-5955(00)00082-4; Peters TA, 2006, ACTA OTO-LARYNGOL, V126, P237, DOI 10.1080/00016480500388893; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Sarrias MR, 2004, CRIT REV IMMUNOL, V24, P1; Scott HS, 2001, NAT GENET, V27, P59, DOI 10.1038/83768; SHNERSON A, 1983, DEV BRAIN RES, V9, P305, DOI 10.1016/0165-3806(83)90028-7; SUDHOF TC, 1985, SCIENCE, V228, P815, DOI 10.1126/science.2988123; VANDRIEL IR, 1987, J BIOL CHEM, V262, P17443; Velasco G, 2002, J BIOL CHEM, V277, P37637, DOI 10.1074/jbc.M203007200; Wang J, 2003, J NEUROSCI, V23, P8596; Wattenhofer M, 2005, HUM GENET, V117, P528, DOI 10.1007/s00439-005-1332-x; Zhong SX, 2004, HEARING RES, V193, P1, DOI 10.1016/j.heares.2004.03.001	32	51	57	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17383	17397		10.1074/jbc.M110.190652	http://dx.doi.org/10.1074/jbc.M110.190652			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454591	Green Published, hybrid			2022-12-25	WOS:000290301900086
J	Liao, BJ; Bao, XC; Liu, LQ; Feng, SP; Zovoilis, A; Liu, WB; Xue, YT; Cai, J; Guo, XP; Qin, BM; Zhang, RS; Wu, JY; Lai, LX; Teng, MK; Niu, LW; Zhang, BL; Esteban, MA; Pei, DQ				Liao, Baojian; Bao, Xichen; Liu, Longqi; Feng, Shipeng; Zovoilis, Athanasios; Liu, Wenbo; Xue, Yanting; Cai, Jie; Guo, Xiangpeng; Qin, Baoming; Zhang, Ruosi; Wu, Jiayan; Lai, Liangxue; Teng, Maikun; Niu, Liwen; Zhang, Biliang; Esteban, Miguel A.; Pei, Duanqing			MicroRNA Cluster 302-367 Enhances Somatic Cell Reprogramming by Accelerating a Mesenchymal-to-Epithelial Transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; PLURIPOTENCY; DIFFERENTIATION; OCT4; ZEB1; SOX2; RNA	MicroRNAs (miRNAs) are emerging critical regulators of cell function that frequently reside in clusters throughout the genome. They influence a myriad of cell functions, including the generation of induced pluripotent stem cells, also termed reprogramming. Here, we have successfully delivered entire miRNA clusters into reprogramming fibroblasts using retroviral vectors. This strategy avoids caveats associated with transient transfection of chemically synthesized miRNA mimics. Overexpression of 2 miRNA clusters, 106a-363 and in particular 302-367, allowed potent increases in induced pluripotent stem cell generation efficiency in mouse fibroblasts using 3 exogenous factors (Sox2, Klf4, and Oct4). Pathway analysis highlighted potential relevant effectors, including mesenchymal-to-epithelial transition, cell cycle, and epigenetic regulators. Further study showed that miRNA cluster 302-367 targeted TGF beta receptor 2, promoted increased E-cadherin expression, and accelerated mesenchymal-to-epithelial changes necessary for colony formation. Our work thus provides an interesting alternative for improving reprogramming using miRNAs and adds new evidence for the emerging relationship between pluripotency and the epithelial phenotype.	[Liao, Baojian; Bao, Xichen; Liu, Longqi; Liu, Wenbo; Xue, Yanting; Cai, Jie; Guo, Xiangpeng; Qin, Baoming; Lai, Liangxue; Esteban, Miguel A.; Pei, Duanqing] Chinese Acad Sci, Key Lab Regenerat Biol, S China Inst Stem Cell Biol & Regenerat Med, Guangzhou 510530, Guangdong, Peoples R China; [Bao, Xichen; Feng, Shipeng; Zhang, Biliang] Chinese Acad Sci, Lab RNA Chem Biol, Guangzhou Inst Biomed & Hlth, Guangzhou 510530, Guangdong, Peoples R China; [Liao, Baojian; Bao, Xichen; Xue, Yanting; Teng, Maikun; Niu, Liwen] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China; [Liao, Baojian; Bao, Xichen; Xue, Yanting; Teng, Maikun; Niu, Liwen] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China; [Zovoilis, Athanasios] European Neurosci Inst Gottingen, D-37077 Gottingen, Germany; [Zhang, Ruosi; Wu, Jiayan] Chinese Acad Sci, Key Lab Genome Sci & Informat, Beijing Inst Genom, Beijing 10029, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS	Esteban, MA (corresponding author), Chinese Acad Sci, Key Lab Regenerat Biol, S China Inst Stem Cell Biol & Regenerat Med, Guangzhou 510530, Guangdong, Peoples R China.	zhang_biliang@gibh.ac.cn; esteban@gibh.org	Qin, Baoming/G-1553-2015; Lai, Liangxue/H-4545-2011; Liao, Baojian/AAI-6286-2021	Qin, Baoming/0000-0001-7652-161X; Feng, Shipeng/0000-0002-3365-9990; wu, jia yan/0000-0001-6048-405X; Zovoilis, Athanasios/0000-0001-6425-0402	Ministry of Science and Technology 973 Program [2007CB948002, 2007CB947804, 2009CB941102, 2009CB940902, 2010CB944800, 2011CBA01106]; International Technology Cooperation Program [2010DFB30430]; Chinese Academy of Sciences [KSCX2-YW-R-221, KSCX2-YW-R-244, KSCX2-YW-R-086, KSCX2-YW-R-237]; Bureau of Science and Technology of Guangzhou Municipality [2007Z1-E4041'2008A1-E4011]	Ministry of Science and Technology 973 Program(National Basic Research Program of China); International Technology Cooperation Program; Chinese Academy of Sciences(Chinese Academy of Sciences); Bureau of Science and Technology of Guangzhou Municipality	This work was supported by Ministry of Science and Technology 973 Program Grants 2007CB948002, 2007CB947804, 2009CB941102, 2009CB940902, 2010CB944800, and 2011CBA01106 and International Technology Cooperation Program Grant 2010DFB30430; Chinese Academy of Sciences Grants KSCX2-YW-R-221, KSCX2-YW-R-244, KSCX2-YW-R-086, and KSCX2-YW-R-237; and Bureau of Science and Technology of Guangzhou Municipality Grant 2007Z1-E4041 ' 2008A1-E4011.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Gunaratne PH, 2009, CURR STEM CELL RES T, V4, P168, DOI 10.2174/157488809789057400; Judson RL, 2009, NAT BIOTECHNOL, V27, P459, DOI 10.1038/nbt.1535; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Li ZH, 2011, EMBO J, V30, P823, DOI 10.1038/emboj.2011.2; Liao BJ, 2011, J BIOL CHEM, V286, P17359, DOI 10.1074/jbc.C111.235960; Lin SL, 2008, RNA, V14, P2115, DOI 10.1261/rna.1162708; Lin SL, 2011, NUCLEIC ACIDS RES, V39, P1054, DOI 10.1093/nar/gkq850; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; van Wolfswinkel JC, 2010, J CELL SCI, V123, P1825, DOI 10.1242/jcs.061713; Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038	20	197	221	1	53	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17359	17364		10.1074/jbc.C111.235960	http://dx.doi.org/10.1074/jbc.C111.235960			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454525	Green Published, hybrid			2022-12-25	WOS:000290301900083
J	Plaza-Menacho, I; Morandi, A; Mologni, L; Boender, P; Gambacorti-Passerini, C; Magee, AI; Hofstra, RMW; Knowles, P; McDonald, NQ; Isacke, CM				Plaza-Menacho, Ivan; Morandi, Andrea; Mologni, Luca; Boender, Piet; Gambacorti-Passerini, Carlo; Magee, Anthony I.; Hofstra, Robert M. W.; Knowles, Phillip; McDonald, Neil Q.; Isacke, Clare M.			Focal Adhesion Kinase (FAK) Binds RET Kinase via Its FERM Domain, Priming a Direct and Reciprocal RET-FAK Transactivation Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; TYROSINE KINASE; THYROID-CANCER; PEPTIDE ARRAYS; IN-VITRO; RECEPTOR; INHIBITION; EXPRESSION; TUMORS; PHOSPHORYLATION	Whether RET is able to directly phosphorylate and activate downstream targets independently of the binding of proteins that contain Src homology 2 or phosphotyrosine binding domains and whether mechanisms in trans by cytoplasmic kinases can modulate RET function and signaling remain largely unexplored. In this study, oligopeptide arrays were used to screen substrates directly phosphorylated by purified recombinant wild-type and oncogenic RET kinase domain in the presence or absence of small molecule inhibitors. The results of the peptide array were validated by enzyme kinetics, in vitro kinase, and cell-based experiments. The identification of focal adhesion kinase (FAK) as a direct substrate for RET kinase revealed (i) a RET-FAK transactivation mechanism consisting of direct phosphorylation of FAK Tyr-576/577 by RET and a reciprocal phosphorylation of RET by FAK, which crucially is able to rescue the kinase-impaired RET K758M mutant and (ii) that FAK binds RET via its FERM domain. Interestingly, this interaction is abolished upon RET phosphorylation, indicating that RET binding to the FERM domain of FAK is a priming step for RET-FAK transactivation. Finally, our data indicate that FAK inhibitors could be used as potential therapeutic agents for patients with multiple endocrine neoplasia type 2 tumors because both, treatment with the FAK kinase inhibitor NVP-TAE226 and FAK down-regulation by siRNA reduced RET phosphorylation and signaling as well as the proliferation and survival of tumor and transfected cell lines expressing oncogenic RET.	[Plaza-Menacho, Ivan; Knowles, Phillip; McDonald, Neil Q.] Canc Res UK, Struct Biol Lab, London Res Inst, London WC2A 3LY, England; [Plaza-Menacho, Ivan; Morandi, Andrea; Isacke, Clare M.] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Mologni, Luca; Gambacorti-Passerini, Carlo] Univ Milano Bicocca, Dept Clin & Prevent Med, I-20052 Monza, Italy; [Boender, Piet] PamGene Int BV, NL-5200 BJ S Hertogenbosh, Netherlands; [Magee, Anthony I.] Univ London Imperial Coll Sci Technol & Med, Sect Mol Med, Natl Heart & Lung Inst, London SW7 2AZ, England; [Hofstra, Robert M. W.] Univ Groningen, Dept Genet, Univ Med Ctr Groningen, NL-9700 RB Groningen, Netherlands	Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Milano-Bicocca; PamGene International BV; Imperial College London; University of Groningen	Plaza-Menacho, I (corresponding author), Canc Res UK, Struct Biol Lab, London Res Inst, London WC2A 3LY, England.	Ivan.Plaza-Menacho@cancer.org.uk	Magee, Anthony/V-8345-2019; Mologni, Luca/AAC-1065-2022; Piris, Alejandro/D-3830-2014; Plaza-Menacho, Ivan/K-8517-2017	Mologni, Luca/0000-0002-6365-5149; Hofstra, Robert/0000-0001-7498-3829; Morandi, Andrea/0000-0002-9222-5332; Isacke, Clare/0000-0002-9222-3345; GAMBACORTI PASSERINI, CARLO/0000-0001-6058-515X; Plaza-Menacho, Ivan/0000-0003-4666-9431	Breakthrough Breast Cancer; Ministerio de Educacion y Ciencia of Spain [EX2006_1341]; Cancer Research UK; National Health Service; Cancer Research UK [10747] Funding Source: researchfish	Breakthrough Breast Cancer; Ministerio de Educacion y Ciencia of Spain(Spanish Government); Cancer Research UK(Cancer Research UK); National Health Service; Cancer Research UK(Cancer Research UK)	This work was supported by grants from Breakthrough Breast Cancer (to C. M. I.), Ministerio de Educacion y Ciencia of Spain Grant EX2006_1341 (to I.P.-M.), and Cancer Research UK (to I.P.-M. and N.Q.M.).; We thank Novartis for the NVP-TAE226 inhibitor, Rob Ruijtenbeek (PamGene) for helpful comments on the manuscript, Prof. M. Schaller for providing the GST-FERM-FAK plasmids, and Roger Georges and the Protein Production Facility (London Research Institute, Cancer Research UK) for helping with baculovirus expression of recombinant protein. The National Institute for Health Research Biomedical Research Centre is supported by the National Health Service.	Airaksinen MS, 1999, MOL CELL NEUROSCI, V13, P313, DOI 10.1006/mcne.1999.0754; Bonome T, 2005, CANCER RES, V65, P10602, DOI 10.1158/0008-5472.CAN-05-2240; Cance WG, 2000, CLIN CANCER RES, V6, P2417; Carlomagno F, 2004, ONCOGENE, V23, P6056, DOI 10.1038/sj.onc.1207810; Carlomagno F, 2006, JNCI-J NATL CANCER I, V98, P326, DOI 10.1093/jnci/djj069; Ceccarelli DFJ, 2006, J BIOL CHEM, V281, P252, DOI 10.1074/jbc.M509188200; de Groot JWB, 2006, ENDOCR REV, V27, P535, DOI 10.1210/er.2006-0017; Golubovskaya VM, 2008, MOL CARCINOGEN, V47, P222, DOI 10.1002/mc.20380; Halder J, 2007, CANCER RES, V67, P10976, DOI 10.1158/0008-5472.CAN-07-2667; Han NM, 1997, ANN SURG ONCOL, V4, P264, DOI 10.1007/BF02306620; Hilhorst R, 2009, ANAL BIOCHEM, V387, P150, DOI 10.1016/j.ab.2009.01.022; ILIC D, 1995, BIOCHEM BIOPH RES CO, V209, P300, DOI 10.1006/bbrc.1995.1503; ILLC D, 1995, NATURE, V377, P539; Knowles PP, 2006, J BIOL CHEM, V281, P33577, DOI 10.1074/jbc.M605604200; Lietha D, 2007, CELL, V129, P1177, DOI 10.1016/j.cell.2007.05.041; Lim ST, 2008, CELL CYCLE, V7, P2306, DOI 10.4161/cc.6367; Liu TJ, 2007, MOL CANCER THER, V6, P1357, DOI 10.1158/1535-7163.MCT-06-0476; Maat W, 2009, BRIT J CANCER, V101, P312, DOI 10.1038/sj.bjc.6605172; Manie S, 2001, TRENDS GENET, V17, P580, DOI 10.1016/S0168-9525(01)02420-9; Mologni L, 2005, PROTEIN EXPRES PURIF, V41, P177, DOI 10.1016/j.pep.2005.01.002; Murakami H, 1999, ONCOGENE, V18, P1975, DOI 10.1038/sj.onc.1202514; Natarajan M, 2003, CANCER J, V9, P126, DOI 10.1097/00130404-200303000-00008; Owens LV, 1996, ANN SURG ONCOL, V3, P100, DOI 10.1007/BF02409059; Panta GR, 2005, SURGERY, V138, P269, DOI 10.1016/j.surg.2005.04.007; Panta GR, 2004, SURGERY, V136, P1212, DOI 10.1016/j.surg.2004.06.048; PARSONS JT, 1994, J CELL SCI, P109; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Plaza-Menacho I, 2010, ONCOGENE, V29, P4648, DOI 10.1038/onc.2010.209; Plaza-Menacho I, 2007, J BIOL CHEM, V282, P29230, DOI 10.1074/jbc.M703461200; Plaza-Menacho I, 2006, TRENDS GENET, V22, P627, DOI 10.1016/j.tig.2006.09.005; Reineke U, 2001, CURR OPIN BIOTECH, V12, P59, DOI 10.1016/S0958-1669(00)00178-6; Sala E, 2006, INT J BIOL MACROMOL, V39, P60, DOI 10.1016/j.ijbiomac.2006.01.006; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; SCHLESSINGER J, 2000, MOL CELL BIOL, V103, P8461; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; Schutkowski M, 2005, CHEMBIOCHEM, V6, P513, DOI 10.1002/cbic.200400314; Shi Q, 2007, MOL CARCINOGEN, V46, P488, DOI 10.1002/mc.20297; Sikkema AH, 2009, CANCER RES, V69, P5987, DOI 10.1158/0008-5472.CAN-08-3660; Thomas JW, 1999, J BIOL CHEM, V274, P36684, DOI 10.1074/jbc.274.51.36684; Tremblay L, 1996, INT J CANCER, V68, P164, DOI 10.1002/(SICI)1097-0215(19961009)68:2<169::AID-IJC4>3.0.CO;2-W; Zwick E, 2001, ENDOCR-RELAT CANCER, V8, P161, DOI 10.1677/erc.0.0080161	42	42	44	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17292	17302		10.1074/jbc.M110.168500	http://dx.doi.org/10.1074/jbc.M110.168500			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454698	Green Published, hybrid			2022-12-25	WOS:000290301900077
J	Waters, LC; Strong, SL; Ferlemann, E; Oka, O; Muskett, FW; Veverka, V; Banerjee, S; Schmedt, T; Henry, AJ; Klempnauer, KH; Carr, MD				Waters, Lorna C.; Strong, Sarah L.; Ferlemann, Eva; Oka, Ojore; Muskett, Frederick W.; Veverka, Vaclav; Banerjee, Sreemoti; Schmedt, Thore; Henry, Alistair J.; Klempnauer, Karl-Heinz; Carr, Mark D.			Structure of the Tandem MA-3 Region of Pdcd4 Protein and Characterization of Its Interactions with eIF4A and eIF4G MOLECULAR MECHANISMS OF A TUMOR SUPPRESSOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EUKARYOTIC INITIATION-FACTORS; PROGRAMMED CELL-DEATH; FACTOR 4G EIF4G; TRANSLATION INITIATION; HELICASE ACTIVITY; INHIBITS TRANSLATION; CRYSTAL-STRUCTURE; MESSENGER-RNA; UP-REGULATION; CORE DOMAIN	One of the key regulatory points of translation initiation is recruitment of the 43S preinitation complex to the 5' mRNA cap by the eIF4F complex (eIF4A, eIF4E, and eIF4G). The tumor suppressor protein Pdcd4 has been shown to inhibit cap-dependent translation by interacting tightly with the RNA helicase eIF4A via its tandem MA-3 domains. The NMR studies reported here reveal a fairly extensive and well defined interface between the two MA-3 domains in solution, which appears to be stabilized by a network of interdomain salt bridges and hydrogen bonds, and reveals a unique orientation of the two domains. Characterization of the stoichiometry of the Pdcd4-eIF4A complex suggests that under physiological conditions Pdcd4 binds to a single molecule of eIF4A, which involves contacts with both Pdcd4 MA-3 domains. We also show that contacts mediated by a conserved acidic patch on the middle MA-3 domain of Pdcd4 are essential for forming a tight complex with eIF4A in vivo, whereas the equivalent region of the C-terminal MA-3 domain appears to have no role in complex formation in vivo. The formation of a 1: 1 eIF4A-Pdcd4 complex in solution is consistent with the reported presence in vivo of only one molecule of eIF4A in the eIF4F complex. Pdcd4 has also been reported to interact directly with the middle region of eIF4G, however, we were unable to obtain any evidence for even a weak, transient direct interaction.	[Waters, Lorna C.; Strong, Sarah L.; Oka, Ojore; Muskett, Frederick W.; Veverka, Vaclav] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England; [Ferlemann, Eva; Schmedt, Thore; Klempnauer, Karl-Heinz] Univ Munster, Inst Biochem, D-48149 Munster, Germany; [Henry, Alistair J.] UCB Celltech, Res & Dev, Slough SL1 3WE, Berks, England	University of Leicester; University of Munster; Celltech Group Ltd	Waters, LC (corresponding author), Univ Leicester, Dept Biochem, Henry Wellcome Bldg,Lancaster Rd, Leicester LE1 9HN, Leics, England.	lw83@le.ac.uk; mdc12@le.ac.uk	Veverka, Vaclav/G-9174-2014; Oka, Ojore/H-4456-2013; Veverka, Vaclav/P-5251-2019	Veverka, Vaclav/0000-0003-3782-5279; Veverka, Vaclav/0000-0003-3782-5279; Carr, Mark/0000-0002-3939-0996	Wellcome Trust [083629, 080085, 063632]; Wilhelm-Sander-Stiftung; Deutsche Krebshilfe	Wellcome Trust(Wellcome TrustEuropean Commission); Wilhelm-Sander-Stiftung; Deutsche Krebshilfe(Deutsche Krebshilfe)	This work was supported Wellcome Trust Grants 083629, 080085, and 063632, the Wilhelm-Sander-Stiftung, and the Deutsche Krebshilfe.	ABRAMSON RD, 1987, J BIOL CHEM, V262, P3826; Afonja O, 2004, ONCOGENE, V23, P8135, DOI 10.1038/sj.onc.1207983; Bitomsky N, 2008, ONCOGENE, V27, P4820, DOI 10.1038/onc.2008.115; Bitomsky N, 2004, ONCOGENE, V23, P7484, DOI 10.1038/sj.onc.1208064; Bohm M, 2003, ONCOGENE, V22, P4905, DOI 10.1038/sj.onc.1206710; Boozer C, 2006, CURR OPIN BIOTECH, V17, P400, DOI 10.1016/j.copbio.2006.06.012; Chang JH, 2009, P NATL ACAD SCI USA, V106, P3148, DOI 10.1073/pnas.0808275106; Chen Y, 2003, J PATHOL, V200, P640, DOI 10.1002/path.1378; Cmarik JL, 1999, P NATL ACAD SCI USA, V96, P14037, DOI 10.1073/pnas.96.24.14037; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; De Gregorio E, 1999, EMBO J, V18, P4865, DOI 10.1093/emboj/18.17.4865; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Hilliard A, 2006, J IMMUNOL, V177, P8095, DOI 10.4049/jimmunol.177.11.8095; Homola J, 2008, CHEM REV, V108, P462, DOI 10.1021/cr068107d; Imataka H, 1997, MOL CELL BIOL, V17, P6940, DOI 10.1128/MCB.17.12.6940; Jansen AP, 2005, CANCER RES, V65, P6034, DOI 10.1158/0008-5472.CAN-04-2119; Jansen AP, 2004, MOL CANCER THER, V3, P103; Kang MJ, 2002, BIOCHEM BIOPH RES CO, V293, P617, DOI 10.1016/S0006-291X(02)00264-4; Korneeva NL, 2001, J BIOL CHEM, V276, P2872, DOI 10.1074/jbc.M006345200; LAMPHEAR BJ, 1995, J BIOL CHEM, V270, P21975, DOI 10.1074/jbc.270.37.21975; Lankat-Buttgereit B, 2009, BIOL CELL, V101, P309, DOI 10.1042/BC20080191; LaRonde-LeBlanc N, 2007, MOL CELL BIOL, V27, P147, DOI 10.1128/MCB.00867-06; Li W, 2001, J BIOL CHEM, V276, P29111, DOI 10.1074/jbc.C100284200; Loh PG, 2009, EMBO J, V28, P274, DOI 10.1038/emboj.2008.278; Marcotrigiano J, 2001, MOL CELL, V7, P193, DOI 10.1016/S1097-2765(01)00167-8; Marintchev A, 2004, Q REV BIOPHYS, V37, P197, DOI 10.1017/S0033583505004026; Marintchev A, 2009, CELL, V136, P447, DOI 10.1016/j.cell.2009.01.014; Morino S, 2000, MOL CELL BIOL, V20, P468, DOI 10.1128/MCB.20.2.468-477.2000; Mudduluru G, 2007, CANCER-AM CANCER SOC, V110, P1697, DOI 10.1002/cncr.22983; Nielsen K. H., 2011, NUCL ACIDS IN PRESS; Oberer M, 2005, GENE DEV, V19, P2212, DOI 10.1101/gad.1335305; PAUSE A, 1994, EMBO J, V13, P1205, DOI 10.1002/j.1460-2075.1994.tb06370.x; Pestova TV, 2007, TRANSLATIONAL CONTRO, V4, P87; Ponting CP, 2000, TRENDS BIOCHEM SCI, V25, P423, DOI 10.1016/S0968-0004(00)01628-5; Renshaw PS, 2002, J BIOL CHEM, V277, P21598, DOI 10.1074/jbc.M201625200; Richter-Cook NJ, 1998, J BIOL CHEM, V273, P7579, DOI 10.1074/jbc.273.13.7579; Rogers GW, 2001, J BIOL CHEM, V276, P30914, DOI 10.1074/jbc.M100157200; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; ROZEN F, 1990, MOL CELL BIOL, V10, P1134, DOI 10.1128/MCB.10.3.1134; Schutz P, 2008, P NATL ACAD SCI USA, V105, P9564, DOI 10.1073/pnas.0800418105; Shibahara K, 1995, GENE, V166, P297, DOI 10.1016/0378-1119(95)00607-9; Singh P, 2009, ONCOGENE, V28, P3758, DOI 10.1038/onc.2009.239; Suzuki C, 2008, P NATL ACAD SCI USA, V105, P3274, DOI 10.1073/pnas.0712235105; Wang Q, 2008, ONCOGENE, V27, P1527, DOI 10.1038/sj.onc.1210793; Wang XY, 2008, ANTICANCER RES, V28, P2991; Waters LC, 2007, ONCOGENE, V26, P4941, DOI 10.1038/sj.onc.1210305; Waters L, 2006, J BIOL CHEM, V281, P14787, DOI 10.1074/jbc.M600237200; Waters LC, 2006, J BIOMOL NMR, V36, P18, DOI 10.1007/s10858-005-5887-6; Waters LC, 2010, BIOMOL NMR ASSIGN, V4, P49, DOI 10.1007/s12104-009-9205-1; Wedeken Lena, 2010, Genes Cancer, V1, P293, DOI 10.1177/1947601910364227; Yang HS, 2003, MOL CELL BIOL, V23, P26, DOI 10.1128/MCB.23.1.26-37.2003; Yang HS, 2004, MOL CELL BIOL, V24, P3894, DOI 10.1128/MCB.24.9.3894-3906.2004; Zhang H, 2006, ONCOGENE, V25, P6101, DOI 10.1038/sj.onc.1209634	53	24	29	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17270	17280		10.1074/jbc.M110.166157	http://dx.doi.org/10.1074/jbc.M110.166157			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454508	hybrid, Green Published			2022-12-25	WOS:000290301900075
J	Gomez, I; Pena, C; Herrera, M; Munoz, C; Larriba, MJ; Garcia, V; Dominguez, G; Silva, J; Rodriguez, R; de Herreros, AG; Bonilla, F; Garcia, JM				Gomez, Irene; Pena, Cristina; Herrera, Mercedes; Munoz, Concepcion; Jesus Larriba, Maria; Garcia, Vanesa; Dominguez, Gemma; Silva, Javier; Rodriguez, Rufo; Garcia de Herreros, Antonio; Bonilla, Felix; Garcia, Jose M.			TWIST1 Is Expressed in Colorectal Carcinomas and Predicts Patient Survival	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TRANSCRIPTION FACTOR SNAIL; E-CADHERIN EXPRESSION; BREAST-CANCER CELLS; COLON-CANCER; GENE-EXPRESSION; TUMOR-CELLS; METASTASIS; OVEREXPRESSION; INDUCTION	TWIST1 is a transcription factor that belongs to the family of basic helix-loop-helix proteins involved in epithelial-to-mesenchymal transition and invasion processes. The TWIST1 protein possesses oncogenic, drug-resistant, angiogenic and invasive properties, and has been related with several human tumors and other pathologies. Colorectal cancer is one of the tumors in which TWIST1 is over-expressed, but its involvement in the clinical outcome of the disease is still unclear. We tested, by RT-PCR, the expression levels of TWIST1 in normal and tumor paired-sample tissues from a series of 151 colorectal cancer patients, in order to investigate its prognostic value as a tumor marker. TWIST1 expression was restricted to tumor tissues (86.1%) and correlated with lymph node metastasis (LNM). Adjusted analysis showed that the expression levels of TWIST1 correlated with overall survival (OS) and disease-free survival (DFS). Importantly, TWIST1 expression levels predicted OS specifically at stages I and II. Moreover, patients with stage II tumors and high TWIST1 levels showed even shorter survival than patients with stage III tumors. These results suggest that TWIST1 expression levels could be a tumor indicator in stage II patients and help select patients at greater risk of poor prognosis who might benefit from adjuvant chemotherapy.	[Gomez, Irene; Pena, Cristina; Herrera, Mercedes; Garcia, Vanesa; Dominguez, Gemma; Silva, Javier; Bonilla, Felix; Garcia, Jose M.] Hosp Univ Puerta de Hierro Majadahonda, Dept Med Oncol, Madrid, Spain; [Garcia de Herreros, Antonio] Univ Pompeu Fabra, Inst Municipal Invest Med, Unitat Biol Cellular & Mol, Barcelona, Spain; [Munoz, Concepcion] Hosp Virgen de la Salud, Dept Gastroenterol, Toledo, Spain; [Rodriguez, Rufo] Hosp Virgen de la Salud, Dept Pathol, Toledo, Spain; [Jesus Larriba, Maria] Univ Autonoma Madrid, Inst Invest Biomed Alberto Sols, CSIC, Madrid, Spain	Hospital Puerta de Hierro-Majadahonda; Pompeu Fabra University; Complejo Hospitalario de Toledo; Complejo Hospitalario de Toledo; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM)	Gomez, I (corresponding author), Hosp Univ Puerta de Hierro Majadahonda, Dept Med Oncol, Madrid, Spain.	fbonilla.hpth@salud.madrid.org; jgarciar.hpth@salud.madrid.org	LARRIBA, MARIA JESUS/O-4652-2014; de Herreros, A Garcia/H-3104-2014	LARRIBA, MARIA JESUS/0000-0001-9035-7414; de Herreros, A Garcia/0000-0001-5270-0808; Garcia-Barberan, Vanesa/0000-0002-2531-0203	Foundation AECC [S-GEN/0266/2006, RD06/0020/0020, SAF2010-20750, RD06/0020/0040];  [ISCIII-CP08/00217]	Foundation AECC; 	This study was supported by grants from: Foundation AECC, S-GEN/0266/2006, RD06/0020/0020, SAF2010-20750 and RD06/0020/0040. JMG is supported by ISCIII-CP08/00217. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansieau S, 2008, CANCER CELL, V14, P79, DOI 10.1016/j.ccr.2008.06.005; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Casas E, 2011, CANCER RES, V71, P245, DOI 10.1158/0008-5472.CAN-10-2330; Cheng GZ, 2007, CANCER RES, V67, P1979, DOI 10.1158/0008-5472.CAN-06-1479; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; DEANS GT, 1992, BRIT J SURG, V79, P608, DOI 10.1002/bjs.1800790706; Eger A, 2005, ONCOGENE, V24, P2375, DOI 10.1038/sj.onc.1208429; ELIAS MC, 2005, TWIST IS EXPRESSED H, P824; Entz-Werle N, 2005, INT J CANCER, V117, P349, DOI 10.1002/ijc.21068; Erlichman C, 1999, J CLIN ONCOL, V17, P1356, DOI 10.1200/JCO.1999.17.5.1356; Fackler MJ, 2003, INT J CANCER, V107, P970, DOI 10.1002/ijc.11508; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Grooteclaes ML, 2000, ONCOGENE, V19, P3823, DOI 10.1038/sj.onc.1203721; Guaita S, 2002, J BIOL CHEM, V277, P39209, DOI 10.1074/jbc.M206400200; Hoek K, 2004, CANCER RES, V64, P5270, DOI 10.1158/0008-5472.CAN-04-0731; Hong Ran, 2009, BASIC APPL PATHOLOGY, V2, P15, DOI DOI 10.1111/j.1755-9294.2009.01030.x; Horikawa T, 2007, CANCER RES, V67, P1970, DOI 10.1158/0008-5472.CAN-06-3933; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kwok WK, 2005, CANCER RES, V65, P5153, DOI 10.1158/0008-5472.CAN-04-3785; Lee TK, 2006, CLIN CANCER RES, V12, P5369, DOI 10.1158/1078-0432.CCR-05-2722; Maestro R, 1999, GENE DEV, V13, P2207, DOI 10.1101/gad.13.17.2207; Mamounas E, 1999, J CLIN ONCOL, V17, P1349, DOI 10.1200/JCO.1999.17.5.1349; Mironchik Y, 2005, CANCER RES, V65, P10801, DOI 10.1158/0008-5472.CAN-05-0712; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; Okada T, 2010, GENE CHROMOSOME CANC, V49, P452, DOI 10.1002/gcc.20755; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Perez-Moreno MA, 2001, J BIOL CHEM, V276, P27424, DOI 10.1074/jbc.M100827200; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; Rosivatz E, 2002, AM J PATHOL, V161, P1881, DOI 10.1016/S0002-9440(10)64464-1; Sasaki K, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-158; Shibata K, 2008, ANN ONCOL, V19, P81, DOI 10.1093/annonc/mdm344; Taal BG, 2001, BRIT J CANCER, V85, P1437, DOI 10.1054/bjoc.2001.2117; Tenesa A, 2009, NAT REV GENET, V10, P353, DOI 10.1038/nrg2574; TOMITA N, 1992, CANCER RES, V52, P6840; Valdes-Mora F, 2009, ANN SURG ONCOL, V16, P78, DOI 10.1245/s10434-008-0166-x; Valsesia-Wittmann S, 2004, CANCER CELL, V6, P625, DOI 10.1016/j.ccr.2004.09.033; van Doorn R, 2004, CANCER RES, V64, P5578, DOI 10.1158/0008-5472.CAN-04-1253; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang XH, 2004, ONCOGENE, V23, P474, DOI 10.1038/sj.onc.1207128; Watanabe O, 2004, ANTICANCER RES, V24, P3851; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Yang MH, 2010, NAT CELL BIOL, V12, P982, DOI 10.1038/ncb2099; Yu QC, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-119	46	56	59	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e18023	10.1371/journal.pone.0018023	http://dx.doi.org/10.1371/journal.pone.0018023			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464926	Green Published, Green Submitted, gold			2022-12-25	WOS:000289053800013
J	Marchi, N; Granata, T; Freri, E; Ciusani, E; Ragona, F; Puvenna, V; Teng, QS; Alexopolous, A; Janigro, D				Marchi, Nicola; Granata, Tiziana; Freri, Elena; Ciusani, Emilio; Ragona, Francesca; Puvenna, Vikram; Teng, Quingshan; Alexopolous, Andreas; Janigro, Damir			Efficacy of Anti-Inflammatory Therapy in a Model of Acute Seizures and in a Population of Pediatric Drug Resistant Epileptics	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; TEMPORAL-LOBE EPILEPSY; IN-VITRO; RASMUSSENS-SYNDROME; INFANTILE SPASMS; HMPAO SPECT; DISRUPTION; PILOCARPINE; EPILEPTOGENESIS; CHILDHOOD	Targeting pro-inflammatory events to reduce seizures is gaining momentum. Experimentally, antagonism of inflammatory processes and of blood-brain barrier (BBB) damage has been demonstrated to be beneficial in reducing status epilepticus (SE). Clinically, a role of inflammation in the pathophysiology of drug resistant epilepsies is suspected. However, the use anti-inflammatory drug such as glucocorticosteroids (GCs) is limited to selected pediatric epileptic syndromes and spasms. Lack of animal data may be one of the reasons for the limited use of GCs in epilepsy. We evaluated the effect of the CG dexamethasone in reducing the onset and the severity of pilocarpine SE in rats. We assessed BBB integrity by measuring serum S100 beta and Evans Blue brain extravasation. Electrophysiological monitoring and hematologic measurements (WBCs and IL-1 beta) were performed. We reviewed the effect of add on dexamethasone treatment on a population of pediatric patients affected by drug resistant epilepsy. We excluded subjects affected by West, Landau-Kleffner or Lennox-Gastaut syndromes and Rasmussen encephalitis, known to respond to GCs or adrenocorticotropic hormone (ACTH). The effect of two additional GCs, methylprednisolone and hydrocortisone, was also reviewed in this population. When dexamethasone treatment preceded exposure to the convulsive agent pilocarpine, the number of rats developing status epilepticus (SE) was reduced. When SE developed, the time-to-onset was significantly delayed compared to pilocarpine alone and mortality associated with pilocarpine-SE was abolished. Dexamethasone significantly protected the BBB from damage. The clinical study included pediatric drug resistant epileptic subjects receiving add on GC treatments. Decreased seizure frequency (>= 50%) or interruption of status epilepticus was observed in the majority of the subjects, regardless of the underlying pathology. Our experimental results point to a seizure-reducing effect of dexamethasone. The mechanism encompasses improvement of BBB integrity. Our results also suggest that add on GCs could be of efficacy in controlling pediatric drug resistant seizures.	[Teng, Quingshan; Janigro, Damir] Cleveland Clin Fdn, Dept Neurol Surg, Cleveland, OH 44195 USA; [Janigro, Damir] Cleveland Clin Fdn, Dept Mol Med, Cleveland, OH 44195 USA; [Marchi, Nicola; Puvenna, Vikram; Janigro, Damir] Cleveland Clin Fdn, Dept Cell Biol, Cleveland, OH 44195 USA; [Alexopolous, Andreas] Cleveland Clin Fdn, Epilepsy Ctr, Cleveland, OH 44195 USA; [Granata, Tiziana; Freri, Elena; Ciusani, Emilio; Ragona, Francesca] Ist Neurol Besta, Milan, Italy	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; IRCCS Istituto Neurologico Besta	Marchi, N (corresponding author), Cleveland Clin Fdn, Dept Cell Biol, 9500 Euclid Ave, Cleveland, OH 44195 USA.	janigrd@ccf.org	Ragona, Francesca/K-9699-2016; Freri, Elena/J-8341-2016; Ciusani, Emilio/J-9822-2016; Granata, Tiziana/J-9012-2016; Marchi, Nicola/J-8607-2016	Ragona, Francesca/0000-0003-1399-8271; Freri, Elena/0000-0002-2293-8687; Ciusani, Emilio/0000-0002-7285-123X; Granata, Tiziana/0000-0002-0170-6836; Marchi, Nicola/0000-0001-9124-0226; Janigro, Damir/0000-0003-2165-5826	Cleveland Clinic-Swedish Satellite Laboratory Feasibility Project, Federal Appropriation Washington State;  [RO1 NS43284];  [RO1 NS38195];  [R21 HD057256]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD057256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043284, R01NS038195] Funding Source: NIH RePORTER	Cleveland Clinic-Swedish Satellite Laboratory Feasibility Project, Federal Appropriation Washington State; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by RO1 NS43284, RO1 NS38195, R21 HD057256 to DJ. Also supported by the Cleveland Clinic-Swedish Satellite Laboratory Feasibility Project, Federal Appropriation Washington State. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez V, 2010, EPILEPSY BEHAV, V17, P302, DOI 10.1016/j.yebeh.2009.12.025; Amato C, 2001, EUR J RADIOL, V38, P50, DOI 10.1016/S0720-048X(00)00284-9; Araki T, 2006, EPILEPSIA, V47, P176, DOI 10.1111/j.1528-1167.2006.00384.x; BETZ AL, 1990, STROKE, V21, P1199, DOI 10.1161/01.STR.21.8.1199; Blair RE, 2009, NEUROSCI LETT, V453, P233, DOI 10.1016/j.neulet.2009.02.035; CARMEN J, 1993, J NATL MED ASSOC, V85, P301; Cornford E M, 1999, Adv Neurol, V79, P845; Cornford EM, 2000, AM J PHYSIOL-HEART C, V279, pH1346, DOI 10.1152/ajpheart.2000.279.3.H1346; Cucullo L, 2004, BRAIN RES, V997, P147, DOI 10.1016/j.brainres.2003.09.079; Elkassabany NM, 2008, J NEUROSURG ANESTH, V20, P45, DOI 10.1097/ANA.0b013e31815d5f1f; Fabene PF, 2008, NAT MED, V14, P1377, DOI 10.1038/nm.1878; Granata T, 2003, NEUROL SCI, V24, pS239, DOI 10.1007/s10072-003-0086-2; Granata T, 2003, NEUROLOGY, V60, P422, DOI 10.1212/WNL.60.3.422; Grosso S, 2008, EPILEPSY RES, V81, P80, DOI 10.1016/j.eplepsyres.2008.04.016; Gutin P H, 1975, Semin Oncol, V2, P49; Hermsen CC, 1998, J INFECT DIS, V178, P1225, DOI 10.1086/515691; HUANG CC, 1995, EUR NEUROL, V35, P199, DOI 10.1159/000117128; Ivens S, 2007, BRAIN, V130, P535, DOI 10.1093/brain/awl317; Ivens S, 2010, J NEUROL, V257, P615, DOI 10.1007/s00415-009-5384-z; Kanner AA, 2003, CANCER, V97, P2806, DOI 10.1002/cncr.11409; Korn A, 2005, J CLIN NEUROPHYSIOL, V22, P1, DOI 10.1097/01.WNP.0000150973.24324.A7; KWAN P, 2009, EPILEPSIA; Lansberg MG, 1999, NEUROLOGY, V52, P1021, DOI 10.1212/WNL.52.5.1021; LEITE JP, 1995, EPILEPSY RES, V20, P93, DOI 10.1016/0920-1211(94)00070-D; Leite JP, 2002, EPILEPSY RES, V50, P93, DOI 10.1016/S0920-1211(02)00072-4; MARCHI N, 2010, BRAIN RES; Marchi N, 2007, EPILEPSIA, V48, P1934, DOI 10.1111/j.1528-1167.2007.01185.x; Marchi N, 2007, EPILEPSIA, V48, P732, DOI 10.1111/j.1528-1167.2007.00988.x; Marchi N, 2009, NEUROBIOL DIS, V33, P171, DOI 10.1016/j.nbd.2008.10.002; Maroso M, 2010, NAT MED, V16, P413, DOI 10.1038/nm.2127; Oby E, 2006, EPILEPSIA, V47, P1761, DOI 10.1111/j.1528-1167.2006.00817.x; Paladin F, 1998, ITAL J NEUROL SCI, V19, P217, DOI 10.1007/BF02427604; Paladin F, 1999, ITAL J NEUROL SCI, V20, P237, DOI 10.1007/s100720050037; Ravizza T, 2008, NEUROBIOL DIS, V29, P142, DOI 10.1016/j.nbd.2007.08.012; Razani-Boroujerdi S, 2008, J NEUROIMMUNOL, V194, P83, DOI 10.1016/j.jneuroim.2007.11.019; Riazi K, 2010, EPILEPSY RES, V89, P34, DOI 10.1016/j.eplepsyres.2009.09.004; Rogawski MA, 2002, INT REV NEUROBIOL, V49, P199; Rook GAW, 1999, BEST PRACT RES CL EN, V13, P567, DOI 10.1053/beem.1999.0044; Seiffert E, 2004, J NEUROSCI, V24, P7829, DOI 10.1523/JNEUROSCI.1751-04.2004; Sevilla-Castillo RA, 2009, NEUROPEDIATRICS, V40, P265, DOI 10.1055/s-0030-1249653; SIEMES H, 1984, EPILEPSIA, V25, P368, DOI 10.1111/j.1528-1157.1984.tb04202.x; Sinclair DB, 2003, PEDIATR NEUROL, V28, P194, DOI 10.1016/S0887-8994(02)00513-1; SNEAD OC, 1983, NEUROLOGY, V33, P966, DOI 10.1212/WNL.33.8.966; Stefan H, 2006, ACTA NEUROL SCAND, V113, P139, DOI 10.1111/j.1600-0404.2005.00561.x; Tan KM, 2008, EPILEPSY RES, V82, P190, DOI 10.1016/j.eplepsyres.2008.08.007; Tomkins O, 2007, NEUROBIOL DIS, V25, P367, DOI 10.1016/j.nbd.2006.10.006; Uva L, 2008, NEUROSCIENCE, V151, P303, DOI 10.1016/j.neuroscience.2007.10.037; van Vliet EA, 2007, BRAIN, V130, P521, DOI 10.1093/brain/awl318; Verhelst H, 2005, SEIZURE-EUR J EPILEP, V14, P412, DOI 10.1016/j.seizure.2005.07.002; Vezzani A, 2005, EPILEPSIA, V46, P1724, DOI 10.1111/j.1528-1167.2005.00298.x; Vezzani A, 2010, CURR OPIN INVEST DR, V11, P43	51	111	118	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e18200	10.1371/journal.pone.0018200	http://dx.doi.org/10.1371/journal.pone.0018200			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464890	gold, Green Submitted, Green Published			2022-12-25	WOS:000289053800028
J	Miller, JH				Miller, Joshua H.			Ghosts of Yellowstone: Multi-Decadal Histories of Wildlife Populations Captured by Bones on a Modern Landscape	PLOS ONE			English	Article							MOLLUSCAN DEATH ASSEMBLAGES; ECOLOGICAL FIDELITY; FAUNAL ASSEMBLAGES; MOUNTAIN GOATS; HABITAT; ORIGIN	Natural accumulations of skeletal material (death assemblages) have the potential to provide historical data on species diversity and population structure for regions lacking decades of wildlife monitoring, thereby contributing valuable baseline data for conservation and management strategies. Previous studies of the ecological and temporal resolutions of death assemblages from terrestrial large-mammal communities, however, have largely focused on broad patterns of community composition in tropical settings. Here, I expand the environmental sampling of large-mammal death assemblages into a temperate biome and explore more demanding assessments of ecological fidelity by testing their capacity to record past population fluctuations of individual species in the well-studied ungulate community of Yellowstone National Park (Yellowstone). Despite dramatic ecological changes following the 1988 wildfires and 1995 wolf re-introduction, the Yellowstone death assemblage is highly faithful to the living community in species richness and community structure. These results agree with studies of tropical death assemblages and establish the broad capability of vertebrate remains to provide high-quality ecological data from disparate ecosystems and biomes. Importantly, the Yellowstone death assemblage also correctly identifies species that changed significantly in abundance over the last 20 to,80 years and the directions of those shifts (including local invasions and extinctions). The relative frequency of fresh versus weathered bones for individual species is also consistent with documented trends in living population sizes. Radiocarbon dating verifies the historical source of bones from Equus caballus (horse): a functionally extinct species. Bone surveys are a broadly valuable tool for obtaining population trends and baseline shifts over decadal-to-centennial timescales.	Univ Chicago, Comm Evolutionary Biol, Chicago, IL 60637 USA	University of Chicago	Miller, JH (corresponding author), Univ Chicago, Comm Evolutionary Biol, Chicago, IL 60637 USA.	millerjh@uchicago.edu			National Science Foundation; Doctoral Dissertation Improvement Grant; Department of Education; Geological Society of America; American Society of Mammalogists; American Museum of Natural History; The Paleontological Society; Sigma Xi; Lawrence Livermore National Laboratory; University of Chicago	National Science Foundation(National Science Foundation (NSF)); Doctoral Dissertation Improvement Grant; Department of Education(US Department of Education); Geological Society of America; American Society of Mammalogists; American Museum of Natural History; The Paleontological Society; Sigma Xi; Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); University of Chicago(University of Chicago)	Support for this project was generously provided by the National Science Foundation (Predoctoral Fellowship Program [http://www.nsf.gov/funding/pgm_summ.jsp?pims_id=6201] and a Doctoral Dissertation Improvement Grant [http://www.nsf.gov/funding/pgm_summ.jsp?pims_id=5234]), the Department of Education (GAANN Fellowship in Evolutionary Ecology [http://www2.ed.gov/programs/gaann/index.html]), the Geological Society of America (Student Research Grant [http://www.geosociety.org/grants/gradgrants.htm]), the American Society of Mammalogists (Grants-in-Aid Program [http://www.mammalsociety.org/applications/]), the American Museum of Natural History (Theodore Roosevelt Fund [http://rggs.amnh.org/pages/academics_and_research/fellowship_and_grant_opportunities#grants]), the Explorer's Club (The Exploration Fund [http://www.explorers.org/index.php/expeditions/funding/expedition_grants]), The Paleontological Society (Steven J. Gould Award [http://www.paleosoc.org/grantin.html]), Sigma Xi (Grant-in-Aid of Research [http://www.sigmaxi.org/programs/giar/]), Lawrence Livermore National Laboratory and The University of Chicago (Berkmann Fellowship, Goodfriend Fund for Paleoecology, and Gurley Fund [http://geosci.uchicago.edu/]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS P, 1983, PALEOBIOLOGY, V9, P289, DOI 10.1017/S0094837300007703; ANDREWS P, 1995, J ARCHAEOL SCI, V22, P147, DOI 10.1006/jasc.1995.0016; Behrensmeyer A.K., 1980, P72; Behrensmeyer A.K., 1993, NATL GEOGRAPHIC RES, V9, P402; BEHRENSMEYER AK, 1978, PALEOBIOLOGY, V4, P150, DOI 10.1017/S0094837300005820; BEHRENSMEYER AK, 1979, PALEOBIOLOGY, V5, P12, DOI 10.1017/S0094837300006254; BROWN TA, 1988, RADIOCARBON, V30, P171, DOI 10.1017/S0033822200044118; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; EBERHARDT LL, 1992, J WILDLIFE MANAGE, V56, P603, DOI 10.2307/3808878; Feldhamer G.A., 2003, WILD MAMMALS N AM BI; Gates CC, 2005, ECOLOGY BISON MOVEME; Gotelli NJ, 2013, ECOSIMR 1 00; Grayson DK, 1981, J ETHNOBIOL, V1, P28; GRIFFITH B, 2002, ARCTIC REFUGE COASTA, P8; Hadly EA, 1999, PALAEOGEOGR PALAEOCL, V149, P389, DOI 10.1016/S0031-0182(98)00214-4; Hadly EA, 2004, PLOS BIOL, V2, P1600, DOI 10.1371/journal.pbio.0020290; Houston D.B., 1982, NO YELLOWSTONE ELK E; Jackson JBC, 2008, P NATL ACAD SCI USA, V105, P11458, DOI 10.1073/pnas.0802812105; Kidwell SM, 2002, GEOLOGY, V30, P803, DOI 10.1130/0091-7613(2002)030<0803:TAMDAP>2.0.CO;2; Kidwell SM, 2008, LETHAIA, V41, P199, DOI 10.1111/j.1502-3931.2007.00050.x; Kidwell SM, 2007, P NATL ACAD SCI USA, V104, P17701, DOI 10.1073/pnas.0707194104; Kidwell SM, 2010, PALEOBIOLOGY, V36, P615, DOI 10.1666/09004.1; Largo E, 2008, WILDLIFE BIOL, V14, P489, DOI 10.2981/0909-6396-14.4.489; Lemke TO, 2004, WILDLIFE SOC B, V32, P532, DOI 10.2193/0091-7648(2004)32[532:OEASOM]2.0.CO;2; Liebig PM, 2003, PALAIOS, V18, P168, DOI 10.1669/0883-1351(2003)18<168:BOTBMM>2.0.CO;2; McGill BJ, 2005, P NATL ACAD SCI USA, V102, P16701, DOI 10.1073/pnas.0504225102; Meldgaard M., 1986, Meddelelser om Gronland Bioscience, V20, P1; NRC, 2005, GEOL REC EC DYN UND; Plumb GE, 2009, BIOL CONSERV, V142, P2377, DOI 10.1016/j.biocon.2009.05.019; Porder S, 2003, PALEOBIOLOGY, V29, P197, DOI 10.1666/0094-8373(2003)029<0197:MTOOFA>2.0.CO;2; Pyenson ND, 2010, PALEOBIOLOGY, V36, P453, DOI 10.1666/09018.1; Reed DN, 2007, VERTEBR PALEOBIOL PA, P217, DOI 10.1007/978-1-4020-3098-7_9; Regehr EV, 2007, J WILDLIFE MANAGE, V71, P2673, DOI 10.2193/2006-180; Saenz-Arroyo A, 2005, P ROY SOC B-BIOL SCI, V272, P1957, DOI 10.1098/rspb.2005.3175; Schullery P, 2001, WEST N AM NATURALIST, V61, P289; SEPT JM, 1994, J ARCHAEOL SCI, V21, P217, DOI 10.1006/jasc.1994.1023; Smith DW, 2003, BIOSCIENCE, V53, P330, DOI 10.1641/0006-3568(2003)053[0330:YAW]2.0.CO;2; Sokal R. R., 2000, BIOMETRY; Sutcliffe Antony J., 2000, Polar Record, V36, P233; TAPPEN M, 1995, CURR ANTHROPOL, V36, P223, DOI 10.1086/204353; Terry RC, 2010, P ROY SOC B-BIOL SCI, V277, P1193, DOI 10.1098/rspb.2009.1984; Terry RC, 2010, PALEOBIOLOGY, V36, P137, DOI 10.1666/0094-8373-36.1.137; Tyers Daniel B., 2006, Alces, V42, P133; Tyers DB, 1995, ALCES N AM, V31, P35; VANVALEN L, 1964, AM NAT, V98, P109, DOI 10.1086/282307; Western D, 2009, SCIENCE, V324, P1061, DOI 10.1126/science.1171155; White PJ, 2008, WILDLIFE BIOL, V14, P138, DOI 10.2981/0909-6396(2008)14[138:IEORWC]2.0.CO;2; White PJ, 2005, WILDLIFE SOC B, V33, P942, DOI 10.2193/0091-7648(2005)33[942:NYEAWR]2.0.CO;2; Yellowstone National Park, 1997, YELL NO RANG COMPL C; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	61	36	37	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e18057	10.1371/journal.pone.0018057	http://dx.doi.org/10.1371/journal.pone.0018057			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464921	gold, Green Published, Green Submitted			2022-12-25	WOS:000289053800018
J	Nojima, S; Kiemle, DJ; Webster, FX; Apperson, CS; Schal, C				Nojima, Satoshi; Kiemle, David J.; Webster, Francis X.; Apperson, Charles S.; Schal, Coby			Nanogram-Scale Preparation and NMR Analysis for Mass-Limited Small Volatile Compounds	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; MULTIDIMENSIONAL GAS-CHROMATOGRAPHY; PROBE; IDENTIFICATION	Semiochemicals are often produced in infinitesimally small quantities, so their isolation requires large amounts of starting material, not only requiring significant effort in sample preparation, but also resulting in a complex mixture of compounds from which the bioactive compound needs to be purified and identified. Often, compounds cannot be unambiguously identified by their mass spectra alone, and NMR analysis is required for absolute chemical identification, further exacerbating the situation because NMR is relatively insensitive and requires large amounts of pure analyte, generally more than several micrograms. We developed an integrated approach for purification and NMR analysis of <1 mu g of material. Collections from high performance preparative gas-chromatography are directly eluted with minimal NMR solvent into capillary NMR tubes. With this technique, (1)H-NMR spectra were obtained on 50 ng of geranyl acetate, which served as a model compound, and reasonable H-H COSY NMR spectra were obtained from 250 ng of geranyl acetate. This simple off-line integration of preparative GC and NMR will facilitate the purification and chemical identification of novel volatile compounds, such as insect pheromones and other semiochemicals, which occur in minute (sub-nanogram), and often limited, quantities.	[Nojima, Satoshi; Apperson, Charles S.; Schal, Coby] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [Nojima, Satoshi; Apperson, Charles S.; Schal, Coby] N Carolina State Univ, WM Keck Ctr Behav Biol, Raleigh, NC 27695 USA; [Kiemle, David J.; Webster, Francis X.] SUNY Coll Environm Sci & Forestry, Dept Chem, Syracuse, NY 13210 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry	Nojima, S (corresponding author), Shin Etsu Chem Co Ltd, Tokyo, Japan.	coby_schal@ncsu.edu	Schal, Coby/A-8717-2010	Schal, Coby/0000-0001-7195-6358	NIH-NIAID [1 U01 AI058303-01]; North Carolina State University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI058303] Funding Source: NIH RePORTER	NIH-NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); North Carolina State University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by a grant from NIH-NIAID (1 U01 AI058303-01) and the Blanton J. Whitmire Endowment at North Carolina State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brey WW, 2006, J MAGN RESON, V179, P290, DOI 10.1016/j.jmr.2005.12.008; Dossey AT, 2006, ACS CHEM BIOL, V1, P511, DOI 10.1021/cb600318u; Eldridge SL, 2008, ADV CHROMATOGR, V46, P351; Eyres GT, 2008, ANAL CHEM, V80, P6293, DOI 10.1021/ac8007847; Eyres GT, 2008, J CHROMATOGR A, V1215, P168, DOI 10.1016/j.chroma.2008.10.102; Grynbaum MD, 2007, ANAL CHEM, V79, P2708, DOI 10.1021/ac0617767; Hu JF, 2005, PHYTOCHEM ANALYSIS, V16, P127, DOI 10.1002/pca.831; Kuhnle M, 2009, J SEP SCI, V32, P719, DOI 10.1002/jssc.200800661; Maguire Y, 2007, P NATL ACAD SCI USA, V104, P9198, DOI 10.1073/pnas.0703001104; Massin C, 2003, J MAGN RESON, V164, P242, DOI 10.1016/S1090-7807(03)00151-4; Nojima S, 2005, SCIENCE, V307, P1104, DOI 10.1126/science.1107163; Nojima S, 2004, J CHEM ECOL, V30, P2153, DOI 10.1023/B:JOEC.0000048780.26118.c0; Nojima S, 2008, J CHEM ECOL, V34, P418, DOI 10.1007/s10886-008-9437-z; Schlotterbeck G, 2002, ANAL CHEM, V74, P4464, DOI 10.1021/ac025556e; Schroeder FC, 2006, ANGEW CHEM INT EDIT, V45, P7122, DOI 10.1002/anie.200601789; WEBSTER FX, 1998, METHODS CHEM ECOLOGY, P153	16	20	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e18178	10.1371/journal.pone.0018178	http://dx.doi.org/10.1371/journal.pone.0018178			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464906	Green Submitted, Green Published, gold			2022-12-25	WOS:000289053800025
J	de Vries, SJ; Bonvin, AMJJ				de Vries, Sjoerd J.; Bonvin, Alexandre M. J. J.			CPORT: A Consensus Interface Predictor and Its Performance in Prediction-Driven Docking with HADDOCK	PLOS ONE			English	Article							PROTEIN-PROTEIN DOCKING; INTERACTION-SITE PREDICTION; SUPPORT VECTOR MACHINES; BIOMOLECULAR COMPLEXES; BLIND PREDICTIONS; BINDING-SITES; WEB SERVER; CAPRI; SURFACE; RECOGNITION	Background: Macromolecular complexes are the molecular machines of the cell. Knowledge at the atomic level is essential to understand and influence their function. However, their number is huge and a significant fraction is extremely difficult to study using classical structural methods such as NMR and X-ray crystallography. Therefore, the importance of large-scale computational approaches in structural biology is evident. This study combines two of these computational approaches, interface prediction and docking, to obtain atomic-level structures of protein-protein complexes, starting from their unbound components. Methodology/Principal Findings: Here we combine six interface prediction web servers into a consensus method called CPORT (Consensus Prediction Of interface Residues in Transient complexes). We show that CPORT gives more stable and reliable predictions than each of the individual predictors on its own. A protocol was developed to integrate CPORT predictions into our data-driven docking program HADDOCK. For cases where experimental information is limited, this prediction-driven docking protocol presents an alternative to ab initio docking, the docking of complexes without the use of any information. Prediction-driven docking was performed on a large and diverse set of protein-protein complexes in a blind manner. Our results indicate that the performance of the HADDOCK-CPORT combination is competitive with ZDOCK-ZRANK, a state-of-the-art ab initio docking/scoring combination. Finally, the original interface predictions could be further improved by interface post-prediction (contact analysis of the docking solutions). Conclusions/Significance: The current study shows that blind, prediction-driven docking using CPORT and HADDOCK is competitive with ab initio docking methods. This is encouraging since prediction-driven docking represents the absolute bottom line for data-driven docking: any additional biological knowledge will greatly improve the results obtained by prediction-driven docking alone. Finally, the fact that original interface predictions could be further improved by interface post-prediction suggests that prediction-driven docking has not yet been pushed to the limit. A web server for CPORT is freely available at http://haddock.chem.uu.nl/services/CPORT.	[de Vries, Sjoerd J.; Bonvin, Alexandre M. J. J.] Univ Utrecht, Fac Sci, Bijvoet Ctr Biomol Res, Utrecht, Netherlands	Utrecht University	de Vries, SJ (corresponding author), Tech Univ Munich, Munich, Germany.	a.m.j.j.bonvin@uu.nl	Bonvin, Alexandre M.J.J./A-5420-2009	Bonvin, Alexandre M.J.J./0000-0001-7369-1322	Netherlands Organization for Scientific Research [700.56.442]; European Community [032220, 213010]; European Commission Capacities Area - Research Infrastructures Initiative [228398]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Community(European Commission); European Commission Capacities Area - Research Infrastructures Initiative	This work was supported by the Netherlands Organization for Scientific Research (VICI grant # 700.56.442 to AMJJB) and by the European Community (Integrated Project SPINE2-COMPLEX contract no. 032220 and FP7 e-Infrastructure grant, contract no. 213010 - e-NMR). The work was carried out under the HPC-EUROPA2 project (project number: 228398) with the support of the European Commission Capacities Area - Research Infrastructures Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonvin AM, 2006, CURR OPIN STRUC BIOL, V16, P194, DOI 10.1016/j.sbi.2006.02.002; Bradford JR, 2005, BIOINFORMATICS, V21, P1487, DOI 10.1093/bioinformatics/bti242; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Caffrey DR, 2004, PROTEIN SCI, V13, P190, DOI 10.1110/ps.03323604; Chen HL, 2005, PROTEINS, V61, P21, DOI 10.1002/prot.20514; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; de Vries SJ, 2006, PROTEINS, V63, P479, DOI 10.1002/prot.20842; de Vries SJ, 2008, CURR PROTEIN PEPT SC, V9, P394, DOI 10.2174/138920308785132712; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; de Vries SJ, 2010, PROTEINS, V78, P3242, DOI 10.1002/prot.22814; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Fernandez-Recio J, 2004, J MOL BIOL, V335, P843, DOI 10.1016/j.jmb.2003.10.069; Huang B, 2008, GENE, V422, P14, DOI 10.1016/j.gene.2008.06.014; Hubbard S. J., 1993, NACCESS; HWANG H, PROTEINS, V78, P3104; Hwang H, 2008, PROTEINS, V73, P705, DOI 10.1002/prot.22106; KATCHALSKIKATZIR E, 1992, P NATL ACAD SCI USA, V89, P2195, DOI 10.1073/pnas.89.6.2195; Kufareva I, 2007, PROTEINS, V67, P400, DOI 10.1002/prot.21233; Lensink MF, 2007, PROTEINS, V69, P704, DOI 10.1002/prot.21804; Lensink MF, 2010, PROTEINS, V78, P3085, DOI 10.1002/prot.22850; Lensink MF, 2010, PROTEINS, V78, P3073, DOI 10.1002/prot.22818; Liang SD, 2006, NUCLEIC ACIDS RES, V34, P3698, DOI 10.1093/nar/gkl454; Liang SD, 2009, PROTEINS, V75, P397, DOI 10.1002/prot.22252; Martin O, 2008, PROTEINS, V70, P1367, DOI 10.1002/prot.21603; MELQUIOND ASJ, 2010, PROTEIN PROTEIN COMP, P183; Mendez R, 2003, PROTEINS, V52, P51, DOI 10.1002/prot.10393; Mintseris J, 2005, PROTEINS, V60, P214, DOI 10.1002/prot.20560; Mintseris J, 2007, PROTEINS, V69, P511, DOI 10.1002/prot.21502; Neuvirth H, 2004, J MOL BIOL, V338, P181, DOI 10.1016/j.jmb.2004.02.040; Ofran Y, 2003, J MOL BIOL, V325, P377, DOI 10.1016/S0022-2836(02)01223-8; Pierce B, 2008, PROTEINS, V72, P270, DOI 10.1002/prot.21920; Pierce B, 2007, PROTEINS, V67, P1078, DOI 10.1002/prot.21373; Porollo A, 2007, PROTEINS, V66, P630, DOI 10.1002/prot.21248; Qin S, 2007, BIOINFORMATICS, V23, P3386, DOI 10.1093/bioinformatics/btm434; Schneidman-Duhovny D, 2003, PROTEINS, V52, P107, DOI 10.1002/prot.10397; Stumpf MPH, 2008, P NATL ACAD SCI USA, V105, P6959, DOI 10.1073/pnas.0708078105; van Dijk ADJ, 2005, FEBS J, V272, P293, DOI 10.1111/j.1742-4658.2004.04473.x; Wiehe K, 2007, PROTEINS, V69, P719, DOI 10.1002/prot.21747; Zhou HX, 2007, BIOINFORMATICS, V23, P2203, DOI 10.1093/bioinformatics/btm323	40	189	192	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e17695	10.1371/journal.pone.0017695	http://dx.doi.org/10.1371/journal.pone.0017695			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464987	gold, Green Submitted, Green Published			2022-12-25	WOS:000288813900005
J	Ryu, HS; Park, SY; Ma, DA; Zhang, J; Lee, W				Ryu, Hyun Su; Park, Seung-Yoon; Ma, Duan; Zhang, Jin; Lee, Wan			The Induction of MicroRNA Targeting IRS-1 Is Involved in the Development of Insulin Resistance under Conditions of Mitochondrial Dysfunction in Hepatocytes	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; PHOSPHATIDYLINOSITOL 3-KINASE; WEIGHT-LOSS; RECEPTOR SUBSTRATE-1; GLUCOSE-UTILIZATION; DEPLETION; GROWTH; DNA; SENSITIVITY; METABOLISM	Background: Mitochondrial dysfunction induces insulin resistance in myocytes via a reduction of insulin receptor substrate-1 (IRS-1) expression. However, the effect of mitochondrial dysfunction on insulin sensitivity is not understood well in hepatocytes. Although research has implicated the translational repression of target genes by endogenous non-coding microRNAs (miRNA) in the pathogenesis of various diseases, the identity and role of the miRNAs that are involved in the development of insulin resistance also remain largely unknown. Methodology: To determine whether mitochondrial dysfunction induced by genetic or metabolic inhibition causes insulin resistance in hepatocytes, we analyzed the expression and insulin-stimulated phosphorylation of insulin signaling intermediates in SK-Hep1 hepatocytes. We used qRT-PCR to measure cellular levels of selected miRNAs that are thought to target IRS-1 3' untranslated regions (3'UTR). Using overexpression of miR-126, we determined whether IRS-1-targeting miRNA causes insulin resistance in hepatocytes. Principal Findings: Mitochondrial dysfunction resulting from genetic (mitochondrial DNA depletion) or metabolic inhibition (Rotenone or Antimycin A) induced insulin resistance in hepatocytes via a reduction in the expression of IRS-1 protein. In addition, we observed a significant up-regulation of several miRNAs presumed to target IRS-1 39UTR in hepatocytes with mitochondrial dysfunction. Using reporter gene assay we confirmed that miR-126 directly targeted to IRS-1 39UTR. Furthermore, the overexpression of miR-126 in hepatocytes caused a substantial reduction in IRS-1 protein expression, and a consequent impairment in insulin signaling. Conclusions/Significance: We demonstrated that miR-126 was actively involved in the development of insulin resistance induced by mitochondrial dysfunction. These data provide novel insights into the molecular basis of insulin resistance, and implicate miRNA in the development of metabolic disease.	[Ryu, Hyun Su; Park, Seung-Yoon; Lee, Wan] Dongguk Univ, Coll Med, Dept Biochem, Kyungju, South Korea; [Ma, Duan; Zhang, Jin] Fudan Univ, Key Lab Mol Med, Shanghai Med Coll, Inst Biomed Sci, Shanghai 200433, Peoples R China	Dongguk University; Fudan University	Ryu, HS (corresponding author), Dongguk Univ, Coll Med, Dept Biochem, Kyungju, South Korea.	wanlee@dongguk.ac.kr	Lee, Wan/B-6252-2013; Ma, Duan/I-8330-2014	Lee, Wan/0000-0002-5181-2135; 	Ministry of Health Welfare [A100370]; Ministry of Education, Science and Technology [M108KM010008-08K1301-00810]; National Research Foundation of Korea, Republic of Korea [2009-006791]	Ministry of Health Welfare; Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation of Korea, Republic of Korea(National Research Foundation of Korea)	This study was supported by grant of the Korea Healthcare R&D Project, Ministry of Health & Welfare (A100370); 21C Frontier Functional Proteomics Project from Ministry of Education, Science and Technology (M108KM010008-08K1301-00810); National Research Foundation of Korea Grant (2009-006791), Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amuthan G, 2001, EMBO J, V20, P1910, DOI 10.1093/emboj/20.8.1910; Anai O, 1998, J BIOL CHEM, V273, P29686, DOI 10.1074/jbc.273.45.29686; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Berggren JR, 2008, AM J PHYSIOL-ENDOC M, V294, pE726, DOI 10.1152/ajpendo.00354.2007; Biswas G, 1999, EMBO J, V18, P522, DOI 10.1093/emboj/18.3.522; Brozinick JT, 2003, DIABETES, V52, P935, DOI 10.2337/diabetes.52.4.935; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Carvalho Eugenia, 2001, FASEB Journal, V15, P1101; Catalano PM, 2002, AM J PHYSIOL-ENDOC M, V282, pE522, DOI 10.1152/ajpendo.00124.2001; CHEN LB, 1989, METHOD CELL BIOL, V29, P103; Cheng ZY, 2009, NAT MED, V15, P1307, DOI 10.1038/nm.2049; Gallagher IJ, 2010, GENOME MED, V2, DOI 10.1186/gm130; Guo CG, 2008, GENE CHROMOSOME CANC, V47, P939, DOI 10.1002/gcc.20596; Hennessy Erica, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000781; Holloszy JO, 2009, AM J CLIN NUTR, V89, p463S, DOI 10.3945/ajcn.2008.26717C; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kelley DE, 2001, DIABETES CARE, V24, P933, DOI 10.2337/diacare.24.5.933; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Kennedy ED, 1998, DIABETES, V47, P374, DOI 10.2337/diabetes.47.3.374; Kerouz NJ, 1997, J CLIN INVEST, V100, P3164, DOI 10.1172/JCI119872; Kim JA, 2008, CIRC RES, V102, P401, DOI 10.1161/CIRCRESAHA.107.165472; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lim JH, 2006, DIABETOLOGIA, V49, P1924, DOI 10.1007/s00125-006-0278-4; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Maassen JA, 2004, DIABETES, V53, pS103, DOI 10.2337/diabetes.53.2007.S103; Marx J, 2004, SCIENCE, V306, P592, DOI 10.1126/science.306.5696.592b; Park KS, 2001, AM J PHYSIOL-ENDOC M, V280, pE1007, DOI 10.1152/ajpendo.2001.280.6.E1007; Park SY, 2005, J BIOL CHEM, V280, P9855, DOI 10.1074/jbc.M409399200; Petersen KF, 2006, AM J MED, V119, p10S, DOI 10.1016/j.amjmed.2006.01.009; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Rondinone CM, 1997, P NATL ACAD SCI USA, V94, P4171, DOI 10.1073/pnas.94.8.4171; SAAD MJA, 1992, J CLIN INVEST, V90, P1839, DOI 10.1172/JCI116060; Saltiel AR, 2002, TRENDS CELL BIOL, V12, P65, DOI 10.1016/S0962-8924(01)02207-3; Schenk S, 2009, J PHYSIOL-LONDON, V587, P4949, DOI 10.1113/jphysiol.2009.175489; Shen WF, 2008, MOL CELL BIOL, V28, P4609, DOI 10.1128/MCB.01652-07; Shi B, 2007, J BIOL CHEM, V282, P32582, DOI 10.1074/jbc.M702806200; SIMONEAU JA, 1995, FASEB J, V9, P273, DOI 10.1096/fasebj.9.2.7781930; Simoneau JA, 1997, J APPL PHYSIOL, V83, P166, DOI 10.1152/jappl.1997.83.1.166; Szendroedi J, 2007, PLOS MED, V4, P858, DOI 10.1371/journal.pmed.0040154; Toledo FGS, 2008, DIABETES, V57, P987, DOI 10.2337/db07-1429; Zeng Y, 2003, RNA, V9, P112, DOI 10.1261/rna.2780503; Zhang J, 2008, BIOCHEM BIOPH RES CO, V377, P136, DOI 10.1016/j.bbrc.2008.09.089	43	121	130	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e17343	10.1371/journal.pone.0017343	http://dx.doi.org/10.1371/journal.pone.0017343			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464990	Green Published, gold, Green Submitted			2022-12-25	WOS:000288813900002
J	Saupe, EE; Papes, M; Selden, PA; Vetter, RS				Saupe, Erin E.; Papes, Monica; Selden, Paul A.; Vetter, Richard S.			Tracking a Medically Important Spider: Climate Change, Ecological Niche Modeling, and the Brown Recluse (Loxosceles reclusa)	PLOS ONE			English	Article							GEOGRAPHIC DISTRIBUTIONS; SPECIES DISTRIBUTIONS; CHAGAS-DISEASE; AREAS; CONSERVATISM; SICARIIDAE; PREDICTION; RESPONSES; ARANEAE; HABITAT	Most spiders use venom to paralyze their prey and are commonly feared for their potential to cause injury to humans. In North America, one species in particular, Loxosceles reclusa (brown recluse spider, Sicariidae), causes the majority of necrotic wounds induced by the Araneae. However, its distributional limitations are poorly understood and, as a result, medical professionals routinely misdiagnose brown recluse bites outside endemic areas, confusing putative spider bites for other serious conditions. To address the issue of brown recluse distribution, we employ ecological niche modeling to investigate the present and future distributional potential of this species. We delineate range boundaries and demonstrate that under future climate change scenarios, the spider's distribution may expand northward, invading previously unaffected regions of the USA. At present, the spider's range is centered in the USA, from Kansas east to Kentucky and from southern Iowa south to Louisiana. Newly influenced areas may include parts of Nebraska, Minnesota, Wisconsin, Michigan, South Dakota, Ohio, and Pennsylvania. These results illustrate a potential negative consequence of climate change on humans and will aid medical professionals in proper bite identification/treatment, potentially reducing bite misdiagnoses.	[Saupe, Erin E.; Selden, Paul A.] Univ Kansas, Inst Paleontol, Lawrence, KS 66045 USA; [Saupe, Erin E.; Selden, Paul A.] Univ Kansas, Dept Geol, Lawrence, KS 66045 USA; [Papes, Monica] Univ Wisconsin, Ctr Limnol, Madison, WI 53706 USA; [Selden, Paul A.] Nat Hist Museum, London SW7 5BD, England; [Vetter, Richard S.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA	University of Kansas; University of Kansas; University of Wisconsin System; University of Wisconsin Madison; Natural History Museum London; University of California System; University of California Riverside	Saupe, EE (corresponding author), Univ Kansas, Inst Paleontol, Lawrence, KS 66045 USA.	eesaupe@ku.edu	Selden, Paul/C-7530-2009	Selden, Paul/0000-0001-7454-4260; Saupe, Erin/0000-0002-0370-9897	University of Kansas; Paleontological Society; Geological Society of America	University of Kansas; Paleontological Society; Geological Society of America	The authors acknowledge a University of Kansas Self Graduate Fellowship (http://www2.ku.edu/similar to selfpro/), a Paleontological Society Caster Research Grant (http://www.paleosoc.org/grantin.html), and a Geological Society of America Student Research Grant (http://www.geosociety.org/grants/gradgrants.htm) for financial support to EES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6; Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; Binford GJ, 2005, TOXICON, V45, P547, DOI 10.1016/j.toxicon.2004.11.011; Brooker S, 2002, TRENDS PARASITOL, V18, P70, DOI 10.1016/S1471-4922(01)02223-1; Costa J, 2002, AM J TROP MED HYG, V67, P516, DOI 10.4269/ajtmh.2002.67.516; Cramer KL, 2008, J ARACHNOL, V36, P136, DOI 10.1636/Sh06-29.1; Davis AJ, 1998, NATURE, V391, P783, DOI 10.1038/35842; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Evangelista PH, 2008, DIVERS DISTRIB, V14, P808, DOI 10.1111/j.1472-4642.2008.00486.x; Ficetola GF, 2007, DIVERS DISTRIB, V13, P476, DOI 10.1111/j.1472-4642.2007.00377.x; Foley DH, 2008, J MED ENTOMOL, V45, P852, DOI 10.1603/0022-2585(2008)45[852:PDOTSI]2.0.CO;2; FUTRELL JM, 1992, AM J MED SCI, V304, P261, DOI 10.1097/00000441-199210000-00008; Gaston JK, 2003, STRUCTURE DYNAMICS G; GERTSCH WJ, 1983, B AM MUS NAT HIST, V175, P265; Giovanelli JGR, 2010, ECOL MODEL, V221, P215, DOI 10.1016/j.ecolmodel.2009.10.009; Glenn JB, 2003, CLIN PEDIATR, V42, P567, DOI 10.1177/000992280304200615; Graham CH, 2008, J APPL ECOL, V45, P239, DOI 10.1111/j.1365-2664.2007.01408.x; Gray J S, 2009, Interdiscip Perspect Infect Dis, V2009, P593232, DOI 10.1155/2009/593232; Grinnell J, 1917, AM NAT, V51, P115, DOI 10.1086/279591; Guisan A, 2007, ECOL MONOGR, V77, P615, DOI 10.1890/06-1060.1; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guralnick RP, 2006, PLOS BIOL, V4, P1908, DOI 10.1371/journal.pbio.0040381; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HITE JM, 1966, AGR EXP STA B, V711, P1; HOLT RD, 1992, EVOL ECOL, V6, P433, DOI 10.1007/BF02270702; HOUGHTON JT, 2001, IPCC 3 ASSESSMENT RE; Jackson ST, 2000, PALEOBIOLOGY, V26, P194, DOI 10.1666/0094-8373(2000)26[194:ROPPAC]2.0.CO;2; Jimenez-Valverde A, 2008, DIVERS DISTRIB, V14, P885, DOI 10.1111/j.1472-4642.2008.00496.x; Joyner TA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009596; Kearney M, 2006, OIKOS, V115, P186, DOI 10.1111/j.2006.0030-1299.14908.x; Lafferty KD, 2009, ECOLOGY, V90, P888, DOI 10.1890/08-0079.1; Maher SP, 2010, AM J TROP MED HYG, V83, P736, DOI 10.4269/ajtmh.2010.10-0042; Mak S, 2010, J MED ENTOMOL, V47, P99, DOI 10.1603/033.047.0114; Martinez-Meyer E, 2004, GLOBAL ECOL BIOGEOGR, V13, P305, DOI 10.1111/j.1466-822X.2004.00107.x; McCarty JP, 2001, CONSERV BIOL, V15, P320, DOI 10.1046/j.1523-1739.2001.015002320.x; Neerinckx S, 2010, AM J TROP MED HYG, V82, P492, DOI 10.4269/ajtmh.2010.09-0426; Neerinckx SB, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-54; Ortega-Huerta MA, 2008, REV MEX BIODIVERS, V79, P205; Papes M., 2003, J WUHAN BOT RES, V21, P137; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Penuelas J, 2001, SCIENCE, V294, P793, DOI 10.1126/science.1066860; Peterson A. T., 2006, BIODIVERSITY INFORM, V3, P59, DOI DOI 10.17161/BI.V3I0.29; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Peterson AT, 2008, EVOLUTION, V62, P173, DOI 10.1111/j.1558-5646.2007.00258.x; Peterson AT, 2007, J MAMMAL, V88, P1544, DOI 10.1644/06-MAMM-A-280R1.1; Peterson AT, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-59; Peterson AT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002441; Peterson AT, 1999, ECOL MODEL, V117, P159, DOI 10.1016/S0304-3800(99)00023-X; Peterson AT, 2003, INT J PARASITOL, V33, P919, DOI 10.1016/S0020-7519(03)00094-8; Peterson AT, 2001, BIOSCIENCE, V51, P363, DOI 10.1641/0006-3568(2001)051[0363:PSIUEN]2.0.CO;2; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Peterson AT, 2002, EMERG INFECT DIS, V8, P662, DOI 10.3201/eid0807.010454; Peterson AT, 2001, ECOL MODEL, V144, P21, DOI 10.1016/S0304-3800(01)00345-3; Peterson AT, 2003, Q REV BIOL, V78, P419, DOI 10.1086/378926; Peterson AT, 2001, CONDOR, V103, P599, DOI 10.1650/0010-5422(2001)103[0599:PSGDBO]2.0.CO;2; Peterson AT, 2002, NATURE, V416, P626, DOI 10.1038/416626a; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; PRESSEY RL, 1994, CONSERV BIOL, V8, P662, DOI 10.1046/j.1523-1739.1994.08030662.x; Price Jeff, 2000, Bird Observer (Arlington), V28, P224; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Roura-Pascual N, 2009, BIOL INVASIONS, V11, P1017, DOI 10.1007/s10530-008-9313-3; Rushton SP, 2004, J APPL ECOL, V41, P193, DOI 10.1111/j.0021-8901.2004.00903.x; Sandidge Jamel S., 2005, Transactions of the Kansas Academy of Science, V108, P99, DOI 10.1660/0022-8443(2005)108[0099:BRSARO]2.0.CO;2; SCACHETTIPEREIR.R, 2003, DESKTOPGARP; Soberon J, 2009, P NATL ACAD SCI USA, V106, P19644, DOI 10.1073/pnas.0901637106; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; Swanson DL, 2005, NEW ENGL J MED, V352, P700, DOI 10.1056/NEJMra041184; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Tsoar A, 2007, DIVERS DISTRIB, V13, P397, DOI 10.1111/j.1472-4642.2007.00346.x; van Meeteren LA, 2004, J BIOL CHEM, V279, P10833, DOI 10.1074/jbc.C300563200; Vetter RS, 2008, J ARACHNOL, V36, P150, DOI 10.1636/RSt08-06.1; Vetter RS, 2000, WESTERN J MED, V173, P357, DOI 10.1136/ewjm.173.5.357; Vetter RS, 2005, J MED ENTOMOL, V42, P512, DOI 10.1603/0022-2585(2005)042[0512:ASASBR]2.0.CO;2; Walther GR, 2005, P ROY SOC B-BIOL SCI, V272, P1427, DOI 10.1098/rspb.2005.3119; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Wieczorek J, 2004, INT J GEOGR INF SCI, V18, P745, DOI 10.1080/13658810412331280211; Williams P, 1996, CONSERV BIOL, V10, P155, DOI 10.1046/j.1523-1739.1996.10010155.x	85	43	45	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e17731	10.1371/journal.pone.0017731	http://dx.doi.org/10.1371/journal.pone.0017731			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464985	gold, Green Submitted, Green Published			2022-12-25	WOS:000288813900008
J	Thorup, K; Ortvad, TE; Rabol, J; Holland, RA; Tottrup, AP; Wikelski, M				Thorup, Kasper; Ortvad, Troels Eske; Rabol, Jorgen; Holland, Richard A.; Tottrup, Anders P.; Wikelski, Martin			Juvenile Songbirds Compensate for Displacement to Oceanic Islands during Autumn Migration	PLOS ONE			English	Article							SEA-TURTLES; ANIMAL NAVIGATION; BIRD MIGRATION; MAGNETIC CUES; ORIENTATION; MIGRANTS; PASSERINES; COMPASS; SYSTEM; TIME	To what degree juvenile migrant birds are able to correct for orientation errors or wind drift is still largely unknown. We studied the orientation of passerines on the Faroe Islands far off the normal migration routes of European migrants. The ability to compensate for displacement was tested in naturally occurring vagrants presumably displaced by wind and in birds experimentally displaced 1100 km from Denmark to the Faroes. The orientation was studied in orientation cages as well as in the free-flying birds after release by tracking departures using small radio transmitters. Both the naturally displaced and the experimentally displaced birds oriented in more easterly directions on the Faroes than was observed in Denmark prior to displacement. This pattern was even more pronounced in departure directions, perhaps because of wind influence. The clear directional compensation found even in experimentally displaced birds indicates that first-year birds can also possess the ability to correct for displacement in some circumstances, possibly involving either some primitive form of true navigation, or 'sign posts', but the cues used for this are highly speculative. We also found some indications of differences between species in the reaction to displacement. Such differences might be involved in the diversity of results reported in displacement studies so far.	[Thorup, Kasper; Ortvad, Troels Eske; Rabol, Jorgen] Univ Copenhagen, Zool Museum, Ctr Macroecol Evolut & Climate, DK-2100 Copenhagen, Denmark; [Holland, Richard A.; Wikelski, Martin] Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Radolfzell am Bodensee, Germany; [Tottrup, Anders P.] Univ Copenhagen, Dept Biol, Ctr Macroecol Evolut & Climate, DK-2100 Copenhagen, Denmark	University of Copenhagen; Max Planck Society; University of Copenhagen	Thorup, K (corresponding author), Univ Copenhagen, Zool Museum, Ctr Macroecol Evolut & Climate, DK-2100 Copenhagen, Denmark.	kthorup@snm.ku.dk	Holland, Richard A/A-6107-2010; Tøttrup, Anders P/N-3836-2013; Thorup, Kasper/A-4835-2013	Holland, Richard A/0000-0003-4495-8061; Tøttrup, Anders P/0000-0001-8776-9629; Thorup, Kasper/0000-0002-0320-0601	Danish Council for Independent Research; Division Of Integrative Organismal Systems [0744704] Funding Source: National Science Foundation	Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	K. Thorup was supported by a grant from the Danish Council for Independent Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akesson S, 2005, CURR BIOL, V15, P1591, DOI 10.1016/j.cub.2005.07.027; AKESSON S, 1993, ORNIS SCAND, V24, P87, DOI 10.2307/3676357; Alerstam T, 1998, J AVIAN BIOL, V29, P343, DOI 10.2307/3677155; Alerstam T, 2006, SCIENCE, V313, P791, DOI 10.1126/science.1129048; Batschelet E, 1981, CIRCULAR STAT BIOL; Beck W., 1988, P1955; Berthold P, 1996, CONTROL BIRD MIGRATI; Bingman VP, 2005, ETHOL ECOL EVOL, V17, P295; Bostrom J, 2010, BEHAV ECOL SOCIOBIOL, V64, P1725, DOI 10.1007/s00265-010-0985-1; Chernetsov N, 2008, CURR BIOL, V18, P188, DOI 10.1016/j.cub.2008.01.018; Cochran WW, 2004, SCIENCE, V304, P405, DOI 10.1126/science.1095844; Fair J., 2010, ORNITHOLOGICAL COUNC; Fischer JH, 2003, AVIAN MIGRATION, P423; Fitzgerald TM, 2008, BEHAV ECOL SOCIOBIOL, V62, P1499, DOI 10.1007/s00265-008-0579-3; Fransson T, 2001, NATURE, V414, P35, DOI 10.1038/35102115; Gauthreaux SA, 1978, ANIMAL MIGRATION NAV, P219; Gould JL, 2008, CURR BIOL, V18, pR214, DOI 10.1016/j.cub.2008.01.011; Gschweng M, 2008, P ROY SOC B-BIOL SCI, V275, P2887, DOI 10.1098/rspb.2008.0575; Gwinner E., 1972, ANIMAL ORIENTATION N, P321; Holland RA, 2010, J R SOC INTERFACE, V7, P1617, DOI 10.1098/rsif.2010.0159; Kullberg C, 2003, P ROY SOC B-BIOL SCI, V270, P373, DOI 10.1098/rspb.2002.2273; Lohmann KJ, 1996, NATURE, V380, P59, DOI 10.1038/380059a0; Lohmann KJ, 1996, J EXP BIOL, V199, P73; LOHMANN KJ, 1994, J EXP BIOL, V194, P23; MOORE FR, 1990, AUK, V107, P245; Mouritsen H, 1998, J EXP BIOL, V201, P2927; Mouritsen H, 2001, J EXP BIOL, V204, P3855; PERDECK A. C., 1958, ARDEA, V46, P1; RABOL J, 1985, Dansk Ornitologisk Forenings Tidsskrift, V79, P133; RABOL J, 1979, ORNIS SCAND, V10, P69, DOI 10.2307/3676346; Reilly JR, 2009, J ANIM ECOL, V78, P990, DOI 10.1111/j.1365-2656.2009.01576.x; Thorup K, 2001, J AVIAN BIOL, V32, P111, DOI 10.1034/j.1600-048X.2001.320203.x; Thorup K, 2007, P NATL ACAD SCI USA, V104, P18115, DOI 10.1073/pnas.0704734104; Thorup K, 2007, BEHAV ECOL SOCIOBIOL, V61, P825, DOI 10.1007/s00265-006-0306-x; Thorup K, 2010, INTEGR COMP BIOL, V50, P315, DOI 10.1093/icb/icq065; Thorup Kasper, 2000, Animal Behaviour Forum, V60, pF3; Wallraff HG., 2005, AVIAN NAVIGATION PIG; WIEDNER DS, 1992, AUK, V109, P500; Wikelski M, 2007, J EXP BIOL, V210, P181, DOI 10.1242/jeb.02629	39	32	33	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e17903	10.1371/journal.pone.0017903	http://dx.doi.org/10.1371/journal.pone.0017903			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464975	Green Published, gold, Green Submitted			2022-12-25	WOS:000288813900016
J	Wark, AR; Greenwood, AK; Taylor, EM; Yoshida, K; Peichel, CL				Wark, Abigail R.; Greenwood, Anna K.; Taylor, Elspeth M.; Yoshida, Kohta; Peichel, Catherine L.			Heritable Differences in Schooling Behavior among Threespine Stickleback Populations Revealed by a Novel Assay	PLOS ONE			English	Article							GUPPY POECILIA-RETICULATA; GASTEROSTEUS-ACULEATUS; 3-SPINED STICKLEBACKS; SYMPATRIC STICKLEBACKS; REPRODUCTIVE ISOLATION; ANTIPREDATOR BEHAVIOR; EMERGENT PROPERTIES; SHOALING DECISIONS; MINNOW SHOALS; SPECIES-PAIR	Identifying the proximate and ultimate mechanisms of social behavior remains a major goal of behavioral biology. In particular, the complex social interactions mediating schooling behavior have long fascinated biologists, leading to theoretical and empirical investigations that have focused on schooling as a group-level phenomenon. However, methods to examine the behavior of individual fish within a school are needed in order to investigate the mechanisms that underlie both the performance and the evolution of schooling behavior. We have developed a technique to quantify the schooling behavior of an individual in standardized but easily manipulated social circumstances. Using our model school assay, we show that threespine sticklebacks (Gasterosteus aculeatus) from alternative habitats differ in behavior when tested in identical social circumstances. Not only do marine sticklebacks show increased association with the model school relative to freshwater benthic sticklebacks, they also display a greater degree of parallel swimming with the models. Taken together, these data indicate that marine sticklebacks exhibit a stronger tendency to school than benthic sticklebacks. We demonstrate that these population-level differences in schooling tendency are heritable and are shared by individuals within a population even when they have experienced mixed-population housing conditions. Finally, we begin to explore the stimuli that elicit schooling behavior in these populations. Our data suggest that the difference in schooling tendency between marine and benthic sticklebacks is accompanied by differential preferences for social vs. non-social and moving vs. stationary shelter options. Our study thus provides novel insights into the evolution of schooling behavior, as well as a new experimental approach to investigate the genetic and neural mechanisms that underlie this complex social behavior.	[Wark, Abigail R.; Greenwood, Anna K.; Taylor, Elspeth M.; Yoshida, Kohta; Peichel, Catherine L.] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98104 USA; [Wark, Abigail R.] Univ Washington, Program Neurobiol & Behav, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Wark, AR (corresponding author), Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA.	akg@stanfordalumni.org; cpeichel@fhcrc.org	Yoshida, Kohta/AGI-9520-2022	Yoshida, Kohta/0000-0002-5896-7383	National Institutes of Health [P50 HG002568]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002568] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was funded by National Institutes of Health grant P50 HG002568 (CLP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boughman JW, 2001, NATURE, V411, P944, DOI 10.1038/35082064; Boulcott P, 2007, EVOL ECOL, V21, P601, DOI 10.1007/s10682-006-9138-4; BREDEN F, 1987, ANIM BEHAV, V35, P618, DOI 10.1016/S0003-3472(87)80297-X; Couzin ID, 2003, ADV STUD BEHAV, V32, P1, DOI 10.1016/S0065-3454(03)01001-5; CRONLYDILLON J, 1968, J EXP BIOL, V49, P679; Faria JJ, 2010, BEHAV ECOL SOCIOBIOL, V64, P1211, DOI 10.1007/s00265-010-0988-y; Frommen JG, 2004, BEHAVIOUR, V141, P1401, DOI 10.1163/1568539042948196; Frommen JG, 2009, BEHAV ECOL SOCIOBIOL, V63, P1141, DOI 10.1007/s00265-009-0767-9; Huntingford FA, 2009, J FISH BIOL, V75, P1943, DOI 10.1111/j.1095-8649.2009.02420.x; Imada H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011248; Kitano J, 2007, BIOL J LINN SOC, V91, P671, DOI 10.1111/j.1095-8312.2007.00824.x; Kozak GM, 2008, BEHAV ECOL, V19, P667, DOI 10.1093/beheco/arn022; Krause J, 2002, LIVING GROUPS; LARSON GL, 1976, CAN J ZOOL, V54, P107, DOI 10.1139/z76-012; MAGURRAN AE, 1986, BEHAV ECOL SOCIOBIOL, V19, P267, DOI 10.1007/BF00300641; MAGURRAN AE, 1990, ANIM BEHAV, V39, P834, DOI 10.1016/S0003-3472(05)80947-9; MAGURRAN AE, 1991, BEHAVIOUR, V118, P214, DOI 10.1163/156853991X00292; MAGURRAN AE, 1987, PROC R SOC SER B-BIO, V229, P439, DOI 10.1098/rspb.1987.0004; MCPHAIL JD, 1992, CAN J ZOOL, V70, P361, DOI 10.1139/z92-054; Milinski M, 1997, P ROY SOC B-BIOL SCI, V264, P831, DOI 10.1098/rspb.1997.0116; Modarressie R, 2006, P ROY SOC B-BIOL SCI, V273, P849, DOI 10.1098/rspb.2005.3397; Parrish JK, 2002, BIOL BULL-US, V202, P296, DOI 10.2307/1543482; PITCHER T, 1979, ANIM BEHAV, V27, P126, DOI 10.1016/0003-3472(79)90133-7; PITCHER TJ, 1983, ANIM BEHAV, V31, P611, DOI 10.1016/S0003-3472(83)80087-6; Pitcher TJ., 1993, Behaviour of teleost fishes, P363, DOI 10.1007/978-94-011-1578-0_12; Reebs SG, 2000, ANIM BEHAV, V59, P403, DOI 10.1006/anbe.1999.1314; ROWLAND WJ, 1989, BEHAV ECOL SOCIOBIOL, V24, P433, DOI 10.1007/BF00293272; ROWLAND WJ, 1979, BEHAV RES METH INSTR, V11, P564, DOI 10.3758/BF03201381; SEGHERS BH, 1974, EVOLUTION, V28, P486, DOI 10.1111/j.1558-5646.1974.tb00774.x; SHAW E, 1965, ANIM BEHAV, V13, P330, DOI 10.1016/0003-3472(65)90052-7; Soria M, 2007, J FISH BIOL, V71, P1257, DOI 10.1111/j.1095-8649.2007.01554.x; Taylor EB, 2000, P ROY SOC B-BIOL SCI, V267, P2375, DOI 10.1098/rspb.2000.1294; TINBERGEN N, 1951, STUDY INSTINCT, P221; Vamosi SM, 2002, ANN ZOOL FENN, V39, P237; Viscido SV, 2004, MAR ECOL PROG SER, V273, P239, DOI 10.3354/meps273239; Ward AJW, 2004, P ROY SOC B-BIOL SCI, V271, pS328, DOI 10.1098/rsbl.2004.0178; Ward AJW, 2008, P NATL ACAD SCI USA, V105, P6948, DOI 10.1073/pnas.0710344105; Wark AR, 2011, BEHAV ECOL SOCIOBIOL, V65, P1147, DOI 10.1007/s00265-010-1130-x; Wootton R.J., 1976, BIOL STICKLEBACKS; Wright D, 2006, NAT PROTOC, V1, P1828, DOI 10.1038/nprot.2006.287	40	45	45	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e18316	10.1371/journal.pone.0018316	http://dx.doi.org/10.1371/journal.pone.0018316			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464914	Green Submitted, Green Published, gold			2022-12-25	WOS:000288813900058
J	Su, JL; Li, SA; Hu, XD; Yu, XL; Wang, YY; Liu, PP; Lu, XS; Zhang, GZ; Hu, XY; Liu, D; Li, XX; Su, WL; Lu, H; Mok, NS; Wang, PY; Wang, M; Tian, KG; Gao, GF				Su, Jingliang; Li, Shuang; Hu, Xudong; Yu, Xiuling; Wang, Yongyue; Liu, Peipei; Lu, Xishan; Zhang, Guozhong; Hu, Xueying; Liu, Di; Li, Xiaoxia; Su, Wenliang; Lu, Hao; Mok, Ngai Shing; Wang, Peiyi; Wang, Ming; Tian, Kegong; Gao, George F.			Duck Egg-Drop Syndrome Caused by BYD Virus, a New Tembusu-Related Flavivirus	PLOS ONE			English	Article							EQUINE ENCEPHALITIS-VIRUS; ANSER-ANSER-DOMESTICUS; WEST-NILE-VIRUS; GENUS FLAVIVIRUS; GEESE; TRANSMISSION; ANTIBODIES; MOSQUITO; SERA	Since April 2010, a severe outbreak of duck viral infection, with egg drop, feed uptake decline and ovary-oviduct disease, has spread around the major duck-producing regions in China. A new virus, named BYD virus, was isolated in different areas, and a similar disease was reproduced in healthy egg-producing ducks, infecting with the isolated virus. The virus was re-isolated from the affected ducks and replicated well in primary duck embryo fibroblasts and Vero cells, causing the cytopathic effect. The virus was identified as an enveloped positive-stranded RNA virus with a size of approximately 55 nm in diameter. Genomic sequencing of the isolated virus revealed that it is closely related to Tembusu virus (a mosquito-borne Ntaya group flavivirus), with 87-91% nucleotide identity of the partial E (envelope) proteins to that of Tembusu virus and 72% of the entire genome coding sequence with Bagaza virus, the most closely related flavivirus with an entirely sequenced genome. Collectively our systematic studies fulfill Koch's postulates, and therefore, the causative agent of the duck egg drop syndrome occurring in China is a new flavivirus. Flavivirus is an emerging and re-emerging zoonotic pathogen and BYD virus that causes severe egg-drop, could be disastrous for the duck industry. More importantly its public health concerns should also be evaluated, and its epidemiology should be closely watched due to the zoonotic nature of flaviviruses.	[Su, Jingliang; Li, Shuang; Hu, Xudong; Wang, Yongyue; Lu, Xishan; Zhang, Guozhong; Su, Wenliang; Wang, Ming] China Agr Univ, Coll Vet Med, Key Lab Zoonosis, Minist Agr, Beijing 100094, Peoples R China; [Hu, Xudong; Liu, Peipei; Lu, Xishan; Liu, Di; Lu, Hao; Mok, Ngai Shing; Wang, Peiyi; Gao, George F.] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China; [Yu, Xiuling; Li, Xiaoxia; Tian, Kegong] China Anim Dis Control Ctr, Beijing, Peoples R China; [Liu, Peipei; Gao, George F.] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Hu, Xueying] Huazhong Agr Univ, Coll Vet Med, Wuhan, Peoples R China; [Liu, Di] Chinese Acad Sci, Network Informat Ctr, Inst Microbiol, Beijing, Peoples R China; [Gao, George F.] Chinese Acad Sci, Beijing Inst Life Sci, Beijing, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs; Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Huazhong Agricultural University; Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences	Su, JL (corresponding author), China Agr Univ, Coll Vet Med, Key Lab Zoonosis, Minist Agr, Beijing 100094, Peoples R China.	jinglsu@yahoo.com; tiankg@263.net; gaof@im.ac.cn	Liu, Di/G-6135-2014; Liu, Di/ABD-2729-2021; Gao, George Fu/ABD-5229-2021	Liu, Di/0000-0003-3693-2726; Liu, Di/0000-0003-3693-2726; 	China Ministry of Science and Technology (MOST) [2010CB530301, 2010CB530303]; Natural Science Foundation of China (NSFC) [30800640]; NSFC Innovative Research Group [81021003]	China Ministry of Science and Technology (MOST)(Ministry of Science and Technology, China); Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NSFC Innovative Research Group	The work is supported by the China Ministry of Science and Technology (MOST) Project 973 (Grant No. 2010CB530301 and 2010CB530303). DL is partly supported by the Natural Science Foundation of China (NSFC, Grant No. 30800640). GFG is a leading principal investigator of the NSFC Innovative Research Group (Grant No. 81021003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAIR BM, 2008, DIS POULTRY, P266; Austin RJ, 2004, CAN VET J, V45, P117; Barnard B.J., 1950, ONDERSTEPOORT J VET, V47, P89; Beckwith WH, 2002, AM J TROP MED HYG, V66, P422, DOI 10.4269/ajtmh.2002.66.422; Bondre VP, 2009, J GEN VIROL, V90, P2644, DOI 10.1099/vir.0.012336-0; BOWEN ETW, 1975, T ROY SOC TROP MED H, V69, P182, DOI 10.1016/0035-9203(75)90151-0; Digoutte J.P., 1978, AM J TROP MED HYG, V27, P376, DOI [10.4269/ajtmh.1978.27.376, DOI 10.4269/AJTMH.1978.27.376]; Djikeng A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-5; Dobler G, 2010, VET MICROBIOL, V140, P221, DOI 10.1016/j.vetmic.2009.08.024; Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X; Gould EA, 2003, ADV VIRUS RES, V59, P277, DOI 10.1016/S0065-3527(03)59008-X; Gubler D.J., 2007, FIELDS VIROLOGY, VVolume 1; HASE T, 1987, ARCH VIROL, V92, P273, DOI 10.1007/BF01317484; HEINZ FX, 2000, VIRUS TAXONOMY, P859; Hlinak A, 1998, J WILDLIFE DIS, V34, P479, DOI 10.7589/0090-3558-34.3.479; Karabatsos N., 1985, INT CATALOGUE ARBOVI; Kono Y, 2000, AM J TROP MED HYG, V63, P94, DOI 10.4269/ajtmh.2000.63.94; Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998; Lindenbach BD, 2007, FIELDS VIROLOGY, P1101; LUKERT PD, 1989, LAB MANUAL ISOLATION, P182; Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144; OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687; Swayne DE, 2001, EMERG INFECT DIS, V7, P751; TRAORELAMIZANA M, 1994, J MED ENTOMOL, V31, P934, DOI 10.1093/jmedent/31.6.934; WAGES DP, 1993, AVIAN DIS, V37, P1163, DOI 10.2307/1591931; WALLACE HG, 1977, MOSQ NEWS, V37, P35; Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008; Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310; WOOLCOCK PR, 2008, DISEASES POULTRY, P414; WOOLHOUSE MEJ, 2006, T16 QUANTITATIVE ANA	30	249	327	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2011	6	3							e18106	10.1371/journal.pone.0018106	http://dx.doi.org/10.1371/journal.pone.0018106			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740RG	21455312	Green Published, gold, Green Submitted			2022-12-25	WOS:000288811500023
J	Todaro, MA; Kanneby, T; Dal Zotto, M; Jondelius, U				Todaro, M. Antonio; Kanneby, Tobias; Dal Zotto, Matteo; Jondelius, Ulf			Phylogeny of Thaumastodermatidae (Gastrotricha: Macrodasyida) Inferred from Nuclear and Mitochondrial Sequence Data	PLOS ONE			English	Article							TETRANCHYRODERMA GASTROTRICHA; MARINE GASTROTRICHS; 18S; TREE; EVOLUTION; POSITION; BASAL; GNATHOSTOMULIDA; ULTRASTRUCTURE; MORPHOLOGY	Background: Phylogenetic relationships within Gastrotricha are poorly known. Attempts to shed light on this subject using morphological traits have led to hypotheses lacking satisfactory statistical support; it seemed therefore that a different approach was needed. Methodology/Principal Findings: In this paper we attempt to elucidate the relationships within the taxonomically vast family Thaumastodermatidae (Macrodasyida) using molecular sequence data. The study includes representatives of all the extant genera of the family and for the first time uses a multi-gene approach to infer evolutionary liaisons within Gastrotricha. The final data set comprises sequences of three genes (18S, 28S rDNA and COI mtDNA) from 41 species, including 29 thaumastodermatids, 11 non-thaumastodermatid macrodasyidans and a single chaetonotidan. Molecular data was analyzed as a combined set of 3 genes and as individual genes, using Bayesian and maximum likelihood approaches. Two different outgroups were used: Xenotrichula intermedia (Chaetonotida) and members of the putative basal Dactylopodola (Macrodasyida). Thaumastodermatidae and all other sampled macrodasyidan families were found monophyletic except for Cephalodasyidae. Within Thaumastodermatidae Diplodasyinae and Thaumastodermatinae are monophyletic and so are most genera. Oregodasys turns out to be the most basal group within Thaumastodermatinae in analyses of the concatenated data set as well as in analyses of the nuclear genes. Thaumastoderma appears as the sister taxon to the remaining species. Surprisingly, Tetranchyroderma is non-monophyletic in our analyses as one group of species clusters with Ptychostomella while another appears as the sister group of Pseudostomella. Conclusions/Significance: Results in general agree with the current classification; however, a revision of the more derived thaumastodermatid taxa seems necessary. We also found that the ostensible COI sequences from several species do not conform to the general invertebrate or any other published mitochondrial genetic code; they may be mitochondrially derived nuclear genes (numts), or one or more modifications of the mitochondrial genetic code within Gastrotricha.	[Todaro, M. Antonio; Dal Zotto, Matteo] Univ Modena & Reggio Emilia, Dept Biol, Modena, Italy; [Kanneby, Tobias; Jondelius, Ulf] Swedish Museum Nat Hist, Dept Invertebrate Zool, S-10405 Stockholm, Sweden	Universita di Modena e Reggio Emilia; Swedish Museum of Natural History	Todaro, MA (corresponding author), Univ Modena & Reggio Emilia, Dept Biol, Modena, Italy.	antonio.todaro@unimore.it	Jondelius, Ulf/A-4992-2009; Jondelius, Ulf/AAF-7943-2020; Todaro, M. Antonio/H-1311-2013	Jondelius, Ulf/0000-0003-2847-2192; Jondelius, Ulf/0000-0003-2847-2192; Todaro, M. Antonio/0000-0002-6353-7281; Kanneby, Tobias/0000-0001-7151-5915; Dal Zotto, Matteo/0000-0003-1386-7626	MIUR; Swedish Taxonomy Initiative (STI)	MIUR(Ministry of Education, Universities and Research (MIUR)); Swedish Taxonomy Initiative (STI)	This study benefited from a MIUR grants to MAT (PRIN-2004 "Contributo della meiofauna alla biodiversiti marina italiana" and PRIN-2007 "Approccio integrato all'identificazione dei Gastrotrichi marini") and from a grant to UJ by the Swedish Taxonomy Initiative (STI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; [Anonymous], HIV SEQUENCE DATABAS; Claparede E., 1867, ANN SCI NAT ZOOL, V8, P16; Dal Zotto Matteo, 2010, Meiofauna Marina, V18, P41; Dujardin F, 1841, HIST NATURELLE ZOOPH, P684; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EHRENBERG CG, 1838, BLICK TIEFERE ORG LE, P386; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gerlach S. A., 1953, Zoologischer Anzeiger, V150, P203; Giribet G, 2000, SYST BIOL, V49, P539, DOI 10.1080/10635159950127385; Guidi L, 2003, ZOOMORPHOLOGY, V122, P135, DOI 10.1007/s00435-003-0079-y; Hejnol A, 2009, P ROY SOC B-BIOL SCI, V276, P4261, DOI 10.1098/rspb.2009.0896; Hochberg R, 2000, BIOL BULL, V198, P299, DOI 10.2307/1542532; Hochberg R, 2001, INVERTEBR BIOL, V120, P124, DOI 10.1111/j.1744-7410.2001.tb00116.x; Hochberg R, 2010, ZOOTAXA, P1; Huelsenbeck JP, 2005, STAT BIOL HEALTH, P183, DOI 10.1007/0-387-27733-1_7; HUMMON WD, 1993, B ZOOL, V60, P109, DOI 10.1080/11250009309355798; Hummon WD, 2010, ZOOTAXA, P1; Hummon WD, 2009, ZOOTAXA, P47, DOI 10.11646/zootaxa.2278.1.3; Hyman LH, 1951, INVERTEBRATES, V3, P53; Kieneke A, 2008, ZOOL SCR, V37, P429, DOI 10.1111/j.1463-6409.2008.00334.x; Leasi F, 2010, J MAR BIOL ASSOC UK, V90, P645, DOI 10.1017/S0025315409991068; Lee JM, 2003, ZOOL SCI, V20, P481, DOI 10.2108/zsj.20.481; Levi C., 1950, Archives de Zoologie Experimentale et Generale Paris, V87, P31; Littlewood DTJ, 1998, MOL PHYLOGENET EVOL, V9, P72, DOI 10.1006/mpev.1997.0448; Ludwig H., 1875, Z WISS ZOOL, V26, P193; LUPORINI P, 1970, PUBBL STAZ ZOOL NAPO, V38, P267; Maddison WP, 2017, MESQUITE MODULAR SYS; Manylov OG, 2004, MOL PHYLOGENET EVOL, V30, P850, DOI 10.1016/S1055-7903(03)00251-3; Marotta Roberto, 2005, Meiofauna Marina, V14, P9; Noren M, 1999, CLADISTICS, V15, P103, DOI 10.1111/j.1096-0031.1999.tb00252.x; Peterson KJ, 2001, EVOL DEV, V3, P170, DOI 10.1046/j.1525-142x.2001.003003170.x; Petrov NB, 2007, MOL BIOL+, V41, P445, DOI 10.1134/S0026893307030107; RAMBAUT A, 2006, FIGTREE V1 1 2; REMANE A, 1927, TIERWELT NORD OSTSEE, P1; RIEGER GE, 1977, Z ZOOL SYST EVOL, V15, P81; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rothe Birgen H., 2010, Meiofauna Marina, V18, P49; Ruppert E.E., 1991, P41; RUPPERT EE, 1982, ZOOMORPHOLOGY, V99, P181, DOI 10.1007/BF00312295; RUPPERT EE, 1978, ZOOL SCR, V7, P93, DOI 10.1111/j.1463-6409.1978.tb00592.x; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Schmidt-Rhaesa A, 1998, J MORPHOL, V238, P263, DOI 10.1002/(SICI)1097-4687(199812)238:3<263::AID-JMOR1>3.0.CO;2-L; Schultze M, 1853, MULLERS ARCH ANATOMI, V6, P241; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Staden R, 1996, MOL BIOTECHNOL, V5, P233, DOI 10.1007/BF02900361; Stamatakis A., 2006, P INT PAR DISTR PROC; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Telford MJ, 2003, P ROY SOC B-BIOL SCI, V270, P1077, DOI 10.1098/rspb.2003.2342; Todaro MA, 2006, ZOOL SCR, V35, P251, DOI 10.1111/j.1463-6409.2006.00228.x; Todaro M. Antonio, 2008, Meiofauna Marina, V16, P3; Todaro MA, 2002, J MAR BIOL ASSOC UK, V82, P555, DOI 10.1017/S0025315402005878; TODARO MA, 1992, B ZOOL, V59, P471, DOI 10.1080/11250009209386709; TONGIORGI P, 1984, B ZOOL, V51, P335, DOI 10.1080/11250008409439471; TRAVIS PB, 1983, Z ZOOL SYST EVOL, V21, P52; Wallberg A, 2007, ZOOL SCR, V36, P509, DOI 10.1111/j.1463-6409.2007.00295.x; Willems W. R., 2009, Meiofauna Marina, V17, P1; WINNEPENNINCKX B, 1995, MOL BIOL EVOL, V12, P1132; Wirz A, 1999, MOL PHYLOGENET EVOL, V13, P314, DOI 10.1006/mpev.1999.0650; Zrzavy J, 2003, ZOOL SCR, V32, P61, DOI 10.1046/j.1463-6409.2003.00104.x	62	42	45	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2011	6	3							e17892	10.1371/journal.pone.0017892	http://dx.doi.org/10.1371/journal.pone.0017892			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740RG	21455302	Green Submitted, Green Published, gold			2022-12-25	WOS:000288811500013
J	Baldys, A; Raymond, JR				Baldys, Aleksander; Raymond, John R.			Role of c-Cbl Carboxyl Terminus in Serotonin 5-HT2A Receptor Recycling and Resensitization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; INDEPENDENT INTERNALIZATION; DOWN-REGULATION; TRAFFICKING; ENDOCYTOSIS; UBIQUITINATION; HRS; DEGRADATION; ENDOSOMES; MECHANISM	The 5-hydroxytryptamine 2A receptor (5-HT2AR) undergoes constitutive and agonist-dependent internalization. Despite many advances in our understanding of G protein-coupled receptor trafficking, the exact mechanism of endocytic sorting of G protein-coupled receptors remains obscure. Recently, we have reported a novel finding documenting a global role for the ubiquitin ligase c-Cbl in regulating vesicular sorting of epidermal growth factor receptor (Baldys, A., Gooz, M., Morinelli, T. A., Lee, M. H., Raymond, J. R., Jr., Luttrell, L. M., and Raymond, J. R., Sr. (2009) Biochemistry 48, 1462-1473). Thus, we tested the hypothesis that c-Cbl might play a role in 5-HT2AR recycling. In this study, we demonstrated an association of 5-HT2AR with c-Cbl. Furthermore, down-regulation of c-Cbl by RNA interference blocked efficient recycling of 5-HT2AR to the plasma membrane. Immunofluorescence microscopy revealed that 5-HT2A receptors were trapped in early endosome antigen 1- and Rab11-positive sorting endosomes in cells overexpressing c-Cbl mutants lacking carboxyl termini. This inhibitory effect was associated with a relative decrease in association of c-Cbl truncation proteins with the 5-HT2AR, compared with that observed for the full-length c-Cbl fusion protein. Consistent with the delayed recycling, 5-HT2AR resensitization was greatly attenuated in the presence of c-Cbl mutants lacking carboxyl termini, as detected by changes in the cytosolic calcium. Taken together, these studies have led to the discovery that the C-terminal region of c-Cbl plays a crucial role in the temporal and spatial control of 5-HT2AR recycling.	Med Univ S Carolina, Dept Med, Div Nephrol, Charleston, SC 29425 USA; Ralph H Johnson Vet Affairs Med Ctr, Med Serv, Charleston, SC 29425 USA; Ralph H Johnson Vet Affairs Med Ctr, Res Serv, Charleston, SC 29425 USA	Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Raymond, JR (corresponding author), Med Coll Wisconsin, Off President, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	jraymondj@mcw.edu			National Institutes of Health [DK052448, GM063909]; Department of Veterans Affairs; American Heart Association; Medical University of South Carolina Division of Nephrology and Dialysis Clinics, Inc.; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052448, R56DK052448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063909] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); American Heart Association(American Heart Association); Medical University of South Carolina Division of Nephrology and Dialysis Clinics, Inc.; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK052448 and GM063909 (to J. R. R.), Department of Veterans Affairs Merit and Research Enhancement Award Program grants (to J. R. R.), a American Heart Association (Mid-Atlantic) fellowship (to A. B.), and laboratory endowments jointly supported by the Medical University of South Carolina Division of Nephrology and Dialysis Clinics, Inc. (to J. R. R.).	Acconcia F, 2009, EXP CELL RES, V315, P1610, DOI 10.1016/j.yexcr.2008.10.014; Baldys A, 2009, BIOCHEMISTRY-US, V48, P9321, DOI 10.1021/bi900865u; Baldys A, 2009, BIOCHEMISTRY-US, V48, P1462, DOI 10.1021/bi801771g; Berg KA, 2005, TRENDS PHARMACOL SCI, V26, P625, DOI 10.1016/j.tips.2005.10.008; Berry SA, 1996, MOL PHARMACOL, V50, P306; Bhatnagar A, 2001, J BIOL CHEM, V276, P8269, DOI 10.1074/jbc.M006968200; Bhattacharyya S, 2002, P NATL ACAD SCI USA, V99, P14470, DOI 10.1073/pnas.212517999; Bonita DP, 1997, MOL CELL BIOL, V17, P4597, DOI 10.1128/MCB.17.8.4597; Drake MT, 2006, CIRC RES, V99, P570, DOI 10.1161/01.RES.0000242563.47507.ce; Duan L, 2003, J BIOL CHEM, V278, P28950, DOI 10.1074/jbc.M304474200; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Gray JA, 2003, MOL PHARMACOL, V63, P961, DOI 10.1124/mol.63.5.961; Gray JA, 2001, BRAIN RES BULL, V56, P441, DOI 10.1016/S0361-9230(01)00623-2; Hanyaloglu AC, 2005, EMBO J, V24, P2265, DOI 10.1038/sj.emboj.7600688; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Hanyaloglu AC, 2007, J BIOL CHEM, V282, P3095, DOI 10.1074/jbc.M605398200; Idkowiak-Baldys J, 2009, J BIOL CHEM, V284, P22322, DOI 10.1074/jbc.M109.026765; Jacob C, 2005, J BIOL CHEM, V280, P16076, DOI 10.1074/jbc.M500109200; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Lill NL, 2000, J BIOL CHEM, V275, P367, DOI 10.1074/jbc.275.1.367; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Schmidt MHH, 2005, NAT REV MOL CELL BIO, V6, P907, DOI 10.1038/nrm1762; Seachrist JL, 2003, LIFE SCI, V74, P225, DOI 10.1016/j.lfs.2003.09.009; Shenoy SK, 2007, CIRC RES, V100, P1142, DOI 10.1161/01.RES.0000261939.88744.5a; Singh AJ, 2007, P NATL ACAD SCI USA, V104, P5413, DOI 10.1073/pnas.0700809104; Stern KA, 2007, MOL CELL BIOL, V27, P888, DOI 10.1128/MCB.02356-05; Swaminathan G, 2006, J CELL PHYSIOL, V209, P21, DOI 10.1002/jcp.20694	28	6	6	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24656	24665		10.1074/jbc.M110.119891	http://dx.doi.org/10.1074/jbc.M110.119891			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21464131	Green Published, hybrid			2022-12-25	WOS:000292547900016
J	Eathiraj, S; Palma, R; Volckova, E; Hirschi, M; France, DS; Ashwell, MA; Chan, TCK				Eathiraj, Sudharshan; Palma, Rocio; Volckova, Erika; Hirschi, Marscha; France, Dennis S.; Ashwell, Mark A.; Chan, Thomas C. K.			Discovery of a Novel Mode of Protein Kinase Inhibition Characterized by the Mechanism of Inhibition of Human Mesenchymal-epithelial Transition Factor (c-Met) Protein Autophosphorylation by ARQ 197	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR TYROSINE KINASE; HEPATOCYTE GROWTH-FACTOR; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; MASS SPECTROMETRY; BINDING MODES; CANCER; AUTOINHIBITION; ACTIVATION; INSULIN	A number of human malignancies exhibit sustained stimulation, mutation, or gene amplification of the receptor tyrosine kinase human mesenchymal-epithelial transition factor (c-Met). ARQ 197 is a clinically advanced, selective, orally bioavailable, and well tolerated c-Met inhibitor, currently in Phase 3 clinical testing in non-small cell lung cancer patients. Herein, we describe the molecular and structural basis by which ARQ 197 selectively targets c-Met. Through our analysis we reveal a previously undisclosed, novel inhibitory mechanism that utilizes distinct regulatory elements of the c-Met kinase. The structure of ARQ 197 in complex with the c-Met kinase domain shows that the inhibitor binds a conformation that is distinct from published kinase structures. ARQ197 inhibits c-Met autophosphorylation and is highly selective for the inactive or unphosphorylated form of c-Met. Through our analysis of the interplay between the regulatory and catalytic residues of c-Met, and by comparison between the autoinhibited canonical conformation of c-Met bound by ARQ 197 to previously described kinase domains of type III receptor tyrosine kinases, we believe this to be the basis of a powerful new in silico approach for the design of similar inhibitors for other protein kinases of therapeutic interest.	[Eathiraj, Sudharshan; Palma, Rocio; Volckova, Erika; Hirschi, Marscha; France, Dennis S.; Ashwell, Mark A.; Chan, Thomas C. K.] ArQule Inc, Woburn, MA 01801 USA		Chan, TCK (corresponding author), 19 Presidential Way, Woburn, MA 01801 USA.	tchan@arqule.com			NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NIBIB NIH HHS [P30 EB009998] Funding Source: Medline	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Albrecht BK, 2008, J MED CHEM, V51, P2879, DOI 10.1021/jm800043g; Asses Y, 2009, CHEM BIOL DRUG DES, V74, P560, DOI 10.1111/j.1747-0285.2009.00895.x; Backes AC, 2008, EXPERT OPIN DRUG DIS, V3, P1427, DOI 10.1517/17460440802580106; Bagai R, 2010, IDRUGS, V13, P404; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARKER SC, 1995, BIOCHEMISTRY-US, V34, P14843, DOI 10.1021/bi00045a027; Bellon SF, 2008, J BIOL CHEM, V283, P2675, DOI 10.1074/jbc.M705774200; Canadas I, 2010, CLIN TRANSL ONCOL, V12, P253, DOI 10.1007/s12094-010-0501-0; Christensen JG, 2005, CANCER LETT, V225, P1, DOI 10.1016/j.canlet.2004.09.044; Comoglio PM, 2008, NAT REV DRUG DISCOV, V7, P504, DOI 10.1038/nrd2530; Danilkovitch-Miagkova A, 2002, J CLIN INVEST, V109, P863; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dikic I, 2003, CURR OPIN CELL BIOL, V15, P128, DOI 10.1016/S0955-0674(03)00004-8; Dussault I, 2008, CELL CYCLE, V7, P1157, DOI 10.4161/cc.7.9.5827; Eder JP, 2009, CLIN CANCER RES, V15, P2207, DOI 10.1158/1078-0432.CCR-08-1306; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Garuti L, 2010, CURR MED CHEM, V17, P2804, DOI 10.2174/092986710791859333; Griffith J, 2004, MOL CELL, V13, P169, DOI 10.1016/S1097-2765(03)00505-7; Hashigasako A, 2004, J BIOL CHEM, V279, P26445, DOI 10.1074/jbc.M314254200; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; Kufareva I, 2008, J MED CHEM, V51, P7921, DOI 10.1021/jm8010299; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; LEE DJ, 2010, CLIN LUNG CANCER, V11, P303; Liu XD, 2010, TRENDS MOL MED, V16, P37, DOI 10.1016/j.molmed.2009.11.005; Martin TA, 2010, ANTI-CANCER AGENT ME, V10, P2, DOI 10.2174/1871520611009010002; Mol CD, 2004, J BIOL CHEM, V279, P31655, DOI 10.1074/jbc.M403319200; Muckenschnabel I, 2004, ANAL BIOCHEM, V324, P241, DOI 10.1016/j.ab.2003.09.040; Munshi N, 2010, MOL CANCER THER, V9, P1544, DOI 10.1158/1535-7163.MCT-09-1173; Porter J, 2009, BIOORG MED CHEM LETT, V19, P2780, DOI 10.1016/j.bmcl.2009.03.110; Reilly JT, 2002, BRIT J HAEMATOL, V116, P744, DOI 10.1046/j.0007-1048.2001.03294.x; Schiering N, 2003, P NATL ACAD SCI USA, V100, P12654, DOI 10.1073/pnas.1734128100; Schiller JH, 2010, J CLIN ONCOL S, V28, p18s; Sheth PR, 2008, BIOCHEMISTRY-US, V47, P4028, DOI 10.1021/bi701892f; Timofeevski SL, 2009, BIOCHEMISTRY-US, V48, P5339, DOI 10.1021/bi900438w; Walter M, 2007, J MOL BIOL, V367, P839, DOI 10.1016/j.jmb.2007.01.036; Wang WR, 2006, P NATL ACAD SCI USA, V103, P3563, DOI 10.1073/pnas.0600048103; Whitehurst CE, 2008, COMB CHEM HIGH T SCR, V11, P427, DOI 10.2174/138620708784911447	40	113	117	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20666	20676		10.1074/jbc.M110.213801	http://dx.doi.org/10.1074/jbc.M110.213801			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21454604	Green Published, hybrid			2022-12-25	WOS:000291267600053
J	Ling, AS; Trotter, JR; Hendriks, EF				Ling, Alexandra S.; Trotter, James R.; Hendriks, Edward F.			A Zinc Finger Protein, TbZC3H20, Stabilizes Two Developmentally Regulated mRNAs in Trypanosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AU-RICH ELEMENTS; CCCH PROTEIN; LIFE-CYCLE; POSTTRANSCRIPTIONAL CONTROL; LEISHMANIA-MAJOR; BRUCEI; GENOME; TRISTETRAPROLIN; BINDING; DIFFERENTIATION	CCCH zinc finger proteins (ZC3Hs) are a novel class of RNA-binding protein involved in post-transcriptional mechanisms controlling gene expression. We show TbZC3H20 from Trypanosoma brucei, the causative agent of sleeping sickness and other diseases, stabilizes two developmentally regulated transcripts encoding a mitochondrial carrier protein (MCP12) and trans-sialidase (TS-like E). TbZC3H20 is shown to be an RNA-binding protein that is enriched in insect procyclic form T. brucei and is the first ZC3H discovered controlling gene expression through modulating mRNA abundance in trypanosomes. Previous studies have demonstrated that RNA recognition motif-containing and PUF family RNA-binding proteins can control gene expression by stabilizing specific target mRNA levels. This work is the first to describe a ZC3H stabilizing rather than destabilizing target mRNAs as a regulatory mechanism and the first report of a ZC3H regulating a gene encoding a mitochondrial protein. This suggests a broader role for ZC3Hs in post-transcriptional regulation of gene expression than previously thought.	[Ling, Alexandra S.; Trotter, James R.; Hendriks, Edward F.] Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, London SW7 2AZ, England	Imperial College London	Hendriks, EF (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, S Kensington Campus, London SW7 2AZ, England.	e.hendriks@imperial.ac.uk			Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by the Wellcome Trust.	Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Belloc E, 2008, NATURE, V452, P1017, DOI 10.1038/nature06809; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; Brown RS, 2005, CURR OPIN STRUC BIOL, V15, P94, DOI 10.1016/j.sbi.2005.01.006; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Carnes J, 2005, P NATL ACAD SCI USA, V102, P16614, DOI 10.1073/pnas.0506133102; Clayton CE, 2002, EMBO J, V21, P1881, DOI 10.1093/emboj/21.8.1881; Colasante C, 2009, MOL BIOCHEM PARASIT, V167, P104, DOI 10.1016/j.molbiopara.2009.05.004; Cuthbertson BJ, 2008, J BIOL CHEM, V283, P2586, DOI 10.1074/jbc.M707154200; Embley TM, 2006, NATURE, V440, P623, DOI 10.1038/nature04546; Estevez AM, 2008, NUCLEIC ACIDS RES, V36, P4573, DOI 10.1093/nar/gkn406; Gao GX, 2002, SCIENCE, V297, P1703, DOI 10.1126/science.1074276; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; Guo XM, 2007, P NATL ACAD SCI USA, V104, P151, DOI 10.1073/pnas.0607063104; HENDRIKS E, 2007, POSTTRANSCRIPTIONAL, P210; Hendriks EF, 2003, J BIOL CHEM, V278, P26870, DOI 10.1074/jbc.M302405200; Hendriks EF, 2005, MOL MICROBIOL, V57, P706, DOI 10.1111/j.1365-2958.2005.04679.x; Hendriks EF, 2001, EMBO J, V20, P6700, DOI 10.1093/emboj/20.23.6700; Hertz-Fowler C, 2004, NUCLEIC ACIDS RES, V32, pD339, DOI 10.1093/nar/gkh007; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Jensen BC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-482; Kabani S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-427; Kelly SM, 2007, P NATL ACAD SCI USA, V104, P12306, DOI 10.1073/pnas.0701244104; Koumandou VL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-298; Kramer S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-283; LaCount DJ, 2002, J BIOL CHEM, V277, P17580, DOI 10.1074/jbc.M200873200; Lai WS, 2006, MOL CELL BIOL, V26, P9196, DOI 10.1128/MCB.00945-06; Lai WS, 2005, J BIOL CHEM, V280, P34365, DOI 10.1074/jbc.M506757200; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Lai WS, 2002, J BIOL CHEM, V277, P9606, DOI 10.1074/jbc.M110395200; Liang J, 2008, J BIOL CHEM, V283, P6337, DOI 10.1074/jbc.M707861200; Liang XH, 2003, EUKARYOT CELL, V2, P830, DOI 10.1128/EC.2.5.830-840.2003; Mackay JP, 1998, TRENDS BIOCHEM SCI, V23, P1, DOI 10.1016/S0968-0004(97)01168-7; Mata J, 2005, TRENDS BIOCHEM SCI, V30, P506, DOI 10.1016/j.tibs.2005.07.005; Matsushita K, 2009, NATURE, V458, P1185, DOI 10.1038/nature07924; Matthews KR, 2004, TRENDS PARASITOL, V20, P40, DOI 10.1016/j.pt.2003.10.016; Matthews KR, 2005, J CELL SCI, V118, P283, DOI 10.1242/jcs.01649; Mayho M, 2006, NUCLEIC ACIDS RES, V34, P5312, DOI 10.1093/nar/gkl598; Montagna GN, 2006, J BIOL CHEM, V281, P33949, DOI 10.1074/jbc.M604951200; Panigrahi AK, 2003, J AM SOC MASS SPECTR, V14, P728, DOI 10.1016/S1044-0305(03)00126-0; Panigrahi AK, 2003, RNA, V9, P484, DOI 10.1261/rna.2194603; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; Paterou A, 2006, J BIOL CHEM, V281, P39002, DOI 10.1074/jbc.M604280200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Queiroz R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-495; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Reese KJ, 2000, MOL CELL, V6, P445, DOI 10.1016/S1097-2765(00)00043-5; Rotureau B, 2005, EXP PARASITOL, V111, P207, DOI 10.1016/j.exppara.2005.07.003; Silva MS, 2009, PARASITOL RES, V105, P1223, DOI 10.1007/s00436-009-1542-6; Tielens AGM, 2009, TRENDS PARASITOL, V25, P482, DOI 10.1016/j.pt.2009.07.007; Vlasova IA, 2008, MOL CELL, V29, P263, DOI 10.1016/j.molcel.2007.11.024; Walrad P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000317; Wang D, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-44; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X	55	27	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20152	20162		10.1074/jbc.M110.139261	http://dx.doi.org/10.1074/jbc.M110.139261			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21467035	Green Published, hybrid			2022-12-25	WOS:000291267600004
J	Braun, RJ; Sommer, C; Carmona-Gutierrez, D; Khoury, CM; Ring, J; Buttner, S; Madeo, F				Braun, Ralf J.; Sommer, Cornelia; Carmona-Gutierrez, Didac; Khoury, Chamel M.; Ring, Julia; Buettner, Sabrina; Madeo, Frank			Neurotoxic 43-kDa TAR DNA-binding Protein (TDP-43) Triggers Mitochondrion-dependent Programmed Cell Death in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; AMYOTROPHIC-LATERAL-SCLEROSIS; SACCHAROMYCES-CEREVISIAE; TRANSGENIC MICE; DROSOPHILA MODEL; REGULATES APOPTOSIS; OXIDATIVE STRESS; ACETIC-ACID; TOXICITY; DISEASE	Pathological neuronal inclusions of the 43-kDa TAR DNA-binding protein (TDP-43) are implicated in dementia and motor neuron disorders; however, the molecular mechanisms of the underlying cell loss remain poorly understood. Here we used a yeast model to elucidate cell death mechanisms upon expression of human TDP-43. TDP-43-expressing cells displayed markedly increased markers of oxidative stress, apoptosis, and necrosis. Cytotoxicity was dose-and age-dependent and was potentiated upon expression of disease-associated variants. TDP-43 was localized in perimitochondrial aggregate-like foci, which correlated with cytotoxicity. Although the deleterious effects of TDP-43 were significantly decreased in cells lacking functional mitochondria, cell death depended neither on the mitochondrial cell death proteins apoptosis-inducing factor, endonuclease G, and cytochrome c nor on the activity of cell death proteases like the yeast caspase 1. In contrast, impairment of the respiratory chain attenuated the lethality upon TDP-43 expression with a stringent correlation between cytotoxicity and the degree of respiratory capacity or mitochondrial DNA stability. Consistently, an increase in the respiratory capacity of yeast resulted in enhanced TDP-43-triggered cytotoxicity, oxidative stress, and cell death markers. These data demonstrate that mitochondria and oxidative stress are important to TDP-43-triggered cell death in yeast and may suggest a similar role in human TDP-43 pathologies.	[Braun, Ralf J.; Sommer, Cornelia; Carmona-Gutierrez, Didac; Khoury, Chamel M.; Ring, Julia; Buettner, Sabrina; Madeo, Frank] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria; [Braun, Ralf J.] Univ Bayreuth, Inst Cell Biol, D-95440 Bayreuth, Germany	University of Graz; University of Bayreuth	Madeo, F (corresponding author), Graz Univ, Inst Mol Biosci, Humboldtstr 50, A-8010 Graz, Austria.	frank.madeo@uni-graz.at	Braun, Ralf/B-9123-2008	Braun, Ralf/0000-0003-4234-8163; Madeo, Frank/0000-0002-5070-1329; Buttner, Sabrina/0000-0002-2786-8542; Ring, Julia/0000-0003-4991-9328; Carmona-Gutierrez, Didac/0000-0001-7548-7771	German Research Foundation (Deutsche Forschungsgemeinschaft) [BR 3706/1-1]; Fonds zur Forderung der Wissenschaftlichen Forschung [W1226-B18]; DKplus Metabolic and Cardiovascular Disease [S-9304-B05, T-414-B09]; European Commission	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Fonds zur Forderung der Wissenschaftlichen Forschung(Austrian Science Fund (FWF)); DKplus Metabolic and Cardiovascular Disease(Austrian Science Fund (FWF)); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by German Research Foundation (Deutsche Forschungsgemeinschaft) Grant BR 3706/1-1 (a postdoctoral fellowship to R. J. B.); by Austrian Science Fund (Fonds zur Forderung der Wissenschaftlichen Forschung) Grants W1226-B18 DKplus Metabolic and Cardiovascular Disease (to C. S. and F. M.), S-9304-B05 (to C. M. K. and F. M.), "Lipotox" (to D. C.-G., C. M. K., and F. M.), and T-414-B09 (a Hertha-Firnberg Fellowship to S. B.); and by the European Commission Project Apoptosis Systems Biology Applied to Cancer and AIDS (APO-SYS) (to F. M.).	Armakola M, 2011, METHODS, V53, P238, DOI 10.1016/j.ymeth.2010.11.006; Ash PEA, 2010, HUM MOL GENET, V19, P3206, DOI 10.1093/hmg/ddq230; Bolanos JP, 2010, TRENDS BIOCHEM SCI, V35, P145, DOI 10.1016/j.tibs.2009.10.006; Braun RJ, 2008, BBA-MOL CELL RES, V1783, P1418, DOI 10.1016/j.bbamcr.2008.01.015; Braun RJ, 2006, J BIOL CHEM, V281, P25757, DOI 10.1074/jbc.M513699200; Braun RJ, 2010, TRENDS BIOCHEM SCI, V35, P135, DOI 10.1016/j.tibs.2009.10.005; Buttner S, 2008, J BIOL CHEM, V283, P7554, DOI 10.1074/jbc.M708477200; Buttner S, 2007, MOL CELL, V25, P233, DOI 10.1016/j.molcel.2006.12.021; Carmona-Gutierrez D, 2010, CELL DEATH DIFFER, V17, P763, DOI 10.1038/cdd.2009.219; Carmona-Gutierrez D, 2010, CELL DEATH DIFFER, V17, P377, DOI 10.1038/cdd.2009.198; Deters N, 2008, EUR J NEUROSCI, V28, P137, DOI 10.1111/j.1460-9568.2008.06318.x; Dormann D, 2009, J NEUROCHEM, V110, P1082, DOI 10.1111/j.1471-4159.2009.06211.x; Duan W, 2010, NEUROSCIENCE, V169, P1621, DOI 10.1016/j.neuroscience.2010.06.018; Eckert A, 2008, J MOL MED, V86, P1255, DOI 10.1007/s00109-008-0391-6; Eisenberg T, 2007, APOPTOSIS, V12, P1011, DOI 10.1007/s10495-007-0758-0; Eisenberg T, 2010, APOPTOSIS, V15, P257, DOI 10.1007/s10495-009-0453-4; Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975; Fahrenkrog B, 2004, J CELL SCI, V117, P115, DOI 10.1242/jcs.00848; Fang J, 2003, FREE RADICAL BIO MED, V34, P478, DOI 10.1016/S0891-5849(02)01328-X; Fiesel FC, 2010, EMBO J, V29, P209, DOI 10.1038/emboj.2009.324; Fukui H, 2008, TRENDS NEUROSCI, V31, P251, DOI 10.1016/j.tins.2008.02.008; Gitler AD, 2008, NEUROSIGNALS, V16, P52, DOI 10.1159/000109759; Hanson KA, 2010, J BIOL CHEM, V285, P11068, DOI 10.1074/jbc.C109.078527; Hauptmann P, 2008, J BIOL CHEM, V283, P19151, DOI 10.1074/jbc.M801303200; Hayashi M, 2005, MOL CELL BIOL, V25, P9478, DOI 10.1128/MCB.25.21.9478-9490.2005; Heo JM, 2010, MOL CELL, V40, P465, DOI 10.1016/j.molcel.2010.10.021; Herker E, 2004, J CELL BIOL, V164, P501, DOI 10.1083/jcb.200310014; Igaz LM, 2009, J BIOL CHEM, V284, P8516, DOI 10.1074/jbc.M809462200; Johnson BS, 2008, P NATL ACAD SCI USA, V105, P6439, DOI 10.1073/pnas.0802082105; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; Khurana V, 2010, NAT REV NEUROSCI, V11, P436, DOI 10.1038/nrn2809; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li W, 2006, MOL BIOL CELL, V17, P1802, DOI 10.1091/mbc.E05-04-0333; Li Y, 2010, P NATL ACAD SCI USA, V107, P3169, DOI 10.1073/pnas.0913602107; Ludovico P, 2002, MOL BIOL CELL, V13, P2598, DOI 10.1091/mbc.E01-12-0161; Madeo F, 2002, MOL CELL, V9, P911, DOI 10.1016/S1097-2765(02)00501-4; Madeo F, 1997, J CELL BIOL, V139, P729, DOI 10.1083/jcb.139.3.729; Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757; Madeo F, 2009, BIOCHEM BIOPH RES CO, V382, P227, DOI 10.1016/j.bbrc.2009.02.117; Martin LJ, 2010, PHARMACEUTICALS, V3, P839, DOI 10.3390/ph3040839; Mason DA, 2005, FEMS YEAST RES, V5, P1237, DOI 10.1016/j.femsyr.2005.07.008; Merz S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r95; Neumann M, 2009, INT J MOL SCI, V10, P232, DOI 10.3390/ijms10010232; Ocampo A, 2010, FASEB J, V24, P1431, DOI 10.1096/fj.09-148601; Outeiro Tiago Fleming, 2006, Biotechnology Journal, V1, P258, DOI 10.1002/biot.200500043; Ritson GP, 2010, J NEUROSCI, V30, P7729, DOI 10.1523/JNEUROSCI.5894-09.2010; Ruckenstuhl C, 2010, AGING-US, V2, P643, DOI 10.18632/aging.100223; Ruckenstuhl C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004592; Shan X, 2010, P NATL ACAD SCI USA, V107, P16325, DOI 10.1073/pnas.1003459107; Shi P, 2010, BBA-MOL BASIS DIS, V1802, P45, DOI 10.1016/j.bbadis.2009.08.012; Solans A, 2006, HUM MOL GENET, V15, P3063, DOI 10.1093/hmg/ddl248; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Tatom JB, 2009, MOL THER, V17, P607, DOI 10.1038/mt.2009.3; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Wang IF, 2008, TRENDS MOL MED, V14, P479, DOI 10.1016/j.molmed.2008.09.001; Wegorzewska I, 2009, P NATL ACAD SCI USA, V106, P18809, DOI 10.1073/pnas.0908767106; Wei M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000467; Westermann B, 2000, YEAST, V16, P1421, DOI 10.1002/1097-0061(200011)16:15<1421::AID-YEA624>3.3.CO;2-L; Wils H, 2010, P NATL ACAD SCI USA, V107, P3858, DOI 10.1073/pnas.0912417107; Wissing S, 2004, J CELL BIOL, V166, P969, DOI 10.1083/jcb.200404138; Xu YF, 2010, J NEUROSCI, V30, P10851, DOI 10.1523/JNEUROSCI.1630-10.2010; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106; Zhou HX, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000887; Zischka H, 2006, MOL CELL PROTEOMICS, V5, P2185, DOI 10.1074/mcp.T600018-MCP200	65	71	71	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19958	19972		10.1074/jbc.M110.194852	http://dx.doi.org/10.1074/jbc.M110.194852			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21471218	hybrid, Green Published			2022-12-25	WOS:000291027700074
J	Park, BH; Lee, SB; Stolz, DB; Lee, YJ; Lee, BC				Park, Bae-Hang; Lee, Sean-Bong; Stolz, Donna B.; Lee, Yong J.; Lee, Byeong-Chel			Synergistic Interactions between Heregulin and Peroxisome Proliferator-activated Receptor-gamma (PPAR gamma) Agonist in Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND TROGLITAZONE; HYDROGEN-PEROXIDE; INDUCED APOPTOSIS; CARCINOMA CELLS; TUMOR-CELLS; DNA-DAMAGE; PHASE-II; IN-VIVO; AUTOPHAGY; GROWTH	Here, we demonstrate that troglitazone (Rezulin), a peroxisome proliferator-activated receptor agonist, acted in synergy with heregulin to induce massive cell death in breast cancer cells. Although the combination of heregulin and troglitazone (HRG/TGZ) induced both apoptosis and necrosis, the main mode of cell death was caspase-independent and occurred via necrosis. This combination increased generation of superoxide in mitochondria, which in turn destabilized mitochondria potential. Pretreatment with N-acetyl-L-cysteine and catalase expression ameliorated cell death induced by the combination treatment, indicating a role of oxidative stress in mediating HRG/TGZ-induced cell death. Notably, pretreatment with pyruvate significantly prevented the cell death, suggesting a potential mechanistic link between metabolic stress and HRG/TGZ-induced cell death. The activation of the HRG signaling axis has been considered as a poor prognostic factor in breast cancer and confers resistance to gefitinib (Iressa) and tamoxifen. However, our data presented here paradoxically suggest that HRG expression can actually be beneficial when it comes to treating breast cancer with peroxisome proliferator-activated receptor-gamma ligands. Taken together, the combination of HRG and TGZ may provide a basis for the development of a novel strategy in the treatment of apoptosis-resistant and/or hormone-refractory breast cancer.	[Lee, Byeong-Chel] Univ Pittsburgh, Sch Med, Hillman Canc Ctr, Univ Pittsburgh Canc Inst, Pittsburgh, PA 15213 USA; [Park, Bae-Hang; Lee, Byeong-Chel] Univ Pittsburgh, Sch Med, Dept Med, Div Hematol & Oncol, Pittsburgh, PA 15213 USA; [Lee, Sean-Bong] NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA; [Stolz, Donna B.] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15213 USA; [Lee, Yong J.] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lee, BC (corresponding author), Univ Pittsburgh, Sch Med, Hillman Canc Ctr, Univ Pittsburgh Canc Inst, 5117 Ctr Ave, Pittsburgh, PA 15213 USA.	leeb4@upmc.edu		Lee, Sean/0000-0001-6211-3498	National Institutes of Health [CA140554]; Department of Defense [W81XWH-09-1-0350]; University of Pittsburgh Cancer Institute; Hillman Foundation; NATIONAL CANCER INSTITUTE [R01CA140554] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK056003] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); University of Pittsburgh Cancer Institute; Hillman Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant CA140554 (to Y. J. L.). This work was also supported by Department of Defense Grant W81XWH-09-1-0350 and University of Pittsburgh Cancer Institute (to B.-C. L.).; Recipient of a research scholar grant from The Hillman Foundation. To whom correspondence should be addressed: University of Pittsburgh Cancer Institute, Hillman Cancer Center, 5117 Centre Ave., Pittsburgh, PA 15213. Tel.: 412-623-2285; Fax: 412-623-7828; E-mail: leeb4@upmc.edu.	Amaravadi RK, 2007, CLIN CANCER RES, V13, P7271, DOI 10.1158/1078-0432.CCR-07-1595; Atlas E, 2003, MOL CANCER RES, V1, P165; Blanchard F, 2002, MOL BIOL CELL, V13, P1536, DOI 10.1091/mbc.02-02-0010; Blanquicett Carmelo, 2008, Cancer Ther, V6, P25; Boone JJM, 2009, MOL CANCER THER, V8, P3015, DOI 10.1158/1535-7163.MCT-09-0219; Breuleux M, 2007, CELL MOL LIFE SCI, V64, P2358, DOI 10.1007/s00018-007-7120-0; Burstein HJ, 2003, BREAST CANCER RES TR, V79, P391, DOI 10.1023/A:1024038127156; Cardillo M, 1996, CANCER IMMUNOL IMMUN, V43, P19, DOI 10.1007/s002620050298; Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev; Daly JM, 1999, ONCOGENE, V18, P3440, DOI 10.1038/sj.onc.1202700; Fung C, 2008, MOL BIOL CELL, V19, P797, DOI 10.1091/mbc.E07-10-1092; Gawlitta D, 2004, CYTOTECHNOLOGY, V46, P139, DOI 10.1007/s10616-005-2551-7; Giandomenico AR, 1997, FREE RADICAL BIO MED, V23, P426, DOI 10.1016/S0891-5849(97)00113-5; Girnun GD, 2007, CANCER CELL, V11, P395, DOI 10.1016/j.ccr.2007.02.025; Guenther GG, 2008, P NATL ACAD SCI USA, V105, P17402, DOI 10.1073/pnas.0802781105; Han J, 2008, J BIOL CHEM, V283, P19665, DOI 10.1074/jbc.M710169200; Hutcheson IR, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1754; Izumi Y, 1997, J NEUROSCI, V17, P9448; Jin S, 2007, J CELL SCI, V120, P379, DOI 10.1242/jcs.03349; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Krane IM, 1996, ONCOGENE, V12, P1781; Kulke MH, 2002, CANCER J, V8, P395, DOI 10.1097/00130404-200209000-00010; Kulms D, 1999, P NATL ACAD SCI USA, V96, P7974, DOI 10.1073/pnas.96.14.7974; Le XF, 2002, APOPTOSIS, V7, P483, DOI 10.1023/A:1020682807922; Le XF, 2001, ONCOGENE, V20, P8258, DOI 10.1038/sj.onc.1205039; Le XF, 2000, CLIN CANCER RES, V6, P260; Lefebvre AM, 1998, NAT MED, V4, P1053, DOI 10.1038/2036; Leist M, 1999, EXP CELL RES, V249, P396, DOI 10.1006/excr.1999.4514; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Liu ZH, 2007, DEV CELL, V12, P484, DOI 10.1016/j.devcel.2007.03.016; Lucarelli E, 2002, INT J CANCER, V98, P344, DOI 10.1002/ijc.10203; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Lunardi C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000473; Lupu R, 1996, BREAST CANCER RES TR, V38, P57, DOI 10.1007/BF01803784; Mackay K, 1999, J BIOL CHEM, V274, P6272, DOI 10.1074/jbc.274.10.6272; Martin G, 2004, BIOL REPROD, V71, P28, DOI 10.1095/biolreprod.103.024281; Mehta RG, 2000, J NATL CANCER I, V92, P418, DOI 10.1093/jnci/92.5.418; Michalik L, 2004, NAT REV CANCER, V4, P61, DOI 10.1038/nrc1254; Mueller E, 1998, MOL CELL, V1, P465, DOI 10.1016/S1097-2765(00)80047-7; Nicol CJ, 2004, CARCINOGENESIS, V25, P1747, DOI 10.1093/carcin/bgh160; Power CP, 2004, J IMMUNOL, V173, P5229, DOI 10.4049/jimmunol.173.8.5229; Saez E, 1998, NAT MED, V4, P1058, DOI 10.1038/2042; Saez E, 2004, GENE DEV, V18, P528, DOI 10.1101/gad.1167804; SALAHUDEEN AK, 1991, J CLIN INVEST, V88, P1886, DOI 10.1172/JCI115511; Sarraf P, 1998, NAT MED, V4, P1046, DOI 10.1038/2030; Scherz-Shouval R, 2007, TRENDS CELL BIOL, V17, P422, DOI 10.1016/j.tcb.2007.07.009; Sirohi B, 2008, ANN ONCOL, V19, P1847, DOI 10.1093/annonc/mdn395; Sun HG, 2005, CANCER RES, V65, P4442, DOI 10.1158/0008-5472.CAN-04-4200; Uehara N, 2008, MOL CANCER RES, V6, P186, DOI 10.1158/1541-7786.MCR-07-0254; Vadlamudi R, 1999, CANCER RES, V59, P2843; Vakkila J, 2004, NAT REV IMMUNOL, V4, P641, DOI 10.1038/nri1415; Xu FJ, 1999, CLIN CANCER RES, V5, P3653; Yin F, 2001, BIOCHEM BIOPH RES CO, V286, P916, DOI 10.1006/bbrc.2001.5491; Yin F, 2004, ONCOGENE, V23, P4614, DOI 10.1038/sj.onc.1207598; Yoshizawa K, 2002, CANCER-AM CANCER SOC, V95, P2243, DOI 10.1002/cncr.10906	56	12	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					20087	20099		10.1074/jbc.M110.191718	http://dx.doi.org/10.1074/jbc.M110.191718			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21467033	Green Published, hybrid			2022-12-25	WOS:000291027700085
J	Aertgeerts, K; Skene, R; Yano, J; Sang, BC; Zou, H; Snell, G; Jennings, A; Iwamoto, K; Habuka, N; Hirokawa, A; Ishikawa, T; Tanaka, T; Miki, H; Ohta, Y; Sogabe, S				Aertgeerts, Kathleen; Skene, Robert; Yano, Jason; Sang, Bi-Ching; Zou, Hua; Snell, Gyorgy; Jennings, Andy; Iwamoto, Keiji; Habuka, Noriyuki; Hirokawa, Aki; Ishikawa, Tomoyasu; Tanaka, Toshimasa; Miki, Hiroshi; Ohta, Yoshikazu; Sogabe, Satoshi			Structural Analysis of the Mechanism of Inhibition and Allosteric Activation of the Kinase Domain of HER2 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; SOMATIC MUTATIONS; EGF RECEPTOR; BREAST; EXPRESSION; RESISTANCE; LAPATINIB; THERAPY; PROGRAM; ERBB-2	Aberrant signaling of ErbB family members human epidermal growth factor 2 (HER2) and epidermal growth factor receptor (EGFR) is implicated in many human cancers, and HER2 expression is predictive of human disease recurrence and prognosis. Small molecule kinase inhibitors of EGFR and of both HER2 and EGFR have received approval for the treatment of cancer. We present the first high resolution crystal structure of the kinase domain of HER2 in complex with a selective inhibitor to understand protein activation, inhibition, and function at the molecular level. HER2 kinase domain crystallizes as a dimer and suggests evidence for an allosteric mechanism of activation comparable with previously reported activation mechanisms for EGFR and HER4. A unique Gly-rich region in HER2 following the alpha-helix C is responsible for increased conformational flexibility within the active site and could explain the low intrinsic catalytic activity previously reported for HER2. In addition, we solved the crystal structure of the kinase domain of EGFR in complex with a HER2/EGFR dual inhibitor (TAK-285). Comparison with previously reported inactive and active EGFR kinase domain structures gave insight into the mechanism of HER2 and EGFR inhibition and may help guide the design and development of new cancer drugs with improved potency and selectivity.	[Aertgeerts, Kathleen; Skene, Robert; Yano, Jason; Sang, Bi-Ching; Zou, Hua; Snell, Gyorgy; Jennings, Andy] Takeda San Diego Inc, San Diego, CA 92121 USA; [Ishikawa, Tomoyasu; Ohta, Yoshikazu] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Tsukuba, Ibaraki 3004293, Japan; [Iwamoto, Keiji; Habuka, Noriyuki; Hirokawa, Aki; Tanaka, Toshimasa; Miki, Hiroshi; Sogabe, Satoshi] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Yodogawa Ku, Osaka 5328686, Japan	Takeda Pharmaceutical Company Ltd; Takeda Pharmaceuticals USA Inc. (TPUSA); Takeda California Inc; Takeda Pharmaceutical Company Ltd; Takeda Pharmaceutical Company Ltd	Aertgeerts, K (corresponding author), Takeda San Diego Inc, 10410 Sci Ctr Dr, San Diego, CA 92130 USA.	kaertgeerts@takedasd.com		Yano, Jason/0000-0002-9774-2611; Skene, Robert/0000-0002-1482-6546	Office of Science, Office of Basic Energy Sciences, Materials Sciences Division of the United States Department of Energy at Lawrence Berkeley National Laboratory [AC03-76SF00098]; TAK-285 project team of Millennium Pharmaceuticals	Office of Science, Office of Basic Energy Sciences, Materials Sciences Division of the United States Department of Energy at Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); TAK-285 project team of Millennium Pharmaceuticals	The authors thank Keith Wilson, Paul Steed, and David Weitz for critical review of this manuscript. We also thank Advanced Light Source, which is supported by the Director, Office of Science, Office of Basic Energy Sciences, Materials Sciences Division of the United States Department of Energy under Contract DE-AC03-76SF00098 at Lawrence Berkeley National Laboratory. The authors thank the office staff of Pharmaceutical Consortium for Protein Structure Analysis and the technical staff of the BL41XU at SPring-8 for facilitating synchrotron data collection. The authors also thank the TAK-285 project team of Millennium Pharmaceuticals and the senior management member of Pharmaceutical Research Division for consultation and research support.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Brignola PS, 2002, J BIOL CHEM, V277, P1576, DOI 10.1074/jbc.M105907200; Cappuzzo F, 2005, J CLIN ONCOL, V23, P5007, DOI 10.1200/JCO.2005.09.111; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; Case D.A., 2022, AMBER 2020; Citri A, 2003, EXP CELL RES, V284, P54, DOI 10.1016/S0014-4827(02)00101-5; Cohen BD, 1996, J BIOL CHEM, V271, P30897, DOI 10.1074/jbc.271.48.30897; Emlet DR, 2006, BRIT J CANCER, V94, P1144, DOI 10.1038/sj.bjc.6603078; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fan YX, 2008, J BIOL CHEM, V283, P1588, DOI 10.1074/jbc.M708116200; Higa GM, 2007, EXPERT REV ANTICANC, V7, P1183, DOI 10.1586/14737140.7.9.1183; ISHIKAWA T, 2007, Patent No. 2007064045; ISHIKAWA T, 2005, Patent No. 2005118588; Jura N, 2009, P NATL ACAD SCI USA, V106, P21608, DOI 10.1073/pnas.0912101106; Lee JW, 2006, CLIN CANCER RES, V12, P57, DOI 10.1158/1078-0432.CCR-05-0976; Lenferink AEG, 1998, EMBO J, V17, P3385, DOI 10.1093/emboj/17.12.3385; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Monsey J, 2010, J BIOL CHEM, V285, P7035, DOI 10.1074/jbc.M109.096032; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; QIAN XL, 1994, P NATL ACAD SCI USA, V91, P1500, DOI 10.1073/pnas.91.4.1500; Qiu C, 2008, STRUCTURE, V16, P460, DOI 10.1016/j.str.2007.12.016; Schlessinger J, 2004, SCIENCE, V306, P1506, DOI 10.1126/science.1105396; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; SCHULTZ RM, 2005, ADV TARGETED CANC TH; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Shi FM, 2010, P NATL ACAD SCI USA, V107, P7692, DOI 10.1073/pnas.1002753107; Shigematsu H, 2005, CANCER RES, V65, P1642, DOI 10.1158/0008-5472.CAN-04-4235; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Stamos J, 2002, J BIOL CHEM, V277, P46265, DOI 10.1074/jbc.M207135200; Stephens P, 2004, NATURE, V431, P525, DOI 10.1038/431525b; Trowe T, 2008, CLIN CANCER RES, V14, P2465, DOI 10.1158/1078-0432.CCR-07-4367; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; WADA T, 1990, ONCOGENE, V5, P489; Wang SZE, 2006, CANCER CELL, V10, P25, DOI 10.1016/j.ccr.2006.05.023; Worthylake R, 1999, J BIOL CHEM, V274, P8865, DOI 10.1074/jbc.274.13.8865; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Ye DW, 1999, ONCOGENE, V18, P731, DOI 10.1038/sj.onc.1202319; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhang XW, 2007, NATURE, V450, P741, DOI 10.1038/nature05998	43	217	229	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18756	18765		10.1074/jbc.M110.206193	http://dx.doi.org/10.1074/jbc.M110.206193			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21454582	Green Published, hybrid			2022-12-25	WOS:000290785700048
J	Cardano, M; Diaferia, GR; Cattaneo, M; Dessl, SS; Long, QM; Conti, L; DeBlasio, P; Cattaneo, E; Biunno, I				Cardano, Marina; Diaferia, Giuseppe R.; Cattaneo, Monica; Dessl, Sara S.; Long, Qiaoming; Conti, Luciano; DeBlasio, Pasquale; Cattaneo, Elena; Biunno, Ida			mSEL-1L (Suppressor/Enhancer Lin12-like) Protein Levels Influence Murine Neural Stem Cell Self-renewal and Lineage Commitment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; CENTRAL-NERVOUS-SYSTEM; IN-VITRO; CAENORHABDITIS-ELEGANS; NS CELLS; DIFFERENTIATION; GENE; DEGRADATION; PROTEASOME; PATHWAY	Murine SEL-1L (mSEL-1L) is a key component of the endoplasmic reticulum-associated degradation pathway. It is essential during development as revealed by the multi-organ dysfunction and in uterus lethality occurring in homozygous mSEL-1L-deficient mice. Here we show that mSEL-1L is highly expressed in pluripotent embryonic stem cells and multipotent neural stem cells (NSCs) but silenced in all mature neural derivatives (i.e. astrocytes, oligodendrocytes, and neurons) by mmu-miR-183. NSCs derived from homozygous mSEL-1L-deficient embryos (mSEL-1L(-/-) NSCs) fail to proliferate in vitro, show a drastic reduction of the Notch effector HES-5, and reveal a significant down-modulation of the early neural progenitor markers PAX-6 and OLIG-2, when compared with the wild type (mSEL-1L(+/+) NSCs) counterpart. Furthermore, these cells are almost completely deprived of the neural marker Nestin, display a significant decrease of SOX-2 expression, and rapidly undergo premature astrocytic commitment and apoptosis. The data suggest severe self-renewal defects occurring in these cells probably mediated by misregulation of the Notch signaling. The results reported here denote mSEL-1L as a primitive marker with a possible involvement in the regulation of neural progenitor stemness maintenance and lineage determination.	[Cattaneo, Monica; Biunno, Ida] Inst Genet & Biomed Res, I-20138 Milan, Italy; [Cardano, Marina] Univ Milan, Doctorate Sch Mol Med, I-20100 Milan, Italy; [Cardano, Marina; Diaferia, Giuseppe R.; Dessl, Sara S.; DeBlasio, Pasquale; Biunno, Ida] Integrated Syst Engn, I-20138 Milan, Italy; [Long, Qiaoming] Cornell Univ, Dept Anim Sci, Ithaca, NY 14853 USA; [Conti, Luciano; Cattaneo, Elena] Univ Milan, Dept Pharmacol Sci, I-20133 Milan, Italy; [DeBlasio, Pasquale] Biorep Srl, I-20138 Milan, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); University of Milan; Cornell University; University of Milan	Biunno, I (corresponding author), Inst Genet & Biomed Res, I-20138 Milan, Italy.	ida.biunno@itb.cnr.it	Diaferia, Giuseppe/AAN-5910-2020; Long, Qiaoming/L-5074-2017; Conti, Luciano/H-4184-2012	Diaferia, Giuseppe/0000-0003-4022-8483; Long, Qiaoming/0000-0001-8243-589X; Conti, Luciano/0000-0002-2050-9846; , IDA_2/0000-0002-1068-4763; CATTANEO, ELENA/0000-0002-0755-4917; /0000-0002-1866-5866	Italian Government [MIUR-FIRB nRBIP064CRT]; Regione Lombardia "Metadistretto"; EU	Italian Government; Regione Lombardia "Metadistretto"; EU(European Commission)	This work was supported by Grant MIUR-FIRB nRBIP064CRT from the Italian Government (to I. B. and P. D. B.), funds from Regione Lombardia "Metadistretto" (to I. B. and P. D. B.), and in part by the EU-FP6 Neuroscreen Project.	Alvarez-Manilla G, 2010, J PROTEOME RES, V9, P2062, DOI 10.1021/pr8007489; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Bernasconi R, 2010, J CELL BIOL, V188, P223, DOI 10.1083/jcb.200910042; Bianchi L, 2005, PROTEOMICS, V5, P2433, DOI 10.1002/pmic.200401283; Biunno I, 2006, J CELL PHYSIOL, V208, P23, DOI 10.1002/jcp.20574; Bonvini P, 1998, ONCOGENE, V16, P1131, DOI 10.1038/sj.onc.1201625; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Bruggeman SWM, 2009, BBA-GEN SUBJECTS, V1790, P351, DOI 10.1016/j.bbagen.2009.03.009; Buszczak M, 2009, SCIENCE, V323, P248, DOI 10.1126/science.1165678; Campos LS, 2005, BIOESSAYS, V27, P698, DOI 10.1002/bies.20256; Cattaneo M, 2005, NEOPLASIA, V7, P1030, DOI 10.1593/neo.05451; Cattaneo M, 2008, J CELL PHYSIOL, V215, P794, DOI 10.1002/jcp.21364; Cattaneo M, 2009, J BIOL CHEM, V284, P11405, DOI 10.1074/jbc.M805408200; Chen DH, 2005, CURR BIOL, V15, P179, DOI 10.1016/j.cub.2005.01.004; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Choi MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011885; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Conti L, 2010, NAT REV NEUROSCI, V11, P176, DOI 10.1038/nrn2761; Dieguez-Acuna F, 2010, INT J BIOCHEM CELL B, V42, P1651, DOI 10.1016/j.biocel.2009.12.001; Donoviel DB, 1998, MECH DEVELOP, V78, P203, DOI 10.1016/S0925-4773(98)00146-4; Francisco AB, 2010, J BIOL CHEM, V285, P13694, DOI 10.1074/jbc.M109.085340; Glaser T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000298; Grant B, 1996, GENETICS, V143, P237; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; Johnson R, 2008, PLOS BIOL, V6, P2205, DOI 10.1371/journal.pbio.0060256; Kaneko M, 2010, J NEUROSCI, V30, P3924, DOI 10.1523/JNEUROSCI.2422-09.2010; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Kehler J, 2004, EMBO REP, V5, P1078, DOI 10.1038/sj.embor.7400279; Kim CG, 2006, MOL CELLS, V21, P343; Kostova Z, 2003, EMBO J, V22, P2309, DOI 10.1093/emboj/cdg227; Kuo CT, 2006, CELL, V127, P1253, DOI 10.1016/j.cell.2006.10.041; Li GR, 2010, J BIOL CHEM, V285, P5461, DOI 10.1074/jbc.M109.037127; Li SA, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-19; LIU Q, 2010, CANC PREV RES, V3, pB52; Losick R, 2008, SCIENCE, V320, P65, DOI 10.1126/science.1147888; Matsuoka S, 2008, GENE DEV, V22, P986, DOI 10.1101/gad.1621808; McGill MA, 2003, J BIOL CHEM, V278, P23196, DOI 10.1074/jbc.M302827200; Mellodew K, 2004, DEV BRAIN RES, V151, P13, DOI 10.1016/j.devbrainres.2004.03.018; Nagao M, 2008, J CELL BIOL, V183, P1243, DOI 10.1083/jcb.200807130; Namihira M, 2008, PHILOS T R SOC B, V363, P2099, DOI 10.1098/rstb.2008.2262; Naujokat C, 2009, ARCH IMMUNOL THER EX, V57, P177, DOI 10.1007/s00005-009-0019-8; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Orlandi R, 2002, CANCER RES, V62, P567; Orlandi R, 2002, INT J BIOL MARKER, V17, P104, DOI 10.1177/172460080201700205; Satoh M, 2000, NEUROSCI LETT, V284, P143, DOI 10.1016/S0304-3940(00)00981-2; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Schwamborn JC, 2009, CELL, V136, P913, DOI 10.1016/j.cell.2008.12.024; Shi YH, 2008, CRIT REV ONCOL HEMAT, V65, P43, DOI 10.1016/j.critrevonc.2007.06.004; Shi YH, 2010, J NEUROSCI, V30, P14931, DOI 10.1523/JNEUROSCI.4280-10.2010; Spiliotopoulos D, 2009, NEUROBIOL DIS, V34, P320, DOI 10.1016/j.nbd.2009.02.007; Stipursky J, 2007, GLIA, V55, P1023, DOI 10.1002/glia.20522; SUNDARAM M, 1993, GENETICS, V135, P765; Suzuki S, 2010, J HISTOCHEM CYTOCHEM, V58, P721, DOI 10.1369/jhc.2010.955609; Szutorisz H, 2006, CELL, V127, P1375, DOI 10.1016/j.cell.2006.10.045; Verret L, 2007, PSYCHONEUROENDOCRINO, V32, pS26, DOI 10.1016/j.psyneuen.2007.04.014; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Wen S, 2009, PROG NEUROBIOL, V87, P98, DOI 10.1016/j.pneurobio.2008.10.002; Westbrook TF, 2008, NATURE, V452, P370, DOI 10.1038/nature06780; Whetton AD, 2008, CELL STEM CELL, V2, P215, DOI 10.1016/j.stem.2008.02.003; Yamasaki L, 2004, CURR OPIN CELL BIOL, V16, P623, DOI 10.1016/j.ceb.2004.08.005; Ying QL, 2003, METHOD ENZYMOL, V365, P327; Zhang XC, 2007, INT J DEV NEUROSCI, V25, P455, DOI 10.1016/j.ijdevneu.2007.08.007; Zhao XD, 2008, NAT CELL BIOL, V10, P643, DOI 10.1038/ncb1727	65	19	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18708	18719		10.1074/jbc.M110.210740	http://dx.doi.org/10.1074/jbc.M110.210740			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21454627	hybrid, Green Published			2022-12-25	WOS:000290785700044
J	Pesiridis, GS; Tripathy, K; Tanik, S; Trojanowski, JQ; Lee, VMY				Pesiridis, G. Scott; Tripathy, Kalyan; Tanik, Selcuk; Trojanowski, John Q.; Lee, Virginia M. -Y.			A "Two-hit" Hypothesis for Inclusion Formation by Carboxyl-terminal Fragments of TDP-43 Protein Linked to RNA Depletion and Impaired Microtubule-dependent Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; DNA-BINDING PROTEIN-43; PRE-MESSENGER-RNA; GENE-EXPRESSION; HNRNP PROTEINS; NUCLEAR; MUTATIONS; COMPLEX; DISEASE	Carboxyl-terminal fragments (CTFs) of TDP-43 aggregate to form the diagnostic signature inclusions of frontotemporal lobar degeneration and amyotrophic lateral sclerosis, but the biological significance of these CTFs and how they are generated remain enigmatic. To address these issues, we engineered mammalian cells with an inducible tobacco etch virus (TEV) protease that cleaves TDP-43 containing a TEV cleavage site. Regions of TDP-43 flanking the second RNA recognition motif (RRM2) are efficiently cleaved by TEV, whereas sites within this domain are more resistant to cleavage. CTFs containing RRM2 generated from de novo cleavage of nuclear TDP-43 are transported to the cytoplasm and efficiently cleared, indicating that cleavage alone is not sufficient to initiate CTF aggregation. However, CTFs rapidly aggregated into stable cytoplasmic inclusions following de novo cleavage when dynein-mediated microtubule transport was disrupted, RNA was depleted, or natively misfolded CTFs were introduced into these cells. Our data support a "two-hit" mechanism of CTF aggregation dependent on TDP-43 cleavage.	[Pesiridis, G. Scott; Tripathy, Kalyan; Tanik, Selcuk; Trojanowski, John Q.; Lee, Virginia M. -Y.] Univ Penn, Sch Med, Ctr Neurodegenerat Dis Res, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Trojanowski, John Q.; Lee, Virginia M. -Y.] Univ Penn, Sch Med, Inst Aging, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Lee, VMY (corresponding author), Univ Penn, Sch Med, Ctr Neurodegenerat Dis Res, Dept Pathol & Lab Med, 3600 Spruce St,3rd Floor,Maloney Bldg, Philadelphia, PA 19104 USA.	vmylee@upenn.edu			National Institutes of Health [AG17586]; Koller Foundation for ALS Research; NATIONAL INSTITUTE ON AGING [P01AG017586] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Koller Foundation for ALS Research; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG17586. This work was also supported by the Koller Foundation for ALS Research as well as a gift from the Podolin family.	Abhyankar MM, 2007, J BIOL CHEM, V282, P36143, DOI 10.1074/jbc.M705811200; Ayala YM, 2008, J CELL SCI, V121, P3778, DOI 10.1242/jcs.038950; BONNER WM, 1975, J CELL BIOL, V64, P421, DOI 10.1083/jcb.64.2.421; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; BURD CG, 1991, MOL CELL BIOL, V11, P3419, DOI 10.1128/MCB.11.7.3419; Chen AKH, 2010, J AM CHEM SOC, V132, P1186, DOI 10.1021/ja9066207; CORTHESYTHEULAZ I, 1992, J CELL BIOL, V118, P1333, DOI 10.1083/jcb.118.6.1333; D'Ambrogio A, 2009, NUCLEIC ACIDS RES, V37, P4116, DOI 10.1093/nar/gkp342; De Strooper B, 2010, ANNU REV CELL DEV BI, V26, P235, DOI 10.1146/annurev-cellbio-100109-104117; Dormann D, 2009, J NEUROCHEM, V110, P1082, DOI 10.1111/j.1471-4159.2009.06211.x; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Hasegawa M, 2008, ANN NEUROL, V64, P60, DOI 10.1002/ana.21425; Igaz LM, 2008, AM J PATHOL, V173, P182, DOI 10.2353/ajpath.2008.080003; Igaz LM, 2009, J BIOL CHEM, V284, P8516, DOI 10.1074/jbc.M809462200; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; Jansens Annemieke, 2003, Methods Mol Biol, V232, P133; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; Kim SH, 2010, J BIOL CHEM, V285, P34097, DOI 10.1074/jbc.M110.154831; Kredel S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004391; Kuo PH, 2009, NUCLEIC ACIDS RES, V37, P1799, DOI 10.1093/nar/gkp013; Lagier-Tourenne C, 2009, CELL, V136, P1001, DOI 10.1016/j.cell.2009.03.006; Li Y, 2010, P NATL ACAD SCI USA, V107, P3169, DOI 10.1073/pnas.0913602107; Ling SC, 2010, P NATL ACAD SCI USA, V107, P13318, DOI 10.1073/pnas.1008227107; Lu YB, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-30; Mili S, 2001, MOL CELL BIOL, V21, P7307, DOI 10.1128/MCB.21.21.7307-7319.2001; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2009, ACTA NEUROPATHOL, V117, P137, DOI 10.1007/s00401-008-0477-9; Nishimura AL, 2010, BRAIN, V133, P1763, DOI 10.1093/brain/awq111; Nonaka T, 2009, HUM MOL GENET, V18, P3353, DOI 10.1093/hmg/ddp275; Pauli A, 2008, DEV CELL, V14, P239, DOI 10.1016/j.devcel.2007.12.009; Pesiridis GS, 2009, HUM MOL GENET, V18, pR156, DOI 10.1093/hmg/ddp303; PinolRoma S, 1997, SEMIN CELL DEV BIOL, V8, P57, DOI 10.1006/scdb.1996.0122; PINOLROMA S, 1992, NATURE, V355, P730, DOI 10.1038/355730a0; Prasanth KV, 2005, CELL, V123, P249, DOI 10.1016/j.cell.2005.08.033; Prasanth KV, 2003, MOL BIOL CELL, V14, P1043, DOI 10.1091/mbc.E02-10-0669; Sephton CF, 2011, J BIOL CHEM, V286, P1204, DOI 10.1074/jbc.M110.190884; WILLIAMS KR, 1985, P NATL ACAD SCI USA, V82, P5666, DOI 10.1073/pnas.82.17.5666; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; Zhang B, 1997, J CELL BIOL, V139, P1307, DOI 10.1083/jcb.139.5.1307; Zhang YJ, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-33; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106; Zhapparova ON, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1233, DOI 10.1134/S0006297907110090	43	86	87	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18845	18855		10.1074/jbc.M111.231118	http://dx.doi.org/10.1074/jbc.M111.231118			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21454607	Green Published, hybrid			2022-12-25	WOS:000290785700057
J	Lamp, J; Keyser, B; Koeller, DM; Ullrich, K; Braulke, T; Muhlhausen, C				Lamp, Jessica; Keyser, Britta; Koeller, David M.; Ullrich, Kurt; Braulke, Thomas; Muehlhausen, Chris			Glutaric Aciduria Type 1 Metabolites Impair the Succinate Transport from Astrocytic to Neuronal Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORGANIC ANION TRANSPORTERS; COA DEHYDROGENASE-DEFICIENCY; ACIDEMIA TYPE-I; 3-HYDROXYGLUTARIC ACID; MOUSE MODEL; FUNCTIONAL-CHARACTERIZATION; EXPRESSION; FAMILY; BRAIN; NEURODEGENERATION	The inherited neurodegenerative disorder glutaric aciduria type 1 (GA1) results from mutations in the gene for the mitochondrial matrix enzyme glutaryl-CoA dehydrogenase (GCDH), which leads to elevations of the dicarboxylates glutaric acid (GA) and 3-hydroxyglutaric acid (3OHGA) in brain and blood. The characteristic clinical presentation of GA1 is a sudden onset of dystonia during catabolic situations, resulting from acute striatal injury. The underlying mechanisms are poorly understood, but the high levels of GA and 3OHGA that accumulate during catabolic illnesses are believed to play a primary role. Both GA and 3OHGA are known to be substrates for Na+-coupled dicarboxylate transporters, which are required for the anaplerotic transfer of the tricarboxylic acid cycle (TCA) intermediate succinate between astrocytes and neurons. We hypothesized that GA and 3OHGA inhibit the transfer of succinate from astrocytes to neurons, leading to reduced TCA cycle activity and cellular injury. Here, we show that both GA and 3OHGA inhibit the uptake of [C-14] succinate by Na+-coupled dicarboxylate transporters in cultured astrocytic and neuronal cells of wild-type and Gcdh(-/-) mice. In addition, we demonstrate that the efflux of [C-14] succinate from Gcdh(-/-) astrocytic cells mediated by a not yet identified transporter is strongly reduced. This is the first experimental evidence that GA and 3OHGA interfere with two essential anaplerotic transport processes: astrocytic efflux and neuronal uptake of TCA cycle intermediates, which occur between neurons and astrocytes. These results suggest that elevated levels of GA and 3OHGA may lead to neuronal injury and cell death via disruption of TCA cycle activity.	[Lamp, Jessica; Keyser, Britta; Ullrich, Kurt; Braulke, Thomas; Muehlhausen, Chris] Univ Med Ctr Hamburg Eppendorf, Childrens Hosp, Dept Biochem, D-20246 Hamburg, Germany; [Koeller, David M.] Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97239 USA	University of Hamburg; University Medical Center Hamburg-Eppendorf; Oregon Health & Science University	Muhlhausen, C (corresponding author), Univ Med Ctr Hamburg Eppendorf, Childrens Hosp, Dept Biochem, Martinistr 52, D-20246 Hamburg, Germany.	muehlhau@uke.uni-hamburg.de	Braulke, Thomas/AAV-9121-2020	Braulke, Thomas/0000-0002-2336-8532; Muhlhausen, Chris/0000-0003-0516-1826	Deutsche Forschungsgemeinschaft [MU1778/2-1, 2-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants MU1778/2-1 and 2-2(to C.M.,B.K., and J.L.).	Alebouyeh M, 2003, J PHARMACOL SCI, V93, P430, DOI 10.1254/jphs.93.430; Anzai N, 2006, J PHARMACOL SCI, V100, P411, DOI 10.1254/jphs.CRJ06006X; Bahn A, 2005, AM J PHYSIOL-CELL PH, V289, pC1075, DOI 10.1152/ajpcell.00619.2004; Das AM, 2003, MOL GENET METAB, V78, P108, DOI 10.1016/S1096-7192(02)00227-5; Freudenberg F, 2004, NEUROBIOL DIS, V16, P581, DOI 10.1016/j.nbd.2004.05.001; Goodman S, 2001, METABOLIC MOL BASES, P2195; Hagos Y, 2008, PFLUG ARCH EUR J PHY, V457, P223, DOI 10.1007/s00424-008-0489-2; Hertz L, 2007, J CEREBR BLOOD F MET, V27, P219, DOI 10.1038/sj.jcbfm.9600343; Inoue K, 2004, BIOCHEM J, V378, P949, DOI 10.1042/BJ20031261; Inoue K, 2002, J BIOL CHEM, V277, P39469, DOI 10.1074/jbc.M207072200; Jitrapakdee S, 2008, BIOCHEM J, V413, P369, DOI 10.1042/BJ20080709; Keyser B, 2008, BBA-MOL BASIS DIS, V1782, P385, DOI 10.1016/j.bbadis.2008.02.008; Keyser B, 2008, HUM MOL GENET, V17, P3854, DOI 10.1093/hmg/ddn284; Koeller DM, 2002, HUM MOL GENET, V11, P347, DOI 10.1093/hmg/11.4.347; Kolker S, 2004, ANN NEUROL, V55, P7, DOI 10.1002/ana.10784; Kulkens S, 2005, NEUROLOGY, V64, P2142, DOI 10.1212/01.WNL.0000167428.12417.B2; LopezNieto CE, 1997, J BIOL CHEM, V272, P6471, DOI 10.1074/jbc.272.10.6471; Lund TM, 2004, J NEUROSCI RES, V77, P143, DOI 10.1002/jnr.20136; Matzner U, 2000, GENE THER, V7, P805, DOI 10.1038/sj.gt.3301150; Muhlhausen C, 2008, J INHERIT METAB DIS, V31, P188, DOI 10.1007/s10545-008-0825-x; Muhlhausen C, 2006, PEDIATR RES, V59, P196, DOI 10.1203/01.pdr.0000197313.44265.cb; Pajor AM, 2001, AM J PHYSIOL-CELL PH, V280, pC1215, DOI 10.1152/ajpcell.2001.280.5.C1215; Pavlova A, 2000, AM J PHYSIOL-RENAL, V278, pF635, DOI 10.1152/ajprenal.2000.278.4.F635; Peirson SN, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng073; Quitsch A, 2005, J NEUROSCI, V25, P479, DOI 10.1523/JNEUROSCI.2699-04.2005; Rizwan AN, 2007, PHARM RES-DORDR, V24, P450, DOI 10.1007/s11095-006-9181-4; Sauer SW, 2005, J BIOL CHEM, V280, P21830, DOI 10.1074/jbc.M502845200; Schousboe A, 1997, GLIA, V21, P99; Stellmer F, 2007, J MOL MED-JMM, V85, P763, DOI 10.1007/s00109-007-0174-5; STOKKE O, 1976, CLIN CHIM ACTA, V66, P411, DOI 10.1016/0009-8981(76)90241-2; Strauss KA, 2003, AM J MED GENET C, V121C, P38, DOI 10.1002/ajmg.c.20007; Ullrich K, 1999, J INHERIT METAB DIS, V22, P392, DOI 10.1023/A:1005595921323; Uwai Y, 1998, FEBS LETT, V438, P321, DOI 10.1016/S0014-5793(98)01328-3; Yodoya E, 2006, J NEUROCHEM, V97, P162, DOI 10.1111/j.1471-4159.2006.03720.x; Zhou FF, 2007, PHARM RES-DORDR, V24, P28, DOI 10.1007/s11095-006-9144-9; Zinnanti WJ, 2007, J CLIN INVEST, V117, P3258, DOI 10.1172/JCI31617; Zinnanti WJ, 2006, BRAIN, V129, P899, DOI 10.1093/brain/awl009	37	63	66	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17777	17784		10.1074/jbc.M111.232744	http://dx.doi.org/10.1074/jbc.M111.232744			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454630	Green Published, hybrid			2022-12-25	WOS:000290585200041
J	Brodbeck, J; McGuire, J; Liu, ZP; Meyer-Franke, A; Balestra, ME; Jeong, DE; Pleiss, M; McComas, C; Hess, F; Witter, D; Peterson, S; Childers, M; Goulet, M; Liverton, N; Hargreaves, R; Freedman, S; Weisgraber, KH; Mahley, RW; Huang, YD				Brodbeck, Jens; McGuire, Jim; Liu, Zhaoping; Meyer-Franke, Anke; Balestra, Maureen E.; Jeong, Dah-eun; Pleiss, Mike; McComas, Casey; Hess, Fred; Witter, David; Peterson, Scott; Childers, Matthew; Goulet, Mark; Liverton, Nigel; Hargreaves, Richard; Freedman, Stephen; Weisgraber, Karl H.; Mahley, Robert W.; Huang, Yadong			Structure-dependent Impairment of Intracellular Apolipoprotein E4 Trafficking and Its Detrimental Effects Are Rescued by Small-molecule Structure Correctors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GREEN FLUORESCENT PROTEIN; CENTRAL NERVOUS-SYSTEM; ALZHEIMERS-DISEASE; ENDOPLASMIC-RETICULUM; TRANSGENIC MICE; QUALITY-CONTROL; DOMAIN INTERACTION; NEURITE OUTGROWTH; NEURONAL CELLS; CONTAINING LIPOPROTEINS	Apolipoprotein (apo) E4 is the major genetic risk factor for Alzheimer disease (AD) and likely contributes to neuropathology through various pathways. Here we report that the intracellular trafficking of apoE4 is impaired in Neuro-2a cells and primary neurons, as shown by measuring fluorescence recovery after photobleaching. In Neuro-2a cells, more apoE4 than apoE3 molecules remained immobilized in the endoplasmic reticulum (ER) and the Golgi apparatus, and the lateral motility of apoE4 was significantly lower in the Golgi apparatus (but not in the ER) than that of apoE3. Likewise, the immobile fraction was larger, and the lateral motility was lower for apoE4 than apoE3 in mouse primary hippocampal neurons. ApoE4 with the R61T mutation, which abolishes apoE4 domain interaction, was less immobilized, and its lateral motility was comparable with that of apoE3. The trafficking impairment of apoE4 was also rescued by disrupting domain interaction with the small-molecule structure correctors GIND25 and PH002. PH002 also rescued apoE4-induced impairments of neurite outgrowth in Neuro-2a cells and dendritic spine development in primary neurons. ApoE4 did not affect trafficking of amyloid precursor protein, another AD-related protein, through the secretory pathway. Thus, domain interaction renders more newly synthesized apoE4 molecules immobile and slows their trafficking along the secretory pathway. Correcting the pathological structure of apoE4 by disrupting domain interaction is a potential therapeutic approach to treat or prevent AD related to apoE4.	[Brodbeck, Jens; McGuire, Jim; Liu, Zhaoping; Balestra, Maureen E.; Jeong, Dah-eun; Weisgraber, Karl H.; Mahley, Robert W.; Huang, Yadong] Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Brodbeck, Jens; McGuire, Jim; Liu, Zhaoping; Meyer-Franke, Anke; Balestra, Maureen E.; Jeong, Dah-eun; Pleiss, Mike; Freedman, Stephen; Weisgraber, Karl H.; Mahley, Robert W.; Huang, Yadong] Univ Calif San Francisco, Gladstone Ctr Translat Res, San Francisco, CA 94158 USA; [Weisgraber, Karl H.; Mahley, Robert W.; Huang, Yadong] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Mahley, Robert W.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94158 USA; [Weisgraber, Karl H.; Mahley, Robert W.; Huang, Yadong] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94158 USA; [Huang, Yadong] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Weisgraber, Karl H.; Mahley, Robert W.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [McComas, Casey; Hess, Fred; Liverton, Nigel; Hargreaves, Richard] Merck Res Labs, West Point, PA 19486 USA; [Witter, David; Peterson, Scott; Childers, Matthew; Goulet, Mark] Merck Res Labs, Boston, MA 02115 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Merck & Company; Merck & Company	Huang, YD (corresponding author), 1650 Owens St, San Francisco, CA 94158 USA.	yhuang@gladstone.ucsf.edu	liu, zhao/GXV-6141-2022; Brodbeck, Jens/AAB-9275-2020		Merck Research Laboratories; National Institutes of Health [P01 AG022074]; NATIONAL INSTITUTE ON AGING [P01AG022074] Funding Source: NIH RePORTER	Merck Research Laboratories(Merck & Company); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Merck Research Laboratories. This work was also supported, in part, by National Institutes of Health Grant P01 AG022074.	Adams CL, 1998, J CELL BIOL, V142, P1105, DOI 10.1083/jcb.142.4.1105; Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; BELLOSTA S, 1995, J BIOL CHEM, V270, P27063, DOI 10.1074/jbc.270.45.27063; Boschert U, 1999, NEUROBIOL DIS, V6, P508, DOI 10.1006/nbdi.1999.0251; BOYLES JK, 1985, J CLIN INVEST, V76, P1501, DOI 10.1172/JCI112130; Brecht WJ, 2004, J NEUROSCI, V24, P2527, DOI 10.1523/JNEUROSCI.4315-03.2004; Brodbeck J, 2008, P NATL ACAD SCI USA, V105, P1343, DOI 10.1073/pnas.0709906104; Buttini M, 2010, AM J PATHOL, V177, P563, DOI 10.2353/ajpath.2010.090973; Chang SJ, 2005, P NATL ACAD SCI USA, V102, P18694, DOI 10.1073/pnas.0508254102; Cole NB, 1996, SCIENCE, V273, P797, DOI 10.1126/science.273.5276.797; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Dayel MJ, 1999, BIOPHYS J, V76, P2843, DOI 10.1016/S0006-3495(99)77438-2; DeMattos RB, 2001, NEUROCHEM INT, V39, P415, DOI 10.1016/S0197-0186(01)00049-3; DILIBERTO EJ, 1976, J NEUROCHEM, V26, P1159, DOI 10.1111/j.1471-4159.1976.tb07001.x; DONG LM, 1994, J BIOL CHEM, V269, P22358; Dong LM, 1996, J BIOL CHEM, V271, P19053, DOI 10.1074/jbc.271.32.19053; Dumanis SB, 2009, J NEUROSCI, V29, P15317, DOI 10.1523/JNEUROSCI.4026-09.2009; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; ELSHOURBAGY NA, 1985, P NATL ACAD SCI USA, V82, P203, DOI 10.1073/pnas.82.1.203; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; Harris FM, 2004, J BIOL CHEM, V279, P3862, DOI 10.1074/jbc.M309475200; Harris FM, 2003, P NATL ACAD SCI USA, V100, P10966, DOI 10.1073/pnas.1434398100; Hatters DM, 2005, J BIOL CHEM, V280, P26477, DOI 10.1074/jbc.M503910200; HOLTZMAN DM, 1995, P NATL ACAD SCI USA, V92, P9480, DOI 10.1073/pnas.92.21.9480; Huang Y, 2006, CURR OPIN DRUG DISC, V9, P627; Huang YD, 2010, TRENDS MOL MED, V16, P287, DOI 10.1016/j.molmed.2010.04.004; Huang YD, 2001, P NATL ACAD SCI USA, V98, P8838, DOI 10.1073/pnas.151254698; Ji Y, 2003, NEUROSCIENCE, V122, P305, DOI 10.1016/j.neuroscience.2003.08.007; Kalid O, 2010, J COMPUT AID MOL DES, V24, P971, DOI 10.1007/s10822-010-9390-0; Li G, 2009, CELL STEM CELL, V5, P634, DOI 10.1016/j.stem.2009.10.015; LINTON MF, 1991, J CLIN INVEST, V88, P270, DOI 10.1172/JCI115288; Mahley RW, 2006, P NATL ACAD SCI USA, V103, P5644, DOI 10.1073/pnas.0600549103; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MessmerJoudrier S, 1996, EUR J NEUROSCI, V8, P2652, DOI 10.1111/j.1460-9568.1996.tb01560.x; Morrow JA, 2002, J BIOL CHEM, V277, P50380, DOI 10.1074/jbc.M204898200; NATHAN BP, 1995, J BIOL CHEM, V270, P19791, DOI 10.1074/jbc.270.34.19791; NATHAN BP, 1994, SCIENCE, V264, P850, DOI 10.1126/science.8171342; Nehls S, 2000, NAT CELL BIOL, V2, P288, DOI 10.1038/35010558; PITAS RE, 1987, BIOCHIM BIOPHYS ACTA, V917, P148, DOI 10.1016/0005-2760(87)90295-5; Raffai RL, 2001, P NATL ACAD SCI USA, V98, P11587, DOI 10.1073/pnas.201279298; Romisch K, 2004, TRAFFIC, V5, P815, DOI 10.1111/j.1600-0854.2004.00231.x; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Sitia R, 2003, NATURE, V426, P891, DOI 10.1038/nature02262; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Swaminathan R, 1997, BIOPHYS J, V72, P1900, DOI 10.1016/S0006-3495(97)78835-0; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; Wang W, 2008, CURR OPIN ONCOL, V20, P90, DOI 10.1097/CCO.0b013e3282f31d6f; WEISGRABER KH, 1994, ADV PROTEIN CHEM, V45, P249; Xu PT, 1999, AM J PATHOL, V154, P601, DOI 10.1016/S0002-9440(10)65305-9; Xu Q, 2004, J BIOL CHEM, V279, P25511, DOI 10.1074/jbc.M311256200; Xu Q, 2008, J NEUROSCI, V28, P1452, DOI 10.1523/JNEUROSCI.3253-07.2008; Xu Q, 2006, J NEUROSCI, V26, P4985, DOI 10.1523/JNEUROSCI.5476-05.2006; Ye SM, 2005, P NATL ACAD SCI USA, V102, P18700, DOI 10.1073/pnas.0508693102; Zhong N, 2009, J BIOL CHEM, V284, P27273, DOI 10.1074/jbc.M109.014464; Zhong N, 2009, J BIOL CHEM, V284, P6027, DOI 10.1074/jbc.R800009200	55	71	73	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17217	17226		10.1074/jbc.M110.217380	http://dx.doi.org/10.1074/jbc.M110.217380			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454574	Green Published, hybrid			2022-12-25	WOS:000290301900070
J	Wade, F; Espagne, A; Persuy, MA; Vidic, J; Monnerie, R; Merola, F; Pajot-Augy, E; Sanz, G				Wade, Fallou; Espagne, Agathe; Persuy, Marie-Annick; Vidic, Jasmina; Monnerie, Regine; Merola, Fabienne; Pajot-Augy, Edith; Sanz, Guenhael			Relationship between Homo-oligomerization of a Mammalian Olfactory Receptor and Its Activation State Demonstrated by Bioluminescence Resonance Energy Transfer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTORS; LIVING CELLS; BETA(2)-ADRENERGIC RECEPTOR; SACCHAROMYCES-CEREVISIAE; CONFORMATIONAL-CHANGES; IN-VIVO; DIMERIZATION; COMPLEXES; YEAST; HETERODIMERIZATION	G-protein-coupled receptor homo-oligomerization has been increasingly reported. However, little is known regarding the relationship between activation of the receptor and its association/conformational states. The mammalian olfactory receptors (ORs) belong to the G protein-coupled receptor superfamily. In this study, the homo-oligomerization status of the human OR1740 receptor and its involvement in receptor activation upon odorant ligand binding were addressed by co-immuno-precipitation and bioluminescence resonance energy transfer approaches using crude membranes or membranes from different cellular compartments. For the first time, our data clearly show that mammalian ORs constitutively self-associate into homodimers at the plasma membrane level. This study also demonstrates that ligand binding mediates a conformational change and promotes an inactive state of the OR dimers at high ligand concentrations. These findings support and validate our previously proposed model of OR activation/inactivation based on the tripartite odorant-binding protein-odorant-OR partnership.	[Wade, Fallou; Persuy, Marie-Annick; Monnerie, Regine; Pajot-Augy, Edith; Sanz, Guenhael] INRA, Neurobiol Olfact & Modelisat Imagerie UR1197, F-78350 Jouy En Josas, France; [Vidic, Jasmina] INRA, Virol & Immunol Mol UR892, F-78350 Jouy En Josas, France; [Espagne, Agathe; Merola, Fabienne] Univ Paris 11, Lab Chim Phys, UMR 8000, IFR Neuro Sud Paris France 144, F-91405 Orsay, France; [Espagne, Agathe; Merola, Fabienne] CNRS, F-91405 Orsay, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS)	Sanz, G (corresponding author), INRA, Neurobiol Olfact & Modelisat Imagerie UR1197, F-78350 Jouy En Josas, France.	guenhael.sanz@jouy.inra.fr	Vidic, Jasmina/AFP-6747-2022; Merola, Fabienne/A-1172-2012	Vidic, Jasmina/0000-0002-8549-8199; Espagne, Agathe/0000-0002-2333-0227	Institut National de la Recherche Agronomique (INRA); Agence Nationale de la Recherche (New Olfactory SEnsors) [ANR-07-PCVI-0027-01]	Institut National de la Recherche Agronomique (INRA); Agence Nationale de la Recherche (New Olfactory SEnsors)(French National Research Agency (ANR))	This work was supported by the Institut National de la Recherche Agronomique (INRA) and Agence Nationale de la Recherche (New Olfactory SEnsors) Grant ANR-07-PCVI-0027-01.	Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697; Araneda RC, 2004, J PHYSIOL-LONDON, V555, P743, DOI 10.1113/jphysiol.2003.058040; Armstrong D, 2001, J BIOL CHEM, V276, P22621, DOI 10.1074/jbc.M006936200; Audet N, 2008, J BIOL CHEM, V283, P15078, DOI 10.1074/jbc.M707941200; Ayoub MA, 2002, J BIOL CHEM, V277, P21522, DOI 10.1074/jbc.M200729200; Bacart Johan, 2008, Biotechnol J, V3, P311, DOI 10.1002/biot.200700222; Baker JG, 2007, TRENDS PHARMACOL SCI, V28, P374, DOI 10.1016/j.tips.2007.06.011; Bush CF, 2007, J BIOL CHEM, V282, P19042, DOI 10.1074/jbc.M610781200; Chabre M, 2009, TRENDS PHARMACOL SCI, V30, P182, DOI 10.1016/j.tips.2009.01.003; Cheng ZJ, 2001, J BIOL CHEM, V276, P48040, DOI 10.1074/jbc.M105668200; Cook BL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002920; Crowe ML, 2000, J RECEPT SIGNAL TR R, V20, P61, DOI 10.3109/10799890009150037; Duncan RR, 2004, J MICROSC-OXFORD, V215, P1, DOI 10.1111/j.0022-2720.2004.01343.x; Eraso P, 2006, BBA-BIOMEMBRANES, V1758, P164, DOI 10.1016/j.bbamem.2006.01.010; Firestein S, 2001, NATURE, V413, P211, DOI 10.1038/35093026; Guan RB, 2009, J BIOL CHEM, V284, P7483, DOI 10.1074/jbc.M809150200; Gurevich VV, 2008, TRENDS PHARMACOL SCI, V29, P234, DOI 10.1016/j.tips.2008.02.004; Hague C, 2004, MOL INTERV, V4, P321, DOI 10.1124/mi.4.6.4; Hague C, 2004, P NATL ACAD SCI USA, V101, P13672, DOI 10.1073/pnas.0403854101; Han Y, 2009, NAT CHEM BIOL, V5, P688, DOI 10.1038/nchembio.199; Hebert TE, 2006, CELL BIOCHEM BIOPHYS, V45, P85, DOI 10.1385/CBB:45:1:85; Herrick-Davis K, 2006, J BIOL CHEM, V281, P27109, DOI 10.1074/jbc.M604390200; Issafras H, 2002, J BIOL CHEM, V277, P34666, DOI 10.1074/jbc.M202386200; Jacquier V, 2006, J NEUROCHEM, V97, P537, DOI 10.1111/j.1471-4159.2006.03771.x; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kenworthy A, 2002, TRENDS BIOCHEM SCI, V27, P435, DOI 10.1016/S0968-0004(02)02178-3; Ko HJ, 2006, BIOL CHEM, V387, P59, DOI 10.1515/BC.2006.009; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Milligan G, 2005, FEBS J, V272, P2914, DOI 10.1111/j.1742-4658.2005.04731.x; Milligan G, 2005, J MOL NEUROSCI, V26, P161, DOI 10.1385/JMN:26:2-3:161; Minic J, 2005, FEBS J, V272, P524, DOI 10.1111/j.1742-4658.2004.04494.x; Mombaerts P, 2004, CURR OPIN NEUROBIOL, V14, P31, DOI 10.1016/j.conb.2004.01.014; Neuhaus EM, 2005, NAT NEUROSCI, V8, P15, DOI 10.1038/nn1371; Pajot-Augy E, 2003, J RECEPT SIG TRANSD, V23, P155, DOI 10.1081/RRS-120025196; Park PSH, 2004, BIOCHEMISTRY-US, V43, P15643, DOI 10.1021/bi047907k; Pfleger KDG, 2005, BIOCHEM J, V385, P625, DOI 10.1042/BJ20041361; PRICE LA, 1995, MOL CELL BIOL, V15, P6188; Salahpour A, 2004, J BIOL CHEM, V279, P33390, DOI 10.1074/jbc.M403363200; Sanz G, 2005, CHEM SENSES, V30, P69, DOI 10.1093/chemse/bji002; SCHIESTL RH, 1993, MOL CELL BIOL, V13, P2697, DOI 10.1128/MCB.13.5.2697; Springael JY, 2007, PHARMACOL THERAPEUT, V115, P410, DOI 10.1016/j.pharmthera.2007.06.004; Steinbrecht RA, 1998, ANN NY ACAD SCI, V855, P323, DOI 10.1111/j.1749-6632.1998.tb10591.x; Terrillon S, 2003, MOL ENDOCRINOL, V17, P677, DOI 10.1210/me.2002-0222; Vidic J, 2008, LAB CHIP, V8, P678, DOI 10.1039/b717724k; Vidic J, 2007, ANAL CHEM, V79, P3280, DOI 10.1021/ac061774m; Vidic JM, 2006, LAB CHIP, V6, P1026, DOI 10.1039/b603189g; Xu PX, 2005, SCIENCE, V310, P798, DOI 10.1126/science.1121249; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	51	29	29	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15252	15259		10.1074/jbc.M110.184580	http://dx.doi.org/10.1074/jbc.M110.184580			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21454689	Green Published, hybrid			2022-12-25	WOS:000289788300056
J	Lundequist, A; Boyce, JA				Lundequist, Anders; Boyce, Joshua A.			LPA5 Is Abundantly Expressed by Human Mast Cells and Important for Lysophosphatidic Acid Induced MIP-1 beta Release	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; MOLECULAR-CLONING; OVARIAN-CANCER; ORPHAN GPCR; IDENTIFICATION; GROWTH; ACTIVATION; GENERATION; ROLES; GPR92	Background: Lysophosphatidic acid (LPA) is a bioactive lipid inducing proliferation, differentiation as well as cytokine release by mast cells through G-protein coupled receptors. Recently GPR92/LPA5 was identified as an LPA receptor highly expressed by cells of the immune system, which prompted us to investigate its presence and influence on mast cells. Principal Findings: Transcript analysis using quantitative real-time PCR revealed that LPA5 is the most prevalent LPA-receptor in human mast cells. Reduction of LPA5 levels using shRNA reduced calcium flux and abolished MIP-1 beta release in response to LPA. Conclusions: LPA5 is a bona fide LPA receptor on human mast cells responsible for the majority of LPA induced MIP-1 beta release.	[Lundequist, Anders; Boyce, Joshua A.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Lundequist, Anders; Boyce, Joshua A.] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Lundequist, Anders] Swedish Univ Agr Sci, Uppsala, Sweden	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Swedish University of Agricultural Sciences	Lundequist, A (corresponding author), Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA.	Anders.Lundequist@slu.se			National Institutes of Health [AI-52353, AI-31599, HL-36110, AI078908]; Consul Th C Bergh's Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL036110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI052353, U01AI031599, R01AI052353, R56AI052353, P01AI031599, R01AI078908, U19AI031599] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Consul Th C Bergh's Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants AI-52353, AI-31599, HL-36110, and AI078908, by Consul Th C Bergh's Foundation, and by a generous contribution from the Vinik Family. The Viniks are private donors who contributed generously to establish an endowment; there are no industry ties. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali H, 2000, J IMMUNOL, V165, P7215, DOI 10.4049/jimmunol.165.12.7215; An SZ, 1998, J BIOL CHEM, V273, P7906, DOI 10.1074/jbc.273.14.7906; An SZ, 1997, BIOCHEM BIOPH RES CO, V231, P619, DOI 10.1006/bbrc.1997.6150; Aoki J, 2002, J BIOL CHEM, V277, P48737, DOI 10.1074/jbc.M206812200; Bagga S, 2004, BLOOD, V104, P4080, DOI 10.1182/blood-2004-03-1166; Bandoh K, 1999, J BIOL CHEM, V274, P27776, DOI 10.1074/jbc.274.39.27776; Boyce JA, 2003, J ALLERGY CLIN IMMUN, V111, P24, DOI 10.1067/mai.2003.60; Fang XJ, 2000, ANN NY ACAD SCI, V905, P188; Hashimoto T, 2006, J PHARMACOL SCI, V100, P82, DOI 10.1254/jphs.FPJ05030X; Jin YX, 2003, EUR J IMMUNOL, V33, P2083, DOI 10.1002/eji.200323711; Kirshenbaum AS, 2003, LEUKEMIA RES, V27, P677, DOI 10.1016/S0145-2126(02)00343-0; Kotarsky K, 2006, J PHARMACOL EXP THER, V318, P619, DOI 10.1124/jpet.105.098848; Lee CW, 2006, J BIOL CHEM, V281, P23589, DOI 10.1074/jbc.M603670200; Lin DA, 2005, J IMMUNOL, V175, P5430, DOI 10.4049/jimmunol.175.8.5430; Menten P, 2002, CYTOKINE GROWTH F R, V13, P455, DOI 10.1016/S1359-6101(02)00045-X; Murakami M, 2008, BIOCHEM BIOPH RES CO, V371, P707, DOI 10.1016/j.bbrc.2008.04.145; Noguchi K, 2003, J BIOL CHEM, V278, P25600, DOI 10.1074/jbc.M302648200; Ochi H, 2000, P NATL ACAD SCI USA, V97, P10509, DOI 10.1073/pnas.180318697; Ochi H, 1999, J EXP MED, V190, P267, DOI 10.1084/jem.190.2.267; Paruchuri S, 2008, J BIOL CHEM, V283, P16477, DOI 10.1074/jbc.M705822200; Pasternack SM, 2008, NAT GENET, V40, P329, DOI 10.1038/ng.84; RADINGER M, 2001, GENERATION ISOLATION; Schwartz BM, 2001, GYNECOL ONCOL, V81, P291, DOI 10.1006/gyno.2001.6124; Supajatura V, 2001, J IMMUNOL, V167, P2250, DOI 10.4049/jimmunol.167.4.2250; Tabata KI, 2007, BIOCHEM BIOPH RES CO, V363, P861, DOI 10.1016/j.bbrc.2007.09.063; TOKUMURA A, 1994, AM J PHYSIOL, V267, pC204, DOI 10.1152/ajpcell.1994.267.1.C204; Umezu-Goto M, 2002, J CELL BIOL, V158, P227, DOI 10.1083/jcb.200204026; Varadaradjalou S, 2003, EUR J IMMUNOL, V33, P899, DOI 10.1002/eji.200323830; Zhao YT, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-114	29	36	36	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e18192	10.1371/journal.pone.0018192	http://dx.doi.org/10.1371/journal.pone.0018192			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464938	Green Published, gold, Green Submitted			2022-12-25	WOS:000289053800026
J	Radl, DB; Ferraris, J; Boti, V; Seilicovich, A; Sarkar, DK; Pisera, D				Betiana Radl, Daniela; Ferraris, Jimena; Boti, Valeria; Seilicovich, Adriana; Sarkar, Dipak Kumar; Pisera, Daniel			Dopamine-Induced Apoptosis of Lactotropes Is Mediated by the Short Isoform of D2 Receptor	PLOS ONE			English	Article							PITUITARY-TUMORS; MESSENGER-RNA; ACTIVATION; EXPRESSION; BROMOCRIPTINE; CABERGOLINE; RESISTANT; PROLIFERATION; INHIBIT; AGONIST	Dopamine, through D2 receptor (D2R), is the major regulator of lactotrope function in the anterior pituitary gland. Both D2R isoforms, long (D2L) and short (D2S), are expressed in lactotropes. Although both isoforms can transduce dopamine signal, they differ in the mechanism that leads to cell response. The administration of D2R agonists, such as cabergoline, is the main pharmacological treatment for prolactinomas, but resistance to these drugs exists, which has been associated with alterations in D2R expression. We previously reported that dopamine and cabergoline induce apoptosis of lactotropes in primary culture in an estrogen-dependent manner. In this study we used an in vivo model to confirm the permissive action of estradiol in the apoptosis of anterior pituitary cells induced by D2R agonists. Administration of cabergoline to female rats induced apoptosis, measured by Annexin-V staining, in anterior pituitary gland from estradiol-treated rats but not from ovariectomized rats. To evaluate the participation of D2R isoforms in the apoptosis induced by dopamine we used lactotrope-derived PR1 cells stably transfected with expression vectors encoding D2L or D2S receptors. In the presence of estradiol, dopamine induced apoptosis, determined by ELISA and TUNEL assay, only in PR1-D2S cells. To study the role of p38 MAPK in apoptosis induced by D2R activation, anterior pituitary cells from primary culture or PR1-D2S were incubated with an inhibitor of the p38 MAPK pathway (SB203850). SB203580 blocked the apoptotic effect of D2R activation in lactotropes from primary cultures and PR1-D2S cells. Dopamine also induced p38 MAPK phosphorylation, determined by western blot, in PR1-D2S cells and estradiol enhanced this effect. These data suggest that, in the presence of estradiol, D2R agonists induce apoptosis of lactotropes by their interaction with D2S receptors and that p38 MAPK is involved in this process.	[Betiana Radl, Daniela; Ferraris, Jimena; Boti, Valeria; Seilicovich, Adriana; Pisera, Daniel] Univ Buenos Aires, Inst Invest Reprod, Fac Med, Buenos Aires, DF, Argentina; [Sarkar, Dipak Kumar] State Univ New Jersey, Dept Anim Sci, Endocrine Program, New Brunswick, NJ USA	University of Buenos Aires; Rutgers State University New Brunswick	Radl, DB (corresponding author), Univ Buenos Aires, Inst Invest Reprod, Fac Med, Buenos Aires, DF, Argentina.	dpisera@fmed.uba.ar	Sarkar, Dipak K/O-7942-2017	Sarkar, Dipak K/0000-0003-3237-9871; Pisera, Daniel/0000-0001-8795-1551; Ferraris, Jimena/0000-0001-7472-0439	ANPCyT [PICT 2006-92]; UBA [UBACyT 2008-2010 M057]; CONICET; NIH [R01 AA11591, 5R37 AA08757]	ANPCyT(ANPCyT); UBA(University of Buenos Aires); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by ANPCyT (PICT 2006-92), UBA (UBACyT 2008-2010 M057), CONICET, NIH (R01 AA11591, 5R37 AA08757). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An JJ, 2003, MOL CELL ENDOCRINOL, V206, P49, DOI 10.1016/S0303-7207(03)00236-3; Ben-Jonathan N, 2001, ENDOCR REV, V22, P724, DOI 10.1210/er.22.6.724; Bonci A, 2005, NEURON, V47, P335, DOI 10.1016/j.neuron.2005.07.015; CACCAVELLI L, 1994, NEUROENDOCRINOLOGY, V60, P314, DOI 10.1159/000126764; Candolfi M, 2002, ENDOCRINOLOGY, V143, P3611, DOI 10.1210/en.2002-220377; Choi EY, 1999, BIOCHEM BIOPH RES CO, V256, P33, DOI 10.1006/bbrc.1999.0286; Choi WS, 2004, J BIOL CHEM, V279, P20451, DOI 10.1074/jbc.M311164200; Colao A, 2009, BEST PRACT RES CL EN, V23, P575, DOI 10.1016/j.beem.2009.05.003; De Mei C, 2009, CURR OPIN PHARMACOL, V9, P53, DOI 10.1016/j.coph.2008.12.002; EGUCHI K, 1995, ENDOCR J, V42, P153, DOI 10.1507/endocrj.42.153; EGUCHI K, 1995, ENDOCR J, V42, P413, DOI 10.1507/endocrj.42.413; EUSUNG J, 2001, J NEUROCHEM, V78, P374; Gillam MP, 2006, ENDOCR REV, V27, P485, DOI 10.1210/er.2005-9998; GUIRAMAND J, 1995, J BIOL CHEM, V270, P7354, DOI 10.1074/jbc.270.13.7354; Guivarc'H D, 1998, ENDOCRINOLOGY, V139, P4213, DOI 10.1210/en.139.10.4213; GUIVARCH D, 1995, NEUROSCIENCE, V69, P159, DOI 10.1016/0306-4522(95)00228-B; Hashi A, 1996, ENDOCRINOLOGY, V137, P3246, DOI 10.1210/en.137.8.3246; Hnasko TS, 2007, NEUROENDOCRINOLOGY, V86, P48, DOI 10.1159/000105242; Hofland LJ, 2010, MOL CELL ENDOCRINOL, V326, P89, DOI 10.1016/j.mce.2010.04.020; Iaccarino C, 2002, P NATL ACAD SCI USA, V99, P14530, DOI 10.1073/pnas.222319599; Jaita G, 2005, ENDOCRINOLOGY, V146, P4737, DOI 10.1210/en.2005-0279; Kelly MA, 1997, NEURON, V19, P103, DOI 10.1016/S0896-6273(00)80351-7; MCCHESNEY R, 1991, MOL CELL ENDOCRINOL, V79, pR1, DOI 10.1016/0303-7207(91)90110-E; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Molitch ME, 2008, J CLIN ENDOCR METAB, V93, P4643, DOI 10.1210/jc.2008-2244; MONTMAYEUR JP, 1991, P NATL ACAD SCI USA, V88, P3135, DOI 10.1073/pnas.88.8.3135; Oomizu S, 2003, ALCOHOL CLIN EXP RES, V27, P975, DOI 10.1097/01.ALC.0000071743.57855.BE; Passos VQ, 2009, NEUROENDOCRINOLOGY, V89, P163, DOI 10.1159/000156116; PASTORCIC M, 1995, CANCER RES, V55, P4892; Pisera D, 2004, AM J PHYSIOL-ENDOC M, V287, pE767, DOI 10.1152/ajpendo.00052.2004; Radl DB, 2008, NEUROENDOCRINOLOGY, V88, P43, DOI 10.1159/000116117; Saiardi A, 1997, NEURON, V19, P115, DOI 10.1016/S0896-6273(00)80352-9; Sarkar DK, 2005, ENDOCRINOLOGY, V146, P4179, DOI 10.1210/en.2005-0430; SENOGLES SE, 1994, J BIOL CHEM, V269, P23120; Takeuchi Y, 2003, J NEUROCHEM, V85, P1064, DOI 10.1046/j.1471-4159.2003.01763.x; Van-Ham II, 2007, J NEUROCHEM, V102, P1796, DOI 10.1111/j.1471-4159.2007.04650.x; Wu GS, 2004, CANCER BIOL THER, V3, P156, DOI 10.4161/cbt.3.2.614; Wu ZB, 2010, J NEURO-ONCOL, V99, P25, DOI 10.1007/s11060-009-0107-y; XUA A, 2002, BRAIN RES, V939, P95; Ying CW, 2000, ENDOCR J, V47, P1, DOI 10.1507/endocrj.47.1; Zaldivar V, 2009, NEUROENDOCRINOLOGY, V90, P292, DOI 10.1159/000235618; Zatelli MC, 2010, J CLIN ENDOCR METAB, V95, P968, DOI 10.1210/jc.2009-1641	42	30	32	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e18097	10.1371/journal.pone.0018097	http://dx.doi.org/10.1371/journal.pone.0018097			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464994	Green Published, Green Submitted, gold			2022-12-25	WOS:000288813900038
J	Jadhav, S; Hussain, A; Devi, S; Kumar, A; Parveen, S; Gandham, N; Wieler, LH; Ewers, C; Ahmed, N				Jadhav, Savita; Hussain, Arif; Devi, Savita; Kumar, Ashutosh; Parveen, Sana; Gandham, Nageshwari; Wieler, Lothar H.; Ewers, Christa; Ahmed, Niyaz			Virulence Characteristics and Genetic Affinities of Multiple Drug Resistant Uropathogenic Escherichia coli from a Semi Urban Locality in India	PLOS ONE			English	Article							URINARY-TRACT-INFECTIONS; REPETITIVE DNA-SEQUENCES; SPECTRUM-BETA-LACTAMASE; PATHOGENS; STRAINS; SUSCEPTIBILITY; EPIDEMIOLOGY; PREVALENCE; EMERGENCE; CLONE	Extraintestinal pathogenic Escherichia coli (ExPEC) are of significant health concern. The emergence of drug resistant E. coli with high virulence potential is alarming. Lack of sufficient data on transmission dynamics, virulence spectrum and antimicrobial resistance of certain pathogens such as the uropathogenic E. coli (UPEC) from countries with high infection burden, such as India, hinders the infection control and management efforts. In this study, we extensively genotyped and phenotyped a collection of 150 UPEC obtained from patients belonging to a semi-urban, industrialized setting near Pune, India. The isolates representing different clinical categories were analyzed in comparison with 50 commensal E. coli isolates from India as well as 50 ExPEC strains from Germany. Virulent strains were identified based on hemolysis, haemagglutination, cell surface hydrophobicity, serum bactericidal activity as well as with the help of O serotyping. We generated antimicrobial resistance profiles for all the clinical isolates and carried out phylogenetic analysis based on repetitive extragenic palindromic (rep)-PCR. E. coli from urinary tract infection cases expressed higher percentages of type I (45%) and P fimbriae (40%) when compared to fecal isolates (25% and 8% respectively). Hemolytic group comprised of 60% of UPEC and only 2% of E. coli from feces. Additionally, we found that serum resistance and cell surface hydrophobicity were not significantly (p = 0.16/p = 0.51) associated with UPEC from clinical cases. Moreover, clinical isolates exhibited highest resistance against amoxicillin (67.3%) and least against nitrofurantoin (57.3%). We also observed that 31.3% of UPEC were extended-spectrum beta-lactamase (ESBL) producers belonging to serotype O25, of which four were also positive for O25b subgroup that is linked to B2-O25b-ST131-CTX-M-15 virulent/multiresistant type. Furthermore, isolates from India and Germany (as well as global sources) were found to be genetically distinct with no evidence to espouse expansion of E. coli from India to the west or vice-versa.	[Jadhav, Savita; Gandham, Nageshwari] Dr D Y Patil Med Coll & Hosp, Dept Microbiol, Pune, Maharashtra, India; [Hussain, Arif; Devi, Savita; Kumar, Ashutosh; Parveen, Sana; Ahmed, Niyaz] Univ Hyderabad, Sch Life Sci, Dept Biotechnol, Pathogen Biol Lab, Hyderabad 500134, Andhra Pradesh, India; [Wieler, Lothar H.; Ewers, Christa] Free Univ Berlin, Inst Microbiol & Epizoot, Fac Vet, Berlin, Germany; [Ahmed, Niyaz] Univ Malaya, Inst Biol Sci, Kuala Lumpur, Malaysia; [Ahmed, Niyaz] Univ Hyderabad Campus, Inst Life Sci, Hyderabad, Andhra Pradesh, India	Dr DY Patil Vidyapeeth Pune; Dr D Y Patil Medical College, Hospital & Research Centre; University of Hyderabad; Free University of Berlin; Universiti Malaya	Jadhav, S (corresponding author), Dr D Y Patil Med Coll & Hosp, Dept Microbiol, Pune, Maharashtra, India.	niyazSL@uohyd.ernet.in	Ahmed, Niyaz/D-2589-2010; Ewers, Christa/AAL-9186-2020; Jadhav, Dr. Savita Vivekanand/AGY-8516-2022	Ahmed, Niyaz/0000-0001-6425-7583; Jadhav, Dr. Savita Vivekanand/0000-0003-3439-9462; Ewers, Christa/0000-0001-6167-1340; Wieler, Lothar H./0000-0003-4365-3717	University of Hyderabad	University of Hyderabad(University of Hyderabad)	This study was funded by the University of Hyderabad through intramural, startup grants to Niyaz Ahmed and was carried out as part of the Indo-German Research Training Group - Internationales Graduiertenkolleg (GRK1673) - Functional Molecular Infection Epidemiology, an initiative of the German Research Foundation (DFG) and the University of Hyderabad (India), of which Niyaz Ahmed and Lothar Wieler are Speakers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babypadmini S, 2004, Indian J Med Microbiol, V22, P172; BLANCO J, 1992, FEMS MICROBIOL LETT, V99, P131, DOI 10.1016/0378-1097(92)90014-F; Blanco M, 1995, Enferm Infecc Microbiol Clin, V13, P236; Clermont O, 2009, J ANTIMICROB CHEMOTH, V64, P274, DOI 10.1093/jac/dkp194; *CLIN LAB STAND I, 2006, MS45A CLIN LAB STAND; Collee JG, 1996, MACKIE MCCARTNEY PRA, P53; Dobrindt U, 2005, INT J MED MICROBIOL, V295, P357, DOI 10.1016/j.ijmm.2005.07.009; Dombek PE, 2000, APPL ENVIRON MICROB, V66, P2572, DOI 10.1128/AEM.66.6.2572-2577.2000; Ewers C, 2007, INT J MED MICROBIOL, V297, P163, DOI 10.1016/j.ijmm.2007.01.003; Ewers C, 2010, J ANTIMICROB CHEMOTH, V65, P651, DOI 10.1093/jac/dkq004; FOWLER JE, 1977, J UROLOGY, V117, P472, DOI 10.1016/S0022-5347(17)58501-8; Gales AC, 2002, DIAGN MICR INFEC DIS, V44, P289, DOI 10.1016/S0732-8893(02)00470-4; Hagan EC, 2007, INFECT IMMUN, V75, P3941, DOI 10.1128/IAI.00337-07; Hannan TJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001042; HUGHES C, 1983, INFECT IMMUN, V39, P546, DOI 10.1128/IAI.39.2.546-551.1983; Jacobsen SM, 2008, CLIN MICROBIOL REV, V21, P26, DOI 10.1128/CMR.00019-07; Johnson JR, 2005, INT J MED MICROBIOL, V295, P383, DOI 10.1016/j.ijmm.2005.07.005; Johnson JR, 2003, INFECT DIS CLIN N AM, V17, P261, DOI 10.1016/S0891-5520(03)00027-8; JOHNSON JR, 1991, CLIN MICROBIOL REV, V4, P80, DOI 10.1128/CMR.4.1.80-128.1991; Karlowsky JA, 2001, INT J ANTIMICROB AG, V18, P121, DOI 10.1016/S0924-8579(01)00369-7; LEFFLER H, 1981, INFECT IMMUN, V34, P920, DOI 10.1128/IAI.34.3.920-929.1981; Mathai D, 2001, DIAGN MICR INFEC DIS, V40, P129, DOI 10.1016/S0732-8893(01)00254-1; MINSHEW BH, 1978, J INFECT DIS, V137, P648, DOI 10.1093/infdis/137.5.648; Najar GA, 2007, RES PHARM SCI, V2, P99; Nicolas-Chanoine MH, 2008, J ANTIMICROB CHEMOTH, V61, P273, DOI 10.1093/jac/dkm464; PEZZLO M, 2004, CLIN MICROBIOLOGY PR, P31211; PUZOVA H, 1994, FEMS IMMUNOL MED MIC, V9, P223, DOI 10.1111/j.1574-695X.1994.tb00497.x; QUACKENBUSH RL, 1979, INFECT IMMUN, V24, P562, DOI 10.1128/IAI.24.2.562-564.1979; Rademaker JLW, 1997, DNA MARKERS, P151; Sahm DF, 2001, ANTIMICROB AGENTS CH, V45, P1402, DOI 10.1128/AAC.45.5.1402-1406.2001; Sakoulas G, 2002, ANTIMICROB AGENTS CH, V46, P1492, DOI 10.1128/AAC.46.5.1492-1502.2002; SIEGFRIED L, 1994, J MED MICROBIOL, V41, P127, DOI 10.1099/00222615-41-2-127; Tambekar DH, 2006, AFR J BIOTECHNOL, V5, P1562; Tankhiwale SS, 2004, INDIAN J MED RES, V120, P553; Ulleryd P, 2003, INT J ANTIMICROB AG, V22, pS89, DOI 10.1016/S0924-8579(03)00228-0; VERSALOVIC J, 1991, NUCLEIC ACIDS RES, V19, P6823, DOI 10.1093/nar/19.24.6823; Wiles TJ, 2008, EXP MOL PATHOL, V85, P11, DOI 10.1016/j.yexmp.2008.03.007	37	80	89	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e18063	10.1371/journal.pone.0018063	http://dx.doi.org/10.1371/journal.pone.0018063			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464963	Green Published, gold, Green Submitted			2022-12-25	WOS:000288813900032
J	Miranda, JJ; Bernabe-Ortiz, A; Stanojevic, S; Malaga, G; Gilman, RH; Smeeth, L				Jaime Miranda, J.; Bernabe-Ortiz, Antonio; Stanojevic, Sanja; Malaga, German; Gilman, Robert H.; Smeeth, Liam			A1C as a Diagnostic Criteria for Diabetes in Low- and Middle-Income Settings: Evidence from Peru	PLOS ONE			English	Article							HEMOGLOBIN A(1C); GLUCOSE	Objectives: To determine the prevalence of type 2 diabetes mellitus, in three groups of Peruvian adults, using fasting glucose and glycosylated hemoglobin (A1C). Methodology/Principal Findings: This study included adults from the PERU MIGRANT Study who had fasted >= 8 h. Fasting glucose >= 126 mg/dL and A1C >= 6.5% were used, separately, to define diabetes. Subjects with a current diagnosis of diabetes were excluded. 964 of 988 subjects were included in this analysis. Overall, 0.9% (95% CI 0.3-1.5) and 3.5% (95% CI 2.4-4.7) had diabetes using fasting glucose and A1C criteria, respectively. Compared to those classified as having diabetes using fasting glucose, newly classified subjects with diabetes using A1C (n = 25), were older, poorer, thinner and more likely to come from rural areas. Of these, 40% (10/25) had impaired fasting glucose (IFG). Conclusions: This study shows that the use of A1C as diagnostic criteria for type 2 diabetes mellitus identifies people of different characteristics than fasting glucose. In the PERU MIGRANT population using A1C to define diabetes tripled the prevalence; the increase was more marked among poorer and rural populations. More than half the newly diagnosed people with diabetes using A1C had normal fasting glucose.	[Jaime Miranda, J.; Bernabe-Ortiz, Antonio; Stanojevic, Sanja; Malaga, German; Gilman, Robert H.; Smeeth, Liam] Univ Peruana Cayetano Heredia, CRONICAS Ctr Excellence Chron Dis, Lima, Peru; [Jaime Miranda, J.; Malaga, German] Univ Peruana Cayetano Heredia, Sch Med, Dept Med, Lima, Peru; [Jaime Miranda, J.; Smeeth, Liam] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England; [Bernabe-Ortiz, Antonio] Univ Peruana Cayetano Heredia, Sch Publ Hlth, Epidemiol Unit, Lima, Peru; [Gilman, Robert H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Gilman, Robert H.] A B PRISMA, Area Invest & Desarrollo, Lima, Peru	Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia; University of London; London School of Hygiene & Tropical Medicine; Universidad Peruana Cayetano Heredia; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Miranda, JJ (corresponding author), Univ Peruana Cayetano Heredia, CRONICAS Ctr Excellence Chron Dis, Lima, Peru.	Jaime.Miranda@upch.pe	Miranda, J. Jaime/A-8482-2008; Stanojevic, Sanja/A-4243-2010; Smeeth, Liam/X-5862-2018	Miranda, J. Jaime/0000-0002-4738-5468; Smeeth, Liam/0000-0002-9168-6022; Stanojevic, Sanja/0000-0001-7931-8051; Malaga, German/0000-0002-7828-300X; Bernabe-Ortiz, Antonio/0000-0002-6834-1376	Wellcome Trust [GR074833MA]; National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health, Department of Health and Human Services [HHSN268200900033C]; National Institute for Health Research [NF-SI-0510-10090] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded in whole by the Wellcome Trust (GR074833MA). LS is supported by a Wellcome Trust Senior Research Fellowship in Clinical Science. The CRONICAS Center of Excellence in Chronic Diseases at UPCH is funded by the National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health, Department of Health and Human Services, under contract No. HHSN268200900033C. The funder had no role in study design, data collection, analysis, or interpretation, in writing the report, or in the decision to submit the article for publication. The researchers are all independent from the funding source.	Borch-Johnsen K, 1998, BMJ-BRIT MED J, V317, P371; Borch-Johnsen K, 1999, LANCET, V354, P617; Carson AP, 2010, DIABETES CARE, V33, P95, DOI 10.2337/dc09-1227; Gama R, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b5648; Gavin JR, 1997, DIABETES CARE, V20, P1183; Genuth S, 2003, DIABETES CARE, V26, P3160; Gilchrist JM, 2009, J CLIN EPIDEMIOL, V62, P1045, DOI 10.1016/j.jclinepi.2008.11.012; Herman WH, 2009, J CLIN ENDOCR METAB, V94, P1689, DOI 10.1210/jc.2008-1940; International Diabetes Federation, 2009, DIAB ATL; Kirk JK, 2006, DIABETES CARE, V29, P2130, DOI 10.2337/dc05-1973; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Miranda JJ, 2008, TROP MED INT HEALTH, V13, P1225, DOI 10.1111/j.1365-3156.2008.02116.x; Miranda JJ, 2009, BMC CARDIOVASC DISOR, V9, DOI 10.1186/1471-2261-9-23; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Pani LN, 2008, DIABETES CARE, V31, P1991, DOI 10.2337/dc08-0577; Qiao Q, 2003, DIABETES CARE, V26, P688; Selvin E, 2010, NEW ENGL J MED, V362, P800, DOI 10.1056/NEJMoa0908359; Soranzo N, 2010, DIABETES, V59, P3229, DOI 10.2337/db10-0502; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Ziemer DC, 2010, ANN INTERN MED, V152, P770, DOI 10.7326/0003-4819-152-12-201006150-00004; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	21	8	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e18069	10.1371/journal.pone.0018069	http://dx.doi.org/10.1371/journal.pone.0018069			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464957	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000288813900034
J	Velpula, KK; Dasari, VR; Tsung, AJ; Gondi, CS; Klopfenstein, JD; Mohanam, S; Rao, JS				Velpula, Kiran Kumar; Dasari, Venkata Ramesh; Tsung, Andrew J.; Gondi, Christopher S.; Klopfenstein, Jeffrey D.; Mohanam, Sanjeeva; Rao, Jasti S.			Regulation of Glioblastoma Progression by Cord Blood Stem Cells Is Mediated by Downregulation of Cyclin D1	PLOS ONE			English	Article							BETA-CATENIN; DEPENDENT KINASE; BREAST-CANCER; BRAIN-TUMORS; GENE-THERAPY; BONE-MARROW; IN-VIVO; GLIOMA; GROWTH; AMPLIFICATION	Background: The normal progression of the cell cycle requires sequential expression of cyclins. Rapid induction of cyclin D1 and its associated binding with cyclin-dependent kinases, in the presence or absence of mitogenic signals, often is considered a rate-limiting step during cell cycle progression through the G(1) phase. Methodology/Principal Findings: In the present study, human umbilical cord blood stem cells (hUCBSC) in co-cultures with glioblastoma cells (U251 and 5310) not only induced G(0)-G(1) phase arrest, but also reduced the number of cells at S and G(2)-M phases of cell cycle. Cell cycle regulatory proteins showed decreased expression levels upon treatment with hUCBSC as revealed by Western and FACS analyses. Inhibition of cyclin D1 activity by hUCBSC treatment is sufficient to abolish the expression levels of Cdk 4, Cdk 6, cyclin B1, beta-Catenin levels. Our immuno precipitation experiments present evidence that, treatment of glioma cells with hUCBSC leads to the arrest of cell-cycle progression through inactivation of both cyclin D1/Cdk 4 and cyclin D1/Cdk 6 complexes. It is observed that hUCBSC, when co-cultured with glioma cells, caused an increased G(0)-G(1) phase despite the reduction of G(0)-G(1) regulatory proteins cyclin D1 and Cdk 4. We found that this reduction of G(0)-G(1) regulatory proteins, cyclin D1 and Cdk 4 may be in part compensated by the expression of cyclin E1, when co-cultured with hUCBSC. Co-localization experiments under in vivo conditions in nude mice brain xenografts with cyclin D1 and CD81 antibodies demonstrated, decreased expression of cyclin D1 in the presence of hUCBSC. Conclusions/Significance: This paper elucidates a model to regulate glioma cell cycle progression in which hUCBSC acts to control cyclin D1 induction and in concert its partner kinases, Cdk 4 and Cdk 6 by mediating cell cycle arrest at G(0)-G(1) phase.	[Velpula, Kiran Kumar; Dasari, Venkata Ramesh; Gondi, Christopher S.; Mohanam, Sanjeeva; Rao, Jasti S.] Univ Illinois, Coll Med, Dept Canc Biol & Pharmacol, Peoria, IL 61656 USA; [Tsung, Andrew J.; Klopfenstein, Jeffrey D.; Rao, Jasti S.] Univ Illinois, Coll Med, Dept Neurosurg, Peoria, IL 61656 USA	University of Illinois System; University of Illinois Peoria; University of Illinois System; University of Illinois Peoria	Velpula, KK (corresponding author), Univ Illinois, Coll Med, Dept Canc Biol & Pharmacol, Peoria, IL 61656 USA.	jsrao@uic.edu	Dasari, Venkata Ramesh/B-3098-2009	Dasari, Venkata Ramesh/0000-0003-0819-2935; Gondi, Christopher/0000-0002-3036-9920	National Institute of Neurological Disorders and Stroke (NINDS) [NS057529]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057529] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The project was supported by Award Number NS057529 (J.S.R.) from the National Institute of Neurological Disorders and Stroke (NINDS). The contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboody KS, 2000, P NATL ACAD SCI USA, V97, P12846, DOI 10.1073/pnas.97.23.12846; Arber N, 1997, CANCER RES, V57, P1569; BARTKOVA J, 1994, INT J CANCER, V58, P568, DOI 10.1002/ijc.2910580420; Benedetti S, 2000, NAT MED, V6, P447, DOI 10.1038/74710; Bowe DB, 2002, ONCOGENE, V21, P291, DOI 10.1038/sj/onc/1205025; Buschges R, 1999, BRAIN PATHOL, V9, P435; Caplan AI, 2001, TRENDS MOL MED, V7, P259, DOI 10.1016/S1471-4914(01)02016-0; Chen Z, 2005, J NEUROCHEM, V92, P1281, DOI 10.1111/j.1471-4159.2004.02934.x; Cheng MG, 1998, P NATL ACAD SCI USA, V95, P1091, DOI 10.1073/pnas.95.3.1091; Dasari VR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010350; Dasari VR, 2008, NEUROBIOL DIS, V32, P486, DOI 10.1016/j.nbd.2008.09.005; Desbois-Mouthon C, 2001, ONCOGENE, V20, P252, DOI 10.1038/sj.onc.1204064; Donato V, 2007, TUMORI, V93, P248; Ehtesham M, 2002, CANCER RES, V62, P7170; Ehtesham M, 2002, CANCER RES, V62, P5657; Etheridge SL, 2004, STEM CELLS, V22, P849, DOI 10.1634/stemcells.22-5-849; Feng B, 2009, CANCER BIOTHER RADIO, V24, P717, DOI 10.1089/cbr.2009.0652; Fu MF, 2004, ENDOCRINOLOGY, V145, P5439, DOI 10.1210/en.2004-0959; Gillett C, 1996, INT J CANCER, V69, P92, DOI 10.1002/(SICI)1097-0215(19960422)69:2<92::AID-IJC4>3.3.CO;2-I; GILLETT C, 1994, CANCER RES, V54, P1812; Gondi CS, 2010, INT J ONCOL, V36, P1165, DOI 10.3892/ijo_00000599; Guo Y, 2005, ONCOGENE, V24, P2599, DOI 10.1038/sj.onc.1208326; Guo Y, 2005, ONCOGENE, V24, P1032, DOI 10.1038/sj.onc.1208299; Hall M, 1996, ADV CANCER RES, V68, P67, DOI 10.1016/S0065-230X(08)60352-8; Han L, 2010, BRAIN RES, V1366, P9, DOI 10.1016/j.brainres.2010.09.097; James CG, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-30; Jeon YT, 2005, CANCER LETT, V223, P259, DOI 10.1016/j.canlet.2004.12.024; Kang SG, 2005, NEUROL MED-CHIR, V45, P232, DOI 10.2176/nmc.45.232; Kong SM, 2000, CANCER RES, V60, P249; Lang FF, 2003, J CLIN ONCOL, V21, P2508, DOI 10.1200/JCO.2003.21.13.2508; LI G, 2010, MOL CELL BIOCH  1224; Lu YR, 2008, CANCER BIOL THER, V7, P245, DOI 10.4161/cbt.7.2.5296; Mejlvang J, 2007, MOL BIOL CELL, V18, P4615, DOI 10.1091/mbc.E07-05-0406; Molenaar JJ, 2008, CANCER RES, V68, P2599, DOI 10.1158/0008-5472.CAN-07-5032; Monick MM, 2001, J IMMUNOL, V166, P4713, DOI 10.4049/jimmunol.166.7.4713; Monteiro E, 2004, CANCER DETECT PREV, V28, P237, DOI 10.1016/j.cdp.2004.04.005; Pu P, 2009, CANCER GENE THER, V16, P351, DOI 10.1038/cgt.2008.78; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Soni R, 2000, BIOCHEM BIOPH RES CO, V275, P877, DOI 10.1006/bbrc.2000.3349; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Surawicz TS, 1998, J NEURO-ONCOL, V40, P151, DOI 10.1023/A:1006091608586; Takahashi M, 2007, DEV BIOL, V303, P549, DOI 10.1016/j.ydbio.2006.11.031; Takayama S, 2006, J BIOL CHEM, V281, P17856, DOI 10.1074/jbc.M602290200; Tocci Angelo, 2003, Hematol J, V4, P92, DOI 10.1038/sj.thj.6200232; WALKER AE, 1985, NEUROLOGY, V35, P219, DOI 10.1212/WNL.35.2.219; Wang JCY, 1997, BLOOD, V89, P3919, DOI 10.1182/blood.V89.11.3919; Williams B, 1996, CANCER GENET CYTOGEN, V91, P77, DOI 10.1016/S0165-4608(96)00155-0; Zheng YL, 2010, BIOMED PHARMACOTHER, V64, P527, DOI 10.1016/j.biopha.2009.04.046	49	21	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2011	6	3							e18017	10.1371/journal.pone.0018017	http://dx.doi.org/10.1371/journal.pone.0018017			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740RG	21455311	gold, Green Published			2022-12-25	WOS:000288811500019
J	Isomura, R; Kitajima, K; Sato, C				Isomura, Ryo; Kitajima, Ken; Sato, Chihiro			Structural and Functional Impairments of Polysialic Acid by a Mutated Polysialyltransferase Found in Schizophrenia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION MOLECULE; FRONTAL AFFINITY-CHROMATOGRAPHY; CENTRAL-NERVOUS-SYSTEM; NEUROTROPHIC FACTOR; DENTATE GYRUS; ADULT-RAT; NCAM-H; N-CAM; EXPRESSION; BRAIN	Polysialic acid (polySia), a unique acidic glycan modifying neural cell adhesion molecule (NCAM), is known to regulate embryonic neural development and adult brain functions. Polysialyltransferase STX is responsible for the synthesis of polySia, and two single nucleotide polymorphisms (SNPs) of the coding region of STX are reported from schizophrenic patients: SNP7 and SNP9, respectively, giving STX(G421A) with E141K and STX(C621G) with silent mutations. In this study, we focused on these mutations and a binding activity of polySia to neural materials, such as brain-derived neurotrophic factor (BDNF). Here we describe three new findings. First, STX(G421A) shows a dramatic decrease in polySia synthetic activity on NCAM, whereas STX(C621G) does not. The STX(G421A)-derived polySia-NCAM contains a lower amount of polySia with a shorter chain length. Second, polySia shows a dopamine (DA) binding activity, which is a new function of polySia as revealed by frontal affinity chromatography for measuring the polySia-neurotransmitter interactions. Interestingly, the STX(G421A)-derived polySia-NCAM completely loses the DA binding activity, whereas it greatly diminishes but does not lose the BDNF binding activity. Third, an impairment of the polySia structure with an endosialidase modulates the DA-mediated Akt signaling. Taken together, impairment of the amount and quality of polySia may be involved in psychiatric disorders through impaired binding to BDNF and DA, which are deeply involved in schizophrenia and other psychiatric disorders, such as depression and bipolar disorder.	[Isomura, Ryo; Kitajima, Ken; Sato, Chihiro] Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan; [Isomura, Ryo; Kitajima, Ken; Sato, Chihiro] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan	Nagoya University; Nagoya University	Sato, C (corresponding author), Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan.	chi@agr.nagoya-u.ac.jp	SATO, Chihiro/B-7396-2014		Ministry of Education, Science, Sports, and Culture [20570107, 23570133]; Hayashi Foundation; CREST of Japan Science and Technology Agency	Ministry of Education, Science, Sports, and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Hayashi Foundation; CREST of Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST))	This research was supported in part by Grants-in-Aid for Scientific Research (C) 20570107 and 23570133 from the Ministry of Education, Science, Sports, and Culture and by the Hayashi Foundation (to C. S.) and by the CREST of Japan Science and Technology Agency (to K. K.).	Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; Angata K, 2003, BIOCHIMIE, V85, P195, DOI 10.1016/S0300-9084(03)00051-8; Angata K, 1998, J BIOL CHEM, V273, P28524, DOI 10.1074/jbc.273.43.28524; Angata K, 2004, J BIOL CHEM, V279, P32603, DOI 10.1074/jbc.M403429200; Angata K, 2007, MOL CELL BIOL, V27, P6659, DOI 10.1128/MCB.00205-07; Arai M, 2006, BIOL PSYCHIAT, V59, P652, DOI 10.1016/j.biopsych.2005.08.016; Asahina S, 2006, J BIOCHEM, V140, P687, DOI 10.1093/jb/mvj200; Ashe PC, 2001, PROG NEURO-PSYCHOPH, V25, P691, DOI 10.1016/S0278-5846(01)00159-2; BARBEAU D, 1995, P NATL ACAD SCI USA, V92, P2785, DOI 10.1073/pnas.92.7.2785; BAUMANN H, 1993, BIOCHEMISTRY-US, V32, P4007, DOI 10.1021/bi00066a022; Bonfanti L, 2006, PROG NEUROBIOL, V80, P129, DOI 10.1016/j.pneurobio.2006.08.003; Brocco M, 2003, J NEUROSCI RES, V74, P744, DOI 10.1002/jnr.10781; Calandreau L, 2010, GENES BRAIN BEHAV, V9, P958, DOI 10.1111/j.1601-183X.2010.00635.x; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Drake PM, 2008, J IMMUNOL, V181, P6850, DOI 10.4049/jimmunol.181.10.6850; ECKHARDT M, 1995, NATURE, V373, P715, DOI 10.1038/373715a0; Eckhardt M, 2000, J NEUROSCI, V20, P5234, DOI 10.1523/JNEUROSCI.20-14-05234.2000; Enomoto A, 2009, NEURON, V63, P774, DOI 10.1016/j.neuron.2009.08.015; Freyberg Z, 2010, AM J PSYCHIAT, V167, P388, DOI 10.1176/appi.ajp.2009.08121873; Guillin O, 2007, INT REV NEUROBIOL, V78, P377, DOI 10.1016/S0074-7742(06)78012-6; HALBERSTADT JB, 1993, ANAL BIOCHEM, V209, P136, DOI 10.1006/abio.1993.1093; Harrison PJ, 2004, PSYCHOPHARMACOLOGY, V174, P151, DOI 10.1007/s00213-003-1761-y; Kanato Y, 2009, BIOSCI BIOTECH BIOCH, V73, P2735, DOI 10.1271/bbb.90637; Kanato Y, 2008, GLYCOBIOLOGY, V18, P1044, DOI 10.1093/glycob/cwn084; KASAI KI, 1978, J BIOCHEM-TOKYO, V84, P1051, DOI 10.1093/oxfordjournals.jbchem.a132219; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; KOJIMA N, 1995, FEBS LETT, V373, P119, DOI 10.1016/0014-5793(95)01024-9; LACKIE PM, 1991, DIFFERENTIATION, V47, P85, DOI 10.1111/j.1432-0436.1991.tb00226.x; Lang UE, 2007, CELL PHYSIOL BIOCHEM, V20, P687, DOI 10.1159/000110430; MACKAY AVP, 1982, ARCH GEN PSYCHIAT, V39, P991; Maziade M, 2005, MOL PSYCHIATR, V10, P486, DOI 10.1038/sj.mp.4001594; Mikkonen M, 1999, EUR J NEUROSCI, V11, P1754, DOI 10.1046/j.1460-9568.1999.00593.x; Millar JK, 2001, MOL PSYCHIATR, V6, P173, DOI 10.1038/sj.mp.4000784; Murphy KJ, 2006, NEUROPSYCHOPHARMACOL, V31, P90, DOI 10.1038/sj.npp.1300810; Nakata D, 2005, J BIOL CHEM, V280, P38305, DOI 10.1074/jbc.M508762200; NAKAYAMA J, 1995, P NATL ACAD SCI USA, V92, P7031, DOI 10.1073/pnas.92.15.7031; Oizumi H, 2008, NEUROSCI RES, V60, P15, DOI 10.1016/j.neures.2007.09.004; Reif A, 2006, MOL PSYCHIATR, V11, P514, DOI 10.1038/sj.mp.4001791; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; Sato C, 1999, TRENDS GLYCOSCI GLYC, V11, P371, DOI 10.4052/tigg.11.371; SATO C, 1995, J BIOL CHEM, V270, P18923, DOI 10.1074/jbc.270.32.18923; Sato C, 1998, ANAL BIOCHEM, V261, P191, DOI 10.1006/abio.1998.2718; Sato C, 2010, METHOD ENZYMOL, V478, P219, DOI 10.1016/S0076-6879(10)78010-1; Schiff M, 2009, J NEUROCHEM, V110, P1661, DOI 10.1111/j.1471-4159.2009.06267.x; Schuster T, 2001, J NEUROBIOL, V49, P142, DOI 10.1002/neu.1071; SEKI T, 1993, NEUROSCI RES, V17, P265, DOI 10.1016/0168-0102(93)90111-3; SEKI T, 1991, NEUROSCI RES, V12, P503, DOI 10.1016/S0168-0102(09)80003-5; Seki T, 2004, TRENDS GLYCOSCI GLYC, V16, P319, DOI 10.4052/tigg.16.319; SEKI T, 1993, J NEUROSCI, V13, P2351, DOI 10.1523/JNEUROSCI.13-06-02351.1993; SOKOLOFF P, 1990, NATURE, V347, P146, DOI 10.1038/347146a0; Strous RD, 1997, PSYCHIAT RES, V69, P71, DOI 10.1016/S0165-1781(96)03111-3; Tan HY, 2008, J CLIN INVEST, V118, P2200, DOI [10.1172/JCI3472S, 10.1172/JCI34725]; Tateno H, 2007, NAT PROTOC, V2, P2529, DOI 10.1038/nprot.2007.357; TOMASIEWICZ H, 1993, NEURON, V11, P1163, DOI 10.1016/0896-6273(93)90228-J; TROY FA, 1996, BIOL SIALIC ACIDS, P95; Turetsky BI, 2003, ARCH GEN PSYCHIAT, V60, P1193, DOI 10.1001/archpsyc.60.12.1193; Uryu K, 1999, J COMP NEUROL, V405, P216, DOI 10.1002/(SICI)1096-9861(19990308)405:2<216::AID-CNE6>3.0.CO;2-6; Weinhold B, 2005, J BIOL CHEM, V280, P42971, DOI 10.1074/jbc.M511097200; Woods BT, 1998, AM J PSYCHIAT, V155, P1661, DOI 10.1176/ajp.155.12.1661; Xiao MF, 2009, J NEUROSCI, V29, P14752, DOI 10.1523/JNEUROSCI.4860-09.2009; Yoshimi K, 2005, ANN NEUROL, V58, P31, DOI 10.1002/ana.20506	62	89	90	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21535	21545		10.1074/jbc.M111.221143	http://dx.doi.org/10.1074/jbc.M111.221143			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21464126	Green Published, hybrid			2022-12-25	WOS:000291464700051
J	Kumar, A; Saigal, K; Malhotra, K; Sinha, KM; Taneja, B				Kumar, Atul; Saigal, Kashyap; Malhotra, Ketan; Sinha, Krishna Murari; Taneja, Bhupesh			Structural and Functional Characterization of Rv2966c Protein Reveals an RsmD-like Methyltransferase from Mycobacterium tuberculosis and the Role of Its N-terminal Domain in Target Recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							M(2) G-METHYLTRANSFERASES; RIBOSOMAL-RNA; DEPENDENT METHYLTRANSFERASE; SUBSTRATE-SPECIFICITY; CRYSTAL-STRUCTURE; GENE ENCODES; IN-VITRO; DNA; 16S; IDENTIFICATION	Nine of ten methylated nucleotides of Escherichia coli 16 S rRNA are conserved in Mycobacterium tuberculosis. All the 10 different methyltransferases are known in E. coli, whereas only TlyA and GidB have been identified in mycobacteria. Here we have identified Rv2966c of M. tuberculosis as an ortholog of RsmD protein of E. coli. We have shown that rv2966c can complement rsmD-deleted E. coli cells. Recombinant Rv2966c can use 30 S ribosomes purified from rsmD-deleted E. coli as substrate and methylate G966 of 16 S rRNA in vitro. Structure determination of the protein shows the protein to be a two-domain structure with a short hairpin domain at the N terminus and a C-terminal domain with the S-adenosylmethionine-MT-fold. We show that the N-terminal hairpin is a minimalist functional domain that helps Rv2966c in target recognition. Deletion of the N-terminal domain prevents binding to nucleic acid substrates, and the truncated protein fails to carry out the m(2)G966 methylation on 16 S rRNA. The N-terminal domain also binds DNA efficiently, a property that may be utilized under specific conditions of cellular growth.	[Saigal, Kashyap; Malhotra, Ketan; Sinha, Krishna Murari] IMM, New Delhi 110020, India; [Kumar, Atul; Taneja, Bhupesh] CSIR, Inst Genom & Integrat Biol, Delhi 110007, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Sinha, KM (corresponding author), IMM, 254 Okhla Ind Estate,Phase 3, New Delhi 110020, India.	krishna@immindia.org; btaneja@igib.res.in		Kumar, Atul/0000-0001-6839-2299; Malhotra, Ketan/0000-0002-3965-2431; Malhotra, Ketan/0000-0001-9934-8557	Council of Scientific and Industrial Research [FAC-02]; Institute of Molecular Medicine	Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Institute of Molecular Medicine	This work was supported by of Council of Scientific and Industrial Research Project Grant FAC-02 (to B. T.) This work was also supported by an institutional start-up fund from the Institute of Molecular Medicine (to K. M. S.).	Alangaden GJ, 1998, ANTIMICROB AGENTS CH, V42, P1295, DOI 10.1128/AAC.42.5.1295; Andersen NM, 2006, J MOL BIOL, V359, P777, DOI 10.1016/j.jmb.2006.04.007; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Basturea GN, 2007, RNA, V13, P1969, DOI 10.1261/rna.700507; Bheemanaik S, 2006, BIOCHEM J, V399, P177, DOI 10.1042/BJ20060854; BRIMACOMBE R, 1993, FASEB J, V7, P161, DOI 10.1096/fasebj.7.1.8422963; Buriankova K, 2004, ANTIMICROB AGENTS CH, V48, P143, DOI 10.1128/AAC.48.1.143-150.2004; Das G, 2008, EMBO J, V27, P840, DOI 10.1038/emboj.2008.20; Decatur WA, 2002, TRENDS BIOCHEM SCI, V27, P344, DOI 10.1016/S0968-0004(02)02109-6; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Dye C, 2002, J INFECT DIS, V185, P1197, DOI 10.1086/339818; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Falzari K, 2005, ANTIMICROB AGENTS CH, V49, P1447, DOI 10.1128/AAC.49.4.1447-1454.2005; Goedecke K, 2001, NAT STRUCT BIOL, V8, P121, DOI 10.1038/84104; Gong WM, 1997, NUCLEIC ACIDS RES, V25, P2702, DOI 10.1093/nar/25.14.2702; Gupta A, 2001, J MOL BIOL, V312, P381, DOI 10.1006/jmbi.2001.4935; Gutgsell NS, 2005, RNA, V11, P1141, DOI 10.1261/rna.2550105; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Jeltsch A, 1999, J BIOL CHEM, V274, P19538, DOI 10.1074/jbc.274.28.19538; Jeltsch A, 2001, BIOL CHEM, V382, P707, DOI 10.1515/BC.2001.084; Johansen SK, 2006, MOL CELL, V23, P173, DOI 10.1016/j.molcel.2006.05.044; Jugheli L, 2009, ANTIMICROB AGENTS CH, V53, P5064, DOI 10.1128/AAC.00851-09; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Lesnyak DV, 2007, J BIOL CHEM, V282, P5880, DOI 10.1074/jbc.M608214200; Lesnyak DV, 2006, J MOL BIOL, V364, P20, DOI 10.1016/j.jmb.2006.09.009; Maher D, 2005, CLIN CHEST MED, V26, P167, DOI 10.1016/j.ccm.2005.02.009; MALONE T, 1995, J MOL BIOL, V253, P618, DOI 10.1006/jmbi.1995.0577; Martin JL, 2002, CURR OPIN STRUC BIOL, V12, P783, DOI 10.1016/S0959-440X(02)00391-3; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Okamoto S, 2007, MOL MICROBIOL, V63, P1096, DOI 10.1111/j.1365-2958.2006.05585.x; Rastogi N, 2000, ANTIMICROB AGENTS CH, V44, P2848, DOI 10.1128/AAC.44.10.2848-2852.2000; Rice PA, 1996, CELL, V87, P1295, DOI 10.1016/S0092-8674(00)81824-3; Schaefer M, 2010, GENE DEV, V24, P1590, DOI 10.1101/gad.586710; Schaefer M, 2010, CHROMOSOMA, V119, P35, DOI 10.1007/s00412-009-0240-6; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Schubert HL, 2003, BIOCHEMISTRY-US, V42, P5592, DOI 10.1021/bi034026p; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Sergiev PV, 2006, J MOL BIOL, V364, P26, DOI 10.1016/j.jmb.2006.09.008; Shah NS, 2007, EMERG INFECT DIS, V13, P380, DOI 10.3201/eid1303.061400; Suzuki Y, 1998, J CLIN MICROBIOL, V36, P1220, DOI 10.1128/JCM.36.5.1220-1225.1998; Swinger KK, 2003, EMBO J, V22, P3749, DOI 10.1093/emboj/cdg351; Tscherne JS, 1999, J BIOL CHEM, V274, P924, DOI 10.1074/jbc.274.2.924; Varshney U, 2004, NUCLEIC ACIDS RES, V32, P1018, DOI 10.1093/nar/gkh207; World Health Organization, 2006, WHOHTM2006361	46	29	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19652	19661		10.1074/jbc.M110.200428	http://dx.doi.org/10.1074/jbc.M110.200428			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21474448	Green Published, hybrid			2022-12-25	WOS:000291027700048
J	Sato, Y; Hirayama, M; Morimoto, K; Yamamoto, N; Okuyama, S; Hori, K				Sato, Yuichiro; Hirayama, Makoto; Morimoto, Kinjiro; Yamamoto, Naoki; Okuyama, Satomi; Hori, Kanji			High Mannose-binding Lectin with Preference for the Cluster of alpha 1-2-Mannose from the Green Alga Boodlea coacta Is a Potent Entry Inhibitor of HIV-1 and Influenza Viruses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONCANONICAL GENETIC-CODE; FRESH-WATER CYANOBACTERIUM; CYANOVIRIN-N; INACTIVATING PROTEIN; OSCILLATORIA-AGARDHII; ANTIVIRAL ACTIVITIES; VIRAL HEMAGGLUTININ; ENVELOPED VIRUSES; PLANT-LECTINS; SPECIFICITY	The complete amino acid sequence of a lectin from the green alga Boodlea coacta (BCA), which was determined by a combination of Edman degradation of its peptide fragments and cDNA cloning, revealed the following: 1) B. coacta used a non-canonical genetic code (where TAA and TAG codons encode glutamine rather than a translation termination), and 2) BCA consisted of three internal tandem-repeated domains, each of which contains the sequence motif similar to the carbohydrate-binding site of Galanthus nivalis agglutinin-related lectins. Carbohydrate binding specificity of BCA was examined by a centrifugal ultrafiltration-HPLC assay using 42 pyridylaminated oligosaccharides. BCA bound to high mannose-type N-glycans but not to the complex-type, hybrid-type core structure of N-glycans or oligosaccharides from glycolipids. This lectin had exclusive specificity for alpha 1-2-linked mannose at the nonreducing terminus. The binding activity was enhanced as the number of terminal alpha 1-2-linked mannose substitutions increased. Mannobiose, mannotriose, and mannopentaose were incapable of binding to BCA. Thus, BCA preferentially recognized the nonreducing terminal alpha 1-2-mannose cluster as a primary target. As predicted from carbohydrate-binding propensity, this lectin inhibited the HIV-1 entry into the host cells at a half-maximal effective concentration of 8.2 nM. A high association constant (3.71 x 10(8) M-1) of BCA with the HIV envelope glycoprotein gp120 was demonstrated by surface plasmon resonance analysis. Moreover, BCA showed the potent anti-influenza activity by directly binding to viral envelope hemagglutinin against various strains, including a clinical isolate of pandemic H1N1-2009 virus, revealing its potential as an antiviral reagent.	[Sato, Yuichiro; Hirayama, Makoto; Okuyama, Satomi; Hori, Kanji] Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima 7398528, Japan; [Sato, Yuichiro; Morimoto, Kinjiro] Yasuda Womens Univ, Fac Pharm, Asaminami Ku, Hiroshima 7310153, Japan; [Yamamoto, Naoki] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Singapore 117597, Singapore	Hiroshima University; National University of Singapore	Hori, K (corresponding author), Hiroshima Univ, Grad Sch Biosphere Sci, Kagamiyama 1-4-4, Higashihiroshima 7398528, Japan.	kanhori@hiroshima-u.ac.jp			Japan Society of the Promotion of Science	Japan Society of the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by a grant-in-aid for scientific research (B) from Japan Society of the Promotion of Science.	Abe Y, 2004, J VIROL, V78, P9605, DOI 10.1128/JVI.78.18.9605-9611.2004; Balzarini Jan, 2007, Antiviral Chemistry & Chemotherapy, V18, P1; Balzarini J, 2007, NAT REV MICROBIOL, V5, P583, DOI 10.1038/nrmicro1707; Barre A, 1996, PLANT PHYSIOL, V112, P1531, DOI 10.1104/pp.112.4.1531; Barre A, 2001, BIOCHIMIE, V83, P645, DOI 10.1016/S0300-9084(01)01315-3; Barrientos LG, 2003, ANTIVIR RES, V58, P47, DOI 10.1016/S0166-3542(02)00183-3; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bewley CA, 1998, NAT STRUCT BIOL, V5, P571, DOI 10.1038/828; Bokesch HR, 2003, BIOCHEMISTRY-US, V42, P2578, DOI 10.1021/bi0205698; Botos I, 2005, PROG BIOPHYS MOL BIO, V88, P233, DOI 10.1016/j.pbiomolbio.2004.05.001; Botos I, 2002, J BIOL CHEM, V277, P34336, DOI 10.1074/jbc.M205909200; Boyd MR, 1997, ANTIMICROB AGENTS CH, V41, P1521, DOI 10.1128/AAC.41.7.1521; Calarese DA, 2005, P NATL ACAD SCI USA, V102, P13372, DOI 10.1073/pnas.0505763102; de Koning AP, 2008, ENVIRON MICROBIOL, V10, P65, DOI 10.1111/j.1462-2920.2007.01430.x; Dey B, 2000, J VIROL, V74, P4562, DOI 10.1128/JVI.74.10.4562-4569.2000; Fouquaert E, 2009, BIOCHEM BIOPH RES CO, V380, P260, DOI 10.1016/j.bbrc.2009.01.048; Fouquaert E, 2007, PLANT CELL PHYSIOL, V48, P1010, DOI 10.1093/pcp/pcm071; Gile GH, 2009, J EUKARYOT MICROBIOL, V56, P367, DOI 10.1111/j.1550-7408.2009.00411.x; Hartshorn KL, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-65; Helle F, 2006, J BIOL CHEM, V281, P25177, DOI 10.1074/jbc.M602431200; Hester G, 1996, J MOL BIOL, V262, P516, DOI 10.1006/jmbi.1996.0532; HORI K, 1986, BOT MAR, V29, P323, DOI 10.1515/botm.1986.29.4.323; Hori K, 2007, GLYCOBIOLOGY, V17, P479, DOI 10.1093/glycob/cwm007; Huskens D, 2008, INT J BIOCHEM CELL B, V40, P2802, DOI 10.1016/j.biocel.2008.05.023; Job ER, 2010, J IMMUNOL, V185, P4284, DOI 10.4049/jimmunol.1001613; Keeling PJ, 2003, J MOL BIOL, V326, P1337, DOI 10.1016/S0022-2836(03)00057-3; Keeling PJ, 1997, MOL BIOL EVOL, V14, P895, DOI 10.1093/oxfordjournals.molbev.a025832; Keeling PJ, 1996, EMBO J, V15, P2285, DOI 10.1002/j.1460-2075.1996.tb00581.x; Krishnamoorthy L, 2009, NAT CHEM BIOL, V5, P244, DOI 10.1038/nchembio.151; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEE YC, 1983, J BIOL CHEM, V258, P199; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lozupone CA, 2001, CURR BIOL, V11, P65, DOI 10.1016/S0960-9822(01)00028-8; MANDAL DK, 1994, EUR J BIOCHEM, V221, P547, DOI 10.1111/j.1432-1033.1994.tb18767.x; McFeeters RL, 2007, J MOL BIOL, V369, P451, DOI 10.1016/j.jmb.2007.03.030; MirShekari SY, 1997, J BIOL CHEM, V272, P4027, DOI 10.1074/jbc.272.7.4027; Mori T, 2005, J BIOL CHEM, V280, P9345, DOI 10.1074/jbc.M411122200; Mortell KH, 1996, J AM CHEM SOC, V118, P2297, DOI 10.1021/ja953574q; O'Keefe BR, 2010, J VIROL, V84, P2511, DOI 10.1128/JVI.02322-09; O'Keefe BR, 2003, ANTIMICROB AGENTS CH, V47, P2518, DOI 10.1128/AAC.47.8.2518-2525.2003; OKAMOTO R, 1990, EXPERIENTIA, V46, P975, DOI 10.1007/BF01939393; Parret AHA, 2005, APPL ENVIRON MICROB, V71, P5197, DOI 10.1128/AEM.71.9.5197-5207.2005; PAUWELS R, 1988, J VIROL METHODS, V20, P309, DOI 10.1016/0166-0934(88)90134-6; Peumans WJ, 2002, PLANT PHYSIOL, V129, P1054, DOI 10.1104/pp.010959; Rudiger H, 1998, ACTA ANAT, V161, P130; Sato Y, 2000, COMP BIOCHEM PHYS B, V125, P169, DOI 10.1016/S0305-0491(99)00164-9; Sato Y, 2007, J BIOL CHEM, V282, P11021, DOI 10.1074/jbc.M701252200; Sato Y, 2011, BIOCHEM BIOPH RES CO, V405, P291, DOI 10.1016/j.bbrc.2011.01.031; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHNEIDER SU, 1991, CURR GENET, V20, P173, DOI 10.1007/BF00312782; SCHNEIDER SU, 1989, MOL GEN GENET, V218, P445, DOI 10.1007/BF00332408; Shahzad-Ul-Hussan S, 2009, J AM CHEM SOC, V131, P16500, DOI 10.1021/ja905929c; Tanaka H, 2009, P NATL ACAD SCI USA, V106, P15633, DOI 10.1073/pnas.0907572106; TOURANCHEAU AB, 1995, EMBO J, V14, P3262, DOI 10.1002/j.1460-2075.1995.tb07329.x; Van Damme EJM, 2007, BIOCHEM J, V404, P51, DOI 10.1042/BJ20061819; VANDAMME EJM, 1992, EUR J BIOCHEM, V206, P413, DOI 10.1111/j.1432-1033.1992.tb16941.x; Williams DC, 2005, J BIOL CHEM, V280, P29269, DOI 10.1074/jbc.M504642200; Yamaguchi M, 1999, BIOCHEM BIOPH RES CO, V265, P703, DOI 10.1006/bbrc.1999.1749; Zhang M, 2004, GLYCOBIOLOGY, V14, P1229, DOI 10.1093/glycob/cwh106; Ziolkowska NE, 2006, ACTA BIOCHIM POL, V53, P617	60	52	57	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19446	19458		10.1074/jbc.M110.216655	http://dx.doi.org/10.1074/jbc.M110.216655			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21460211	Green Published, hybrid			2022-12-25	WOS:000291027700028
J	Lobito, AA; Ramani, SR; Tom, I; Bazan, JF; Luis, E; Fairbrother, WJ; Ouyang, WJ; Gonzalez, LC				Lobito, Adrian A.; Ramani, Sree R.; Tom, Irene; Bazan, J. Fernando; Luis, Elizabeth; Fairbrother, Wayne J.; Ouyang, Wenjun; Gonzalez, Lino C.			Murine Insulin Growth Factor-like (IGFL) and Human IGFL1 Proteins Are Induced in Inflammatory Skin Conditions and Bind to a Novel Tumor Necrosis Factor Receptor Family Member, IGFLR1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA TNF-ALPHA; INTERFERON-GAMMA; PSORIASIS; KERATINOCYTES; CELLS; LIGAND; IL-22; SUPERFAMILY; MONOTHERAPY; ENHANCEMENT	Psoriasis is a human skin condition characterized by epidermal hyperproliferation and infiltration of multiple leukocyte populations. In characterizing a novel insulin growth factor (IGF)-like (IGFL) gene in mice (mIGFL), we found transcripts of this gene to be most highly expressed in skin with enhanced expression in models of skin wounding and psoriatic-like inflammation. A possible functional ortholog in humans, IGFL1, was uniquely and significantly induced in psoriatic skin samples. In vitro IGFL1 expression was up-regulated in cultured primary keratinocytes stimulated with tumor necrosis factor alpha but not by other psoriasis-associated cytokines. Finally, using a secreted and transmembrane protein library, we discovered high affinity interactions between human IGFL1 and mIGFL and the TMEM149 ectodomain. TMEM149 (renamed here as IGFLR1) is an uncharacterized gene with structural similarity to the tumor necrosis factor receptor family. Our studies demonstrate that IGFLR1 is expressed primarily on the surface of mouse T cells. The connection between mIGFL and IGFLR1 receptor suggests mIGFL may influence T cell biology within inflammatory skin conditions.	[Lobito, Adrian A.; Ramani, Sree R.; Tom, Irene; Luis, Elizabeth; Gonzalez, Lino C.] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; [Bazan, J. Fernando; Fairbrother, Wayne J.] Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA; [Ouyang, Wenjun] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Gonzalez, LC (corresponding author), Genentech Inc, Dept Prot Chem, 1 DNA Way MS63, San Francisco, CA 94080 USA.	gonzalez.lino@gene.com	Gonzalez, Lino/E-4102-2012; Ouyang, Wenjun/ABA-8763-2020	Gonzalez, Lino/0000-0003-3817-6450; Ouyang, Wenjun/0000-0002-1811-5864				Albanesi C, 2007, CLIN DERMATOL, V25, P581, DOI 10.1016/j.clindermatol.2007.08.013; Banno T, 2003, ANTIVIR THER, V8, P541; Banno T, 2004, J BIOL CHEM, V279, P32633, DOI 10.1074/jbc.M400642200; Barker PA, 2004, NEURON, V42, P529, DOI 10.1016/j.neuron.2004.04.001; BETTINGER DA, 1994, J TRAUMA, V36, P810, DOI 10.1097/00005373-199406000-00010; Buck M, 1996, AM J PATHOL, V149, P195; Cai GF, 2008, NAT IMMUNOL, V9, P176, DOI 10.1038/ni1554; Chaudhari U, 2001, LANCET, V357, P1842, DOI 10.1016/S0140-6736(00)04954-0; Cheung TC, 2009, P NATL ACAD SCI USA, V106, P6244, DOI 10.1073/pnas.0902115106; Clark HF, 2003, GENOME RES, V13, P2265, DOI 10.1101/gr.1293003; Emtage P, 2006, GENOMICS, V88, P513, DOI 10.1016/j.ygeno.2006.05.012; ETTEHADI P, 1994, CLIN EXP IMMUNOL, V96, P146, DOI 10.1111/j.1365-2249.1994.tb06244.x; FLOCKNER H, 1995, PROTEINS, V23, P376, DOI 10.1002/prot.340230311; Freeman GJ, 2010, IMMUNOL REV, V235, P172, DOI 10.1111/j.0105-2896.2010.00903.x; Gonzalez LC, 2005, P NATL ACAD SCI USA, V102, P1116, DOI 10.1073/pnas.0409071102; Jubb Adrian M, 2006, Methods Mol Biol, V326, P255; KJELDSEN T, 1991, P NATL ACAD SCI USA, V88, P4404, DOI 10.1073/pnas.88.10.4404; Lai JJ, 2009, J CLIN INVEST, V119, P3739, DOI 10.1172/JCI39335; Leonardi CL, 2003, NEW ENGL J MED, V349, P2014, DOI 10.1056/NEJMoa030409; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Lowes MA, 2008, J INVEST DERMATOL, V128, P1207, DOI 10.1038/sj.jid.5701213; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Mori R, 2002, FASEB J, V16, P963, DOI 10.1096/fj.01-0776com; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; Naismith JH, 1998, TRENDS BIOCHEM SCI, V23, P74, DOI 10.1016/S0968-0004(97)01164-X; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Reich K, 2005, LANCET, V366, P1367, DOI 10.1016/S0140-6736(05)67566-6; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sa SM, 2007, J IMMUNOL, V178, P2229, DOI 10.4049/jimmunol.178.4.2229; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sano S, 2005, NAT MED, V11, P43, DOI 10.1038/nm1162; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Teunissen MBM, 1998, J INVEST DERMATOL, V111, P645, DOI 10.1046/j.1523-1747.1998.00347.x; Tonel G, 2009, INT J BIOCHEM CELL B, V41, P963, DOI 10.1016/j.biocel.2008.10.022; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Varki A, 2006, GLYCOBIOLOGY, V16, p1R, DOI 10.1093/glycob/cwj008; Vashisth H, 2010, J MOL BIOL, V400, P645, DOI 10.1016/j.jmb.2010.05.025; WARD CW, 1995, PROTEINS, V22, P141, DOI 10.1002/prot.340220207; Whitbeck JC, 1997, J VIROL, V71, P6083, DOI 10.1128/JVI.71.8.6083-6093.1997; Wolk K, 2006, EUR J IMMUNOL, V36, P1309, DOI 10.1002/eji.200535503; Wolk K, 2009, EUR J IMMUNOL, V39, P3570, DOI 10.1002/eji.200939687; Wolk K, 2009, J MOL MED, V87, P523, DOI 10.1007/s00109-009-0457-0; Wong AW, 2007, J BIOL CHEM, V282, P22953, DOI 10.1074/jbc.M611015200; Wong AW, 2010, BIOTECHNOL BIOENG, V106, P751, DOI 10.1002/bit.22749; Zhang GY, 2004, CURR OPIN STRUC BIOL, V14, P154, DOI 10.1016/j.sbi.2004.03.003	47	27	34	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18969	18981		10.1074/jbc.M111.224626	http://dx.doi.org/10.1074/jbc.M111.224626			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21454693	hybrid, Green Published			2022-12-25	WOS:000290785700068
J	Asmat, TM; Agarwal, V; Rath, S; Hildebrandt, JP; Hammerschmidt, S				Asmat, Tauseef M.; Agarwal, Vaibhav; Raeth, Susann; Hildebrandt, Jan-Peter; Hammerschmidt, Sven			Streptococcus pneumoniae Infection of Host Epithelial Cells via Polymeric Immunoglobulin Receptor Transiently Induces Calcium Release from Intracellular Stores	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LISTERIA-MONOCYTOGENES; SIGNAL-TRANSDUCTION; PHOSPHOLIPASE-C; MEDIATED INTERNALIZATION; SALMONELLA-TYPHIMURIUM; SECRETORY COMPONENT; VIRULENCE FACTORS; CA2+ ENTRY; PROTEIN; INVASION	The pneumococcal surface protein C (PspC) is a major adhesin of Streptococcus pneumoniae (pneumococci) that interacts in a human-specific manner with the ectodomain of the human polymeric immunoglobulin receptor (pIgR) produced by respiratory epithelial cells. This interaction promotes bacterial colonization and bacterial internalization by initiating host signal transduction cascades. Here, we examined alterations of intracellular calcium ([Ca2+](i)) levels in epithelial cells during host cell infections with pneumococci via the PspC-hpIgR mechanism. The release of [Ca2+](i) from intracellular stores in host cells was significantly increased by wild-type pneumococci but not by PspC-deficient pneumococci. The increase in [Ca2+](i) was dependent on phospholipase C as pretreatment of cells with a phospholipase C-specific inhibitor U73122 abolished the increase in [Ca2+](i). In addition, we demonstrated the effect of [Ca2+](i) on pneumococcal internalization by epithelial cells. Uptake of pneumococci was significantly increased after pretreatment of epithelial cells with the cell-permeable calcium chelator 1,2-bis-(o-aminophenoxy)-ethane-N,N,N' ,N' -tetraacetic acid-tetraacetoxymethyl ester or use of EGTA as an extracellular Ca2+ -chelating agent. In contrast, thapsigargin, an inhibitor of endoplasmic reticulum Ca2+ ATPase, which increases [Ca2+](i) in a sustained fashion, significantly reduced pIgR-mediated pneumococcal invasion. Importantly, pneumococcal adherence to pIgR-expressing cells was not altered in the presence of inhibitors as demonstrated by immunofluorescence microscopy. In conclusion, these results demonstrate that pneumococcal infections induce mobilization of [Ca2+](i) from intracellular stores. This may constitute a defense response of host cells as the experimental reduction of intracellular calcium levels facilitates pneumococcal internalization by pIgR-expressing cells, whereas elevated calcium levels diminished bacterial internalization by host epithelial cells.	[Asmat, Tauseef M.; Agarwal, Vaibhav; Hammerschmidt, Sven] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, Dept Genet Microorganisms, D-17487 Greifswald, Germany; [Raeth, Susann; Hildebrandt, Jan-Peter] Ernst Moritz Arndt Univ Greifswald, Inst Zool, D-17487 Greifswald, Germany	Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald	Hammerschmidt, S (corresponding author), Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, Dept Genet Microorganisms, Friedrich Ludwig Jahn Str 15A, D-17487 Greifswald, Germany.	sven.hammerschmidt@uni-greifswald.de	Asmat, Tauseef M/Q-3801-2019; Hammerschmidt, Sven/G-2598-2010	Hammerschmidt, Sven/0000-0002-6382-6681; Hildebrandt, Jan-Peter/0000-0001-7827-8481	Deutsche Forschungsgemeinschaft [HA 3125/2-1, HA 3125/4-1]; European Union [EU-CP223111]; Higher Education Commission of Pakistan; German Academic Exchange Service	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union(European Commission); Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported in part by Deutsche Forschungsgemeinschaft Grants HA 3125/2-1 and HA 3125/4-1 and European Union Grant EU FP7 CAREPNEUMO (EU-CP223111).; Recipient of a fellowship from the Higher Education Commission of Pakistan and German Academic Exchange Service.	Agarwal V, 2010, J BIOL CHEM, V285, P35615, DOI 10.1074/jbc.M110.172999; Agarwal V, 2009, J BIOL CHEM, V284, P19427, DOI 10.1074/jbc.M109.003442; Bergmann S, 2006, MICROBIOL-SGM, V152, P295, DOI 10.1099/mic.0.28610-0; Bergmann S, 2009, J CELL SCI, V122, P256, DOI 10.1242/jcs.035600; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bierne H, 2000, CELL MICROBIOL, V2, P465, DOI 10.1046/j.1462-5822.2000.00069.x; Birnbaumer L, 2000, RECENT PROG HORM RES, V55, P127; BLEASDALE JE, 1990, J PHARMACOL EXP THER, V255, P756; BOOTMAN MD, 1995, CELL, V83, P675, DOI 10.1016/0092-8674(95)90179-5; Boulay G, 1999, P NATL ACAD SCI USA, V96, P14955, DOI 10.1073/pnas.96.26.14955; Carafoli E, 2002, P NATL ACAD SCI USA, V99, P1115, DOI 10.1073/pnas.032427999; Cardone MH, 1996, J CELL BIOL, V133, P997, DOI 10.1083/jcb.133.5.997; Cartwright K, 2002, EUR J PEDIATR, V161, P188, DOI 10.1007/s00431-001-0907-3; Chang LC, 2000, EUR J PHARMACOL, V390, P61, DOI 10.1016/S0014-2999(00)00033-9; Denlinger LC, 1996, J BIOL CHEM, V271, P337, DOI 10.1074/jbc.271.1.337; Eichstaedt S, 2009, CELL CALCIUM, V45, P165, DOI 10.1016/j.ceca.2008.09.001; Elm C, 2004, J BIOL CHEM, V279, P6296, DOI 10.1074/jbc.M310528200; Eto DS, 2008, CELL MICROBIOL, V10, P2553, DOI 10.1111/j.1462-5822.2008.01229.x; Gekara NO, 2007, CELL MICROBIOL, V9, P2008, DOI 10.1111/j.1462-5822.2007.00932.x; Gewirtz AT, 2000, J CLIN INVEST, V105, P79, DOI 10.1172/JCI8066; Giffroy D, 2001, SCAND J IMMUNOL, V53, P56, DOI 10.1046/j.1365-3083.2001.00843.x; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hammerschmidt S, 2006, CURR OPIN MICROBIOL, V9, P12, DOI 10.1016/j.mib.2005.11.001; Hammerschmidt S, 1997, MOL MICROBIOL, V25, P1113, DOI 10.1046/j.1365-2958.1997.5391899.x; Hammerschmidt S, 2000, MOL MICROBIOL, V36, P726, DOI 10.1046/j.1365-2958.2000.01897.x; Hammerschmidt S, 2007, J IMMUNOL, V178, P5848, DOI 10.4049/jimmunol.178.9.5848; HORIKOSHI Y, 1994, BIOCHEM J, V304, P57, DOI 10.1042/bj3040057; Hu L, 2005, MICROBIOL-SGM, V151, P3097, DOI 10.1099/mic.0.27866-0; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Lu L, 2003, J BIOL CHEM, V278, P48178, DOI 10.1074/jbc.M306906200; MAJEED M, 1994, INFECT IMMUN, V62, P126, DOI 10.1128/IAI.62.1.126-134.1994; PACE J, 1993, CELL, V72, P505, DOI 10.1016/0092-8674(93)90070-7; Rennemeier C, 2007, FASEB J, V21, P3118, DOI 10.1096/fj.06-7992com; Repp H, 2002, CELL MICROBIOL, V4, P483, DOI 10.1046/j.1462-5822.2002.00207.x; Rose F, 2001, INFECT IMMUN, V69, P897, DOI 10.1128/IAI.69.2.897-905.2001; RUSCHKOWSKI S, 1992, FEMS MICROBIOL LETT, V95, P121; Saha S, 2005, TOXICON, V45, P361, DOI 10.1016/j.toxicon.2004.11.007; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; THOMPSON AK, 1991, J BIOL CHEM, V266, P23856; TSIEN RY, 1989, METHOD CELL BIOL, V30, P127; van Haasteren G, 1999, J RECEPT SIGNAL TR R, V19, P481, DOI 10.3109/10799899909036666; Wadsworth SJ, 1999, INFECT IMMUN, V67, P1770; Wu J, 2000, MOL PHARMACOL, V58, P1368, DOI 10.1124/mol.58.6.1368; Yordy JS, 2000, ONCOGENE, V19, P6503, DOI 10.1038/sj.onc.1204036; Yoshihara M, 2004, NEUROSCIENTIST, V10, P566, DOI 10.1177/1073858404268770; Zhang JR, 2000, CELL, V102, P827, DOI 10.1016/S0092-8674(00)00071-4	46	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17861	17869		10.1074/jbc.M110.212225	http://dx.doi.org/10.1074/jbc.M110.212225			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454571	Green Published, hybrid			2022-12-25	WOS:000290585200049
J	Chien, R; Zeng, WH; Kawauchi, S; Bender, MA; Santos, R; Gregson, HC; Schmiesing, JA; Newkirk, DA; Kong, XD; Ball, AR; Calof, AL; Lander, AD; Groudine, MT; Yokomori, K				Chien, Richard; Zeng, Weihua; Kawauchi, Shimako; Bender, M. A.; Santos, Rosaysela; Gregson, Heather C.; Schmiesing, John A.; Newkirk, Daniel A.; Kong, Xiangduo; Ball, Alexander R., Jr.; Calof, Anne L.; Lander, Arthur D.; Groudine, Mark T.; Yokomori, Kyoko			Cohesin Mediates Chromatin Interactions That Regulate Mammalian beta-globin Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOCUS-CONTROL REGION; GENE-EXPRESSION; ERYTHROID-DIFFERENTIATION; SACCHAROMYCES-CEREVISIAE; HEMOGLOBIN SYNTHESIS; ACTIVE CHROMATIN; NIPPED-B; CTCF; TRANSCRIPTION; PROTEIN	The beta-globin locus undergoes dynamic chromatin interaction changes in differentiating erythroid cells that are thought to be important for proper globin gene expression. However, the underlying mechanisms are unclear. The CCCTC-binding factor, CTCF, binds to the insulator elements at the 5' and 3' boundaries of the locus, but these sites were shown to be dispensable for globin gene activation. We found that, upon induction of differentiation, cohesin and the cohesin loading factor Nipped-B-like (Nipbl) bind to the locus control region (LCR) at the CTCF insulator and distal enhancer regions as well as at the specific target globin gene that undergoes activation upon differentiation. Nipbl-dependent cohesin binding is critical for long-range chromatin interactions, both between the CTCF insulator elements and between the LCR distal enhancer and the target gene. We show that the latter interaction is important for globin gene expression in vivo and in vitro. Furthermore, the results indicate that such cohesin-mediated chromatin interactions associated with gene regulation are sensitive to the partial reduction of Nipbl caused by heterozygous mutation. This provides the first direct evidence that Nipbl haploinsufficiency affects cohesin-mediated chromatin interactions and gene expression. Our results reveal that dynamic Nipbl/cohesin binding is critical for developmental chromatin organization and the gene activation function of the LCR in mammalian cells.	[Yokomori, Kyoko] Univ Calif Irvine, Sch Med, Dept Biol Chem, Irvine, CA 92697 USA; [Kawauchi, Shimako; Santos, Rosaysela; Calof, Anne L.] Univ Calif Irvine, Sch Med, Dept Anat & Neurobiol, Irvine, CA 92697 USA; [Lander, Arthur D.] Univ Calif Irvine, Sch Biol Sci, Dept Dev & Cell Biol, Irvine, CA 92697 USA; [Bender, M. A.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Groudine, Mark T.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Yokomori, K (corresponding author), Univ Calif Irvine, Sch Med, Dept Biol Chem, Irvine, CA 92697 USA.	kyokomor@uci.edu	Lander, Arthur/L-2827-2019; Calof, Anne/A-8644-2013; Lander, Arthur D/C-9008-2011; Zeng, Weihua/E-9146-2012	Lander, Arthur/0000-0002-4380-5525; Calof, Anne/0000-0003-3676-2499; Lander, Arthur D/0000-0002-4380-5525; 	National Institutes of Health [HD052860, DK044746, HL065440, AR058548, HD062951, T32 CA113265]; FSH Society [FSHS-DHY-001, FSHS-DHY-002]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD052860, T32HD060555] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD062951] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA062203, T32CA113265] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR058548] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044746, R37DK044746] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FSH Society; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HD052860 (to A. D. L. and A. L. C.), DK044746 (to M. T. G.), HL065440 (to M. T. G.), AR058548 (to K. Y.), HD062951 (to K. Y.), and T32 CA113265 (to R. C.). This work was also supported by FSH Society Helen Younger and David Younger Fellowship Grant FSHS-DHY-001 (to K. Y.) and FSHS-DHY-002 (to W. Z.).	Alami R, 2000, GENOMICS, V63, P417, DOI 10.1006/geno.1999.6104; ANDREWS NC, 1993, NATURE, V362, P722, DOI 10.1038/362722a0; Bausch C, 2007, MOL CELL BIOL, V27, P8522, DOI 10.1128/MCB.01007-07; Bender MA, 2006, BLOOD, V108, P1395, DOI 10.1182/blood-2006-04-014431; Bender MA, 1998, BLOOD, V92, P4394, DOI 10.1182/blood.V92.11.4394.423k48_4394_4403; BENZ EJ, 1980, P NATL ACAD SCI-BIOL, V77, P3509, DOI 10.1073/pnas.77.6.3509; Brand M, 2004, NAT STRUCT MOL BIOL, V11, P73, DOI 10.1038/nsmb713; Bulger M, 2010, DEV BIOL, V339, P250, DOI 10.1016/j.ydbio.2009.11.035; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; Donze D, 1999, GENE DEV, V13, P698, DOI 10.1101/gad.13.6.698; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Douay Luc, 2009, V482, P127, DOI 10.1007/978-1-59745-060-7_8; Drissen R, 2004, GENE DEV, V18, P2485, DOI 10.1101/gad.317004; Farrell CM, 2002, MOL CELL BIOL, V22, P3820, DOI 10.1128/MCB.22.11.3820-3831.2002; Farrell CM, 2000, P NATL ACAD SCI USA, V97, P14554, DOI 10.1073/pnas.97.26.14554; FRIEND C, 1971, P NATL ACAD SCI USA, V68, P378; Hadjur S, 2009, NATURE, V460, P410, DOI 10.1038/nature08079; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Hallson G, 2008, P NATL ACAD SCI USA, V105, P12405, DOI 10.1073/pnas.0801698105; Hou CH, 2010, P NATL ACAD SCI USA, V107, P3651, DOI 10.1073/pnas.0912087107; Jahnke P, 2008, NUCLEIC ACIDS RES, V36, P6450, DOI 10.1093/nar/gkn688; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kawauchi S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000650; Kogut I, 2009, GENE DEV, V23, P2345, DOI 10.1101/gad.1819409; Kong X, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp221; Kooren J, 2007, J BIOL CHEM, V282, P16544, DOI 10.1074/jbc.M701159200; KOVACH JS, 1967, J MOL BIOL, V25, P131, DOI 10.1016/0022-2836(67)90284-7; Lechner MS, 2005, BIOCHEM BIOPH RES CO, V331, P929, DOI 10.1016/j.bbrc.2005.04.016; Lengronne A, 2004, NATURE, V430, P573, DOI 10.1038/nature02742; Li QL, 2002, BLOOD, V100, P3077, DOI 10.1182/blood-2002-04-1104; Liu J, 2009, CLIN GENET, V76, P303, DOI 10.1111/j.1399-0004.2009.01271.x; Mishiro T, 2009, EMBO J, V28, P1234, DOI 10.1038/emboj.2009.81; Misulovin Z, 2008, CHROMOSOMA, V117, P89, DOI 10.1007/s00412-007-0129-1; Nativio R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000739; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Rollins RA, 2004, MOL CELL BIOL, V24, P3100, DOI 10.1128/MCB.24.8.3100-3111.2004; Rubio ED, 2008, P NATL ACAD SCI USA, V105, P8309, DOI 10.1073/pnas.0801273105; Schmidt D, 2010, GENOME RES, V20, P578, DOI 10.1101/gr.100479.109; Schneider R, 2007, GENE DEV, V21, P3027, DOI 10.1101/gad.1604607; Song SH, 2007, MOL CELL, V28, P810, DOI 10.1016/j.molcel.2007.09.025; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; Stedman W, 2008, EMBO J, V27, P654, DOI 10.1038/emboj.2008.1; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Vakoc CR, 2005, MOL CELL, V17, P453, DOI 10.1016/j.molcel.2004.12.028; Wada Y, 2009, P NATL ACAD SCI USA, V106, P18357, DOI 10.1073/pnas.0902573106; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Wood AJ, 2010, NAT REV GENET, V11, P391, DOI 10.1038/nrg2794; Zeng WH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000559; Zlatanova J, 2009, J CELL SCI, V122, P1275, DOI 10.1242/jcs.039990	51	71	77	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17870	17878		10.1074/jbc.M110.207365	http://dx.doi.org/10.1074/jbc.M110.207365			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454523	Green Published, hybrid			2022-12-25	WOS:000290585200050
J	Fox, JH; Connor, T; Stiles, M; Kama, J; Lu, Z; Dorsey, K; Liebermann, G; Sapp, E; Cherny, RA; Banks, M; Volitakis, I; DiFiglia, M; Berezovska, O; Bush, AI; Hersch, SM				Fox, Jonathan H.; Connor, Teal; Stiles, Megan; Kama, Jibrin; Lu, Zhen; Dorsey, Kathryn; Liebermann, Gregory; Sapp, Ellen; Cherny, Robert A.; Banks, Mary; Volitakis, Irene; DiFiglia, Marian; Berezovska, Oksana; Bush, Ashley I.; Hersch, Steven M.			Cysteine Oxidation within N-terminal Mutant Huntingtin Promotes Oligomerization and Delays Clearance of Soluble Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE MODEL; BASAL GANGLIA; IN-VIVO; DISEASE; METABOLISM; STRESS; ACID; NEURODEGENERATION; CONFORMATION; DEGRADATION	Huntington disease (HD) is a progressive neurodegenerative disorder caused by expression of polyglutamine-expanded mutant huntingtin protein (mhtt). Most evidence indicates that soluble mhtt species, rather than insoluble aggregates, are the important mediators of HD pathogenesis. However, the differential roles of soluble monomeric and oligomeric mhtt species in HD and the mechanisms of oligomer formation are not yet understood. We have shown previously that copper interacts with and oxidizes the polyglutamine-containing N171 fragment of huntingtin. In this study we report that oxidation-dependent oligomers of huntingtin form spontaneously in cell and mouse HD models. Levels of these species are modulated by copper, hydrogen peroxide, and glutathione. Mutagenesis of all cysteine residues within N171 blocks the formation of these oligomers. In cells, levels of oligomerization-blocked mutant N171 were decreased compared with native N171. We further show that a subset of the oligomerization-blocked form of glutamine-expanded N171 huntingtin is rapidly depleted from the soluble pool compared with "native" mutant N171. Taken together, our data indicate that huntingtin is subject to specific oxidations that are involved in the formation of stable oligomers and that also delay removal from the soluble pool. These findings show that inhibiting formation of oxidation-dependent huntingtin oligomers, or promoting their dissolution, may have protective effects in HD by decreasing the burden of soluble mutant huntingtin.	[Fox, Jonathan H.; Stiles, Megan; Lu, Zhen] Univ Wyoming, Dept Vet Sci, Laramie, WY 82071 USA; [Fox, Jonathan H.; Stiles, Megan; Lu, Zhen] Univ Wyoming, Grad Program Neurosci, Laramie, WY 82071 USA; [Fox, Jonathan H.; Connor, Teal; Kama, Jibrin; Dorsey, Kathryn; Liebermann, Gregory; Sapp, Ellen; Banks, Mary; DiFiglia, Marian; Berezovska, Oksana; Hersch, Steven M.] MassGen Inst Neurodegenerat Dis, Charlestown, MA 02129 USA; [Cherny, Robert A.; Volitakis, Irene; Bush, Ashley I.] Mental Hlth Res Inst Victoria, Parkville, Vic 3052, Australia	University of Wyoming; University of Wyoming	Fox, JH (corresponding author), 1174 Snowy Range Rd, Laramie, WY 82070 USA.	jfox7@uwyo.edu	Bush, Ashley/Y-2457-2019; Bush, Ashley I/A-1186-2007	Bush, Ashley/0000-0001-8259-9069; Bush, Ashley I/0000-0001-8259-9069; Volitakis, Irene/0000-0003-0766-817X	National Institutes of Health [NS045806, 5P20RR015640-10, 1R21NS072372]; Huntington's Disease Society of America; Cure Huntington's Disease initiative; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015640] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS045806, R21NS072372] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Huntington's Disease Society of America; Cure Huntington's Disease initiative; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS045806 (to S. H.), 5P20RR015640-10 (to University of Wyoming Neuroscience COBRE), and 1R21NS072372 (to J. F.). This work was also supported by Huntington's Disease Society of America awards (to S. H. (Coalition for the Cure) and J. F.) and also by the Cure Huntington's Disease initiative (to S. H.).	Sorolla MA, 2010, FREE RADICAL BIO MED, V49, P612, DOI 10.1016/j.freeradbiomed.2010.05.016; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Azzu V, 2010, BIOCHEM J, V426, P13, DOI 10.1042/BJ20091321; Berezovska O, 2005, J NEUROSCI, V25, P3009, DOI 10.1523/JNEUROSCI.0364-05.2005; Bogdanov MB, 2001, J NEUROCHEM, V79, P1246, DOI 10.1046/j.1471-4159.2001.00689.x; Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660; Browne SE, 1997, ANN NEUROL, V41, P646, DOI 10.1002/ana.410410514; Browne SE, 1999, BRAIN PATHOL, V9, P147; Cumming RC, 2004, J BIOL CHEM, V279, P21749, DOI 10.1074/jbc.M312267200; DeRooij KE, 1996, HUM MOL GENET, V5, P1093, DOI 10.1093/hmg/5.8.1093; DEXTER DT, 1991, BRAIN, V114, P1953, DOI 10.1093/brain/114.4.1953; Fox JH, 2004, J NEUROCHEM, V91, P413, DOI 10.1111/j.1471-4159.2004.02726.x; Fox JH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000334; FREEDMAN JH, 1989, J BIOL CHEM, V264, P5598; Fujiwara N, 2007, J BIOL CHEM, V282, P35933, DOI 10.1074/jbc.M702941200; Furukawa Y, 2004, EMBO J, V23, P2872, DOI 10.1038/sj.emboj.7600276; Gerber R, 2007, J BIOL CHEM, V282, P6300, DOI 10.1074/jbc.M608926200; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Hashemy SI, 2007, J BIOL CHEM, V282, P14428, DOI 10.1074/jbc.M700927200; Hillmer AS, 2010, BIOCHEM BIOPH RES CO, V391, P461, DOI 10.1016/j.bbrc.2009.11.080; Horng YC, 2005, J BIOL CHEM, V280, P34113, DOI 10.1074/jbc.M506801200; Jeong H, 2009, CELL, V137, P60, DOI 10.1016/j.cell.2009.03.018; Kegel KB, 2005, J BIOL CHEM, V280, P36464, DOI 10.1074/jbc.M503672200; Landles C, 2010, J BIOL CHEM, V285, P8808, DOI 10.1074/jbc.M109.075028; Legleiter J, 2010, J BIOL CHEM, V285, P14777, DOI 10.1074/jbc.M109.093708; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Menalled LB, 2003, J COMP NEUROL, V465, P11, DOI 10.1002/cne.10776; Nadanaka S, 2007, MOL CELL BIOL, V27, P1027, DOI 10.1128/MCB.00408-06; Sahara N, 2007, EUR J NEUROSCI, V25, P3020, DOI 10.1111/j.1460-9568.2007.05555.x; Sanchez I, 2003, NATURE, V421, P373, DOI 10.1038/nature01301; Sathyasaikumar KV, 2010, J NEUROCHEM, V113, P1416, DOI 10.1111/j.1471-4159.2010.06675.x; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Slow EJ, 2005, P NATL ACAD SCI USA, V102, P11402, DOI 10.1073/pnas.0503634102; Stadtman E. R., 2006, REDOX PROTEOMICS PRO, P10; Thompson LM, 2009, J CELL BIOL, V187, P1083, DOI 10.1083/jcb.200909067; Tsika E, 2010, J NEUROSCI, V30, P3409, DOI 10.1523/JNEUROSCI.4977-09.2010; Wang JJ, 2008, J CELL BIOL, V180, P1177, DOI 10.1083/jcb.200709080; Wanker EE, 1999, METHOD ENZYMOL, V309, P375; Woo HA, 2005, J BIOL CHEM, V280, P3125, DOI 10.1074/jbc.C400496200; Yanai A, 2006, NAT NEUROSCI, V9, P824, DOI 10.1038/nn1702; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200; Zainelli GM, 2003, J NEUROPATH EXP NEUR, V62, P14, DOI 10.1093/jnen/62.1.14	42	46	46	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					18320	18330		10.1074/jbc.M110.199448	http://dx.doi.org/10.1074/jbc.M110.199448			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454633	Green Published, hybrid			2022-12-25	WOS:000290585200092
J	Godard, F; Tetaud, E; Duvezin-Caubet, S; di Rago, JP				Godard, Francois; Tetaud, Emmanuel; Duvezin-Caubet, Stephane; di Rago, Jean-Paul			A Genetic Screen Targeted on the F-O Component of Mitochondrial ATP Synthase in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-RING ROTATION; NUCLEAR GENE; F1F0-ATP SYNTHASE; BUDDING YEAST; DELTA-SUBUNIT; OLI1 GENE; EXPRESSION; F-1-ATPASE; IDENTIFICATION; MECHANISM	In yeast, the two main F-O proton-translocating subunits of the ATP synthase (subunits 6/a and 9/c) are encoded by mitochondrial DNA (mtDNA). Unfortunately, mutations that inactivate the F-O typically result in loss of mtDNA under the form of rho(-)/rho(0) cells. Thus, we have designed a novel genetic strategy to circumvent this problem. It exploits previous findings that a null mutation in the nuclear ATP16 gene encoding ATP synthase subunit delta results in massive and lethal F-O-mediated protons leaks across the inner mitochondrial membrane. Mutations that inactivate the F-O can thus, in these conditions, be selected positively as cell viability rescuing events. A first set of seven mutants was analyzed and all showed, as expected, very severe F-O deficiencies. Two mutants carried nuclear mutations in known genes (AEP1, AEP2) required for subunit c expression. The five other mutations were located in mtDNA. Of these, three affect synthesis or stability of subunit a transcripts and the two last consisted in a single amino acid replacement in subunit c. One of the subunit c mutations is particularly interesting. It consists in an alanine to valine change at position 60 of subunit c adjacent to the essential glutamate of subunit c (at position 59) that interacts with the essential arginine 186 of subunit a. The properties of this mutant suggest that the contact zone between subunit a and the ten subunits c-ring structure only involves critical transient interactions confined to the region where protons are exchanged between the subunit a and the c-ring.	[Godard, Francois; Tetaud, Emmanuel; Duvezin-Caubet, Stephane; di Rago, Jean-Paul] Univ Bordeaux 2, CNRS, UMR 5095, Inst Biochim & Genet Cellulaires, F-33077 Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Tetaud, E (corresponding author), Univ Bordeaux 2, CNRS, UMR 5095, Inst Biochim & Genet Cellulaires, F-33077 Bordeaux, France.	tetaud@ibgc.cnrs.fr; jp.dirago@ibgc.cnrs.fr		Duvezin-Caubet, Stephane/0000-0002-0243-2697	Conseil Regional d'Aquitaine; Agence Nationale de la Recherche (ANR)	Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR))	This work was supported by grants from the Conseil Regional d'Aquitaine and the Agence Nationale de la Recherche (ANR).	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Ackerman SH, 2005, PROG NUCLEIC ACID RE, V80, P95, DOI 10.1016/S0079-6603(05)80003-0; ACKERMAN SH, 1991, FEBS LETT, V278, P234, DOI 10.1016/0014-5793(91)80124-L; ALLEN RD, 1995, PROTOPLASMA, V189, P1, DOI 10.1007/BF01280286; Arnold I, 1998, EMBO J, V17, P7170, DOI 10.1093/emboj/17.24.7170; Arselin G, 1996, J BIOL CHEM, V271, P20284, DOI 10.1074/jbc.271.34.20284; Bianchet MA, 1998, P NATL ACAD SCI USA, V95, P11065, DOI 10.1073/pnas.95.19.11065; Bonnefoy N, 2001, METHOD CELL BIOL, V65, P381, DOI 10.1016/S0091-679X(01)65022-2; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; CLAISSE ML, 1974, EUR J BIOCHEM, V49, P49, DOI 10.1111/j.1432-1033.1974.tb03810.x; Contamine V, 2000, MICROBIOL MOL BIOL R, V64, P281, DOI 10.1128/MMBR.64.2.281-315.2000; Dautant A, 2010, J BIOL CHEM, V285, P29502, DOI 10.1074/jbc.M110.124529; Devenish RJ, 2008, INT REV CEL MOL BIO, V267, P1, DOI 10.1016/S1937-6448(08)00601-1; Duvezin-Caubet S, 2003, P NATL ACAD SCI USA, V100, P13235, DOI 10.1073/pnas.2135169100; Duvezin-Caubet S, 2006, J BIOL CHEM, V281, P16305, DOI 10.1074/jbc.M513805200; Ellis TP, 2004, J BIOL CHEM, V279, P15728, DOI 10.1074/jbc.M314162200; Fillingame RH, 2002, BBA-BIOMEMBRANES, V1565, P232, DOI 10.1016/S0005-2736(02)00572-2; Fillingame RH, 2003, FEBS LETT, V555, P29, DOI 10.1016/S0014-5793(03)01101-3; FINNEGAN PM, 1995, FEBS LETT, V368, P505, DOI 10.1016/0014-5793(95)00727-Q; FINNEGAN PM, 1991, CURR GENET, V20, P53, DOI 10.1007/BF00312765; Fontanesi F, 2006, AM J PHYSIOL-CELL PH, V291, pC1129, DOI 10.1152/ajpcell.00233.2006; Giraud MF, 1997, EUR J BIOCHEM, V245, P813, DOI 10.1111/j.1432-1033.1997.00813.x; Guerin B, 1979, Methods Enzymol, V55, P149; Hong S, 2002, ARCH BIOCHEM BIOPHYS, V405, P38, DOI 10.1016/S0003-9861(02)00303-X; Jie LZ, 1999, EMBO J, V18, P58, DOI 10.1093/emboj/18.1.58; Kabaleeswaran V, 2006, EMBO J, V25, P5433, DOI 10.1038/sj.emboj.7601410; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lefebvre-Legendre L, 2003, MOL MICROBIOL, V47, P1329, DOI 10.1046/j.1365-2958.2003.03371.x; Lefebvre-Legendre L, 2001, J BIOL CHEM, V276, P6789, DOI 10.1074/jbc.M009557200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Meier T, 2009, J MOL BIOL, V391, P498, DOI 10.1016/j.jmb.2009.05.082; Mitome N, 2010, BIOCHEM J, V430, P171, DOI 10.1042/BJ20100621; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; PAUL MF, 1989, EUR J BIOCHEM, V185, P163, DOI 10.1111/j.1432-1033.1989.tb15098.x; PAUL MF, 1992, THESIS U BORDEAUX 2; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; PAYNE MJ, 1993, CURR GENET, V24, P126, DOI 10.1007/BF00324676; PAYNE MJ, 1991, CURR GENET, V19, P343, DOI 10.1007/BF00309594; Preiss L, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000443; Rak M, 2007, J BIOL CHEM, V282, P34039, DOI 10.1074/jbc.M703053200; Rak M, 2011, EMBO J, V30, P920, DOI 10.1038/emboj.2010.364; Rak M, 2009, P NATL ACAD SCI USA, V106, P18509, DOI 10.1073/pnas.0910351106; Rak M, 2009, BBA-MOL CELL RES, V1793, P108, DOI 10.1016/j.bbamcr.2008.07.001; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Senior AE, 2002, BBA-BIOENERGETICS, V1553, P188, DOI 10.1016/S0005-2728(02)00185-8; Steele DF, 1996, P NATL ACAD SCI USA, V93, P5253, DOI 10.1073/pnas.93.11.5253; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Stock D, 2000, CURR OPIN STRUC BIOL, V10, P672, DOI 10.1016/S0959-440X(00)00147-0; Tsunoda SP, 2001, P NATL ACAD SCI USA, V98, P898, DOI 10.1073/pnas.031564198; Velours J, 2000, J BIOENERG BIOMEMBR, V32, P383, DOI 10.1023/A:1005580020547; Voth WP, 2003, YEAST, V20, P985, DOI 10.1002/yea.1018; Zeng XM, 2007, MOL BIOL CELL, V18, P617, DOI 10.1091/mbc.E06-09-0801; ZIAJA K, 1993, J MOL BIOL, V229, P909, DOI 10.1006/jmbi.1993.1095	54	15	15	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					18181	18189		10.1074/jbc.M110.214825	http://dx.doi.org/10.1074/jbc.M110.214825			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454598	Green Published, hybrid			2022-12-25	WOS:000290585200078
J	Klenchin, VA; Frye, JJ; Jones, MH; Winey, M; Rayment, I				Klenchin, Vadim A.; Frye, Jeremiah J.; Jones, Michele H.; Winey, Mark; Rayment, Ivan			Structure-Function Analysis of the C-terminal Domain of CNM67, a Core Component of the Saccharomyces cerevisiae Spindle Pole Body	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIKELIHOOD DENSITY MODIFICATION; PREDICTING COILED COILS; CRYSTAL-STRUCTURE; ATOMIC STRUCTURES; SPACER PROTEIN; DUPLICATION; VECTORS; MICROTUBULES; TROPOMYOSIN; RECOGNITION	The spindle pole body of the budding yeast Saccharomyces cerevisiae has served as a model system for understanding microtubule organizing centers, yet very little is known about the molecular structure of its components. We report here the structure of the C-terminal domain of the core component Cnm67 at 2.3 angstrom resolution. The structure determination was aided by a novel approach to crystallization of proteins containing coiled-coils that utilizes globular domains to stabilize the coiled-coils. This enhances their solubility in Escherichia coli and improves their crystallization. The Cnm67 C-terminal domain (residues Asn-429-Lys-581) exhibits a previously unseen dimeric, interdigitated, all alpha-helical fold. In vivo studies demonstrate that this domain alone is able to localize to the spindle pole body. In addition, the structure reveals a large functionally indispensable positively charged surface patch that is implicated in spindle pole body localization. Finally, the C-terminal eight residues are disordered but are critical for protein folding and structural stability.	[Klenchin, Vadim A.; Frye, Jeremiah J.; Rayment, Ivan] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Jones, Michele H.; Winey, Mark] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	University of Wisconsin System; University of Wisconsin Madison; University of Colorado System; University of Colorado Boulder	Rayment, I (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.	ivan_rayment@biochem.wisc.edu	rayment, ivan/A-2720-2008	rayment, ivan/0000-0001-9279-7835	National Institutes of Health [GM083987, GM051312]; United States Department of Energy, Office of Energy Research [W-31-109-ENG-38]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083987, R01GM051312] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy, Office of Energy Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM083987 (to I. R.) and GM051312 (to M. W.).; We thank Dr. Dwight Anderson (University of Minnesota) for the expression vector encoding the scaffolding protein Gp7 from bacteriophage phi 29. We also thank Kirsten Dennison for help in constructing the Gp7 expression vector and construction of pKLD115 and Sean Newmister for recording the CD spectra. We thank Dr. Hazel Holden for help in the initial model building of Gp-Cnm67. Use of the Structural Biology BM19 beamline Argonne National Laboratory Advanced Photon Source was supported by the United States Department of Energy, Office of Energy Research, under Contract W-31-109-ENG-38.	Adams IR, 1999, J CELL BIOL, V145, P809, DOI 10.1083/jcb.145.4.809; Al-Bassam J, 2007, STRUCTURE, V15, P355, DOI 10.1016/j.str.2007.01.012; Aldaz H, 2005, NATURE, V435, P523, DOI 10.1038/nature03586; [Anonymous], 1991, Methods Enzymol, V194, P1; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BERGER B, 1995, P NATL ACAD SCI USA, V92, P8259, DOI 10.1073/pnas.92.18.8259; Blommel PG, 2007, PROTEIN EXPRES PURIF, V55, P53, DOI 10.1016/j.pep.2007.04.013; Brachat A, 1998, MOL BIOL CELL, V9, P977, DOI 10.1091/mbc.9.5.977; Bullitt E, 1997, CELL, V89, P1077, DOI 10.1016/S0092-8674(00)80295-0; Chen GJ, 2000, BIOTECHNIQUES, V28, P498, DOI 10.2144/00283st08; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Doxsey S, 2005, ANNU REV CELL DEV BI, V21, P411, DOI 10.1146/annurev.cellbio.21.122303.120418; Elliott S, 1999, P NATL ACAD SCI USA, V96, P6205, DOI 10.1073/pnas.96.11.6205; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Jaspersen SL, 2004, ANNU REV CELL DEV BI, V20, P1, DOI 10.1146/annurev.cellbio.20.022003.114106; KILMARTIN JV, 1993, J CELL BIOL, V123, P1175, DOI 10.1083/jcb.123.5.1175; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lau CK, 2004, EUKARYOT CELL, V3, P447, DOI 10.1128/EC.3.2.447-458.2004; Li S, 2006, J CELL BIOL, V173, P867, DOI 10.1083/jcb.200603153; Li Y, 2003, NATURE, V424, P341, DOI 10.1038/nature01801; Li Y, 2002, P NATL ACAD SCI USA, V99, P7378, DOI 10.1073/pnas.102179999; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; Morais MC, 2003, NAT STRUCT BIOL, V10, P572, DOI 10.1038/nsb939; Morrow JA, 2000, BIOCHEMISTRY-US, V39, P11657, DOI 10.1021/bi000099m; Muller EGD, 2005, MOL BIOL CELL, V16, P3341, DOI 10.1091/mbc.E05-03-0214; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; Nitanai Y, 2007, ADV EXP MED BIOL, V592, P137; O'Toole ET, 1999, MOL BIOL CELL, V10, P2017, DOI 10.1091/mbc.10.6.2017; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Rocco CJ, 2008, PLASMID, V59, P231, DOI 10.1016/j.plasmid.2008.01.001; Rose A, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-66; Schaerer F, 2001, MOL BIOL CELL, V12, P2519, DOI 10.1091/mbc.12.8.2519; Sibanda BL, 2001, NAT STRUCT BIOL, V8, P1015, DOI 10.1038/nsb725; SIKORSKI RS, 1989, GENETICS, V122, P19; Skubak P, 2004, ACTA CRYSTALLOGR D, V60, P2196, DOI 10.1107/S0907444904019079; Slep KC, 2005, J CELL BIOL, V168, P587, DOI 10.1083/jcb.200410114; Strelkov SV, 2002, EMBO J, V21, P1255, DOI 10.1093/emboj/21.6.1255; Terwilliger TC, 2001, ACTA CRYSTALLOGR D, V57, P1755, DOI 10.1107/S0907444901013737; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Terwilliger TC, 1997, ACTA CRYSTALLOGR D, V53, P571, DOI 10.1107/S0907444997005398; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606; Zizlsperger N, 2008, BIOCHEMISTRY-US, V47, P11858, DOI 10.1021/bi801378z	50	19	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					18240	18250		10.1074/jbc.M111.227371	http://dx.doi.org/10.1074/jbc.M111.227371			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454609	Green Published, hybrid			2022-12-25	WOS:000290585200084
J	Guo, Q; Fast, W				Guo, Qin; Fast, Walter			Citrullination of Inhibitor of Growth 4 (ING4) by Peptidylarginine Deminase 4 (PAD4) Disrupts the Interaction between ING4 and p53	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR ING4; MYELIN BASIC-PROTEIN; ARGININE DEIMINASE 4; STRUCTURAL BASIS; GENE-EXPRESSION; METHYLATION; BINDING; DEMETHYLIMINATION; ACTIVATION; DEACETYLATION	Gene expression is regulated by a number of interrelated posttranslational modifications of histones, including citrullination. For example, peptidylarginine deminase 4 (PAD4) converts peptidyl arginine to citrulline in histone H3 and can repress gene expression. However, regulation of gene expression through citrullination of non-histone proteins is less well defined. Herein, we identify a tumor suppressor protein, inhibitor of growth 4 (ING4), as a novel non-histone substrate of PAD4. ING4 is known to bind p53 via its nuclear localization signal (NLS) region and to enhance transcriptional activity of p53. We show that PAD4 preferentially citrullinates ING4 in the same NLS region and thereby disrupts the interaction between ING4 and p53. A citrulline-mimicking Arg-NLS-Gln ING4 mutant, which has all Arg residues in the NLS mutated to Gln, loses its affinity for p53, can no longer promote p53 acetylation, and results in repression of downstream p21 expression. In addition, we found that citrullination leads to increased susceptibility of ING4 to degradation, likely impacting p53-independent pathways as well. These findings elucidate an interaction between posttranslational citrullination, acetylation, and methylation and highlight an unusual mechanism whereby citrullination of a non-histone protein impacts gene regulation.	[Guo, Qin; Fast, Walter] Univ Texas Austin, Coll Pharm, Div Med Chem, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Fast, W (corresponding author), Univ Texas Austin, Coll Pharm, Div Med Chem, BME 6-202D,1 Univ Stn,C0850, Austin, TX 78712 USA.	waltfast@mail.utexas.edu			National Institutes of Health [GM69754]; Robert A. Welch Foundation [F-1572]; Texas Institute for Drug and Diagnostic Development [H-F-0032]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069754] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); Texas Institute for Drug and Diagnostic Development; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM69754. This work was also supported by grants from the Robert A. Welch Foundation (F-1572) and a seed grant from the Texas Institute for Drug and Diagnostic Development (Welch Foundation Grant H-F-0032).	Andrade F, 2010, ARTHRITIS RHEUM-US, V62, P1630, DOI 10.1002/art.27439; Arita K, 2006, P NATL ACAD SCI USA, V103, P5291, DOI 10.1073/pnas.0509639103; Arita K, 2004, NAT STRUCT MOL BIOL, V11, P777, DOI 10.1038/nsmb799; Bates IR, 2002, PROTEIN EXPRES PURIF, V25, P330, DOI 10.1016/S1046-5928(02)00017-7; Culurgioni S, 2010, ACTA CRYSTALLOGR F, V66, P567, DOI 10.1107/S1744309110010080; Cuthbert GL, 2004, CELL, V118, P545, DOI 10.1016/j.cell.2004.08.020; Denis H, 2009, MOL CELL BIOL, V29, P4982, DOI 10.1128/MCB.00285-09; Fang F, 2009, CANCER EPIDEM BIOMAR, V18, P409, DOI 10.1158/1055-9965.EPI-08-0575; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Jones JE, 2009, CURR OPIN DRUG DISC, V12, P616; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Lee YH, 2005, P NATL ACAD SCI USA, V102, P3611, DOI 10.1073/pnas.0407159102; Li M, 2009, J PATHOL, V219, P87, DOI 10.1002/path.2571; Li P, 2010, ONCOGENE, V29, P3153, DOI 10.1038/onc.2010.51; Li PX, 2008, MOL CELL BIOL, V28, P4745, DOI 10.1128/MCB.01747-07; Li XH, 2011, ORAL ONCOL, V47, P217, DOI 10.1016/j.oraloncology.2011.01.004; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; ORRENIUS S, 1994, J NEURAL TRANSM-SUPP, P1; Palacios A, 2008, J BIOL CHEM, V283, P15956, DOI 10.1074/jbc.M710020200; Palacios A, 2006, FEBS LETT, V580, P6903, DOI 10.1016/j.febslet.2006.11.055; Palacios A, 2010, J MOL BIOL, V396, P1117, DOI 10.1016/j.jmb.2009.12.049; Pritzker LB, 2000, BIOCHEMISTRY-US, V39, P5374, DOI 10.1021/bi9925569; Saha A, 2011, J VIROL, V85, P2079, DOI 10.1128/JVI.02279-10; Schreiber G, 2011, CURR OPIN STRUC BIOL, V21, P50, DOI 10.1016/j.sbi.2010.10.002; Shiseki M, 2003, CANCER RES, V63, P2373; Slack JL, 2011, CELL MOL LIFE SCI, V68, P709, DOI 10.1007/s00018-010-0480-x; Stensland ME, 2009, BIOL CHEM, V390, P99, DOI 10.1515/BC.2009.019; Stone EM, 2005, BIOCHEMISTRY-US, V44, P13744, DOI 10.1021/bi051341y; Struyf S, 2009, J IMMUNOL, V182, P666, DOI 10.4049/jimmunol.182.1.666; Tanikawa C, 2009, CANCER RES, V69, P8761, DOI 10.1158/0008-5472.CAN-09-2280; Tarcsa E, 1996, J BIOL CHEM, V271, P30709, DOI 10.1074/jbc.271.48.30709; Tsai KW, 2008, EXP CELL RES, V314, P3130, DOI 10.1016/j.yexcr.2008.08.002; Unoki M, 2009, CANCER SCI, V100, P1173, DOI 10.1111/j.1349-7006.2009.01183.x; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wang QS, 2010, HISTOPATHOLOGY, V57, P271, DOI 10.1111/j.1365-2559.2010.03623.x; Wang Y, 2004, SCIENCE, V306, P279, DOI 10.1126/science.1101400; Zhang X, 2005, BIOCHEM BIOPH RES CO, V331, P1032, DOI 10.1016/j.bbrc.2005.04.023	38	83	88	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17069	17078		10.1074/jbc.M111.230961	http://dx.doi.org/10.1074/jbc.M111.230961			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454715	Green Published, hybrid			2022-12-25	WOS:000290301900057
J	Siddals, KW; Allen, J; Sinha, S; Canfield, AE; Kalra, PA; Gibson, JM				Siddals, Kirk W.; Allen, Justine; Sinha, Smeeta; Canfield, Ann E.; Kalra, Philip A.; Gibson, J. Martin			Apposite Insulin-like Growth Factor (IGF) Receptor Glycosylation Is Critical to the Maintenance of Vascular Smooth Muscle Phenotype in the Presence of Factors Promoting Osteogenic Differentiation and Mineralization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-LINKED GLYCOSYLATION; BONE MORPHOGENETIC PROTEIN-2; COA REDUCTASE INHIBITORS; LIPID-LOWERING TREATMENT; HUMAN CAROTID ARTERIES; FACTOR-I; ATHEROSCLEROTIC LESIONS; AORTIC-STENOSIS; REGULATORY ROLE; MEVALONIC ACID	Vascular calcification is strongly linked with increased morbidity and mortality from cardiovascular disease. Vascular calcification is an active cell-mediated process that involves the differentiation of vascular smooth muscle cells (VSMCs) to an osteoblast-like phenotype. Several inhibitors of this process have been identified, including insulin-like growth factor-I (IGF-I). In this study, we examined the role of the IGF receptor (IGFR) and the importance of IGFR glycosylation in the maintenance of the VSMC phenotype in the face of factors known to promote osteogenic conversion. IGF-I (25 ng/ml) significantly protected VSMCs from beta-glycerophosphate-induced osteogenic differentiation (p < 0.005) and mineral deposition (p < 0.01). Mevalonic acid depletion (induced by 100 nM cerivastatin) significantly inhibited these IGF protective effects (p < 0.01). Mevalonic acid depletion impaired IGFR processing, decreased the expression of mature IGFRs at the cell surface, and inhibited the downstream activation of Akt and MAPK. Inhibitors of N-linked glycosylation (tunicamycin, deoxymannojirimycin, and deoxynojirimycin) also markedly attenuated the inhibitory effect of IGF-I on beta-glycerophosphate-induced mineralization (p < 0.05) and activation of Akt and MAPK. These results demonstrate that alterations in the glycosylation of the IGFR disrupt the ability of IGF-I to protect against the osteogenic differentiation and mineralization of VSMCs by several interrelated mechanisms: decreased IGFR processing, reduced IGFR cell-surface expression, and reduced downstream signaling via the Akt and MAPK pathways. IGF-I thus occupies a critical position in the maintenance of normal VSMC phenotype and protection from factors known to stimulate vascular calcification.	[Siddals, Kirk W.; Allen, Justine; Sinha, Smeeta; Kalra, Philip A.; Gibson, J. Martin] Salford Royal Fdn Trust, Vasc Res Grp, Salford M6 8HD, Lancs, England; [Siddals, Kirk W.; Allen, Justine; Sinha, Smeeta; Kalra, Philip A.; Gibson, J. Martin] Univ Manchester, Sch Canc & Enabling Sci, Imaging Genom & Prote Grp, Manchester M13 9PY, Lancs, England; [Canfield, Ann E.] Univ Manchester, Fac Med & Human Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England; [Canfield, Ann E.] Univ Manchester, Fac Med & Human Sci, Cardiovasc Res Grp, Manchester M13 9PT, Lancs, England	Salford Royal NHS Foundation Trust; University of Manchester; University of Manchester; University of Manchester	Siddals, KW (corresponding author), Salford Royal Fdn Trust, Vasc Res Grp, Clin Sci Bldg,Stott Lane, Salford M6 8HD, Lancs, England.	kirk.siddals@manchester.ac.uk		Canfield, Ann/0000-0002-8983-5674; gibson, martin/0000-0002-1331-1524				Abedin M, 2004, ARTERIOSCL THROM VAS, V24, P1161, DOI 10.1161/01.ATV.0000133194.94939.42; Arad Y, 2005, J AM COLL CARDIOL, V46, P166, DOI 10.1016/j.jacc.2005.02.089; Bellosta S, 2000, ANN MED, V32, P164, DOI 10.3109/07853890008998823; Bellosta S, 2000, DIABETES CARE, V23, pB72; Bellosta S, 1998, ATHEROSCLEROSIS, V137, pS101, DOI 10.1016/S0021-9150(97)00319-5; Benton JA, 2009, ARTERIOSCL THROM VAS, V29, P1950, DOI 10.1161/ATVBAHA.109.195271; BOSTROM K, 1993, J CLIN INVEST, V91, P1800, DOI 10.1172/JCI116391; Boucher K, 2006, MICROVASC RES, V71, P91, DOI 10.1016/j.mvr.2005.11.007; Burda P, 1999, BBA-GEN SUBJECTS, V1426, P239, DOI 10.1016/S0304-4165(98)00127-5; Carlberg M, 1996, J BIOL CHEM, V271, P17453, DOI 10.1074/jbc.271.29.17453; Cheng SL, 2003, J BIOL CHEM, V278, P45969, DOI 10.1074/jbc.M306972200; Clarke MCH, 2008, CIRC RES, V102, P1529, DOI 10.1161/CIRCRESAHA.108.175976; Collett GDM, 2005, CIRC RES, V96, P930, DOI 10.1161/01.RES.0000163634.51301.0d; COLLIER E, 1993, BIOCHEMISTRY-US, V32, P7818, DOI 10.1021/bi00081a029; Cowell SJ, 2005, NEW ENGL J MED, V352, P2389, DOI 10.1056/NEJMoa043876; Cuthbert JA, 1997, CANCER RES, V57, P3498; Demer LL, 2008, CIRCULATION, V117, P2938, DOI 10.1161/CIRCULATIONAHA.107.743161; Dricu A, 1999, GLYCOBIOLOGY, V9, P571, DOI 10.1093/glycob/9.6.571; Emmanuele L, 2003, BIOCHEM BIOPH RES CO, V302, P67, DOI 10.1016/S0006-291X(03)00109-8; FRINK RJ, 1970, AM J CARDIOL, V26, P241, DOI 10.1016/0002-9149(70)90790-3; FUHRMANN U, 1984, NATURE, V307, P755, DOI 10.1038/307755a0; Giachelli CM, 2004, J AM SOC NEPHROL, V15, P2959, DOI 10.1097/01.ASN.0000145894.57533.C4; Houslay ES, 2006, HEART, V92, P1207, DOI 10.1136/hrt.2005.080929; Hruska KA, 2005, CIRC RES, V97, P105, DOI 10.1161/01.RES.00000175571.53833.6c; Hwang JB, 1999, J BIOL CHEM, V274, P22813, DOI 10.1074/jbc.274.32.22813; Jaffe IZ, 2007, ARTERIOSCL THROM VAS, V27, P799, DOI 10.1161/01.ATV.0000258414.59393.89; Jeziorska M, 1998, J PATHOL, V185, P10; Jeziorska M, 1998, VIRCHOWS ARCH, V433, P559, DOI 10.1007/s004280050289; Kanazawa I, 2009, HORM METAB RES, V41, P612, DOI 10.1055/s-0029-1220684; Kizu A, 2004, J CELL BIOCHEM, V93, P1011, DOI 10.1002/jcb.20207; Konig J, 2006, N-S ARCH PHARMACOL, V372, P432, DOI 10.1007/s00210-006-0040-y; LANGAN TJ, 1991, J CELL PHYSIOL, V149, P284, DOI 10.1002/jcp.1041490215; LARSSON O, 1992, J CELL SCI, V103, P1065; Li XW, 2008, ATHEROSCLEROSIS, V199, P271, DOI 10.1016/j.atherosclerosis.2007.11.031; LODISH HF, 1984, J CELL BIOL, V98, P1720, DOI 10.1083/jcb.98.5.1720; Maeda T, 2003, ENDOCRINOLOGY, V144, P681, DOI 10.1210/en.2002-220682; Maeda T, 2004, J CELL BIOCHEM, V92, P458, DOI 10.1002/jcb.20074; MartinezGonzalez J, 1996, EUR J CLIN INVEST, V26, P1023, DOI 10.1046/j.1365-2362.1996.2550586.x; MCDOWELL W, 1988, BIOCHIMIE, V70, P1535, DOI 10.1016/0300-9084(88)90290-8; Monzack EL, 2009, ARTERIOSCL THROM VAS, V29, P246, DOI 10.1161/ATVBAHA.108.179218; Porter KE, 2002, J VASC SURG, V36, P150, DOI 10.1067/mva.2002.122029; Proudfoot D, 2000, CIRC RES, V87, P1055, DOI 10.1161/01.RES.87.11.1055; Proudfoot D, 1998, ARTERIOSCL THROM VAS, V18, P379, DOI 10.1161/01.ATV.18.3.379; Qiao JH, 2003, HUM PATHOL, V34, P402, DOI 10.1053/hupa.2003.72; Radcliff K, 2005, CIRC RES, V96, P398, DOI 10.1161/01.RES.0000157671.47477.71; Rossebo AB, 2008, NEW ENGL J MED, V359, P1343, DOI 10.1056/NEJMoa0804602; Schenk B, 2001, GLYCOBIOLOGY, V11, p61R, DOI 10.1093/glycob/11.5.61R; Schmermund A, 2006, CIRCULATION, V113, P427, DOI 10.1161/CIRCULATIONAHA.105.568147; Shroff RC, 2008, CIRCULATION, V118, P1748, DOI 10.1161/CIRCULATIONAHA.108.783738; Siddals KW, 2004, J BIOL CHEM, V279, P38353, DOI 10.1074/jbc.M404838200; SMITH PJ, 1988, J BIOL CHEM, V263, P9402; Son BK, 2006, CIRC RES, V98, P1024, DOI 10.1161/01.RES.0000218859.90970.8d; Takemoto M, 2001, ARTERIOSCL THROM VAS, V21, P1712, DOI 10.1161/hq1101.098486; Trion A, 2008, MOL CELL BIOCHEM, V308, P25, DOI 10.1007/s11010-007-9608-1; Valentinis B, 2001, J CLIN PATHOL-MOL PA, V54, P133, DOI 10.1136/mp.54.3.133; Wang M, 1999, EXP CELL RES, V246, P38, DOI 10.1006/excr.1998.4280; Wexler L, 1996, CIRCULATION, V94, P1175, DOI 10.1161/01.CIR.94.5.1175; Xi G, 2004, J CELL PHYSIOL, V200, P387, DOI 10.1002/jcp.20068	58	20	20	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16623	16630		10.1074/jbc.M110.202929	http://dx.doi.org/10.1074/jbc.M110.202929			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454560	hybrid, Green Published			2022-12-25	WOS:000290301900011
J	Su, D; Hu, Q; Zhou, H; Thompson, JR; Xu, RM; Zhang, ZG; Mer, G				Su, Dan; Hu, Qi; Zhou, Hui; Thompson, James R.; Xu, Rui-Ming; Zhang, Zhiguo; Mer, Georges			Structure and Histone Binding Properties of the Vps75-Rtt109 Chaperone-Lysine Acetyltransferase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTALLOGRAPHIC STRUCTURE DETERMINATION; DNA-REPLICATION; RTT109; ACETYLATION; H3; SOFTWARE; SPECIFICITY; ACTIVATION; PHENIX; MODEL	The histone chaperone Vps75 presents the remarkable property of stimulating the Rtt109-dependent acetylation of several histone H3 lysine residues within (H3-H4)(2) tetramers. To investigate this activation mechanism, we determined x-ray structures of full-length Vps75 in complex with full-length Rtt109 in two crystal forms. Both structures show similar asymmetric assemblies of a Vps75 dimer bound to an Rtt109 monomer. In the Vps75-Rtt109 complexes, the catalytic site of Rtt109 is confined to an enclosed space that can accommodate the N-terminal tail of histone H3 in (H3-H4)(2). Investigation of Vps75-Rtt109-(H3-H4)(2) and Vps75-(H3-H4)(2) complexes by NMR spectroscopy-probed hydrogen/deuterium exchange suggests that Vps75 guides histone H3 in the catalytic enclosure. These findings clarify the basis for the enhanced acetylation of histone H3 tail residues by Vps75-Rtt109.	[Su, Dan; Hu, Qi; Zhou, Hui; Zhang, Zhiguo; Mer, Georges] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Thompson, James R.] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA; [Xu, Rui-Ming] Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China	Mayo Clinic; Mayo Clinic; Chinese Academy of Sciences; Institute of Biophysics, CAS	Zhang, ZG (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, 200 First St SW, Rochester, MN 55905 USA.	zhang.zhiguo@mayo.edu; mer.georges@mayo.edu	xu, rui/GRX-5734-2022; Mer, Georges/AAT-4946-2021; hu, qi/K-1462-2014; su, dan/GYJ-1940-2022	Mer, Georges/0000-0002-1900-1578; 	National Institutes of Health [CA132878, GM81838]; United States Department of Energy [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [R01CA132878] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081838] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA132878 (to G. M.) and GM81838 (to Z. Z.).; We acknowledge the use of beamline 19-ID at the APS, Argonne National Laboratory. The APS is operated by UChicago Argonne, LLC, for the United States Department of Energy under Contract DE-AC02-06CH11357. We are grateful to Younchang Kim and Rongguang Zhang at the APS for expert assistance with x-ray data collection. We thank Karolin Luger and Aaron Hieb for the advice on histone purification. We thank Maria Victoria Botuyan for careful reading of the manuscript.	Adams PD, 2004, J SYNCHROTRON RADIAT, V11, P53, DOI 10.1107/S0909049503024130; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Albaugh BN, 2010, BIOCHEMISTRY-US, V49, P6375, DOI 10.1021/bi100381y; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Berndsen CE, 2008, NAT STRUCT MOL BIOL, V15, P948, DOI 10.1038/nsmb.1459; Burgess RJ, 2010, MOL CELL, V37, P469, DOI 10.1016/j.molcel.2010.01.020; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Driscoll R, 2007, SCIENCE, V315, P649, DOI 10.1126/science.1135862; Dyson HJ, 2008, FEBS LETT, V582, P1495, DOI 10.1016/j.febslet.2008.03.043; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; Fillingham J, 2008, MOL CELL BIOL, V28, P4342, DOI 10.1128/MCB.00182-08; Han JH, 2007, J BIOL CHEM, V282, P28587, DOI 10.1074/jbc.M702496200; Han JH, 2007, J BIOL CHEM, V282, P14158, DOI 10.1074/jbc.M700611200; Han JH, 2007, SCIENCE, V315, P653, DOI 10.1126/science.1133234; Kato H, 2009, J AM CHEM SOC, V131, P15104, DOI 10.1021/ja9070078; Kolonko EM, 2010, P NATL ACAD SCI USA, V107, P20275, DOI 10.1073/pnas.1009860107; Lin CQ, 2008, STRUCTURE, V16, P1503, DOI 10.1016/j.str.2008.07.006; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Natsume R, 2007, NATURE, V446, P338, DOI 10.1038/nature05613; Park YJ, 2008, NAT STRUCT MOL BIOL, V15, P957, DOI 10.1038/nsmb.1480; Ransom M, 2010, CELL, V140, P183, DOI 10.1016/j.cell.2010.01.004; Schneider J, 2006, J BIOL CHEM, V281, P37270, DOI 10.1074/jbc.C600265200; Stavropoulos P, 2008, P NATL ACAD SCI USA, V105, P12236, DOI 10.1073/pnas.0805813105; Tang Y, 2008, P NATL ACAD SCI USA, V105, P12206, DOI 10.1073/pnas.0802393105; Tsubota T, 2007, MOL CELL, V25, P703, DOI 10.1016/j.molcel.2007.02.006	29	32	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.C111.220715	http://dx.doi.org/10.1074/jbc.C111.220715			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454705	Green Published, hybrid			2022-12-25	WOS:000290022800002
J	Rolland, M; Frahm, N; Nickle, DC; Jojic, N; Deng, WJ; Allen, TM; Brander, C; Heckerman, DE; Mullins, JI				Rolland, Morgane; Frahm, Nicole; Nickle, David C.; Jojic, Nebojsa; Deng, Wenjie; Allen, Todd M.; Brander, Christian; Heckerman, David E.; Mullins, James I.			Increased Breadth and Depth of Cytotoxic T Lymphocytes Responses against HIV-1-B Nef by Inclusion of Epitope Variant Sequences	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CELLULAR IMMUNE-RESPONSES; RECOGNITION; VIREMIA	Different vaccine approaches cope with HIV-1 diversity, ranging from centralized(1-4) to variability-encompassing(5-7) antigens. For all these strategies, a concern remains: how does HIV-1 diversity impact epitope recognition by the immune system? We studied the relationship between HIV-1 diversity and CD8(+) T Lymphocytes (CTL) targeting of HIV-1 subtype B Nef using 944 peptides (10-mers overlapping by nine amino acids (AA)) that corresponded to consensus peptides and their most common variants in the HIV-1-B virus population. IFN-gamma ELISpot assays were performed using freshly isolated PBMC from 26 HIV-1-infected persons. Three hundred and fifty peptides elicited a response in at least one individual. Individuals targeted a median of 7 discrete regions. Overall, 33% of responses were directed against viral variants but not elicited against consensus-based test peptides. However, there was no significant relationship between the frequency of a 10-mer in the viral population and either its frequency of recognition (Spearman's correlation coefficient rho = 0.24) or the magnitude of the responses (rho = 0.16). We found that peptides with a single mutation compared to the consensus were likely to be recognized (especially if the change was conservative) and to elicit responses of similar magnitude as the consensus peptide. Our results indicate that cross-reactivity between rare and frequent variants is likely to play a role in the expansion of CTL responses, and that maximizing antigenic diversity in a vaccine may increase the breadth and depth of CTL responses. However, since there are few obvious preferred pathways to virologic escape, the diversity that may be required to block all potential escape pathways may be too large for a realistic vaccine to accommodate. Furthermore, since peptides were not recognized based on their frequency in the population, it remains unclear by which mechanisms variability-inclusive antigens (i.e., constructs enriched with frequent variants) expand CTL recognition.	[Rolland, Morgane; Nickle, David C.; Deng, Wenjie; Mullins, James I.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Frahm, Nicole; Allen, Todd M.; Brander, Christian] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA USA; [Jojic, Nebojsa; Brander, Christian] Hosp Badalona Germans Trias & Pujol, AIDS Res Inst IrsiCaixa HIVACAT, Barcelona, Spain; [Brander, Christian] ICREA, Barcelona, Spain; [Heckerman, David E.] Microsoft Res, Redmond, WA USA	University of Washington; University of Washington Seattle; Harvard University; Harvard Medical School; Massachusetts General Hospital; Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa; ICREA; Microsoft	Rolland, M (corresponding author), Henry M Jackson Fdn, Mil HIV Res Program, Rockville, MD 20852 USA.	mrolland@hivresearch.org	Allen, Todd/F-5473-2011; Nickle, David/ABF-2727-2020	Allen, Todd/0000-0002-6609-1318; Brander, Christian/0000-0002-0548-5778	Microsoft Research; Bill and Melinda Gates Foundation [43437]; amfAR [107005-43-RFNT]; Computational Biology Core of the University of Washington Centers for AIDS Research and STD (National Institutes of Health) [AI27757]; University of Washington Center for AIDS Research [P30 AI27757]; ICREA Funding Source: Custom; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI057005, P30AI027757] Funding Source: NIH RePORTER	Microsoft Research(Microsoft); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); amfAR; Computational Biology Core of the University of Washington Centers for AIDS Research and STD (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington Center for AIDS Research; ICREA(ICREA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by an unrestricted gift from Microsoft Research, the Bill and Melinda Gates Foundation (43437) and by grants to MR from amfAR (Mathilde Krim Fellowship - 107005-43-RFNT), the Computational Biology Core of the University of Washington Centers for AIDS Research and STD (National Institutes of Health AI27757), and a grant to JIM from the University of Washington Center for AIDS Research (P30 AI27757)(bioinformatics core). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. DEH is an employee of Microsoft Research and MR is currently employed by the Henry M. Jackson Foundation for the Advancement of Military Medicine (HJF) (this study was completed prior to MR's employment at HJF).	Barouch DH, 2010, NAT MED, V16, P319, DOI 10.1038/nm.2089; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Buseyne F, 2001, INT IMMUNOL, V13, P941, DOI 10.1093/intimm/13.7.941; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; DAYHOFF MO, 1965, J THEOR BIOL, V8, P97, DOI 10.1016/0022-5193(65)90096-2; Fischer W, 2007, NAT MED, V13, P100, DOI 10.1038/nm1461; Frahm N, 2005, J VIROL, V79, P10218, DOI 10.1128/JVI.79.16.10218-10225.2005; Frahm N, 2004, J VIROL, V78, P2187, DOI 10.1128/JVI.78.5.2187-2200.2004; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; Kent SJ, 1997, J INFECT DIS, V176, P1188, DOI 10.1086/514112; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; KLEIN MR, 1995, TRENDS MICROBIOL, V3, P386, DOI 10.1016/S0966-842X(00)88984-2; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Liu Y, 2006, J VIROL, V80, P9519, DOI 10.1128/JVI.00575-06; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; McKinney DM, 2004, J IMMUNOL, V173, P1941, DOI 10.4049/jimmunol.173.3.1941; McMichael AJ, 2001, NATURE, V410, P980, DOI 10.1038/35073658; Nickle DC, 2007, PLOS COMPUT BIOL, V3, P754, DOI 10.1371/journal.pcbi.0030075; Ogg GS, 1998, SCIENCE, V279, P2103, DOI 10.1126/science.279.5359.2103; Rolland M, 2007, PLOS PATHOG, V3, P1551, DOI 10.1371/journal.ppat.0030157; Rolland M, 2007, J VIROL, V81, P8507, DOI 10.1128/JVI.02683-06; Santra S, 2010, NAT MED, V16, P324, DOI 10.1038/nm.2108; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Yerly D, 2008, J IMMUNOL, V181, P6361, DOI 10.4049/jimmunol.181.9.6361	24	20	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e17969	10.1371/journal.pone.0017969	http://dx.doi.org/10.1371/journal.pone.0017969			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464919	gold, Green Published, Green Submitted			2022-12-25	WOS:000289053800009
J	Stegmaier, P; Voss, N; Meier, T; Kel, A; Wingender, E; Borlak, J				Stegmaier, Philip; Voss, Nico; Meier, Tatiana; Kel, Alexander; Wingender, Edgar; Borlak, Juergen			Advanced Computational Biology Methods Identify Molecular Switches for Malignancy in an EGF Mouse Model of Liver Cancer	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; TRANSCRIPTION FACTORS; STEM-CELLS; TUMOR-SUPPRESSOR; HUMAN BREAST; PROTEIN-1; PROMOTER; IDENTIFICATION; APOPTOSIS; BIOINFORMATICS	The molecular causes by which the epidermal growth factor receptor tyrosine kinase induces malignant transformation are largely unknown. To better understand EGFs' transforming capacity whole genome scans were applied to a transgenic mouse model of liver cancer and subjected to advanced methods of computational analysis to construct de novo gene regulatory networks based on a combination of sequence analysis and entrained graph-topological algorithms. Here we identified transcription factors, processes, key nodes and molecules to connect as yet unknown interacting partners at the level of protein-DNA interaction. Many of those could be confirmed by electromobility band shift assay at recognition sites of gene specific promoters and by western blotting of nuclear proteins. A novel cellular regulatory circuitry could therefore be proposed that connects cell cycle regulated genes with components of the EGF signaling pathway. Promoter analysis of differentially expressed genes suggested the majority of regulated transcription factors to display specificity to either the pre-tumor or the tumor state. Subsequent search for signal transduction key nodes upstream of the identified transcription factors and their targets suggested the insulin-like growth factor pathway to render the tumor cells independent of EGF receptor activity. Notably, expression of IGF2 in addition to many components of this pathway was highly upregulated in tumors. Together, we propose a switch in autocrine signaling to foster tumor growth that was initially triggered by EGF and demonstrate the knowledge gain form promoter analysis combined with upstream key node identification.	[Stegmaier, Philip; Voss, Nico; Kel, Alexander; Wingender, Edgar] BIOBASE GmbH, Wolfenbuettel, Germany; [Meier, Tatiana; Borlak, Juergen] Fraunhofer Inst Toxicol & Expt Med, Dept Mol Med & Med Biotechnol, Hannover, Germany; [Meier, Tatiana; Borlak, Juergen] Hannover Med Sch, Ctr Pharmacol & Toxicol, D-3000 Hannover, Germany; [Kel, Alexander; Wingender, Edgar] GeneXplain GmbH, Wolfenbuettel, Germany; [Kel, Alexander] Inst Chem Biol & Fundamental Med, Novosibirsk, Russia; [Wingender, Edgar] Univ Gottingen, Dept Bioinformat, Gottingen, Germany	Fraunhofer Gesellschaft; Hannover Medical School; Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; University of Gottingen	Stegmaier, P (corresponding author), BIOBASE GmbH, Wolfenbuettel, Germany.	juergen.borlak@item.fraunhofer.de	Kel, Alexander E/I-7284-2013	Wingender, Edgar/0000-0002-7729-8453	EU [LSHM-CT-2006-518153, LSHB-CT-2007-037590]; ETB; Russian Ministry Sciences and Education; Ministry of Science and Culture, Lower Saxony, Germany [25A.5-76251-99-3/00]	EU(European Commission); ETB; Russian Ministry Sciences and Education; Ministry of Science and Culture, Lower Saxony, Germany	Parts of the work were funded by EU grants "EuroDia" (LSHM-CT-2006-518153) and Net2Drug (LSHB-CT-2007-037590) and the ETB grant GlobCell and BMBF project TcellTalk as well as the program of intenational collaboration of the Russian Ministry Sciences and Education and Ministry of Science and Culture, Lower Saxony, Germany; Grant number: 25A.5-76251-99-3/00 to Juergen Borlak. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. PS, NV, AK, EW are employees of BIOBASE GmbH, Wolfenbuettel, Germany. AK is also an employee of Institute of Systems Biology Ltd., Novosibirsk, Russia.	Babaie Y, 2007, STEM CELLS, V25, P500, DOI 10.1634/stemcells.2006-0426; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Borlak J, 2005, ONCOGENE, V24, P1809, DOI 10.1038/sj.onc.1208196; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; Desbois-Mouthon C, 2006, INT J CANCER, V119, P2557, DOI 10.1002/ijc.22221; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; FIGUEROA JA, 1995, J CLIN ENDOCR METAB, V80, P3476, DOI 10.1210/jc.80.12.3476; Fu VX, 2004, J BIOL CHEM, V279, P52218, DOI 10.1074/jbc.M405015200; Fu YC, 2007, J BIOL CHEM, V282, P31525, DOI 10.1074/jbc.M701132200; GALSON DL, 1995, MOL CELL BIOL, V15, P2135; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Guo Y, 2002, P NATL ACAD SCI USA, V99, P3663, DOI 10.1073/pnas.062041099; Hayashida K, 2000, J IMMUNOL, V164, P1110, DOI 10.4049/jimmunol.164.2.1110; Hosui A, 2009, J EXP MED, V206, P819, DOI 10.1084/jem.20080003; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Jiang JT, 2006, LIPIDS HEALTH DIS, V5, DOI 10.1186/1476-511X-5-4; Jones HE, 2004, ENDOCR-RELAT CANCER, V11, P793, DOI 10.1677/erc.1.00799; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kel A, 2008, SAR QSAR ENVIRON RES, V19, P481, DOI 10.1080/10629360802083806; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kel AE, 2001, J MOL BIOL, V309, P99, DOI 10.1006/jmbi.2001.4650; Kel A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S2-S13; Kendziorski CM, 2003, STAT MED, V22, P3899, DOI 10.1002/sim.1548; Krull M, 2006, NUCLEIC ACIDS RES, V34, pD546, DOI 10.1093/nar/gkj107; Lopes EC, 2008, CANCER RES, V68, P7258, DOI 10.1158/0008-5472.CAN-08-0344; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Michael H, 2008, BRIEF BIOINFORM, V9, P518, DOI 10.1093/bib/bbn038; MIETUSSNYDER M, 1992, MOL CELL BIOL, V12, P1708, DOI 10.1128/MCB.12.4.1708; Morin S, 2000, EMBO J, V19, P2046, DOI 10.1093/emboj/19.9.2046; Nioi P, 2008, CHEM-BIOL INTERACT, V176, P252, DOI 10.1016/j.cbi.2008.09.005; Otaegi G, 2006, J CELL SCI, V119, P2739, DOI 10.1242/jcs.03012; Pham-Gia T, 2000, COMMUN STAT-THEOR M, V29, P2693, DOI 10.1080/03610920008832632; RAHMANN S, 2003, STAT APPL GENET MOL; Riedemann J, 2007, BIOCHEM BIOPH RES CO, V355, P700, DOI 10.1016/j.bbrc.2007.02.041; Sala A, 2005, EUR J CANCER, V41, P2479, DOI 10.1016/j.ejca.2005.08.004; Schmid CD, 2006, NUCLEIC ACIDS RES, V34, pD82, DOI 10.1093/nar/gkj146; Seth A, 2005, EUR J CANCER, V41, P2462, DOI 10.1016/j.ejca.2005.08.013; Shah JJ, 2009, LEUKEMIA, V23, P1964, DOI 10.1038/leu.2009.173; Shea CM, 2003, J CELL BIOCHEM, V90, P1112, DOI 10.1002/jcb.10734; Tai MH, 2005, CARCINOGENESIS, V26, P495, DOI 10.1093/carcin/bgh321; van Roy FM, 2005, NAT REV CANCER, V5, P956, DOI 10.1038/nrc1752; Ventii KH, 2008, CANCER RES, V68, P6953, DOI 10.1158/0008-5472.CAN-08-0365; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wingender E, 2007, J BIOSCIENCES, V32, P169, DOI 10.1007/s12038-007-0015-2; Yamashita R, 2010, NUCLEIC ACIDS RES, V38, pD98, DOI 10.1093/nar/gkp1017; Yang CQ, 2003, CANCER RES, V63, P8312; Yeh LCC, 2000, ENDOCRINOLOGY, V141, P3278, DOI 10.1210/en.141.9.3278; Zhang S, 2003, AM J PHYSIOL-LUNG C, V285, pL740, DOI 10.1152/ajplung.00284.2002	49	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e17738	10.1371/journal.pone.0017738	http://dx.doi.org/10.1371/journal.pone.0017738			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464922	gold, Green Published			2022-12-25	WOS:000289053800002
J	Power, BD; Alfonso, H; Flicker, L; Hankey, GJ; Yeap, BB; Almeida, OP				Power, Brian D.; Alfonso, Helman; Flicker, Leon; Hankey, Graeme J.; Yeap, Bu B.; Almeida, Osvaldo P.			Body Adiposity in Later Life and the Incidence of Dementia: The Health in Men Study	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; MASS INDEX; WAIST CIRCUMFERENCE; ALZHEIMER-DISEASE; LEPTIN LEVELS; FOLLOW-UP; OBESITY; ASSOCIATION; MIDLIFE; WEIGHT	Objective: To determine if adiposity in later life increases dementia hazard. Methods: Cohort study of 12,047 men aged 65-84 years living in Perth, Australia. Adiposity exposures were baseline body mass index (BMI), waist circumference (WC) and waist-to-hip ratio (WHR). We used the Western Australian Data Linkage System (WADLS) to establish the presence of new cases of dementia between 1996 and 2009 according to the International Classification of Diseases (ICD). Crude and adjusted hazard ratio (HR, 95% confidence interval, 95% CI) of dementia for each adiposity marker was calculated using Cox regression models. Other measured factors included age, marital status, education, alcohol use, smoking, diet, physical activity, and prevalent hypertension, diabetes, dyslipidaemia and cardiovascular disease. Results: Compared with men with BMI < 25, participants with BMI between 25-30 had lower adjusted HR of dementia (HR = 0.82, 95% CI = 0.70-0.95). The HR of dementia for men with BMI >= 30 was comparable to men with BMI, 25 (HR = 0.82, 95% CI = 0.67-1.01). Waist circumference showed no obvious association with dementia hazard. Men with WHR >= 0.9 had lower adjusted HR of dementia than men with WHR < 0.9 (HR = 0.82, 95% CI = 0.69-0.98). We found a "J" shape association between measures of obesity and the hazard of dementia, with the nadir of risk being in the overweight range of BMI and about 1 for WHR. Conclusions: Higher adiposity is not associated with incident dementia in this Australian cohort of older men. Overweight men and those with WHR >= 0.9 have lower hazard of dementia than men with normal weight and with WHR < 0.9.	[Power, Brian D.; Almeida, Osvaldo P.] Royal Perth Hosp, Dept Psychiat, Perth, WA, Australia; [Power, Brian D.; Alfonso, Helman; Flicker, Leon; Almeida, Osvaldo P.] Univ Western Australia, Western Australian Ctr Hlth & Ageing, Med Res Ctr, Perth, WA 6009, Australia; [Power, Brian D.; Alfonso, Helman; Almeida, Osvaldo P.] Univ Western Australia, Sch Psychiat & Clin Neurosci, Perth, WA 6009, Australia; [Flicker, Leon; Hankey, Graeme J.; Yeap, Bu B.] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Flicker, Leon] Royal Perth Hosp, Dept Geriatr Med, Perth, WA, Australia; [Hankey, Graeme J.] Royal Perth Hosp, Dept Neurol, Perth, WA, Australia; [Yeap, Bu B.] Fremantle Hosp, Dept Endocrinol & Diabet, Perth, WA, Australia	Royal Perth Hospital; University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia; Royal Perth Hospital; University of Western Australia; Royal Perth Hospital; University of Western Australia	Power, BD (corresponding author), Royal Perth Hosp, Dept Psychiat, Perth, WA, Australia.	osvaldo.almeida@uwa.edu.au	Hankey, Graeme J/H-4968-2014; Almeida, Osvaldo P./A-4925-2008; Flicker, Leon/AAE-1530-2022	Hankey, Graeme J/0000-0002-6044-7328; Almeida, Osvaldo P./0000-0002-8689-6199; Flicker, Leon/0000-0002-3650-0475	National Health and Medical Research Council of Australia (NHMRC) [279408, 379600, 403963]; BUPA Foundation of Australia [DS 080608]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); BUPA Foundation of Australia	This work was funded by competitive project grants from the National Health and Medical Research Council of Australia (NHMRC) numbers 279408, 379600, and 403963 to Hankey, Flicker, and Almeida (http://www.nhmrc.gov.au), and from the BUPA Foundation of Australia number DS 080608 to Almeida (http://www.bupa.com.au/Bupa/about-us/bupa-health-foundation/about). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atti AR, 2008, J AM GERIATR SOC, V56, P111, DOI 10.1111/j.1532-5415.2007.01458.x; Australian Institute of Health and Welfare, 2004, OB TRENDS OLD AUSTR; Boyko EJ, 2000, DIABETES CARE, V23, P465, DOI 10.2337/diacare.23.4.465; Bradshaw PJ, 2000, MED J AUSTRALIA, V172, P566, DOI 10.5694/j.1326-5377.2000.tb124115.x; Davidson TL, 2005, PHYSIOL BEHAV, V86, P731, DOI 10.1016/j.physbeh.2005.09.004; Fitzpatrick AL, 2009, ARCH NEUROL-CHICAGO, V66, P336, DOI 10.1001/archneurol.2008.582; Flicker L, 2010, J AM GERIATR SOC, V58, P234, DOI 10.1111/j.1532-5415.2009.02677.x; Gavin JR, 1997, DIABETES CARE, V20, P1183; Gustafson D, 2003, ARCH INTERN MED, V163, P1524, DOI 10.1001/archinte.163.13.1524; Gustafson DR, 2009, NEUROLOGY, V73, P1559, DOI 10.1212/WNL.0b013e3181c0d4b6; Harvey J, 2005, BIOCHEM SOC T, V33, P1029, DOI 10.1042/BST0331029; Harvey J, 2006, PROG LIPID RES, V45, P369, DOI 10.1016/j.plipres.2006.03.001; Hayden KM, 2006, ALZ DIS ASSOC DIS, V20, P93, DOI 10.1097/01.wad.0000213814.43047.86; Heiat A, 2001, ARCH INTERN MED, V161, P1194, DOI 10.1001/archinte.161.9.1194; Heinzl H, 1997, COMPUT METH PROG BIO, V54, P201, DOI 10.1016/S0169-2607(97)00043-6; Holman CDJ, 1999, AUST NZ J PUBL HEAL, V23, P453, DOI 10.1111/j.1467-842X.1999.tb01297.x; Janssen I, 2004, AM J CLIN NUTR, V79, P379; Kivipelto M, 2005, ARCH NEUROL-CHICAGO, V62, P1556, DOI 10.1001/archneur.62.10.1556; Klein S, 2007, DIABETES CARE, V30, P1647, DOI 10.2337/dc07-9921; Lieb W, 2009, JAMA-J AM MED ASSOC, V302, P2565, DOI 10.1001/jama.2009.1836; Luchsinger JA, 2007, ARCH NEUROL-CHICAGO, V64, P392, DOI 10.1001/archneur.64.3.392; Luchsinger JA, 2009, CURR OPIN CLIN NUTR, V12, P15, DOI 10.1097/MCO.0b013e32831c8c71; Norman PE, 2009, INT J EPIDEMIOL, V38, P48, DOI 10.1093/ije/dyn041; Norman PE, 2004, BRIT MED J, V329, P1259, DOI 10.1136/bmj.38272.478438.55; Nourhashemi F, 2003, NEUROLOGY, V60, P117, DOI 10.1212/01.WNL.0000038910.46217.AA; Okosun IS, 1998, DIABETES CARE, V21, P1836, DOI 10.2337/diacare.21.11.1836; Organization WH, 2000, WHO TECHN REP SER, DOI DOI 10.1016/J.BBI.2016.02.019; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Power DA, 2001, DEMENT GERIATR COGN, V12, P167, DOI 10.1159/000051252; Quesenberry CP, 1998, ARCH INTERN MED, V158, P466, DOI 10.1001/archinte.158.5.466; Rankinen T, 1999, INT J OBESITY, V23, P801, DOI 10.1038/sj.ijo.0800929; Rosengren A, 2005, ARCH INTERN MED, V165, P321, DOI 10.1001/archinte.165.3.321; Stewart R, 2005, ARCH NEUROL-CHICAGO, V62, P55, DOI 10.1001/archneur.62.1.55; Whitmer RA, 2008, NEUROLOGY, V71, P1057, DOI 10.1212/01.wnl.0000306313.89165.ef; Whitmer RA, 2005, NEUROLOGY, V64, P277, DOI 10.1212/01.WNL.0000149519.47454.F2; Whitmer RA, 2005, BMJ-BRIT MED J, V330, P1360, DOI 10.1136/bmj.38446.466238.E0; Zhu SK, 2004, OBES RES, V12, P633, DOI 10.1038/oby.2004.73	37	40	42	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e17902	10.1371/journal.pone.0017902	http://dx.doi.org/10.1371/journal.pone.0017902			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464984	gold, Green Published			2022-12-25	WOS:000288813900015
J	Alli, R; Zhang, ZM; Nguyen, P; Zheng, JJ; Geiger, TL				Alli, Rajshekhar; Zhang, Ziwei M.; Phuong Nguyen; Zheng, Jie J.; Geiger, Terrence L.			Rational Design of T Cell Receptors with Enhanced Sensitivity for Antigen	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; REGION DISEASE HYPOTHESIS; HIGH-AFFINITY; SELF-REACTIVITY; PHAGE DISPLAY; SPECIFICITY; MICE; TCRS; LYMPHOCYTES	Enhancing the affinity of therapeutic T cell receptors (TCR) without altering their specificity is a significant challenge for adoptive immunotherapy. Current efforts have primarily relied on empirical approaches. Here, we used structural analyses to identify a glycine-serine variation in the TCR that modulates antigen sensitivity. A G at position 107 within the CDR3 beta stalk is encoded within a single mouse and human TCR, TRBV13-2 and TRBV12-5 respectively. Most TCR bear a S107. The S hydroxymethyl side chain intercalates into the core of the CDR3 beta loop, stabilizing it. G107 TRBV possess a gap in their CDR3 beta where this S hydroxymethyl moiety would fit. We predicted based on modeling and molecular dynamics simulations that a G107S substitution would increase CDR3 beta stability and thereby augment receptor sensitivity. Experimentally, a G107S replacement led to an similar to 10-1000 fold enhanced antigen sensitivity in 3 of 4 TRBV13-2(+) TCR tested. Analysis of fine specificity indicated a preserved binding orientation. These results support the feasibility of developing high affinity antigen specific TCR for therapeutic purposes through the identification and manipulation of critical framework residues. They further indicate that amino acid variations within TRBV not directly involved in ligand contact can program TCR sensitivity, and suggest a role for CDR3 stability in this programming.	[Alli, Rajshekhar; Phuong Nguyen; Geiger, Terrence L.] St Jude Childrens Hosp, Dept Pathol, Memphis, TN 38105 USA; [Zhang, Ziwei M.; Zheng, Jie J.] St Jude Childrens Hosp, Dept Biol Struct, Memphis, TN 38105 USA; [Geiger, Terrence L.] Univ Tennessee, Ctr Hlth Sci, Dept Pathol, Memphis, TN 38163 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center	Alli, R (corresponding author), St Jude Childrens Hosp, Dept Pathol, 332 N Lauderdale St, Memphis, TN 38105 USA.	terrence.geiger@stjude.org	Geiger, Terrence/M-4516-2018	Geiger, Terrence/0000-0001-8290-5732; Zheng, Jie/0000-0001-6524-6800	National Institutes of Health [R01 AI056153]; American Lebanese Syrian Associated Charities (ALSAC)/St. Jude Children's Research Hospital; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069916] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities (ALSAC)/St. Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health Grant R01 AI056153 (to TLG) and by the American Lebanese Syrian Associated Charities (ALSAC)/St. Jude Children's Research Hospital (to all authors). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHAORBEA H, 1988, CELL, V54, P263, DOI 10.1016/0092-8674(88)90558-2; Alli R, 2008, J IMMUNOL, V181, P136, DOI 10.4049/jimmunol.181.1.136; Andricioaei I, 2001, J CHEM PHYS, V115, P6289, DOI 10.1063/1.1401821; Benichou G, 1999, J INVEST DERM SYMP P, V4, P224, DOI 10.1038/sj.jidsp.5640216; Berry LJ, 2009, TISSUE ANTIGENS, V74, P277, DOI 10.1111/j.1399-0039.2009.01336.x; Brusko TM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011726; Burton AR, 2008, DIABETES, V57, P1321, DOI 10.2337/db07-1129; CIBOTTI R, 1994, J EXP MED, V180, P861, DOI 10.1084/jem.180.3.861; DEKERLERO RNM, 1996, EUR J IMMUNOL, V26, P2470; Donermeyer DL, 2006, J IMMUNOL, V177, P6911, DOI 10.4049/jimmunol.177.10.6911; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Fasso M, 2000, J EXP MED, V192, P1719, DOI 10.1084/jem.192.12.1719; Garcia KC, 2009, NAT IMMUNOL, V10, P143, DOI 10.1038/ni.f.219; HAQQI TM, 1992, P NATL ACAD SCI USA, V89, P1253, DOI 10.1073/pnas.89.4.1253; Hare BJ, 1999, NAT STRUCT BIOL, V6, P574; HEBERKATZ E, 1989, IMMUNOL TODAY, V10, P164, DOI 10.1016/0167-5699(89)90174-6; Holler PD, 2004, MOL IMMUNOL, V40, P1027, DOI 10.1016/j.molimm.2003.11.013; Holler PD, 2003, NAT IMMUNOL, V4, P55, DOI 10.1038/ni863; Jackola DR, 2008, MOL IMMUNOL, V45, P1494, DOI 10.1016/j.molimm.2007.08.023; JANEWAY CA, 1992, ANNU REV IMMUNOL, V10, P645, DOI 10.1146/annurev.immunol.10.1.645; JOHNSON NA, 1989, J IMMUNOL, V142, P3298; Kieback E, 2010, EXPERT OPIN BIOL TH, V10, P749, DOI 10.1517/14712591003689998; Kumar V, 1997, J EXP MED, V185, P1725, DOI 10.1084/jem.185.10.1725; Li Y, 2005, NAT BIOTECHNOL, V23, P349, DOI 10.1038/nbt1070; Marrack P, 2008, ANNU REV IMMUNOL, V26, P171, DOI 10.1146/annurev.immunol.26.021607.090421; Masuda K, 1997, J IMMUNOL, V158, P2076; MENDEL I, 1995, EUR J IMMUNOL, V25, P1951, DOI 10.1002/eji.1830250723; Mongan J, 2007, J CHEM THEORY COMPUT, V3, P156, DOI 10.1021/ct600085e; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Nguyen P, 2010, J IMMUNOL, V185, P3895, DOI 10.4049/jimmunol.1001550; OSMAN GE, 1993, J EXP MED, V177, P387, DOI 10.1084/jem.177.2.387; Richman SA, 2007, BIOMOL ENG, V24, P361, DOI 10.1016/j.bioeng.2007.02.009; Robbins PF, 2008, J IMMUNOL, V180, P6116, DOI 10.4049/jimmunol.180.9.6116; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Thielges MC, 2008, BIOCHEMISTRY-US, V47, P7237, DOI 10.1021/bi800374q; Thorpe IF, 2007, P NATL ACAD SCI USA, V104, P8821, DOI 10.1073/pnas.0610064104; Turner SJ, 2006, NAT REV IMMUNOL, V6, P883, DOI 10.1038/nri1977; Udyavar A, 2009, J IMMUNOL, V182, P4439, DOI 10.4049/jimmunol.0804377; Weber KS, 2005, P NATL ACAD SCI USA, V102, P19033, DOI 10.1073/pnas.0507554102; WILSON DB, 1993, IMMUNOL TODAY, V14, P376, DOI 10.1016/0167-5699(93)90136-9; Wilson DB, 2004, MOL IMMUNOL, V40, P1047, DOI 10.1016/j.molimm.2003.11.022; Yang Y, 1996, IMMUNITY, V4, P189, DOI 10.1016/S1074-7613(00)80683-4; Zhao Y, 2007, J IMMUNOL, V179, P5845, DOI 10.4049/jimmunol.179.9.5845	43	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e18027	10.1371/journal.pone.0018027	http://dx.doi.org/10.1371/journal.pone.0018027			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21455495	Green Published, gold, Green Submitted			2022-12-25	WOS:000288810500029
J	Jin, HO; Seo, SK; Kim, YS; Woo, SH; Lee, KH; Yi, JY; Lee, SJ; Choe, TB; Lee, JH; An, S; Hong, SI; Park, IC				Jin, H-O; Seo, S-K; Kim, Y-S; Woo, S-H; Lee, K-H; Yi, J-Y; Lee, S-J; Choe, T-B; Lee, J-H; An, S.; Hong, S-I; Park, I-C			TXNIP potentiates Redd1-induced mTOR suppression through stabilization of Redd1	ONCOGENE			English	Article						ATF4; mTOR; Redd1; TXNIP; 2-deoxyglucose	THIOREDOXIN-INTERACTING PROTEIN; CELL-GROWTH; OXIDATIVE STRESS; MAMMALIAN TARGET; ENERGY STRESS; EXPRESSION; KINASE; RAPAMYCIN; HYPOXIA; CANCER	The mammalian target of rapamycin (mTOR) is a highly conserved serine-threonine kinase activated in response to growth factors and nutrients. Because of frequent dysregulation of the mTOR signaling pathway in diverse human cancers, this kinase is a key therapeutic target. Redd1 is a negative regulator of mTOR, mediating dissociation of 14-3-3 from tuberous sclerosis complex (TSC)2, which allows formation of a TSC-TSC2 complex. In the present study, we identify TXNIP that inhibits mTOR activity by binding to and stabilizing Redd1 protein. Redd1 and TXNIP expression was induced by a synthetic glucose analog, 2-deoxyglucose (2-DG). Moreover, Redd1 expression in response to 2-DG was regulated by activating transcription factor 4 (ATF4). Overexpression of TXNIP was associated with reduced mTOR activity mediated by an increase in Redd1 level, whereas knockdown of TXNIP using small interfering RNA resulted in recovery of mTOR activity via downregulation of Redd1 during treatment with 2-DG. Interestingly, Redd1 was additionally stabilized via interactions with N-terminal-truncated TXNIP, leading to suppression of mTOR activity. Our results collectively demonstrate that TXNIP stabilizes Redd1 protein induced by ATF4 in response to 2-DG, resulting in potentiation of mTOR suppression. To the best of our knowledge, this is the first study to identify TXNIP as a novel member of the mTOR upstream that acts as a negative regulator in response to stress signals. Oncogene (2011) 30, 3792-3801; doi:10.1038/onc.2011.102; published online 4 April 2011	[Jin, H-O; Seo, S-K; Kim, Y-S; Woo, S-H; Lee, K-H; Hong, S-I; Park, I-C] Korea Inst Radiol & Med Sci, Div Radiat Canc Res, Seoul 139706, South Korea; [Yi, J-Y] Korea Inst Radiol & Med Sci, Lab Modulat Radiobiol Responses, Seoul 139706, South Korea; [Lee, S-J] Hanyang Univ, Dept Chem, Lab Mol Biochem, Seoul 133791, South Korea; [Choe, T-B; Lee, J-H; An, S.] Konkuk Univ, Dept Microbiol Engn, Seoul, South Korea	Korea Institute of Radiological & Medical Sciences; Korea Institute of Radiological & Medical Sciences; Hanyang University; Konkuk University	Jin, HO (corresponding author), Korea Inst Radiol & Med Sci, Div Radiat Canc Res, 215-4 Gongneung Dong, Seoul 139706, South Korea.	hyeonok@kirams.re.kr; parkic@kirams.re.kr			National Nuclear RD Program; Basic Science Research Program; Ministry of Education, Science and Technology in Republic of Korea [2010-0009503]	National Nuclear RD Program; Basic Science Research Program; Ministry of Education, Science and Technology in Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the National Nuclear R&D Program and the Basic Science Research Program and the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2010-0009503) in Republic of Korea.	Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Chung JW, 2006, J DERMATOL, V33, P662, DOI 10.1111/j.1346-8138.2006.00156.x; Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518; DeYoung MP, 2008, GENE DEV, V22, P239, DOI 10.1101/gad.1617608; Ellisen LW, 2002, MOL CELL, V10, P995, DOI 10.1016/S1097-2765(02)00706-2; Fidler IJ, 1996, J NATL CANCER I, V88, P1700, DOI 10.1093/jnci/88.23.1700; Goldberg SF, 2003, CANCER RES, V63, P432; Han SH, 2003, ONCOGENE, V22, P4035, DOI 10.1038/sj.onc.1206610; Hardie DG, 2001, BIOESSAYS, V23, P1112, DOI 10.1002/bies.10009; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Horak P, 2010, P NATL ACAD SCI USA, V107, P4675, DOI 10.1073/pnas.0907705107; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jin HO, 2009, IUBMB LIFE, V61, P1153, DOI 10.1002/iub.271; Jin HO, 2009, FREE RADICAL BIO MED, V46, P1158, DOI 10.1016/j.freeradbiomed.2009.01.015; Junn E, 2000, J IMMUNOL, V164, P6287, DOI 10.4049/jimmunol.164.12.6287; Kang HT, 2006, LIFE SCI, V78, P1392, DOI 10.1016/j.lfs.2005.07.001; Katiyar S, 2009, EMBO REP, V10, P866, DOI 10.1038/embor.2009.93; Kim KY, 2004, BIOCHEM BIOPH RES CO, V315, P369, DOI 10.1016/j.bbrc.2004.01.047; Little Edward, 1994, Critical Reviews in Eukaryotic Gene Expression, V4, P1; Nakamura H, 2006, SEMIN CANCER BIOL, V16, P444, DOI 10.1016/j.semcancer.2006.09.001; Nishinaka Y, 2004, J BIOL CHEM, V279, P37559, DOI 10.1074/jbc.M405473200; Oka S, 2006, FASEB J, V20, pA45, DOI 10.1096/fj.05-4439fje; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Saxena G, 2010, J BIOL CHEM, V285, P3997, DOI 10.1074/jbc.M109.034421; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Schneider A, 2008, NEOPLASIA, V10, P1295, DOI 10.1593/neo.08586; Schulze PC, 2004, J BIOL CHEM, V279, P30369, DOI 10.1074/jbc.M400549200; Schulze PC, 2002, CIRC RES, V91, P689, DOI 10.1161/01.RES.0000037982.55074.F6; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Sheth SS, 2006, ONCOGENE, V25, P3528, DOI 10.1038/sj.onc.1209394; Shor B, 2009, CELL CYCLE, V8, P3831, DOI 10.4161/cc.8.23.10070; Sofer A, 2005, MOL CELL BIOL, V25, P5834, DOI 10.1128/MCB.25.14.5834-5845.2005; Stein SC, 2000, BIOCHEM J, V345, P437, DOI 10.1042/0264-6021:3450437; Stoltzman CA, 2008, P NATL ACAD SCI USA, V105, P6912, DOI 10.1073/pnas.0712199105; Sudarsanam S, 2010, CURR OPIN DRUG DISC, V13, P31; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Wang HM, 2006, J BIOL CHEM, V281, P39128, DOI 10.1074/jbc.M610023200; Wang Z, 2006, ONCOGENE, V25, P1903, DOI 10.1038/sj.onc.1209218; Whitney ML, 2009, BIOCHEM BIOPH RES CO, V379, P451, DOI 10.1016/j.bbrc.2008.12.079	40	59	63	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	2011	30	35					3792	3801		10.1038/onc.2011.102	http://dx.doi.org/10.1038/onc.2011.102			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	814TZ	21460850				2022-12-25	WOS:000294481400006
J	Canal, F; Palygin, O; Pankratov, Y; Correa, SAL; Muller, J				Canal, Frederic; Palygin, Oleg; Pankratov, Yuriy; Correa, Sonia A. L.; Mueller, Juergen			Compartmentalization of the MAPK scaffold protein KSR1 modulates synaptic plasticity in hippocampal neurons	FASEB JOURNAL			English	Article						signaling; ERK1/2; dendritic spine; long-term potentiation	LONG-TERM POTENTIATION; SIGNAL-REGULATED KINASE; NEUROFIBROMATOSIS TYPE-1; PHOSPHORYLATION SITES; RECEPTOR TRAFFICKING; DOCKING SITES; GENE ENCODES; MOUSE MODEL; C-ELEGANS; RAS	ERK1/2 is required for certain forms of synaptic plasticity, including the long-term potentiation of synaptic strength. However, the molecular mechanisms regulating synaptically localized ERK1/2 signaling are poorly understood. Here, we show that the MAPK scaffold protein kinase suppressor of Ras 1 (KSR1) is directly phosphorylated by the downstream kinase ERK1/2. Quantitative Western blot analysis further demonstrates that expression of mutated, feedback-deficient KSR1 promotes sustained ERK1/2 activation in HEK293 cells in response to EGF stimulation, compared to a more transient activation in control cells expressing wild-type KSR1. Immunocytochemistry and confocal imaging of primary hippocampal neurons from newborn C57BL6 mice further show that feedback phosphorylation of KSR1 significantly reduces its localization to dendritic spines. This effect can be reversed by tetrodotoxin (1 mu M) or PD184352 (2 mu M) treatment, further suggesting that neuronal activity and phosphorylation by ERK1/2 lead to KSR1 removal from the postsynaptic compartment. Consequently, electrophysiological recordings in hippocampal neurons expressing wild-type or feedback-deficient KSR1 demonstrate that KSR1 feedback phosphorylation restricts the potentiation of excitatory postsynaptic currents. Our findings, therefore, suggest that feedback phosphorylation of the scaffold protein KSR1 prevents excessive ERK1/2 signaling in the postsynaptic compartment and thus contributes to maintaining physiological levels of synaptic excitability.-Canal, F., Palygin, O., Pankratov, Y., Correa, S. A. L., Muller, J. Compartmentalization of the MAPK scaffold protein KSR1 modulates synaptic plasticity in hippocampal neurons. FASEB J. 25, 2362-2372 (2011). www.fasebj.org	[Canal, Frederic; Mueller, Juergen] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Palygin, Oleg; Pankratov, Yuriy; Correa, Sonia A. L.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England	University of Warwick; University of Warwick	Muller, J (corresponding author), Univ Warwick, Warwick Med Sch, Gibbet Hill Rd, Coventry CV4 7AL, W Midlands, England.	jurgen.muller@warwick.ac.uk	Palygin, Oleg/AAT-3047-2020	Palygin, Oleg/0000-0002-3680-5527; Correa, Sonia AL/0000-0002-7434-1073; Muller, Jurgen/0000-0002-5487-0736	UK Medical Research Council (MRC) [G0600790]; North West Cancer Research Fund; University of Warwick [08141]; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/H0183441/1]; BBSRC [BB/H018344/1, BB/F021445/1] Funding Source: UKRI; MRC [G0600790] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H018344/1, BB/F021445/1] Funding Source: researchfish; Medical Research Council [G0600790] Funding Source: researchfish	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); North West Cancer Research Fund; University of Warwick; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors thank Bruno Frenguelli for critical reading of the manuscript. This work was funded by the UK Medical Research Council (MRC; G0600790). J.M. was supported by the North West Cancer Research Fund during parts of this study. S. A. L. C. is a Warwick Research Fellow supported by Researcher Development Fund (RDF; 08141; University of Warwick) and Biotechnology and Biological Sciences Research Council (BBSRC; BB/H0183441/1) awards.	Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; BALLESTER R, 1990, CELL, V63, P851, DOI 10.1016/0092-8674(90)90151-4; Brown MD, 2009, CELL SIGNAL, V21, P462, DOI 10.1016/j.cellsig.2008.11.013; Cacace AM, 1999, MOL CELL BIOL, V19, P229; Cohen E, 2008, BRAIN RES, V1235, P21, DOI 10.1016/j.brainres.2008.06.022; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Correa SAL, 2009, J CELL SCI, V122, P4186, DOI 10.1242/jcs.058420; Costa RM, 2002, NATURE, V415, P526, DOI 10.1038/nature711; Denouel-Galy A, 1998, CURR BIOL, V8, P46, DOI 10.1016/S0960-9822(98)70019-3; Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055; Dudek SM, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-02-j0002.2001; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; Fantz DA, 2001, J BIOL CHEM, V276, P27256, DOI 10.1074/jbc.M102512200; Fitzjohn SM, 2001, NEUROPHARMACOLOGY, V41, P693, DOI 10.1016/S0028-3908(01)00128-9; GARDNER AM, 1994, MOL BIOL CELL, V5, P193, DOI 10.1091/mbc.5.2.193; Gerdjikov TV, 2004, BEHAV NEUROSCI, V118, P740, DOI 10.1037/0735-7044.118.4.740; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Jacobs D, 1999, GENE DEV, V13, P163, DOI 10.1101/gad.13.2.163; Kim JH, 2003, J NEUROSCI, V23, P1119; Komiyama NH, 2002, J NEUROSCI, V22, P9721; KORNFELD K, 1995, CELL, V83, P903, DOI 10.1016/0092-8674(95)90206-6; LANGLOIS WJ, 1995, J BIOL CHEM, V270, P25320, DOI 10.1074/jbc.270.43.25320; MALGAROLI A, 1992, NATURE, V357, P134, DOI 10.1038/357134a0; MANABE T, 1992, NATURE, V355, P50, DOI 10.1038/355050a0; MANSOUR SJ, 1994, J BIOCHEM-TOKYO, V116, P304, DOI 10.1093/oxfordjournals.jbchem.a124524; MARTIN GA, 1990, CELL, V63, P843, DOI 10.1016/0092-8674(90)90150-D; McKay MM, 2009, P NATL ACAD SCI USA, V106, P11022, DOI 10.1073/pnas.0901590106; Muller J, 2001, MOL CELL, V8, P983, DOI 10.1016/S1097-2765(01)00383-5; Muller J, 2003, EMBO J, V22, P4431, DOI 10.1093/emboj/cdg426; Muller J, 2000, MOL CELL BIOL, V20, P5529, DOI 10.1128/MCB.20.15.5529-5539.2000; MURPHY TH, 1994, J NEUROSCI, V14, P1320, DOI 10.1523/JNEUROSCI.14-03-01320.1994; North K, 2000, AM J MED GENET, V97, P119, DOI 10.1002/1096-8628(200022)97:2<119::AID-AJMG3>3.0.CO;2-3; Pankratov Y, 2007, J GEN PHYSIOL, V129, P257, DOI 10.1085/jgp.200609693; Pankratov YV, 2003, BIOPHYS J, V85, P3375, DOI 10.1016/S0006-3495(03)74757-2; Selcher JC, 1999, LEARN MEMORY, V6, P478, DOI 10.1101/lm.6.5.478; Shalin SC, 2006, NEURON, V50, P765, DOI 10.1016/j.neuron.2006.04.029; Silva AJ, 1997, NAT GENET, V15, P281, DOI 10.1038/ng0397-281; Stricker C, 1996, J PHYSIOL-LONDON, V490, P443, DOI 10.1113/jphysiol.1996.sp021156; SUNDARAM M, 1995, CELL, V83, P889, DOI 10.1016/0092-8674(95)90205-8; THERRIEN M, 1995, CELL, V83, P879, DOI 10.1016/0092-8674(95)90204-X; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Volle DJ, 1999, BIOCHEMISTRY-US, V38, P5130, DOI 10.1021/bi983050d; XU GF, 1990, CELL, V63, P835, DOI 10.1016/0092-8674(90)90149-9; Yu W, 1998, CURR BIOL, V8, P56, DOI 10.1016/S0960-9822(98)70020-X; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8	45	14	14	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUL	2011	25	7					2362	2372		10.1096/fj.10-173153	http://dx.doi.org/10.1096/fj.10-173153			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	785PY	21471251				2022-12-25	WOS:000292242200028
J	Marom, B; Heining, E; Knaus, P; Henis, YI				Marom, Barak; Heining, Eva; Knaus, Petra; Henis, Yoav I.			Formation of Stable Homomeric and Transient Heteromeric Bone Morphogenetic Protein (BMP) Receptor Complexes Regulates Smad Protein Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-BETA RECEPTORS; GERMLINE MUTATIONS; II RECEPTOR; OLIGOMERIC STRUCTURE; MODE; ENDOCYTOSIS; MECHANISMS; MEMBRANE; BINDING; KINASE	The type I and type II bone morphogenetic protein receptors (BMPRI and BMPRII) are present at the plasma membrane as monomers and homomeric and heteromeric complexes, which are modulated by ligand binding. The complexes of their extracellular domains with ligand were shown to form heterotetramers. However, the dynamics of the oligomeric interactions among the full-length receptors in live cell membranes were not explored, and the roles of BMP receptor homodimerization were unknown. Here, we investigated these issues by combining patching/immobilization of an epitope-tagged BMP receptor at the cell surface with measurements of the lateral diffusion of a co-expressed, differently tagged BMP receptor by fluorescence recovery after photobleaching (FRAP). These studies led to several novel conclusions. (a) All homomeric complexes (without or with BMP-2) were stable on the patch/FRAP time scale (minutes), whereas the heterocomplexes were transient, a difference that may affect signaling. (b) Patch/FRAP between HA- and myc-tagged BMPRII combined with competition by untagged BMPRIb showed that the heterocomplexes form at the expense of homodimers. (c) Stabilization of BMPRII.BMPRIb heterocomplexes (but not homomeric complexes) by IgG binding to same-tag receptors elevated phospho-Smad formation both without and with BMP-2. These findings suggest two mechanisms that may suppress the tendency of preformed BMP receptor hetero-oligomers to signal without ligand: (a) competition between homo- and heterocomplex formation, which reduces the steady-state level of the latter, and (b) the transient nature of the heterocomplexes, which limits the time during which BMPRI can be phosphorylated by BMPRII in the heterocomplex.	[Marom, Barak; Henis, Yoav I.] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel; [Heining, Eva; Knaus, Petra] Free Univ Berlin, Inst Chem & Biochem, D-1495 Berlin, Germany	Tel Aviv University; Free University of Berlin	Henis, YI (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel.	henis@post.tau.ac.il		Henis, Yoav/0000-0002-1408-3877	German-Israeli Foundation for Scientific Research and Development [932-244.13/2006]	German-Israeli Foundation for Scientific Research and Development(German-Israeli Foundation for Scientific Research and Development)	This work was supported in part by Grant 932-244.13/2006 from the German-Israeli Foundation for Scientific Research and Development (to Y. I. H. and P. K.).	Allendorph GP, 2006, P NATL ACAD SCI USA, V103, P7643, DOI 10.1073/pnas.0602558103; Boergermann JH, 2010, INT J BIOCHEM CELL B, V42, P1802, DOI 10.1016/j.biocel.2010.07.018; Derynck Rik, 2008, P29; Dorsch S, 2009, NAT METHODS, V6, P225, DOI [10.1038/NMETH.1304, 10.1038/nmeth.1304]; Ehrlich M, 2001, J CELL SCI, V114, P1777; Eisenberg S, 2006, MOL CELL BIOL, V26, P7190, DOI 10.1128/MCB.01059-06; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Gilboa L, 1998, J CELL BIOL, V140, P767, DOI 10.1083/jcb.140.4.767; Gilboa L, 2000, MOL BIOL CELL, V11, P1023, DOI 10.1091/mbc.11.3.1023; Greenwald J, 2003, MOL CELL, V11, P605, DOI 10.1016/S1097-2765(03)00094-7; Groppe J, 2008, MOL CELL, V29, P157, DOI 10.1016/j.molcel.2007.11.039; Haramis APG, 2004, SCIENCE, V303, P1684, DOI 10.1126/science.1093587; Hardwick JC, 2008, NAT REV CANCER, V8, P806, DOI 10.1038/nrc2467; Hartung A, 2006, MOL CELL BIOL, V26, P7791, DOI 10.1128/MCB.00022-06; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; HENIS YI, 1990, J CELL BIOL, V111, P1409, DOI 10.1083/jcb.111.4.1409; HENIS YI, 1994, J CELL BIOL, V126, P139, DOI 10.1083/jcb.126.1.139; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Hoodless PA, 1996, CELL, V85, P489, DOI 10.1016/S0092-8674(00)81250-7; Howe JR, 2001, NAT GENET, V28, P184, DOI 10.1038/88919; Kfir S, 2005, MOL CELL BIOL, V25, P8239, DOI 10.1128/MCB.25.18.8239-8250.2005; Kirsch T, 2000, EMBO J, V19, P3314, DOI 10.1093/emboj/19.13.3314; Kirsch T, 2000, NAT STRUCT BIOL, V7, P492; Lane KB, 2000, NAT GENET, V26, P81, DOI 10.1038/79226; Lehmann K, 2003, P NATL ACAD SCI USA, V100, P12277, DOI 10.1073/pnas.2133476100; Lories RJU, 2005, CYTOKINE GROWTH F R, V16, P287, DOI 10.1016/j.cytogfr.2005.02.009; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Nickel J, 2009, CYTOKINE GROWTH F R, V20, P367, DOI 10.1016/j.cytogfr.2009.10.022; Nohe A, 2002, J BIOL CHEM, V277, P5330, DOI 10.1074/jbc.M102750200; Oldridge M, 2000, NAT GENET, V24, P275, DOI 10.1038/73495; PETERSEN NO, 1986, HDB EXPT IMMUNOLOGY; Rechtman MM, 2009, J BIOL CHEM, V284, P7843, DOI 10.1074/jbc.M809215200; Reddi AH, 2005, CYTOKINE GROWTH F R, V16, P249, DOI 10.1016/j.cytogfr.2005.04.003; ROSENZWEIG BL, 1995, P NATL ACAD SCI USA, V92, P7632, DOI 10.1073/pnas.92.17.7632; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; Sebald W, 2003, TRENDS BIOCHEM SCI, V28, P518, DOI 10.1016/j.tibs.2003.08.001; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sieber C, 2006, BIOL CHEM, V387, P451, DOI 10.1515/BC.2006.060; Sieber C, 2009, CYTOKINE GROWTH F R, V20, P343, DOI 10.1016/j.cytogfr.2009.10.007; Thomas JT, 1997, NAT GENET, V17, P58, DOI 10.1038/ng0997-58; Thomson JR, 2000, J MED GENET, V37, P741, DOI 10.1136/jmg.37.10.741; Varga AC, 2005, ONCOGENE, V24, P5713, DOI 10.1038/sj.onc.1208919; Weber D, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-6; Wells RG, 1999, J BIOL CHEM, V274, P5716, DOI 10.1074/jbc.274.9.5716; Zhang W, 2009, P NATL ACAD SCI USA, V106, P15679, DOI 10.1073/pnas.0908279106	47	25	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19287	19296		10.1074/jbc.M110.210377	http://dx.doi.org/10.1074/jbc.M110.210377			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21471205	hybrid, Green Published			2022-12-25	WOS:000291027700011
J	Beer, NL; van de Bunt, M; Colclough, K; Lukacs, C; Arundel, P; Chik, CL; Grimsby, J; Ellard, S; Gloyn, AL				Beer, Nicola L.; van de Bunt, Martijn; Colclough, Kevin; Lukacs, Christine; Arundel, Paul; Chik, Constance L.; Grimsby, Joseph; Ellard, Sian; Gloyn, Anna L.			Discovery of a Novel Site Regulating Glucokinase Activity following Characterization of a New Mutation Causing Hyperinsulinemic Hypoglycemia in Humans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEONATAL DIABETES-MELLITUS; PANCREATIC BETA-CELLS; YOUNG TYPE-2 MODY-2; PLASMA-GLUCOSE; ACTIVATOR RO4389620; FASTING GLUCOSE; PROTEIN; PREVALENCE; CHILDREN; OVEREXPRESSION	Type 2 diabetes is a global problem, and current ineffective therapeutic strategies pave the way for novel treatments like small molecular activators targeting glucokinase (GCK). GCK activity is fundamental to beta cell and hepatocyte glucose metabolism, and heterozygous activating and inactivating GCK mutations cause hyperinsulinemic hypoglycemia (HH) and maturity onset diabetes of the young (MODY) respectively. Over 600 naturally occurring inactivating mutations have been reported, whereas only 13 activating mutations are documented to date. We report two novel GCK HH mutations (V389L and T103S) at residues where MODY mutations also occur (V389D and T103I). Using recombinant proteins with in vitro assays, we demonstrated that both HH mutants had a greater relative activity index than wild type (6.0 for V389L, 8.4 for T103S, and 1.0 for wild type). This was driven by an increased affinity for glucose (S-0.5, 3.3 +/- 0.1 and 3.5 +/- 0.1 mM, respectively) versus wild type (7.5 +/- 0.1 mM). Correspondingly, the V389D and T103I MODY mutants had markedly reduced relative activity indexes (<0.1). T103I had an altered affinity for glucose (S-0.5, 24.9 +/- 0.6 mM), whereas V389D also exhibited a reduced affinity for ATP and decreased catalysis rate (S-0.5, 78.6 +/- 4.5 mM; ATP(Km), 1.5 +/- 0.1 mM; K-cat, 10.3 +/- 1.1s(-1)) compared with wild type (ATP(Km), 0.4 +/- <0.1; K-cat, 62.9 +/- 1.2). Both Thr-103 mutants showed reduced inhibition by the endogenous hepatic inhibitor glucokinase regulatory protein. Molecular modeling demonstrated that Thr-103 maps to the allosteric activator site, whereas Val-389 is located remotely to this position and all other previously reported activating mutations, highlighting alpha -helix 11 as a novel region regulating GCK activity. Our data suggest that pharmacological manipulation of GCK activity at locations distal from the allosteric activator site is possible.	[Beer, Nicola L.; van de Bunt, Martijn; Gloyn, Anna L.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; [Colclough, Kevin] Royal Devon & Exeter Natl Hlth Serv NHS Fdn, Dept Mol Genet, Exeter EX2 5AD, Devon, England; [Lukacs, Christine] Hoffmann La Roche Inc, Dept Discovery Technol, Nutley, NJ 07110 USA; [Grimsby, Joseph] Hoffmann La Roche Inc, Dept Metab Dis, Nutley, NJ 07110 USA; [Arundel, Paul] Sheffield Childrens Natl Hlth Serv NHS Fdn Trust, Sheffield S10 2TH, S Yorkshire, England; [Chik, Constance L.] Univ Alberta, Div Endocrinol & Metab, Edmonton, AB T6G 2S2, Canada; [Ellard, Sian] Univ Exeter, Peninsula Med Sch, Inst Biomed & Clin Sci, Exeter EX2 5DW, Devon, England	University of Oxford; Roche Holding; Roche Holding; University of Alberta; University of Exeter	Gloyn, AL (corresponding author), Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Old Rd, Oxford OX3 7LJ, England.	anna.gloyn@drl.ox.ac.uk		Gloyn, Anna/0000-0003-1205-1844; van de Bunt, Martijn/0000-0002-6744-6125; Ellard, Sian/0000-0002-7620-5526	Oxford by the Medical Research Council (MRC); MRC [81696]; MRC [G0700222] Funding Source: UKRI; Medical Research Council [G0700222] Funding Source: researchfish	Oxford by the Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part in Oxford by the Medical Research Council (MRC).; Supported by MRC New Investigator Grant 81696. To whom correspondence should be addressed: Oxford Centre for Diabetes Endocrinology and Metabolism, Churchill Hospital, Old Rd., Headington, Oxford OX3 7LJ, UK. Fax: 44-1865-857299; E-mail: anna.gloyn@drl.ox.ac.uk.	Alvarez E, 2002, J NEUROCHEM, V80, P45, DOI 10.1046/j.0022-3042.2001.00677.x; Arden C, 2007, DIABETES, V56, P1773, DOI 10.2337/db06-1151; *ARR BIOPHARMA INC, 2009, GLUC ACT ARRY 403 PH; Baltrusch S, 2005, DIABETES, V54, P2829, DOI 10.2337/diabetes.54.10.2829; Baltrusch S, 2001, J BIOL CHEM, V276, P43915, DOI 10.1074/jbc.M105470200; Barbetti F, 2009, MOL ENDOCRINOL, V23, P1983, DOI 10.1210/me.2009-0094; Beer NL, 2009, HUM MOL GENET, V18, P4081, DOI 10.1093/hmg/ddp357; Bjorkhaug L, 2007, J BIOL CHEM, V282, P22757, DOI 10.1074/jbc.M700517200; Bonadonna RC, 2008, DIABETOLOGIA, V51, pS371; Bonadonna RC, 2010, J CLIN ENDOCR METAB, V95, P5028, DOI 10.1210/jc.2010-1041; Brocklehurst KJ, 2004, BIOCHEM J, V378, P693, DOI 10.1042/BJ20031414; Brocklehurst KJ, 2004, DIABETES, V53, P535, DOI 10.2337/diabetes.53.3.535; Bruce S, 2000, AM J HUM BIOL, V12, P542, DOI 10.1002/1520-6300(200007/08)12:4&lt;542::AID-AJHB13&gt;3.0.CO;2-7; Burke CV, 1999, BIOCHEM J, V342, P345, DOI 10.1042/0264-6021:3420345; Castelhano AL, 2005, BIOORG MED CHEM LETT, V15, P1501, DOI 10.1016/j.bmcl.2004.12.083; Christesen HBT, 2002, DIABETES, V51, P1240, DOI 10.2337/diabetes.51.4.1240; Christesen HBT, 2008, EUR J ENDOCRINOL, V159, P27, DOI 10.1530/EJE-08-0203; Coghlan M, 2008, EXPERT OPIN INV DRUG, V17, P145, DOI 10.1517/13543784.17.2.145; Cuesta-Munoz AL, 2004, DIABETES, V53, P2164, DOI 10.2337/diabetes.53.8.2164; Danial NN, 2008, NAT MED, V14, P144, DOI 10.1038/nm1717; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; Davis EA, 1999, DIABETOLOGIA, V42, P1175, DOI 10.1007/s001250051289; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; FROGUEL P, 1992, NATURE, V356, P162, DOI 10.1038/356162a0; Glaser B, 1998, NEW ENGL J MED, V338, P226, DOI 10.1056/NEJM199801223380404; Gloyn AL, 2004, FRONT DIABETES, V16, P92; Gloyn AL, 2005, J BIOL CHEM, V280, P14105, DOI 10.1074/jbc.M413146200; Gloyn AL, 2003, DIABETES, V52, P2433, DOI 10.2337/diabetes.52.9.2433; Grimsby J, 2004, FRONT DIABETES, V16, P360; Grimsby J, 2000, J BIOL CHEM, V275, P7826, DOI 10.1074/jbc.275.11.7826; Grimsby J, 2003, SCIENCE, V301, P370, DOI 10.1126/science.1084073; HATTERSLEY AT, 1992, LANCET, V339, P1307, DOI 10.1016/0140-6736(92)91958-B; Heredia VV, 2006, J BIOL CHEM, V281, P40201, DOI 10.1074/jbc.M607987200; HOLLAND GW, 2004, Patent No. 1169312; HOLLAND GW, 2004, Patent No. 0058293; Kamata K, 2004, STRUCTURE, V12, P429, DOI 10.1016/j.str.2004.02.005; Kassem S, 2010, NEW ENGL J MED, V362, P1348, DOI 10.1056/NEJMc0909845; LIANG Y, 1995, BIOCHEM J, V309, P167, DOI 10.1042/bj3090167; LYNEDJIAN P, 2004, GLUCOKINASE GLYCAEMI, P156; Massa L, 2004, DIABETES, V53, P1020, DOI 10.2337/diabetes.53.4.1020; Massa O, 2001, DIABETOLOGIA, V44, P898; Matschinsky F. M., 2010, F1000 MED REP, V2, P43, DOI DOI 10.3410/M2-43; Matschinsky FM, 2002, DIABETES, V51, pS394, DOI 10.2337/diabetes.51.2007.S394; MATSCHINSKY FM, 1990, DIABETES, V39, P647, DOI 10.2337/diabetes.39.6.647; Matschinsky FM, 2009, NAT REV DRUG DISCOV, V8, P399, DOI 10.1038/nrd2850; McKerrecher D, 2006, BIOORG MED CHEM LETT, V16, P2705, DOI 10.1016/j.bmcl.2006.02.022; McKerrecher D, 2005, BIOORG MED CHEM LETT, V15, P2103, DOI 10.1016/j.bmcl.2005.01.087; MCKERRECHER D, 2004, Patent No. 1404335; MCKERRECHER D, 2004, Patent No. 03000267; Meissner T, 2009, HORM METAB RES, V41, P320, DOI 10.1055/s-0028-1102922; Miller SP, 1999, DIABETES, V48, P1645, DOI 10.2337/diabetes.48.8.1645; Njolstad PR, 2001, NEW ENGL J MED, V344, P1588, DOI 10.1056/NEJM200105243442104; Njolstad PR, 2003, DIABETES, V52, P2854, DOI 10.2337/diabetes.52.11.2854; O'Doherty RM, 1999, DIABETES, V48, P2022, DOI 10.2337/diabetes.48.10.2022; Osbak KK, 2009, HUM MUTAT, V30, P1512, DOI 10.1002/humu.21110; Pal P, 2009, BIOCHEMISTRY-US, V48, P814, DOI 10.1021/bi802142q; Porter JR, 2005, J PEDIATR-US, V146, P131, DOI 10.1016/j.jpeds.2004.09.008; Rubio-Cabezas O, 2008, PEDIATR DIABETES, V9, P245, DOI 10.1111/j.1399-5448.2007.00361.x; Sagen JV, 2006, DIABETES, V55, P1713, DOI 10.2337/db05-1513; Sayed S, 2009, DIABETES, V58, P1419, DOI 10.2337/db08-1792; Shiota C, 1999, J BIOL CHEM, V274, P37125, DOI 10.1074/jbc.274.52.37125; Slosberg ED, 2001, DIABETES, V50, P1813, DOI 10.2337/diabetes.50.8.1813; Turkkahraman D, 2008, J PEDIATR-US, V153, P122, DOI 10.1016/j.jpeds.2007.12.037; van Schaftingen E, 2004, FRONT DIABETES, V16, P193; Wabitsch M, 2007, DIABETIC MED, V24, P1393, DOI 10.1111/j.1464-5491.2007.02285.x; Weedon MN, 2006, AM J HUM GENET, V79, P991, DOI 10.1086/509517; YIN L, 1992, DIABETES, V41, P792; ZAWALICH WS, 1977, J BIOL CHEM, V252, P8519; Zhai S, 2008, DIABETOLOGIA, V51, pS372; Zhi J, 2008, DIABETOLOGIA, V51, pS23; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	71	19	21	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					19118	19126		10.1074/jbc.M111.223362	http://dx.doi.org/10.1074/jbc.M111.223362			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21454522	Green Published, hybrid			2022-12-25	WOS:000290785700081
J	Zuckerman, DM; Hicks, SW; Charron, G; Hang, HC; Machamer, CE				Zuckerman, David M.; Hicks, Stuart W.; Charron, Guillaume; Hang, Howard C.; Machamer, Carolyn E.			Differential Regulation of Two Palmitoylation Sites in the Cytoplasmic Tail of the beta(1)-Adrenergic Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; BETA-ADRENERGIC-RECEPTORS; 5-HYDROXYTRYPTAMINE(4A) RECEPTOR; BETA(2)-ADRENERGIC RECEPTORS; SIGNALING PATHWAYS; CRYSTAL-STRUCTURE; CARDIAC MYOCYTES; HEART-FAILURE; ENDOCYTOSIS; RHODOPSIN	S-Palmitoylation of G protein-coupled receptors (GPCRs) is a prevalent modification, contributing to the regulation of receptor function. Despite its importance, the palmitoylation status of the beta(1)-adrenergic receptor, a GPCR critical for heart function, has never been determined. We report here that the beta(1)-adrenergic receptor is palmitoylated on three cysteine residues at two sites in the C-terminal tail. One site (proximal) is adjacent to the seventh transmembrane domain and is a consensus site for GPCRs, and the other (distal) is downstream. These sites are modified in different cellular compartments, and the distal palmitoylation site contributes to efficient internalization of the receptor following agonist stimulation. Using a bioorthogonal palmitate reporter to quantify palmitoylation accurately, we found that the rates of palmitate turnover at each site are dramatically different. Although palmitoylation at the proximal site is remarkably stable, palmitoylation at the distal site is rapidly turned over. This is the first report documenting differential dynamics of palmitoylation sites in a GPCR. Our results have important implications for function and regulation of the clinically important beta(1)-adrenergic receptor.	[Zuckerman, David M.; Machamer, Carolyn E.] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA; [Hicks, Stuart W.] Yale Univ, Sch Med, Sect Microbial Pathogenesis, New Haven, CT 06519 USA; [Charron, Guillaume; Hang, Howard C.] Rockefeller Univ, Lab Chem Biol & Microbial Pathogenesis, New York, NY 10065 USA	Johns Hopkins University; Yale University; Rockefeller University	Machamer, CE (corresponding author), 725 N Wolfe St,WBSB 104, Baltimore, MD 21205 USA.	machamer@jhmi.edu	Hicks, Stuart/R-9815-2019		National Institutes of Health [GM42522, 1R01GM087544, AI069704]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI069704] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007445, R01GM042522, R01GM087544] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM42522 (to C. E. M.) and 1R01GM087544 (to H. C. H.).; Supported by National Research Service Award Postdoctoral Fellowship AI069704 from the National Institutes of Health.	Blanpain C, 2001, J BIOL CHEM, V276, P23795, DOI 10.1074/jbc.M100583200; CAHILL L, 1994, NATURE, V371, P702, DOI 10.1038/371702a0; Charron G, 2009, CURR OPIN CHEM BIOL, V13, P382, DOI 10.1016/j.cbpa.2009.07.010; Charron G, 2009, J AM CHEM SOC, V131, P4967, DOI 10.1021/ja810122f; Chini B, 2009, J MOL ENDOCRINOL, V42, P371, DOI 10.1677/JME-08-0114; Claing A, 2002, PROG NEUROBIOL, V66, P61, DOI 10.1016/S0301-0082(01)00023-5; Delos Santos NM, 2006, J BIOL CHEM, V281, P12896, DOI 10.1074/jbc.M508500200; Drisdel RC, 2006, METHODS, V40, P127, DOI 10.1016/j.ymeth.2006.04.015; Ernst OP, 2000, J BIOL CHEM, V275, P1937, DOI 10.1074/jbc.275.3.1937; Escriba PV, 2007, BBA-BIOMEMBRANES, V1768, P836, DOI 10.1016/j.bbamem.2006.09.001; Fukushima Y, 2001, BBA-MOL CELL RES, V1539, P181, DOI 10.1016/S0167-4889(01)00104-5; Greaves J, 2007, J CELL BIOL, V176, P249, DOI 10.1083/jcb.200610151; Hakalahti AE, 2010, J BIOL CHEM, V285, P28850, DOI 10.1074/jbc.M110.149989; Hall RA, 2004, SEMIN CELL DEV BIOL, V15, P281, DOI 10.1016/j.semcdb.2003.12.017; Hicks SW, 2006, TRAFFIC, V7, P1666, DOI 10.1111/j.1600-0854.2006.00504.x; Hicks SW, 2002, J BIOL CHEM, V277, P35833, DOI 10.1074/jbc.M206280200; Kaumann AJ, 2008, PHARMACOL THERAPEUT, V118, P303, DOI 10.1016/j.pharmthera.2008.03.009; KONIG B, 1989, P NATL ACAD SCI USA, V86, P6878, DOI 10.1073/pnas.86.18.6878; Kvachnina E, 2009, BBA-MOL CELL RES, V1793, P1646, DOI 10.1016/j.bbamcr.2009.08.008; LASKEY RA, 1975, EUR J BIOCHEM, V56, P335, DOI 10.1111/j.1432-1033.1975.tb02238.x; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Lundstrom K, 2009, METHODS MOL BIOL, V552, P51, DOI 10.1007/978-1-60327-317-6_4; Maeda A, 2010, P NATL ACAD SCI USA, V107, P8428, DOI 10.1073/pnas.1000640107; Mason DA, 1999, J BIOL CHEM, V274, P12670, DOI 10.1074/jbc.274.18.12670; Morisco C, 2008, CARDIOVASC RES, V78, P36, DOI 10.1093/cvr/cvn008; Muthumala A, 2008, EUR J HEART FAIL, V10, P3, DOI 10.1016/j.ejheart.2007.11.008; ODOWD BF, 1989, J BIOL CHEM, V264, P7564; Ohta E, 2003, J BIOL CHEM, V278, P51957, DOI 10.1074/jbc.M310014200; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Patel PA, 2009, J MOL CELL CARDIOL, V46, P300, DOI 10.1016/j.yjmcc.2008.11.015; Percherancier Y, 2001, J BIOL CHEM, V276, P31936, DOI 10.1074/jbc.M104013200; Petaja-Repo UE, 2006, J BIOL CHEM, V281, P15780, DOI 10.1074/jbc.M602267200; Ponimaskin E, 2005, MOL PHARMACOL, V67, P1434, DOI 10.1124/mol.104.008748; Ponimaskin EG, 2002, J BIOL CHEM, V277, P2534, DOI 10.1074/jbc.M106529200; Qanbar R, 2003, PHARMACOL THERAPEUT, V97, P1, DOI 10.1016/S0163-7258(02)00300-5; Rapacciuolo A, 2003, J BIOL CHEM, V278, P35403, DOI 10.1074/jbc.M305675200; Reid HM, 2007, CELL SIGNAL, V19, P1056, DOI 10.1016/j.cellsig.2006.12.001; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; RESH MD, 2006, SCI STKE, pRE114; Richter W, 2008, EMBO J, V27, P384, DOI 10.1038/sj.emboj.7601968; Rohrer DK, 1996, P NATL ACAD SCI USA, V93, P7375, DOI 10.1073/pnas.93.14.7375; Rybin VO, 2000, J BIOL CHEM, V275, P41447, DOI 10.1074/jbc.M006951200; Shcherbakova OG, 2007, J CELL BIOL, V176, P521, DOI 10.1083/jcb.200604167; Shiina T, 2000, J BIOL CHEM, V275, P29082, DOI 10.1074/jbc.M909757199; Shimamura T, 2008, J BIOL CHEM, V283, P17753, DOI 10.1074/jbc.C800040200; Small KM, 2003, ANNU REV PHARMACOL, V43, P381, DOI 10.1146/annurev.pharmtox.43.100901.135823; Swarthout JT, 2005, J BIOL CHEM, V280, P31141, DOI 10.1074/jbc.M504113200; Uribe A, 2008, BIOL REPROD, V78, P869, DOI 10.1095/biolreprod.107.063925; Van Tassell BW, 2008, PHARMACOTHERAPY, V28, P1523, DOI 10.1592/phco.28.12.1523; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Winder DG, 1999, NEURON, V24, P715, DOI 10.1016/S0896-6273(00)81124-1; Xiao RP, 2004, TRENDS PHARMACOL SCI, V25, P358, DOI 10.1016/j.tips.2004.05.007; Xue Y, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-458	53	32	33	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					19014	19023		10.1074/jbc.M110.189977	http://dx.doi.org/10.1074/jbc.M110.189977			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21464135	Green Published, hybrid			2022-12-25	WOS:000290785700072
J	Bu, LT; Beckham, GT; Shirts, MR; Nimlos, MR; Adney, WS; Himmel, ME; Crowley, MF				Bu, Lintao; Beckham, Gregg T.; Shirts, Michael R.; Nimlos, Mark R.; Adney, William S.; Himmel, Michael E.; Crowley, Michael F.			Probing Carbohydrate Product Expulsion from a Processive Cellulase with Multiple Absolute Binding Free Energy Methods	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRICHODERMA-REESEI CELLOBIOHYDROLASE; MOLECULAR-DYNAMICS SIMULATIONS; FACTORS INFLUENCING GLYCOSYLATION; ENZYMATIC-HYDROLYSIS; PERTURBATION CALCULATIONS; FORCE-FIELDS; SIMULTANEOUS SACCHARIFICATION; THERMODYNAMIC INTEGRATION; WATER-MOLECULES; N-GLYCOSYLATION	Understanding the enzymatic mechanism that cellulases employ to degrade cellulose is critical to efforts to efficiently utilize plant biomass as a sustainable energy resource. A key component of cellulase action on cellulose is product inhibition from monosaccharide and disaccharides in the product site of cellulase tunnel. The absolute binding free energy of cellobiose and glucose to the product site of the catalytic tunnel of the Family 7 cellobiohydrolase (Cel7A) of Trichoderma reesei (Hypocrea jecorina) was calculated using two different approaches: steered molecular dynamics (SMD) simulations and alchemical free energy perturbation molecular dynamics (FEP/MD) simulations. For the SMD approach, three methods based on Jarzynski's equality were used to construct the potential of mean force from multiple pulling trajectories. The calculated binding free energies, -14.4 kcal/mol using SMD and -11.2 kcal/mol using FEP/MD, are in good qualitative agreement. Analysis of the SMD pulling trajectories suggests that several protein residues (Arg-251, Asp-259, Asp-262, Trp-376, and Tyr-381) play key roles in cellobiose and glucose binding to the catalytic tunnel. Five mutations (R251A, D259A, D262A, W376A, and Y381A) were made computationally to measure the changes in free energy during the product expulsion process. The absolute binding free energies of cellobiose to the catalytic tunnel of these five mutants are -13.1, -6.0, -11.5, -7.5, and -8.8 kcal/mol, respectively. The results demonstrated that all of the mutants tested can lower the binding free energy of cellobiose, which provides potential applications in engineering the enzyme to accelerate the product expulsion process and improve the efficiency of biomass conversion.	[Bu, Lintao; Beckham, Gregg T.; Nimlos, Mark R.] Natl Renewable Energy Lab, Natl Bioenergy Ctr, Golden, CO 80401 USA; [Adney, William S.; Himmel, Michael E.; Crowley, Michael F.] Natl Renewable Energy Lab, Biosci Ctr, Golden, CO 80401 USA; [Beckham, Gregg T.] Colorado Sch Mines, Dept Chem Engn, Golden, CO 80401 USA; [Shirts, Michael R.] Univ Virginia, Dept Chem Engn, Charlottesville, VA 22904 USA	United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; Colorado School of Mines; University of Virginia	Bu, LT (corresponding author), Natl Renewable Energy Lab, Natl Bioenergy Ctr, Golden, CO 80401 USA.	Lintao.Bu@nrel.gov; Michael.Crowley@nrel.gov	crowley, michael F/A-4852-2013	crowley, michael F/0000-0001-5163-9398	Department of Energy Office of the Biomass Program; National Science Foundation through Ranger at Texas Advanced Computing Center and Athena at the National Institute for Computational Sciences [TG-MCB090159]; Office of Energy Efficiency and Renewable Energy of the United States Department of Energy [DE-AC36-08GO28308]	Department of Energy Office of the Biomass Program(United States Department of Energy (DOE)); National Science Foundation through Ranger at Texas Advanced Computing Center and Athena at the National Institute for Computational Sciences; Office of Energy Efficiency and Renewable Energy of the United States Department of Energy(United States Department of Energy (DOE))	This work was supported by the Department of Energy Office of the Biomass Program and in part by the National Science Foundation through TeraGrid resources provided by Ranger at Texas Advanced Computing Center and Athena at the National Institute for Computational Sciences under Grant TG-MCB090159, as well as by the National Renewable Energy Laboratory Computational Science Center, which is supported by the Office of Energy Efficiency and Renewable Energy of the United States Department of Energy under Contract DE-AC36-08GO28308.	Adney WS, 2009, CELLULOSE, V16, P699, DOI 10.1007/s10570-009-9305-1; Andric P, 2010, BIOTECHNOL ADV, V28, P308, DOI 10.1016/j.biotechadv.2010.01.003; Bansal P, 2009, BIOTECHNOL ADV, V27, P833, DOI 10.1016/j.biotechadv.2009.06.005; Barr BK, 1996, BIOCHEMISTRY-US, V35, P586, DOI 10.1021/bi9520388; Beckham G. T., 2011, CURR OPIN BIOTECH, DOI [10.1016/j.10pbio.2010.11.005, DOI 10.1016/J.10PBIO.2010.11.005]; Beckham GT, 2010, BIOPHYS J, V99, P3773, DOI 10.1016/j.bpj.2010.10.032; Beckham GT, 2010, J PHYS CHEM B, V114, P1447, DOI 10.1021/jp908810a; BEVERIDGE DL, 1989, ANNU REV BIOPHYS BIO, V18, P431, DOI 10.1146/annurev.bb.18.060189.002243; Bezerra RMF, 2005, APPL BIOCHEM BIOTECH, V126, P49, DOI 10.1007/s12010-005-0005-5; Bezerra RMF, 2004, APPL BIOCHEM BIOTECH, V112, P173, DOI 10.1385/ABAB:112:3:173; Boresch S, 2003, J PHYS CHEM B, V107, P9535, DOI 10.1021/jp0217839; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Bu LT, 2009, J PHYS CHEM B, V113, P10994, DOI 10.1021/jp904003z; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chundawat S., 2011, ANN REV CHE IN PRESS, DOI [10.1146/annurev-chem-bioeng-061010-114205, DOI 10.1146/ANNUREV-CHEM-BIOENG-061010-114205]; Crespo A, 2005, J AM CHEM SOC, V127, P6940, DOI 10.1021/ja0452830; Crowley MF, 2009, INT J QUANTUM CHEM, V109, P3767, DOI 10.1002/qua.22372; Cuendet MA, 2008, BIOPHYS J, V95, P3575, DOI 10.1529/biophysj.108.131383; Deng YQ, 2004, J PHYS CHEM B, V108, P16567, DOI 10.1021/jp048502c; Deng YQ, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2842080; Deng YQ, 2006, J CHEM THEORY COMPUT, V2, P1255, DOI 10.1021/ct060037v; Deng YQ, 2009, J PHYS CHEM B, V113, P2234, DOI 10.1021/jp807701h; Divne C, 1998, J MOL BIOL, V275, P309, DOI 10.1006/jmbi.1997.1437; DIVNE C, 1994, SCIENCE, V265, P524, DOI 10.1126/science.8036495; Efron B., 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Feig M, 2003, J PHYS CHEM B, V107, P2831, DOI 10.1021/jp027293y; Florian J, 2000, J PHYS CHEM B, V104, P10092, DOI 10.1021/jp001760z; Gan Q, 2003, PROCESS BIOCHEM, V38, P1003, DOI 10.1016/S0032-9592(02)00220-0; Gilson MK, 1997, BIOPHYS J, V72, P1047, DOI 10.1016/S0006-3495(97)78756-3; Godbole S, 1999, BIOTECHNOL PROGR, V15, P828, DOI 10.1021/bp9901116; Gruno M, 2004, BIOTECHNOL BIOENG, V86, P503, DOI 10.1002/bit.10838; GUSAKOV AV, 1987, BIOTECHNOL BIOENG, V29, P906, DOI 10.1002/bit.260290715; Guvench O, 2008, J COMPUT CHEM, V29, P2543, DOI 10.1002/jcc.21004; Guvench O, 2009, J CHEM THEORY COMPUT, V5, P2353, DOI 10.1021/ct900242e; Harrison MJ, 1998, EUR J BIOCHEM, V256, P119, DOI 10.1046/j.1432-1327.1998.2560119.x; Hermans J, 1997, J AM CHEM SOC, V119, P2707, DOI 10.1021/ja963568+; Himmel ME, 1999, CURR OPIN BIOTECH, V10, P358, DOI 10.1016/S0958-1669(99)80065-2; Himmel ME, 2008, BIOMASS RECALCITRANC; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; HSU TA, 1980, BIOTECHNOL BIOENG, V22, P2305, DOI 10.1002/bit.260221108; Hui JPM, 2001, J CHROMATOGR B, V752, P349, DOI 10.1016/S0378-4347(00)00373-X; Hummer G, 2001, P NATL ACAD SCI USA, V98, P3658, DOI 10.1073/pnas.071034098; Hummer G, 2001, J CHEM PHYS, V114, P7330, DOI 10.1063/1.1363668; Isralewitz B, 2001, J MOL GRAPH MODEL, V19, P13, DOI 10.1016/S1093-3263(00)00133-9; Jarzynski C, 1997, PHYS REV LETT, V78, P2690, DOI 10.1103/PhysRevLett.78.2690; Jayachandran G, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2221680; Jensen MO, 2002, P NATL ACAD SCI USA, V99, P6731, DOI 10.1073/pnas.102649299; Jeoh T, 2008, BIOTECHNOL BIOFUELS, V1, DOI 10.1186/1754-6834-1-10; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Klarskov K, 1997, CARBOHYD RES, V304, P143, DOI 10.1016/S0008-6215(97)00215-2; KOLLMAN P, 1993, CHEM REV, V93, P2395, DOI 10.1021/cr00023a004; Levine SE, 2010, BIOTECHNOL BIOENG, V107, P37, DOI 10.1002/bit.22789; Lu ND, 2001, J CHEM PHYS, V114, P7303, DOI 10.1063/1.1359181; Lu ND, 2001, J CHEM PHYS, V115, P6866, DOI 10.1063/1.1405449; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 2004, J AM CHEM SOC, V126, P698, DOI 10.1021/ja036959e; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Martin HSC, 2009, J CHEM THEORY COMPUT, V5, P2135, DOI 10.1021/ct9000894; Mobley DL, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2221683; NIDETZKY B, 1994, ENZYME MICROB TECH, V16, P43, DOI 10.1016/0141-0229(94)90108-2; Nimlos MR, 2007, PROTEIN ENG DES SEL, V20, P179, DOI 10.1093/protein/gzm010; Oh KK, 2000, APPL BIOCHEM BIOTECH, V89, P15, DOI 10.1385/ABAB:89:1:15; Park S, 2003, J CHEM PHYS, V119, P3559, DOI 10.1063/1.1590311; PHILIPPIDIS GP, 1993, BIOTECHNOL BIOENG, V41, P846, DOI 10.1002/bit.260410903; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Roux B, 1996, BIOPHYS J, V71, P670, DOI 10.1016/S0006-3495(96)79267-6; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Shirts MR, 2007, ANN REP COMP CHEM, V3, P41, DOI 10.1016/S1574-1400(07)03004-6; Shirts MR, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1873592; Simonson T, 2002, ACCOUNTS CHEM RES, V35, P430, DOI 10.1021/ar010030m; Spiro RG, 2002, GLYCOBIOLOGY, V12, p43R, DOI 10.1093/glycob/12.4.43R; SRISODSUK M, 1993, J BIOL CHEM, V268, P20756; Stals I, 2004, GLYCOBIOLOGY, V14, P713, DOI 10.1093/glycob/cwh080; Stals I, 2004, GLYCOBIOLOGY, V14, P725, DOI 10.1093/glycob/cwh081; STRAATSMA TP, 1992, ANNU REV PHYS CHEM, V43, P407; TEERI TT, 1987, GENE, V51, P43, DOI 10.1016/0378-1119(87)90472-0; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; von Ossowski I, 2003, J MOL BIOL, V333, P817, DOI 10.1016/S0022-2836(03)00881-7; VRSANSKA M, 1992, CARBOHYD RES, V227, P19, DOI 10.1016/0008-6215(92)85058-8; WALD S, 1984, BIOTECHNOL BIOENG, V26, P221, DOI 10.1002/bit.260260305; Wang JY, 2006, BIOPHYS J, V91, P2798, DOI 10.1529/biophysj.106.084301; WEEKS JD, 1971, J CHEM PHYS, V54, P5237, DOI 10.1063/1.1674820; Woo HJ, 2005, P NATL ACAD SCI USA, V102, P6825, DOI 10.1073/pnas.0409005102; Ytreberg FM, 2004, J COMPUT CHEM, V25, P1749, DOI 10.1002/jcc.20103; Zhang DQ, 2006, J AM CHEM SOC, V128, P3019, DOI 10.1021/ja057292u; Zhong L, 2008, CELLULOSE, V15, P261, DOI 10.1007/s10570-007-9186-0; Zhong LH, 2009, CARBOHYD RES, V344, P1984, DOI 10.1016/j.carres.2009.07.005	89	61	62	0	51	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					18161	18169		10.1074/jbc.M110.212076	http://dx.doi.org/10.1074/jbc.M110.212076			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454590	hybrid, Green Published			2022-12-25	WOS:000290585200076
J	Mathias, A; Corthesy, B				Mathias, Amandine; Corthesy, Blaise			Recognition of Gram-positive Intestinal Bacteria by Hybridoma- and Colostrum-derived Secretory Immunoglobulin A Is Mediated by Carbohydrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; BIOFILM FORMATION; DENDRITIC CELLS; IGA; MUCOSAL; COMPONENT; GUT; ANTIGEN; PROTECTION; INNATE	Humans live in symbiosis with 10(14) commensal bacteria among which > 99% resides in their gastrointestinal tract. The molecular bases pertaining to the interaction between mucosal secretory IgA (SIgA) and bacteria residing in the intestine are not known. Previous studies have demonstrated that commensals are naturally coated by SIgA in the gut lumen. Thus, understanding how natural SIgA interacts with commensal bacteria can provide new clues on its multiple functions at mucosal surfaces. Using fluorescently labeled, nonspecific SIgA or secretory component (SC), we visualized by confocal microscopy the interaction with various commensal bacteria, including Lactobacillus, Bifidobacteria, Escherichia coli, and Bacteroides strains. These experiments revealed that the interaction between SIgA and commensal bacteria involves Fab- and Fc-independent structural motifs, featuring SC as a crucial partner. Removal of glycans present on free SC or bound in SIgA resulted in a drastic drop in the interaction with Gram-positive bacteria, indicating the essential role of carbohydrates in the process. In contrast, poor binding of Gram-positive bacteria by control IgG was observed. The interaction with Gram-negative bacteria was preserved whatever the molecular form of protein partner used, suggesting the involvement of different binding motifs. Purified SIgA and SC from either mouse hybridoma cells or human colostrum exhibited identical patterns of recognition for Gram-positive bacteria, emphasizing conserved plasticity between species. Thus, sugar-mediated binding of commensals by SIgA highlights the currently underappreciated role of glycans in mediating the interaction between a highly diverse microbiota and the mucosal immune system.	[Corthesy, Blaise] CHU Vaudois, Univ State Hosp, Dept Immunol & Allergy, R&D Lab,Div Immunol & Allergy, CH-1011 Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Corthesy, B (corresponding author), CHU Vaudois, Univ State Hosp, Dept Immunol & Allergy, R&D Lab,Div Immunol & Allergy, Rue Bugnon 46, CH-1011 Lausanne, Switzerland.	blaise.corthesy@chuv.ch			Swiss Science Research Foundation [3200-122039]	Swiss Science Research Foundation(Swiss National Science Foundation (SNSF))	This work was supported by Swiss Science Research Foundation Grant 3200-122039.	Bollinger RR, 2003, IMMUNOLOGY, V109, P580; Bonner A, 2009, MUCOSAL IMMUNOL, V2, P74, DOI 10.1038/mi.2008.68; Bos NA, 2001, GUT, V48, P762, DOI 10.1136/gut.48.6.762; Busch N, 1998, GASTROENTEROLOGY, V115, P129, DOI 10.1016/S0016-5085(98)70374-9; Carbonare CB, 2005, PEDIAT ALLERG IMM-UK, V16, P574, DOI 10.1111/j.1399-3038.2005.00332.x; Chapot-Chartier MP, 2010, J BIOL CHEM, V285, P10464, DOI 10.1074/jbc.M109.082958; Corthesy B, 2010, FUTURE MICROBIOL, V5, P817, DOI 10.2217/FMB.10.39; Crottet P, 1998, J IMMUNOL, V161, P5445; Crottet P, 1999, J BIOL CHEM, V274, P31445, DOI 10.1074/jbc.274.44.31445; Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336; Favre LI, 2003, J CHROMATOGR B, V786, P143, DOI 10.1016/S1570-0232(02)00723-7; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Frankel G, 2001, TRENDS MICROBIOL, V9, P214, DOI 10.1016/S0966-842X(01)02016-9; Gonzalez-Chavez SA, 2009, INT J ANTIMICROB AG, V33, DOI 10.1016/j.ijantimicag.2008.07.020; Hapfelmeier S, 2010, SCIENCE, V328, P1705, DOI 10.1126/science.1188454; Harris NL, 2006, J IMMUNOL, V177, P6256, DOI 10.4049/jimmunol.177.9.6256; Hendrickson BA, 1996, J IMMUNOL, V157, P750; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Hughes GJ, 1999, BBA-PROTEIN STRUCT M, V1434, P86, DOI 10.1016/S0167-4838(99)00168-5; Kadaoui KA, 2007, J IMMUNOL, V179, P7751, DOI 10.4049/jimmunol.179.11.7751; Le Blay G, 2007, LETT APPL MICROBIOL, V45, P252, DOI 10.1111/j.1472-765X.2007.02178.x; Lullau E, 1996, J BIOL CHEM, V271, P16300, DOI 10.1074/jbc.271.27.16300; MacKenzie DA, 2009, J BIOL CHEM, V284, P32444, DOI 10.1074/jbc.M109.040907; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Mathias A, 2010, J BIOL CHEM, V285, P33906, DOI 10.1074/jbc.M110.135111; Mestecky J, 1999, GUT, V44, P2, DOI 10.1136/gut.44.1.2; Mestecky J, 2009, IMMUNOL LETT, V124, P57, DOI 10.1016/j.imlet.2009.03.013; MICHETTI P, 1992, INFECT IMMUN, V60, P1786, DOI 10.1128/IAI.60.5.1786-1792.1992; MOREAU MC, 1978, INFECT IMMUN, V21, P532, DOI 10.1128/IAI.21.2.532-539.1978; Newburg DS, 2007, PEDIATR RES, V61, P2, DOI 10.1203/01.pdr.0000250274.68571.18; Orndorff PE, 2004, INFECT IMMUN, V72, P1929, DOI 10.1128/IAI.72.4.1929-1938.2004; PARR EL, 1995, J IMMUNOL METHODS, V180, P147, DOI 10.1016/0022-1759(94)00310-S; Perrier C, 2006, J BIOL CHEM, V281, P14280, DOI 10.1074/jbc.M512958200; Phalipon A, 2006, J IMMUNOL, V176, P1686, DOI 10.4049/jimmunol.176.3.1686; Phalipon A, 2002, IMMUNITY, V17, P107, DOI 10.1016/S1074-7613(02)00341-2; PHALIPON A, 1995, J EXP MED, V182, P769, DOI 10.1084/jem.182.3.769; POGER ME, 1974, J EXP MED, V139, P629, DOI 10.1084/jem.139.3.629; Quan CP, 1997, INFECT IMMUN, V65, P3997, DOI 10.1128/IAI.65.10.3997-4004.1997; Riedel CU, 2006, INT J FOOD MICROBIOL, V110, P62, DOI 10.1016/j.ijfoodmicro.2006.01.040; Rojas R, 2002, NAT REV MOL CELL BIO, V3, P944, DOI 10.1038/nrm972; Royle L, 2003, J BIOL CHEM, V278, P20140, DOI 10.1074/jbc.M301436200; Schenk M, 2007, SEMIN IMMUNOL, V19, P84, DOI 10.1016/j.smim.2006.09.002; Schroten H, 1998, INFECT IMMUN, V66, P3971, DOI 10.1128/IAI.66.8.3971-3973.1998; SHROFF KE, 1995, INFECT IMMUN, V63, P3904, DOI 10.1128/IAI.63.10.3904-3913.1995; Sjogren YM, 2009, CLIN EXP ALLERGY, V39, P1842, DOI 10.1111/j.1365-2222.2009.03326.x; Stoel M, 2005, J IMMUNOL, V174, P1046, DOI 10.4049/jimmunol.174.2.1046; Talham GL, 1999, INFECT IMMUN, V67, P1992; Thierry AC, 2009, CLIN EXP ALLERGY, V39, P527, DOI 10.1111/j.1365-2222.2008.03185.x; Tsuruta T, 2009, FEMS IMMUNOL MED MIC, V56, P185, DOI 10.1111/j.1574-695X.2009.00568.x; van der Waaij LA, 2004, EUR J GASTROEN HEPAT, V16, P669, DOI 10.1097/01.meg.0000108346.41221.19; VANDERMEER JWM, 1984, SEMIN HEMATOL, V21, P123; vanderWaaij LA, 1996, GUT, V38, P348, DOI 10.1136/gut.38.3.348; WELTZIN R, 1994, ANTIMICROB AGENTS CH, V38, P2785, DOI 10.1128/AAC.38.12.2785; WOLD AE, 1990, INFECT IMMUN, V58, P3073, DOI 10.1128/IAI.58.9.3073-3077.1990	54	79	80	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17239	17247		10.1074/jbc.M110.209015	http://dx.doi.org/10.1074/jbc.M110.209015			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454510	hybrid, Green Published			2022-12-25	WOS:000290301900072
J	Baljuls, A; Mahr, R; Schwarzenau, I; Muller, T; Polzien, L; Hekman, M; Rapp, UR				Baljuls, Angela; Mahr, Regina; Schwarzenau, Inge; Mueller, Thomas; Polzien, Lisa; Hekman, Mirko; Rapp, Ulf R.			Single Substitution within the RKTR Motif Impairs Kinase Activity but Promotes Dimerization of RAF Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B-RAF; PROTEIN-KINASE; A-RAF; C-RAF; BIOLOGICAL-ACTIVITY; PHOSPHATIDIC-ACID; WILD-TYPE; FEEDBACK PHOSPHORYLATION; ONCOGENIC RAS; LIPID RAFTS	The serine/threonine kinase RAF is a central component of the MAPK cascade. Regulation of RAF activity is highly complex and involves recruitment to membranes and association with Ras and scaffold proteins as well as multiple phosphorylation and dephosphorylation events. Previously, we identified by molecular modeling an interaction between the N-region and the RKTR motif of the kinase domain in RAF and assigned a new function to this tetrapeptide segment. Here we found that a single substitution of each basic residue within the RKTR motif inhibited catalytic activity of all three RAF isoforms. However, the inhibition and phosphorylation pattern of C-RAF and A-RAF differed from B-RAF. Furthermore, substitution of the first arginine led to hyperphosphorylation and accumulation of A-RAF and C-RAF in plasma membrane fraction, indicating that this residue interferes with the recycling process of A-RAF and C-RAF but not B-RAF. In contrast, all RAF isoforms behave similarly with respect to the RKTR motif-dependent dimerization. The exchange of the second arginine led to exceedingly increased dimerization as long as one of the protomers was not mutated, suggesting that substitution of this residue with alanine may result in similar a structural rearrangement of the RAF kinase domain, as has been found for the C-RAF kinase domain co-crystallized with a dimerization-stabilizing RAF inhibitor. In summary, we provide evidence that each of the basic residues within the RKTR motif is indispensable for correct RAF function.	[Baljuls, Angela; Mahr, Regina; Schwarzenau, Inge; Polzien, Lisa; Hekman, Mirko; Rapp, Ulf R.] Univ Wurzburg, Dept Microbiol, Theodor Boveri Inst Biosci, D-97074 Wurzburg, Germany; [Mueller, Thomas] Univ Wurzburg, Dept Mol Plant Physiol & Biophys, Julius von Sachs Inst Biosci, D-97082 Wurzburg, Germany; [Rapp, Ulf R.] Max Planck Inst Biochem, Dept Mol Biol, D-82159 Martinsried, Germany	University of Wurzburg; University of Wurzburg; Max Planck Society	Rapp, UR (corresponding author), Univ Wurzburg, Dept Microbiol, Theodor Boveri Inst Biosci, D-97074 Wurzburg, Germany.	angela.baljuls@mail.uni-wuerzburg.de		Mueller, Thomas/0000-0003-1862-7357	Deutsche Forschungsgemeinschaft [SFB 487, C3, B2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB 487, Projects C3 and B2.	ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Andresen BT, 2002, FEBS LETT, V531, P65, DOI 10.1016/S0014-5793(02)03483-X; Baljuls A, 2008, J BIOL CHEM, V283, P27239, DOI 10.1074/jbc.M801782200; Baljuls A, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702429200; BONNER TI, 1985, MOL CELL BIOL, V5, P1400, DOI 10.1128/MCB.5.6.1400; Chen CM, 2004, BLOOD, V104, P73, DOI 10.1182/blood-2003-04-1340; Cox AD, 2010, CANCER CELL, V17, P221, DOI 10.1016/j.ccr.2010.02.029; DAUM G, 1994, TRENDS BIOCHEM SCI, V19, P474, DOI 10.1016/0968-0004(94)90133-3; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dhillon AS, 2002, ARCH BIOCHEM BIOPHYS, V404, P3, DOI 10.1016/S0003-9861(02)00244-8; Diaz B, 1997, MOL CELL BIOL, V17, P4509, DOI 10.1128/MCB.17.8.4509; Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055; FABIAN JR, 1993, MOL CELL BIOL, V13, P7170, DOI 10.1128/MCB.13.11.7170; Fischer A, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M607458200; Garnett MJ, 2005, MOL CELL, V20, P963, DOI 10.1016/j.molcel.2005.10.022; Ghosh S, 2003, J BIOL CHEM, V278, P45690, DOI 10.1074/jbc.M302933200; Ghosh S, 1996, J BIOL CHEM, V271, P8472, DOI 10.1074/jbc.271.14.8472; Hagemann C, 1999, EXP CELL RES, V253, P34, DOI 10.1006/excr.1999.4689; Hall-Jackson CA, 1999, CHEM BIOL, V6, P559, DOI 10.1016/S1074-5521(99)80088-X; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Hekman M, 2002, J BIOL CHEM, V277, P24090, DOI 10.1074/jbc.M200576200; Hekman M, 2005, FEBS LETT, V579, P464, DOI 10.1016/j.febslet.2004.11.105; Hekman M, 2004, J BIOL CHEM, V279, P14074, DOI 10.1074/jbc.M309620200; HULEIHEL M, 1986, MOL CELL BIOL, V6, P2655, DOI 10.1128/MCB.6.7.2655; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; IKAWA S, 1988, MOL CELL BIOL, V8, P2651, DOI 10.1128/MCB.8.6.2651; Johnson LM, 2005, BIOCHEMISTRY-US, V44, P3432, DOI 10.1021/bi0487692; Lu KK, 1998, CELL GROWTH DIFFER, V9, P367; Marais R, 1997, J BIOL CHEM, V272, P4378, DOI 10.1074/jbc.272.7.4378; Mason CS, 1999, EMBO J, V18, P2137, DOI 10.1093/emboj/18.8.2137; Matheny SA, 2004, NATURE, V427, P256, DOI 10.1038/nature02237; MOODIE SA, 1993, SCIENCE, V260, P1658, DOI 10.1126/science.8503013; MORRISON DK, 1988, P NATL ACAD SCI USA, V85, P8855, DOI 10.1073/pnas.85.23.8855; MU FT, 1995, J BIOL CHEM, V270, P13503, DOI 10.1074/jbc.270.22.13503; Nekhoroshkova E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004647; Pelkmans L, 2005, NATURE, V436, P128, DOI 10.1038/nature03866; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Prior IA, 2001, NAT CELL BIOL, V3, P368, DOI 10.1038/35070050; Rajakulendran T, 2009, NATURE, V461, P542, DOI 10.1038/nature08314; Rajalingam K, 2007, BBA-MOL CELL RES, V1773, P1177, DOI 10.1016/j.bbamcr.2007.01.012; Rapp UR, 2006, CANCER CELL, V9, P9, DOI 10.1016/j.ccr.2005.12.022; RAPP UR, 1983, P NATL ACAD SCI-BIOL, V80, P4218, DOI 10.1073/pnas.80.14.4218; Ritt DA, 2007, CURR BIOL, V17, P179, DOI 10.1016/j.cub.2006.11.061; Ritt DA, 2010, MOL CELL BIOL, V30, P806, DOI 10.1128/MCB.00569-09; Rizzo MA, 2000, J BIOL CHEM, V275, P23911, DOI 10.1074/jbc.M001553200; Roskoski R, 2010, BIOCHEM BIOPH RES CO, V399, P313, DOI 10.1016/j.bbrc.2010.07.092; Rushworth LK, 2006, MOL CELL BIOL, V26, P2262, DOI 10.1128/MCB.26.6.2262-2272.2006; Schreck R, 2006, INT J CANCER, V119, P2261, DOI 10.1002/ijc.22144; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wartmann M, 1997, J BIOL CHEM, V272, P3915, DOI 10.1074/jbc.272.7.3915; WARTMANN M, 1994, J BIOL CHEM, V269, P6695; Weber CK, 2001, CANCER RES, V61, P3595; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Zhang BH, 2000, EMBO J, V19, P5429, DOI 10.1093/emboj/19.20.5429; ZHANG XF, 1993, NATURE, V364, P308, DOI 10.1038/364308a0	57	25	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.194167	http://dx.doi.org/10.1074/jbc.M110.194167			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454547	hybrid, Green Published			2022-12-25	WOS:000290022800086
J	Bozna, BL; Polzella, P; Rankl, C; Zhu, R; Salio, M; Shepherd, D; Duman, M; Cerundolo, V; Hinterdorfer, P				Bozna, Bianca L.; Polzella, Paolo; Rankl, Christian; Zhu, Rong; Salio, Mariolina; Shepherd, Dawn; Duman, Memed; Cerundolo, Vincenzo; Hinterdorfer, Peter			Binding Strength and Dynamics of Invariant Natural Killer Cell T Cell Receptor/CD1d-Glycosphingolipid Interaction on Living Cells by Single Molecule Force Spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATOMIC-FORCE; NKT CELLS; ALPHA-GALACTOSYLCERAMIDE; RECOGNITION EVENTS; DENDRITIC CELLS; ADHESION FORCES; CROSS-LINKING; HUMAN CD1D; IN-VIVO; MICROSCOPY	Invariant natural killer T (iNKT) cells are a population of T lymphocytes that play an important role in regulating immunity to infection and tumors by recognizing endogenous and exogenous CD1d-bound lipid molecules. Using soluble iNKT T cell receptor (TCR) molecules, we applied single molecule force spectroscopy for the investigation of the iNKT TCR affinity for human CD1d molecules loaded with glycolipids differing in the length of the phytosphingosine chain using either recombinant CD1d molecules or lipid-pulsed THP1 cells. In both settings, the dissociation of the iNKT TCR from human CD1d molecules loaded with the lipid containing the longer phytosphingosine chain required higher unbinding forces compared with the shorter phytosphingosine lipid. Our findings are discussed in the context of previous results obtained by surface plasmon resonance measurements. We present new insights into the energy landscape and the kinetic rate constants of the iNKT TCR/human CD1d-glycosphingolipid interaction and emphasize the unique potential of single molecule force spectroscopy on living cells.	[Bozna, Bianca L.; Zhu, Rong; Duman, Memed; Hinterdorfer, Peter] Johannes Kepler Univ Linz, Inst Biophys, A-4040 Linz, Austria; [Rankl, Christian] Agilent Technol Austria GmbH, A-4040 Linz, Austria; [Hinterdorfer, Peter] Univ Linz, Christian Doppler Lab Nanoscop Methods Biophys, A-4040 Linz, Austria; [Polzella, Paolo; Salio, Mariolina; Shepherd, Dawn; Cerundolo, Vincenzo] Univ Oxford, MRC, Human Immunol Unit, Weatherall Inst Mol Med,Nuffield Dept Med, Oxford OX3 7BN, England	Johannes Kepler University Linz; Agilent Technologies; Johannes Kepler University Linz; University of Oxford	Hinterdorfer, P (corresponding author), Johannes Kepler Univ Linz, Inst Biophys, Altenberger Str 69, A-4040 Linz, Austria.	peter.hinterdorfer@jku.at	Duman, Memed/B-9957-2014; Hinterdorfer, Peter/C-4235-2013	Shepherd, Dawn/0000-0003-1304-6051; Rankl, Christian/0000-0002-7354-7651; Cerundolo, Vincenzo/0000-0003-0040-3793; Salio, Mariolina/0000-0002-4821-3801; Hinterdorfer, Peter/0000-0003-2583-1305	European Commission [RTN-CT-2006-035946 IMMUNANOMAP]; Cancer Research UK [C399/A2291]; Cancer Research UK [11331] Funding Source: researchfish; Medical Research Council [G1000800] Funding Source: researchfish; MRC [G1000800] Funding Source: UKRI	European Commission(European CommissionEuropean Commission Joint Research Centre); Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by European Commission Grant Marie Curie RTN-CT-2006-035946 IMMUNANOMAP and Cancer Research UK Grant C399/A2291.	Atkins P., 2014, ATKINSPHYSICAL CHEM, V10th Edn.; Baumgartner W, 2000, ULTRAMICROSCOPY, V82, P85, DOI 10.1016/S0304-3991(99)00154-0; Baumgartner W., 2000, Single Molecules, V1, P119, DOI 10.1002/1438-5171(200006)1:2<119::AID-SIMO119>3.0.CO;2-K; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Benoit M, 2000, NAT CELL BIOL, V2, P313, DOI 10.1038/35014000; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; BUTT HJ, 1995, NANOTECHNOLOGY, V6, P1, DOI 10.1088/0957-4484/6/1/001; Cerundolo V, 2009, NAT REV IMMUNOL, V9, P28, DOI 10.1038/nri2451; Chen A, 2000, BIOPHYS J, V78, P2814, DOI 10.1016/S0006-3495(00)76824-X; Dupres V, 2005, NAT METHODS, V2, P515, DOI 10.1038/NMETH769; Ebner A, 2007, BIOCONJUGATE CHEM, V18, P1176, DOI 10.1021/bc070030s; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; Evans E, 1999, BIOPHYS J, V76, P2439, DOI 10.1016/S0006-3495(99)77399-6; FLORIN EL, 1994, SCIENCE, V264, P415, DOI 10.1126/science.8153628; Fujii S, 2003, J EXP MED, V198, P267, DOI 10.1084/jem.20030324; HASELGRUBLER T, 1995, BIOCONJUGATE CHEM, V6, P242, DOI 10.1021/bc00033a002; Hermans IF, 2003, J IMMUNOL, V171, P5140, DOI 10.4049/jimmunol.171.10.5140; Hinterdorfer P, 1996, P NATL ACAD SCI USA, V93, P3477, DOI 10.1073/pnas.93.8.3477; Hinterdorfer P, 2006, NAT METHODS, V3, P347, DOI 10.1038/NMETH871; Hosseini BH, 2009, P NATL ACAD SCI USA, V106, P17852, DOI 10.1073/pnas.0905384106; HUTTER JL, 1993, REV SCI INSTRUM, V64, P1868, DOI 10.1063/1.1143970; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Koch M, 2005, NAT IMMUNOL, V6, P819, DOI 10.1038/ni1225; LEE GU, 1994, LANGMUIR, V10, P354, DOI 10.1021/la00014a003; Lehenkari PP, 1999, BIOCHEM BIOPH RES CO, V259, P645, DOI 10.1006/bbrc.1999.0827; McCarthy C, 2007, J EXP MED, V204, P1131, DOI 10.1084/jem.20062342; Muller DJ, 2007, NAT PROTOC, V2, P2191, DOI 10.1038/nprot.2007.309; Pfister G, 2005, J CELL SCI, V118, P1587, DOI 10.1242/jcs.02292; Rankl C, 2008, P NATL ACAD SCI USA, V105, P17778, DOI 10.1073/pnas.0806451105; Spada FM, 1998, J EXP MED, V188, P1529, DOI 10.1084/jem.188.8.1529; te Riet J, 2007, J CELL SCI, V120, P3965, DOI 10.1242/jcs.004010; Wojcikiewicz EP, 2006, BIOMACROMOLECULES, V7, P3188, DOI 10.1021/bm060559c; Zajonc DM, 2005, NAT IMMUNOL, V6, P810, DOI 10.1038/ni1224; Zhang XH, 2002, BIOPHYS J, V83, P2270, DOI 10.1016/S0006-3495(02)73987-8	34	19	19	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.192674	http://dx.doi.org/10.1074/jbc.M110.192674			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454514	Green Published, hybrid			2022-12-25	WOS:000290022800037
J	Liu, XH; Xu, WQ; Russ, J; Eiden, LE; Eiden, MV				Liu, Xiu-Huai; Xu, Wenqin; Russ, Jill; Eiden, Lee E.; Eiden, Maribeth V.			The Host Range of Gammaretroviruses and Gammaretroviral Vectors Includes Post-Mitotic Neural Cells	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; IMMUNODEFICIENCY-VIRUS TYPE-1; MURINE LEUKEMIA-VIRUS; CEREBRAL CORTICAL-NEURONS; PC12 CELLS; NUCLEAR IMPORT; PREINTEGRATION COMPLEX; FLUORESCENT PROTEIN; GENE-THERAPY; RETROVIRUS	Background: Gammaretroviruses and gammaretroviral vectors, in contrast to lentiviruses and lentiviral vectors, are reported to be restricted in their ability to infect growth-arrested cells. The block to this restriction has never been clearly defined. The original assessment of the inability of gammaretroviruses and gammaretroviral vectors to infect growth-arrested cells was carried out using established cell lines that had been growth-arrested by chemical means, and has been generalized to neurons, which are post-mitotic. We re-examined the capability of gammaretroviruses and their derived vectors to efficiently infect terminally differentiated neuroendocrine cells and primary cortical neurons, a target of both experimental and therapeutic interest. Methodology/Principal Findings: Using GFP expression as a marker for infection, we determined that both growth-arrested (NGF-differentiated) rat pheochromocytoma cells (PC12 cells) and primary rat cortical neurons could be efficiently transduced, and maintained long-term protein expression, after exposure to murine leukemia virus (MLV) and MLV-based retroviral vectors. Terminally differentiated PC12 cells transduced with a gammaretroviral vector encoding the antiapoptotic protein Bcl-xL were protected from cell death induced by withdrawal of nerve growth factor (NGF), demonstrating gammaretroviral vector-mediated delivery and expression of genes at levels sufficient for therapeutic effect in non-dividing cells. Post-mitotic rat cortical neurons were also shown to be susceptible to transduction by murine replication-competent gammaretroviruses and gammaretroviral vectors. Conclusions/Significance: These findings suggest that the host range of gammaretroviruses includes post-mitotic and other growth-arrested cells in mammals, and have implications for re-direction of gammaretroviral gene therapy to neurological disease.	[Liu, Xiu-Huai; Eiden, Lee E.] NIMH, Mol Neurosci Sect, Lab Cellular & Mol Regulat, NIH, Bethesda, MD 20892 USA; [Xu, Wenqin; Russ, Jill; Eiden, Maribeth V.] NIMH, Sect Directed Gene Transfer, Lab Cellular & Mol Regulat, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Liu, XH (corresponding author), NIMH, Mol Neurosci Sect, Lab Cellular & Mol Regulat, NIH, Bethesda, MD 20892 USA.	eidenm@mail.nih.gov		Eiden, Lee/0000-0001-7524-944X	National Institute of Mental Health; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002592, ZIAMH002386] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded by the National Institute of Mental Health Intramural Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRITTON LM, 1989, CELL, V57, P659, DOI 10.1016/0092-8674(89)90134-7; Bacsi A, 2005, CELL MOL NEUROBIOL, V25, P1123, DOI 10.1007/s10571-005-8222-6; Blomer U, 1998, P NATL ACAD SCI USA, V95, P2603, DOI 10.1073/pnas.95.5.2603; BOWERMAN B, 1989, GENE DEV, V3, P469, DOI 10.1101/gad.3.4.469; BREWER GJ, 1995, J NEUROSCI RES, V42, P674, DOI 10.1002/jnr.490420510; BUKRINSKY MI, 1993, P NATL ACAD SCI USA, V90, P6125, DOI 10.1073/pnas.90.13.6125; BUKRINSKY MI, 1992, P NATL ACAD SCI USA, V89, P6580, DOI 10.1073/pnas.89.14.6580; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chen J, 2001, VIROLOGY, V282, P186, DOI 10.1006/viro.2001.0826; Depienne C, 2000, EXP CELL RES, V260, P387, DOI 10.1006/excr.2000.5016; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; EZZEDDINE ZD, 1991, NEW BIOL, V3, P608; FARNET CM, 1991, J VIROL, V65, P1910, DOI 10.1128/JVI.65.4.1910-1915.1991; FARNET CM, 1990, P NATL ACAD SCI USA, V87, P4164, DOI 10.1073/pnas.87.11.4164; Galla M, 2004, MOL CELL, V16, P309, DOI 10.1016/j.molcel.2004.09.023; GALLAY P, 1995, CELL, V83, P569, DOI 10.1016/0092-8674(95)90097-7; Goff SP, 2001, J GENE MED, V3, P517, DOI 10.1002/1521-2254(200111)3:6<517::AID-JGM234>3.0.CO;2-E; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Guenechea G, 2000, MOL THER, V1, P566, DOI 10.1006/mthe.2000.0077; Haffar OK, 2000, J MOL BIOL, V299, P359, DOI 10.1006/jmbi.2000.3768; Hahn AT, 2009, CELL CYCLE, V8, P1044, DOI 10.4161/cc.8.7.8042; HAREL J, 1981, VIROLOGY, V110, P202, DOI 10.1016/0042-6822(81)90022-2; Hashimoto R, 2002, J NEUROCHEM, V80, P589, DOI 10.1046/j.0022-3042.2001.00728.x; Hossle JP, 2002, NEWS PHYSIOL SCI, V17, P87, DOI 10.1152/nips.01343.2001; Iordanskiy S, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-4; Jarrosson-Wuilleme L, 2006, J VIROL, V80, P1152, DOI 10.1128/JVI.80.3.1152-1159.2006; Kamau SW, 2001, ANTIMICROB AGENTS CH, V45, P3654, DOI 10.1128/AAC.45.12.3654-3656.2001; Kaushik R, 2009, CELL HOST MICROBE, V6, P68, DOI 10.1016/j.chom.2009.05.022; KAVANAUGH MP, 1994, P NATL ACAD SCI USA, V91, P7071, DOI 10.1073/pnas.91.15.7071; LANDER MR, 1984, J VIROL, V52, P695, DOI 10.1128/JVI.52.2.695-698.1984; Li L, 2000, J VIROL, V74, P10965, DOI 10.1128/JVI.74.23.10965-10974.2000; Liu XH, 2001, J BIOL CHEM, V276, P46326, DOI 10.1074/jbc.M108930200; Logg CR, 2007, J MOL BIOL, V369, P1214, DOI 10.1016/j.jmb.2007.04.026; Logg CR, 2001, J VIROL, V75, P6989, DOI 10.1128/JVI.75.15.6989-6998.2001; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; MESNER PW, 1992, J CELL BIOL, V119, P1669, DOI 10.1083/jcb.119.6.1669; MILLER AD, 1990, HUM GENE THER, V1, P5, DOI 10.1089/hum.1990.1.1-5; MILLER DG, 1990, MOL CELL BIOL, V10, P4239, DOI 10.1128/MCB.10.8.4239; Persengiev SP, 2001, ONCOGENE, V20, P5124, DOI 10.1038/sj.onc.1204663; RAUSCH DM, 1990, CELL MOL NEUROBIOL, V10, P237, DOI 10.1007/BF00734577; Ravni A, 2008, MOL PHARMACOL, V73, P1688, DOI 10.1124/mol.107.044792; ROE TY, 1993, EMBO J, V12, P2099, DOI 10.1002/j.1460-2075.1993.tb05858.x; SPRINGETT GM, 1989, J VIROL, V63, P3865, DOI 10.1128/JVI.63.9.3865-3869.1989; Suzuki Y, 2007, NAT REV MICROBIOL, V5, P187, DOI 10.1038/nrmicro1579; Thornhill SI, 2008, MOL THER, V16, P590, DOI 10.1038/sj.mt.6300393; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; vanGrunsven LA, 1996, ONCOGENE, V12, P1347; vanGrunsven LA, 1996, ONCOGENE, V12, P855; WILSON CA, 1995, J VIROL, V69, P534, DOI 10.1128/JVI.69.1.534-537.1995; WILSON CA, 1994, J VIROL, V68, P7697, DOI 10.1128/JVI.68.12.7697-7703.1994; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Zhang YZ, 2006, CELL BIOL INT, V30, P777, DOI 10.1016/j.cellbi.2006.05.010	52	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e18072	10.1371/journal.pone.0018072	http://dx.doi.org/10.1371/journal.pone.0018072			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464894	gold, Green Published, Green Submitted			2022-12-25	WOS:000289053800021
J	Weaver, EA; Rubrum, AM; Webby, RJ; Barry, MA				Weaver, Eric A.; Rubrum, Adam M.; Webby, Richard J.; Barry, Michael A.			Protection against Divergent Influenza H1N1 Virus by a Centralized Influenza Hemagglutinin	PLOS ONE			English	Article							CONSENSUS SEQUENCE; IMMUNE-RESPONSES; AVIAN INFLUENZA; DNA VACCINES; MICE; AIDS; IMMUNOGENICITY; IMMUNIZATION; INTRANASAL; ADAPTATION	Influenza poses a persistent worldwide threat to the human population. As evidenced by the 2009 H1N1 pandemic, current vaccine technologies are unable to respond rapidly to this constantly diverging pathogen. We tested the utility of adenovirus (Ad) vaccines expressing centralized consensus influenza antigens. Ad vaccines were produced within 2 months and protected against influenza in mice within 3 days of vaccination. Ad vaccines were able to protect at doses as low as 10 7 virus particles/kg indicating that approximately 1,000 human doses could be rapidly generated from standard Ad preparations. To generate broadly cross-reactive immune responses, centralized consensus antigens were constructed against H1 influenza and against H1 through H5 influenza. Twenty full-length H1 HA sequences representing the main branches of the H1 HA phylogenetic tree were used to create a synthetic centralized gene, HA1-con. HA1-con minimizes the degree of sequence dissimilarity between the vaccine and existing circulating viruses. The centralized H1 gene, HA1-con, induced stronger immune responses and better protection against mismatched virus challenges as compared to two wildtype H1 genes. HA1-con protected against three genetically diverse lethal influenza challenges. When mice were challenged with 1934 influenza A/PR/8/34, HA1-con protected 100% of mice while vaccine generated from 2009 A/TX/05/09 only protected 40%. Vaccination with 1934 A/PR/8/34 and 2009 A/TX/05/09 protected 60% and 20% against 1947 influenza A/FM/1/47, respectively, whereas 80% of mice vaccinated with HA1-con were protected. Notably, 80% of mice challenged with 2009 swine flu isolate A/California/4/09 were protected by HA1-con vaccination. These data show that HA1-con in Ad has potential as a rapid and universal vaccine for H1N1 influenza viruses.	[Weaver, Eric A.; Barry, Michael A.] Mayo Clin, Dept Internal Med, Div Infect Dis, Rochester, MN 55905 USA; [Rubrum, Adam M.; Webby, Richard J.] St Jude Childrens Hosp, Dept Infect Dis, Memphis, TN 38105 USA; [Barry, Michael A.] Mayo Clin, Dept Immunol, Rochester, MN USA; [Barry, Michael A.] Mayo Clin, Dept Mol Med, Rochester, MN USA; [Barry, Michael A.] Mayo Clin, Translat Immunovirol & Biodef Program, Rochester, MN USA	Mayo Clinic; St Jude Children's Research Hospital; Mayo Clinic; Mayo Clinic; Mayo Clinic	Weaver, EA (corresponding author), Mayo Clin, Dept Internal Med, Div Infect Dis, Rochester, MN 55905 USA.	weaver.eric@mayo.edu	Webby, Richard J/N-5657-2018		US National Institute of Allergy and Infectious Diseases, National Institutes of Health [HHSN266200700005C]	US National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Work conducted at St Jude Children's Research Hospital was funded by the US National Institute of Allergy and Infectious Diseases, National Institutes of Health, under Contract No. HHSN266200700005C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Casimiro DR, 2003, J VIROL, V77, P7663, DOI 10.1128/JVI.77.13.7663-7668.2003; CDC, 2009, H1N1 FLU VACC WHY DE; CDC, 2009, FIST GLOB EST 2009 H; Chen MW, 2008, P NATL ACAD SCI USA, V105, P13538, DOI 10.1073/pnas.0806901105; CLEMENTS ML, 1986, J CLIN MICROBIOL, V24, P157, DOI 10.1128/JCM.24.1.157-160.1986; Ellenberger DL, 2002, VIROLOGY, V302, P155, DOI 10.1006/viro.2002.1577; Ennis FA, 1999, VIROLOGY, V259, P256, DOI 10.1006/viro.1999.9765; Fiers W, 2009, VACCINE, V27, P6280, DOI 10.1016/j.vaccine.2009.07.007; Gao Feng, 2004, Expert Rev Vaccines, V3, pS161, DOI 10.1586/14760584.3.4.S161; Gao WT, 2006, J VIROL, V80, P1959, DOI 10.1128/JVI.80.4.1959-1964.2006; Gaschen B, 2002, SCIENCE, V296, P2354, DOI 10.1126/science.1070441; GITELMAN AK, 1984, VIROLOGY, V134, P230, DOI 10.1016/0042-6822(84)90288-5; Hirota Y, 1997, VACCINE, V15, P962, DOI 10.1016/S0264-410X(96)00302-7; Hoelscher MA, 2006, LANCET, V367, P475, DOI 10.1016/S0140-6736(06)68076-8; Ilyushina NA, 2010, J VIROL, V84, P8607, DOI 10.1128/JVI.00159-10; Kilbourne ED, 2002, P NATL ACAD SCI USA, V99, P10748, DOI 10.1073/pnas.162366899; Korber B, 2000, SCIENCE, V288, P1789, DOI 10.1126/science.288.5472.1789; Laddy DJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002517; Laddy DJ, 2007, VACCINE, V25, P2984, DOI 10.1016/j.vaccine.2007.01.063; Mok H, 2005, MOL THER, V11, P66, DOI 10.1016/j.ymthe.2004.09.015; Muszkat M, 2003, VACCINE, V21, P1180, DOI 10.1016/S0264-410X(02)00481-4; Muszkat M, 2000, VACCINE, V18, P1696, DOI 10.1016/S0264-410X(99)00509-5; Muthumani K, 2008, VACCINE, V26, P5128, DOI 10.1016/j.vaccine.2008.03.060; Nicholson KG, 2003, PEDIATR INFECT DIS J, V22, pS228, DOI 10.1097/01.inf.0000092193.91306.2f; Nickle DC, 2003, SCIENCE, V299, P1515; Novitsky V, 2002, J VIROL, V76, P5435, DOI 10.1128/JVI.76.11.5435-5451.2002; Potter C W, 1977, Dev Biol Stand, V39, P323; Rimmelzwaan GF, 2001, VACCINE, V20, P158, DOI 10.1016/S0264-410X(01)00262-6; Rimmelzwaan GF, 2001, J VIROL, V75, P6687, DOI 10.1128/JVI.75.14.6687-6691.2001; Rimmelzwaan Guus F., 2001, Current Opinion in Pharmacology, V1, P491, DOI 10.1016/S1471-4892(01)00085-6; SCHILD GC, 1983, NATURE, V303, P706, DOI 10.1038/303706a0; Subbarao K, 1999, ADV VIRUS RES, V54, P349, DOI 10.1016/S0065-3527(08)60371-1; Weaver EA, 2006, J VIROL, V80, P6745, DOI 10.1128/JVI.02484-05; Weaver EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005059; WEBSTER RG, 1980, EUR J IMMUNOL, V10, P396, DOI 10.1002/eji.1830100515; World Health Organization, 2009, INFL FACT SHEET; 1998, MMWR MORB MORTAL WKL, V47, P280; 2004, MMWR MORB MORTAL WKL, V53, P547; 2001, MMWR MORB MORTAL WKL, V50, P466; 2003, MMWR MORB MORTAL WKL, V52, P26	40	47	55	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e18314	10.1371/journal.pone.0018314	http://dx.doi.org/10.1371/journal.pone.0018314			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464940	Green Published, gold, Green Submitted			2022-12-25	WOS:000289053800040
J	Chou, CW; Wu, MS; Huang, WC; Chen, CC				Chou, Chia-Wei; Wu, Ming-Shiang; Huang, Wei-Chien; Chen, Ching-Chow			HDAC Inhibition Decreases the Expression of EGFR in Colorectal Cancer Cells	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; HISTONE DEACETYLASE INHIBITOR; COLON-CANCER; GENE-EXPRESSION; TYROSINE KINASE; LUNG-CANCER; TRANSCRIPTION; SURVIVAL; APOPTOSIS; CETUXIMAB	Epidermal growth factor receptor (EGFR), a receptor tyrosine kinase which promotes cell proliferation and survival, is abnormally overexpressed in numerous tumors of epithelial origin, including colorectal cancer (CRC). EGFR monoclonal antibodies have been shown to increase the median survival and are approved for the treatment of colorectal cancer. Histone deacetylases (HDACs), frequently overexpressed in colorectal cancer and several malignancies, are another attractive targets for cancer therapy. Several inhibitors of HDACs (HDACi) are developed and exhibit powerful antitumor abilities. In this study, human colorectal cancer cells treated with HDACi exhibited reduced EGFR expression, thereby disturbed EGF-induced ERK and Akt phosphorylation. HDACi also decreased the expression of SGLT1, an active glucose transporter found to be stabilized by EGFR, and suppressed the glucose uptake of cancer cells. HDACi suppressed the transcription of EGFR and class I HDACs were proved to be involved in this event. Chromatin immunoprecipitation analysis showed that HDACi caused the dissociation of SP1, HDAC3 and CBP from EGFR promoter. Our data suggested that HDACi could serve as a single agent to block both EGFR and HDAC, and may bring more benefits to the development of CRC therapy.	[Chou, Chia-Wei; Chen, Ching-Chow] Natl Taiwan Univ, Coll Med, Dept Pharmacol, Taipei 10764, Taiwan; [Wu, Ming-Shiang] Natl Taiwan Univ, Coll Med, Dept Internal Med & Primary Care Med, Div Gastroenterol, Taipei 10764, Taiwan; [Wu, Ming-Shiang] Natl Taiwan Univ Hosp, Taipei, Taiwan; [Huang, Wei-Chien] China Med Univ, Grad Inst Canc Biol, Taichung, Taiwan; [Huang, Wei-Chien] China Med Univ Hosp, Ctr Mol Med, Taichung, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Chou, CW (corresponding author), Natl Taiwan Univ, Coll Med, Dept Pharmacol, Taipei 10764, Taiwan.	chingchowchen@ntu.edu.tw	Huang, Wei-Chien/D-1740-2012; Huang, Wei-Chien/H-3126-2019	Huang, Wei-Chien/0000-0001-6467-8716; Huang, Wei-Chien/0000-0001-6467-8716; Wu, Ming-Shiang/0000-0002-1940-6428; CHEN, CHING-CHOW/0000-0002-7810-0939	National Science Council of Taiwan	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by a research grant from National Science Council of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Banck MS, 2009, CLIN CANCER RES, V15, P7492, DOI 10.1158/1078-0432.CCR-09-0188; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; BLAIS A, 1991, AM J PHYSIOL, V260, pC1245, DOI 10.1152/ajpcell.1991.260.6.C1245; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Brandt B, 2006, CLIN CANCER RES, V12, P7252, DOI 10.1158/1078-0432.CCR-06-0626; Casneuf VF, 2008, CANCER INVEST, V26, P852, DOI 10.1080/07357900801956363; Chen CJ, 2008, EUR J PHARMACOL, V591, P36, DOI 10.1016/j.ejphar.2008.06.041; Chou CW, 2008, FEBS LETT, V582, P4059, DOI 10.1016/j.febslet.2008.10.048; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; Deribe YL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000576; Engelman JA, 2008, CANCER CELL, V13, P375, DOI 10.1016/j.ccr.2008.04.008; Ewald JA, 2003, EXP CELL RES, V282, P121, DOI 10.1016/S0014-4827(02)00014-9; Fakih MG, 2009, CLIN CANCER RES, V15, P3189, DOI 10.1158/1078-0432.CCR-08-2999; Fazzone W, 2009, INT J CANCER, V125, P463, DOI 10.1002/ijc.24403; Ganapathy V, 2009, PHARMACOL THERAPEUT, V121, P29, DOI 10.1016/j.pharmthera.2008.09.005; Gao YS, 2010, J BIOL CHEM, V285, P11219, DOI 10.1074/jbc.M109.042754; Harari PM, 2004, INT J RADIAT ONCOL, V58, P976, DOI 10.1016/j.ijrobp.2003.09.097; Heerdt BG, 1997, CELL GROWTH DIFFER, V8, P523; Helmke BM, 2004, ORAL ONCOL, V40, P28, DOI 10.1016/S1368-8375(03)00129-5; Ishikawa N, 2001, JPN J CANCER RES, V92, P874, DOI 10.1111/j.1349-7006.2001.tb01175.x; Jepsen K, 2002, J CELL SCI, V115, P689; Johnson AC, 2000, MOL MED, V6, P17, DOI 10.1007/BF03401931; KAGEYAMA R, 1988, J BIOL CHEM, V263, P6329; Kobayashi H, 2003, NUTR CANCER, V46, P202, DOI 10.1207/S15327914NC4602_14; Koshiji M, 2005, MOL CELL, V17, P793, DOI 10.1016/j.molcel.2005.02.015; Lai CJ, 2010, CANCER RES, V70, P3647, DOI 10.1158/0008-5472.CAN-09-3360; Lin YC, 2008, CANCER RES, V68, P2375, DOI 10.1158/0008-5472.CAN-07-5807; Linardou H, 2008, LANCET ONCOL, V9, P962, DOI 10.1016/S1470-2045(08)70206-7; LUETTEKE NC, 1994, GENE DEV, V8, P399, DOI 10.1101/gad.8.4.399; MAHRAOUI L, 1994, BIOCHEM J, V298, P629, DOI 10.1042/bj2980629; Mariadason JM, 2008, EPIGENETICS-US, V3, P28, DOI 10.4161/epi.3.1.5736; Levy EM, 2009, INNATE IMMUN-LONDON, V15, P91, DOI 10.1177/1753425908101404; MIETTINEN PJ, 1995, NATURE, V376, P337, DOI 10.1038/376337a0; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Ritter CA, 2003, SEMIN ONCOL, V30, P3, DOI 10.1053/sonc.2003.50027; Rossig L, 2002, CIRC RES, V91, P837, DOI 10.1161/01.RES.0000037983.07158.B1; Sasakawa Y, 2003, BIOCHEM PHARMACOL, V66, P897, DOI 10.1016/S0006-2952(03)00411-8; Schwartz B, 1998, MOL CELL BIOCHEM, V188, P21, DOI 10.1023/A:1006831330340; Tong X, 2004, BIOCHEM BIOPH RES CO, V317, P463, DOI 10.1016/j.bbrc.2004.03.066; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Waby JS, 2008, CURR GENOMICS, V9, P301, DOI 10.2174/138920208785133244; Walther A, 2009, NAT REV CANCER, V9, P489, DOI 10.1038/nrc2645; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Weihua Z, 2008, CANCER CELL, V13, P385, DOI 10.1016/j.ccr.2008.03.015; Wilson AJ, 2006, J BIOL CHEM, V281, P13548, DOI 10.1074/jbc.M510023200; WILSON PM, 2010, CANCER CHEMOTH PHARM, P979; Xu WS, 2005, CANCER RES, V65, P7832, DOI 10.1158/0008-5472.CAN-04-4608; Yu CR, 2007, CLIN CANCER RES, V13, P1140, DOI 10.1158/1078-0432.CCR-06-1751; Yu XD, 2007, CANCER J, V13, P105, DOI 10.1097/PPO.0b013e318046eedc; Zhou Q, 2009, BREAST CANCER RES TR, V117, P443, DOI 10.1007/s10549-008-0148-5	51	79	83	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e18087	10.1371/journal.pone.0018087	http://dx.doi.org/10.1371/journal.pone.0018087			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464950	Green Published, gold, Green Submitted			2022-12-25	WOS:000288813900037
J	Inderbitzin, P; Davis, RM; Bostock, RM; Subbarao, KV				Inderbitzin, Patrik; Davis, R. Michael; Bostock, Richard M.; Subbarao, Krishna V.			The Ascomycete Verticillium longisporum Is a Hybrid and a Plant Pathogen with an Expanded Host Range	PLOS ONE			English	Article							VEGETATIVE COMPATIBILITY GROUPS; INTERSPECIFIC HYBRIDIZATION; FUNGAL ENDOPHYTES; ALBO-ATRUM; VERTICAL TRANSMISSION; NATURAL HYBRID; V-LONGISPORUM; OILSEED RAPE; MATING-TYPE; DNA-CONTENT	Hybridization plays a central role in plant evolution, but its overall importance in fungi is unknown. New plant pathogens are thought to arise by hybridization between formerly separated fungal species. Evolution of hybrid plant pathogens from non-pathogenic ancestors in the fungal-like protist Phytophthora has been demonstrated, but in fungi, the most important group of plant pathogens, there are few well-characterized examples of hybrids. We focused our attention on the hybrid and plant pathogen Verticillium longisporum, the causal agent of the Verticillium wilt disease in crucifer crops. In order to address questions related to the evolutionary origin of V. longisporum, we used phylogenetic analyses of seven nuclear loci and a dataset of 203 isolates of V. longisporum, V. dahliae and related species. We confirmed that V. longisporum was diploid, and originated three different times, involving four different lineages and three different parental species. All hybrids shared a common parent, species A1, that hybridized respectively with species D1, V. dahliae lineage D2 and V. dahliae lineage D3, to give rise to three different lineages of V. longisporum. Species A1 and species D1 constituted as yet unknown taxa. Verticillium longisporum likely originated recently, as each V. longisporum lineage was genetically homogenous, and comprised species A1 alleles that were identical across lineages.	[Inderbitzin, Patrik; Davis, R. Michael; Bostock, Richard M.; Subbarao, Krishna V.] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA	University of California System; University of California Davis	Inderbitzin, P (corresponding author), Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA.	kvsubbarao@ucdavis.edu	Subbarao, Krishna/X-3870-2019	Subbarao, Krishna/0000-0002-2075-1835	California Leafy Greens Board, United States Department of Agriculture-National Institute of Food and Agriculture (USDA-NIFA) [2007-51100-03846]; Hatch funds [CA-D*-PPA-5681-H]	California Leafy Greens Board, United States Department of Agriculture-National Institute of Food and Agriculture (USDA-NIFA); Hatch funds	Financial support was provided by the California Leafy Greens Board (2008-10, 2008-11, 2009-10, and 2009-11), United States Department of Agriculture-National Institute of Food and Agriculture (USDA-NIFA) (2007-51100-03846), and the Hatch funds allocated to University of California Agricultural Experiment Station Project CA-D*-PPA-5681-H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babadoost M, 2004, PLANT PATHOL, V53, P669, DOI 10.1111/j.1365-3059.2004.01070.x; Barbara DJ, 2003, MOL PLANT PATHOL, V4, P297, DOI 10.1046/J.1364-3703.2003.00172.X; Beser J, 2007, J CLIN MICROBIOL, V45, P881, DOI 10.1128/JCM.02245-06; Bhat RG, 1999, PHYTOPATHOLOGY, V89, P1218, DOI 10.1094/PHYTO.1999.89.12.1218; Brady B.L., 2002, VERTICILLIUM WILTS, P552; Brasier C, 2000, NATURE, V405, P134, DOI 10.1038/35012193; Brasier CM, 1999, P NATL ACAD SCI USA, V96, P5878, DOI 10.1073/pnas.96.10.5878; Brasier CM, 1998, MYCOL RES, V102, P45, DOI 10.1017/S0953756297004541; Brasier CM, 2001, BIOSCIENCE, V51, P123, DOI 10.1641/0006-3568(2001)051[0123:REOIPP]2.0.CO;2; CHRISTEN AA, 1979, PHYTOPATHOLOGY, V69, P263, DOI 10.1094/Phyto-69-263; CLARKSON JM, 1985, PLANT PATHOL, V34, P129, DOI 10.1111/j.1365-3059.1985.tb02769.x; Clewes E, 2008, PLANT PATHOL, V57, P1047, DOI 10.1111/j.1365-3059.2008.01897.x; Clewes E, 2008, NEW PHYTOL, V177, P583, DOI 10.1111/j.1469-8137.2007.02327.x; Collado-Romero M, 2008, PHYTOPATHOLOGY, V98, P1019, DOI 10.1094/PHYTO-98-9-1019; Collado-Romero M, 2010, FUNGAL BIOL-UK, V114, P209, DOI 10.1016/j.funbio.2009.12.005; Collins A, 2003, PHYTOPATHOLOGY, V93, P364, DOI 10.1094/PHYTO.2003.93.3.364; Eynck C, 2007, EUR J PLANT PATHOL, V118, P259, DOI 10.1007/s10658-007-9144-6; Flor HH, 1932, J AGRIC RES, V44, P0049; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Gonthier P, 2007, MOL ECOL, V16, P1389, DOI 10.1111/j.1365-294X.2007.03250.x; HASTIE AC, 1964, GENET RES, V5, P305, DOI 10.1017/S0016672300001245; HASTIE AC, 1973, T BRIT MYCOL SOC, V60, P511, DOI 10.1016/S0007-1536(73)80035-X; HEAL J, 2000, P ARISTOTELIAN SOC S, P1; Heale JB, 1999, CAN J PLANT PATHOL, V21, P1; Hegarty MJ, 2005, NEW PHYTOL, V165, P411, DOI 10.1111/j.1469-8137.2004.01253.x; Hernandez-Bello MA, 2006, PHYTOPATHOLOGY, V96, P1148, DOI 10.1094/PHYTO-96-1148; HORIUCHI S, 1990, BIOLOGICAL CONTROL OF SOIL-BORNE PLANT PATHOGENS, P285; INGRAM R, 1968, T BRIT MYCOL SOC, V51, P339, DOI 10.1016/S0007-1536(68)80073-7; JACKSON CW, 1985, J GEN MICROBIOL, V131, P3229; Johansson A, 2006, EUR J PLANT PATHOL, V114, P139, DOI 10.1007/s10658-005-2333-2; Joly DL, 2006, PLANT DIS, V90, P1552, DOI 10.1094/PD-90-1552A; Karapapa VK, 1997, MYCOL RES, V101, P1281, DOI 10.1017/S0953756297003985; Kauserud H, 2007, MOL ECOL, V16, P389, DOI 10.1111/j.1365-294X.2006.03129.x; Lin X, 2007, PLOS GENET, V3, P1975, DOI 10.1371/journal.pgen.0030186; Ma XF, 2008, ANN BOT-LONDON, V101, P825, DOI 10.1093/aob/mcm331; MANINTVELD WA, 2006, EUR J PLANT PATHOL, V117, P25; Masneuf I, 1998, APPL ENVIRON MICROB, V64, P3887; METZENBERG RL, 1990, BIOESSAYS, V12, P53, DOI 10.1002/bies.950120202; Moon CD, 2004, MOL ECOL, V13, P1455, DOI 10.1111/j.1365-294X.2004.02138.x; Moon CD, 2002, MYCOLOGIA, V94, P694, DOI 10.2307/3761720; Moon CD, 2007, MYCOLOGIA, V99, P895, DOI 10.3852/mycologia.99.6.895; Morin L, 2009, MYCOL RES, V113, P725, DOI 10.1016/j.mycres.2009.02.008; Newcombe G, 2000, MYCOL RES, V104, P261, DOI 10.1017/S0953756299001665; O'Donnell K, 2004, FUNGAL GENET BIOL, V41, P600, DOI 10.1016/j.fgb.2004.03.003; O'Donnell K, 1998, MYCOLOGIA, V90, P465, DOI 10.2307/3761407; Oliver SG., 1981, FUNGAL NUCLEUS, P191; Osborn TC, 2003, TRENDS GENET, V19, P141, DOI 10.1016/S0168-9525(03)00015-5; Pantou MP, 2005, MYCOL RES, V109, P889, DOI 10.1017/S0953756205003345; Pantou MP, 2005, FEMS MICROBIOL LETT, V245, P213, DOI 10.1016/j.femsle.2005.03.011; Paun O, 2007, TAXON, V56, P649, DOI 10.2307/25065850; Pethybridge GH., 1919, T BRIT MYCOL SOC, V6, P104; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; PUHALLA JE, 1983, PHYTOPATHOLOGY, V73, P1305, DOI 10.1094/Phyto-73-1305; Qin QM, 2006, PHYTOPATHOLOGY, V96, P582, DOI 10.1094/PHYTO-96-0582; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SAMBROOK J, MOLECULAR CLONING; Schardl CL, 2003, MOL ECOL, V12, P2861, DOI 10.1046/j.1365-294X.2003.01965.x; Selosse MA, 2007, NEW PHYTOL, V173, P452, DOI 10.1111/j.1469-8137.2007.01978.x; SOLTIS DE, 1993, CRIT REV PLANT SCI, V12, P243, DOI 10.1080/713608048; SPIERS AG, 1994, MYCOL RES, V98, P889, DOI 10.1016/S0953-7562(09)80260-8; Staats M, 2005, MOL BIOL EVOL, V22, P333, DOI 10.1093/molbev/msi020; STARK C., 1961, Gartenbauwissenschaft, V26, P493; Steventon LA, 2002, MYCOL RES, V106, P570, DOI 10.1017/S0953756202005865; SUBBARAO KV, 1995, PHYTOPATHOLOGY, V85, P1105, DOI 10.1094/Phyto-85-1105; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Taylor JW, 1999, CLIN MICROBIOL REV, V12, P126, DOI 10.1128/CMR.12.1.126; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; TSAI HF, 1994, P NATL ACAD SCI USA, V91, P2542, DOI 10.1073/pnas.91.7.2542; Turgeon G, 2000, FUNGAL GENET BIOL, V31, P1, DOI 10.1006/fgbi.2000.1227; TYPAS MA, 1980, J GEN MICROBIOL, V121, P231; Usami T, 2008, J GEN PLANT PATHOL, V74, P61, DOI 10.1007/s10327-007-0043-7; Usami T, 2009, J GEN PLANT PATHOL, V75, P422, DOI 10.1007/s10327-009-0197-6; White T., 1990, PCR PROTOCOLS GUIDE, P315; Zeise K, 2002, J PHYTOPATHOL, V150, P112, DOI 10.1046/j.1439-0434.2002.00730.x; Zeise K, 2002, J PHYTOPATHOL, V150, P557, DOI 10.1046/j.1439-0434.2002.00799.x; ZOLAN ME, 1995, MICROBIOL REV, V59, P686, DOI 10.1128/MMBR.59.4.686-698.1995	76	114	118	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2011	6	3							e18260	10.1371/journal.pone.0018260	http://dx.doi.org/10.1371/journal.pone.0018260			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740RG	21455321	Green Published, Green Submitted, gold			2022-12-25	WOS:000288811500034
J	Silver, J; Mei, YF				Silver, Jim; Mei, Ya-Fang			Transduction and Oncolytic Profile of a Potent Replication-Competent Adenovirus 11p Vector (RCAd11pGFP) in Colon Carcinoma Cells	PLOS ONE			English	Article							GENE-TRANSFER VECTOR; CARCINOEMBRYONIC ANTIGEN; NUCLEOTIDE-SEQUENCE; COLORECTAL-CANCER; CELLULAR RECEPTOR; CD46 RECEPTOR; THERAPY; VIRUS; EXPRESSION; SEROTYPE-3	Replication-competent adenovirus type 5 (Ad5) vectors promise to be more efficient gene delivery vehicles than their replication-deficient counterparts, and chimeric Ad5 vectors that are capable of targeting CD46 are more effective than Ad5 vectors with native fibers. Although several strategies have been used to improve gene transduction and oncolysis, either by modifying their tropism or enhancing their replication capacity, some tumor cells are still relatively refractory to infection by chimeric Ad5. The oncolytic effects of the vectors are apparent in certain tumors but not in others. Here, we report the biological and oncolytic profiles of a replication-competent adenovirus 11p vector (RCAd11pGFP) in colon carcinoma cells. CD46 was abundantly expressed in all cells studied; however, the transduction efficiency of RCAd11pGFP varied. RCAd11pGFP efficiently transduced HT-29, HCT-8, and LS174T cells, but it transduced T84 cells, derived from a colon cancer metastasis in the lung, less efficiently. Interestingly, RCAd11p replicated more rapidly in the T84 cells than in HCT-8 and LS174T cells and as rapidly as in HT-29 cells. Cell toxicity and proliferation assays indicated that RCAd11pGFP had the highest cell-killing activities in HT29 and T84 cells, the latter of which also expressed the highest levels of glycoproteins of the carcinoma embryonic antigen (CEA) family. In vivo experiments showed significant growth inhibition of T84 and HT-29 tumors in xenograft mice treated with either RCAd11pGFP or Ad11pwt compared to untreated controls. Thus, RCAd11pGFP has a potent cytotoxic effect on colon carcinoma cells.	[Silver, Jim; Mei, Ya-Fang] Umea Univ, Dept Clin Microbiol Virol, Umea, Sweden	Umea University	Silver, J (corresponding author), Umea Univ, Dept Clin Microbiol Virol, Umea, Sweden.	mei.ya-fang@climi.umu.se			Swedish Society of Medicine [2006-18791]; Cancer Research Foundation in Northern Sweden [AMP 08-571, AMP 08-6009, AMP 09-637]; Lion's Cancer Research Foundation at Umea University, Magn [LP 10-1855]; Umea University	Swedish Society of Medicine; Cancer Research Foundation in Northern Sweden; Lion's Cancer Research Foundation at Umea University, Magn; Umea University	This work was supported by a Swedish Society of Medicine grant 2006-18791 (Dr. YF Mei); Cancer Research Foundation in Northern Sweden: grants AMP 08-571 (Dr. YF Mei), AMP 08-6009 (Dr. YF Mei), AMP 09-637(Dr. YF Mei); Lion's Cancer Research Foundation at Umea University, grant LP 10-1855 (Dr. YF Mei); Magn. Bergvalls Stifitelse 2008 (Dr. YF Mei); and by Umea University, Medical Faculty's Insamligsstifteser grant 2009 and 2010 (Dr. YF Mei). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson BD, 2004, CANCER RES, V64, P4919, DOI 10.1158/0008-5472.CAN-04-0884; Bakalakos EA, 1999, AM J SURG, V177, P2, DOI 10.1016/S0002-9610(98)00303-1; Blumenthal RD, 2005, CANCER RES, V65, P8809, DOI 10.1158/0008-5472.CAN-05-0420; Brouwer E, 2007, CANCER GENE THER, V14, P211, DOI 10.1038/sj.cgt.7701010; CAWKWELL L, 1994, BRIT J CANCER, V70, P813, DOI 10.1038/bjc.1994.404; Chartier C, 1996, J VIROL, V70, P4805, DOI 10.1128/JVI.70.7.4805-4810.1996; Chung-Faye GA, 2000, BRIT MED J, V321, P1397, DOI 10.1136/bmj.321.7273.1397; Douglas JT, 1999, NAT BIOTECHNOL, V17, P470, DOI 10.1038/8647; Fleischli C, 2007, J GEN VIROL, V88, P2925, DOI 10.1099/vir.0.83142-0; Gaggar A, 2003, NAT MED, V9, P1408, DOI 10.1038/nm952; Hammarstrom S, 1999, SEMIN CANCER BIOL, V9, P67, DOI 10.1006/scbi.1998.0119; Hoffmann D, 2006, MOL CANCER THER, V5, P374, DOI 10.1158/1535-7163.MCT-05-0374; Holterman L, 2004, J VIROL, V78, P13207, DOI 10.1128/JVI.78.23.13207-13215.2004; Huarte E, 2006, MOL THER, V14, P129, DOI 10.1016/j.ymthe.2006.02.015; Kawakami Y, 2003, CANCER RES, V63, P1262; Kim M, 2003, BRIT J CANCER, V88, P1411, DOI 10.1038/sj.bjc.6600932; Mei YF, 2002, VIROLOGY, V295, P30, DOI 10.1006/viro.2002.1359; MEI YF, 1993, VIROLOGY, V194, P453, DOI 10.1006/viro.1993.1284; Mel YF, 1998, VIROLOGY, V240, P254, DOI 10.1006/viro.1997.8904; Nemerow GR, 1999, MICROBIOL MOL BIOL R, V63, P725, DOI 10.1128/MMBR.63.3.725-734.1999; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Rea D, 2001, J IMMUNOL, V166, P5236, DOI 10.4049/jimmunol.166.8.5236; Sandberg L, 2009, HUM GENE THER, V20, P361, DOI 10.1089/hum.2007.124; Segerman A, 2003, J VIROL, V77, P9183, DOI 10.1128/JVI.77.17.9183-9191.2003; Segerman A, 2003, J VIROL, V77, P1157, DOI 10.1128/JVI.77.2.1157-1162.2003; Short JJ, 2006, VIRUS RES, V122, P144, DOI 10.1016/j.virusres.2006.07.009; Sirena D, 2005, VIROLOGY, V343, P283, DOI 10.1016/j.virol.2005.08.024; Skog J, 2002, J GEN VIROL, V83, P1299, DOI 10.1099/0022-1317-83-6-1299; Stevenson SC, 1997, J VIROL, V71, P4782, DOI 10.1128/JVI.71.6.4782-4790.1997; Stone D, 2005, J VIROL, V79, P5090, DOI 10.1128/JVI.79.8.5090-5104.2005; Tomko RP, 1997, P NATL ACAD SCI USA, V94, P3352, DOI 10.1073/pnas.94.7.3352; Tomlinson I, 1997, CANCER METAST REV, V16, P67, DOI 10.1023/A:1005744323215; VELCICH A, 1995, CELL GROWTH DIFFER, V6, P749; Vogels R, 2003, J VIROL, V77, P8263, DOI 10.1128/JVI.77.15.8263-8271.2003; Waddington SN, 2008, CELL, V132, P397, DOI 10.1016/j.cell.2008.01.016; Wang HJ, 2011, NAT MED, V17, P96, DOI 10.1038/nm.2270; Wang J, 1998, MOL MICROBIOL, V30, P657, DOI 10.1046/j.1365-2958.1998.01102.x; Wang YH, 2009, J CLIN INVEST, V119, P1604, DOI 10.1172/JCI37905; WICKHAM TJ, 1993, CELL, V73, P309, DOI 10.1016/0092-8674(93)90231-E; Wildner O, 1999, CANCER RES, V59, P410; Wilson JM, 1996, NEW ENGL J MED, V334, P1185, DOI 10.1056/NEJM199605023341809; Zwacka RM, 1998, HEMATOL ONCOL CLIN N, V12, P595, DOI 10.1016/S0889-8588(05)70010-1	42	11	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2011	6	3							e17532	10.1371/journal.pone.0017532	http://dx.doi.org/10.1371/journal.pone.0017532			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740RG	21455297	Green Published, gold, Green Submitted			2022-12-25	WOS:000288811500005
J	Logue, JS; Whiting, JL; Tunquist, B; Langeberg, LK; Scott, JD				Logue, Jeremy S.; Whiting, Jennifer L.; Tunquist, Brian; Langeberg, Lorene K.; Scott, John D.			Anchored Protein Kinase A Recruitment of Active Rac GTPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IQGAP1 INTEGRATES CA2+/CALMODULIN; REGULATORY SUBUNIT RII; CELL-MIGRATION; AKAP-LBC; SIGNALING COMPLEX; CDC42; BINDING; SCAFFOLD; IDENTIFICATION; LOCALIZATION	Protein kinase A-anchoring proteins (AKAPs) influence fundamental cellular processes by directing the cAMP-dependent protein kinase (PKA) toward its intended substrates. In this report we describe the identification and characterization of a ternary complex of AKAP220, the PKA holoenzyme, and the IQ domain GTPase-activating protein 2 isoform (IQGAP2) that is enriched at cortical regions of the cell. Formation of an IQGAP2-AKAP220 core complex initiates a subsequent phase of protein recruitment that includes the small GTPase Rac. Biochemical and molecular biology approaches reveal that PKA phosphorylation of Thr-716 on IQGAP2 enhances association with the active form of the Rac GTPase. Cell-based experiments indicate that overexpression of an IQGAP2 phosphomimetic mutant (IQGAP2 T716D) enhances the formation of actin-rich membrane ruffles at the periphery of HEK 293 cells. In contrast, expression of a nonphosphorylatable IQGAP2 T716A mutant or gene silencing of AKAP220 suppresses formation of membrane ruffles. These findings imply that IQGAP2 and AKAP220 act synergistically to sustain PKA-mediated recruitment of effectors such as Rac GTPases that impact the actin cytoskeleton.	[Logue, Jeremy S.; Whiting, Jennifer L.; Tunquist, Brian; Langeberg, Lorene K.; Scott, John D.] Univ Washington, Sch Med, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Whiting, Jennifer L.; Langeberg, Lorene K.; Scott, John D.] Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA; [Logue, Jeremy S.] Univ Washington, Sch Med, Mol & Cellular Biol Program, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Scott, JD (corresponding author), Univ Washington, Sch Med, Howard Hughes Med Inst, 1959 Pacific Ave NE,Box 357750, Seattle, WA 98195 USA.	scottjdw@u.washington.edu			National Institutes of Health [DK54441]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK054441] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported, in whole or in part, by National Institutes of Health Grant DK54441.	Alto NM, 2003, P NATL ACAD SCI USA, V100, P4445, DOI 10.1073/pnas.0330734100; Appert-Collin A, 2007, P NATL ACAD SCI USA, V104, P10140, DOI 10.1073/pnas.0701099104; Bauman AL, 2002, NAT CELL BIOL, V4, pE203, DOI 10.1038/ncb0802-e203; Bauman AL, 2006, MOL CELL, V23, P925, DOI 10.1016/j.molcel.2006.07.025; Brandt DT, 2007, EMBO REP, V8, P1019, DOI 10.1038/sj.embor.7401089; Briggs MW, 2003, FEBS LETT, V542, P7, DOI 10.1016/S0014-5793(03)00333-8; Brown MD, 2006, TRENDS CELL BIOL, V16, P242, DOI 10.1016/j.tcb.2006.03.002; Carnegie GK, 2004, MOL CELL, V15, P889, DOI 10.1016/j.molcel.2004.09.015; CARR DW, 1992, TRENDS BIOCHEM SCI, V17, P246, DOI 10.1016/0968-0004(92)90402-U; CARR DW, 1992, J BIOL CHEM, V267, P13376; CARR DW, 1991, J BIOL CHEM, V266, P14188; Corbin J D, 1974, Methods Enzymol, V38, P287; Dessauer CW, 2009, MOL PHARMACOL, V76, P935, DOI 10.1124/mol.109.059345; Diviani D, 2001, J BIOL CHEM, V276, P44247, DOI 10.1074/jbc.M106629200; Diviani D, 2004, EMBO J, V23, P2811, DOI 10.1038/sj.emboj.7600287; Dodge KL, 2001, EMBO J, V20, P1921, DOI 10.1093/emboj/20.8.1921; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; FIRST EA, 1988, J BIOL CHEM, V263, P5176; FLOCKHART DA, 1980, J BIOL CHEM, V255, P4435; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; Grohmanova K, 2004, J BIOL CHEM, V279, P48495, DOI 10.1074/jbc.M408113200; Ho YD, 1999, J BIOL CHEM, V274, P464, DOI 10.1074/jbc.274.1.464; Howe AK, 2005, P NATL ACAD SCI USA, V102, P14320, DOI 10.1073/pnas.0507072102; Howe AK, 2000, NAT CELL BIOL, V2, P593, DOI 10.1038/35023536; Huang LJS, 1997, J BIOL CHEM, V272, P8057, DOI 10.1074/jbc.272.12.8057; Jin J, 2004, CURR BIOL, V14, P1436, DOI 10.1016/j.cub.2004.07.051; Johnson M, 2009, CELL SIGNAL, V21, P1471, DOI 10.1016/j.cellsig.2009.02.023; Kapiloff MS, 2009, J BIOL CHEM, V284, P23540, DOI 10.1074/jbc.M109.030072; Kuroda S, 1996, J BIOL CHEM, V271, P23363, DOI 10.1074/jbc.271.38.23363; Kuroda S, 1998, SCIENCE, V281, P832, DOI 10.1126/science.281.5378.832; Lester LB, 1996, J BIOL CHEM, V271, P9460, DOI 10.1074/jbc.271.16.9460; Li JY, 2007, NAT CELL BIOL, V9, P276, DOI 10.1038/ncb1541; Li ZG, 1999, J BIOL CHEM, V274, P37885, DOI 10.1074/jbc.274.53.37885; Logue JS, 2010, FEBS J, V277, P4370, DOI 10.1111/j.1742-4658.2010.07866.x; LOHMANN SM, 1984, P NATL ACAD SCI-BIOL, V81, P6723, DOI 10.1073/pnas.81.21.6723; Mataraza JM, 2007, CELL SIGNAL, V19, P1857, DOI 10.1016/j.cellsig.2007.04.011; Mataraza JM, 2003, J BIOL CHEM, V278, P41237, DOI 10.1074/jbc.M304838200; Meiri D, 2009, MOL CELL BIOL, V29, P5963, DOI 10.1128/MCB.01268-08; Noritake J, 2005, J CELL SCI, V118, P2085, DOI 10.1242/jcs.02379; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Paulucci-Holthauzen AA, 2009, J BIOL CHEM, V284, P5956, DOI 10.1074/jbc.M805606200; Pidoux G, 2010, J MOL ENDOCRINOL, V44, P271, DOI 10.1677/JME-10-0010; Reinton N, 2000, DEV BIOL, V223, P194, DOI 10.1006/dbio.2000.9725; Ren JG, 2008, J BIOL CHEM, V283, P22972, DOI 10.1074/jbc.M804626200; Schillace RV, 1999, CURR BIOL, V9, P321, DOI 10.1016/S0960-9822(99)80141-9; SCOTT JD, 1994, MOL ENDOCRINOL, V8, P5, DOI 10.1210/me.8.1.5; SCOTT JD, 1990, J BIOL CHEM, V265, P21561; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Soderling SH, 2007, J NEUROSCI, V27, P355, DOI 10.1523/JNEUROSCI.3209-06.2006; Soderling SH, 2003, P NATL ACAD SCI USA, V100, P1723, DOI 10.1073/pnas.0438033100; Soderling SH, 2002, NAT CELL BIOL, V4, P970, DOI 10.1038/ncb886; Tanji C, 2002, J BIOL CHEM, V277, P36955, DOI 10.1074/jbc.M206210200; Tao JC, 2003, EMBO J, V22, P6419, DOI 10.1093/emboj/cdg628; Tasken KA, 2001, J BIOL CHEM, V276, P21999, DOI 10.1074/jbc.C000911200; THEURKAUF WE, 1982, J BIOL CHEM, V257, P3284; Wang SJ, 2007, J CELL SCI, V120, P567, DOI 10.1242/jcs.03356; Watanabe T, 2009, J CELL SCI, V122, P2969, DOI 10.1242/jcs.046649; Westphal RS, 2000, EMBO J, V19, P4589, DOI 10.1093/emboj/19.17.4589; White CD, 2009, FEBS LETT, V583, P1817, DOI 10.1016/j.febslet.2009.05.007; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527	60	20	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22113	22121		10.1074/jbc.M111.232660	http://dx.doi.org/10.1074/jbc.M111.232660			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21460214	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000291719900017
J	Gonzalez-Cabo, P; Bolinches-Amoros, A; Cabello, J; Ros, S; Moreno, S; Baylis, HA; Palau, F; Vazquez-Manrique, RP				Gonzalez-Cabo, Pilar; Bolinches-Amoros, Arantxa; Cabello, Juan; Ros, Sheila; Moreno, Sergio; Baylis, Howard A.; Palau, Francesc; Vazquez-Manrique, Rafael P.			Disruption of the ATP-binding Cassette B7 (ABTM-1/ABCB7) Induces Oxidative Stress and Premature Cell Death in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED SIDEROBLASTIC ANEMIA; SULFUR CLUSTER BIOGENESIS; LIFE-SPAN; FRIEDREICHS-ATAXIA; SENSITIVE MUTANT; TRANSPORTER; NEMATODE; FRATAXIN; MUTATION; PROTEINS	X-linked sideroblastic anemia with ataxia (XLSA/A) is a rare inherited disorder characterized by mild anemia and ataxia. XLSA/A is caused by mutations in the ABCB7 gene, which encodes a member of the ATP-binding cassette transporter family. Studies in yeast, mammalian cells, and mice have shown that ABCB7 functions in the transport of iron-sulfur (Fe-S) clusters into the cytoplasm. To further investigate the mechanism of this disease, we have identified and characterized the Caenorhabditis elegans homologue of the ABCB7 gene, abtm-1. We have studied the function of abtm-1 using mutants and RNAi. abtm-1-depleted animals produce arrested embryos that have morphogenetic defects and unusual premature, putative apoptotic events. abtm-1(RNAi) animals also show accumulation of ferric iron and increased oxidative stress. Despite the increased level of oxidative stress in abtm-1(RNAi) animals, they have an increased life span. We observed accumulation of DAF-16/FOXO in the nuclei of affected animals and elevation of the expression of SOD-3, a well established target of DAF-16, which may explain the increased life span extension of these animals. abtm-1 is strongly expressed in tissues with a high energy demand, and abtm-1(RNAi) animals have phenotypes that reflect the need for abtm-1 in these tissues. Finally, we show that reducing the function of other genes involved in Fe-S cluster production produces similar phenotypic consequences to abtm-1 loss of function. Therefore, ablation of abtm-1 in C. elegans provides a model in which to investigate the mechanism underlying XLSA/A.	[Gonzalez-Cabo, Pilar; Bolinches-Amoros, Arantxa; Ros, Sheila; Palau, Francesc] CSIC, Inst Biomed Valencia, Lab Genet & Mol Med, Valencia 46010, Spain; [Gonzalez-Cabo, Pilar; Bolinches-Amoros, Arantxa; Palau, Francesc] CIBER Enfermedades Raras, Valencia 46010, Spain; [Cabello, Juan; Moreno, Sergio] Univ Salamanca, CSIC, Ctr Invest Canc, Inst Biol Mol & Celular Canc, Salamanca 37007, Spain; [Cabello, Juan] Ctr Biomed Res La Rioja, Oncol Area, Logrono 26006, Spain; [Baylis, Howard A.; Vazquez-Manrique, Rafael P.] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; University of Cambridge	Vazquez-Manrique, RP (corresponding author), INSERM, Lab Neuronal Cell Biol & Pathol, Psychiat & Neurosci Ctr U894, 2Ter Rue Alesia, F-75014 Paris, France.	rafael.vazquez@inserm.fr	Palau, Francesc/A-9391-2014; Cabello, Juan/AAM-1683-2020; González-Cabo, Pilar/ABG-5080-2020; Moreno, Sergio/K-3671-2014; Gonzalez-Cabo, Pilar/H-1862-2015; Vázquez-Manrique, Rafael/K-7882-2014	Palau, Francesc/0000-0002-8635-5421; Cabello, Juan/0000-0002-3835-0116; González-Cabo, Pilar/0000-0003-3131-6334; Moreno, Sergio/0000-0002-8039-1413; Gonzalez-Cabo, Pilar/0000-0003-3131-6334; Vázquez-Manrique, Rafael/0000-0002-1594-0033; Baylis, Howard/0000-0002-5959-3256	Spanish Ministry of Education and Science [SAF2006-01147, BFU2008-01808, BFU2010-21794]; Consolider [CSD2007-00015]; Generalitat Valenciana; Junta de Castilla y Leon [CSI03A08]; Grupo de Excelencia [GR 265]; Welcome Trust; Medical Research Council; Medical Research Council [G117/466] Funding Source: researchfish; MRC [G117/466] Funding Source: UKRI	Spanish Ministry of Education and Science(Spanish Government); Consolider(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Junta de Castilla y Leon(Junta de Castilla y Leon); Grupo de Excelencia; Welcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by The Spanish Ministry of Education and Science Grants SAF2006-01147, BFU2008-01808, BFU2010-21794, and Consolider CSD2007-00015, Generalitat Valenciana, Junta de Castilla y Leon Grants CSI03A08 and Grupo de Excelencia GR 265, The Welcome Trust, and Medical Research Council. The CIBERER is an initiative of the Instituto de Salud Carlos III.	Allikmets R, 1999, HUM MOL GENET, V8, P743, DOI 10.1093/hmg/8.5.743; Baumeister R, 2006, J ENDOCRINOL, V190, P191, DOI 10.1677/joe.1.06856; Baylis HA, 2005, CELL, V123, P5, DOI 10.1016/j.cell.2005.09.018; Bekri S, 2000, BLOOD, V96, P3256; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Cavadini P, 2007, BLOOD, V109, P3552, DOI 10.1182/blood-2006-08-041632; Chisholm A. D., 2005, WORMBOOK, P1, DOI DOI 10.1895/WORMBOOK.1.35.1; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Cypser JR, 2002, J GERONTOL A-BIOL, V57, pB109, DOI 10.1093/gerona/57.3.B109; ELLIS HM, 1986, CELL, V44, P817, DOI 10.1016/0092-8674(86)90004-8; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5; Gonzalez-Cabo P, 2009, ADV EXP MED BIOL, V652, P247, DOI 10.1007/978-90-481-2813-6_17; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; ISHII N, 1990, MUTAT RES, V237, P165, DOI 10.1016/0921-8734(90)90022-J; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Kharade SV, 2005, FEBS LETT, V579, P6809, DOI 10.1016/j.febslet.2005.11.017; Kinchen JM, 2005, NATURE, V434, P93, DOI 10.1038/nature03263; Kispal G, 1997, FEBS LETT, V418, P346, DOI 10.1016/S0014-5793(97)01414-2; Kispal G, 1999, EMBO J, V18, P3981, DOI 10.1093/emboj/18.14.3981; Koppen M, 2001, NAT CELL BIOL, V3, P983, DOI 10.1038/ncb1101-983; Lehner B, 2006, NAT GENET, V38, P896, DOI 10.1038/ng1844; Lesuisse E, 2003, HUM MOL GENET, V12, P879, DOI 10.1093/hmg/ddg096; Lewis JA, 1995, METHOD CELL BIOL, V48, P3; Lill R, 2006, ANNU REV CELL DEV BI, V22, P457, DOI 10.1146/annurev.cellbio.22.010305.104538; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Maguire A, 2001, BRIT J HAEMATOL, V115, P910, DOI 10.1046/j.1365-2141.2001.03015.x; Mandal S, 2005, DEV CELL, V9, P843, DOI 10.1016/j.devcel.2005.11.006; Mello C, 1995, METHOD CELL BIOL, V48, P451; Miao R, 2008, BIOCHEMISTRY-US, V47, P9888, DOI 10.1021/bi801047q; Miao R, 2009, BIOCHEMISTRY-US, V48, P9556, DOI 10.1021/bi901110n; Miguel-Aliaga I, 1999, HUM MOL GENET, V8, P2133, DOI 10.1093/hmg/8.12.2133; MURRAY AW, 1993, CELL CYCLE INTRO, P42; PAGON RA, 1985, J MED GENET, V22, P267, DOI 10.1136/jmg.22.4.267; Palau F, 2001, INT J MOL MED, V7, P581; Pondarre C, 2006, HUM MOL GENET, V15, P953, DOI 10.1093/hmg/ddl012; Pondarre C, 2007, BLOOD, V109, P3567, DOI 10.1182/blood-2006-04-015768; ROSE AM, 1984, MOL GEN GENET, V195, P52, DOI 10.1007/BF00332723; Rouault TA, 2005, NAT REV MOL CELL BIO, V6, P345, DOI 10.1038/nrm1620; Rouault TA, 2008, TRENDS GENET, V24, P398, DOI 10.1016/j.tig.2008.05.008; Savary S, 1997, GENOMICS, V41, P275, DOI 10.1006/geno.1997.4658; Schnabel R, 1997, DEV BIOL, V184, P234, DOI 10.1006/dbio.1997.8509; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Segalat L, 2006, ACS CHEM BIOL, V1, P277, DOI 10.1021/cb600221m; Stemmler TL, 2010, J BIOL CHEM, V285, P26737, DOI 10.1074/jbc.R110.118679; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Tsang WY, 2003, BBA-MOL BASIS DIS, V1638, P91, DOI 10.1016/S0925-4439(03)00079-6; Vazquez-Manrique RP, 2005, FASEB J, V19, P172, DOI 10.1096/fj.05-4212fje; Ventura N, 2005, AGING CELL, V4, P109, DOI 10.1111/j.1474-9726.2005.00149.x; Wilicox BJ, 2008, P NATL ACAD SCI USA, V105, P13987, DOI 10.1073/pnas.0801030105; Wilson Robert B, 2006, Semin Pediatr Neurol, V13, P166, DOI 10.1016/j.spen.2006.08.005; Wingert RA, 2005, NATURE, V436, P1035, DOI 10.1038/nature03887; Yamamoto K, 1996, MUTAT RES-FUND MOL M, V358, P1, DOI 10.1016/0027-5107(96)00070-X; Zeviani M, 2003, CURR OPIN NEUROL, V16, P585, DOI 10.1097/00019052-200310000-00004; Zeviani M, 2007, CURR OPIN NEUROL, V20, P564, DOI 10.1097/WCO.0b013e3282ef58cd; Zwaal RR, 1996, CELL, V86, P619, DOI 10.1016/S0092-8674(00)80135-X	57	22	24	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21304	21314		10.1074/jbc.M110.211201	http://dx.doi.org/10.1074/jbc.M110.211201			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21464130	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000291464700029
J	Bernier, M; Paul, RK; Martin-Montalvo, A; Scheibye-Knudsen, M; Song, SM; He, HJ; Armour, SM; Hubbard, BP; Bohr, VA; Wang, LL; Zong, YP; Sinclair, DA; de Cabo, R				Bernier, Michel; Paul, Rajib K.; Martin-Montalvo, Alejandro; Scheibye-Knudsen, Morten; Song, Shaoming; He, Hua-Jun; Armour, Sean M.; Hubbard, Basil P.; Bohr, Vilhelm A.; Wang, Lili; Zong, Yaping; Sinclair, David A.; de Cabo, Rafael			Negative Regulation of STAT3 Protein-mediated Cellular Respiration by SIRT1 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-KAPPA-B; SERINE PHOSPHORYLATION; SIGNAL TRANSDUCER; CALORIE RESTRICTION; MITOCHONDRIAL STAT3; DIRECT ACTIVATOR; RESVERATROL; INSULIN; TRANSCRIPTION; ACETYLATION	In mammals, the transcriptional activity of signal transducer and activator of transcription 3 (STAT3) is regulated by the deacetylase SIRT1. However, whether the newly described non-genomic actions of STAT3 toward mitochondrial oxidative phosphorylation are dependent on SIRT1 is unclear. In this study, Sirt1 gene knock-out murine embryonic fibroblast (MEF) cells were used to delineate the role of SIRT1 in the regulation of STAT3 mitochondrial function. Here, we show that STAT3 mRNA and protein levels and the accumulation of serine-phosphorylated STAT3 in mitochondria were increased significantly in Sirt1-KO cells as compared with wild-type MEFs. Various mitochondrial bioenergetic parameters, such as the oxygen consumption rate in cell cultures, enzyme activities of the electron transport chain complexes in isolated mitochondria, and production of ATP and lactate, indicated that Sirt1-KO cells exhibited higher mitochondrial respiration as compared with wildtype MEFs. Two independent approaches, including ectopic expression of SIRT1 and siRNA-mediated knockdown of STAT3, led to reduction in intracellular ATP levels and increased lactate production in Sirt1-KO cells that were approaching those of wild-type controls. Comparison of profiles of phospho-antibody array data indicated that the deletion of SirT1 was accompanied by constitutive activation of the proinflammatory NF-kappa B pathway, which is key for STAT3 induction and increased cellular respiration in Sirt1-KO cells. Thus, SIRT1 appears to be a functional regulator of NF-kappa B-dependent STAT3 expression that induces mitochondrial biogenesis. These results have implications for understanding the interplay between STAT3 and SIRT1 in pro-inflammatory conditions.	[Bernier, Michel] NIA, Clin Invest Lab, NIH, Biomed Res Ctr, Baltimore, MD 21224 USA; [He, Hua-Jun; Wang, Lili] Natl Inst Stand & Technol, Gaithersburg, MD 20899 USA; [Paul, Rajib K.; Martin-Montalvo, Alejandro; de Cabo, Rafael] NIA, Lab Expt Gerontol, NIH, Baltimore, MD 21224 USA; [Scheibye-Knudsen, Morten; Bohr, Vilhelm A.] NIA, Lab Mol Gerontol, NIH, Baltimore, MD 21224 USA; [Armour, Sean M.; Hubbard, Basil P.; Sinclair, David A.] Harvard Univ, Sch Med, Dept Pathol, Paul F Glenn Labs, Boston, MA 02115 USA; [Zong, Yaping] Full Moon Biosyst Inc, Sunnyvale, CA 94085 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institute of Standards & Technology (NIST) - USA; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Harvard University; Harvard Medical School	Bernier, M (corresponding author), NIA, Clin Invest Lab, NIH, Biomed Res Ctr, 251 Bayview Blvd,Ste 100, Baltimore, MD 21224 USA.	Bernierm@mail.nih.gov; deCaboRa@grc.nia.nih.gov	de Cabo, Rafael Carlos/J-5230-2016; wang, lili/HDL-7210-2022; de Cabo, Rafael/E-7996-2010; Martin-Montalvo, Alejandro/C-2031-2017; Bohr, Vilhelm/AAP-5931-2020; Bernier, Michel/Y-7139-2019; Bernier, Michel/AAO-3983-2021; de Cabo, Rafael/J-5230-2016	de Cabo, Rafael Carlos/0000-0003-2830-5693; de Cabo, Rafael/0000-0003-2830-5693; Martin-Montalvo, Alejandro/0000-0002-3886-5355; Bernier, Michel/0000-0002-5948-368X; de Cabo, Rafael/0000-0002-3354-2442; Sinclair, David/0000-0002-9936-436X; Scheibye-Knudsen, Morten/0000-0002-6637-1280; Hubbard, Basil/0000-0003-4353-9674	National Institutes of Health NIA; NATIONAL INSTITUTE ON AGING [ZIAAG000900, R37AG028730, ZIAAG000733, ZIAAG000361, R01AG019719, ZIAAG000362, ZIAAG000363, R01AG028730] Funding Source: NIH RePORTER	National Institutes of Health NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health NIA Intramural Research Program.	Affourtit C, 2009, METHOD ENZYMOL, V457, P405, DOI 10.1016/S0076-6879(09)05023-X; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Beher D, 2009, CHEM BIOL DRUG DES, V74, P619, DOI 10.1111/j.1747-0285.2009.00901.x; Bhardwaj A, 2007, BLOOD, V109, P2293, DOI 10.1182/blood-2006-02-003988; Boengler K, 2010, BASIC RES CARDIOL, V105, P771, DOI 10.1007/s00395-010-0124-1; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Ceresa BP, 1996, J BIOL CHEM, V271, P12121, DOI 10.1074/jbc.271.21.12121; Ceresa BP, 1997, ENDOCRINOLOGY, V138, P4131, DOI 10.1210/en.138.10.4131; Cheadle C, 2003, J MOL DIAGN, V5, P73, DOI 10.1016/S1525-1578(10)60455-2; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Csiszar A, 2009, MECH AGEING DEV, V130, P518, DOI 10.1016/j.mad.2009.06.004; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; Fern R, 2003, J NEUROSCI RES, V71, P759, DOI 10.1002/jnr.10553; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Ghosh HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009199; Gnaiger E, 2003, ADV EXP MED BIOL, V543, P39; Gorospe M, 2008, TRENDS CELL BIOL, V18, P77, DOI 10.1016/j.tcb.2007.11.007; Gough DJ, 2009, SCIENCE, V324, P1713, DOI 10.1126/science.1171721; Grivennikov SI, 2010, CURR OPIN GENET DEV, V20, P65, DOI 10.1016/j.gde.2009.11.004; Guarente L, 2007, COLD SPRING HARB SYM, V72, P483, DOI 10.1101/sqb.2007.72.024; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; He HJ, 2009, PROTEOM CLIN APPL, V3, P1440, DOI 10.1002/prca.200900020; Holness MJ, 2003, BIOCHEM SOC T, V31, P1143; Huang JY, 2010, BBA-PROTEINS PROTEOM, V1804, P1645, DOI 10.1016/j.bbapap.2009.12.021; Jeong K, 2009, EXP MOL MED, V41, P226, DOI 10.3858/emm.2009.41.4.025; Kang SM, 2010, J CLIN INVEST, V120, P1165, DOI 10.1172/JCI40582; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kojima H, 2005, P NATL ACAD SCI USA, V102, P4524, DOI 10.1073/pnas.0500679102; Lee JL, 2009, J CELL BIOL, V185, P949, DOI 10.1083/jcb.200812060; Leslie K, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2725; Liu HT, 2003, BLOOD, V102, P344, DOI 10.1182/blood-2002-11-3396; Lopez-Lluch G, 2006, P NATL ACAD SCI USA, V103, P1768, DOI 10.1073/pnas.0510452103; Lufei CC, 2003, EMBO J, V22, P1325, DOI 10.1093/emboj/cdg135; Meyer T, 2002, EXP CELL RES, V272, P45, DOI 10.1006/excr.2001.5405; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Myers MG, 2009, SCIENCE, V323, P723, DOI 10.1126/science.1169660; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; Nie YZ, 2009, NAT CELL BIOL, V11, P492, DOI 10.1038/ncb1857; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Pauli JR, 2010, MECH AGEING DEV, V131, P323, DOI 10.1016/j.mad.2010.03.004; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105; Phillips D, 2010, J BIOL CHEM, V285, P23532, DOI 10.1074/jbc.C110.152652; Potla R, 2006, MOL CELL BIOL, V26, P8562, DOI 10.1128/MCB.00497-06; Quinzii C, 2006, AM J HUM GENET, V78, P345, DOI 10.1086/500092; Ray S, 2005, GASTROENTEROLOGY, V129, P1616, DOI 10.1053/j.gastro.2005.07.055; Ray S, 2008, NUCLEIC ACIDS RES, V36, P4510, DOI 10.1093/nar/gkn419; Reich NC, 2006, NAT REV IMMUNOL, V6, P602, DOI 10.1038/nri1885; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; Salminen A, 2008, BIOESSAYS, V30, P939, DOI 10.1002/bies.20799; Sato N, 2005, INT IMMUNOL, V17, P1543, DOI 10.1093/intimm/dxh331; Schug TT, 2010, MOL CELL BIOL, V30, P4712, DOI 10.1128/MCB.00657-10; Schuringa JJ, 2001, J BIOL CHEM, V276, P27709, DOI 10.1074/jbc.M009821200; Shulga N, 2010, J CELL SCI, V123, P894, DOI 10.1242/jcs.061846; Tang BL, 2010, BRAIN RES BULL, V81, P359, DOI 10.1016/j.brainresbull.2009.12.007; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Togi S, 2009, BIOCHEM BIOPH RES CO, V379, P616, DOI 10.1016/j.bbrc.2008.12.132; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Valenza F, 2005, CRIT CARE, V9, P588, DOI 10.1186/cc3818; Vaquero A, 2009, GENE DEV, V23, P1849, DOI 10.1101/gad.1807009; Wang R, 2005, J BIOL CHEM, V280, P11528, DOI 10.1074/jbc.M413930200; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Wierenga ATJ, 2003, EXP HEMATOL, V31, P398, DOI 10.1016/S0301-472X(03)00045-6; Xie Y, 2009, ENDOCRINOLOGY, V150, P1122, DOI 10.1210/en.2008-1241; Yeh YT, 2006, INT J CANCER, V118, P2943, DOI 10.1002/ijc.21771; Yokogami K, 2000, CURR BIOL, V10, P47, DOI 10.1016/S0960-9822(99)00268-7; Yu LJ, 2008, NEOPLASIA, V10, P736, DOI 10.1593/neo.08304; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166; Zhang J, 2003, P NATL ACAD SCI USA, V100, P9342, DOI 10.1073/pnas.1633516100; Zhang YG, 2003, J BIOL CHEM, V278, P12650, DOI 10.1074/jbc.M210368200; Zhang YG, 2001, J BIOL CHEM, V276, P42534, DOI 10.1074/jbc.M106044200; Zhou JB, 2007, P NATL ACAD SCI USA, V104, P16158, DOI 10.1073/pnas.0702596104	72	95	101	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19270	19279		10.1074/jbc.M110.200311	http://dx.doi.org/10.1074/jbc.M110.200311			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21467030	Green Published, hybrid			2022-12-25	WOS:000291027700009
J	Gaidukov, L; Nager, AR; Xu, SZ; Penman, M; Krieger, M				Gaidukov, Leonid; Nager, Andrew R.; Xu, Shangzhe; Penman, Marsha; Krieger, Monty			Glycine Dimerization Motif in the N-terminal Transmembrane Domain of the High Density Lipoprotein Receptor SR-BI Required for Normal Receptor Oligomerization and Lipid Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LARGE-LIGAND ADSORPTION; CORONARY-HEART-DISEASE; NITRIC-OXIDE SYNTHASE; SCAVENGER RECEPTOR; NEGATIVE COOPERATIVITY; STRUCTURAL BASIS; LDL RECEPTOR; CHOLESTERYL ESTER; DEFICIENT MICE; ERYTHROPOIETIN RECEPTOR	Scavenger receptor class B, type I (SR-BI), a CD36 superfamily member, is an oligomeric high density lipoprotein (HDL) receptor that mediates negatively cooperative HDL binding and selective lipid uptake. We identified in the N-terminal transmembrane (N-TM) domain of SR-BI a conserved glycine dimerization motif, G(15)X(2)G(18)X(3)AX(2)G(25), of which the submotif G(18)X(3)AX(2)G(25) significantly contributes to homodimerization and lipid uptake activity. SR-BI variants were generated by mutations (single or multiple Gly -> Leu substitutions) or by replacing the N-TM domain with those from other CD36 super-family members containing (croquemort) or lacking (lysosomal integral membrane protein (LIMP) II) this glycine motif (chimeras). None of the SR-BI variants exhibited altered surface expression (based on antibody binding) or HDL binding. However, the G15L/G18L/G25L triple mutant exhibited reductions in cell surface homo-oligomerization (> 10-fold) and the rate of selective lipid uptake (similar to 2-fold). Gly(18) and Gly(25) were necessary for normal lipid uptake activity of SR-BI and the SR-BI/croquemort chimera. The lipid uptake activity of the glycine motif-deficient SR-BI/LIMP II chimera was low but could be increased by introducing glycines at positions 18 and 25. The rate of lipid uptake mediated by SR-BI/LIMP II chimeras was proportional to the extent of receptor oligomerization. Thus, the glycine dimerization motif G(18)X(3)AX(2)G(25) in the N-TM domain of SR-BI contributes substantially to the homo-oligomerization and lipid transport activity of SR-BI but does not influence the negative cooperativity of HDL binding. Oligomerization-independent binding cooperativity suggests that classic allostery is not involved and that the negative cooperativity is probably the consequence of a "lattice effect" (interligand steric interference accompanying binding to adjacent receptors).	[Gaidukov, Leonid; Nager, Andrew R.; Xu, Shangzhe; Penman, Marsha; Krieger, Monty] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Krieger, M (corresponding author), MIT, Dept Biol, Rm 68-483,77 Massachusetts Ave, Cambridge, MA 02139 USA.	krieger@mit.edu			National Institutes of Health [HL52212, HL066105]; Merck/Massachusetts Institute of Technology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052212, P01HL066105] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck/Massachusetts Institute of Technology(Merck & Company); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL52212 and HL066105 (to M. K.). This work was also supported by a Merck/Massachusetts Institute of Technology fellowship (to L. G.).	Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; Alvarado D, 2010, CELL, V142, P568, DOI 10.1016/j.cell.2010.07.015; Arai T, 1999, J BIOL CHEM, V274, P2366, DOI 10.1074/jbc.274.4.2366; Archibald K, 1998, NEUROPHARMACOLOGY, V37, P1345, DOI 10.1016/S0028-3908(98)00135-X; ASHKENAS J, 1993, J LIPID RES, V34, P983; Azhar S, 2002, J LIPID RES, V43, P861; Babitt J, 1997, J BIOL CHEM, V272, P13242, DOI 10.1074/jbc.272.20.13242; Braun A, 2003, P NATL ACAD SCI USA, V100, P7283, DOI 10.1073/pnas.1237725100; Braun A, 2002, CIRC RES, V90, P270, DOI 10.1161/hh0302.104462; CHAPPELL DA, 1991, J BIOL CHEM, V266, P19296; CHUNG BH, 1980, J LIPID RES, V21, P284; Connelly MA, 1999, J BIOL CHEM, V274, P41, DOI 10.1074/jbc.274.1.41; Constantinescu SN, 2001, P NATL ACAD SCI USA, V98, P4379, DOI 10.1073/pnas.081069198; De Meyts P, 2008, TRENDS BIOCHEM SCI, V33, P376, DOI 10.1016/j.tibs.2008.06.003; De Meyts P, 2009, ANN NY ACAD SCI, V1160, P45, DOI 10.1111/j.1749-6632.2009.03837.x; DEMEYTS P, 1976, J BIOL CHEM, V251, P1877; DEMEYTS P, 1973, BIOCHEM BIOPH RES CO, V55, P154, DOI 10.1016/S0006-291X(73)80072-5; Ebie AZ, 2007, J MOL BIOL, V366, P517, DOI 10.1016/j.jmb.2006.11.035; Franc NC, 1996, IMMUNITY, V4, P431, DOI 10.1016/S1074-7613(00)80410-0; GLASS C, 1983, P NATL ACAD SCI-BIOL, V80, P5435, DOI 10.1073/pnas.80.17.5435; GLOMSET JA, 1968, J LIPID RES, V9, P155; Goetz H, 2004, J BIOCHEM BIOPH METH, V60, P281, DOI 10.1016/j.jbbm.2004.01.007; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; GREENWALT DE, 1992, BLOOD, V80, P1105; Gu XJ, 2000, J BIOL CHEM, V275, P9120, DOI 10.1074/jbc.275.13.9120; Gu XJ, 1998, J BIOL CHEM, V273, P35388, DOI 10.1074/jbc.273.41.26338; Gu XJ, 2000, J BIOL CHEM, V275, P29993, DOI 10.1074/jbc.275.39.29993; Guo Q, 1996, J BIOL CHEM, V271, P11191, DOI 10.1074/jbc.271.19.11191; GWYNNE JT, 1989, J BIOL CHEM, V264, P8141; HARDY MR, 1985, BIOCHEMISTRY-US, V24, P22, DOI 10.1021/bi00322a004; Hatzopoulos AK, 1998, J LIPID RES, V39, P495; Huszar D, 2000, ARTERIOSCL THROM VAS, V20, P1068, DOI 10.1161/01.ATV.20.4.1068; Ji Y, 1997, J BIOL CHEM, V272, P20982, DOI 10.1074/jbc.272.34.20982; KINGSLEY DM, 1984, P NATL ACAD SCI-BIOL, V81, P5454, DOI 10.1073/pnas.81.17.5454; Koshland DE, 1996, CURR OPIN STRUC BIOL, V6, P757, DOI 10.1016/S0959-440X(96)80004-2; Kozarsky KF, 2000, ARTERIOSCL THROM VAS, V20, P721, DOI 10.1161/01.ATV.20.3.721; Krieger M, 1999, ANNU REV BIOCHEM, V68, P523, DOI 10.1146/annurev.biochem.68.1.523; Landschulz KT, 1996, J CLIN INVEST, V98, P984, DOI 10.1172/JCI118883; Lau TL, 2009, EMBO J, V28, P1351, DOI 10.1038/emboj.2009.63; Lear JD, 2004, BIOPHYS J, V87, P3421, DOI 10.1529/biophysj.103.032839; LEMMON MA, 1992, J BIOL CHEM, V267, P7683; LEVITZKI A, 1969, P NATL ACAD SCI USA, V62, P1121, DOI 10.1073/pnas.62.4.1121; Li E, 2006, BIOCHEMISTRY-US, V45, P6241, DOI 10.1021/bi060609y; Li W, 2005, P NATL ACAD SCI USA, V102, P1424, DOI 10.1073/pnas.0409334102; LIMBIRD LE, 2005, CELL SURFACE RECEPTO, P113; Liu T, 2002, J BIOL CHEM, V277, P21576, DOI 10.1074/jbc.M112103200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luo BH, 2005, P NATL ACAD SCI USA, V102, P3679, DOI 10.1073/pnas.0409440102; Macdonald JL, 2008, P NATL ACAD SCI USA, V105, P112, DOI 10.1073/pnas.0707080105; MacKenzie KR, 2006, CHEM REV, V106, P1931, DOI 10.1021/cr0404388; MCGHEE JD, 1974, J MOL BIOL, V86, P469, DOI 10.1016/0022-2836(74)90031-X; Mendrola JM, 2002, J BIOL CHEM, V277, P4704, DOI 10.1074/jbc.M108681200; MILLER GJ, 1975, LANCET, V1, P16; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Moore DT, 2008, STRUCTURE, V16, P991, DOI 10.1016/j.str.2008.05.007; Nieland TJF, 2011, BIOCHEMISTRY-US, V50, P1818, DOI 10.1021/bi101657j; Patsch J R, 1986, Methods Enzymol, V129, P3; Peng Y, 2004, MOL BIOL CELL, V15, P384, DOI 10.1091/mbc.e03-06-0445; PITTMAN RC, 1987, J BIOL CHEM, V262, P2443; Reaven E, 2004, J LIPID RES, V45, P513, DOI 10.1194/jlr.M300370-JLR200; Riek RP, 2008, MOL PHARMACOL, V73, P1092, DOI 10.1124/mol.107.043042; Rigotti A, 2003, ENDOCR REV, V24, P357, DOI 10.1210/er.2001-0037; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; Rothblat GH, 2010, CURR OPIN LIPIDOL, V21, P229, DOI 10.1097/MOL.0b013e328338472d; Sackett DL, 1996, FEBS LETT, V397, P1, DOI 10.1016/S0014-5793(96)01020-4; Sahoo D, 2007, BBA-MOL CELL BIOL L, V1771, P818, DOI 10.1016/j.bbalip.2007.04.019; Sahoo D, 2007, BBA-MOL CELL BIOL L, V1771, P807, DOI 10.1016/j.bbalip.2006.03.003; SALHANY JM, 1989, BIOCHEM BIOPH RES CO, V159, P1337, DOI 10.1016/0006-291X(89)92257-2; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; SCHOUTEN D, 1990, ARTERIOSCLEROSIS, V10, P1127, DOI 10.1161/01.ATV.10.6.1127; Senes A, 2000, J MOL BIOL, V296, P921, DOI 10.1006/jmbi.1999.3488; Senes A, 2004, CURR OPIN STRUC BIOL, V14, P465, DOI 10.1016/j.sbi.2004.07.007; STANKOWSKI S, 1983, BIOCHIM BIOPHYS ACTA, V735, P352, DOI 10.1016/0005-2736(83)90149-9; STANKOWSKI S, 1983, BIOCHIM BIOPHYS ACTA, V735, P341, DOI 10.1016/0005-2736(83)90148-7; STEIN Y, 1983, BIOCHIM BIOPHYS ACTA, V752, P98, DOI 10.1016/0005-2760(83)90237-0; Stouffer AL, 2008, NATURE, V451, P596, DOI 10.1038/nature06528; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Trigatti B, 1999, P NATL ACAD SCI USA, V96, P9322, DOI 10.1073/pnas.96.16.9322; Ueda Y, 2000, J BIOL CHEM, V275, P20368, DOI 10.1074/jbc.M000730200; Uittenbogaard A, 2000, J BIOL CHEM, V275, P11278, DOI 10.1074/jbc.275.15.11278; VEGA MA, 1991, J BIOL CHEM, V266, P16818; Vergeer M, 2011, NEW ENGL J MED, V364, P136, DOI 10.1056/NEJMoa0907687; Vinals M, 2003, J BIOL CHEM, V278, P5325, DOI 10.1074/jbc.M211073200; Williams DL, 2000, J BIOL CHEM, V275, P18897, DOI 10.1074/jbc.M002411200; Yuhanna IS, 2001, NAT MED, V7, P853, DOI 10.1038/89986	88	44	44	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18452	18464		10.1074/jbc.M111.229872	http://dx.doi.org/10.1074/jbc.M111.229872			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21454587	hybrid, Green Published			2022-12-25	WOS:000290785700018
J	Liu, W; Iiizumi-Gairani, M; Okuda, H; Kobayashi, A; Watabe, M; Pai, SK; Pandey, PR; Xing, F; Fukuda, K; Modur, V; Hirota, S; Suzuki, K; Chiba, T; Endo, M; Sugai, T; Watabe, K				Liu, Wen; Iiizumi-Gairani, Megumi; Okuda, Hiroshi; Kobayashi, Aya; Watabe, Misako; Pai, Sudha K.; Pandey, Puspa R.; Xing, Fei; Fukuda, Koji; Modur, Vishnu; Hirota, Shigeru; Suzuki, Kazuyuki; Chiba, Toshimi; Endo, Masaki; Sugai, Tamotsu; Watabe, Kounosuke			KAI1 Gene Is Engaged in NDRG1 Gene-mediated Metastasis Suppression through the ATF3-NF kappa B Complex in Human Prostate Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN COLON-CANCER; FACTOR-KAPPA-B; TUMOR-METASTASIS; DOWN-REGULATION; MECHANISTIC INSIGHTS; PANCREATIC-CANCER; ALLELIC LOSS; CELL-LINES; SHORT ARM; EXPRESSION	NDRG1 and KAI1 belong to metastasis suppressor genes, which impede the dissemination of tumor cells from primary tumors to distant organs. Previously, we identified the metastasis promoting transcription factor, ATF3, as a downstream target of NDRG1. Further analysis revealed that the KAI1 promoter contained a consensus binding motif of ATF3, suggesting a possibility that NDRG1 suppresses metastasis through inhibition of ATF3 expression followed by activation of the KAI1 gene. In this report, we found that ectopic expression of NDRG1 was able to augment endogenous KAI1 gene expression in prostate cancer cell lines, whereas silencing NDRG1 was accompanied with significant decrease in KAI1 expression in vitro and in vivo. In addition, our results of ChIP analysis indicate that ATF3 indeed bound to the promoter of the KAI1 gene. Importantly, our promoter-based analysis revealed that ATF3 modulated KAI1 transcription through cooperation with other endogenous transcription factor as co-activator (ATF3-JunB) or co-repressor (ATF3-NF kappa B). Moreover, loss of KAI1 expression significantly abrogated NDRG1-mediated metastatic suppression in vitro as well as in a spontaneous metastasis animal model, indicating that KAI1 is a functional downstream target of the NDRG1 pathway. Our result of immunohistochemical analysis showed that loss of NDRG1 and KAI1 occurs in parallel as prostate cancer progresses. We also found that a combined expression status of these two genes serves as a strong independent prognostic marker to predict metastasis-free survival of prostate cancer patients. Taken together, our result revealed a novel regulatory network of two metastasis suppressor genes, NDRG1 and KAI1, which together concerted metastasis-suppressive activities through an intrinsic transcriptional cascade.	[Liu, Wen; Iiizumi-Gairani, Megumi; Okuda, Hiroshi; Kobayashi, Aya; Watabe, Misako; Pai, Sudha K.; Pandey, Puspa R.; Xing, Fei; Fukuda, Koji; Modur, Vishnu; Watabe, Kounosuke] So Illinois Univ, Sch Med, Dept Med Microbiol Immunol & Cell Biol, Springfield, IL 62794 USA; [Hirota, Shigeru] Iwate Med Sch, Dept Internal Med, Morioka, Iwate 0208505, Japan; [Suzuki, Kazuyuki; Chiba, Toshimi; Endo, Masaki] Iwate Med Sch, Dept Gastroenterol & Hepatol, Morioka, Iwate 0208505, Japan; [Sugai, Tamotsu] Iwate Med Sch, Dept Diagnost Pathol, Morioka, Iwate 0208505, Japan	Southern Illinois University System; Southern Illinois University; Iwate Medical University; Iwate Medical University; Iwate Medical University	Watabe, K (corresponding author), So Illinois Univ, Sch Med, Dept Med Microbiol Immunol & Cell Biol, Springfield, IL 62794 USA.	kwatabe@siumed.edu	Kobayashi, Aya/AAA-2530-2020	Okuda, Hiroshi/0000-0002-5747-8086; Chiba, Toshimi/0000-0001-7072-3157	National Institutes of Health [R01CA124650, R01CA129000]; U. S. Department of Defense [BC044370, PC061256]; NATIONAL CANCER INSTITUTE [R01CA129000, R01CA124650] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U. S. Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA124650 and R01CA129000 (to K. W.). This work was also supported by U. S. Department of Defense Grants BC044370 and PC061256 (to K. W.).	Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; Bandyopadhyay S, 2003, CANCER RES, V63, P1731; Bandyopadhyay S, 2006, CANCER RES, V66, P11983, DOI 10.1158/0008-5472.CAN-06-0943; Berger JC, 2005, CANCER BIOL THER, V4, P805, DOI 10.4161/cbt.4.8.1865; DONG JT, 1995, SCIENCE, V268, P884, DOI 10.1126/science.7754374; Dong JT, 1997, GENOMICS, V41, P25, DOI 10.1006/geno.1997.4618; Dong JT, 1996, CANCER RES, V56, P4387; Eccles SA, 2007, LANCET, V369, P1742, DOI 10.1016/S0140-6736(07)60781-8; El Touny LH, 2007, BIOCHEM BIOPH RES CO, V361, P169, DOI 10.1016/j.bbrc.2007.07.010; Ellen TP, 2008, CARCINOGENESIS, V29, P2, DOI 10.1093/carcin/bgm200; GAUGITSCH HW, 1991, EUR J IMMUNOL, V21, P377, DOI 10.1002/eji.1830210219; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Guang RJ, 2000, CANCER RES, V60, P749; Hai T, 1999, GENE EXPRESSION, V7, P321; Hosoi F, 2009, CANCER RES, V69, P4983, DOI 10.1158/0008-5472.CAN-08-4882; ICHIKAWA T, 1991, CANCER RES, V51, P3788; ICHIKAWA T, 1992, CANCER RES, V52, P3486; Iiizumi M, 2008, BBA-REV CANCER, V1786, P87, DOI 10.1016/j.bbcan.2008.07.002; Ishiguro T, 1996, CANCER RES, V56, P875; Ishiguro T, 2000, JPN J CANCER RES, V91, P833, DOI 10.1111/j.1349-7006.2000.tb01021.x; Jackson P, 2000, CANCER LETT, V157, P169, DOI 10.1016/S0304-3835(00)00483-3; Jin RJ, 2008, CANCER RES, V68, P6762, DOI 10.1158/0008-5472.CAN-08-0107; Kawana Y, 1997, PROSTATE, V32, P205; Kim JH, 2005, NATURE, V434, P921, DOI 10.1038/nature03452; Konishi N, 2008, CLIN CANCER RES, V14, P4408, DOI 10.1158/1078-0432.CCR-07-4120; Kovacevic Z, 2006, CARCINOGENESIS, V27, P2355, DOI 10.1093/carcin/bgl146; Kurdistani SK, 1998, CANCER RES, V58, P4439; Lakshman M, 2011, CLIN EXP METASTAS, V28, P39, DOI 10.1007/s10585-010-9356-6; Lee JH, 2003, CANCER RES, V63, P7247; Liu WM, 2006, CANCER LETT, V240, P183, DOI 10.1016/j.canlet.2005.08.018; Luo JL, 2007, NATURE, V446, P690, DOI 10.1038/nature05656; Marreiros A, 2005, ONCOGENE, V24, P637, DOI 10.1038/sj.onc.1208216; Marreiros A, 2003, GENE, V302, P155, DOI 10.1016/S0378-1119(02)01101-0; Maruyama Y, 2006, CANCER RES, V66, P6233, DOI 10.1158/0008-5472.CAN-06-0183; Mashimo T, 1998, P NATL ACAD SCI USA, V95, P11307, DOI 10.1073/pnas.95.19.11307; Mashimo T, 2000, BIOCHEM BIOPH RES CO, V274, P370, DOI 10.1006/bbrc.2000.3139; Miyazaki K, 2009, NUCLEIC ACIDS RES, V37, P1438, DOI 10.1093/nar/gkn1082; Miyazaki T, 2000, CANCER-AM CANCER SOC, V89, P955, DOI 10.1002/1097-0142(20000901)89:5<955::AID-CNCR3>3.0.CO;2-Z; Nash KT, 2006, FRONT BIOSCI-LANDMRK, V11, P647, DOI 10.2741/1824; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nishio S, 2008, CANCER LETT, V264, P36, DOI 10.1016/j.canlet.2008.01.020; Ono M, 1999, CANCER RES, V59, P2335; Ross JS, 2004, CLIN CANCER RES, V10, P2466, DOI 10.1158/1078-0432.CCR-0543-3; Schoenfeld N, 2004, FASEB J, V18, P158, DOI 10.1096/fj.03-0420fje; Shevde LA, 2003, CANCER LETT, V198, P1, DOI 10.1016/S0304-3835(03)00304-5; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Steeg Patricia S, 2003, Clin Breast Cancer, V4, P51, DOI 10.3816/CBC.2003.n.012; Steeg PS, 2003, NAT REV CANCER, V3, P55, DOI 10.1038/nrc967; Suh J, 2004, J CELL BIOCHEM, V91, P100, DOI 10.1002/jcb.10729; Tagawa K, 1999, JPN J CANCER RES, V90, P970, DOI 10.1111/j.1349-7006.1999.tb00843.x; Telese F, 2005, EMBO REP, V6, P77, DOI 10.1038/sj.embor.7400309; vanBelzen N, 1997, LAB INVEST, V77, P85; Xu X, 2008, MOL PHARMACOL, V73, P833, DOI 10.1124/mol.107.041335; Zhang Q, 2009, CLIN CANCER RES, V15, P3557, DOI 10.1158/1078-0432.CCR-08-1656	54	77	78	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18949	18959		10.1074/jbc.M111.232637	http://dx.doi.org/10.1074/jbc.M111.232637			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21454613	Green Published, hybrid			2022-12-25	WOS:000290785700066
J	Sotomayor-Perez, AC; Ladant, D; Chenal, A				Sotomayor-Perez, Ana Cristina; Ladant, Daniel; Chenal, Alexandre			Calcium-induced Folding of Intrinsically Disordered Repeat-in-Toxin (RTX) Motifs via Changes of Protein Charges and Oligomerization States	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENYLATE-CYCLASE TOXIN; NATIVELY UNFOLDED PROTEINS; CRYSTAL-STRUCTURE; 3-DIMENSIONAL STRUCTURE; BETA-HELIX; SECRETION; DOMAIN; BACTERIA	Ligand-induced disorder-to-order transition plays a key role in the biological functions of many proteins that contain intrinsically disordered regions. This trait is exhibited by so-called RTX (repeat-in-toxin) motifs found in many virulence factors secreted by numerous Gram-negative pathogenic bacteria: RTX proteins are natively disordered in the absence of calcium but fold upon calcium binding. The adenylate cyclase toxin (CyaA) produced by Bordetella pertussis, the causative agent of whooping cough, contains similar to 40 RTX motifs organized in five successive blocks separated by non-RTX flanking regions. This RTX domain mediates toxin binding to its eukaryotic cell receptor. We previously showed that the last block of the RTX domain, block V, which is critical for CyaA toxicity, exhibits the hall-marks of intrinsically disordered proteins in the absence of calcium. Moreover, the C-terminal flanking region of CyaA block V is required for its calcium-induced folding. Here, we describe a comprehensive analysis of the hydrodynamic and electrophoretic properties of several block V RTX polypeptides that differ in the presence and/or length of the flanking regions. Our results indicate that the length of the C-terminal flanking region not only controls the calcium-induced folding but also the calcium-induced multimerization of the RTX polypeptides. Moreover, we showed that calcium binding is accompanied by a strong reduction of the net charge of the RTX polypeptides. These data indicate that the disorder-to-order transition in RTX proteins is controlled by a calcium-induced change of the polypeptide charges and stabilized by multimerization.	[Sotomayor-Perez, Ana Cristina; Ladant, Daniel; Chenal, Alexandre] Inst Pasteur, CNRS, URA 2185, Unite Biochim Interact Macromol,Dept Biol Struct, F-75724 Paris 15, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Ladant, D (corresponding author), Inst Pasteur, CNRS, URA 2185, Unite Biochim Interact Macromol,Dept Biol Struct, 28 Rue Dr Roux, F-75724 Paris 15, France.	daniel.ladant@pasteur.fr; alexandre.chenal@pasteur.fr	Chenal, Alexandre/C-2240-2009	Chenal, Alexandre/0000-0002-4959-1003; LADANT, Daniel/0000-0003-1955-548X	CNRS Institut Pasteur Projet Transversal de Recherche [374]; Agence Nationale de la Recherche Programme Jeunes Chercheurs [ANR-09-JCJC-0012]; Allocation de These de la Region Ile-de-France	CNRS Institut Pasteur Projet Transversal de Recherche; Agence Nationale de la Recherche Programme Jeunes Chercheurs(French National Research Agency (ANR)); Allocation de These de la Region Ile-de-France(Region Ile-de-France)	This work was supported by CNRS Institut Pasteur Projet Transversal de Recherche Grant PTR#374 and the Agence Nationale de la Recherche Programme Jeunes Chercheurs Grant ANR-09-JCJC-0012.; Supported by the Allocation de These de la Region Ile-de-France Ph.D. program.	BASAK SK, 1995, ANAL BIOCHEM, V226, P51, DOI 10.1006/abio.1995.1190; Bauche C, 2006, J BIOL CHEM, V281, P16914, DOI 10.1074/jbc.M601594200; BAUMANN U, 1993, EMBO J, V12, P3357, DOI 10.1002/j.1460-2075.1993.tb06009.x; Beaman TW, 1997, BIOCHEMISTRY-US, V36, P489, DOI 10.1021/bi962522q; Bejerano M, 1999, MOL MICROBIOL, V31, P381, DOI 10.1046/j.1365-2958.1999.01183.x; Blenner MA, 2010, J MOL BIOL, V400, P244, DOI 10.1016/j.jmb.2010.04.056; Bourdeau RW, 2009, J BIOL CHEM, V284, P14645, DOI 10.1074/jbc.M807631200; Chenal A, 2010, BIOPHYS J, V99, P3744, DOI 10.1016/j.bpj.2010.10.016; Chenal A, 2009, J BIOL CHEM, V284, P1781, DOI 10.1074/jbc.M807312200; COOTE JG, 1992, FEMS MICROBIOL LETT, V88, P137, DOI 10.1016/0378-1097(92)90688-K; Delepelaire P, 2004, BBA-MOL CELL RES, V1694, P149, DOI 10.1016/j.bbamcr.2004.05.001; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Eliezer D, 2009, CURR OPIN STRUC BIOL, V19, P23, DOI 10.1016/j.sbi.2008.12.004; Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; HARDING SE, 1995, ANAL BIOCHEM, V228, P131, DOI 10.1006/abio.1995.1324; Holland IB, 2005, MOL MEMBR BIOL, V22, P29, DOI 10.1080/09687860500042013; IWAKI M, 1995, MOL MICROBIOL, V17, P1015, DOI 10.1111/j.1365-2958.1995.mmi_17061015.x; Karst JC, 2010, BIOCHEMISTRY-US, V49, P318, DOI 10.1021/bi9016389; Kisker C, 1996, EMBO J, V15, P2323, DOI 10.1002/j.1460-2075.1996.tb00588.x; Ladant D, 1999, TRENDS MICROBIOL, V7, P172, DOI 10.1016/S0966-842X(99)01468-7; Lilie H, 2000, FEBS LETT, V470, P173, DOI 10.1016/S0014-5793(00)01308-9; Linhartova I, 2010, FEMS MICROBIOL REV, V34, P1076, DOI 10.1111/j.1574-6976.2010.00231.x; Meier R, 2007, J BIOL CHEM, V282, P31477, DOI 10.1074/jbc.M704942200; Midic U, 2009, PROTEIN PEPTIDE LETT, V16, P1533, DOI 10.2174/092986609789839377; Pimenta AL, 2005, J BACTERIOL, V187, P7471, DOI 10.1128/JB.187.21.7471-7480.2005; RAETZ CRH, 1995, SCIENCE, V270, P997, DOI 10.1126/science.270.5238.997; Receveur-Brechot V, 2006, PROTEINS, V62, P24, DOI 10.1002/prot.20750; Sotomayor Perez AC, 2010, J MOL BIOL, V397, P534, DOI 10.1016/j.jmb.2010.01.031; STEINBACHER S, 1994, SCIENCE, V265, P383, DOI 10.1126/science.8023158; Szilvay GR, 2009, BIOCHEMISTRY-US, V48, P11273, DOI 10.1021/bi901447j; Tompa P, 2010, BIOCHEM CELL BIOL, V88, P167, DOI [10.1139/O09-163, 10.1139/o09-163]; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Vojtova J, 2006, CURR OPIN MICROBIOL, V9, P69, DOI 10.1016/j.mib.2005.12.011; Welch RA, 2001, CURR TOP MICROBIOL, V257, P85; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003	38	38	39	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16997	17004		10.1074/jbc.M110.210393	http://dx.doi.org/10.1074/jbc.M110.210393			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454565	Green Published, hybrid			2022-12-25	WOS:000290301900050
J	Afanasieva, EG; Kushnirov, VV; Tuite, MF; Ter-Avanesyan, MD				Afanasieva, Evgenia G.; Kushnirov, Vitaly V.; Tuite, Mick F.; Ter-Avanesyan, Michael D.			Molecular Basis for Transmission Barrier and Interference between Closely Related Prion Proteins in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; SPECIES BARRIER; SUP35 PROTEIN; PROPAGATION; AMYLOIDS; GENE; ELECTROPHORESIS; DETERMINANT; DIVERSITY; DISEASE	Replicating amyloids, called prions, are responsible for transmissible neurodegenerative diseases in mammals and some heritable phenotypes in fungi. The transmission of prions between species is usually inhibited, being highly sensitive to small differences in amino acid sequence of the prion-forming proteins. To understand the molecular basis of this prion interspecies barrier, we studied the transmission of the [PSI+] prion state from Sup35 of Saccharomyces cerevisiae to hybrid Sup35 proteins with prion-forming domains from four other closely related Saccharomyces species. Whereas all the hybrid Sup35 proteins could adopt a prion form in S. cerevisiae, they could not readily acquire the prion form from the [PSI+] prion of S. cerevisiae. Expression of the hybrid Sup35 proteins in S. cerevisiae [PSI+] cells often resulted in frequent loss of the native [PSI+] prion. Furthermore, all hybrid Sup35 proteins showed different patterns of interaction with the native [PSI+] prion in terms of co-polymerization, acquisition of the prion state, and induced prion loss, all of which were also dependent on the [PSI+] variant. The observed loss of S. cerevisiae [PSI+] can be related to inhibition of prion polymerization of S. cerevisiae Sup35 and formation of a non-heritable form of amyloid. We have therefore identified two distinct molecular origins of prion transmission barriers between closely sequence-related prion proteins: first, the inability of heterologous proteins to co-aggregate with host prion polymers, and second, acquisition by these proteins of a non-heritable amyloid fold.	[Afanasieva, Evgenia G.; Kushnirov, Vitaly V.; Ter-Avanesyan, Michael D.] Cardiol Res Ctr, Moscow 121552, Russia; [Tuite, Mick F.] Univ Kent, Sch Biosci, Canterbury CT2 7NJ, Kent, England	National Medical Research Center of Cardiology; University of Kent	Kushnirov, VV (corresponding author), Cardiol Res Ctr, 3rd Cherepkovskaya Str 15A, Moscow 121552, Russia.	vvkushnirov@gmail.com; mdter@cardio.ru	Tuite, Mick/ABC-7909-2020; Vitaly, Kushnirov/AAU-6003-2021	Tuite, Mick/0000-0002-5214-540X; Kushnirov, Vitaly/0000-0003-0316-0766	Wellcome Trust; Russian Foundation for Fundamental Research	Wellcome Trust(Wellcome TrustEuropean Commission); Russian Foundation for Fundamental Research(Russian Foundation for Basic Research (RFBR))	The work was supported by the Wellcome Trust (to V. V. K. and M. F. T.) and the Russian Foundation for Fundamental Research (to M. D. T.-A.).	Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Alexandrov IM, 2008, J BIOL CHEM, V283, P15185, DOI 10.1074/jbc.M802071200; Bagriantsev SN, 2006, METHOD ENZYMOL, V412, P33, DOI 10.1016/S0076-6879(06)12003-0; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Caughey B, 2001, ADV VIRUS RES, V56, P277, DOI 10.1016/S0065-3527(01)56031-5; Chen BX, 2007, P NATL ACAD SCI USA, V104, P2791, DOI 10.1073/pnas.0611158104; Chen BX, 2010, MOL MICROBIOL, V76, P1483, DOI 10.1111/j.1365-2958.2010.07177.x; Chien P, 2001, NATURE, V410, P223, DOI 10.1038/35065632; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Coustou V, 1997, P NATL ACAD SCI USA, V94, P9773, DOI 10.1073/pnas.94.18.9773; Derkatch IL, 1996, GENETICS, V144, P1375; Du ZQ, 2008, NAT GENET, V40, P460, DOI 10.1038/ng.112; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Horwich AL, 1997, CELL, V89, P499, DOI 10.1016/S0092-8674(00)80232-9; Kochneva-Pervukhova NV, 2001, YEAST, V18, P489, DOI 10.1002/yea.700; Krishnan R, 2005, NATURE, V435, P765, DOI 10.1038/nature03679; Kryndushkin DS, 2003, J BIOL CHEM, V278, P49636, DOI 10.1074/jbc.M307996200; Kushnirov VV, 2006, METHODS, V39, P50, DOI 10.1016/j.ymeth.2006.04.007; Kushnirov VV, 2007, PRION, V1, P179, DOI 10.4161/pri.1.3.4840; Kushnirov VV, 2000, EMBO J, V19, P324, DOI 10.1093/emboj/19.3.324; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Naumova ES, 2003, FEMS YEAST RES, V3, P177, DOI 10.1016/S1567-1356(02)00191-5; Naumova ES, 2003, ANTON LEEUW INT J G, V83, P155, DOI 10.1023/A:1023328320228; Nemecek J, 2009, P NATL ACAD SCI USA, V106, P1892, DOI 10.1073/pnas.0812470106; Patel BK, 2009, NAT CELL BIOL, V11, P344, DOI 10.1038/ncb1843; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Paushkin SV, 1997, MOL CELL BIOL, V17, P2798, DOI 10.1128/MCB.17.5.2798; Paushkin SV, 1996, EMBO J, V15, P3127, DOI 10.1002/j.1460-2075.1996.tb00675.x; PRIOLA SA, 1994, J VIROL, V68, P4873, DOI 10.1128/JVI.68.8.4873-4878.1994; Prusiner SB, 1998, CELL, V93, P337, DOI 10.1016/S0092-8674(00)81163-0; Salnikova AB, 2005, J BIOL CHEM, V280, P8808, DOI 10.1074/jbc.M410150200; Santoso A, 2000, CELL, V100, P277, DOI 10.1016/S0092-8674(00)81565-2; SCOTT M, 1993, CELL, V73, P979, DOI 10.1016/0092-8674(93)90275-U; Shkundina IS, 2006, GENETICS, V172, P827, DOI 10.1534/genetics.105.048660; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; TERAVANESYAN MD, 1994, GENETICS, V137, P671; TERAVANESYAN MD, 1993, MOL MICROBIOL, V7, P683, DOI 10.1111/j.1365-2958.1993.tb01159.x; Urakov VN, 2010, PRION, V4, P45, DOI 10.4161/pri.4.1.11074; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170	42	22	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.183889	http://dx.doi.org/10.1074/jbc.M110.183889			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454674	hybrid, Green Accepted, Green Published			2022-12-25	WOS:000290022800017
J	Hemsworth, GR; Moroz, OV; Fogg, MJ; Scott, B; Bosch-Navarrete, C; Gonzalez-Pacanowska, D; Wilson, KS				Hemsworth, Glyn R.; Moroz, Olga V.; Fogg, Mark J.; Scott, Benjamin; Bosch-Navarrete, Cristina; Gonzalez-Pacanowska, Dolores; Wilson, Keith S.			The Crystal Structure of the Leishmania major Deoxyuridine Triphosphate Nucleotidohydrolase in Complex with Nucleotide Analogues, dUMP, and Deoxyuridine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINETIC CHARACTERIZATION; METAL-BINDING; DUTPASE; HYDROLYSIS; REFINEMENT; MECHANISM; ENZYME; SITE; ION	Members of the Leishmania genus are the causative agents of the life-threatening disease leishmaniasis. New drugs are being sought due to increasing resistance and adverse side effects with current treatments. The knowledge that dUTPase is an essential enzyme and that the all alpha-helical dimeric kinetoplastid dUT-Pases have completely different structures compared with the trimeric beta-sheet type dUTPase possessed by most organisms, including humans, make the dimeric enzymes attractive drug targets. Here, we present crystal structures of the Leishmania major dUTPase in complex with substrate analogues, the product dUMP and a substrate fragment, and of the homologous Campylobacter jejuni dUTPase in complex with a triphosphate substrate analogue. The metal-binding properties of both enzymes are shown to be dependent upon the ligand identity, a previously unseen characteristic of this family. Furthermore, structures of the Leishmania enzyme in the presence of dUMP and deoxyuridine coupled with tryptophan fluorescence quenching indicate that occupation of the phosphate binding region is essential for induction of the closed conformation and hence for substrate binding. These findings will aid in the development of dUTPase inhibitors as potential new lead anti-trypanosomal compounds.	[Hemsworth, Glyn R.; Moroz, Olga V.; Fogg, Mark J.; Scott, Benjamin; Wilson, Keith S.] Univ York, Dept Chem, Struct Biol Lab, York YO10 5DD, N Yorkshire, England; [Bosch-Navarrete, Cristina; Gonzalez-Pacanowska, Dolores] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada 18100, Armilla, Spain	University of York - UK; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN)	Wilson, KS (corresponding author), Univ York, Dept Chem, Struct Biol Lab, York YO10 5DD, N Yorkshire, England.	keith@ysbl.york.ac.uk	Hemsworth, Glyn/AAS-5473-2021	Hemsworth, Glyn/0000-0002-8226-1380; Wilson, Keith/0000-0002-3581-2194; bosch-navarrete, cristina/0000-0002-6064-0064; Gonzalez-Pacanowska, Dolores/0000-0002-4303-5209; Fogg, Mark/0000-0002-6692-122X; Moroz, Olga/0000-0002-0354-6119	European Union [223238]; Spanish Plan Nacional [SAF2007-62596]; FIS Network [RD06/0021]; Junta de Andalucia [CVI-199]	European Union(European Commission); Spanish Plan Nacional(Spanish Government); FIS Network; Junta de Andalucia(Junta de Andalucia)	This work was funded by European Union Grant agreement 223238, Spanish Plan Nacional Grant SAF2007-62596, FIS Network Grant RD06/0021, and the Junta de Andalucia Grant CVI-199.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barabas O, 2004, J BIOL CHEM, V279, P42907, DOI 10.1074/jbc.M406135200; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Camacho A, 2000, BIOCHEM J, V346, P163, DOI 10.1042/0264-6021:3460163; Castillo-Acosta VM, 2008, INT J BIOCHEM CELL B, V40, P2901, DOI 10.1016/j.biocel.2008.06.009; Dauter Z, 1999, J MOL BIOL, V285, P655, DOI 10.1006/jmbi.1998.2332; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DESJEUX P, 1996, Nat Struct Biol, V14, P485; ELHAJJ HH, 1988, J BACTERIOL, V170, P1069, DOI 10.1128/jb.170.3.1069-1075.1988; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fogg MJ, 2008, BIOCHEM SOC T, V36, P771, DOI 10.1042/BST0360771; GADSDEN MH, 1993, EMBO J, V12, P4425, DOI 10.1002/j.1460-2075.1993.tb06127.x; Galperin MY, 2006, MOL MICROBIOL, V59, P5, DOI 10.1111/j.1365-2958.2005.04950.x; Harding MM, 2001, ACTA CRYSTALLOGR D, V57, P401, DOI 10.1107/S0907444900019168; Harkiolaki M, 2004, STRUCTURE, V12, P41, DOI 10.1016/j.str.2003.11.016; Hidalgo-Zarco F, 2001, CURR PROTEIN PEPT SC, V2, P389, DOI 10.2174/1389203013381026; Hidalgo-Zarco F, 2001, PROTEIN SCI, V10, P1426, DOI 10.1110/ps.48801; Kovari J, 2004, J BIOL CHEM, V279, P17932, DOI 10.1074/jbc.M313643200; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; Larsson G, 1996, J BIOL CHEM, V271, P24010, DOI 10.1074/jbc.271.39.24010; Leslie AGW, 1999, ACTA CRYSTALLOGR D, V55, P1696, DOI 10.1107/S090744499900846X; MCGEOCH DJ, 1990, NUCLEIC ACIDS RES, V18, P4105, DOI 10.1093/nar/18.14.4105; Moroz OV, 2004, J MOL BIOL, V342, P1583, DOI 10.1016/j.jmb.2004.07.050; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Mustafi D, 2003, P NATL ACAD SCI USA, V100, P5670, DOI 10.1073/pnas.1031504100; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Persson R, 2001, CURR PROTEIN PEPT SC, V2, P287, DOI 10.2174/1389203013381035; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; STEITZ TA, 1993, CURR OPIN STRUC BIOL, V3, P31, DOI 10.1016/0959-440X(93)90198-T; Tellez-Sanz R, 2007, BIOCHIMIE, V89, P972, DOI 10.1016/j.biochi.2007.03.007; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766	33	29	29	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M111.224873	http://dx.doi.org/10.1074/jbc.M111.224873			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454646	Green Published, hybrid			2022-12-25	WOS:000290022800084
J	Farias, AS; Talaisys, RL; Blanco, YC; Lopes, SCP; Longhini, ALF; Pradella, F; Santos, LMB; Costa, FTM				Farias, Alessandro S.; Talaisys, Rafael L.; Blanco, Yara C.; Lopes, Stefanie C. P.; Longhini, Ana Leda F.; Pradella, Fernando; Santos, Leonilda M. B.; Costa, Fabio T. M.			Regulatory T Cell Induction during Plasmodium chabaudi Infection Modifies the Clinical Course of Experimental Autoimmune Encephalomyelitis	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; TGF-BETA; SELF-TOLERANCE; IMMUNE EVASION; TH17 CELLS; MALARIA; EFFECTOR; DISEASE; INFLAMMATION	Background: Experimental autoimmune encephalomyelitis (EAE) is used as an animal model for human multiple sclerosis (MS), which is an inflammatory demyelinating autoimmune disease of the central nervous system characterized by activation of Th1 and/or Th17 cells. Human autoimmune diseases can be either exacerbated or suppressed by infectious agents. Recent studies have shown that regulatory T cells play a crucial role in the escape mechanism of Plasmodium spp. both in humans and in experimental models. These cells suppress the Th1 response against the parasite and prevent its elimination. Regulatory T cells have been largely associated with protection or amelioration in several autoimmune diseases, mainly by their capacity to suppress proinflammatory response. Methodology/Principal Findings: In this study, we verified that CD4(+)CD25(+) regulatory T cells (T regs) generated during malaria infection (6 days after EAE induction) interfere with the evolution of EAE. We observed a positive correlation between the reduction of EAE clinical symptoms and an increase of parasitemia levels. Suppression of the disease was also accompanied by a decrease in the expression of IL-17 and IFN-gamma and increases in the expression of IL-10 and TGF-beta 1 relative to EAE control mice. The adoptive transfer of CD4(+)CD25(+) cells from P. chabaudi-infected mice reduced the clinical evolution of EAE, confirming the role of these T regs. Conclusions/Significance: These data corroborate previous findings showing that infections interfere with the prevalence and evolution of autoimmune diseases by inducing regulatory T cells, which regulate EAE in an apparently non-specific manner.	[Farias, Alessandro S.; Talaisys, Rafael L.; Blanco, Yara C.; Lopes, Stefanie C. P.; Longhini, Ana Leda F.; Pradella, Fernando; Santos, Leonilda M. B.; Costa, Fabio T. M.] Univ Estadual Campinas UNICAMP, Dept Genet Evolucao & Bioagentes, Campinas, SP, Brazil	Universidade Estadual de Campinas	Farias, AS (corresponding author), Univ Estadual Campinas UNICAMP, Dept Genet Evolucao & Bioagentes, Campinas, SP, Brazil.	asfarias@unicamp.br; costaftm@unicamp.br	Farias, Alessandro/AAH-2228-2020; Costa, Fabio/E-1181-2012; Lopes, Stefanie/A-8314-2012; Farias, Alessandro/C-6879-2012	Farias, Alessandro/0000-0001-6759-1819; Costa, Fabio/0000-0001-9969-7300; Farias, Alessandro/0000-0001-6759-1819; Lopes, Stefanie/0000-0002-6981-2192	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2009/15620-9]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Academy of Sciences for the Developing World (TWAS) [05-049 RG/BIO/LA]; National Institute for Vaccine Development and Technology (CNPq-INCTV); Rede de Malaria (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Academy of Sciences for the Developing World (TWAS); National Institute for Vaccine Development and Technology (CNPq-INCTV); Rede de Malaria (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported financially by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and The Academy of Sciences for the Developing World (TWAS; Grant # 05-049 RG/BIO/LA), The National Institute for Vaccine Development and Technology (CNPq-INCTV) and Rede de Malaria (CNPq). ASF was supported by a FAPESP fellowship (# 2009/15620-9). RLT, YCB and ALFL received a Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) fellowship and SCPL was supported by CNPq. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderton SM, 2008, CURR OPIN NEUROL, V21, P248, DOI 10.1097/WCO.0b013e3282febf58; Bach JF, 2001, J AUTOIMMUN, V16, P347, DOI 10.1006/jaut.2000.0478; Bettini M, 2009, CURR OPIN IMMUNOL, V21, P612, DOI 10.1016/j.coi.2009.09.011; Blanco YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003126; BROCKE S, 1993, NATURE, V365, P642, DOI 10.1038/365642a0; BUENO LL, PLOS ONE, V5, pE9623; Cambos M, 2008, INT J PARASITOL, V38, P229, DOI 10.1016/j.ijpara.2007.07.006; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Farias AS, 2007, NEUROIMMUNOMODULAT, V14, P32, DOI 10.1159/000107286; Feger U, 2007, CLIN EXP IMMUNOL, V147, P412, DOI 10.1111/j.1365-2249.2006.03271.x; Finney OC, 2009, EUR J IMMUNOL, V39, P1288, DOI 10.1002/eji.200839112; Furtado GD, 2001, IMMUNOL REV, V182, P122; Hafler DA, 2005, IMMUNOL REV, V204, P208, DOI 10.1111/j.0105-2896.2005.00240.x; Hauser SL, 2006, NEURON, V52, P61, DOI 10.1016/j.neuron.2006.09.011; Hisaeda H, 2005, INT J BIOCHEM CELL B, V37, P700, DOI 10.1016/j.biocel.2004.10.009; Korn T, 2007, SEMIN IMMUNOL, V19, P362, DOI 10.1016/j.smim.2007.10.007; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; LEHMANN D, 1992, J AUTOIMMUN, V5, P675, DOI 10.1016/0896-8411(92)90185-S; Liu YZ, 2008, NAT IMMUNOL, V9, P632, DOI 10.1038/ni.1607; McGeachy MJ, 2005, J IMMUNOL, V175, P3025, DOI 10.4049/jimmunol.175.5.3025; Minigo G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000402; Nie CQ, 2007, INFECT IMMUN, V75, P2275, DOI 10.1128/IAI.01783-06; O'Connor RA, 2008, J IMMUNOL, V181, P3750, DOI 10.4049/jimmunol.181.6.3750; O'Connor RA, 2008, J NEUROIMMUNOL, V193, P1, DOI 10.1016/j.jneuroim.2007.11.016; Olivares-Villagomez D, 1998, J EXP MED, V188, P1883, DOI 10.1084/jem.188.10.1883; Omer FM, 2003, J EXP MED, V198, P1817, DOI 10.1084/jem.20030713; Peacock JW, 2003, EUR J IMMUNOL, V33, P1849, DOI 10.1002/eji.200323148; Riley EM, 2006, PARASITE IMMUNOL, V28, P35, DOI 10.1111/j.1365-3024.2006.00775.x; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Scholzen A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000543; Strauch UG, 2005, GUT, V54, P1546, DOI 10.1136/gut.2004.059451; Tadokoro CE, 2004, J AUTOIMMUN, V23, P103, DOI 10.1016/j.jaut.2004.05.003; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Thornton AM, 2000, J IMMUNOL, V164, P183, DOI 10.4049/jimmunol.164.1.183; Todryk SM, 2009, EUR J IMMUNOL, V39, P3042, DOI 10.1002/eji.200939434; Walther M, 2005, IMMUNITY, V23, P287, DOI 10.1016/j.immuni.2005.08.006; Walther M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000364; Wing K, 2010, NAT IMMUNOL, V11, P7, DOI 10.1038/ni.1818	38	24	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e17849	10.1371/journal.pone.0017849	http://dx.doi.org/10.1371/journal.pone.0017849			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464982	Green Published, gold, Green Submitted			2022-12-25	WOS:000288813900014
J	Braeckman, U; Provoost, P; Moens, T; Soetaert, K; Middelburg, JJ; Vincx, M; Vanaverbeke, J				Braeckman, Ulrike; Provoost, Pieter; Moens, Tom; Soetaert, Karline; Middelburg, Jack J.; Vincx, Magda; Vanaverbeke, Jan			Biological vs. Physical Mixing Effects on Benthic Food Web Dynamics	PLOS ONE			English	Article							DEEP-SEA NEMATODES; ESTUARINE TIDAL FLAT; LANICE-CONCHILEGA; ORGANIC-MATTER; VERTICAL-DISTRIBUTION; NORTH-SEA; SEDIMENTS; BACTERIA; CARBON; PHYTOPLANKTON	Biological particle mixing (bioturbation) and solute transfer (bio-irrigation) contribute extensively to ecosystem functioning in sediments where physical mixing is low. Macrobenthos transports oxygen and organic matter deeper into the sediment, thereby likely providing favourable niches to lower trophic levels (i.e., smaller benthic animals such as meiofauna and bacteria) and thus stimulating mineralisation. Whether this biological transport facilitates fresh organic matter assimilation by the metazoan lower part of the food web through niche establishment (i.e., ecosystem engineering) or rather deprives them from food sources, is so far unclear. We investigated the effects of the ecosystem engineers Lanice conchilega (bio-irrigator) and Abra alba (bioturbator) compared to abiotic physical mixing events on survival and food uptake of nematodes after a simulated phytoplankton bloom. The C-13 labelled diatom Skeletonema costatum was added to 4 treatments: (1) microcosms containing the bioturbator, (2) microcosms containing the bio-irrigator, (3) control microcosms and (4) microcosms with abiotic manual surface mixing. Nematode survival and subsurface peaks in nematode density profiles were most pronounced in the bio-irrigator treatment. However, nematode specific uptake (Delta delta C-13) of the added diatoms was highest in the physical mixing treatment, where macrobenthos was absent and the diatom C-13 was homogenised. Overall, nematodes fed preferentially on bulk sedimentary organic material rather than the added diatoms. The total C budget (mu g C m(-2)), which included (TOC)-C-13 remaining in the sediment, respiration, nematode and macrobenthic uptake, highlighted the limited assimilation by the metazoan benthos and the major role of bacterial respiration. In summary, bioturbation and especially bio-irrigation facilitated the lower trophic levels mainly over the long-term through niche establishment. Since the freshly added diatoms represented only a limited food source for nematodes, the macrobenthic effect was more pronounced in niche establishment than the negative structuring effects such as competition.	[Braeckman, Ulrike; Moens, Tom; Vincx, Magda; Vanaverbeke, Jan] Univ Ghent, Marine Biol Sect, Dept Biol, B-9000 Ghent, Belgium; [Provoost, Pieter; Soetaert, Karline; Middelburg, Jack J.] Netherlands Inst Ecol NIOO KNAW, Ctr Estuarine & Marine Ecol, Yerseke, Netherlands; [Middelburg, Jack J.] Univ Utrecht, Fac Geosci, Utrecht, Netherlands	Ghent University; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Utrecht University	Braeckman, U (corresponding author), Univ Ghent, Marine Biol Sect, Dept Biol, B-9000 Ghent, Belgium.	Ulrike.Braeckman@UGent.be	Braeckman, Ulrike/AAJ-4801-2021; Vanaverbeke, jan/A-1118-2012; Soetaert, Karline E/A-9839-2011; Moens, Tom/AAB-8701-2019; Middelburg, Jack/B-4951-2011	Soetaert, Karline E/0000-0003-4603-7100; Middelburg, Jack/0000-0003-3601-9072; Braeckman, Ulrike/0000-0002-7558-6363	Research Foundation - Flanders (FWO); Belgian Science Policy (BelSPO) [SD/BN/01A, GOA 01600705, G.0041.08]; European Union Network of Excellence MarBEF [GOCE-CT-2003-505446]	Research Foundation - Flanders (FWO)(FWO); Belgian Science Policy (BelSPO)(Belgian Federal Science Policy Office); European Union Network of Excellence MarBEF	Support was given to U.B. by the Research Foundation - Flanders (FWO). This paper contributes to the Westbanks project (www.vliz.be/projects/westbanks), which is supported by the Belgian Science Policy (BelSPO, contract no. SD/BN/01A) to the Ghent University BBSea Project (GOA 01600705), FWO project (G.0041.08) and the European Union Network of Excellence MarBEF (GOCE-CT-2003-505446). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle N, 2003, MAR ECOL PROG SER, V251, P37, DOI 10.3354/meps251037; AMOUROUX JM, 1989, MAR ECOL PROG SER, V51, P87, DOI 10.3354/meps051087; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2004, J EXP MAR BIOL ECOL, V305, P191, DOI 10.1016/j.jembe.2003.12.011; Anderson MJ, 2003, AUST NZ J STAT, V45, P301, DOI 10.1111/1467-842X.00285; Bouchet VMP, 2009, J EXP MAR BIOL ECOL, V371, P20, DOI 10.1016/j.jembe.2008.12.012; Braeckman U, 2011, MAR ECOL PROG SER, V422, P179, DOI 10.3354/meps08910; Braeckman U, 2010, MAR ECOL PROG SER, V399, P173, DOI 10.3354/meps08336; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; Dashfield SL, 2008, J EXP MAR BIOL ECOL, V365, P46, DOI 10.1016/j.jembe.2008.07.039; Degraer S., 2006, MACROBENTHOS ATLAS B; FORSTER S, 1995, MAR BIOL, V123, P335, DOI 10.1007/BF00353625; Franco MA, 2008, J EXP MAR BIOL ECOL, V362, P1, DOI 10.1016/j.jembe.2008.04.010; Franco MA, 2008, MAR ECOL PROG SER, V358, P51, DOI 10.3354/meps07361; Friedrichs M, 2000, MAR ECOL PROG SER, V192, P219, DOI 10.3354/meps192219; Gallucci F, 2008, MAR ECOL PROG SER, V367, P173, DOI 10.3354/meps07537; GRAF G, 1992, OCEANOGR MAR BIOL, V30, P149; Guilini K, 2010, LIMNOL OCEANOGR, V55, P1977, DOI 10.4319/lo.2010.55.5.1977; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; HARGRAVE BT, 1973, J FISH RES BOARD CAN, V30, P1317, DOI 10.1139/f73-212; HEIP C, 1985, OCEANOGR MAR BIOL, V23, P399; Ingels J, 2010, MAR ECOL PROG SER, V406, P121, DOI 10.3354/meps08535; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Kamp A, 2005, MAR ECOL PROG SER, V297, P61, DOI 10.3354/meps297061; KRISTENSEN E, 2005, INTERACTIONS MACRO M, P125, DOI DOI 10.1029/CE060P0125; KRISTENSEN E, 1987, J MARINE RES JMMRAO, V45; Lancelot C, 2005, MAR ECOL PROG SER, V289, P63, DOI 10.3354/meps289063; Levin L, 1997, J MAR RES, V55, P595, DOI 10.1357/0022240973224337; Meysman FJR, 2006, TRENDS ECOL EVOL, V21, P688, DOI 10.1016/j.tree.2006.08.002; Middelburg JJ, 2000, LIMNOL OCEANOGR, V45, P1224, DOI 10.4319/lo.2000.45.6.1224; Moens T, 2002, MAR ECOL PROG SER, V234, P127, DOI 10.3354/meps234127; Moodley L, 2002, MAR ECOL PROG SER, V236, P23, DOI 10.3354/meps236023; Olafsson E, 2003, VIE MILIEU, V53, P249; Posey M, 1996, B MAR SCI, V59, P523; Rabaut M., 2009, THESIS GHENT U; Rabaut M, 2007, ESTUAR COAST SHELF S, V75, P525, DOI 10.1016/j.ecss.2007.05.041; Rabaut M, 2009, HELGOLAND MAR RES, V63, P37, DOI 10.1007/s10152-008-0137-4; REISE K, 1983, MAR ECOL PROG SER, V12, P229, DOI 10.3354/meps012229; REISE K, 1985, ECOLOGICAL STUDIES A, V54, P119; Rousseau V, 2002, MAR ECOL PROG SER, V236, P61, DOI 10.3354/meps236061; SOLAN M, 2005, INTERACTIONS MACRO M, P105; Steyaert M, 2001, MAR ECOL PROG SER, V224, P299, DOI 10.3354/meps224299; Steyaert M., 2005, ELECT KEY FREE LIVIN; Sun MY, 2005, MAR CHEM, V96, P201, DOI 10.1016/j.marchem.2004.11.003; Sun MY, 2002, ORG GEOCHEM, V33, P445, DOI 10.1016/S0146-6380(02)00005-0; Van Hoey G, 2005, ESTUAR COAST SHELF S, V64, P751, DOI 10.1016/j.ecss.2005.03.022; Van Hoey G, 2004, ESTUAR COAST SHELF S, V59, P599, DOI 10.1016/j.ecss.2003.11.005; Van Hoey G, 2008, MAR BIOL, V154, P1009, DOI 10.1007/s00227-008-0992-1; van Nugteren P, 2009, LIMNOL OCEANOGR, V54, P1413, DOI 10.4319/lo.2009.54.5.1413; van Oevelen D, 2006, LIMNOL OCEANOGR, V51, P1302, DOI 10.4319/lo.2006.51.3.1302; van Oevelen D, 2009, MAR ECOL PROG SER, V380, P19, DOI 10.3354/meps07921; Vanaverbeke J, 2008, CURRENT STATUS EUTRO, P73; Warwick R.M., 1998, SYNOPSES BRIT FAUNA, P53; Wetzel MA, 1995, MAR BIOL, V124, P301, DOI 10.1007/BF00347134; Witte U, 2003, MAR ECOL PROG SER, V251, P27, DOI 10.3354/meps251027; Wright S., 1997, PHYTOPLANKTON PIGMEN, P327; ZIEGELMEIER E, 1969, HELGOLAND WISS MEER, V19, P216, DOI 10.1007/BF01625607; Ziegelmeier E., 1954, Helgolander Wissenschaftliche Meeresuntersuchungen, V4, P107, DOI 10.1007/BF02178540	58	35	35	0	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2011	6	3							e18078	10.1371/journal.pone.0018078	http://dx.doi.org/10.1371/journal.pone.0018078			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740RG	21455308	Green Published, gold, Green Submitted			2022-12-25	WOS:000288811500020
J	Shouse, GP; Nobumori, Y; Panowicz, MJ; Liu, X				Shouse, G. P.; Nobumori, Y.; Panowicz, M. J.; Liu, X.			ATM-mediated phosphorylation activates the tumor-suppressive function of B56 gamma-PP2A	ONCOGENE			English	Article						ATM; PP2A; B56 gamma; MDM2; p53	PROTEIN PHOSPHATASE 2A; REGULATORY SUBUNIT; B56-DELTA SUBUNIT; C-MYC; PP2A; KINASE; IDENTIFICATION; PATHWAY; P53; TRANSFORMATION	Protein phosphatase 2A (PP2A) is a family of heterotrimeric protein phosphatases that has a multitude of functions inside the cell, acting through various substrate targets in cell-signaling pathways. Recent evidence suggests that a subset of PP2A holoenzymes function as tumor suppressors and one particular family of B subunits, B56, are implicated in this function. However, the regulatory mechanisms that govern activation of B56-PP2A tumor-suppressive function have not been elucidated. In the present study, we demonstrate that ataxia-telangiectasia mutated (ATM) directly phosphorylates and specifically regulates B56 gamma 3, B56 gamma 2 and B56 delta, after DNA damage. We further show that phosphorylation of B56 gamma 3 at Ser510 leads to an increase in B56 gamma 3-PP2A complexes, and direction of PP2A phosphatase activity toward the substrate p53, activating its tumor-suppressive functions. In addition, we found that under cell growth conditions B56 gamma 3 is kept at low levels through the actions of the E3 ubiquitin ligase MDM2, and, importantly, phosphorylation of B56 gamma 3 by ATM leads to upregulation of the protein by blocking MDM2-mediated B56 gamma 3 ubiquitination. Finally, we show that Ser510 phosphorylation significantly enhances the ability of B56 gamma 3 to inhibit cell proliferation and anchorage-independent growth. These results provide mechanistic insight into the regulation of PP2A tumor-suppressive function, and suggest a model for parallel regulation of p53 and B56 gamma 3. Oncogene (2011) 30, 3755-3765; doi:10.1038/onc.2011.95; published online 4 April 2011	[Shouse, G. P.; Nobumori, Y.; Panowicz, M. J.; Liu, X.] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA	University of California System; University of California Riverside	Liu, X (corresponding author), Univ Calif Riverside, Dept Biochem, 5414 Boyce Hall, Riverside, CA 92521 USA.	xuan.liu@ucr.edu		Shouse, Geoffrey/0000-0002-7917-5713	National Institute of Cancer [CA075180]; NATIONAL CANCER INSTITUTE [R29CA075180, R01CA075180] Funding Source: NIH RePORTER	National Institute of Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are very grateful to Dr D Virshup for providing B56 delta antibody, to Dr M Kastan for providing ATM plasmids, to Dr J Momand for providing SJSA-1 cells, and to Dr G Smith and Kudos Pharmaceuticals for providing the ATM inhibitor KU55933. We thank Drs E Lee, D Virshup, JA Traugh, and all members of our laboratory for the many helpful discussions. This work was supported by NIH grant CA075180 from the National Institute of Cancer.	Ahn JH, 2007, P NATL ACAD SCI USA, V104, P2979, DOI 10.1073/pnas.0611532104; Arnold HK, 2006, MOL CELL BIOL, V26, P2832, DOI 10.1128/MCB.26.7.2832-2844.2006; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Janssens V, 2008, TRENDS BIOCHEM SCI, V33, P113, DOI 10.1016/j.tibs.2007.12.004; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Li HH, 2007, EMBO J, V26, P402, DOI 10.1038/sj.emboj.7601519; Lim DS, 2000, NATURE, V404, P613, DOI 10.1038/35007091; Margolis SS, 2006, CELL, V127, P759, DOI 10.1016/j.cell.2006.10.035; Mumby M, 2007, CELL, V130, P21, DOI 10.1016/j.cell.2007.06.034; Muneer S, 2002, GENOMICS, V79, P344, DOI 10.1006/geno.2002.6721; Nousiainen M, 2006, P NATL ACAD SCI USA, V103, P5391, DOI 10.1073/pnas.0507066103; O'Neill T, 2000, J BIOL CHEM, V275, P22719, DOI 10.1074/jbc.M001002200; Okamoto K, 2002, MOL CELL, V9, P761, DOI 10.1016/S1097-2765(02)00504-X; Ortega-Lazaro JC, 2003, CYTOGENET GENOME RES, V103, P345, DOI 10.1159/000076823; Shouse GP, 2010, ONCOGENE, V29, P3933, DOI 10.1038/onc.2010.161; Shouse GP, 2008, MOL CELL BIOL, V28, P448, DOI 10.1128/MCB.00983-07; Silverstein AM, 2002, P NATL ACAD SCI USA, V99, P4221, DOI 10.1073/pnas.072071699; Sontag E, 2001, CELL SIGNAL, V13, P7, DOI 10.1016/S0898-6568(00)00123-6; Strack S, 2002, J BIOL CHEM, V277, P20750, DOI 10.1074/jbc.M202992200; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Westermarck J, 2008, TRENDS MOL MED, V14, P152, DOI 10.1016/j.molmed.2008.02.001; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110	24	34	35	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP	2011	30	35					3755	3765		10.1038/onc.2011.95	http://dx.doi.org/10.1038/onc.2011.95			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	814TZ	21460856				2022-12-25	WOS:000294481400003
J	Colleran, A; Ryan, A; O'Gorman, A; Mureau, C; Liptrot, C; Dockery, P; Fearnhead, H; Egan, LJ				Colleran, Amy; Ryan, Aideen; O'Gorman, Angela; Mureau, Coralie; Liptrot, Catherine; Dockery, Peter; Fearnhead, Howard; Egan, Laurence J.			Autophagosomal I kappa B alpha Degradation Plays a Role in the Long Term Control of Tumor Necrosis Factor-alpha-induced Nuclear Factor-kappa B (NF-kappa B) Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMATORY-BOWEL-DISEASE; INTESTINAL PANETH CELLS; TRANSCRIPTION FACTOR; EPITHELIAL-CELLS; FAMILY-MEMBERS; CROHN-DISEASE; ACTIVATION; KINASE; INHIBITOR; PHOSPHORYLATION	Transcription factor NF-kappa B is persistently activated in many chronic inflammatory diseases and cancers. The short term regulation of NF-kappa B is well understood, but little is known about the mechanisms of its long term activation. We studied the effect of a single application of TNF-alpha on NF-kappa B activity for up to 48 h in intestinal epithelial cells. Results show that NF-kappa B remained persistently activated up to 48 h after TNF-alpha and that the long term activation of NF-kappa B was accompanied by a biphasic degradation of I kappa B alpha. The first phase of I kappa B alpha degradation was proteasome-dependent, but the second was not. Further investigation showed that TNF-alpha stimulated formation of autophagosomes in intestinal epithelial cells and that I kappa B alpha co-localized with autophagosomal vesicles. Pharmacological or genetic blockade of autophagosome formation or the inhibition of lysosomal proteases decreased TNF-alpha-induced degradation of I kappa B alpha and lowered NF-kappa B target gene expression. Together, these findings indicate a role of autophagy in the control of long term NF-kappa B activity. Because abnormalities in autophagy have been linked to ineffective innate immunity, we propose that alterations in NF-kappa B may mediate this effect.	[Colleran, Amy; Ryan, Aideen; O'Gorman, Angela; Mureau, Coralie; Fearnhead, Howard; Egan, Laurence J.] Natl Univ Ireland, Dept Pharmacol & Therapeut, Galway, Ireland; [Liptrot, Catherine; Dockery, Peter] Natl Univ Ireland, Sch Med, Dept Anat, Galway, Ireland	Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway	Egan, LJ (corresponding author), Univ Hosp Galway, Inst Clin Sci, Newcastle Rd, Galway, Ireland.	laurence.egan@nuigalway.ie	Ryan, Aideen/H-3909-2019; Fearnhead, Howard O/D-4826-2012; Liptrot, Catherine/D-7056-2012	Ryan, Aideen/0000-0002-5831-6783; Liptrot, Catherine/0000-0003-3882-8084; Fearnhead, Howard/0000-0002-8054-9794; Dockery, Peter/0000-0001-5103-6589	Science Foundation Ireland	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported by Science Foundation Ireland.	Artis D, 2002, J IMMUNOL, V169, P4481, DOI 10.4049/jimmunol.169.8.4481; Ashall L, 2009, SCIENCE, V324, P242, DOI 10.1126/science.1164860; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Barkett M, 1997, J BIOL CHEM, V272, P29419, DOI 10.1074/jbc.272.47.29419; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Cadwell K, 2009, AUTOPHAGY, V5, P250, DOI 10.4161/auto.5.2.7560; Chen F, 1997, ARCH BIOCHEM BIOPHYS, V342, P383, DOI 10.1006/abbi.1997.0132; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Copetti T, 2009, AUTOPHAGY, V5, P858, DOI 10.4161/auto.8822; Criollo A, 2010, EMBO J, V29, P619, DOI 10.1038/emboj.2009.364; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Djavaheri-Mergny M, 2006, J BIOL CHEM, V281, P30373, DOI 10.1074/jbc.M602097200; Elewaut D, 1999, J IMMUNOL, V163, P1457; Erdman SE, 2001, J IMMUNOL, V166, P1443, DOI 10.4049/jimmunol.166.3.1443; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; HENKEL T, 1993, NATURE, V365, P182, DOI 10.1038/365182a0; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Howard CV, 2005, UNBIASED STEREOLOGY; Jobin C, 1997, J IMMUNOL, V158, P226; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Khalkhali-Ellis Z, 2008, J CELL BIOCHEM, V105, P208, DOI 10.1002/jcb.21814; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lin RT, 1996, MOL CELL BIOL, V16, P1401; Lind DS, 2001, SURGERY, V130, P363, DOI 10.1067/msy.2001.116672; Massey AC, 2006, P NATL ACAD SCI USA, V103, P5805, DOI 10.1073/pnas.0507436103; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Neurath MF, 1998, ANN NY ACAD SCI, V859, P149, DOI 10.1111/j.1749-6632.1998.tb11119.x; Ozes ON, 1999, NATURE, V401, P82; Qing GL, 2007, CELL RES, V17, P520, DOI 10.1038/cr.2007.47; Rogler G, 1998, GASTROENTEROLOGY, V115, P357, DOI 10.1016/S0016-5085(98)70202-1; Romieu-Mourez R, 2002, CANCER RES, V62, P6770; Rosenstiel P, 2009, ADV EXP MED BIOL, V653, P35; Schreiber S, 1998, GUT, V42, P477, DOI 10.1136/gut.42.4.477; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Tam WF, 2001, MOL CELL BIOL, V21, P4837, DOI 10.1128/MCB.21.14.4837-4846.2001; Tassa A, 2003, BIOCHEM J, V376, P577, DOI 10.1042/BJ20030826; TRAENCKNER EBM, 1994, EMBO J, V13, P5433, DOI 10.1002/j.1460-2075.1994.tb06878.x; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Yla-Anttila P, 2009, METHOD ENZYMOL, V452, P143, DOI 10.1016/S0076-6879(08)03610-0; Yuan H, 2009, AM J PHYSIOL-HEART C, V296, pH470, DOI 10.1152/ajpheart.01051.2008; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0	46	49	55	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					22886	22893		10.1074/jbc.M110.199950	http://dx.doi.org/10.1074/jbc.M110.199950			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21454695	Green Published, hybrid			2022-12-25	WOS:000292025000023
J	Muller, P; Ahmad, M				Mueller, Pavel; Ahmad, Margaret			Light-activated Cryptochrome Reacts with Molecular Oxygen to Form a Flavin-Superoxide Radical Pair Consistent with Magnetoreception	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED ELECTRON-TRANSFER; BLUE-LIGHT; CHEMICAL MAGNETORECEPTION; DNA PHOTOLYASE; PHOTORECEPTOR; MECHANISM; COFACTOR; COMPASS; BIRDS; MODEL	Cryptochromes are flavin-based photoreceptors occurring throughout the biological kingdom, which regulate growth and development in plants and are involved in the entrainment of circadian rhythms of both plants and animals. A number of recent theoretical works suggest that cryptochromes might also be the receptors responsible for the sensing of the magnetic field of the earth (e.g. in insects, migratory birds, or migratory fish). Cryptochromes undergo forward light-induced reactions involving electron transfer to excited state flavin to generate radical intermediates, which correlate with biological activity. Here, we give evidence of a mechanism for the reverse reaction, namely dark reoxidation of protein-bound flavin in Arabidopsis thaliana cryptochrome (AtCRY1) by molecular oxygen that involves formation of a spin-correlated FADH(center dot)-superoxide radical pair. Formation of analogous radical pairs in animal cryptochromes might enable them to function as magnetoreceptors.	[Mueller, Pavel; Ahmad, Margaret] Univ Paris 06, F-75005 Paris, France; [Mueller, Pavel] CEA, Inst Biol & Technol Saclay, Lab Photocatalyse & Biohydrogene, F-91191 Gif Sur Yvette, France; [Ahmad, Margaret] Penn State Univ, Media, PA 19063 USA	UDICE-French Research Universities; Sorbonne Universite; CEA; UDICE-French Research Universities; Universite Paris Saclay; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Ahmad, M (corresponding author), Univ Paris 06, Casier 156,4 Pl Jussieu, F-75005 Paris, France.	margaret.ahmad@upmc.fr	Müller, Pavel/I-8299-2012	Müller, Pavel/0000-0002-3245-0810; Ahmad, Margaret/0000-0003-4524-5813	National Science Foundation [0848311]; Human Frontiers; Agence Nationale de la Recherche	National Science Foundation(National Science Foundation (NSF)); Human Frontiers; Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by National Science Foundation Grant 0848311 (to M. A.), a grant from Human Frontiers (to M. A. and T. Ritz), and a grant from the Agence Nationale de la Recherche (to M. A., K. Brettel, and F. Rouyer).	Balland V, 2009, J AM CHEM SOC, V131, P426, DOI 10.1021/ja806540j; Banerjee R, 2007, J BIOL CHEM, V282, P14916, DOI 10.1074/jbc.M700616200; Berndt A, 2007, J BIOL CHEM, V282, P13011, DOI 10.1074/jbc.M608872200; Bouly JP, 2007, J BIOL CHEM, V282, P9383, DOI 10.1074/jbc.M609842200; Brazard J, 2010, J AM CHEM SOC, V132, P4935, DOI 10.1021/ja1002372; Brettel K, 2010, CURR OPIN STRUC BIOL, V20, P693, DOI 10.1016/j.sbi.2010.07.003; Burney S, 2009, FEBS LETT, V583, P1427, DOI 10.1016/j.febslet.2009.03.040; CHAVES I, 2011, ANN REV PLA IN PRESS; Clausen MR, 2010, J AGR FOOD CHEM, V58, P481, DOI 10.1021/jf903470p; Devlin PF, 2000, PLANT CELL, V12, P2499, DOI 10.1105/tpc.12.12.2499; Everett SA, 1996, BIOCHEM J, V317, P17, DOI 10.1042/bj3170017; Fujiwara K, 2006, INT J ENVIRON AN CH, V86, P337, DOI 10.1080/03067310500352312; GAMPP H, 1985, TALANTA, V32, P257, DOI 10.1016/0039-9140(85)80077-1; Gegear RJ, 2008, NATURE, V454, P1014, DOI 10.1038/nature07183; Gegear RJ, 2010, NATURE, V463, P804, DOI 10.1038/nature08719; Giovani B, 2003, NAT STRUCT BIOL, V10, P489, DOI 10.1038/nsb933; Hoang N, 2008, PLOS BIOL, V6, P1559, DOI 10.1371/journal.pbio.0060160; Hogben HJ, 2009, CHEM PHYS LETT, V480, P118, DOI 10.1016/j.cplett.2009.08.051; Kao YT, 2008, J AM CHEM SOC, V130, P7695, DOI 10.1021/ja801152h; Langenbacher T, 2009, J AM CHEM SOC, V131, P14274, DOI 10.1021/ja901628y; Liedvogel M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001106; Lin CT, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-220; Liu B, 2010, CURR OPIN PLANT BIOL, V13, P578, DOI 10.1016/j.pbi.2010.09.005; Maeda K, 2008, NATURE, V453, P387, DOI 10.1038/nature06834; MASSEY V, 1994, J BIOL CHEM, V269, P22459; Mouritsen H, 2005, CURR OPIN NEUROBIOL, V15, P406, DOI 10.1016/j.conb.2005.06.003; Ozturk N, 2008, J BIOL CHEM, V283, P3256, DOI 10.1074/jbc.M708612200; PRYOR WA, 1986, ANNU REV PHYSIOL, V48, P657, DOI 10.1146/annurev.ph.48.030186.003301; RAO PS, 1973, BIOCHEM BIOPH RES CO, V51, P468, DOI 10.1016/0006-291X(73)91280-1; Ritz T, 2000, BIOPHYS J, V78, P707, DOI 10.1016/S0006-3495(00)76629-X; Ritz T, 2009, BIOPHYS J, V96, P3451, DOI 10.1016/j.bpj.2008.11.072; Rodgers CT, 2009, P NATL ACAD SCI USA, V106, P353, DOI 10.1073/pnas.0711968106; Sancar A, 2003, CHEM REV, V103, P2203, DOI 10.1021/cr0204348; Song SH, 2007, J BIOL CHEM, V282, P17608, DOI 10.1074/jbc.M702874200; Stanewsky R, 2003, J NEUROBIOL, V54, P111, DOI 10.1002/neu.10164; vanVickle-Chavez SJ, 2007, J BIOL CHEM, V282, P10561, DOI 10.1074/jbc.M609314200; Yoshii T, 2009, PLOS BIOL, V7, P813, DOI 10.1371/journal.pbio.1000086; Zeugner A, 2005, J BIOL CHEM, V280, P19437, DOI 10.1074/jbc.C500077200	38	107	110	1	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21033	21040		10.1074/jbc.M111.228940	http://dx.doi.org/10.1074/jbc.M111.228940			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21467031	Green Published, hybrid			2022-12-25	WOS:000291464700002
J	Carnes, J; Soares, CZ; Wickham, C; Stuart, K				Carnes, Jason; Soares, Carmen Zelaya; Wickham, Carey; Stuart, Kenneth			Endonuclease Associations with Three Distinct Editosomes in Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-BINDING COMPLEX; MESSENGER-RNA; EDITING COMPLEX; IN-VITRO; STRUCTURAL INTEGRITY; U-INSERTION; DELETION; MITOCHONDRIA; PROTEINS; MECHANISM	Three distinct editosomes, typified by mutually exclusive KREN1, KREN2, or KREN3 endonucleases, are essential for mitochondrial RNA editing in Trypanosoma brucei. The three editosomes differ in substrate endoribonucleolytic cleavage specificity, which may reflect the vast number of editing sites that need insertion or deletion of uridine nucleotides (Us). Each editosome requires the single RNase III domain in each endonuclease for catalysis. Studies reported here show that the editing endonucleases do not form homodimeric domains, and may therefore function as intermolecular heterodimers, perhaps with KREPB4 and/or KREPB5. Editosomes isolated via TAP tag fused to KREPB6, KREPB7, or KREPB8 have a common set of 12 proteins. In addition, KREN3 is only found in KREPB6 editosomes, KREN2 is only found in KREPB7 editosomes, and KREN1 is only found in KREPB8 editosomes. These are the same associations previously found in editosomes isolated via the TAP-tagged endonucleases KREN1, KREN2, or KREN3. Furthermore, TAP-tagged KREPB6, KREPB7, and KREPB8 complexes isolated from cells in which expression of their respective endonuclease were knocked down were disrupted and lacked the heterotrimeric insertion subcomplex (KRET2, KREPA1, and KREL2). These results and published data suggest that KREPB6, KREPB7, and KREPB8 associate with the deletion subcomplex, whereas the KREN1, KREN2, and KREN3 endonucleases associate with the insertion subcomplex.	[Carnes, Jason; Soares, Carmen Zelaya; Wickham, Carey; Stuart, Kenneth] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Stuart, Kenneth] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA	Center for Infectious Disease Research; University of Washington; University of Washington Seattle	Stuart, K (corresponding author), Seattle Biomed Res Inst, 307 Westlake Ave N,Suite 500, Seattle, WA 98109 USA.	ken.stuart@seattlebiomed.org		Carnes, Jason/0000-0001-7302-1935	National Institutes of Health [AI014102]; Economic Development Administration; United States Department of Commerce; M. J. Murdock Charitable Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI014102, R01AI014102] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Economic Development Administration; United States Department of Commerce; M. J. Murdock Charitable Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI014102, the Economic Development Administration, United States Department of Commerce, and the M. J. Murdock Charitable Trust.	Acestor N, 2009, RNA, V15, P277, DOI 10.1261/rna.1353209; Ammerman ML, 2010, RNA, V16, P2239, DOI 10.1261/rna.2285510; Aphasizhev R, 2003, RNA, V9, P62, DOI 10.1261/rna.2134303; Aphasizheva I, 2010, MOL CELL BIOL, V30, P1555, DOI 10.1128/MCB.01281-09; Aphasizheva I, 2009, RNA, V15, P1322, DOI 10.1261/rna.1538809; Babbarwal VK, 2007, RNA, V13, P737, DOI 10.1261/rna.327707; BLUM B, 1990, CELL, V60, P189, DOI 10.1016/0092-8674(90)90735-W; Carnes J, 2005, P NATL ACAD SCI USA, V102, P16614, DOI 10.1073/pnas.0506133102; Carnes J, 2008, MOL CELL BIOL, V28, P122, DOI 10.1128/MCB.01374-07; Cruz-Reyes J, 1998, MOL CELL, V1, P401, DOI 10.1016/S1097-2765(00)80040-4; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Ernst NL, 2009, RNA, V15, P947, DOI 10.1261/rna.1373009; Etheridge RD, 2008, EMBO J, V27, P1596, DOI 10.1038/emboj.2008.87; Fisk JC, 2009, MOL CELL BIOL, V29, P5214, DOI 10.1128/MCB.00520-09; Flaspohler JA, 2010, EUKARYOT CELL, V9, P1702, DOI 10.1128/EC.00106-10; Hans J, 2007, RNA, V13, P881, DOI 10.1261/rna.486107; Hashimi H, 2008, RNA, V14, P970, DOI 10.1261/rna.888808; Hashimi H, 2009, RNA, V15, P588, DOI 10.1261/rna.1411809; Hayman ML, 2001, NUCLEIC ACIDS RES, V29, P5216, DOI 10.1093/nar/29.24.5216; HEINRICHS V, 1990, SCIENCE, V247, P69, DOI 10.1126/science.2136774; Hernandez A, 2008, J MOL BIOL, V381, P35, DOI 10.1016/j.jmb.2008.05.003; Hernandez A, 2010, J BIOL CHEM, V285, P1220, DOI 10.1074/jbc.M109.051862; Igo RP, 2000, MOL CELL BIOL, V20, P8447, DOI 10.1128/MCB.20.22.8447-8457.2000; Igo RP, 2002, EUKARYOT CELL, V1, P112, DOI 10.1128/EC.1.1.112-118.2002; Jensen BC, 2007, MOL BIOCHEM PARASIT, V151, P28, DOI 10.1016/j.molbiopara.2006.10.002; Kable ML, 1996, SCIENCE, V273, P1189, DOI 10.1126/science.273.5279.1189; Kang XD, 2005, P NATL ACAD SCI USA, V102, P1017, DOI 10.1073/pnas.0409275102; Kang XD, 2006, P NATL ACAD SCI USA, V103, P13944, DOI 10.1073/pnas.0604476103; KOSLOWSKY DJ, 1991, CELL, V67, P537, DOI 10.1016/0092-8674(91)90528-7; Lambert L, 1999, NUCLEIC ACIDS RES, V27, P1429, DOI 10.1093/nar/27.6.1429; Law JA, 2008, RNA, V14, P1187, DOI 10.1261/rna.899508; MacRae IJ, 2007, CURR OPIN STRUC BIOL, V17, P138, DOI 10.1016/j.sbi.2006.12.002; Miller MM, 2006, RNA, V12, P1292, DOI 10.1261/rna.2331506; NELISSEN RLH, 1994, EMBO J, V13, P4113, DOI 10.1002/j.1460-2075.1994.tb06729.x; Panigrahi AK, 2001, MOL CELL BIOL, V21, P6833, DOI 10.1128/MCB.21.20.6833-6840.2001; Panigrahi AK, 2001, MOL CELL BIOL, V21, P380, DOI 10.1128/MCB.21.2.380-389.2001; Panigrahi AK, 2008, MOL CELL PROTEOMICS, V7, P534, DOI 10.1074/mcp.M700430-MCP200; Panigrahi AK, 2006, RNA, V12, P1038, DOI 10.1261/rna.45506; Pelletier M, 2003, RNA, V9, P457, DOI 10.1261/rna.2160803; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; SABATINI R, 1995, J BIOL CHEM, V270, P7233, DOI 10.1074/jbc.270.13.7233; Schnaufer A, 2003, MOL CELL, V12, P307, DOI 10.1016/S1097-2765(03)00286-7; Schnaufer A, 2002, INT J PARASITOL, V32, P1071, DOI 10.1016/S0020-7519(02)00020-6; Schnaufer A, 2010, J BIOL CHEM, V285, P5282, DOI 10.1074/jbc.M109.059378; Schumacher MA, 2006, CELL, V126, P701, DOI 10.1016/j.cell.2006.06.047; Seiwert SD, 1996, CELL, V84, P831, DOI 10.1016/S0092-8674(00)81062-4; Stuart KD, 2005, TRENDS BIOCHEM SCI, V30, P97, DOI 10.1016/j.tibs.2004.12.006; Trotter JR, 2005, MOL CELL, V20, P403, DOI 10.1016/j.molcel.2005.09.016; Wang BB, 2003, EUKARYOT CELL, V2, P578, DOI 10.1128/EC.2.3.578-587.2003; Weng J, 2008, MOL CELL, V32, P198, DOI 10.1016/j.molcel.2008.08.023; Wu MT, 2011, J STRUCT BIOL, V174, P124, DOI 10.1016/j.jsb.2010.10.007	51	41	41	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19320	19330		10.1074/jbc.M111.228965	http://dx.doi.org/10.1074/jbc.M111.228965			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21474442	Green Published, hybrid			2022-12-25	WOS:000291027700014
J	Pareek, G; Samaddar, M; D'Silva, P				Pareek, Gautam; Samaddar, Madhuja; D'Silva, Patrick			Primary Sequence That Determines the Functional Overlap between Mitochondrial Heat Shock Protein 70 Ssc1 and Ssc3 of Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHAPERONE DNAK; PROTEIN IMPORT MOTOR; SUBSTRATE-BINDING DOMAIN; HSP70 CHAPERONES; INNER-MEMBRANE; ALLOSTERIC REGULATION; INTERDOMAIN LINKER; ATPASE DOMAIN; TRANSLOCATION; MATRIX	The evolutionary diversity of the HSP70 gene family at the genetic level has generated complex structural variations leading to altered functional specificity and mode of regulation in different cellular compartments. By utilizing Saccharomyces cerevisiae as a model system for better understanding the global functional cooperativity between Hsp70 paralogs, we have dissected the differences in functional properties at the biochemical level between mitochondrial heat shock protein 70 (mtHsp70) Ssc1 and an uncharacterized Ssc3 paralog. Based on the evolutionary origin of Ssc3 and a high degree of sequence homology with Ssc1, it has been proposed that both have a close functional overlap in the mitochondrial matrix. Surprisingly, our results demonstrate that there is no functional cross-talk between Ssc1 and Ssc3 paralogs. The lack of in vivo functional overlap is due to altered conformation and significant lower stability associated with Ssc3. The substrate-binding domain of Ssc3 showed poor affinity toward mitochondrial client proteins and Tim44 due to the open conformation in ADP-bound state. In addition to that, the nucleotide-binding domain of Ssc3 showed an altered regulation by the Mge1 co-chaperone due to a high degree of conformational plasticity, which strongly promotes aggregation. Besides, Ssc3 possesses a dysfunctional inter-domain interface thus rendering it unable to perform functions similar to generic Hsp70s. Moreover, we have identified the critical amino acid sequence of Ssc1 and Ssc3 that can "make or break" mtHsp70 chaperone function. Together, our analysis provides the first evidence to show that the nucleotide-binding domain of mtHsp70s plays a critical role in determining the functional specificity among paralogs and orthologs across kingdoms.	[Pareek, Gautam; Samaddar, Madhuja; D'Silva, Patrick] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	D'Silva, P (corresponding author), CV Raman Ave, Bangalore 560012, Karnataka, India.	patrick@biochem.iisc.ernet.in	D'Silva, Patrick/L-6653-2019; PAREEK, GAUTAM/AAN-4638-2020; Samaddar, Madhuja/AAJ-7908-2020	PAREEK, GAUTAM/0000-0001-8430-9870; Samaddar, Madhuja/0000-0001-5046-1604	Wellcome Trust [WT081643MA]; Council of Scientific and Industrial Research	Wellcome Trust(Wellcome TrustEuropean Commission); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by Wellcome Trust International Senior Research Fellowship WT081643MA in Biomedical Science (to P. D.) and Council of Scientific and Industrial Research fellowships (to G. P. and M. S.).	Baumann F, 2000, FEBS LETT, V487, P307, DOI 10.1016/S0014-5793(00)02364-4; Bertelsen EB, 2009, P NATL ACAD SCI USA, V106, P8471, DOI 10.1073/pnas.0903503106; Bettencourt BR, 2001, MOL BIOL EVOL, V18, P1272, DOI 10.1093/oxfordjournals.molbev.a003912; Blamowska M, 2010, J BIOL CHEM, V285, P4423, DOI 10.1074/jbc.M109.061697; Brocchieri L, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-19; BUCHBERGER A, 1995, J BIOL CHEM, V270, P16903, DOI 10.1074/jbc.270.28.16903; Buczynski G, 2001, J BIOL CHEM, V276, P27231, DOI 10.1074/jbc.M100237200; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; CRAIG EA, 1989, MOL CELL BIOL, V9, P3000, DOI 10.1128/MCB.9.7.3000; D'Silva P, 2004, NAT STRUCT MOL BIOL, V11, P1084, DOI 10.1038/nsmb846; D'Silva PD, 2003, P NATL ACAD SCI USA, V100, P13839, DOI 10.1073/pnas.1936150100; D'Silva PR, 2005, P NATL ACAD SCI USA, V102, P12419, DOI 10.1073/pnas.0505969102; Davis JE, 1999, P NATL ACAD SCI USA, V96, P9269, DOI 10.1073/pnas.96.16.9269; de Marcos-Lousa C, 2006, TRENDS BIOCHEM SCI, V31, P259, DOI 10.1016/j.tibs.2006.03.006; Fernandez-Saiz V, 2006, J BIOL CHEM, V281, P7479, DOI 10.1074/jbc.M512744200; Frazier AE, 2004, NAT STRUCT MOL BIOL, V11, P226, DOI 10.1038/nsmb735; Goswami AV, 2010, J BIOL CHEM, V285, P19472, DOI 10.1074/jbc.M110.105957; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Horst M, 1997, EMBO J, V16, P1842, DOI 10.1093/emboj/16.8.1842; KANG PJ, 1990, NATURE, V348, P137, DOI 10.1038/348137a0; Knieszner H, 2005, J BIOL CHEM, V280, P28966, DOI 10.1074/jbc.M503031200; Kozany C, 2004, NAT STRUCT MOL BIOL, V11, P234, DOI 10.1038/nsmb734; LALORAYA S, 1994, P NATL ACAD SCI USA, V91, P6481, DOI 10.1073/pnas.91.14.6481; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Liu QL, 2001, J BIOL CHEM, V276, P6112, DOI 10.1074/jbc.M009519200; Lussier M, 1997, GENETICS, V147, P435; Mayer MP, 2000, NAT STRUCT BIOL, V7, P586; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Miao BJ, 1997, J MOL BIOL, V265, P541, DOI 10.1006/jmbi.1996.0762; Mokranjac D, 2003, EMBO J, V22, P4945, DOI 10.1093/emboj/cdg485; Momose T, 2007, EMBO REP, V8, P664, DOI 10.1038/sj.embor.7400990; Montgomery DL, 1999, J MOL BIOL, V286, P915, DOI 10.1006/jmbi.1998.2514; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Ram AFJ, 2006, NAT PROTOC, V1, P2253, DOI 10.1038/nprot.2006.397; Rastogi S, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-28; ROWLEY N, 1994, CELL, V77, P249, DOI 10.1016/0092-8674(94)90317-4; Sakasegawa Y, 2003, BIOCHEM BIOPH RES CO, V309, P217, DOI 10.1016/S0006-291X(03)01548-1; Schilke B, 1996, J CELL BIOL, V134, P603, DOI 10.1083/jcb.134.3.603; Schilke B, 2006, CURR BIOL, V16, P1660, DOI 10.1016/j.cub.2006.06.069; Schmidt O, 2010, NAT REV MOL CELL BIO, V11, P655, DOI 10.1038/nrm2959; Sehorn MG, 2002, BIOCHEMISTRY-US, V41, P8499, DOI 10.1021/bi025810x; Sichting M, 2005, EMBO J, V24, P1046, DOI 10.1038/sj.emboj.7600580; Sinha D, 2010, HUM MOL GENET, V19, P1248, DOI 10.1093/hmg/ddq002; Slepenkov SV, 2003, BIOCHEMISTRY-US, V42, P5867, DOI 10.1021/bi034126v; Slepenkov SV, 2002, BIOCHEMISTRY-US, V41, P12224, DOI 10.1021/bi0263208; Slutsky-Leiderman O, 2007, J BIOL CHEM, V282, P33935, DOI 10.1074/jbc.M704435200; Strub A, 2002, EMBO J, V21, P2626, DOI 10.1093/emboj/21.11.2626; Swain JF, 2007, MOL CELL, V26, P27, DOI 10.1016/j.molcel.2007.02.020; Truscott KN, 2003, J CELL BIOL, V163, P707, DOI 10.1083/jcb.200308004; Vogel M, 2006, MOL CELL, V21, P359, DOI 10.1016/j.molcel.2005.12.017; Vogel M, 2006, J BIOL CHEM, V281, P38705, DOI 10.1074/jbc.M609020200; Voisine C, 1999, CELL, V97, P565, DOI 10.1016/S0092-8674(00)80768-0; Zhai P, 2008, J BIOL CHEM, V283, P26098, DOI 10.1074/jbc.M803475200	55	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					19001	19013		10.1074/jbc.M110.197434	http://dx.doi.org/10.1074/jbc.M110.197434			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21474445	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000290785700071
J	Franzmann, TM; Czekalla, A; Walter, SG				Franzmann, Titus M.; Czekalla, Anna; Walter, Stefan G.			Regulatory Circuits of the AAA plus Disaggregase Hsp104	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHAPERONE HSP104; PROTEIN DISAGGREGATION; AGGREGATED PROTEINS; SACCHAROMYCES-CEREVISIAE; CONFORMATIONAL-CHANGES; THERMUS-THERMOPHILUS; PRION PROPAGATION; ATPASE ACTIVITY; BINDING-SITES; TUMOR-ANTIGEN	Yeast Hsp104 is an AAA+ chaperone that rescues proteins from the aggregated state. Six protomers associate to form the functional hexamer. Each protomer contains two AAA+ modules, NBD1 and NBD2. Hsp104 converts energy provided by ATP into mechanical force used to thread polypeptides through its axial channel, thereby disrupting protein aggregates. But how the action of its 12 AAA+ domains is co-ordinated to catalyze disaggregation remained unexplained. Here, we identify a sophisticated allosteric network consisting of three distinct pathways that senses the nucleotide state of AAA+ modules and transmits this information across the Hsp104 hexamer. As a result of this communication, NBD1 and NBD2 each adopt two distinct conformations (relaxed and tense) that are reciprocally regulated. The key element in the network is the NBD1-ATP state that enables Hsp104 to switch from a barely active [(T)(R)] state to a highly active [(R)(T)] state. This concerted switch involves both cis and trans protomer interactions and provides Hsp104 with the mechanistic scaffold to catalyze disaggregation. It prepares the chaperone for polypeptide binding and activates NBD2 to generate the power strokes required to resolve protein aggregates. ATP hydrolysis in NBD1 resolves the high affinity [(R)(T)] state and switches the chaperone back into the low affinity [(T)(R)] state. Our model integrates previously unexplained observations and provides the first comprehensive map of nucleotide-related allosteric signals in a class-1 AAA+ protein.	[Franzmann, Titus M.; Czekalla, Anna; Walter, Stefan G.] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Walter, SG (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, 830 N Univ, Ann Arbor, MI 48109 USA.	sgwalter@umich.edu	Franzmann, Titus M/D-1962-2011	Franzmann, Titus/0000-0002-4281-7209				Augustin S, 2009, MOL CELL, V35, P574, DOI 10.1016/j.molcel.2009.07.018; Barends TRM, 2010, CURR OPIN STRUC BIOL, V20, P46, DOI 10.1016/j.sbi.2009.12.014; Beinker P, 2005, J BIOL CHEM, V280, P37965, DOI 10.1074/jbc.M506672200; Beinker P, 2002, J BIOL CHEM, V277, P47160, DOI 10.1074/jbc.M207853200; Benaroudj N, 2000, NAT CELL BIOL, V2, P833, DOI 10.1038/35041081; Bendz H, 2007, J BIOL CHEM, V282, P31688, DOI 10.1074/jbc.M704129200; Beuron F, 2006, EMBO J, V25, P1967, DOI 10.1038/sj.emboj.7601055; Bosl B, 2006, J STRUCT BIOL, V156, P139, DOI 10.1016/j.jsb.2006.02.004; Bosl B, 2005, J BIOL CHEM, V280, P38170, DOI 10.1074/jbc.M506149200; Cha SS, 2010, EMBO J, V29, P3520, DOI 10.1038/emboj.2010.226; Doyle SM, 2007, NAT STRUCT MOL BIOL, V14, P114, DOI 10.1038/nsmb1198; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Glynn SE, 2009, CELL, V139, P744, DOI 10.1016/j.cell.2009.09.034; Goloubinoff P, 1999, P NATL ACAD SCI USA, V96, P13732, DOI 10.1073/pnas.96.24.13732; Grimminger V, 2004, J BIOL CHEM, V279, P7378, DOI 10.1074/jbc.M312403200; Haslberger T, 2010, BIOCHEM CELL BIOL, V88, P63, DOI [10.1139/O09-118, 10.1139/o09-118]; Hattendorf DA, 2002, EMBO J, V21, P12, DOI 10.1093/emboj/21.1.12; Hoskins JR, 2009, P NATL ACAD SCI USA, V106, P22233, DOI 10.1073/pnas.0911937106; Kenniston JA, 2003, CELL, V114, P511, DOI 10.1016/S0092-8674(03)00612-3; Lee S, 2003, CELL, V115, P229, DOI 10.1016/S0092-8674(03)00807-9; Lee S, 2010, P NATL ACAD SCI USA, V107, P8135, DOI 10.1073/pnas.1003572107; Lum R, 2004, J BIOL CHEM, V279, P29139, DOI 10.1074/jbc.M403777200; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Motohashi K, 1999, P NATL ACAD SCI USA, V96, P7184, DOI 10.1073/pnas.96.13.7184; Navon A, 2001, MOL CELL, V8, P1339, DOI 10.1016/S1097-2765(01)00407-5; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Osorio H, 2003, EUR J BIOCHEM, V270, P1578, DOI 10.1046/j.1432-1033.2003.03529.x; PARSELL DA, 1991, NATURE, V353, P270, DOI 10.1038/353270a0; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; Rouiller I, 2002, NAT STRUCT BIOL, V9, P950, DOI 10.1038/nsb872; SANCHEZ Y, 1990, SCIENCE, V248, P1112, DOI 10.1126/science.2188365; Schaupp A, 2007, J MOL BIOL, V370, P674, DOI 10.1016/j.jmb.2007.04.070; Schirmer EC, 2001, P NATL ACAD SCI USA, V98, P914, DOI 10.1073/pnas.031568098; Schirmer EC, 1998, J BIOL CHEM, V273, P15546, DOI 10.1074/jbc.273.25.15546; Schlieker C, 2004, FEBS LETT, V578, P351, DOI 10.1016/j.febslet.2004.11.051; Sielaff B, 2010, J MOL BIOL, V402, P30, DOI 10.1016/j.jmb.2010.07.030; Tessarz P, 2008, MOL MICROBIOL, V68, P87, DOI 10.1111/j.1365-2958.2008.06135.x; Watanabe YH, 2002, J BIOL CHEM, V277, P5804, DOI 10.1074/jbc.M109349200; Weber-Ban EU, 1999, NATURE, V401, P90, DOI 10.1038/43481; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027; Wendler P, 2007, CELL, V131, P1366, DOI 10.1016/j.cell.2007.10.047; Wendler P, 2009, MOL CELL, V34, P81, DOI 10.1016/j.molcel.2009.02.026; Werbeck ND, 2008, J MOL BIOL, V378, P178, DOI 10.1016/j.jmb.2008.02.026	46	37	37	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17992	18001		10.1074/jbc.M110.216176	http://dx.doi.org/10.1074/jbc.M110.216176			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454552	hybrid, Green Published			2022-12-25	WOS:000290585200061
J	Haag, AF; Wehmeier, S; Muszynski, A; Kerscher, B; Fletcher, V; Berry, SH; Hold, GL; Carlson, RW; Ferguson, GP				Haag, Andreas F.; Wehmeier, Silvia; Muszynski, Artur; Kerscher, Bernhard; Fletcher, Vivien; Berry, Susan H.; Hold, Georgina L.; Carlson, Russell W.; Ferguson, Gail P.			Biochemical Characterization of Sinorhizobium meliloti Mutants Reveals Gene Products Involved in the Biosynthesis of the Unusual Lipid A Very Long-chain Fatty Acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHIZOBIUM-MELILOTI; LEGUME SYMBIOSIS; ACPXL MUTANT; LIPOPOLYSACCHARIDE; BACTERIA; NODULES; PROTEIN; FORM; EXOPOLYSACCHARIDE; DEFICIENT	Sinorhizobium meliloti forms a symbiosis with the legume alfalfa, whereby it differentiates into a nitrogen-fixing bacteroid. The lipid A species of S. meliloti are modified with very long-chain fatty acids (VLCFAs), which play a central role in bacteroid development. A six-gene cluster was hypothesized to be essential for the biosynthesis of VLCFA-modified lipid A. Previously, two cluster gene products, AcpXL and LpxXL, were found to be essential for S. meliloti lipid A VLCFA biosynthesis. In this paper, we show that the remaining four cluster genes are all involved in lipid A VLCFA biosynthesis. Therefore, we have identified novel gene products involved in the biosynthesis of these unusual lipid modifications. By physiological characterization of the cluster mutant strains, we demonstrate the importance of this gene cluster in the legume symbiosis and for growth in the absence of salt. Bacterial LPS species modified with VLCFAs are substantially less immunogenic than Escherichia coli LPS species, which lack VLCFAs. However, we show that the VLCFA modifications do not suppress the immunogenicity of S. meliloti LPS or affect the ability of S. meliloti to induce fluorescent plant defense molecules within the legume. Because VLCFA-modified lipids are produced by other rhizobia and mammalian pathogens, these findings will also be important in understanding the function and biosynthesis of these unusual fatty acids in diverse bacterial species.	[Haag, Andreas F.; Wehmeier, Silvia; Fletcher, Vivien; Berry, Susan H.; Hold, Georgina L.; Ferguson, Gail P.] Univ Aberdeen, Inst Med Sci, Sch Med & Dent, Aberdeen AB25 2ZD, Scotland; [Muszynski, Artur; Carlson, Russell W.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	University of Aberdeen; University System of Georgia; University of Georgia	Ferguson, GP (corresponding author), Univ Aberdeen, Inst Med Sci, Sch Med & Dent, Foresterhill, Aberdeen AB25 2ZD, Scotland.	g.ferguson@abdn.ac.uk	Kerscher, Bernhard G R/B-1907-2015; Haag, Andreas F/R-8775-2019; Hold, Georgina Louise/AAG-9923-2020; Wehmeier, Silvia/T-3815-2019	Kerscher, Bernhard G R/0000-0001-9300-7401; Haag, Andreas F/0000-0002-6783-0231; Hold, Georgina Louise/0000-0001-7573-3397; Muszynski, Artur/0000-0003-3497-9977; Wehmeier, Silvia/0000-0002-9824-0859	Biotechnology and Biological Sciences Research Council [BB/D000564/1]; Medical Research Council [G0501107]; Department of Energy [DE-FG02-09ER20097]; IMS; BBSRC [BB/D000564/1] Funding Source: UKRI; MRC [G0501107] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Energy(United States Department of Energy (DOE)); IMS; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by Biotechnology and Biological Sciences Research Council Grant BB/D000564/1 and Medical Research Council New Investigator Grant G0501107 (to G. P. F.). Structural analysis was supported in part by Department of Energy Grant DE-FG02-09ER20097 (to the Complex Carbohydrate Research Center).; Supported by an IMS Ph.D. studentship.	Ardissone S., 2011, J BACTERIOL IN PRESS; Beck S, 2008, MICROBIOL-SGM, V154, P1258, DOI 10.1099/mic.0.2007/014894-0; BHAT UR, 1994, J BIOL CHEM, V269, P14402; BHAT UR, 1991, INT J SYST BACTERIOL, V41, P213; Campbell GRO, 2002, P NATL ACAD SCI USA, V99, P3938, DOI 10.1073/pnas.062425699; Ferguson GP, 2005, MOL MICROBIOL, V56, P68, DOI 10.1111/j.1365-2958.2005.04536.x; Ferguson GP, 2004, P NATL ACAD SCI USA, V101, P5012, DOI 10.1073/pnas.0307137101; FINAN TM, 1986, J BACTERIOL, V167, P66, DOI 10.1128/jb.167.1.66-72.1986; Galibert F, 2001, SCIENCE, V293, P668, DOI 10.1126/science.1060966; Galkiewicz JP, 2008, APPL ENVIRON MICROB, V74, P7828, DOI 10.1128/AEM.01303-08; Gibson KE, 2008, ANNU REV GENET, V42, P413, DOI 10.1146/annurev.genet.42.110807.091427; Gudlavalleti SK, 2003, J BIOL CHEM, V278, P3957, DOI 10.1074/jbc.M210491200; Haag AF, 2009, J BACTERIOL, V191, P4681, DOI 10.1128/JB.00318-09; Hold GL, 2011, BACTERIAL LIPOPOLYSACCHARIDES: STRUCTURE, CHEMICAL SYNTHESIS, BIOGENESIS AND INTERACTION WITH HOST CELLS, P371, DOI 10.1007/978-3-7091-0733-1_12; Jones KM, 2007, NAT REV MICROBIOL, V5, P619, DOI 10.1038/nrmicro1705; Katzen F, 1999, APPL ENVIRON MICROB, V65, P278; LEIGH JA, 1985, P NATL ACAD SCI USA, V82, P6231, DOI 10.1073/pnas.82.18.6231; MEADE HM, 1982, J BACTERIOL, V149, P114, DOI 10.1128/JB.149.1.114-122.1982; Mergaert P, 2006, P NATL ACAD SCI USA, V103, P5230, DOI 10.1073/pnas.0600912103; MOHAN S, 1994, J BIOL CHEM, V269, P32896; Muszynski A, 2011, GLYCOBIOLOGY, V21, P55, DOI 10.1093/glycob/cwq131; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; REUHS BL, 1994, MOL PLANT MICROBE IN, V7, P240, DOI 10.1094/MPMI-7-0240; Sambrook J., 1989, MOL CLONING, pA1; Scheidle H, 2005, NEW PHYTOL, V165, P559, DOI 10.1111/j.1469-8137.2004.01214.x; Schild S, 2005, J BIOL CHEM, V280, P25936, DOI 10.1074/jbc.M501259200; Serrania J, 2008, J BIOTECHNOL, V135, P309, DOI 10.1016/j.jbiotec.2008.04.011; Sharypova LA, 2003, J BIOL CHEM, V278, P12946, DOI 10.1074/jbc.M209389200; Tsukushi Y, 2004, J ENDOTOXIN RES, V10, P25, DOI 10.1179/096805104225003799; Vandenplas ML, 2002, J BIOL CHEM, V277, P41811, DOI 10.1074/jbc.M205252200; Vanderlinde EM, 2009, MICROBIOL-SGM, V155, P3055, DOI 10.1099/mic.0.025031-0; Vedam V, 2006, J BACTERIOL, V188, P2126, DOI 10.1128/JB.188.6.2126-2133.2006; Vedam V, 2004, MOL PLANT MICROBE IN, V17, P283, DOI 10.1094/MPMI.2004.17.3.283; Wells DH, 2002, MOL MICROBIOL, V43, P1115, DOI 10.1046/j.1365-2958.2002.02826.x; YORK WS, 1986, METHOD ENZYMOL, V118, P3; Zhang YH, 2007, BIOORGAN MED CHEM, V15, P4800, DOI 10.1016/j.bmc.2007.05.012	36	17	19	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17455	17466		10.1074/jbc.M111.236356	http://dx.doi.org/10.1074/jbc.M111.236356			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454518	Green Published, hybrid			2022-12-25	WOS:000290585200007
J	Sato, M; Hiraoka, M; Suzuki, H; Bai, YZ; Kurotani, R; Yokoyama, U; Okumura, S; Cismowski, MJ; Lanier, SM; Ishikawa, Y				Sato, Motohiko; Hiraoka, Masahiro; Suzuki, Hiroko; Bai, Yunzhe; Kurotani, Reiko; Yokoyama, Utako; Okumura, Satoshi; Cismowski, Mary J.; Lanier, Stephen M.; Ishikawa, Yoshihiro			Identification of Transcription Factor E3 (TFE3) as a Receptor-independent Activator of G alpha(16) GENE REGULATION BY NUCLEAR G alpha SUBUNIT AND ITS ACTIVATOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECESSIVE DEAFNESS DFNB29; G-PROTEIN; BETA-GAMMA; CARDIAC-HYPERTROPHY; SIGNAL-TRANSDUCTION; PRESSURE-OVERLOAD; RGS PROTEINS; LOCALIZATION; GI-ALPHA-3; MODULATORS	Receptor-independent G-protein regulators provide diverse mechanisms for signal input to G-protein-based signaling systems, revealing unexpected functional roles for G-proteins. As part of a broader effort to identify disease-specific regulators for heterotrimeric G-proteins, we screened for such proteins in cardiac hypertrophy using a yeast-based functional screen of mammalian cDNAs as a discovery platform. We report the identification of three transcription factors belonging to the same family, transcription factor E3 (TFE3), microphthalmia-associated transcription factor, and transcription factor EB, as novel receptor-independent activators of G-protein signaling selective for G alpha(16). TFE3 and G alpha(16) were both up-regulated in cardiac hypertrophy initiated by transverse aortic constriction. In protein interaction studies in vitro, TFE3 formed a complex with G alpha(16) but not with G alpha(i3) or G alpha(s). Although increased expression of TFE3 in heterologous systems had no influence on receptor-mediated G alpha(16) signaling at the plasma membrane, TFE3 actually translocated G alpha(16) to the nucleus, leading to the induction of claudin 14 expression, a key component of membrane structure in cardiomyocytes. The induction of claudin 14 was dependent on both the accumulation and activation of G alpha(16) by TFE3 in the nucleus. These findings indicate that TFE3 and G alpha(16) are up-regulated under pathologic conditions and are involved in a novel mechanism of transcriptional regulation via the relocalization and activation of G alpha(16).	[Okumura, Satoshi; Ishikawa, Yoshihiro] Yokohama City Univ, Sch Med, Cardiovasc Res Inst, Yokohama, Kanagawa 2360004, Japan; [Cismowski, Mary J.] Nationwide Childrens Hosp, Res Inst, Ctr Cardiovasc & Pulm Res, Columbus, OH 43205 USA; [Lanier, Stephen M.] Med Univ S Carolina, Dept Pharmacol, Charleston, SC 29425 USA	Yokohama City University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; Medical University of South Carolina	Ishikawa, Y (corresponding author), Yokohama City Univ, Sch Med, Cardiovasc Res Inst, Yokohama, Kanagawa 2360004, Japan.	yishikaw@med.yokohama-cu.ac.jp	Yokoyama, Utako/AAD-1404-2022; Cismowski, Mary/E-2897-2011	Yokoyama, Utako/0000-0003-1803-0155; Lanier, Stephen/0000-0002-2740-7607	National Institutes of Health [NS24821, DA025896]; Yokohama Foundation for Advancement of Medical Science [18599006, 20590212]; Yokohama City University, Japan [K18017, K19021]; Ministry of Health Labor and Welfare; Ministry of Education, Culture, Sports, Science and Technology of Japan; Takeda Science Foundation; Cosmetology Research Foundation; Kitsuen Research Foundation; NOVARTIS Foundation (Japan) for the Promotion of Science; Mitsubishi Pharma Research Foundation; Ichiro Kanehara Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024821, R29NS024821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025896] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [21590936] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yokohama Foundation for Advancement of Medical Science; Yokohama City University, Japan; Ministry of Health Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Cosmetology Research Foundation; Kitsuen Research Foundation; NOVARTIS Foundation (Japan) for the Promotion of Science(Novartis); Mitsubishi Pharma Research Foundation; Ichiro Kanehara Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by National Institutes of Health Grants NS24821 and DA025896 (both to S. M. L.). This work was also supported by Grants-in-aid for Scientific Research (C) 18599006 and 20590212, the Yokohama Foundation for Advancement of Medical Science, and Strategic Research Project Grants K18017 and K19021 from Yokohama City University, Japan (all to M. S.) and by grants from the Ministry of Health Labor and Welfare; Ministry of Education, Culture, Sports, Science and Technology of Japan; Takeda Science Foundation; Cosmetology Research Foundation; and Kitsuen Research Foundation (all to Y.I.).; Supported by the Takeda Science Foundation, the NOVARTIS Foundation (Japan) for the Promotion of Science, the Mitsubishi Pharma Research Foundation, The Ichiro Kanehara Foundation, and the Mochida Memorial Foundation for Medical and Pharmaceutical Research.	Ben-Yosef T, 2003, HUM MOL GENET, V12, P2049, DOI 10.1093/hmg/ddg210; Birnbaumer L, 2007, BBA-BIOMEMBRANES, V1768, P772, DOI 10.1016/j.bbamem.2006.12.002; Blumer JB, 2008, ENDOCRINOLOGY, V149, P3842, DOI 10.1210/en.2008-0050; Blumer JB, 2007, PHARMACOL THERAPEUT, V113, P488, DOI 10.1016/j.pharmthera.2006.11.001; Blumer JB, 2006, EUR J CELL BIOL, V85, P1233, DOI 10.1016/j.ejcb.2006.08.002; Burchett SA, 2003, J NEUROCHEM, V87, P551, DOI 10.1046/j.1471-4159.2003.02047.x; Cismowski MJ, 2006, SEMIN CELL DEV BIOL, V17, P334, DOI 10.1016/j.semcdb.2006.03.003; Cismowski MJ, 2002, METHOD ENZYMOL, V344, P153; Cismowski MJ, 1999, NAT BIOTECHNOL, V17, P878, DOI 10.1038/12867; Du QS, 2001, NAT CELL BIOL, V3, P1069, DOI 10.1038/ncb1201-1069; Garcia-Marcos M, 2009, P NATL ACAD SCI USA, V106, P3178, DOI 10.1073/pnas.0900294106; Giannone F, 2010, J MOL ENDOCRINOL, V44, P259, DOI 10.1677/JME-09-0134; Gotta M, 2003, CURR BIOL, V13, P1029, DOI 10.1016/S0960-9822(03)00371-3; Heasley LE, 1996, MOL CELL BIOL, V16, P648; Hendriks-Balk MC, 2008, EUR J PHARMACOL, V585, P278, DOI 10.1016/j.ejphar.2008.02.088; HEPLER JR, 2005, SCI STKE, pPE38; Heximer SP, 1999, J BIOL CHEM, V274, P34253, DOI 10.1074/jbc.274.48.34253; Hill JA, 2000, CIRCULATION, V101, P2863, DOI 10.1161/01.CIR.101.24.2863; HODGKINSON CA, 1993, CELL, V74, P395, DOI 10.1016/0092-8674(93)90429-T; Hu YH, 2010, MOL BIOL REP, V37, P3381, DOI 10.1007/s11033-009-9926-3; Huang J., 2006, UCSD NATURE MOL PAGE, DOI [10.1038/mp.a000972.01, DOI 10.1038/MP.A000972.01]; HUGHES MJ, 1993, J BIOL CHEM, V268, P20687; IRVINE RF, 2002, SCI STKE, pRE13; Lee MJ, 2008, CURR BIOL, V18, P211, DOI 10.1016/j.cub.2008.01.007; Mays TA, 2008, J MOL CELL CARDIOL, V45, P81, DOI 10.1016/j.yjmcc.2008.04.005; Miyamori H, 2001, J BIOL CHEM, V276, P28204, DOI 10.1074/jbc.M103083200; OFFERMANNS S, 1995, J BIOL CHEM, V270, P15175, DOI 10.1074/jbc.270.25.15175; Oldham WM, 2006, Q REV BIOPHYS, V39, P117, DOI 10.1017/S0033583506004306; Riddle EL, 2005, CIRC RES, V96, P401, DOI 10.1161/01.RES.0000158287.49872.4e; Rogers JH, 1999, J CLIN INVEST, V104, P567, DOI 10.1172/JCI6713; Sanada K, 2005, CELL, V122, P119, DOI 10.1016/j.cell.2005.05.009; Sanford Jamie L, 2005, J Mol Cell Cardiol, V38, P323, DOI 10.1016/j.yjmcc.2004.11.025; Sato M, 2006, P NATL ACAD SCI USA, V103, P797, DOI 10.1073/pnas.0507467103; Sato M, 2004, J BIOL CHEM, V279, P13375, DOI 10.1074/jbc.M312660200; Sato M, 1996, J BIOL CHEM, V271, P30052, DOI 10.1074/jbc.271.47.30052; SATO M, 1995, J BIOL CHEM, V270, P15269, DOI 10.1074/jbc.270.25.15269; Sato M, 2006, ANNU REV PHARMACOL, V46, P151, DOI 10.1146/annurev.pharmtox.46.120604.141115; Sato Motohiko, 2010, Pathophysiology, V17, P89, DOI 10.1016/j.pathophys.2009.03.011; Sato M, 2009, J BIOL CHEM, V284, P31431, DOI 10.1074/jbc.M109.014068; Shu FJ, 2007, CELL SIGNAL, V19, P163, DOI 10.1016/j.cellsig.2006.06.002; Spiegelberg BD, 2007, CURR OPIN GENET DEV, V17, P40, DOI 10.1016/j.gde.2006.12.002; Steingrimsson E, 2004, ANNU REV GENET, V38, P365, DOI 10.1146/annurev.genet.38.072902.092717; Takesono A, 1999, J BIOL CHEM, V274, P33202, DOI 10.1074/jbc.274.47.33202; Tall GG, 2005, P NATL ACAD SCI USA, V102, P16584, DOI 10.1073/pnas.0508306102; Tshori S, 2006, J CLIN INVEST, V116, P2673, DOI 10.1172/JCI27643; Tsukita S, 2002, CURR OPIN CELL BIOL, V14, P531, DOI 10.1016/S0955-0674(02)00362-9; Wilcox ER, 2001, CELL, V104, P165, DOI 10.1016/S0092-8674(01)00200-8; WILKIE TM, 1991, P NATL ACAD SCI USA, V88, P10049, DOI 10.1073/pnas.88.22.10049; Willars GB, 2006, SEMIN CELL DEV BIOL, V17, P363, DOI 10.1016/j.semcdb.2006.03.005; WU DQ, 1995, J BIOL CHEM, V270, P16008, DOI 10.1074/jbc.270.27.16008; Zhou J, 1998, EUR J IMMUNOL, V28, P1645, DOI 10.1002/(SICI)1521-4141(199805)28:05<1645::AID-IMMU1645>3.0.CO;2-D	51	26	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17766	17776		10.1074/jbc.M111.219816	http://dx.doi.org/10.1074/jbc.M111.219816			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454667	hybrid, Green Published			2022-12-25	WOS:000290585200040
J	Martin-Galiano, AJ; Oliva, MA; Sanz, L; Bhattacharyya, A; Serna, M; Yebenes, H; Valpuesta, JM; Andreu, JM				Martin-Galiano, Antonio J.; Oliva, Maria A.; Sanz, Laura; Bhattacharyya, Anamitra; Serna, Marina; Yebenes, Hugo; Valpuesta, Jose M.; Andreu, Jose M.			Bacterial Tubulin Distinct Loop Sequences and Primitive Assembly Properties Support Its Origin from a Eukaryotic Tubulin Ancestor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIVISION PROTEIN FTSZ; ALPHA-BETA-TUBULIN; STRUCTURAL INSIGHTS; CRYSTAL-STRUCTURE; BINDING; RING; MICROTUBULES; HYDROLYSIS; STABILITY; PLASMID	The structure of the unique bacterial tubulin BtubA/B from Prosthecobacter is very similar to eukaryotic alpha beta-tubulin but, strikingly, BtubA/B fold without eukaryotic chaperones. Our sequence comparisons indicate that BtubA and BtubB do not really correspond to either alpha- or beta-tubulin but have mosaic sequences with intertwining features from both. Their nucleotide-binding loops are more conserved, and their more divergent sequences correspond to discrete surface zones of tubulin involved in microtubule assembly and binding to eukaryotic cytosolic chaperonin, which is absent from the Prosthecobacter dejongeii draft genome. BtubA/B cooperatively assembles over a wider range of conditions than alpha beta-tubulin, forming pairs of protofilaments that coalesce into bundles instead of microtubules, and it lacks the ability to differentially interact with divalent cations and bind typical tubulin drugs. Assembled BtubA/B contain close to one bound GTP and GDP. Both BtubA and BtubB subunits hydrolyze GTP, leading to disassembly. The mutant BtubA/B-S144G in the tubulin signature motif GGG((T/S) under bar )G(S/T)G has strongly inhibited GTPase, but BtubA-T147G/B does not, suggesting that BtubB is a more active GTPase, like beta-tubulin. BtubA/B chimera bearing the beta-tubulin loops M, H1-S2, and S9-S10 in BtubB fold, assemble, and have reduced GTPase activity. However, introduction of the alpha-tubulin loop S9-S10 with its unique eight-residue insertion impaired folding. From the sequence analyses, its primitive assembly features, and the properties of the chimeras, we propose that BtubA/B were acquired shortly after duplication of a spontaneously folding alpha- and beta-tubulin ancestor, possibly by horizontal gene transfer from a primitive eukaryotic cell, followed by divergent evolution.	[Martin-Galiano, Antonio J.; Oliva, Maria A.; Sanz, Laura; Andreu, Jose M.] CSIC, Ctr Invest Biol, Madrid 28040, Spain; [Sanz, Laura; Serna, Marina; Yebenes, Hugo; Valpuesta, Jose M.] CSIC, Ctr Nacl Biotecnol, E-28049 Madrid, Spain; [Bhattacharyya, Anamitra] Integrated Genom, Mt Prospect, IL 60056 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Andreu, JM (corresponding author), CSIC, Ctr Invest Biol, Ramiro de Maeztu 9, Madrid 28040, Spain.	j.m.andreu@cib.csic.es	Oliva, Marian/H-8867-2015; Valpuesta, Jose M/AAA-6002-2019; Valpuesta, José M/T-1977-2017	Oliva, Marian/0000-0002-2215-4639; Valpuesta, José M/0000-0001-7468-8053; Andreu, Jose M/0000-0001-8064-6933; Serna, Marina/0000-0002-6827-496X; Martin-Galiano, Antonio Javier/0000-0002-6662-329X; Yebenes, Hugo/0000-0002-0448-217X	Ministerio de Ciencia e Innovacion [BFU2008-00013, BFU2010-15703]; Juan de la Cierva; Consejo Superior de Investigaciones Cientificas Junta de Ampliacion de Estudios-Doctores; Formacion de Personal Universitario fellowship; Madrid Regional Government	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Juan de la Cierva(Instituto de Salud Carlos III); Consejo Superior de Investigaciones Cientificas Junta de Ampliacion de Estudios-Doctores; Formacion de Personal Universitario fellowship; Madrid Regional Government	This work was supported in part by Ministerio de Ciencia e Innovacion Grants BFU2008-00013 (to J. M. A.) and BFU2010-15703 (to J. M. V.) and contracts Juan de la Cierva (to A. J. M.-G. and M. A. O.), a contract from the Consejo Superior de Investigaciones Cientificas Junta de Ampliacion de Estudios-Doctores (to A. J. M.-G.), a Formacion de Personal Universitario fellowship (to L. S.), and a fellowship from the Madrid Regional Government (to M. S.).	Aldaz H, 2005, NATURE, V435, P523, DOI 10.1038/nature03586; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andreu JM, 1998, BIOCHEMISTRY-US, V37, P8356, DOI 10.1021/bi9728553; Andreu JM, 2002, J BIOL CHEM, V277, P43262, DOI 10.1074/jbc.M206723200; Andreu Jose Manuel, 2007, Methods Mol Med, V137, P17, DOI 10.1007/978-1-59745-442-1_2; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Aylett CHS, 2010, P NATL ACAD SCI USA, V107, P19766, DOI 10.1073/pnas.1010176107; Barbier P, 1998, BIOCHEMISTRY-US, V37, P758, DOI 10.1021/bi970568t; Bertrand S, 2005, J MOL BIOL, V346, P319, DOI 10.1016/j.jmb.2004.11.054; Buey RM, 2005, CHEM BIOL, V12, P1269, DOI 10.1016/j.chembiol.2005.09.010; Caplow M, 2002, MOL BIOL CELL, V13, P2120, DOI 10.1091/mbc.E01-10-0089; CASARI G, 1995, NAT STRUCT BIOL, V2, P171, DOI 10.1038/nsb0295-171; Devos DP, 2010, SCIENCE, V330, P1187, DOI 10.1126/science.1196720; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Erickson HP, 2007, BIOESSAYS, V29, P668, DOI 10.1002/bies.20601; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; GASKIN F, 1981, BIOCHEMISTRY-US, V20, P1318, DOI 10.1021/bi00508a043; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; HAMEL E, 1982, BIOCHEMISTRY-US, V21, P503, DOI 10.1021/bi00532a014; Haydon DJ, 2008, SCIENCE, V321, P1673, DOI 10.1126/science.1159961; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Huecas S, 2003, J BIOL CHEM, V278, P46146, DOI 10.1074/jbc.M307128200; Huecas S, 2008, BIOPHYS J, V94, P1796, DOI 10.1529/biophysj.107.115493; Huecas S, 2007, J BIOL CHEM, V282, P37515, DOI 10.1074/jbc.M706399200; Jenkins C, 2002, P NATL ACAD SCI USA, V99, P17049, DOI 10.1073/pnas.012516899; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; KODAMA T, 1986, J BIOCHEM-TOKYO, V99, P1465, DOI 10.1093/oxfordjournals.jbchem.a135616; Kollman JM, 2010, NATURE, V466, P879, DOI 10.1038/nature09207; Larsen RA, 2007, GENE DEV, V21, P1340, DOI 10.1101/gad.1546107; LEE JC, 1977, BIOCHEMISTRY-US, V16, P1754, DOI 10.1021/bi00627a037; Lewis SA, 2002, NAT MED, V8, P1202, DOI 10.1038/nm1102-1202; Li HL, 2002, STRUCTURE, V10, P1317, DOI 10.1016/S0969-2126(02)00827-4; Lowe J, 1998, NATURE, V391, P203, DOI 10.1038/34472; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; Lowe J, 2009, INT J BIOCHEM CELL B, V41, P323, DOI 10.1016/j.biocel.2008.08.010; Luduena RF, 1998, INT REV CYTOL, V178, P207; LUDUENA RF, 2009, ASCB 49 ANN M SAN DI, P116; McIntosh JR, 2010, J CELL SCI, V123, P3425, DOI 10.1242/jcs.067611; Menendez M, 1998, J BIOL CHEM, V273, P167, DOI 10.1074/jbc.273.1.167; Mukherjee A, 2001, J BACTERIOL, V183, P7190, DOI 10.1128/JB.183.24.7190-7197.2001; Ni LS, 2010, P NATL ACAD SCI USA, V107, P11763, DOI 10.1073/pnas.1003817107; Nogales E, 2000, ANNU REV BIOCHEM, V69, P277, DOI 10.1146/annurev.biochem.69.1.277; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Nogales E, 1998, NAT STRUCT BIOL, V5, P451, DOI 10.1038/nsb0698-451; Oliva MA, 2004, NAT STRUCT MOL BIOL, V11, P1243, DOI 10.1038/nsmb855; Oliva MA, 2003, J BIOL CHEM, V278, P33562, DOI 10.1074/jbc.M303798200; OOSAWA F, 1975, THERMODYNAMICS POLYM, P25; Panda D, 2000, BIOCHEMISTRY-US, V39, P5075, DOI 10.1021/bi992217f; Perez-Ramirez B, 1998, BIOCHEMISTRY-US, V37, P1646, DOI 10.1021/bi971344d; Petroni G, 2000, P NATL ACAD SCI USA, V97, P1813, DOI 10.1073/pnas.030438197; PEYROT V, 1989, J BIOL CHEM, V264, P21296; Pilhofer M, 2007, MOL BIOL EVOL, V24, P1439, DOI 10.1093/molbev/msm069; Pirovano W, 2006, NUCLEIC ACIDS RES, V34, P6540, DOI 10.1093/nar/gkl901; Schlieper D, 2005, P NATL ACAD SCI USA, V102, P9170, DOI 10.1073/pnas.0502859102; Sontag CA, 2005, J CELL BIOL, V169, P233, DOI 10.1083/jcb.200410027; Sontag CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007253; SPIEGELMAN BM, 1977, CELL, V12, P587, DOI 10.1016/0092-8674(77)90259-8; Staley JT, 2005, FEMS MICROBIOL LETT, V243, P9, DOI 10.1016/j.femsle.2004.11.034; STALEY JT, 1976, A VAN LEEUW J MICROB, V42, P333, DOI 10.1007/BF00394132; Stricker J, 2002, P NATL ACAD SCI USA, V99, P3171, DOI 10.1073/pnas.052595099; Takeda M, 2008, INT J SYST EVOL MICR, V58, P1561, DOI 10.1099/ijs.0.65787-0; Tinsley E, 2006, J BACTERIOL, V188, P2829, DOI 10.1128/JB.188.8.2829-2835.2006; Yee B, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-37; Zhou HX, 2008, ANNU REV BIOPHYS, V37, P375, DOI 10.1146/annurev.biophys.37.032807.125817	66	25	26	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19789	19803		10.1074/jbc.M111.230094	http://dx.doi.org/10.1074/jbc.M111.230094			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21467045	Green Published, hybrid			2022-12-25	WOS:000291027700061
J	Chen, LS; Zheng, JS; Yang, N; Li, H; Guo, S				Chen, Lishan; Zheng, Jiashun; Yang, Nan; Li, Hao; Guo, Su			Genomic Selection Identifies Vertebrate Transcription Factor Fezf2 Binding Sites and Target Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER GENE; PROTEIN-DNA INTERACTIONS; IN-VIVO; ZEBRAFISH FOREBRAIN; REGULATORY PATHWAYS; NEURONS; EXPRESSION; DIFFERENTIATION; MOTIFS; NEUROGENESIS	Identification of transcription factor targets is critical to understanding gene regulatory networks. Here, we uncover transcription factor binding sites and target genes employing systematic evolution of ligands by exponential enrichment (SELEX). Instead of selecting randomly synthesized DNA oligonucleotides as in most SELEX studies, we utilized zebrafish genomic DNA to isolate fragments bound by Fezf2, an evolutionarily conserved gene critical for vertebrate forebrain development. This is, to our knowledge, the first time that SELEX is applied to a vertebrate genome. Computational analysis of bound genomic fragments predicted a core consensus binding site, which identified response elements that mediated Fezf2-dependent transcription both in vitro and in vivo. Fezf2-bound fragments were enriched for conserved sequences. Surprisingly, similar to 20% of these fragments overlapped well annotated protein-coding exons. Through loss of function, gain of function, and chromatin immunoprecipitation, we further identified and validated eomesa/tbr2 and lhx2b as biologically relevant target genes of Fezf2. Mutations in eomesa/tbr2 cause microcephaly in humans, whereas lhx2b is a critical regulator of cell fate and axonal targeting in the developing forebrain. These results demonstrate the feasibility of employing genomic SELEX to identify vertebrate transcription factor binding sites and target genes and reveal Fezf2 as a transcription activator and a candidate for evaluation in human microcephaly.	[Chen, Lishan; Yang, Nan; Guo, Su] Univ Calif San Francisco, Program Human Genet, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA; [Chen, Lishan; Yang, Nan; Guo, Su] Univ Calif San Francisco, Program Biol Sci, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA; [Zheng, Jiashun; Li, Hao] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Zheng, Jiashun; Li, Hao] Univ Calif San Francisco, Calif Inst Quantitat Biomed Res, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Guo, S (corresponding author), Univ Calif San Francisco, Program Human Genet, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA.	su.guo@ucsf.edu	Zheng, Jiashun/A-3098-2012; Yang, Nan/H-3174-2012	Yang, Nan/0000-0003-3663-1288	National Institutes of Health [NS042626]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042626] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS042626 (to S. G.).	Anderson BJ, 2008, METHOD ENZYMOL, V450, P253, DOI 10.1016/S0076-6879(08)03412-5; Arnold SJ, 2008, GENE DEV, V22, P2479, DOI 10.1101/gad.475408; Baala L, 2007, NAT GENET, V39, P454, DOI 10.1038/ng1993; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Berberoglu MA, 2009, GENE EXPR PATTERNS, V9, P411, DOI 10.1016/j.gep.2009.06.002; BLACKWELL TK, 1990, SCIENCE, V250, P1104, DOI 10.1126/science.2174572; Chen B, 2005, P NATL ACAD SCI USA, V102, P17184, DOI 10.1073/pnas.0508732102; Chen H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006918; Chin J, 2004, METHOD ENZYMOL, V376, P3; De Val S, 2008, CELL, V135, P1053, DOI 10.1016/j.cell.2008.10.049; Djordjevic M, 2007, BIOMOL ENG, V24, P179, DOI 10.1016/j.bioeng.2007.03.001; Dong XJ, 2010, NUCLEIC ACIDS RES, V38, P1071, DOI 10.1093/nar/gkp1124; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Fordyce PM, 2010, NAT BIOTECHNOL, V28, P970, DOI 10.1038/nbt.1675; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Guo S, 1999, DEV BIOL, V208, P473, DOI 10.1006/dbio.1999.9204; Guo S, 1999, NEURON, V24, P555, DOI 10.1016/S0896-6273(00)81112-5; Hashimoto H, 2000, MECH DEVELOP, V97, P191, DOI 10.1016/S0925-4773(00)00418-4; Hirata T, 2004, DEV DYNAM, V230, P546, DOI 10.1002/dvdy.20068; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Jeong JY, 2007, DEVELOPMENT, V134, P127, DOI 10.1242/dev.02705; Jeong JY, 2006, P NATL ACAD SCI USA, V103, P5143, DOI 10.1073/pnas.0600337103; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Jolma A, 2010, GENOME RES, V20, P861, DOI 10.1101/gr.100552.109; Krishnan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003621; Lampe X, 2008, NUCLEIC ACIDS RES, V36, P3214, DOI 10.1093/nar/gkn148; Levkowitz G, 2003, NAT NEUROSCI, V6, P28, DOI 10.1038/nn979; Li Q, 2010, DEV BIOL, V337, P484, DOI 10.1016/j.ydbio.2009.10.019; Liu X, 2001, Pac Symp Biocomput, P127; Mangale VS, 2008, SCIENCE, V319, P304, DOI 10.1126/science.1151695; Matsuo-Takasaki M, 2000, MECH DEVELOP, V93, P201, DOI 10.1016/S0925-4773(00)00264-1; Molyneaux BJ, 2005, NEURON, V47, P817, DOI 10.1016/j.neuron.2005.08.030; Porter FD, 1997, DEVELOPMENT, V124, P2935; Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939; Rouaux C, 2010, NAT NEUROSCI, V13, P1345, DOI 10.1038/nn.2658; Sessa A, 2008, NEURON, V60, P56, DOI 10.1016/j.neuron.2008.09.028; Seth A, 2006, DEVELOPMENT, V133, P725, DOI 10.1242/dev.02244; Shimizu T, 2010, DEVELOPMENT, V137, P1875, DOI 10.1242/dev.047167; Shimizu T, 2009, DEV GROWTH DIFFER, V51, P221, DOI 10.1111/j.1440-169X.2009.01088.x; Shostak Y, 2004, GENE DEV, V18, P2529, DOI 10.1101/gad.1218504; Shtatland T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.21.e93; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Tumpel S, 2008, P NATL ACAD SCI USA, V105, P20077, DOI 10.1073/pnas.0806360105; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE	45	15	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18641	18649		10.1074/jbc.M111.236471	http://dx.doi.org/10.1074/jbc.M111.236471			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21471212	Green Published, hybrid			2022-12-25	WOS:000290785700036
J	Flynn, AN; Tillu, DV; Asiedu, MN; Hoffman, J; Vagner, J; Price, TJ; Boitano, S				Flynn, Andrea N.; Tillu, Dipti V.; Asiedu, Marina N.; Hoffman, Justin; Vagner, Josef; Price, Theodore J.; Boitano, Scott			The Protease-activated Receptor-2-specific Agonists 2-Aminothiazol-4-yl-LIGRL-NH2 and 6-Aminonicotinyl-LIGRL-NH2 Stimulate Multiple Signaling Pathways to Induce Physiological Responses in Vitro and in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-CELLS; RECEPTOR 2; PROTEASE-ACTIVATED-RECEPTOR-2 SENSITIZES; INFLAMMATORY PAIN; MOLECULAR-CLONING; SERINE PROTEASES; CANCER PAIN; HYPERALGESIA; MECHANISMS; LIGANDS	Protease-activated receptor-2 (PAR(2)) is one of four protease-activated G-protein-coupled receptors. PAR(2) is expressed on multiple cell types where it contributes to cellular responses to endogenous and exogenous proteases. Proteolytic cleavage of PAR(2) reveals a tethered ligand that activates PAR(2) and two major downstream signaling pathways: mitogen-activated protein kinase (MAPK) and intracellular Ca2+ signaling. Peptides or peptidomimetics can mimic binding of the tethered ligand to stimulate signaling without the nonspecific effects of proteases. The most commonly used peptide activators of PAR(2) (e.g. SLIGRL-NH2 and SLIGKV-NH2) lack potency at the receptor. However, although the potency of 2-furoyl-LIGRLO-NH2 (2-f-LIGRLO-NH2) underscores the use of peptidomimetic PAR(2) ligands as a mechanism to enhance pharmacological action at PAR(2), 2-f-LIGRLO-NH2 has not been thoroughly evaluated. We evaluated the known agonist 2-f-LIGRLO-NH2 and two recently described pentapeptidomimetic PAR(2)-specific agonists, 2-aminothiazol-4-yl-LIGRL-NH2 (2-at-LIGRL-NH2) and 6-aminonicotinyl-LIGRL-NH2 (6-an-LIGRL-NH2). All peptidomimetic agonists stimulated PAR(2)-dependent in vitro physiological responses, MAPK signaling, and Ca2+ signaling with an overall rank order of potency of 2-f-LIGRLO-NH2 approximate to 2-at-LIGRL-NH2 > 6-an-LIGRL-NH2 >> SLIGRL-NH2. Because PAR(2) plays a major role in pathological pain conditions and to test potency of the peptidomimetic agonists in vivo, we evaluated these agonists in models relevant to nociception. All three agonists activated Ca2+ signaling in nociceptors in vitro, and both 2-at-LIGRL-NH2 and 2-f-LIGRLO-NH2 stimulated PAR(2)-dependent thermal hyperalgesia in vivo. We have characterized three high potency ligands that can be used to explore the physiological role of PAR(2) in a variety of systems and pathologies.	[Flynn, Andrea N.; Hoffman, Justin; Boitano, Scott] Arizona Hlth Sci Ctr, Arizona Resp Ctr, Tucson, AZ 85724 USA; [Flynn, Andrea N.; Hoffman, Justin; Boitano, Scott] Arizona Hlth Sci Ctr, Dept Physiol, Tucson, AZ 85724 USA; [Tillu, Dipti V.; Asiedu, Marina N.; Price, Theodore J.] Arizona Hlth Sci Ctr, Dept Pharmacol, Tucson, AZ 85724 USA; [Flynn, Andrea N.; Hoffman, Justin; Vagner, Josef; Price, Theodore J.; Boitano, Scott] Arizona Hlth Sci Ctr, Collaborat Res Inst Bio5, Tucson, AZ 85724 USA	University of Arizona Health Sciences; University of Arizona Health Sciences; University of Arizona Health Sciences; University of Arizona Health Sciences	Boitano, S (corresponding author), Arizona Hlth Sci Ctr, Arizona Resp Ctr, 1501 N Campbell Ave, Tucson, AZ 85724 USA.	sboitano@email.arizona.edu	Price, Theodore/A-5094-2010; Price, Theodore/M-3810-2018	Price, Theodore/0000-0002-6971-6221	NIEHS [ES 04940]; Semiconductor Research Corp. [425.024]; State of Arizona Technology and Research Initiative;  [R01NS065926];  [T32-HL007249]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007249] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065926, R01NS073664] Funding Source: NIH RePORTER	NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Semiconductor Research Corp.; State of Arizona Technology and Research Initiative; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant ES 04940 from the NIEHS Superfund (to S. B.), Grant R01NS065926 (to T. J. P.), and Training Grant T32-HL007249 (to A. N. F.). This work was also supported by Semiconductor Research Corp. Project 425.024 (to S. B.) and by the State of Arizona Technology and Research Initiative Fund awarded through Bio5 (to J. V.). This work is part of a multi-principal investigator collaboration between J. V., T. J. P., and S. B.	Abassi YA, 2009, CHEM BIOL, V16, P712, DOI 10.1016/j.chembiol.2009.05.011; Amadesi S, 2004, J NEUROSCI, V24, P4300, DOI 10.1523/JNEUROSCI.5679-03.2004; Amadesi S, 2006, J PHYSIOL-LONDON, V575, P555, DOI 10.1113/jphysiol.2006.111534; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Boitano S, 2011, AM J PHYSIOL-LUNG C, V300, pL605, DOI 10.1152/ajplung.00359.2010; Boitano S, 2011, J MED CHEM, V54, P1308, DOI 10.1021/jm1013049; Bunnett NW, 2006, SEMIN THROMB HEMOST, V32, P39, DOI 10.1055/s-2006-939553; Burnstock G, 2007, CELL MOL LIFE SCI, V64, P1471, DOI 10.1007/s00018-007-6497-0; Chen HX, 2005, ANAL BIOCHEM, V338, P136, DOI 10.1016/j.ab.2004.11.015; Costigan M, 2009, ANNU REV NEUROSCI, V32, P1, DOI 10.1146/annurev.neuro.051508.135531; Dai Y, 2004, J NEUROSCI, V24, P4293, DOI 10.1523/JNEUROSCI.0454-04.2004; Dai Y, 2007, J CLIN INVEST, V117, P1979, DOI 10.1172/JCI30951; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; Dulon S, 2003, AM J RESP CELL MOL, V28, P339, DOI 10.1165/rcmb.4908; Ewen D, 2010, CLIN EXP ALLERGY, V40, P435, DOI 10.1111/j.1365-2222.2010.03453.x; Gardell LR, 2008, J PHARMACOL EXP THER, V327, P799, DOI 10.1124/jpet.108.142570; Grant AD, 2007, J PHYSIOL-LONDON, V578, P715, DOI 10.1113/jphysiol.2006.121111; GRUENERT DC, 1995, AM J PHYSIOL-LUNG C, V268, pL347, DOI 10.1152/ajplung.1995.268.3.L347; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hollenberg MD, 2008, J PHARMACOL EXP THER, V326, P453, DOI 10.1124/jpet.108.136432; Josan JS, 2008, INT J PEPT RES THER, V14, P293, DOI 10.1007/s10989-008-9150-3; Kanke T, 2005, J PHARMACOL SCI, V97, P38, DOI 10.1254/jphs.FMJ04005X7; Kawabata A, 1999, J PHARMACOL EXP THER, V288, P358; Lam DK, 2010, PAIN, V149, P263, DOI 10.1016/j.pain.2010.02.010; Mantyh PW, 2006, NAT REV NEUROSCI, V7, P797, DOI 10.1038/nrn1914; McGuire JJ, 2004, J PHARMACOL EXP THER, V309, P1124, DOI 10.1124/jpet.103.064584; McGuire JJ, 2002, J PHARMACOL EXP THER, V303, P985, DOI 10.1124/jpet.102.040352; NYSTEDT S, 1995, EUR J BIOCHEM, V232, P84, DOI 10.1111/j.1432-1033.1995.tb20784.x; NYSTEDT S, 1994, P NATL ACAD SCI USA, V91, P9208, DOI 10.1073/pnas.91.20.9208; Page K, 2003, J ALLERGY CLIN IMMUN, V112, P1112, DOI 10.1016/j.jaci.2003.08.050; Ramachandran R, 2008, BRIT J PHARMACOL, V153, pS263, DOI 10.1038/sj.bjp.0707507; Ramachandran R, 2009, MOL PHARMACOL, V76, P791, DOI 10.1124/mol.109.055509; Russo A, 2009, MOL INTERV, V9, P87, DOI 10.1124/mi.9.2.8; Soh UJK, 2010, BRIT J PHARMACOL, V160, P191, DOI 10.1111/j.1476-5381.2010.00705.x; Stalheim L, 2005, MOL PHARMACOL, V67, P78, DOI 10.1124/mol.104.006072; Vagner J, 2008, ANGEW CHEM INT EDIT, V47, P1685, DOI 10.1002/anie.200702770; Vergnolle N, 1998, P NATL ACAD SCI USA, V95, P7766, DOI 10.1073/pnas.95.13.7766; Vergnolle N, 2001, NAT MED, V7, P821, DOI 10.1038/89945; Woolf CJ, 2007, NEURON, V55, P353, DOI 10.1016/j.neuron.2007.07.016; Xi Biao, 2008, Biotechnology Journal, V3, P484, DOI 10.1002/biot.200800020; Zheng H, 2010, IUBMB LIFE, V62, P112, DOI 10.1002/iub.293; Zoudilova M, 2007, J BIOL CHEM, V282, P20634, DOI 10.1074/jbc.M701391200; Zoudilova M, 2010, J BIOL CHEM, V285, P14318, DOI 10.1074/jbc.M109.055806	44	20	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					19076	19088		10.1074/jbc.M110.185264	http://dx.doi.org/10.1074/jbc.M110.185264			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21467041	hybrid, Green Published			2022-12-25	WOS:000290785700077
J	Horowitz, S; Yesselman, JD; Al-Hashimi, HM; Trievel, RC				Horowitz, Scott; Yesselman, Joseph D.; Al-Hashimi, Hashim M.; Trievel, Raymond C.			Direct Evidence for Methyl Group Coordination by Carbon-Oxygen Hydrogen Bonds in the Lysine Methyltransferase SET7/9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTER-DOT-O; ADENOSYL-L-METHIONINE; S-ADENOSYLMETHIONINE SYNTHETASE; MOLECULAR-ORBITAL METHODS; PRODUCT SPECIFICITY; CATALYTIC MECHANISM; ACTIVE-SITE; NMR-SPECTROSCOPY; 1ST-ROW ELEMENTS; STRUCTURAL BASIS	SET domain lysine methyltransferases (KMTs) are S-adenosylmethionine (AdoMet)-dependent enzymes that catalyze the site-specific methylation of lysyl residues in histone and nonhistone proteins. Based on crystallographic and cofactor binding studies, carbon-oxygen (CH center dot center dot center dot O) hydrogen bonds have been proposed to coordinate the methyl groups of AdoMet and methyllysine within the SET domain active site. However, the presence of these hydrogen bonds has only been inferred due to the uncertainty of hydrogen atom positions in x-ray crystal structures. To experimentally resolve the positions of the methyl hydrogen atoms, we used NMR H-1 chemical shift coupled with quantum mechanics calculations to examine the interactions of the AdoMet methyl group in the active site of the human KMT SET7/9. Our results indicated that at least two of the three hydrogens in the AdoMet methyl group engage in CH center dot center dot center dot O hydrogen bonding. These findings represent direct, quantitative evidence of CH center dot center dot center dot O hydrogen bond formation in the SET domain active site and suggest a role for these interactions in catalysis. Furthermore, thermodynamic analysis of AdoMet binding indicated that these interactions are important for cofactor binding across SET domain enzymes.	[Trievel, Raymond C.] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Al-Hashimi, Hashim M.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Horowitz, Scott; Yesselman, Joseph D.; Al-Hashimi, Hashim M.] Univ Michigan, Dept Biophys, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Trievel, RC (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, 1150 W Med Ctr Dr,5301 MSRB 3, Ann Arbor, MI 48109 USA.	rtrievel@umich.edu	Yesselman, Joseph/AAH-9031-2020	Horowitz, Scott/0000-0002-1148-0105	National Institutes of Health [R01-GM073839, P41 RR001081, T32-GM008270]; National Science Foundation [MCB 0644278]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008270, R01GM073839] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01-GM073839 (to R. C. T.) and a National Science Foundation CAREER award (MCB 0644278) (to H. M. A.). The UCSF Chimera package is developed and distributed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by National Institutes of Health Grant P41 RR001081).; Supported by National Institutes of Health Training Grant T32-GM008270 in Molecular Biophysics.	Afonin AV, 2009, MAGN RESON CHEM, V47, P105, DOI 10.1002/mrc.2358; Afonin AV, 2002, MAGN RESON CHEM, V40, P114, DOI 10.1002/mrc.969; Albert M, 2010, SEMIN CELL DEV BIOL, V21, P209, DOI 10.1016/j.semcdb.2009.10.007; Ash EL, 2000, P NATL ACAD SCI USA, V97, P10371, DOI 10.1073/pnas.97.19.10371; Bach RD, 2002, J PHYS CHEM B, V106, P4325, DOI 10.1021/jp020029k; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; BENEVIDES JM, 1988, BIOCHEMISTRY-US, V27, P3868, DOI 10.1021/bi00410a051; BINKLEY JS, 1980, J AM CHEM SOC, V102, P939, DOI 10.1021/ja00523a008; Bond CS, 1999, STRUCTURE, V7, P81, DOI 10.1016/S0969-2126(99)80011-2; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; CHIRLIAN LE, 1987, J COMPUT CHEM, V8, P894, DOI 10.1002/jcc.540080616; CLARK T, 1983, J COMPUT CHEM, V4, P294, DOI 10.1002/jcc.540040303; Cordier F, 2003, J AM CHEM SOC, V125, P15750, DOI 10.1021/ja038616m; Couture JF, 2006, J BIOL CHEM, V281, P19280, DOI 10.1074/jbc.M602257200; Couture JF, 2008, P NATL ACAD SCI USA, V105, P20659, DOI 10.1073/pnas.0806712105; Del Rizzo PA, 2010, J BIOL CHEM, V285, P31849, DOI 10.1074/jbc.M110.114587; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DEREWENDA Z, 1995, FASEB J, V9, pA1246; DEREWENDA ZS, 1994, J MOL BIOL, V241, P83, DOI 10.1006/jmbi.1994.1475; DESIRAJU GR, 1991, ACCOUNTS CHEM RES, V24, P290, DOI 10.1021/ar00010a002; Desiraju GR, 1996, ACCOUNTS CHEM RES, V29, P441, DOI 10.1021/ar950135n; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; DITCHFIELD R, 1971, J CHEM PHYS, V54, P724, DOI 10.1063/1.1674902; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Frisch M., 2016, GAUSSIAN 16 REVISION; Ghosh A, 1999, J MOL BIOL, V294, P1149, DOI 10.1006/jmbi.1999.3323; Goddard T. D., 2006, SPARKY 3; Guo HB, 2007, P NATL ACAD SCI USA, V104, P8797, DOI 10.1073/pnas.0702981104; Harris R. K., 1983, NUCL MAGNETIC RESONA; Hu P, 2006, J AM CHEM SOC, V128, P1272, DOI 10.1021/ja056153+; Hu P, 2008, J AM CHEM SOC, V130, P3806, DOI 10.1021/ja075896n; Iwig DF, 2004, BIOCHEMISTRY-US, V43, P13496, DOI 10.1021/bi048693+; Jacobs SA, 2002, NAT STRUCT BIOL, V9, P833, DOI 10.1038/nsb861; Jiang L, 2002, J BIOL CHEM, V277, P37732, DOI 10.1074/jbc.M204514200; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KRIMM S, 1967, SCIENCE, V158, P530, DOI 10.1126/science.158.3800.530-c; Kwon T, 2003, EMBO J, V22, P292, DOI 10.1093/emboj/cdg025; Liu H, 2002, J MOL BIOL, V322, P955, DOI 10.1016/S0022-2836(02)00876-8; MARKHAM GD, 1980, J BIOL CHEM, V255, P9082; Markham GD, 2002, BIOCHEMISTRY-US, V41, P7636, DOI 10.1021/bi025682c; Meyer P, 2000, EMBO J, V19, P3520, DOI 10.1093/emboj/19.14.3520; MIERTUS S, 1981, CHEM PHYS, V55, P117, DOI 10.1016/0301-0104(81)85090-2; Mizuno K, 1998, J CHEM PHYS, V109, P9502, DOI 10.1063/1.477612; NOSE S, 1986, PHYS REV B, V33, P339, DOI 10.1103/PhysRevB.33.339; PARK J, 1995, BIOORG MED CHEM LETT, V5, P2203, DOI 10.1016/0960-894X(95)00384-6; Peralta JE, 1999, J MOL STRUC-THEOCHEM, V491, P23, DOI 10.1016/S0166-1280(99)00027-5; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pradhan S, 2009, EPIGENETICS, V4, P282; Qingzhong L., 2007, J MOL STRUC-THEOCHEM, V847, P68; Quinn JR, 2007, J AM CHEM SOC, V129, P934, DOI 10.1021/ja066341f; RAMACHANDRAN GN, 1965, BIOCHIM BIOPHYS ACTA, V109, P314, DOI 10.1016/0926-6585(65)90119-6; Ratajczyk T, 2005, ANGEW CHEM INT EDIT, V44, P1230, DOI 10.1002/anie.200461383; Sarkhel S, 2004, PROTEINS, V54, P247, DOI 10.1002/prot.10567; Schalk-Hihi C, 1999, BIOCHEMISTRY-US, V38, P2542, DOI 10.1021/bi9822933; Scheiner S, 2005, J PHYS CHEM B, V109, P16132, DOI 10.1021/jp053416d; Scheiner S, 2000, J MOL STRUC-THEOCHEM, V500, P441, DOI 10.1016/S0166-1280(00)00375-4; Scheiner S, 2010, INT J QUANTUM CHEM, V110, P2775, DOI 10.1002/qua.22756; Scheiner S, 2009, J PHYS CHEM B, V113, P10421, DOI 10.1021/jp9035138; Seeger K, 2005, BIOCHEMISTRY-US, V44, P6208, DOI 10.1021/bi047749x; Sheppard D, 2010, J AM CHEM SOC, V132, P7709, DOI 10.1021/ja101691s; Sigalov M, 2005, J ORG CHEM, V70, P92, DOI 10.1021/jo048592h; Subramanian K, 2008, MOL CELL, V30, P336, DOI 10.1016/j.molcel.2008.03.022; Sukumar N, 2010, P NATL ACAD SCI USA, V107, P6817, DOI 10.1073/pnas.0912672107; Trievel RC, 2003, NAT STRUCT BIOL, V10, P545, DOI 10.1038/nsb946; Trievel RC, 2002, CELL, V111, P91, DOI 10.1016/S0092-8674(02)01000-0; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; WOLINSKI K, 1990, J AM CHEM SOC, V112, P8251, DOI 10.1021/ja00179a005; Xiao B, 2003, NATURE, V421, P652, DOI 10.1038/nature01378; Xiao B, 2005, GENE DEV, V19, P1444, DOI 10.1101/gad.1315905; Yates JR, 2005, J AM CHEM SOC, V127, P10216, DOI 10.1021/ja051019a; Zhang X, 2003, MOL CELL, V12, P177, DOI 10.1016/S1097-2765(03)00224-7; Zhang X, 2007, BIOCHEMISTRY-US, V46, P14838, DOI 10.1021/bi7014579	72	49	50	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18658	18663		10.1074/jbc.M111.232876	http://dx.doi.org/10.1074/jbc.M111.232876			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21454678	Green Published, hybrid			2022-12-25	WOS:000290785700038
J	MacDonald, MJ; Longacre, MJ; Stoker, SW; Kendrick, M; Thonpho, A; Brown, LJ; Hasan, NM; Jitrapakdee, S; Fukao, T; Hanson, MS; Fernandez, LA; Odorico, J				MacDonald, Michael J.; Longacre, Melissa J.; Stoker, Scott W.; Kendrick, Mindy; Thonpho, Ansaya; Brown, Laura J.; Hasan, Noaman M.; Jitrapakdee, Sarawut; Fukao, Toshiyuki; Hanson, Matthew S.; Fernandez, Luis A.; Odorico, Jon			Differences between Human and Rodent Pancreatic Islets LOW PYRUVATE CARBOXYLASE, ATP CITRATE LYASE, AND PYRUVATE CARBOXYLATION AND HIGH GLUCOSE-STIMULATED ACETOACETATE IN HUMAN PANCREATIC ISLETS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCEROL PHOSPHATE DEHYDROGENASE; ACETYL-COA CARBOXYLASE; INSULIN-SECRETION; MALIC ENZYME; BETA-CELLS; REGULATED ANAPLEROSIS; METHYL SUCCINATE; GENE-EXPRESSION; RAT; MOUSE	Anaplerosis, the net synthesis in mitochondria of citric acid cycle intermediates, and cataplerosis, their export to the cytosol, have been shown to be important for insulin secretion in rodent beta cells. However, human islets may be different. We observed that the enzyme activity, protein level, and relative mRNA level of the key anaplerotic enzyme pyruvate carboxylase (PC) were 80-90% lower in human pancreatic islets compared with islets of rats and mice and the rat insulinoma cell line INS-1 832/13. Activity and protein of ATP citrate lyase, which uses anaplerotic products in the cytosol, were 60-75% lower in human islets than in rodent islets or the cell line. In line with the lower PC, the percentage of glucose-derived pyruvate that entered mitochondrial metabolism via carboxylation in human islets was only 20-30% that in rat islets. This suggests human islets depend less on pyruvate carboxylation than rodent models that were used to establish the role of PC in insulin secretion. Human islets possessed high levels of succinyl-CoA:3-ketoacid-CoA transferase, an enzyme that forms acetoacetate in the mitochondria, and acetoacetyl-CoA synthetase, which uses acetoacetate to form acyl-CoAs in the cytosol. Glucose-stimulated human islets released insulin similarly to rat islets but formed much more acetoacetate. beta-Hydroxybutyrate augmented insulin secretion in human islets. This information supports previous data that indicate beta cells can use a pathway involving succinyl-CoA: 3-ketoacid-CoA transferase and acetoacetyl-CoA synthetase to synthesize and use acetoacetate and suggests human islets may use this pathway more than PC and citrate to form cytosolic acyl-CoAs.	[MacDonald, Michael J.; Longacre, Melissa J.; Stoker, Scott W.; Kendrick, Mindy; Thonpho, Ansaya; Brown, Laura J.; Hasan, Noaman M.] Univ Wisconsin, Dept Pediat, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Thonpho, Ansaya; Jitrapakdee, Sarawut] Mahidol Univ, Fac Sci, Dept Biochem, Bangkok 10400, Thailand; [Fukao, Toshiyuki] Gifu Univ, Dept Pediat, Gifu 5011194, Japan; [Fukao, Toshiyuki] Gifu Univ, Med Informat Sci Div, Univ Grad Sch, Gifu 5011194, Japan; [Hanson, Matthew S.; Fernandez, Luis A.; Odorico, Jon] Univ Wisconsin, Dept Surg, Sch Med & Publ Hlth, Madison, WI 53792 USA	University of Wisconsin System; University of Wisconsin Madison; Mahidol University; Gifu University; Gifu University; University of Wisconsin System; University of Wisconsin Madison	MacDonald, MJ (corresponding author), Univ Wisconsin, Dept Pediat, Sch Med & Publ Hlth, Madison, WI 53706 USA.	mjmacdon@wisc.edu		MacDonald, Michael/0000-0002-0201-9245	National Institutes of Health [DK28348]; Nowlin Family Trust of the Lutheran Community Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK028348, R55DK028348] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nowlin Family Trust of the Lutheran Community Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK28348. This work was also supported by the Nowlin Family Trust of the Lutheran Community Foundation.	BERNE C, 1975, J HISTOCHEM CYTOCHEM, V23, P660, DOI 10.1177/23.9.240882; Brown LJ, 2009, J BIOL CHEM, V284, P35359, DOI 10.1074/jbc.M109.040394; BRUN T, 1993, J BIOL CHEM, V268, P18905; Brunengraber H, 2006, J INHERIT METAB DIS, V29, P327, DOI 10.1007/s10545-006-0320-1; Corkey BE, 2000, J NUTR, V130, p299S, DOI 10.1093/jn/130.2.299S; DEVOS A, 1995, J CLIN INVEST, V96, P2489, DOI 10.1172/JCI118308; Farfari S, 2000, DIABETES, V49, P718, DOI 10.2337/diabetes.49.5.718; FERNANDEZALVAREZ J, 1994, DIABETOLOGIA, V37, P177, DOI 10.1007/s001250050090; Flamez D, 2002, DIABETES, V51, P2018, DOI 10.2337/diabetes.51.7.2018; GIROIX MH, 1991, DIABETES, V40, P227, DOI 10.2337/diabetes.40.2.227; Gong QM, 2000, J BIOL CHEM, V275, P38012, DOI 10.1074/jbc.M004078200; Guay C, 2007, J BIOL CHEM, V282, P35657, DOI 10.1074/jbc.M707294200; Hasan NM, 2002, GENE, V296, P221, DOI 10.1016/S0378-1119(02)00865-X; Hasan NM, 2008, J BIOL CHEM, V283, P28048, DOI 10.1074/jbc.M804170200; Hasan NM, 2010, ARCH BIOCHEM BIOPHYS, V499, P62, DOI 10.1016/j.abb.2010.05.007; Henquin JC, 2006, DIABETES, V55, P3470, DOI 10.2337/db06-0868; IKEDA T, 1987, ARCH BIOCHEM BIOPHYS, V257, P140, DOI 10.1016/0003-9861(87)90552-2; Jensen MV, 2006, J BIOL CHEM, V281, P22342, DOI 10.1074/jbc.M604350200; Jitrapakdee S, 2010, DIABETOLOGIA, V53, P1019, DOI 10.1007/s00125-010-1685-0; Joseph JW, 2007, J BIOL CHEM, V282, P31592, DOI 10.1074/jbc.M706080200; KELLEHER JK, 1985, ANAL BIOCHEM, V151, P55, DOI 10.1016/0003-2697(85)90052-1; Khan A, 1996, J BIOL CHEM, V271, P2539, DOI 10.1074/jbc.271.5.2539; Kim A, 2009, ISLETS, V1, P129, DOI 10.4161/isl.1.2.9480; Koza RA, 1996, ARCH BIOCHEM BIOPHYS, V336, P97, DOI 10.1006/abbi.1996.0536; Kutlu B, 2009, PHYSIOL GENOMICS, V39, P72, DOI 10.1152/physiolgenomics.00063.2009; LANOUE K, 1970, J BIOL CHEM, V245, P102; Laybutt DR, 2003, J BIOL CHEM, V278, P2997, DOI 10.1074/jbc.M210581200; Lehmann R, 2007, DIABETES, V56, P594, DOI 10.2337/db06-0779; Li CH, 2008, J BIOL CHEM, V283, P17238, DOI 10.1074/jbc.M709235200; LOUIS NA, 1992, J BIOL CHEM, V267, P2287; Lu DH, 2002, P NATL ACAD SCI USA, V99, P2708, DOI 10.1073/pnas.052005699; MacDonald MJ, 2009, DIABETOLOGIA, V52, P1087, DOI 10.1007/s00125-009-1319-6; MacDonald MJ, 2008, BBA-GEN SUBJECTS, V1780, P966, DOI 10.1016/j.bbagen.2008.03.017; MacDonald MJ, 2008, ARCH BIOCHEM BIOPHYS, V470, P153, DOI 10.1016/j.abb.2007.11.017; MacDonald MJ, 2008, AM J PHYSIOL-CELL PH, V294, pC442, DOI 10.1152/ajpcell.00368.2007; MacDonald MJ, 2007, J BIOL CHEM, V282, P30596, DOI 10.1074/jbc.M702732200; MacDonald MJ, 2007, J BIOL CHEM, V282, P6043, DOI 10.1074/jbc.M606652200; MacDonald MJ, 2009, ARCH BIOCHEM BIOPHYS, V488, P100, DOI 10.1016/j.abb.2009.07.004; MACDONALD MJ, 1993, ARCH BIOCHEM BIOPHYS, V300, P201, DOI 10.1006/abbi.1993.1028; MacDonald MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1, DOI 10.1152/ajpendo.00218.2004; MACDONALD MJ, 1993, METABOLISM, V42, P1229, DOI 10.1016/0026-0495(93)90118-8; MACDONALD MJ, 1992, HORM METAB RES, V24, P158, DOI 10.1055/s-2007-1003284; MACDONALD MJ, 1993, ARCH BIOCHEM BIOPHYS, V305, P205, DOI 10.1006/abbi.1993.1413; MacDonald MJ, 2003, METABOLISM, V52, P993, DOI 10.1016/S0026-0495(03)00149-5; MacDonald MJ, 2003, BBA-GEN SUBJECTS, V1619, P77, DOI 10.1016/S0304-4165(02)00443-9; MacDonald MJ, 1996, DIABETES, V45, P1626, DOI 10.2337/diabetes.45.11.1626; MACDONALD MJ, 1981, ENDOCRINOLOGY, V108, P1899, DOI 10.1210/endo-108-5-1899; MacDonald MJ, 2002, AM J PHYSIOL-ENDOC M, V283, pE302, DOI 10.1152/ajpendo.00041.2002; MACDONALD MJ, 1981, J BIOL CHEM, V256, P8287; MACDONALD MJ, 1982, ARCH BIOCHEM BIOPHYS, V213, P643, DOI 10.1016/0003-9861(82)90594-X; MacDonald MJ, 2001, MOL CELL BIOCHEM, V220, P117, DOI 10.1023/A:1010821821921; MACDONALD MJ, 1995, J BIOL CHEM, V270, P20051; MacDonald MJ, 1996, DIABETES, V45, P886, DOI 10.2337/diabetes.45.7.886; MACDONALD MJ, 1991, J BIOL CHEM, V266, P22392; MACDONALD MJ, 1990, CANCER RES, V50, P7203; MACDONALD MJ, 1983, J CLIN ENDOCR METAB, V57, P662, DOI 10.1210/jcem-57-3-662; MALAISSE WJ, 1990, AM J PHYSIOL, V259, pE117, DOI 10.1152/ajpendo.1990.259.1.E117; Newgard CB, 2002, DIABETES, V51, pS389, DOI 10.2337/diabetes.51.2007.S389; Ni QH, 2008, ANAL CHEM, V80, P3539, DOI 10.1021/ac800406f; OSTENSON CG, 1993, DIABETOLOGIA, V36, P722, DOI 10.1007/BF00401142; Owen OE, 2002, J BIOL CHEM, V277, P30409, DOI 10.1074/jbc.R200006200; Pietilainen KH, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050051; Pisania A, 2010, LAB INVEST, V90, P1661, DOI 10.1038/labinvest.2010.124; Pongratz RL, 2007, J BIOL CHEM, V282, P200, DOI 10.1074/jbc.M602954200; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Schuit F, 1997, J BIOL CHEM, V272, P18572, DOI 10.1074/jbc.272.30.18572; Simpson NE, 2006, DIABETOLOGIA, V49, P1338, DOI 10.1007/s00125-006-0216-5; SRERE PA, 1974, LIFE SCI, V15, P1695, DOI 10.1016/0024-3205(74)90172-6; Sunyakumthorn P, 2005, BIOCHEM BIOPH RES CO, V329, P188, DOI 10.1016/j.bbrc.2005.01.108; WALTER P, 1966, J BIOL CHEM, V241, P2523; WHITEHOUSE S, 1974, BIOCHEM J, V141, P761, DOI 10.1042/bj1410761; Xu J, 2008, DIABETOLOGIA, V51, P2022, DOI 10.1007/s00125-008-1130-9; Zhang XQ, 2005, P NATL ACAD SCI USA, V102, P892, DOI 10.1073/pnas.0408936102	73	68	68	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18383	18396		10.1074/jbc.M111.241182	http://dx.doi.org/10.1074/jbc.M111.241182			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21454710	hybrid, Green Published			2022-12-25	WOS:000290785700011
J	Mangialavori, I; Villamil-Giraldo, AM; Pignataro, MF; Ferreira-Gomes, M; Caride, AJ; Rossi, JPFC				Mangialavori, Irene; Maria Villamil-Giraldo, Ana; Pignataro, Maria F.; Ferreira-Gomes, Mariela; Caride, Ariel J.; Rossi, Juan Pablo F. C.			Plasma Membrane Calcium Pump (PMCA) Differential Exposure of Hydrophobic Domains after Calmodulin and Phosphatidic Acid Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOACTIVATABLE PHOSPHOLIPIDIC PROBE; POLYACRYLAMIDE-GEL-ELECTROPHORESIS; FLUORESCENCE ENERGY-TRANSFER; HUMAN-ERYTHROCYTE MEMBRANES; LIPID-BINDING REGION; CA2+ PUMP; CA-2+ PUMP; SARCOPLASMIC-RETICULUM; MONOCLONAL-ANTIBODIES; CRYSTAL-STRUCTURE	The exposure of the plasma membrane calcium pump (PMCA) to the surrounding phospholipids was assessed by measuring the incorporation of the photoactivatable phosphatidylcholine analog [I-125]TID-PC/16 to the protein. In the presence of Ca2+ both calmodulin (CaM) and phosphatidic acid (PA) greatly decreased the incorporation of [I-125] TID-PC/16 to PMCA. Proteolysis of PMCA with V8 protease results in three main fragments: N, which includes transmembrane segments M1 and M2; M, which includes M3 and M4; and C, which includes M5 to M10. CaM decreased the level of incorporation of [I-125] TID-PC/16 to fragments M and C, whereas phosphatidic acid decreased the incorporation of [I-125] TID-PC/16 to fragments N and M. This suggests that the conformational changes induced by binding of CaM or PA extend to the adjacent transmembrane domains. Interestingly, this result also denotes differences between the active conformations produced by CaM and PA. To verify this point, we measured resonance energy transfer between PMCA labeled with eosin isothiocyanate at the ATP-binding site and the phospholipid RhoPE included in PMCA micelles. CaM decreased the efficiency of the energy transfer between these two probes, whereas PA did not. This result indicates that activation by CaM increases the distance between the ATP-binding site and the membrane, but PA does not affect this distance. Our results disclose main differences between PMCA conformations induced by CaM or PA and show that those differences involve transmembrane regions.	[Mangialavori, Irene; Maria Villamil-Giraldo, Ana; Pignataro, Maria F.; Ferreira-Gomes, Mariela; Rossi, Juan Pablo F. C.] Univ Buenos Aires, Consejo Nacl Invest Cient & Tecn, Fac Farm & Bioquim, Inst Quim & Fis Quim Biol, RA-1113 Buenos Aires, DF, Argentina; [Caride, Ariel J.] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Mayo Clinic	Villamil-Giraldo, AM (corresponding author), Univ Buenos Aires, Consejo Nacl Invest Cient & Tecn, Fac Farm & Bioquim, Inst Quim & Fis Quim Biol, Junin 956, RA-1113 Buenos Aires, DF, Argentina.	am.villamil.giraldo@umontreal.ca; jprossi@qb.ffyb.uba.ar	Mangialavori, Irene/GLU-8182-2022	Mangialavori, Irene/0000-0003-3187-3130; Rossi, Juan Pablo/0000-0001-7087-844X	National Institutes of Health, Fogarty International Center [R03TW006837]; Agencia Nacional de Promocion Cientifica y Tecnologica; Consejo Nacional de Investigaciones Cientificas y Tecnicas; Universidad de Buenos Aires Ciencia y Tecnica (Argentina); FOGARTY INTERNATIONAL CENTER [R03TW006837] Funding Source: NIH RePORTER	National Institutes of Health, Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires Ciencia y Tecnica (Argentina); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by, in whole or in part, by National Institutes of Health, Fogarty International Center Grant R03TW006837. This work was also supported by Agencia Nacional de Promocion Cientifica y Tecnologica, Consejo Nacional de Investigaciones Cientificas y Tecnicas, and Universidad de Buenos Aires Ciencia y Tecnica (Argentina).	ADAMO HP, 1992, J BIOL CHEM, V267, P14244; BALL EH, 1986, ANAL BIOCHEM, V155, P23, DOI 10.1016/0003-2697(86)90218-6; Bredeston LM, 2004, J BIOL CHEM, V279, P41619, DOI 10.1074/jbc.M403116200; Brini M, 2010, J BIOL CHEM, V285, P30779, DOI 10.1074/jbc.M110.140475; BRODIN P, 1992, EUR J BIOCHEM, V204, P939, DOI 10.1111/j.1432-1033.1992.tb16715.x; BRUNNER J, 1981, BIOCHEMISTRY-US, V20, P7174, DOI 10.1021/bi00528a019; BRUNNER J, 1993, ANNU REV BIOCHEM, V62, P483, DOI 10.1146/annurev.bi.62.070193.002411; Caride AJ, 1999, J BIOL CHEM, V274, P35227, DOI 10.1074/jbc.274.49.35227; Caride AJ, 1996, BIOCHEM J, V316, P353, DOI 10.1042/bj3160353; CASTELLO PR, 1994, BIOCHEM BIOPH RES CO, V201, P194, DOI 10.1006/bbrc.1994.1688; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; Corradi GR, 2007, J BIOL CHEM, V282, P35440, DOI 10.1074/jbc.M703377200; Donnet C, 1998, J MEMBRANE BIOL, V163, P217, DOI 10.1007/s002329900385; ENYEDI A, 1989, J BIOL CHEM, V264, P12313; ENYEDI A, 1987, J BIOL CHEM, V262, P6425; FALCHETTO R, 1992, PROTEIN SCI, V1, P1613, DOI 10.1002/pro.5560011209; FALCHETTO R, 1991, J BIOL CHEM, V266, P2930; Filomatori CV, 2003, J BIOL CHEM, V278, P22265, DOI 10.1074/jbc.M302657200; FILOTEO AG, 1987, J BIOL CHEM, V262, P6526; Filoteo AG, 1997, J BIOL CHEM, V272, P23741, DOI 10.1074/jbc.272.38.23741; FILOTEO AG, 1992, J BIOL CHEM, V267, P11800; Fiske CH, 1925, J BIOL CHEM, V66, P375; FUNG BKK, 1978, BIOCHEMISTRY-US, V17, P5241, DOI 10.1021/bi00617a025; GATTO C, 1993, AM J PHYSIOL, V264, pC1577, DOI 10.1152/ajpcell.1993.264.6.C1577; Giraldo AMV, 2006, FEBS LETT, V580, P607, DOI 10.1016/j.febslet.2005.12.078; GRAF E, 1981, ARCH BIOCHEM BIOPHYS, V210, P257, DOI 10.1016/0003-9861(81)90187-9; HOEKSTRA D, 1982, BIOCHEMISTRY-US, V21, P1055, DOI 10.1021/bi00534a036; JAMES P, 1988, J BIOL CHEM, V263, P2905; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Levi V, 2000, FEBS LETT, V483, P99, DOI 10.1016/S0014-5793(00)02093-7; Liyanage MR, 2009, ANAL BIOCHEM, V385, P1, DOI 10.1016/j.ab.2008.10.022; Mangialavori I, 2010, J BIOL CHEM, V285, P123, DOI 10.1074/jbc.M109.076679; Mangialavori I, 2009, J BIOL CHEM, V284, P4823, DOI 10.1074/jbc.M806912200; MUNKONGE F, 1988, BIOCHEMISTRY-US, V27, P6800, DOI 10.1021/bi00418a023; NIGGLI V, 1979, J BIOL CHEM, V254, P9955; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Padanyi R, 2003, J BIOL CHEM, V278, P35798, DOI 10.1074/jbc.M305794200; PAPP S, 1987, BIOPHYS J, V51, P205, DOI 10.1016/S0006-3495(87)83326-X; Pinto FD, 2002, J BIOL CHEM, V277, P12784, DOI 10.1074/jbc.M111055200; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Takahashi M, 2007, P NATL ACAD SCI USA, V104, P5800, DOI 10.1073/pnas.0700979104; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; VORHERR T, 1990, BIOCHEMISTRY-US, V29, P355, DOI 10.1021/bi00454a008; WEBER T, 1995, J AM CHEM SOC, V117, P3084, DOI 10.1021/ja00116a013; Ye YZ, 2005, BIOINFORMATICS, V21, P2362, DOI 10.1093/bioinformatics/bti353; ZVARITCH E, 1990, BIOCHEMISTRY-US, V29, P8070, DOI 10.1021/bi00487a012	49	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18397	18404		10.1074/jbc.M110.210088	http://dx.doi.org/10.1074/jbc.M110.210088			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21454645	hybrid, Green Published			2022-12-25	WOS:000290785700012
J	Webb, KJ; Al-Hadid, Q; Zurita-Lopez, CI; Young, BD; Lipson, RS; Clarke, SG				Webb, Kristofor J.; Al-Hadid, Qais; Zurita-Lopez, Cecilia I.; Young, Brian D.; Lipson, Rebecca S.; Clarke, Steven G.			The Ribosomal L1 Protuberance in Yeast Is Methylated on a Lysine Residue Catalyzed by a Seven-beta-strand Methyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SET DOMAIN METHYLTRANSFERASE; PROTEIN-ARGININE METHYLTRANSFERASE; ION EXCHANGE CHROMATOGRAPHY; POSTTRANSLATIONAL MODIFICATIONS; SACCHAROMYCES-CEREVISIAE; MASS-SPECTROMETRY; ESCHERICHIA-COLI; AMINO-ACIDS; IDENTIFICATION; SUBUNIT	Modification of proteins of the translational apparatus is common in many organisms. In the yeast Saccharomyces cerevisiae, we provide evidence for the methylation of Rpl1ab, a well conserved protein forming the ribosomal L1 protuberance of the large subunit that functions in the release of tRNA from the exit site. We show that the intact mass of Rpl1ab is 14 Da larger than its calculated mass with the previously described loss of the initiator methionine residue and N-terminal acetylation. We determined that the increase in mass of yeast Rpl1ab is consistent with the addition of a methyl group to lysine 46 using top-down mass spectrometry. Lysine modification was confirmed by detecting H-3-N-epsilon-monomethyllysine in hydrolysates of Rpl1ab purified from yeast cells radiolabeled in vivo with S-adenosyl-L-[methyl-H-3] methionine. Mass spectrometric analysis of intact Rpl1ab purified from 37 deletion strains of known and putative yeast methyltransferases revealed that only the deletion of the YLR137W gene, encoding a seven-beta-strand methyltransferase, results in the loss of the + 14-Da modification. We expressed the YLR137W gene as a His-tagged protein in Escherichia coli and showed that it catalyzes N-epsilon-monomethyllysine formation within Rpl1ab on ribosomes from the Delta YLR137W mutant strain lacking the methyltransferase activity but not from wild-type ribosomes. We also showed that the His-tagged protein could catalyze monomethyllysine formation on a 16-residue peptide corresponding to residues 38-53 of Rpl1ab. We propose that the YLR137W gene be given the standard name RKM5 (ribosomal lysine (K) methyltransferase 5). Orthologs of RKM5 are found only in fungal species, suggesting a role unique to their survival.	[Clarke, Steven G.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Clarke, Steven G.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Clarke, SG (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 607 Charles E Young Dr E, Los Angeles, CA 90095 USA.	clarke@mbi.ucla.edu	Zurita-Lopez, Cecilia I./AAC-6509-2020	Webb, Kristofor/0000-0001-8111-9756	National Institutes of Health [GM026020]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM026020, R01GM026020] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM026020.	Arnold RJ, 1999, ANAL BIOCHEM, V269, P105, DOI 10.1006/abio.1998.3077; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Botting CH, 2010, ARCHAEA, V2010, DOI 10.1155/2010/106341; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; Carroll AJ, 2008, MOL CELL PROTEOMICS, V7, P347, DOI 10.1074/mcp.M700052-MCP200; CAVALLIUS J, 1993, BIOCHIM BIOPHYS ACTA, V1163, P75, DOI 10.1016/0167-4838(93)90281-U; Chern MK, 2002, J BIOL CHEM, V277, P15345, DOI 10.1074/jbc.M111379200; CLARKE S, 1984, METHOD ENZYMOL, V106, P330; Cornish PV, 2009, P NATL ACAD SCI USA, V106, P2571, DOI 10.1073/pnas.0813180106; Demirci H, 2008, STRUCTURE, V16, P1059, DOI 10.1016/j.str.2008.03.016; Febbraio F, 2004, J BIOL CHEM, V279, P10185, DOI 10.1074/jbc.M308520200; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Gary JD, 1996, J BIOL CHEM, V271, P12585, DOI 10.1074/jbc.271.21.12585; GOTTSCHLING H, 1962, NATURE, V196, P829, DOI 10.1038/196829a0; GUERIN MF, 1989, BIOCHIMIE, V71, P805, DOI 10.1016/0300-9084(89)90043-6; KLEENE SJ, 1977, J BIOL CHEM, V252, P3214; KLEIN PD, 1967, ANAL CHEM, V39, P1276, DOI 10.1021/ac60255a005; Lee SW, 2002, P NATL ACAD SCI USA, V99, P5942, DOI 10.1073/pnas.082119899; LHOEST J, 1990, PROTEIN METHYLATION, P155; Lipson RS, 2010, ARCH BIOCHEM BIOPHYS, V500, P137, DOI 10.1016/j.abb.2010.05.023; Magnani R, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1044; Nevskaya N, 2006, J MOL BIOL, V355, P747, DOI 10.1016/j.jmb.2005.10.084; Niewmierzycka A, 1999, J BIOL CHEM, V274, P814, DOI 10.1074/jbc.274.2.814; Nikulin A, 2003, NAT STRUCT BIOL, V10, P104, DOI 10.1038/nsb886; Odintsova TI, 2003, J PROTEIN CHEM, V22, P249, DOI 10.1023/A:1025068419698; Olsson I, 2007, EXP CELL RES, V313, P1778, DOI 10.1016/j.yexcr.2007.03.007; Pesavento JJ, 2008, J BIOL CHEM, V283, P14927, DOI 10.1074/jbc.M709796200; PETITJEAN A, 1995, MOL CELL BIOL, V15, P5071; Petrossian T, 2009, EPIGENOMICS-UK, V1, P163, DOI 10.2217/EPI.09.3; Petrossian TC, 2009, MOL CELL PROTEOMICS, V8, P1516, DOI 10.1074/mcp.M900025-MCP200; Polevoda B, 2000, J BIOL CHEM, V275, P20508, DOI 10.1074/jbc.M001891200; Polevoda B, 2003, J MOL BIOL, V325, P595, DOI 10.1016/S0022-2836(02)01269-X; Polevoda B, 2007, MOL MICROBIOL, V65, P590, DOI 10.1111/j.1365-2958.2007.05831.x; Porras-Yakushi TR, 2007, J BIOL CHEM, V282, P12368, DOI 10.1074/jbc.M611896200; Porras-Yakushi TR, 2006, J BIOL CHEM, V281, P35835, DOI 10.1074/jbc.M606578200; Porras-Yakushi TR, 2005, J BIOL CHEM, V280, P34590, DOI 10.1074/jbc.M507672200; Ren JQ, 2010, J BIOL CHEM, V285, P12695, DOI 10.1074/jbc.M110.103911; RICE RH, 1977, BIOCHIM BIOPHYS ACTA, V492, P316, DOI 10.1016/0005-2795(77)90082-4; Sadaie M, 2008, J BIOL CHEM, V283, P7185, DOI 10.1074/jbc.M709429200; Schubert HL, 2003, BIOCHEMISTRY-US, V42, P5592, DOI 10.1021/bi034026p; Shirai A, 2010, J BIOL CHEM, V285, P22448, DOI 10.1074/jbc.M110.132274; Sledz P, 2010, PROTEIN SCI, V19, P1395, DOI 10.1002/pro.420; Swiercz R, 2007, J BIOL CHEM, V282, P16917, DOI 10.1074/jbc.M609778200; Tooley CES, 2010, NATURE, V466, P1125, DOI 10.1038/nature09343; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; VANET A, 1994, MOL MICROBIOL, V14, P947, DOI 10.1111/j.1365-2958.1994.tb01330.x; Webb KJ, 2010, J BIOL CHEM, V285, P37598, DOI 10.1074/jbc.M110.170787; Webb KJ, 2010, BIOCHEMISTRY-US, V49, P5225, DOI 10.1021/bi100428x; Webb KJ, 2008, J BIOL CHEM, V283, P35561, DOI 10.1074/jbc.M806006200; Williamson NA, 1997, EUR J BIOCHEM, V246, P786, DOI 10.1111/j.1432-1033.1997.00786.x	50	25	28	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18405	18413		10.1074/jbc.M110.200410	http://dx.doi.org/10.1074/jbc.M110.200410			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21460220	Green Published, hybrid			2022-12-25	WOS:000290785700013
J	Guo, LL; Chen, ZY; Cox, BE; Amarnath, V; Epand, RF; Epand, RM; Davies, SS				Guo, Lilu; Chen, Zhongyi; Cox, Brian E.; Amarnath, Venkataraman; Epand, Raquel F.; Epand, Richard M.; Davies, Sean S.			Phosphatidylethanolamines Modified by gamma-Ketoaldehyde (gamma KA) Induce Endoplasmic Reticulum Stress and Endothelial Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCAVENGER RECEPTOR CD36; ER STRESS; OXIDIZED PHOSPHOLIPIDS; LIPID-PEROXIDATION; COVALENT BINDING; HYDROXY-ALKENALS; ALDEHYDES; CELLS; INFLAMMATION; APOPTOSIS	Peroxidation of plasma lipoproteins has been implicated in the endothelial cell activation and monocyte adhesion that initiate atherosclerosis, but the exact mechanisms underlying this activation remain unclear. Lipid peroxidation generates lipid aldehydes, including the gamma-ketoaldehydes (gamma KA), also termed isoketals or isolevuglandins, that readily modify the amine headgroup of phosphatidylethanolamine (PE). We hypothesized that aldehyde modification of PE could mediate some of the proinflammatory effects of lipid peroxidation. We found that PE modified by gamma KA (gamma KA-PE) induced THP-1 monocyte adhesion to human umbilical cord endothelial cells. gamma KA-PE also induced expression of adhesion molecules and increased MCP-1 and IL-8 mRNA in human umbilical cord endothelial cells. To determine the structural requirements for gamma KA-PE activity, we tested several related compounds. PE modified by 4-oxo-pentanal induced THP-1 adhesion, but N-glutaroyl-PE and C18:0N-acyl-PE did not, suggesting that an N-pyrrole moiety was essential for cellular activity. As the N-pyrrole headgroup might distort the membrane, we tested the effect of the pyrrole-PEs on membrane parameters. gamma KA-PE and 4-oxo-pentanal significantly reduced the temperature for the liquid crystalline to hexagonal phase transition in artificial bilayers, suggesting that these pyrrole-PE markedly altered membrane curvature. Additionally, fluorescently labeled gamma KA-PE rapidly internalized to the endoplasmic reticulum (ER); gamma KA-PE induced C/EBP homologous protein CHOP and BiP expression and p38 MAPK activity, and inhibitors of ER stress reduced gamma KA-PE-induced C/EBP homologous protein CHOP and BiP expression as well as EC activation, consistent with gamma KA-PE inducing ER stress responses that have been previously linked to inflammatory chemokine expression. Thus, gamma KA-PE is a potential mediator of the inflammation induced by lipid peroxidation.	[Guo, Lilu; Chen, Zhongyi; Cox, Brian E.; Davies, Sean S.] Vanderbilt Univ, Div Clin Pharmacol, Nashville, TN 37232 USA; [Amarnath, Venkataraman] Vanderbilt Univ, Dept Pathol, Nashville, TN 37232 USA; [Davies, Sean S.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; [Epand, Raquel F.; Epand, Richard M.] McMaster Univ, Dept Biochem & Biomed Serv, Hamilton, ON L8N 3Z5, Canada	Vanderbilt University; Vanderbilt University; Vanderbilt University; McMaster University	Davies, SS (corresponding author), 2222 Pierce Ave,506A RRB, Nashville, TN 37232 USA.	sean.davies@vanderbilt.edu	, Richard/R-2316-2019	, Richard/0000-0002-9602-9558; Davies, Sean/0000-0001-9879-8062	National Institutes of Health [OD003137-01, UL1 RR024975]; Vanderbilt Department of Pharmacology; Heart and Stroke Foundation of Ontario [T6915]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD003137] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Department of Pharmacology; Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants OD003137-01 (to S. S. D.) and UL1 RR024975 (to Vanderbilt Institute for Clinical and Translation Research). This work was also supported by Vanderbilt Department of Pharmacology (to S. S. D.) and Heart and Stroke Foundation of Ontario Grant T6915 (to R. M. E.).	Amarnath V, 2005, SYNTHETIC COMMUN, V35, P397, DOI 10.1081/SCC-200048945; Amarnath V, 2004, CHEM RES TOXICOL, V17, P410, DOI 10.1021/tx0300535; Bach D, 2009, CHEM PHYS LIPIDS, V161, P95, DOI 10.1016/j.chemphyslip.2009.07.006; Bacot S, 2003, J LIPID RES, V44, P917, DOI 10.1194/jlr.M200450-JLR200; Bacot S, 2007, J LIPID RES, V48, P816, DOI 10.1194/jlr.M600340-JLR200; Balasubramanian K, 2001, BIOCHEMISTRY-US, V40, P8672, DOI 10.1021/bi010841y; Bernoud-Hubac N, 2004, FREE RADICAL BIO MED, V37, P1604, DOI 10.1016/j.freeradbiomed.2004.07.031; Berry KAZ, 2007, CHEM RES TOXICOL, V20, P1342, DOI 10.1021/tx700102n; BHUYAN KC, 1986, MECH AGEING DEV, V34, P289, DOI 10.1016/0047-6374(86)90080-1; DeVries-Seimon T, 2005, J CELL BIOL, V171, P61, DOI 10.1083/jcb.200502078; Epand RF, 2009, BBA-BIOMEMBRANES, V1788, P1967, DOI 10.1016/j.bbamem.2009.06.015; EPAND RM, 1985, BIOCHEMISTRY-US, V24, P7092, DOI 10.1021/bi00346a011; Friedman JR, 2010, J CELL BIOL, V190, P363, DOI 10.1083/jcb.200911024; Gargalovic PS, 2006, ARTERIOSCL THROM VAS, V26, P2490, DOI 10.1161/01.ATV.0000242903.41158.a1; Gargalovic PS, 2006, P NATL ACAD SCI USA, V103, P12741, DOI 10.1073/pnas.0605457103; Go YM, 2007, AM J PATHOL, V171, P1670, DOI 10.2353/ajpath.2007.070218; Graham TR, 2010, CURR OPIN CELL BIOL, V22, P430, DOI 10.1016/j.ceb.2010.05.002; Greenberg ME, 2008, J BIOL CHEM, V283, P2385, DOI 10.1074/jbc.M707348200; Guichardant M, 1998, FREE RADICAL BIO MED, V25, P1049, DOI 10.1016/S0891-5849(98)00149-X; Guichardant M, 2002, PROSTAG LEUKOTR ESS, V67, P147, DOI 10.1054/plef.2002.0412; Guo LL, 2010, ANAL BIOCHEM, V405, P236, DOI 10.1016/j.ab.2010.06.027; Haberzettl P, 2009, TOXICOL APPL PHARM, V234, P14, DOI 10.1016/j.taap.2008.09.019; Hidalgo FJ, 2004, ANAL BIOCHEM, V334, P155, DOI 10.1016/j.ab.2004.08.001; Hidalgo FJ, 2008, FOOD CHEM TOXICOL, V46, P43, DOI 10.1016/j.fct.2007.05.035; Hill GE, 1998, ATHEROSCLEROSIS, V141, P107, DOI 10.1016/S0021-9150(98)00153-1; Jiao P, 2011, OBESITY, V19, P483, DOI 10.1038/oby.2010.200; Karaskov E, 2006, ENDOCRINOLOGY, V147, P3398, DOI 10.1210/en.2005-1494; KILGORE KS, 1995, J IMMUNOL, V155, P1434; Lee JY, 2004, EUR J BIOCHEM, V271, P1339, DOI 10.1111/j.1432-1033.2004.04042.x; Lee YY, 2010, BIOCHEM BIOPH RES CO, V397, P735, DOI 10.1016/j.bbrc.2010.06.022; Li W, 2009, FREE RADICAL BIO MED, V47, P1539, DOI 10.1016/j.freeradbiomed.2009.09.003; Miyazawa T, 2012, AMINO ACIDS, V42, P1163, DOI 10.1007/s00726-010-0772-3; Moretto N, 2009, AM J PHYSIOL-LUNG C, V296, pL839, DOI 10.1152/ajplung.90570.2008; Nitti M, 2002, BIOCHEM BIOPH RES CO, V294, P547, DOI 10.1016/S0006-291X(02)00512-0; NJOROGE FG, 1987, CARBOHYD RES, V167, P211; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Okada T, 2003, J BIOL CHEM, V278, P31024, DOI 10.1074/jbc.M300923200; Park SH, 2010, EMBO REP, V11, P515, DOI 10.1038/embor.2010.92; Podrez EA, 2002, J BIOL CHEM, V277, P38517, DOI 10.1074/jbc.M205924200; Podrez EA, 2002, J BIOL CHEM, V277, P38503, DOI 10.1074/jbc.M203318200; PRIVALOV G, 1995, ANAL BIOCHEM, V232, P79, DOI 10.1006/abio.1995.9957; Razinkov VI, 1998, J GEN PHYSIOL, V112, P409, DOI 10.1085/jgp.112.4.409; Sanson M, 2009, CIRC RES, V104, P328, DOI 10.1161/CIRCRESAHA.108.183749; SAYRE LM, 1993, CHEM RES TOXICOL, V6, P19, DOI 10.1021/tx00031a002; Settles EI, 2010, BIOPHYS J, V99, P1539, DOI 10.1016/j.bpj.2010.06.059; Shanmugam N, 2008, DIABETES, V57, P879, DOI 10.2337/db07-1204; Shibata Y, 2009, ANNU REV CELL DEV BI, V25, P329, DOI 10.1146/annurev.cellbio.042308.113324; Stadelmann-Ingrand S, 2004, CHEM PHYS LIPIDS, V131, P93, DOI 10.1016/j.chemphyslip.2004.04.008; Sullivan CB, 2010, J LIPID RES, V51, P999, DOI 10.1194/jlr.M001040; Tabas I, 2009, ANTIOXID REDOX SIGN, V11, P2333, DOI [10.1089/ars.2009.2469, 10.1089/ARS.2009.2469]; West JD, 2005, CHEM RES TOXICOL, V18, P1642, DOI 10.1021/tx050211n; Yamawaki H, 2008, AM J PHYSIOL-CELL PH, V295, pC1510, DOI 10.1152/ajpcell.00252.2008; Zhang WH, 2003, CHEM RES TOXICOL, V16, P512, DOI 10.1021/tx020105a	53	42	42	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					18170	18180		10.1074/jbc.M110.213470	http://dx.doi.org/10.1074/jbc.M110.213470			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454544	Green Published, hybrid			2022-12-25	WOS:000290585200077
J	Matthes, F; Wolte, P; Bockenhoff, A; Huwel, S; Schulz, M; Hyden, P; Fogh, J; Gieselmann, V; Galla, HJ; Matzner, U				Matthes, Frank; Woelte, Philipp; Boeckenhoff, Annika; Huewel, Sabine; Schulz, Mareike; Hyden, Pia; Fogh, Jens; Gieselmann, Volkmar; Galla, Hans-Joachim; Matzner, Ulrich			Transport of Arylsulfatase A across the Blood-Brain Barrier in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENZYME-REPLACEMENT-THERAPY; MOUSE MODEL; ENDOTHELIAL-CELLS; GENTAMICIN; STORAGE; DELIVERY; SYSTEM; ENDOCYTOSIS; CORRECTS; PEPTIDE	Enzyme replacement therapy is an option to treat lysosomal storage diseases caused by functional deficiencies of lysosomal hydrolases as intravenous injection of therapeutic enzymes can correct the catabolic defect within many organ systems. However, beneficial effects on central nervous system manifestations are very limited because the blood-brain barrier (BBB) prevents the transfer of enzyme from the circulation to the brain parenchyma. Preclinical studies in mouse models of metachromatic leukodystrophy, however, showed that arylsulfatase A (ASA) is able to cross the BBB to some extent, thus reducing lysosomal storage in brain microglial cells. The present study aims to investigate the routing of ASA across the BBB and to improve the transfer in vitro using a well established cell culture model consisting of primary porcine brain capillary endothelial cells cultured on Transwell filter inserts. Passive apical-to-basolateral ASA transfer was observed, which was not saturable up to high ASA concentrations. No active transport could be determined. The passive transendothelial transfer was, however, charge-dependent as reduced concentrations of negatively charged monosaccharides in the N-glycans of ASA or the addition of polycations increased basolateral ASA levels. Adsorptive transcytosis is therefore considered to be the major transport pathway. Partial inhibition of the transcellular ASA transfer by mannose 6-phosphate indicated a second route depending on the insulin-like growth factor II/mannose 6-phosphate receptor, MPR300. We conclude that cationization of ASA and an increase of the mannose 6-phosphate content of the enzyme may promote blood-to-brain transfer of ASA, thus leading to an improved therapeutic efficacy of enzyme replacement therapy behind the BBB.	[Matthes, Frank; Boeckenhoff, Annika; Gieselmann, Volkmar; Matzner, Ulrich] Univ Bonn, Inst Biochem & Mol Biol, D-53115 Bonn, Germany; [Woelte, Philipp; Huewel, Sabine; Schulz, Mareike; Galla, Hans-Joachim] Univ Munster, Inst Biochem, D-48149 Munster, Germany; [Hyden, Pia; Fogh, Jens] Zymenex AS, DK-3400 Hillerod, Denmark	University of Bonn; University of Munster	Matzner, U (corresponding author), Nussallee 11, D-53115 Bonn, Germany.	matzner@ibmb.uni-bonn.de		Matthes, Frank/0000-0002-5115-8831	"Eva Luise und Horst Kohler Stiftung fur Menschen mit Seltenen Erkrankungen," Germany; International Graduate School Biotech-Pharma of North-Rhine West-phalia, Germany	"Eva Luise und Horst Kohler Stiftung fur Menschen mit Seltenen Erkrankungen," Germany; International Graduate School Biotech-Pharma of North-Rhine West-phalia, Germany	This work was supported by research grants from the "Eva Luise und Horst Kohler Stiftung fur Menschen mit Seltenen Erkrankungen," Germany, and the International Graduate School Biotech-Pharma of North-Rhine West-phalia, Germany.	BAUM H, 1959, CLIN CHIM ACTA, V4, P453, DOI 10.1016/0009-8981(59)90119-6; Beck M, 2010, IUBMB LIFE, V62, P33, DOI 10.1002/iub.284; Blanz J, 2008, HUM MOL GENET, V17, P3437, DOI 10.1093/hmg/ddn237; Desnick RJ, 2002, NAT REV GENET, V3, P954, DOI 10.1038/nrg963; Dunder U, 2000, FASEB J, V14, P361, DOI 10.1096/fasebj.14.2.361; Franke H, 2000, BRAIN RES PROTOC, V5, P248, DOI 10.1016/S1385-299X(00)00020-9; GIURGEAMARION L, 1986, TOXICOL APPL PHARM, V86, P271, DOI 10.1016/0041-008X(86)90058-X; Greiner-Tollersrud Ole Kristian, 2005, P60; Grubb JH, 2008, P NATL ACAD SCI USA, V105, P2616, DOI 10.1073/pnas.0712147105; Herve F, 2008, AAPS J, V10, P455, DOI 10.1208/s12248-008-9055-2; KUMAGAI AK, 1987, J BIOL CHEM, V262, P15214; Lischper M, 2010, BRAIN RES, V1326, P114, DOI 10.1016/j.brainres.2010.02.054; Lukatela G, 1998, BIOCHEMISTRY-US, V37, P3654, DOI 10.1021/bi9714924; Matzner U, 2005, HUM MOL GENET, V14, P1139, DOI 10.1093/hmg/ddi126; Matzner U, 2000, GENE THER, V7, P805, DOI 10.1038/sj.gt.3301150; Matzner U, 2009, MOL THER, V17, P600, DOI 10.1038/mt.2008.305; Meikle PJ, 1999, JAMA-J AM MED ASSOC, V281, P249, DOI 10.1001/jama.281.3.249; Mitsunaga-Nakatsubo K, 2009, DEV GENES EVOL, V219, P281, DOI 10.1007/s00427-009-0289-5; Mitsunaga-Nakatsubo K, 2009, MED MOL MORPHOL, V42, P63, DOI 10.1007/s00795-009-0447-x; Pohl S, 2009, BIOL CHEM, V390, P521, DOI 10.1515/BC.2009.076; Polito VA, 2009, AM J HUM GENET, V85, P296, DOI 10.1016/j.ajhg.2009.07.011; Poon GMK, 2007, BIOCHEM SOC T, V35, P788, DOI 10.1042/BST0350788; Segrest J P, 1971, Biochem Biophys Res Commun, V44, P390; Roces DP, 2004, HUM MOL GENET, V13, P1979, DOI 10.1093/hmg/ddh220; Sarrazin S, 2010, MOL THER, V18, P1268, DOI 10.1038/mt.2010.78; Schroder S, 2010, GLYCOBIOLOGY, V20, P248, DOI 10.1093/glycob/cwp171; SILVERBLATT FJ, 1979, KIDNEY INT, V15, P335, DOI 10.1038/ki.1979.45; Skopicki HA, 1996, AM J PHYSIOL-RENAL, V270, pF531, DOI 10.1152/ajprenal.1996.270.3.F531; Sorribas V, 2001, KIDNEY INT, V59, P1024, DOI 10.1046/j.1523-1755.2001.0590031024.x; STEVENS RL, 1975, J BIOL CHEM, V250, P2495; Storch Stephan, 2005, P17; TRIGUERO D, 1989, P NATL ACAD SCI USA, V86, P4761, DOI 10.1073/pnas.86.12.4761; Urayama A, 2007, P NATL ACAD SCI USA, V104, P12873, DOI 10.1073/pnas.0705611104; Vagedes P, 2002, BIOPHYS J, V83, P3066, DOI 10.1016/S0006-3495(02)75311-3; Vogler C, 2005, P NATL ACAD SCI USA, V102, P14777, DOI 10.1073/pnas.0506892102; von Wedel-Parlow M, 2009, J NEUROCHEM, V111, P111, DOI 10.1111/j.1471-4159.2009.06305.x; VONFIGURA K, 2001, METABOLIC MOL BASES, P3695	37	21	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17487	17494		10.1074/jbc.M110.189381	http://dx.doi.org/10.1074/jbc.M110.189381			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454621	Green Published, hybrid			2022-12-25	WOS:000290585200010
J	Townley, RA; Bulow, HE				Townley, Robert A.; Buelow, Hannes E.			Genetic Analysis of the Heparan Modification Network in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SULFATE 6-O-SULFOTRANSFERASE; IN-VIVO; SUBSTRATE-SPECIFICITY; LIGAND-BINDING; FINE-STRUCTURE; BIOSYNTHESIS; GLYCOSAMINOGLYCANS; ACID; 2-O-SULFOTRANSFERASE; PROTEOGLYCANS	Heparan sulfates (HS) are highly modified sugar polymers in multicellular organisms that function in cell adhesion and cellular responses to protein signaling. Functionally distinct, cell type-dependent HS modification patterns arise as the result of a conserved network of enzymes that catalyze deacetylations, sulfations, and epimerizations in specific positions of the sugar residues. To understand the genetic interactions of the enzymes during the HS modification process, we have measured the composition of HS purified from mutant strains of Caenorhabditis elegans. From these measurements we have developed a genetic network model of HS modification. We find the interactions to be highly recursive positive feed-forward and negative feedback loops. Our genetic analyses show that the HS C-5 epimerase hse-5, the HS 2-O-sulfotransferase hst-2, or the HS 6-O-sulfotransferase hst-6 inhibit N-sulfation. In contrast, hse-5 stimulates both 2-O- and 6-O-sulfation and, hst-2 and hst-6 inhibit 6-O- and 2-O-sulfation, respectively. The effects of hst-2 and hst-6 on N-sulfation, 6-O-sulfation, and 2-O-sulfation appear largely dependent on hse-5 function. This core of regulatory interactions is further modulated by 6-O-endosulfatase activity (sul-1). 47% of all 6-O-sulfates get removed from HS and this editing process is dependent on hst-2, thereby providing additional negative feedback between 2-O- and 6-O-sulfation. These findings suggest that the modification patterns are highly sensitive to the relative composition of the HS modification enzymes. Our comprehensive genetic analysis forms the basis of understanding the HS modification network in metazoans.	[Townley, Robert A.; Buelow, Hannes E.] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA; [Buelow, Hannes E.] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Bulow, HE (corresponding author), 1300 Morris Pk Ave, Bronx, NY 10461 USA.	hannes.buelow@einstein.yu.edu		Townley, Robert/0000-0002-9347-2431	National Institutes of Health [5R01HD055380, RC1GM090825, 5T32NS07098]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD055380] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC1GM090825] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007098] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants 5R01HD055380 and RC1GM090825 (to H. E. B.) and 5T32NS07098 (to R. A. T.).	Ai XB, 2003, J CELL BIOL, V162, P341, DOI 10.1083/jcb.200212083; Bai XM, 1996, J BIOL CHEM, V271, P17711, DOI 10.1074/jbc.271.30.17711; Bhattacharya R, 2009, J CELL SCI, V122, P4492, DOI 10.1242/jcs.050732; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Bulow HE, 2008, CURR BIOL, V18, P1978, DOI 10.1016/j.cub.2008.11.023; Bulow HE, 2006, ANNU REV CELL DEV BI, V22, P375, DOI 10.1146/annurev.cellbio.22.010605.093433; Bulow HE, 2002, P NATL ACAD SCI USA, V99, P6346, DOI 10.1073/pnas.092128099; Bulow HE, 2004, NEURON, V41, P723, DOI 10.1016/S0896-6273(04)00084-4; Clement A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000136; Dejima K, 2010, J BIOL CHEM, V285, P24717, DOI 10.1074/jbc.M109.088229; Dhoot GK, 2001, SCIENCE, V293, P1663, DOI 10.1126/science.293.5535.1663; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Frese MA, 2009, J BIOL CHEM, V284, P28033, DOI 10.1074/jbc.M109.035808; Guimond SE, 2009, J BIOL CHEM, V284, P25714, DOI 10.1074/jbc.M109.032755; Habuchi H, 2003, BIOCHEM J, V371, P131, DOI 10.1042/BJ20021259; Habuchi H, 2000, J BIOL CHEM, V275, P2859, DOI 10.1074/jbc.275.4.2859; Habuchi H, 2007, J BIOL CHEM, V282, P15578, DOI 10.1074/jbc.M607434200; JACOBSSON I, 1984, J BIOL CHEM, V259, P1056; JACOBSSON I, 1980, J BIOL CHEM, V255, P5094; Jemth P, 2003, J BIOL CHEM, V278, P24371, DOI 10.1074/jbc.M212155200; Kamimura K, 2006, J CELL BIOL, V174, P773, DOI 10.1083/jcb.200603129; KATO M, 1994, J BIOL CHEM, V269, P18881; Kinnunen T, 2005, P NATL ACAD SCI USA, V102, P1507, DOI 10.1073/pnas.0401591102; Kobayashi M, 1996, J BIOL CHEM, V271, P7645, DOI 10.1074/jbc.271.13.7645; Lamanna WC, 2006, BIOCHEM J, V400, P63, DOI 10.1042/BJ20060848; Lawrence R, 2008, J BIOL CHEM, V283, P33674, DOI 10.1074/jbc.M804288200; Lawrence R, 2008, NAT METHODS, V5, P291, DOI 10.1038/nmeth0408-291; Ledin J, 2004, J BIOL CHEM, V279, P42732, DOI 10.1074/jbc.M405382200; Li FC, 2011, J CELL BIOL, V192, P691, DOI 10.1083/jcb.201008087; Li JP, 2003, J BIOL CHEM, V278, P28363, DOI 10.1074/jbc.C300219200; Lindahl U, 2009, INT REV CEL MOL BIO, V276, P105, DOI 10.1016/S1937-6448(09)76003-4; Merry CLR, 2001, J BIOL CHEM, V276, P35429, DOI 10.1074/jbc.M100379200; Morimoto-Tomita M, 2002, J BIOL CHEM, V277, P49175, DOI 10.1074/jbc.M205131200; Nagai N, 2004, J CELL SCI, V117, P3331, DOI 10.1242/jcs.01191; Pinhal MAS, 2001, P NATL ACAD SCI USA, V98, P12984, DOI 10.1073/pnas.241175798; Presto J, 2008, P NATL ACAD SCI USA, V105, P4751, DOI 10.1073/pnas.0705807105; Safaiyan F, 1999, J BIOL CHEM, V274, P36267, DOI 10.1074/jbc.274.51.36267; SHWORAK NW, 1993, HAEMOSTASIS, V23, P161; Smeds E, 2010, GLYCOBIOLOGY, V20, P1274, DOI 10.1093/glycob/cwq089; Stanford KI, 2010, J BIOL CHEM, V285, P286, DOI 10.1074/jbc.M109.063701; Toyoda H, 2000, J BIOL CHEM, V275, P2269, DOI 10.1074/jbc.275.4.2269; Tveit H, 2005, J BIOL CHEM, V280, P29596, DOI 10.1074/jbc.M503691200; Yamada S, 1999, FEBS LETT, V459, P327, DOI 10.1016/S0014-5793(99)01286-7; Zako M, 2003, J BIOL CHEM, V278, P13561, DOI 10.1074/jbc.M209658200	44	22	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16824	16831		10.1074/jbc.M111.227926	http://dx.doi.org/10.1074/jbc.M111.227926			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454666	hybrid, Green Published			2022-12-25	WOS:000290301900032
J	Zhang, YH; Yan, WS; Chen, XB				Zhang, Yanhong; Yan, Wensheng; Chen, Xinbin			Mutant p53 Disrupts MCF-10A Cell Polarity in Three-dimensional Culture via Epithelial-to-mesenchymal Transitions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LI-FRAUMENI-SYNDROME; WILD-TYPE P53; GAIN; MUTATIONS; APOPTOSIS; SUPPRESSION; RESISTANCE; SURVIVAL; INVASION; BINDING	Mutant p53 is not only deficient in tumor suppression but also acquires additional activity, called gain of function. Mutant p53 gain of function is recapitulated in knock-in mice that carry one null allele and one mutant allele of the p53 gene. These knock-in mice develop aggressive tumors compared with p53-null mice. Recently, we and others showed that tumor cells carrying a mutant p53 are addicted to the mutant for cell survival and resistance to DNA damage. To further define mutant p53 gain of function, we used the MCF-10A three-dimensional model of mammary morphogenesis. MCF-10A cells in three-dimensional culture undergo a series of morphological changes and form polarized and growth-arrested spheroids with hollow lumen, which resembles normal glandular architectures in vivo. Here, we found that endogenous wild-type p53 in MCF-10A cells was not required for acinus formation, but knockdown of endogenous wild-type p53 (p53-KD) led to partial clearance of cells in the lumen due to decreased apoptosis. Consistent with this, p53-KD altered expression patterns of the cell adhesion molecule E-cadherin, the cytoskeletal marker beta-catenin, and the extracellular matrix protein laminin V. We also found that ectopic expression of the mutant G245S led to a phenotype similar to p53-KD, whereas a combination of ectopic expression of siRNA-resistant G245S with p53-KD led to a less cleared lumen. In contrast, ectopic expression of mutant R248W, R175H, and R273H disrupted normal acinus architectures with filled lumen and led to formation of irregular and multiacinus structures regardless of p53-KD. In addition, these mutants altered normal expression patterns and/or levels of E-cadherin, beta-catenin, laminin V, and tight junction marker ZO-1. Furthermore, epithelial-to-mesenchymal transitions (EMT) markers, Snail, Slug, and Twist, were highly induced by mutant p53 and/or p53-KD. Together, we postulate that EMT represents a mutant p53 gain of function and mutant p53 alters cell polarity via EMT.	[Zhang, Yanhong; Yan, Wensheng; Chen, Xinbin] Univ Calif Davis, Comparat Oncol Lab, Davis, CA 95616 USA	University of California System; University of California Davis	Chen, XB (corresponding author), Univ Calif Davis, Comparat Oncol Lab, Davis, CA 95616 USA.	xbchen@ucdavis.edu	qiao, zhixin/I-3408-2012		National Institutes of Health [CA121137]; NATIONAL CANCER INSTITUTE [P30CA093373, R01CA121137] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health Grant CA121137.	Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Carroll DK, 2006, NAT CELL BIOL, V8, P551, DOI 10.1038/ncb1420; Chang CJ, 2011, NAT CELL BIOL, V13, P317, DOI 10.1038/ncb2173; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; Danes CG, 2008, CANCER RES, V68, P1760, DOI 10.1158/0008-5472.CAN-07-3177; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Feigin ME, 2009, CURR OPIN CELL BIOL, V21, P694, DOI 10.1016/j.ceb.2009.07.003; HOLLSTEIN M, 1994, NUCLEIC ACIDS RES, V22, P3551; Irwin MS, 2003, CANCER CELL, V3, P403, DOI 10.1016/S1535-6108(03)00078-3; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; MERLO GR, 1995, J CELL BIOL, V128, P1185, DOI 10.1083/jcb.128.6.1185; MILNER J, 1991, CELL, V65, P765, DOI 10.1016/0092-8674(91)90384-B; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Reginato MJ, 2003, NAT CELL BIOL, V5, P733, DOI 10.1038/ncb1026; ROLLEY N, 1995, ONCOGENE, V11, P763; Sarig R, 2010, J EXP MED, V207, P2127, DOI 10.1084/jem.20100797; Seewaldt VL, 2001, J CELL BIOL, V155, P471, DOI 10.1083/jcb.200011001; Seton-Rogers SE, 2004, P NATL ACAD SCI USA, V101, P1257, DOI 10.1073/pnas.0308090100; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; St Johnston D, 2010, CELL, V141, P757, DOI 10.1016/j.cell.2010.05.011; Weaver VM, 2002, CANCER CELL, V2, P205, DOI 10.1016/S1535-6108(02)00125-3; Willis A, 2004, ONCOGENE, V23, P2330, DOI 10.1038/sj.onc.1207396; Yan WS, 2008, CANCER RES, V68, P6789, DOI 10.1158/0008-5472.CAN-08-0810; Yan WS, 2010, J BIOL CHEM, V285, P14229, DOI 10.1074/jbc.M109.097253; Yan WS, 2009, J BIOL CHEM, V284, P12178, DOI 10.1074/jbc.M900994200; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183	29	61	65	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.214585	http://dx.doi.org/10.1074/jbc.M110.214585			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454711	hybrid, Green Published			2022-12-25	WOS:000290022800061
J	Sekimoto, T; Miyamoto, Y; Arai, S; Yoneda, Y				Sekimoto, Toshihiro; Miyamoto, Yoshimi; Arai, Shouko; Yoneda, Yoshihiro			Importin alpha Protein Acts as a Negative Regulator for Snail Protein Nuclear Import	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TRANSCRIPTION FACTOR SNAIL; E-CADHERIN EXPRESSION; ZINC-FINGER; TUMOR PROGRESSION; REPRESSOR SNAIL; BREAST-CANCER; BETA; LOCALIZATION; PHOSPHORYLATION	Snail, a zinc finger-containing transcriptional regulator, migrates into the nucleus where it controls gene expression. We demonstrated previously that importin beta 1 directly recognizes the zinc finger domain of Snail and transports it into the nucleus. Here, using in vitro and in vivo assays, we show that importin alpha, an adaptor protein for importin beta 1, negatively regulates the nuclear import of Snail mediated by importin beta 1. In vitro binding assays indicated that importin alpha interacted with the zinc finger domain of Snail to compete with the binding of importin beta 1 and that Snail did not form a ternary complex with importin alpha/importin beta 1. Overexpression of importin alpha in A549 cells reduced the endogenous Snail protein level, which was restored by inhibitors of the proteasome and glycogen synthase kinase 3 beta. Furthermore, knockdown of importin alpha by siRNA treatment increased the endogenous Snail protein level in several cancer cell lines. This study provides a novel regulatory mechanism of the nuclear protein import process by importin alpha and gives an implication to control Snail activity by inhibiting its nuclear localization.	[Sekimoto, Toshihiro; Yoneda, Yoshihiro] Osaka Univ, Grad Sch Med, Dept Biochem, Osaka 5650871, Japan; [Miyamoto, Yoshimi; Arai, Shouko; Yoneda, Yoshihiro] Osaka Univ, Grad Sch Frontier Biosci, Dept Frontier Biosci, Osaka 5650871, Japan; [Miyamoto, Yoshimi; Arai, Shouko; Yoneda, Yoshihiro] Osaka Univ, Japan Sci & Technol Agcy, Osaka 5650871, Japan	Osaka University; Osaka University; Japan Science & Technology Agency (JST); Osaka University	Yoneda, Y (corresponding author), 1-3 Yamada Oka, Osaka 5650871, Japan.	yyoneda@anat3.med.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; JST; Grants-in-Aid for Scientific Research [23657130] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JST(Japan Science & Technology Agency (JST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan and JST, CREST.	Nieto MA, 2009, INT J DEV BIOL, V53, P1541, DOI 10.1387/ijdb.072410mn; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Carver EA, 2001, MOL CELL BIOL, V21, P8184, DOI 10.1128/MCB.21.23.8184-8188.2001; Catimel B, 2001, J BIOL CHEM, V276, P34189, DOI 10.1074/jbc.M103531200; Cowin P, 2005, CURR OPIN CELL BIOL, V17, P499, DOI 10.1016/j.ceb.2005.08.014; De Craene B, 2005, CANCER RES, V65, P6237, DOI 10.1158/0008-5472.CAN-04-3545; Dominguez D, 2003, MOL CELL BIOL, V23, P5078, DOI 10.1128/MCB.23.14.5078-5089.2003; Forwood JK, 2010, STRUCTURE, V18, P1171, DOI 10.1016/j.str.2010.06.015; Forwood JK, 2002, BIOCHEMISTRY-US, V41, P9333, DOI 10.1021/bi025548s; Hajra KM, 2002, CANCER RES, V62, P1613; Harreman MT, 2003, J BIOL CHEM, V278, P5854, DOI 10.1074/jbc.M210951200; Ito T, 2010, BIOCHEM BIOPH RES CO, V403, P161, DOI 10.1016/j.bbrc.2010.10.036; Jakel S, 1999, EMBO J, V18, P2411, DOI 10.1093/emboj/18.9.2411; Ko H, 2007, CELLS TISSUES ORGANS, V185, P66, DOI 10.1159/000101305; Kotera I, 2005, EMBO J, V24, P942, DOI 10.1038/sj.emboj.7600587; Lam MHC, 1999, J BIOL CHEM, V274, P7391, DOI 10.1074/jbc.274.11.7391; Lee SJ, 2005, NATURE, V435, P693, DOI 10.1038/nature03578; Lee SJ, 2003, SCIENCE, V302, P1571, DOI 10.1126/science.1088372; Mingot JM, 2009, J CELL SCI, V122, P1452, DOI 10.1242/jcs.041749; Nagoshi E, 1999, MOL BIOL CELL, V10, P2221, DOI 10.1091/mbc.10.7.2221; Nitahara-Kasahara Y, 2007, J VIROL, V81, P5284, DOI 10.1128/JVI.01928-06; Olmeda D, 2007, ONCOGENE, V26, P1862, DOI 10.1038/sj.onc.1209997; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Poser I, 2001, J BIOL CHEM, V276, P24661, DOI 10.1074/jbc.M011224200; Quadrini KJ, 2002, J BIOL CHEM, V277, P32243, DOI 10.1074/jbc.M205677200; Sekimoto T, 2004, EMBO J, V23, P1934, DOI 10.1038/sj.emboj.7600198; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Wu YD, 2009, J BIOL CHEM, V284, P640, DOI 10.1074/jbc.M806916200; Yamasaki H, 2005, GENES CELLS, V10, P455, DOI 10.1111/j.1365-2443.2005.00850.x; Yamashita S, 2004, NATURE, V429, P298, DOI 10.1038/nature02545; Yang ZB, 2005, CANCER RES, V65, P3179, DOI 10.1158/0008-5472.CAN-04-3480; Ying M, 2007, BBA-MOL CELL RES, V1773, P804, DOI 10.1016/j.bbamcr.2007.03.006; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	36	17	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15126	15131		10.1074/jbc.M110.213579	http://dx.doi.org/10.1074/jbc.M110.213579			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21454664	hybrid, Green Published			2022-12-25	WOS:000289788300043
J	Kerry, PS; Ayllon, J; Taylor, MA; Hass, C; Lewis, A; Garcia-Sastre, A; Randall, RE; Hale, BG; Russell, RJ				Kerry, Philip S.; Ayllon, Juan; Taylor, Margaret A.; Hass, Claudia; Lewis, Andrew; Garcia-Sastre, Adolfo; Randall, Richard E.; Hale, Benjamin G.; Russell, Rupert J.			A Transient Homotypic Interaction Model for the Influenza A Virus NS1 Protein Effector Domain	PLOS ONE			English	Article							X-RAY-STRUCTURE; RNA-BINDING; NONSTRUCTURAL PROTEIN-1; STRUCTURAL BASIS; INFECTED-CELLS; INTERFERON; ACTIVATION; MOTIF; DIMERIZATION; RECOGNITION	Influenza A virus NS1 protein is a multifunctional virulence factor consisting of an RNA binding domain (RBD), a short linker, an effector domain (ED), and a C-terminal 'tail'. Although poorly understood, NS1 multimerization may autoregulate its actions. While RBD dimerization seems functionally conserved, two possible apo ED dimers have been proposed (helix-helix and strand-strand). Here, we analyze all available RBD, ED, and full-length NS1 structures, including four novel crystal structures obtained using EDs from divergent human and avian viruses, as well as two forms of a monomeric ED mutant. The data reveal the helix-helix interface as the only strictly conserved ED homodimeric contact. Furthermore, a mutant NS1 unable to form the helix-helix dimer is compromised in its ability to bind dsRNA efficiently, implying that ED multimerization influences RBD activity. Our bioinformatical work also suggests that the helix-helix interface is variable and transient, thereby allowing two ED monomers to twist relative to one another and possibly separate. In this regard, we found a mAb that recognizes NS1 via a residue completely buried within the ED helix-helix interface, and which may help highlight potential different conformational populations of NS1 (putatively termed 'helix-closed' and 'helix-open') in virus-infected cells. 'Helix-closed' conformations appear to enhance dsRNA binding, and 'helix-open' conformations allow otherwise inaccessible interactions with host factors. Our data support a new model of NS1 regulation in which the RBD remains dimeric throughout infection, while the ED switches between several quaternary states in order to expand its functional space. Such a concept may be applicable to other small multifunctional proteins.	[Kerry, Philip S.; Taylor, Margaret A.; Hass, Claudia; Lewis, Andrew; Randall, Richard E.; Russell, Rupert J.] Univ St Andrews, St Andrews, Fife, Scotland; [Ayllon, Juan; Garcia-Sastre, Adolfo; Hale, Benjamin G.] Mt Sinai Sch Med, Dept Microbiol, New York, NY USA; [Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Div Infect Dis, Dept Med, New York, NY USA; [Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Global Hlth & Emerging Pathogens Inst, New York, NY USA	University of St Andrews; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Kerry, PS (corresponding author), Univ St Andrews, Biomed Sci Res Complex, St Andrews, Fife, Scotland.	ben.hale@mssm.edu; rjmr@st-andrews.ac.uk	Barasoain, Juan Ayllón/AAA-3899-2019; Hale, Benjamin G./D-4958-2015	Barasoain, Juan Ayllón/0000-0002-7556-8106; Hale, Benjamin G./0000-0002-3891-9480; Garcia-Sastre, Adolfo/0000-0002-6551-1827; Randall, Richard/0000-0002-9304-6678	Medical Research Council, UK; Scottish Funding Council; CRIP, a National Institute of Allergy and Infectious Diseases (NIAID) [HHSN266200700010C]; NIAID [RO1AI46954, U19AI83025, PO1AI58113]; National Institutes of Health-National Cancer Institute (NIH-NCI) [5R24 CA095823-04]; NSF [DBI-9724504]; NIH [1 S10 RR0 9145-01]; NATIONAL CANCER INSTITUTE [R24CA095823] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR009145] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI058113, U19AI083025, R01AI046954] Funding Source: NIH RePORTER; MRC [G0601126] Funding Source: UKRI; Medical Research Council [G0601126] Funding Source: researchfish	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Scottish Funding Council; CRIP, a National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health-National Cancer Institute (NIH-NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Work in St. Andrews was supported by the Medical Research Council, UK (RER and RJR), and the Scottish Funding Council (RJR). Work performed at MSSM was partially supported by CRIP, a National Institute of Allergy and Infectious Diseases (NIAID) funded Center for Research in Influenza Pathogenesis (contract number HHSN266200700010C), and by NIAID grants RO1AI46954, U19AI83025 and PO1AI58113 (to AG-S). Confocal laser scanning microscopy was performed at the MSSM-Microscopy Shared Resource Facility, supported with funding from National Institutes of Health-National Cancer Institute (NIH-NCI) shared resources grant (5R24 CA095823-04), NSF Major Research Instrumentation grant (DBI-9724504) and NIH shared instrumentation grant (1 S10 RR0 9145-01). The University of St. Andrews is a charity registered in Scotland (No. SC013532). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bahadur RP, 2003, PROTEINS, V53, P708, DOI 10.1002/prot.10461; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bornholdt ZA, 2006, NAT STRUCT MOL BIOL, V13, P559, DOI 10.1038/nsmb1099; Bornholdt ZA, 2008, NATURE, V456, P985, DOI 10.1038/nature07444; Burgui I, 2003, J GEN VIROL, V84, P3263, DOI 10.1099/vir.0.19487-0; Cheng A, 2009, CELL RES, V19, P187, DOI 10.1038/cr.2008.288; Chien CY, 1997, NAT STRUCT BIOL, V4, P891, DOI 10.1038/nsb1197-891; Das K, 2008, P NATL ACAD SCI USA, V105, P13093, DOI 10.1073/pnas.0805213105; Dey S, 2010, J MOL BIOL, V398, P146, DOI 10.1016/j.jmb.2010.02.020; Donelan NR, 2003, J VIROL, V77, P13257, DOI 10.1128/JVI.77.24.13257-13266.2003; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gack MU, 2009, CELL HOST MICROBE, V5, P439, DOI 10.1016/j.chom.2009.04.006; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hale BG, 2008, VIROLOGY, V378, P1, DOI 10.1016/j.virol.2008.05.026; Hale BG, 2006, P NATL ACAD SCI USA, V103, P14194, DOI 10.1073/pnas.0606109103; Hale BG, 2010, J VIROL, V84, P6909, DOI 10.1128/JVI.00081-10; Hale BG, 2010, P NATL ACAD SCI USA, V107, P1954, DOI 10.1073/pnas.0910715107; Hale BG, 2009, VIROLOGY, V383, P6, DOI 10.1016/j.virol.2008.10.002; Hayman A, 2006, VIROLOGY, V347, P52, DOI 10.1016/j.virol.2005.11.024; Heikkinen LS, 2008, J BIOL CHEM, V283, P5719, DOI 10.1074/jbc.M707195200; Janin J, 2008, Q REV BIOPHYS, V41, P133, DOI 10.1017/S0033583508004708; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Keiner B, 2010, J VIROL, V84, P11858, DOI 10.1128/JVI.01011-10; Kochs G, 2007, J VIROL, V81, P7011, DOI 10.1128/JVI.02581-06; Li SD, 2006, VIROLOGY, V349, P13, DOI 10.1016/j.virol.2006.01.005; Liu HB, 2010, J VIROL, V84, P11164, DOI 10.1128/JVI.01278-10; Liu JS, 1997, NAT STRUCT BIOL, V4, P896, DOI 10.1038/nsb1197-896; Long JX, 2008, VIRUS GENES, V36, P471, DOI 10.1007/s11262-007-0187-8; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miknis ZJ, 2009, J VIROL, V83, P3007, DOI 10.1128/JVI.01505-08; Min JY, 2006, P NATL ACAD SCI USA, V103, P7100, DOI 10.1073/pnas.0602184103; Nemeroff ME, 1998, MOL CELL, V1, P991, DOI 10.1016/S1097-2765(00)80099-4; NEMEROFF ME, 1995, VIROLOGY, V212, P422, DOI 10.1006/viro.1995.1499; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Nooren IMA, 2003, J MOL BIOL, V325, P991, DOI 10.1016/S0022-2836(02)01281-0; Otwinowski Z., 1993, DATA COLLECTION PROC, P556; Perkins JR, 2010, STRUCTURE, V18, P1233, DOI 10.1016/j.str.2010.08.007; Qian XY, 1995, RNA, V1, P948; Reynolds C, 2009, BIOINFORMATICS, V25, P413, DOI 10.1093/bioinformatics/btn584; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Saha RP, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-11; Schrodinger L., 2020, PYMOL; Senes A, 2004, CURR OPIN STRUC BIOL, V14, P465, DOI 10.1016/j.sbi.2004.07.007; Seo SH, 2002, NAT MED, V8, P950, DOI 10.1038/nm757; Steidle S, 2010, J VIROL, V84, P12761, DOI 10.1128/JVI.00701-10; Twu KY, 2007, J VIROL, V81, P8112, DOI 10.1128/JVI.00006-07; Volmer R, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-63; Wang W, 1999, RNA, V5, P195, DOI 10.1017/S1355838299981621; Wang XY, 2002, J VIROL, V76, P12951, DOI 10.1128/JVI.76.24.12951-12962.2002; Xia SL, 2010, ARCH BIOCHEM BIOPHYS, V494, P198, DOI 10.1016/j.abb.2009.12.008; Xia SL, 2009, ACTA CRYSTALLOGR D, V65, P11, DOI 10.1107/S0907444908032186; Xu K, 2011, J VIROL, V85, P1086, DOI 10.1128/JVI.00877-10; Xu QF, 2011, NUCLEIC ACIDS RES, V39, pD761, DOI 10.1093/nar/gkq1059; Yin CF, 2007, J BIOL CHEM, V282, P20584, DOI 10.1074/jbc.M611619200; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Zhao C, 2010, P NATL ACAD SCI USA, V107, P2253, DOI 10.1073/pnas.0909144107	58	40	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e17946	10.1371/journal.pone.0017946	http://dx.doi.org/10.1371/journal.pone.0017946			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464929	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000289053800008
J	Tsalatsanis, A; Barnes, L; Hozo, I; Skvoretz, J; Djulbegovic, B				Tsalatsanis, Athanasios; Barnes, Laura; Hozo, Iztok; Skvoretz, John; Djulbegovic, Benjamin			A Social Network Analysis of Treatment Discoveries in Cancer	PLOS ONE			English	Article							PHYSICIANS; BREAST; TRIAL	Controlled clinical trials are widely considered to be the vehicle to treatment discovery in cancer that leads to significant improvements in health outcomes including an increase in life expectancy. We have previously shown that the pattern of therapeutic discovery in randomized controlled trials (RCTs) can be described by a power law distribution. However, the mechanism generating this pattern is unknown. Here, we propose an explanation in terms of the social relations between researchers in RCTs. We use social network analysis to study the impact of interactions between RCTs on treatment success. Our dataset consists of 280 phase III RCTs conducted by the NCI from 1955 to 2006. The RCT networks are formed through trial interactions formed i) at random, ii) based on common characteristics, or iii) based on treatment success. We analyze treatment success in terms of survival hazard ratio as a function of the network structures. Our results show that the discovery process displays power law if there are preferential interactions between trials that may stem from researchers' tendency to interact selectively with established and successful peers. Furthermore, the RCT networks are "small worlds": trials are connected through a small number of ties, yet there is much clustering among subsets of trials. We also find that treatment success (improved survival) is proportional to the network centrality measures of closeness and betweenness. Negative correlation exists between survival and the extent to which trials operate within a limited scope of information. Finally, the trials testing curative treatments in solid tumors showed the highest centrality and the most influential group was the ECOG. We conclude that the chances of discovering life-saving treatments are directly related to the richness of social interactions between researchers inherent in a preferential interaction model.	[Tsalatsanis, Athanasios; Barnes, Laura; Djulbegovic, Benjamin] Univ S Florida, Ctr Evidence Based Med & Hlth Outcomes Res, Tampa, FL 33606 USA; [Hozo, Iztok] Indiana Univ NW, Dept Math, Gary, IN USA; [Skvoretz, John] Univ S Florida, Dept Sociol, Tampa, FL USA; [Djulbegovic, Benjamin] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA	State University System of Florida; University of South Florida; Indiana University System; Indiana University Northwest; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Tsalatsanis, A (corresponding author), Univ S Florida, Ctr Evidence Based Med & Hlth Outcomes Res, Tampa, FL 33606 USA.	atsalats@health.usf.edu	Djulbegovic, Benjamin/I-3661-2012; Tsalatsanis, Athanasios/A-8742-2009; Hozo, ihozo@iun.edu/R-3498-2016	Djulbegovic, Benjamin/0000-0003-0671-1447; Tsalatsanis, Athanasios/0000-0003-3818-8283; Hozo, ihozo@iun.edu/0000-0003-2349-5707	Office of Research Integrity and National Institutes of Health [1R01NS044417-01, 1R01NS052956-01, 1R01CA133594-01 NIH/ORI]; NATIONAL CANCER INSTITUTE [R01CA133594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052956, R01NS044417] Funding Source: NIH RePORTER	Office of Research Integrity and National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research has been supported by: Research program on research integrity, Office of Research Integrity and National Institutes of Health (grants: No 1R01NS044417-01, 1R01NS052956-01 and 1R01CA133594-01 NIH/ORI); PI: Dr. Djulbegovic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; [Anonymous], 1676, COMMUNICATION; Barabasi A, 1999, EMERGENCE SCALING RA, P509; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Burt RS, 2004, AM J SOCIOL, V110, P349, DOI 10.1086/421787; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Collins R, 2001, LANCET, V357, P373, DOI 10.1016/S0140-6736(00)03651-5; Cullen R, 1997, B MED LIBR ASSOC, V85, P348; Djulbegovic B, 2000, LANCET, V356, P635, DOI 10.1016/S0140-6736(00)02605-2; Djulbegovic B, 2001, Curr Oncol Rep, V3, P389, DOI 10.1007/s11912-001-0024-5; Djulbegovic B, 2009, CANCER CONTROL, V16, P158, DOI 10.1177/107327480901600208; Djulbegovic B, 2008, ARCH INTERN MED, V168, P632, DOI 10.1001/archinte.168.6.632; Erdos P, 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Fisher B, 2002, NEW ENGL J MED, V347, P1233, DOI 10.1056/NEJMoa022152; FISHER B, 1980, CANCER, V15, P4; Grann A, 2005, JAMA-J AM MED ASSOC, V293, P1001, DOI 10.1001/jama.293.8.1001; Haug JD, 1997, B MED LIBR ASSOC, V85, P223; Hyams DM, 1997, DIS COLON RECTUM, V40, P131, DOI 10.1007/BF02054976; Jackson MO, 2008, SOCIAL AND ECONOMIC NETWORKS, P1; JADAD A, 1998, RANDOMIZED CONTROLLE; Keating NL, 2007, J GEN INTERN MED, V22, P794, DOI 10.1007/s11606-007-0190-8; Kleinberg J.M., 1998, P 9 ANN ACM SIAM S D, P668; Klemm K, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.057102; Kuhn T. S., 1962, STRUCTURE SCI REVOLU; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; NEWMAN MEJ, 2005, POWER LAWS PARETO DI, P323; Popper, 1972, OBJECTIVE KNOWLEDGE; Popper K, 1945, ECONOMICA-NEW SER, V12, P69, DOI 10.2307/2549898; Reaman Gregory H, 2004, J Pediatr Oncol Nurs, V21, P123, DOI 10.1177/1043454204264406; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	30	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e18060	10.1371/journal.pone.0018060	http://dx.doi.org/10.1371/journal.pone.0018060			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	743XV	21464896	Green Submitted, Green Published, gold			2022-12-25	WOS:000289053800020
J	Sipola-Leppanen, M; Hovi, P; Andersson, S; Wehkalampi, K; Vaarasmaki, M; Strang-Karlsson, S; Jarvenpaa, AL; Makitie, O; Eriksson, JG; Kajantie, E				Sipola-Leppanen, Marika; Hovi, Petteri; Andersson, Sture; Wehkalampi, Karoliina; Vaarasmaki, Marja; Strang-Karlsson, Sonja; Jarvenpaa, Anna-Liisa; Makitie, Outi; Eriksson, Johan G.; Kajantie, Eero			Resting Energy Expenditure in Young Adults Born Preterm-The Helsinki Study of Very Low Birth Weight Adults	PLOS ONE			English	Article							FAT-FREE MASS; X-RAY ABSORPTIOMETRY; CARDIOVASCULAR RISK-FACTORS; BASAL METABOLIC-RATE; BODY-COMPOSITION; BLOOD-PRESSURE; FETAL-GROWTH; DISEASE; AGE; VALIDATION	Background: Adults born preterm with very low birth weight (VLBW; < 1500g) have higher levels of cardiovascular and metabolic risk factors than their counterparts born at term. Resting energy expenditure (REE) could be one factor contributing to, or protecting from, these risks. We studied the effects of premature birth with VLBW on REE. Methodology/Principal Findings: We used indirect calorimetry to measure REE and dual x-ray absorptiometry (DXA) to measure lean body mass (LBM) in 116 VLBW and in 118 term-born control individuals (mean age: 22.5 years, SD 2.2) participating in a cohort study. Compared with controls VLBW adults had 6.3% lower REE (95% CI 3.2, 9.3) adjusted for age and sex, but 6.1% higher REE/LBM ratio (95% CI 3.4, 8.6). These differences remained similar when further adjusted for parental education, daily smoking, body fat percentage and self-reported leisure time exercise intensity, duration and frequency. Conclusions/Significance: Adults born prematurely with very low birth weight have higher resting energy expenditure per unit lean body mass than their peers born at term. This is not explained by differences in childhood socio-economic status, current fat percentage, smoking or leisure time physical activity. Presence of metabolically more active tissue could protect people with very low birth weight from obesity and subsequent risk of chronic disease.	[Sipola-Leppanen, Marika] Natl Inst Hlth & Welf, Diabet Prevent Unit, Dept Chron Dis Prevent, Oulu, Finland; [Sipola-Leppanen, Marika] Univ Oulu, Dept Pediat & Adolescence, Oulu, Finland; [Hovi, Petteri; Wehkalampi, Karoliina; Strang-Karlsson, Sonja; Eriksson, Johan G.; Kajantie, Eero] Natl Inst Hlth & Welf, Diabet Prevent Unit, Dept Chron Dis Prevent, Helsinki, Finland; [Hovi, Petteri; Andersson, Sture; Wehkalampi, Karoliina; Strang-Karlsson, Sonja; Jarvenpaa, Anna-Liisa; Makitie, Outi; Kajantie, Eero] Helsinki Univ Cent Hosp, Hosp Children & Adolescents, Helsinki, Finland; [Vaarasmaki, Marja] Oulu Univ Hosp, Dept Obstet & Gynaecol, Oulu, Finland; [Vaarasmaki, Marja] Natl Inst Hlth & Welf, Dept Children Young People & Families, Oulu, Finland; [Eriksson, Johan G.] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland; [Eriksson, Johan G.] Vasa Cent Hosp, Vaasa, Finland; [Eriksson, Johan G.] Folkhalsan Res Inst, Helsinki, Finland; [Eriksson, Johan G.] Univ Helsinki, Helsinki Univ Cent Hosp, Unit Gen Practice, Helsinki, Finland	Finland National Institute for Health & Welfare; University of Oulu; Finland National Institute for Health & Welfare; University of Helsinki; Helsinki University Central Hospital; University of Oulu; Finland National Institute for Health & Welfare; University of Helsinki; Vaasa Central Hospital; Folkhalsan Research Center; University of Helsinki; Helsinki University Central Hospital	Sipola-Leppanen, M (corresponding author), Natl Inst Hlth & Welf, Diabet Prevent Unit, Dept Chron Dis Prevent, Oulu, Finland.	eero.kajantie@helsinki.fi	Paalanne, Marika/ABE-5008-2020	Paalanne, Marika/0000-0003-1626-9410; Vaarasmaki, Marja/0000-0002-8234-4434; Makitie, Outi/0000-0002-4547-001X; Eriksson, Johan/0000-0002-2516-2060	Academy of Finland [135252, 132700, 132894, 126775, 129255, 129907, 135072, 127437, 129306, 130326, 134791]; Biomedicum Helsinki Foundation; Finnish Concordia Foundation; Finska Lakaresallskapet; Finnish Medical Society Duodecim; Finnish Foundation for Pediatric Research; Finnish Pediatric Society; Finnish Special Governmental Subsidy for Health Sciences; Finnish National Graduate School of Clinical Investigation; Jalmari and Rauha Ahokas Foundation; Juho Vainio Foundation; Novo Nordisk Foundation; Paivikki and Sakari Sohlberg Foundation; Pediatric Graduate School and the Clinical Graduate School in Paediatrics and Obstetrics/Gynaecology, University of Helsinki; Signe and Ane Gyllenberg Foundation; Sigrid Juselius Foundation; Vasa Nation and Wiipurilainen osakunta at Helsinki University; Wilhelm and Else Stockmann Foundation; Yrjo Jahnsson Foundation	Academy of Finland(Academy of Finland); Biomedicum Helsinki Foundation; Finnish Concordia Foundation; Finska Lakaresallskapet; Finnish Medical Society Duodecim; Finnish Foundation for Pediatric Research; Finnish Pediatric Society; Finnish Special Governmental Subsidy for Health Sciences; Finnish National Graduate School of Clinical Investigation; Jalmari and Rauha Ahokas Foundation; Juho Vainio Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Paivikki and Sakari Sohlberg Foundation; Pediatric Graduate School and the Clinical Graduate School in Paediatrics and Obstetrics/Gynaecology, University of Helsinki; Signe and Ane Gyllenberg Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Vasa Nation and Wiipurilainen osakunta at Helsinki University; Wilhelm and Else Stockmann Foundation; Yrjo Jahnsson Foundation	Grant support: Academy of Finland (grants 135252 to SA; 132700 to KW; 132894 to OM; 126775, 129255, 129907, 135072 to JGE; 127437, 129306, 130326, 134791 to EK) the Biomedicum Helsinki Foundation; the Finnish Concordia Foundation; Finska Lakaresallskapet; the Finnish Medical Society Duodecim; the Finnish Foundation for Pediatric Research; the Finnish Pediatric Society; the Finnish Special Governmental Subsidy for Health Sciences; the Finnish National Graduate School of Clinical Investigation; the Jalmari and Rauha Ahokas Foundation; the Juho Vainio Foundation; the Novo Nordisk Foundation; the Paivikki and Sakari Sohlberg Foundation; the Pediatric Graduate School and the Clinical Graduate School in Paediatrics and Obstetrics/Gynaecology, University of Helsinki; the Signe and Ane Gyllenberg Foundation; the Sigrid Juselius Foundation; Vasa Nation and Wiipurilainen osakunta at Helsinki University; the Wilhelm and Else Stockmann Foundation; and the Yrjo Jahnsson Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen LG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008192; Astrup A, 1999, AM J CLIN NUTR, V69, P1117; Au-Yong ITH, 2009, DIABETES, V58, P2583, DOI 10.2337/db09-0833; BARKER DJP, 1989, LANCET, V2, P577; Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; Compher C, 2006, J AM DIET ASSOC, V106, P881, DOI 10.1016/j.jada.2006.02.009; Doyle LW, 2003, PEDIATRICS, V111, P252, DOI 10.1542/peds.111.2.252; Dulloo AG, 1998, AM J CLIN NUTR, V68, P599, DOI 10.1093/ajcn/68.3.599; Eriksson J, 2002, HORM METAB RES, V34, P72, DOI 10.1055/s-2002-20518; Evensen KAI, 2009, EARLY HUM DEV, V85, P239, DOI 10.1016/j.earlhumdev.2008.10.008; Glickman SG, 2004, J APPL PHYSIOL, V97, P509, DOI 10.1152/japplphysiol.01234.2003; HAARBO J, 1991, CLIN PHYSIOL, V11, P331, DOI 10.1111/j.1475-097X.1991.tb00662.x; Hack M, 2005, PEDIATR RES, V58, P677, DOI 10.1203/01.PDR.0000180551.93470.56; Hack M, 2003, PEDIATRICS, V112, pE30, DOI 10.1542/peds.112.1.e30; Hack M, 2007, J PEDIATR-US, V151, P635, DOI 10.1016/j.jpeds.2007.04.063; Heymsfield SB, 2002, AM J PHYSIOL-ENDOC M, V282, pE132, DOI 10.1152/ajpendo.2002.282.1.E132; Hovi P, 2007, NEW ENGL J MED, V356, P2053, DOI 10.1056/NEJMoa067187; Hovi P, 2010, J PEDIATR-US, V156, P54, DOI 10.1016/j.jpeds.2009.07.022; Hovi P, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000135; Huxley R, 2007, AM J CLIN NUTR, V85, P1244, DOI 10.1093/ajcn/85.5.1244; Irving RJ, 2000, LANCET, V355, P2135, DOI 10.1016/S0140-6736(00)02384-9; JARVENPAA AL, 1991, ANN MED, V23, P699, DOI 10.3109/07853899109148106; Johnstone AM, 2005, AM J CLIN NUTR, V82, P941, DOI 10.1093/ajcn/82.5.941; Jorgensen JOL, 1998, METABOLISM, V47, P1134, DOI 10.1016/S0026-0495(98)90289-X; Kajantie E, 2010, J PEDIAT; Kajantie E, 2008, PEDIATRICS, V122, pE62, DOI 10.1542/peds.2007-3858; Kensara OA, 2006, AM J PHYSIOL-ENDOC M, V291, pE365, DOI 10.1152/ajpendo.00599.2005; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Martinussen M, 2009, J PEDIAT, V155, P848; National Center for Health Statistics, 2008, FIN NAT DAT VER LOW; NELSON KM, 1992, AM J CLIN NUTR, V56, P848, DOI 10.1093/ajcn/56.5.848; Philip AGS, 2005, PEDIATR RES, V58, P799, DOI 10.1203/01.PDR.0000151693.46655.66; Pihkala J, 1989, Duodecim, V105, P1540; Pyhala R, 2009, PEDIATRICS, V123, P731, DOI 10.1542/peds.2008-0277; RAVUSSIN E, 1988, NEW ENGL J MED, V318, P467, DOI 10.1056/NEJM198802253180802; Rogers M, 2005, PEDIATRICS, V116, pE58, DOI 10.1542/peds.2004-1603; Saigal S, 2007, PEDIATRICS, V119, pE562, DOI 10.1542/peds.2006-2328; Sophie A, 2008, 2008 EUROPERISTAT SC, P12; SVENDSEN OL, 1993, METABOLISM, V42, P1588, DOI 10.1016/0026-0495(93)90155-H; SVENDSEN OL, 1993, AM J CLIN NUTR, V57, P605, DOI 10.1093/ajcn/57.5.605; Taylor HG, 2011, DEV NEUROPSYCHOL, V36, P96, DOI 10.1080/87565641.2011.540544; TISSOT S, 1995, INTENS CARE MED, V21, P149, DOI 10.1007/BF01726538; Wang ZM, 2010, AM J CLIN NUTR, V92, P1369, DOI 10.3945/ajcn.2010.29885; Wang ZM, 2000, AM J PHYSIOL-ENDOC M, V279, pE539, DOI 10.1152/ajpendo.2000.279.3.E539; Weitz G, 2003, J HYPERTENS, V21, P943, DOI 10.1097/00004872-200305000-00019; Wells JCK, 1998, EUR J CLIN NUTR, V52, P536, DOI 10.1038/sj.ejcn.1600604; Whincup PH, 2008, JAMA-J AM MED ASSOC, V300, P2886, DOI 10.1001/jama.2008.886	48	17	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e17700	10.1371/journal.pone.0017700	http://dx.doi.org/10.1371/journal.pone.0017700			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464981	gold, Green Published, Green Submitted			2022-12-25	WOS:000288813900007
J	Bottomly, D; Walter, NAR; Hunter, JE; Darakjian, P; Kawane, S; Buck, KJ; Searles, RP; Mooney, M; McWeeney, SK; Hitzemann, R				Bottomly, Daniel; Walter, Nicole A. R.; Hunter, Jessica Ezzell; Darakjian, Priscila; Kawane, Sunita; Buck, Kari J.; Searles, Robert P.; Mooney, Michael; McWeeney, Shannon K.; Hitzemann, Robert			Evaluating Gene Expression in C57BL/6J and DBA/2J Mouse Striatum Using RNA-Seq and Microarrays	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION; ALCOHOL-DRINKING; CANDIDATE GENES; TRANSCRIPTOME; QTL; MOUSE-CHROMOSOME-1; IDENTIFICATION; NORMALIZATION; LOCI; RATS	C57BL/6J (B6) and DBA/2J (D2) are two of the most commonly used inbred mouse strains in neuroscience research. However, the only currently available mouse genome is based entirely on the B6 strain sequence. Subsequently, oligonucleotide microarray probes are based solely on this B6 reference sequence, making their application for gene expression profiling comparisons across mouse strains dubious due to their allelic sequence differences, including single nucleotide polymorphisms (SNPs). The emergence of next-generation sequencing (NGS) and the RNA-Seq application provides a clear alternative to oligonucleotide arrays for detecting differential gene expression without the problems inherent to hybridization-based technologies. Using RNA-Seq, an average of 22 million short sequencing reads were generated per sample for 21 samples (10 B6 and 11 D2), and these reads were aligned to the mouse reference genome, allowing 16,183 Ensembl genes to be queried in striatum for both strains. To determine differential expression, 'digital mRNA counting' is applied based on reads that map to exons. The current study compares RNA-Seq (Illumina GA IIx) with two microarray platforms (Illumina MouseRef-8 v2.0 and Affymetrix MOE 430 2.0) to detect differential striatal gene expression between the B6 and D2 inbred mouse strains. We show that by using stringent data processing requirements differential expression as determined by RNA-Seq is concordant with both the Affymetrix and Illumina platforms in more instances than it is concordant with only a single platform, and that instances of discordance with respect to direction of fold change were rare. Finally, we show that additional information is gained from RNA-Seq compared to hybridization-based techniques as RNA-Seq detects more genes than either microarray platform. The majority of genes differentially expressed in RNA-Seq were only detected as present in RNA-Seq, which is important for studies with smaller effect sizes where the sensitivity of hybridization-based techniques could bias interpretation.	[Bottomly, Daniel; Kawane, Sunita; McWeeney, Shannon K.] Oregon Hlth & Sci Univ, Oregon Clin & Translat Res Inst, Portland, OR 97201 USA; [Walter, Nicole A. R.; Buck, Kari J.; Hitzemann, Robert] Oregon Hlth & Sci Univ, Vet Affairs Med Ctr, Res Serv, Portland, OR 97201 USA; [Walter, Nicole A. R.; Hunter, Jessica Ezzell; Darakjian, Priscila; Hitzemann, Robert] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA; [Searles, Robert P.] Oregon Hlth & Sci Univ, Massively Parallel Sequencing Shared Resource, Portland, OR 97201 USA; [Mooney, Michael; McWeeney, Shannon K.] Oregon Hlth & Sci Univ, Div Bioinformat & Computat Biol Med Informat & Cl, Portland, OR 97201 USA; [McWeeney, Shannon K.] Oregon Hlth & Sci Univ, Div Biostat Publ Hlth & Preventat Med, Portland, OR 97201 USA; [McWeeney, Shannon K.] Oregon Hlth & Sci Univ, OHSU Knight Canc Inst, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Bottomly, D (corresponding author), Oregon Hlth & Sci Univ, Oregon Clin & Translat Res Inst, Portland, OR 97201 USA.	bottomly@ohsu.edu		McWeeney, Shannon/0000-0001-8333-6607; Mooney, Michael/0000-0003-1372-8722; Walter, Nicole/0000-0003-0431-8078; Hunter, Jessica/0000-0002-1117-1097	Veterans Affairs Research Service; MJ Murdock Charitable Trust;  [DA005228];  [AA011114];  [AA011034];  [AA013484];  [AA010760];  [T32AA07468];  [T32DA07262];  [MH051372];  [5UL1RR024140];  [5P30CA069533-13];  [5T15LM007088]; NATIONAL CANCER INSTITUTE [P30CA069533] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH051372] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P60AA010760, P50AA010760, T32AA007468, R01AA011034, R01AA011114, R29AA011114, U01AA013484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007262, R01DA005228] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007088] Funding Source: NIH RePORTER	Veterans Affairs Research Service(US Department of Veterans Affairs); MJ Murdock Charitable Trust; ; ; ; ; ; ; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by grants DA005228 (KB and NW), AA011114 (KB and NW), AA011034 (RH), AA013484 (RH), AA010760 (RH, KB, SKM, PD and NW), T32AA07468 (JH and DO), T32DA07262 (DO), MH051372 (RH), 5UL1RR024140 (DB and SKM), 5P30CA069533-13 (SKM), 5T15LM007088 (MM), the Veterans Affairs Research Service, and a grant from the MJ Murdock Charitable Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bice PJ, 2010, ALCOHOL, V44, P477, DOI 10.1016/j.alcohol.2010.06.004; Bice PJ, 2006, BEHAV GENET, V36, P248, DOI 10.1007/s10519-005-9019-6; Bloom JS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-221; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bradford JR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-282; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Denmark DL, 2008, GENES BRAIN BEHAV, V7, P599, DOI 10.1111/j.1601-183X.2008.00396.x; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Fagnani M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r108; Griffith M, 2010, NAT METHODS, V7, P843, DOI [10.1038/NMETH.1503, 10.1038/nmeth.1503]; Hansen KD, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq224; Hitzemann R, 1995, INT REV NEUROBIOL, V38, P43, DOI 10.1016/S0074-7742(08)60524-3; Hitzemann R, 2003, MAMM GENOME, V14, P733, DOI 10.1007/s00335-003-2277-9; Hofstetter JR, 2008, GENES BRAIN BEHAV, V7, P214, DOI 10.1111/j.1601-183X.2007.00340.x; Iancu OD, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-585; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kim H, 2004, NAT GENET, V36, P915, DOI 10.1038/ng0904-915; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000299; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Malmanger B, 2006, MAMM GENOME, V17, P1193, DOI 10.1007/s00335-006-0070-2; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mulligan MK, 2006, P NATL ACAD SCI USA, V103, P6368, DOI 10.1073/pnas.0510188103; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; *OR HLTH SCI U, OR HLTH SCI U MASS P; *OR HLTH SCI U, GEN MICR SHAR RES; Oshlack A, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-14; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Peirce JL, 2006, MAMM GENOME, V17, P643, DOI 10.1007/s00335-005-0187-8; Pozhitkov AE, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1122; *R DEV COR TEAM WO, 2010, TITL R FDN STAT COMP; Robinson MD, 2008, BIOSTATISTICS, V9, P321, DOI 10.1093/biostatistics/kxm030; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rosen GD, 2003, NEUROINFORMATICS, V1, P327, DOI 10.1385/NI:1:4:327; Rosen Glenn D, 2007, Methods Mol Biol, V401, P287, DOI 10.1007/978-1-59745-520-6_16; Rosen GD, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-5; Sandberg R, 2000, P NATL ACAD SCI USA, V97, P11038, DOI 10.1073/pnas.97.20.11038; Sikela JM, 2006, ALCOHOL CLIN EXP RES, V30, P700, DOI 10.1111/j.1530-0277.2006.00081.x; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Tabakoff B, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-70; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Walter NAR, 2007, NAT METHODS, V4, P679, DOI 10.1038/nmeth0907-679; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang H, 2003, EXP BRAIN RES, V149, P413, DOI 10.1007/s00221-002-1369-1; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilhelm BT, 2009, METHODS, V48, P249, DOI 10.1016/j.ymeth.2009.03.016	50	148	150	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2011	6	3							e17820	10.1371/journal.pone.0017820	http://dx.doi.org/10.1371/journal.pone.0017820			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740RG	21455293	Green Published, gold, Green Submitted			2022-12-25	WOS:000288811500010
J	Haberlandt, C; Derouiche, A; Wyczynski, A; Haseleu, J; Pohle, J; Karram, K; Trotter, J; Seifert, G; Frotscher, M; Steinhauser, C; Jabs, R				Haberlandt, Christian; Derouiche, Amin; Wyczynski, Alexandra; Haseleu, Julia; Pohle, Joerg; Karram, Khalad; Trotter, Jacqueline; Seifert, Gerald; Frotscher, Michael; Steinhaeuser, Christian; Jabs, Ronald			Gray Matter NG2 Cells Display Multiple Ca2+-Signaling Pathways and Highly Motile Processes	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; OLIGODENDROCYTE PRECURSOR CELLS; PROTEIN DISULFIDE-ISOMERASE; HIPPOCAMPAL GLIAL-CELLS; CENTRAL-NERVOUS-SYSTEM; MOUSE HIPPOCAMPUS; ENDOPLASMIC-RETICULUM; SYNAPTIC-TRANSMISSION; NA+/CA2+ EXCHANGE; CALCIUM-CHANNELS	NG2 cells, the fourth type of glia in the mammalian CNS, receive synaptic input from neurons. The function of this innervation is unknown yet. Postsynaptic changes in intracellular Ca2+-concentration ([Ca2+](i)) might be a possible consequence. We employed transgenic mice with fluorescently labeled NG2 cells to address this issue. To identify Ca2+-signaling pathways we combined patch-clamp recordings, Ca2+-imaging, mRNA-transcript analysis and focal pressure-application of various substances to identified NG2-cells in acute hippocampal slices. We show that activation of voltage-gated Ca2+-channels, Ca2+-permeable AMPA-receptors, and group I metabotropic glutamate-receptors provoke [Ca2+](i-) elevations in NG2 cells. The Ca2+-influx is amplified by Ca2+-induced Ca2+-release. Minimal electrical stimulation of presynaptic neurons caused postsynaptic currents but no somatic [Ca2+](i) elevations, suggesting that [Ca2+](i) elevations in NG2 cells might be restricted to their processes. Local Ca2+-signaling might provoke transmitter release or changes in cell motility. To identify structural prerequisites for such a scenario, we used electron microscopy, immunostaining, mRNA-transcript analysis, and time lapse imaging. We found that NG2 cells form symmetric and asymmetric synapses with presynaptic neurons and show immunoreactivity for vesicular glutamate transporter 1. The processes are actin-based, contain ezrin but not glial filaments, microtubules or endoplasmic reticulum. Furthermore, we demonstrate that NG2 cell processes in situ are highly motile. Our findings demonstrate that gray matter NG2 cells are endowed with the cellular machinery for two-way communication with neighboring cells.	[Haberlandt, Christian; Derouiche, Amin; Wyczynski, Alexandra; Haseleu, Julia; Pohle, Joerg; Seifert, Gerald; Steinhaeuser, Christian; Jabs, Ronald] Univ Bonn, Inst Cellular Neurosci, D-5300 Bonn, Germany; [Derouiche, Amin; Frotscher, Michael] Univ Freiburg, Inst Anat & Cell Biol, Freiburg, Germany; [Derouiche, Amin] Goethe Univ Frankfurt, Inst Anat 2, Frankfurt, Germany; [Pohle, Joerg] Univ Basel, Inst Physiol, Dept Biomed, Basel, Switzerland; [Karram, Khalad; Trotter, Jacqueline] Johannes Gutenberg Univ Mainz, Mainz, Germany	University of Bonn; University of Freiburg; Goethe University Frankfurt; University of Basel; Johannes Gutenberg University of Mainz	Haberlandt, C (corresponding author), Univ Bonn, Inst Cellular Neurosci, D-5300 Bonn, Germany.	christian.steinhaeuser@ukb.uni-bonn.de; ronald.jabs@ukb.uni-bonn.de	Derouiche, Amin/G-7390-2015; Jabs, Ronald/C-5132-2008	Derouiche, Amin/0000-0002-7309-2044; Jabs, Ronald/0000-0001-6612-7678; Haseleu, Julia/0000-0002-6827-074X	DFG [SFB/TR3, SPP1172]; EC [FP7-202167]; Land NRW (Graduate School Biotech-Pharma)	DFG(German Research Foundation (DFG)); EC(European CommissionEuropean Commission Joint Research Centre); Land NRW (Graduate School Biotech-Pharma)	This work was supported by DFG (SFB/TR3 to CS, AD and MF; SPP1172 to CS, GS and JT), EC (FP7-202167 NeuroGLIA to CS) and Land NRW (Graduate School Biotech-Pharma to CH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agulhon C, 2008, NEURON, V59, P932, DOI 10.1016/j.neuron.2008.09.004; Akopian G, 1996, GLIA, V17, P181; Anlauf E, 2005, GLIA, V49, P96, DOI 10.1002/glia.20094; Anlauf E, 2009, J MICROSC-OXFORD, V233, P225, DOI 10.1111/j.1365-2818.2009.03112.x; Bergersen LH, 2009, NEUROSCIENCE, V158, P260, DOI 10.1016/j.neuroscience.2008.03.074; Bergles DE, 2000, NATURE, V405, P187, DOI 10.1038/35012083; Bergles DE, 2010, BRAIN RES REV, V63, P130, DOI 10.1016/j.brainresrev.2009.12.003; BERRYMAN M, 1993, J CELL SCI, V105, P1025; Bezzi P, 2004, NAT NEUROSCI, V7, P613, DOI 10.1038/nn1246; Butt AM, 2005, J ANAT, V207, P695, DOI 10.1111/j.1469-7580.2005.00458.x; Darcy DP, 2009, J NEUROSCI, V29, P2510, DOI 10.1523/JNEUROSCI.5333-08.2009; De Biase LM, 2010, J NEUROSCI, V30, P3600, DOI 10.1523/JNEUROSCI.6000-09.2010; Derouiche A, 2001, GLIA, V36, P330, DOI 10.1002/glia.1120; Dimou L, 2008, J NEUROSCI, V28, P10434, DOI 10.1523/JNEUROSCI.2831-08.2008; Etxeberria A, 2010, NAT NEUROSCI, V13, P287, DOI 10.1038/nn.2500; Ferraguti F, 2008, PHARMACOL REV, V60, P536, DOI 10.1124/pr.108.000166; Fitzjohn SM, 1998, NEUROPHARMACOLOGY, V37, P1445, DOI 10.1016/S0028-3908(98)00145-2; Gautreau A, 2002, CURR OPIN CELL BIOL, V14, P104, DOI 10.1016/S0955-0674(01)00300-3; Ge WP, 2006, SCIENCE, V312, P1533, DOI 10.1126/science.1124669; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; Hirrlinger J, 2004, EUR J NEUROSCI, V20, P2235, DOI 10.1111/j.1460-9568.2004.03689.x; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; Huguenard JR, 1996, ANNU REV PHYSIOL, V58, P329, DOI 10.1146/annurev.physiol.58.1.329; Iwamoto T, 2004, MOL PHARMACOL, V66, P45, DOI 10.1124/mol.66.1.45; Iwamoto T, 1998, AM J PHYSIOL-CELL PH, V275, pC423, DOI 10.1152/ajpcell.1998.275.2.C423; Jabs R, 2005, J CELL SCI, V118, P3791, DOI 10.1242/jcs.02515; JABS R, 1994, PFLUG ARCH EUR J PHY, V426, P310, DOI 10.1007/BF00374787; Karram K, 2008, GENESIS, V46, P743, DOI 10.1002/dvg.20440; Kimelberg HK, 2000, J NEUROSCI RES, V61, P577, DOI 10.1002/1097-4547(20000915)61:6<577::AID-JNR1>3.0.CO;2-T; KIRCHHOFF F, 1992, EUR J NEUROSCI, V4, P1049, DOI 10.1111/j.1460-9568.1992.tb00131.x; Kitajiri S, 2004, J CELL BIOL, V166, P559, DOI 10.1083/jcb.200402007; LAMBERT N, 1985, BIOCHEM J, V228, P635, DOI 10.1042/bj2280635; Laver DR, 2007, CLIN EXP PHARMACOL P, V34, P889, DOI 10.1111/j.1440-1681.2007.04708.x; LERANTH C, 1987, J COMP NEUROL, V261, P33, DOI 10.1002/cne.902610104; Lin SC, 2004, NAT NEUROSCI, V7, P24, DOI 10.1038/nn1162; Lovatt D, 2007, J NEUROSCI, V27, P12255, DOI 10.1523/JNEUROSCI.3404-07.2007; Lu YB, 2006, P NATL ACAD SCI USA, V103, P17759, DOI 10.1073/pnas.0606150103; LYTTON J, 1991, J BIOL CHEM, V266, P17067; Majewska A, 2000, J NEUROSCI, V20, P8262, DOI 10.1523/JNEUROSCI.20-22-08262.2000; Matthias K, 2003, J NEUROSCI, V23, P1750; Nishiyama A, 2007, NEUROSCIENTIST, V13, P62, DOI 10.1177/1073858406295586; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Niswender CM, 2010, ANNU REV PHARMACOL, V50, P295, DOI 10.1146/annurev.pharmtox.011008.145533; NOIVA R, 1992, J BIOL CHEM, V267, P3553; Nolte C, 2001, GLIA, V33, P72; Paglini G, 1998, J CELL BIOL, V143, P443, DOI 10.1083/jcb.143.2.443; Paredes RM, 2008, METHODS, V46, P143, DOI 10.1016/j.ymeth.2008.09.025; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Peters A, 2004, J NEUROCYTOL, V33, P345, DOI 10.1023/B:NEUR.0000044195.64009.27; Rodriguez-Moreno A, 2007, TRENDS NEUROSCI, V30, P630, DOI 10.1016/j.tins.2007.10.001; Schoepp DD, 1999, NEUROPHARMACOLOGY, V38, P1431, DOI 10.1016/S0028-3908(99)00092-1; SEIFERT G, 1995, EUR J NEUROSCI, V7, P1872, DOI 10.1111/j.1460-9568.1995.tb00708.x; Seifert G, 1997, MOL BRAIN RES, V47, P286, DOI 10.1016/S0169-328X(97)00059-4; Seifert G, 1997, J NEUROPHYSIOL, V78, P2916, DOI 10.1152/jn.1997.78.6.2916; STEINHAUSER C, 1994, PFLUG ARCH EUR J PHY, V428, P610, DOI 10.1007/BF00374585; STEINHAUSER C, 1994, HIPPOCAMPUS, V4, P19, DOI 10.1002/hipo.450040105; Takamori S, 2000, NATURE, V407, P189, DOI 10.1038/35025070; Tong XP, 2009, J CELL BIOL, V186, P113, DOI 10.1083/jcb.200811071; Trotter J, 2010, BRAIN RES REV, V63, P72, DOI 10.1016/j.brainresrev.2009.12.006; Verkhratsky A, 2002, CELL CALCIUM, V32, P393, DOI 10.1016/S0143416002001896; Watano T, 1996, BRIT J PHARMACOL, V119, P555, DOI 10.1111/j.1476-5381.1996.tb15708.x; Zamponi GW, 1996, J MEMBRANE BIOL, V151, P77, DOI 10.1007/s002329900059; Zhu XQ, 2008, DEVELOPMENT, V135, P145, DOI 10.1242/dev.004895	64	73	73	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2011	6	3							e17575	10.1371/journal.pone.0017575	http://dx.doi.org/10.1371/journal.pone.0017575			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740RG	21455301	Green Published, Green Submitted, gold			2022-12-25	WOS:000288811500006
J	Wang, YC; Lee, CM; Lee, LC; Tung, LC; Hsieh-Li, HM; Lee-Chen, GJ; Su, MT				Wang, Yu-Chun; Lee, Chi-Mei; Lee, Li-Ching; Tung, Li-Chu; Hsieh-Li, Hsiu-Mei; Lee-Chen, Guey-Jen; Su, Ming-Tsan			Mitochondrial Dysfunction and Oxidative Stress Contribute to the Pathogenesis of Spinocerebellar Ataxia Type 12 (SCA12)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE 2A; REGULATORY SUBUNIT; CELL-DEATH; DROSOPHILA; APOPTOSIS; MUTATION; PPP2R2B; LOCALIZATION; SURVIVAL; FISSION	Spinal cerebellar ataxia type 12 (SCA12) has been attributed to the elevated expression of ppp2r2b. To better elucidate the pathomechanism of the neuronal disorder and to search for a pharmacological treatment, Drosophila models of SCA12 were generated by overexpression of a human ppp2r2b and its Drosophila homolog tws. Ectopic expression of ppp2r2b or tws caused various pathological features, including neurodegeneration, apoptosis, and shortened life span. More detailed analysis revealed that elevated ppp2r2b and tws induced fission of mitochondria accompanied by increases in cytosolic reactive oxygen species (ROS), cytochrome c, and caspase 3 activity. Transmission electron microscopy revealed that fragmented mitochondria with disrupted cristae were engulfed by autophagosomes in photoreceptor neurons of flies overexpressing tws. Additionally, transgenic flies were more susceptible to oxidative injury induced by paraquat. By contrast, ectopic Drosophila Sod2 expression and antioxidant treatment reduced ROS and caspase 3 activity and extended the life span of the SCA12 fly model. In summary, our study demonstrates that oxidative stress induced by mitochondrial dysfunction plays a causal role in SCA12, and reduction of ROS is a potential therapeutic intervention for this neuropathy.	[Wang, Yu-Chun; Lee, Chi-Mei; Lee, Li-Ching; Tung, Li-Chu; Hsieh-Li, Hsiu-Mei; Lee-Chen, Guey-Jen; Su, Ming-Tsan] Natl Taiwan Normal Univ, Dept Life Sci, Taipei 11677, Taiwan	National Taiwan Normal University	Su, MT (corresponding author), 88,Sect 4,Ting Chou Rd, Taipei 11677, Taiwan.	mtsu@ntnu.edu.tw	Chen, Chiung-Mei/AAL-6260-2020		National Science Council of Taiwan [NSC 95-2311-B-003-006-MY2, NSC 96-2311-B-003-005]; National Taiwan Normal University [96TOP001]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan Normal University	This work was supported by the National Science Council Grants NSC 95-2311-B-003-006-MY2 and NSC 96-2311-B-003-005 of Taiwan and National Taiwan Normal University Grant 96TOP001.	ABRAMS JM, 1993, DEVELOPMENT, V117, P29; Bajpai R, 2004, DEVELOPMENT, V131, P1007, DOI 10.1242/dev.00980; Bauer JH, 2004, P NATL ACAD SCI USA, V101, P12980, DOI 10.1073/pnas.0403493101; Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chabu C, 2009, DEV BIOL, V330, P399, DOI 10.1016/j.ydbio.2009.04.014; Chen CM, 2009, AM J MED GENET B, V150B, P124, DOI 10.1002/ajmg.b.30785; Cheng WT, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-91; Chiang CW, 2003, MOL CELL BIOL, V23, P6350, DOI 10.1128/MCB.23.18.6350-6362.2003; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; COX DR, 1972, J R STAT SOC B, V34, P187; Cox RT, 2003, DEVELOPMENT, V130, P1579, DOI 10.1242/dev.00365; Dagda RK, 2005, J BIOL CHEM, V280, P27375, DOI 10.1074/jbc.M503693200; Dagda RK, 2003, J BIOL CHEM, V278, P24976, DOI 10.1074/jbc.M302832200; Dagda RK, 2008, J BIOL CHEM, V283, P36241, DOI 10.1074/jbc.M800989200; Duenas AM, 2006, BRAIN, V129, P1357, DOI 10.1093/brain/awl081; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; GOMES R, 1993, J CELL SCI, V104, P583; HOLEN I, 1992, BIOCHEM J, V284, P633, DOI 10.1042/bj2840633; Holmes SE, 1999, NAT GENET, V23, P391, DOI 10.1038/70493; Holmes SE, 2003, CYTOGENET GENOME RES, V100, P189, DOI 10.1159/000072854; Holmes SE, 2001, BRAIN RES BULL, V56, P397, DOI 10.1016/S0361-9230(01)00596-2; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; Li XH, 2002, MOL CELL BIOL, V22, P3674, DOI 10.1128/MCB.22.11.3674-3684.2002; Lin CH, 2010, HUM GENET, V128, P205, DOI 10.1007/s00439-010-0843-2; Louie K, 2008, COMP BIOCHEM PHYS A, V151, P159, DOI 10.1016/j.cbpa.2008.06.023; Manto M, 2009, CURR OPIN NEUROL, V22, P419, DOI 10.1097/WCO.0b013e32832b9897; Trujillo-Martin MM, 2009, MOVEMENT DISORD, V24, P1111, DOI 10.1002/mds.22564; MAYERJAEKEL RE, 1993, CELL, V72, P621, DOI 10.1016/0092-8674(93)90080-A; Missirlis F, 2003, J BIOL CHEM, V278, P47365, DOI 10.1074/jbc.M307700200; Owusu-Ansah E., 2008, PROTOCOL EXCHANGE, DOI [10.1038/nprot.2008.1023., DOI 10.1038/NPROT.2008.1023, 10.1038/nprot.2008.1023,http://www.nature.com/protocolexchange/protocols/414]; Pignoni F, 1997, DEVELOPMENT, V124, P271; Ray RM, 2005, J BIOL CHEM, V280, P31091, DOI 10.1074/jbc.M503041200; Ruvolo PP, 2002, J BIOL CHEM, V277, P22847, DOI 10.1074/jbc.M201830200; Sathyanarayanan S, 2004, CELL, V116, P603, DOI 10.1016/S0092-8674(04)00128-X; Senoo-Matsuda N, 2005, EMBO J, V24, P2700, DOI 10.1038/sj.emboj.7600721; Sinha KK, 2004, J NEUROL NEUROSUR PS, V75, P448, DOI 10.1136/jnnp.2002.004895; Todd Amy M., 2004, Drosophila Information Service, V87, P101; UEMURA T, 1993, GENE DEV, V7, P429, DOI 10.1101/gad.7.3.429; Van Hoof C, 2003, BBA-MOL CELL RES, V1640, P97, DOI 10.1016/S0167-4889(03)00029-6; Wasilewski M, 2009, TRENDS ENDOCRIN MET, V20, P287, DOI 10.1016/j.tem.2009.03.007; Yarovinsky TO, 2000, BIOTECHNIQUES, V28, P1160, DOI 10.2144/00286st06; Yeh PA, 2010, BIOCHEM BIOPH RES CO, V391, P510, DOI 10.1016/j.bbrc.2009.11.089; Yu TZ, 2005, J CELL SCI, V118, P4141, DOI 10.1242/jcs.02537	47	41	42	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21742	21754		10.1074/jbc.M110.160697	http://dx.doi.org/10.1074/jbc.M110.160697			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21471219	Green Published, hybrid			2022-12-25	WOS:000291464700070
J	Hong, J; Bae, S; Jhun, H; Lee, S; Choi, J; Kang, T; Kwak, A; Hong, K; Kim, E; Jo, S; Kim, S				Hong, Jaewoo; Bae, Suyoung; Jhun, Hyunjhung; Lee, Siyoung; Choi, Jida; Kang, Taebong; Kwak, Areum; Hong, Kwangwon; Kim, Eunsom; Jo, Seunghyun; Kim, Soohyun			Identification of Constitutively Active Interleukin 33 (IL-33) Splice Variant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR ACCESSORY PROTEIN; RHEUMATOID-ARTHRITIS; CYTOKINE PRODUCTION; BINDING-PROTEIN; HUMAN BASOPHILS; GROWTH-FACTOR; ST2; IL-18; FAMILY; GENE	IL-33/IL-1F11 is a new member of the IL-1 family ligand and provokesThelper-type immune responses. IL-33 is the ligand of ST2 and IL-1 receptor accessory protein (IL-1RAcP) that triggers nuclear factor-kappa light chain enhancer of activated B cells (NF-kappa B) and MAPK signaling. We discovered a novel short splice variant of IL-33 that was termed spIL-33. The new spIL-33 lacks exon 3 containing a proposed caspase-1 cleavage site. We isolated spIL-33 cDNA from the Huh7 human hepatocarcinoma cell line and expressed the recombinant spIL-33 protein in Escherichia coli. The recombinant spIL-33 and pro-IL-33 were not cleaved by caspase-1, unlike IL-18 (IL-1F4). The recombinant spIL-33 was constitutively active, and spIL-33-induced inflammatory cytokine production was caspase-1-independent in HMC-1 and Raw 264.7 cells. The recombinant spIL-33 induced the phosphorylation of IL-1 receptor-associated kinase (IRAK1), NF-kappa B, p38 MAPK, p44/42 MAPK, and JNK in a time- and dose-dependent manner. Anti-ST2 monoclonal antibody specifically blocked the spIL-33-induced cytokine production. In this study, we identified and characterized a new IL-33 splice variant, which was a constitutively active IL-33 isoform. The existence of constitutively active spIL-33 suggests that the biological activity of IL-33 could be triggered by diverse stimulations during immune responses. Further investigation of the spIL-33 expression pattern may contribute to understanding the involvement of IL-33 in inflammatory disorders.	[Hong, Jaewoo; Bae, Suyoung; Jhun, Hyunjhung; Lee, Siyoung; Choi, Jida; Kang, Taebong; Kwak, Areum; Hong, Kwangwon; Kim, Eunsom; Jo, Seunghyun; Kim, Soohyun] Konkuk Univ, Lab Cytokine Immunol, Med Immunol Ctr, Seoul 143701, South Korea	Konkuk University; Konkuk University Medical Center	Kim, S (corresponding author), Konkuk Univ, Lab Cytokine Immunol, Med Immunol Ctr, 1 Hwayang Dong, Seoul 143701, South Korea.	soohyun@konkuk.ac.kr		Hong, Jaewoo/0000-0003-3456-3672; kang, tae-bong/0000-0003-1441-9470	Korean government [R33-2008-000-10022-0, KRF-2008-313-C00644]; Ministry of Health & Welfare, Republic of Korea [A100460]	Korean government(Korean Government); Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by National Research Foundation Grants WCU R33-2008-000-10022-0 and KRF-2008-313-C00644 funded by the Korean government and the Korea Healthcare Technology R&D Project Grant A100460 from the Ministry of Health & Welfare, Republic of Korea.	Aksentijevich I, 2002, ARTHRITIS RHEUM-US, V46, P3340, DOI 10.1002/art.10688; Allakhverdi Z, 2009, J ALLERGY CLIN IMMUN, V123, P472, DOI 10.1016/j.jaci.2008.10.022; Allakhverdi Z, 2007, J IMMUNOL, V179, P2051, DOI 10.4049/jimmunol.179.4.2051; Arend WP, 2008, IMMUNOL REV, V223, P20, DOI 10.1111/j.1600-065X.2008.00624.x; Ast G, 2004, NAT REV GENET, V5, P773, DOI 10.1038/nrg1451; Baekkevold ES, 2003, AM J PATHOL, V163, P69, DOI 10.1016/S0002-9440(10)63631-0; BAGGIOLINI M, 1978, AGENTS ACTIONS, V8, P3, DOI 10.1007/BF01972395; BERGERS G, 1994, EMBO J, V13, P1176, DOI 10.1002/j.1460-2075.1994.tb06367.x; Bresnihan B, 1998, ARTHRITIS RHEUM, V41, P2196, DOI 10.1002/1529-0131(199812)41:12<2196::AID-ART15>3.3.CO;2-U; Brint EK, 2004, NAT IMMUNOL, V5, P373, DOI 10.1038/ni1050; Bufler P, 2002, P NATL ACAD SCI USA, V99, P13723, DOI 10.1073/pnas.212519099; Carriere V, 2007, P NATL ACAD SCI USA, V104, P282, DOI 10.1073/pnas.0606854104; Cayrol C, 2009, P NATL ACAD SCI USA, V106, P9021, DOI 10.1073/pnas.0812690106; Chackerian AA, 2007, J IMMUNOL, V179, P2551, DOI 10.4049/jimmunol.179.4.2551; Cherry WB, 2008, J ALLERGY CLIN IMMUN, V121, P1484, DOI 10.1016/j.jaci.2008.04.005; Coeshott C, 1999, P NATL ACAD SCI USA, V96, P6261, DOI 10.1073/pnas.96.11.6261; Csernok E, 1996, CLIN EXP IMMUNOL, V105, P104, DOI 10.1046/j.1365-2249.1996.d01-715.x; Dinarello CA, 2004, CURR OPIN PHARMACOL, V4, P378, DOI 10.1016/j.coph.2004.03.010; Dinarello CA, 1998, ANN NY ACAD SCI, V856, P1, DOI 10.1111/j.1749-6632.1998.tb08307.x; Guo LY, 2009, P NATL ACAD SCI USA, V106, P13463, DOI 10.1073/pnas.0906988106; Haibel H, 2005, ANN RHEUM DIS, V64, P296, DOI 10.1136/ard.2004.023176; Han SY, 2002, J BIOL CHEM, V277, P47167, DOI 10.1074/jbc.M204270200; Hawkins PN, 2004, ARTHRITIS RHEUM-US, V50, P607, DOI 10.1002/art.20033; Hayakawa M, 2009, BIOCHEM BIOPH RES CO, V387, P218, DOI 10.1016/j.bbrc.2009.07.018; Ho LH, 2007, J LEUKOCYTE BIOL, V82, P1481, DOI 10.1189/jlb.0407200; Hoshino K, 1999, J EXP MED, V190, P1541, DOI 10.1084/jem.190.10.1541; Iikura M, 2007, LAB INVEST, V87, P971, DOI 10.1038/labinvest.3700663; Kim SH, 2000, P NATL ACAD SCI USA, V97, P1190, DOI 10.1073/pnas.97.3.1190; Kim SH, 2005, IMMUNITY, V22, P131, DOI 10.1016/j.immuni.2004.12.003; KLEMENZ R, 1989, P NATL ACAD SCI USA, V86, P5708, DOI 10.1073/pnas.86.15.5708; Kondo Y, 2008, INT IMMUNOL, V20, P791, DOI 10.1093/intimm/dxn037; Kriventseva EV, 2003, TRENDS GENET, V19, P124, DOI 10.1016/S0168-9525(03)00023-4; Kumar S, 2002, CYTOKINE, V18, P61, DOI 10.1006/cyto.2002.0873; Kurowska-Stolarska M, 2009, J IMMUNOL, V183, P6469, DOI 10.4049/jimmunol.0901575; Lamkanfi M, 2009, IMMUNITY, V31, P5, DOI 10.1016/j.immuni.2009.06.011; Luthi AU, 2009, IMMUNITY, V31, P84, DOI 10.1016/j.immuni.2009.05.007; Meazza R, 1996, ONCOGENE, V12, P2187; Moulin D, 2007, CYTOKINE, V40, P216, DOI 10.1016/j.cyto.2007.09.013; Moussion C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003331; Nishimura H, 1998, J IMMUNOL, V160, P936; Novick D, 2006, P NATL ACAD SCI USA, V103, P3316, DOI 10.1073/pnas.0511206103; Novick D, 1999, IMMUNITY, V10, P127, DOI 10.1016/S1074-7613(00)80013-8; Ohno T, 2009, J IMMUNOL, V183, P7890, DOI 10.4049/jimmunol.0802449; PADRINES M, 1994, FEBS LETT, V352, P231, DOI 10.1016/0014-5793(94)00952-X; Palmer G, 2008, CYTOKINE, V42, P358, DOI 10.1016/j.cyto.2008.03.008; Pecaric-Petkovic T, 2009, BLOOD, V113, P1526, DOI 10.1182/blood-2008-05-157818; Philips AV, 2000, CELL MOL LIFE SCI, V57, P235, DOI 10.1007/PL00000687; Pufe T, 2001, ARTHRITIS RHEUM, V44, P1082, DOI 10.1002/1529-0131(200105)44:5<1082::AID-ANR188>3.0.CO;2-X; Rank MA, 2009, J ALLERGY CLIN IMMUN, V123, P1047, DOI 10.1016/j.jaci.2009.02.026; ROBACHEGALLEA S, 1995, J BIOL CHEM, V270, P23688, DOI 10.1074/jbc.270.40.23688; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Senn KA, 2000, EUR J IMMUNOL, V30, P1929, DOI 10.1002/1521-4141(200007)30:7&lt;1929::AID-IMMU1929&gt;3.0.CO;2-1; Smithgall MD, 2008, INT IMMUNOL, V20, P1019, DOI 10.1093/intimm/dxn060; Stamm S, 2005, GENE, V344, P1, DOI 10.1016/j.gene.2004.10.022; Sugawara S, 2001, J IMMUNOL, V167, P6568, DOI 10.4049/jimmunol.167.11.6568; Sullivan BM, 2009, IMMUNITY, V30, P12, DOI 10.1016/j.immuni.2008.12.006; Suzukawa M, 2008, J IMMUNOL, V181, P5981, DOI 10.4049/jimmunol.181.9.5981; Suzukawa M, 2008, LAB INVEST, V88, P1245, DOI 10.1038/labinvest.2008.82; Tagaya Y, 1997, P NATL ACAD SCI USA, V94, P14444, DOI 10.1073/pnas.94.26.14444; TOMINAGA S, 1992, BIOCHIM BIOPHYS ACTA, V1171, P215, DOI 10.1016/0167-4781(92)90125-J; TOMINAGA S, 1989, FEBS LETT, V258, P301, DOI 10.1016/0014-5793(89)81679-5; TOMINAGA S, 1991, BIOCHIM BIOPHYS ACTA, V1090, P1, DOI 10.1016/0167-4781(91)90029-L; Townsend MJ, 2000, J EXP MED, V191, P1069, DOI 10.1084/jem.191.6.1069; Trajkovic V, 2004, CYTOKINE GROWTH F R, V15, P87, DOI 10.1016/j.cytogfr.2004.02.004; Verri WA, 2010, ANN RHEUM DIS, V69, P1697, DOI 10.1136/ard.2009.122655	66	58	60	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					20078	20086		10.1074/jbc.M111.219089	http://dx.doi.org/10.1074/jbc.M111.219089			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21454686	Green Published, hybrid			2022-12-25	WOS:000291027700084
J	Ori, A; Wilkinson, MC; Fernig, DG				Ori, Alessandro; Wilkinson, Mark C.; Fernig, David G.			A Systems Biology Approach for the Investigation of the Heparin/Heparan Sulfate Interactome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE; EXTRACELLULAR-MATRIX; PROTEIN-PROTEIN; BINDING SITES; GENE ONTOLOGY; DOMAIN; GLYCOSAMINOGLYCANS; EXPRESSION; EVOLUTION; IDENTIFICATION	A large body of evidence supports the involvement of heparan sulfate (HS) proteoglycans in physiological processes such as development and diseases including cancer and neurodegenerative disorders. The role of HS emerges from its ability to interact and regulate the activity of a vast number of extracellular proteins including growth factors and extracellular matrix components. A global view on how protein-HS interactions influence the extracellular proteome and, consequently, cell function is currently lacking. Here, we systematically investigate the functional and structural properties that characterize HS-interacting proteins and the network they form. We collected 435 human proteins interacting with HS or the structurally related heparin by integrating literature-derived and affinity proteomics data. We used this data set to identify the topological features that distinguish the heparin/HS-interacting network from the rest of the extracellular proteome and to analyze the enrichment of gene ontology terms, pathways, and domain families in heparin/HS-binding proteins. Our analysis revealed that heparin/HS-binding proteins form a highly interconnected network, which is functionally linked to physiological and pathological processes that are characteristic of higher organisms. Therefore, we then investigated the existence of a correlation between the expansion of domain families characteristic of the heparin/HS interactome and the increase in biological complexity in the metazoan lineage. A strong positive correlation between the expansion of the heparin/HS interactome and biosynthetic machinery and organism complexity emerged. The evolutionary role of HS was reinforced by the presence of a rudimentary HS biosynthetic machinery in a unicellular organism at the root of the metazoan lineage.	[Fernig, David G.] Univ Liverpool, Inst Integrat Biol, Liverpool L69 7ZB, Merseyside, England; [Fernig, David G.] Univ Liverpool, Ctr Glycobiol, Liverpool L69 7ZB, Merseyside, England	University of Liverpool; University of Liverpool	Fernig, DG (corresponding author), Univ Liverpool, Inst Integrat Biol, Biosci Bldg,Crown St, Liverpool L69 7ZB, Merseyside, England.	dgfernig@liv.ac.uk	Ori, Alessandro/B-7067-2011; Fernig, David G/A-3590-2008; Ori, Alessandro/M-8586-2019	Ori, Alessandro/0000-0002-3046-0871; Fernig, David G/0000-0003-4875-4293; Ori, Alessandro/0000-0002-3046-0871; Wilkinson, Mark/0000-0003-3109-6888	European Commission; Cancer and Polio Research Fund Laboratories; North West Cancer Research Fund	European Commission(European CommissionEuropean Commission Joint Research Centre); Cancer and Polio Research Fund Laboratories; North West Cancer Research Fund	This work was supported by the European Commission Marie Curie Early Stage Training Program MolFun (to A. O.), the Cancer and Polio Research Fund Laboratories, and the North West Cancer Research Fund (to D. G. F.).	Abedin M, 2008, SCIENCE, V319, P946, DOI 10.1126/science.1151084; Allen BL, 2003, J CELL BIOL, V163, P637, DOI 10.1083/jcb.200307053; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Bandyopadhyay S, 2006, GENOME RES, V16, P428, DOI 10.1101/gr.4526006; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Belenkaya TY, 2004, CELL, V119, P231, DOI 10.1016/j.cell.2004.09.031; Beltrao P, 2007, PLOS COMPUT BIOL, V3, P258, DOI 10.1371/journal.pcbi.0030025; Blom AM, 2001, J BIOL CHEM, V276, P27136, DOI 10.1074/jbc.M102445200; Bornemann DJ, 2008, DEVELOPMENT, V135, P1039, DOI 10.1242/dev.017061; Chautard E, 2009, BIOINFORMATICS, V25, P690, DOI 10.1093/bioinformatics/btp025; Chen LG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004947; Chen Y, 2008, MOL CELLS, V26, P415; Clarris HJ, 1997, J NEUROCHEM, V68, P1164; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; DeAngelis PL, 2002, ANAT RECORD, V268, P317, DOI 10.1002/ar.10163; Domon B, 2010, NAT BIOTECHNOL, V28, P710, DOI 10.1038/nbt.1661; ErsdalBadju E, 1997, J BIOL CHEM, V272, P19393, DOI 10.1074/jbc.272.31.19393; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Fraser HB, 2006, CURR OPIN GENET DEV, V16, P637, DOI 10.1016/j.gde.2006.09.001; Freilich S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-247; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Grove CA, 2009, CELL, V138, P314, DOI 10.1016/j.cell.2009.04.058; Handel TM, 2005, ANNU REV BIOCHEM, V74, P385, DOI 10.1146/annurev.biochem.72.121801.161747; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huxley-Jones J, 2009, INT J EXP PATHOL, V90, P95, DOI 10.1111/j.1365-2613.2008.00637.x; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; INGHAM KC, 1990, BIOCHEM J, V272, P605, DOI 10.1042/bj2720605; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Julenius K, 2006, MOL BIOL EVOL, V23, P2039, DOI 10.1093/molbev/msl081; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kappler J, 2000, BIOCHEM BIOPH RES CO, V271, P287, DOI 10.1006/bbrc.2000.2583; Kerrien S, 2007, NUCLEIC ACIDS RES, V35, pD561, DOI 10.1093/nar/gkl958; Kim BT, 2001, P NATL ACAD SCI USA, V98, P7176, DOI 10.1073/pnas.131188498; King N, 2003, SCIENCE, V301, P361, DOI 10.1126/science.1083853; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Kitagawa H, 2007, J BIOL CHEM, V282, P8533, DOI 10.1074/jbc.M611107200; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Kuang ZH, 2006, J MOL BIOL, V364, P690, DOI 10.1016/j.jmb.2006.09.006; Kuno K, 1998, J BIOL CHEM, V273, P13912, DOI 10.1074/jbc.273.22.13912; Kusche-Gullberg M, 2003, CURR OPIN STRUC BIOL, V13, P605, DOI 10.1016/j.sbi.2003.08.002; Lee JS, 2004, NAT REV GENET, V5, P923, DOI 10.1038/nrg1490; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; Lyon M, 1997, J BIOL CHEM, V272, P18000, DOI 10.1074/jbc.272.29.18000; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Medeiros GF, 2000, BBA-GEN SUBJECTS, V1475, P287, DOI 10.1016/S0304-4165(00)00079-9; Mine S, 2002, BIOCHEMISTRY-US, V41, P78, DOI 10.1021/bi011299g; Murphy KJ, 2004, J BIOL CHEM, V279, P27239, DOI 10.1074/jbc.M401774200; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Ori A, 2008, FRONT BIOSCI-LANDMRK, V13, P4309, DOI 10.2741/3007; Ori A, 2009, MOL CELL PROTEOMICS, V8, P2256, DOI 10.1074/mcp.M900031-MCP200; Panopoulou G, 2005, TRENDS GENET, V21, P559, DOI 10.1016/j.tig.2005.08.004; Parish CR, 2006, NAT REV IMMUNOL, V6, P633, DOI 10.1038/nri1918; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Rastegar-Lari G, 2002, BIOCHEMISTRY-US, V41, P6668, DOI 10.1021/bi020044f; Ritty TM, 2003, BIOCHEM J, V375, P425, DOI 10.1042/BJ20030649; Sachchidanand, 2002, J BIOL CHEM, V277, P50629, DOI 10.1074/jbc.M208956200; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shao CH, 2006, J BIOL CHEM, V281, P31689, DOI 10.1074/jbc.M604502200; Shen L, 1999, THROMB HAEMOSTASIS, V82, P72, DOI 10.1055/s-0037-1614632; STEPHENS RW, 1992, BIOCHEMISTRY-US, V31, P7572, DOI 10.1021/bi00148a019; Taylor IW, 2009, NAT BIOTECHNOL, V27, P199, DOI 10.1038/nbt.1522; Thompson SM, 2010, BIRTH DEFECTS RES C, V90, P32, DOI 10.1002/bdrc.20169; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Tucker CL, 2001, TRENDS CELL BIOL, V11, P102, DOI 10.1016/S0962-8924(00)01902-4; Turnbull J, 2001, TRENDS CELL BIOL, V11, P75, DOI 10.1016/S0962-8924(00)01897-3; TURNBULL JE, 1991, BIOCHEM J, V273, P553, DOI 10.1042/bj2730553; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Uniewicz KA, 2008, FRONT BIOSCI-LANDMRK, V13, P4339, DOI 10.2741/3008; Van Vactor D, 2006, CURR OPIN NEUROBIOL, V16, P40, DOI 10.1016/j.conb.2006.01.011; Vogel C, 2006, PLOS COMPUT BIOL, V2, P370, DOI 10.1371/journal.pcbi.0020048; Vyas N, 2008, CELL, V133, P1214, DOI 10.1016/j.cell.2008.05.026; Wei G, 2000, J BIOL CHEM, V275, P27733; Yamada S, 2007, GLYCOBIOLOGY, V17, P886, DOI 10.1093/glycob/cwm051; Yu HN, 2005, BBA-GEN SUBJECTS, V1726, P168, DOI 10.1016/j.bbagen.2005.08.003; Yu SR, 2009, NATURE, V461, P533, DOI 10.1038/nature08391	83	163	168	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19892	19904		10.1074/jbc.M111.228114	http://dx.doi.org/10.1074/jbc.M111.228114			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21454685	Green Published, hybrid			2022-12-25	WOS:000291027700069
J	Zavala, LE; Pardo-Lopez, L; Canton, PE; Gomez, I; Soberon, M; Bravo, A				Enrique Zavala, Luis; Pardo-Lopez, Liliana; Emiliano Canton, Pablo; Gomez, Isabel; Soberon, Mario; Bravo, Alejandra			Domains II and III of Bacillus thuringiensis Cry1Ab Toxin Remain Exposed to the Solvent after Insertion of Part of Domain I into the Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OLIGOMERIC PRE-PORE; MANDUCA-SEXTA; DELTA-ENDOTOXIN; PROTEIN TOXINS; FORMING DOMAIN; MUTANTS; MIDGUT; ORGANIZATION; BINDING	Bacillus thuringiensis produces insecticidal proteins named Cry toxins, that are used commercially for the control of economical important insect pests. These are pore-forming toxins that interact with different receptors in the insect gut, forming pores in the apical membrane causing cell burst and insect death. Elucidation of the structure of the membrane-inserted toxin is important to fully understand its mechanism of action. One hypothesis proposed that the hairpin of alpha-helices 4-5 of domain I inserts into the phospholipid bilayer, whereas the rest of helices of domain I are spread on the membrane surface in an umbrella-like conformation. However, a second hypothesis proposed that the three domains of the Cry toxin insert into the bilayer without major conformational changes. In this work we constructed single Cys Cry1Ab mutants that remain active against Manduca sexta larvae and labeled them with different fluorescent probes that have different responses to solvent polarity. Different soluble quenchers as well as a membrane-bound quencher were used to compare the properties of the soluble and brush border membrane-inserted forms of Cry1Ab toxin. The fluorescence and quenching analysis presented here, revealed that domains II and III of the toxin remain in the surface of the membrane and only a discrete region of domain I is inserted into the lipid bilayer, supporting the umbrella model of toxin insertion.	[Enrique Zavala, Luis; Pardo-Lopez, Liliana; Emiliano Canton, Pablo; Gomez, Isabel; Soberon, Mario; Bravo, Alejandra] Univ Nacl Autonoma Mexico, Inst Biotecnol, Cuernavaca 62250, Morelos, Mexico	Universidad Nacional Autonoma de Mexico	Bravo, A (corresponding author), Apdo Postal 510-3, Cuernavaca 62250, Morelos, Mexico.	bravo@ibt.unam.mx	Ojeda, Pablo Emiliano Cantón/AAH-1044-2021; de la Parra, Maria Alejandra Bravo/R-6740-2017	Ojeda, Pablo Emiliano Cantón/0000-0002-9463-2441; Bravo, Alejandra/0000-0002-7573-7475; Pardo Lopez, Liliana/0000-0002-8927-1733	DGAPA/UNAM [IN206209-3, IN218409]; CONACyT [128883, 81679-Q]	DGAPA/UNAM(Universidad Nacional Autonoma de Mexico); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported in part through Grants IN206209-3 and IN218409 from DGAPA/UNAM and CONACyT Grants 128883 and 81679-Q.	ARANTES O, 1991, GENE, V108, P115, DOI 10.1016/0378-1119(91)90495-W; Arenas I, 2010, J BIOL CHEM, V285, P12497, DOI 10.1074/jbc.M109.085266; Bravo A, 2004, BBA-BIOMEMBRANES, V1667, P38, DOI 10.1016/j.bbamem.2004.08.013; BRAVO A, 2005, COMPREHENSIVE MOL IN, V4, P175; Bravo A, 2010, INSECT CONTROL, P248; Caputo GA, 2003, BIOCHEMISTRY-US, V42, P3265, DOI 10.1021/bi026696l; Cobb BA, 2000, J BIOL CHEM, V275, P6664, DOI 10.1074/jbc.275.9.6664; de Maagd RA, 2003, ANNU REV GENET, V37, P409, DOI 10.1146/annurev.genet.37.110801.143042; Gazit E, 1998, P NATL ACAD SCI USA, V95, P12289, DOI 10.1073/pnas.95.21.12289; Gerber D, 2000, J BIOL CHEM, V275, P23602, DOI 10.1074/jbc.M002596200; Girard F, 2009, BBA-BIOMEMBRANES, V1788, P575, DOI 10.1016/j.bbamem.2008.11.001; Girard F, 2008, APPL ENVIRON MICROB, V74, P2565, DOI 10.1128/AEM.00094-08; Huang SJ, 2004, ELECTROPHORESIS, V25, P779, DOI 10.1002/elps.200305723; HUDSON EN, 1973, BIOCHEMISTRY-US, V12, P4154, DOI 10.1021/bi00745a019; Jimenez-Juarez N, 2007, J BIOL CHEM, V282, P21222, DOI 10.1074/jbc.M701314200; Kumar ASM, 1999, J BACTERIOL, V181, P6103; Lakowicz J.R., 2010, PRINCIPLE FLUORESCEN, DOI 10.1007/978-0-387-46312-4/COVER; Loseva OI, 2001, BIOCHEMISTRY-US, V40, P14143, DOI 10.1021/bi010171w; Mueller M, 2009, NATURE, V459, P726, DOI 10.1038/nature08026; Munoz-Garay C, 2006, J MEMBRANE BIOL, V212, P61, DOI 10.1007/s00232-006-0003-8; Munoz-Garay C, 2009, BBA-BIOMEMBRANES, V1788, P2229, DOI 10.1016/j.bbamem.2009.06.014; Nair MS, 2008, J BIOL CHEM, V283, P26324, DOI 10.1074/jbc.M802895200; Pacheco S, 2009, J BIOL CHEM, V284, P32750, DOI 10.1074/jbc.M109.024968; Panchuk-Voloshina N, 1999, J HISTOCHEM CYTOCHEM, V47, P1179, DOI 10.1177/002215549904700910; Pardo-Lopez L, 2006, BIOCHEMISTRY-US, V45, P10329, DOI 10.1021/bi060297z; Parker MW, 2005, PROG BIOPHYS MOL BIO, V88, P91, DOI 10.1016/j.pbiomolbio.2004.01.009; Penefsky H S, 1979, Methods Enzymol, V56, P527; Ramachandran R, 2004, NAT STRUCT MOL BIOL, V11, P697, DOI 10.1038/nsmb793; Rausell C, 2004, J BIOL CHEM, V279, P55168, DOI 10.1074/jbc.M406279200; Rausell C, 2004, BIOCHEMISTRY-US, V43, P166, DOI 10.1021/bi035527d; Rodriguez-Almazan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005545; Schwartz JL, 1997, FEBS LETT, V410, P397, DOI 10.1016/S0014-5793(97)00626-1; SHAHROKH Z, 1991, J BIOL CHEM, V266, P12082; Soberon M, 2009, CELL MOL LIFE SCI, V66, P1337, DOI 10.1007/s00018-008-8330-9; Spruijt RB, 1996, BIOCHEMISTRY-US, V35, P10383, DOI 10.1021/bi960410t; Taveecharoenkool T., 2010, PMC BIOPHYS, V3, P1; Vachon V, 2004, APPL ENVIRON MICROB, V70, P6123, DOI 10.1128/AEM.70.10.6123-6130.2004; Vachon V, 2002, BIOCHEMISTRY-US, V41, P6178, DOI 10.1021/bi011572e; WOLFERSBERGER M, 1987, COMP BIOCHEM PHYS A, V86, P301, DOI 10.1016/0300-9629(87)90334-3; Zhuang MB, 2002, J BIOL CHEM, V277, P13863, DOI 10.1074/jbc.M110057200	40	16	18	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					19109	19117		10.1074/jbc.M110.202994	http://dx.doi.org/10.1074/jbc.M110.202994			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21464133	Green Published, hybrid			2022-12-25	WOS:000290785700080
J	Dong, AW; Gupta, A; Pai, RK; Tun, M; Lowe, AW				Dong, Aiwen; Gupta, Aparna; Pai, Reetesh K.; Tun, May; Lowe, Anson W.			The Human Adenocarcinoma-associated Gene, AGR2, Induces Expression of Amphiregulin through Hippo Pathway Co-activator YAP1 Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORGAN SIZE CONTROL; HUMAN HOMOLOG; CELL; CANCER; PROTEIN; REGENERATION; DROSOPHILA; GROWTH; EGFR; AUTOCRINE	Anterior Gradient Homolog 2 (AGR2) is expressed by the normal intestine and by most human adenocarcinomas, including those derived from the esophagus, pancreas, lung, breast, ovary, and prostate. Xenografts of human adenocarcinoma cell lines in nude mice previously demonstrated that AGR2 supports tumor growth. In addition, AGR2 is able to induce in vitro a transformed phenotype in fibroblast and epithelial cell lines. The mechanism underlying the growth promoting effects of AGR2 is unknown. The present study shows that AGR2 induces expression of amphiregulin (AREG), a growth promoting EGFR ligand. Induced AREG expression in adenocarcinoma cells is able to rescue the transformed phenotype that is lost when AGR2 expression is reduced. Additional experiments demonstrate that AGR2 induction of AREG is mediated by activation of the Hippo signaling pathway co-activator, YAP1. Thus AGR2 promotes growth by regulating the Hippo and EGF receptor signaling pathways.	[Dong, Aiwen; Gupta, Aparna; Tun, May; Lowe, Anson W.] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Pai, Reetesh K.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Lowe, Anson W.] Stanford Univ, Stanford Digest Dis Ctr, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Lowe, AW (corresponding author), Alway Bldg,Rm M211,300 Pasteur Dr, Stanford, CA 94305 USA.	lowe@stanford.edu	Dong, Aiwen/B-1258-2013	Dong, Aiwen/0000-0003-4931-3633	National Institutes of Health [DK063624]; Stanford University Digestive Disease Center [DK56339]; Stanford Cancer Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063624, P30DK056339] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford University Digestive Disease Center; Stanford Cancer Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK063624 (to A. W. L.), DK56339 (Stanford University Digestive Disease Center), and the Stanford Cancer Center.	Aberger F, 1998, MECH DEVELOP, V72, P115, DOI 10.1016/S0925-4773(98)00021-5; AKAGI M, 1995, CANCER, V75, P1460, DOI 10.1002/1097-0142(19950315)75:6+<1460::AID-CNCR2820751513>3.0.CO;2-L; Alvarez H, 2008, CANCER BIOL THER, V7, P1753; Baldys A, 2009, BIOCHEMISTRY-US, V48, P1462, DOI 10.1021/bi801771g; BANKSSCHLEGEL SP, 1985, CANCER RES, V45, P1187; Berasain C, 2005, GASTROENTEROLOGY, V128, P424, DOI 10.1053/j.gastro.2004.11.006; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Boonstra JJ, 2010, JNCI-J NATL CANCER I, V102, P271, DOI 10.1093/jnci/djp499; Bostwick DG, 2004, PROSTATE, V58, P164, DOI 10.1002/pros.10322; Brown CL, 1998, J BIOL CHEM, V273, P17258, DOI 10.1074/jbc.273.27.17258; Brown CL, 2001, J BIOL CHEM, V276, P29538, DOI 10.1074/jbc.M102114200; Cai J, 2010, GENE DEV, V24, P2383, DOI 10.1101/gad.1978810; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Castillo J, 2006, CANCER RES, V66, P6129, DOI 10.1158/0008-5472.CAN-06-0404; COX AD, 1994, METHOD ENZYMOL, V238, P277; D'Antonio A, 2002, INT J ONCOL, V21, P941; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; EBERT M, 1994, CANCER RES, V54, P3959; Edgell TA, 2010, CLIN SCI, V118, P717, DOI 10.1042/CS20090537; Fritzsche FR, 2007, HISTOL HISTOPATHOL, V22, P703, DOI 10.14670/HH-22.703; Gan Y, 2010, ONCOGENE, V29, P4947, DOI 10.1038/onc.2010.240; Hao Y, 2006, GASTROENTEROLOGY, V131, P925, DOI 10.1053/j.gastro.2006.04.026; JOHNSON GR, 1992, J CELL BIOL, V118, P741, DOI 10.1083/jcb.118.3.741; Kumar A, 2007, SCIENCE, V318, P772, DOI 10.1126/science.1147710; Lian I, 2010, GENE DEV, V24, P1106, DOI 10.1101/gad.1903310; Liu D, 2005, CANCER RES, V65, P3796, DOI 10.1158/0008-5472.CAN-04-3823; Lowe AW, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000323; Ma L, 1999, ONCOGENE, V18, P6513, DOI 10.1038/sj.onc.1203042; MartinezLacaci I, 1996, J CELL PHYSIOL, V169, P497, DOI 10.1002/(SICI)1097-4652(199612)169:3<497::AID-JCP10>3.0.CO;2-3; Persson S, 2005, MOL PHYLOGENET EVOL, V36, P734, DOI 10.1016/j.ympev.2005.04.002; Ramachandran V, 2008, CANCER RES, V68, P7811, DOI 10.1158/0008-5472.CAN-08-1320; Ren FF, 2010, P NATL ACAD SCI USA, V107, P21064, DOI 10.1073/pnas.1012759107; Rockett JC, 1997, BRIT J CANCER, V75, P258, DOI 10.1038/bjc.1997.42; SAEKI T, 1992, CANCER RES, V52, P3467; Schuger L, 1996, DEVELOPMENT, V122, P1759; Shao JY, 2010, ENDOCRINOLOGY, V151, P3728, DOI 10.1210/en.2010-0319; SHOYAB M, 1989, SCIENCE, V243, P1074, DOI 10.1126/science.2466334; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Staley BK, 2010, CURR BIOL, V20, P1580, DOI 10.1016/j.cub.2010.07.041; Steinhardt AA, 2008, HUM PATHOL, V39, P1582, DOI 10.1016/j.humpath.2008.04.012; Stern KA, 2008, BIOCHEM J, V410, P585, DOI 10.1042/BJ20071505; Sternlicht MD, 2005, DEVELOPMENT, V132, P3923, DOI 10.1242/dev.01966; Thompson DA, 1998, BIOCHEM BIOPH RES CO, V251, P111, DOI 10.1006/bbrc.1998.9440; Wang Z, 2008, CANCER RES, V68, P492, DOI 10.1158/0008-5472.CAN-07-2930; Willmarth NE, 2006, J BIOL CHEM, V281, P37728, DOI 10.1074/jbc.M606532200; Yotsumoto F, 2008, BIOCHEM BIOPH RES CO, V365, P555, DOI 10.1016/j.bbrc.2007.11.015; Zeng Q, 2008, CANCER CELL, V13, P188, DOI 10.1016/j.ccr.2008.02.011; Zhang JM, 2008, CANCER RES, V68, P2789, DOI 10.1158/0008-5472.CAN-07-6205; Zhang JM, 2009, NAT CELL BIOL, V11, P1444, DOI 10.1038/ncb1993; Zhang JS, 2005, GENE CHROMOSOME CANC, V43, P249, DOI 10.1002/gcc.20188; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; Zhu H, 2007, CANCER LETT, V245, P303, DOI 10.1016/j.canlet.2006.01.020	52	72	75	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					18301	18310		10.1074/jbc.M110.215707	http://dx.doi.org/10.1074/jbc.M110.215707			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454516	Green Published, hybrid			2022-12-25	WOS:000290585200090
J	Fecto, F; Shi, Y; Huda, R; Martina, M; Siddique, T; Deng, HX				Fecto, Faisal; Shi, Yong; Huda, Rafiq; Martina, Marco; Siddique, Teepu; Deng, Han-Xiang			Mutant TRPV4-mediated Toxicity Is Linked to Increased Constitutive Function in Axonal Neuropathies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINAL MUSCULAR-ATROPHY; SENSORY NEUROPATHY; HEREDITARY MOTOR; TRPV4; CALCIUM; DISEASE; DISORDERS; MUTATIONS; HMSN2C; GENE	Mutations in TRPV4 have been linked to three distinct axonal neuropathies. However, the pathogenic mechanism underlying these disorders remains unclear. Both gain and loss of calcium channel activity of the mutant TRPV4 have been suggested. Here, we show that the three previously reported TRPV4 mutant channels have a physiological localization and display an increased calcium channel activity, leading to increased cytotoxicity in three different cell types. Patch clamp experiments showed that cells expressing mutant TRPV4 have much larger whole-cell currents than those expressing the wild-type TRPV4 channel. Single channel recordings showed that the mutant channels have higher open probability, due to a modification of gating, and no change in single-channel conductance. These data support the hypothesis that a "gain of function" mechanism, possibly leading to increased intracellular calcium influx, underlies the pathogenesis of the TRPV4-linked axonal neuropathies, and may have immediate implications for designing rational therapies.	[Fecto, Faisal; Shi, Yong; Siddique, Teepu; Deng, Han-Xiang] Northwestern Univ, Feinberg Sch Med, Div Neuromuscular Med, Davee Dept Neurol & Clin Neurosci, Chicago, IL 60611 USA; [Fecto, Faisal; Huda, Rafiq; Martina, Marco; Siddique, Teepu] Northwestern Univ, Feinberg Sch Med, Interdept Neurosci Program, Chicago, IL 60611 USA; [Huda, Rafiq; Martina, Marco] Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; [Siddique, Teepu] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Deng, HX (corresponding author), Northwestern Univ, Feinberg Sch Med, Div Neuromuscular Med, Davee Dept Neurol & Clin Neurosci, Chicago, IL 60611 USA.	h-deng@northwestern.edu	Siddique, Teepu/AAT-8166-2021	Huda, Rafiq/0000-0002-6814-9966; martina, marco/0000-0002-9648-2918; Deng, Han-Xiang/0000-0002-0030-8465; Siddique, Teepu/0000-0001-7293-9146; Fecto, Faisal/0000-0002-7587-8024	NINDS [NS050641]; NHLBI [HL095731]; National Institutes of Health [T32 AG20506, T32 MH067564]; Les Turner ALS Foundation; Vena E. Schaff ALS Research Fund; Harold Post Research Professorship; Herbert and Florence C. Wenske Foundation; David C. Asselin MD Memorial Fund; Help America Foundation; Les Turner ALS Foundation/Herbert C. Wenske Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095731] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH067564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050641] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG020506] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Les Turner ALS Foundation; Vena E. Schaff ALS Research Fund; Harold Post Research Professorship; Herbert and Florence C. Wenske Foundation; David C. Asselin MD Memorial Fund; Help America Foundation; Les Turner ALS Foundation/Herbert C. Wenske Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by NINDS Grant NS050641, NHLBI Grant HL095731, and Grants T32 AG20506 and T32 MH067564 from the National Institutes of Health. This work was also supported by the Les Turner ALS Foundation, the Vena E. Schaff ALS Research Fund, the Harold Post Research Professorship, the Herbert and Florence C. Wenske Foundation, the David C. Asselin MD Memorial Fund, the Help America Foundation, and the Les Turner ALS Foundation/Herbert C. Wenske Foundation Professorship.	Auer-Grumbach M, 2010, NAT GENET, V42, P160, DOI 10.1038/ng.508; DELONG R, 1992, ARCH NEUROL-CHICAGO, V49, P905, DOI 10.1001/archneur.1992.00530330027010; Dempster J., 1993, COMPUTER ANAL ELECTR; Deng HX, 2010, NAT GENET, V42, P165, DOI 10.1038/ng.509; Deng HX, 2006, P NATL ACAD SCI USA, V103, P7142, DOI 10.1073/pnas.0602046103; DYCK PJ, 1994, ANN NEUROL, V35, P608, DOI 10.1002/ana.410350515; Everaerts W, 2010, P NATL ACAD SCI USA, V107, P19084, DOI 10.1073/pnas.1005333107; FARBER JL, 1981, LIFE SCI, V29, P1289, DOI 10.1016/0024-3205(81)90670-6; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Isozumi K, 1996, HUM MOL GENET, V5, P1377, DOI 10.1093/hmg/5.9.1377; Klein CJ, 2011, NEUROLOGY, V76, P887, DOI 10.1212/WNL.0b013e31820f2de3; Klein CJ, 2003, NEUROLOGY, V60, P1151, DOI 10.1212/01.WNL.0000055900.30217.EA; Landoure G, 2010, NAT GENET, V42, P170, DOI 10.1038/ng.512; Liedtke W, 2008, ANN NY ACAD SCI, V1144, P42, DOI 10.1196/annals.1418.012; Loukin S, 2010, J BIOL CHEM, V285, P27176, DOI 10.1074/jbc.M110.143370; Marongiu R, 2009, J NEUROCHEM, V108, P1561, DOI 10.1111/j.1471-4159.2009.05932.x; Mattson MP, 2007, AGING CELL, V6, P337, DOI 10.1111/j.1474-9726.2007.00275.x; McEntagart ME, 2005, ANN NEUROL, V57, P293, DOI 10.1002/ana.20375; Nilius B, 2010, NAT GENET, V42, P98, DOI 10.1038/ng0210-98; Ritz B, 2010, ANN NEUROL, V67, P600, DOI 10.1002/ana.21937; Suzuki M, 2003, J BIOL CHEM, V278, P51448, DOI 10.1074/jbc.M308212200; Wegierski T, 2009, J BIOL CHEM, V284, P2923, DOI 10.1074/jbc.M805357200; Wissenbach U, 2000, FEBS LETT, V485, P127, DOI 10.1016/S0014-5793(00)02212-2; Zimon M, 2010, BRAIN, V133, P1798, DOI 10.1093/brain/awq109	24	37	37	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17281	17291		10.1074/jbc.M111.237685	http://dx.doi.org/10.1074/jbc.M111.237685			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454511	Green Published, hybrid			2022-12-25	WOS:000290301900076
J	Horl, G; Wagner, A; Cole, LK; Malli, R; Reicher, H; Kotzbeck, P; Kofeler, H; Hofler, G; Frank, S; Bogner-Strauss, JG; Sattler, W; Vance, DE; Steyrer, E				Hoerl, Gerd; Wagner, Andrea; Cole, Laura K.; Malli, Roland; Reicher, Helga; Kotzbeck, Petra; Koefeler, Harald; Hoefler, Gerald; Frank, Sasa; Bogner-Strauss, Juliane G.; Sattler, Wolfgang; Vance, Dennis E.; Steyrer, Ernst			Sequential Synthesis and Methylation of Phosphatidylethanolamine Promote Lipid Droplet Biosynthesis and Stability in Tissue Culture and in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CTP-PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE; ADIPOSE TRIGLYCERIDE LIPASE; DIET-INDUCED OBESITY; N-METHYLTRANSFERASE; RAT-LIVER; PHOSPHATIDYLCHOLINE SYNTHESIS; PHOSPHOLIPID-COMPOSITION; ENDOPLASMIC-RETICULUM; ADIPOCYTE LIPOLYSIS; MEMBRANE-FRACTION	Triacylglycerols are stored in eukaryotic cells within lipid droplets (LD). The LD core is enwrapped by a phospholipid monolayer with phosphatidylcholine (PC), the major phospholipid, and phosphatidylethanolamine (PE), a minor component. We demonstrate that the onset of LD formation is characterized by a change in cellular PC, PE, and phosphatidylserine (PS). With induction of differentiation of 3T3-L1 fibroblasts into adipocytes, the cellular PC/PE ratio decreased concomitant with LD formation, with the most pronounced decline between confluency and day 5. The mRNA for PS synthase-1 (forms PS from PC) and PS decarboxylase (forms PE from PS) increased after day 5. Activity and protein of PE N-methyltransferase (PEMT), which produces PC by methylation of PE, are absent in 3T3-L1 fibroblasts but were induced at day 5. High fat challenge induced PEMT expression in mouse adipose tissue. PE, produced via PS decarboxylase, was the preferred substrate for methylation to PC. A PEMT-GFP fusion protein decorated the periphery of LD. PEMT knockdown in 3T3-L1 adipocytes correlated with increased basal triacylglycerol hydrolysis. Pemt(-/-) mice developed desensitization against adenosine-mediated inhibition of basal hydrolysis in adipose tissue, and adipocyte hypotrophy was observed in Pemt(-/-) animals on a high fat diet. Knock-out of PEMT in adipose tissue down-regulated PS synthase-1 mRNA, suggesting coordination between PE supply and converting pathways during LD biosynthesis. We conclude that two consecutive processes not previously related to LD biogenesis, (i) PE production via PS and (ii) PE conversion via PEMT, are implicated in LD formation and stability.	[Hoerl, Gerd; Wagner, Andrea; Malli, Roland; Reicher, Helga; Frank, Sasa; Sattler, Wolfgang; Steyrer, Ernst] Med Univ Graz, Dept Mol Biol & Biochem, Ctr Mol Med, A-8010 Graz, Austria; [Cole, Laura K.; Vance, Dennis E.] Univ Alberta, Grp Mol & Cell Biol Lipids, Edmonton, AB T6G 2S2, Canada; [Cole, Laura K.; Vance, Dennis E.] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2S2, Canada; [Kotzbeck, Petra] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria; [Koefeler, Harald] Med Univ Graz, Med Res Ctr, A-8010 Graz, Austria; [Hoefler, Gerald] Med Univ Graz, Dept Pathol, A-8010 Graz, Austria; [Bogner-Strauss, Juliane G.] Graz Univ Technol, Inst Genom & Bioinformat, A-8010 Graz, Austria	Medical University of Graz; University of Alberta; University of Alberta; University of Graz; Medical University of Graz; Medical University of Graz; Graz University of Technology	Steyrer, E (corresponding author), Med Univ Graz, Dept Mol Biol & Biochem, Ctr Mol Med, Harrachgasse 21, A-8010 Graz, Austria.	ernst.steyrer@medunigraz.at		Bogner-Strauss, Juliane/0000-0003-2459-0124; Kotzbeck, Petra/0000-0003-4039-3745; Groselj-Strele, Andrea/0000-0002-0709-5458; Kofeler, Harald/0000-0002-2725-9616; Hoerl, Gerd/0000-0002-0884-0851; Malli, Roland/0000-0001-6327-8729	Austrian Science Funds [P-15.358, F3007 SFB LIPOTOX, F3002-B05 SFB LIPTOX, P-19473]; Austrian Heart Foundation [01/08]; Franz-Lanyar Foundation (Graz, Austria) [P-308, P-323]; Austrian Ministry for Science and Research; Canadian Institutes of Health Research; Alberta Heritage Foundation for Medical Research; National Science and Engineering Research Council; Austrian Science Fund (FWF) [F 3007, W 901] Funding Source: researchfish	Austrian Science Funds(Austrian Science Fund (FWF)); Austrian Heart Foundation; Franz-Lanyar Foundation (Graz, Austria); Austrian Ministry for Science and Research; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); National Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Austrian Science Funds P-15.358 (to E. S.), F3007 SFB LIPOTOX (to W. S.), F3002-B05 SFB LIPTOX (to G. H.), and P-19473 (to S. F.), Austrian Heart Foundation Project 01/08 (to E. S.), Franz-Lanyar Foundation (Graz, Austria) Grants P-308 (to G. Horl) and P-323 (to E. S.), Austrian Ministry for Science and Research GEN-AU Project GOLDIII (to J. G. B.-S.), and the Canadian Institutes of Health Research (to D. E. V.).; Recipient of studentship awards from the Alberta Heritage Foundation for Medical Research and the National Science and Engineering Research Council.	Andersson L, 2006, J CELL SCI, V119, P2246, DOI 10.1242/jcs.02941; Arikketh D, 2008, J BIOL CHEM, V283, P12888, DOI 10.1074/jbc.M800714200; Badman MK, 2007, GASTROENTEROLOGY, V132, P2103, DOI 10.1053/j.gastro.2007.03.058; Bartz R, 2007, J LIPID RES, V48, P837, DOI 10.1194/jlr.M600413-JLR200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Blouin CM, 2010, J LIPID RES, V51, P945, DOI 10.1194/jlr.M001016; Borglum JD, 1996, MOL CELL ENDOCRINOL, V117, P17, DOI 10.1016/0303-7207(95)03728-4; Bostrom P, 2007, NAT CELL BIOL, V9, P1286, DOI 10.1038/ncb1648; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Brasaemle DL, 2000, J BIOL CHEM, V275, P38486, DOI 10.1074/jbc.M007322200; Brugger B, 1997, P NATL ACAD SCI USA, V94, P2339, DOI 10.1073/pnas.94.6.2339; Chang BHJ, 2007, AM J PHYSIOL-GASTR L, V292, pG1465, DOI 10.1152/ajpgi.00566.2006; Ciruela F, 2010, BBA-BIOMEMBRANES, V1798, P9, DOI 10.1016/j.bbamem.2009.10.016; Cole LK, 2010, J BIOL CHEM, V285, P11880, DOI 10.1074/jbc.M110.109843; CUI Z, 1993, J BIOL CHEM, V268, P16655; DeLong CJ, 1999, J BIOL CHEM, V274, P29683, DOI 10.1074/jbc.274.42.29683; Dowhan W, 2008, N COMP BIOC, P1, DOI 10.1016/B978-044453219-0.50003-9; FAST DG, 1995, BBA-LIPID LIPID MET, V1258, P159, DOI 10.1016/0005-2760(95)00116-T; Fujimoto T, 2008, HISTOCHEM CELL BIOL, V130, P263, DOI 10.1007/s00418-008-0449-0; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; HOFFMAN BB, 1986, J CLIN INVEST, V78, P185, DOI 10.1172/JCI112550; Jacobs RL, 2010, J BIOL CHEM, V285, P22403, DOI 10.1074/jbc.M110.108514; Karim M, 2003, BBA-MOL CELL BIOL L, V1633, P1, DOI 10.1016/S1388-1981(03)00067-2; Kast HR, 2001, J LIPID RES, V42, P1266; KASTURI R, 1983, J BIOL CHEM, V258, P3559; Kornmann B, 2010, J CELL SCI, V123, P1389, DOI 10.1242/jcs.058636; Kuerschner L, 2008, TRAFFIC, V9, P338, DOI 10.1111/j.1600-0854.2007.00689.x; Lehner R, 1999, BIOCHEM J, V338, P761, DOI 10.1042/0264-6021:3380761; Levine T, 2004, TRENDS CELL BIOL, V14, P483, DOI 10.1016/j.tcb.2004.07.017; Liu PS, 2007, BBA-MOL CELL RES, V1773, P784, DOI 10.1016/j.bbamcr.2007.02.004; Marchesan D, 2003, J BIOL CHEM, V278, P27293, DOI 10.1074/jbc.M301430200; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Martinez-Botas J, 2000, NAT GENET, V26, P474, DOI 10.1038/82630; Murphy DJ, 1999, TRENDS BIOCHEM SCI, V24, P109, DOI 10.1016/S0968-0004(98)01349-8; Nakamura N, 2005, BIOCHEM BIOPH RES CO, V335, P117, DOI 10.1016/j.bbrc.2005.07.050; Nishimaki-Mogami T, 2002, J LIPID RES, V43, P1035, DOI 10.1194/jlr.M100354-JLR200; Noga AA, 2002, J BIOL CHEM, V277, P42358, DOI 10.1074/jbc.M204542200; Ost A, 2005, J BIOL CHEM, V280, P5, DOI 10.1074/jbc.C400429200; Prattes S, 2000, J CELL SCI, V113, P2977; Rasband W. S., 1997, IMAGEJ VER 1 44; RIDGWAY ND, 1992, METHOD ENZYMOL, V209, P366; Robenek H, 2006, J CELL SCI, V119, P4215, DOI 10.1242/jcs.03191; Sattler W, 1996, LIPIDS, V31, P1303, DOI 10.1007/BF02587917; Schrader M, 2001, J HISTOCHEM CYTOCHEM, V49, P1421, DOI 10.1177/002215540104901110; SCOW RO, 1991, BRAIN RES BULL, V27, P487, DOI 10.1016/0361-9230(91)90147-C; Shields DJ, 2003, J BIOL CHEM, V278, P35826, DOI 10.1074/jbc.M306308200; Shields DJ, 2003, J BIOL CHEM, V278, P2956, DOI 10.1074/jbc.M210904200; Sprong H, 2001, NAT REV MOL CELL BIO, V2, P504, DOI 10.1038/35080071; Steenbergen R, 2006, BBA-MOL CELL BIOL L, V1761, P313, DOI 10.1016/j.bbalip.2006.03.005; Tansey JT, 2004, IUBMB LIFE, V56, P379, DOI 10.1080/15216540400009968; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; Tansey JT, 2003, J BIOL CHEM, V278, P8401, DOI 10.1074/jbc.M211005200; Tauchi-Sato K, 2002, J BIOL CHEM, V277, P44507, DOI 10.1074/jbc.M207712200; Trenker M, 2007, NAT CELL BIOL, V9, P445, DOI 10.1038/ncb1556; Vance DE, 2008, N COMP BIOC, P213, DOI 10.1016/B978-044453219-0.50010-6; VANCE JE, 1986, J BIOL CHEM, V261, P4486; VANCE JE, 1990, J BIOL CHEM, V265, P7248; Vance JE, 2008, J LIPID RES, V49, P1377, DOI 10.1194/jlr.R700020-JLR200; VERKADE HJ, 1993, J BIOL CHEM, V268, P24990; Viswanadha S, 2006, J LIPID RES, V47, P1859, DOI 10.1194/jlr.D600005-JLR200; VOELKER DR, 1989, J BIOL CHEM, V264, P8019; VOELKER DR, 1989, P NATL ACAD SCI USA, V86, P9921, DOI 10.1073/pnas.86.24.9921; Walkey CJ, 1997, P NATL ACAD SCI USA, V94, P12880, DOI 10.1073/pnas.94.24.12880; Wolins NE, 2006, FEBS LETT, V580, P5484, DOI 10.1016/j.febslet.2006.08.040; Wolins NE, 2006, J LIPID RES, V47, P450, DOI 10.1194/jlr.D500037-JLR200; Zechner R, 2005, CURR OPIN LIPIDOL, V16, P333, DOI 10.1097/01.mol.0000169354.20395.1c; Zhu XN, 2003, BIOCHEM J, V370, P987, DOI 10.1042/BJ20021523; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	69	75	77	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17338	17350		10.1074/jbc.M111.234534	http://dx.doi.org/10.1074/jbc.M111.234534			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454708	Green Published, hybrid			2022-12-25	WOS:000290301900081
J	Piantadosi, CA; Withers, CM; Bartz, RR; MacGarvey, NC; Fu, P; Sweeney, TE; Welty-Wolf, KE; Suliman, HB				Piantadosi, Claude A.; Withers, Crystal M.; Bartz, Raquel R.; MacGarvey, Nancy Chou; Fu, Ping; Sweeney, Timothy E.; Welty-Wolf, Karen E.; Suliman, Hagir B.			Heme Oxygenase-1 Couples Activation of Mitochondrial Biogenesis to Anti-inflammatory Cytokine Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; HUMAN IL-10 GENE; NF-KAPPA-B; CARBON-MONOXIDE; TRANSCRIPTION FACTOR; OXIDATIVE-METABOLISM; ENDOTOXIC-SHOCK; PROTECTS MICE; INTERLEUKIN-10; INDUCTION	The induction of heme oxygenase-1 (HO-1; Hmox1) by inflammation, for instance in sepsis, is associated both with an anti-inflammatory response and with mitochondrial biogenesis. Here, we tested the idea that HO-1, acting through the Nfe2l2 (Nrf2) transcription factor, links anti-inflammatory cytokine expression to activation of mitochondrial biogenesis. HO-1 induction after LPS stimulated anti-inflammatory IL-10 and IL-1 receptor antagonist (IL-1Ra) expression in mouse liver, human HepG2 cells, and mouse J774.1 macrophages but blunted tumor necrosis factor-alpha expression. This was accompanied by nuclear Nfe2l2 accumulation and led us to identify abundant Nfe2l2 and other mitochondrial biogenesis transcription factor binding sites in the promoter regions of IL10 and IL1Ra compared with pro-inflammatory genes regulated by NF-kappa B. Mechanistically, HO-1, through its CO product, enabled these transcription factors to bind the core IL10 and IL1Ra promoters, which for IL10 included Nfe2l2, nuclear respiratory factor (NRF)-2 (Gabpa), and MEF2, and for IL1Ra, included NRF-1 and MEF2. In cells, Hmox1 or Nfe2l2 RNA silencing prevented IL-10 and IL-1Ra up-regulation, and HO-1 induction failed post-LPS in Nfe2l2-silenced cells and post-sepsis in Nfe2l2(-/-) mice. Nfe2l2(-/-) mice compared with WT mice, showed more liver damage, higher mortality, and ineffective CO rescue in sepsis. Nfe2l2(-/-) mice in sepsis also generated higher hepatic TNF-alpha mRNA levels, lower NRF-1 and PGC-1 alpha mRNA levels, and no enhancement of anti-inflammatory Il10, Socs3, or bcl-x(L) gene expression. These findings disclose a highly structured transcriptional network that couples mitochondrial biogenesis to counter-inflammation with major implications for immune suppression in sepsis.	[Piantadosi, Claude A.; MacGarvey, Nancy Chou; Welty-Wolf, Karen E.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Piantadosi, Claude A.; Bartz, Raquel R.; Fu, Ping; Suliman, Hagir B.] Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC 27710 USA; [Piantadosi, Claude A.; Withers, Crystal M.; Sweeney, Timothy E.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Piantadosi, Claude A.; Welty-Wolf, Karen E.] Durham Vet Affairs Med Ctr, Dept Med, Durham, NC 27710 USA; [Bartz, Raquel R.] Durham Vet Affairs Med Ctr, Dept Anesthesiol, Durham, NC 27710 USA	Duke University; Duke University; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center	Piantadosi, CA (corresponding author), Duke Univ, Med Ctr, Dept Med, 0570 White Zone,CR 2 Bldg, Durham, NC 27710 USA.	piant001@mc.duke.edu		Sweeney, Timothy/0000-0002-3596-1093	National Institutes of Health [AI064789, GM084116]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI064789, R01AI064789] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K08GM087429, R01GM084116] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI064789 and GM084116.	Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071; Alvarez Y, 2009, J IMMUNOL, V183, P1471, DOI 10.4049/jimmunol.0900312; BERG DJ, 1995, J CLIN INVEST, V96, P2339, DOI 10.1172/JCI118290; Bourdi M, 2002, HEPATOLOGY, V35, P289, DOI 10.1053/jhep.2002.30956; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Brandtzaeg P, 1996, J EXP MED, V184, P51, DOI 10.1084/jem.184.1.51; Brealey David, 2002, Lancet (North American Edition), V360, P219, DOI 10.1016/S0140-6736(02)09459-X; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Brouard S, 2000, J EXP MED, V192, P1015, DOI 10.1084/jem.192.7.1015; Bruey JM, 2007, CELL, V129, P45, DOI 10.1016/j.cell.2007.01.045; Carre JE, 2010, AM J RESP CRIT CARE, V182, P745, DOI 10.1164/rccm.201003-0326OC; Cauwels A, 2003, NAT IMMUNOL, V4, P387, DOI 10.1038/ni914; Chhikara M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008139; Crouser ED, 2006, CRIT CARE MED, V34, P2439, DOI 10.1097/01.CCM.0000230240.02216.21; Czubryt MP, 2003, P NATL ACAD SCI USA, V100, P1711, DOI 10.1073/pnas.0337639100; Dasgupta J, 2006, ANTIOXID REDOX SIGN, V8, P1295, DOI 10.1089/ars.2006.8.1295; Deng JP, 2001, KIDNEY INT, V60, P2118, DOI 10.1046/j.1523-1755.2001.00043.x; Dhingra S, 2009, CARDIOVASC RES, V82, P59, DOI 10.1093/cvr/cvp040; Dinarello CA, 2010, EUR J IMMUNOL, V40, P599, DOI 10.1002/eji.201040319; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Drechsler Y, 2006, J IMMUNOL, V177, P2592, DOI 10.4049/jimmunol.177.4.2592; GERARD C, 1993, J EXP MED, V177, P547, DOI 10.1084/jem.177.2.547; Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600; Haden DW, 2007, AM J RESP CRIT CARE, V176, P768, DOI 10.1164/rccm.200701-161OC; Hotchkiss RS, 2010, NEW ENGL J MED, V363, P87, DOI 10.1056/NEJMcibr1004371; HOWARD M, 1993, J EXP MED, V177, P1205, DOI 10.1084/jem.177.4.1205; Kanneganti TD, 2007, IMMUNITY, V26, P433, DOI 10.1016/j.immuni.2007.03.008; Kantrow SP, 1997, ARCH BIOCHEM BIOPHYS, V345, P278, DOI 10.1006/abbi.1997.0264; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; KNOLLE P, 1995, J HEPATOL, V22, P226, DOI 10.1016/0168-8278(95)80433-1; Lai CF, 1996, J BIOL CHEM, V271, P13968, DOI 10.1074/jbc.271.24.13968; Lee BS, 2006, BIOCHEM BIOPH RES CO, V343, P965, DOI 10.1016/j.bbrc.2006.03.058; Lee TS, 2002, NAT MED, V8, P240, DOI 10.1038/nm0302-240; Li MH, 2007, J BIOL CHEM, V282, P28577, DOI 10.1074/jbc.M701916200; Lin CY, 2007, J HEPATOL, V46, P816, DOI 10.1016/j.jhep.2006.12.018; Liochev SI, 1997, FREE RADICAL BIO MED, V23, P668, DOI 10.1016/S0891-5849(97)00060-9; Lo SC, 2006, EMBO J, V25, P3605, DOI 10.1038/sj.emboj.7601243; Loots GG, 2002, GENOME RES, V12, P832, DOI 10.1101/gr.225502; Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383; Lowe PR, 2003, CRIT CARE MED, V31, P34, DOI 10.1097/00003246-200301000-00005; Madan R, 2009, J IMMUNOL, V183, P2312, DOI 10.4049/jimmunol.0900185; Maines MD, 2005, ANTIOXID REDOX SIGN, V7, P1761, DOI 10.1089/ars.2005.7.1761; Mandal P, 2010, HEPATOLOGY, V51, P1420, DOI 10.1002/hep.23427; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Menezes GB, 2009, J IMMUNOL, V183, P7557, DOI 10.4049/jimmunol.0901786; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; Oka SI, 2009, J MOL MED, V87, P785, DOI 10.1007/s00109-009-0471-2; Otterbein LE, 2003, TRENDS IMMUNOL, V24, P449, DOI 10.1016/S1471-4906(03)00181-9; Pajkrt D, 1997, J IMMUNOL, V158, P3971; Palmer DC, 2009, TRENDS IMMUNOL, V30, P592, DOI 10.1016/j.it.2009.09.009; Piantadosi CA, 2006, FREE RADICAL BIO MED, V40, P1332, DOI 10.1016/j.freeradbiomed.2005.11.020; Piantadosi CA, 2006, J BIOL CHEM, V281, P324, DOI 10.1074/jbc.M508805200; Piantadosi CA, 2008, CIRC RES, V103, P1232, DOI 10.1161/01.RES.0000338597.71702.ad; Platzer C, 1999, EUR J IMMUNOL, V29, P3098, DOI 10.1002/(SICI)1521-4141(199910)29:10<3098::AID-IMMU3098>3.0.CO;2-H; Rai RM, 1997, HEPATOLOGY, V25, P889, DOI 10.1002/hep.510250417; Ramachandran B, 2008, J BIOL CHEM, V283, P11935, DOI 10.1074/jbc.M707389200; Ranatunga D, 2009, P NATL ACAD SCI USA, V106, P17123, DOI 10.1073/pnas.0904955106; Reynolds CM, 2009, FREE RADICAL BIO MED, V46, P564, DOI 10.1016/j.freeradbiomed.2008.11.007; Ricchetti GA, 2004, J LEUKOCYTE BIOL, V76, P719, DOI 10.1189/jlb.0104046; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Sarady JK, 2004, FASEB J, V18, P854, DOI 10.1096/fj.03-0643fje; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shin HD, 2000, P NATL ACAD SCI USA, V97, P14467, DOI 10.1073/pnas.97.26.14467; Siewe L, 2006, EUR J IMMUNOL, V36, P3248, DOI 10.1002/eji.200636012; Singer M, 2007, CRIT CARE MED, V35, pS441, DOI 10.1097/01.CCM.0000278049.48333.78; STANDIFORD TJ, 1995, J IMMUNOL, V155, P2222; Stumpo R, 2003, CYTOKINE, V24, P46, DOI 10.1016/S1043-4666(03)00270-9; Suliman HB, 2007, J CLIN INVEST, V117, P3730, DOI 10.1172/JCI32967; Suliman HB, 2010, J CELL SCI, V123, P2565, DOI 10.1242/jcs.064089; Suliman HB, 2010, FREE RADICAL BIO MED, V48, P736, DOI 10.1016/j.freeradbiomed.2009.12.019; Suliman HB, 2007, J CELL SCI, V120, P299, DOI 10.1242/jcs.03318; Suliman HB, 2005, FASEB J, V19, P1531, DOI 10.1096/fj.04-3500fje; Suliman HB, 2004, CARDIOVASC RES, V64, P279, DOI 10.1016/j.cardiores.2004.07.005; Suliman HB, 2003, J BIOL CHEM, V278, P41510, DOI 10.1074/jbc.M304719200; Suliman HB, 2003, AM J RESP CRIT CARE, V167, P570, DOI 10.1164/rccm.200206-518OC; Unterberger C, 2008, MOL IMMUNOL, V45, P3230, DOI 10.1016/j.molimm.2008.02.020; VANDERPOLL T, 1995, J IMMUNOL, V155, P5397; Wang SC, 1998, J BIOL CHEM, V273, P302, DOI 10.1074/jbc.273.1.302; Wang XM, 2004, GASTROENTEROLOGY, V127, P1174, DOI 10.1053/j.gastro.2004.07.007; Winters BD, 2010, CRIT CARE MED, V38, P1276, DOI 10.1097/CCM.0b013e3181d8cc1d; Yao P, 2009, AM J PHYSIOL-GASTR L, V296, pG1318, DOI 10.1152/ajpgi.00555.2007; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003; Zhang L, 2000, SCIENCE, V290, P989, DOI 10.1126/science.290.5493.989; Zhang XC, 2005, J BIOL CHEM, V280, P8714, DOI 10.1074/jbc.M408092200; Ziegler-Heitbrock L, 2003, J IMMUNOL, V171, P285, DOI 10.4049/jimmunol.171.1.285	89	200	207	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.207738	http://dx.doi.org/10.1074/jbc.M110.207738			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454555	Green Published, hybrid			2022-12-25	WOS:000290022800075
J	Roumenina, LT; Radanova, M; Atanasov, BP; Popov, KT; Kaveri, SV; Lacroix-Desmazes, S; Fremeaux-Bacchi, V; Dimitrov, JD				Roumenina, Lubka T.; Radanova, Maria; Atanasov, Boris P.; Popov, Krastio T.; Kaveri, Srinivas V.; Lacroix-Desmazes, Sebastien; Fremeaux-Bacchi, Veronique; Dimitrov, Jordan D.			Heme Interacts with C1q and Inhibits the Classical Complement Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-REACTIVE PROTEIN; GRAPHICS PROCESSORS; PATTERN-RECOGNITION; GLOBULAR HEAD; 2 PARTS; ACTIVATION; BINDING; INFLAMMATION; ANTIBODY; DOCKING	C1q is the recognition subunit of the first component of the classical complement pathway. It participates in clearance of immune complexes and apoptotic cells as well as in defense against pathogens. Inappropriate activation of the complement contributes to cellular and tissue damage in different pathologies, urging the need for the development of therapeutic agents that are able to inhibit the complement system. In this study, we report heme as an inhibitor of C1q. Exposure of C1q to heme significantly reduced the activation of the classical complement pathway, mediated by C-reactive protein (CRP) and IgG. Interaction analyses revealed that heme reduces the binding of C1q to CRP and IgG. Furthermore, we demonstrated that the inhibition of C1q interactions results from a direct binding of heme to C1q. Formation of complex of heme with C1q caused changes in the mechanism of recognition of IgG and CRP. Taken together, our data suggest that heme is a natural negative regulator of the classical complement pathway at the level of C1q. Heme may play a role at sites of excessive tissue damage and hemolysis where large amounts of free heme are released.	[Roumenina, Lubka T.] Univ Paris 06, Ctr Rech Cordeliers, INSERM, Equipe 13,UMR S 872, F-75006 Paris, France; [Dimitrov, Jordan D.] Univ Paris 05, UMR S 872, Ctr Rech Cordeliers, INSERM,Equipe 16, F-75006 Paris, France; [Roumenina, Lubka T.; Kaveri, Srinivas V.; Lacroix-Desmazes, Sebastien; Fremeaux-Bacchi, Veronique; Dimitrov, Jordan D.] INSERM, U872, F-75006 Paris, France; [Radanova, Maria] Med Univ Varna, Dept Biochem Mol Med & Nutrigen, Varna 9002, Bulgaria; [Atanasov, Boris P.] Bulgarian Acad Sci, Inst Organ Chem, Biophys Chem Grp, BU-1113 Sofia, Bulgaria; [Popov, Krastio T.] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Fremeaux-Bacchi, Veronique] Hop Europeen Georges Pompidou, Assistance Publ Hop Paris, Serv Immunol Biol, F-75908 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Medical University Varna; Bulgarian Academy of Sciences; Helmholtz Association; German Cancer Research Center (DKFZ); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite	Roumenina, LT (corresponding author), Univ Paris 06, Ctr Rech Cordeliers, INSERM, Equipe 13,UMR S 872, 15 Rue Ecole Med, F-75006 Paris, France.	lubka.roumenina@crc.jussieu.fr; jordan.dimitrov@crc.jussieu.fr	Radanova, Maria/AHA-8156-2022; Radanova, Maria A/A-7081-2015; Roumenina, Lubka/L-2638-2017; Roumenina, Lubka/P-5906-2019; Dimitrov, Jordan/N-2141-2014	Roumenina, Lubka/0000-0002-9940-0324; Radanova, Maria/0000-0002-0941-6139; Lacroix-Desmazes, Sebastien/0000-0001-5625-8447; Dimitrov, Jordan/0000-0001-8536-8995; Kaveri, Srini/0000-0002-0837-4053	Institut National de la Sante et de la Recherche Medicale (France); Centre National de la Recherche Scientifique (France); Universite Pierre et Marie Curie (Paris 6); French-Bulgarian Project EGIDE-Rila [19296UK]; Fondation pour le Recherche Medicale (Paris, France)	Institut National de la Sante et de la Recherche Medicale (France)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique (France)(Centre National de la Recherche Scientifique (CNRS)); Universite Pierre et Marie Curie (Paris 6); French-Bulgarian Project EGIDE-Rila; Fondation pour le Recherche Medicale (Paris, France)	This work was supported by the Institut National de la Sante et de la Recherche Medicale (France), by Centre National de la Recherche Scientifique (France), and by Universite Pierre et Marie Curie (Paris 6).; Supported by the French-Bulgarian Project EGIDE-Rila 19296UK.; Recipient of a fellowship from the Fondation pour le Recherche Medicale (Paris, France). To whom correspondence may be addressed: Equipe 16 INSERM UMR S 872, Centre de Recherche des Cordeliers, 15 rue de l'Ecole de Medecine, 75006 Paris, France. Tel.: 33-0-1-55-42-82-71; Fax: 33-0-1-55-42-82-62; E-mail: jordan.dimitrov@crc.jussieu.fr.	Agrawal A, 2001, J IMMUNOL, V166, P3998, DOI 10.4049/jimmunol.166.6.3998; Agrawal A, 2009, ADV EXP MED BIOL, V653, P98; Amzel LM, 2000, METHOD ENZYMOL, V323, P167; Arriaga SM, 1999, BBA-GEN SUBJECTS, V1473, P329, DOI 10.1016/S0304-4165(99)00201-9; BALLA J, 1993, P NATL ACAD SCI USA, V90, P9285, DOI 10.1073/pnas.90.20.9285; Basiglio CL, 2007, BBA-GEN SUBJECTS, V1770, P1003, DOI 10.1016/j.bbagen.2007.03.005; Biro A, 2007, IMMUNOLOGY, V121, P40, DOI 10.1111/j.1365-2567.2007.02535.x; Bureeva S, 2005, BIOORGAN MED CHEM, V13, P1045, DOI 10.1016/j.bmc.2004.11.056; Bureeva S, 2007, BIOORGAN MED CHEM, V15, P3489, DOI 10.1016/j.bmc.2007.03.002; Castellano G, 2010, AM J PATHOL, V176, P1648, DOI 10.2353/ajpath.2010.090276; del Zoppo GJ, 1999, NAT MED, V5, P995, DOI 10.1038/12431; Dimitrov JD, 2007, SCAND J IMMUNOL, V65, P230, DOI 10.1111/j.1365-3083.2006.01893.x; Dimitrov JD, 2007, J BIOL CHEM, V282, P26696, DOI 10.1074/jbc.M702751200; Dimitrov JD, 2007, MOL IMMUNOL, V44, P1854, DOI 10.1016/j.molimm.2006.10.002; Dimitrov JD, 2009, NAT BIOTECHNOL, V27, P892, DOI 10.1038/nbt1009-892a; Eisenhardt SU, 2009, CIRC RES, V105, P128, DOI 10.1161/CIRCRESAHA.108.190611; Gaboriaud C, 2004, TRENDS IMMUNOL, V25, P368, DOI 10.1016/j.it.2004.04.008; Gaboriaud C, 2003, J BIOL CHEM, V278, P46974, DOI 10.1074/jbc.M307764200; GALANAKIS DK, 1994, J CLIN INVEST, V93, P303, DOI 10.1172/JCI116960; GREEN D, 1986, THROMB HAEMOSTASIS, V56, P277; Griselli M, 1999, J EXP MED, V190, P1733, DOI 10.1084/jem.190.12.1733; JANIN J, 1995, BIOCHIMIE, V77, P497, DOI 10.1016/0300-9084(96)88166-1; Jeney V, 2002, BLOOD, V100, P879, DOI 10.1182/blood.V100.3.879; Ji SR, 2007, FASEB J, V21, P284, DOI 10.1096/fj.06-6722com; Ji SR, 2006, ARTERIOSCL THROM VAS, V26, P935, DOI 10.1161/01.ATV.0000206211.21895.73; Kang YH, 2009, ADV EXP MED BIOL, V653, P117; Kantardjiev AA, 2006, NUCLEIC ACIDS RES, V34, pW43, DOI 10.1093/nar/gkl165; Kantardjiev AA, 2009, NUCLEIC ACIDS RES, V37, pW422, DOI 10.1093/nar/gkp336; Kirschfink M, 2001, Expert Opin Pharmacother, V2, P1073, DOI 10.1517/14656566.2.7.1073; Kumar S, 2005, TOXICOL LETT, V157, P175, DOI 10.1016/j.toxlet.2005.03.004; Macindoe G, 2010, NUCLEIC ACIDS RES, V38, pW445, DOI 10.1093/nar/gkq311; Manivel V, 2000, IMMUNITY, V13, P611, DOI 10.1016/S1074-7613(00)00061-3; MORGAN WT, 1985, BIOCHEMISTRY-US, V24, P1496, DOI 10.1021/bi00327a031; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; MULLEREBERHARD U, 1968, BLOOD, V32, P811, DOI 10.1182/blood.V32.5.811.811; Pawluczkowycz AW, 2007, J IMMUNOL, V179, P5543, DOI 10.4049/jimmunol.179.8.5543; Pepys MB, 2006, NATURE, V440, P1217, DOI 10.1038/nature04672; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Ritchie DW, 2010, BIOINFORMATICS, V26, P2398, DOI 10.1093/bioinformatics/btq444; Roos A, 2002, IMMUNOBIOLOGY, V205, P595, DOI 10.1078/0171-2985-00157; Roos A, 2001, J IMMUNOL, V167, P7052, DOI 10.4049/jimmunol.167.12.7052; Roumenina LT, 2006, BIOCHEMISTRY-US, V45, P4093, DOI 10.1021/bi052646f; Roumenina LT, 2005, BIOCHEMISTRY-US, V44, P14097, DOI 10.1021/bi051186n; Roumenina L, 2007, J MOL RECOGNIT, V20, P405, DOI 10.1002/jmr.853; SEARS DA, 1970, J CLIN INVEST, V49, P5, DOI 10.1172/JCI106222; Sjoberg AP, 2009, TRENDS IMMUNOL, V30, P83, DOI 10.1016/j.it.2008.11.003; Stites WE, 1997, CHEM REV, V97, P1233, DOI 10.1021/cr960387h; Thompson D, 1999, STRUCTURE, V7, P169, DOI 10.1016/S0969-2126(99)80023-9; Volanakis JE, 2001, MOL IMMUNOL, V38, P189, DOI 10.1016/S0161-5890(01)00042-6; Wagener FADTG, 2003, PHARMACOL REV, V55, P551, DOI 10.1124/pr.55.3.5; Wagener FADTG, 2001, BLOOD, V98, P1802, DOI 10.1182/blood.V98.6.1802; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Weiser MR, 1996, J EXP MED, V183, P2343, DOI 10.1084/jem.183.5.2343	54	38	38	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.206136	http://dx.doi.org/10.1074/jbc.M110.206136			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454703	Green Published, hybrid			2022-12-25	WOS:000290022800083
J	Garbers, C; Janner, N; Chalaris, A; Moss, ML; Floss, DM; Meyer, D; Koch-Nolte, F; Rose-John, S; Scheller, J				Garbers, Christoph; Jaenner, Nathalie; Chalaris, Athena; Moss, Marcia L.; Floss, Doreen M.; Meyer, Doerte; Koch-Nolte, Friedrich; Rose-John, Stefan; Scheller, Juergen			Species Specificity of ADAM10 and ADAM17 Proteins in Interleukin-6 (IL-6) Trans-signaling and Novel Role of ADAM10 in Inducible IL-6 Receptor Shedding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; L-SELECTIN; INTESTINAL INFLAMMATION; ECTODOMAIN; DISINTEGRIN; CLEAVAGE; INACTIVATION; DEFICIENCY; COMPONENTS; EXPRESSION	Hypomorphic ADAM17(ex/ex) mice showed defects in mucosal regeneration due to inefficient enhanced GFR shedding. ADAM17 is the main sheddase of interleukin-6 receptor (IL-6R) to induce IL-6 trans-signaling. However, serum levels of soluble murine IL-6R were not reduced in ADAM17ex/ex mice, and murine ADAM17 was not the major sheddase of murine IL-6R. Shedding of murine IL-6R by murine ADAM17 was rescued in chimeric murine IL-6R proteins containing any extracellular domain but not the transmembrane and intracellular domain of human IL-6R. Apoptosis is a physiological stimulus of ADAM17-mediated shedding of human IL-6R. Even though apoptosis induced IL-6R shedding in mice, the responsible protease was identified as ADAM10. ADAM10 also was identified as protease responsible for ionomycin-induced shedding of murine and human IL-6R. However, in ADAM10-deficient murine embryonic fibroblasts, compensatory shedding of human IL-6R was mediated by ADAM17, but loss of ADAM10-mediated shedding of murine IL-6R was compensated by an as-yet-unidentified protease. Finally, we identified physiological purinergic P2X7 receptor stimulation as a novel inducer of murine and human IL-6R shedding solely mediated by ADAM10. In conclusion, we describe an unexpected species specificity of ADAM10 and ADAM17 and identified ADAM10 as novel inducible sheddase of IL-6R in mice and humans, which might have consequences for the interpretation of phenotypes from ADAM17- and ADAM10-deficient mice.	[Garbers, Christoph; Jaenner, Nathalie; Chalaris, Athena; Meyer, Doerte; Rose-John, Stefan; Scheller, Juergen] Univ Kiel, Inst Biochem, D-2300 Kiel, Germany; [Moss, Marcia L.] BioZyme Inc, Apex, NC 27523 USA; [Floss, Doreen M.; Scheller, Juergen] Univ Dusseldorf, Fac Med, Inst Biochem & Mol Biol 2, Dusseldorf, Germany; [Koch-Nolte, Friedrich] Univ Med Ctr Hamburg Eppendorf, Inst Immunol, Hamburg, Germany	University of Kiel; Heinrich Heine University Dusseldorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Rose-John, S (corresponding author), Univ Kiel, Inst Biochem, Olshausenstr 40, D-2300 Kiel, Germany.	rosejohn@biochem.uni-kiel.de; jscheller@uni-duesseldorf.de	Garbers, Christoph/D-9932-2015; Scheller, Jürgen/K-5290-2015; Rose-John, Stefan/A-7998-2010	Garbers, Christoph/0000-0003-4939-6950; Rose-John, Stefan/0000-0002-7519-3279; Koch-Nolte, Friedrich/0000-0003-1730-6674	Deutsche Forschungsgemeinschaft (Bonn, Germany) [SFB877, A2]; Cluster of Excellence "Inflammation at Interfaces"	Deutsche Forschungsgemeinschaft (Bonn, Germany)(German Research Foundation (DFG)); Cluster of Excellence "Inflammation at Interfaces"	This work was supported by grants from the Deutsche Forschungsgemeinschaft (Bonn, Germany; SFB877 Project A2) and by the Cluster of Excellence "Inflammation at Interfaces."	Atreya R, 2000, NAT MED, V6, P583, DOI 10.1038/75068; Becker C, 2004, IMMUNITY, V21, P491, DOI 10.1016/j.immuni.2004.07.020; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Caescu CI, 2009, BIOCHEM J, V424, P79, DOI 10.1042/BJ20090549; CHALARIS A, 2011, EUR J CELL BIOL; Chalaris A, 2007, BLOOD, V110, P1748, DOI 10.1182/blood-2007-01-067918; Chalaris A, 2010, J EXP MED, V207, P1617, DOI 10.1084/jem.20092366; Dethlefsen SM, 1998, J CELL BIOCHEM, V69, P143, DOI 10.1002/(SICI)1097-4644(19980501)69:2<143::AID-JCB5>3.0.CO;2-S; Fischer M, 1997, NAT BIOTECHNOL, V15, P142, DOI 10.1038/nbt0297-142; Grivennikov S, 2008, CANCER CELL, V13, P7, DOI 10.1016/j.ccr.2007.12.020; Gu B, 1998, BLOOD, V92, P946; Hamaoka M, 2010, J BIOCHEM, V148, P55, DOI 10.1093/jb/mvq033; Hansen HP, 2004, FASEB J, V18, P893, DOI 10.1096/fj.03-0901fje; Horiuchi K, 2007, J IMMUNOL, V179, P2686, DOI 10.4049/jimmunol.179.5.2686; Horiuchi K, 2009, J IMMUNOL, V182, P2093, DOI 10.4049/jimmunol.0802491; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Jones SA, 1998, EUR J IMMUNOL, V28, P3514, DOI 10.1002/(SICI)1521-4141(199811)28:11<3514::AID-IMMU3514>3.3.CO;2-K; Jorissen E, 2010, J NEUROSCI, V30, P4833, DOI 10.1523/JNEUROSCI.5221-09.2010; Ketteler R, 2002, GENE THER, V9, P477, DOI 10.1038/sj.gt.3301653; Klaus C, 2004, BLOOD, V103, P4514, DOI 10.1182/blood-2003-12-4165; Le Gall SM, 2009, MOL BIOL CELL, V20, P1785, DOI 10.1091/mbc.E08-11-1135; Li Y, 2006, BLOOD, V108, P2275, DOI 10.1182/blood-2006-02-005827; Matthews V, 2003, J BIOL CHEM, V278, P38829, DOI 10.1074/jbc.M210584200; McFarland-Mancini MM, 2010, J IMMUNOL, V184, P7219, DOI 10.4049/jimmunol.0901929; Moss ML, 2007, J BIOL CHEM, V282, P35712, DOI 10.1074/jbc.M703231200; MULLBERG J, 1994, J IMMUNOL, V152, P4958; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Rabe B, 2008, BLOOD, V111, P1021, DOI 10.1182/blood-2007-07-102137; Reiss K, 2006, J BIOL CHEM, V281, P21735, DOI 10.1074/jbc.M602663200; Rose-John S, 2007, EXPERT OPIN THER TAR, V11, P613, DOI 10.1517/14728222.11.5.613; ROSEJOHN S, 1994, BIOCHEM J, V300, P281, DOI 10.1042/bj3000281; Scholz F, 2007, J INVEST DERMATOL, V127, P1444, DOI 10.1038/sj.jid.5700751; Schwarz N, 2009, PURINERG SIGNAL, V5, P139, DOI 10.1007/s11302-009-9135-5; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Vollmer P, 1996, INFECT IMMUN, V64, P3646, DOI 10.1128/IAI.64.9.3646-3651.1996; Walev I, 1996, P NATL ACAD SCI USA, V93, P7882, DOI 10.1073/pnas.93.15.7882; Weskamp G, 2006, NAT IMMUNOL, V7, P1293, DOI 10.1038/ni1399; Zheng YF, 2004, J BIOL CHEM, V279, P42898, DOI 10.1074/jbc.M403193200	39	146	147	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					14804	14811		10.1074/jbc.M111.229393	http://dx.doi.org/10.1074/jbc.M111.229393			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21454673	Green Published, hybrid			2022-12-25	WOS:000289788300010
J	Binder, A; May, D; Baron, R; Maier, C; Tolle, TR; Treede, RD; Berthele, A; Faltraco, F; Flor, H; Gierthmuhlen, J; Haenisch, S; Huge, V; Magerl, W; Maihofner, C; Richter, H; Rolke, R; Scherens, A; Uceyler, N; Ufer, M; Wasner, G; Zhu, JH; Cascorbi, I				Binder, Andreas; May, Denisa; Baron, Ralf; Maier, Christoph; Toelle, Thomas R.; Treede, Rolf-Detlef; Berthele, Achim; Faltraco, Frank; Flor, Herta; Gierthmuehlen, Janne; Haenisch, Sierk; Huge, Volker; Magerl, Walter; Maihoefner, Christian; Richter, Helmut; Rolke, Roman; Scherens, Andrea; Ueceyler, Nurcan; Ufer, Mike; Wasner, Gunnar; Zhu, Jihong; Cascorbi, Ingolf			Transient Receptor Potential Channel Polymorphisms Are Associated with the Somatosensory Function in Neuropathic Pain Patients	PLOS ONE			English	Article							PARADOXICAL HEAT SENSATION; CAPSAICIN RECEPTOR; TRP CHANNEL; COLD; MECHANISMS; HYPERALGESIA; SENSITIVITY; EXPRESSION; NEURONS	Transient receptor potential channels are important mediators of thermal and mechanical stimuli and play an important role in neuropathic pain. The contribution of hereditary variants in the genes of transient receptor potential channels to neuropathic pain is unknown. We investigated the frequency of transient receptor potential ankyrin 1, transient receptor potential melastin 8 and transient receptor potential vanilloid 1 single nucleotide polymorphisms and their impact on somatosensory abnormalities in neuropathic pain patients. Within the German Research Network on Neuropathic Pain (Deutscher Forscbungsverbund Neuropathischer Schmerz) 371 neuropathic pain patients were phenotypically characterized using standardized quantitative sensory testing. Pyrosequencing was employed to determine a total of eleven single nucleotide polymorphisms in transient receptor potential channel genes of the neuropathic pain patients and a cohort of 253 German healthy volunteers. Associations of quantitative sensory testing parameters and single nucleotide polymorphisms between and within groups and subgroups, based on sensory phenotypes, were analyzed. Single nucleotide polymorphisms frequencies did not differ between both the cohorts. However, in neuropathic pain patients transient receptor potential ankyrin 1 710G>A (rs920829, E179K) was associated with the presence of paradoxical heat sensation (p=0.03), and transient receptor potential vanilloid 1 1911A>G (rs8065080, I585V) with cold hypoalgesia (p=0.0035). Two main subgroups characterized by preserved (1) and impaired (2) sensory function were identified. In subgroup 1 transient receptor potential vanilloid 1 1911A>G led to significantly less heat hyperalgesia, pinprick hyperalgesia and mechanical hypaesthesia (p=0.006, p=0.005 and p<0.001) and transient receptor potential vanilloid 1 1103C>G (rs222747, M315I) to cold hypaesthesia (p=0.002), but there was absence of associations in subgroup 2. In this study we found no evidence that genetic variants of transient receptor potential channels are involved in the expression of neuropathic pain, but transient receptor potential channel polymorphisms contributed significantly to the somatosensory abnormalities of neuropathic pain patients.	[Binder, Andreas; Baron, Ralf; Gierthmuehlen, Janne; Wasner, Gunnar] Univ Hosp Schleswig Holstein, Dept Neurol, Div Neurol Pain Res & Therapy, Kiel, Germany; [May, Denisa; Faltraco, Frank; Haenisch, Sierk; Ufer, Mike; Zhu, Jihong; Cascorbi, Ingolf] Univ Hosp Schleswig Holstein, Inst Expt & Clin Pharmacol, Kiel, Germany; [Maier, Christoph; Richter, Helmut; Scherens, Andrea] Ruhr Univ Bochum, Dept Pain Management, BG Kliniken Bergmannsheil, Bochum, Germany; [Toelle, Thomas R.; Berthele, Achim] Tech Univ Munich, Klinikum Rechts Isar, Dept Neurol, D-8000 Munich, Germany; [Treede, Rolf-Detlef; Magerl, Walter] Heidelberg Univ, Ctr Biomed & Med Technol Mannheim, Mannheim, Germany; [Flor, Herta] Heidelberg Univ, Cent Inst Mental Hlth, Inst Clin & Cognit Neurosci, D-6800 Mannheim, Germany; [Huge, Volker] Univ Munich, Dept Anaesthesiol, Munich, Germany; [Maihoefner, Christian] Univ Erlangen Nurnberg, Dept Neurol, Erlangen, Germany; [Rolke, Roman] Univ Bonn, Dept Palliat Care, D-5300 Bonn, Germany; [Rolke, Roman] Johannes Gutenberg Univ Mainz, Dept Neurol, Univ Med Ctr, Mainz, Germany; [Ueceyler, Nurcan] Univ Wurzburg, Dept Neurol, D-8700 Wurzburg, Germany	University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; Ruhr University Bochum; Technical University of Munich; Ruprecht Karls University Heidelberg; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; University of Munich; University of Erlangen Nuremberg; University of Bonn; Johannes Gutenberg University of Mainz; University of Wurzburg	Binder, A (corresponding author), Univ Hosp Schleswig Holstein, Dept Neurol, Div Neurol Pain Res & Therapy, Campus Kiel, Kiel, Germany.	a.binder@neurologie.uni-kiel.de	Sommer, Claudia/A-9820-2010; Haenisch, Sierk/I-4689-2012; zhu, ji/HDM-1538-2022; Cascorbi, Ingolf/AAT-1927-2021; Rolke, Roman/C-9042-2014; Treede, Rolf-Detlef/I-3632-2014	Sommer, Claudia/0000-0002-7064-5002; Cascorbi, Ingolf/0000-0002-2182-9534; Rolke, Roman/0000-0003-4279-9837; Faltraco, Frank/0000-0002-7943-7971; Flor, Herta/0000-0003-4809-5398; Uceyler, Nurcan/0000-0001-6973-6428; Treede, Rolf-Detlef/0000-0001-8065-1708	German Ministry for Education and Research, BMBF; Pfizer Pharma; National Health and Medical Research Council of Australia (NHMRC); EFIC-Grunenthal-Grant (EGG); Ministry of Science, Commerce and Transportation of Schleswig-Holstein, Germany; Alexander von Humboldt-Stiftung; Pfizer; Grunenthal; Genzyme; Medtronic	German Ministry for Education and Research, BMBF(Federal Ministry of Education & Research (BMBF)); Pfizer Pharma(Pfizer); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); EFIC-Grunenthal-Grant (EGG); Ministry of Science, Commerce and Transportation of Schleswig-Holstein, Germany; Alexander von Humboldt-Stiftung(Alexander von Humboldt Foundation); Pfizer(Pfizer); Grunenthal(HAL Allergy Group); Genzyme(Sanofi-AventisGenzyme Corporation); Medtronic(Medtronic)	This work was supported by the German Ministry for Education and Research, BMBF, an unrestricted educational grant from Pfizer Pharma, the National Health and Medical Research Council of Australia (NHMRC), the EFIC-Grunenthal-Grant (EGG), the Ministry of Science, Commerce and Transportation of Schleswig-Holstein, Germany and the Alexander von Humboldt-Stiftung. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; A. Binder received support for travel from the BMBF, honoraria for lectures from Grunenthal, Allergan and Pfizer, payment for development of educational presentations from Pfizer and travel/accommodation expenses from Pfizer, Allergan and Grunenthal and his institution received financial support from the BMBF. RB received support for travel from the BMBF, has consultancies with and received honoraria and travel/accommodation expenses from Pfizer, Genzyme, Grunenthal, Mundipharma, Allergan, Sanofi Pasteur, Medtronic, Eisai, UCB, Lilly, Astellas, received grants from Pfizer, Grunenthal, Genzyme, received payment for development of educational presentations from Pfizer, Medtronic and his institution received financial support from the BMBF. TT is board member at Pfizer, Lilly, Boehringer Grunenthal, and has consultancies with and received travel/accommodation expenses from Pfizer, Lilly, Boehringer, Grunenthal, Mundipharma, UCB/Schwarz. A. Berthele received honoraria and travel/accommodations expenses from Pfizer and his institution a grant from the BMBF. JG received support for travel from the BMBF and her institution received financial support from the BMBF. VH's institution received financial support from the BMBF. CMh received honoraria from Pfizer and travel/accommodation expenses from Allergan. RR is a board member at Astellas Pharma and received honoraria for lectures from Lilly and Pfizer. GW received honoraria and travel/accommodation expenses from Grunenthal, Medtronic, Pfizer, Mundipharma, his institution received financial support from the BMBF and Pfizer Pharma, and he received financial support for research from the National Health and Medical Research Council of Australia (NHMRC), the EFIC-Grunenthal-Grant (EGG), the Ministry of Science, Commerce and Transportation of Schleswig-Holstein, Germany and the Alexander von Humboldt-Stiftung. IC received honoraria and travel/accommodation expenses from MSD, Bayer-Schering and Sanofi Aventis for lectures. DM, RDT, FF, HF, SH, CM, AS, MU, NU, JZ, WM, HR have disclosed no competing interests. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Backonja M, 2008, LANCET NEUROL, V7, P1106, DOI 10.1016/S1474-4422(08)70228-X; Baron R, 2010, LANCET NEUROL, V9, P807, DOI 10.1016/S1474-4422(10)70143-5; Baron R, 2009, PAIN, V146, P34, DOI 10.1016/j.pain.2009.06.001; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Bevan S, 2009, CURR OPIN INVEST DR, V10, P655; Birklein F, 2008, NEUROSCI LETT, V437, P199, DOI 10.1016/j.neulet.2008.03.081; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cortright DN, 2009, CURR PHARM DESIGN, V15, P1736, DOI 10.2174/138161209788186308; CRAIG AD, 1994, SCIENCE, V265, P252, DOI 10.1126/science.8023144; Facer P, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-11; Geber C, 2008, PAIN, V139, P73, DOI 10.1016/j.pain.2008.03.006; Hansen C, 1996, BRAIN, V119, P1729, DOI 10.1093/brain/119.5.1729; Hayes P, 2000, PAIN, V88, P205, DOI 10.1016/S0304-3959(00)00353-5; Huge V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002742; Jensen TS, 2003, PAIN, V102, P1, DOI 10.1016/S0304-3959(03)00006-X; Kim H, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.036079; Kim HS, 2004, PAIN, V109, P488, DOI 10.1016/j.pain.2004.02.027; Klein T, 2005, PAIN, V115, P227, DOI 10.1016/j.pain.2005.03.021; Kobayashi K, 2005, J COMP NEUROL, V493, P596, DOI 10.1002/cne.20794; Kremeyer B, 2010, NEURON, V66, P671, DOI 10.1016/j.neuron.2010.04.030; Maier C, 2010, PAIN, V150, P439, DOI 10.1016/j.pain.2010.05.002; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; OCHOA JL, 1994, BRAIN, V117, P185, DOI 10.1093/brain/117.1.185; Okazawa M, 2004, NEUROSCI LETT, V359, P33, DOI 10.1016/j.neulet.2004.01.074; Patapoutian A, 2009, NAT REV DRUG DISCOV, V8, P55, DOI 10.1038/nrd2757; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Premkumar LS, 2010, AAPS J, V12, P361, DOI 10.1208/s12248-010-9196-y; Rolke R, 2006, PAIN, V123, P231, DOI 10.1016/j.pain.2006.01.041; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Stucky CL, 2009, BRAIN RES REV, V60, P2, DOI 10.1016/j.brainresrev.2008.12.018; Susser E, 1999, BRAIN, V122, P239, DOI 10.1093/brain/122.2.239; Tominaga M., 2007, V179, P489; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Wang H, 2010, BRIT J DERMATOL, V162, P1023, DOI 10.1111/j.1365-2133.2009.09628.x; Woolf CJ, 1998, PAIN, V77, P227, DOI 10.1016/S0304-3959(98)00099-2; Xu H, 2007, AM J PHYSIOL-RENAL, V293, pF1865, DOI 10.1152/ajprenal.00347.2007; YARNITSKY D, 1990, BRAIN, V113, P893, DOI 10.1093/brain/113.4.893	38	94	95	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e17387	10.1371/journal.pone.0017387	http://dx.doi.org/10.1371/journal.pone.0017387			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21468319	Green Published, Green Submitted, gold			2022-12-25	WOS:000289054600010
J	Kennedy, EM; Daddacha, W; Slater, R; Gavegnano, C; Fromentin, E; Schinazi, RF; Kim, B				Kennedy, Edward M.; Daddacha, Waaqo; Slater, Rebecca; Gavegnano, Christina; Fromentin, Emilie; Schinazi, Raymond F.; Kim, Baek			Abundant Non-canonical dUTP Found in Primary Human Macrophages Drives Its Frequent Incorporation by HIV-1 Reverse Transcriptase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; URACIL-DNA GLYCOSYLASE; ESCHERICHIA-COLI; VIRAL-INFECTION; DNTP BINDING; POLYMERASE-I; FIDELITY; ENZYME; REPLICATION; SEQUENCE	Terminally differentiated/non-dividing macrophages contain extremely low cellular dNTP concentrations (20-40 nM), compared with activated CD4(+) T cells (2-5 mu M). However, our LC-MS/MS study revealed that the non-canonical dUTP concentration (2.9 mu M) is similar to 60 times higher than TTP in macrophages, whereas the concentrations of dUTP and TTP in dividing human primary lymphocytes are very similar. Specifically, we evaluated the contribution of HIV-1 reverse transcriptase to proviral DNA uracilation under the physiological conditions found in HIV-1 target cells. Indeed, biochemical simulation of HIV-1 reverse transcription demonstrates that HIV-1 RT efficiently incorporates dUTP in the macrophage nucleotide pools but not in the T cell nucleotide pools. Measurement of both pre-steady state and steady state kinetic parameters of dUTP incorporation reveals minimal selectivity of HIV-1 RT for TTP over dUTP, implying that the cellular dUTP/TTP ratio determines the frequency of HIV-1 RT-mediated dUTP incorporation. The RT of another lentivirus, simian immunodeficiency virus, also displays efficient dUTP incorporation in the dNTP/dUTP pools found in macrophages but not in T cells. Finally, 2',3'-dideoxyuridine was inhibitory to HIV-1 proviral DNA synthesis in macrophages but not in T cells. The data presented demonstrates that the non-canonical dUTP was abundant relative to TTP, and efficiently incorporated during HIV-1 reverse transcription, particularly in non-dividing macrophages.	[Kennedy, Edward M.; Daddacha, Waaqo; Slater, Rebecca; Kim, Baek] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Gavegnano, Christina; Fromentin, Emilie; Schinazi, Raymond F.] Emory Univ, Sch Med, Dept Pediat, Ctr AIDS Res,Lab Biochem Pharmacol, Decatur, GA 30033 USA; [Gavegnano, Christina; Fromentin, Emilie; Schinazi, Raymond F.] Vet Affairs Med Ctr, Decatur, GA 30033 USA	University of Rochester; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Kim, B (corresponding author), Univ Rochester, Med Ctr, Dept Microbiol & Immunol, 601 Elmwood Ave,Box 672, Rochester, NY 14642 USA.	baek_kim@urmc.rochester.edu	Schinazi, Raymond F/B-6777-2017	Kennedy, Edward/0000-0002-2817-4809	National Institutes of Health [AI049781, T32 AI007362, 1R01-RR-025996-01A1, 2P30-AI-050409]; Department of Veterans Affairs; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR025996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049781, R56AI049781, P30AI050409, T32AI007362] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI049781 (to B. K.), T32 AI007362 (to E. M. K.), 1R01-RR-025996-01A1 (to R. F. S.), and 2P30-AI-050409 (to R. F. S.). This work was also supported by a grant from the Department of Veterans Affairs (to R. F. S.).	Abergel C, 1999, J VIROL, V73, P751, DOI 10.1128/JVI.73.1.751-753.1999; Aquaro S, 1998, J BIOL REG HOMEOS AG, V12, P23; Astatke M, 1998, J MOL BIOL, V278, P147, DOI 10.1006/jmbi.1998.1672; BEBENEK K, 1990, J BIOL CHEM, V265, P13878; BJORKLUND S, 1990, BIOCHEMISTRY-US, V29, P5452; Bjornberg O, 2003, J BIOL CHEM, V278, P20667, DOI 10.1074/jbc.M213010200; Bouhamdan M, 1996, J VIROL, V70, P697, DOI 10.1128/JVI.70.2.697-704.1996; BRYNOLF K, 1978, CELL, V13, P573, DOI 10.1016/0092-8674(78)90330-6; Chen RX, 2002, J GEN VIROL, V83, P2339, DOI 10.1099/0022-1317-83-10-2339; Chugh P, 2007, J MOL BIOL, V366, P67, DOI 10.1016/j.jmb.2006.11.011; DEVCHAND PR, 1993, NUCLEIC ACIDS RES, V21, P3437, DOI 10.1093/nar/21.15.3437; Diamond TL, 2004, J BIOL CHEM, V279, P51545, DOI 10.1074/jbc.M408573200; Diamond TL, 2001, J BIOL CHEM, V276, P23624, DOI 10.1074/jbc.M102496200; DUBE DK, 1979, BIOCHIM BIOPHYS ACTA, V561, P369, DOI 10.1016/0005-2787(79)90145-X; ELDER JH, 1992, J VIROL, V66, P1791, DOI 10.1128/JVI.66.3.1791-1794.1992; ELHAJJ HH, 1988, J BACTERIOL, V170, P1069, DOI 10.1128/jb.170.3.1069-1075.1988; Fromentin E, 2010, ANAL CHEM, V82, P1982, DOI 10.1021/ac902737j; GADSDEN MH, 1993, EMBO J, V12, P4425, DOI 10.1002/j.1460-2075.1993.tb06127.x; Graciet JCG, 1998, NUCLEOS NUCLEOT NUCL, V17, P711, DOI 10.1080/07328319808004670; Horowitz RW, 1997, BIOCHEM PHARMACOL, V54, P635, DOI 10.1016/S0006-2952(97)00259-1; Jamburuthugoda VK, 2008, J BIOL CHEM, V283, P9206, DOI 10.1074/jbc.M710149200; Jamburuthugoda VK, 2006, J BIOL CHEM, V281, P13388, DOI 10.1074/jbc.M600291200; Kaiser SM, 2006, J VIROL, V80, P875, DOI 10.1128/JVI.80.2.875-882.2006; Kelly J, 2008, VIROLOGY, V372, P300, DOI 10.1016/j.virol.2007.11.007; Kennedy EM, 2010, J BIOL CHEM, V285, P39380, DOI 10.1074/jbc.M110.178582; Kennedy EM, 2009, BIOCHEMISTRY-US, V48, P11161, DOI 10.1021/bi9010122; Krokan HE, 2002, ONCOGENE, V21, P8935, DOI 10.1038/sj.onc.1205996; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; LEGRICE SFJ, 1991, EMBO J, V10, P3905, DOI 10.1002/j.1460-2075.1991.tb04960.x; LINDAHL T, 1977, J BIOL CHEM, V252, P3286; LINDAHL T, 1974, P NATL ACAD SCI USA, V71, P3649, DOI 10.1073/pnas.71.9.3649; Mansky LM, 2000, J VIROL, V74, P7039, DOI 10.1128/JVI.74.15.7039-7047.2000; MCGEOCH DJ, 1990, NUCLEIC ACIDS RES, V18, P4105, DOI 10.1093/nar/18.14.4105; MCINTOSH EM, 1992, P NATL ACAD SCI USA, V89, P8020, DOI 10.1073/pnas.89.17.8020; Montaner LJ, 2006, J LEUKOCYTE BIOL, V80, P961, DOI 10.1189/jlb.0806488; MOSBAUGH DW, 1988, NUCLEIC ACIDS RES, V16, P5645, DOI 10.1093/nar/16.12.5645; Nilsen H, 2000, MOL CELL, V5, P1059, DOI 10.1016/S1097-2765(00)80271-3; PRESTON VG, 1984, VIROLOGY, V138, P58, DOI 10.1016/0042-6822(84)90147-8; Priet S, 2005, MOL CELL, V17, P479, DOI 10.1016/j.molcel.2005.01.016; Priet S, 2003, VIROLOGY, V307, P283, DOI 10.1016/S0042-6822(02)00073-9; Santos-Velazquez J, 2008, J VIROL, V82, P8235, DOI 10.1128/JVI.00088-08; Sire J, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-45; Skasko M, 2005, J BIOL CHEM, V280, P12190, DOI 10.1074/jbc.M412859200; Skasko M, 2008, J VIROL, V82, P7716, DOI 10.1128/JVI.00120-08; Skasko M, 2009, BIOCHEMISTRY-US, V48, P5389, DOI 10.1021/bi900346m; STRAHLER JR, 1993, P NATL ACAD SCI USA, V90, P4991, DOI 10.1073/pnas.90.11.4991; THELANDER L, 1979, ANNU REV BIOCHEM, V48, P133, DOI 10.1146/annurev.bi.48.070179.001025; Toth J, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706230200; Traut T., 1994, MOL CELL BIOCHEM, V140, P1573; TYE BK, 1978, P NATL ACAD SCI USA, V75, P233, DOI 10.1073/pnas.75.1.233; Weiss KK, 2000, BIOCHEMISTRY-US, V39, P10684, DOI 10.1021/bi000788y; Weiss KK, 2004, BIOCHEMISTRY-US, V43, P4490, DOI 10.1021/bi035258r; Weiss KK, 2002, J BIOL CHEM, V277, P22662, DOI 10.1074/jbc.M200202200; Yang GW, 2002, BIOCHEMISTRY-US, V41, P10256, DOI 10.1021/bi0202171	54	29	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25047	25055		10.1074/jbc.M111.234047	http://dx.doi.org/10.1074/jbc.M111.234047			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21454906	Green Published, hybrid			2022-12-25	WOS:000292547900053
J	Renzi, F; Zhang, XL; Rice, WJ; Torres-Arancivia, C; Gomez-Llorente, Y; Diaz, R; Ahn, K; Yu, CJ; Li, YM; Sisodia, SS; Ubarretxena-Belandia, I				Renzi, Fabiana; Zhang, Xulun; Rice, William J.; Torres-Arancivia, Celia; Gomez-Llorente, Yacob; Diaz, Ruben; Ahn, Kwangwook; Yu, Chunjiang; Li, Yue-Ming; Sisodia, Sangram S.; Ubarretxena-Belandia, Iban			Structure of gamma-Secretase and Its Trimeric Pre-activation Intermediate by Single-particle Electron Microscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL PEPTIDE PEPTIDASE; ALZHEIMERS-DISEASE; TRANSMEMBRANE DOMAIN; INTRAMEMBRANE PROTEASE; TRANSGENIC MODELS; MEMBRANE-PROTEINS; C-TERMINUS; COMPLEX; PRESENILIN-1; NICASTRIN	The gamma-secretase membrane protein complex is responsible for proteolytic maturation of signaling precursors and catalyzes the final step in the production of the amyloid beta-peptides implicated in the pathogenesis of Alzheimer disease. The incorporation of PEN-2 (presenilin enhancer 2) into a pre-activation intermediate, composed of the catalytic subunit presenilin and the accessory proteins APH-1 (anterior pharynx-defective 1) and nicastrin, triggers the endoproteolysis of presenilin and results in an active tetrameric gamma-secretase. We have determined the three-dimensional reconstruction of a mature and catalytically active gamma-secretase using single-particle cryo-electron microscopy. gamma-Secretase has a cup-like shape with a lateral belt of similar to 40-50 angstrom in height that encloses a water-accessible internal chamber. Active site labeling with a gold-coupled transition state analog inhibitor suggested that the gamma-secretase active site faces this chamber. Comparison with the structure of a trimeric pre-activation intermediate suggested that the incorporation of PEN-2 might contribute to the maturation of the active site architecture.	[Zhang, Xulun; Sisodia, Sangram S.] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA; [Renzi, Fabiana; Torres-Arancivia, Celia; Gomez-Llorente, Yacob; Ubarretxena-Belandia, Iban] Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY 10029 USA; [Renzi, Fabiana] Univ Roma Tor Vergata, I-00185 Rome, Italy; [Rice, William J.; Diaz, Ruben] New York Struct Biol Ctr, New York, NY 10027 USA; [Torres-Arancivia, Celia] CUNY, Grad Ctr, New York, NY 10016 USA; [Ahn, Kwangwook; Li, Yue-Ming] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA; [Yu, Chunjiang] Univ Illinois, Dept Anat & Cell Biol, Chicago, IL 60612 USA	University of Chicago; Icahn School of Medicine at Mount Sinai; University of Rome Tor Vergata; City University of New York (CUNY) System; Memorial Sloan Kettering Cancer Center; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Sisodia, SS (corresponding author), Univ Chicago, Dept Neurobiol, 947 E 58th St,MC0926, Chicago, IL 60637 USA.	ssisodia@bsd.uchicago.edu; iban.ubarretxena@mssm.edu	Gomez-Llorente, Yacob/E-5631-2013; LI, Yue/GRS-8071-2022; Yu, Chunjiang/E-9419-2012; Ubarretxena-Belandia, Iban/AAA-8939-2019	Rice, William/0000-0002-5187-255X	National Institutes of Health [R01 AG027854-01A1, R01 AG026660]; European Community; Alzheimer's Association [IIRG-06-26572]; American Health Assistance Foundation; National Science Foundation [MCB-0546087]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027854, R01AG026660] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Community(European Commission); Alzheimer's Association(Alzheimer's Association); American Health Assistance Foundation; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AG027854-01A1 (to S. S. S.) and R01 AG026660 (to Y.-M. L.). This work was also supported by a Marie Curie International outgoing fellowship within the 7th European Community Framework Program (to F. R.), Alzheimer's Association Grant IIRG-06-26572 (to S. S. S.), the American Health Assistance Foundation (to Y.-M. L.), and National Science Foundation Grant MCB-0546087 (to I. U.-B.). S. S. Sisodia discloses that he is a paid consultant of Neuropharma Inc. and Eisai Research Labs Inc. but does not hold shares in any company that is a maker or owner of a Food and Drug Administration-regulated drug or device.	Bergman A, 2004, J BIOL CHEM, V279, P45564, DOI 10.1074/jbc.M407717200; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Cacquevel M, 2008, J NEUROCHEM, V104, P210, DOI 10.1111/j.1471-4159.2007.05041.x; Capell A, 2003, J BIOL CHEM, V278, P52519, DOI 10.1074/jbc.C300435200; Crystal AS, 2003, J BIOL CHEM, V278, P20117, DOI 10.1074/jbc.M213107200; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; Edbauer D, 2004, J BIOL CHEM, V279, P37311, DOI 10.1074/jbc.M406228200; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Feng L, 2007, SCIENCE, V318, P1608, DOI 10.1126/science.1150755; Fischer H, 2004, PROTEIN SCI, V13, P2825, DOI 10.1110/ps.04688204; Fortna RR, 2004, J BIOL CHEM, V279, P3685, DOI 10.1074/jbc.M310505200; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P9774, DOI 10.1021/bi0494976; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Grigorieff N, 2007, J STRUCT BIOL, V157, P117, DOI 10.1016/j.jsb.2006.05.004; Hasegawa H, 2004, J BIOL CHEM, V279, P46455, DOI 10.1074/jbc.M406289200; Henricson A, 2005, FEBS J, V272, P2727, DOI 10.1111/j.1742-4658.2005.04691.x; Heymann JB, 2001, J STRUCT BIOL, V133, P156, DOI 10.1006/jsbi.2001.4339; Hu Y, 2003, J CELL BIOL, V161, P685, DOI 10.1083/jcb.200304014; Kaether C, 2006, NEURODEGENER DIS, V3, P275, DOI 10.1159/000095267; Kern J, 2007, PHOTOSYNTH RES, V92, P389, DOI 10.1007/s11120-007-9173-1; Kim SH, 2005, J BIOL CHEM, V280, P1992, DOI 10.1074/jbc.M412404200; Kim SH, 2004, J BIOL CHEM, V279, P48615, DOI 10.1074/jbc.C400396200; Kim SH, 2003, J BIOL CHEM, V278, P33992, DOI 10.1074/jbc.M305834200; Knappenberger KS, 2004, BIOCHEMISTRY-US, V43, P6208, DOI 10.1021/bi036072v; Kounnas MZ, 2010, NEURON, V67, P769, DOI 10.1016/j.neuron.2010.08.018; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Laudon H, 2005, J BIOL CHEM, V280, P35352, DOI 10.1074/jbc.M507217200; LaVoie MJ, 2003, J BIOL CHEM, V278, P37213, DOI 10.1074/jbc.M303941200; Lazarov VK, 2006, P NATL ACAD SCI USA, V103, P6889, DOI 10.1073/pnas.0602321103; Leal-Pinto E, 2010, J BIOL CHEM, V285, P39790, DOI 10.1074/jbc.M110.151373; Lee SF, 2004, J BIOL CHEM, V279, P4144, DOI 10.1074/jbc.M309745200; Li YM, 2000, P NATL ACAD SCI USA, V97, P6138, DOI 10.1073/pnas.110126897; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Lucic V, 2005, ANNU REV BIOCHEM, V74, P833, DOI 10.1146/annurev.biochem.73.011303.074112; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Luo WJ, 2003, J BIOL CHEM, V278, P7850, DOI 10.1074/jbc.C200648200; Marabini R, 1996, J STRUCT BIOL, V116, P237, DOI 10.1006/jsbi.1996.0036; Martoglio B, 2003, HUM MOL GENET, V12, pR201, DOI 10.1093/hmg/ddg303; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Mitra K, 2004, P NATL ACAD SCI USA, V101, P4083, DOI 10.1073/pnas.0307332101; Morais VA, 2003, J BIOL CHEM, V278, P43284, DOI 10.1074/jbc.M305685200; Niimura M, 2005, J BIOL CHEM, V280, P12967, DOI 10.1074/jbc.M409829200; NILSSON B, 1987, PROTEIN ENG, V1, P107, DOI 10.1093/protein/1.2.107; Osenkowski P, 2009, J MOL BIOL, V385, P642, DOI 10.1016/j.jmb.2008.10.078; Periz G, 2004, J NEUROSCI RES, V77, P309, DOI 10.1002/jnr.20203; Placanica L, 2009, J BIOL CHEM, V284, P2967, DOI 10.1074/jbc.M807269200; Price DL, 1998, SCIENCE, V282, P1079, DOI 10.1126/science.282.5391.1079; Price DL, 1998, ANNU REV NEUROSCI, V21, P479, DOI 10.1146/annurev.neuro.21.1.479; Prokop S, 2004, J BIOL CHEM, V279, P23255, DOI 10.1074/jbc.M401789200; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; RADERMACHER M, 1987, J MICROSC-OXFORD, V146, P113, DOI 10.1111/j.1365-2818.1987.tb01333.x; Sato C, 2006, J NEUROSCI, V26, P12081, DOI 10.1523/JNEUROSCI.3614-06.2006; Sato T, 2007, J BIOL CHEM, V282, P33985, DOI 10.1074/jbc.M705248200; Scheres SHW, 2008, NAT PROTOC, V3, P977, DOI 10.1038/nprot.2008.62; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Shirotani K, 2004, J NEUROCHEM, V89, P1520, DOI 10.1111/j.1471-4159.2004.02447.x; Shirotani K, 2003, J BIOL CHEM, V278, P16474, DOI 10.1074/jbc.C300095200; Sisodia SS, 2002, NAT REV NEUROSCI, V3, P281, DOI 10.1038/nrn785; Sloane PD, 2002, ANNU REV PUBL HEALTH, V23, P213, DOI 10.1146/annurev.publhealth.23.100901.140525; Steiner H, 1999, J BIOL CHEM, V274, P7615, DOI 10.1074/jbc.274.12.7615; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Thinakaran G, 1998, NEUROBIOL DIS, V4, P438, DOI 10.1006/nbdi.1998.0171; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Tolia A, 2006, J BIOL CHEM, V281, P27633, DOI 10.1074/jbc.M604997200; Torres-Arancivia C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013072; Ubarretxena-Belandia I, 2001, CURR OPIN STRUC BIOL, V11, P370, DOI 10.1016/S0959-440X(00)00217-7; VANHEEL M, 1987, ULTRAMICROSCOPY, V21, P95, DOI 10.1016/0304-3991(87)90010-6; Von Koch CS, 1997, NEUROBIOL AGING, V18, P661, DOI 10.1016/S0197-4580(97)00151-6; Wang YC, 2006, NATURE, V444, P179, DOI 10.1038/nature05255; Watanabe N, 2005, J BIOL CHEM, V280, P41967, DOI 10.1074/jbc.M509066200; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Weipoltshammer K, 2000, HISTOCHEM CELL BIOL, V114, P489; Wolfe MS, 2004, SCIENCE, V305, P1119, DOI 10.1126/science.1096187; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077	76	30	31	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21440	21449		10.1074/jbc.M110.193326	http://dx.doi.org/10.1074/jbc.M110.193326			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21454611	hybrid, Green Published			2022-12-25	WOS:000291464700042
J	Kreft, SG; Hochstrasser, M				Kreft, Stefan G.; Hochstrasser, Mark			An Unusual Transmembrane Helix in the Endoplasmic Reticulum Ubiquitin Ligase Doa10 Modulates Degradation of Its Cognate E2 Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; MEMBRANE-PROTEIN; IN-VIVO; MAT-ALPHA-2 REPRESSOR; LUMINAL PROTEIN; TRANSLOCATION; MACHINERY; CUE1P; CONJUGATION; CYTOSOL	In the endoplasmic reticulum (ER), nascent membrane and secreted proteins that are misfolded are retrotranslocated into the cytosol and degraded by the proteasome. For most ER-associated degradation (ERAD) substrates, ubiquitylation is essential for both their retrotranslocation and degradation. Yeast Doa10 is a polytopic membrane ubiquitin ligase (E3) that along with its cognate ubiquitin-conjugating enzymes (E2s), Ubc7 and the C-terminally membrane-anchored Ubc6, makes a major contribution to ER-associated degradation. Ubc6 is also a substrate of Doa10. One highly conserved Doa10 element, the uncharacterized similar to 130-residue TEB4-Doa10 domain, includes three transmembrane helices (TMs). We find that the first of these, TM5, includes an absolutely conserved Phi P Phi XXG motif that is required for Doa10 function, as well as highly conserved negatively charged glutamate and aspartate residues. The conservative exchange of the TM5 glutamate to aspartate (doa10-E633D) results in complete stabilization of Ubc6 but has little if any effect on other substrates. Unexpectedly, mutating the glutamate to glutamine (doa10-E633Q) specifically accelerates Ubc6 degradation by similar to 5-fold. Other substrates are weakly stabilized in doa10-E633Q cells, consistent with reduced Ubc6 levels. Notably, catalytically inactive ubc6-C87A is degraded in doa10-E633Q but not wild-type cells, but an active version of Ubc6 is required in trans. Fusion of the Ubc6 TM to a soluble protein yields a protein that is degraded in a doa10-E633Q-dependent manner, whereas fusion of the C-terminal TM from an unrelated protein does not. These results suggest that the TEB4-Doa10 domain regulates Doa10 association with the Ubc6 membrane anchor, thereby controlling the degradation rate of the E2.	[Kreft, Stefan G.] Univ Konstanz, Dept Biol, D-78457 Constance, Germany; [Kreft, Stefan G.; Hochstrasser, Mark] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	University of Konstanz; Yale University	Kreft, SG (corresponding author), Univ Konstanz, Dept Biol, Box 642, D-78457 Constance, Germany.	stefan.kreft@uni-konstanz.de; mark.hochstrasser@yale.edu		Hochstrasser, Mark/0000-0002-1131-5484	National Institutes of Health [GM046904]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046904, R37GM046904] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM046904 (to M.H.).	Arteaga MF, 2006, P NATL ACAD SCI USA, V103, P11178, DOI 10.1073/pnas.0604816103; Bagola K, 2011, BBA-BIOMEMBRANES, V1808, P925, DOI 10.1016/j.bbamem.2010.06.025; Bartee E, 2004, J VIROL, V78, P1109, DOI 10.1128/JVI.78.3.1109-1120.2004; Bazirgan OA, 2008, J BIOL CHEM, V283, P12797, DOI 10.1074/jbc.M801122200; Beilharz T, 2003, J BIOL CHEM, V278, P8219, DOI 10.1074/jbc.M212725200; Biederer T, 1997, SCIENCE, V278, P1806, DOI 10.1126/science.278.5344.1806; BLOBEL G, 1975, J CELL BIOL, V67, P835, DOI 10.1083/jcb.67.3.835; Chandrasekaran A, 2006, J NEUROCHEM, V98, P1551, DOI 10.1111/J.1471-4159.2006.03975.X; CHEN P, 1993, CELL, V74, P357, DOI 10.1016/0092-8674(93)90426-Q; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Deng M, 2006, NATURE, V443, P827, DOI 10.1038/nature05170; Dodd RB, 2004, J BIOL CHEM, V279, P53840, DOI 10.1074/jbc.M409662200; Gao X, 2009, SCIENCE, V324, P1565, DOI 10.1126/science.1173654; Guthrie C., 1991, GUIDE YEAST GENETICS, V194; Hall SE, 2009, J MOL GRAPH MODEL, V27, P944, DOI 10.1016/j.jmgm.2009.02.004; Hassink G, 2005, BIOCHEM J, V388, P647, DOI 10.1042/BJ20041241; Hegde RS, 2010, CURR OPIN CELL BIOL, V22, P437, DOI 10.1016/j.ceb.2010.05.005; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; HOCHSTRASSER M, 1990, CELL, V61, P697, DOI 10.1016/0092-8674(90)90481-S; Huyer G, 2004, J BIOL CHEM, V279, P38369, DOI 10.1074/jbc.M402468200; Jacob J, 1999, BIOPHYS J, V76, P1367, DOI 10.1016/S0006-3495(99)77298-X; Koonin EV, 2010, CELL, V140, P606, DOI 10.1016/j.cell.2010.02.022; Kostova Z, 2009, J CELL SCI, V122, P1374, DOI 10.1242/jcs.044255; Kreft SG, 2006, J BIOL CHEM, V281, P4646, DOI 10.1074/jbc.M512215200; Langosch D, 2009, PROTEIN SCI, V18, P1343, DOI 10.1002/pro.154; Loayza D, 1998, MOL BIOL CELL, V9, P2767, DOI 10.1091/mbc.9.10.2767; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Moore DT, 2008, STRUCTURE, V16, P991, DOI 10.1016/j.str.2008.05.007; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Ravid T, 2006, EMBO J, V25, P533, DOI 10.1038/sj.emboj.7600946; Ravid T, 2007, NAT CELL BIOL, V9, P422, DOI 10.1038/ncb1558; Schulze S, 2010, NATURE, V467, P233, DOI 10.1038/nature09310; Shen S, 2009, MOL BIOL CELL, V20, P2438, DOI 10.1091/mbc.E08-10-0987; SOMMER T, 1993, NATURE, V365, P176, DOI 10.1038/365176a0; Storici F, 2001, NAT BIOTECHNOL, V19, P773, DOI 10.1038/90837; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Ulmschneider MB, 2005, PROTEINS, V59, P252, DOI 10.1002/prot.20334; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Walter J, 2001, EMBO J, V20, P3124, DOI 10.1093/emboj/20.12.3124; Werner ED, 1996, P NATL ACAD SCI USA, V93, P13797, DOI 10.1073/pnas.93.24.13797; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yohannan S, 2004, P NATL ACAD SCI USA, V101, P959, DOI 10.1073/pnas.0306077101	47	23	24	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20163	20174		10.1074/jbc.M110.196360	http://dx.doi.org/10.1074/jbc.M110.196360			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21467040	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000291267600005
J	Manzanares, D; Gonzalez, C; Ivonnet, P; Chen, RS; Valencia-Gattas, M; Conner, GE; Larsson, HP; Salathe, M				Manzanares, Dahis; Gonzalez, Carlos; Ivonnet, Pedro; Chen, Ren-Shiang; Valencia-Gattas, Monica; Conner, Gregory E.; Larsson, H. Peter; Salathe, Matthias			Functional Apical Large Conductance, Ca2+-activated, and Voltage-dependent K+ Channels Are Required for Maintenance of Airway Surface Liquid Volume	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED POTASSIUM CHANNEL; CILIARY BEAT FREQUENCY; CANINE TRACHEAL EPITHELIUM; SMOOTH-MUSCLE-CELLS; PHASIC SHEAR-STRESS; BETA-SUBUNIT; CHLORIDE SECRETION; ARACHIDONIC-ACID; MEMBRANE STRETCH; ION-TRANSPORT	Large conductance, Ca2+-activated, and voltage-dependent K+ (BK) channels control a variety of physiological processes in nervous, muscular, and renal epithelial tissues. In bronchial airway epithelia, extracellular ATP-mediated, apical increases in intracellular Ca2+ are important signals for ion movement through the apical membrane and regulation of water secretion. Although other, mainly basolaterally expressed K+ channels are recognized as modulators of ion transport in airway epithelial cells, the role of BK in this process, especially as a regulator of airway surface liquid volume, has not been examined. Using patch clamp and Ussing chamber approaches, this study reveals that BK channels are present and functional at the apical membrane of airway epithelial cells. BK channels open in response to ATP stimulation at the apical membrane and allow K+ flux to the airway surface liquid, whereas no functional BK channels were found basolaterally. Ion transport modeling supports the notion that apically expressed BK channels are part of an apical loop current, favoring apical Cl- efflux. Importantly, apical BK channels were found to be critical for the maintenance of adequate airway surface liquid volume because continuous inhibition of BK channels or knockdown of KCNMA1, the gene coding for the BK alpha subunit (KCNMA1), lead to airway surface dehydration and thus periciliary fluid height collapse revealed by low ciliary beat frequency that could be fully rescued by addition of apical fluid. Thus, apical BK channels play an important, previously unrecognized role in maintaining adequate airway surface hydration.	[Manzanares, Dahis; Ivonnet, Pedro; Conner, Gregory E.; Salathe, Matthias] Univ Miami, Div Pulm & Crit Care, Miami, FL 33136 USA; [Gonzalez, Carlos; Chen, Ren-Shiang; Larsson, H. Peter] Univ Miami, Dept Physiol & Biophys, Miami, FL 33136 USA; [Valencia-Gattas, Monica; Conner, Gregory E.] Univ Miami, Dept Cell Biol & Anat, Miami, FL 33136 USA; [Gonzalez, Carlos] Univ Valparaiso, Ctr Interdisciplinario Neurociencia, Valparaiso, Chile	University of Miami; University of Miami; University of Miami; Universidad de Valparaiso	Salathe, M (corresponding author), 1600 NW 10th Ave,RMSB 7063, Miami, FL 33136 USA.	msalathe@med.miami.edu	Chen, Renshiang/GYD-4500-2022; Gonzalez, Carlos/V-7628-2019; Conner, Gregory/AAI-1285-2021	Conner, Gregory/0000-0003-2217-2252; Salathe, Matthias/0000-0001-9092-4861	NHLBI, National Institutes of Health [HL-089399, HL-060644, HL-095920, AR32805, HL-066125]; American Heart Association [10GRNT4150069]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089399, R01HL095920, R01HL060644, R01HL066125] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR032805, R37AR032805] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by NHLBI, National Institutes of Health Grants HL-089399 and HL-060644 (to M. S.), HL-095920 (to H. P. L.), AR32805 (to R.-S.C.), and HL-066125 (to G. E. C.). This work was also supported by American Heart Association Grant 10GRNT4150069 (to H. P. L.).	Begenisich T, 1998, J MEMBRANE BIOL, V163, P77, DOI 10.1007/s002329900372; Behrens R, 2000, FEBS LETT, V474, P99, DOI 10.1016/S0014-5793(00)01584-2; Bernacki SH, 1999, AM J RESP CELL MOL, V20, P595, DOI 10.1165/ajrcmb.20.4.3442; Bernard K, 2003, J MEMBRANE BIOL, V196, P15, DOI 10.1007/s00232-003-0621-3; Brenner R, 2000, J BIOL CHEM, V275, P6453, DOI 10.1074/jbc.275.9.6453; Button B, 2008, RESP PHYSIOL NEUROBI, V163, P189, DOI 10.1016/j.resp.2008.04.020; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Clarke LL, 1997, AM J PHYSIOL-LUNG C, V272, pL1084, DOI 10.1152/ajplung.1997.272.6.L1084; COOK DI, 1989, J MEMBRANE BIOL, V110, P139, DOI 10.1007/BF01869469; Cotton CU, 2000, AM J RESP CELL MOL, V23, P270, DOI 10.1165/ajrcmb.23.3.f198; Davis CW, 2008, RESP PHYSIOL NEUROBI, V163, P208, DOI 10.1016/j.resp.2008.05.015; Faria D, 2009, PFLUG ARCH EUR J PHY, V457, P1373, DOI 10.1007/s00424-008-0606-2; Fernandez-Fernandez JM, 2002, AM J PHYSIOL-CELL PH, V283, pC1705, DOI 10.1152/ajpcell.00245.2002; Fernandez-Fernandez JM, 2008, PFLUG ARCH EUR J PHY, V457, P149, DOI 10.1007/s00424-008-0516-3; Fragoso MA, 2004, J PHYSIOL-LONDON, V561, P183, DOI 10.1113/jphysiol.2004.071548; GALIETTA LJV, 1994, PFLUG ARCH EUR J PHY, V426, P534, DOI 10.1007/BF00378531; Gattas MV, 2009, FREE RADICAL BIO MED, V47, P1450, DOI 10.1016/j.freeradbiomed.2009.08.017; Hammami S, 2009, J PHYSIOL-LONDON, V587, P2225, DOI 10.1113/jphysiol.2008.163550; Hou SW, 2009, PHYSIOLOGY, V24, P26, DOI 10.1152/physiol.00032.2008; KIRBER MT, 1992, FEBS LETT, V297, P24, DOI 10.1016/0014-5793(92)80319-C; Kreda SM, 2007, J PHYSIOL-LONDON, V584, P245, DOI 10.1113/jphysiol.2007.139840; Lazarowski ER, 2009, CURR OPIN PHARMACOL, V9, P262, DOI 10.1016/j.coph.2009.02.004; Lazarowski ER, 2004, J BIOL CHEM, V279, P36855, DOI 10.1074/jbc.M405367200; Lazarowski ER, 2003, MOL PHARMACOL, V64, P785, DOI 10.1124/mol.64.4.785; Lieb T, 2002, J PHYSIOL-LONDON, V538, P633, DOI 10.1113/jphysiol.2001.013222; Liu B, 2009, BBA-BIOMEMBRANES, V1788, P2174, DOI 10.1016/j.bbamem.2009.07.016; Lu R, 2006, J PHYSIOL-LONDON, V570, P65, DOI 10.1113/jphysiol.2005.098913; Lu T, 2005, DIABETES, V54, P2155, DOI 10.2337/diabetes.54.7.2155; Magleby RL, 2003, J GEN PHYSIOL, V121, P81, DOI 10.1085/jgp.20028721; Mall M, 2003, PEDIATR RES, V53, P608, DOI 10.1203/01.PDR.0000057204.51420.DC; Mall M, 2000, AM J RESP CELL MOL, V23, P283, DOI 10.1165/ajrcmb.23.3.4060; Morimoto T, 2007, MOL PHARMACOL, V71, P1075, DOI 10.1124/mol.106.031146; Moser SL, 2008, J MEMBRANE BIOL, V221, P153, DOI 10.1007/s00232-008-9093-9; Namkung W, 2011, J BIOL CHEM, V286, P2365, DOI 10.1074/jbc.M110.175109; Namkung W, 2009, J BIOL CHEM, V284, P15916, DOI 10.1074/jbc.M808021200; Nlend MC, 2002, AM J RESP CELL MOL, V27, P436, DOI 10.1165/rcmb.2002-0012OC; Orio P, 2005, J GEN PHYSIOL, V125, P395, DOI 10.1085/jgp.200409236; Orio P, 2002, NEWS PHYSIOL SCI, V17, P156, DOI 10.1152/nips.01387.2002; Paradiso AM, 2001, J GEN PHYSIOL, V117, P53, DOI 10.1085/jgp.117.1.53; Ransford GA, 2009, AM J RESP CELL MOL, V41, P525, DOI 10.1165/rcmb.2008-0367OC; RICH DP, 1990, NATURE, V347, P358, DOI 10.1038/347358a0; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rock JR, 2009, J BIOL CHEM, V284, P14875, DOI 10.1074/jbc.C109.000869; RUGOLO M, 1993, J BIOL CHEM, V268, P24779; Salathe M, 1999, J PHYSIOL-LONDON, V520, P851, DOI 10.1111/j.1469-7793.1999.00851.x; Sanchez M, 1996, NEUROPHARMACOLOGY, V35, P963, DOI 10.1016/0028-3908(96)00137-2; Schmid A, 2006, J CELL SCI, V119, P4176, DOI 10.1242/jcs.03181; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Sun X, 2007, J NEUROPHYSIOL, V97, P62, DOI 10.1152/jn.00700.2006; Sun XP, 2004, J PHYSIOL-LONDON, V557, P207, DOI 10.1113/jphysiol.2003.060509; Sweet TB, 2009, J GEN PHYSIOL, V133, P139, DOI 10.1085/jgp.200810129; Tarran R, 2006, J GEN PHYSIOL, V127, P591, DOI 10.1085/jgp.200509468; Tarran R, 2006, ANNU REV PHYSIOL, V68, P543, DOI 10.1146/annurev.physiol.68.072304.112754; Tarran R, 2005, J BIOL CHEM, V280, P35751, DOI 10.1074/jbc.M505832200; Tarran R, 2001, J GEN PHYSIOL, V118, P223, DOI 10.1085/jgp.118.2.223; Wallner M, 1999, P NATL ACAD SCI USA, V96, P4137, DOI 10.1073/pnas.96.7.4137; WELSH MJ, 1983, J CLIN INVEST, V71, P1392, DOI 10.1172/JCI110892; WELSH MJ, 1983, J MEMBRANE BIOL, V71, P209, DOI 10.1007/BF01875462; Willumsen NJ, 1989, AM J PHYSIOL, V256, pC1054, DOI 10.1152/ajpcell.1989.256.5.C1054; Xia XM, 2003, J GEN PHYSIOL, V121, P125, DOI 10.1085/jgp.20028667; Xia XM, 2000, J NEUROSCI, V20, P4890; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Zhou XB, 2010, P NATL ACAD SCI USA, V107, P8005, DOI 10.1073/pnas.0912029107	63	57	57	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19830	19839		10.1074/jbc.M110.185074	http://dx.doi.org/10.1074/jbc.M110.185074			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21454692	hybrid, Green Published			2022-12-25	WOS:000291027700064
J	Andra, J; Goldmann, T; Ernst, CM; Peschel, A; Gutsmann, T				Andrae, Joerg; Goldmann, Torsten; Ernst, Christoph M.; Peschel, Andreas; Gutsmann, Thomas			Multiple Peptide Resistance Factor (MprF)-mediated Resistance of Staphylococcus aureus against Antimicrobial Peptides Coincides with a Modulated Peptide Interaction with Artificial Membranes Comprising Lysyl-Phosphatidylglycerol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NK-LYSIN; ANTIBACTERIAL ACTIVITY; CYTOLYTIC ACTIVITY; MOLECULAR-BASIS; CELL-MEMBRANE; IN-VITRO; LIPID-II; MELITTIN; MODE; LIPOPOLYSACCHARIDE	Modification of the membrane lipid phosphatidylglycerol (PG) of Staphylococcus aureus by enzymatic transfer of a L-lysine residue leading to lysyl-PG converts the net charge of PG from -1 to +1 and is thought to confer resistance to cationic antimicrobial peptides (AMPs). Lysyl-PG synthesis and translocation to the outer leaflet of the bacterial membrane are achieved by the membrane protein MprF. Consequently, mutants lacking a functional mprF gene are in particular vulnerable to the action of AMPs. Hence, we aim at elucidating whether and to which extent lysyl-PG modulates membrane binding, insertion, and permeabilization by various AMPs. Lysyl-PG was incorporated into artificial lipid bilayers, mimicking the cytoplasmic membrane of S. aureus. Moreover, we determined the activity of the peptides against a clinical isolate of S. aureus strain SA113 and two mutants lacking a functional mprF gene and visualized peptide-induced ultrastructural changes of bacteria by transmission electron microscopy. The studied peptides were: (i) NK-2, an alpha-helical fragment of mammalian NK-lysin, (ii) arenicin-1, a lugworm alpha-sheet peptide, and (iii) bee venom melittin. Biophysical data obtained by FRET spectroscopy, Fourier transform infrared spectroscopy, and electrical measurements with planar lipid bilayers were correlated with the biological activities of the peptides. They strongly support the hypothesis that peptide-membrane interactions are a prerequisite for eradication of S. aureus. However, degree and mode of modulation of membrane properties such as fluidity, capacitance, and conductivity were unique for each of the peptides. Altogether, our data support and underline the significance of lysyl-PG for S. aureus resistance to AMPs.	[Andrae, Joerg] Leibniz Ctr Med & Biosci, Res Ctr Borstel, Div Biophys, D-23845 Borstel, Germany; [Ernst, Christoph M.; Peschel, Andreas] Univ Tubingen, Cellular & Mol Microbiol Div, Interfac Inst Microbiol & Infect Med, D-72074 Tubingen, Germany	Forschungszentrum Borstel; Eberhard Karls University of Tubingen	Andra, J (corresponding author), Leibniz Ctr Med & Biosci, Res Ctr Borstel, Div Biophys, Pk Allee 10, D-23845 Borstel, Germany.	jandrae@fz-borstel.de	Goldmann, Torsten/E-5906-2010; Gutsmann, Thomas/E-6100-2011	Goldmann, Torsten/0000-0002-1621-560X; Ernst, Christoph/0000-0002-5575-1325	Deutsche Forschungsgemeinschaft [SFB617 A17, GU 568/4-1, AN301/5-1, SFB766]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants SFB617 A17 and GU 568/4-1 (to T. G.), AN301/5-1 (to J. A.), and SFB766 (to A. P.).	Andra J, 2004, ANTIMICROB AGENTS CH, V48, P1593, DOI 10.1128/AAC.48.5.1593-1599.2004; Andra J, 1996, FEBS LETT, V385, P96, DOI 10.1016/0014-5793(96)00359-6; Andra J, 1999, MED MICROBIOL IMMUN, V188, P117, DOI 10.1007/s004300050113; Andra J, 2008, BIOCHEM J, V410, P113, DOI 10.1042/BJ20071051; Andra J, 2007, J BIOL CHEM, V282, P14719, DOI 10.1074/jbc.M608920200; Andra J, 2009, BIOL CHEM, V390, P337, DOI 10.1515/BC.2009.039; BLONDELLE SE, 1991, BIOCHEMISTRY-US, V30, P4671, DOI 10.1021/bi00233a006; Bohling A, 2006, BIOCHEMISTRY-US, V45, P5663, DOI 10.1021/bi052026e; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Christ K, 2007, BBA-BIOMEMBRANES, V1768, P694, DOI 10.1016/j.bbamem.2006.12.003; COLLINS SH, 1976, J BACTERIOL, V126, P1224, DOI 10.1128/JB.126.3.1224-1231.1976; Danner S, 2008, BIOPHYS J, V94, P2150, DOI 10.1529/biophysj.107.123422; Ernst CM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000660; Gutsmann T, 2005, J ENDOTOXIN RES, V11, P167, DOI 10.1179/096805105X37330; HABERMANN E, 1967, H-S Z PHYSIOL CHEM, V348, P37, DOI 10.1515/bchm2.1967.348.1.37; Hale JD, 2007, EXPERT REV ANTI-INFE, V5, P951, DOI 10.1586/14787210.5.6.951; Hammer MU, 2010, BIOCHEM J, V427, P477, DOI 10.1042/BJ20091607; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Kilelee E, 2010, ANTIMICROB AGENTS CH, V54, P4476, DOI 10.1128/AAC.00191-10; Koo SP, 1996, INFECT IMMUN, V64, P1070, DOI 10.1128/IAI.64.3.1070-1074.1996; LEIPPE M, 1994, P NATL ACAD SCI USA, V91, P2602, DOI 10.1073/pnas.91.7.2602; MATSUZAKI K, 1995, BIOCHEMISTRY-US, V34, P3423, DOI 10.1021/bi00010a034; Mishra NN, 2011, ANTIMICROB AGENTS CH, V55, P526, DOI 10.1128/AAC.00680-10; Mishra NN, 2009, ANTIMICROB AGENTS CH, V53, P2312, DOI 10.1128/AAC.01682-08; MONTAL M, 1972, P NATL ACAD SCI USA, V69, P3561, DOI 10.1073/pnas.69.12.3561; Nishi H, 2004, ANTIMICROB AGENTS CH, V48, P4800, DOI 10.1128/AAC.48.12.4800-4807.2004; Ovchinnikova TV, 2004, FEBS LETT, V577, P209, DOI 10.1016/j.febslet.2004.10.012; Pag U, 2004, J ANTIMICROB CHEMOTH, V53, P230, DOI 10.1093/jac/dkh083; Peschel A, 2001, J EXP MED, V193, P1067, DOI 10.1084/jem.193.9.1067; Russell PJ, 2004, CANCER IMMUNOL IMMUN, V53, P411, DOI 10.1007/s00262-003-0457-9; Samant S, 2009, J BACTERIOL, V191, P1311, DOI 10.1128/JB.01345-08; Schroder-Borm H, 2005, FEBS LETT, V579, P6128, DOI 10.1016/j.febslet.2005.09.084; Schroder-Borm H, 2003, BBA-BIOMEMBRANES, V1612, P164, DOI 10.1016/S0005-2736(03)00115-9; Schromm AB, 1996, FEBS LETT, V399, P267, DOI 10.1016/S0014-5793(96)01338-5; Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260; SHORT SA, 1971, J BACTERIOL, V108, P219, DOI 10.1128/JB.108.1.219-226.1971; Staubitz P, 2004, FEMS MICROBIOL LETT, V231, P67, DOI 10.1016/S0378-1097(03)00921-2; WARD JB, 1968, BIOCHEM J, V106, P391, DOI 10.1042/bj1060391; WERKMEISTER JA, 1993, BIOCHIM BIOPHYS ACTA, V1157, P50, DOI 10.1016/0304-4165(93)90077-L; Wiedemann I, 2006, MOL MICROBIOL, V61, P285, DOI 10.1111/j.1365-2958.2006.05223.x; Wiese A, 2000, METH MOL B, V145, P355; Xiong YQ, 2005, ANTIMICROB AGENTS CH, V49, P3114, DOI 10.1128/AAC.49.8.3114-3121.2005; Yang L, 2001, BIOPHYS J, V81, P1475, DOI 10.1016/S0006-3495(01)75802-X; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	44	71	72	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18692	18700		10.1074/jbc.M111.226886	http://dx.doi.org/10.1074/jbc.M111.226886			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21474443	hybrid, Green Published			2022-12-25	WOS:000290785700042
J	Fu, J; Li, LN; Bouvier, M				Fu, Jie; Li, Lenong; Bouvier, Marlene			Adenovirus E3-19K Proteins of Different Serotypes and Subgroups Have Similar, Yet Distinct, Immunomodulatory Functions toward Major Histocompatibility Class I Molecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM LUMENAL DOMAIN; CELL-SURFACE EXPRESSION; ENDOPLASMIC-RETICULUM; E3/19K PROTEIN; E3-GP19K PROTEIN; DOWN-REGULATION; T-LYMPHOCYTES; TYPE-2; GLYCOPROTEIN; ANTIGENS	Our understanding of the mechanism by which the E3-19K protein from adenovirus (Ad) targets major histocompatibility complex (MHC) class I molecules for retention in the endoplasmic reticulum is derived largely from studies of Ad serotype 2 (subgroup C). It is not well understood to what extent observations on the Ad2 E3-19K/MHC I association can be generalized to E3-19K proteins of other serotypes and subgroups. The low levels of amino acid sequence homology between E3-19K proteins suggest that these proteins are likely to manifest distinct MHC I binding properties. This information is important as the E3-19K/MHC I interaction is thought to play a critical role in enabling Ads to cause persistent infections. Here, we characterized interaction between E3-19K proteins of serotypes 7 and 35 (subgroup B), 5 (subgroup C), 37 (subgroup D), and 4 (subgroup E) and a panel of HLA-A, -B, and -C molecules using native gel, surface plasmon resonance (SPR), and flow cytometry. Results show that all E3-19K proteins exhibited allele specificity toward HLA-A and -B molecules; this was less evident for Ad37 E3-19K. The allele specificity for HLA-A molecules was remarkably similar for different serotypes of subgroup B as well as subgroup C. Interestingly, all E3-19K proteins characterized also exhibited MHC I locus specificity. Importantly, we show that Lys(91) in the conserved region of Ad2 E3-19K targets the C terminus of the alpha 2-helix (MHC residue 177) on MHC class I molecules. From our data, we propose a model of interaction between E3-19K and MHC class I molecules.	[Fu, Jie; Li, Lenong; Bouvier, Marlene] Univ Illinois, Coll Med, Dept Microbiol & Immunol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Bouvier, M (corresponding author), Univ Illinois, Coll Med, Dept Microbiol & Immunol, M-C 790,835 S Wolcott Ave, Chicago, IL 60612 USA.	mbouvier@uic.edu			National Institutes of Health from NIAID [AI045070]; University of Illinois at Chicago, Center for Clinical and Translational Science from the NCRR [UL1RR029879]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI045070, R01AI045070] Funding Source: NIH RePORTER	National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Illinois at Chicago, Center for Clinical and Translational Science from the NCRR; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI045070 from NIAID. This work was also supported by University of Illinois at Chicago, Center for Clinical and Translational Science Award UL1RR029879 from the NCRR.	ANDERSSON M, 1987, J IMMUNOL, V138, P3960; ANDERSSON M, 1985, CELL, V43, P215, DOI 10.1016/0092-8674(85)90026-1; BEIER DC, 1994, J IMMUNOL, V152, P3862; BURGERT HG, 1985, CELL, V41, P987, DOI 10.1016/S0092-8674(85)80079-9; BURGERT HG, 1987, P NATL ACAD SCI USA, V84, P1356, DOI 10.1073/pnas.84.5.1356; Burgert HG, 2002, CURR TOP MICROBIOL, V269, P273; BURGERT HG, 1987, EMBO J, V6, P2019, DOI 10.1002/j.1460-2075.1987.tb02466.x; CHALLBERG SS, 1981, VIROLOGY, V114, P196, DOI 10.1016/0042-6822(81)90265-8; CHATTERJEE D, 1984, P NATL ACAD SCI-BIOL, V81, P6039, DOI 10.1073/pnas.81.19.6039; Cohen GB, 1999, IMMUNITY, V10, P661, DOI 10.1016/S1074-7613(00)80065-5; COX JH, 1990, SCIENCE, V247, P715, DOI 10.1126/science.2137259; COX JH, 1991, J EXP MED, V174, P1629, DOI 10.1084/jem.174.6.1629; Deryckere F, 1996, J VIROL, V70, P2832, DOI 10.1128/JVI.70.5.2832-2841.1996; FEUERBACH D, 1994, J IMMUNOL, V153, P1626; FLOMENBERG P, 1994, MOL IMMUNOL, V31, P1277, DOI 10.1016/0161-5890(94)90078-7; Flomenberg P, 1996, J VIROL, V70, P6314, DOI 10.1128/JVI.70.9.6314-6322.1996; FLOMENBERG P, 1994, J INFECT DIS, V169, P775, DOI 10.1093/infdis/169.4.775; FLOMENBERG P, 1992, J VIROL, V66, P4778, DOI 10.1128/JVI.66.8.4778-4783.1992; FOX JP, 1969, AM J EPIDEMIOL, V89, P25, DOI 10.1093/oxfordjournals.aje.a120913; FOX JP, 1977, AM J EPIDEMIOL, V105, P362, DOI 10.1093/oxfordjournals.aje.a112394; Fu J, 2009, 2ND EUROPEAN CONGRESS OF IMMUNOLOGY (ECI), P123; Fu J, 2011, MOL IMMUNOL, V48, P532, DOI 10.1016/j.molimm.2010.10.017; GABATHULER R, 1990, J VIROL, V64, P3679, DOI 10.1128/JVI.64.8.3679-3685.1990; GARBOCZI DN, 1992, P NATL ACAD SCI USA, V89, P3429, DOI 10.1073/pnas.89.8.3429; GINSBERG HS, 1989, P NATL ACAD SCI USA, V86, P3823, DOI 10.1073/pnas.86.10.3823; GREEN M, 1979, VIROLOGY, V93, P481, DOI 10.1016/0042-6822(79)90251-4; HERMISTON TW, 1993, VIROLOGY, V197, P593, DOI 10.1006/viro.1993.1633; HERMISTON TW, 1993, J VIROL, V67, P5289, DOI 10.1128/JVI.67.9.5289-5298.1993; HIERHOLZER JC, 1992, CLIN MICROBIOL REV, V5, P262, DOI 10.1128/CMR.5.3.262-274.1992; Ishido S, 2000, J VIROL, V74, P5300, DOI 10.1128/JVI.74.11.5300-5309.2000; KRILOV LR, 1990, REV INFECT DIS, V12, P303; KVIST S, 1978, P NATL ACAD SCI USA, V75, P5674, DOI 10.1073/pnas.75.11.5674; Li LN, 2002, ACTA CRYSTALLOGR D, V58, P1195, DOI 10.1107/S0907444902007928; Liu H, 2005, J VIROL, V79, P13317, DOI 10.1128/JVI.79.21.13317-13325.2005; Liu H, 2007, J IMMUNOL, V178, P4567, DOI 10.4049/jimmunol.178.7.4567; McSharry BP, 2008, J VIROL, V82, P4585, DOI 10.1128/JVI.02251-07; PAABO S, 1987, CELL, V50, P311, DOI 10.1016/0092-8674(87)90226-1; RAWLE FC, 1989, J IMMUNOL, V143, P2031; SESTER M, 1994, J VIROL, V68, P5423, DOI 10.1128/JVI.68.9.5423-5432.1994; SEVERINSSON L, 1986, J IMMUNOL, V137, P1003; TANAKA Y, 1988, VIROLOGY, V165, P357, DOI 10.1016/0042-6822(88)90580-6; WADELL G, 1984, CURR TOP MICROBIOL, V110, P191; WOLD WSM, 1989, MOL BIOL MED, V6, P433; Yokoyama WM, 1998, CURR OPIN IMMUNOL, V10, P298, DOI 10.1016/S0952-7915(98)80168-4; ZAHRADNIK JM, 1980, AM J MED, V68, P725, DOI 10.1016/0002-9343(80)90262-4	45	20	20	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17631	17639		10.1074/jbc.M110.212050	http://dx.doi.org/10.1074/jbc.M110.212050			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454588	Green Published, hybrid			2022-12-25	WOS:000290585200026
J	Hu, W; Ross, J; Geng, TY; Brice, SE; Cowart, LA				Hu, Wei; Ross, Jessica; Geng, Tuoyu; Brice, Sarah E.; Cowart, L. Ashley			Differential Regulation of Dihydroceramide Desaturase by Palmitate versus Monounsaturated Fatty Acids IMPLICATIONS FOR INSULIN RESISTANCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE CELLS; PROTEIN-KINASE-C; SPHINGOLIPID METABOLISM; CELLULAR-RESPONSES; CERAMIDE SYNTHASES; SPHINGOSINE KINASE; ACCUMULATION; DIACYLGLYCEROL; INVOLVEMENT; DISEASE	Much data implicate saturated fatty acids in deleterious processes associated with obesity, diabetes, and the metabolic syndrome. Many of these changes may be due to aberrant generation of bioactive lipids when saturated fatty acid availability to tissues is increased. On the other hand, studies are emerging that implicate the monounsaturated fatty acid oleate in protection from saturated fat mediated toxicity; however, the mechanisms are not well understood. Our data demonstrate a novel role for palmitate in increasing mRNA encoding DES1, which is the enzyme responsible for generating ceramide from its precursor dihydroceramide and thus controls synthesis of the bioactive lipid ceramide. Moreover, co-treatment with oleate prevented the increase in ceramide, and this occurred through attenuation of the increase in message and activity of DES1. Knockdown of DES1 also protected from palmitate-induced insulin resistance, and overexpression of this enzyme ameliorated the protective effect of oleate. Together, these findings provide insight into the mechanisms of oleate-mediated protection against metabolic disease and provide novel evidence for fatty acid-mediated regulation of a key enzyme of ceramide biosynthesis.	[Hu, Wei; Ross, Jessica; Geng, Tuoyu; Brice, Sarah E.; Cowart, L. Ashley] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29403 USA; [Cowart, L. Ashley] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29403 USA	Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Cowart, LA (corresponding author), 114 Doughty St,Strom Thurmond Bldg,Rm 423, Charleston, SC 29403 USA.	cowartl@musc.edu			Department of Veterans Affairs; National Institutes of Health COBRE in Lipidomics and Pathobiology at the Medical University of South Carolina; Centers of Biomedical Research Excellence in Lipidomics in Pathobiology (NIH) [P20RR017077]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM072643] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health COBRE in Lipidomics and Pathobiology at the Medical University of South Carolina; Centers of Biomedical Research Excellence in Lipidomics in Pathobiology (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a Merit Award from the Department of Veterans Affairs (to L. A. C.) and the National Institutes of Health COBRE in Lipidomics and Pathobiology at the Medical University of South Carolina (to L. A. C.). Lipidomics were supported by the Centers of Biomedical Research Excellence in Lipidomics in Pathobiology (NIH P20RR017077).	Alvarez-Vasquez F, 2005, NATURE, V433, P425, DOI 10.1038/nature03232; Arana L, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-15; BERKOWITZ D, 1966, J AMER MED ASSOC, V197, P77, DOI 10.1001/jama.197.2.77; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Boden G, 2002, EUR J CLIN INVEST, V32, P14, DOI 10.1046/j.1365-2362.32.s3.3.x; Chavez JA, 2003, ARCH BIOCHEM BIOPHYS, V419, P101, DOI 10.1016/j.abb.2003.08.020; Chavez JA, 2005, J BIOL CHEM, V280, P20148, DOI 10.1074/jbc.M412769200; Chavez JA, 2003, J BIOL CHEM, V278, P10297, DOI 10.1074/jbc.M212307200; Coll T, 2008, J BIOL CHEM, V283, P11107, DOI 10.1074/jbc.M708700200; Cowart LA, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.3; Das SK, 2010, J LIPID RES, V51, P2121, DOI 10.1194/jlr.M004275; Erion DM, 2010, NAT MED, V16, P400, DOI 10.1038/nm0410-400; Frangioudakis G, 2010, ENDOCRINOLOGY, V151, P4187, DOI 10.1210/en.2010-0250; Gao D, 2009, BRIT J NUTR, V102, P1557, DOI 10.1017/S0007114509990948; Gaster M, 2005, DIABETES, V54, P648, DOI 10.2337/diabetes.54.3.648; Geeraert L, 1997, BIOCHEM J, V327, P125, DOI 10.1042/bj3270125; Ghosh N, 2007, ENDOCRINOLOGY, V148, P1359, DOI 10.1210/en.2006-0750; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hansen BC, 1999, ANN NY ACAD SCI, V892, P1, DOI 10.1111/j.1749-6632.1999.tb07782.x; Henique C, 2010, J BIOL CHEM, V285, P36818, DOI 10.1074/jbc.M110.170431; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Hu W, 2009, J LIPID RES, V50, P1852, DOI 10.1194/jlr.M800635-JLR200; Itani SI, 2002, DIABETES, V51, P2005, DOI 10.2337/diabetes.51.7.2005; Kadotani A, 2009, AM J PHYSIOL-ENDOC M, V297, pE1291, DOI 10.1152/ajpendo.00293.2009; Kitatani K, 2009, J BIOL CHEM, V284, P12979, DOI 10.1074/jbc.M809500200; Kraegen EW, 2008, CURR OPIN LIPIDOL, V19, P235, DOI 10.1097/01.mol.0000319118.44995.9a; Kraveka JM, 2007, J BIOL CHEM, V282, P16718, DOI 10.1074/jbc.M700647200; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Lee JS, 2006, J APPL PHYSIOL, V100, P1467, DOI 10.1152/japplphysiol.01438.2005; Mao CG, 2003, J BIOL CHEM, V278, P31184, DOI 10.1074/jbc.M303875200; Mazzone T, 2008, LANCET, V371, P1800, DOI 10.1016/S0140-6736(08)60768-0; Mesicek J, 2010, CELL SIGNAL, V22, P1300, DOI 10.1016/j.cellsig.2010.04.006; Michel C, 1997, FEBS LETT, V416, P153, DOI 10.1016/S0014-5793(97)01187-3; Miyazaki M, 2001, J BIOL CHEM, V276, P39455, DOI 10.1074/jbc.M106442200; Moro C, 2009, J CLIN ENDOCR METAB, V94, P3440, DOI 10.1210/jc.2009-0053; Mullen KL, 2009, AM J PHYSIOL-REG I, V296, pR243, DOI 10.1152/ajpregu.90774.2008; OBEID LM, 1995, J CELL BIOCHEM, V58, P191, DOI 10.1002/jcb.240580208; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Pickersgill L, 2007, J BIOL CHEM, V282, P12583, DOI 10.1074/jbc.M611157200; Roden M, 2004, NEWS PHYSIOL SCI, V19, P92, DOI 10.1152/nips.01459.2003; Sabin MA, 2007, J CELL PHYSIOL, V211, P244, DOI 10.1002/jcp.20922; Samuel VT, 2010, LANCET, V375, P2267, DOI 10.1016/S0140-6736(10)60408-4; Schmitz-Peiffer C, 1999, J BIOL CHEM, V274, P24202, DOI 10.1074/jbc.274.34.24202; Schmitz-Peiffer C, 2002, ANN NY ACAD SCI, V967, P146; Schulze H, 2000, METHOD ENZYMOL, V311, P22; Sell H, 2008, AM J PHYSIOL-ENDOC M, V294, pE1070, DOI 10.1152/ajpendo.00529.2007; Senkal CE, 2007, MOL CANCER THER, V6, P712, DOI 10.1158/1535-7163.MCT-06-0558; Senkal CE, 2010, FASEB J, V24, P296, DOI 10.1096/fj.09-135087; Shimabukuro M, 1998, J BIOL CHEM, V273, P32487, DOI 10.1074/jbc.273.49.32487; Spiegel S, 1996, FASEB J, V10, P1388, DOI 10.1096/fasebj.10.12.8903509; SPRINGER ML, 1997, CURRENT PROTOCOLS HU; Summers SA, 2006, PROG LIPID RES, V45, P42, DOI 10.1016/j.plipres.2005.11.002; Summers SA, 2010, CURR OPIN LIPIDOL, V21, P128, DOI 10.1097/MOL.0b013e3283373b66; Taha TA, 2006, J BIOCHEM MOL BIOL, V39, P113; Turpin SM, 2009, J PHYSIOL-LONDON, V587, P1593, DOI 10.1113/jphysiol.2008.166033; Unger RH, 2003, ENDOCRINOLOGY, V144, P5159, DOI 10.1210/en.2003-0870; Venable ME, 1995, J BIOL CHEM, V270, P30701, DOI 10.1074/jbc.270.51.30701; Wei YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE275, DOI 10.1152/ajpendo.00644.2005; Ye Jianping, 2007, Endocrine Metabolic & Immune Disorders-Drug Targets, V7, P65; Zhou YT, 2000, P NATL ACAD SCI USA, V97, P1784, DOI 10.1073/pnas.97.4.1784	61	58	59	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16596	16605		10.1074/jbc.M110.186916	http://dx.doi.org/10.1074/jbc.M110.186916			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454530	Green Published, hybrid			2022-12-25	WOS:000290301900008
J	Saino, H; Ukita, Y; Ago, H; Irikura, D; Nisawa, A; Ueno, G; Yamamoto, M; Kanaoka, Y; Lam, BK; Austen, KF; Miyano, M				Saino, Hiromichi; Ukita, Yoko; Ago, Hideo; Irikura, Daisuke; Nisawa, Atsushi; Ueno, Go; Yamamoto, Masaki; Kanaoka, Yoshihide; Lam, Bing K.; Austen, K. Frank; Miyano, Masashi			The Catalytic Architecture of Leukotriene C-4 Synthase with Two Arginine Residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTATHIONE-S-TRANSFERASE; IN-VIVO; PROTEIN; 5-LIPOXYGENASE; GENERATION; IDENTIFICATION; PURIFICATION; REQUIREMENT; RECOGNITION; ANTAGONIST	Leukotriene (LT) C-4 and its metabolites, LTD4 and LTE4, are involved in the pathobiology of bronchial asthma. LTC4 synthase is the nuclear membrane-embedded enzyme responsible for LTC4 biosynthesis, catalyzing the conjugation of two substrates that have considerably different water solubility; that amphipathic LTA(4) as a derivative of arachidonic acid and a water-soluble glutathione (GSH). A previous crystal structure revealed important details of GSH binding and implied a GSH activating function for Arg-104. In addition, Arg-31 was also proposed to participate in the catalysis based on the putative LTA(4) binding model. In this study enzymatic assay with mutant enzymes demonstrates that Arg-104 is required for the binding and activation of GSH and that Arg-31 is needed for catalysis probably by activating the epoxide group of LTA(4).	[Saino, Hiromichi; Ukita, Yoko; Ago, Hideo; Irikura, Daisuke; Miyano, Masashi] RIKEN SPring 8 Ctr, Harima Inst, Struct Biophys Lab, Sayo, Hyogo 6795148, Japan; [Nisawa, Atsushi; Ueno, Go; Yamamoto, Masaki] RIKEN SPring 8 Ctr, Harima Inst, Res Infrastruct Grp, Sayo, Hyogo 6795148, Japan; [Kanaoka, Yoshihide; Lam, Bing K.; Austen, K. Frank] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Kanaoka, Yoshihide; Lam, Bing K.; Austen, K. Frank] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA	RIKEN; RIKEN; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Ago, H (corresponding author), RIKEN SPring 8 Ctr, Harima Inst, Struct Biophys Lab, 1-1-1 Kouto, Sayo, Hyogo 6795148, Japan.	ago@spring8.or.jp; miyano@spring8.or.jp	Yamamoto, Masaki/B-7844-2015; Miyano, Masashi/R-2785-2016	Yamamoto, Masaki/0000-0002-1311-1768; Miyano, Masashi/0000-0003-2253-6175; Ago, Hideo/0000-0002-9040-488X	National Institutes of Health [AI31599, HL36110, HL82695, HL90630]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [A-12]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090630, K08HL003611, P01HL036110, R01HL082695] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI031599, U01AI031599, P01AI031599] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI31599, HL36110, and HL82695 (to B. K. L.) and HL90630 (to Y. K.). This work was supported in part by a grant-in-aid for Scientific Research in the Global Center of Excellence program (A-12) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to H. A.).	Adachi S, 2001, NUCL INSTRUM METH A, V467, P711, DOI 10.1016/S0168-9002(01)00472-7; Ago H, 2007, NATURE, V448, P609, DOI 10.1038/nature05936; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barrett NA, 2009, J IMMUNOL, V182, P1119, DOI 10.4049/jimmunol.182.2.1119; Beller TC, 2004, P NATL ACAD SCI USA, V101, P3047, DOI 10.1073/pnas.0400235101; Bresell A, 2005, FEBS J, V272, P1688, DOI 10.1111/j.1742-4658.2005.04596.x; CARRIER DJ, 1988, PROSTAG LEUKOTR ESS, V34, P27, DOI 10.1016/0952-3278(88)90021-X; CHEN WJ, 1988, BIOCHEMISTRY-US, V27, P647, DOI 10.1021/bi00402a023; CLARK JD, 1990, P NATL ACAD SCI USA, V87, P7708, DOI 10.1073/pnas.87.19.7708; DAHLEN SE, 1980, NATURE, V288, P484, DOI 10.1038/288484a0; DAHLEN SE, 1981, P NATL ACAD SCI-BIOL, V78, P3887, DOI 10.1073/pnas.78.6.3887; DIXON RAF, 1990, NATURE, V343, P282, DOI 10.1038/343282a0; DONNELLY AL, 1995, AM J RESP CRIT CARE, V151, P1734, DOI 10.1164/ajrccm.151.6.7767514; Gu YJ, 2000, BIOCHEMISTRY-US, V39, P12552, DOI 10.1021/bi001396u; Habib GM, 2003, FASEB J, V17, P1313, DOI 10.1096/fj.02-0899fje; Heise CE, 2000, J BIOL CHEM, V275, P30531, DOI 10.1074/jbc.M003490200; Hoff RH, 2000, BIOCHEMISTRY-US, V39, P46, DOI 10.1021/bi991570i; ISRAEL E, 1990, NEW ENGL J MED, V323, P1740, DOI 10.1056/NEJM199012203232505; Jakobsson PJ, 1999, PROTEIN SCI, V8, P689, DOI 10.1110/ps.8.3.689; Kim DC, 2006, J IMMUNOL, V176, P4440, DOI 10.4049/jimmunol.176.7.4440; KNAPP HR, 1990, NEW ENGL J MED, V323, P1745, DOI 10.1056/NEJM199012203232506; KRILIS S, 1983, J CLIN INVEST, V71, P909, DOI 10.1172/JCI110845; LAM BK, 1994, P NATL ACAD SCI USA, V91, P7663, DOI 10.1073/pnas.91.16.7663; Lam BK, 1997, J BIOL CHEM, V272, P13923, DOI 10.1074/jbc.272.21.13923; LEWIS RA, 1980, P NATL ACAD SCI-BIOL, V77, P3710, DOI 10.1073/pnas.77.6.3710; Lovell SC, 2000, PROTEINS, V40, P389, DOI 10.1002/1097-0134(20000815)40:3<389::AID-PROT50>3.0.CO;2-2; Lynch KR, 1999, NATURE, V399, P789; MACGLASHAN DW, 1986, J IMMUNOL, V136, P2231; MACGLASHAN DW, 1982, J CLIN INVEST, V70, P747, DOI 10.1172/JCI110670; Maekawa A, 2008, P NATL ACAD SCI USA, V105, P16695, DOI 10.1073/pnas.0808993105; MANNING PJ, 1990, NEW ENGL J MED, V323, P1736, DOI 10.1056/NEJM199012203232504; MAYCOCK AL, 1982, J BIOL CHEM, V257, P3911; Molina DM, 2007, NATURE, V448, P613, DOI 10.1038/nature06009; OKAZAKI K, 1990, NUCLEIC ACIDS RES, V18, P6485, DOI 10.1093/nar/18.22.6485; Pacor ML, 2001, CLIN EXP ALLERGY, V31, P1607, DOI 10.1046/j.1365-2222.2001.01189.x; Paruchuri S, 2008, J BIOL CHEM, V283, P16477, DOI 10.1074/jbc.M705822200; Paruchuri S, 2009, J EXP MED, V206, P2543, DOI 10.1084/jem.20091240; RADMARK O, 1980, J BIOL CHEM, V255, P1828; ROUZER CA, 1985, P NATL ACAD SCI USA, V82, P6040, DOI 10.1073/pnas.82.18.6040; ROUZER CA, 1980, P NATL ACAD SCI-BIOL, V77, P4928, DOI 10.1073/pnas.77.8.4928; SALA A, 1990, J BIOL CHEM, V265, P21771; Schmidt- Krey I, 2004, STRUCTURE, V12, P2009, DOI 10.1016/j.str.2004.08.008; Shi ZZ, 2001, MOL CELL BIOL, V21, P5389, DOI 10.1128/MCB.21.16.5389-5395.2001; Silva PJ, 2010, J PHYS CHEM B, V114, P8994, DOI 10.1021/jp100961s; Silva PJ, 2005, J PHYS CHEM B, V109, P18195, DOI 10.1021/jp051792s; SMITH CM, 1991, AM REV RESPIR DIS, V144, P1411, DOI 10.1164/ajrccm/144.6.1411; SOTER NA, 1983, J INVEST DERMATOL, V80, P115, DOI 10.1111/1523-1747.ep12531738; STEINER EC, 1963, J AM CHEM SOC, V85, P3054, DOI 10.1021/ja00902a062; Ueno Go, 2006, Journal of Structural and Functional Genomics, V7, P15, DOI 10.1007/s10969-005-9005-5; WARDLAW AJ, 1989, J ALLERGY CLIN IMMUN, V84, P19, DOI 10.1016/0091-6749(89)90173-5; WEISS JW, 1982, SCIENCE, V216, P196, DOI 10.1126/science.7063880; WELLER PF, 1983, P NATL ACAD SCI-BIOL, V80, P7626, DOI 10.1073/pnas.80.24.7626; WOODS JW, 1993, J EXP MED, V178, P1935, DOI 10.1084/jem.178.6.1935; YOSHIMOTO T, 1988, J CLIN INVEST, V81, P866, DOI 10.1172/JCI113396	55	30	30	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.150177	http://dx.doi.org/10.1074/jbc.M110.150177			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454538	Green Published, hybrid			2022-12-25	WOS:000290022800077
J	Grech, A; Sheppard, J; Marsh, H				Grech, Alana; Sheppard, James; Marsh, Helene			Informing Species Conservation at Multiple Scales Using Data Collected for Marine Mammal Stock Assessments	PLOS ONE			English	Article							GREAT-BARRIER-REEF; TORRES STRAIT; AERIAL SURVEYS; DUGONG; ABUNDANCE; SEAGRASS; QUEENSLAND; CETACEANS; RESERVES; DESIGN	Background: Conservation planning and the design of marine protected areas (MPAs) requires spatially explicit information on the distribution of ecological features. Most species of marine mammals range over large areas and across multiple planning regions. The spatial distributions of marine mammals are difficult to predict using habitat modelling at ecological scales because of insufficient understanding of their habitat needs, however, relevant information may be available from surveys conducted to inform mandatory stock assessments. Methodology and Results: We use a 20-year time series of systematic aerial surveys of dugong (Dugong dugong) abundance to create spatially-explicit models of dugong distribution and relative density at the scale of the coastal waters of northeast Australia (similar to 136,000 km(2)). We interpolated the corrected data at the scale of 2 km * 2 km planning units using geostatistics. Planning units were classified as low, medium, high and very high dugong density on the basis of the relative density of dugongs estimated from the models and a frequency analysis. Torres Strait was identified as the most significant dugong habitat in northeast Australia and the most globally significant habitat known for any member of the Order Sirenia. The models are used by local, State and Federal agencies to inform management decisions related to the Indigenous harvest of dugongs, gill-net fisheries and Australia's National Representative System of Marine Protected Areas. Conclusion/Significance: In this paper we demonstrate that spatially-explicit population models add value to data collected for stock assessments, provide a robust alternative to predictive habitat distribution models, and inform species conservation at multiple scales.	[Grech, Alana] James Cook Univ, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Grech, Alana; Sheppard, James; Marsh, Helene] James Cook Univ, Sch Earth & Environm Sci, Townsville, Qld 4811, Australia; [Sheppard, James] San Diego Zoo, San Diego Zoo Inst Conservat Res, Escondido, CA USA	James Cook University; James Cook University; Zoological Society of San Diego	Grech, A (corresponding author), James Cook Univ, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	alana.grech@jcu.edu.au	Grech, Alana/U-7776-2019; Grech, Alana/E-9464-2011	Grech, Alana/0000-0003-4117-3779; Grech, Alana/0000-0003-4117-3779; Marsh, Helene/0000-0003-3492-4992	Australian Marine Mammal Centre; Australian Department of Sustainability, Environment, Water, Population and Communities; Queensland Department of Environment and Resource Management; Great Barrier Reef Marine Park Authority; Queensland Government Growing the Smart State PhD Funding Programme; Northern Territory Government; Torres Strait Regional Authority; School of Earth and Environmental Sciences, James Cook University	Australian Marine Mammal Centre; Australian Department of Sustainability, Environment, Water, Population and Communities(Australian Government); Queensland Department of Environment and Resource Management; Great Barrier Reef Marine Park Authority; Queensland Government Growing the Smart State PhD Funding Programme; Northern Territory Government; Torres Strait Regional Authority; School of Earth and Environmental Sciences, James Cook University	Australian Marine Mammal Centre (http://www.marinemammals.gov.au/ammc-grants-scheme); Australian Department of Sustainability, Environment, Water, Population and Communities (http://www.environment.gov.au); Queensland Department of Environment and Resource Management (http://www.derm.qld.gov.au); Great Barrier Reef Marine Park Authority (http://www.gbrmpa.gov.au); Queensland Government Growing the Smart State PhD Funding Programme (http://education.qld.gov.au/corporate/research/smartstate.html); Northern Territory Government (www.nt.gov.au); Torres Strait Regional Authority (www.tsra.gov.au); School of Earth and Environmental Sciences, James Cook University (http://www.jcu.edu.au/ees/index.htm); and an anonymous donor. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre J, 2005, WILDLIFE RES, V32, P53, DOI 10.1071/WR04015; Bicho N., 2015, HUMAN ORIGIN SITES W; Brown JH, 1996, ANNU REV ECOL SYST, V27, P597, DOI 10.1146/annurev.ecolsys.27.1.597; Carr MH, 2003, ECOL APPL, V13, pS90; COLES RG, 2007, DEEDI PUBLICATION; de Stephanis R, 2008, MAR ECOL PROG SER, V353, P275, DOI 10.3354/meps07164; Dobbs K, 2008, OCEAN COAST MANAGE, V51, P368, DOI 10.1016/j.ocecoaman.2007.08.001; Erasmus BFN, 1999, P ROY SOC B-BIOL SCI, V266, P315, DOI 10.1098/rspb.1999.0640; Fernandes L, 2005, CONSERV BIOL, V19, P1733, DOI 10.1111/j.1523-1739.2005.00302.x; Foley MM, 2010, MAR POLICY, V34, P955, DOI 10.1016/j.marpol.2010.02.001; *GREAT BARR REEF M, 2009, GREAT BARR REEF OUTL; Grech A, 2008, AQUAT CONSERV, V18, P1127, DOI 10.1002/aqc.943; Grech A, 2008, CONSERV BIOL, V22, P711, DOI 10.1111/j.1523-1739.2008.00923.x; Grech A, 2010, AQUAT CONSERV, V20, P437, DOI 10.1002/aqc.1107; Grech A, 2007, APPL GIS, V3, P1; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; HINES E, 2011, INT STRATEGIES MANAT; Hooker SK, 2004, BIOSCIENCE, V54, P27, DOI 10.1641/0006-3568(2004)054[0027:MRAATF]2.0.CO;2; *INT UN CONS NAT, 2012, IUCN RED LIST CAT CR; JONES S, 1981, DUGONG, P24; Kaschner K, 2006, MAR ECOL PROG SER, V316, P285, DOI 10.3354/meps316285; Laidre KL, 2010, MAR ECOL PROG SER, V402, P269, DOI 10.3354/meps08423; Lawler JJ, 2006, GLOBAL CHANGE BIOL, V12, P1568, DOI 10.1111/j.1365-2486.2006.01191.x; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Marsh H, 2005, ECOL APPL, V15, P481, DOI 10.1890/04-0673; Marsh H, 2004, ANIM CONSERV, V7, P435, DOI 10.1017/S1367943004001635; MARSH H, 1989, AUST WILDLIFE RES, V16, P639; MARSH H, 1990, AUST WILDLIFE RES, V17, P511; Marsh H., 2002, EARLY WARNING ASSESS; Marsh H., 2002, DUGONG DISTRIBUTION; Marsh H., 2007, CONDITION STATUS TRE; Marsh H, 2001, DUGONG DISTRIBUTION; MARSH HD, 2008, DISTRIBUTION ABUNDAN; MARSH HD, 2006, IS DUGONG MANAGEMENT; Marsh H, 2008, CONT SHELF RES, V28, P2152, DOI 10.1016/j.csr.2008.03.023; Marsh Helene, 2003, P1; McCook LJ, 2010, P NATL ACAD SCI USA, V107, P18278, DOI 10.1073/pnas.0909335107; Palumbi SR, 2004, ANNU REV ENV RESOUR, V29, P31, DOI 10.1146/annurev.energy.29.062403.102254; Pershing AJ, 2009, MAR ECOL PROG SER, V378, P245, DOI 10.3354/meps07829; Pollock KH, 2006, J WILDLIFE MANAGE, V70, P255, DOI 10.2193/0022-541X(2006)70[255:EAAIHE]2.0.CO;2; PREEN A, 1995, WILDLIFE RES, V22, P507, DOI 10.1071/WR9950507; PREEN A, 1995, J MAMMAL, V76, P163, DOI 10.2307/1382325; Preen A., 1992, THESIS J COOK U TOWN; Rasheed MA, 2011, MAR ECOL PROG SER, V422, P93, DOI 10.3354/meps08925; Sheppard JK, 2006, J EXP MAR BIOL ECOL, V334, P64, DOI 10.1016/j.jembe.2006.01.011; Sheppard JK, 2010, MAR MAMMAL SCI, V26, P855, DOI 10.1111/j.1748-7692.2010.00374.x; Sheppard JK, 2009, J WILDLIFE MANAGE, V73, P45, DOI 10.2193/2007-468; Short FT, 2001, GLOBAL SEAGRASS RESEARCH METHODS, P5, DOI 10.1016/B978-044450891-1/50002-5; Taylor BL, 2007, MAR MAMMAL SCI, V23, P157, DOI 10.1111/j.1748-7692.2006.00092.x; Taylor H.A., 2010, DEEDI PUBLICATION; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Vigness-Raposa KJ, 2010, MAR MAMMAL SCI, V26, P161, DOI 10.1111/j.1748-7692.2009.00336.x; Wade PR, 1998, MAR MAMMAL SCI, V14, P1, DOI 10.1111/j.1748-7692.1998.tb00688.x	53	16	16	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e17993	10.1371/journal.pone.0017993	http://dx.doi.org/10.1371/journal.pone.0017993			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464933	Green Submitted, Green Accepted, gold, Green Published			2022-12-25	WOS:000289053800010
J	Pratt, CH; Curtain, M; Donahue, LR; Shopland, LS				Pratt, C. Herbert; Curtain, Michelle; Donahue, Leah Rae; Shopland, Lindsay S.			Mitotic Defects Lead to Pervasive Aneuploidy and Accompany Loss of RB1 Activity in Mouse Lmna(Dhe) Dermal Fibroblasts	PLOS ONE			English	Article							CELL-CYCLE PROGRESSION; DNA-DAMAGE RESPONSES; A-TYPE LAMINS; NUCLEAR LAMINS; GENOMIC INSTABILITY; PRELAMIN-A; LAMINOPATHIES; ORGANIZATION; MATURATION; CHROMATIN	Background: Lamin A (LMNA) is a component of the nuclear lamina and is mutated in several human diseases, including Emery-Dreifuss muscular dystrophy (EDMD; OMIM ID# 181350) and the premature aging syndrome Hutchinson-Gilford progeria syndrome (HGPS; OMIM ID# 176670). Cells from progeria patients exhibit cell cycle defects in both interphase and mitosis. Mouse models with loss of LMNA function have reduced Retinoblastoma protein (RB1) activity, leading to aberrant cell cycle control in interphase, but how mitosis is affected by LMNA is not well understood. Results: We examined the cell cycle and structural phenotypes of cells from mice with the Lmna allele, Disheveled hair and ears (Lmna(Dhe)). We found that dermal fibroblasts from heterozygous Lmna(Dhe) (Lmna(Dhe/+)) mice exhibit many phenotypes of human laminopathy cells. These include severe perturbations to the nuclear shape and lamina, increased DNA damage, and slow growth rates due to mitotic delay. Interestingly, Lmna(Dhe/+) fibroblasts also had reduced levels of hypophosphorylated RB1 and the non-SMC condensin II-subunit D3 (NCAP-D3), a mitosis specific centromere condensin subunit that depends on RB1 activity. Mitotic check point control by mitotic arrest deficient-like 1 (MAD2L1) also was perturbed in Lmna(Dhe/+) cells. Lmna(Dhe/+) fibroblasts were consistently aneuploid and had higher levels of micronuclei and anaphase bridges than normal fibroblasts, consistent with chromosome segregation defects. Conclusions: These data indicate that RB1 may be a key regulator of cellular phenotype in laminopathy-related cells, and suggest that the effects of LMNA on RB1 include both interphase and mitotic cell cycle control.	[Pratt, C. Herbert; Curtain, Michelle; Donahue, Leah Rae; Shopland, Lindsay S.] Jackson Lab, Bar Harbor, ME 04609 USA	Jackson Laboratory	Pratt, CH (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	craig.pratt@jax.org		Pratt, Herb/0000-0002-4964-8292	Eunice Kennedy Shriver National Institute of Child Health and Human Development [T32 HD007065]; Jackson Laboratory; National Science Foundation [MCB 0817787]; National Eye Institute [EY015073]; Jackson Laboratory's Cancer Center, National Cancer Institute [CA034196]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007065] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY015073] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Jackson Laboratory; National Science Foundation(National Science Foundation (NSF)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Jackson Laboratory's Cancer Center, National Cancer Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was made possible by grants T32 HD007065 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development and a Jackson Laboratory Postodoctoral Fellowship from The Jackson Laboratory to CHP; MCB 0817787 from the National Science Foundation to LSS; EY015073 from the National Eye Institute to LRD and The Jackson Laboratory's Cancer Center Support Grant CA034196 from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato A, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-79; Beaudouin J, 2002, CELL, V108, P83, DOI 10.1016/S0092-8674(01)00627-4; BENSON EK, J CELL SCI; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cao K, 2007, P NATL ACAD SCI USA, V104, P4949, DOI 10.1073/pnas.0611640104; CHI HI, 1990, J INVEST DERMATOL, V95, P154, DOI 10.1111/1523-1747.ep12477921; COSCHI CH, GENES DEV, V24, P1351; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; Dechat T, 2007, P NATL ACAD SCI USA, V104, P4955, DOI 10.1073/pnas.0700854104; Dorner D, 2006, J CELL BIOL, V173, P83, DOI 10.1083/jcb.200511149; Frock RL, 2006, GENE DEV, V20, P486, DOI 10.1101/gad.1364906; Gonzalez-Suarez I, 2009, EMBO J, V28, P2414, DOI 10.1038/emboj.2009.196; Gruenbaum Y, 2003, INT REV CYTOL, V226, P1, DOI 10.1016/S0074-7696(03)01001-5; Johnson BR, 2004, P NATL ACAD SCI USA, V101, P9677, DOI 10.1073/pnas.0403250101; LANDEGREN U, 1984, J IMMUNOL METHODS, V67, P379, DOI 10.1016/0022-1759(84)90477-0; Liu BH, 2005, NAT MED, V11, P780, DOI 10.1038/nm1266; Liu Y, 2008, FASEB J, V22, P603, DOI 10.1096/fj.07-8598com; Liu YY, 2006, J CELL SCI, V119, P4644, DOI 10.1242/jcs.03263; Longworth MS, 2008, GENE DEV, V22, P1011, DOI 10.1101/gad.1631508; Mann MB, 2005, HUM MOL GENET, V14, P813, DOI 10.1093/hmg/ddi075; MANNING AL, GENES DEV, V24, P1364; MARJI J, PLOS ONE, V5; Mattout A, 2006, CURR OPIN CELL BIOL, V18, P335, DOI 10.1016/j.ceb.2006.03.007; Moir RD, 2000, J CELL BIOL, V149, P1179, DOI 10.1083/jcb.149.6.1179; Moir RD, 2000, J STRUCT BIOL, V129, P324, DOI 10.1006/jsbi.2000.4251; Mounkes L, 2003, CURR OPIN GENET DEV, V13, P223, DOI 10.1016/S0959-437X(03)00058-3; Mukherjee AB, 1998, MECH AGEING DEV, V103, P209, DOI 10.1016/S0047-6374(98)00041-4; Musich PR, 2009, AGING-US, V1, P28, DOI 10.18632/aging.100012; Naetar N, 2008, NAT CELL BIOL, V10, P1341, DOI 10.1038/ncb1793; ODGREN PR, PLOS ONE, V5, pE9959; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Shimi T, 2008, GENE DEV, V22, P3409, DOI 10.1101/gad.1735208; Stewart CL, 2007, EXP CELL RES, V313, P2144, DOI 10.1016/j.yexcr.2007.03.026; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; TAKASHIMI A, 1998, CURRENT PROTOCOLS CE; vanEngeland M, 1996, CYTOMETRY, V24, P131, DOI 10.1002/(SICI)1097-0320(19960601)24:2<131::AID-CYTO5>3.0.CO;2-M; VANHARN T, GENES DEV, V24, P1377; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Wolfram T, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-64; Worman HJ, 2007, EXP CELL RES, V313, P2121, DOI 10.1016/j.yexcr.2007.03.028; Worman HJ, 2009, J CLIN INVEST, V119, P1825, DOI 10.1172/JCI37679; Wright SM, 2009, CANCER RES, V69, P4454, DOI 10.1158/0008-5472.CAN-08-4515	43	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e18065	10.1371/journal.pone.0018065	http://dx.doi.org/10.1371/journal.pone.0018065			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464947	Green Published, gold, Green Submitted			2022-12-25	WOS:000288813900033
J	Rothman, RB; Cadet, JL; Dersch, CM; McCoy, MT; Lehrmann, E; Becker, KG; Bader, M; Alenina, N; Baumann, MH				Rothman, Richard B.; Cadet, Jean L.; Dersch, Christina M.; McCoy, Michael T.; Lehrmann, Elin; Becker, Kevin G.; Bader, Michael; Alenina, Natalia; Baumann, Michael H.			Altered Gene Expression in Pulmonary Tissue of Tryptophan Hydroxylase-1 Knockout Mice: Implications for Pulmonary Arterial Hypertension	PLOS ONE			English	Article							5-HYDROXYTRYPTAMINE TRANSPORTER GENE; VASCULAR SMOOTH-MUSCLE; SEROTONIN TRANSPORTER; PLASMA SEROTONIN; CARDIAC-FUNCTION; TRANSGENIC MICE; CHRONIC HYPOXIA; DEXFENFLURAMINE; FENFLURAMINE; RECEPTORS	The use of fenfluramines can increase the risk of developing pulmonary arterial hypertension (PAH) in humans, but the mechanisms responsible are unresolved. A recent study reported that female mice lacking the gene for tryptophan hydroxylase-1 (Tph1(-/-) mice) were protected from PAH caused by chronic dexfenfluramine, suggesting a pivotal role for peripheral serotonin (5-HT) in the disease process. Here we tested two alternative hypotheses which might explain the lack of dexfenfluramine-induced PAH in Tph1(-/-) mice. We postulated that: 1) Tph1(-/-) mice express lower levels of pulmonary 5-HT transporter (SERT) when compared to wild-type controls, and 2) Tph1(-/-) mice display adaptive changes in the expression of non-serotonergic pulmonary genes which are implicated in PAH. SERT was measured using radioligand binding methods, whereas gene expression was measured using microarrays followed by quantitative real time PCR (qRT-PCR). Contrary to our first hypothesis, the number of pulmonary SERT sites was modestly up-regulated in female Tph1(-/-) mice. The expression of 51 distinct genes was significantly altered in the lungs of female Tph1(-/-) mice. Consistent with our second hypothesis, qRT-PCR confirmed that at least three genes implicated in the pathogenesis of PAH were markedly up-regulated: Has2, Hapln3 and Retlna. The finding that female Tph1(-/-) mice are protected from dexfenfluramine-induced PAH could be related to compensatory changes in pulmonary gene expression, in addition to reductions in peripheral 5-HT. These observations emphasize the intrinsic limitation of interpreting data from studies conducted in transgenic mice that are not fully characterized.	[Rothman, Richard B.; Dersch, Christina M.; Baumann, Michael H.] NIDA, Translat Pharmacol Sect, Intramural Res Program, NIH, Baltimore, MD USA; [Cadet, Jean L.; McCoy, Michael T.] NIDA, Mol Neuropsychiat Res Branch, Intramural Res Program, NIH, Baltimore, MD USA; [Lehrmann, Elin; Becker, Kevin G.] NIA, Gene Express & Genom Unit, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Bader, Michael; Alenina, Natalia] Max Delbruck Ctr Mol Med, Berlin, Germany	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Helmholtz Association; Max Delbruck Center for Molecular Medicine	Rothman, RB (corresponding author), NIDA, Translat Pharmacol Sect, Intramural Res Program, NIH, Baltimore, MD USA.	rrothman@mail.nih.gov	Bader, Michael/K-2124-2013	Lehrmann, Elin/0000-0002-9869-9475; Becker, Kevin/0000-0002-6794-6656; Bader, Michael/0000-0003-4780-4164; Baumann, Michael/0000-0001-7758-1470	National Institute on Drug Abuse; National Institute on Aging, National Institutes of Health, DHHS; NATIONAL INSTITUTE ON AGING [ZICAG000616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000522, ZIADA000174, ZIADA000551] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Aging, National Institutes of Health, DHHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the Intramural Research Programs, National Institute on Drug Abuse and the National Institute on Aging, National Institutes of Health, DHHS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelini DJ, 2009, AM J PHYSIOL-LUNG C, V296, pL582, DOI 10.1152/ajplung.90526.2008; Cote F, 2003, P NATL ACAD SCI USA, V100, P13525, DOI 10.1073/pnas.2233056100; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Dempsie Y, 2008, CIRCULATION, V117, P2928, DOI 10.1161/CIRCULATIONAHA.108.767558; Eddahibi S, 1998, AM J RESP CRIT CARE, V157, P1111, DOI 10.1164/ajrccm.157.4.9704095; Eddahibi S, 2000, J CLIN INVEST, V105, P1555, DOI 10.1172/JCI8678; Fan CL, 2009, AM J PHYSIOL-LUNG C, V297, pL263, DOI 10.1152/ajplung.90416.2008; Fanburg BL, 2000, J CLIN INVEST, V105, P1521, DOI 10.1172/JCI10230; Fligny C, 2008, FASEB J, V22, P2340, DOI 10.1096/fj.07-100743; Guignabert C, 2006, CIRC RES, V98, P1323, DOI 10.1161/01.RES.0000222546.45372.a0; Guilluy C, 2007, J BIOL CHEM, V282, P2918, DOI 10.1074/jbc.M604195200; Hamidi SA, 2008, EUR RESPIR J, V31, P135, DOI 10.1183/09031936.00105807; Launay JM, 2002, NAT MED, V8, P1129, DOI 10.1038/nm764; Lee SL, 2001, FASEB J, V15, P1324, DOI 10.1096/fj.00-0431fje; Lesurtel M, 2006, SCIENCE, V312, P104, DOI 10.1126/science.1123842; MacLean MR, 2000, BRIT J PHARMACOL, V131, P161, DOI 10.1038/sj.bjp.0703570; MacLean MR, 2004, CIRCULATION, V109, P2150, DOI 10.1161/01.CIR.0000127375.56172.92; Morecroft I, 2005, J PHARMACOL EXP THER, V313, P539, DOI 10.1124/jpet.104.081182; Papakonstantinou E, 2008, EUR RESPIR J, V32, P1504, DOI 10.1183/09031936.00159507; Rochefort GY, 2006, EUR J PHARMACOL, V550, P149, DOI 10.1016/j.ejphar.2006.08.050; Rothman RB, 1999, CIRCULATION, V100, P869, DOI 10.1161/01.CIR.100.8.869; ROTHMAN RB, 1991, MOL PHARMACOL, V39, P222; Rothman RB, 2009, EXPERT OPIN DRUG SAF, V8, P317, DOI 10.1517/14740330902931524; Walther DJ, 2003, CELL, V115, P851, DOI 10.1016/S0092-8674(03)01014-6; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; Weir EK, 1996, CIRCULATION, V94, P2216, DOI 10.1161/01.CIR.94.9.2216; West J, 2008, AM J PHYSIOL-LUNG C, V295, pL744, DOI 10.1152/ajplung.90255.2008; Zolkowska D, 2008, J PHARMACOL EXP THER, V324, P791, DOI 10.1124/jpet.107.132654; Zolkowska D, 2006, J PHARMACOL EXP THER, V318, P604, DOI 10.1124/jpet.106.101618	29	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e17735	10.1371/journal.pone.0017735	http://dx.doi.org/10.1371/journal.pone.0017735			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464983	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000288813900009
J	Horsch, M; Seeburg, PH; Adler, T; Aguilar-Pimentel, JA; Becker, L; Calzada-Wack, J; Garrett, L; Gotz, A; Hans, W; Higuchi, M; Holter, SM; Naton, B; Prehn, C; Puk, O; Racz, I; Rathkolb, B; Rozman, J; Schrewe, A; Adamski, J; Busch, DH; Esposito, I; Graw, J; Ivandic, B; Klingenspor, M; Klopstock, T; Mempel, M; Ollert, M; Schulz, H; Wolf, E; Wurst, W; Zimmer, A; Gailus-Durner, V; Fuchs, H; de Angelis, MH; Beckers, J				Horsch, Marion; Seeburg, Peter H.; Adler, Thure; Aguilar-Pimentel, Juan Antonio; Becker, Lore; Calzada-Wack, Julia; Garrett, Lilian; Goetz, Alexander; Hans, Wolfgang; Higuchi, Miyoko; Hoelter, Sabine M.; Naton, Beatrix; Prehn, Cornelia; Puk, Oliver; Racz, Ildiko; Rathkolb, Birgit; Rozman, Jan; Schrewe, Anja; Adamski, Jerzy; Busch, Dirk H.; Esposito, Irene; Graw, Jochen; Ivandic, Boris; Klingenspor, Martin; Klopstock, Thomas; Mempel, Martin; Ollert, Markus; Schulz, Holger; Wolf, Eckhard; Wurst, Wolfgang; Zimmer, Andreas; Gailus-Durner, Valerie; Fuchs, Helmut; de Angelis, Martin Hrabe; Beckers, Johannes			Requirement of the RNA-editing Enzyme ADAR2 for Normal Physiology in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBUNIT GLUR-B; PREPULSE INHIBITION; RECEPTOR; GENE; EXPRESSION; ADENOSINE; SCHIZOPHRENIA; DEFICIENT; LETHALITY; EPILEPSY	ADAR2, an RNA editing enzyme that converts specific adenosines to inosines in certain pre-mRNAs, often leading to amino acid substitutions in the encoded proteins, is mainly expressed in brain. Of all ADAR2-mediated edits, a single one in the pre-mRNA of the AMPA receptor subunit GluA2 is essential for survival. Hence, early postnatal death of mice lacking ADAR2 is averted when the critical edit is engineered into both GluA2 encoding Gria2 alleles. Adar2(-/-)/Gria2(R/R) mice display normal appearance and life span, but the general phenotypic effects of global lack of ADAR2 have remained unexplored. Here we have employed the Adar2(-/-)/Gria2(R/R) mouse line, and Gria2(R/R) mice as controls, to study the phenotypic consequences of loss of all ADAR2-mediated edits except the critical one in GluA2. Our extended phenotypic analysis covering similar to 320 parameters identified significant changes related to absence of ADAR2 in behavior, hearing ability, allergy parameters and transcript profiles of brain.	[Horsch, Marion; Hans, Wolfgang; Naton, Beatrix; Prehn, Cornelia; Schrewe, Anja; Adamski, Jerzy; Gailus-Durner, Valerie; Fuchs, Helmut; de Angelis, Martin Hrabe; Beckers, Johannes] Helmholtz Zentrum Munchen GmbH, German Res Ctr Environm Hlth, Inst Expt Genet, D-85764 Neuherberg, Germany; [Seeburg, Peter H.; Higuchi, Miyoko] Max Planck Inst Med Res, Dept Mol Neurobiol, D-69120 Heidelberg, Germany; [Seeburg, Peter H.; Higuchi, Miyoko] Max Planck Inst Med Res, Dept Cell Physiol, D-69120 Heidelberg, Germany; [Adler, Thure; Busch, Dirk H.] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-81675 Munich, Germany; [Aguilar-Pimentel, Juan Antonio; Mempel, Martin; Ollert, Markus] TUM Helmholtz Zentrum Munchen GmbH, Clin Res Div Mol & Clin Allergotoxicol, Dept Dermatol & Allergy, D-85764 Neuherberg, Germany; [Aguilar-Pimentel, Juan Antonio; Mempel, Martin] TUM Helmholtz Zentrum Munchen GmbH, Div Environm Dermatol & Allergy, D-85764 Neuherberg, Germany; [Becker, Lore; Klopstock, Thomas] Univ Munich, Friedrich Baur Inst, Dept Neurol, D-80336 Munich, Germany; [Calzada-Wack, Julia; Esposito, Irene] Helmholtz Zentrum Munchen GmbH, German Res Ctr Environm Hlth, Inst Pathol, D-85764 Neuherberg, Germany; [Garrett, Lilian; Hoelter, Sabine M.; Puk, Oliver; Graw, Jochen; Wurst, Wolfgang] Helmholtz Zentrum Munchen GmbH, German Res Ctr Environm Hlth, Inst Dev Genet, D-85764 Neuherberg, Germany; [Goetz, Alexander; Schulz, Holger] Helmholtz Zentrum Munchen GmbH, German Res Ctr Environm Hlth, Inst Lung Biol & Dis, Comprehens Pneumol Ctr, D-85764 Neuherberg, Germany; [Racz, Ildiko; Zimmer, Andreas] Univ Bonn, Inst Mol Psychiat, D-53125 Bonn, Germany; [Rathkolb, Birgit] Univ Munich, Gene Ctr, Chair Mol Anim Breeding & Biotechnol, D-81377 Munich, Germany; [Rozman, Jan; Klingenspor, Martin] Tech Univ Munich, Else Kroner Fresenius Ctr, D-85350 Freising Weihenstephan, Germany; [Schrewe, Anja; Ivandic, Boris] Univ Heidelberg, Otto Meyerhof Zentrum, Dept Med 3, Div Cardiol, D-69120 Heidelberg, Germany; [Adamski, Jerzy; de Angelis, Martin Hrabe; Beckers, Johannes] Tech Univ Munich, Chair Expt Genet, D-85350 Freising Weihenstephan, Germany; [Esposito, Irene] Tech Univ Munich, Klinikum Rechts Isar, Inst Allgemeine Pathol & Pathol Anat, D-81675 Munich, Germany; [Mempel, Martin] Univ Gottingen, Dept Dermatol Venerol & Allergy, D-37073 Gottingen, Germany; [Schulz, Holger] Tech Univ Munich, Chair Dev Genet, D-85350 Freising Weihenstephan, Germany; [Wurst, Wolfgang] Helmholtz Zentrum Munchen GmbH, German Res Ctr Environm Hlth, Inst Epidemiol 1, D-85764 Neuherberg, Germany; [Wurst, Wolfgang] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Wurst, Wolfgang] Deutsch Zentrum Neurodegenerat Erkrankungen eV, D-80336 Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Max Planck Society; Max Planck Society; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Bonn; University of Munich; Technical University of Munich; Ruprecht Karls University Heidelberg; Technical University of Munich; Technical University of Munich; University of Gottingen; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Max Planck Society; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Seeburg, PH (corresponding author), Max Planck Inst Med Res, Dept Mol Neurobiol, Jahnstr 29, D-69120 Heidelberg, Germany.	seeburg@mpimf-heidelberg.mpg.de	Klingenspor, Martin/K-5033-2019; Hölter, Sabine M./N-5868-2014; Becker, Lore/E-3717-2010; Naton, Beatrix/B-5392-2013; Rathkolb, Birgit/F-7041-2013; Zimmer, Andreas/B-8357-2009; Schulz, Holger/J-5643-2015; Racz, I./C-3074-2009; Becker, Lore/AAJ-1203-2020; Gailus-Durner, Valerie/M-7337-2014; Rozman, Jan/A-2540-2010; Graw, Jochen/D-9336-2013; Fuchs, Helmut/M-7347-2014; de Angelis, Martin Hrabe/F-5531-2012; Beckers, Johannes/K-7237-2012; Puk, Oliver/E-1443-2013; Klingenspor, Martin/D-6930-2011	Hölter, Sabine M./0000-0003-4878-5241; Naton, Beatrix/0000-0002-9453-8877; Schulz, Holger/0000-0002-1157-200X; Racz, I./0000-0002-1549-3616; Becker, Lore/0000-0002-6890-4984; Rozman, Jan/0000-0002-8035-8904; Fuchs, Helmut/0000-0002-5143-2677; de Angelis, Martin Hrabe/0000-0002-7898-2353; Beckers, Johannes/0000-0001-7874-3822; Klingenspor, Martin/0000-0002-4502-6664; Wurst, Wolfgang/0000-0003-4422-7410; Adamski, Jerzy/0000-0001-9259-0199; Prehn, Cornelia/0000-0002-1274-4715; Calzada, Julia/0000-0003-0816-9305; Ollert, Markus W./0000-0002-8055-0103; Graw, Jochen/0000-0003-0298-9660; Wolf, Eckhard/0000-0002-0430-9510; Garrett, Lillian/0000-0003-4880-7076	Bundesministerium fur Bildung und Forschung (BMBF) Nationales Genomforschungsnetz (NGFN-Plus) [01GS0850, 01GS0851, 01GS0852, 01GS0868, 01GS0869, 01GS0853, 01GS0854]; European Union (German Mouse Clinic) [EUMODIC LSHG-2006037188]	Bundesministerium fur Bildung und Forschung (BMBF) Nationales Genomforschungsnetz (NGFN-Plus)(Federal Ministry of Education & Research (BMBF)); European Union (German Mouse Clinic)(European Commission)	This work was supported by the Bundesministerium fur Bildung und Forschung (BMBF) Nationales Genomforschungsnetz (NGFN-Plus) Grants 01GS0850, 01GS0851, 01GS0852, 01GS0868, 01GS0869, 01GS0853, and 01GS0854) and by European Union Grant EUMODIC LSHG-2006037188 (German Mouse Clinic).	Alessandrini F, 2001, INT ARCH ALLERGY IMM, V124, P25, DOI 10.1159/000053659; BASS BL, 1988, CELL, V55, P1089, DOI 10.1016/0092-8674(88)90253-X; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; BRUSA R, 1995, SCIENCE, V270, P1677, DOI 10.1126/science.270.5242.1677; Chao MY, 2004, P NATL ACAD SCI USA, V101, P15512, DOI 10.1073/pnas.0403369101; Corteling Randolph, 2004, BMC Pharmacology, V4, P4, DOI 10.1186/1471-2210-4-4; Dosemeci A, 2010, BIOCHEM BIOPH RES CO, V391, P78, DOI 10.1016/j.bbrc.2009.10.167; Feldmeyer D, 1999, NAT NEUROSCI, V2, P57, DOI 10.1038/4561; Ferkey DM, 2007, NEURON, V53, P39, DOI 10.1016/j.neuron.2006.11.015; Fuchs H, 2011, METHODS, V53, P120, DOI 10.1016/j.ymeth.2010.08.006; Gailus-Durner V, 2005, NAT METHODS, V2, P403, DOI 10.1038/nmeth0605-403; Gailus-Durner Valerie, 2009, V530, P463, DOI 10.1007/978-1-59745-471-1_25; Geyer MA, 2001, PSYCHOPHARMACOLOGY, V156, P117, DOI 10.1007/s002130100811; Heale BSE, 2009, CELL CYCLE, V8, P4011, DOI 10.4161/cc.8.24.10214; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; HIGUCHI M, 1993, CELL, V75, P1361, DOI 10.1016/0092-8674(93)90622-W; Holt AG, 2005, J NEUROCHEM, V93, P1069, DOI 10.1111/j.1471-4159.2005.03090.x; Horsch M, 2008, PROTEOMICS, V8, P1248, DOI 10.1002/pmic.200700725; Kask K, 1998, P NATL ACAD SCI USA, V95, P13777, DOI 10.1073/pnas.95.23.13777; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; Kiran A, 2010, BIOINFORMATICS, V26, P1772, DOI 10.1093/bioinformatics/btq285; Krestel HE, 2004, J NEUROSCI, V24, P10568, DOI 10.1523/JNEUROSCI.4579-03.2004; Levanon EY, 2005, NUCLEIC ACIDS RES, V33, P1162, DOI 10.1093/nar/gki239; Li JB, 2009, SCIENCE, V324, P1210, DOI 10.1126/science.1170995; LOMELI H, 1994, SCIENCE, V266, P1709, DOI 10.1126/science.7992055; Maas Stefan, 2006, RNA Biol, V3, P1; Melcher T, 1996, J BIOL CHEM, V271, P31795, DOI 10.1074/jbc.271.50.31795; Noguchi E, 2001, J ALLERGY CLIN IMMUN, V108, P382, DOI 10.1067/mai.2001.117456; Oh CK, 1999, MOL BRAIN RES, V70, P135, DOI 10.1016/S0169-328X(99)00110-2; Reenan RA, 2001, TRENDS GENET, V17, P53, DOI 10.1016/S0168-9525(00)02169-7; Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551; Rueter SM, 1999, NATURE, V399, P75, DOI 10.1038/19992; SCHMAUSS C, 2002, SCI STKE, pPE26; Schneider I, 2006, J NEUROSCI METH, V157, P82, DOI 10.1016/j.jneumeth.2006.04.002; Schutt J, 2009, J BIOL CHEM, V284, P25479, DOI 10.1074/jbc.M109.042663; Seeburg PH, 2002, NEURON, V35, P17, DOI 10.1016/S0896-6273(02)00760-2; Seymour Brian W P, 2002, Dev Immunol, V9, P47, DOI 10.1080/1044667021000003989; Sodhi MS, 2001, MOL PSYCHIATR, V6, P373, DOI 10.1038/sj.mp.4000920; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; Zaranek AW, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000954	41	68	70	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18614	18622		10.1074/jbc.M110.200881	http://dx.doi.org/10.1074/jbc.M110.200881			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21467037	hybrid, Green Published			2022-12-25	WOS:000290785700033
J	Shimizu, T; Tanaka, T; Iso, T; Matsui, H; Ooyama, Y; Kawai-Kowase, K; Arai, M; Kurabayashi, M				Shimizu, Takehisa; Tanaka, Toru; Iso, Tatsuya; Matsui, Hiroki; Ooyama, Yoshiaki; Kawai-Kowase, Keiko; Arai, Masashi; Kurabayashi, Masahiko			Notch Signaling Pathway Enhances Bone Morphogenetic Protein 2 (BMP2) Responsiveness of Msx2 Gene to Induce Osteogenic Differentiation and Mineralization of Vascular Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSTEOBLAST DIFFERENTIATION; ENDOTHELIAL-CELLS; STEM-CELLS; CALCIFICATION; EXPRESSION; TARGET; TRANSCRIPTION; ARTERIES; RUNX2; MICE	Vascular calcification is regulated in a process similar to bone formation. BMP2 (bone morphogenetic protein 2) is essential for osteoblastic differentiation of mesenchymal progenitor cells and thus has been implicated in the development of vascular calcification. Here we examined whether Notch signaling interacts with BMP2 signaling to regulate osteogenic differentiation and mineralization of vascular smooth muscle cells (SMCs). BMP2 alone scarcely induced the expression of alkaline phosphatase (ALP), an ectoenzyme crucially required for active biomineralization, in human aortic SMCs (HASMCs), despite its strong induction in osteoblast precursor MC3T3-E1 cells. Notably, overexpression of the Notch1 intracellular domain (N1-ICD) markedly enhanced BMP2-mediated induction of ALP activity and mineralization of HASMCs. In HASMCs, expression of Msx2 gene, a well documented BMP2 target gene in osteoblasts, was barely induced by BMP2 alone, and N1-ICD clearly enhanced the BMP2-driven Msx2 gene expression. Deletion and site-directed mutation analysis of Msx2 gene promoter revealed that the RBPJk-binding site was necessary for BMP2 responsiveness. Using the RBPJk-deficient cells and siRNA for RBPJk, we showed that RBPJk was required for BMP2 induction of Msx2 gene expression and ALP activity. Moreover, we showed that Smad1, a transcription factor downstream of BMP2 signaling, interacted with N1-ICD to form a complex within the Msx2 promoter. Immunohistochemistry of human calcifying atherosclerotic plaques revealed colocalized expression of Notch1, BMP2, and Msx2. These results indicate that the Notch intracellular domain.RBPJk complex enhances the BMP2-induced Msx2 gene expression by cooperating with Smad1 and suggest that Notch signaling makes vascular SMC responsive to BMP2 and promotes vascular calcification.	[Shimizu, Takehisa; Tanaka, Toru; Iso, Tatsuya; Matsui, Hiroki; Ooyama, Yoshiaki; Kawai-Kowase, Keiko; Arai, Masashi; Kurabayashi, Masahiko] Gunma Univ, Grad Sch Med, Dept Med & Biol Sci, Gunma 3718511, Japan; [Iso, Tatsuya] Gunma Univ, Grad Sch Med, Educ & Res Ctr, Gunma 3718511, Japan	Gunma University; Gunma University	Kurabayashi, M (corresponding author), 3-39-15 Showa Machi, Gunma 3718511, Japan.	mkuraba@med.gunma-u.ac.jp	Matsui, Hiroki/P-4033-2019	Matsui, Hiroki/0000-0003-3243-333X; Iso, Tatsuya/0000-0001-5045-1676	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Research Promotion Society for Cardiovascular Disease; Grants-in-Aid for Scientific Research [23590661] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Research Promotion Society for Cardiovascular Disease; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to M. K.), a memorial research grant from the Japan Research Promotion Society for Cardiovascular Disease (to T. T.), and Initiatives for Attractive Education in Graduate School from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to T. S.).	Abedin M, 2004, ARTERIOSCL THROM VAS, V24, P1161, DOI 10.1161/01.ATV.0000133194.94939.42; Aikawa E, 2007, CIRCULATION, V116, P2841, DOI 10.1161/CIRCULATIONAHA.107.732867; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; BOSTROM K, 1993, J CLIN INVEST, V91, P1800, DOI 10.1172/JCI116391; Brugger SM, 2004, DEVELOPMENT, V131, P5153, DOI 10.1242/dev.01390; Brunelli S, 2004, CIRC RES, V94, P1571, DOI 10.1161/01.RES.0000132747.12860.10; Carlson ME, 2007, CURR OPIN PHARMACOL, V7, P303, DOI 10.1016/j.coph.2007.02.004; Cheng SL, 2003, J BIOL CHEM, V278, P45969, DOI 10.1074/jbc.M306972200; Demer LL, 2008, CIRCULATION, V117, P2938, DOI 10.1161/CIRCULATIONAHA.107.743161; Doi H, 2005, ARTERIOSCL THROM VAS, V25, P2328, DOI 10.1161/01.ATV.0000185829.47163.32; Doi H, 2006, J BIOL CHEM, V281, P28555, DOI 10.1074/jbc.M602749200; Fung E, 2007, CIRCULATION, V115, P2948, DOI 10.1161/CIRCULATIONAHA.106.675462; Giachelli CM, 2004, J AM SOC NEPHROL, V15, P2959, DOI 10.1097/01.ASN.0000145894.57533.C4; Han J, 2007, MECH DEVELOP, V124, P729, DOI 10.1016/j.mod.2007.06.006; Hayashi K, 2006, MOL CELL BIOL, V26, P9456, DOI 10.1128/MCB.00759-06; Hruska KA, 2005, CIRC RES, V97, P105, DOI 10.1161/01.RES.00000175571.53833.6c; Iso T, 2006, BIOCHEM BIOPH RES CO, V341, P708, DOI 10.1016/j.bbrc.2006.01.020; Iso T, 2003, ARTERIOSCL THROM VAS, V23, P543, DOI 10.1161/01.ATV.0000060892.81529.8F; Iso T, 2001, MOL CELL BIOL, V21, P6071, DOI 10.1128/MCB.21.17.6071-6079.2001; Itoh F, 2004, EMBO J, V23, P541, DOI 10.1038/sj.emboj.7600065; Iyemere VP, 2006, J INTERN MED, V260, P192, DOI 10.1111/j.1365-2796.2006.01692.x; JABS EW, 1993, CELL, V75, P443, DOI 10.1016/0092-8674(93)90379-5; Kim YJ, 2004, J BIOL CHEM, V279, P50773, DOI 10.1074/jbc.M404145200; Lee HL, 2010, EXP MOL MED, V42, P437, DOI 10.3858/emm.2010.42.6.045; Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000; Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0; Marijanovic I, 2009, COLLEGIUM ANTROPOL, V33, P919; Matsubara T, 2008, J BIOL CHEM, V283, P29119, DOI 10.1074/jbc.M801774200; Noseda M, 2006, CIRC RES, V98, P1468, DOI 10.1161/01.RES.0000229683.81357.26; Price PA, 1998, ARTERIOSCL THROM VAS, V18, P1400, DOI 10.1161/01.ATV.18.9.1400; Sciaudone M, 2003, ENDOCRINOLOGY, V144, P5631, DOI 10.1210/en.2003-0463; Shao JS, 2005, J CLIN INVEST, V115, P1210, DOI 10.1172/JCI200524140; Shimizu T, 2009, ARTERIOSCL THROM VAS, V29, P1104, DOI 10.1161/ATVBAHA.109.187856; Speer MY, 2009, CIRC RES, V104, P733, DOI 10.1161/CIRCRESAHA.108.183053; Takizawa T, 2003, NUCLEIC ACIDS RES, V31, P5723, DOI 10.1093/nar/gkg778; Tanaka T, 2008, MOL CELL BIOL, V28, P1147, DOI 10.1128/MCB.01771-07; Tezuka K, 2002, J BONE MINER RES, V17, P231, DOI 10.1359/jbmr.2002.17.2.231; Towler DA, 1998, J BIOL CHEM, V273, P30427, DOI 10.1074/jbc.273.46.30427; Tyson KL, 2003, ARTERIOSCL THROM VAS, V23, P489, DOI 10.1161/01.ATV.0000059406.92165.31; Vattikuti R, 2004, AM J PHYSIOL-ENDOC M, V286, pE686, DOI 10.1152/ajpendo.00552.2003; Wilkie AOM, 2000, NAT GENET, V24, P387, DOI 10.1038/74224; Zanotti S, 2010, MOL CELL BIOL, V30, P886, DOI 10.1128/MCB.01285-09	42	52	61	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					19138	19148		10.1074/jbc.M110.175786	http://dx.doi.org/10.1074/jbc.M110.175786			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21471203	Green Published, hybrid			2022-12-25	WOS:000290785700083
J	Guo, X; Shen, S; Song, SS; He, S; Cui, Y; Xing, GC; Wang, J; Yin, YX; Fan, LB; He, FC; Zhang, LQ				Guo, Xing; Shen, Shan; Song, Shanshan; He, Shan; Cui, Yu; Xing, Guichun; Wang, Jian; Yin, Yuxin; Fan, Libin; He, Fuchu; Zhang, Lingqiang			The E3 Ligase Smurf1 Regulates Wolfram Syndrome Protein Stability at the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; UBIQUITIN LIGASES; DIDMOAD SYNDROME; WFS1 GENE; DEGRADATION; STRESS; EXPRESSION; P53; ACTIVATION; POLARITY	The HECT-type ubiquitin ligase (E3) Smad ubiquitination regulatory factor 1 (Smurf1) targets various substrates, including Smad1/5, RhoA, Prickle 1, MEKK2, and JunB for degradation and thereby regulates adult bone formation and embryonic development. Here, we identify the endoplasmic reticulum (ER)-localized Wolfram syndrome protein (WFS1) as a specific degradation substrate of Smurf1. Mutations in the WFS1 gene cause Wolfram syndrome, an autosomal recessive disorder characterized by diabetes mellitus and optic atrophy. WFS1 negatively regulates the ER stress response, and WFS1 deficiency in mice increases ER stress and triggers apoptosis. We show that Smurf1 interacts with WFS1 at the ER and promotes the ubiquitination and proteasomal degradation of WFS1. A C-terminal luminal region in WFS1, including residues 667-700, is involved in this degradation. Wild-type WFS1 as well as a subset of WFS1 mutants that include this degron region are susceptible to Smurf1-mediated degradation. By contrast, pathophysiological deletion mutants of WFS1 lacking the degron, such as W648X, Y660X, and Q667X, are resistant to degradation by Smurf1. Depletion of Smurf1 by RNA interference results in increased WFS1 and decreased ATF6 alpha levels. Furthermore, we show that ER stress induces Smurf1 degradation and WFS1 up-regulation. These findings reveal for the first time that Smurf1 targets an ER-localized protein for degradation and that Smurf1 is regulated by ER stress.	[Guo, Xing; Song, Shanshan; He, Shan; Cui, Yu; Xing, Guichun; Wang, Jian; He, Fuchu; Zhang, Lingqiang] Beijing Inst Radiat Med, Beijing Proteome Res Ctr, State Key Lab Prote, Beijing 100850, Peoples R China; [Shen, Shan; Fan, Libin; Zhang, Lingqiang] Anhui Med Univ, Dept Biol, Hefei 230032, Anhui, Peoples R China; [Shen, Shan; Fan, Libin; Zhang, Lingqiang] Anhui Med Univ, Cell Biol Lab, Hefei 230032, Anhui, Peoples R China; [Yin, Yuxin] Peking Univ, Sch Basic Med Sci, Dept Pathol, Beijing 100191, Peoples R China; [Guo, Xing; Song, Shanshan; He, Fuchu] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Med Genet, Beijing 100730, Peoples R China; [Guo, Xing; Song, Shanshan; He, Fuchu] Peking Union Med Coll, Beijing 100730, Peoples R China	Academy of Military Medical Sciences - China; Anhui Medical University; Anhui Medical University; Peking University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	He, FC (corresponding author), Beijing Inst Radiat Med, Beijing Proteome Res Ctr, State Key Lab Prote, 27 Taiping Rd, Beijing 100850, Peoples R China.	hefc@nic.bmi.ac.cn; zhanglq@nic.bmi.ac.cn			National Basic Research Programs [2011CB910602, 2007CB914601, 2010CB912202]; National Natural Science Foundation [30830029]; National Key Technologies R&D Program for New Drugs [2009ZX09503-002, 2009ZX09301-002]	National Basic Research Programs(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Key Technologies R&D Program for New Drugs(National Key Technology R&D Program)	This work was supported by National Basic Research Programs 2011CB910602, 2007CB914601, and 2010CB912202, National Natural Science Foundation Projects (30830029), and National Key Technologies R&D Program for New Drugs (2009ZX09503-002, 2009ZX09301-002).	Barrett TG, 1997, J MED GENET, V34, P838, DOI 10.1136/jmg.34.10.838; BARRETT TG, 1995, LANCET, V346, P1458, DOI 10.1016/S0140-6736(95)92473-6; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Fonseca SG, 2010, J CLIN INVEST, V120, P744, DOI 10.1172/JCI39678; Hofmann S, 2006, FEBS LETT, V580, P4000, DOI 10.1016/j.febslet.2006.06.036; Inoue H, 1998, NAT GENET, V20, P143, DOI 10.1038/2441; Ishihara H, 2004, HUM MOL GENET, V13, P1159, DOI 10.1093/hmg/ddh125; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Li S, 2010, MOL CELL BIOCHEM, V338, P11, DOI 10.1007/s11010-009-0315-y; Lu KF, 2008, NAT CELL BIOL, V10, P994, DOI 10.1038/ncb1760; Narimatsu M, 2009, CELL, V137, P295, DOI 10.1016/j.cell.2009.02.025; Nie J, 2010, J BIOL CHEM, V285, P22816, DOI 10.1074/jbc.M110.126920; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Riggs AC, 2005, DIABETOLOGIA, V48, P2313, DOI 10.1007/s00125-005-1947-4; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Sandhu MS, 2007, NAT GENET, V39, P951, DOI 10.1038/ng2067; Tajima Y, 2003, J BIOL CHEM, V278, P10716, DOI 10.1074/jbc.M212663200; Takeda K, 2001, HUM MOL GENET, V10, P477, DOI 10.1093/hmg/10.5.477; Ueda K, 2005, EUR J ENDOCRINOL, V153, P167, DOI 10.1530/eje.1.01945; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; Wolfram DJ, 1938, P MAYO CLIN, V13, P715; Yamada T, 2006, HUM MOL GENET, V15, P1600, DOI 10.1093/hmg/ddl081; Yamaguchi S, 2004, BIOCHEM BIOPH RES CO, V325, P250, DOI 10.1016/j.bbrc.2004.10.017; Yamashita M, 2005, CELL, V121, P101, DOI 10.1016/j.cell.2005.01.035; Zhao L, 2010, J BONE MINER RES, V25, P1246, DOI 10.1002/jbmr.28; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293	30	51	52	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					18037	18047		10.1074/jbc.M111.225615	http://dx.doi.org/10.1074/jbc.M111.225615			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454619	hybrid, Green Published			2022-12-25	WOS:000290585200065
J	Marques, JC; Lamosa, P; Russell, C; Ventura, R; Maycock, C; Semmelhack, MF; Miller, ST; Xavier, KB				Marques, Joao C.; Lamosa, Pedro; Russell, Caitlin; Ventura, Rita; Maycock, Christopher; Semmelhack, Martin F.; Miller, Stephen T.; Xavier, Karina B.			Processing the Interspecies Quorum-sensing Signal Autoinducer-2 (AI-2) CHARACTERIZATION OF PHOSPHO-(S)-4,5-DIHYDROXY-2,3-PENTANEDIONE ISOMERIZATION BY LsrG PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; LUXS; COMMUNICATION; METABOLISM; EXPRESSION; AL-2	The molecule (S)-4,5-dihydroxy-2,3-pentanedione (DPD) is produced by many different species of bacteria and is the precursor of the signal molecule autoinducer-2 (AI-2). AI-2 mediates interspecies communication and facilitates regulation of bacterial behaviors such as biofilm formation and virulence. A variety of bacterial species have the ability to sequester and process the AI-2 present in their environment, thereby interfering with the cell-cell communication of other bacteria. This process involves the AI-2-regulated lsr operon, comprised of the Lsr transport system that facilitates uptake of the signal, a kinase that phosphorylates the signal to phospho-DPD (P-DPD), and enzymes (like LsrG) that are responsible for processing the phosphorylated signal. Because P-DPD is the intracellular inducer of the lsr operon, enzymes involved in P-DPD processing impact the levels of Lsr expression. Here we show that LsrG catalyzes isomerization of P-DPD into 3,4,4-trihydroxy-2-pentanone-5-phosphate. We present the crystal structure of LsrG, identify potential catalytic residues, and determine which of these residues affects P-DPD processing in vivo and in vitro. We also show that an lsrG deletion mutant accumulates at least 10 times more P-DPD than wild type cells. Consistent with this result, we find that the lsrG mutant has increased expression of the lsr operon and an altered profile of AI-2 accumulation and removal. Understanding of the biochemical mechanisms employed by bacteria to quench signaling of other species can be of great utility in the development of therapies to control bacterial behavior.	[Marques, Joao C.; Lamosa, Pedro; Ventura, Rita; Maycock, Christopher; Xavier, Karina B.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, P-2780 Oeiras, Portugal; [Marques, Joao C.; Xavier, Karina B.] Inst Gulbenkian Ciencias, P-2780 Oeiras, Portugal; [Russell, Caitlin; Miller, Stephen T.] Swarthmore Coll, Dept Chem & Biochem, Swarthmore, PA 19081 USA; [Maycock, Christopher] Univ Lisbon, Dept Quim & Bioquim, Fac Ciencias, P-1749 Lisbon, Portugal; [Semmelhack, Martin F.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA	Universidade Nova de Lisboa; Instituto Gulbenkian de Ciencia; Swarthmore College; Universidade de Lisboa; Princeton University	Miller, ST (corresponding author), 500 Coll Ave, Swarthmore, PA 19081 USA.	smiller1@swarthmore.edu; kxavier@igc.gulbenkian.pt	Maycock, Christopher/Z-3471-2019; Ventura, Rita/B-8011-2008; Maycock, Christopher/H-9875-2012; Xavier, Karina/B-9425-2008	Maycock, Christopher/0000-0002-6687-4435; Ventura, Rita/0000-0002-6854-7278; Maycock, Christopher/0000-0002-6687-4435; Xavier, Karina/0000-0001-5210-1434; marques, joao/0000-0003-0972-1149; Lamosa, Pedro/0000-0002-3003-1516	National Institutes of Health [AI074041]; Fundacao para a Ciencia e Tecnologia (Portugal) [PPCDT/DG/BIA/82010/2006]; Camille and Henry Dreyfus Foundation; Swarthmore College; Programa Operacional Ciencia e Inovacao (POCTI); Fundacao para a Ciencia e Tecnologia; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI074041] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao para a Ciencia e Tecnologia (Portugal)(Portuguese Foundation for Science and Technology); Camille and Henry Dreyfus Foundation; Swarthmore College; Programa Operacional Ciencia e Inovacao (POCTI); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant of AI074041 (to S. T. M.). This work was also supported by the Fundacao para a Ciencia e Tecnologia (PPCDT/DG/BIA/82010/2006, Portugal (to K. B. X.) and by the Camille and Henry Dreyfus Foundation and Swarthmore College (to S. T. M.).; We thank Frederick M. Hughson (Princeton University) and Helena Santos (Instituto Tecnologia Quimica e Biologica) for critically reading the manuscript. We thank Ana R. Neves and Teresa Catarino for precious help in optimizing the NMR conditions and preparing the anaerobic samples, respectively. The NMR spectrometers are part of The National NMR Network (REDE/1517/RMN/2005), supported by "Programa Operacional Ciencia e Inovacao (POCTI) 2010" and Fundacao para a Ciencia e Tecnologia. We acknowledge National BioResource Project (Japan):E. coli for providing strain JCM62.	Adams MA, 2005, J BIOL CHEM, V280, P8358, DOI 10.1074/jbc.M412637200; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ascenso OS, 2011, BIOORGAN MED CHEM, V19, P1236, DOI 10.1016/j.bmc.2010.12.036; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bassler BL, 1997, J BACTERIOL, V179, P4043, DOI 10.1128/jb.179.12.4043-4045.1997; Chen X, 2002, NATURE, V415, P545, DOI 10.1038/415545a; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; DAMITIO J, 1992, J AM CHEM SOC, V114, P3081, DOI 10.1021/ja00034a049; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dong YH, 2001, NATURE, V411, P813, DOI 10.1038/35081101; Dong YH, 2007, PHILOS T R SOC B, V362, P1201, DOI 10.1098/rstb.2007.2045; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Federle MJ, 2009, CONTRIB MICROBIOL, V16, P18, DOI 10.1159/000219371; Fetzner S, 2010, APPL MICROBIOL BIOT, V86, P791, DOI 10.1007/s00253-010-2455-0; Grocholski T, 2010, BIOCHEMISTRY-US, V49, P934, DOI 10.1021/bi901985b; Hardie KR, 2008, NAT REV MICROBIOL, V6, P635, DOI 10.1038/nrmicro1916; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Leadbetter JR, 2000, J BACTERIOL, V182, P6921, DOI 10.1128/JB.182.24.6921-6926.2000; Lowery CA, 2008, CHEM SOC REV, V37, P1337, DOI 10.1039/b702781h; Lyon GJ, 2004, PEPTIDES, V25, P1389, DOI 10.1016/j.peptides.2003.11.026; Matheus C. K., 1999, BIOCHEMISTRY-US, P280; Miller ST, 2004, MOL CELL, V15, P677, DOI 10.1016/j.molcel.2004.07.020; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ng WL, 2009, ANNU REV GENET, V43, P197, DOI 10.1146/annurev-genet-102108-134304; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pereira CS, 2009, J BACTERIOL, V191, P6975, DOI 10.1128/JB.00976-09; Pereira CS, 2008, MOL MICROBIOL, V70, P1223, DOI 10.1111/j.1365-2958.2008.06477.x; Rajamani S, 2007, BIOCHEMISTRY-US, V46, P3990, DOI 10.1021/bi602479e; Rasko DA, 2010, NAT REV DRUG DISCOV, V9, P117, DOI 10.1038/nrd3013; Roy V, 2010, ACS CHEM BIOL, V5, P223, DOI 10.1021/cb9002738; Sambrook J, 2001, MOL CLONING LAB MANU; SANTOS H, 1986, FEBS LETT, V194, P73, DOI 10.1016/0014-5793(86)80054-0; Schauder S, 2001, MOL MICROBIOL, V41, P463, DOI 10.1046/j.1365-2958.2001.02532.x; Sciara G, 2003, EMBO J, V22, P205, DOI 10.1093/emboj/cdg031; SHAKA AJ, 1985, J MAGN RESON, V64, P547, DOI 10.1016/0022-2364(85)90122-2; Silhavy T. J., 1984, EXPT GENE FUSIONS, P107; Surette MG, 1998, P NATL ACAD SCI USA, V95, P7046, DOI 10.1073/pnas.95.12.7046; Surette MG, 1999, MOL MICROBIOL, V31, P585, DOI 10.1046/j.1365-2958.1999.01199.x; Taga ME, 2003, MOL MICROBIOL, V50, P1411, DOI 10.1046/j.1365-2958.2003.03781.x; Taga ME, 2001, MOL MICROBIOL, V42, P777, DOI 10.1046/j.1365-2958.2001.02669.x; Vendeville A, 2005, NAT REV MICROBIOL, V3, P383, DOI 10.1038/nrmicro1146; Wang L, 2005, J BACTERIOL, V187, P8350, DOI 10.1128/JB.187.24.8350-8360.2005; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Xavier KB, 2007, ACS CHEM BIOL, V2, P128, DOI 10.1021/cb600444h; Xavier KB, 2005, NATURE, V437, P750, DOI 10.1038/nature03960; Xavier KB, 2003, CURR OPIN MICROBIOL, V6, P191, DOI 10.1016/S1369-5274(03)00028-6; Xavier KB, 2005, J BACTERIOL, V187, P238, DOI 10.1128/JB.187.1.238-248.2005; Xue T, 2009, CELL RES, V19, P1258, DOI 10.1038/cr.2009.91; Yang F, 2005, FEBS LETT, V579, P3713, DOI 10.1016/j.febslet.2005.05.060	50	42	43	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					18331	18343		10.1074/jbc.M111.230227	http://dx.doi.org/10.1074/jbc.M111.230227			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454635	hybrid, Green Published			2022-12-25	WOS:000290585200093
J	Mazur, O; Zimmer, J				Mazur, Olga; Zimmer, Jochen			Apo- and Cellopentaose-bound Structures of the Bacterial Cellulose Synthase Subunit BcsZ	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-BONDING SYSTEM; SYNCHROTRON X-RAY; ACETOBACTER-XYLINUM; CRYSTAL-STRUCTURE; ENDO-BETA-1,4-GLUCANASE; BIOSYNTHESIS; MECHANISM	Cellulose, a very abundant extracellular polysaccharide, is synthesized in a finely tuned process that involves the activity of glycosyl-transferases and hydrolases. The cellulose microfibril consists of bundles of linear beta-1,4-glucan chains that are synthesized inside the cell; however, the mechanism by which these polymers traverse the cell membrane is currently unknown. In Gram-negative bacteria, the cellulose synthase complex forms a trans-envelope complex consisting of at least four subunits. Although three of these subunits account for the synthesis and translocation of the polysaccharide, the fourth subunit, BcsZ, is a periplasmic protein with endo-beta-1,4-glucanase activity. BcsZ belongs to family eight of glycosyl-hydrolases, and its activity is required for optimal synthesis and membrane translocation of cellulose. In this study we report two crystal structures of BcsZ from Escherichia coli. One structure shows the wild-type enzyme in its apo form, and the second structure is for a catalytically inactive mutant of BcsZ in complex with the substrate cellopentaose. The structures demonstrate that BcsZ adopts an (alpha/alpha)(6)-barrel fold and that it binds four glucan moieties of cellopentaose via highly conserved residues exclusively on the nonreducing side of its catalytic center. Thus, the BcsZ-cellopentaose structure most likely represents a posthydrolysis state in which the newly formed nonreducing end has already left the substrate binding pocket while the enzyme remains attached to the truncated polysaccharide chain. We further show that BcsZ efficiently degrades beta-1,4-glucans in in vitro cellulase assays with carboxymethyl-cellulose as substrate.	[Mazur, Olga; Zimmer, Jochen] Univ Virginia, Dept Mol Physiol & Biol Phys, Ctr Membrane Biol, Charlottesville, VA 22908 USA	University of Virginia	Zimmer, J (corresponding author), 480 Ray C Hunt Dr,Snyder Bldg, Charlottesville, VA 22908 USA.	jochen_zimmer@virginia.edu		Zimmer, Jochen/0000-0002-8423-2882	University of Virginia, School of Medicine; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]	University of Virginia, School of Medicine; United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE))	This work was supported by start-up funds from the University of Virginia, School of Medicine (to J. Z.). Data were collected at the Southeast Regional Collaborative Access Team (SER-CAT) 22-ID and 22-BM beamlines at the Advanced Photon Source, Argonne National Laboratory. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract W-31-109-Eng-38.	ALONI Y, 1982, P NATL ACAD SCI-BIOL, V79, P6448, DOI 10.1073/pnas.79.21.6448; Alzari PM, 1996, STRUCTURE, V4, P265, DOI 10.1016/S0969-2126(96)00031-7; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BUREAU TE, 1987, P NATL ACAD SCI USA, V84, P6985, DOI 10.1073/pnas.84.20.6985; Cowtan KD, 1999, PROG BIOPHYS MOL BIO, V72, P245, DOI 10.1016/S0079-6107(99)00008-5; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GHOSE TK, 1987, PURE APPL CHEM, V59, P257, DOI 10.1351/pac198759020257; Gray MC, 2003, APPL BIOCHEM BIOTECH, V105, P179, DOI 10.1385/ABAB:105:1-3:179; Guerin DMA, 2002, J MOL BIOL, V316, P1061, DOI 10.1006/jmbi.2001.5404; Iguchi M, 2000, J MATER SCI, V35, P261, DOI 10.1023/A:1004775229149; Ito F., 2004, J APPL GLYCOSCI, V51, P297, DOI [10.5458/jag.51.297, DOI 10.5458/JAG.51.297]; Kawano S, 2002, J BIOSCI BIOENG, V94, P275, DOI 10.1263/jbb.94.275; Koo HM, 1998, BIOSCI BIOTECH BIOCH, V62, P2257, DOI 10.1271/bbb.62.2257; LEVER M, 1973, BIOCHEM MED METAB B, V7, P274, DOI 10.1016/0006-2944(73)90083-5; Ly HD, 1999, ANNU REV BIOCHEM, V68, P487, DOI 10.1146/annurev.biochem.68.1.487; Maloney VJ, 2010, PLANT BIOTECHNOL J, V8, P294, DOI 10.1111/j.1467-7652.2009.00483.x; MATTHYSSE AG, 1995, J BACTERIOL, V177, P1076, DOI 10.1128/jb.177.4.1076-1081.1995; Molhoj M, 2002, PLANT CELL PHYSIOL, V43, P1399, DOI 10.1093/pcp/pcf163; Morris RJ, 2002, ACTA CRYSTALLOGR D, V58, P968, DOI 10.1107/S0907444902005462; Nishiyama Y, 2002, J AM CHEM SOC, V124, P9074, DOI 10.1021/ja0257319; Nishiyama Y, 2003, J AM CHEM SOC, V125, P14300, DOI 10.1021/ja037055w; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Pointing Stephen B., 1999, Fungal Diversity, V2, P17; Rabinovich ML, 2002, BIOCHEMISTRY-MOSCOW+, V67, P850, DOI 10.1023/A:1019958419032; Romling U, 2002, RES MICROBIOL, V153, P205, DOI 10.1016/S0923-2508(02)01316-5; Saxena IM, 2005, ANN BOT-LONDON, V96, P9, DOI 10.1093/aob/mci155; SAXENA IM, 1994, J BACTERIOL, V176, P5735, DOI 10.1128/JB.176.18.5735-5752.1994; Saxena IM, 2001, PHYTOCHEMISTRY, V57, P1135, DOI 10.1016/S0031-9422(01)00048-6; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Somerville C, 2006, ANNU REV CELL DEV BI, V22, P53, DOI 10.1146/annurev.cellbio.22.022206.160206; STANDAL R, 1994, J BACTERIOL, V176, P665, DOI 10.1128/jb.176.3.665-672.1994; Yasutake Y, 2006, PROTEINS, V64, P1069, DOI 10.1002/prot.21052; Zhang YHP, 2009, METHODS MOL BIOL, V581, P213, DOI 10.1007/978-1-60761-214-8_14	39	60	60	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17601	17606		10.1074/jbc.M111.227660	http://dx.doi.org/10.1074/jbc.M111.227660			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454578	Green Published			2022-12-25	WOS:000290585200023
J	Tenhaken, R; Voglas, E; Cock, JM; Neu, V; Huber, CG				Tenhaken, Raimund; Voglas, Elena; Cock, J. Mark; Neu, Volker; Huber, Christian G.			Characterization of GDP-mannose Dehydrogenase from the Brown Alga Ectocarpus siliculosus Providing the Precursor for the Alginate Polymer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UDP-GLUCOSE DEHYDROGENASE; PSEUDOMONAS-AERUGINOSA; KEY ENZYME; MATRIX POLYSACCHARIDES; BIOSYNTHESIS; PURIFICATION; EVOLUTION; RESIDUES; SEQUENCE; GENOME	Alginate is a major cell wall polymer of brown algae. The precursor for the polymer is GDP-mannuronic acid, which is believed to be derived from a four-electron oxidation of GDPmannose through the enzyme GDP-mannose dehydrogenase (GMD). So far no eukaryotic GMD has been biochemically characterized. We have identified a candidate gene in the Ectocarpus siliculosus genome and expressed it as a recombinant protein in Escherichia coli. The GMD from Ectocarpus differs strongly from related enzymes in bacteria and is as distant to the bacterial proteins as it is to the group of UDP-glucose dehydrogenases. It lacks the C-terminal similar to 120 amino acid domain present in bacterial GMDs, which is believed to be involved in catalysis. The GMD from brown algae is highly active at alkaline pH and contains a catalytic Cys residue, sensitive to heavy metals. The product GDP-mannuronic acid was analyzed by HPLC and mass spectroscopy. The K-m for GDP-mannose was 95 mu M, and 86 mu M for NAD(+). No substrate other than GDP-mannose was oxidized by the enzyme. In gel filtration experiments the enzyme behaved as a dimer. The Ectocarpus GMD is stimulated by salts even at low molar concentrations as a possible adaptation to marine life. It is rapidly inactivated at temperatures above 30 degrees C.	[Tenhaken, Raimund; Voglas, Elena] Salzburg Univ, Dept Cell Biol, Div Plant Physiol, A-5020 Salzburg, Austria; [Cock, J. Mark] Marine Plants & Biomol Stn, Algal Genet Grp, F-29682 Roscoff, France; [Neu, Volker; Huber, Christian G.] Salzburg Univ, Dept Mol Biol, Div Chem & Bioanalyt, A-5020 Salzburg, Austria	Salzburg University; Salzburg University	Tenhaken, R (corresponding author), Salzburg Univ, Dept Cell Biol, Div Plant Physiol, Hellbrunnerstr 34, A-5020 Salzburg, Austria.	raimund.tenhaken@sbg.ac.at	Tenhaken, Raimund/O-6556-2019; Huber, Christian G./E-5445-2011	Tenhaken, Raimund/0000-0002-6764-4826; Huber, Christian G./0000-0001-8358-1880; Cock, J. Mark/0000-0002-2650-0383				Campbell RE, 2000, BIOCHEMISTRY-US, V39, P7012, DOI 10.1021/bi000181h; Cock JM, 2010, NATURE, V465, P617, DOI 10.1038/nature09016; Conklin PL, 1999, P NATL ACAD SCI USA, V96, P4198, DOI 10.1073/pnas.96.7.4198; Delaroque N, 2001, VIROLOGY, V287, P112, DOI 10.1006/viro.2001.1028; DERETIC V, 1987, J BACTERIOL, V169, P351, DOI 10.1128/jb.169.1.351-358.1987; Draget K. I., 2002, BIOPOLYMERS POLYSACC, VII, P215; Ge X, 2004, EUR J BIOCHEM, V271, P14, DOI 10.1046/j.1432-1033.2003.03876.x; Hinterberg B, 2002, PLANT PHYSIOL BIOCH, V40, P1011, DOI 10.1016/S0981-9428(02)01465-1; Klinghammer M, 2007, J EXP BOT, V58, P3609, DOI 10.1093/jxb/erm209; KLOAREG B., 1988, OCEANOGR MAR BIOL, V26, P259; LIN TY, 1966, J BIOL CHEM, V241, P5284; Michel G, 2010, NEW PHYTOL, V188, P82, DOI 10.1111/j.1469-8137.2010.03374.x; Naught LE, 2002, BIOCHEMISTRY-US, V41, P9637, DOI 10.1021/bi025862m; Nyvall P, 2003, PLANT PHYSIOL, V133, P726, DOI 10.1104/pp.103.025981; Reyes-Prieto A, 2007, ANNU REV GENET, V41, P147, DOI 10.1146/annurev.genet.41.110306.130134; ROYCHOUDHURY S, 1989, J BIOL CHEM, V264, P9380; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; SKJAKBRAEK G, 1986, CARBOHYD RES, V154, P239; Snook CF, 2003, BIOCHEMISTRY-US, V42, P4658, DOI 10.1021/bi027328k	19	22	22	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16707	16715		10.1074/jbc.M111.230979	http://dx.doi.org/10.1074/jbc.M111.230979			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454608	Green Published, hybrid			2022-12-25	WOS:000290301900018
J	Vitrac, H; Bogdanov, M; Heacock, P; Dowhan, W				Vitrac, Heidi; Bogdanov, Mikhail; Heacock, Phil; Dowhan, William			Lipids and Topological Rules of Membrane Protein Assembly BALANCE BETWEEN LONG AND SHORT RANGE LIPID-PROTEIN INTERACTIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; PHOSPHOLIPID-COMPOSITION; TOPOGENIC SIGNALS; CYSTEINE RESIDUES; TRANSPORT PROTEIN; LACTOSE PERMEASE; CHARGED RESIDUES; PLASMA-MEMBRANE; ATP SYNTHASE	The N-terminal six-transmembrane domain (TM) bundle of lactose permease of Escherichia coli is uniformly inverted when assembled in membranes lacking phosphatidylethanolamine (PE). Inversion is dependent on the net charge of cytoplasmically exposed protein domains containing positive and negative residues, net charge of the membrane surface, and low hydrophobicity of TM VII acting as a molecular hinge between the two halves of lactose permease (Bogdanov, M., Xie, J., Heacock, P., and Dowhan, W. (2008) J. Cell Biol. 182, 925-935). Net neutral lipids suppress the membrane translocation potential of negatively charged amino acids, thus increasing the cytoplasmic retention potential of positively charged amino acids. Herein, TM organization of sucrose permease (CscB) and phenylalanine permease (PheP) as a function of membrane lipid composition was investigated to extend these principles to other proteins. For CscB, topological dependence on PE only becomes evident after a significant increase in the net negative charge of the cytoplasmic surface of the N-terminal TM bundle. High negative charge is required to overcome the thermodynamic block to inversion due to the high hydrophobicity of TM VII. Increasing the positive charge of the cytoplasmic surface of the N-terminal TM hairpin of PheP, which is misoriented in PE-lacking cells, favors native orientation in the absence of PE. PheP and CscB also display co-existing dual topologies dependent on changes in the charge balance between protein domains and the membrane lipids. Therefore, the topology of both permeases is dependent on PE. However, CscB topology is governed by thermodynamic balance between opposing lipid-dependent electrostatic and hydrophobic interactions.	[Vitrac, Heidi; Bogdanov, Mikhail; Heacock, Phil; Dowhan, William] Univ Texas Med Sch, Dept Biochem & Mol Biol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Bogdanov, M (corresponding author), Univ Texas Med Sch, Dept Biochem & Mol Biol, 6431 Fannin St,Suite 6-200, Houston, TX 77030 USA.	Mikhail.V.Bogdanov@uth.tmc.edu; William.Dowhan@uth.tmc.edu	Bogdanov, Mikhail/J-3695-2017; Vitrac, Heidi/R-7117-2018	Vitrac, Heidi/0000-0002-8858-4914	National Institutes of Health [GM R37 20478]; John Dunn Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM020478] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John Dunn Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM R37 20478 (to W.D.). This work was also supported by a grant from the John Dunn Research Foundation (to W.D.).	BELTZER JP, 1991, J BIOL CHEM, V266, P973; Bogdanov M, 2002, EMBO J, V21, P2107, DOI 10.1093/emboj/21.9.2107; Bogdanov M, 2005, METHODS, V36, P148, DOI 10.1016/j.ymeth.2004.11.002; Bogdanov M, 1996, J BIOL CHEM, V271, P11615, DOI 10.1074/jbc.271.20.11615; Bogdanov M, 2008, J CELL BIOL, V182, P925, DOI 10.1083/jcb.200803097; Bogdanov M, 2010, P NATL ACAD SCI USA, V107, P15057, DOI 10.1073/pnas.1006286107; Bogdanov M, 2010, METHODS MOL BIOL, V619, P79, DOI 10.1007/978-1-60327-412-8_5; Bogdanov M, 2009, J BIOL CHEM, V284, P9637, DOI 10.1074/jbc.R800081200; DECHAVIGNY A, 1991, J BIOL CHEM, V266, P5323; Dowhan W, 2009, ANNU REV BIOCHEM, V78, P515, DOI 10.1146/annurev.biochem.77.060806.091251; Dowhan W, 2009, J LIPID RES, V50, pS305, DOI 10.1194/jlr.R800041-JLR200; DUNLOP J, 1995, EMBO J, V14, P3609, DOI 10.1002/j.1460-2075.1995.tb00030.x; ENGELMAN DM, 1986, ANNU REV BIOPHYS BIO, V15, P321, DOI 10.1146/annurev.bb.15.060186.001541; Frillingos S, 1998, FASEB J, V12, P1281, DOI 10.1096/fasebj.12.13.1281; Goder V, 2004, MOL BIOL CELL, V15, P1470, DOI 10.1091/mbc.E03-08-0599; Granseth E, 2005, J MOL BIOL, V346, P377, DOI 10.1016/j.jmb.2004.11.036; Gulshan K, 2010, MOL BIOL CELL, V21, P443, DOI 10.1091/mbc.E09-06-0519; Guo DP, 1996, J BIOL CHEM, V271, P30829, DOI 10.1074/jbc.271.48.30829; Guo Y, 2010, J BIOL CHEM, V285, P39564, DOI 10.1074/jbc.M110.177055; Junne T, 2010, MOL BIOL CELL, V21, P1662, DOI 10.1091/mbc.E10-01-0060; LEE E, 1994, J BIOL CHEM, V269, P28822; Long JC, 1998, J BIOL CHEM, V273, P16235, DOI 10.1074/jbc.273.26.16235; LOO TW, 1995, J BIOL CHEM, V270, P843, DOI 10.1074/jbc.270.2.843; Monne M, 2005, FEBS J, V272, P28, DOI 10.1111/j.1432-1033.2004.04394.x; Nakamura H, 2000, BIOSCI BIOTECH BIOCH, V64, P167, DOI 10.1271/bbb.64.167; NILSSON IM, 1990, CELL, V62, P1135, DOI 10.1016/0092-8674(90)90390-Z; Opekarova M, 2002, BBA-BIOMEMBRANES, V1564, P9, DOI 10.1016/S0005-2736(02)00455-8; Rutz C, 1999, J BIOL CHEM, V274, P33757, DOI 10.1074/jbc.274.47.33757; Sahin-Toth M, 2000, BIOCHEMISTRY-US, V39, P6164, DOI 10.1021/bi000124o; Saier MH, 2006, NUCLEIC ACIDS RES, V34, pD181, DOI 10.1093/nar/gkj001; Seppala S, 2010, SCIENCE, V328, P1698, DOI 10.1126/science.1188950; Skach WR, 2009, NAT STRUCT MOL BIOL, V16, P606, DOI 10.1038/nsmb.1600; Soekarjo M, 1996, BIOCHEMISTRY-US, V35, P1232, DOI 10.1021/bi951087h; STEITZ TA, 1982, BIOPHYS J, V37, P124, DOI 10.1016/S0006-3495(82)84633-X; vanKlompenburg W, 1997, EMBO J, V16, P4261, DOI 10.1093/emboj/16.14.4261; von Heijne G, 2006, NAT REV MOL CELL BIO, V7, P909, DOI 10.1038/nrm2063; VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671; VONHEIJNE G, 1989, NATURE, V341, P456, DOI 10.1038/341456a0; Wada T, 1999, J BIOL CHEM, V274, P17353, DOI 10.1074/jbc.274.24.17353; Wang XY, 2002, EMBO J, V21, P5673, DOI 10.1093/emboj/cdf571; White SH, 2005, BIOCHEM SOC T, V33, P1012, DOI 10.1042/BST0331012; Wikstrom M, 2004, J BIOL CHEM, V279, P10484, DOI 10.1074/jbc.M310183200; Wikstrom M, 2009, J BIOL CHEM, V284, P954, DOI 10.1074/jbc.M804482200; Xie J, 2006, J BIOL CHEM, V281, P19172, DOI 10.1074/jbc.M602565200; Zhang W, 2005, J BIOL CHEM, V280, P26032, DOI 10.1074/jbc.M504929200; Zhang W, 2003, J BIOL CHEM, V278, P50128, DOI 10.1074/jbc.M309840200; Zhu QS, 1999, J BIOL CHEM, V274, P27898, DOI 10.1074/jbc.274.39.27898	47	31	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15182	15194		10.1074/jbc.M110.214387	http://dx.doi.org/10.1074/jbc.M110.214387			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21454589	hybrid, Green Published			2022-12-25	WOS:000289788300050
J	Itkin, A; Dupres, V; Dufrene, YF; Bechinger, B; Ruysschaert, JM; Raussens, V				Itkin, Anna; Dupres, Vincent; Dufrene, Yves F.; Bechinger, Burkhard; Ruysschaert, Jean-Marie; Raussens, Vincent			Calcium Ions Promote Formation of Amyloid beta-Peptide (1-40) Oligomers Causally Implicated in Neuronal Toxicity of Alzheimer's Disease	PLOS ONE			English	Article							LONG-TERM POTENTIATION; A-BETA; PHYSIOLOGICAL CONCENTRATIONS; SOLUBLE OLIGOMERS; THIOFLAVIN-T; PROTEIN; CA2+; NEURODEGENERATION; AGGREGATION; CHANNELS	Amyloid beta-peptide (A beta) is directly linked to Alzheimer's disease (AD). In its monomeric form, A beta aggregates to produce fibrils and a range of oligomers, the latter being the most neurotoxic. Dysregulation of Ca2+ homeostasis in aging brains and in neurodegenerative disorders plays a crucial role in numerous processes and contributes to cell dysfunction and death. Here we postulated that calcium may enable or accelerate the aggregation of A beta. We compared the aggregation pattern of A beta(1-40) and that of A beta(1-40)E22G, an amyloid peptide carrying the Arctic mutation that causes early onset of the disease. We found that in the presence of Ca2+, A beta(1-40) preferentially formed oligomers similar to those formed by A beta(1-40) E22G with or without added Ca2+, whereas in the absence of added Ca2+ the A beta(1-40) aggregated to form fibrils. Morphological similarities of the oligomers were confirmed by contact mode atomic force microscopy imaging. The distribution of oligomeric and fibrillar species in different samples was detected by gel electrophoresis and Western blot analysis, the results of which were further supported by thioflavin T fluorescence experiments. In the samples without Ca2+, Fourier transform infrared spectroscopy revealed conversion of oligomers from an anti-parallel beta-sheet to the parallel b-sheet conformation characteristic of fibrils. Overall, these results led us to conclude that calcium ions stimulate the formation of oligomers of A beta(1-40), that have been implicated in the pathogenesis of AD.	[Itkin, Anna; Ruysschaert, Jean-Marie; Raussens, Vincent] Univ Libre Bruxelles, Ctr Struct Biol & Bioinformat, Lab Struct & Funct Biol Membranes, Brussels, Belgium; [Itkin, Anna; Bechinger, Burkhard] Univ Strasbourg, Int Ctr Frontier Res Chem, Inst Chem, Strasbourg, France; [Itkin, Anna; Bechinger, Burkhard] Univ Strasbourg, NMR, Strasbourg, France; [Dupres, Vincent; Dufrene, Yves F.] Catholic Univ Louvain, Inst Condensed Matter & Nanosci, B-1348 Louvain, Belgium	Universite Libre de Bruxelles; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite Catholique Louvain	Itkin, A (corresponding author), Univ Libre Bruxelles, Ctr Struct Biol & Bioinformat, Lab Struct & Funct Biol Membranes, Brussels, Belgium.	vrauss@ulb.ac.be	Dupres, Vincent/GLQ-5321-2022	Dupres, Vincent/0000-0002-1970-3633; Dufrene, Yves/0000-0002-7289-4248	European Community [MRTN-CT-2006-033439]; National Foundation for Scientific Research (FNRS); Foundation for Training in Industrial and Agricultural Research (FRIA); Universite Catholique de Louvain; Federal Office for Scientific, Technical and Cultural Affairs; Research Department of the Communaute Francaise de Belgique	European Community(European Commission); National Foundation for Scientific Research (FNRS)(Fonds de la Recherche Scientifique - FNRS); Foundation for Training in Industrial and Agricultural Research (FRIA)(Fonds de la Recherche Scientifique - FNRS); Universite Catholique de Louvain; Federal Office for Scientific, Technical and Cultural Affairs; Research Department of the Communaute Francaise de Belgique	This work received funding from the European Community's Sixth Framework Programme through a Marie Curie Research Training Network ("Biocontrol" MRTN-CT-2006-033439, http://ibis.tau.ac.il/wiki/biocontrol/index.php/Main_Page). Work in the team of V. D. and Y.F.D. was supported by the National Foundation for Scientific Research (FNRS, www.frs-fnrs.be), the Foundation for Training in Industrial and Agricultural Research (FRIA, http://www1.frs-fnrs.be/fr/financer-les-chercheurs/carriere-chercheur/doctorants/86-bourse-du-fria.html), the Universite Catholique de Louvain (Fonds Speciaux de Recherche), the Federal Office for Scientific, Technical and Cultural Affairs (Interuniversity Attraction Poles Programme), and the Research Department of the Communaute Francaise de Belgique (Concerted Research Action). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2009, BBA-PROTEINS PROTEOM, V1794, P1537, DOI 10.1016/j.bbapap.2009.06.022; ARISPE N, 1993, P NATL ACAD SCI USA, V90, P10573, DOI 10.1073/pnas.90.22.10573; ARISPE N, 1993, P NATL ACAD SCI USA, V90, P567, DOI 10.1073/pnas.90.2.567; Benseny-Cases N, 2007, BIOCHEM BIOPH RES CO, V361, P916, DOI 10.1016/j.bbrc.2007.07.082; Bezprozvanny I, 2008, TRENDS NEUROSCI, V31, P454, DOI 10.1016/j.tins.2008.06.005; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Bojarski L, 2008, NEUROCHEM INT, V52, P621, DOI 10.1016/j.neuint.2007.10.002; Bossy-Wetzel E, 2004, NAT MED, V10, pS2, DOI 10.1038/nm1067; Bucciantini M, 2004, J BIOL CHEM, V279, P31374, DOI 10.1074/jbc.M400348200; Budd SL, 1999, ESSAYS BIOCHEM, V33, P43; Cerf E, 2009, BIOCHEM J, V421, P415, DOI 10.1042/BJ20090379; CHIRGADZE YN, 1976, BIOPOLYMERS, V15, P607, DOI 10.1002/bip.1976.360150402; Chui DH, 1999, NAT MED, V5, P560, DOI 10.1038/8438; CUMMINGS BJ, 1995, LANCET, V346, P1524, DOI 10.1016/S0140-6736(95)92053-6; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200; Dewachter I, 2009, NEUROBIOL AGING, V30, P241, DOI 10.1016/j.neurobiolaging.2007.06.011; Etcheberrigaray R, 1998, NEUROBIOL DIS, V5, P37, DOI 10.1006/nbdi.1998.0176; Ferreiro E, 2004, J NEUROSCI RES, V76, P872, DOI 10.1002/jnr.20135; Goormaghtigh E, 1994, Subcell Biochem, V23, P329; Green KN, 2008, NEURON, V59, P190, DOI 10.1016/j.neuron.2008.07.013; Groenning M, 2007, J STRUCT BIOL, V158, P358, DOI 10.1016/j.jsb.2006.12.010; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Irizarry MC, 1997, J NEUROSCI, V17, P7053; Isaacs AM, 2006, J BIOL CHEM, V281, P27916, DOI 10.1074/jbc.M602061200; ITO E, 1994, P NATL ACAD SCI USA, V91, P534, DOI 10.1073/pnas.91.2.534; Kagan BL, 2004, J MEMBRANE BIOL, V202, P1, DOI 10.1007/s00232-004-0709-4; KAMINO K, 1992, AM J HUM GENET, V51, P998; Kawahara M, 2000, J BIOL CHEM, V275, P14077, DOI 10.1074/jbc.275.19.14077; KHACHATURIAN ZS, 1994, ANN NY ACAD SCI, V747, P1; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Krebs MRH, 2005, J STRUCT BIOL, V149, P30, DOI 10.1016/j.jsb.2004.08.002; KURODA Y, 1994, TOHOKU J EXP MED, V174, P263, DOI 10.1620/tjem.174.263; LaFerla FM, 2002, NAT REV NEUROSCI, V3, P862, DOI 10.1038/nrn960; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lashuel HA, 2003, J MOL BIOL, V332, P795, DOI 10.1016/S0022-2836(03)00927-6; Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012; Lord A, 2006, NEUROBIOL AGING, V27, P67, DOI 10.1016/j.neurobiolaging.2004.12.007; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; Mastrangelo IA, 2006, J MOL BIOL, V358, P106, DOI 10.1016/j.jmb.2006.01.042; MATTSON MP, 1992, J NEUROSCI, V12, P376, DOI 10.1523/jneurosci.12-02-00376.1992; MATTSON MP, 1991, MOL CHEM NEUROPATHOL, V15, P117, DOI 10.1007/BF03159951; MATTSON MP, 1994, ANN NY ACAD SCI, V747, P50; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Molnar Z, 2004, NEUROREPORT, V15, P1649, DOI 10.1097/01.wnr.0000134471.06244.d2; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Naslund J, 2000, JAMA-J AM MED ASSOC, V283, P1571, DOI 10.1001/jama.283.12.1571; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Paivio A, 2004, J MOL BIOL, V339, P145, DOI 10.1016/j.jmb.2004.03.028; Paula-Lima AC, 2011, ANTIOXID REDOX SIGN, V14, P1209, DOI 10.1089/ars.2010.3287; Pierrot N, 2006, J BIOL CHEM, V281, P39907, DOI 10.1074/jbc.M606015200; QUERFURTH HW, 1994, BIOCHEMISTRY-US, V33, P4550, DOI 10.1021/bi00181a016; Rovira C, 2002, BIOCHEM BIOPH RES CO, V296, P1317, DOI 10.1016/S0006-291X(02)02072-7; Rowan MJ, 2007, BIOCHEM SOC T, V35, P1219, DOI 10.1042/BST0351219; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Smith IF, 2005, CELL CALCIUM, V38, P427, DOI 10.1016/j.ceca.2005.06.021; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Stutzmann GE, 2005, NEUROSCIENTIST, V11, P110, DOI 10.1177/1073858404270899; Stutzmann GE, 2007, NEUROSCIENTIST, V13, P546, DOI 10.1177/1073858407299730; Toescu E.C., 2007, ALTERED CALCIUM HOME; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang HW, 2002, BRAIN RES, V924, P133, DOI 10.1016/S0006-8993(01)03058-X; Whalen BM, 2005, NEUROBIOL DIS, V20, P254, DOI 10.1016/j.nbd.2005.03.007; Xiong J, 2002, J NEUROSCI, V22, P10761	70	87	94	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e18250	10.1371/journal.pone.0018250	http://dx.doi.org/10.1371/journal.pone.0018250			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464905	Green Submitted, Green Published, gold			2022-12-25	WOS:000289053800033
J	Kim, SM; Kim, H; Kim, JE; Park, KS; Sung, JJ; Kim, SH; Lee, KW				Kim, Sung-Min; Kim, Heejaung; Kim, Jee-Eun; Park, Kyung Seok; Sung, Jung-Joon; Kim, Seung Hyun; Lee, Kwang-Woo			Amyotrophic Lateral Sclerosis Is Associated with Hypolipidemia at the Presymptomatic Stage in Mice	PLOS ONE			English	Article							MOTOR-NEURON DEGENERATION; DISEASE PROGRESSION; TRANSGENIC MOUSE; ALS; IMPAIRMENT; MODEL; ONSET; DIET	Objective: To demonstrate that hypolipidemia is a typical feature of the mouse model of amyotrophic lateral sclerosis (ALS) and to assess the association between hypolipidemia and disease stage, dietary intake, and sex. Methods: We compared daily dietary intake, body weight, and serumlipid and glucose levels in ALS mice and wild-type controls at different stages of the disease. Findings: Total cholesterol low-density lipoprotein (LDL) and LDL/high-density lipoprotein (HDL) ratio were significantly lower in ALS mice compared with controls. Subgroup analysis revealed that the incidence of hypolipidemia was significantly greater in male, but not female, ALS mice compared with control mice and that hypolipidemia was present at the presymptomatic stage of the disease. This hypolipidemia can be found without a decrease in the serum levels of other energy sources, such as glucose, in the presymptomatic stage. Conclusions: Hypolipidemia is present at the presymptomatic stage of the ALS mouse model in the absence of malnutrition, significant neuromuscular degeneration or regeneration, and respiratory difficulty. Our findings suggest that hypolipidemia might be associated with the pathomechanism of ALS and/or lipid-specific metabolism rather than simply an epiphenomenon of neuromuscular degeneration or energy imbalance.	[Kim, Sung-Min; Kim, Jee-Eun; Park, Kyung Seok; Sung, Jung-Joon; Lee, Kwang-Woo] Seoul Natl Univ, Coll Med, Dept Neurol, Seoul, South Korea; [Kim, Heejaung; Kim, Seung Hyun] Hanyang Univ, Dept Neurol, Coll Med, Seoul 133791, South Korea	Seoul National University (SNU); Hanyang University	Kim, SM (corresponding author), Seoul Natl Univ, Coll Med, Dept Neurol, Seoul, South Korea.	jjsaint@snu.ac.kr; kimsh1@hanyang.ac.kr	Kim, Seung Hyun/T-5133-2017; Park, Kyung Seok/J-5472-2012; Lee, Kwang Woo/J-5571-2012	Kim, Seung Hyun/0000-0001-9644-9598; Kim, Heejaung/0000-0002-0755-1740	National Research foundation [2010-0024351]; Seoul National University [04-2007-0930]	National Research foundation; Seoul National University	This work was supported by grant NO. "2010-0024351" from National Research foundation fund and by grant NO. "04-2007-0930" from Seoul National University Hospital fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson S, 2005, P NATL ACAD SCI USA, V102, P3857, DOI 10.1073/pnas.0500634102; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Bouteloup C, 2009, J NEUROL, V256, P1236, DOI 10.1007/s00415-009-5100-z; BROOKS BR, 1995, ADV NEUROL, V68, P163; Chio A, 2009, NEUROLOGY, V73, P1681, DOI 10.1212/WNL.0b013e3181c1df1e; Choi CI, 2008, J NEUROL SCI, V268, P40, DOI 10.1016/j.jns.2007.10.024; de Aguilar JLG, 2005, BIOMED PHARMACOTHER, V59, P190, DOI 10.1016/j.biopha.2005.03.003; Desport JC, 2001, AM J CLIN NUTR, V74, P328; Dupuis L, 2008, NEUROLOGY, V70, P1004, DOI 10.1212/01.wnl.0000285080.70324.27; Dupuis L, 2004, P NATL ACAD SCI USA, V101, P11159, DOI 10.1073/pnas.0402026101; Fergani A, 2007, J LIPID RES, V48, P1571, DOI 10.1194/jlr.M700017-JLR200; Funalot B, 2009, AMYOTROPH LATERAL SC, V10, P113, DOI 10.1080/17482960802295192; Gallou-Kabani C, 2007, OBESITY, V15, P1996, DOI 10.1038/oby.2007.238; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Kieran D, 2007, P NATL ACAD SCI USA, V104, P20606, DOI 10.1073/pnas.0707906105; Kim SM, 2007, J NEUROL NEUROSUR PS, V78, P1387, DOI 10.1136/jnnp.2006.111195; Lacomblez L, 2002, NEUROLOGY, V58, P1112, DOI 10.1212/WNL.58.7.1112; Park JH, 2007, NEUROSCI LETT, V413, P265, DOI 10.1016/j.neulet.2006.11.058; Ringholz GM, 2005, NEUROLOGY, V65, P586, DOI 10.1212/01.wnl.0000172911.39167.b6; Rothstein JD, 2009, ANN NEUROL, V65, pS3, DOI 10.1002/ana.21543; Tu PH, 1996, P NATL ACAD SCI USA, V93, P3155, DOI 10.1073/pnas.93.7.3155	22	43	43	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e17985	10.1371/journal.pone.0017985	http://dx.doi.org/10.1371/journal.pone.0017985			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464953	Green Published, gold, Green Submitted			2022-12-25	WOS:000288813900025
J	Nayak, TK; Garmestani, K; Milenic, DE; Baidoo, KE; Brechbiel, MW				Nayak, Tapan K.; Garmestani, Kayhan; Milenic, Diane E.; Baidoo, Kwamena E.; Brechbiel, Martin W.			HER1-Targeted Y-86-Panitumumab Possesses Superior Targeting Characteristics than Y-86-Cetuximab for PET Imaging of Human Malignant Mesothelioma Tumors Xenografts	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; COPPER-64-LABELED MONOCLONAL-ANTIBODY; DISSEMINATED PERITONEAL DISEASE; PLEURAL MESOTHELIOMA; PHASE-II; CANCER; EXPRESSION; PROTEIN; MODEL; RADIOIMMUNOTHERAPY	Malignant mesothelioma (MM), a rare form of cancer is often associated with previous exposure to fibrous minerals, such as asbestos. Asbestos exposure increases HER1-activity and expression in pre-clinical models. Additionally, HER1 over-expression is observed in the majority of MM cases. In this study, the utility of HER1-targeted chimeric IgG(1), cetuximab, and a human IgG(2), panitumumab, radiolabeled with Y-86, were evaluated for PET imaging to detect MM non-invasively in vivo, and to select an antibody candidate for radioimmunotherapy (RIT). Methods: Radioimmunoconjugates (RICs) of cetuximab and panitumumab were prepared by conjugation with CHX-A"-DTPA followed by radiolabeling with Y-86. The HER1 expression of NCI-H226, NCI-H2052, NCI-H2452 and MSTO-211H human mesothelioma cells was characterized by flow cytometry. In vivo biodistribution, pharmacokinetic analysis, and PET imaging were performed in tumor bearing athymic mice. Results: In vivo studies demonstrated high HER1 tumor uptake of both RICs. Significant reduction in tumor uptake was observed in mice co-injected with excess mAb (0.1 mg), demonstrating that uptake in the tumor was receptor specific. Significant differences were observed in the in vivo characteristics of the RICs. The blood clearance T1/2 alpha of Y-86-cetuximab (0.9-1.1 h) was faster than Y-86-panitumumab (2.6-3.1 h). Also, the tumor area under the curve (AUC) to liver AUC ratios of Y-86-panitumumab were 1.5 to 2.5 times greater than Y-86-cetuximab as observed by the differences in PET tumor to background ratios, which could be critical when imaging orthotopic tumors and concerns regarding radiation doses to normal organs such as the liver. Conclusion: This study demonstrates the more favorable HER1-targeting characteristics of Y-86-panitumumab than Y-86-cetuximab for non-invasive assessment of the HER1 status of MM by PET imaging. Due to lower liver uptake, panitumumab based immunoconjugates may fare better in therapy than corresponding cetuximab based immunoconjugates.	[Nayak, Tapan K.; Garmestani, Kayhan; Milenic, Diane E.; Baidoo, Kwamena E.; Brechbiel, Martin W.] NCI, Radiat Oncol Branch, NIH, Radioimmune & Inorgan Chem Sect, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Nayak, TK (corresponding author), NCI, Radiat Oncol Branch, NIH, Radioimmune & Inorgan Chem Sect, Bldg 10, Bethesda, MD 20892 USA.	tapann@gmail.com; martinwb@mail.nih.gov		Nayak, Tapan/0000-0002-3706-6092	NIH; NCI; Center for Cancer Research; United States Department of Health and Human Services; NATIONAL CANCER INSTITUTE [ZIASC006353] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); United States Department of Health and Human Services; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The Intramural Research Program of the NIH, NCI, Center for Cancer Research and the United States Department of Health and Human Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behr TM, 1999, CANCER RES, V59, P2635; Benamore RE, 2005, CLIN RADIOL, V60, P1237, DOI 10.1016/j.crad.2005.05.015; Boswell CA, 2007, NUCL MED BIOL, V34, P757, DOI 10.1016/j.nucmedbio.2007.04.001; CUTLER PD, 1995, J NUCL MED, V36, P2363; Destro A, 2006, LUNG CANCER, V51, P207, DOI 10.1016/j.lungcan.2005.10.016; Edwards JG, 2006, LUNG CANCER, V54, P399, DOI 10.1016/j.lungcan.2006.08.012; Faux SP, 2000, CARCINOGENESIS, V21, P2275, DOI 10.1093/carcin/21.12.2275; Gaafar R, 2010, LUNG CANCER, V70, P43, DOI 10.1016/j.lungcan.2010.01.002; Garland LL, 2007, J CLIN ONCOL, V25, P2406, DOI 10.1200/JCO.2006.09.7634; Garmestani K, 2002, NUCL MED BIOL, V29, P599, DOI 10.1016/S0969-8051(02)00322-0; GIBALDI M, 1982, PHARMACOKINETICS, V8, P494; Govindan R, 2005, CLIN CANCER RES, V11, P2300, DOI 10.1158/1078-0432.CCR-04-1940; Heelan RT, 1999, AM J ROENTGENOL, V172, P1039, DOI 10.2214/ajr.172.4.10587144; Helisch A, 2004, EUR J NUCL MED MOL I, V31, P1386, DOI 10.1007/s00259-004-1561-6; Kamp DW, 2009, TRANSL RES, V153, P143, DOI 10.1016/j.trsl.2009.01.004; KOTHMAIER H, 2007, THORAX; Kramer H, 2004, J NUCL MED, V45, P995; Lee AY, 2007, CANCER-AM CANCER SOC, V109, P1454, DOI 10.1002/cncr.22552; Lee HY, ANN SURG ONCOL; Lobo ED, 2004, J PHARM SCI-US, V93, P2645, DOI 10.1002/jps.20178; Lovqvist A, 2001, J NUCL MED, V42, P1281; Milenic DE, 2004, CLIN CANCER RES, V10, P7834, DOI 10.1158/1078-0432.CCR-04-1226; Milenic DE, 2007, CLIN CANCER RES, V13, P1926, DOI 10.1158/1078-0432.CCR-06-2300; Nayak TK, 2011, INT J CANCER, V128, P920, DOI 10.1002/ijc.25409; Nayak TK, 2010, EUR J NUCL MED MOL I, V37, P1368, DOI 10.1007/s00259-009-1370-z; Nayak TK, 2010, J NUCL MED, V51, P942, DOI 10.2967/jnumed.109.071290; Nowak AK, 2010, CLIN CANCER RES, V16, P2409, DOI 10.1158/1078-0432.CCR-09-2313; Okuda K, 2008, J CANCER RES CLIN, V134, P1105, DOI 10.1007/s00432-008-0384-4; Pache JC, 1998, AM J PATHOL, V152, P333; PHILPOTT GW, 1995, J NUCL MED, V36, P1818; Richman CM, 2001, CRIT REV ONCOL HEMAT, V38, P25, DOI 10.1016/S1040-8428(00)00136-0; Robinson BWS, 2005, LANCET, V366, P397, DOI 10.1016/S0140-6736(05)67025-0; Robinson BWS, 2005, NEW ENGL J MED, V353, P1591, DOI 10.1056/NEJMra050152; Sharkey RM, 2005, J NUCL MED, V46, p115S; Tsao AS, 2009, J CLIN ONCOL, V27, P2081, DOI 10.1200/JCO.2008.19.8523; Verel I, 2003, J NUCL MED, V44, P1663; Vogelzang NJ, 2005, SEMIN ONCOL, V32, P336, DOI 10.1053/j.seminoncol.2005.02.010; Wang W, 2008, CLIN PHARMACOL THER, V84, P548, DOI 10.1038/clpt.2008.170; Wong JYC, 2006, CANCER BIOTHER RADIO, V21, P88, DOI 10.1089/cbr.2006.21.88; Yang HC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-196; Zanella CL, 1996, CANCER RES, V56, P5334; Zinzani PL, 2010, CLIN CANCER RES, V16, P3998, DOI 10.1158/1078-0432.CCR-10-0162	42	46	46	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e18198	10.1371/journal.pone.0018198	http://dx.doi.org/10.1371/journal.pone.0018198			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464917	Green Submitted, gold, Green Published			2022-12-25	WOS:000288813900050
J	Simmons, LW; Beveridge, M				Simmons, Leigh W.; Beveridge, Maxine			Seminal Fluid Affects Sperm Viability in a Cricket	PLOS ONE			English	Article							COMPETITION; EVOLUTION; QUALITY; DISPLACEMENT; ASSOCIATION; PROTEINS; ADJUST; MALES	Recent studies have suggested that males may vary the quality of their ejaculates in response to sperm competition, although the mechanisms by which they do so remain unclear. The viability of sperm is an important aspect of ejaculate quality that determines competitive fertilization success in the field cricket Teleogryllus oceanicus. Using in vitro mixtures of sperm and seminal fluid from pairs of male crickets, we show that seminal fluid can affect the viability of sperm in this species. We found that males who invest greatly in the viability of their own sperm can enhance the viability of rival sperm, providing the opportunity for males to exploit the investments in sperm competition made by their rivals. Transitive effects of seminal fluids across the ejaculates of different males are expected to have important implications for the dynamics of male investments in sperm competition.	[Simmons, Leigh W.; Beveridge, Maxine] Univ Western Australia, Sch Anim Biol, Ctr Evolutionary Biol, Crawley, Australia	University of Western Australia	Simmons, LW (corresponding author), Univ Western Australia, Sch Anim Biol, Ctr Evolutionary Biol, Crawley, Australia.	leigh.simmons@uwa.edu.au	Simmons, Leigh W/B-1815-2011	Simmons, Leigh W/0000-0003-0562-1474	Australian Research Council [DP35600500]	Australian Research Council(Australian Research Council)	This research was funded by the Australian Research Council (DP35600500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken RJ, 2006, MOL CELL ENDOCRINOL, V250, P66, DOI 10.1016/j.mce.2005.12.026; Andres JA, 2006, MOL BIOL EVOL, V23, P1574, DOI 10.1093/molbev/msl020; Aziz N, 2004, FERTIL STERIL, V81, P349, DOI 10.1016/j.fertnstert.2003.06.026; Birkhead TR, 1998, SPERM COMPETITION SE; Bjork A, 2007, P ROY SOC B-BIOL SCI, V274, P1779, DOI 10.1098/rspb.2007.0293; Braswell WE, 2006, GENOME, V49, P1069, DOI 10.1139/G06-061; Cameron E, 2007, AM NAT, V169, pE158, DOI 10.1086/516718; Chapman T, 2008, PLOS BIOL, V6, P1379, DOI 10.1371/journal.pbio.0060179; CLARK AG, 1995, GENETICS, V139, P189; Cornwallis CK, 2007, AM NAT, V170, P758, DOI 10.1086/521955; Cornwallis CK, 2009, P ROY SOC B-BIOL SCI, V276, P3467, DOI 10.1098/rspb.2009.0807; den Boer SPA, 2010, SCIENCE, V327, P1506, DOI 10.1126/science.1184709; Dowling DK, 2009, P ROY SOC B-BIOL SCI, V276, P1737, DOI 10.1098/rspb.2008.1791; Fiumera AC, 2005, GENETICS, V169, P243, DOI 10.1534/genetics.104.032870; Fiumera AC, 2007, GENETICS, V176, P1245, DOI 10.1534/genetics.106.064915; Garcia-Gonzalez F, 2005, J EVOLUTION BIOL, V18, P1097, DOI 10.1111/j.1420-9101.2005.00889.x; Garcia-Gonzalez F, 2005, CURR BIOL, V15, P271, DOI 10.1016/j.cub.2005.01.032; Garcia-Gonzalez F, 2007, CURR BIOL, V17, P32, DOI 10.1016/j.cub.2006.10.054; Garcia-Gonzalez F, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-140; Gasparini C, 2009, BIOL LETTERS, V5, P792, DOI 10.1098/rsbl.2009.0413; Hodgson DJ, 2006, J THEOR BIOL, V243, P230, DOI 10.1016/j.jtbi.2006.06.024; Holman L, 2009, FUNCT ECOL, V23, P180, DOI 10.1111/j.1365-2435.2008.01509.x; Kilgallon SJ, 2005, BIOL LETTERS, V1, P253, DOI 10.1098/rsbl.2005.0324; Parker GA, 2010, BIOL REV, V85, P897, DOI 10.1111/j.1469-185X.2010.00140.x; Poiani A, 2006, BEHAV ECOL SOCIOBIOL, V60, P289, DOI 10.1007/s00265-006-0178-0; Price CSC, 1999, NATURE, V400, P449, DOI 10.1038/22755; Rudolfsen G, 2006, P ROY SOC B-BIOL SCI, V273, P325, DOI 10.1098/rspb.2005.3305; Simmons L. W., 2001, MG BEH ECOL; Simmons LW, 2007, BIOL LETTERS, V3, P520, DOI 10.1098/rsbl.2007.0328; Simmons LW, 2005, SCIENCE, V309, P2031, DOI 10.1126/science.1114500; Snook RR, 2004, NATURE, V428, P939, DOI 10.1038/nature02455; Snook RR, 2005, TRENDS ECOL EVOL, V20, P46, DOI 10.1016/j.tree.2004.10.011; Thomas ML, 2007, AM NAT, V170, P190, DOI 10.1086/519404; Thomas ML, 2009, P R SOC B, V276, P383, DOI 10.1098/rspb.2008.1206; Wedell N, 2002, TRENDS ECOL EVOL, V17, P313, DOI 10.1016/S0169-5347(02)02533-8; Wigby S, 2009, CURR BIOL, V19, P751, DOI 10.1016/j.cub.2009.03.036; Wolfner MF, 1997, INSECT BIOCHEM MOLEC, V27, P179, DOI 10.1016/S0965-1748(96)00084-7; 1988, J REPROD FERTILITY, V84, P341; 2006, MOL CELLULAR ENDOCRI, V250, P80	39	39	39	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2011	6	3							e17975	10.1371/journal.pone.0017975	http://dx.doi.org/10.1371/journal.pone.0017975			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740RG	21455309	Green Published, gold, Green Submitted			2022-12-25	WOS:000288811500016
J	Huang, TT; Wang, YM; Yin, J; Du, YH; Tao, MF; Xu, J; Chen, WQ; Lin, SJ; Deng, ZX				Huang, Tingting; Wang, Yemin; Yin, Jun; Du, Yanhua; Tao, Meifeng; Xu, Jing; Chen, Wenqing; Lin, Shuangjun; Deng, Zixin			Identification and Characterization of the Pyridomycin Biosynthetic Gene Cluster of Streptomyces pyridomyceticus NRRL B-2517	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONRIBOSOMAL PEPTIDE SYNTHETASES; PRISTINAMYCIN I BIOSYNTHESIS; MBTH-LIKE PROTEINS; BACILLUS-SUBTILIS; ADENYLATION DOMAINS; NATURAL-PRODUCTS; ASSEMBLY-LINE; POLYKETIDE; ENZYME; PRISTINAESPIRALIS	Pyridomycin is a structurally unique antimycobacterial cyclodepsipeptide containing rare 3-(3-pyridyl)-L-alanine and 2-hydroxy-3-methylpent-2-enoic acid moieties. The biosynthetic gene cluster for pyridomycin has been cloned and identified from Streptomyces pyridomyceticus NRRL B-2517. Sequence analysis of a 42.5-kb DNA region revealed 26 putative open reading frames, including two nonribosomal peptide synthetase (NRPS) genes and a polyketide synthase gene. A special feature is the presence of a polyketide synthase-type ketoreductase domain embedded in an NRPS. Furthermore, we showed that PyrA functioned as an NRPS adenylation domain that activates 3-hydroxypicolinic acid and transfers it to a discrete peptidyl carrier protein, PyrU, which functions as a loading module that initiates pyridomycin biosynthesis in vivo and in vitro. PyrA could also activate other aromatic acids, generating three pyridomycin analogues in vivo.	[Huang, Tingting; Wang, Yemin; Yin, Jun; Du, Yanhua; Tao, Meifeng; Xu, Jing; Chen, Wenqing; Lin, Shuangjun; Deng, Zixin] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [Huang, Tingting; Wang, Yemin; Yin, Jun; Du, Yanhua; Tao, Meifeng; Xu, Jing; Chen, Wenqing; Lin, Shuangjun; Deng, Zixin] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Lin, SJ (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, 1954 Huashan Rd, Shanghai 200030, Peoples R China.	linsj@sjtu.edu.cn		Chen, Wenqing/0000-0003-2557-8960	Ministry of Science and Technology of China; National Science Foundation of China	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Ministry of Science and Technology of China 973 and 863 programs and the National Science Foundation of China.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ansari MZ, 2004, NUCLEIC ACIDS RES, V32, pW405, DOI 10.1093/nar/gkh359; Bruntner C, 1998, EUR J BIOCHEM, V254, P347, DOI 10.1046/j.1432-1327.1998.2540347.x; Cane DE, 1997, CHEM REV, V97, P2463, DOI 10.1021/cr970097g; Cheng YQ, 2006, CHEMBIOCHEM, V7, P471, DOI 10.1002/cbic.200500425; deCrecyLagard V, 1997, J BACTERIOL, V179, P705, DOI 10.1128/jb.179.3.705-713.1997; Dewick P. M, 2002, MED NATURAL PRODUCTS, P307; DEWICK PM, 1995, NAT PROD REP, V12, P579, DOI 10.1039/np9951200579; Du L, 2001, Curr Opin Drug Discov Devel, V4, P215; Du LH, 2001, METAB ENG, V3, P78, DOI 10.1006/mben.2000.0171; Ehling-Schulz M, 2005, APPL ENVIRON MICROB, V71, P105, DOI 10.1128/AEM.71.1.105-113.2005; Felnagle EA, 2010, BIOCHEMISTRY-US, V49, P8815, DOI 10.1021/bi1012854; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; FOSTER JW, 1980, MICROBIOL REV, V44, P83, DOI 10.1128/MMBR.44.1.83-105.1980; Gehring AM, 1997, BIOCHEMISTRY-US, V36, P8495, DOI 10.1021/bi970453p; Grunewald J, 2006, MICROBIOL MOL BIOL R, V70, P121, DOI 10.1128/MMBR.70.1.121-146.2006; Ishikawa J, 1999, FEMS MICROBIOL LETT, V174, P251, DOI 10.1111/j.1574-6968.1999.tb13576.x; KELLER U, 1992, J BIOL CHEM, V267, P11745; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; KINOSHITA M, 1989, TETRAHEDRON LETT, V30, P7419, DOI 10.1016/S0040-4039(00)70713-1; Koehn FE, 2005, NAT REV DRUG DISCOV, V4, P206, DOI 10.1038/nrd1657; Lambalot RH, 1996, CHEM BIOL, V3, P923, DOI 10.1016/S1074-5521(96)90181-7; Lin SJ, 2009, P NATL ACAD SCI USA, V106, P4183, DOI 10.1073/pnas.0808880106; MAEDA K, 1957, J ANTIBIOT, V10, P94; MAEDA KENJI, 1953, JOUR ANTIBIOTICS [TOKYO], V6, P140; Magarvey NA, 2006, ACS CHEM BIOL, V1, P766, DOI 10.1021/cb6004307; Magarvey NA, 2006, J AM CHEM SOC, V128, P10698, DOI 10.1021/ja0640187; Marahiel MA, 1997, CHEM REV, V97, P2651, DOI 10.1021/cr960029e; Mast Y, 2011, MICROB BIOTECHNOL, V4, P192, DOI 10.1111/j.1751-7915.2010.00213.x; May JJ, 2001, J BIOL CHEM, V276, P7209, DOI 10.1074/jbc.M009140200; Molnar I, 2000, CHEM BIOL, V7, P97, DOI 10.1016/S1074-5521(00)00075-2; NAKANO MM, 1992, MOL GEN GENET, V232, P313, DOI 10.1007/BF00280011; Namwat W, 2002, J BACTERIOL, V184, P4811, DOI 10.1128/JB.184.17.4811-4818.2002; Namwat W, 2002, GENE, V286, P283, DOI 10.1016/S0378-1119(02)00424-9; OGAWARA H, 1968, CHEM PHARM BULL, V16, P679; OGAWARA H, 1968, BIOCHEMISTRY-US, V7, P3296, DOI 10.1021/bi00849a037; Olsen JG, 1999, FEBS LETT, V460, P46, DOI 10.1016/S0014-5793(99)01303-4; Orsburn BC, 2010, MOL MICROBIOL, V75, P178, DOI 10.1111/j.1365-2958.2009.06975.x; Quadri LEN, 1998, BIOCHEMISTRY-US, V37, P1585, DOI 10.1021/bi9719861; Ramaswamy AV, 2007, J NAT PROD, V70, P1977, DOI 10.1021/np0704250; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Rausch C, 2005, NUCLEIC ACIDS RES, V33, P5799, DOI 10.1093/nar/gki885; Reid R, 2003, BIOCHEMISTRY-US, V42, P72, DOI 10.1021/bi0268706; Rose TM, 2003, NUCLEIC ACIDS RES, V31, P3763, DOI 10.1093/nar/gkg524; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCHLUMBOHM W, 1990, J BIOL CHEM, V265, P2156; Schmoock G, 2005, J BIOL CHEM, V280, P4339, DOI 10.1074/jbc.M411026200; Shen B, 2001, J IND MICROBIOL BIOT, V27, P378, DOI 10.1038/sj.jim.7000194; Stachelhaus T, 1999, CHEM BIOL, V6, P493, DOI 10.1016/S1074-5521(99)80082-9; Staunton J, 2001, NAT PROD REP, V18, P380, DOI 10.1039/a909079g; Thibaut D, 1997, J BACTERIOL, V179, P697, DOI 10.1128/jb.179.3.697-704.1997; UMBARGER HE, 1978, ANNU REV BIOCHEM, V47, P533, DOI 10.1146/annurev.bi.47.070178.002533; Waters B, 2002, J ANTIBIOT, V55, P407, DOI 10.7164/antibiotics.55.407; Weber T, 2000, STRUCT FOLD DES, V8, P407, DOI 10.1016/S0969-2126(00)00120-9; Wolpert M, 2007, MICROBIOL-SGM, V153, P1413, DOI 10.1099/mic.0.2006/002998-0; YUAN L, 1983, ANTIBIOTICS, V8, P380; Zaleta-Rivera K, 2006, BIOCHEMISTRY-US, V45, P2561, DOI 10.1021/bi052085s; Zhang WJ, 2010, BIOCHEMISTRY-US, V49, P9946, DOI 10.1021/bi101539b	58	40	44	0	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20648	20657		10.1074/jbc.M110.180000	http://dx.doi.org/10.1074/jbc.M110.180000			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21454714	Green Submitted, hybrid, Green Published			2022-12-25	WOS:000291267600051
J	Xiao, L; Hu, C; Feng, CZ; Chen, YZ				Xiao, Lin; Hu, Chun; Feng, Chunzhi; Chen, Yizhang			Switching of N-Methyl-D-aspartate (NMDA) Receptor-favorite Intracellular Signal Pathways from ERK1/2 Protein to p38 Mitogen-activated Protein Kinase Leads to Developmental Changes in NMDA Neurotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL CELL-DEATH; MEDIATED BIDIRECTIONAL CONTROL; CULTURED HIPPOCAMPAL-NEURONS; CEREBELLAR GRANULE CELLS; LONG-TERM POTENTIATION; DIFFERENTIAL ROLES; GLUTAMATE RECEPTORS; CORTICAL-NEURONS; IN-VITRO; TYROSINE-PHOSPHATASE	Excitotoxicity mediated by overactivation of N-methyl-D-aspartate receptors (NMDARs) has been implicated in a variety of neuropathological conditions in the central nervous system (CNS). It has been suggested that N-methyl-D-aspartate (NMDA) neurotoxicity is developmentally regulated, but the definite pattern of the regulation has been controversial, and the underlying mechanism remains largely unknown. Here, we show that NMDA treatment leads to significant cell death in mature (9 and 12 days in vitro) hippocampal neurons or hippocampi of young postnatal day 12 and adult rats but not in immature (3 and 6 days in vitro) neurons or embryonic day 18 and neonatal rat hippocampi. In contrast, NMDA promotes survival of immature neurons against tropic deprivation. Interestingly, it is found that NMDA preferentially activates p38 MAPK in mature neuron and adult rat hippocampus, but it favors ERK1/2 activation in immature neuron and postnatal day 0 rat hippocampus. Moreover, it is shown that NMDA neurotoxicity in mature neuron is mediated via p38 MAPK activation, and neuroprotection in immature neuron is mediated via ERK1/2 activation, whereas all these effects are NR2B-containing NMDAR-dependent, as well as Ca2+-dependent. We also revealed that mature and immature neurons showed no difference in the amplitude of NMDA-induced intracellular calcium ([Ca2+](i)) increase. However, the basal level of [Ca2+](i) is shown to elevate with the maturation of neuron, and this elevation is attributable to the changes in NMDA neurotoxicity but not to the switch of the NMDAR signaling pathway. Taken together, our results suggest that a switch of NMDA receptor-favorite intracellular signal pathways from ERK1/2 to p38 MAPK and the elevated basal level of [Ca2+](i) with age might be critical for the developmental changes in NMDA neurotoxicity in the hippocampal neuron.	[Xiao, Lin; Hu, Chun; Chen, Yizhang] Second Mil Med Univ, Inst Neurosci, Key Lab Mol Neurobiol, Minist Educ,Neurosci Ctr,Changzheng Hosp, Shanghai 200433, Peoples R China; [Feng, Chunzhi] Fudan Univ, Univ Hosp, Shanghai 200433, Peoples R China	Naval Medical University; Fudan University	Xiao, L (corresponding author), Second Mil Med Univ, Inst Neurosci, Key Lab Mol Neurobiol, Minist Educ,Neurosci Ctr,Changzheng Hosp, Shanghai 200433, Peoples R China.	liuyangxiaolin@yahoo.com.cn; yzchen0928@yahoo.com			National Natural Science Foundation of China [30900431]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Grant 30900431 from the National Natural Science Foundation of China.	ABELE AE, 1990, NEURON, V4, P413, DOI 10.1016/0896-6273(90)90053-I; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Auberson YP, 2002, BIOORG MED CHEM LETT, V12, P1099, DOI 10.1016/S0960-894X(02)00074-4; Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; BOULANGER LM, 1995, J NEUROSCI, V15, P1532; BRUCE AJ, 1995, EXP NEUROL, V132, P209, DOI 10.1016/0014-4886(95)90026-8; Bubenikova-Valesova V, 2006, NEUROCHEM INT, V48, P515, DOI 10.1016/j.neuint.2006.01.019; Cao J, 2004, J BIOL CHEM, V279, P35903, DOI 10.1074/jbc.M402353200; Chandler LJ, 2001, J BIOL CHEM, V276, P2627, DOI 10.1074/jbc.M003390200; Chen HJ, 1998, NEURON, V20, P895, DOI 10.1016/S0896-6273(00)80471-7; Chen J, 2009, EUR J NEUROSCI, V29, P287, DOI 10.1111/j.1460-9568.2008.06590.x; Chen M, 2008, STROKE, V39, P3042, DOI 10.1161/STROKEAHA.108.521898; Chen Q, 2007, J NEUROSCI, V27, P542, DOI 10.1523/JNEUROSCI.3607-06.2007; Cheng CL, 1999, BRAIN RES, V849, P97, DOI 10.1016/S0006-8993(99)01995-2; Chohan MO, 2006, J ALZHEIMERS DIS, V10, P81; Chu CT, 2004, EUR J BIOCHEM, V271, P2060, DOI 10.1111/j.1432-1033.2004.04132.x; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; EIMERL S, 1994, J NEUROCHEM, V62, P1223; Fischer G, 1997, J PHARMACOL EXP THER, V283, P1285; Fogal B, 2005, NEUROSCIENCE, V132, P929, DOI 10.1016/j.neuroscience.2005.01.036; FRANDSEN A, 1990, INT J DEV NEUROSCI, V8, P209, DOI 10.1016/0736-5748(90)90013-R; Fredriksson A, 2004, BEHAV BRAIN RES, V153, P367, DOI 10.1016/j.bbr.2003.12.026; Hardingham GE, 2002, BBA-PROTEINS PROTEOM, V1600, P148, DOI 10.1016/S1570-9639(02)00455-7; Hardingham GE, 2006, J PHYSIOL-LONDON, V572, P614, DOI 10.1113/jphysiol.2006.109603; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 2003, TRENDS NEUROSCI, V26, P81, DOI 10.1016/S0166-2236(02)00040-1; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Harper SJ, 2001, CELL SIGNAL, V13, P299, DOI 10.1016/S0898-6568(01)00148-6; HARTLEY DM, 1993, J NEUROSCI, V13, P1993; Heng MY, 2009, J NEUROSCI, V29, P3200, DOI 10.1523/JNEUROSCI.5599-08.2009; Hetman M, 2006, CURR TOP MED CHEM, V6, P787, DOI 10.2174/156802606777057553; Hetman M, 2004, EUR J BIOCHEM, V271, P2050, DOI 10.1111/j.1432-1033.2004.04133.x; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Ivanov A, 2006, J PHYSIOL-LONDON, V572, P789, DOI 10.1113/jphysiol.2006.105510; Johnson KA, 2009, CNS NEUROL DISORD-DR, V8, P475, DOI 10.2174/187152709789824606; Kalia LV, 2008, LANCET NEUROL, V7, P742, DOI 10.1016/S1474-4422(08)70165-0; Kawasaki H, 1997, J BIOL CHEM, V272, P18518, DOI 10.1074/jbc.272.30.18518; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Kim MJ, 2005, NEURON, V46, P745, DOI 10.1016/j.neuron.2005.04.031; King AE, 2006, J COMP NEUROL, V498, P277, DOI 10.1002/cne.21053; Komiyama NH, 2002, J NEUROSCI, V22, P9721; Krapivinsky G, 2003, NEURON, V40, P775, DOI 10.1016/S0896-6273(03)00645-7; LAI TW, 2011, TRENDS MOL IN PRESS; Li JH, 1998, EUR J NEUROSCI, V10, P1704, DOI 10.1046/j.1460-9568.1998.00169.x; Li SM, 2006, J NEUROSCI, V26, P1721, DOI 10.1523/JNEUROSCI.3990-05.2006; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Liu XB, 2004, J NEUROSCI, V24, P8885, DOI 10.1523/JNEUROSCI.2476-04.2004; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; Liu Z, 1996, DEV BRAIN RES, V97, P178, DOI 10.1016/S0165-3806(96)00141-1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lynch DR, 2001, CURR DRUG TARGETS, V2, P215, DOI 10.2174/1389450013348434; MacDonald JF, 2006, TRENDS NEUROSCI, V29, P75, DOI 10.1016/j.tins.2005.12.001; Marks JD, 2000, DEV BRAIN RES, V124, P101, DOI 10.1016/S0165-3806(00)00096-1; Martel MA, 2009, NEUROSCIENCE, V158, P334, DOI 10.1016/j.neuroscience.2008.01.080; Massey PV, 2004, J NEUROSCI, V24, P7821, DOI 10.1523/JNEUROSCI.1697-04.2004; MCDONALD JW, 1988, BRAIN RES, V459, P200, DOI 10.1016/0006-8993(88)90306-X; Mizuta I, 1998, CELL MOL LIFE SCI, V54, P721, DOI 10.1007/s000180050199; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Paul S, 2003, NAT NEUROSCI, V6, P34, DOI 10.1038/nn989; PETERSON C, 1989, DEV BRAIN RES, V48, P187, DOI 10.1016/0165-3806(89)90075-8; Poddar R, 2010, J NEUROCHEM, V115, P1350, DOI 10.1111/j.1471-4159.2010.07035.x; Rao A, 1998, J NEUROSCI, V18, P1217; Sala C, 2000, J NEUROSCI, V20, P3529, DOI 10.1523/JNEUROSCI.20-10-03529.2000; Sattler R, 1998, J NEUROCHEM, V71, P2349; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Sherwood NM., 1970, STEREOTAXIC ATLAS DE; Soriano SG, 2010, ANESTHESIOLOGY, V112, P1155, DOI 10.1097/ALN.0b013e3181d3e0c2; Stocca G, 1998, J PHYSIOL-LONDON, V507, P13, DOI 10.1111/j.1469-7793.1998.013bu.x; Thomas CG, 2006, J NEUROPHYSIOL, V95, P1727, DOI 10.1152/jn.00771.2005; Tian XJ, 2004, EMBO J, V23, P1567, DOI 10.1038/sj.emboj.7600151; Tovar KR, 1999, J NEUROSCI, V19, P4180; Tu WH, 2010, CELL, V140, P222, DOI 10.1016/j.cell.2009.12.055; Wang JQ, 2007, J NEUROCHEM, V100, P1, DOI 10.1111/j.1471-4159.2006.04208.x; WATANABE M, 1992, NEUROREPORT, V3, P1138, DOI 10.1097/00001756-199212000-00027; Waxman EA, 2005, J BIOL CHEM, V280, P29322, DOI 10.1074/jbc.M502080200; Wenzel A, 1997, J NEUROCHEM, V68, P469; XIA Y, 1995, NEUROCHEM RES, V20, P617, DOI 10.1007/BF01694545; Xiao L, 2005, ENDOCRINOLOGY, V146, P4036, DOI 10.1210/en.2004-1652; Xiao L, 2010, MOL ENDOCRINOL, V24, P497, DOI 10.1210/me.2009-0422; Xu J, 2009, J NEUROSCI, V29, P9330, DOI 10.1523/JNEUROSCI.2212-09.2009; ZHONG J, 1994, MOL PHARMACOL, V45, P846; Zhou M, 2006, J NEUROSCI, V26, P2956, DOI 10.1523/JNEUROSCI.4299-05.2006; Zhou XJ, 2009, J NEUROSCI RES, V87, P2632, DOI 10.1002/jnr.22103; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8	85	25	27	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20175	20193		10.1074/jbc.M110.188854	http://dx.doi.org/10.1074/jbc.M110.188854			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21474451	hybrid, Green Published			2022-12-25	WOS:000291267600006
J	Daleke, MH; Cascioferro, A; de Punder, K; Ummels, R; Abdallah, AM; van der Wel, N; Peters, PJ; Luirink, J; Manganelli, R; Bitter, W				Daleke, Maria H.; Cascioferro, Alessandro; de Punder, Karin; Ummels, Roy; Abdallah, Abdallah M.; van der Wel, Nicole; Peters, Peter J.; Luirink, Joen; Manganelli, Riccardo; Bitter, Wilbert			Conserved Pro-Glu (PE) and Pro-Pro-Glu (PPE) Protein Domains Target LipY Lipases of Pathogenic Mycobacteria to the Cell Surface via the ESX-5 Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PGRS PROTEINS; SIGNAL PEPTIDE; GENE-CLUSTER; TUBERCULOSIS; SECRETION; VIRULENCE; TRIACYLGLYCEROL; PLASMID; LOCALIZATION; EXPRESSION	The type VII secretion system ESX-5 is a major pathway for export of PE and PPE proteins in pathogenic mycobacteria. These mycobacteria-specific protein families are characterized by conserved N-terminal domains of 100 and 180 amino acids, which contain the proline-glutamic acid (PE) and proline-proline-glutamic acid (PPE) motifs after which they are named. Here we investigated secretion of the triacylglycerol lipase LipY, which in fast-growing mycobacteria contains a signal sequence, but in slow-growing species appears to have replaced the signal peptide with a PE or PPE domain. Selected LipY homologues were expressed in wild-type Mycobacterium marinum and its corresponding ESX-5 mutant, and localization of the proteins was investigated by immunoblotting and electron microscopy. Our study shows that Mycobacterium tuberculosis PE-LipY (LipY(tub)) and M. marinum PPE-LipY (LipY(mar)) are both secreted to the bacterial surface in an ESX-5-dependent fashion. After transport, the PE/PPE domains are removed by proteolytic cleavage. In contrast, Mycobacterium gilvum LipY, which has a signal sequence, is not transported to the cell surface. Furthermore, we show that LipY(tub) and LipY(mar) require their respective PE and PPE domains for ESX-5-dependent secretion. The role of the PE domain in ESX-5 secretion was confirmed in a whole cell lipase assay, in which wild-type bacteria expressing full-length LipY(tub), but not LipY(tub) lacking its PE domain, were shown to hydrolyze extracellular lipids. In conclusion, both PE and PPE domains contain a signal required for secretion of LipY by the ESX-5 system, and these domains are proteolytically removed upon translocation.	[Daleke, Maria H.; Ummels, Roy; Abdallah, Abdallah M.; Bitter, Wilbert] Vrije Univ Amsterdam, Dept Med Microbiol & Infect Control, Med Ctr, NL-1081 BT Amsterdam, Netherlands; [Daleke, Maria H.; Luirink, Joen; Bitter, Wilbert] Vrije Univ Amsterdam, Dept Mol Microbiol, NL-1081 HV Amsterdam, Netherlands; [Cascioferro, Alessandro; Manganelli, Riccardo] Univ Padua, Dept Histol Microbiol & Med Biotechnol, I-35121 Padua, Italy; [de Punder, Karin; Abdallah, Abdallah M.; van der Wel, Nicole; Peters, Peter J.] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Padua; Netherlands Cancer Institute	Bitter, W (corresponding author), Boechorststr 7, NL-1081 BT Amsterdam, Netherlands.	w.bitter@vumc.nl	Manganelli, Riccardo/A-7361-2009; Bitter, Wilbert/ABG-3726-2020; Bitter, Wilbert/AAA-6872-2019; Van Der Wel, Nicole/AAE-7569-2020; Bitter, W/CAJ-5778-2022; Luirink, Joen/AAB-8658-2021; Abdallah, Abdallah Musa/AAW-1826-2020; Cascioferro, Alessandro/E-3445-2017	Manganelli, Riccardo/0000-0003-0940-7336; Bitter, Wilbert/0000-0001-8347-6511; Luirink, J./0000-0001-8431-0804; Cascioferro, Alessandro/0000-0001-7751-7348; Abdallah, Abdallah Musa/0000-0002-9773-8700; van der Wel, Nicole/0000-0001-6392-3417	Netherlands Organization for Scientific Research (NWO); European Community [201762]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); European Community(European Commission)	This work was supported by funding from an "Earth and Life Sciences (ALW) Open Program" grant from the Netherlands Organization for Scientific Research (NWO) (to M. H. D.) and from the European Community Seventh Framework Programme (FP7/2007-2013) under Grant Agreement 201762.	Abdallah AM, 2009, MOL MICROBIOL, V73, P329, DOI 10.1111/j.1365-2958.2009.06783.x; Abdallah AM, 2006, MOL MICROBIOL, V62, P667, DOI 10.1111/j.1365-2958.2006.05409.x; Bachrach G, 2000, MICROBIOL-UK, V146, P297, DOI 10.1099/00221287-146-2-297; Banu S, 2002, MOL MICROBIOL, V44, P9, DOI 10.1046/j.1365-2958.2002.02813.x; Basu S, 2007, J BIOL CHEM, V282, P1039, DOI 10.1074/jbc.M604379200; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Brennan MJ, 2001, INFECT IMMUN, V69, P7326, DOI 10.1128/IAI.69.12.7326-7333.2001; Brodin P, 2004, TRENDS MICROBIOL, V12, P500, DOI 10.1016/j.tim.2004.09.007; Carlsson F, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000285; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Cascioferro A, 2007, MOL MICROBIOL, V66, P1536, DOI 10.1111/j.1365-2958.2007.06023.x; Champion PAD, 2007, CELL MICROBIOL, V9, P1376, DOI 10.1111/j.1462-5822.2007.00943.x; Champion PAD, 2006, SCIENCE, V313, P1632, DOI 10.1126/science.1131167; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; DALEKE MH, UNPUB; Daniel J, 2004, J BACTERIOL, V186, P5017, DOI 10.1128/jb.186.15.5017-5030.2004; DeanRoss D, 1996, APPL MICROBIOL BIOT, V46, P307, DOI 10.1007/s002530050822; Deb C, 2006, J BIOL CHEM, V281, P3866, DOI 10.1074/jbc.M505556200; Delogu G, 2004, MOL MICROBIOL, V52, P725, DOI 10.1111/j.1365-2958.2004.04007.x; Fortune SM, 2005, P NATL ACAD SCI USA, V102, P10676, DOI 10.1073/pnas.0504922102; Gao LY, 2004, MOL MICROBIOL, V53, P1677, DOI 10.1111/j.1365-2958.2004.04261.x; Gey van Pittius NC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-95; GHRAYEB J, 1985, J BIOL CHEM, V260, P961; Guinn KM, 2004, MOL MICROBIOL, V51, P359, DOI 10.1046/j.1365-2958.2003.03844.x; Hayward CMM, 1999, VACCINE, V17, P1272, DOI 10.1016/S0264-410X(98)00350-8; HERMANS PWM, 1992, J BACTERIOL, V174, P4157, DOI 10.1128/jb.174.12.4157-4165.1992; Leung AS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-413; Li YJ, 2005, CELL MICROBIOL, V7, P539, DOI 10.1111/j.1462-5822.2004.00484.x; MacGurn JA, 2005, MOL MICROBIOL, V57, P1653, DOI 10.1111/j.1365-2958.2005.04800.x; McLaughlin B, 2007, PLOS PATHOG, V3, P1051, DOI 10.1371/journal.ppat.0030105; Mishra KC, 2008, INFECT IMMUN, V76, P127, DOI 10.1128/IAI.00410-07; Munoz-Elias EJ, 2005, NAT MED, V11, P638, DOI 10.1038/nm1252; Nair S, 2009, J IMMUNOL, V183, P6269, DOI 10.4049/jimmunol.0901367; Ohol YM, 2010, CELL HOST MICROBE, V7, P210, DOI 10.1016/j.chom.2010.02.006; POULET S, 1995, ARCH MICROBIOL, V163, P87, DOI 10.1007/s002030050176; Puttinaowarat S., 2000, Fish Veterinary Journal, P6; Pym AS, 2003, NAT MED, V9, P533, DOI 10.1038/nm859; Raghavan S, 2008, NATURE, V454, P717, DOI 10.1038/nature07219; Ramakrishnan L, 2000, SCIENCE, V288, P1436, DOI 10.1126/science.288.5470.1436; RAMAKRISHNAN L, 1994, INFECT IMMUN, V62, P3222, DOI 10.1128/IAI.62.8.3222-3229.1994; Riley R, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000174; Sampson SL, 2004, INFECT IMMUN, V72, P3031, DOI 10.1128/IAI.72.5.3031-3037.2004; Sampson SL, 2001, TUBERCULOSIS, V81, P305, DOI 10.1054/tube.2001.0304; Sani M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000794; SEGAL W, 1956, J BACTERIOL, V72, P132, DOI 10.1128/JB.72.2.132-141.1956; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Srivastava V, 2007, MICROBIOL-SGM, V153, P659, DOI 10.1099/mic.0.2006/000547-0; Stanley SA, 2003, P NATL ACAD SCI USA, V100, P13001, DOI 10.1073/pnas.2235593100; Stolt P, 1996, MICROBIOL-SGM, V142, P2795, DOI 10.1099/13500872-142-10-2795; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; SUOMINEN I, 1995, MICROBIOL-UK, V141, P649, DOI 10.1099/13500872-141-3-649; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tekaia F., 1999, Tubercle and Lung Disease, V79, P329, DOI 10.1054/tuld.1999.0220; VANDENBROUCKEGR.J, 2007, NAT REV MICROBIOL, V5, P883; VANPITTIUS NCG, 2001, GENOME BIOL, V2, DOI DOI 10.1186/GB-2001-2-10-RESEARCH0044	55	106	112	1	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					19024	19034		10.1074/jbc.M110.204966	http://dx.doi.org/10.1074/jbc.M110.204966			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21471225	Green Published, hybrid			2022-12-25	WOS:000290785700073
J	Dong, L; Vecchio, AJ; Sharma, NP; Jurban, BJ; Malkowski, MG; Smith, WL				Dong, Liang; Vecchio, Alex J.; Sharma, Narayan P.; Jurban, Brice J.; Malkowski, Michael G.; Smith, William L.			Human Cyclooxygenase-2 Is a Sequence Homodimer That Functions as a Conformational Heterodimer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTAGLANDIN-H SYNTHASE; ARACHIDONIC-ACID; SUBCELLULAR-LOCALIZATION; PROTEIN-DEGRADATION; MOLECULAR-GRAPHICS; GENETIC-VARIANTS; FATTY-ACIDS; CROSS-TALK; CRYSTALLOGRAPHY; BINDING	Prostaglandin endoperoxide H synthases 1 and 2, also known as cyclooxygenases (COXs) 1 and 2, convert arachidonic acid (AA) to prostaglandin endoperoxide H-2. Prostaglandin endoperoxide H synthases are targets of nonspecific nonsteroidal anti-inflammatory drugs and COX-2-specific inhibitors called coxibs. PGHS-2 is a sequence homodimer. Each monomer has a peroxidase and a COX active site. We find that human PGHS-2 functions as a conformational heterodimer having a catalytic monomer (E-cat) and an allosteric monomer (E-allo). Heme binds tightly only to the peroxidase site of E-cat, whereas substrates, as well as certain inhibitors (e.g. celecoxib), bind the COX site of E-cat. E-cat is regulated by E-allo in a manner dependent on what ligand is bound to E-allo. Substrate and nonsubstrate fatty acids (FAs) and some COX inhibitors (e. g. naproxen) preferentially bind to the COX site of E-allo. AA can bind to E-cat and E-allo, but the affinity of AA for E-allo is 25 times that for E-cat. Palmitic acid, an efficacious stimulator of human PGHS-2, binds only E-allo in palmitic acid/murine PGHS-2 co-crystals. Nonsubstrate FAs can potentiate or attenuate actions of COX inhibitors depending on the FA and whether the inhibitor binds E-cat or E-allo. Our studies suggest that the concentration and composition of the free FA pool in the environment in which PGHS-2 functions in cells, the FA tone, is a key factor regulating PGHS-2 activity and its responses to COX inhibitors. We suggest that differences in FA tone occurring with different diets will likely affect both baseline prostanoid synthesis and responses to COX inhibitors.	[Dong, Liang; Sharma, Narayan P.; Jurban, Brice J.; Smith, William L.] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Vecchio, Alex J.; Malkowski, Michael G.] SUNY Buffalo, Hauptman Woodward Med Res Inst, Buffalo, NY 14203 USA; [Vecchio, Alex J.; Malkowski, Michael G.] SUNY Buffalo, Dept Biol Struct, Buffalo, NY 14203 USA	University of Michigan System; University of Michigan; Hauptman Woodward Medical Research Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Smith, WL (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, 5301 MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	smithww@umich.edu	Malkowski, Michael G/G-4939-2011	Malkowski, Michael G/0000-0003-1025-0014; Vecchio, Alex/0000-0002-4222-7874; Malkowski, Michael/0000-0002-1203-7463	National Institutes of Health [GM 068848, GM 077176]; National Science Foundation [DMR-0225180]; National Institutes of Health, NCRR [RR-01646]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068848, R01GM077176] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health, NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM 068848 (to W. L. S.) and GM 077176 (to M. G. M.). This work was based on research conducted at the Cornell High Energy Synchrotron Source (CHESS), which is supported by National Science Foundation Award DMR-0225180, using the Macromolecular Diffraction at CHESS (MacCHESS) facility, which is supported by National Institutes of Health Award RR-01646 from NCRR.	Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burian M, 2005, PHARMACOL THERAPEUT, V107, P139, DOI 10.1016/j.pharmthera.2005.02.004; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dodson EJ, 1997, METHOD ENZYMOL, V277, P620, DOI 10.1016/S0076-6879(97)77034-4; Duncan T, 1999, J LIPID RES, V40, P1222; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gorski J, 1998, MOL CELL BIOCHEM, V178, P113, DOI 10.1023/A:1006820907955; Grosser T, 2010, ANNU REV MED, V61, P17, DOI 10.1146/annurev-med-011209-153129; HAMBERG M, 1967, J BIOL CHEM, V242, P5336; Huber WJ, 2008, ANAL BIOCHEM, V373, P167, DOI 10.1016/j.ab.2007.10.010; Kang YJ, 2007, PROG LIPID RES, V46, P108, DOI 10.1016/j.plipres.2007.01.001; Kiefer JR, 2000, NATURE, V405, P97, DOI 10.1038/35011103; KULMACZ RJ, 1984, J BIOL CHEM, V259, P6358; KULMACZ RJ, 1985, J BIOL CHEM, V260, P2572; LAGARDE M, 1984, BIOMED BIOCHIM ACTA, V43, pS319; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lapicque F, 2000, CLIN PHARMACOKINET, V39, P369, DOI 10.2165/00003088-200039050-00005; Liu JY, 2007, J BIOL CHEM, V282, P18233, DOI 10.1074/jbc.M701235200; Malkowski MG, 2000, SCIENCE, V289, P1933, DOI 10.1126/science.289.5486.1933; Malkowski MG, 2001, J BIOL CHEM, V276, P37547, DOI 10.1074/jbc.M105982200; Mathias RA, 2010, J LIPID RES, V51, P2766, DOI 10.1194/jlr.M008359; Mbonye UR, 2008, J BIOL CHEM, V283, P8611, DOI 10.1074/jbc.M710137200; McAdam BF, 1999, P NATL ACAD SCI USA, V96, P272, DOI 10.1073/pnas.96.1.272; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Muth-Selbach US, 1999, ANESTHESIOLOGY, V91, P231, DOI 10.1097/00000542-199907000-00032; OTTO JC, 1994, J BIOL CHEM, V269, P19868; PERCIVAL MD, 1994, ARCH BIOCHEM BIOPHYS, V315, P111, DOI 10.1006/abbi.1994.1478; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Prusakiewicz JJ, 2009, BIOCHEMISTRY-US, V48, P7353, DOI 10.1021/bi900999z; Rimon G, 2010, P NATL ACAD SCI USA, V107, P28, DOI 10.1073/pnas.0909765106; ROLLINS TE, 1980, J BIOL CHEM, V255, P4872; Rouzer CA, 2009, J LIPID RES, V50, pS29, DOI 10.1194/jlr.R800042-JLR200; Schneider C, 2007, CHEM BIOL, V14, P473, DOI 10.1016/j.chembiol.2007.04.007; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sharma NP, 2010, MOL PHARMACOL, V77, P979, DOI 10.1124/mol.109.063115; Sidhu RS, 2010, BIOCHEMISTRY-US, V49, P7069, DOI 10.1021/bi1003298; Simopoulos AP, 2010, EXP BIOL MED, V235, P785, DOI 10.1258/ebm.2010.009298; Smith WL, 2008, TRENDS BIOCHEM SCI, V33, P27, DOI 10.1016/j.tibs.2007.09.013; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Spencer AG, 1999, J BIOL CHEM, V274, P32936, DOI 10.1074/jbc.274.46.32936; Spencer AG, 1998, J BIOL CHEM, V273, P9886, DOI 10.1074/jbc.273.16.9886; Thuresson ED, 2001, J BIOL CHEM, V276, P10358, DOI 10.1074/jbc.M009378200; Tsai AL, 2010, ARCH BIOCHEM BIOPHYS, V493, P103, DOI 10.1016/j.abb.2009.08.019; Tsai AL, 2002, J BIOL CHEM, V277, P38311, DOI 10.1074/jbc.M206961200; van der Donk WA, 2002, BIOCHEMISTRY-US, V41, P15451, DOI 10.1021/bi026938h; Vecchio AJ, 2010, J BIOL CHEM, V285, P22152, DOI 10.1074/jbc.M110.119867; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Xiao GS, 1998, J BIOL CHEM, V273, P6801, DOI 10.1074/jbc.273.12.6801; Yu Y, 2005, J CLIN INVEST, V115, P986, DOI 10.1172/JCI23683; Yu Y, 2007, J BIOL CHEM, V282, P1498, DOI 10.1074/jbc.M609930200; Yuan C, 2006, P NATL ACAD SCI USA, V103, P6142, DOI 10.1073/pnas.0601805103; Yuan C, 2009, J BIOL CHEM, V284, P10046, DOI 10.1074/jbc.M808634200	54	77	81	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					19035	19046		10.1074/jbc.M111.231969	http://dx.doi.org/10.1074/jbc.M111.231969			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21467029	hybrid, Green Published			2022-12-25	WOS:000290785700074
J	Viktorovskaya, OV; Appling, FD; Schneider, DA				Viktorovskaya, Olga V.; Appling, Francis D.; Schneider, David A.			Yeast Transcription Elongation Factor Spt5 Associates with RNA Polymerase I and RNA Polymerase II Directly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; COMPLEX; PROTEIN; RECRUITMENT; BINDING; DSIF; ARCHITECTURE; MACHINERY; SPT4-SPT5; SUBUNIT	Spt5 is a transcription factor conserved in all three domains of life. Spt5 homologues from bacteria and archaea bind the largest subunit of their respective RNA polymerases. Here we demonstrate that Spt5 directly associates with RNA polymerase (Pol) I and RNA Pol II in yeast through its central region containing conserved NusG N-terminal homology and KOW domains. Deletion analysis of SPT5 supports our biochemical data, demonstrating the importance of the KOW domains in Spt5 function. Far Western blot analysis implicates A190 of Pol I as well as Rpb1 of Pol II in binding Spt5. Three additional subunits of Pol I may also participate in this interaction. One of these subunits, A49, has known roles in transcription elongation by Pol I. Interestingly, spt5 truncation mutations suppress the cold-sensitive phenotype of rpa49 Delta strain, which lacks the A49 subunit in the Pol I complex. Finally, we observed that Spt5 directly binds to an essential Pol I transcription initiation factor, Rrn3, and to the ribosomal RNA. Based on these data, we propose a model in which Spt5 is recruited to the rDNA early in transcription and propose that it plays an important role in ribosomal RNA synthesis through direct binding to the Pol I complex.	[Viktorovskaya, Olga V.; Appling, Francis D.; Schneider, David A.] Univ Alabama, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Schneider, DA (corresponding author), 720 20th St S,Rm 442, Birmingham, AL 35294 USA.	dschneid@uab.edu		Schneider, David/0000-0003-0635-5091	National Institutes of Health [GM084946]; Alabama Health Science Foundation; University of Alabama at Birmingham Comprehensive Cancer Center Young Supporters Board; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084946] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alabama Health Science Foundation; University of Alabama at Birmingham Comprehensive Cancer Center Young Supporters Board; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM084946 (to D. A. S.). This work was also supported by the Alabama Health Science Foundation and grants from the University of Alabama at Birmingham Comprehensive Cancer Center Young Supporters Board.	Anderson SJ, 2011, J BIOL CHEM, V286, P18816, DOI 10.1074/jbc.M110.202101; Arabi A, 2005, NAT CELL BIOL, V7, P303, DOI 10.1038/ncb1225; Beckouet F, 2008, MOL CELL BIOL, V28, P1596, DOI 10.1128/MCB.01464-07; Belogurov GA, 2007, MOL CELL, V26, P117, DOI 10.1016/j.molcel.2007.02.021; Bier M, 2004, FEBS LETT, V564, P41, DOI 10.1016/S0014-5793(04)00311-4; Claypool JA, 2004, MOL BIOL CELL, V15, P946, DOI 10.1091/mbc.E03-08-0594; Cramer P, 2002, CURR OPIN STRUC BIOL, V12, P89, DOI 10.1016/S0959-440X(02)00294-4; Ding BJ, 2010, J BIOL CHEM, V285, P5317, DOI 10.1074/jbc.M109.082818; EDMONDSON D, 2001, CURRENT PROTOCOLS PR; Gadal O, 1997, MOL CELL BIOL, V17, P1787, DOI 10.1128/MCB.17.4.1787; Guo M, 2008, STRUCTURE, V16, P1649, DOI 10.1016/j.str.2008.08.013; Hartzog GA, 1998, GENE DEV, V12, P357, DOI 10.1101/gad.12.3.357; Hellman LM, 2007, NAT PROTOC, V2, P1849, DOI 10.1038/nprot.2007.249; Ivanov D, 2000, MOL CELL BIOL, V20, P2970, DOI 10.1128/MCB.20.9.2970-2983.2000; Keener J, 1998, J BIOL CHEM, V273, P33795, DOI 10.1074/jbc.273.50.33795; Klein BJ, 2011, P NATL ACAD SCI USA, V108, P546, DOI 10.1073/pnas.1013828108; Kuhn CD, 2007, CELL, V131, P1260, DOI 10.1016/j.cell.2007.10.051; LILJELUND P, 1992, P NATL ACAD SCI USA, V89, P9302, DOI 10.1073/pnas.89.19.9302; Lindstrom DL, 2001, GENETICS, V159, P487; Liu Y, 2009, MOL CELL BIOL, V29, P4852, DOI 10.1128/MCB.00609-09; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Martinez-Rucobo FW, 2011, EMBO J, V30, P1302, DOI 10.1038/emboj.2011.64; Missra A, 2010, P NATL ACAD SCI USA, V107, P11301, DOI 10.1073/pnas.1000681107; Mooney RA, 2009, J MOL BIOL, V391, P341, DOI 10.1016/j.jmb.2009.05.078; Moss T, 2007, CELL MOL LIFE SCI, V64, P29, DOI 10.1007/s00018-006-6278-1; Peyroche G, 2000, EMBO J, V19, P5473, DOI 10.1093/emboj/19.20.5473; Philippi A, 2010, NUCLEIC ACIDS RES, V38, P5315, DOI 10.1093/nar/gkq264; Ponting CP, 2002, NUCLEIC ACIDS RES, V30, P3643, DOI 10.1093/nar/gkf498; Rondon AG, 2003, EMBO J, V22, P612, DOI 10.1093/emboj/cdg047; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Schneider DA, 2006, P NATL ACAD SCI USA, V103, P12707, DOI 10.1073/pnas.0605686103; Schneider DA, 2007, MOL CELL, V26, P217, DOI 10.1016/j.molcel.2007.04.007; Steiner T, 2002, EMBO J, V21, P4641, DOI 10.1093/emboj/cdf455; SWANSON MS, 1992, GENETICS, V132, P325; Torres M, 2004, J BACTERIOL, V186, P1304, DOI 10.1128/JB.186.5.1304-1310.2004; Trere D, 2004, J HISTOCHEM CYTOCHEM, V52, P1601, DOI 10.1369/jhc.4A6454.2004; Wada T, 1998, EMBO J, V17, P7395, DOI 10.1093/emboj/17.24.7395; Wenzel S, 2010, BIOCHEM J, V425, P373, DOI 10.1042/BJ20091422; Yamaguchi Y, 1999, J BIOL CHEM, V274, P8085, DOI 10.1074/jbc.274.12.8085; Zhang YF, 2010, J BIOL CHEM, V285, P14152, DOI 10.1074/jbc.M110.115220	40	33	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18825	18833		10.1074/jbc.M110.202119	http://dx.doi.org/10.1074/jbc.M110.202119			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21467036	Green Published, hybrid			2022-12-25	WOS:000290785700055
J	Kuda, O; Jenkins, CM; Skinner, JR; Moon, SH; Su, X; Gross, RW; Abumrad, NA				Kuda, Ondrej; Jenkins, Christopher M.; Skinner, James R.; Moon, Sung Ho; Su, Xiong; Gross, Richard W.; Abumrad, Nada A.			CD36 Protein Is Involved in Store-operated Calcium Flux, Phospholipase A2 Activation, and Production of Prostaglandin E2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARACHIDONIC-ACID RELEASE; ENDOPLASMIC-RETICULUM STRESS; MECHANISM-BASED DISCRIMINATION; SCAVENGER RECEPTOR CD36; HAMSTER OVARY CELLS; CYTOSOLIC PHOSPHOLIPASE; FATTY-ACID; TYROSINE KINASES; CYCLOOXYGENASE-2 GENE; ENDOTHELIAL-CELLS	The scavenger receptor FAT/CD36 contributes to the inflammation associated with diabetes, atherosclerosis, thrombosis, and Alzheimer disease. Underlying mechanisms include CD36 promotion of oxidative stress and its signaling to stress kinases. Here we document an additional mechanism for the role of CD36 in inflammation. CD36 regulates membrane calcium influx in response to endoplasmic reticulum (ER) stress, release of arachidonic acid (AA) from cellular membranes by cytoplasmic phospholipase A(2)alpha (cPLA(2)alpha) and contributes to the generation of proinflammatory eicosanoids. CHO cells stably expressing human CD36 released severalfold more AA and prostaglandin E-2 (PGE(2)), a major product of AA metabolism by cyclooxygenases, in response to thapsigargin-induced ER stress as compared with control cells. Calcium influx after ER calcium release resulted in phosphorylation of cPLA(2) and its translocation to membranes in a CD36-dependent manner. Peritoneal macrophages from CD36(-/-) mice exhibited diminished calcium transients and reduced AA release after thapsigargin or UTP treatment with decreased ERK1/2 and cPLA(2) phosphorylation. However, PGE(2) production was unexpectedly enhanced in CD36(-/-) macrophages, which probably resulted from a large induction of cyclooxygenase 2 mRNA and protein. The data demonstrate participation of CD36 in membrane calcium influx in response to ER stress or purinergic receptor stimulation resulting in AA liberation for PGE(2) formation. Collectively, these results identify a mechanism contributing to the pleiotropic proinflammatory effects of CD36 and suggest that its targeted inhibition may reduce the acute inflammatory response.	[Kuda, Ondrej; Skinner, James R.; Su, Xiong; Abumrad, Nada A.] Washington Univ, Sch Med, Ctr Human Nutr, Dept Med, St Louis, MO 63110 USA; [Jenkins, Christopher M.; Moon, Sung Ho; Gross, Richard W.] Washington Univ, Sch Med, Div Bioorgan Chem & Mol Pharmacol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Abumrad, NA (corresponding author), Washington Univ, Sch Med, Ctr Human Nutr, Dept Med, Campus Box 8031, St Louis, MO 63110 USA.	NAbumrad@DOM.wustl.edu	Kuda, Ondrej/B-7990-2012	Kuda, Ondrej/0000-0001-7034-4536	National Institutes of Health (NIH) [P01 HL057278, R01 DK33301, DK56351, DK 56341, R01 HL-41250]; NIH, NHLBI [T32 HL-007275]; American Heart Association [835140N]; Nutrition and Obesity Research Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007275, R01HL041250, P01HL057278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033301, P30DK056341] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); Nutrition and Obesity Research Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grants P01 HL057278, R01 DK33301, DK56351, and R01 HL-41250 and NIH, NHLBI, Training Grant T32 HL-007275 (to J.S.). This work was also supported by American Heart Association Scientist Development Grant 835140N (to X. S.).; We thank Dr. Dmitri Samovski for help with the microscopy and Terri Pietka and the Adipocyte Biology and Molecular Nutrition Core (supported by National Institutes of Health Grant DK 56341; Nutrition and Obesity Research Center) for valuable technical assistance.	ALONSO F, 1986, BIOCHIM BIOPHYS ACTA, V878, P273, DOI 10.1016/0005-2760(86)90156-6; Babnigg G, 1997, J BIOL CHEM, V272, P29434, DOI 10.1074/jbc.272.47.29434; Balboa MA, 1997, J BIOL CHEM, V272, P8576, DOI 10.1074/jbc.272.13.8576; Bours MJL, 2006, PHARMACOL THERAPEUT, V112, P358, DOI 10.1016/j.pharmthera.2005.04.013; Brash AR, 2001, J CLIN INVEST, V107, P1339, DOI 10.1172/JCI13210; BULL HA, 1994, FEBS LETT, V351, P41, DOI 10.1016/0014-5793(94)00814-0; Chang WC, 2004, J BIOL CHEM, V279, P29994, DOI 10.1074/jbc.M403969200; Cipollone F, 2004, JAMA-J AM MED ASSOC, V291, P2221, DOI 10.1001/jama.291.18.2221; Cubells L, 2008, J BIOL CHEM, V283, P10174, DOI 10.1074/jbc.M706618200; Degagne E, 2009, J IMMUNOL, V183, P4521, DOI 10.4049/jimmunol.0803977; Dickenson JM, 1998, BRIT J PHARMACOL, V124, P1491, DOI 10.1038/sj.bjp.0701977; Dimitrov T, 1997, J VIROL, V71, P2830, DOI 10.1128/JVI.71.4.2830-2837.1997; El-Yassimi A, 2008, J BIOL CHEM, V283, P12949, DOI 10.1074/jbc.M707478200; Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Furuyashiki T, 2009, CURR OPIN PHARMACOL, V9, P31, DOI 10.1016/j.coph.2008.12.010; GARCIA M, 1994, BIOCHEM PHARMACOL, V48, P1735, DOI 10.1016/0006-2952(94)90459-6; Geijsen N, 2000, FEBS LETT, V471, P83, DOI 10.1016/S0014-5793(00)01373-9; Ghomashchi F, 2001, BBA-BIOMEMBRANES, V1513, P160, DOI 10.1016/S0005-2736(01)00349-2; Gijon MA, 1999, J LEUKOCYTE BIOL, V65, P330, DOI 10.1002/jlb.65.3.330; Glatz JFC, 2010, PHYSIOL REV, V90, P367, DOI 10.1152/physrev.00003.2009; Golej DL, 2011, J LIPID RES, V52, P782, DOI 10.1194/jlr.M013292; Haeggstrom JZ, 2010, BIOCHEM BIOPH RES CO, V396, P135, DOI 10.1016/j.bbrc.2010.03.140; Hamar P, 2004, P NATL ACAD SCI USA, V101, P14883, DOI 10.1073/pnas.0406421101; Handberg A, 2008, STROKE, V39, P3092, DOI 10.1161/STROKEAHA.108.517128; Handberg A, 2006, CIRCULATION, V114, P1169, DOI 10.1161/CIRCULATIONAHA.106.626135; HARMON CM, 1991, J MEMBRANE BIOL, V121, P261, DOI 10.1007/BF01951559; Harper MT, 2010, PLATELETS, V21, P445, DOI 10.3109/09537104.2010.483295; HAZEN SL, 1991, J BIOL CHEM, V266, P7227; Hefner Y, 2000, J BIOL CHEM, V275, P37542, DOI 10.1074/jbc.M003395200; Hirabayashi T, 1999, J BIOL CHEM, V274, P5163, DOI 10.1074/jbc.274.8.5163; Hirano K, 2003, TRENDS CARDIOVAS MED, V13, P136, DOI 10.1016/S1050-1738(03)00026-4; Hirao A, 1997, EMBO J, V16, P2342, DOI 10.1093/emboj/16.9.2342; Hisatsune C, 2004, J BIOL CHEM, V279, P18887, DOI 10.1074/jbc.M311274200; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; HUANG MM, 1991, P NATL ACAD SCI USA, V88, P7844, DOI 10.1073/pnas.88.17.7844; Ikram MA, 2009, NEW ENGL J MED, V360, P1718, DOI 10.1056/NEJMoa0900094; Jenkins CM, 2002, J BIOL CHEM, V277, P32807, DOI 10.1074/jbc.M202568200; Kennedy DJ, 2011, CARDIOVASC RES, V89, P604, DOI 10.1093/cvr/cvq360; Kim KB, 2004, PROTEOMICS, V4, P3527, DOI 10.1002/pmic.200401001; Kohsaka S, 2008, ATHEROSCLEROSIS, V196, P926, DOI 10.1016/j.atherosclerosis.2007.02.010; Konheim YL, 2003, HUM GENET, V113, P377, DOI 10.1007/s00439-003-1000-y; Le Foll C, 2009, AM J PHYSIOL-REG I, V297, pR655, DOI 10.1152/ajpregu.00223.2009; Lee H, 2001, J BIOL CHEM, V276, P35150, DOI 10.1074/jbc.M104530200; Lin WW, 1998, BRIT J PHARMACOL, V123, P1173, DOI 10.1038/sj.bjp.0701705; Lipsky RH, 1997, RECEPT SIGNAL TRANS, V7, P1; Love-Gregory L, 2008, HUM MOL GENET, V17, P1695, DOI 10.1093/hmg/ddn060; Love-Gregory L, 2011, HUM MOL GENET, V20, P193, DOI 10.1093/hmg/ddq449; Ma XW, 2004, HUM MOL GENET, V13, P2197, DOI 10.1093/hmg/ddh233; Maulon L, 2001, ONCOGENE, V20, P1964, DOI 10.1038/sj.onc.1204266; Millanvoye-Van Brussel E, 1999, J VASC RES, V36, P235, DOI 10.1159/000025647; Moon SH, 2008, J BIOL CHEM, V283, P33975, DOI 10.1074/jbc.M805817200; Mounier CM, 2004, J BIOL CHEM, V279, P25024, DOI 10.1074/jbc.M313019200; Murakami M, 2004, PROG LIPID RES, V43, P3, DOI 10.1016/S0163-7827(03)00037-7; Newcomer ME, 2010, J BIOL CHEM, V285, P25109, DOI 10.1074/jbc.R110.125880; Park YM, 2009, J CLIN INVEST, V119, P136, DOI 10.1172/JCI35535; Pereira C, 2009, EUR J GASTROEN HEPAT, V21, P76, DOI 10.1097/MEG.0b013e32830ce7ba; Perez-Chacon G, 2009, BBA-MOL CELL BIOL L, V1791, P1103, DOI 10.1016/j.bbalip.2009.08.007; Poeckel D, 2010, CARDIOVASC RES, V86, P243, DOI 10.1093/cvr/cvq016; Rahaman SO, 2006, CELL METAB, V4, P211, DOI 10.1016/j.cmet.2006.06.007; Rudock ME, 2009, ATHEROSCLEROSIS, V203, P459, DOI 10.1016/j.atherosclerosis.2008.07.018; Rutkai I, 2009, CARDIOVASC RES, V83, P148, DOI 10.1093/cvr/cvp098; Sampson MJ, 2003, ATHEROSCLEROSIS, V167, P129, DOI 10.1016/S0021-9150(02)00421-5; Santovito D, 2009, CURR OPIN LIPIDOL, V20, P402, DOI 10.1097/MOL.0b013e32832fa22c; Seimon TA, 2010, CELL METAB, V12, P467, DOI 10.1016/j.cmet.2010.09.010; Shimizu M, 2009, CELL SIGNAL, V21, P440, DOI 10.1016/j.cellsig.2008.11.014; Silverstein RL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.272re3; Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0; Smith J, 2008, J BIOL CHEM, V283, P13578, DOI 10.1074/jbc.M800008200; Su X, 2009, TRENDS ENDOCRIN MET, V20, P72, DOI 10.1016/j.tem.2008.11.001; Sun JF, 2009, AM J PHYSIOL-HEART C, V296, pH1344, DOI 10.1152/ajpheart.01246.2008; Tabas I, 2010, CIRC RES, V107, P839, DOI 10.1161/CIRCRESAHA.110.224766; Takahashi A, 1999, PHYSIOL REV, V79, P1089, DOI 10.1152/physrev.1999.79.4.1089; Taylor AA, 2001, ENDOCRIN METAB CLIN, V30, P983, DOI 10.1016/S0889-8529(05)70223-1; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Vazquez G, 2004, J BIOL CHEM, V279, P40521, DOI 10.1074/jbc.M405280200; Zhu XD, 2002, J LEUKOCYTE BIOL, V72, P1046	78	65	67	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17785	17795		10.1074/jbc.M111.232975	http://dx.doi.org/10.1074/jbc.M111.232975			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454644	hybrid, Green Published			2022-12-25	WOS:000290585200042
J	Taschler, U; Radner, FPW; Heier, C; Schreiber, R; Schweiger, M; Schoiswohl, G; Preiss-Landl, K; Jaeger, D; Reiter, B; Koefeler, HC; Wojciechowski, J; Theussl, C; Penninger, JM; Lass, A; Haemmerle, G; Zechner, R; Zimmermann, R				Taschler, Ulrike; Radner, Franz P. W.; Heier, Christoph; Schreiber, Renate; Schweiger, Martina; Schoiswohl, Gabriele; Preiss-Landl, Karina; Jaeger, Doris; Reiter, Birgit; Koefeler, Harald C.; Wojciechowski, Jacek; Theussl, Christian; Penninger, Josef M.; Lass, Achim; Haemmerle, Guenter; Zechner, Rudolf; Zimmermann, Robert			Monoglyceride Lipase Deficiency in Mice Impairs Lipolysis and Attenuates Diet-induced Insulin Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE TRIGLYCERIDE LIPASE; HORMONE-SENSITIVE LIPASE; ENDOCANNABINOID SYSTEM; MONOACYLGLYCEROL LIPASE; LIPOPROTEIN-LIPASE; ENERGY-METABOLISM; TISSUE; OBESITY; 2-ARACHIDONOYLGLYCEROL; TRIACYLGLYCEROL	Monoglyceride lipase (MGL) influences energy metabolism by at least two mechanisms. First, it hydrolyzes monoacylglycerols (MG) into fatty acids and glycerol. These products can be used for energy production or synthetic reactions. Second, MGL degrades 2-arachidonoyl glycerol (2-AG), the most abundant endogenous ligand of cannabinoid receptors (CBR). Activation of CBR affects energy homeostasis by central orexigenic stimuli, by promoting lipid storage, and by reducing energy expenditure. To characterize the metabolic role of MGL in vivo, we generated an MGL-deficient mouse model (MGL-ko). These mice exhibit a reduction in MG hydrolase activity and a concomitant increase in MG levels in adipose tissue, brain, and liver. In adipose tissue, the lack of MGL activity is partially compensated by hormone-sensitive lipase. Nonetheless, fasted MGL-ko mice exhibit reduced plasma glycerol and triacylglycerol, as well as liver triacylglycerol levels indicative for impaired lipolysis. Despite a strong elevation of 2-AG levels, MGL-ko mice exhibit normal food intake, fat mass, and energy expenditure. Yet mice lacking MGL show a pharmacological tolerance to the CBR agonist CP 55,940 suggesting that the elevated 2-AG levels are functionally antagonized by desensitization of CBR. Interestingly, however, MGL-ko mice receiving a high fat diet exhibit significantly improved glucose tolerance and insulin sensitivity in comparison with wild-type controls despite equal weight gain. In conclusion, our observations implicate that MGL deficiency impairs lipolysis and attenuates diet-induced insulin resistance. Defective degradation of 2-AG does not provoke cannabinoid-like effects on feeding behavior, lipid storage, and energy expenditure, which may be explained by desensitization of CBR.	[Taschler, Ulrike; Radner, Franz P. W.; Heier, Christoph; Schreiber, Renate; Schweiger, Martina; Schoiswohl, Gabriele; Preiss-Landl, Karina; Jaeger, Doris; Lass, Achim; Haemmerle, Guenter; Zechner, Rudolf; Zimmermann, Robert] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria; [Reiter, Birgit; Koefeler, Harald C.] Med Univ Graz, Med Res Ctr, A-8010 Graz, Austria; [Wojciechowski, Jacek; Theussl, Christian; Penninger, Josef M.] Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria	University of Graz; Medical University of Graz; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Zimmermann, R (corresponding author), Graz Univ, Inst Mol Biosci, Heinrichstr 31A, A-8010 Graz, Austria.	robert.zimmermann@uni-graz.at	Penninger, Josef M/I-6860-2013; Lass, Achim/C-3332-2008	Penninger, Josef M/0000-0002-8194-3777; Lass, Achim/0000-0002-8190-7151; Kofeler, Harald/0000-0002-2725-9616; Schoiswohl, Gabriele/0000-0002-7346-2834; Schreiber, Renate/0000-0002-3475-157X; Zechner, Rudolf/0000-0001-5483-1182; Heier, Christoph/0000-0001-6858-408X; Schweiger, Martina/0000-0002-3419-1007; Radner, Franz/0000-0003-3466-0181; Zimmermann, Robert/0000-0002-7354-870X; Taschler, Ulrike/0000-0001-9000-1602; Haemmerle, Guenter/0000-0001-9900-5896	Austrian Science Funds [P21296]; DK Molecular Enzymology Grant [W901-B05 DK]; Austrian Federal Ministry for Science and Research; Austrian Science Fund (FWF) [F 3002, Z 136, P 21296, W 901] Funding Source: researchfish	Austrian Science Funds(Austrian Science Fund (FWF)); DK Molecular Enzymology Grant(Austrian Science Fund (FWF)); Austrian Federal Ministry for Science and Research; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Austrian Science Funds, Project P21296, the DK Molecular Enzymology Grant W901-B05 DK, and by the Austrian Federal Ministry for Science and Research, Project "GOLD-Genomics of Lipid-associated Disorders" in the framework of the Austrian Genome Project "GEN-AU Genome Research in Austria."	Blankman JL, 2007, CHEM BIOL, V14, P1347, DOI 10.1016/j.chembiol.2007.11.006; Chanda PK, 2010, MOL PHARMACOL, V78, P996, DOI 10.1124/mol.110.068304; Cota D, 2003, J CLIN INVEST, V112, P423, DOI 10.1172/JCI17725; Di Marzo V, 2008, DIABETOLOGIA, V51, P1356, DOI 10.1007/s00125-008-1048-2; Di Marzo V, 2009, PHARMACOL RES, V60, P77, DOI 10.1016/j.phrs.2009.02.010; Fiskerstrand T, 2010, AM J HUM GENET, V87, P410, DOI 10.1016/j.ajhg.2010.08.002; FREDRIKSON G, 1986, BIOCHIM BIOPHYS ACTA, V876, P288, DOI 10.1016/0005-2760(86)90286-9; Gao Y, 2010, J NEUROSCI, V30, P2017, DOI 10.1523/JNEUROSCI.5693-09.2010; Goldberg IJ, 2001, FRONT BIOSCI-LANDMRK, V6, pD388, DOI 10.2741/Goldberg; Haemmerle G, 2002, J BIOL CHEM, V277, P12946, DOI 10.1074/jbc.M108640200; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Heier C, 2010, BBA-MOL CELL BIOL L, V1801, P1063, DOI 10.1016/j.bbalip.2010.06.001; Hue L, 2009, AM J PHYSIOL-ENDOC M, V297, pE578, DOI 10.1152/ajpendo.00093.2009; Huijsman E, 2009, AM J PHYSIOL-ENDOC M, V297, pE505, DOI 10.1152/ajpendo.00190.2009; Karlsson M, 1997, J BIOL CHEM, V272, P27218, DOI 10.1074/jbc.272.43.27218; Karlsson M, 2000, PROTEIN EXPRES PURIF, V18, P286, DOI 10.1006/prep.1999.1194; Kienesberger PC, 2009, J BIOL CHEM, V284, P30218, DOI 10.1074/jbc.M109.047787; Kunos G, 2008, J BIOL CHEM, V283, P33021, DOI 10.1074/jbc.R800012200; Leite CE, 2009, PHARMACOL REP, V61, P217, DOI 10.1016/S1734-1140(09)70025-8; Lichtman AH, 2005, HANDB EXP PHARMACOL, V168, P691; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; Lowe ME, 1997, ANNU REV NUTR, V17, P141, DOI 10.1146/annurev.nutr.17.1.141; Maccarrone M, 2010, ANNU REV NUTR, V30, P423, DOI 10.1146/annurev.nutr.012809.104701; Marrs WR, 2010, NAT NEUROSCI, V13, P951, DOI 10.1038/nn.2601; Millar JS, 2005, J LIPID RES, V46, P2023, DOI 10.1194/jlr.D500019-JLR200; Osei-Hyiaman D, 2005, J CLIN INVEST, V115, P1298, DOI 10.1172/JCI200523057; Osuga J, 2000, P NATL ACAD SCI USA, V97, P787, DOI 10.1073/pnas.97.2.787; Rodriguez JA, 2010, BBA-MOL CELL BIOL L, V1801, P77, DOI 10.1016/j.bbalip.2009.09.020; Ruby MA, 2008, P NATL ACAD SCI USA, V105, P14561, DOI 10.1073/pnas.0807232105; Schaffer JE, 2003, CURR OPIN LIPIDOL, V14, P281, DOI 10.1097/00041433-200306000-00008; Schlosburg JE, 2010, NAT NEUROSCI, V13, P1113, DOI 10.1038/nn.2616; Schoiswohl G, 2010, J LIPID RES, V51, P490, DOI 10.1194/jlr.M001073; Schweiger M, 2006, J BIOL CHEM, V281, P40236, DOI 10.1074/jbc.M608048200; Sugiura T, 2006, PROG LIPID RES, V45, P405, DOI 10.1016/j.plipres.2006.03.003; TORNQVIST H, 1974, J LIPID RES, V15, P291; TORNQVIST H, 1976, J BIOL CHEM, V251, P813; Wiley JL, 2005, BRIT J PHARMACOL, V145, P293, DOI 10.1038/sj.bjp.0706157; Yen CLE, 2009, NAT MED, V15, P442, DOI 10.1038/nm.1937; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	39	184	190	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17467	17477		10.1074/jbc.M110.215434	http://dx.doi.org/10.1074/jbc.M110.215434			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454566	hybrid, Green Published			2022-12-25	WOS:000290585200008
J	Bojja, RS; Andrake, MD; Weigand, S; Merkel, G; Yarychkivska, O; Henderson, A; Kummerling, M; Skalka, AM				Bojja, Ravi S.; Andrake, Mark D.; Weigand, Steven; Merkel, George; Yarychkivska, Olya; Henderson, Adam; Kummerling, Marissa; Skalka, Anna Marie			Architecture of a Full-length Retroviral Integrase Monomer and Dimer, Revealed by Small Angle X-ray Scattering and Chemical Cross-linking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOMA-VIRUS INTEGRASE; DNA-BINDING DOMAIN; C-TERMINAL DOMAIN; INHIBITORY MONOCLONAL-ANTIBODY; REFINED SOLUTION STRUCTURE; HIV-1 INTEGRASE; CATALYTIC DOMAIN; CRYSTAL-STRUCTURE; TYPE-1 INTEGRASE; ACTIVE-SITE	We determined the size and shape of full-length avian sarcoma virus (ASV) integrase (IN) monomers and dimers in solution using small angle x-ray scattering. The low resolution data obtained establish constraints for the relative arrangements of the three component domains in both forms. Domain organization within the small angle x-ray envelopes was determined by combining available atomic resolution data for individual domains with results from cross-linking coupled with mass spectrometry. The full-length dimer architecture so revealed is unequivocally different from that proposed from x-ray crystallographic analyses of two-domain fragments, in which interactions between the catalytic core domains play a prominent role. Core-core interactions are detected only in cross-linked IN tetramers and are required for concerted integration. The solution dimer is stabilized by C-terminal domain (CTD-CTD) interactions and by interactions of the N-terminal domain in one subunit with the core and CTD in the second subunit. These results suggest a pathway for formation of functional IN-DNA complexes that has not previously been considered and possible strategies for preventing such assembly.	[Bojja, Ravi S.; Andrake, Mark D.; Merkel, George; Yarychkivska, Olya; Henderson, Adam; Kummerling, Marissa; Skalka, Anna Marie] Fox Chase Canc Ctr, Inst Canc Res, Philadelphia, PA 19111 USA; [Weigand, Steven] Northwestern Univ, Dupont NW Dow Collaborat Access Team, Synchrotron Res Ctr, Argonne, IL 60439 USA	Fox Chase Cancer Center; Northwestern University	Skalka, AM (corresponding author), Fox Chase Canc Ctr, Inst Canc Res, 333 Cottman Ave, Philadelphia, PA 19111 USA.	AM_Skalka@fccc.edu	Weigand, Steven/G-6181-2015	Weigand, Steven/0000-0003-3137-0672	National Institutes of Health [AI40385, CA71515, CA006927]; Commonwealth of Pennsylvania; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [P30CA006927, R01CA071515] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040385] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Commonwealth of Pennsylvania; United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI40385, CA71515, and CA006927. This work was also supported by an appropriation from the Commonwealth of Pennsylvania.; We thank Drs. Richard Katz, Eileen Jaffe, and Roland Dunbrack for critical comments and helpful discussions and Marie Estes for valuable help in preparing our manuscript. Dr. Peter Cherepanov generously provided a plasmid that expresses PFV IN protein, advice for its preparation, and PFV intasome coordinates prior to publication. Dr. Zimei Bu performed some preliminary SAXS analyses at the Fox Chase Cancer Center, and Dr. S. Seeholzer provided advice for our mass spectrometry analyses. Molecular modeling was performed with the help of the Fox Chase Molecular Modeling Facility and mass spectrometry analyses benefited from assistance of Dr. Yibai Chen in the Fox Chase Biotechnology and Biochemistry Facility. Sequences of all expression plasmid constructs were verified by the Fox Chase DNA Sequencing Facility. Use of APS was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences Grant DE-AC02-06CH11357.	Al-Mawsawi LQ, 2008, VIROLOGY, V377, P353, DOI 10.1016/j.virol.2008.04.030; ANDRAKE MD, 1995, J BIOL CHEM, V270, P29299, DOI 10.1074/jbc.270.49.29299; Baker NM, 2011, NUCLEIC ACIDS RES, V39, P755, DOI 10.1093/nar/gkq799; Bao KK, 2003, J BIOL CHEM, V278, P1323, DOI 10.1074/jbc.C200550200; Bujacz G, 1997, J BIOL CHEM, V272, P18161, DOI 10.1074/jbc.272.29.18161; BUJACZ G, 1995, J MOL BIOL, V253, P333, DOI 10.1006/jmbi.1995.0556; Bujacz G, 1996, STRUCTURE, V4, P89, DOI 10.1016/S0969-2126(96)00012-3; BUSHMAN FD, 1993, P NATL ACAD SCI USA, V90, P3428, DOI 10.1073/pnas.90.8.3428; Cai ML, 1997, NAT STRUCT BIOL, V4, P567, DOI 10.1038/nsb0797-567; Ceccherini-Silberstein F, 2009, AIDS REV, V11, P17; Chen JCH, 2000, P NATL ACAD SCI USA, V97, P8233, DOI 10.1073/pnas.150220297; Chen ZG, 2000, J MOL BIOL, V296, P521, DOI 10.1006/jmbi.1999.3451; Coleman J, 1999, J BIOL CHEM, V274, P32842, DOI 10.1074/jbc.274.46.32842; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Deprez E, 2000, BIOCHEMISTRY-US, V39, P9275, DOI 10.1021/bi000397j; DYDA F, 1994, SCIENCE, V266, P1981, DOI 10.1126/science.7801124; Eijkelenboom APAM, 1997, CURR BIOL, V7, P739, DOI 10.1016/S0960-9822(06)00332-0; Eijkelenboom APAM, 2000, J BIOMOL NMR, V18, P119, DOI 10.1023/A:1008342312269; Eijkelenboom APAM, 1999, PROTEINS, V36, P556, DOI 10.1002/(SICI)1097-0134(19990901)36:4<556::AID-PROT18>3.0.CO;2-6; EIJKELENBOOM APAM, 1995, NAT STRUCT BIOL, V2, P807, DOI 10.1038/nsb0995-807; ELLISON V, 1995, J BIOL CHEM, V270, P3320, DOI 10.1074/jbc.270.7.3320; ENGELMAN A, 1993, EMBO J, V12, P3269, DOI 10.1002/j.1460-2075.1993.tb05996.x; Faure A, 2005, NUCLEIC ACIDS RES, V33, P977, DOI 10.1093/nar/gki241; Gao K, 2001, EMBO J, V20, P3565, DOI 10.1093/emboj/20.13.3565; Gao YG, 1998, NAT STRUCT BIOL, V5, P782, DOI 10.1038/1822; Goldgur Y, 1998, P NATL ACAD SCI USA, V95, P9150, DOI 10.1073/pnas.95.16.9150; Guiot E, 2006, J BIOL CHEM, V281, P22707, DOI 10.1074/jbc.M602198200; Gupta K, 2010, J BIOL CHEM, V285, P20303, DOI 10.1074/jbc.M110.114413; Hare S, 2010, NATURE, V464, P232, DOI 10.1038/nature08784; Hayouka Z, 2007, P NATL ACAD SCI USA, V104, P8316, DOI 10.1073/pnas.0700781104; Hojrup P., 1990, GEN PROTEIN MASS ANA, P61; Ilavsky J, 2009, J APPL CRYSTALLOGR, V42, P347, DOI 10.1107/S0021889809002222; Jaskolski M, 2009, FEBS J, V276, P2926, DOI 10.1111/j.1742-4658.2009.07009.x; JENKINS TM, 1995, P NATL ACAD SCI USA, V92, P6057, DOI 10.1073/pnas.92.13.6057; Jenkins TM, 1996, J BIOL CHEM, V271, P7712, DOI 10.1074/jbc.271.13.7712; JONES KS, 1992, J BIOL CHEM, V267, P16037; Karki RG, 2004, J COMPUT AID MOL DES, V18, P739, DOI 10.1007/s10822-005-0365-5; KATZ RA, 1990, CELL, V63, P87, DOI 10.1016/0092-8674(90)90290-U; Kessl JJ, 2009, MOL PHARMACOL, V76, P824, DOI 10.1124/mol.109.058883; Lawrence SH, 2008, CHEM BIOL, V15, P586, DOI 10.1016/j.chembiol.2008.04.012; Lee SP, 1997, BIOCHEMISTRY-US, V36, P173, DOI 10.1021/bi961849o; LevyMintz P, 1996, J VIROL, V70, P8821, DOI 10.1128/JVI.70.12.8821-8832.1996; Li M, 2006, EMBO J, V25, P1295, DOI 10.1038/sj.emboj.7601005; Lins RD, 2000, BIOPOLYMERS, V53, P308, DOI 10.1002/(SICI)1097-0282(20000405)53:4<308::AID-BIP3>3.0.CO;2-H; Liu QA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-244; Lo Conte L, 1999, J MOL BIOL, V285, P2177; LODI PJ, 1995, BIOCHEMISTRY-US, V34, P9826, DOI 10.1021/bi00031a002; Maertens GN, 2010, NATURE, V468, P326, DOI 10.1038/nature09517; Maignan S, 1998, J MOL BIOL, V282, P359, DOI 10.1006/jmbi.1998.2002; Moreau K, 2003, EUR J BIOCHEM, V270, P4426, DOI 10.1046/j.1432-1033.2003.03833.x; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Podtelezhnikov AA, 2003, BIOPOLYMERS, V68, P110, DOI 10.1002/bip.10217; Ramcharan J, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-34; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; VANGENT DC, 1993, EMBO J, V12, P3261, DOI 10.1002/j.1460-2075.1993.tb05995.x; Wang JY, 2001, EMBO J, V20, P7333, DOI 10.1093/emboj/20.24.7333; Wriggers W, 2001, J STRUCT BIOL, V133, P193, DOI 10.1006/jsbi.2000.4350; Xu H, 2009, PROTEOMICS, V9, P1548, DOI 10.1002/pmic.200700322; Yang ZN, 2000, J MOL BIOL, V296, P535, DOI 10.1006/jmbi.1999.3463; Yi JZ, 2002, J BIOL CHEM, V277, P12164, DOI 10.1074/jbc.M105072200; Yi JZ, 2000, J BIOL CHEM, V275, P38739, DOI 10.1074/jbc.M005499200; Zhao Z, 2008, J BIOL CHEM, V283, P5632, DOI 10.1074/jbc.M705241200; Zheng RL, 1996, P NATL ACAD SCI USA, V93, P13659, DOI 10.1073/pnas.93.24.13659	65	25	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17047	17059		10.1074/jbc.M110.212571	http://dx.doi.org/10.1074/jbc.M110.212571			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454648	hybrid, Green Published			2022-12-25	WOS:000290301900055
J	Sucharitakul, J; Wongnate, T; Chaiyen, P				Sucharitakul, Jeerus; Wongnate, Thanyaporn; Chaiyen, Pimchai			Hydrogen Peroxide Elimination from C4a-hydroperoxyflavin in a Flavoprotein Oxidase Occurs through a Single Proton Transfer from Flavin N5 to a Peroxide Leaving Group	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRANOSE 2-OXIDASE; OXYGEN ACTIVATION; HYDRIDE TRANSFER; MECHANISM; ENZYME; STABILIZATION; OXIDATION; PROTEIN; MONOOXYGENASES; INTERMEDIATE	C4a-hydroperoxyflavin is found commonly in the reactions of flavin-dependent monooxygenases, in which it plays a key role as an intermediate that incorporates an oxygen atom into substrates. Only recently has evidence for its involvement in the reactions of flavoprotein oxidases been reported. Previous studies of pyranose 2-oxidase (P2O), an enzyme catalyzing the oxidation of pyranoses using oxygen as an electron acceptor to generate oxidized sugars and hydrogen peroxide (H2O2), have shown that C4a-hydroperoxyflavin forms in P2O reactions before it eliminates H2O2 as a product (Sucharitakul, J., Prongjit, M., Haltrich, D., and Chaiyen, P. (2008) Biochemistry 47, 84858490). In this report, the solvent kinetic isotope effects (SKIE) on the reaction of reduced P2O with oxygen were investigated using transient kinetics. Our results showed that D2O has a negligible effect on the formation of C4a-hydroperoxyflavin. The ensuing step of H2O2 elimination from C4a-hydroperoxyflavin was shown to be modulated by an SKIE of 2.8 +/- 0.2, and a proton inventory analysis of this step indicates a linear plot. These data suggest that a single-proton transfer process causes SKIE at the H2O2 elimination step. Double and single mixing stopped-flow experiments performed in H2O buffer revealed that reduced flavin specifically labeled with deuterium at the flavin N5 position generated kinetic isotope effects similar to those found with experiments performed with the enzyme pre-equilibrated in D2O buffer. This suggests that the proton at the flavin N5 position is responsible for the SKIE and is the proton-in-flight that is transferred during the transition state. The mechanism of H2O2 elimination from C4a-hydroperoxyflavin is consistent with a single proton transfer from the flavin N5 to the peroxide leaving group, possibly via the formation of an intramolecular hydrogen bridge.	[Sucharitakul, Jeerus] Chulalongkorn Univ, Fac Dent, Dept Biochem, Bangkok 10300, Thailand; [Wongnate, Thanyaporn; Chaiyen, Pimchai] Mahidol Univ, Fac Sci, Dept Biochem, Bangkok 10400, Thailand; [Wongnate, Thanyaporn; Chaiyen, Pimchai] Mahidol Univ, Fac Sci, Ctr Excellence Prot Struct & Funct, Bangkok 10400, Thailand	Chulalongkorn University; Mahidol University; Mahidol University	Chaiyen, P (corresponding author), Rama 6 Rd, Bangkok 10400, Thailand.	scpcy@mahidol.ac.th	Chaiyen, Pimchai/R-5052-2019	Chaiyen, Pimchai/0000-0002-8533-1604	Thailand Research Fund [BRG5480001, MRG5380240]; Faculty of Science, Mahidol University; National Research University; Ratchadaphiseksomphot Endowment Fund [HR1166I]; Chulalongkorn University; National Science and Technology Development Agency	Thailand Research Fund(Thailand Research Fund (TRF)); Faculty of Science, Mahidol University; National Research University; Ratchadaphiseksomphot Endowment Fund; Chulalongkorn University(Chulalongkorn University); National Science and Technology Development Agency	This work was supported by The Thailand Research Fund Grants BRG5480001 (to P. C.) and MRG5380240 (to J. S.) and grants from the Faculty of Science, Mahidol University (to P. C.), from the National Research University Project of Commission on Higher Education and the Ratchadaphiseksomphot Endowment Fund (HR1166I), Chulalongkorn University (to J. S.), and from National Science and Technology Development Agency (to T. W.). This work was presented at the Gordon Research Conference 2010 (July 19-23) at Waterville Valley Resort, NH, Enzymes, Co-enzymes & Metabolic Pathways.	Ballou DP, 2005, BIOCHEM BIOPH RES CO, V338, P590, DOI 10.1016/j.bbrc.2005.09.081; BRUICE TC, 1984, ISRAEL J CHEM, V24, P54; Chaiyen P, 2010, ARCH BIOCHEM BIOPHYS, V493, P62, DOI 10.1016/j.abb.2009.08.021; Cook P. F., 1991, ENZYME MECH ISOTOPE, P74; DANNEEL HJ, 1993, EUR J BIOCHEM, V214, P795, DOI 10.1111/j.1432-1033.1993.tb17982.x; EBERLEIN G, 1982, J AM CHEM SOC, V104, P1449, DOI 10.1021/ja00369a061; Entsch B, 2005, ARCH BIOCHEM BIOPHYS, V433, P297, DOI 10.1016/j.abb.2004.09.029; EVANS MG, 1949, T FARADAY SOC, V45, P224, DOI 10.1039/tf9494500224; Fitzpatrick PF, 2001, ACCOUNTS CHEM RES, V34, P299, DOI 10.1021/ar0000511; Francisco WA, 1998, BIOCHEMISTRY-US, V37, P2596, DOI 10.1021/bi972266x; Gadda G, 2008, BIOCHEMISTRY-US, V47, P13745, DOI 10.1021/bi801994c; Hallberg BM, 2004, J MOL BIOL, V341, P781, DOI 10.1016/j.jmb.2004.06.033; Klinman JP, 2007, ACCOUNTS CHEM RES, V40, P325, DOI 10.1021/ar6000507; Kujawa M, 2006, J BIOL CHEM, V281, P35104, DOI 10.1074/jbc.M604718200; Leitner C, 1998, APPL BIOCHEM BIOTECH, V70-2, P237, DOI 10.1007/BF02920140; Macheroux Peter, 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091/6/26; MASSEY V, 1994, J BIOL CHEM, V269, P22459; Mattevi A, 2006, TRENDS BIOCHEM SCI, V31, P276, DOI 10.1016/j.tibs.2006.03.003; MERENYI G, 1991, J AM CHEM SOC, V113, P3146, DOI 10.1021/ja00008a051; Orru R, 2010, J BIOL CHEM, V285, P35021, DOI 10.1074/jbc.M110.161372; Orville AM, 2009, BIOCHEMISTRY-US, V48, P720, DOI 10.1021/bi801918u; Palfey B. A., 1995, ACTIVE OXYGEN BIOCH, P37, DOI DOI 10.1007/978-94-011-0609-2_2; Palfey B. A., 1998, COMPREHENSIVE BIOL C, VIII, P83; Palfey BA, 2010, ARCH BIOCHEM BIOPHYS, V493, P26, DOI 10.1016/j.abb.2009.11.028; Pazmino DET, 2010, J BIOTECHNOL, V146, P9, DOI 10.1016/j.jbiotec.2010.01.021; Pennati A, 2011, BIOCHEMISTRY-US, V50, P1, DOI 10.1021/bi101387w; Pitsawong W, 2010, J BIOL CHEM, V285, P9697, DOI 10.1074/jbc.M109.073247; POMPON D, 1980, EUR J BIOCHEM, V104, P479, DOI 10.1111/j.1432-1033.1980.tb04450.x; Pozzi MH, 2010, ARCH BIOCHEM BIOPHYS, V498, P83, DOI 10.1016/j.abb.2010.04.015; Prongjit M, 2009, BIOCHEMISTRY-US, V48, P4170, DOI 10.1021/bi802331r; Ruangchan N, 2011, J BIOL CHEM, V286, P223, DOI 10.1074/jbc.M110.163881; Rungsrisuriyachai K, 2010, BIOCHEMISTRY-US, V49, P2483, DOI 10.1021/bi901796a; SCHOWEN KB, 1982, METHOD ENZYMOL, V87, P551; Schowen KB, 2000, BBA-BIOENERGETICS, V1458, P43, DOI 10.1016/S0005-2728(00)00059-1; Sheng DW, 2001, BIOCHEMISTRY-US, V40, P11156, DOI 10.1021/bi011153h; Sobrado P, 2003, BIOCHEMISTRY-US, V42, P15208, DOI 10.1021/bi035546n; Spadiut O, 2010, FEBS J, V277, P2892, DOI 10.1111/j.1742-4658.2010.07705.x; Su QJ, 1999, BIOCHEMISTRY-US, V38, P8572, DOI 10.1021/bi990044o; Sucharitakul J, 2008, BIOCHEMISTRY-US, V47, P8485, DOI 10.1021/bi801039d; Sucharitakul J, 2006, J BIOL CHEM, V281, P17044, DOI 10.1074/jbc.M512385200; Sucharitakul J, 2010, BIOCHEMISTRY-US, V49, P3753, DOI 10.1021/bi100187b; Tan TC, 2010, J MOL BIOL, V402, P578, DOI 10.1016/j.jmb.2010.08.011; van Berkel WJH, 2006, J BIOTECHNOL, V124, P670, DOI 10.1016/j.jbiotec.2006.03.044; VENKATASUBBAN KS, 1984, CRC CR REV BIOCH MOL, V17, P1, DOI 10.3109/10409238409110268	44	40	40	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16900	16909		10.1074/jbc.M111.222976	http://dx.doi.org/10.1074/jbc.M111.222976			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454569	Green Published, hybrid			2022-12-25	WOS:000290301900039
J	Wang, H; Bei, L; Shah, CA; Horvath, E; Eklund, EA				Wang, Hao; Bei, Ling; Shah, Chirag A.; Horvath, Elizabeth; Eklund, Elizabeth A.			HoxA10 Influences Protein Ubiquitination by Activating Transcription of ARIH2, the Gene Encoding Triad1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNDIFFERENTIATED MYELOID CELLS; HUMAN HEMATOPOIETIC-CELLS; BONE-MARROW-CELLS; HOMEOBOX GENE; DNA-BINDING; IN-VITRO; EXPRESSION; LEUKEMIA; DIFFERENTIATION; SUBPOPULATIONS	HoxA10 is a homeodomain transcription factor that is maximally expressed in myeloid progenitor cells. An increase in HoxA10 expression correlates with poor prognosis in human acute myeloid leukemia (AML). Consistent with this scenario, HoxA10 overexpression in murine bone marrow induces a myeloproliferative neoplasm that advances AML over time. Despite the importance of HoxA10 for leukemogenesis, few genuine HoxA10 target genes have been identified. The current study identified ARIH2, the gene encoding Triad1, as a HoxA10 target gene. We identified two distinct HoxA10-binding cis elements in the ARIH2 promoter and determined that HoxA10 activates these cis elements in myeloid cells. Triad1 has E3 ubiquitin ligase activity, and we found that HoxA10-overexpressing myeloid cells exhibited a Triad1-dependent increase in protein ubiquitination. Therefore, these studies have identified the regulation of protein ubiquitination as a novel function of Hox transcription factors. Forced overexpression of Triad1 has been show previously to inhibit colony formation by myeloid progenitor cells. In contrast, HoxA10-overexpressing myeloid progenitor cells exhibited increased proliferation in response to low doses of various cytokines. We found that Triad1 knockdown further increased cytokine-induced proliferation in HoxA10-overexpressing cells. Therefore, these studies have identified a HoxA10 target gene that antagonizes the overall influence of overexpressed HoxA10 on myeloproliferation. This result suggests that the consequences of HoxA10 overexpression reflect a balance between the target genes that facilitate and antagonize proliferation. These results have implications for understanding the mechanisms of leukemogenesis in AML with Hox overexpression.	[Wang, Hao; Bei, Ling; Shah, Chirag A.; Horvath, Elizabeth; Eklund, Elizabeth A.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Wang, Hao; Bei, Ling; Shah, Chirag A.; Horvath, Elizabeth; Eklund, Elizabeth A.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Bei, Ling; Horvath, Elizabeth; Eklund, Elizabeth A.] Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60612 USA	Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Eklund, EA (corresponding author), Northwestern Univ, Feinberg Sch Med, 303 E Super St,Lurie 5-105, Chicago, IL 60611 USA.	e-eklund@northwestern.edu	Shah, Chirag/C-6770-2011	Wang, Hao/0000-0003-2131-0377	National Institutes of Health [R01-HL87717]; Veterans Affairs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087717] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-HL87717. This work was also supported by a Veterans Affairs Merit Review award (to E. A. E.).	ACAMPORA D, 1989, NUCLEIC ACIDS RES, V17, P10385, DOI 10.1093/nar/17.24.10385; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Bei L, 2007, J BIOL CHEM, V282, P16846, DOI 10.1074/jbc.M609744200; Bjornsson JM, 2001, BLOOD, V98, P3301, DOI 10.1182/blood.V98.12.3301; Buske C, 2001, BLOOD, V97, P2286, DOI 10.1182/blood.V97.8.2286; Calvo KR, 2000, MOL CELL BIOL, V20, P3274, DOI 10.1128/MCB.20.9.3274-3285.2000; Camos M, 2006, CANCER RES, V66, P6947, DOI 10.1158/0008-5472.CAN-05-4601; Compendia Biosciences, ONC 4 4; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Eklund EA, 1998, J BIOL CHEM, V273, P13957, DOI 10.1074/jbc.273.22.13957; Eklund EA, 2002, J BIOL CHEM, V277, P36878, DOI 10.1074/jbc.M203917200; Eklund EA, 2000, J BIOL CHEM, V275, P20117, DOI 10.1074/jbc.M907915199; Gabellini D, 2003, EMBO J, V22, P3715, DOI 10.1093/emboj/cdg340; Kawagoe H, 1999, LEUKEMIA, V13, P687, DOI 10.1038/sj.leu.2401410; LARRICK JW, 1980, J IMMUNOL, V125, P6; Lawrence HJ, 1997, BLOOD, V89, P1922, DOI 10.1182/blood.V89.6.1922; LAWRENCE HJ, 1995, EXP HEMATOL, V23, P1160; Lindsey S, 2005, J IMMUNOL, V175, P5269, DOI 10.4049/jimmunol.175.8.5269; Loots GG, 2002, GENOME RES, V12, P832, DOI 10.1101/gr.225502; LOWNEY P, 1991, NUCLEIC ACIDS RES, V19, P3443, DOI 10.1093/nar/19.12.3443; Lu YF, 2003, J BIOL CHEM, V278, P47792, DOI 10.1074/jbc.M305885200; Marteijn JA, 2009, LEUKEMIA, V23, P1480, DOI 10.1038/leu.2009.57; Marteijn JAF, 2005, BLOOD, V106, P4114, DOI 10.1182/blood-2005-04-1450; Oberley MJ, 2003, METHOD ENZYMOL, V371, P577; SATOKATA I, 1995, NATURE, V374, P460, DOI 10.1038/374460a0; SAUVAGEAU G, 1994, P NATL ACAD SCI USA, V91, P12223, DOI 10.1073/pnas.91.25.12223; SAUVAGEAU G, 1995, GENE DEV, V9, P1753, DOI 10.1101/gad.9.14.1753; Shah CA, 2011, J BIOL CHEM, V286, P3161, DOI 10.1074/jbc.M110.183251; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466, DOI 10.1128/MCB.8.1.466; Thorsteinsdottir U, 2002, BLOOD, V99, P121, DOI 10.1182/blood.V99.1.121; Thorsteinsdottir U, 2001, MOL CELL BIOL, V21, P224, DOI 10.1128/MCB.21.1.224-234.2001; Van der Reijden BA, 1999, PROTEIN SCI, V8, P1557, DOI 10.1110/ps.8.7.1557; Wang H, 2007, J BIOL CHEM, V282, P16164, DOI 10.1074/jbc.M610556200; Wang H, 2009, J BIOL CHEM, V284, P2549, DOI 10.1074/jbc.M804704200; Xirodimas DP, 2008, BIOCHEM SOC T, V36, P802, DOI 10.1042/BST0360802; Zhang Y, 2003, EMBO J, V22, P6057, DOI 10.1093/emboj/cdg577; Zhu CL, 2004, J BIOL CHEM, V279, P50874, DOI 10.1074/jbc.M405736200	37	24	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16832	16845		10.1074/jbc.M110.213975	http://dx.doi.org/10.1074/jbc.M110.213975			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454682	Green Published, hybrid			2022-12-25	WOS:000290301900033
J	Miller, LJ; Chen, Q; Lam, PCH; Pinon, DI; Sexton, PM; Abagyan, R; Dong, MQ				Miller, Laurence J.; Chen, Quan; Lam, Polo C. -H.; Pinon, Delia I.; Sexton, Patrick M.; Abagyan, Ruben; Dong, Maoqing			Refinement of Glucagon-like Peptide 1 Docking to Its Intact Receptor Using Mid-region Photolabile Probes and Molecular Modeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTOR; CORTICOTROPIN-RELEASING-FACTOR; PHOTOAFFINITY CROSS-LINKING; PARATHYROID-HORMONE PTH; AMINO-TERMINAL REGION; 3RD EXTRACELLULAR LOOP; SECRETIN RECEPTOR; CALCITONIN RECEPTOR; AGONIST-BINDING; SPATIAL APPROXIMATION	The glucagon-like peptide 1 (GLP1) receptor is an important drug target within the B family of G protein-coupled receptors. Its natural agonist ligand, GLP1, has incretin-like actions and the receptor is a recognized target for management of type 2 diabetes mellitus. Despite recent solution of the structure of the amino terminus of the GLP1 receptor and several close family members, the molecular basis for GLP1 binding to and activation of the intact receptor remains unclear. We previously demonstrated molecular approximations between amino-and carboxyl-terminal residues of GLP1 and its receptor. In this work, we study spatial approximations with the mid-region of this peptide to gain insights into the orientation of the intact receptor and the ligand-receptor complex. Wehave prepared two new photolabile probes incorporating a p-benzoyl-L-phenylalanine into positions 16 and 20 of GLP1(7-36). Both probes bound to the GLP1 receptor specifically and with high affinity. These were each fully efficacious agonists, stimulating cAMP accumulation in receptor-bearing CHO cells in a concentration-dependent manner. Each probe specifically labeled a single receptor site. Protease cleavage and radiochemical sequencing identified receptor residue Leu(141) above transmembrane segment one as its site of labeling for the position 16 probe, whereas the position 20 probe labeled receptor residue Trp(297) within the second extracellular loop. Establishing ligand residue approximation with this loop region is unique among family members and may help to orient the receptor amino-terminal domain relative to its helical bundle region.	[Miller, Laurence J.; Chen, Quan; Pinon, Delia I.; Dong, Maoqing] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Scottsdale, AZ 85259 USA; [Lam, Polo C. -H.; Abagyan, Ruben] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92037 USA; [Lam, Polo C. -H.; Abagyan, Ruben] Molsoft LLC, La Jolla, CA 92037 USA; [Sexton, Patrick M.] Monash Univ, Drug Discovery Biol Lab, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Sexton, Patrick M.] Monash Univ, Dept Pharmacol, Parkville, Vic 3052, Australia	Mayo Clinic; Mayo Clinic Phoenix; University of California System; University of California San Diego; Monash University; Monash University	Miller, LJ (corresponding author), 13400 E Shea Blvd, Scottsdale, AZ 85259 USA.	miller@mayo.edu; dongmq@mayo.edu	Sexton, Patrick M/B-1319-2008	Sexton, Patrick M/0000-0001-8902-2473	National Institutes of Health [DK46577]; American Diabetes Association [1-08-RA-42]; Australian National Health and Medical Research Council (NHMRC) [APP1002180]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046577, R56DK046577] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK46577, American Diabetes Association Grant 1-08-RA-42, and Australian National Health and Medical Research Council (NHMRC) Grant APP1002180.	ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Adams AE, 1998, MOL ENDOCRINOL, V12, P1673, DOI 10.1210/me.12.11.1673; ADELHORST K, 1994, J BIOL CHEM, V269, P6275; Al-Sabah S, 2003, FEBS LETT, V553, P342, DOI 10.1016/S0014-5793(03)01043-3; Assil-Kishawi I, 2002, J BIOL CHEM, V277, P32558, DOI 10.1074/jbc.M204964200; Bergwitz C, 1997, J BIOL CHEM, V272, P28861, DOI 10.1074/jbc.272.46.28861; Bisello A, 1998, J BIOL CHEM, V273, P22498, DOI 10.1074/jbc.273.35.22498; CAO YJ, 1995, BIOCHEM BIOPH RES CO, V212, P673, DOI 10.1006/bbrc.1995.2021; Carter PH, 1999, J BIOL CHEM, V274, P31955, DOI 10.1074/jbc.274.45.31955; Ceraudo E, 2008, MOL ENDOCRINOL, V22, P147, DOI 10.1210/me.2007-0361; Ceraudo E, 2008, J MOL NEUROSCI, V36, P245, DOI 10.1007/s12031-008-9073-7; Chen QA, 2010, J BIOL CHEM, V285, P24508, DOI 10.1074/jbc.M110.135749; Chen Q, 2009, J BIOL CHEM, V284, P34135, DOI 10.1074/jbc.M109.038109; Chorev M, 2002, RECEPTOR CHANNEL, V8, P219, DOI 10.1080/10606820213685; COUVINEAU A, 1995, BIOCHEM BIOPH RES CO, V206, P246, DOI 10.1006/bbrc.1995.1034; Dautzenberg FM, 2002, MOL PHARMACOL, V61, P1132, DOI 10.1124/mol.61.5.1132; de Maturana RL, 2004, PROTEIN PEPTIDE LETT, V11, P15, DOI 10.2174/0929866043478491; Dong MQ, 2008, MOL PHARMACOL, V74, P413, DOI 10.1124/mol.108.047209; Dong MQ, 2008, MOL ENDOCRINOL, V22, P1489, DOI 10.1210/me.2008-0025; Dong MQ, 2007, MOL PHARMACOL, V72, P280, DOI 10.1124/mol.107.035402; Dong MQ, 2010, J BIOL CHEM, V285, P9919, DOI 10.1074/jbc.M109.089730; Dong MQ, 2009, J BIOL CHEM, V284, P21839, DOI 10.1074/jbc.M109.011924; Dong MQ, 2004, J BIOL CHEM, V279, P31177, DOI 10.1074/jbc.M404113200; Dong MQ, 2004, J BIOL CHEM, V279, P2894, DOI 10.1074/jbc.M310407200; Dong MQ, 2004, J BIOL CHEM, V279, P1167, DOI 10.1074/jbc.M305719200; Dong MQ, 1999, J BIOL CHEM, V274, P903, DOI 10.1074/jbc.274.2.903; Estall JL, 2006, CURR PHARM DESIGN, V12, P1731, DOI 10.2174/138161206776873671; Gaylinn BD, 2002, RECEPTOR CHANNEL, V8, P155, DOI 10.1080/10606820213679; Gensure RC, 2003, MOL ENDOCRINOL, V17, P2647, DOI 10.1210/me.2003-0275; Gensure RC, 2001, J BIOL CHEM, V276, P28650, DOI 10.1074/jbc.M100717200; Gourlet P, 1996, PEPTIDES, V17, P825, DOI 10.1016/0196-9781(96)00107-6; Grace CRR, 2007, P NATL ACAD SCI USA, V104, P4858, DOI 10.1073/pnas.0700682104; Grace CRR, 2004, P NATL ACAD SCI USA, V101, P12836, DOI 10.1073/pnas.0404702101; Graziano MP, 1996, RECEPTOR CHANNEL, V4, P9; Greenberg Z, 2000, BIOCHEMISTRY-US, V39, P8142, DOI 10.1021/bi000195n; Hadac EM, 1996, PANCREAS, V13, P130, DOI 10.1097/00006676-199608000-00003; Holtmann MH, 1996, J BIOL CHEM, V271, P14944, DOI 10.1074/jbc.271.25.14944; HOLTMANN MH, 1995, J BIOL CHEM, V270, P14394, DOI 10.1074/jbc.270.24.14394; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Ji ZS, 1997, J BIOL CHEM, V272, P24393, DOI 10.1074/jbc.272.39.24393; JUPPNER H, 1994, ENDOCRINOLOGY, V134, P879, DOI 10.1210/en.134.2.879; Koth CM, 2010, BIOCHEMISTRY-US, V49, P1862, DOI 10.1021/bi901848m; Kraetke O, 2005, BIOCHEMISTRY-US, V44, P15569, DOI 10.1021/bi0507027; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE CW, 1995, MOL ENDOCRINOL, V9, P1269, DOI 10.1210/me.9.10.1269; Liaw CW, 1997, MOL ENDOCRINOL, V11, P980, DOI 10.1210/me.11.7.980; Lin F, 2009, J MOL MODEL, V15, P53, DOI 10.1007/s00894-008-0372-2; Mann RJ, 2010, PEPTIDES, V31, P2289, DOI 10.1016/j.peptides.2010.09.015; Mayo KE, 2003, PHARMACOL REV, V55, P167, DOI 10.1124/pr.55.1.6; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Michino M, 2009, NAT REV DRUG DISCOV, V8, P455, DOI 10.1038/nrd2877; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; Olde B, 1998, J MOL NEUROSCI, V11, P127, DOI 10.1385/JMN:11:2:127; Parthier C, 2007, P NATL ACAD SCI USA, V104, P13942, DOI 10.1073/pnas.0706404104; Pham V, 2004, J BIOL CHEM, V279, P6720, DOI 10.1074/jbc.M307214200; Pioszak AA, 2008, J BIOL CHEM, V283, P32900, DOI 10.1074/jbc.M805749200; Pioszak AA, 2008, P NATL ACAD SCI USA, V105, P5034, DOI 10.1073/pnas.0801027105; POWERS SP, 1988, INT J PEPT PROT RES, V31, P429; Runge S, 2003, J BIOL CHEM, V278, P28005, DOI 10.1074/jbc.M301085200; Runge S, 2008, J BIOL CHEM, V283, P11340, DOI 10.1074/jbc.M708740200; Stroop SD, 1996, ENDOCRINOLOGY, V137, P4752, DOI 10.1210/en.137.11.4752; Sun CH, 2007, P NATL ACAD SCI USA, V104, P7875, DOI 10.1073/pnas.0611397104; Tan YV, 2006, J BIOL CHEM, V281, P12792, DOI 10.1074/jbc.M513305200; ter Haar E, 2010, STRUCTURE, V18, P1083, DOI 10.1016/j.str.2010.05.014; Tokuyama Y, 2004, DIABETES RES CLIN PR, V66, P63, DOI 10.1016/j.diabres.2004.02.004; ULRICH CD, 1993, GASTROENTEROLOGY, V105, P1534, DOI 10.1016/0016-5085(93)90162-6; Underwood CR, 2010, J BIOL CHEM, V285, P723, DOI 10.1074/jbc.M109.033829; Wittelsberger A, 2006, BIOCHEMISTRY-US, V45, P2027, DOI 10.1021/bi051833a; Zang MW, 2003, MOL PHARMACOL, V63, P993, DOI 10.1124/mol.63.5.993; Zhou AT, 1997, P NATL ACAD SCI USA, V94, P3644, DOI 10.1073/pnas.94.8.3644	71	46	46	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.217901	http://dx.doi.org/10.1074/jbc.M110.217901			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454562	Green Published, hybrid			2022-12-25	WOS:000290022800030
J	Pode-Shakked, N; Harari-Steinberg, O; Haberman-Ziv, Y; Rom-Gross, E; Bahar, S; Omer, D; Metsuyanim, S; Buzhor, E; Jacob-Hirsch, J; Goldstein, RS; Mark-Danieli, M; Dekel, B				Pode-Shakked, N.; Harari-Steinberg, O.; Haberman-Ziv, Y.; Rom-Gross, E.; Bahar, S.; Omer, D.; Metsuyanim, S.; Buzhor, E.; Jacob-Hirsch, J.; Goldstein, R. S.; Mark-Danieli, M.; Dekel, B.			Resistance or sensitivity of Wilms' tumor to anti-FZD7 antibody highlights the Wnt pathway as a possible therapeutic target	ONCOGENE			English	Article						frizzled7; wnt pathway; stem cells; Wilms' tumor; sensitive; resistant	FREQUENT EPIGENETIC INACTIVATION; STEM-CELLS; BETA-CATENIN; CANCER; GENES; IDENTIFICATION; MODEL; ACTIVATION; WTX	Wilms' tumor (WT), the most frequent renal solid tumor in children, has been linked to aberrant Wnt signaling. Herein, we demonstrate that different WTs can be grouped according to either sensitivity or resistance to an antibody (Ab) specific to frizzled7 (FZD7), a Wnt receptor. In the FZD7-sensitive WT phenotype, the Ab induced cell death of the FZD7(+) fraction, which in turn depleted primary WT cultures of their clonogenic and sphere-forming cells and decreased in vivo proliferation and survival on xenografting to the chick chorio-allantoic-membrane. In contrast, FZD7-resistant WT in which no cell death was induced showed a different intracellular route of the Ab-FZD7 complex compared with sensitive tumors and accumulation of beta-catenin. This coincided with a low sFRP1 and DKK1 (Wnt inhibitors) expression pattern, restored epigenetically with de-methylating agents, and lack of beta-catenin or WTX mutations. The addition of exogenous DKK1 and sFRP1 to the tumor cells enabled the sensitization of FZD7-resistant WT to the FZD7 Ab. Finally, although extremely difficult to achieve because of dynamic cellular localization of FZD7, sorting of FZD7(+) cells from resistant WT, showed them to be highly clonogenic/proliferative, overexpressing WT 'stemness' genes, emphasizing the importance of targeting this fraction. FZD7 Ab therapy alone or in combination with Wnt pathway antagonists may have a significant role in the treatment of WT via targeting of a tumor progenitor population. Oncogene (2011) 30, 1664-1680; doi:10.1038/onc.2010.549; published online 17 January 2011	[Pode-Shakked, N.; Harari-Steinberg, O.; Haberman-Ziv, Y.; Bahar, S.; Omer, D.; Metsuyanim, S.; Buzhor, E.; Mark-Danieli, M.; Dekel, B.] Safra Childrens Hosp, Pediat Stem Cell Res Inst, Tel Hashomer, Israel; [Pode-Shakked, N.; Harari-Steinberg, O.; Haberman-Ziv, Y.; Bahar, S.; Omer, D.; Metsuyanim, S.; Buzhor, E.; Mark-Danieli, M.; Dekel, B.] Sheba Med Ctr, Sheba Ctr Regenerat Med, Tel Hashomer, Israel; [Pode-Shakked, N.; Haberman-Ziv, Y.; Bahar, S.; Omer, D.; Buzhor, E.; Dekel, B.] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Rom-Gross, E.] Hebrew Univ Jerusalem, Hadassah Med Ctr, Dept Pediat Surg, Jerusalem, Israel; [Metsuyanim, S.; Jacob-Hirsch, J.] Sheba Med Ctr, Ctr Canc Res, Tel Hashomer, Israel; [Goldstein, R. S.] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Hebrew University of Jerusalem; Hadassah University Medical Center; Chaim Sheba Medical Center; Bar Ilan University	Dekel, B (corresponding author), Edmond & Lili Safra Childrens Hosp, Sheba Med Ctr, Pediat Stem Cell Res Inst, IL-52621 Tel Hashomer, Israel.	benjamin.dekel@gmail.com	Goldstein, Ronald/H-5765-2011		ISF [1139/07]; ICRF; TAU Cancer Biology Research Center; TAU Stem Cell Research Center; Schreiber Foundation; Brettler Foundation; Sackler School of Medicine; Tel Aviv University	ISF(Israel Science Foundation); ICRF; TAU Cancer Biology Research Center; TAU Stem Cell Research Center; Schreiber Foundation; Brettler Foundation; Sackler School of Medicine; Tel Aviv University	We thank Lior Zangi, Tsahi Neuman and Igor Grinberg for technical assistance. This work was supported by ISF grant number 1139/07, ICRF Clinical Career Development Award, TAU Cancer Biology Research Center and TAU Stem Cell Research Center, The Schreiber and Brettler Foundations, Sackler School of Medicine, Tel Aviv University (BD). This work is part of the requirements toward a PhD degree, Sackler School of Medicine, Tel Aviv University (NPS).	Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Barker N, 2006, NAT REV DRUG DISCOV, V5, P997, DOI 10.1038/nrd2154; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Dekel B, 2006, CANCER RES, V66, P6040, DOI 10.1158/0008-5472.CAN-05-4528; Dekel B, 2006, J AM SOC NEPHROL, V17, P3300, DOI 10.1681/ASN.2005020195; Deryugina EI, 2008, HISTOCHEM CELL BIOL, V130, P1119, DOI 10.1007/s00418-008-0536-2; Feinberg Andrew P, 2003, Methods Mol Biol, V222, P239; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Galmozzi E, 2006, CURR MED CHEM, V13, P603, DOI 10.2174/092986706776055661; Geenen MM, 2007, JAMA-J AM MED ASSOC, V297, P2705, DOI 10.1001/jama.297.24.2705; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Jost E, 2008, BRIT J HAEMATOL, V142, P745, DOI 10.1111/j.1365-2141.2008.07242.x; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Koesters R, 1999, CANCER RES, V59, P3880; Li CM, 2002, AM J PATHOL, V160, P2181, DOI 10.1016/S0002-9440(10)61166-2; Maiti S, 2000, CANCER RES, V60, P6288; Major MB, 2007, SCIENCE, V316, P1043, DOI 10.1126/science/1141515; Metsuyanim S, 2008, STEM CELLS, V26, P1808, DOI 10.1634/stemcells.2007-0322; Metsuyanim S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006709; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Nojima M, 2007, ONCOGENE, V26, P4699, DOI 10.1038/sj.onc.1210259; Park JS, 2007, DEVELOPMENT, V134, P2533, DOI 10.1242/dev.006155; Pfeiffer P, 2007, ONCOGENE, V26, P3661, DOI 10.1038/sj.onc.1210377; Pode-Shakked N, 2009, J CELL MOL MED, V13, P1792, DOI 10.1111/j.1582-4934.2008.00607.x; Rahman N, 1996, NAT GENET, V13, P461, DOI 10.1038/ng0896-461; Rashidi H, 2009, BIOESSAYS, V31, P459, DOI 10.1002/bies.200800168; Ren X, 2007, CELL DEATH DIFFER, V14, P2076, DOI 10.1038/sj.cdd.4402220; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rivera MN, 2007, SCIENCE, V315, P642, DOI 10.1126/science.1137509; Rivera MN, 2005, NAT REV CANCER, V5, P699, DOI 10.1038/nrc1696; Robison Leslie L, 2005, Minn Med, V88, P45; Schedl A, 2007, NAT REV GENET, V8, P791, DOI 10.1038/nrg2205; Schmidt-Ott KM, 2008, KIDNEY INT, V74, P1004, DOI 10.1038/ki.2008.322; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Somervaille TCP, 2006, CANCER CELL, V10, P257, DOI 10.1016/j.ccr.2006.08.020; Spreafico F, 2009, EXPERT REV ANTICANC, V9, P693, DOI 10.1586/ERA.09.45; Suzuki H, 2008, BRIT J CANCER, V98, P1147, DOI 10.1038/sj.bjc.6604259; Taizi M, 2006, EXP HEMATOL, V34, P1698, DOI 10.1016/j.exphem.2006.07.005; Tropepe V, 1999, DEV BIOL, V208, P166, DOI 10.1006/dbio.1998.9192; van der Kooy D, 2000, SCIENCE, V287, P1439, DOI 10.1126/science.287.5457.1439; Wittmann S, 2008, GENE CHROMOSOME CANC, V47, P386, DOI 10.1002/gcc.20544; Zirn B, 2006, GENE CHROMOSOME CANC, V45, P565, DOI 10.1002/gcc.20319	43	51	62	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2011	30	14					1664	1680		10.1038/onc.2010.549	http://dx.doi.org/10.1038/onc.2010.549			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	746IS	21472018				2022-12-25	WOS:000289239400005
J	Lempiainen, H; Muller, A; Brasa, S; Teo, SS; Roloff, TC; Morawiec, L; Zamurovic, N; Vicart, A; Funhoff, E; Couttet, P; Schubeler, D; Grenet, O; Marlowe, J; Moggs, J; Terranova, R				Lempiaeinen, Harri; Mueller, Arne; Brasa, Sarah; Teo, Soon-Siong; Roloff, Tim-Christoph; Morawiec, Laurent; Zamurovic, Natasa; Vicart, Axel; Funhoff, Enrico; Couttet, Philippe; Schuebeler, Dirk; Grenet, Olivier; Marlowe, Jennifer; Moggs, Jonathan; Terranova, Remi			Phenobarbital Mediates an Epigenetic Switch at the Constitutive Androstane Receptor (CAR) Target Gene Cyp2b10 in the Liver of B6C3F1 Mice	PLOS ONE			English	Article							COVALENT HISTONE MODIFICATIONS; RESPONSIVE ENHANCER MODULE; DNA METHYLATION; HUMAN CANCERS; EXPRESSION; CELLS; HYPOMETHYLATION; TUMORIGENESIS; TRANSCRIPTION; POLYCOMB	Evidence suggests that epigenetic perturbations are involved in the adverse effects associated with some drugs and toxicants, including certain classes of non-genotoxic carcinogens. Such epigenetic changes (altered DNA methylation and covalent histone modifications) may take place at the earliest stages of carcinogenesis and their identification holds great promise for biomedical research. Here, we evaluate the sensitivity and specificity of genome-wide epigenomic and transcriptomic profiling in phenobarbital (PB)-treated B6C3F1 mice, a well-characterized rodent model of non-genotoxic liver carcinogenesis. Methylated DNA Immunoprecipitation (MeDIP)-coupled microarray profiling of 17,967 promoter regions and 4,566 intergenic CpG islands was combined with genome-wide mRNA expression profiling to identify liver tissue-specific PB-mediated DNA methylation and transcriptional alterations. Only a limited number of significant anti-correlations were observed between PB-induced transcriptional and promoter-based DNA methylation perturbations. However, the constitutive androstane receptor (CAR) target gene Cyp2b10 was found to be concomitantly hypomethylated and transcriptionally activated in a liver tissue-specific manner following PB treatment. Furthermore, analysis of active and repressive histone modifications using chromatin immunoprecipitation revealed a strong PB-mediated epigenetic switch at the Cyp2b10 promoter. Our data reveal that PB-induced transcriptional perturbations are not generally associated with broad changes in the DNA methylation status at proximal promoters and suggest that the drug-inducible CAR pathway regulates an epigenetic switch from repressive to active chromatin at the target gene Cyp2b10. This study demonstrates the utility of integrated epigenomic and transcriptomic profiling for elucidating early mechanisms and biomarkers of nongenotoxic carcinogenesis.	[Lempiaeinen, Harri; Mueller, Arne; Brasa, Sarah; Teo, Soon-Siong; Morawiec, Laurent; Zamurovic, Natasa; Vicart, Axel; Funhoff, Enrico; Couttet, Philippe; Grenet, Olivier; Marlowe, Jennifer; Moggs, Jonathan; Terranova, Remi] Novartis Inst Biomed Res, Basel, Switzerland; [Roloff, Tim-Christoph; Schuebeler, Dirk] Friedrich Miescher Inst Biomed Res, Basel, Switzerland	Novartis; Friedrich Miescher Institute for Biomedical Research	Lempiainen, H (corresponding author), Novartis Inst Biomed Res, Basel, Switzerland.	remi.terranova@novartis.com	Couttet, Philippe/AAH-5489-2019	Couttet, Philippe/0000-0002-5255-6647; Lempiainen, Harri/0000-0002-8945-6295; Vicart, Axel/0000-0002-2841-8471	Innovative Medicine Initiative Joint Undertaking (IMI JU) [115001]	Innovative Medicine Initiative Joint Undertaking (IMI JU)	The research leading to these results is funded by the Innovative Medicine Initiative Joint Undertaking (IMI JU) under grant agreement number 115001 (MARCAR project). URL: http://www.imi-marcar.eu/.Novartis is a full participant in the IMI consortium and provides in kind financial contribution to the scientific program. All IMI-MARCAR consortium partners had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachman AN, 2006, TOXICOL SCI, V91, P393, DOI 10.1093/toxsci/kfj155; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; BECKER FF, 1982, CANCER RES, V42, P3918; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Bombail V, 2004, TOXICOL LETT, V149, P51, DOI 10.1016/j.toxlet.2004.01.003; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chi P, 2010, NAT REV CANCER, V10, P457, DOI 10.1038/nrc2876; Csoka AB, 2009, MED HYPOTHESES, V73, P770, DOI 10.1016/j.mehy.2008.10.039; Ehrlich M, 2009, EPIGENOMICS-UK, V1, P239, DOI 10.2217/EPI.09.33; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Gachon F, 2006, CELL METAB, V4, P25, DOI 10.1016/j.cmet.2006.04.015; GOELZ SE, 1985, SCIENCE, V228, P187, DOI 10.1126/science.2579435; Goodman JI, 2010, TOXICOL SCI, V116, P375, DOI 10.1093/toxsci/kfq133; Gronemeyer H, 2004, NAT REV DRUG DISCOV, V3, P950, DOI 10.1038/nrd1551; Handel AE, 2010, TRENDS MOL MED, V16, P7, DOI 10.1016/j.molmed.2009.11.003; HIROSE M, 1981, CARCINOGENESIS, V2, P1299, DOI 10.1093/carcin/2.12.1299; HONKAKOSKI P, 1992, BIOCHEM J, V285, P979, DOI 10.1042/bj2850979; Honkakoski P, 1997, J BIOL CHEM, V272, P14943, DOI 10.1074/jbc.272.23.14943; Honkakoski P, 1998, MOL CELL BIOL, V18, P5652, DOI 10.1128/MCB.18.10.5652; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Jones PL, 1999, SEMIN CANCER BIOL, V9, P339, DOI 10.1006/scbi.1999.0134; Kawamoto T, 1999, MOL CELL BIOL, V19, P6318; Khorasanizadeh S, 2004, CELL, V116, P259, DOI 10.1016/S0092-8674(04)00044-3; Kim MS, 2009, NATURE, V461, P1007, DOI 10.1038/nature08456; Klug M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r63; LeBaron MJ, 2010, MUTAT RES-REV MUTAT, V705, P83, DOI 10.1016/j.mrrev.2010.04.003; Lee GH, 2000, TOXICOL PATHOL, V28, P215, DOI 10.1177/019262330002800201; Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Mohn Fabio, 2009, V507, P55, DOI 10.1007/978-1-59745-522-0_5; MONCMAN CL, 1995, CELL MOTIL CYTOSKEL, V32, P205, DOI 10.1002/cm.970320305; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; PERAINO C, 1973, JNCI-J NATL CANCER I, V51, P1349, DOI 10.1093/jnci/51.4.1349; PERAINO C, 1971, CANCER RES, V31, P1506; Phillips JM, 2007, TOXICOL SCI, V96, P72, DOI 10.1093/toxsci/kfl188; Phillips JM, 2009, TOXICOL SCI, V110, P319, DOI 10.1093/toxsci/kfp108; Phillips JM, 2009, TOXICOL SCI, V109, P193, DOI 10.1093/toxsci/kfp050; Phillips JM, 2009, TOXICOL SCI, V108, P273, DOI 10.1093/toxsci/kfp031; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Ross J, 2010, TOXICOL SCI, V116, P452, DOI 10.1093/toxsci/kfq118; Schmidl C, 2009, GENOME RES, V19, P1165, DOI 10.1101/gr.091470.109; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; UCHIDA E, 1981, J CANCER RES CLIN, V100, P231, DOI 10.1007/BF00410683; Umlauf David, 2004, Methods Mol Biol, V287, P99; Watson RE, 2002, TOXICOL SCI, V67, P11, DOI 10.1093/toxsci/67.1.11; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; WOLFFE AP, 1994, DEV GENET, V15, P463, DOI 10.1002/dvg.1020150604; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Yamamoto Y, 2003, ARCH BIOCHEM BIOPHYS, V409, P207, DOI 10.1016/S0003-9861(02)00456-3	61	61	63	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2011	6	3							e18216	10.1371/journal.pone.0018216	http://dx.doi.org/10.1371/journal.pone.0018216			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740RG	21455306	Green Published, gold, Green Submitted			2022-12-25	WOS:000288811500029
J	Zhang, Q; Zhong, Q; Evans, AG; Levy, D; Zhong, S				Zhang, Q.; Zhong, Q.; Evans, A. G.; Levy, D.; Zhong, S.			Phosphorylation of histone H3 serine 28 modulates RNA polymerase III-dependent transcription	ONCOGENE			English	Article						phosphorylation; histone H3; EGFR; Pol III transcription; Brf1; cell transformation	B-INDUCED PHOSPHORYLATION; ONCOGENIC TRANSFORMATION; CHROMOSOME CONDENSATION; POL II; GROWTH; TFIIIB; GENES; TRICHOSTATIN; ACETYLATION; DEACETYLASE	Deregulation of RNA polymerase III (Pol III) transcription enhances cellular tRNAs and 5S rRNA production, leading to an increase in translational capacity to promote cell proliferation, transformation and tumor formation. Phosphorylation of histone H3 (H3ph) is induced by tumor promoters (EGF, UV and TPA) and immediate early genes, such as c-myc, c-jun and c-fos. However, it remains to be determined whether H3ph is involved in RNA Pol III transcription. Here, we report that EGF strongly induced H3ph at serine 28 (H3S28ph). EGF significantly increased transcription of RNA Pol III-dependent genes (Pol III genes), tRNA(Leu), tRNA(Tyr), 5S rRNA and 7SL RNA. Inhibition of EGFR, but not PI3K, reduced both H3S28ph and tRNA(Leu) and 5S rRNA transcription. EGF enhanced occupancy of H3S28ph in the promoters of tRNA(Leu) and 5S rRNA. Further analysis indicates that EGF augmented cellular levels of protein and mRNA of TFIIIB subunits, Brf1 and TATA box-binding protein (TBP). Brf1 is a specific transcription factor for RNA Pol III genes. EGF enhanced occupancy of H3S28ph in the Brf1 and TBP promoters. Inhibition of H3S28ph by mutant H3S28A repressed Brf1, TBP and tRNA(Leu) and 5S rRNA expression and decreased occupancy of H3S28ph in their promoters. Reduction of Brf1 significantly decreased tRNA(Leu) and 5S rRNA transcription and repressed EGF-induced anchorage-independent growth. Blocking H3S28ph signaling by using mutant H3S28A reduced EGF-induced cell transformation. Together, these results indicate that EGF activates EGFR signaling to induce H3S28ph, which, in turn, upregulates tRNA(Leu) and 5S rRNA transcription through Brf1 and TBP and promotes cell transformation. The studies demonstrate that epigenetic modification of H3S28ph has a critical role in the activity of Pol III genes. Oncogene (2011) 30, 3943-3952; doi:10.1038/onc.2011.105; published online 4 April 2011	[Zhang, Q.; Zhong, Q.; Evans, A. G.; Levy, D.; Zhong, S.] Univ So Calif, Dept Biochem & Mol Biol, Keck Sch Med, Los Angeles, CA 90033 USA; [Zhang, Q.] Jinling Hosp, Dept Med Oncol, Nanjing, Jiangsu, Peoples R China	University of Southern California	Zhong, S (corresponding author), Univ So Calif, Dept Biochem & Mol Biol, Keck Sch Med, 2011 Zonal Ave,HMR 605, Los Angeles, CA 90033 USA.	szhong@usc.edu			National Institutes of Health [AA017288, DK025836-26]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK025836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA017288, R21AA023247] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We want to thank DL, Johnson and MR Stallcup (University of Southern California) for scientific discussions. We would like to thank Z Dong (University of Minnesota) and C Huang (University of New York) who provided cell lines. This work was supported by National Institutes of Health grants AA017288 to SZ and DK025836-26 to DL.	Barski A, 2010, NAT STRUCT MOL BIOL, V17, P629, DOI 10.1038/nsmb.1806; Brunmeir R, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000927; Chen NY, 2001, J BIOL CHEM, V276, P46722, DOI 10.1074/jbc.M107156200; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Crighton D, 2003, EMBO J, V22, P2810, DOI 10.1093/emboj/cdg265; Dieci G, 2007, TRENDS GENET, V23, P614, DOI 10.1016/j.tig.2007.09.001; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; Finnin MS, 1999, NATURE, V401, P188, DOI 10.1038/43710; Gehani SS, 2010, MOL CELL, V39, P886, DOI 10.1016/j.molcel.2010.08.020; Goodfellow SJ, 2006, EMBO J, V25, P1522, DOI 10.1038/sj.emboj.7601040; Goto H, 1999, J BIOL CHEM, V274, P25543, DOI 10.1074/jbc.274.36.25543; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Johnson DL, 2008, SCIENCE, V320, P461, DOI 10.1126/science.1158680; Johnson SAS, 2008, J BIOL CHEM, V283, P19184, DOI 10.1074/jbc.M802872200; Kenneth NS, 2007, P NATL ACAD SCI USA, V104, P14917, DOI 10.1073/pnas.0702909104; KIJIMA M, 1993, J BIOL CHEM, V268, P22429; Kim HG, 2008, CANCER RES, V68, P2538, DOI 10.1158/0008-5472.CAN-07-6597; Marshall L, 2008, CELL, V133, P78, DOI 10.1016/j.cell.2008.02.035; Metzger E, 2010, NATURE, V464, P792, DOI 10.1038/nature08839; Moqtaderi Z, 2010, NAT STRUCT MOL BIOL, V17, P635, DOI 10.1038/nsmb.1794; Oler AJ, 2010, NAT STRUCT MOL BIOL, V17, P620, DOI 10.1038/nsmb.1801; Raha D, 2010, P NATL ACAD SCI USA, V107, P3639, DOI 10.1073/pnas.0911315106; Shimada M, 2010, J BIOL CHEM, V285, P9390, DOI 10.1074/jbc.M109.057745; Struhl K, 1998, CELL, V94, P1, DOI 10.1016/S0092-8674(00)81213-1; ULLU E, 1984, NATURE, V312, P171, DOI 10.1038/312171a0; Wang FW, 2010, SCIENCE, V330, P231, DOI 10.1126/science.1189435; Wei Y, 1999, CELL, V97, P99, DOI 10.1016/S0092-8674(00)80718-7; White RJ, 2004, ONCOGENE, V23, P3208, DOI 10.1038/sj.onc.1207547; Winter AG, 2000, P NATL ACAD SCI USA, V97, P12619, DOI 10.1073/pnas.230224097; Woiwode A, 2008, MOL CELL BIOL, V28, P4204, DOI 10.1128/MCB.01912-07; Yoshida M, 1999, ANN NY ACAD SCI, V886, P23, DOI 10.1111/j.1749-6632.1999.tb09397.x; Zhong SP, 2009, P NATL ACAD SCI USA, V106, P12682, DOI 10.1073/pnas.0904843106; Zhong SP, 2000, J BIOL CHEM, V275, P20980, DOI 10.1074/jbc.M909934199; Zhong SP, 2004, MOL CELL BIOL, V24, P5119, DOI 10.1128/MCB.24.12.5119-5129.2004; Zhong SP, 2003, ONCOGENE, V22, P5291, DOI 10.1038/sj.onc.1206507; Zhong SP, 2001, J BIOL CHEM, V276, P33213, DOI 10.1074/jbc.M103973200; Zhong SP, 2001, J BIOL CHEM, V276, P12932, DOI 10.1074/jbc.M010931200	37	23	25	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP	2011	30	37					3943	3952		10.1038/onc.2011.105	http://dx.doi.org/10.1038/onc.2011.105			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	820FG	21460852	Green Accepted			2022-12-25	WOS:000294890400004
J	Joubert, MK; Luo, QZ; Nashed-Samuel, Y; Wypych, J; Narhi, LO				Joubert, Marisa K.; Luo, Quanzhou; Nashed-Samuel, Yasser; Wypych, Jette; Narhi, Linda O.			Classification and Characterization of Therapeutic Antibody Aggregates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNE TOLERANT MICE; STRUCTURAL-CHARACTERIZATION; MONOCLONAL-ANTIBODY; PROTEIN AGGREGATION; HEMOPHILIA-A; FACTOR-VIII; WILD-TYPE; IMMUNOGENICITY; PARTICLES; PATHWAY	A host of diverse stress techniques was applied to a monoclonal antibody (IgG(2)) to yield protein particles with varying attributes and morphologies. Aggregated solutions were evaluated for percent aggregation, particle counts, size distribution, morphology, changes in secondary and tertiary structure, surface hydrophobicity, metal content, and reversibility. Chemical modifications were also identified in a separate report (Luo, Q., Joubert, M. K., Stevenson, R., Narhi, L. O., and Wypych, J. (2011) J. Biol. Chem. 286, 25134-25144). Aggregates were categorized into seven discrete classes, based on the traits described. Several additional molecules (from the IgG(1) and IgG(2) subtypes as well as intravenous IgG) were stressed and found to be defined with the same classification system. The mechanism of protein aggregation and the type of aggregate formed depends on the nature of the stress applied. Different IgG molecules appear to aggregate by a similar mechanism under the same applied stress. Aggregates created by harsh mechanical stress showed the largest number of subvisible particles, and the class generated by thermal stress displayed the largest number of visible particles. Most classes showed a disruption of the higher order structure, with the degree of disorder depending on the stress process. Particles in all classes (except thermal stress) were at least partially reversible upon dilution in pH 5 buffer. High copper content was detected in isolated metal-catalyzed aggregates, a stress previously shown to produce immunogenic aggregates. In conclusion, protein aggregates can be a very heterogeneous population, whose qualities are the result of the type of stress that was experienced.	[Joubert, Marisa K.; Nashed-Samuel, Yasser; Narhi, Linda O.] Amgen Inc, Dept Formulat & Analyt Resources, Thousand Oaks, CA 91320 USA; [Luo, Quanzhou; Wypych, Jette] Amgen Inc, Dept Analyt & Formulat Sci, Thousand Oaks, CA 91320 USA	Amgen; Amgen	Joubert, MK (corresponding author), 1 Amgen Ctr Dr, Thousand Oaks, CA 91320 USA.	mjoubert@amgen.com; lnarhi@amgen.com						[Anonymous], 2004, INT ALPH 2B, V2, P1812; Arvinte T., 2007, BIOWORLD EUR, V1, P6; Bachmann MF, 1997, ANNU REV IMMUNOL, V15, P235, DOI 10.1146/annurev.immunol.15.1.235; Baszkin A, 2001, J COLLOID INTERF SCI, V239, P1, DOI 10.1006/jcis.2001.7521; Braun A, 1997, PHARMACEUT RES, V14, P1472, DOI 10.1023/A:1012193326789; Carpenter JF, 2009, J PHARM SCI-US, V98, P1201, DOI 10.1002/jps.21530; Carpenter ML, 2000, METH MOL B, V148, P491; Chackerian B, 2002, J IMMUNOL, V169, P6120, DOI 10.4049/jimmunol.169.11.6120; Chang SH, 2005, COLLOID SURFACE B, V41, P1, DOI 10.1016/j.colsurfb.2004.10.015; Chen S, 2010, PROTEIN SCI, V19, P1191, DOI 10.1002/pro.396; COVER TM, 1967, IEEE T INFORM THEORY, V13, P21, DOI 10.1109/TIT.1967.1053964; De Groot AS, 2007, TRENDS IMMUNOL, V28, P482, DOI 10.1016/j.it.2007.07.011; Demeule B, 2006, EUR J PHARM BIOPHARM, V62, P121, DOI 10.1016/j.ejpb.2005.08.008; Denis J, 2007, VIROLOGY, V363, P59, DOI 10.1016/j.virol.2007.01.011; DINTZIS HM, 1976, P NATL ACAD SCI USA, V73, P3671, DOI 10.1073/pnas.73.10.3671; Eakins M. N., 2010, PHARM OUTSOURCING, V11, P10; European Directorate for the Quality of Medicines and Healthcare, 2010, PART CONT SUBV PART; European Directorate for the Quality of Medicines and Healthcare, 2010, PART CONT VIS PART; Fesinmeyer RM, 2009, PHARM RES-DORDR, V26, P903, DOI 10.1007/s11095-008-9792-z; Fifis T, 2004, J IMMUNOL, V173, P3148, DOI 10.4049/jimmunol.173.5.3148; Filipe V, 2010, PHARM RES-DORDR, V27, P796, DOI 10.1007/s11095-010-0073-2; Foguel B, 2004, BIOCHEMISTRY-US, V43, P11361; Fradkin AH, 2009, J PHARM SCI-US, V98, P3247, DOI 10.1002/jps.21834; Frare E, 2009, J MOL BIOL, V387, P17, DOI 10.1016/j.jmb.2009.01.049; Friede M, 2005, ADV DRUG DELIVER REV, V57, P325, DOI 10.1016/j.addr.2004.10.001; Gulseren I, 2007, ULTRASON SONOCHEM, V14, P173, DOI 10.1016/j.ultsonch.2005.07.006; Hari SB, 2010, BIOCHEMISTRY-US, V49, P9328, DOI 10.1021/bi100841u; Hawe A, 2008, PHARM RES-DORDR, V25, P1487, DOI 10.1007/s11095-007-9516-9; Hawe A, 2009, EUR J PHARM SCI, V38, P79, DOI 10.1016/j.ejps.2009.06.001; He F, 2010, J PHARM SCI-US, V99, P2598, DOI 10.1002/jps.22036; Hermeling S, 2006, J PHARM SCI-US, V95, P1084, DOI 10.1002/jps.20599; Hermeling S, 2005, PHARM RES-DORDR, V22, P1997, DOI 10.1007/s11095-005-8177-9; Huang CT, 2009, J PHARM SCI-US, V98, P3058, DOI 10.1002/jps.21575; Jiang Y., 2011, J PHARM SCI IN PRESS; Jiang YJ, 2009, J PHARM SCI-US, V98, P4695, DOI 10.1002/jps.21778; Juarez J, 2009, BIOPHYS J, V96, P2353, DOI 10.1016/j.bpj.2008.12.3901; Kessler M, 2006, NEPHROL DIAL TRANSPL, V21, P9, DOI 10.1093/ndt/gfl476; Kiese S, 2008, J PHARM SCI-US, V97, P4347, DOI 10.1002/jps.21328; Knapp JZ, 2000, PDA J PHARM SCI TECH, V54, P218; Krishnan S, 2003, BIOCHEMISTRY-US, V42, P829, DOI 10.1021/bi026528t; Krishnan S, 2009, BIOPHYS J, V96, P199, DOI 10.1016/j.bpj.2008.10.002; Lahendro B., 2008, ONDRUGDELIVERY, P24; Li CH, 2009, CURR PHARM BIOTECHNO, V10, P391, DOI 10.2174/138920109788488950; Lindgren M, 2005, BIOPHYS J, V88, P4200, DOI 10.1529/biophysj.104.049700; Luo QZ, 2011, J BIOL CHEM, V286, P25134, DOI 10.1074/jbc.M110.160440; Maas C, 2007, J BIOL CHEM, V282, P2229, DOI 10.1074/jbc.M605984200; Mahler HC, 2009, J PHARM SCI-US, V98, P2909, DOI 10.1002/jps.21566; Morefield GL, 2005, VACCINE, V23, P1588, DOI 10.1016/j.vaccine.2004.07.050; Morris AM, 2009, BBA-PROTEINS PROTEOM, V1794, P375, DOI 10.1016/j.bbapap.2008.10.016; Narhi LO, 2009, CURR PHARM BIOTECHNO, V10, P373, DOI 10.2174/138920109788488905; Purohit VS, 2006, J PHARM SCI-US, V95, P358, DOI 10.1002/jps.20529; Randolph TW, 2002, BBA-PROTEIN STRUCT M, V1595, P224, DOI 10.1016/S0167-4838(01)00346-6; Reipert BM, 2007, BRIT J HAEMATOL, V136, P12, DOI 10.1111/j.1365-2141.2006.06359.x; Rosenberg A., 2009, 13 S INT REG AN SCI, P23; Rosenberg AS, 2006, AAPS J, V8, pE501, DOI 10.1208/aapsj080359; Seaver S, 2008, BIOQUALITY, V13, P3; Silva JL, 2006, BBA-PROTEINS PROTEOM, V1764, P443, DOI 10.1016/j.bbapap.2005.11.012; Silva JL, 2001, TRENDS BIOCHEM SCI, V26, P612, DOI 10.1016/S0968-0004(01)01949-1; Singh SK, 2010, J PHARM SCI-US, V99, P3302, DOI 10.1002/jps.22097; Souillac PO, 2005, J PHARM SCI-US, V94, P2069, DOI 10.1002/jps.20423; United States Pharmacopeia, 2010, 34NF USP; Valente JJ, 2005, CURR PHARM BIOTECHNO, V6, P427, DOI 10.2174/138920105775159313; Wang W, 2010, INT J PHARMACEUT, V390, P89, DOI 10.1016/j.ijpharm.2010.02.025	63	229	240	0	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25118	25133		10.1074/jbc.M110.160457	http://dx.doi.org/10.1074/jbc.M110.160457			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21454532	Green Published, hybrid			2022-12-25	WOS:000292547900060
J	Salonikidis, PS; Niebert, M; Ullrich, T; Bao, GB; Zeug, A; Richter, DW				Salonikidis, Petrus S.; Niebert, Marcus; Ullrich, Tim; Bao, Guobin; Zeug, Andre; Richter, Diethelm W.			An Ion-insensitive cAMP Biosensor for Long Term Quantitative Ratiometric Fluorescence Resonance Energy Transfer (FRET) Measurements under Variable Physiological Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRACELLULAR PH; EPAC ACTIVATION; CELL-DEATH; PROTEIN; MICRODOMAINS; CALMODULIN; MECHANISM; NEURONS; SENSORS; THERMODYNAMICS	Ratiometric measurements with FRET-based biosensors in living cells using a single fluorescence excitation wavelength are often affected by a significant ion sensitivity and the aggregation behavior of the FRET pair. This is an important problem for quantitative approaches. Here we report on the influence of physiological ion concentration changes on quantitative ratiometric measurements by comparing different FRET pairs for a cAMP-detecting biosensor. We exchanged the enhanced CFP/enhanced YFP FRET pair of an established Epac1-based biosensor by the fluorophores mCerulean/mCitrine. In the case of enhanced CFP/enhanced YFP, we showed that changes in proton, and (to a lesser extent) chloride ion concentrations result in incorrect ratiometric FRET signals, which may exceed the dynamic range of the biosensor. Calcium ions have no direct, but an indirect pH-driven effect by mobilizing protons. These ion dependences were greatly eliminated when mCerulean/mCitrine fluorophores were used. For such advanced FRET pairs the biosensor is less sensitive to changes in ion concentration and allows consistent cAMP concentration measurements under different physiological conditions, as occur in metabolically active cells. In addition, we verified that the described FRET pair exchange increased the dynamic range of the FRET efficiency response. The time window for stable experimental conditions was also prolonged by a faster biosensor expression rate in transfected cells and a greatly reduced tendency to aggregate, which reduces cytotoxicity. These properties were verified in functional tests in single cells co-expressing the biosensor and the 5-HT1A receptor.	[Salonikidis, Petrus S.; Niebert, Marcus; Ullrich, Tim; Richter, Diethelm W.] Univ Gottingen, Dept Neuro & Sensory Physiol, D-37073 Gottingen, Germany; [Bao, Guobin] Univ Gottingen, Dept Neurophysiol & Cellular Biophys, D-37073 Gottingen, Germany; [Zeug, Andre] Hannover Med Sch, Dept Cellular Neurophysiol, D-30625 Hannover, Germany; [Salonikidis, Petrus S.; Niebert, Marcus; Richter, Diethelm W.] Deutsch Forsch Gemeinschaft Res Ctr Mol Physiol B, D-37073 Gottingen, Germany	University of Gottingen; University of Gottingen; Hannover Medical School	Salonikidis, PS (corresponding author), Humboldtallee 23, D-37073 Gottingen, Germany.	psaloni@gwdg.de	Zeug, Andre/X-3208-2019	Zeug, Andre/0000-0001-9858-5841	Deutsche Forschungsgemeinschaft through the Research Center for Molecular Physiology of the Brain [FZT 103]	Deutsche Forschungsgemeinschaft through the Research Center for Molecular Physiology of the Brain	This work was supported by the Deutsche Forschungsgemeinschaft through the Research Center for Molecular Physiology of the Brain (FZT 103)/Cluster of Excellence 171.	BALLANYI K, 1994, NEUROREPORT, V6, P33, DOI 10.1097/00001756-199412300-00010; Burnashev N, 2005, CELL CALCIUM, V37, P489, DOI 10.1016/j.ceca.2005.01.003; CHESLER M, 1992, TRENDS NEUROSCI, V15, P396, DOI 10.1016/0166-2236(92)90191-A; de Rooij J, 2000, J BIOL CHEM, V275, P20829, DOI 10.1074/jbc.M001113200; DiPilato LM, 2004, P NATL ACAD SCI USA, V101, P16513, DOI 10.1073/pnas.0405973101; Dityatev A, 2000, NEURON, V26, P207, DOI 10.1016/S0896-6273(00)81151-4; Duebel J, 2006, NEURON, V49, P81, DOI 10.1016/j.neuron.2005.10.035; FLOGEL U, 1994, NMR BIOMED, V7, P157, DOI 10.1002/nbm.1940070402; GORES GJ, 1989, J CLIN INVEST, V83, P386, DOI 10.1172/JCI113896; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; HARTLEY Z, 1993, J NEUROSCI, V13, P4690; Heine M, 2002, PFLUG ARCH EUR J PHY, V443, P418, DOI 10.1007/s004240100690; Hoppe A, 2002, BIOPHYS J, V83, P3652, DOI 10.1016/S0006-3495(02)75365-4; Jayaraman S, 2000, J BIOL CHEM, V275, P6047, DOI 10.1074/jbc.275.9.6047; Koivumaki JT, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001067; KRAUSE KH, 1991, J BIOL CHEM, V266, P9453; Lakowicz R. J., 2006, PRINCIPLES FLUORESCE, P443; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; MILOS M, 1986, BIOCHEMISTRY-US, V25, P6279, DOI 10.1021/bi00368a067; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Muller M, 2000, NEUROSCIENCE, V97, P33, DOI 10.1016/S0306-4522(00)00025-7; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Papoucheva E, 2004, J BIOL CHEM, V279, P3280, DOI 10.1074/jbc.M308177200; Parekh AB, 2008, J PHYSIOL-LONDON, V586, P3043, DOI 10.1113/jphysiol.2008.153460; Patterson G, 2001, J CELL SCI, V114, P837; Patton C, 2004, CELL CALCIUM, V35, P427, DOI 10.1016/j.ceca.2003.10.006; Ponimaskin EG, 2007, FRONT NEUROSCI, P19; Ponsioen B, 2004, EMBO REP, V5, P1176, DOI 10.1038/sj.embor.7400290; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Rizzo MA, 2006, MICROSC MICROANAL, V12, P238, DOI 10.1017/S1431927606060235; Robertson RM, 2010, NEUROREPORT, V21, P943, DOI 10.1097/WNR.0b013e32833e332d; Salonikidis PS, 2008, BIOPHYS J, V95, P5412, DOI 10.1529/biophysj.107.125666; Schoenmakers T. J., 1992, BIOTECHNIQUES, V12, P876; SCHOENMAKERS TJM, 1992, BIOTECHNIQUES, V12, P870; SELLERS P, 1991, BIOPHYS CHEM, V39, P199, DOI 10.1016/0301-4622(91)85022-I; Shahrezaei V, 2004, BIOPHYS J, V87, P2352, DOI 10.1529/biophysj.104.043380; Thevenaz P, 2007, MICROSC RES TECHNIQ, V70, P135, DOI 10.1002/jemt.20393; van der Krogt GNM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001916; Wlodarczyk J, 2008, BIOPHYS J, V94, P986, DOI 10.1529/biophysj.107.111773; Woehler A, 2010, BIOPHYS J, V99, P2344, DOI 10.1016/j.bpj.2010.07.053; Woehler Andrew, 2009, Curr Mol Pharmacol, V2, P237; Yao H, 2004, CELL CALCIUM, V36, P247, DOI 10.1016/j.ceca.2004.02.013; Zaccolo M, 2002, SCIENCE, V295, P1711, DOI 10.1126/science.1069982; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	46	28	30	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23419	23431		10.1074/jbc.M111.236869	http://dx.doi.org/10.1074/jbc.M111.236869			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21454618	hybrid, Green Published			2022-12-25	WOS:000292025000073
J	Eathiraj, S; Palma, R; Hirschi, M; Volckova, E; Nakuci, E; Castro, J; Chen, CR; Chan, TCK; France, DS; Ashwell, MA				Eathiraj, Sudharshan; Palma, Rocio; Hirschi, Marscha; Volckova, Erika; Nakuci, Enkeleda; Castro, Jennifer; Chen, Chang-Rung; Chan, Thomas C. K.; France, Dennis S.; Ashwell, Mark A.			A Novel Mode of Protein Kinase Inhibition Exploiting Hydrophobic Motifs of Autoinhibited Kinases DISCOVERY OF ATP-INDEPENDENT INHIBITORS OF FIBROBLAST GROWTH FACTOR RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THERMAL SHIFT ASSAYS; TYROSINE KINASE; ACTIVATION STATE; AUTOPHOSPHORYLATION; MECHANISMS; BINDING; REVEALS; DOMAIN; FGFR2	Protein kinase inhibitors with enhanced selectivity can be designed by optimizing binding interactions with less conserved inactive conformations because such inhibitors will be less likely to compete with ATP for binding and therefore may be less impacted by high intracellular concentrations of ATP. Analysis of the ATP-binding cleft in a number of inactive protein kinases, particularly in the autoinhibited conformation, led to the identification of a previously undisclosed non-polar region in this cleft. This ATP-incompatible hydrophobic region is distinct from the previously characterized hydrophobic allosteric back pocket, as well as the main pocket. Generalized hypothetical models of inactive kinases were constructed and, for the work described here, we selected the fibroblast growth factor receptor (FGFR) tyrosine kinase family as a case study. Initial optimization of a FGFR2 inhibitor identified from a library of commercial compounds was guided using structural information from the model. We describe the inhibitory characteristics of this compound in biophysical, biochemical, and cell-based assays, and have characterized the binding mode using x-ray crystallographic studies. The results demonstrate, as expected, that these inhibitors prevent activation of the autoinhibited conformation, retain full inhibitory potency in the presence of physiological concentrations of ATP, and have favorable inhibitory activity in cancer cells. Given the widespread regulation of kinases by autoinhibitory mechanisms, the approach described herein provides a new paradigm for the discovery of inhibitors by targeting inactive conformations of protein kinases.	[Eathiraj, Sudharshan; Palma, Rocio; Hirschi, Marscha; Volckova, Erika; Nakuci, Enkeleda; Castro, Jennifer; Chen, Chang-Rung; Chan, Thomas C. K.; France, Dennis S.; Ashwell, Mark A.] ArQule Inc, Woburn, MA 01801 USA		Ashwell, MA (corresponding author), 19 Presidential Way, Woburn, MA 01801 USA.	mashwell@arqule.com			NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NIBIB NIH HHS [P30 EB009998] Funding Source: Medline	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Bae JH, 2010, P NATL ACAD SCI USA, V107, P2866, DOI 10.1073/pnas.0914157107; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARKER SC, 1995, BIOCHEMISTRY-US, V34, P14843, DOI 10.1021/bi00045a027; Cheetham GMT, 2004, CURR OPIN STRUC BIOL, V14, P700, DOI 10.1016/j.sbi.2004.10.011; Chen HB, 2007, MOL CELL, V27, P717, DOI 10.1016/j.molcel.2007.06.028; Cowan-Jacob SW, 2009, CURR OPIN CELL BIOL, V21, P280, DOI 10.1016/j.ceb.2009.01.012; Dubreuil P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007258; Eathiraj S, 2011, J BIOL CHEM, V286, P20666, DOI 10.1074/jbc.M110.213801; Engh RA, 2002, PHARMACOL THERAPEUT, V93, P99, DOI 10.1016/S0163-7258(02)00180-8; Eswarakumar VP, 2004, P NATL ACAD SCI USA, V101, P12555, DOI 10.1073/pnas.0405031101; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Frantz B, 1998, BIOCHEMISTRY-US, V37, P13846, DOI 10.1021/bi980832y; Furdui CM, 2006, MOL CELL, V21, P711, DOI 10.1016/j.molcel.2006.01.022; Gajiwala KS, 2009, P NATL ACAD SCI USA, V106, P1542, DOI 10.1073/pnas.0812413106; Hubbard SR, 2004, NAT REV MOL CELL BIO, V5, P464, DOI 10.1038/nrm1399; Hubbard SR, 2002, FRONT BIOSCI, V7, pD330, DOI 10.2741/hubbard; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Johnson LN, 2009, Q REV BIOPHYS, V42, P1, DOI 10.1017/S0033583508004745; Karni R, 2003, FEBS LETT, V537, P47, DOI 10.1016/S0014-5793(03)00069-3; Knight ZA, 2005, CHEM BIOL, V12, P621, DOI 10.1016/j.chembiol.2005.04.011; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; Kufareva I, 2008, J MED CHEM, V51, P7921, DOI 10.1021/jm8010299; Kunii K, 2008, CANCER RES, V68, P2340, DOI 10.1158/0008-5472.CAN-07-5229; Lee T, 2005, J MOL BIOL, V353, P600, DOI 10.1016/j.jmb.2005.08.029; Lew ED, 2007, P NATL ACAD SCI USA, V104, P19802, DOI 10.1073/pnas.0709905104; Lew ED, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000021; Liu Y, 2006, NAT CHEM BIOL, V2, P358, DOI 10.1038/nchembio799; Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031; Masterson LR, 2008, P NATL ACAD SCI USA, V105, P506, DOI 10.1073/pnas.0709214104; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Mohammadi M, 1996, CELL, V86, P577, DOI 10.1016/S0092-8674(00)80131-2; Montalban AG, 2008, BIOORG MED CHEM LETT, V18, P5456, DOI 10.1016/j.bmcl.2008.09.028; Munshi N, 2010, MOL CANCER THER, V9, P1544, DOI 10.1158/1535-7163.MCT-09-1173; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Peterson JR, 2004, J CELL BIOCHEM, V93, P68, DOI 10.1002/jcb.20184; Ravindranathan KP, 2010, J MED CHEM, V53, P1662, DOI 10.1021/jm901386e; Richards MW, 2009, MOL CELL, V36, P560, DOI 10.1016/j.molcel.2009.09.038; Szwaya J, 2007, J BIOMOL SCREEN, V12, P159, DOI 10.1177/1087057106297787; Taylor SS, 2004, BBA-PROTEINS PROTEOM, V1697, P259, DOI 10.1016/j.bbapap.2003.11.029; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Wodicka LM, 2010, CHEM BIOL, V17, P1241, DOI 10.1016/j.chembiol.2010.09.010; Wong TW, 2006, CLIN CANCER RES, V12, P6186, DOI 10.1158/1078-0432.CCR-06-0642; Zhao BG, 2008, PROTEIN SCI, V17, P1791, DOI 10.1110/ps.036590.108	44	41	46	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20677	20687		10.1074/jbc.M110.213736	http://dx.doi.org/10.1074/jbc.M110.213736			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21454610	Green Published, hybrid			2022-12-25	WOS:000291267600054
J	Sato, I; Shimatani, K; Fujita, K; Abe, T; Shimizu, M; Fujii, T; Hoshino, T; Takaya, N				Sato, Ikuo; Shimatani, Kanami; Fujita, Kensaku; Abe, Tsuyoshi; Shimizu, Motoyuki; Fujii, Tatsuya; Hoshino, Takayuki; Takaya, Naoki			Glutathione Reductase/Glutathione Is Responsible for Cytotoxic Elemental Sulfur Tolerance via Polysulfide Shuttle in Fungi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPERGILLUS-NIDULANS; FUSARIUM-OXYSPORUM; SACCHAROMYCES-CEREVISIAE; WOLINELLA-SUCCINOGENES; HYDROGEN-SULFIDE; REDUCTASE; THIOREDOXIN; GROWTH; FERMENTATION; MECHANISM	Fungi that can reduce elemental sulfur to sulfide are widely distributed, but the mechanism and physiological significance of the reaction have been poorly characterized. Here, we purified elemental sulfur-reductase (SR) and cloned its gene from the elemental sulfur-reducing fungus Fusarium oxysporum. We found that NADPH-glutathione reductase (GR) reduces elemental sulfur via glutathione as an intermediate. Aloss-of-function mutant of the SR/GR gene generated less sulfide from elemental sulfur than the wild-type strain. Its growth was hypersensitive to elemental sulfur, and it accumulated higher levels of oxidized glutathione, indicating that the GR/glutathione system confers tolerance to cytotoxic elemental sulfur by reducing it to less harmful sulfide. The SR/GR reduced polysulfide as efficiently as elemental sulfur, which implies that soluble polysulfide shuttles reducing equivalents to exocellular insoluble elemental sulfur and generates sulfide. The ubiquitous distribution of the GR/glutathione system together with our findings that GR-deficient mutants derived from Saccharomyces cerevisiae and Aspergillus nidulans reduced less sulfur and that their growth was hypersensitive to elemental sulfur indicated a wide distribution of the system among fungi. These results indicate a novel biological function of the GR/glutathione system in elemental sulfur reduction, which is distinguishable from bacterial and archaeal mechanisms of glutathione-independent sulfur reduction.	[Sato, Ikuo; Shimatani, Kanami; Fujita, Kensaku; Abe, Tsuyoshi; Shimizu, Motoyuki; Fujii, Tatsuya; Hoshino, Takayuki; Takaya, Naoki] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan	University of Tsukuba	Takaya, N (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan.	ntakaya@sakura.cc.tsukuba.ac.jp	Fujii, Tatsuya/M-8202-2018; SATO, Ikuo/F-8365-2012	Fujii, Tatsuya/0000-0001-7247-9442; 	Bio-oriented Technology Research Advancement Institution; Ministry of Education, Science, Culture, and Sports, Japan; Grants-in-Aid for Scientific Research [21380055] Funding Source: KAKEN	Bio-oriented Technology Research Advancement Institution; Ministry of Education, Science, Culture, and Sports, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by the Bio-oriented Technology Research Advancement Institution and a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Culture, and Sports, Japan.	Abe T, 2007, BIOSCI BIOTECH BIOCH, V71, P2402, DOI 10.1271/bbb.70083; ANDERSON ME, 1985, METHOD ENZYMOL, V113, P548; BEERS RF, 1952, J BIOL CHEM, V195, P133; BOULEGUE J, 1978, PHOSPHORUS SULFUR, V5, P127, DOI 10.1080/03086647808069875; Canfield DE, 2000, SCIENCE, V288, P658, DOI 10.1126/science.288.5466.658; Chueh PJ, 2002, BIOCHEMISTRY-US, V41, P3732, DOI 10.1021/bi012041t; Dym O, 2001, PROTEIN SCI, V10, P1712, DOI 10.1110/ps.12801; FAUQUE GD, 1994, METHOD ENZYMOL, V243, P353; Fuji T, 2008, BIOSCI BIOTECH BIOCH, V72, P412, DOI 10.1271/bbb.70538; GIGGENBACH W, 1972, INORG CHEM, V11, P1201, DOI 10.1021/ic50112a009; GOODHEW CF, 1990, BIOCHEM J, V271, P707, DOI 10.1042/bj2710707; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Herst PM, 2008, FEMS YEAST RES, V8, P897, DOI 10.1111/j.1567-1364.2008.00418.x; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; IKEDA S, 1972, TALANTA, V19, P1650, DOI 10.1016/0039-9140(72)80240-6; Kaden J, 2002, ARCH MICROBIOL, V178, P53, DOI 10.1007/s00203-002-0425-3; KING TE, 1967, METHOD ENZYMOL, V10, P634; KOSOWER NS, 1995, METHOD ENZYMOL, V251, P123, DOI 10.1016/0076-6879(95)51116-4; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laska S, 2003, MICROBIOL-SGM, V149, P2357, DOI 10.1099/mic.0.26455-0; Lee J, 1997, J BIOL CHEM, V272, P23042, DOI 10.1074/jbc.272.37.23042; Lomans BP, 2002, CELL MOL LIFE SCI, V59, P575, DOI 10.1007/s00018-002-8450-6; Ma KS, 2000, J BACTERIOL, V182, P1864, DOI 10.1128/JB.182.7.1864-1871.2000; MASSEY V, 1965, J BIOL CHEM, V240, P4470; MCALLAN SEA, 1931, CONTR BOYCE TOMPSON, V3, P13; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Michielse CB, 2009, MOL PLANT PATHOL, V10, P311, DOI [10.1111/J.1364-3703.2009.00538.X, 10.1111/j.1364-3703.2009.00538.x]; Muller EGD, 1996, MOL BIOL CELL, V7, P1805, DOI 10.1091/mbc.7.11.1805; Penninckx MJ, 2002, FEMS YEAST RES, V2, P295, DOI 10.1111/j.1567-1364.2002.tb00098.x; Prisner T, 2003, J BIOL INORG CHEM, V8, P419, DOI 10.1007/s00775-002-0432-5; Rosenfeld E, 2003, YEAST, V20, P1115, DOI 10.1002/yea.1026; Roy AB, 1970, BIOCH INORGANIC COMP; Sato I, 2009, J BIOL CHEM, V284, P8042, DOI 10.1074/jbc.M807771200; SCHUTZ M, 1977, AM J ENOL VITICULT, V28, P137; Searcy DG, 1998, J EXP ZOOL, V282, P310, DOI 10.1002/(SICI)1097-010X(19981015)282:3<310::AID-JEZ4>3.0.CO;2-P; Shimizu M, 2009, PROTEOMICS, V9, P7, DOI 10.1002/pmic.200701163; Sluiter E, 1930, BIOCHEM J, V24, P549, DOI 10.1042/bj0240549; Straub KL, 2003, FEMS MICROBIOL LETT, V220, P229, DOI 10.1016/S0378-1097(03)00130-7; SUGIO T, 1987, J BACTERIOL, V169, P4916, DOI 10.1128/jb.169.11.4916-4922.1987; Takasaki K, 2004, J BIOL CHEM, V279, P12414, DOI 10.1074/jbc.M313761200; Thon M, 2007, J BIOL CHEM, V282, P27259, DOI 10.1074/jbc.M704298200; Tweedy B. G., 1981, RESIDUE REV, V78, P43; WOODS JP, 1993, J BACTERIOL, V175, P636, DOI 10.1128/JB.175.3.636-641.1993	43	35	35	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20283	20291		10.1074/jbc.M111.225979	http://dx.doi.org/10.1074/jbc.M111.225979			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21474441	hybrid, Green Published			2022-12-25	WOS:000291267600016
J	Anderson, SJ; Sikes, ML; Zhang, YF; French, SL; Salgia, S; Beyer, AL; Nomura, M; Schneider, DA				Anderson, Susan J.; Sikes, Martha L.; Zhang, Yinfeng; French, Sarah L.; Salgia, Shilpa; Beyer, Ann L.; Nomura, Masayasu; Schneider, David A.			The Transcription Elongation Factor Spt5 Influences Transcription by RNA Polymerase I Positively and Negatively	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOMAL-RNA; SACCHAROMYCES-CEREVISIAE; PAF1 COMPLEX; CAPPING ENZYME; FISSION YEAST; ACTIVE GENES; DSIF; PHOSPHORYLATION; CHROMATIN; PROMOTER	Spt5p is a universally conserved transcription factor that plays multiple roles in eukaryotic transcription elongation. Spt5p forms a heterodimer with Spt4p and collaborates with other transcription factors to pause or promote RNA polymerase II transcription elongation. We have shown previously that Spt4p and Spt5p also influence synthesis of ribosomal RNA by RNA polymerase (Pol) I; however, previous studies only characterized defects in Pol I transcription induced by deletion of SPT4. Here we describe two new, partially active mutations in SPT5 and use these mutant strains to characterize the effect of Spt5p on Pol I transcription. Genetic interactions between spt5 and rpa49 Delta mutations together with measurements of ribosomal RNA synthesis rates, rDNA copy number, and Pol I occupancy of the rDNA demonstrate that Spt5p plays both positive and negative roles in transcription by Pol I. Electron microscopic analysis of mutant and WT strains confirms these observations and supports the model that Spt4/5 may contribute to pausing of RNA polymerase I early during transcription elongation but promotes transcription elongation downstream of the pause(s). These findings bolster the model that Spt5p and related homologues serve diverse critical roles in the control of transcription.	[Anderson, Susan J.; Zhang, Yinfeng; Schneider, David A.] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; [Sikes, Martha L.; French, Sarah L.; Beyer, Ann L.] Univ Virginia Hlth Syst, Dept Microbiol, Charlottesville, VA 22908 USA; [Salgia, Shilpa; Nomura, Masayasu] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA	University of Alabama System; University of Alabama Birmingham; University of Virginia; University of California System; University of California Irvine	Schneider, DA (corresponding author), 720 20th St S,Rm 442, Birmingham, AL 35294 USA.	dschneid@uab.edu		Schneider, David/0000-0003-0635-5091	National Institutes of Health [GM63952, GM35949, GM84946]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM035949, R01GM035949, R01GM084946, R01GM063952] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM63952 (to A. L. B.), GM35949 (to M. N.), and GM84946 (to D. A. S.).	Beckouet F, 2008, MOL CELL BIOL, V28, P1596, DOI 10.1128/MCB.01464-07; Birch JL, 2009, EMBO J, V28, P854, DOI 10.1038/emboj.2009.33; Chen YX, 2009, GENE DEV, V23, P2765, DOI 10.1101/gad.1834709; Cioci F, 2003, MOL CELL, V12, P135, DOI 10.1016/S1097-2765(03)00262-4; Claypool JA, 2004, MOL BIOL CELL, V15, P946, DOI 10.1091/mbc.E03-08-0594; CONCONI A, 1989, CELL, V57, P753, DOI 10.1016/0092-8674(89)90790-3; El Hage A, 2010, GENE DEV, V24, P1546, DOI 10.1101/gad.573310; Fath S, 2001, P NATL ACAD SCI USA, V98, P14334, DOI 10.1073/pnas.231181398; French SL, 2003, MOL CELL BIOL, V23, P1558, DOI 10.1128/MCB.23.5.1558-1568.2003; Guo M, 2008, STRUCTURE, V16, P1649, DOI 10.1016/j.str.2008.08.013; Hartzog GA, 1998, GENE DEV, V12, P357, DOI 10.1101/gad.12.3.357; Hirtreiter A, 2010, NUCLEIC ACIDS RES, V38, P4040, DOI 10.1093/nar/gkq135; Ide S, 2010, SCIENCE, V327, P693, DOI 10.1126/science.1179044; Kos M, 2010, MOL CELL, V37, P809, DOI 10.1016/j.molcel.2010.02.024; Kuai L, 2004, P NATL ACAD SCI USA, V101, P8581, DOI 10.1073/pnas.0402888101; Kuhn CD, 2007, CELL, V131, P1260, DOI 10.1016/j.cell.2007.10.051; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Lee CY, 2008, MOL CELL BIOL, V28, P3290, DOI 10.1128/MCB.02224-07; Liu Y, 2009, MOL CELL BIOL, V29, P4852, DOI 10.1128/MCB.00609-09; Malagon F, 1996, CURR GENET, V30, P101, DOI 10.1007/s002940050107; Mandal SS, 2004, P NATL ACAD SCI USA, V101, P7572, DOI 10.1073/pnas.0401493101; Mason PB, 2005, MOL CELL, V17, P831, DOI 10.1016/j.molcel.2005.02.017; Mayer C, 2005, GENE DEV, V19, P933, DOI 10.1101/gad.333205; Mayer C, 2004, GENE DEV, V18, P423, DOI 10.1101/gad.285504; MCKNIGHT SL, 1976, CELL, V8, P305, DOI 10.1016/0092-8674(76)90014-3; Milkereit P, 1998, EMBO J, V17, P3692, DOI 10.1093/emboj/17.13.3692; Murayama A, 2008, CELL, V133, P627, DOI 10.1016/j.cell.2008.03.030; NOMURA M, 2004, NUCLEOLUS; Oakes ML, 2006, MOL CELL BIOL, V26, P3889, DOI 10.1128/MCB.26.10.3889-3901.2006; Osheim YN, 2004, MOL CELL, V16, P943, DOI 10.1016/j.molcel.2004.11.031; Pei Y, 2003, J BIOL CHEM, V278, P7180, DOI 10.1074/jbc.M211713200; Ping YH, 2001, J BIOL CHEM, V276, P12951, DOI 10.1074/jbc.M006130200; Qiu HF, 2006, MOL CELL BIOL, V26, P3135, DOI 10.1128/MCB.26.8.3135-3148.2006; Sandmeier JJ, 2002, EMBO J, V21, P4959, DOI 10.1093/emboj/cdf498; Schneider DA, 2006, P NATL ACAD SCI USA, V103, P12707, DOI 10.1073/pnas.0605686103; Schneider DA, 2007, MOL CELL, V26, P217, DOI 10.1016/j.molcel.2007.04.007; Squazzo SL, 2002, EMBO J, V21, P1764, DOI 10.1093/emboj/21.7.1764; Stefanovsky V, 2006, MOL CELL, V21, P629, DOI 10.1016/j.molcel.2006.01.023; SWANSON MS, 1992, GENETICS, V132, P325; VIKTOROVSKAYA OV, 2011, J BIOL CHEM IN PRESS, V286; Viladevall L, 2009, MOL CELL, V33, P738, DOI 10.1016/j.molcel.2009.01.029; Wada T, 1998, GENE DEV, V12, P343, DOI 10.1101/gad.12.3.343; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; WARNER JR, 1991, METHOD ENZYMOL, V194, P423; Werner F, 2007, MOL MICROBIOL, V65, P1395, DOI 10.1111/j.1365-2958.2007.05876.x; WINSTON F, 1984, GENETICS, V107, P179; Wu CH, 2003, GENE DEV, V17, P1402, DOI 10.1101/gad.1091403; Yamaguchi Y, 1999, J BIOL CHEM, V274, P8085, DOI 10.1074/jbc.274.12.8085; Zhai WG, 2000, MOL CELL BIOL, V20, P5930, DOI 10.1128/MCB.20.16.5930-5938.2000; Zhang C, 2005, MOL CELL BIOL, V25, P6899, DOI 10.1128/MCB.25.16.6899-6911.2005; Zhang YF, 2010, J BIOL CHEM, V285, P14152, DOI 10.1074/jbc.M110.115220; Zhang YF, 2009, P NATL ACAD SCI USA, V106, P2153, DOI 10.1073/pnas.0812939106	52	36	39	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18816	18824		10.1074/jbc.M110.202101	http://dx.doi.org/10.1074/jbc.M110.202101			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21467039	Green Published, hybrid			2022-12-25	WOS:000290785700054
J	Bruck, I; Kaplan, DL				Bruck, Irina; Kaplan, Daniel L.			Origin Single-stranded DNA Releases Sld3 Protein from the Mcm2-7 Complex, Allowing the GINS Tetramer to Bind the Mcm2-7 Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-PHASE PROGRESSION; BUDDING YEAST; SACCHAROMYCES-CEREVISIAE; REPLICATION ORIGINS; CHROMOSOME-REPLICATION; PHOSPHORYLATION; DPB11; CDC45; ASSOCIATION; INTERACTS	The replication fork helicase in eukaryotic cells is comprised of Cdc45, Mcm2-7, and GINS (CMG complex). In budding yeast, Sld3, Sld2, and Dpb11 are required for the initiation of DNA replication, but Sld3 and Dpb11 do not travel with the replication fork. Sld3 and Cdc45 bind to early replication origins during the G(1) phase of the cell cycle, whereas Sld2, GINS, polymerase epsilon, and Dpb11 form a transient preloading complex that associates with origins during S phase. We show here that Sld3 binds tightly to origin single-stranded DNA (ssDNA). CDK-phosphorylated Sld3 binds to origin ssDNA with similar high affinity. Origin ssDNA does not disrupt the interaction between Sld3 and Dpb11, and origin ssDNA does not disrupt the interaction between Sld3 and Cdc45. However, origin ssDNA substantially disrupts the interaction between Sld3 and Mcm2-7. GINS and Sld3 compete with one another for binding to Mcm2-7. However, in a mixture of Sld3, GINS, and Mcm2-7, origin ssDNA inhibits the interaction between Sld3 and Mcm2-7, whereas origin ssDNA promotes the association between GINS and Mcm2-7. We also show that origin single-stranded DNA promotes the formation of the CMG complex. We conclude that origin single-stranded DNA releases Sld3 from Mcm2-7, allowing GINS to bind Mcm2-7.	[Bruck, Irina; Kaplan, Daniel L.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA	Vanderbilt University	Kaplan, DL (corresponding author), VU Stn B,Box 35-1634, Nashville, TN 37235 USA.	Daniel.Kaplan@Vanderbilt.edu		Kaplan, Daniel/0000-0003-2760-7745	American Cancer Society [RSG-08-124-01-CCG]; Vanderbilt University; Vanderbilt Ingram Cancer Center	American Cancer Society(American Cancer Society); Vanderbilt University; Vanderbilt Ingram Cancer Center	This work was supported by American Cancer Society Research Scholar Grant RSG-08-124-01-CCG (to D. L. K.), a Vanderbilt University Discovery grant (to D. L. K.), and a Vanderbilt Ingram Cancer Center grant (to D. L. K.).	ARAKI H, 1995, P NATL ACAD SCI USA, V92, P11791, DOI 10.1073/pnas.92.25.11791; Araki H, 2010, CURR OPIN CELL BIOL, V22, P766, DOI 10.1016/j.ceb.2010.07.015; Bochman ML, 2008, MOL CELL, V31, P287, DOI 10.1016/j.molcel.2008.05.020; Bruck I, 2011, J BIOL CHEM, V286, P14157, DOI 10.1074/jbc.M111.218305; Bruck I, 2009, J BIOL CHEM, V284, P28823, DOI 10.1074/jbc.M109.039123; Davey MJ, 2003, J BIOL CHEM, V278, P4491, DOI 10.1074/jbc.M210511200; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; Evrin C, 2009, P NATL ACAD SCI USA, V106, P20240, DOI 10.1073/pnas.0911500106; Finkelstein J, 2003, ANAL BIOCHEM, V319, P78, DOI 10.1016/S0003-2697(03)00273-2; Gai DH, 2010, CURR OPIN STRUC BIOL, V20, P756, DOI 10.1016/j.sbi.2010.08.009; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Geraghty DS, 2000, J BIOL CHEM, V275, P18011, DOI 10.1074/jbc.M909787199; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; HUANG RY, 1993, EMBO J, V12, P4521, DOI 10.1002/j.1460-2075.1993.tb06141.x; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Kamimura Y, 1998, MOL CELL BIOL, V18, P6102, DOI 10.1128/MCB.18.10.6102; Kamimura Y, 2001, EMBO J, V20, P2097, DOI 10.1093/emboj/20.8.2097; Kanemaki M, 2006, EMBO J, V25, P1753, DOI 10.1038/sj.emboj.7601063; KANTER D, 2010, NUCL ACIDS RES; Kumagai A, 2010, CELL, V140, P349, DOI 10.1016/j.cell.2009.12.049; Labib K, 2007, TRENDS CELL BIOL, V17, P271, DOI 10.1016/j.tcb.2007.04.002; Labib K, 2010, GENE DEV, V24, P1208, DOI 10.1101/gad.1933010; Lydeard JR, 2010, GENE DEV, V24, P1133, DOI 10.1101/gad.1922610; MARAHRENS Y, 1992, SCIENCE, V255, P817, DOI 10.1126/science.1536007; Masumoto H, 2000, MOL CELL BIOL, V20, P2809, DOI 10.1128/MCB.20.8.2809-2817.2000; Muramatsu S, 2010, GENE DEV, V24, P602, DOI 10.1101/gad.1883410; NATALE DA, 1993, NUCLEIC ACIDS RES, V21, P555, DOI 10.1093/nar/21.3.555; NEWLON CS, 1993, CURR OPIN GENET DEV, V3, P752, DOI 10.1016/S0959-437X(05)80094-2; Pacek M, 2006, MOL CELL, V21, P581, DOI 10.1016/j.molcel.2006.01.030; Randell JCW, 2010, MOL CELL, V40, P353, DOI 10.1016/j.molcel.2010.10.017; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Sansam CL, 2010, GENE DEV, V24, P183, DOI 10.1101/gad.1860310; Schwacha A, 2001, MOL CELL, V8, P1093, DOI 10.1016/S1097-2765(01)00389-6; Sclafani RA, 2007, ANNU REV GENET, V41, P237, DOI 10.1146/annurev.genet.41.110306.130308; Sheu YJ, 2006, MOL CELL, V24, P101, DOI 10.1016/j.molcel.2006.07.033; Sheu YJ, 2010, NATURE, V463, P113, DOI 10.1038/nature08647; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tak YS, 2006, EMBO J, V25, P1987, DOI 10.1038/sj.emboj.7601075; Takayama Y, 2003, GENE DEV, V17, P1153, DOI 10.1101/gad.1065903; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Wyrick JJ, 2001, SCIENCE, V294, P2357, DOI 10.1126/science.1066101; Yardimci H, 2010, MOL CELL, V40, P834, DOI 10.1016/j.molcel.2010.11.027; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432	43	25	27	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18602	18613		10.1074/jbc.M111.226332	http://dx.doi.org/10.1074/jbc.M111.226332			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21460226	hybrid, Green Published			2022-12-25	WOS:000290785700032
J	Haldimann, P; Muriset, M; Vigh, L; Goloubinoff, P				Haldimann, Pierre; Muriset, Maude; Vigh, Laszlo; Goloubinoff, Pierre			The Novel Hydroxylamine Derivative NG-094 Suppresses Polyglutamine Protein Toxicity in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; DELAYS DISEASE PROGRESSION; MEMBRANE-LIPID THERAPY; HUNTINGTONS-DISEASE; MOLECULAR CHAPERONES; MOUSE MODEL; NEURODEGENERATIVE DISEASES; C-ELEGANS; GLUTAMINE REPEATS; HSP70 CHAPERONE	Aggregation-prone polyglutamine (polyQ) expansion proteins cause several neurodegenerative disorders, including Huntington disease. The pharmacological activation of cellular stress responses could be a new strategy to combat protein conformational diseases. Hydroxylamine derivatives act as co-inducers of heat-shock proteins (HSPs) and can enhance HSP expression in diseased cells, without significant adverse effects. Here, we used Caenorhabditis elegans expressing polyQ expansions with 35 glutamines fused to the yellow fluorescent protein (Q35-YFP) in body wall muscle cells as a model system to investigate the effects of treatment with a novel hydroxylamine derivative, NG-094, on the progression of polyQ diseases. NG-094 significantly ameliorated polyQ-mediated animal paralysis, reduced the number of Q35-YFP aggregates and delayed polyQ-dependent acceleration of aging. Micromolar concentrations of NG-094 in animal tissues with only marginal effects on the nematode fitness sufficed to confer protection against polyQ proteotoxicity, even when the drug was administered after disease onset. NG-094 did not reduce insulin/insulin-like growth factor 1-like signaling, but conferred cytoprotection by a mechanism involving the heat-shock transcription factor HSF-1 that potentiated the expression of stress-inducible HSPs. NG-094 is thus a promising candidate for tests on mammalian models of polyQ and other protein conformational diseases.	[Haldimann, Pierre; Muriset, Maude; Goloubinoff, Pierre] Univ Lausanne, Dept Plant Mol Biol, CH-1015 Lausanne, Switzerland; [Vigh, Laszlo] Hungarian Acad Sci, Inst Biochem, Biol Res Ctr, H-6726 Szeged, Hungary	University of Lausanne; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center	Haldimann, P (corresponding author), Univ Lausanne, Dept Plant Mol Biol, CH-1015 Lausanne, Switzerland.	pierre.haldimann@bluewin.ch; pierre.goloubinoff@unil.ch		Goloubinoff, Pierre/0000-0002-4802-0807	Swiss National Science Foundation [3100A0-109290, NRP57]; Hungarian National Scientific Research Foundation [OTKA NN 76716]; National Institutes of Health National Center for Research Resources	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Hungarian National Scientific Research Foundation(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part from Grants 3100A0-109290 and NRP57, both from the Swiss National Science Foundation and from the Hungarian National Scientific Research Foundation, OTKA NN 76716.; We thank Dr. R. I. Morimoto and Dr. A. Ben-Zvi (Northwestern University, Evanston, IL) for providing the Q35 and Q0 C. elegans strains and advice on motility assay, Dr. F. Muller (University of Fribourg, Switzerland) for information on C. elegans manipulation, and Dr. C. D. Link (Colorado University) for providing the HSP16.2 antibody. We thank Dr. Maria Peter and Dr. Ibolya Horvath for the determination of the concentration of NG-094 in animal tissues and for helpful comments on the manuscript. We thank the Caenorhabditis Genetics Center, which is funded by the National Institutes of Health National Center for Research Resources, for providing some of the strains used in this study and N-Gene Research Laboratories, Inc. (Budapest, Hungary) for providing NG-094.	Adachi H, 2003, J NEUROSCI, V23, P2203; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Beal MF, 2004, NAT REV NEUROSCI, V5, P373, DOI 10.1038/nrn1386; Ben-Zvi A, 2009, P NATL ACAD SCI USA, V106, P14914, DOI 10.1073/pnas.0902882106; BRENNER S, 1974, GENETICS, V77, P71; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Calderwood SK, 2009, GERONTOLOGY, V55, P550, DOI 10.1159/000225957; Chung J, 2008, P NATL ACAD SCI USA, V105, P1739, DOI 10.1073/pnas.0705799105; Cohen E, 2008, NAT REV NEUROSCI, V9, P759, DOI 10.1038/nrn2474; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Cummings CJ, 2001, HUM MOL GENET, V10, P1511, DOI 10.1093/hmg/10.14.1511; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; Escriba PV, 2006, TRENDS MOL MED, V12, P34, DOI 10.1016/j.molmed.2005.11.004; Finka A, 2011, CELL STRESS CHAPERON, V16, P15, DOI 10.1007/s12192-010-0216-8; Finkbeiner S, 2006, J NEUROSCI, V26, P10349, DOI 10.1523/JNEUROSCI.3829-06.2006; Fonte V, 2008, J BIOL CHEM, V283, P784, DOI 10.1074/jbc.M703339200; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Hageman J, 2010, MOL CELL, V37, P355, DOI 10.1016/j.molcel.2010.01.001; Hansson O, 2003, BRAIN RES, V970, P47, DOI 10.1016/S0006-8993(02)04275-0; Hargitai J, 2003, BIOCHEM BIOPH RES CO, V307, P689, DOI 10.1016/S0006-291X(03)01254-3; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Hay DG, 2004, HUM MOL GENET, V13, P1389, DOI 10.1093/hmg/ddh144; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Herbst M, 2007, NEURODEGENER DIS, V4, P254, DOI 10.1159/000101849; Hinault MP, 2006, J MOL NEUROSCI, V30, P249, DOI 10.1385/JMN:30:3:249; Hinault MP, 2010, J BIOL CHEM, V285, P38173, DOI 10.1074/jbc.M110.127753; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Kalmar B, 2008, J NEUROCHEM, V107, P339, DOI 10.1111/j.1471-4159.2008.05595.x; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Katsuno M, 2005, P NATL ACAD SCI USA, V102, P16801, DOI 10.1073/pnas.0506249102; Kieran D, 2004, NAT MED, V10, P402, DOI 10.1038/nm1021; Link CD, 1999, CELL STRESS CHAPERON, V4, P235, DOI 10.1379/1466-1268(1999)004<0235:DOOSRI>2.3.CO;2; Lotz GP, 2010, J BIOL CHEM, V285, P38183, DOI 10.1074/jbc.M110.160218; Macario AJL, 2005, NEW ENGL J MED, V353, P1489, DOI 10.1056/NEJMra050111; McKay SJ, 2003, COLD SPRING HARB SYM, V68, P159, DOI 10.1101/sqb.2003.68.159; Morimoto RI, 1998, NAT BIOTECHNOL, V16, P833, DOI 10.1038/nbt0998-833; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Muchowskil PJ, 2002, NEURON, V35, P9, DOI 10.1016/S0896-6273(02)00761-4; Nagai Y, 2010, CURR PHARM BIOTECHNO, V11, P188, DOI 10.2174/138920110790909650; Nollen EAA, 2004, P NATL ACAD SCI USA, V101, P6403, DOI 10.1073/pnas.0307697101; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Perutz MF, 1999, TRENDS BIOCHEM SCI, V24, P58, DOI 10.1016/S0968-0004(98)01350-4; Poirier MA, 2005, HUM MOL GENET, V14, P765, DOI 10.1093/hmg/ddi071; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Prahlad V, 2009, TRENDS CELL BIOL, V19, P52, DOI 10.1016/j.tcb.2008.11.002; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Ross CA, 2002, NEURON, V35, P819, DOI 10.1016/S0896-6273(02)00872-3; Satyal SH, 2000, P NATL ACAD SCI USA, V97, P5750, DOI 10.1073/pnas.100107297; Sharma SK, 2010, NAT CHEM BIOL, V6, P914, DOI 10.1038/NCHEMBIO.455; Soti C, 2005, BRIT J PHARMACOL, V146, P769, DOI 10.1038/sj.bjp.0706396; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Tokui K, 2009, HUM MOL GENET, V18, P898, DOI 10.1093/hmg/ddn419; Torok Z, 2003, P NATL ACAD SCI USA, V100, P3131, DOI 10.1073/pnas.0438003100; Veinger L, 1998, J BIOL CHEM, V273, P11032, DOI 10.1074/jbc.273.18.11032; Vigh L, 1997, NAT MED, V3, P1150, DOI 10.1038/nm1097-1150; Vigh L, 2007, TRENDS BIOCHEM SCI, V32, P357, DOI 10.1016/j.tibs.2007.06.009; Wacker JL, 2009, J NEUROSCI, V29, P9104, DOI 10.1523/JNEUROSCI.2250-09.2009; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; Walker GA, 2003, AGING CELL, V2, P131, DOI 10.1046/j.1474-9728.2003.00045.x; Walker GA, 2001, J GERONTOL A-BIOL, V56, pB281, DOI 10.1093/gerona/56.7.B281; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200; Wexler NS, 2004, P NATL ACAD SCI USA, V101, P3498, DOI 10.1073/pnas.0308479101; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217; Zourlidou A, 2007, HUM MOL GENET, V16, P1078, DOI 10.1093/hmg/ddm057; Zuccato C, 2010, PHYSIOL REV, V90, P905, DOI 10.1152/physrev.00041.2009	70	27	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18784	18794		10.1074/jbc.M111.234773	http://dx.doi.org/10.1074/jbc.M111.234773			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21471208	Green Published, hybrid			2022-12-25	WOS:000290785700051
J	Zhang, XM; Tan, FL; Brovkovych, V; Zhang, YK; Skidgel, RA				Zhang, Xianming; Tan, Fulong; Brovkovych, Viktor; Zhang, Yongkang; Skidgel, Randal A.			Cross-talk between Carboxypeptidase M and the Kinin B1 Receptor Mediates a New Mode of G Protein-coupled Receptor Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE PRODUCTION; MEMBRANE-BOUND CARBOXYPEPTIDASE; SPONTANEOUSLY HYPERTENSIVE-RATS; CONVERTING-ENZYME INHIBITORS; ENDOTHELIAL-CELLS; CRYSTAL-STRUCTURE; B-1 RECEPTORS; BRADYKININ B1; ENKEPHALIN CONVERTASE; INTERNATIONAL UNION	G protein-coupled receptor (GPCR) signaling is affected by formation of GPCR homo-or heterodimers, but GPCR regulation by other cell surface proteins is not well understood. We reported that the kinin B1 receptor (B1R) heterodimerizes with membrane carboxypeptidase M (CPM), facilitating receptor signaling via CPM-mediated conversion of bradykinin or kallidin to des-Arg kinin B1R agonists. Here, we found that a catalytically inactive CPM mutant that still binds substrate (CPM-E264Q) also facilitates efficient B1R signaling by B2 receptor agonists bradykinin or kallidin. This response required co-expression of B1R and CPM-E264Q in the same cell, was disrupted by antibody that dissociates CPM from B1R, and was not found with a CPM-E264Q-B1R fusion protein. An additional mutation that reduced the affinity of CPM for C-terminal Arg and increased the affinity for C-terminal Lys inhibited the B1R response to bradykinin (with C-terminal Arg) but generated a response to Lys(9)-bradykinin. CPM-E264Q-mediated activation of B1Rs by bradykinin resulted in increased intramolecular fluorescence resonance energy transfer (FRET) in a B1R FRET construct, similar to that generated directly by a B1R agonist. In cytokine-treated human lung microvascular endothelial cells, disruption of B1R-CPM heterodimers inhibited B1R-dependent NO production stimulated by bradykinin and blocked the increased endothelial permeability caused by treatment with bradykinin and pyrogallol (a superoxide generator). Thus, CPM and B1Rs on cell membranes form a critical complex that potentiates B1R signaling. Kinin peptide binding to CPM causes a conformational change in the B1R leading to intracellular signaling and reveals a new mode of GPCR activation by a cell surface peptidase.	[Zhang, Xianming; Tan, Fulong; Brovkovych, Viktor; Zhang, Yongkang; Skidgel, Randal A.] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Skidgel, RA (corresponding author), Univ Illinois, Coll Med, Dept Pharmacol MC 868, 835 S Wolcott, Chicago, IL 60612 USA.	rskidgel@uic.edu	zhang, xian/GYA-0290-2022		National Institutes of Health [DK41431, HL60678]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL060678] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK041431, R56DK041431, R01DK041431] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK41431 and HL60678.; Recipient of an American Heart Association postdoctoral fellowship.	Alberts B, 1998, CELL, V92, P291, DOI 10.1016/S0092-8674(00)80922-8; Aloy P, 2001, J BIOL CHEM, V276, P16177, DOI 10.1074/jbc.M011457200; BHOOLA KD, 1992, PHARMACOL REV, V44, P1; Brovkovych V, 1999, J PHARMACEUT BIOMED, V19, P135, DOI 10.1016/S0731-7085(98)00090-9; Brovkovych V, 2011, J CELL MOL MED, V15, P258, DOI 10.1111/j.1582-4934.2009.00992.x; Campos MM, 2006, TRENDS PHARMACOL SCI, V27, P646, DOI 10.1016/j.tips.2006.10.007; Chen ZL, 2006, FASEB J, V20, P2261, DOI 10.1096/fj.06-6113com; Couture R, 2004, EUR J PHARMACOL, V500, P467, DOI 10.1016/j.ejphar.2004.07.045; DEDDISH PA, 1989, BIOCHEM J, V261, P289, DOI 10.1042/bj2610289; Deiteren K, 2009, CLIN CHIM ACTA, V399, P24, DOI 10.1016/j.cca.2008.10.003; Emanueli C, 2002, CIRCULATION, V105, P360, DOI 10.1161/hc0302.102142; Eng FJ, 1998, J BIOL CHEM, V273, P8382, DOI 10.1074/jbc.273.14.8382; Erdos EG, 2010, HYPERTENSION, V55, P214, DOI 10.1161/HYPERTENSIONAHA.109.144600; FRICKER LD, 1983, BIOCHEM BIOPH RES CO, V111, P994, DOI 10.1016/0006-291X(83)91398-0; Ha SN, 2006, BIOCHEMISTRY-US, V45, P14355, DOI 10.1021/bi060673f; Hadkar V, 2004, AM J PHYSIOL-LUNG C, V287, pL35, DOI 10.1152/ajplung.00346.2003; Hagiwara M, 2004, HYPERTENS RES, V27, P399, DOI 10.1291/hypres.27.399; Hoffmann C, 2005, NAT METHODS, V2, P171, DOI 10.1038/NMETH742; Ignjatovic T, 2004, MOL PHARMACOL, V66, P1310, DOI 10.1124/mol.104.001990; Jacoby E, 2006, CHEMMEDCHEM, V1, P760, DOI 10.1002/cmdc.200600134; Kakoki M, 2007, P NATL ACAD SCI USA, V104, P7576, DOI 10.1073/pnas.0701617104; Keil C, 2007, J MOL BIOL, V366, P504, DOI 10.1016/j.jmb.2006.11.025; Kenakin TP, 2008, MOL PHARMACOL, V74, P541, DOI 10.1124/mol.108.050062; Kenakin TP, 2009, TRENDS PHARMACOL SCI, V30, P460, DOI 10.1016/j.tips.2009.06.007; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Kuhr F, 2010, NEUROPEPTIDES, V44, P145, DOI 10.1016/j.npep.2009.12.004; Leeb-Lundberg LMF, 2005, PHARMACOL REV, V57, P27, DOI 10.1124/pr.57.1.2; Marcic B, 2000, J BIOL CHEM, V275, P16110, DOI 10.1074/jbc.M909490199; McGwire GB, 1997, LIFE SCI, V60, P715, DOI 10.1016/S0024-3205(96)00642-X; Merino VF, 2008, J MOL MED, V86, P791, DOI 10.1007/s00109-008-0345-z; Milligan G, 2007, TRENDS PHARMACOL SCI, V28, P615, DOI 10.1016/j.tips.2007.11.001; Moniwa N, 2006, BIOL CHEM, V387, P203, DOI 10.1515/BC.2006.027; NAGAE A, 1993, AM J RESP CELL MOL, V9, P221, DOI 10.1165/ajrcmb/9.2.221; NAGAE A, 1992, J NEUROCHEM, V59, P2201; Nakanishi J, 2006, BIOCHEM BIOPH RES CO, V343, P1191, DOI 10.1016/j.bbrc.2006.03.064; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Parenti A, 2001, FASEB J, V15, P1487, DOI 10.1096/fj.00-0503fje; Paria BC, 2004, AM J PHYSIOL-LUNG C, V287, pL1303, DOI 10.1152/ajplung.00240.2004; Pesquero JB, 2006, BIOL CHEM, V387, P119, DOI 10.1515/BC.2006.017; Pin JP, 2007, PHARMACOL REV, V59, P5, DOI 10.1124/pr.59.1.5; PLUMMER TH, 1981, BIOCHEM BIOPH RES CO, V98, P448, DOI 10.1016/0006-291X(81)90860-3; Qian YM, 1999, J BIOL CHEM, V274, P11582, DOI 10.1074/jbc.274.17.11582; Reverter D, 2004, J MOL BIOL, V338, P257, DOI 10.1016/j.jmb.2004.02.058; Rios CD, 2001, PHARMACOL THERAPEUT, V92, P71, DOI 10.1016/S0163-7258(01)00160-7; Ritter SL, 2009, NAT REV MOL CELL BIO, V10, P819, DOI 10.1038/nrm2803; Sangsree S, 2003, AM J PHYSIOL-HEART C, V284, pH1959, DOI 10.1152/ajpheart.00036.2003; Schremmer-Danninger E, 1998, BIOCHEM BIOPH RES CO, V243, P246, DOI 10.1006/bbrc.1997.7999; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Sittipunt C, 2001, AM J RESP CRIT CARE, V163, P503, DOI 10.1164/ajrccm.163.2.2004187; Skidgel RA, 2006, BIOL CHEM, V387, P159, DOI 10.1515/BC.2006.021; Skidgel RA, 1998, IMMUNOL REV, V161, P129, DOI 10.1111/j.1600-065X.1998.tb01577.x; SKIDGEL RA, 1989, J BIOL CHEM, V264, P2236; SKIDGEL RA, 1995, METHOD ENZYMOL, V248, P653; SKIDGEL RA, 1984, BIOCHEM PHARMACOL, V33, P3471, DOI 10.1016/0006-2952(84)90122-9; Skidgel RA, 2007, INT IMMUNOPHARMACOL, V7, P1888, DOI 10.1016/j.intimp.2007.07.014; TAN FL, 1995, METHOD ENZYMOL, V248, P663; TAN FL, 1989, J BIOL CHEM, V264, P13165; Tan FL, 2003, BIOCHEM J, V370, P567, DOI 10.1042/BJ20021495; Tan FL, 1997, BIOCHEM J, V327, P81, DOI 10.1042/bj3270081; TIRUPPATHI C, 1992, P NATL ACAD SCI USA, V89, P7919, DOI 10.1073/pnas.89.17.7919; Wang LY, 2009, J PHARMACOL EXP THER, V331, P340, DOI 10.1124/jpet.109.156380; Gomis-Ruth FX, 2008, CRIT REV BIOCHEM MOL, V43, P319, DOI 10.1080/10409230802376375 ; Zhang XM, 2008, J BIOL CHEM, V283, P7994, DOI 10.1074/jbc.M709837200; Zhang YK, 2007, J BIOL CHEM, V282, P32453, DOI 10.1074/jbc.M706242200	64	25	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18547	18561		10.1074/jbc.M110.214940	http://dx.doi.org/10.1074/jbc.M110.214940			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21454694	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000290785700027
J	Lee, DW; Selamoglu, N; Lanciano, P; Cooley, JW; Forquer, I; Kramer, DM; Daldal, F				Lee, Dong-Woo; Selamoglu, Nur; Lanciano, Pascal; Cooley, Jason W.; Forquer, Isaac; Kramer, David M.; Daldal, Fevzi			Loss of a Conserved Tyrosine Residue of Cytochrome b Induces Reactive Oxygen Species Production by Cytochrome bc(1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL-COMPLEX-III; IRON-SULFUR PROTEIN; ELECTRON-TRANSFER; RHODOBACTER-CAPSULATUS; Q(O) SITE; Q-CYCLE; UBIHYDROQUINONE OXIDATION; DOMAIN MOVEMENT; PLASMODIUM-FALCIPARUM; SUPEROXIDE-PRODUCTION	Production of reactive oxygen species (ROS) induces oxidative damages, decreases cellular energy conversion efficiencies, and induces metabolic diseases in humans. During respiration, cytochrome bc(1) efficiently oxidizes hydroquinone to quinone, but how it performs this reaction without any leak of electrons to O-2 to yield ROS is not understood. Using the bacterial enzyme, here we show that a conserved Tyr residue of the cytochrome b subunit of cytochrome bc(1) is critical for this process. Substitution of this residue with other amino acids decreases cytochrome bc(1) activity and enhances ROS production. Moreover, the Tyr to Cys mutation cross-links together the cytochrome b and iron-sulfur subunits and renders the bacterial enzyme sensitive to O-2 by oxidative disruption of its catalytic [2Fe-2S] cluster. Hence, this Tyr residue is essential in controlling unproductive encounters between O-2 and catalytic intermediates at the quinol oxidation site of cytochrome bc(1) to prevent ROS generation. Remarkably, the same Tyr to Cys mutation is encountered in humans with mitochondrial disorders and in Plasmodium species that are resistant to the anti-malarial drug atovaquone. These findings illustrate the harmful consequences of this mutation in human diseases.	[Lee, Dong-Woo; Selamoglu, Nur; Lanciano, Pascal; Cooley, Jason W.; Daldal, Fevzi] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Forquer, Isaac; Kramer, David M.] Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA	University of Pennsylvania; Washington State University	Daldal, F (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	fdaldal@sas.upenn.edu	Kramer, David M/B-9588-2016	Kramer, David M/0000-0003-2181-6888	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038237] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM038237] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404; ATTAASAFOADJEI E, 1991, P NATL ACAD SCI USA, V88, P492, DOI 10.1073/pnas.88.2.492; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Berry EA, 2000, ANNU REV BIOCHEM, V69, P1005, DOI 10.1146/annurev.biochem.69.1.1005; Berry EA, 2004, PHOTOSYNTH RES, V81, P251, DOI 10.1023/B:PRES.0000036888.18223.0e; Cape JL, 2006, TRENDS PLANT SCI, V11, P46, DOI 10.1016/j.tplants.2005.11.007; Cape JL, 2007, P NATL ACAD SCI USA, V104, P7887, DOI 10.1073/pnas.0702621104; Crofts AR, 2004, ANNU REV PHYSIOL, V66, P689, DOI 10.1146/annurev.physiol.66.032102.150251; Crofts AR, 1999, P NATL ACAD SCI USA, V96, P10021, DOI 10.1073/pnas.96.18.10021; Crofts AR, 2000, BBA-BIOENERGETICS, V1459, P456, DOI 10.1016/S0005-2728(00)00184-5; Darrouzet E, 2000, P NATL ACAD SCI USA, V97, P4567, DOI 10.1073/pnas.97.9.4567; Darrouzet E, 2002, J BIOL CHEM, V277, P3464, DOI 10.1074/jbc.M107973200; Darrouzet E, 2001, TRENDS BIOCHEM SCI, V26, P445, DOI 10.1016/S0968-0004(01)01897-7; DAVIDSON E, 1987, J MOL BIOL, V195, P13, DOI 10.1016/0022-2836(87)90323-8; Drose S, 2008, J BIOL CHEM, V283, P21649, DOI 10.1074/jbc.M803236200; Esser L, 2006, P NATL ACAD SCI USA, V103, P13045, DOI 10.1073/pnas.0601149103; Fisher N, 2004, J BIOL CHEM, V279, P12951, DOI 10.1074/jbc.M313866200; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Hoffman DL, 2009, J BIOL CHEM, V284, P16236, DOI 10.1074/jbc.M809512200; Klimova T, 2008, CELL DEATH DIFFER, V15, P660, DOI 10.1038/sj.cdd.4402307; Kolling DJ, 2007, STRUCTURE, V15, P29, DOI 10.1016/j.str.2006.11.012; Korsinczky M, 2000, ANTIMICROB AGENTS CH, V44, P2100, DOI 10.1128/AAC.44.8.2100-2108.2000; Lee DW, 2008, J BIOL CHEM, V283, P13973, DOI 10.1074/jbc.M800091200; Lesnefsky EJ, 2003, ARCH BIOCHEM BIOPHYS, V420, P287, DOI 10.1016/j.abb.2003.09.046; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; MarinGarcia J, 1996, BIOCHEM MOL BIOL INT, V40, P487; Mather MW, 2005, J BIOL CHEM, V280, P27458, DOI 10.1074/jbc.M502319200; Muller F, 2002, BIOCHEMISTRY-US, V41, P7866, DOI 10.1021/bi025581e; Onder O, 2008, MOL CELL PROTEOMICS, V7, P875, DOI 10.1074/mcp.M700433-MCP200; Onder O, 2006, MOL CELL PROTEOMICS, V5, P1426, DOI 10.1074/mcp.M600099-MCP200; Onder O, 2010, ADV EXP MED BIOL, V675, P179, DOI 10.1007/978-1-4419-1528-3_11; Osyczka A, 2005, TRENDS BIOCHEM SCI, V30, P176, DOI 10.1016/j.tibs.2005.02.001; Osyczka A, 2004, NATURE, V427, P607, DOI 10.1038/nature02242; Ow YLP, 2008, NAT REV MOL CELL BIO, V9, P532, DOI 10.1038/nrm2434; Painter HJ, 2007, NATURE, V446, P88, DOI 10.1038/nature05572; Poole LB, 2008, CURR OPIN CHEM BIOL, V12, P18, DOI 10.1016/j.cbpa.2008.01.021; Poyton RO, 2009, TRENDS ENDOCRIN MET, V20, P332, DOI 10.1016/j.tem.2009.04.001; Snyder CH, 2000, J BIOL CHEM, V275, P13535, DOI 10.1074/jbc.275.18.13535; Solmaz SRN, 2008, J BIOL CHEM, V283, P17542, DOI 10.1074/jbc.M710126200; Srivastava IK, 1999, MOL MICROBIOL, V33, P704, DOI 10.1046/j.1365-2958.1999.01515.x; Tatsuta T, 2008, EMBO J, V27, P306, DOI 10.1038/sj.emboj.7601972; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Valkova-Valchanova MB, 1998, BIOCHEMISTRY-US, V37, P16242, DOI 10.1021/bi981651z; Weinberg F, 2009, ANN NY ACAD SCI, V1177, P66, DOI 10.1111/j.1749-6632.2009.05039.x; Wenz T, 2007, J BIOL CHEM, V282, P3977, DOI 10.1074/jbc.M606482200; Wibrand F, 2001, ANN NEUROL, V50, P540, DOI 10.1002/ana.1224; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612	48	35	36	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					18139	18148		10.1074/jbc.M110.214460	http://dx.doi.org/10.1074/jbc.M110.214460			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454570	hybrid, Green Published			2022-12-25	WOS:000290585200074
J	Li, S; Tsalkova, T; White, MA; Mei, FC; Liu, T; Wang, D; Woods, VL; Cheng, XD				Li, Sheng; Tsalkova, Tamara; White, Mark A.; Mei, Fang C.; Liu, Tong; Wang, Daphne; Woods, Virgil L., Jr.; Cheng, Xiaodong			Mechanism of Intracellular cAMP Sensor Epac2 Activation cAMP-INDUCED CONFORMATIONAL CHANGES IDENTIFIED BY AMIDE HYDROGEN/DEUTERIUM EXCHANGE MASS SPECTROMETRY (DXMS)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-A; MASS-SPECTROMETRY; CYCLIC-AMP; SUBCELLULAR-LOCALIZATION; PHOSPHOLIPASE A(2); DEUTERIUM-EXCHANGE; DOMAIN; RAP1; EXOCYTOSIS; COMPLEX	Epac2, a guanine nucleotide exchange factor, regulates a wide variety of intracellular processes in response to second messenger cAMP. In this study, we have used peptide amide hydrogen/deuterium exchange mass spectrometry to probe the solution structural and conformational dynamics of full-length Epac2 in the presence and absence of cAMP. The results support a mechanism in which cAMP-induced Epac2 activation is mediated by a major hinge motion centered on the C terminus of the second cAMP binding domain. This conformational change realigns the regulatory components of Epac2 away from the catalytic core, making the later available for effector binding. Furthermore, the interface between the first and second cAMP binding domains is highly dynamic, providing an explanation of how cAMP gains access to the ligand binding sites that, in the crystal structure, are seen to be mutually occluded by the other cAMP binding domain. Moreover, cAMP also induces conformational changes at the ionic latch/hairpin structure, which is directly involved in RAP1 binding. These results suggest that in addition to relieving the steric hindrance imposed upon the catalytic lobe by the regulatory lobe, cAMP may also be an allosteric modulator directly affecting the interaction between Epac2 and RAP1. Finally, cAMP binding also induces significant conformational changes in the dishevelled/Egl/pleckstrin (DEP) domain, a conserved structural motif that, although missing from the active Epac2 crystal structure, is important for Epac subcellular targeting and in vivo functions.	[Li, Sheng; Liu, Tong; Wang, Daphne; Woods, Virgil L., Jr.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Li, Sheng; Liu, Tong; Wang, Daphne; Woods, Virgil L., Jr.] Univ Calif San Diego, Biomed Sci Grad program, La Jolla, CA 92093 USA; [Tsalkova, Tamara; White, Mark A.; Mei, Fang C.; Cheng, Xiaodong] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA; [Tsalkova, Tamara; Mei, Fang C.; Cheng, Xiaodong] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Woods, VL (corresponding author), Univ Calif San Diego, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	vwoods@ucsd.edu; xcheng@utmb.edu	Cheng, Xiaodong/O-8176-2019; White, Mark Andrew/B-1723-2012	Cheng, Xiaodong/0000-0002-3479-1694; White, Mark Andrew/0000-0003-1057-4203	National Institutes of Health [GM066170, GM020501, NS070899 GM093325, RR029388]; NIEHS [ES06676]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020501, R01GM093325, R01GM066170, F32GM020501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070899] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM066170 (to X. C. and V. L. W.) and GM020501, NS070899 GM093325 and RR029388 (V. L. W.) and NIEHS Center Grant ES06676 (to X. C.).	Brock M, 2007, J BIOL CHEM, V282, P32256, DOI 10.1074/jbc.M706231200; Burke JE, 2009, J AM CHEM SOC, V131, P8083, DOI 10.1021/ja900098y; Burns-Hamuro LL, 2005, PROTEIN SCI, V14, P2982, DOI 10.1110/ps.051687305; Cheng XD, 2008, ACTA BIOCH BIOPH SIN, V40, P651, DOI 10.1111/j.1745-7270.2008.00438.x; de Rooij J, 2000, J BIOL CHEM, V275, P20829, DOI 10.1074/jbc.M001113200; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; Englander JJ, 2003, P NATL ACAD SCI USA, V100, P7057, DOI 10.1073/pnas.1232301100; Gloerich M, 2010, ANNU REV PHARMACOL, V50, P355, DOI 10.1146/annurev.pharmtox.010909.105714; Hamuro Y, 2004, J MOL BIOL, V340, P1185, DOI 10.1016/j.jmb.2004.05.042; Hsu S, 2009, BIOCHEMISTRY-US, V48, P9891, DOI 10.1021/bi9008853; Hsu YH, 2008, J BIOL CHEM, V283, P9820, DOI 10.1074/jbc.M708143200; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Liu C, 2010, MOL CELL BIOL, V30, P3956, DOI 10.1128/MCB.00242-10; Mei FC, 2005, MOL BIOSYST, V1, P325, DOI 10.1039/b511267b; Mei FC, 2002, J BIOL CHEM, V277, P11497, DOI 10.1074/jbc.M110856200; Niimura M, 2009, J CELL PHYSIOL, V219, P652, DOI 10.1002/jcp.21709; Nijholt IM, 2008, CELL SIGNAL, V20, P1715, DOI 10.1016/j.cellsig.2008.05.001; Ozaki N, 2000, NAT CELL BIOL, V2, P805, DOI 10.1038/35041046; Ponsioen B, 2009, MOL CELL BIOL, V29, P2521, DOI 10.1128/MCB.01630-08; Ponting CP, 1996, TRENDS BIOCHEM SCI, V21, P245, DOI 10.1016/S0968-0004(96)30027-3; Qiao JB, 2002, J BIOL CHEM, V277, P26581, DOI 10.1074/jbc.M203571200; Rehmann H, 2003, J BIOL CHEM, V278, P23508, DOI 10.1074/jbc.M301680200; Rehmann H, 2006, NATURE, V439, P625, DOI 10.1038/nature04468; Rehmann H, 2008, NATURE, V455, P124, DOI 10.1038/nature07187; Shibasaki T, 2004, J BIOL CHEM, V279, P7956, DOI 10.1074/jbc.M309068200; Simons M, 2009, NAT CELL BIOL, V11, P286, DOI 10.1038/ncb1836; Tsalkova T, 2011, ASSAY DRUG DEV TECHN, V9, P88, DOI 10.1089/adt.2010.0338; Tsalkova T, 2009, J BIOL CHEM, V284, P23644, DOI 10.1074/jbc.M109.024950; Wong HC, 2000, NAT STRUCT BIOL, V7, P1178; Wong L, 2004, J MOL BIOL, V341, P93, DOI 10.1016/j.jmb.2004.05.060; ZHANG ZQ, 1993, PROTEIN SCI, V2, P522	32	53	55	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17889	17897		10.1074/jbc.M111.224535	http://dx.doi.org/10.1074/jbc.M111.224535			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454623	Green Published, hybrid			2022-12-25	WOS:000290585200052
J	Melchior-Becker, A; Dai, G; Ding, ZP; Schafer, L; Schrader, J; Young, MF; Fischer, JW				Melchior-Becker, Ariane; Dai, Guang; Ding, Zhaoping; Schaefer, Liliana; Schrader, Juergen; Young, Marian F.; Fischer, Jens W.			Deficiency of Biglycan Causes Cardiac Fibroblasts to Differentiate into a Myofibroblast Phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; EXTRACELLULAR-MATRIX TURNOVER; COLLAGEN GEL CONTRACTION; TGF-BETA; TARGETED DISRUPTION; DECORIN; TISSUE; EXPRESSION; RECEPTOR; SMAD7	Myocardial infarction (MI) is followed by extracellular matrix (ECM) remodeling, which is on the one hand required for the healing response and the formation of stable scar tissue. However, on the other hand, ECM remodeling can lead to fibrosis and decreased ventricular compliance. The small leucine-rich proteoglycan (SLRP), biglycan (bgn), has been shown to be critically involved in these processes. During post-infarct remodeling cardiac fibroblasts differentiate into myofibroblasts which are the main cell type mediating ECM remodeling. The aim of the present study was to characterize the role of bgn in modulating the phenotype of cardiac fibroblasts. Cardiac fibroblasts were isolated from hearts of wild-type (WT) versus bgn(-/0) mice. Phenotypic characterization of the bgn(-/0) fibroblasts revealed increased proliferation. Importantly, this phenotype of bgn(-/0) fibroblasts was abolished to the WT level by reconstitution of biglycan in the ECM. TGF-beta receptor II expression and phosphorylation of SMAD2 were increased. Furthermore, indicative of a myofibroblast phenotype bgn(-/0) fibroblasts were characterized by increased alpha-smooth muscle actin (alpha-SMA) incorporated into stress fibers, increased formation of focal adhesions, and increased contraction of collagen gels. Administration of neutralizing antibodies to TGF-beta reversed the pro-proliferative, myofibroblastic phenotype. In vivo post-MI alpha-SMA, TGF-beta receptor II expression, and SMAD2 phosphorylation were markedly increased in bgn(-/0) mice. Collectively, the data suggest that bgn deficiency promotes myofibroblast differentiation and proliferation in vitro and in vivo likely due to increased responses to TGF-beta and SMAD2 signaling.	[Melchior-Becker, Ariane; Dai, Guang; Fischer, Jens W.] Univ Dusseldorf, Inst Pharmakol & Klin Pharmakol, Univ Klinikum Dusseldorf, D-40225 Dusseldorf, Germany; [Ding, Zhaoping; Schrader, Juergen] Univ Dusseldorf, Inst Herz & Kreislaufphysiol, D-40225 Dusseldorf, Germany; [Schaefer, Liliana] Klinikum JW Goethe Univ, Pharmazentrum Frankfurt, Inst Allgemeine Pharmakol & Toxikol ZAFES, D-60590 Frankfurt, Germany; [Young, Marian F.] NIDCR, Craniofacial & Skeletal Dis Branch, NIH, Bethesda, MD 20892 USA	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Heinrich Heine University Dusseldorf; Goethe University Frankfurt; Goethe University Frankfurt Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Fischer, JW (corresponding author), Univ Dusseldorf, Inst Pharmakol & Klin Pharmakol, Univ Klinikum Dusseldorf, Moorenstr 5, D-40225 Dusseldorf, Germany.	jens.fischer@uni-duesseldorf.de		Schaefer, Liliana/0000-0002-3318-3005; Young, Marian F/0000-0003-0929-8854	Deutsche Forschungsgemeinschaft [GRK 1089]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000379] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by Deutsche Forschungsgemeinschaft Grant GRK 1089.	Acharya PS, 2008, J CELL SCI, V121, P1393, DOI 10.1242/jcs.021683; BERSCHNEIDER HM, 1992, J CLIN INVEST, V89, P484, DOI 10.1172/JCI115610; BERSCHNEIDER HM, 1992, ANN NY ACAD SCI, V664, P140, DOI 10.1111/j.1749-6632.1992.tb39756.x; Bochaton-Piallat ML, 2000, INVEST OPHTH VIS SCI, V41, P2336; Bonni S, 2001, NAT CELL BIOL, V3, P587, DOI 10.1038/35078562; Campbell Patrick H., 2008, Molecular & Cellular Biomechanics, V5, P27; Corsi A, 2002, J BONE MINER RES, V17, P1180, DOI 10.1359/jbmr.2002.17.7.1180; Cunnington RH, 2009, CAN J PHYSIOL PHARM, V87, P764, DOI 10.1139/Y09-076; Dai G, 2007, AM J PATHOL, V171, P1451, DOI 10.2353/ajpath.2007.070136; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; DESMOULIERE A, 1995, AM J PATHOL, V146, P56; Dobaczewski M, 2006, CELL TISSUE RES, V324, P475, DOI 10.1007/s00441-005-0144-6; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Edlund S, 2005, MOL CELL BIOL, V25, P1475, DOI 10.1128/MCB.25.4.1475-1488.2005; Edlund S, 2003, MOL BIOL CELL, V14, P529, DOI 10.1091/mbc.02-03-0037; Embree MC, 2010, AM J PATHOL, V176, P812, DOI 10.2353/ajpath.2010.090450; Ferdous Z, 2007, J BIOL CHEM, V282, P35887, DOI 10.1074/jbc.M705180200; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; Hinterleitner TA, 1996, AM J PHYSIOL-CELL PH, V271, pC1262, DOI 10.1152/ajpcell.1996.271.4.C1262; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Huebener P, 2008, J IMMUNOL, V180, P2625, DOI 10.4049/jimmunol.180.4.2625; Inkson CA, 2009, CELLS TISSUES ORGANS, V189, P153, DOI 10.1159/000151377; Jarvelainen H, 2004, ARTERIOSCL THROM VAS, V24, P67, DOI 10.1161/01.ATV.0000107026.98626.3b; JONES PA, 1979, P NATL ACAD SCI USA, V76, P353, DOI 10.1073/pnas.76.1.353; Kalmes M, 2006, BIOL CHEM, V387, P1201, DOI 10.1515/BC.2006.148; Kitaya K, 2009, J LEUKOCYTE BIOL, V85, P391, DOI 10.1189/jlb.0908535; Kresse H, 1997, J BIOL CHEM, V272, P18404, DOI 10.1074/jbc.272.29.18404; Kresse H, 2001, J BIOL CHEM, V276, P13411, DOI 10.1074/jbc.M009321200; Landstrom M, 2000, CURR BIOL, V10, P535, DOI 10.1016/S0960-9822(00)00470-X; Leurs C, 2003, HUM GENE THER, V14, P509, DOI 10.1089/104303403764539305; Lijnen P, 2003, J RENIN-ANGIO-ALDO S, V4, P113, DOI 10.3317/jraas.2003.011; Lijnen P, 2003, METHOD FIND EXP CLIN, V25, P79, DOI 10.1358/mf.2003.25.2.723680; Mann BK, 2001, BIOMATERIALS, V22, P439, DOI 10.1016/S0142-9612(00)00196-4; Marzoll A., 2009, J CELL MOL IN PRESS; Masters KSB, 2005, J BIOMAT SCI-POLYM E, V16, P659, DOI 10.1163/1568562053783722; Mazars A, 2001, J BIOL CHEM, V276, P36797, DOI 10.1074/jbc.M101672200; Nagy N, 2010, BASIC RES CARDIOL, V105, P29, DOI 10.1007/s00395-009-0051-1; PETERKOFSKY B, 1972, BIOCHEM BIOPH RES CO, V49, P1343, DOI 10.1016/0006-291X(72)90614-6; Porter KE, 2009, PHARMACOL THERAPEUT, V123, P255, DOI 10.1016/j.pharmthera.2009.05.002; Reinboth B, 2002, J BIOL CHEM, V277, P3950, DOI 10.1074/jbc.M109540200; Rock K., 2010, DERMATOLOGY IN PRESS; Schaefer L, 2004, AM J PATHOL, V165, P383, DOI 10.1016/S0002-9440(10)63305-6; Schaefer L, 2005, J CLIN INVEST, V115, P2223, DOI 10.1172/JCI23755; Schaefer L, 2003, J BIOL CHEM, V278, P26227, DOI 10.1074/jbc.M210574200; SCHWARZ RI, 1977, P NATL ACAD SCI USA, V74, P4453, DOI 10.1073/pnas.74.10.4453; Shimizu-Hirota R, 2004, CIRC RES, V94, P1067, DOI 10.1161/01.RES.0000126049.79800.CA; Sun Y, 2000, CARDIOVASC RES, V46, P250, DOI 10.1016/S0008-6363(00)00032-8; Sun Y, 1996, J MOL CELL CARDIOL, V28, P851, DOI 10.1006/jmcc.1996.0080; Tang Y, 2008, J BIOL CHEM, V283, P23956, DOI 10.1074/jbc.M800351200; Tiede K, 2010, BASIC RES CARDIOL, V105, P99, DOI 10.1007/s00395-009-0049-8; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Vernon RB, 2002, IN VITRO CELL DEV-AN, V38, P97, DOI 10.1290/1071-2690(2002)038<0097:AIMFTC>2.0.CO;2; Webber J, 2009, AM J PATHOL, V175, P148, DOI 10.2353/ajpath.2009.080837; Weber CK, 2001, GASTROENTEROLOGY, V121, P657, DOI 10.1053/gast.2001.27222; Weis SM, 2005, MATRIX BIOL, V24, P313, DOI 10.1016/j.matbio.2005.05.003; WELCH MP, 1990, J CELL BIOL, V110, P133, DOI 10.1083/jcb.110.1.133; Westermann D, 2008, CIRCULATION, V117, P1269, DOI 10.1161/CIRCULATIONAHA.107.714147; WILBORN J, 1995, AM J PHYSIOL-LUNG C, V268, pL294, DOI 10.1152/ajplung.1995.268.2.L294; WILBORN J, 1995, J CLIN INVEST, V95, P1861, DOI 10.1172/JCI117866; WILLEMS IEMG, 1994, AM J PATHOL, V145, P868; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Xu TS, 1998, NAT GENET, V20, P78, DOI 10.1038/1746; Young MF, 2002, GLYCOCONJUGATE J, V19, P257, DOI 10.1023/A:1025336114352; Yu Q, 2000, GENE DEV, V14, P163; Zamilpa R, 2010, J MOL CELL CARDIOL, V48, P558, DOI 10.1016/j.yjmcc.2009.06.012; ZERN MA, 1985, EXP CELL RES, V160, P307, DOI 10.1016/0014-4827(85)90178-8; Zhang Z, 2009, BURNS, V35, P527, DOI 10.1016/j.burns.2008.08.021	67	59	61	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17365	17375		10.1074/jbc.M110.192682	http://dx.doi.org/10.1074/jbc.M110.192682			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454527	Green Published, hybrid			2022-12-25	WOS:000290301900084
J	Chan, D; Citro, A; Cordy, JM; Shen, GC; Wolozin, B				Chan, Diane; Citro, Allison; Cordy, Joanna M.; Shen, Grace C.; Wolozin, Benjamin			Rac1 Protein Rescues Neurite Retraction Caused by G2019S Leucine-rich Repeat Kinase 2 (LRRK2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE; ALPHA-SYNUCLEIN; RHO GTPASES; ACTIVATION; EXPRESSION; EZRIN/RADIXIN/MOESIN; PHOSPHORYLATION; VULNERABILITY; MITOCHONDRIA; PATHOGENESIS	Mutations in leucine-rich repeat kinase 2 (LRRK2) are currently the most common genetic cause of familial late-onset Parkinson disease, which is clinically indistinguishable from idiopathic disease. The most common pathological mutation in LRRK2, G2019S LRRK2, is known to cause neurite retraction. However, molecular mechanisms underlying regulation of neurite length by LRRK2 are unknown. Here, we demonstrate a novel interaction between LRRK2 and the Rho GTPase, Rac1, which plays a critical role in actin cytoskeleton remodeling necessary for the maintenance of neurite morphology. LRRK2 binds strongly to endogenous or expressed Rac1, while showing weak binding to Cdc42 and no binding to RhoA. Co-expression with LRRK2 increases Rac1 activity, as shown by increased binding to the p21-activated kinase, which modulates actin cytoskeletal dynamics. LRRK2 constructs carrying mutations that inactivate the kinase or GTPase activities do not activate Rac1. Interestingly, LRRK2 does not increase levels of membrane-bound Rac1 but dramatically changes the cellular localization of Rac1, causing polarization, which is augmented further when LRRK2 is co-expressed with constitutively active Rac1. Four different disease-related mutations in LRRK2 altered binding to Rac1, with the G2019S and R1441C LRRK2 mutations attenuating Rac1 binding and the Y1699C and I2020T LRRK2 mutations increasing binding. Co-expressing Rac1 in SH-SY5Y cells rescues the G2019S mutant phenotype of neurite retraction. We hypothesize that pathological mutations in LRRK2 attenuates activation of Rac1, causing disassembly of actin filaments, leading to neurite retraction. The interactions between LRRK2 and Rho GTPases provide a novel pathway through which LRRK2 might modulate cellular dynamics and contribute to the pathophysiology of Parkinson disease.	[Chan, Diane; Citro, Allison; Cordy, Joanna M.; Shen, Grace C.; Wolozin, Benjamin] Boston Univ, Sch Med, Dept Pharmacol, Boston, MA 02118 USA; [Wolozin, Benjamin] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA	Boston University; Boston University	Wolozin, B (corresponding author), Boston Univ, Sch Med, Dept Pharmacol, 72 E Concord St,R-614, Boston, MA 02118 USA.	bwolozin@bu.edu		Chan, Diane/0000-0003-3765-190X	National Institutes of Health [NIEHS ES15567, NINDS NS41786, 066108, NINDS NS066658]; Alzheimer Association and Michael J. Fox Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041786, R01NS060872, F30NS066658] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer Association and Michael J. Fox Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NIEHS ES15567 and NINDS NS41786 and 066108 (to B. W.) and NINDS NS066658 (to D. C.). This work was also supported by the Alzheimer Association and Michael J. Fox Foundation (to B. W.).	Anand VS, 2009, FEBS J, V276, P466, DOI 10.1111/j.1742-4658.2008.06789.x; Biskup S, 2008, J NEUROL, V255, P8, DOI 10.1007/s00415-008-5005-2; Biskup S, 2006, ANN NEUROL, V60, P557, DOI 10.1002/ana.21019; Carballo-Carbajal I, 2010, CELL SIGNAL, V22, P821, DOI 10.1016/j.cellsig.2010.01.006; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Dawson TM, 2009, BBA-MOL BASIS DIS, V1792, P585, DOI 10.1016/j.bbadis.2009.06.001; Deng JP, 2008, P NATL ACAD SCI USA, V105, P1499, DOI 10.1073/pnas.0709098105; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007; Festjens N, 2007, CELL DEATH DIFFER, V14, P400, DOI 10.1038/sj.cdd.4402085; Gloeckner CJ, 2009, J NEUROCHEM, V109, P959, DOI 10.1111/j.1471-4159.2009.06024.x; Greggio E, 2008, J BIOL CHEM, V283, P16906, DOI 10.1074/jbc.M708718200; Greggio E, 2007, J NEUROCHEM, V102, P93, DOI 10.1111/j.1471-4159.2007.04523.x; Greggio E, 2009, ASN NEURO, V1, DOI 10.1042/AN20090007; Guo FK, 2006, J BIOL CHEM, V281, P18652, DOI 10.1074/jbc.M603508200; Haebig K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013762; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Ho CCY, 2009, J NEUROSCI, V29, P1011, DOI 10.1523/JNEUROSCI.5175-08.2009; Hsu CH, 2010, NEURODEGENER DIS, V7, P68, DOI 10.1159/000285509; Hsu CH, 2010, J NEUROCHEM, V112, P1593, DOI 10.1111/j.1471-4159.2010.06568.x; Hughes SC, 2007, CURR OPIN CELL BIOL, V19, P51, DOI 10.1016/j.ceb.2006.12.004; Imai Y, 2008, EMBO J, V27, P2432, DOI 10.1038/emboj.2008.163; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jaleel M, 2007, BIOCHEM J, V405, P307, DOI 10.1042/BJ20070209; Klein CL, 2009, J NEUROCHEM, V111, P703, DOI 10.1111/j.1471-4159.2009.06358.x; Ko HS, 2009, P NATL ACAD SCI USA, V106, P2897, DOI 10.1073/pnas.0810123106; Kreis P, 2009, CELL SIGNAL, V21, P384, DOI 10.1016/j.cellsig.2008.11.001; Kumar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008730; Lewis PA, 2007, BIOCHEM BIOPH RES CO, V357, P668, DOI 10.1016/j.bbrc.2007.04.006; Li XT, 2007, J NEUROCHEM, V103, P238, DOI 10.1111/j.1471-4159.2007.04743.x; Linseman DA, 2008, FRONT BIOSCI-LANDMRK, V13, P657, DOI 10.2741/2710; Liou AKF, 2008, NEUROBIOL DIS, V32, P116, DOI 10.1016/j.nbd.2008.06.016; MacLeod D, 2006, NEURON, V52, P587, DOI 10.1016/j.neuron.2006.10.008; Mata IF, 2006, TRENDS NEUROSCI, V29, P286, DOI 10.1016/j.tins.2006.03.006; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Nichols RJ, 2010, BIOCHEM J, V430, P393, DOI 10.1042/BJ20100483; Niggli V, 2008, INT J BIOCHEM CELL B, V40, P344, DOI 10.1016/j.biocel.2007.02.012; Ogita H, 2006, METHOD ENZYMOL, V406, P415, DOI 10.1016/S0076-6879(06)06030-7; Parisiadou L, 2009, J NEUROSCI, V29, P13971, DOI 10.1523/JNEUROSCI.3799-09.2009; Plowey ED, 2008, J NEUROCHEM, V105, P1048, DOI 10.1111/j.1471-4159.2008.05217.x; Saha S, 2009, J NEUROSCI, V29, P9210, DOI 10.1523/JNEUROSCI.2281-09.2009; Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7; Sen S, 2009, J BIOL CHEM, V284, P36346, DOI 10.1074/jbc.M109.025437; Shin N, 2008, EXP CELL RES, V314, P2055, DOI 10.1016/j.yexcr.2008.02.015; Smith SD, 2008, J CELL SCI, V121, P3729, DOI 10.1242/jcs.027680; Smith WW, 2005, P NATL ACAD SCI USA, V102, P18676, DOI 10.1073/pnas.0508052102; Subauste MC, 2000, J BIOL CHEM, V275, P9725, DOI 10.1074/jbc.275.13.9725; Taylor JP, 2006, TRENDS MOL MED, V12, P76, DOI 10.1016/j.molmed.2005.12.004; Ved R, 2005, J BIOL CHEM, V280, P42655, DOI 10.1074/jbc.M505910200; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Watabe-Uchida M, 2006, J NEUROSCI, V26, P10633, DOI 10.1523/JNEUROSCI.4084-06.2006; White LR, 2007, J NEUROSCI RES, V85, P1288, DOI 10.1002/jnr.21240	53	88	88	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M111.234005	http://dx.doi.org/10.1074/jbc.M111.234005			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454543	hybrid, Green Published			2022-12-25	WOS:000290022800054
J	Wang, HB; Xiao, LQ; Kazanietz, MG				Wang, HongBin; Xiao, Liqing; Kazanietz, Marcelo G.			p23/Tmp21 Associates with Protein Kinase C delta(PKC delta) and Modulates Its Apoptotic Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER CELLS; ESTER-INDUCED APOPTOSIS; C-DELTA; PHORBOL ESTER; PKC-DELTA; SUBCELLULAR-LOCALIZATION; TRANSMEMBRANE PROTEIN; DIFFERENTIAL LOCALIZATION; DEPENDENT BINDING; GOLGI-COMPLEX	There is emerging evidence that C1 domains, motifs originally identified in PKC isozymes and responsible for binding of phorbol esters and diacylglycerol, interact with the Golgi/endoplasmic reticulum protein p23 (Tmp21). In this study, we investigated whether PKC delta, a kinase widely implicated in apoptosis and inhibition of cell cycle progression, associates with p23 and determined the potential functional implications of this interaction. Using a yeast two-hybrid approach, we found that the PKC delta C1b domain associates with p23 and identified two key residues (Asp(245) and Met(266)) implicated in this interaction. Interestingly, silencing p23 from LNCaP prostate cancer cells using RNAi markedly enhanced PKC delta-dependent apoptosis and activation of PKC delta downstream effectors ROCK and JNK by phorbol 12-myristate 13-acetate. Moreover, translocation of PKC delta to the plasma membrane by phorbol 12-myristate 13-acetate was enhanced in p23-depleted LNCaP cells. Notably, a PKC delta mutant that failed to interact with p23 triggered a strong apoptotic response when expressed in LNCaP cells. In summary, our data compellingly support the concept that C1 domains have dual roles both in lipid and protein associations and provide strong evidence that p23 acts as an anchoring protein that retains PKC delta at the perinuclear region, thus limiting the availability of this kinase for activation in response to stimuli.	[Wang, HongBin; Xiao, Liqing; Kazanietz, Marcelo G.] Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA	University of Pennsylvania	Wang, HB (corresponding author), Univ Penn, Sch Med, Dept Pharmacol, 1238 Biomed Res Bldg,2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.	hongbin@mail.med.upenn.edu; marcelog@upenn.edu	wang, hongbin/E-5541-2011		National Institutes of Health [RO1-CA89202]; NATIONAL CANCER INSTITUTE [R01CA089202] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1-CA89202 from (to M. G. K.).	Anilkumar N, 2003, EMBO J, V22, P5390, DOI 10.1093/emboj/cdg521; Blass M, 2002, MOL CELL BIOL, V22, P182, DOI 10.1128/MCB.22.1.182-195.2002; Blumberg PM, 2008, CURR DRUG TARGETS, V9, P641, DOI 10.2174/138945008785132376; Bogi K, 1998, CANCER RES, V58, P1423; Caino MC, 2011, J BIOL CHEM, V286, P11254, DOI 10.1074/jbc.M110.194332; Caloca MJ, 1999, P NATL ACAD SCI USA, V96, P11854, DOI 10.1073/pnas.96.21.11854; Caloca MJ, 2003, J BIOL CHEM, V278, P33465, DOI 10.1074/jbc.M302807200; Caloca MJ, 1997, J BIOL CHEM, V272, P26488, DOI 10.1074/jbc.272.42.26488; Caloca MJ, 2001, J BIOL CHEM, V276, P18303, DOI 10.1074/jbc.M011368200; Carrasco S, 2004, MOL BIOL CELL, V15, P2932, DOI 10.1091/mbc.E03-11-0844; Chen D, 2004, J BIOL CHEM, V279, P4829, DOI 10.1074/jbc.M311196200; Chen D, 2007, J BIOL CHEM, V282, P33776, DOI 10.1074/jbc.M703320200; Chen FS, 2006, NATURE, V440, P1208, DOI 10.1038/nature04667; Colon-Gonzalez F, 2006, BBA-MOL CELL BIOL L, V1761, P827, DOI 10.1016/j.bbalip.2006.05.001; Colon-Gonzalez F, 2008, J BIOL CHEM, V283, P35247, DOI 10.1074/jbc.M806264200; Csukai M, 1999, PHARMACOL RES, V39, P253, DOI 10.1006/phrs.1998.0418; DeVries TA, 2002, EMBO J, V21, P6050, DOI 10.1093/emboj/cdf606; Fikaris AJ, 2005, J BIOL CHEM, V280, P32107, DOI 10.1074/jbc.M504432200; Fucini RV, 2002, MOL BIOL CELL, V13, P621, DOI 10.1091/mbc.01-11-0547; Fujii T, 2000, J BIOL CHEM, V275, P7574, DOI 10.1074/jbc.275.11.7574; Gavrielides MV, 2006, CANCER RES, V66, P11792, DOI 10.1158/0008-5472.CAN-06-1139; Gomel R, 2007, MOL CANCER RES, V5, P627, DOI 10.1158/1541-7786.MCR-06-0255; Gonzalez-Guerrico AM, 2005, J BIOL CHEM, V280, P38982, DOI 10.1074/jbc.M506767200; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Kajimoto T, 2004, J BIOL CHEM, V279, P12668, DOI 10.1074/jbc.M312350200; Lagory EL, 2010, J BIOL CHEM, V285, P1879, DOI 10.1074/jbc.M109.055392; Lim JH, 2009, CARCINOGENESIS, V30, P729, DOI 10.1093/carcin/bgn265; Majoul I, 2001, DEV CELL, V1, P139, DOI 10.1016/S1534-5807(01)00004-1; NEWTON AC, 1995, J BIOL CHEM, V270, P28495, DOI 10.1074/jbc.270.48.28495; Nguyen TA, 2004, J BIOL CHEM, V279, P52714, DOI 10.1074/jbc.M403040200; Panaretakis T, 2005, MOL BIOL CELL, V16, P3821, DOI 10.1091/mbc.E04-10-0862; Perego C, 2002, BIOCHEM BIOPH RES CO, V294, P127, DOI 10.1016/S0006-291X(02)00448-5; Pu YM, 2006, J BIOL CHEM, V281, P33773, DOI 10.1074/jbc.M606560200; Qi X, 2008, J CELL SCI, V121, P804, DOI 10.1242/jcs.024653; Rojo M, 2000, J CELL SCI, V113, P1043; Rojo M, 1997, J CELL BIOL, V139, P1119, DOI 10.1083/jcb.139.5.1119; Schultz A, 2004, J BIOL CHEM, V279, P31750, DOI 10.1074/jbc.M313017200; Schultz A, 2003, CELL DEATH DIFFER, V10, P662, DOI 10.1038/sj.cdd.4401235; Sohn K, 1996, J CELL BIOL, V135, P1239, DOI 10.1083/jcb.135.5.1239; STAMNES MA, 1995, P NATL ACAD SCI USA, V92, P8011, DOI 10.1073/pnas.92.17.8011; Strating JRPM, 2009, BIOL CELL, V101, P495, DOI 10.1042/BC20080233; Sumitomo M, 2002, J CLIN INVEST, V109, P827, DOI 10.1172/JCI200214146; Sunesson L, 2008, J BIOL CHEM, V283, P16653, DOI 10.1074/jbc.M710436200; Tanaka Y, 2003, J BIOL CHEM, V278, P33753, DOI 10.1074/jbc.M303313200; Torgersen ML, 2007, J BIOL CHEM, V282, P16317, DOI 10.1074/jbc.M610886200; von Burstin VA, 2010, MOL PHARMACOL, V78, P325, DOI 10.1124/mol.110.064741; Wang H, 2006, BIOCHEM SOC T, V34, P855, DOI 10.1042/BST0340855; Wang HB, 2002, J BIOL CHEM, V277, P4541, DOI 10.1074/jbc.M107150200; Wang HB, 2006, EMBO J, V25, P2062, DOI 10.1038/sj.emboj.7601098; Wang HB, 2010, MOL BIOL CELL, V21, P1398, DOI 10.1091/mbc.E09-08-0735; Wang QMJ, 1999, J BIOL CHEM, V274, P37233, DOI 10.1074/jbc.274.52.37233; WATANABE T, 1992, P NATL ACAD SCI USA, V89, P10159, DOI 10.1073/pnas.89.21.10159; Xiao LQ, 2009, J BIOL CHEM, V284, P29365, DOI 10.1074/jbc.M109.007971; Zhao LY, 1999, J BIOL CHEM, V274, P14198, DOI 10.1074/jbc.274.20.14198	54	32	32	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M111.227991	http://dx.doi.org/10.1074/jbc.M111.227991			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454541	hybrid, Green Published			2022-12-25	WOS:000290022800023
J	Xia, Y; Lundback, AK; Sahaf, N; Nordlund, G; Brzezinski, P; Eshaghi, S				Xia, Yu; Lundbaeck, Anna-Karin; Sahaf, Newsha; Nordlund, Gustav; Brzezinski, Peter; Eshaghi, Said			Co2+ Selectivity of Thermotoga maritima CorA and Its Inability to Regulate Mg2+ Homeostasis Present a New Class of CorA Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAGNESIUM TRANSPORT; SALMONELLA-TYPHIMURIUM; CRYSTAL-STRUCTURE; HYPERTHERMOPHILIC BACTERIUM; ALKALINE-PHOSPHATASE; ANGSTROM RESOLUTION; STABILITY; SYSTEM; HOMOTETRAMER; CLONING	CorA is a family of divalent cation transporters ubiquitously present in bacteria and archaea. Although CorA can transport both Mg2+ and Co2+ almost equally well, its main role has been suggested to be that of primary Mg2+ transporter of prokaryotes and hence the regulator of Mg2+ homeostasis. The reason is that the affinity of CorA for Co2+ is relatively low and thus considered non-physiological. Here, we show that Thermotoga maritima CorA (TmCorA) is incapable of regulating the Mg2+ homeostasis and therefore cannot be the primary Mg2+ transporter of T. maritima. Further, our in vivo experiments confirm that TmCorA is a highly selective Co2+ transporter, as it selects Co2+ over Mg2+ at > 100 times lower concentrations. In addition, we present data that show TmCorA to be extremely thermostable in the presence of Co2+. Mg2+ could not stabilize the protein to the same extent, even at high concentrations. We also show that addition of Co2+, but not Mg2+, specifically induces structural changes to the protein. Altogether, these data show that TmCorA has the role of being the transporter of Co2+ but not Mg2+. The physiological relevance and requirements of Co2+ in T. maritima is discussed and highlighted. We suggest that CorA may have different roles in different organisms. Such functional diversity is presumably a reflection of minor, but important structural differences within the CorA family that regulate the gating, substrate selection, and transport.	[Xia, Yu; Lundbaeck, Anna-Karin; Sahaf, Newsha; Eshaghi, Said] Nanyang Technol Univ, Sch Biol Sci, Singapore 138673, Singapore; [Nordlund, Gustav; Brzezinski, Peter] Stockholm Univ, Arrhenius Labs Nat Sci, Dept Biochem & Biophys, S-10691 Stockholm, Sweden	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Stockholm University	Eshaghi, S (corresponding author), 61 Biopolis Dr, Singapore 138673, Singapore.	Said.Eshaghi@ntu.edu.sg			Nanyang Technological University; National Research Foundation (NRF); Biomedical Research Council (BMRC) of Singapore; Swedish Research Council; Center for Biomembrane Research at Stockholm University; Knut and Alice Wallenberg Foundation	Nanyang Technological University(Nanyang Technological University); National Research Foundation (NRF); Biomedical Research Council (BMRC) of Singapore(Agency for Science Technology & Research (A*STAR)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Center for Biomembrane Research at Stockholm University; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This work was supported by grants from Nanyang Technological University, the National Research Foundation (NRF) and Biomedical Research Council (BMRC) of Singapore, the Swedish Research Council, the Center for Biomembrane Research at Stockholm University, and the Knut and Alice Wallenberg Foundation.	Alexandrov AI, 2008, STRUCTURE, V16, P351, DOI 10.1016/j.str.2008.02.004; BALCH WE, 1979, MICROBIOL REV, V43, P260, DOI 10.1128/MMBR.43.2.260-296.1979; Cannio R, 2004, EXTREMOPHILES, V8, P117, DOI 10.1007/s00792-003-0370-3; Chakrabarti N, 2010, BIOPHYS J, V98, P784, DOI 10.1016/j.bpj.2009.11.009; Epting KL, 2005, FEBS J, V272, P1454, DOI 10.1111/j.1742-4658.2005.04577.x; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Eshaghi S, 2006, SCIENCE, V313, P354, DOI 10.1126/science.1127121; HMIEL SP, 1989, J BACTERIOL, V171, P4742, DOI 10.1128/jb.171.9.4742-4751.1989; HMIEL SP, 1986, J BACTERIOL, V168, P1444, DOI 10.1128/jb.168.3.1444-1450.1986; Hogbom M, 2004, SCIENCE, V305, P245, DOI 10.1126/science.1098419; Holden JF, 2003, CURR OPIN CHEM BIOL, V7, P160, DOI 10.1016/S1367-5931(03)00026-7; HUBER R, 1986, ARCH MICROBIOL, V144, P324, DOI 10.1007/BF00409880; Jorge CD, 2007, EXTREMOPHILES, V11, P115, DOI 10.1007/s00792-006-0021-6; Kehres D G, 1998, Microb Comp Genomics, V3, P151, DOI 10.1089/omi.1.1998.3.151; Kehres DG, 2002, BIOMETALS, V15, P261, DOI 10.1023/A:1016078832697; Llanos J, 2000, CURR MICROBIOL, V41, P201, DOI 10.1007/s002840010119; Lunin VV, 2006, NATURE, V440, P833, DOI 10.1038/nature04642; Majava V, 2008, FEBS J, V275, P4583, DOI 10.1111/j.1742-4658.2008.06601.x; Nakajima M, 2003, ARCH BIOCHEM BIOPHYS, V415, P87, DOI 10.1016/S0003-9861(03)00222-4; Niegowski D, 2007, CELL MOL LIFE SCI, V64, P2564, DOI 10.1007/s00018-007-7174-z; Payandeh J, 2008, J BIOL CHEM, V283, P11721, DOI 10.1074/jbc.M707889200; Payandeh J, 2006, EMBO J, V25, P3762, DOI 10.1038/sj.emboj.7601269; SCHUMANN J, 1991, FEBS LETT, V282, P122, DOI 10.1016/0014-5793(91)80459-G; Smith RL, 1998, J BACTERIOL, V180, P2788, DOI 10.1128/JB.180.10.2788-2791.1998; Smith RL, 1998, MICROBIOL-SGM, V144, P1835, DOI 10.1099/00221287-144-7-1835; SMITH RL, 1995, J BACTERIOL, V177, P1638, DOI 10.1128/jb.177.6.1638-1640.1995; SNAVELY MD, 1989, J BACTERIOL, V171, P4761, DOI 10.1128/jb.171.9.4761-4766.1989; Song SH, 2008, APPL MICROBIOL BIOT, V81, P485, DOI 10.1007/s00253-008-1633-9; Spraggon G, 2004, PROTEINS, V55, P1078, DOI 10.1002/prot.20034; Sterner R, 1996, PROTEIN SCI, V5, P2000, DOI 10.1002/pro.5560051006; Svidova S., 2010, BIOCH BIOPH IN PRESS; Tan KM, 2009, PROTEIN SCI, V18, P2043, DOI 10.1002/pro.215; Tetin SY, 2000, METHODS, V20, P341, DOI 10.1006/meth.1999.0927; Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103; Wang J, 2005, BIOCHEMISTRY-US, V44, P8378, DOI 10.1021/bi050155p; Wang SZ, 2006, J BIOL CHEM, V281, P26813, DOI 10.1074/jbc.M602342200; Warren MA, 2004, J BACTERIOL, V186, P4605, DOI 10.1128/JB.186.14.4605-4612.2004; Wojciechowski CL, 2002, PROTEIN SCI, V11, P903, DOI 10.1110/ps.4260102	38	21	22	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M111.222166	http://dx.doi.org/10.1074/jbc.M111.222166			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454699	hybrid, Green Submitted, Green Published			2022-12-25	WOS:000290022800089
J	Yoon, S; Choi, MH; Chang, MS; Baik, JH				Yoon, Sehyoun; Choi, Mi-hyun; Chang, Min Seok; Baik, Ja-Hyun			Wnt5a-Dopamine D2 Receptor Interactions Regulate Dopamine Neuron Development via Extracellular Signal-regulated Kinase (ERK) Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; DISHEVELLED PHOSPHORYLATION; SUBVENTRICULAR ZONE; 2 ISOFORMS; CELLS; WNT-5A; D-3; STIMULATION; EXPRESSION; SURVIVAL	The dopamine D2 receptor (D2R) plays an important role in mesencephalic dopaminergic neuronal development, particularly coupled with extracellular signal-regulated kinase (ERK) activation. Wnt5a protein is known to regulate the development of dopaminergic neurons. We analyzed the effect of Wnt5a on dopaminergic neuron development in mesencephalic primary cultures from wild-type (WT) and D2R knock-out (D2R(-/-)) mice. Treatment with Wnt5a increased the number and neuritic length of dopamine neurons in primary mesencephalic neuronal cultures from WT mice, but not from D2R(-/-) mice. The effect of Wnt5a was completely blocked by treatment with D2R antagonist or inhibitors of MAPK or EGFR. Wnt5a-mediated ERK activation in mesencephalic neuronal cultures was inhibited by treatment of D2R antagonist and EGFR inhibitors in WT mice. However, these regulations were not observed for D2R(-/-) mice. Co-immunoprecipitation and displacement of [H-3] spiperone from D2R by Wnt5a demonstrated that Wnt5a could bind with D2R. This interaction was confirmed by GST pulldown assays demonstrating that the domain including transmembrane domain 4, second extracellular loop, and transmembrane domain 5 of D2R binds to Wnt5a. These results suggest that the interaction between D2R and Wnt5a has an important role in dopamine neuron development in association with EGFR and the ERK pathway.	[Baik, Ja-Hyun] Korea Univ, Sch Life Sci & Biotechnol, Mol Neurobiol Lab, Seoul 136701, South Korea	Korea University	Baik, JH (corresponding author), Korea Univ, Sch Life Sci & Biotechnol, Mol Neurobiol Lab, Seoul 136701, South Korea.	jahyunb@korea.ac.kr	soler, martha maricel m gomez/L-6025-2014	soler, martha maricel m gomez/0000-0002-4412-8108; Yoon, Sehyoun/0000-0001-6545-3615	Korea Healthcare Technology RD Project [A084139]; Ministry of Education, Science and Technology, the Republic of Korea [2009K001254, 2010K000814]; Korea University; Seoul Scholarship Foundation	Korea Healthcare Technology RD Project; Ministry of Education, Science and Technology, the Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea University; Seoul Scholarship Foundation	This work was supported in part by a research grant from the Korea Healthcare Technology R&D Project A084139, Grants 2009K001254 and 2010K000814 from the Brain Research Center of the 21st Century Frontier Research Program funded by the Ministry of Education, Science and Technology, the Republic of Korea, and by a Korea University grant.; Supported by a Hi Seoul Science (Humanities) fellowship from the Seoul Scholarship Foundation.	Abe Y, 2009, NEUROSCIENCE, V161, P95, DOI 10.1016/j.neuroscience.2009.03.022; Almeida M, 2005, J BIOL CHEM, V280, P41342, DOI 10.1074/jbc.M502168200; An JJ, 2003, MOL CELL ENDOCRINOL, V206, P49, DOI 10.1016/S0303-7207(03)00236-3; Andersson ER, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003517; Arenas E, 2005, ANN NY ACAD SCI, V1049, P51, DOI 10.1196/annals.1334.007; Bryja V, 2007, J CELL SCI, V120, P586, DOI 10.1242/jcs.03368; CASPER D, 1991, J NEUROSCI RES, V30, P372, DOI 10.1002/jnr.490300213; CASPER D, 1994, J NEUROCHEM, V62, P2166; Castelo-Branco GA, 2003, P NATL ACAD SCI USA, V100, P12747, DOI 10.1073/pnas.1534900100; Choi EY, 1999, BIOCHEM BIOPH RES CO, V256, P33, DOI 10.1006/bbrc.1999.0286; Civenni G, 2003, EMBO REP, V4, P166, DOI 10.1038/sj.embor.embor735; Collo G, 2008, EUR J NEUROSCI, V28, P1231, DOI 10.1111/j.1460-9568.2008.06423.x; GROVES PM, 1975, SCIENCE, V190, P522, DOI 10.1126/science.242074; Inoue H, 2007, P NATL ACAD SCI USA, V104, P14430, DOI 10.1073/pnas.0700901104; Kim HS, 2006, J NEUROCHEM, V99, P458, DOI 10.1111/j.1471-4159.2006.04108.x; Kim KS, 2010, J BIOL CHEM, V285, P8905, DOI 10.1074/jbc.M109.079590; Kim SJ, 2004, MOL ENDOCRINOL, V18, P640, DOI 10.1210/me.2003-0066; Kim SY, 2008, EXP NEUROL, V214, P69, DOI 10.1016/j.expneurol.2008.07.014; Kim SY, 2006, J NEUROSCI, V26, P4567, DOI 10.1523/JNEUROSCI.5236-05.2006; Lindvall O, 2009, TRENDS PHARMACOL SCI, V30, P260, DOI 10.1016/j.tips.2009.03.001; Lu WG, 2004, CELL, V119, P97, DOI 10.1016/j.cell.2004.09.019; MEIERGERD SM, 1993, J NEUROCHEM, V61, P764; Moses D, 2006, EXP NEUROL, V199, P209, DOI 10.1016/j.expneurol.2006.02.120; O'Keeffe GC, 2009, P NATL ACAD SCI USA, V106, P8754, DOI 10.1073/pnas.0803955106; Perlmann T, 2004, CELL TISSUE RES, V318, P45, DOI 10.1007/s00441-004-0974-7; Perrone-Capano C, 2000, NEUROSCI BIOBEHAV R, V24, P119, DOI 10.1016/S0149-7634(99)00054-8; Riddle R, 2003, DEV BRAIN RES, V147, P3, DOI 10.1016/j.devbrainres.2003.09.010; Ryu JH, 2006, J BIOL CHEM, V281, P22039, DOI 10.1074/jbc.M601804200; Schulte G, 2005, J NEUROCHEM, V92, P1550, DOI 10.1111/j.1471-4159.2004.03022.x; Shimogori T, 2004, J COMP NEUROL, V473, P496, DOI 10.1002/cne.20135; Simon HH, 2003, ANN NY ACAD SCI, V991, P36; Smidt MP, 2007, NAT REV NEUROSCI, V8, P21, DOI 10.1038/nrn2039; Sutton LP, 2007, J NEUROCHEM, V102, P153, DOI 10.1111/j.1471-4159.2007.04527.x; SWARZENSKI BC, 1994, P NATL ACAD SCI USA, V91, P649, DOI 10.1073/pnas.91.2.649; Van Kampen JM, 2006, J NEUROSCI, V26, P7272, DOI 10.1523/JNEUROSCI.0837-06.2006; Van Kampen JM, 2005, NEUROSCIENCE, V136, P381, DOI 10.1016/j.neuroscience.2005.07.054; Van Kampen JM, 2004, EUR J NEUROSCI, V19, P2377, DOI 10.1111/j.0953-816X.2004.03342.x; Winner B, 2009, EXP NEUROL, V219, P543, DOI 10.1016/j.expneurol.2009.07.013; Yamada M, 1997, PROG NEUROBIOL, V51, P19, DOI 10.1016/S0301-0082(96)00046-9	39	27	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.188078	http://dx.doi.org/10.1074/jbc.M110.188078			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454669	hybrid, Green Published			2022-12-25	WOS:000290022800004
J	Shrestha, B; Reed, JM; Starks, PT; Kaufman, GE; Goldstone, JV; Roelke, ME; O'Brien, SJ; Koepfli, KP; Frank, LG; Court, MH				Shrestha, Binu; Reed, J. Michael; Starks, Philip T.; Kaufman, Gretchen E.; Goldstone, Jared V.; Roelke, Melody E.; O'Brien, Stephen J.; Koepfli, Klaus-Peter; Frank, Laurence G.; Court, Michael H.			Evolution of a Major Drug Metabolizing Enzyme Defect in the Domestic Cat and Other Felidae: Phylogenetic Timing and the Role of Hypercarnivory	PLOS ONE			English	Article							DEFICIENT ACETAMINOPHEN GLUCURONIDATION; SPECIES-DIFFERENCES; CONJUGATION; BIOTRANSFORMATION; SUPERFAMILY; PSEUDOGENES; CARNIVORA; ELEPHANT; GENOME; UGT1A6	The domestic cat (Felis catus) shows remarkable sensitivity to the adverse effects of phenolic drugs, including acetaminophen and aspirin, as well as structurally-related toxicants found in the diet and environment. This idiosyncrasy results from pseudogenization of the gene encoding UDP-glucuronosyltransferase (UGT) 1A6, the major species-conserved phenol detoxification enzyme. Here, we established the phylogenetic timing of disruptive UGT1A6 mutations and explored the hypothesis that gene inactivation in cats was enabled by minimal exposure to plant-derived toxicants. Fixation of the UGT1A6 pseudogene was estimated to have occurred between 35 and 11 million years ago with all extant Felidae having dysfunctional UGT1A6. Out of 22 additional taxa sampled, representative of most Carnivora families, only brown hyena (Parahyaena brunnea) and northern elephant seal (Mirounga angustirostris) showed inactivating UGT1A6 mutations. A comprehensive literature review of the natural diet of the sampled taxa indicated that all species with defective UGT1A6 were hypercarnivores (>70% dietary animal matter). Furthermore those species with UGT1A6 defects showed evidence for reduced amino acid constraint (increased dN/dS ratios approaching the neutral selection value of 1.0) as compared with species with intact UGT1A6. In contrast, there was no evidence for reduced amino acid constraint for these same species within UGT1A1, the gene encoding the enzyme responsible for detoxification of endogenously generated bilirubin. Our results provide the first evidence suggesting that diet may have played a permissive role in the devolution of a mammalian drug metabolizing enzyme. Further work is needed to establish whether these preliminary findings can be generalized to all Carnivora.	[Shrestha, Binu; Court, Michael H.] Tufts Univ, Sch Med, Dept Mol Physiol & Pharmacol, Comparat & Mol Pharmacogen Lab, Boston, MA 02111 USA; [Shrestha, Binu; Reed, J. Michael; Starks, Philip T.] Tufts Univ, Dept Biol, Medford, MA 02155 USA; [Kaufman, Gretchen E.] Tufts Cummings Sch Vet Med, Dept Environm & Populat Hlth, North Grafton, MA USA; [Goldstone, Jared V.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [Roelke, Melody E.] NCI, Lab Genom Divers, SAIC Frederick Inc, Frederick, MD 21701 USA; [Frank, Laurence G.] Univ Calif Berkeley, Living Lions Project Kenya, Museum Vertebrate Zool, Berkeley, CA 94720 USA	Tufts University; Tufts University; Woods Hole Oceanographic Institution; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; University of California System; University of California Berkeley	Shrestha, B (corresponding author), Tufts Univ, Sch Med, Dept Mol Physiol & Pharmacol, Comparat & Mol Pharmacogen Lab, Boston, MA 02111 USA.	michael.court@tufts.edu	Koepfli, Klaus-Peter/AAT-9320-2020; OBRIEN, STEPHEN/ABD-1346-2020; Johnson, Warren/D-4149-2016	Johnson, Warren/0000-0002-5954-186X; OBRIEN, STEPHEN/0000-0001-7857-0757; Goldstone, Jared/0000-0002-9618-4961	United States Department of State; National Institute of General Medical Sciences [R01GM061834]; National Cancer Institute (NCI) [N01-CO-12400]; NCI Center for Cancer Research, National Institutes of Health (NIH); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061834] Funding Source: NIH RePORTER	United States Department of State; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI Center for Cancer Research, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Binu Shrestha was supported by a Fulbright scholarship from the United States Department of State. This project was funded by grant R01GM061834 from the National Institute of General Medical Sciences, contract N01-CO-12400 from the National Cancer Institute (NCI), and by the Intramural Research Program, NCI Center for Cancer Research, National Institutes of Health (NIH). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH, nor does mention of trade names, commercial products, or organizations imply endorsement by the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bock KW, 2003, BIOCHEM PHARMACOL, V66, P691, DOI 10.1016/S0006-2952(03)00296-X; BOSMA PJ, 1994, J BIOL CHEM, V269, P17960; Bustamante CD, 2002, MOL BIOL EVOL, V19, P110, DOI 10.1093/oxfordjournals.molbev.a003975; CALDWELL J, 1981, DRUG METAB REV, V12, P221, DOI 10.3109/03602538108994030; CALDWELL J, 1975, FEBS LETT, V60, P391, DOI 10.1016/0014-5793(75)80756-3; CAPEL ID, 1972, XENOBIOTICA, V2, P25, DOI 10.3109/00498257209036231; CAPEL ID, 1974, XENOBIOTICA, V4, P601, DOI 10.1080/00498257409169763; Court MH, 1997, BIOCHEM PHARMACOL, V53, P1041, DOI 10.1016/S0006-2952(97)00072-5; Court MH, 2001, J VET PHARMACOL THER, V24, P415, DOI 10.1046/j.1365-2885.2001.00366.x; Court MH, 1997, J PHARM PHARMACOL, V49, P446, DOI 10.1111/j.2042-7158.1997.tb06822.x; Court MH, 2000, PHARMACOGENETICS, V10, P355, DOI 10.1097/00008571-200006000-00009; DAVIS LE, 1972, AM J VET RES, V33, P1253; FRENCH MR, 1974, FEBS LETT, V46, P134, DOI 10.1016/0014-5793(74)80352-2; Gaubert P, 2003, P ROY SOC B-BIOL SCI, V270, P2523, DOI 10.1098/rspb.2003.2521; GONZALEZ FJ, 1990, TRENDS GENET, V6, P182, DOI 10.1016/0168-9525(90)90174-5; Higdon JW, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-216; HOELZEL AR, 1993, J HERED, V84, P443, DOI 10.1093/oxfordjournals.jhered.a111370; Johnson WE, 2006, SCIENCE, V311, P73, DOI 10.1126/science.1122277; Khachane AN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-435; Koepfli KP, 2006, MOL PHYLOGENET EVOL, V38, P603, DOI 10.1016/j.ympev.2005.10.017; Li X, 2005, PLOS GENET, V1, P27, DOI 10.1371/journal.pgen.0010003; Li X, 2009, J HERED, V100, pS90, DOI 10.1093/jhered/esp015; Mackenzie PI, 2005, PHARMACOGENET GENOM, V15, P677, DOI 10.1097/01.fpc.0000173483.13689.56; MCGEACHIN RL, 1979, COMP BIOCHEM PHYS B, V63, P437, DOI 10.1016/0305-0491(79)90274-8; Morris JG, 2002, NUTR RES REV, V15, P153, DOI 10.1079/NRR200238; Nowak R. M., 2005, WALKERS CARNIVORES W; Pfeifer GP, 2006, CURR TOP MICROBIOL, V301, P259; ROBINSON D, 1958, BIOCHEM J, V68, pP23; SAVIDES MC, 1984, TOXICOL APPL PHARM, V74, P26, DOI 10.1016/0041-008X(84)90266-7; Torrents D, 2003, GENOME RES, V13, P2559, DOI 10.1101/gr.1455503; Trepanier LA, 1997, BIOCHEM PHARMACOL, V54, P73, DOI 10.1016/S0006-2952(97)00140-8; Van Valkenburgh B, 1999, ANNU REV EARTH PL SC, V27, P463, DOI 10.1146/annurev.earth.27.1.463; van Valkenburgh B., 1989, P410; Van Valkenburgh B, 2007, INTEGR COMP BIOL, V47, P147, DOI 10.1093/icb/icm016; Zhang ZL, 2003, GENOME RES, V13, P2541, DOI 10.1101/gr.1429003	35	58	59	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e18046	10.1371/journal.pone.0018046	http://dx.doi.org/10.1371/journal.pone.0018046			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464924	gold, Green Submitted, Green Published			2022-12-25	WOS:000289053800014
J	Wang, YJ; Wang, RL; Jiang, SJ; Zhou, WJ; Liu, Y; Wang, YJ; Gu, Q; Gu, Y; Dong, YY; Liu, M; Gu, XX; Ding, F; Gu, XS				Wang, Yongjun; Wang, Ruili; Jiang, Shengjuan; Zhou, Weijuan; Liu, Yan; Wang, Yingjie; Gu, Qing; Gu, Yun; Dong, Yingying; Liu, Mei; Gu, Xingxing; Ding, Fei; Gu, Xiaosong			Gecko CD59 Is Implicated in Proximodistal Identity during Tail Regeneration	PLOS ONE			English	Article							AMPHIBIAN LIMB REGENERATION; FUNCTIONAL-CHARACTERIZATION; POSITIONAL IDENTITY; SEQUENCE-ANALYSIS; AXOLOTL LIMBS; CELLS; EXPRESSION; NEWT; COMPLEMENT; DATABASE	Several adult reptiles, such as Gekko japonicus, have the ability to precisely re-create a missing tail after amputation. To ascertain the associated acquisition of positional information from blastemal cells and the underlying molecular mechanism of tail regeneration, a candidate molecule CD59 was isolated from gecko. CD59 transcripts displayed a graded expression in the adult gecko spinal cord with the highest level in the anterior segment, with a stable expression along the normal tail. After tail amputation, CD59 transcripts in the spinal cord proximal to the injury sites increased markedly at 1 day and 2 weeks; whereas in the regenerating blastema, strong CD59 positive signals were detected in the blastemal cells anterior to the blastema, with a gradual decrease along the proximodistal (PD) axis. When treated with RA following amputation, CD59 transcripts in the blastema were up-regulated. PD confrontation assays revealed that the proximal blastema engulfed the distal one after in vitro culture, and rabbit-anti human CD59 antibody was able to block this PD engulfment. Overexpression of the CD59 during tail regeneration causes distal blastemal cells to translocate to a more proximal location. Our results suggest that position identity is not restricted to amphibian limb regeneration, but has already been established in tail blastema of reptiles. The CD59, a cell surface molecule, acted as a determinant of proximal-distal cell identity.	[Wang, Yongjun; Wang, Ruili; Zhou, Weijuan; Liu, Yan; Wang, Yingjie; Gu, Qing; Gu, Yun; Dong, Yingying; Liu, Mei; Gu, Xingxing; Ding, Fei; Gu, Xiaosong] Nantong Univ, Key Lab Neuroregenerat, Nantong, Peoples R China; [Jiang, Shengjuan] Anhui Sci & Technol Univ, Coll Life Sci, Fengyang, Peoples R China	Nantong University; Anhui Science & Technology University	Wang, YJ (corresponding author), Nantong Univ, Key Lab Neuroregenerat, Nantong, Peoples R China.	neurongu@public.nt.js.cn		Wang, Yongjun/0000-0001-5040-8926	Ministry of Science and Technology of China [2003CB515306]; National Natural Science Foundation of China [30670283]; Jiangsu Education Department [10KJA180041, 09KJA180005]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Education Department	The work was financially supported by the National Basic Research Program (973 Program) of the Ministry of Science and Technology of China (2003CB515306), the National Natural Science Foundation of China (30670283), and the Basic Research Program of Jiangsu Education Department (10KJA180041; 09KJA180005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdek-Karim Ahmed E., 1993, Qatar University Science Journal, V13, P293; ABDELKARIM, 1994, QATAR U SCI J, V14, P82; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], BIOL REPTILIA; AXELROD D, 1979, BIOPHYS J, V26, P557, DOI 10.1016/S0006-3495(79)85271-6; Brockes JP, 1997, SCIENCE, V276, P81, DOI 10.1126/science.276.5309.81; Burland T G, 2000, Methods Mol Biol, V132, P71; CRAWFORD K, 1988, DEVELOPMENT, V102, P687; da Silva SM, 2002, DEV CELL, V3, P547, DOI 10.1016/S1534-5807(02)00288-5; DAVIES A, 1989, J EXP MED, V170, P637, DOI 10.1084/jem.170.3.637; Del Rio-Tsonis K, 1998, J IMMUNOL, V161, P6819; Echeverri K, 2005, DEV BIOL, V279, P391, DOI 10.1016/j.ydbio.2004.12.029; Echeverri K, 2002, SCIENCE, V298, P1993, DOI 10.1126/science.1077804; Ferre F, 2005, NUCLEIC ACIDS RES, V33, pW230, DOI 10.1093/nar/gki412; Gargioli C, 2004, DEVELOPMENT, V131, P2669, DOI 10.1242/dev.01155; Garza-Garcia A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007123; GHOSH S, 1994, INT J DEV BIOL, V38, P479; Hinchliffe SJ, 1998, J IMMUNOL, V160, P3924; Jiang MR, 2009, MOL BIOL REP, V36, P215, DOI 10.1007/s11033-007-9169-0; Kimberley FC, 2007, MOL IMMUNOL, V44, P73, DOI 10.1016/j.molimm.2006.06.019; Kimura Y, 2003, J IMMUNOL, V170, P2331, DOI 10.4049/jimmunol.170.5.2331; Kragl M, 2009, NATURE, V460, P60, DOI 10.1038/nature08152; Kumar A, 2007, CR BIOL, V330, P485, DOI 10.1016/j.crvi.2007.01.006; Liu GZ, 2007, MOL IMMUNOL, V44, P3661, DOI 10.1016/j.molimm.2007.04.006; Liu Y, 2006, J MOL NEUROSCI, V29, P21, DOI 10.1385/JMN:29:1:21; Maden M, 2002, CURR BIOL, V12, pR773, DOI 10.1016/S0960-9822(02)01290-3; MADEN M, 1982, NATURE, V295, P672, DOI 10.1038/295672a0; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Mercader N, 2005, DEVELOPMENT, V132, P4131, DOI 10.1242/dev.01976; MITASHOV IV, 1996, INT J DEV BIOL, V40, P833; Mochii M, 2007, DEV GROWTH DIFFER, V49, P155, DOI 10.1111/j.1440-169X.2007.00912.x; MONKEMEYER J, 1992, DEV DYNAM, V193, P286, DOI 10.1002/aja.1001930309; NARDI JB, 1983, DIFFERENTIATION, V25, P27; Nye HLD, 2003, DEV DYNAM, V226, P280, DOI 10.1002/dvdy.10236; OBERPRILLER JO, 1974, J EXP ZOOL, V187, P249, DOI 10.1002/jez.1401870208; Papanastasiou AD, 2007, MOL IMMUNOL, V44, P1300, DOI 10.1016/j.molimm.2006.05.014; PHILBRICK WM, 1990, EUR J IMMUNOL, V20, P87, DOI 10.1002/eji.1830200113; Rehm BHA, 2001, APPL MICROBIOL BIOT, V57, P579, DOI 10.1007/s00253-001-0844-0; REYER RW, 1954, Q REV BIOL, V29, P1, DOI 10.1086/399936; SAWADA R, 1990, DNA CELL BIOL, V9, P213, DOI 10.1089/dna.1990.9.213; TONE M, 1992, J MOL BIOL, V227, P971, DOI 10.1016/0022-2836(92)90239-G; Wang SH, 2009, MOL CELL ENDOCRINOL, V313, P57, DOI 10.1016/j.mce.2009.08.024; Wang YJ, 2009, BRAIN RES BULL, V80, P414, DOI 10.1016/j.brainresbull.2009.08.010; Zhenkun C, 1990, J YUNNAN AGR, V7, P51	44	18	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e17878	10.1371/journal.pone.0017878	http://dx.doi.org/10.1371/journal.pone.0017878			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464923	gold, Green Published, Green Submitted			2022-12-25	WOS:000289053800004
J	Chung, MC; Tonry, JH; Narayanan, A; Manes, NP; Mackie, RS; Gutting, B; Mukherjee, DV; Popova, TG; Kashanchi, F; Bailey, CL; Popov, SG				Chung, Myung-Chul; Tonry, Jessica H.; Narayanan, Aarthi; Manes, Nathan P.; Mackie, Ryan S.; Gutting, Bradford; Mukherjee, Dhritiman V.; Popova, Taissia G.; Kashanchi, Fatah; Bailey, Charles L.; Popov, Serguei G.			Bacillus anthracis Interacts with Plasmin(ogen) to Evade C3b-Dependent Innate Immunity	PLOS ONE			English	Article							PLASMINOGEN-BINDING-PROTEIN; COMPLEMENT COMPONENT C3; STREPTOCOCCUS-PNEUMONIAE; ALPHA-ENOLASE; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; MYCOBACTERIUM-TUBERCULOSIS; FACTOR-H; SURFACE; ACTIVATION; IDENTIFICATION	The causative agent of anthrax, Bacillus anthracis, is capable of circumventing the humoral and innate immune defense of the host and modulating the blood chemistry in circulation to initiate a productive infection. It has been shown that the pathogen employs a number of strategies against immune cells using secreted pathogenic factors such as toxins. However, interference of B. anthracis with the innate immune system through specific interaction of the spore surface with host proteins such as the complement system has heretofore attracted little attention. In order to assess the mechanisms by which B. anthracis evades the defense system, we employed a proteomic analysis to identify human serum proteins interacting with B. anthracis spores, and found that plasminogen (PLG) is a major surface-bound protein. PLG efficiently bound to spores in a lysine- and exosporium-dependent manner. We identified alpha-enolase and elongation factor tu as PLG receptors. PLG-bound spores were capable of exhibiting anti-opsonic properties by cleaving C3b molecules in vitro and in rabbit bronchoalveolar lavage fluid, resulting in a decrease in macrophage phagocytosis. Our findings represent a step forward in understanding the mechanisms involved in the evasion of innate immunity by B. anthracis through recruitment of PLG resulting in the enhancement of anti-complement and anti-opsonization properties of the pathogen.	[Chung, Myung-Chul; Tonry, Jessica H.; Narayanan, Aarthi; Manes, Nathan P.; Mukherjee, Dhritiman V.; Popova, Taissia G.; Kashanchi, Fatah; Bailey, Charles L.; Popov, Serguei G.] George Mason Univ, Natl Ctr Biodef & Infect Dis, Manassas, VA USA; [Mackie, Ryan S.; Gutting, Bradford] Naval Surface Warfare Ctr, Dahlgren Div, Chem Biol & Radiol Def Div, Dahlgren, VA USA	George Mason University	Chung, MC (corresponding author), George Mason Univ, Natl Ctr Biodef & Infect Dis, Manassas, VA USA.	mchung3@gmu.edu	Manes, Nathan P/E-2817-2012	Manes, Nathan P/0000-0001-6701-3314	U.S. Department of Energy [DE-FC52-FC04NA25455]	U.S. Department of Energy(United States Department of Energy (DOE))	This work was supported by U.S. Department of Energy grant DE-FC52-FC04NA25455. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2008, BBA-PROTEINS PROTEOM, V1784, P986, DOI 10.1016/j.bbapap.2008.03.017; Attali C, 2008, INFECT IMMUN, V76, P5350, DOI 10.1128/IAI.00184-08; Beaufort N, 2008, BIOCHEM J, V410, P157, DOI 10.1042/BJ20070650; Bergmann S, 2004, INFECT IMMUN, V72, P2416, DOI 10.1128/IAI.72.4.2416-2419.2004; Bergmann S, 2003, MOL MICROBIOL, V49, P411, DOI 10.1046/j.1365-2958.2003.03557.x; Blom AM, 2009, MOL IMMUNOL, V46, P2808, DOI 10.1016/j.molimm.2009.04.025; Boxx GM, 2009, MOL IMMUNOL, V46, P473, DOI 10.1016/j.molimm.2008.10.008; Boydston JA, 2005, J BACTERIOL, V187, P5310, DOI 10.1128/JB.187.15.5310-5317.2005; Brittingham KC, 2005, J IMMUNOL, V174, P5545, DOI 10.4049/jimmunol.174.9.5545; Chitlaru T, 2007, INFECT IMMUN, V75, P2841, DOI 10.1128/IAI.02029-06; Chung MC, 2006, J BIOL CHEM, V281, P31408, DOI 10.1074/jbc.M605526200; Comer JE, 2005, INFECT IMMUN, V73, P8275, DOI 10.1128/IAI.73.12.8275-8281.2005; Cowan GJM, 2007, VACCINE, V25, P7197, DOI 10.1016/j.vaccine.2007.07.040; DelVecchio VG, 2006, APPL ENVIRON MICROB, V72, P6355, DOI 10.1128/AEM.00455-06; Dixon TC, 1999, NEW ENGL J MED, V341, P815, DOI 10.1056/NEJM199909093411107; Feng YJ, 2009, J INFECT DIS, V200, P1583, DOI 10.1086/644602; Ferguson JS, 2004, INFECT IMMUN, V72, P2564, DOI 10.1128/IAI.72.5.2564-2573.2004; FREDENBURGH JC, 1992, J BIOL CHEM, V267, P26150; Gadjeva M, 1998, J IMMUNOL, V161, P985; Gatfield J, 2003, ADV IMMUNOL, V81, P45, DOI 10.1016/S0065-2776(03)81002-7; Glomski IJ, 2007, PLOS PATHOG, V3, P699, DOI 10.1371/journal.ppat.0030076; Goto H, 1998, P NATL ACAD SCI USA, V95, P10224, DOI 10.1073/pnas.95.17.10224; GROSS GN, 1978, J CLIN INVEST, V62, P373, DOI 10.1172/JCI109138; Grosskinsky S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004858; Guidi-Rontani C, 1999, MOL MICROBIOL, V31, P9, DOI 10.1046/j.1365-2958.1999.01137.x; Guidi-Rontani C, 2002, TRENDS MICROBIOL, V10, P405, DOI 10.1016/S0966-842X(02)02422-8; Harvill ET, 2005, INFECT IMMUN, V73, P4420, DOI 10.1128/IAI.73.7.4420-4422.2005; Khan AS, 2006, J CHEM INF MODEL, V46, P111, DOI 10.1021/ci0501138; Kraiczy P, 2006, MOL IMMUNOL, V43, P31, DOI 10.1016/j.molimm.2005.06.016; Kunert A, 2007, J IMMUNOL, V179, P2979, DOI 10.4049/jimmunol.179.5.2979; Lahteenmaki K, 2005, TRENDS MICROBIOL, V13, P79, DOI 10.1016/j.tim.2004.12.003; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; LIOTTA LA, 1981, CANCER RES, V41, P4629; Loving CL, 2007, INFECT IMMUN, V75, P2689, DOI 10.1128/IAI.01875-06; Madico G, 2006, J IMMUNOL, V177, P501, DOI 10.4049/jimmunol.177.1.501; MANGEL WF, 1990, SCIENCE, V248, P69, DOI 10.1126/science.2108500; Matta SK, 2010, BBA-PROTEINS PROTEOM, V1804, P2111, DOI 10.1016/j.bbapap.2010.08.004; MCCOY HE, 1991, J INFECT DIS, V164, P515, DOI 10.1093/infdis/164.3.515; Monroy V, 2000, INFECT IMMUN, V68, P4327, DOI 10.1128/IAI.68.7.4327-4330.2000; Mueller-Ortiz SL, 2001, INFECT IMMUN, V69, P7501, DOI 10.1128/IAI.69.12.7501-7511.2001; Mukhopadhyay S, 2009, MOL CELL PROTEOMICS, V8, P1174, DOI 10.1074/mcp.M800403-MCP200; Narasaki R, 2005, J BIOL CHEM, V280, P14278, DOI 10.1074/jbc.M500241200; Okumura Y, 1999, FEBS LETT, V442, P39, DOI 10.1016/S0014-5793(98)01612-3; Pancholi V, 1998, J BIOL CHEM, V273, P14503, DOI 10.1074/jbc.273.23.14503; Pancholi V, 2003, MICROB PATHOGENESIS, V35, P293, DOI 10.1016/j.micpath.2003.08.004; Park JM, 2002, SCIENCE, V297, P2048, DOI 10.1126/science.1073163; Premanandan C, 2009, MICROB PATHOGENESIS, V46, P306, DOI 10.1016/j.micpath.2009.03.004; Redmond C, 2004, MICROBIOL-SGM, V150, P355, DOI 10.1099/mic.0.26681-0; Rojas M, 2008, ACTA TROP, V107, P54, DOI 10.1016/j.actatropica.2008.04.013; Russell BH, 2007, CELL MICROBIOL, V9, P1262, DOI 10.1111/j.1462-5822.2006.00869.x; Schlott B, 1997, J BIOL CHEM, V272, P6067, DOI 10.1074/jbc.272.9.6067; Shaw CA, 2008, INFECT IMMUN, V76, P2603, DOI 10.1128/IAI.01718-07; SIM RB, 1981, BIOCHEM J, V193, P115, DOI 10.1042/bj1930115; SODEINDE OA, 1992, SCIENCE, V258, P1004, DOI 10.1126/science.1439793; Stie J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005780; Sylvestre P, 2002, MOL MICROBIOL, V45, P169, DOI 10.1046/j.1365-2958.2000.03000.x; Vieira ML, 2009, INFECT IMMUN, V77, P4092, DOI 10.1128/IAI.00353-09; Walz Alexander, 2007, Proteome Sci, V5, P11, DOI 10.1186/1477-5956-5-11; WELKOS SL, 1986, INFECT IMMUN, V51, P795, DOI 10.1128/IAI.51.3.795-800.1986	59	45	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e18119	10.1371/journal.pone.0018119	http://dx.doi.org/10.1371/journal.pone.0018119			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464960	Green Published, Green Submitted, gold			2022-12-25	WOS:000288813900040
J	Pang, YP; Park, JG; Wang, SH; Vummenthala, A; Mishra, RK; McLaughlin, JE; Di, R; Kahn, JN; Tumer, NE; Janosi, L; Davis, J; Millard, CB				Pang, Yuan-Ping; Park, Jewn Giew; Wang, Shaohua; Vummenthala, Anuradha; Mishra, Rajesh K.; McLaughlin, John E.; Di, Rong; Kahn, Jennifer Nielsen; Tumer, Nilgun E.; Janosi, Laszlo; Davis, Jon; Millard, Charles B.			Small-Molecule Inhibitor Leads of Ribosome-Inactivating Proteins Developed Using the Doorstop Approach	PLOS ONE			English	Article							RICIN-A-CHAIN; ESCHERICHIA-COLI O157-H7; SHIGA-LIKE TOXINS; X-RAY-STRUCTURE; TRANSITION-STATE; FIREFLY LUCIFERASE; ACTIVE-SITE; AMINO-ACIDS; LOOP RNA; IDENTIFICATION	Ribosome-inactivating proteins (RIPs) are toxic because they bind to 28S rRNA and depurinate a specific adenine residue from the alpha-sarcin/ricin loop (SRL), thereby inhibiting protein synthesis. Shiga-like toxins (Stx1 and Stx2), produced by Escherichia coli, are RIPs that cause outbreaks of foodborne diseases with significant morbidity and mortality. Ricin, produced by the castor bean plant, is another RIP lethal to mammals. Currently, no US Food and Drug Administration-approved vaccines nor therapeutics exist to protect against ricin, Shiga-like toxins, or other RIPs. Development of effective small-molecule RIP inhibitors as therapeutics is challenging because strong electrostatic interactions at the RIP center dot SRL interface make drug-like molecules ineffective in competing with the rRNA for binding to RIPs. Herein, we report small molecules that show up to 20% cell protection against ricin or Stx2 at a drug concentration of 300 nM. These molecules were discovered using the doorstop approach, a new approach to protein center dot polynucleotide inhibitors that identifies small molecules as doorstops to prevent an active-site residue of an RIP (e.g., Tyr80 of ricin or Tyr77 of Stx2) from adopting an active conformation thereby blocking the function of the protein rather than contenders in the competition for binding to the RIP. This work offers promising leads for developing RIP therapeutics. The results suggest that the doorstop approach might also be applicable in the development of other protein center dot polynucleotide inhibitors as antiviral agents such as inhibitors of the Z-DNA binding proteins in poxviruses. This work also calls for careful chemical and biological characterization of drug leads obtained from chemical screens to avoid the identification of irrelevant chemical structures and to avoid the interference caused by direct interactions between the chemicals being screened and the luciferase reporter used in screening assays.	[Pang, Yuan-Ping; Park, Jewn Giew; Wang, Shaohua; Vummenthala, Anuradha; Mishra, Rajesh K.] Mayo Clin, Comp Aided Mol Design Lab, Rochester, MN 55905 USA; [McLaughlin, John E.; Di, Rong; Kahn, Jennifer Nielsen; Tumer, Nilgun E.] Rutgers State Univ, Sch Environm & Biol Sci, Dept Plant Biol & Pathol, New Brunswick, NJ 08903 USA; [Janosi, Laszlo; Davis, Jon; Millard, Charles B.] Walter Reed Army Inst Res, Div Biochem, Silver Spring, MD USA	Mayo Clinic; Rutgers State University New Brunswick; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Pang, YP (corresponding author), Mayo Clin, Comp Aided Mol Design Lab, Rochester, MN 55905 USA.	pang@mayo.edu; tumer@aesop.rutgers.edu; charles.b.millard@us.army.mil	McLaughlin, John/AAE-5024-2019; McLaughlin, John/D-6966-2011	McLaughlin, John/0000-0003-4511-6202; Pang, Yuan-Ping/0000-0003-0838-2560	United States Army Medical Research and Materiel Command [W81XWH-04-2-0001]; Mayo Foundation for Medical Education and Research; United States National Institute of Allergy and Infectious Diseases [1U01AI082120-01, R01AI072425]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072425, U01AI082120] Funding Source: NIH RePORTER	United States Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Mayo Foundation for Medical Education and Research; United States National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the United States Army Medical Research and Materiel Command (W81XWH-04-2-0001 to YPP), the Mayo Foundation for Medical Education and Research (to YPP), and the United States National Institute of Allergy and Infectious Diseases (1U01AI082120-01 to YPP, NET and CBM; R01AI072425 to NET). The computational studies were supported in part by the University of Minnesota Supercomputing Institute. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The opinions or assertions contained herein belong to the authors and are not necessarily the official views of the funders.	Audi J, 2005, JAMA-J AM MED ASSOC, V294, P2342, DOI 10.1001/jama.294.18.2342; Auld DS, 2008, ACS CHEM BIOL, V3, P463, DOI 10.1021/cb8000793; Auld DS, 2010, P NATL ACAD SCI USA, V107, P4878, DOI 10.1073/pnas.0909141107; Auld DS, 2009, P NATL ACAD SCI USA, V106, P3585, DOI 10.1073/pnas.0813345106; Bai Y, 2009, ARCH BIOCHEM BIOPHYS, V483, P23, DOI 10.1016/j.abb.2008.12.013; Benary E, 1913, BER DTSCH CHEM GES, V46, P1363, DOI 10.1002/cber.19130460215; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BOYCE TG, 1995, NEW ENGL J MED, V333, P364, DOI 10.1056/NEJM199508103330608; Braibante MEF, 2002, TETRAHEDRON LETT, V43, P8079, DOI 10.1016/S0040-4039(02)01961-5; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chen XY, 2000, J AM CHEM SOC, V122, P1609, DOI 10.1021/ja992750i; Chen XY, 2000, J AM CHEM SOC, V122, P6527, DOI 10.1021/ja992751a; CIEPLAK P, 1995, J COMPUT CHEM, V16, P1357, DOI 10.1002/jcc.540161106; CORWIN AH, 1955, J AM CHEM SOC, V77, P464, DOI 10.1021/ja01607a073; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DAVOLL J, 1953, J CHEM SOC, P3802, DOI 10.1039/jr9530003802; Dooley AJ, 2006, BIOORG MED CHEM LETT, V16, P830, DOI 10.1016/j.bmcl.2005.11.018; Ekstrom F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005957; ENDO Y, 1988, EUR J BIOCHEM, V171, P45, DOI 10.1111/j.1432-1033.1988.tb13756.x; Fan F, 2007, ASSAY DRUG DEV TECHN, V5, P127, DOI 10.1089/adt.2006.053; Fraser ME, 2004, J BIOL CHEM, V279, P27511, DOI 10.1074/jbc.M401939200; FRISCH MJ, 1999, GAUSSIAN, V98; GALDINO SL, 1985, EUR J MED CHIM THER, V5, P439; Heitman LH, 2008, J MED CHEM, V51, P4724, DOI 10.1021/jm8004509; Ho MC, 2009, P NATL ACAD SCI USA, V106, P20276, DOI 10.1073/pnas.0911606106; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Iizuka N, 1997, METHODS, V11, P353, DOI 10.1006/meth.1996.0433; JANOSI L, 2006, ASM BIOD RES M; Johannes L, 2010, NAT REV MICROBIOL, V8, P105, DOI 10.1038/nrmicro2279; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kahmann JD, 2004, P NATL ACAD SCI USA, V101, P2712, DOI 10.1073/pnas.0308612100; KIM Y, 1992, PROTEIN ENG, V5, P775, DOI 10.1093/protein/5.8.775; Kim YG, 2003, P NATL ACAD SCI USA, V100, P6974, DOI 10.1073/pnas.0431131100; KIM YS, 1992, BIOCHEMISTRY-US, V31, P3294, DOI 10.1021/bi00127a035; KORA FA, 1986, J SERB CHEM SOC, V51, P529; Korennykh AV, 2007, BIOCHEMISTRY-US, V46, P12744, DOI 10.1021/bi700931y; Korennykh AV, 2006, NAT STRUCT MOL BIOL, V13, P436, DOI 10.1038/nsmb1082; Li XP, 2009, BIOCHEMISTRY-US, V48, P3853, DOI 10.1021/bi802371h; Melton-Celsa AR, 2002, MOL MICROBIOL, V43, P207, DOI 10.1046/j.1365-2958.2002.02733.x; MeltonCelsa AR, 1996, INFECT IMMUN, V64, P1569, DOI 10.1128/IAI.64.5.1569-1576.1996; Miller DJ, 2002, J MED CHEM, V45, P90, DOI 10.1021/jm010186s; MLSNA D, 1993, PROTEIN SCI, V2, P429; MONZINGO AF, 1992, J MOL BIOL, V227, P1136, DOI 10.1016/0022-2836(92)90526-P; Nakatsu T, 2006, NATURE, V440, P372, DOI 10.1038/nature04542; OBRIEN AD, 1987, MICROBIOL REV, V51, P206, DOI 10.1128/MMBR.51.2.206-220.1987; OBRIG TG, 1987, BIOCHEM J, V244, P287, DOI 10.1042/bj2440287; Olsnes S, 2004, TOXICON, V44, P361, DOI 10.1016/j.toxicon.2004.05.003; Pang YP, 2008, IBM J RES DEV, V52, P69, DOI 10.1147/rd.521.0069; Pang YP, 2001, J COMPUT CHEM, V22, P1750, DOI 10.1002/jcc.1129; Pang YP, 2001, FEBS LETT, V502, P93, DOI 10.1016/S0014-5793(01)02672-2; Pastan I, 2006, NAT REV CANCER, V6, P559, DOI 10.1038/nrc1891; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Perola E, 2000, J MED CHEM, V43, P401, DOI 10.1021/jm990408a; Reyes A, 2000, TETRAHEDRON-ASYMMETR, V11, P1411, DOI 10.1016/S0957-4166(00)00066-5; Roday S, 2004, BIOCHEMISTRY-US, V43, P4923, DOI 10.1021/bi0498499; Roday S, 2007, BIOCHEMISTRY-US, V46, P6169, DOI 10.1021/bi0621821; RUTENBER E, 1991, PROTEINS, V10, P240, DOI 10.1002/prot.340100308; Saenz JB, 2007, INFECT IMMUN, V75, P4552, DOI 10.1128/IAI.00442-07; Shimizu T, 2007, MICROB PATHOGENESIS, V43, P88, DOI 10.1016/j.micpath.2007.04.003; Snedeker KG, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-144; Stechmann B, 2010, CELL, V141, P231, DOI 10.1016/j.cell.2010.01.043; Sturm MB, 2007, J AM CHEM SOC, V129, P5544, DOI 10.1021/ja068054h; Sturm MB, 2009, BIOCHEMISTRY-US, V48, P9941, DOI 10.1021/bi901425h; Tan C, 2004, BIOORG MED CHEM LETT, V14, P1407, DOI 10.1016/j.bmcl.2004.01.064; Too PHM, 2009, NUCLEIC ACIDS RES, V37, P602, DOI 10.1093/nar/gkn922; WAHOME PG, 2010, TOXICON, P1; Wang Q, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000531; WESTON SA, 1994, J MOL BIOL, V244, P410, DOI 10.1006/jmbi.1994.1739; Wickstrom L, 2009, BIOPHYS J, V97, P853, DOI 10.1016/j.bpj.2009.04.063; Yan XJ, 1997, J MOL BIOL, V266, P1043, DOI 10.1006/jmbi.1996.0865	70	28	31	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2011	6	3							e17883	10.1371/journal.pone.0017883	http://dx.doi.org/10.1371/journal.pone.0017883			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740RG	21455295	Green Submitted, gold, Green Published			2022-12-25	WOS:000288811500012
J	Zhang, SZ; Zheng, MQ; Kibe, R; Huang, YP; Marrero, L; Warren, S; Zieske, AW; Iwakuma, T; Kolls, JK; Cui, Y				Zhang, Shuzhong; Zheng, Mingquan; Kibe, Ryoko; Huang, Yunping; Marrero, Luis; Warren, Samantha; Zieske, Arthur W.; Iwakuma, Tomoo; Kolls, Jay K.; Cui, Yan			Trp53 negatively regulates autoimmunity via the STAT3-Th17 axis	FASEB JOURNAL			English	Article						IL-17; IL-6; CD45.1; inflammatory cytokines	NF-KAPPA-B; T-CELLS; RHEUMATOID-ARTHRITIS; MULTIPLE-SCLEROSIS; TUMOR-SUPPRESSOR; POINT MUTATION; T-H-17 CELLS; TH17 CELLS; P53; INFLAMMATION	Emerging evidence suggests that the tumor suppressor p53 is also a crucial regulator for many physiological processes. Previous observations indicate that p53 suppresses inflammation by inhibiting inflammatory antigen-presenting cells. To investigate the potential role of p53 in autoimmune effector T cells, we generated p53(null)CD45.1 mice by crossing p53(null)CD45.2 and CD45.1 mice. We demonstrate that p53(null)CD45.1 mice spontaneously developed autoimmunity, with a significant increase in IL-17-producing Th17 effectors in their lymph nodes (4.7 +/- 1.0%) compared to the age-matched counterparts (1.9 +/- 0.8% for p53(null)CD45.2, 1.1 +/- 0.2% for CD45.1, and 0.5 +/- 0.1% for CD45.2 mice). Likewise, p53(null)CD45.1 mice possess highly elevated serum levels of inflammatory cytokines IL-17 and IL-6. This enhanced Th17 response results largely from an increased sensitivity of p53(null)CD45.1 T cells to IL-6-induced STAT3 phosphorylation. Administration of STAT3 inhibitor S31-201 (IC50 of 38.0 +/- 7.2 mu M for IL-6-induced STAT3 phosphorylation), but not PBS control, to p53(null)CD45.1 mice suppressed Th17 effectors and alleviated autoimmune pathology. This is the first report revealing that p53 activity in T cells suppresses autoimmunity by controlling Th17 effectors. This study suggests that p53 serves as a guardian of immunological functions and that the p53-STAT3-Th17 axis might be a therapeutic target for autoimmunity.-Zhang, S., Zheng, M., Kibe, R., Huang, Y., Marrero, L., Warren, S., Zieske, A. W., Iwakuma, T., Kolls, J. K., Cui, Y. Trp53 negatively regulates autoimmunity via the STAT3-Th17 axis. FASEB J. 25, 2387-2398 (2011). www.fasebj.org	[Zhang, Shuzhong; Kibe, Ryoko; Huang, Yunping; Marrero, Luis; Warren, Samantha; Cui, Yan] Louisiana State Univ, Hlth Sci Ctr, Gene Therapy Program, Dept Microbiol Immunol & Parasitol, New Orleans, LA 70112 USA; [Zheng, Mingquan; Iwakuma, Tomoo; Kolls, Jay K.; Cui, Yan] Louisiana State Univ, Hlth Sci Ctr, Dept Genet, New Orleans, LA 70112 USA; [Iwakuma, Tomoo; Kolls, Jay K.; Cui, Yan] Louisiana State Univ, Hlth Sci Ctr, Stanley S Scott Canc Ctr, New Orleans, LA 70112 USA; [Zieske, Arthur W.] Louisiana State Univ, Hlth Sci Ctr, Dept Pathol, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Cui, Y (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Gene Therapy Program, Dept Microbiol Immunol & Parasitol, 533 Bolivar St, New Orleans, LA 70112 USA.	ycui@lsuhsc.edu	Kolls, Jay/AAH-1829-2019	Kolls, Jay/0000-0001-5151-6304; Cui, Yan/0000-0002-2800-6039	Louisiana Gene Therapy Research Consortium; Louisiana Cancer Research Consortium; U.S. National Institutes of Health [CA112065, P20RR021970]; NATIONAL CANCER INSTITUTE [R01CA112065] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021970] Funding Source: NIH RePORTER	Louisiana Gene Therapy Research Consortium; Louisiana Cancer Research Consortium; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The authors give special thanks to Dr. Defu Zheng for constructive suggestions; Drs. Alistair Ramsay, Augusto Ochoa, Paulo Rodriguez, and Daitoku Sakamuro for critical reading; Dr. Heidi Davis for editorial assistance; and Dr. Zaili Chen, Dr. Weitao Huang, and Ms. Candice Pereira for technical assistance. This work is supported in part by research funding from the Louisiana Gene Therapy Research Consortium and the Louisiana Cancer Research Consortium, grants from the U.S. National Institutes of Health to Y.C. (CA112065 and P20RR021970).	Ak P, 2010, FASEB J, V24, P3643, DOI 10.1096/fj.10-160549; Aparicio S, 2009, CELL, V138, P1060, DOI 10.1016/j.cell.2009.09.004; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Bromberg J, 2009, CANCER CELL, V15, P79, DOI 10.1016/j.ccr.2009.01.009; Chen Z, 2008, IMMUNOL RES, V41, P87, DOI 10.1007/s12026-007-8014-9; Danilova N, 2008, MECH DEVELOP, V125, P919, DOI 10.1016/j.mod.2008.09.003; Diveu C, 2008, CURR OPIN IMMUNOL, V20, P663, DOI 10.1016/j.coi.2008.09.003; Do HT, 2006, J IMMUNOL, V176, P931, DOI 10.4049/jimmunol.176.2.931; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Fouser LA, 2008, IMMUNOL REV, V226, P87, DOI 10.1111/j.1600-065X.2008.00712.x; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Harris TJ, 2007, J IMMUNOL, V179, P4313, DOI 10.4049/jimmunol.179.7.4313; Hirano Toshio, 1997, Cytokine and Growth Factor Reviews, V8, P241, DOI 10.1016/S1359-6101(98)80005-1; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Hussain SP, 2000, CANCER RES, V60, P3333; Jacobsen M, 2000, NAT GENET, V26, P495, DOI 10.1038/82659; Karin M, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000141; Komarova EA, 2005, FASEB J, V19, P1030, DOI 10.1096/fj.04-3213fje; Lee H, 2009, CANCER CELL, V15, P283, DOI 10.1016/j.ccr.2009.02.015; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Lin JY, 2002, CANCER RES, V62, P376; Majeti R, 2000, CELL, V103, P1059, DOI 10.1016/S0092-8674(00)00209-9; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; McGeachy MJ, 2008, IMMUNITY, V28, P445, DOI 10.1016/j.immuni.2008.03.001; Okuda Y, 2003, J NEUROIMMUNOL, V135, P29, DOI 10.1016/S0165-5728(02)00428-9; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Palmer MT, 2010, NAT IMMUNOL, V11, P36, DOI 10.1038/ni.1802; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Puzio-Kuter AM, 2009, NAT BIOTECHNOL, V27, P914, DOI 10.1038/nbt1009-914; RASCHKE WC, 1995, IMMUNOGENETICS, V41, P144, DOI 10.1007/BF00182327; Salvador JM, 2005, NAT IMMUNOL, V6, P396, DOI 10.1038/ni1176; Salvador JM, 2002, IMMUNITY, V16, P499, DOI 10.1016/S1074-7613(02)00302-3; SANTHANAM U, 1991, P NATL ACAD SCI USA, V88, P7605, DOI 10.1073/pnas.88.17.7605; SHEN FW, 1985, P NATL ACAD SCI USA, V82, P7360, DOI 10.1073/pnas.82.21.7360; Siddiquee K, 2007, P NATL ACAD SCI USA, V104, P7391, DOI 10.1073/pnas.0609757104; Steinman L, 2010, NAT IMMUNOL, V11, P41, DOI 10.1038/ni.1803; Tak PP, 2000, IMMUNOL TODAY, V21, P78, DOI 10.1016/S0167-5699(99)01552-2; Tapinos NI, 1999, ARTHRITIS RHEUM-US, V42, P1466, DOI 10.1002/1529-0131(199907)42:7<1466::AID-ANR21>3.0.CO;2-L; Tergaonkar V, 2007, MOL CELL, V26, P158, DOI 10.1016/j.molcel.2007.04.006; Tesmer LA, 2008, IMMUNOL REV, V223, P87, DOI 10.1111/j.1600-065X.2008.00628.x; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Vang T, 2008, ANNU REV IMMUNOL, V26, P29, DOI 10.1146/annurev.immunol.26.021607.090418; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wang L, 2009, J EXP MED, V206, P1457, DOI 10.1084/jem.20090207; Webster GA, 1999, MOL CELL BIOL, V19, P3485; Windhagen A, 2007, CLIN EXP IMMUNOL, V150, P509, DOI 10.1111/j.1365-2249.2007.03508.x; Yamanishi Y, 2002, P NATL ACAD SCI USA, V99, P10025, DOI 10.1073/pnas.152333199; Yamanishi Y, 2002, AM J PATHOL, V160, P123, DOI 10.1016/S0002-9440(10)64356-8; Yao QP, 2001, MOL THER, V3, P901, DOI 10.1006/mthe.2001.0343; ZEBEDEE SL, 1991, EUR J IMMUNOGENET, V18, P155, DOI 10.1111/j.1744-313X.1991.tb00015.x; Zheng SJ, 2005, DIABETES, V54, P1423, DOI 10.2337/diabetes.54.5.1423; Zhou L, 2009, CURR OPIN IMMUNOL, V21, P146, DOI 10.1016/j.coi.2009.03.001	60	37	40	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUL	2011	25	7					2387	2398		10.1096/fj.10-175299	http://dx.doi.org/10.1096/fj.10-175299			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	785PY	21471252	Green Published			2022-12-25	WOS:000292242200030
J	Montanier, CY; Correia, MAS; Flint, JE; Zhu, YP; Basle, A; Mckee, LS; Prates, JAM; Polizzi, SJ; Coutinho, PM; Lewis, RJ; Henrissat, B; Fontes, CMGA; Gilbert, HJ				Montanier, Cedric Y.; Correia, Marcia A. S.; Flint, James E.; Zhu, Yanping; Basle, Arnaud; McKee, Lauren S.; Prates, Jose A. M.; Polizzi, Samuel J.; Coutinho, Pedro M.; Lewis, Richard J.; Henrissat, Bernard; Fontes, Carlos M. G. A.; Gilbert, Harry J.			A Novel, Noncatalytic Carbohydrate-binding Module Displays Specificity for Galactose-containing Polysaccharides through Calcium-mediated Oligomerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING; CLOSTRIDIUM-THERMOCELLUM; DOMAINS; COMPLEX; FAMILY; PROTEIN; DISTRIBUTIONS; CELLULOSOMES; GLUCANS; SITE	The enzymic degradation of plant cell walls plays a central role in the carbon cycle and is of increasing environmental and industrial significance. The catalytic modules of enzymes that catalyze this process are generally appended to noncatalytic carbohydrate-binding modules (CBMs). CBMs potentiate the rate of catalysis by bringing their cognate enzymes into intimate contact with the target substrate. A powerful plant cell wall-degrading system is the Clostridium thermocellum multienzyme complex, termed the "cellulosome." Here, we identify a novel CBM (CtCBM62) within the large C. thermocellum cellulosomal protein Cthe_2193 (defined as CtXyl5A), which establishes a new CBM family. Phylogenetic analysis of CBM62 members indicates that a circular permutation occurred within the family. CtCBM62 binds to D-galactose and L-arabinopyranose in either anomeric configuration. The crystal structures of CtCBM62, in complex with oligosaccharides containing alpha- and beta-galactose residues, show that the ligand-binding site in the beta-sandwich protein is located in the loops that connect the two beta-sheets. Specificity is conferred through numerous interactions with the axial O4 of the target sugars, a feature that distinguishes galactose and arabinose from the other major sugars located in plant cell walls. CtCBM62 displays tighter affinity for multivalent ligands compared with molecules containing single galactose residues, which is associated with precipitation of these complex carbohydrates. These avidity effects, which confer the targeting of polysaccharides, are mediated by calcium-dependent oligomerization of the CBM.	[Zhu, Yanping; Prates, Jose A. M.; Fontes, Carlos M. G. A.] Univ Tecn Lisboa, Ctr Invest Interdisciplinar Sanidade Anim, Fac Med Vet, P-1300477 Lisbon, Portugal; [Montanier, Cedric Y.; Correia, Marcia A. S.; Flint, James E.; Zhu, Yanping; Basle, Arnaud; McKee, Lauren S.; Lewis, Richard J.; Gilbert, Harry J.] Newcastle Univ, Inst Cell & Mol Biosci, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Coutinho, Pedro M.; Henrissat, Bernard] Univ Aix Marseille 1, CNRS, UMR6098, F-13288 Marseille, France; [Coutinho, Pedro M.; Henrissat, Bernard] Univ Aix Marseille 2, CNRS, UMR6098, F-13288 Marseille, France; [Zhu, Yanping; McKee, Lauren S.; Gilbert, Harry J.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Polizzi, Samuel J.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA	Universidade de Lisboa; Newcastle University - UK; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Fontes, CMGA (corresponding author), Univ Tecn Lisboa, Ctr Invest Interdisciplinar Sanidade Anim, Fac Med Vet, Ave Univ Tecn, P-1300477 Lisbon, Portugal.	cafontes@fmv.utl.pt; h.j.gilbert@newcastle.ac.uk	McKee, Lauren/A-2782-2013; Montanier, Cédric/P-7727-2019; Henrissat, Bernard/J-2475-2012; Correia, Márcia/D-2077-2013; Prates, José A M/K-9934-2013	McKee, Lauren/0000-0002-3372-8773; Montanier, Cédric/0000-0002-8205-7160; Henrissat, Bernard/0000-0002-3434-8588; Correia, Márcia/0000-0003-0636-8095; Prates, José A M/0000-0003-1032-5987; Fontes, Carlos/0000-0002-1219-9753; Basle, Arnaud/0000-0002-4899-3086; lewis, richard/0000-0003-2641-8643; Flint, James/0000-0003-2923-7813	Fundacao para a Ciencia e Tecnologia (Portugal) [PTDC/BIAPRO/69732/2006];  [SFRH/BD/16731/2004]; Biotechnology and Biological Sciences Research Council [BB/C005074/1] Funding Source: researchfish	Fundacao para a Ciencia e Tecnologia (Portugal)(Portuguese Foundation for Science and Technology); ; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Grants PTDC/BIAPRO/69732/2006 from Fundacao para a Ciencia e Tecnologia (Portugal) and SFRH/BD/16731/2004 (to M. C.).	Abbott DW, 2009, BIOCHEMISTRY-US, V48, P10395, DOI 10.1021/bi9013424; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bayer EA, 2004, ANNU REV MICROBIOL, V58, P521, DOI 10.1146/annurev.micro.57.030502.091022; Black GW, 1997, J BIOTECHNOL, V57, P59, DOI 10.1016/S0168-1656(97)00089-8; Bolam DN, 2001, BIOCHEMISTRY-US, V40, P2468, DOI 10.1021/bi002564l; Bolam DN, 1998, BIOCHEM J, V331, P775, DOI 10.1042/bj3310775; Boraston AB, 2002, MOL MICROBIOL, V43, P187, DOI 10.1046/j.1365-2958.2002.02730.x; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Boraston AB, 2006, J BIOL CHEM, V281, P35263, DOI 10.1074/jbc.M607620200; Brett CT, 1996, PHYSL BIOCH PLANT CE; Brown PH, 2007, BIOMACROMOLECULES, V8, P2011, DOI 10.1021/bm070193j; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Carvalho AL, 2004, J BIOL CHEM, V279, P34785, DOI 10.1074/jbc.M405867200; Charnock SJ, 2002, P NATL ACAD SCI USA, V99, P14077, DOI 10.1073/pnas.212516199; Charnock SJ, 2000, BIOCHEMISTRY-US, V39, P5013, DOI 10.1021/bi992821q; CORREIA AS, 2011, J BIOL CHEM, V286; Correia MAS, 2010, BIOCHEMISTRY-US, V49, P6193, DOI 10.1021/bi1006139; Czjzek M, 2001, J BIOL CHEM, V276, P48580, DOI 10.1074/jbc.M109142200; Dvortsov IA, 2009, MICROBIOL-SGM, V155, P2442, DOI 10.1099/mic.0.026930-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P. R., 1993, DATA COLLECTION PROC, P114; FERREIRA LMA, 1990, BIOCHEM J, V269, P261, DOI 10.1042/bj2690261; Ficko-Blean E, 2006, J BIOL CHEM, V281, P37748, DOI 10.1074/jbc.M606126200; Fontes CMGA, 2010, ANNU REV BIOCHEM, V79, P655, DOI 10.1146/annurev-biochem-091208-085603; Freelove ACJ, 2001, J BIOL CHEM, V276, P43010, DOI 10.1074/jbc.M107143200; GASKELL A, 1995, STRUCTURE, V3, P1197, DOI 10.1016/S0969-2126(01)00255-6; Gloster TM, 2007, J BIOL CHEM, V282, P19177, DOI 10.1074/jbc.M700224200; Henshaw JL, 2004, J BIOL CHEM, V279, P21552, DOI 10.1074/jbc.M401620200; Henshaw J, 2006, J BIOL CHEM, V281, P17099, DOI 10.1074/jbc.M600702200; Herve C, 2010, P NATL ACAD SCI USA, V107, P15293, DOI 10.1073/pnas.1005732107; Jamal-Talabani S, 2004, STRUCTURE, V12, P1177, DOI 10.1016/j.str.2004.04.022; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Lindqvist Y, 1997, CURR OPIN STRUC BIOL, V7, P422, DOI 10.1016/S0959-440X(97)80061-9; Lo WC, 2009, NUCLEIC ACIDS RES, V37, pD328, DOI 10.1093/nar/gkn679; MAYER F, 1987, APPL ENVIRON MICROB, V53, P2785, DOI 10.1128/AEM.53.12.2785-2792.1987; Montanier C, 2009, P NATL ACAD SCI USA, V106, P3065, DOI 10.1073/pnas.0808972106; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagy T, 1998, FEBS LETT, V429, P312, DOI 10.1016/S0014-5793(98)00625-5; Najmudin S, 2006, J BIOL CHEM, V281, P8815, DOI 10.1074/jbc.M510559200; Pell G, 2003, BIOCHEMISTRY-US, V42, P9316, DOI 10.1021/bi0347510; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Raghothama S, 2000, BIOCHEMISTRY-US, V39, P978, DOI 10.1021/bi992163+; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Shatalov AA, 1999, CARBOHYD RES, V320, P93, DOI 10.1016/S0008-6215(99)00136-6; SHELDRICK GM, 1990, ACTA CRYSTALLOGR A, V46, P467, DOI 10.1107/S0108767390000277; Simpson PJ, 2000, J BIOL CHEM, V275, P41137, DOI 10.1074/jbc.M006948200; Tormo J, 1996, EMBO J, V15, P5739, DOI 10.1002/j.1460-2075.1996.tb00960.x; van Bueren AL, 2005, J BIOL CHEM, V280, P530, DOI 10.1074/jbc.M410113200; Vijayan M, 1999, CURR OPIN STRUC BIOL, V9, P707, DOI 10.1016/S0959-440X(99)00034-2	50	28	29	2	26	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22499	22509		10.1074/jbc.M110.217372	http://dx.doi.org/10.1074/jbc.M110.217372			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21454512	Green Published, hybrid			2022-12-25	WOS:000291719900058
J	Spiller, MP; Stirling, CJ				Spiller, Michael P.; Stirling, Colin J.			Preferential Targeting of a Signal Recognition Particle-dependent Precursor to the Ssh1p Translocon in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM MEMBRANE; PROTEIN TRANSLOCATION; SACCHAROMYCES-CEREVISIAE; ER MEMBRANE; IN-VIVO; SEC63P; RIBOSOME; INSERTION; COMPLEX; DOMAIN	Protein translocation across the endoplasmic reticulum membrane occurs via a "translocon" channel formed by the Sec61p complex. In yeast, two channels exist: the canonical Sec61p channel and a homolog called Ssh1p. Here, we used trapped translocation intermediates to demonstrate that a specific signal recognition particle-dependent substrate, Sec71p, is targeted exclusively to Ssh1p. Strikingly, we found that, in the absence of Ssh1p, precursor could be successfully redirected to canonical Sec61p, demonstrating that the normal targeting reaction must involve preferential sorting to Ssh1p. Our data therefore demonstrate that Ssh1p is the primary translocon for Sec71p and reveal a novel sorting mechanism at the level of the endoplasmic reticulum membrane enabling precursors to be directed to distinct translocons. Interestingly, the Ssh1p-dependent translocation of Sec71p was found to be dependent upon Sec63p, demonstrating a previously unappreciated functional interaction between Sec63p and the Ssh1p translocon.	[Spiller, Michael P.; Stirling, Colin J.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Stirling, CJ (corresponding author), Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England.	colin.stirling@manchester.ac.uk						Abell BM, 2004, EMBO J, V23, P2755, DOI 10.1038/sj.emboj.7600281; ADELMAN MR, 1973, J CELL BIOL, V56, P206, DOI 10.1083/jcb.56.1.206; Alder NN, 2005, J CELL BIOL, V168, P389, DOI 10.1083/jcb.200409174; Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; BRODSKY JL, 1995, P NATL ACAD SCI USA, V92, P9643, DOI 10.1073/pnas.92.21.9643; Cross BCS, 2009, NAT REV MOL CELL BIO, V10, P255, DOI 10.1038/nrm2657; FELDHEIM D, 1993, MOL BIOL CELL, V4, P931, DOI 10.1091/mbc.4.9.931; Finke K, 1996, EMBO J, V15, P1482, DOI 10.1002/j.1460-2075.1996.tb00492.x; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; Halic M, 2005, CURR OPIN STRUC BIOL, V15, P116, DOI 10.1016/j.sbi.2005.01.013; Halic M, 2004, NATURE, V427, P808, DOI 10.1038/nature02342; Heinrich SU, 2000, CELL, V102, P233, DOI 10.1016/S0092-8674(00)00028-3; Helmers J, 2003, J BIOL CHEM, V278, P23686, DOI 10.1074/jbc.C300180200; HIGH S, 1993, J CELL BIOL, V121, P743, DOI 10.1083/jcb.121.4.743; HIGH S, 1993, J BIOL CHEM, V268, P26745; Jermy AJ, 2006, J BIOL CHEM, V281, P7899, DOI 10.1074/jbc.M511402200; Jiang Y, 2008, J CELL BIOL, V180, P1149, DOI 10.1083/jcb.200707196; Kabani M, 2000, MOL CELL BIOL, V20, P6923, DOI 10.1128/MCB.20.18.6923-6934.2000; Keenan RJ, 2001, ANNU REV BIOCHEM, V70, P755, DOI 10.1146/annurev.biochem.70.1.755; Liao SR, 1997, CELL, V90, P31, DOI 10.1016/S0092-8674(00)80311-6; LYMAN SK, 1995, J CELL BIOL, V131, P1163, DOI 10.1083/jcb.131.5.1163; MOTHES W, 1994, EMBO J, V13, P3973, DOI 10.1002/j.1460-2075.1994.tb06713.x; Ng DTW, 1996, J CELL BIOL, V134, P269, DOI 10.1083/jcb.134.2.269; Plath K, 2004, MOL BIOL CELL, V15, P1, DOI 10.1091/mbc.E03-06-0390; Rabu C, 2009, J CELL SCI, V122, P3605, DOI 10.1242/jcs.041210; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Steel GJ, 2002, BIOCHEMISTRY-US, V41, P11914, DOI 10.1021/bi026105r; STIRLING CJ, 1992, NATURE, V356, P534, DOI 10.1038/356534a0; STIRLING CJ, 1992, MOL BIOL CELL, V3, P129, DOI 10.1091/mbc.3.2.129; Wilkinson BM, 1997, J MEMBRANE BIOL, V155, P189, DOI 10.1007/s002329900171; Wilkinson BM, 2001, DEV CELL, V1, P401, DOI 10.1016/S1534-5807(01)00043-0; Willer M, 2003, BIOCHEMISTRY-US, V42, P7171, DOI 10.1021/bi034395l; Wittke S, 1999, MOL BIOL CELL, V10, P2519, DOI 10.1091/mbc.10.8.2519; Wittke S, 2002, MOL BIOL CELL, V13, P2223, DOI 10.1091/mbc.01-10-0518; Young BP, 2001, EMBO J, V20, P262, DOI 10.1093/emboj/20.1.262	35	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					21953	21960		10.1074/jbc.M111.219568	http://dx.doi.org/10.1074/jbc.M111.219568			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21454595	Green Published, hybrid			2022-12-25	WOS:000291719900002
J	Tateno, H; Toyota, M; Saito, S; Onuma, Y; Ito, Y; Hiemori, K; Fukumura, M; Matsushima, A; Nakanishi, M; Ohnuma, K; Akutsu, H; Umezawa, A; Horimoto, K; Hirabayashi, J; Asashima, M				Tateno, Hiroaki; Toyota, Masashi; Saito, Shigeru; Onuma, Yasuko; Ito, Yuzuru; Hiemori, Keiko; Fukumura, Mihoko; Matsushima, Asako; Nakanishi, Mio; Ohnuma, Kiyoshi; Akutsu, Hidenori; Umezawa, Akihiro; Horimoto, Katsuhisa; Hirabayashi, Jun; Asashima, Makoto			Glycome Diagnosis of Human Induced Pluripotent Stem Cells Using Lectin Microarray	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRONTAL AFFINITY-CHROMATOGRAPHY; STRATEGY; OLIGOSACCHARIDES; SPECIFICITY; TECHNOLOGY; DYSTROPHIN; MODEL	Induced pluripotent stem cells (iPSCs) can now be produced from various somatic cell (SC) lines by ectopic expression of the four transcription factors. Although the procedure has been demonstrated to induce global change in gene and microRNA expressions and even epigenetic modification, it remains largely unknown how this transcription factor-induced reprogramming affects the total glycan repertoire expressed on the cells. Here we performed a comprehensive glycan analysis using 114 types of human iPSCs generated from five different SCs and compared their glycomes with those of human embryonic stem cells (ESCs; nine cell types) using a high density lectin microarray. In unsupervised cluster analysis of the results obtained by lectin microarray, both undifferentiated iPSCs and ESCs were clustered as one large group. However, they were clearly separated from the group of differentiated SCs, whereas all of the four SCs had apparently distinct glycome profiles from one another, demonstrating that SCs with originally distinct glycan profiles have acquired those similar to ESCs upon induction of pluripotency. Thirty-eight lectins discriminating between SCs and iPSCs/ESCs were statistically selected, and characteristic features of the pluripotent state were then obtained at the level of the cellular glycome. The expression profiles of relevant glycosyltransferase genes agreed well with the results obtained by lectin microarray. Amongthe 38 lectins, rBC2LCN was found to detect only undifferentiated iPSCs/ESCs and not differentiated SCs. Hence, the high density lectin microarray has proved to be valid for not only comprehensive analysis of glycans but also diagnosis of stem cells under the concept of the cellular glycome.	[Tateno, Hiroaki; Hiemori, Keiko; Fukumura, Mihoko; Matsushima, Asako; Hirabayashi, Jun] Natl Inst Adv Ind Sci & Technol, Res Ctr Med Glycosci, Tsukuba, Ibaraki 3058568, Japan; [Toyota, Masashi; Akutsu, Hidenori; Umezawa, Akihiro] Natl Res Inst Child Hlth & Dev, Dept Reprod Biol, Setagaya Ku, Tokyo 1578535, Japan; [Saito, Shigeru; Horimoto, Katsuhisa] Natl Inst Adv Ind Sci & Technol, Computat Biol Res Ctr, Koto Ku, Tokyo 1350064, Japan; [Saito, Shigeru] Infocom Corp, Shibuya Ku, Tokyo 1500001, Japan; [Onuma, Yasuko; Ito, Yuzuru; Asashima, Makoto] Natl Inst Adv Ind Sci & Technol, Res Ctr Stem Cell Engn, Tsukuba, Ibaraki 3058562, Japan; [Nakanishi, Mio; Ohnuma, Kiyoshi; Asashima, Makoto] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci Biol, Meguro Ku, Tokyo 1538902, Japan	National Institute of Advanced Industrial Science & Technology (AIST); National Center for Child Health & Development - Japan; National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); University of Tokyo	Hirabayashi, J (corresponding author), AIST, Cent 2,1-1-1 Umezono, Tsukuba, Ibaraki 3058568, Japan.	jun-hirabayashi@aist.go.jp	Saito, Shigeru/B-2785-2012; Ito, Yuzuru/M-1085-2018; Hirabayashi, Jun/M-3998-2018; Tateno, Hiroaki/M-2706-2018; Onuma, Yasuko/L-7083-2018; Asashima, Makoto/O-8389-2018	Saito, Shigeru/0000-0002-8708-9102; Ito, Yuzuru/0000-0001-7923-865X; Hirabayashi, Jun/0000-0002-8571-359X; Tateno, Hiroaki/0000-0003-3006-1659; Onuma, Yasuko/0000-0002-9330-194X; Asashima, Makoto/0000-0002-0012-026X; Ohnuma, Kiyoshi/0000-0002-2272-3643	New Energy and Industrial Technology Development Organization in Japan	New Energy and Industrial Technology Development Organization in Japan(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported by the New Energy and Industrial Technology Development Organization in Japan.	BREMER EG, 1984, J BIOL CHEM, V259, P4773; Cui CH, 2011, HUM MOL GENET, V20, P235, DOI 10.1093/hmg/ddq458; Ebe Y, 2006, J BIOCHEM, V139, P323, DOI 10.1093/jb/mvj070; Gagneux P, 1999, GLYCOBIOLOGY, V9, P747, DOI 10.1093/glycob/9.8.747; Grahn E, 2007, J MOL BIOL, V369, P710, DOI 10.1016/j.jmb.2007.03.016; Gupta G, 2010, OMICS, V14, P419, DOI 10.1089/omi.2009.0150; Hirabayashi J, 2008, J BIOCHEM, V144, P139, DOI 10.1093/jb/mvn043; Hsu KL, 2006, NAT CHEM BIOL, V2, P153, DOI 10.1038/nchembio767; Kawamichi Y, 2010, J CELL PHYSIOL, V223, P695, DOI 10.1002/jcp.22076; Klim JR, 2010, NAT METHODS, V7, P989, DOI 10.1038/NMETH.1532; Krishnamoorthy L, 2009, NAT CHEM BIOL, V5, P244, DOI 10.1038/nchembio.151; Kuno A, 2005, NAT METHODS, V2, P851, DOI 10.1038/NMETH803; Kuno A, 2008, J PROTEOM BIOINFORM, V1, P68, DOI DOI 10.4172/JPB.1000011; Kuno A, 2009, MOL CELL PROTEOMICS, V8, P99, DOI 10.1074/mcp.M800308-MCP200; Lanctot PM, 2007, CURR OPIN CHEM BIOL, V11, P373, DOI 10.1016/j.cbpa.2007.05.032; Liang YJ, 2010, P NATL ACAD SCI USA, V107, P22564, DOI 10.1073/pnas.1007290108; Makino H, 2009, EXP CELL RES, V315, P2727, DOI 10.1016/j.yexcr.2009.06.016; Matsuda A, 2008, BIOCHEM BIOPH RES CO, V370, P259, DOI 10.1016/j.bbrc.2008.03.090; Matsuda A, 2010, HEPATOLOGY, V52, P174, DOI 10.1002/hep.23654; Miyazaki T, 2008, BIOCHEM BIOPH RES CO, V375, P27, DOI 10.1016/j.bbrc.2008.07.111; Muramatsu T, 2004, GLYCOCONJUGATE J, V21, P41, DOI 10.1023/B:GLYC.0000043746.77504.28; Nagata S, 2009, GENES CELLS, V14, P1395, DOI 10.1111/j.1365-2443.2009.01356.x; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nakamura-Tsuruta S, 2006, J BIOCHEM, V140, P285, DOI 10.1093/jb/mvj148; Narimatsu H, 2010, FEBS J, V277, P95, DOI 10.1111/j.1742-4658.2009.07430.x; NATUNEN S, 2011, GLYCOBIOLOG IN PRESS; Nishino K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013017; Pilobello KT, 2007, P NATL ACAD SCI USA, V104, P11534, DOI 10.1073/pnas.0704954104; Pilobello KT, 2005, CHEMBIOCHEM, V6, P985, DOI 10.1002/cbic.200400403; SAITO S, 2010, 4 INT C COMP SYST BI, P381; Sasaki N, 2008, J BIOL CHEM, V283, P3594, DOI 10.1074/jbc.M705621200; Sasaki N, 2010, BIOCHEM BIOPH RES CO, V401, P480, DOI 10.1016/j.bbrc.2010.09.085; Satomaa T, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-42; Schopperle WM, 2007, STEM CELLS, V25, P723, DOI 10.1634/stemcells.2005-0597; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Suemori H, 2006, BIOCHEM BIOPH RES CO, V345, P926, DOI 10.1016/j.bbrc.2006.04.135; Sulak O, 2010, STRUCTURE, V18, P59, DOI 10.1016/j.str.2009.10.021; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tateno H, 2008, GLYCOBIOLOGY, V18, P789, DOI 10.1093/glycob/cwn068; Tateno H, 2007, NAT PROTOC, V2, P2529, DOI 10.1038/nprot.2007.357; Tateno H, 2007, GLYCOBIOLOGY, V17, P1138, DOI 10.1093/glycob/cwm084; Tateno H, 2010, METHOD ENZYMOL, V478, P181, DOI 10.1016/S0076-6879(10)78008-3; Toyoda M, 2011, GENES CELLS, V16, P1, DOI 10.1111/j.1365-2443.2010.01459.x; Tsuji H, 2010, CIRC RES, V106, P1613, DOI 10.1161/CIRCRESAHA.109.205260; Uchiyama N, 2008, PROTEOMICS, V8, P3042, DOI 10.1002/pmic.200701114; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Wearne KA, 2008, GLYCOCONJUGATE J, V25, P121, DOI 10.1007/s10719-007-9064-x; Wearne KA, 2006, GLYCOBIOLOGY, V16, P981, DOI 10.1093/glycob/cwl019; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhuo Y, 2011, J BIOL CHEM, V286, P5935, DOI 10.1074/jbc.R110.191429	50	140	148	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20345	20353		10.1074/jbc.M111.231274	http://dx.doi.org/10.1074/jbc.M111.231274			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21471226	Green Published, hybrid			2022-12-25	WOS:000291267600022
J	Shibata, T; Shimozu, Y; Wakita, C; Shibata, N; Kobayashi, M; Machida, S; Kato, R; Itabe, H; Zhu, XC; Sayre, LM; Uchida, K				Shibata, Takahiro; Shimozu, Yuuki; Wakita, Chika; Shibata, Noriyuki; Kobayashi, Makio; Machida, Sachiko; Kato, Rina; Itabe, Hiroyuki; Zhu, Xiaochun; Sayre, Lawrence M.; Uchida, Koji			Lipid Peroxidation Modification of Protein Generates N-epsilon-(4-Oxononanoyl)lysine as a Pro-inflammatory Ligand	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; OXIDIZED LDL RECEPTOR-1; ARTERY ENDOTHELIAL-CELLS; CROSS-LINKING; ATHEROSCLEROTIC LESIONS; DECOMPOSITION PRODUCTS; SCAVENGER RECEPTOR; LOX-1 EXPRESSION; MICHAEL ADDUCTS; OX-LDL	4-Oxo-2(E)-nonenal (ONE), a peroxidation product of omega-6 polyunsaturated fatty acids, covalently reacts with lysine residues to generate a 4-ketoamide-type ONE-lysine adduct, N-epsilon-(4oxononanoyl) lysine (ONL). Using an ONL-coupled protein as the immunogen, we raised the monoclonal antibody (mAb) 9K3 directed to the ONL and conclusively demonstrated that the ONL was produced during the oxidative modification of a low density lipoprotein (LDL) in vitro. In addition, we observed that the ONL was present in atherosclerotic lesions, in which an intense immunoreactivity was mainly localized in the vascular endothelial cells and macrophage-and vascular smooth muscle cell-derived foam cells. Using liquid chromatography with on-line electrospray ionization tandem mass spectrometry, we also established a highly sensitive method for quantification of the ONL and confirmed that the ONL was indeed formed during the lipid peroxidation-mediated modification of protein in vitro and in vivo. To evaluate the biological implications for ONL formation, we examined the recognition of ONL by the scavenger receptor lectin-like oxidized LDL receptor-1 (LOX-1). Using CHO cells stably expressing LOX-1, we evaluated the ability of ONL to compete with the acetylated LDL and found that both the ONE-modified and ONL-coupled proteins inhibited the binding and uptake of the modified LDL. In addition, we demonstrated that the ONL-coupled protein was incorporated into differentiated THP-1 cells via LOX-1. Finally, we examined the effect of ONL on the expression of the inflammation-associated gene in THP-1 and observed that the ONL-coupled proteins significantly induced the expression of atherogenesis-related genes, such as the monocyte chemoattractant protein-1 and tumor necrosis factor-alpha, in a LOX-1-dependent manner. Thus, ONL was identified to be a potential endogenous ligand for LOX-1.	[Shibata, Takahiro; Shimozu, Yuuki; Wakita, Chika; Uchida, Koji] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Shibata, Noriyuki; Kobayashi, Makio] Tokyo Womens Med Univ, Dept Pathol, Tokyo 1628666, Japan; [Machida, Sachiko] Natl Food Res Inst, Tsukuba, Ibaraki 3058642, Japan; [Kato, Rina; Itabe, Hiroyuki] Showa Univ, Dept Biol Chem, Sch Pharm, Tokyo 1428555, Japan; [Zhu, Xiaochun; Sayre, Lawrence M.] Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA	Nagoya University; Tokyo Women's Medical University; National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan; Showa University; Case Western Reserve University	Uchida, K (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan.	uchidak@agr.nagoya-u.ac.jp	板部板部, 洋之/ABC-7746-2020; Shimozu, Yuuki/AAW-1504-2021; Shibata, Takahiro/I-6872-2014	Shibata, Takahiro/0000-0003-3194-607X; Uchida, Koji/0000-0003-3894-5299	Iijima Memorial Foundation	Iijima Memorial Foundation	This work was supported by grants-in-aid for scientific research on innovative areas (research in a proposed research area), Japan (to K. U.), and The Iijima Memorial Foundation (to T. S.).	Chen MJ, 2002, PHARMACOL THERAPEUT, V95, P89, DOI 10.1016/S0163-7258(02)00236-X; Chen MY, 2000, ARTERIOSCL THROM VAS, V20, P1107, DOI 10.1161/01.ATV.20.4.1107; Chen MY, 2001, BIOCHEM BIOPH RES CO, V287, P962, DOI 10.1006/bbrc.2001.5674; Chen XP, 2007, CARDIOVASC DRUG REV, V25, P146, DOI 10.1111/j.1527-3466.2007.00009.x; Cominacini L, 2001, J BIOL CHEM, V276, P13750, DOI 10.1074/jbc.M010612200; Cominacini L, 2000, J BIOL CHEM, V275, P12633, DOI 10.1074/jbc.275.17.12633; Doorn JA, 2002, CHEM RES TOXICOL, V15, P1445, DOI 10.1021/tx025590o; Draude G, 1999, BIOCHEM PHARMACOL, V57, P383, DOI 10.1016/S0006-2952(98)00313-X; Duryee MJ, 2003, BIOCHEM PHARMACOL, V66, P1045, DOI 10.1016/S0006-2952(03)00416-7; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; ESTERBAUER H, 1990, CHEM RES TOXICOL, V3, P77, DOI 10.1021/tx00014a001; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Honjo M, 2003, P NATL ACAD SCI USA, V100, P1274, DOI 10.1073/pnas.0337528100; Inoue K, 2005, CIRC RES, V97, P176, DOI 10.1161/01.RES.0000174286.73200.d4; Ishino K, 2010, J BIOL CHEM, V285, P15302, DOI 10.1074/jbc.M109.068023; Jian WY, 2005, FREE RADICAL BIO MED, V39, P1162, DOI 10.1016/j.freeradbiomed.2005.06.008; JURGENS G, 1986, BIOCHIM BIOPHYS ACTA, V875, P103, DOI 10.1016/0005-2760(86)90016-0; Kakutani M, 2000, P NATL ACAD SCI USA, V97, P360, DOI 10.1073/pnas.97.1.360; Kataoka H, 1999, CIRCULATION, V99, P3110, DOI 10.1161/01.CIR.99.24.3110; Kawai Y, 2004, FREE RADICAL BIO MED, V36, P529, DOI 10.1016/j.freeradbiomed.2003.12.006; Kawai Y, 2002, CARCINOGENESIS, V23, P485, DOI 10.1093/carcin/23.3.485; Kume N, 1998, CIRC RES, V83, P322, DOI 10.1161/01.RES.83.3.322; Lee SH, 2000, CHEM RES TOXICOL, V13, P698, DOI 10.1021/tx000101a; Lee SH, 2000, CHEM RES TOXICOL, V13, P565, DOI 10.1021/tx000057z; Li AC, 2002, NAT MED, V8, P1235, DOI 10.1038/nm1102-1235; Li DY, 2003, ARTERIOSCL THROM VAS, V23, P816, DOI 10.1161/01.ATV.0000066685.13434.FA; Li DY, 2001, CARDIOVASC RES, V52, P130, DOI 10.1016/S0008-6363(01)00371-6; Li DY, 2000, CIRCULATION, V101, P2889, DOI 10.1161/01.CIR.101.25.2889; Lin D, 2005, CHEM RES TOXICOL, V18, P1219, DOI 10.1021/tx050080q; Lougheed M, 1996, J BIOL CHEM, V271, P11798, DOI 10.1074/jbc.271.20.11798; Matsunaga S, 2007, EXP CELL RES, V313, P1203, DOI 10.1016/j.yexcr.2007.01.007; Mehta JL, 2002, J AM COLL CARDIOL, V39, P1429, DOI 10.1016/S0735-1097(02)01803-X; Moriwaki H, 1998, FEBS LETT, V440, P29, DOI 10.1016/S0014-5793(98)01414-8; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; Oe T, 2003, CHEM RES TOXICOL, V16, P1598, DOI 10.1021/tx034178l; Podrez EA, 2002, J BIOL CHEM, V277, P38503, DOI 10.1074/jbc.M203318200; Pollack M, 2003, CHEM RES TOXICOL, V16, P893, DOI 10.1021/tx030009p; RAMOS P, 1995, J LIPID RES, V36, P2113; Rindgen D, 1999, CHEM RES TOXICOL, V12, P1195, DOI 10.1021/tx990034o; Rindgen D, 2000, CHEM RES TOXICOL, V13, P846, DOI 10.1021/tx0000771; Sawamura T, 1997, NATURE, V386, P73, DOI 10.1038/386073a0; Sayre LM, 1996, CHEM RES TOXICOL, V9, P1194, DOI 10.1021/tx960094j; Shi XH, 2001, J CELL SCI, V114, P1273; Shibata T, 2006, J BIOL CHEM, V281, P1196, DOI 10.1074/jbc.M509065200; Shimozu Y, 2009, CHEM RES TOXICOL, V22, P957, DOI 10.1021/tx900059k; STEINBERG D, 1995, ADV EXP MED BIOL, V369, P39; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; STEINBRECHER UP, 1987, J BIOL CHEM, V262, P3603; STEPHAN ZF, 1993, J LIPID RES, V34, P325; Sun MJ, 2002, J ORG CHEM, V67, P3575, DOI 10.1021/jo0105383; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Uchida K, 2003, PROG LIPID RES, V42, P318, DOI 10.1016/S0163-7827(03)00014-6; West JD, 2004, CHEM RES TOXICOL, V17, P453, DOI 10.1021/tx034248o; Williams MV, 2007, CHEM RES TOXICOL, V20, P767, DOI 10.1021/tx600289r; Xu GZ, 1999, CHEM RES TOXICOL, V12, P855, DOI 10.1021/tx990056a; Xu GZ, 1998, CHEM RES TOXICOL, V11, P247, DOI 10.1021/tx980003d; Yoshida H, 1998, BIOCHEM J, V334, P9, DOI 10.1042/bj3340009; Zhang WH, 2003, CHEM RES TOXICOL, V16, P512, DOI 10.1021/tx020105a; Zhu XC, 2007, CHEM RES TOXICOL, V20, P165, DOI 10.1021/tx600295j; Zhu X, 2009, CHEM RES TOXICOL, V22, P1386, DOI 10.1021/tx9000072; Zhu X, 2009, CHEM RES TOXICOL, V22, P1050, DOI 10.1021/tx9000144	61	28	28	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19943	19957		10.1074/jbc.M110.187047	http://dx.doi.org/10.1074/jbc.M110.187047			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21471194	hybrid, Green Published			2022-12-25	WOS:000291027700073
J	Bibert, S; Liu, CC; Figtree, GA; Garcia, A; Hamilton, EJ; Marassi, FM; Sweadner, KJ; Cornelius, F; Geering, K; Rasmussen, HH				Bibert, Stephanie; Liu, Chia-Chi; Figtree, Gemma A.; Garcia, Alvaro; Hamilton, Elisha J.; Marassi, Francesca M.; Sweadner, Kathleen J.; Cornelius, Flemming; Geering, Kaethi; Rasmussen, Helge H.			FXYD Proteins Reverse Inhibition of the Na+-K+ Pump Mediated by Glutathionylation of Its beta(1) Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-POTASSIUM PUMP; SHARK RECTAL GLANDS; OXIDATIVE MODIFICATION; PHOSPHOLEMMAN FXYD1; CRYSTAL-STRUCTURE; CARDIAC MYOCYTES; PROSTATE-CANCER; XENOPUS OOCYTES; ALPHA-SUBUNIT; MICE LACKING	The seven members of the FXYD protein family associate with the Na+-K+ pump and modulate its activity. We investigated whether conserved cysteines in FXYD proteins are susceptible to glutathionylation and whether such reactivity affects Na+-K+ pump function in cardiac myocytes and Xenopus oocytes. Glutathionylation was detected by immunoblotting streptavidin precipitate from biotin-GSH loaded cells or by a GSH antibody. Incubation of myocytes with recombinant FXYD proteins resulted in competitive displacement of native FXYD1. Myocyte and Xenopus oocyte pump currents were measured with whole-cell and two-electrode voltage clamp techniques, respectively. Native FXYD1 in myocytes and FXYD1 expressed in oocytes were susceptible to glutathionylation. Mutagenesis identified the specific cysteine in the cytoplasmic terminal that was reactive. Its reactivity was dependent on flanking basic amino acids. We have reported that Na+-K(+)pump beta(1) subunit glutathionylation induced by oxidative signals causes pump inhibition in a previous study. In the present study, we found that beta(1) subunit glutathionylation and pump inhibition could be reversed by exposing myocytes to exogenous wild-type FXYD3. A cysteine-free FXYD3 derivative had no effect. Similar results were obtained with wild-type and mutant FXYD proteins expressed in oocytes. Glutathionylation of the beta(1) subunit was increased in myocardium from FXYD1(-/-) mice. In conclusion, there is a dependence of Na+-K+ pump regulation on reactivity of two specifically identified cysteines on separate components of the multimeric Na+-K+ pump complex. By facilitating deglutathionylation of the beta(1) subunit, FXYD proteins reverse oxidative inhibition of the Na+-K+ pump and play a dynamic role in its regulation.	[Bibert, Stephanie; Geering, Kaethi] Univ Lausanne, Dept Pharmacol & Toxicol, CH-1005 Lausanne, Switzerland; [Liu, Chia-Chi; Figtree, Gemma A.; Garcia, Alvaro; Hamilton, Elisha J.; Rasmussen, Helge H.] Univ Sydney, Kolling Inst, N Shore Heart Res Grp, St Leonards, NSW 2065, Australia; [Figtree, Gemma A.; Garcia, Alvaro; Rasmussen, Helge H.] Royal N Shore Hosp, Dept Cardiol, St Leonards, NSW 2065, Australia; [Marassi, Francesca M.] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Sweadner, Kathleen J.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Sweadner, Kathleen J.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Cornelius, Flemming] Aarhus Univ, Dept Physiol & Biophys, DK-8000 Aarhus, Denmark	University of Lausanne; University of Sydney; Kolling Institute of Medical Research; Royal North Shore Hospital; Sanford Burnham Prebys Medical Discovery Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Aarhus University	Rasmussen, HH (corresponding author), Royal N Shore Hosp, Dept Cardiol, St Leonards, NSW 2065, Australia.	helge.rasmussen@sydney.edu.au	Cornelius, Flemming/C-1912-2019; Hamilton, Elisha/F-8187-2010; Garcia, Alvaro/E-6573-2015	Cornelius, Flemming/0000-0003-1566-0020; Hamilton, Elisha/0000-0002-1892-352X; Garcia, Alvaro/0000-0002-1159-4567; Bibert, Stephanie/0000-0001-5170-7506; Rasmussen, Helge/0000-0003-2409-4083	North Shore Heart Research Foundation; National Health and Medical Research Council (Australia) [633252]; National Institutes of Health [CA082864, R01 NS050696]; Medical Foundation (University of Sydney); The Danish Medical Research Council; Danish Agency for Science, Technology and Innovation; Swiss National Science Foundation [3100A0-107513]; NATIONAL CANCER INSTITUTE [R01CA082864] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050696] Funding Source: NIH RePORTER	North Shore Heart Research Foundation; National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Foundation (University of Sydney)(University of Sydney); The Danish Medical Research Council(Danish Medical Research Council); Danish Agency for Science, Technology and Innovation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by a grant from the North Shore Heart Research Foundation, National Health and Medical Research Council (Australia) Project Grant 633252, and Grant CA082864 from the National Institutes of Health (to F. M. M.).; Supported by the Medical Foundation (University of Sydney).; Supported by National Institutes of Health Grant R01 NS050696.; Supported by The Danish Medical Research Council and Danish Agency for Science, Technology and Innovation.; Supported by Swiss National Science Foundation Grant 3100A0-107513.	Arimochi J, 2007, BIOL PHARM BULL, V30, P648, DOI 10.1248/bpb.30.648; Bibert S, 2008, J BIOL CHEM, V283, P476, DOI 10.1074/jbc.M705830200; Bossuyt J, 2005, CIRC RES, V97, P558, DOI 10.1161/01.RES.0000181172.27931.c3; Bundgaard H, 2010, CIRCULATION, V122, P2699, DOI 10.1161/CIRCULATIONAHA.110.964619; Cornelius F, 2005, BIOCHEMISTRY-US, V44, P13051, DOI 10.1021/bi0504456; Cornelius F, 2003, NEWS PHYSIOL SCI, V18, P119, DOI 10.1152/nips.01434.2003; Crambert G, 2002, P NATL ACAD SCI USA, V99, P11476, DOI 10.1073/pnas.182267299; Dalle-Donne I, 2008, ANTIOXID REDOX SIGN, V10, P445, DOI 10.1089/ars.2007.1716; Dempski RE, 2006, J BIOL CHEM, V281, P36338, DOI 10.1074/jbc.M604788200; Figtree GA, 2009, CIRC RES, V105, P185, DOI 10.1161/CIRCRESAHA.109.199547; Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003; Gallogly MM, 2009, ANTIOXID REDOX SIGN, V11, P1059, DOI [10.1089/ars.2008.2291, 10.1089/ARS.2008.2291]; GEERING K, 1989, AM J PHYSIOL, V257, pC851, DOI 10.1152/ajpcell.1989.257.5.C851; Geering K, 2006, AM J PHYSIOL-RENAL, V290, pF241, DOI 10.1152/ajprenal.00126.2005; Grzmil M, 2004, INT J ONCOL, V24, P97; Hansen RE, 2005, BIOCHEMISTRY-US, V44, P5899, DOI 10.1021/bi0500372; Hansen RE, 2009, P NATL ACAD SCI USA, V106, P422, DOI 10.1073/pnas.0812149106; Hashemy SI, 2007, J BIOL CHEM, V282, P14428, DOI 10.1074/jbc.M700927200; Horisberger JD, 2004, J BIOL CHEM, V279, P29542, DOI 10.1074/jbc.M400585200; Huang YT, 2004, BIOCHEM PHARMACOL, V67, P727, DOI 10.1016/j.bcp.2003.10.013; JAUNIN P, 1992, J BIOL CHEM, V267, P577; Jia LG, 2005, AM J PHYSIOL-HEART C, V288, pH1982, DOI 10.1152/ajpheart.00142.2004; Jones DH, 2005, J BIOL CHEM, V280, P19003, DOI 10.1074/jbc.M500697200; Kuster GM, 2010, FREE RADICAL BIO MED, V48, P1182, DOI 10.1016/j.freeradbiomed.2010.01.038; Lifshitz Y, 2007, BIOCHEMISTRY-US, V46, P14937, DOI 10.1021/bi701812c; Liochev SI, 2007, FREE RADICAL BIO MED, V42, P1465, DOI 10.1016/j.freeradbiomed.2007.02.015; Mahmmoud YA, 2000, J BIOL CHEM, V275, P35969, DOI 10.1074/jbc.M005168200; Mahmmoud YA, 2005, J BIOL CHEM, V280, P27776, DOI 10.1074/jbc.M503150200; Mijatovic T, 2007, BBA-REV CANCER, V1776, P32, DOI 10.1016/j.bbcan.2007.06.002; Moens AL, 2009, J MOL CELL CARDIOL, V47, P576, DOI 10.1016/j.yjmcc.2009.06.005; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Pani G, 2009, ANTIOXID REDOX SIGN, V11, P2791, DOI 10.1089/ars.2009.2739; PRESTI CF, 1985, J BIOL CHEM, V260, P3860; Rasmussen HH, 2010, TRENDS CARDIOVAS MED, V20, P85, DOI 10.1016/j.tcm.2010.06.002; Shattock MJ, 2009, CURR OPIN PHARMACOL, V9, P160, DOI 10.1016/j.coph.2008.12.015; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Starke DW, 2003, J BIOL CHEM, V278, P14607, DOI 10.1074/jbc.M210434200; Sweadner KJ, 2000, GENOMICS, V68, P41, DOI 10.1006/geno.2000.6274; Teriete P, 2007, BIOCHEMISTRY-US, V46, P6774, DOI 10.1021/bi700391b; White CN, 2008, AM J PHYSIOL-CELL PH, V294, pC572, DOI 10.1152/ajpcell.00242.2007; White CN, 2010, J BIOL CHEM, V285, P13712, DOI 10.1074/jbc.M109.090225; White CN, 2009, AM J PHYSIOL-CELL PH, V296, pC693, DOI 10.1152/ajpcell.00648.2008; Winterbourn CC, 2008, FREE RADICAL BIO MED, V45, P549, DOI 10.1016/j.freeradbiomed.2008.05.004; Zhang XQ, 2009, AM J PHYSIOL-CELL PH, V296, pC911, DOI 10.1152/ajpcell.00196.2008	44	69	81	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18562	18572		10.1074/jbc.M110.184101	http://dx.doi.org/10.1074/jbc.M110.184101			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21454534	Green Published, hybrid			2022-12-25	WOS:000290785700028
J	Feng, S; Rodat-Despoix, L; Delmas, P; Ong, ACM				Feng, Shuang; Rodat-Despoix, Lise; Delmas, Patrick; Ong, Albert C. M.			A Single Amino Acid Residue Constitutes the Third Dimerization Domain Essential for the Assembly and Function of the Tetrameric Polycystin-2 (TRPP2) Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KIDNEY-DISEASE; CYSTIC TISSUE; RECEPTOR; COMPLEX; PKD1; IDENTIFICATION; LOCALIZATION; GENE; ASSOCIATION; ACTIVATION	Autosomal dominant polycystic kidney disease (ADPKD), the most common inherited cause of kidney failure, is caused by mutations in either PKD1 (85%) or PKD2 (15%). The PKD2 protein, polycystin-2 (PC2 or TRPP2), is a member of the transient receptor potential (TRP) superfamily and functions as a nonselective calcium channel. PC2 has been found to form oligomers in native tissues, suggesting that similar to other TRP channels, it may form functional homo- or heterotetramers with other TRP subunits. We have recently demonstrated that the homodimerization of PC2 is mediated by both N-terminal and C-terminal domains, and it is known that PC2 can heterodimerize with PC1, TRPC1, and TRPV4. In this paper, we report that a single cysteine residue, Cys(632), mutated in a known PKD2 pedigree, constitutes the third dimerization domain for PC2. PC2 truncation mutants lacking both N and C termini could still dimerize under nonreducing conditions. Mutation of Cys(632) alone abolished dimerization in these mutants, indicating that it was the critical residue mediating disulfide bond formation between PC2 monomers. Co-expression of C632A PC2 mutants with wild-type PC2 channels reduced ATP-sensitive endoplasmic reticulum Ca2+ release in HEK293 cells. The combination of C632A and mutations disrupting the C-terminal coiled-coil domain (Val(846), Ile(853), Ile(860), Leu(867) or 4M) nearly abolished dimer formation and ATP-dependent Ca2+ release. However, unlike the 4M PC2 mutant, a C632A mutant could still heterodimerize with polycystin-1 (PC1). Our results indicate that PC2 homodimerization is regulated by three distinct domains and that these events regulate formation of the tetrameric PC2 channel.	[Feng, Shuang; Ong, Albert C. M.] Univ Sheffield, Sch Med, Kidney Genet Grp, Acad Unit Nephrol,Henry Wellcome Labs Med Res, Sheffield S10 2RX, S Yorkshire, England; [Rodat-Despoix, Lise; Delmas, Patrick] Univ Mediterrane, Ctr Rech Neurophysiol & Neurobiol Marseille, CNRS, CS80011,UMR 6231, F-13344 Marseille 15, France	University of Sheffield; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Ong, ACM (corresponding author), Univ Sheffield, Sch Med, Kidney Genet Grp, Acad Unit Nephrol,Henry Wellcome Labs Med Res, Sheffield S10 2RX, S Yorkshire, England.	a.ong@sheffield.ac.uk	Ong, Albert/AAN-9430-2021	Ong, Albert/0000-0002-7211-5400; Despoix, Lise/0000-0002-2456-6039	Wellcome Trust [GR071201]; Sheffield Kidney Research Foundation; Sheffield Area Kidney Association	Wellcome Trust(Wellcome TrustEuropean Commission); Sheffield Kidney Research Foundation; Sheffield Area Kidney Association	This work was funded by Wellcome Trust Grant GR071201 (to A. C. M. O.) and a Sheffield Kidney Research Foundation (to A. C. M. O.).; Brayshaw Research Associate and holder of a Ph.D. studentship from the Sheffield Area Kidney Association.	Anyatonwu GI, 2007, P NATL ACAD SCI USA, V104, P6454, DOI 10.1073/pnas.0610324104; Bai CX, 2008, EMBO J, V27, P1345, DOI 10.1038/emboj.2008.70; Bai CX, 2008, EMBO REP, V9, P472, DOI 10.1038/embor.2008.29; Calvet JP, 2001, SEMIN NEPHROL, V21, P107, DOI 10.1053/snep.2001.20929; Celic A, 2008, J BIOL CHEM, V283, P28305, DOI 10.1074/jbc.M802743200; Delmas P, 2004, FASEB J, V18, P740, DOI 10.1096/fj.03-0319fje; Feng S, 2008, J BIOL CHEM, V283, P28471, DOI 10.1074/jbc.M803834200; Fu X, 2008, J AM SOC NEPHROL, V19, P1342, DOI 10.1681/ASN.2007070730; Giamarchi A, 2010, EMBO J, V29, P1176, DOI 10.1038/emboj.2010.18; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hanaoka K, 2000, NATURE, V408, P990, DOI 10.1038/35050128; HIRS CHW, 1967, METHOD ENZYMOL, V11, P198; Kotttgen M, 2008, J CELL BIOL, V182, P437, DOI 10.1083/jcb.200805124; Koulen P, 2002, NAT CELL BIOL, V4, P191, DOI 10.1038/ncb754; Li Y, 2005, J BIOL CHEM, V280, P41298, DOI 10.1074/jbc.M510082200; Magistroni R, 2003, J AM SOC NEPHROL, V14, P1164, DOI 10.1097/01.ASN.0000061774.90975.25; McGrath J, 2003, CELL, V114, P61, DOI 10.1016/S0092-8674(03)00511-7; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Montell C, 2002, MOL CELL, V9, P229, DOI 10.1016/S1097-2765(02)00448-3; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Newby LJ, 2002, J BIOL CHEM, V277, P20763, DOI 10.1074/jbc.M107788200; Ong ACM, 1999, AM J PATHOL, V154, P1721, DOI 10.1016/S0002-9440(10)65428-4; Ong ACM, 1999, KIDNEY INT, V56, P1324, DOI 10.1046/j.1523-1755.1999.00659.x; Qian F, 1997, NAT GENET, V16, P179, DOI 10.1038/ng0697-179; Sammels E, 2010, J BIOL CHEM, V285, P18794, DOI 10.1074/jbc.M109.090662; Streets AJ, 2006, HUM MOL GENET, V15, P1465, DOI 10.1093/hmg/ddl070; Streets AJ, 2003, J AM SOC NEPHROL, V14, P1804, DOI 10.1097/01.ASN.0000076075.49819.9B; Tsiokas L, 1999, P NATL ACAD SCI USA, V96, P3934, DOI 10.1073/pnas.96.7.3934; Tsiokas L, 1997, P NATL ACAD SCI USA, V94, P6965, DOI 10.1073/pnas.94.13.6965; Wilson PD, 2004, NEW ENGL J MED, V350, P151, DOI 10.1056/NEJMra022161; Xu GM, 2003, J BIOL CHEM, V278, P1457, DOI 10.1074/jbc.M209996200; Yu Y, 2009, P NATL ACAD SCI USA, V106, P11558, DOI 10.1073/pnas.0903684106	32	21	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18994	19000		10.1074/jbc.M110.192286	http://dx.doi.org/10.1074/jbc.M110.192286			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21474446	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000290785700070
J	Lim, KG; Tonelli, F; Li, ZG; Lu, XQ; Bittman, R; Pyne, S; Pyne, NJ				Lim, Keng G.; Tonelli, Francesca; Li, Zaiguo; Lu, Xuequan; Bittman, Robert; Pyne, Susan; Pyne, Nigel J.			FTY720 Analogues as Sphingosine Kinase 1 Inhibitors ENZYME INHIBITION KINETICS, ALLOSTERISM, PROTEASOMAL DEGRADATION, AND ACTIN REARRANGEMENT IN MCF-7 BREAST CANCER CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDEPENDENT PROSTATE-CANCER; PROTEIN-COUPLED RECEPTORS; TUMOR-GROWTH; 1-PHOSPHATE RECEPTORS; MAMMALIAN-CELLS; IN-VITRO; SPHINGOSINE-1-PHOSPHATE; ANGIOGENESIS; EXPRESSION; DISCOVERY	Sphingosine kinase 1 (SK1) catalyzes the conversion of sphingosine to the bioactive lipid sphingosine 1-phosphate. We have previously demonstrated that FTY720 and (S)-FTY720 vinylphosphonate are novel inhibitors of SK1 activity. Here, we show that (S)-FTY720 vinylphosphonate binds to a putative allosteric site in SK1 contingent on formation of the enzyme-sphingosine complex. We report that SK1 is an oligomeric protein (minimally a dimer) containing noncooperative catalytic sites and that the allosteric site exerts an autoinhibition of the catalytic site. A model is proposed in which (S)-FTY720 vinylphosphonate binding to and stabilization of the allosteric site might enhance the autoinhibitory effect on SK1 activity. Further evidence for the existence of allosteric site(s) in SK1 was demonstrated by data showing that two new FTY720 analogues (a conjugate of sphingosine with a fluorophore and (S)-FTY720 regioisomer) increased SK1 activity, suggesting relief of autoinhibition of SK1 activity. Comparisons with the SK1 inhibitor, SKi or siRNA knockdown of SK1 indicated that (S)-FTY720 vinylphosphonate and FTY720 behave as typical SK1 inhibitors in preventing sphingosine 1-phosphate-stimulated rearrangement of actin in MCF-7 cells. These findings are discussed in relation to the anticancer properties of SK1 inhibitors.	[Lim, Keng G.; Tonelli, Francesca; Pyne, Susan; Pyne, Nigel J.] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Cell Biol Grp, Glasgow G4 0RE, Lanark, Scotland; [Li, Zaiguo; Lu, Xuequan; Bittman, Robert] CUNY Queens Coll, Dept Chem & Biochem, Flushing, NY 11367 USA	University of Strathclyde; City University of New York (CUNY) System; Queens College NY (CUNY)	Pyne, NJ (corresponding author), Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Cell Biol Grp, 161 Cathedral St, Glasgow G4 0RE, Lanark, Scotland.	n.j.pyne@strath.ac.uk	Pyne, Susan/AAF-5001-2019	Pyne, Susan/0000-0002-6608-9584; Tonelli, Francesca/0000-0002-4600-6630; Pyne, Nigel/0000-0002-5657-4578	National Institutes of Health [HL083187]; Strathclyde University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R24HL083187] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Strathclyde University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL083187 (to R. B.). This work was also supported by two Strathclyde University scholarships (to K. G. L. and F. T.).	Alderton F, 2001, J BIOL CHEM, V276, P28578, DOI 10.1074/jbc.M102771200; Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; Azuma H, 2002, CANCER RES, V62, P1410; Azuma H, 2003, J UROLOGY, V169, P2372, DOI 10.1097/01.ju.0000064938.32318.91; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Chua CW, 2005, INT J CANCER, V117, P1039, DOI 10.1002/ijc.21243; Cortes A, 2001, BIOCHEM J, V357, P263, DOI 10.1042/0264-6021:3570263; Delon C, 2004, J BIOL CHEM, V279, P44763, DOI 10.1074/jbc.M405771200; French KJ, 2006, J PHARMACOL EXP THER, V318, P596, DOI 10.1124/jpet.106.101345; French KJ, 2003, CANCER RES, V63, P5962; Graler MH, 2004, FASEB J, V18, P551, DOI 10.1096/fj.03-0910fje; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Ho JWY, 2005, MOL CANCER THER, V4, P1430, DOI 10.1158/1535-7163.MCT-05-0021; Kawamori T, 2006, FASEB J, V20, P386, DOI 10.1096/fj.05-4331fje; Kihara A, 2006, J BIOL CHEM, V281, P4532, DOI 10.1074/jbc.M510308200; Long JS, 2010, MOL CELL BIOL, V30, P3827, DOI 10.1128/MCB.01133-09; Loveridge C, 2010, J BIOL CHEM, V285, P38841, DOI 10.1074/jbc.M110.127993; Maines LW, 2008, DIGEST DIS SCI, V53, P997, DOI 10.1007/s10620-007-0133-6; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Pitson SM, 2000, J BIOL CHEM, V275, P33945, DOI 10.1074/jbc.M006176200; Pitson SM, 2001, FEBS LETT, V509, P169; Pyne NJ, 2010, NAT REV CANCER, V10, P489, DOI 10.1038/nrc2875; Sanchez T, 2003, J BIOL CHEM, V278, P47281, DOI 10.1074/jbc.M306896200; Taha TA, 2005, FASEB J, V19, P482, DOI 10.1096/fj.05-4412fje; Tonelli F, 2010, CELL SIGNAL, V22, P1536, DOI 10.1016/j.cellsig.2010.05.022; Ubai T, 2007, ANTICANCER RES, V27, P75; Visentin B, 2006, CANCER CELL, V9, P225, DOI 10.1016/j.ccr.2006.02.023; Watson C, 2010, AM J PATHOL, V177, P2205, DOI 10.2353/ajpath.2010.100220; Yokota S, 2004, FEBS LETT, V578, P106, DOI 10.1016/j.febslet.2004.10.081	30	98	108	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18633	18640		10.1074/jbc.M111.220756	http://dx.doi.org/10.1074/jbc.M111.220756			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21464128	Green Published, hybrid			2022-12-25	WOS:000290785700035
J	Overton, JD; Leibel, RL				Overton, John D.; Leibel, Rudolph L.			Mahoganoid and Mahogany Mutations Rectify the Obesity of the Yellow Mouse by Effects on Endosomal Traffic of MC4R Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AGOUTI-RELATED PROTEIN; MELANOCYTE-STIMULATING-HORMONE; MELANOCORTIN-4 RECEPTOR; IN-VITRO; MUTANT MICE; COAT COLOR; ATTRACTIN; MAHOGUNIN; NEURODEGENERATION; GENE	The ubiquitous overexpression of agouti-signaling protein (ASP), a paracrine-signaling molecule that regulates pigment-type switching in the hair follicle of the mouse, is responsible for the obesity and yellow pelage of the Yellow mouse (Ay). Mahogany (Attractin, Atrn/mg) and mahoganoid (Mahogunin Ring Finger-1, Mgrn1/md) are mutations epistatic to Ay. These mutations have been described as suppressors of ASP action, blocking its antagonizing effects on the melanocortin 1 and 4 receptors (MC1R and MC4R) in the skin and the brain, respectively, via unknown mechanisms. Here, we describe the molecular bases for the md- and mg-dependent rescue of the Ay phenotype at the MC4R. We show that overexpression of ASP inhibits the rise in cAMP levels in response to alpha-melanocyte-stimulating hormone, an MC4R agonist, by blocking ligand binding and by directing MC4R trafficking to the lysosome. Loss-of-function of either attractin or MGRN1 blocks ASP-dependent MC4R degradation and promotes increased trafficking of internalized MC4R to the cell surface, but it does not restore alpha-melanocyte-stimulating hormone-dependent cAMP signaling. We propose that MGRN1 and attractin are components of an evolutionarily conserved receptor trafficking pathway and that the md- and mg mutations rescue the Ay phenotypes by a primarily cAMP-independent mechanism promoting trafficking of MC4R and likely MC1R away from the lysosome toward the cell surface.	Columbia Univ, Div Mol Genet, Dept Pediat, Naomi Berrie Diabet Ctr, New York, NY 10032 USA; Columbia Univ, Inst Human Nutr, New York, NY 10032 USA	Columbia University; Columbia University	Overton, JD (corresponding author), Yale Univ, Dept Genet, Howard Hughes Med Inst, New Haven, CT 06519 USA.	john.overton@yale.edu; rl232@columbia.edu			National Institutes of Health [R01-DK52431, P30-DK26687]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026687, R01DK052431] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grants R01-DK52431 and P30-DK26687.	Abdel-Malek ZA, 2001, CELL MOL LIFE SCI, V58, P434, DOI 10.1007/PL00000868; Artigas RA, 2008, J CLIN ENDOCR METAB, V93, P3097, DOI 10.1210/jc.2008-0048; Azouz A, 2007, EXP CELL RES, V313, P761, DOI 10.1016/j.yexcr.2006.11.018; Bagher P, 2006, PIGM CELL RES, V19, P635, DOI 10.1111/j.1600-0749.2006.00340.x; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Barsh GS, 1999, ANN NY ACAD SCI, V885, P143; Barsh GS, 2002, J RECEPT SIGNAL TR R, V22, P63, DOI 10.1081/RRS-120014588; Breit A, 2006, J BIOL CHEM, V281, P37447, DOI 10.1074/jbc.M605982200; Candille SI, 2007, SCIENCE, V318, P1418, DOI 10.1126/science.1147880; Chai BX, 2003, PEPTIDES, V24, P603, DOI 10.1016/S0196-9781(03)00104-9; Chakrabarti O, 2009, CELL, V137, P1136, DOI 10.1016/j.cell.2009.03.042; Chen WB, 1997, CELL, V91, P789, DOI 10.1016/S0092-8674(00)80467-5; Cota CD, 2006, DEV DYNAM, V235, P3438, DOI 10.1002/dvdy.20992; Creemers JWM, 2006, ENDOCRINOLOGY, V147, P1621, DOI 10.1210/en.2005-1373; Duke-Cohan JS, 2004, J ENVIRON PATHOL TOX, V23, P1, DOI 10.1615/JEnvPathToxOncol.v23.i1.10; Duke-Cohan JS, 1998, P NATL ACAD SCI USA, V95, P11336, DOI 10.1073/pnas.95.19.11336; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; GANTZ I, 1993, J BIOL CHEM, V268, P15174; Gao ZH, 2003, J PHARMACOL EXP THER, V307, P870, DOI 10.1124/jpet.103.055525; Gunn TM, 1999, NATURE, V398, P152, DOI 10.1038/18217; Gunn TM, 2001, GENETICS, V158, P1683; Haqq AM, 2003, BIOCHEM J, V376, P595, DOI 10.1042/BJ20031241; He L, 2003, SCIENCE, V299, P710, DOI 10.1126/science.1079694; He L, 2001, NAT GENET, V27, P40, DOI 10.1038/83741; Hida T, 2009, PIGM CELL MELANOMA R, V22, P623, DOI 10.1111/j.1755-148X.2009.00582.x; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Jackson PJ, 2006, CHEM BIOL, V13, P1297, DOI 10.1016/j.chembiol.2006.10.006; Jiao J, 2009, BBA-MOL BASIS DIS, V1792, P1027, DOI 10.1016/j.bbadis.2009.08.009; Jiao J, 2009, GENESIS, V47, P524, DOI 10.1002/dvg.20529; Kim BY, 2007, MOL BIOL CELL, V18, P1129, DOI 10.1091/mbc.E06-09-0787; LANE PRISCILLA W., 1960, JOUR HEREDITY, V51, P228; LANE PW, 1960, MOUSE NEWS LETT, V22, P35; Lee HH, 2008, SCIENCE, V322, P576, DOI 10.1126/science.1162042; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; LU DS, 1994, NATURE, V371, P799, DOI 10.1038/371799a0; Lubrano-Berthelier C, 2003, HUM MOL GENET, V12, P145, DOI 10.1093/hmg/ddg016; MICHAUD EJ, 1993, GENE DEV, V7, P1203, DOI 10.1101/gad.7.7a.1203; MILLAR SE, 1995, DEVELOPMENT, V121, P3223; Miller KA, 1997, GENETICS, V146, P1407; MILLER MW, 1993, GENE DEV, V7, P454, DOI 10.1101/gad.7.3.454; MILLIGAN G, 1995, TRENDS PHARMACOL SCI, V16, P10, DOI 10.1016/S0165-6147(00)88963-4; Mohammad S, 2007, J BIOL CHEM, V282, P4963, DOI [10.1074/jbc.m608283200, 10.1074/jbc.M608283200]; Nagle DL, 1999, NATURE, V398, P148, DOI 10.1038/18210; Ollmann MM, 1999, J BIOL CHEM, V274, P15837, DOI 10.1074/jbc.274.22.15837; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Ollmann MM, 1998, GENE DEV, V12, P316, DOI 10.1101/gad.12.3.316; Oshikawa J, 2003, AM J PHYSIOL-CELL PH, V285, pC567, DOI 10.1152/ajpcell.00422.2002; Paz J, 2007, NEUROBIOL AGING, V28, P1446, DOI 10.1016/j.neurobiolaging.2006.06.014; Perez-Oliva AB, 2009, J BIOL CHEM, V284, P31714, DOI 10.1074/jbc.M109.028100; Phan LK, 2002, J CLIN INVEST, V110, P1449, DOI 10.1172/JC1200216131; Phan LK, 2006, AM J PHYSIOL-ENDOC M, V291, pE611, DOI 10.1152/ajpendo.00034.2006; Raiborg C, 2003, CURR OPIN CELL BIOL, V15, P446, DOI 10.1016/S0955-0674(03)00080-2; ROBBINS LS, 1993, CELL, V72, P827, DOI 10.1016/0092-8674(93)90572-8; Shinyama H, 2003, ENDOCRINOLOGY, V144, P1301, DOI 10.1210/en.2002-220931; Siegrist W, 1996, BIOCHEM BIOPH RES CO, V218, P171, DOI 10.1006/bbrc.1996.0030; STAR RA, 1995, P NATL ACAD SCI USA, V92, P8016, DOI 10.1073/pnas.92.17.8016; Sun K, 2007, NEUROBIOL AGING, V28, P1840, DOI 10.1016/j.neurobiolaging.2007.07.012; Tao YX, 2010, ENDOCR REV, V31, P506, DOI 10.1210/er.2009-0037; Van der Ploeg LHT, 2002, P NATL ACAD SCI USA, V99, P11381, DOI 10.1073/pnas.172378699; Walker WP, 2007, GENESIS, V45, P744, DOI 10.1002/dvg.20351; ZHOU A, 1993, J BIOL CHEM, V268, P1763	61	26	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18914	18929		10.1074/jbc.M111.224592	http://dx.doi.org/10.1074/jbc.M111.224592			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21460229	Green Published, hybrid			2022-12-25	WOS:000290785700063
J	Hao, F; Pysz, MA; Curry, KJ; Haas, KN; Seedhouse, SJ; Black, AR; Black, JD				Hao, Fang; Pysz, Marybeth A.; Curry, Kathryn J.; Haas, Kristin N.; Seedhouse, Steven J.; Black, Adrian R.; Black, Jennifer D.			Protein Kinase C alpha Signaling Regulates Inhibitor of DNA Binding 1 in the Intestinal Epithelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOOP-HELIX PROTEINS; CELL-CYCLE ARREST; ID PROTEINS; COLON CARCINOGENESIS; INCREASED EXPRESSION; DIFFERENTIATION ID1; GROWTH-FACTOR; CANCER CELLS; STEM-CELLS; ACTIVATION	Increasing evidence supports a role forPKC alpha in growth arrest and tumor suppression in the intestinal epithelium. In contrast, the Id1 transcriptional repressor has pro-proliferative and tumorigenic properties in this tissue. Here, we identify Id1 as a novel target of PKC alpha signaling. Using a highly specific antibody and a combined morphological/biochemical approach, we establish that Id1 is a nuclear protein restricted to proliferating intestinal crypt cells. A relationship between PKC alpha and Id1 was supported by the demonstration that (a) down-regulation of Id1 at the crypt/villus junction coincides with PKC alpha activation, and (b) loss ofPKC alpha in intestinal tumors is associated with increased levels of nuclear Id1. Manipulation of PKC alpha activity in IEC-18 nontransformed intestinal crypt cells determined that PKC alpha suppresses Id1 mRNA and protein via an Erk-dependent mechanism. PKC alpha, but not PKC delta, also inhibited Id1 expression in colon cancer cells. Id1 was found to regulate cyclin D1 levels in IEC-18 and colon cancer cells, pointing to a role for Id1 suppression in the antiproliferative/tumor suppressive activities of PKC alpha. Notably, Id1 expression was elevated in the intestinal epithelium of PKC alpha-knock-out mice, confirming that PKC alpha regulates Id1 in vivo. A wider role for PKC alpha in control of inhibitor of DNA binding factors is supported by its ability to down-regulate Id2 and Id3 in IEC-18 cells, although their suppression is more modest than that of Id1. This study provides the first demonstrated link between a specific PKC isozyme and inhibitor of DNA binding factors, and it points to a role for a PKC alpha -> 3 Erk (sic) Id1 -> cyclin D1 signaling axis in the maintenance of intestinal homeostasis.	[Hao, Fang; Pysz, Marybeth A.; Curry, Kathryn J.; Haas, Kristin N.; Seedhouse, Steven J.; Black, Adrian R.; Black, Jennifer D.] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA	Roswell Park Cancer Institute	Black, JD (corresponding author), Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Elm & Carlton St, Buffalo, NY 14263 USA.	jennifer.black@roswellpark.org			National Institutes of Health [DK60632, DK54909, CA16056, CA113048]; NATIONAL CANCER INSTITUTE [F32CA113048, P30CA016056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054909, R56DK060632, R01DK060632] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK60632, DK54909, and CA16056 and Postdoctoral Fellowship CA113048 (to M. A. P.).	Akakura S, 2010, CELL CYCLE, V9, P4656, DOI 10.4161/cc.9.23.13974; Alani RM, 2001, P NATL ACAD SCI USA, V98, P7812, DOI 10.1073/pnas.141235398; Bai G, 2007, DEV CELL, V13, P283, DOI 10.1016/j.devcel.2007.05.014; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Black JD, 2001, GASTROENTEROLOGY, V120, P1868, DOI 10.1053/gast.2001.25287; Black JD, 2000, FRONT BIOSCI-LANDMRK, V5, pD406, DOI 10.2741/Black; Braz JC, 2004, NAT MED, V10, P248, DOI 10.1038/nm1000; Caldon CE, 2008, CANCER RES, V68, P3026, DOI 10.1158/0008-5472.CAN-07-3079; Cameron AJ, 2008, INT J CANCER, V123, P769, DOI 10.1002/ijc.23560; Chaudhary J, 2005, BIOL REPROD, V72, P1205, DOI 10.1095/biolreprod.104.035717; Chaudhary J, 2001, ENDOCRINOLOGY, V142, P1727, DOI 10.1210/en.142.5.1727; Ciarrocchi A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001338; Clark JA, 2004, J BIOL CHEM, V279, P9233, DOI 10.1074/jbc.M312268200; de Lau W, 2007, FRONT BIOSCI-LANDMRK, V12, P471, DOI 10.2741/2076; Detjen KM, 2000, J CELL SCI, V113, P3025; Dupasquier S, 2009, J CELL SCI, V122, P2191, DOI 10.1242/jcs.036483; Fields Alan P, 2003, Methods Mol Biol, V233, P539; Fields AP, 2007, PHARMACOL RES, V55, P487, DOI 10.1016/j.phrs.2007.04.015; FLINT N, 1991, BIOCHEM J, V280, P331, DOI 10.1042/bj2800331; Fong S, 2004, TRENDS MOL MED, V10, P387, DOI 10.1016/j.molmed.2004.06.008; Frey MR, 2000, J CELL BIOL, V151, P763, DOI 10.1083/jcb.151.4.763; Frey MR, 1997, J BIOL CHEM, V272, P9424; Garcia-Bermejo ML, 2002, J BIOL CHEM, V277, P645, DOI 10.1074/jbc.M107639200; Gil-Bazo I, 2010, CLIN TRANSL ONCOL, V12, P69, DOI 10.1007/s12094-010-0470-3; Gorin MA, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-9; Gregorieff A, 2005, GASTROENTEROLOGY, V129, P626, DOI 10.1053/j.gastro.2005.06.007; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Guan LJ, 2007, J BIOL CHEM, V282, P14213, DOI 10.1074/jbc.M610513200; Hizli AA, 2006, J BIOL CHEM, V281, P14596, DOI 10.1074/jbc.M601959200; Howarth GS, 2003, GROWTH FACTORS, V21, P79, DOI 10.1080/08977190310001605779; Israel MA, 1999, CANCER RES, V59, p1726S; Jedlicka P, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-197; Jones JM, 2006, J NEUROSCI, V26, P550, DOI 10.1523/JNEUROSCI.3859-05.2006; KAHLRAINER P, 1994, CARCINOGENESIS, V15, P779, DOI 10.1093/carcin/15.4.779; KahlRainer P, 1996, GASTROENTEROLOGY, V110, P1753, DOI 10.1053/gast.1996.v110.pm8964400; Kebebew E, 2000, SURGERY, V128, P952, DOI 10.1067/msy.2000.111082; KRAFT AS, 1983, NATURE, V301, P621, DOI 10.1038/301621a0; Kress TR, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-1; Lee JY, 2009, ONCOGENE, V28, P824, DOI 10.1038/onc.2008.451; Lee JM, 2010, MOL CELL, V37, P183, DOI 10.1016/j.molcel.2009.12.022; Leow CC, 2004, CANCER RES, V64, P6050, DOI 10.1158/0008-5472.CAN-04-0290; Ling MT, 2006, DIFFERENTIATION, V74, P481, DOI 10.1111/j.1432-0436.2006.00083.x; Ling MT, 2004, CARCINOGENESIS, V25, P517, DOI 10.1093/carcin/bgh047; Lingbeck JM, 2005, ONCOGENE, V24, P6376, DOI 10.1038/sj.onc.1208789; Lingbeck JM, 2008, FASEB J, V22, P1694, DOI 10.1096/fj.07-095000; Lowery JW, 2010, AM J PHYSIOL-REG I, V299, pR1463, DOI 10.1152/ajpregu.00866.2009; Martiny-Baron G, 2007, PHARMACOL RES, V55, P477, DOI 10.1016/j.phrs.2007.04.001; Meteoglu I, 2009, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-69; Nair R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011947; Nakashima A, 2005, J BIOL CHEM, V280, P37660, DOI 10.1074/jbc.M504612200; Norton JD, 2000, J CELL SCI, V113, P3897; Ohtani N, 2001, NATURE, V409, P1067, DOI 10.1038/35059131; Oster H, 2006, CANCER RES, V66, P6955, DOI 10.1158/0008-5472.CAN-06-0268; Ozeki M, 2007, J NEUROSCI RES, V85, P515, DOI 10.1002/jnr.21133; Pache G, 2006, AM J PHYSIOL-RENAL, V291, pF654, DOI 10.1152/ajprenal.00214.2004; Paoni NF, 2003, PHYSIOL GENOMICS, V15, P228, DOI 10.1152/physiolgenomics.00078.2003; Peddada S, 2006, HUM MOL GENET, V15, P2003, DOI 10.1093/hmg/ddl124; Perk J, 2005, NAT REV CANCER, V5, P603, DOI 10.1038/nrc1673; Perk J, 2006, CANCER RES, V66, P10870, DOI 10.1158/0008-5472.CAN-06-2643; Prabhu S, 1997, MOL CELL BIOL, V17, P5888, DOI 10.1128/MCB.17.10.5888; Pysz MA, 2009, EXP CELL RES, V315, P1415, DOI 10.1016/j.yexcr.2009.02.002; QUARONI A, 1981, J NATL CANCER I, V67, P1353; Ruzinova MB, 2003, TRENDS CELL BIOL, V13, P410, DOI 10.1016/S0962-8924(03)00147-8; Sabates-Beliver J, 2007, MOL CANCER RES, V5, P1263, DOI 10.1158/1541-7786.MCR-07-0267; Santiskulvong C, 2007, CELL SIGNAL, V19, P1348, DOI 10.1016/j.cellsig.2007.01.006; SAXON ML, 1994, J CELL BIOL, V126, P747, DOI 10.1083/jcb.126.3.747; Sheldahl LC, 1999, CURR BIOL, V9, P695, DOI 10.1016/S0960-9822(99)80310-8; Slosberg ED, 1999, ONCOGENE, V18, P6658, DOI 10.1038/sj.onc.1203083; Swarbrick A, 2005, ONCOGENE, V24, P381, DOI 10.1038/sj.onc.1208188; Ushio K, 2009, MOL CANCER RES, V7, P1179, DOI 10.1158/1541-7786.MCR-08-0289; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Verstovsek G, 1998, GASTROENTEROLOGY, V115, P75, DOI 10.1016/S0016-5085(98)70367-1; Vinals F, 2004, EMBO J, V23, P3527, DOI 10.1038/sj.emboj.7600360; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; Wice BM, 1998, J BIOL CHEM, V273, P25310, DOI 10.1074/jbc.273.39.25310; Wilson JW, 2001, CANCER RES, V61, P8803; Yang DH, 2009, CIRC RES, V104, P372, DOI 10.1161/CIRCRESAHA.108.185405; Yeh JJ, 2009, MOL CANCER THER, V8, P834, DOI 10.1158/1535-7163.MCT-08-0972; Zhang X, 2004, BRIT J CANCER, V91, P2042, DOI 10.1038/sj.bjc.6602254; Zhao ZR, 2008, ONCOL REP, V19, P419	80	15	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					18104	18117		10.1074/jbc.M110.208488	http://dx.doi.org/10.1074/jbc.M110.208488			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454537	Green Published, hybrid			2022-12-25	WOS:000290585200071
J	Ozeki, C; Sawai, Y; Shibata, T; Kohno, T; Okamoto, K; Yokota, J; Tashiro, F; Tanuma, S; Sakai, R; Kawase, T; Kitabayashi, I; Taya, Y; Ohki, R				Ozeki, Chikako; Sawai, Yuichiro; Shibata, Tatsuhiro; Kohno, Takashi; Okamoto, Koji; Yokota, Jun; Tashiro, Fumio; Tanuma, Sei-ichi; Sakai, Ryuichi; Kawase, Tatsuya; Kitabayashi, Issay; Taya, Yoichi; Ohki, Rieko			Cancer Susceptibility Polymorphism of p53 at Codon 72 Affects Phosphorylation and Degradation of p53 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRO72 HOMOZYGOUS GENOTYPE; P53-DEPENDENT APOPTOSIS; TGF-BETA; ASSOCIATION; EXPRESSION; PATHWAY; DOMAIN; CELLS; RISK	The common polymorphism of p53 at codon 72, either encoding proline or arginine, has drawn attention as a genetic factor associated with clinical outcome or cancer risk for the last 2 decades. We now show that these two polymorphic variants differ in protein structure, especially within the N-terminal region and, as a consequence, differ in post-translational modification at the N terminus. The arginine form (p53-72R) shows significantly enhanced phosphorylation at Ser-6 and Ser-20 compared with the proline form (p53-72P). We also show diminished Mdm2-mediated degradation of p53-72R compared with p53-72P, which is at least partly brought about by higher levels of phosphorylation at Ser-20 in p53-72R. Furthermore, enhanced p21 expression in p53-72R-expressing cells, which is dependent on phosphorylation at Ser-6, was demonstrated. Differential p21 expression between the variants was also observed upon activation of TGF-beta signaling. Collectively, we demonstrate a novel molecular difference and simultaneously suggest a difference in the tumor-suppressing function of the variants.	[Ozeki, Chikako; Okamoto, Koji; Kawase, Tatsuya; Taya, Yoichi; Ohki, Rieko] Natl Canc Ctr, Div Radiobiol, Chuo Ku, Tokyo 1040045, Japan; [Ozeki, Chikako; Kitabayashi, Issay] Natl Canc Ctr, Div Mol Oncol, Chuo Ku, Tokyo 1040045, Japan; [Shibata, Tatsuhiro] Natl Canc Ctr, Div Canc Genom, Chuo Ku, Tokyo 1040045, Japan; [Kohno, Takashi; Yokota, Jun] Natl Canc Ctr, Div Biol, Chuo Ku, Tokyo 1040045, Japan; [Okamoto, Koji] Natl Canc Ctr, Early Oncogenesis Res Project, Chuo Ku, Tokyo 1040045, Japan; [Sakai, Ryuichi; Ohki, Rieko] Natl Canc Ctr, Growth Factor Div, Chuo Ku, Tokyo 1040045, Japan; [Sawai, Yuichiro; Ohki, Rieko] Natl Canc Ctr, Div Canc Biol, Chuo Ku, Tokyo 1040045, Japan; [Ozeki, Chikako; Tanuma, Sei-ichi] Tokyo Univ Sci, Fac Pharmaceut Sci, Dept Biochem, Noda, Chiba 2708510, Japan; [Sawai, Yuichiro; Tashiro, Fumio; Kawase, Tatsuya] Tokyo Univ Sci, Fac Ind Sci & Technol, Dept Biol Sci & Technol, Noda, Chiba 2708510, Japan; [Taya, Yoichi] Natl Univ Singapore, Canc Sci Inst Singapore, Ctr Life Sci 02 07, Singapore 117456, Singapore; [Taya, Yoichi] Natl Univ Singapore, Dept Biochem, Ctr Life Sci 02 07, Singapore 117456, Singapore	National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; Tokyo University of Science; Tokyo University of Science; National University of Singapore; National University of Singapore	Taya, Y (corresponding author), Natl Canc Ctr, Div Radiobiol, Chuo Ku, Tsukiji 5-1-1, Tokyo 1040045, Japan.	csiyt@nus.edu.sag; rohki@ncc.go.jp	Kitabayashi, Issay/G-2204-2017; Shibata, Tatsuhiro/AAO-1278-2021; Sakai, Ryuichi/R-7741-2017; Shibata, Tatsuhiro/ABA-8234-2020	Sakai, Ryuichi/0000-0001-6833-1103; Kitabayashi, Issay/0000-0002-8409-0407	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Ministry of Health, Labor, and Welfare Japan; National Institute of Biomedical Innovation; New Energy and Industrial Technology Development Organization; Hayashi Memorial Foundation for Female Natural Scientists; Sagawa Foundation for Promoting Cancer Research; Takeda Science Foundation; Kobayashi Foundation for Cancer Research; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Grants-in-Aid for Scientific Research [23501271] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare Japan(Ministry of Health, Labour and Welfare, Japan); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); Hayashi Memorial Foundation for Female Natural Scientists(Hayashi Memorial Foundation for Female Natural Scientists); Sagawa Foundation for Promoting Cancer Research; Takeda Science Foundation(Takeda Science Foundation (TSF)); Kobayashi Foundation for Cancer Research(Kobayashi Foundation for Cancer Research); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to R. O., T. K., and Y. T.), grants-in-aid for the Third Term Comprehensive Ten-year Strategy for Cancer Control from the Ministry of Health, Labor, and Welfare Japan (to T. S., J. Y., and Y. T.), Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (to T. S., T. K., and J. Y.), New Energy and Industrial Technology Development Organization (to R. O.), research grants from Hayashi Memorial Foundation for Female Natural Scientists (to R. O.), the Sagawa Foundation for Promoting Cancer Research (to R. O.), Takeda Science Foundation (to R. O.), Kobayashi Foundation for Cancer Research (to R. O.), and the Mochida Memorial Foundation for Medical and Pharmaceutical Research (to R. O.).	Bergamaschi D, 2006, NAT GENET, V38, P1133, DOI 10.1038/ng1879; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Boldrini L, 2008, ONCOL REP, V19, P771; Cordenonsi M, 2003, CELL, V113, P301, DOI 10.1016/S0092-8674(03)00308-8; Cordenonsi M, 2007, SCIENCE, V315, P840, DOI 10.1126/science.1135961; Fan R, 2000, CANCER EPIDEM BIOMAR, V9, P1037; HARRIS N, 1986, MOL CELL BIOL, V6, P4650, DOI 10.1128/MCB.6.12.4650; Kawase T, 2008, ONCOGENE, V27, P3797, DOI 10.1038/onc.2008.32; Kawase T, 2009, CELL, V136, P535, DOI 10.1016/j.cell.2008.12.002; MATLASHEWSKI GJ, 1987, MOL CELL BIOL, V7, P961, DOI 10.1128/MCB.7.2.961; Murphy ME, 2006, CELL DEATH DIFFER, V13, P916, DOI 10.1038/sj.cdd.4401907; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Ohki R, 2007, CANCER SCI, V98, P189, DOI 10.1111/j.1349-7006.2006.00375.x; Okamoto K, 2005, MOL CELL BIOL, V25, P9608, DOI 10.1128/MCB.25.21.9608-9620.2005; Phang BH, 2007, ONCOGENE, V26, P2964, DOI 10.1038/sj.onc.1210112; Sakiyama T, 2005, INT J CANCER, V114, P730, DOI 10.1002/ijc.20790; Shibata T, 2005, CLIN CANCER RES, V11, P6177, DOI 10.1158/1078-0432.CCR-05-0293; Soussi T, 2007, CANCER CELL, V12, P303, DOI 10.1016/j.ccr.2007.10.001; Su L, 2003, LUNG CANCER-J IASLC, V40, P259, DOI 10.1016/S0169-5002(03)00081-3; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Tommiska J, 2005, CLIN CANCER RES, V11, P5098, DOI 10.1158/1078-0432.CCR-05-0173; Unger T, 1999, ONCOGENE, V18, P3205, DOI 10.1038/sj.onc.1202656; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Xu Y, 2003, CELL DEATH DIFFER, V10, P1213, DOI 10.1038/sj.cdd.4401292; Zilfou JT, 2001, MOL CELL BIOL, V21, P3974, DOI 10.1128/MCB.21.12.3974-3985.2001	26	21	22	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					18251	18260		10.1074/jbc.M110.208587	http://dx.doi.org/10.1074/jbc.M110.208587			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454683	Green Published, hybrid			2022-12-25	WOS:000290585200085
J	Sweadner, KJ; Pascoa, JL; Salazar, CA; Arystarkhova, E				Sweadner, Kathleen J.; Pascoa, Jennifer L.; Salazar, Cynthia A.; Arystarkhova, Elena			Post-transcriptional Control of Na,K-ATPase Activity and Cell Growth by a Splice Variant of FXYD2 Protein with Modified mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ION-TRANSPORT REGULATORS; SODIUM-POTASSIUM PUMP; NA+-K+-ATPASE; GAMMA-SUBUNIT; ENDOPLASMIC-RETICULUM; RENAL NA,K-ATPASE; TRANSMEMBRANE PROTEINS; CRYSTAL-STRUCTURE; MAMMALIAN-CELLS; KINASE-C	In kidney, FXYD proteins regulate Na,K-ATPase in a nephron segment-specific way. FXYD2 is the most abundant renal FXYD but is not expressed in most renal cell lines unless induced by hypertonicity. Expression by transfection of FXYD2a or FXYD2b splice variants in NRK-52E cells reduces the apparent Na+ affinity of the Na, K-ATPase and slows the cell proliferation rate. Based on RT-PCR, mRNAs for both splice variants were expressed in wild type NRK-52E cells as low abundance species. DNA sequencing of the PCR products revealed a base alteration from C to T in FXYD2b but not FXYD2a from both untreated and hypertonicity-treated NRK-52E cells. The 172C -> T sequence change exposed a cryptic KKXX endoplasmic reticulum retrieval signal via a premature stop codon. The truncation affected trafficking of FXYD2b and its association with Na,K-ATPase and blocked its effect on enzyme kinetics and cell growth. The data may be explained by altered splicing or selective RNA editing of FXYD2b, a supplementary process that would ensure that it was inactive even if transcribed and translated, in these cells that normally express only FXYD2a. 172C -> T mutation was also identified after mutagenesis of FXYD2b by error-prone PCR coupled with a selection for cell proliferation. Furthermore, the error-prone PCR alone introduced the mutation with high frequency, implying a structural peculiarity. The data confirm truncation of FXYD2b as a potential mechanism to regulate the amount of FXYD2 at the cell surface to control activity of Na,K-ATPase and cell growth.	[Arystarkhova, Elena] Massachusetts Gen Hosp, Dept Neurosurg, Lab Membrane Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Arystarkhova, E (corresponding author), Massachusetts Gen Hosp, Dept Neurosurg, Lab Membrane Biol, Edwards 410,55 Fruit St, Boston, MA 02114 USA.	aristarkhova@helix.mgh.harvard.edu			National Institutes of Health [HL036271, NS045083, NS050696]; American Recovery and Reinvestment Act [NS050696]; Harvard Medical School 50th Anniversary Scholars in Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050696, R21NS045083] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Recovery and Reinvestment Act; Harvard Medical School 50th Anniversary Scholars in Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL036271, NS045083, and NS050696 and an American Recovery and Reinvestment Act supplement to Grant NS050696. This work was also supported by a grant from the Harvard Medical School 50th Anniversary Scholars in Medicine Margaret H. Walter and Daughters Fellowship in memory of Carl W. Walter, M. D., '32.	Arystarkhova E, 1999, J BIOL CHEM, V274, P33183, DOI 10.1074/jbc.274.47.33183; Arystarkhova E, 2003, ANN NY ACAD SCI, V986, P416, DOI 10.1111/j.1749-6632.2003.tb07223.x; Arystarkhova E, 2002, J BIOL CHEM, V277, P10162, DOI 10.1074/jbc.M111552200; Arystarkhova E, 2002, AM J PHYSIOL-RENAL, V282, pF393, DOI 10.1152/ajprenal.00146.2001; Arystarkhova E, 2007, AM J PHYSIOL-CELL PH, V292, pC1179, DOI 10.1152/ajpcell.00328.2006; Beguin P, 1997, EMBO J, V16, P4250, DOI 10.1093/emboj/16.14.4250; Bibert S, 2008, J BIOL CHEM, V283, P476, DOI 10.1074/jbc.M705830200; Bibert S, 2006, J BIOL CHEM, V281, P39142, DOI 10.1074/jbc.M605221200; Blanc V, 2003, J BIOL CHEM, V278, P1395, DOI 10.1074/jbc.R200024200; Capasso JM, 2001, P NATL ACAD SCI USA, V98, P13414, DOI 10.1073/pnas.231309198; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Choi YS, 1997, ARCH BIOCHEM BIOPHYS, V344, P165, DOI 10.1006/abbi.1997.0183; Colina C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000540; COLLINS JH, 1987, BIOCHEMISTRY-US, V26, P8665, DOI 10.1021/bi00400a026; Crambert G, 2004, J BIOL CHEM, V279, P30888, DOI 10.1074/jbc.M313494200; Donnet C, 2001, J BIOL CHEM, V276, P7357, DOI 10.1074/jbc.M009131200; FELSENFELD DP, 1988, J BIOL CHEM, V263, P10932; Feschenko MS, 1997, J BIOL CHEM, V272, P17726, DOI 10.1074/jbc.272.28.17726; FORBUSH B, 1978, BIOCHEMISTRY-US, V17, P3667, DOI 10.1021/bi00610a037; Fuller W, 2009, AM J PHYSIOL-CELL PH, V296, pC1346, DOI 10.1152/ajpcell.00523.2008; Geering K, 2006, AM J PHYSIOL-RENAL, V290, pF241, DOI 10.1152/ajprenal.00126.2005; Hirohashi S, 2003, CANCER SCI, V94, P575, DOI 10.1111/j.1349-7006.2003.tb01485.x; Ino Y, 2002, P NATL ACAD SCI USA, V99, P365, DOI 10.1073/pnas.012425299; JACKSON MR, 1993, J CELL BIOL, V121, P317, DOI 10.1083/jcb.121.2.317; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; Jones DH, 2005, J BIOL CHEM, V280, P19003, DOI 10.1074/jbc.M500697200; Jorgensen P L, 1974, Methods Enzymol, V32, P277; Kuster B, 2000, J BIOL CHEM, V275, P18441, DOI 10.1074/jbc.M001411200; Laughery MD, 2003, J BIOL CHEM, V278, P34794, DOI 10.1074/jbc.M302899200; Li JB, 2009, SCIENCE, V324, P1210, DOI 10.1126/science.1170995; Lindzen M, 2003, J BIOL CHEM, V278, P18738, DOI 10.1074/jbc.M213253200; Lubarski I, 2005, J BIOL CHEM, V280, P37717, DOI 10.1074/jbc.M506397200; Lubarski I, 2007, AM J PHYSIOL-RENAL, V293, pF1818, DOI 10.1152/ajprenal.00367.2007; Meier JC, 2005, NAT NEUROSCI, V8, P736, DOI 10.1038/nn1467; MERCER RW, 1993, J CELL BIOL, V121, P579, DOI 10.1083/jcb.121.3.579; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Morton MJ, 2010, J BIOL CHEM, V285, P33737, DOI 10.1074/jbc.M110.141119; Murphy GJ, 2006, NAT MED, V12, P1093, DOI 10.1038/nm1376; Pihakaski-Maunsbach K, 2008, ACTA HISTOCHEM CYTOC, V41, P105, DOI 10.1267/ahc.08018; Pihakaski-Maunsbach K, 2006, AM J PHYSIOL-RENAL, V291, pF1033, DOI 10.1152/ajprenal.00086.2006; Pu HX, 2002, J BIOL CHEM, V277, P20270, DOI 10.1074/jbc.M201009200; Pu HX, 2001, J BIOL CHEM, V276, P20370, DOI 10.1074/jbc.M010836200; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; SWEADNER KJ, 1985, J BIOL CHEM, V260, P9016; Sweadner KJ, 2000, BIOCHEM BIOPH RES CO, V279, P196, DOI 10.1006/bbrc.2000.3907; Sweadner KJ, 2000, GENOMICS, V68, P41, DOI 10.1006/geno.2000.6274; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; Thanaraj TA, 2001, NUCLEIC ACIDS RES, V29, P2581, DOI 10.1093/nar/29.12.2581; Wetzel RK, 2004, J BIOL CHEM, V279, P41750, DOI 10.1074/jbc.M405622200; Zouzoulas A, 2005, J MEMBRANE BIOL, V204, P49, DOI 10.1007/s00232-005-0746-7	50	7	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					18290	18300		10.1074/jbc.M111.241901	http://dx.doi.org/10.1074/jbc.M111.241901			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21460224	hybrid, Green Published			2022-12-25	WOS:000290585200089
J	Dejima, K; Kanai, MI; Akiyama, T; Levings, DC; Nakato, H				Dejima, Katsufumi; Kanai, Makoto I.; Akiyama, Takuya; Levings, Daniel C.; Nakato, Hiroshi			Novel Contact-dependent Bone Morphogenetic Protein (BMP) Signaling Mediated by Heparan Sulfate Proteoglycans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE; DROSOPHILA GLYPICAN; DALLY-LIKE; GRADIENT FORMATION; CORE PROTEIN; DPP; RANGE; HEDGEHOG; DIFFERENTIATION; DIVISION	We previously proposed a model that DALLY, a Drosophila glypican, acts as a trans co-receptor to regulate BMP signaling in the germ line stem cell niche. To investigate the molecular mechanisms of contact-dependent BMP signaling, we developed novel in vitro assay systems to monitor trans signaling using Drosophila S2 cells. Using immunoblot-based as well as single-cell assay systems, we present evidence that Drosophila glypicans indeed enhance BMP signaling in trans in a contact-dependent manner in vitro. Our analysis showed that heparan sulfate modification is required for the trans co-receptor activity of DALLY. Two BMP-like molecules, Decapentaplegic (DPP) and Glass bottom boat, can mediate trans signaling through a heparan sulfate proteoglycan co-receptor in S2 cells. The in vitro systems reflect the molecular characteristics of heparan sulfate proteoglycan functions observed previously in vivo, such as ligand specificity and biphasic activity dependent on the ligand dosage. In addition, experiments using a DALLY-coated surface suggested that DALLY regulates DPP signaling in trans by its effect on the stability of DPP protein on the surface of the contacting cells. Our findings provide the molecular foundation for novel contact-dependent signaling, which defines the physical space of the stem cell niche in vivo.	[Dejima, Katsufumi; Kanai, Makoto I.; Akiyama, Takuya; Levings, Daniel C.; Nakato, Hiroshi] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Nakato, H (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, 321 Church St SE, Minneapolis, MN 55455 USA.	nakat003@umn.edu		Levings, Daniel/0000-0002-8678-0794	National Institutes of Health [R01 HD042769]; American Heart Association; Uehara Memorial Foundation; Grants-in-Aid for Scientific Research [23770262] Funding Source: KAKEN; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042769] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Uehara Memorial Foundation(Uehara Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported in part by National Institutes of Health Grant R01 HD042769. This work was also supported by the American Heart Association (to H. N.) and a Uehara Memorial Foundation Postdoctoral Fellowship (to K. D.).	Akiyama T, 2008, DEV BIOL, V313, P408, DOI 10.1016/j.ydbio.2007.10.035; Belenkaya TY, 2004, CELL, V119, P231, DOI 10.1016/j.cell.2004.09.031; BUNCH TA, 1992, DEVELOPMENT, V116, P239; Feinberg EH, 2008, NEURON, V57, P353, DOI 10.1016/j.neuron.2007.11.030; Fujise M, 2003, DEVELOPMENT, V130, P1515, DOI 10.1242/dev.00379; Ghosh I, 2000, J AM CHEM SOC, V122, P5658, DOI 10.1021/ja994421w; Guo Z, 2009, DEVELOPMENT, V136, P3627, DOI 10.1242/dev.036939; Hacker U, 1997, DEVELOPMENT, V124, P3565; Hayashi Y, 2009, J CELL BIOL, V187, P473, DOI 10.1083/jcb.200904118; Irie A, 2003, BIOCHEM BIOPH RES CO, V308, P858, DOI 10.1016/S0006-291X(03)01500-6; Jackson SM, 1997, DEVELOPMENT, V124, P4113; Jakobsson L, 2006, DEV CELL, V10, P625, DOI 10.1016/j.devcel.2006.03.009; Jiao XY, 2007, J BIOL CHEM, V282, P1080, DOI 10.1074/jbc.M513414200; Jortikka L, 1997, CELL SIGNAL, V9, P47, DOI 10.1016/S0898-6568(96)00094-0; Kasevayuth K, 2004, BIOCHEM BIOPH RES CO, V324, P205, DOI 10.1016/j.bbrc.2004.09.036; Kirkpatrick CA, 2004, DEV CELL, V7, P513, DOI 10.1016/j.devcel.2004.08.004; Kirkpatrick CA, 2007, J CELL SCI, V120, P1829, DOI 10.1242/jcs.03432; Kirkpatrick CA, 2006, DEV BIOL, V300, P570, DOI 10.1016/j.ydbio.2006.09.011; Kornberg TB, 2007, CURR OPIN GENET DEV, V17, P264, DOI 10.1016/j.gde.2007.05.010; Kramer KL, 2002, DEV CELL, V2, P115, DOI 10.1016/S1534-5807(01)00107-1; Kuo WJ, 2010, MOL BIOL CELL, V21, P4028, DOI 10.1091/mbc.E10-04-0348; Maeda N, 1996, DEVELOPMENT, V122, P647; Miller AF, 2000, J BIOL CHEM, V275, P17937, DOI 10.1074/jbc.275.24.17937; NAKATO H, 1995, DEVELOPMENT, V121, P3687; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; Nusse R, 2008, COLD SH Q B, V73, P59, DOI 10.1101/sqb.2008.73.035; Ross JJ, 2001, NATURE, V410, P479, DOI 10.1038/35068578; Serpe M, 2008, DEV CELL, V14, P940, DOI 10.1016/j.devcel.2008.03.023; Shimmi O, 2003, DEVELOPMENT, V130, P4673, DOI 10.1242/dev.00684; Shimmi O, 2005, CELL, V120, P873, DOI 10.1016/j.cell.2005.02.009; Takada T, 2003, J BIOL CHEM, V278, P43229, DOI 10.1074/jbc.M300937200; Takeo S, 2005, DEV BIOL, V284, P204, DOI 10.1016/j.ydbio.2005.05.014; Tsuda M, 1999, NATURE, V400, P276, DOI 10.1038/22336; Watabe T, 2009, CELL RES, V19, P103, DOI 10.1038/cr.2008.323; Williams EH, 2010, P NATL ACAD SCI USA, V107, P5869, DOI 10.1073/pnas.1001777107; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5; Yan D, 2010, DEVELOPMENT, V137, P2033, DOI 10.1242/dev.045740; Yan D, 2009, DEV CELL, V17, P470, DOI 10.1016/j.devcel.2009.09.001; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W	39	51	52	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17103	17111		10.1074/jbc.M110.208082	http://dx.doi.org/10.1074/jbc.M110.208082			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454551	hybrid, Green Published			2022-12-25	WOS:000290301900060
J	Pena, A; Ripoll-Rozada, J; Zunzunegui, S; Cabezon, E; de la Cruz, F; Arechaga, I				Pena, Alejandro; Ripoll-Rozada, Jorge; Zunzunegui, Sandra; Cabezon, Elena; de la Cruz, Fernando; Arechaga, Ignacio			Autoinhibitory Regulation of TrwK, an Essential VirB4 ATPase in Type IV Secretion Systems	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE H+-ATPASE; MULTIPLE SEQUENCE ALIGNMENT; DEPENDENT PROTEIN-KINASE; INCW PLASMID R388; BACTERIAL CONJUGATION; STRUCTURE PREDICTION; PATHOGENIC BACTERIA; CARBOXYL-TERMINUS; DOMAIN; MECHANISM	Type IV secretion systems (T4SS) mediate the transfer of DNA and protein substrates to target cells. TrwK, encoded by the conjugative plasmid R388, is a member of the VirB4 family, comprising the largest and most conserved proteins of T4SS. In a previous work we demonstrated that TrwK is able to hydrolyze ATP. Here, based on the structural homology of VirB4 proteins with the DNA-pumping ATPase TrwB coupling protein, we generated a series of variants of TrwK where fragments of the C-terminal domain were sequentially truncated. Surprisingly, the in vitro ATPase activity of these TrwK variants was much higher than that of the wild-type enzyme. Moreover, addition of a synthetic peptide containing the amino acid residues comprising this C-terminal region resulted in the specific inhibition of the TrwK variants lacking such domain. These results indicate that the C-terminal end of TrwK plays an important regulatory role in the functioning of the T4SS.	[Arechaga, Ignacio] Univ Cantabria, Dept Biol Mol, Fac Med, Santander 39011, Spain; UC IDICAN CSIC, Inst Biomed & Biotecnol Cantabria IBBTEC, Santander 39011, Spain	Universidad de Cantabria; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC)	Arechaga, I (corresponding author), Univ Cantabria, Dept Biol Mol, Fac Med, Santander 39011, Spain.	arechagai@unican.es	Cabezon, Elena/K-5874-2014; de la Cruz, Fernando/L-2812-2014; Ripoll Rozada, Jorge/L-1574-2016; Rozada, Jorge Ripoll/AAA-8049-2020; Arechaga, Ignacio/K-2198-2014	de la Cruz, Fernando/0000-0003-4758-6857; Ripoll Rozada, Jorge/0000-0001-7235-317X; Rozada, Jorge Ripoll/0000-0001-7235-317X; Arechaga, Ignacio/0000-0002-1342-9370; Pena, Alejandro/0000-0001-5674-7064; Cabezon, Elena/0000-0002-6177-5016	Ministerio de Ciencia e Innovacion (MCINN, Spain) [BFU2008-00806, BFU2008-00995/BMC]; Instituto de Salud Carlos III (Spain) [RD06/0008/1012]; European VI Framework Program [LSHM-CT-2005_019023]; MCINN	Ministerio de Ciencia e Innovacion (MCINN, Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Instituto de Salud Carlos III (Spain)(Instituto de Salud Carlos III); European VI Framework Program; MCINN(European Commission)	This work was supported by the Ministerio de Ciencia e Innovacion (MCINN, Spain) Grants BFU2008-00806 and BFU2008-00995/BMC, RD06/0008/1012 from Instituto de Salud Carlos III (Spain) and LSHM-CT-2005_019023 from the European VI Framework Program.; Supported by a predoctoral fellowship from the MCINN.	Arechaga I, 2008, J BACTERIOL, V190, P5472, DOI 10.1128/JB.00321-08; Baekgaard L, 2005, J BIOENERG BIOMEMBR, V37, P369, DOI 10.1007/s10863-005-9473-0; Baron C, 2002, MOL MICROBIOL, V43, P1359, DOI 10.1046/j.1365-2958.2002.02816.x; BERGER BR, 1993, J BACTERIOL, V175, P1723, DOI 10.1128/JB.175.6.1723-1734.1993; BOLLAND S, 1990, J BACTERIOL, V172, P5795, DOI 10.1128/jb.172.10.5795-5802.1990; Burns DL, 2003, CURR OPIN MICROBIOL, V6, P29, DOI 10.1016/S1369-5274(02)00006-1; Cabezon E, 1997, MOL GEN GENET, V254, P400, DOI 10.1007/s004380050432; Cabezon E, 2003, NAT STRUCT BIOL, V10, P744, DOI 10.1038/nsb966; Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630; Covacci A, 1999, SCIENCE, V284, P1328, DOI 10.1126/science.284.5418.1328; Curran AC, 2000, J BIOL CHEM, V275, P30301, DOI 10.1074/jbc.M002047200; Durand E, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-4; Durand E, 2010, J BACTERIOL, V192, P2315, DOI 10.1128/JB.01384-09; Ekberg K, 2010, J BIOL CHEM, V285, P7344, DOI 10.1074/jbc.M109.096123; ENYEDI A, 1993, J BIOL CHEM, V268, P17120; Fernandez-Lopez R, 2006, FEMS MICROBIOL REV, V30, P942, DOI 10.1111/j.1574-6976.2006.00042.x; Fischer W, 2002, INT J MED MICROBIOL, V292, P159, DOI 10.1078/1438-4221-00199; Fronzes R, 2009, NAT REV MICROBIOL, V7, P703, DOI 10.1038/nrmicro2218; Gledhill JR, 2007, P NATL ACAD SCI USA, V104, P15671, DOI 10.1073/pnas.0707326104; Gomis-Ruth FX, 2001, NATURE, V409, P637, DOI 10.1038/35054586; Hackney DD, 2000, NAT CELL BIOL, V2, P257, DOI 10.1038/35010525; Hwang I, 2000, P NATL ACAD SCI USA, V97, P6224, DOI 10.1073/pnas.97.11.6224; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kerr JE, 2010, J BACTERIOL, V192, P4923, DOI 10.1128/JB.00557-10; KREUZER KN, 1983, METHOD ENZYMOL, V100, P144; Malmstrom S, 2000, PLANT PHYSIOL, V122, P517, DOI 10.1104/pp.122.2.517; Matilla I, 2010, J BIOL CHEM, V285, P17537, DOI 10.1074/jbc.M109.084137; Middleton R, 2005, P NATL ACAD SCI USA, V102, P1685, DOI 10.1073/pnas.0409399102; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Moncalian G, 1999, J BIOL CHEM, V274, P36117, DOI 10.1074/jbc.274.51.36117; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; OSBORN MJ, 1972, J BIOL CHEM, V247, P3962; Owen BAL, 2002, J BIOL CHEM, V277, P7086, DOI 10.1074/jbc.M111450200; PALMGREN MG, 1991, J BIOL CHEM, V266, P20470; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PORTILLO F, 1989, FEBS LETT, V247, P381, DOI 10.1016/0014-5793(89)81375-4; Rabel C, 2003, J BACTERIOL, V185, P1045, DOI 10.1128/JB.185.3.1045-1058.2003; Rangrez AY, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-10; Reddy LG, 1999, BIOPHYS J, V76, P3058, DOI 10.1016/S0006-3495(99)77458-8; Rivas S, 1997, J BIOL CHEM, V272, P25583, DOI 10.1074/jbc.272.41.25583; Sambrook J., 2002, MOL CLONING LAB MANU; SANCHEZ VE, 1993, J BIOL CHEM, V268, P17889; Seiler S, 2000, NAT CELL BIOL, V2, P333, DOI 10.1038/35014022; SMITH MK, 1992, J BIOL CHEM, V267, P1761; Tato I, 2005, P NATL ACAD SCI USA, V102, P8156, DOI 10.1073/pnas.0503402102; Tato I, 2007, J BIOL CHEM, V282, P25569, DOI 10.1074/jbc.M703464200; Tsunoda SP, 2001, P NATL ACAD SCI USA, V98, P6560, DOI 10.1073/pnas.111128098; WALKER JE, 1994, CURR OPIN STRUC BIOL, V4, P912, DOI 10.1016/0959-440X(94)90274-7; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Waters V L, 1999, Front Biosci, V4, pD433, DOI 10.2741/Waters; Weikl T, 2000, J MOL BIOL, V303, P583, DOI 10.1006/jmbi.2000.4157; Yeo HJ, 2000, MOL CELL, V6, P1461, DOI 10.1016/S1097-2765(00)00142-8; Yonekura H, 2006, BIOCHEM BIOPH RES CO, V343, P420, DOI 10.1016/j.bbrc.2006.02.169; ZU YL, 1995, J BIOL CHEM, V270, P202, DOI 10.1074/jbc.270.1.202	55	15	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17376	17382		10.1074/jbc.M110.208942	http://dx.doi.org/10.1074/jbc.M110.208942			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454654	Green Published, hybrid			2022-12-25	WOS:000290301900085
J	Wu, Y; Wei, S; Van Doren, SR; Brew, K				Wu, Ying; Wei, Shuo; Van Doren, Steven R.; Brew, Keith			Entropy Increases from Different Sources Support the High-affinity Binding of the N-terminal Inhibitory Domains of Tissue Inhibitors of Metalloproteinases to the Catalytic Domains of Matrix Metalloproteinases-1 and-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTION; CRYSTAL-STRUCTURE; HEAT-CAPACITY; 1-MATRIX METALLOPROTEINASE; ESCHERICHIA-COLI; POTENT INHIBITOR; TIMP-1; COMPLEX; SPECIFICITY; SURFACE	The avid binding of tissue inhibitors of metalloproteinases (TIMPs) to matrix metalloproteinases (MMPs) is crucial for the regulation of pericellular and extracellular proteolysis. The interactions of the catalytic domain (cd) of MMP-1 with the inhibitory domains of TIMP-1 and TIMP-2 (N-TIMPs) and MMP-3cd with N-TIMP-2 have been characterized by isothermal titration calorimetry and compared with published data for the N-TIMP-1/MMP-3cd interaction. All interactions are largely driven by increases in entropy but there are significant differences in the profiles for the interactions of both N-TIMPs with MMP-1cd as compared with MMP-3cd; the enthalpy change ranges from small for MMP-1cd to highly unfavorable for MMP-3cd (-0.1 +/- 0.7 versus 6.0 +/- 0.5 kcal mol(-1)). The heat capacity change (Delta C-p) of binding to MMP-1cd (temperature dependence of Delta H) is large and negative (-210 +/- 20 cal K-1 mol(-1)), indicating a large hydrophobic contribution, whereas the Delta C-p values for the binding to MMP-3cd are much smaller (-53 +/- 3 cal K-1 mol(-1)), and some of the entropy increase may arise from increased conformational entropy. Apart from differences in ionization effects, it appears that the properties of the MMPmay have a predominant influence in the thermodynamic profiles for these N-TIMP/MMP interactions.	[Wu, Ying; Wei, Shuo; Brew, Keith] Florida Atlantic Univ, Dept Basic Sci, Charles E Schmidt Coll Med, Boca Raton, FL 33431 USA; [Van Doren, Steven R.] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA	State University System of Florida; Florida Atlantic University; University of Missouri System; University of Missouri Columbia	Brew, K (corresponding author), Florida Atlantic Univ, Dept Basic Sci, Charles E Schmidt Coll Med, Boca Raton, FL 33431 USA.	kbrew@fau.edu	Brew, Keith/A-6746-2009; Brew, Keith/W-1643-2019	Brew, Keith/0000-0003-1306-1032; Wei, Shuo/0000-0001-8203-4922; Van Doren, Steven/0000-0003-2838-4598	National Institutes of Health [R01 AR40994, R01GM57289]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040994] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057289] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AR40994 (to K. B.) and R01GM57289 (to S. R. V. D.).	Arumugam S, 2003, J MOL BIOL, V327, P719, DOI 10.1016/S0022-2836(03)00180-3; Baker BM, 1996, BIOPHYS J, V71, P2049, DOI 10.1016/S0006-3495(96)79403-1; Baker BM, 1998, METHOD ENZYMOL, V295, P294; BALDWIN RL, 1986, P NATL ACAD SCI USA, V83, P8069, DOI 10.1073/pnas.83.21.8069; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Butler GS, 1999, J BIOL CHEM, V274, P20391, DOI 10.1074/jbc.274.29.20391; Chen LY, 1999, J MOL BIOL, V293, P545, DOI 10.1006/jmbi.1999.3147; Cho S, 2010, BIOCHEMISTRY-US, V49, P9256, DOI 10.1021/bi1008968; Cooper A, 2007, BIOCHEM SOC T, V35, P1547, DOI 10.1042/BST0351547; Cooper A, 2005, BIOPHYS CHEM, V115, P89, DOI 10.1016/j.bpc.2004.12.011; Fernandez-Catalan C, 1998, EMBO J, V17, P5238, DOI 10.1093/emboj/17.17.5238; FU L, 1992, P NATL ACAD SCI USA, V89, P9335, DOI 10.1073/pnas.89.19.9335; Goldberg RN, 2002, J PHYS CHEM REF DATA, V31, P231, DOI 10.1063/1.1416902; GomisRuth FX, 1997, NATURE, V389, P77, DOI 10.1038/37995; Grimsley GR, 2009, PROTEIN SCI, V18, P247, DOI 10.1002/pro.19; Hamze AB, 2007, PROTEIN SCI, V16, P1905, DOI 10.1110/ps.072978507; Higashi S, 1999, J BIOL CHEM, V274, P10497, DOI 10.1074/jbc.274.15.10497; Holman CM, 1999, BIOCHEMISTRY-US, V38, P677, DOI 10.1021/bi9822170; Huang W, 1996, FEBS LETT, V384, P155, DOI 10.1016/0014-5793(96)00304-3; Huang W, 1997, J BIOL CHEM, V272, P22086, DOI 10.1074/jbc.272.35.22086; Iyer S, 2007, J BIOL CHEM, V282, P364, DOI 10.1074/jbc.M607625200; Janin J, 1996, PROTEINS, V24, pR1, DOI 10.1002/prot.340240402; Kashiwagi M, 2001, J BIOL CHEM, V276, P12501, DOI 10.1074/jbc.C000848200; Lee MH, 2004, J BIOL CHEM, V279, P17562, DOI 10.1074/jbc.M312589200; Lee MH, 2003, J BIOL CHEM, V278, P40224, DOI 10.1074/jbc.M305678200; Lim NH, 2010, BIOCHEM J, V431, P113, DOI 10.1042/BJ20100725; Maskos K, 2007, J MOL BIOL, V366, P1222, DOI 10.1016/j.jmb.2006.11.072; McCawley LJ, 2001, CURR OPIN CELL BIOL, V13, P534, DOI 10.1016/S0955-0674(00)00248-9; Meng Q, 1999, J BIOL CHEM, V274, P10184, DOI 10.1074/jbc.274.15.10184; Murphy G, 2008, MOL ASPECTS MED, V29, P290, DOI 10.1016/j.mam.2008.05.002; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rapti M, 2008, BIOCHEM J, V411, P433, DOI 10.1042/BJ20071430; Reynolds C, 2009, BIOINFORMATICS, V25, P413, DOI 10.1093/bioinformatics/btn584; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; SPOLAR RS, 1992, BIOCHEMISTRY-US, V31, P3947, DOI 10.1021/bi00131a009; Van Doren SR, 2008, BIOPOLYMERS, V89, P960, DOI 10.1002/bip.21043; Wei S, 2005, J BIOL CHEM, V280, P32877, DOI 10.1074/jbc.C500220200; Wei S, 2003, BIOCHEMISTRY-US, V42, P12200, DOI 10.1021/bi035358x; Wei S, 2003, J BIOL CHEM, V278, P9831, DOI 10.1074/jbc.M211793200; Williamson RA, 1999, J BIOL CHEM, V274, P37226, DOI 10.1074/jbc.274.52.37226; Wingfield PT, 1999, J BIOL CHEM, V274, P21362, DOI 10.1074/jbc.274.30.21362; Yu YB, 2001, BIOPHYS J, V81, P1632, DOI 10.1016/S0006-3495(01)75817-1	43	7	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16891	16899		10.1074/jbc.M111.222307	http://dx.doi.org/10.1074/jbc.M111.222307			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454617	hybrid, Green Published			2022-12-25	WOS:000290301900038
J	Cenik, B; Sephton, CF; Dewey, CM; Xian, XD; Wei, SG; Yu, K; Niu, WZ; Coppola, G; Coughlin, SE; Lee, SE; Dries, DR; Almeida, S; Geschwind, DH; Gao, FB; Miller, BL; Farese, RV; Posner, BA; Yu, G; Herz, J				Cenik, Basar; Sephton, Chantelle F.; Dewey, Colleen M.; Xian, Xunde; Wei, Shuguang; Yu, Kimberley; Niu, Wenze; Coppola, Giovanni; Coughlin, Sarah E.; Lee, Suzee E.; Dries, Daniel R.; Almeida, Sandra; Geschwind, Daniel H.; Gao, Fen-Biao; Miller, Bruce L.; Farese, Robert V., Jr.; Posner, Bruce A.; Yu, Gang; Herz, Joachim			Suberoylanilide Hydroxamic Acid (Vorinostat) Up-regulates Progranulin Transcription RATIONAL THERAPEUTIC APPROACH TO FRONTOTEMPORAL DEMENTIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE INHIBITORS; LOBAR DEGENERATION; HDAC INHIBITORS; IN-VITRO; RESVERATROL; MUTATIONS; DISEASE; VIVO; ACETYLATION; ACTIVATION	Progranulin (GRN) haploinsufficiency is a frequent cause of familial frontotemporal dementia, a currently untreatable progressive neurodegenerative disease. By chemical library screening, we identified suberoylanilide hydroxamic acid (SAHA), a Food and Drug Administration-approved histone deacetylase inhibitor, as an enhancer of GRN expression. SAHA dose-dependently increased GRN mRNA and protein levels in cultured cells and restored near-normal GRN expression in haploinsufficient cells from human subjects. Although elevation of secreted progranulin levels through a post-transcriptional mechanism has recently been reported, this is, to the best of our knowledge, the first report of a small molecule enhancer of progranulin transcription. SAHA has demonstrated therapeutic potential in other neurodegenerative diseases and thus holds promise as a first generation drug for the prevention and treatment of frontotemporal dementia.	[Dries, Daniel R.; Yu, Gang; Herz, Joachim] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Cenik, Basar; Xian, Xunde; Herz, Joachim] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Herz, Joachim] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA; [Wei, Shuguang; Posner, Bruce A.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Coppola, Giovanni; Geschwind, Daniel H.] Univ Calif Los Angeles, Program Neurogenet, Dept Neurol, David Geffen Sch Med, Los Angeles, CA 90024 USA; [Coughlin, Sarah E.; Farese, Robert V., Jr.] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Lee, Suzee E.; Miller, Bruce L.] Univ Calif San Francisco, Memory & Aging Ctr, San Francisco, CA 94143 USA; [Farese, Robert V., Jr.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Farese, Robert V., Jr.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Almeida, Sandra; Gao, Fen-Biao] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA 01605 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Massachusetts System; University of Massachusetts Worcester	Yu, G (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurosci, 6000 Harry Hines Blvd, Dallas, TX 75390 USA.	gang.yu@utsouthwestern.edu; joachim.herz@utsouthwestern.edu	Lee, Suzee/AAG-2393-2019; Coughlin, Sarah/ABG-7079-2020; Xian, Xunde/B-9490-2012	Xian, Xunde/0000-0003-3059-1254; DRIES, DANIEL/0000-0002-0530-5212; Yu, Kimberley/0000-0002-3993-923X	National Institutes of Health; Consortium for Frontotemporal Dementia Research; California Institute for Regenerative Medicine; National Cell Repository for Alzheimer's Disease; Ted Nash Long Life Foundation; Welch Foundation; Humboldt Foundation; American Health Assistance Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL063762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U24AG021886, R01AG029547, P01AG019724] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Consortium for Frontotemporal Dementia Research; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); National Cell Repository for Alzheimer's Disease; Ted Nash Long Life Foundation; Welch Foundation(The Welch Foundation); Humboldt Foundation(Alexander von Humboldt Foundation); American Health Assistance Foundation(BrightFocus Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health, the Consortium for Frontotemporal Dementia Research, the California Institute for Regenerative Medicine, the National Cell Repository for Alzheimer's Disease, the Ted Nash Long Life Foundation, the Welch Foundation, the Humboldt Foundation, and the American Health Assistance Foundation.	Ahmed Z, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-7; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Bhandari V, 1996, BIOCHEM J, V319, P441, DOI 10.1042/bj3190441; Butler KV, 2010, J AM CHEM SOC, V132, P10842, DOI 10.1021/ja102758v; Calamini B, 2010, BIOCHEM J, V429, P273, DOI 10.1042/BJ20091857; Capell A, 2011, J NEUROSCI, V31, P1885, DOI 10.1523/JNEUROSCI.5757-10.2011; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Eriksen JL, 2008, J NEUROCHEM, V104, P287, DOI 10.1111/j.1471-4159.2007.04968.x; Finch N, 2009, BRAIN, V132, P583, DOI 10.1093/brain/awn352; Finkelstein RA, 2010, J SURG RES, V163, P146, DOI 10.1016/j.jss.2010.04.024; Gass J, 2006, HUM MOL GENET, V15, P2988, DOI 10.1093/hmg/ddl241; Glauben R, 2006, J IMMUNOL, V176, P5015, DOI 10.4049/jimmunol.176.8.5015; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; Hahnen E, 2006, J NEUROCHEM, V98, P193, DOI 10.1111/j.1471-4159.2006.03868.x; Halili MA, 2010, J LEUKOCYTE BIOL, V87, P1103, DOI 10.1189/jlb.0509363; Heltweg B, 2004, J MED CHEM, V47, P5235, DOI 10.1021/jm0497592; Hockly E, 2003, P NATL ACAD SCI USA, V100, P2041, DOI 10.1073/pnas.0437870100; Hodges JR, 2003, NEUROLOGY, V61, P349, DOI 10.1212/01.WNL.0000078928.20107.52; Iorio F, 2010, P NATL ACAD SCI USA, V107, P14621, DOI 10.1073/pnas.1000138107; Jiao J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010551; Kai L, 2010, INT J CANCER, V126, P1538, DOI 10.1002/ijc.24928; Kazantsev AG, 2008, NAT REV DRUG DISCOV, V7, P854, DOI 10.1038/nrd2681; Kirshner HS, 2010, CURR NEUROL NEUROSCI, V10, P504, DOI 10.1007/s11910-010-0145-z; Lane AA, 2009, J CLIN ONCOL, V27, P5459, DOI 10.1200/JCO.2009.22.1291; Lin HS, 2007, BRIT J PHARMACOL, V150, P862, DOI 10.1038/sj.bjp.0707165; Liu SJ, 2010, CANCER CELL, V17, P333, DOI 10.1016/j.ccr.2010.03.008; MA PTS, 1986, P NATL ACAD SCI USA, V83, P8370, DOI 10.1073/pnas.83.21.8370; Mann BS, 2007, ONCOLOGIST, V12, P1247, DOI 10.1634/theoncologist.12-10-1247; NEITZEL H, 1986, HUM GENET, V73, P320, DOI 10.1007/BF00279094; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Rademakers R, 2008, HUM MOL GENET, V17, P3631, DOI 10.1093/hmg/ddn257; Sleegers K, 2009, ANN NEUROL, V65, P603, DOI 10.1002/ana.21621; Tang BL, 2010, BRAIN RES BULL, V81, P359, DOI 10.1016/j.brainresbull.2009.12.007; Tang W., 2011, SCIENCE IN PRESS; van Swieten JC, 2008, LANCET NEUROL, V7, P965, DOI 10.1016/S1474-4422(08)70194-7; Vingtdeux V, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S2-S6; Wang WX, 2010, AM J PATHOL, V177, P334, DOI 10.2353/ajpath.2010.091202; Watamoto K, 2003, ONCOGENE, V22, P9176, DOI 10.1038/sj.onc.1206902; Yang JQ, 2009, J BIOL CHEM, V284, P27042, DOI 10.1074/jbc.M109.047340; Yin D, 2007, CLIN CANCER RES, V13, P1045, DOI 10.1158/1078-0432.CCR-06-1261; Yin FF, 2010, J EXP MED, V207, P117, DOI 10.1084/jem.20091568; Zhang F, 2010, EUR J PHARMACOL, V636, P1, DOI 10.1016/j.ejphar.2010.03.043	45	112	118	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.193433	http://dx.doi.org/10.1074/jbc.M110.193433			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454553	hybrid, Green Published			2022-12-25	WOS:000290022800050
J	Bochner, BR; Siri, M; Huang, RH; Noble, S; Lei, XH; Clemons, PA; Wagner, BK				Bochner, Barry R.; Siri, Mark; Huang, Richard H.; Noble, Shawn; Lei, Xiang-He; Clemons, Paul A.; Wagner, Bridget K.			Assay of the Multiple Energy-Producing Pathways of Mammalian Cells	PLOS ONE			English	Article							GLUTAMINE-METABOLISM; GLUCOSE-HOMEOSTASIS; CARBOHYDRATE; BROWN; MITOCHONDRIAL; GLYCOLYSIS; OXIDATION; COMPLEX; MUSCLE; SUGAR	Background: To elucidate metabolic changes that occur in diabetes, obesity, and cancer, it is important to understand cellular energy metabolism pathways and their alterations in various cells. Methodology and Principal Findings: Here we describe a technology for simultaneous assessment of cellular energy metabolism pathways. The technology employs a redox dye chemistry specifically coupled to catabolic energy-producing pathways. Using this colorimetric assay, we show that human cancer cell lines from different organ tissues produce distinct profiles of metabolic activity. Further, we show that murine white and brown adipocyte cell lines produce profiles that are distinct from each other as well as from precursor cells undergoing differentiation. Conclusions: This technology can be employed as a fundamental tool in genotype-phenotype studies to determine changes in cells from shared lineages due to differentiation or mutation.	[Bochner, Barry R.; Siri, Mark; Huang, Richard H.; Noble, Shawn; Lei, Xiang-He] Biolog Inc, Hayward, CA 94545 USA; [Clemons, Paul A.; Wagner, Bridget K.] Harvard & MIT, Broad Inst, Chem Biol Program, Cambridge, MA USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Bochner, BR (corresponding author), Biolog Inc, Hayward, CA 94545 USA.	bbochner@biolog.com			National Institutes of Health-National Cancer Institute (NIH-NCI) [R43-CA101605]; National Institutes of Health-National Institute of Mental Health (NIH-NIMH) [R44-MH074145]; Biolog, Inc.; NCI's Initiative for Chemical Genetics [N01-CO-12400]; NIH [RL1-HG004671]; NIH Molecular Libraries Network [U54-HG005032]; Juvenile Diabetes Research Foundation; NIH-NIDDK [DP2-DK-083048]; NATIONAL CANCER INSTITUTE [R43CA101605] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RL1HG004671, U54HG005032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP2DK083048, R24DK080261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R44MH074145] Funding Source: NIH RePORTER	National Institutes of Health-National Cancer Institute (NIH-NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health-National Institute of Mental Health (NIH-NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Biolog, Inc.; NCI's Initiative for Chemical Genetics; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Molecular Libraries Network; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NIH-NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Principal funding for the research at Biolog was provided by National Institutes of Health (NIH) Grants R43-CA101605 from National Institutes of Health-National Cancer Institute (NIH-NCI) and grant R44-MH074145 (Small Business Innovation Research) from National Institutes of Health-National Institute of Mental Health (NIH-NIMH). Additional funding and support was from Biolog, Inc., which employed the authors who designed the studies, collected the data, analyzed the data, and prepared the manuscript. P.A.C. is supported in part by NCI's Initiative for Chemical Genetics (N01-CO-12400), NIH Genomics-Based Drug Discovery/Target ID Project (RL1-HG004671), and NIH Molecular Libraries Network (U54-HG005032). B.K.W. is supported by the Juvenile Diabetes Research Foundation and a Type 1 Diabetes Pathfinder Award (DP2-DK-083048, NIH-NIDDK). Barry Bochner, CEO and CSO at Biolog, made the decision to publish the manuscript.	Aft RL, 2002, BRIT J CANCER, V87, P805, DOI 10.1038/sj.bjc.6600547; Barnett SF, 2005, BIOCHEM J, V385, P399, DOI 10.1042/BJ20041140; Bernas T, 2000, ARCH BIOCHEM BIOPHYS, V380, P108, DOI 10.1006/abbi.2000.1907; Bernas T, 2002, CYTOMETRY, V47, P236, DOI 10.1002/cyto.10080; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; Bochner B.R., 2006, ENCY RAPID MICROBIOL, V2, P55; Bochner BR, 2008, MOL MICROBIOL, V70, P274, DOI 10.1111/j.1365-2958.2008.06383.x; Bochner BR, 2009, FEMS MICROBIOL REV, V33, P191, DOI 10.1111/j.1574-6976.2008.00149.x; Bochner BR, 2003, NAT REV GENET, V4, P309, DOI 10.1038/nrg1046; BOCHNER BR, 1989, NATURE, V339, P157, DOI 10.1038/339157a0; Bochner BR, 2001, GENOME RES, V11, P1246, DOI 10.1101/gr.186501; BURNS RL, 1976, J CELL PHYSIOL, V88, P307, DOI 10.1002/jcp.1040880306; Butler M, 1987, Adv Biochem Eng Biotechnol, V34, P57; Caraccio N, 2005, J CLIN ENDOCR METAB, V90, P4057, DOI 10.1210/jc.2004-2344; COONEY G, 1986, BIOCHEM BIOPH RES CO, V138, P687, DOI 10.1016/S0006-291X(86)80551-4; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; Dhaliwal R, 2005, CURR OPIN CRIT CARE, V11, P461; EAGLE H, 1958, J BIOL CHEM, V233, P551; FITZPATRICK L, 1993, APPL BIOCHEM BIOTECH, V43, P93, DOI 10.1007/BF02916435; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; GOLDBERG AL, 1978, FED PROC, V37, P2301; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Griffin JL, 2004, NAT REV CANCER, V4, P551, DOI 10.1038/nrc1390; Haqq AM, 2005, CONTEMP CLIN TRIALS, V26, P616, DOI 10.1016/j.cct.2005.09.003; Iizuka K, 2004, P NATL ACAD SCI USA, V101, P7281, DOI 10.1073/pnas.0401516101; Joachimiak Romana, 2007, Acta Pol Pharm, V64, P561; JOHANNES K, 2002, BIOESSAYS, V24, P382; JUNGAS RL, 1992, PHYSIOL REV, V72, P419, DOI 10.1152/physrev.1992.72.2.419; KELLY JH, 1994, Patent No. 5290684; Lee CH, 2006, P NATL ACAD SCI USA, V103, P3444, DOI 10.1073/pnas.0511253103; Lerin C, 2006, CELL METAB, V3, P429, DOI 10.1016/j.cmet.2006.04.013; Lewis GD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001006; Li L, 2005, AM J PHYSIOL-ENDOC M, V288, pE208, DOI 10.1152/ajpendo.00346.2004; Mitro N, 2007, NATURE, V445, P219, DOI 10.1038/nature05449; MORGAN MJ, 1981, BIOSCIENCE REP, V1, P669, DOI 10.1007/BF01116465; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; Ramshur EB, 2002, J CELL PHYSIOL, V192, P339, DOI 10.1002/jcp.10139; REITZER LJ, 1979, J BIOL CHEM, V254, P2669; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; SCRIVER CR, 1985, METABOLISM, V34, P868, DOI 10.1016/0026-0495(85)90112-X; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Simpson NH, 1998, BIOTECHNOL BIOENG, V59, P90, DOI 10.1002/(SICI)1097-0290(19980705)59:1<90::AID-BIT12>3.0.CO;2-6; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104; Ukropcova B, 2005, J CLIN INVEST, V115, P1934, DOI 10.1172/JCI24332; VanItallie TB, 2003, NUTR REV, V61, P327, DOI 10.1301/nr.2003.oct.327-341; Vega RB, 1997, J BIOL CHEM, V272, P31693, DOI 10.1074/jbc.272.50.31693; VISTICA DT, 1991, CANCER RES, V51, P2515; WICE BM, 1983, J BIOL CHEM, V258, P3134; WICE BM, 1981, J BIOL CHEM, V256, P7812; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923	51	40	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2011	6	3							e18147	10.1371/journal.pone.0018147	http://dx.doi.org/10.1371/journal.pone.0018147			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740RG	21455318	Green Submitted, Green Published, gold			2022-12-25	WOS:000288811500025
J	Nishiura, H; Chowell, G; Castillo-Chavez, C				Nishiura, Hiroshi; Chowell, Gerardo; Castillo-Chavez, Carlos			Did Modeling Overestimate the Transmission Potential of Pandemic (H1N1-2009)? Sample Size Estimation for Post-Epidemic Seroepidemiological Studies	PLOS ONE			English	Article							H1N1 2009 VIRUS; FINAL-SIZE; INTERVAL ESTIMATION; INFECTIOUS-DISEASE; REAL-TIME; INFLUENZA; INFERENCE; PREVALENCE; ANTIBODIES; SEVERITY	Background: Seroepidemiological studies before and after the epidemic wave of H1N1-2009 are useful for estimating population attack rates with a potential to validate early estimates of the reproduction number, R, in modeling studies. Methodology/Principal Findings: Since the final epidemic size, the proportion of individuals in a population who become infected during an epidemic, is not the result of a binomial sampling process because infection events are not independent of each other, we propose the use of an asymptotic distribution of the final size to compute approximate 95% confidence intervals of the observed final size. This allows the comparison of the observed final sizes against predictions based on the modeling study (R = 1.15, 1.40 and 1.90), which also yields simple formulae for determining sample sizes for future seroepidemiological studies. We examine a total of eleven published seroepidemiological studies of H1N1-2009 that took place after observing the peak incidence in a number of countries. Observed seropositive proportions in six studies appear to be smaller than that predicted from R = 1.40; four of the six studies sampled serum less than one month after the reported peak incidence. The comparison of the observed final sizes against R = 1.15 and 1.90 reveals that all eleven studies appear not to be significantly deviating from the prediction with R = 1.15, but final sizes in nine studies indicate overestimation if the value R = 1.90 is used. Conclusions: Sample sizes of published seroepidemiological studies were too small to assess the validity of model predictions except when R = 1.90 was used. We recommend the use of the proposed approach in determining the sample size of post-epidemic seroepidemiological studies, calculating the 95% confidence interval of observed final size, and conducting relevant hypothesis testing instead of the use of methods that rely on a binomial proportion.	[Nishiura, Hiroshi] PRESTO, Japan Sci & Technol Agcy, Saitama, Japan; [Nishiura, Hiroshi] Univ Utrecht, Utrecht, Netherlands; [Nishiura, Hiroshi] Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Chowell, Gerardo; Castillo-Chavez, Carlos] Arizona State Univ, Math & Computat Modeling Sci Ctr, Sch Human Evolut & Social Change, Tempe, AZ USA; [Chowell, Gerardo] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Castillo-Chavez, Carlos] Santa Fe Inst, Santa Fe, NM 87501 USA	Japan Science & Technology Agency (JST); Utrecht University; University of Hong Kong; Arizona State University; Arizona State University-Tempe; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); The Santa Fe Institute	Nishiura, H (corresponding author), PRESTO, Japan Sci & Technol Agcy, Saitama, Japan.	nishiura@hku.hk	Castillo-Chavez, Carlos/E-1412-2014; Nishiura, Hiroshi/D-1426-2011; Chowell, Gerardo/F-5038-2012	Castillo-Chavez, Carlos/0000-0002-1046-3901; Chowell, Gerardo/0000-0003-2194-2251; Nishiura, Hiroshi/0000-0003-0941-8537	Japan Science and Technology Agency PRESTO; College of the Liberal Arts and Sciences of Arizona State University; National Science Foundation (NSF) [DMS - 0502349]; U.S. Department of Defense (NSA) [H98230-06-1-0097]; Alfred T. Sloan Foundation; Office of the Provost of Arizona State University	Japan Science and Technology Agency PRESTO(Japan Science & Technology Agency (JST)); College of the Liberal Arts and Sciences of Arizona State University; National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); U.S. Department of Defense (NSA)(National Security AgencyUnited States Department of Defense); Alfred T. Sloan Foundation(Alfred P. Sloan Foundation); Office of the Provost of Arizona State University	HN was supported by the Japan Science and Technology Agency PRESTO program. GC received financial support from the College of the Liberal Arts and Sciences of Arizona State University. National Science Foundation (NSF - Grant DMS - 0502349), U.S. Department of Defense (NSA - Grant H98230-06-1-0097), the Alfred T. Sloan Foundation and the Office of the Provost of Arizona State University support CCC's research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; AHO M, 2010, EURO SURVEILL, V15; Allwinn R, 2010, MED MICROBIOL IMMUN, V199, P117, DOI 10.1007/s00430-010-0143-4; Andersson H, 2000, LECT NOTES STAT, V151, DOI 10.1007/978-1-4612-1158-7; Andreasen V, 2011, B MATH BIOL, V73, P2305, DOI 10.1007/s11538-010-9623-3; [Anonymous], 2010, Wkly Epidemiol Rec, V85, P229; Bacaer N, 2011, J MATH BIOL, V62, P741, DOI 10.1007/s00285-010-0354-8; Bacaer N, 2009, B MATH BIOL, V71, P1954, DOI 10.1007/s11538-009-9433-7; Balcan D, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-45; Ball F, 1999, J APPL PROBAB, V36, P473, DOI 10.1017/S0021900200017265; BALL F, 1995, J APPL PROBAB, V32, P579, DOI 10.2307/3215114; BALL F, 1993, ADV APPL PROBAB, V25, P721, DOI 10.2307/1427788; Bandaranayake D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013211; Boelle PY, 2009, EUROSURVEILLANCE, V14, P10; Brauer F, 2010, MATH BIOSCI ENG, V7, P1, DOI 10.3934/mbe.2010.7.1; Brauer Fred, 2009, Journal of Biological Dynamics, V3, P324, DOI 10.1080/17513750802415822; Brauer F, 2008, MATH BIOSCI ENG, V5, P681, DOI 10.3934/mbe.2008.5.681; Britton T, 2010, MATH BIOSCI, V225, P24, DOI 10.1016/j.mbs.2010.01.006; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; Call SA, 2005, JAMA-J AM MED ASSOC, V293, P987, DOI 10.1001/jama.293.8.987; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Chan YJ, 2010, J CHIN MED ASSOC, V73, P62, DOI 10.1016/S1726-4901(10)70003-4; Chen HL, 2009, EMERG INFECT DIS, V15, P1849, DOI 10.3201/eid1511.090868; CHEN M, 2010, JAMA-J AM MED ASSOC, V303, P1381; Cohen J, 1977, STAT POWER ANAL BEHA, V2 2 ed, DOI DOI 10.1016/B978-0-12-179060-8.50006-2; Deng Y, 2011, EPIDEMIOL INFECT, V139, P52, DOI 10.1017/S0950268810002189; DESILVA UC, 2009, EURO SURVEILL, V14; DESU MM, 1988, SAMPLE SIZE METHODOL; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Gilbert GL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012562; Graubard BI, 2002, STAT SCI, V17, P73, DOI 10.1214/ss/1023798999; Hahne S, 2009, EUROSURVEILLANCE, V14, P2; HALLORAN ME, 1995, EPIDEMIOLOGY, V6, P142, DOI 10.1097/00001648-199503000-00010; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Hens N, 2011, VACCINE, V29, P896, DOI 10.1016/j.vaccine.2010.05.010; Ikonen N, 2010, EUROSURVEILLANCE, V15, P16; LACHIN JM, 1981, CONTROL CLIN TRIALS, V2, P93, DOI 10.1016/0197-2456(81)90001-5; Lee VJ, 2010, J INFECT DIS, V202, P1319, DOI 10.1086/656480; Ma JL, 2006, B MATH BIOL, V68, P679, DOI 10.1007/s11538-005-9047-7; McBryde ES, 2009, EUROSURVEILLANCE, V14, P45; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Munayco CV, 2009, EUROSURVEILLANCE, V14, P6; *NAT I INF DIS, 2010, SURV SER STAT INFL 2; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Nishiura H, 2009, EUROSURVEILLANCE, V14; NISHIURA H, 2009, MATH STAT ESTIMATION, P53, DOI DOI 10.1007/978-90-481-2313-1_3; Nishiura H, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-15; Nishiura H, 2010, MATH BIOSCI ENG, V7, P851, DOI 10.3934/mbe.2010.7.851; Nishiura H, 2010, THEOR BIOL MED MODEL, V7, DOI 10.1186/1742-4682-7-1; Omori R, 2011, THEOR BIOL MED MODEL, V8, DOI 10.1186/1742-4682-8-2; Pourbohloul B, 2009, INFLUENZA OTHER RESP, V3, P215, DOI 10.1111/j.1750-2659.2009.00100.x; Scalia-Tomba G., 1990, STOCHASTIC PROCESSES, P189, DOI [10.1007/978-3-662-10067-7_18, DOI 10.1007/978-3-662-10067-7_18]; SCALIATOMBA G, 1985, ADV APPL PROBAB, V17, P477, DOI 10.2307/1427116; SELLKE T, 1983, J APPL PROBAB, V20, P390, DOI 10.2307/3213811; Skowronski DM, 2010, CAN MED ASSOC J, V182, P1851, DOI 10.1503/cmaj.100910; Tandale BV, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-255; TUITE AR, 2009, CMAJ, V182, P131, DOI DOI 10.1503/CMAJ.091807; Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754; Watts DJ, 2005, P NATL ACAD SCI USA, V102, P11157, DOI 10.1073/pnas.0501226102; White LF, 2009, INFLUENZA OTHER RESP, V3, P267, DOI 10.1111/j.1750-2659.2009.00106.x; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; Wu JT, 2010, CLIN INFECT DIS, V51, P1184, DOI 10.1086/656740; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373; Zimmer SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011601	65	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2011	6	3							e17908	10.1371/journal.pone.0017908	http://dx.doi.org/10.1371/journal.pone.0017908			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740RG	21455307	Green Submitted, gold, Green Published			2022-12-25	WOS:000288811500015
J	Metzger, F; Sajid, W; Saenger, S; Staudenmaier, C; van der Poel, C; Sobottka, B; Schuler, A; Sawitzky, M; Poirier, R; Tuerck, D; Schick, E; Schaubmar, A; Hesse, F; Amrein, K; Loetscher, H; Lynch, GS; Hoeflich, A; De Meyts, P; Schoenfeld, HJ				Metzger, Friedrich; Sajid, Waseem; Saenger, Stefanie; Staudenmaier, Christian; van der Poel, Chris; Sobottka, Bettina; Schuler, Angelika; Sawitzky, Mandy; Poirier, Raphael; Tuerck, Dietrich; Schick, Eginhard; Schaubmar, Andreas; Hesse, Friederike; Amrein, Kurt; Loetscher, Hansruedi; Lynch, Gordon S.; Hoeflich, Andreas; De Meyts, Pierre; Schoenfeld, Hans-Joachim			Separation of Fast from Slow Anabolism by Site-specific PEGylation of Insulin-like Growth Factor I (IGF-I)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-BINDING; MECASERMIN RINFABATE; DIABETES-MELLITUS; TRANSGENIC MICE; HYPERTROPHY; DIFFERENTIATION; COMPLEX; CELLS; OVEREXPRESSION; RESISTANCE	Insulin-like growth factor I (IGF-I) has important anabolic and homeostatic functions in tissues like skeletal muscle, and a decline in circulating levels is linked with catabolic conditions. Whereas IGF-I therapies for musculoskeletal disorders have been postulated, dosing issues and disruptions of the homeostasis have so far precluded clinical application. We have developed a novel IGF-I variant by site-specific addition of polyethylene glycol (PEG) to lysine 68 (PEG-IGF-I). In vitro, this modification decreased the affinity for the IGF-I and insulin receptors, presumably through decreased association rates, and slowed down the association to IGF-I-binding proteins, selectively limiting fast but maintaining sustained anabolic activity. Desirable in vivo effects of PEG-IGF-I included increased half-life and recruitment of IGF-binding proteins, thereby reducing risk of hypoglycemia. PEG-IGF-I was equipotent to IGF-I in ameliorating contraction-induced muscle injury in vivo without affecting muscle metabolism as IGF-I did. The data provide an important step in understanding the differences of IGF-I and insulin receptor contribution to the in vivo activity of IGF-I. In addition, PEG-IGF-I presents an innovative concept for IGF-I therapy in diseases with indicated muscle dysfunction.	[Metzger, Friedrich; Saenger, Stefanie; Staudenmaier, Christian; Sobottka, Bettina; Schuler, Angelika; Poirier, Raphael; Tuerck, Dietrich; Schick, Eginhard; Amrein, Kurt; Loetscher, Hansruedi; Schoenfeld, Hans-Joachim] Roche pRED, CH-4070 Basel, Switzerland; [Sajid, Waseem; De Meyts, Pierre] Hagedorn Res Inst, Receptor Syst Biol Lab, DK-2820 Gentofte, Denmark; [van der Poel, Chris; Lynch, Gordon S.] Univ Melbourne, Dept Physiol, Basic & Clin Myol Lab, Melbourne, Vic 3010, Australia; [Sawitzky, Mandy; Hoeflich, Andreas] FBN, Leibniz Inst Farm Anim Biol, Lab Mouse Genet, D-18196 Dummerstorf, Germany; [Schaubmar, Andreas; Hesse, Friederike] Roche pRED, D-82377 Penzberg, Germany	Roche Holding; Novo Nordisk; Hagedorn Research Institute; University of Melbourne; Forschungsinstitut fur Nutztierbiologie (FBN)	Metzger, F (corresponding author), F Hoffmann La Roche Ltd, CNS Discovery Res, Bldg 68-410, CH-4070 Basel, Switzerland.	friedrich.metzger@roche.com	Lynch, Gordon/G-9553-2015	Lynch, Gordon/0000-0001-9220-9810; Hoeflich, Andreas/0000-0003-2018-2836; Sobottka, Bettina/0000-0002-0890-5248; De Meyts, Pierre/0000-0001-6214-0824	Roche	Roche(Roche Holding)	This work was supported in part by a Roche Postdoctoral Fellowship (to C. v. d. P.).	Baudry A, 2001, FEBS LETT, V488, P174, DOI 10.1016/S0014-5793(00)02435-2; BAYNE ML, 1989, J BIOL CHEM, V264, P11004; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Cheetham TD, 1997, CLIN ENDOCRINOL, V46, P415, DOI 10.1046/j.1365-2265.1997.1320953.x; Clemmons DR, 2000, J CLIN ENDOCR METAB, V85, P1518, DOI 10.1210/jc.85.4.1518; Clemmons DR, 1998, MOL CELL ENDOCRINOL, V140, P19, DOI 10.1016/S0303-7207(98)00024-0; COLEMAN ME, 1995, J BIOL CHEM, V270, P12109, DOI 10.1074/jbc.270.20.12109; Conti E., 2008, Cardiovascular & Hematological Agents in Medicinal Chemistry, V6, P258, DOI 10.2174/187152508785909456; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; De Meyts P, 2009, ANN NY ACAD SCI, V1160, P45, DOI 10.1111/j.1749-6632.2009.03837.x; Denley A, 2005, CYTOKINE GROWTH F R, V16, P421, DOI 10.1016/j.cytogfr.2005.04.004; Diehl D, 2004, CANCER RES, V64, P1600, DOI 10.1158/0008-5472.CAN-03-2844; DREJER K, 1991, DIABETES, V40, P1488, DOI 10.2337/diabetes.40.11.1488; Duttaroy A, 2005, DIABETES, V54, P251, DOI 10.2337/diabetes.54.1.251; Epa VC, 2006, PROTEIN ENG DES SEL, V19, P377, DOI 10.1093/protein/gzl022; Fang Peng, 2004, Novartis Found Symp, V262, P215; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Gauguin L, 2008, J BIOL CHEM, V283, P20821, DOI 10.1074/jbc.M802620200; GERMAINLEE EL, 1992, BIOCHEM J, V281, P413, DOI 10.1042/bj2810413; Glass DJ, 2003, NAT CELL BIOL, V5, P87, DOI 10.1038/ncb0203-87; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Gregorevic P, 2002, AM J PATHOL, V161, P2263, DOI 10.1016/S0002-9440(10)64502-6; Guan J, 2003, PROG NEUROBIOL, V70, P443, DOI 10.1016/j.pneurobio.2003.08.002; Harris JM, 2003, NAT REV DRUG DISCOV, V2, P214, DOI 10.1038/nrd1033; Hoeflich A, 1999, ENDOCRINOLOGY, V140, P5488, DOI 10.1210/en.140.12.5488; Hoeflich A, 2008, GROWTH HORM IGF RES, V18, P181, DOI 10.1016/j.ghir.2008.01.003; Jain A, 2008, CRIT REV THER DRUG, V25, P403, DOI 10.1615/CritRevTherDrugCarrierSyst.v25.i5.10; Jevsevar S, 2010, BIOTECHNOL J, V5, P113, DOI 10.1002/biot.200900218; Kemp SF, 2007, DRUG TODAY, V43, P149, DOI 10.1358/dot.2007.43.3.1079876; Kiselyov VV, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.78; KNUSEL B, 1990, J NEUROSCI, V10, P558; McKern NM, 2006, NATURE, V443, P218, DOI 10.1038/nature05106; Palsgaard J, 2009, GROWTH HORM IGF RES, V19, P168, DOI 10.1016/j.ghir.2008.09.004; Philippou A., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P208; QUINN LS, 1993, EXP CELL RES, V208, P504, DOI 10.1006/excr.1993.1273; Ranke MB, 2005, TRENDS ENDOCRIN MET, V16, P190, DOI 10.1016/j.tem.2005.03.011; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Sajid W, 2009, BIOCHEMISTRY-US, V48, P11283, DOI 10.1021/bi901269j; Saukkonen T, 2004, J CLIN ENDOCR METAB, V89, P4634, DOI 10.1210/jc.2004-0243; Schertzer JD, 2006, AM J PHYSIOL-ENDOC M, V291, pE499, DOI 10.1152/ajpendo.00101.2006; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; SVRZIC D, 1990, BIOCHEM BIOPH RES CO, V172, P54, DOI 10.1016/S0006-291X(05)80172-X; VACCARELLO MA, 1993, J CLIN ENDOCR METAB, V77, P273, DOI 10.1210/jc.77.1.273; Vashisth H, 2010, J MOL BIOL, V400, P645, DOI 10.1016/j.jmb.2010.05.025; Wheatcroft SB, 2007, DIABETES, V56, P285, DOI 10.2337/db06-0436; Williams RM, 2008, EXPERT OPIN DRUG MET, V4, P311, DOI [10.1517/17425255.4.3.311, 10.1517/17425255.4.3.311 ]; Yakar S, 1999, P NATL ACAD SCI USA, V96, P7324, DOI 10.1073/pnas.96.13.7324; ZHANG WG, 1994, J BIOL CHEM, V269, P10609	48	37	38	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19501	19510		10.1074/jbc.M110.172189	http://dx.doi.org/10.1074/jbc.M110.172189			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21460230	hybrid, Green Published			2022-12-25	WOS:000291027700033
J	Ramathal, C; Wang, W; Hunt, E; Bagchi, IC; Bagchi, MK				Ramathal, Cyril; Wang, Wei; Hunt, Elizabeth; Bagchi, Indrani C.; Bagchi, Milan K.			Transcription Factor CCAAT Enhancer-binding Protein beta (C/EBP beta) Regulates the Formation of a Unique Extracellular Matrix That Controls Uterine Stromal Differentiation and Embryo Implantation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASEMENT-MEMBRANES; CELL-PROLIFERATION; TROPHOBLAST CELLS; MESSENGER-RNA; IN-VITRO; LAMININ; MOUSE; DECIDUALIZATION; EXPRESSION; LOCALIZATION	During implantation, the uterine stromal cells undergo terminal differentiation into decidual cells, which support the proper progression of maternal-embryo interactions to successful establishment of pregnancy. The decidual cells synthesize extracellular matrix (ECM) components, such as laminins and collagens, which assemble into a unique basal lamina-like network that surrounds these cells. The functional significance of this matrix during implantation is unknown. We previously showed that the transcription factor CCAAT enhancer-binding protein beta (C/EBP beta) critically regulates decidualization in the mouse. We now provide evidence that C/EBP beta directly controls the Lamc1 gene, which encodes a predominant laminin constituent of the ECM produced by the decidual cells. Suppression of Lamc1 expression in mouse primary endometrial stromal cells prevented the assembly of this ECM and impaired stromal differentiation. Attenuation of expression of integrin beta 1, a major constituent of the integrin receptors targeted by decidual laminins, also inhibited this differentiation process. Disruption of laminin-integrin interactions led to impaired activation of the focal adhesion kinase, an integrin-mediated regulator of cytoskeletal remodeling during decidualization. To further analyze the role of the decidual ECM in modulating maternal-embryo interactions, we monitored trophoblast invasion into differentiating uterine stromal monolayers, using a co-culture system. Silencing of stromal Lamc1 expression, which prevented formation of the basal lamina-like matrix, resulted in marked reduction in trophoblast outgrowth. Collectively, our findings identified C/EBP beta as a critical regulator of the unique ECM that controls decidual cell architecture and differentiation, and it provided new insights into the mechanisms by which the uterine stromal microenvironment controls the progression of embryo implantation.	[Wang, Wei; Hunt, Elizabeth; Bagchi, Milan K.] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; [Ramathal, Cyril] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA; [Bagchi, Indrani C.] Univ Illinois, Dept Comparat Biosci, Urbana, IL 61801 USA; [Ramathal, Cyril; Wang, Wei; Hunt, Elizabeth; Bagchi, Indrani C.; Bagchi, Milan K.] Univ Illinois, Ctr Res Reprod & Infertil, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Bagchi, MK (corresponding author), Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA.	mbagchi@life.illinois.edu			National Institutes of Health Eunice Kennedy Shriver NICHD [U54 HD055787]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD055787] Funding Source: NIH RePORTER	National Institutes of Health Eunice Kennedy Shriver NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Eunice Kennedy Shriver NICHD Cooperative Agreement U54 HD055787 as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research.	Armant DR, 2005, DEV BIOL, V280, P260, DOI 10.1016/j.ydbio.2005.02.009; Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; Babiarz B, 1996, DEV DYNAM, V206, P330, DOI 10.1002/(SICI)1097-0177(199607)206:3<330::AID-AJA10>3.0.CO;2-3; Bagchi MK, 2006, CELL CYCLE, V5, P922, DOI 10.4161/cc.5.9.2712; Bischof P, 2000, PLACENTA, V21, pS55, DOI 10.1053/plac.2000.0521; BURGESON RE, 1994, MATRIX BIOL, V14, P209, DOI 10.1016/0945-053X(94)90184-8; Carson DD, 2000, DEV BIOL, V223, P217, DOI 10.1006/dbio.2000.9767; Cheon YP, 2004, J BIOL CHEM, V279, P10357, DOI 10.1074/jbc.M309434200; Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R; Colognato H, 1999, J CELL BIOL, V145, P619, DOI 10.1083/jcb.145.3.619; Dey SK, 2004, ENDOCR REV, V25, P341, DOI 10.1210/er.2003-0020; FARRAR JD, 1992, BIOL REPROD, V46, P1095, DOI 10.1095/biolreprod46.6.1095; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; GLASSER SR, 1987, DIFFERENTIATION, V35, P132, DOI 10.1111/j.1432-0436.1987.tb00161.x; Gonzalez AM, 2002, P NATL ACAD SCI USA, V99, P16075, DOI 10.1073/pnas.252649399; Grewal S, 2008, P NATL ACAD SCI USA, V105, P16189, DOI 10.1073/pnas.0806219105; GU Y, 1999, ENCY REPROD, P836; Irwin J. C., 1999, ENCY REPROD, V1, P823; Kannan A, 2010, REPROD SCI, V17, P434, DOI 10.1177/1933719110361384; Kikkawa Y, 2000, J CELL SCI, V113, P869; Kim JY, 2008, MOL CELL BIOL, V28, P1770, DOI 10.1128/MCB.01556-07; Klaffky E, 2001, DEV BIOL, V239, P161, DOI 10.1006/dbio.2001.0404; Klaffky EJ, 2006, DEV BIOL, V292, P277, DOI 10.1016/j.ydbio.2005.12.033; Li QX, 2007, J BIOL CHEM, V282, P31725, DOI 10.1074/jbc.M704723200; Li SH, 2003, DEV CELL, V4, P613, DOI 10.1016/S1534-5807(03)00128-X; Mantena SR, 2006, P NATL ACAD SCI USA, V103, P1870, DOI 10.1073/pnas.0507261103; Mardon H, 2007, SEMIN REPROD MED, V25, P410, DOI 10.1055/s-2007-991038; Miner JH, 2004, DEVELOPMENT, V131, P2247, DOI 10.1242/dev.01112; Miranti CK, 2002, NAT CELL BIOL, V4, pE83, DOI 10.1038/ncb0402-e83; Murray P, 2001, J CELL SCI, V114, P931; Parsons JT, 2000, ONCOGENE, V19, P5606, DOI 10.1038/sj.onc.1203877; Plante BJ, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-15; Ramathal C, 2010, MOL CELL BIOL, V30, P1607, DOI 10.1128/MCB.00872-09; Ramathal CY, 2010, SEMIN REPROD MED, V28, P17, DOI 10.1055/s-0029-1242989; Rasband Wayne, 2010, IMAGEJ; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pW249, DOI 10.1093/nar/gkh372; Schug Jonathan, 2008, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0206s21; SENIOR PV, 1988, DEVELOPMENT, V104, P431; Smyth N, 1999, J CELL BIOL, V144, P151, DOI 10.1083/jcb.144.1.151; SUTHERLAND AE, 1988, J CELL BIOL, V106, P1331, DOI 10.1083/jcb.106.4.1331; TIMPL R, 1994, MATRIX BIOL, V14, P275, DOI 10.1016/0945-053X(94)90192-9; Timpl R, 1996, BIOESSAYS, V18, P123, DOI 10.1002/bies.950180208; UTANI A, 1994, J BIOL CHEM, V269, P19167; Wang W, 2010, ENDOCRINOLOGY, V151, P3929, DOI 10.1210/en.2009-1437; WEWER UM, 1985, LAB INVEST, V53, P624; Yurchenco PD, 1997, P NATL ACAD SCI USA, V94, P10189, DOI 10.1073/pnas.94.19.10189; Zhang JW, 2004, P NATL ACAD SCI USA, V101, P43, DOI 10.1073/pnas.0307229101	47	22	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19860	19871		10.1074/jbc.M110.191759	http://dx.doi.org/10.1074/jbc.M110.191759			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21471197	Green Published, hybrid			2022-12-25	WOS:000291027700066
J	Sheng, JZ; Liu, RP; Xu, YM; Liu, J				Sheng, Juzheng; Liu, Renpeng; Xu, Yongmei; Liu, Jian			The Dominating Role of N-Deacetylase/N-Sulfotransferase 1 in Forming Domain Structures in Heparan Sulfate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOSYNTHESIS; SPECIFICITY; EXPRESSION; MEMBER	Heparan sulfate (HS) is a highly sulfated polysaccharide participated in essential physiological functions from regulating cell growth to blood coagulation. HS contains sulfated domains known as N-S domains and low sulfate domains known as N-Ac domains. The distribution of the domain structures is likely governed by the action of glucosaminyl N-deacetylase/N-sulfotransferase (NDST). Here, we sought to determine the substrate specificity of NDST using model substrates and recombinant NDST protein. We discovered that NDST-1 carries out the modification in a highly ordered fashion. The enzyme sulfates the substrate from the nonreducing end toward the reducing end consecutively, leading to the product with a cluster of N-sulfo glucosamine residues. Furthermore, a preexisting N-sulfo glucosamine residue prevents the action of NDST-1 at the residues immediately located at the nonreducing end, allowing the formation of an N-Ac domain. Our results provide the long sought evidence for understanding the formation of sulfated versus nonsulfated domains in the HS isolated from cells and tissues. The study demonstrates the regulating role of NDST-1 in mapping the sulfation patterns of HS.	[Sheng, Juzheng; Liu, Renpeng; Xu, Yongmei; Liu, Jian] Univ N Carolina, Div Med Chem & Nat Prod, Eshelman Sch Pharm, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Liu, J (corresponding author), Univ N Carolina, Div Med Chem & Nat Prod, Eshelman Sch Pharm, Rm 303,Beard Hall, Chapel Hill, NC 27599 USA.	jian_liu@unc.edu	Sheng, Juzheng/G-2693-2013; Liu, Renpeng/G-1625-2011	Sheng, Juzheng/0000-0003-2856-9162; 	National Institutes of Health [AI50050, HL094463, HL096972, AI074775]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096972, R01HL094463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050050, R21AI074775] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI50050, HL094463, HL096972, and AI074775.	Aikawa J, 1999, J BIOL CHEM, V274, P2690, DOI 10.1074/jbc.274.5.2690; Aikawa J, 2001, J BIOL CHEM, V276, P5876, DOI 10.1074/jbc.M009606200; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Carlsson P, 2008, J BIOL CHEM, V283, P20008, DOI 10.1074/jbc.M801652200; Chen J, 2007, CHEM BIOL, V14, P986, DOI 10.1016/j.chembiol.2007.07.015; Chen M, 2006, BIOCHEMISTRY-US, V45, P12358, DOI 10.1021/bi060844g; Crawford BE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010691; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; Duncan MB, 2006, BIOCHEM BIOPH RES CO, V339, P1232, DOI 10.1016/j.bbrc.2005.11.142; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Fan GP, 2000, FEBS LETT, V467, P7, DOI 10.1016/S0014-5793(00)01111-X; Forsberg E, 2001, J CLIN INVEST, V108, P175, DOI 10.1172/JCI13561; Fuster MM, 2007, J CELL BIOL, V177, P539, DOI 10.1083/jcb.200610086; Gama CI, 2006, NAT CHEM BIOL, V2, P467, DOI 10.1038/nchembio810; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Li JP, 2001, J BIOL CHEM, V276, P20069, DOI 10.1074/jbc.M011783200; Liu RP, 2010, J BIOL CHEM, V285, P34240, DOI 10.1074/jbc.M110.159152; MacArthur JM, 2007, J CLIN INVEST, V117, P153, DOI 10.1172/JCI29154; Murphy KJ, 2004, J BIOL CHEM, V279, P27239, DOI 10.1074/jbc.M401774200; Pallerla SR, 2008, J BIOL CHEM, V283, P16885, DOI 10.1074/jbc.M709774200; Peterson S, 2009, NAT PROD REP, V26, P610, DOI 10.1039/b803795g; Presto J, 2008, P NATL ACAD SCI USA, V105, P4751, DOI 10.1073/pnas.0705807105; Rong JH, 2001, BIOCHEMISTRY-US, V40, P5548, DOI 10.1021/bi002926p; Saribas AS, 2004, GLYCOBIOLOGY, V14, P1217, DOI 10.1093/glycob/cwh129; Sigulinsky C, 2010, CARBOHYD RES, V345, P250, DOI 10.1016/j.carres.2009.10.024; Sismey-Ragatz AE, 2007, J BIOL CHEM, V282, P28321, DOI 10.1074/jbc.M701599200; Staples GO, 2010, J BIOL CHEM, V285, P18336, DOI 10.1074/jbc.M110.101592; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233	28	55	56	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19768	19776		10.1074/jbc.M111.224311	http://dx.doi.org/10.1074/jbc.M111.224311			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21454625	Green Published, hybrid			2022-12-25	WOS:000291027700059
J	Verhoog, NJD; Du Toit, A; Avenant, C; Hapgood, JP				Verhoog, Nicolette J. D.; Du Toit, Andrea; Avenant, Chanel; Hapgood, Janet P.			Glucocorticoid-independent Repression of Tumor Necrosis Factor (TNF) alpha-stimulated Interleukin (IL)-6 Expression by the Glucocorticoid Receptor A POTENTIAL MECHANISM FOR PROTECTION AGAINST AN EXCESSIVE INFLAMMATORY RESPONSE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; CREB-BINDING-PROTEIN; FEMALE GENITAL-TRACT; ESTROGEN-RECEPTOR; PROGESTERONE-RECEPTOR; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; CROSS-TALK; TRANSCRIPTIONAL ACTIVITY; ANTIINFLAMMATORY ACTION	TNF alpha signaling and cytokine levels play a crucial role in cervical immunity and the host response to infections. We investigated the role of liganded and unliganded glucocorticoid receptor (GR) in IL-6 and IL-8 gene regulation in response to TNF alpha in the End1/E6E7 immortalized human endocervical epithelial cell line. In the absence of glucocorticoids, both decreasing GR protein levels by an siRNA strategy and results with the GR antagonist RU486 suggest a role for the unliganded GR in reduction of TNF alpha-induced IL-6 and IL-8 mRNA levels in End1/E6E7 cells. Moreover, GR-dependent repression of endogenous IL-6 mRNA as well as a minimal IL-6 promoter-reporter gene is also demonstrated in COS-1 cells in the absence of GR ligand, suggesting a transcriptional mechanism that is not cell-specific. TNF alpha induced recruitment of both the unliganded GR and GR-interacting protein type 1 (GRIP-1) to the IL-6 promoter. This, together with GRIP-1 overexpression studies, suggests a function for GRIP-1 as a GR co-repressor in this context. TNF alpha was shown to induce phosphorylation of the unliganded human GR at Ser-226 but not Ser-211, unlike dexamethasone, which induced hyperphosphorylation at both serine residues. Ser-226 is shown to be required for the ligand-independent GR-mediated repression of IL-6 in response to TNF alpha. Taken together, these results support a model whereby the unliganded GR attenuates TNF alpha-stimulated IL-6 transcription by a mechanism involving selective phosphorylation and recruitment of the unliganded GR and GRIP-1 to the IL-6 promoter. These findings suggest the presence of a novel autoregulatory mechanism that may prevent overproduction of IL-6 in the endocervix, possibly protecting against negative effects of excessive inflammation.	[Verhoog, Nicolette J. D.; Du Toit, Andrea; Avenant, Chanel; Hapgood, Janet P.] Univ Cape Town, Dept Mol & Cell Biol, ZA-7701 Rondebosch, South Africa	University of Cape Town	Hapgood, JP (corresponding author), Univ Cape Town, Dept Mol & Cell Biol, Private Bag X3, ZA-7701 Rondebosch, South Africa.	Janet.Hapgood@uct.ac.za	Hapgood, Janet P/P-2549-2018	Hapgood, Janet P/0000-0002-4414-4861; Verhoog, Nicolette/0000-0002-3786-6452				Adcock IM, 2001, IMMUNOL CELL BIOL, V79, P376, DOI 10.1046/j.1440-1711.2001.01025.x; An BS, 2006, J BIOL CHEM, V281, P20817, DOI 10.1074/jbc.M600743200; Avenant C, 2010, BIOCHEMISTRY-US, V49, P972, DOI 10.1021/bi901956s; BARCLAY CG, 1993, AM J OBSTET GYNECOL, V169, P625, DOI 10.1016/0002-9378(93)90634-U; Beck IME, 2009, ENDOCR REV, V30, P830, DOI 10.1210/er.2009-0013; Brogan IJ, 1999, MOL CELL ENDOCRINOL, V157, P95, DOI 10.1016/S0303-7207(99)00156-2; Bruna A, 2003, EMBO J, V22, P6035, DOI 10.1093/emboj/cdg590; Bunone G, 1996, EMBO J, V15, P2174, DOI 10.1002/j.1460-2075.1996.tb00571.x; Cadepond F, 1997, ANNU REV MED, V48, P129; CALDENHOVEN E, 1995, MOL ENDOCRINOL, V9, P401, DOI 10.1210/me.9.4.401; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; CROMWELL O, 1992, IMMUNOLOGY, V77, P330; Cvoro A, 2006, MOL CELL, V21, P555, DOI 10.1016/j.molcel.2006.01.014; De Bosscher K, 2000, J NEUROIMMUNOL, V109, P16, DOI 10.1016/S0165-5728(00)00297-6; De Bosscher K, 2006, ONCOGENE, V25, P6868, DOI 10.1038/sj.onc.1209935; De Bosscher K, 2001, MOL ENDOCRINOL, V15, P219, DOI 10.1210/me.15.2.219; De Bosscher K, 2009, MOL ENDOCRINOL, V23, P281, DOI 10.1210/me.2008-0283; Deblois G, 2003, J STEROID BIOCHEM, V85, P123, DOI 10.1016/S0960-0760(03)00225-5; DeBosscher K, 1997, P NATL ACAD SCI USA, V94, P13504, DOI 10.1073/pnas.94.25.13504; Dutertre M, 2003, MOL ENDOCRINOL, V17, P1296, DOI 10.1210/me.2001-0316; Eickelberg O, 1999, J BIOL CHEM, V274, P1005, DOI 10.1074/jbc.274.2.1005; ElTanani MKK, 1997, MOL ENDOCRINOL, V11, P928, DOI 10.1210/me.11.7.928; Fichorova RN, 1999, BIOL REPROD, V60, P508, DOI 10.1095/biolreprod60.2.508; Fichorova RN, 2004, BIOL REPROD, V71, P761, DOI 10.1095/biolreprod.104.029603; Fichorova RN, 1997, BIOL REPROD, V57, P847, DOI 10.1095/biolreprod57.4.847; Fichorova RN, 2001, INFECT IMMUN, V69, P5840, DOI 10.1128/IAI.69.9.5840-5848.2001; Griekspoor A., 2007, NUCL RECEPT SIGNAL, V9, pE003, DOI DOI 10.1621/NRS.05003; Herbein G, 2008, TRENDS IMMUNOL, V29, P61, DOI 10.1016/j.it.2007.10.008; HIRANO T, 1990, IMMUNOL TODAY, V11, P443, DOI 10.1016/0167-5699(90)90173-7; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; IGLESIAS M, 1995, AM J PATHOL, V146, P944; Ismaili N, 2004, ANN NY ACAD SCI, V1024, P86, DOI 10.1196/annals.1321.007; JONAT C, 1990, CELL, V62, P1189, DOI 10.1016/0092-8674(90)90395-U; Jones RL, 2005, HUM REPROD, V20, P2724, DOI 10.1093/humrep/dei140; Kalkhoven E, 1996, J BIOL CHEM, V271, P6217, DOI 10.1074/jbc.271.11.6217; Kaushic C, 2010, AM J REPROD IMMUNOL, V63, P566, DOI 10.1111/j.1600-0897.2010.00843.x; KISHIMOTO T, 1989, BLOOD, V74, P1, DOI 10.1182/blood.V74.1.1.1; Kotitschke A, 2009, MOL ENDOCRINOL, V23, P1726, DOI 10.1210/me.2008-0462; Koubovec D, 2004, MOL CELL ENDOCRINOL, V221, P75, DOI 10.1016/j.mce.2004.03.006; Lavinsky RM, 1998, P NATL ACAD SCI USA, V95, P2920, DOI 10.1073/pnas.95.6.2920; Lee SY, 1997, IMMUNITY, V7, P703, DOI 10.1016/S1074-7613(00)80390-8; Lin HM, 2002, J BIOL CHEM, V277, P28733, DOI 10.1074/jbc.M203380200; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Ma H, 2003, METHOD ENZYMOL, V364, P284; MALEJCZYK J, 1991, CELL IMMUNOL, V136, P155, DOI 10.1016/0008-8749(91)90390-W; McKay LI, 2000, MOL ENDOCRINOL, V14, P1222, DOI 10.1210/me.14.8.1222; McKenna NJ, 2002, ENDOCRINOLOGY, V143, P2461, DOI 10.1210/endo.143.7.8892; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; Miller CJ, 2003, MICROBES INFECT, V5, P59, DOI 10.1016/S1286-4579(02)00056-4; Natoli G, 1997, SCIENCE, V275, P200, DOI 10.1126/science.275.5297.200; Nazli A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000852; Newton R, 2000, THORAX, V55, P603, DOI 10.1136/thorax.55.7.603; NG SB, 1994, J BIOL CHEM, V269, P19021; Nissen RM, 2000, GENE DEV, V14, P2314, DOI 10.1101/gad.827900; Oakeshott P, 2003, INT J STD AIDS, V14, P289, DOI 10.1258/095646203321264962; PARTRIDGE M, 1991, J INVEST DERMATOL, V96, P771, DOI 10.1111/1523-1747.ep12471723; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PICARD D, 1990, CELL REGUL, V1, P291, DOI 10.1091/mbc.1.3.291; Pierson-Mullany LK, 2004, MOL CELL BIOL, V24, P10542, DOI 10.1128/MCB.24.24.10542-10557.2004; Plaisance S, 1997, MOL CELL BIOL, V17, P3733, DOI 10.1128/MCB.17.7.3733; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Rasmussen SJ, 1997, J CLIN INVEST, V99, P77, DOI 10.1172/JCI119136; RAY A, 1994, P NATL ACAD SCI USA, V91, P752, DOI 10.1073/pnas.91.2.752; Reichardt HM, 2001, EMBO J, V20, P7168, DOI 10.1093/emboj/20.24.7168; Reinhard C, 1997, EMBO J, V16, P1080, DOI 10.1093/emboj/16.5.1080; Rogatsky I, 2002, P NATL ACAD SCI USA, V99, P16701, DOI 10.1073/pnas.262671599; Rogatsky I, 2001, EMBO J, V20, P6071, DOI 10.1093/emboj/20.21.6071; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; Rowan BG, 2000, MOL CELL BIOL, V20, P8720, DOI 10.1128/MCB.20.23.8720-8730.2000; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sarabdjitsingh RA, 2010, BRAIN RES, V1331, P1, DOI 10.1016/j.brainres.2010.03.052; SCHEINMAN RI, 1995, MOL CELL BIOL, V15, P943; SMITH CL, 1993, P NATL ACAD SCI USA, V90, P6120, DOI 10.1073/pnas.90.13.6120; Tanaka H, 1996, J IMMUNOL, V156, P1601; Tremblay A, 2001, J STEROID BIOCHEM, V77, P19, DOI 10.1016/S0960-0760(01)00031-0; Trifonova RT, 2009, ANTIMICROB AGENTS CH, V53, P1490, DOI 10.1128/AAC.01152-08; Ueda T, 2002, J BIOL CHEM, V277, P38087, DOI 10.1074/jbc.M203313200; Ueda T, 2002, J BIOL CHEM, V277, P7076, DOI 10.1074/jbc.M108255200; Vanden Berghe W, 1998, J BIOL CHEM, V273, P3285, DOI 10.1074/jbc.273.6.3285; Vanden Berghe W, 1999, J BIOL CHEM, V274, P32091, DOI 10.1074/jbc.274.45.32091; Vanden Berghe W, 2006, CANCER RES, V66, P4852, DOI 10.1158/0008-5472.CAN-05-2957; Weigel Nancy L, 2007, Nucl Recept Signal, V5, pe005; Wira CR, 2005, IMMUNOL REV, V206, P306, DOI 10.1111/j.0105-2896.2005.00287.x; WOODWORTH CD, 1993, AM J PATHOL, V142, P1544; YOSHIZAKI K, 1990, Cytokine, V2, P381, DOI 10.1016/1043-4666(90)90069-6; Yu C, 2005, J BIOL CHEM, V280, P13600, DOI 10.1074/jbc.M409468200; ZHANG Y, 1990, MOL CELL BIOL, V10, P3818, DOI 10.1128/MCB.10.7.3818; Zhou JG, 2005, STEROIDS, V70, P407, DOI 10.1016/j.steroids.2005.02.006; Zwijsen RML, 1998, GENE DEV, V12, P3488, DOI 10.1101/gad.12.22.3488	90	38	41	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19297	19310		10.1074/jbc.M110.193672	http://dx.doi.org/10.1074/jbc.M110.193672			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21474440	Green Published, hybrid			2022-12-25	WOS:000291027700012
J	Naik, RJ; Chandra, P; Mann, A; Ganguli, M				Naik, Rangeetha J.; Chandra, Pallavi; Mann, Anita; Ganguli, Munia			Exogenous and Cell Surface Glycosaminoglycans Alter DNA Delivery Efficiency of Arginine and Lysine Homopeptides in Distinctly Different Ways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; MEMBRANE-ASSOCIATED PROTEOGLYCANS; PROTEIN TRANSDUCTION DOMAINS; MEDIATED GENE-TRANSFER; PENETRATING PEPTIDES; RICH PEPTIDES; EXTRACELLULAR GLYCOSAMINOGLYCANS; INTERNALIZATION MECHANISMS; TAT PROTEIN; IN-VITRO	Glycosaminoglycans (GAGs) expressed ubiquitously on the cell surface are known to interact with a variety of ligands to mediate different cellular processes. However, their role in the internalization of cationic gene delivery vectors such as liposomes, polymers, and peptides is still ambiguous and seems to be controlled by multiple factors. In this report, taking peptides as model systems, we show that peptide chemistry is one of the key factors that determine the dependence on cell surface glycosaminoglycans for cellular internalization and gene delivery. Arginine peptides and their complexes with plasmid DNA show efficient uptake and functional gene transfer independent of the cell surface GAGs. On the other hand, lysine peptides and complexes primarily enter through a GAG-dependent pathway. The peptide-DNA complexes also show differential interaction with soluble GAGs. In the presence of exogenous GAGs under certain conditions, arginine peptide-DNA complexes show increased transfection efficiency that is not observed with lysine. This is attributed to a change in the complex nature that ensures better protection of the compacted DNA in the case of arginine complexes, whereas the lysine complexes get destabilized under these conditions. The presence of a GAG coating also ensures better cell association of arginine complexes, resulting in increased uptake. Our results indicate that the role of both the cell surface and exogenous glycosaminoglycans in gene delivery is controlled by the nature of the peptide and its complex with DNA.	[Ganguli, Munia] Inst Genom & Integrat Biol, Lab 203, Delhi 110007, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Ganguli, M (corresponding author), Inst Genom & Integrat Biol, Lab 203, Mall Rd,Jubilee Hall, Delhi 110007, India.	mganguli@igib.res.in	Mann, Anita/B-6756-2014; Mann, Anita/GQP-9814-2022	Mann, Anita/0000-0002-8368-4262; 	Council of Scientific and Industrial Research, Government of India [NWP35]; Department of Biotechnology, Government of India; Council of Scientific and Industrial Research	Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the Council of Scientific and Industrial Research, Government of India (Project NWP35).; Recipients of fellowships from Department of Biotechnology, Government of India and Council of Scientific and Industrial Research.	Belting M, 1999, BIOCHEM J, V342, P281, DOI 10.1042/0264-6021:3420281; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Burke RS, 2008, BIOCONJUGATE CHEM, V19, P693, DOI 10.1021/bc700388u; Chen Y, 2008, MOL CELLS, V26, P415; Console S, 2003, J BIOL CHEM, V278, P35109, DOI 10.1074/jbc.M301726200; Duchardt F, 2007, TRAFFIC, V8, P848, DOI 10.1111/j.1600-0854.2007.00572.x; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; FROMM JR, 1995, ARCH BIOCHEM BIOPHYS, V323, P279, DOI 10.1006/abbi.1995.9963; Fuchs SM, 2004, BIOCHEMISTRY-US, V43, P2438, DOI 10.1021/bi035933x; Futaki S, 2007, BIOCHEM SOC T, V35, P784, DOI 10.1042/BST0350784; Gump JM, 2010, J BIOL CHEM, V285, P1500, DOI 10.1074/jbc.M109.021964; Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#; Jiao CY, 2009, J BIOL CHEM, V284, P33957, DOI 10.1074/jbc.M109.056309; Kosuge M, 2008, BIOCONJUGATE CHEM, V19, P656, DOI 10.1021/bc700289w; Lundberg M, 2003, MOL THER, V8, P143, DOI 10.1016/S1525-0016(03)00135-7; Mann A, 2008, DRUG DISCOV TODAY, V13, P152, DOI 10.1016/j.drudis.2007.11.008; Martin ME, 2007, AAPS J, V9, pE18, DOI 10.1208/aapsj0901003; Mislick KA, 1996, P NATL ACAD SCI USA, V93, P12349, DOI 10.1073/pnas.93.22.12349; Mitchell DJ, 2000, J PEPT RES, V56, P318, DOI 10.1034/j.1399-3011.2000.00723.x; Mounkes LC, 1998, J BIOL CHEM, V273, P26164, DOI 10.1074/jbc.273.40.26164; Nakase I, 2008, ADV DRUG DELIVER REV, V60, P598, DOI 10.1016/j.addr.2007.10.006; Nakase I, 2007, BIOCHEMISTRY-US, V46, P492, DOI 10.1021/bi0612824; Poon GMK, 2007, BIOCHEM SOC T, V35, P788, DOI 10.1042/BST0350788; Richard JP, 2005, J BIOL CHEM, V280, P15300, DOI 10.1074/jbc.M401604200; Richard JP, 2003, J BIOL CHEM, V278, P585, DOI 10.1074/jbc.M209548200; Rothbard JB, 2005, ADV DRUG DELIVER REV, V57, P495, DOI 10.1016/j.addr.2004.10.003; Ruponen M, 2001, J BIOL CHEM, V276, P33875, DOI 10.1074/jbc.M011553200; Ruponen M, 1999, BBA-BIOMEMBRANES, V1415, P331, DOI 10.1016/S0005-2736(98)00199-0; Ruponen M, 2004, J GENE MED, V6, P405, DOI 10.1002/jgm.522; Rusnati M, 1997, J BIOL CHEM, V272, P11313, DOI 10.1074/jbc.272.17.11313; Sandgren S, 2002, J BIOL CHEM, V277, P38877, DOI 10.1074/jbc.M205395200; Summerford C, 1998, J VIROL, V72, P1438, DOI 10.1128/JVI.72.2.1438-1445.1998; Tyagi M, 2001, J BIOL CHEM, V276, P3254, DOI 10.1074/jbc.M006701200; Verrecchio A, 2000, J BIOL CHEM, V275, P7701, DOI 10.1074/jbc.275.11.7701; Zelphati O, 1996, P NATL ACAD SCI USA, V93, P11493, DOI 10.1073/pnas.93.21.11493	35	44	44	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18982	18993		10.1074/jbc.M111.227793	http://dx.doi.org/10.1074/jbc.M111.227793			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21471199	hybrid, Green Published			2022-12-25	WOS:000290785700069
J	Henderson, A; Erales, J; Hoyt, MA; Coffino, P				Henderson, Allen; Erales, Jenny; Hoyt, Martin A.; Coffino, Philip			Dependence of Proteasome Processing Rate on Substrate Unfolding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							26 S PROTEASOME; MULTIUBIQUITIN-CHAIN-BINDING; ORNITHINE-DECARBOXYLASE; DIHYDROFOLATE-REDUCTASE; DEGRADATION MACHINE; SACCHAROMYCES-CEREVISIAE; MECHANICAL STABILITY; STRUCTURAL ELEMENTS; PROTEIN; CLPXP	Protein degradation by eukaryotic proteasomes is a multi-step process involving substrate recognition, ATP-dependent unfolding, translocation into the proteolytic core particle, and finally proteolysis. To date, most investigations of proteasome function have focused on the first and the last steps in this process. Here we examine the relationship between the stability of a folded protein domain and its degradation rate. Test proteins were targeted to the proteasome independently of ubiquitination by directly tethering them to the protease. Degradation kinetics were compared for test protein pairs whose stability was altered by either point mutation or ligand binding, but were otherwise identical. In both intact cells and in reactions using purified proteasomes and substrates, increased substrate stability led to an increase in substrate turnover time. The steady-state time for degradation ranged from similar to 5 min (dihydrofolate reductase) to 40 min (I27 domain of titin). ATP turnover was 110/min./proteasome, and was not markedly changed by substrate. Proteasomes engage tightly folded substrates in multiple iterative rounds of ATP hydrolysis, a process that can be rate-limiting for degradation.	[Henderson, Allen; Erales, Jenny; Hoyt, Martin A.; Coffino, Philip] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94127 USA	University of California System; University of California San Francisco	Coffino, P (corresponding author), 513 Parnassus Ave,Room S-430, San Francisco, CA 94143 USA.	Philip.Coffino@ucsf.edu		Coffino, Philip/0000-0003-0344-5083	National Institutes of Health [GM45335, GM074760, 5T32 CA09043]; NATIONAL CANCER INSTITUTE [T32CA009043] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045335, R01GM074760] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM45335 and GM074760 (to P. C.) and National Institutes of Health Training Grant 5T32 CA09043 (to A. H.).	Ainavarapu RK, 2005, BIOPHYS J, V89, P3337, DOI 10.1529/biophysj.105.062034; Babbitt SE, 2005, CELL, V121, P553, DOI 10.1016/j.cell.2005.03.028; Bajorek M, 2004, CELL MOL LIFE SCI, V61, P1579, DOI 10.1007/s00018-004-4131-y; Burton RE, 2001, EMBO J, V20, P3092, DOI 10.1093/emboj/20.12.3092; Chen H, 2002, J BIOL CHEM, V277, P45957, DOI 10.1074/jbc.M206799200; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; EILERS M, 1986, NATURE, V322, P228, DOI 10.1038/322228a0; Elsasser S, 2005, METHOD ENZYMOL, V398, P353, DOI 10.1016/S0076-6879(05)98029-4; Elsasser S, 2004, J BIOL CHEM, V279, P26817, DOI 10.1074/jbc.M404020200; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Fowler SB, 2001, STRUCTURE, V9, P355, DOI 10.1016/S0969-2126(01)00596-2; Fowler SB, 2002, J MOL BIOL, V322, P841, DOI 10.1016/S0022-2836(02)00805-7; Fu HY, 1998, J BIOL CHEM, V273, P1970, DOI 10.1074/jbc.273.4.1970; GHODA L, 1989, SCIENCE, V243, P1493, DOI 10.1126/science.2928784; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Hoffman L, 1996, J BIOL CHEM, V271, P32538, DOI 10.1074/jbc.271.51.32538; Hoskins JR, 2000, P NATL ACAD SCI USA, V97, P8892, DOI 10.1073/pnas.97.16.8892; Hoyt MA, 2004, CELL MOL LIFE SCI, V61, P1596, DOI 10.1007/s00018-004-4133-9; Hoyt MA, 2003, J BIOL CHEM, V278, P12135, DOI 10.1074/jbc.M211802200; Hoyt MA, 2006, EMBO J, V25, P1720, DOI 10.1038/sj.emboj.7601058; JOHNSTON JA, 1995, J BIOL CHEM, V270, P8172, DOI 10.1074/jbc.270.14.8172; Kenniston JA, 2003, CELL, V114, P511, DOI 10.1016/S0092-8674(03)00612-3; Kenniston JA, 2005, P NATL ACAD SCI USA, V102, P1390, DOI 10.1073/pnas.0409634102; Kim YI, 2000, MOL CELL, V5, P639, DOI 10.1016/S1097-2765(00)80243-9; Klingenberg O, 1996, BIOCHEM J, V313, P647, DOI 10.1042/bj3130647; Koodathingal P, 2009, J BIOL CHEM, V284, P18674, DOI 10.1074/jbc.M900783200; Lam YA, 2002, NATURE, V416, P763, DOI 10.1038/416763a; Lee C, 2001, MOL CELL, V7, P627, DOI 10.1016/S1097-2765(01)00209-X; Li HB, 2000, P NATL ACAD SCI USA, V97, P6527, DOI 10.1073/pnas.120048697; Li HB, 2000, NAT STRUCT BIOL, V7, P1117; Li H, 2007, ORG BIOMOL CHEM, V5, P3399, DOI 10.1039/b710321m; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; NORBY JG, 1988, METHOD ENZYMOL, V156, P116; Peth A, 2010, MOL CELL, V40, P671, DOI 10.1016/j.molcel.2010.11.002; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Salvador N, 2000, J BIOL CHEM, V275, P27447; Sears C, 1998, J BIOL CHEM, V273, P1409, DOI 10.1074/jbc.273.3.1409; Shin Y, 2009, P NATL ACAD SCI USA, V106, P19340, DOI 10.1073/pnas.0910484106; Singh SK, 2000, P NATL ACAD SCI USA, V97, P8898, DOI 10.1073/pnas.97.16.8898; Sone T, 2004, J BIOL CHEM, V279, P28807, DOI 10.1074/jbc.M403165200; Takeuchi J, 2008, BIOCHEM J, V410, P401, DOI 10.1042/BJ20071239; Takeuchi J, 2007, EMBO J, V26, P123, DOI 10.1038/sj.emboj.7601476; Thompson D, 2009, J BIOL CHEM, V284, P24891, DOI 10.1074/jbc.M109.023218; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; vanNocker S, 1996, MOL CELL BIOL, V16, P6020; Verma R, 2000, CELL, V101, P341, DOI 10.1016/S0092-8674(00)80843-0; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Zhang MS, 2004, J BIOL CHEM, V279, P20959, DOI 10.1074/jbc.M314043200; Zhang MS, 2004, J BIOL CHEM, V279, P8635, DOI 10.1074/jbc.M310449200	52	35	35	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17495	17502		10.1074/jbc.M110.212027	http://dx.doi.org/10.1074/jbc.M110.212027			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454622	Green Published, hybrid			2022-12-25	WOS:000290585200011
J	Le Pennec, S; Mirebeau-Prunier, D; Boutet-Bouzamondo, N; Jacques, C; Guillotin, D; Lauret, E; Houlgatte, R; Malthiery, Y; Savagner, F				Le Pennec, Soazig; Mirebeau-Prunier, Delphine; Boutet-Bouzamondo, Nathalie; Jacques, Caroline; Guillotin, Delphine; Lauret, Emilie; Houlgatte, Remi; Malthiery, Yves; Savagner, Frederique			Nitric Oxide and Calcium Participate in the Fine Regulation of Mitochondrial Biogenesis in Follicular Thyroid Carcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; PGC-1-RELATED COACTIVATOR; SKELETAL-MUSCLE; GAMMA COACTIVATOR-1-ALPHA; INDUCIBLE COACTIVATOR; RESPIRATORY-CHAIN; RECEPTOR-ALPHA; EXPRESSION; TRANSCRIPTION; SYNTHASE	Members of the peroxisome proliferator-activated receptor gamma coactivator-1 family (i.e. PGC-1 alpha, PGC-1 beta, and the PGC-1-related coactivator (PRC)) are key regulators of mitochondrial biogenesis and function. These regulators serve as mediators between environmental or endogenous signals and the transcriptional machinery governing mitochondrial biogenesis. The FTC-133 and RO82 W-1 follicular thyroid carcinoma cell lines, which present significantly different numbers of mitochondria, metabolic mechanisms, and expression levels of PRC and PGC-1 alpha, may employ retrograde signaling in response to respiratory dysfunction. Nitric oxide (NO) and calcium have been hypothesized to participate in this activity. We investigated the effects of the S-nitroso-N-acetyl-DL-penicillamine-NO donor, on the expression of genes involved in mitochondrial biogenesis and cellular metabolic functions in FTC-133 and RO82 W-1 cells by measuring lactate dehydrogenase and cytochrome c oxidase (COX) activities. We studied the action of ionomycin and 1,2-bis(2-aminophenoxy)ethane-N, N, N', N'-tetraacetic acid-acetoxymethyl ester (BAPTA/AM) (i.e. a calcium ionophore and a cytosolic calcium chelator) on whole genome expression and mitochondrial biogenesis in RO82 W-1 cells. COX activity and the dynamics of endoplasmic reticulum and mitochondrial networks were analyzed in regard to calcium-modulating treatments. In the FTC-133 and RO82 W-1 cells, the mitochondrial biogenesis induced by NO was mainly related to PRC expression as a retrograde mitochondrial signaling. Ionomycin diminished COX activity and negatively regulated PRC-mediated mitochondrial biogenesis in RO82 W-1 cells, whereas BAPTA/AM produced the opposite effects with a reorganization of the mitochondrial network. This is the first demonstration that NO and calcium regulate mitochondrial biogenesis through the PRC pathway in thyroid cell lines.	[Savagner, Frederique] CHU Angers, INSERM, UMR 694, Biochim Lab, F-49033 Angers, France; [Le Pennec, Soazig; Mirebeau-Prunier, Delphine; Jacques, Caroline; Guillotin, Delphine; Lauret, Emilie; Malthiery, Yves; Savagner, Frederique] Univ Angers, F-49033 Angers, France; [Houlgatte, Remi; Savagner, Frederique] Inst Thorax, INSERM, UMR915, F-44007 Nantes, France; [Houlgatte, Remi] Univ Nantes, F-44035 Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Nantes Universite	Savagner, F (corresponding author), CHU Angers, INSERM, UMR 694, Biochim Lab, 4 Rue Larrey, F-49033 Angers, France.	frederique.savagner@univ-angers.fr	Prunier, Delphine/K-3301-2015; Houlgatte, Remi/P-3020-2017; LE PENNEC, Soazig/H-3817-2017	Guillotin, Delphine/0000-0002-2464-6848	Region Pays de la Loire (Ciblage Moleculare et Applications Therapeutiques)	Region Pays de la Loire (Ciblage Moleculare et Applications Therapeutiques)(Region Pays de la Loire)	This work was supported by grants from the Region Pays de la Loire (Ciblage Moleculare et Applications Therapeutiques).	Andersson U, 2001, MOL CELL BIOL, V21, P3738, DOI 10.1128/MCB.21.11.3738-3749.2001; Arnould T, 2002, EMBO J, V21, P53, DOI 10.1093/emboj/21.1.53; Bender E, 2000, FEBS LETT, V466, P130, DOI 10.1016/S0014-5793(99)01773-1; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Calderon-Cortes E, 2008, MITOCHONDRION, V8, P262, DOI 10.1016/j.mito.2008.04.005; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; CLEETER MWJ, 1994, FEBS LETT, V345, P50, DOI 10.1016/0014-5793(94)00424-2; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Freyssenet D, 2004, AM J PHYSIOL-CELL PH, V286, pC1053, DOI 10.1152/ajpcell.00418.2003; Gleyzer N, 2005, MOL CELL BIOL, V25, P1354, DOI 10.1128/MCB.25.4.1354-1366.2005; Guha M, 2010, BBA-BIOENERGETICS, V1797, P1055, DOI 10.1016/j.bbabio.2010.02.008; HARRIS DA, 1991, BIOCHEM J, V280, P561, DOI 10.1042/bj2800561; Irrcher I, 2003, AM J PHYSIOL-CELL PH, V284, pC1669, DOI 10.1152/ajpcell.00409.2002; Lopez-Rios F, 2007, CANCER RES, V67, P9013, DOI 10.1158/0008-5472.CAN-07-1678; McConell GK, 2010, J APPL PHYSIOL, V108, P589, DOI 10.1152/japplphysiol.00377.2009; Mercy L, 2005, FEBS J, V272, P5031, DOI 10.1111/j.1742-4658.2005.04913.x; Mirebeau-Prunier D, 2010, FEBS J, V277, P713, DOI 10.1111/j.1742-4658.2009.07516.x; Miyazaki T, 2003, J CELL BIOL, V160, P709, DOI 10.1083/jcb.200209098; Moncada S, 2006, J NEUROCHEM, V97, P1676, DOI 10.1111/j.1471-4159.2006.03988.x; MORENOSANCHEZ R, 1985, J BIOL CHEM, V260, P2554; Nisoli E, 2003, SCIENCE, V299, P896, DOI 10.1126/science.1079368; Nisoli E, 2004, P NATL ACAD SCI USA, V101, P16507, DOI 10.1073/pnas.0405432101; Ojuka EO, 2003, FASEB J, V17, P675, DOI 10.1096/fj.02-0951com; Ojuka EO, 2002, AM J PHYSIOL-ENDOC M, V283, pE1040, DOI 10.1152/ajpendo.00242.2002; Papa S, 1996, FEBS LETT, V379, P299, DOI 10.1016/0014-5793(95)01532-9; Perry CGR, 2010, J PHYSIOL-LONDON, V588, P4795, DOI 10.1113/jphysiol.2010.199448; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Raharijaona M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007964; Rustin P, 2004, METHOD ENZYMOL, V382, P81; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Soriano FX, 2006, DIABETES, V55, P1783, DOI 10.2337/db05-0509; Sumi D, 2003, P NATL ACAD SCI USA, V100, P14451, DOI 10.1073/pnas.2235590100; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vercauteren K, 2008, J BIOL CHEM, V283, P12102, DOI 10.1074/jbc.M710150200; Vercauteren K, 2006, MOL CELL BIOL, V26, P7409, DOI 10.1128/MCB.00585-06; Wu H, 2002, SCIENCE, V296, P349, DOI 10.1126/science.1071163; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28	38	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					18229	18239		10.1074/jbc.M110.217521	http://dx.doi.org/10.1074/jbc.M110.217521			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454643	hybrid, Green Published			2022-12-25	WOS:000290585200083
J	Orban, T; Palczewska, G; Palczewski, K				Orban, Tivadar; Palczewska, Grazyna; Palczewski, Krzysztof			Retinyl Ester Storage Particles (Retinosomes) from the Retinal Pigmented Epithelium Resemble Lipid Droplets in Other Tissues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIATION-RELATED PROTEIN; LEBER CONGENITAL AMAUROSIS; VISUAL CYCLE; ENDOPLASMIC-RETICULUM; MOUSE MODEL; VERTEBRATE RETINA; FATTY-ACID; CELLS; RPE65; ACYLTRANSFERASE	Levels of many hydrophobic cellular substances are tightly regulated because of their potential cytotoxicity. These compounds tend to self-aggregate in cytoplasmic storage depots termed lipid droplets/bodies that have well defined structures that contain additional components, including cholesterol and various proteins. Hydrophobic substances in these structures become mobilized in a specific and regulated manner as dictated by cellular requirements. Retinal pigmented epithelial cells in the eye produce retinyl ester-containing lipid droplets named retinosomes. These esters are mobilized to replenish the visual chromophore, 11-cis-retinal, and their storage ensures proper visual function despite fluctuations in dietary vitamin A intake. But it remains unclear whether retinosomes are structures specific to the eye or similar to lipid droplets in other organs/tissues that contain substances other than retinyl esters. Thus, we initially investigated the production of these lipid droplets in experimental cell lines expressing lecithin: retinol acyltransferase, a key enzyme involved in formation of retinyl ester-containing retinosomes from all-trans-retinol. We found that retinosomes and oleate-derived lipid droplets form and co-localize concomitantly, indicating their intrinsic structural similarities. Next, we isolated native retinosomes from bovine retinal pigmented epithelium and found that their protein and hydrophobic small molecular constituents were similar to those of lipid droplets reported for other experimental cell lines and tissues. These unexpected findings suggest a common mechanism for lipid droplet formation that exhibits broad chemical specificity for the hydrophobic substances being stored.	[Orban, Tivadar; Palczewski, Krzysztof] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Palczewska, Grazyna] Polgenix Inc, Cleveland, OH 44106 USA	Case Western Reserve University	Palczewski, K (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	kxp65@case.edu			National Institutes of Health [EY009339, EY021126, EY020715, P30 EY11373]; State of Ohio Department of Development [09-004]; Klaus Tschira Foundation, Heidelberg, Germany; NATIONAL EYE INSTITUTE [P30EY011373, R01EY009339, R24EY021126, R43EY020715] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of Ohio Department of Development; Klaus Tschira Foundation, Heidelberg, Germany; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY009339, EY021126, EY020715, and P30 EY11373. This work was also supported by TECH 09-004 from the State of Ohio Department of Development and Third Frontier Commission, European Life Scientist Organization sponsored by the Klaus Tschira Foundation, Heidelberg, Germany.	Atshaves BP, 2000, J BIOL CHEM, V275, P36852, DOI 10.1074/jbc.M003434200; Bartz R, 2007, J LIPID RES, V48, P837, DOI 10.1194/jlr.M600413-JLR200; Batten ML, 2005, PLOS MED, V2, P1177, DOI 10.1371/journal.pmed.0020333; Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; Beller M, 2010, FEBS LETT, V584, P2176, DOI 10.1016/j.febslet.2010.03.022; Bereta G, 2008, BIOCHEMISTRY-US, V47, P9856, DOI 10.1021/bi800905v; Binns D, 2006, J CELL BIOL, V173, P719, DOI 10.1083/jcb.200511125; Blaner WS, 2009, BBA-MOL CELL BIOL L, V1791, P467, DOI 10.1016/j.bbalip.2008.11.001; Blouin CM, 2010, J LIPID RES, V51, P945, DOI 10.1194/jlr.M001016; BOK D, 1993, J CELL SCI, P189; Bozza PT, 2009, BBA-MOL CELL BIOL L, V1791, P540, DOI 10.1016/j.bbalip.2009.01.005; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Brasaemle DL, 1997, J LIPID RES, V38, P2249; Brasaemle DL, 2000, J BIOL CHEM, V275, P38486, DOI 10.1074/jbc.M007322200; Brown DA, 2001, CURR BIOL, V11, pR446, DOI 10.1016/S0960-9822(01)00257-3; Cermelli S, 2006, CURR BIOL, V16, P1783, DOI 10.1016/j.cub.2006.07.062; CHRISTIANSEN K, 1972, BIOCHIM BIOPHYS ACTA, V260, P449, DOI 10.1016/0005-2760(72)90060-4; CUSHMAN SW, 1970, J CELL BIOL, V46, P326, DOI 10.1083/jcb.46.2.326; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; FLANNERY JG, 1990, EXP EYE RES, V51, P717, DOI 10.1016/0014-4835(90)90057-2; Golczak M, 2005, J BIOL CHEM, V280, P42263, DOI 10.1074/jbc.M509351200; Golczak M, 2005, P NATL ACAD SCI USA, V102, P8162, DOI 10.1073/pnas.0503318102; Golczak M, 2008, J BIOL CHEM, V283, P9543, DOI 10.1074/jbc.M708982200; Golczak M, 2010, J BIOL CHEM, V285, P9667, DOI 10.1074/jbc.M109.063941; Goodman JM, 2009, J LIPID RES, V50, P2148, DOI 10.1194/jlr.R001446; Guo XJ, 2000, CARCINOGENESIS, V21, P1925, DOI 10.1093/carcin/21.11.1925; Guo Y, 2009, J CELL SCI, V122, P749, DOI 10.1242/jcs.037630; HENAULT MA, 1993, ANAT REC, V237, P466, DOI 10.1002/ar.1092370405; Imanishi Y, 2004, J CELL BIOL, V166, P447, DOI 10.1083/jcb.200405110; Imanishi Y, 2004, J CELL BIOL, V164, P373, DOI 10.1083/jcb.200311079; Imanishi Y, 2008, J BIOL CHEM, V283, P25091, DOI 10.1074/jbc.M802981200; Imanishi Y, 2010, METHODS MOL BIOL, V652, P247, DOI 10.1007/978-1-60327-325-1_14; Jagerstrom S, 2009, CELL BIOL INT, V33, P934, DOI 10.1016/j.cellbi.2009.06.011; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jiang HF, 2007, BBA-MOL CELL BIOL L, V1771, P66, DOI 10.1016/j.bbalip.2006.10.004; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; KASURINEN J, 1992, BIOCHEM BIOPH RES CO, V187, P1594, DOI 10.1016/0006-291X(92)90485-4; Kevany BM, 2010, PHYSIOLOGY, V25, P8, DOI 10.1152/physiol.00038.2009; Kimmel AR, 2010, J LIPID RES, V51, P468, DOI 10.1194/jlr.R000034; Kiser PD, 2010, PROG RETIN EYE RES, V29, P428, DOI 10.1016/j.preteyeres.2010.03.002; Kuerschner L, 2008, TRAFFIC, V9, P338, DOI 10.1111/j.1600-0854.2007.00689.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lieber JG, 1996, J CELL SCI, V109, P3047; Liu PS, 2007, BBA-MOL CELL RES, V1773, P784, DOI 10.1016/j.bbamcr.2007.02.004; Londos C, 1999, SEMIN CELL DEV BIOL, V10, P51, DOI 10.1006/scdb.1998.0275; Londos C, 1999, ANN NY ACAD SCI, V892, P155, DOI 10.1111/j.1749-6632.1999.tb07794.x; Maeda A, 2006, BIOCHEMISTRY-US, V45, P4210, DOI 10.1021/bi052382x; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Mata NL, 2004, J BIOL CHEM, V279, P635, DOI 10.1074/jbc.M310042200; McBee JK, 2001, PROG RETIN EYE RES, V20, P469, DOI 10.1016/S1350-9462(01)00002-7; MCGOOKEY DJ, 1983, J CELL BIOL, V97, P1156, DOI 10.1083/jcb.97.4.1156; Moise AR, 2007, BIOCHEMISTRY-US, V46, P4449, DOI 10.1021/bi7003069; Moise AR, 2007, J BIOL CHEM, V282, P2081, DOI 10.1074/jbc.M608315200; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Moiseyev G, 2003, BIOCHEMISTRY-US, V42, P2229, DOI 10.1021/bi026911y; MORIWAKI H, 1988, J LIPID RES, V29, P1523; Palczewska G, 2010, NAT MED, V16, P1444, DOI 10.1038/nm.2260; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Palczewski K, 2010, TRENDS PHARMACOL SCI, V31, P284, DOI 10.1016/j.tips.2010.03.001; Ploegh HL, 2007, NATURE, V448, P435, DOI 10.1038/nature06004; Pol A, 2004, MOL BIOL CELL, V15, P99, DOI 10.1091/mbc.E03-06-0368; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Redmond TM, 2005, P NATL ACAD SCI USA, V102, P13658, DOI 10.1073/pnas.0504167102; Rinia HA, 2008, BIOPHYS J, V95, P4908, DOI 10.1529/biophysj.108.137737; Robenek MJ, 2004, FASEB J, V18, P866, DOI 10.1096/fj.03-0782fje; Russell TD, 2008, J LIPID RES, V49, P206, DOI 10.1194/jlr.M700396-JLR200; SAARI JC, 1988, J BIOL CHEM, V263, P8084; Stone SJ, 2009, J BIOL CHEM, V284, P5352, DOI 10.1074/jbc.M805768200; Tauchi-Sato K, 2002, J BIOL CHEM, V277, P44507, DOI 10.1074/jbc.M207712200; Travis GH, 2007, ANNU REV PHARMACOL, V47, P469, DOI 10.1146/annurev.pharmtox.47.120505.105225; Uhlenhuth E, 1916, J EXP MED, V24, P689, DOI 10.1084/jem.24.6.689; Van Hooser JP, 2000, P NATL ACAD SCI USA, V97, P8623, DOI 10.1073/pnas.150236297; Van Hooser JP, 2002, J BIOL CHEM, V277, P19173, DOI 10.1074/jbc.M112384200; von Lintig J, 2010, TRENDS BIOCHEM SCI, V35, P400, DOI 10.1016/j.tibs.2010.01.005; Wan HC, 2007, FASEB J, V21, P167, DOI 10.1096/fj.06-6711com; Wang HJ, 2010, MOL BIOL CELL, V21, P1991, DOI 10.1091/mbc.E09-05-0364; Wingerath T, 1997, ANAL CHEM, V69, P3855, DOI 10.1021/ac970463w; Wolins NE, 2001, J BIOL CHEM, V276, P5101, DOI 10.1074/jbc.M006775200; Wongsiriroj N, 2008, J BIOL CHEM, V283, P13510, DOI 10.1074/jbc.M800777200; Wu CC, 2000, ELECTROPHORESIS, V21, P3470, DOI 10.1002/1522-2683(20001001)21:16<3470::AID-ELPS3470>3.3.CO;2-7; Xie XS, 2006, SCIENCE, V312, P228, DOI 10.1126/science.1127566; Yamaguchi T, 2009, BBA-MOL CELL BIOL L, V1791, P519, DOI 10.1016/j.bbalip.2008.10.012	82	57	57	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17248	17258		10.1074/jbc.M110.195198	http://dx.doi.org/10.1074/jbc.M110.195198			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454509	hybrid, Green Published			2022-12-25	WOS:000290301900073
J	Jara-Oseguera, A; Ishida, IG; Rangel-Yescas, GE; Espinosa-Jalapa, N; Perez-Guzman, JA; Elias-Vinas, D; Le Lagadec, R; Rosenbaum, T; Islas, LD				Jara-Oseguera, Andres; Ishida, Itzel G.; Rangel-Yescas, Gisela E.; Espinosa-Jalapa, Noel; Perez-Guzman, Jose A.; Elias-Vinas, David; Le Lagadec, Ronan; Rosenbaum, Tamara; Islas, Leon D.			Uncoupling Charge Movement from Channel Opening in Voltage-gated Potassium Channels by Ruthenium Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHAKER K+ CHANNELS; GATING CURRENTS; CARBON-MONOXIDE; ION CHANNELS; ACTIVATION PATHWAY; SENSING DOMAINS; S4-S5 LINKER; PORE DOMAINS; KV CHANNELS; S5 SEGMENT	The Kv2.1 channel generates a delayed-rectifier current in neurons and is responsible for modulation of neuronal spike frequency and membrane repolarization in pancreatic beta-cells and cardiomyocytes. As with other tetrameric voltage-activated K+-channels, it has been proposed that each of the four Kv2.1 voltage-sensing domains activates independently upon depolarization, leading to a final concerted transition that causes channel opening. The mechanism by which voltage-sensor activation is coupled to the gating of the pore is still not understood. Here we show that the carbon-monoxide releasing molecule 2 (CORM-2) is an allosteric inhibitor of the Kv2.1 channel and that its inhibitory properties derive from the CORM-2 ability to largely reduce the voltage dependence of the opening transition, uncoupling voltage-sensor activation from the concerted opening transition. We additionally demonstrate that CORM-2 modulates Shaker K+-channels in a similar manner. Our data suggest that the mechanism of inhibition by CORM-2 may be common to voltage-activated channels and that this compound should be a useful tool for understanding the mechanisms of electromechanical coupling.	[Jara-Oseguera, Andres; Ishida, Itzel G.; Rangel-Yescas, Gisela E.; Islas, Leon D.] Univ Nacl Autonoma Mexico, Fac Med, Dept Fisiol, Mexico City 04510, DF, Mexico; [Espinosa-Jalapa, Noel; Le Lagadec, Ronan] Univ Nacl Autonoma Mexico, Inst Quim, Dept Quim Inorgan, Mexico City 04510, DF, Mexico; [Perez-Guzman, Jose A.; Elias-Vinas, David] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Div Neurociencias, Dept Neurodesarrollo & Fisiol, Mexico City 04510, DF, Mexico; [Rosenbaum, Tamara] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Secc Bioelect, Dept Ingn Elect, Mexico City 07360, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico	Islas, LD (corresponding author), Univ Nacl Autonoma Mexico, Fac Med, Dept Fisiol, Mexico City 04510, DF, Mexico.	islas@liceaga.facmed.unam.mx	Le Lagadec, Ronan/J-4035-2015; Islas, Leon D/AAW-9845-2020; Le Lagadec, Ronan/ABE-6445-2020	Le Lagadec, Ronan/0000-0002-5679-2081; Islas, Leon D/0000-0002-7461-5214; Rangel-Yescas, Gisela Edith/0000-0003-2766-6040; Rosenbaum, Tamara/0000-0002-4791-3195; Espinosa Jalapa, Noel Angel/0000-0003-2425-2707; Jara Oseguera, Andres/0000-0001-5921-9320	Consejo Nacional de Ciencia y Tecnologia [48990]; Direccion General de Asuntos del Personal Academico-PAPIIT [IN209209]; Instituto de Ciencia y Tecnologia del Distrito Federal [PIFUTP09-262]	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Direccion General de Asuntos del Personal Academico-PAPIIT; Instituto de Ciencia y Tecnologia del Distrito Federal	This study was supported by Consejo Nacional de Ciencia y Tecnologia Grant 48990, Direccion General de Asuntos del Personal Academico-PAPIIT Grant IN209209, and Instituto de Ciencia y Tecnologia del Distrito Federal Grant PIFUTP09-262 (to L. D. I.).	Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; Alabi AA, 2007, NATURE, V450, P370, DOI 10.1038/nature06266; ALESSIO E, 1995, INORG CHEM, V34, P4722, DOI 10.1021/ic00123a004; ALESSIO E, 1988, INORG CHEM, V27, P4099, DOI 10.1021/ic00296a006; ARMSTRONG CM, 1971, J GEN PHYSIOL, V58, P413, DOI 10.1085/jgp.58.4.413; Armstrong CM, 2001, BIOPHYS J, V81, P895, DOI 10.1016/S0006-3495(01)75749-9; Bezanilla F, 2005, IEEE T NANOBIOSCI, V4, P34, DOI 10.1109/TNB.2004.842463; BEZANILLA F, 1994, BIOPHYS J, V66, P1011, DOI 10.1016/S0006-3495(94)80882-3; Brindell M, 2007, EUR J INORG CHEM, P2353, DOI 10.1002/ejic.200600987; Caprini M, 2005, J BIOL CHEM, V280, P18253, DOI 10.1074/jbc.M413389200; Claydon TW, 2007, J PHARMACOL EXP THER, V320, P162, DOI 10.1124/jpet.106.110411; Duhovny D, 2002, LECT NOTES COMPUT SC, V2452, P185; EVANS IP, 1973, J CHEM SOC DALTON, P204, DOI 10.1039/dt9730000204; GOLDIN AL, 1992, METHOD ENZYMOL, V207, P266; HEINEMANN SH, 1992, METHOD ENZYMOL, V207, P131; Holmgren M, 1996, J GEN PHYSIOL, V108, P195, DOI 10.1085/jgp.108.3.195; Hou SW, 2008, P NATL ACAD SCI USA, V105, P4039, DOI 10.1073/pnas.0800304105; Islas LD, 1999, J GEN PHYSIOL, V114, P723, DOI 10.1085/jgp.114.5.723; Kanevsky M, 1999, J GEN PHYSIOL, V114, P215, DOI 10.1085/jgp.114.2.215; Khalili-Araghi F, 2010, BIOPHYS J, V98, P2189, DOI 10.1016/j.bpj.2010.02.056; Klemic KG, 1998, BIOPHYS J, V74, P1779, DOI 10.1016/S0006-3495(98)77888-9; Labro AJ, 2008, J GEN PHYSIOL, V132, P667, DOI 10.1085/jgp.200810048; Lai HC, 2005, NEURON, V47, P395, DOI 10.1016/j.neuron.2005.06.019; Ledwell JL, 1999, J GEN PHYSIOL, V113, P389, DOI 10.1085/jgp.113.3.389; Lee HC, 2003, NEURON, V40, P527, DOI 10.1016/S0896-6273(03)00636-6; Lee SY, 2009, PLOS BIOL, V7, P676, DOI 10.1371/journal.pbio.1000047; Li-Smerin YY, 2000, NEURON, V25, P411, DOI 10.1016/S0896-6273(00)80904-6; Li-Smerin YY, 2000, J GEN PHYSIOL, V115, P33, DOI 10.1085/jgp.115.1.33; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; LOPATIN AN, 1994, J GEN PHYSIOL, V103, P203, DOI 10.1085/jgp.103.2.203; Lu Z, 2001, NATURE, V413, P809, DOI 10.1038/35101535; Lu Z, 2002, J GEN PHYSIOL, V120, P663, DOI 10.1085/jgp.20028696; MacKinnon R, 1998, SCIENCE, V280, P106, DOI 10.1126/science.280.5360.106; Magidovich E, 2004, BIOCHEMISTRY-US, V43, P13242, DOI 10.1021/bi048377v; Motterlini R, 2002, CIRC RES, V90, pE17, DOI 10.1161/hh0202.104530; Muroi Y, 2009, J GEN PHYSIOL, V133, P1, DOI 10.1085/jgp.200810103; Pathak M, 2005, J GEN PHYSIOL, V125, P57, DOI 10.1085/jgp.200409197; PEROZO E, 1992, BIOPHYS J, V62, P160, DOI 10.1016/S0006-3495(92)81802-7; PEROZO E, 1993, NEURON, V11, P353, DOI 10.1016/0896-6273(93)90190-3; Phillips LR, 2005, NATURE, V436, P857, DOI 10.1038/nature03873; Rosenbaum T, 2002, NEURON, V33, P703, DOI 10.1016/S0896-6273(02)00599-8; Roux B, 2006, NEURON, V52, P568, DOI 10.1016/j.neuron.2006.11.002; Sack JT, 2006, J GEN PHYSIOL, V128, P119, DOI 10.1085/jgp.200609492; Sakmann B., 1995, SINGLE CHANNEL RECOR, P483; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Scholle A, 2004, J MEMBRANE BIOL, V198, P103, DOI 10.1007/s00232-004-0664-0; Schoppa NE, 1998, J GEN PHYSIOL, V111, P313, DOI 10.1085/jgp.111.2.313; Schoppa NE, 1998, J GEN PHYSIOL, V111, P271, DOI 10.1085/jgp.111.2.271; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; SHAO XM, 1993, NEURON, V11, P343, DOI 10.1016/0896-6273(93)90189-X; Shieh CC, 1997, J GEN PHYSIOL, V109, P767, DOI 10.1085/jgp.109.6.767; SIGG D, 1994, BIOPHYS J, V66, pA136; SIGWORTH FJ, 1992, METHOD ENZYMOL, V207, P746; SIGWORTH FJ, 1980, J PHYSIOL-LONDON, V307, P97, DOI 10.1113/jphysiol.1980.sp013426; Sigworth FJ, 2007, BIOPHYS J, V93, P2981, DOI 10.1529/biophysj.107.115741; Smith-Maxwell CJ, 1998, J GEN PHYSIOL, V111, P399, DOI 10.1085/jgp.111.3.399; Smith-Maxwell CJ, 1998, J GEN PHYSIOL, V111, P421, DOI 10.1085/jgp.111.3.421; Soler-Llavina GJ, 2006, NEURON, V52, P623, DOI 10.1016/j.neuron.2006.10.005; Sukhareva M, 2003, J GEN PHYSIOL, V122, P541, DOI 10.1085/jgp.200308905; Swartz KJ, 1997, NEURON, V18, P665, DOI 10.1016/S0896-6273(00)80306-2; TAGLIALATELA M, 1993, P NATL ACAD SCI USA, V90, P4758, DOI 10.1073/pnas.90.10.4758; Tao X, 2008, J MOL BIOL, V382, P24, DOI 10.1016/j.jmb.2008.06.085; Tombola F, 2006, ANNU REV CELL DEV BI, V22, P23, DOI 10.1146/annurev.cellbio.21.020404.145837; Tristani-Firouzi M, 2002, J BIOL CHEM, V277, P18994, DOI 10.1074/jbc.M200410200; Wilkinson WJ, 2009, BRIT J PHARMACOL, V158, P862, DOI 10.1111/j.1476-5381.2009.00354.x; Williams SEJ, 2004, SCIENCE, V306, P2093, DOI 10.1126/science.1105010; Yang YS, 2004, J GEN PHYSIOL, V124, P163, DOI 10.1085/jgp.200409057; Yang YS, 1997, J GEN PHYSIOL, V109, P779, DOI 10.1085/jgp.109.6.779; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P321, DOI 10.1085/jgp.103.2.321; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P279, DOI 10.1085/jgp.103.2.279	72	24	24	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.198010	http://dx.doi.org/10.1074/jbc.M110.198010			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454671	Green Published, hybrid			2022-12-25	WOS:000290022800079
J	Becker, NG; Wang, DC				Becker, Niels G.; Wang, Dingcheng			Can Antiviral Drugs Contain Pandemic Influenza Transmission?	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; NEURAMINIDASE INHIBITOR OSELTAMIVIR; VARIANCE HETEROGENEITY; EFFICACY; SAFETY; APPROXIMATION; PROPHYLAXIS; MANAGEMENT; HOUSEHOLDS; STOCKPILE	Antiviral drugs dispensed during the 2009 influenza pandemic generally failed to contain transmission. This poses the question of whether preparedness for a future pandemic should include plans to use antiviral drugs to mitigate transmission. Simulations using a standard transmission model that allows for infected arrivals and delayed vaccination show that attempts to contain transmission require relatively few antiviral doses. In contrast, persistent use of antiviral drugs when the reproduction number remains above 1 use very many doses and are unlikely to reduce the eventual attack rate appreciably unless the stockpile is very large. A second model, in which the community has a household structure, shows that the effectiveness of a strategy of dispensing antiviral drugs to infected households decreases rapidly with time delays in dispensing the antivirals. Using characteristics of past pandemics it is estimated that at least 80% of primary household cases must present upon show of symptoms to have a chance of containing transmission by dispensing antiviral drugs to households. To determine data needs, household outbreaks were simulated with 50% receiving antiviral drugs early and 50% receiving antiviral drugs late. A test to compare the size of household outbreaks indicates that at least 100-200 household outbreaks need to be monitored to find evidence that antiviral drugs can mitigate transmission of the newly emerged virus. Use of antiviral drugs in an early attempt to contain transmission should be part of preparedness plans for a future influenza pandemic. Data on the incidence of the first 350 cases and the eventual attack rates of the first 200 hundred household outbreaks should be used to estimate the initial reproduction number R and the effectiveness of antiviral drugs to mitigate transmission. Use of antiviral drugs to mitigate general transmission should cease if these estimates indicate that containment of transmission is unlikely.	[Becker, Niels G.; Wang, Dingcheng] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia	Australian National University	Becker, NG (corresponding author), Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia.	Niels.Becker@anu.edu.au			National Health and Medical Research Council [471436]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work is supported by National Health and Medical Research Council grant 471436. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RA, 1994, J EDUC STAT, V19, P91, DOI 10.3102/10769986019002091; Bailey NTJ, 1975, MATH THEORY INFECT D; Ball F, 2006, STAT METHODS MED RES, V15, P481, DOI 10.1177/0962280206071643; Barnes B, 2007, MATH BIOSCI, V209, P403, DOI 10.1016/j.mbs.2007.02.008; BARTOSZYNSKI R, 1972, APPL MATH, V13, P139; Becker N G, 2010, Euro Surveill, V15; BECKER NG, 1995, MATH BIOSCI, V127, P207, DOI 10.1016/0025-5564(94)00055-5; BECKER NG, 1989, ANAL INFECT DIS DATA; Caley P, 2008, J R SOC INTERFACE, V5, P631, DOI 10.1098/rsif.2007.1197; Cheng MH, 2005, LANCET INFECT DIS, V5, P746, DOI 10.1016/S1473-3099(05)70290-5; Cowling BJ, 2010, EPIDEMIOLOGY, V21, P842, DOI 10.1097/EDE.0b013e3181f20977; Esveld M, 2006, VACCINE, V24, P6793, DOI 10.1016/j.vaccine.2006.06.068; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Glass K, 2009, J R SOC INTERFACE, V6, P695, DOI 10.1098/rsif.2008.0404; Harrod ME, 2006, MED J AUSTRALIA, V185, pS58; Hayden FG, 2004, J INFECT DIS, V189, P440, DOI 10.1086/381128; Hayden FG, 1996, JAMA-J AM MED ASSOC, V275, P295, DOI 10.1001/jama.275.4.295; Hayden FG, 1999, JAMA-J AM MED ASSOC, V282, P1240, DOI 10.1001/jama.282.13.1240; Hayden FG, 1997, NEW ENGL J MED, V337, P874, DOI 10.1056/NEJM199709253371302; Jefferson T, 2006, LANCET, V367, P303, DOI 10.1016/S0140-6736(06)67970-1; Jefferson T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5106; Lett D, 2005, CAN MED ASSOC J, V172, P1167, DOI 10.1503/cmaj.050332; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Mccaw JM, 2007, MATH BIOSCI, V209, P336, DOI 10.1016/j.mbs.2007.02.003; Mercer GN, 2011, STAT MED, V30, P984, DOI 10.1002/sim.4174; MERCER GN, 2010, STAT MED IN PRESS; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; Nicholson KG, 2000, LANCET, V355, P1845, DOI 10.1016/S0140-6736(00)02288-1; Schneider PJ, 1997, J EXP EDUC, V65, P271, DOI 10.1080/00220973.1997.9943459; Treanor JJ, 2000, JAMA-J AM MED ASSOC, V283, P1016, DOI 10.1001/jama.283.8.1016; Welliver R, 2001, JAMA-J AM MED ASSOC, V285, P748, DOI 10.1001/jama.285.6.748	31	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e17764	10.1371/journal.pone.0017764	http://dx.doi.org/10.1371/journal.pone.0017764			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464934	Green Submitted, Green Published, gold			2022-12-25	WOS:000289053800003
J	Blackburn, MB; Martin, PAW; Kuhar, D; Farrar, RR; Gundersen-Rindal, DE				Blackburn, Michael B.; Martin, Phyllis A. W.; Kuhar, Daniel; Farrar, Robert R., Jr.; Gundersen-Rindal, Dawn E.			The Occurrence of Photorhabdus-Like Toxin Complexes in Bacillus thuringiensis	PLOS ONE			English	Article							INSECTICIDAL TOXINS; SEQUENCE; GENES; AGENT; SOIL	Recently, genomic sequencing of a Bacillus thuringiensis (Bt) isolate from our collection revealed the presence of an apparent operon encoding an insecticidal toxin complex (Tca) similar to that first described from the entomopathogen Photorhabdus luminescens. To determine whether these genes are widespread among Bt strains, we screened isolates from the collection for the presence of tccC, one of the genes needed for the expression of fully functional toxin complexes. Among 81 isolates chosen to represent commonly encountered biochemical phenotypes, 17 were found to possess a tccC. Phylogenetic analysis of the 81 isolates by multilocus sequence typing revealed that all the isolates possessing a tccC gene were restricted to two sequence types related to Bt varieties morrisoni, tenebrionis, israelensis and toumanoffi. Sequencing of the similar to 17 kb tca operon from two isolates representing each of the two sequence types revealed >99% sequence identity. Optical mapping of DNA from Bt isolates representing each of the sequence types revealed nearly identical plasmids of ca. 333 and 338 kbp, respectively. Selected isolates were found to be toxic to gypsy moth larvae, but were not as effective as a commercial strain of Bt kurstaki. Some isolates were found to inhibit growth of Colorado potato beetle. Custom Taqman (R) relative quantitative real-time PCR assays for Tc-encoding Bt revealed both tcaA and tcaB genes were expressed within infected gypsy moth larvae.	[Blackburn, Michael B.; Martin, Phyllis A. W.; Kuhar, Daniel; Farrar, Robert R., Jr.; Gundersen-Rindal, Dawn E.] Henry A Wallace Beltsville Agr Res Ctr, USDA, ARS, Invas Insect Biocontrol & Behav Lab, Beltsville, MD USA	United States Department of Agriculture (USDA)	Blackburn, MB (corresponding author), Henry A Wallace Beltsville Agr Res Ctr, USDA, ARS, Invas Insect Biocontrol & Behav Lab, Beltsville, MD USA.	mike.blackburn@ars.usda.gov	huang, tiffany/F-9764-2012	Blackburn, Michael/0000-0001-5541-4831	Agricultural Research Service of the USDA	Agricultural Research Service of the USDA(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	The research was fully funded by the Agricultural Research Service of the USDA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Atlas RM., 2004, HDB MICROBIOLOGICAL; BAUM JA, 2010, Patent No. 7662940; Bell RA., 1981, USDA TECH B, P599; Bizzarri MF, 2008, MICROB ECOL, V56, P133, DOI 10.1007/s00248-007-9331-1; Blackburn MB, 2005, J INSECT SCI, V5, DOI 10.1093/jis/5.1.32; Bowen D, 1998, SCIENCE, V280, P2129, DOI 10.1126/science.280.5372.2129; ffrench-Constant RH, 2007, TOXICON, V49, P436, DOI 10.1016/j.toxicon.2006.11.019; Gelman D B, 2001, J Insect Sci, V1, P7; HEY TD, 2009, Patent No. 7491698; Hurst MRH, 2000, J BACTERIOL, V182, P5127, DOI 10.1128/JB.182.18.5127-5138.2000; Jolley KA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-86; Martin PAW, 2004, BIOL CONTROL, V29, P109, DOI 10.1016/S1049-9644(03)00125-7; Martin PAW, 2010, SYST APPL MICROBIOL, V33, P204, DOI 10.1016/j.syapm.2010.04.002; Morgan JAW, 2001, APPL ENVIRON MICROB, V67, P2062, DOI 10.1128/AEM.67.5.2062-2069.2001; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; Priest FG, 2004, J BACTERIOL, V186, P7959, DOI 10.1128/JB.186.23.7959-7970.2004; Reslewic S, 2005, APPL ENVIRON MICROB, V71, P5511, DOI 10.1128/AEM.71.9.5511-5522.2005; TRAVERS RS, 1987, APPL ENVIRON MICROB, V53, P1263, DOI 10.1128/AEM.53.6.1263-1266.1987; Waterfield N, 2005, CELL MICROBIOL, V7, P373, DOI 10.1111/j.1462-5822.2004.00467.x; Waterfield NR, 2001, TRENDS MICROBIOL, V9, P185, DOI 10.1016/S0966-842X(01)01978-3	21	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e18122	10.1371/journal.pone.0018122	http://dx.doi.org/10.1371/journal.pone.0018122			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464948	Green Published, gold, Green Submitted			2022-12-25	WOS:000288813900041
J	Pinto, VV; Ditlev, SB; Jensen, KE; Resende, M; Dahlback, M; Andersen, G; Andersen, P; Theander, TG; Salanti, A; Nielsen, MA				Pinto, Vera V.; Ditlev, Sisse B.; Jensen, Kamilla E.; Resende, Mafalda; Dahlback, Madeleine; Andersen, Gorm; Andersen, Pernille; Theander, Thor G.; Salanti, Ali; Nielsen, Morten A.			Differential Induction of Functional IgG Using the Plasmodium falciparum Placental Malaria Vaccine Candidate VAR2CSA	PLOS ONE			English	Article							PREGNANCY-ASSOCIATED MALARIA; CROSS-REACTIVE ANTIBODIES; CHONDROITIN-SULFATE-A; IMMUNOGLOBULIN-G; STRUCTURAL BASIS; CELL-SURFACE; B-CELLS; BINDING; PARASITES; EPITOPES	Background: In Plasmodium falciparum malaria endemic areas placental malaria (PM) is an important complication of malaria. The recurrence of malaria in primigravidae women irrespective of acquired protection during childhood is caused by the interaction between the parasite-expressed VAR2CSA antigen and chondroitin sulfate A (CSA) in the placental intervillous space and lack of protective antibodies. PM impairs fetal development mainly by excessive inflammation processes. After infections during pregnancy women acquire immunity to PM conferred by antibodies against VAR2CSA. Ideally, a vaccine against PM will induce antibody-mediated immune responses that block the adhesion of infected erythrocytes (IE) in the placenta. Principal Findings: We have previously shown that antibodies raised in rat against individual domains of VAR2CSA can block IE binding to CSA. In this study we have immunized mice, rats and rabbits with each individual domain and the full-length protein corresponding to the FCR3 VAR2CSA variant. We found there is an inherently higher immunogenicity of C-terminal domains compared to N-terminally located domains. This was irrespective of whether antibodies were induced against single domains or the full-length protein. Species-specific antibody responses were also found, these were mainly directed against single domains and not the full-length VAR2CSA protein. Conclusions/Significance: Binding inhibitory antibodies appeared to be against conformational B-cell epitopes. Nonbinding inhibitory antibodies reacted highly against the C-terminal end of the VAR2CSA molecule especially the highly polymorphic DBL6 epsilon domain. Differential species-specific induction of antibody responses may allow for more direct analysis of functional versus non-functional B-cell epitopes.	[Pinto, Vera V.; Ditlev, Sisse B.; Jensen, Kamilla E.; Resende, Mafalda; Dahlback, Madeleine; Andersen, Gorm; Andersen, Pernille; Theander, Thor G.; Salanti, Ali; Nielsen, Morten A.] Univ Copenhagen, Ctr Med Parasitol, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark; [Pinto, Vera V.; Ditlev, Sisse B.; Jensen, Kamilla E.; Resende, Mafalda; Dahlback, Madeleine; Andersen, Gorm; Andersen, Pernille; Theander, Thor G.; Salanti, Ali; Nielsen, Morten A.] Rigshosp, Copenhagen Univ Hosp, Dept Infect Dis, DK-2100 Copenhagen, Denmark	University of Copenhagen; Rigshospitalet; University of Copenhagen	Pinto, VV (corresponding author), Univ Copenhagen, Ctr Med Parasitol, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark.	mortenn@sund.ku.dk	Theander, Thor/F-6714-2015	Theander, Thor/0000-0002-3509-7514; Salanti, Ali/0000-0003-2207-5575; Nielsen, Morten Agertoug/0000-0003-2668-4992; Ditlev, Sisse Bolm/0000-0003-4417-9711	Bill and Melinda Gates Foundation [47029]; Danish Research Council (SSVF) [22-03-0333]; Novo Nordisk Foundation [10335]; Danish Research Council for Development Research (RUF) [104.Dan.8.L.306, 8.L.306]; PreMalStruct [FP7-HEALTH-2007-A ID 201222]; University of Copenhagen	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Danish Research Council (SSVF)(Det Frie Forskningsrad (DFF)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Research Council for Development Research (RUF); PreMalStruct; University of Copenhagen	This study received funding primarily from the PMI2 (#47029) Gates Malaria Programme grant from the Bill and Melinda Gates Foundation. The work was also supported by the Danish Research Council (SSVF) (grant 22-03-0333), The Novo Nordisk Foundation (grant 10335), the Danish Research Council for Development Research (RUF) (grant 104.Dan.8.L.306 and 8.L.306), The PreMalStruct FP7-HEALTH-2007-A ID 201222 and The University of Copenhagen Program of Excellence (Membrane topology and quaternary structure of key parasite proteins involved in Plasmodium falciparum malaria pathogenesis and immunity). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard C, 2009, IMMUNOL CELL BIOL, V87, P279, DOI 10.1038/icb.2009.14; Andersen P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040042; Avril M, 2008, INFECT IMMUN, V76, P1791, DOI 10.1128/IAI.01470-07; Avril M, 2010, INFECT IMMUN, V78, P2248, DOI 10.1128/IAI.00410-09; Barfod L, 2007, MOL MICROBIOL, V63, P335, DOI 10.1111/j.1365-2958.2006.05503.x; Barfod L, 2006, INFECT IMMUN, V74, P4357, DOI 10.1128/IAI.01617-05; BRABIN BJ, 1983, B WORLD HEALTH ORGAN, V61, P1005; Dahlback M, 2006, PLOS PATHOG, V2, P1069, DOI 10.1371/journal.ppat.0020124; Davies DH, 2005, P NATL ACAD SCI USA, V102, P547, DOI 10.1073/pnas.0408782102; Duffy MF, 2006, MOL BIOCHEM PARASIT, V148, P117, DOI 10.1016/j.molbiopara.2006.03.006; Fernandez P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012558; Fernandez P, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-170; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Fried M, 1998, NATURE, V395, P851, DOI 10.1038/27570; Fried Michal, 2002, Methods Mol Med, V72, P555, DOI 10.1385/1-59259-271-6:555; Greenwood BM, 2008, J CLIN INVEST, V118, P1266, DOI 10.1172/JCI33996; Guinovart C, 2007, AM J TROP MED HYG, V77, P276, DOI 10.4269/ajtmh.2007.77.276; Haase RN, 2006, INFECT IMMUN, V74, P3035, DOI 10.1128/IAI.74.5.3035-3038.2006; Higgins MK, 2008, J BIOL CHEM, V283, P21842, DOI 10.1074/jbc.C800086200; Hviid L, 2005, ACTA TROP, V95, P270, DOI 10.1016/j.actatropica.2005.06.012; Jimenez-Diaz MB, 2009, ANTIMICROB AGENTS CH; Khunrae P, 2010, J MOL BIOL, V397, P826, DOI 10.1016/j.jmb.2010.01.040; Kriek N, 2003, MOL MICROBIOL, V50, P1215, DOI 10.1046/j.1365-2958.2003.03784.x; Magistrado P, 2008, J INFECT DIS, V198, P1071, DOI 10.1086/591502; Magistrado PA, 2011, VACCINE, V29, P437, DOI 10.1016/j.vaccine.2010.10.080; Ndam NGT, 2006, J INFECT DIS, V193, P713, DOI 10.1086/500146; Ndam NGT, 2005, J INFECT DIS, V192, P331, DOI 10.1086/430933; Nielsen MA, 2007, EXP PARASITOL, V117, P1, DOI 10.1016/j.exppara.2007.03.002; Nielsen MA, 2009, INFECT IMMUN, V77, P2482, DOI 10.1128/IAI.00159-09; Oleinikov AV, 2008, J INFECT DIS, V197, P1119, DOI 10.1086/529526; Paus D, 2006, P NATL ACAD SCI USA, V103, P9172, DOI 10.1073/pnas.0600263103; ROGERSON SJ, 1995, J EXP MED, V182, P15, DOI 10.1084/jem.182.1.15; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; Salanti A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-11; Singh SK, 2006, NATURE, V439, P741, DOI 10.1038/nature04443; Srivastava A, 2010, P NATL ACAD SCI USA, V107, P4884, DOI 10.1073/pnas.1000951107; SURH CD, 1990, J IMMUNOL, V144, P2647; Tolia NH, 2005, CELL, V122, P183, DOI 10.1016/j.cell.2005.05.033; Traggiai E, 2004, NAT MED, V10, P871, DOI 10.1038/nm1080; Trimnell AR, 2006, MOL BIOCHEM PARASIT, V148, P169, DOI 10.1016/j.molbiopara.2006.03.012; Walker BD, 2008, SCIENCE, V320, P760, DOI 10.1126/science.1152622	42	12	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e17942	10.1371/journal.pone.0017942	http://dx.doi.org/10.1371/journal.pone.0017942			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464946	Green Published, Green Submitted, gold			2022-12-25	WOS:000288813900022
J	Vial, C; Gutierrez, J; Santander, C; Cabrera, D; Brandan, E				Vial, Cecilia; Gutierrez, Jaime; Santander, Cristian; Cabrera, Daniel; Brandan, Enrique			Decorin Interacts with Connective Tissue Growth Factor (CTGF)/CCN2 by LRR12 Inhibiting Its Biological Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE DIFFERENTIATION; DERMATAN SULFATE PROTEOGLYCAN; MESSENGER-RNA EXPRESSION; HEPATIC STELLATE CELLS; FACTOR GENE-EXPRESSION; FACTOR-BETA; TGF-BETA; LUNG FIBROSIS; TRANSFORMING GROWTH-FACTOR-BETA-1	Fibrotic disorders are the end point of many chronic diseases in different tissues, where an accumulation of the extracellular matrix occurs, mainly because of the action of the connective tissue growth factor (CTGF/CCN2). Little is known about how this growth factor activity is regulated. We found that decorin null myoblasts are more sensitive to CTGF than wild type myoblasts, as evaluated by the accumulation of fibronectin or collagen III. Decorin added exogenously negatively regulated CTGF pro-fibrotic activity and the induction of actin stress fibers. Using co-immunoprecipitation and in vitro interaction assays, decorin and CTGF were shown to interact in a saturable manner with a K-d of 4.4 nM. This interaction requires the core protein of decorin. Experiments using the deletion mutant decorin indicated that the leucine-rich repeats (LRR) 10-12 are important for the interaction with CTGF and the negative regulation of the cytokine activity, moreover, a peptide derived from the LRR12 was able to inhibit CTGF-decorin complex formation and CTGF activity. Finally, we showed that CTGF specifically induced the synthesis of decorin, suggesting a mechanism of autoregulation. These results suggest that decorin interacts with CTGF and regulates its biological activity.	[Vial, Cecilia; Gutierrez, Jaime; Santander, Cristian; Cabrera, Daniel; Brandan, Enrique] Pontificia Univ Catolica Chile, Ctr Regulac Celular & Patol, Ctr Regenerac & Envejecimiento, Dept Biol Celular & Mol,MIFAB, Santiago, Chile	Pontificia Universidad Catolica de Chile	Brandan, E (corresponding author), Pontificia Univ Catolica Chile, Ctr Regulac Celular & Patol, Ctr Regenerac & Envejecimiento, Dept Biol Celular & Mol,MIFAB, Casilla 114-D, Santiago, Chile.	ebrandan@bio.puc.cl	CABRERA, DANIEL/AAR-5027-2020; Vial, Maria Cecilia/GVS-4266-2022; Brandan, Enrique/A-7063-2017	CABRERA, DANIEL/0000-0001-9634-725X; Vial, Cecilia/0000-0002-0399-6144; Brandan, Enrique/0000-0002-6820-5059	FONDAP-Biomedicine [13980001]; CARE [PFB12/2007]; FONDECYT [103193, 21050032, MDA 89419]; Fundacion Chilena para Biologia Celular Proyecto [MF-100]	FONDAP-Biomedicine(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDAP); CARE; FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Fundacion Chilena para Biologia Celular Proyecto	This work was supported by Research Grants FONDAP-Biomedicine 13980001, CARE PFB12/2007, FONDECYT 103193 (to C. V.) and 21050032 (to J. G.), MDA 89419, and Fundacion Chilena para Biologia Celular Proyecto MF-100.	Abraham D, 2008, RHEUMATOLOGY, V47, pV8, DOI 10.1093/rheumatology/ken278; Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Alvarez K, 2002, J CELL BIOCHEM, V85, P703, DOI 10.1002/jcb.10184; Bernasconi P, 1999, NEUROMUSCULAR DISORD, V9, P28, DOI 10.1016/S0960-8966(98)00093-5; BOLSTER MB, 1993, BAILLIERE CLIN RHEUM, V7, P79, DOI 10.1016/S0950-3579(05)80269-9; BORDER WA, 1992, NATURE, V360, P361, DOI 10.1038/360361a0; BORK P, 1993, FEBS LETT, V327, P125, DOI 10.1016/0014-5793(93)80155-N; BRADHAM DM, 1991, J CELL BIOL, V114, P1285, DOI 10.1083/jcb.114.6.1285; BRANDAN E, 1991, EUR J CELL BIOL, V55, P209; BRANDAN E, 1992, J NEUROSCI RES, V32, P51, DOI 10.1002/jnr.490320107; Brandan E, 2006, J BIOL CHEM, V281, P31562, DOI 10.1074/jbc.M602919200; Brandan E, 2008, MATRIX BIOL, V27, P700, DOI 10.1016/j.matbio.2008.07.004; Caceres S, 2000, EUR J CELL BIOL, V79, P173, DOI 10.1078/S0171-9335(04)70020-5; Casar JC, 2004, DEV BIOL, V268, P358, DOI 10.1016/j.ydbio.2003.12.025; Chen YL, 2004, MOL BIOL CELL, V15, P5635, DOI 10.1091/mbc.E04-06-0490; Cicha I, 2009, BIOFACTORS, V35, P200, DOI 10.1002/biof.30; Cossu G, 2007, TRENDS MOL MED, V13, P520, DOI 10.1016/j.molmed.2007.10.003; Costacurta A, 2002, J CLIN LAB ANAL, V16, P178, DOI 10.1002/jcla.10038; De Winter P, 2008, GROWTH FACTORS, V26, P80, DOI 10.1080/08977190802025602; Denton CP, 2001, CURR OPIN RHEUMATOL, V13, P505, DOI 10.1097/00002281-200111000-00010; Droguett R, 2006, MATRIX BIOL, V25, P332, DOI 10.1016/j.matbio.2006.04.004; Droppelmann CA, 2009, J BIOL CHEM, V284, P13551, DOI 10.1074/jbc.M807352200; Fadic R, 2006, J CELL MOL MED, V10, P758, DOI 10.1111/j.1582-4934.2006.tb00435.x; Faust SM, 2009, J IMMUNOL, V183, P7307, DOI 10.4049/jimmunol.0902736; Frazier K, 1996, J INVEST DERMATOL, V107, P404, DOI 10.1111/1523-1747.ep12363389; Gargioli C, 2008, NAT MED, V14, P973, DOI 10.1038/nm.1852; Giri SN, 2003, ANNU REV PHARMACOL, V43, P73, DOI 10.1146/annurev.pharmtox.43.100901.135740; Giri SN, 1997, BIOCHEM PHARMACOL, V54, P1205, DOI 10.1016/S0006-2952(97)00343-2; Goldoni S, 2004, J BIOL CHEM, V279, P6606, DOI 10.1074/jbc.M310342200; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Holbourn KP, 2008, TRENDS BIOCHEM SCI, V33, P461, DOI 10.1016/j.tibs.2008.07.006; IGARASHI A, 1995, J INVEST DERMATOL, V105, P280, DOI 10.1111/1523-1747.ep12318465; Igarashi A, 1996, J INVEST DERMATOL, V106, P729, DOI 10.1111/1523-1747.ep12345771; Inoki I, 2001, FASEB J, V15, P219, DOI 10.1096/fj.01-0332fje; Iozzo RV, 1999, J BIOL CHEM, V274, P18843, DOI 10.1074/jbc.274.27.18843; Ito Y, 1998, KIDNEY INT, V53, P853, DOI 10.1046/j.1523-1755.1998.00820.x; Jedsadayanmata A, 1999, J BIOL CHEM, V274, P24321, DOI 10.1074/jbc.274.34.24321; Kireeva ML, 1997, EXP CELL RES, V233, P63, DOI 10.1006/excr.1997.3548; Kisseleva T, 2008, EXP BIOL MED, V233, P109, DOI 10.3181/0707-MR-190; Kresse H, 2001, J CELL PHYSIOL, V189, P266, DOI 10.1002/jcp.10030; Larrain J, 2000, DEVELOPMENT, V127, P821; Lasky JA, 1998, AM J PHYSIOL-LUNG C, V275, pL365, DOI 10.1152/ajplung.1998.275.2.L365; Leask A, 2004, J INVEST DERMATOL, V122, P1, DOI 10.1046/j.0022-202X.2003.22133.x; Leask A, 2007, CARDIOVASC RES, V74, P207, DOI 10.1016/j.cardiores.2006.07.012; Leask Andrew, 2009, Front Biosci (Elite Ed), V1, P115; Li Y, 2004, AM J PATHOL, V164, P1007, DOI 10.1016/S0002-9440(10)63188-4; Li Y, 2007, MOL THER, V15, P1616, DOI 10.1038/sj.mt.6300250; Lopez-Casillas F, 2003, J BIOL CHEM, V278, P382, DOI 10.1074/jbc.M208520200; Miyazono K, 2000, J CELL SCI, V113, P1101; Nguyen TQ, 2008, J AM SOC NEPHROL, V19, P2098, DOI 10.1681/ASN.2007111261; Nishida T, 2000, J CELL PHYSIOL, V184, P197, DOI 10.1002/1097-4652(200008)184:2<197::AID-JCP7>3.0.CO;2-R; Paradis V, 2002, LAB INVEST, V82, P767, DOI 10.1097/01.LAB.0000017365.18894.D3; Prud'homme GJ, 2007, LAB INVEST, V87, P1077, DOI 10.1038/labinvest.3700669; Ramamurthy P, 1996, J BIOL CHEM, V271, P19578, DOI 10.1074/jbc.271.32.19578; RAMPOLDI E, 1986, EUR J CELL BIOL, V42, P27; Riquelme C, 2001, J BIOL CHEM, V276, P3589, DOI 10.1074/jbc.M004602200; Santra M, 2002, J BIOL CHEM, V277, P35671, DOI 10.1074/jbc.M205317200; SCHMIDT G, 1991, BIOCHEM J, V280, P411, DOI 10.1042/bj2800411; Schonherr E, 2005, J BIOL CHEM, V280, P15767, DOI 10.1074/jbc.M500451200; Schonherr E, 1998, ARCH BIOCHEM BIOPHYS, V355, P241, DOI 10.1006/abbi.1998.0720; SCHWARZ K, 1990, J BIOL CHEM, V265, P22023; Scott PG, 2004, P NATL ACAD SCI USA, V101, P15633, DOI 10.1073/pnas.0402976101; Segarini PR, 2001, J BIOL CHEM, V276, P40659, DOI 10.1074/jbc.M105180200; Shi-Wen X, 2008, CYTOKINE GROWTH F R, V19, P133, DOI 10.1016/j.cytogfr.2008.01.002; Sun G, 2008, J NEUROL SCI, V267, P48, DOI 10.1016/j.jns.2007.09.043; SVENSSON L, 1995, J BIOL CHEM, V270, P20712, DOI 10.1074/jbc.270.35.20712; Vial C, 2008, J CELL PHYSIOL, V215, P410, DOI 10.1002/jcp.21324; Weber IT, 1996, J BIOL CHEM, V271, P31767, DOI 10.1074/jbc.271.50.31767; Wickert L, 2002, BIOCHEM BIOPH RES CO, V295, P330, DOI 10.1016/S0006-291X(02)00669-1; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; YAMAGUCHI Y, 1990, NATURE, V346, P281, DOI 10.1038/346281a0; Zhu J, 2007, J BIOL CHEM, V282, P25852, DOI 10.1074/jbc.M704146200; ZIYADEH FN, 1993, AM J KIDNEY DIS, V22, P736, DOI 10.1016/S0272-6386(12)80440-9	74	85	88	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24242	24252		10.1074/jbc.M110.189365	http://dx.doi.org/10.1074/jbc.M110.189365			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21454550	hybrid, Green Published			2022-12-25	WOS:000292294900066
J	Pan, Y; Fiscus, V; Meng, WY; Zheng, ZD; Zhang, LH; Fuqua, C; Chen, LL				Pan, Yi; Fiscus, Valena; Meng, Wuyi; Zheng, Zhida; Zhang, Lian-Hui; Fuqua, Clay; Chen, Lingling			The Agrobacterium tumefaciens Transcription Factor BlcR Is Regulated via Oligomerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; ACETATE OPERON; STREPTOMYCES-GRISEUS; VIBRIO-CHOLERAE; ICLR REPRESSOR; DNA; GLYOXYLATE; GENE; PROTEIN	The Agrobacterium tumefaciens BlcR is a member of the emerging isocitrate lyase transcription regulators that negatively regulates metabolism of gamma-butyrolactone, and its repressing function is relieved by succinate semialdehyde (SSA). Our crystal structure showed that BlcR folded into the DNA-and SSA-binding domains and dimerized via the DNA-binding domains. Mutational analysis identified residues, including Phe(147), that are important for SSA association; BlcR(F147A) existed as tetramer. Two BlcR dimers bound to target DNA and in a cooperative manner, and the distance between the two BlcR-binding sequences in DNA was critical for BlcR-DNA association. Tetrameric BlcR(F147A) retained DNA binding activity, and importantly, this activity was not affected by the distance separating the BlcR-binding sequences in DNA. SSA did not dissociate tetrameric BlcR(F147A) or BlcR(F147A)-DNA. As well as in the SSA-binding site, Phe(147) is located in a structurally flexible loop that may be involved in BlcR oligomerization. We propose that SSA regulates BlcR DNA-binding function via oligomerization.	[Pan, Yi; Zheng, Zhida; Chen, Lingling] Indiana Univ, Interdisciplinary Biochem Program, Bloomington, IN 47405 USA; [Fiscus, Valena; Fuqua, Clay; Chen, Lingling] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Meng, Wuyi] Indiana Univ, Dept Chem, Bloomington, IN 47405 USA; [Chen, Lingling] Indiana Univ, Dept Mol & Cellular Biochem, Bloomington, IN 47405 USA; [Zhang, Lian-Hui] Inst Mol & Cell Biol, Singapore 138673, Singapore	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Chen, LL (corresponding author), Indiana Univ, Interdisciplinary Biochem Program, Bloomington, IN 47405 USA.	linchen@indiana.edu	Chen, Ling-Ling/AAY-3547-2021		National Science Foundation [MCB-0416447]; National Institutes of Health [R01-GM80546]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080546] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported in part by National Science Foundation Grant MCB-0416447 (to L. C.) and by National Institutes of Health Grant R01-GM80546 (to C. F.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BRENNAN RG, 1989, J BIOL CHEM, V264, P1903; Brune I, 2007, J BACTERIOL, V189, P2720, DOI 10.1128/JB.01876-06; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carlier A, 2004, MOL PLANT MICROBE IN, V17, P951, DOI 10.1094/MPMI.2004.17.9.951; Chai YR, 2007, J BACTERIOL, V189, P3674, DOI 10.1128/JB.01274-06; Donald LJ, 1996, PROTEIN SCI, V5, P1613, DOI 10.1002/pro.5560050815; Donald LJ, 2001, PROTEIN SCI, V10, P1370, DOI 10.1110/ps.780101; GALINIER A, 1990, NUCLEIC ACIDS RES, V18, P3656, DOI 10.1093/nar/18.12.3656; Guazzaroni ME, 2007, J MOL BIOL, V369, P927, DOI 10.1016/j.jmb.2007.04.022; HARRISON SC, 1991, NATURE, V353, P715, DOI 10.1038/353715a0; Hase CC, 1999, P NATL ACAD SCI USA, V96, P3183, DOI 10.1073/pnas.96.6.3183; Jiang H, 2000, J BACTERIOL, V182, P5521, DOI 10.1128/JB.182.19.5521-5529.2000; KORNBERG HL, 1966, BIOCHEM J, V99, P1; Krell T, 2006, PROTEIN SCI, V15, P1207, DOI 10.1110/ps.051857206; Lewis M, 1996, SCIENCE, V271, P1247, DOI 10.1126/science.271.5253.1247; Lorca GL, 2007, J BIOL CHEM, V282, P16476, DOI 10.1074/jbc.M610838200; Lowden MJ, 2010, P NATL ACAD SCI USA, V107, P2860, DOI 10.1073/pnas.0915021107; MALOY SR, 1982, J BACTERIOL, V149, P173, DOI 10.1128/JB.149.1.173-180.1982; Molina-Henares AJ, 2006, FEMS MICROBIOL REV, V30, P157, DOI 10.1111/j.1574-6976.2005.00008.x; NEGRE D, 1992, J MOL BIOL, V228, P23, DOI 10.1016/0022-2836(92)90488-6; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; OEHLER S, 1990, EMBO J, V9, P973, DOI 10.1002/j.1460-2075.1990.tb08199.x; OTWINOWSKI Z, 1988, NATURE, V335, P321, DOI 10.1038/335321a0; PABO CO, 1992, ANNU REV BIOCHEM, V61, P1053, DOI 10.1146/annurev.bi.61.070192.005201; Pan B, 1996, J BACTERIOL, V178, P3982, DOI 10.1128/jb.178.13.3982-3984.1996; REVERCHON S, 1991, MOL MICROBIOL, V5, P2203, DOI 10.1111/j.1365-2958.1991.tb02150.x; ROMEROSTEINER S, 1994, J BACTERIOL, V176, P5771, DOI 10.1128/JB.176.18.5771-5779.1994; SCHLEIF R, 1992, ANNU REV BIOCHEM, V61, P199, DOI 10.1146/annurev.bi.61.070192.001215; SUNNARBORG A, 1990, J BACTERIOL, V172, P2642, DOI 10.1128/jb.172.5.2642-2649.1990; Traag BA, 2004, MOL MICROBIOL, V53, P985, DOI 10.1111/j.1365-2958.2004.04186.x; Tsoi TV, 1999, APPL ENVIRON MICROB, V65, P2151; Walker JR, 2006, J MOL BIOL, V358, P810, DOI 10.1016/j.jmb.2006.02.034; Wang C, 2006, MOL MICROBIOL, V62, P45, DOI 10.1111/j.1365-2958.2006.05351.x; Wang LH, 2004, J BIOL CHEM, V279, P13645, DOI 10.1074/jbc.M311194200; Yamamoto K, 2003, MOL MICROBIOL, V47, P183, DOI 10.1046/j.1365-2958.2003.03287.x; Yamazaki H, 2003, J BACTERIOL, V185, P1273, DOI 10.1128/JB.185.4.1273-1283.2003; Zhang HB, 2002, P NATL ACAD SCI USA, V99, P4638, DOI 10.1073/pnas.022056699; ZHANG RG, 1987, NATURE, V327, P591, DOI 10.1038/327591a0; Zhang RG, 2002, J BIOL CHEM, V277, P19183, DOI 10.1074/jbc.M112171200	40	5	5	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20431	20440		10.1074/jbc.M110.196154	http://dx.doi.org/10.1074/jbc.M110.196154			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21467043	Green Published, hybrid			2022-12-25	WOS:000291267600031
J	Leupin, O; Piters, E; Halleux, C; Hu, S; Kramer, I; Morvan, F; Bouwmeester, T; Schirle, M; Bueno-Lozano, M; Fuentes, FJR; Itin, PH; Boudin, E; de Freitas, F; Jennes, K; Brannetti, B; Charara, N; Ebersbach, H; Geisse, S; Lu, CX; Bauer, A; Van Hul, W; Kneissel, M				Leupin, Olivier; Piters, Elke; Halleux, Christine; Hu, Shouih; Kramer, Ina; Morvan, Frederic; Bouwmeester, Tewis; Schirle, Markus; Bueno-Lozano, Manuel; Fuentes, Feliciano J. Ramos; Itin, Peter H.; Boudin, Eveline; de Freitas, Fenna; Jennes, Karen; Brannetti, Barbara; Charara, Nadine; Ebersbach, Hilmar; Geisse, Sabine; Lu, Chris X.; Bauer, Andreas; Van Hul, Wim; Kneissel, Michaela			Bone Overgrowth-associated Mutations in the LRP4 Gene Impair Sclerostin Facilitator Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VAN-BUCHEM-DISEASE; RECEPTOR-RELATED PROTEIN-5; LIMB DEVELOPMENT; MINERAL DENSITY; BMP ANTAGONIST; SOST GENE; DELETION; CELLS; AGRIN; IDENTIFICATION	Humans lacking sclerostin display progressive bone over-growth due to increased bone formation. Although it is well established that sclerostin is an osteocyte-secreted bone formation inhibitor, the underlying molecular mechanisms are not fully elucidated. We identified in tandem affinity purification proteomics screens LRP4 (low density lipoprotein-related protein 4) as a sclerostin interaction partner. Biochemical assays with recombinant proteins confirmed that sclerostin LRP4 interaction is direct. Interestingly, in vitro overexpression and RNAi-mediated knockdown experiments revealed that LRP4 specifically facilitates the previously described inhibitory action of sclerostin on Wnt1/beta-catenin signaling. We found the extracellular beta-propeller structured domain of LRP4 to be required for this sclerostin facilitator activity. Immunohistochemistry demonstrated that LRP4 protein is present in human and rodent osteoblasts and osteocytes, both presumed target cells of sclerostin action. Silencing of LRP4 by lentivirus-mediated shRNA delivery blocked sclerostin inhibitory action on in vitro bone mineralization. Notably, we identified two mutations in LRP4 (R1170W and W1186S) in patients suffering from bone overgrowth. We found that these mutations impair LRP4 interaction with sclerostin and its concomitant sclerostin facilitator effect. Together these data indicate that the interaction of sclerostin with LRP4 is required to mediate the inhibitory function of sclerostin on bone formation, thus identifying a novel role for LRP4 in bone.	[Leupin, Olivier; Halleux, Christine; Hu, Shouih; Kramer, Ina; Morvan, Frederic; Kneissel, Michaela] Novartis Pharma AG, Musculoskeletal Dis Area, Novartis Inst Biomed Res, CH-4002 Basel, Switzerland; [Piters, Elke; Boudin, Eveline; de Freitas, Fenna; Jennes, Karen; Van Hul, Wim] Univ Antwerp, Dept Mol Genet, Antwerp, Belgium; [Bouwmeester, Tewis; Bauer, Andreas] Cellzome AG, D-69117 Heidelberg, Germany; [Schirle, Markus] Global Discovery Chem, Novartis Inst BioMed Res, Cambridge, MA 02139 USA; [Bueno-Lozano, Manuel; Fuentes, Feliciano J. Ramos] Univ Zaragoza, Hosp Clin Univ, Fac Med, Dept Pediat, Zaragoza 50009, Spain; [Itin, Peter H.] Univ Basel Hosp, Dept Dermatol, Kantonsspital Aarau, CH-4031 Basel, Switzerland; [Brannetti, Barbara] Novartis Pharma AG, Novartis Biol, Prot Sci & Design, CH-4002 Basel, Switzerland; [Charara, Nadine; Ebersbach, Hilmar; Geisse, Sabine] Novartis Pharma AG, Novartis Biol Ctr, Novartis Inst Biomed Res, CH-4002 Basel, Switzerland; [Lu, Chris X.] BioMed Res Co Ltd, China Novartis Inst, Shanghai 201203, Peoples R China	Novartis; University of Antwerp; GlaxoSmithKline; Cellzome GmbH; Novartis; Universidad de la Laguna; University of Zaragoza; Kantonsspital Aarau AG (KSA); University of Basel; Novartis; Novartis	Leupin, O (corresponding author), Novartis Pharma AG, Musculoskeletal Dis Area, Novartis Inst Biomed Res, CH-4002 Basel, Switzerland.	olivier.leupin@novartis.com	BOUDIN, EVELINE/O-3966-2019	BOUDIN, EVELINE/0000-0003-4818-6804; Van Hul, Wim/0000-0002-5065-7858; , Barbara/0000-0001-9436-0362	European Commission [HEALTH-F2-2008-201099]; Fonds voor Wetenschappelijk Onderzoek [G.0117.06]; University of Antwerp; Agency for Innovation by Science and Technology	European Commission(European CommissionEuropean Commission Joint Research Centre); Fonds voor Wetenschappelijk Onderzoek(FWO); University of Antwerp; Agency for Innovation by Science and Technology	This work was supported by the European Commission (HEALTH-F2-2008-201099, TALOS) and by "Fonds voor Wetenschappelijk Onderzoek" Grant G.0117.06 and by a grant from the Special Research Funds (Bijzonder Onderzoeksfonds TOP and Nieuwe Onderzoeksinitiatieven) of the University of Antwerp (all to W. V. H.). O. ., C. H., S. H., I. K., F. M., T. B., M. S., B. B., N. C., H. E., S. G., C. X. L., A. B., and M. K. are employees of Novartis.; Holder of a Ph.D. grant from the Agency for Innovation by Science and Technology.	Balemans W, 2002, J MED GENET, V39, P91, DOI 10.1136/jmg.39.2.91; Balemans W, 2001, HUM MOL GENET, V10, P537, DOI 10.1093/hmg/10.5.537; Balemans W, 2008, CALCIFIED TISSUE INT, V82, P445, DOI 10.1007/s00223-008-9130-9; Balemans W, 2007, ENDOCRINOLOGY, V148, P2622, DOI 10.1210/en.2006-1352; Balemans W, 2007, J BONE MINER RES, V22, P708, DOI 10.1359/JBMR.070211; Bonewald LF, 2007, ANN NY ACAD SCI, V1116, P281, DOI 10.1196/annals.1402.018; Bonewald Lynda F, 2006, Bonekey Osteovision, V3, P7; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Brunkow ME, 2001, AM J HUM GENET, V68, P577, DOI 10.1086/318811; BUENO M, 1994, J MED GENET, V31, P976, DOI 10.1136/jmg.31.12.976; Burckstummer T, 2006, NAT METHODS, V3, P1013, DOI 10.1038/nmeth968; Cho MS, 2002, J BIOMED SCI, V9, P631, DOI 10.1159/000067294; Choi HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007930; Collette NM, 2010, DEV BIOL, V342, P169, DOI 10.1016/j.ydbio.2010.03.021; Drogemuller C, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-5; Duchesne A, 2006, GENOMICS, V88, P610, DOI 10.1016/j.ygeno.2006.05.007; Ellies DL, 2006, J BONE MINER RES, V21, P1738, DOI 10.1359/JBMR.060810; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Hausser HJ, 2007, HISTOCHEM CELL BIOL, V127, P363, DOI 10.1007/s00418-006-0258-2; Henriksen K, 2009, BONE, V44, P1026, DOI 10.1016/j.bone.2009.03.671; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Itin PH, 2001, DERMATOLOGY, V202, P259, DOI 10.1159/000051649; Johnson EB, 2005, HUM MOL GENET, V14, P3523, DOI 10.1093/hmg/ddi381; Johnson EB, 2006, GENOMICS, V88, P600, DOI 10.1016/j.ygeno.2006.08.005; Johnson ML, 2007, CURR OPIN RHEUMATOL, V19, P376, DOI 10.1097/BOR.0b013e32816e06f9; Kawashima N, 2005, J BONE MINER METAB, V23, P123, DOI 10.1007/s00774-004-0550-y; Kim N, 2008, CELL, V135, P334, DOI 10.1016/j.cell.2008.10.002; Li WF, 2010, HUM GENET, V127, P249, DOI 10.1007/s00439-009-0773-z; Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200; Li XD, 2008, J BONE MINER RES, V23, P860, DOI 10.1359/JBMR.080216; Li Y, 2010, AM J HUM GENET, V86, P696, DOI 10.1016/j.ajhg.2010.03.004; Lin CW, 2009, J BONE MINER RES, V24, P1651, DOI [10.1359/JBMR.090411, 10.1359/jbmr.090411]; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Loots GG, 2005, GENOME RES, V15, P928, DOI 10.1101/gr.3437105; Mani A, 2007, SCIENCE, V315, P1278, DOI 10.1126/science.1136370; Mannstadt M, 1999, AM J PHYSIOL-RENAL, V277, pF665, DOI 10.1152/ajprenal.1999.277.5.F665; Martin TJ, 2009, CRIT REV EUKAR GENE, V19, P73, DOI 10.1615/CritRevEukarGeneExpr.v19.i1.40; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ohazama A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004092; Padhi D, 2011, J BONE MINER RES, V26, P19, DOI 10.1002/jbmr.173; Paszty C, 2010, J BONE MINER RES, V25, P1897, DOI 10.1002/jbmr.161; Poole KES, 2005, FASEB J, V19, P1842, DOI 10.1096/fj.05-4221fje; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Semenov M, 2005, J BIOL CHEM, V280, P26770, DOI 10.1074/jbc.M504308200; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Simon-Chazottes D, 2006, GENOMICS, V87, P673, DOI 10.1016/j.ygeno.2006.01.007; Staehling-Hampton K, 2002, AM J MED GENET, V110, P144, DOI 10.1002/ajmg.10401; Styrkarsdottir U, 2008, NEW ENGL J MED, V358, P2355, DOI 10.1056/NEJMoa0801197; Styrkarsdottir U, 2009, NAT GENET, V41, P15, DOI 10.1038/ng.284; ten Dijke P, 2008, J BONE JOINT SURG AM, V90A, P31, DOI 10.2106/JBJS.G.01183; van Bezooijen RL, 2004, J EXP MED, V199, P805, DOI 10.1084/jem.20031454; Weatherbee SD, 2006, DEVELOPMENT, V133, P4993, DOI 10.1242/dev.02696; Winkler DG, 2003, EMBO J, V22, P6267, DOI 10.1093/emboj/cdg599; Yadav VK, 2008, CELL, V135, P825, DOI 10.1016/j.cell.2008.09.059; Zhang B, 2008, NEURON, V60, P285, DOI 10.1016/j.neuron.2008.10.006	56	205	215	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19489	19500		10.1074/jbc.M110.190330	http://dx.doi.org/10.1074/jbc.M110.190330			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21471202	Green Published, hybrid			2022-12-25	WOS:000291027700032
J	He, J; Scott, JL; Heroux, A; Roy, S; Lenoir, M; Overduin, M; Stahelin, RV; Kutateladze, TG				He, Ju; Scott, Jordan L.; Heroux, Annie; Roy, Siddhartha; Lenoir, Marc; Overduin, Michael; Stahelin, Robert V.; Kutateladze, Tatiana G.			Molecular Basis of Phosphatidylinositol 4-Phosphate and ARF1 GTPase Recognition by the FAPP1 Pleckstrin Homology (PH) Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; FYVE DOMAIN; MEMBRANE; BINDING; PROTEINS; ACIDIFICATION; PTDINS(4)P; MECHANISM; APOPTOSIS; SOFTWARE	Four-phosphate-adaptor protein 1 (FAPP1) regulates secretory transport from the trans-Golgi network (TGN) to the plasma membrane. FAPP1 is recruited to the Golgi through binding of its pleckstrin homology (PH) domain to phosphatidylinositol 4-phosphate (PtdIns(4) P) and a small GTPase ADP-ribosylation factor 1 (ARF1). Despite the critical role of FAPP1 in membrane trafficking, the molecular basis of its dual function remains unclear. Here, we report a 1.9 angstrom resolution crystal structure of the FAPP1 PH domain and detail the molecular mechanisms of the PtdIns(4) P and ARF1 recognition. The FAPP1 PH domain folds into a seven-stranded beta-barrel capped by an beta-helix at one edge, whereas the opposite edge is flanked by three loops and the beta 4 and beta 7 strands that form a lipid-binding pocket within the beta-barrel. The ARF1-binding site is located on the outer side of the beta-barrel as determined by NMR resonance perturbation analysis, mutagenesis, and measurements of binding affinities. The two binding sites have little overlap, allowing FAPP1 PH to associate with both ligands simultaneously and independently. Binding to PtdIns(4) P is enhanced in an acidic environment and is required for membrane penetration and tubulation activity of FAPP1, whereas the GTP-bound conformation of the GTPase is necessary for the interaction with ARF1. Together, these findings provide structural and biochemical insight into the multivalent membrane anchoring by the PH domain that may augment affinity and selectivity of FAPP1 toward the TGN membranes enriched in both PtdIns(4) P and GTP-bound ARF1.	[Scott, Jordan L.; Stahelin, Robert V.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [He, Ju; Roy, Siddhartha; Kutateladze, Tatiana G.] Univ Colorado, Sch Med, Dept Pharmacol, Aurora, CO 80045 USA; [Scott, Jordan L.; Stahelin, Robert V.] Univ Notre Dame, Walther Ctr Canc Res, Notre Dame, IN 46556 USA; [Stahelin, Robert V.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, South Bend, IN 46617 USA; [Heroux, Annie] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [Lenoir, Marc; Overduin, Michael] Univ Birmingham, Sch Canc Sci, Birmingham B15 2TT, W Midlands, England	University of Notre Dame; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Notre Dame; Walther Cancer Institute; Indiana University System; Indiana University South Bend; United States Department of Energy (DOE); Brookhaven National Laboratory; University of Birmingham	Stahelin, RV (corresponding author), Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA.	rstaheli@iupui.edu; Tatiana.Kutateladze@ucdenver.edu	Overduin, Michael/AAG-3632-2020; Stahelin, Robert/L-3567-2019	Overduin, Michael/0000-0002-3114-6585; Kutateladze, Tatiana/0000-0001-7375-6990; Stahelin, Robert/0000-0001-5443-7863; Lenoir, Marc/0000-0001-7410-2323	National Institutes of Health [GM071424, CA95144]; American Heart Association; Indiana University Biomedical Research; American Cancer Society; Cancer Research UK; Offices of Biological and Environmental Research and of Basic Energy Sciences of the United States Department of Energy; National Center for Research Resources of the National Institutes of Health [P41RR012408]; Biotechnology and Biological Sciences Research Council [BBS/B/10714] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA095144] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR012408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM075762, R01GM071424] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Indiana University Biomedical Research; American Cancer Society(American Cancer Society); Cancer Research UK(Cancer Research UK); Offices of Biological and Environmental Research and of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM071424 and CA95144 and the American Heart Association (to T. G. K.). This work was also supported by grants from Indiana University Biomedical Research and the American Cancer Society (to R. V. S.) and Cancer Research UK (to M. O.).; We thank Y. Gedle, M. Lemmon, C. Musselman, E. Odintsova, and R. Zhao for discussions and helping with experiments and R. Prekeris and S. Wakatsuki for providing cDNAs of wild type and ARF1 Q71L. X-ray crystallographic data were collected at beamline X25 of the NSLS. Financial support for NSLS comes from the Offices of Biological and Environmental Research and of Basic Energy Sciences of the United States Department of Energy and from the National Center for Research Resources of the National Institutes of Health (Grant P41RR012408).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Balla A, 2005, MOL BIOL CELL, V16, P1282, DOI 10.1091/mbc.E04-07-0578; Bunney TD, 2009, MOL CELL, V34, P223, DOI 10.1016/j.molcel.2009.02.023; Cao XW, 2009, P NATL ACAD SCI USA, V106, P21121, DOI 10.1073/pnas.0911789106; Cho WW, 2001, ANAL BIOCHEM, V296, P153, DOI 10.1006/abio.2001.5225; Cohen LA, 2007, MOL BIOL CELL, V18, P2244, DOI 10.1091/mbc.E06-11-0998; D'Angelo G, 2008, J CELL SCI, V121, P1955, DOI 10.1242/jcs.023630; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DiNitto JP, 2006, BBA-MOL CELL BIOL L, V1761, P850, DOI 10.1016/j.bbalip.2006.04.008; Donaldson Julie G, 2008, Biochem J, V414, pe1, DOI 10.1042/BJ20081438; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferguson KM, 2000, MOL CELL, V6, P373, DOI 10.1016/S1097-2765(00)00037-X; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Godi A, 2004, NAT CELL BIOL, V6, P393, DOI 10.1038/ncb1119; GOTTLIEB RA, 1995, P NATL ACAD SCI USA, V92, P5965, DOI 10.1073/pnas.92.13.5965; He J, 2008, J LIPID RES, V49, P1807, DOI 10.1194/jlr.M800150-JLR200; He J, 2009, PROTEINS, V76, P852, DOI 10.1002/prot.22392; Hom RA, 2007, J MOL BIOL, V373, P412, DOI 10.1016/j.jmb.2007.08.016; Jezyk MR, 2006, NAT STRUCT MOL BIOL, V13, P1135, DOI 10.1038/nsmb1175; Kahn RA, 2006, J CELL BIOL, V172, P645, DOI 10.1083/jcb.200512057; Lee SA, 2005, P NATL ACAD SCI USA, V102, P13052, DOI 10.1073/pnas.0503900102; Lee SA, 2006, J BIOL CHEM, V281, P37091, DOI 10.1074/jbc.M608610200; Lemmon MA, 2004, BIOCHEM SOC T, V32, P707, DOI 10.1042/BST0320707; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Lenoir M, 2010, EMBO REP, V11, P279, DOI 10.1038/embor.2010.28; Levine TP, 2002, CURR BIOL, V12, P695, DOI 10.1016/S0960-9822(02)00779-0; Lietzke SE, 2000, MOL CELL, V6, P385, DOI 10.1016/S1097-2765(00)00038-1; Liu YZ, 2009, STRUCTURE, V17, P79, DOI 10.1016/j.str.2008.10.020; Menetrey J, 2007, EMBO J, V26, P1953, DOI 10.1038/sj.emboj.7601634; MOOLENAAR WH, 1983, NATURE, V304, P645, DOI 10.1038/304645a0; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; SCHULDINER S, 1982, P NATL ACAD SCI-BIOL, V79, P7778, DOI 10.1073/pnas.79.24.7778; Snyder JT, 2003, J BIOL CHEM, V278, P21099, DOI 10.1074/jbc.M301418200; Thangaraju M, 1999, J BIOL CHEM, V274, P29549, DOI 10.1074/jbc.274.41.29549; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; ZEUZEM S, 1992, P NATL ACAD SCI USA, V89, P6619, DOI 10.1073/pnas.89.14.6619	38	62	64	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18650	18657		10.1074/jbc.M111.233015	http://dx.doi.org/10.1074/jbc.M111.233015			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21454700	Green Published, hybrid			2022-12-25	WOS:000290785700037
J	Radu, RA; Hu, J; Yuan, Q; Welch, DL; Makshanoff, J; Lloyd, M; McMullen, S; Travis, GH; Bok, D				Radu, Roxana A.; Hu, Jane; Yuan, Quan; Welch, Darcy L.; Makshanoff, Jacob; Lloyd, Marcia; McMullen, Stephen; Travis, Gabriel H.; Bok, Dean			Complement System Dysregulation and Inflammation in the Retinal Pigment Epithelium of a Mouse Model for Stargardt Macular Degeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-H POLYMORPHISM; C-REACTIVE PROTEIN; OXIDATIVE DAMAGE; HUMAN-DISEASE; RIM PROTEIN; LIPOFUSCIN; A2E; ABCR; RISK; GENE	Accumulation of vitamin A-derived lipofuscin fluorophores in the retinal pigment epithelium (RPE) is a pathologic feature of recessive Stargardt macular dystrophy, a blinding disease caused by dysfunction or loss of the ABCA4 transporter in rods and cones. Age-related macular degeneration, a prevalent blinding disease of the elderly, is strongly associated with mutations in the genes for complement regulatory proteins (CRP), causing chronic inflammation of the RPE. Here we explore the possible relationship between lipofuscin accumulation and complement activation in vivo. Using the abca4(-/-) mouse model for recessive Stargardt, we investigated the role of lipofuscin fluorophores (A2E-lipofuscin) on oxidative stress and complement activation. We observed higher expression of oxidative-stress genes and elevated products of lipid peroxidation in eyes from abca4(-/-) versus wild-type mice. We also observed higher levels of complement-activation products in abca4(-/-) RPE cells. Unexpectedly, expression of multiple CRPs, which protect cells from attack by the complement system, were lower in abca4(-/-) versus wildtype RPE. To test whether acute exposure of healthy RPE cells to A2E-lipofuscin affects oxidative stress and expression of CRPs, we fed cultured fetal-derived human RPE cells with rod outer segments from wild-type or abca4(-/-) retinas. In contrast to RPE cells in abca4(-/-) mice, human RPE cells exposed to abca4(-/-) rod outer segments adaptively increased expression of both oxidative-stress and CRP genes. These results suggest that A2E accumulation causes oxidative stress, complement activation, and down-regulation of protective CRP in the Stargardt mouse model. Thus, Stargardt disease and age-related macular degeneration may both be caused by chronic inflammation of the RPE.	[Radu, Roxana A.; Hu, Jane; Yuan, Quan; Welch, Darcy L.; Makshanoff, Jacob; Lloyd, Marcia; McMullen, Stephen; Travis, Gabriel H.; Bok, Dean] Univ Calif Los Angeles, Sch Med, Jules Stein Eye Inst, Dept Ophthalmol, Los Angeles, CA 90095 USA; [Travis, Gabriel H.] Univ Calif Los Angeles, Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Bok, Dean] Univ Calif Los Angeles, Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; [Bok, Dean] Univ Calif Los Angeles, Sch Med, Brain Res Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Radu, RA (corresponding author), Univ Calif Los Angeles, Sch Med, Jules Stein Eye Inst, Dept Ophthalmol, 100 Stein Plaza, Los Angeles, CA 90095 USA.	radu@jsei.ucla.edu	yuan, quan/GZM-5597-2022; Radu, Roxana A./K-8924-2019; Travis, Gabriel Harvey/AIF-1062-2022	Travis, Gabriel Harvey/0000-0003-4020-9493; Radu, Roxana/0000-0002-5064-6403	National Institutes of Health [EY00331, R24 EY017404]; American Health Assistance Foundation; Macula Vision Research Foundation; Foundation Fighting Blindness; NATIONAL EYE INSTITUTE [R01EY011713, R24EY017404, P30EY000331] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Health Assistance Foundation; Macula Vision Research Foundation; Foundation Fighting Blindness(European Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY00331 (NEI; to D. B.) and R24 EY017404. This work was also supported by grants from the American Health Assistance Foundation (to R. A. R.), the Macula Vision Research Foundation (to D. B. and G. H. T.), and the Foundation Fighting Blindness (to D. B. and G. H. T.).	Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950; Avalle LB, 2004, EXP EYE RES, V78, P895, DOI 10.1016/j.exer.2003.10.023; Beatty S, 2000, SURV OPHTHALMOL, V45, P115, DOI 10.1016/S0039-6257(00)00140-5; Bither P P, 1988, J Am Optom Assoc, V59, P106; Booij JC, 2010, PROG RETIN EYE RES, V29, P1, DOI 10.1016/j.preteyeres.2009.08.003; Boon CJF, 2008, VISION RES, V48, P2569, DOI 10.1016/j.visres.2008.01.010; Cideciyan AV, 2004, HUM MOL GENET, V13, P525, DOI 10.1093/hmg/ddh048; DELORI FC, 1995, INVEST OPHTH VIS SCI, V36, P2327; Dillon J, 2004, EXP EYE RES, V79, P537, DOI 10.1016/j.exer.2004.06.024; Donoso LA, 2006, SURV OPHTHALMOL, V51, P137, DOI 10.1016/j.survophthal.2005.12.001; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; FLIESLER SJ, 1983, PROG LIPID RES, V22, P79; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Gu XR, 2003, J BIOL CHEM, V278, P42027, DOI 10.1074/jbc.M305460200; Hageman GS, 2006, ANN MED, V38, P592, DOI 10.1080/07853890601097030; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hecker LA, 2010, HUM MOL GENET, V19, P209, DOI 10.1093/hmg/ddp472; Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709; Hu J, 2001, MOL VIS, V7, P14; Hughes AE, 2006, NAT GENET, V38, P1173, DOI 10.1038/ng1890; Illing M, 1997, J BIOL CHEM, V272, P10303, DOI 10.1074/jbc.272.15.10303; Johnson PT, 2006, P NATL ACAD SCI USA, V103, P17456, DOI 10.1073/pnas.0606234103; Kapphahn RJ, 2006, EXP EYE RES, V83, P165, DOI 10.1016/j.exer.2005.11.017; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kurth I, 2007, MOL CELL BIOL, V27, P1370, DOI 10.1128/MCB.01486-06; LI B, 1993, J IMMUNOL, V151, P4295; Maller JB, 2007, NAT GENET, V39, P1200, DOI 10.1038/ng2131; Mata NL, 2000, P NATL ACAD SCI USA, V97, P7154, DOI 10.1073/pnas.130110497; Maugeri A, 2000, AM J HUM GENET, V67, P960, DOI 10.1086/303079; Okubo A, 1999, INVEST OPHTH VIS SCI, V40, P443; Parish CA, 1998, P NATL ACAD SCI USA, V95, P14609, DOI 10.1073/pnas.95.25.14609; Radu RA, 2004, P NATL ACAD SCI USA, V101, P5928, DOI 10.1073/pnas.0308302101; Radu RA, 2008, INVEST OPHTH VIS SCI, V49, P3821, DOI 10.1167/iovs.07-1470; Richards A, 2007, ADV IMMUNOL, V96, P141, DOI 10.1016/S0065-2776(07)96004-6; Seddon JM, 2005, ARCH OPHTHALMOL-CHIC, V123, P774, DOI 10.1001/archopht.123.6.774; Shen JK, 2007, HISTOL HISTOPATHOL, V22, P1301, DOI 10.14670/HH-22.1301; Sparrow JR, 2002, INVEST OPHTH VIS SCI, V43, P1222; Sun H, 1999, J BIOL CHEM, V274, P8269, DOI 10.1074/jbc.274.12.8269; Tanito M, 2005, INVEST OPHTH VIS SCI, V46, P3859, DOI 10.1167/iovs.05-0672; Wang Z, 2006, PHOTOCHEM PHOTOBIOL, V82, P474, DOI 10.1562/2005-10-21-RA-725; Wang Z, 2006, PHOTOCHEM PHOTOBIOL, V82, P1251, DOI 10.1562/2006-04-01-RA-864; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Yang P, 2009, INVEST OPHTH VIS SCI, V50, P3473, DOI 10.1167/iovs.08-3202; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618; YOUNG B, 1991, PATHOLOGY, V23, P118, DOI 10.3109/00313029109060809; YOUNG RW, 1969, J CELL BIOL, V42, P392, DOI 10.1083/jcb.42.2.392; YOUNG RW, 1987, SURV OPHTHALMOL, V31, P291, DOI 10.1145/1165387.275645; Zhou JL, 2006, P NATL ACAD SCI USA, V103, P16182, DOI 10.1073/pnas.0604255103; Zhou J, 2009, INVEST OPHTH VIS SCI, V50, P1392, DOI 10.1167/iovs.08-2868	51	108	112	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18593	18601		10.1074/jbc.M110.191866	http://dx.doi.org/10.1074/jbc.M110.191866			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21464132	Green Published, hybrid			2022-12-25	WOS:000290785700031
J	Pike, GM; Madden, BJ; Melder, DC; Charlesworth, MC; Federspiel, MJ				Pike, Gennett M.; Madden, Benjamin J.; Melder, Deborah C.; Charlesworth, M. Cristine; Federspiel, Mark J.			Simple, Automated, High Resolution Mass Spectrometry Method to Determine the Disulfide Bond and Glycosylation Patterns of a Complex Protein SUBGROUP A AVIAN SARCOMA AND LEUKOSIS VIRUS ENVELOPE GLYCOPROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-CAPTURE DISSOCIATION; MEMBRANE-FUSION PROTEIN; EBOLA-VIRUS; RECEPTOR-BINDING; LOW PH; CELLULAR RECEPTOR; INFECTION; IDENTIFICATION; SUBUNIT; CHICKEN	Enveloped viruses must fuse the viral and cellular membranes to enter the cell. Understanding how viral fusion proteins mediate entry will provide valuable information for antiviral intervention to combat associated disease. The avian sarcoma and leukosis virus envelope glycoproteins, trimers composed of surface (SU) and transmembrane heterodimers, break the fusion process into several steps. First, interactions between SU and a cell surface receptor at neutral pH trigger an initial conformational change in the viral glycoprotein trimer followed by exposure to low pH enabling additional conformational changes to complete the fusion of the viral and cellular membranes. Here, we describe the structural characterization of the extracellular region of the subgroup A avian sarcoma and leukosis viruses envelope glycoproteins, SUATM129 produced in chicken DF-1 cells. We developed a simple, automated method for acquiring high resolution mass spectrometry data using electron capture dissociation conditions that preferentially cleave the disulfide bond more readily than the peptide backbone amide bonds that enabled the identification of disulfide-linked peptides. Seven of nine disulfide bonds were definitively assigned; the remaining two bonds were assigned to an adjacent pair of cysteine residues. The first cysteine of surface and the last cysteine of the transmembrane form a disulfide bond linking the heterodimer. The surface glycoprotein contains a free cysteine at residue 38 previously reported to be critical for virus entry. Eleven of 13 possible SUATM129 N-linked glycosylation sites were modified with carbohydrate. This study demonstrates the utility of this simple yet powerful method for assigning disulfide bonds in a complex glycoprotein.	[Pike, Gennett M.; Melder, Deborah C.; Federspiel, Mark J.] Mayo Clin, Dept Mol Med, Rochester, MN 55905 USA; [Madden, Benjamin J.; Charlesworth, M. Cristine] Mayo Clin, Mayo Prote Res Ctr, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Federspiel, MJ (corresponding author), Mayo Clin, Dept Mol Med, 200 1st St SW, Rochester, MN 55905 USA.	federspiel.mark@mayo.edu		Federspiel, Mark/0000-0002-3713-186X	National Institutes of Health [AI48682]; Mayo Clinic; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048682] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI48682. This work was also supported by the Mayo Clinic.	Adkins HB, 1997, P NATL ACAD SCI USA, V94, P11617, DOI 10.1073/pnas.94.21.11617; Adkins HB, 2000, J VIROL, V74, P3572, DOI 10.1128/JVI.74.8.3572-3578.2000; Barnard RJO, 2003, CURR TOP MICROBIOL, V281, P107; BATES P, 1993, CELL, V74, P1043, DOI 10.1016/0092-8674(93)90726-7; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Brojatsch J, 1996, CELL, V87, P845, DOI 10.1016/S0092-8674(00)81992-3; COFFIN JM, 1992, CURR TOP MICROBIOL, V176, P143; Damico R, 2000, J VIROL, V74, P6469, DOI 10.1128/JVI.74.14.6469-6475.2000; Einfeld DA, 1997, J VIROL, V71, P2383, DOI 10.1128/JVI.71.3.2383-2389.1997; Elleder D, 2005, J VIROL, V79, P10408, DOI 10.1128/JVI.79.16.10408-10419.2005; FEDERSPIEL MJ, 1989, VIROLOGY, V173, P167, DOI 10.1016/0042-6822(89)90232-8; Gallaher WR, 1996, CELL, V85, P477, DOI 10.1016/S0092-8674(00)81248-9; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Hernandez LD, 1997, J CELL BIOL, V139, P1455, DOI 10.1083/jcb.139.6.1455; Himly M, 1998, VIROLOGY, V248, P295, DOI 10.1006/viro.1998.9290; Holmen SL, 1999, J VIROL, V73, P10051, DOI 10.1128/JVI.73.12.10051-10060.1999; Holmen SL, 2000, VIROLOGY, V273, P364, DOI 10.1006/viro.2000.0424; Holmen SL, 2001, J VIROL, V75, P726, DOI 10.1128/JVI.75.2.726-737.2001; Hunter E., 1997, P71; Jeffers SA, 2002, J VIROL, V76, P12463, DOI 10.1128/JVI.76.24.12463-12472.2002; Kvaratskhelia M, 2004, VIROLOGY, V326, P171, DOI 10.1016/j.virol.2004.05.020; Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082; Malashkevich VN, 1999, P NATL ACAD SCI USA, V96, P2662, DOI 10.1073/pnas.96.6.2662; Markosyan RM, 2004, BIOPHYS J, V87, P3291, DOI 10.1529/biophysj.104.047696; Matsuyama S, 2004, J VIROL, V78, P8201, DOI 10.1128/JVI.78.15.8201-8209.2004; Melikyan GB, 2005, P NATL ACAD SCI USA, V102, P8728, DOI 10.1073/pnas.0501864102; Mothes W, 2000, CELL, V103, P679, DOI 10.1016/S0092-8674(00)00170-7; Ochsenbauer-Jambor C, 2002, J VIROL, V76, P7518, DOI 10.1128/JVI.76.15.7518-7527.2002; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Sanchez A, 1998, J VIROL, V72, P6442, DOI 10.1128/JVI.72.8.6442-6447.1998; Schaefer-Klein J, 1998, VIROLOGY, V248, P305, DOI 10.1006/viro.1998.9291; Smith JG, 2007, PLOS PATHOG, V3, P1971, DOI 10.1371/journal.ppat.0030198; Smith JG, 2004, J VIROL, V78, P1403, DOI 10.1128/JVI.78.3.1403-1410.2004; Swanstrom R., 1997, P263; Tamm LK, 2003, BBA-BIOMEMBRANES, V1614, P14, DOI 10.1016/S0005-2736(03)00159-7; Weiss R. A., 1992, RETROVIRIDAE, P1; Weissenhorn W, 1998, P NATL ACAD SCI USA, V95, P6032, DOI 10.1073/pnas.95.11.6032; Weissenhorn W, 1998, MOL CELL, V2, P605, DOI 10.1016/S1097-2765(00)80159-8; White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]; YOUNG JAT, 1993, J VIROL, V67, P1811, DOI 10.1128/JVI.67.4.1811-1816.1993; YOUNG JAT, 2001, FIELDS VIROLOGY, P87; Zubarev RA, 2004, CURR OPIN BIOTECH, V15, P12, DOI 10.1016/j.copbio.2003.12.002; Zubarev RA, 2000, ANAL CHEM, V72, P563, DOI 10.1021/ac990811p	43	7	7	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17954	17967		10.1074/jbc.M111.229377	http://dx.doi.org/10.1074/jbc.M111.229377			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454567	hybrid, Green Published			2022-12-25	WOS:000290585200058
J	Treberg, JR; Brand, MD				Treberg, Jason R.; Brand, Martin D.			A Model of the Proton Translocation Mechanism of Complex I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADH-UBIQUINONE OXIDOREDUCTASE; IRON-SULFUR CLUSTERS; SUPEROXIDE-PRODUCTION; HEART-MITOCHONDRIA; ESCHERICHIA-COLI; ELECTRON; REDOX; GENERATION; MEMBRANE; MATRIX	Despite decades of speculation, the proton pumping mechanism of complex I (NADH-ubiquinone oxidoreductase) is unknown and continues to be controversial. Recent descriptions of the architecture of the hydrophobic region of complex I have resolved one vital issue: this region appears to have multiple proton transporters that are mechanically interlinked. Thus, transduction of conformational changes to drive the transmembrane transporters linked by a "connecting rod" during the reduction of ubiquinone (Q) can account for two or three of the four protons pumped per NADH oxidized. The remaining proton(s) must be pumped by direct coupling at the Q-binding site. Here, we present a mixed model based on a crucial constraint: the strong dependence on the pH gradient across the membrane (Delta pH) of superoxide generation at the Q-binding site of complex I. This model combines direct and indirect coupling mechanisms to account for the pumping of the four protons. It explains the observed properties of the semiquinone in the Q-binding site, the rapid superoxide production from this site during reverse electron transport, its low superoxide production during forward electron transport except in the presence of inhibitory Q-analogs and high protonmotive force, and the strong dependence of both modes of superoxide production on Delta pH.	[Treberg, Jason R.; Brand, Martin D.] Buck Inst Res Aging, Novato, CA 94945 USA	Buck Institute for Research on Aging	Treberg, JR (corresponding author), 8001 Redwood Blvd, Novato, CA 94945 USA.	jtreberg@mun.ca	Brand, Martin D/A-9423-2012	Brand, Martin D/0000-0003-4418-6153; Treberg, Jason/0000-0001-5112-7325	National Institutes of Health [P01 AG025901, PL1 AG032118, R01 AG033542]; Ellison Medical Foundation [AG-SS-2288-09]; NATIONAL INSTITUTE ON AGING [P01AG025901, R01AG033542, PL1AG032118] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported, in whole or in part, by National Institutes of Health Grants P01 AG025901, PL1 AG032118, and R01 AG033542. This work was also supported by The Ellison Medical Foundation Grant AG-SS-2288-09.	Adam-Vizi V, 2006, TRENDS PHARMACOL SCI, V27, P639, DOI 10.1016/j.tips.2006.10.005; Amarneh B, 2003, BIOCHEMISTRY-US, V42, P4800, DOI 10.1021/bi0340346; Birrell JA, 2010, FEBS LETT, V584, P4247, DOI 10.1016/j.febslet.2010.09.017; Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003; Brand MD, 2005, BIOCHEM SOC T, V33, P897, DOI 10.1042/BST0330897; Brandt U, 1997, BBA-BIOENERGETICS, V1318, P79, DOI 10.1016/S0005-2728(96)00141-7; BRANDT U, 2006, BIOCHEM J, V75, P473; Dutton PL, 1998, BBA-BIOENERGETICS, V1364, P245, DOI 10.1016/S0005-2728(98)00031-0; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Esterhazy D, 2008, BIOCHEMISTRY-US, V47, P3964, DOI 10.1021/bi702243b; Friedrich T, 2001, J BIOENERG BIOMEMBR, V33, P169, DOI 10.1023/A:1010722717257; Galkin AS, 1999, FEBS LETT, V451, P157, DOI 10.1016/S0014-5793(99)00575-X; Hinchliffe P, 2005, SCIENCE, V309, P771, DOI 10.1126/science.1113988; Hirst J, 2008, BIOCHEM SOC T, V36, P976, DOI 10.1042/BST0360976; Hunte C, 2010, SCIENCE, V329, P448, DOI 10.1126/science.1191046; Jastroch M, 2010, ESSAYS BIOCHEM, V47, P53, DOI [10.1042/bse0470053, 10.1042/BSE0470053]; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Kussmaul L, 2006, P NATL ACAD SCI USA, V103, P7607, DOI 10.1073/pnas.0510977103; Lambert AJ, 2008, FEBS LETT, V582, P1711, DOI 10.1016/j.febslet.2008.04.030; Lambert AJ, 2004, J BIOL CHEM, V279, P39414, DOI 10.1074/jbc.M406576200; Lambert AJ, 2004, BIOCHEM J, V382, P511, DOI 10.1042/BJ20040485; Liu SS, 1997, BIOSCIENCE REP, V17, P259, DOI 10.1023/A:1027328510931; Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x; Magnitsky S, 2002, J BIOENERG BIOMEMBR, V34, P193, DOI 10.1023/A:1016083419979; Medvedev ES, 2010, BBA-BIOENERGETICS, V1797, P1665, DOI 10.1016/j.bbabio.2010.05.011; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Ohnishi ST, 2010, BBA-BIOENERGETICS, V1797, P1901, DOI 10.1016/j.bbabio.2010.05.012; Ohnishi ST, 2010, BBA-BIOENERGETICS, V1797, P1891, DOI 10.1016/j.bbabio.2010.06.010; Ohnishi ST, 2005, J BIOENERG BIOMEMBR, V37, P1, DOI 10.1007/s10863-005-4117-y; Ohnishi T, 1998, BBA-BIOENERGETICS, V1364, P186, DOI 10.1016/S0005-2728(98)00027-9; Ohnishi T, 2010, FEBS LETT, V584, P4131, DOI 10.1016/j.febslet.2010.08.039; POZZAN T, 1979, J BIOL CHEM, V254, P200; RICH PR, 1984, BIOCHIM BIOPHYS ACTA, V768, P53, DOI 10.1016/0304-4173(84)90007-7; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Treberg JR, 2010, FEBS J, V277, P2766, DOI 10.1111/j.1742-4658.2010.07693.x; Verkhovskaya ML, 2008, P NATL ACAD SCI USA, V105, P3763, DOI 10.1073/pnas.0711249105; Votyakova TV, 2001, J NEUROCHEM, V79, P266, DOI 10.1046/j.1471-4159.2001.00548.x; WIKSTROM M, 1984, FEBS LETT, V169, P300, DOI 10.1016/0014-5793(84)80338-5; Zwicker K, 2006, J BIOL CHEM, V281, P23013, DOI 10.1074/jbc.M603442200	39	35	35	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17579	17584		10.1074/jbc.M111.227751	http://dx.doi.org/10.1074/jbc.M111.227751			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454533	hybrid, Green Published			2022-12-25	WOS:000290585200020
J	Zaharieva, I; Wichmann, JM; Dau, H				Zaharieva, Ivelina; Wichmann, Joerg M.; Dau, Holger			Thermodynamic Limitations of Photosynthetic Water Oxidation at High Proton Concentrations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYGEN-EVOLVING CENTER; II MEMBRANE-PARTICLES; PHOTOSYSTEM-II; PH-DEPENDENCE; MANGANESE COMPLEX; ELECTRON-TRANSFER; DIOXYGEN FORMATION; KINETIC-ANALYSIS; REACTION CYCLE; EVOLUTION	In oxygenic photosynthesis, solar energy drives the oxidation of water catalyzed by a Mn4Ca complex bound to the proteins of Photosystem II. Four protons are released during one turnover of the water oxidation cycle (S-state cycle), implying thermodynamic limitations at low pH. For proton concentrations ranging from 1 nM (pH 9) to 1 mM (pH 3), we have characterized the low-pH limitations using a new experimental approach: a specific pH-jump protocol combined with time-resolved measurement of the delayed chlorophyll fluorescence after nanosecond flash excitation. Effective pK values were determined for low-pH inhibition of the light-induced S-state transitions: pK(1) = 3.3 +/- 0.3, pK(2) = 3.5 +/- 0.2, and pK(3) approximate to pK(4) = 4.6 +/- 0.2. Alkaline inhibition was not observed. An extension of the classical Kok model facilitated assignment of these four pK values to specific deprotonation steps in the reaction cycle. Our results provide important support to the extended S-state cycle model and criteria needed for assessment of quantum chemical calculations of the mechanism of water oxidation. They also imply that, in intact organisms, the pH in the lumen compartment can hardly drop below 5, thereby limiting the Delta pH contribution to the driving force of ATP synthesis.	[Zaharieva, Ivelina; Wichmann, Joerg M.; Dau, Holger] Free Univ Berlin, Fachbereich Phys, D-14195 Berlin, Germany	Free University of Berlin	Dau, H (corresponding author), Free Univ Berlin, Fachbereich Phys, Arnimallee 14, D-14195 Berlin, Germany.	holger.dau@fu-berlin.de	Zaharieva, Ivelina S/H-6119-2012	Zaharieva, Ivelina S/0000-0002-4745-5307; Dau, Holger/0000-0001-6482-7494	Deutsche Forschungsgemeinschaft (Berlin) [SFB 498]; UniCat Cluster of Excellence (Unifying Concepts in Catalysis, Berlin); German Ministry of Education and Research [03SF0318C, 03SF0355D]; European Union [SOLAR-H2 516510]; Alexander-von-Humboldt Foundation	Deutsche Forschungsgemeinschaft (Berlin)(German Research Foundation (DFG)); UniCat Cluster of Excellence (Unifying Concepts in Catalysis, Berlin); German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); European Union(European Commission); Alexander-von-Humboldt Foundation(Alexander von Humboldt Foundation)	This work was supported in part by the Deutsche Forschungsgemeinschaft (SFB 498, Berlin), the UniCat Cluster of Excellence (Unifying Concepts in Catalysis, Berlin), the German Ministry of Education and Research (Bio-H<INF>2</INF>, 03SF0318C; and H<INF>2</INF> Design Cell, 03SF0355D), and the European Union (SOLAR-H2 516510).; Supported by a fellowship from the Alexander-von-Humboldt Foundation.	[Anonymous], 2002, PHOTOSYNTHETICA; Avenson TJ, 2005, P NATL ACAD SCI USA, V102, P9709, DOI 10.1073/pnas.0503952102; Bernat G, 2002, BIOCHEMISTRY-US, V41, P5830, DOI 10.1021/bi011691u; Brudvig GW, 2008, COORDIN CHEM REV, V252, P231, DOI 10.1016/j.ccr.2007.08.028; Buchta J, 2007, BBA-BIOENERGETICS, V1767, P565, DOI 10.1016/j.bbabio.2007.04.003; Clausen J, 2004, NATURE, V430, P480, DOI 10.1038/nature02676; Dau H, 2006, SCIENCE, V312, P1471; DAU H, 1989, PHOTOSYNTH RES, V20, P59, DOI 10.1007/BF00028622; Dau H, 2001, BBA-BIOENERGETICS, V1503, P24, DOI 10.1016/S0005-2728(00)00230-9; Dau H, 2008, COORDIN CHEM REV, V252, P273, DOI 10.1016/j.ccr.2007.09.001; Dau H, 2007, BBA-BIOENERGETICS, V1767, P472, DOI 10.1016/j.bbabio.2007.02.022; Dau H, 2007, PHOTOSYNTH RES, V92, P327, DOI 10.1007/s11120-007-9141-9; Dau H, 2010, CHEMCATCHEM, V2, P724, DOI 10.1002/cctc.201000126; Dau H, 2009, ACCOUNTS CHEM RES, V42, P1861, DOI 10.1021/ar900225y; de Wijn R, 2001, BIOCHEMISTRY-US, V40, P5821, DOI 10.1021/bi002824z; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Grabolle M, 2005, BBA-BIOENERGETICS, V1708, P209, DOI 10.1016/j.bbabio.2005.03.007; Grabolle M, 2007, PHYSIOL PLANTARUM, V131, P50, DOI 10.1111/j.1399-3054.2007.00941.x; Gust D, 2009, ACCOUNTS CHEM RES, V42, P1890, DOI 10.1021/ar900209b; Haumann M, 2005, SCIENCE, V310, P1019, DOI 10.1126/science.1117551; Haumann M, 2005, BIOCHEMISTRY-US, V44, P1894, DOI 10.1021/bi048697e; Haumann M, 1997, PHOTOSYNTH RES, V51, P193, DOI 10.1023/A:1005861917596; Haumann M, 2008, P NATL ACAD SCI USA, V105, P17384, DOI 10.1073/pnas.0802596105; Heinze I, 1996, BER BUNSEN PHYS CHEM, V100, P2008, DOI 10.1002/bbpc.19961001214; Herrero C, 2008, COORDIN CHEM REV, V252, P456, DOI 10.1016/j.ccr.2007.09.002; JOLIOT P, 1968, BIOCHIM BIOPHYS ACTA, V153, P625, DOI 10.1016/0005-2728(68)90190-4; Junge W, 2002, PHILOS T ROY SOC B, V357, P1407, DOI 10.1098/rstb.2002.1137; KOK B, 1970, PHOTOCHEM PHOTOBIOL, V11, P457, DOI 10.1111/j.1751-1097.1970.tb06017.x; Kolling DRJ, 2009, BIOCHEMISTRY-US, V48, P1381, DOI 10.1021/bi801774f; KRISHTALIK LI, 1986, BIOCHIM BIOPHYS ACTA, V849, P162, DOI 10.1016/0005-2728(86)90107-6; Lewis NS, 2006, P NATL ACAD SCI USA, V103, P15729, DOI 10.1073/pnas.0603395103; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; Magnuson A, 2009, ACCOUNTS CHEM RES, V42, P1899, DOI 10.1021/ar900127h; McEvoy JP, 2006, CHEM REV, V106, P4455, DOI 10.1021/cr0204294; McEvoy JP, 2004, PHYS CHEM CHEM PHYS, V6, P4754, DOI 10.1039/b407500e; MESSINGER J, 1994, BIOCHEMISTRY-US, V33, P10896, DOI 10.1021/bi00202a008; RAPPAPORT F, 1994, BBA-BIOENERGETICS, V1184, P178, DOI 10.1016/0005-2728(94)90222-4; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; Schiller H, 2000, J PHOTOCH PHOTOBIO B, V55, P138, DOI 10.1016/S1011-1344(00)00036-1; Shevela D, 2011, P NATL ACAD SCI USA, V108, P3602, DOI 10.1073/pnas.1014249108; Siegbahn PEM, 2009, ACCOUNTS CHEM RES, V42, P1871, DOI 10.1021/ar900117k; Siegbahn PEM, 2009, DALTON T, P5832, DOI 10.1039/b903007g; Siegbahn PEM, 2008, CHEM-EUR J, V14, P8290, DOI 10.1002/chem.200800445; Sproviero EM, 2008, J AM CHEM SOC, V130, P6728, DOI 10.1021/ja801979n; Suzuki H, 2005, BIOCHEMISTRY-US, V44, P1708, DOI 10.1021/bi0483312; Takizawa K, 2007, BBA-BIOENERGETICS, V1767, P1233, DOI 10.1016/j.bbabio.2007.07.006; Zaharieva I., 2011, ENERGY ENV SCI  0303, DOI [10.1039/c1030ee00815j, DOI 10.1039/C1030EE00815J]; ZANKEL KL, 1971, BIOCHIM BIOPHYS ACTA, V245, P373, DOI 10.1016/0005-2728(71)90156-3	48	33	34	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					18222	18228		10.1074/jbc.M111.237941	http://dx.doi.org/10.1074/jbc.M111.237941			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21464129	hybrid, Green Published			2022-12-25	WOS:000290585200082
J	Zhang, DX; Jiang, PP; Xu, QQ; Zhang, XT				Zhang, Dingxiao; Jiang, Pingping; Xu, Qinqin; Zhang, Xiaoting			Arginine and Glutamate-rich 1 (ARGLU1) Interacts with Mediator Subunit 1 (MED1) and Is Required for Estrogen Receptor-mediated Gene Transcription and Breast Cancer Cell Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; ACTIVATED PROTEIN-KINASE; COACTIVATOR COMPLEX; NUCLEAR RECEPTORS; DEPENDENT TRANSCRIPTION; TRAP/MEDIATOR-SUBUNIT; TRAP220; EXPRESSION; PHOSPHORYLATION; MECHANISMS	Estrogen receptor is a nuclear receptor superfamily member of transcriptional activators that regulate gene expression by recruiting diverese transcriptional coregulators. The Mediator complex is a central transcriptional coactivator complex that acts as a bridge between transcriptional activators and RNA polymerase II. MED1 (Mediator subunit 1) is the key Mediator subunit that directly interacts with estrogen receptor to mediate its functions both in vitro and in vivo. Interestingly, our previous biochemical analyses indicated that MED1 exists only in a subpopulation of the Mediator complex that is enriched with a number of distinct Mediator subunits and RNA polymerase II. Here, we report ARGLU1 as a MED1/Mediator-associated protein. We found that ARGLU1 (arginine and glutamate rich 1) not only colocalizes with MED1 in the nucleus, but also directly interacts with a far C-terminal region of MED1. Reporter assays indicate that ARGLU1 is able to cooperate with MED1 to regulate estrogen receptor-mediated gene transcription. Importantly, ARGLU1 is recruited, in a ligand-dependent manner, to endogenous estrogen receptor target gene promoters and is required for their expression. Furthermore, by ChIP-reChIP assay, we confirm that ARGLU1 and MED1 colocalize on the same estrogen receptor target gene promoter upon estrogen induction. Moreover, we found that depletion of ARGLU1 significantly impairs the growth, as well as anchorage-dependent and -independent colony formation of breast cancer cells. Taken together, these results establish ARGLU1 as a new MED1-interacting protein required for estrogen-dependent gene transcription and breast cancer cell growth.	[Zhang, Dingxiao; Jiang, Pingping; Xu, Qinqin; Zhang, Xiaoting] Univ Cincinnati, Coll Med, Dept Canc & Cell Biol, Cincinnati, OH 45267 USA; [Jiang, Pingping; Xu, Qinqin] Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China	University System of Ohio; University of Cincinnati; Zhejiang University	Zhang, XT (corresponding author), 3125 Eden Ave, Cincinnati, OH 45267 USA.	zhangxt@ucmail.uc.edu	Xu, Qinqin/I-2202-2019; Zhang, Dingxiao/A-1902-2016	JIANG, PINGPING/0000-0002-4975-4861; Zhang, Dingxiao/0000-0001-8505-8831	National Institutes of Health from the United States Public Health Service [DK P30 DK078392]; University of Cincinnati Cancer Center Start-up and Pilot; American Heart Association; Ride Cincinnati Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392] Funding Source: NIH RePORTER	National Institutes of Health from the United States Public Health Service; University of Cincinnati Cancer Center Start-up and Pilot; American Heart Association(American Heart Association); Ride Cincinnati Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK P30 DK078392 from the United States Public Health Service, University of Cincinnati Cancer Center Start-up and Pilot Grants, American Heart Association Beginning Grant-in-aid, and a Ride Cincinnati Award (to X. Z.).	Acevedo ML, 2004, MOL CELL, V13, P725, DOI 10.1016/S1097-2765(04)00121-2; Acevedo ML, 2003, MOL CELL BIOL, V23, P335, DOI 10.1128/MCB.23.1.335-348.2003; Baek HJ, 2002, MOL CELL BIOL, V22, P2842, DOI 10.1128/MCB.22.8.2842-2852.2002; Baek HJ, 2006, J BIOL CHEM, V281, P15172, DOI 10.1074/jbc.M601983200; Belakavadi M, 2008, MOL CELL BIOL, V28, P3932, DOI 10.1128/MCB.02191-07; Blazek E, 2005, CHROMOSOMA, V113, P399, DOI 10.1007/s00412-005-0329-5; Boube M, 2002, CELL, V110, P143, DOI 10.1016/S0092-8674(02)00830-9; Burakov D, 2000, J BIOL CHEM, V275, P20928, DOI 10.1074/jbc.M002013200; Conaway RC, 2005, TRENDS BIOCHEM SCI, V30, P250, DOI 10.1016/j.tibs.2005.03.002; Crawford SE, 2002, J BIOL CHEM, V277, P3585, DOI 10.1074/jbc.M107995200; Fondell JD, 1996, P NATL ACAD SCI USA, V93, P8329, DOI 10.1073/pnas.93.16.8329; Ge K, 2008, MOL CELL BIOL, V28, P1081, DOI 10.1128/MCB.00967-07; Glass CK, 2000, GENE DEV, V14, P121; Gordon DF, 2006, MOL ENDOCRINOL, V20, P1073, DOI 10.1210/me.2005-0115; Hock R, 2007, TRENDS CELL BIOL, V17, P72, DOI 10.1016/j.tcb.2006.12.001; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Jiang PP, 2010, P NATL ACAD SCI USA, V107, P6765, DOI 10.1073/pnas.1001814107; Johnson KM, 2002, GENE DEV, V16, P1852, DOI 10.1101/gad.995702; Kang YK, 2002, P NATL ACAD SCI USA, V99, P2642, DOI 10.1073/pnas.261715899; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luoh SW, 2002, CANCER GENET CYTOGEN, V136, P43, DOI 10.1016/S0165-4608(01)00657-4; Malik S, 2005, TRENDS BIOCHEM SCI, V30, P256, DOI 10.1016/j.tibs.2005.03.009; Malik S, 2000, TRENDS BIOCHEM SCI, V25, P277, DOI 10.1016/S0968-0004(00)01596-6; Malik S, 2004, MOL CELL BIOL, V24, P8244, DOI 10.1128/MCB.24.18.8244-8254.2004; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Misra P, 2002, J BIOL CHEM, V277, P48745, DOI 10.1074/jbc.M208829200; Pandey PK, 2005, MOL CELL BIOL, V25, P10695, DOI 10.1128/MCB.25.24.10695-10710.2005; Ren YS, 2000, MOL CELL BIOL, V20, P5433, DOI 10.1128/MCB.20.15.5433-5446.2000; Roeder RG, 1998, COLD SPRING HARB SYM, V63, P201, DOI 10.1101/sqb.1998.63.201; Roeder RG, 2003, NAT MED, V9, P1239, DOI 10.1038/nm938; Sato S, 2004, MOL CELL, V14, P685, DOI 10.1016/j.molcel.2004.05.006; Savkur RS, 2004, J PEPT RES, V63, P207, DOI 10.1111/j.1399-3011.2004.00126.x; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Stumpf M, 2006, P NATL ACAD SCI USA, V103, P18504, DOI 10.1073/pnas.0604494103; Taatjes DJ, 2010, TRENDS BIOCHEM SCI, V35, P315, DOI 10.1016/j.tibs.2010.02.004; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.biochem.63.1.451; Wallberg AE, 2003, MOL CELL, V12, P1137, DOI 10.1016/S1097-2765(03)00391-5; Warnmark A, 2001, J BIOL CHEM, V276, P23397, DOI 10.1074/jbc.M011651200; Yuan CX, 1998, P NATL ACAD SCI USA, V95, P7939, DOI 10.1073/pnas.95.14.7939; Zhang XT, 2005, MOL CELL, V19, P89, DOI 10.1016/j.molcel.2005.05.015; Zhu YJ, 1999, P NATL ACAD SCI USA, V96, P10848, DOI 10.1073/pnas.96.19.10848	44	40	42	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17746	17754		10.1074/jbc.M110.206029	http://dx.doi.org/10.1074/jbc.M110.206029			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454576	Green Published, hybrid			2022-12-25	WOS:000290585200038
J	Bonacci, G; Schopfer, FJ; Batthyany, CI; Rudolph, TK; Rudolph, V; Khoo, NKH; Kelley, EE; Freeman, BA				Bonacci, Gustavo; Schopfer, Francisco J.; Batthyany, Carlos I.; Rudolph, Tanja K.; Rudolph, Volker; Khoo, Nicholas K. H.; Kelley, Eric E.; Freeman, Bruce A.			Electrophilic Fatty Acids Regulate Matrix Metalloproteinase Activity and Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED-RECEPTOR-GAMMA; ATHEROSCLEROTIC PLAQUE STABILITY; NITRIC-OXIDE; CYSTEINE SWITCH; NITROLINOLEIC ACID; SIGNALING PATHWAY; NITROGEN-DIOXIDE; MECHANISM; PEROXYNITRITE; INFLAMMATION	Nitro-fatty acids (NO2-FA) are electrophilic signaling mediators formed by reactions of nitric oxide and nitrite. NO2-FA exert anti-inflammatory signaling actions through post-translational protein modifications. We report that nitro-oleic acid (OA-NO2) stimulates proMMP-7 and proMMP-9 proteolytic activity via adduction of the conserved cysteine switch domain thiolate. Biotin-labeled OA-NO2 showed this adduction occurs preferentially with latent forms of MMP, confirming a role for thiol alkylation by OA-NO2 in MMP activation. In addition to regulating pro-MMP activation, MMP expression was modulated by OA-NO2 via activation of peroxisome proliferator-activated receptor-gamma. MMP-9 transcription was decreased in phorbol 12-myristate 13-acetate-stimulated THP-1 macrophages to an extent similar to that induced by the peroxisome proliferator-activated receptor-gamma agonist Rosiglitazone. This was affirmed using a murine model of atherosclerosis, ApoE(-/-) mice, where in vivo OA-NO2 administration suppressed MMP expression in atherosclerotic lesions. These findings reveal that electrophilic fatty acid derivatives can serve as effectors during inflammation, first by activating pro-MMP proteolytic activity via alkylation of the cysteine switch domain, and then by transcriptionally inhibiting MMP expression, thereby limiting the further progression of inflammatory processes.	[Bonacci, Gustavo; Schopfer, Francisco J.; Rudolph, Tanja K.; Rudolph, Volker; Khoo, Nicholas K. H.; Freeman, Bruce A.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA; [Kelley, Eric E.] Univ Pittsburgh, Dept Anesthesiol, Pittsburgh, PA 15213 USA; [Rudolph, Tanja K.; Rudolph, Volker] Univ Heart Ctr Hamburg, Dept Cardiol, D-20246 Hamburg, Germany; [Batthyany, Carlos I.] Inst Pasteur, Montevideo 11400, Uruguay	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Hamburg; University Medical Center Hamburg-Eppendorf; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo	Freeman, BA (corresponding author), Univ Pittsburgh, Dept Pharmacol & Chem Biol, Thomas E Starzl Biomed Sci Tower,200 Lothrop St, Pittsburgh, PA 15213 USA.	freerad@pitt.edu	Schopfer, Francisco Jose/AAE-8125-2020; Freeman, Bruce A/H-9342-2012; Schopfer, Francisco/AAW-6505-2021	Schopfer, Francisco Jose/0000-0001-9526-695X; Batthyany, Carlos/0000-0002-0627-1982	National Institutes of Health [R01 HL58115, R01 HL64937]; American Diabetes Association [7-08-JF-52]; American Heart Association [0665418U]; Deutsche Herzstiftung; Complexa, Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058115, R01HL064937, R37HL058115] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); American Heart Association(American Heart Association); Deutsche Herzstiftung; Complexa, Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL58115 and R01 HL64937 (to B. A. F.), American Diabetes Association Grant 7-08-JF-52 (to F. J. S.), American Heart Association Grant 0665418U (to F. J. S.), and a grant from the Deutsche Herzstiftung (to V. R.). B. A. F. acknowledges financial interest in Complexa, Inc.	Alexander RL, 2006, BIOCHEMISTRY-US, V45, P7889, DOI 10.1021/bi0605639; Baker LMS, 2007, J BIOL CHEM, V282, P31085, DOI 10.1074/jbc.M704085200; Baker PRS, 2009, FREE RADICAL BIO MED, V46, P989, DOI 10.1016/j.freeradbiomed.2008.11.021; Baker PRS, 2005, J BIOL CHEM, V280, P42464, DOI 10.1074/jbc.M504212200; Baker PRS, 2004, P NATL ACAD SCI USA, V101, P11577, DOI 10.1073/pnas.0402587101; Batthyany C, 2006, J BIOL CHEM, V281, P20450, DOI 10.1074/jbc.M602814200; Casella L, 2002, ENVIRON HEALTH PERSP, V110, P709, DOI 10.1289/ehp.02110s5709; Cui T, 2006, J BIOL CHEM, V281, P35686, DOI 10.1074/jbc.M603357200; Deshmukh HS, 2008, AM J RESP CELL MOL, V38, P446, DOI 10.1165/rcmb.2006-0339OC; Dollery CM, 2006, CARDIOVASC RES, V69, P625, DOI 10.1016/j.cardiores.2005.11.003; Ferreira AM, 2009, BIOCHEM J, V417, P223, DOI 10.1042/BJ20080701; Fu XY, 2003, J BIOL CHEM, V278, P28403, DOI 10.1074/jbc.M304739200; Fu XY, 2001, J BIOL CHEM, V276, P41279, DOI 10.1074/jbc.M106958200; Gladwin MT, 2008, BLOOD, V112, P2636, DOI 10.1182/blood-2008-01-115261; Gu ZZ, 2002, SCIENCE, V297, P1186, DOI 10.1126/science.1073634; Ichikawa T, 2008, ENDOCRINOLOGY, V149, P4086, DOI 10.1210/en.2007-1639; Jain K, 2008, FREE RADICAL BIO MED, V45, P269, DOI 10.1016/j.freeradbiomed.2008.04.015; Johnson JL, 2005, P NATL ACAD SCI USA, V102, P15575, DOI 10.1073/pnas.0506201102; Kansanen E, 2011, J BIOL CHEM, V286, P14019, DOI 10.1074/jbc.M110.190710; Kansanen E, 2009, J BIOL CHEM, V284, P33233, DOI 10.1074/jbc.M109.064873; Lemaitre Vincent, 2006, Birth Defects Research, V78, P1, DOI 10.1002/bdrc.20065; Lin D, 2008, CHEM RES TOXICOL, V21, P2361, DOI 10.1021/tx800248x; Manicone AM, 2008, SEMIN CELL DEV BIOL, V19, P34, DOI 10.1016/j.semcdb.2007.07.003; McCarthy SM, 2008, BIOCHEMISTRY-US, V47, P5832, DOI 10.1021/bi702496v; Nadtochiy SM, 2009, CARDIOVASC RES, V82, P333, DOI 10.1093/cvr/cvn323; Newby AC, 2006, CARDIOVASC RES, V69, P614, DOI 10.1016/j.cardiores.2005.08.002; Newby AC, 2007, TRENDS CARDIOVAS MED, V17, P253, DOI 10.1016/j.tcm.2007.09.001; Newby AC, 2009, THROMB HAEMOSTASIS, V101, P1006, DOI 10.1160/TH08-07-0469; O'Donnell VB, 1999, CHEM RES TOXICOL, V12, P83, DOI 10.1021/tx980207u; Okamoto T, 2001, J BIOL CHEM, V276, P29596, DOI 10.1074/jbc.M102417200; Okamoto T, 1997, ARCH BIOCHEM BIOPHYS, V342, P261, DOI 10.1006/abbi.1997.0127; Ra HJ, 2007, MATRIX BIOL, V26, P587, DOI 10.1016/j.matbio.2007.07.001; Rajagopalan S, 1996, J CLIN INVEST, V98, P2572, DOI 10.1172/JCI119076; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Rudolph TK, 2010, ARTERIOSCL THROM VAS, V30, P938, DOI 10.1161/ATVBAHA.109.201582; Rudolph TK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.290re7; Rudolph V, 2010, CARDIOVASC RES, V85, P155, DOI 10.1093/cvr/cvp275; Rudolph V, 2009, CIRC RES, V105, P511, DOI 10.1161/CIRCRESAHA.109.202077; Rudolph V, 2009, J BIOL CHEM, V284, P1461, DOI 10.1074/jbc.M802298200; Schopfer FJ, 2005, P NATL ACAD SCI USA, V102, P2340, DOI 10.1073/pnas.0408384102; Schopfer FJ, 2010, J BIOL CHEM, V285, P12321, DOI 10.1074/jbc.M109.091512; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; VANWART HE, 1990, P NATL ACAD SCI USA, V87, P5578, DOI 10.1073/pnas.87.14.5578; Villacorta L, 2007, AM J PHYSIOL-HEART C, V293, pH770, DOI 10.1152/ajpheart.00261.2007	44	42	51	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M111.225029	http://dx.doi.org/10.1074/jbc.M111.225029			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454668	Green Published, hybrid			2022-12-25	WOS:000290022800047
J	Hoa, NT; Tran, TBC; Tran, TTN; Dung, NV; Campbell, J; Anh, PH; Tho, HH; Nguyen, VVC; Bryant, JE; Hien, TT; Farrar, J; Schultsz, C				Ngo Thi Hoa; Tran Thi Bich Chieu; Tran Thi Thu Nga; Nguyen Van Dung; Campbell, James; Pham Hong Anh; Huynh Huu Tho; Nguyen Van Vinh Chau; Bryant, Juliet E.; Tran Tinh Hien; Farrar, Jeremy; Schultsz, Constance			Slaughterhouse Pigs Are a Major Reservoir of Streptococcus suis Serotype 2 Capable of Causing Human Infection in Southern Vietnam	PLOS ONE			English	Article							MURAMIDASE-RELEASED PROTEIN; NORTH-AMERICA; DISEASED PIGS; TYPE-2; VIRULENCE; SEQUENCE; CHINA; GENE; IDENTIFICATION; GENOTYPES	Streptococcus suis is a pathogen of major economic significance to the swine industry and is increasingly recognized as an emerging zoonotic agent in Asia. In Vietnam, S. suis is the leading cause of bacterial meningitis in adult humans. Zoonotic transmission is most frequently associated with serotype 2 strains and occupational exposure to pigs or consumption of infected pork. To gain insight into the role of pigs for human consumption as a reservoir for zoonotic infection in southern Vietnam, we determined the prevalence and diversity of S. suis carriage in healthy slaughterhouse pigs. Nasopharyngeal tonsils were sampled from pigs at slaughterhouses serving six provinces in southern Vietnam and Ho Chi Minh City area from September 2006 to November 2007. Samples were screened by bacterial culture. Isolates of S. suis were serotyped and characterized by multi locus sequence typing (MLST) and pulse field gel electrophoresis (PFGE). Antibiotic susceptibility profiles and associated genetic resistance determinants, and the presence of putative virulence factors were determined. 41% (222/542) of pigs carried S. suis of one or multiple serotypes. 8% (45/542) carried S. suis serotype 2 which was the most common serotype found (45/317 strains, 14%). 80% of serotype 2 strains belonged to the MLST clonal complex 1, which was previously associated with meningitis cases in Vietnam and outbreaks of severe disease in China in 1998 and 2005. These strains clustered with representative strains isolated from patients with meningitis in PFGE analysis, and showed similar antimicrobial resistance and virulence factor profiles. Slaughterhouse pigs are a major reservoir of S. suis serotype 2 capable of causing human infection in southern Vietnam. Strict hygiene at processing facilities, and health education programs addressing food safety and proper handling of pork should be encouraged.	[Ngo Thi Hoa; Tran Thi Bich Chieu; Tran Thi Thu Nga; Campbell, James; Pham Hong Anh; Bryant, Juliet E.; Farrar, Jeremy; Schultsz, Constance] Univ Oxford, Clin Res Unit, Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Nguyen Van Dung; Huynh Huu Tho] Subdept Anim Hlth, Ho Chi Minh City, Vietnam; [Ngo Thi Hoa; Bryant, Juliet E.; Farrar, Jeremy] Univ Oxford, Ctr Trop Med, Oxford, England; [Schultsz, Constance] Univ Amsterdam, Acad Med Ctr, Ctr Poverty Related Communicable Dis, NL-1105 AZ Amsterdam, Netherlands	University of Oxford; University of Oxford; University of Amsterdam; Academic Medical Center Amsterdam	Hoa, NT (corresponding author), Univ Oxford, Clin Res Unit, Hosp Trop Dis, Ho Chi Minh City, Vietnam.	hoant@oucru.org	Farrar, Jeremy J./HGA-7610-2022	Ngo, Hoa/0000-0001-9320-4050; Farrar, Jeremy/0000-0002-2700-623X; Bryant, Juliet/0000-0001-9535-4925; Van Nguyen, Dung/0000-0002-0590-0679	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This research was supported by the Wellcome Trust Major Overseas Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amass SF, 1997, J CLIN MICROBIOL, V35, P1595, DOI 10.1128/JCM.35.6.1595-1596.1997; Chang B, 2006, JPN J INFECT DIS, V59, P397; CLIFTONHADLEY FA, 1980, VET REC, V107, P40, DOI 10.1136/vr.107.2.40; CLIFTONHADLEY FA, 1983, BRIT VET J, V139, P1; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Fittipaldi N, 2009, VET MICROBIOL, V139, P310, DOI 10.1016/j.vetmic.2009.06.024; Gottschalk M, 1998, CAN J VET RES, V62, P75; Gottschalk M., 2010, Clinical Microbiology Newsletter, V32, P97, DOI 10.1016/j.clinmicnews.2010.06.001; Gottschalk Marcelo, 2007, Animal Health Research Reviews, V8, P29, DOI 10.1017/S1466252307001247; Haleis A, 2009, EMERG INFECT DIS, V15, P350, DOI 10.3201/eid1502.080842; Han DU, 2001, CAN J VET RES, V65, P151; HOA NT, BMC INFECT DIS, V11, P6; Holden MTG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006072; Kerdsin A, 2009, J MED MICROBIOL, V58, P1508, DOI 10.1099/jmm.0.013656-0; King SJ, 2002, J CLIN MICROBIOL, V40, P3671, DOI 10.1128/JCM.40.10.3671-3680.2002; Malhotra-Kumar S, 2005, ANTIMICROB AGENTS CH, V49, P4798, DOI 10.1128/AAC.49.11.4798-4800.2005; Marois C, 2007, CAN J VET RES, V71, P14; Montanari MP, 2003, J CLIN MICROBIOL, V41, P428, DOI 10.1128/JCM.41.1.428-431.2003; Nghia HDT, 2008, EMERG INFECT DIS, V14, P155, DOI 10.3201/eid1401.070534; Nguyen THM, 2008, CLIN INFECT DIS, V46, P659, DOI 10.1086/527385; Princivalli MS, 2009, EURO SURVEILL, V14; Silva LMG, 2006, VET MICROBIOL, V115, P117, DOI 10.1016/j.vetmic.2005.12.013; SMITH HE, 1992, INFECT IMMUN, V60, P2361, DOI 10.1128/IAI.60.6.2361-2367.1992; Staats JJ, 1999, VET MICROBIOL, V70, P201, DOI 10.1016/S0378-1135(99)00147-9; Takamatsu D, 2008, EMERG INFECT DIS, V14, P181, DOI 10.3201/eid1401.070568; VECHT U, 1991, INFECT IMMUN, V59, P3156, DOI 10.1128/IAI.59.9.3156-3162.1991; Wangsomboonsiri W, 2008, J INFECTION, V57, P392, DOI 10.1016/j.jinf.2008.08.006; Wei ZG, 2009, VET MICROBIOL, V137, P196, DOI 10.1016/j.vetmic.2008.12.015; Wertheim HFL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005973; Wertheim HFL, 2009, CLIN INFECT DIS, V48, P617, DOI 10.1086/596763; WILKLER MA, 2008, 28 CLIN LAB STAND S; Wisselink HJ, 2000, VET MICROBIOL, V74, P237, DOI 10.1016/S0378-1135(00)00188-7; Ye CY, 2006, EMERG INFECT DIS, V12, P1203, DOI 10.3201/eid1708.060232; Yu HJ, 2006, EMERG INFECT DIS, V12, P914, DOI 10.3201/eid1206.051194; Zhang Chun-Ping, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P235	35	50	55	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e17943	10.1371/journal.pone.0017943	http://dx.doi.org/10.1371/journal.pone.0017943			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464930	Green Published, Green Submitted, gold			2022-12-25	WOS:000289053800007
J	Yoshii, SR; Kishi, C; Ishihara, N; Mizushima, N				Yoshii, Saori R.; Kishi, Chieko; Ishihara, Naotada; Mizushima, Noboru			Parkin Mediates Proteasome-dependent Protein Degradation and Rupture of the Outer Mitochondrial Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN-CELLS; PERMEABILITY TRANSITION; AUTOPHAGOSOME FORMATION; PREPROTEIN TRANSLOCASE; ENDOPLASMIC-RETICULUM; TNF-ALPHA; MITOPHAGY; DISEASE; MITOFUSIN; PINK1	Upon mitochondrial depolarization, Parkin, a Parkinson disease-related E3 ubiquitin ligase, translocates from the cytosol to mitochondria and promotes their degradation by mitophagy, a selective type of autophagy. Here, we report that in addition to mitophagy, Parkin mediates proteasome-dependent degradation of outer membrane proteins such as Tom20, Tom40, Tom70, and Omp25 of depolarized mitochondria. By contrast, degradation of the inner membrane and matrix proteins largely depends on mitophagy. Furthermore, Parkin induces rupture of the outer membrane of depolarized mitochondria, which also depends on proteasomal activity. Upon induction of mitochondrial depolarization, proteasomes are recruited to mitochondria in the perinuclear region. Neither proteasome-dependent degradation of outer membrane proteins nor outer membrane rupture is required for mitophagy. These results suggest that Parkin regulates degradation of outer and inner mitochondrial membrane proteins differently through proteasome-and mitophagy-dependent pathways.	[Mizushima, Noboru] Tokyo Med & Dent Univ, Dept Physiol & Cell Biol, Bunkyo Ku, Tokyo 1138519, Japan; [Ishihara, Naotada] Kurume Univ, Inst Life Sci, Dept Prot Biochem, Kurume, Fukuoka 8390864, Japan	Tokyo Medical & Dental University (TMDU); Kurume University	Mizushima, N (corresponding author), Tokyo Med & Dent Univ, Dept Physiol & Cell Biol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	nmizu.phy2@tmd.ac.jp	Yoshii, Saori/M-6170-2016; Mizushima, Noboru/C-3635-2009	Yoshii, Saori/0000-0002-0814-4776; Mizushima, Noboru/0000-0002-6258-6444; Ishihara, Naotada/0000-0002-6305-7149	Ministry of Education, Culture, Sports, Science and Technology, Japan; Takeda Science Foundation; Funding Program for Next Generation World-Leading Researchers	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Funding Program for Next Generation World-Leading Researchers(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (to N. I. and N. M.), the Takeda Science Foundation (to N. M.), and the Funding Program for Next Generation World-Leading Researchers (to N. I. and N. M.).	Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868; Angermuller S, 1998, J HISTOCHEM CYTOCHEM, V46, P1175, DOI 10.1177/002215549804601009; Chan N. C., 2011, HUM MOL GEN IN PRESS; Chen D, 2010, J BIOL CHEM, V285, P38214, DOI 10.1074/jbc.M110.101469; Chu CT, 2010, HUM MOL GENET, V19, pR28, DOI 10.1093/hmg/ddq143; Cohen MMJ, 2008, MOL BIOL CELL, V19, P2457, DOI 10.1091/mbc.E08-02-0227; Dickson DW, 2009, LANCET NEUROL, V8, P1150, DOI 10.1016/S1474-4422(09)70238-8; Ding WX, 2010, J BIOL CHEM, V285, P27879, DOI 10.1074/jbc.M110.119537; Eskelinen EL, 2005, AUTOPHAGY, V1, P1, DOI 10.4161/auto.1.1.1270; Eura Y, 2003, J BIOCHEM, V134, P333, DOI 10.1093/jb/mvg150; Feldmann G, 2000, HEPATOLOGY, V31, P674, DOI 10.1002/hep.510310318; Gan BY, 2006, J CELL BIOL, V175, P121, DOI 10.1083/jcb.200604129; Gegg ME, 2010, HUM MOL GENET, V19, P4861, DOI 10.1093/hmg/ddq419; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Hamazaki J, 2007, MOL CELL BIOL, V27, P6629, DOI 10.1128/MCB.00509-07; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Hayashi-Nishino M, 2009, NAT CELL BIOL, V11, P1433, DOI 10.1038/ncb1991; Horie C, 2002, MOL BIOL CELL, V13, P1615, DOI 10.1091/mbc.01-12-0570; Hosokawa N, 2006, FEBS LETT, V580, P2623, DOI 10.1016/j.febslet.2006.04.008; Ishihara N, 1998, J BIOCHEM-TOKYO, V123, P722; Iwahashi J, 1997, J BIOL CHEM, V272, P18467, DOI 10.1074/jbc.272.29.18467; Karbowski M, 2007, J CELL BIOL, V178, P71, DOI 10.1083/jcb.200611064; Kawajiri S, 2010, FEBS LETT, V584, P1073, DOI 10.1016/j.febslet.2010.02.016; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lee JY, 2010, J CELL BIOL, V189, P671, DOI 10.1083/jcb.201001039; Livnat-Levanon N, 2011, BBA-GENE REGUL MECH, V1809, P80, DOI 10.1016/j.bbagrm.2010.07.005; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; Nakagawa T, 2007, GENES CELLS, V12, P709, DOI 10.1111/j.1365-2443.2007.01086.x; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, AUTOPHAGY, V6, P1090, DOI 10.4161/auto.6.8.13426; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Neutzner A, 2008, ANN NY ACAD SCI, V1147, P242, DOI 10.1196/annals.1427.012; Newman RM, 2004, J BIOL CHEM, V279, P41504, DOI 10.1074/jbc.M407349200; Obeso JA, 2010, NAT MED, V16, P653, DOI 10.1038/nm.2165; Okatsu K, 2010, GENES CELLS, V15, P887, DOI 10.1111/j.1365-2443.2010.01426.x; Poole AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010054; Prakash S, 2009, NAT CHEM BIOL, V5, P29, DOI 10.1038/nchembio.130; Rakovic A, 2010, HUM MOL GENET, V19, P3124, DOI 10.1093/hmg/ddq215; Rehling P, 2004, NAT REV MOL CELL BIO, V5, P519, DOI 10.1038/nrm1426; Suzuki H, 2002, J CELL SCI, V115, P1895; Suzuki H, 2000, J BIOL CHEM, V275, P37930, DOI 10.1074/jbc.M006558200; Takeda K, 2010, P NATL ACAD SCI USA, V107, P3540, DOI 10.1073/pnas.0911055107; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Tanaka A, 2010, FEBS LETT, V584, P1386, DOI 10.1016/j.febslet.2010.02.060; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Wang HX, 2011, J BIOL CHEM, V286, P11649, DOI 10.1074/jbc.M110.144238; Xu S, 2011, MOL BIOL CELL, V22, P291, DOI 10.1091/mbc.E10-09-0748; Yla-Anttila P, 2009, AUTOPHAGY, V5, P1180; Yonashiro R, 2006, EMBO J, V25, P3618, DOI 10.1038/sj.emboj.7601249; Yonashiro R, 2009, MOL BIOL CELL, V20, P4524, DOI 10.1091/mbc.E09-02-0112; Yoshimori T, 2000, MOL BIOL CELL, V11, P747, DOI 10.1091/mbc.11.2.747; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612; Zhu JH, 2010, J ALZHEIMERS DIS, V20, pS325, DOI 10.3233/JAD-2010-100363; Zischka H, 2008, ANAL CHEM, V80, P5051, DOI 10.1021/ac800173r; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107	58	441	451	2	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19630	19640		10.1074/jbc.M110.209338	http://dx.doi.org/10.1074/jbc.M110.209338			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21454557	Green Published, hybrid			2022-12-25	WOS:000291027700046
J	Sun, Y; Perera, J; Rubin, BP; Huang, JT				Sun, Yin; Perera, Juanita; Rubin, Brian P.; Huang, Jiaoti			SYT-SSX1 (Synovial Sarcoma Translocated) Regulates PIASy Ligase Activity to Cause Overexpression of NCOA3 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR RECEPTOR COACTIVATOR; POLYMERASE CHAIN-REACTION; KAPPA-B ACTIVATION; PROSTATE-CANCER; TRANSCRIPTIONAL ACTIVITY; GENOTOXIC STRESS; DIAGNOSTIC-TOOL; ONCOPROTEIN SYT; RAR-ALPHA; AIB1	Chromosomal translocations are a major source of genetic abnormalities causally linked to certain malignancies. Synovial sarcoma is an aggressive soft tissue tumor characterized by a chromosomal translocation between chromosome 18 and X, generating oncoproteins such as SYT-SSX1 and SYT-SSX2. The molecular mechanism underlying the oncogenic potential of SYT-SSX1/2 is not clear. Here we show that SYT-SSX1 leads to up-regulation of NCOA3, a protein critical for the formation of various cancers. The increase of NCOA3 is essential for SYT-SSX1-mediated synovial sarcoma formation. SYT-SSX1 does so by increasing the sumoylation of NCOA3 through interaction with a SUMO E3 ligase, PIASy, as well as the sumoylation of NEMO. NEMO has also been shown to physically interact with NCOA3. Increased sumoylation of NCOA3 leads to its increased steady state level and nuclear localization. Our findings represent the first example that an oncoprotein directly regulates substrate modification by a SUMO E3 ligase, and leads to overexpression of a protein essential for tumor formation. Such a mechanistic finding provides an opportunity to design specific therapeutic interventions to treat synovial sarcoma.	[Rubin, Brian P.] Cleveland Clin Fdn, Dept Anat Pathol & Mol Genet, Taussig Canc Ctr, Cleveland, OH 44195 USA; [Rubin, Brian P.] Cleveland Clin Fdn, Lerner Res Inst, Cleveland, OH 44195 USA; [Sun, Yin; Huang, Jiaoti] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Huang, Jiaoti] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Huang, Jiaoti] Univ Calif Los Angeles, David Geffen Sch Med, Broad Ctr Regenerat Med & Stem Cell Res, Los Angeles, CA 90095 USA; [Perera, Juanita] Univ Rochester, Dept Biomed Genet, Rochester, NY 14620 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Rochester	Rubin, BP (corresponding author), Cleveland Clin Fdn, Dept Anat Pathol & Mol Genet, Taussig Canc Ctr, L25, Cleveland, OH 44195 USA.	yinsun@mednet.ucla.edu; jiaotihuang@mednet.ucla.edu		Huang, Jiaoti/0000-0003-1195-1998	National Institutes of Health [R01 CA093848]; American Cancer Society [RSG-07-092-01-TBE]; Dept. of Defense [PC061456]; UCLA SPORE in prostate cancer; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE [R01CA093848] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Dept. of Defense(United States Department of Defense); UCLA SPORE in prostate cancer; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA093848 (to Y. S.). This work was also supported by Grants from the American Cancer Society (RSG-07-092-01-TBE), Dept. of Defense Prostate Cancer Research Program (PC061456), a developmental research award from UCLA SPORE in prostate cancer (PI: R. Reiter) and a challenge award from the Prostate Cancer Foundation (PI: O. Witte) (to J. H.).	Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Bae SH, 2004, BIOCHEM BIOPH RES CO, V324, P394, DOI 10.1016/j.bbrc.2004.09.068; Chung ACK, 2007, CANCER RES, V67, P5965, DOI 10.1158/0008-5472.CAN-06-3168; CLARK J, 1994, NAT GENET, V7, P502, DOI 10.1038/ng0894-502; CREW AJ, 1995, EMBO J, V14, P2333, DOI 10.1002/j.1460-2075.1995.tb07228.x; Dawlaty MM, 2008, CELL, V133, P103, DOI 10.1016/j.cell.2008.01.045; DELEEUW B, 1995, HUM MOL GENET, V4, P1097, DOI 10.1093/hmg/4.6.1097; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; dos Santos NR, 2001, GENE CHROMOSOME CANC, V30, P1, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1056>3.0.CO;2-G; Eid JE, 2000, CELL, V102, P839, DOI 10.1016/S0092-8674(00)00072-6; Freedman DA, 1998, MOL CELL BIOL, V18, P7288, DOI 10.1128/MCB.18.12.7288; Glaeser M, 2001, HORM METAB RES, V33, P121, DOI 10.1055/s-2001-14938; Gnanapragasam VJ, 2001, BRIT J CANCER, V85, P1928, DOI 10.1054/bjoc.2001.2179; Gocke CB, 2005, J BIOL CHEM, V280, P5004, DOI 10.1074/jbc.M411718200; Guillou L, 2001, HUM PATHOL, V32, P105, DOI 10.1053/hupa.2001.21130; Haldar M, 2007, CANCER CELL, V11, P375, DOI 10.1016/j.ccr.2007.01.016; Hiraga H, 1998, DIAGN MOL PATHOL, V7, P102, DOI 10.1097/00019606-199804000-00007; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Iwasaki T, 2005, ENDOCRINOLOGY, V146, P3892, DOI 10.1210/en.2004-1513; Kajiro M, 2009, NAT CELL BIOL, V11, P312, DOI 10.1038/ncb1839; Kato H, 2002, J BIOL CHEM, V277, P5498, DOI 10.1074/jbc.M108702200; Kawai A, 2004, CANCER LETT, V204, P105, DOI 10.1016/j.canlet.2003.09.031; Kim KI, 2006, MOL CELLS, V22, P247; Kuang SQ, 2004, CANCER RES, V64, P1875, DOI 10.1158/0008-5472.CAN-03-3745; Ladanyi M, 2000, HUM PATHOL, V31, P532, DOI 10.1053/hp.2000.6706; Ladanyi M, 2001, ONCOGENE, V20, P5755, DOI 10.1038/sj.onc.1204601; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Li XT, 2007, MOL CELL, V26, P831, DOI 10.1016/j.molcel.2007.05.028; LIMON J, 1986, CANCER GENET CYTOGEN, V23, P87, DOI 10.1016/0165-4608(86)90152-4; List HJ, 2001, BREAST CANCER RES TR, V68, P21, DOI 10.1023/A:1017910924390; Lonard DM, 2000, MOL CELL, V5, P939, DOI 10.1016/S1097-2765(00)80259-2; Mabb AM, 2006, NAT CELL BIOL, V8, P986, DOI 10.1038/ncb1458; Mani A, 2006, CANCER RES, V66, P8680, DOI 10.1158/0008-5472.CAN-06-0557; Nagai M, 2001, P NATL ACAD SCI USA, V98, P3843, DOI 10.1073/pnas.061036798; Palapattu GS, 2009, PROSTATE, V69, P787, DOI 10.1002/pros.20928; Panagopoulos I, 2001, GENE CHROMOSOME CANC, V31, P362, DOI 10.1002/gcc.1155; Perani M, 2005, J BIOL CHEM, V280, P42863, DOI 10.1074/jbc.M502963200; Pichler A, 2002, TRAFFIC, V3, P381, DOI 10.1034/j.1600-0854.2002.30601.x; Poteat HT, 1995, CANCER GENET CYTOGEN, V84, P76, DOI 10.1016/0165-4608(95)00090-9; Pretto D, 2006, ONCOGENE, V25, P3661, DOI 10.1038/sj.onc.1209413; Sakakura C, 2000, INT J CANCER, V89, P217; Schmidt D, 2002, P NATL ACAD SCI USA, V99, P2872, DOI 10.1073/pnas.052559499; Skytting B, 1999, J NATL CANCER I, V91, P974, DOI 10.1093/jnci/91.11.974; SMITH S, 1987, CANCER GENET CYTOGEN, V26, P179, DOI 10.1016/0165-4608(87)90147-6; Sun Y, 2006, ONCOGENE, V25, P1042, DOI 10.1038/sj.onc.1209143; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Thaete C, 1999, HUM MOL GENET, V8, P585, DOI 10.1093/hmg/8.4.585; Torres-Arzayus MI, 2004, CANCER CELL, V6, P263, DOI 10.1016/j.ccr.2004.06.027; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Willeke F, 1998, EUR J CANCER, V34, P2087, DOI 10.1016/S0959-8049(98)00240-8; Wu HJ, 2006, J BIOL CHEM, V281, P21848, DOI 10.1074/jbc.M603772200; Wu RC, 2007, CELL, V129, P1125, DOI 10.1016/j.cell.2007.04.039; Wu RC, 2002, MOL CELL BIOL, V22, P3549, DOI 10.1128/MCB.22.10.3549-3561.2002; Wuerzberger-Davis SM, 2007, ONCOGENE, V26, P641, DOI 10.1038/sj.onc.1209815; Yi P, 2008, MOL CELL, V29, P465, DOI 10.1016/j.molcel.2007.12.030; Zhang XW, 2010, SCIENCE, V328, P240, DOI 10.1126/science.1183424; Zheng LX, 2004, P NATL ACAD SCI USA, V101, P135, DOI 10.1073/pnas.2136685100; Zhu J, 2005, CANCER CELL, V7, P143, DOI 10.1016/j.ccr.2005.01.005	58	5	5	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18623	18632		10.1074/jbc.M110.176693	http://dx.doi.org/10.1074/jbc.M110.176693			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21454665	hybrid, Green Published			2022-12-25	WOS:000290785700034
J	Antonenko, YN; Avetisyan, AV; Cherepanov, DA; Knorre, DA; Korshunova, GA; Markova, OV; Ojovan, SM; Perevoshchikova, IV; Pustovidko, AV; Rokitskaya, TI; Severina, II; Simonyan, RA; Smirnova, EA; Sobko, AA; Sumbatyan, NV; Severin, FF; Skulachev, VP				Antonenko, Yuri N.; Avetisyan, Armine V.; Cherepanov, Dmitry A.; Knorre, Dmitry A.; Korshunova, Galina A.; Markova, Olga V.; Ojovan, Silvia M.; Perevoshchikova, Irina V.; Pustovidko, Antonina V.; Rokitskaya, Tatyana I.; Severina, Inna I.; Simonyan, Ruben A.; Smirnova, Ekaterina A.; Sobko, Alexander A.; Sumbatyan, Natalia V.; Severin, Fedor F.; Skulachev, Vladimir P.			Derivatives of Rhodamine 19 as Mild Mitochondria-targeted Cationic Uncouplers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROPHOBIC ION INTERACTIONS; LIPID BILAYER MEMBRANES; FATTY-ACIDS; PLASTOQUINONE DERIVATIVES; OXIDATIVE-PHOSPHORYLATION; SACCHAROMYCES-CEREVISIAE; LIPOPHILIC DICATIONS; INTERRUPT EXECUTION; YEAST; MECHANISM	A limited decrease in mitochondrial membrane potential can be beneficial for cells, especially under some pathological conditions, suggesting that mild uncouplers (protonophores) causing such an effect are promising candidates for therapeutic uses. The great majority of protonophores are weak acids capable of permeating across membranes in their neutral and anionic forms. In the present study, protonophorous activity of a series of derivatives of cationic rhodamine 19, including dodecylrhodamine (C(12)R1) and its conjugate with plastoquinone (SkQR1), was revealed using a variety of assays. Derivatives of rhodamine B, lacking dissociable protons, showed no protonophorous properties. In planar bilayer lipid membranes, separating two compartments differing in pH, diffusion potential of H+ ions was generated in the presence of C(12)R1 and SkQR1. These compounds induced pH equilibration in liposomes loaded with the pH probe pyranine. C(12)R1 and SkQR1 partially stimulated respiration of rat liver mitochondria in State 4 and decreased their membrane potential. Also, C(12)R1 partially stimulated respiration of yeast cells but, unlike the anionic protonophore FCCP, did not suppress their growth. Loss of function of mitochondrial DNA in yeast (grande-petite transformation) is known to cause a major decrease in the mitochondrial membrane potential. We found that petite yeast cells are relatively more sensitive to the anionic uncouplers than to C(12)R1 compared with grande cells. Together, our data suggest that rhodamine 19-based cationic protonophores are self-limiting; their uncoupling activity is maximal at high membrane potential, but the activity decreases membrane potentials, which causes partial efflux of the uncouplers from mitochondria and, hence, prevents further membrane potential decrease.	[Antonenko, Yuri N.; Avetisyan, Armine V.; Cherepanov, Dmitry A.; Knorre, Dmitry A.; Korshunova, Galina A.; Markova, Olga V.; Ojovan, Silvia M.; Perevoshchikova, Irina V.; Pustovidko, Antonina V.; Rokitskaya, Tatyana I.; Severina, Inna I.; Simonyan, Ruben A.; Smirnova, Ekaterina A.; Sobko, Alexander A.; Severin, Fedor F.; Skulachev, Vladimir P.] Moscow MV Lomonosov State Univ, Belozersky Inst Physicochem Biol, Moscow 119991, Russia; [Sumbatyan, Natalia V.] Moscow MV Lomonosov State Univ, Fac Chem, Moscow 119991, Russia; [Skulachev, Vladimir P.] Moscow MV Lomonosov State Univ, Fac Bioengn & Bioinformat, Moscow 119991, Russia; [Skulachev, Vladimir P.] Moscow MV Lomonosov State Univ, Inst Mitoengn, Moscow 119991, Russia	Lomonosov Moscow State University; Lomonosov Moscow State University; Lomonosov Moscow State University; Lomonosov Moscow State University	Antonenko, YN (corresponding author), Moscow MV Lomonosov State Univ, Belozersky Inst Physicochem Biol, Leninskie Gory 1, Moscow 119991, Russia.	antonen@genebee.msu.ru; skulach@belozersky.msu.ru	Knorre, Dmitry/D-8478-2012; Ruben, Simonyan/F-6493-2015; Cherepanov, Dmitry A./R-8391-2016; Markova, Olga/J-5261-2013; Sumbatyan, Nataliya V./B-2902-2015; Antonenko, Yuri N/K-1323-2013; Severin, Fedor/AAD-5444-2019; Avetisyan, Armine/O-2426-2014; Rokitskaya, Tatyana/J-3541-2013; Sumbatyan, Natalia/AAI-4474-2021; Skulachev, Vladimir P/J-4164-2012	Knorre, Dmitry/0000-0001-7468-6963; Ruben, Simonyan/0000-0003-0252-1216; Cherepanov, Dmitry A./0000-0001-6286-4638; Sumbatyan, Natalia/0000-0001-9361-7314; Skulachev, Vladimir P/0000-0003-4886-2243; Rokitskaya, Tatyana/0000-0002-7719-1875; Skulachev, Vladimir/0000-0001-5141-7517; Avetisyan, Armine/0000-0002-3882-2013; Severin, Fedor/0000-0001-6703-1256	Russian Foundation for Basic Research [09-04-00890]; Institute of Mitoengineering, Moscow State University; Rostok Group of A.V. Chikunov	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Institute of Mitoengineering, Moscow State University; Rostok Group of A.V. Chikunov	This work was supported in part by Russian Foundation for Basic Research Grant 09-04-00890; the Institute of Mitoengineering, Moscow State University; and the Rostok Group of A.V. Chikunov.	ANDREYEV AY, 1988, FEBS LETT, V226, P265, DOI 10.1016/0014-5793(88)81436-4; ANDREYEV AY, 1989, EUR J BIOCHEM, V182, P585, DOI 10.1111/j.1432-1033.1989.tb14867.x; Antonenko YN, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1273, DOI 10.1134/S0006297908120018; Avnir Y, 2005, ANAL BIOCHEM, V347, P34, DOI 10.1016/j.ab.2005.09.026; Bakeeva LE, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1288, DOI 10.1134/S000629790812002X; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Blaikie FH, 2006, BIOSCIENCE REP, V26, P231, DOI 10.1007/s10540-006-9018-8; BLAUSTEIN RO, 1988, BIOCHIM BIOPHYS ACTA, V946, P221, DOI 10.1016/0005-2736(88)90396-3; BORISOVA MP, 1974, J MEMBRANE BIOL, V18, P243, DOI 10.1007/BF01870115; Chen Y, 1999, J BIOL CHEM, V274, P18364, DOI 10.1074/jbc.274.26.18364; Darden T, 1999, STRUCT FOLD DES, V7, pR55, DOI 10.1016/S0969-2126(99)80033-1; Duvvuri M, 2004, J BIOL CHEM, V279, P32367, DOI 10.1074/jbc.M400735200; Fetisova EK, 2010, FEBS LETT, V584, P562, DOI 10.1016/j.febslet.2009.12.002; FLEWELLING RF, 1986, BIOPHYS J, V49, P541, DOI 10.1016/S0006-3495(86)83664-5; FLEWELLING RF, 1986, BIOPHYS J, V49, P531, DOI 10.1016/S0006-3495(86)83663-3; Gancedo JM, 1998, MICROBIOL MOL BIOL R, V62, P334, DOI 10.1128/MMBR.62.2.334-361.1998; Hallstrom TC, 2000, J BIOL CHEM, V275, P37347, DOI 10.1074/jbc.M007338200; Harper J A, 2001, Obes Rev, V2, P255, DOI 10.1046/j.1467-789X.2001.00043.x; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Johnson  D., 1967, METHOD ENZYMOL, V10, P94, DOI DOI 10.1016/0076-6879(67)10018-9; KAMP F, 1992, P NATL ACAD SCI USA, V89, P11367, DOI 10.1073/pnas.89.23.11367; Kelso GF, 2001, J BIOL CHEM, V276, P4588, DOI 10.1074/jbc.M009093200; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Kyrychenko A, 2010, CHEM PHYS LETT, V485, P95, DOI 10.1016/j.cplett.2009.12.015; Lanni A, 2003, FEBS LETT, V543, P5, DOI 10.1016/S0014-5793(03)00320-X; LARIS PC, 1975, BIOCHIM BIOPHYS ACTA, V376, P415, DOI 10.1016/0005-2728(75)90163-2; LEBLANC OH, 1971, J MEMBRANE BIOL, V4, P227, DOI 10.1007/BF02431973; LIBERMAN EA, 1970, BIOCHIM BIOPHYS ACTA, V216, P30, DOI 10.1016/0005-2728(70)90156-8; LIBERMAN EA, 1969, BIOPHYSICS-USSR, V14, P477; Lou PH, 2007, BIOCHEM J, V407, P129, DOI 10.1042/BJ20070606; MCLAUGHLIN SGA, 1980, PHYSIOL REV, V60, P825, DOI 10.1152/physrev.1980.60.3.825; Murphy MP, 2007, ANNU REV PHARMACOL, V47, P629, DOI 10.1146/annurev.pharmtox.47.120505.105110; NAGAMUNE H, 1993, BIOCHIM BIOPHYS ACTA, V1141, P231, DOI 10.1016/0005-2728(93)90047-J; Nedergaard J, 2003, EXP PHYSIOL, V88, P65, DOI 10.1113/eph8802502; Pandit SA, 2008, LANGMUIR, V24, P6858, DOI 10.1021/la8004135; Petit PX, 1996, CYTOMETRY, V23, P28, DOI 10.1002/(SICI)1097-0320(19960101)23:1<28::AID-CYTO5>3.0.CO;2-I; PICKAR AD, 1978, J MEMBRANE BIOL, V44, P353, DOI 10.1007/BF01944229; Plotnikov EY, 2011, BBA-MOL BASIS DIS, V1812, P77, DOI 10.1016/j.bbadis.2010.09.008; Plotnikov EY, 2010, BIOCHEMISTRY-MOSCOW+, V75, P145, DOI 10.1134/S0006297910020045; Pozniakovsky AI, 2005, J CELL BIOL, V168, P257, DOI 10.1083/jcb.200408145; RAYMOND M, 1994, MOL CELL BIOL, V14, P277, DOI 10.1128/MCB.14.1.277; Rokitskaya TI, 2008, J MEMBRANE BIOL, V224, P9, DOI 10.1007/s00232-008-9124-6; Rokitskaya TI, 2010, BBA-BIOMEMBRANES, V1798, P1698, DOI 10.1016/j.bbamem.2010.05.018; Ross MF, 2006, BIOCHEM J, V400, P199, DOI 10.1042/BJ20060919; SCHWALLER MA, 1995, J BIOL CHEM, V270, P22709, DOI 10.1074/jbc.270.39.22709; Severin FF, 2010, P NATL ACAD SCI USA, V107, P663, DOI 10.1073/pnas.0910216107; Severina II, 2007, BBA-BIOENERGETICS, V1767, P1164, DOI 10.1016/j.bbabio.2007.05.010; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Skulachev VP, 1998, BBA-BIOENERGETICS, V1363, P100, DOI 10.1016/S0005-2728(97)00091-1; SKULACHEV VP, 1967, NATURE, V216, P718, DOI 10.1038/216718a0; Skulachev VP, 1996, Q REV BIOPHYS, V29, P169, DOI 10.1017/S0033583500005795; SLONIMSKI PP, 1968, BIOCHEM BIOPH RES CO, V30, P232, DOI 10.1016/0006-291X(68)90440-3; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SUN XC, 1992, J BIOL CHEM, V267, P19147; TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291	56	65	76	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17831	17840		10.1074/jbc.M110.212837	http://dx.doi.org/10.1074/jbc.M110.212837			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454507	hybrid, Green Published			2022-12-25	WOS:000290585200046
J	Norrgard, MA; Hellman, U; Mannervik, B				Norrgard, Malena A.; Hellman, Ulf; Mannervik, Bengt			Cys-X Scanning for Expansion of Active-site Residues and Modulation of Catalytic Functions in a Glutathione Transferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-SPECIFICITY; ENZYME PROMISCUITY; ESCHERICHIA-COLI; GENETIC-CODE; MECHANISM; EVOLUTION; MUTAGENESIS; MUTATIONS; SELECTIVITY; ACTIVATION	We propose Cys-X scanning as a semisynthetic approach to engineer the functional properties of recombinant proteins. As in the case of Ala scanning, key residues in the primary structure are identified, and one of them is replaced by Cys via site-directed mutagenesis. The thiol of the residue introduced is subsequently modified by alternative chemical reagents to yield diverse Cys-X mutants of the protein. This chemical approach is orthogonal to Ala or Cys scanning and allows the expansion of the repertoire of amino acid side chains far beyond those present in natural proteins. In its present application, we have introduced Cys-X residues in human glutathione transferase (GST) M2-2, replacing Met-212 in the substrate-binding site. To achieve selectivity of the modifications, the Cys residues in the wild-type enzyme were replaced by Ala. A suite of simple substitutions resulted in a set of homologous Met derivatives ranging from normethionine to S-heptyl-cysteine. The chemical modifications were validated by HPLC and mass spectrometry. The derivatized mutant enzymes were assayed with alternative GST substrates representing diverse chemical reactions: aromatic substitution, epoxide opening, transnitrosylation, and addition to an ortho-quinone. The Cys substitutions had different effects on the alternative substrates and differentially enhanced or suppressed catalytic activities depending on both the Cys-X substitution and the substrate assayed. As a consequence, the enzyme specificity profile could be changed among the alternative substrates. The procedure lends itself to large-scale production of Cys-X modified protein variants.	[Norrgard, Malena A.; Mannervik, Bengt] Uppsala Univ, Dept Biochem & Organ Chem, Biomed Ctr, SE-75123 Uppsala, Sweden; [Hellman, Ulf] Uppsala Univ, Ludwig Inst Canc Res, Biomed Ctr, SE-75123 Uppsala, Sweden; [Mannervik, Bengt] Stockholm Univ, Dept Neurochem, SE-10691 Stockholm, Sweden	Uppsala University; Ludwig Institute for Cancer Research; Uppsala University; Stockholm University	Mannervik, B (corresponding author), Uppsala Univ, Dept Biochem & Organ Chem, Biomed Ctr, Box 576, SE-75123 Uppsala, Sweden.	Bengt.Mannervik@biorg.uu.se			Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the Swedish Research Council.	Armstrong RN, 1997, CHEM RES TOXICOL, V10, P2, DOI 10.1021/tx960072x; BJORNESTEDT R, 1995, J BIOL CHEM, V270, P29705; Blikstad C, 2008, BBA-GEN SUBJECTS, V1780, P1458, DOI 10.1016/j.bbagen.2008.07.007; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; Dagnino-Subiabre A, 2000, BIOCHEM BIOPH RES CO, V274, P32, DOI 10.1006/bbrc.2000.3087; Davidson VL, 2011, MOL BIOSYST, V7, P29, DOI 10.1039/c005311b; DeSantis G, 1999, CURR OPIN BIOTECH, V10, P324, DOI 10.1016/S0958-1669(99)80059-7; DeSantis G, 1999, BIOORGAN MED CHEM, V7, P1381, DOI 10.1016/S0968-0896(99)00068-1; Dourado DFAR, 2008, CHEM-EUR J, V14, P9591, DOI 10.1002/chem.200800946; Dourado DFAR, 2010, J PHYS CHEM B, V114, P12972, DOI 10.1021/jp1053875; Eklund BI, 2006, MOL PHARMACOL, V70, P747, DOI 10.1124/mol.106.025288; Emren LO, 2006, P NATL ACAD SCI USA, V103, P10866, DOI 10.1073/pnas.0604030103; Grahn E, 2006, ACTA CRYSTALLOGR D, V62, P197, DOI 10.1107/S0907444905039296; Hegazy U. M., 2009, AMINO ACIDS PEPTIDES, V2, P379; Hegazy UM, 2006, CHEM BIOL, V13, P929, DOI 10.1016/j.chembiol.2006.07.005; Hult K, 2007, TRENDS BIOTECHNOL, V25, P231, DOI 10.1016/j.tibtech.2007.03.002; Ivarsson Y, 2003, J BIOL CHEM, V278, P8733, DOI 10.1074/jbc.M211776200; Ivarsson Y, 2007, BBA-GEN SUBJECTS, V1770, P1374, DOI 10.1016/j.bbagen.2007.06.002; Jemth P., 1999, CURRENT PROTOCOLS TO, P641; Jestin JL, 2005, RES MICROBIOL, V156, P961, DOI 10.1016/j.resmic.2005.09.004; Johansson AS, 1999, PROTEIN EXPRES PURIF, V17, P105, DOI 10.1006/prep.1999.1117; JOHNSON WW, 1993, J BIOL CHEM, V268, P11508; Josephy PD, 2006, MOL TOXICOLOGY, P333; KANAYA E, 1990, BIOCHEM BIOPH RES CO, V173, P1194, DOI 10.1016/S0006-291X(05)80912-X; Kauffman S.A., 1993, ORIGINS ORDER; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; Kiss G, 2010, PROTEIN SCI, V19, P1760, DOI 10.1002/pro.462; Kubo Y, 1998, FEBS LETT, V435, P69, DOI 10.1016/S0014-5793(98)01038-2; Lien S, 2001, J BIOL CHEM, V276, P35599, DOI 10.1074/jbc.M103789200; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; Lu Y, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-1-102; Manning TC, 1996, J IMMUNOL METHODS, V192, P125, DOI 10.1016/0022-1759(96)00048-8; Nath A, 2008, BIOCHEMISTRY-US, V47, P157, DOI 10.1021/bi701448p; Nilsson LO, 2000, P NATL ACAD SCI USA, V97, P9408, DOI 10.1073/pnas.150084897; Nobeli I, 2009, NAT BIOTECHNOL, V27, P157, DOI 10.1038/nbt1519; Norrgard MA, 2006, P NATL ACAD SCI USA, V103, P4876, DOI 10.1073/pnas.0600849103; Nuccetelli M, 1998, BIOCHEM BIOPH RES CO, V252, P184, DOI 10.1006/bbrc.1998.9575; Pettersson PL, 2002, J BIOL CHEM, V277, P30019, DOI 10.1074/jbc.M204485200; Pinto LH, 1997, P NATL ACAD SCI USA, V94, P11301, DOI 10.1073/pnas.94.21.11301; Romero PA, 2009, NAT REV MOL CELL BIO, V10, P866, DOI 10.1038/nrm2805; SAHINTOTH M, 1993, PROTEIN SCI, V2, P1024, DOI 10.1002/pro.5560020615; Sella G, 2006, J MOL EVOL, V63, P297, DOI 10.1007/s00239-004-0176-7; Simons P C, 1981, Methods Enzymol, V77, P235; SINGER TP, 1984, METHOD ENZYMOL, V106, P369; Theorell H, 1941, J AM CHEM SOC, V63, P1804, DOI 10.1021/ja01852a005; Thorn KS, 2001, BIOINFORMATICS, V17, P284, DOI 10.1093/bioinformatics/17.3.284; Walsh CT, 2005, ANGEW CHEM INT EDIT, V44, P7342, DOI 10.1002/anie.200501023; Wang Q, 2009, CHEM BIOL, V16, P323, DOI 10.1016/j.chembiol.2009.03.001; Weiss GA, 2000, P NATL ACAD SCI USA, V97, P8950, DOI 10.1073/pnas.160252097; WIDERSTEN M, 1995, J MOL BIOL, V250, P115, DOI 10.1006/jmbi.1995.0362; Wright SK, 2001, J BIOL CHEM, V276, P31151, DOI 10.1074/jbc.M100892200	51	6	6	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16871	16878		10.1074/jbc.M111.230078	http://dx.doi.org/10.1074/jbc.M111.230078			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454564	Green Published, hybrid			2022-12-25	WOS:000290301900036
J	Chambers, JW; LoGrasso, PV				Chambers, Jeremy W.; LoGrasso, Philip V.			Mitochondrial c-Jun N-terminal Kinase (JNK) Signaling Initiates Physiological Changes Resulting in Amplification of Reactive Oxygen Species Generation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; P38 MAPK; ARSENIC TRIOXIDE; SAB SH3BP5; ACTIVATION; TRANSDUCTION; APOPTOSIS; SUPEROXIDE; COMPLEX; PROTEIN	The JNK signaling cascade is critical for cellular responses to a variety of environmental and cellular stimuli. Although gene expression aspects of JNK signal transduction are well studied, there are minimal data on the physiological impact of JNK signaling. To bridge this gap, we investigated how JNK impacted physiology in HeLa cells. We observed that inhibition of JNK activity and JNK silencing with siRNA reduced the level of reactive oxygen species (ROS) generated during anisomycin-induced stress in HeLa cells. Silencing p38 had no significant impact on ROS generation under anisomycin stress. Moreover, JNK signaling mediated amplification of ROS production during stress. Mitochondrial superoxide production was shown to be the source of JNK-induced ROS amplification, as an NADPH oxidase inhibitor demonstrated little impact on JNK-mediated ROS generation. Using mitochondrial isolation from JNK null fibroblasts and targeting the mitochondrial scaffold of JNK, Sab, we demonstrated that mitochondrial JNK signaling was responsible for mitochondrial superoxide amplification. These results suggest that cellular stress altered mitochondria, causing JNK to translocate to the mitochondria and amplify up to 80% of the ROS generated largely by Complex I. This work demonstrates that a sequence of events exist for JNK mitochondrial signaling whereby ROS activates JNK, thereby affecting mitochondrial physiology, which can have effects on cell survival and death.	[LoGrasso, Philip V.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA; Scripps Res Inst, Translat Res Inst, Jupiter, FL 33458 USA	Scripps Research Institute; Scripps Research Institute	LoGrasso, PV (corresponding author), Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA.	lograsso@scripps.edu		Chambers, Jeremy/0000-0002-6143-3091	National Institutes of Health [NS057153]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS057153] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS057153 (to P. V. L.).	Anuradha CD, 2001, FREE RADICAL BIO MED, V31, P367, DOI 10.1016/S0891-5849(01)00591-3; Aoki H, 2002, J BIOL CHEM, V277, P10244, DOI 10.1074/jbc.M112355200; Bagowski CP, 2003, CURR BIOL, V13, P315, DOI 10.1016/S0960-9822(03)00083-6; Cao DX, 2005, J CELL BIOCHEM, V96, P810, DOI 10.1002/jcb.20563; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Dickens M, 1997, SCIENCE, V277, P693, DOI 10.1126/science.277.5326.693; Dougherty CJ, 2004, FASEB J, V18, P1060, DOI 10.1096/fj.04-1505com; Forkink M, 2010, BBA-BIOENERGETICS, V1797, P1034, DOI 10.1016/j.bbabio.2010.01.022; Garcia J, 2010, J BIOL CHEM, V285, P39646, DOI 10.1074/jbc.M110.164160; Grivennikova VG, 2006, BBA-BIOENERGETICS, V1757, P553, DOI 10.1016/j.bbabio.2006.03.013; Hamanaka RB, 2010, TRENDS BIOCHEM SCI, V35, P505, DOI 10.1016/j.tibs.2010.04.002; Hanawa N, 2008, J BIOL CHEM, V283, P13565, DOI 10.1074/jbc.M708916200; Hawkins BJ, 2007, MOL BIOL CELL, V18, P2002, DOI 10.1091/mbc.E06-09-0830; Horbinski C, 2005, FREE RADICAL BIO MED, V38, P2, DOI 10.1016/j.freeradbiomed.2004.09.030; Hurd TR, 2005, ANTIOXID REDOX SIGN, V7, P999, DOI 10.1089/ars.2005.7.999; Ito Y, 2001, CELL DEATH DIFFER, V8, P794, DOI 10.1038/sj.cdd.4400886; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kamenecka T, 2010, J MED CHEM, V53, P419, DOI 10.1021/jm901351f; Kang YH, 2008, ONCOL REP, V20, P637, DOI 10.3892/or_00000053; Kang YH, 2008, J CELL PHYSIOL, V217, P23, DOI 10.1002/jcp.21470; Kharbanda S, 2000, J BIOL CHEM, V275, P322, DOI 10.1074/jbc.275.1.322; Kim MJ, 2008, FEBS J, V275, P2096, DOI 10.1111/j.1742-4658.2008.06363.x; Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X; Koopman Werner J H, 2010, Antioxid Redox Signal, V12, P1431, DOI 10.1089/ars.2009.2743; Kristiansen M, 2010, J NEUROSCI, V30, P10820, DOI 10.1523/JNEUROSCI.2824-10.2010; Lee JJ, 2010, ONCOGENE, V29, P561, DOI 10.1038/onc.2009.355; Lei K, 2002, MOL CELL BIOL, V22, P4929, DOI 10.1128/MCB.22.13.4929-4942.2002; Mukhopadhyay P, 2007, NAT PROTOC, V2, P2295, DOI 10.1038/nprot.2007.327; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nemoto S, 2000, MOL CELL BIOL, V20, P7311, DOI 10.1128/MCB.20.19.7311-7318.2000; Pagliarini DJ, 2006, TRENDS BIOCHEM SCI, V31, P26, DOI 10.1016/j.tibs.2005.11.005; Pallotti F, 2007, METHOD CELL BIOL, V80, P3, DOI 10.1016/S0091-679X(06)80001-4; Patel VB, 2007, FREE RADICAL BIO MED, V43, P1499, DOI 10.1016/j.freeradbiomed.2007.08.004; REITZER LJ, 1979, J BIOL CHEM, V254, P2669; Shen HM, 2006, FREE RADICAL BIO MED, V40, P928, DOI 10.1016/j.freeradbiomed.2005.10.056; Soberanes S, 2009, J BIOL CHEM, V284, P2176, DOI 10.1074/jbc.M808844200; Soubannier V, 2009, BBA-MOL CELL RES, V1793, P154, DOI 10.1016/j.bbamcr.2008.07.008; STOLK J, 1994, AM J RESP CELL MOL, V11, P95, DOI 10.1165/ajrcmb.11.1.8018341; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; TRUMPOWER BL, 1979, J BIOL CHEM, V254, P8697; Ventura JJ, 2004, GENE DEV, V18, P2905, DOI 10.1101/gad.1223004; Ventura JJ, 2006, MOL CELL, V21, P701, DOI 10.1016/j.molcel.2006.01.018; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Wiltshire C, 2004, BIOCHEM SOC T, V32, P1075, DOI 10.1042/BST0321075; Wiltshire C, 2002, BIOCHEM J, V367, P577, DOI 10.1042/BJ20020553; Zhao Y, 2009, MOL CELL NEUROSCI, V41, P186, DOI 10.1016/j.mcn.2009.02.012; Zhou Q, 2008, J NEUROCHEM, V104, P325, DOI 10.1111/j.1471-4159.2007.04957.x	48	133	137	2	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M111.223602	http://dx.doi.org/10.1074/jbc.M111.223602			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454558	Green Published, hybrid			2022-12-25	WOS:000290022800045
J	Cremer, S; Schrempf, A; Heinze, J				Cremer, Sylvia; Schrempf, Alexandra; Heinze, Juergen			Competition and Opportunity Shape the Reproductive Tactics of Males in the Ant Cardiocondyla obscurior	PLOS ONE			English	Article							DIMORPHIC MALES; DISPERSAL; EVOLUTION; MIMICRY; QUEENS	Context-dependent adjustment of mating tactics can drastically increase the mating success of behaviourally flexible animals. We used the ant Cardiocondyla obscurior as a model system to study adaptive adjustment of male mating tactics. This species shows a male diphenism of wingless fighter males and peaceful winged males. Whereas the wingless males stay and exclusively mate in the maternal colony, the mating behaviour of winged males is plastic. They copulate with female sexuals in their natal nests early in life but later disperse in search for sexuals outside. In this study, we observed the nest-leaving behaviour of winged males under different conditions and found that they adaptively adjust the timing of their dispersal to the availability of mating partners, as well as the presence, and even the type of competitors in their natal nests. In colonies with virgin female queens winged males stayed longest when they were the only male in the nest. They left earlier when mating partners were not available or when other males were present. In the presence of wingless, locally mating fighter males, winged males dispersed earlier than in the presence of docile, winged competitors. This suggests that C. obscurior males are capable of estimating their local breeding chances and adaptively adjust their dispersal behaviour in both an opportunistic and a risk-sensitive way, thus showing hitherto unknown behavioural plasticity in social insect males.	[Cremer, Sylvia; Schrempf, Alexandra; Heinze, Juergen] Univ Regensburg, Regensburg, Germany	University of Regensburg	Cremer, S (corresponding author), IST Austria, Klosterneuburg, Austria.	sylvia.cremer@ist.ac.at	Cremer, Sylvia/B-2199-2013	Cremer, Sylvia/0000-0002-2193-3868	German Science Foundation [He 1623/23]	German Science Foundation(German Research Foundation (DFG))	This work was supported by the German Science Foundation (www.dfg.de, He 1623/23). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson C, 2003, BEHAV ECOL, V14, P54, DOI 10.1093/beheco/14.1.54; Boomsma JJ, 2005, ANNU REV ENTOMOL, V50, P395, DOI 10.1146/annurev.ento.50.071803.130416; Cremer S, 2003, CURR BIOL, V13, P219, DOI 10.1016/S0960-9822(03)00012-5; Cremer S, 2002, NATURE, V419, P897, DOI 10.1038/419897a; Cremer S, 2008, NATURWISSENSCHAFTEN, V95, P1101, DOI 10.1007/s00114-008-0430-8; Gross MR, 1996, TRENDS ECOL EVOL, V11, P92, DOI 10.1016/0169-5347(96)81050-0; Heinze J, 1998, BEHAV ECOL SOCIOBIOL, V42, P239, DOI 10.1007/s002650050435; HEINZE J, 1993, P NATL ACAD SCI USA, V90, P8412, DOI 10.1073/pnas.90.18.8412; Heinze J, 2005, MOL PHYLOGENET EVOL, V37, P278, DOI 10.1016/j.ympev.2005.04.005; KINOMURA K, 1987, J ETHOL, V5, P75, DOI 10.1007/BF02347897; KODRICBROWN A, 1986, BEHAV ECOL SOCIOBIOL, V19, P425, DOI 10.1007/BF00300545; LAWRENCE WS, 1987, BEHAV ECOL SOCIOBIOL, V21, P367, DOI 10.1007/BF00299931; OLIVEIRA RF, ALTERNATIVE REPROD T; STEPHENS DW, FORAGING BEHAV ECOLO; STUART RJ, 1987, NATURWISSENSCHAFTEN, V74, P548, DOI 10.1007/BF00367076; Thornhill R., 1983, pi	16	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e17323	10.1371/journal.pone.0017323	http://dx.doi.org/10.1371/journal.pone.0017323			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21468323	gold, Green Published			2022-12-25	WOS:000289054600009
J	Bott-Flugel, L; Bernshausen, A; Schneider, H; Luppa, P; Zimmermann, K; Albrecht-Kupper, B; Kast, R; Laugwitz, KL; Ehmke, H; Knorr, A; Seyfarth, M				Bott-Fluegel, Lorenz; Bernshausen, Alexandra; Schneider, Heike; Luppa, Peter; Zimmermann, Katja; Albrecht-Kuepper, Barbara; Kast, Raimund; Laugwitz, Karl-Ludwig; Ehmke, Heimo; Knorr, Andreas; Seyfarth, Melchior			Selective Attenuation of Norepinephrine Release and Stress-Induced Heart Rate Increase by Partial Adenosine A(1) Agonism	PLOS ONE			English	Article							SPONTANEOUSLY HYPERTENSIVE-RATS; RECEPTOR AGONISTS; ACTIVATION; STIMULATION; MECHANISM; NORADRENALINE; HYPERTROPHY; SUBTYPES; FAILURE; DRUGS	The release of the neurotransmitter norepinephrine (NE) is modulated by presynaptic adenosine receptors. In the present study we investigated the effect of a partial activation of this feedback mechanism. We hypothesized that partial agonism would have differential effects on NE release in isolated hearts as well as on heart rate in vivo depending on the genetic background and baseline sympathetic activity. In isolated perfused hearts of Wistar and Spontaneously Hypertensive Rats (SHR), NE release was induced by electrical stimulation under control conditions (S1), and with capadenoson 6 . 10(-8) M (30 mu g/l), 6 . 10(-7) M (300 mu g/l) or 2-chloro-N-6-cyclopentyladenosine (CCPA) 10(-6) M (S2). Under control conditions (S1), NE release was significantly higher in SHR hearts compared to Wistar (766+/-87 pmol/g vs. 173+/-18 pmol/g, p<0.01). Capadenoson led to a concentration-dependent decrease of the stimulation-induced NE release in SHR (S2/S1 = 0.90+/-0.08 with capadenoson 6 . 10(-8) M, 0.54+/-0.02 with 6 . 10(-7) M), but not in Wistar hearts (S2/S1 = 1.05+/-0.12 with 6 . 10(-8) M, 1.03+/-0.09 with 6 . 10(-7) M). CCPA reduced NE release to a similar degree in hearts from both strains. In vivo capadenoson did not alter resting heart rate in Wistar rats or SHR. Restraint stress induced a significantly greater increase of heart rate in SHR than in Wistar rats. Capadenoson blunted this stress-induced tachycardia by 45% in SHR, but not in Wistar rats. Using a [S-35]GTP gamma S assay we demonstrated that capadenoson is a partial agonist compared to the full agonist CCPA (74+/22% A(1)-receptor stimulation). These results suggest that partial adenosine A(1)-agonism dampens stress-induced tachycardia selectively in rats susceptible to strong increases in sympathetic activity, most likely due to a presynaptic attenuation of NE release.	[Bott-Fluegel, Lorenz; Bernshausen, Alexandra; Laugwitz, Karl-Ludwig] Tech Univ Munich, Klinikum Rechts Isar, Med Klin 1, D-8000 Munich, Germany; [Bott-Fluegel, Lorenz; Bernshausen, Alexandra; Laugwitz, Karl-Ludwig] Tech Univ Munich, Deutsch Herzzentrum Munchen, Munich, Germany; [Schneider, Heike; Luppa, Peter] Tech Univ Munich, Klinikum Rechts Isar, Inst Klin Chem & Pathobiochem, D-8000 Munich, Germany; [Zimmermann, Katja; Albrecht-Kuepper, Barbara; Kast, Raimund; Knorr, Andreas] Bayer Schering Pharma AG, Global Drug Discovery, Wuppertal, Germany; [Ehmke, Heimo] Univ Klinikum Hamburg Eppendorf, Inst Vegetat Physiol & Pathophysiol, Hamburg, Germany; [Seyfarth, Melchior] Univ Witten Herdecke, Med Klin 3, HELIOS Klinikum Wuppertal, Witten, Germany; [Seyfarth, Melchior] Univ Witten Herdecke, Lehrstuhl Kardiol, Witten, Germany	Technical University of Munich; German Heart Centre Munich; Technical University of Munich; Technical University of Munich; Bayer AG; Bayer Healthcare Pharmaceuticals; University of Hamburg; University Medical Center Hamburg-Eppendorf; Helios Kliniken; Witten Herdecke University; Witten Herdecke University	Bott-Flugel, L (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Med Klin 1, D-8000 Munich, Germany.	bottfluegel@online.de		Bott-Flugel, Lorenz/0000-0003-0932-1241	Medizinische Klinik and Institut fur Klinische Chemie und Pathobiochemie, Klinikum rechts der Isar, TU Munchen; Bayer Schering Pharma; Bayer Schering Pharma GmbH	Medizinische Klinik and Institut fur Klinische Chemie und Pathobiochemie, Klinikum rechts der Isar, TU Munchen; Bayer Schering Pharma(Bayer AG); Bayer Schering Pharma GmbH	The in vitro experiments were funded by 1. Medizinische Klinik and Institut fur Klinische Chemie und Pathobiochemie, Klinikum rechts der Isar, TU Munchen. Bayer Schering Pharma provided funding for the in vivo studies and took part in the design and data aquisition/analysis of the in vivo experiments. Bayer Schering had no role in data interpretation and decision to publish.; L. Bott-Flugel received travel fees from Bayer Schering Pharma GmbH. H. Ehmke serves as consultant to Bayer Schering Pharma GmbH. K. Zimmermann, A. Knorr, B. Albrecht-Kupper, and R. Kast are employees of Bayer Schering Pharma GmbH. Bayer Schering Pharma provided funding for the in vivo studies and took part in the design, data aquisition and analysis of the in vivo experiments. The principal investigators (L. Bott-Flugel, H. Ehmke, and Melchior Seyfarth) had access to the raw data, and Bayer Schering had no role in the interpretation of the data and decision to publish. The authors declare that funding by Bayer Schering Pharma does not influence their adherence to the PLoS ONE policies on sharing data and materials.	ARMAH BI, 1988, ARZNEIMITTEL-FORSCH, V38-2, P1426; Brodde OE, 1999, PHARMACOL REV, V51, P651; Burgdorf C, 2001, CARDIOVASC RES, V49, P713, DOI 10.1016/S0008-6363(00)00309-6; CONRAD CH, 1995, CIRCULATION, V91, P161, DOI 10.1161/01.CIR.91.1.161; Dart AM, 2002, CARDIOVASC RES, V53, P678, DOI 10.1016/S0008-6363(01)00508-9; ELWORTHY PM, 1986, J CHROMATOGR, V380, P33, DOI 10.1016/S0378-4347(00)83622-1; Elzein E, 2008, EXPERT OPIN INV DRUG, V17, P1901, DOI [10.1517/13543780802497284, 10.1517/13543780802497284 ]; Ernsberger P, 1997, AM J PHYSIOL-REG I, V273, pR1572, DOI 10.1152/ajpregu.1997.273.5.R1572; Gan XHT, 2005, J PHARMACOL EXP THER, V312, P27, DOI 10.1124/jpet.104.073122; Grundemann D, 2002, BRIT J PHARMACOL, V137, P910, DOI 10.1038/sj.bjp.0704926; Guyenet PG, 1997, AM J PHYSIOL-REG I, V273, pR1580, DOI 10.1152/ajpregu.1997.273.5.R1580; Hattori Y, 1998, LIFE SCI, V62, P1449, DOI 10.1016/S0024-3205(98)00088-5; Head GA, 1997, CLIN EXP HYPERTENS, V19, P591, DOI 10.3109/10641969709083172; Kobayashi S, 1996, AM J PHYSIOL-REG I, V271, pR704, DOI 10.1152/ajpregu.1996.271.3.R704; LOHSE MJ, 1984, N-S ARCH PHARMACOL, V326, P69, DOI 10.1007/BF00518781; LOHSE MJ, 1987, N-S ARCH PHARMACOL, V336, P204, DOI 10.1007/BF00165806; Lorbar M, 2004, CAN J PHYSIOL PHARM, V82, P1026, DOI 10.1139/Y04-108; Lorenzen A, 1996, MOL PHARMACOL, V49, P915; LORENZEN A, 1993, MOL PHARMACOL, V44, P115; McDougall SJ, 2000, HYPERTENSION, V35, P126, DOI 10.1161/01.HYP.35.1.126; Nell PG, 2009, PROGR MED CHEM, V47, P163, DOI 10.1016/S0079-6468(08)00204-X; PACKER M, 1987, CIRCULATION, V75, P80; Persson H, 2002, EUR J HEART FAIL, V4, P73, DOI 10.1016/S1388-9842(01)00196-9; PRICHARD B N C, 1987, European Heart Journal, V8, P121; RICHARDT G, 1989, J MOL CELL CARDIOL, V21, P269, DOI 10.1016/0022-2828(89)90742-6; SEYFARTH M, 1993, CIRC RES, V73, P496, DOI 10.1161/01.RES.73.3.496; Song Y, 2002, CIRCULATION, V105, P118, DOI 10.1161/hc0102.101392; Szabo B, 2002, PHARMACOL THERAPEUT, V93, P1, DOI 10.1016/S0163-7258(01)00170-X; Tendera M, 2007, J AM COLL CARDIOL, V49, p232A; TSUBOI H, 1987, J HYPERTENS, V5, P323, DOI 10.1097/00004872-198706000-00010; VANDERWENDEN EM, 1995, EUR J PHARM-MOLEC PH, V290, P189, DOI 10.1016/0922-4106(95)00064-X; YAMADA K, 1992, CLIN EXP PHARMACOL P, V19, P563, DOI 10.1111/j.1440-1681.1992.tb00505.x; ZSOTER TT, 1982, CLIN EXP HYPERTENS, V4, P431, DOI 10.3109/10641968209060753; Zugck C, 2003, J HYPERTENS, V21, P1363, DOI 10.1097/00004872-200307000-00026	34	23	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e18048	10.1371/journal.pone.0018048	http://dx.doi.org/10.1371/journal.pone.0018048			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464936	Green Submitted, Green Published, gold			2022-12-25	WOS:000289053800016
J	der Rieden, PMJI; Jansen, HJ; Durston, AJ				der Rieden, Paul M. J. In; Jansen, Hans J.; Durston, Antony J.			XMeis3 Is Necessary for Mesodermal Hox Gene Expression and Function	PLOS ONE			English	Article							COOPERATIVE DNA-BINDING; NUCLEAR-LOCALIZATION; HOMEODOMAIN PROTEIN; HOMEOBOX GENES; SEGMENTAL EXPRESSION; PBX PROTEINS; XENOPUS; EXTRADENTICLE; ACTIVATION; HINDBRAIN	Hox transcription factors provide positional information during patterning of the anteroposterior axis. Hox transcription factors can co-operatively bind with PBC-class co-factors, enhancing specificity and affinity for their appropriate binding sites. The nuclear localisation of these co-factors is regulated by the Meis-class of homeodomain proteins. During development of the zebrafish hindbrain, Meis3 has previously been shown to synergise with Hoxb1 in the autoregulation of Hoxb1. In Xenopus XMeis3 posteriorises the embryo upon ectopic expression. Recently, an early temporally collinear expression sequence of Hox genes was detected in Xenopus gastrula mesoderm (see intro. P3). There is evidence that this sequence sets up the embryo's later axial Hox expression pattern by time-space translation. We investigated whether XMeis3 is involved in regulation of this early mesodermal Hox gene expression. Here, we present evidence that XMeis3 is necessary for expression of Hoxd1, Hoxb4 and Hoxc6 in mesoderm during gastrulation. In addition, we show that XMeis3 function is necessary for the progression of gastrulation. Finally, we present evidence for synergy between XMeis3 and Hoxd1 in Hoxd1 autoregulation in mesoderm during gastrulation.	[der Rieden, Paul M. J. In] Studiekring, Utrecht, Netherlands; [Jansen, Hans J.; Durston, Antony J.] Sylvius Lab, Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC	der Rieden, PMJI (corresponding author), Studiekring, Utrecht, Netherlands.	A.J.Durston@biology.leidenuniv.nl		Jansen, Hans/0000-0002-8563-4146	EU [LSHM-CT-2003-504468]	EU(European Commission)	This work was supported by EU grant FP6 No. LSHM-CT-2003-504468. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Shaar M, 1999, GENE DEV, V13, P935, DOI 10.1101/gad.13.8.935; Berkes CA, 2004, MOL CELL, V14, P465, DOI 10.1016/S1097-2765(04)00260-6; BURGLIN TR, 1991, NATURE, V351, P703, DOI 10.1038/351703a0; Burglin TR, 1997, NUCLEIC ACIDS RES, V25, P4173, DOI 10.1093/nar/25.21.4173; BURGLIN TR, 1993, CURR OPIN GENET DEV, V3, P615, DOI 10.1016/0959-437X(93)90097-9; CHANG CP, 1995, GENE DEV, V9, P663, DOI 10.1101/gad.9.6.663; DEROBERTIS EM, 1989, CELL, V57, P189, DOI 10.1016/0092-8674(89)90954-9; Deschamps J, 1999, INT J DEV BIOL, V43, P635; Dibner C, 2001, DEVELOPMENT, V128, P3415; DUBOULE D, 1989, EMBO J, V8, P1497, DOI 10.1002/j.1460-2075.1989.tb03534.x; DURSTON AJ, 2010, GENOMICS IN PRESS; Elkouby YM, 2010, DEVELOPMENT, V137, P1531, DOI 10.1242/dev.044750; Ferretti E, 2000, DEVELOPMENT, V127, P155; Gaunt SJ, 1996, DEV DYNAM, V207, P270, DOI 10.1002/(SICI)1097-0177(199611)207:3<270::AID-AJA4>3.0.CO;2-E; Godsave SF, 1998, DEV DYNAM, V213, P39, DOI 10.1002/(SICI)1097-0177(199809)213:1<39::AID-AJA4>3.0.CO;2-Z; Gould A, 1997, GENE DEV, V11, P900, DOI 10.1101/gad.11.7.900; GRAHAM A, 1989, CELL, V57, P367, DOI 10.1016/0092-8674(89)90912-4; Grieder NC, 1997, EMBO J, V16, P7402, DOI 10.1093/emboj/16.24.7402; HARVEY RP, 1988, CELL, V53, P687, DOI 10.1016/0092-8674(88)90087-6; Heasman J, 2002, DEV BIOL, V243, P209, DOI 10.1006/dbio.2001.0565; Iimura T, 2006, NATURE, V442, P568, DOI 10.1038/nature04838; INDERRIEDEN PMJ, 2010, DEV DYNAM, V29, P226; Jabet C, 1999, J MOL BIOL, V291, P521, DOI 10.1006/jmbi.1999.2983; Jaw TJ, 2000, MECH DEVELOP, V91, P279, DOI 10.1016/S0925-4773(99)00316-0; KNOEPFLER PS, 1995, MOL CELL BIOL, V15, P5811; KOLM PJ, 1995, DEV BIOL, V167, P34, DOI 10.1006/dbio.1995.1005; LAWRENCE PA, 1994, CELL, V78, P181, DOI 10.1016/0092-8674(94)90289-5; MANAK JR, 1994, DEVELOPMENT, P61; Marty T, 2001, DEVELOPMENT, V128, P2833; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; McNulty CL, 2005, DEVELOPMENT, V132, P2861, DOI 10.1242/dev.01872; Morrison AD, 1998, BIOESSAYS, V20, P794, DOI 10.1002/(SICI)1521-1878(199810)20:10<794::AID-BIES4>3.0.CO;2-E; Neuteboom STC, 1997, MOL CELL BIOL, V17, P4696, DOI 10.1128/MCB.17.8.4696; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; OLIVER G, 1988, EMBO J, V7, P3199, DOI 10.1002/j.1460-2075.1988.tb03187.x; Passner JM, 1999, NATURE, V397, P714, DOI 10.1038/17833; Peltenburg LTC, 1996, EMBO J, V15, P3385, DOI 10.1002/j.1460-2075.1996.tb00704.x; Pinsonneault J, 1997, EMBO J, V16, P2032, DOI 10.1093/emboj/16.8.2032; Piper DE, 1999, CELL, V96, P587, DOI 10.1016/S0092-8674(00)80662-5; POPPERL H, 1995, CELL, V81, P1031, DOI 10.1016/S0092-8674(05)80008-X; Pownall ME, 1996, DEVELOPMENT, V122, P3881; RUPP RAW, 1994, GENE DEV, V8, P1311, DOI 10.1101/gad.8.11.1311; Ryoo HD, 1999, GENE DEV, V13, P1704, DOI 10.1101/gad.13.13.1704; Ryoo HD, 1999, DEVELOPMENT, V126, P5137; Salzberg A, 1999, MECH DEVELOP, V80, P3, DOI 10.1016/S0925-4773(98)00187-7; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; SIVE HL, 1991, GENE DEV, V5, P1321, DOI 10.1101/gad.5.8.1321; SMITH JC, 1991, CELL, V67, P79, DOI 10.1016/0092-8674(91)90573-H; Streit A, 2002, DEV BIOL, V242, P96, DOI 10.1006/dbio.2001.0544; VANDIJK MA, 1994, CELL, V78, P617, DOI 10.1016/0092-8674(94)90526-6; Vlachakis N, 2001, DEVELOPMENT, V128, P1299; Wacker SA, 2004, DEV BIOL, V268, P207, DOI 10.1016/j.ydbio.2003.12.022; Waskiewicz AJ, 2001, DEVELOPMENT, V128, P4139	53	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e18010	10.1371/journal.pone.0018010	http://dx.doi.org/10.1371/journal.pone.0018010			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464931	gold, Green Submitted, Green Published			2022-12-25	WOS:000289053800012
J	Nyangoga, H; Mercier, P; Libouban, H; Basle, MF; Chappard, D				Nyangoga, Herve; Mercier, Philippe; Libouban, Helene; Basle, Michel Felix; Chappard, Daniel			Three-Dimensional Characterization of the Vascular Bed in Bone Metastasis of the Rat by Microcomputed Tomography (MicroCT)	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; ANGIOGENESIS; CANCER; CELLS; MODEL; TUMORS; NEOVASCULARIZATION; MICROENVIRONMENT; SKELETON; MARROW	Background: Angiogenesis contributes to proliferation and metastatic dissemination of cancer cells. Anatomy of blood vessels in tumors has been characterized with 2D techniques (histology or angiography). They are not fully representative of the trajectories of vessels throughout the tissues and are not adapted to analyze changes occurring inside the bone marrow cavities. Methodology/Principal Findings: We have characterized the vasculature of bone metastases in 3D at different times of evolution of the disease. Metastases were induced in the femur of Wistar rats by a local injection of Walker 256/B cells. Microfil(R), (a silicone-based polymer) was injected at euthanasia in the aorta 12, 19 and 26 days after injection of tumor cells. Undecalcified bones (containing the radio opaque vascular casts) were analyzed by microCT, and a first 3D model was reconstructed. Bones were then decalcified and reanalyzed by microCT; a second model (comprising only the vessels) was obtained and overimposed on the former, thus providing a clear visualization of vessel trajectories in the invaded metaphysic allowing quantitative evaluation of the vascular volume and vessel diameter. Histological analysis of the marrow was possible on the decalcified specimens. Walker 256/B cells induced a marked osteolysis with cortical perforations. The metaphysis of invaded bones became progressively hypervascular. New vessels replaced the major central medullar artery coming from the diaphyseal shaft. They sprouted from the periosteum and extended into the metastatic area. The newly formed vessels were irregular in diameter, tortuous with a disorganized architecture. A quantitative analysis of vascular volume indicated that neoangiogenesis increased with the development of the tumor with the appearance of vessels with a larger diameter. Conclusion: This new method evidenced the tumor angiogenesis in 3D at different development times of the metastasis growth. Bone and the vascular bed can be identified by a double reconstruction and allowed a quantitative evaluation of angiogenesis upon time.	[Nyangoga, Herve; Mercier, Philippe; Libouban, Helene; Basle, Michel Felix; Chappard, Daniel] CHU Angers, INSERM, LHEA U922, IRIS IBS Inst Biol Sante, Angers, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Centre Hospitalier Universitaire d'Angers	Nyangoga, H (corresponding author), CHU Angers, INSERM, LHEA U922, IRIS IBS Inst Biol Sante, Angers, France.	daniel.chappard@univ-angers.fr	Libouban, Hélène/ABA-6927-2021; Daniel, chappard/AAG-3528-2022; Daniel, chappard/AFK-4857-2022	LIBOUBAN, Helene/0000-0002-8293-4143	INSERM; Contrat de Plan Etat - Region "Pays de la Loire''; BIOREGOS2 project	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Contrat de Plan Etat - Region "Pays de la Loire''(Region Pays de la Loire); BIOREGOS2 project	This work was made possible by grants from INSERM, Contrat de Plan Etat - Region "Pays de la Loire'' and BIOREGOS2 project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI Y, 1993, CANCER, V72, P32, DOI 10.1002/1097-0142(19930701)72:1<32::AID-CNCR2820720108>3.0.CO;2-6; Andersen TL, 2009, AM J PATHOL, V174, P239, DOI 10.2353/ajpath.2009.080627; Badraoui R, 2009, CHEM-BIOL INTERACT, V182, P98, DOI 10.1016/j.cbi.2009.09.010; Baron-Menguy C, 2007, FASEB J, V21, P3511, DOI 10.1096/fj.06-7782com; Blouin S, 2006, CELLS TISSUES ORGANS, V182, P182, DOI 10.1159/000093967; Blouin S, 2005, CLIN EXP METASTAS, V22, P605, DOI 10.1007/s10585-006-9002-5; Brandi ML, 2006, J BONE MINER RES, V21, P183, DOI 10.1359/JBMR.050917; Bussard KM, 2008, CANCER METAST REV, V27, P41, DOI 10.1007/s10555-007-9109-4; Chantrain CF, 2008, CANCER MICROENVIRON, V1, P23, DOI 10.1007/s12307-008-0010-7; Chappard D, 2005, J BONE MINER RES, V20, P1177, DOI 10.1359/JBMR.050205; Chen Q, 2003, CANCER IMMUNOL IMMUN, V52, P670, DOI 10.1007/s00262-003-0425-4; Duvall CL, 2004, AM J PHYSIOL-HEART C, V287, pH302, DOI 10.1152/ajpheart.00928.2003; Eichhorn ME, 2008, CANCER BIOL THER, V7, P1006, DOI 10.4161/cbt.7.7.5997; Eriksen EF, 2007, J BONE MINER RES, V22, P1, DOI 10.1359/JBMR.060910; FILMON R, 2009, IMAGE ANAL STEREOL, V28, P1; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Ganter P., 1969, HISTOCHIMIE NORMALE, VVolume 1; Guise TA, 2003, CLIN ORTHOP RELAT R, pS32, DOI 10.1097/01.blo.0000093055.96273.69; Guise TA, 1998, ENDOCR REV, V19, P18, DOI 10.1210/er.19.1.18; Guzman R, 2005, EUR SPINE J, V14, P263, DOI 10.1007/s00586-004-0757-6; Hauge EM, 2001, J BONE MINER RES, V16, P1575, DOI 10.1359/jbmr.2001.16.9.1575; Hildebrand T, 1997, J MICROSC-OXFORD, V185, P67, DOI 10.1046/j.1365-2818.1997.1340694.x; Iyer AK, 2006, DRUG DISCOV TODAY, V11, P812, DOI 10.1016/j.drudis.2006.07.005; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Liao D, 2007, CANCER METAST REV, V26, P281, DOI 10.1007/s10555-007-9066-y; Lorusso G, 2008, HISTOCHEM CELL BIOL, V130, P1091, DOI 10.1007/s00418-008-0530-8; Maehara N, 2003, EUR RADIOL, V13, P1559, DOI 10.1007/s00330-002-1729-z; Marxen M, 2004, MED PHYS, V31, P305, DOI 10.1118/1.1637971; Mastro AM, 2003, CLIN EXP METASTAS, V20, P275, DOI 10.1023/A:1022995403081; Mazo IB, 1999, J LEUKOCYTE BIOL, V66, P25, DOI 10.1002/jlb.66.1.25; MILLER SC, 1980, METAB BONE DIS RELAT, V2, P239, DOI 10.1016/0221-8747(80)90013-2; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Nieman K, 2001, LANCET, V357, P599, DOI 10.1016/S0140-6736(00)04058-7; Pugsley MK, 2000, J PHARMACOL TOX MET, V44, P333, DOI 10.1016/S1056-8719(00)00125-8; Savai R, 2009, NEOPLASIA, V11, P48, DOI 10.1593/neo.81036; Schirmer Clemens M, 2006, Neurosurgery, V59, pE431, DOI 10.1227/01.NEU.0000223503.92392.CE; Schneider P, 2009, MICROSC RES TECHNIQ, V72, P690, DOI 10.1002/jemt.20720; Semenza GL, 2003, ANNU REV MED, V54, P17, DOI 10.1146/annurev.med.54.101601.152418; Silvestre JS, 2003, CIRC RES, V93, P114, DOI 10.1161/01.RES.0000081594.21764.44; Sugimoto K, 2007, HEPATOL RES, V37, P464, DOI 10.1111/j.1872-034X.2007.00060.x; WIETHOLT C, 2008, IEEE NUCL SCI S, P4848; Yamashita T, 2001, INVEST RADIOL, V36, P713, DOI 10.1097/00004424-200112000-00006; Zhang FJ, 2009, J BONE MINER RES, V24, P1224, DOI [10.1359/JBMR.090204, 10.1359/jbmr.090204]	46	43	45	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e17336	10.1371/journal.pone.0017336	http://dx.doi.org/10.1371/journal.pone.0017336			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464932	Green Published, Green Submitted, gold			2022-12-25	WOS:000289053800001
J	de Goede, J; Verschuren, WMM; Boer, JMA; Kromhout, D; Geleijnse, JM				de Goede, Janette; Verschuren, W. M. Monique; Boer, Jolanda M. A.; Kromhout, Daan; Geleijnse, Johanna M.			Alpha-Linolenic Acid Intake and 10-Year Incidence of Coronary Heart Disease and Stroke in 20,000 Middle-Aged Men and Women in The Netherlands	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; CARDIOVASCULAR RISK; RELATIVE VALIDITY; DIETARY-INTAKE; COHORT; FISH; REPRODUCIBILITY; OUTCOMES; HEALTH; CHAIN	Background: Whether intake of alpha-linolenic acid (ALA), the plant-derived n-3 polyunsaturated fatty acid (PUFA), could prevent cardiovascular diseases is not yet clear. We examined the associations of ALA intake with 10-year incidence of coronary heart disease (CHD) and stroke in the Netherlands. Methods: Data were collected from a general population of 20,069 generally healthy men and women, aged 20 to 65 years. Habitual diet was assessed at baseline (1993-1997) with a validated 178-item food frequency questionnaire. Incidences of CHD and stroke were assessed through linkage with mortality and morbidity registers. Hazard ratios (HR) were calculated with multivariable Cox proportional hazards models, adjusted for age, gender, lifestyle, and dietary factors. Results: During 8-13 years of follow-up, we observed 280 incident CHD events (19% fatal) and 221 strokes (4% fatal). Intakes of energy-adjusted ALA in quintiles ranged from less than 1.0 g/d in the bottom quintile (Q1) to more than 1.9 g/d in the top quintile (Q5). ALA intake was not associated with incident CHD, with HRs varying between 0.89 and 1.01 (all p > 0.05) in Q2-Q5 compared with the bottom quintile of ALA intake. For incident stroke, however, participants in Q2-Q5 had a 35-50% lower risk compared with the reference group. HRs were 0.65 (0.43-0.97), 0.49 (0.31-0.76), 0.53 (0.34-0.83), and 0.65 (0.41-1.04) for Q2-Q5 respectively. Conclusion: In this general Dutch population, ALA intake was not associated with incident CHD. The data suggested that a low intake of ALA may be a risk factor for incident stroke. These results warrant confirmation in other population-based studies and in trials.	[de Goede, Janette; Kromhout, Daan; Geleijnse, Johanna M.] Wageningen Univ, Div Human Nutr, Wageningen, Netherlands; [Verschuren, W. M. Monique; Boer, Jolanda M. A.] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands	Wageningen University & Research; Netherlands National Institute for Public Health & the Environment	de Goede, J (corresponding author), Wageningen Univ, Div Human Nutr, Wageningen, Netherlands.	Marianne.geleijnse@wur.nl	Kromhout, Daan/A-8566-2014; Geleijnse, Johanna Marianna M/B-5749-2012	Geleijnse, Johanna Marianna M/0000-0001-7638-0589	Alpro Foundation, Belgium; Ministry of Health, Welfare and Sport of The Netherlands; National Institute for Public Health and the Environment, Bilthoven, The Netherlands; European Union	Alpro Foundation, Belgium; Ministry of Health, Welfare and Sport of The Netherlands; National Institute for Public Health and the Environment, Bilthoven, The Netherlands(Netherlands Government); European Union(European Commission)	Dr. Geleijnse obtained an unrestricted grant from the Alpro Foundation, Belgium, to cover the costs of data analysis for the present study. The other authors report no financial disclosures. The Monitoring Project on Risk Factors for Chronic Diseases (MORGEN) study was financially supported by the Ministry of Health, Welfare and Sport of The Netherlands and the National Institute for Public Health and the Environment, Bilthoven, The Netherlands, and the Europe Against Cancer Program of the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert CM, 2005, CIRCULATION, V112, P3232, DOI 10.1161/CIRCULATIONAHA.105.572008; Ascherio A, 1996, BMJ-BRIT MED J, V313, P84, DOI 10.1136/bmj.313.7049.84; Brenna JT, 2009, PROSTAG LEUKOTR ESS, V80, P85, DOI 10.1016/j.plefa.2009.01.004; Brouwer IA, 2004, J NUTR, V134, P919, DOI 10.1093/jn/134.4.919; Burdge GC, 2006, PROSTAG LEUKOTR ESS, V75, P161, DOI 10.1016/j.plefa.2006.05.013; Burdge GC, 2006, NUTR RES REV, V19, P26, DOI 10.1079/NRR2005113; Campos H, 2008, CIRCULATION, V118, P339, DOI 10.1161/CIRCULATIONAHA.107.762419; De Bruin A, LINKING DATA NATL AM; DOLECEK TA, 1991, WORLD REV NUTR DIET, V66, P205; Elmadfa I, 2009, ANN NUTR METAB, V55, P56, DOI 10.1159/000228996; Harris WS, 2008, CIRCULATION, V118, P323, DOI 10.1161/CIRCULATIONAHA.108.791467; Harris WS, 2005, CIRCULATION, V111, P2872, DOI 10.1161/CIRCULATIONAHA.105.545640; He K, 2004, CIRCULATION, V109, pE107; He K, 2004, STROKE, V35, P1538, DOI 10.1161/01.STR.0000130856.31468.47; HOEVENAARBLOM MP, 2010, EUR J CARDIOVASC PRE; Hu FB, 1999, AM J CLIN NUTR, V69, P890; Iso H, 2002, STROKE, V33, P2086, DOI 10.1161/01.STR.0000023890.25066.50; Kris-Etherton PM, 2000, AM J CLIN NUTR, V71, p179S, DOI 10.1093/ajcn/71.1.179S; Laaksonen DE, 2005, ARCH INTERN MED, V165, P193, DOI 10.1001/archinte.165.2.193; Merry AH, 2009, EUR J EPIDEMIOL; Mozaffarian D, 2005, CIRCULATION, V111, P157, DOI 10.1161/01.CIR.0000152099.87287.83; Mozaffarian D, 2006, JAMA-J AM MED ASSOC, V296, P1885, DOI 10.1001/jama.296.15.1885; Nguemeni C, PHARM RES, V61, P226; Ocke MC, 1997, INT J EPIDEMIOL, V26, pS37, DOI 10.1093/ije/26.suppl_1.S37; Ocke MC, 1997, INT J EPIDEMIOL, V26, pS49, DOI 10.1093/ije/26.suppl_1.S49; Oomen CM, 2001, AM J CLIN NUTR, V74, P457; Pietinen P, 1997, AM J EPIDEMIOL, V145, P876, DOI 10.1093/oxfordjournals.aje.a009047; Pols MA, 1997, INT J EPIDEMIOL, V26, pS181, DOI 10.1093/ije/26.suppl_1.S181; Reimer WJMSO, 2006, STROKE, V37, P1844, DOI 10.1161/01.STR.0000226463.17988.a3; Riboli E, 1997, INT J EPIDEMIOL, V26, pS6, DOI 10.1093/ije/26.suppl_1.S6; Sanderson P, 2002, BRIT J NUTR, V88, P573, DOI 10.1079/BJN2002691; SIMON JA, 1995, STROKE, V26, P778, DOI 10.1161/01.STR.26.5.778; Stark AH, 2008, NUTR REV, V66, P326, DOI 10.1111/j.1753-4887.2008.00040.x; Verschuren WMM, 2008, INT J EPIDEMIOL, V37, P1236, DOI 10.1093/ije/dym292; Voskuil DW, 1996, EUR J CLIN NUTR, V50, P784; Wang CC, 2006, AM J CLIN NUTR, V84, P5, DOI 10.1093/ajcn/84.1.5; Wendland E, 2006, HEART, V92, P166, DOI 10.1136/hrt.2004.053538; Willett W.C., 1998, SAUPTIKAPARVAN MAHAB, DOI [10.1093/acprof:oso/9780195122978.001.0001, DOI 10.1093/ACPROF:OSO/9780195122978.001.0001, DOI 10.1093/ACPROF:OSO/9780195122978.003.11]; Zhao GX, 2004, J NUTR, V134, P2991, DOI 10.1093/jn/134.11.2991	39	54	55	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e17967	10.1371/journal.pone.0017967	http://dx.doi.org/10.1371/journal.pone.0017967			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464993	Green Published, gold, Green Submitted			2022-12-25	WOS:000288813900024
J	Li, J; Kushima, A; Eapen, J; Lin, X; Qian, XF; Mauro, JC; Diep, P; Yip, S				Li, Ju; Kushima, Akihiro; Eapen, Jacob; Lin, Xi; Qian, Xiaofeng; Mauro, John C.; Diep, Phong; Yip, Sidney			Computing the Viscosity of Supercooled Liquids: Markov Network Model	PLOS ONE			English	Article							LONG-TIME DYNAMICS; GLASS-TRANSITION; BROKEN ERGODICITY; ENERGY LANDSCAPE; TEMPERATURE	The microscopic origin of glass transition, when liquid viscosity changes continuously by more than ten orders of magnitude, is challenging to explain from first principles. Here we describe the detailed derivation and implementation of a Markovian Network model to calculate the shear viscosity of deeply supercooled liquids based on numerical sampling of an atomistic energy landscape, which sheds some light on this transition. Shear stress relaxation is calculated from a master-equation description in which the system follows a transition-state pathway trajectory of hopping among local energy minima separated by activation barriers, which is in turn sampled by a metadynamics-based algorithm. Quantitative connection is established between the temperature variation of the calculated viscosity and the underlying potential energy and inherent stress landscape, showing a different landscape topography or "terrain" is needed for low-temperature viscosity (of order 10(7) Pa.s) from that associated with high-temperature viscosity (10(-5) Pa.s). Within this range our results clearly indicate the crossover from an essentially Arrhenius scaling behavior at high temperatures to a low-temperature behavior that is clearly super-Arrhenius (fragile) for a Kob-Andersen model of binary liquid. Experimentally the manifestation of this crossover in atomic dynamics continues to raise questions concerning its fundamental origin. In this context this work explicitly demonstrates that a temperature-dependent "terrain" characterizing different parts of the same potential energy surface is sufficient to explain the signature behavior of vitrification, at the same time the notion of a temperature-dependent effective activation barrier is quantified.	[Li, Ju; Kushima, Akihiro] Univ Penn, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA; [Kushima, Akihiro; Qian, Xiaofeng; Yip, Sidney] MIT, Dept Nucl Sci & Engn, Cambridge, MA 02139 USA; [Kushima, Akihiro; Qian, Xiaofeng; Yip, Sidney] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Eapen, Jacob] N Carolina State Univ, Dept Nucl Engn, Raleigh, NC 27695 USA; [Lin, Xi] Boston Univ, Div Engn & Mat Sci, Dept Mech Engn, Boston, MA 02215 USA; [Mauro, John C.; Diep, Phong] Corning Inc, Div Sci & Technol, Corning, NY 14831 USA	University of Pennsylvania; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of North Carolina; North Carolina State University; Boston University; Corning Inc; State University of New York (SUNY) System; SUNY Community College	Li, J (corresponding author), Univ Penn, Dept Mat Sci & Engn, 3231 Walnut St, Philadelphia, PA 19104 USA.	liju@seas.upenn.edu	Lin, Xi/D-5321-2011; Qian, Xiaofeng/E-7727-2012; Li, Ju/A-2993-2008; lin, xi/GZL-4959-2022; Kushima, Akihiro/H-2347-2011; Qian, Xiaofeng/P-4715-2016; Qian, Xiaofeng/AAE-9530-2019; Eapen, Jacob/A-2777-2011	Qian, Xiaofeng/0000-0003-1627-288X; Li, Ju/0000-0002-7841-8058; Kushima, Akihiro/0000-0001-5166-4198; Qian, Xiaofeng/0000-0003-1627-288X; Qian, Xiaofeng/0000-0003-1627-288X; Eapen, Jacob/0000-0001-6796-4013; Mauro, John/0000-0002-4319-3530	Corning Inc.; Boston University Center for Scientific Computing and Visualization; NSF [DMR-1008104, DMR-0520020]; AFOSR [FA9550-08-1-0325]	Corning Inc.; Boston University Center for Scientific Computing and Visualization; NSF(National Science Foundation (NSF)); AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This work was supported by Corning Inc. and Boston University Center for Scientific Computing and Visualization. JL and AK acknowledge the support by NSF DMR-1008104, DMR-0520020 and AFOSR FA9550-08-1-0325. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Even though Corning Inc. is the employer of John C. Mauro and Phong Diep and provided partial funding for this work, the purpose of this paper is entirely on the fundamental science of viscosity, and therefore the company played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelani L, 2000, PHYS REV E, V61, P1681, DOI 10.1103/PhysRevE.61.1681; Angelani L, 1998, PHYS REV LETT, V81, P4648, DOI 10.1103/PhysRevLett.81.4648; ANGELL CA, 1988, J PHYS CHEM SOLIDS, V49, P863, DOI 10.1016/0022-3697(88)90002-9; Chong SH, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.041501; Gotze W., 1991, LIQUIDS FREEZING GLA; Gupta PK, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2738471; Heuer A, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/37/373101; Horbach J, 1999, PHYS REV B, V60, P3169, DOI 10.1103/PhysRevB.60.3169; Kivelson D, 1996, PHYS REV E, V53, P751, DOI 10.1103/PhysRevE.53.751; KOB W, 1995, PHYS REV E, V51, P4626, DOI 10.1103/PhysRevE.51.4626; Kushima A, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3243854; Kushima A, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3139006; Laio A, 2005, J PHYS CHEM B, V109, P6714, DOI 10.1021/jp045424k; Mallamace F, 2010, P NATL ACAD SCI USA, V107, P22457, DOI 10.1073/pnas.1015340107; Mauro JC, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2731774; Mauro JC, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2733674; Mauro JC, 2007, J PHYS CHEM A, V111, P7957, DOI 10.1021/jp0731194; Mauro JC, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.094204; Mauro JC, 2008, SCI MODEL SIMUL, V15, P241, DOI 10.1007/s10820-008-9092-2; Mauro JC, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.174202; McQuarrie D. A., 1973, STAT MECH; PALMER RG, 1982, ADV PHYS, V31, P669, DOI 10.1080/00018738200101438; Sastry S, 1998, NATURE, V393, P554, DOI 10.1038/31146; Sciortino F, 1999, PHYS REV LETT, V83, P3214, DOI 10.1103/PhysRevLett.83.3214; STILLINGER FH, 1982, PHYS REV A, V25, P978, DOI 10.1103/PhysRevA.25.978	25	23	23	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e17909	10.1371/journal.pone.0017909	http://dx.doi.org/10.1371/journal.pone.0017909			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464988	Green Published, Green Submitted, gold			2022-12-25	WOS:000288813900017
J	Spencer, KL; Olson, LM; Schnetz-Boutaud, N; Gallins, P; Agarwal, A; Iannaccone, A; Kritchevsky, SB; Garcia, M; Nalls, MA; Newman, AB; Scott, WK; Pericak-Vance, MA; Haines, JL				Spencer, Kylee L.; Olson, Lana M.; Schnetz-Boutaud, Nathalie; Gallins, Paul; Agarwal, Anita; Iannaccone, Alessandro; Kritchevsky, Stephen B.; Garcia, Melissa; Nalls, Michael A.; Newman, Anne B.; Scott, William K.; Pericak-Vance, Margaret A.; Haines, Jonathan L.			Using Genetic Variation and Environmental Risk Factor Data to Identify Individuals at High Risk for Age-Related Macular Degeneration	PLOS ONE			English	Article							COMPLEMENT FACTOR-H; PIGMENT OPTICAL-DENSITY; BREAST-CANCER; UNITED-STATES; FACTOR-B; ASSOCIATION; POLYMORPHISM; DISEASE; VARIANT; SUSCEPTIBILITY	A major goal of personalized medicine is to pre-symptomatically identify individuals at high risk for disease using knowledge of each individual's particular genetic profile and constellation of environmental risk factors. With the identification of several well-replicated risk factors for age-related macular degeneration (AMD), the leading cause of legal blindness in older adults, this previously unreachable goal is beginning to seem less elusive. However, recently developed algorithms have either been much less accurate than expected, given the strong effects of the identified risk factors, or have not been applied to independent datasets, leaving unknown how well they would perform in the population at large. We sought to increase accuracy by using novel modeling strategies, including multifactor dimensionality reduction (MDR) and grammatical evolution of neural networks (GENN), in addition to the traditional logistic regression approach. Furthermore, we rigorously designed and tested our models in three distinct datasets: a Vanderbilt-Miami (VM) clinic-based case-control dataset, a VM family dataset, and the population-based Age-related Maculopathy Ancillary (ARMA) Study cohort. Using a consensus approach to combine the results from logistic regression and GENN models, our algorithm was successful in differentiating between high- and low-risk groups (sensitivity 77.0%, specificity 74.1%). In the ARMA cohort, the positive and negative predictive values were 63.3% and 70.7%, respectively. We expect that future efforts to refine this algorithm by increasing the sample size available for model building, including novel susceptibility factors as they are discovered, and by calibrating the model for diverse populations will improve accuracy.	[Spencer, Kylee L.; Olson, Lana M.; Schnetz-Boutaud, Nathalie; Haines, Jonathan L.] Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN 37235 USA; [Gallins, Paul; Scott, William K.; Pericak-Vance, Margaret A.] Univ Miami, Miller Sch Med, John P Hussman Inst Human Genom, Miami, FL 33136 USA; [Agarwal, Anita] Vanderbilt Univ, Med Ctr, Vanderbilt Eye Inst, Nashville, TN USA; [Iannaccone, Alessandro] Univ Tennessee, Hlth Sci Ctr, Hamilton Eye Inst, Memphis, TN USA; [Kritchevsky, Stephen B.] Univ Tennessee, Hlth Sci Ctr, Dept Prevent Med, Memphis, TN USA; [Kritchevsky, Stephen B.] Wake Forest Univ, Sticht Ctr Aging, Winston Salem, NC 27109 USA; [Garcia, Melissa] NIA, Lab Epidemiol Demog & Biometry, Bethesda, MD 20892 USA; [Nalls, Michael A.] NIA, Neurogenet Lab, Bethesda, MD 20892 USA; [Newman, Anne B.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA	Vanderbilt University; University of Miami; Vanderbilt University; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Wake Forest University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Spencer, KL (corresponding author), Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN 37235 USA.	Kylee.Spencer@vanderbilt.edu	Haines, Jonathan/C-3374-2012; Newman, Anne B./C-6408-2013	Haines, Jonathan/0000-0002-4351-4728; Newman, Anne B./0000-0002-0106-1150; Kritchevsky, Stephen/0000-0003-3336-6781; Scott, William/0000-0001-9336-6404; Iannaccone, Alessandro/0000-0001-5737-8424	National Institutes of Health (NIH)/National Eye Institute [EY12118, EY000409]; NIH/National Institute on Aging (NIA) [N01-AG-6-2101, N01-AG-6-2103, N01-AG-6-2106]; International Retinal Research Foundation, Inc., Birmingham, AL; Research to Prevent Blindness, New York, NY; NIH/NIA; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY012118, K23EY000409, U10EY012118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [N01AG062103, N01AG062101, N01AG062106] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIH/National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); International Retinal Research Foundation, Inc., Birmingham, AL; Research to Prevent Blindness, New York, NY(Research to Prevent Blindness (RPB)); NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants EY12118 (to M.A.P.-V. and J.L.H.) and EY000409 (K23 Award to A.I.) from the National Institutes of Health (NIH)/National Eye Institute, contracts N01-AG-6-2101, N01-AG-6-2103, N01-AG-6-2106 (to S.B.K.) from the NIH/National Institute on Aging (NIA), grants from the International Retinal Research Foundation, Inc., Birmingham, AL (to A.I.), by Research to Prevent Blindness, New York, NY (Career Development Award to A.I. and an unrestricted grant to the UTHSC Hamilton Eye Institute), and in part by the Intramural Research Program of the NIH/NIA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen W, 2010, P NATL ACAD SCI USA, V107, P7401, DOI 10.1073/pnas.0912702107; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Fagerness JA, 2009, EUR J HUM GENET, V17, P100, DOI 10.1038/ejhg.2008.140; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P532; Gallaher KT, 2007, VISION RES, V47, P1253, DOI 10.1016/j.visres.2007.01.013; Gibson J, 2010, BRIT J OPHTHALMOL, V94, P1382, DOI 10.1136/bjo.2010.182568; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Hageman GS, 2006, ANN MED, V38, P592, DOI 10.1080/07853890601097030; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hughes AE, 2007, PLOS MED, V4, P1993, DOI 10.1371/journal.pmed.0040355; Humphrey LL, 2002, ANN INTERN MED, V137, P347, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00012; Iannaccone A, 2007, INVEST OPHTH VIS SCI, V48, P1458, DOI 10.1167/iovs.06-0438; Jakobsdottir J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000337; Jakobsdottir J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002199; Janssens ACJW, 2007, GENET MED, V9, P528, DOI 10.1097/GIM.0b013e31812eece0; Kassoff A, 1999, CONTROL CLIN TRIALS, V20, P573; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Maller J, 2006, NAT GENET, V38, P1055, DOI 10.1038/ng1873; Maller JB, 2007, NAT GENET, V39, P1200, DOI 10.1038/ng2131; Mistry K, 2003, J AM BOARD FAM PRACT, V16, P95, DOI 10.3122/jabfm.16.2.95; Motsinger-Reif AA, 2008, GENET EPIDEMIOL, V32, P325, DOI 10.1002/gepi.20307; Neale BM, 2010, P NATL ACAD SCI USA, V107, P7395, DOI 10.1073/pnas.0912019107; Pepe MS, 2004, STAT EVALUATION MED; Postel EA, 2005, AM J OPHTHALMOL, V139, P820, DOI 10.1016/j.ajo.2004.12.029; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; Schmidt S, 2006, AM J HUM GENET, V78, P852, DOI 10.1086/503822; Schmidt S, 2000, MOL VIS, V6, P287; Seddon Johanna M., 2004, International Ophthalmology Clinics, V44, P17, DOI 10.1097/00004397-200404440-00004; Seddon JM, 2009, INVEST OPHTH VIS SCI, V50, P2044, DOI 10.1167/iovs.08-3064; Smith RA, 2009, CA-CANCER J CLIN, V59, P27, DOI 10.3322/caac.20008; Spencer KL, 2008, HUM MOL GENET, V17, P1821, DOI 10.1093/hmg/ddn075; Spencer KL, 2007, HUM MOL GENET, V16, P1986, DOI 10.1093/hmg/ddm146; Thornton J, 2005, EYE, V19, P935, DOI 10.1038/sj.eye.6701978; VELEZ DR, 2007, GENET EPIDEMIOL; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618	38	37	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2011	6	3							e17784	10.1371/journal.pone.0017784	http://dx.doi.org/10.1371/journal.pone.0017784			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740RG	21455292	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000288811500009
J	Malik, SA; Orhon, I; Morselli, E; Criollo, A; Shen, S; Marino, G; BenYounes, A; Benit, P; Rustin, P; Maiuri, MC; Kroemer, G				Malik, S. A.; Orhon, I.; Morselli, E.; Criollo, A.; Shen, S.; Marino, G.; BenYounes, A.; Benit, P.; Rustin, P.; Maiuri, M. C.; Kroemer, G.			BH3 mimetics activate multiple pro-autophagic pathways	ONCOGENE			English	Article						autophagy; Beclin 1; Bcl-2 family protein; ABT737	BH3-ONLY PROTEINS; BCL-2 FAMILY; BECLIN 1; INDUCTION; COMPLEX; CELLS; IKK	The BH3 mimetic ABT737 induces autophagy by competitively disrupting the inhibitory interaction between the BH3 domain of Beclin 1 and the anti-apoptotic proteins Bcl-2 and Bcl-XL, thereby stimulating the Beclin 1-dependent allosteric activation of the pro-autophagic lipid kinase VPS34. Here, we examined whether ABT737 stimulates other pro-autophagic signal-transduction pathways. ABT737 caused the activating phosphorylation of AMP-dependent kinase (AMPK) and of the AMPK substrate acetyl CoA carboxylase, the activating phosphorylation of several subunits of the inhibitor of NF-kappa B (I kappa B) kinase (IKK) and the hyperphosphorylation of the IKK substrate I kappa B, inhibition of the activity of mammalian target of rapamycin (mTOR) and consequent dephosphorylation of the mTOR substrate S6 kinase. In addition, ABT737 treatment dephosphorylates (and hence likewise inhibits) p53, glycogen synthase kinase-3 and Akt. All these effects were shared by ABT737 and another structurally unrelated BH3 mimetic, HA14-1. Functional experiments revealed that pharmacological or genetic inhibition of IKK, Sirtuin and the p53-depleting ubiquitin ligase MDM2 prevented ABT737-induced autophagy. These results point to unexpected and pleiotropic proautophagic effects of BH3 mimetics involving the modulation of multiple signalling pathways. Oncogene (2011) 30, 3918-3929; doi:10.1038/onc.2011.104; published online 4 April 2011	[Malik, S. A.; Orhon, I.; Morselli, E.; Criollo, A.; Shen, S.; Marino, G.; BenYounes, A.; Maiuri, M. C.; Kroemer, G.] Inst Gustave Roussy, INSERM, U848, F-94805 Villejuif, Val De Marne, France; [Malik, S. A.; Orhon, I.; Morselli, E.; Criollo, A.; Shen, S.; Marino, G.; BenYounes, A.; Maiuri, M. C.; Kroemer, G.] Univ Paris 11, Villejuif, France; [Benit, P.; Rustin, P.] INSERM, U676, Paris, France; [Kroemer, G.] Ctr Rech Cordeliers, Paris, France; [Kroemer, G.] Hop Europe Georges Pompidou, AP HP, Paris, France; [Kroemer, G.] Univ Paris 05, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Kroemer, G (corresponding author), Inst Gustave Roussy, INSERM, U848, Pavillon Rech 1,39 Rue Camille Desmoulins, F-94805 Villejuif, Val De Marne, France.	kroemer@orange.fr	GARCÍA, GUILLERMO MARIÑO/AAI-8015-2020; Kroemer, Guido/AAY-9859-2020; orhon, idil/AAB-1940-2020; Malik, Shoaib Ahmad/O-7022-2017; GARCÍA, GUILLERMO MARIÑO/J-1726-2012; marino, guillermo/HGB-8664-2022; KROEMER, Guido/B-4263-2013; SHEN, Shensi/AAW-2735-2020	orhon, idil/0000-0002-0779-8719; Malik, Shoaib Ahmad/0000-0002-0843-8512; GARCÍA, GUILLERMO MARIÑO/0000-0003-1960-1677; KROEMER, Guido/0000-0002-9334-4405; SHEN, Shensi/0000-0002-5087-8220; Criollo, Alfredo/0000-0002-2737-7751	Ligue Nationale contre le Cancer (Equipes labellisee); Agence Nationale pour la Recherche (ANR); AXA Foundation; European Commission; Fondation pour la Recherche Medicale (FRM); Institut National du Cancer (INCa); Canceropole Ile-de-France; Higher Education Commission (HEC) of Pakistan	Ligue Nationale contre le Cancer (Equipes labellisee); Agence Nationale pour la Recherche (ANR)(French National Research Agency (ANR)); AXA Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Canceropole Ile-de-France(Region Ile-de-France); Higher Education Commission (HEC) of Pakistan(Higher Education Commission of Pakistan)	We thank Drs B Vogelstein (John Hopkins University, Bethesda, MD, USA) and S Korsmeyer (Harvard University) for HCT116 cells and double-knockout MEF, respectively. We thank Dr K-L Guan for Rheb constructs. GK is supported by the Ligue Nationale contre le Cancer (Equipes labellisee), Agence Nationale pour la Recherche (ANR), AXA Foundation (Chair for Longevity Research), European Commission (Active p53, Apo-Sys, ChemoRes, ApopTrain, ArtForce), Fondation pour la Recherche Medicale (FRM), Institut National du Cancer (INCa) and Canceropole Ile-de-France. SA Malik is the recipient of a grant from the Higher Education Commission (HEC) of Pakistan.	Apel A, 2008, CANCER RES, V68, P1485, DOI 10.1158/0008-5472.CAN-07-0562; Benit P, 2006, CLIN CHIM ACTA, V374, P81, DOI 10.1016/j.cca.2006.05.034; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Boya P, 2009, ONCOGENE, V28, P2125, DOI 10.1038/onc.2009.83; Broemer M, 2004, ONCOGENE, V23, P5378, DOI 10.1038/sj.onc.1207705; Criollo A, 2010, EMBO J, V29, P619, DOI 10.1038/emboj.2009.364; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Galluzzi L, 2007, CELL DEATH DIFFER, V14, P1237, DOI 10.1038/sj.cdd.4402148; Galluzzi L, 2008, CURR MOL MED, V8, P78; Harborth J, 2001, J CELL SCI, V114, P4557; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kessel D, 2007, CANCER LETT, V249, P294, DOI 10.1016/j.canlet.2006.09.009; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Klionsky DJ, 2010, AUTOPHAGY, V6, P438, DOI 10.4161/auto.6.4.12244; Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lian J, 2011, CELL DEATH DIFFER, V18, P60, DOI 10.1038/cdd.2010.74; Madeo F, 2010, NAT CELL BIOL, V12, P842, DOI 10.1038/ncb0910-842; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Maiuri MC, 2007, AUTOPHAGY, V3, P374, DOI 10.4161/auto.4237; Maiuri MC, 2010, CURR OPIN CELL BIOL, V22, P181, DOI 10.1016/j.ceb.2009.12.001; Maiuri MC, 2009, CELL CYCLE, V8, P1571, DOI 10.4161/cc.8.10.8498; Mason KD, 2007, CELL, V128, P1173, DOI 10.1016/j.cell.2007.01.037; Morselli E, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.8; Oberstein A, 2007, J BIOL CHEM, V282, P13123, DOI 10.1074/jbc.M700492200; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Petros AM, 2004, BBA-MOL CELL RES, V1644, P83, DOI 10.1016/j.bbamcr.2003.08.012; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; Sinha S, 2008, ONCOGENE, V27, pS137, DOI 10.1038/onc.2009.51; Tasdemir E, 2008, CELL CYCLE, V7, P3006, DOI 10.4161/cc.7.19.6702; Tasdemir E, 2008, NAT CELL BIOL, V10, P676, DOI 10.1038/ncb1730; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Zhang XD, 2009, J NEUROSCI RES, V87, P3600, DOI 10.1002/jnr.22152; Zhou XM, 2009, P NATL ACAD SCI USA, V106, P8923, DOI 10.1073/pnas.0903621106	38	91	95	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	2011	30	37					3918	3929		10.1038/onc.2011.104	http://dx.doi.org/10.1038/onc.2011.104			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	820FG	21460857				2022-12-25	WOS:000294890400002
J	Nakatsu, Y; Sakoda, H; Kushiyama, A; Zhang, J; Ono, H; Fujishiro, M; Kikuchi, T; Fukushima, T; Yoneda, M; Ohno, H; Horike, N; Kanna, M; Tsuchiya, Y; Kamata, H; Nishimura, F; Isobe, T; Ogihara, T; Katagiri, H; Oka, Y; Takahashi, S; Kurihara, H; Uchida, T; Asano, T				Nakatsu, Yusuke; Sakoda, Hideyuki; Kushiyama, Akifumi; Zhang, Jun; Ono, Hiraku; Fujishiro, Midori; Kikuchi, Takako; Fukushima, Toshiaki; Yoneda, Masayasu; Ohno, Haruya; Horike, Nanao; Kanna, Machi; Tsuchiya, Yoshihiro; Kamata, Hideaki; Nishimura, Fusanori; Isobe, Toshiaki; Ogihara, Takehide; Katagiri, Hideki; Oka, Yoshitomo; Takahashi, Shin-ichiro; Kurihara, Hiroki; Uchida, Takafumi; Asano, Tomoichiro			Peptidyl-prolyl Cis/Trans Isomerase NIMA-interacting 1 Associates with Insulin Receptor Substrate-1 and Enhances Insulin Actions and Adipogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOCYTE DIFFERENTIATION; TRANSCRIPTIONAL ACTIVITY; DEPENDENT INTERACTION; BINDING-PROTEIN; CYCLOSPORINE-A; MICE LACKING; PIN1; PHOSPHORYLATION; RESISTANCE; DOMAIN	Peptidyl-prolyl cis/trans isomerase NIMA-interacting 1 (Pin1) is a unique enzyme that associates with the pSer/Thr-Pro motif and catalyzes cis-trans isomerization. We identified Pin1 in the immunoprecipitates of overexpressed IRS-1 with myc and FLAG tags in mouse livers and confirmed the association between IRS-1 and Pin1 by not only overexpression experiments but also endogenously in the mouse liver. The analysis using deletion-and point-mutated Pin1 and IRS-1 constructs revealed the WW domain located in the N terminus of Pin1 and Ser-434 in the SAIN (Shc and IRS-1 NPXY binding) domain of IRS-1 to be involved in their association. Subsequently, we investigated the role of Pin1 in IRS-1 mediation of insulin signaling. The overexpression of Pin1 in HepG2 cells markedly enhanced insulin-induced IRS-1 phosphorylation and its downstream events: phosphatidylinositol 3-kinase binding with IRS-1 and Akt phosphorylation. In contrast, the treatment of HepG2 cells with Pin1 siRNA or the Pin1 inhibitor Juglone suppressed these events. In good agreement with these in vitro data, Pin1 knock-out mice exhibited impaired insulin signaling with glucose intolerance, whereas adenoviral gene transfer of Pin1 into the ob/ob mouse liver mostly normalized insulin signaling and restored glucose tolerance. In addition, it was also demonstrated that Pin1 plays a critical role in adipose differentiation, making Pin1 knock-out mice resistant to diet-induced obesity. Importantly, Pin1 expression was shown to be up-regulated in accordance with nutrient conditions such as food intake or a high-fat diet. Taken together, these observations indicate that Pin1 binds to IRS-1 and thereby markedly enhances insulin action, essential for adipogenesis.	[Nakatsu, Yusuke; Zhang, Jun; Fukushima, Toshiaki; Yoneda, Masayasu; Ohno, Haruya; Kanna, Machi; Tsuchiya, Yoshihiro; Kamata, Hideaki; Asano, Tomoichiro] Hiroshima Univ, Grad Sch Med, Dept Med Sci, Minami Ku, Hiroshima 7348553, Japan; [Sakoda, Hideyuki; Ono, Hiraku; Fujishiro, Midori; Kikuchi, Takako] Univ Tokyo, Dept Internal Med, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan; [Kushiyama, Akifumi] Asahi Life Fdn, Inst Adult Dis, Tokyo 1000006, Japan; [Nishimura, Fusanori] Hiroshima Univ, Grad Sch Biomed Sci, Dept Dent Sci Hlth Promot, Hiroshima 7348553, Japan; [Isobe, Toshiaki] Tokyo Metropolitan Univ, Ctr Prior Areas, Tokyo 1920397, Japan; [Ogihara, Takehide; Katagiri, Hideki; Oka, Yoshitomo] Tohoku Univ, Grad Sch Med, Div Mol Metab & Diabet, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Kurihara, Hiroki] Univ Tokyo, Grad Sch Med, Dept Physiol Chem & Metab, Bunkyo Ku, Tokyo 1130033, Japan; [Takahashi, Shin-ichiro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1130033, Japan; [Uchida, Takafumi] Tohoku Univ, Grad Sch Agr Sci, Dept Mol Cell Biol, Sendai, Miyagi 1130033, Japan	Hiroshima University; University of Tokyo; Asahi Life Foundation; Hiroshima University; Tokyo Metropolitan University; Tohoku University; University of Tokyo; University of Tokyo; Tohoku University	Asano, T (corresponding author), Hiroshima Univ, Grad Sch Med, Dept Med Sci, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan.	asano-tky@umin.ac.jp	Kamata, Hideaki/N-3907-2017; Kushiyama, Akifumi/W-5988-2019; Isobe, Toshiaki/Q-9279-2017; 祐介, 中津/AAP-8396-2020; Kanna, Machi/D-7028-2011; Kushiyama, Akifumi/A-6386-2011	Kushiyama, Akifumi/0000-0003-1385-7487; Kanna, Machi/0000-0001-9841-433X; Kushiyama, Akifumi/0000-0003-1385-7487; Nakatsu, Yusuke/0000-0003-3279-1276; Takahashi, Shin-Ichiro/0000-0002-2323-2010; Kurihara, Hiroki/0000-0002-6476-5593; Ohno, Haruya/0000-0001-5400-1162; Uchida, Takafumi/0000-0003-3665-4906	Grants-in-Aid for Scientific Research [22780249] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Choi JW, 1996, SCIENCE, V273, P239, DOI 10.1126/science.273.5272.239; FISCHER G, 1989, NATURE, V337, P476, DOI 10.1038/337476a0; Fujimori F, 1999, BIOCHEM BIOPH RES CO, V265, P658, DOI 10.1006/bbrc.1999.1736; GUSTAFSON TA, 1995, MOL CELL BIOL, V15, P2500; Hennig L, 1998, BIOCHEMISTRY-US, V37, P5953, DOI 10.1021/bi973162p; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; Ichimura T, 2005, J BIOL CHEM, V280, P13187, DOI 10.1074/jbc.M412884200; Jiang L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006884; Kerouz NJ, 1997, J CLIN INVEST, V100, P3164, DOI 10.1172/JCI119872; KUNZ J, 1993, TRENDS BIOCHEM SCI, V18, P334, DOI 10.1016/0968-0004(93)90069-Y; Liou YC, 2003, NATURE, V424, P556, DOI 10.1038/nature01832; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Lu KP, 1996, NATURE, V380, P544; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Lu PJ, 1999, NATURE, V399, P784; Lufei C, 2007, ONCOGENE, V26, P7656, DOI 10.1038/sj.onc.1210567; Morino K, 2008, DIABETES, V57, P2644, DOI 10.2337/db06-0454; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Nakatsu Y, 2010, J BIOL CHEM, V285, P33018, DOI 10.1074/jbc.M110.137836; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ono H, 2003, DIABETES, V52, P2905, DOI 10.2337/diabetes.52.12.2905; Pastorino L, 2006, NATURE, V440, P528, DOI 10.1038/nature04543; Pirola L, 2004, DIABETOLOGIA, V47, P170, DOI 10.1007/s00125-003-1313-3; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Ryo A, 2001, NAT CELL BIOL, V3, P793, DOI 10.1038/ncb0901-793; SCHREIBER SL, 1991, SCIENCE, V251, P283, DOI 10.1126/science.1702904; Spiegelman BM, 1998, DIABETES, V47, P507, DOI 10.2337/diabetes.47.4.507; Takahashi K, 2008, CELL MOL LIFE SCI, V65, P359, DOI 10.1007/s00018-007-7270-0; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; TONTONOZ P, 1993, MOL CELL BIOL, V13, P4753, DOI 10.1128/MCB.13.8.4753; UMEK RM, 1991, SCIENCE, V251, P288, DOI 10.1126/science.1987644; Werner ED, 2004, J BIOL CHEM, V279, P35298, DOI 10.1074/jbc.M405203200; Winkler KE, 2000, SCIENCE, V287, P1644, DOI 10.1126/science.287.5458.1644; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Wulf G, 2005, NAT CELL BIOL, V7, P435, DOI 10.1038/ncb0505-435; Wulf GM, 2001, EMBO J, V20, P3459, DOI 10.1093/emboj/20.13.3459; Yenush L, 1996, J BIOL CHEM, V271, P24300, DOI 10.1074/jbc.271.39.24300; Zacchi P, 2002, NATURE, V419, P853, DOI 10.1038/nature01120; Zheng HW, 2002, NATURE, V419, P849, DOI 10.1038/nature01116; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(00)00085-X	43	51	52	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20812	20822		10.1074/jbc.M110.206904	http://dx.doi.org/10.1074/jbc.M110.206904			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21454638	Green Published, hybrid			2022-12-25	WOS:000291267600066
J	Johnson, MP; Ruban, AV				Johnson, Matthew P.; Ruban, Alexander V.			Restoration of Rapidly Reversible Photoprotective Energy Dissipation in the Absence of PsbS Protein by Enhanced Delta pH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOSYSTEM-II ANTENNA; CYCLIC ELECTRON FLOW; CHLOROPHYLL-A FLUORESCENCE; LIGHT-HARVESTING COMPLEXES; EXCITATION-ENERGY; XANTHOPHYLL CYCLE; IN-VIVO; CHLOROPLASTS; ARABIDOPSIS; ZEAXANTHIN	Variations in the light environment require higher plants to regulate the light harvesting process. Under high light a mechanism known as non-photochemical quenching (NPQ) is triggered to dissipate excess absorbed light energy within the photosystem II (PSII) antenna as heat, preventing photodamage to the reaction center. The major component of NPQ, known as qE, is rapidly reversible in the dark and dependent upon the transmembrane proton gradient (Delta pH), formed as a result of photosynthetic electron transport. Using diaminodurene and phenazine metasulfate, mediators of cyclic electron flow around photosystem I, to enhance Delta pH, it is demonstrated that rapidly reversible qE-type quenching can be observed in intact chloroplasts from Arabidopsis plants lacking the PsbS protein, previously believed to be indispensible for the process. The qE in chloroplasts lacking PsbS significantly quenched the level of fluorescence when all PSII reaction centers were in the open state (F-o state), protected PSII reaction centers from photoinhibition, was modulated by zeaxanthin and was accompanied by the qE-typical absorption spectral changes, known as Delta A(535). Titrations of the Delta pH dependence of qE in the absence of PsbS reveal that this protein affects the cooperativity and sensitivity of the photoprotective process to protons. The roles of PsbS and zeaxanthin are discussed in light of their involvement in the control of the proton-antenna association constant, pK, via regulation of the interconnected phenomena of PSII antenna reorganization/aggregation and hydrophobicity.	[Johnson, Matthew P.; Ruban, Alexander V.] Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England	University of London; Queen Mary University London	Ruban, AV (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, Mile End Rd, London E1 4NS, England.	a.ruban@qmul.ac.uk		Johnson, Matthew/0000-0002-1663-0205	Biotechnology and Biological Sciences Research Council UK; Engineering and Environmental Sciences Research Council UK	Biotechnology and Biological Sciences Research Council UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Environmental Sciences Research Council UK	The work was supported by Biotechnology and Biological Sciences Research Council UK and Engineering and Environmental Sciences Research Council UK research grants	AMESZ J, 1967, BIOCHIM BIOPHYS ACTA, V143, P97, DOI 10.1016/0005-2728(67)90114-4; ARNON DI, 1954, NATURE, V174, P394, DOI 10.1038/174394a0; Aspinall-O'Dea M, 2002, P NATL ACAD SCI USA, V99, P16331, DOI 10.1073/pnas.252500999; Betterle N, 2009, J BIOL CHEM, V284, P15255, DOI 10.1074/jbc.M808625200; Bonente G, 2008, J BIOL CHEM, V283, P8434, DOI 10.1074/jbc.M708291200; BRAUN G, 1992, BIOCHIM BIOPHYS ACTA, V1100, P58, DOI 10.1016/0167-4838(92)90536-M; CROFTS J, 1991, BIOCHIM BIOPHYS ACTA, V1058, P187, DOI 10.1016/S0005-2728(05)80236-1; Crouchman S, 2006, FEBS LETT, V580, P2053, DOI 10.1016/j.febslet.2006.03.005; Dall'Osto L, 2005, PLANT CELL, V17, P1217, DOI 10.1105/tpc.104.030601; Dekker JP, 2005, BBA-BIOENERGETICS, V1706, P12, DOI 10.1016/j.bbabio.2004.09.009; DEMMIGADAMS B, 1990, PLANT PHYSIOL, V92, P293, DOI 10.1104/pp.92.2.293; Dominici P, 2002, J BIOL CHEM, V277, P22750, DOI 10.1074/jbc.M200604200; HAUSKA GA, 1974, FEBS LETT, V41, P35, DOI 10.1016/0014-5793(74)80947-6; Holt NE, 2004, BIOCHEMISTRY-US, V43, P8281, DOI 10.1021/bi0494020; Horton P, 2000, PHILOS T R SOC B, V355, P1361, DOI 10.1098/rstb.2000.0698; Horton P, 1996, ANNU REV PLANT PHYS, V47, P655, DOI 10.1146/annurev.arplant.47.1.655; HORTON P, 1991, FEBS LETT, V292, P1, DOI 10.1016/0014-5793(91)80819-O; Horton P, 2008, FEBS J, V275, P1069, DOI 10.1111/j.1742-4658.2008.06263.x; Jahns P, 2009, BBA-BIOENERGETICS, V1787, P3, DOI 10.1016/j.bbabio.2008.09.013; Johnson MP, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702831200; Johnson MP, 2011, PLANT CELL, V23, P1468, DOI 10.1105/tpc.110.081646; Johnson MP, 2010, PLANT J, V61, P283, DOI 10.1111/j.1365-313X.2009.04051.x; Johnson MP, 2009, PLANT PHYSIOL, V149, P1061, DOI 10.1104/pp.108.129957; Joliot PA, 2010, P NATL ACAD SCI USA, V107, P12728, DOI 10.1073/pnas.1006399107; Kereiche S, 2010, FEBS LETT, V584, P759, DOI 10.1016/j.febslet.2009.12.031; Kiss AZ, 2008, J BIOL CHEM, V283, P3972, DOI 10.1074/jbc.M707410200; Kramer DM, 1999, PHOTOSYNTH RES, V60, P151, DOI 10.1023/A:1006212014787; Kramer DM, 2004, TRENDS PLANT SCI, V9, P349, DOI 10.1016/j.tplants.2004.05.001; KRIEGER A, 1992, BIOCHIM BIOPHYS ACTA, V1102, P167, DOI 10.1016/0167-4838(92)90507-A; KRIEGER A, 1993, PHOTOSYNTH RES, V37, P117, DOI 10.1007/BF02187470; Kulheim C, 2002, SCIENCE, V297, P91, DOI 10.1126/science.1072359; Li H, 2004, PROTEINS, V55, P689, DOI 10.1002/prot.20032; Li XP, 2004, J BIOL CHEM, V279, P22866, DOI 10.1074/jbc.M402461200; Li XP, 2002, P NATL ACAD SCI USA, V99, P15222, DOI 10.1073/pnas.232447699; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Lokstein H, 2002, BBA-BIOENERGETICS, V1553, P309, DOI 10.1016/S0005-2728(02)00184-6; Mehler EL, 2002, PROTEINS, V48, P283, DOI 10.1002/prot.10153; MILLS J, 1975, ARCH BIOCHEM BIOPHYS, V170, P306, DOI 10.1016/0003-9861(75)90122-8; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Munekage Y, 2002, CELL, V110, P361, DOI 10.1016/S0092-8674(02)00867-X; Nelson N, 2004, NAT REV MOL CELL BIO, V5, P971, DOI 10.1038/nrm1525; Niyogi KK, 1998, PLANT CELL, V10, P1121, DOI 10.1105/tpc.10.7.1121; NOCTOR G, 1993, BIOCHIM BIOPHYS ACTA, V1183, P339, DOI 10.1016/0005-2728(93)90237-A; NOCTOR G, 1991, BIOCHIM BIOPHYS ACTA, V1057, P320, DOI 10.1016/S0005-2728(05)80143-4; Paulsen H, 1999, ADV PHOTOSYNTH, V8, P123; Perez-Bueno ML, 2008, FEBS LETT, V582, P1477, DOI 10.1016/j.febslet.2008.03.040; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; REES D, 1990, PHOTOSYNTH RES, V25, P199, DOI 10.1007/BF00033161; REES D, 1989, FEBS LETT, V256, P85, DOI 10.1016/0014-5793(89)81723-5; REES D, 1992, PHOTOSYNTH RES, V31, P11, DOI 10.1007/BF00049532; ROTTENBERG H, 1972, EUR J BIOCHEM, V25, P54, DOI 10.1111/j.1432-1033.1972.tb01666.x; Ruban AV, 2010, ARCH BIOCHEM BIOPHYS, V504, P78, DOI 10.1016/j.abb.2010.06.034; Ruban AV, 1999, PLANT PHYSIOL, V119, P531, DOI 10.1104/pp.119.2.531; Ruban AV, 1997, BIOCHEMISTRY-US, V36, P7855, DOI 10.1021/bi9630725; Ruban AV, 2001, BIOCHEMISTRY-US, V40, P9896, DOI 10.1021/bi010370f; RUBAN AV, 1993, J PHOTOCH PHOTOBIO B, V21, P229, DOI 10.1016/1011-1344(93)80188-F; SCHULDINER S, 1972, EUR J BIOCHEM, V25, P64, DOI 10.1111/j.1432-1033.1972.tb01667.x; Shikanai T, 2007, ANNU REV PLANT BIOL, V58, P199, DOI 10.1146/annurev.arplant.58.091406.110525; Spetea C, 1997, BBA-BIOENERGETICS, V1318, P275, DOI 10.1016/S0005-2728(96)00145-4; Takizawa K, 2007, BBA-BIOENERGETICS, V1767, P1233, DOI 10.1016/j.bbabio.2007.07.006; Thurlkill RL, 2006, J MOL BIOL, V362, P594, DOI 10.1016/j.jmb.2006.07.056; Walters RG, 1996, P NATL ACAD SCI USA, V93, P14204, DOI 10.1073/pnas.93.24.14204; WALTERS RG, 1994, EUR J BIOCHEM, V226, P1063, DOI 10.1111/j.1432-1033.1994.01063.x; WRAIGHT CA, 1970, EUR J BIOCHEM, V17, P319, DOI 10.1111/j.1432-1033.1970.tb01169.x; Yamamoto H, 2006, PLANT CELL PHYSIOL, V47, P1355, DOI 10.1093/pcp/pcl005; Zia A, 2011, PLANTA, V233, P1253, DOI 10.1007/s00425-011-1380-5	66	103	107	2	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19973	19981		10.1074/jbc.M111.237255	http://dx.doi.org/10.1074/jbc.M111.237255			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21474447	Green Published, hybrid			2022-12-25	WOS:000291027700075
J	Fan, HP; Guan, JL				Fan, Huaping; Guan, Jun-Lin			Compensatory Function of Pyk2 Protein in the Promotion of Focal Adhesion Kinase (FAK)-null Mammary Cancer Stem Cell Tumorigenicity and Metastatic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-SPECIFIC DISRUPTION; TUMOR-INITIATING CELLS; HUMAN BREAST-CANCER; TYROSINE KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; MOUSE MODEL; V-SRC; FAK; PHOSPHORYLATION; MIGRATION	Mammary cancer stem cells (MaCSCs) have been identified as a rare population of cells capable of self-renewal to drive mammary tumorigenesis and metastasis. Nevertheless, relatively little is known about the intracellular signaling pathways regulating self-renewal and metastatic activities of MaCSCs in vivo. Using a recently developed breast cancer mouse model with focal adhesion kinase (FAK) deletion in mammary tumor cells (MFCKO-MT mice), here we present evidence suggesting a compensatory function of Pyk2, a FAK-related kinase, in the regulation of MaCSCs and metastasis in these mice. Increased expression of Pyk2 was found selectively in pulmonary metastatic nodules of MFCKO-MT mice, and its inhibition significantly reduced mammary tumor development and metastasis in these mice. Consistent with the idea of metastasis driven by MaCSCs, we detected selective up-regulation of Pyk2 in MaCSCs, but not bulk mammary tumor cells, of primary tumors developed in MFCKO-MT mice. We further showed that inhibition of Pyk2 in FAK-null MaCSCs significantly decreased their tumorsphere formation and migration in vitro as well as self-renewal, tumorigenicity, and metastatic activity in vivo. Last, we identified PI3K/Akt signaling as a major mediator of FAK regulation of MaCSCs as well as a target for the compensatory function of Pyk2 in FAK-null MaCSCs. Together, these results further advance our understanding of FAK and its related tyrosine kinase Pyk2 in regulation of MaCSCs in breast cancer and suggest that pharmaceutically targeting these kinases may hold promise as a novel treatment for the disease by targeting and eradicating MaCSCs.	[Fan, Huaping; Guan, Jun-Lin] Univ Michigan, Sch Med, Dept Internal Med, Div Genet, Ann Arbor, MI 48109 USA; [Guan, Jun-Lin] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Fan, Huaping; Guan, Jun-Lin] Univ Michigan, Sch Med, Dept Internal Med, Div Mol Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Guan, JL (corresponding author), Univ Michigan, Sch Med, Dept Internal Med, Div Mol Med, Ann Arbor, MI 48109 USA.	jlguan@umich.edu	Fan, Huaping/B-8762-2012		National Institutes of Health [GM052890, CA150926, HL073394]; NATIONAL CANCER INSTITUTE [R01CA150926] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073394] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052890] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM052890, CA150926, and HL073394 (to J.-L. G.).	Astier A, 1997, J BIOL CHEM, V272, P228; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Braren R, 2006, J CELL BIOL, V172, P151, DOI 10.1083/jcb.200506184; Cary LA, 1998, J CELL BIOL, V140, P211, DOI 10.1083/jcb.140.1.211; Chan PC, 1999, J BIOL CHEM, V274, P26901, DOI 10.1074/jbc.274.38.26901; CHEN HC, 1994, P NATL ACAD SCI USA, V91, P10148, DOI 10.1073/pnas.91.21.10148; Chen HC, 1996, J BIOL CHEM, V271, P26329, DOI 10.1074/jbc.271.42.26329; Cohen LA, 2005, CURR CANCER DRUG TAR, V5, P629, DOI 10.2174/156800905774932798; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Diehl JA, 1997, GENE DEV, V11, P957, DOI 10.1101/gad.11.8.957; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Ginestier C, 2010, J CLIN INVEST, V120, P485, DOI 10.1172/JCI39397; Golubovskaya VM, 2007, INT REV CYTOL, V263, P103, DOI 10.1016/S0074-7696(07)63003-4; Hauck CR, 2002, EMBO J, V21, P6289, DOI 10.1093/emboj/cdf631; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Iliopoulos D, 2010, MOL CELL, V39, P761, DOI 10.1016/j.molcel.2010.08.013; Korkaya H, 2008, ONCOGENE, V27, P6120, DOI 10.1038/onc.2008.207; Kouros-Mehr H, 2008, CANCER CELL, V13, P141, DOI 10.1016/j.ccr.2008.01.011; Lahlou H, 2007, P NATL ACAD SCI USA, V104, P20302, DOI 10.1073/pnas.0710091104; Li JZ, 1996, BLOOD, V88, P417, DOI 10.1182/blood.V88.2.417.bloodjournal882417; Li X, 1997, J BIOL CHEM, V272, P14341, DOI 10.1074/jbc.272.22.14341; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Lim Y, 2008, J CELL BIOL, V180, P187, DOI 10.1083/jcb.200708194; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Luo M, 2009, CANCER RES, V69, P466, DOI 10.1158/0008-5472.CAN-08-3078; Ma EA, 1997, EUR J IMMUNOL, V27, P329, DOI 10.1002/eji.1830270147; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Park AYJ, 2009, J BIOL CHEM, V284, P9418, DOI 10.1074/jbc.M809040200; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Provenzano PP, 2008, AM J PATHOL, V173, P1551, DOI 10.2353/ajpath.2008.080308; Pylayeva Y, 2009, J CLIN INVEST, V119, P252, DOI 10.1172/JCI37160; Raja S, 1997, J BIOL CHEM, V272, P10941; Reiske HR, 1999, J BIOL CHEM, V274, P12361, DOI 10.1074/jbc.274.18.12361; Roberts WG, 2008, CANCER RES, V68, P1935, DOI 10.1158/0008-5472.CAN-07-5155; Rosen JM, 2009, SCIENCE, V324, P1670, DOI 10.1126/science.1171837; Salgia R, 1996, J BIOL CHEM, V271, P31222, DOI 10.1074/jbc.271.49.31222; Schaller MD, 2001, BBA-MOL CELL RES, V1540, P1, DOI 10.1016/S0167-4889(01)00123-9; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Schlaepfer DD, 2004, CURR OPIN GENET DEV, V14, P92, DOI 10.1016/j.gde.2003.12.002; Shen TL, 2005, J CELL BIOL, V169, P941, DOI 10.1083/jcb.200411155; Sieg DJ, 1998, EMBO J, V17, P5933, DOI 10.1093/emboj/17.20.5933; Siesser PMF, 2006, CLIN CANCER RES, V12, P3233, DOI 10.1158/1078-0432.CCR-06-0456; Slack-Davis JK, 2007, J BIOL CHEM, V282, P14845, DOI 10.1074/jbc.M606695200; Sonoda Y, 2000, J BIOL CHEM, V275, P16309, DOI 10.1074/jbc.275.21.16309; Stingl J, 2007, NAT REV CANCER, V7, P791, DOI 10.1038/nrc2212; Wang CR, 2010, J BIOL CHEM, V285, P29398, DOI 10.1074/jbc.M110.141440; Weis SM, 2008, J CELL BIOL, V181, P43, DOI 10.1083/jcb.200710038; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Woodward WA, 2007, P NATL ACAD SCI USA, V104, P618, DOI 10.1073/pnas.0606599104; XING Z, 1994, MOL BIOL CELL, V5, P413, DOI 10.1091/mbc.5.4.413; Zhang M, 2008, CANCER RES, V68, P4674, DOI 10.1158/0008-5472.CAN-07-6353; Zhang M, 2010, P NATL ACAD SCI USA, V107, P3522, DOI 10.1073/pnas.0910179107; Zhao JH, 2000, J CELL SCI, V113, P3063; Zheng CH, 1998, J BIOL CHEM, V273, P2384, DOI 10.1074/jbc.273.4.2384	58	47	49	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18573	18582		10.1074/jbc.M110.200717	http://dx.doi.org/10.1074/jbc.M110.200717			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21471206	Green Published, hybrid			2022-12-25	WOS:000290785700029
J	Hansen, JC; Wexler, BB; Rogers, DJ; Hite, KC; Panchenko, T; Ajith, S; Black, BE				Hansen, Jeffrey C.; Wexler, Brian B.; Rogers, Danielle J.; Hite, Kristopher C.; Panchenko, Tanya; Ajith, Sandya; Black, Ben E.			DNA Binding Restricts the Intrinsic Conformational Flexibility of Methyl CpG Binding Protein 2 (MeCP2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETT-SYNDROME; TRANSCRIPTIONAL REPRESSION; CHROMOSOMAL PROTEIN; MASS-SPECTROMETRY; NEURONAL MECP2; CHROMATIN; MUTATIONS; EXCHANGE; DISORDER; COMPLEX	Mass spectrometry-based hydrogen/deuterium exchange (H/DX) has been used to define the polypeptide backbone dynamics of full-length methyl CpG binding protein 2 MeCP2) when free in solution and when bound to unmethylated and methylated DNA. Essentially the entire MeCP2 polypeptide chain underwent H/DX at rates faster than could be measured i.e. complete exchange in <= 10 s), with the exception of the methyl DNA binding domain (MBD). Even the H/DX of the MBD was rapid compared with that of a typical globular protein. Thus, there is no single tertiary structure of MeCP2. Rather, the full-length protein rapidly samples many different conformations when free in solution. When MeCP2 binds to unmethylated DNA, H/DX is slowed several orders of magnitude throughout the MBD. Binding of MeCP2 to methylated DNA led to additional minor H/DX protection, and only locally within the N-terminal portion of the MBD. H/DX also was used to examine the structural dynamics of the isolated MBD carrying three frequent mutations associated with Rett syndrome. The effects of the mutations ranged from very little R106W) to a substantial increase in conformational sampling F155S). Our H/DX results have yielded fine resolution mapping of the structure of full-length MeCP2 in the absence and presence of DNA, provided a biochemical basis for understanding MeCP2 function in normal cells, and predicted potential approaches for the treatment of a subset of RTT cases caused by point mutations that destabilize the MBD.	[Hansen, Jeffrey C.; Hite, Kristopher C.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA; [Wexler, Brian B.; Rogers, Danielle J.; Panchenko, Tanya; Ajith, Sandya; Black, Ben E.] Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Panchenko, Tanya; Black, Ben E.] Univ Penn, Sch Med, Grad Grp Cell & Mol Biol, Philadelphia, PA 19104 USA; [Ajith, Sandya; Black, Ben E.] Univ Penn, Sch Med, Grad Grp Biochem & Mol Biophys, Philadelphia, PA 19104 USA	Colorado State University; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Hansen, JC (corresponding author), Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA.	jeffrey.c.hansen@colostate.edu; blackbe@mail.med.upenn.edu			National Institutes of Health [GM66834, GM82989, GM08275]; Burroughs Wellcome Fund; Rita Allen Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082989, T32GM008275, R01GM066834] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Rita Allen Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants to GM66834 (to J. C. H.), GM82989 (to B. E. B.), and GM08275 (University of Pennsylvania Structural Biology Training Grant) (to T. P.). This work is also supported by a career award in the biomedical sciences from the Burroughs Wellcome Fund and a Rita Allen Foundation scholar award (to B. E. B.).	Adams VH, 2007, J BIOL CHEM, V282, P15057, DOI 10.1074/jbc.M700855200; Agarwal N, 2007, NUCLEIC ACIDS RES, V35, P5402, DOI 10.1093/nar/gkm599; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Ballestar E, 2005, BIOCHEM CELL BIOL, V83, P374, DOI 10.1139/o05-035; Bernard D, 2006, ONCOGENE, V25, P1358, DOI 10.1038/sj.onc.1209179; Bienvenu T, 2006, NAT REV GENET, V7, P415, DOI 10.1038/nrg1878; Black BE, 2004, NATURE, V430, P578, DOI 10.1038/nature02766; Black BE, 2007, P NATL ACAD SCI USA, V104, P5008, DOI 10.1073/pnas.0700390104; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chong SR, 1998, NUCLEIC ACIDS RES, V26, P5109, DOI 10.1093/nar/26.22.5109; Coales SJ, 2010, RAPID COMMUN MASS SP, V24, P3585, DOI 10.1002/rcm.4814; Del Mar C, 2005, P NATL ACAD SCI USA, V102, P15477, DOI 10.1073/pnas.0507405102; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Englander SW, 2006, J AM SOC MASS SPECTR, V17, P1481, DOI 10.1016/j.jasms.2006.06.006; Fraga MF, 2003, NUCLEIC ACIDS RES, V31, P1765, DOI 10.1093/nar/gkg249; Fuks F, 2003, J BIOL CHEM, V278, P4035, DOI 10.1074/jbc.M210256200; Fuxreiter M, 2008, NAT CHEM BIOL, V4, P728, DOI 10.1038/nchembio.127; Georgel PT, 2003, J BIOL CHEM, V278, P32181, DOI 10.1074/jbc.M305308200; Ghosh RP, 2008, J BIOL CHEM, V283, P20523, DOI 10.1074/jbc.M803021200; Ghosh RP, 2010, MOL CELL BIOL, V30, P4656, DOI 10.1128/MCB.00379-10; Ghosh RP, 2010, BIOCHEMISTRY-US, V49, P4395, DOI 10.1021/bi9019753; Hamuro Y, 2002, J MOL BIOL, V323, P871, DOI 10.1016/S0022-2836(02)01003-3; Hansen JC, 2006, J BIOL CHEM, V281, P1853, DOI 10.1074/jbc.R500022200; Hansen JC, 2010, IUBMB LIFE, V62, P732, DOI 10.1002/iub.386; Harikrishnan KN, 2005, NAT GENET, V37, P254, DOI 10.1038/ng1516; Hite KC, 2009, BIOCHEM CELL BIOL, V87, P219, DOI 10.1139/O08-115; Ho KL, 2008, MOL CELL, V29, P525, DOI 10.1016/j.molcel.2007.12.028; Jeffery L, 2004, J BIOL CHEM, V279, P49479, DOI 10.1074/jbc.M409070200; Kalodimos CG, 2004, SCIENCE, V305, P386, DOI 10.1126/science.1097064; Kimura H, 2003, J BIOL CHEM, V278, P4806, DOI 10.1074/jbc.M209923200; Kokura K, 2001, J BIOL CHEM, V276, P34115, DOI 10.1074/jbc.M105747200; Kumar A, 2008, J CELL SCI, V121, P1128, DOI 10.1242/jcs.016865; LaSalle JM, 2005, INT REV NEUROBIOL, V71, P131, DOI 10.1016/S0074-7742(05)71006-0; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Lewis M, 1996, SCIENCE, V271, P1247, DOI 10.1126/science.271.5253.1247; LIN SY, 1975, CELL, V4, P107, DOI 10.1016/0092-8674(75)90116-6; Moretti P, 2006, CURR OPIN GENET DEV, V16, P276, DOI 10.1016/j.gde.2006.04.009; Nan XS, 2007, P NATL ACAD SCI USA, V104, P2709, DOI 10.1073/pnas.0608056104; NAN XS, 1993, NUCLEIC ACIDS RES, V21, P4886, DOI 10.1093/nar/21.21.4886; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Nikitina T, 2007, J BIOL CHEM, V282, P28237, DOI 10.1074/jbc.M704304200; Nikitina T, 2007, MOL CELL BIOL, V27, P864, DOI 10.1128/MCB.01593-06; Pantazatos D, 2004, P NATL ACAD SCI USA, V101, P751, DOI 10.1073/pnas.0307204101; Ringe Dagmar, 2009, J Biol, V8, P80, DOI 10.1186/jbiol186; Sekulic N, 2010, NATURE, V467, P347, DOI 10.1038/nature09323; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Suzuki M, 2003, ONCOGENE, V22, P8688, DOI 10.1038/sj.onc.1207182; Tompa P, 2009, STRUCTURE FUNCTION I; Wakefield RID, 1999, J MOL BIOL, V291, P1055, DOI 10.1006/jmbi.1999.3023; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; YANG C, 2011, NUCL ACIDS IN PRESS; Yasui DH, 2007, P NATL ACAD SCI USA, V104, P19416, DOI 10.1073/pnas.0707442104; Young JI, 2005, P NATL ACAD SCI USA, V102, P17551, DOI 10.1073/pnas.0507856102	55	24	26	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18938	18948		10.1074/jbc.M111.234609	http://dx.doi.org/10.1074/jbc.M111.234609			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21467044	hybrid, Green Published			2022-12-25	WOS:000290785700065
J	Jimenez, S; Torres, M; Vizuete, M; Sanchez-Varo, R; Sanchez-Mejias, E; Trujillo-Estrada, L; Carmona-Cuenca, I; Caballero, C; Ruano, D; Gutierrez, A; Vitorica, J				Jimenez, Sebastian; Torres, Manuel; Vizuete, Marisa; Sanchez-Varo, Raquel; Sanchez-Mejias, Elisabeth; Trujillo-Estrada, Laura; Carmona-Cuenca, Irene; Caballero, Cristina; Ruano, Diego; Gutierrez, Antonia; Vitorica, Javier			Age-dependent Accumulation of Soluble Amyloid beta (A beta) Oligomers Reverses the Neuroprotective Effect of Soluble Amyloid Precursor Protein-alpha (sAPP alpha) by Modulating Phosphatidylinositol 3-Kinase (PI3K)/Akt-GSK-3 beta Pathway in Alzheimer Mouse Model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P75 NEUROTROPHIN RECEPTOR; GLYCOGEN-SYNTHASE KINASE-3; TRANSGENIC MICE; INSULIN-RECEPTOR; NERVOUS-SYSTEM; IN-VIVO; TAU-HYPERPHOSPHORYLATION; SIGNALING PATHWAY; DISEASE; BRAIN	Neurotrophins, activating the PI3K/Akt signaling pathway, control neuronal survival and plasticity. Alterations in NGF, BDNF, IGF-1, or insulin signaling are implicated in the pathogenesis of Alzheimer disease. We have previously characterized a bigenic PS1 x APP transgenic mouse displaying early hippocampal A beta deposition (3 to 4 months) but late (17 to 18 months) neurodegeneration of pyramidal cells, paralleled to the accumulation of soluble A beta oligomers. We hypothesized that PI3K/Akt/GSK-3 beta signaling pathway could be involved in this apparent age-dependent neuroprotective/neurodegenerative status. In fact, our data demonstrated that, as compared with age-matched nontransgenic controls, the Ser-9 phosphorylation of GSK-3 beta was increased in the 6-month PS1 x APP hippocampus, whereas in aged PS1 x APP animals (18 months), GSK-3 beta phosphorylation levels displayed a marked decrease. Using N2a and primary neuronal cell cultures, we demonstrated that soluble amyloid precursor protein-alpha (sAPP alpha), the predominant APP-derived fragment in young PS1 x APP mice, acting through IGF-1 and/or insulin receptors, activated the PI3K/Akt pathway, phosphorylated the GSK-3 beta activity, and in consequence, exerted a neuroprotective action. On the contrary, several oligomeric A beta forms, present in the soluble fractions of aged PS1 x APP mice, inhibited the induced phosphorylation of Akt/GSK-3 beta and decreased the neuronal survival. Furthermore, synthetic A beta oligomers blocked the effect mediated by different neurotrophins (NGF, BDNF, insulin, and IGF-1) and sAPP alpha, displaying high selectivity for NGF. In conclusion, the age-dependent appearance of APP-derived soluble factors modulated the PI3K/Akt/GSK-3 beta signaling pathway through the major neurotrophin receptors. sAPP alpha stimulated and A beta oligomers blocked the prosurvival signaling. Our data might provide insights into the selective vulnerability of specific neuronal groups in Alzheimer disease.	[Jimenez, Sebastian; Torres, Manuel; Vizuete, Marisa; Carmona-Cuenca, Irene; Caballero, Cristina; Ruano, Diego; Vitorica, Javier] Univ Seville, Dept Bioquim & Biol Mol, Fac Farm, E-41012 Seville, Spain; [Sanchez-Varo, Raquel; Sanchez-Mejias, Elisabeth; Trujillo-Estrada, Laura; Gutierrez, Antonia] Univ Malaga, Fac Ciencias, Dept Biol Celular Genet & Fisiol, E-29071 Malaga, Spain; [Jimenez, Sebastian; Torres, Manuel; Vizuete, Marisa; Sanchez-Varo, Raquel; Sanchez-Mejias, Elisabeth; Trujillo-Estrada, Laura; Carmona-Cuenca, Irene; Caballero, Cristina; Ruano, Diego; Gutierrez, Antonia; Vitorica, Javier] Ctr Invest Biomed Red Sobre Enfermedades Neurodeg, Seville 41013, Spain; [Jimenez, Sebastian; Torres, Manuel; Vizuete, Marisa; Carmona-Cuenca, Irene; Caballero, Cristina; Ruano, Diego; Vitorica, Javier] Univ Seville, CSIC, Inst Biomed Sevilla Hosp Univ Virgen Rocio, Seville 41013, Spain	University of Sevilla; Universidad de Malaga; CIBERNED; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla	Vitorica, J (corresponding author), Univ Seville, Dept Bioquim & Biol Mol, Fac Farm, E-41012 Seville, Spain.	vitorica@us.es	IBIS, ALZHEIMER/O-9867-2015; Sanchez-Varo, Raquel/AAC-8881-2022; CABALLERO, DIEGO RUANO/I-4471-2014; Sanchez-Varo, Raquel/AAS-1465-2020; Jimenez, Sebastian Jimenez S/K-6168-2017; Torres, Manuel/F-7963-2016	CABALLERO, DIEGO RUANO/0000-0001-6131-3033; Sanchez-Varo, Raquel/0000-0001-5296-9786; Jimenez, Sebastian Jimenez S/0000-0002-9151-7587; Torres, Manuel/0000-0002-5076-8486; Trujillo-Estrada, Laura/0000-0001-6696-4505; Gutierrez Perez, Antonia/0000-0002-6264-6152; Vitorica Ferrandez, Javier/0000-0002-0641-7902; Vizuete Chacon, Maria Luisa/0000-0001-5114-9428	Fondo de Investigacion Sanitaria (Instituto de Salud Carlos III, Spain) [PS09/00151, PS09/00099, PS09/00848]; Junta de Andalucia (Spain) [CTS-4795, SAS PI-0496/2009]; Centro de Investigacion Biomedica en Red Sobre Enfermedades Neurodegenerativas; Formacion de Proferorado Universitario (FPU) Program (Spain)	Fondo de Investigacion Sanitaria (Instituto de Salud Carlos III, Spain)(Instituto de Salud Carlos III); Junta de Andalucia (Spain)(Junta de Andalucia); Centro de Investigacion Biomedica en Red Sobre Enfermedades Neurodegenerativas; Formacion de Proferorado Universitario (FPU) Program (Spain)(Spanish Government)	This work was supported in part by Grants PS09/00151 (to J. V.), PS09/00099 (to A. G.), and PS09/00848 (to D. R.) from the Fondo de Investigacion Sanitaria (Instituto de Salud Carlos III, Spain) and by Grants CTS-4795 (to J. V.) and SAS PI-0496/2009 (to A. G.) from Junta de Andalucia (Spain).; Recipient of a contract from the Centro de Investigacion Biomedica en Red Sobre Enfermedades Neurodegenerativas.; Recipient of a Ph.D. fellowship from the Formacion de Proferorado Universitario (FPU) Program (Spain).	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Araujo F, 1996, J BIOL CHEM, V271, P27902, DOI 10.1074/jbc.271.44.27902; Baglietto-Vargas D, 2010, J ALZHEIMERS DIS, V21, P119, DOI 10.3233/JAD-2010-100066; Balaraman Y, 2006, CELL MOL LIFE SCI, V63, P1226, DOI 10.1007/s00018-005-5597-y; Beurel E, 2006, PROG NEUROBIOL, V79, P173, DOI 10.1016/j.pneurobio.2006.07.006; Blanchard V, 2003, EXP NEUROL, V184, P247, DOI 10.1016/S0014-4886(03)00252-8; Bondy CA, 2004, EUR J PHARMACOL, V490, P25, DOI 10.1016/j.ejphar.2004.02.042; Braithwaite SP, 2010, NEUROBIOL DIS, V39, P311, DOI 10.1016/j.nbd.2010.04.015; Caballero C, 2007, J NEUROSCI RES, V85, P787, DOI 10.1002/jnr.21172; Capsoni S, 2002, MOL CELL NEUROSCI, V21, P15, DOI 10.1006/mcne.2002.1163; Capsoni S, 2010, P NATL ACAD SCI USA, V107, P12299, DOI 10.1073/pnas.1007181107; Carro E, 2002, NAT MED, V8, P1390, DOI 10.1038/nm793; Cole GM, 2007, EXP GERONTOL, V42, P10, DOI 10.1016/j.exger.2006.08.009; De Felice FG, 2008, NEUROBIOL AGING, V29, P1334, DOI 10.1016/j.neurobiolaging.2007.02.029; Decker H, 2010, J NEUROCHEM, V115, P1520, DOI 10.1111/j.1471-4159.2010.07058.x; Deshpande A, 2006, J NEUROSCI, V26, P6011, DOI 10.1523/JNEUROSCI.1189-06.2006; Engel T, 2006, J NEUROSCI, V26, P5083, DOI 10.1523/JNEUROSCI.0604-06.2006; Ernfors P, 2003, TRENDS NEUROSCI, V26, P171, DOI 10.1016/S0166-2236(03)00064-X; Giuffrida ML, 2009, J NEUROSCI, V29, P10582, DOI 10.1523/JNEUROSCI.1736-09.2009; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Griffin RJ, 2005, J NEUROCHEM, V93, P105, DOI 10.1111/j.1471-4159.2004.02949.x; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hongisto V, 2003, MOL CELL BIOL, V23, P6027, DOI 10.1128/MCB.23.17.6027-6036.2003; Houeland G, 2010, J NEUROSCI, V30, P13089, DOI 10.1523/JNEUROSCI.0457-10.2010; Hoyer S, 1998, J NEURAL TRANSM-SUPP, P187; Jimenez S, 2008, J NEUROSCI, V28, P11650, DOI 10.1523/JNEUROSCI.3024-08.2008; Karlnoski R, 2007, NEUROBIOL DIS, V25, P179, DOI 10.1016/j.nbd.2006.09.007; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Knowles JK, 2009, J NEUROSCI, V29, P10627, DOI 10.1523/JNEUROSCI.0620-09.2009; Kojro E, 2006, FASEB J, V20, P512, DOI 10.1096/fj.05-4812fje; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Lucas JJ, 2001, EMBO J, V20, P27, DOI 10.1093/emboj/20.1.27; Ma QL, 2009, J NEUROSCI, V29, P9078, DOI 10.1523/JNEUROSCI.1071-09.2009; Malm TM, 2007, J NEUROSCI, V27, P3712, DOI 10.1523/JNEUROSCI.0059-07.2007; Masliah E, 1997, NEUROSCIENCE, V78, P135, DOI 10.1016/S0306-4522(96)00553-2; Moloney AM, 2010, NEUROBIOL AGING, V31, P224, DOI 10.1016/j.neurobiolaging.2008.04.002; Moreno-Gonzalez I, 2009, J ALZHEIMERS DIS, V18, P755, DOI 10.3233/JAD-2009-1192; Mufson Elliott J, 2008, Expert Rev Neurother, V8, P1703, DOI 10.1586/14737175.8.11.1703; Noble W, 2005, P NATL ACAD SCI USA, V102, P6990, DOI 10.1073/pnas.0500466102; Peineau S, 2007, NEURON, V53, P703, DOI 10.1016/j.neuron.2007.01.029; Ramos B, 2006, NEUROBIOL AGING, V27, P1658, DOI 10.1016/j.neurobiolaging.2005.09.022; Reger MA, 2008, NEUROLOGY, V70, P440, DOI 10.1212/01.WNL.0000265401.62434.36; Rockenstein E, 2007, J NEUROSCI, V27, P1981, DOI 10.1523/JNEUROSCI.4321-06.2007; RUANO D, 1992, J NEUROCHEM, V58, P485, DOI 10.1111/j.1471-4159.1992.tb09747.x; Scali C, 2006, NEUROBIOL DIS, V24, P254, DOI 10.1016/j.nbd.2006.06.016; Schulte-Herbruggen O, 2008, CURR ALZHEIMER RES, V5, P38; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Sotthibundhu A, 2008, J NEUROSCI, V28, P3941, DOI 10.1523/JNEUROSCI.0350-08.2008; Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107; Su Y, 2004, BIOCHEMISTRY-US, V43, P6899, DOI 10.1021/bi035627j; Terwel D, 2008, AM J PATHOL, V172, P786, DOI 10.2353/ajpath.2008.070904; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; Townsend M, 2007, J BIOL CHEM, V282, P33305, DOI 10.1074/jbc.M610390200; Tropea D, 2006, NAT NEUROSCI, V9, P660, DOI 10.1038/nn1689; Woodgett JR, 2005, NAT IMMUNOL, V6, P751, DOI 10.1038/ni0805-751; Xie L, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-10-j0001.2002; Zhao WQ, 2008, FASEB J, V22, P246, DOI 10.1096/fj.06-7703com; Zhao WQ, 2009, J BIOL CHEM, V284, P18742, DOI 10.1074/jbc.M109.011015	62	141	152	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18414	18425		10.1074/jbc.M110.209718	http://dx.doi.org/10.1074/jbc.M110.209718			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21460223	Green Published, hybrid			2022-12-25	WOS:000290785700014
J	Seron, K; Couturier, C; Belouzard, S; Bacart, J; Monte, D; Corset, L; Bocquet, O; Dam, J; Vauthier, V; Lecoeur, C; Bailleul, B; Hoflack, B; Froguel, P; Jockers, R; Rouille, Y				Seron, Karin; Couturier, Cyril; Belouzard, Sandrine; Bacart, Johan; Monte, Didier; Corset, Laetitia; Bocquet, Olivier; Dam, Julie; Vauthier, Virginie; Lecoeur, Cecile; Bailleul, Bernard; Hoflack, Bernard; Froguel, Philippe; Jockers, Ralf; Rouille, Yves			Endospanins Regulate a Postinternalization Step of the Leptin Receptor Endocytic Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-PROTEINS; CELL-SURFACE; EXPRESSION; INTERNALIZATION; TRAFFICKING; ACTIVATION; MECHANISMS; TRANSPORT; ISOFORMS; VECTORS	Endospanin-1 is a negative regulator of the cell surface expression of leptin receptor (OB-R), and endospanin-2 is a homologue of unknown function. We investigated the mechanism for endospanin-1 action in regulating OB-R cell surface expression. Here we show that endospanin-1 and -2 are small integral membrane proteins that localize in endosomes and the trans-Golgi network. Antibody uptake experiments showed that both endospanins are transported to the plasma membrane and then internalized into early endosomes but do not recycle back to the trans-Golgi network. Overexpression of endospanin-1 or endospanin-2 led to a decrease of OB-R cell surface expression, whereas shRNA-mediated depletion of each protein increased OB-R cell surface expression. This increased cell surface expression was not observed with OB-Ra mutants defective in endocytosis or with transferrin and EGF receptors. Endospanin-1 or endospanin-2 depletion did not change the internalization rate of OB-Ra but slowed down its lysosomal degradation. Thus, both endospanins are regulators of postinternalization membrane traffic of the endocytic pathway of OB-R.	[Rouille, Yves] Inst Pasteur, INSERM, CNRS, CIIL,UMR8204,U1019, F-59021 Lille, France; [Seron, Karin; Couturier, Cyril; Belouzard, Sandrine; Bacart, Johan; Monte, Didier; Corset, Laetitia; Bocquet, Olivier; Lecoeur, Cecile; Bailleul, Bernard; Froguel, Philippe; Rouille, Yves] Univ Lille Nord France, F-59021 Lille, France; [Couturier, Cyril; Dam, Julie; Vauthier, Virginie; Jockers, Ralf] Univ Paris 05, Dept Cell Biol, CNRS, Inst Cochin,UMR 8104, F-75014 Paris, France; [Couturier, Cyril; Dam, Julie; Vauthier, Virginie; Jockers, Ralf] INSERM, U1016, F-75014 Paris, France; [Monte, Didier] CNRS, UMR 8161, F-59021 Lille, France; [Bailleul, Bernard] INSERM, U1011, F-59021 Lille, France; [Hoflack, Bernard] Tech Univ Dresden, Ctr Biotechnol, D-01307 Dresden, Germany; [Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Genom Med, London SW7 2AZ, England; [Seron, Karin; Couturier, Cyril; Bacart, Johan; Monte, Didier; Corset, Laetitia; Bocquet, Olivier; Lecoeur, Cecile; Froguel, Philippe] CNRS, UMR 8199, F-59021 Lille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Technische Universitat Dresden; Imperial College London; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille	Rouille, Y (corresponding author), Inst Pasteur, INSERM, CNRS, CIIL,UMR8204,U1019, Batiment IBL,1 Rue Prof Calmette,BP 447, F-59021 Lille, France.	yves.rouille@ibl.fr	Couturier, Cyril CC/I-3020-2016; Couturier, Cyril/ABG-9063-2020; Belouzard, Sandrine/O-8527-2016; Rouillé, Yves/P-2405-2016; Seron, Karin/O-8481-2016; Jockers, Ralf/Q-2100-2019; FROGUEL, Philippe/O-6799-2017; Jockers, Ralf/P-2272-2017; Dam, Julie/O-1625-2018; Belouzard, Sandrine/AAX-1584-2021; HOFLACK, Bernard/AAZ-6668-2020	Belouzard, Sandrine/0000-0002-9972-4054; Seron, Karin/0000-0002-9667-133X; Jockers, Ralf/0000-0002-4354-1750; FROGUEL, Philippe/0000-0003-2972-0784; Jockers, Ralf/0000-0002-4354-1750; Dam, Julie/0000-0001-6871-2678; Belouzard, Sandrine/0000-0002-9972-4054; Babin, Laetitia/0000-0002-9912-7321; Rouille, Yves/0000-0003-0788-9271; monte, didier/0000-0002-0613-6203	CNRS; INSERM; Region Nord-Pas de Calais	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Region Nord-Pas de Calais(Region Hauts-de-FranceEuropean Commission)	This research was supported in part by grants from CNRS (Programme Biologie Cellulaire), INSERM (Programme National de Recherche sur le Diabete), and the Region Nord-Pas de Calais.	Ayoub MA, 2004, MOL PHARMACOL, V66, P312, DOI 10.1124/mol.104.000398; Ayoub MA, 2002, J BIOL CHEM, V277, P21522, DOI 10.1074/jbc.M200729200; Bailleul B, 1997, NUCLEIC ACIDS RES, V25, P2752, DOI 10.1093/nar/25.14.2752; Barr VA, 1999, J BIOL CHEM, V274, P21416, DOI 10.1074/jbc.274.30.21416; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Bates SH, 2003, TRENDS ENDOCRIN MET, V14, P447, DOI 10.1016/j.tem.2003.10.003; Belgareh-Touze N, 2002, MOL BIOL CELL, V13, P1694, DOI 10.1091/mbc.01-12-0597; Belouzard S, 2006, EMBO J, V25, P932, DOI 10.1038/sj.emboj.7600989; Belouzard S, 2004, J BIOL CHEM, V279, P28499, DOI 10.1074/jbc.M400508200; Chartier C, 1996, J VIROL, V70, P4805, DOI 10.1128/JVI.70.7.4805-4810.1996; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; CHU G, 1987, NUCLEIC ACIDS RES, V15, P1311, DOI 10.1093/nar/15.3.1311; Conchon S, 1999, EMBO J, V18, P3934, DOI 10.1093/emboj/18.14.3934; Couturier C, 2003, J BIOL CHEM, V278, P26604, DOI 10.1074/jbc.M302002200; Couturier C, 2007, P NATL ACAD SCI USA, V104, P19476, DOI 10.1073/pnas.0706671104; Fallaux FJ, 1996, HUM GENE THER, V7, P215, DOI 10.1089/hum.1996.7.2-215; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Fruhbeck G, 2006, BIOCHEM J, V393, P7, DOI 10.1042/BJ20051578; HORN M, 1994, BIOCHEM J, V301, P69, DOI 10.1042/bj3010069; Huang Y, 2001, BBA-GENE STRUCT EXPR, V1517, P327, DOI 10.1016/S0167-4781(00)00266-9; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lindell K, 2001, MOL CELL ENDOCRINOL, V172, P37, DOI 10.1016/S0303-7207(00)00382-8; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Puertollano R, 1999, J CELL BIOL, V145, P141, DOI 10.1083/jcb.145.1.141; Sanders CR, 2001, BIOCHEMISTRY-US, V40, P9453, DOI 10.1021/bi010894f; Sato K, 2003, MOL BIOL CELL, V14, P3605, DOI 10.1091/mbc.E02-12-0777; Schluter C, 2008, MOL BIOL CELL, V19, P1282, DOI 10.1091/mbc.E07-07-0659; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Tartaglia LA, 1997, J BIOL CHEM, V272, P6093, DOI 10.1074/jbc.272.10.6093; Touvier T, 2009, J CLIN INVEST, V119, P3830, DOI 10.1172/JCI34997; Uotani S, 1999, DIABETES, V48, P279, DOI 10.2337/diabetes.48.2.279; Zabeau L, 2003, FEBS LETT, V546, P45, DOI 10.1016/S0014-5793(03)00440-X	32	34	36	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17968	17981		10.1074/jbc.M111.224857	http://dx.doi.org/10.1074/jbc.M111.224857			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454707	Green Published, hybrid			2022-12-25	WOS:000290585200059
J	Smith, AJ; Dai, HM; Correia, C; Takahashi, R; Lee, SH; Schmitz, I; Kaufmann, SH				Smith, Alyson J.; Dai, Haiming; Correia, Cristina; Takahashi, Rie; Lee, Sun-Hee; Schmitz, Ingo; Kaufmann, Scott H.			Noxa/Bcl-2 Protein Interactions Contribute to Bortezomib Resistance in Human Lymphoid Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEASOME INHIBITOR PS-341; CHRONIC LYMPHOCYTIC-LEUKEMIA; BCL-2 FAMILY-MEMBERS; ACUTE MYELOGENOUS LEUKEMIA; TRAIL-INDUCED APOPTOSIS; MANTLE-CELL; BH3-ONLY PROTEINS; BH3 DOMAINS; FOLLICULAR LYMPHOMA; MEDIATED APOPTOSIS	Previous studies have suggested that the BH3 domain of the proapoptotic Bcl-2 family member Noxa only interacts with the anti-apoptotic proteins Mcl-1 and A1 but not Bcl-2. In view of the similarity of the BH3 binding domains of these anti-apoptotic proteins as well as recent evidence that studies of isolated BH3 domains can potentially underestimate the binding between full-length Bcl-2 family members, we examined the interaction of full-length human Noxa with anti-apoptotic human Bcl-2 family members. Surface plasmon resonance using bacterially expressed proteins demonstrated that Noxa binds with mean dissociation constants (K-D) of 3.4 nM for Mcl-1, 70 nM for Bcl-x(L), and 250 nM for wild type human Bcl-2, demonstrating selectivity but not absolute specificity of Noxa for Mcl-1. Further analysis showed that the Noxa/Bcl-2 interaction reflected binding between the Noxa BH3 domain and the Bcl-2 BH3 binding groove. Analysis of proteins expressed in vivo demonstrated that Noxa and Bcl-2 can be pulled down together from a variety of cells. Moreover, when compared with wild type Bcl-2, certain lymphoma-derived Bcl-2 mutants bound Noxa up to 20-fold more tightly in vitro, pulled down more Noxa from cells, and protected cells against killing by transfected Noxa to a greater extent. When killing by bortezomib (an agent whose cytotoxicity in Jurkat T-cell leukemia cells is dependent on Noxa) was examined, apoptosis was enhanced by the Bcl-2/Bcl-x(L) antagonist ABT-737 or by Bcl-2 down-regulation and diminished by Bcl-2 overexpression. Collectively, these observations not only establish the ability of Noxa and Bcl-2 to interact but also identify Bcl-2 overexpression as a potential mechanism of bortezomib resistance.	[Dai, Haiming; Correia, Cristina; Kaufmann, Scott H.] Mayo Clin, Div Oncol Res, Rochester, MN 55905 USA; [Smith, Alyson J.; Lee, Sun-Hee; Kaufmann, Scott H.] Mayo Clin, Dept Mol Pharmacol, Rochester, MN 55905 USA; [Takahashi, Rie] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Schmitz, Ingo] Otto VonGuericke Univ Magdegurg, Inst Mol & Clin Immunol, Lab Syst Oriented Immunol & Inflammat Res, D-38124 Braunschweig, Germany; [Schmitz, Ingo] Helmholtz Ctr Infect Res, Div Immune Control, D-38124 Braunschweig, Germany	Mayo Clinic; Mayo Clinic; Mayo Clinic; Otto von Guericke University; Helmholtz Association; Helmholtz-Center for Infection Research	Kaufmann, SH (corresponding author), Mayo Clin, Div Oncol Res, Gonda 19-212,200 1st St SW, Rochester, MN 55905 USA.	Kaufmann.scott@mayo.edu	Schmitz, Ingo/G-2093-2013	Schmitz, Ingo/0000-0002-5360-0419; Kaufmann, Scott/0000-0002-4900-7145; Dai, Haiming/0000-0002-0484-7407; Correia, Cristina/0000-0002-9464-7555	National Institutes of Health [R01 CA69008]; Leukemia and Lymphoma Society [6125-10]; Mayo Foundation for Education and Research; NATIONAL CANCER INSTITUTE [R01CA069008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM072474] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Mayo Foundation for Education and Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant R01 CA69008. This work was also supported by Leukemia and Lymphoma Society Grant 6125-10 as well as predoctoral fellowships from the Mayo Foundation for Education and Research (to A.J.S. and S.-H. L.).	Adams J, 2001, SEMIN ONCOL, V28, P613, DOI 10.1053/sonc.2001.28609; Adams JM, 2007, CURR OPIN IMMUNOL, V19, P488, DOI 10.1016/j.coi.2007.05.004; Akhtar RS, 2006, J NEUROSCI, V26, P7257, DOI 10.1523/JNEUROSCI.0196-06.2006; Baou M, 2010, HAEMATOL-HEMATOL J, V95, P1510, DOI 10.3324/haematol.2010.022368; Blum KA, 2007, LEUKEMIA LYMPHOMA, V48, P1313, DOI 10.1080/10428190701411458; Brooks AD, 2010, MOL CANCER RES, V8, P729, DOI 10.1158/1541-7786.MCR-10-0022; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chauhan D, 2007, ONCOGENE, V26, P2374, DOI 10.1038/sj.onc.1210028; Chauhan D, 2005, ANNU REV PHARMACOL, V45, P465, DOI 10.1146/annurev.pharmtox.45.120403.100037; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chen SQ, 2010, CANCER RES, V70, P4318, DOI 10.1158/0008-5472.CAN-09-4428; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; CHENLEVY Z, 1989, MOL CELL BIOL, V9, P701, DOI 10.1128/MCB.9.2.701; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Chittenden T, 2002, CANCER CELL, V2, P165, DOI 10.1016/S1535-6108(02)00128-9; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; CLEARY ML, 1986, CELL, V47, P19, DOI 10.1016/0092-8674(86)90362-4; Cliby WA, 2002, J BIOL CHEM, V277, P1599, DOI 10.1074/jbc.M106287200; Conticello C, 2007, J CLIN ENDOCR METAB, V92, P1938, DOI 10.1210/jc.2006-2157; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Dai HM, 2009, J BIOL CHEM, V284, P18311, DOI 10.1074/jbc.M109.004770; Du H, 2011, J BIOL CHEM, V286, P491, DOI 10.1074/jbc.M110.167148; Fernandez Y, 2005, CANCER RES, V65, P6294, DOI 10.1158/0008-5472.CAN-05-0686; Fribley AM, 2006, J BIOL CHEM, V281, P31440, DOI 10.1074/jbc.M604356200; Gerecitano J, 2009, BRIT J HAEMATOL, V146, P652, DOI 10.1111/j.1365-2141.2009.07775.x; Hackbarth JS, 2004, BIOTECHNIQUES, V37, P835; Hagenbuchner J, 2010, J BIOL CHEM, V285, P6904, DOI 10.1074/jbc.M109.038331; HARLOW E, 1988, ANTIBODIES LAB MANUA, P522; Hideshima T, 2003, BLOOD, V101, P1530, DOI 10.1182/blood-2002-08-2543; Hotchkiss RS, 2009, NEW ENGL J MED, V361, P1570, DOI 10.1056/NEJMra0901217; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Jung Laura, 2004, Oncology (Williston Park), V18, P4; Juo P, 1999, CELL GROWTH DIFFER, V10, P797; Juo P, 1998, CURR BIOL, V8, P1001, DOI 10.1016/S0960-9822(07)00420-4; Kabore AF, 2006, APOPTOSIS, V11, P1175, DOI 10.1007/s10495-006-8048-9; Kandasamy K, 2008, MOL CANCER THER, V7, P1091, DOI 10.1158/1535-7163.MCT-07-2368; Karp JE, 2009, BLOOD, V113, P4841, DOI 10.1182/blood-2008-08-172726; Kaufmann SH, 2000, EXP CELL RES, V256, P42, DOI 10.1006/excr.2000.4838; Kaufmann SH, 1996, J NATL CANCER I, V88, P734, DOI 10.1093/jnci/88.11.734; Kawahara A, 1998, J CELL BIOL, V143, P1353, DOI 10.1083/jcb.143.5.1353; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Le SB, 2007, J BIOL CHEM, V282, P8860, DOI 10.1074/jbc.M611777200; Lesinski GB, 2008, CANCER RES, V68, P8351, DOI 10.1158/0008-5472.CAN-08-0426; Lessene G, 2008, NAT REV DRUG DISCOV, V7, P989, DOI 10.1038/nrd2658; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Letai AG, 2008, NAT REV CANCER, V8, P121, DOI 10.1038/nrc2297; Liu XG, 2007, CANCER RES, V67, P4981, DOI 10.1158/0008-5472.CAN-06-4274; Lopez H, 2010, J BIOL CHEM, V285, P15016, DOI 10.1074/jbc.M109.086231; McConkey DJ, 2008, DRUG RESIST UPDATE, V11, P164, DOI 10.1016/j.drup.2008.08.002; Meng XW, 2007, J BIOL CHEM, V282, P29831, DOI 10.1074/jbc.M706110200; Meng XW, 2010, J BIOL CHEM, V285, P888, DOI 10.1074/jbc.M109.057638; Meng XW, 2003, J BIOL CHEM, V278, P47326, DOI 10.1074/jbc.M304793200; Mesa RA, 2005, BLOOD, V106, P318, DOI 10.1182/blood-2004-09-3523; Michalak EM, 2009, CELL DEATH DIFFER, V16, P684, DOI 10.1038/cdd.2008.195; Naik E, 2007, J CELL BIOL, V176, P415, DOI 10.1083/jcb.200608070; NGAN BY, 1988, NEW ENGL J MED, V318, P1638, DOI 10.1056/NEJM198806233182502; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; O'Connor OA, 2010, CLIN CANCER RES, V16, P719, DOI 10.1158/1078-0432.CCR-08-2647; Obeng EA, 2006, BLOOD, V107, P4907, DOI 10.1182/blood-2005-08-3531; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Okumura K, 2008, CLIN CANCER RES, V14, P8132, DOI 10.1158/1078-0432.CCR-08-1665; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Pahler JC, 2003, CLIN CANCER RES, V9, P4570; Paoluzzi L, 2010, CLIN CANCER RES, V16, P554, DOI 10.1158/1078-0432.CCR-09-1937; Perez-Galan P, 2006, BLOOD, V107, P257, DOI 10.1182/blood-2005-05-2091; Petros AM, 2001, P NATL ACAD SCI USA, V98, P3012, DOI 10.1073/pnas.041619798; Puthalakath H, 2002, CELL DEATH DIFFER, V9, P505, DOI 10.1038/sj.cdd.4400998; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Qin JZ, 2005, CANCER RES, V65, P6282, DOI 10.1158/0008-5472.CAN-05-0676; Rao R, 2010, CLIN CANCER RES, V16, P4742, DOI 10.1158/1078-0432.CCR-10-0529; REED JC, 1993, LEUKEMIA LYMPHOMA, V10, P157, DOI 10.3109/10428199309145877; Ren DC, 2010, SCIENCE, V330, P1390, DOI 10.1126/science.1190217; Samraj AK, 2006, J BIOL CHEM, V281, P29652, DOI 10.1074/jbc.M603487200; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; SETO M, 1988, EMBO J, V7, P123, DOI 10.1002/j.1460-2075.1988.tb02791.x; Sub KS, 2008, FUTURE ONCOL, V4, P149, DOI 10.2217/14796694.4.2.149; Troch M, 2009, HAEMATOL-HEMATOL J, V94, P738, DOI 10.3324/haematol.2008.001537; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; TSUJIMOTO Y, 1986, P NATL ACAD SCI USA, V83, P5214, DOI 10.1073/pnas.83.14.5214; van Delft MF, 2006, CELL RES, V16, P203, DOI 10.1038/sj.cr.7310028; Voortman J, 2007, MOL CANCER THER, V6, P2103, DOI 10.1158/1535-7163.MCT-07-0167; Wei AH, 2008, LEUKEMIA LYMPHOMA, V49, P657, DOI 10.1080/10428190801942378; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Willis SN, 2005, CURR OPIN CELL BIOL, V17, P617, DOI 10.1016/j.ceb.2005.10.001; Wright JJ, 2010, CLIN CANCER RES, V16, P4094, DOI 10.1158/1078-0432.CCR-09-2882; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zinzani PL, 2007, J CLIN ONCOL, V25, P4293, DOI 10.1200/JCO.2007.11.4207	89	70	71	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17682	17692		10.1074/jbc.M110.189092	http://dx.doi.org/10.1074/jbc.M110.189092			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454712	Green Published, hybrid			2022-12-25	WOS:000290585200032
J	Crane, JM; Lam, C; Rossi, A; Gupta, T; Bennett, JL; Verkman, AS				Crane, Jonathan M.; Lam, Chiwah; Rossi, Andrea; Gupta, Tripta; Bennett, Jeffrey L.; Verkman, A. S.			Binding Affinity and Specificity of Neuromyelitis Optica Autoantibodies to Aquaporin-4 M1/M23 Isoforms and Orthogonal Arrays	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSENSITIVE WATER CHANNEL; BRAIN EDEMA; MICE; ANTIBODY; PARTICLES; MIGRATION; DYNAMICS; CLONING; INJURY; CELLS	Autoantibodies against astrocyte water channel aquaporin-4 (AQP4) are highly specific for the neuroinflammatory disease neuromyelitis optica (NMO). We measured the binding of NMO autoantibodies to AQP4 in human astrocyte-derived U87MG cells expressing M1 and/or M23 AQP4, or M23 mutants that do not form orthogonal array of particles (OAPs). Binding affinity was quantified by two-color fluorescence ratio imaging of cells stained with NMO serum or a recombinant monoclonal NMO autoantibody (NMO-rAb), together with a C terminus anti-AQP4 antibody. NMO-rAb titrations showed binding with dissociation constants down to 44 +/- 7 nM. Different NMO-rAbs and NMO patient sera showed a wide variation in NMO-IgG binding to M1 versus M23 AQP4. Differences in binding affinity rather than stoichiometry accounted for M1 versus M23 binding specificity, with consistently greater affinity of NMO-IgG binding to M23 than M1 AQP4. Binding and OAP measurements in cells expressing different M1: M23 ratios or AQP4 mutants indicated that the differential binding of NMO-IgG to M1 versus M23 was due to OAP assembly rather than to differences in the M1 versus M23 N termini. Purified Fab fragments of NMO-IgG showed similar patterns of AQP4 isoform binding, indicating that structural changes in the AQP4 epitope upon array assembly, and not bivalent cross-linking of whole IgG, result in the greater binding affinity to OAPs. Our study establishes a quantitative assay of NMO-IgG binding to AQP4 and indicates remarkable, OAP-dependent heterogeneity in NMO autoantibody binding specificity.	[Crane, Jonathan M.; Rossi, Andrea; Gupta, Tripta; Verkman, A. S.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Crane, Jonathan M.; Rossi, Andrea; Gupta, Tripta; Verkman, A. S.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Lam, Chiwah; Bennett, Jeffrey L.] Univ Colorado Denver, Dept Neurol, Aurora, CO 80045 USA; [Lam, Chiwah; Bennett, Jeffrey L.] Univ Colorado Denver, Dept Ophthalmol, Aurora, CO 80045 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Verkman, AS (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	alan.verkman@ucsf.edu		Rossi, Andrea/0000-0001-5863-6448	National Institutes of Health [EY13574, EB00415, DK35124, HL73856, DK86125, DK72517]; Guthy-Jackson Charitable Foundation; National Multiple Sclerosis Society [NMSSRG4320]; NATIONAL EYE INSTITUTE [R01EY013574] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R37EB000415, R01EB000415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC1DK086125, R01DK035124, R37DK035124, P30DK072517] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Guthy-Jackson Charitable Foundation; National Multiple Sclerosis Society(National Multiple Sclerosis Society); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants EY13574, EB00415, DK35124, HL73856, DK86125, and DK72517 (to A. S. V.). This work was also supported by grants from the Guthy-Jackson Charitable Foundation (to A. S. V. and J. L. B.) and Grant NMSSRG4320 from the National Multiple Sclerosis Society (to J. L. B.).	Auguste KI, 2007, FASEB J, V21, P108, DOI 10.1096/fj.06-6848com; Bennett JL, 2009, ANN NEUROL, V66, P617, DOI 10.1002/ana.21802; Binder DK, 2006, ACTA NEUROCHIR SUPPL, V96, P389; Bradl M, 2009, ANN NEUROL, V66, P630, DOI 10.1002/ana.21837; Crane JM, 2008, MOL BIOL CELL, V19, P3369, DOI 10.1091/mbc.E08-03-0322; Crane JM, 2008, BIOPHYS J, V94, P702, DOI 10.1529/biophysj.107.115121; Crane JM, 2009, J BIOL CHEM, V284, P35850, DOI 10.1074/jbc.M109.071670; Crane JM, 2009, J CELL SCI, V122, P813, DOI 10.1242/jcs.042341; Furman CS, 2003, P NATL ACAD SCI USA, V100, P13609, DOI 10.1073/pnas.2235843100; Harris LJ, 1998, J MOL BIOL, V275, P861, DOI 10.1006/jmbi.1997.1508; HASEGAWA H, 1994, J BIOL CHEM, V269, P5497; Hinson SR, 2007, NEUROLOGY, V69, P2221, DOI 10.1212/01.WNL.0000289761.64862.ce; Ho JD, 2009, P NATL ACAD SCI USA, V106, P7437, DOI 10.1073/pnas.0902725106; Jarius S, 2008, BRAIN, V131, P3072, DOI 10.1093/brain/awn240; JUNG JS, 1994, P NATL ACAD SCI USA, V91, P13052, DOI 10.1073/pnas.91.26.13052; Kinoshita M, 2010, BIOCHEM BIOPH RES CO, V394, P205, DOI 10.1016/j.bbrc.2010.02.157; LANDIS DMD, 1974, J CELL BIOL, V60, P316, DOI 10.1083/jcb.60.1.316; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Li J, 2001, J BIOL CHEM, V276, P31233, DOI 10.1074/jbc.M104368200; Lu DC, 2008, FASEB J, V22, P3216, DOI 10.1096/fj.07-104836; Lu MQ, 1996, P NATL ACAD SCI USA, V93, P10908, DOI 10.1073/pnas.93.20.10908; Mader S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010455; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Matiello M, 2008, NEUROLOGY, V70, P2197, DOI 10.1212/01.wnl.0000303817.82134.da; Neely JD, 1999, BIOCHEMISTRY-US, V38, P11156, DOI 10.1021/bi990941s; Nicchia GP, 2009, GLIA, V57, P1363, DOI 10.1002/glia.20855; Padmawar P, 2005, NAT METHODS, V2, P825, DOI 10.1038/NMETH801; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; PONTEN J, 1968, ACTA PATHOL MIC SC, V74, P465; Saadoun S, 2005, J CELL SCI, V118, P5691, DOI 10.1242/jcs.02680; Saadoun S, 2008, BRAIN, V131, P1087, DOI 10.1093/brain/awn014; Saadoun S, 2010, BRAIN, V133, P349, DOI 10.1093/brain/awp309; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; SOSNICK TR, 1992, BIOCHEMISTRY-US, V31, P1779, DOI 10.1021/bi00121a028; Tajima M, 2010, J BIOL CHEM, V285, P8163, DOI 10.1074/jbc.M109.093948; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; WOLBURG H, 1995, J BRAIN RES, V36, P239; YANG BX, 1995, J BIOL CHEM, V270, P22907, DOI 10.1074/jbc.270.39.22907	39	137	146	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M111.227298	http://dx.doi.org/10.1074/jbc.M111.227298			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454592	Green Published, hybrid			2022-12-25	WOS:000290022800088
J	Han, YH; Chen, JH; Zhao, XK; Liang, CZ; Wang, Y; Sun, LA; Jiang, ZM; Zhang, ZF; Yang, RL; Chen, J; Li, ZS; Tang, AF; Li, XX; Ye, JX; Guan, ZC; Gui, YT; Cai, ZM				Han, Yonghua; Chen, Jiahao; Zhao, Xiaokun; Liang, Chaozhao; Wang, Yong; Sun, Liang; Jiang, Zhimao; Zhang, Zhongfu; Yang, Ruilin; Chen, Jing; Li, Zesong; Tang, Aifa; Li, Xianxin; Ye, Jiongxian; Guan, Zhichen; Gui, Yaoting; Cai, Zhiming			MicroRNA Expression Signatures of Bladder Cancer Revealed by Deep Sequencing	PLOS ONE			English	Article							IDENTIFICATION; GENES	Background: MicroRNAs (miRNAs) are a class of small noncoding RNAs that regulate gene expression. They are aberrantly expressed in many types of cancers. In this study, we determined the genome-wide miRNA profiles in bladder urothelial carcinoma by deep sequencing. Methodology/Principal Findings: We detected 656 differentially expressed known human miRNAs and miRNA antisense sequences (miRNA*s) in nine bladder urothelial carcinoma patients by deep sequencing. Many miRNAs and miRNA*s were significantly upregulated or downregulated in bladder urothelial carcinoma compared to matched histologically normal urothelium. hsa-miR-96 was the most significantly upregulated miRNA and hsa-miR-490-5p was the most significantly downregulated one. Upregulated miRNAs were more common than downregulated ones. The hsa-miR-183, hsa-miR-200b similar to 429, hsa-miR-200c similar to 141 and hsa-miR-17 similar to 92 clusters were significantly upregulated. The hsa-miR-143 similar to 145 cluster was significantly downregulated. hsa-miR-182, hsa-miR-183, hsa-miR-200a, hsa-miR-143 and hsa-miR-195 were evaluated by Real-Time qPCR in a total of fifty-one bladder urothelial carcinoma patients. They were aberrantly expressed in bladder urothelial carcinoma compared to matched histologically normal urothelium (p < 0.001 for each miRNA). Conclusions/Significance: To date, this is the first study to determine genome-wide miRNA expression patterns in human bladder urothelial carcinoma by deep sequencing. We found that a collection of miRNAs were aberrantly expressed in bladder urothelial carcinoma compared to matched histologically normal urothelium, suggesting that they might play roles as oncogenes or tumor suppressors in the development and/or progression of this cancer. Our data provide novel insights into cancer biology.	[Han, Yonghua; Li, Xianxin; Guan, Zhichen; Cai, Zhiming] Peking Univ, Shenzhen Hosp, Dept Urol, Shenzhen, Peoples R China; [Han, Yonghua; Wang, Yong; Sun, Liang; Jiang, Zhimao; Zhang, Zhongfu; Yang, Ruilin; Chen, Jing; Li, Zesong; Tang, Aifa; Ye, Jiongxian; Gui, Yaoting; Cai, Zhiming] Peking Univ, Shenzhen Hosp, Guangdong Key Lab Male Reprod Med & Genet, Shenzhen, Peoples R China; [Chen, Jiahao] Beijing Genom Inst Shenzhen, Shenzhen, Peoples R China; [Zhao, Xiaokun] Cent S Univ, Xiangya Hosp 2, Dept Urol, Changsha, Hunan, Peoples R China; [Liang, Chaozhao] Anhui Med Univ, Affiliated Hosp 1, Dept Urol, Hefei, Peoples R China; [Wang, Yong; Sun, Liang; Jiang, Zhimao; Zhang, Zhongfu; Chen, Jing; Li, Zesong; Tang, Aifa; Li, Xianxin; Ye, Jiongxian; Guan, Zhichen; Gui, Yaoting] Shenzhen PKU HKUST Med Ctr, Inst Urol, Shenzhen, Peoples R China; [Yang, Ruilin] Shantou Univ, Coll Med, Shantou, Peoples R China; [Cai, Zhiming] Second Peoples Hosp Shenzhen, Dept Urol, Shenzhen, Peoples R China	Peking University; Peking University; Beijing Genomics Institute (BGI); Central South University; Anhui Medical University; Hong Kong University of Science & Technology; Peking University; Shenzhen PKU-HKUST Medical Center; Shantou University; Second People's Hospital of Shenzhen	Han, YH (corresponding author), Peking Univ, Shenzhen Hosp, Dept Urol, Shenzhen, Peoples R China.	caizhiming2000@yahoo.com.cn	gui, yaoting/GLT-3684-2022	Chen, Jiahao/0000-0001-7719-3216	National High Technology Research and Development Program of China [2006AA02A302, 2009AA022707]; Promotion Program for Shenzhen Key Laboratory, Shenzhen, China [CXB200903090055A]; Bank of Clinical Data of Major Diseases and Biological Specimens of Shenzhen [CXC201005260001A]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Promotion Program for Shenzhen Key Laboratory, Shenzhen, China; Bank of Clinical Data of Major Diseases and Biological Specimens of Shenzhen	This work was supported by grants from the National High Technology Research and Development Program of China (863 Program, 2006AA02A302 and 2009AA022707) and the Promotion Program for Shenzhen Key Laboratory, Shenzhen, China (CXB200903090055A), Bank of Clinical Data of Major Diseases and Biological Specimens of Shenzhen (CXC201005260001A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Creighton CJ, 2009, BRIEF BIOINFORM, V10, P490, DOI 10.1093/bib/bbp019; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Dyrskjot L, 2009, CANCER RES, V69, P4851, DOI 10.1158/0008-5472.CAN-08-4043; Friedman JM, 2009, CANCER RES, V69, P2623, DOI 10.1158/0008-5472.CAN-08-3114; Gottardo F, 2007, UROL ONCOL-SEMIN ORI, V25, P387, DOI 10.1016/j.urolonc.2007.01.019; Hartmann A, 1999, AM J PATHOL, V154, P721, DOI 10.1016/S0002-9440(10)65318-7; Ichimi T, 2009, INT J CANCER, V125, P345, DOI 10.1002/ijc.24390; Katoh Y, 2008, INT J MOL MED, V22, P271, DOI 10.3892/ijmm_00000019; Kim WJ, 2008, CANCER SCI, V99, P646, DOI 10.1111/j.1349-7006.2008.00735.x; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lee JW, 2008, CLIN CANCER RES, V14, P2535, DOI 10.1158/1078-0432.CCR-07-1231; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lin TX, 2009, J UROLOGY, V181, P1372, DOI 10.1016/j.juro.2008.10.149; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Neely LA, 2010, UROL ONCOL-SEMIN ORI, V28, P39, DOI 10.1016/j.urolonc.2008.06.006; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P354, DOI 10.1038/nsmb.1409; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Raponi M, 2009, CANCER RES, V69, P5776, DOI 10.1158/0008-5472.CAN-09-0587; Rathjen T, 2009, FEBS LETT, V583, P1422, DOI 10.1016/j.febslet.2009.03.048; Rosenfeld N, 2008, NAT BIOTECHNOL, V26, P462, DOI 10.1038/nbt1392; Schaefer A, 2010, INT J CANCER, V126, P1166, DOI 10.1002/ijc.24827; Schmittgen TD, 2008, METHODS, V44, P31, DOI 10.1016/j.ymeth.2007.09.006; Stenvang J, 2008, SEMIN CANCER BIOL, V18, P89, DOI 10.1016/j.semcancer.2008.01.004; Wang G, 2010, INT UROL NEPHROL, V42, P95, DOI 10.1007/s11255-009-9584-3; Witten D, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-58; Wyman SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005311	31	204	216	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e18286	10.1371/journal.pone.0018286	http://dx.doi.org/10.1371/journal.pone.0018286			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464941	gold, Green Submitted, Green Published			2022-12-25	WOS:000289053800037
J	Evans, JT; Wani, RLS; Anderson, L; Gibson, AL; Smith, EG; Wood, A; Olowokure, B; Abubakar, I; Mann, JS; Gardiner, S; Jones, H; Sonnenberg, P; Hawkey, PM				Evans, Jason T.; Wani, Robert L. Serafino; Anderson, Laura; Gibson, Andrea L.; Smith, E. Grace; Wood, Annette; Olowokure, Babatunde; Abubakar, Ibrahim; Mann, Jonathan S.; Gardiner, Sarah; Jones, Helen; Sonnenberg, Pam; Hawkey, Peter M.			A Geographically-Restricted but Prevalent Mycobacterium tuberculosis Strain Identified in the West Midlands Region of the UK between 1995 and 2008	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; GENETIC DIVERSITY; NEW-YORK; TRANSMISSION; OUTBREAK; CLUSTER; USERS; CITY	Background: We describe the identification of, and risk factors for, the single most prevalent Mycobacterium tuberculosis strain in the West Midlands region of the UK. Methodology/Principal Findings: Prospective 15-locus MIRU-VNTR genotyping of all M. tuberculosis isolates in the West Midlands between 2004 and 2008 was undertaken. Two retrospective epidemiological investigations were also undertaken using univariable and multivariable logistic regression analysis. The first study of all TB patients in the West Midlands between 2004 and 2008 identified a single prevalent strain in each of the study years (total 155/3,056 (5%) isolates). This prevalent MIRU-VNTR profile (32333 2432515314 434443183) remained clustered after typing with an additional 9-loci MIRU-VNTR and spoligotyping. The majority of these patients (122/155, 79%) resided in three major cities located within a 40 km radius. From the apparent geographical restriction, we have named this the "Mercian" strain. A multivariate analysis of all TB patients in the West Midlands identified that infection with a Mercian strain was significantly associated with being UK-born (OR = 9.03, 95% CI = 4.56-17.87, p < 0.01), Black Caribbean (OR = 5.68, 95% CI = 2.96-10.91, p < 0.01) resident in Wolverhampton (OR = 9.29, 95% CI = 5.69-15.19, p < 0.01) and negatively associated with age > 65 years old (OR = 0.25, 95% CI = 0.09-0.67, p < 0.01). A second more detailed investigation analyzed a cohort of 82 patients resident in Wolverhampton between 2003 and 2006. A significant association with being born in the UK remained after a multivariate analysis (OR = 9.68, 95% CI = 2.00-46.78, p < 0.01) and excess alcohol intake and cannabis use (OR = 6.26, 95% CI = 1.45-27.02, p = .01) were observed as social risk factors for infection. Conclusions/Significance: The continued consistent presence of the Mercian strain suggests ongoing community transmission. Whilst significant associations have been found, there may be other common risk factors yet to be identified. Future investigations should focus on targeting the relevant risk groups and elucidating the biological factors that mediate continued transmission of this strain.	[Evans, Jason T.; Gibson, Andrea L.; Smith, E. Grace; Gardiner, Sarah; Hawkey, Peter M.] Heart England NHS Fdn Trust, Hlth Protect Agcy, W Midlands Lab, Birmingham, W Midlands, England; [Wani, Robert L. Serafino] Guys & St Thomas NHS Fdn Trust, Dept Infect, London, England; [Anderson, Laura; Abubakar, Ibrahim] Hlth Protect Agcy, Dept Resp Dis, TB Sect, Ctr Infect, London, England; [Wood, Annette] Hlth Protect Agcy, W Midlands E Hlth Protect Unit, Birmingham, W Midlands, England; [Olowokure, Babatunde] Hlth Protect Agcy, W Midlands Reg Epidemiol Unit, Birmingham, W Midlands, England; [Mann, Jonathan S.] New Cross Hosp, Dept Resp Med, Wolverhampton, W Midlands, England; [Jones, Helen] New Cross Hosp, Dept Microbiol, Wolverhampton, W Midlands, England; [Sonnenberg, Pam] UCL, Dept Infect & Populat Hlth, Ctr Sexual Hlth & HIV Res, London, England; [Hawkey, Peter M.] Univ Birmingham, Sch Immun & Infect, Coll Med & Dent Sci, Birmingham, W Midlands, England	Health Protection Agency; Heart of England NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; Health Protection Agency; Health Protection Agency; Health Protection Agency; New Cross Hospital; New Cross Hospital; University of London; University College London; University of Birmingham	Evans, JT (corresponding author), Heart England NHS Fdn Trust, Hlth Protect Agcy, W Midlands Lab, Birmingham, W Midlands, England.	jason.evans@heartofengland.nhs.uk		Abubakar, Ibrahim/0000-0002-0370-1430; Sonnenberg, Pam/0000-0002-1067-1583	UK Department of Health	UK Department of Health	The implementation of prospective DNA fingerprinting was enabled by a grant from the UK Department of Health. The Department of Health had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAND D, 1994, NEW ENGL J MED, V330, P1710, DOI 10.1056/NEJM199406163302403; Borgdorff MW, 2001, AM J EPIDEMIOL, V154, P934, DOI 10.1093/aje/154.10.934; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Cowan LS, 2004, J CLIN MICROBIOL, V42, P474, DOI 10.1128/JCM.42.1.474-477.2004; de Vries G, 2007, AM J RESP CRIT CARE, V176, P201, DOI 10.1164/rccm.200612-1877OC; Evans JT, 2007, LANCET, V369, P1270, DOI 10.1016/S0140-6736(07)60598-4; Fok A, 2008, INT J TUBERC LUNG D, V12, P480; Frothingham R, 1998, MICROBIOL-UK, V144, P1189, DOI 10.1099/00221287-144-5-1189; Ghebremichael S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010893; Gibson AL, 2008, J CLIN MICROBIOL, V46, P1259, DOI 10.1128/JCM.02231-07; Hawkey PM, 2003, J CLIN MICROBIOL, V41, P3514, DOI 10.1128/JCM.41.8.3514-3520.2003; *HLTH PROT AG, 2009, TUBERCULOSIS UK ANN; *HPA, 2010, HPA UK MYC TUB STRAI; Jackson AD, 2009, INT J TUBERC LUNG D, V13, P486; Kik SV, 2008, AM J RESP CRIT CARE, V178, P96, DOI 10.1164/rccm.200708-1256OC; Love J, 2009, INT J TUBERC LUNG D, V13, P201; McNabb SJN, 2004, AM J EPIDEMIOL, V160, P589, DOI 10.1093/aje/kwh253; Moss AR, 1997, INT J TUBERC LUNG D, V1, P115; Oeltmann JE, 2006, EMERG INFECT DIS, V12, P1156, DOI 10.3201/eid1207.051436; *OFF NAT STAT, 2010, W MIDL POP MIGR; Lazzarini LCO, 2008, J CLIN MICROBIOL, V46, P2175, DOI 10.1128/JCM.00065-08; Lazzarini LCO, 2007, J CLIN MICROBIOL, V45, P3891, DOI 10.1128/JCM.01394-07; Perlman DC, 1997, J SUBST ABUSE TREAT, V14, P3, DOI 10.1016/S0740-5472(96)00182-1; Ruddy MC, 2004, THORAX, V59, P279, DOI 10.1136/thx.2003.010405; SMALL PM, 1994, NEW ENGL J MED, V330, P1703, DOI 10.1056/NEJM199406163302402; Stavrum R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004540; Supply P, 2000, MOL MICROBIOL, V36, P762, DOI 10.1046/j.1365-2958.2000.01905.x; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; van Soolingen D, 1999, J INFECT DIS, V180, P726, DOI 10.1086/314930; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; VANWEEZENBEEK CSL, 2003, INT J TUBERC LUNG D, V7, pS463; ZALUCKYJ S, 2001, MERCIAN ANGLO SAXON	32	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e17930	10.1371/journal.pone.0017930	http://dx.doi.org/10.1371/journal.pone.0017930			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464965	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000288813900020
J	Ferri, F; Frassinetti, F; Costantini, M; Gallese, V				Ferri, Francesca; Frassinetti, Francesca; Costantini, Marcello; Gallese, Vittorio			Motor Simulation and the Bodily Self	PLOS ONE			English	Article							MENTAL ROTATION; BODY-OWNERSHIP; NEURAL BASIS; CORTEX; REPRESENTATIONS; ASYMMETRY; HANDS; RECOGNITION; PERCEPTION; MOVEMENT	Previous studies demonstrated the human ability to implicitly recognize their own body. When submitted to a visual matching task, participants showed the so-called self-advantage, that is, a better performance with self rather than others' body or body parts. Here, we investigated whether the body self-advantage relies upon a motor representation of one's body. Participants were submitted to a laterality judgment of self and others' hands (Experiment 1 and 3), which involves a sensory-motor mental simulation. Moreover, to investigate whether the self-advantage emerges also when an explicit self processing is required, the same participants were submitted to an explicit self-body recognition task (Experiment 2). Participants showed the self-advantage when performing the laterality judgment, but not when self-recognition was explicitly required. Thus, implicit and explicit recognition of the bodily self dissociate and only an implicit recognition of the bodily self, mapped in motor terms, allows the self-advantage to emerge.	[Ferri, Francesca; Gallese, Vittorio] Univ Parma, Dept Neurosci, I-43100 Parma, Italy; [Frassinetti, Francesca] Univ Bologna, Dept Psychol, Bologna, Italy; [Costantini, Marcello] Univ G DAnnunzio, Dept Neurosci & Imaging, Chieti, Italy; [Costantini, Marcello] Fdn Univ G dAnnunzio, ITAB, Chieti, Italy; [Gallese, Vittorio] Italian Inst Technol, Brain Ctr Social & Motor Cognit, Parma, Italy	University of Parma; University of Bologna; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; Istituto Italiano di Tecnologia - IIT	Ferri, F (corresponding author), Univ Parma, Dept Neurosci, I-43100 Parma, Italy.	francesca.ferri@nemo.unipr.it	Gallese, Vittorio/ABD-5097-2021; FRASSINETTI, FRANCESCA/ABI-1533-2020; Costantini, Marcello/F-7083-2011; Frassinetti, Francesca/K-1474-2016; Ferri, Francesca/AAC-2527-2022	Gallese, Vittorio/0000-0003-4815-3607; FRASSINETTI, FRANCESCA/0000-0001-6810-2861; Frassinetti, Francesca/0000-0001-6810-2861; Ferri, Francesca/0000-0003-1821-5870; Costantini, Marcello/0000-0002-0504-1296	Ministry of University and Research; Vittorio Gallese; EU	Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); Vittorio Gallese; EU(European Commission)	This work was supported by grants from the Ministry of University and Research to Francesca Frassinetti and Vittorio Gallese, and from the EU grant DISCOS (http://www.schattauer-discos.de) to Vittorio Gallese. Francesca Ferri was supported by the EU grant ROSSI (http://win.rossiproject.net). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amunts K, 1996, NEUROIMAGE, V4, P216, DOI 10.1006/nimg.1996.0073; Aranda C, 2010, ATTEN PERCEPT PSYCHO, V72, P1756, DOI 10.3758/APP.72.7.1756; BERTI A, 1992, J COGNITIVE NEUROSCI, V4, P345, DOI 10.1162/jocn.1992.4.4.345; BERTI A, 1994, CORTEX, V30, P181, DOI 10.1016/S0010-9452(13)80192-X; Bracci S, 2010, J NEUROPHYSIOL, V103, P3389, DOI 10.1152/jn.00215.2010; Buchner H, 1995, Electromyogr Clin Neurophysiol, V35, P207; Casile A, 2006, CURR BIOL, V16, P69, DOI 10.1016/j.cub.2005.10.071; Conson M, 2010, EXP BRAIN RES, V206, P449, DOI 10.1007/s00221-010-2418-9; COOPER LA, 1975, J EXP PSYCHOL HUMAN, V104, P48, DOI 10.1037/0096-1523.1.1.48; DECETY J, 1991, BEHAV BRAIN RES, V42, P1, DOI 10.1016/S0166-4328(05)80033-6; DECETY J, 1994, NATURE, V371, P600, DOI 10.1038/371600a0; Devue C, 2007, BRAIN RES, V1143, P169, DOI 10.1016/j.brainres.2007.01.055; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; Frassinetti F, 2008, J COGNITIVE NEUROSCI, V20, P1507, DOI 10.1162/jocn.2008.20067; Frassinetti F, 2010, CORTEX, V46, P322, DOI 10.1016/j.cortex.2009.03.015; Frassinetti F, 2009, NEUROPSYCHOLOGIA, V47, P1988, DOI 10.1016/j.neuropsychologia.2009.03.012; Gallese V, 2010, NEUROPSYCHOLOGIA, V48, P746, DOI 10.1016/j.neuropsychologia.2009.09.038; Gentilucci M, 1998, COGNITIVE BRAIN RES, V6, P185, DOI 10.1016/S0926-6410(97)00034-7; Ionta S, 2007, EXP BRAIN RES, V183, P1, DOI 10.1007/s00221-007-1020-2; Jeannerod M, 2004, NAT NEUROSCI, V7, P422, DOI 10.1038/nn0504-422; Jung P, 2003, NEUROIMAGE, V19, P913, DOI 10.1016/S1053-8119(03)00164-2; Kawashima R, 1997, NEUROREPORT, V8, P1729, DOI 10.1097/00001756-199705060-00032; Linkenauger SA, 2009, PSYCHOL SCI, V20, P1373, DOI 10.1111/j.1467-9280.2009.02447.x; Loula F, 2005, J EXP PSYCHOL HUMAN, V31, P210, DOI 10.1037/0096-1523.31.1.210; Moro V, 2008, NEURON, V60, P235, DOI 10.1016/j.neuron.2008.09.022; Orlov T, 2010, NEURON, V68, P586, DOI 10.1016/j.neuron.2010.09.032; PARSONS LM, 1994, J EXP PSYCHOL HUMAN, V20, P709, DOI 10.1037/0096-1523.20.4.709; PARSONS LM, 1987, J EXP PSYCHOL GEN, V116, P172, DOI 10.1037/0096-3445.116.2.172; Parsons LM, 1998, J NEUROSCI, V18, P6539; Peelen MV, 2007, NAT REV NEUROSCI, V8, P636, DOI 10.1038/nrn2195; Peelen MV, 2005, NAT NEUROSCI, V8, P125, DOI 10.1038/nn0205-125a; Petit LS, 2003, BRAIN COGNITION, V51, P95, DOI 10.1016/S0278-2626(02)00526-2; Porro CA, 1996, J NEUROSCI, V16, P7688; Rochat P, 2003, CONSCIOUS COGN, V12, P717, DOI 10.1016/S1053-8100(03)00081-3; Rochat P, 2010, NEUROPSYCHOLOGIA, V48, P738, DOI 10.1016/j.neuropsychologia.2009.11.021; Schneider W., 2002, E PRIME VERSION 20 C; Schneider W., 2002, E PRIME USERS GUIDE; Schwarzlose RF, 2005, J NEUROSCI, V25, P11055, DOI 10.1523/JNEUROSCI.2621-05.2005; Sugiura M, 2006, NEUROIMAGE, V32, P1905, DOI 10.1016/j.neuroimage.2006.05.026; Thayer ZC, 2001, NEUROREPORT, V12, P3433, DOI 10.1097/00001756-200111160-00011; Tsakiris M, 2007, CONSCIOUS COGN, V16, P645, DOI 10.1016/j.concog.2007.05.012; Tsakiris M, 2006, CONSCIOUS COGN, V15, P423, DOI 10.1016/j.concog.2005.09.004; Tsakiris M, 2010, NEUROPSYCHOLOGIA, V48, P703, DOI 10.1016/j.neuropsychologia.2009.09.034; Zilles K, 1997, HUM BRAIN MAPP, V5, P218, DOI 10.1002/(SICI)1097-0193(1997)5:4<218::AID-HBM2>3.0.CO;2-6	45	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e17927	10.1371/journal.pone.0017927	http://dx.doi.org/10.1371/journal.pone.0017927			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464959	Green Published, Green Submitted, gold			2022-12-25	WOS:000288813900019
J	Gibbons, HS; Broomall, SM; McNew, LA; Daligault, H; Chapman, C; Bruce, D; Karavis, M; Krepps, M; McGregor, PA; Hong, C; Park, KH; Akmal, A; Feldman, A; Lin, JS; Chang, WLE; Higgs, BW; Demirev, P; Lindquist, J; Liem, A; Fochler, E; Read, TD; Tapia, R; Johnson, S; Bishop-Lilly, KA; Detter, C; Han, C; Sozhamannan, S; Rosenzweig, CN; Skowronski, EW				Gibbons, Henry S.; Broomall, Stacey M.; McNew, Lauren A.; Daligault, Hajnalka; Chapman, Carol; Bruce, David; Karavis, Mark; Krepps, Michael; McGregor, Paul A.; Hong, Charles; Park, Kyong H.; Akmal, Arya; Feldman, Andrew; Lin, Jeffrey S.; Chang, Wenling E.; Higgs, Brandon W.; Demirev, Plamen; Lindquist, John; Liem, Alvin; Fochler, Ed; Read, Timothy D.; Tapia, Roxanne; Johnson, Shannon; Bishop-Lilly, Kimberly A.; Detter, Chris; Han, Cliff; Sozhamannan, Shanmuga; Rosenzweig, C. Nicole; Skowronski, Evan W.			Genomic Signatures of Strain Selection and Enhancement in Bacillus atrophaeus var. globigii, a Historical Biowarfare Simulant	PLOS ONE			English	Article							EXPERIMENTAL POPULATIONS; BACTERIAL-POPULATIONS; SURFACTIN PRODUCTION; RESPONSE REGULATOR; NITRIC-OXIDE; SUBTILIS; SPORULATION; GENE; ANTHRACIS; SEQUENCE	Background: Despite the decades-long use of Bacillus atrophaeus var. globigii (BG) as a simulant for biological warfare (BW) agents, knowledge of its genome composition is limited. Furthermore, the ability to differentiate signatures of deliberate adaptation and selection from natural variation is lacking for most bacterial agents. We characterized a lineage of BGwith a long history of use as a simulant for BW operations, focusing on classical bacteriological markers, metabolic profiling and whole-genome shotgun sequencing (WGS). Results: Archival strains and two "present day" type strains were compared to simulant strains on different laboratory media. Several of the samples produced multiple colony morphotypes that differed from that of an archival isolate. To trace the microevolutionary history of these isolates, we obtained WGS data for several archival and present-day strains and morphotypes. Bacillus-wide phylogenetic analysis identified B. subtilis as the nearest neighbor to B. atrophaeus. The genome of B. atrophaeus is, on average, 86% identical to B. subtilis on the nucleotide level. WGS of variants revealed that several strains were mixed but highly related populations and uncovered a progressive accumulation of mutations among the "military" isolates. Metabolic profiling and microscopic examination of bacterial cultures revealed enhanced growth of "military" isolates on lactate-containing media, and showed that the "military" strains exhibited a hypersporulating phenotype. Conclusions: Our analysis revealed the genomic and phenotypic signatures of strain adaptation and deliberate selection for traits that were desirable in a simulant organism. Together, these results demonstrate the power of whole-genome and modern systems-level approaches to characterize microbial lineages to develop and validate forensic markers for strain discrimination and reveal signatures of deliberate adaptation.	[Gibbons, Henry S.; Broomall, Stacey M.; McNew, Lauren A.; Karavis, Mark; Krepps, Michael; McGregor, Paul A.; Hong, Charles; Park, Kyong H.; Liem, Alvin; Fochler, Ed; Rosenzweig, C. Nicole; Skowronski, Evan W.] Edgewood Chem Biol Ctr, BioSci Div, Aberdeen Proving Ground, MD USA; [McNew, Lauren A.] Battelle Mem Inst, Aberdeen Proving Ground, MD USA; [McGregor, Paul A.] Sci Applicat Int Corp, Aberdeen Proving Ground, MD USA; [Feldman, Andrew; Lin, Jeffrey S.; Demirev, Plamen] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD USA; [Lindquist, John] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Liem, Alvin; Fochler, Ed] OptiMetrics Inc, Abingdon, Oxon, England; [Chapman, Carol; Akmal, Arya; Read, Timothy D.; Bishop-Lilly, Kimberly A.; Sozhamannan, Shanmuga] USN, Med Res Ctr, Biol Def Res Directorate, Silver Spring, MD USA; [Hong, Charles] Def Threat Reduct Agcy, Ft Belvoir, VA USA; [Chang, Wenling E.; Higgs, Brandon W.] Mitre Corp, Mclean, VA USA; [Daligault, Hajnalka; Bruce, David; Tapia, Roxanne; Johnson, Shannon; Detter, Chris; Han, Cliff] Los Alamos Natl Lab, Dept Energy, Joint Genome Inst, Los Alamos, NM USA; [Krepps, Michael] Excet Inc, Aberdeen Proving Ground, MD USA	United States Department of Defense; US Army Research, Development & Engineering Command (RDECOM); Science Applications International Corporation (SAIC); Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; University of Wisconsin System; University of Wisconsin Madison; United States Department of Defense; United States Navy; United States Department of Defense; Defense Threat Reduction Agency; MITRE Corporation; United States Department of Energy (DOE); Los Alamos National Laboratory	Gibbons, HS (corresponding author), Edgewood Chem Biol Ctr, BioSci Div, Aberdeen Proving Ground, MD USA.	henry.gibbons@us.army.mil	Sozhamannan, Shanmuga/AAN-7809-2020; Sozhamannan, Shanmuga/AGF-2410-2022; Johnson, Shannon Lyn/H-2799-2019; Read, Timothy/E-6240-2011	Sozhamannan, Shanmuga/0000-0002-6762-7874; Johnson, Shannon Lyn/0000-0002-3972-9208; Read, Timothy/0000-0001-8966-9680; Gibbons, Henry/0000-0002-5603-8679; Bishop-Lilly, Kimberly/0000-0002-5744-8493; Higgs, Brandon/0000-0002-2951-0245	Department of Homeland [NBCHC070040]	Department of Homeland(United States Department of Homeland Security (DHS))	This work was made possible by the Defense Threat Reduction Agency Transformational Medical Technologies Initiative CB2847 to HSG and ES; by TMTI0068_07_NM_T (to KBL and SS), and by Department of Homeland Security award number NBCHC070040 to AF, PD, and JL. The funders had no role in study design, data collection and analysis, or preparation of the manuscript. The opinions therein are those of the authors and are not necessarily those of the U. S. Government or any of its agencies. Information in this report is unclassified and cleared for public release.	Asai K, 2007, BIOSCI BIOTECH BIOCH, V71, P397, DOI 10.1271/bbb.60445; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bagyan I, 1998, J BACTERIOL, V180, P2057, DOI 10.1128/JB.180.8.2057-2062.1998; BAI U, 1990, J BACTERIOL, V172, P5432, DOI 10.1128/jb.172.9.5432-5439.1990; BARRICK JE, 2009, COLD SPRING HARB S Q; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Bennett S, 2004, PHARMACOGENOMICS, V5, P433, DOI 10.1517/14622416.5.4.433; Brunstetter BC, 1932, J BACTERIOL, V24, P85, DOI 10.1128/JB.24.2.85-122.1932; Bryan EM, 1996, J BACTERIOL, V178, P4778, DOI 10.1128/jb.178.16.4778-4786.1996; Burke SA, 2004, APPL ENVIRON MICROB, V70, P2786, DOI 10.1128/AEM.70.5.2786-2790.2004; Buttner MP, 2004, APPL ENVIRON MICROB, V70, P7040, DOI 10.1128/AEM.70.12.7040-7045.2004; Carrera M, 2007, J APPL MICROBIOL, V102, P303, DOI 10.1111/j.1365-2672.2006.03111.x; Casadevall A, 2010, BIOSECUR BIOTERROR, V8, P151, DOI 10.1089/bsp.2010.0012; CasillasMartinez L, 1997, J BACTERIOL, V179, P7420, DOI 10.1128/jb.179.23.7420-7425.1997; Chemerilova VI, 2007, MICROBIOLOGY+, V76, P446, DOI 10.1134/S0026261707040108; Cooper TF, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-11; Cummings CA, 2009, FORENS SCI INT-GEN S, V2, P300, DOI 10.1016/j.fsigss.2009.08.097; Daegelen P, 2009, J MOL BIOL, V394, P634, DOI 10.1016/j.jmb.2009.09.022; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Ferenci T, 2008, HEREDITY, V100, P446, DOI 10.1038/sj.hdy.6801077; Ferenci T, 2009, J BACTERIOL, V191, P4025, DOI 10.1128/JB.00118-09; Fritze D, 2001, INT J SYST EVOL MICR, V51, P35, DOI 10.1099/00207713-51-1-35; Gerike U, 1998, MICROBIOL-UK, V144, P929, DOI 10.1099/00221287-144-4-929; Gonzalez-Pastor JE, 2003, SCIENCE, V301, P510, DOI 10.1126/science.1086462; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Greenberg David L, 2010, Investig Genet, V1, P4, DOI 10.1186/2041-2223-1-4; Gusarov I, 2009, SCIENCE, V325, P1380, DOI 10.1126/science.1175439; HARRISWARRICK RM, 1978, J BACTERIOL, V133, P1237, DOI 10.1128/JB.133.3.1237-1245.1978; HAYWARD AE, 1946, J BACTERIOL, V52, P51, DOI 10.1128/JB.52.1.51-54.1946; Holt KE, 2009, BIOINFORMATICS, V25, P2074, DOI 10.1093/bioinformatics/btp344; Hullo MF, 2001, J BACTERIOL, V183, P5426, DOI 10.1128/JB.183.18.5426-5430.2001; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; IOERGER TR, 2010, J BACTERIOL; Jarvik T, 2010, J BACTERIOL, V192, P560, DOI 10.1128/JB.01233-09; Kinsinger RF, 2003, J BACTERIOL, V185, P5627, DOI 10.1128/JB.185.18.5627-5631.2003; KLOCKGETHER J, 2009, J BACTERIOL; Kojetin DJ, 2005, BIOMETALS, V18, P449, DOI 10.1007/s10534-005-4303-8; Kotewicz ML, 2007, MICROBIOL-SGM, V153, P1720, DOI 10.1099/mic.0.2006/004507-0; Kotewicz ML, 2008, MICROBIOL-SGM, V154, P3518, DOI 10.1099/mic.0.2008/019026-0; Kournikakis B, 2010, J OCCUP ENVIRON HYG, V7, P71, DOI 10.1080/15459620903389558; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Latreille P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-321; LIGGETT RW, 1948, BACTERIOL REV, V12, P297, DOI 10.1128/MMBR.12.4.297-311.1948; Liu CM, 2010, J VIROL METHODS, V163, P109, DOI 10.1016/j.jviromet.2009.09.007; Liu HB, 2004, J BACTERIOL, V186, P164, DOI 10.1128/JB.186.1.164-178.2004; Maharjan R, 2006, SCIENCE, V313, P514, DOI 10.1126/science.1129865; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Maughan H, 2004, J BACTERIOL, V186, P2212, DOI 10.1128/JB.186.7.2212-2214.2004; Maughan H, 2007, GENETICS, V177, P937, DOI 10.1534/genetics.107.075663; Maughan H, 2006, EVOLUTION, V60, P686; McNeil LK, 2007, NUCLEIC ACIDS RES, V35, pD347, DOI 10.1093/nar/gkl947; NAKAMURA LK, 1989, INT J SYST BACTERIOL, V39, P295, DOI 10.1099/00207713-39-3-295; NAKANO MM, 1989, J BACTERIOL, V171, P5347, DOI 10.1128/jb.171.10.5347-5353.1989; NAKANO MM, 1991, J BACTERIOL, V173, P1770, DOI 10.1128/jb.173.5.1770-1778.1991; NAKANO MM, 1988, J BACTERIOL, V170, P5662, DOI 10.1128/jb.170.12.5662-5668.1988; Nakano MM, 2002, J BACTERIOL, V184, P1783, DOI 10.1128/JB.184.6.1783-1787.2002; PAGE WF, 2007, LONG TERM HLTH EFFEC, V18; PEREGO M, 1988, J BACTERIOL, V170, P2560, DOI 10.1128/jb.170.6.2560-2567.1988; PHILLIPS CR, 1949, AM J HYG, V50, P280, DOI 10.1093/oxfordjournals.aje.a119360; Piggot PJ, 2004, CURR OPIN MICROBIOL, V7, P579, DOI 10.1016/j.mib.2004.10.001; PREDICH M, 1992, J BACTERIOL, V174, P2771, DOI 10.1128/JB.174.9.2771-2778.1992; REGIS E, 1999, BIOL DOOM HIST AM SE; ROTH NG, 1955, DEV PROCESSES PRODUC; Sagripanti JL, 2007, J APPL MICROBIOL, V102, P11, DOI 10.1111/j.1365-2672.2006.03235.x; Schuch R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006532; Silva J M F, 2007, PDA J Pharm Sci Technol, V61, P204; Srivatsan A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000139; STEIN DC, 1984, APPL ENVIRON MICROB, V48, P280, DOI 10.1128/AEM.48.2.280-284.1984; Stratis-Cullum DN, 2003, ANAL CHEM, V75, P275, DOI 10.1021/ac026068+; TAKAHASHI I, 1965, J BACTERIOL, V89, P294, DOI 10.1128/JB.89.2.294-298.1965; Team RDC, 2009, R LANG ENV STAT COMP; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Turnbough CL, 2003, J MICROBIOL METH, V53, P263, DOI 10.1016/S0167-7012(03)00030-7; Tzeng YL, 1997, J MOL BIOL, V272, P200, DOI 10.1006/jmbi.1997.1226; *US PHARM, 2000, BIOL IND ETH OX STER, P231; Van Ert MN, 2007, J CLIN MICROBIOL, V45, P47, DOI 10.1128/JCM.01233-06; Worsham PL, 1999, CAN J MICROBIOL, V45, P1, DOI 10.1139/cjm-45-1-1; Yang ACC, 2005, J COMPUT BIOL, V12, P1103, DOI 10.1089/cmb.2005.12.1103; YOUNG FE, 1964, J BIOL CHEM, V239, P3600; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	81	32	33	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e17836	10.1371/journal.pone.0017836	http://dx.doi.org/10.1371/journal.pone.0017836			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464989	gold, Green Published, Green Submitted			2022-12-25	WOS:000288813900013
J	Guo, FK; Zhang, SM; Tripathi, P; Mattner, J; Phelan, J; Sproles, A; Mo, J; Wills-Karp, M; Grimes, HL; Hildeman, D; Zheng, Y				Guo, Fukun; Zhang, Shuangmin; Tripathi, Pulak; Mattner, Jochen; Phelan, James; Sproles, Alyssa; Mo, Jun; Wills-Karp, Marsha; Grimes, H. Leighton; Hildeman, David; Zheng, Yi			Distinct Roles of Cdc42 in Thymopoiesis and Effector and Memory T Cell Differentiation	PLOS ONE			English	Article							IMMUNOLOGICAL SYNAPSE; GTPASE CDC42; RECEPTOR MICROCLUSTERS; SIGNAL-TRANSDUCTION; DIRECTED MIGRATION; RHO-GTPASES; ACTIVATION; POLARIZATION; BALANCE; NAIVE	Cdc42 of the Rho GTPase family has been implicated in cell actin organization, proliferation, survival, and migration but its physiological role is likely cell-type specific. By a T cell-specific deletion of Cdc42 in mouse, we have recently shown that Cdc42 maintains naive T cell homeostasis through promoting cell survival and suppressing T cell activation. Here we have further investigated the involvement of Cdc42 in multiple stages of T cell differentiation. We found that in Cdc42(-/-) thymus, positive selection of CD4(+)CD8(+) double-positive thymocytes was defective, CD4(+) and CD8(+) single-positive thymocytes were impaired in migration and showed an increase in cell apoptosis triggered by anti-CD3/-CD28 antibodies, and thymocytes were hyporesponsive to anti-CD3/-CD28-induced cell proliferation and hyperresponsive to anti-CD3/-CD28-stimulated MAP kinase activation. At the periphery, Cdc42-deficient naive T cells displayed an impaired actin polymerization and TCR clustering during the formation of mature immunological synapse, and showed an enhanced differentiation to Th1 and CD8(+) effector and memory cells in vitro and in vivo. Finally, Cdc42(-/-) mice exhibited exacerbated liver damage in an induced autoimmune disease model. Collectively, these data establish that Cdc42 is critically involved in thymopoiesis and plays a restrictive role in effector and memory T cell differentiation and autoimmunity.	[Guo, Fukun; Zhang, Shuangmin; Zheng, Yi] Childrens Hosp Res Fdn, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA; [Tripathi, Pulak; Mattner, Jochen; Phelan, James; Sproles, Alyssa; Wills-Karp, Marsha; Grimes, H. Leighton; Hildeman, David] Childrens Hosp Res Fdn, Div Immunobiol, Cincinnati, OH 45229 USA; [Mattner, Jochen] Univ Klinikum Erlangen, Microbiol Inst Clin Microbiol Immunol & Hyg, Erlangen, Germany; [Mattner, Jochen] Univ Erlangen Nurnberg, Erlangen, Germany; [Mo, Jun] Childrens Hosp, Div Pathol, Res Fdn, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; University of Erlangen Nuremberg; University of Erlangen Nuremberg; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation	Guo, FK (corresponding author), Childrens Hosp Res Fdn, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA.	fukun.guo@cchmc.org	Hildeman, David/AAA-1757-2020; Hildeman, David/I-4884-2015; Zheng, Yi/J-7235-2015; Mattner, Jochen/AAT-7866-2021	Hildeman, David/0000-0002-0421-8483; Hildeman, David/0000-0002-0421-8483; Zheng, Yi/0000-0001-7089-6074; Tripp, Ralph/0000-0002-2924-9956; Grimes, H. Leighton/0000-0001-8162-6758	National Institutes of Health [R01 HL085362]; Cincinnati Children's Hospital; NATIONAL CANCER INSTITUTE [T32CA117846] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085362] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cincinnati Children's Hospital; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grant R01 HL085362 (to Yi Zheng)(www.nih.gov) and Cincinnati Children's Hospital Trustee Grant (to Fukun Guo)(www.cchmc.org). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Becart S, 2007, J CLIN INVEST, V117, P2164, DOI 10.1172/JCI31640; Bowen H, 2008, CLIN EXP ALLERGY, V38, P1422, DOI 10.1111/j.1365-2222.2008.03067.x; Cannon JL, 2002, IMMUNOL REV, V186, P90, DOI 10.1034/j.1600-065X.2002.18609.x; Czuchra A, 2005, MOL BIOL CELL, V16, P4473, DOI 10.1091/mbc.E05-01-0061; Davis DM, 2004, TRENDS IMMUNOL, V25, P323, DOI 10.1016/j.it.2004.03.007; Dorn T, 2007, BLOOD, V109, P2346, DOI 10.1182/BLOOD-2006-04-019034; Dumont C, 2009, BLOOD, V113, P3990, DOI 10.1182/blood-2008-09-181180; Gu Y, 2006, NAT IMMUNOL, V7, P1182, DOI 10.1038/ni1396; Guo F, 2008, BLOOD, V112, P1767, DOI 10.1182/blood-2008-01-132068; Guo FK, 2010, P NATL ACAD SCI USA, V107, P18505, DOI 10.1073/pnas.1010249107; Guo FK, 2009, BLOOD, V114, P2909, DOI 10.1182/blood-2009-04-214676; Haddad E, 2001, BLOOD, V97, P33, DOI 10.1182/blood.V97.1.33; Holsinger LJ, 1998, CURR BIOL, V8, P563, DOI 10.1016/S0960-9822(98)70225-8; Ilani T, 2009, NAT IMMUNOL, V10, P531, DOI 10.1038/ni.1723; Johnson DI, 1999, MICROBIOL MOL BIOL R, V63, P54, DOI 10.1128/MMBR.63.1.54-105.1999; Kaiko GE, 2008, IMMUNOLOGY, V123, P326, DOI 10.1111/j.1365-2567.2007.02719.x; Kato Y, 2003, CELL IMMUNOL, V224, P29, DOI 10.1016/j.cellimm.2003.07.001; Koh CG, 2006, NEUROSIGNALS, V15, P228, DOI 10.1159/000101527; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; Leitenberg D, 1999, SEMIN IMMUNOL, V11, P283, DOI 10.1006/smim.1999.0184; Mattner J, 2008, CELL HOST MICROBE, V3, P304, DOI 10.1016/j.chom.2008.03.009; Melendez J, 2011, J BIOL CHEM, V286, P2375, DOI 10.1074/jbc.R110.200329; Mohammed JP, 2009, EXPERT REV CLIN IMMU, V5, P369, DOI 10.1586/ECI.09.23; Morales-Tirado V, 2010, BLOOD, V115, P3498, DOI 10.1182/blood-2009-07-235754; Na SQ, 1999, ONCOGENE, V18, P7966, DOI 10.1038/sj.onc.1203122; Nakayama T, 2010, SEMIN IMMUNOL, V22, P303, DOI 10.1016/j.smim.2010.04.010; Nembrini C, 2006, J IMMUNOL, V176, P7180, DOI 10.4049/jimmunol.176.12.7180; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; Rincon M, 1998, J EXP MED, V188, P1817, DOI 10.1084/jem.188.10.1817; Rosloniec EF, 2002, ARTHRITIS RES, V4, P333, DOI 10.1186/ar432; Rutishauser RL, 2010, IMMUNOL REV, V235, P219, DOI 10.1111/j.0105-2896.2010.00901.x; Seminario MC, 2008, IMMUNOL REV, V221, P90, DOI 10.1111/j.1600-065X.2008.00593.x; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Herruzo JAS, 2009, REV ESP ENFERM DIG, V101, P413; STOWERS L, 1995, P NATL ACAD SCI USA, V92, P5027, DOI 10.1073/pnas.92.11.5027; Szczur K, 2006, BLOOD, V108, P4205, DOI 10.1182/blood-2006-03-013789; Tskvitaria-Fuller I, 2006, J IMMUNOL, V177, P1708, DOI 10.4049/jimmunol.177.3.1708; van Leeuwen EMM, 2009, CURR OPIN IMMUNOL, V21, P167, DOI 10.1016/j.coi.2009.02.005; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Wang L, 2007, TRENDS CELL BIOL, V17, P58, DOI 10.1016/j.tcb.2006.11.009; Williams MA, 2008, IMMUNITY, V28, P533, DOI 10.1016/j.immuni.2008.02.014; Wojciechowski S, 2007, J EXP MED, V204, P1665, DOI 10.1084/jem.20070618; Yang L, 2007, BLOOD, V110, P3853, DOI 10.1182/blood-2007-03-079582; Yang L, 2007, P NATL ACAD SCI USA, V104, P5091, DOI 10.1073/pnas.0610819104; Yang L, 2006, MOL BIOL CELL, V17, P4675, DOI 10.1091/mbc.E06-05-0466; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272	48	26	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2011	6	3							e18002	10.1371/journal.pone.0018002	http://dx.doi.org/10.1371/journal.pone.0018002			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740RG	21455314	gold, Green Published, Green Submitted			2022-12-25	WOS:000288811500018
J	Warfel, NA; Niederst, M; Stevens, MW; Brennan, PM; Frame, MC; Newton, AC				Warfel, Noel A.; Niederst, Matt; Stevens, Michael W.; Brennan, Paul M.; Frame, Margaret C.; Newton, Alexandra C.			Mislocalization of the E3 Ligase, beta-Transducin Repeat-containing Protein 1 (beta-TrCP1), in Glioblastoma Uncouples Negative Feedback between the Pleckstrin Homology Domain Leucine-rich Repeat Protein Phosphatase 1 (PHLPP1) and Akt	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRCP-UBIQUITIN LIGASE; PHOSPHORYLATION-DEPENDENT INTERACTION; KAPPA-B-ALPHA; TUMOR-SUPPRESSOR; BREAST-CANCER; WNT PATHWAY; CATENIN; EXPRESSION; MUTATIONS; REVEALS	The PH domain leucine-rich repeat protein phosphatase, PHLPP, plays a central role in controlling the amplitude of growth factor signaling by directly dephosphorylating and thereby inactivating Akt. The cellular levels of PHLPP1 have recently been shown to be enhanced by its substrate, activated Akt, via modulation of a phosphodegron recognized by the E3 ligase beta-TrCP1, thus providing a negative feedback loop to tightly control cellular Akt output. Here we show that this feedback loop is lost in aggressive glioblastoma but not less aggressive astrocytoma. Overexpression and pharmacological studies reveal that loss of the feedback loop does not result from a defect in PHLPP1 protein or in the upstream kinases that control its phosphodegron. Rather, the defect arises from altered localization of beta-TrCP1; in astrocytoma cell lines and in normal brain tissue the E3 ligase is predominantly cytoplasmic, whereas in glioblastoma cell lines and patient-derived tumor neurospheres, the E3 ligase is confined to the nucleus and thus spatially separated from PHLPP1, which is cytoplasmic. Restoring the localization of beta-TrCP1 to the cytosol of glioblastoma cells rescues the ability of Akt to regulate PHLPP1 stability. Additionally, we show that the degradation of another beta-TrCP1 substrate, beta-catenin, is impaired and accumulates in the cytosol of glioblastoma cell lines. Our findings reveal that the cellular localization of beta-TrCP1 is altered in glioblastoma, resulting in dysregulation of PHLPP1 and other substrates such as beta-catenin.	[Warfel, Noel A.; Niederst, Matt; Stevens, Michael W.; Newton, Alexandra C.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Warfel, Noel A.; Niederst, Matt] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Brennan, Paul M.; Frame, Margaret C.] Univ Edinburgh, Edinburgh Canc Res Ctr, Western Gen Hosp, Edinburgh EH4 2XR, Midlothian, Scotland	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Edinburgh	Newton, AC (corresponding author), 9500 Gilman Dr,MC 0721, La Jolla, CA 92093 USA.	anewton@ucsd.edu		Warfel, Noel/0000-0001-6410-9011; Brennan, Paul/0000-0002-7347-830X	National Institutes of Health [GM067946]; Department of Defense; University of California; Molecular Pharmacology through NIGMS, National Institutes of Health Institutional [T32 GM007752]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067946, T32GM007752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005131] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); University of California(University of California System); Molecular Pharmacology through NIGMS, National Institutes of Health Institutional(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant GM067946 (to A. C. N.). This work was also supported by Department of Defense Breast Cancer Research Program Award BC093021 (to N. W.).; Supported in part by the University of California at San Diego Graduate Training Program in Cellular and Molecular Pharmacology through NIGMS, National Institutes of Health Institutional Training Grant T32 GM007752.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Al-Mayhani TMF, 2009, J NEUROSCI METH, V176, P192, DOI 10.1016/j.jneumeth.2008.07.022; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Bredel M, 2005, CANCER RES, V65, P4088, DOI 10.1158/0008-5472.CAN-04-4229; Brognard J, 2008, TRENDS ENDOCRIN MET, V19, P223, DOI 10.1016/j.tem.2008.04.001; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Calleja V, 2007, PLOS BIOL, V5, P780, DOI 10.1371/journal.pbio.0050095; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Davis M, 2002, GENE DEV, V16, P439, DOI 10.1101/gad.218702; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Fuchs SY, 2004, ONCOGENE, V23, P2028, DOI 10.1038/sj.onc.1207389; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Gao T, 2008, J BIOL CHEM, V283, P6300, DOI 10.1074/jbc.M707319200; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Gaspar C, 2008, AM J PATHOL, V172, P1363, DOI 10.2353/ajpath.2008.070851; Gilbertson RJ, 2004, LANCET ONCOL, V5, P209, DOI 10.1016/S1470-2045(04)01424-X; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hao Y, 2006, GASTROENTEROLOGY, V131, P925, DOI 10.1053/j.gastro.2006.04.026; Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; Hasselblatt P, 2008, ONCOGENE, V27, P6102, DOI 10.1038/onc.2008.211; Inda MD, 2010, GENE DEV, V24, P1731, DOI 10.1101/gad.1890510; Joazeiro CAP, 2000, SCIENCE, V289, P2061, DOI 10.1126/science.289.5487.2061; Kaiser S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r131; Karin M, 1999, J BIOL CHEM, V274, P27339, DOI 10.1074/jbc.274.39.27339; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Lassot I, 2001, MOL CELL BIOL, V21, P2192, DOI 10.1128/MCB.21.6.2192-2202.2001; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li X, 2009, MOL CELL BIOL, V29, P6192, DOI 10.1128/MCB.00681-09; LIU C, 2010, CLIN EXP ME IN PRESS; Liu J, 2009, ONCOGENE, V28, P994, DOI 10.1038/onc.2008.450; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Mantovani F, 2003, J BIOL CHEM, V278, P42477, DOI 10.1074/jbc.M302799200; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; Ohta T, 2001, CANCER RES, V61, P1347; Ougolkov A, 2004, JNCI-J NATL CANCER I, V96, P1161, DOI 10.1093/jnci/djh219; Ouillette P, 2008, CANCER RES, V68, P1012, DOI 10.1158/0008-5472.CAN-07-3105; Park WS, 1999, CANCER RES, V59, P4257; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; POWELL SM, 1992, NATURE, V359, P235, DOI 10.1038/359235a0; Pu P, 2009, CANCER GENE THER, V16, P351, DOI 10.1038/cgt.2008.78; Qiao M, 2010, MOL CELL, V38, P512, DOI 10.1016/j.molcel.2010.03.017; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Sabates-Beliver J, 2007, MOL CANCER RES, V5, P1263, DOI 10.1158/1541-7786.MCR-07-0267; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Seo E, 2009, CELL SIGNAL, V21, P43, DOI 10.1016/j.cellsig.2008.09.009; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Talantov D, 2005, CLIN CANCER RES, V11, P7234, DOI 10.1158/1078-0432.CCR-05-0683; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Uematsu K, 2003, ONCOGENE, V22, P7218, DOI 10.1038/sj.onc.1206817; Utsuki S, 2002, J NEURO-ONCOL, V57, P187, DOI 10.1023/A:1015720220602; Vogt PK, 2007, TRENDS BIOCHEM SCI, V32, P342, DOI 10.1016/j.tibs.2007.05.005; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Yano H, 2000, NEUROL RES, V22, P650; Yaron A, 1998, NATURE, V396, P590, DOI 10.1038/25159; Yokota N, 2002, INT J CANCER, V101, P198, DOI 10.1002/ijc.10559	61	36	38	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19777	19788		10.1074/jbc.M111.237081	http://dx.doi.org/10.1074/jbc.M111.237081			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21454620	Green Published, hybrid			2022-12-25	WOS:000291027700060
J	Furukawa, Y; Kaneko, K; Watanabe, S; Yamanaka, K; Nukina, N				Furukawa, Yoshiaki; Kaneko, Kumi; Watanabe, Shoji; Yamanaka, Koji; Nukina, Nobuyuki			A Seeding Reaction Recapitulates Intracellular Formation of Sarkosyl-insoluble Transactivation Response Element (TAR) DNA-binding Protein-43 Inclusions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; C-TERMINAL FRAGMENTS; NEURODEGENERATIVE DISEASES; NEURONAL INCLUSIONS; AMYLOID FORMATION; TDP-43; MUTATIONS; AGGREGATION; PROGRANULIN	The transactivation response element (TAR) DNA-binding protein-43 (TDP-43) is a nuclear protein that normally regulates transcription and splicing. Abnormal accumulation of insoluble inclusions containing TDP-43 has been recently reported in the affected tissues of amyotrophic lateral sclerosis (ALS) patients. Here, we show that intracellular aggregation of TDP-43 can be triggered by transduction of fibrillar aggregates prepared from in vitro functional TDP-43. Sarkosyl is found to be incapable of solubilizing those intracellularly seeded aggregates of TDP-43, which is consistent with the observation that TDP-43 inclusions in ALS patients are sarkosyl-insoluble. In addition, intracellular seeding in our cell models reproduces ubiquitination of TDP-43 aggregates, which is another prominent feature of TDP-43 inclusions in ALS patients. Although it has been so far difficult to initiate disease-associated changes of TDP-43 using cultured cell models, we propose that a seeding reaction is a key to construct a model to monitor TDP-43 pathologies.	[Furukawa, Yoshiaki; Kaneko, Kumi; Nukina, Nobuyuki] RIKEN Brain Sci Inst, Lab Struct Neuropathol, Wako, Saitama 3510198, Japan; [Watanabe, Shoji; Yamanaka, Koji] RIKEN Brain Sci Inst, Lab Motor Neuron Dis, Wako, Saitama 3510198, Japan; [Furukawa, Yoshiaki] Keio Univ, Dept Chem, Kanagawa 2238522, Japan	RIKEN; RIKEN; Keio University	Furukawa, Y (corresponding author), 3-14-1 Hiyoshi, Kanagawa 2238522, Japan.	furukawa@chem.keio.ac.jp; nukina@brain.riken.jp	Nukina, Nobuyuki/GPP-6265-2022; Furukawa, Yoshiaki/F-2871-2014; Yamanaka, Koji/ABD-1034-2020; Yamanaka, Koji/H-5806-2011	Furukawa, Yoshiaki/0000-0002-1918-372X; Yamanaka, Koji/0000-0003-4655-0035; Yamanaka, Koji/0000-0003-4655-0035	Ministry of Education, Culture, Sports, Science and Technology of Japan [22240037, 22110004, 22770162, 21390274]; Core Research for Evolutional Science and Technology of Japan Science and Technology Agency; Japanese Health and Labor Sciences Research Grant; Strategic Research Program for Brain Science; Naito Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Core Research for Evolutional Science and Technology of Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Japanese Health and Labor Sciences Research Grant; Strategic Research Program for Brain Science; Naito Foundation(Naito Memorial Foundation)	This work was supported by Grants-in-Aid 22240037 (to N. N.), 22110004 for Scientific Research on Innovative Areas (to N. N.), 22770162 (to Y. F.), and 21390274 (to K. Y.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, a grant from Core Research for Evolutional Science and Technology of Japan Science and Technology Agency (to K. Y.) a Japanese Health and Labor Sciences Research Grant (to K. Y.), a Strategic Research Program for Brain Science (to N. N.), and a grant from the Naito Foundation (to Y. F.).	Aguzzi A, 2010, NAT REV DRUG DISCOV, V9, P237, DOI 10.1038/nrd3050; Aguzzi A, 2009, NEURON, V64, P783, DOI 10.1016/j.neuron.2009.12.016; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Brundin P, 2010, NAT REV MOL CELL BIO, V11, P301, DOI 10.1038/nrm2873; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Dormann D, 2009, J NEUROCHEM, V110, P1082, DOI 10.1111/j.1471-4159.2009.06211.x; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Furukawa Y, 2010, J BIOL CHEM, V285, P22221, DOI 10.1074/jbc.M110.113597; Gitcho MA, 2008, ANN NEUROL, V63, P535, DOI 10.1002/ana.21344; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Hasegawa M, 2008, ANN NEUROL, V64, P60, DOI 10.1002/ana.21425; Igaz LM, 2008, AM J PATHOL, V173, P182, DOI 10.2353/ajpath.2008.080003; Igaz LM, 2011, J CLIN INVEST, V121, P726, DOI 10.1172/JCI44867; Igaz LM, 2009, J BIOL CHEM, V284, P8516, DOI 10.1074/jbc.M809462200; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kerman A, 2010, ACTA NEUROPATHOL, V119, P335, DOI 10.1007/s00401-010-0646-5; Kuo PH, 2009, NUCLEIC ACIDS RES, V37, P1799, DOI 10.1093/nar/gkp013; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Lin WL, 2008, ACTA NEUROPATHOL, V116, P205, DOI 10.1007/s00401-008-0408-9; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nonaka T, 2009, HUM MOL GENET, V18, P3353, DOI 10.1093/hmg/ddp275; Nonaka T, 2009, FEBS LETT, V583, P394, DOI 10.1016/j.febslet.2008.12.031; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Van Deerlin VM, 2008, LANCET NEUROL, V7, P409, DOI 10.1016/S1474-4422(08)70071-1; Wegorzewska I, 2009, P NATL ACAD SCI USA, V106, P18809, DOI 10.1073/pnas.0908767106; Wils H, 2010, P NATL ACAD SCI USA, V107, P3858, DOI 10.1073/pnas.0912417107; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506; WONG I, 1993, P NATL ACAD SCI USA, V90, P5428, DOI 10.1073/pnas.90.12.5428; Zhang YJ, 2007, J NEUROSCI, V27, P10530, DOI 10.1523/JNEUROSCI.3421-07.2007; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106	36	179	184	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18664	18672		10.1074/jbc.M111.231209	http://dx.doi.org/10.1074/jbc.M111.231209			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21454603	Green Published, hybrid			2022-12-25	WOS:000290785700039
J	Luderer, HF; Gori, F; Demay, MB				Luderer, Hilary F.; Gori, Francesca; Demay, Marie B.			Lymphoid Enhancer-binding Factor-1 (LEF1) Interacts with the DNA-binding Domain of the Vitamin D Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAIR FOLLICLE MORPHOGENESIS; STEM-CELL DIFFERENTIATION; 2 DISTINCT COACTIVATORS; BETA-CATENIN; KERATINOCYTE DIFFERENTIATION; SONIC HEDGEHOG; KNOCKOUT MICE; ANIMAL-MODEL; D-DEFICIENCY; GENE	Ligand-independent actions of the vitamin D receptor (VDR) are required for normal post-morphogenic hair cycles; however, the molecular mechanisms by which the VDR exerts these actions are not clear. Previous studies demonstrated impaired regulation of the canonical Wnt signaling pathway in primary keratinocytes lacking the VDR. To identify the key effector of canonical Wnt signaling that interacts with the VDR, GST pull-down studies were performed. A novel interaction between the VDR and LEF1 (lymphoid enhancer-binding factor-1) that is independent of beta-catenin was identified. This interaction is dependent upon sequences within the N-terminal region of the VDR, a domain required for VDR-DNA interactions and normal hair cycling in mice. Mutation of specific residues within the N-terminal region of the VDR not only abrogated interactions between the VDR and LEF1 but also impaired the ability of the VDR to enhance Wnt signaling in vdr(-/-) primary keratinocytes. Thus, this study demonstrates a novel interaction between the VDR and LEF1 that is mediated by the DNA-binding domain of the VDR and that is required for normal canonical Wnt signaling in keratinocytes.	[Demay, Marie B.] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Demay, MB (corresponding author), Massachusetts Gen Hosp, Endocrine Unit, Thier 1101,50 Blossom St, Boston, MA 02114 USA.	demay@helix.mgh.harvard.edu	Gori, Francesca/S-9422-2019		National Institutes of Health from NIAMS [F32 AR056933-01A1, T32 DK007028]; National Institutes of Health from NIDDK [DK 46974]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR056933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007028, R01DK046974] Funding Source: NIH RePORTER	National Institutes of Health from NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institutes of Health from NIDDK; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants F32 AR056933-01A1 and T32 DK007028 from NIAMS and DK 46974 from NIDDK.	Ahmad W, 1998, SCIENCE, V279, P720, DOI 10.1126/science.279.5351.720; Amir AL, 2003, J BIOL CHEM, V278, P30828, DOI 10.1074/jbc.M301208200; Beaudoin GMJ, 2005, P NATL ACAD SCI USA, V102, P14653, DOI 10.1073/pnas.0507609102; Beildeck ME, 2010, EXP CELL RES, V316, P1763, DOI 10.1016/j.yexcr.2010.02.001; Bikle D, 2007, J STEROID BIOCHEM, V103, P396, DOI 10.1016/j.jsbmb.2006.12.063; Bikle DD, 2010, J STEROID BIOCHEM, V121, P308, DOI 10.1016/j.jsbmb.2010.03.027; Cianferotti L, 2007, P NATL ACAD SCI USA, V104, P9428, DOI 10.1073/pnas.0702884104; Cui CY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010009; Dardenne O, 2001, ENDOCRINOLOGY, V142, P3135, DOI 10.1210/en.142.7.3135; DEMAY MB, 1992, MOL ENDOCRINOL, V6, P557, DOI 10.1210/me.6.4.557; El-Tanani M, 2001, J BIOL CHEM, V276, P41675, DOI 10.1074/jbc.M103966200; Erben RG, 2002, MOL ENDOCRINOL, V16, P1524, DOI 10.1210/me.16.7.1524; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; GLORIEUX FH, 1995, J CLIN ENDOCR METAB, V80, P2255, DOI 10.1210/jc.80.7.2255; Haussler MR, 2010, J STEROID BIOCHEM, V121, P88, DOI 10.1016/j.jsbmb.2010.03.019; Hsieh JC, 2003, J BIOL CHEM, V278, P38665, DOI 10.1074/jbc.M304886200; Hsieh JC, 1999, BIOCHEMISTRY-US, V38, P16347, DOI 10.1021/bi9916574; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; HUGHES MR, 1988, SCIENCE, V242, P1702, DOI 10.1126/science.2849209; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Li M, 2001, DEVELOPMENT, V128, P675; Li YC, 1997, P NATL ACAD SCI USA, V94, P9831, DOI 10.1073/pnas.94.18.9831; Li YC, 1998, ENDOCRINOLOGY, V139, P4391, DOI 10.1210/en.139.10.4391; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malloy PJ, 1999, ENDOCR REV, V20, P156, DOI 10.1210/er.20.2.156; Merrill BJ, 2001, GENE DEV, V15, P1688, DOI 10.1101/gad.891401; Moras D, 1998, CURR OPIN CELL BIOL, V10, P384, DOI 10.1016/S0955-0674(98)80015-X; Niemann C, 2002, DEVELOPMENT, V129, P95; Nothen MM, 1998, AM J HUM GENET, V62, P386, DOI 10.1086/301717; Oda Y, 2004, J STEROID BIOCHEM, V89-90, P273, DOI 10.1016/j.jsbmb.2004.03.106; Oda Y, 2003, MOL ENDOCRINOL, V17, P2329, DOI 10.1210/me.2003-0063; Oda Y, 2007, J STEROID BIOCHEM, V103, P776, DOI 10.1016/j.jsbmb.2006.12.069; Palmer HG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001483; Palmer HG, 2001, J CELL BIOL, V154, P369, DOI 10.1083/jcb.200102028; Sakai Y, 2001, J CLIN INVEST, V107, P961, DOI 10.1172/JCI11676; Sato N, 1999, J CLIN INVEST, V104, P855, DOI 10.1172/JCI7691; Shah S, 2006, MOL CELL, V21, P799, DOI 10.1016/j.molcel.2006.01.037; Skorija K, 2005, MOL ENDOCRINOL, V19, P855, DOI 10.1210/me.2004-0415; Sprecher E, 1998, AM J MED GENET, V80, P546, DOI 10.1002/(SICI)1096-8628(19981228)80:5<546::AID-AJMG28>3.0.CO;2-I; St-Jacques B, 1998, CURR BIOL, V8, P1058, DOI 10.1016/S0960-9822(98)70443-9; Suzuki K, 2009, DEVELOPMENT, V136, P367, DOI 10.1242/dev.021295; Teichert A, 2010, J CELL PHYSIOL, V225, P482, DOI 10.1002/jcp.22227; Thompson CC, 2006, CELL CYCLE, V5, P1913, DOI 10.4161/cc.5.17.3189; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; Wang LC, 2000, J INVEST DERMATOL, V114, P901, DOI 10.1046/j.1523-1747.2000.00951.x; Zarach JM, 2004, DEVELOPMENT, V131, P4189, DOI 10.1242/dev.01303	46	28	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18444	18451		10.1074/jbc.M110.188219	http://dx.doi.org/10.1074/jbc.M110.188219			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21471213	Green Published, hybrid			2022-12-25	WOS:000290785700017
J	Cheng, H; Mohammed, F; Nam, G; Chen, Y; Qi, JX; Garner, LI; Allen, RL; Yan, JH; Willcox, BE; Gao, GF				Cheng, Hao; Mohammed, Fiyaz; Nam, Gol; Chen, Yong; Qi, Jianxun; Garner, Lee I.; Allen, Rachel L.; Yan, Jinghua; Willcox, Benjamin E.; Gao, George F.			Crystal Structure of Leukocyte Ig-like Receptor LILRB4 (ILT3/LIR-5/CD85k) A MYELOID INHIBITORY RECEPTOR INVOLVED IN IMMUNE TOLERANCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY T-CELLS; DENDRITIC CELLS; ACTIVATING RECEPTOR; SUPPRESSOR-CELLS; ILT3; COMPLEX; MOLECULES; LIR-1; RESPONSES; FAMILY	The myeloid inhibitory receptor LILRB4 (also called ILT3, LIR-5, CD85k), a member of the leukocyte immunoglobulin-like receptors (LILRs/LIRs), is an important mediator of immune tolerance. Up-regulated on tolerogenic dendritic cells, it has been shown to modulate immune responses via induction of T cell anergy and differentiation of CD8(+) T suppressor cells and may play a role in establishing immune tolerance in cancer. Consequently, characterizing the molecular mechanisms involved in LILRB4 function and in particular its structure and ligands is a key aim but has remained elusive to date. Here we describe the production, crystallization, and structure of the LILRB4 ectodomain to 1.7 angstrom using an expression strategy involving engineering of an additional disulfide bond in the D2 domain to enhance protein stability. LILRB4 comprises two immunoglobulin domains similar in structure to other LILRs; however, the D2 domain, which is most closely related to the D4 domains of other family members, contains 3(10) helices not previously observed. At the D1-D2 interface, reduced interdomain contacts resulted in an obtuse interdomain angle of similar to 107 degrees. Comparison with MHC class I binding Group 1 LILRs suggests LILRB4 is both conformationally and electrostatically unsuited to MHC ligation, consistent with LILRB4 status as a Group 2 LILR likely to bind novel non-MHC class I ligands. Finally, examination of the LILRB4 surface highlighted distinctive surface patches on the D1 domain and D1D2 hinge region, which may be involved in ligand binding. These findings will facilitate our attempts to precisely define the role of LILRB4 in the regulation of immune tolerance.	[Yan, Jinghua; Gao, George F.] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China; [Cheng, Hao; Nam, Gol; Chen, Yong; Gao, George F.] Chinese Acad Sci, Grad Univ, Beijing 100149, Peoples R China; [Mohammed, Fiyaz; Garner, Lee I.; Willcox, Benjamin E.] Univ Birmingham, Sch Canc Sci, Birmingham CRUK Canc Ctr, Birmingham B15 2TT, W Midlands, England; [Allen, Rachel L.] Univ London, Div Cellular & Mol Med, Ctr Infect, London, England; [Qi, Jianxun; Gao, George F.] Chinese Acad Sci, Beijing Inst Life Sci, Res Network Immun & Hlth, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Birmingham; University of London; Chinese Academy of Sciences	Gao, GF (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China.	gaof@im.ac.cn	Gao, George Fu/ABD-5229-2021; Qi, Jianxun/ABF-1646-2021	Allen, Rachel/0000-0001-9834-8475	Ministry of Science and Technology of China (MOST) [2010CB911902]; National Natural Science Foundation of China [31030030]; Biotechnology and Biological Sciences Research Council [BB/E009417/1]; National Natural Science Foundation of China Innovative Research Group [81021003]; BBSRC [BB/E009417/1] Funding Source: UKRI	Ministry of Science and Technology of China (MOST)(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Natural Science Foundation of China Innovative Research Group; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work is supported by grants from Ministry of Science and Technology of China (MOST, 973 Project 2010CB911902) and National Natural Science Foundation of China Grant 31030030.; The laboratory work of B. E. W. is supported by Biotechnology and Biological Sciences Research Council project grant funding (Grant BB/E009417/1).; A leading principal investigator of the National Natural Science Foundation of China Innovative Research Group (Grant 81021003). To whom correspondence should be addressed: CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China. Tel.: 86-10-64807688; Fax: 86-1064807882; E-mail: gaof@im.ac.cn.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Belkaid Y, 2008, IMMUNITY, V29, P362, DOI 10.1016/j.immuni.2008.08.005; Bellon T, 2002, J IMMUNOL, V168, P3351, DOI 10.4049/jimmunol.168.7.3351; Borges L, 2003, BLOOD, V101, P1484, DOI 10.1182/blood-2002-05-1432; Borges L, 1997, J IMMUNOL, V159, P5192; Cao W, 2006, J EXP MED, V203, P1399, DOI 10.1084/jem.20052454; Cao W, 2009, J EXP MED, V206, P1603, DOI 10.1084/jem.20090547; Cella M, 1997, J EXP MED, V185, P1743, DOI 10.1084/jem.185.10.1743; Chang CC, 2002, NAT IMMUNOL, V3, P237, DOI 10.1038/ni760; Chapman TL, 1999, IMMUNITY, V11, P603, DOI 10.1016/S1074-7613(00)80135-1; Chapman TL, 2000, IMMUNITY, V13, P727, DOI 10.1016/S1074-7613(00)00071-6; Chen Y, 2007, PROTEIN EXPRES PURIF, V56, P253, DOI 10.1016/j.pep.2007.08.010; Chen Y, 2010, PROTEIN CELL, V1, P153, DOI 10.1007/s13238-010-0022-1; Chen Y, 2009, J MOL BIOL, V386, P841, DOI 10.1016/j.jmb.2009.01.006; Colonna M, 2000, SEMIN IMMUNOL, V12, P121, DOI 10.1006/smim.2000.0214; Colonna M, 1997, J EXP MED, V186, P1809, DOI 10.1084/jem.186.11.1809; Cosman D, 1997, IMMUNITY, V7, P273, DOI 10.1016/S1074-7613(00)80529-4; Dietrich J, 2000, MICROBES INFECT, V2, P323, DOI 10.1016/S1286-4579(00)00294-X; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fanger NA, 1998, EUR J IMMUNOL, V28, P3423, DOI 10.1002/(SICI)1521-4141(199811)28:11<3423::AID-IMMU3423>3.0.CO;2-2; Fenn TD, 2003, J APPL CRYSTALLOGR, V36, P944, DOI 10.1107/S0021889803006721; Filaci G, 2004, HUM IMMUNOL, V65, P142, DOI 10.1016/j.humimm.2003.12.001; Foster CE, 2003, J BIOL CHEM, V278, P46081, DOI 10.1074/jbc.M308491200; Gao GF, 1997, NATURE, V387, P630, DOI 10.1038/42523; Garner LI, 2006, PROTEIN EXPRES PURIF, V47, P490, DOI 10.1016/j.pep.2005.11.020; Gleissner CA, 2007, EUR J IMMUNOL, V37, P177, DOI 10.1002/eji.200636498; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kim-Schulze S, 2006, J IMMUNOL, V176, P2790, DOI 10.4049/jimmunol.176.5.2790; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Liu WR, 2000, IMMUNOGENETICS, V51, P659, DOI 10.1007/s002510000183; Liu Z, 1998, INT IMMUNOL, V10, P775, DOI 10.1093/intimm/10.6.775; Manavalan JS, 2004, INT IMMUNOL, V16, P1055, DOI 10.1093/intimm/dxh107; Manavalan JS, 2003, TRANSPL IMMUNOL, V11, P245, DOI 10.1016/S0966-3274(03)00058-3; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morel E, 2008, J IMMUNOL, V181, P2368, DOI 10.4049/jimmunol.181.4.2368; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakajima H, 1999, J IMMUNOL, V162, P5; Nemazee D, 2006, NAT REV IMMUNOL, V6, P728, DOI 10.1038/nri1939; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Porollo A, 2007, PROTEINS, V66, P630, DOI 10.1002/prot.21248; Prod'homme V, 2007, J IMMUNOL, V178, P4473, DOI 10.4049/jimmunol.178.7.4473; Prud'homme GJ, 2004, J LEUKOCYTE BIOL, V75, P586, DOI 10.1189/jlb.0803394; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Samaridis J, 1997, EUR J IMMUNOL, V27, P660, DOI 10.1002/eji.1830270313; Saulquin X, 2003, J EXP MED, V197, P933, DOI 10.1084/jem.20021624; Saverino D, 2000, J IMMUNOL, V165, P3742, DOI 10.4049/jimmunol.165.7.3742; Sayos J, 2004, BIOCHEM BIOPH RES CO, V324, P640, DOI 10.1016/j.bbrc.2004.09.097; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shiroishi M, 2006, P NATL ACAD SCI USA, V103, P16412, DOI 10.1073/pnas.0605228103; Shiroishi M, 2006, J BIOL CHEM, V281, P19536, DOI 10.1074/jbc.M603076200; Snyder GA, 1999, P NATL ACAD SCI USA, V96, P3864, DOI 10.1073/pnas.96.7.3864; Suciu-Foca N, 2005, INT IMMUNOPHARMACOL, V5, P7, DOI 10.1016/j.intimp.2004.09.003; Suciu-Foca N, 2007, CELL IMMUNOL, V248, P59, DOI 10.1016/j.cellimm.2007.01.013; Suciu-Foca N, 2007, J IMMUNOL, V178, P7432, DOI 10.4049/jimmunol.178.11.7432; Svajger U, 2008, INT IMMUNOPHARMACOL, V8, P997, DOI 10.1016/j.intimp.2008.03.006; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Vlad G, 2008, HUM IMMUNOL, V69, P681, DOI 10.1016/j.humimm.2008.08.286; Volz A, 2001, IMMUNOL REV, V181, P39, DOI 10.1034/j.1600-065X.2001.1810103.x; Willcox BE, 1999, PROTEIN SCI, V8, P2418; Willcox BE, 2003, NAT IMMUNOL, V4, P913, DOI 10.1038/ni961; Willcox Benjamin E, 2002, BMC Struct Biol, V2, P6, DOI 10.1186/1472-6807-2-6; Young NT, 2001, IMMUNOGENETICS, V53, P270, DOI 10.1007/s002510100332	66	29	35	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					18013	18025		10.1074/jbc.M111.221028	http://dx.doi.org/10.1074/jbc.M111.221028			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454581	Green Published, hybrid			2022-12-25	WOS:000290585200063
J	Lacroix, J; Halaszovich, CR; Schreiber, DN; Leitner, MG; Bezanilla, F; Oliver, D; Villalba-Galea, CA				Lacroix, Jerome; Halaszovich, Christian R.; Schreiber, Daniela N.; Leitner, Michael G.; Bezanilla, Francisco; Oliver, Dominik; Villalba-Galea, Carlos A.			Controlling the Activity of a Phosphatase and Tensin Homolog (PTEN) by Membrane Potential	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PTEN; CI-VSP; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; PLASMA-MEMBRANE; XENOPUS-OOCYTES; VOLTAGE SENSOR; LIVING CELLS; CHANNEL; PROTEIN; PIP2	The recently discovered voltage-sensitive phosphatases (VSPs) hydrolyze phosphoinositides upon depolarization of the membrane potential, thus representing a novel principle for the transduction of electrical activity into biochemical signals. Here, we demonstrate the possibility to confer voltage sensitivity to cytosolic enzymes. By fusing the tumor suppressor PTEN to the voltage sensor of the prototypic VSP from Ciona intestinalis, Ci-VSP, we generated chimeric proteins that are voltage-sensitive and display PTEN-like enzymatic activity in a strictly depolarization-dependent manner in vivo. Functional coupling of the exogenous enzymatic activity to the voltage sensor is mediated by a phospholipid-binding motif at the interface between voltage sensor and catalytic domains. Our findings reveal that the main domains of VSPs and related phosphoinositide phosphatases are intrinsically modular and define structural requirements for coupling of enzymatic activity to a voltage sensor domain. A key feature of this prototype of novel engineered voltage-sensitive enzymes, termed Ci-VSPTEN, is the novel ability to switch enzymatic activity of PTEN rapidly and reversibly. We demonstrate that experimental control of Ci-VSPTEN can be obtained either by electrophysiological techniques or more general techniques, using potassium-induced depolarization of intact cells. Thus, Ci-VSPTEN provides a novel approach for studying the complex mechanism of activation, cellular control, and pharmacology of this important tumor suppressor. Moreover, by inducing temporally precise perturbation of phosphoinositide concentrations, Ci-VSPTEN will be useful for probing the role and specificity of these messengers in many cellular processes and to analyze the timing of phosphoinositide signaling.	[Halaszovich, Christian R.; Schreiber, Daniela N.; Leitner, Michael G.; Oliver, Dominik] Univ Marburg, Inst Physiol & Pathophysiol, D-35037 Marburg, Germany; [Lacroix, Jerome; Bezanilla, Francisco] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Villalba-Galea, Carlos A.] Virginia Commonwealth Univ, Dept Physiol & Biophys, Richmond, VA 23298 USA	Philipps University Marburg; University of Chicago; Virginia Commonwealth University	Oliver, D (corresponding author), Univ Marburg, Inst Physiol & Pathophysiol, Deutschhausstr 1-2, D-35037 Marburg, Germany.	oliverd@staff.uni-marburg.de; cavillalbaga@vcu.edu	Halaszovich, Christian/I-7231-2012; Leitner, Michael G./D-7887-2014; Leitner, Michael/N-8793-2019; Oliver, Dominik/F-5845-2013	Leitner, Michael G./0000-0002-3259-6481; Leitner, Michael/0000-0002-3259-6481; Oliver, Dominik/0000-0002-8368-0923; Villalba-Galea, Carlos A./0000-0002-6489-4651	National Institutes of Health [GM030376]; Deutsche Forschungsgemeinschaft [SFB593 TPA12]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030376, R01GM030376] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM030376 (to F. B.). This work was also supported by Deutsche Forschungsgemeinschaft Grant SFB593 TPA12 (to D. O.).	Balla A, 2005, MOL BIOL CELL, V16, P1282, DOI 10.1091/mbc.E04-07-0578; Campbell RB, 2003, J BIOL CHEM, V278, P33617, DOI 10.1074/jbc.C300296200; Cha A, 1998, METHOD ENZYMOL, V296, P566; Chen XD, 2006, P NATL ACAD SCI USA, V103, P3422, DOI 10.1073/pnas.0507710103; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; Das S, 2003, P NATL ACAD SCI USA, V100, P7491, DOI 10.1073/pnas.0932835100; Denning G, 2007, ONCOGENE, V26, P3930, DOI 10.1038/sj.onc.1210175; Falkenburger BH, 2010, J GEN PHYSIOL, V135, P99, DOI 10.1085/jgp.200910345; Finkbeiner S, 1998, J NEUROBIOL, V37, P171, DOI 10.1002/(SICI)1097-4695(199810)37:1<171::AID-NEU13>3.0.CO;2-H; Halaszovich CR, 2009, J BIOL CHEM, V284, P2106, DOI 10.1074/jbc.M803543200; Haucke V, 2005, BIOCHEM SOC T, V33, P1285, DOI 10.1042/BST0331285; Hossain MI, 2008, J BIOL CHEM, V283, P18248, DOI 10.1074/jbc.M706184200; Iwasaki H, 2008, P NATL ACAD SCI USA, V105, P7970, DOI 10.1073/pnas.0803936105; Kimber WA, 2002, BIOCHEM J, V361, P525, DOI 10.1042/0264-6021:3610525; Kingsbury TJ, 2007, J NEUROCHEM, V103, P761, DOI 10.1111/j.1471-4159.2007.04801.x; Kohout SC, 2008, NAT STRUCT MOL BIOL, V15, P106, DOI 10.1038/nsmb1320; Kohout SC, 2010, NAT CHEM BIOL, V6, P369, DOI 10.1038/nchembio.349; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Lee SR, 2002, J BIOL CHEM, V277, P20336, DOI 10.1074/jbc.M111899200; Leslie NR, 2008, ONCOGENE, V27, P5464, DOI 10.1038/onc.2008.243; Leslie NR, 2002, CELL SIGNAL, V14, P285, DOI 10.1016/S0898-6568(01)00234-0; Liu Y, 2010, PROG LIPID RES, V49, P201, DOI 10.1016/j.plipres.2009.12.001; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Milosevic I, 2005, J NEUROSCI, V25, P2557, DOI 10.1523/JNEUROSCI.3761-04.2005; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; Murata Y, 2007, J PHYSIOL-LONDON, V583, P875, DOI 10.1113/jphysiol.2007.134775; Ooms LM, 2009, BIOCHEM J, V419, P29, DOI 10.1042/BJ20081673; Pagliarini DJ, 2004, J BIOL CHEM, V279, P38590, DOI 10.1074/jbc.M404959200; Rahdar M, 2009, P NATL ACAD SCI USA, V106, P480, DOI 10.1073/pnas.0811212106; Redfern RE, 2008, BIOCHEMISTRY-US, V47, P2162, DOI 10.1021/bi702114w; Schaechinger TJ, 2007, P NATL ACAD SCI USA, V104, P7693, DOI 10.1073/pnas.0608583104; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Stefani E, 1998, METHOD ENZYMOL, V293, P300; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Suh BC, 2006, SCIENCE, V314, P1454, DOI 10.1126/science.1131163; Tapparel C, 2003, GENE, V323, P189, DOI 10.1016/j.gene.2003.09.038; Van der Kaay J, 1999, J BIOL CHEM, V274, P35963, DOI 10.1074/jbc.274.50.35963; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; Vazquez F, 2006, P NATL ACAD SCI USA, V103, P3633, DOI 10.1073/pnas.0510570103; Villalba-Galea CA, 2008, P NATL ACAD SCI USA, V105, P17600, DOI 10.1073/pnas.0807387105; Villalba-Galea CA, 2009, J GEN PHYSIOL, V134, P5, DOI 10.1085/jgp.200910215; Walker SM, 2004, BIOCHEM J, V379, P301, DOI 10.1042/BJ20031839; Walker SM, 2001, BIOCHEM J, V360, P277, DOI 10.1042/0264-6021:3600277; Wang YJ, 2004, J CELL BIOL, V167, P1005, DOI 10.1083/jcb.200408008; Wheeler DG, 2008, J CELL BIOL, V183, P849, DOI 10.1083/jcb.200805048; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335	48	35	37	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17945	17953		10.1074/jbc.M110.201749	http://dx.doi.org/10.1074/jbc.M110.201749			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454672	Green Published, hybrid			2022-12-25	WOS:000290585200057
J	Lin, MH; Yang, YL; Chen, YP; Hua, KF; Lu, CP; Sheu, F; Lin, GH; Tsay, SS; Liang, SM; Wu, SH				Lin, Miao-Hsia; Yang, Yu-Liang; Chen, Yen-Po; Hua, Kuo-Feng; Lu, Chun-Ping; Sheu, Fuu; Lin, Guang-Huey; Tsay, San-San; Liang, Shu-Mei; Wu, Shih-Hsiung			A Novel Exopolysaccharide from the Biofilm of Thermus aquaticus YT-1 Induces the Immune Response through Toll-like Receptor 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTREME THERMOPHILE; CYTOKINE PRODUCTION; IN-VIVO; PATHOGEN RECOGNITION; DENDRITIC CELLS; INNATE IMMUNITY; POLYSACCHARIDES; IDENTIFICATION; MACROPHAGES; INDUCTION	Bacterial polysaccharides are known to induce the immune response in macrophages. Here we isolated a novel extracellular polysaccharide from the biofilm of Thermus aquaticus YT-1 and evaluated its structure and immunomodulatory effects. The size of this polysaccharide, TA-1, was deduced by size-exclusion chromatography as 500 kDa. GC-MS, high performance anion-exchange chromatography with pulsed amperometric detection, electrospray ionization-MS/MS, and NMR revealed the novel structure of TA-1. The polysaccharide is composed of tetrasaccharide-repeating units of galactofuranose, galactopyranose, and N-acetylgalactosamine (1: 1: 2) and lacked acidic sugars. TA-1 stimulated macrophage cells to produce the cytokines TNF-alpha and IL-6. Screening of Toll-like receptors and antibody-blocking experiments indicated that the natural receptor of TA-1 in its immunoactivity is TLR2. Recognition of TA-1 by TLR2 was confirmed by TA-1 induction of IL-6 production in peritoneal macrophages from wild-type mice but not from TLR2 (-/-) mice. TA-1, as a TLR2 agonist, could possibly be used as an adjuvant and could enhance cytokine release, which increases the immune response. Furthermore, TA-1 induced cytokine release is dependent on MyD88/TIRAP.	[Chen, Yen-Po; Liang, Shu-Mei] Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan; [Lin, Miao-Hsia; Yang, Yu-Liang; Lu, Chun-Ping; Wu, Shih-Hsiung] Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan; [Hua, Kuo-Feng] Natl Ilan Univ, Inst Biotechnol, Ilan 260, Taiwan; [Sheu, Fuu] Natl Taiwan Univ, Dept Hort, Taipei 106, Taiwan; [Lin, Guang-Huey] Tzu Chi Univ, Inst Microbiol Immunol & Mol Med, Hualien 970, Taiwan; [Tsay, San-San] Natl Taiwan Univ, Dept Life Sci, Taipei 106, Taiwan; [Tsay, San-San] Natl Taiwan Univ, Inst Plant Biol, Taipei 106, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Ilan University; National Taiwan University; Tzu Chi University; National Taiwan University; National Taiwan University	Liang, SM (corresponding author), Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan.	smyang@gate.sinica.edu.tw; shwu@gate.sinica.edu.tw	Chen, Yen Po/GLQ-6423-2022; Lu, Chun-Ping/B-9999-2011	Chen, Yen Po/0000-0003-0621-6219; Sheu, Fuu/0000-0001-9794-3483; Liang, Shu-Mei/0000-0001-8926-4747	National Science Council and Academia Sinica, Taiwan	National Science Council and Academia Sinica, Taiwan	This work was supported by the National Science Council and Academia Sinica, Taiwan.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Albiger B, 2007, J INTERN MED, V261, P511, DOI 10.1111/j.1365-2796.2007.01821.x; Alexander C, 2001, J ENDOTOXIN RES, V7, P167, DOI 10.1179/096805101101532675; Bakker H, 2005, BIOL CHEM, V386, P657, DOI 10.1515/BC.2005.076; BROCK TD, 1970, J BACTERIOL, V104, P509, DOI 10.1128/JB.104.1.509-517.1970; BROCK TD, 1969, J BACTERIOL, V98, P289, DOI 10.1128/JB.98.1.289-297.1969; CHIEN A, 1976, J BACTERIOL, V127, P1550, DOI 10.1128/JB.127.3.1550-1557.1976; Chu SF, 2006, PLASMID, V56, P46, DOI 10.1016/j.plasmid.2006.01.005; Cohen N, 2008, J IMMUNOL, V180, P2409, DOI 10.4049/jimmunol.180.4.2409; FIDLER IJ, 1988, CIBA F SYMP, V141, P211; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Guy B, 2010, J COMP PATHOL, V141, pS133, DOI [10.1016/j.jepa.2009.09.009, 10.1016/j.jcpa.2009.09.009]; Guy B, 2007, NAT REV MICROBIOL, V5, P505, DOI 10.1038/nrmicro1681; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Hsu HY, 2004, J IMMUNOL, V173, P5989, DOI 10.4049/jimmunol.173.10.5989; Iwamoto M, 2005, FEBS LETT, V579, P4423, DOI 10.1016/j.febslet.2005.07.007; Jackson DC, 2004, P NATL ACAD SCI USA, V101, P15440, DOI 10.1073/pnas.0406740101; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kumagai Yutaro, 2008, Journal of Infection and Chemotherapy, V14, P86, DOI 10.1007/s10156-008-0596-1; Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062; Leone S, 2006, GLYCOBIOLOGY, V16, P766, DOI 10.1093/glycob/cwj120; Maletto BA, 2005, CLIN IMMUNOL, V117, P251, DOI 10.1016/j.clim.2005.08.016; Maue AC, 2009, J IMMUNOL, V182, P6129, DOI 10.4049/jimmunol.0804226; Mojica K, 2007, J MICROBIOL METH, V71, P61, DOI 10.1016/j.mimet.2007.07.010; Nassau PM, 1996, J BACTERIOL, V178, P1047, DOI 10.1128/jb.178.4.1047-1052.1996; OKAZAKI M, 1995, BIOL PHARM BULL, V18, P1320, DOI 10.1248/bpb.18.1320; Ooi VEC, 2000, CURR MED CHEM, V7, P715; OTTERLEI M, 1991, J IMMUNOTHER, V10, P286, DOI 10.1097/00002371-199108000-00007; Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720; Rosenberg SA, 2006, J IMMUNOTHER, V29, P313, DOI 10.1097/01.cji.0000210386.55951.c2; Schepetkin IA, 2006, INT IMMUNOPHARMACOL, V6, P317, DOI 10.1016/j.intimp.2005.10.005; SELJELID R, 1989, SCAND J IMMUNOL, V29, P181, DOI 10.1111/j.1365-3083.1989.tb01115.x; Sen G, 2005, J IMMUNOL, V175, P3084, DOI 10.4049/jimmunol.175.5.3084; Seong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372; Sportes C, 2008, J EXP MED, V205, P1701, DOI 10.1084/jem.20071681; Sutherland IW, 2001, MICROBIOL-UK, V147, P3, DOI 10.1099/00221287-147-1-3; Sutherland IW, 2001, WATER SCI TECHNOL, V43, P77, DOI 10.2166/wst.2001.0345; TZIANABOS AO, 1993, SCIENCE, V262, P416, DOI 10.1126/science.8211161; van Putten JPM, 2010, IMMUNOL LETT, V128, P8, DOI 10.1016/j.imlet.2009.09.007; VERSTOVSEK S, 1992, CANCER RES, V52, P3880; WAEGHE TJ, 1983, CARBOHYD RES, V123, P281, DOI 10.1016/0008-6215(83)88484-5; Wang Q, 2006, J EXP MED, V203, P2853, DOI 10.1084/jem.20062008; Watnick P, 2000, J BACTERIOL, V182, P2675, DOI 10.1128/JB.182.10.2675-2679.2000; Weston A, 1998, TUBERCLE LUNG DIS, V78, P123, DOI 10.1016/S0962-8479(98)80005-1; Wozniak DJ, 2003, P NATL ACAD SCI USA, V100, P7907, DOI 10.1073/pnas.1231792100; Yildiz FH, 1999, P NATL ACAD SCI USA, V96, P4028, DOI 10.1073/pnas.96.7.4028; Yim JH, 2005, MAR BIOTECHNOL, V7, P331, DOI 10.1007/s10126-004-0404-6	47	44	49	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17736	17745		10.1074/jbc.M110.200113	http://dx.doi.org/10.1074/jbc.M110.200113			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454596	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000290585200037
J	Nishitsuji, K; Hosono, T; Nakamura, T; Bu, GJ; Michikawa, M				Nishitsuji, Kazuchika; Hosono, Takashi; Nakamura, Toshiyuki; Bu, Guojun; Michikawa, Makoto			Apolipoprotein E Regulates the Integrity of Tight Junctions in an Isoform-dependent Manner in an in Vitro Blood-Brain Barrier Model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; RECEPTOR-RELATED PROTEIN; ALZHEIMERS-DISEASE; A-BETA; LIPOPROTEIN RECEPTORS; PLAQUE-FORMATION; LDL-RECEPTOR; MOUSE MODEL; CHOLESTEROL-METABOLISM; ENDOTHELIAL-CELLS	Apolipoprotein E (apoE) is a major apolipoprotein in the brain. The epsilon 4 allele of apoE is a major risk factor for Alzheimer disease, and apoE deficiency in mice leads to blood-brain barrier (BBB) leakage. However, the effect of apoE isoforms on BBB properties are as yet unknown. Here, using an in vitro BBB model consisting of brain endothelial cells and pericytes prepared from wild-type (WT) mice, and primary astrocytes prepared from human apoE3- and apoE4-knock- in mice, we show that the barrier function of tight junctions (TJs) was impaired when the BBB was reconstituted with primary astrocytes from apoE4-knock- in mice (apoE4-BBB model). The phosphorylation of occludin at Thr residues and the activation of protein kinase C (PKC)eta in mBECs were attenuated in the apoE4-BBB model compared with those in the apoE3- BBB model. The differential effects of apoE isoforms on the activation of PKC eta, the phosphorylation of occludin at Thr residues, and TJ integrity were abolished following the treatment with an anti-low density lipoprotein receptor-related protein 1 (LRP1) antibody or a LRP1 antagonist receptor-associated protein. Consistent with the results of in vitro studies, BBB permeability was higher in apoE4-knock- in mice than in apoE3- knock-in mice. Our studies provide evidence that TJ integrity in BBB is regulated by apoE in an isoform-dependent manner.	[Nishitsuji, Kazuchika; Hosono, Takashi; Nakamura, Toshiyuki; Michikawa, Makoto] Natl Ctr Geriatr & Gerontol, Natl Inst Longev Sci, Dept Alzheimers Dis Res, Aichi 4748522, Japan; [Bu, Guojun] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA	National Center for Geriatrics & Gerontology; Mayo Clinic	Michikawa, M (corresponding author), Natl Ctr Geriatr & Gerontol, Dept Alzheimers Dis Res, 35 Gengo, Aichi 4748511, Japan.	michi@ncgg.go.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [19300138, 21300145]; Ministry of Health, Labor, and Welfare of Japan [H20-007]; National Center for Geriatrics and Gerontology, Japan [21-11]; National Institutes of Health [R01AG027924, R01AG035355]; Alzheimer Association; NATIONAL INSTITUTE ON AGING [R01AG035355, P01AG030128, R01AG027924] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [21300145] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); National Center for Geriatrics and Gerontology, Japan; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer Association(Alzheimer's AssociationBrightFocus Foundation); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by Grants-in-aid for Scientific Research (B) 19300138 and 21300145 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to M. M.), a grant from the Ministry of Health, Labor, and Welfare of Japan (Research on Dementia, Health and Labor Sciences Research Grant H20-007) (to M. M.), Research Funding for Longevity Sciences Grant 21-11 from the National Center for Geriatrics and Gerontology, Japan (to M. M.), National Institutes of Health Grants R01AG027924 and R01AG035355 (to G. B.), and a Zenith Fellows award from the Alzheimer Association (to G. B.).	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Bales KR, 2009, J NEUROSCI, V29, P6771, DOI 10.1523/JNEUROSCI.0887-09.2009; Basuroy S, 2003, J BIOL CHEM, V278, P11916, DOI 10.1074/jbc.M211710200; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Bell RD, 2009, NAT CELL BIOL, V11, P143, DOI 10.1038/ncb1819; BROWN MS, 1976, SCIENCE, V191, P150, DOI 10.1126/science.174194; BU GJ, 1995, EMBO J, V14, P2269, DOI 10.1002/j.1460-2075.1995.tb07221.x; Bu GJ, 2000, TRENDS CARDIOVAS MED, V10, P148, DOI 10.1016/S1050-1738(00)00045-1; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Buttini M, 2002, J NEUROSCI, V22, P10539; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Deane R, 2008, J CLIN INVEST, V118, P4002, DOI 10.1172/JCI36663; Dickstein DL, 2006, FASEB J, V20, P426, DOI 10.1096/fj.05-3956com; Dolev I, 2004, P NATL ACAD SCI USA, V101, P13909, DOI 10.1073/pnas.0404458101; Elias BC, 2009, J BIOL CHEM, V284, P1559, DOI 10.1074/jbc.M804783200; Fagan AM, 2002, NEUROBIOL DIS, V9, P305, DOI 10.1006/nbdi.2002.0483; Fullerton SM, 2001, EXP NEUROL, V169, P13, DOI 10.1006/exnr.2001.7631; Gong JS, 2002, J BIOL CHEM, V277, P29919, DOI 10.1074/jbc.M203934200; Hafezi-Moghadam A, 2007, AM J PHYSIOL-CELL PH, V292, pC1256, DOI 10.1152/ajpcell.00563.2005; Hamanaka H, 2000, HUM MOL GENET, V9, P353, DOI 10.1093/hmg/9.3.353; Hara M, 2003, ARTERIOSCL THROM VAS, V23, P269, DOI 10.1161/01.ATV.0000054199.78458.4B; Hayashi H, 2009, J BIOL CHEM, V284, P29605, DOI 10.1074/jbc.M109.039560; He XY, 2007, J NEUROSCI, V27, P4052, DOI 10.1523/JNEUROSCI.3993-06.2007; Helfrich I, 2007, J INVEST DERMATOL, V127, P782, DOI 10.1038/sj.jid.5700621; Herz J, 2002, ANNU REV BIOCHEM, V71, P405, DOI 10.1146/annurev.biochem.71.110601.135342; Herz J, 2006, NAT REV NEUROSCI, V7, P850, DOI 10.1038/nrn2009; Holtzman DM, 2000, P NATL ACAD SCI USA, V97, P2892, DOI 10.1073/pnas.050004797; IADONATO SP, 1993, BIOCHEM J, V296, P867, DOI 10.1042/bj2960867; Ito S, 2007, J NEUROCHEM, V103, P2482, DOI 10.1111/j.1471-4159.2007.04938.x; JANZER RC, 1987, NATURE, V325, P253, DOI 10.1038/325253a0; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Kanekiyo T, 2009, J BIOL CHEM, V284, P33352, DOI 10.1074/jbc.M109.015032; Li YH, 2005, J CELL SCI, V118, P5305, DOI 10.1242/jcs.02651; Liu QA, 2010, J NEUROSCI, V30, P17068, DOI 10.1523/JNEUROSCI.4067-10.2010; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Methia N, 2001, MOL MED, V7, P810, DOI 10.1007/BF03401973; Michikawa M, 2000, J NEUROCHEM, V74, P1008, DOI 10.1046/j.1471-4159.2000.0741008.x; Michikawa M, 2001, J NEUROSCI, V21, P7226, DOI 10.1523/JNEUROSCI.21-18-07226.2001; Minagawa H, 2010, J BIOL CHEM, V285, P38382, DOI 10.1074/jbc.M110.146258; Minagawa Hirohisa, 2009, J Neurosci Res, V87, P2498, DOI 10.1002/jnr.22073; Nagababu E, 2009, J ALZHEIMERS DIS, V17, P845, DOI 10.3233/JAD-2009-1104; Nakagawa S, 2007, CELL MOL NEUROBIOL, V27, P687, DOI 10.1007/s10571-007-9195-4; Redig AJ, 2009, J BIOL CHEM, V284, P10301, DOI 10.1074/jbc.M807254200; REESE TS, 1967, J CELL BIOL, V34, P207, DOI 10.1083/jcb.34.1.207; Rubin LL, 1999, ANNU REV NEUROSCI, V22, P11, DOI 10.1146/annurev.neuro.22.1.11; Ruiz J, 2005, J LIPID RES, V46, P1721, DOI 10.1194/jlr.M500114-JLR200; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; STUART RO, 1995, P NATL ACAD SCI USA, V92, P6072, DOI 10.1073/pnas.92.13.6072; Suzuki T, 2009, P NATL ACAD SCI USA, V106, P61, DOI 10.1073/pnas.0802741106; TAOCHENG JH, 1987, J NEUROSCI, V7, P3293; Tsukita S, 1999, TRENDS CELL BIOL, V9, P268, DOI 10.1016/S0962-8924(99)01578-0; Ujiie M, 2003, MICROCIRCULATION, V10, P463, DOI 10.1038/sj.mn.7800212; WARSHAWSKY I, 1993, J CLIN INVEST, V92, P937, DOI 10.1172/JCI116669; Ye SM, 2005, P NATL ACAD SCI USA, V102, P18700, DOI 10.1073/pnas.0508693102; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	56	165	173	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17536	17542		10.1074/jbc.M111.225532	http://dx.doi.org/10.1074/jbc.M111.225532			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21471207	Green Published, hybrid			2022-12-25	WOS:000290585200016
J	Regue, L; Sdelci, S; Bertran, MT; Caelles, C; Reverter, D; Roig, J				Regue, Laura; Sdelci, Sara; Teresa Bertran, M.; Caelles, Carme; Reverter, David; Roig, Joan			DYNLL/LC8 Protein Controls Signal Transduction through the Nek9/Nek6 Signaling Module by Regulating Nek6 Binding to Nek9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-CHAIN LC8; MITOTIC SPINDLE FORMATION; NIMA-FAMILY KINASE; CELL-CYCLE ARREST; CYTOPLASMIC DYNEIN; INTERMEDIATE CHAIN; PHOSPHORYLATION; DIMERIZATION; PROGRESSION; MITOSIS	The NIMA family protein kinases Nek9/Nercc1 and the highly similar Nek6 and Nek7 form a signaling module activated in mitosis, when they are involved in the control of spindle organization and function. Here we report that Nek9, the module upstream kinase, binds to DYNLL/LC8, a highly conserved protein originally described as a component of the dynein complex. LC8 is a dimer that interacts with different proteins and has been suggested to act as a dimerization hub promoting the organization and oligomerization of partially disorganized partners. We find that the interaction of LC8 with Nek9 depends on a (K/R)XTQT motif adjacent to the Nek9 C-terminal coiled coil motif, results in Nek9 multimerization, and increases the rate of Nek9 autoactivation. LC8 binding to Nek9 is regulated by Nek9 activity through the autophosphorylation of Ser(944), a residue immediately N-terminal to the (K/R)XTQT motif. Remarkably, LC8 binding interferes with the interaction of Nek9 with its downstream partner Nek6 as well as with Nek6 activation, thus controlling both processes. Our work sheds light into the control of signal transduction through the module formed by Nek9 and Nek6/7 and uncovers a novel manner in which LC8 can regulate partner physiology by interfering with protein complex formation. We suggest that this and other LC8 functions can be specifically regulated by partner phosphorylation.	[Regue, Laura; Sdelci, Sara; Teresa Bertran, M.; Caelles, Carme; Roig, Joan] Inst Res Biomed IRB Barcelona, Program Mol Med, Cell Signaling Grp, Barcelona 08028, Spain; [Reverter, David] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, Struct Biol Unit, Bellaterra 08193, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Autonomous University of Barcelona	Roig, J (corresponding author), IRB Barcelona, Cell Signaling Res Grp, Parc Cient Barcelona,C Baldiri & Reixac 10-12, Barcelona 08028, Spain.	joan.roig@irbbarcelona.org	Bertran, M. Teresa/C-4169-2019; Reverter, David/H-5360-2015; sdelci, sara/S-2243-2018; Barrufet, Laura Regue/AAB-9465-2020; Roig, Joan/E-2836-2017	Bertran, M. Teresa/0000-0002-8336-0903; Reverter, David/0000-0002-5347-0992; sdelci, sara/0000-0003-1330-4364; Barrufet, Laura Regue/0000-0003-1341-3413; Roig, Joan/0000-0002-3872-4712	Ramon y Cajal Program; Ministerio de Ciencia e Innovacion (MICINN), Spain [BFU2008-00364/BMC, BFU2008-03441/BMC]	Ramon y Cajal Program(Spanish Government); Ministerio de Ciencia e Innovacion (MICINN), Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	Supported by the Ramon y Cajal Program and the Plan Nacional I + D Grant BFU2008-00364/BMC (Ministerio de Ciencia e Innovacion (MICINN), Spain).; Supported by the Ramon y Cajal Program and the Plan Nacional I + D Grant BFU2008-03441/BMC (MICINN, Spain) and institutional funds. To whom correspondence should be addressed: Cell Signaling Research Group, IRB Barcelona, Parc Cientific de Barcelona, c/Baldiri i Reixac, 10-12, 08028 Barcelona, Spain. Tel.: 34-638297563; Fax: 34-934037114; E-mail: joan.roig@irbbarcelona.org.	Barbar E, 2008, BIOCHEMISTRY-US, V47, P503, DOI 10.1021/bi701995m; Belham C, 2003, J BIOL CHEM, V278, P34897, DOI 10.1074/jbc.M303663200; Benashski SE, 1997, J BIOL CHEM, V272, P20929, DOI 10.1074/jbc.272.33.20929; Benison G, 2007, J MOL BIOL, V371, P457, DOI 10.1016/j.jmb.2007.05.046; Chen YM, 2008, CELL CYCLE, V7, P3194, DOI 10.4161/cc.7.20.6815; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Dick T, 1996, MOL GEN GENET, V251, P38; Dick T, 1996, MOL CELL BIOL, V16, P1966; Jeon YJ, 2010, J BIOL CHEM, V285, P28126, DOI 10.1074/jbc.M110.137190; Jung YY, 2008, J BIOL CHEM, V283, P23863, DOI 10.1074/jbc.M803072200; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Liang J, 1999, NAT STRUCT BIOL, V6, P735; Lightcap CM, 2008, J BIOL CHEM, V283, P27314, DOI 10.1074/jbc.M800758200; Lightcap CM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006025; Lo KWH, 2001, J BIOL CHEM, V276, P14059, DOI 10.1074/jbc.M010320200; Makokha M, 2002, BIOCHEMISTRY-US, V41, P4302, DOI 10.1021/bi011970h; Melixetian M, 2009, NAT CELL BIOL, V11, P1247, DOI 10.1038/ncb1969; Miki F, 2002, MOL BIOL CELL, V13, P930, DOI 10.1091/mbc.01-11-0543; Mohan PMK, 2006, PROTEIN SCI, V15, P335, DOI 10.1110/ps.051854906; Moniz LS, 2011, MOL CELL BIOL, V31, P30, DOI 10.1128/MCB.00648-10; Nassirpour R, 2010, MOL CANCER RES, V8, P717, DOI 10.1158/1541-7786.MCR-09-0291; Noguchi K, 2002, J BIOL CHEM, V277, P39655, DOI 10.1074/jbc.M204599200; Nyarko A, 2004, BIOCHEMISTRY-US, V43, P15595, DOI 10.1021/bi048451+; O'Connell MJ, 2003, TRENDS CELL BIOL, V13, P221, DOI 10.1016/S0962-8924(03)00056-4; O'Regan L, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-25; O'Regan L, 2009, MOL CELL BIOL, V29, P3975, DOI 10.1128/MCB.01867-08; Pelegrini AL, 2010, MUTAGENESIS, V25, P447, DOI 10.1093/mutage/geq026; Phillis R, 1996, DEVELOPMENT, V122, P2955; Quarmby LM, 2005, J CELL SCI, V118, P5161, DOI 10.1242/jcs.02681; Rapley J, 2008, J CELL SCI, V121, P3912, DOI 10.1242/jcs.035360; Richards MW, 2009, MOL CELL, V36, P560, DOI 10.1016/j.molcel.2009.09.038; Rodriguez-Crespo I, 2001, FEBS LETT, V503, P135, DOI 10.1016/S0014-5793(01)02718-1; Roig J, 2005, MOL BIOL CELL, V16, P4827, DOI 10.1091/mbc.E05-04-0315; Roig J, 2002, GENE DEV, V16, P1640, DOI 10.1101/gad.972202; ROIG J, 2010, UCSD NATURE MOL PAGE, DOI DOI 10.1038/MP.A003029.01; ROIG J, 2006, SIGMA RBI HDB RECEPT, P286; Salem H, 2010, ONCOGENE, V29, P4046, DOI 10.1038/onc.2010.162; Song CY, 2008, J BIOL CHEM, V283, P4004, DOI 10.1074/jbc.M704512200; Song YJ, 2007, J BIOL CHEM, V282, P17272, DOI 10.1074/jbc.M610445200; Traer CJ, 2007, NAT CELL BIOL, V9, P1370, DOI 10.1038/ncb1656; Vadlamudi RK, 2004, CANCER CELL, V5, P575, DOI 10.1016/j.ccr.2004.05.022; Wilson MJ, 2001, CELL MOTIL CYTOSKEL, V49, P229, DOI 10.1002/cm.1036; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; Yin MJ, 2003, J BIOL CHEM, V278, P52454, DOI 10.1074/jbc.M308080200; Yissachar N, 2006, FEBS LETT, V580, P6489, DOI 10.1016/j.febslet.2006.10.069	45	23	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					18118	18129		10.1074/jbc.M110.209080	http://dx.doi.org/10.1074/jbc.M110.209080			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454704	hybrid, Green Published			2022-12-25	WOS:000290585200072
J	Tatum, D; Li, SS				Tatum, Danielle; Li, Shisheng			Evidence That the Histone Methyltransferase Dot1 Mediates Global Genomic Repair by Methylating Histone H3 on Lysine 79	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-EXCISION-REPAIR; CYCLOBUTANE PYRIMIDINE DIMERS; NUCLEOSOME CORE PARTICLE; DNA-DAMAGE CHECKPOINT; RNA-POLYMERASE-II; SACCHAROMYCES-CEREVISIAE; NONTRANSCRIBED STRAND; ACTIVE GENE; UV DAMAGE; YEAST	Global genomic repair (GGR) and transcription coupled repair (TCR) are two pathways of nucleotide excision repair (NER) that differ in the damage recognition step. How NER factors, especially GGR factors, access DNA damage in the chromatin of eukaryotic cells has been poorly understood. Dot1, a histone methyltransferase required for methylation of histone H3 lysine 79 (H3K79), has been shown to confer yeast cells with resistance to DNA-damaging agents and play a role in activation of DNA damage checkpoints. Here, we show that Dot1 and H3K79 methylation are required for GGR in both nucleosomal core regions and internucleosomal linker DNA, but play no role in TCR. H3K79 trimethylation contributes to but is not absolutely required for GGR, and lower levels of H3K79 methylation (mono- and dimethylation) also promote GGR. Our results also indicate that the roles of Dot1 and H3K79 methylation in GGR are not achieved by either activating DNA damage checkpoints or regulating the expression of the GGR-specific factor Rad16. Rather, the methylated H3K79 may serve as a docking site for the GGR machinery on the chromatin. Our studies identified a novel GGR-specific NER factor and unveiled the critical link between a covalent histone modification and GGR.	[Tatum, Danielle; Li, Shisheng] Louisiana State Univ, Sch Vet Med, Dept Comparat Biomed Sci, Baton Rouge, LA 70803 USA	Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University	Li, SS (corresponding author), Louisiana State Univ, Sch Vet Med, Dept Comparat Biomed Sci, Baton Rouge, LA 70803 USA.	shli@vetmed.lsu.edu	Li, Shisheng/H-9126-2012	Tatum, Danielle/0000-0002-3281-3853	National Science Foundation [MCB-0745229]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant MCB-0745229.	Bostelman LJ, 2007, DNA REPAIR, V6, P383, DOI 10.1016/j.dnarep.2006.12.010; Capiaghi C, 2004, MOL CELL BIOL, V24, P6907, DOI 10.1128/MCB.24.16.6907-6918.2004; Chaudhuri S, 2009, NUCLEIC ACIDS RES, V37, P1690, DOI 10.1093/nar/gkp003; FRIEDBERG EC, 2006, DNA REPAIR MUTAGENES, P227; Giannattasio M, 2005, J BIOL CHEM, V280, P9879, DOI 10.1074/jbc.M414453200; Giannattasio M, 2004, EMBO J, V23, P429, DOI 10.1038/sj.emboj.7600051; Gillette TG, 2006, EMBO J, V25, P2529, DOI 10.1038/sj.emboj.7601120; Gong F, 2005, DNA REPAIR, V4, P884, DOI 10.1016/j.dnarep.2005.04.007; Gong F, 2006, NAT STRUCT MOL BIOL, V13, P902, DOI 10.1038/nsmb1152; Guzder SN, 1998, J BIOL CHEM, V273, P6292, DOI 10.1074/jbc.273.11.6292; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Jiang CZ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r109; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; LeJeune D, 2009, DNA REPAIR, V8, P40, DOI 10.1016/j.dnarep.2008.08.010; Lettieri T, 2008, DNA REPAIR, V7, P734, DOI 10.1016/j.dnarep.2008.01.016; Levesque N, 2010, J BIOL CHEM, V285, P35113, DOI 10.1074/jbc.M110.116855; Li SS, 2007, DNA REPAIR, V6, P1596, DOI 10.1016/j.dnarep.2007.05.005; Li SS, 1996, CARCINOGENESIS, V17, P1549, DOI 10.1093/carcin/17.8.1549; Li SS, 2004, J BIOL CHEM, V279, P14418, DOI 10.1074/jbc.M312004200; Li SS, 1997, J MOL BIOL, V271, P31, DOI 10.1006/jmbi.1997.1154; Li SS, 2002, EMBO J, V21, P5921, DOI 10.1093/emboj/cdf589; Lloyd RS, 2005, MUTAT RES-FUND MOL M, V577, P77, DOI 10.1016/j.mrfmmm.2005.04.003; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Nakanishi S, 2008, NAT STRUCT MOL BIOL, V15, P881, DOI 10.1038/nsmb.1454; Ng HH, 2003, P NATL ACAD SCI USA, V100, P1820, DOI 10.1073/pnas.0437846100; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Ribar B, 2007, MOL CELL BIOL, V27, P3211, DOI 10.1128/MCB.00091-07; Rochette PJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000926; Siede W, 1996, J BACTERIOL, V178, P5841, DOI 10.1128/jb.178.19.5841-5843.1996; Struhl K, 2007, NAT STRUCT MOL BIOL, V14, P103, DOI 10.1038/nsmb0207-103; Teng Y, 2008, EMBO REP, V9, P97, DOI 10.1038/sj.embor.7401112; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; VERHAGE R, 1994, MOL CELL BIOL, V14, P6135, DOI 10.1128/MCB.14.9.6135; Waters R, 2009, DNA REPAIR, V8, P146, DOI 10.1016/j.dnarep.2008.11.001; Wellinger RE, 1997, EMBO J, V16, P5046, DOI 10.1093/emboj/16.16.5046; White CL, 2001, EMBO J, V20, P5207, DOI 10.1093/emboj/20.18.5207; Yu YC, 2005, P NATL ACAD SCI USA, V102, P8650, DOI 10.1073/pnas.0501458102	38	48	49	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17530	17535		10.1074/jbc.M111.241570	http://dx.doi.org/10.1074/jbc.M111.241570			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21460225	hybrid, Green Published			2022-12-25	WOS:000290585200015
J	Zheng, YF; Ao, ZJ; Wang, BC; Jayappa, KD; Yao, XJ				Zheng, Yingfeng; Ao, Zhujun; Wang, Binchen; Jayappa, Kallesh Danappa; Yao, Xiaojian			Host Protein Ku70 Binds and Protects HIV-1 Integrase from Proteasomal Degradation and Is Required for HIV Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MURINE LEUKEMIA-VIRUS; CATALYTIC CORE DOMAIN; DNA END; PREINTEGRATION COMPLEXES; NUCLEAR IMPORT; RETROVIRAL DNA; V(D)J RECOMBINATION; MUTAGENIC ANALYSIS; CHROMATIN BINDING	HIV-1 integrase (IN) is a key viral enzymatic protein acting in several viral replication steps, including integration. IN has been shown to be an unstable protein degraded by the N-end rule pathway through the host ubiquitin-proteasome machinery. However, it is still not fully understood how this viral protein is protected from the host ubiquitin-proteasome system within cells during HIV replication. In the present study, we provide evidence that the host protein Ku70 interacts with HIV-1 IN and protects it from the Lys(48)-linked polyubiquitination proteasomal pathway. Moreover, Ku70 is able to down-regulate the overall protein polyubiquitination level within the host cells and to specifically deubiquitinate IN through their interaction. Mutagenic studies revealed that the C terminus of IN (residues 230-288) is required for IN binding to the N-terminal part of Ku70 (Ku70(1-430)), and their interaction is independent of Ku70/80 heterodimerization. Finally, knockdown of Ku70 expression in both virus-producing and target CD4(+) T cells significantly disrupted HIV-1 replication and rendered two-long terminal repeat circles and integration undetectable, indicating that Ku70 is required for both the early and the late stages of the HIV-1 life cycle. Interestingly, Ku70 was incorporated into the progeny virus in an IN-dependent way. We proposed that Ku70 may interact with IN during viral assembly and accompany HIV-1 IN upon entry into the new target cells, acting to 1) protect IN from the host defense system and 2) assist IN integration activity. Overall, this report provides another example of how HIV-1 hijacks host cellular machinery to protect the virus itself and to facilitate its replication.	[Zheng, Yingfeng; Ao, Zhujun; Wang, Binchen; Jayappa, Kallesh Danappa; Yao, Xiaojian] Univ Manitoba, Fac Med, Dept Med Microbiol, Lab Mol Human Retrovirol, Winnipeg, MB R3E 0J9, Canada	University of Manitoba	Yao, XJ (corresponding author), Univ Manitoba, Fac Med, Dept Med Microbiol, Lab Mol Human Retrovirol, 508-745 William Ave, Winnipeg, MB R3E 0J9, Canada.	yao2@cc.umanitoba.ca	JAYAPPA, KALLESH DANAPPA/M-6571-2018; Zheng, Yingfeng/AAE-2983-2022	JAYAPPA, KALLESH DANAPPA/0000-0002-7239-5246; Yao, Xiaojian/0000-0002-5022-1309	Canadian Institutes of Health Research (CIHR) [HOP-81180, HBF 103212]; Canadian Foundation of Innovation; Manitoba Health Research Council/Manitoba Institute of Child Health (MHRC/MICH); CIHR International Infectious Disease and Global Health; Manitoba Medical Service Foundation	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Foundation of Innovation(Canada Foundation for Innovation); Manitoba Health Research Council/Manitoba Institute of Child Health (MHRC/MICH); CIHR International Infectious Disease and Global Health(Canadian Institutes of Health Research (CIHR)); Manitoba Medical Service Foundation	This work was supported by Canadian Institutes of Health Research (CIHR) Grants HOP-81180 and HBF 103212 and the Leaders Opportunity Fund Award from the Canadian Foundation of Innovation (to X.-J.Y.).; Recipient of studentships from the Manitoba Health Research Council/Manitoba Institute of Child Health (MHRC/MICH) and the CIHR International Infectious Disease and Global Health Training Program.; Recipient of the Basic Science Career Development Research Award from the Manitoba Medical Service Foundation.	Amsel AD, 2008, P NATL ACAD SCI USA, V105, P5117, DOI 10.1073/pnas.0706700105; Ao Z, 2004, J VIROL, V78, P3170, DOI 10.1128/JVI.78.6.3170-3177.2004; Ao ZJ, 2007, J BIOL CHEM, V282, P13456, DOI 10.1074/jbc.M610546200; Ao ZJ, 2010, J VIROL, V84, P8650, DOI 10.1128/JVI.00508-10; Ao ZJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001995; Ao ZJ, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-62; Berthoux L, 2007, VIROLOGY, V364, P227, DOI 10.1016/j.virol.2007.02.029; BUKRINSKY MI, 1992, P NATL ACAD SCI USA, V89, P6580, DOI 10.1073/pnas.89.14.6580; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Ciuffi A, 2005, NAT MED, V11, P1287, DOI 10.1038/nm1329; Conticello SG, 2003, CURR BIOL, V13, P2009, DOI 10.1016/j.cub.2003.10.034; Daniel R, 2005, NAT CELL BIOL, V7, P452, DOI 10.1038/ncb0505-452; Daniel R, 2004, J VIROL, V78, P8573, DOI 10.1128/JVI.78.16.8573-8581.2004; Daniel R, 2001, MOL CELL BIOL, V21, P1164, DOI 10.1128/MCB.21.4.1164-1172.2001; Daniel R, 2001, J VIROL, V75, P3121, DOI 10.1128/JVI.75.7.3121-3128.2001; Daniel R, 1999, SCIENCE, V284, P644, DOI 10.1126/science.284.5414.644; Doherty AJ, 2001, FEBS LETT, V500, P186, DOI 10.1016/S0014-5793(01)02589-3; Douglas JL, 2009, J VIROL, V83, P7931, DOI 10.1128/JVI.00242-09; Downs JA, 2004, NAT REV MOL CELL BIO, V5, P367, DOI 10.1038/nrm1367; Downs JA, 1999, MOL CELL BIOL, V19, P6260; Dubiel W, 1999, CURR BIOL, V9, pR554, DOI 10.1016/S0960-9822(99)80353-4; Emiliani S, 2005, J BIOL CHEM, V280, P25517, DOI 10.1074/jbc.M501378200; Farnet CM, 1997, CELL, V88, P483, DOI 10.1016/S0092-8674(00)81888-7; Giffin W, 1996, NATURE, V380, P265, DOI 10.1038/380265a0; Greene WC, 2002, NAT MED, V8, P673, DOI 10.1038/nm0702-673; Gu YS, 1997, P NATL ACAD SCI USA, V94, P8076, DOI 10.1073/pnas.94.15.8076; Jeanson L, 2002, VIROLOGY, V300, P100, DOI 10.1006/viro.2002.1515; Jeanson L, 2002, J BIOL CHEM, V277, P4918, DOI 10.1074/jbc.M110830200; Jin SF, 1997, EMBO J, V16, P6874, DOI 10.1093/emboj/16.22.6874; KALPANA GV, 1994, SCIENCE, V266, P2002, DOI 10.1126/science.7801128; Kiel C, 2006, J MOL BIOL, V355, P821, DOI 10.1016/j.jmb.2005.10.010; Kilzer JM, 2003, VIROLOGY, V314, P460, DOI 10.1016/S0042-6822(03)00455-0; Klinger Patricia P, 2005, Expert Rev Anti Infect Ther, V3, P61, DOI 10.1586/14787210.3.1.61; Koike M, 2001, J BIOL CHEM, V276, P11167, DOI 10.1074/jbc.M010902200; Lau A, 2005, NAT CELL BIOL, V7, P493, DOI 10.1038/ncb1250; Le Rouzic E, 2008, J BIOL CHEM, V283, P21686, DOI 10.1074/jbc.M710298200; LEE MS, 1994, P NATL ACAD SCI USA, V91, P9823, DOI 10.1073/pnas.91.21.9823; Li L, 2001, EMBO J, V20, P3272, DOI 10.1093/emboj/20.12.3272; Lin CW, 2003, J VIROL, V77, P5030, DOI 10.1128/JVI.77.8.5030-5036.2003; Llano M, 2004, J BIOL CHEM, V279, P55570, DOI 10.1074/jbc.M408508200; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Mckee CJ, 2008, J BIOL CHEM, V283, P31802, DOI 10.1074/jbc.M805843200; Miller MD, 1997, J VIROL, V71, P5382, DOI 10.1128/JVI.71.7.5382-5390.1997; Mouland AJ, 2000, J VIROL, V74, P5441, DOI 10.1128/JVI.74.12.5441-5451.2000; Mulder LCF, 2000, J BIOL CHEM, V275, P29749, DOI 10.1074/jbc.M004670200; Mulder LCF, 2002, J BIOL CHEM, V277, P27489, DOI 10.1074/jbc.M203061200; Nussenzweig A, 1996, NATURE, V382, P551, DOI 10.1038/382551a0; Ott David E., 2009, V485, P15, DOI 10.1007/978-1-59745-170-3_2; Ott DE, 1998, J VIROL, V72, P2962, DOI 10.1128/JVI.72.4.2962-2968.1998; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Pornillos O, 2002, TRENDS CELL BIOL, V12, P569, DOI 10.1016/S0962-8924(02)02402-9; Roe T, 1997, J VIROL, V71, P1334, DOI 10.1128/JVI.71.2.1334-1340.1997; Sadowski M, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-19; Sawada M, 2003, NAT CELL BIOL, V5, P320, DOI 10.1038/ncb950; Schubert U, 2000, P NATL ACAD SCI USA, V97, P13057, DOI 10.1073/pnas.97.24.13057; Shun MC, 2007, GENE DEV, V21, P1767, DOI 10.1101/gad.1565107; Strack B, 2002, J VIROL, V76, P5472, DOI 10.1128/JVI.76.11.5472-5479.2002; Studamire B, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-48; Tuteja R, 2000, CRIT REV BIOCHEM MOL, V35, P1, DOI 10.1080/10409230091169177; Van Maele B, 2005, AIDS REV, V7, P26; Wang GP, 2007, GENOME RES, V17, P1186, DOI 10.1101/gr.6286907; Wang JS, 1998, J BIOL CHEM, V273, P842, DOI 10.1074/jbc.273.2.842; Wu XT, 1996, MOL CELL BIOL, V16, P5186; Xu ZK, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-102; YAO XJ, 1995, J VIROL, V69, P7032, DOI 10.1128/JVI.69.11.7032-7044.1995; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zheng YF, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-68	67	52	53	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17722	17735		10.1074/jbc.M110.184739	http://dx.doi.org/10.1074/jbc.M110.184739			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454661	Green Published, hybrid			2022-12-25	WOS:000290585200036
J	Kang, BH; Xia, F; Pop, R; Dohi, T; Socolovsky, M; Altieri, DC				Kang, Byoung Heon; Xia, Fang; Pop, Ramona; Dohi, Takehiko; Socolovsky, Merav; Altieri, Dario C.			Developmental Control of Apoptosis by the Immunophilin Aryl Hydrocarbon Receptor-interacting Protein (AIP) Involves Mitochondrial Import of the Survivin Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PITUITARY-ADENOMA PREDISPOSITION; IN-VIVO; INHIBITS APOPTOSIS; PRECURSOR PROTEINS; OUTER-MEMBRANE; CANCER; GENE; COMPLEX; IAP; DIFFERENTIATION	Survivin is a multifunctional protein with essential roles in cell division and inhibition of apoptosis, but the molecular underpinnings of its cytoprotective properties are poorly understood. Here we show that homozygous deletion of the aryl hydrocarbon receptor-interacting protein (AIP), a survivin-associated immunophilin, causes embryonic lethality in mice by embryonic day 13.5-14, increased apoptosis of Ter119(-)/CD71(-) early erythropoietic progenitors, and loss of survivin expression in its cytosolic and mitochondrial compartments in vivo. In import assays using recombinant proteins, AIP directly mediated the import of survivin to mitochondria, thus enabling its anti-apoptotic function, whereas a survivin 1-141 mutant that does not bind AIP was not imported to mitochondria and failed to inhibit apoptosis. AIP-directed mitochondrial import of survivin did not affect cell division, was independent of the organelle transmembrane potential, did not require the chaperone Heat Shock Protein 90 (Hsp90), and was inhibited by cytosolic factor(s) present in normal cells. shRNA knockdown of the mitochondrial import receptor Tom20 abolished mitochondrial import of survivin and sensitized tumor cells to apoptosis, whereas silencing of Tom70 had no effect. Therefore, an AIP-Tom20 recognition contributes to cell survival in development and cancer by mediating the mitochondrial import of survivin.	[Dohi, Takehiko; Altieri, Dario C.] Wistar Inst Anat & Biol, Ctr Canc, Philadelphia, PA 19104 USA; [Kang, Byoung Heon; Xia, Fang; Dohi, Takehiko; Altieri, Dario C.] Univ Massachusetts, Sch Med, Prostate Canc Discovery & Dev Program, Worcester, MA 01605 USA; [Kang, Byoung Heon; Xia, Fang] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA; [Pop, Ramona; Socolovsky, Merav] Univ Massachusetts, Sch Med, Dept Pediat, Worcester, MA 01605 USA	The Wistar Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Altieri, DC (corresponding author), Wistar Inst Anat & Biol, Ctr Canc, 3601 Spruce St, Philadelphia, PA 19104 USA.	daltieri@wistar.org	Kang, Byoung Heon/E-6165-2010	Kang, Byoung Heon/0000-0001-5902-0549; Socolovsky, Merav/0000-0001-6747-7960	National Institutes of Health [CA78810, CA140043, HL54131, HL084168, CA118005]; NATIONAL CANCER INSTITUTE [R01CA078810, P01CA140043, R01CA118005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL054131, R01HL054131, R01HL084168] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA78810, CA140043, HL54131, HL084168, and CA118005.	Ach M, 2009, LEUKEMIA, V23, P712, DOI 10.1038/leu.2008.363; Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Baker MJ, 2007, TRENDS CELL BIOL, V17, P456, DOI 10.1016/j.tcb.2007.07.010; Beckers A, 2007, EUR J ENDOCRINOL, V157, P371, DOI 10.1530/EJE-07-0348; Bolender N, 2008, EMBO REP, V9, P42, DOI 10.1038/sj.embor.7401126; Carver LA, 1997, J BIOL CHEM, V272, P11452; Ceballos-Cancino G, 2007, ONCOGENE, V26, P7569, DOI 10.1038/sj.onc.1210560; Colnaghi R, 2006, J BIOL CHEM, V281, P33450, DOI 10.1074/jbc.C600164200; DiGiovanni R, 2007, ENDOCR PATHOL, V18, P76, DOI 10.1007/s12022-007-0010-z; Dohi T, 2004, J BIOL CHEM, V279, P34087, DOI 10.1074/jbc.C400236200; Dohi T, 2004, J CLIN INVEST, V114, P1117, DOI 10.1172/JCI200422222; Dohi T, 2007, MOL CELL, V27, P17, DOI 10.1016/j.molcel.2007.06.004; Fortugno P, 2003, P NATL ACAD SCI USA, V100, P13791, DOI 10.1073/pnas.2434345100; Georgitsi M, 2008, J CLIN ENDOCR METAB, V93, P4146, DOI 10.1210/jc.2008-1003; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; Heliovaara E, 2009, AM J PATHOL, V175, P2501, DOI 10.2353/ajpath.2009.081131; Igney FH, 2002, NAT REV CANCER, V2, P277, DOI 10.1038/nrc776; Kang BH, 2006, J BIOL CHEM, V281, P24721, DOI 10.1074/jbc.M603175200; Koehler CM, 2004, ANNU REV CELL DEV BI, V20, P309, DOI 10.1146/annurev.cellbio.20.010403.105057; LaPres JJ, 2000, J BIOL CHEM, V275, P6153, DOI 10.1074/jbc.275.9.6153; Leontiou CA, 2008, J CLIN ENDOCR METAB, V93, P2390, DOI 10.1210/jc.2007-2611; Leung CG, 2007, J EXP MED, V204, P1603, DOI 10.1084/jem.20062395; Li FZ, 2010, AM J PATHOL, V176, P1629, DOI 10.2353/ajpath.2010.090414; Lin BC, 2007, J BIOL CHEM, V282, P35924, DOI 10.1074/jbc.M705471200; Ma Q, 1997, J BIOL CHEM, V272, P8878; Mehrotra S, 2010, CANCER CELL, V17, P53, DOI 10.1016/j.ccr.2009.11.021; Meyer BK, 1999, BIOCHEMISTRY-US, V38, P8907, DOI 10.1021/bi982223w; Mita AC, 2008, CLIN CANCER RES, V14, P5000, DOI 10.1158/1078-0432.CCR-08-0746; Motz C, 2002, J MOL BIOL, V323, P729, DOI 10.1016/S0022-2836(02)00995-6; Musacchio A, 2010, SCIENCE, V330, P183, DOI 10.1126/science.1197261; Nukaya M, 2010, J BIOL CHEM, V285, P35599, DOI 10.1074/jbc.M110.132043; Ozfirat Z, 2010, MOL CELL ENDOCRINOL, V326, P71, DOI 10.1016/j.mce.2010.05.001; Pop R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000484; Raitila A, 2010, AM J PATHOL, V177, P1969, DOI 10.2353/ajpath.2010.100138; Rapaport D, 2005, J CELL BIOL, V171, P419, DOI 10.1083/jcb.200507147; Small S, 2010, LEUKEMIA, V24, P1920, DOI 10.1038/leu.2010.198; Socolovsky M, 2007, PLOS BIOL, V5, P2296, DOI 10.1371/journal.pbio.0050252; Song ZY, 2003, J BIOL CHEM, V278, P23130, DOI 10.1074/jbc.M300957200; Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008; Vierimaa O, 2006, SCIENCE, V312, P1228, DOI 10.1126/science.1126100; Wilson TR, 2009, CURR CANCER DRUG TAR, V9, P307, DOI 10.2174/156800909788166547; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1; Xia F, 2006, CANCER RES, V66, P3392, DOI 10.1158/0008-5472.CAN-05-4537; Yano M, 2003, J CELL BIOL, V163, P45, DOI 10.1083/jcb.200305051; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3; Zhang J, 2003, BLOOD, V102, P3938, DOI 10.1182/blood-2003-05-1479; Zwerts F, 2007, BLOOD, V109, P4742, DOI 10.1182/blood-2006-06-028068	47	32	33	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16758	16767		10.1074/jbc.M110.210120	http://dx.doi.org/10.1074/jbc.M110.210120			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454573	Green Published, hybrid			2022-12-25	WOS:000290301900024
J	Liu, HB; Chen, CH; Espinoza-Lewis, RA; Jiao, Z; Sheu, I; Hu, XF; Lin, MK; Zhang, YD; Chen, YP				Liu, Hongbing; Chen, Chao-Hui; Espinoza-Lewis, Ramon A.; Jiao, Zhen; Sheu, Ivana; Hu, Xuefeng; Lin, Minkui; Zhang, Yanding; Chen, YiPing			Functional Redundancy between Human SHOX and Mouse Shox2 Genes in the Regulation of Sinoatrial Node Formation and Pacemaking Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOMEOBOX GENE; TURNER-SYNDROME; SHORT-STATURE; LERI-WEILL; TARGETED MUTATION; HEART; MICE; DYSCHONDROSTEOSIS; EXPRESSION; DYSPLASIA	The homeodomain transcription factor Shox2 plays a crucial regulatory role in the development of sinoatrial node (SAN) by repressing the expression of Nkx2.5, as demonstrated by failed differentiation of SAN in Shox2 null mice. The SHOX (short stature homeobox) gene family consists of two closely related members, SHOX and SHOX2 in humans, but a SHOX ortholog does not exist in the mouse genome. These two genes exhibit overlapping and distinct expression patterns in many developing organs but whether they share functional redundancy is not known. In this study, we set to investigate possible functional redundancy between SHOX and SHOX2 in vitro and in vivo. We first showed that human SHOX and SHOX2 and mouse Shox2 possess similar transcriptional repressive activities in cell cultures, particularly the repressive effects on the Nkx2.5 promoter activity. We further created an SHOX/Shox2 knock-in mouse line (replacement of Shox2 with SHOX, referred as Shox2(KI/KI)). Mice carrying the hypomorphic Shox2(KI+Neo/KI+Neo) allele exhibit bradycardia and arrhythmia and die a few days after birth. However, mice carrying the Shox2(KI/KI) allele grow to adulthood. Physiological, histological, and molecular analyses demonstrate a fully developed SAN and normal pacemaking function in Shox2(KI/KI) mice. Our results demonstrate a functional redundancy between human SHOX and mouse Shox2 in the regulation of SAN formation and pacemaking function in addition to several other organs. The SHOX/Shox2 dose appears to be critical for normal pacemaking function.	[Liu, Hongbing; Chen, Chao-Hui; Espinoza-Lewis, Ramon A.; Sheu, Ivana; Lin, Minkui; Chen, YiPing] Tulane Univ, Dept Cell & Mol Biol, New Orleans, LA 70118 USA; [Jiao, Zhen] Tulane Univ, Div Cardiol, Dept Med, New Orleans, LA 70118 USA; [Hu, Xuefeng; Zhang, Yanding; Chen, YiPing] Fujian Normal Univ, Coll Life Sci, Fujian Key Lab Dev & Neurobiol, Fuzhou 350108, Fujian Province, Peoples R China	Tulane University; Tulane University; Fujian Normal University	Chen, YP (corresponding author), Tulane Univ, Dept Cell & Mol Biol, New Orleans, LA 70118 USA.	ychen@tulane.edu	Liu, Hongbing/I-4052-2014	Liu, Hongbing/0000-0002-3411-4597; Espinoza-Lewis, Ramon/0000-0003-3068-5517	National Institutes of Health [R01 DE17792]; NSF of China [30871422]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE017792] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DE17792 (to Y. P. C.). This work was also supported by an NSF of China Grant 30871422 (to Y. Z.).	Belin V, 1998, NAT GENET, V19, P67, DOI 10.1038/ng0198-67; Blaschke RJ, 1998, P NATL ACAD SCI USA, V95, P2406, DOI 10.1073/pnas.95.5.2406; Blaschke RJ, 2007, CIRCULATION, V115, P1830, DOI 10.1161/CIRCULATIONAHA.106.637819; Christoffels VM, 2010, CIRC RES, V106, P240, DOI 10.1161/CIRCRESAHA.109.205419; Clement-Jones M, 2000, HUM MOL GENET, V9, P695, DOI 10.1093/hmg/9.5.695; Cobb J, 2006, P NATL ACAD SCI USA, V103, P4511, DOI 10.1073/pnas.0510544103; Durham D, 2002, Crit Care Resusc, V4, P35; Ellison JW, 1997, HUM MOL GENET, V6, P1341, DOI 10.1093/hmg/6.8.1341; Espinoza-Lewis RA, 2009, DEV BIOL, V327, P376, DOI 10.1016/j.ydbio.2008.12.028; Furukawa T, 1997, P NATL ACAD SCI USA, V94, P3088, DOI 10.1073/pnas.94.7.3088; Gu SP, 2008, MECH DEVELOP, V125, P729, DOI 10.1016/j.mod.2008.04.003; LILLIE JW, 1989, NATURE, V338, P39, DOI 10.1038/338039a0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Presnell JK, 1997, HUMASONS ANIMAL TISS, P124; Puskaric S, 2010, HUM MOL GENET, V19, P4625, DOI 10.1093/hmg/ddq393; Rao E, 1997, NAT GENET, V16, P54, DOI 10.1038/ng0597-54; Rao E, 2001, HUM MOL GENET, V10, P3083, DOI 10.1093/hmg/10.26.3083; Rovescalli AC, 1996, P NATL ACAD SCI USA, V93, P10691, DOI 10.1073/pnas.93.20.10691; Semina EV, 1998, HUM MOL GENET, V7, P415, DOI 10.1093/hmg/7.3.415; Shears DJ, 1998, NAT GENET, V19, P70, DOI 10.1038/ng0198-70; SWIATEK PJ, 1993, GENE DEV, V7, P2071, DOI 10.1101/gad.7.11.2071; Van Mierop L H, 1970, Am J Cardiol, V25, P204, DOI 10.1016/0002-9149(70)90580-1; Yu L, 2005, DEVELOPMENT, V132, P4397, DOI 10.1242/dev.02013; Yu L, 2007, DEV BIOL, V306, P549, DOI 10.1016/j.ydbio.2007.03.518; Zinn AR, 2002, AM J MED GENET, V110, P158, DOI 10.1002/ajmg.10422	25	36	37	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17029	17038		10.1074/jbc.M111.234252	http://dx.doi.org/10.1074/jbc.M111.234252			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454626	Green Published, hybrid			2022-12-25	WOS:000290301900053
J	Martin, J; Masri, J; Cloninger, C; Holmes, B; Artinian, N; Funk, A; Ruegg, T; Anderson, L; Bashir, T; Bernath, A; Lichtenstein, A; Gera, J				Martin, Jheralyn; Masri, Janine; Cloninger, Cheri; Holmes, Brent; Artinian, Nicholas; Funk, Alexander; Ruegg, Teresa; Anderson, Lauren; Bashir, Tariq; Bernath, Andrew; Lichtenstein, Alan; Gera, Joseph			Phosphomimetic Substitution of Heterogeneous Nuclear Ribonucleoprotein A1 at Serine 199 Abolishes AKT-dependent Internal Ribosome Entry Site-transacting Factor (ITAF) Function via Effects on Strand Annealing and Results in Mammalian Target of Rapamycin Complex 1 (mTORC1) Inhibitor Sensitivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-BINDING-PROTEINS; TRANS-ACTING FACTORS; MESSENGER-RNA; CYCLIN D1; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; ENHANCED SENSITIVITY; GENE-EXPRESSION; TRANSLATION; PHOSPHORYLATION; PATHWAY	The relative activity of the AKT kinase has been demonstrated to be a major determinant of sensitivity of tumor cells to mammalian target of rapamycin (mTOR) complex 1 inhibitors. Our previous studies have shown that the multifunctional RNA-binding protein heterogeneous nuclear ribonucleoprotein (hnRNP) A1 regulates a salvage pathway facilitating internal ribosome entry site (IRES)-dependent mRNA translation of critical cellular determinants in an AKT-dependent manner following mTOR inhibitor exposure. This pathway functions by stimulating IRES-dependent translation in cells with relatively quiescent AKT, resulting in resistance to rapamycin. However, the pathway is repressed in cells with elevated AKT activity, rendering them sensitive to rapamycin-induced G(1) arrest as a result of the inhibition of global eIF-4E-mediated translation. AKT phosphorylation of hnRNP A1 at serine 199 has been demonstrated to inhibit IRES-mediated translation initiation. Here we describe a phosphomimetic mutant of hnRNP A1 (S199E) that is capable of binding both the cyclin D1 and c-MYC IRES RNAs in vitro but lacks nucleic acid annealing activity, resulting in inhibition of IRES function in dicistronic mRNA reporter assays. Utilizing cells in which AKT is conditionally active, we demonstrate that overexpression of this mutant renders quiescent AKT-containing cells sensitive to rapamycin in vitro and in xenografts. We also demonstrate that activated AKT is strongly correlated with elevated Ser(P)(199)-hnRNP A1 levels in a panel of 22 glioblastomas. These data demonstrate that the phosphorylation status of hnRNP A1 serine 199 regulates the AKT-dependent sensitivity of cells to rapamycin and functionally links IRES-transacting factor annealing activity to cellular responses to mTOR complex 1 inhibition.	[Martin, Jheralyn; Masri, Janine; Cloninger, Cheri; Holmes, Brent; Artinian, Nicholas; Funk, Alexander; Ruegg, Teresa; Anderson, Lauren; Bashir, Tariq; Bernath, Andrew; Lichtenstein, Alan; Gera, Joseph] Greater Los Angeles Vet Affairs Healthcare Syst, Dept Res & Dev, Los Angeles, CA 91343 USA; [Lichtenstein, Alan; Gera, Joseph] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90048 USA; [Lichtenstein, Alan; Gera, Joseph] Univ Calif Los Angeles, Jonnson Comprehens Canc Ctr, Los Angeles, CA 90048 USA; [Gera, Joseph] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90048 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Gera, J (corresponding author), 16111 Plummer Str 151,Bldg 1,Rm C111A, Sepulveda, CA 91343 USA.	jgera@mednet.ucla.edu		Holmes, Brent/0000-0002-2768-2991; Gera, Joseph/0000-0002-2908-6894	National Institutes of Health [R01CA111448, R01CA109312]; Department of Veterans Affairs; Department of Defense; NATIONAL CANCER INSTITUTE [R01CA109312, R01CA111448, R01CA132778] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA111448 (to A. L.) and R01CA109312 (to J. G.). This work was also supported by funds from the Department of Veterans Affairs and the Department of Defense.	Bonnal S, 2005, J BIOL CHEM, V280, P4144, DOI 10.1074/jbc.M411492200; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Cammas A, 2007, MOL BIOL CELL, V18, P5048, DOI 10.1091/mbc.E07-06-0603; Cammas A, 2008, BIOCHEM PHARMACOL, V76, P1395, DOI 10.1016/j.bcp.2008.05.022; Chakravarti A, 2004, J CLIN ONCOL, V22, P1926, DOI 10.1200/JCO.2004.07.193; Choe G, 2003, CANCER RES, V63, P2742; COBIANCHI F, 1993, NUCLEIC ACIDS RES, V21, P949, DOI 10.1093/nar/21.4.949; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Fleischer TC, 2006, GENE DEV, V20, P1294, DOI 10.1101/gad.1422006; Gera JF, 2004, J BIOL CHEM, V279, P2737, DOI 10.1074/jbc.M309999200; Gratton JP, 2001, J BIOL CHEM, V276, P30359, DOI 10.1074/jbc.M009698200; HAMILTON BJ, 1993, J BIOL CHEM, V268, P8881; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; HENICS T, 1994, J BIOL CHEM, V269, P5377; Holcik M, 2004, CURR CANCER DRUG TAR, V4, P299, DOI 10.2174/1568009043333005; IDRISS H, 1994, BIOCHEMISTRY-US, V33, P11382, DOI 10.1021/bi00203a037; Jo OD, 2008, J BIOL CHEM, V283, P23274, DOI 10.1074/jbc.M801185200; King P H, 2000, Nucleic Acids Res, V28, pE20, DOI 10.1093/nar/28.7.e20; Kohn AD, 1998, J BIOL CHEM, V273, P11937, DOI 10.1074/jbc.273.19.11937; KUMAR A, 1990, BIOCHEMISTRY-US, V29, P10717, DOI 10.1021/bi00500a001; Le Quesne JPC, 2010, J PATHOL, V220, P140, DOI 10.1002/path.2627; Lewis SM, 2008, ONCOGENE, V27, P1033, DOI 10.1038/sj.onc.1210777; Masri J, 2007, CANCER RES, V67, P11712, DOI 10.1158/0008-5472.CAN-07-2223; Mitchell SA, 2003, MOL CELL, V11, P757, DOI 10.1016/S1097-2765(03)00093-5; Neshat MS, 2001, P NATL ACAD SCI USA, V98, P10314, DOI 10.1073/pnas.171076798; Pedrotti S, 2010, EMBO J, V29, P1235, DOI 10.1038/emboj.2010.19; Pickering BM, 2004, MOL CELL BIOL, V24, P5595, DOI 10.1128/MCB.24.12.5595-5605.2004; PINOLROMA S, 1991, SCIENCE, V253, P312, DOI 10.1126/science.1857966; Sammons MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009301; Schultz DE, 1996, J BIOL CHEM, V271, P14134, DOI 10.1074/jbc.271.24.14134; Semler BL, 2008, TRENDS MICROBIOL, V16, P1, DOI 10.1016/j.tim.2007.11.001; Shi YJ, 2005, J BIOL CHEM, V280, P10964, DOI 10.1074/jbc.M407874200; Shi YJ, 2002, CANCER RES, V62, P5027; SIOMI H, 1995, J CELL BIOL, V129, P551, DOI 10.1083/jcb.129.3.551; Spriggs KA, 2008, BIOL CELL, V100, P27, DOI 10.1042/BC20070098; Stoneley M, 2004, ONCOGENE, V23, P3200, DOI 10.1038/sj.onc.1207551; Svitkin YV, 1996, EMBO J, V15, P7147, DOI 10.1002/j.1460-2075.1996.tb01106.x; Yi MY, 2000, J VIROL, V74, P6459, DOI 10.1128/JVI.74.14.6459-6468.2000; Zimmermann S, 1999, SCIENCE, V286, P1741, DOI 10.1126/science.286.5445.1741	39	19	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.205096	http://dx.doi.org/10.1074/jbc.M110.205096			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454539	Green Published, hybrid			2022-12-25	WOS:000290022800078
J	Balfry, S; Welch, DW; Atkinson, J; Lill, A; Vincent, S				Balfry, Shannon; Welch, David W.; Atkinson, Jody; Lill, Al; Vincent, Stephen			The Effect of Hatchery Release Strategy on Marine Migratory Behaviour and Apparent Survival of Seymour River Steelhead Smolts (Oncorhynchus mykiss)	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; JUVENILE CHINOOK SALMON; RENIBACTERIUM-SALMONINARUM; DETECTION PROBABILITIES; STRESS RESPONSES; BRITISH-COLUMBIA; RAINBOW-TROUT; FISH; MORTALITY; CORTISOL	Early marine migratory behaviour and apparent survival of hatchery-reared Seymour River steelhead (Oncorhynchus mykiss) smolts was examined over a four year period (2006-2009) to assess the impact of various management strategies on improving early marine survival. Acoustically tagged smolts were released to measure their survival using estuary and coastal marine receivers forming components of the Pacific Ocean Shelf Tracking (POST) array. Early marine survival was statistically indistinguishable between releases of summer run and winter run steelhead races, night and day releases, and groups released 10 days apart. In 2009, the survival of summer run steelhead released into the river was again trialed against groups released directly into the ocean at a distance from the river mouth. Apparent survival was improved significantly for the ocean released groups. The health and physiological status of the various release groups were monitored in years 20072009, and results indicate that the fish were in good health, with no clinical signs of disease at the time of release. The possibility of a disease event contributing to early marine mortality was further examined in 2009 by vaccinating half of the released fish against common fish diseases (vibriosis, furunculosis). The results suggest that marine survival may be enhanced using this approach, although not to the extent observed when the smolts were transported away from the river mouth before release. In summary, direct experimental testing of different release strategies using the POST array to measure ocean survival accelerated the scientific process by allowing rapid collection of data which enabled the rejection of several existing theories and allowed tentative identification of several new alternative approaches that might improve early marine survival of Seymour River steelhead.	[Balfry, Shannon] Univ British Columbia, Fac Land & Food Syst, Vancouver, BC V5Z 1M9, Canada; [Welch, David W.] Kintama Res Serv Ltd, Nanaimo, BC, Canada; [Atkinson, Jody] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Lill, Al] Living Rivers Georgia Basin Vancouver Isl, N Vancouver, BC, Canada; [Vincent, Stephen] Seymour Salmonid Soc, N Vancouver, BC, Canada	University of British Columbia; University of British Columbia	Balfry, S (corresponding author), DFO UBC Ctr Aquaculture & Environm Res, W Vancouver, BC, Canada.	balfry@mail.ubc.ca			Pacific Salmon Foundation (PSF); Pacific Ocean Shelf Tracking (POST)(Census of Marine Life)	Pacific Salmon Foundation (PSF); Pacific Ocean Shelf Tracking (POST)(Census of Marine Life)	Pacific Salmon Foundation (PSF) (www.psf.ca); Pacific Ocean Shelf Tracking (POST)(Census of Marine Life)(www.vanaqua.org/post). The POST and PSF funding was used to purchase materials and supplies for this research. Neither the POST nor PSF had any role in the design of the study, data collection and analyses, decision to publish, or preparation of the manuscript. Additional in-kind support: Seymour Salmonid Society (www.seymoursalmon.com) provided staff time, equipment, and supplies in-kind for this project; Freshwater Fisheries Society of BC (www.gofishbc.ca) provided staff time, use of transport truck (all in-kind contributions) for this project. The FFSBC had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Kintama Research Corporation (www.kintamaresearch.org) provided salary in-kind contributions for tagging staff and salary for author D. Welch to participate in this project; BC Living Rivers Trust Fund (www.livingrivers.ca) provided funding for this project and in-kind support for the salary of co-author A. Lill to participate in this project. The PSF and POST had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON DP, 1992, VET IMMUNOL IMMUNOP, V30, P419, DOI 10.1016/0165-2427(92)90110-C; Arkoosh MR, 2001, J AQUAT ANIM HEALTH, V13, P257, DOI 10.1577/1548-8667(2001)013&lt;0257:ISOJCS&gt;2.0.CO;2; BANNER CR, 1986, J FISH DIS, V9, P273, DOI 10.1111/j.1365-2761.1986.tb01013.x; BARRY TP, 1993, AQUACULTURE, V117, P351, DOI 10.1016/0044-8486(93)90331-R; BARTON BA, 1985, GEN COMP ENDOCR, V59, P468, DOI 10.1016/0016-6480(85)90406-X; CHITTENDEN CM, PLOS ONE, V5; CHITTENDEN CM, 2008, ENVIRON BIOL FISH, V84, P129; Crozier LG, 2008, EVOL APPL, V1, P252, DOI 10.1111/j.1752-4571.2008.00033.x; ENGLISH KK, 2008, UPSTREAM BATTLE DECL; *FISH HLTH SEC AM, 2003, AFS FHS SUGG PROC DE; GOEDE RW, 1990, AM FISHERIES SOC S, V8, P93; Handeland SO, 1996, CAN J FISH AQUAT SCI, V53, P2673, DOI 10.1139/f96-227; HILLE S, 1982, J FISH BIOL, V20, P535, DOI 10.1111/j.1095-8649.1982.tb03954.x; Kent ML, 1998, J AQUAT ANIM HEALTH, V10, P211, DOI 10.1577/1548-8667(1998)010&lt;0211:SOSPIO&gt;2.0.CO;2; Klontz G.W., 1994, TECHNIQUES FISH IMMU, P121; Lacroix GL, 2004, T AM FISH SOC, V133, P211, DOI 10.1577/T03-071; LUDWIG B, 1995, AM FISH S S, V15, P139; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; McCormick S.D., 1987, AM FISH SOC S, V1, P211; MCCORMICK SD, 1993, CAN J FISH AQUAT SCI, V50, P656, DOI 10.1139/f93-075; Melnychuk MC, 2009, J FISH BIOL, V75, P1773, DOI 10.1111/j.1095-8649.2009.02428.x; Melnychuk MC, 2010, CAN J FISH AQUAT SCI, V67, P641, DOI 10.1139/F09-199; Melnychuk MC, 2009, MAR FRESHWATER RES, V60, P1231, DOI 10.1071/MF08361; MELYNCHUK MC, 2009, 2 CAN NAT RAILW CO; Mesa MG, 1998, CAN J FISH AQUAT SCI, V55, P1599, DOI 10.1139/cjfas-55-7-1599; Moore A, 2003, AQUACULTURE, V222, P253, DOI 10.1016/S0044-8486(03)00126-1; Moore ME, 2010, T AM FISH SOC, V139, P49, DOI 10.1577/T09-012.1; PASCHO RJ, 1987, CAN J FISH AQUAT SCI, V44, P183, DOI 10.1139/f87-024; Pascho RJ, 1998, J VET DIAGN INVEST, V10, P60, DOI 10.1177/104063879801000111; PAYAN P, 1984, FISH PHYSIOL, V10, P39; RECHISKY EL, 2010, PACIFIC NW AQUATIC M, P71; Rechisky EL, 2009, CAN J FISH AQUAT SCI, V66, P1019, DOI 10.1139/F09-078; ROBERSON BS, 1990, TECHNIQUES FISH IMMU, P81; SCHROCK RM, 1994, T AM FISH SOC, V123, P223, DOI 10.1577/1548-8659(1994)123&lt;0223:AMFGSP&gt;2.3.CO;2; SORUM U, 2004, AQUAC, V232, P33; Ward BR, 2000, CAN J FISH AQUAT SCI, V57, P298, DOI 10.1139/cjfas-57-2-298; Welch DW, 2007, HYDROBIOLOGIA, V582, P289, DOI 10.1007/s10750-006-0553-x; Welch DW, 2008, PLOS BIOL, V6, P2101, DOI 10.1371/journal.pbio.0060265; Welch DW, 2009, CAN J FISH AQUAT SCI, V66, P736, DOI 10.1139/F09-032; Welch DW, 2000, FISH OCEANOGR, V9, P17; Welch DW, 2004, DEEP-SEA RES PT II, V51, P897, DOI 10.1016/j.dsr2.2004.05.010; Welch DW, 2002, OCEANOL ACTA, V25, P243, DOI 10.1016/S0399-1784(02)01206-9; WELCH DW, 2011, P NAT ACAD IN PRESS; WOOD CC, 2011, T AM FISH S IN PRESS	44	10	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e14779	10.1371/journal.pone.0014779	http://dx.doi.org/10.1371/journal.pone.0014779			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21468320	Green Submitted, Green Published, gold			2022-12-25	WOS:000289054600001
J	Li, YZ; Li, GB; Wen, ZN; Yin, H; Hu, M; Xiao, JM; Li, ML				Li, Yizhou; Li, Gongbing; Wen, Zhining; Yin, Hui; Hu, Mei; Xiao, Jiamin; Li, Menglong			Novel Feature for Catalytic Protein Residues Reflecting Interactions with Other Residues	PLOS ONE			English	Article							FUNCTIONALLY IMPORTANT RESIDUES; ACTIVE-SITES; PREDICTION; NETWORK; ENZYME; SEQUENCE; EVOLUTION	Owing to their potential for systematic analysis, complex networks have been widely used in proteomics. Representing a protein structure as a topology network provides novel insight into understanding protein folding mechanisms, stability and function. Here, we develop a new feature to reveal correlations between residues using a protein structure network. In an original attempt to quantify the effects of several key residues on catalytic residues, a power function was used to model interactions between residues. The results indicate that focusing on a few residues is a feasible approach to identifying catalytic residues. The spatial environment surrounding a catalytic residue was analyzed in a layered manner. We present evidence that correlation between residues is related to their distance apart: most environmental parameters of the outer layer make a smaller contribution to prediction; and (ii) catalytic residues tend to be located near key positions in enzyme folds. Feature analysis revealed satisfactory performance for our features, which were combined with several conventional features in a prediction model for catalytic residues using a comprehensive data set from the Catalytic Site Atlas. Values of 88.6% for sensitivity and 88.4% for specificity were obtained by 10-fold cross-validation. These results suggest that these features reveal the mutual dependence of residues and are promising for further study of structure-function relationship.	[Li, Yizhou] Sichuan Univ, Coll Chem, Chengdu 610064, Peoples R China; Sichuan Univ, State Key Lab Biotherapy, Chengdu 610064, Peoples R China	Sichuan University; Sichuan University	Li, YZ (corresponding author), Sichuan Univ, Coll Chem, Chengdu 610064, Peoples R China.	liml@scu.edu.cn	meng, li/GVT-2063-2022		National Nature Science Foundation of China [20972103]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Nature Science Foundation of China (No. 20972103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amitai G, 2004, J MOL BIOL, V344, P1135, DOI 10.1016/j.jmb.2004.10.055; Bagler G, 2005, PHYSICA A, V346, P27, DOI 10.1016/j.physa.2004.08.046; Bartlett GJ, 2002, J MOL BIOL, V324, P105, DOI 10.1016/S0022-2836(02)01036-7; Ben-Shimon A, 2005, J MOL BIOL, V351, P309, DOI 10.1016/j.jmb.2005.06.047; Brinda KV, 2005, BIOPHYS J, V89, P4159, DOI 10.1529/biophysj.105.064485; Burt RS, 2004, AM J SOCIOL, V110, P349, DOI 10.1086/421787; Capra JA, 2007, BIOINFORMATICS, V23, P1875, DOI 10.1093/bioinformatics/btm270; Chea E, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-153; Cheng G, 2005, NUCLEIC ACIDS RES, V33, P5861, DOI 10.1093/nar/gki894; Csardi N., 2006, INT J COMP SYST, V1695, P1; del Sol A, 2006, PROTEIN SCI, V15, P2120, DOI 10.1110/ps.062249106; Dokholyan NV, 2002, P NATL ACAD SCI USA, V99, P8637, DOI 10.1073/pnas.122076099; Fischer JD, 2008, BIOINFORMATICS, V24, P613, DOI 10.1093/bioinformatics/btm626; Goyal K, 2007, NUCLEIC ACIDS RES, V35, pW503, DOI 10.1093/nar/gkm252; Greene LH, 2003, J MOL BIOL, V334, P781, DOI 10.1016/j.jmb.2003.08.061; Gutteridge A, 2003, J MOL BIOL, V330, P719, DOI 10.1016/S0022-2836(03)00515-1; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Hall M., 2009, SIGKDD EXPLOR, V11, P10, DOI [DOI 10.1145/1656274.1656278, 10.1145/1656274.1656278]; Ikura T, 2008, PROTEIN ENG DES SEL, V21, P83, DOI 10.1093/protein/gzm087; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kleinberg JM, 1999, J ACM, V46, P604, DOI 10.1145/324133.324140; Ko J, 2005, BIOINFORMATICS, V21, pI258, DOI 10.1093/bioinformatics/bti1039; La D, 2005, PROTEINS, V58, P309, DOI 10.1002/prot.20321; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Ondrechen MJ, 2001, P NATL ACAD SCI USA, V98, P12473, DOI 10.1073/pnas.211436698; Pazos F, 2004, P NATL ACAD SCI USA, V101, P14754, DOI 10.1073/pnas.0404569101; Petrova NV, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-312; Porter CT, 2004, NUCLEIC ACIDS RES, V32, pD129, DOI 10.1093/nar/gkh028; Pugalenthi G, 2008, BIOCHEM BIOPH RES CO, V367, P630, DOI 10.1016/j.bbrc.2008.01.038; Sacquin-Mora S, 2007, PROTEINS, V67, P350, DOI 10.1002/prot.21353; Sankararaman S, 2010, BIOINFORMATICS, V26, P617, DOI 10.1093/bioinformatics/btq008; Stark A, 2004, STRUCTURE, V12, P1405, DOI 10.1016/j.str.2004.05.012; Sterner B, 2007, J COMPUT BIOL, V14, P1058, DOI 10.1089/cmb.2007.0042; Tang YR, 2008, PROTEIN ENG DES SEL, V21, P295, DOI 10.1093/protein/gzn003; Tokuriki N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000002; Tong WX, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000266; Torrance JW, 2005, J MOL BIOL, V347, P565, DOI 10.1016/j.jmb.2005.01.044; Vendruscolo M, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.061910; Vendruscolo M, 2001, NATURE, V409, P641, DOI 10.1038/35054591; Wangikar PP, 2003, J MOL BIOL, V326, P955, DOI 10.1016/S0022-2836(02)01384-0; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Youn E, 2007, PROTEIN SCI, V16, P216, DOI 10.1110/ps.062523907; Zhang T, 2008, BIOINFORMATICS, V24, P2329, DOI 10.1093/bioinformatics/btn433	45	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e16932	10.1371/journal.pone.0016932	http://dx.doi.org/10.1371/journal.pone.0016932			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21468322	Green Submitted, Green Published, gold			2022-12-25	WOS:000289054600007
J	Yin, HE; Vosters, JL; Roescher, N; D'Souza, A; Kurien, BT; Tak, PP; Chiorini, JA				Yin, Hongen; Vosters, Jelle L.; Roescher, Nienke; D'Souza, Anil; Kurien, Biji T.; Tak, Paul P.; Chiorini, John A.			Location of Immunization and Interferon-gamma Are Central to Induction of Salivary Gland Dysfunction in Ro60 Peptide Immunized Model of Sjogren's Syndrome	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CELL-LINE; ANTI-RO; AUTOANTIGEN; MICE; MOUSE	Introduction: Anti-Ro antibodies can be found in the serum of the majority of patients with Sjogren's syndrome (SS). Immunization with a 60-kDa Ro peptide has been shown to induce SS-like symptoms in mice. The aim of this study was to investigate factors involved in salivary gland (SG) dysfunction after immunization and to test whether the induction of SS could be improved. Methods: Ro60 peptide immunization was tested in Balb/c mice, multiple antigenic peptide (MAP)-Ro60 and Pertussis toxin (PTX) were tested in SJL/J mice. In addition, two injection sites were compared in these two strains: the abdominal area and the tailbase. Each group of mice was tested for a loss of SG function, SG lymphocytic infiltration, anti-Ro and anti-La antibody formation, and cytokine production in cultured cells or homogenized SG extracts. Results: Ro60 peptide immunization in the abdominal area of female Balb/c mice led to impaired SG function, which corresponded with increased Th1 cytokines (IFN-gamma and IL-12) systemically and locally in the SG. Moreover, changing the immunization conditions to MAP-Ro60 in the abdominal area, and to lesser extend in the tailbase, also led to impaired SG function in SJL/J mice. As was seen in the Balb/c mice, increased IFN-gamma in the SG draining lymph nodes accompanied the SG dysfunction. However, no correlation was observed with anti-MAP-Ro60 antibody titers, and there was no additional effect on disease onset or severity. Conclusions: Effective induction of salivary gland dysfunction after Ro60 peptide immunization depended on the site of injection. Disease induction was not affected by changing the immunization conditions. However, of interest is that the mechanism of action of Ro60 peptide immunization appears to involve an increase in Th1 cytokines, resulting in the induction of SG dysfunction.	[Yin, Hongen; Vosters, Jelle L.; Roescher, Nienke; Chiorini, John A.] Natl Inst Dent & Craniofacial Res, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD 20892 USA; [Vosters, Jelle L.; Roescher, Nienke; Tak, Paul P.] Univ Amsterdam, Acad Med Ctr, Div Clin Immunol & Rheumatol, NL-1105 AZ Amsterdam, Netherlands; [D'Souza, Anil; Kurien, Biji T.] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of Amsterdam; Academic Medical Center Amsterdam; University of Oklahoma System; University of Oklahoma Health Sciences Center	Yin, HE (corresponding author), Natl Inst Dent & Craniofacial Res, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD 20892 USA.	jchiorini@dir.nidcr.nih.gov	Kurien, Biji T/C-2392-2008	Kurien, Biji T/0000-0002-7877-6859	Dutch Arthritis Association [NR 07-1-406]; NIH, NIDCR; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000695] Funding Source: NIH RePORTER	Dutch Arthritis Association; NIH, NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work is supported by a Dutch Arthritis Association grant [NR 07-1-406] to JLV and an NIH, NIDCR intramural research grant to JAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson AK, 2009, ANN RHEUM DIS, V68, P1746, DOI 10.1136/ard.2008.097642; Bombardieri M, 2004, ARTHRITIS RES THER, V6, pR447, DOI 10.1186/ar1209; Cruz LJ, 2004, BIOCONJUGATE CHEM, V15, P112, DOI 10.1021/bc034119j; Fox RI, 2005, LANCET, V366, P321, DOI 10.1016/S0140-6736(05)66990-5; Hansen A, 2003, CURR OPIN RHEUMATOL, V15, P563, DOI 10.1097/00002281-200309000-00007; HARLEY JB, 1992, RHEUM DIS CLIN N AM, V18, P337; JAMES JA, 1995, J EXP MED, V181, P453, DOI 10.1084/jem.181.2.453; Lodde BM, 2006, ORAL DIS, V12, P566, DOI 10.1111/j.1601-0825.2006.01241.x; Meehan S, 1997, AM J PHYSIOL-CELL PH, V273, pC2030, DOI 10.1152/ajpcell.1997.273.6.C2030; Oscherwitz J, 2009, INFECT IMMUN, V77, P5509, DOI 10.1128/IAI.00899-09; Papenfuss TL, 2004, J NEUROIMMUNOL, V150, P59, DOI 10.1016/j.jneuroim.2004.01.018; Pastor S, 2009, J IMMUNOL, V182, P5268, DOI 10.4049/jimmunol.0800681; Praprotnik S, 1999, CLIN EXP RHEUMATOL, V17, P63; Rhodes DA, 2002, IMMUNOLOGY, V106, P246, DOI 10.1046/j.1365-2567.2002.01417.x; Sasaki Motoko, 2002, Dev Immunol, V9, P103, DOI 10.1080/1044667021000096455; Scofield RH, 2005, J IMMUNOL, V175, P8409, DOI 10.4049/jimmunol.175.12.8409; Scofield RH, 1996, J IMMUNOL, V156, P4059; Scofield RH, 1999, ARTHRITIS RHEUM, V42, P1017, DOI 10.1002/1529-0131(199905)42:5<1017::AID-ANR22>3.0.CO;2-7; Silver PB, 1999, INVEST OPHTH VIS SCI, V40, P2898; Vivino FB, 2002, J RHEUMATOL, V29, P938; Vosters JL, 2009, ARTHRITIS RHEUM-US, V60, P3633, DOI 10.1002/art.24980; Wu AJ, 1997, J CELL PHYSIOL, V173, P110, DOI 10.1002/(SICI)1097-4652(199710)173:1<110::AID-JCP13>3.0.CO;2-M	22	16	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e18003	10.1371/journal.pone.0018003	http://dx.doi.org/10.1371/journal.pone.0018003			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464925	Green Published, Green Submitted, gold			2022-12-25	WOS:000289053800011
J	Barbet-Massin, M; Jiguet, F				Barbet-Massin, Morgane; Jiguet, Frederic			Back from a Predicted Climatic Extinction of an Island Endemic: A Future for the Corsican Nuthatch	PLOS ONE			English	Article							SPECIES RANGE SHIFTS; BIOTIC INTERACTIONS; DISTRIBUTIONS; MODELS; BIODIVERSITY; DIVERSITY; IMPACTS; THREATS	The Corsican Nuthatch (Sitta whiteheadi) is red-listed as vulnerable to extinction by the IUCN because of its endemism, reduced population size, and recent decline. A further cause is the fragmentation and loss of its spatially-restricted favourite habitat, the Corsican pine (Pinus nigra laricio) forest. In this study, we aimed at estimating the potential impact of climate change on the distribution of the Corsican Nuthatch using species distribution models. Because this species has a strong trophic association with the Corsican and Maritime pines (P. nigra laricio and P. pinaster), we first modelled the current and future potential distribution of both pine species in order to use them as habitat variables when modelling the nuthatch distribution. However, the Corsican pine has suffered large distribution losses in the past centuries due to the development of anthropogenic activities, and is now restricted to mountainous woodland. As a consequence, its realized niche is likely significantly smaller than its fundamental niche, so that a projection of the current distribution under future climatic conditions would produce misleading results. To obtain a predicted pine distribution at closest to the geographic projection of the fundamental niche, we used available information on the current pine distribution associated to information on the persistence of isolated natural pine coppices. While common thresholds (maximizing the sum of sensitivity and specificity) predicted a potential large loss of the Corsican Nuthatch distribution by 2100, the use of more appropriate thresholds aiming at getting closer to the fundamental distribution of the Corsican pine predicted that 98% of the current presence points should remain potentially suitable for the nuthatch and its range could be 10% larger in the future. The habitat of the endemic Corsican Nuthatch is therefore more likely threatened by an increasing frequency and intensity of wildfires or anthropogenic activities than by climate change.	[Barbet-Massin, Morgane; Jiguet, Frederic] Museum Natl Hist Nat, Ctr Rech Biol Populat Oiseaux, UMR MNHN CNRS UPMC 7204, F-75231 Paris, France	Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite	Barbet-Massin, M (corresponding author), Museum Natl Hist Nat, Ctr Rech Biol Populat Oiseaux, UMR MNHN CNRS UPMC 7204, F-75231 Paris, France.	barbet@mnhn.fr			Centre National de la Recherche Scientifique; University Pierre et Marie Curie; Museum National d'Histoire Naturelle	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); University Pierre et Marie Curie; Museum National d'Histoire Naturelle	The study has been funded by the Centre National de la Recherche Scientifique, the University Pierre et Marie Curie and the Museum National d'Histoire Naturelle. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; [Anonymous], GLOB CLIM DAT; Araujo MB, 2007, GLOBAL ECOL BIOGEOGR, V16, P743, DOI 10.1111/j.1466-8238.2007.00359.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Araujo MB, 2009, P NATL ACAD SCI USA, V106, pE45, DOI 10.1073/pnas.0813294106; Barbet-Massin M, 2009, BIOL LETTERS, V5, P248, DOI 10.1098/rsbl.2008.0715; BARTLEIN PJ, 1986, J BIOGEOGR, V13, P35, DOI 10.2307/2844848; Benichou P, 1987, AGROMETEOROLOGIE REG, P51; Blackburn TM, 2004, SCIENCE, V305, P1955, DOI 10.1126/science.1101617; Brooker RW, 2007, J THEOR BIOL, V245, P59, DOI 10.1016/j.jtbi.2006.09.033; Brotons L, 2010, EFFECTS CLIMATE CHAN; Caujape-Castells J, 2010, PERSPECT PLANT ECOL, V12, P107, DOI 10.1016/j.ppees.2009.10.001; Coetzee BWT, 2009, GLOBAL ECOL BIOGEOGR, V18, P701, DOI 10.1111/j.1466-8238.2009.00485.x; Cronk QCB, 1997, BIODIVERS CONSERV, V6, P477, DOI 10.1023/A:1018372910025; Diamond J., 1989, P37; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Heikkinen RK, 2007, GLOBAL ECOL BIOGEOGR, V16, P754, DOI 10.1111/j.1466-8238.2007.00345.x; IUCN, 2010, RED LIST THREATENED; Jimenez-Valverde A, 2007, ACTA OECOL, V31, P361, DOI 10.1016/j.actao.2007.02.001; JOHNSON TH, 1990, IBIS, V132, P167, DOI 10.1111/j.1474-919X.1990.tb01036.x; Kreft H, 2008, ECOL LETT, V11, P116, DOI 10.1111/j.1461-0248.2007.01129.x; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Manel S, 2001, J APPL ECOL, V38, P921, DOI 10.1046/j.1365-2664.2001.00647.x; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; Moneglia P, 2009, J ORNITHOL, V150, P577, DOI 10.1007/s10336-009-0379-1; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; PRENTICE IC, 1992, J BIOGEOGR, V19, P117, DOI 10.2307/2845499; Preston K, 2008, GLOBAL CHANGE BIOL, V14, P2501, DOI 10.1111/j.1365-2486.2008.01671.x; ROOT T, 1988, J BIOGEOGR, V15, P489, DOI 10.2307/2845278; Sadler JP, 1999, J BIOGEOGR, V26, P75, DOI 10.1046/j.1365-2699.1999.00285.x; Sodhi NS, 2004, ANNU REV ECOL EVOL S, V35, P323, DOI 10.1146/annurev.ecolsys.35.112202.130209; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Syphard AD, 2009, CONSERV BIOL, V23, P758, DOI 10.1111/j.1523-1739.2009.01223.x; Thibault JC, BIRD CONSER IN PRESS; Thibault JC, 2006, J AVIAN BIOL, V37, P477, DOI 10.1111/j.0908-8857.2006.03645.x; Thibault Jean-Claude, 2004, Ecologia Mediterranea, V30, P195; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Thuiller W, 2004, GLOBAL CHANGE BIOL, V10, P2020, DOI 10.1111/j.1365-2486.2004.00859.x; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; Van der Putten WH, 2010, PHILOS T R SOC B, V365, P2025, DOI 10.1098/rstb.2010.0037	44	15	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e18228	10.1371/journal.pone.0018228	http://dx.doi.org/10.1371/journal.pone.0018228			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464916	Green Published, Green Submitted, gold			2022-12-25	WOS:000288813900054
J	Caro, LN; Moreau, CJ; Revilloud, J; Vivaudou, M				Caro, Lydia N.; Moreau, Christophe J.; Revilloud, Jean; Vivaudou, Michel			beta(2)-Adrenergic Ion-Channel Coupled Receptors as Conformational Motion Detectors	PLOS ONE			English	Article							K-ATP CHANNEL; SULFONYLUREA RECEPTOR; INTERFACE; SUBUNIT; BETA(2); KIR6.2; TRAFFICKING; MUTATIONS; COMPLEXES; RESIDUES	Ion Channel-Coupled Receptors (ICCRs) are artificial proteins comprised of a G protein-coupled receptor and a fused ion channel, engineered to couple channel gating to ligand binding. These novel biological objects have potential use in drug screening and functional characterization, in addition to providing new tools in the synthetic biology repertoire as synthetic K+-selective ligand-gated channels. The ICCR concept was previously validated with fusion proteins between the K+ channel Kir6.2 and muscarinic M-2 or dopaminergic D-2 receptors. Here, we extend the concept to the distinct, longer beta(2)-adrenergic receptor which, unlike M-2 and D-2 receptors, displayed barely detectable surface expression in our Xenopus oocyte expression system and did not couple to Kir6.2 when unmodified. Here, we show that a Kir6.2-binding protein, the N-terminal transmembrane domain of the sulfonylurea receptor, can greatly increase plasma membrane expression of beta(2) constructs. We then demonstrate how engineering of both receptor and channel can produce beta(2)-Kir6.2 ICCRs. Specifically, removal of 62-72 residues from the cytoplasmic C-terminus of the receptor was required to enable coupling, suggesting that ligand-dependent conformational changes do not efficiently propagate to the distal C-terminus. Characterization of the beta(2) ICCRs demonstrated that full and partial agonists had the same coupling efficacy, that an inverse agonist had no effect and that the stabilizing mutation E122 W reduced agonist-induced coupling efficacy without affecting affinity. Because the ICCRs are expected to report motions of the receptor C-terminus, these results provide novel insights into the conformational dynamics of the beta(2) receptor.	[Caro, Lydia N.; Moreau, Christophe J.; Revilloud, Jean; Vivaudou, Michel] CNRS, Inst Biol Struct, Grenoble, France; [Caro, Lydia N.; Moreau, Christophe J.; Revilloud, Jean; Vivaudou, Michel] CEA, Inst Biol Struct, Grenoble, France; [Caro, Lydia N.; Moreau, Christophe J.; Revilloud, Jean; Vivaudou, Michel] Univ Grenoble 1, Inst Biol Struct, Grenoble, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Caro, LN (corresponding author), CNRS, Inst Biol Struct, Grenoble, France.	vivaudou@ibs.fr	MOREAU, Christophe/AAC-7912-2020; MOREAU, Christophe J/D-3736-2009; Vivaudou, Michel/C-5338-2008	MOREAU, Christophe/0000-0002-5463-9593; MOREAU, Christophe J/0000-0002-5463-9593; Vivaudou, Michel/0000-0002-9777-3127	European Union [STREP NMP4-CT-2005-017114]; Agence Nationale de la Recherche [ANR-09-PIRI-0010]	European Union(European Commission); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was funded by the Sixth Framework Program of the European Union (Receptronics project, STREP NMP4-CT-2005-017114) and the Agence Nationale de la Recherche (ICCR project, grant ANR-09-PIRI-0010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson H, 2003, MOL PHARMACOL, V64, P570, DOI 10.1124/mol.64.3.570; Antcliff JF, 2005, EMBO J, V24, P229, DOI 10.1038/sj.emboj.7600487; Baker JG, 2010, BRIT J PHARMACOL, V160, P1048, DOI 10.1111/j.1476-5381.2010.00754.x; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Caro LN, 2010, BIOPHYS J, V98, p193A, DOI 10.1016/j.bpj.2009.12.1025; Chan KW, 2003, EMBO J, V22, P3833, DOI 10.1093/emboj/cdg376; Chelikani P, 2007, P NATL ACAD SCI USA, V104, P7027, DOI 10.1073/pnas.0702024104; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Corringer PJ, 2010, J PHYSIOL-LONDON, V588, P565, DOI 10.1113/jphysiol.2009.183160; Davare MA, 2001, SCIENCE, V293, P98, DOI 10.1126/science.293.5527.98; Doupnik CA, 2008, J RECEPT SIG TRANSD, V28, P83, DOI [10.1080/10799890801941970, 10.1080/10799890801941970 ]; Dupuis JP, 2008, J PHYSIOL-LONDON, V586, P3075, DOI 10.1113/jphysiol.2008.152744; Frishman WH, 2008, AM J THER, V15, P565, DOI 10.1097/MJT.0b013e318188bdca; Granier S, 2007, J BIOL CHEM, V282, P13895, DOI 10.1074/jbc.M611904200; Hague C, 2004, J PHARMACOL EXP THER, V309, P388, DOI 10.1124/jpet.103.060509; Hosy E, 2007, J PHYSIOL-LONDON, V582, P27, DOI 10.1113/jphysiol.2007.134288; Hosy E, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.043307; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; Kisilevsky AE, 2008, NEURON, V58, P557, DOI 10.1016/j.neuron.2008.03.002; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Lavine N, 2002, J BIOL CHEM, V277, P46010, DOI 10.1074/jbc.M205035200; Lee FJS, 2002, CELL, V111, P219, DOI 10.1016/S0092-8674(02)00962-5; Liu F, 2000, NATURE, V403, P274, DOI 10.1038/35002014; Makarova O, 2000, BIOTECHNIQUES, V29, P970, DOI 10.2144/00295bm08; Mikhailov MV, 2005, EMBO J, V24, P4166, DOI 10.1038/sj.emboj.7600877; MINNEMAN KP, 1981, ANNU REV NEUROSCI, V4, P419, DOI 10.1146/annurev.ne.04.030181.002223; Moreau C, 2005, J MOL CELL CARDIOL, V38, P951, DOI 10.1016/j.yjmcc.2004.11.030; Moreau C, 2000, EMBO J, V19, P6644, DOI 10.1093/emboj/19.24.6644; Moreau CJ, 2008, NAT NANOTECHNOL, V3, P620, DOI 10.1038/nnano.2008.242; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Roth CB, 2008, J MOL BIOL, V376, P1305, DOI 10.1016/j.jmb.2007.12.028; Taira CA, 2010, METHOD ENZYMOL, V485, P37, DOI [10.1016/S0076-6879(10)85003-7, 10.1016/B978-0-12-381296-4.00003-8]; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tucker SJ, 1997, NATURE, V387, P179, DOI 10.1038/387179a0; Wacker D, 2010, J AM CHEM SOC, V132, P11443, DOI 10.1021/ja105108q; Yao XJ, 2006, NAT CHEM BIOL, V2, P417, DOI 10.1038/nchembio801; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4	38	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e18226	10.1371/journal.pone.0018226	http://dx.doi.org/10.1371/journal.pone.0018226			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464970	Green Published, Green Submitted, gold			2022-12-25	WOS:000288813900053
J	Wang, Z; Zhang, XC; Le, MH; Xu, D; Stacey, G; Cheng, JL				Wang, Zheng; Zhang, Xue-Cheng; Le, Mi Ha; Xu, Dong; Stacey, Gary; Cheng, Jianlin			A Protein Domain Co-Occurrence Network Approach for Predicting Protein Function and Inferring Species Phylogeny	PLOS ONE			English	Article							LARGE-SCALE ORGANIZATION; GLOBAL ALIGNMENT; GENE ONTOLOGY; BIOLOGY; CLASSIFICATION; EVOLUTION; DATABASE; YEAST; LIFE; TOOL	Protein Domain Co-occurrence Network (DCN) is a biological network that has not been fully-studied. We analyzed the properties of the DCNs of H. sapiens, S. cerevisiae, C. elegans, D. melanogaster, and 15 plant genomes. These DCNs have the hallmark features of scale-free networks. We investigated the possibility of using DCNs to predict protein and domain functions. Based on our experiment conducted on 66 randomly selected proteins, the best of top 3 predictions made by our DCN-based aggregated neighbor-counting method achieved a semantic similarity score of 0.81 to the actual Gene Ontology terms of the proteins. Moreover, the top 3 predictions using neighbor-counting, chi(2), and a SVM-based method achieved an accuracy of 66%, 59%, and 61%, respectively, when used to predict specific Gene Ontology terms of human target domains. These predictions on average had a semantic similarity score of 0.82, 0.80, and 0.79 to the actual Gene Ontology terms, respectively. We also used DCNs to predict whether a domain is an enzyme domain, and our SVM-based and neighbor-inference method correctly classified 79% and 77% of the target domains, respectively. When using DCNs to classify a target domain into one of the six enzyme classes, we found that, as long as there is one EC number available in the neighboring domains, our SVM-based and neighboring-counting method correctly classified 92.4% and 91.9% of the target domains, respectively. Furthermore, we benchmarked the performance of using DCNs to infer species phylogenies on six different combinations of 398 single-chromosome prokaryotic genomes. The phylogenetic tree of 54 prokaryotic taxa generated by our DCNs-alignment-based method achieved a 93.45% similarity score compared to the Bergey's taxonomy. In summary, our studies show that genome-wide DCNs contain rich information that can be effectively used to decipher protein function and reveal the evolutionary relationship among species.	[Wang, Zheng; Xu, Dong; Cheng, Jianlin] Univ Missouri, Dept Comp Sci, Columbia, MO 65211 USA; [Zhang, Xue-Cheng; Xu, Dong; Stacey, Gary; Cheng, Jianlin] Univ Missouri, Christopher S Bond Life Sci Ctr, Columbia, MO USA; [Zhang, Xue-Cheng; Le, Mi Ha; Stacey, Gary] Univ Missouri, Div Plant Sci, Columbia, MO USA; [Xu, Dong; Cheng, Jianlin] Univ Missouri, Inst Informat, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Wang, Z (corresponding author), Univ Missouri, Dept Comp Sci, Columbia, MO 65211 USA.	chengji@missouri.edu	Cheng, Jianlin/N-8209-2013	Cheng, Jianlin/0000-0003-0305-2853	National Institute of General Medical Science [1R01GM093123, R21/R33 GM078601]; Department of Energy [DE-SC0004898]; National Science Foundation [IOS-1025752]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM078601, R01GM093123] Funding Source: NIH RePORTER; Division Of Integrative Organismal Systems [1025752] Funding Source: National Science Foundation	National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work is partially supported by a National Institutes of Health (NIH) grant 1R01GM093123 from National Institute of General Medical Science (http://www.nigms.nih.gov/), an NIH grant R21/R33 GM078601 from National Institute of General Medical Science (http://www.nigms.nih.gov/), a DOE grant DE-SC0004898 from Department of Energy (http://www.energy.gov/), and an NSF grant IOS-1025752 from National Science Foundation (http://www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Agarwal S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000817; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Basu MK, 2008, GENOME RES, V18, P449, DOI 10.1101/gr.6943508; BATEMAN A, 2004, NUCLEIC ACIDS RES, V32, P276; Bergey D.H., BERGEYS MANUAL DETER; Bonneau R, 2008, NAT CHEM BIOL, V4, P658, DOI 10.1038/nchembio.122; Borgwardt K, 2005, KERNEL METHODS PROTE; Borgwardt KM, 2005, BIOINFORMATICS, V21, pI47, DOI 10.1093/bioinformatics/bti1007; Bork P, 2004, CURR OPIN STRUC BIOL, V14, P292, DOI 10.1016/j.sbi.2004.05.003; Cai CZ, 2004, PROTEINS, V55, P66, DOI 10.1002/prot.20045; Chen XW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001562; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; CHENG J, 2005, IEEE INTELL SYST APP, V20, P1; Deeds EJ, 2005, GENOME RES, V15, P393, DOI 10.1101/gr.3033805; Du ZD, 2009, NUCLEIC ACIDS RES, V37, pW345, DOI 10.1093/nar/gkp463; Ekman D, 2005, J MOL BIOL, V348, P231, DOI 10.1016/j.jmb.2005.02.007; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fong JH, 2007, J MOL BIOL, V366, P307, DOI 10.1016/j.jmb.2006.11.017; Gao L, 2007, SCI CHINA SER C, V50, P587, DOI 10.1007/s11427-007-0084-3; Hakes L, 2008, NAT BIOTECHNOL, V26, P69, DOI 10.1038/nbt0108-69; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; HIROTO S, 2010, BMC BIOINFORMATICS, V11, pS31; Hishigaki H, 2001, YEAST, V18, P523, DOI 10.1002/yea.706; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Ideker T, 2001, ANNU REV GENOM HUM G, V2, P343, DOI 10.1146/annurev.genom.2.1.343; Issel-Tarver L, 2002, METHOD ENZYMOL, V350, P329, DOI 10.1016/S0076-6879(02)50972-1; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jensen LJ, 2003, BIOINFORMATICS, V19, P635, DOI 10.1093/bioinformatics/btg036; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Joachims T., 1999, ADV KERNEL METHODS S; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Komurov K, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000889; Lanckriet GRG, 2003, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2004, P300; Lewis ACF, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-100; Li D, 2006, PROTEOMICS, V6, P456, DOI 10.1002/pmic.200500228; Li F, 2010, BIOINFORMATICS, V26, P275, DOI 10.1093/bioinformatics/btp634; Liao CS, 2009, BIOINFORMATICS, V25, pI253, DOI 10.1093/bioinformatics/btp203; Lin GN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S5; Luo YQ, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-266; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nguyen TP, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-103; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Ramirez F, 2007, PROTEOMICS, V7, P2541, DOI 10.1002/pmic.200600924; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; RHEE S, 2003, NUCLEIC ACIDS RES, P224; Rinner O, 2007, NAT BIOTECHNOL, V25, P345, DOI 10.1038/nbt1289; Saigo H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S31; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SARAH K, 2009, BMC BIOINFORMATICS, V10, P39; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; Scott J, 2006, J COMPUT BIOL, V13, P133, DOI 10.1089/cmb.2006.13.133; Segre D, 2002, P NATL ACAD SCI USA, V99, P15112, DOI 10.1073/pnas.232349399; Servant Florence, 2002, Brief Bioinform, V3, P246, DOI 10.1093/bib/3.3.246; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Singh R, 2008, P NATL ACAD SCI USA, V105, P12763, DOI 10.1073/pnas.0806627105; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sonnhammer ELL, 1998, NUCLEIC ACIDS RES, V26, P320, DOI 10.1093/nar/26.1.320; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Whisstock JC, 2003, Q REV BIOPHYS, V36, P307, DOI 10.1017/S0033583503003901; Wu GM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r53; Wu XM, 2007, BIOINFORMATICS, V23, P1744, DOI 10.1093/bioinformatics/btm248; Wuchty S, 2001, MOL BIOL EVOL, V18, P1694, DOI 10.1093/oxfordjournals.molbev.a003957; Wuchty S, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-24; ZHANG A, PROTEIN INTERACTION; ZHANG C, 2009, INT J COMPU IN PRESS	70	28	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2011	6	3							e17906	10.1371/journal.pone.0017906	http://dx.doi.org/10.1371/journal.pone.0017906			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740RG	21455299	Green Published, gold, Green Submitted			2022-12-25	WOS:000288811500014
J	Goetz, EM; Shankar, B; Zou, Y; Morales, JC; Luo, X; Araki, S; Bachoo, R; Mayo, LD; Boothman, DA				Goetz, E. M.; Shankar, B.; Zou, Y.; Morales, J. C.; Luo, X.; Araki, S.; Bachoo, R.; Mayo, L. D.; Boothman, D. A.			ATM-dependent IGF-1 induction regulates secretory clusterin expression after DNA damage and in genetic instability	ONCOGENE			English	Article						secretory clusterin; ATM; IGF-1; p53; ionizing radiation; genetic instability	Y TRANSCRIPTION FACTOR; GROWTH-FACTOR-BETA; NF-Y; GENOMIC INSTABILITY; ATAXIA-TELANGIECTASIA; SIGNALING PATHWAY; PROSTATE-CANCER; MELANOMA-CELLS; IN-VITRO; P53	Secretory clusterin (sCLU) is a stress-induced, prosurvival glycoprotein elevated in early-stage cancers, in particular in APC/Min-defective colon cancers. sCLU is upregulated after exposure to various cytotoxic agents, including ionizing radiation (IR), leading to a survival advantage. We found that stimulation of insulin-like growth factor-1 (IGF-1) and IGF-1R protein kinase signaling was required for sCLU induction after IR exposure. Here, we show that activation of Ataxia telangiectasia-mutated kinase (ATM) by endogenous or exogenous forms of DNA damage was required to relieve basal repression of IGF-1 transcription by the p53/NF-YA complex, leading to sCLU expression. Although p53 levels were stabilized and elevated after DNA damage, dissociation of NF-YA, and thereby p53, from the IGF-1 promoter resulted in IGF-1 induction, indicating that NF-YA was rate limiting. Cells with elevated endogenous DNA damage (deficient in H2AX, MDC1, NBS1, mTR or hMLH1) or cells exposed to DNA-damaging agents had elevated IGF-1 expression, resulting in activation of IGF-1R signaling and sCLU induction. In contrast, ATM-deficient cells were unable to induce sCLU after DNA damage. Our results integrate DNA damage resulting from genetic instability, IR, or chemotherapeutic agents, to ATM activation and abrogation of p53/NF-YA-mediated IGF-1 transcriptional repression, that induces IGF-1-sCLU expression. Elucidation of this pathway should uncover new mechanisms for cancer progression and reveal new targets for drug development to overcome resistance to therapy. Oncogene (2011) 30, 3745-3754; doi:10.1038/onc.2011.92; published online 4 April 2011	[Goetz, E. M.; Shankar, B.; Zou, Y.; Morales, J. C.; Luo, X.; Araki, S.; Boothman, D. A.] Univ Texas SW Med Ctr Dallas, Dept Oncol, Lab Mol Stress Responses, Dallas, TX 75390 USA; [Goetz, E. M.; Shankar, B.; Zou, Y.; Morales, J. C.; Luo, X.; Araki, S.; Boothman, D. A.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Lab Mol Stress Responses, Dallas, TX 75390 USA; [Goetz, E. M.; Shankar, B.; Zou, Y.; Morales, J. C.; Luo, X.; Araki, S.; Boothman, D. A.] Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, Lab Mol Stress Responses, Dallas, TX 75390 USA; [Bachoo, R.] Univ Texas SW Med Ctr Dallas, Simmons Comprehens Canc Ctr, Dept Neurooncol, Program Cell Stress & Canc Nanomed, Dallas, TX 75390 USA; [Mayo, L. D.] Indiana Univ Sch Med, Indiana Univ Simon Canc Ctr, Dept Pediat, Herman B Wells Ctr Pediat Res,Dept Biochem & Mol, Indianapolis, IN USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Indiana University System; Indiana University Bloomington	Boothman, DA (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Oncol, Lab Mol Stress Responses, 6001 Forest Pk Rd,ND2-210K, Dallas, TX 75390 USA.	David.Boothman@UTSouthwestern.edu	Boothman, David/Q-7776-2019	Morales, Julio/0000-0002-0854-7866	DOE [DE-FG02-06ER64186-17]; DOD BCRP [W81XWH-06-0748]; DOD PCRP [X8IXWH-09-1-0168]; Robert B and Virginia Payne Endowment; SAIR NIH [CA126608]; Imaging Shared Resource of the Simmons Cancer Center; NATIONAL CANCER INSTITUTE [U24CA126608, P30CA142543, R01CA139217] Funding Source: NIH RePORTER	DOE(United States Department of Energy (DOE)); DOD BCRP(United States Department of Defense); DOD PCRP; Robert B and Virginia Payne Endowment; SAIR NIH; Imaging Shared Resource of the Simmons Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by DOE grant (#DE-FG02-06ER64186-17) to DAB, a DOD BCRP pre-doctoral fellowship (W81XWH-06-0748) to EMG and a DOD PCRP post-doctoral fellowship (X8IXWH-09-1-0168) to XL. We are grateful to the Robert B and Virginia Payne Endowment for support of this work. We also thank the support received from the SAIR NIH U24 grant CA126608 and the Imaging Shared Resource of the Simmons Cancer Center. This is CSCN #024 and used the Flow Cytometry and Biostatistics cores of the Simmons Comprehensive Cancer Center.	Andarawewa KL, 2007, CANCER RES, V67, P8662, DOI 10.1158/0008-5472.CAN-07-1294; Bellorini M, 1997, NUCLEIC ACIDS RES, V25, P2174, DOI 10.1093/nar/25.11.2174; Bentle MS, 2006, J BIOL CHEM, V281, P33684, DOI 10.1074/jbc.M603678200; Bocchetta M, 2008, CANCER RES, V68, P1022, DOI 10.1158/0008-5472.CAN-07-5203; Boggs LN, 1996, J NEUROCHEM, V67, P1324; BOOTHMAN DA, 1993, P NATL ACAD SCI USA, V90, P7200, DOI 10.1073/pnas.90.15.7200; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Chen XD, 2003, P NATL ACAD SCI USA, V100, P9530, DOI 10.1073/pnas.1233633100; Chi KN, 2010, J CLIN ONCOL, V28, P4247, DOI 10.1200/JCO.2009.26.8771; Criswell T, 2005, J BIOL CHEM, V280, P14212, DOI 10.1074/jbc.M412569200; Criswell T, 2003, CANCER BIOL THER, V2, P372, DOI 10.4161/cbt.2.4.430; DARPA P, 1990, CANCER RES, V50, P6919; DESILVA HV, 1990, BIOCHEMISTRY-US, V29, P5380, DOI 10.1021/bi00474a025; Dumaz N, 1999, EMBO J, V18, P7002, DOI 10.1093/emboj/18.24.7002; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Hao LY, 2004, CHROMOSOMA, V113, P62, DOI 10.1007/s00412-004-0291-7; Imbriano C, 2005, MOL CELL BIOL, V25, P3737, DOI 10.1128/MCB.25.9.3737-3751.2005; Jin G, 1997, J BIOL CHEM, V272, P26620, DOI 10.1074/jbc.272.42.26620; Jones SE, 2002, INT J BIOCHEM CELL B, V34, P427, DOI 10.1016/S1357-2725(01)00155-8; Klokov D, 2004, MUTAT RES-FUND MOL M, V568, P97, DOI 10.1016/j.mrfmmm.2004.06.049; KOJIS TL, 1991, CANCER GENET CYTOGEN, V56, P143, DOI 10.1016/0165-4608(91)90164-P; Leri A, 1999, AM J PATHOL, V154, P567, DOI 10.1016/S0002-9440(10)65302-3; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Macaulay VM, 2001, ONCOGENE, V20, P4029, DOI 10.1038/sj.onc.1204565; MANTOVANI R, 1994, J BIOL CHEM, V269, P20340; Matsui T, 2004, J BIOL CHEM, V279, P25093, DOI 10.1074/jbc.M403232200; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Mittanck DW, 1997, MOL CELL ENDOCRINOL, V126, P153, DOI 10.1016/S0303-7207(96)03979-2; Miyake H, 2000, CANCER RES, V60, P2547; Peng Y, 2007, ONCOGENE, V26, P7576, DOI 10.1038/sj.onc.1210565; PERRY ME, 1993, P NATL ACAD SCI USA, V90, P11623, DOI 10.1073/pnas.90.24.11623; Ryan PD, 2008, ONCOLOGIST, V13, P16, DOI 10.1634/theoncologist.2007-0199; Shahrabani-Gargir L, 2004, ENDOCRINOLOGY, V145, P5679, DOI 10.1210/en.2004-0613; So A, 2005, MOL CANCER THER, V4, P1837, DOI 10.1158/1535-7163.MCT-05-0178; Stiff T, 2006, EMBO J, V25, P5775, DOI 10.1038/sj.emboj.7601446; Sulkowski S, 2009, CLIN CHEM LAB MED, V47, P1439, DOI 10.1515/CCLM.2009.305; Wagner MW, 2008, J BIOL CHEM, V283, P21382, DOI 10.1074/jbc.M709953200; Wang ZY, 2000, P NATL ACAD SCI USA, V97, P13549, DOI 10.1073/pnas.260463097; Williams BR, 2002, CURR BIOL, V12, P648, DOI 10.1016/S0960-9822(02)00763-7; Wilson MR, 2000, TRENDS BIOCHEM SCI, V25, P95, DOI 10.1016/S0968-0004(99)01534-0; Yan J, 2006, CANCER RES, V66, P11039, DOI 10.1158/0008-5472.CAN-06-2442; Yun J, 1999, J BIOL CHEM, V274, P29677, DOI 10.1074/jbc.274.42.29677; Yun JH, 2003, J BIOL CHEM, V278, P36966, DOI 10.1074/jbc.M305178200; Zhang HL, 2005, NAT CELL BIOL, V7, P909, DOI 10.1038/ncb1291; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Ziv Y, 1997, ONCOGENE, V15, P159, DOI 10.1038/sj.onc.1201319	46	35	37	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP	2011	30	35					3745	3754		10.1038/onc.2011.92	http://dx.doi.org/10.1038/onc.2011.92			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	814TZ	21460853	Green Accepted			2022-12-25	WOS:000294481400002
J	David, A; Netzer, N; Strader, MB; Das, SR; Chen, CY; Gibbs, J; Pierre, P; Bennink, JR; Yewdell, JW				David, Alexandre; Netzer, Nir; Strader, Michael Brad; Das, Suman R.; Chen, Cai Yun; Gibbs, James; Pierre, Philippe; Bennink, Jack R.; Yewdell, Jonathan W.			RNA Binding Targets Aminoacyl-tRNA Synthetases to Translating Ribosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTIONS; MESSENGER-RNA; ENDOPLASMIC-RETICULUM; MAMMALIAN-CELLS; MACROMOLECULAR ASSEMBLAGE; SUBCELLULAR-DISTRIBUTION; STRESS GRANULES; SHEEP LIVER; COMPLEX; PHOSPHORYLATION	Here, we examine tRNA-aminoacyl synthetase (ARS) localization in protein synthesis. Proteomics reveals that ten of the twenty cytosolic ARSs associate with ribosomes in sucrose gradients: phenylalanyl-RS (FRS), and the 9 ARSs that form the multi-ARS complex (MSC). Using the ribopuromycylation method (RPM) for localizing intracellular translation, we show that FRS and the MSC, and to a lesser extent other ARSs, localize to translating ribosomes, most strikingly when translation is restricted to poxvirus or alphavirus factories in infected cells. Immunoproximity fluorescence indicates close proximity between MSC and the ribosome. Stress induced-translational shutdown recruits the MSC to stress-granules, a depot for mRNA and translation components. MSC binding to mRNA provides a facile explanation for its delivery to translating ribosomes and stress granules. These findings, along with the abundance of the MSC (9 x 10(6) copies per cell, roughly equimolar with ribosomes), is consistent with the idea that MSC specificity, recently reported to vary with cellular stress (Netzer, N., Goodenbour, J. M., David, A., Dittmar, K. A., Jones, R. B., Schneider, J. R., Boone, D., Eves, E. M., Rosner, M. R., Gibbs, J. S., Embry, A., Dolan, B., Das, S., Hickman, H. D., Berglund, P., Bennink, J. R., Yewdell, J. W., and Pan, T. (2009) Nature 462, 522-526) can be modulated at the level of individual mRNAs to modify decoding of specific gene products.	[Yewdell, Jonathan W.] NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA; [Strader, Michael Brad; Chen, Cai Yun] NIMH, Lab Neurotoxicol, NIH, Bethesda, MD 20892 USA; [Pierre, Philippe] Ctr Immunol Marseille Luminy, Marseille, France	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Yewdell, JW (corresponding author), NIAID, Viral Dis Lab, NIH, Bldg 33,33 North Dr, Bethesda, MD 20892 USA.	jyewdell@nih.gov	David, Alexandre/B-2447-2013; yewdell, jyewdell@nih.gov jonathan/A-1702-2012; Das, Suman/ABB-7273-2020; David, Alexandre/AAL-2758-2021; chen, caiyun/HHY-7684-2022; Das, Suman R/C-8760-2009	David, Alexandre/0000-0003-3365-1339; Das, Suman/0000-0003-2496-9724; David, Alexandre/0000-0003-3365-1339; pierre, philippe/0000-0003-0863-8255	Division of Intramural Research, NIAID, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000542] Funding Source: NIH RePORTER	Division of Intramural Research, NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by the Division of Intramural Research, NIAID, National Institutes of Health.	BANDYOPADHYAY AK, 1971, J MOL BIOL, V60, P113, DOI 10.1016/0022-2836(71)90451-7; Blobel G, 2000, CHEMBIOCHEM, V1, P87; DUNCAN R, 1983, J BIOL CHEM, V258, P7228; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; GEELS J, 1971, ARCH BIOCHEM BIOPHYS, V144, P773, DOI 10.1016/0003-9861(71)90386-9; Griffing LR, 2010, BIOCHEM SOC T, V38, P747, DOI 10.1042/BST0380747; HAMPEL A, 1973, J MOL BIOL, V79, P285, DOI 10.1016/0022-2836(73)90006-5; Holt CE, 2009, SCIENCE, V326, P1212, DOI 10.1126/science.1176488; Hovland R, 1996, INT J BIOCHEM CELL B, V28, P1089, DOI 10.1016/1357-2725(96)00059-3; Jansen RP, 1999, FASEB J, V13, P455, DOI 10.1096/fasebj.13.3.455; Kaminska M, 2009, J BIOL CHEM, V284, P13746, DOI 10.1074/jbc.M900480200; KAPPEN LS, 1973, P NATL ACAD SCI USA, V70, P22, DOI 10.1073/pnas.70.1.22; Katsafanas GC, 2007, CELL HOST MICROBE, V2, P221, DOI 10.1016/j.chom.2007.08.005; Kedersha N, 2002, BIOCHEM SOC T, V30, P963, DOI 10.1042/BST0300963; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; KELLERMANN O, 1979, EUR J BIOCHEM, V99, P541, DOI 10.1111/j.1432-1033.1979.tb13286.x; KERJAN P, 1994, BBA-GEN SUBJECTS, V1199, P293, DOI 10.1016/0304-4165(94)90009-4; Kyriacou SV, 2008, MOL CELL, V29, P419, DOI 10.1016/j.molcel.2007.11.038; Lelouard H, 2002, NATURE, V417, P177, DOI 10.1038/417177a; Lerner RS, 2006, RNA, V12, P775, DOI 10.1261/rna.2318906; Lev A, 2010, P NATL ACAD SCI USA, V107, P6964, DOI 10.1073/pnas.0910997107; Luo S, 2009, FASEB J, V23, P464, DOI 10.1096/fj.08-118414; McFarland MA, 2008, MOL CELL PROTEOMICS, V7, P2123, DOI 10.1074/mcp.M800116-MCP200; McInerney GM, 2005, MOL BIOL CELL, V16, P3753, DOI 10.1091/mbc.E05-02-0124; MIRANDE M, 1985, EXP CELL RES, V156, P91, DOI 10.1016/0014-4827(85)90264-2; MISETA A, 1991, J BIOL CHEM, V266, P19158; MOSYAK L, 1995, NAT STRUCT BIOL, V2, P537, DOI 10.1038/nsb0795-537; Netzer N, 2009, NATURE, V462, P522, DOI 10.1038/nature08576; Nevo-Dinur K, 2011, SCIENCE, V331, P1081, DOI 10.1126/science.1195691; PAILLIEZ JP, 1984, J BIOL CHEM, V259, P5491; Park SG, 2005, TRENDS BIOCHEM SCI, V30, P569, DOI 10.1016/j.tibs.2005.08.004; Park SG, 2005, P NATL ACAD SCI USA, V102, P6356, DOI 10.1073/pnas.0500226102; POPENKO VI, 1994, EUR J CELL BIOL, V65, P60; Potter MD, 2002, J BIOL CHEM, V277, P23314, DOI 10.1074/jbc.M202559200; Princiotta MF, 2003, IMMUNITY, V18, P343, DOI 10.1016/S1074-7613(03)00051-7; Pyhtila B, 2008, RNA, V14, P445, DOI 10.1261/rna.721108; Quevillon S, 1999, J MOL BIOL, V285, P183, DOI 10.1006/jmbi.1998.2316; Remacha M, 1995, BIOCHEM CELL BIOL, V73, P959, DOI 10.1139/o95-103; Robinson JC, 2000, J MOL BIOL, V304, P983, DOI 10.1006/jmbi.2000.4242; SCHIMMEL PR, 1979, ANNU REV BIOCHEM, V48, P601, DOI 10.1146/annurev.bi.48.070179.003125; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; SCHRAY B, 1991, NUCLEIC ACIDS RES, V19, P5307, DOI 10.1093/nar/19.19.5307; Slotta DJ, 2010, PROTEOMICS, V10, P3035, DOI 10.1002/pmic.200900370; SPIRIN AS, 1978, FEBS LETT, V88, P15, DOI 10.1016/0014-5793(78)80596-1; STAPULIONIS R, 1995, P NATL ACAD SCI USA, V92, P7158, DOI 10.1073/pnas.92.16.7158; Stephens SB, 2008, MOL BIOL CELL, V19, P623, DOI 10.1091/mbc.E07-07-0677; Stephens SB, 2007, METHOD ENZYMOL, V431, P47, DOI 10.1016/S0076-6879(07)31004-5; Stephens SB, 2005, MOL BIOL CELL, V16, P5819, DOI 10.1091/mbc.E05-07-0685; USSERY MA, 1977, EUR J BIOCHEM, V72, P491, DOI 10.1111/j.1432-1033.1977.tb11272.x; Yewdell JW, 2006, TRENDS IMMUNOL, V27, P368, DOI 10.1016/j.it.2006.06.008	50	60	60	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20688	20700		10.1074/jbc.M110.209452	http://dx.doi.org/10.1074/jbc.M110.209452			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21460219	Green Published, hybrid			2022-12-25	WOS:000291267600055
J	Song, CC; Rahim, RT; Davey, PC; Bednar, F; Bardi, G; Zhang, L; Zhang, N; Oppenheim, JJ; Rogers, TJ				Song, Changcheng; Rahim, Rahil T.; Davey, Penelope C.; Bednar, Filip; Bardi, Giuseppe; Zhang, Lily; Zhang, Ning; Oppenheim, Joost J.; Rogers, Thomas J.			Protein Kinase C zeta Mediates mu-Opioid Receptor-induced Cross-desensitization of Chemokine Receptor CCR5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROLOGOUS DESENSITIZATION; INDUCED CHEMOTAXIS; HUMAN-MONOCYTES; RAT ADIPOCYTES; IMMUNE-SYSTEM; PKC-ZETA; ACTIVATION; TRANSLOCATION; 3-KINASE; CELLS	We have previously shown that the mu-opioid receptor (MOR) is capable of mediating cross-desensitization of several chemokine receptors including CCR5, but the biochemical mechanism of this process has not been fully elucidated. We have carried out a series of functional and biochemical studies and found that the mechanism of MOR-induced cross-desensitization of CCR5 involves the activation of PKC zeta. Inhibition of PKC zeta by its pseudosubstrate inhibitor, or its siRNA, or dominant negative mutants suppresses the cross-desensitization of CCR5. Our results further indicate that the activation of PKC zeta is mediated through a pathway involving phosphoinositol-dependent kinase-1 (PDK1). In addition, activation of MOR elevates the phosphorylation level and kinase activity of PKC zeta. The phosphorylation of PKC zeta can be suppressed by a dominant negative mutant of PDK1. We observed that following MOR activation, the interaction between PKC zeta and PDK1 is immediately increased based on the analysis of fluorescent resonance energy transfer in cells with the expression of PKC zeta-YFP and PDK1-CFP. In addition, cells expressing PKC zeta kinase motif mutants (Lys-281, Thr-410, Thr-560) fail to exhibit full MOR-induced desensitization of CCR5 activity. Taken together, we propose that upon DAMGO treatment, MOR activates PKC zeta through a PDK1-dependent signaling pathway to induce CCR5 phosphorylation and desensitization. Because CCR5 is a highly proinflammatory receptor, and a critical coreceptor for HIV-1, these results may provide a novel approach for the development of specific therapeutic agents to treat patients with certain inflammatory diseases or AIDS.	[Song, Changcheng; Rahim, Rahil T.; Davey, Penelope C.; Bardi, Giuseppe; Zhang, Lily; Rogers, Thomas J.] Temple Univ, Sch Med, Fels Inst Canc Res & Mol Biol, Ctr Subst Abuse Res, Philadelphia, PA 19140 USA; [Bednar, Filip] Temple Univ, Sch Med, Dept Microbiol & Immunol, Philadelphia, PA 19140 USA; [Zhang, Ning; Oppenheim, Joost J.] NCI, Mol Immunoregulat Lab, Div Basic Sci, Frederick Canc Res & Dev Ctr, Frederick, MD 21702 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Rogers, TJ (corresponding author), Temple Univ, Sch Med, Fels Inst Canc Res & Mol Biol, Ctr Subst Abuse Res, 3307 N Broad St, Philadelphia, PA 19140 USA.	rogerst@temple.edu	Bardi, Giuseppe/B-6452-2013; Bardi, Giuseppe/K-7057-2019	Bardi, Giuseppe/0000-0001-9662-3007; Bardi, Giuseppe/0000-0001-9662-3007	National Institutes of Health, NIDA [DA-14230, DA-25532, P01DA-23860, P30DA-13429, T32DA-07237, DA-06650]; NATIONAL CANCER INSTITUTE [ZIABC010708] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027910] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA013429, R01DA006650, T32DA007237, R01DA014230, P01DA023860, R01DA025532] Funding Source: NIH RePORTER	National Institutes of Health, NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA-14230, DA-25532, P01DA-23860, P30DA-13429, T32DA-07237, and DA-06650 from NIDA.	Ali H, 1999, J BIOL CHEM, V274, P6027, DOI 10.1074/jbc.274.10.6027; Anderson KE, 1998, CURR BIOL, V8, P684, DOI 10.1016/S0960-9822(98)70274-X; Chen CG, 2004, EUR J PHARMACOL, V483, P175, DOI 10.1016/j.ejphar.2003.10.033; Choi Y, 1999, IN VIVO, V13, P389; Chou MM, 1998, CURR BIOL, V8, P1069, DOI 10.1016/S0960-9822(98)70444-0; Diaz-Meco MT, 2001, MOL CELL BIOL, V21, P1218, DOI 10.1128/MCB.21.4.1218-1227.2001; Eisenstein TK, 1998, J NEUROIMMUNOL, V83, P36, DOI 10.1016/S0165-5728(97)00219-1; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; GalveRoperh I, 1997, FEBS LETT, V415, P271, DOI 10.1016/S0014-5793(97)00985-X; Grimm MC, 1998, ANN NY ACAD SCI, V840, P9, DOI 10.1111/j.1749-6632.1998.tb09544.x; Grimm MC, 1998, J EXP MED, V188, P317, DOI 10.1084/jem.188.2.317; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hirai T, 2003, J BIOCHEM, V133, P1, DOI 10.1093/jb/mvg017; Hu SX, 2000, J PSYCHOPHARMACOL, V14, P238, DOI 10.1177/026988110001400307; KAZANIETZ MG, 1993, MOL PHARMACOL, V44, P298; Laudanna C, 1998, J BIOL CHEM, V273, P30306, DOI 10.1074/jbc.273.46.30306; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Le YY, 2001, CLIN IMMUNOL, V99, P365, DOI 10.1006/clim.2001.5021; Macey TA, 2006, J BIOL CHEM, V281, P34515, DOI 10.1074/jbc.M604278200; Madden JJ, 1998, J NEUROIMMUNOL, V83, P57, DOI 10.1016/S0165-5728(97)00221-X; Mamidipudi V, 2002, J NEUROSCI RES, V68, P373, DOI 10.1002/jnr.10244; Mandyam CD, 2003, J PHARMACOL EXP THER, V306, P965, DOI 10.1124/jpet.103.051599; Martin P, 2005, P NATL ACAD SCI USA, V102, P9866, DOI 10.1073/pnas.0501202102; McCarthy L, 2001, DRUG ALCOHOL DEPEN, V62, P111, DOI 10.1016/S0376-8716(00)00181-2; McPherson J, 2010, MOL PHARMACOL, V78, P756, DOI 10.1124/mol.110.066613; Nasser MW, 2005, J IMMUNOL, V174, P6927, DOI 10.4049/jimmunol.174.11.6927; Noda Y, 2003, J BIOL CHEM, V278, P43516, DOI 10.1074/jbc.M306330200; PEREZCASTRILLON JL, 1992, IMMUNOPHARMACOLOGY, V23, P57, DOI 10.1016/0162-3109(92)90009-2; Peterson PK, 1998, J NEUROIMMUNOL, V83, P63, DOI 10.1016/S0165-5728(97)00222-1; Pollok-Kopp B, 2003, J BIOL CHEM, V278, P2190, DOI 10.1074/jbc.M209844200; Rubino T, 2006, MOL NEUROBIOL, V33, P199, DOI 10.1385/MN:33:3:199; RUFF MR, 1985, NEUROPEPTIDES, V5, P363, DOI 10.1016/0143-4179(85)90029-0; Sharp BM, 1998, J NEUROIMMUNOL, V83, P45, DOI 10.1016/S0165-5728(97)00220-8; Shen WP, 2000, BLOOD, V96, P2887, DOI 10.1182/blood.V96.8.2887.h8002887_2887_2894; Standaert ML, 1999, J BIOL CHEM, V274, P25308, DOI 10.1074/jbc.274.36.25308; Standaert ML, 1997, J BIOL CHEM, V272, P30075, DOI 10.1074/jbc.272.48.30075; Steele AD, 2002, CYTOKINE GROWTH F R, V13, P209, DOI 10.1016/S1359-6101(02)00007-2; Szabo I, 2003, J LEUKOCYTE BIOL, V74, P1074, DOI 10.1189/jlb.0203067; Szabo I, 2002, P NATL ACAD SCI USA, V99, P10276, DOI 10.1073/pnas.102327699; Szabo I, 2001, ADV EXP MED BIOL, V493, P75; TUBARO E, 1985, INT J IMMUNOPHARMACO, V7, P865, DOI 10.1016/0192-0561(85)90049-9; Ueda Y, 1996, J BIOL CHEM, V271, P23512, DOI 10.1074/jbc.271.38.23512; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Whistler JL, 1999, NEURON, V23, P737, DOI 10.1016/S0896-6273(01)80032-5; Zhang N, 2003, J BIOL CHEM, V278, P12729, DOI 10.1074/jbc.M300430200	45	26	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20354	20365		10.1074/jbc.M110.177303	http://dx.doi.org/10.1074/jbc.M110.177303			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21454526	Green Published, hybrid			2022-12-25	WOS:000291267600023
J	Coppotelli, G; Mughal, N; Marescotti, D; Masucci, MG				Coppotelli, Giuseppe; Mughal, Nouman; Marescotti, Diego; Masucci, Maria G.			High Avidity Binding to DNA Protects Ubiquitylated Substrates from Proteasomal Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPSTEIN-BARR-VIRUS; GLY-ALA REPEAT; NUCLEAR ANTIGEN 1; HISTONE H1; IN-VIVO; PROTEINS; INHIBITION; CHROMATIN; PATHWAY; SYSTEM	Protein domains that act as degradation and stabilization signals regulate the rate of turnover of proteasomal substrates. Here we report that the bipartite Gly-Arg repeat of the Epstein-Barr virus (EBV) nuclear antigen (EBNA)-1 acts as a stabilization signal that inhibits proteasomal degradation in the nucleus by promoting binding to cellular DNA. Protection can be transferred by grafting the domain to unrelated proteasomal substrates and does not involve changes of ubiquitylation. Protection is also afforded by other protein domains that, similar to the Gly-Arg repeat, mediate high avidity binding to DNA, as exemplified by resistance to detergent extraction. Our findings identify high avidity binding to DNA as a portable inhibitory signal that counteracts proteasomal degradation.	[Coppotelli, Giuseppe; Mughal, Nouman; Marescotti, Diego; Masucci, Maria G.] Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden	Karolinska Institutet	Masucci, MG (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, Box 285, S-17177 Stockholm, Sweden.	maria.masucci@ki.se	Masucci, Maria/AAC-6666-2019	Masucci, Maria/0000-0002-5541-2809; Marescotti, Diego/0000-0003-1007-8074	Swedish Cancer Society; Swedish Medical Research Council; European Community [LSG-CT-2006-037874, LSG-CT-2005-018683]	Swedish Cancer Society(Swedish Cancer Society); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); European Community(European Commission)	This work was supported by grants awarded by the Swedish Cancer Society and Swedish Medical Research Council and by the European Community Contracts LSG-CT-2006-037874 and LSG-CT-2005-018683.	Abu Hatoum O, 1998, MOL CELL BIOL, V18, P5670, DOI 10.1128/MCB.18.10.5670; Apcher S, 2009, J VIROL, V83, P1289, DOI 10.1128/JVI.01369-08; Catez F, 2004, MOL CELL BIOL, V24, P4321, DOI 10.1128/MCB.24.10.4321-4328.2004; Catez F, 2002, EMBO REP, V3, P760, DOI 10.1093/embo-reports/kvf156; Cohen S, 2001, J BIOL CHEM, V276, P26769, DOI 10.1074/jbc.M102448200; Dantuma NP, 2000, P NATL ACAD SCI USA, V97, P8381, DOI 10.1073/pnas.140217397; Dantuma NP, 2002, FEBS LETT, V529, P22, DOI 10.1016/S0014-5793(02)03252-0; Daskalogianni C, 2008, J BIOL CHEM, V283, P30090, DOI 10.1074/jbc.M803290200; FALK K, 1995, J GEN VIROL, V76, P779, DOI 10.1099/0022-1317-76-4-779; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Gruhne B, 2009, P NATL ACAD SCI USA, V106, P2313, DOI 10.1073/pnas.0810619106; Harrer M, 2004, J CELL SCI, V117, P3459, DOI 10.1242/jcs.01160; Heessen S, 2002, P NATL ACAD SCI USA, V99, P1532, DOI 10.1073/pnas.022306499; Hill DA, 1997, NUCLEIC ACIDS RES, V25, P3523, DOI 10.1093/nar/25.17.3523; Holowaty MN, 2003, J BIOL CHEM, V278, P29987, DOI 10.1074/jbc.M303977200; Hung SC, 2001, P NATL ACAD SCI USA, V98, P1865, DOI 10.1073/pnas.031584698; Huth JR, 1997, NAT STRUCT BIOL, V4, P657, DOI 10.1038/nsb0897-657; Ishimaru D, 2009, BIOCHEMISTRY-US, V48, P6126, DOI 10.1021/bi9003028; Iwamoto M, 2010, CHEM BIOL, V17, P981, DOI 10.1016/j.chembiol.2010.07.009; Jung Y, 2006, J BIOL CHEM, V281, P1361, DOI 10.1074/jbc.M509688200; Kapoor P, 2003, J VIROL, V77, P6946, DOI 10.1128/JVI.77.12.6946-6956.2003; Kitamura R, 2006, J VIROL, V80, P1979, DOI 10.1128/JVI.80.4.1979-1991.2006; Leight ER, 2000, REV MED VIROL, V10, P83, DOI 10.1002/(SICI)1099-1654(200003/04)10:2&lt;83::AID-RMV262&gt;3.0.CO;2-T; Levitskaya J, 1997, P NATL ACAD SCI USA, V94, P12616, DOI 10.1073/pnas.94.23.12616; LEVITSKAYA J, 1995, NATURE, V375, P685, DOI 10.1038/375685a0; Liau SS, 2006, CANCER RES, V66, P11613, DOI 10.1158/0008-5472.CAN-06-1460; Lu F, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-262; Ossevoort M, 2006, CANCER GENE THER, V13, P584, DOI 10.1038/sj.cgt.7700925; Ossevoort M, 2003, GENE THER, V10, P2020, DOI 10.1038/sj.gt.3302098; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Reeves R, 2000, MOL CELL BIOL, V20, P4666, DOI 10.1128/MCB.20.13.4666-4679.2000; Reeves R, 2001, GENE, V277, P63, DOI 10.1016/S0378-1119(01)00689-8; ROBERTSON E, 1995, J VIROL, V69, P983, DOI 10.1128/JVI.69.2.983-993.1995; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Schrader EK, 2009, NAT CHEM BIOL, V5, P815, DOI 10.1038/nchembio.250; Sears J, 2004, J VIROL, V78, P11487, DOI 10.1128/JVI.78.21.11487-11505.2004; Sharipo A, 1998, NAT MED, V4, P939, DOI 10.1038/nm0898-939; Singh G, 2009, J VIROL, V83, P4227, DOI 10.1128/JVI.02578-08; Sompallae R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012052; Souza PP, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-41; Thorley-Lawson DA, 2008, NAT REV MICROBIOL, V6, P913, DOI 10.1038/nrmicro2015; Verhoef LGGC, 2009, FASEB J, V23, P123, DOI 10.1096/fj.08-115055; Verma R, 2011, MOL CELL, V41, P82, DOI 10.1016/j.molcel.2010.12.017; Zhang MS, 2004, J BIOL CHEM, V279, P8635, DOI 10.1074/jbc.M310449200	45	10	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19565	19575		10.1074/jbc.M111.224782	http://dx.doi.org/10.1074/jbc.M111.224782			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21471195	hybrid, Green Published			2022-12-25	WOS:000291027700040
J	de la Pena, P; Alonso-Ron, C; Machin, A; Fernandez-Trillo, J; Carretero, L; Dominguez, P; Barros, F				de la Pena, Pilar; Alonso-Ron, Carlos; Machin, Angeles; Fernandez-Trillo, Jorge; Carretero, Luis; Dominguez, Pedro; Barros, Francisco			Demonstration of Physical Proximity between the N Terminus and the S4-S5 Linker of the Human ether-a-go-go-related Gene (hERG) Potassium Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-QT SYNDROME; HUMAN INWARD RECTIFIER; TORSADE-DE-POINTES; K+ CHANNELS; VOLTAGE SENSOR; INTERVAL PROLONGATION; PAS DOMAIN; ACTIVATION; DEACTIVATION; INACTIVATION	Potassium channels encoded by the human ether-a-go-go-related gene (hERG) contribute to cardiac repolarization as a result of their characteristic gating properties. The hERG channel N terminus acts as a crucial determinant in gating. It is also known that the S4-S5 linker couples the voltage-sensing machinery to the channel gate. Moreover, this linker has been repeatedly proposed as an interaction site for the distal portion of the N terminus controlling channel gating, but direct evidence for such an interaction is still lacking. In this study, we used disulfide bond formation between pairs of engineered cysteines to demonstrate the close proximity between the beginning of the N terminus and the S4-S5 linker. Currents from channels with introduced cysteines were rapidly and strongly attenuated by an oxidizing agent, this effect being maximal for cysteine pairs located around amino acids 3 and 542 of the hERG sequence. The state-dependent modification of the double-mutant channels, but not the single-cysteine mutants, and the ability to readily reverse modification with the reducing agent dithiothreitol indicate that a disulfide bond is formed under oxidizing conditions, locking the channels in a non-conducting state. We conclude that physical interactions between the N-terminal-most segment of the N terminus and the S4-S5 linker constitute an essential component of the hERG gating machinery, thus providing a molecular basis for previous data and indicating an important contribution of these cytoplasmic domains in controlling its unusual gating and hence determining its physiological role in setting the electrical behavior of cardiac and other cell types.	[de la Pena, Pilar; Alonso-Ron, Carlos; Machin, Angeles; Fernandez-Trillo, Jorge; Carretero, Luis; Dominguez, Pedro; Barros, Francisco] Univ Oviedo, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain	University of Oviedo	de la Pena, P (corresponding author), Univ Oviedo, Dept Bioquim & Biol Mol, Ed Santiago Gascon, E-33006 Oviedo, Spain.	pdelapena@uniovi.es	Dominguez, Pedro/A-8266-2012; De-la-Pena-Cortines, Pilar/B-1453-2012; Barros, Francisco/O-6647-2019; Barros, Francisco/H-3297-2015	Dominguez, Pedro/0000-0003-4788-1071; De-la-Pena-Cortines, Pilar/0000-0002-3915-730X; Barros, Francisco/0000-0001-9040-1948; Barros, Francisco/0000-0001-9040-1948; Carretero, Luis/0000-0001-7850-7440; Fernandez-Trillo, Jorge/0000-0002-2086-1727	Spanish Ministerio de Ciencia e Innovacion (MICINN) [BFU2009-11262]; Spanish Ion Channel Initiative (SICI) Consolider-Ingenio [CSD2008-00005]; Spanish Ion Channel Initiative Consolider; Ministerio de Educacion y Ciencia (MEC); Fondo de Investigacion Cientifica y Tecnica (FICYT) of Spain; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER	Spanish Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ion Channel Initiative (SICI) Consolider-Ingenio(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ion Channel Initiative Consolider; Ministerio de Educacion y Ciencia (MEC)(Spanish Government); Fondo de Investigacion Cientifica y Tecnica (FICYT) of Spain; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by Spanish Ministerio de Ciencia e Innovacion (MICINN) Grant BFU2009-11262 and Spanish Ion Channel Initiative (SICI) Consolider-Ingenio Project CSD2008-00005.; Supported by a postdoctoral contract from Spanish Ion Channel Initiative Consolider 2008.; Supported by predoctoral fellowships from the Ministerio de Educacion y Ciencia (MEC) and the Fondo de Investigacion Cientifica y Tecnica (FICYT) of Spain.	Al-Owais M, 2009, EUR BIOPHYS J BIOPHY, V38, P569, DOI 10.1007/s00249-009-0408-2; Alonso-Ron C, 2008, BIOPHYS J, V94, P3893, DOI 10.1529/biophysj.107.116731; Alonso-Ron C, 2009, PFLUG ARCH EUR J PHY, V457, P1237, DOI 10.1007/s00424-008-0599-x; Barghaan J, 2009, J GEN PHYSIOL, V133, P205, DOI 10.1085/jgp.200810073; Bass RB, 2007, METHOD ENZYMOL, V423, P25, DOI 10.1016/S0076-6879(07)23002-2; Bell DC, 2009, PFLUG ARCH EUR J PHY, V458, P259, DOI 10.1007/s00424-008-0613-3; Brown S, 2008, CELL PHYSIOL BIOCHEM, V22, P601, DOI 10.1159/000185544; Cabral JHM, 1998, CELL, V95, P649, DOI 10.1016/S0092-8674(00)81635-9; Chen J, 1999, J BIOL CHEM, V274, P10113, DOI 10.1074/jbc.274.15.10113; Chiang CE, 2000, J AM COLL CARDIOL, V36, P1, DOI 10.1016/S0735-1097(00)00716-6; Choveau FS, 2011, J BIOL CHEM, V286, P707, DOI 10.1074/jbc.M110.146324; FALKE JJ, 1988, J BIOL CHEM, V263, P14850; Ferrer T, 2006, J BIOL CHEM, V281, P12858, DOI 10.1074/jbc.M513518200; Finlayson K, 2004, EUR J PHARMACOL, V500, P129, DOI 10.1016/j.ejphar.2004.07.019; Gomez-Varela D, 2003, FEBS LETT, V535, P125, DOI 10.1016/S0014-5793(02)03888-7; Gomez-Varela D, 2002, J MEMBRANE BIOL, V187, P117, DOI 10.1007/s00232-001-0156-4; Gustina AS, 2009, P NATL ACAD SCI USA, V106, P13082, DOI 10.1073/pnas.0900180106; Horenstein J, 2001, NAT NEUROSCI, V4, P477, DOI 10.1038/87425; Ju PC, 2009, J BIOL CHEM, V284, P1000, DOI 10.1074/jbc.M806400200; Keating MT, 2001, CELL, V104, P569, DOI 10.1016/S0092-8674(01)00243-4; Kolbe K, 2010, J PHYSIOL-LONDON, V588, P2999, DOI 10.1113/jphysiol.2010.192468; Li QX, 2010, BIOCHEM BIOPH RES CO, V403, P126, DOI 10.1016/j.bbrc.2010.10.132; Liu J, 2003, J GEN PHYSIOL, V121, P599, DOI 10.1085/jgp.200308788; Liu J, 2002, J GEN PHYSIOL, V120, P723, DOI 10.1085/jgp.20028687; Lu Y, 2001, J PHYSIOL-LONDON, V537, P843, DOI 10.1113/jphysiol.2001.012690; Miranda P, 2008, BBA-MOL CELL RES, V1783, P1681, DOI 10.1016/j.bbamcr.2008.06.009; Muskett FW, 2011, J BIOL CHEM, V286, P6184, DOI 10.1074/jbc.M110.199364; Ng CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016191; Piper DR, 2003, P NATL ACAD SCI USA, V100, P10534, DOI 10.1073/pnas.1832721100; Redfern WS, 2003, CARDIOVASC RES, V58, P32, DOI 10.1016/S0008-6363(02)00846-5; Roden DM, 1996, CIRCULATION, V94, P1996, DOI 10.1161/01.CIR.94.8.1996; Saenen JB, 2006, BIOPHYS J, V91, P4381, DOI 10.1529/biophysj.106.087247; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Sanguinetti MC, 1999, J PHYSIOL-LONDON, V514, P667, DOI 10.1111/j.1469-7793.1999.667ad.x; Schonherr R, 1996, J PHYSIOL-LONDON, V493, P635, DOI 10.1113/jphysiol.1996.sp021410; Schwartz PJ, 2005, NAT CLIN PRACT CARD, V2, P346, DOI 10.1038/ncpcardio0239; Smith PL, 2002, J GEN PHYSIOL, V119, P275, DOI 10.1085/jgp.119.3.275; Smith PL, 1996, NATURE, V379, P833, DOI 10.1038/379833a0; Spector PS, 1996, J GEN PHYSIOL, V107, P611, DOI 10.1085/jgp.107.5.611; Subbiah RN, 2005, J PHYSIOL-LONDON, V569, P367, DOI 10.1113/jphysiol.2005.097386; Subbiah RN, 2004, J PHYSIOL-LONDON, V558, P417, DOI 10.1113/jphysiol.2004.062588; Thomas D, 2003, CARDIOVASC RES, V59, P14, DOI 10.1016/S0008-6363(03)00386-9; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Van Slyke AC, 2010, BIOPHYS J, V99, P2841, DOI 10.1016/j.bpj.2010.08.030; Viloria CG, 2000, BIOPHYS J, V79, P231, DOI 10.1016/S0006-3495(00)76286-2; Viskin S, 1999, LANCET, V354, P1625, DOI 10.1016/S0140-6736(99)02107-8; Wang JL, 1998, J GEN PHYSIOL, V112, P637, DOI 10.1085/jgp.112.5.637; Wang JL, 2000, J GEN PHYSIOL, V115, P749, DOI 10.1085/jgp.115.6.749; Zhang M, 2005, J MEMBRANE BIOL, V207, P169, DOI 10.1007/s00232-005-0812-1; Zhang M, 2004, J GEN PHYSIOL, V124, P703, DOI 10.1085/jgp.200409119	50	42	43	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					19065	19075		10.1074/jbc.M111.238899	http://dx.doi.org/10.1074/jbc.M111.238899			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21474444	Green Published, hybrid			2022-12-25	WOS:000290785700076
J	Gupta-Rossi, N; Ortica, S; Meas-Yedid, V; Heuss, S; Moretti, J; Olivo-Marin, JC; Israel, A				Gupta-Rossi, Neetu; Ortica, Sara; Meas-Yedid, Vannary; Heuss, Sara; Moretti, Julien; Olivo-Marin, Jean-Christophe; Israel, Alain			The Adaptor-associated Kinase 1, AAK1, Is a Positive Regulator of the Notch Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; INTRACELLULAR DOMAIN; PLASMA-MEMBRANE; CAENORHABDITIS-ELEGANS; TRANSCRIPTION FACTOR; CELL-MIGRATION; IN-VIVO; RECEPTOR; PROTEIN; NUMB	The Notch pathway is involved in cell-cell signaling during development and adulthood from invertebrates to higher eukaryotes. Activation of the Notch receptor by its ligands relies upon a multi-step processing. The extracellular part of the receptor is removed by a metalloprotease of the ADAM family and the remaining fragment is cleaved within its transmembrane domain by a presenilin-dependent gamma-secretase activity. gamma-Secretase processing of Notch has been shown to depend upon monoubiquitination as well as clathrin-mediated endocytosis (CME). We show here that AAK1, the adaptor-associated kinase 1, directly interacts with the membrane-tethered active form of Notch released by metalloprotease cleavage. Active AAK1 acts upstream of the gamma-secretase cleavage by stabilizing both the membrane-tethered activated form of Notch and its monoubiquitinated counterpart. We propose that AAK1 acts as an adaptor for Notch interaction with components of the clathrin-mediated pathway such as Eps15b. Moreover, transfected AAK1 increases the localization of activated Notch to Rab5-positive endocytic vesicles, while AAK1 depletion or overexpression of Numb, an inhibitor of the pathway, interferes with this localization. These results suggest that after ligand-induced activation of Notch, the membrane-tethered form can be directed to different endocytic pathways leading to distinct fates.	[Gupta-Rossi, Neetu; Ortica, Sara; Heuss, Sara; Moretti, Julien; Israel, Alain] Inst Pasteur, Unite Signalisat Mol & Activat Cellulair, CNRS URA 2582, F-75724 Paris 15, France; [Meas-Yedid, Vannary; Olivo-Marin, Jean-Christophe] Inst Pasteur, Unite Anal Images Quantitat, CNRS URA 2582, F-75724 Paris 15, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Gupta-Rossi, N (corresponding author), Inst Pasteur, Unite Signalisat Mol & Activat Cellulair, CNRS URA 2582, 25 Rue Dr Roux, F-75724 Paris 15, France.	neetu.gupta@pasteur.fr	Olivo-Marin, Jean-Christophe/K-4428-2015; Gupta-Rossi, Neetu/AAE-3117-2022	Olivo-Marin, Jean-Christophe/0000-0001-6796-0696; Gupta-Rossi, Neetu/0000-0003-0043-264X; Moretti, Julien/0000-0002-3415-9058	EC; DIM	EC(European CommissionEuropean Commission Joint Research Centre); DIM	This work was supported in part by the Rubicon EC FP6 Grant and a DIM Stem-Pole grant (to S. O.).	Benmerah A, 1995, J CELL BIOL, V131, P1831, DOI 10.1083/jcb.131.6.1831; Berdnik D, 2002, DEV CELL, V3, P221, DOI 10.1016/S1534-5807(02)00215-0; Blaumueller CM, 1997, CELL, V90, P281, DOI 10.1016/S0092-8674(00)80336-0; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Chastagner P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002735; Chien CT, 1998, MOL CELL BIOL, V18, P598, DOI 10.1128/MCB.18.1.598; Childress JL, 2006, CURR BIOL, V16, P2228, DOI 10.1016/j.cub.2006.09.031; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Conner SD, 2003, J CELL BIOL, V162, P773, DOI 10.1083/jcb.200304069; Conner SD, 2003, TRAFFIC, V4, P885, DOI 10.1046/j.1398-9219.2003.0142.x; Conner SD, 2002, J CELL BIOL, V156, P921, DOI 10.1083/jcb.200108123; Cope MJTV, 1999, J CELL BIOL, V144, P1203, DOI 10.1083/jcb.144.6.1203; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Fares H, 1999, GENETICS, V153, P1641; Frise E, 1996, P NATL ACAD SCI USA, V93, P11925, DOI 10.1073/pnas.93.21.11925; Gallagher CM, 2006, DEV CELL, V11, P641, DOI 10.1016/j.devcel.2006.09.014; Guo M, 1996, NEURON, V17, P27, DOI 10.1016/S0896-6273(00)80278-0; Gupta-Rossi N, 2001, J BIOL CHEM, V276, P34371, DOI 10.1074/jbc.M101343200; Gupta-Rossi N, 2004, J CELL BIOL, V166, P73, DOI 10.1083/jcb.200310098; Henderson DM, 2007, MOL BIOL CELL, V18, P2698, DOI 10.1091/mbc.E06-09-0831; Heuss SF, 2008, P NATL ACAD SCI USA, V105, P11212, DOI 10.1073/pnas.0800695105; Honing S, 2005, MOL CELL, V18, P519, DOI 10.1016/j.molcel.2005.04.019; Honjo T, 1996, GENES CELLS, V1, P1, DOI 10.1046/j.1365-2443.1996.10010.x; Jackson AP, 2003, J CELL BIOL, V163, P231, DOI 10.1083/jcb.200304079; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Jha A, 2004, J BIOL CHEM, V279, P2281, DOI 10.1074/jbc.M305644200; Kikuno R, 1999, DNA Res, V6, P197, DOI 10.1093/dnares/6.3.197; Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Le Borgne R, 2006, CURR OPIN CELL BIOL, V18, P213, DOI 10.1016/j.ceb.2006.02.011; Logeat F, 1998, P NATL ACAD SCI USA, V95, P8108, DOI 10.1073/pnas.95.14.8108; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; McGill MA, 2003, J BIOL CHEM, V278, P23196, DOI 10.1074/jbc.M302827200; McGill MA, 2009, J BIOL CHEM, V284, P26427, DOI 10.1074/jbc.M109.014845; Minoguchi S, 1997, MOL CELL BIOL, V17, P2679, DOI 10.1128/MCB.17.5.2679; Morgan JR, 2000, J NEUROSCI, V20, P8667; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Nichols JT, 2007, TRAFFIC, V8, P959, DOI 10.1111/j.1600-0854.2007.00592.x; Nishimura T, 2007, DEV CELL, V13, P15, DOI 10.1016/j.devcel.2007.05.003; Olivo-Marin JC, 2002, PATTERN RECOGN, V35, P1989, DOI 10.1016/S0031-3203(01)00127-3; Owen DJ, 2000, CURR OPIN CELL BIOL, V12, P467, DOI 10.1016/S0955-0674(00)00118-6; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Polo S, 2002, NATURE, V416, P451, DOI 10.1038/416451a; Ricotta D, 2002, J CELL BIOL, V156, P791, DOI 10.1083/jcb.200111068; Roxrud I, 2008, J CELL BIOL, V180, P1205, DOI 10.1083/jcb.200708115; Salcini AE, 1997, GENE DEV, V11, P2239, DOI 10.1101/gad.11.17.2239; Santolini E, 2000, J CELL BIOL, V151, P1345, DOI 10.1083/jcb.151.6.1345; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Seugnet L, 1997, DEV BIOL, V192, P585, DOI 10.1006/dbio.1997.8723; Shaye DD, 2002, NATURE, V420, P686, DOI 10.1038/nature01234; Shih SC, 2002, NAT CELL BIOL, V4, P389, DOI 10.1038/ncb790; Six EM, 2004, J BIOL CHEM, V279, P55818, DOI 10.1074/jbc.M408022200; Sorensen EB, 2008, TRAFFIC, V9, P1791, DOI 10.1111/j.1600-0854.2008.00790.x; Sorensen EB, 2010, TRAFFIC, V11, P1234, DOI 10.1111/j.1600-0854.2010.01090.x; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Tokumitsu H, 2006, FEBS LETT, V580, P5797, DOI 10.1016/j.febslet.2006.09.043; Umeda A, 2000, EUR J CELL BIOL, V79, P336, DOI 10.1078/S0171-9335(04)70037-0; Vaccari T, 2008, J CELL BIOL, V180, P755, DOI 10.1083/jcb.200708127; Wendland B, 2002, NAT REV MOL CELL BIO, V3, P971, DOI 10.1038/nrm970; Wilkin M, 2008, DEV CELL, V15, P762, DOI 10.1016/j.devcel.2008.09.002; Windler SL, 2010, CURR BIOL, V20, P538, DOI 10.1016/j.cub.2010.01.049; Wu PY, 2003, EMBO J, V22, P5241, DOI 10.1093/emboj/cdg501; Yamamoto S, 2010, CURR TOP DEV BIOL, V92, P165, DOI 10.1016/S0070-2153(10)92005-X	64	30	36	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18720	18730		10.1074/jbc.M110.190769	http://dx.doi.org/10.1074/jbc.M110.190769			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21464124	Green Published, hybrid			2022-12-25	WOS:000290785700045
J	Togi, S; Ikeda, O; Kamitani, S; Nakasuji, M; Sekine, Y; Muromoto, R; Nanbo, A; Oritani, K; Kawai, T; Akira, S; Matsuda, T				Togi, Sumihito; Ikeda, Osamu; Kamitani, Shinya; Nakasuji, Misa; Sekine, Yuichi; Muromoto, Ryuta; Nanbo, Asuka; Oritani, Kenji; Kawai, Taro; Akira, Shizuo; Matsuda, Tadashi			Zipper-interacting Protein Kinase (ZIPK) Modulates Canonical Wnt/beta-Catenin Signaling through Interaction with Nemo-like Kinase and T-cell Factor 4 (NLK/TCF4)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; TRANSCRIPTION FACTOR; BINDING PROTEIN; SERINE/THREONINE KINASE; FUNCTIONAL INTERACTIONS; APOPTOSIS; PATHWAY; TARGET; TCF; PHOSPHORYLATION	Zipper-interacting protein kinase (ZIPK) is a widely expressed serine/threonine kinase that has been implicated in apoptosis and transcriptional regulation. Here, we identified Nemo-like kinase (NLK) as a novel ZIPK-binding partner and found that ZIPK regulates NLK-mediated repression of canonical Wnt/beta-catenin signaling. Indeed, siRNA-mediated reduction of endogenous ZIPK expression reduced Wnt/beta-catenin signaling. Furthermore, ZIPK affected the formation of NLK-T-cell factor 4 (TCF4) complex. Importantly, ZIPK siRNA treatment in human colon carcinoma cells resulted in a reduction of beta-catenin/TCF-mediated gene expression and cell growth. These results indicate that ZIPK may serve as a transcriptional regulator of canonical Wnt/beta-catenin signaling through interaction with NLK/TCF4.	[Matsuda, Tadashi] Hokkaido Univ, Dept Immunol, Grad Sch Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Oritani, Kenji] Osaka Univ, Grad Sch Med, Dept Hematol & Oncol, Suita, Osaka 5650871, Japan; [Kawai, Taro; Akira, Shizuo] Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Suita, Osaka 5650871, Japan	Hokkaido University; Osaka University; Osaka University	Matsuda, T (corresponding author), Hokkaido Univ, Dept Immunol, Grad Sch Pharmaceut Sci, Kita Ku, Kita 12,Nishi 6, Sapporo, Hokkaido 0600812, Japan.	tmatsuda@pharm.hokudai.ac.jp	Matsuda, Tadashi/A-3835-2012; Togi, Sumihito/ABH-6734-2020; Nanbo, Asuka/P-2478-2019; Muromoto, Ryuta/E-4203-2012; Nanbo, Asuka/C-6630-2012; Akira, Shizuo/C-3134-2009; Sekine, Yuichi/S-8813-2019	Matsuda, Tadashi/0000-0002-3089-3757; Nanbo, Asuka/0000-0001-8764-1350; Muromoto, Ryuta/0000-0002-7474-493X; Nanbo, Asuka/0000-0001-8764-1350; Sekine, Yuichi/0000-0002-2861-603X; Togi, Sumihito/0000-0002-3189-8111; Kawai, Taro/0000-0001-7510-4662	Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Barre B, 2005, J BIOL CHEM, V280, P15673, DOI 10.1074/jbc.M413203200; Bauer A, 1998, P NATL ACAD SCI USA, V95, P14787, DOI 10.1073/pnas.95.25.14787; Bialik S, 2006, ANNU REV BIOCHEM, V75, P189, DOI 10.1146/annurev.biochem.75.103004.142615; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Hecht A, 1999, J BIOL CHEM, V274, P18017, DOI 10.1074/jbc.274.25.18017; Ikeda O, 2008, MOL CELL BIOL, V28, P5027, DOI 10.1128/MCB.00194-08; Inbal B, 1997, NATURE, V390, P180, DOI 10.1038/36599; Ishitani T, 2003, MOL CELL BIOL, V23, P1379, DOI 10.1128/MCB.23.4.1379-1389.2003; Ishitani T, 1999, NATURE, V399, P798, DOI 10.1038/21674; Kawai T, 2003, MOL CELL BIOL, V23, P6174, DOI 10.1128/MCB.23.17.6174-6186.2003; Kawai T, 1998, MOL CELL BIOL, V18, P1642, DOI 10.1128/MCB.18.3.1642; Kogel D, 1998, ONCOGENE, V17, P2645, DOI 10.1038/sj.onc.1202204; Kramps T, 2002, CELL, V109, P47, DOI 10.1016/S0092-8674(02)00679-7; Matsuda T, 2004, BIOCHEM BIOPH RES CO, V325, P586, DOI 10.1016/j.bbrc.2004.10.071; Matsuzawa S, 2001, MOL CELL, V7, P915, DOI 10.1016/S1097-2765(01)00242-8; McGargill MA, 2004, IMMUNITY, V21, P781, DOI 10.1016/j.immuni.2004.10.008; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Muromoto R, 2006, J IMMUNOL, V177, P1160, DOI 10.4049/jimmunol.177.2.1160; Ohbayashi N, 2008, BIOCHEM BIOPH RES CO, V372, P708, DOI 10.1016/j.bbrc.2008.05.113; Polakis P, 2000, GENE DEV, V14, P1837; Raveh T, 2001, NAT CELL BIOL, V3, P1, DOI 10.1038/35050500; Rottinger E, 2006, DEVELOPMENT, V133, P4341, DOI 10.1242/dev.02603; Sato N, 2006, IMMUNOL LETT, V103, P127, DOI 10.1016/j.imlet.2005.10.015; Sato N, 2005, INT IMMUNOL, V17, P1543, DOI 10.1093/intimm/dxh331; Sierra J, 2006, GENE DEV, V20, P586, DOI 10.1101/gad.1385806; Stevens C, 2009, J BIOL CHEM, V284, P334, DOI 10.1074/jbc.M805165200; Tago K, 2000, GENE DEV, V14, P1741; Takemaru KI, 2003, NATURE, V422, P905, DOI 10.1038/nature01570; Topol LL, 2009, J BIOL CHEM, V284, P3323, DOI 10.1074/jbc.M808048200; Townsley FM, 2004, NAT CELL BIOL, V6, P626, DOI 10.1038/ncb1141; Willert K, 2006, GENE DEV, V20, P1394, DOI 10.1101/gad.1424006; Wu YY, 2010, J BIOL CHEM, V285, P34621, DOI 10.1074/jbc.M110.148791; Yamada M, 2006, J BIOL CHEM, V281, P20749, DOI 10.1074/jbc.M602089200	33	25	29	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					19170	19177		10.1074/jbc.M110.189829	http://dx.doi.org/10.1074/jbc.M110.189829			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21454679	Green Published, hybrid			2022-12-25	WOS:000290785700086
J	Holm, J; Ferreras, M; Ipsen, H; Wurtzen, PA; Gajhede, M; Larsen, JN; Lund, K; Spangfort, MD				Holm, Jens; Ferreras, Mercedes; Ipsen, Henrik; Wurtzen, Peter A.; Gajhede, Michael; Larsen, Jorgen N.; Lund, Kaare; Spangfort, Michael D.			Epitope Grafting, Re-creating a Conformational Bet v 1 Antibody Epitope on the Surface of the Homologous Apple Allergen Mal d 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIRCH POLLEN ALLERGEN; CROSS-REACTIVITY; MAJOR ALLERGENS; IMMUNOCHEMICAL CHARACTERIZATION; MOLECULAR-BASIS; IGE-BINDING; PRU AV-1; X-RAY; AVIUM	Birch-allergic patients often experience oral allergy syndrome upon ingestion of vegetables and fruits, most prominently apple, that is caused by antibody cross-reactivity of the IgE antibodies in patients to proteins sharing molecular surface structures with the major birch pollen group 1 allergen from Betula verrucosa (Bet v 1). Still, to what extent two molecular surfaces need to be similar for clinically relevant antibody cross-reactivity to occur is unknown. Here, we describe the grafting of a defined conformational antibody epitope from Bet v 1 onto the surface of the homologous apple allergen Malus domestica group 1 (Mal d 1). Engineering of the epitope was accomplished by genetic engineering substituting amino acid residues in Mal d 1 differing between Bet v 1 and Mal d 1 within the epitope defined by the mAb BV16. The kinetic parameters characterizing the antibody binding interaction to Bet v 1 and to the mutated Mal d 1 variant, respectively, were assessed by Biacore experiments demonstrating indistinguishable binding kinetics. This demonstrates that a conformational epitope defined by a high affinity antibody-allergen interaction can successfully be grafted onto a homologous scaffold molecule without loss of epitope functionality. Furthermore, we show that increasing surface similarity to Bet v 1 of Mal d 1 variants by substitution of 6-8 residues increased the ability to trigger basophil histamine release with blood from birch-allergic patients not responding to natural Mal d 1. Conversely, reducing surface similarity to Bet v 1 of a Mal d 1 variant by substitution of three residues abolished histamine release in one patient reacting to Mal d 1.	[Holm, Jens; Ferreras, Mercedes; Ipsen, Henrik; Wurtzen, Peter A.; Larsen, Jorgen N.; Lund, Kaare; Spangfort, Michael D.] ALK ABELLO, Res Dept, DK-2970 Horsholm, Denmark; [Gajhede, Michael] Univ Copenhagen, Fac Pharmaceut Sci, Dept Med Chem, DK-2100 Copenhagen, Denmark	ALK-Abello AS; University of Copenhagen	Larsen, JN (corresponding author), ALK ABELLO, Dept Expt Immunol, Boge Alle 6-8, DK-2970 Horsholm, Denmark.	jhodk@alk-abello.com	Larsen, Jørgen Nedergaard/AAI-3423-2020	Gajhede, Michael/0000-0001-9864-2287				Aalberse RC, 2001, ALLERGY, V56, P27, DOI 10.1034/j.1398-9995.2001.00909.x; Aalberse RC, 2001, ALLERGY, V56, P478, DOI 10.1034/j.1398-9995.2001.056006478.x; Alam R., 2009, ALLERGY ALLERGIC DIS, V1, P203; Alexander C, 2005, CLIN EXP ALLERGY, V35, P52, DOI 10.1111/j.1365-2222.2005.02143.x; AMLOT PL, 1987, CLIN ALLERGY, V17, P33, DOI 10.1111/j.1365-2222.1987.tb02317.x; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Ausucua M, 2009, MED ORAL PATOL ORAL, V14, pE568, DOI 10.4317/medoral.14.e568; Bousquet J, 1998, ALLERGY, V53, P4; Braden BC, 1995, ANN NY ACAD SCI, V764, P315; Christensen LH, 2008, J ALLERGY CLIN IMMUN, V122, P298, DOI 10.1016/j.jaci.2008.05.026; DAVIES DR, 1990, ANNU REV BIOCHEM, V59, P439, DOI 10.1146/annurev.bi.59.070190.002255; EBNER C, 1991, J ALLERGY CLIN IMMUN, V88, P588, DOI 10.1016/0091-6749(91)90152-E; Flicker S, 2003, INT ARCH ALLERGY IMM, V132, P13, DOI 10.1159/000073260; Fritsch R, 1998, J ALLERGY CLIN IMMUN, V102, P679, DOI 10.1016/S0091-6749(98)70287-8; Gajhede M, 1996, NAT STRUCT BIOL, V3, P1040, DOI 10.1038/nsb1296-1040; HANNUKSELA M, 1977, CONTACT DERMATITIS, V3, P79, DOI 10.1111/j.1600-0536.1977.tb03603.x; Holm J, 2004, J IMMUNOL, V173, P5258, DOI 10.4049/jimmunol.173.8.5258; Holm J, 2001, J CHROMATOGR B, V756, P307, DOI 10.1016/S0378-4347(01)00089-5; IPSEN H, 1985, ALLERGY, V40, P510, DOI 10.1111/j.1398-9995.1985.tb00259.x; IPSEN H, 1983, J ALLERGY CLIN IMMUN, V72, P150, DOI 10.1016/0091-6749(83)90523-7; IPSEN H, 1992, CLIN EXP ALLERGY, V22, P391, DOI 10.1111/j.1365-2222.1992.tb03101.x; Jahn-Schmid B, 2005, J ALLERGY CLIN IMMUN, V116, P213, DOI 10.1016/j.jaci.2005.04.019; Jogi R, 1998, CLIN EXP ALLERGY, V28, P1072; Larsen Jorgen Nedergaard, 2004, Clin Allergy Immunol, V18, P433; LICHTENSTEIN LM, 1968, J IMMUNOL, V101, P317; Linneberg A, 2007, CLIN EXP ALLERGY, V37, P1137, DOI 10.1111/j.1365-2222.2007.02760.x; Mirza O, 2000, J IMMUNOL, V165, P331, DOI 10.4049/jimmunol.165.1.331; Neudecker P, 2003, BIOCHEM J, V376, P97, DOI 10.1042/BJ20031057; Norman PS, 1996, AM J RESP CRIT CARE, V154, P1623, DOI 10.1164/ajrccm.154.6.8970345; Spangfort MD, 2003, J IMMUNOL, V171, P3084, DOI 10.4049/jimmunol.171.6.3084; Spangfort MD, 1996, PROTEIN EXPRES PURIF, V8, P365, DOI 10.1006/prep.1996.0112; Vieths S, 2002, ANN NY ACAD SCI, V964, P47; Wiche R, 2005, BIOCHEM J, V385, P319, DOI 10.1042/BJ20040842	33	30	31	5	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17569	17578		10.1074/jbc.M110.194878	http://dx.doi.org/10.1074/jbc.M110.194878			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454600	Green Published, hybrid			2022-12-25	WOS:000290585200019
J	Hong, M; Wilkes, MC; Penheiter, SG; Gupta, SK; Edens, M; Leof, EB				Hong, Min; Wilkes, Mark C.; Penheiter, Sumedha G.; Gupta, Shiv K.; Edens, Maryanne; Leof, Edward B.			Non-Smad Transforming Growth Factor-beta Signaling Regulated by Focal Adhesion Kinase Binding the p85 Subunit of Phosphatidylinositol 3-Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; MESENCHYMAL TRANSITION; CELL-PROLIFERATION; TYROSINE KINASE; FERM DOMAIN; C-ABL; INTEGRIN; FAK; ACTIVATION; CANCER	TGF-beta modulates numerous diverse cellular phenotypes including growth arrest in epithelial cells and proliferation in fibroblasts. Although the Smad pathway is fundamental for the majority of these responses, recent evidence indicates that non-Smad pathways may also have a critical role. Here we report a novel mechanism whereby the nonreceptor tyrosine focal adhesion kinase (FAK) functions as an adaptor necessary for cell type-specific responses to TGF-beta. We show that in contrast to Smad actions, non-Smad pathways, including c-Abl, PAK2, and Akt, display an obligate requirement for FAK. Interestingly, this occurs in Src null SYF cells and is independent of FAK tyrosine phosphorylation, kinase activity, and/or proline-rich sequences in the C-terminal FAT domain. FAK binds the phosphatidylinositol 3-kinase (PI3K) p85 regulatory subunit following TGF-beta treatment in a subset of fibroblasts but not epithelial cells and has an obligate role in TGF-beta-stimulated anchorage-independent growth and migration. Together, these results uncover a new scaffolding role for FAK as the most upstream component regulating the profibrogenic action of TGF-beta and suggest that inhibiting this interaction may be useful in treating a number of fibrotic diseases.	[Leof, Edward B.] Mayo Clin, Mayo Clin Canc Ctr, Thorac Dis Res Unit, Dept Biochem Mol Biol, Rochester, MN 55905 USA; Mayo Clin, Mayo Clin Canc Ctr, Thorac Dis Res Unit, Dept Med, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Leof, EB (corresponding author), Mayo Clin, Mayo Clin Canc Ctr, Thorac Dis Res Unit, Dept Biochem Mol Biol, Stabile 8-58,200 1st St SW, Rochester, MN 55905 USA.	leof.edward@mayo.edu		Wilkes, Mark/0000-0002-9600-6831	Public Health Service from the National Institute of General Medical Sciences [GM-54200, GM-55816]; Scleroderma Foundation; Mayo Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055816, R01GM054200, R37GM055816] Funding Source: NIH RePORTER	Public Health Service from the National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Scleroderma Foundation; Mayo Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Public Health Service Grants GM-54200 and GM-55816 from the National Institute of General Medical Sciences, the Scleroderma Foundation, and the Mayo Foundation (to E. B. L.).	AVRAHAM S, 1995, J BIOL CHEM, V270, P27742, DOI 10.1074/jbc.270.46.27742; Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Berking C, 2001, CANCER RES, V61, P8306; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Brunton VG, 2008, CURR OPIN PHARMACOL, V8, P427, DOI 10.1016/j.coph.2008.06.012; Chishti AH, 1998, TRENDS BIOCHEM SCI, V23, P281, DOI 10.1016/S0968-0004(98)01237-7; Daniels CE, 2004, J CLIN INVEST, V114, P1308, DOI 10.1175/JCI200419603; Davidson L, 2004, J BIOL CHEM, V279, P1980, DOI 10.1074/jbc.M309827200; DeMali KA, 2003, CURR OPIN CELL BIOL, V15, P572, DOI 10.1016/S0955-0674(03)00109-1; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dunty JM, 2004, MOL CELL BIOL, V24, P5353, DOI 10.1128/MCB.24.12.5353-5368.2004; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Engel ME, 1999, J BIOL CHEM, V274, P37413, DOI 10.1074/jbc.274.52.37413; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Genua M, 2009, VITAM HORM, V80, P77, DOI 10.1016/S0083-6729(08)00604-3; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Heldin CH, 2009, CURR OPIN CELL BIOL, V21, P166, DOI 10.1016/j.ceb.2009.01.021; HILDEBRAND JD, 1993, J CELL BIOL, V123, P993, DOI 10.1083/jcb.123.4.993; Hocevar BA, 1999, EMBO J, V18, P1345, DOI 10.1093/emboj/18.5.1345; Horowitz JC, 2007, CELL SIGNAL, V19, P761, DOI 10.1016/j.cellsig.2006.10.001; Ilic Dusko, 1995, Nature (London), V377, P539, DOI 10.1038/377539a0; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Korc M, 2007, AM J SURG, V194, pS84, DOI 10.1016/j.amjsurg.2007.05.004; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Levy L, 2005, MOL CELL BIOL, V25, P8108, DOI 10.1128/MCB.25.18.8108-8125.2005; Lim ST, 2008, CELL CYCLE, V7, P2306, DOI 10.4161/cc.6367; Lim ST, 2008, MOL CELL, V29, P9, DOI 10.1016/j.molcel.2007.11.031; Liu SX, 2007, MOL BIOL CELL, V18, P2169, DOI 10.1091/mbc.E06-12-1121; Lohr M, 2001, CANCER RES, V61, P550; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Michael KE, 2009, MOL BIOL CELL, V20, P2508, DOI 10.1091/mbc.E08-01-0076; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Palazzo AF, 2004, SCIENCE, V303, P836, DOI 10.1126/science.1091325; Parsons JT, 1996, CURR OPIN CELL BIOL, V8, P146, DOI 10.1016/S0955-0674(96)80059-7; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Rahimi RA, 2007, J CELL BIOCHEM, V102, P593, DOI 10.1002/jcb.21501; Rahimi RA, 2009, CANCER RES, V69, P84, DOI 10.1158/0008-5472.CAN-08-2146; Reif S, 2003, J BIOL CHEM, V278, P8083, DOI 10.1074/jbc.M212927200; Ross S, 2008, INT J BIOCHEM CELL B, V40, P383, DOI 10.1016/j.biocel.2007.09.006; SASAKI H, 1995, J BIOL CHEM, V270, P21206, DOI 10.1074/jbc.270.36.21206; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Walsh MF, 2009, BBA-GENE REGUL MECH, V1789, P88, DOI 10.1016/j.bbagrm.2008.11.002; Wang SE, 2009, CANCER RES, V69, P475, DOI 10.1158/0008-5472.CAN-08-2649; Wilkes MC, 2006, J BIOL CHEM, V281, P27846, DOI 10.1074/jbc.M603721200; Wilkes MC, 2009, DEV CELL, V16, P433, DOI 10.1016/j.devcel.2009.01.009; Wilkes MC, 2005, CANCER RES, V65, P10431, DOI 10.1158/0008-5472.CAN-05-1522; Wilkes MC, 2003, MOL CELL BIOL, V23, P8878, DOI 10.1128/MCB.23.23.8878-8889.2003; Wisniewska M, 2005, J MOL BIOL, V347, P1005, DOI 10.1016/j.jmb.2005.02.017; Yue JB, 2001, PHARMACOL THERAPEUT, V91, P1, DOI 10.1016/S0163-7258(01)00143-7; Zhao J, 2009, CANCER METAST REV, V28, P35, DOI 10.1007/s10555-008-9165-4	52	38	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17841	17850		10.1074/jbc.M111.233676	http://dx.doi.org/10.1074/jbc.M111.233676			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454615	Green Published, hybrid			2022-12-25	WOS:000290585200047
J	Lovelace, LL; Cooper, CL; Sodetz, JM; Lebioda, L				Lovelace, Leslie L.; Cooper, Christopher L.; Sodetz, James M.; Lebioda, Lukasz			Structure of Human C8 Protein Provides Mechanistic Insight into Membrane Pore Formation by Complement	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ATTACK COMPLEX; 8TH COMPONENT; MACPF DOMAIN; BINDING-SITE; C8-GAMMA; C8-ALPHA; SUBUNIT; REVEALS; FAMILY	C8 is one of five complement proteins that assemble on bacterial membranes to form the lethal pore-like "membrane attack complex" (MAC) of complement. TheMACconsists of one C5b, C6, C7, and C8 and 12-18 molecules of C9. C8 is composed of three genetically distinct subunits, C8 alpha, C8 beta, and C8 gamma. The C6, C7, C8 alpha, C8 beta, and C9 proteins are homologous and together comprise the MAC family of proteins. All contain N- and C-terminal modules and a central 40-kDa membrane attack complex perforin (MACPF) domain that has a key role in forming the MACpore. Here, we report the 2.5A resolution crystal structure of human C8 purified from blood. This is the first structure of a MAC family member and of a human MACPF-containing protein. The structure shows the modules in C8 alpha and C8 beta are located on the periphery of C8 and not likely to interact with the target membrane. The C8 gamma subunit, a member of the lipocalin family of proteins that bind and transport small lipophilic molecules, shows no occupancy of its putative ligand-binding site. C8 alpha and C8 beta are related by a rotation of similar to 22 degrees with only a small translational component along the rotation axis. Evolutionary arguments suggest the geometry of binding between these two subunits is similar to the arrangement of C9 molecules within the MAC pore. This leads to a model of the MAC that explains how C8-C9 and C9-C9 interactions could facilitate refolding and insertion of putative MACPF transmembrane beta-hairpins to form a circular pore.	[Lovelace, Leslie L.; Cooper, Christopher L.; Sodetz, James M.; Lebioda, Lukasz] Univ S Carolina, Dept Chem & Biochem, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Sodetz, JM (corresponding author), Univ S Carolina, Dept Chem & Biochem, Columbia, SC 29208 USA.	sodetz@mail.chem.sc.edu; lebioda@mail.chem.sc.edu			National Institutes of Health [GM042898]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042898] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM042898 (to J. M. S.).	Aybar L, 2009, FISH SHELLFISH IMMUN, V27, P397, DOI 10.1016/j.fsi.2009.05.020; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brannen CL, 2007, MOL IMMUNOL, V44, P960, DOI 10.1016/j.molimm.2006.03.012; BRICKNER A, 1985, BIOCHEMISTRY-US, V24, P4603, DOI 10.1021/bi00338a019; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DEBEER T, 1995, BIOCHEMISTRY-US, V34, P11785, DOI 10.1021/bi00037a016; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; DiScipio RG, 1999, MOL IMMUNOL, V36, P575, DOI 10.1016/S0161-5890(99)00073-5; DISCIPIO RG, 1991, J IMMUNOL, V147, P4239; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESSER AF, 1994, TOXICOLOGY, V87, P229, DOI 10.1016/0300-483X(94)90253-4; Flower DR, 2000, BBA-PROTEIN STRUCT M, V1482, P9, DOI 10.1016/S0167-4838(00)00148-5; Hadders MA, 2007, SCIENCE, V317, P1552, DOI 10.1126/science.1147103; Hofsteenge J, 1999, J BIOL CHEM, V274, P32786, DOI 10.1074/jbc.274.46.32786; HOROWITZ N. H., 1965, P15; HOROWITZ NH, 1945, P NATL ACAD SCI USA, V31, P153, DOI 10.1073/pnas.31.6.153; Huang Y, 2006, J BIOL CHEM, V281, P27398, DOI 10.1074/jbc.M603690200; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Law RHP, 2010, NATURE, V468, P447, DOI 10.1038/nature09518; LEBIODA L, 1988, NATURE, V333, P683, DOI 10.1038/333683a0; Lebioda L, 2005, STRUCTURAL BIOLOGY OF THE COMPLEMENT SYSTEM, P233; Lengweiler S, 1996, FEBS LETT, V380, P8, DOI 10.1016/0014-5793(95)01541-8; LOCKERT DH, 1995, J BIOL CHEM, V270, P19723, DOI 10.1074/jbc.270.34.19723; Lu HS, 2001, J BIOL CHEM, V276, P34913, DOI 10.1074/jbc.M102874200; Luft JR, 2003, J STRUCT BIOL, V142, P170, DOI 10.1016/S1047-8477(03)00048-0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; MULLEREBERHARD HJ, 1988, ANNU REV BIOCHEM, V57, P321, DOI 10.1146/annurev.biochem.57.1.321; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NG SC, 1987, BIOCHEMISTRY-US, V26, P5229, DOI 10.1021/bi00391a003; NINOMIYA H, 1992, J BIOL CHEM, V267, P13675; Ortlund E, 2002, BIOCHEMISTRY-US, V41, P7030, DOI 10.1021/bi025696i; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paakkonen K., 2006, PROTEINS, V64, P1268; Parker CL, 2002, MOL IMMUNOL, V39, P453, DOI 10.1016/S0161-5890(02)00121-9; Plumb ME, 2000, BIOCHEMISTRY-US, V39, P13078, DOI 10.1021/bi001451z; PLUMB ME, 1998, HUMAN COMPLEMENT SYS, P119; PODACK ER, 1991, ANNU REV IMMUNOL, V9, P129, DOI 10.1146/annurev.iy.09.040191.001021; Ponting CP, 1999, CURR BIOL, V9, pR911, DOI 10.1016/S0960-9822(00)80102-5; Rosado CJ, 2007, SCIENCE, V317, P1548, DOI 10.1126/science.1144706; Rossjohn J, 2007, J MOL BIOL, V367, P1227, DOI 10.1016/j.jmb.2007.01.042; ROUSSEL A, 1991, TURBO FRODO SILICON; Schreck SF, 1998, J IMMUNOL, V161, P311; Slade DJ, 2008, J MOL BIOL, V379, P331, DOI 10.1016/j.jmb.2008.03.061; Slade DJ, 2006, BIOCHEMISTRY-US, V45, P5290, DOI 10.1021/bi0601860; STECKEL EW, 1983, J BIOL CHEM, V258, P4318; STECKEL EW, 1980, J BIOL CHEM, V255, P1997; Tang LY, 2007, MOL CELL PROTEOMICS, V6, P1952, DOI 10.1074/mcp.M700120-MCP200; Teichmann SA, 2001, J MOL BIOL, V311, P693, DOI 10.1006/jmbi.2001.4912; Thai CT, 2004, J IMMUNOL, V173, P4547, DOI 10.4049/jimmunol.173.7.4547; Tilley SJ, 2005, CELL, V121, P247, DOI 10.1016/j.cell.2005.02.033; Tweten RK, 2005, INFECT IMMUN, V73, P6199, DOI 10.1128/IAI.73.10.6199-6209.2005; Xu QP, 2010, ACTA CRYSTALLOGR F, V66, P1297, DOI 10.1107/S1744309110023055; ZALMAN LS, 1990, MOL IMMUNOL, V27, P533, DOI 10.1016/0161-5890(90)90072-8	56	73	75	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17585	17592		10.1074/jbc.M111.219766	http://dx.doi.org/10.1074/jbc.M111.219766			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454577	Green Published			2022-12-25	WOS:000290585200021
J	Xu, DS; Meyer, F; Ehlers, E; Blasnitz, L; Zhang, LW				Xu, Dongsheng; Meyer, Florencia; Ehlers, Erica; Blasnitz, Laura; Zhang, Luwen			Interferon Regulatory Factor 4 (IRF-4) Targets IRF-5 to Regulate Epstein-Barr Virus Transformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; T-CELL LEUKEMIA; HUMAN B-CELLS; KAPOSIS-SARCOMA; TRANSCRIPTION FACTOR; LATENT MEMBRANE-PROTEIN-1; INDUCED APOPTOSIS; MULTIPLE-MYELOMA; GENE-EXPRESSION; DNA	The cellular interferon regulatory factor-4 (IRF-4), which is a member of IRF family, is involved in the development of multiple myeloma and Epstein-Barr virus (EBV)-mediated transformation of B lymphocytes. However, the molecular mechanism of IRF-4 in cellular transformation is unknown. We have found that knockdown of IRF-4 leads to high expression of IRF-5, a pro-apoptotic member in the IRF family. Overexpression of IRF-4 represses IRF-5 expression. Reduction of IRF-4 leads to growth inhibition, and the restoration of IRF-4 by exogenous plasmids correlates with the growth recovery and reduces IRF-5 expression. In addition, IRF-4 negatively regulates IRF-5 promoter reporter activities and binds to IRF-5 promoters in vivo and in vitro. Knockdown of IRF-5 rescues IRF-4 knockdown-mediated growth inhibition, and IRF-5 overexpression alone is sufficient to induce cellular growth inhibition of EBV-transformed cells. Therefore, IRF-5 is one of the targets of IRF-4, and IRF-4 regulates the growth of EBV-transformed cells partially through IRF-5. This work provides insight on how IRFs interact with one another to participate in viral pathogenesis and transformation.	[Xu, Dongsheng; Meyer, Florencia; Ehlers, Erica; Blasnitz, Laura; Zhang, Luwen] Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA; [Zhang, Luwen] Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Zhang, LW (corresponding author), Univ Nebraska, Nebraska Ctr Virol, Morrison Ctr 238, 4240 Fair St, Lincoln, NE 68583 USA.	lzhang2@unlnotes.unl.edu	Meyer, Florencia/V-3406-2019		National Institutes of Health [CA138213, CA108951]; NCRR [RR15635]; IDeA Networks of Biomedical Research Excellence; NATIONAL CANCER INSTITUTE [R01CA108951, R01CA138213] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015635] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); IDeA Networks of Biomedical Research Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants CA138213 and CA108951 and Grant RR15635 from NCRR (to L. Z.).; Supported in part by the IDeA Networks of Biomedical Research Excellence.	Acquaviva J, 2008, BLOOD, V112, P3798, DOI 10.1182/blood-2007-10-117838; Alexander L, 2000, J VIROL, V74, P3388, DOI 10.1128/JVI.74.7.3388-3398.2000; ALLDAY MJ, 1995, EMBO J, V14, P1382, DOI 10.1002/j.1460-2075.1995.tb07124.x; Altmann M, 2005, PLOS BIOL, V3, P2148, DOI 10.1371/journal.pbio.0030404; Barnes BJ, 2003, CANCER RES, V63, P6424; Bellows DS, 2002, J VIROL, V76, P2469, DOI 10.1128/JVI.76.5.2469-2479.2002; BENBASSAT H, 1977, INT J CANCER, V19, P27, DOI 10.1002/ijc.2910190105; Cahir-McFarland ED, 2000, P NATL ACAD SCI USA, V97, P6055, DOI 10.1073/pnas.100119497; Carter KL, 2002, J VIROL, V76, P10427, DOI 10.1128/JVI.76.20.10427-10436.2002; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chang Y, 1996, INFECT AGENT DIS, V5, P215; Couzinet A, 2008, P NATL ACAD SCI USA, V105, P2556, DOI 10.1073/pnas.0712295105; Della Ragione F, 2003, J BIOL CHEM, V278, P23360, DOI 10.1074/jbc.M300771200; Dourmishev LA, 2003, MICROBIOL MOL BIOL R, V67, P175, DOI 10.1128/MMBR.67.2.175-212.2003; Dupuis S, 2003, NAT GENET, V33, P388, DOI 10.1038/ng1097; Frost V, 2001, J GEN VIROL, V82, P3057, DOI 10.1099/0022-1317-82-12-3057; HENDERSON A, 1983, P NATL ACAD SCI-BIOL, V80, P1987, DOI 10.1073/pnas.80.7.1987; HENDERSON S, 1993, P NATL ACAD SCI USA, V90, P8479, DOI 10.1073/pnas.90.18.8479; Hu GD, 2005, CANCER RES, V65, P7403, DOI 10.1158/0008-5472.CAN-05-0583; HURLEY EA, 1991, J VIROL, V65, P3958, DOI 10.1128/JVI.65.7.3958-3963.1991; Jin L, 2004, J VIROL METHODS, V118, P9, DOI 10.1016/j.jviromet.2004.01.011; Kieff E., 1996, FIELDS VIROLOGY, V2, P2343; Lu RQ, 2003, GENE DEV, V17, P1703, DOI 10.1101/gad.1104803; Mamane Y, 2005, J INTERF CYTOK RES, V25, P43, DOI 10.1089/jir.2005.25.43; Mamane Y, 2002, ONCOGENE, V21, P6751, DOI 10.1038/sj.onc.1205843; Mancl ME, 2005, J BIOL CHEM, V280, P21078, DOI 10.1074/jbc.M500543200; Marshall WL, 1999, J VIROL, V73, P5181, DOI 10.1128/JVI.73.6.5181-5185.1999; Martin HJ, 2007, J VIROL, V81, P9748, DOI 10.1128/JVI.01122-07; McFarland EDC, 1999, ONCOGENE, V18, P6959, DOI 10.1038/sj.onc.1203217; Mittrucker HW, 1997, SCIENCE, V275, P540, DOI 10.1126/science.275.5299.540; Moore P., 2001, VIROLOGY, P2803; Mori T, 2002, ONCOGENE, V21, P2914, DOI 10.1038/sj.onc.1205459; Negishi H, 2005, P NATL ACAD SCI USA, V102, P15989, DOI 10.1073/pnas.0508327102; NGUYEN H, 1995, ONCOGENE, V11, P537; Nguyen Hannah, 1997, Cytokine and Growth Factor Reviews, V8, P293, DOI 10.1016/S1359-6101(97)00019-1; Ning S, 2003, J VIROL, V77, P9359, DOI 10.1128/JVI.77.17.9359-9368.2003; Nonkwelo C, 1996, J VIROL, V70, P623, DOI 10.1128/JVI.70.1.623-627.1996; Pagano JS, 1999, P ASSOC AM PHYSICIAN, V111, P573, DOI 10.1046/j.1525-1381.1999.t01-1-99220.x; Pitha PM, 1998, BIOCHIMIE, V80, P651, DOI 10.1016/S0300-9084(99)80018-2; Saito T, 1999, BIOCHEM BIOPH RES CO, V260, P329, DOI 10.1006/bbrc.1999.0911; Shaffer AL, 2008, NATURE, V454, P226, DOI 10.1038/nature07064; Tamura T, 2005, J IMMUNOL, V174, P2573, DOI 10.4049/jimmunol.174.5.2573; Tanaka N, 2000, SEMIN CANCER BIOL, V10, P73, DOI 10.1006/scbi.2000.0310; TANIGUCHI T, 1995, J CANCER RES CLIN, V121, P516, DOI 10.1007/BF01197763; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; West JT, 2003, ONCOGENE, V22, P5150, DOI 10.1038/sj.onc.1206555; WILLMAN CL, 1993, SCIENCE, V259, P968, DOI 10.1126/science.8438156; Xu DS, 2008, J VIROL, V82, P6251, DOI 10.1128/JVI.00163-08; Xu DS, 2007, J VIROL, V81, P6068, DOI 10.1128/JVI.02743-06; Yamagata T, 1996, MOL CELL BIOL, V16, P1283; Yanai H, 2007, P NATL ACAD SCI USA, V104, P3402, DOI 10.1073/pnas.0611559104; Zhang LW, 2004, J VIROL, V78, P12987, DOI 10.1128/JVI.78.23.12987-12995.2004; Zhang LW, 1997, MOL CELL BIOL, V17, P5748, DOI 10.1128/MCB.17.10.5748; Zhang LW, 2001, SEMIN CANCER BIOL, V11, P445, DOI 10.1006/scbi.2001.0411; Zhang LW, 2001, J VIROL, V75, P12393, DOI 10.1128/JVI.75.24.12393-12401.2001; Zhang LW, 2001, J VIROL, V75, P341, DOI 10.1128/JVI.75.1.341-350.2001; Zhang LW, 2000, J VIROL, V74, P1061, DOI 10.1128/JVI.74.3.1061-1068.2000	57	30	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					18261	18267		10.1074/jbc.M110.210542	http://dx.doi.org/10.1074/jbc.M110.210542			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454650	Green Published, hybrid			2022-12-25	WOS:000290585200086
J	Moshe, Y; Bar-On, O; Ganoth, D; Hershko, A				Moshe, Yakir; Bar-On, Ortal; Ganoth, Dvora; Hershko, Avram			Regulation of the Action of Early Mitotic Inhibitor 1 on the Anaphase-promoting Complex/Cyclosome by Cyclin-dependent Kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS-LAEVIS EGGS; POLO-LIKE KINASE-1; SCF-BETA-TRCP; AFFINITY PURIFICATION; CELL-CYCLE; DNA-REPLICATION; IN-VIVO; EMI1; COMPLEX; PHOSPHORYLATION	Cell cycle regulation is characterized by alternating activities of cyclin-dependent kinases (CDKs) and of the ubiquitin ligase anaphase promoting complex/cyclosome (APC/C). During S-phase APC/C is inhibited by early mitotic inhibitor 1 (Emi1) to allow the accumulation of cyclins A and B and to prevent re-replication. Emi1 is degraded at prophase by a Plk1-dependent pathway. Recent studies in which the degradation pathway of Emi1 was disrupted have shown that APC/C is activated at mitotic entry despite stabilization of Emi1. These results suggested the possibility of additional mechanisms other than degradation of Emi1, which release APC/C from inhibition by Emi1 upon entry into mitosis. In this study we report one such mechanism, by which the ability of Emi1 to inhibit APC/C is negatively regulated by CDKs. We show that in Plk1-inhibited cells Emi1 is stabilized and phosphorylated, that Emi1 is phosphorylated by CDKs in mitotic but not S-phase cell extracts, and that Emi1 phosphorylation by mitotic cell extracts or purified CDKs markedly reduces the ability of Emi1 to bind and to inhibit APC/C. Finally, we show that the addition of extracts from S-phase cells to extracts from mitotic cells protects Emi1 from CDK-mediated inactivation.	[Moshe, Yakir; Bar-On, Ortal; Ganoth, Dvora; Hershko, Avram] Technion Israel Inst Technol, Biochem Unit, Rappaport Fac Med, IL-31096 Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Hershko, A (corresponding author), Technion Israel Inst Technol, Biochem Unit, Rappaport Fac Med, IL-31096 Haifa, Israel.	hershko@tx.technion.ac.il			Israel Science Foundation	Israel Science Foundation(Israel Science Foundation)	This work was supported by a grant from the Israel Science Foundation (to A. H.).	Aristarkhov A, 1996, P NATL ACAD SCI USA, V93, P4294, DOI 10.1073/pnas.93.9.4294; Bernis C, 2007, EMBO REP, V8, P91, DOI 10.1038/sj.embor.7400853; den Elzen N, 2001, J CELL BIOL, V153, P121, DOI 10.1083/jcb.153.1.121; Di Fiore B, 2008, CHROMOSOMA, V117, P333, DOI 10.1007/s00412-008-0152-x; Di Fiore B, 2007, J CELL BIOL, V177, P425, DOI 10.1083/jcb.200611166; Dong XZ, 1997, GENE DEV, V11, P94, DOI 10.1101/gad.11.1.94; Eldridge AG, 2006, CELL, V124, P367, DOI 10.1016/j.cell.2005.10.038; Geley S, 2001, J CELL BIOL, V153, P137, DOI 10.1083/jcb.153.1.137; Golan A, 2002, J BIOL CHEM, V277, P15552, DOI 10.1074/jbc.M111476200; Grosskortenhaus R, 2002, DEV CELL, V2, P29, DOI 10.1016/S1534-5807(01)00104-6; Guardavaccaro D, 2003, DEV CELL, V4, P799, DOI 10.1016/S1534-5807(03)00154-0; Hansen DV, 2007, CELL CYCLE, V6, P732, DOI 10.4161/cc.6.6.3937; Hansen DV, 2004, MOL BIOL CELL, V15, P5623, DOI 10.1091/mbc.E04-07-0598; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; Hershko A, 2005, METHOD ENZYMOL, V398, P170, DOI 10.1016/S0076-6879(05)98015-4; Hochegger H, 2008, NAT REV MOL CELL BIO, V9, P910, DOI 10.1038/nrm2510; Hsu JY, 2002, NAT CELL BIOL, V4, P358, DOI 10.1038/ncb785; Inoue D, 2007, NATURE, V446, P1100, DOI 10.1038/nature05688; Lee H, 2006, MOL CELL BIOL, V26, P5373, DOI 10.1128/MCB.00043-06; Lehman NL, 2007, AM J PATHOL, V170, P1793, DOI 10.2353/ajpath.2007.060767; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Liu JJ, 2006, J BIOL CHEM, V281, P34736, DOI 10.1074/jbc.M606607200; Lu KP, 2002, TRENDS CELL BIOL, V12, P164, DOI 10.1016/S0962-8924(02)02253-5; Machida YJ, 2007, GENE DEV, V21, P184, DOI 10.1101/gad.1495007; Margottin-Goguet F, 2003, DEV CELL, V4, P813, DOI 10.1016/S1534-5807(03)00153-9; MAYER AN, 1989, BIOCHEMISTRY-US, V28, P166, DOI 10.1021/bi00427a024; Miller JJ, 2006, GENE DEV, V20, P2410, DOI 10.1101/gad.1454006; Montagnoli A, 1999, GENE DEV, V13, P1181, DOI 10.1101/gad.13.9.1181; Moshe Y, 2004, P NATL ACAD SCI USA, V101, P7937, DOI 10.1073/pnas.0402442101; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Nishiyama T, 2007, NATURE, V446, P1096, DOI 10.1038/nature05696; Ohe M, 2010, MOL BIOL CELL, V21, P905, DOI 10.1091/mbc.E09-11-0974; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Reed SI, 2003, NAT REV MOL CELL BIO, V4, P855, DOI 10.1038/nrm1246; Reimann JDR, 2001, CELL, V105, P645, DOI 10.1016/S0092-8674(01)00361-0; Reimann JDR, 2001, GENE DEV, V15, P3278, DOI 10.1101/gad.945701; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Sudakin V, 1997, J BIOL CHEM, V272, P18051, DOI 10.1074/jbc.272.29.18051; Sumara I, 2004, CURR BIOL, V14, P1712, DOI 10.1016/j.cub.2004.09.049; Thornton BR, 2003, NAT CELL BIOL, V5, P1090, DOI 10.1038/ncb1066; van Vugt MATM, 2004, J BIOL CHEM, V279, P36841, DOI 10.1074/jbc.M313681200; Wu JQ, 2008, J CELL SCI, V121, P3509, DOI 10.1242/jcs.036855; Wu JQ, 2007, P NATL ACAD SCI USA, V104, P16564, DOI 10.1073/pnas.0707537104; Wu QJ, 2007, CURR BIOL, V17, P213, DOI 10.1016/j.cub.2006.12.045	44	24	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16647	16657		10.1074/jbc.M111.223339	http://dx.doi.org/10.1074/jbc.M111.223339			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454540	Green Published, hybrid			2022-12-25	WOS:000290301900013
J	Zieba, BJ; Artamonov, MV; Jin, L; Momotani, K; Ho, R; Franke, AS; Neppl, RL; Stevenson, AS; Khromov, AS; Chrzanowska-Wodnicka, M; Somlyo, AV				Zieba, Bartosz J.; Artamonov, Mykhaylo V.; Jin, Li; Momotani, Ko; Ho, Ruoya; Franke, Aaron S.; Neppl, Ronald L.; Stevenson, Andra S.; Khromov, Alexander S.; Chrzanowska-Wodnicka, Magdalena; Somlyo, Avril V.			The cAMP-responsive Rap1 Guanine Nucleotide Exchange Factor, Epac, Induces Smooth Muscle Relaxation by Down-regulation of RhoA Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; ENDOTHELIAL BARRIER FUNCTION; LIGHT-CHAIN PHOSPHATASE; INDUCED CA2+ SENSITIZATION; GUINEA-PIG ILEUM; CYCLIC-AMP; MYOSIN PHOSPHATASE; SIGNALING PATHWAY; PULMONARY-ARTERY; MEDIATED INHIBITION	Agonist activation of the small GTPase, RhoA, and its effector Rho kinase leads to down-regulation of smooth muscle (SM) myosin light chain phosphatase activity, an increase in myosin light chain (RLC20) phosphorylation and force. Cyclic nucleotides can reverse this process. We report a new mechanism of cAMP-mediated relaxation through Epac, a GTP exchange factor for the small GTPase Rap1 resulting in an increase in Rap1 activity and suppression of RhoA activity. An Epac-selective cAMP analog, 8-pCPT-2'-O-Me-cAMP ("007"), significantly reduced agonist-induced contractile force, RLC20, and myosin light chain phosphatase phosphorylation in both intact and permeabilized vascular, gut, and airway SMs independently of PKA and PKG. The vasodilator PGI(2) analog, cicaprost, increased Rap1 activity and decreased RhoA activity in intact SMs. Forskolin, phosphodiesterase inhibitor isobutylmethylxanthine, and isoproterenol also significantly increased Rap1-GTP in rat aortic SM cells. The PKA inhibitor H89 was without effect on the 007-induced increase in Rap1-GTP. Lysophosphatidic acid-induced RhoA activity was reduced by treatment with 007 in WT but not Rap1B null fibroblasts, consistent with Epac signaling through Rap1B to down-regulate RhoA activity. Isoproterenol-induced increase in Rap1 activity was inhibited by silencing Epac1 in rat aortic SM cells. Evidence is presented that cooperative cAMP activation of PKA and Epac contribute to relaxation of SM. Our findings demonstrate a cAMP-mediated signaling mechanism whereby activation of Epac results in a PKA-independent, Rap1-dependent Ca2+ desensitization of force in SM through down-regulation of RhoA activity. Cyclic AMP inhibition of RhoA is mediated through activation of both Epac and PKA.	[Zieba, Bartosz J.; Artamonov, Mykhaylo V.; Jin, Li; Momotani, Ko; Ho, Ruoya; Franke, Aaron S.; Stevenson, Andra S.; Khromov, Alexander S.; Somlyo, Avril V.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Zieba, Bartosz J.] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Cell Biochem, PL-30387 Krakow, Poland; [Chrzanowska-Wodnicka, Magdalena] BloodCtr Wisconsin, Blood Res Inst, Milwaukee, WI 53101 USA; [Neppl, Ronald L.] Harvard Univ, Sch Med, Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA	University of Virginia; Jagiellonian University; Versiti Blood Center of Wisconsin; Harvard University; Boston Children's Hospital; Harvard Medical School	Somlyo, AV (corresponding author), Univ Virginia, Dept Mol Physiol & Biol Phys, POB 800736, Charlottesville, VA 22908 USA.	avs5u@virginia.edu	Neppl, Ronald L/AAW-1257-2020; Artamonov, Mykhaylo/AAD-3488-2021	Neppl, Ronald L/0000-0003-1497-6058; Artamonov, Mykhaylo/0000-0002-0848-2054; Chrzanowska, Magdalena/0000-0003-4182-2126	National Institutes of Health [R01GM086457-02, 1R01DK088905-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088905] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086457] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM086457-02 and 1R01DK088905-01 (to A. V. S.).	Birukova AA, 2008, J CELL PHYSIOL, V215, P715, DOI 10.1002/jcp.21354; Birukova AA, 2007, EXP CELL RES, V313, P2504, DOI 10.1016/j.yexcr.2007.03.036; Boettner B, 2009, CURR OPIN CELL BIOL, V21, P684, DOI 10.1016/j.ceb.2009.06.004; Bos JL, 2001, NAT REV MOL CELL BIO, V2, P369, DOI 10.1038/35073073; Carvajal JA, 2000, J CELL PHYSIOL, V184, P409, DOI 10.1002/1097-4652(200009)184:3<409::AID-JCP16>3.3.CO;2-B; Christensen AE, 2003, J BIOL CHEM, V278, P35394, DOI 10.1074/jbc.M302179200; Chrzanowska-Wodnicka M, 2005, J CLIN INVEST, V115, P680, DOI 10.1172/JCI200522973; Clapp LH, 2002, AM J RESP CELL MOL, V26, P194, DOI 10.1165/ajrcmb.26.2.4695; Conner D A, 2001, Curr Protoc Mol Biol, VChapter 23, DOI [10.1002/0471142727.mb2303s51, 10.1002/0471142727.mb2302s51]; Cullere X, 2005, BLOOD, V105, P1950, DOI 10.1182/blood-2004-05-1987; Dao KK, 2006, J BIOL CHEM, V281, P21500, DOI 10.1074/jbc.M603116200; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; DiPilato LM, 2004, P NATL ACAD SCI USA, V101, P16513, DOI 10.1073/pnas.0405973101; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; Ellerbroek SM, 2003, J BIOL CHEM, V278, P19023, DOI 10.1074/jbc.M213066200; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Franke B, 1997, EMBO J, V16, P252, DOI 10.1093/emboj/16.2.252; Fukuhara S, 2005, MOL CELL BIOL, V25, P136, DOI 10.1128/MCB.25.1.136-146.2005; Gloerich M, 2010, ANNU REV PHARMACOL, V50, P355, DOI 10.1146/annurev.pharmtox.010909.105714; Gudi T, 2002, J BIOL CHEM, V277, P37382, DOI 10.1074/jbc.M204491200; HIMPENS B, 1989, J PHYSIOL-LONDON, V413, P489, DOI 10.1113/jphysiol.1989.sp017665; Houslay MD, 2007, CIRC RES, V100, P950, DOI 10.1161/01.RES.0000261934.56938.38; Kasahara H, 2005, METH MOLEC MED, V112, P155, DOI 10.1007/978-1-59259-879-3_9; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; KITAZAWA T, 1991, P NATL ACAD SCI USA, V88, P9307, DOI 10.1073/pnas.88.20.9307; Kooistra MRH, 2005, FEBS LETT, V579, P4966, DOI 10.1016/j.febslet.2005.07.080; Krugmann S, 2004, CURR BIOL, V14, P1380, DOI 10.1016/j.cub.2004.07.058; Krugmann S, 2002, MOL CELL, V9, P95, DOI 10.1016/S1097-2765(02)00434-3; Lang P, 1996, EMBO J, V15, P510, DOI 10.1002/j.1460-2075.1996.tb00383.x; Lubomirov LT, 2006, CIRC RES, V98, P1159, DOI 10.1161/01.RES.0000219904.43852.3e; Mack CP, 2001, J BIOL CHEM, V276, P341, DOI 10.1074/jbc.M005505200; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; Mei FC, 2002, J BIOL CHEM, V277, P11497, DOI 10.1074/jbc.M110856200; MONCADA S, 1983, STROKE, V14, P157, DOI 10.1161/01.STR.14.2.157; Nakamura K, 2007, CIRC RES, V101, P712, DOI 10.1161/CIRCRESAHA.107.153981; Neppl RL, 2009, J BIOL CHEM, V284, P6348, DOI 10.1074/jbc.M807040200; Poppe H, 2008, NAT METHODS, V5, P277, DOI 10.1038/nmeth0408-277; Puetz S, 2009, PHYSIOLOGY, V24, P342, DOI 10.1152/physiol.00023.2009; Purves GI, 2009, J PHYSIOL-LONDON, V587, P3639, DOI 10.1113/jphysiol.2009.173534; Qiao JB, 2002, J BIOL CHEM, V277, P26581, DOI 10.1074/jbc.M203571200; Rehmann H, 2003, J BIOL CHEM, V278, P38548, DOI 10.1074/jbc.M306292200; Ren XD, 2000, METHOD ENZYMOL, V325, P264; Roscioni SS, 2008, N-S ARCH PHARMACOL, V377, P345, DOI 10.1007/s00210-007-0246-7; Roscioni SS, 2010, J CELL MOL IN PRESS; Sand C, 2010, THROMB HAEMOSTASIS, V103, P662, DOI 10.1160/TH09-06-0341; Sanders LC, 1999, SCIENCE, V283, P2083, DOI 10.1126/science.283.5410.2083; Sauzeau V, 2000, J BIOL CHEM, V275, P21722, DOI 10.1074/jbc.M000753200; Sawada N, 2001, BIOCHEM BIOPH RES CO, V280, P798, DOI 10.1006/bbrc.2000.4194; Shi GX, 2006, MOL CELL BIOL, V26, P9136, DOI 10.1128/MCB.00332-06; Sobolewski A, 2004, AM J PHYSIOL-LUNG C, V287, pL352, DOI 10.1152/ajplung.00270.2003; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; SOMLYO AP, 1989, ADV PROTEIN PHOSPHAT, V5, P181; Ster J, 2007, P NATL ACAD SCI USA, V104, P2519, DOI 10.1073/pnas.0611031104; Sukhanova I F, 2006, Dokl Biol Sci, V411, P441, DOI 10.1134/S0012496606060044; Surks HK, 1999, SCIENCE, V286, P1583, DOI 10.1126/science.286.5444.1583; Sward K, 2000, J PHYSIOL-LONDON, V522, P33, DOI 10.1111/j.1469-7793.2000.0033m.x; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Van Eyk JE, 1998, J BIOL CHEM, V273, P23433, DOI 10.1074/jbc.273.36.23433; WALSH MP, 1995, CAN J PHYSIOL PHARM, V73, P565, DOI 10.1139/y95-072; Weisbrod RM, 1998, BRIT J PHARMACOL, V125, P1695, DOI 10.1038/sj.bjp.0702233; Wittchen ES, 2005, J BIOL CHEM, V280, P11675, DOI 10.1074/jbc.M412595200; Wooldridge AA, 2004, J BIOL CHEM, V279, P34496, DOI 10.1074/jbc.M405957200; Wu XQ, 1996, BIOCHEM BIOPH RES CO, V220, P658, DOI 10.1006/bbrc.1996.0460; Wu XQ, 1998, J BIOL CHEM, V273, P11362, DOI 10.1074/jbc.273.18.11362; Yamada T, 2005, J BIOL CHEM, V280, P33026, DOI 10.1074/jbc.M504587200; Yokoyama U, 2008, J BIOL CHEM, V283, P28702, DOI 10.1074/jbc.M804223200; Yokoyama U, 2008, AM J PHYSIOL-HEART C, V295, pH1547, DOI 10.1152/ajpheart.01317.2007; Yokoyama U, 2008, P NATL ACAD SCI USA, V105, P6386, DOI 10.1073/pnas.0801490105	68	70	75	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16681	16692		10.1074/jbc.M110.205062	http://dx.doi.org/10.1074/jbc.M110.205062			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454546	hybrid, Green Published			2022-12-25	WOS:000290301900016
J	Nath, S; Banerjee, T; Sen, D; Das, T; Roychoudhury, S				Nath, Somsubhra; Banerjee, Taraswi; Sen, Debrup; Das, Tania; Roychoudhury, Susanta			Spindle Assembly Checkpoint Protein Cdc20 Transcriptionally Activates Expression of Ubiquitin Carrier Protein UbcH10	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANAPHASE-PROMOTING COMPLEX; CELL-CYCLE; CONJUGATING ENZYME; CANCER-CELLS; WD REPEAT; APC/C; OVEREXPRESSION; CARCINOMAS; P53; ANEUPLOIDY	The spindle assembly checkpoint (SAC) ensures accurate segregation of chromosomes by monitoring kinetochore attachment of spindles during mitosis. Proper progression of mitosis depends on orderly ubiquitination and subsequent degradation of various mitotic inhibitors. At the molecular level, upon removal of SAC, Cdc20 activates E3 ubiquitin ligase anaphase-promoting complex/cyclosome that, along with E2 ubiquitin-conjugating enzyme UbcH10, executes this function. Both Cdc20 and UbcH10 are overexpressed in many cancer types and are associated with defective SAC function leading to chromosomal instability. The precise mechanism of correlated overexpression of these two proteins remains elusive. We show that Cdc20 transcriptionally up-regulates UbcH10 expression. The WD40 domain of Cdc20 is required for this activity. Physical interaction between Cdc20 and anaphase-promoting complex/cyclosome-CBP/p300 complex and its subsequent recruitment to the UBCH10 promoter are involved in this transactivation process. This transcriptional regulatory function of Cdc20 was observed to be cell cycle-specific. We hypothesize that this coregulated overexpression of both proteins contributes to chromosomal instability.	[Nath, Somsubhra; Banerjee, Taraswi; Sen, Debrup; Das, Tania; Roychoudhury, Susanta] Indian Inst Chem Biol, Council Sci & Ind Res, Mol & Human Genet Div, Kolkata 700032, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Roychoudhury, S (corresponding author), Indian Inst Chem Biol, Council Sci & Ind Res, Mol & Human Genet Div, 4 Raja SC Mullick Rd, Kolkata 700032, India.	susanta@iicb.res.in	Nath, Somsubhra/AAL-6377-2020; Banerjee, Taraswi/AAC-6093-2020; Roychoudhury, Susanta/AAD-7946-2021	Nath, Somsubhra/0000-0001-8214-1218	Department of Biotechnology [BT/PR/5524/Med/14/649/2004, BT/01/COE/05/04]; Council of Scientific and Industrial Research [IAP 001]; Council of Scientific and Industrial Research, New Delhi, India; Lady Tata Memorial Trust, Mumbai, India	Department of Biotechnology; Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Council of Scientific and Industrial Research, New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India); Lady Tata Memorial Trust, Mumbai, India	This work was supported in part by Department of Biotechnology Grants BT/PR/5524/Med/14/649/2004 and BT/01/COE/05/04 and Council of Scientific and Industrial Research Grant IAP 001 (to S. R.).; Supported by Council of Scientific and Industrial Research, New Delhi, India.; Supported by Lady Tata Memorial Trust, Mumbai, India.	Baker DJ, 2007, CELL MOL LIFE SCI, V64, P589, DOI 10.1007/s00018-007-6443-1; Banerjee T, 2009, NUCLEIC ACIDS RES, V37, P2688, DOI 10.1093/nar/gkp110; Benanti JA, 2008, MOL CELL, V32, P460, DOI 10.1016/j.molcel.2008.11.006; Berlingieri MT, 2007, ONCOGENE, V26, P2136, DOI 10.1038/sj.onc.1210010; Berlingieri MT, 2007, EUR J CANCER, V43, P2729, DOI 10.1016/j.ejca.2007.09.003; Bharadwaj R, 2004, ONCOGENE, V23, P2016, DOI 10.1038/sj.onc.1207374; Chan HM, 2001, J CELL SCI, V114, P2363; Chi YH, 2007, J CELL BIOCHEM, V102, P531, DOI 10.1002/jcb.21484; Cho RJ, 2001, NAT GENET, V27, P48, DOI 10.1038/83751; Chun ACS, 2003, J BIOL CHEM, V278, P37439, DOI 10.1074/jbc.M307185200; Fraschini R, 2001, EMBO J, V20, P6648, DOI 10.1093/emboj/20.23.6648; Fujita T, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-87; Garnett MJ, 2009, NAT CELL BIOL, V11, P1363, DOI 10.1038/ncb1983; Harper JW, 2002, GENE DEV, V16, P2179, DOI 10.1101/gad.1013102; Jeong SJ, 2004, CANCER RES, V64, P8666, DOI 10.1158/0008-5472.CAN-03-3455; Jiang L, 2010, J CANCER RES CLIN, V136, P211, DOI 10.1007/s00432-009-0651-z; Kidokoro T, 2008, ONCOGENE, V27, P1562, DOI 10.1038/sj.onc.1210799; Kimata Y, 2008, MOL CELL, V32, P576, DOI 10.1016/j.molcel.2008.09.023; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li M, 2009, J CELL BIOL, V185, P983, DOI 10.1083/jcb.200904020; Liu JH, 2006, CANCER BIOL THER, V5, P760, DOI 10.4161/cbt.5.7.3103; Manchado E, 2010, BIOCHEM SOC T, V38, P65, DOI 10.1042/BST0380065; Mapelli M, 2006, EMBO J, V25, P1273, DOI 10.1038/sj.emboj.7601033; Mondal G, 2007, CARCINOGENESIS, V28, P81, DOI 10.1093/carcin/bgl100; Mondal G, 2006, BIOCHEM J, V396, P243, DOI 10.1042/BJ20051914; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Oikawa T, 2005, MOL CELL BIOL, V25, P4046, DOI 10.1128/MCB.25.10.4046-4061.2005; Okamoto Y, 2003, CANCER RES, V63, P4167; Pallante P, 2005, BRIT J CANCER, V93, P464, DOI 10.1038/sj.bjc.6602721; Park HY, 2007, EXP MOL MED, V39, P195, DOI 10.1038/emm.2007.22; Pesin JA, 2008, ANNU REV CELL DEV BI, V24, P475, DOI 10.1146/annurev.cellbio.041408.115949; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pines J, 2009, MOL CELL, V34, P135, DOI 10.1016/j.molcel.2009.04.006; Rape M, 2006, CELL, V124, P89, DOI 10.1016/j.cell.2005.10.032; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Reddy SK, 2007, NATURE, V446, P921, DOI 10.1038/nature05734; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Stegmeier F, 2007, NATURE, V446, P876, DOI 10.1038/nature05694; Thornton BR, 2006, GENE DEV, V20, P3069, DOI 10.1101/gad.1478306; Townsley FM, 1997, P NATL ACAD SCI USA, V94, P2362, DOI 10.1073/pnas.94.6.2362; Turnell AS, 2005, NATURE, V438, P690, DOI 10.1038/nature04151; van Ree JH, 2010, J CELL BIOL, V188, P83, DOI 10.1083/jcb.200906147; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Wagner KW, 2004, ONCOGENE, V23, P6621, DOI 10.1038/sj.onc.1207861; Weaver BAA, 2006, CURR OPIN CELL BIOL, V18, P658, DOI 10.1016/j.ceb.2006.10.002; Williamson A, 2009, P NATL ACAD SCI USA, V106, P18213, DOI 10.1073/pnas.0907887106; Wu T, 2010, P NATL ACAD SCI USA, V107, P1355, DOI 10.1073/pnas.0912802107; Yang Y, 2010, CURR OPIN NEUROBIOL, V20, P92, DOI 10.1016/j.conb.2009.12.004; Yoon YM, 2004, FEBS LETT, V575, P23, DOI 10.1016/j.febslet.2004.07.089; Yu H, 2007, MOL CELL, V27, P3, DOI 10.1016/j.molcel.2007.06.009; Yuan BB, 2006, CLIN CANCER RES, V12, P405, DOI 10.1158/1078-0432.CCR-05-0903; Yuen KWY, 2005, CURR OPIN CELL BIOL, V17, P576, DOI 10.1016/j.ceb.2005.09.012	54	17	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.160671	http://dx.doi.org/10.1074/jbc.M110.160671			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454660	Green Published, hybrid			2022-12-25	WOS:000290022800006
J	Qi, XP; Nishida, J; Chaves, L; Ohmori, K; Huang, H				Qi, Xiaopeng; Nishida, Jun; Chaves, Lee; Ohmori, Keitaro; Huang, Hua			CCAAT/Enhancer-binding Protein alpha (C/EBP alpha) Is Critical for Interleukin-4 Expression in Response to Fc epsilon RI Receptor Cross-linking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN IL-4 PROMOTER; T-CELLS; GENE-EXPRESSION; NUCLEAR-FACTOR; MAST-CELLS; IN-VIVO; SIGNALING PATHWAYS; IL4 GENE; C-MAF; TRANSCRIPTION	Basophils mediate many of their biological functions by producing IL-4. However, it is unknown how the Il4 gene is regulated in basophils. Here, we report that CCAAT/enhancer-binding protein alpha (C/EBP alpha), a major myeloid transcription factor, was highly expressed in basophils. We show that C/EBP alpha selectively activated Il4 promoter-luciferase reporter gene transcription in response to IgE cross-linking, but C/EBP alpha did not activate other known Th2 or mast cell enhancers. We found that the PI3K pathway and calcineurin were essential in C/EBP alpha-driven Il4 promoter-luciferase gene transcription. Our mutation analyses revealed that C/EBP alpha drove Il4 promoter-luciferase activity depending on its DNA binding domain. Mutation of the C/EBP alpha-binding site in the Il4 promoter region abolished C/EBP alpha-driven Il4 promoter-luciferase activity. Our results further showed that a mutation in nuclear factor of activated T cells (NFAT)-binding sites in the Il4 promoter also negated C/EBP alpha-driven Il4 promoter-luciferase activity. Our study demonstrates that C/EBP alpha, in cooperation with NFAT, directly regulates Il4 gene transcription.	[Qi, Xiaopeng; Nishida, Jun; Chaves, Lee; Ohmori, Keitaro; Huang, Hua] Univ Colorado, Dept Med, Div Allergy & Immunol, Natl Jewish Hlth,Denver Sch Med, Denver, CO 80206 USA; [Huang, Hua] Univ Colorado, Integrated Dept Immunol, Denver Sch Med, Denver, CO 80206 USA	National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Huang, H (corresponding author), Univ Colorado, Dept Med, Div Allergy & Immunol, Natl Jewish Hlth,Denver Sch Med, Denver, CO 80206 USA.	huangh@njhealth.org	OHMORI, Keitaro/G-1143-2013	OHMORI, Keitaro/0000-0002-0582-4880; Huang, Hua/0000-0001-7317-8983	National Institutes of Health [RO1 AI05917, RO1 AI068083]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068083] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 AI05917 and RO1 AI068083 (to H. H.).	Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Ansel KM, 2004, NAT IMMUNOL, V5, P1251, DOI 10.1038/ni1135; Arock M, 2002, J LEUKOCYTE BIOL, V71, P557; Behre G, 2002, J BIOL CHEM, V277, P26293, DOI 10.1074/jbc.M202301200; DAVYDOV IV, 1995, J IMMUNOL, V155, P5273; Denzel A, 2008, NAT IMMUNOL, V9, P733, DOI 10.1038/ni.1621; ERICKSON J, 1986, MOL IMMUNOL, V23, P769, DOI 10.1016/0161-5890(86)90089-1; FINKELMAN FD, 1993, J IMMUNOL, V151, P1235; Gilfillan AM, 2006, NAT REV IMMUNOL, V6, P218, DOI 10.1038/nri1782; Hammad H, 2010, J EXP MED, V207, P2097, DOI 10.1084/jem.20101563; HENKEL G, 1994, P NATL ACAD SCI USA, V91, P7737, DOI 10.1073/pnas.91.16.7737; Ho IC, 1996, CELL, V85, P973, DOI 10.1016/S0092-8674(00)81299-4; Huang H, 1997, J IMMUNOL, V159, P3731; Iwasaki H, 2006, GENE DEV, V20, P3010, DOI 10.1101/gad.1493506; Kalesnikoff J, 2001, IMMUNITY, V14, P801, DOI 10.1016/S1074-7613(01)00159-5; Khanna-Gupta A, 2008, BLOOD CELL MOL DIS, V41, P77, DOI 10.1016/j.bcmd.2008.02.011; Kim JI, 1999, IMMUNITY, V10, P745, DOI 10.1016/S1074-7613(00)80073-4; Kuroda E, 2011, J IMMUNOL, V186, P323, DOI 10.4049/jimmunol.1002778; Lee GR, 2001, IMMUNITY, V14, P447, DOI 10.1016/S1074-7613(01)00125-X; Li BY, 1999, EMBO J, V18, P420, DOI 10.1093/emboj/18.2.420; Li-Weber M, 2003, NAT REV IMMUNOL, V3, P534, DOI 10.1038/nri1128; Li-Weber M, 1998, J IMMUNOL, V161, P1380; Liu HK, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-14; Luccioli S, 2002, J ALLERGY CLIN IMMUN, V110, P117, DOI 10.1067/mai.2002.125828; Monticelli S, 2002, EUR J IMMUNOL, V32, P2971, DOI 10.1002/1521-4141(2002010)32:10<2971::AID-IMMU2971>3.0.CO;2-G; Mulero MC, 2009, J BIOL CHEM, V284, P9394, DOI 10.1074/jbc.M805889200; Obata K, 2007, BLOOD, V110, P913, DOI 10.1182/blood-2007-01-068718; Ohmori K, 2009, J IMMUNOL, V182, P2835, DOI 10.4049/jimmunol.0802870; Ohnmacht C, 2010, IMMUNITY, V33, P364, DOI 10.1016/j.immuni.2010.08.011; Paz-Priel I, 2005, MOL CANCER RES, V3, P585, DOI 10.1158/1541-7786.MCR-05-0111; Perrigoue JG, 2009, NAT IMMUNOL, V10, P697, DOI 10.1038/ni.1740; Radomska HS, 2006, J EXP MED, V203, P371, DOI 10.1084/jem.20052242; ROONEY JW, 1995, IMMUNITY, V2, P473, DOI 10.1016/1074-7613(95)90028-4; Ross SE, 2004, MOL CELL BIOL, V24, P675, DOI 10.1128/MCB.24.2.675-686.2004; SCOTT LM, 1992, BLOOD, V80, P1725; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Sokol CL, 2009, NAT IMMUNOL, V10, P713, DOI 10.1038/ni.1738; Urban A, 1997, NUCLEIC ACIDS RES, V25, P2227, DOI 10.1093/nar/25.11.2227; Wang GL, 2004, GENE DEV, V18, P912, DOI 10.1101/gad.1183304; Weiss DL, 2001, IMMUNOL REV, V179, P35, DOI 10.1034/j.1600-065X.2001.790104.x; Yagi R, 2007, MOL CELL BIOL, V27, P8087, DOI 10.1128/MCB.00631-07; Yoshimoto T, 2009, NAT IMMUNOL, V10, P706, DOI 10.1038/ni.1737; Zhang P, 1998, J EXP MED, V188, P1173, DOI 10.1084/jem.188.6.1173; Zhang P, 2004, IMMUNITY, V21, P853, DOI 10.1016/j.immuni.2004.11.006; Zhang YK, 2001, J EXP MED, V194, P165, DOI 10.1084/jem.194.2.165; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	47	19	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.213389	http://dx.doi.org/10.1074/jbc.M110.213389			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454593	Green Published, hybrid			2022-12-25	WOS:000290022800046
J	Wen, ZN; Wang, ZJ; Wang, S; Ravula, R; Yang, L; Xu, J; Wang, C; Zuo, Z; Chow, MSS; Shi, LM; Huang, Y				Wen, Zhining; Wang, Zhijun; Wang, Steven; Ravula, Ranadheer; Yang, Lun; Xu, Jun; Wang, Charles; Zuo, Zhong; Chow, Moses S. S.; Shi, Leming; Huang, Ying			Discovery of Molecular Mechanisms of Traditional Chinese Medicinal Formula Si-Wu-Tang Using Gene Expression Microarray and Connectivity Map	PLOS ONE			English	Article							HEME OXYGENASE-1; UP-REGULATION; CONSTITUENTS; DETOXIFICATION; CONSISTENCY; PROFILES; THERAPY; EXTRACT; INDUCE; KEGG	To pursue a systematic approach to discovery of mechanisms of action of traditional Chinese medicine (TCM), we used microarrays, bioinformatics and the "Connectivity Map" (CMAP) to examine TCM-induced changes in gene expression. We demonstrated that this approach can be used to elucidate new molecular targets using a model TCM herbal formula Si-Wu-Tang (SWT) which is widely used for women's health. The human breast cancer MCF-7 cells treated with 0.1 mu M estradiol or 2.56 mg/ml of SWT showed dramatic gene expression changes, while no significant change was detected for ferulic acid, a known bioactive compound of SWT. Pathway analysis using differentially expressed genes related to the treatment effect identified that expression of genes in the nuclear factor erythroid 2-related factor 2 (Nrf2) cytoprotective pathway was most significantly affected by SWT, but not by estradiol or ferulic acid. The Nrf2-regulated genes HMOX1, GCLC, GCLM, SLC7A11 and NQO1 were upreguated by SWT in a dose-dependent manner, which was validated by real-time RT-PCR. Consistently, treatment with SWT and its four herbal ingredients resulted in an increased antioxidant response element (ARE)-luciferase reporter activity in MCF-7 and HEK293 cells. Furthermore, the gene expression profile of differentially expressed genes related to SWT treatment was used to compare with those of 1,309 compounds in the CMAP database. The CMAP profiles of estradiol-treated MCF-7 cells showed an excellent match with SWT treatment, consistent with SWT's widely claimed use for women's diseases and indicating a phytoestrogenic effect. The CMAP profiles of chemopreventive agents withaferin A and resveratrol also showed high similarity to the profiles of SWT. This study identified SWT as an Nrf2 activator and phytoestrogen, suggesting its use as a nontoxic chemopreventive agent, and demonstrated the feasibility of combining microarray gene expression profiling with CMAP mining to discover mechanisms of actions and to identify new health benefits of TCMs.	[Wen, Zhining; Yang, Lun; Shi, Leming] US FDA, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA; [Wen, Zhining] Sichuan Univ, Coll Chem, Chengdu 610064, Sichuan, Peoples R China; [Wang, Zhijun; Wang, Steven; Ravula, Ranadheer; Chow, Moses S. S.; Huang, Ying] Western Univ Hlth Sci, Coll Pharm, Dept Pharmaceut Sci, Pomona, CA USA; [Wang, Zhijun; Wang, Steven; Ravula, Ranadheer; Chow, Moses S. S.; Huang, Ying] Western Univ Hlth Sci, Coll Pharm, Ctr Adv Drug Res & Evaluat, Pomona, CA USA; [Yang, Lun; Shi, Leming] Fudan Univ, Sch Pharm, Dept Clin Pharm, Shanghai 200433, Peoples R China; [Yang, Lun; Shi, Leming] Fudan Univ, Sch Pharm, Ctr Pharmacogenom, Shanghai 200433, Peoples R China; [Xu, Jun] Univ Calif Los Angeles, Cedars Sinai Med Ctr, Inst Med Genet, David Geffen Sch Med, Los Angeles, CA 90048 USA; [Wang, Charles] City Hope Comprehens Canc Ctr, Beckman Res Inst, Duarte, CA USA; [Zuo, Zhong] Chinese Univ Hong Kong, Fac Med, Sch Pharm, Hong Kong, Hong Kong, Peoples R China	US Food & Drug Administration (FDA); Sichuan University; Western University of Health Sciences; Western University of Health Sciences; Fudan University; Fudan University; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; City of Hope; Beckman Research Institute of City of Hope; Chinese University of Hong Kong	Wen, ZN (corresponding author), US FDA, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA.	leming.shi@gmail.com; yhuang@westernu.edu	Zuo, Zhong/B-6884-2008; Yang, Lun/B-4859-2012; Shi, Leming/B-3150-2010; Wang, zhijun/G-8543-2015	Shi, Leming/0000-0002-7143-2033; Wang, zhijun/0000-0001-8783-8946; Zuo, Zhong/0000-0002-6976-6157	U.S. Food and Drug Administration; Innovation and Technology Commission of the Hong Kong Special Administrative Region of the People's Republic of China [ITS/112/07, ITS/446/09]	U.S. Food and Drug Administration; Innovation and Technology Commission of the Hong Kong Special Administrative Region of the People's Republic of China	This work was supported by the U.S. Food and Drug Administration. The preparation of Si-Wu-Tang product was supported by the Innovation and Technology Fund (ITS/112/07) from the Innovation and Technology Commission of the Hong Kong Special Administrative Region of the People's Republic of China. This study was partially supported by the Innovation and Technology Grant (ITS/446/09) from the Innovation and Technology Commission of the Hong Kong Special Administrative Region of the People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views presented in this article do not necessarily reflect those of the U.S. Food and Drug Administration.	Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Bancos S, 2010, CELL IMMUNOL, V262, P18, DOI 10.1016/j.cellimm.2009.12.003; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhattacharyya RP, 2006, SCIENCE, V311, P822, DOI 10.1126/science.1120941; Chan E, 2010, CURR OPIN DRUG DISC, V13, P50; Chang CJ, 2006, EUR J CLIN INVEST, V36, P588, DOI 10.1111/j.1365-2362.2006.01676.x; Chang CJ, 2006, MENOPAUSE, V13, P967, DOI 10.1097/01.gme.0000227025.96686.8b; Chavan P, 2006, EVID-BASED COMPL ALT, V3, P447, DOI 10.1093/ecam/nel075; Cheng WY, 2008, AM J CHINESE MED, V36, P783, DOI 10.1142/S0192415X08006235; Chow Moses Sing Sum, 2010, Curr Drug Discov Technol, V7, P1; De Preter K, 2009, CLIN CANCER RES, V15, P3690, DOI 10.1158/1078-0432.CCR-08-2699; Dietz BM, 2008, CHEM RES TOXICOL, V21, P1939, DOI 10.1021/tx8001274; Efferth T, 2007, TRENDS MOL MED, V13, P353, DOI 10.1016/j.molmed.2007.07.001; Gheeya J, 2010, CANCER LETT, V293, P124, DOI 10.1016/j.canlet.2010.01.004; Guo L, 2006, NAT BIOTECHNOL, V24, P1162, DOI 10.1038/nbt1238; Hieronymus H, 2006, CANCER CELL, V10, P321, DOI 10.1016/j.ccr.2006.09.005; Hsu HY, 1996, J ETHNOPHARMACOL, V52, P113, DOI 10.1016/0378-8741(96)01400-6; Huang Y, 2005, CANCER RES, V65, P7446, DOI 10.1158/0008-5472.CAN-04-4267; Irizarry RA, 2006, BIOINFORMATICS, V22, P789, DOI 10.1093/bioinformatics/btk046; Jarmi T, 2009, CURR HYPERTENS REP, V11, P56, DOI 10.1007/s11906-009-0011-z; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kang JX, 2005, CARCINOGENESIS, V26, P1934, DOI 10.1093/carcin/bgi154; Kronke G, 2003, J BIOL CHEM, V278, P51006, DOI 10.1074/jbc.M304103200; Kwak MK, 2010, TOXICOL APPL PHARM, V244, P66, DOI 10.1016/j.taap.2009.08.028; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lee SE, 1999, AM J CHINESE MED, V27, P387, DOI 10.1142/S0192415X99000446; Li WG, 2009, MOL CARCINOGEN, V48, P91, DOI 10.1002/mc.20465; Liang QD, 2006, BIOL PHARM BULL, V29, P1378, DOI 10.1248/bpb.29.1378; Lv Guanghua, 2010, Zhongguo Zhong Yao Za Zhi, V35, P194; Masoudi-Nejad Ali, 2007, V406, P437; McMahon M, 2001, CANCER RES, V61, P3299; Moiseeva EP, 2009, CANCER PREV RES, V2, P611, DOI 10.1158/1940-6207.CAPR-08-0102; OHTA H, 1993, PHARMACOL BIOCHEM BE, V45, P719, DOI 10.1016/0091-3057(93)90530-7; Pon D, 2010, THER DELIV, V1, P335, DOI 10.4155/TDE.10.29; Riggs BL, 2003, NEW ENGL J MED, V348, P618, DOI 10.1056/NEJMra022219; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Shi LM, 2009, INTEGR ANAL SYST, P3, DOI 10.1007/978-0-387-72719-6_1; Shi LM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S9-S10; Shi LM, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S2-S12; Simon R, 2009, BEST PRACT RES CL HA, V22, P271, DOI 10.1016/j.beha.2009.07.001; *STAT PHARM COMM P, 2005, PHARM PEOPL REPUBLIC; Sun Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006588; Tong WD, 2003, ENVIRON HEALTH PERSP, V111, P1819, DOI 10.1289/ehp.6497; Vanaja DK, 2000, CANCER RES, V60, P4714; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; Wang CC, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-108; Wang L, 2008, P NATL ACAD SCI USA, V105, P4826, DOI 10.1073/pnas.0712365105; Wang L, 2011, INT J PHARMACEUT, V406, P99, DOI 10.1016/j.ijpharm.2011.01.001; Wang Steven, 2010, Curr Drug Discov Technol, V7, P67; Wang ZJ, 2009, J PHARMACEUT BIOMED, V50, P232, DOI 10.1016/j.jpba.2009.04.001; Watanabe Hiroshi, 1998, Journal of Toxicological Sciences, V23, P234; Wixon J, 2000, YEAST, V17, P48, DOI 10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H; Yang NS, 2004, J BIOMED SCI, V11, P418, DOI [10.1159/000077111, 10.1007/BF02254447]; Yeh LLL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000719; Zhang HJ, 2004, J PHARMACEUT BIOMED, V34, P705, DOI 10.1016/S0731-7085(03)00650-2; Zhang JL, 2009, PLANTA MED, V75, P396, DOI 10.1055/s-0028-1088381	56	108	120	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e18278	10.1371/journal.pone.0018278	http://dx.doi.org/10.1371/journal.pone.0018278			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464939	Green Published, gold, Green Submitted			2022-12-25	WOS:000289053800036
J	Censolo, R; Craighero, L; Ponti, G; Rizzo, L; Canto, R; Fadiga, L				Censolo, Roberto; Craighero, Laila; Ponti, Giovanni; Rizzo, Leonzio; Canto, Rosario; Fadiga, Luciano			Electromyographic Activity of Hand Muscles in a Motor Coordination Game: Effect of Incentive Scheme and Its Relation with Social Capital	PLOS ONE			English	Article							CONSEQUENCES	Background: A vast body of social and cognitive psychology studies in humans reports evidence that external rewards, typically monetary ones, undermine intrinsic motivation. These findings challenge the standard selfish-rationality assumption at the core of economic reasoning. In the present work we aimed at investigating whether the different modulation of a given monetary reward automatically and unconsciously affects effort and performance of participants involved in a game devoid of visual and verbal interaction and without any perspective-taking activity. Methodology/Principal Findings: Twelve pairs of participants were submitted to a simple motor coordination game while recording the electromyographic activity of First Dorsal Interosseus (FDI), the muscle mainly involved in the task. EMG data show a clear effect of alternative rewards strategies on subjects' motor behavior. Moreover, participants' stock of relevant past social experiences, measured by a specifically designed questionnaire, was significantly correlated with EMG activity, showing that only low social capital subjects responded to monetary incentives consistently with a standard rationality prediction. Conclusions/Significance: Our findings show that the effect of extrinsic motivations on performance may arise outside social contexts involving complex cognitive processes due to conscious perspective-taking activity. More importantly, the peculiar performance of low social capital individuals, in agreement with standard economic reasoning, adds to the knowledge of the circumstances that makes the crowding out/in of intrinsic motivation likely to occur. This may help in improving the prediction and accuracy of economic models and reconcile this puzzling effect of external incentives with economic theory.	[Censolo, Roberto; Craighero, Laila; Ponti, Giovanni; Rizzo, Leonzio; Canto, Rosario; Fadiga, Luciano] Univ Ferrara, I-44100 Ferrara, Italy; [Fadiga, Luciano] Italian Inst Technol, Genoa, Italy	University of Ferrara; Istituto Italiano di Tecnologia - IIT	Censolo, R (corresponding author), Univ Ferrara, I-44100 Ferrara, Italy.	fdl@unife.it	Fadiga, Luciano/AAC-7404-2022; Craighero, Laila/F-3408-2015	Craighero, Laila/0000-0002-5400-8732; Rizzo, Leonzio/0000-0001-8099-8699; fadiga, luciano/0000-0001-5691-5080; Ponti, Giovanni/0000-0003-1680-3580	European Community	European Community(European Commission)	This work has been accomplished with the contribution of the European Community Grants Robot-Cub and Poeticon and of the Fondazione Cassa di Risparmio di Ferrara. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	[Anonymous], 2001, SOC CAP COMM BENCHM; Bargh E, 1985, J EXP PSYCHOL LEARN, V11, P59; Bargh JA, 1999, AM PSYCHOL, V54, P462, DOI 10.1037/0003-066x.54.7.462; Bargh JA, 2008, PERSPECT PSYCHOL SCI, V3, P73, DOI 10.1111/j.1745-6916.2008.00064.x; Benabou R, 2003, REV ECON STUD, V70, P489, DOI 10.1111/1467-937X.00253; Benabou R, 2006, AM ECON REV, V96, P1652, DOI 10.1257/aer.96.5.1652; Bohnet I, 2001, AM POLIT SCI REV, V95, P131, DOI 10.1017/S0003055401000211; Cardenas JC, 2000, WORLD DEV, V28, P1719, DOI 10.1016/S0305-750X(00)00055-3; Chen M, 1999, PERS SOC PSYCHOL B, V25, P215, DOI 10.1177/0146167299025002007; Deci E., 1975, INTRINSIC MOTIVATION; Deci EL, 1999, PSYCHOL BULL, V125, P627, DOI 10.1037/0033-2909.125.6.627; Dijksterhuis A, 2001, ADV EXPT SOCIAL PSYC; EDIN BB, 1995, J NEUROSCI, V15, P830; ELIASSON AC, 1995, EXP BRAIN RES, V106, P425; EPSTEIN S, 1994, AM PSYCHOL, V49, P709, DOI 10.1037/0003-066X.49.8.709; Fehr E, 2002, 34 I EMP RES EC; Frey B., 1997, NOT JUST MONEY EC TH; Frey BS, 1997, AM ECON REV, V87, P746; Frey BS, 2001, J ECON SURV, V15, P589, DOI 10.1111/1467-6419.00150; Gneezy U, 2000, J LEGAL STUD, V29, P1, DOI 10.1086/468061; Gneezy U, 2000, Q J ECON, V115, P791, DOI 10.1162/003355300554917; Gollwitzer P, 1996, SOCIAL PSYCHOL HDB B; JOHANSSON RS, 1984, EXP BRAIN RES, V56, P550; KIHLSTROM JF, 1987, SCIENCE, V237, P1445, DOI 10.1126/science.3629249; Lepper M., 1978, HIDDEN COST REWARD N; Neely J. H., 1991, BASIC PROCESSES READ, P264, DOI DOI 10.1016/J.BRAINRES.2007.05.058; Neumann R, 2003, PSYCHOL EVALUATION A; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Paternoster R, 1998, CRIMINOLOGY, V36, P859, DOI 10.1111/j.1745-9125.1998.tb01268.x; Shah J, 2002, MOTIVATED SOCIAL PER; Spencer S, 2005, SOCIAL MOTIVATION CO; Vohs KD, 2006, SCIENCE, V314, P1154, DOI 10.1126/science.1132491; Westen D, 1998, PSYCHOL BULL, V124, P333, DOI 10.1037/0033-2909.124.3.333	34	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e17372	10.1371/journal.pone.0017372	http://dx.doi.org/10.1371/journal.pone.0017372			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	740SE	21464986	Green Submitted, Green Published, gold			2022-12-25	WOS:000288813900003
J	Choi, SS; Chivers, PT; Berg, DE				Choi, Sung Sook; Chivers, Peter T.; Berg, Douglas E.			Point Mutations in Helicobacter pylori's fur Regulatory Gene that Alter Resistance to Metronidazole, a Prodrug Activated by Chemical Reduction	PLOS ONE			English	Article							FERRIC UPTAKE REGULATOR; DNA-BINDING; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; DOMAIN INTERACTIONS; AMINO-ACIDS; REPRESSOR; PROTEIN; RDXA; PERR	Background: Helicobacter pylori's Fur regulatory protein controls transcription of dozens of genes in response to iron availability, acidity and oxidative stress, and affects the vigor of infection and severity of disease. It is unusual among Fur family proteins in being active both when iron-loaded and iron-free. Metholodolgy/Principal Findings: We tested if H. pylori fur mutations could affect resistance to metronidazole (Mtz), an anti-H. pylori prodrug rendered bactericidal by chemical reduction. Point mutations were made by PCR in DNA containing fur and a downstream chloramphenicol resistance gene, and were placed in the H. pylori chromosome by transformation of a fur-deletion (Dfur) strain. Several substitutions affecting H. pylori Fur's,10 residue N terminal arm, which has no counterpart in prototype (E. coli-type) Fur proteins, increased Mtz resistance, as did mutations affecting the region between DNA binding and dimerization domains. Three types of mutations decreased resistance more than did Dfur: substitutions affecting the N-terminal arm; substitutions affecting the metal binding pocket; and nonsense mutations that resulted in a truncated Fur protein with no C-terminal dimerization domain. Most metal binding pocket mutations were obtained only in fur genes with additional inactivating mutations, and thus seemed deleterious or lethal because they. Conclusions/Significance: These results establish that H. pylori Fur's distinctive N terminal arm is functional, and more generally illustrate that point mutations can confer informative phenotypes, distinct from those conferred by null mutations. We propose that fur mutations can affect Mtz susceptibility by altering the balance among Fur's several competing activities, and thereby the expression of genes that control cellular redox potential or elimination of bactericidal Mtz activation products. Further analyses of selected mutants should provide insights into Fur interactions with other cellular components, metabolic circuitry, and how H. pylori thrives in its special gastric niche.	[Choi, Sung Sook; Berg, Douglas E.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Chivers, Peter T.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Choi, SS (corresponding author), Sahmyook Univ, Coll Pharm, Seoul, South Korea.	berg@borcim.wustl.edu		Chivers, Peter/0000-0002-8779-1452	U.S. National Institutes of Health (NIH) [RO1 DK63041, R21 AI078237, R21 AI088337]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI088337, R21AI078237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063041] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by grants from the U.S. National Institutes of Health (NIH) RO1 DK63041, R21 AI078237 and R21 AI088337. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akada JK, 2003, MICROBIOL-SGM, V149, P1901, DOI 10.1099/mic.0.26129-0; Albert TJ, 2005, NAT METHODS, V2, P951, DOI 10.1038/NMETH805; Benanti EL, 2007, J BIOL CHEM, V282, P20365, DOI 10.1074/jbc.M702982200; Benanti EL, 2010, J BACTERIOL, V192, P4327, DOI 10.1128/JB.00152-10; Boneca IG, 2008, APPL ENVIRON MICROB, V74, P2095, DOI 10.1128/AEM.01348-07; Carpenter BM, 2010, J BACTERIOL, V192, P5037, DOI 10.1128/JB.00198-10; Carpenter BM, 2009, INFECT IMMUN, V77, P2590, DOI 10.1128/IAI.00116-09; Chalker AF, 2001, J BACTERIOL, V183, P1259, DOI 10.1128/JB.183.4.1259-1268.2001; Cover TL, 2009, GASTROENTEROLOGY, V136, P1863, DOI 10.1053/j.gastro.2009.01.073; Croxen MA, 2006, J BACTERIOL, V188, P2656, DOI 10.1128/JB.188.7.2656-2665.2006; Danielli A, 2010, FEMS MICROBIOL REV, V34, P738, DOI 10.1111/j.1574-6976.2010.00233.x; Dian C, 2011, MOL MICROBIOL, V79, P1260, DOI 10.1111/j.1365-2958.2010.07517.x; Ernst FD, 2005, MICROBIOL-SGM, V151, P533, DOI 10.1099/mic.0.27404-0; Goodwin A, 1998, MOL MICROBIOL, V28, P383, DOI 10.1046/j.1365-2958.1998.00806.x; Hall HK, 1996, J BACTERIOL, V178, P5683, DOI 10.1128/jb.178.19.5683-5691.1996; HOCHSCHILD A, 1983, CELL, V32, P319, DOI 10.1016/0092-8674(83)90451-8; Jacquamet L, 2009, MOL MICROBIOL, V73, P20, DOI 10.1111/j.1365-2958.2009.06753.x; Jeong JY, 2000, ANTIMICROB AGENTS CH, V44, P3127, DOI 10.1128/AAC.44.11.3127-3132.2000; Jeong JY, 2001, J BACTERIOL, V183, P5155, DOI 10.1128/JB.183.17.5155-5162.2001; Kumar A, 2007, P NATL ACAD SCI USA, V104, P11568, DOI 10.1073/pnas.0705054104; Lee JW, 2007, BIOMETALS, V20, P485, DOI 10.1007/s10534-006-9070-7; Lee JW, 2006, NATURE, V440, P363, DOI 10.1038/nature04537; PABO CO, 1982, NATURE, V298, P441, DOI 10.1038/298441a0; Pecqueur L, 2006, J BIOL CHEM, V281, P21286, DOI 10.1074/jbc.M601278200; Peek RM, 2010, PHYSIOL REV, V90, P831, DOI 10.1152/physrev.00039.2009; Pennella MA, 2006, J MOL BIOL, V356, P1124, DOI 10.1016/j.jmb.2005.12.019; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pohl E, 2003, MOL MICROBIOL, V47, P903, DOI 10.1046/j.1365-2958.2003.03337.x; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; Saviola B, 1998, J MOL BIOL, V278, P539, DOI 10.1006/jmbi.1998.1712; Schreiber S, 2004, P NATL ACAD SCI USA, V101, P5024, DOI 10.1073/pnas.0308386101; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Sheikh MA, 2009, MOL MICROBIOL, V72, P1208, DOI 10.1111/j.1365-2958.2009.06718.x; Sisson G, 2000, J BACTERIOL, V182, P5091, DOI 10.1128/JB.182.18.5091-5096.2000; Tan SM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000407; Tan SM, 2004, J BACTERIOL, V186, P885, DOI 10.1128/JB.186.3.885-888.2004; Tiss A, 2005, FEBS LETT, V579, P5454, DOI 10.1016/j.febslet.2005.08.067; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Traore DAK, 2006, MOL MICROBIOL, V61, P1211, DOI 10.1111/j.1365-2958.2006.05313.x; Tsugawa H, 2011, ANTIOXID REDOX SIGN, V14, P15, DOI 10.1089/ars.2010.3146; White A, 1998, NATURE, V394, P502, DOI 10.1038/28893; Whitmire JM, 2007, CURR MED CHEM, V14, P469, DOI 10.2174/092986707779941069; Wu M, 2001, J MOL BIOL, V307, P1001, DOI 10.1006/jmbi.2001.4531	43	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e18236	10.1371/journal.pone.0018236	http://dx.doi.org/10.1371/journal.pone.0018236			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464913	Green Published, gold			2022-12-25	WOS:000288813900055
J	Xu, HB; Wang, XL; Morici, LA; Pahar, B; Veazey, RS				Xu, Huanbin; Wang, Xiaolei; Morici, Lisa A.; Pahar, Bapi; Veazey, Ronald S.			Early Divergent Host Responses in SHIVsf162P3 and SIVmac251 Infected Macaques Correlate with Control of Viremia	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; MEMORY T-CELLS; SIV INFECTION; GASTROINTESTINAL-TRACT; NONHUMAN-PRIMATES; AIDS; MAINTENANCE; APOPTOSIS; DEPLETION; MONKEYS	We previously showed intravaginal inoculation with SHIVsf162p3 results in transient viremia followed by undetectable viremia in most macaques, and some displayed subsequent immunity to superinfection with pathogenic SIVmac251. Here we compare early T cell activation, proliferation, and plasma cytokine/chemokine responses in macaques intravaginally infected with either SHIVsf162p3 or SIVmac251 to determine whether distinct differences in host responses may be associated with early viral containment. The data show SIVmac251 infection results in significantly higher levels of T cell activation, proliferation, and a mixed cytokine/chemokine "storm" in plasma in primary infection, whereas infection with SHIVsf162p3 resulted in significantly lower levels of T cell activation, proliferation, and better preservation of memory CD4+ T cells in early infection which immediately preceded control of viremia. These results support the hypothesis that early systemic immune activation, T cell proliferation, and a more prominent and broader array of cytokine/chemokine responses facilitate SIV replication, and may play a key role in persistence of infection, and the progression to AIDS. In contrast, immune unresponsiveness may be associated with eventual clearance of virus, a concept that may have key significance for therapy and vaccine design.	[Xu, Huanbin; Wang, Xiaolei; Pahar, Bapi; Veazey, Ronald S.] Tulane Natl Primate Res Ctr, Div Comparat Pathol, Covington, LA USA; [Morici, Lisa A.] Tulane Univ, Sch Med, Dept Microbiol & Immunol, New Orleans, LA 70112 USA	Tulane University; Tulane University	Xu, HB (corresponding author), Tulane Natl Primate Res Ctr, Div Comparat Pathol, Covington, LA USA.	rveazey@tulane.edu	Xu, Huanbin/S-4870-2019; Pahar, Bapi/AFM-3129-2022	Pahar, Bapi/0000-0003-1949-973X	United States National Institutes of Health [AI49080, AI084793, RR000164]; Tulane University; James B. Pendleton Charitable Trust Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049080, R01AI084793] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011104] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tulane University; James B. Pendleton Charitable Trust Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by United States National Institutes of Health grants AI49080, AI084793, and RR000164, a Tulane University Enhancement Grant, and a grant from the James B. Pendleton Charitable Trust Foundation. None of the funders had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bangs SC, 2009, J IMMUNOL, V182, P1962, DOI 10.4049/jimmunol.0802596; Bessis AS, 2003, AMINO ACIDS, V24, P303, DOI 10.1007/s00726-002-0405-6; Cumont MC, 2008, J VIROL, V82, P1175, DOI 10.1128/JVI.00450-07; Gea-Banacloche JC, 2000, J IMMUNOL, V165, P1082, DOI 10.4049/jimmunol.165.2.1082; Harouse JM, 1999, SCIENCE, V284, P816, DOI 10.1126/science.284.5415.816; Harouse JM, 2001, J VIROL, V75, P1990, DOI 10.1128/JVI.75.4.1990-1995.2001; Kaur A, 2008, J VIROL, V82, P1084, DOI 10.1128/JVI.02197-07; Kornfeld C, 2005, J CLIN INVEST, V115, P1082, DOI 10.1172/JCI200523006; Letvin NL, 2006, SCIENCE, V312, P1530, DOI 10.1126/science.1124226; Manches O, 2009, J CLIN INVEST, V119, P3512, DOI 10.1172/JCI41509; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; Meythaler M, 2009, J VIROL, V83, P572, DOI 10.1128/JVI.01715-08; PAHAR B, 2009, VIROLOGY; Pahar B, 2009, VIROLOGY, V387, P273, DOI 10.1016/j.virol.2009.02.014; Paiardini M, 2009, BLOOD, V113, P612, DOI 10.1182/blood-2008-06-159442; Pandrea I, 2007, BLOOD, V109, P1069, DOI 10.1182/blood-2006-05-024364; Silvestri G, 2007, J CLIN INVEST, V117, P3148, DOI 10.1172/JCI33034; Sodora DL, 2009, NAT MED, V15, P861, DOI 10.1038/nm.2013; Veazey Ronald, 2003, AIDS Rev, V5, P245; Veazey RS, 2003, J EXP MED, V198, P1551, DOI 10.1084/jem.20031266; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Zou W, 1997, AIDS, V11, P533	23	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e17965	10.1371/journal.pone.0017965	http://dx.doi.org/10.1371/journal.pone.0017965			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464951	Green Published, Green Submitted, gold			2022-12-25	WOS:000288813900023
J	Hertlein, T; Sturm, V; Kircher, S; Basse-Lusebrink, T; Haddad, D; Ohlsen, K; Jakob, P				Hertlein, Tobias; Sturm, Volker; Kircher, Stefan; Basse-Luesebrink, Thomas; Haddad, Daniel; Ohlsen, Knut; Jakob, Peter			Visualization of Abscess Formation in a Murine Thigh Infection Model of Staphylococcus aureus by F-19-Magnetic Resonance Imaging (MRI)	PLOS ONE			English	Article							SOFT-TISSUE INFECTION; IN-VIVO; IRON-OXIDE; F-19 MRI; INFLAMMATION; PARTICLES; LESIONS	Background: During the last years, F-19-MRI and perfluorocarbon nanoemulsion (PFC) emerged as a powerful contrast agent methodology to track cells and to visualize inflammation. We applied this new modality to visualize deep tissue abscesses during acute and chronic phase of inflammation caused by Staphylococcus aureus infection. Methodology and Principal Findings: In this study, a murine thigh infection model was used to induce abscess formation and PFC or CLIO (cross linked ironoxides) was administered during acute or chronic phase of inflammation. 24 h after inoculation, the contrast agent accumulation was imaged at the site of infection by MRI. Measurements revealed a strong accumulation of PFC at the abscess rim at acute and chronic phase of infection. The pattern was similar to CLIO accumulation at chronic phase and formed a hollow sphere around the edema area. Histology revealed strong influx of neutrophils at the site of infection and to a smaller extend macrophages during acute phase and strong influx of macrophages at chronic phase of inflammation. Conclusion and Significance: We introduce F-19-MRI in combination with PFC nanoemulsions as a new platform to visualize abscess formation in a murine thigh infection model of S. aureus. The possibility to track immune cells in vivo by this modality offers new opportunities to investigate host immune response, the efficacy of antibacterial therapies and the influence of virulence factors for pathogenesis.	[Hertlein, Tobias; Ohlsen, Knut] Univ Wurzburg, Inst Mol Infect Biol, Wurzburg, Germany; [Sturm, Volker; Basse-Luesebrink, Thomas; Jakob, Peter] Univ Wurzburg, Dept Expt Phys 5, Wurzburg, Germany; [Kircher, Stefan] Uniklin Wurzburg, Inst Pathol, Wurzburg, Germany; [Haddad, Daniel] Magnet Resonance Bavaria, Wurzburg, Germany	University of Wurzburg; University of Wurzburg; University of Wurzburg	Hertlein, T (corresponding author), Univ Wurzburg, Inst Mol Infect Biol, Wurzburg, Germany.	knut.ohlsen@mail.uni-wuerzburg.de; peja@physik.uni-wuerzburg.de		Jakob, Peter/0000-0002-3481-5545	German Science Foundation (DFG) [SFB 630]	German Science Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the German Science Foundation (DFG) SFB 630. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens ET, 2005, NAT BIOTECHNOL, V23, P983, DOI 10.1038/nbt1121; Bettegowda C, 2005, P NATL ACAD SCI USA, V102, P1145, DOI 10.1073/pnas.0408861102; Bleeker-Rovers CP, 2005, J NUCL MED, V46, P2014; CRAIG WA, 1991, J ANTIMICROB CHEM SC, V27; Ebner B, 2010, CIRC-CARDIOVASC IMAG, V3, P202, DOI 10.1161/CIRCIMAGING.109.902312; Engelsman AF, 2009, J BIOMED MATER RES B, V88B, P123, DOI 10.1002/jbm.b.31158; Flogel U, 2008, CIRCULATION, V118, P140, DOI 10.1161/CIRCULATIONAHA.107.737890; Janjic JM, 2009, WIRES NANOMED NANOBI, V1, P492, DOI 10.1002/wnan.35; Kaim AH, 2003, RADIOLOGY, V227, P169, DOI 10.1148/radiol.2272020490; Kaim AH, 2002, RADIOLOGY, V225, P808, DOI 10.1148/radiol.2253011485; Krafft MP, 2001, ADV DRUG DELIVER REV, V47, P209, DOI 10.1016/S0169-409X(01)00107-7; Kraft SL, 2004, INFECT IMMUN, V72, P5963, DOI 10.1128/IAI.72.10.5963-5971.2004; Kuklin NA, 2003, ANTIMICROB AGENTS CH, V47, P2740, DOI 10.1128/AAC.47.9.2740-2748.2003; Ledermann HP, 2000, EUR RADIOL, V10, P1815, DOI 10.1007/s003300000480; Lee JS, 2006, RADIOLOGY, V241, P142, DOI 10.1148/radiol.2403051156; Pohmann R, 2001, MAGN RESON MED, V45, P817, DOI 10.1002/mrm.1110; Ruiz-Cabello J, 1999, MAGN RESON IMAGING, V17, P1327, DOI 10.1016/S0730-725X(99)00061-2; Sijbers J, 1999, INT J IMAG SYST TECH, V10, P109, DOI 10.1002/(SICI)1098-1098(1999)10:2<109::AID-IMA2>3.0.CO;2-R; Speck O, 2002, MAGNET RESON MED, V48, P633, DOI 10.1002/mrm.10279; Srinivas M, 2007, MAGN RESON MED, V58, P725, DOI 10.1002/mrm.21352; Tournebize R, 2006, CELL MICROBIOL, V8, P33, DOI 10.1111/j.1462-5822.2005.00597.x	21	50	50	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2011	6	3							e18246	10.1371/journal.pone.0018246	http://dx.doi.org/10.1371/journal.pone.0018246			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740RG	21455319	Green Submitted, gold, Green Published			2022-12-25	WOS:000288811500032
J	Sagona, AP; Nezis, IP; Bache, KG; Haglund, K; Bakken, AC; Skotheim, RI; Stenmark, H				Sagona, Antonia P.; Nezis, Ioannis P.; Bache, Kristi G.; Haglund, Kaisa; Bakken, Anne Cathrine; Skotheim, Rolf I.; Stenmark, Harald			A Tumor-Associated Mutation of FYVE-CENT Prevents Its Interaction with Beclin 1 and Interferes with Cytokinesis	PLOS ONE			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE; BREAST-CANCER; AUTOPHAGY; TUMORIGENESIS; UVRAG; PROTEIN; GENE	The tumor suppressor activity of Beclin 1 (BECN1), a subunit of class III phosphatidylinositol 3-kinase complex, has been attributed to its regulation of apoptosis and autophagy. Here, we identify FYVE-CENT (ZFYVE26), a phosphatidylinositol 3-phosphate binding protein important for cytokinesis, as a novel interacting protein of Beclin 1. A mutation in FYVE-CENT (R1945Q) associated with breast cancer abolished the interaction between FYVE-CENT and Beclin 1, and reduced the localization of these proteins at the intercellular bridge during cytokinesis. Breast cancer cells containing the FYVE-CENT R1945Q mutation displayed a significant increase in cytokinetic profiles and bi - multinuclear phenotype. Both Beclin 1 and FYVE-CENT were found to be downregulated in advanced breast cancers. These findings suggest a positive feedback loop for recruitment of FYVE-CENT and Beclin 1 to the intercellular bridge during cytokinesis, and reveal a novel potential tumor suppressor mechanism for Beclin 1.	[Sagona, Antonia P.; Nezis, Ioannis P.; Bache, Kristi G.; Haglund, Kaisa; Bakken, Anne Cathrine; Skotheim, Rolf I.; Stenmark, Harald] Univ Oslo, Fac Med, Ctr Canc Biomed, Oslo, Norway; [Sagona, Antonia P.; Nezis, Ioannis P.; Bache, Kristi G.; Haglund, Kaisa; Stenmark, Harald] Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Dept Biochem, Oslo, Norway; [Bakken, Anne Cathrine; Skotheim, Rolf I.] Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Dept Canc Prevent, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo	Sagona, AP (corresponding author), Univ Oslo, Fac Med, Ctr Canc Biomed, Oslo, Norway.	stenmark@ulrik.uio.no	Nezis, Ioannis/AAE-8625-2020; Bache, Kristi G./AAD-9335-2020; Stenmark, Harald/B-8868-2008; Nezis, Ioannis P/I-4910-2014; Nezis, Ioannis/Q-6124-2019; Skotheim, Rolf I./H-6192-2017; Haglund, Kaisa/B-3927-2017	Nezis, Ioannis P/0000-0003-0233-7574; Nezis, Ioannis/0000-0003-0233-7574; Skotheim, Rolf I./0000-0002-5609-4048; Haglund, Kaisa/0000-0002-7946-3299	ENDOCYTE Research training network of the European Union; Research Council of Norway; Norwegian Cancer Society; European Research Council	ENDOCYTE Research training network of the European Union; Research Council of Norway(Research Council of Norway); Norwegian Cancer Society(Norwegian Cancer Society); European Research Council(European Research Council (ERC)European Commission)	A.P.S. is a Ph.D. student supported by ENDOCYTE Research training network of the European Union Marie Curie Program and by the FUGE Program of the Research Council of Norway. I.P.N. is a postdoctoral fellow of European Research Council. K.G.B. is a postdoctoral fellow and K.H. a senior research fellow of the Research Council of Norway. R.I.S. is a group leader supported by the Norwegian Cancer Society, and A.C.B. is a research associate supported by the Research Council of Norway. This work was supported by an Advanced Grant from the European Research Council (to H.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aita VM, 1999, GENOMICS, V59, P59, DOI 10.1006/geno.1999.5851; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Funderburk SF, 2010, TRENDS CELL BIOL, V20, P355, DOI 10.1016/j.tcb.2010.03.002; Furuya N, 2005, AUTOPHAGY, V1, P46, DOI 10.4161/auto.1.1.1542; Itakura E, 2008, MOL BIOL CELL, V19, P5360, DOI 10.1091/mbc.E08-01-0080; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lomonosova E, 2008, ONCOGENE, V27, pS2, DOI 10.1038/onc.2009.39; Nezis IP, 2010, TRENDS CELL BIOL, V20, P642, DOI 10.1016/j.tcb.2010.08.010; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Sagona AP, 2010, FEBS LETT, V584, P2652, DOI 10.1016/j.febslet.2010.03.044; Sagona AP, 2010, NAT CELL BIOL, V12, P362, DOI 10.1038/ncb2036; Sinha S, 2008, ONCOGENE, V27, pS137, DOI 10.1038/onc.2009.51; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; Sun QM, 2008, P NATL ACAD SCI USA, V105, P19211, DOI 10.1073/pnas.0810452105; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; THORESEN SB, 2010, EXP CELL RES	20	24	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2011	6	3							e17086	10.1371/journal.pone.0017086	http://dx.doi.org/10.1371/journal.pone.0017086			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740RG	21455500	Green Published, Green Submitted, gold			2022-12-25	WOS:000288811500002
J	Tabunoki, H; Ode, H; Banno, Y; Katsuma, S; Shimada, T; Mita, K; Yamamoto, K; Sato, R; Ishii-Nozawa, R; Satoh, J				Tabunoki, Hiroko; Ode, Hiroaki; Banno, Yutaka; Katsuma, Susumu; Shimada, Toru; Mita, Kazuei; Yamamoto, Kimiko; Sato, Ryoichi; Ishii-Nozawa, Reiko; Satoh, Jun-ichi			BmDJ-1 Is a Key Regulator of Oxidative Modification in the Development of the Silkworm, Bombyx mori	PLOS ONE			English	Article							PARKINSONS-DISEASE; DOPAMINERGIC-NEURONS; DROSOPHILA DJ-1; PROTEIN; SEQUENCE; GENOME; MODEL	We cloned cDNA for the Bombyx mori DJ-1 protein (BmDJ-1) from the brains of larvae. BmDJ-1 is composed of 190 amino acids and encoded by 672 nucleotides. Northern blot analysis showed that BmDJ-1 is transcribed as a 756-bp mRNA and has one isoform. Reverse transcriptase (RT)-PCR experiments revealed that the BmDJ-1 was present in the brain, fatbody, Malpighian tubule, ovary and testis but present in only low amounts in the silkgland and hemocyte of day 4 fifth instar larvae. Immunological analysis demonstrated the presence of BmDJ-1 in the brain, midgut, fatbody, Malpighian tubule, testis and ovary from the larvae to the adult. We found that BmDJ-1 has a unique expression pattern through the fifth instar larval to adult developmental stage. We assessed the anti-oxidative function of BmDJ-1 using rotenone (ROT) in day 3 fifth instar larvae. Administration of ROT to day 3 fifth instar larvae, together with exogenous (BmNPV-BmDJ-1 infection for 4 days in advance) BmDJ-1, produced significantly lower 24-h mortality in BmDJ-1 groups than in the control. 2D-PAGE revealed an isoelectric point (pI) shift to an acidic form for BmDJ-1 in BmN4 cells upon ROT stimulus. Among the factors examined for their effects on expression level of BmDJ-1 in the hemolymph, nitric oxide (NO) concentration was identified based on dramatic developmental stage-dependent changes. Administration of isosorbide dinitrate (ISDN), which is an NO donor, to BmN4 cells produced increased expression of BmDJ-1 compared to the control. These results suggest that BmDJ-1 might control oxidative stress in the cell due to NO and serves as a development modulation factor in B. mori.	[Tabunoki, Hiroko; Ode, Hiroaki; Satoh, Jun-ichi] Meiji Pharmaceut Univ, Dept Bioinformat & Mol Neuropathol, Tokyo, Japan; [Banno, Yutaka] Kyushu Univ, Ctr Genet Resources, Fukuoka 812, Japan; [Katsuma, Susumu; Shimada, Toru] Univ Tokyo, Dept Agr & Environm Biol, Grad Sch Agr & Life Sci, Tokyo, Japan; [Mita, Kazuei; Yamamoto, Kimiko] Natl Inst Agrobiol Sci, Insect Genome Lab, Tsukuba, Ibaraki, Japan; [Sato, Ryoichi] Tokyo Univ Agr & Technol, Bioapplicat & Syst Engn, Tokyo, Japan; [Ishii-Nozawa, Reiko] Meiji Pharmaceut Univ, Dept Clin Pharmacol, Tokyo, Japan	Meiji Pharmaceutical University; Kyushu University; University of Tokyo; National Institute of Agrobiological Sciences - Japan; Tokyo University of Agriculture & Technology; Meiji Pharmaceutical University	Tabunoki, H (corresponding author), Meiji Pharmaceut Univ, Dept Bioinformat & Mol Neuropathol, Tokyo, Japan.	tabunoki@my-pharm.ac.jp	Shimada, Toru/AAZ-2703-2021; Sato, Ryoichi/G-1074-2013; TABUNOKI, Hiroko/H-6593-2013; Shimada, Toru/A-2033-2011	Shimada, Toru/0000-0002-5791-0000; TABUNOKI, Hiroko/0000-0003-1823-9952; Shimada, Toru/0000-0002-5791-0000	Ministry of Education, Science, Sports and Culture [22710195]; High-Tech Research Center; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [S0801043]; Ministry of Health, Labour and Welfare of Japan [H22-Nanchi-Ippan-136]	Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); High-Tech Research Center(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	H.T. was supported by the Ministry of Education, Science, Sports and Culture, Grant-in-Aid (http://www.jsps.go.jp/english/e-grants/grants.html) for Young Scientists (B), 2010, 22710195. This work was in part supported by grants from the High-Tech Research Center Project (http://www.mext.go.jp/english/), the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan (S0801043), and the Research on Intractable Diseases (http://www.nanbyou.or.jp/english/index.htm), the Ministry of Health, Labour and Welfare of Japan (H22-Nanchi-Ippan-136) to J.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Anderson PC, 2008, BIOCHEMISTRY-US, V47, P9380, DOI 10.1021/bi800677k; Bandyopadhyay S, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-6; Blackinton J, 2009, J BIOL CHEM, V284, P6476, DOI 10.1074/jbc.M806599200; Bove Jordi, 2005, NeuroRx, V2, P484, DOI 10.1602/neurorx.2.3.484; CHOI SK, 1995, BIOCHEM BIOPH RES CO, V207, P452, DOI 10.1006/bbrc.1995.1209; da Costa CA, 2007, CURR MOL MED, V7, P650, DOI 10.2174/156652407782564426; Fan J, 2008, J BIOL CHEM, V283, P4022, DOI 10.1074/jbc.M707176200; Finny D., 1947, PROBIT ANAL STAT TRE; Inden M, 2006, NEUROBIOL DIS, V24, P144, DOI 10.1016/j.nbd.2006.06.004; Inoue M, 2004, REDOX REP, V9, P237, DOI 10.1179/135100004225006010; Kinumi T, 2004, BIOCHEM BIOPH RES CO, V317, P722, DOI 10.1016/j.bbrc.2004.03.110; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; MAEDA S, 1985, NATURE, V315, P592, DOI 10.1038/315592a0; Menzies FM, 2005, CURR BIOL, V15, P1578, DOI 10.1016/j.cub.2005.07.036; Meulener M, 2005, CURR BIOL, V15, P1572, DOI 10.1016/j.cub.2005.07.064; Meulener MC, 2006, P NATL ACAD SCI USA, V103, P12517, DOI 10.1073/pnas.0601891103; Mita K, 2004, DNA RES, V11, P27, DOI 10.1093/dnares/11.1.27; Ohnishi A, 2006, P NATL ACAD SCI USA, V103, P4398, DOI 10.1073/pnas.0511270103; Olzmann JA, 2004, J BIOL CHEM, V279, P8506, DOI 10.1074/jbc.M311017200; Panov A, 2005, J BIOL CHEM, V280, P42026, DOI 10.1074/jbc.M508628200; Pedersen AG, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P226; Tabunoki H, 2002, J BIOL CHEM, V277, P32133, DOI 10.1074/jbc.M204507200; Tabunoki H, 2008, NEUROSCI RES, V61, P271, DOI 10.1016/j.neures.2008.03.007; Tao X, 2003, J BIOL CHEM, V278, P31372, DOI 10.1074/jbc.M304221200; Terzioglu M, 2008, FEBS J, V275, P1384, DOI 10.1111/j.1742-4658.2008.06302.x; Tomita M, 2003, NAT BIOTECHNOL, V21, P52, DOI 10.1038/nbt771; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Xia QY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r162; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210; Yamamoto K, 2006, GENETICS, V173, P151, DOI 10.1534/genetics.105.053801	30	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2011	6	3							e17683	10.1371/journal.pone.0017683	http://dx.doi.org/10.1371/journal.pone.0017683			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740RG	21455296	Green Published, gold, Green Submitted			2022-12-25	WOS:000288811500007
J	Takada, Y; Gresh, L; Bozec, A; Ikeda, E; Kamiya, K; Watanabe, M; Kobayashi, K; Asano, K; Toyama, Y; Wagner, EF; Matsuo, K				Takada, Y.; Gresh, L.; Bozec, A.; Ikeda, E.; Kamiya, K.; Watanabe, M.; Kobayashi, K.; Asano, K.; Toyama, Y.; Wagner, E. F.; Matsuo, K.			Interstitial lung disease induced by gefitinib and Toll-like receptor ligands is mediated by Fra-1	ONCOGENE			English	Article						Fra-1; gefitinib; interstitial lung disease; MCP-1; AP-1; TLR	SYSTEMIC INFLAMMATORY RESPONSE; DOUBLE-EDGED-SWORD; NF-KAPPA-B; PULMONARY-FIBROSIS; C-FOS; OSTEOCLAST DIFFERENTIATION; TYROSINE KINASE; INNATE IMMUNITY; BONE-FORMATION; JUN PROTEINS	The role of the AP-1 transcription factor Fra-1 (encoded by Fosl1) in inflammatory responses associated with lung disease is largely unknown. Here, we show that Fra-1 overexpression in mice reduced proinflammatory cytokine production in response to injection of lipopolysaccharide (LPS), a Toll-like receptor (TLR)-ligand. Unexpectedly, Fra-1 transgenic mice died rapidly following LPS treatment, showing severe interstitial lung disease and displaying massive accumulation of macrophages and overproduction of several chemokines, including macrophage chemoattractant protein-1 (MCP-1, encoded by Ccl2). To assess the clinical relevance of Fra-1 in lung pathology, mice were treated with the anticancer drug gefitinib (Iressa), which can lead to interstitial lung disease in patients. Gefitinib-treated mice showed increased Fosl1 and Ccl2 expression and developed interstitial lung disease in response to LPS, endogenous TLR ligands and chemotherapy. Moreover, deletion of Fra-1 or blocking MCP-1 receptor signaling in mice attenuated gefitinib-enhanced lethality in response to LPS. Importantly, human alveolar macrophages showed enhanced LPS-induced FOSL1 and CCL2 expression after gefitinib treatment. These results indicate that Fra-1 is an important mediator of interstitial lung disease following gefitinib treatment. Oncogene (2011) 30, 3821-3832;doi:10.1038/onc.2011.101; published online 4 April 2011	[Matsuo, K.] Keio Univ, Lab Cell & Tissue Biol, Sch Med, Shinjuku Ku, Tokyo 1608582, Japan; [Gresh, L.] Res Inst Mol Pathol IMP, Vienna, Austria; [Bozec, A.; Wagner, E. F.] Spanish Natl Canc Res Ctr CNIO, Canc Cell Biol Programme, Madrid, Spain; [Ikeda, E.] Keio Univ, Dept Pathol, Sch Med, Tokyo 1608582, Japan; [Kamiya, K.; Watanabe, M.; Kobayashi, K.] Keio Univ, Dept Surg, Sch Med, Tokyo 1608582, Japan; [Asano, K.] Keio Univ, Dept Med, Sch Med, Tokyo 1608582, Japan; [Toyama, Y.] Keio Univ, Dept Orthopaed Surg, Sch Med, Tokyo 1608582, Japan	Keio University; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Centro Nacional de Investigaciones Oncologicas (CNIO); Keio University; Keio University; Keio University; Keio University	Matsuo, K (corresponding author), Keio Univ, Lab Cell & Tissue Biol, Sch Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	matsuo@sc.itc.keio.ac.jp	Toyama, Yoshiaki/K-5743-2013; Matsuo, Koichi/K-5695-2012	Matsuo, Koichi/0000-0002-1490-8955; Wagner, Erwin F/0000-0001-7872-0196; Gresh, Lionel/0000-0002-2333-1748	global COE; MEXT of Japan [21390425]; Naito Foundation; EMBO; Boehringer Ingelheim; Grants-in-Aid for Scientific Research [23791663] Funding Source: KAKEN	global COE(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation(Naito Memorial Foundation); EMBO(European Molecular Biology Organization (EMBO)); Boehringer Ingelheim(Boehringer Ingelheim); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank A Oide, M Asakawa and S Fukuse for technical support; T Yamaguchi for Fra-1 mouse maintenance; A Dent, A Ueda and M Busslinger for plasmids; H Daub for AX14596; and H Handa, S Sakamoto, K Maruyama, T Mitsudomi and L Bakiri for helpful input. We thank the Core Instrumentation Facility, Keio University School of Medicine, for technical assistance. This work was funded by a grant-in-aid from the global COE program, a grant-in-aid for Scientific Research (B) from MEXT of Japan (21390425), and a grant-in-aid for Scientific Research on Priority Areas and the Naito Foundation (YT). LG was funded by an EMBO Long-Term Fellowship. IMP is funded by Boehringer Ingelheim.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Bakiri L, 2007, BONE, V40, P867, DOI 10.1016/j.bone.2006.11.005; BERGERS G, 1995, MOL CELL BIOL, V15, P3748; Bozec A, 2008, NATURE, V454, P221, DOI 10.1038/nature07019; Bozec A, 2010, J CELL BIOL, V190, P1093, DOI 10.1083/jcb.201002111; Brehmer D, 2005, CANCER RES, V65, P379; Cohen MH, 2003, ONCOLOGIST, V8, P303, DOI 10.1634/theoncologist.8-4-303; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Eferl R, 2004, EMBO J, V23, P2789, DOI 10.1038/sj.emboj.7600282; Eferl R, 2008, P NATL ACAD SCI USA, V105, P10525, DOI 10.1073/pnas.0801414105; Finzer P, 2000, ONCOGENE, V19, P3235, DOI 10.1038/sj.onc.1203643; Fukuoka M, 2003, J CLIN ONCOL, V21, P2237, DOI 10.1200/JCO.2003.10.038; Giaccone G, 2004, J CLIN ONCOL, V22, P777, DOI 10.1200/JCO.2004.08.001; Guinea-Viniegra J, 2009, GENE DEV, V23, P2663, DOI 10.1101/gad.543109; Han JH, 2005, NAT IMMUNOL, V6, P1198, DOI 10.1038/ni1274; Inoue A, 2003, LANCET, V361, P137, DOI 10.1016/S0140-6736(03)12190-3; Ishii Y, 2006, AM J RESP CRIT CARE, V174, P550, DOI 10.1164/rccm.200509-1534OC; Ishizaka A, 2001, CRIT CARE MED, V29, P896, DOI 10.1097/00003246-200104000-00043; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Jochum W, 2000, NAT MED, V6, P980, DOI 10.1038/79676; Johnson GB, 2004, J IMMUNOL, V172, P20, DOI 10.4049/jimmunol.172.1.20; Katzenstein ALA, 1998, AM J RESP CRIT CARE, V157, P1301, DOI 10.1164/ajrccm.157.4.9707039; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kida H, 2005, AM J PHYSIOL-LUNG C, V288, pL342, DOI 10.1152/ajplung.00016.2004; Kris MG, 2003, JAMA-J AM MED ASSOC, V290, P2149, DOI 10.1001/jama.290.16.2149; Lee DH, 2010, CLIN CANCER RES, V16, P1307, DOI 10.1158/1078-0432.CCR-09-1903; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Matsuo K, 2000, NAT GENET, V24, P184, DOI 10.1038/72855; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Mollen KP, 2006, SHOCK, V26, P430, DOI 10.1097/01.shk.0000228797.41044.08; Morishita H, 2009, INT IMMUNOL, V21, P457, DOI 10.1093/intimm/dxp015; PAINE R, 1993, J IMMUNOL, V150, P4561; PETERSGOLDEN M, 1987, AM REV RESPIR DIS, V135, P1020; Pircher A, 2010, LUNG CANCER, V69, P265, DOI 10.1016/j.lungcan.2010.01.017; Ray N, 2006, INT IMMUNOL, V18, P671, DOI 10.1093/intimm/dxl004; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; Salojin KV, 2006, J IMMUNOL, V176, P1899, DOI 10.4049/jimmunol.176.3.1899; Suzuki H, 2003, CANCER RES, V63, P5054; Takada Y, 2004, J BIOL CHEM, V279, P39541, DOI 10.1074/jbc.M403449200; Takada Y, 2010, J IMMUNOL, V184, P1014, DOI 10.4049/jimmunol.0901196; Tallquist MD, 2000, GENESIS, V26, P113, DOI 10.1002/(SICI)1526-968X(200002)26:2<113::AID-GENE3>3.0.CO;2-2; Toney LM, 2000, NAT IMMUNOL, V1, P214, DOI 10.1038/79749; ULICH TR, 1991, AM J PATHOL, V138, P1485; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Watanabe M, 2003, ANN THORAC SURG, V76, P1668, DOI 10.1016/S0003-4975(03)01015-4; Wolter S, 2008, MOL CELL BIOL, V28, P4407, DOI 10.1128/MCB.00535-07; Yamaguchi T, 2009, J BONE MINER RES, V24, P2056, DOI [10.1359/JBMR.090603, 10.1359/jbmr.090603]; Zenz R, 2005, NATURE, V437, P369, DOI 10.1038/nature03963; Zhang Q, 2006, J BIOL CHEM, V281, P10174, DOI 10.1074/jbc.M513008200; Zhao C, 2006, CELL METAB, V4, P111, DOI 10.1016/j.cmet.2006.05.012	51	20	21	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP	2011	30	36					3821	3832		10.1038/onc.2011.101	http://dx.doi.org/10.1038/onc.2011.101			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	817PV	21460858				2022-12-25	WOS:000294687200001
J	Fujiwara, Y; Fujiwara, K; Goda, N; Iwaya, N; Tenno, T; Shirakawa, M; Hiroaki, H				Fujiwara, Yoshie; Fujiwara, Ken-ichiro; Goda, Natsuko; Iwaya, Naoko; Tenno, Takeshi; Shirakawa, Masahiro; Hiroaki, Hidekazu			Structure and Function of the N-terminal Nucleolin Binding Domain of Nuclear Valosin-containing Protein-like 2 (NVL2) Harboring a Nucleolar Localization Signal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AAA-ATPASE; MEMBRANE-FUSION; PEROXISOME BIOGENESIS; RNA-BINDING; CRYSTAL-STRUCTURE; ALPHA-HELIX; TAR RNA; RECOGNITION; CELL; NSF	The N-terminal regions of AAA-ATPases (ATPase associated with various cellular activities) often contain a domain that defines the distinct functions of the enzymes, such as substrate specificity and subcellular localization. As described herein, we have determined the solution structure of an N-terminal unique domain isolated from nuclear valosin-containing protein (VCP)-like protein 2 (NVL2(UD)). NVL2(UD) contains three alpha-helices with an organization resembling that of a winged helix motif, whereas a pair of beta-strands is missing. The structure is unique and distinct from those of other known type II AAA-ATPases, such as VCP. Consequently, we identified nucleolin from a HeLa cell extract as a binding partner of this domain. Nucleolin contains a long (similar to 300 amino acids) intrinsically unstructured region, followed by the four tandem RNA recognition motifs and the C-terminal glycine/arginine-rich domain. Binding analyses revealed that NVL2(UD) potentially binds to any of the combinations of two successive RNA binding domains in the presence of RNA. Furthermore, NVL2(UD) has a characteristic loop, in which the key basic residues RRKR are exposed to the solvent at the edge of the molecule. The mutation study showed that these residues are necessary and sufficient for nucleolin-RNA complex binding as well as nucleolar localization. Based on the observations presented above, we propose that NVL2 serves as an unfoldase for the nucleolin-RNA complex. As inferred from its RNA dependence and its ATPase activity, NVL2 might facilitate the dissociation and recycling of nucleolin, thereby promoting efficient ribosome biogenesis.	[Fujiwara, Yoshie; Goda, Natsuko; Iwaya, Naoko; Tenno, Takeshi; Hiroaki, Hidekazu] Kobe Univ, Div Struct Biol, Grad Sch Med, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Fujiwara, Yoshie; Tenno, Takeshi; Hiroaki, Hidekazu] Kobe Univ, Global Ctr Excellence Program Integrat Membrane B, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Fujiwara, Yoshie; Goda, Natsuko; Iwaya, Naoko; Hiroaki, Hidekazu] Japan Sci & Technol Agcy, Inst Bioinformat Res & Dev, Kawaguchi, Saitama 3320012, Japan; [Fujiwara, Ken-ichiro] Yokohama City Univ, Field Supramol Biol, Int Grad Sch Arts & Sci, Tsurumi Ku, Kanagawa 2300045, Japan; [Fujiwara, Ken-ichiro] Shionogi & Co Ltd, Shionogi Res Labs, Fukushima Ku, Osaka 5530002, Japan; [Iwaya, Naoko; Shirakawa, Masahiro] Kyoto Univ, Dept Mol Engn, Grad Sch Engn, Nishikyo Ku, Kyoto 6158510, Japan	Kobe University; Kobe University; Japan Science & Technology Agency (JST); Yokohama City University; Shionogi & Company Limited; Kyoto University	Hiroaki, H (corresponding author), Kobe Univ, Div Struct Biol, Grad Sch Med, Chuo Ku, 7-5-1 Kusunokicho, Kobe, Hyogo 6500017, Japan.	hiroakih@med.kobe-u.ac.jp	Hiroaki, Hidekazu/G-9564-2012; HIROAKI, HIDEKAZU/N-1658-2019	HIROAKI, HIDEKAZU/0000-0003-1621-5893	Japan Science and Technology Agency Institute for Bioinformatics Research and Development; Japanese Ministry of Education, Culture, Sports, Science, and Technology [22570118]	Japan Science and Technology Agency Institute for Bioinformatics Research and Development; Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by the Japan Science and Technology Agency Institute for Bioinformatics Research and Development and by a grant-in-aid for scientific research on Innovative Areas. This work was also supported by Grant-in-aid for Scientific Research (c) 22570118 from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (to H. H.).	Allain FHT, 2000, EMBO J, V19, P6870, DOI 10.1093/emboj/19.24.6870; Amin MA, 2008, BIOCHEM J, V415, P345, DOI 10.1042/BJ20081411; Arumugam S, 2010, J BIOMOL NMR, V47, P79, DOI 10.1007/s10858-010-9412-1; Battiste JL, 1996, SCIENCE, V273, P1547, DOI 10.1126/science.273.5281.1547; Chen HY, 2002, J VIROL, V76, P5233, DOI 10.1128/JVI.76.10.5233-5250.2002; CLARY DO, 1990, CELL, V61, P709, DOI 10.1016/0092-8674(90)90482-T; Cmarko D, 2008, HISTOL HISTOPATHOL, V23, P1291, DOI 10.14670/HH-23.1291; Dalal S, 2004, MOL BIOL CELL, V15, P637, DOI 10.1091/mbc.E03-02-0097; DAVID MJ, 2008, CELL CYCLE, V7, P17; Emmott E, 2009, EMBO REP, V10, P231, DOI 10.1038/embor.2009.14; Fujiki Y, 2000, CELL BIOCHEM BIOPHYS, V32, P155, DOI 10.1385/CBB:32:1-3:155; Fujiki Y, 2008, BIOCHEM SOC T, V36, P109, DOI 10.1042/BST0360109; Gadal O, 2001, EMBO J, V20, P3695, DOI 10.1093/emboj/20.14.3695; GermainLee EL, 1997, GENOMICS, V44, P22, DOI 10.1006/geno.1997.4856; GHISOLFI L, 1992, EUR J BIOCHEM, V209, P541, DOI 10.1111/j.1432-1033.1992.tb17318.x; Goda N, 2004, PROTEIN SCI, V13, P652, DOI 10.1110/ps.03439004; Greco A, 2009, REV MED VIROL, V19, P201, DOI 10.1002/rmv.614; Hay JC, 1997, CURR OPIN CELL BIOL, V9, P505, DOI 10.1016/S0955-0674(97)80026-9; Hegyi H, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-65; Hernandez-Verdun D, 2006, HISTOCHEM CELL BIOL, V126, P135, DOI 10.1007/s00418-006-0212-3; Higurashi M, 2008, PROTEIN SCI, V17, P72, DOI 10.1110/ps.073196308; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Iwaya N, 2007, J BIOMOL NMR, V37, P53, DOI 10.1007/s10858-006-9103-0; Kondo H, 1997, NATURE, V388, P75, DOI 10.1038/40411; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kressler D, 2008, J CELL BIOL, V181, P935, DOI 10.1083/jcb.200801181; Kurki S, 2004, CANCER CELL, V5, P465, DOI 10.1016/S1535-6108(04)00110-2; Lenzen CU, 1998, CELL, V94, P525, DOI 10.1016/S0092-8674(00)81593-7; Li YP, 1997, J VIROL, V71, P4098, DOI 10.1128/JVI.71.5.4098-4102.1997; Long AR, 1998, GENE, V208, P191, DOI 10.1016/S0378-1119(97)00652-5; Long AR, 1998, MECH DEVELOP, V76, P33, DOI 10.1016/S0925-4773(98)00110-5; Lupas AN, 2002, CURR OPIN STRUC BIOL, V12, P746, DOI 10.1016/S0959-440X(02)00388-3; Ma N, 2007, J CELL SCI, V120, P2091, DOI 10.1242/jcs.008771; Matthews DA, 2006, EMBO REP, V7, P870, DOI 10.1038/sj.embor.7400786; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Montanaro L, 2008, AM J PATHOL, V173, P301, DOI 10.2353/ajpath.2008.070752; Nagahama M, 2004, MOL BIOL CELL, V15, P5712, DOI 10.1091/mbc.E04-08-0692; Neuwald AF, 1999, GENOME RES, V9, P27; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; PASTERNACK MS, 1991, J BIOL CHEM, V266, P14703; Patel S, 1998, TRENDS CELL BIOL, V8, P65, DOI 10.1016/S0962-8924(97)01212-9; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; RABOUILLE C, 1995, CELL, V82, P905, DOI 10.1016/0092-8674(95)90270-8; Saxena A, 2006, ONCOGENE, V25, P7274, DOI 10.1038/sj.onc.1209714; Serin G, 1997, J BIOL CHEM, V272, P13109, DOI 10.1074/jbc.272.20.13109; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Shiozawa K, 2004, J BIOL CHEM, V279, P50060, DOI 10.1074/jbc.M407837200; Shiozawa K, 2006, FEBS J, V273, P4959, DOI 10.1111/j.1742-4658.2006.05494.x; SIOMI H, 1988, CELL, V55, P197, DOI 10.1016/0092-8674(88)90043-8; Stark LA, 2009, EMBO REP, V10, P35, DOI 10.1038/embor.2008.230; Storck S, 2009, BIOL CELL, V101, P153, DOI 10.1042/BC20080054; SZEBENI A, 1995, BIOCHEMISTRY-US, V34, P8037, DOI 10.1021/bi00025a009; Tamura S, 1998, BIOCHEM BIOPH RES CO, V245, P883, DOI 10.1006/bbrc.1998.8522; TAN RY, 1993, CELL, V73, P1031, DOI 10.1016/0092-8674(93)90280-4; Tan YW, 2006, NUCLEIC ACIDS RES, V34, P4816, DOI 10.1093/nar/gkl650; TAO JS, 1992, P NATL ACAD SCI USA, V89, P2723, DOI 10.1073/pnas.89.7.2723; Tenno T, 2004, PROTEIN ENG DES SEL, V17, P305, DOI 10.1093/protein/gzh044; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tomii K, 2004, BIOINFORMATICS, V20, P594, DOI 10.1093/bioinformatics/btg474; Uchiyama K, 2002, J CELL BIOL, V159, P855, DOI 10.1083/jcb.200208112; Uchiyama K, 2006, DEV CELL, V11, P803, DOI 10.1016/j.devcel.2006.10.016; Ugrinova I, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-66; Weber JD, 2000, MOL CELL BIOL, V20, P2517, DOI 10.1128/MCB.20.7.2517-2528.2000; WEEKS KM, 1990, SCIENCE, V249, P1281, DOI 10.1126/science.2205002; Weller S, 2003, ANNU REV GENOM HUM G, V4, P165, DOI 10.1146/annurev.genom.4.070802.110424; WHITEHEART SW, 1995, TRENDS CELL BIOL, V5, P64, DOI 10.1016/S0962-8924(00)88948-5; Wu DY, 1999, DEVELOPMENT, V126, P2021; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2005, P NATL ACAD SCI USA, V102, P14132, DOI 10.1073/pnas.0505006102; Yu RC, 1999, MOL CELL, V4, P97, DOI 10.1016/S1097-2765(00)80191-4; Zhang XD, 2000, MOL CELL, V6, P1473, DOI 10.1016/S1097-2765(00)00143-X	71	11	15	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21732	21741		10.1074/jbc.M110.174680	http://dx.doi.org/10.1074/jbc.M110.174680			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21474449	Green Published, hybrid			2022-12-25	WOS:000291464700069
J	Jin, HJ; Kanthasamy, A; Anantharam, V; Rana, A; Kanthasamy, AG				Jin, Huajun; Kanthasamy, Arthi; Anantharam, Vellareddy; Rana, Ajay; Kanthasamy, Anumantha G.			Transcriptional Regulation of Pro-apoptotic Protein Kinase C delta IMPLICATIONS FOR OXIDATIVE STRESS-INDUCED NEURONAL CELL DEATH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASPASE-3-DEPENDENT PROTEOLYTIC CLEAVAGE; BREAST-CANCER CELLS; PKC-DELTA; GENE-EXPRESSION; PARKINSONS-DISEASE; DOPAMINERGIC CELLS; PROMOTER ANALYSIS; GENOMIC STRUCTURE; PHORBOL ESTER; IN-VITRO	We previously demonstrated that protein kinase C delta (PKC delta; PKC delta) is an oxidative stress-sensitive kinase that plays a causal role in apoptotic cell death in neuronal cells. Although PKC delta activation has been extensively studied, relatively little is known about the molecular mechanisms controlling PKC delta expression. To characterize the regulation of PKC delta expression, we cloned an similar to 2-kbp 5 ' -promoter segment of the mouse Prkcd gene. Deletion analysis indicated that the noncoding exon 1 region contained multiple Sp sites, including four GC boxes and one CACCC box, which directed the highest levels of transcription in neuronal cells. In addition, an upstream regulatory region containing adjacent repressive and anti-repressive elements with opposing regulatory activities was identified within the region -712 to -560. Detailed mutagenesis studies revealed that each Sp site made a positive contribution to PKC delta promoter expression. Overexpression of Sp family proteins markedly stimulated PKC delta promoter activity without any synergistic transactivating effect. Furthermore, experiments in Sp-deficient SL2 cells indicated long isoform Sp3 as the essential activator of PKC delta transcription. Importantly, both PKC delta promoter activity and endogenous PKC delta expression in NIE115 cells and primary striatal cultures were inhibited by mithramycin A. The results from chromatin immunoprecipitation and gel shift assays further confirmed the functional binding of Sp proteins to the PKC delta promoter. Additionally, we demonstrated that overexpression of p300 or CREB-binding protein increases the PKC delta promoter activity. This stimulatory effect requires intact Sp-binding sites and is independent of p300 histone acetyltransferase activity. Finally, modulation of Sp transcriptional activity or protein level profoundly altered the cell death induced by oxidative insult, demonstrating the functional significance of Sp-dependent PKC delta gene expression. Collectively, our findings may have implications for development of new translational strategies against oxidative damage.	[Jin, Huajun; Kanthasamy, Arthi; Anantharam, Vellareddy; Kanthasamy, Anumantha G.] Iowa State Univ, Dept Biomed Sci, Parkinsons Disorder Res Lab, Iowa Ctr Adv Neurotoxicol, Ames, IA 50011 USA; [Rana, Ajay] Loyola Univ Chicago, Dept Pharmacol, Stritch Sch Med, Maywood, IL 60153 USA; [Rana, Ajay] Hines VA Med Ctr, Hines, IL 60141 USA	Iowa State University; Loyola University Chicago; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital	Kanthasamy, AG (corresponding author), Iowa State Univ, Dept Biomed Sci, Parkinsons Disorder Res Lab, Iowa Ctr Adv Neurotoxicol, 2062 Coll Vet Med Bldg, Ames, IA 50011 USA.	akanthas@iastate.edu		Kanthasamy, Anumantha/0000-0002-6454-4264; Kanthasamy, Arthi/0000-0003-4654-9907	National Institutes of Health [ES10586, NS065167, GM055835]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055835] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065167] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants ES10586 (to A. G. K.), NS065167 (to A. K.), and GM055835 (to A. R.).	Alonso-Escolano D, 2006, J PHARMACOL EXP THER, V318, P373, DOI 10.1124/jpet.106.103358; Ammanamanchi S, 2003, J BIOL CHEM, V278, P35775, DOI 10.1074/jbc.M305961200; Anantharam V, 2002, J NEUROSCI, V22, P1738, DOI 10.1523/JNEUROSCI.22-05-01738.2002; Balasubramanian N, 2002, LEUKEMIA RES, V26, P67, DOI 10.1016/S0145-2126(01)00098-4; Barmack NH, 2000, J COMP NEUROL, V427, P235, DOI 10.1002/1096-9861(20001113)427:2<235::AID-CNE6>3.0.CO;2-6; Battaini F, 2005, ANN NY ACAD SCI, V1057, P177, DOI 10.1196/annals.1356.011; BATTAINI F, 1995, NEUROBIOL AGING, V16, P137, DOI 10.1016/0197-4580(94)00154-5; Berry DM, 1996, J BIOL CHEM, V271, P16090, DOI 10.1074/jbc.271.27.16090; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; BLUME SW, 1991, J CLIN INVEST, V88, P1613, DOI 10.1172/JCI115474; Boyes J, 1998, NATURE, V396, P594, DOI 10.1038/25166; BRAND AH, 1985, CELL, V41, P41, DOI 10.1016/0092-8674(85)90059-5; Bright R, 2004, J NEUROSCI, V24, P6880, DOI 10.1523/JNEUROSCI.4474-03.2004; Brodie C, 2003, APOPTOSIS, V8, P19, DOI 10.1023/A:1021640817208; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Cataldi A, 2009, ANAT REC, V292, P1135, DOI 10.1002/ar.20936; Choi SH, 2006, CANCER RES, V66, P7261, DOI 10.1158/0008-5472.CAN-05-4177; Chou WH, 2004, J CLIN INVEST, V114, P49, DOI 10.1172/JC1200421655; Chou WH, 2005, TRENDS CARDIOVAS MED, V15, P47, DOI 10.1016/j.tcm.2005.01.003; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; Dempsey EC, 2000, AM J PHYSIOL-LUNG C, V279, pL429, DOI 10.1152/ajplung.2000.279.3.L429; DeVries TA, 2002, EMBO J, V21, P6050, DOI 10.1093/emboj/cdf606; Evans JD, 2003, AM J CLIN PATHOL, V119, P392, DOI 10.1309/BKPC9DX98R781B87; Gavrielides MV, 2006, CANCER RES, V66, P11792, DOI 10.1158/0008-5472.CAN-06-1139; Giorgi C, 2010, ANTIOXID REDOX SIGN, V13, P1051, DOI 10.1089/ars.2009.2825; Greenamyre JT, 2004, SCIENCE, V304, P1120, DOI 10.1126/science.1098966; HAGEN G, 1992, NUCLEIC ACIDS RES, V20, P5519, DOI 10.1093/nar/20.21.5519; Hlavackova M, 2010, MOL CELL BIOCHEM, V345, P271, DOI 10.1007/s11010-010-0581-8; Horovitz-Fried M, 2006, CELL SIGNAL, V18, P183, DOI 10.1016/j.cellsig.2005.04.004; Horovitz-Fried M, 2007, CELL SIGNAL, V19, P556, DOI 10.1016/j.cellsig.2006.08.005; Hung JJ, 2006, MOL CELL BIOL, V26, P1770, DOI 10.1128/MCB.26.5.1770-1785.2006; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; Kaneki M, 1999, MOL CELL BIOL, V19, P461; Kanthasamy AG, 2003, ANN NY ACAD SCI, V1010, P683, DOI 10.1196/annals.1299.125; Kanthasamy AG, 2003, ANTIOXID REDOX SIGN, V5, P609, DOI 10.1089/152308603770310275; Kanthasamy A, 2010, NEUROTOXICOLOGY, V31, P555, DOI 10.1016/j.neuro.2009.12.003; Kanthasamy AG, 2006, FREE RADICAL BIO MED, V41, P1578, DOI 10.1016/j.freeradbiomed.2006.08.016; Karban AS, 2004, HUM MOL GENET, V13, P35, DOI 10.1093/hmg/ddh008; Kaul S, 2005, MOL BRAIN RES, V139, P137, DOI 10.1016/j.molbrainres.2005.05.022; Kaul S, 2005, J BIOL CHEM, V280, P28721, DOI 10.1074/jbc.M501092200; Kaul S, 2003, EUR J NEUROSCI, V18, P1387, DOI 10.1046/j.1460-9568.2003.02864.x; Kavurma MM, 2001, J BIOL CHEM, V276, P4964, DOI 10.1074/jbc.M009251200; Kharait S, 2006, BIOCHEM BIOPH RES CO, V343, P848, DOI 10.1016/j.bbrc.2006.03.044; Kiley SC, 1999, ONCOGENE, V18, P6748, DOI 10.1038/sj.onc.1203101; Kitazawa M, 2003, NEUROSCIENCE, V119, P945, DOI 10.1016/S0306-4522(03)00226-4; Koike K, 2006, THYROID, V16, P333, DOI 10.1089/thy.2006.16.333; Kruger JS, 2003, MOL CANCER RES, V1, P801; Kudo S, 1998, MOL CELL BIOL, V18, P5492, DOI 10.1128/MCB.18.9.5492; Kurkinen KMA, 2000, GENE, V242, P115, DOI 10.1016/S0378-1119(99)00539-9; Latchoumycandane C, 2005, J PHARMACOL EXP THER, V313, P46, DOI 10.1124/jpet.104.078469; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; LEIBERSPERGER H, 1991, J BIOL CHEM, V266, P14778; Li XH, 2010, PROSTAG OTH LIPID M, V93, P84, DOI 10.1016/j.prostaglandins.2010.06.008; Liedtke C, 2003, J BIOL CHEM, V278, P27593, DOI 10.1074/jbc.M304077200; Liu J, 2006, MOL CELL, V21, P467, DOI 10.1016/j.molcel.2005.12.020; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Soto A, 2006, J BIOL CHEM, V281, P30419, DOI 10.1074/jbc.M604868200; MacCarthy-Morrogh L, 2000, ONCOGENE, V19, P5534, DOI 10.1038/sj.onc.1203949; Majumder PK, 2001, CELL GROWTH DIFFER, V12, P465; Mavrothalassitis G, 2000, ONCOGENE, V19, P6524, DOI 10.1038/sj.onc.1204045; Miettinen S, 1996, J NEUROSCI, V16, P6236; Morgenstern B, 1996, P NATL ACAD SCI USA, V93, P12098, DOI 10.1073/pnas.93.22.12098; Naik MU, 2000, J COMP NEUROL, V426, P243, DOI 10.1002/1096-9861(20001016)426:2<243::AID-CNE6>3.0.CO;2-8; Noti JD, 1997, J BIOL CHEM, V272, P24038, DOI 10.1074/jbc.272.38.24038; ONO Y, 1988, J BIOL CHEM, V263, P6927; Pascale A, 1998, MOL NEUROBIOL, V16, P49, DOI 10.1007/BF02740602; Pascale A, 2007, PHARMACOL RES, V55, P560, DOI 10.1016/j.phrs.2007.04.013; Peters CA, 2000, MOL CELL ENDOCRINOL, V162, P181, DOI 10.1016/S0303-7207(00)00193-3; Ponassi R, 2006, BIOCHEM PHARMACOL, V72, P1417, DOI 10.1016/j.bcp.2006.07.031; Quan TH, 1999, J BIOL CHEM, V274, P28566, DOI 10.1074/jbc.274.40.28566; Ramana CV, 2000, ONCOGENE, V19, P2619, DOI 10.1038/sj.onc.1203525; RAY R, 1989, J CLIN INVEST, V83, P2003, DOI 10.1172/JCI114110; Reno EM, 2008, HUM PATHOL, V39, P21, DOI 10.1016/j.humpath.2007.05.023; Roth BL, 1997, APPL ENVIRON MICROB, V63, P2421, DOI 10.1128/AEM.63.6.2421-2431.1997; Rybin VO, 2007, J BIOL CHEM, V282, P23631, DOI 10.1074/jbc.M701676200; Ryu H, 2003, P NATL ACAD SCI USA, V100, P4281, DOI 10.1073/pnas.0737363100; Saito N, 1995, Nihon Yakurigaku Zasshi, V105, P127; Sapetschnig A, 2004, J BIOL CHEM, V279, P42095, DOI 10.1074/jbc.M404989200; Saur D, 2002, J BIOL CHEM, V277, P25798, DOI 10.1074/jbc.M109802200; Shanmugam M, 1999, MOL CELL ENDOCRINOL, V148, P109, DOI 10.1016/S0303-7207(98)00229-9; Sherer TB, 2002, J NEUROSCI, V22, P7006; Shin SY, 2004, J MOL BIOL, V340, P681, DOI 10.1016/j.jmb.2004.04.006; Solovyev VV, 2003, NUCLEIC ACIDS RES, V31, P3540, DOI 10.1093/nar/gkg525; Sowa Y, 1999, CANCER RES, V59, P4266; Spengler ML, 2006, J BIOL CHEM, V281, P5567, DOI 10.1074/jbc.M600035200; Steinberg SF, 2004, BIOCHEM J, V384, P449, DOI 10.1042/BJ20040704; Stempka L, 1999, J BIOL CHEM, V274, P8886, DOI 10.1074/jbc.274.13.8886; Sudhakar C, 2008, FEBS J, V275, P2200, DOI 10.1111/j.1742-4658.2008.06373.x; Suh KS, 2003, GENOMICS, V82, P57, DOI 10.1016/S0888-7543(03)00072-7; Sun XG, 2000, J BIOL CHEM, V275, P7470, DOI 10.1074/jbc.275.11.7470; Suske G, 2000, Methods Mol Biol, V130, P175; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Suzuki T, 2000, GENES CELLS, V5, P29, DOI 10.1046/j.1365-2443.2000.00302.x; Takayama M, 2001, JPN CIRC J, V65, P1071, DOI 10.1253/jcj.65.1071; Tavares D, 1999, J BIOL CHEM, V274, P30066, DOI 10.1074/jbc.274.42.30066; Tsai JH, 2000, CANCER LETT, V161, P171, DOI 10.1016/S0304-3835(00)00597-8; Villar J, 2007, CANCER RES, V67, P10859, DOI 10.1158/0008-5472.CAN-07-2041; Vucenik I, 2005, BREAST CANCER RES TR, V91, P35, DOI 10.1007/s10549-004-6456-5; Walker GE, 2001, ENDOCRINOLOGY, V142, P3817, DOI 10.1210/en.142.9.3817; Welman A, 2007, PROTEIN SCI, V16, P2711, DOI 10.1110/ps.072874607; Whetstine JR, 2002, BIOCHEM J, V367, P629, DOI 10.1042/BJ20020512; Wu YZ, 2004, ONCOGENE, V23, P168, DOI 10.1038/sj.onc.1207003; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; Yang YJ, 2004, MOL CELL NEUROSCI, V25, P406, DOI 10.1016/j.mcn.2003.11.011; Zhang DH, 2007, J PHARMACOL EXP THER, V322, P913, DOI 10.1124/jpet.107.124669; Zhang DH, 2007, J NEUROSCI, V27, P5349, DOI 10.1523/JNEUROSCI.4107-06.2007	106	35	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19840	19859		10.1074/jbc.M110.203687	http://dx.doi.org/10.1074/jbc.M110.203687			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21467032	hybrid, Green Published			2022-12-25	WOS:000291027700065
J	Lee, IH; Song, SH; Campbell, CR; Kumar, S; Cook, DI; Dinudom, A				Lee, Il-Ha; Song, Sung-Hee; Campbell, Craig R.; Kumar, Sharad; Cook, David I.; Dinudom, Anuwat			Regulation of the Epithelial Na+ Channel by the RH Domain of G Protein-coupled Receptor Kinase, GRK2, and G alpha q/11	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHORYLATION-INDEPENDENT REGULATION; G-ALPHA-Q; SODIUM-CHANNELS; GLUCOSE-TRANSPORT; CYTOSOLIC NA+; SELECTIVE REGULATION; MUCIN SECRETION; GAMMA-SUBUNIT; P2 RECEPTORS; CELLS	The G protein-coupled receptor kinase (GRK2) belongs to a family of protein kinases that phosphorylates agonist-activated G protein-coupled receptors, leading to G protein-receptor uncoupling and termination of G protein signaling. GRK2 also contains a regulator of G protein signaling homology (RH) domain, which selectively interacts with alpha-subunits of the Gq/11 family that are released during G protein-coupled receptor activation. We have previously reported that kinase activity of GRK2 up-regulates activity of the epithelial sodium channel (ENaC) in a Na+ absorptive epithelium by blocking Nedd4-2-dependent inhibition of ENaC. In the present study, we report that GRK2 also regulates ENaC by a mechanism that does not depend on its kinase activity. We show that a wild-type GRK2 (wtGRK2) and a kinase-dead GRK2 mutant ((K220R)GRK2), but not a GRK2 mutant that lacks the C-terminal RH domain (Delta RH-GRK2) or a GRK2 mutant that cannot interact with G alpha q/11/14 ((D110A)GRK2), increase activity of ENaC. GRK2 up-regulates the basal activity of the channel as a consequence of its RH domain binding the alpha-subunits of Gq/11. We further found that expression of constitutively active G alpha q/11 mutants significantly inhibits activity of ENaC. Conversely, co-expression of siRNA against G alpha q/11 increases ENaC activity. The effect of G alpha q on ENaC activity is not due to change in ENaC membrane expression and is independent of Nedd4-2. These findings reveal a novel mechanism by which GRK2 and Gq/11 alpha-subunits regulate the activity ENaC.	[Lee, Il-Ha; Song, Sung-Hee; Campbell, Craig R.; Cook, David I.; Dinudom, Anuwat] Univ Sydney, Fac Med, Bosch Inst, Discipline Physiol, Sydney, NSW 2006, Australia; [Kumar, Sharad] SA Pathol, Ctr Canc Biol, Adelaide, SA 5000, Australia	University of Sydney; Centre for Cancer Biology; SA Pathology	Dinudom, A (corresponding author), Med Fdn Bldg,92-94 Parramatta Rd, Sydney, NSW 2050, Australia.	anuwat@physiol.usyd.edu.au	Kumar, Sharad/AAX-7787-2020; Campbell, Craig R/B-5983-2012	Kumar, Sharad/0000-0001-7126-9814; Campbell, Craig R/0000-0002-0843-7579	National Health and Medical Research Council of Australia [508086]; Australian Research Council [DP0774320]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported by grants from the National Health and Medical Research Council of Australia (508086) and the Australian Research Council (DP0774320).	Abriel H, 1999, J CLIN INVEST, V103, P667, DOI 10.1172/JCI5713; Arthur JW, 2006, BIOINFORMATICS, V22, P2192, DOI 10.1093/bioinformatics/btl381; Ballou LM, 2003, J BIOL CHEM, V278, P23472, DOI 10.1074/jbc.M212232200; Bengrine A, 2007, J BIOL CHEM, V282, P26884, DOI 10.1074/jbc.M611829200; Carattino MD, 2008, J BIOL CHEM, V283, P25290, DOI 10.1074/jbc.M803931200; Carman CV, 1999, J BIOL CHEM, V274, P34483, DOI 10.1074/jbc.274.48.34483; Chen XD, 2006, P NATL ACAD SCI USA, V103, P3422, DOI 10.1073/pnas.0507710103; Cook DI, 1998, EUR J MORPHOL, V36, P67; Cummins MM, 2002, PFLUG ARCH EUR J PHY, V444, P644, DOI 10.1007/s00424-002-0856-3; Dale LB, 2000, J BIOL CHEM, V275, P38213, DOI 10.1074/jbc.M006075200; Day PW, 2004, J BIOL CHEM, V279, P53643, DOI 10.1074/jbc.M401438200; Day PW, 2003, BIOCHEMISTRY-US, V42, P9176, DOI 10.1021/bi034442+; DEVIVO M, 1992, J BIOL CHEM, V267, P18263; Dhami GK, 2005, J BIOL CHEM, V280, P24420, DOI 10.1074/jbc.M501650200; Dhami GK, 2002, J BIOL CHEM, V277, P25266, DOI 10.1074/jbc.M203593200; Dicker F, 1999, P NATL ACAD SCI USA, V96, P5476, DOI 10.1073/pnas.96.10.5476; DINUDOM A, 1995, J PHYSIOL-LONDON, V487, P549, DOI 10.1113/jphysiol.1995.sp020899; Dinudom A, 2004, P NATL ACAD SCI USA, V101, P11886, DOI 10.1073/pnas.0402178101; Dinudom A, 1998, P NATL ACAD SCI USA, V95, P7169, DOI 10.1073/pnas.95.12.7169; Ehre C, 2007, AM J PHYSIOL-CELL PH, V293, pC1445, DOI 10.1152/ajpcell.00051.2007; Erb L, 2006, PFLUG ARCH EUR J PHY, V452, P552, DOI 10.1007/s00424-006-0069-2; Ferguson SSG, 2007, TRENDS PHARMACOL SCI, V28, P173, DOI 10.1016/j.tips.2007.02.008; Flores SY, 2003, PFLUG ARCH EUR J PHY, V446, P334, DOI 10.1007/s00424-003-1027-x; Fotia AB, 2002, FASEB J, V16, P70, DOI 10.1096/fj.02-0497fje; Freedman NJ, 1997, J BIOL CHEM, V272, P17734, DOI 10.1074/jbc.272.28.17734; HARA K, 1994, P NATL ACAD SCI USA, V91, P7415, DOI 10.1073/pnas.91.16.7415; Harvey KF, 2001, J BIOL CHEM, V276, P8597, DOI 10.1074/jbc.C000906200; Hennig B, 2008, EUR J PHARMACOL, V583, P156, DOI 10.1016/j.ejphar.2008.01.017; Hou CF, 2004, J PHARMACOL EXP THER, V309, P697, DOI 10.1124/jpet.103.060574; Hubbard KB, 2006, CELL SIGNAL, V18, P135, DOI 10.1016/j.cellsig.2005.08.004; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Hughey RP, 2003, J BIOL CHEM, V278, P37073, DOI 10.1074/jbc.M307003200; Hummler E, 1999, AM J PHYSIOL-GASTR L, V276, pG567, DOI 10.1152/ajpgi.1999.276.3.G567; Imamura T, 1999, MOL CELL BIOL, V19, P6765; Kemp PA, 2004, AM J RESP CELL MOL, V31, P446, DOI 10.1165/rcmb.2003-0211OC; Komwatana P, 1998, J MEMBRANE BIOL, V162, P225, DOI 10.1007/s002329900360; Komwatana P, 1996, P NATL ACAD SCI USA, V93, P8107, DOI 10.1073/pnas.93.15.8107; KONG GH, 1994, J BIOL CHEM, V269, P13084; Kunzelmann K, 2005, FASEB J, V19, P969, DOI 10.1096/fj.04-2469fje; Lee IH, 2008, CLIN EXP PHARMACOL P, V35, P235, DOI 10.1111/j.1440-1681.2007.04844.x; Lee IH, 2007, J BIOL CHEM, V282, P29866, DOI 10.1074/jbc.M701923200; Lee IH, 2009, J BIOL CHEM, V284, P12663, DOI 10.1074/jbc.M809737200; Leipziger J, 2003, AM J PHYSIOL-RENAL, V284, pF419, DOI 10.1152/ajprenal.00075.2002; Lodowski DT, 2003, SCIENCE, V300, P1256, DOI 10.1126/science.1082348; Luo JS, 2008, MOL PHARMACOL, V74, P338, DOI 10.1124/mol.107.044750; Ma HP, 2007, PFLUG ARCH EUR J PHY, V455, P169, DOI 10.1007/s00424-007-0294-3; Matalon S, 1999, ANNU REV PHYSIOL, V61, P627, DOI 10.1146/annurev.physiol.61.1.627; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Ribas C, 2007, BBA-BIOMEMBRANES, V1768, P913, DOI 10.1016/j.bbamem.2006.09.019; Sallese M, 2000, MOL PHARMACOL, V57, P826, DOI 10.1124/mol.57.4.826; Sanchez-Perez A, 2007, BIOCHEM BIOPH RES CO, V359, P611, DOI 10.1016/j.bbrc.2007.05.134; Snyder PM, 2002, ENDOCR REV, V23, P258, DOI 10.1210/er.23.2.258; Sterne-Marr R, 2003, J BIOL CHEM, V278, P6050, DOI 10.1074/jbc.M208787200; STOOS BA, 1991, KIDNEY INT, V39, P1168, DOI 10.1038/ki.1991.148; TURNHEIM K, 1991, PHYSIOL REV, V71, P429, DOI 10.1152/physrev.1991.71.2.429; Usui I, 2004, EMBO J, V23, P2821, DOI 10.1038/sj.emboj.7600297; Wang J, 2008, AM J PHYSIOL-RENAL, V295, pF843, DOI 10.1152/ajprenal.90348.2008; Willets JM, 2005, J BIOL CHEM, V280, P18950, DOI 10.1074/jbc.M412682200	58	10	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19259	19269		10.1074/jbc.M111.239772	http://dx.doi.org/10.1074/jbc.M111.239772			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21464134	hybrid, Green Published			2022-12-25	WOS:000291027700008
J	Stockbridge, RB; Wolfenden, R				Stockbridge, Randy B.; Wolfenden, Richard			Enhancement of the Rate of Pyrophosphate Hydrolysis by Nonenzymatic Catalysts and by Inorganic Pyrophosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; EVOLUTIONARY CONSERVATION; MANGANESE METALLOENZYMES; PHOSPHORYL TRANSFER; CRYSTAL-STRUCTURE; ENZYMES; MECHANISM; FAMILY; PROFICIENCIES; HYDROXIDE	To estimate the proficiency of inorganic pyrophosphatase as a catalyst, P-31 NMR was used to determine rate constants and thermodynamics of activation for the spontaneous hydrolysis of inorganic pyrophosphate (PPi) in the presence and absence of Mg2+ at elevated temperatures. These values were compared with rate constants and activation parameters determined for the reaction catalyzed by Escherichia coli inorganic pyrophosphatase using isothermal titration calorimetry. At 25 degrees C and pH 8.5, the hydrolysis of MgPPi2- proceeds with a rate constant of 2.8 x 10(-10) s(-1), whereas E. coli pyrophosphatase was found to have a turnover number of 570 s(-1) under the same conditions. The resulting rate enhancement (2 x 10(12)-fold) is achieved entirely by reducing the enthalpy of activation (Delta Delta H-double dagger = -16.6 kcal/mol). The presence of Mg2+ ions or the transfer of the substrate from bulk water to dimethyl sulfoxide was found to increase the rate of pyrophosphate hydrolysis by as much as similar to 10(6)-fold. Transfer to dimethyl sulfoxide accelerated PPi hydrolysis by reducing the enthalpy of activation. Mg2+ increased the rate of PPi hydrolysis by both increasing the entropy of activation and reducing the enthalpy of activation.	[Stockbridge, Randy B.; Wolfenden, Richard] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Wolfenden, R (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Genet Med Suite 3010,120 Mason Farm Rd, Chapel Hill, NC 27599 USA.	water@med.unc.edu	Wolfenden, Richard/CAH-1293-2022	Stockbridge, Randy/0000-0001-8848-3032	National Institutes of Health [GM18325]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM018325, R37GM018325] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM18325.	ARTHUR EM, 1996, METAL COMPLEXES AQUE; BALTSCHEFFSKY H, 1986, CHEM SCRIPTA, V26B, P259; Baykov AA, 1996, BIOCHEMISTRY-US, V35, P4655, DOI 10.1021/bi952635u; BORDWELL FG, 1988, ACCOUNTS CHEM RES, V21, P456, DOI 10.1021/ar00156a004; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; Christianson DW, 1999, ANNU REV BIOCHEM, V68, P33, DOI 10.1146/annurev.biochem.68.1.33; Christianson DW, 1997, PROG BIOPHYS MOL BIO, V67, P217, DOI 10.1016/S0079-6107(97)88477-5; COOPERMAN BS, 1992, TRENDS BIOCHEM SCI, V17, P262, DOI 10.1016/0968-0004(92)90406-Y; COOPERMAN BS, 1982, METHOD ENZYMOL, V87, P526; COWAN JA, 1995, BIOL CHEM MAGNESIUM, P8; Dismukes GC, 1996, CHEM REV, V96, P2909, DOI 10.1021/cr950053c; Fabrichniy IP, 2007, J BIOL CHEM, V282, P1422, DOI 10.1074/jbc.M513161200; Gill R, 2005, ACTA CRYSTALLOGR D, V61, P545, DOI 10.1107/S0907444905004038; GUTZ IGR, 1992, CURTIPOT VERSION 3 5; Hagelueken G, 2006, P NATL ACAD SCI USA, V103, P7631, DOI 10.1073/pnas.0510501103; Hedlund J, 2006, FEBS J, V273, P5183, DOI 10.1111/j.1742-4658.2006.05514.x; Heikinheimo P, 1996, STRUCTURE, V4, P1491, DOI 10.1016/S0969-2126(96)00155-4; Heikinheimo P, 2001, P NATL ACAD SCI USA, V98, P3121, DOI 10.1073/pnas.061612498; Heinonen J. K., 2001, BIOL ROLE INORGANIC; JENCKS WP, 1968, HDB BIOCH, pJ150; JOSSE J, 1966, J BIOL CHEM, V241, P1948; KNIGHT WB, 1981, BIOCHEMISTRY-US, V20, P4079, DOI 10.1021/bi00517a021; KNOWLES JR, 1980, ANNU REV BIOCHEM, V49, P877, DOI 10.1146/annurev.bi.49.070180.004305; KONSOWITZ LM, 1976, J AM CHEM SOC, V98, P1993, DOI 10.1021/ja00423a072; Lad C, 2003, P NATL ACAD SCI USA, V100, P5607, DOI 10.1073/pnas.0631607100; Lipscomb WN, 1996, CHEM REV, V96, P2375, DOI 10.1021/cr950042j; Maegley KA, 1996, P NATL ACAD SCI USA, V93, P8160, DOI 10.1073/pnas.93.16.8160; Malinen AM, 2007, BIOCHEMISTRY-US, V46, P8872, DOI 10.1021/bi700564b; MARAT K, 1999, SPINWORKS VERSION 2; Merckel MC, 2001, STRUCTURE, V9, P289, DOI 10.1016/S0969-2126(01)00587-1; OSTERHELD RK, 1958, J PHYS CHEM-US, V62, P1133, DOI 10.1021/j150567a028; PAGE MI, 1971, P NATL ACAD SCI USA, V68, P1678, DOI 10.1073/pnas.68.8.1678; Pohjanjoki P, 1998, BIOCHEMISTRY-US, V37, P1754, DOI 10.1021/bi971771r; ROBINSON RA, 1970, ELECTROLYTE SOLUTION, P363; Ronimus RS, 2001, EXTREMOPHILES, V5, P357, DOI 10.1007/s007920100215; SALMINEN T, 1995, BIOCHEMISTRY-US, V34, P782, DOI 10.1021/bi00003a011; Shintani T, 1998, FEBS LETT, V439, P263, DOI 10.1016/S0014-5793(98)01381-7; Smith RM, 1974, CRITICAL STABILITY C, V1-6; Sorensen-Stowell K, 2006, J ORG CHEM, V71, P7180, DOI 10.1021/jo060896b; Stockbridge RB, 2010, P NATL ACAD SCI USA, V107, P22102, DOI 10.1073/pnas.1013647107; Stockbridge RB, 2010, CHEM COMMUN, V46, P4306, DOI 10.1039/c0cc00229a; Stockbridge RB, 2009, J AM CHEM SOC, V131, P18248, DOI 10.1021/ja907967y; Stockbridge RB, 2009, J BIOL CHEM, V284, P22747, DOI 10.1074/jbc.M109.017806; Todd MJ, 2001, ANAL BIOCHEM, V296, P179, DOI 10.1006/abio.2001.5218; WESTHEIMER FH, 1957, J PHYS CHEM-US, V60, P1668, DOI 10.1021/j150546a024; Wilcox DE, 1996, CHEM REV, V96, P2435, DOI 10.1021/cr950043b; Wolfenden R, 2006, CHEM REV, V106, P3379, DOI 10.1021/cr050311y; Zea CJ, 2008, CHEM CENT J, V2, DOI 10.1186/1752-153X-2-15	48	28	29	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18538	18546		10.1074/jbc.M110.214510	http://dx.doi.org/10.1074/jbc.M110.214510			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21460215	Green Published, hybrid			2022-12-25	WOS:000290785700026
J	Meran, S; Luo, DD; Simpson, R; Martin, J; Wells, A; Steadman, R; Phillips, AO				Meran, Soma; Luo, Dong Dong; Simpson, Russell; Martin, John; Wells, Alan; Steadman, Robert; Phillips, Aled O.			Hyaluronan Facilitates Transforming Growth Factor-beta 1-dependent Proliferation via CD44 and Epidermal Growth Factor Receptor Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR-MATRIX REORGANIZATION; SMOOTH-MUSCLE-CELLS; TGF-BETA; EGF RECEPTOR; WOUND CONTRACTION; ORAL FIBROBLASTS; FIBROSIS; MIGRATION; ACTIVATION; PHENOTYPE	Fibroblast proliferation is an early feature of progressive tissue fibrosis and is largely regulated by the cytokine transforming growth factor-beta 1 (TGF-beta 1). In the oral mucosa, fibroblasts have a unique phenotype and demonstrate healing with no fibrosis/scarring. Our previous studies show that whereas dermal fibroblasts proliferate in response to TGF-beta 1, oral fibroblasts have an antiproliferative response to this cytokine. Hyaluronan (HA) was directly linked to this TGF-beta 1-dependent response. The aim of this study was to understand the underlying mechanism through which HA regulates TGF-beta-dependent responses. Using patient-matched oral and dermal fibroblasts, we show that TGF-beta 1-dependent proliferation is mediated through the HA receptor CD44, whereas the TGF-beta 1-mediated antiproliferative response is CD44-independent. Furthermore, overexpression of HAS2 (HA synthase-2) in oral cells modifies their response, and they subsequently demonstrate a proliferative, CD44-dependent response to TGF-beta 1. We also show that epidermal growth factor (EGF) and its receptor (EGFR) are essential for TGF-beta 1/HA/CD44-dependent proliferation. Increased HA levels promote EGFR and CD44 coupling, potentiating signal transduction through the MAPK/ERK pathway. Thus, in a HA-rich environment, late ERK1/2 activation results from EGFR/CD44 coupling and leads to a proliferative response to TGF-beta 1. In comparison, in a non-HA-rich environment, only early ERK1/2 activation occurs, and this is associated with an antiproliferative response to TGF-beta 1. In summary, HA facilitates TGF-beta 1-dependent fibroblast proliferation through promoting interaction between CD44 and EGFR, which then promotes specific MAPK/ERK activation, inducing cellular proliferation.	[Meran, Soma; Luo, Dong Dong; Simpson, Russell; Martin, John; Steadman, Robert; Phillips, Aled O.] Univ Wales Hosp, Inst Nephrol, Cardiff CF14 4XN, S Glam, Wales; [Wells, Alan] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15260 USA	Cardiff University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Meran, S (corresponding author), Univ Wales Hosp, Inst Nephrol, Heath Pk, Cardiff CF14 4XN, S Glam, Wales.	merans@cf.ac.uk	Steadman, Robert/O-1614-2016	Steadman, Robert/0000-0002-1303-2496; Wells, Alan/0000-0002-1637-8150				alKhateeb T, 1997, J PERIODONTOL, V68, P1063, DOI 10.1902/jop.1997.68.11.1063; ANSCHER MS, 1993, NEW ENGL J MED, V328, P1592, DOI 10.1056/NEJM199306033282203; ARMSTRONG JR, 1995, DEV BIOL, V169, P242, DOI 10.1006/dbio.1995.1141; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Beanes Steven R., 2003, Expert Reviews in Molecular Medicine, V5, P1, DOI 10.1017/S1462399403005817; Bedossa P, 2003, J PATHOL, V200, P504, DOI 10.1002/path.1397; BORDER WA, 1995, J CLIN INVEST, V96, P655, DOI 10.1172/JCI118107; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Border WA, 1997, KIDNEY INT, V51, P1388, DOI 10.1038/ki.1997.190; Bourguignon LYW, 2007, J BIOL CHEM, V282, P19426, DOI 10.1074/jbc.M610054200; Bourguignon LYW, 2006, J BIOL CHEM, V281, P14026, DOI 10.1074/jbc.M507734200; BRECHT M, 1986, BIOCHEM J, V239, P445, DOI 10.1042/bj2390445; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Chen PY, 2007, BIOCHEM BIOPH RES CO, V360, P1, DOI 10.1016/j.bbrc.2007.04.211; Chen WYJ, 1999, WOUND REPAIR REGEN, V7, P79, DOI 10.1046/j.1524-475X.1999.00079.x; Chipev Constantin C, 2002, BMC Dermatol, V2, P13, DOI 10.1186/1471-5945-2-13; CONNOR TB, 1989, J CLIN INVEST, V83, P1661, DOI 10.1172/JCI114065; Deng ZY, 2009, CHINESE MED J-PEKING, V122, P1449, DOI 10.3760/cma.j.issn.0366-6999.2009.12.018; Docherty NG, 2006, AM J PHYSIOL-RENAL, V290, pF1202, DOI 10.1152/ajprenal.00406.2005; Dong J, 2004, AM J PHYSIOL-RENAL, V287, pF1049, DOI 10.1152/ajprenal.00132.2004; EDDY AA, 1994, J AM SOC NEPHROL, V5, P1273; Ellis IR, 2007, EXP CELL RES, V313, P732, DOI 10.1016/j.yexcr.2006.11.016; Engel ME, 1999, J BIOL CHEM, V274, P37413, DOI 10.1074/jbc.274.52.37413; Evanko SP, 1999, ARTERIOSCL THROM VAS, V19, P1004, DOI 10.1161/01.ATV.19.4.1004; FRANCIS GS, 1995, AM J CARDIOL, V75, pA11, DOI 10.1016/S0002-9149(99)80378-6; Funaba M, 2008, J BIOCHEM BIOPH METH, V70, P816, DOI 10.1016/j.jbbm.2007.10.001; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; GRINNELL F, 1994, J CELL BIOL, V124, P401, DOI 10.1083/jcb.124.4.401; Hardie WD, 2008, AM J PHYSIOL-LUNG C, V294, pL1217, DOI 10.1152/ajplung.00020.2008; Itano N, 2002, P NATL ACAD SCI USA, V99, P3609, DOI 10.1073/pnas.052026799; Ito T, 2004, KIDNEY INT, V65, P823, DOI 10.1111/j.1523-1755.2004.00457.x; Javelaud D, 2005, ONCOGENE, V24, P5742, DOI 10.1038/sj.onc.1208928; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; Kim Y, 2008, J BIOL CHEM, V283, P22513, DOI 10.1074/jbc.M708319200; Knudson C. B., 2000, GLYCOFORUM; Krieg T, 1989, Recenti Prog Med, V80, P594; Legg JW, 2002, NAT CELL BIOL, V4, P399, DOI 10.1038/ncb797; Ma Frank Y, 2009, Front Biosci (Schol Ed), V1, P171, DOI 10.2741/s17; Meran S, 2008, J BIOL CHEM, V283, P6530, DOI 10.1074/jbc.M704819200; Meran S, 2007, J BIOL CHEM, V282, P25687, DOI 10.1074/jbc.M700773200; Palyi-Krekk Z, 2008, CANCER LETT, V263, P231, DOI 10.1016/j.canlet.2008.01.014; PANDIELLA A, 1989, ONCOGENE, V4, P1299; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Poumay Yves, 2009, Folia Med (Plovdiv), V51, P5; Samarakoon R, 2008, J MOL CELL CARDIOL, V44, P527, DOI 10.1016/j.yjmcc.2007.12.006; Simpson RML, 2010, AM J PATHOL, V176, P1215, DOI 10.2353/ajpath.2010.090802; Simpson RML, 2009, AM J PATHOL, V175, P1915, DOI 10.2353/ajpath.2009.090045; Spicer A. P., 1999, GLYCOFORUM; Spicer AP, 1998, J BIOL CHEM, V273, P1923, DOI 10.1074/jbc.273.4.1923; Stephens P, 1996, J DENT RES, V75, P1358, DOI 10.1177/00220345960750060601; Stephens P, 2001, BRIT J DERMATOL, V144, P229, DOI 10.1046/j.1365-2133.2001.04006.x; Terzi F, 2000, J CLIN INVEST, V106, P225, DOI 10.1172/JCI8315; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Turley EA, 1999, GLYCOFORUM; van den Bogaerdt AJ, 2002, ARCH DERMATOL RES, V294, P135, DOI 10.1007/s00403-002-0305-3; Webber J, 2009, J BIOL CHEM, V284, P9083, DOI 10.1074/jbc.M806989200; Zhang Y, 1998, NATURE, V394, P909, DOI 10.1038/29814; Zoltan-Jones A, 2003, J BIOL CHEM, V278, P45801, DOI 10.1074/jbc.M308168200	59	87	90	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17618	17630		10.1074/jbc.M111.226563	http://dx.doi.org/10.1074/jbc.M111.226563			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454519	hybrid, Green Published			2022-12-25	WOS:000290585200025
J	Xu, Y; Lee, M; Moeller, A; Song, S; Yoon, BY; Kim, HM; Jun, SY; Lee, K; Ha, NC				Xu, Yongbin; Lee, Minho; Moeller, Arne; Song, Saemee; Yoon, Bo-Young; Kim, Hong-Man; Jun, So-Young; Lee, Kangseok; Ha, Nam-Chul			Funnel-like Hexameric Assembly of the Periplasmic Adapter Protein in the Tripartite Multidrug Efflux Pump in Gram-negative Bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-FUSION PROTEINS; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; PSEUDOMONAS-AERUGINOSA; TRANSPORTER ACRB; TIP REGION; TOLC; COMPONENT; CHANNEL; CRYSTALLIZATION	Gram-negative bacteria expel diverse toxic chemicals through the tripartite efflux pumps spanning both the inner and outer membranes. The Escherichia coli AcrAB-TolC pump is the principal multidrug exporter that confers intrinsic drug tolerance to the bacteria. The inner membrane transporter AcrB requires the outer membrane factor TolC and the periplasmic adapter protein AcrA. However, it remains ambiguous how the three proteins are assembled. In this study, a hexameric model of the adapter protein was generated based on the propensity for trimerization of a dimeric unit, and this model was further validated by presenting its channel-forming property that determines the substrate specificity. Genetic, in vitro complementation, and electron microscopic studies provided evidence for the binding of the hexameric adapter protein to the outer membrane factor in an intermeshing cogwheel manner. Structural analyses suggested that the adapter covers the periplasmic region of the inner membrane transporter. Taken together, we propose an adapter bridging model for the assembly of the tripartite pump, where the adapter protein provides a bridging channel and induces the channel opening of the outer membrane factor in the intermeshing tip-to-tip manner.	[Lee, Minho; Song, Saemee; Kim, Hong-Man; Lee, Kangseok] Chung Ang Univ, Res Ctr Biomol & Biosyst, Dept Life Sci, Program BK21, Seoul 156756, South Korea; [Moeller, Arne] Scripps Res Inst, Natl Resource Automated Mol Microscopy, La Jolla, CA 92037 USA; [Xu, Yongbin; Yoon, Bo-Young; Jun, So-Young; Ha, Nam-Chul] Pusan Natl Univ, Res Inst Drug Dev, Pusan 609735, South Korea; [Xu, Yongbin; Yoon, Bo-Young; Jun, So-Young; Ha, Nam-Chul] Pusan Natl Univ, Coll Pharm, Dept Mfg Pharm, Pusan 609735, South Korea	Chung Ang University; Scripps Research Institute; Pusan National University; Pusan National University	Lee, K (corresponding author), Chung Ang Univ, Res Ctr Biomol & Biosyst, Dept Life Sci, Program BK21, Seoul 156756, South Korea.	kangseok@cau.ac.kr; hnc@pusan.ac.kr	Lee, Minho/AAK-4109-2021	Lee, Minho/0000-0002-8404-5702; Moeller, Arne/0000-0003-1101-5366	National Research Foundation [NRF-2010-0016052]; National Research Program of Korea [20100002201]; Joint Center for Innovation in Membrane Protein Production for Structure Determination [RFA-RM-08-019]; National Institutes of Health through the NCRR P41 [RR17573, P41]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR017573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM073197] Funding Source: NIH RePORTER	National Research Foundation; National Research Program of Korea; Joint Center for Innovation in Membrane Protein Production for Structure Determination; National Institutes of Health through the NCRR P41(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Research Foundation Grant NRF-2010-0016052 (to N.-C. H.) and Pioneer Research Center Program Grant 20100002201 from the National Research Program of Korea (to K. L.).; Recipient of Grant RFA-RM-08-019 from the Joint Center for Innovation in Membrane Protein Production for Structure Determination.; We thank Erica Jacovetty for assistance with EM data collection. EM imaging was performed at the National Resource for Automated Molecular Microscopy, which is supported by National Institutes of Health Grant RR17573 through the NCRR P41 program.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Akama H, 2004, J BIOL CHEM, V279, P25939, DOI 10.1074/jbc.C400164200; Avila-Sakar AJ, 2001, J STRUCT BIOL, V136, P81, DOI 10.1006/jsbi.2001.4418; Bavro VN, 2008, MOL CELL, V30, P114, DOI 10.1016/j.molcel.2008.02.015; De Angelis F, 2010, P NATL ACAD SCI USA, V107, P11038, DOI 10.1073/pnas.1003908107; Gerken H, 2004, MOL MICROBIOL, V54, P620, DOI 10.1111/j.1365-2958.2004.04301.x; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Gristwood T, 2008, MOL MICROBIOL, V69, P418, DOI 10.1111/j.1365-2958.2008.06291.x; Higgins MK, 2004, P NATL ACAD SCI USA, V101, P9994, DOI 10.1073/pnas.0400375101; Husain F, 2004, J BACTERIOL, V186, P8533, DOI 10.1128/JB.186.24.8533-8536.2004; Kim HM, 2010, J BACTERIOL, V192, P4498, DOI 10.1128/JB.00334-10; Koronakis V, 2004, ANNU REV BIOCHEM, V73, P467, DOI 10.1146/annurev.biochem.73.011303.074104; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Lewis K, 2000, CURR BIOL, V10, pR678, DOI 10.1016/S0960-9822(00)00682-5; Lobedanz S, 2007, P NATL ACAD SCI USA, V104, P4612, DOI 10.1073/pnas.0610160104; Mikolosko J, 2006, STRUCTURE, V14, P577, DOI 10.1016/j.str.2005.11.015; Mima T, 2007, J BACTERIOL, V189, P7600, DOI 10.1128/JB.00850-07; Misra R, 2009, BBA-PROTEINS PROTEOM, V1794, P817, DOI 10.1016/j.bbapap.2009.02.017; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Nikaido H, 1999, CURR OPIN INFECT DIS, V12, P529, DOI 10.1097/00001432-199912000-00001; Nikaido H, 2001, J MOL MICROB BIOTECH, V3, P215; Piao S, 2008, ACTA CRYSTALLOGR F, V64, P391, DOI 10.1107/S1744309108008701; Sennhauser G, 2009, J MOL BIOL, V389, P134, DOI 10.1016/j.jmb.2009.04.001; Su CC, 2009, J MOL BIOL, V393, P342, DOI 10.1016/j.jmb.2009.08.029; Symmons MF, 2009, P NATL ACAD SCI USA, V106, P7173, DOI 10.1073/pnas.0900693106; Takatsuka Y, 2009, J BACTERIOL, V191, P1729, DOI 10.1128/JB.01441-08; Tamura N, 2005, BIOCHEMISTRY-US, V44, P11115, DOI 10.1021/bi050452u; Thanabalu T, 1998, EMBO J, V17, P6487, DOI 10.1093/emboj/17.22.6487; Tikhonova EB, 2004, J BIOL CHEM, V279, P32116, DOI 10.1074/jbc.M402230200; Tikhonova EB, 2009, P NATL ACAD SCI USA, V106, P16416, DOI 10.1073/pnas.0906601106; Trepout S, 2010, BBA-BIOMEMBRANES, V1798, P1953, DOI 10.1016/j.bbamem.2010.06.019; Weeks JW, 2010, MOL MICROBIOL, V75, P1468, DOI 10.1111/j.1365-2958.2010.07068.x; Xu Y, 2011, J BIOL CHEM, V286, P13541, DOI 10.1074/jbc.M110.202598; Xu YB, 2010, BIOCHEM BIOPH RES CO, V394, P962, DOI 10.1016/j.bbrc.2010.03.097; Xu Y, 2009, BIOCHEMISTRY-US, V48, P5218, DOI 10.1021/bi900415t; Yum SW, 2009, J MOL BIOL, V387, P1286, DOI 10.1016/j.jmb.2009.02.048; Zgurskaya HI, 1999, P NATL ACAD SCI USA, V96, P7190, DOI 10.1073/pnas.96.13.7190	37	49	49	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17910	17920		10.1074/jbc.M111.238535	http://dx.doi.org/10.1074/jbc.M111.238535			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454662	hybrid, Green Published			2022-12-25	WOS:000290585200054
J	Doseth, B; Visnes, T; Wallenius, A; Ericsson, I; Sarno, A; Pettersen, HS; Flatberg, A; Catterall, T; Slupphaug, G; Krokan, HE; Kavli, B				Doseth, Berit; Visnes, Torkild; Wallenius, Anders; Ericsson, Ida; Sarno, Antonio; Pettersen, Henrik Sahlin; Flatberg, Arnar; Catterall, Tara; Slupphaug, Geir; Krokan, Hans E.; Kavli, Bodil			Uracil-DNA Glycosylase in Base Excision Repair and Adaptive Immunity SPECIES DIFFERENCES BETWEEN MAN AND MOUSE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS-SWITCH RECOMBINATION; UNG GENE; SOMATIC HYPERMUTATION; DEFICIENT MICE; CYTOTOXICITY; REPLICATION; CELLS; 5-FLUOROURACIL; RECOGNITION; SPECIFICITY	Genomic uracil is a DNA lesion but also an essential key intermediate in adaptive immunity. In B cells, activation-induced cytidine deaminase deaminates cytosine to uracil (U:G mispairs) in Ig genes to initiate antibody maturation. Uracil-DNA glycosylases (UDGs) such as uracil N-glycosylase (UNG), single strand-selective monofunctional uracil-DNA glycosylase 1 (SMUG1), and thymine-DNA glycosylase remove uracil from DNA. Gene-targeted mouse models are extensively used to investigate the role of these enzymes in DNA repair and Ig diversification. However, possible species differences in uracil processing in humans and mice are yet not established. To address this, we analyzed UDG activities and quantities in human and mouse cell lines and in splenic B cells from Ung(+/+) and Ung(-/-) backcrossed mice. Interestingly, human cells displayed similar to 15-fold higher total uracil excision capacity due to higher levels of UNG. In contrast, SMUG1 activity was similar to 8-fold higher in mouse cells, constituting similar to 50% of the total U:G excision activity compared with less than 1% in human cells. In activated B cells, both UNG and SMUG1 activities were at levels comparable with those measured for mouse cell lines. Moreover, SMUG1 activity per cell was not down-regulated after activation. We therefore suggest that SMUG1 may work as a weak backup activity for UNG2 during class switch recombination in Ung(-/-) mice. Our results reveal significant species differences in genomic uracil processing. These findings should be taken into account when mouse models are used in studies of uracil DNA repair and adaptive immunity.	[Doseth, Berit; Visnes, Torkild; Wallenius, Anders; Ericsson, Ida; Sarno, Antonio; Pettersen, Henrik Sahlin; Flatberg, Arnar; Catterall, Tara; Slupphaug, Geir; Krokan, Hans E.; Kavli, Bodil] Norwegian Univ Sci & Technol NTNU, Dept Canc Res & Mol Med, Fac Med, N-7491 Trondheim, Norway	Norwegian University of Science & Technology (NTNU)	Kavli, B (corresponding author), Norwegian Univ Sci & Technol NTNU, Dept Canc Res & Mol Med, Fac Med, POB 8905, N-7491 Trondheim, Norway.	bodil.kavli@ntnu.no	Pettersen, Henrik Sahlin/B-9901-2011; Visnes, Torkild/H-3242-2017; Slupphaug, Geir/AAN-3794-2020; kavli, bodil/ABC-8889-2020	Visnes, Torkild/0000-0003-1047-988X; Sarno, Antonio/0000-0002-9308-8018; Slupphaug, Geir/0000-0002-7498-3500; Pettersen, Henrik Sahlin/0000-0003-3219-0577	Research Council of Norway; Norwegian Cancer Association; St. Olavs's Hospital in Trondheim, Norway; Svanhild and Arne Must Fund for Medical Research	Research Council of Norway(Research Council of Norway); Norwegian Cancer Association; St. Olavs's Hospital in Trondheim, Norway; Svanhild and Arne Must Fund for Medical Research	This work was supported by The Research Council of Norway (National Program for Research in Functional Genomics); The Norwegian Cancer Association; the Cancer Fund at St. Olavs's Hospital in Trondheim, Norway; and The Svanhild and Arne Must Fund for Medical Research.	Akbari M, 2004, NUCLEIC ACIDS RES, V32, P5486, DOI 10.1093/nar/gkh872; An Q, 2007, CANCER RES, V67, P940, DOI 10.1158/0008-5472.CAN-06-2960; Andersen S, 2005, DNA REPAIR, V4, P1432, DOI 10.1016/j.dnarep.2005.08.004; Begum NA, 2004, SCIENCE, V305, P1160, DOI 10.1126/science.1098444; Begum NA, 2007, J BIOL CHEM, V282, P731, DOI 10.1074/jbc.M607439200; Cappelli E, 2001, CARCINOGENESIS, V22, P387, DOI 10.1093/carcin/22.3.387; Cseresnyes Z, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-88; Dhillon KK, 2010, DNA REPAIR, V9, P11, DOI 10.1016/j.dnarep.2009.09.013; Di Noia JM, 2007, J EXP MED, V204, P3209, DOI 10.1084/jem.20071768; GOWER JC, 1996, CHAPMANHALL CRC MONO, V54; Hagen L, 2008, EMBO J, V27, P51, DOI 10.1038/sj.emboj.7601958; Hardeland U, 2000, J BIOL CHEM, V275, P33449, DOI 10.1074/jbc.M005095200; Hardeland U, 2002, EMBO J, V21, P1456, DOI 10.1093/emboj/21.6.1456; Hardeland U, 2007, NUCLEIC ACIDS RES, V35, P3859, DOI 10.1093/nar/gkm337; Haug T, 1998, NUCLEIC ACIDS RES, V26, P1449, DOI 10.1093/nar/26.6.1449; Imai K, 2003, NAT IMMUNOL, V4, P1023, DOI 10.1038/ni974; Jolliffe, 2002, PRINCIPAL COMPONENT; Kavli B, 2005, J EXP MED, V201, P2011, DOI 10.1084/jem.20050042; Kavli B, 2002, J BIOL CHEM, V277, P39926, DOI 10.1074/jbc.M207107200; Krokan HE, 2001, PROG NUCLEIC ACID RE, V68, P365; Kunz C, 2009, PLOS BIOL, V7, P967, DOI 10.1371/journal.pbio.1000091; Kvaloy K, 2001, MUTAT RES-DNA REPAIR, V461, P325, DOI 10.1016/S0921-8777(00)00063-X; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; MOSBAUGH DW, 1994, PROG NUCLEIC ACID RE, V48, P315, DOI 10.1016/S0079-6603(08)60859-4; Nilsen H, 2000, NUCLEIC ACIDS RES, V28, P2277, DOI 10.1093/nar/28.12.2277; Nilsen H, 2000, MOL CELL, V5, P1059, DOI 10.1016/S1097-2765(00)80271-3; Nilsen H, 2003, ONCOGENE, V22, P5381, DOI 10.1038/sj.onc.1206860; NISSENMEYER J, 1987, CANCER RES, V47, P2251; Otterlei M, 1999, EMBO J, V18, P3834, DOI 10.1093/emboj/18.13.3834; Pettersen HS, 2007, NUCLEIC ACIDS RES, V35, P3879, DOI 10.1093/nar/gkm372; Rada C, 2004, MOL CELL, V16, P163, DOI 10.1016/j.molcel.2004.10.011; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; Scaramozzino N, 2003, NUCLEIC ACIDS RES, V31, P4950, DOI 10.1093/nar/gkg672; Shen HM, 2006, J IMMUNOL, V177, P5386, DOI 10.4049/jimmunol.177.8.5386; SLUPPHAUG G, 1995, BIOCHEMISTRY-US, V34, P128, DOI 10.1021/bi00001a016; Turner DP, 2006, CANCER RES, V66, P7686, DOI 10.1158/0008-5472.CAN-05-4488; Visnes T, 2008, DNA REPAIR, V7, P1869, DOI 10.1016/j.dnarep.2008.07.012	37	38	39	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16669	16680		10.1074/jbc.M111.230052	http://dx.doi.org/10.1074/jbc.M111.230052			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454529	Green Published, hybrid			2022-12-25	WOS:000290301900015
J	Kavuri, SM; Geserick, P; Berg, D; Dimitrova, DP; Feoktistova, M; Siegmund, D; Gollnick, H; Neumann, M; Wajant, H; Leverkus, M				Kavuri, Shyam M.; Geserick, Peter; Berg, Daniela; Dimitrova, Diana Panayotova; Feoktistova, Maria; Siegmund, Daniela; Gollnick, Harald; Neumann, Manfred; Wajant, Harald; Leverkus, Martin			Cellular FLICE-inhibitory Protein (cFLIP) Isoforms Block CD95-and TRAIL Death Receptor-induced Gene Induction Irrespective of Processing of Caspase-8 or cFLIP in the Death-inducing Signaling Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; INDUCED APOPTOSIS; FAMILY-MEMBERS; LONG FORM; TNF-ALPHA; ACTIVATION; CELLS; KERATINOCYTES; FAS	Death receptors (DRs) induce apoptosis but also stimulate proinflammatory "non-apoptotic" signaling (e. g. NF-kappa B and mitogen-activated protein kinase (MAPK) activation) and inhibit distinct steps of DR-activated maturation of procaspase-8. To examine whether isoforms of cellular FLIP (cFLIP) or its cleavage products differentially regulate DR signaling, we established HaCaT cells expressing cFLIP(S), cFLIP(L), or mutants of cFLIP(L) (cFLIP(D376N) and cFLIP(p43)). cFLIP variants blocked TRAIL- and CD95L-induced apoptosis, but the cleavage pattern of caspase-8 in the death inducing signaling complex was different: cFLIP(L) induced processing of caspase-8 to the p43/41 fragments irrespective of cFLIP cleavage. cFLIP(S) or cFLIP(p43) blocked procaspase-8 cleavage. Analyzing non-apoptotic signaling pathways, we found that TRAIL and CD95L activate JNK and p38 within 15 min. cFLIP variants and different caspase inhibitors blocked late death ligand-induced JNK or p38 MAPK activation suggesting that these responses are secondary to cell death. cFLIP isoforms/mutants also blocked death ligand-mediated gene induction of CXCL-8 (IL-8). Knockdown of caspase-8 fully suppressed apoptotic and non-apoptotic signaling. Knockdown of cFLIP isoforms in primary human keratinocytes enhanced CD95L- and TRAIL-induced NF-kappa B activation, and JNK and p38 activation, underscoring the regulatory role of cFLIP for these DR-mediated signals. Whereas the presence of caspase-8 is critical for apoptotic and non-apoptotic signaling, cFLIP isoforms are potent inhibitors of TRAIL- and CD95L-induced apoptosis, NF-kappa B activation, and the late JNK and p38 MAPK activation. cFLIP-mediated inhibition of CD95 and TRAIL DR could be of crucial importance during keratinocyte skin carcinogenesis and for the activation of innate and/or adaptive immune responses triggered by DR activation in the skin.	[Kavuri, Shyam M.; Geserick, Peter; Dimitrova, Diana Panayotova; Feoktistova, Maria; Leverkus, Martin] Heidelberg Univ, Dept Dermatol Venereol & Allergol, Sect Mol Dermatol, Med Fac Mannheim, D-68167 Mannheim, Germany; [Kavuri, Shyam M.; Geserick, Peter; Dimitrova, Diana Panayotova; Feoktistova, Maria; Gollnick, Harald; Leverkus, Martin] Otto VonGuericke Univ Magdegurg, Lab Expt Dermatol, Dept Dermatol & Venereol, D-39120 Magdeburg, Germany; [Berg, Daniela; Siegmund, Daniela; Wajant, Harald] Univ Wurzburg, Dept Mol Internal Med, Med Clin & Polyclin 2, D-97080 Wurzburg, Germany; [Neumann, Manfred] Univ Tubingen, Inst Pathol, Dept Mol Pathol, D-72076 Tubingen, Germany	Ruprecht Karls University Heidelberg; Otto von Guericke University; University of Wurzburg; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Leverkus, M (corresponding author), Heidelberg Univ, Dept Dermatol Venereol & Allergol, Sect Mol Dermatol, Med Fac Mannheim, Theodor Kutzer Ufer 1-3, D-68167 Mannheim, Germany.	martin.leverkus@medma.uni-heidelberg.de	Feoktistova, Maria/HHN-5423-2022; Wajant, Harald/A-3020-2017	Wajant, Harald/0000-0002-2005-3949	Deutsche Forschungsgemeinschaft [Le 953/5-1, Le 953/6-1]; Deutsche Forschungsgemeinschaft Graduiertenkolleg [1167]; Wilhelm-Sander-Stiftung [2008.072.1]; Deutsche Krebshilfe [106849]; Center of Excellence Dermatology Mannheim of Baden-Wurttemberg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft Graduiertenkolleg(German Research Foundation (DFG)); Wilhelm-Sander-Stiftung; Deutsche Krebshilfe(Deutsche Krebshilfe); Center of Excellence Dermatology Mannheim of Baden-Wurttemberg	This work was supported by Deutsche Forschungsgemeinschaft Grants Le 953/5-1 and Le 953/6-1, Deutsche Forschungsgemeinschaft Graduiertenkolleg 1167, Wilhelm-Sander-Stiftung Grant 2008.072.1, and Deutsche Krebshilfe Grant 106849 (to M. L.). S. M. K. and M. F. were supported by the "Center of Excellence Dermatology Mannheim of Baden-Wurttemberg."	Ashkenazi A, 2002, NAT REV CANCER, V2, P420, DOI 10.1038/nrc821; Azoitei N, 2005, J NEUROCHEM, V93, P1487, DOI 10.1111/j.1471-4159.2005.03148.x; Banno T, 2005, J BIOL CHEM, V280, P18973, DOI 10.1074/jbc.M411758200; Berg D, 2007, CELL DEATH DIFFER, V14, P2021, DOI 10.1038/sj.cdd.4402213; Boatright KM, 2004, BIOCHEM J, V382, P651, DOI 10.1042/BJ20040809; Bossen C, 2006, J BIOL CHEM, V281, P13964, DOI 10.1074/jbc.M601553200; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Budd RC, 2006, NAT REV IMMUNOL, V6, P196, DOI 10.1038/nri1787; Chang DW, 2003, EMBO J, V22, P4132, DOI 10.1093/emboj/cdg414; Choi C, 2001, CANCER RES, V61, P3084; Devin A, 2003, EMBO REP, V4, P623, DOI 10.1038/sj.embor.embor854; Diessenbacher P, 2008, J INVEST DERMATOL, V128, P1134, DOI 10.1038/sj.jid.5701141; Dohrman A, 2005, J IMMUNOL, V174, P5270, DOI 10.4049/jimmunol.174.9.5270; Duckett Colin S, 2005, Biochem J, V385, pe1; Ehrenschwender M, 2010, CELL DEATH DIFFER, V17, P1435, DOI 10.1038/cdd.2010.36; Falschlehner C, 2007, INT J BIOCHEM CELL B, V39, P1462, DOI 10.1016/j.biocel.2007.02.007; Farley SM, 2006, J INVEST DERMATOL, V126, P2438, DOI 10.1038/sj.jid.5700477; Fricker N, 2010, J CELL BIOL, V190, P377, DOI 10.1083/jcb.201002060; Geserick P, 2008, ONCOGENE, V27, P3211, DOI 10.1038/sj.onc.1210985; Geserick P, 2009, J CELL BIOL, V187, P1037, DOI 10.1083/jcb.200904158; Goebeler M, 2001, BLOOD, V97, P46, DOI 10.1182/blood.V97.1.46; Golks A, 2006, J EXP MED, V203, P1295, DOI 10.1084/jem.20051556; Haas TL, 2009, MOL CELL, V36, P831, DOI 10.1016/j.molcel.2009.10.013; Harper N, 2001, J BIOL CHEM, V276, P34743, DOI 10.1074/jbc.M105693200; Hughes MA, 2009, MOL CELL, V35, P265, DOI 10.1016/j.molcel.2009.06.012; Jin ZY, 2009, CELL, V137, P721, DOI 10.1016/j.cell.2009.03.015; Kataoka T, 2004, MOL CELL BIOL, V24, P2627, DOI 10.1128/MCB.24.7.2627-2636.2004; Kataoka T, 2000, CURR BIOL, V10, P640, DOI 10.1016/S0960-9822(00)00512-1; Kataoka T, 2005, CRIT REV IMMUNOL, V25, P31, DOI 10.1615/CritRevImmunol.v25.i1.30; Kerstan A, 2009, EXP DERMATOL, V18, P893, DOI 10.1111/j.1600-0625.2009.00919.x; Kim HS, 2005, CANCER RES, V65, P6111, DOI 10.1158/0008-5472.CAN-05-0472; Krammer PH, 2007, ADV CANCER RES, V97, P111, DOI 10.1016/S0065-230X(06)97005-5; Kreuz S, 2004, J CELL BIOL, V166, P369, DOI 10.1083/jcb.200401036; Krueger A, 2001, J BIOL CHEM, V276, P20633, DOI 10.1074/jbc.M101780200; Leverkus M, 2000, CANCER RES, V60, P553; Leverkus M, 2003, J INVEST DERMATOL, V121, P149, DOI 10.1046/j.1523-1747.2003.12332.x; Leverkus M, 2003, MOL CELL BIOL, V23, P777, DOI 10.1128/MCB.23.3.777-790.2003; Leverkus M, 2008, EXP DERMATOL, V17, P614, DOI 10.1111/j.1600-0625.2008.00728.x; Leverkus M, 2006, J INVEST DERMATOL, V126, P91, DOI 10.1038/sj.jid.5700012; Martinon F, 2000, FEBS LETT, V468, P134, DOI 10.1016/S0014-5793(00)01212-6; Matta H, 2003, J BIOL CHEM, V278, P52406, DOI 10.1074/jbc.M307308200; Micheau O, 2002, J BIOL CHEM, V277, P45162, DOI 10.1074/jbc.M206882200; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Mueller MM, 2001, AM J PATHOL, V159, P1567, DOI 10.1016/S0002-9440(10)62541-2; Neumann L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.6; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Oberst A, 2010, J BIOL CHEM, V285, P16632, DOI 10.1074/jbc.M109.095083; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Peter ME, 2007, CELL, V129, P447, DOI 10.1016/j.cell.2007.04.031; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Scaffidi C, 1999, J BIOL CHEM, V274, P1541, DOI 10.1074/jbc.274.3.1541; Schmidt M, 2000, J BIOL CHEM, V275, P41011, DOI 10.1074/jbc.M003716200; Schmidt M, 2010, J CELL MOL MED, V14, P1760, DOI 10.1111/j.1582-4934.2009.00823.x; Siegmund D, 2007, CELL SIGNAL, V19, P1172, DOI 10.1016/j.cellsig.2006.12.008; Silke J, 2005, P NATL ACAD SCI USA, V102, P16182, DOI 10.1073/pnas.0502828102; Sun QM, 2003, J BIOL CHEM, V278, P52437, DOI 10.1074/jbc.M304199200; Thome M, 2001, NAT REV IMMUNOL, V1, P50, DOI 10.1038/35095508; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Trauzold A, 2006, ONCOGENE, V25, P7434, DOI 10.1038/sj.onc.1209719; Varfolomeev E, 2005, J BIOL CHEM, V280, P40599, DOI 10.1074/jbc.M509560200; Wachter T, 2004, J BIOL CHEM, V279, P52824, DOI 10.1074/jbc.M409554200; Wicovsky A, 2007, J BIOL CHEM, V282, P2174, DOI 10.1074/jbc.M606167200; Wong WWL, 2010, CELL DEATH DIFFER, V17, P482, DOI 10.1038/cdd.2009.178; Wu YT, 2011, CELL DEATH DIFFER, V18, P26, DOI 10.1038/cdd.2010.72; Yu JW, 2008, ONCOGENE, V27, P6216, DOI 10.1038/onc.2008.299; Zhang LQ, 2009, J MOL BIOL, V389, P495, DOI 10.1016/j.jmb.2009.04.054	66	70	71	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16631	16646		10.1074/jbc.M110.148585	http://dx.doi.org/10.1074/jbc.M110.148585			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454681	Green Published, hybrid			2022-12-25	WOS:000290301900012
J	Dauletbaev, N; Eklove, D; Mawji, N; Iskandar, M; Di Marco, S; Gallouzi, IE; Lands, LC				Dauletbaev, Nurlan; Eklove, Daniel; Mawji, Nadir; Iskandar, Michele; Di Marco, Sergio; Gallouzi, Imed-Eddine; Lands, Larry C.			Down-regulation of Cytokine-induced Interleukin-8 Requires Inhibition of p38 Mitogen-activated Protein Kinase (MAPK) via MAPK Phosphatase 1-dependent and -independent Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRONCHIAL EPITHELIAL-CELLS; NF-KAPPA-B; TRANSMEMBRANE CONDUCTANCE REGULATOR; OBSTRUCTIVE PULMONARY-DISEASE; LOWER AIRWAY INFLAMMATION; INNATE IMMUNE-RESPONSES; HIGH-DOSE IBUPROFEN; CYSTIC-FIBROSIS; IL-8 PRODUCTION; LUNG-DISEASE	Down-regulation of overabundant interleukin (IL)-8 present in cystic fibrosis (CF) airways could ease excessive neutrophil burden and its deleterious consequences for the lung. IL-8 production in airway epithelial cells, stimulated with e. g. inflammatory cytokines IL-1 beta and tumor necrosis factor (TNF)-alpha, is regulated by several signaling pathways including nuclear factor (NF)-kappa B and p38 mitogen-activated protein kinase (MAPK). We previously demonstrated that the anti-inflammatory drugs dexamethasone and ibuprofen suppress NF-kappa B; however, only dexamethasone down-regulates cytokine-induced IL-8, highlighting the importance of non-NF-kappa B mechanisms. Here, we tested the hypothesis that down-regulation of cytokine-induced IL-8 requires modulation of the MAPK phosphatase (MKP)-1/p38 MAPK/mRNA stability pathway. The effects of dexamethasone (5 nM) and ibuprofen (480 mu M) on this pathway and IL-8 were studied in CF (CFTE29o-, CFBE41o-) and non-CF (1HAEo-) airway epithelial cells. We observed that dexamethasone, but not ibuprofen, destabilizes IL-8 mRNA and up-regulates MKP-1mRNA. Further, siRNA silencing of MKP-1, via p38 MAPK, leads to IL-8 overproduction and diminishes the anti-IL-8 potential of dexamethasone. However, MKP-1 overexpression does not significantly alter IL-8 production. By contrast, direct inhibition of p38 MAPK (inhibitor SB203580) efficiently suppresses IL-8 with potency comparable with dexamethasone. Similar to dexamethasone, SB203580 decreases IL-8mRNA stability. Dexamethasone does not affect p38 MAPK activation, which excludes its effects upstream of p38 MAPK. In conclusion, normal levels of MKP-1 are necessary for a full anti-IL-8 potential of pharmacological agents; however, efficient pharmacological down-regulation of cytokine-induced IL-8 also requires direct effects on p38 MAPK and mRNA stability independently of MKP-1.	[Dauletbaev, Nurlan; Eklove, Daniel; Mawji, Nadir; Iskandar, Michele; Lands, Larry C.] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ H3H 1P3, Canada; [Di Marco, Sergio; Gallouzi, Imed-Eddine] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Dauletbaev, Nurlan; Lands, Larry C.] McGill Univ, Ctr Hlth, Div Resp Med, Montreal Childrens Hosp, Montreal, PQ H3H 1P3, Canada	McGill University; McGill University; McGill University	Dauletbaev, N (corresponding author), McGill Univ, Ctr Hlth, Div Resp Med, Montreal Childrens Hosp, D-380,2300 Tupper St, Montreal, PQ H3H 1P3, Canada.	nurlan.dauletbaev@muhc.mcgill.ca; larry.lands@muhc.mcgill.ca	Iskandar, Michele M./U-6627-2019	Di Marco, Sergio/0000-0002-4039-0600	Canadian Cystic Fibrosis Foundation; BREATHE Initiative	Canadian Cystic Fibrosis Foundation; BREATHE Initiative	The work was supported by grants from the Canadian Cystic Fibrosis Foundation and its BREATHE Initiative.	Abraham SM, 2006, BIOCHEM SOC T, V34, P1018, DOI 10.1042/BST0341018; Aoki Y, 1998, AM J PHYSIOL-LUNG C, V274, pL1030, DOI 10.1152/ajplung.1998.274.6.L1030; Armstrong DS, 2005, PEDIATR PULM, V40, P500, DOI 10.1002/ppul.20294; Armstrong DS, 1997, AM J RESP CRIT CARE, V156, P1197, DOI 10.1164/ajrccm.156.4.96-11058; AUERBACH HS, 1985, LANCET, V2, P686; BALOUGH K, 1995, PEDIATR PULM, V20, P63, DOI 10.1002/ppul.1950200203; Banner KH, 2009, J CYST FIBROS, V8, P1, DOI 10.1016/j.jcf.2008.10.002; Barnes PJ, 2008, J CLIN INVEST, V118, P3546, DOI 10.1172/JCI36130; Barnes PJ, 2009, LANCET, V373, P1905, DOI 10.1016/S0140-6736(09)60326-3; Becker MN, 2004, AM J RESP CRIT CARE, V169, P645, DOI 10.1164/rccm.200207-765OC; Bhattacharyya S, 2011, J BIOL CHEM, V286, P11604, DOI 10.1074/jbc.M110.198390; Bhavsar P, 2008, THORAX, V63, P784, DOI 10.1136/thx.2007.090027; Bhavsar P, 2010, EUR RESPIR J, V35, P750, DOI 10.1183/09031936.00071309; BONFIELD TL, 1995, AM J RESP CRIT CARE, V152, P2111, DOI 10.1164/ajrccm.152.6.8520783; Chang MMJ, 2001, AM J PHYSIOL-LUNG C, V280, pL107, DOI 10.1152/ajplung.2001.280.1.L107; Chen PL, 2002, J IMMUNOL, V169, P6408, DOI 10.4049/jimmunol.169.11.6408; CHENG K, 2000, COCHRANE DB SYST REV; Chmiel JF, 2002, CLIN REV ALLERG IMMU, V23, P5, DOI 10.1385/CRIAI:23:1:005; Dauletbaev N, 2004, J Cyst Fibros, V3, P119, DOI 10.1016/j.jcf.2004.03.005; Dauletbaev N, 2010, RESPIRATION, V79, P234, DOI 10.1159/000255342; Dechecchi MC, 2007, AM J RESP CELL MOL, V36, P615, DOI 10.1165/rcmb.2006-0200OC; Di Marco S, 2005, MOL CELL BIOL, V25, P6533, DOI 10.1128/MCB.25.15.6533-6545.2005; Eickmeier O, 2010, CYTOKINE, V50, P152, DOI 10.1016/j.cyto.2010.02.004; EIGEN H, 1995, J PEDIATR-US, V126, P515, DOI 10.1016/S0022-3476(95)70343-8; Elizur A, 2008, CHEST, V133, P489, DOI 10.1378/chest.07-1631; Escotte S, 2003, EUR RESPIR J, V21, P574, DOI 10.1183/09031936.03.00031803; GREALLY P, 1994, ARCH DIS CHILD, V71, P35, DOI 10.1136/adc.71.1.35; Gruenert D C, 2004, J Cyst Fibros, V3 Suppl 2, P191, DOI 10.1016/j.jcf.2004.05.040; Hallows KR, 2006, J BIOL CHEM, V281, P4231, DOI 10.1074/jbc.M511029200; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Humlicek AL, 2007, J IMMUNOL, V178, P6395, DOI 10.4049/jimmunol.178.10.6395; Issa R, 2007, J IMMUNOL, V178, P7366, DOI 10.4049/jimmunol.178.11.7366; Jacquot J, 2008, EXPERT REV MOL DIAGN, V8, P359, DOI 10.1586/14737159.8.4.359; John G, 2010, AM J RESP CELL MOL, V42, P424, DOI 10.1165/rcmb.2008-0408OC; Kassel O, 2001, EMBO J, V20, P7108, DOI 10.1093/emboj/20.24.7108; KHAN TZ, 1995, AM J RESP CRIT CARE, V151, P1075; King EM, 2009, J BIOL CHEM, V284, P26803, DOI 10.1074/jbc.M109.028381; Kobayashi Y, 2008, FRONT BIOSCI-LANDMRK, V13, P2400, DOI 10.2741/2853; Konstan MW, 2008, CURR OPIN PULM MED, V14, P567, DOI 10.1097/MCP.0b013e32831311e8; Konstan MW, 2002, ADV DRUG DELIVER REV, V54, P1409, DOI 10.1016/S0169-409X(02)00146-1; KONSTAN MW, 1995, NEW ENGL J MED, V332, P848, DOI 10.1056/NEJM199503303321303; Kube D, 2001, AM J PHYSIOL-LUNG C, V280, pL493, DOI 10.1152/ajplung.2001.280.3.L493; Kumar S, 1999, BIOCHEM BIOPH RES CO, V263, P825, DOI 10.1006/bbrc.1999.1454; KUNZELMANN K, 1993, AM J RESP CELL MOL, V8, P522, DOI 10.1165/ajrcmb/8.5.522; KWON OJ, 1994, AM J PHYSIOL-LUNG C, V267, pL398, DOI 10.1152/ajplung.1994.267.4.L398; Lai HC, 2000, NEW ENGL J MED, V342, P851, DOI 10.1056/NEJM200003233421204; Lands LC, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001505.pub2; Lands LC, 2007, J PEDIATR-US, V151, P249, DOI 10.1016/j.jpeds.2007.04.009; Lands LC, 2010, PHARMACEUTICALS, V3, P2213, DOI 10.3390/ph3072213; Lasa M, 2002, MOL CELL BIOL, V22, P7802, DOI 10.1128/MCB.22.22.7802-7811.2002; Li LW, 2009, INT J CLIN EXP MED, V2, P48; Liu YS, 2007, NAT REV IMMUNOL, V7, P202, DOI 10.1038/nri2035; McGarvey L P A, 2002, J Cyst Fibros, V1, P269, DOI 10.1016/S1569-1993(02)00098-X; Muselet-Charlier C, 2007, BIOCHEM BIOPH RES CO, V357, P402, DOI 10.1016/j.bbrc.2007.03.141; Noah TL, 1997, J INFECT DIS, V175, P638, DOI 10.1093/infdis/175.3.638; Pan NY, 2006, RESP MED, V100, P1614, DOI 10.1016/j.rmed.2005.12.003; Park HS, 1999, ANN ALLERG ASTHMA IM, V82, P371, DOI 10.1016/S1081-1206(10)63286-3; Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234; Quante T, 2008, AM J RESP CELL MOL, V39, P208, DOI 10.1165/rcmb.2007-0014OC; Ratjen FA, 2009, RESP CARE, V54, P595, DOI 10.4187/aarc0427; RICHMANEISENSTAT JBY, 1993, AM J PHYSIOL, V264, pL413, DOI 10.1152/ajplung.1993.264.4.L413; Robert R, 2010, MOL PHARMACOL, V77, P922, DOI 10.1124/mol.109.062679; Roebuck KA, 1999, J INTERF CYTOK RES, V19, P429, DOI 10.1089/107999099313866; Roger T, 2005, EUR J IMMUNOL, V35, P3405, DOI 10.1002/eji.200535413; Rottner M, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-23; Sagel SD, 2001, AM J RESP CRIT CARE, V164, P1425, DOI 10.1164/ajrccm.164.8.2104075; Shannon J, 2008, CHEST, V133, P420, DOI 10.1378/chest.07-1881; Sloane AJ, 2005, AM J RESP CRIT CARE, V172, P1416, DOI 10.1164/rccm.200409-1215OC; Sly PD, 2009, AM J RESP CRIT CARE, V180, P146, DOI 10.1164/rccm.200901-0069OC; Smountas AA, 2004, CLIN BIOCHEM, V37, P1031, DOI 10.1016/j.clinbiochem.2004.07.008; Stecenko AA, 2001, INFLAMMATION, V25, P145, DOI 10.1023/A:1011080229374; Sutanto EN, 2011, AM J RESP CELL MOL, V44, P761, DOI 10.1165/rcmb.2010-0368OC; Sutherland ER, 2008, AM J RESP CRIT CARE, V178, P682, DOI 10.1164/rccm.200801-076OC; Sutherland ER, 2010, AM J RESP CRIT CARE, V181, P699, DOI 10.1164/rccm.200911-1710OC; Taggart C, 2000, AM J PHYSIOL-LUNG C, V278, pL33, DOI 10.1152/ajplung.2000.278.1.L33; Turpeinen T, 2010, J PHARMACOL EXP THER, V333, P310, DOI 10.1124/jpet.109.157438; van der Velden VHJ, 1998, EUR CYTOKINE NETW, V9, P269; Vij N, 2008, AM J RESP CELL MOL, V38, P176, DOI 10.1165/rcmb.2007-0197OC; Vij N, 2006, J BIOL CHEM, V281, P17369, DOI 10.1074/jbc.M600509200; Xu YQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011004	80	25	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.205724	http://dx.doi.org/10.1074/jbc.M110.205724			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454676	Green Published, hybrid			2022-12-25	WOS:000290022800040
J	Koralewski, TE; Krutovsky, KV				Koralewski, Tomasz E.; Krutovsky, Konstantin V.			Evolution of Exon-Intron Structure and Alternative Splicing	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; TRANSCRIPTIONAL INITIATION; GENE DUPLICATION; DIVERSITY; HISTORY; ORIGIN	Despite significant advances in high-throughput DNA sequencing, many important species remain understudied at the genome level. In this study we addressed a question of what can be predicted about the genome-wide characteristics of less studied species, based on the genomic data from completely sequenced species. Using NCBI databases we performed a comparative genome-wide analysis of such characteristics as alternative splicing, number of genes, gene products and exons in 36 completely sequenced model species. We created statistical regression models to fit these data and applied them to loblolly pine (Pinus taeda L.), an example of an important species whose genome has not been completely sequenced yet. Using these models, the genome-wide characteristics, such as total number of genes and exons, can be roughly predicted based on parameters estimated from available limited genomic data, e. g. exon length and exon/gene ratio.	[Koralewski, Tomasz E.; Krutovsky, Konstantin V.] Texas A&M Univ, Dept Ecosyst Sci & Management, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Koralewski, TE (corresponding author), Texas A&M Univ, Dept Ecosyst Sci & Management, College Stn, TX 77843 USA.	k-krutovsky@tamu.edu	Krutovsky, Konstantin V./A-5419-2012	Krutovsky, Konstantin V./0000-0002-8819-7084	United States Department of Agriculture (USDA) Cooperative State Research, Education, and Extension Service (CSREES); Texas Agricultural Experiment Station (TAES)	United States Department of Agriculture (USDA) Cooperative State Research, Education, and Extension Service (CSREES)(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Texas Agricultural Experiment Station (TAES)	This study was funded by the United States Department of Agriculture (USDA) Cooperative State Research, Education, and Extension Service (CSREES) and the Texas Agricultural Experiment Station (TAES) McIntire-Stennis Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adami C, 2000, P NATL ACAD SCI USA, V97, P4463, DOI 10.1073/pnas.97.9.4463; Ahuja MR, 2005, SILVAE GENET, V54, P59, DOI 10.1515/sg-2005-0010; Babenko VN, 2004, NUCLEIC ACIDS RES, V32, P3724, DOI 10.1093/nar/gkh686; Ben-Dov C, 2008, J BIOL CHEM, V283, P1229, DOI 10.1074/jbc.R700033200; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Black DL, 2000, CELL, V103, P367, DOI 10.1016/S0092-8674(00)00128-8; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Brett D, 2002, NAT GENET, V30, P29, DOI 10.1038/ng803; Campbell MA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-327; Chi KR, 2008, NAT METHODS, V5, P11, DOI 10.1038/NMETH1154; Cui LY, 2006, GENOME RES, V16, P738, DOI 10.1101/gr.4825606; Deutsch M, 1999, NUCLEIC ACIDS RES, V27, P3219, DOI 10.1093/nar/27.15.3219; Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4; Gray MW, 2009, IUBMB LIFE, V61, P1101, DOI 10.1002/iub.272; Gray MW, 2003, IUBMB LIFE, V55, P227, DOI 10.1080/1521654031000119425; Grotkopp E, 2004, EVOLUTION, V58, P1705, DOI 10.1111/j.0014-3820.2004.tb00456.x; Hughes AL, 2008, GENETICA, V134, P181, DOI 10.1007/s10709-007-9223-9; Iida K, 2004, NUCLEIC ACIDS RES, V32, P5096, DOI 10.1093/nar/gkh845; Kim E, 2007, NUCLEIC ACIDS RES, V35, P125, DOI 10.1093/nar/gkl924; Kondrashov FA, 2003, TRENDS GENET, V19, P115, DOI 10.1016/S0168-9525(02)00029-X; Kondrashov FA, 2001, HUM MOL GENET, V10, P2661, DOI 10.1093/hmg/10.23.2661; Kopelman NM, 2005, NAT GENET, V37, P588, DOI 10.1038/ng1575; Li JB, 2009, SCIENCE, V324, P1210, DOI 10.1126/science.1170995; Long MY, 1995, P NATL ACAD SCI USA, V92, P12495, DOI 10.1073/pnas.92.26.12495; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Mano S, 1999, PLANT J, V17, P309, DOI 10.1046/j.1365-313X.1999.00378.x; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; McGuire AM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r50; MCKEOWN M, 1992, ANNU REV CELL BIOL, V8, P133, DOI 10.1146/annurev.cb.08.110192.001025; Morse AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004332; Nagasaki H, 2005, GENE, V364, P53, DOI 10.1016/j.gene.2005.07.027; Nagasaki H, 2006, BIOINFORMATICS, V22, P1211, DOI 10.1093/bioinformatics/btl067; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Orphanides G, 2002, CELL, V108, P439, DOI 10.1016/S0092-8674(02)00655-4; Sammeth M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000147; Severing EI, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-154; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Su ZX, 2006, GENOME RES, V16, P182, DOI 10.1101/gr.4197006; *USDA, 2010, COMP GRANTS PROGR SB, V5, P10; Valentine JW, 2000, PALEOBIOLOGY, V26, P513, DOI 10.1666/0094-8373(2000)026<0513:TGPTTE>2.0.CO;2; von Bubnoff A, 2008, CELL, V132, P721, DOI 10.1016/j.cell.2008.02.028; Wang BB, 2006, P NATL ACAD SCI USA, V103, P7175, DOI 10.1073/pnas.0602039103; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884	43	56	59	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e18055	10.1371/journal.pone.0018055	http://dx.doi.org/10.1371/journal.pone.0018055			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464961	Green Published, gold			2022-12-25	WOS:000288813900031
J	Nijman, V; Shepherd, CR				Nijman, Vincent; Shepherd, Chris R.			The Role of Thailand in the International Trade in CITES-Listed Live Reptiles and Amphibians	PLOS ONE			English	Article							WILDLIFE; ASIA	Background: International wildlife trade is one of the leading threats to biodiversity conservation. The Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES) is the most important initiative to monitor and regulate the international trade of wildlife but its credibility is dependent on the quality of the trade data. We report on the performance of CITES reporting by focussing on the commercial trade in non-native reptiles and amphibians into Thailand as to illustrate trends, species composition and numbers of wild-caught vs. captive-bred specimens. Methodology/Principal Findings: Based on data in the WCMC-CITES trade database, we establish that a total of 75,594 individuals of 169 species of reptiles and amphibians (including 27 globally threatened species) were imported into Thailand in 1990-2007. The majority of individuals (59,895, 79%) were listed as captive-bred and a smaller number (15,699, 21%) as wild-caught. In the 1990s small numbers of individuals of a few species were imported into Thailand, but in 2003 both volumes and species diversity increased rapidly. The proportion of captive-bred animals differed greatly between years (from 0 to > 80%). Wild-caught individuals were mainly sourced from African countries, and captive-bred individuals from Asian countries (including from non-CITES Parties). There were significant discrepancies between exports and imports. Thailand reports the import of > 10,000 individuals (51 species) originating from Kazakhstan, but Kazakhstan reports no exports of these species. Similar discrepancies, involving smaller numbers (> 100 individuals of 9 species), can be seen in the import of reptiles into Thailand via Macao. Conclusion/Significance: While there has been an increase in imports of amphibian and reptiles into Thailand, erratic patterns in proportions of captive-bred specimens and volumes suggests either capricious markets or errors in reporting. Large discrepancies with respect to origin point to misreporting or possible violations of the rules and intentions of CITES.	[Nijman, Vincent; Shepherd, Chris R.] Oxford Brookes Univ, Oxford Wildlife Trade Res Grp, Sch Social Sci & Law, Oxford OX3 0BP, England; [Shepherd, Chris R.] TRAFFIC SE Asia, Petaling Jaya, Selangor, Malaysia	Oxford Brookes University	Nijman, V (corresponding author), Oxford Brookes Univ, Oxford Wildlife Trade Res Grp, Sch Social Sci & Law, Oxford OX3 0BP, England.	vnijman@brookes.ac.uk	Nijman, Vincent/AHD-8685-2022	Nijman, Vincent/0000-0002-5600-4276				[Anonymous], 2008, CITES SECR 23 M AN C; Auliya M., 2003, HOT TRADE COOL CREAT; Bell D, 2004, PHILOS T R SOC B, V359, P1107, DOI 10.1098/rstb.2004.1492; Bickford D, 2011, SCIENCE, V331, P857, DOI 10.1126/science.331.6019.857-c; Blundell AG, 2005, CONSERV BIOL, V19, P2020, DOI 10.1111/j.1523-1739.2005.00253.x; Bridges V. E., 2001, REPTILE AMPHIBIAN CO; Carpenter AI, 2004, BIOL CONSERV, V120, P291, DOI 10.1016/j.biocon.2004.03.002; Chen TH, 2009, CHELONIAN CONSERV BI, V8, P11, DOI 10.2744/CCB-0747.1; DODD C K JR, 1986, Herpetological Review, V17, P76; Franke J., 2001, REPTILES PETS EXAMIN; Gehring T, 2008, GLOBAL ENVIRON POLIT, V8, P123, DOI 10.1162/glep.2008.8.2.123; Gibbons JW, 2000, BIOSCIENCE, V50, P653, DOI 10.1641/0006-3568(2000)050[0653:TGDORD]2.0.CO;2; Gorzula Stefan, 1996, Herpetological Review, V27, P116; Highfield AC, 2009, CAPTIVE BRED ILLEGAL; Hoover C, 1998, US ROLE INT LIVE REP; Nijman V, 2009, ASIA BIODIV CONSERV, V19, P1101; Nijman V., 2009, WILDLIFE TRADE ASEAN; Nijman V, 2011, WILDLIFE TR IN PRESS; Nijman V, 2007, CONTRIB ZOOL, V76, P207, DOI 10.1163/18759866-07603007; Nijman V, 2010, BIODIVERS CONSERV, V19, P1963, DOI 10.1007/s10531-010-9814-0; Nooren H., 2001, WILDLIFE TRADE LAOS; Phelps J, 2010, SCIENCE, V330, P1752, DOI 10.1126/science.1195558; Schlaepfer MA, 2005, BIOSCIENCE, V55, P256, DOI 10.1641/0006-3568(2005)055[0256:CIETIO]2.0.CO;2; Shepherd C.R., 2008, ASSESSMENT TRADE FRE; Shepherd CR, 2008, BIODIVERS CONSERV, V17, P35, DOI 10.1007/s10531-007-9228-9; Smith KF, 2009, SCIENCE, V324, P594, DOI 10.1126/science.1174460; Smith MJ, 2011, BIOL CONSERV, V144, P82, DOI 10.1016/j.biocon.2010.10.018; Stuart BL, 2006, SCIENCE, V312, P1137, DOI 10.1126/science.312.5777.1137b; Styles D, 2009, ELEPHANT IVORY TRADE; Sutherland WJ, 2009, CONSERV BIOL, V23, P557, DOI 10.1111/j.1523-1739.2009.01212.x; Todd M., 2011, TRADE MADAGASCARS RE; Van Borm S, 2005, EMERG INFECT DIS, V11, P702, DOI 10.3201/eid1105.050211; van Dijk P. P., 2000, CHELONIAN RES MONOGR, V2; van Dijk PP, 2000, CHELON RES MONOGR, P137; Vinke T., 2010, SCHILDKROTEN IM FOKU, V7, P1; Weldon C, 2004, EMERG INFECT DIS, V10, P2100, DOI 10.3201/eid1012.030804; Zhang L, 2008, BIODIVERS CONSERV, V17, P1493, DOI 10.1007/s10531-008-9358-8; Zhou ZH, 2004, CONSERV BIOL, V18, P1386, DOI 10.1111/j.1523-1739.2004.00251.x	38	24	28	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e17825	10.1371/journal.pone.0017825	http://dx.doi.org/10.1371/journal.pone.0017825			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464976	Green Published, gold, Green Submitted			2022-12-25	WOS:000288813900012
J	Riscili, BP; Anderson, TB; Prescott, HC; Exline, MC; Sopirala, MM; Phillips, GS; Ali, NA				Riscili, Brent P.; Anderson, Tyler B.; Prescott, Hallie C.; Exline, Matthew C.; Sopirala, Madhuri M.; Phillips, Gary S.; Ali, Naeem A.			An Assessment of H1N1 Influenza-Associated Acute Respiratory Distress Syndrome Severity after Adjustment for Treatment Characteristics	PLOS ONE			English	Article							ACUTE LUNG INJURY; CRITICALLY-ILL PATIENTS; A(H1N1) INFECTION; UNITED-STATES; VIRUS; VENTILATION; STRATEGIES	Pandemic influenza caused significant increases in healthcare utilization across several continents including the use of high-intensity rescue therapies like extracorporeal membrane oxygenation (ECMO) or high-frequency oscillatory ventilation (HFOV). The severity of illness observed with pandemic influenza in 2009 strained healthcare resources. Because lung injury in ARDS can be influenced by daily management and multiple organ failure, we performed a retrospective cohort study to understand the severity of H1N1 associated ARDS after adjustment for treatment. Sixty subjects were identified in our hospital with ARDS from "direct injury" within 24 hours of ICU admission over a three month period. Twenty-three subjects (38.3%) were positive for H1N1 within 72 hours of hospitalization. These cases of H1N1-associated ARDS were compared to non-H1N1 associated ARDS patients. Subjects with H1N1-associated ARDS were younger and more likely to have a higher body mass index (BMI), present more rapidly and have worse oxygenation. Severity of illness (SOFA score) was directly related to worse oxygenation. Management was similar between the two groups on the day of admission and subsequent five days with respect to tidal volumes used, fluid balance and transfusion practices. There was, however, more frequent use of "rescue" therapy like prone ventilation, HFOV or ECMO in H1N1 patients. First morning set tidal volumes and BMI were significantly associated with increased severity of lung injury (Lung injury score, LIS) at presentation and over time while prior prescription of statins was protective. After assessment of the effect of these co-interventions LIS was significantly higher in H1N1 patients. Patients with pandemic influenza-associated ARDS had higher LIS both at presentation and over the course of the first six days of treatment when compared to non-H1N1 associated ARDS controls. The difference in LIS persisted over the duration of observation in patients with H1N1 possibly explaining the increased duration of mechanical ventilation.	[Riscili, Brent P.; Exline, Matthew C.; Ali, Naeem A.] Ohio State Univ, Med Ctr, Div Pulm Allergy Crit Care & Sleep Med, Columbus, OH 43210 USA; [Sopirala, Madhuri M.] Ohio State Univ, Med Ctr, Div Infect Dis, Columbus, OH 43210 USA; [Riscili, Brent P.; Anderson, Tyler B.; Prescott, Hallie C.; Exline, Matthew C.; Sopirala, Madhuri M.; Ali, Naeem A.] Ohio State Univ, Med Ctr, Dept Internal Med, Columbus, OH 43210 USA; [Phillips, Gary S.] Ohio State Univ, Med Ctr, Ctr Biostat, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Riscili, BP (corresponding author), Ohio State Univ, Med Ctr, Div Pulm Allergy Crit Care & Sleep Med, Columbus, OH 43210 USA.	naeem.ali@osumc.edu	Exline, Matthew/E-3047-2011	ALI, NORA'AINI/0000-0003-1391-2757; Prescott, Hallie/0000-0002-8442-6724	NIH [K23 RR019544, K23 HL095772]; NATIONAL CENTER FOR RESEARCH RESOURCES [K23RR019544, UL1RR025755] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL095772] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	K23 RR019544, NIH to NAA; K23 HL095772, NIH to MCE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral ACKB, 2005, INTENS CARE MED, V31, P243, DOI 10.1007/s00134-004-2528-6; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Davies A, 2009, JAMA-J AM MED ASSOC, V302, P1888, DOI 10.1001/jama.2009.1535; Dominguez-Cherit G, 2009, JAMA-J AM MED ASSOC, V302, P1880, DOI 10.1001/jama.2009.1536; Estenssoro E, 2010, AM J RESP CRIT CARE, V182, P41, DOI [10.1164/rccm.201001-0037OC, 10.1164/201001-0037OC]; Gajic O, 2007, AM J RESP CRIT CARE, V176, P886, DOI 10.1164/rccm.200702-271OC; Gill JR, 2010, ARCH PATHOL LAB MED, V134, P235, DOI 10.1043/1543-2165-134.2.235; Ginocchio CC, 2009, J CLIN MICROBIOL, V47, P2347, DOI 10.1128/JCM.01027-09; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; Lee N, 2007, CLIN INFECT DIS, V45, P723, DOI 10.1086/520981; Mauad T, 2010, AM J RESP CRIT CARE, V181, P72, DOI 10.1164/rccm.200909-1420OC; McCallister J, 2009, CLIN CHEST MED, V30, P495, DOI 10.1016/j.ccm.2009.05.008; Miller RR, 2010, CHEST, V137, P752, DOI 10.1378/chest.09-2517; Mitchell MD, 2010, CRIT CARE MED, V38, P1398, DOI 10.1097/CCM.0b013e3181de45db; O'Brien JM, 2004, ANN INTERN MED, V140, P338, DOI 10.7326/0003-4819-140-5-200403020-00009; Peek GJ, 2009, LANCET, V374, P1351, DOI 10.1016/S0140-6736(09)61069-2; Siston AM, 2010, JAMA-J AM MED ASSOC, V303, P1517, DOI 10.1001/jama.2010.479; Steinberg KP, 2006, NEW ENGL J MED, V354, P1671; Vincent Jean-Louis, 2006, Surg Infect (Larchmt), V7 Suppl 2, pS69; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481; Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564; Woo PCY, 2010, J INFECT DIS, V201, P346, DOI 10.1086/649785	24	15	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e18166	10.1371/journal.pone.0018166	http://dx.doi.org/10.1371/journal.pone.0018166			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464952	gold, Green Published, Green Submitted			2022-12-25	WOS:000288813900044
J	Smallwood, J; Brown, KS; Tipper, C; Giesbrecht, B; Franklin, MS; Mrazek, MD; Carlson, JM; Schooler, JW				Smallwood, Jonathan; Brown, Kevin S.; Tipper, Christine; Giesbrecht, Barry; Franklin, Michael S.; Mrazek, Michael D.; Carlson, Jean M.; Schooler, Jonathan W.			Pupillometric Evidence for the Decoupling of Attention from Perceptual Input during Offline Thought	PLOS ONE			English	Article							STIMULUS-INDEPENDENT THOUGHT; SUSTAINED ATTENTION; LOCUS-COERULEUS; DEFAULT NETWORK; EXECUTIVE-CONTROL; WANDERING MINDS; WORKING-MEMORY; BRAIN-FUNCTION; ADAPTIVE GAIN; TASK	Accumulating evidence suggests that the brain can efficiently process both external and internal information. The processing of internal information is a distinct "offline" cognitive mode that requires not only spontaneously generated mental activity; it has also been hypothesized to require a decoupling of attention from perception in order to separate competing streams of internal and external information. This process of decoupling is potentially adaptive because it could prevent unimportant external events from disrupting an internal train of thought. Here, we use measurements of pupil diameter (PD) to provide concrete evidence for the role of decoupling during spontaneous cognitive activity. First, during periods conducive to offline thought but not during periods of task focus, PD exhibited spontaneous activity decoupled from task events. Second, periods requiring external task focus were characterized by large task evoked changes in PD; in contrast, encoding failures were preceded by episodes of high spontaneous baseline PD activity. Finally, high spontaneous PD activity also occurred prior to only the slowest 20% of correct responses, suggesting high baseline PD indexes a distinct mode of cognitive functioning. Together, these data are consistent with the decoupling hypothesis, which suggests that the capacity for spontaneous cognitive activity depends upon minimizing disruptions from the external world.	[Smallwood, Jonathan] Max Planck Inst Human Cognit & Brain Sci, Dept Social Neurosci, Leipzig, Germany; [Brown, Kevin S.; Carlson, Jean M.] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; [Tipper, Christine; Giesbrecht, Barry; Franklin, Michael S.; Mrazek, Michael D.; Schooler, Jonathan W.] Univ Calif Santa Barbara, Dept Psychol, Santa Barbara, CA 93106 USA	Max Planck Society; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Smallwood, J (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Dept Social Neurosci, Leipzig, Germany.	smallwood@cbs.mpg.de	Schooler, Jonathan/AAZ-3977-2020; Schooler, Jonathan/ABE-6434-2020; Tipper, Christine/F-9409-2013; Smallwood, Jonathan/ABE-8365-2020	Tipper, Christine/0000-0003-1666-9203; Brown, Kevin/0000-0003-2959-2401; Smallwood, Jonathan/0000-0002-7298-2459	David and Lucile Packard Foundation; U. S. Army Research Office [W911NF-09-D-0001]; Bower Foundation	David and Lucile Packard Foundation(The David & Lucile Packard Foundation); U. S. Army Research Office; Bower Foundation	KSB and JMC thank the David and Lucile Packard Foundation and the Institute for Collaborative Biotechnologies through contract no. W911NF-09-D-0001 from the U. S. Army Research Office. JWS and MSF were supported by a grant from the Bower Foundation.	Aston-Jones G, 1999, BIOL PSYCHIAT, V46, P1309, DOI 10.1016/S0006-3223(99)00140-7; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; BEATTY J, 1982, PSYCHOL BULL, V91, P276, DOI 10.1037/0033-2909.91.2.276; Beatty J., 2000, HDB PSYCHOPHYSIOL, V2, P142; Carriere JSA, 2008, CONSCIOUS COGN, V17, P835, DOI 10.1016/j.concog.2007.04.008; Carriere JSA, 2010, PSYCHOL AGING, V25, P569, DOI 10.1037/a0019363; Christoff K, 2009, P NATL ACAD SCI USA, V106, P8719, DOI 10.1073/pnas.0900234106; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Dehaene S, 2005, PLOS BIOL, V3, P910, DOI 10.1371/journal.pbio.0030141; Dehaene S, 2001, COGNITION, V79, P1, DOI 10.1016/S0010-0277(00)00123-2; Einhauser W, 2008, P NATL ACAD SCI USA, V105, P1704, DOI 10.1073/pnas.0707727105; FernandezDuque D, 1997, NEUROPSYCHOLOGIA, V35, P477, DOI 10.1016/S0028-3932(96)00103-0; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Frith CD, 2006, NEURON, V50, P531, DOI 10.1016/j.neuron.2006.05.001; Gilzenrat MS, 2010, COGN AFFECT BEHAV NE, V10, P252, DOI 10.3758/CABN.10.2.252; Harrison NA, 2007, EMOTION, V7, P724, DOI 10.1037/1528-3542.7.4.724; Hupe JM, 2009, J VISION, V9, DOI 10.1167/9.7.10; Kam JWY, 2011, J COGNITIVE NEUROSCI, V23, P460, DOI 10.1162/jocn.2010.21443; Kane MJ, 2007, PSYCHOL SCI, V18, P614, DOI 10.1111/j.1467-9280.2007.01948.x; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Mcvay JC, 2010, PSYCHOL BULL, V136, P188, DOI 10.1037/a0018298; McVay JC, 2009, J EXP PSYCHOL LEARN, V35, P196, DOI 10.1037/a0014104; Nieuwenhuis S, 2005, PSYCHOL BULL, V131, P510, DOI 10.1037/0033-2909.131.4.510; Partala T, 2003, INT J HUM-COMPUT ST, V59, P185, DOI 10.1016/S1071-5819(03)00017-X; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Posner MI, 2007, ANNU REV PSYCHOL, V58, P1, DOI 10.1146/annurev.psych.58.110405.085516; Raichle ME, 2009, J NEUROSCI, V29, P12729, DOI 10.1523/JNEUROSCI.4366-09.2009; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Reichle ME, 2010, TRENDS COGN SCI, V14, P180, DOI 10.1016/j.tics.2010.01.008; Siegle GJ, 2003, NEUROIMAGE, V20, P114, DOI 10.1016/S1053-8119(03)00298-2; Singer J.L., 1966, DAYDREAMING INTRO EX; Smallwood J, 2006, CONSCIOUS COGN, V15, P218, DOI 10.1016/j.concog.2005.03.003; Smallwood J, 2004, CONSCIOUS COGN, V13, P657, DOI 10.1016/j.concog.2004.06.003; Smallwood J., 2006, IMAGINATION COGNITIO, V24, P355; Smallwood J, SELFREFLECT IN PRESS; Smallwood JM, 2003, CONSCIOUS COGN, V12, P452, DOI 10.1016/S1053-8100(03)00018-7; Smallwood J, 2008, J COGNITIVE NEUROSCI, V20, P458, DOI 10.1162/jocn.2008.20037; Smallwood J, 2007, COGNITION EMOTION, V21, P816, DOI 10.1080/02699930600911531; Smallwood J, 2007, PSYCHON B REV, V14, P527, DOI 10.3758/BF03194102; Smallwood J, 2006, PSYCHOL BULL, V132, P946, DOI 10.1037/0033-2909.132.6.946; Smallwood J, 2010, PSYCHOL BULL, V136, P202, DOI 10.1037/a0018673; Smallwood J, 2009, CONSCIOUS COGN, V18, P118, DOI 10.1016/j.concog.2008.11.004; Smallwood J, 2009, EMOTION, V9, P271, DOI 10.1037/a0014855; Smilek D, 2010, NEUROPSYCHOLOGIA, V48, P2564, DOI 10.1016/j.neuropsychologia.2010.05.002; Spreng RN, 2010, NEUROIMAGE, V53, P303, DOI 10.1016/j.neuroimage.2010.06.016; TEASDALE JD, 1995, MEM COGNITION, V23, P551, DOI 10.3758/BF03197257; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727	49	175	175	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e18298	10.1371/journal.pone.0018298	http://dx.doi.org/10.1371/journal.pone.0018298			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	740SE	21464969	Green Published, gold			2022-12-25	WOS:000288813900057
J	Wheatley, AK; Kramski, M; Alexander, MR; Toe, JG; Center, RJ; Purcell, DFJ				Wheatley, Adam K.; Kramski, Marit; Alexander, Marina R.; Toe, Jesse G.; Center, Rob J.; Purcell, Damian F. J.			Co-Expression of miRNA Targeting the Expression of PERK, but Not PKR, Enhances Cellular Immunity from an HIV-1 Env DNA Vaccine	PLOS ONE			English	Article							PROTEIN-KINASE PKR; ENDOPLASMIC-RETICULUM-STRESS; DOUBLE-STRANDED-RNA; INITIATION-FACTOR 2; CD4 T-CELLS; IMMUNODEFICIENCY-VIRUS; MAMMALIAN-CELLS; BINDING-PROTEIN; MEDIATED-IMMUNITY; ENVELOPE PROTEIN	Small non-coding micro-RNAs (miRNA) are important post-transcriptional regulators of mammalian gene expression that can be used to direct the knockdown of expression from targeted genes. We examined whether DNA vaccine vectors co-expressing miRNA with HIV-1 envelope (Env) antigens could influence the magnitude or quality of the immune responses to Env in mice. Human miR-155 and flanking regions from the non-protein encoding gene mirhg155 were introduced into an artificial intron within an expression vector for HIV-1 Env gp140. Using the miR-155-expressing intron as a scaffold, we developed novel vectors for miRNA-mediated targeting of the cellular antiviral proteins PKR and PERK, which significantly down-modulated target gene expression and led to increased Env expression in vitro. Finally, vaccinating BALB/c mice with a DNA vaccine vector delivering miRNA targeting PERK, but not PKR, was able to augment the generation of Env-specific T-cell immunity. This study provides proof-of-concept evidence that miRNA effectors incorporated into vaccine constructs can positively influence vaccine immunogenicity. Further testing of vaccine-encoded miRNA will determine if such strategies can enhance protective efficacy from vaccines against HIV-1 for eventual human use.	[Wheatley, Adam K.; Kramski, Marit; Alexander, Marina R.; Toe, Jesse G.; Center, Rob J.; Purcell, Damian F. J.] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia; [Toe, Jesse G.] Walter & Eliza Hall Inst Med Res, Div Infect & Immun, Melbourne, Vic 3050, Australia	University of Melbourne; Walter & Eliza Hall Institute	Wheatley, AK (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia.	dfjp@unimelb.edu.au	Alexander, Marina/AAK-9995-2021; Purcell, Damian F/G-5068-2011	Alexander, Marina/0000-0003-0745-7903; Wheatley, Adam/0000-0002-5593-9387	National Health and Medical Research Council of Australia [510488, 359233]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council of Australia grants 510488 and Career Development Award 359233 to RJC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander MR, 2010, NUCLEIC ACIDS RES, V38, P3041, DOI 10.1093/nar/gkp1224; Alexander M, 2010, J VIROL, V84, P4100, DOI 10.1128/JVI.02068-09; BEATTIE E, 1995, VIROLOGY, V210, P254, DOI 10.1006/viro.1995.1342; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Cai RR, 2000, ARCH BIOCHEM BIOPHYS, V373, P361, DOI 10.1006/abbi.1999.1583; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Center RJ, 2000, J VIROL, V74, P4448, DOI 10.1128/JVI.74.10.4448-4455.2000; Center RJ, 2009, VACCINE, V27, P6605, DOI 10.1016/j.vaccine.2009.08.016; Chan SW, 2005, FASEB J, V19, P1510, DOI 10.1096/fj.04-3455fje; Child SJ, 2004, J VIROL, V78, P197, DOI 10.1128/JVI.78.1.197-205.2004; CHONG KL, 1992, EMBO J, V11, P1553, DOI 10.1002/j.1460-2075.1992.tb05200.x; Christensen HS, 2007, J VIROL, V81, P5121, DOI 10.1128/JVI.01511-06; Chung KH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl143; Corr M, 1996, J EXP MED, V184, P1555, DOI 10.1084/jem.184.4.1555; Dale CJ, 2004, J VIROL, V78, P13819, DOI 10.1128/JVI.78.24.13819-13828.2004; de Vries W, 2008, GENE THER, V15, P545, DOI 10.1038/gt.2008.12; Droemann D, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-1; Du GW, 2006, FEBS J, V273, P5421, DOI 10.1111/j.1742-4658.2006.05534.x; EARL PL, 1991, J VIROL, V65, P2047, DOI 10.1128/JVI.65.4.2047-2055.1991; Fang ZY, 2001, VIROLOGY, V291, P272, DOI 10.1006/viro.2001.1209; Faraoni I, 2009, BBA-MOL BASIS DIS, V1792, P497, DOI 10.1016/j.bbadis.2009.02.013; GALABRU J, 1987, J BIOL CHEM, V262, P15538; Gil J, 2000, ONCOGENE, V19, P3665, DOI 10.1038/sj.onc.1203710; Gilfoy FD, 2007, J VIROL, V81, P11148, DOI 10.1128/JVI.00446-07; Hansmann L, 2008, CLIN IMMUNOL, V127, P252, DOI 10.1016/j.clim.2008.01.014; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; He B, 2006, CELL DEATH DIFFER, V13, P393, DOI 10.1038/sj.cdd.4401833; He B, 1997, P NATL ACAD SCI USA, V94, P843, DOI 10.1073/pnas.94.3.843; HERSHEY JWB, 1991, ANNU REV BIOCHEM, V60, P717, DOI 10.1146/annurev.bi.60.070191.003441; Hu T, 2009, INT J MOL SCI, V10, P2158, DOI 10.3390/ijms10052158; Itano AA, 2003, NAT IMMUNOL, V4, P733, DOI 10.1038/ni957; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Ito T, 1999, J BIOL CHEM, V274, P15427, DOI 10.1074/jbc.274.22.15427; Kataoka N, 2009, MOL CELL BIOL, V29, P3243, DOI 10.1128/MCB.00360-09; Kim KM, 2007, CIRC RES, V101, P919, DOI 10.1161/CIRCRESAHA.107.154781; Kim YK, 2007, EMBO J, V26, P775, DOI 10.1038/sj.emboj.7601512; KIT S, 1963, EXP CELL RES, V31, P297, DOI 10.1016/0014-4827(63)90007-7; Krug A, 2001, EUR J IMMUNOL, V31, P3026, DOI 10.1002/1521-4141(2001010)31:10<3026::AID-IMMU3026>3.0.CO;2-H; KRUST B, 1984, J BIOL CHEM, V259, P8494; KUMAR A, 1994, P NATL ACAD SCI USA, V91, P6288, DOI 10.1073/pnas.91.14.6288; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lee ES, 2007, FEBS LETT, V581, P4325, DOI 10.1016/j.febslet.2007.08.001; Lemaire PA, 2008, J MOL BIOL, V381, P351, DOI 10.1016/j.jmb.2008.05.056; Li SY, 2000, EUR J BIOCHEM, V267, P1598, DOI 10.1046/j.1432-1327.2000.01134.x; Lu W, 2009, J BIOL CHEM, V284, P24281, DOI 10.1074/jbc.M109.008821; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; Medigeshi GR, 2007, J VIROL, V81, P10849, DOI 10.1128/JVI.01151-07; Meurs EF, 1995, VIROLOGY, V214, P653, DOI 10.1006/viro.1995.0080; MONACO JJ, 1992, IMMUNOL RES, V11, P125, DOI 10.1007/BF02918617; Morris JA, 1997, J BIOL CHEM, V272, P4327, DOI 10.1074/jbc.272.7.4327; Muto NF, 1999, J VIROL, V73, P9021, DOI 10.1128/JVI.73.11.9021-9028.1999; Ong CL, 2005, J VIROL, V79, P12763, DOI 10.1128/JVI.79.20.12763-12772.2005; Otteken A, 1996, J VIROL, V70, P3407, DOI 10.1128/JVI.70.6.3407-3415.1996; PARK HS, 1994, P NATL ACAD SCI USA, V91, P4713, DOI 10.1073/pnas.91.11.4713; Patel RC, 1998, EMBO J, V17, P4379, DOI 10.1093/emboj/17.15.4379; Pavio N, 2003, J VIROL, V77, P3578, DOI 10.1128/JVI.77.6.3578-3585.2003; Su J, 2008, VIROLOGY, V375, P48, DOI 10.1016/j.virol.2008.01.011; Sudhakar A, 2000, BIOCHEMISTRY-US, V39, P12929, DOI 10.1021/bi0008682; TAKAHASHI H, 1988, P NATL ACAD SCI USA, V85, P3105, DOI 10.1073/pnas.85.9.3105; Urano F, 2000, J CELL SCI, V113, P3697; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang Y, 2000, J BIOL CHEM, V275, P27013; Wu SY, 1996, J BIOL CHEM, V271, P1756, DOI 10.1074/jbc.271.3.1756; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Zhang P, 2007, J VIROL, V81, P8192, DOI 10.1128/JVI.00426-07; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	66	10	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e18225	10.1371/journal.pone.0018225	http://dx.doi.org/10.1371/journal.pone.0018225			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464971	Green Published, gold			2022-12-25	WOS:000288813900052
J	Walker, TL; Turnbull, GW; Mackay, EW; Hannan, AJ; Bartlett, PF				Walker, Tara L.; Turnbull, Geoff W.; Mackay, Eirinn W.; Hannan, Anthony J.; Bartlett, Perry F.			The Latent Stem Cell Population Is Retained in the Hippocampus of Transgenic Huntington's Disease Mice but Not Wild-Type Mice	PLOS ONE			English	Article							MOUSE MODEL; ENVIRONMENTAL ENRICHMENT; PROGENITOR CELLS; DENTATE GYRUS; R6/2 MOUSE; NEUROGENESIS; DEFICITS; BRAIN; PROLIFERATION; PRECURSORS	The demonstration of the brain's ability to initiate repair in response to disease or injury has sparked considerable interest in therapeutic strategies to stimulate adult neurogenesis. In this study we examined the effect of a progressive neurodegenerative condition on neural precursor activity in the subventricular zone (SVZ) and hippocampus of the R6/1 transgenic mouse model of Huntington's disease (HD). Our results revealed an age-related decline in SVZ precursor numbers in both wild-type (WT) and HD mice. Interestingly, hippocampal precursor numbers declined with age in WT mice, although we observed maintenance in hippocampal precursor number in the HD animals in response to advancement of the disease. This maintenance was consistent with activation of a recently identified latent hippocampal precursor population. We found that the small latent stem cell population was also maintained in the HD hippocampus at 33 weeks, whereas it was not present in the WT. Our findings demonstrate that, despite a loss of neurogenesis in the HD hippocampus in vivo, there is a unique maintenance of the precursor and stem cells, which may potentially be activated to ameliorate disease symptoms.	[Walker, Tara L.; Turnbull, Geoff W.; Mackay, Eirinn W.; Bartlett, Perry F.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Hannan, Anthony J.] Univ Melbourne, Howard Florey Inst, Melbourne, Vic 3010, Australia	University of Queensland; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Walker, TL (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia.	p.bartlett@uq.edu.au	Bartlett, Perry/F-3813-2012; Walker, Tara/C-6242-2017	Walker, Tara/0000-0002-8472-0245; Hannan, Anthony/0000-0001-7532-8922; Mackay, Eirinn/0000-0003-1436-2259	National Health and Medical Research Council; Australian Research Council	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This study was funded by a National Health and Medical Research Council program grant (PFB). PFB is supported by an Australian Research Council Federation Fellowship. The authors would like to thank Frank and Patsy Youngleson for a private donation, which helped to fund this work. No commercial funding was received to fund this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batista CMC, 2006, J NEUROSCI, V26, P10452, DOI 10.1523/JNEUROSCI.2850-06.2006; Bull ND, 2005, J NEUROSCI, V25, P10815, DOI 10.1523/JNEUROSCI.3249-05.2005; Curtis MA, 2005, NEUROSCIENCE, V132, P777, DOI 10.1016/j.neuroscience.2004.12.051; Curtis MA, 2003, P NATL ACAD SCI USA, V100, P9023, DOI 10.1073/pnas.1532244100; Felling RJ, 2003, J NEUROSCI RES, V73, P277, DOI 10.1002/jnr.10670; Grote HE, 2005, EUR J NEUROSCI, V22, P2081, DOI 10.1111/j.1460-9568.2005.04365.x; Jhaveri DJ, 2010, J NEUROSCI, V30, P2795, DOI 10.1523/JNEUROSCI.3780-09.2010; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lazic SE, 2006, EUR J NEUROSCI, V23, P1829, DOI 10.1111/j.1460-9568.2006.04715.x; Lazic SE, 2004, NEUROREPORT, V15, P811, DOI 10.1097/00001756-200404090-00014; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Mazarakis NK, 2005, J NEUROSCI, V25, P3059, DOI 10.1523/JNEUROSCI.4320-04.2005; Pang TYC, 2006, NEUROSCIENCE, V141, P569, DOI 10.1016/j.neuroscience.2006.04.013; Phillips W, 2005, J NEUROSCI, V25, P11564, DOI 10.1523/JNEUROSCI.3796-05.2005; Seki T, 1995, NEUROREPORT, V6, P2479, DOI 10.1097/00001756-199512150-00010; Spires TL, 2004, J NEUROSCI, V24, P2270, DOI 10.1523/JNEUROSCI.1658-03.2004; Tattersfield AS, 2004, NEUROSCIENCE, V127, P319, DOI 10.1016/j.neuroscience.2004.04.061; Turmaine M, 2000, P NATL ACAD SCI USA, V97, P8093, DOI 10.1073/pnas.110078997; van Dellen A, 2000, NATURE, V404, P721, DOI 10.1038/35008142; Walker TL, 2008, J NEUROSCI, V28, P5240, DOI 10.1523/JNEUROSCI.0344-08.2008; Walker TL, 2007, J NEUROSCI, V27, P3734, DOI 10.1523/JNEUROSCI.5060-06.2007	21	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2011	6	3							e18153	10.1371/journal.pone.0018153	http://dx.doi.org/10.1371/journal.pone.0018153			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740RG	21455316	Green Published, gold			2022-12-25	WOS:000288811500026
J	Yu, HY; Peng, ZX; Zhan, YH; Wang, J; Yan, YL; Chen, M; Lu, W; Ping, SZ; Zhang, W; Zhao, ZL; Li, SY; Takeo, M; Lin, M				Yu, Haiying; Peng, Zixin; Zhan, Yuhua; Wang, Jin; Yan, Yongliang; Chen, Ming; Lu, Wei; Ping, Shuzhen; Zhang, Wei; Zhao, Zhonglin; Li, Shuying; Takeo, Masahiro; Lin, Min			Novel Regulator MphX Represses Activation of Phenol Hydroxylase Genes Caused by a XylR/DmpR-Type Regulator MphR in Acinetobacter calcoaceticus	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; COMAMONAS-TESTOSTERONI R5; CARBON CATABOLITE REPRESSION; INTEGRATION HOST FACTOR; PSEUDOMONAS-PUTIDA; ALCOHOL-DEHYDROGENASE; METABOLIZING ENZYMES; DEGRADING BACTERIA; AROMATIC-COMPOUNDS; ESCHERICHIA-COLI	Acinetobacter calcoaceticus PHEA-2 utilizes phenol as its sole carbon and energy source and has a multi-component phenol hydroxylase-encoding gene operon (mphKLMNOP) for phenol degradation. Two additional genes, mphR and mphX, were found upstream and downstream of mphKLMNOP, respectively. The mphR gene encodes a XylR/DmpR-type regulator-like protein and is transcribed in the opposite direction to mphKLMNOP. The mphX gene is transcribed in the same direction as mphKLMNOP and encodes a protein with 293 amino acid residues showing weak identity with some unknown proteins encoded in the meta-cleavage pathway gene clusters for aromatic compound degradation. Disruption of mphR by homologous recombination resulted in the loss of phenol degradation while disruption of mphX caused significantly faster phenol degradation than in the wild type strain. Transcriptional assays for mphK, mphR, and mphX revealed that mphR activated mphKLMNOP transcription in the presence of phenol, but mphX partially repressed this activation. Gel mobility-shift assay demonstrated a direct interaction of MphR with the mphK promoter region. These results indicate the involvement of a novel repressor protein MphX in transcriptional regulation of phenol hydroxylase genes caused by a XylR/DmpR-type regulator MphR.	[Peng, Zixin; Takeo, Masahiro] Univ Hyogo, Grad Sch Engn, Dept Mat Sci & Chem, Himeji, Hyogo, Japan; [Yu, Haiying; Lin, Min] China Agr Univ, Coll Biol Sci, Beijing 100094, Peoples R China; [Yu, Haiying; Peng, Zixin; Zhan, Yuhua; Wang, Jin; Yan, Yongliang; Chen, Ming; Lu, Wei; Ping, Shuzhen; Zhang, Wei; Zhao, Zhonglin; Li, Shuying; Lin, Min] Chinese Acad Agr Sci, Minist Agr, Biotechnol Res Inst, Key Lab Crop Biotechnol, Beijing, Peoples R China; [Yan, Yongliang; Zhang, Wei] Natl Ctr Plant Gene Res, Beijing, Peoples R China	University of Hyogo; China Agricultural University; Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Sciences	Yu, HY (corresponding author), China Agr Univ, Coll Biol Sci, Beijing 100094, Peoples R China.	takeo@eng.u-hyogo.ac.jp; linmin57@vip.163.com	Takeo, Masahiro/GYA-3639-2022; min, lin/AAJ-7325-2020; li, shuying/GLR-8636-2022	yan, yongliang/0000-0002-4297-6648	National Natural Science Foundation of China [30925002, 30800022]; National Basic Research (973) Program of China [2007CB707805, 2010CB126504]; National High-Tech (863) Program of China [2007AA021304, 2010AA10A203]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research (973) Program of China(National Basic Research Program of China); National High-Tech (863) Program of China(National High Technology Research and Development Program of China)	This work was supported by grants from the National Natural Science Foundation of China (No. 30925002 and 30800022), the National Basic Research (973) Program of China (No. 2007CB707805 and 2010CB126504) and the National High-Tech (863) Program of China (No. 2007AA021304 and 2010AA10A203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai H, 1999, MOL MICROBIOL, V33, P1132, DOI 10.1046/j.1365-2958.1999.01554.x; Arai H, 2000, MICROBIOL-UK, V146, P1707, DOI 10.1099/00221287-146-7-1707; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Butler JE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-180; Cases I, 2005, NAT REV MICROBIOL, V3, P105, DOI 10.1038/nrmicro1084; Cheng Q, 2000, J BACTERIOL, V182, P4744, DOI 10.1128/JB.182.17.4744-4751.2000; Dago AE, 2007, J BIOL CHEM, V282, P1087, DOI 10.1074/jbc.M608715200; Diaz E, 2000, CURR OPIN BIOTECH, V11, P467, DOI 10.1016/S0958-1669(00)00126-9; DITTA G, 1985, PLASMID, V13, P149, DOI 10.1016/0147-619X(85)90068-X; Duffner FM, 2000, GENE, V256, P215, DOI 10.1016/S0378-1119(00)00352-8; EHRT S, 1995, MOL MICROBIOL, V18, P13, DOI 10.1111/j.1365-2958.1995.mmi_18010013.x; FOLSOM BR, 1990, APPL ENVIRON MICROB, V56, P1279, DOI 10.1128/AEM.56.5.1279-1285.1990; Fukumori F, 2001, J GEN APPL MICROBIOL, V47, P329, DOI 10.2323/jgam.47.329; Garmendia J, 2000, MOL MICROBIOL, V38, P401, DOI 10.1046/j.1365-2958.2000.02139.x; HALES LM, 1994, J BACTERIOL, V176, P2999, DOI 10.1128/JB.176.10.2999-3006.1994; Heinaru E, 2000, FEMS MICROBIOL ECOL, V31, P195, DOI 10.1111/j.1574-6941.2000.tb00684.x; James KD, 2000, J BACTERIOL, V182, P3136, DOI 10.1128/JB.182.11.3136-3141.2000; KALIN M, 1992, J BACTERIOL, V174, P7112; KUKOR JJ, 1992, J BACTERIOL, V174, P6518, DOI 10.1128/JB.174.20.6518-6526.1992; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Laurie AD, 2003, J BIOL CHEM, V278, P1494, DOI 10.1074/jbc.M209268200; Li DH, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-36; Liang O, 2005, MICROBIOL-SGM, V151, P3435, DOI 10.1099/mic.0.28137-0; MORETT E, 1993, J BACTERIOL, V175, P6067, DOI 10.1128/JB.175.19.6067-6074.1993; Muller C, 1996, J BACTERIOL, V178, P2030; Ng LC, 1996, J BIOL CHEM, V271, P17281, DOI 10.1074/jbc.271.29.17281; NG LC, 1995, J BACTERIOL, V177, P1485, DOI 10.1128/jb.177.6.1485-1490.1995; NORDLUND I, 1990, J BACTERIOL, V172, P6826, DOI 10.1128/jb.172.12.6826-6833.1990; O'Neill E, 2001, EMBO J, V20, P819, DOI 10.1093/emboj/20.4.819; Omokoko B, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-197; Park SM, 2003, J BIOTECHNOL, V103, P227, DOI 10.1016/S0168-1656(03)00122-6; Peng ZX, 2010, BIOTECHNOL LETT, V32, P1265, DOI 10.1007/s10529-010-0317-6; Petruschka L, 2001, MOL GENET GENOMICS, V266, P199, DOI 10.1007/s004380100539; Powlowski Justin, 1994, Biodegradation, V5, P219, DOI 10.1007/BF00696461; Ramos JL, 1997, ANNU REV MICROBIOL, V51, P341, DOI 10.1146/annurev.micro.51.1.341; Rappas M, 2007, CURR OPIN STRUC BIOL, V17, P110, DOI 10.1016/j.sbi.2006.11.002; Sandhu A, 2009, MICROB ECOL, V57, P276, DOI 10.1007/s00248-008-9473-9; Sarand I, 2001, APPL ENVIRON MICROB, V67, P162, DOI 10.1128/AEM.67.1.162-171.2001; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Schirmer F, 1998, MOL GEN GENET, V257, P330, DOI 10.1007/s004380050654; Schirmer F, 1997, J BACTERIOL, V179, P1329, DOI 10.1128/jb.179.4.1329-1336.1997; Shingler V, 2003, ENVIRON MICROBIOL, V5, P1226, DOI 10.1111/j.1462-2920.2003.00472.x; SHINGLER V, 1993, J BACTERIOL, V175, P1596, DOI 10.1128/JB.175.6.1596-1604.1993; Sze CC, 2001, J BACTERIOL, V183, P2842, DOI 10.1128/JB.183.9.2842-2851.2001; Takahashi Y, 2009, APPL ENVIRON MICROB, V75, P3920, DOI 10.1128/AEM.02373-08; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Teramoto M, 1999, MOL GEN GENET, V262, P552, DOI 10.1007/s004380051117; Teramoto M, 2002, J BACTERIOL, V184, P3941, DOI 10.1128/JB.184.14.3941-3946.2002; Teramoto M, 2001, J BACTERIOL, V183, P4227, DOI 10.1128/JB.183.14.4227-4234.2001; Toyama H, 2003, BIOSCI BIOTECH BIOCH, V67, P1397, DOI 10.1271/bbb.67.1397; Tropel D, 2004, MICROBIOL MOL BIOL R, V68, P474, DOI 10.1128/MMBR.68.3.474-500.2004; Wigneshweplaraj SR, 2005, PROG NUCLEIC ACID RE, V79, P339, DOI 10.1016/S0079-6603(04)79007-8; Xu YQ, 2003, CURR MICROBIOL, V46, P235, DOI 10.1007/s00284-002-3840-4; Zhan YH, 2009, CURR MICROBIOL, V59, P368, DOI 10.1007/s00284-009-9446-3; Zhan YH, 2008, CURR MICROBIOL, V57, P609, DOI 10.1007/s00284-008-9251-4	55	17	19	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2011	6	3							e17350	10.1371/journal.pone.0017350	http://dx.doi.org/10.1371/journal.pone.0017350			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740RG	21455294	Green Submitted, gold, Green Published			2022-12-25	WOS:000288811500003
J	Porcher, C; Hatchett, C; Longbottom, RE; McAinch, K; Sihra, TS; Moss, SJ; Thomson, AM; Jovanovic, JN				Porcher, Christophe; Hatchett, Caroline; Longbottom, Rebecca E.; McAinch, Kristina; Sihra, Talvinder S.; Moss, Stephen J.; Thomson, Alex M.; Jovanovic, Jasmina N.			Positive Feedback Regulation between gamma-Aminobutyric Acid Type A (GABA(A)) Receptor Signaling and Brain-derived Neurotrophic Factor (BDNF) Release in Developing Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE TRAFFICKING; INHIBITORY SYNAPSES; HIPPOCAMPAL-NEURONS; GABAERGIC SYNAPSES; CORTICAL-NEURONS; FACTOR PROMOTES; AMPA RECEPTORS; BETA 3; MATURATION; CELLS	During the early development of the nervous system, gamma-aminobutyric acid (GABA) type A receptor (GABA(A)R)-mediated signaling parallels the neurotrophin/tropomyosin-related kinase (Trk)-dependent signaling in controlling a number of processes from cell proliferation and migration, via dendritic and axonal outgrowth, to synapse formation and plasticity. Here we present the first evidence that these two signaling systems regulate each other through a complex positive feedback mechanism. We first demonstrate that GABA(A)R activation leads to an increase in the cell surface expression of these receptors in cultured embryonic cerebrocortical neurons, specifically at the stage when this activity causes depolarization of the plasma membrane and Ca2+ influx through L-type voltage-gated Ca2+ channels. We further demonstrate that GABA(A)R activity triggers release of the brain-derived neurotrophic factor (BDNF), which, in turn by activating TrkB receptors, mediates the observed increase in cell surface expression of GABA(A)Rs. This BDNF/TrkB-dependent increase in surface levels of GABA(A)Rs requires the activity of phosphoinositide 3-kinase (PI3K) and protein kinase C (PKC) and does not involve the extracellular signal-regulated kinase (ERK) 1/2 activity. The increase in GABA(A)R surface levels occurs due to an inhibition of the receptor endocytosis by BDNF, whereas the receptor reinsertion into the plasma membrane remains unaltered. Thus, GABA(A)R activity is a potent regulator of the BDNF release during neuronal development, and at the same time, it is strongly enhanced by the activity of the BDNF/TrkB/PI3K/PKC signaling pathway.	[Hatchett, Caroline; Thomson, Alex M.; Jovanovic, Jasmina N.] Univ London, Sch Pharm, Dept Pharmacol, London WC1N 1AX, England; [Porcher, Christophe] INSERM, Inst Neurobiol Mediterranee, U901, F-13273 Marseille 09, France; [Porcher, Christophe] Univ Mediterranee, F-13273 Marseille 09, France; [Longbottom, Rebecca E.; McAinch, Kristina; Sihra, Talvinder S.; Moss, Stephen J.] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England; [Moss, Stephen J.] Tufts Univ, Dept Neurosci, Boston, MA 02111 USA	University of London; University College London; University of London School of Pharmacy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; University of London; University College London; Tufts University	Jovanovic, JN (corresponding author), Univ London, Sch Pharm, Dept Pharmacol, 29-39 Brunswick Sq, London WC1N 1AX, England.	jasmina.jovanovic@pharmacy.ac.uk	Sihra, Talvinder S/A-4581-2009; Porcher, Christophe/C-3758-2009	Porcher, Christophe/0000-0002-6026-6367	Biotechnology and Biological Sciences Research Council UK [BB/C507237/1]; Medical Research Council [G0800498]; INSERM and Agence Nationale pour la Recherche; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS081986, R01NS051195, R21NS080064] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/C507237/1] Funding Source: researchfish; Medical Research Council [G0401248] Funding Source: researchfish; MRC [G0401248, G0800498] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); INSERM and Agence Nationale pour la Recherche(French National Research Agency (ANR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Biotechnology and Biological Sciences Research Council UK New Investigator Grant BB/C507237/1 (to J. N. J.), Medical Research Council Grant G0800498 (to J. N. J. and A. M. T.), and INSERM and Agence Nationale pour la Recherche (to C. P.).	Aguado F, 2003, DEVELOPMENT, V130, P1267, DOI 10.1242/dev.00351; Arancibia-Carcamo IL, 2009, PHARMACOL THERAPEUT, V123, P17, DOI 10.1016/j.pharmthera.2009.03.012; Balslev Y, 1996, ACTA ANAT, V156, P2; Bao SW, 1999, LEARN MEMORY, V6, P276; Barker JL, 1998, PERSPECT DEV NEUROBI, V5, P305; Behar TN, 1996, J NEUROSCI, V16, P1808; Belhage B, 1998, PERSPECT DEV NEUROBI, V5, P235; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Ben-Ari Y, 2007, PHYSIOL REV, V87, P1215, DOI 10.1152/physrev.00017.2006; BERNINGER B, 1995, DEVELOPMENT, V121, P2327; BOURGEOIS JP, 1993, J NEUROSCI, V13, P2801; Boxall AR, 2000, J PHYSIOL-LONDON, V524, P677, DOI 10.1111/j.1469-7793.2000.00677.x; Brunig I, 2001, EUR J NEUROSCI, V13, P1320, DOI 10.1046/j.0953-816x.2001.01506.x; Cancedda L, 2007, J NEUROSCI, V27, P5224, DOI 10.1523/JNEUROSCI.5169-06.2007; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Chao MV, 2006, CLIN SCI, V110, P167, DOI 10.1042/CS20050163; Chapleau CA, 2009, J NEURODEV DISORD, V1, P185, DOI 10.1007/s11689-009-9027-6; Cheng Q, 2003, J PHYSIOL-LONDON, V548, P711, DOI 10.1113/jphysiol.2002.037846; CHERUBINI E, 1990, INT J DEV NEUROSCI, V8, P481, DOI 10.1016/0736-5748(90)90080-L; Cohen-Cory S, 2010, DEV NEUROBIOL, V70, P271, DOI 10.1002/dneu.20774; Conover JC, 1997, REV NEUROSCIENCE, V8, P13; Cunha C, 2010, FRONT MOL NEUROSCI, V3, DOI 10.3389/neuro.02.001.2010; Davies P, 1998, PROG NEUROBIOL, V55, P651, DOI 10.1016/S0301-0082(98)00024-0; Demarque M, 2002, NEURON, V36, P1051, DOI 10.1016/S0896-6273(02)01053-X; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Elmariah SB, 2005, J NEUROSCI, V25, P3638, DOI 10.1523/JNEUROSCI.3980-04.2005; Elmariah SB, 2004, J NEUROSCI, V24, P2380, DOI 10.1523/JNEUROSCI.4112-03.2004; Fagiolini M, 2004, SCIENCE, V303, P1681, DOI 10.1126/science.1091032; Farrant M, 2007, PROG BRAIN RES, V160, P59, DOI 10.1016/S0079-6123(06)60005-8; Fiorentino H, 2009, J NEUROSCI, V29, P11650, DOI 10.1523/JNEUROSCI.3587-09.2009; Frerking M, 1998, J NEUROPHYSIOL, V80, P3383, DOI 10.1152/jn.1998.80.6.3383; Fujii M, 2007, NEUROSCIENCE, V146, P1044, DOI 10.1016/j.neuroscience.2007.02.050; Ganguly K, 2001, CELL, V105, P521, DOI 10.1016/S0092-8674(01)00341-5; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; Goffin D, 2010, J NEUROSCI, V30, P2935, DOI 10.1523/JNEUROSCI.4411-09.2010; Goslin K., 1998, CULTURING NERVE CELL, P339; Gottmann K, 2009, EXP BRAIN RES, V199, P203, DOI 10.1007/s00221-009-1994-z; Greenberg ME, 2009, J NEUROSCI, V29, P12764, DOI 10.1523/JNEUROSCI.3566-09.2009; GUNTHER U, 1995, P NATL ACAD SCI USA, V92, P7749, DOI 10.1073/pnas.92.17.7749; Haubensak W, 1998, J CELL SCI, V111, P1483; Haydar TF, 2000, J NEUROSCI, V20, P5764, DOI 10.1523/JNEUROSCI.20-15-05764.2000; Hensch TK, 2004, SCIENCE, V303, P1678, DOI 10.1126/science.1091031; Hewitt SA, 2006, J NEUROPHYSIOL, V95, P2193, DOI 10.1152/jn.01135.2005; Homanics GE, 1997, P NATL ACAD SCI USA, V94, P4143, DOI 10.1073/pnas.94.8.4143; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Hutcheon B, 2000, J PHYSIOL-LONDON, V522, P3, DOI 10.1111/j.1469-7793.2000.t01-5-00003.xm; Jovanovic JN, 2004, J NEUROSCI, V24, P522, DOI 10.1523/JNEUROSCI.3606-03.2004; Kalb R, 2005, TRENDS NEUROSCI, V28, P5, DOI 10.1016/j.tins.2004.11.003; Kanematsu T, 2006, J BIOL CHEM, V281, P22180, DOI 10.1074/jbc.M603118200; Khazipov R, 1997, J PHYSIOL-LONDON, V498, P763, DOI 10.1113/jphysiol.1997.sp021900; Kittler JT, 2005, P NATL ACAD SCI USA, V102, P14871, DOI 10.1073/pnas.0506653102; Kittler JT, 2004, P NATL ACAD SCI USA, V101, P12736, DOI 10.1073/pnas.0401860101; Kuczewski N, 2008, J NEUROSCI, V28, P7013, DOI 10.1523/JNEUROSCI.1673-08.2008; Kuczewski N, 2010, EUR J NEUROSCI, V32, P1239, DOI 10.1111/j.1460-9568.2010.07378.x; LAURIE DJ, 1992, J NEUROSCI, V12, P4151; LEINEKUGEL X, 1995, J PHYSIOL-LONDON, V487, P319, DOI 10.1113/jphysiol.1995.sp020882; LoTurco JJ, 1995, NEURON, V15, P1287, DOI 10.1016/0896-6273(95)90008-X; Lu B, 2009, CURR OPIN NEUROBIOL, V19, P162, DOI 10.1016/j.conb.2009.04.004; LUHMANN HJ, 1991, J NEUROPHYSIOL, V65, P247, DOI 10.1152/jn.1991.65.2.247; MA W, 1995, J NEUROSCI, V15, P2547, DOI 10.1523/JNEUROSCI.15-03-02547.1995; Mammen AL, 1997, J NEUROSCI, V17, P7351; Maric D, 1997, EUR J NEUROSCI, V9, P507, DOI 10.1111/j.1460-9568.1997.tb01628.x; Marty S, 2000, J NEUROSCI, V20, P8087; Matsuda N, 2009, J NEUROSCI, V29, P14185, DOI 10.1523/JNEUROSCI.1863-09.2009; McDonald BJ, 1998, NAT NEUROSCI, V1, P23, DOI 10.1038/223; Mizoguchi Y, 2003, J BIOL CHEM, V278, P44097, DOI 10.1074/jbc.M305872200; MIZUNO K, 1994, DEV BIOL, V165, P243, DOI 10.1006/dbio.1994.1250; Moss SJ, 2001, NAT REV NEUROSCI, V2, P240, DOI 10.1038/35067500; MUELLER AL, 1984, J NEUROSCI, V4, P860; Noel J, 1999, NEURON, V23, P365, DOI 10.1016/S0896-6273(00)80786-2; Nusser Z, 1997, NEURON, V19, P697, DOI 10.1016/S0896-6273(00)80382-7; OBRIETAN K, 1995, J NEUROSCI, V15, P5065; Owens DF, 1996, J NEUROSCI, V16, P6414; Owens DF, 1999, J NEUROPHYSIOL, V82, P570, DOI 10.1152/jn.1999.82.2.570; Palizvan MR, 2004, NEUROSCIENCE, V126, P955, DOI 10.1016/j.neuroscience.2004.03.053; Rico B, 2002, NAT NEUROSCI, V5, P225, DOI 10.1038/nn808; Seil FJ, 2000, J NEUROSCI, V20, P5367, DOI 10.1523/JNEUROSCI.20-14-05367.2000; Serafini R, 1998, EUR J NEUROSCI, V10, P1771, DOI 10.1046/j.1460-9568.1998.00187.x; Sernagor E, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00011; Tanaka T, 1997, J NEUROSCI, V17, P2959; Thomson AM, 2010, EUR J NEUROSCI, V31, P2193, DOI 10.1111/j.1460-9568.2010.07252.x; Vicario-Abejon C, 2002, NAT REV NEUROSCI, V3, P965, DOI 10.1038/nrn988; Vicario-Abejon C, 1998, J NEUROSCI, V18, P7256; Wang DD, 2009, J PHYSIOL-LONDON, V587, P1873, DOI 10.1113/jphysiol.2008.167635; Wardle RA, 2003, J NEUROSCI, V23, P8722; Whiting PJ, 1999, ANN NY ACAD SCI, V868, P645, DOI 10.1111/j.1749-6632.1999.tb11341.x; WIDMER HR, 1994, DEV BRAIN RES, V80, P279, DOI 10.1016/0165-3806(94)90114-7; Yamada MK, 2002, J NEUROSCI, V22, P7580; Yoshii A, 2010, DEV NEUROBIOL, V70, P304, DOI 10.1002/dneu.20765	90	63	73	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21667	21677		10.1074/jbc.M110.201582	http://dx.doi.org/10.1074/jbc.M110.201582			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21474450	hybrid, Green Published			2022-12-25	WOS:000291464700063
J	Wenstrup, RJ; Smith, SM; Florer, JB; Zhang, GY; Beason, DP; Seegmiller, RE; Soslowsky, LJ; Birk, DE				Wenstrup, Richard J.; Smith, Simone M.; Florer, Jane B.; Zhang, Guiyun; Beason, David P.; Seegmiller, Robert E.; Soslowsky, Louis J.; Birk, David E.			Regulation of Collagen Fibril Nucleation and Initial Fibril Assembly Involves Coordinate Interactions with Collagens V and XI in Developing Tendon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EHLERS-DANLOS-SYNDROME; FIBRILLOGENESIS IN-SITU; COL5A1 GENE; DIFFERENTIAL EXPRESSION; LATERAL GROWTH; GRAVIS FORM; TENASCIN-X; MUTATION; MATRIX; MICE	Collagens V and XI comprise a single regulatory type of fibril-forming collagen with multiple isoforms. Both co-assemble with collagen I or II to form heterotypic fibrils and have been implicated in regulation of fibril assembly. The objective of this study was to determine the roles of collagens V and XI in the regulation of tendon fibrillogenesis. Flexor digitorum longus tendons from a haplo-insufficient collagen V mouse model of classic Ehlers Danlos syndrome (EDS) had decreased biomechanical stiffness compared with controls consistent with joint laxity in EDS patients. However, fibril structure was relatively normal, an unexpected finding given the altered fibrils observed in dermis and cornea from this model. This suggested roles for other related molecules, i.e. collagen XI, and compound Col5a1(+/-), Col11a1(+/-) tendons had altered fibril structures, supporting a role for collagen XI. To further evaluate this, transcript expression was analyzed in wild type tendons. During development (E18-P10) both collagen V and XI were comparably expressed; however, collagen V predominated in mature (P30) tendons. The collagens had a similar expression pattern. Tendons with altered collagen V and/or XI expression (Col5a1(+/-); Col11a1(+/-); Col5a1(+/-), Col11a1(+/-); Col11a1(-/-); Col5a1(+/-), Col11a1(-/-)) were analyzed at E18. All genotypes demonstrated a reduced fibril number and altered structure. This phenotype was more severe with a reduction in collagen XI. However, the absence of collagen XI with a reduction in collagen V was associated with the most severe fibril phenotype. The data demonstrate coordinate roles for collagens V and XI in the regulation of fibril nucleation and assembly during tendon development.	[Smith, Simone M.; Birk, David E.] Univ S Florida, Coll Med, Dept Pathol & Cell Biol, Tampa, FL 33612 USA; [Wenstrup, Richard J.] Myriad Genet Labs Inc, Salt Lake City, UT 84108 USA; [Florer, Jane B.] Cincinnati Childrens Hosp Res Fdn, Cincinnati, OH 45229 USA; [Zhang, Guiyun] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; [Beason, David P.; Soslowsky, Louis J.] Univ Pennsylvania, McKay Orthopaed Res Lab, Philadelphia, PA 19104 USA; [Seegmiller, Robert E.] Brigham Young Univ, Dept Physiol & Dev Biol, Provo, UT 84602 USA	State University System of Florida; University of South Florida; Myriad Genetics, Inc; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; Jefferson University; University of Pennsylvania; Brigham Young University	Birk, DE (corresponding author), Univ S Florida, Coll Med, Dept Pathol & Cell Biol, 12901 Bruce B Downs Blvd,MDC11, Tampa, FL 33612 USA.	dbirk@health.usf.edu	Birk, David/I-4072-2012	Birk, David/0000-0002-4865-9088	National Institutes of Health (NIAMS) [AR044745, AR050950]; National Research Service Award Post Doctoral Fellowship [AR056937]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR050950, R01AR044745, F32AR056937] Funding Source: NIH RePORTER	National Institutes of Health (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Research Service Award Post Doctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR044745 (NIAMS; to D. E. B.) and AR050950 (NIAMS, supporting the Penn Center for Musculoskeletal Disorders (to L. J. S.)). This work was also supported by National Research Service Award Post Doctoral Fellowship AR056937 (to S. M. S.).	Ameye L, 2002, FASEB J, V16, DOI 10.1096/fj.01-0848com; Ansorge HL, 2009, J BIOL CHEM, V284, P8427, DOI 10.1074/jbc.M805582200; Aszodi A, 1998, J CELL BIOL, V143, P1399, DOI 10.1083/jcb.143.5.1399; BEIGHTON P, 1992, MCKUSICKS HERITABLE, P189; Birk DE, 2011, BIOL EXTRACELL MATR, P77, DOI 10.1007/978-3-642-16555-9_3; BIRK DE, 1995, DEV DYNAM, V202, P229, DOI 10.1002/aja.1002020303; BIRK DE, 1994, J ANAT, V184, P457; BIRK DE, 1986, J CELL BIOL, V103, P231, DOI 10.1083/jcb.103.1.231; Birk DE, 1997, DEV DYNAM, V208, P291; BIRK DE, 1989, P NATL ACAD SCI USA, V86, P4549, DOI 10.1073/pnas.86.12.4549; Birk DE, 2001, MICRON, V32, P223, DOI 10.1016/S0968-4328(00)00043-3; BIRK DE, 1994, EXTRACELLULAR MATRIX; Blaschke UK, 2000, J BIOL CHEM, V275, P10370, DOI 10.1074/jbc.275.14.10370; Boot-Handford RP, 2003, BIOESSAYS, V25, P142, DOI 10.1002/bies.10230; Bouma P, 2001, J BIOL CHEM, V276, P13356, DOI 10.1074/jbc.M011742200; Bristow J, 2005, AM J MED GENET C, V139C, P24, DOI 10.1002/ajmg.c.30071; Burrows NP, 1996, J INVEST DERMATOL, V106, P1273, DOI 10.1111/1523-1747.ep12348978; Burrows NP, 1997, CLIN EXP DERMATOL, V22, P174, DOI 10.1046/j.1365-2230.1997.2290654.x; Canty EG, 2004, J CELL BIOL, V165, P553, DOI 10.1083/jcb.200312071; Christner PJ, 2006, J INVEST DERMATOL, V126, P595, DOI 10.1038/sj.jid.5700100; Colige A, 2004, J INVEST DERMATOL, V123, P656, DOI 10.1111/j.0022-202X.2004.23406.x; DePaepe A, 1997, AM J HUM GENET, V60, P547; DERWIN KA, 1994, J BIOMECH, V27, P1277, DOI 10.1016/0021-9290(94)90281-X; Ezura Y, 2000, J CELL BIOL, V151, P779, DOI 10.1083/jcb.151.4.779; Fernandes RJ, 2007, MATRIX BIOL, V26, P597, DOI 10.1016/j.matbio.2007.06.007; Graham HK, 2000, J MOL BIOL, V295, P891, DOI 10.1006/jmbi.1999.3384; Hansen U, 2003, J BIOL CHEM, V278, P37352, DOI 10.1074/jbc.M304325200; Hoffman GG, 2010, MATRIX BIOL, V29, P261, DOI 10.1016/j.matbio.2010.01.006; HULMES DJS, 1989, J MOL BIOL, V210, P337, DOI 10.1016/0022-2836(89)90335-5; KLEMAN JP, 1992, EUR J BIOCHEM, V210, P329, DOI 10.1111/j.1432-1033.1992.tb17425.x; LENAERS A, 1971, EUR J BIOCHEM, V23, P533, DOI 10.1111/j.1432-1033.1971.tb01651.x; LI SW, 1995, GENE DEV, V9, P2821, DOI 10.1101/gad.9.22.2821; LI Y, 1995, CELL, V80, P423, DOI 10.1016/0092-8674(95)90492-1; Lin TW, 2006, J BIOMECH, V39, P61, DOI 10.1016/j.jbiomech.2004.11.009; Lin TW, 2005, J BIOMECH, V38, P99, DOI 10.1016/j.jbiomech.2004.03.008; Lincoln J, 2006, DEV DYNAM, V235, P3295, DOI 10.1002/dvdy.20980; Mao JR, 2002, NAT GENET, V30, P421, DOI 10.1038/ng850; MAYNE R, 1993, J BIOL CHEM, V268, P9381; Michalickova K, 1998, HUM MOL GENET, V7, P249, DOI 10.1093/hmg/7.2.249; Murchison ND, 2007, DEVELOPMENT, V134, P2697, DOI 10.1242/DEV.001933; Nicholls AC, 1996, J MED GENET, V33, P940, DOI 10.1136/jmg.33.11.940; OXFORD JT, 1994, EXP CELL RES, V213, P28, DOI 10.1006/excr.1994.1169; Richards AJ, 1998, J MED GENET, V35, P846, DOI 10.1136/jmg.35.10.846; Schwarze U, 2000, AM J HUM GENET, V66, P1757, DOI 10.1086/302933; Schweitzer R, 2010, DEVELOPMENT, V137, P2807, DOI 10.1242/dev.047498; SEEGMILLER R, 1971, J CELL BIOL, V48, P580, DOI 10.1083/jcb.48.3.580; Segev F, 2006, INVEST OPHTH VIS SCI, V47, P565, DOI 10.1167/iovs.05-0771; Smith SM, 2012, EXP EYE RES, V98, P105, DOI 10.1016/j.exer.2010.08.003; SOKOLOV BP, 1991, HUM GENET, V88, P125; Starborg T, 2009, SCAND J MED SCI SPOR, V19, P547, DOI 10.1111/j.1600-0838.2009.00907.x; Steinmann B., 2002, CONNECTIVE TISSUE IT, P431, DOI DOI 10.1002/0471221929.CH9; Symoens S, 2011, BIOCHEM J, V433, P371, DOI 10.1042/BJ20101061; Toriello HV, 1996, NAT GENET, V13, P361, DOI 10.1038/ng0796-361; VOGEL A, 1979, LAB INVEST, V40, P201; Watson SS, 2009, DEV DYNAM, V238, P693, DOI 10.1002/dvdy.21866; Wenstrup RJ, 1996, HUM MOL GENET, V5, P1733, DOI 10.1093/hmg/5.11.1733; Wenstrup RJ, 2000, AM J HUM GENET, V66, P1766, DOI 10.1086/302930; Wenstrup RJ, 2006, J BIOL CHEM, V281, P12888, DOI 10.1074/jbc.M511528200; Wenstrup RJ, 2004, J BIOL CHEM, V279, P53331, DOI 10.1074/jbc.M409622200; WORDSWORTH BP, 1991, BRIT J RHEUMATOL, V30, P173; Wu JJ, 2009, J BIOL CHEM, V284, P5539, DOI 10.1074/jbc.M806369200; Xu L, 2003, ARTHRITIS RHEUM, V48, P2509, DOI 10.1002/art.11233; YOSHIOKA H, 1995, DEV DYNAM, V204, P41, DOI 10.1002/aja.1002040106; Young BB, 2000, DEV DYNAM, V217, P430, DOI 10.1002/(SICI)1097-0177(200004)217:4<430::AID-DVDY10>3.0.CO;2-5; Zhang G., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P5; Zhang GY, 2006, J CELL BIOCHEM, V98, P1436, DOI 10.1002/jcb.20776; Zhang GY, 2003, J ANAT, V202, P411, DOI 10.1046/j.1469-7580.2003.00174.x	67	94	94	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20455	20465		10.1074/jbc.M111.223693	http://dx.doi.org/10.1074/jbc.M111.223693			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21467034	Green Published, hybrid			2022-12-25	WOS:000291267600033
J	Gagan, J; Dey, BK; Layer, R; Yan, Z; Dutta, A				Gagan, Jeffrey; Dey, Bijan K.; Layer, Ryan; Yan, Zhen; Dutta, Anindya			MicroRNA-378 Targets the Myogenic Repressor MyoR during Myoblast Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HELIX TRANSCRIPTION FACTOR; MUSCLE-SPECIFIC MICRORNA; SKELETAL-MUSCLE; MAMMALIAN-CELLS; DOWN-REGULATION; EXPRESSION; MIR-206; PROLIFERATION; REGENERATION; FIBROBLASTS	MicroRNAs play important roles in many cell processes, including the differentiation process in several different lineages. For example, microRNAs can promote differentiation by repressing negative regulators of transcriptional activity. These regulated transcription factors can further up-regulate levels of the microRNA in a feed-forward mechanism. Here we show that MyoDup-regulates miR-378 during myogenic differentiation in C2C12 cells. ChIP and high throughput sequencing analysis shows that MyoD binds in close proximity to the miR-378 gene and causes both transactivation and chromatin remodeling. Overexpression of miR-378 increases the transcriptional activity of MyoD, in part by repressing an antagonist, MyoR. The 3' untranslated region of MyoR contains a direct binding site for miR-378. The presence of this binding site significantly reduces the ability of MyoR to prevent the MyoD-driven transdifferentiation of fibroblasts. MyoR and miR-378 were anticorrelated during cardiotoxin-induced adult muscle regeneration in mice. Taken together, this shows a feed-forward loop where MyoD indirectly down-regulates MyoR via miR-378.	[Gagan, Jeffrey; Dey, Bijan K.; Layer, Ryan; Dutta, Anindya] Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA 22908 USA; [Layer, Ryan] Univ Virginia, Sch Med, Dept Comp Sci, Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA 22908 USA; [Yan, Zhen] Univ Virginia, Sch Med, Dept Med, Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA 22908 USA; [Yan, Zhen] Univ Virginia, Sch Med, Dept Pharmacol, Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia	Dutta, A (corresponding author), Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA 22908 USA.	ad8q@virginia.edu	Dutta, Anindya/P-3203-2016	Yan, Zhen/0000-0002-4826-9813; Dey, Bijan/0000-0001-9386-2475; Dutta, Anindya/0000-0002-4319-0073	National Institutes of Health [R01 AR053948]; Heart and Stroke Foundation of Canada; Cell and Molecular Biology Training Grant [T32 GM008136]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053948, R01AR050429] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007267, T32GM008136] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Cell and Molecular Biology Training Grant; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AR053948 (to A. D.). This work was also supported by a postdoctoral fellowship from the Heart and Stroke Foundation of Canada (to B. K. D.) and by Cell and Molecular Biology Training Grant T32 GM008136 (to J. G.).	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bergstrom DA, 2002, MOL CELL, V9, P587, DOI 10.1016/S1097-2765(02)00481-1; Buas MF, 2009, J CELL PHYSIOL, V218, P84, DOI 10.1002/jcp.21571; Cao Y, 2006, EMBO J, V25, P502, DOI 10.1038/sj.emboj.7600958; Cao Y, 2010, DEV CELL, V18, P662, DOI 10.1016/j.devcel.2010.02.014; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen JF, 2010, J CELL BIOL, V190, P867, DOI 10.1083/jcb.200911036; Crist CG, 2009, P NATL ACAD SCI USA, V106, P13383, DOI 10.1073/pnas.0900210106; Dey BK, 2011, MOL CELL BIOL, V31, P203, DOI 10.1128/MCB.01009-10; Gao XM, 2001, J CELL BIOL, V154, P1161, DOI 10.1083/jcb.200104058; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Haraguchi T, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp040; Hirai H, 2010, J CELL BIOL, V191, P347, DOI 10.1083/jcb.201006025; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Juan AH, 2009, MOL CELL, V36, P61, DOI 10.1016/j.molcel.2009.08.008; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; KURABAYASHI M, 1994, J BIOL CHEM, V269, P6031; Kuroda K, 1999, J BIOL CHEM, V274, P7238, DOI 10.1074/jbc.274.11.7238; LASSAR AB, 1991, CELL, V66, P305, DOI 10.1016/0092-8674(91)90620-E; Liu N, 2007, P NATL ACAD SCI USA, V104, P20844, DOI 10.1073/pnas.0710558105; Lu JR, 1999, P NATL ACAD SCI USA, V96, P552, DOI 10.1073/pnas.96.2.552; Paddison PJ, 2004, NAT METHODS, V1, P163, DOI 10.1038/nmeth1104-163; Puri PL, 1997, MOL CELL, V1, P35, DOI 10.1016/S1097-2765(00)80005-2; Rao PK, 2006, P NATL ACAD SCI USA, V103, P8721, DOI 10.1073/pnas.0602831103; Rosenberg MI, 2006, J CELL BIOL, V175, P77, DOI 10.1083/jcb.200603039; Sarkar S, 2010, MOL BIOL CELL, V21, P2138, DOI 10.1091/mbc.E10-01-0062; Spicer DB, 1996, SCIENCE, V272, P1476, DOI 10.1126/science.272.5267.1476; Sweetman D, 2008, DEV BIOL, V321, P491, DOI 10.1016/j.ydbio.2008.06.019; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; TAPSCOTT SJ, 1988, SCIENCE, V242, P405, DOI 10.1126/science.3175662; Williams AH, 2009, SCIENCE, V326, P1549, DOI 10.1126/science.1181046; Yuasa K, 2008, CELL STRUCT FUNCT, V33, P163, DOI 10.1247/csf.08022; Zhang KM, 2010, J CELL BIOL, V188, P39, DOI 10.1083/jcb.200904144; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	34	120	134	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19431	19438		10.1074/jbc.M111.219006	http://dx.doi.org/10.1074/jbc.M111.219006			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21471220	Green Published, hybrid			2022-12-25	WOS:000291027700026
J	Jones, CG; Moniodis, J; Zulak, KG; Scaffidi, A; Plummer, JA; Ghisalberti, EL; Barbour, EL; Bohlmann, J				Jones, Christopher G.; Moniodis, Jessie; Zulak, Katherine G.; Scaffidi, Adrian; Plummer, Julie A.; Ghisalberti, Emilio L.; Barbour, Elizabeth L.; Bohlmann, Joerg			Sandalwood Fragrance Biosynthesis Involves Sesquiterpene Synthases of Both the Terpene Synthase (TPS)-a and TPS-b Subfamilies, including Santalene Synthases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESSENTIAL-OIL; BIOLOGICAL EVALUATION; INDIAN SANDALWOOD; INSIGHTS; QUALITY; WILD	Sandalwood oil is one of the worlds most highly prized fragrances. To identify the genes and encoded enzymes responsible for santalene biosynthesis, we cloned and characterized three orthologous terpene synthase (TPS) genes SaSSy, SauSSy, and SspiSSy from three divergent sandalwood species; Santalum album, S. austrocaledonicum, and S. spicatum, respectively. The encoded enzymes catalyze the formation of alpha-, beta-, epi-beta-santalene, and alpha-exo-bergamotene from (E,E)-farnesyl diphosphate (E,E-FPP). Recombinant SaSSy was additionally tested with (Z,Z)-farnesyl diphosphate (Z,Z-FPP) and remarkably, found to produce a mixture of alpha-endo-bergamotene, alpha-santalene, (Z)-beta-farnesene, epi-beta-santalene, and beta-santalene. Additional cDNAs that encode bisabolene/bisabolol synthases were also cloned and functionally characterized from these three species. Both the santalene synthases and the bisabolene/bisabolol synthases reside in the TPS-b phylogenetic clade, which is more commonly associated with angiosperm monoterpene synthases. An orthologous set of TPS-a synthases responsible for formation of macrocyclic and bicyclic sesquiterpenes were characterized. Strict functionality and limited sequence divergence in the santalene and bisabolene synthases are in contrast to the TPS-a synthases, suggesting these compounds have played a significant role in the evolution of the Santalum genus.	[Jones, Christopher G.; Moniodis, Jessie; Zulak, Katherine G.; Plummer, Julie A.; Barbour, Elizabeth L.] Univ Western Australia Crawley, Fac Nat & Agr Sci, Sch Plant Biol M084, Crawley, WA 6009, Australia; [Scaffidi, Adrian; Ghisalberti, Emilio L.] Univ Western Australia Crawley, Sch Biomed Biomol & Chem Sci M313, Fac Life & Phys Sci, Crawley, WA 6009, Australia; [Barbour, Elizabeth L.] Forest Prod Commiss Western Australia, Rivervale, WA 6103, Australia; [Zulak, Katherine G.; Bohlmann, Joerg] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada	University of Western Australia; University of Western Australia; University of British Columbia	Jones, CG (corresponding author), Univ Western Australia Crawley, Fac Nat & Agr Sci, Sch Plant Biol M084, Crawley, WA 6009, Australia.	christopher.jones@uwa.edu.au	Zulak, Katherine G/B-5939-2011; Scaffidi, Adrian/J-2707-2012	Zulak, Katherine G/0000-0003-0415-8975; Barbour, Elizabeth/0000-0002-3533-2422	Australian Research Council (ARC); Forest Products Commission of Western Australia (FPC) [LP0882690]; Natural Sciences and Engineering Council of Canada (NSERC)	Australian Research Council (ARC)(Australian Research Council); Forest Products Commission of Western Australia (FPC); Natural Sciences and Engineering Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by the Australian Research Council (ARC) and the Forest Products Commission of Western Australia (FPC) as part of linkage project LP0882690 (to J. A. P. and E. L. G.) and a Discovery Grant of the Natural Sciences and Engineering Council of Canada (NSERC) (to J. B.).	Adams R.P., 1995, IDENTIFICATION ESSEN; Aharoni A, 2004, PLANT CELL, V16, P3110, DOI 10.1105/tpc.104.023895; Applegate GB, 1990, P S SAND PAC APR 9 1, P1; Bohlmann J, 1998, P NATL ACAD SCI USA, V95, P4126, DOI 10.1073/pnas.95.8.4126; Braun NA, 2005, J ESSENT OIL RES, V17, P477, DOI 10.1080/10412905.2005.9698969; Choi HS, 2003, J AGR FOOD CHEM, V51, P2687, DOI 10.1021/jf021069o; CHUNG TY, 1993, J AGR FOOD CHEM, V41, P1693, DOI 10.1021/jf00034a033; Cyr A, 2007, J AM CHEM SOC, V129, P6684, DOI 10.1021/ja071158n; DAVIES NW, 1990, J CHROMATOGR, V503, P1, DOI 10.1016/S0021-9673(01)81487-4; de Kraker JW, 1998, PLANT PHYSIOL, V117, P1381, DOI 10.1104/pp.117.4.1381; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gershenzon J, 2007, NAT CHEM BIOL, V3, P408, DOI 10.1038/nchembio.2007.5; Howes MJR, 2004, J CHROMATOGR A, V1028, P307, DOI 10.1016/j.chroma.2003.11.093; Huang QL, 2001, BIOORGAN MED CHEM, V9, P2237, DOI 10.1016/S0968-0896(01)00072-4; Jones CG, 2009, SILVAE GENET, V58, P279, DOI 10.1515/sg-2009-0036; Jones CG, 2008, ARCH BIOCHEM BIOPHYS, V477, P121, DOI 10.1016/j.abb.2008.05.008; Jones CG, 2006, PHYTOCHEMISTRY, V67, P2463, DOI 10.1016/j.phytochem.2006.09.013; Kampranis SC, 2007, PLANT CELL, V19, P1994, DOI 10.1105/tpc.106.047779; Kollner TG, 2004, PLANT CELL, V16, P1115, DOI 10.1105/tpc.019877; Kolosova N, 2004, BIOTECHNIQUES, V36, P821, DOI 10.2144/04365ST06; Kreipl AT, 2004, PHYTOCHEMISTRY, V65, P2045, DOI 10.1016/j.phytochem.2004.05.007; Lesburg CA, 1997, SCIENCE, V277, P1820, DOI 10.1126/science.277.5333.1820; O'Maille PE, 2004, ANAL BIOCHEM, V335, P210, DOI 10.1016/j.ab.2004.09.011; Page T, 2010, CHEM BIODIVERS, V7, P1990, DOI 10.1002/cbdv.200900382; Pala-Paul J, 2005, J CHROMATOGR A, V1074, P235, DOI 10.1016/j.chroma.2005.03.036; Paolini J, 2007, FLAVOUR FRAG J, V22, P479, DOI 10.1002/ffj.1824; Piggott MJ, 1997, FLAVOUR FRAG J, V12, P43, DOI 10.1002/(SICI)1099-1026(199701)12:1<43::AID-FFJ601>3.0.CO;2-H; Sallaud C, 2009, PLANT CELL, V21, P301, DOI 10.1105/tpc.107.057885; Shao Y, 1999, ORG LETT, V1, P627, DOI 10.1021/ol990714i; Skaltsa HD, 2003, PHYTOCHEMISTRY, V64, P743, DOI 10.1016/S0031-9422(03)00386-8; SOUTHWELL IA, 1970, PHYTOCHEMISTRY, V9, P2243, DOI 10.1016/S0031-9422(00)85393-5; Trapp SC, 2001, GENETICS, V158, P811; Valder C, 2003, J ESSENT OIL RES, V15, P178, DOI 10.1080/10412905.2003.9712106; Williams DC, 1998, BIOCHEMISTRY-US, V37, P12213, DOI 10.1021/bi980854k; Xie HB, 2000, J ORG CHEM, V65, P8552, DOI 10.1021/jo000942m	36	96	126	3	62	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17445	17454		10.1074/jbc.M111.231787	http://dx.doi.org/10.1074/jbc.M111.231787			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454632	hybrid, Green Published			2022-12-25	WOS:000290585200006
J	Park, SY; Jin, WZ; Woo, JR; Shoelson, SE				Park, Sang-Youn; Jin, Wanzhu; Woo, Ju Rang; Shoelson, Steven E.			Crystal Structures of Human TBC1D1 and TBC1D4 (AS160) RabGTPase-activating Protein (RabGAP) Domains Reveal Critical Elements for GLUT4 Translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AKT SUBSTRATE; GAP DOMAIN; MEMBRANE; MUTATION; GTPASES; RAB10	We have solved the x-ray crystal structures of the RabGAP domains of human TBC1D1 and human TBC1D4 (AS160), at 2.2 and 3.5 angstrom resolution, respectively. Like the yeast Gyp1p RabGAP domain, whose structure was solved previously in complex with mouse Rab33B, the human TBC1D1 and TBC1D4 domains both have 16 alpha-helices and no beta-sheet elements. We expected the yeast Gyp1p RabGAP/mouse Rab33B structure to predict the corresponding interfaces between cognate mammalian RabGAPs and Rabs, but found that residues were poorly conserved. We further tested the relevance of this model by Ala-scanning mutagenesis, but only one of five substitutions within the inferred binding site of the TBC1D1 RabGAP significantly perturbed catalytic efficiency. In addition, substitution of TBC1D1 residues with corresponding residues from Gyp1p did not enhance catalytic efficiency. We hypothesized that biologically relevant RabGAP/Rab partners utilize additional contacts not described in the yeast Gyp1p/mouse Rab33B structure, which we predicted using our two new human TBC1D1 and TBC1D4 structures. Ala substitution of TBC1D1 Met(930), corresponding to a residue outside of the Gyp1p/Rab33B contact, substantially reduced catalytic activity. GLUT4 translocation assays confirmed the biological relevance of our findings. Substitutions with lowest RabGAP activity, including catalytically dead RK and Met(930) and Leu(1019) predicted to perturb Rab binding, confirmed that biological activity requires contacts between cognate RabGAPs and Rabs beyond those in the yeast Gyp1p RabGAP/mouse Rab33B structure.	[Shoelson, Steven E.] Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School	Shoelson, SE (corresponding author), Harvard Univ, Sch Med, Joslin Diabet Ctr, 1 Joslin Pl, Boston, MA 02215 USA.	steven.shoelson@joslin.harvard.edu	Jin, Wanzhu/B-5699-2012	Jin, Wanzhu/0000-0002-5860-2958	National Institutes of Health [R01 DK43123, R01 DK51729, F32 DK77485, P30 DK36836]; United States Department of Energy, Division of Materials Sciences and Division of Chemical Sciences [DE-AC02-98CH10886]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK077485, R01DK043123, P30DK036836, R01DK051729] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy, Division of Materials Sciences and Division of Chemical Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK43123 and R01 DK51729 (to S. E. S.), F32 DK77485 (to S.-Y. P.), and P30 DK36836 (to the Joslin Diabetes Center). Data were collected at beams X29A and X12C of National Synchrotron Light Source, Brookhaven National Laboratory, which is supported by the United States Department of Energy, Division of Materials Sciences and Division of Chemical Sciences, Contract DE-AC02-98CH10886.	Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chadt A, 2008, NAT GENET, V40, P1354, DOI 10.1038/ng.244; Cowtan K., 1994, CRYSTALLOGRAPHY, V31, P34; Dash S, 2009, P NATL ACAD SCI USA, V106, P9350, DOI 10.1073/pnas.0900909106; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Kane S, 2002, J BIOL CHEM, V277, P22115, DOI 10.1074/jbc.C200198200; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Miinea CP, 2005, BIOCHEM J, V391, P87, DOI 10.1042/BJ20050887; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pan XJ, 2006, NATURE, V442, P303, DOI 10.1038/nature04847; Peck GR, 2006, MOL ENDOCRINOL, V20, P2576, DOI 10.1210/me.2005-0476; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Rak A, 2000, EMBO J, V19, P5105, DOI 10.1093/emboj/19.19.5105; Roach WG, 2007, BIOCHEM J, V403, P353, DOI 10.1042/BJ20061798; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Sano H, 2008, BIOCHEM J, V411, P89, DOI 10.1042/BJ20071318; Sano H, 2007, CELL METAB, V5, P293, DOI 10.1016/j.cmet.2007.03.001; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Watson RT, 2006, TRENDS BIOCHEM SCI, V31, P215, DOI 10.1016/j.tibs.2006.02.007; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	23	18	22	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					18130	18138		10.1074/jbc.M110.217323	http://dx.doi.org/10.1074/jbc.M110.217323			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454505	hybrid, Green Published			2022-12-25	WOS:000290585200073
J	Wang, YC; Yang, F; Fu, Y; Huang, XH; Wang, W; Jiang, XN; Gritsenko, MA; Zhao, R; Monore, ME; Pertz, OC; Purvine, SO; Orton, DJ; Jacobs, JM; Camp, DG; Smith, RD; Klemke, RL				Wang, Yingchun; Yang, Feng; Fu, Yi; Huang, Xiahe; Wang, Wei; Jiang, Xinning; Gritsenko, Marina A.; Zhao, Rui; Monore, Matthew E.; Pertz, Olivier C.; Purvine, Samuel O.; Orton, Daniel J.; Jacobs, Jon M.; Camp, David G., II; Smith, Richard D.; Klemke, Richard L.			Spatial Phosphoprotein Profiling Reveals a Compartmentalized Extracellular Signal-regulated Kinase Switch Governing Neurite Growth and Retraction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; ABL TYROSINE KINASE; ADULT DRG NEURONS; LYSOPHOSPHATIDIC ACID; CELL-MIGRATION; ERK ACTIVATION; AXON GUIDANCE; MAP-KINASE; CYTOSKELETAL DYNAMICS; CONE GUIDANCE	Brain development and spinal cord regeneration require neurite sprouting and growth cone navigation in response to extension and collapsing factors present in the extracellular environment. These external guidance cues control neurite growth cone extension and retraction processes through intracellular protein phosphorylation of numerous cytoskeletal, adhesion, and polarity complex signaling proteins. However, the complex kinase/substrate signaling networks that mediate neuritogenesis have not been investigated. Here, we compare the neurite phosphoproteome under growth and retraction conditions using neurite purification methodology combined with mass spectrometry. More than 4000 non-redundant phosphorylation sites from 1883 proteins have been annotated and mapped to signaling pathways that control kinase/phosphatase networks, cytoskeleton remodeling, and axon/dendrite specification. Comprehensive informatics and functional studies revealed a compartmentalized ERK activation/deactivation cytoskeletal switch that governs neurite growth and retraction, respectively. Our findings provide the first system-wide analysis of the phosphoprotein signaling networks that enable neurite growth and retraction and reveal an important molecular switch that governs neuritogenesis.	[Wang, Yingchun; Wang, Wei; Jiang, Xinning; Pertz, Olivier C.; Klemke, Richard L.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Wang, Yingchun; Wang, Wei; Jiang, Xinning; Pertz, Olivier C.; Klemke, Richard L.] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Yang, Feng; Gritsenko, Marina A.; Zhao, Rui; Monore, Matthew E.; Purvine, Samuel O.; Orton, Daniel J.; Jacobs, Jon M.; Camp, David G., II; Smith, Richard D.] Pacific NW Natl Lab, Environm Mol Sci Lab, Div Biol Sci, Richland, WA 99354 USA; [Wang, Yingchun; Fu, Yi; Huang, Xiahe; Wang, Wei] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol & Dev Biol, Beijing 100101, Peoples R China	University of California System; University of California San Diego; University of California System; University of California San Diego; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Klemke, RL (corresponding author), Univ Calif San Diego, Dept Pathol, Basic Sci Bldg 1040,9500 Gilman Dr,MC 0612, La Jolla, CA 92093 USA.	rklemke@ucsd.edu	Jiang, Xinning/F-2140-2010; Purvine, Samuel O/O-3358-2017; Smith, Richard D/J-3664-2012	Jiang, Xinning/0000-0001-6414-6226; Purvine, Samuel O/0000-0002-2257-2400; Smith, Richard D/0000-0002-2381-2349; pertz, olivier/0000-0001-8579-4919; Orton, Daniel/0000-0002-0253-6859	National Institutes of Health [GM068487, CA097022, RR018522]; Chinese Academy of Sciences; Department of Energy [DE-AC05-76RLO 1830]; NATIONAL CANCER INSTITUTE [R01CA097022] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068487] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese Academy of Sciences(Chinese Academy of Sciences); Department of Energy(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM068487 (to R. L. K.), CA097022 (to R. L. K.), and RR018522 (to R. D. S.).; Supported by the One Hundred Talents project of the Chinese Academy of Sciences.; We thank Monica Holcomb for excellent technical assistance. We also thank Dr. Andrew D. Catling (Louisiana State University Health Sciences Center, New Orleans, LA) for providing the MEK constructs and Drs. Rune Linding and Tony Pawson for assistance and advice on using NetworKIN. Portions of the research were performed in the Environmental Molecular Sciences Laboratory, a United States Department of Energy scientific user facility located at Pacific Northwest National Laboratory in Richland, WA. Pacific Northwest National Laboratory is operated by Battelle for the United States Department of Energy under Contract DE-AC05-76RLO 1830.	Alessandrini A, 1996, J BIOL CHEM, V271, P31612, DOI 10.1074/jbc.271.49.31612; Allen J, 2009, DEV BIOL, V327, P4, DOI 10.1016/j.ydbio.2008.12.013; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Arimura N, 2005, NEURON, V48, P881, DOI 10.1016/j.neuron.2005.11.007; Arimura N, 2000, J BIOL CHEM, V275, P23973, DOI 10.1074/jbc.M001032200; Arimura N, 2005, MOL CELL BIOL, V25, P9973, DOI 10.1128/MCB.25.22.9973-9984.2005; Barnes AP, 2008, CURR OPIN NEUROBIOL, V18, P44, DOI 10.1016/j.conb.2008.05.003; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Bordt SL, 2001, BBA-MOL CELL RES, V1499, P257, DOI 10.1016/S0167-4889(00)00127-0; Brill LM, 2004, ANAL CHEM, V76, P2763, DOI 10.1021/ac035352d; Chodniewicz D, 2004, EXP CELL RES, V301, P31, DOI 10.1016/j.yexcr.2004.08.006; Chodniewicz D, 2004, BBA-MOL CELL RES, V1692, P63, DOI 10.1016/j.bbamcr.2004.03.006; Darenfed H, 2007, CELL MOTIL CYTOSKEL, V64, P97, DOI 10.1002/cm.20168; Dehmelt L, 2007, CURR BIOL, V17, pR611, DOI 10.1016/j.cub.2007.05.059; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Desbarats J, 2003, NAT CELL BIOL, V5, P118, DOI 10.1038/ncb916; Dhillon AS, 2003, MOL CELL BIOL, V23, P1983, DOI 10.1128/MCB.23.6.1983-1993.2003; Dickson BJ, 2001, CURR OPIN NEUROBIOL, V11, P103, DOI 10.1016/S0959-4388(00)00180-X; Dimitropoulou A, 2000, BRAIN RES, V858, P205, DOI 10.1016/S0006-8993(00)01946-6; Ding SJ, 2008, J PROTEOME RES, V7, P4215, DOI 10.1021/pr7007785; Drees F, 2008, CURR OPIN NEUROBIOL, V18, P53, DOI 10.1016/j.conb.2008.05.007; Du XX, 2008, J PROTEOME RES, V7, P2195, DOI 10.1021/pr070510t; Eblen ST, 2004, MOL CELL BIOL, V24, P2308, DOI 10.1128/MCB.24.6.2308-2317.2004; Eblen ST, 2002, MOL CELL BIOL, V22, P6023, DOI 10.1128/MCB.22.17.6023-6033.2002; Ehler E, 1997, MOL CELL NEUROSCI, V9, P1, DOI 10.1006/mcne.1997.0602; Ehrenreiter K, 2005, J CELL BIOL, V168, P955, DOI 10.1083/jcb.200409162; Elowe S, 2001, MOL CELL BIOL, V21, P7429, DOI 10.1128/MCB.21.21.7429-7441.2001; Enserink JM, 2004, J BIOL CHEM, V279, P44889, DOI 10.1074/jbc.M404599200; Fukata M, 2003, CURR OPIN CELL BIOL, V15, P590, DOI 10.1016/S0955-0674(03)00097-8; Fukushima N, 2002, MOL CELL NEUROSCI, V20, P271, DOI 10.1006/mcne.2002.1123; Geraldo S, 2009, J CELL SCI, V122, P3595, DOI 10.1242/jcs.042309; Gerits N, 2008, CELL SIGNAL, V20, P1592, DOI 10.1016/j.cellsig.2008.02.022; Giannone G, 2009, TRENDS CELL BIOL, V19, P475, DOI 10.1016/j.tcb.2009.07.001; Haeusgen W, 2009, NEUROSCIENCE, V161, P951, DOI 10.1016/j.neuroscience.2009.04.014; Halpain S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-224; Heibeck TH, 2009, J PROTEOME RES, V8, P3852, DOI 10.1021/pr900044c; Hernandez SE, 2004, CURR BIOL, V14, P691, DOI 10.1016/j.cub.2004.03.062; Hirose M, 1998, J CELL BIOL, V141, P1625, DOI 10.1083/jcb.141.7.1625; Hollis ER, 2009, P NATL ACAD SCI USA, V106, P7215, DOI 10.1073/pnas.0810624106; Howe AK, 2002, CURR OPIN GENET DEV, V12, P30, DOI 10.1016/S0959-437X(01)00260-X; Huang J, 2006, MOL BIOL CELL, V17, P3187, DOI 10.1091/mbc.E05-12-1122; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Ivankovic-Dikic I, 2000, NAT CELL BIOL, V2, P574, DOI 10.1038/35023515; Jeon S, 2010, NEUROCHEM INT, V56, P810, DOI 10.1016/j.neuint.2010.03.005; Jorgensen C, 2010, CURR OPIN GENET DEV, V20, P15, DOI 10.1016/j.gde.2009.12.003; Jorgensen C, 2009, SCIENCE, V326, P1502, DOI 10.1126/science.1176615; Kain KH, 2001, J BIOL CHEM, V276, P16185, DOI 10.1074/jbc.M100095200; Kalil K, 2000, J NEUROBIOL, V44, P145, DOI 10.1002/1097-4695(200008)44:2<145::AID-NEU5>3.0.CO;2-X; Kao HT, 2002, NAT NEUROSCI, V5, P431, DOI 10.1038/nn840; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Kinbara K, 2003, NAT REV MOL CELL BIO, V4, P767, DOI 10.1038/nrm1229; Koh CG, 2006, NEUROSIGNALS, V15, P228, DOI 10.1159/000101527; Kranenburg O, 1999, MOL BIOL CELL, V10, P1851, DOI 10.1091/mbc.10.6.1851; Kushner SA, 2005, J NEUROSCI, V25, P9721, DOI 10.1523/JNEUROSCI.2836-05.2005; Lanier LM, 2000, CURR OPIN NEUROBIOL, V10, P80, DOI 10.1016/S0959-4388(99)00058-6; Li GN, 2008, ANN BIOMED ENG, V36, P889, DOI 10.1007/s10439-008-9486-z; Liang XQ, 2007, J AM SOC MASS SPECTR, V18, P1932, DOI 10.1016/j.jasms.2007.08.001; Lin YH, 2004, J CELL BIOL, V165, P421, DOI 10.1083/jcb.200311045; Linding R, 2008, NUCLEIC ACIDS RES, V36, pD695, DOI 10.1093/nar/gkm902; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; Lowery LA, 2009, NAT REV MOL CELL BIO, V10, P332, DOI 10.1038/nrm2679; Maina F, 1997, GENE DEV, V11, P3341, DOI 10.1101/gad.11.24.3341; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Manning G, 2002, TRENDS BIOCHEM SCI, V27, P514, DOI 10.1016/S0968-0004(02)02179-5; Mavria G, 2006, CANCER CELL, V9, P33, DOI 10.1016/j.ccr.2005.12.021; McLeod SJ, 2004, J BIOL CHEM, V279, P12009, DOI 10.1074/jbc.M313098200; Moser K, 2006, J PROTEOME RES, V5, P98, DOI 10.1021/pr0503073; Mruthyunjaya S, 2010, BIOCHEM BIOPH RES CO, V391, P43, DOI 10.1016/j.bbrc.2009.10.158; Nakata H, 2007, BIOCHEM BIOPH RES CO, V355, P842, DOI 10.1016/j.bbrc.2007.02.045; Narumiya S, 2000, METHOD ENZYMOL, V325, P273; Nikolic M, 2002, INT J BIOCHEM CELL B, V34, P731, DOI 10.1016/S1357-2725(01)00167-4; Nusser N, 2006, CELL SIGNAL, V18, P704, DOI 10.1016/j.cellsig.2005.06.010; O'Donnell M, 2009, ANNU REV NEUROSCI, V32, P383, DOI 10.1146/annurev.neuro.051508.135614; Paglini G, 2001, EUR J BIOCHEM, V268, P1528, DOI 10.1046/j.1432-1033.2001.02023.x; Park ER, 2007, CELL SIGNAL, V19, P1488, DOI 10.1016/j.cellsig.2007.01.018; Perlson E, 2005, NEURON, V45, P715, DOI 10.1016/j.neuron.2005.01.023; Perron JC, 1999, MOL CELL NEUROSCI, V13, P362, DOI 10.1006/mcne.1999.0753; Pertz OC, 2008, P NATL ACAD SCI USA, V105, P1931, DOI 10.1073/pnas.0706545105; PHAM CD, 1995, ONCOGENE, V10, P1683; Piper M, 2007, ADV EXP MED BIOL, V621, P134, DOI 10.1007/978-0-387-76715-4_10; Plantman S, 2008, MOL CELL NEUROSCI, V39, P50, DOI 10.1016/j.mcn.2008.05.015; Pouyssegur J, 2002, BIOCHEM PHARMACOL, V64, P755, DOI 10.1016/S0006-2952(02)01135-8; Prager-Khoutorsky M, 2009, BRAIN RES, V1251, P65, DOI 10.1016/j.brainres.2008.10.049; Pullikuth AK, 2007, CELL SIGNAL, V19, P1621, DOI 10.1016/j.cellsig.2007.04.012; Quinn CC, 2008, TRENDS CELL BIOL, V18, P597, DOI 10.1016/j.tcb.2008.09.005; Ramos JW, 2008, INT J BIOCHEM CELL B, V40, P2707, DOI 10.1016/j.biocel.2008.04.009; Round J, 2007, CURR OPIN NEUROBIOL, V17, P15, DOI 10.1016/j.conb.2007.01.003; Sayas CL, 1999, J BIOL CHEM, V274, P37046, DOI 10.1074/jbc.274.52.37046; Sayas CL, 2002, BBA-MOL CELL BIOL L, V1582, P144, DOI 10.1016/S1388-1981(02)00149-X; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Shelly M, 2010, SCIENCE, V327, P547, DOI 10.1126/science.1179735; Slack-Davis JK, 2003, J CELL BIOL, V162, P281, DOI 10.1083/jcb.200212141; Spencer TK, 2008, MOL CELL NEUROSCI, V38, P110, DOI 10.1016/j.mcn.2008.02.005; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Suetsugu S, 2002, DEV CELL, V3, P645, DOI 10.1016/S1534-5807(02)00324-6; Tahirovic S, 2010, J NEUROSCI, V30, P6930, DOI 10.1523/JNEUROSCI.5395-09.2010; Tan CSH, 2009, PROTEOMICS, V9, P5233, DOI 10.1002/pmic.200900266; Tigyi G, 1996, J NEUROCHEM, V66, P537; To KCW, 2008, NEUROSCIENCE, V153, P645, DOI 10.1016/j.neuroscience.2008.02.043; Tucker BA, 2008, CELL SIGNAL, V20, P241, DOI 10.1016/j.cellsig.2007.10.014; Van Hoof D, 2009, CELL STEM CELL, V5, P214, DOI 10.1016/j.stem.2009.05.021; van Horck FPG, 2004, CURR OPIN NEUROBIOL, V14, P61, DOI 10.1016/j.conb.2004.01.002; van Vugt MATM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000287; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Vogelezang M, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-44; Wang YC, 2007, P NATL ACAD SCI USA, V104, P8328, DOI 10.1073/pnas.0701103104; Woodring PJ, 2002, J CELL BIOL, V156, P879, DOI 10.1083/jcb.200110014; Wu HT, 2009, BBA-MOL CELL BIOL L, V1791, P8, DOI 10.1016/j.bbalip.2008.10.004; Xiang Y, 2002, NAT NEUROSCI, V5, P843, DOI 10.1038/nn899; Yamauchi J, 2006, EXP CELL RES, V312, P2954, DOI 10.1016/j.yexcr.2006.05.016; Yang F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014152; Yang YC, 2006, MOL CELL BIOL, V26, P8357, DOI 10.1128/MCB.01017-06; Yasui H, 2010, FREE RADICAL RES, V44, P645, DOI 10.3109/10715761003692537; Yee KL, 2008, IET SYST BIOL, V2, P8, DOI 10.1049/iet-syb:20060058; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Zhang XF, 2003, NEURON, V40, P931, DOI 10.1016/S0896-6273(03)00754-2	116	16	16	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					18190	18201		10.1074/jbc.M111.236133	http://dx.doi.org/10.1074/jbc.M111.236133			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454597	hybrid, Green Published			2022-12-25	WOS:000290585200079
J	Georgelis, N; Tabuchi, A; Nikolaidis, N; Cosgrove, DJ				Georgelis, Nikolaos; Tabuchi, Akira; Nikolaidis, Nikolas; Cosgrove, Daniel J.			Structure-Function Analysis of the Bacterial Expansin EXLX1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLULOSE-BINDING DOMAIN; PROTEIN SECONDARY STRUCTURE; PLANT-CELL WALLS; CIRCULAR-DICHROISM SPECTROSCOPY; LYTIC TRANSGLYCOSYLASE-B; DEEP-WATER RICE; CLOSTRIDIUM-CELLULOVORANS; CRYSTAL-STRUCTURE; GENE-EXPRESSION; BETA-EXPANSINS	We made use of EXLX1, an expansin from Bacillus subtilis, to investigate protein features essential for its plant cell wall binding and wall loosening activities. We found that the two expansin domains, D1 and D2, need to be linked for wall extension activity and that D2 mediates EXLX1 binding to whole cell walls and to cellulose via distinct residues on the D2 surface. Binding to cellulose is mediated by three aromatic residues arranged linearly on the putative binding surface that spans D1 and D2. Mutation of these three residues to alanine eliminated cellulose binding and concomitantly eliminated wall loosening activity measured either by cell wall extension or by weakening of filter paper but hardly affected binding to whole cell walls, which is mediated by basic residues located on other D2 surfaces. Mutation of these basic residues to glutamine reduced cell wall binding but not wall loosening activities. We propose domain D2 as the founding member of a new carbohydrate binding module family, CBM63, but its function in expansin activity apparently goes beyond simply anchoring D1 to the wall. Several polar residues on the putative binding surface of domain D1 are also important for activity, most notably Asp82, whose mutation to alanine or asparagine completely eliminated wall loosening activity. The functional insights based on this bacterial expansin may be extrapolated to the interactions of plant expansins with cell walls.	[Georgelis, Nikolaos; Tabuchi, Akira; Nikolaidis, Nikolas; Cosgrove, Daniel J.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Georgelis, N (corresponding author), Penn State Univ, Dept Biol, University Pk, PA 16802 USA.	nug5@psu.edu	/AAE-9630-2019		United States Department of Energy, Office of Basic Energy Sciences [DE-FG02-84ER13179]	United States Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE))	This work was supported by United States Department of Energy Grant DE-FG02-84ER13179 from the Office of Basic Energy Sciences.	Ali MK, 2001, BIOSCI BIOTECH BIOCH, V65, P41, DOI 10.1271/bbb.65.41; Barre A, 2002, BIOCHEM BIOPH RES CO, V296, P1346, DOI 10.1016/S0006-291X(02)02091-0; Bolam DN, 1998, BIOCHEM J, V331, P775, DOI 10.1042/bj3310775; Boraston AB, 2003, J BIOL CHEM, V278, P6120, DOI 10.1074/jbc.M209554200; Boraston AB, 2000, BIOCHEMISTRY-US, V39, P11129, DOI 10.1021/bi0007728; Bras JLA, 2011, P NATL ACAD SCI USA, V108, P5237, DOI 10.1073/pnas.1015006108; Brummell DA, 1999, PLANT MOL BIOL, V39, P161, DOI 10.1023/A:1006130018931; CARPITA NC, 1984, PLANT PHYSIOL, V76, P205, DOI 10.1104/pp.76.1.205; Carpita NC, 2001, PLANT PHYSIOL, V127, P551, DOI 10.1104/pp.010146; Charnock SJ, 2002, P NATL ACAD SCI USA, V99, P14077, DOI 10.1073/pnas.212516199; Charnock SJ, 2000, BIOCHEMISTRY-US, V39, P5013, DOI 10.1021/bi992821q; Cho HT, 2000, P NATL ACAD SCI USA, V97, P9783, DOI 10.1073/pnas.160276997; Cho HT, 2002, PLANT CELL, V14, P3237, DOI 10.1105/tpc.006437; Cho HT, 1997, PLANT CELL, V9, P1661, DOI 10.1105/tpc.9.9.1661; Choi DS, 2003, PLANT CELL, V15, P1386, DOI 10.1105/tpc.011965; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Cosgrove DJ, 1996, BIOESSAYS, V18, P533, DOI 10.1002/bies.950180704; Cosgrove DJ, 1997, P NATL ACAD SCI USA, V94, P6559, DOI 10.1073/pnas.94.12.6559; Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Davies GJ, 1995, BIOCHEMISTRY-US, V34, P16210, DOI 10.1021/bi00049a037; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gilbert HJ, 2010, PLANT PHYSIOL, V153, P444, DOI 10.1104/pp.110.156646; GILKES NR, 1988, J BIOL CHEM, V263, P10401; GOLDSTEIN MA, 1993, J BACTERIOL, V175, P5762, DOI 10.1128/JB.175.18.5762-5768.1993; GOLDSTEIN MA, 1994, J BACTERIOL, V176, P7328, DOI 10.1128/JB.176.23.7328-7334.1994; HALL J, 1995, BIOCHEM J, V309, P749, DOI 10.1042/bj3090749; Hall M, 2010, FEBS J, V277, P1571, DOI 10.1111/j.1742-4658.2010.07585.x; Henshaw JL, 2004, J BIOL CHEM, V279, P21552, DOI 10.1074/jbc.M401620200; Herve C, 2010, P NATL ACAD SCI USA, V107, P15293, DOI 10.1073/pnas.1005732107; HESTRIN S, 1954, BIOCHEM J, V58, P345, DOI 10.1042/bj0580345; Jahr H, 2000, MOL PLANT MICROBE IN, V13, P703, DOI 10.1094/MPMI.2000.13.7.703; Kende H, 2004, PLANT MOL BIOL, V55, P311, DOI 10.1007/s11103-004-0158-6; Kerff F, 2008, P NATL ACAD SCI USA, V105, P16876, DOI 10.1073/pnas.0809382105; Kim ES, 2009, BIOTECHNOL BIOENG, V102, P1342, DOI 10.1002/bit.22193; Koivula A, 2002, J AM CHEM SOC, V124, P10015, DOI 10.1021/ja012659q; Lee Y, 2001, PLANT PHYSIOL, V127, P645, DOI 10.1104/pp.010345; Lees JG, 2006, BIOINFORMATICS, V22, P1955, DOI 10.1093/bioinformatics/btl327; Li LC, 2003, PLANT PHYSIOL, V132, P2073, DOI 10.1104/pp.103.020024; Li Y, 2002, PLANT PHYSIOL, V128, P854, DOI 10.1104/pp.010658; Linder M, 1996, J BIOL CHEM, V271, P21268, DOI 10.1074/jbc.271.35.21268; MAGLIONE G, 1992, APPL ENVIRON MICROB, V58, P3593, DOI 10.1128/AEM.58.11.3593-3597.1992; McLean BW, 2000, PROTEIN ENG, V13, P801, DOI 10.1093/protein/13.11.801; MCQUEENMASON S, 1992, PLANT CELL, V4, P1425, DOI 10.1105/tpc.4.11.1425; MCQUEENMASON S, 1994, P NATL ACAD SCI USA, V91, P6574, DOI 10.1073/pnas.91.14.6574; MCQUEENMASON SJ, 1995, PLANT PHYSIOL, V107, P87, DOI 10.1104/pp.107.1.87; Murashima K, 2005, J BACTERIOL, V187, P7146, DOI 10.1128/JB.187.20.7146-7149.2005; Pages S, 1997, J BACTERIOL, V179, P2810, DOI 10.1128/jb.179.9.2810-2816.1997; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pien S, 2001, P NATL ACAD SCI USA, V98, P11812, DOI 10.1073/pnas.191380498; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Reid CW, 2007, FEBS LETT, V581, P4988, DOI 10.1016/j.febslet.2007.09.037; Reid CW, 2004, FEBS LETT, V574, P73, DOI 10.1016/j.febslet.2004.08.006; Reinhardt D, 1998, PLANT CELL, V10, P1427, DOI 10.1105/tpc.10.9.1427; Sampedro J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-242; Scheurwater E, 2008, INT J BIOCHEM CELL B, V40, P586, DOI 10.1016/j.biocel.2007.03.018; Shoseyov O, 2006, MICROBIOL MOL BIOL R, V70, P283, DOI 10.1128/MMBR.00028-05; TOMME P, 1988, EUR J BIOCHEM, V170, P575, DOI 10.1111/j.1432-1033.1988.tb13736.x; Valdivia ER, 2007, PLANT PHYSIOL, V143, P1269, DOI 10.1104/pp.106.092544; Valdivia ER, 2009, SEX PLANT REPROD, V22, P141, DOI 10.1007/s00497-009-0099-y; van Straaten KE, 2005, J MOL BIOL, V352, P1068, DOI 10.1016/j.jmb.2005.07.067; VANSTOKKUM IHM, 1990, ANAL BIOCHEM, V191, P110, DOI 10.1016/0003-2697(90)90396-Q; Vriezen WH, 2000, PLANTA, V210, P956, DOI 10.1007/s004250050703; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Whitney SEC, 2000, PLANT J, V22, P327, DOI 10.1046/j.1365-313x.2000.00742.x; Willats WGT, 2001, J BIOL CHEM, V276, P19404, DOI 10.1074/jbc.M011242200; Wu YJ, 2001, PLANT PHYSIOL, V126, P1471, DOI 10.1104/pp.126.4.1471; Yennawar NH, 2006, P NATL ACAD SCI USA, V103, P14664, DOI 10.1073/pnas.0605979103; Zenoni S, 2004, PLANT CELL, V16, P295, DOI 10.1105/tpc.018705; Zverlov VV, 2001, MICROBIOL-SGM, V147, P621, DOI 10.1099/00221287-147-3-621	71	85	89	2	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16814	16823		10.1074/jbc.M111.225037	http://dx.doi.org/10.1074/jbc.M111.225037			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454649	Green Published, hybrid			2022-12-25	WOS:000290301900031
J	Wen, Y; Li, WJ; Poteet, EC; Xie, LK; Tan, C; Yan, LJ; Ju, XH; Liu, R; Qian, H; Marvin, MA; Goldberg, MS; She, H; Mao, ZX; Simpkins, JW; Yang, SH				Wen, Yi; Li, Wenjun; Poteet, Ethan C.; Xie, Luokun; Tan, Cong; Yan, Liang-Jun; Ju, Xiaohua; Liu, Ran; Qian, Hai; Marvin, Marian A.; Goldberg, Matthew S.; She, Hua; Mao, Zixu; Simpkins, James W.; Yang, Shao-Hua			Alternative Mitochondrial Electron Transfer as a Novel Strategy for Neuroprotection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHYLENE-BLUE; PARKINSONS-DISEASE; COMPLEX-I; OXIDATIVE STRESS; COENZYME Q(10); ACUTE STROKE; DOUBLE-BLIND; MODELS; INHIBITION; DAMAGE	Neuroprotective strategies, including free radical scavengers, ion channel modulators, and anti-inflammatory agents, have been extensively explored in the last 2 decades for the treatment of neurological diseases. Unfortunately, none of the neuroprotectants has been proved effective in clinical trails. In the current study, we demonstrated that methylene blue (MB) functions as an alternative electron carrier, which accepts electrons from NADH and transfers them to cytochrome c and bypasses complex I/III blockage. A de novo synthesized MB derivative, with the redox center disabled by N-acetylation, had no effect on mitochondrial complex activities. MB increases cellular oxygen consumption rates and reduces anaerobic glycolysis in cultured neuronal cells. MB is protective against various insults in vitro at low nanomolar concentrations. Our data indicate that MB has a unique mechanism and is fundamentally different from traditional antioxidants. We examined the effects of MB in two animal models of neurological diseases. MB dramatically attenuates behavioral, neurochemical, and neuropathological impairment in a Parkinson disease model. Rotenone caused severe dopamine depletion in the striatum, which was almost completely rescued by MB. MB rescued the effects of rotenone on mitochondrial complex I-III inhibition and free radical overproduction. Rotenone induced a severe loss of nigral dopaminergic neurons, which was dramatically attenuated by MB. In addition, MB significantly reduced cerebral ischemia reperfusion damage in a transient focal cerebral ischemia model. The present study indicates that rerouting mitochondrial electron transfer by MB or similar molecules provides a novel strategy for neuroprotection against both chronic and acute neurological diseases involving mitochondrial dysfunction.	[Wen, Yi; Li, Wenjun; Poteet, Ethan C.; Xie, Luokun; Tan, Cong; Yan, Liang-Jun; Ju, Xiaohua; Liu, Ran; Qian, Hai; Simpkins, James W.; Yang, Shao-Hua] Univ N Texas, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Inst Alzheimers Dis & Aging Res, Ft Worth, TX 76107 USA; [Marvin, Marian A.; Goldberg, Matthew S.] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA; [Goldberg, Matthew S.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [She, Hua; Mao, Zixu] Emory Univ, Dept Pharmacol, Atlanta, GA 30322 USA; [She, Hua] Emory Univ, Dept Neurol, Atlanta, GA 30322 USA	University of North Texas System; University of North Texas Health Science Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Emory University; Emory University	Yang, SH (corresponding author), Univ N Texas, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Inst Alzheimers Dis & Aging Res, 3500 Camp Bowie Blvd, Ft Worth, TX 76107 USA.	shaohua.yang@unthsc.edu	Goldberg, Matthew/T-7827-2019; Wen, Yi/C-6013-2009; Yang, Shaohua/D-1738-2013	Liu, Ran/0000-0002-3882-0616; Yan, Liang-Jun/0000-0002-5815-5430; Goldberg, Matthew/0000-0002-5172-9841	National Institutes of Health [R01NS054687, R01NS054651, P01AG22550, P01AG10485, ES015317, AG023695, NS048254]; Alzheimer's Association [NIRG57698]; Texas Garvey Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054651, R01NS048254, R01NS054687] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG010485, R01AG023695, P01AG022550] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); Texas Garvey Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01NS054687 (to S.-H. Y.), R01NS054651 (to S.-H. Y.), P01AG22550 (to J. W. S.), P01AG10485 (to J. W. S.), ES015317 (to Z. M.), AG023695 (to Z. M.), and NS048254 (to Z. M.). This work was also supported by Alzheimer's Association Grant NIRG57698 (to Y. W.) and Texas Garvey Foundation (to Y. W.).	Atamna H, 2008, FASEB J, V22, P703, DOI 10.1096/fj.07-9610com; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Callaway NL, 2004, PHARMACOL BIOCHEM BE, V77, P175, DOI 10.1016/j.pbb.2003.10.007; Cassarino DS, 1997, BBA-MOL BASIS DIS, V1362, P77, DOI 10.1016/S0925-4439(97)00070-7; Chaturvedi RK, 2008, ANN NY ACAD SCI, V1147, P395, DOI 10.1196/annals.1427.027; Chen Q, 2008, AM J PHYSIOL-CELL PH, V294, pC460, DOI 10.1152/ajpcell.00211.2007; Demirbilek S, 2006, EUR SURG RES, V38, P35, DOI 10.1159/000091525; Dhillon Amanpreet S, 2008, J Agromedicine, V13, P37, DOI 10.1080/10599240801986215; Diener HC, 2008, STROKE, V39, P1751, DOI 10.1161/STROKEAHA.107.503334; Fukui H, 2008, TRENDS NEUROSCI, V31, P251, DOI 10.1016/j.tins.2008.02.008; Furian AF, 2007, NEUROCHEM INT, V50, P164, DOI 10.1016/j.neuint.2006.07.012; Galili Y, 1997, EUR SURG RES, V29, P390, DOI 10.1159/000129548; Galluzzi L, 2009, NAT REV NEUROSCI, V10, P481, DOI 10.1038/nrn2665; Gandhi S, 2005, HUM MOL GENET, V14, P2749, DOI 10.1093/hmg/ddi308; Ganguly A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011253; Ginsberg MD, 2008, NEUROPHARMACOLOGY, V55, P363, DOI 10.1016/j.neuropharm.2007.12.007; Greenamyre JT, 1999, BIOCHEM SOC SYMP, V66, P85, DOI 10.1042/bss0660085; HAAS RH, 1995, ANN NEUROL, V37, P714, DOI 10.1002/ana.410370604; Haluzik M, 1999, ENDOCR RES, V25, P163, DOI 10.1080/07435809909066138; HRUSHESKY WJM, 1985, LANCET, V1, P565; Klintenberg R, 2003, EUR J PHARMACOL, V459, P231, DOI 10.1016/S0014-2999(02)02817-0; Ladiges W, 2010, AGING CELL, V9, P462, DOI 10.1111/j.1474-9726.2010.00579.x; Lenaz G, 2004, METHOD ENZYMOL, V382, P3; Liu DZ, 2007, J ETHNOPHARMACOL, V112, P327, DOI 10.1016/j.jep.2007.03.022; Liu WC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004597; Lohe M, 2010, J NEUROL SCI, V289, P104, DOI 10.1016/j.jns.2009.08.025; MARCZIN N, 1992, J PHARMACOL EXP THER, V263, P170; MAYER B, 1993, EUR HEART J, V14, P22; MIZUNO Y, 1989, BIOCHEM BIOPH RES CO, V163, P1450, DOI 10.1016/0006-291X(89)91141-8; Muftuoglu M, 2004, MOVEMENT DISORD, V19, P544, DOI 10.1002/mds.10695; NAYLOR GJ, 1986, BIOL PSYCHIAT, V21, P915, DOI 10.1016/0006-3223(86)90265-9; NICKLAS WJ, 1985, LIFE SCI, V36, P2503, DOI 10.1016/0024-3205(85)90146-8; O'Lone R, 2007, MOL ENDOCRINOL, V21, P1281, DOI 10.1210/me.2006-0497; Olanow CW, 2008, ANN NEUROL, V64, pS101, DOI 10.1002/ana.21461; Peei G, 2001, NEPHROL DIAL TRANSPL, V16, P1436, DOI 10.1093/ndt/16.7.1436; Ramsay RR, 2007, BRIT J PHARMACOL, V152, P946, DOI 10.1038/sj.bjp.0707430; Rezzani R, 2001, NEPHRON, V89, P329, DOI 10.1159/000046094; Riedel W, 2003, MOL CELL BIOCHEM, V247, P83, DOI 10.1023/A:1024142400835; ROUSLIN W, 1983, AM J PHYSIOL, V244, pH743, DOI 10.1152/ajpheart.1983.244.6.H743; Schaller B, 2004, J CEREBR BLOOD F MET, V24, P351, DOI 10.1097/00004647-200404000-00001; Seo BB, 2006, J BIOL CHEM, V281, P14250, DOI 10.1074/jbc.M600922200; Srinivasan J, 2004, BEHAV BRAIN RES, V151, P191, DOI 10.1016/j.bbr.2003.08.016; Storch A, 2007, ARCH NEUROL-CHICAGO, V64, P938, DOI 10.1001/archneur.64.7.nct60005; Testa CM, 2005, MOL BRAIN RES, V134, P109, DOI 10.1016/j.molbrainres.2004.11.007; TOKUMITSU Y, 1973, BIOCHIM BIOPHYS ACTA, V292, P310, DOI 10.1016/0005-2728(73)90038-8; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; Vosler PS, 2009, STROKE, V40, P3149, DOI 10.1161/STROKEAHA.108.543769; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Yang LC, 2009, J NEUROCHEM, V109, P1427, DOI 10.1111/j.1471-4159.2009.06074.x; Yao J, 2009, P NATL ACAD SCI USA, V106, P14670, DOI 10.1073/pnas.0903563106	51	194	204	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.208447	http://dx.doi.org/10.1074/jbc.M110.208447			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454572	hybrid, Green Published			2022-12-25	WOS:000290022800087
J	Babigumira, JB; Castelnuovo, B; Stergachis, A; Kiragga, A; Shaefer, P; Lamorde, M; Kambugu, A; Muwanga, A; Garrison, LP				Babigumira, Joseph B.; Castelnuovo, Barbara; Stergachis, Andy; Kiragga, Agnes; Shaefer, Petra; Lamorde, Mohammed; Kambugu, Andrew; Muwanga, Alice; Garrison, Louis P.			Cost Effectiveness of a Pharmacy-Only Refill Program in a Large Urban HIV/AIDS Clinic in Uganda	PLOS ONE			English	Article							HUMAN-RESOURCES; HEALTH; CARE	Background: HIV/AIDS clinics in Uganda and other low-income countries face increasing numbers of patients and workforce shortages. We performed a cost-effectiveness analysis comparing a Pharmacy-only Refill Program (PRP), a form of task-shifting, to the Standard of Care (SOC) at a large HIV/AIDS clinic in Uganda, the Infectious Diseases Institute (IDI). The PRP was started to reduce workforce shortages and optimize patient care by substituting pharmacy visits for SOC involving monthly physician visits for accessing antiretroviral medicines. Methodology/Principal Findings: We used a retrospective cohort analysis to compare the effectiveness of the PRP compared to SOC. Effectiveness was defined as Favorable Immune Response (FIR), measured as having a CD4 lymphocyte count of over 500 cells/mu l at follow-up. We used multivariate logistic regression to assess the difference in FIR between patients in the PRP and SOC. We incorporated estimates of effectiveness into an incremental cost-effectiveness analysis performed from a limited societal perspective. We estimated costs from previous studies at IDI and conducted univariate and probabilistic sensitivity analyses. We identified 829 patients, 578 in the PRP and 251 in SOC. After 12.8 months (PRP) and 15.1 months (SOC) of follow-up, 18.9% of patients had a FIR, 18.6% in the PRP and 19.6% in SOC. There was a non-significant 9% decrease in the odds of having a FIR for PRP compared to SOC after adjusting for other variables (OR 0.93, 95% CI 0.55-1.58). The PRP was less costly than the SOC (US$ 520 vs. 655 annually, respectively). The incremental cost-effectiveness ratio comparing PRP to SOC was US$ 13,500 per FIR. PRP remained cost-effective at univariate and probabilistic sensitivity analysis. Conclusion/Significance: The PRP is more cost-effective than the standard of care. Similar task-shifting programs might help large HIV/AIDS clinics in Uganda and other low-income countries to cope with increasing numbers of patients seeking care.	[Babigumira, Joseph B.; Stergachis, Andy; Garrison, Louis P.] Univ Washington, Sch Pharm, Pharmaceut Outcomes Res & Policy Program, Seattle, WA 98195 USA; [Castelnuovo, Barbara; Kiragga, Agnes; Shaefer, Petra; Lamorde, Mohammed; Kambugu, Andrew; Muwanga, Alice] Makerere Univ, Infect Dis Inst, Kampala, Uganda; [Stergachis, Andy] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Stergachis, Andy] Univ Washington, Sch Publ Hlth, Dept Global Hlth, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Makerere University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Babigumira, JB (corresponding author), Univ Washington, Sch Pharm, Pharmaceut Outcomes Res & Policy Program, Seattle, WA 98195 USA.	babijo@uw.edu	Babigumira, Joseph/T-4208-2019		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757] Funding Source: NIH RePORTER; NIAID NIH HHS [P30 AI027757] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		[Anonymous], 2022, WORLD HLTH STAT; Anyangwe Stella C E, 2007, Int J Environ Res Public Health, V4, P93, DOI 10.3390/ijerph2007040002; Babigumira JB, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-192; Bemelmans M, 2010, TROP MED INT HEALTH, V15, P1413, DOI 10.1111/j.1365-3156.2010.02649.x; Brentlinger PE, 2010, HUM RESOUR HEALTH, V8, DOI 10.1186/1478-4491-8-23; Callaghan M, 2010, HUM RESOUR HEALTH, V8, DOI 10.1186/1478-4491-8-8; Castelnuovo B, 2009, INT J STD AIDS, V20, P123, DOI 10.1258/ijsa.2008.008174; Chen L, 2004, LANCET, V364, P1984, DOI 10.1016/S0140-6736(04)17482-5; Garrison LP, 2010, VALUE HEALTH, V13, P8, DOI 10.1111/j.1524-4733.2009.00660.x; Gold MR, 1996, COST EFFECTIVENESS H; Jaffar S, 2009, LANCET, V374, P2080, DOI 10.1016/S0140-6736(09)61674-3; *JOINT UN PROGR HI, 2009, AIDS EP UPD; McCollum ED, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009626; Morris MB, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-5; Price J, 2010, DEV WORLD BIOETH, V10, P99, DOI 10.1111/j.1471-8847.2010.00281.x; Samb B, 2007, NEW ENGL J MED, V357, P2510, DOI 10.1056/NEJMsb071889; Sanne I, 2010, LANCET, V376, P33, DOI 10.1016/S0140-6736(10)60894-X; SCHRANTZ S, 2007, 45 ANN C INF DIS SOC; Selke HM, 2010, JAIDS-J ACQ IMM DEF, V55, P483, DOI 10.1097/QAI.0b013e3181eb5edb; Shumbusho F, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000163; TUGUME SB, 1995, CLIN DIAGN LAB IMMUN, V2, P233, DOI 10.1128/CDLI.2.2.233-235.1995; *WHOCHOICE, 2010, EST UN COSTS PAT SER; Zachariah R, 2009, T ROY SOC TROP MED H, V103, P549, DOI 10.1016/j.trstmh.2008.09.019	23	40	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e18193	10.1371/journal.pone.0018193	http://dx.doi.org/10.1371/journal.pone.0018193			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464895	Green Submitted, Green Published, gold			2022-12-25	WOS:000289053800027
J	Timpka, T; Eriksson, H; Gursky, EA; Stromgren, M; Holm, E; Ekberg, J; Eriksson, O; Grimvall, A; Valter, L; Nyce, JM				Timpka, Toomas; Eriksson, Henrik; Gursky, Elin A.; Stromgren, Magnus; Holm, Einar; Ekberg, Joakim; Eriksson, Olle; Grimvall, Anders; Valter, Lars; Nyce, James M.			Requirements and Design of the PROSPER Protocol for Implementation of Information Infrastructures Supporting Pandemic Response: A Nominal Group Study	PLOS ONE			English	Article							PUBLIC-HEALTH; INFECTIOUS-DISEASE; INFLUENZA; SURVEILLANCE; SYSTEMS; EVOLUTION; QUALITY; CARE; EPIDEMIOLOGY; UNCERTAINTY	Background: Advanced technical systems and analytic methods promise to provide policy makers with information to help them recognize the consequences of alternative courses of action during pandemics. Evaluations still show that response programs are insufficiently supported by information systems. This paper sets out to derive a protocol for implementation of integrated information infrastructures supporting regional and local pandemic response programs at the stage(s) when the outbreak no longer can be contained at its source. Methods: Nominal group methods for reaching consensus on complex problems were used to transform requirements data obtained from international experts into an implementation protocol. The analysis was performed in a cyclical process in which the experts first individually provided input to working documents and then discussed them in conferences calls. Argument-based representation in design patterns was used to define the protocol at technical, system, and pandemic evidence levels. Results: The Protocol for a Standardized information infrastructure for Pandemic and Emerging infectious disease Response (PROSPER) outlines the implementation of information infrastructure aligned with pandemic response programs. The protocol covers analyses of the community at risk, the response processes, and response impacts. For each of these, the protocol outlines the implementation of a supporting information infrastructure in hierarchical patterns ranging from technical components and system functions to pandemic evidence production. Conclusions: The PROSPER protocol provides guidelines for implementation of an information infrastructure for pandemic response programs both in settings where sophisticated health information systems already are used and in developing communities where there is limited access to financial and technical resources. The protocol is based on a generic health service model and its functions are adjusted for community-level analyses of outbreak detection and progress, and response program effectiveness. Scientifically grounded reporting principles need to be established for interpretation of information derived from outbreak detection algorithms and predictive modeling.	[Timpka, Toomas; Ekberg, Joakim; Valter, Lars; Nyce, James M.] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden; [Timpka, Toomas; Eriksson, Henrik; Ekberg, Joakim; Eriksson, Olle; Grimvall, Anders] Linkoping Univ, Dept Comp Sci, Linkoping, Sweden; [Gursky, Elin A.] ANSER Analyt Serv Inc, Natl Strategies Support Directorate, Arlington, VA USA; [Stromgren, Magnus; Holm, Einar] Umea Univ, Dept Social & Econ Geog, Umea, Sweden; [Nyce, James M.] Ball State Univ, Dept Anthropol, Muncie, IN 47306 USA	Linkoping University; Linkoping University; Umea University; Ball State University	Timpka, T (corresponding author), Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden.	toomas.timpka@liu.se	Timpka, Toomas/E-8065-2018		Swedish Research Council [2006-4433, 2008-5252]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This research was supported by the Swedish Research Council (www.vr.se) under contracts 2006-4433 and 2008-5252. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKOFF RL, 1979, J OPER RES SOC, V30, P189, DOI 10.1057/jors.1979.41; Alexander C., 1979, TIMELESS WAY BUILDIN; Armstrong R, 2006, J PUBLIC HEALTH-UK, V28, P384, DOI 10.1093/pubmed/fdl072; Buckeridge DL, 2008, J AM MED INFORM ASSN, V15, P760, DOI 10.1197/jamia.M2799; BUSCHMANN F, 1996, SYSTEM PATTERNS PATT; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Dato V, 2004, PUBLIC HEALTH REP, V119, P464, DOI 10.1016/j.phr.2004.07.003; Davidoff F, 2008, QUAL SAF HEALTH CARE, V17, P3, DOI 10.1136/qshc.2008.029066; DONABEDIAN A, 1966, MILBANK FUND Q, V44, P166, DOI 10.2307/3348969; Eccles MP, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-18; EKBERG J, 2009, ELECT HEALTHCARE, P28; Eriksson Henrik, 2009, AMIA Annu Symp Proc, V2009, P173; Eriksson H, 2007, STUD HEALTH TECHNOL, V129, P755; ERIKSSON O, 2007, THESIS LINKOPING U L; Ernesater A, 2009, J ADV NURS, V65, P1074, DOI 10.1111/j.1365-2648.2009.04966.x; Gennari JH, 2003, INT J HUM-COMPUT ST, V58, P89, DOI 10.1016/S1071-5819(02)00127-1; Halloran ME, 2008, P NATL ACAD SCI USA, V105, P4639, DOI 10.1073/pnas.0706849105; HOLM E, 2002, GERUM, V4; Holm E, 2007, STUD HEALTH TECHNOL, V129, P464; Hutwagner L, 2003, J URBAN HEALTH, V80, pI89; JONES J, 1995, BRIT MED J, V311, P376, DOI 10.1136/bmj.311.7001.376; KNORR E, 2008, INFOWORLD       0407; Krumkamp R, 2009, HEALTH POLICY, V92, P21, DOI 10.1016/j.healthpol.2009.01.006; Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059; Levy PP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-179; Liechti R, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq004; Lipsitch M, 2009, NEW ENGL J MED, V361, P112, DOI 10.1056/NEJMp0904380; MONLONEY A, 2009, LANCET, V373, P1591; Morse SS, 2007, HEALTH AFFAIR, V26, P1069, DOI 10.1377/hlthaff.26.4.1069; Mounier-Jack S, 2007, B WORLD HEALTH ORGAN, V85, P923, DOI 10.2471/BLT.06.039834; Naditz A, 2009, TELEMED J E-HEALTH, V15, P825, DOI 10.1089/tmj.2009.9938; Pappaioanou M, 2003, SOC SCI MED, V57, P1925, DOI 10.1016/S0277-9536(03)00058-3; Perry HN, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-24; Petric M, 2006, J INFECT DIS, V194, pS98, DOI 10.1086/507554; RAINE R, 2005, BMJ-BRIT MED J, V331, P6313; Ringel JS, 2009, DISASTER MED PUBLIC, V3, pS160, DOI 10.1097/DMP.0b013e3181ad1833; RITTEL HWJ, 1973, POLICY SCI, V4, P155, DOI 10.1007/BF01405730; SANDIFORD P, 1992, SOC SCI MED, V34, P1077, DOI 10.1016/0277-9536(92)90281-T; Sintchenko V, 2009, ARCH PATHOL LAB MED, V133, P916, DOI 10.1043/1543-2165-133.6.916; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Suk JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001253; Ten Eyck RP, 2008, PREHOSPITAL DISASTER, V23, P103, DOI 10.1017/S1049023X00005707; Timpka T, 2009, B WORLD HEALTH ORGAN, V87, P305, DOI 10.2471/BLT.07.050203; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI [10.1016/j.jclinepi.2007.11.008, 10.2471/BLT.07.045120]; Wahlin K, 2008, ENVIRON SCI POLICY, V11, P115, DOI 10.1016/j.envsci.2007.12.001; Wilson JW, 1998, B AM METEOROL SOC, V79, P2079, DOI 10.1175/1520-0477(1998)079<2079:NTASR>2.0.CO;2; Wilson Nick, 2005, Hum Resour Health, V3, P7, DOI 10.1186/1478-4491-3-7; Wirehn ABE, 2007, SCAND J PUBLIC HEALT, V35, P424, DOI 10.1080/14034940701195230; 2009, LANCET INFECT DIS, V9, P331	49	16	17	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e17941	10.1371/journal.pone.0017941	http://dx.doi.org/10.1371/journal.pone.0017941			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	743XV	21464918	Green Published, Green Submitted, gold			2022-12-25	WOS:000289053800006
J	Pedersen, KS; Bamlet, WR; Oberg, AL; de Andrade, M; Matsumoto, ME; Tang, H; Thibodeau, SN; Petersen, GM; Wang, LA				Pedersen, Katrina S.; Bamlet, William R.; Oberg, Ann L.; de Andrade, Mariza; Matsumoto, Martha E.; Tang, Hui; Thibodeau, Stephen N.; Petersen, Gloria M.; Wang, Liang			Leukocyte DNA Methylation Signature Differentiates Pancreatic Cancer Patients from Healthy Controls	PLOS ONE			English	Article							GELATINASE-ASSOCIATED LIPOCALIN; ABERRANT METHYLATION; SUSCEPTIBILITY; EPIGENETICS; CARCINOMA; BIOMARKER; INVASION; COMMON; BLOOD	Pancreatic adenocarcinoma (PaC) is one of most difficult tumors to treat. Much of this is attributed to the late diagnosis. To identify biomarkers for early detection, we examined DNA methylation differences in leukocyte DNA between PaC cases and controls in a two-phase study. In phase I, we measured methylation levels at 1,505 CpG sites in treatment-naive leukocyte DNA from 132 never-smoker PaC patients and 60 never-smoker healthy controls. We found significant differences in 110 CpG sites (false discovery rate < 0.05). In phase II, we tested and validated 88 of 96 phase I selected CpG sites in 240 PaC cases and 240 matched controls (p <= 0.05). Using penalized logistic regression, we built a prediction model consisting of five CpG sites (IL10_P348, LCN2_P86, ZAP70_P220, AIM2_P624, TAL1_P817) that discriminated PaC patients from controls (C-statistic = 0.85 in phase I; 0.76 in phase II). Interestingly, one CpG site (LCN2_P86) alone could discriminate resectable patients from controls (C-statistic = 0.78 in phase I; 0.74 in phase II). We also performed methylation quantitative trait loci (methQTL) analysis and identified three CpG sites (AGXT_P180_F, ALOX12_E85_R, JAK3_P1075_R) where the methylation levels were significantly associated with single nucleotide polymorphisms (SNPs) (false discovery rate,0.05). Our results demonstrate that epigenetic variation in easily obtainable leukocyte DNA, manifested by reproducible methylation differences, may be used to detect PaC patients. The methylation differences at certain CpG sites are partially attributable to genetic variation. This study strongly supports future epigenome-wide association study using leukocyte DNA for biomarker discovery in human diseases.	[Pedersen, Katrina S.] Mayo Clin, Coll Med, Dept Internal Med, Rochester, MN 55905 USA; [Bamlet, William R.; Oberg, Ann L.; de Andrade, Mariza; Matsumoto, Martha E.; Tang, Hui; Petersen, Gloria M.] Mayo Clin, Coll Med, Dept Hlth Sci, Rochester, MN USA; [Thibodeau, Stephen N.; Wang, Liang] Mayo Clin, Coll Med, Dept Lab Med & Pathol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Pedersen, KS (corresponding author), Mayo Clin, Coll Med, Dept Internal Med, Rochester, MN 55905 USA.	wang.liang@mayo.edu		Pedersen, Katrina/0000-0003-2793-6901; de Andrade, Mariza/0000-0003-2329-2686; Bamlet, William/0000-0003-2903-1284	Mayo Clinic SPORE in Pancreatic Cancer [P50 CA102701]; Department of Laboratory Medicine and Pathology, Mayo Clinic; NATIONAL CANCER INSTITUTE [R25CA092049, P50CA102701] Funding Source: NIH RePORTER	Mayo Clinic SPORE in Pancreatic Cancer; Department of Laboratory Medicine and Pathology, Mayo Clinic; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by Mayo Clinic SPORE in Pancreatic Cancer (P50 CA102701) and the Department of Laboratory Medicine and Pathology, Mayo Clinic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Boks MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006767; Duffy MJ, 2009, EUR J CANCER, V45, P335, DOI 10.1016/j.ejca.2008.12.008; Ebrahimi B, 2004, CANCER-AM CANCER SOC, V101, P2727, DOI 10.1002/cncr.20672; Faca VM, 2008, PLOS MED, V5, P953, DOI 10.1371/journal.pmed.0050123; Feinberg Andrew P, 2008, JAMA, V299, P1345, DOI 10.1001/jama.299.11.1345; Fukushima N, 2003, CANCER BIOL THER, V2, P78; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Goeman JJ, 2010, BIOMETRICAL J, V52, P70, DOI 10.1002/bimj.200900028; Hsiung DT, 2007, CANCER EPIDEM BIOMAR, V16, P108, DOI 10.1158/1055-9965.EPI-06-0636; Jansen M, 2002, CANCER BIOL THER, V1, P293, DOI 10.4161/cbt.84; Javierre BM, 2010, GENOME RES, V20, P170, DOI 10.1101/gr.100289.109; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kerkel K, 2008, NAT GENET, V40, P904, DOI 10.1038/ng.174; Lopez J, 2009, BRIT J CANCER, V100, P571, DOI 10.1038/sj.bjc.6604930; Matsubayashi H, 2006, CANCER RES, V66, P1208, DOI 10.1158/0008-5472.CAN-05-2664; Matsubayashi H, 2003, CLIN CANCER RES, V9, P1446; Moniaux N, 2008, BRIT J CANCER, V98, P1540, DOI 10.1038/sj.bjc.6604329; Moore LE, 2008, LANCET ONCOL, V9, P359, DOI 10.1016/S1470-2045(08)70038-X; *NCI, 2010, SEER STAT FACT SHEET; Petersen GM, 2010, NAT GENET, V42, P224, DOI 10.1038/ng.522; Poch B, 2007, LANGENBECK ARCH SURG, V392, P353, DOI 10.1007/s00423-006-0140-7; Sato N, 2005, ONCOGENE, V24, P850, DOI 10.1038/sj.onc.1208050; Sato N, 2003, CANCER RES, V63, P3735; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tan AC, 2009, MOL ONCOL, V3, P425, DOI 10.1016/j.molonc.2009.03.004; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tong ZM, 2008, CANCER RES, V68, P6100, DOI 10.1158/0008-5472.CAN-08-0540; Ueki T, 2000, CANCER RES, V60, P1835; *USPSTF, 2004, US PREV SERV TASK FO; Wang L, 2010, J THORAC ONCOL, V5, P778, DOI 10.1097/JTO.0b013e3181d6e0b3; Widschwendter M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002656; Zhang Yingying, 2009, PLoS Genet, V5, pe1000438, DOI 10.1371/journal.pgen.1000438	33	65	67	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2011	6	3							e18223	10.1371/journal.pone.0018223	http://dx.doi.org/10.1371/journal.pone.0018223			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740RG	21455317	gold, Green Submitted, Green Published			2022-12-25	WOS:000288811500030
J	Qiao, JJ; Li, SY; Wei, LX; Jiang, J; Long, R; Mao, H; Wei, L; Wang, LY; Yang, H; Grossniklaus, HE; Liu, ZR; Yang, JJ				Qiao, Jingjuan; Li, Shunyi; Wei, Lixia; Jiang, Jie; Long, Robert; Mao, Hui; Wei, Ling; Wang, Liya; Yang, Hua; Grossniklaus, Hans E.; Liu, Zhi-Ren; Yang, Jenny J.			HER2 Targeted Molecular MR Imaging Using a De Novo Designed Protein Contrast Agent	PLOS ONE			English	Article							BREAST-CANCER; IN-VIVO; RECEPTORS; CELLS	The application of magnetic resonance imaging (MRI) to non-invasively assess disease biomarkers has been hampered by the lack of desired contrast agents with high relaxivity, targeting capability, and optimized pharmacokinetics. We have developed a novel MR imaging probe targeting to HER2, a biomarker for various cancer types and a drug target for anticancer therapies. This multimodal HER20targeted MR imaging probe integrates a de novo designed protein contrast agent with a high affinity HER2 affibody and a near IR fluorescent dye. Our probe can differentially monitor tumors with different expression levels of HER2 in both human cell lines and xenograft mice models. In addition to its 100-fold higher dose efficiency compared to clinically approved non-targeting contrast agent DTPA, our developed agent also exhibits advantages in crossing the endothelial boundary, tissue distribution, and tumor tissue retention over reported contrast agents as demonstrated by even distribution of the imaging probe across the entire tumor mass. This contrast agent will provide a powerful tool for quantitative assessment of molecular markers, and improved resolution for diagnosis, prognosis and drug discovery.	[Qiao, Jingjuan; Li, Shunyi; Jiang, Jie; Wei, Ling; Yang, Jenny J.] Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA; [Wei, Lixia; Liu, Zhi-Ren] Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA; [Long, Robert; Mao, Hui; Wang, Liya] Emory Univ, Dept Radiol, Atlanta, GA 30322 USA; [Yang, Hua; Grossniklaus, Hans E.] Emory Univ, Sch Med, Dept Ophthalmol, Atlanta, GA 30322 USA	University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; Emory University; Emory University	Qiao, JJ (corresponding author), Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA.	biozrl@langate.gsu.edu; chejjy@langate.gsu.edu			NIH [CA118113, GM62999, EB007268]; Georgia State University; NATIONAL CANCER INSTITUTE [R01CA118113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB007268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062999] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia State University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported in part by research grants from NIH CA118113 to Zhi-Ren Liu, NIH GM62999 and EB007268 to Jenny J Yang, and Georgia State University Brain and Behavior fellowship to Jingjuan Qiao. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aime S, 2005, ANGEW CHEM INT EDIT, V44, P1813, DOI 10.1002/anie.200462566; Allison M, 2010, NAT BIOTECHNOL, V28, P117, DOI 10.1038/nbt0210-117; Artemov D, 2004, CURR PHARM BIOTECHNO, V5, P485, DOI 10.2174/1389201043376553; Chen T.-J., 2008, J BIOL INORG CHEM; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Crich SG, 2005, J BIOL INORG CHEM, V10, P78, DOI 10.1007/s00775-004-0616-2; Farokhzad OC, 2004, CANCER RES, V64, P7668, DOI 10.1158/0008-5472.CAN-04-2550; Frullano L, 2004, CHEM-EUR J, V10, P5205, DOI 10.1002/chem.200400369; Funovics MA, 2004, MAGN RESON IMAGING, V22, P843, DOI 10.1016/j.mri.2004.01.050; Gillies RJ, 2002, J MAGN RESON IMAGING, V16, P430, DOI 10.1002/jmri.10181; Gown AM, 2008, MODERN PATHOL, V21, pS8, DOI 10.1038/modpathol.2008.34; Kobayashi H, 2003, CANCER RES, V63, P271; Menard S, 2001, ANN ONCOL, V12, P15, DOI 10.1023/A:1011151505425; Morawski AM, 2004, MAGN RESON MED, V51, P480, DOI 10.1002/mrm.20010; Nunn A D, 1997, Q J Nucl Med, V41, P155; PARK JG, 1990, CANCER RES, V50, P2773; Phillips KA, 2009, CANCER-AM CANCER SOC, V115, P5166, DOI 10.1002/cncr.24574; Sherry AD, 2008, ANNU REV BIOMED ENG, V10, P391, DOI 10.1146/annurev.bioeng.9.060906.151929; Sipkins DA, 1998, NAT MED, V4, P623, DOI 10.1038/nm0598-623; Tagliabue E, 2001, BREAST CANCER RES TR, V70, P155, DOI 10.1023/A:1012955229031; Tweedle MF, 2009, ACCOUNTS CHEM RES, V42, P958, DOI 10.1021/ar800215p; Waters EA, 2008, BASIC RES CARDIOL, V103, P114, DOI 10.1007/s00395-008-0711-6; Weinmann HJ, 2003, EUR J RADIOL, V46, P33, DOI 10.1016/S0720-048X(02)00332-7; Weissleder R, 2008, NATURE, V452, P580, DOI 10.1038/nature06917; Wikman M, 2004, PROTEIN ENG DES SEL, V17, P455, DOI 10.1093/protein/gzh053; Yang DJ, 1998, CLIN CANCER RES, V4, P993; Yang JJ, 2008, J AM CHEM SOC, V130, P9260, DOI 10.1021/ja800736h; Yang W, 2005, J AM CHEM SOC, V127, P2085, DOI 10.1021/ja0431307; Zhu WL, 2008, MAGN RESON MED, V59, P679, DOI 10.1002/mrm.21508	29	32	37	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2011	6	3							e18103	10.1371/journal.pone.0018103	http://dx.doi.org/10.1371/journal.pone.0018103			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740RG	21455310	Green Published, Green Submitted, gold			2022-12-25	WOS:000288811500022
J	Zhang, Q; Chen, DD; Lin, J; Liao, RJ; Tong, W; Xu, ZN; Liu, W				Zhang, Qi; Chen, Dandan; Lin, Jun; Liao, Rijing; Tong, Wei; Xu, Zhinan; Liu, Wen			Characterization of NocL Involved in Thiopeptide Nocathiacin I Biosynthesis A [4Fe-4S] CLUSTER AND THE CATALYSIS OF A RADICAL S-ADENOSYLMETHIONINE ENZYME	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANAEROBIC RIBONUCLEOTIDE REDUCTASE; THIAZOLYL PEPTIDE ANTIBIOTICS; ESCHERICHIA-COLI; NOCARDIA SP; IRON; SULFUR; PROTEIN; SAM; SYNTHASE; SULFIDE	The radical S-adenosylmethionine (AdoMet) enzyme superfamily is remarkable at catalyzing chemically diverse and complex reactions. We have previously shown that NosL, which is involved in forming the indole side ring of the thiopeptide nosiheptide, is a radical AdoMet enzyme that processes L-Trp to afford 3-methyl-2-indolic acid (MIA) via an unusual fragmentation-recombination mechanism. We now report the expansion of the MIA synthase family by characterization of NocL, which is involved in nocathiacin I biosynthesis. EPR and UV-visible absorbance spectroscopic analyses demonstrated the interaction between L-Trp and the [4Fe-4S] cluster of NocL, leading to the assumption of nonspecific interaction of [4Fe-4S] cluster with other nucleophiles via the unique Fe site. This notion is supported by the finding of the heterogeneity in the [4Fe-4S] cluster of NocL in the absence of AdoMet, which was revealed by the EPR study at very low temperature. Furthermore, a free radical was observed by EPR during the catalysis, which is in good agreement with the hypothesis of a glycyl radical intermediate. Combined with the mutational analysis, these studies provide new insights into the function of the [4Fe-4S] cluster of radical AdoMet enzymes as well as the mechanism of the radical-mediated complex carbon chain rearrangement catalyzed by MIA synthase.	[Zhang, Qi; Chen, Dandan; Liao, Rijing; Liu, Wen] Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Bioorgan & Nat Prod Chem, Shanghai 200032, Peoples R China; [Chen, Dandan; Xu, Zhinan] Zhejiang Univ, Dept Chem Engn & Biotechnol, Hangzhou 310027, Peoples R China; [Lin, Jun] Chinese Acad Sci, Shanghai Inst Appl Phys, Shanghai 201800, Peoples R China; [Tong, Wei] Chinese Acad Sci, High Field Magnet Lab, Hefei 230031, Anhui, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS; Zhejiang University; Chinese Academy of Sciences; Shanghai Institute of Applied Physics, CAS; Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS	Liu, W (corresponding author), Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Bioorgan & Nat Prod Chem, 345 Lingling Rd, Shanghai 200032, Peoples R China.	wliu@mail.sioc.ac.cn	Chen, Dan/GRY-2691-2022	Chen, Dan/0000-0002-1570-9034; Xu, Zhinan/0000-0001-7833-026X	National Natural Science Foundation [20832009, 30525001, 20921091]; Ministry of Science and Technology [2009ZX09501-008]; National Basic Research Program ("973 Program") [2010CB833200]; Chinese Academy of Sciences [KJCX2-YW-H08, KSCX2-YW-G-06]; Science and Technology Commission of Shanghai Municipality of China [09QH1402700]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Basic Research Program ("973 Program")(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); Science and Technology Commission of Shanghai Municipality of China(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported in part by National Natural Science Foundation Grants 20832009, 30525001, and 20921091, Ministry of Science and Technology Grant 2009ZX09501-008, National Basic Research Program ("973 Program") Grant 2010CB833200, Chinese Academy of Sciences Grants KJCX2-YW-H08 and KSCX2-YW-G-06, and Science and Technology Commission of Shanghai Municipality of China Grant 09QH1402700.	Bagley MC, 2005, CHEM REV, V105, P685, DOI 10.1021/cr0300441; Beinert H, 2000, J BIOL INORG CHEM, V5, P2, DOI 10.1007/s007750050002; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; BEINERT H, 1983, ANAL BIOCHEM, V131, P373, DOI 10.1016/0003-2697(83)90186-0; Beinert H, 1996, CHEM REV, V96, P2335, DOI 10.1021/cr950040z; Brindley AA, 2010, FEBS LETT, V584, P2461, DOI 10.1016/j.febslet.2010.04.053; Chatterjee A, 2008, NAT CHEM BIOL, V4, P758, DOI 10.1038/nchembio.121; Cheek J, 2001, J BIOL INORG CHEM, V6, P209, DOI 10.1007/s007750100210; CHIRPICH TP, 1970, J BIOL CHEM, V245, P1778; Ding Y, 2010, MOL BIOSYST, V6, P1180, DOI 10.1039/c005121g; Driesener RC, 2010, ANGEW CHEM INT EDIT, V49, P1687, DOI 10.1002/anie.200907047; Frey PA, 2003, CHEM REV, V103, P2129, DOI 10.1021/cr020422m; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; Hanzelmann P, 2006, P NATL ACAD SCI USA, V103, P6829, DOI 10.1073/pnas.0510711103; Hanzelmann P, 2002, J BIOL CHEM, V277, P18303, DOI 10.1074/jbc.M200947200; Hanzelmann P, 2004, P NATL ACAD SCI USA, V101, P12870, DOI 10.1073/pnas.0404624101; Himo F, 2003, CHEM REV, V103, P2421, DOI 10.1021/cr020436s; Jarrett JT, 2003, CURR OPIN CHEM BIOL, V7, P174, DOI 10.1016/S1367-5931(03)00022-X; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; JOHNSON MK, 1994, ENCY INORGANIC CHEM, V4, P1896; KENNEDY MC, 1984, J BIOL CHEM, V259, P4463; Krieger CJ, 2001, J BIOL CHEM, V276, P12924, DOI 10.1074/jbc.M009453200; Kriek M, 2007, ANGEW CHEM INT EDIT, V46, P9223, DOI 10.1002/anie.200702554; Kriek M, 2007, J BIOL CHEM, V282, P17413, DOI 10.1074/jbc.M700782200; Layer G, 2005, J BIOL CHEM, V280, P29038, DOI 10.1074/jbc.M501275200; Leet JE, 2003, J ANTIBIOT, V56, P232, DOI 10.7164/antibiotics.56.232; Lendzian F, 1996, J AM CHEM SOC, V118, P8111, DOI 10.1021/ja960917r; Li WY, 2003, J ANTIBIOT, V56, P226, DOI 10.7164/antibiotics.56.226; Liu A, 2000, J BIOL CHEM, V275, P12367, DOI 10.1074/jbc.275.17.12367; Miller JE, 2003, J AM CHEM SOC, V125, P14220, DOI 10.1021/ja037203i; Nicolet Y, 2004, NUCLEIC ACIDS RES, V32, P4015, DOI 10.1093/nar/gkh728; Sambrook J, 2001, MOL CLONING LAB MANU; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Sun XY, 1996, J BIOL CHEM, V271, P6827, DOI 10.1074/jbc.271.12.6827; Walsby CJ, 2005, INORG CHEM, V44, P727, DOI 10.1021/ic0484811; Walsby CJ, 2002, J AM CHEM SOC, V124, P3143, DOI 10.1021/ja012034s; Yu Y, 2009, ACS CHEM BIOL, V4, P855, DOI 10.1021/cb900133x; Zhang Q, 2011, NAT CHEM BIOL, V7, P154, DOI [10.1038/nchembio.512, 10.1038/NCHEMBIO.512]	38	33	34	1	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21287	21294		10.1074/jbc.M111.224832	http://dx.doi.org/10.1074/jbc.M111.224832			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21454624	Green Published, hybrid			2022-12-25	WOS:000291464700027
J	Kumazawa, T; Nishimura, K; Kuroda, T; Ono, W; Yamaguchi, C; Katagiri, N; Tsuchiya, M; Masumoto, H; Nakajima, Y; Murayama, A; Kimura, K; Yanagisawa, J				Kumazawa, Takuya; Nishimura, Kazuho; Kuroda, Takao; Ono, Wakana; Yamaguchi, Chie; Katagiri, Naohiro; Tsuchiya, Mai; Masumoto, Hiroshi; Nakajima, Yuka; Murayama, Akiko; Kimura, Keiji; Yanagisawa, Junn			Novel Nucleolar Pathway Connecting Intracellular Energy Status with p53 Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOMAL-RNA SYNTHESIS; FACTOR TIF-IA; CELL-PROLIFERATION; DNA-BINDING; 18 S; PROTEIN; STRESS; KINASE; ACETYLATION; APOPTOSIS	In response to a shortage of intracellular energy, mammalian cells reduce energy consumption and induce cell cycle arrest, both of which contribute to cell survival. Here we report that a novel nucleolar pathway involving the energy-dependent nucleolar silencing complex (eNoSC) and Myb-binding protein 1a (MYBBP1A) is implicated in these processes. Namely, in response to glucose starvation, eNoSC suppresses rRNA transcription, which results in a reduction in nucleolar RNA content. As a consequence, MYBBP1A, which is anchored to the nucleolus via RNA, translocates from the nucleolus to the nucleoplasm. The translocated MYBBP1A induces acetylation and accumulation of p53 by enhancing the interaction between p300 and p53, which eventually leads to the cell cycle arrest (or apoptosis). Taken together, our results indicate that the nucleolus works as a sensor that transduces the intracellular energy status into the cell cycle machinery.	[Kumazawa, Takuya; Nishimura, Kazuho; Ono, Wakana; Yamaguchi, Chie; Katagiri, Naohiro; Tsuchiya, Mai; Masumoto, Hiroshi; Nakajima, Yuka; Murayama, Akiko; Kimura, Keiji; Yanagisawa, Junn] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058577, Japan; [Kuroda, Takao; Nakajima, Yuka; Murayama, Akiko; Yanagisawa, Junn] Univ Tsukuba, Ctr Tsukuba Adv Res Alliance, Tsukuba, Ibaraki 3058577, Japan; [Murayama, Akiko] JST, PREST, Saitama, Japan	University of Tsukuba; University of Tsukuba; Japan Science & Technology Agency (JST)	Yanagisawa, J (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058577, Japan.	junny@agbi.tsukuba.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan	Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a nuclear system to decipher operation code (DECODE) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan.	Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Boulon S, 2010, MOL CELL, V40, P216, DOI 10.1016/j.molcel.2010.09.024; Castle CD, 2010, MOL CELL BIOL, V30, P4404, DOI 10.1128/MCB.00358-10; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Holzel M, 2010, J BIOL CHEM, V285, P6364, DOI 10.1074/jbc.M109.054734; Honda R, 1999, EMBO J, V18, P22, DOI 10.1093/emboj/18.1.22; Hoppe S, 2009, P NATL ACAD SCI USA, V106, P17781, DOI 10.1073/pnas.0909873106; Ide T, 2009, MOL CELL, V36, P379, DOI 10.1016/j.molcel.2009.09.031; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Kuroda T, 2011, EMBO J, V30, P1054, DOI 10.1038/emboj.2011.23; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; Luo JY, 2004, P NATL ACAD SCI USA, V101, P2259, DOI 10.1073/pnas.0308762101; Mayer C, 2005, GENE DEV, V19, P933, DOI 10.1101/gad.333205; McMahon M, 2010, J BIOL CHEM, V285, P18309, DOI 10.1074/jbc.M110.108555; Murayama A, 2008, CELL, V133, P627, DOI 10.1016/j.cell.2008.03.030; Okoshi R, 2008, J BIOL CHEM, V283, P3979, DOI 10.1074/jbc.M705232200; Prives C, 1999, J PATHOL, V187, P112; Rubbi CP, 2003, EMBO J, V22, P6068, DOI 10.1093/emboj/cdg579; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991; Yuan XJ, 2005, MOL CELL, V19, P77, DOI 10.1016/j.molcel.2005.05.023	27	23	23	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20861	20869		10.1074/jbc.M110.209916	http://dx.doi.org/10.1074/jbc.M110.209916			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21471221	hybrid, Green Published			2022-12-25	WOS:000291267600070
J	Ruffell, B; Poon, GFT; Lee, SSM; Brown, KL; Tjew, SL; Cooper, J; Johnson, P				Ruffell, Brian; Poon, Grace F. T.; Lee, Sally S. M.; Brown, Kelly L.; Tjew, Sie-Lung; Cooper, Jessie; Johnson, Pauline			Differential Use of Chondroitin Sulfate to Regulate Hyaluronan Binding by Receptor CD44 in Inflammatory and Interleukin 4-activated Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERIPHERAL-BLOOD MONOCYTES; CELL-SURFACE RECEPTOR; SMOOTH-MUSCLE-CELLS; TNF-ALPHA; TRANSFORMING GROWTH-FACTOR-BETA-1; GROWTH-FACTOR; T-CELLS; ALTERNATIVE ACTIVATION; DENDRITIC CELLS; PROTEOGLYCAN	CD44 is a cell surface receptor for the extracellular matrix glycosaminoglycan hyaluronan and is involved in processes ranging from leukocyte recruitment to wound healing. In the immune system, the binding of hyaluronan to CD44 is tightly regulated, and exposure of human peripheral blood monocytes to inflammatory stimuli increases CD44 expression and induces hyaluronan binding. Here we sought to understand how mouse macrophages regulate hyaluronan binding upon inflammatory and anti-inflammatory stimuli. Mouse bone marrow-derived macrophages stimulated with tumor necrosis factor alpha or lipopolysaccharide and interferon-gamma (LPS/IFN gamma) induced hyaluronan binding by up-regulating CD44 and down-regulating chondroitin sulfation on CD44. Hyaluronan binding was induced to a lesser extent in interleukin-4 (IL-4)-activated macrophages despite increased CD44 expression, and this was attributable to increased chondroitin sulfation on CD44, as treatment with beta-D-xyloside to prevent chondroitin sulfate addition significantly enhanced hyaluronan binding. These changes in the chondroitin sulfation of CD44 were associated with changes in mRNA expression of two chondroitin sulfotransferases, CHST3 and CHST7, which were decreased in LPS/IFN gamma-stimulated macrophages and increased in IL-4-stimulated macrophages. Thus, inflammatory and anti-inflammatory stimuli differentially regulate the chondroitin sulfation of CD44, which is a dynamic physiological regulator of hyaluronan binding by CD44 in mouse macrophages.	[Ruffell, Brian; Poon, Grace F. T.; Lee, Sally S. M.; Brown, Kelly L.; Tjew, Sie-Lung; Cooper, Jessie; Johnson, Pauline] Univ British Columbia, Dept Microbiol & Immunol, Inst Life Sci, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Johnson, P (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, Inst Life Sci, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	pauline@mail.ubc.ca	Johnson, Pauline/G-9659-2019	Johnson, Pauline/0000-0001-7367-4653; Ruffell, Brian/0000-0002-3846-6872; Brown, Kelly/0000-0001-5385-3582	Canadian Institutes of Health Research [81314]; Heart and Stroke Foundation of British Columbia and Yukon, Canada; Heart and Stroke Foundation of British Columbia and Yukon; Natural Sciences and Engineering Research Council of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of British Columbia and Yukon, Canada; Heart and Stroke Foundation of British Columbia and Yukon; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported in part by Canadian Institutes of Health Research Grant 81314 (to P. J.) and a grant from the Heart and Stroke Foundation of British Columbia and Yukon, Canada.; Supported by a fellowship from the Heart and Stroke Foundation of British Columbia and Yukon.; Supported by a fellowship from the Natural Sciences and Engineering Research Council of Canada.	Antonchuk J, 2001, EXP HEMATOL, V29, P1125, DOI 10.1016/S0301-472X(01)00681-6; ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; Banerji S, 2007, NAT STRUCT MOL BIOL, V14, P234, DOI 10.1038/nsmb1201; Brown KL, 2011, J IMMUNOL, V186, P5497, DOI 10.4049/jimmunol.1002508; Brown KL, 2005, EXP CELL RES, V303, P400, DOI 10.1016/j.yexcr.2004.10.002; Brown KL, 2001, J IMMUNOL, V167, P5367, DOI 10.4049/jimmunol.167.9.5367; Clark RAF, 2004, J INVEST DERMATOL, V122, P266, DOI 10.1046/j.0022-202X.2004.22205.x; Crowther M, 2001, J LEUKOCYTE BIOL, V70, P478; Cuff CA, 2001, J CLIN INVEST, V108, P1031, DOI 10.1172/JCI12455; CULTY M, 1994, J LEUKOCYTE BIOL, V56, P605, DOI 10.1002/jlb.56.5.605; CULTY M, 1992, J CELL BIOL, V116, P1055, DOI 10.1083/jcb.116.4.1055; DEBELDER AN, 1975, CARBOHYD RES, V44, P251, DOI 10.1016/S0008-6215(00)84168-3; Delcommenne M, 2002, GLYCOBIOLOGY, V12, P613, DOI 10.1093/glycob/cwf080; DOUGHERTY GJ, 1994, J BIOL CHEM, V269, P9074; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Ehnis T, 1996, EXP CELL RES, V229, P388, DOI 10.1006/excr.1996.0384; English NM, 1998, CANCER RES, V58, P3736; FAASSEN AE, 1993, J CELL SCI, V105, P501; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Gordon S, 2007, EUR J IMMUNOL, V37, pS9, DOI 10.1002/eji.200737638; Hayes GM, 2002, J BIOL CHEM, V277, P50529, DOI 10.1074/jbc.M206719200; Henke CA, 1996, J CLIN INVEST, V97, P2541, DOI 10.1172/JCI118702; Hollingsworth JW, 2007, AM J RESP CELL MOL, V37, P248, DOI 10.1165/rcmb.2006-0363OC; Izumikawa T, 2011, BIOCHEM J, V434, P321, DOI 10.1042/BJ20101456; JALKANEN S, 1992, J CELL BIOL, V116, P817, DOI 10.1083/jcb.116.3.817; Jameson JM, 2005, J EXP MED, V201, P1269, DOI 10.1084/jem.20042057; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; KAHARI VM, 1991, J BIOL CHEM, V266, P10608; Katoh S, 1999, J IMMUNOL, V162, P5058; KATOH S, 1995, J EXP MED, V182, P419, DOI 10.1084/jem.182.2.419; Kawana H, 2008, J IMMUNOL, V180, P4235, DOI 10.4049/jimmunol.180.6.4235; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; Knutson JR, 1996, MOL BIOL CELL, V7, P383, DOI 10.1091/mbc.7.3.383; Kusche-Gullberg M, 2003, CURR OPIN STRUC BIOL, V13, P605, DOI 10.1016/j.sbi.2003.08.002; Leemans JC, 2003, J CLIN INVEST, V111, P681, DOI 10.1172/JCI200316936; LEIBOVICH SJ, 1975, AM J PATHOL, V78, P71; LESLEY J, 1994, J EXP MED, V180, P383, DOI 10.1084/jem.180.1.383; Levesque MC, 1997, J IMMUNOL, V159, P6184; Levesque MC, 1999, CELL IMMUNOL, V193, P209, DOI 10.1006/cimm.1999.1456; Li RH, 2001, J BIOL CHEM, V276, P28767, DOI 10.1074/jbc.M100158200; Liang JR, 2007, J IMMUNOL, V178, P2469, DOI 10.4049/jimmunol.178.4.2469; Maeshima N, 2011, EUR J IMMUNOL, V41, P1108, DOI 10.1002/eji.201040870; Maiti A, 1998, SCIENCE, V282, P941, DOI 10.1126/science.282.5390.941; MARKOWITZ D, 1988, J VIROL, V62, P1120, DOI 10.1128/JVI.62.4.1120-1124.1988; Marriott HM, 2007, EXP LUNG RES, V33, P493, DOI 10.1080/01902140701756562; Mohamadzadeh M, 1998, J CLIN INVEST, V101, P97, DOI 10.1172/JCI1604; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; OHMORI K, 1993, BLOOD, V82, P2797; PEACH RJ, 1993, J CELL BIOL, V122, P257, DOI 10.1083/jcb.122.1.257; ROMARIS M, 1995, BIOCHEM J, V310, P73, DOI 10.1042/bj3100073; Ruffell B, 2005, BIOCHEM BIOPH RES CO, V334, P306, DOI 10.1016/j.bbrc.2005.06.108; Ruffell B., 2009, GLYCOFORUM SCI HYALU, V33, P1; Ruffell B, 2008, J IMMUNOL, V181, P7044, DOI 10.4049/jimmunol.181.10.7044; Schakel K, 2002, IMMUNITY, V17, P289, DOI 10.1016/S1074-7613(02)00393-X; Schmits R, 1997, BLOOD, V90, P2217, DOI 10.1182/blood.V90.6.2217.2217_2217_2233; SCHONHERR E, 1993, ARTERIOSCLER THROMB, V13, P1026, DOI 10.1161/01.ATV.13.7.1026; SCHONHERR E, 1991, J BIOL CHEM, V266, P17640; SCHWARTZ NB, 1974, P NATL ACAD SCI USA, V71, P4047, DOI 10.1073/pnas.71.10.4047; Skelton TP, 1998, J CELL BIOL, V140, P431, DOI 10.1083/jcb.140.2.431; Teder P, 2002, SCIENCE, V296, P155, DOI 10.1126/science.1069659; Tjew SL, 2005, GLYCOBIOLOGY, V15, p7C, DOI 10.1093/glycob/cwi050; UNDERHILL CB, 1993, DEV BIOL, V155, P324, DOI 10.1006/dbio.1993.1032; Van Ginderachter JA, 2006, IMMUNOBIOLOGY, V211, P487, DOI 10.1016/j.imbio.2006.06.002; Zhang X, 2008, J PATHOL, V214, P161, DOI 10.1002/path.2284; ZHOU DFH, 1989, J IMMUNOL, V143, P3390	66	46	49	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19179	19190		10.1074/jbc.M110.200790	http://dx.doi.org/10.1074/jbc.M110.200790			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21471214	Green Published, hybrid			2022-12-25	WOS:000291027700001
J	Gong, C; Yao, YD; Wang, Y; Liu, BD; Wu, W; Chen, JN; Su, FX; Yao, HR; Song, EW				Gong, Chang; Yao, Yandan; Wang, Ying; Liu, Bodu; Wu, Wei; Chen, Jianing; Su, Fengxi; Yao, Herui; Song, Erwei			Up-regulation of miR-21 Mediates Resistance to Trastuzumab Therapy for Breast Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR GENE; MICRORNA-21 TARGETS; DOWN-REGULATION; EXPRESSION; PTEN; CELLS; GROWTH; INVASION; PROMOTES; OVEREXPRESSION	Trastuzumab resistance emerges to be a major issue in anti-human epidermal growth factor receptor 2 (HER2) therapy for breast cancers. Here, we demonstrated that miR-21 expression was up-regulated and its function was elevated in HER2(+) BT474, SKBR3, and MDA-MB-453 breast cancer cells that are induced to acquire trastuzumab resistance by long-term exposure to the antibody, whereas protein expression of the PTEN gene, a miR-21 target, was reduced. Blocking the action of miR-21 with antisense oligonucleotides re-sensitized the resistant cells to the therapeutic activities of trastuzumab by inducing growth arrest, proliferation inhibition, and G(1)-S cell cycle checking in the presence of the antibody. Ectopic expression of miR-21 in HER2(+) breast cancer cells confers resistance to trastuzumab. Rescuing PTEN expression with a p3XFLAG-PTEN-mut construct with deleted miR-21 targeting sequence at its 3' UTR restored the growth inhibition of trastuzumab in the resistant cells by inducing PTEN activation and AKT inhibition. In vivo, administering miR-21 antisense oligonucleotides restored trastuzumab sensitivity in the resistant breast cancer xenografts by inducing PTEN expression, whereas injection of miR-21 mimics conferred trastuzumab resistant in the sensitive breast tumors via PTEN silence. Up-regulatin of miR-21 in tumor biopsies obtained from patients receiving pre-operative trastuzumab therapy was associated with poor trastuzumab response. Therefore, miR-21 overexpression contributes to trastuzumab resistance in HER2(+) breast cancers and antagonizing miR-21 demonstrates therapeutic potential by sensitizing the malignancy to anti-HER2 treatment.	[Yao, Herui] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Med Oncol, Guangzhou 510120, Peoples R China; [Gong, Chang; Yao, Yandan; Wang, Ying; Liu, Bodu; Wu, Wei; Chen, Jianing; Su, Fengxi; Song, Erwei] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Breast Tumor Ctr, Guangzhou 510120, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Yao, HR (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Med Oncol, Guangzhou 510120, Peoples R China.	yaoherui@163.com; songerwei02@yahoo.com.cn	Liu, Bodu/AAR-9402-2021; Liu, Bodu/G-5222-2016	Liu, Bodu/0000-0003-2097-725X; Liu, Bodu/0000-0003-2097-725X; Yao, Herui/0000-0001-5520-6469	National Natural Science Foundation of China [30772550, 30801376, 30830110, 30831160515, 30921140312, 30973505, 30945201]; Sun-Yat-Sen Excellent Medicine Youth Project, 973 [2010CB912800, 2009CB521706, 2005CB724605]; Ministry of Science and Technology of China Science Foundation of Guangdong Province [8251008901000011, 2009B030801005]; Foundation of Guangzhou Science and Technology Bureau [2009Y-C011-1]; Guangdong Higher Education Institutes, Sun-Yat-sen University [KLB09001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sun-Yat-Sen Excellent Medicine Youth Project, 973; Ministry of Science and Technology of China Science Foundation of Guangdong Province; Foundation of Guangzhou Science and Technology Bureau; Guangdong Higher Education Institutes, Sun-Yat-sen University	This work was supported by National Natural Science Foundation of China Grants 30772550, 30801376, 30830110, 30831160515, 30921140312, 30973505, and 30945201, the Sun-Yat-Sen Excellent Medicine Youth Project, 973 Grants 2010CB912800, 2009CB521706, and 2005CB724605, Projects from Ministry of Science and Technology of China Science Foundation of Guangdong Province Grants 8251008901000011 and 2009B030801005, Foundation of Guangzhou Science and Technology Bureau Grant 2009Y-C011-1, and the Key Laboratory of malignant tumor gene regulation and target therapy of Guangdong Higher Education Institutes, Sun-Yat-sen University, Grant KLB09001.	Ali S, 2010, CANCER RES, V70, P3606, DOI 10.1158/0008-5472.CAN-09-4598; Bourguignon LYW, 2009, J BIOL CHEM, V284, P26533, DOI 10.1074/jbc.M109.027466; Camps C, 2008, CLIN CANCER RES, V14, P1340, DOI 10.1158/1078-0432.CCR-07-1755; Carr JR, 2010, CANCER RES, V70, P5054, DOI 10.1158/0008-5472.CAN-10-0545; Chan CT, 2005, BREAST CANCER RES TR, V91, P187, DOI 10.1007/s10549-004-7715-1; Connolly EC, 2010, MOL CANCER RES, V8, P691, DOI 10.1158/1541-7786.MCR-09-0465; Cooke T, 2001, ANN ONCOL, V12, P23, DOI 10.1023/A:1011159723172; Du J, 2009, CELL RES, V19, P487, DOI 10.1038/cr.2009.34; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Esteva FJ, 2002, J CLIN ONCOL, V20, P1800, DOI 10.1200/JCO.2002.07.058; Gabriely G, 2008, MOL CELL BIOL, V28, P5369, DOI 10.1128/MCB.00479-08; Huang TH, 2009, J BIOL CHEM, V284, P18515, DOI 10.1074/jbc.M109.006676; Huse JT, 2009, GENE DEV, V23, P1327, DOI 10.1101/gad.1777409; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Jazbutyte V, 2010, CURR DRUG TARGETS, V11, P926, DOI 10.2174/138945010791591403; Jiang J, 2008, CLIN CANCER RES, V14, P419, DOI 10.1158/1078-0432.CCR-07-0523; Kato M, 2009, NAT CELL BIOL, V11, P881, DOI 10.1038/ncb1897; Li JS, 2009, CLIN CANCER RES, V15, P3998, DOI 10.1158/1078-0432.CCR-08-3053; Liu LH, 2010, LIFE SCI, V86, P192, DOI 10.1016/j.lfs.2009.12.002; Loayza-Puch F, 2010, ONCOGENE, V29, P2638, DOI 10.1038/onc.2010.23; Loffler D, 2007, BLOOD, V110, P1330, DOI 10.1182/blood-2007-03-081133; Mariani G, 2009, NAT CLIN PRACT ONCOL, V6, P93, DOI 10.1038/ncponc1298; Medina PP, 2010, NATURE, V467, P86, DOI 10.1038/nature09284; Mei M, 2010, TECHNOL CANCER RES T, V9, P77, DOI 10.1177/153303461000900109; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Narayan M, 2009, CANCER RES, V69, P2191, DOI 10.1158/0008-5472.CAN-08-1056; Park JK, 2009, PANCREAS, V38, pE190, DOI 10.1097/MPA.0b013e3181ba82e1; Pezzolesi MG, 2008, AM J HUM GENET, V82, P1141, DOI 10.1016/j.ajhg.2008.04.005; Pohlmann PR, 2009, CLIN CANCER RES, V15, P7479, DOI 10.1158/1078-0432.CCR-09-0636; Ribas J, 2009, CANCER RES, V69, P7165, DOI 10.1158/0008-5472.CAN-09-1448; Seike M, 2009, P NATL ACAD SCI USA, V106, P12085, DOI 10.1073/pnas.0905234106; Shi GH, 2010, ACTA PHARMACOL SIN, V31, P867, DOI 10.1038/aps.2010.48; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Song B, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-29; Song EW, 2005, NAT BIOTECHNOL, V23, P709, DOI 10.1038/nbt1101; Talotta F, 2009, ONCOGENE, V28, P73, DOI 10.1038/onc.2008.370; Wang K, 2010, J BIOL CHEM, V285, P16958, DOI 10.1074/jbc.M109.093005; Wang P, 2009, CANCER RES, V69, P8157, DOI 10.1158/0008-5472.CAN-09-1996; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808; Zhang CZ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-367; Zhang LM, 2010, CARCINOGENESIS, V31, P559, DOI 10.1093/carcin/bgp335; Zhang ZY, 2008, LAB INVEST, V88, P1358, DOI 10.1038/labinvest.2008.94; Zhou X, 2010, LAB INVEST, V90, P144, DOI 10.1038/labinvest.2009.126; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24; Zhu SM, 2007, J BIOL CHEM, V282, P14328, DOI 10.1074/jbc.M611393200	50	237	252	1	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					19127	19137		10.1074/jbc.M110.216887	http://dx.doi.org/10.1074/jbc.M110.216887			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21471222	Green Published, hybrid			2022-12-25	WOS:000290785700082
J	Rogov, VV; Rogova, NY; Bernhard, F; Lohr, F; Dotsch, V				Rogov, Vladimir V.; Rogova, Natalia Yu.; Bernhard, Frank; Loehr, Frank; Doetsch, Volker			A Disulfide Bridge Network within the Soluble Periplasmic Domain Determines Structure and Function of the Outer Membrane Protein RCSF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPSULAR POLYSACCHARIDE SYNTHESIS; PHOSPHORELAY SIGNALING PATHWAY; TORSION ANGLE DYNAMICS; ESCHERICHIA-COLI K-12; CELL NMR-SPECTROSCOPY; ERWINIA-AMYLOVORA; EXOPOLYSACCHARIDE BIOSYNTHESIS; HISTIDINE KINASES; CHEMICAL-SHIFT; SENSOR KINASE	RcsF, a proposed auxiliary regulator of the regulation of capsule synthesis (rcs) phosphorelay system, is a key element for understanding the RcsC-D-A/B signaling cascade, which is responsible for the regulation of more than 100 genes and is involved in cell division, motility, biofilm formation, and virulence. The RcsC-D-A/B system is one of the most complex bacterial signal transduction pathways, consisting of several membrane-bound and soluble proteins. RcsF is a lipoprotein attached to the outer membrane and plays an important role in activating the RcsC-D-A/B pathway. The exact mechanism of activation of the rcs phosphorelay by RcsF, however, remains unknown. We have analyzed the sequence of RcsF and identified three structural elements: 1) an N-terminal membrane-anchored helix (residues 3-13), 2) a loop (residues 14-48), and 3) a C-terminal folded domain (residues 49-134). We have determined the structure of this C-terminal domain and started to investigate its interaction with potential partners. Important features of its structure are two disulfide bridges between Cys-74 and Cys-118 and between Cys-109 and Cys-124. To evaluate the importance of this RcsF disulfide bridge network in vivo, we have examined the ability of the full-length protein and of specific Cys mutants to initiate the rcs signaling cascade. The results indicate that the Cys-74/Cys-118 and the Cys-109/Cys-124 residues correlate pairwise with the activity of RcsF. Interaction studies showed a weak interaction with an RNA hairpin. However, no interaction could be detected with reagents that are believed to activate the rcs phosphorelay, such as lysozyme, glucose, or Zn2+ ions.	[Rogov, Vladimir V.; Rogova, Natalia Yu.; Bernhard, Frank; Loehr, Frank; Doetsch, Volker] Goethe Univ Frankfurt, Inst Biophys Chem, D-60438 Frankfurt, Germany; [Rogov, Vladimir V.; Rogova, Natalia Yu.; Bernhard, Frank; Loehr, Frank; Doetsch, Volker] Goethe Univ Frankfurt, Ctr Biomol Magnet Resonance, D-60438 Frankfurt, Germany; [Rogov, Vladimir V.] Inst Prot Res, Pushchino 142290, Russia	Goethe University Frankfurt; Goethe University Frankfurt	Dotsch, V (corresponding author), Goethe Univ Frankfurt, Inst Biophys Chem, Max von Laue Str 9, D-60438 Frankfurt, Germany.	vdoetsch@em.uni-frankfurt.de	Doetsch, Volker/D-5697-2011	Dotsch, Volker/0000-0001-5720-212X; Bernhard, Frank/0000-0002-4860-1783	Deutsche Forschungsgemeinschaft [BE 1911/4-1]; Center for Biomolecular Magnetic Resonance (BMRZ); Cluster of Excellence Frankfurt Macromolecular Complexes (CEF)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Center for Biomolecular Magnetic Resonance (BMRZ); Cluster of Excellence Frankfurt Macromolecular Complexes (CEF)	This work was supported by Deutsche Forschungsgemeinschaft Grant BE 1911/4-1, the Center for Biomolecular Magnetic Resonance (BMRZ), and the Cluster of Excellence Frankfurt Macromolecular Complexes (CEF).	Andresen L, 2007, FEMS MICROBIOL LETT, V273, P229, DOI 10.1111/j.1574-6968.2007.00794.x; BERNHARD F, 1990, MOL PLANT MICROBE IN, V3, P429, DOI 10.1094/MPMI-3-429; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Callewaert L, 2009, J BACTERIOL, V191, P1979, DOI 10.1128/JB.01549-08; Castanie-Cornet MP, 2006, J BACTERIOL, V188, P4264, DOI 10.1128/JB.00004-06; Chen MH, 2001, BIOSCI BIOTECH BIOCH, V65, P2364, DOI 10.1271/bbb.65.2364; Clarke DJ, 2010, FUTURE MICROBIOL, V5, P1173, DOI 10.2217/FMB.10.83; Clarke DJ, 2002, J BACTERIOL, V184, P1204, DOI 10.1128/jb.184.4.1204-1208.2002; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Farris C, 2010, J BACTERIOL, V192, P4894, DOI 10.1128/JB.00505-10; Francez-Charlot A, 2003, MOL MICROBIOL, V49, P823, DOI 10.1046/j.1365-2958.2003.03601.x; GERVAIS FG, 1992, J BACTERIOL, V174, P3964, DOI 10.1128/jb.174.12.3964-3971.1992; Goddard T.D., SPARKY 3; GOTTESMAN S, 1985, J BACTERIOL, V162, P1111, DOI 10.1128/JB.162.3.1111-1119.1985; GOTTESMAN S, 1991, MOL MICROBIOL, V5, P1599, DOI 10.1111/j.1365-2958.1991.tb01906.x; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hagiwara D, 2003, J BACTERIOL, V185, P5735, DOI 10.1128/JB.185.19.5735-5746.2003; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Kadokura H, 2004, SCIENCE, V303, P534, DOI 10.1126/science.1091724; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Laubacher ME, 2008, J BACTERIOL, V190, P2065, DOI 10.1128/JB.01740-07; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Majdalani N, 2005, ANNU REV MICROBIOL, V59, P379, DOI 10.1146/annurev.micro.59.050405.101230; Majdalani N, 2005, J BACTERIOL, V187, P6770, DOI 10.1128/JB.187.19.6770-6778.2005; Pristovsek P, 2003, J BIOL CHEM, V278, P17752, DOI 10.1074/jbc.M301328200; Rogov VV, 2007, J BIOMOL NMR, V38, P165, DOI 10.1007/s10858-006-9059-0; Rogov VV, 2006, J MOL BIOL, V364, P68, DOI 10.1016/j.jmb.2006.07.052; Rogov VV, 2004, J MOL BIOL, V343, P1035, DOI 10.1016/j.jmb.2004.08.096; Sambrock J, 1989, MOL CLONING LAB MANU; Schmoe K, 2011, STRUCTURE, V19, P577, DOI 10.1016/j.str.2011.01.012; Serber Z, 2005, METHOD ENZYMOL, V394, P17, DOI 10.1016/S0076-6879(05)94002-0; Serber Z, 2006, NAT PROTOC, V1, P2701, DOI 10.1038/nprot.2006.181; Seydel A, 1999, MOL MICROBIOL, V34, P810, DOI 10.1046/j.1365-2958.1999.01647.x; Singh P, 2008, ANAL CHEM, V80, P8799, DOI 10.1021/ac801646f; Wehland M, 1999, J BIOL CHEM, V274, P3300, DOI 10.1074/jbc.274.6.3300; Wehland M, 2000, J BIOL CHEM, V275, P7013, DOI 10.1074/jbc.275.10.7013; West AH, 2001, TRENDS BIOCHEM SCI, V26, P369, DOI 10.1016/S0968-0004(01)01852-7; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Zhang WW, 2005, MICROBIOL-SGM, V151, P2159, DOI 10.1099/mic.0.27987-0	43	24	25	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18775	18783		10.1074/jbc.M111.230185	http://dx.doi.org/10.1074/jbc.M111.230185			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21471196	Green Published, hybrid			2022-12-25	WOS:000290785700050
J	Brickley, K; Stephenson, FA				Brickley, Kieran; Stephenson, F. Anne			Trafficking Kinesin Protein (TRAK)-mediated Transport of Mitochondria in Axons of Hippocampal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COIL DOMAIN PROTEINS; IDENTIFICATION; ANTEROGRADE; FAMILY; GRIF-1; REGULATOR; MECHANISM; SYNAPSES; DYNAMICS; MOTILITY	In neurons, the proper distribution of mitochondria is essential because of a requirement for high energy and calcium buffering during synaptic neurotransmission. The efficient, regulated transport of mitochondria along axons to synapses is therefore crucial for maintaining function. The trafficking kinesin protein (TRAK)/Milton family of proteins comprises kinesin adaptors that have been implicated in the neuronal trafficking of mitochondria via their association with the mitochondrial protein Miro and kinesin motors. In this study, we used gene silencing by targeted shRNAi and dominant negative approaches in conjunction with live imaging to investigate the contribution of endogenous TRAKs, TRAK1 and TRAK2, to the transport of mitochondria in axons of hippocampal pyramidal neurons. We report that both strategies resulted in impairing mitochondrial mobility in axonal processes. Differences were apparent in terms of the contribution of TRAK1 and TRAK2 to this transport because knockdown of TRAK1 but not TRAK2 impaired mitochondrial mobility, yet both TRAK1 and TRAK2 were shown to rescue transport impaired by TRAK1 gene knock-out. Thus, we demonstrate for the first time the pivotal contribution of the endogenous TRAK family of kinesin adaptors to the regulation of mitochondrial mobility.	[Brickley, Kieran; Stephenson, F. Anne] Univ London, Sch Pharm, London WC1N 1AX, England	University of London; University College London; University of London School of Pharmacy	Stephenson, FA (corresponding author), Univ London, Sch Pharm, 29-39 Brunswick Sq, London WC1N 1AX, England.	anne.stephenson@pharmacy.ac.uk			Biotechnology and Biological Sciences Research Council (United Kingdom); Wellcome Trust; MRC [G0800498] Funding Source: UKRI; Medical Research Council [G0800498] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (United Kingdom)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Biotechnology and Biological Sciences Research Council (United Kingdom).; We thank Dr. Karine Pozo for help and advice on the culturing and transfection of hippocampal pyramidal neurons. We also thank Dr. Sarah Cousins for generating the clones pTurboFP635-NMito1, pEGFP-ratTRAK1silent, and pIRES-GFPTRAK2 DN; Tom Randall for help with Fig. 5; and Dr. Carolyn Moores, Birkbeck College, London, UK for insightful discussions. We gratefully acknowledge the financial contribution from The Wellcome Trust for the purchase of the Zeiss 710 confocal microscope.	Beck M, 2002, J BIOL CHEM, V277, P30079, DOI 10.1074/jbc.M200438200; Boldogh IR, 2007, TRENDS CELL BIOL, V17, P502, DOI 10.1016/j.tcb.2007.07.008; Brickley K, 2005, J BIOL CHEM, V280, P14723, DOI 10.1074/jbc.M409095200; Cai Q, 2005, J CELL BIOL, V170, P959, DOI 10.1083/jcb.200506042; Cai Q, 2007, J NEUROSCI, V27, P7284, DOI 10.1523/JNEUROSCI.0731-07.2007; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Fransson A, 2006, BIOCHEM BIOPH RES CO, V344, P500, DOI 10.1016/j.bbrc.2006.03.163; Gilbert SL, 2006, NAT GENET, V38, P245, DOI 10.1038/ng1715; Glater EE, 2006, J CELL BIOL, V173, P545, DOI 10.1083/jcb.200601067; Goslin K., 1998, CULTURING NERVE CELL, P339; Grishin A, 2006, J BIOL CHEM, V281, P30104, DOI 10.1074/jbc.M602439200; Hendricks AG, 2010, CURR BIOL, V20, P697, DOI 10.1016/j.cub.2010.02.058; Iyer SPN, 2003, J BIOL CHEM, V278, P5399, DOI 10.1074/jbc.M209384200; Jiang M, 2006, NAT PROTOC, V1, P695, DOI 10.1038/nprot.2006.86; Kang JS, 2008, CELL, V132, P137, DOI 10.1016/j.cell.2007.11.024; Kirk E, 2006, J CELL SCI, V119, P4689, DOI 10.1242/jcs.03249; Koutsopoulos OS, 2010, BBA-MOL CELL RES, V1803, P564, DOI 10.1016/j.bbamcr.2010.03.006; Ligon LA, 2000, J COMP NEUROL, V427, P340, DOI 10.1002/1096-9861(20001120)427:3<340::AID-CNE2>3.0.CO;2-Y; MacAskill AF, 2010, TRENDS CELL BIOL, V20, P102, DOI 10.1016/j.tcb.2009.11.002; MacAskill AF, 2009, NEURON, V61, P541, DOI 10.1016/j.neuron.2009.01.030; MacAskill AF, 2009, MOL CELL NEUROSCI, V40, P301, DOI 10.1016/j.mcn.2008.10.016; Misko A, 2010, J NEUROSCI, V30, P4232, DOI 10.1523/JNEUROSCI.6248-09.2010; Ojla G., 2003, BR NEUROSCI ABSTR, V17, P2612; Pozo KBK, 2011, BBA-MOL CELL RES, V1813, P269, DOI 10.1016/j.bbamcr.2010.10.011; Russo GJ, 2009, J NEUROSCI, V29, P5443, DOI 10.1523/JNEUROSCI.5417-08.2009; Saotome M, 2008, P NATL ACAD SCI USA, V105, P20728, DOI 10.1073/pnas.0808953105; Smith MJ, 2006, J BIOL CHEM, V281, P27216, DOI 10.1074/jbc.M600522200; Stephenson F. A., 2010, PROTEIN FOLDING SYNA, P105; Stowers RS, 2002, NEURON, V36, P1063, DOI 10.1016/S0896-6273(02)01094-2; Wang XN, 2009, CELL, V136, P163, DOI 10.1016/j.cell.2008.11.046; Webber E, 2008, J MOL BIOL, V382, P638, DOI 10.1016/j.jmb.2008.07.045; Yi MQ, 2004, J CELL BIOL, V167, P661, DOI 10.1083/jcb.200406038	32	116	119	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					18079	18092		10.1074/jbc.M111.236018	http://dx.doi.org/10.1074/jbc.M111.236018			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454691	Green Published, hybrid			2022-12-25	WOS:000290585200069
J	Dang, M; Dubbin, K; D'Aiello, A; Hartmann, M; Lodish, H; Herrlich, A				Dang, Michelle; Dubbin, Karen; D'Aiello, Antonio; Hartmann, Monika; Lodish, Harvey; Herrlich, Andreas			Epidermal Growth Factor (EGF) Ligand Release by Substrate-specific A Disintegrin and Metalloproteases (ADAMs) Involves Different Protein Kinase C (PKC) Isoenzymes Depending on the Stimulus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; INTRACELLULAR MATURATION; L-SELECTIN; HB-EGF; RECEPTOR; TRANSACTIVATION; CLEAVAGE; LOCALIZATION; COMPONENTS; CLONING	The dysregulation of EGF family ligand cleavage has severe consequences for the developing as well as the adult organism. Therefore, their production is highly regulated. The limiting step is the ectodomain cleavage of membrane-bound precursors by one of several a disintegrin and metalloprotease (ADAM) metalloproteases, and understanding the regulation of cleavage is an important goal of current research. We have previously reported that in mouse lung epithelial cells, the pro-EGF ligands TGF alpha, neuregulin 1 beta (NRG), and heparin-binding EGF are differentially cleaved depending on the cleavage stimulus (Herrlich, A., Klinman, E., Fu, J., Sadegh, C., and Lodish, H. (2008) FASEB J.). In this study in mouse embryonic fibroblasts that lack different ADAMs, we show that induced cleavage of EGF ligands can involve the same substrate-specific metalloprotease but does require different stimulus-dependent signaling pathways. Cleavage was stimulated by phorbol ester (12-O-tetradecanoylphorbol-13-acetate (TPA), a mimic of diacylglycerol and PKC activator), hypertonic stress, lysophosphatidic acid (LPA)-induced G protein-coupled receptor activation, or by ionomycin-induced intracellular calcium release. Although ADAMs showed substrate preference (ADAM17, TGF alpha and heparin-binding EGF; and ADAM9, NRG), substrate cleavage differed substantially with the stimulus, and cleavage of the same substrate depended on the presence of different, sometimes multiple, PKC isoforms. For instance, classical PKC was required for TPA-induced but not hypertonic stress-induced cleavage of all EGF family ligands. Inhibition of PKC zeta enhanced NRG release upon TPA stimulation, but it blocked NRG release in response to hypertonic stress. Our results suggest a model in which substantial regulation of ectodomain cleavage occurs not only on the metalloprotease level but also on the level of the substrate or of a third protein.	[Dang, Michelle; Dubbin, Karen; D'Aiello, Antonio; Lodish, Harvey; Herrlich, Andreas] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Dang, Michelle; Lodish, Harvey] MIT, Dept Biol, Cambridge, MA 02142 USA; [Dubbin, Karen] MIT, Dept Mat Sci, Cambridge, MA 02142 USA; [D'Aiello, Antonio; Herrlich, Andreas] Harvard Univ, Sch Med, Brigham & Womens Hosp, Renal Unit, Boston, MA 02114 USA; [Hartmann, Monika] Fritz Lipman Inst Age Res, D-07745 Jena, Germany	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Brigham & Women's Hospital; Harvard Medical School	Herrlich, A (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	herrlich@wi.mit.edu		Dubbin, Karen/0000-0002-9495-4766	National Institutes of Health [K99-DK077731-01, 4 R00 DK077731-03]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK077731, K99DK077731] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants K99-DK077731-01 and 4 R00 DK077731-03.	Arribas J, 2006, CANCER METAST REV, V25, P57, DOI 10.1007/s10555-006-7889-6; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Blobel CR, 2009, EXP CELL RES, V315, P671, DOI 10.1016/j.yexcr.2008.10.011; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Bogan JS, 2003, NATURE, V425, P727, DOI 10.1038/nature01989; Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4; Caescu CI, 2009, BIOCHEM J, V424, P79, DOI 10.1042/BJ20090549; Doedens JR, 2003, BIOCHEM BIOPH RES CO, V308, P331, DOI 10.1016/S0006-291X(03)01381-0; Fischer OM, 2003, BIOCHEM SOC T, V31, P1203; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Herrlich A, 2008, FASEB J, V22, P4281, DOI 10.1096/fj.08-113852; Higashiyama S, 2005, BBA-PROTEINS PROTEOM, V1751, P110, DOI 10.1016/j.bbapap.2004.11.009; Horiuchi K, 2005, DEV BIOL, V283, P459, DOI 10.1016/j.ydbio.2005.05.004; Horiuchi K, 2007, MOL BIOL CELL, V18, P176, DOI 10.1091/mbc.E06-01-0014; Howard L, 2000, BIOCHEM J, V348, P21, DOI 10.1042/0264-6021:3480021; Izumi Y, 1998, EMBO J, V17, P7260, DOI 10.1093/emboj/17.24.7260; Janes PW, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000215; Killock DJ, 2010, BIOCHEM J, V428, P293, DOI 10.1042/BJ20091611; Lautrette A, 2005, NAT MED, V11, P867, DOI 10.1038/nm1275; Le Gall SM, 2009, MOL BIOL CELL, V20, P1785, DOI 10.1091/mbc.E08-11-1135; Lin JQ, 2001, J BIOL CHEM, V276, P30127, DOI 10.1074/jbc.M010237200; Lopez-Otin C, 2007, NAT REV CANCER, V7, P800, DOI 10.1038/nrc2228; Lum L, 1998, J BIOL CHEM, V273, P26236, DOI 10.1074/jbc.273.40.26236; Maretzky T, 2011, ONCOGENE, V30, P611, DOI 10.1038/onc.2010.443; Murphy G, 2008, NAT REV CANCER, V8, P929, DOI 10.1038/nrc2459; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Reddy P, 2000, J BIOL CHEM, V275, P14608, DOI 10.1074/jbc.275.19.14608; Roghani M, 1999, J BIOL CHEM, V274, P3531, DOI 10.1074/jbc.274.6.3531; Schlondorff J, 2000, BIOCHEM J, V347, P131, DOI 10.1042/0264-6021:3470131; Seals DF, 2003, GENE DEV, V17, P7, DOI 10.1101/gad.1039703; Turk Benjamin E., 2009, V539, P79, DOI 10.1007/978-1-60327-003-8_5; Wang X, 2006, CELL STRUCT FUNCT, V31, P15, DOI 10.1247/csf.31.15; Weskamp G, 2002, MOL CELL BIOL, V22, P1537, DOI 10.1128/MCB.22.5.1537-1544.2002; Yan YB, 2002, J CELL BIOL, V158, P221, DOI 10.1083/jcb.200112026	35	30	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17704	17713		10.1074/jbc.M110.187823	http://dx.doi.org/10.1074/jbc.M110.187823			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454702	Green Published, hybrid			2022-12-25	WOS:000290585200034
J	Lu, P; Hankel, IL; Hostager, BS; Swartzendruber, JA; Friedman, AD; Brenton, JL; Rothman, PB; Colgan, JD				Lu, Ping; Hankel, Isaiah L.; Hostager, Bruce S.; Swartzendruber, Julie A.; Friedman, Ann D.; Brenton, Janet L.; Rothman, Paul B.; Colgan, John D.			The Developmental Regulator Protein Gon4l Associates with Protein YY1, Co-repressor Sin3a, and Histone Deacetylase 1 and Mediates Transcriptional Repression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B-CELL DEVELOPMENT; GENE-EXPRESSION; N-COR; SANT DOMAIN; LINEAGE; COREPRESSOR; COMPLEX; IDENTIFICATION; RECOMBINATION; COACTIVATOR	Genetic studies involving zebrafish and mice have demonstrated that the protein Gon4l (Gon4-like) is essential for hematopoiesis. These studies also suggested that Gon4l regulates gene expression during hematopoietic development, yet the biochemical function of Gon4l has not been defined. Here, we describe the identification of factors that interact with Gon4l and may cooperate with this protein to regulate gene expression. As predicted by polypeptide sequence conservation, Gon4l interacted and co-localized with the DNA-binding protein YY1 (Yin Yang 1). Density gradient sedimentation analysis of protein lysates from mouse M12 B cells showed that Gon4l and YY1 co-sediment with the transcriptional co-repressor Sin3a and its functional partner histone deacetylase (HDAC) 1. Consistent with these results, immunoprecipitation studies showed that Gon4l associates with Sin3a, HDAC1, and YY1 as a part of complexes that form in M12 cells. Sequential immunoprecipitation studies demonstrated that Gon4l, YY1, Sin3a, and HDAC1 could all associate as components of a single complex and that a conserved domain spanning the central portion of Gon4l was required for formation of this complex. When targeted to DNA, Gon4l repressed the activity of a nearby promoter, which correlated with the ability to interact with Sin3a and HDAC1. Our data suggest that Sin3a, HDAC1, and YY1 are co-factors for Gon4l and that Gon4l may function as a platform for the assembly of complexes that regulate gene expression.	[Lu, Ping; Rothman, Paul B.; Colgan, John D.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Interdisciplinary Immunol Grad Program, Iowa City, IA 52242 USA; [Hostager, Bruce S.; Swartzendruber, Julie A.; Friedman, Ann D.; Brenton, Janet L.; Rothman, Paul B.; Colgan, John D.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [Hankel, Isaiah L.; Colgan, John D.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Anat & Cell Biol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa	Colgan, JD (corresponding author), 375 Newton Rd,3270 CBRB, Iowa City, IA 52242 USA.	john-colgan@uiowa.edu		Colgan, John/0000-0001-9273-2644	National Institutes of Health [R01AI067489]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067489] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AI067489 (to J. D. C.).	ALT F, 1981, CELL, V27, P381, DOI 10.1016/0092-8674(81)90421-9; Boyer LA, 2004, NAT REV MOL CELL BIO, V5, P158, DOI 10.1038/nrm1314; Bulchand S, 2010, J CELL SCI, V123, P2697, DOI 10.1242/jcs.063172; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Dannenberg JH, 2005, GENE DEV, V19, P1581, DOI 10.1101/gad.1286905; DAVIDSON WF, 1988, J EXP MED, V168, P389, DOI 10.1084/jem.168.1.389; de la Cruz X, 2005, BIOESSAYS, V27, P164, DOI 10.1002/bies.20176; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Fleischer TC, 2003, MOL CELL BIOL, V23, P3456, DOI 10.1128/MCB.23.10.3456-3467.2003; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; Frehlick LJ, 2007, BIOESSAYS, V29, P49, DOI 10.1002/bies.20512; Friedman L, 2000, DEV BIOL, V228, P350, DOI 10.1006/dbio.2000.9944; Gordon S, 2006, ONCOGENE, V25, P1125, DOI 10.1038/sj.onc.1209080; Grzenda A, 2009, BBA-GENE REGUL MECH, V1789, P443, DOI 10.1016/j.bbagrm.2009.05.007; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; HAMANO T, 1982, J IMMUNOL, V129, P1403; Hammerschmidt M, 1996, DEVELOPMENT, V123, P143; Hardy RR, 2007, IMMUNITY, V26, P703, DOI 10.1016/j.immuni.2007.05.013; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; Hoffmann R, 2002, GENOME RES, V12, P98, DOI 10.1101/gr.201501; Hostager BS, 2003, J BIOL CHEM, V278, P45382, DOI 10.1074/jbc.M306708200; Hystad ME, 2007, J IMMUNOL, V179, P3662, DOI 10.4049/jimmunol.179.6.3662; Jazayeri A, 2004, P NATL ACAD SCI USA, V101, P1644, DOI 10.1073/pnas.0304797101; Jung D, 2006, ANNU REV IMMUNOL, V24, P541, DOI 10.1146/annurev.immunol.23.021704.115830; Kuryshev VY, 2006, GENOMICS, V88, P143, DOI 10.1016/j.ygeno.2006.02.002; Laiosa CV, 2006, ANNU REV IMMUNOL, V24, P705, DOI 10.1146/annurev.immunol.24.021605.090742; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Lim CH, 2009, MOL BIOL CELL, V20, P4183, DOI 10.1091/mbc.E09-02-0109; Liu HF, 2007, GENE DEV, V21, P1179, DOI 10.1101/gad.1529307; Liu YM, 2007, BLOOD, V110, P99, DOI 10.1182/blood-2006-11-059204; Lu P, 2010, J EXP MED, V207, P1359, DOI 10.1084/jem.20100147; Lutterbach B, 1998, MOL CELL BIOL, V18, P7176, DOI 10.1128/MCB.18.12.7176; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Mo XM, 2005, GENE DEV, V19, P2447, DOI 10.1101/gad.355405; Ohtomo T, 2007, AMINO ACIDS, V33, P645, DOI 10.1007/s00726-006-0482-z; Palko L, 2004, J CELL SCI, V117, P465, DOI 10.1242/jcs.00870; Rowland SL, 2007, J IMMUNOL, V179, P4645, DOI 10.4049/jimmunol.179.7.4645; Rumfelt LL, 2006, J EXP MED, V203, P675, DOI 10.1084/jem.20052444; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Sen R, 2006, CURR OPIN IMMUNOL, V18, P237, DOI 10.1016/j.coi.2006.03.008; SIDEN EJ, 1979, CELL, V16, P389, DOI 10.1016/0092-8674(79)90014-X; Silverstein RA, 2005, CURR GENET, V47, P1, DOI 10.1007/s00294-004-0541-5; Wang CY, 2004, J BIOL CHEM, V279, P17750, DOI 10.1074/jbc.M310532200; Wu S, 2007, NAT STRUCT MOL BIOL, V14, P1165, DOI 10.1038/nsmb1332; Wu S, 2009, MOL CELL BIOL, V29, P6245, DOI 10.1128/MCB.00679-09	45	26	32	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					18311	18319		10.1074/jbc.M110.133603	http://dx.doi.org/10.1074/jbc.M110.133603			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454521	hybrid, Green Published			2022-12-25	WOS:000290585200091
J	El Bouhassani, M; Gilibert, S; Moreau, M; Saint-Charles, F; Treguier, M; Poti, F; Chapman, MJ; Le Goff, W; Lesnik, P; Huby, T				El Bouhassani, Majda; Gilibert, Sophie; Moreau, Martine; Saint-Charles, Flora; Treguier, Morgan; Poti, Francesco; Chapman, M. John; Le Goff, Wilfried; Lesnik, Philippe; Huby, Thierry			Cholesteryl Ester Transfer Protein Expression Partially Attenuates the Adverse Effects of SR-BI Receptor Deficiency on Cholesterol Metabolism and Atherosclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSPORT IN-VIVO; DENSITY-LIPOPROTEIN HDL; SCAVENGER RECEPTOR; SELECTIVE UPTAKE; APOLIPOPROTEIN-E; TRANSGENIC MICE; KNOCKOUT MOUSE; LDL RECEPTOR; LIVER; MACROPHAGE	Scavenger receptor SR-BI significantly contributes to HDL cholesterol metabolism and atherogenesis in mice. However, the role of SR-BI may not be as pronounced in humans due to cholesteryl ester transfer protein (CETP) activity. To address the impact of CETP expression on the adverse effects associated with SR-BI deficiency, we cross-bred our SR-BI conditional knock-out mouse model with CETP transgenic mice. CETP almost completely restored the abnormal HDL-C distribution in SR-BI-deficient mice. However, it did not normalize the elevated plasma free to total cholesterol ratio characteristic of hepatic SR-BI deficiency. Red blood cell and platelet count abnormalities observed in mice liver deficient for SR-BI were partially restored by CETP, but the elevated erythrocyte cholesterol to phopholipid ratio remained unchanged. Complete deletion of SR-BI was associated with diminished adrenal cholesterol stores, whereas hepatic SR-BI deficiency resulted in a significant increase in adrenal gland cholesterol content. In both mouse models, CETP had no impact on adrenal cholesterol metabolism. In diet-induced atherosclerosis studies, hepatic SR-BI deficiency accelerated aortic lipid lesion formation in both CETP-expressing (4-fold) and non-CETP-expressing (8-fold) mice when compared with controls. Impaired macrophage to feces reverse cholesterol transport in mice deficient for SR-BI in liver, which was not corrected by CETP, most likely contributed by such an increase in atherosclerosis susceptibility. Finally, comparison of the atherosclerosis burden in SR-BI liver-deficient and fully deficient mice demonstrated that SR-BI exerted an atheroprotective activity in extra-hepatic tissues whether CETP was present or not. These findings support the contention that the SR-BI pathway contributes in unique ways to cholesterol metabolism and atherosclerosis susceptibility even in the presence of CETP.	[El Bouhassani, Majda; Gilibert, Sophie; Moreau, Martine; Saint-Charles, Flora; Treguier, Morgan; Poti, Francesco; Chapman, M. John; Le Goff, Wilfried; Lesnik, Philippe; Huby, Thierry] Hop Pitie, INSERM, UMR S 939, F-75013 Paris, France; [El Bouhassani, Majda; Gilibert, Sophie; Moreau, Martine; Saint-Charles, Flora; Treguier, Morgan; Poti, Francesco; Chapman, M. John; Le Goff, Wilfried; Lesnik, Philippe; Huby, Thierry] Univ Paris 06, UMR S 939, F-75013 Paris, France; [Huby, Thierry] Grp Hosp Pitie Salpetriere, Assistance Publ Hop Paris, Serv Endocrinol Metab, F-75013 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite	Huby, T (corresponding author), Hop Pitie, INSERM, UMR S 939, Pavillon Benjamin Delessert,83 Blvd Hosp, F-75013 Paris, France.	thierry.huby@upmc.fr	Lesnik, Philippe/AAD-7393-2020; HUBY, Thierry/N-4820-2019; Le Goff, Wilfried/N-7593-2019; Lesnik, Philippe F/F-7803-2011; chapman, john/Y-2742-2019; Huby, Thierry/E-6768-2017; Le Goff, Wilfried/N-6326-2017; Poti, Francesco/O-6600-2016	Lesnik, Philippe/0000-0002-6909-7715; HUBY, Thierry/0000-0001-6634-551X; Le Goff, Wilfried/0000-0002-7611-9644; Huby, Thierry/0000-0001-6634-551X; Le Goff, Wilfried/0000-0002-7611-9644; Poti, Francesco/0000-0002-1708-0719	French National Institute for Health and Medical Research (INSERM); French Ministry of Research; INSERM-APHP	French National Institute for Health and Medical Research (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); French Ministry of Research(Ministry of Research, FranceEuropean Commission); INSERM-APHP(Institut National de la Sante et de la Recherche Medicale (Inserm))	This work was supported in part by the French National Institute for Health and Medical Research (INSERM).; Supported by a Fellowship from the French Ministry of Research.; Supported by a contrat d'interface INSERM-APHP. To whom correspondence should be addressed: INSERM UMR-S 939, Hopital de la Pitie, Pavillon Benjamin Delessert, 83 Boulevard de l'hopital, F-75013 Paris, France. Tel.: 33-1-42177860; Fax: 33-1-45828198; E-mail: thierry.huby@upmc.fr.	Braun A, 2003, P NATL ACAD SCI USA, V100, P7283, DOI 10.1073/pnas.1237725100; Brousseau ME, 2005, ARTERIOSCL THROM VAS, V25, P1057, DOI 10.1161/01.ATV.0000161928.16334.dd; Dole VS, 2008, ARTERIOSCL THROM VAS, V28, P1111, DOI 10.1161/ATVBAHA.108.162347; Gauthier A, 2005, ARTERIOSCL THROM VAS, V25, P2177, DOI 10.1161/01.ATV.0000183613.13929.13; Guo L, 2009, J BIOL CHEM, V284, P19826, DOI 10.1074/jbc.M109.020933; Harada LM, 2007, ATHEROSCLEROSIS, V191, P313, DOI 10.1016/j.atherosclerosis.2006.05.036; Harder C, 2007, ARTERIOSCL THROM VAS, V27, P858, DOI 10.1161/01.ATV.0000259357.42089.dc; Hildebrand RB, 2010, ARTERIOSCL THROM VAS, V30, P1439, DOI 10.1161/ATVBAHA.110.205153; Hoekstra M, 2009, J LIPID RES, V50, P1039, DOI 10.1194/jlr.M800410-JLR200; Holm TM, 2002, BLOOD, V99, P1817, DOI 10.1182/blood.V99.5.1817; Huby T, 2006, J CLIN INVEST, V116, P2767, DOI 10.1172/JCI26893; Huszar D, 2000, ARTERIOSCL THROM VAS, V20, P1068, DOI 10.1161/01.ATV.20.4.1068; Ji Y, 1999, J BIOL CHEM, V274, P33398, DOI 10.1074/jbc.274.47.33398; Kocher O, 2008, BBA-MOL BASIS DIS, V1782, P310, DOI 10.1016/j.bbadis.2008.02.004; Kockx M, 2007, CIRC RES, V101, P607, DOI 10.1161/CIRCRESAHA.107.157198; Kozarsky KF, 1997, NATURE, V387, P414, DOI 10.1038/387414a0; Lee JY, 2007, J LIPID RES, V48, P1052, DOI 10.1194/jlr.M600417-JLR200; Lesnik P, 2003, J CLIN INVEST, V111, P333, DOI 10.1172/JCI200315555; Li XA, 2006, CIRC RES, V98, pE60, DOI 10.1161/01.RES.0000219310.00308.10; Ma K, 2005, ARTERIOSCL THROM VAS, V25, P149, DOI 10.1161/01.ATV.0000150414.89591.6a; MAROTTI KR, 1993, NATURE, V364, P73, DOI 10.1038/364073a0; Meurs I, 2005, EXP HEMATOL, V33, P1309, DOI 10.1016/j.exphem.2005.07.004; Out R, 2004, J LIPID RES, V45, P2088, DOI 10.1194/jlr.M400191-JLR200; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; Rotllan N, 2008, ATHEROSCLEROSIS, V196, P505, DOI 10.1016/j.atherosclerosis.2007.05.007; Schwartz CC, 2004, J LIPID RES, V45, P1594, DOI 10.1194/jlr.M300511-JLR200; Seetharam D, 2006, CIRC RES, V98, P63, DOI 10.1161/01.RES.0000199272.59432.5b; Sehayek E, 2008, ARTERIOSCL THROM VAS, V28, P1296, DOI 10.1161/ATVBAHA.108.165803; Stein O, 2002, ATHEROSCLEROSIS, V164, P73, DOI 10.1016/S0021-9150(02)00061-8; Tanigawa H, 2007, CIRCULATION, V116, P1267, DOI 10.1161/CIRCULATIONAHA.107.704254; Tchoua U, 2008, CARDIOVASC RES, V77, P732, DOI 10.1093/cvr/cvm087; Ueda Y, 2000, J BIOL CHEM, V275, P20368, DOI 10.1074/jbc.M000730200; Ueda Y, 1999, J BIOL CHEM, V274, P7165, DOI 10.1074/jbc.274.11.7165; Van Eck M, 2003, J BIOL CHEM, V278, P23699, DOI 10.1074/jbc.M211233200; Vergeer M, 2011, NEW ENGL J MED, V364, P136, DOI 10.1056/NEJMoa0907687; Wang X, 2007, J CLIN INVEST, V117, P2216, DOI 10.1172/JCI32057; WERB Z, 1983, J CELL BIOL, V97, P1113, DOI 10.1083/jcb.97.4.1113; Yuhanna IS, 2001, NAT MED, V7, P853, DOI 10.1038/89986; Zanotti I, 2011, ARTERIOSCL THROM VAS, V31, P74, DOI 10.1161/ATVBAHA.110.213892; Zhang YZ, 2005, J CLIN INVEST, V115, P2870, DOI 10.1172/JCI25327; Zhang YZ, 2003, CIRCULATION, V108, P661, DOI 10.1161/01.CIR.0000086981.09834.E0; Zhou HW, 2006, BBA-MOL CELL BIOL L, V1761, P1482, DOI 10.1016/j.bbalip.2006.09.008	43	39	40	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17227	17238		10.1074/jbc.M111.220483	http://dx.doi.org/10.1074/jbc.M111.220483			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454568	hybrid, Green Published			2022-12-25	WOS:000290301900071
J	Iida, Y; Fujimori, T; Okawa, K; Nagata, K; Wada, I; Hosokawa, N				Iida, Yasutaka; Fujimori, Tsutomu; Okawa, Katsuya; Nagata, Kazuhiro; Wada, Ikuo; Hosokawa, Nobuko			SEL1L Protein Critically Determines the Stability of the HRD1-SEL1L Endoplasmic Reticulum-associated Degradation (ERAD) Complex to Optimize the Degradation Kinetics of ERAD Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN LIGASE COMPLEX; MEMBRANE-PROTEIN; QUALITY-CONTROL; RETRO-TRANSLOCATION; MISFOLDED PROTEINS; DISLOCATION; CYTOSOL; HRD1; MACHINERY; STRESS	The mammalian HRD1-SEL1L complex provides a scaffold for endoplasmic reticulum (ER)-associated degradation (ERAD), thereby connecting luminal substrates for ubiquitination at the cytoplasmic surface after their retrotranslocation through the endoplasmic reticulum membrane. In this study the stability of the mammalian HRD1-SEL1L complex was assessed by performing siRNA-mediated knockdown of each of its components. Although endogenous SEL1L is a long-lived protein, the half-life of SEL1L was greatly reduced when HRD1 is silenced. Conversely, transiently expressed SEL1L was rapidly degraded but was stabilized when HRD1 was coexpressed. This was in contrast to the yeast Hrd1p-Hrd3p, where Hrd1p is destabilized by the depletion of Hrd3p, the SEL1L homologue. Endogenous HRD1-SEL1L formed a large ERAD complex (Complex I) associating with numerous ERAD components including ERAD lectin OS-9, membrane-spanning Derlin-1/2, VIMP, and Herp, whereas transiently expressed HRD1-SEL1L formed a smaller complex (Complex II) that was associated with OS-9 but not with Derlin-1/2, VIMP, or Herp. Despite its lack of stable association with the latter components, Complex II supported the retrotranslocation and degradation of model ERAD substrates alpha 1-antitrypsin null Hong-Kong (NHK) and its variant NHK-QQQ lacking the N-glycosylation sites. NHK-QQQ was rapidly degraded when SEL1L was transiently expressed, whereas the simultaneous transfection of HRD1 diminished that effect. SEL1L unassociated with HRD1 was degraded by the ubiquitin-proteasome pathway, which suggests the involvement of a ubiquitin-ligase other than HRD1 in the rapid degradation of both SEL1L and NHK-QQQ. These results indicate that the regulation of the stability and assembly of the HRD1-SEL1L complex is critical to optimize the degradation kinetics of ERAD substrates.	[Iida, Yasutaka; Fujimori, Tsutomu; Hosokawa, Nobuko] Kyoto Univ, Inst Frontier Med Sci, Dept Mol & Cellular Biol, Sakyo Ku, Kyoto 6068397, Japan; [Okawa, Katsuya] Kyowa Hakko Kirin Co Ltd, Drug Discovery Res Labs, Nagaizumi, Shizuoka 4118731, Japan; [Nagata, Kazuhiro] Kyoto Sangyo Univ, Fac Life Sci, Mol & Cellular Biol Lab, Kita Ku, Kyoto 6038555, Japan; [Wada, Ikuo] Fukushima Med Univ, Sch Med, Inst Biomed Sci, Dept Cell Sci, Fukushima 9601295, Japan	Kyoto University; Kyowa Kirin Ltd; Kyoto Sangyo University; Fukushima Medical University	Hosokawa, N (corresponding author), Kyoto Univ, Inst Frontier Med Sci, Dept Mol & Cellular Biol, Sakyo Ku, 53 Kawahara Cho, Kyoto 6068397, Japan.	nobukoh@frontier.kyoto-u.ac.jp		Wada, Ikuo/0000-0001-5668-6994	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Hayashi Memorial Foundation for Female Natural Scientists	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Hayashi Memorial Foundation for Female Natural Scientists(Hayashi Memorial Foundation for Female Natural Scientists)	This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to K. N., I. W., and N. H.) and by the Hayashi Memorial Foundation for Female Natural Scientists (to N. H.).	Aebi M, 2010, TRENDS BIOCHEM SCI, V35, P74, DOI 10.1016/j.tibs.2009.10.001; Amano T, 2003, GENE DEV, V17, P2436, DOI 10.1101/gad.1096603; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Bernasconi R, 2008, J BIOL CHEM, V283, P16446, DOI 10.1074/jbc.M802272200; Bernasconi R, 2010, J CELL BIOL, V188, P223, DOI 10.1083/jcb.200910042; Biunno I, 2006, J CELL PHYSIOL, V208, P23, DOI 10.1002/jcp.20574; Bordallo J, 1998, MOL BIOL CELL, V9, P209, DOI 10.1091/mbc.9.1.209; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Cattaneo M, 2008, J CELL PHYSIOL, V215, P794, DOI 10.1002/jcp.21364; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Deak PM, 2001, J BIOL CHEM, V276, P10663, DOI 10.1074/jbc.M008608200; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; Francisco AB, 2010, J BIOL CHEM, V285, P13694, DOI 10.1074/jbc.M109.085340; Gardner RG, 2000, J CELL BIOL, V151, P69, DOI 10.1083/jcb.151.1.69; Gauss R, 2006, EMBO J, V25, P1827, DOI 10.1038/sj.emboj.7601088; Gauss R, 2006, NAT CELL BIOL, V8, P849, DOI 10.1038/ncb1445; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; Hirao K, 2006, J BIOL CHEM, V281, P9650, DOI 10.1074/jbc.M512191200; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Hosokawa N, 2001, EMBO REP, V2, P415, DOI 10.1093/embo-reports/kve084; Hosokawa N, 2008, J BIOL CHEM, V283, P20914, DOI 10.1074/jbc.M709336200; Hosokawa N, 2010, GLYCOBIOLOGY, V20, P651, DOI 10.1093/glycob/cwq013; Hosokawa N, 2009, J BIOL CHEM, V284, P17061, DOI 10.1074/jbc.M809725200; Huyer G, 2004, J BIOL CHEM, V279, P38369, DOI 10.1074/jbc.M402468200; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; Kokame K, 2000, J BIOL CHEM, V275, P32846, DOI 10.1074/jbc.M002063200; Kokame K, 2001, J BIOL CHEM, V276, P9199, DOI 10.1074/jbc.M010486200; Lederkremer GZ, 2009, CURR OPIN STRUC BIOL, V19, P515, DOI 10.1016/j.sbi.2009.06.004; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Morito D, 2008, MOL BIOL CELL, V19, P1328, DOI 10.1091/mbc.E07-06-0601; Mueller B, 2008, P NATL ACAD SCI USA, V105, P12325, DOI 10.1073/pnas.0805371105; Mueller B, 2006, J CELL BIOL, V175, P261, DOI 10.1083/jcb.200605196; Nagasawa K, 2007, EMBO REP, V8, P483, DOI 10.1038/sj.embor.7400933; Oda Y, 2006, J CELL BIOL, V172, P383, DOI 10.1083/jcb.200507057; Okuda-Shimizu Y, 2007, MOL CELL, V28, P544, DOI 10.1016/j.molcel.2007.09.012; Omura T, 2006, J NEUROCHEM, V99, P1456, DOI 10.1111/j.1471-4159.2006.04155.x; Plemper RK, 1999, J CELL SCI, V112, P4123; Plemper RK, 1999, TRENDS BIOCHEM SCI, V24, P266, DOI 10.1016/S0968-0004(99)01420-6; Ravid T, 2006, EMBO J, V25, P533, DOI 10.1038/sj.emboj.7600946; Schulze A, 2005, J MOL BIOL, V354, P1021, DOI 10.1016/j.jmb.2005.10.020; SIFERS RN, 1988, J BIOL CHEM, V263, P7330; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Tamura T, 2008, TRENDS BIOCHEM SCI, V33, P298, DOI 10.1016/j.tibs.2008.04.013; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656	51	71	72	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16929	16939		10.1074/jbc.M110.215871	http://dx.doi.org/10.1074/jbc.M110.215871			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454652	Green Published, hybrid			2022-12-25	WOS:000290301900042
J	Lodder-Gadaczek, J; Becker, I; Gieselmann, V; Wang-Eckhardt, L; Eckhardt, M				Lodder-Gadaczek, Julia; Becker, Ivonne; Gieselmann, Volkmar; Wang-Eckhardt, Lihua; Eckhardt, Matthias			N-Acetylaspartylglutamate Synthetase II Synthesizes N-Acetylaspartylglutamylglutamate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYL-L-ASPARTATE; CENTRAL-NERVOUS-SYSTEM; ISCHEMIC BRAIN-INJURY; GLUTAMIC-ACID; HIGH-AFFINITY; RAT-BRAIN; ACETYLASPARTATE; CELLS; NAAG; CSF	N-Acetylaspartylglutamate (NAAG) is found at high concentrations in the vertebrate nervous system. NAAG is an agonist at group II metabotropic glutamate receptors. In addition to its role as a neuropeptide, a number of functions have been proposed for NAAG, including a role as a non-excitotoxic transport form of glutamate and a molecular water pump. We recently identified a NAAG synthetase (now renamed NAAG synthetase I, NAAGS-I), encoded by the ribosomal modification protein rimK-like family member B (Rimklb) gene, as a member of the ATP-grasp protein family. We show here that a structurally related protein, encoded by the ribosomal modification protein rimK-like family member A (Rimkla) gene, is another NAAG synthetase (NAAGS-II), which in addition, synthesizes the N-acetylated tripeptide N-acetylaspartylglutamylglutamate (NAAG(2)). In contrast, NAAG(2) synthetase activity was undetectable in cells expressing NAAGS-I. Furthermore, we demonstrate by mass spectrometry the presence of NAAG(2) in murine brain tissue and sciatic nerves. The highest concentrations of both, NAAG(2) and NAAG, were found in sciatic nerves, spinal cord, and the brain stem, in accordance with the expression level of NAAGS-II. To our knowledge the presence of NAAG(2) in the vertebrate nervous system has not been described before. The physiological role of NAAG(2), e.g. whether it acts as a neurotransmitter, remains to be determined.	[Lodder-Gadaczek, Julia; Becker, Ivonne; Gieselmann, Volkmar; Wang-Eckhardt, Lihua; Eckhardt, Matthias] Univ Bonn, Inst Biochem & Mol Biol, D-53115 Bonn, Germany	University of Bonn	Eckhardt, M (corresponding author), Nussallee 11, D-53115 Bonn, Germany.	eckhardt@uni-bonn.de						Bacich DJ, 2005, J NEUROCHEM, V95, P314, DOI 10.1111/j.1471-4159.2005.03361.x; Baslow MH, 2000, J NEUROCHEM, V75, P453, DOI 10.1046/j.1471-4159.2000.0750453.x; Baslow MH, 2010, AMINO ACIDS, V39, P1139, DOI 10.1007/s00726-010-0656-6; Baslow MH, 2010, AMINO ACIDS, V38, P51, DOI 10.1007/s00726-009-0232-0; Becker I, 2008, HISTOCHEM CELL BIOL, V129, P233, DOI 10.1007/s00418-007-0344-0; Becker I, 2010, J BIOL CHEM, V285, P29156, DOI 10.1074/jbc.M110.111765; Bischofberger J, 1996, J NEUROPHYSIOL, V76, P2089, DOI 10.1152/jn.1996.76.3.2089; Bruno V, 1998, NEUROSCIENCE, V85, P751, DOI 10.1016/S0306-4522(97)00531-9; BURLINA AP, 1994, J NEUROCHEM, V63, P1174; BURRI R, 1991, DEV NEUROSCI-BASEL, V13, P403, DOI 10.1159/000112191; CASSIDY M, 1993, J NEUROCHEM, V60, P1631, DOI 10.1111/j.1471-4159.1993.tb13385.x; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Collard F, 2010, J BIOL CHEM, V285, P29826, DOI 10.1074/jbc.M110.152629; Coyle JT, 1997, NEUROBIOL DIS, V4, P231, DOI 10.1006/nbdi.1997.0153; CURATOLO A, 1965, J NEUROCHEM, V12, P339, DOI 10.1111/j.1471-4159.1965.tb06771.x; Eckhardt M, 2000, J BIOL CHEM, V275, P2328, DOI 10.1074/jbc.275.4.2328; Ganapathy V, 2006, ADV EXP MED BIOL, V576, P67; Gehl LM, 2004, J NEUROCHEM, V90, P989, DOI 10.1111/j.1471-4159.2004.02578.x; Hamada-Kanazawa M, 2010, BIOL PHARM BULL, V33, P729, DOI 10.1248/bpb.33.729; KANG WK, 1989, MOL GEN GENET, V217, P281, DOI 10.1007/BF02464894; KOLLER KJ, 1984, J NEUROCHEM, V43, P1136, DOI 10.1111/j.1471-4159.1984.tb12854.x; Losi G, 2004, NEUROPHARMACOLOGY, V46, P490, DOI 10.1016/j.neuropharm.2003.10.007; MIYAKE M, 1981, J NEUROCHEM, V37, P1064, DOI 10.1111/j.1471-4159.1981.tb04500.x; Mochel F, 2010, NEUROLOGY, V74, P302, DOI 10.1212/WNL.0b013e3181cbcdc4; Mochel F, 2010, BBA-MOL BASIS DIS, V1802, P1112, DOI 10.1016/j.bbadis.2010.07.005; Moffett JR, 2007, PROG NEUROBIOL, V81, P89, DOI 10.1016/j.pneurobio.2006.12.003; Moffett JR, 2006, ADV EXP MED BIOL, V576, P7; MOFFETT JR, 1994, J COMP NEUROL, V347, P598, DOI 10.1002/cne.903470410; Namboodiri AMA, 2006, MOL CELL ENDOCRINOL, V252, P216, DOI 10.1016/j.mce.2006.03.016; Neale JH, 2000, J NEUROCHEM, V75, P443, DOI 10.1046/j.1471-4159.2000.0750443.x; Neale JH, 2005, TRENDS PHARMACOL SCI, V26, P477, DOI 10.1016/j.tips.2005.07.004; ORYLAVOLLEE L, 1987, J NEUROCHEM, V48, P895, DOI 10.1111/j.1471-4159.1987.tb05601.x; Passani L, 1998, BRAIN RES, V794, P143, DOI 10.1016/S0006-8993(98)00308-4; Sambrook J., 2002, MOL CLONING LAB MANU; Sartori S, 2008, EUR J PAEDIATR NEURO, V12, P348, DOI 10.1016/j.ejpn.2007.07.011; SEKIGUCHI M, 1992, FEBS LETT, V311, P285, DOI 10.1016/0014-5793(92)81121-2; Slusher BS, 1999, NAT MED, V5, P1396, DOI 10.1038/70971; Wolf NI, 2004, NEUROLOGY, V62, P1503, DOI 10.1212/01.WNL.0000123094.13406.20; Wroblewska B, 1997, J NEUROCHEM, V69, P174; ZACZEK R, 1983, P NATL ACAD SCI-BIOL, V80, P1116, DOI 10.1073/pnas.80.4.1116	40	26	28	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16693	16706		10.1074/jbc.M111.230136	http://dx.doi.org/10.1074/jbc.M111.230136			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454531	Green Published, hybrid			2022-12-25	WOS:000290301900017
J	McCusker, EC; D'Avanzo, N; Nichols, CG; Wallace, BA				McCusker, Emily C.; D'Avanzo, Nazzareno; Nichols, Colin G.; Wallace, B. A.			Simplified Bacterial "Pore" Channel Provides Insight into the Assembly, Stability, and Structure of Sodium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; CIRCULAR-DICHROISM SPECTROSCOPY; DEPENDENT K+ CHANNEL; ALKALIPHILIC BACILLUS; NACHBAC; INACTIVATION; ENVIRONMENT; CHEMOTAXIS; MOTILITY; SPECTRA	Eukaryotic sodium channels are important membrane proteins involved in ion permeation, homeostasis, and electrical signaling. They are long, multidomain proteins that do not express well in heterologous systems, and hence, structure/function and biochemical studies on purified sodium channel proteins have been limited. Bacteria produce smaller, homologous tetrameric single domain channels specific for the conductance of sodium ions. They consist of N-terminal voltage sensor and C-terminal pore subdomains. We designed a functional pore-only channel consisting of the final two transmembrane helices, the intervening P-region, and the C-terminal extramembranous region of the sodium channel from the marine bacterium Silicibacter pomeroyi. This sodium "pore" channel forms a tetrameric, folded structure that is capable of supporting sodium flux in phospholipid vesicles. The pore-only channel is more thermally stable than its full-length counterpart, suggesting that the voltage sensor subdomain may destabilize the full-length channel. The pore subdomains can assemble, fold, and function independently from the voltage sensor and exhibit similar ligand-blocking characteristics as the intact channel. The availability of this simple pore-only construct should enable high-level expression for the testing of potential new ligands and enhance our understanding of the structural features that govern sodium selectivity and permeability.	[McCusker, Emily C.; Wallace, B. A.] Univ London, Birkbeck Coll, Inst Struct & Mol Biol, Dept Crystallog, London WC1E 7HX, England; [D'Avanzo, Nazzareno; Nichols, Colin G.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [D'Avanzo, Nazzareno; Nichols, Colin G.] Washington Univ, Sch Med, Ctr Invest Membrane Excitabil Dis, St Louis, MO 63110 USA	University of London; Birkbeck University London; Washington University (WUSTL); Washington University (WUSTL)	Wallace, BA (corresponding author), Univ London, Birkbeck Coll, Inst Struct & Mol Biol, Dept Crystallog, Malet St, London WC1E 7HX, England.	b.wallace@mail.cryst.bbk.ac.uk	Nichols, Colin/D-6336-2012; Wallace, B A/C-3753-2008	Wallace, B A/0000-0001-9649-5092	Biotechnology and Biological Science Research Council (BBSRC); National Institutes of Health [HL54171]; BBSRC [BB/H01070X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H01070X/1] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054171] Funding Source: NIH RePORTER	Biotechnology and Biological Science Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a project grant from the Biotechnology and Biological Science Research Council (BBSRC) (to B. A. W.) and a BBSRC SPORT programme grant to the Membrane Protein Structure Initiative consortium (to N. Isaacs, principal investigator). This work was supported in part by National Institutes of Health Grant HL54171 (to C. G. N.).	Anderson JD, 2003, MOL CANCER THER, V2, P1149; Chakrapani S, 2010, P NATL ACAD SCI USA, V107, P5435, DOI 10.1073/pnas.0914109107; Chen ZH, 2002, J BIOL CHEM, V277, P24653, DOI 10.1074/jbc.M111862200; Clayton GM, 2008, P NATL ACAD SCI USA, V105, P1511, DOI 10.1073/pnas.0711533105; Cuello LG, 2010, NATURE, V466, P272, DOI 10.1038/nature09136; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Fraser SP, 2005, CLIN CANCER RES, V11, P5381, DOI 10.1158/1078-0432.CCR-05-0327; Fujinami S, 2009, FUTURE MICROBIOL, V4, P1137, DOI 10.2217/FMB.09.76; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Irie K, 2010, J BIOL CHEM, V285, P3685, DOI 10.1074/jbc.M109.057455; Ito M, 2004, P NATL ACAD SCI USA, V101, P10566, DOI 10.1073/pnas.0402692101; Jarvis MF, 2007, P NATL ACAD SCI USA, V104, P8520, DOI 10.1073/pnas.0611364104; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Klose DP, 2010, BIOINFORMATICS, V26, P2624, DOI 10.1093/bioinformatics/btq480; Koishi R, 2004, J BIOL CHEM, V279, P9532, DOI 10.1074/jbc.M313100200; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lees JG, 2004, ANAL BIOCHEM, V332, P285, DOI 10.1016/j.ab.2004.06.002; Lees JG, 2006, BIOINFORMATICS, V22, P1955, DOI 10.1093/bioinformatics/btl327; Liu Y, 2009, EPILEPSY RES, V83, P66, DOI 10.1016/j.eplepsyres.2008.09.006; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Mio K, 2010, PROG BIOPHYS MOL BIO, V103, P111, DOI 10.1016/j.pbiomolbio.2010.05.002; Nurani G, 2008, BIOCHEMISTRY-US, V47, P8114, DOI 10.1021/bi800645w; O'Reilly AO, 2008, MOL MEMBR BIOL, V25, P670, DOI 10.1080/09687680802508754; Powl AM, 2010, P NATL ACAD SCI USA, V107, P14064, DOI 10.1073/pnas.1001793107; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Ren DJ, 2001, SCIENCE, V294, P2372, DOI 10.1126/science.1065635; Shimomura T, 2011, J BIOL CHEM, V286, P7409, DOI 10.1074/jbc.M110.186510; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Ulmschneider MB, 2010, J AM CHEM SOC, V132, P3452, DOI 10.1021/ja909347x; VANSTOKKUM IHM, 1990, ANAL BIOCHEM, V191, P110, DOI 10.1016/0003-2697(90)90396-Q; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Zimmer T, 2008, PROG BIOPHYS MOL BIO, V98, P120, DOI 10.1016/j.pbiomolbio.2008.10.005	34	29	29	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.C111.228122	http://dx.doi.org/10.1074/jbc.C111.228122			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454659	hybrid, Green Published			2022-12-25	WOS:000290022800076
J	Laayouni, H; Montanucci, L; Sikora, M; Mele, M; Dall'Olio, GM; Lorente-Galdos, B; McGee, KM; Graffelman, J; Awadalla, P; Bosch, E; Comas, D; Navarro, A; Calafell, F; Casals, F; Bertranpetit, J				Laayouni, Hafid; Montanucci, Ludovica; Sikora, Martin; Mele, Marta; Marco Dall'Olio, Giovanni; Lorente-Galdos, Belen; McGee, Kate M.; Graffelman, Jan; Awadalla, Philip; Bosch, Elena; Comas, David; Navarro, Arcadi; Calafell, Francesc; Casals, Ferran; Bertranpetit, Jaume			Similarity in Recombination Rate Estimates Highly Correlates with Genetic Differentiation in Humans	PLOS ONE			English	Article							CELL-LINE PANEL; HUMAN GENOME; HUMAN-POPULATIONS; LINKAGE DISEQUILIBRIUM; MEIOTIC RECOMBINATION; HAPLOTYPE MAP; PATTERNS; HOTSPOTS; ASSOCIATION; CHIMPANZEES	Recombination varies greatly among species, as illustrated by the poor conservation of the recombination landscape between humans and chimpanzees. Thus, shorter evolutionary time frames are needed to understand the evolution of recombination. Here, we analyze its recent evolution in humans. We calculated the recombination rates between adjacent pairs of 636,933 common single-nucleotide polymorphism loci in 28 worldwide human populations and analyzed them in relation to genetic distances between populations. We found a strong and highly significant correlation between similarity in the recombination rates corrected for effective population size and genetic differentiation between populations. This correlation is observed at the genome-wide level, but also for each chromosome and when genetic distances and recombination similarities are calculated independently from different parts of the genome. Moreover, and more relevant, this relationship is robustly maintained when considering presence/absence of recombination hotspots. Simulations show that this correlation cannot be explained by biases in the inference of recombination rates caused by haplotype sharing among similar populations. This result indicates a rapid pace of evolution of recombination, within the time span of differentiation of modern humans.	[Laayouni, Hafid; Montanucci, Ludovica; Sikora, Martin; Mele, Marta; Marco Dall'Olio, Giovanni; Lorente-Galdos, Belen; Bosch, Elena; Comas, David; Navarro, Arcadi; Calafell, Francesc; Casals, Ferran; Bertranpetit, Jaume] CEXS UPF PRBB, Inst Evolutionary Biol UPF CSIC, IBE, Barcelona, Catalonia, Spain; [McGee, Kate M.] NCI, NIH, Frederick, MD 21701 USA; [Graffelman, Jan] Univ Politecn Cataluna, Dept Stat & Operat Res, Barcelona, Spain; [Awadalla, Philip; Casals, Ferran] Univ Montreal, Fac Med, Ste Justine Hosp, Res Ctr, Montreal, PQ H3C 3J7, Canada; [Navarro, Arcadi] Inst Catalana Recerca & Estudis Avancats, Barcelona, Catalonia, Spain; [Navarro, Arcadi] Natl Inst Bioinformat INB, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Universitat Politecnica de Catalunya; Universite de Montreal; ICREA	Laayouni, H (corresponding author), CEXS UPF PRBB, Inst Evolutionary Biol UPF CSIC, IBE, Barcelona, Catalonia, Spain.	jaume.bertranpetit@upf.edu	Comas, David/D-5382-2014; Laayouni, Hafid/AAA-9254-2019; Bertranpetit, Jaume/F-8550-2012; Calafell, Francesc/C-8595-2014; Sikora, Martin/C-8609-2015; Graffelman, Jan/L-8056-2014; Bosch, Elena/N-7603-2019; Navarro, Arcadi/F-1592-2011; Bosch, Elena/D-8681-2014; Awadalla, Philip/AAC-4896-2021; Casals, Ferran/H-4347-2015	Comas, David/0000-0002-5075-0956; Laayouni, Hafid/0000-0003-1297-5078; Bertranpetit, Jaume/0000-0003-0100-0590; Calafell, Francesc/0000-0002-1083-9438; Sikora, Martin/0000-0003-2818-8319; Graffelman, Jan/0000-0003-3900-0780; Bosch, Elena/0000-0003-2848-103X; Navarro, Arcadi/0000-0003-2162-8246; Bosch, Elena/0000-0003-2848-103X; Casals, Ferran/0000-0002-8941-0369; mele, marta/0000-0001-8874-6453; Dall'Olio, Giovanni Marco/0000-0001-9057-2480; MONTANUCCI, LUDOVICA/0000-0003-2375-7359; Lorente-Galdos, Belen/0000-0001-5390-2452	Ministerio de Educacion y Ciencia (Spain) [BFU2007-63657, BFU2009-13409-C02-02, SAF-2007-63171]; Direccio General de Recerca of Generalitat de Catalunya (Grup de Recerca Consolidat) [2005SGR/00608, 2009 SGR 1101]; National Institute for Bioinformatics; ICREA Funding Source: Custom	Ministerio de Educacion y Ciencia (Spain)(Spanish Government); Direccio General de Recerca of Generalitat de Catalunya (Grup de Recerca Consolidat)(Generalitat de Catalunya); National Institute for Bioinformatics; ICREA(ICREA)	This research was funded by grants BFU2007-63657, BFU2009-13409-C02-02 and SAF-2007-63171 awarded by Ministerio de Educacion y Ciencia (Spain), by the Direccio General de Recerca of Generalitat de Catalunya (Grup de Recerca Consolidat 2005SGR/00608 and 2009 SGR 1101), and by the National Institute for Bioinformatics (www.inab.org), a platform of Genoma Espana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Auton A, 2007, GENOME RES, V17, P1219, DOI 10.1101/gr.6386707; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Bertranpetit J, 2003, COLD SPRING HARB SYM, V68, P79, DOI 10.1101/sqb.2003.68.79; Cann HM, 2002, SCIENCE, V296, P261; Conrad DF, 2006, NAT GENET, V38, P1251, DOI 10.1038/ng1911; Coop G, 2008, SCIENCE, V319, P1395, DOI 10.1126/science.1151851; Coop G, 2007, NAT REV GENET, V8, P23, DOI 10.1038/nrg1947; Crawford DC, 2004, NAT GENET, V36, P700, DOI 10.1038/ng1376; Evans DM, 2005, AM J HUM GENET, V76, P681, DOI 10.1086/429274; Fearnhead P, 2001, GENETICS, V159, P1299; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gardner M, 2006, MOL PSYCHIATR, V11, P66, DOI 10.1038/sj.mp.4001749; Graffelman J, 2007, HUM GENET, V122, P301, DOI 10.1007/s00439-007-0391-6; GROSSMAN SR, SCIENCE, V327, P883; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Jeffreys AJ, 2005, NAT GENET, V37, P601, DOI 10.1038/ng1565; Khil PP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000831; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kong A, 2004, NAT GENET, V36, P1203, DOI 10.1038/ng1445; Kong A, 2010, NATURE, V467, P1099, DOI 10.1038/nature09525; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; Ptak SE, 2005, NAT GENET, V37, P429, DOI 10.1038/ng1529; Rosenberg NA, 2006, ANN HUM GENET, V70, P841, DOI 10.1111/j.1469-1809.2006.00285.x; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Serre D, 2005, GENOME RES, V15, P1547, DOI 10.1101/gr.4211905; Smith NGC, 2005, GENETICS, V171, P2051, DOI 10.1534/genetics.104.036293; Sokal RR, 1995, BIOMETRY; Stajich JE, 2005, MOL BIOL EVOL, V22, P63, DOI 10.1093/molbev/msh252; Stumpf MPH, 2003, NAT REV GENET, V4, P959, DOI 10.1038/nrg1227; The International HapMap Consortium, 2005, NATURE, V437, P1299, DOI DOI 10.1038/NATURE04226; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Winckler W, 2005, SCIENCE, V308, P107, DOI 10.1126/science.1105322	37	12	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e17913	10.1371/journal.pone.0017913	http://dx.doi.org/10.1371/journal.pone.0017913			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464928	gold, Green Published, Green Submitted			2022-12-25	WOS:000289053800005
J	Yotoko, KSC; Dornelas, MC; Togni, PD; Fonseca, TC; Salzano, FM; Bonatto, SL; Freitas, LB				Yotoko, Karla S. C.; Dornelas, Marcelo C.; Togni, Pakisa D.; Fonseca, Tamara C.; Salzano, Francisco M.; Bonatto, Sandro L.; Freitas, Loreta B.			Does Variation in Genome Sizes Reflect Adaptive or Neutral Processes? New Clues from Passiflora	PLOS ONE			English	Article							NUCLEAR-DNA CONTENT; PHYLOGENETIC ANALYSIS; METABOLIC-RATE; CELL-VOLUME; JUNK DNA; EVOLUTION; RECOMBINATION; SELECTION; AMPLIFICATION; GENERATION	One of the long-standing paradoxes in genomic evolution is the observation that much of the genome is composed of repetitive DNA which has been typically regarded as superfluous to the function of the genome in generating phenotypes. In this work, we used comparative phylogenetic approaches to investigate if the variations in genome sizes (GS) should be considered as adaptive or neutral processes by the comparison between GS and flower diameters (FD) of 50 Passiflora species, more specifically, within its two most species-rich subgenera, Passiflora and Decaloba. For this, we have constructed a phylogenetic tree of these species, estimated GS and FD of them, inferred the tempo and mode of evolution of these traits and their correlations, using both current and phylogenetically independent contrasted values. We found significant correlations among the traits, when considering the complete set of data or only the subgenus Passiflora, whereas no correlations were observed within Decaloba. Herein, we present convincing evidence of adaptive evolution of GS, as well as clues that this pattern is limited by a minimum genome size, which could reduce both the possibilities of changes in GS and the possibility of phenotypic responses to environment changes.	[Yotoko, Karla S. C.] Univ Fed Vicosa, Dept Biol Geral, Lab Bioinformat & Evolucao, Vicosa, MG, Brazil; [Dornelas, Marcelo C.; Fonseca, Tamara C.] Univ Estadual Campinas, Inst Biol, Dept Biol Vegetal, Campinas, Brazil; [Togni, Pakisa D.; Salzano, Francisco M.; Freitas, Loreta B.] Univ Fed Rio Grande do Sul, Dept Genet, Lab Evolucao Mol, Porto Alegre, RS, Brazil; [Bonatto, Sandro L.] Pontificia Univ Catolica Rio Grande do Sul, Fac Biociencias, Lab Biol Genom & Mol, Porto Alegre, RS, Brazil	Universidade Federal de Vicosa; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Federal do Rio Grande do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul	Yotoko, KSC (corresponding author), Univ Fed Vicosa, Dept Biol Geral, Lab Bioinformat & Evolucao, Vicosa, MG, Brazil.	dornelas@unicamp.br	Dornelas, Marcelo C/A-6104-2013; Yotoko, Karla/G-5151-2010; Salzano, Francisco M/L-7916-2015; Freitas, Loreta B/D-9948-2013; Freitas, Loreta B/E-7366-2010; Bonatto, Sandro L/A-1240-2010	Dornelas, Marcelo C/0000-0002-6710-3050; Yotoko, Karla/0000-0003-2051-4204; Freitas, Loreta B/0000-0002-0728-4945; Freitas, Loreta B/0000-0002-0728-4945; Bonatto, Sandro L/0000-0002-0064-467X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Institutos do Milenio, Programa de Apoio a Nucleos de Excelencia (PRONEX); Programa Especial de Taxonomia (CNPq-PROTAX); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS); Pro-Reitoria de Pesquisa da Universidade Federal do Rio Grande do Sul (PROPESQ-UFRGS)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Institutos do Milenio, Programa de Apoio a Nucleos de Excelencia (PRONEX)(Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Programa Especial de Taxonomia (CNPq-PROTAX)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); Pro-Reitoria de Pesquisa da Universidade Federal do Rio Grande do Sul (PROPESQ-UFRGS)	This project was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Institutos do Milenio, Programa de Apoio a Nucleos de Excelencia (PRONEX), Programa Especial de Taxonomia (CNPq-PROTAX), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS), and Pro-Reitoria de Pesquisa da Universidade Federal do Rio Grande do Sul (PROPESQ-UFRGS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achigan-Dako EG, 2008, PLANT SYST EVOL, V276, P9, DOI 10.1007/s00606-008-0075-2; ALBERTINI AM, 1982, CELL, V29, P319, DOI 10.1016/0092-8674(82)90148-9; Ashman TL, 2004, P ROY SOC B-BIOL SCI, V271, P553, DOI 10.1098/rspb.2003.2642; Ashman TL, 2006, HEREDITY, V96, P343, DOI 10.1038/sj.hdy.6800815; Beaulieu JM, 2007, ANN BOT-LONDON, V99, P495, DOI 10.1093/aob/mcl271; BEBENEK K, 1990, P NATL ACAD SCI USA, V87, P4946, DOI 10.1073/pnas.87.13.4946; Bennett MD, 2005, ANN BOT-LONDON, V95, P1, DOI 10.1093/aob/mci001; BENNETT MD, 1977, PHILOS T R SOC B, V277, P201, DOI 10.1098/rstb.1977.0012; BENNETT MD, 1976, PHILOS T R SOC B, V274, P227, DOI 10.1098/rstb.1976.0044; BENNETT MD, 1972, PROC R SOC SER B-BIO, V181, P109, DOI 10.1098/rspb.1972.0042; Bennetzen JL, 2002, GENETICA, V115, P29, DOI 10.1023/A:1016015913350; CAVALIERSMITH T, 1978, J CELL SCI, V34, P247; Chung J, 1998, THEOR APPL GENET, V96, P1064, DOI 10.1007/s001220050840; Cui LY, 2006, GENOME RES, V16, P738, DOI 10.1101/gr.4825606; Devos KM, 2002, GENOME RES, V12, P1075, DOI 10.1101/gr.132102; Dolezel J, 2005, ANN BOT-LONDON, V95, P99, DOI 10.1093/aob/mci005; DUNN IS, 1987, NUCLEIC ACIDS RES, V15, P2677; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Garland T, 1999, AM ZOOL, V39, P374; GARLAND T, 2006, PDAP PHENOTYPIC DIVE; Gaut BS, 2008, SCIENCE, V320, P484, DOI 10.1126/science.1153586; Gregory TR, 2005, ANN BOT-LONDON, V95, P133, DOI 10.1093/aob/mci009; Gregory TR, 2004, PALEOBIOLOGY, V30, P179, DOI 10.1666/0094-8373(2004)030<0179:MHTATC>2.0.CO;2; Hansen AK, 2006, SYST BOT, V31, P138, DOI 10.1600/036364406775971769; Hawkins JS, 2006, GENOME RES, V16, P1252, DOI 10.1101/gr.5282906; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; JASIENSKI M, 1995, NATURE, V376, P559, DOI 10.1038/376559b0; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Knight CA, 2002, ECOL LETT, V5, P66, DOI 10.1046/j.1461-0248.2002.00283.x; Knight CA, 2008, ANN BOT-LONDON, V101, P759, DOI 10.1093/aob/mcm321; Kozlowski J, 2003, P NATL ACAD SCI USA, V100, P14080, DOI 10.1073/pnas.2334605100; KUNKEL TA, 1990, BIOCHEMISTRY-US, V29, P8003, DOI 10.1021/bi00487a001; Meagher TR, 2008, GENET RES, V90, P111, DOI 10.1017/S001667230700897X; MEAGHER TR, 1994, AM J BOT, V81, P1198, DOI 10.2307/2445482; Muschner VC, 2003, AM J BOT, V90, P1229, DOI 10.3732/ajb.90.8.1229; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; OHNO S, 1972, BROOKHAVEN SYM BIOL, P366; Oliver MJ, 2007, GENOME RES, V17, P594, DOI 10.1101/gr.6096207; ORGEL LE, 1980, NATURE, V284, P604, DOI 10.1038/284604a0; Otto F, 1990, Methods Cell Biol, V33, P105; Pagel M, 1997, ZOOL SCR, V26, P331, DOI 10.1111/j.1463-6409.1997.tb00423.x; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; Petrov DA, 2002, THEOR POPUL BIOL, V61, P531, DOI 10.1006/tpbi.2002.1605; Price H. James, 1996, P115; PRICE HJ, 1973, EXPERIENTIA, V29, P1028, DOI 10.1007/BF01930444; Rambaut A., 2003, TRACER MCMC TRACE AN; Ross-Ibarra J, 2007, J EVOLUTION BIOL, V20, P800, DOI 10.1111/j.1420-9101.2006.01275.x; ROY A, 1992, THEOR APPL GENET, V85, P173, DOI 10.1007/BF00222856; Savolainen V, 2000, SYST BIOL, V49, P306, DOI 10.1093/sysbio/49.2.306; Smarda P, 2008, ANN BOT-LONDON, V102, P599, DOI 10.1093/aob/mcn133; Soltis DE, 1999, TRENDS ECOL EVOL, V14, P348, DOI 10.1016/S0169-5347(99)01638-9; SouzaChies TT, 1997, PLANT SYST EVOL, V204, P109, DOI 10.1007/BF00982535; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMAS CA, 1971, ANNU REV GENET, V5, P237, DOI 10.1146/annurev.ge.05.120171.001321; Ulmer T., 2004, PASSIFLORA PASSIONFL; Vinogradov AE, 1995, EVOLUTION, V49, P1249, DOI 10.1111/j.1558-5646.1995.tb04451.x; Vinogradov AE, 1997, EVOLUTION, V51, P220, DOI 10.1111/j.1558-5646.1997.tb02403.x; WAKAMIYA I, 1993, AM J BOT, V80, P1235, DOI 10.2307/2445706; Wendel JF, 2002, GENETICA, V115, P37, DOI 10.1023/A:1016020030189; Wyman J, 1997, AM J BOT, V84, P1351, DOI 10.2307/2446133	62	41	45	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e18212	10.1371/journal.pone.0018212	http://dx.doi.org/10.1371/journal.pone.0018212			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464897	Green Published, Green Submitted, gold			2022-12-25	WOS:000289053800029
J	Chesnokova, V; Zonis, S; Zhou, CQ; Ben-Shlomo, A; Wawrowsky, K; Toledano, Y; Tong, YG; Kovacs, K; Scheithauer, B; Melmed, S				Chesnokova, Vera; Zonis, Svetlana; Zhou, Cuiqi; Ben-Shlomo, Anat; Wawrowsky, Kolja; Toledano, Yoel; Tong, Yunguang; Kovacs, Kalman; Scheithauer, Bernd; Melmed, Shlomo			Lineage-Specific Restraint of Pituitary Gonadotroph Cell Adenoma Growth	PLOS ONE			English	Article							TUMOR-TRANSFORMING GENE; TRANSCRIPTION FACTORS; CYCLE PROGRESSION; EPITHELIAL-CELLS; PTTG EXPRESSION; TRANSGENIC MICE; C/EBP-DELTA; DNA-DAMAGE; FACTOR-I; SENESCENCE	Although pituitary adenomas are usually benign, unique trophic mechanisms restraining cell proliferation are unclear. As GH-secreting adenomas are associated with p53/p21-dependent senescence, we tested mechanisms constraining non-functioning pituitary adenoma growth. Thirty six gonadotroph-derived non-functioning pituitary adenomas all exhibited DNA damage, but undetectable p21 expression. However, these adenomas all expressed p16, and > 90% abundantly expressed cytoplasmic clusterin associated with induction of the Cdk inhibitor p15 in 70% of gonadotroph and in 26% of somatotroph lineage adenomas (p = 0.006). Murine L beta T2 and alpha T3 gonadotroph pituitary cells, and alpha GSU.PTTG transgenic mice with targeted gonadotroph cell adenomas also abundantly expressed clusterin and exhibited features of oncogene-induced senescence as evidenced by C/EBP beta and C/EBP delta induction. In turn, C/EBPs activated the clusterin promoter similar to 5 fold, and elevated clusterin subsequently elicited p15 and p16 expression, acting to arrest murine gonadotroph cell proliferation. In contrast, specific clusterin suppression by RNAis enhanced gonadotroph proliferation. FOXL2, a tissue-specific gonadotroph lineage factor, also induced the clusterin promoter similar to 3 fold in alpha T3 pituitary cells. As nine of 12 pituitary carcinomas were devoid of clusterin expression, this protein may limit proliferation of benign adenomatous pituitary cells. These results point to lineage-specific pathways restricting uncontrolled murine and human pituitary gonadotroph adenoma cell growth.	[Chesnokova, Vera; Zonis, Svetlana; Zhou, Cuiqi; Ben-Shlomo, Anat; Wawrowsky, Kolja; Toledano, Yoel; Tong, Yunguang; Melmed, Shlomo] Cedars Sinai Med Ctr, Dept Med, Pituitary Ctr, Los Angeles, CA 90048 USA; [Tong, Yunguang; Kovacs, Kalman] St Michaels Hosp, Dept Pathol, Toronto, ON M5B 1W8, Canada; [Tong, Yunguang; Scheithauer, Bernd] Mayo Clin, Rochester, MN USA	Cedars Sinai Medical Center; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Mayo Clinic	Chesnokova, V (corresponding author), Cedars Sinai Med Ctr, Dept Med, Pituitary Ctr, Los Angeles, CA 90048 USA.	Melmed@csmc.edu	Ben-Shlomo, Anat/AAH-6009-2021; Chesnokova, Vera/AAI-4168-2020		National Institutes of Health [CA75979, T32 DK07770]; Doris Factor Molecular Endocrinology Laboratory; NATIONAL CANCER INSTITUTE [R01CA075979, K99CA138914] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007770] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Factor Molecular Endocrinology Laboratory; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health, CA75979 (SM) and T32 DK07770 (SM to YT), and the Doris Factor Molecular Endocrinology Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbud RA, 2005, MOL ENDOCRINOL, V19, P1383, DOI 10.1210/me.2004-0403; Alarid ET, 1996, DEVELOPMENT, V122, P3319; Bernal JA, 2008, CELL DEATH DIFFER, V15, P202, DOI 10.1038/sj.cdd.4402254; Bettuzzi S, 2002, ONCOGENE, V21, P4328, DOI 10.1038/sj.onc.1205594; Bettuzzi S, 2009, ONCOGENE, V28, P4344, DOI 10.1038/onc.2009.286; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Chayka O, 2009, JNCI-J NATL CANCER I, V101, P663, DOI 10.1093/jnci/djp063; Chen TG, 2004, CANCER RES, V64, P7412, DOI 10.1158/0008-5472.CAN-04-2077; Chesnokova V, 2008, P NATL ACAD SCI USA, V105, P17498, DOI 10.1073/pnas.0804810105; Chesnokova V, 2007, CANCER RES, V67, P10564, DOI 10.1158/0008-5472.CAN-07-0974; Chi KN, 2008, EXPERT OPIN INV DRUG, V17, P1955, DOI [10.1517/13543780802528609, 10.1517/13543780802528609 ]; Chou TY, 2009, CELL SIGNAL, V21, P704, DOI 10.1016/j.cellsig.2009.01.008; Ciccone NA, 2010, MOL CELL BIOL, V30, P1028, DOI 10.1128/MCB.00848-09; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Criswell T, 2005, J BIOL CHEM, V280, P14212, DOI 10.1074/jbc.M412569200; Cuadrado M, 2009, CANCER RES, V69, P8726, DOI 10.1158/0008-5472.CAN-09-0729; Donangelo I, 2006, ENDOCRINOLOGY, V147, P4781, DOI 10.1210/en.2006-0544; EGASHIRA N, 2010, MODERN PATHOLOGY, P1; Ellsworth BS, 2006, MOL ENDOCRINOL, V20, P2796, DOI 10.1210/me.2005-0303; Fernandez A, 2010, CLIN ENDOCRINOL, V72, P377, DOI 10.1111/j.1365-2265.2009.03667.x; Filippella M, 2006, CLIN ENDOCRINOL, V65, P536, DOI 10.1111/j.1365-2265.2006.02630.x; Flanagan L, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-107; Frost SJ, 2001, MOL CELL ENDOCRINOL, V176, P29, DOI 10.1016/S0303-7207(01)00477-4; Gery S, 2005, ONCOGENE, V24, P1589, DOI 10.1038/sj.onc.1208393; Goffin V, 2002, ANNU REV PHYSIOL, V64, P47, DOI 10.1146/annurev.physiol.64.081501.131049; Heaney AP, 1999, NAT MED, V5, P1317, DOI 10.1038/15275; Hsu YH, 2010, J BIOL CHEM, V285, P22630, DOI 10.1074/jbc.M109.096255; Janovick JA, 2010, P NATL ACAD SCI USA, V107, P4454, DOI 10.1073/pnas.0914261107; JENNE DE, 1989, P NATL ACAD SCI USA, V86, P7123, DOI 10.1073/pnas.86.18.7123; Kim HJ, 2009, ARTERIOSCL THROM VAS, V29, P1558, DOI 10.1161/ATVBAHA.109.190058; KIRSZBAUM L, 1992, FEBS LETT, V297, P70, DOI 10.1016/0014-5793(92)80330-J; Kleinberg DL, 2009, ENDOCR REV, V30, P51, DOI 10.1210/er.2008-0022; Kovacs K, 2001, J NEURO-ONCOL, V54, P121, DOI 10.1023/A:1012945129981; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560; Melmed S, 2003, J CLIN INVEST, V112, P1603, DOI 10.1172/JCI200320401; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Nam JS, 2008, CANCER RES, V68, P3915, DOI 10.1158/0008-5472.CAN-08-0206; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Nerlov C, 2007, TRENDS CELL BIOL, V17, P318, DOI 10.1016/j.tcb.2007.07.004; Panico F, 2009, ADV CANCER RES, V105, P63, DOI 10.1016/S0065-230X(09)05004-0; Pei L, 1997, MOL ENDOCRINOL, V11, P433, DOI 10.1210/me.11.4.433; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Rizzi F, 2010, ENDOCR-RELAT CANCER, V17, pR1, DOI 10.1677/ERC-09-0140; Rizzi F, 2009, J CELL PHYSIOL, V219, P314, DOI 10.1002/jcp.21671; Salehi F, 2008, ENDOCR-RELAT CANCER, V15, P721, DOI 10.1677/ERC-08-0012; Scheithauer BW, 2006, NEUROSURGERY, V59, P341, DOI 10.1227/01.NEU.0000223437.51435.6E; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Serrano M, 2001, CURR OPIN CELL BIOL, V13, P748, DOI 10.1016/S0955-0674(00)00278-7; Sharpless NE, 2004, J CLIN INVEST, V113, P160, DOI 10.1172/JCI200420761; Shen KC, 2005, CANCER RES, V65, P8747, DOI 10.1158/0008-5472.CAN-05-1471; Sivamurthy N, 2001, J VASC SURG, V34, P716, DOI 10.1067/mva.2001.116301; SWANSON SM, 2007, SCI STKE, pPE69; Thangaraju M, 2005, DEVELOPMENT, V132, P4675, DOI 10.1242/dev.02050; Thomas-Tikhonenko A, 2004, CANCER RES, V64, P3126, DOI 10.1158/0008-5472.CAN-03-1953; Trougakos IP, 2009, CANCER RES, V69, P403, DOI 10.1158/0008-5472.CAN-08-2912; Vlotides G, 2007, ENDOCR REV, V28, P165, DOI 10.1210/er.2006-0042; Wakefield LM, 2002, CURR OPIN GENET DEV, V12, P22, DOI 10.1016/S0959-437X(01)00259-3; Wang ZY, 2001, MOL ENDOCRINOL, V15, P1870, DOI 10.1210/me.15.11.1870; Zhang X, 1999, J CLIN ENDOCR METAB, V84, P761, DOI 10.1210/jc.84.2.761; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	64	40	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e17924	10.1371/journal.pone.0017924	http://dx.doi.org/10.1371/journal.pone.0017924			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464964	gold, Green Submitted, Green Published			2022-12-25	WOS:000288813900018
J	Oelemann, MC; Gomes, HM; Willery, E; Possuelo, L; Lima, KVB; Allix-Beguec, C; Locht, C; de la Salmoniere, YOLG; Gutierrez, MC; Suffys, P; Supply, P				Oelemann, Maranibia Cardoso; Gomes, Harrison M.; Willery, Eve; Possuelo, Lia; Batista Lima, Karla Valeria; Allix-Beguec, Caroline; Locht, Camille; de la Salmoniere, Yves-Olivier L. Goguet; Gutierrez, Maria Cristina; Suffys, Philip; Supply, Philip			The Forest behind the Tree: Phylogenetic Exploration of a Dominant Mycobacterium tuberculosis Strain Lineage from a High Tuberculosis Burden Country	PLOS ONE			English	Article							RIO-DE-JANEIRO; TANDEM-REPEAT; MOLECULAR EPIDEMIOLOGY; GENETIC DIVERSITY; BEIJING GENOTYPE; REPETITIVE UNITS; VARIABLE NUMBERS; DRUG-RESISTANCE; MIRU-VNTRPLUS; POPULATION	Background: Genotyping of Mycobacterium tuberculosis isolates is a powerful tool for epidemiological control of tuberculosis (TB) and phylogenetic exploration of the pathogen. Standardized PCR-based typing, based on 15 to 24 mycobacterial interspersed repetitive unit-variable number of tandem repeat (MIRU-VNTR) loci combined with spoligotyping, has been shown to have adequate resolution power for tracing TB transmission and to be useful for predicting diverse strain lineages in European settings. Its informative value needs to be tested in high TB-burden countries, where the use of genotyping is often complicated by dominance of geographically specific, genetically homogeneous strain lineages. Methodology/Principal Findings: We tested this genotyping system for molecular epidemiological analysis of 369 M. tuberculosis isolates from 3 regions of Brazil, a high TB-burden country. Deligotyping, targeting 43 large sequence polymorphisms (LSPs), and the MIRU-VNTRplus identification database were used to assess phylogenetic predictions. High congruence between the different typing results consistently revealed the countrywide supremacy of the Latin-American-Mediterranean (LAM) lineage, comprised of three main branches. In addition to an already known RDRio branch, at least one other branch characterized by a phylogenetically informative LAM3 spoligo-signature seems to be globally distributed beyond Brazil. Nevertheless, by distinguishing 321 genotypes in this strain population, combined MIRU-VNTR typing and spoligotyping demonstrated the presence of multiple distinct clones. The use of 15 to 24 loci discriminated 21 to 25% more strains within the LAM lineage, compared to a restricted lineage-specific locus set suggested to be used after SNP analysis. Noteworthy, 23 of the 28 molecular clusters identified were exclusively composed of patient isolates from a same region, consistent with expected patterns of mostly local TB transmission. Conclusions/Significance: Standard MIRU-VNTR typing combined with spoligotyping can reveal epidemiologically meaningful clonal diversity behind a dominant M. tuberculosis strain lineage in a high TB-burden country and is useful to explore international phylogenetical ramifications.	[Oelemann, Maranibia Cardoso; Gomes, Harrison M.; Suffys, Philip] Fiocruz MS, Inst Oswaldo Cruz, Lab Mol Biol Appl Mycobacteria, BR-21045900 Rio De Janeiro, Brazil; [Willery, Eve; Allix-Beguec, Caroline; Locht, Camille; Gutierrez, Maria Cristina; Supply, Philip] INSERM, U1019, F-59045 Lille, France; [Willery, Eve; Allix-Beguec, Caroline; Locht, Camille; Gutierrez, Maria Cristina; Supply, Philip] Inst Pasteur, Ctr Immunol & Biol Parasitaire, CNRS, UMR 8204, F-59019 Lille, France; [Willery, Eve; Allix-Beguec, Caroline; Locht, Camille; Gutierrez, Maria Cristina; Supply, Philip] Univ Lille Nord France, Lille, France; [Willery, Eve; Allix-Beguec, Caroline; Locht, Camille; Gutierrez, Maria Cristina; Supply, Philip] Inst Pasteur, Ctr Infect & Immun Lille, F-59019 Lille, France; [Possuelo, Lia] Fundaco Estadual Prod & Pesquisa Saude, Ctr Sci & Technol Dev, Porto Alegre, RS, Brazil; [Batista Lima, Karla Valeria] Inst Evandro Chagas, Belem, Para, Brazil; [de la Salmoniere, Yves-Olivier L. Goguet; Gutierrez, Maria Cristina] Inst Pasteur, Dept Infect & Epidemiol, Paris, France	Fundacao Oswaldo Cruz; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Instituto Evandro Chagas; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Oelemann, MC (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Mol Biol Appl Mycobacteria, BR-21045900 Rio De Janeiro, Brazil.	philip.supply@ibl.fr	Gomes, Harrison M/E-2942-2013; Locht, Camille/L-3516-2018; Lima, Karla Valéria/AAF-8256-2021; Gutierrez, Cristina/B-5597-2012; POSSUELO, LIA G/K-6695-2014; suffys, philip/E-3009-2013; Allix-Béguec, Caroline/AAI-4645-2021; Supply, Philip/A-9580-2019	Gomes, Harrison M/0000-0002-6489-8003; Lima, Karla Valéria/0000-0001-5807-0392; Gutierrez, Cristina/0000-0002-5567-5908; POSSUELO, LIA G/0000-0002-6425-3678; Allix-Béguec, Caroline/0000-0001-7642-4844; Supply, Philip/0000-0003-3690-3853; Locht, Camille/0000-0001-7295-7336	CAPES, Brazil	CAPES, Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	MCO held a fellowship from the CAPES (www.capes.gov.br), Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajoj SAM, 2010, J CLIN MICROBIOL, V48, P3813, DOI 10.1128/JCM.00556-10; Allix C, 2004, CLIN INFECT DIS, V39, P783, DOI 10.1086/423383; Allix-Beguec C, 2008, EUR RESPIR J, V31, P1077, DOI 10.1183/09031936.00053307; Allix-Beguec C, 2010, EUR RESPIR J, V35, P692, DOI 10.1183/09031936.00137309; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P2692, DOI 10.1128/JCM.00540-08; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P1398, DOI 10.1128/JCM.02089-07; Alonso-Rodriguez N, 2009, J CLIN MICROBIOL, V47, P2026, DOI 10.1128/JCM.02308-08; Aminian M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S3-S4; Baptista IMFD, 2002, MEM I OSWALDO CRUZ, V97, P1147, DOI 10.1590/S0074-02762002000800015; Barnes PF, 2003, NEW ENGL J MED, V349, P1149, DOI 10.1056/NEJMra021964; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Cafrune PI, 2006, J INFECTION, V53, P370, DOI 10.1016/j.jinf.2005.12.027; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Cowan LS, 2005, J CLIN MICROBIOL, V43, P688, DOI 10.1128/JCM.43.2.688-695.2005; Cowan LS, 2002, EMERG INFECT DIS, V8, P1294, DOI 10.3201/eid0811.020313; de la Salmoniere YOLG, 2004, J CLIN MICROBIOL, V42, P2913, DOI 10.1128/JCM.42.7.2913-2918.2004; Evans JT, 2010, EMERG INFECT DIS, V16, P542, DOI 10.3201/eid1603.090813; Ferrazoli L, 2000, INT J TUBERC LUNG D, V4, P18; Frothingham R, 1998, MICROBIOL-UK, V144, P1189, DOI 10.1099/00221287-144-5-1189; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Gibson AL, 2008, J CLIN MICROBIOL, V46, P1259, DOI 10.1128/JCM.02231-07; Gutierrez MC, 2006, EMERG INFECT DIS, V12, P1367, DOI 10.3201/eid1209.050017; Gutierrez MC, 2005, PLOS PATHOG, V1, P55, DOI 10.1371/journal.ppat.0010005; Han H, 2007, J MED MICROBIOL, V56, P1219, DOI 10.1099/jmm.0.47005-0; Hanekom M, 2008, J CLIN MICROBIOL, V46, P3338, DOI 10.1128/JCM.00770-08; Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311; Hirsh AE, 2004, P NATL ACAD SCI USA, V101, P4871, DOI 10.1073/pnas.0305627101; Ivens-de-Araujo ME, 1998, BRAZ J MED BIOL RES, V31, P369, DOI 10.1590/S0100-879X1998000300006; Jiao WW, 2008, J CLIN MICROBIOL, V46, P1045, DOI 10.1128/JCM.01869-07; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Mathema B, 2006, CLIN MICROBIOL REV, V19, P658, DOI 10.1128/CMR.00061-05; Mokrousov I, 2006, J CLIN MICROBIOL, V44, P2851, DOI 10.1128/JCM.00705-06; Nikolayevskyy V, 2006, EMERG INFECT DIS, V12, P1406, DOI 10.3201/eid1209.041623; Niobe-Eyangoh SN, 2004, J CLIN MICROBIOL, V42, P5029, DOI 10.1128/JCM.42.11.5029-5035.2004; Oelemann MC, 2007, J CLIN MICROBIOL, V45, P691, DOI 10.1128/JCM.01393-06; Oelemann MC, 2007, MEM I OSWALDO CRUZ, V102, P455, DOI 10.1590/S0074-02762007005000034; Lazzarini LCO, 2007, J CLIN MICROBIOL, V45, P3891, DOI 10.1128/JCM.01394-07; Organization WH, 2006, GLOB TUB CONTR WHO R; Reed MB, 2009, J CLIN MICROBIOL, V47, P1119, DOI 10.1128/JCM.02142-08; Ritacco V, 2008, MEM I OSWALDO CRUZ, V103, P489, DOI 10.1590/S0074-02762008000500014; Savine E, 2002, J CLIN MICROBIOL, V40, P4561, DOI 10.1128/JCM.40.12.4561-4566.2002; Shamputa IC, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-99; Shamputa IC, 2010, J CLIN MICROBIOL, V48, P387, DOI 10.1128/JCM.02167-09; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; Supply P, 2000, MOL MICROBIOL, V36, P762, DOI 10.1046/j.1365-2958.2000.01905.x; Supply P, 2003, MOL MICROBIOL, V47, P529, DOI 10.1046/j.1365-2958.2003.03315.x; Supply P, 1997, MOL MICROBIOL, V26, P991, DOI 10.1046/j.1365-2958.1997.6361999.x; Supply P, 2001, J CLIN MICROBIOL, V39, P3563, DOI 10.1128/JCM.39.10.3563-3571.2001; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Telles MAS, 2005, INT J TUBERC LUNG D, V9, P970; Tsolaki AG, 2004, P NATL ACAD SCI USA, V101, P4865, DOI 10.1073/pnas.0305634101; van Deutekom H, 2005, J CLIN MICROBIOL, V43, P4473, DOI 10.1128/JCM.43.9.4473-4479.2005; Van Rie A, 1999, NEW ENGL J MED, V341, P1174, DOI 10.1056/NEJM199910143411602; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; VANSOOLINGEN D, 1995, J CLIN MICROBIOL, V33, P3234, DOI 10.1128/JCM.33.12.3234-3238.1995; Velji P, 2009, EMERG INFECT DIS, V15, P1609, DOI 10.3201/eid1510.090463; Wada T, 2007, J MED MICROBIOL, V56, P1052, DOI 10.1099/jmm.0.46990-0; Warren RM, 2004, J CLIN MICROBIOL, V42, P5774, DOI 10.1128/JCM.42.12.5774-5782.2004; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351; Wirth T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000160	62	45	46	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e18256	10.1371/journal.pone.0018256	http://dx.doi.org/10.1371/journal.pone.0018256			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464915	Green Submitted, Green Published, gold			2022-12-25	WOS:000288813900056
J	Liu, JX; Pinnock, SB; Herbert, J				Liu, Jian Xin; Pinnock, Scarlett B.; Herbert, Joe			Novel Control by the CA3 Region of the Hippocampus on Neurogenesis in the Dentate Gyrus of the Adult Rat	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; MOSSY FIBERS; KAINIC ACID; ADRENAL-STEROIDS; BRAIN; CORTICOSTERONE; EXPRESSION; CELLS; FLUOXETINE; SURVIVAL	The dentate gyrus is a site of continued neurogenesis in the adult brain. The CA3 region of the hippocampus is the major projection area from the dentate gyrus. CA3 sends reciprocal projections back to the dentate gyrus. Does this imply that CA3 exerts some control over neurogenesis? We studied the effects of lesions of CA3 on neurogenesis in the dentate gyrus, and on the ability of fluoxetine to stimulate mitotic activity in the progenitor cells. Unilateral ibotenic-acid generated lesions were made in CA3. Four days later there was no change on the number of either BrdU or Ki67-positive progenitor cells in the dentate gyrus. However, after 15 or 28 days, there was a marked reduction in surviving BrdU-labelled cells on the lesioned side (but no change in Ki-67+ cells). pCREB or Wnt3a did not co-localise with Ki-67 but with NeuN, a marker of mature neurons. Lesions had no effect on the basal expression of either pCREB or Wnt3a. Subcutaneous fluoxetine (10 mg/kg/day) for 14 days increased the number of Ki67+ cells as expected on the control (non-lesioned) side but not on that with a CA3 lesion. Nevertheless, the expected increase in BDNF, pCREB and Wnt3a still occurred on the lesioned side following fluoxetine treatment. Fluoxetine has been reported to decrease the number of "mature" calbindin-positive cells in the dentate gyrus; we found this still occurred on the side of a CA3 lesion. We then showed that the expression GAP-43 was reduced in the dentate gyrus on the lesioned side, confirming the existence of a synaptic connection between CA3 and the dentate gyrus. These results show that CA3 has a hitherto unsuspected role in regulating neurogenesis in the dentate gyrus of the adult rat.	[Liu, Jian Xin] Xi An Jiao Tong Univ, Inst Neurobiol, Sch Med, Xian, Peoples R China; [Pinnock, Scarlett B.; Herbert, Joe] Univ Cambridge, Cambridge Ctr Brain Repair, Dept Clin Neurosci, Cambridge, England; [Pinnock, Scarlett B.; Herbert, Joe] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England	Xi'an Jiaotong University; University of Cambridge; University of Cambridge	Liu, JX (corresponding author), Xi An Jiao Tong Univ, Inst Neurobiol, Sch Med, Xian, Peoples R China.	jh24@cam.ac.uk	Herbert, Joe/K-5877-2013		Wellcome Trust; Institute of Neurobiology, Xi'an Jiaotong University, P.R. China	Wellcome Trust(Wellcome TrustEuropean Commission); Institute of Neurobiology, Xi'an Jiaotong University, P.R. China	Work was supported by a grant from the Wellcome Trust. Dr. J. Liu is supported by the Institute of Neurobiology, Xi'an Jiaotong University, P.R. China. The authors declare that they have no financial or other matters to disclose. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Adlard PA, 2004, NEUROSCIENCE, V124, P985, DOI 10.1016/j.neuroscience.2003.12.039; ALME MN, 2007, NEURAL PLAST, V2007; Balu DT, 2009, NEUROSCI BIOBEHAV R, V33, P232, DOI 10.1016/j.neubiorev.2008.08.007; Bendotti C, 2000, EXP NEUROL, V161, P317, DOI 10.1006/exnr.1999.7262; BENDOTTI C, 1994, EUR J NEUROSCI, V6, P509, DOI 10.1111/j.1460-9568.1994.tb00294.x; Bendotti C, 1997, EUR J NEUROSCI, V9, P93, DOI 10.1111/j.1460-9568.1997.tb01357.x; Cameron H, 1996, J COMP NEUROL, V369, P56, DOI 10.1002/(SICI)1096-9861(19960520)369:1<56::AID-CNE4>3.0.CO;2-J; CAMERON HA, 1994, NEUROSCIENCE, V61, P203, DOI 10.1016/0306-4522(94)90224-0; CASTREN E, DEV NEUROBIOL, V70, P289; CRONIN J, 1988, BRAIN RES, V474, P181, DOI 10.1016/0006-8993(88)90681-6; DAVENPORT CJ, 1990, EXP NEUROL, V109, P180, DOI 10.1016/0014-4886(90)90072-Z; Dias BG, 2003, NEUROPHARMACOLOGY, V45, P553, DOI 10.1016/S0028-3908(03)00198-9; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; Gold AE, 2005, HIPPOCAMPUS, V15, P808, DOI 10.1002/hipo.20103; GOULD E, 1991, J COMP NEUROL, V313, P486, DOI 10.1002/cne.903130309; HANSON ND, 2011, J PHARM EXP THER; Herbert J, 2006, J NEUROENDOCRINOL, V18, P393, DOI 10.1111/j.1365-2826.2006.01429.x; Huang GJ, 2008, MOL PSYCHIATR, V13, P119, DOI 10.1038/sj.mp.4002104; Huang GJ, 2006, BIOL PSYCHIAT, V59, P619, DOI 10.1016/j.biopsych.2005.09.016; Karishma KK, 2002, EUR J NEUROSCI, V16, P445, DOI 10.1046/j.1460-9568.2002.02099.x; KNEISLER TB, 1995, J PHYSIOL-LONDON, V487, P125, DOI 10.1113/jphysiol.1995.sp020866; Kobayashi K, 2010, P NATL ACAD SCI USA, V107, P8434, DOI 10.1073/pnas.0912690107; Lucassen PJ, 2010, EUR NEUROPSYCHOPHARM, V20, P1, DOI 10.1016/j.euroneuro.2009.08.003; Marlatt MW, 2010, BRAIN RES, V1341, P93, DOI 10.1016/j.brainres.2010.03.086; Nair A, 2006, J BIOSCIENCES, V31, P423, DOI 10.1007/BF02704114; Navailles S, 2008, J COMP NEUROL, V509, P372, DOI 10.1002/cne.21775; Oestreicher AB, 1997, PROG NEUROBIOL, V53, P627, DOI 10.1016/S0301-0082(97)00043-9; Paxinos G, 1998, RAT BRAIN STEROTAXIC; Pinnock SB, 2008, EUR J NEUROSCI, V27, P2493, DOI 10.1111/j.1460-9568.2008.06250.x; Pinnock SB, 2007, NEUROPSYCHOPHARMACOL, V32, P493, DOI 10.1038/sj.npp.1301245; Pinnock SB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013652; Prickaerts J, 2004, NEUROBIOL LEARN MEM, V81, P1, DOI 10.1016/j.nlm.2003.09.001; Scharfman HE, 2007, PROG BRAIN RES, V163, P627, DOI 10.1016/S0079-6123(07)63034-9	34	21	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17562	10.1371/journal.pone.0017562	http://dx.doi.org/10.1371/journal.pone.0017562			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21464973	Green Submitted, Green Published, gold			2022-12-25	WOS:000288545100017
J	Wang, Q; Li, DC; Li, ZF; Liu, CX; Xiao, YM; Zhang, B; Li, XD; Zhao, J; Chen, LP; Xing, XM; Tang, SF; Lin, YC; Lai, YD; Yang, P; Zeng, JL; Xiao, Q; Zeng, XW; Lin, ZN; Zhuang, ZX; Zhuang, SM; Chen, W				Wang, Q.; Li, D-C; Li, Z-F; Liu, C-X; Xiao, Y-M; Zhang, B.; Li, X-D; Zhao, J.; Chen, L-P; Xing, X-M; Tang, S-F; Lin, Y-C; Lai, Y-D; Yang, P.; Zeng, J-L; Xiao, Q.; Zeng, X-W; Lin, Z-N; Zhuang, Z-X; Zhuang, S-M; Chen, W.			Upregulation of miR-27a contributes to the malignant transformation of human bronchial epithelial cells induced by SV40 small T antigen	ONCOGENE			English	Article						viral oncogene; SV40 small T antigen; miR-27a; protein phosphatase 2A; transformation; human cells	PROTEIN PHOSPHATASE 2A; SMALL TUMOR-ANTIGEN; HUMAN HEPATOCELLULAR-CARCINOMA; BREAST-CANCER CELLS; EARLY MESSENGER-RNA; SIMIAN VIRUS-40; CELLULAR-TRANSFORMATION; MICRORNA TARGETS; UBIQUITIN LIGASE; C-MYC	The introduction of the Simian virus 40 (SV40) early region, the telomerase catalytic subunit (hTERT) and an oncogenic allele of H-Ras directly transforms primary human cells. SV40 small T antigen (ST), which forms a complex with protein phosphatase 2A (PP2A) and inhibits PP2A activity, is believed to have a critical role in the malignant transformation of human cells. Recent evidence has shown that aberrant microRNA (miRNA) expression patterns are correlated with cancer development. Here, we identified miR-27a as a differentially expressed miRNA in SV40 ST-expressing cells. miR-27a is upregulated in SV40 ST-transformed human bronchial epithelial cells (HBERST). Suppression of miR-27a expression in HBERST cells or lung cancer cell lines (NCI-H226 and SK-MES-1) that exhibited high levels of miR-27a expression lead to cell growth arrested in the G(0)-G(1) phase. In addition, suppression of miR-27a in HBERST cells attenuated the capacity of such cells to grow in an anchorage-independent manner. We also found that suppression of the PP2A B56 gamma expression resulted in upregulation of miR-27a similar to that achieved by the introduction of ST, indicating that dysregulation of miR-27a expression in ST-expressing cells was mediated by the ST-PP2A interaction. Moreover, we discovered that Fbxw7 gene encoding F-box/WD repeat-containing protein 7 was a potential miR-27a target validated by dual-luciferase reporter system analysis. The inverse correlation between miR-27a expression levels and Fbxw7 protein expression was further confirmed in both cell models and human tumor samples. Fbxw7 regulates cell-cycle progression through the ubiquitin-dependent proteolysis of a set of substrates, including c-Myc, c-Jun, cyclin E1 and Notch 1. Thus, promotion of cell growth arising from the suppression of Fbxw7 by miR-27a overexpression might be responsible for the viral oncoprotein ST-induced malignant transformation. These observations demonstrate that miR-27a functions as an oncogene in human tumorigenesis. Oncogene (2011) 30, 3875-3886; doi:10.1038/onc.2011.103; published online 4 April 2011	[Chen, W.] Sun Yat Sen Univ, Sch Publ Hlth, Fac Prevent Med,Dept Toxicol, Guangdong Prov Key Lab Food Nutr & Hlth, Guangzhou 510080, Guangdong, Peoples R China; [Li, X-D] Sun Yat Sen Univ, Dept Thorac Surg, Ctr Canc, Guangzhou 510080, Guangdong, Peoples R China; [Zhao, J.] Guangzhou Med Univ, Dept Thorac Surg, Affiliated Canc Hosp, Guangzhou, Guangdong, Peoples R China; [Zhuang, Z-X] Shenzhen Ctr Dis Control & Prevent, Dept Toxicol, Shenzhen, Peoples R China; [Zhuang, S-M] Sun Yat Sen Univ, Sch Life Sci, Key Lab Gene Engn, Minist Educ,State Key Lab Biocontrol, Guangzhou 510080, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Guangzhou Medical University; Shenzhen Center for Disease Control & Prevention (SZCDC); Sun Yat Sen University	Chen, W (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Fac Prevent Med,Dept Toxicol, Guangdong Prov Key Lab Food Nutr & Hlth, 74 Zhongshan Rd 2, Guangzhou 510080, Guangdong, Peoples R China.	chenwen@mail.sysu.edu.cn	ZHANG, BO/K-4561-2013	ZHANG, BO/0000-0002-6352-1757; Zhuang, Shi-Mei/0000-0002-2512-3942	NSFC [30925029, 30925036, 30630055, 30800930, 30771832, 30901211]; National Key Basic Research and Development Program [2010CB912803]; National High Technology Research and Development Key Program of China [2008AA062504]; Ministry of Health of China [200902006]; Fundamental Research Funds for the Central Universities [10ykjc05, 10lgzd10]; Guangdong Province Universities; Colleges Pearl River Scholar Funded Scheme GDUPS	NSFC(National Natural Science Foundation of China (NSFC)); National Key Basic Research and Development Program(National Basic Research Program of China); National High Technology Research and Development Key Program of China(National High Technology Research and Development Program of China); Ministry of Health of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Guangdong Province Universities; Colleges Pearl River Scholar Funded Scheme GDUPS	This work was supported by program of Distinguished Young Scholar of NSFC (30925029, 30925036), a Key NSFC Program (30630055) and NSFC (30800930, 30771832, 30901211), National Key Basic Research and Development Program (2010CB912803), National High Technology Research and Development Key Program of China (2008AA062504), Ministry of Health of China (200902006), the Fundamental Research Funds for the Central Universities (10ykjc05 and 10lgzd10), Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme GDUPS (2010).	Akhoondi S, 2007, CANCER RES, V67, P9006, DOI 10.1158/0008-5472.CAN-07-1320; Ali SH, 2001, SEMIN CANCER BIOL, V11, P15, DOI 10.1006/scbi.2000.0342; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Arnold HK, 2006, MOL CELL BIOL, V26, P2832, DOI 10.1128/MCB.26.7.2832-2844.2006; Arroyo JD, 2005, ONCOGENE, V24, P7746, DOI 10.1038/sj.onc.1209038; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; CEGIELSKA A, 1994, MOL CELL BIOL, V14, P4616, DOI 10.1128/MCB.14.7.4616; Chen W, 2004, CANCER CELL, V5, P127, DOI 10.1016/S1535-6108(04)00026-1; Chen W, 2003, HISTOL HISTOPATHOL, V18, P541, DOI 10.14670/HH-18.541; CHOI YW, 1988, MOL CELL BIOL, V8, P3382, DOI 10.1128/MCB.8.8.3382; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; Connolly E, 2008, AM J PATHOL, V173, P856, DOI 10.2353/ajpath.2008.080096; CRAWFORD LV, 1978, P NATL ACAD SCI USA, V75, P117, DOI 10.1073/pnas.75.1.117; Crusio KM, 2010, ONCOGENE, V29, P4865, DOI 10.1038/onc.2010.222; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Engels BM, 2006, ONCOGENE, V25, P6163, DOI 10.1038/sj.onc.1209909; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; FERRIGNO P, 1993, MOL BIOL CELL, V4, P669, DOI 10.1091/mbc.4.7.669; Godshalk SE, 2008, CELL CYCLE, V7, P3595, DOI 10.4161/cc.7.22.7120; Grochola LF, 2009, CLIN CANCER RES, V15, P6301, DOI 10.1158/1078-0432.CCR-09-0797; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Guttilla IK, 2009, J BIOL CHEM, V284, P23204, DOI 10.1074/jbc.M109.031427; Hahn WC, 2002, MOL CELL BIOL, V22, P2111, DOI 10.1128/MCB.22.7.2111-2123.2002; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; HIRAKAWA T, 1988, P NATL ACAD SCI USA, V85, P1519, DOI 10.1073/pnas.85.5.1519; Huang SL, 2008, INT J CANCER, V123, P972, DOI 10.1002/ijc.23580; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; KHALILI K, 1987, CELL, V48, P639, DOI 10.1016/0092-8674(87)90242-X; Knuutila S, 1999, AM J PATHOL, V155, P683, DOI 10.1016/S0002-9440(10)65166-8; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Lai EC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-115; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu T, 2009, CANCER LETT, V273, P233, DOI 10.1016/j.canlet.2008.08.003; Ma YH, 2010, CANCER LETT, V298, P150, DOI 10.1016/j.canlet.2010.06.012; Mao JH, 2004, NATURE, V432, P775, DOI 10.1038/nature03155; Margolis SS, 2006, CELL, V127, P759, DOI 10.1016/j.cell.2006.10.035; Mertens-Talcott SU, 2007, CANCER RES, V67, P11001, DOI 10.1158/0008-5472.CAN-07-2416; MICHALOVITZ D, 1987, J VIROL, V61, P2648, DOI 10.1128/JVI.61.8.2648-2654.1987; Moreno CS, 2004, CANCER RES, V64, P6978, DOI 10.1158/0008-5472.CAN-04-1150; MUMBY M, 1995, SEMIN CANCER BIOL, V6, P229, DOI 10.1006/scbi.1995.0030; PALLAS DC, 1990, CELL, V60, P167, DOI 10.1016/0092-8674(90)90726-U; Pang YQ, 2008, TOXICOL APPL PHARM, V232, P478, DOI 10.1016/j.taap.2008.08.009; Perez-Losada J, 2005, CANCER RES, V65, P6488, DOI 10.1158/0008-5472.CAN-05-1294; Pichler K, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-100; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Rundell K, 2001, SEMIN CANCER BIOL, V11, P5, DOI 10.1006/scbi.2000.0341; Sablina AA, 2008, CANCER METAST REV, V27, P137, DOI 10.1007/s10555-008-9116-0; SHENK TE, 1976, J VIROL, V18, P664, DOI 10.1128/JVI.18.2.664-671.1976; Shouse GP, 2010, ONCOGENE, V29, P3933, DOI 10.1038/onc.2010.161; SLEIGH MJ, 1978, CELL, V14, P79, DOI 10.1016/0092-8674(78)90303-3; SONTAG E, 1993, CELL, V75, P887, DOI 10.1016/0092-8674(93)90533-V; Sontag JM, 2006, CELL MOL LIFE SCI, V63, P2979, DOI 10.1007/s00018-006-6300-7; Tan YM, 2008, CANCER LETT, V271, P1, DOI 10.1016/j.canlet.2008.04.036; TOMITA M, 2009, INT J CANC IN PRESS; Tsunematsu R, 2004, J BIOL CHEM, V279, P9417, DOI 10.1074/jbc.M312337200; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; YANG SI, 1991, MOL CELL BIOL, V11, P1988, DOI 10.1128/MCB.11.4.1988; Yu J, 2001, VIROLOGY, V290, P192, DOI 10.1006/viro.2001.1204; Zeng CX, 2010, HEPATOLOGY, V52, P1702, DOI 10.1002/hep.23875; ZERRAHN J, 1993, EMBO J, V12, P4739, DOI 10.1002/j.1460-2075.1993.tb06162.x; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	62	60	65	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	2011	30	36					3875	3886		10.1038/onc.2011.103	http://dx.doi.org/10.1038/onc.2011.103			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	817PV	21460851				2022-12-25	WOS:000294687200005
J	Javaherian, AD; Yusifov, T; Pantazis, A; Franklin, S; Gandhi, CS; Olcese, R				Javaherian, Anoosh D.; Yusifov, Taleh; Pantazis, Antonios; Franklin, Sarah; Gandhi, Chris S.; Olcese, Riccardo			Metal-driven Operation of the Human Large-conductance Voltage- and Ca2+-dependent Potassium Channel (BK) Gating Ring Apparatus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT K+ CHANNEL; BINDING-SITES; RCK1 DOMAIN; CA2+ SENSITIVITY; LIPID-MEMBRANE; ION-CHANNEL; N-TERMINUS; CALCIUM; ACTIVATION; SENSOR	Large-conductance voltage-and Ca2+-dependent K+ (BK, also known as MaxiK) channels are homo-tetrameric proteins with a broad expression pattern that potently regulate cellular excitability and Ca2+ homeostasis. Their activation results from the complex synergy between the transmembrane voltage sensors and a large (>300 kDa) C-terminal, cytoplasmic complex (the "gating ring"), which confers sensitivity to intracellular Ca2+ and other ligands. However, the molecular and biophysical operation of the gating ring remains unclear. We have used spectroscopic and particle-scale optical approaches to probe the metal-sensing properties of the human BK gating ring under physiologically relevant conditions. This functional molecular sensor undergoes Ca2+- and Mg2+-dependent conformational changes at physiologically relevant concentrations, detected by time-resolved and steady-state fluorescence spectroscopy. The lack of detectable Ba2+-evoked structural changes defined the metal selectivity of the gating ring. Neutralization of a high-affinity Ca2+-binding site (the "calcium bowl") reduced the Ca2+ and abolished the Mg2+ dependence of structural rearrangements. In congruence with electrophysiological investigations, these findings provide biochemical evidence that the gating ring possesses an additional high-affinity Ca2+-binding site and that Mg2+ can bind to the calcium bowl with less affinity than Ca2+. Dynamic light scattering analysis revealed a reversible Ca2+-dependent decrease of the hydrodynamic radius of the gating ring, consistent with a more compact overall shape. These structural changes, resolved under physiologically relevant conditions, likely represent the molecular transitions that initiate the ligand-induced activation of the human BK channel.	[Javaherian, Anoosh D.; Yusifov, Taleh; Pantazis, Antonios; Franklin, Sarah; Olcese, Riccardo] Univ Calif Los Angeles, David Geffen Sch Med, Div Mol Med, Dept Anesthesiol, Los Angeles, CA 90095 USA; [Olcese, Riccardo] Univ Calif Los Angeles, David Geffen Sch Med, Cardiovasc Res Lab, Los Angeles, CA 90095 USA; [Olcese, Riccardo] Univ Calif Los Angeles, David Geffen Sch Med, Brain Res Inst, Los Angeles, CA 90095 USA; [Gandhi, Chris S.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; California Institute of Technology	Olcese, R (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Mol Med, Dept Anesthesiol, BH-570 CHS, Los Angeles, CA 90095 USA.	rolcese@ucla.edu	Pantazis, Antonios/AAB-3846-2019	Pantazis, Antonios/0000-0002-6467-1327	National Institutes of Health Research [NIGMS R01GM082289]; Laubisch Foundation; American Heart Association [09POST2250648]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082289] Funding Source: NIH RePORTER	National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Laubisch Foundation; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Research Grant NIGMS R01GM082289 and the Laubisch Foundation (to R. O.).; Recipient of American Heart Association (Western States Affiliate) Postdoctoral Fellowship 09POST2250648.	Bao L, 2004, J GEN PHYSIOL, V123, P475, DOI 10.1085/jgp.200409052; Bao L, 2002, J GEN PHYSIOL, V120, P173, DOI 10.1085/jgp.20028627; Bezanilla F, 2008, NAT REV MOL CELL BIO, V9, P323, DOI 10.1038/nrm2376; Bian S, 2001, P NATL ACAD SCI USA, V98, P4776, DOI 10.1073/pnas.081072398; Braun AP, 2001, J PHYSIOL-LONDON, V533, P681, DOI 10.1111/j.1469-7793.2001.00681.x; Cantor C. R., 1980, BIOPHYSICAL CHEM 2, P539; Carvacho I, 2008, J GEN PHYSIOL, V131, P147, DOI 10.1085/jgp.200709862; Chakrapani S, 2007, NAT STRUCT MOL BIOL, V14, P180, DOI 10.1038/nsmb0307-180; Cui J, 2009, CELL MOL LIFE SCI, V66, P852, DOI 10.1007/s00018-008-8609-x; Cui JM, 2010, J PHYSIOL-LONDON, V588, P4651, DOI 10.1113/jphysiol.2010.194514; Du W, 2005, NAT GENET, V37, P733, DOI 10.1038/ng1585; Fakler B, 2008, NEURON, V59, P873, DOI 10.1016/j.neuron.2008.09.001; Horrigan FT, 2008, NAT STRUCT MOL BIOL, V15, P1130, DOI 10.1038/nsmb1108-1130; Hou SW, 2008, NAT STRUCT MOL BIOL, V15, P403, DOI 10.1038/nsmb.1398; Hou SW, 2008, P NATL ACAD SCI USA, V105, P4039, DOI 10.1073/pnas.0800304105; Hou SW, 2009, PHYSIOLOGY, V24, P26, DOI 10.1152/physiol.00032.2008; Hu L, 2006, J GEN PHYSIOL, V127, P35, DOI 10.1085/jgp.200509317; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Lakowicz JR., 2006, PRINCIPLES FLUORESCE, P97, DOI [10.1007/978-0-387-46312-4, DOI 10.1007/978-0-387-46312-4_4]; LATORRE R, 1983, J MEMBRANE BIOL, V71, P11, DOI 10.1007/BF01870671; Latorre R, 2006, BIOL RES, V39, P385, DOI 10.4067/S0716-97602006000300003; Latorre R, 2010, J PHYSIOL-LONDON, V588, P3141, DOI 10.1113/jphysiol.2010.191999; Lee US, 2010, TRENDS NEUROSCI, V33, P415, DOI 10.1016/j.tins.2010.06.004; Li M, 2010, P NATL ACAD SCI USA, V107, P19096, DOI 10.1073/pnas.1002685107; Lingle CJ, 2007, J GEN PHYSIOL, V129, P101, DOI 10.1085/jgp.200709739; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Lu R, 2006, J PHYSIOL-LONDON, V570, P65, DOI 10.1113/jphysiol.2005.098913; Ma ZM, 2006, J GEN PHYSIOL, V127, P309, DOI 10.1085/jgp.200509421; Magleby RL, 2003, J GEN PHYSIOL, V121, P81, DOI 10.1085/jgp.20028721; Meera P, 1997, P NATL ACAD SCI USA, V94, P14066, DOI 10.1073/pnas.94.25.14066; Niu XW, 2004, NEURON, V42, P745, DOI 10.1016/j.neuron.2004.05.001; OBERHAUSER A, 1988, J GEN PHYSIOL, V92, P67, DOI 10.1085/jgp.92.1.67; Pantazis A, 2010, J GEN PHYSIOL, V136, P645, DOI 10.1085/jgp.201010503; Pantazis A, 2010, P NATL ACAD SCI USA, V107, P4459, DOI 10.1073/pnas.0911959107; Proteau Ariane, 2010, Curr Protoc Protein Sci, VChapter 17, DOI 10.1002/0471140864.ps1710s61; Qian X, 2006, J GEN PHYSIOL, V128, P389, DOI 10.1085/jgp.200609486; Salkoff L, 2006, NAT REV NEUROSCI, V7, P921, DOI 10.1038/nrn1992; Savalli N, 2006, P NATL ACAD SCI USA, V103, P12619, DOI 10.1073/pnas.0601176103; Schreiber M, 1997, BIOPHYS J, V73, P1355, DOI 10.1016/S0006-3495(97)78168-2; Sheng JZ, 2005, BIOPHYS J, V89, P3079, DOI 10.1529/biophysj.105.063610; Shi JY, 2002, NATURE, V418, P876, DOI 10.1038/nature00941; Shi JY, 2001, J GEN PHYSIOL, V118, P589, DOI 10.1085/jgp.118.5.589; Sreerama N, 2004, METHOD ENZYMOL, V383, P318; Stefani E, 1997, P NATL ACAD SCI USA, V94, P5427, DOI 10.1073/pnas.94.10.5427; Swartz KJ, 2008, NATURE, V456, P891, DOI 10.1038/nature07620; Sweet TB, 2008, J GEN PHYSIOL, V132, P491, DOI 10.1085/jgp.200810094; Tombola F, 2006, ANNU REV CELL DEV BI, V22, P23, DOI 10.1146/annurev.cellbio.21.020404.145837; VERGARA C, 1983, J GEN PHYSIOL, V82, P543, DOI 10.1085/jgp.82.4.543; Vergara C, 1999, J GEN PHYSIOL, V114, P365, DOI 10.1085/jgp.114.3.365; Vergara C, 1998, CURR OPIN NEUROBIOL, V8, P321, DOI 10.1016/S0959-4388(98)80056-1; Wallner M, 1996, P NATL ACAD SCI USA, V93, P14922, DOI 10.1073/pnas.93.25.14922; Wang LG, 2009, NATURE, V461, P292, DOI 10.1038/nature08291; Wu RS, 2010, KIDNEY INT, V78, P963, DOI 10.1038/ki.2010.325; Wu YK, 2010, NATURE, V466, P393, DOI 10.1038/nature09252; Xia XM, 2002, NATURE, V418, P880, DOI 10.1038/nature00956; Yang HH, 2008, NAT STRUCT MOL BIOL, V15, P1152, DOI 10.1038/nsmb.1507; Yang JQ, 2010, NEURON, V66, P871, DOI 10.1016/j.neuron.2010.05.009; Ye S, 2006, CELL, V126, P1161, DOI 10.1016/j.cell.2006.08.029; Yuan P, 2010, SCIENCE, V329, P182, DOI 10.1126/science.1190414; Yusifov T, 2008, P NATL ACAD SCI USA, V105, P376, DOI 10.1073/pnas.0705261105; Yusifov T, 2010, J GEN PHYSIOL, V136, P189, DOI 10.1085/jgp.200910374; Zeng XH, 2005, J GEN PHYSIOL, V125, P273, DOI 10.1085/jgp.200409239; Zhang GH, 2010, P NATL ACAD SCI USA, V107, P18700, DOI 10.1073/pnas.1010124107; Zhang X, 2001, J GEN PHYSIOL, V118, P607, DOI 10.1085/jgp.118.5.607	64	20	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20701	20709		10.1074/jbc.M111.235234	http://dx.doi.org/10.1074/jbc.M111.235234			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21471215	Green Published, hybrid			2022-12-25	WOS:000291267600056
J	Kang, YH; Park, CH; Kim, TS; Soung, NK; Bang, JK; Kim, BY; Park, JE; Lee, KS				Kang, Young H.; Park, Chi-Hoon; Kim, Tae-Sung; Soung, Nak-Kyun; Bang, Jeong K.; Kim, Bo Y.; Park, Jung-Eun; Lee, Kyung S.			Mammalian Polo-like Kinase 1-dependent Regulation of the PBIP1-CENP-Q Complex at Kinetochores	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOX DOMAIN; PLK1-PBIP1 INTERACTION; PLK1 LOCALIZATION; PROTEIN-KINASE; CENP-A; POLO-LIKE-KINASE-1; CYTOKINESIS; PHOSPHORYLATION; STABILITY; REVEALS	Mammalian polo-like kinase 1 (Plk1) plays a pivotal role during M-phase progression. Plk1 localizes to specific subcellular structures through the targeting activity of the C-terminal polobox domain (PBD). Disruption of the PBD function results in improper bipolar spindle formation, chromosome missegregation, and cytokinesis defect that ultimately lead to the generation of aneuploidy. It has been shown that Plk1 recruits itself to centromeres by phosphorylating and binding to a centromere scaffold, PBIP1 (also called MLF1IP and CENP-U[ 50]) through its PBD. However, how PBIP1 itself is targeted to centromeres and what roles it plays in the regulation of Plk1-dependent mitotic events remain unknown. Here, we demonstrated that PBIP1 directly interacts with CENP-Q, and this interaction was mutually required not only for their stability but also for their centromere localization. Plk1 did not appear to interact with CENP-Q directly. However, Plk1 formed a ternary complex with PBIP1 and CENP-Q through a self-generated p-T78 motif on PBIP1. This complex formation was central for Plk1-dependent phosphorylation of PBIP1-bound CENP-Q and delocalization of the PBIP1-CENP-Q complex from mitotic centromeres. This study reveals a unique mechanism of how PBIP1 mediates Plk1-dependent phosphorylation event onto a third protein, and provides new insights into the mechanism of how Plk1 and its recruitment scaffold, PBIP1-CENP-Q complex, are localized to and delocalized from centromeres.	[Kang, Young H.; Park, Chi-Hoon; Kim, Tae-Sung; Soung, Nak-Kyun; Park, Jung-Eun; Lee, Kyung S.] NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Bang, Jeong K.] Korean Basic Sci Inst, Div Magnet Resonance, Ochang 363883, Chung Buk, South Korea; [Soung, Nak-Kyun; Kim, Bo Y.] Korea Res Inst Biosci & Biotechnol, Chem Biol Res Ctr, Ochang 363883, Chung Buk, South Korea	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Korea Basic Science Institute (KBSI); Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Lee, KS (corresponding author), NCI, Lab Metab, Ctr Canc Res, NIH, 9000 Rockville Pike,Bldg 37,Rm 3118, Bethesda, MD 20892 USA.	kyunglee@mail.nih.gov			NCI, National Institutes of Health [Z01 BC 010520]; Korea Basic Science Institute [T3022B]; Ministry of Education, Science and Technology of Korea; NATIONAL CANCER INSTITUTE [ZIABC010680, ZIABC011324, Z01BC010520] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Korea Basic Science Institute; Ministry of Education, Science and Technology of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by NCI, National Institutes of Health intramural Grant Z01 BC 010520 (to K. S. L.), the Korea Basic Science Institute's high field NMR Research Program Grant T3022B (to J. K. B.), and the World Class Institute research program of the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology of Korea (to B. Y. K.).	Amaro AC, 2010, NAT CELL BIOL, V12, P319, DOI 10.1038/ncb2033; Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Bornberg-Bauer E, 1998, NUCLEIC ACIDS RES, V26, P2740, DOI 10.1093/nar/26.11.2740; Cheng KY, 2003, EMBO J, V22, P5757, DOI 10.1093/emboj/cdg558; de Carcer G, 2001, EMBO J, V20, P2878, DOI 10.1093/emboj/20.11.2878; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Elowe S, 2007, GENE DEV, V21, P2205, DOI 10.1101/gad.436007; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; GOLSTEYN RM, 1995, J CELL BIOL, V129, P1617, DOI 10.1083/jcb.129.6.1617; Hanissian SH, 2004, ONCOGENE, V23, P3700, DOI 10.1038/sj.onc.1207448; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hori T, 2008, MOL BIOL CELL, V19, P843, DOI 10.1091/mbc.E07-06-0556; Jang YJ, 2002, P NATL ACAD SCI USA, V99, P1984, DOI 10.1073/pnas.042689299; Kang YH, 2006, MOL CELL, V24, P409, DOI 10.1016/j.molcel.2006.10.016; Lane HA, 1996, J CELL BIOL, V135, P1701, DOI 10.1083/jcb.135.6.1701; LEE KS, 1995, MOL CELL BIOL, V15, P7143; Lee KS, 1997, MOL CELL BIOL, V17, P3408, DOI 10.1128/MCB.17.6.3408; Lee KS, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-4; Lee KS, 2008, CELL CYCLE, V7, P141, DOI 10.4161/cc.7.2.5272; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Lowery DM, 2005, ONCOGENE, V24, P248, DOI 10.1038/sj.onc.1208280; Lowery DM, 2004, CELL CYCLE, V3, P128; Minoshima Y, 2005, MOL CELL BIOL, V25, P10315, DOI 10.1128/MCB.25.23.10315-10328.2005; Okada M, 2006, NAT CELL BIOL, V8, P446, DOI 10.1038/ncb1396; Park JE, 2010, CELL MOL LIFE SCI, V67, P1957, DOI 10.1007/s00018-010-0279-9; Petronczki M, 2008, DEV CELL, V14, P646, DOI 10.1016/j.devcel.2008.04.014; Qi W, 2006, MOL BIOL CELL, V17, P3705, DOI 10.1091/mbc.E06-03-0240; Seong YS, 2002, J BIOL CHEM, V277, P32282, DOI 10.1074/jbc.M202602200; Takaki T, 2008, CURR OPIN CELL BIOL, V20, P650, DOI 10.1016/j.ceb.2008.10.005; Winkles JA, 2005, ONCOGENE, V24, P260, DOI 10.1038/sj.onc.1208219; Yun SM, 2009, NAT STRUCT MOL BIOL, V16, P876, DOI 10.1038/nsmb.1628	33	38	38	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19744	19757		10.1074/jbc.M111.224105	http://dx.doi.org/10.1074/jbc.M111.224105			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21454580	Green Published, hybrid			2022-12-25	WOS:000291027700057
J	Xiao, ZH; Wang, TT; Qin, HH; Huang, C; Feng, YM; Xia, Y				Xiao, Zhihong; Wang, Tingting; Qin, Honghua; Huang, Chao; Feng, Youmei; Xia, Yong			Endoplasmic Reticulum Ca2+ Release Modulates Endothelial Nitric-oxide Synthase via Extracellular Signal-regulated Kinase (ERK) 1/2-mediated Serine 635 Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM; CELLS; ACTIVATION; ENOS; MECHANISM; CHANNELS; PERMEABILITY; CALMODULIN; PATHWAYS; SER(635)	Endothelial nitric-oxide synthase (eNOS) plays a central role in cardiovascular regulation. eNOS function is critically modulated by Ca2+ and protein phosphorylation, but the interrelationship between intracellular Ca2+ mobilization and eNOS phosphorylation is poorly understood. Here we show that endoplasmic reticulum (ER) Ca2+ release activates eNOS by selectively promoting its Ser-635/633 (bovine/human) phosphorylation. With bovine endothelial cells, thapsigargin-induced ER Ca2+ release caused a dose-dependent increase ineNOSSer-635 phosphorylation, leading to elevated NO production. ER Ca2+ release also promoted eNOS Ser-633 phosphorylation in mouse vessels in vivo. This effect was independent of extracellular Ca2+ and selective to Ser-635 because the phosphorylation status of other eNOS sites, including Ser-1179 or Thr-497, was unaffected in thapsigargin-treated cells. Blocking ERK1/2 abolished ER Ca2+ release-induced eNOS Ser-635 phosphorylation, whereas inhibiting protein kinase A or Ca2+/calmodulin-dependent protein kinase II had no effect. Protein phosphorylation assay confirmed that ERK1/2 directly phosphorylated the eNOS Ser-635 residue in vitro. Further studies demonstrated that ER Ca2+ release-induced ERK1/2 activation mediated the enhancing action of purine or bradykinin receptor stimulation on eNOS Ser-635/633 phosphorylation in bovine/human endothelial cells. Mutating the Ser-635 to nonphosphorylatable alanine prevented ATP from activating eNOS in cells. Taken together, these studies reveal that ER Ca2+ release enhances eNOS Ser-635 phosphorylation and function via ERK1/2 activation. Because ER Ca2+ is commonly mobilized by agonists or physicochemical stimuli, the identified ER Ca2+-ERK1/2-eNOS Ser-635 phosphorylation pathway may have a broad role in the regulation of endothelial function.	[Xiao, Zhihong; Wang, Tingting; Qin, Honghua; Huang, Chao; Xia, Yong] Ohio State Univ, Coll Med, Davis Heart & Lung Res Inst, Div Cardiovasc Med,Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Xiao, Zhihong; Feng, Youmei] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Biochem, Wuhan 430030, Peoples R China	University System of Ohio; Ohio State University; Huazhong University of Science & Technology	Xia, Y (corresponding author), Ohio State Univ, Davis Heart & Lung Res Inst 605, 473 W 12th Ave, Columbus, OH 43210 USA.	yong.xia@osumc.edu	wang, tingting/AAK-2640-2020		National Institutes of Health [HL77575, HL86965]; China Scholarship Council [2008616047]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077575, R01HL086965] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL77575 and HL86965.; Supported by Predoctoral Fellowship 2008616047 from the China Scholarship Council.	Ayajiki K, 1996, CIRC RES, V78, P750, DOI 10.1161/01.RES.78.5.750; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Boo YC, 2003, FREE RADICAL BIO MED, V35, P729, DOI 10.1016/S0891-5849(03)00397-6; Boo YC, 2002, AM J PHYSIOL-HEART C, V283, pH1819, DOI 10.1152/ajpheart.00214.2002; Bootman MD, 2002, CURR BIOL, V12, pR563, DOI 10.1016/S0960-9822(02)01055-2; BREDT DS, 1994, ANNU REV BIOCHEM, V63, P175, DOI 10.1146/annurev.bi.63.070194.001135; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; da Silva CG, 2009, CIRCULATION, V119, P871, DOI 10.1161/CIRCULATIONAHA.108.764571; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Dudzinski DM, 2007, CARDIOVASC RES, V75, P247, DOI 10.1016/j.cardiores.2007.03.023; Fleming I, 2001, CIRC RES, V88, pE68, DOI 10.1161/hh1101.092677; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; GRIFFITH OW, 1995, ANNU REV PHYSIOL, V57, P707, DOI 10.1146/annurev.ph.57.030195.003423; Hung CC, 2003, J BIOL CHEM, V278, P29317, DOI 10.1074/jbc.M302368200; KUCHAN MJ, 1994, AM J PHYSIOL, V266, pC628, DOI 10.1152/ajpcell.1994.266.3.C628; McCabe TJ, 2000, J BIOL CHEM, V275, P6123, DOI 10.1074/jbc.275.9.6123; Michell BJ, 2002, J BIOL CHEM, V277, P42344, DOI 10.1074/jbc.M205144200; MONCADA S, 1991, PHARMACOL REV, V43, P109; Moore TM, 1998, AM J PHYSIOL-LUNG C, V275, pL203, DOI 10.1152/ajplung.1998.275.2.L203; Mount PF, 2007, J MOL CELL CARDIOL, V42, P271, DOI 10.1016/j.yjmcc.2006.05.023; NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6; Nilius B, 2001, PHYSIOL REV, V81, P1415, DOI 10.1152/physrev.2001.81.4.1415; Oh-Hashi K, 2006, NEUROSCI LETT, V405, P100, DOI 10.1016/j.neulet.2006.06.027; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; REED JC, 1994, J CELL BIOL, V124, P1, DOI 10.1083/jcb.124.1.1; Tiruppathi C, 2002, VASC PHARMACOL, V39, P173, DOI 10.1016/S1537-1891(03)00007-7; Toma I, 2008, AM J PHYSIOL-REG I, V294, pR1769, DOI 10.1152/ajpregu.00489.2007; Wei Q, 2006, J BIOL CHEM, V281, P21652, DOI 10.1074/jbc.M602105200; Xia Y, 1998, J BIOL CHEM, V273, P25804, DOI 10.1074/jbc.273.40.25804; Yamamoto K, 2000, AM J PHYSIOL-HEART C, V279, pH285, DOI 10.1152/ajpheart.2000.279.1.H285	31	28	31	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					20100	20108		10.1074/jbc.M111.220236	http://dx.doi.org/10.1074/jbc.M111.220236			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21454579	hybrid, Green Published			2022-12-25	WOS:000291027700086
J	Lopez, D; Jimenez, M; Garcia-Calvo, M; Del Val, M				Lopez, Daniel; Jimenez, Mercedes; Garcia-Calvo, Margarita; Del Val, Margarita			Concerted Antigen Processing of a Short Viral Antigen by Human Caspase-5 and-10	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS-INFECTED CELLS; CD8(+) T-LYMPHOCYTES; TRIPEPTIDYL-PEPTIDASE; ENDOPLASMIC-RETICULUM; APOPTOSIS; RECOGNITION; PROTEASOMES; EPITOPE; ENZYME	The generation of peptides presented by MHC class I molecules requires the proteolytic activity of the proteasome and/or other peptidases. The processing of a short vaccinia virus-encoded antigen can take place by a proteasome-independent pathway involving initiator caspase-5 and -10, which generate antigenic peptides recognized by CD8(+) T lymphocytes. In the present study, comparing single versus double enzyme digestions by mass spectrometry analysis, both qualitative and quantitative differences in the products obtained were identified. These in vitro data suggest that each enzyme can use the degradation products of the other as substrate for new cleavages, indicating concerted endoproteolytic activity of caspase-5 and -10.	[Lopez, Daniel] Inst Salud Carlos III, Ctr Nacl Microbiol, Unidad Proc Antigen Prote, E-28220 Majadahonda, Madrid, Spain; [Garcia-Calvo, Margarita] Merck Res Labs, Dept Metab Disorders & Diabet, Rahway, NJ 07065 USA; [Del Val, Margarita] Univ Autonoma Madrid, Consejo Super Invest Cient, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Merck & Company; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Lopez, D (corresponding author), Inst Salud Carlos III, Ctr Nacl Microbiol, Unidad Proc Antigen Prote, E-28220 Majadahonda, Madrid, Spain.	dlopez@isciii.es	Del Val, Margarita/E-4769-2010; López, Daniel/I-2632-2014	Del Val, Margarita/0000-0001-6769-4279; López, Daniel/0000-0003-0268-5878	European Union; Ministerio de Ciencia e Innovacion; Comunidad de Madrid; Instituto de Salud Carlos III; Programa Ramon y Cajal; FIPSE Foundation	European Union(European Commission); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Comunidad de Madrid(Comunidad de Madrid); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Programa Ramon y Cajal(Spanish Government); FIPSE Foundation	This work was supported by grants provided by the European Union, Ministerio de Ciencia e Innovacion, Comunidad de Madrid, and Instituto de Salud Carlos III (to M. D. V.) and by Programa Ramon y Cajal and FIPSE Foundation (to D. L.).	Clarke P, 2009, NAT REV MICROBIOL, V7, P144, DOI 10.1038/nrmicro2071; Del Val M., 2011, CELL MOL LIFE SCI; Del-Val M, 2002, MOL IMMUNOL, V39, P235, DOI 10.1016/S0161-5890(02)00104-9; DELVAL M, 1988, J VIROL, V62, P3965, DOI 10.1128/JVI.62.11.3965-3972.1988; EGGERS M, 1995, J EXP MED, V182, P1865, DOI 10.1084/jem.182.6.1865; Garcia-Calvo M, 1999, CELL DEATH DIFFER, V6, P362, DOI 10.1038/sj.cdd.4400497; Gil-Torregrosa BC, 1998, J EXP MED, V188, P1105, DOI 10.1084/jem.188.6.1105; Guil S, 2006, J BIOL CHEM, V281, P39925, DOI 10.1074/jbc.M608522200; Hammer GE, 2007, IMMUNITY, V26, P397, DOI 10.1016/j.immuni.2007.04.003; Kessler JH, 2011, NAT IMMUNOL, V12, P45, DOI 10.1038/ni.1974; Kettle S, 1997, J GEN VIROL, V78, P677, DOI 10.1099/0022-1317-78-3-677; Kloetzel PM, 2004, CURR OPIN IMMUNOL, V16, P76, DOI 10.1016/j.coi.2003.11.004; Knuehl C, 2001, J IMMUNOL, V167, P1515, DOI 10.4049/jimmunol.167.3.1515; Lopez D, 2006, J BIOL CHEM, V281, P30315, DOI 10.1074/jbc.M605973200; Lopez D, 2010, J IMMUNOL, V184, P5193, DOI 10.4049/jimmunol.1000050; Parmentier N, 2010, NAT IMMUNOL, V11, P449, DOI 10.1038/ni.1862; Pogo BGT, 2004, INT REV IMMUNOL, V23, P61, DOI 10.1080/08830180490265547; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Rock KL, 2004, NAT IMMUNOL, V5, P670, DOI 10.1038/ni1089; Samino Y, 2006, J BIOL CHEM, V281, P6358, DOI 10.1074/jbc.M512263200; Saveanu L, 2005, IMMUNOL REV, V207, P42, DOI 10.1111/j.0105-2896.2005.00313.x; Saveanu L, 2005, NAT IMMUNOL, V6, P689, DOI 10.1038/ni1208; Seifert U, 2003, NAT IMMUNOL, V4, P375, DOI 10.1038/ni905; Siegel RM, 2006, NAT REV IMMUNOL, V6, P308, DOI 10.1038/nri1809	24	4	4	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16910	16913		10.1074/jbc.M111.234658	http://dx.doi.org/10.1074/jbc.M111.234658			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454616	Green Published, hybrid			2022-12-25	WOS:000290301900040
J	Livesey, MR; Cooper, MA; Lambert, JJ; Peters, JA				Livesey, Matthew R.; Cooper, Michelle A.; Lambert, Jeremy J.; Peters, John A.			Rings of Charge within the Extracellular Vestibule Influence Ion Permeation of the 5-HT(3)A Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; SINGLE-CHANNEL CONDUCTANCE; 5-HYDROXYTRYPTAMINE TYPE-3; STRUCTURAL DETERMINANTS; CALCIUM PERMEABILITY; 5-HT3 RECEPTORS; AMINO-ACIDS; SELECTIVITY; LOOP; DOMAIN	The determinants of single channel conductance (gamma) and ion selectivity within eukaryotic pentameric ligand-gated ion channels have traditionally been ascribed to amino acid residues within the second transmembrane domain and flanking sequences of their component subunits. However, recent evidence suggests that gamma is additionally controlled by residues within the intracellular and extracellular domains. We examined the influence of two anionic residues (Asp(113) and Asp(127)) within the extracellular vestibule of a high conductance human mutant 5-hydroxytryptamine type-3A (5-HT(3)A) receptor (5-HT(3)A(QDA)) upon gamma, modulation of the latter by extracellular Ca2+, and the permeability of Ca2+ with respect to Cs+ (P-Ca/P-Cs). Mutations neutralizing (Asp -> Asn), or reversing (Asp -> Lys), charge at the 113 locus decreased inward gamma by 46 and 58%, respectively, but outward currents were unaffected. The D127N mutation decreased inward gamma by 82% and also suppressed outward currents, whereas the D127K mutation caused loss of observable single channel currents. The forgoing mutations, except for D127K, which could not be evaluated, ameliorated suppression of inwardly directed single channel currents by extracellular Ca2+. The P-Ca/P-Cs of 3.8 previously reported for the 5-HT(3)A(QDA) construct was reduced to 0.13 and 0.06 by the D127N and D127K mutations, respectively, with lesser, but clearly significant, effects caused by the D113N (1.04) and D113K (0.60) substitutions. Charge selectivity between monovalent cations and anions (P-Na/P-Cl) was unaffected by any of the mutations examined. The data identify two key residues in the extracellular vestibule of the 5-HT(3)A receptor that markedly influence gamma, P-Ca/P-Cs, and additionally the suppression of gamma by Ca2+.	[Livesey, Matthew R.; Cooper, Michelle A.; Lambert, Jeremy J.; Peters, John A.] Univ Dundee, Ninewells Hosp & Med Sch, Ctr Neurosci, Div Med Sci, Dundee DD1 9SY, Scotland	University of Dundee	Peters, JA (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Ctr Neurosci, Div Med Sci, Mail Box 6, Dundee DD1 9SY, Scotland.	j.a.peters@dundee.ac.uk		Livesey, Matthew/0000-0002-3441-7977	Wellcome Trust; Tenovus Scotland; Anonymous Trust	Wellcome Trust(Wellcome TrustEuropean Commission); Tenovus Scotland; Anonymous Trust	This work was supported in part by grants from the Wellcome Trust (to J. J. L. and J. A. P.) and Tenovus Scotland and the Anonymous Trust (to J. A. P.).	Absalom NL, 2009, NEUROCHEM RES, V34, P1805, DOI 10.1007/s11064-009-9971-2; Bernal JA, 2009, BBA-BIOMEMBRANES, V1788, P410, DOI 10.1016/j.bbamem.2008.11.004; BERTRAND D, 1993, P NATL ACAD SCI USA, V90, P6971, DOI 10.1073/pnas.90.15.6971; Brams M, 2011, J BIOL CHEM, V286, P4420, DOI 10.1074/jbc.M110.188730; Brown AM, 1998, J PHYSIOL-LONDON, V507, P653, DOI 10.1111/j.1469-7793.1998.653bs.x; Carland JE, 2009, J BIOL CHEM, V284, P2023, DOI 10.1074/jbc.M806618200; DANI JA, 1986, BIOPHYS J, V49, P607, DOI 10.1016/S0006-3495(86)83688-8; Davies PA, 1999, NATURE, V397, P359, DOI 10.1038/16941; Deeb TZ, 2007, J BIOL CHEM, V282, P6172, DOI 10.1074/jbc.M607698200; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; FENWICK EM, 1982, J PHYSIOL-LONDON, V331, P577, DOI 10.1113/jphysiol.1982.sp014393; GALZI JL, 1992, NATURE, V359, P500, DOI 10.1038/359500a0; Haghighi AP, 2000, J NEUROSCI, V20, P529, DOI 10.1523/JNEUROSCI.20-02-00529.2000; Hales TG, 2006, J BIOL CHEM, V281, P8062, DOI 10.1074/jbc.M513222200; Hansen SB, 2008, J BIOL CHEM, V283, P36066, DOI 10.1074/jbc.C800194200; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; Jensen ML, 2005, J NEUROCHEM, V92, P217, DOI 10.1111/j.1471-4159.2004.02883.x; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; Kelley SP, 2003, NATURE, V424, P321, DOI 10.1038/nature01788; Keramidas A, 2004, PROG BIOPHYS MOL BIO, V86, P161, DOI 10.1016/j.pbiomolbio.2003.09.002; Keramidas A, 2002, J GEN PHYSIOL, V119, P393, DOI 10.1085/jgp.20028552; KIENKER P, 1994, BIOPHYS J, V66, P325, DOI 10.1016/S0006-3495(94)80781-7; Kukhtina V, 2006, J NEUROCHEM, V97, P63, DOI 10.1111/j.1471-4159.2005.03468.x; LEWIS CA, 1979, J PHYSIOL-LONDON, V286, P417, DOI 10.1113/jphysiol.1979.sp012629; Livesey M., 2009, P BRIT PHARM SOC; Livesey MR, 2008, J BIOL CHEM, V283, P19301, DOI 10.1074/jbc.M802406200; Meltzer RH, 2006, BIOPHYS J, V91, P1325, DOI 10.1529/biophysj.106.081455; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; O'Mara M, 2005, BIOPHYS J, V88, P3286, DOI 10.1529/biophysj.104.051664; Panicker S, 2002, J NEUROSCI, V22, P1629, DOI 10.1523/JNEUROSCI.22-05-01629.2002; Peters JA, 2010, J PHYSIOL-LONDON, V588, P587, DOI 10.1113/jphysiol.2009.183137; Reeves DC, 2005, J NEUROSCI, V25, P9358, DOI 10.1523/JNEUROSCI.1045-05.2005; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Sine SM, 2010, J MOL NEUROSCI, V40, P70, DOI 10.1007/s12031-009-9260-1; Song C, 2009, BBA-BIOMEMBRANES, V1788, P1466, DOI 10.1016/j.bbamem.2009.04.015; Thompson AJ, 2003, BRIT J PHARMACOL, V140, P359, DOI 10.1038/sj.bjp.0705424; Thompson AJ, 2010, Q REV BIOPHYS, V43, P449, DOI 10.1017/S0033583510000168; Tsetlin V, 2009, CURR OPIN PHARMACOL, V9, P306, DOI 10.1016/j.coph.2009.03.005; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Wang HL, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040041	40	17	17	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M111.219618	http://dx.doi.org/10.1074/jbc.M111.219618			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454663	Green Published, hybrid			2022-12-25	WOS:000290022800041
J	Carvalho, FA; de Oliveira, S; Freitas, T; Goncalves, S; Santos, NC				Carvalho, Filomena A.; de Oliveira, Sofia; Freitas, Teresa; Goncalves, Sonia; Santos, Nuno C.			Variations on Fibrinogen-Erythrocyte Interactions during Cell Aging	PLOS ONE			English	Article							RED-BLOOD-CELLS; MOLECULAR RECOGNITION; GOLD NANOPARTICLES; FORCE SPECTROSCOPY; BINDING-SITES; SIALIC-ACID; MEMBRANE; CENTRIFUGATION; AGGREGATION; POPULATIONS	Erythrocyte hyperaggregation, a cardiovascular risk factor, is considered to be caused by an increase in plasma adhesion proteins, particularly fibrinogen. We have recently reported a specific binding between fibrinogen and an erythrocyte integrin receptor with a beta(3) or beta(3)-like subunit. In this study we evaluate the influence of erythrocyte aging on the fibrinogen binding. By atomic force microscopy-based force spectroscopy measurements we found that increasing erythrocyte age, there is a decrease of the binding to fibrinogen by decreasing the frequency of its occurrence but not its force. This observation is reinforced by zeta-potential and fluorescence spectroscopy measurements. We conclude that upon erythrocyte aging the number of fibrinogen molecules bound to each cell decreases significantly, due to the progressive impairment of the specific fibrinogen-erythrocyte receptor interaction. Knowing that younger erythrocytes bind more to fibrinogen, we could presume that this population is the main contributor to the cardiovascular diseases associated with increased fibrinogen content in blood, which could disturb the blood flow. Our data also show that the sialic acids exposed on the erythrocyte membrane contribute for the interaction with fibrinogen, possibly by facilitating its binding to the erythrocyte membrane receptor.	[Carvalho, Filomena A.; de Oliveira, Sofia; Freitas, Teresa; Goncalves, Sonia; Santos, Nuno C.] Univ Lisbon, Fac Med, Inst Mol Med, P-1699 Lisbon, Portugal	Universidade de Lisboa	Carvalho, FA (corresponding author), Univ Lisbon, Fac Med, Inst Mol Med, P-1699 Lisbon, Portugal.	nsantos@fm.ul.pt	de Oliveira, Sofia/AAV-4304-2020; Gonçalves, Sónia/H-9482-2017; Pieper, Maja/AAN-8539-2020; Santos, Nuno/N-7248-2013; Carvalho, Filomena A./M-9202-2013	de Oliveira, Sofia/0000-0003-0893-111X; Gonçalves, Sónia/0000-0003-2903-4282; Santos, Nuno/0000-0002-0580-0475; Carvalho, Filomena A./0000-0001-6088-3894	Fundacao para a Ciencia e a Tecnologia - Ministerio da Ciencia, Tecnologia e Ensino Superior (FCT-MCTES, Portugal) [CONC-REEQ/140/2001, PTDC/SAU-OSM/73449/2006]; Fundacao Calouste Gulbenkian (Portugal)	Fundacao para a Ciencia e a Tecnologia - Ministerio da Ciencia, Tecnologia e Ensino Superior (FCT-MCTES, Portugal)(Portuguese Foundation for Science and Technology); Fundacao Calouste Gulbenkian (Portugal)	This work was supported by Fundacao para a Ciencia e a Tecnologia - Ministerio da Ciencia, Tecnologia e Ensino Superior (FCT-MCTES, Portugal; grants CONC-REEQ/140/2001 and PTDC/SAU-OSM/73449/2006) and by Fundacao Calouste Gulbenkian (Portugal). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDERMAN EM, 1980, BLOOD, V55, P817; Barattin R, 2008, CHEM COMMUN, P1513, DOI 10.1039/b614328h; BOSCH FH, 1992, BLOOD, V79, P254; Bratosin D, 1998, BIOCHIMIE, V80, P173, DOI 10.1016/S0300-9084(98)80024-2; Brewer SH, 2005, LANGMUIR, V21, P9303, DOI 10.1021/la050588t; Carvalho FA, 2010, ACS NANO, V4, P4609, DOI 10.1021/nn1009648; CHEN XY, 2007, CURRENT APPL PHYS, V7, pE94, DOI DOI 10.1016/J.CAP.2006.11.024; Chtcheglova LA, 2008, BIOPOLYMERS, V89, P292, DOI 10.1002/bip.20910; CLARK MR, 1988, PHYSIOL REV, V68, P503, DOI 10.1152/physrev.1988.68.2.503; Corsi D, 1999, EUR J BIOCHEM, V261, P775, DOI 10.1046/j.1432-1327.1999.00336.x; DANON D, 1988, BLOOD CELLS, V14, P7; Dimitrova MN, 2000, INT J BIOL MACROMOL, V27, P187, DOI 10.1016/S0141-8130(00)00123-9; Domingues MM, 2008, J PEPT SCI, V14, P394, DOI 10.1002/psc.1007; Domingues MM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008385; Goncalves S, 2007, J PHOTOCH PHOTOBIO B, V86, P170, DOI 10.1016/j.jphotobiol.2006.09.001; Hadengue AL, 1998, HYPERTENSION, V32, P324, DOI 10.1161/01.HYP.32.2.324; Kaufman ED, 2007, LANGMUIR, V23, P6053, DOI 10.1021/la063725a; KAY MMB, 1985, GERONTOLOGY, V31, P215, DOI 10.1159/000212706; KOSOWER NS, 1993, AM J HEMATOL, V42, P241, DOI 10.1002/ajh.2830420302; Lominadze D, 2002, FEBS LETT, V517, P41, DOI 10.1016/S0014-5793(02)02575-9; Lominadze D, 2002, CLIN EXP HYPERTENS, V24, P397, DOI 10.1081/CEH-120005376; MAEDA N, 1987, BIOCHIM BIOPHYS ACTA, V904, P81, DOI 10.1016/0005-2736(87)90089-7; MARIKOVS.Y, 1969, J CELL BIOL, V43, P1, DOI 10.1083/jcb.43.1.1; Matos PM, 2008, J PEPT SCI, V14, P407, DOI 10.1002/psc.1005; Matos PM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009830; Racca A, 1999, MEDICINA-BUENOS AIRE, V59, P33; Ratto TV, 2006, LANGMUIR, V22, P1749, DOI 10.1021/la052087d; TERAYAMA K, 1993, IND HEALTH, V31, P113, DOI 10.2486/indhealth.31.113; Venerando B, 2002, BLOOD, V99, P1064, DOI 10.1182/blood.V99.3.1064; WALLACH DFH, 1974, BIOCHIM BIOPHYS ACTA, V356, P68, DOI 10.1016/0005-2736(74)90294-6; WARREN L, 1959, J BIOL CHEM, V234, P1971; Zawisza I, 2003, BIOPHYS J, V85, P4055, DOI 10.1016/S0006-3495(03)74819-X	33	34	36	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e18167	10.1371/journal.pone.0018167	http://dx.doi.org/10.1371/journal.pone.0018167			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464904	Green Published, gold			2022-12-25	WOS:000289053800024
J	Couvreur, O; Ferezou, J; Gripois, D; Serougne, C; Crepin, D; Aubourg, A; Gertler, A; Vacher, CM; Taouis, M				Couvreur, Odile; Ferezou, Jacqueline; Gripois, Daniel; Serougne, Colette; Crepin, Delphine; Aubourg, Alain; Gertler, Arieh; Vacher, Claire-Marie; Taouis, Mohammed			Unexpected Long-Term Protection of Adult Offspring Born to High-Fat Fed Dams against Obesity Induced by a Sucrose-Rich Diet	PLOS ONE			English	Article							METABOLIC SYNDROME; INSULIN-RESISTANCE; LEPTIN RESISTANCE; MATERNAL OBESITY; BIRTH-WEIGHT; RATS; SUSCEPTIBILITY; LACTATION; PREGNANCY; ORIGINS	Background: Metabolic and endocrine environment during early life is crucial for metabolic imprinting. When dams were fed a high fat diet (HF diet), rat offspring developed hypothalamic leptin resistance with lean phenotype when weaned on a normal diet. Interestingly, when grown on the HF diet, they appeared to be protected against the effects of HF diet as compared to offspring of normally fed dams. The mechanisms involved in the protective effect of maternal HF diet are unclear. Methodology/Principal Findings: We thus investigated the impact of maternal high fat diet on offspring subjected to normal or high palatable diet (P diet) on metabolic and endocrine parameters. We compared offspring born to dams fed P or HF diet. Offspring born to dams fed control or P diet, when fed P diet exhibited a higher body weight, altered hypothalamic leptin sensitivity and metabolic parameters suggesting that maternal P diet has no protective effect on offspring. Whereas, maternal HF diet reduces body weight gain and circulating triglycerides, and ameliorates corpulence index of offspring, even when subjected to P diet. Interestingly, this protective effect is differently expressed in male and female offspring. Male offspring exhibited higher energy expenditure as mirrored by increased hypothalamic UCP-2 and liver AdipoR1/R2 expression, and a profound change in the arcuate nucleus astrocytic organization. In female offspring, the most striking impact of maternal HF diet is the reduced hypothalamic expression of NPY and POMC. Conclusions/Significance: HF diet given during gestation and lactation protects, at least partially, offspring from excessive weight gain through several mechanisms depending upon gender including changes in arcuate nucleus astrocytic organization and increased hypothalamic UCP-2 and liver AdipoR1/2 expression in males and reduced hypothalamic expression of NPY and POMC in females. Taken together our results reveal new mechanisms involved in the protective effect of maternal HF diet.	[Couvreur, Odile; Ferezou, Jacqueline; Gripois, Daniel; Serougne, Colette; Crepin, Delphine; Aubourg, Alain; Vacher, Claire-Marie; Taouis, Mohammed] Univ Paris 11, UMR 8195, Orsay, France; [Couvreur, Odile; Ferezou, Jacqueline; Gripois, Daniel; Serougne, Colette; Crepin, Delphine; Aubourg, Alain; Vacher, Claire-Marie; Taouis, Mohammed] Ctr Neurosci Paris Sud, CNRS, UMR8195, Orsay, France; [Gertler, Arieh] Hebrew Univ Jerusalem, Fac Agr Food & Environm Qual Sci, Inst Biochem Food Sci & Nutr, IL-76100 Rehovot, Israel	UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Universite Jean Monnet; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Universite Jean Monnet; Hebrew University of Jerusalem	Couvreur, O (corresponding author), Univ Paris 11, UMR 8195, Orsay, France.	mohammed.taouis@u-psud.fr	Taouis, Mohammed/CAA-1797-2022	Taouis, Mohammed/0000-0002-4101-691X; Crepin, Delphine/0000-0003-1224-3926; Vacher, Claire-Marie/0000-0002-2966-8149	University of Paris-Sud 11; Groupe Lipide et Nutrition [GLN 2009-2010]	University of Paris-Sud 11; Groupe Lipide et Nutrition	The funding for this work came from University of Paris-Sud 11 and Groupe Lipide et Nutrition (GLN 2009-2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amateau SK, 2002, J NEUROENDOCRINOL, V14, P904, DOI 10.1046/j.1365-2826.2002.00858.x; Andrews ZB, 2008, NATURE, V454, P846, DOI 10.1038/nature07181; Armitage JA, 2008, FRONT HORM RES, V36, P73, DOI 10.1159/000115355; Attig L, 2008, INT J OBESITY, V32, P1153, DOI 10.1038/ijo.2008.39; Benomar Y, 2005, MOL CELL ENDOCRINOL, V242, P59, DOI 10.1016/j.mce.2005.07.003; Bouret SG, 2007, J NEUROENDOCRINOL, V19, P575, DOI 10.1111/j.1365-2826.2007.01563.x; Coppola A, 2007, CELL METAB, V5, P21, DOI 10.1016/j.cmet.2006.12.002; Cripps RL, 2007, BIOCHEM SOC T, V35, P1203, DOI 10.1042/BST0351203; Davidowa H, 2007, NEUROREPORT, V18, P521, DOI 10.1097/WNR.0b013e32805dfb93; Degasperi GR, 2008, FEBS LETT, V582, P3103, DOI 10.1016/j.febslet.2008.08.006; Ferezou-Viala J, 2007, AM J PHYSIOL-REG I, V293, pR1056, DOI 10.1152/ajpregu.00117.2007; Gallou-Kabani C, 2005, DIABETES, V54, P1899, DOI 10.2337/diabetes.54.7.1899; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; GUO F, 1995, PHYSIOL BEHAV, V57, P681, DOI 10.1016/0031-9384(94)00342-4; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Harder T, 2007, LANCET, V369, P1859, DOI 10.1016/S0140-6736(07)60847-2; Holemans K, 2004, AM J OBSTET GYNECOL, V190, P858, DOI 10.1016/j.ajog.2003.09.025; Ikenasio-Thorpe BA, 2007, J ENDOCRINOL, V193, P31, DOI 10.1677/joe.1.07017; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Khan I, 2004, CIRCULATION, V110, P1097, DOI 10.1161/01.CIR.0000139843.05436.A0; Khan IY, 2005, AM J PHYSIOL-REG I, V288, pR127, DOI 10.1152/ajpregu.00354.2004; Khan LY, 2003, HYPERTENSION, V41, P168, DOI 10.1161/01.HYP.0000047511.97879.FC; Levin BE, 2006, PHILOS T R SOC B, V361, P1107, DOI 10.1098/rstb.2006.1851; Lins MC, 2005, REGUL PEPTIDES, V127, P197, DOI 10.1016/j.regpep.2004.12.005; McMillen IC, 2009, ADV EXP MED BIOL, V646, P71, DOI 10.1007/978-1-4020-9173-5_8; Mong JA, 1999, J NEUROSCI, V19, P1464; Nohr EA, 2009, AM J CLIN NUTR, V90, P1288, DOI 10.3945/ajcn.2009.27919; Phillips DIW, 2006, ANN NY ACAD SCI, V1083, P28, DOI 10.1196/annals.1367.027; Salomon G, 2006, PROTEIN EXPRES PURIF, V47, P128, DOI 10.1016/j.pep.2005.09.016; Shankar K, 2008, AM J PHYSIOL-REG I, V294, pR528, DOI 10.1152/ajpregu.00316.2007; Shapiro A, 2008, AM J PHYSIOL-REG I, V295, pR1370, DOI 10.1152/ajpregu.00195.2008; Stocker C, 2004, INT J OBESITY, V28, P129, DOI 10.1038/sj.ijo.0802476; Stocker CJ, 2007, AM J PHYSIOL-REG I, V292, pR1810, DOI 10.1152/ajpregu.00676.2006; TURNER RC, 1993, FRONT DIABETES, V12, P66; Vickers MH, 2005, ENDOCRINOLOGY, V146, P4211, DOI 10.1210/en.2005-0581; Vickers MH, 2000, AM J PHYSIOL-ENDOC M, V279, pE83; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	37	23	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e18043	10.1371/journal.pone.0018043	http://dx.doi.org/10.1371/journal.pone.0018043			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464991	Green Published, gold, Green Submitted			2022-12-25	WOS:000288813900029
J	Villani, M; Barbieri, A; Serra, R				Villani, Marco; Barbieri, Alessia; Serra, Roberto			A Dynamical Model of Genetic Networks for Cell Differentiation	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; NOISE; EXPRESSION; STOCHASTICITY; FIBROBLASTS; COMMITMENT	A mathematical model is proposed which is able to describe the most important features of cell differentiation, without requiring specific detailed assumptions concerning the interactions which drive the phenomenon. On the contrary, cell differentiation is described here as an emergent property of a generic model of the underlying gene regulatory network, and it can therefore be applied to a variety of different organisms. The model points to a peculiar role of cellular noise in differentiation and leads to non trivial predictions which could be subject to experimental testing. Moreover, a single model proves able to describe several different phenomena observed in various differentiation processes.	[Villani, Marco; Barbieri, Alessia; Serra, Roberto] Univ Modena & Reggio Emilia, Modelling & Simulat Lab, Dept Commun & Econ, Reggio Emilia, Italy; [Villani, Marco; Serra, Roberto] European Ctr Living Technol, Venice, Italy	Universita di Modena e Reggio Emilia	Serra, R (corresponding author), Univ Modena & Reggio Emilia, Modelling & Simulat Lab, Dept Commun & Econ, Reggio Emilia, Italy.	roberto.serra@unimore.it	Villani, Marco/K-9733-2016; Serra, Roberto/L-5084-2016	Villani, Marco/0000-0002-5991-5470; Serra, Roberto/0000-0002-1417-5106	Italian Miur [2982/Ric]; Fondazione di Venezia	Italian Miur(Ministry of Education, Universities and Research (MIUR)); Fondazione di Venezia	This work has been supported in part by the Italian Miur Project MITICA (FISR nr. 2982/Ric) and by the DICE project of the Fondazione di Venezia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDANA M, 2003, APPL MATH SCI SERIES; Aldana M, 2007, J THEOR BIOL, V245, P433, DOI 10.1016/j.jtbi.2006.10.027; [Anonymous], 1995, HOME UNIVERSE SEARCH; Baron MH, 1993, CURR OPIN CELL BIOL, V5, P1050, DOI 10.1016/0955-0674(93)90091-4; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Furusawa C, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-17; Giorgetti A, 2009, CELL STEM CELL, V5, P353, DOI 10.1016/j.stem.2009.09.008; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Hoffmann M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002922; Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; Huang S, 2007, DEV BIOL, V305, P695, DOI 10.1016/j.ydbio.2007.02.036; Huang S, 2009, BIOESSAYS, V31, P546, DOI 10.1002/bies.200800189; Hume DA, 2000, BLOOD, V96, P2323, DOI 10.1182/blood.V96.7.2323.h8002323_2323_2328; Johnson NC, 2008, GENE DEV, V22, P3282, DOI 10.1101/gad.1727208; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Kaneko K, 2006; Kashiwagi A, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000049; Kauffman S. A., 1993, ORIGINS ORDER; KAUFFMAN SA, 1969, J THEOR BIOL; KUPIEC JJ, 1983, SPECULAT SCI TECHNOL, V6, P471; Kuznetsov VA, 2002, GENETICS, V161, P1321; LANGTON CG, 1992, SFI S SCI C, V10, P41; Lestas I, 2008, IEEE T AUTOMAT CONTR, V53, P189, DOI 10.1109/TAC.2007.911347; Maduro MF, 2010, DEV DYNAM, V239, P1315, DOI 10.1002/dvdy.22233; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Miyamoto T, 2002, DEV CELL, V3, P137, DOI 10.1016/S1534-5807(02)00201-0; Musashi M, 1991, Rinsho Ketsueki, V32, P439; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Ramo P, 2006, J THEOR BIOL, V242, P164, DOI 10.1016/j.jtbi.2006.02.011; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Ribeiro AS, 2007, J THEOR BIOL, V247, P743, DOI 10.1016/j.jtbi.2007.04.020; Serra R, 2007, J THEOR BIOL, V246, P449, DOI 10.1016/j.jtbi.2007.01.012; Serra R, 2004, J THEOR BIOL, V227, P149, DOI 10.1016/j.jtbi.2003.10.018; Serra R, 2010, J THEOR BIOL, V265, P185, DOI 10.1016/j.jtbi.2010.04.012; Shmulevich I, 2005, P NATL ACAD SCI USA, V102, P13439, DOI 10.1073/pnas.0506771102; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; VILLANI M, 2010, P 7 EUR C COMPL SYST, P24; WOLPERT L, 1994, SCIENCE, V266, P571, DOI 10.1126/science.7939707; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180	47	48	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17703	10.1371/journal.pone.0017703	http://dx.doi.org/10.1371/journal.pone.0017703			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21464974	gold, Green Published			2022-12-25	WOS:000288545100026
J	Toubiana, J; Rossi, AL; Grimaldi, D; Belaidouni, N; Chafey, P; Clary, G; Courtine, E; Pene, F; Mira, JP; Claessens, YE; Chiche, JD				Toubiana, Julie; Rossi, Anne-Lise; Grimaldi, David; Belaidouni, Nadia; Chafey, Philippe; Clary, Guilhem; Courtine, Emilie; Pene, Frederic; Mira, Jean-Paul; Claessens, Yann-Erick; Chiche, Jean-Daniel			IMPDHII Protein Inhibits Toll-like Receptor 2-mediated Activation of NF-kappa B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSINE 5'-MONOPHOSPHATE DEHYDROGENASE; PHOSPHATIDYLINOSITOL 3-KINASE; TYROSINE PHOSPHORYLATION; NEGATIVE REGULATOR; MONOPHOSPHATE DEHYDROGENASE; INFLAMMATORY RESPONSES; PATTERN-RECOGNITION; HUMAN NEUTROPHILS; EPITHELIAL-CELLS; LIPID RAFTS	Toll-like receptor 2 (TLR2) plays an essential role in innate immunity by the recognition of a large variety of pathogen-associated molecular patterns. It induces its recruitment to lipid rafts induces the formation of a membranous activation cluster necessary to enhance, amplify, and control downstream signaling. However, the exact composition of the TLR2-mediated molecular complex is unknown. We performed a proteomic analysis in lipopeptide-stimulated THP1 and found IMPDHII protein rapidly recruited to lipid raft. Whereas IMPDHII is essential for lymphocyte proliferation, its biologic function within innate immune signal pathways has not been established yet. We report here that IMPDHII plays an important role in the negative regulation of TLR2 signaling by modulating PI3K activity. Indeed, IMPDHII increases the phosphatase activity of SHP1, which participates to the inactivation of PI3K.	[Grimaldi, David; Pene, Frederic; Mira, Jean-Paul; Claessens, Yann-Erick; Chiche, Jean-Daniel] Cochin Univ Hosp, Med Intens Care Unit, F-75014 Paris, France; [Toubiana, Julie; Rossi, Anne-Lise; Grimaldi, David; Belaidouni, Nadia; Chafey, Philippe; Clary, Guilhem; Courtine, Emilie; Pene, Frederic; Mira, Jean-Paul; Claessens, Yann-Erick; Chiche, Jean-Daniel] Paris Descartes Univ, F-75006 Paris, France; [Toubiana, Julie; Rossi, Anne-Lise; Grimaldi, David; Belaidouni, Nadia; Chafey, Philippe; Clary, Guilhem; Courtine, Emilie; Pene, Frederic; Mira, Jean-Paul; Claessens, Yann-Erick; Chiche, Jean-Daniel] CNRS, INSERM, U1016, UMR 8104, F-75014 Paris, France; [Chafey, Philippe; Clary, Guilhem] Cochin Inst, F-75014 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Chiche, JD (corresponding author), Cochin Univ Hosp, Med Intens Care Unit, 27 Rue Faubourg, F-75014 Paris, France.	jean-daniel.chiche@cch.aphp.fr	Toubiana, Julie/AAZ-8996-2020; Chiche, Jean-Daniel/P-5220-2017	Toubiana, Julie/0000-0001-9561-669X; Chiche, Jean-Daniel/0000-0002-6433-6254; Pene, Frederic/0000-0003-3639-3849; Rossi, Anne-Lise/0000-0001-9991-2445	INSERM; Cochin Association for Research on Inflammation, Sepsis, and Molecular Advances (CARISMA); Assistance Publique-Hopitaux de Paris (AP-HP)-CNRS; Fondation pour la Recherche Medicale; European Society of Intensive Care Medicine (ESICM)	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Cochin Association for Research on Inflammation, Sepsis, and Molecular Advances (CARISMA); Assistance Publique-Hopitaux de Paris (AP-HP)-CNRS(Centre National de la Recherche Scientifique (CNRS)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); European Society of Intensive Care Medicine (ESICM)	This work was supported by grants from INSERM and the Cochin Association for Research on Inflammation, Sepsis, and Molecular Advances (CARISMA).; Supported by grants from Assistance Publique-Hopitaux de Paris (AP-HP)-CNRS and Fondation pour la Recherche Medicale and by the Levi Montalcini Biomedical Sciences Award from the European Society of Intensive Care Medicine (ESICM).	Abram CL, 2009, ANNU REV IMMUNOL, V27, P339, DOI 10.1146/annurev.immunol.021908.132554; Abu-Dayyeh I, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000305; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Allison AC, 2000, IMMUNOPHARMACOLOGY, V47, P85, DOI 10.1016/S0162-3109(00)00188-0; AlShami A, 1997, BLOOD, V89, P1035, DOI 10.1182/blood.V89.3.1035; Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Brumell JH, 1997, J BIOL CHEM, V272, P875, DOI 10.1074/jbc.272.2.875; CARR SF, 1993, J BIOL CHEM, V268, P27286; Chacko GW, 1996, J IMMUNOL, V157, P2234; Colby TD, 1999, P NATL ACAD SCI USA, V96, P3531, DOI 10.1073/pnas.96.7.3531; COLLART FR, 1988, J BIOL CHEM, V263, P15769; Cuevas BD, 2001, J BIOL CHEM, V276, P27455, DOI 10.1074/jbc.M100556200; Farhat K, 2008, J LEUKOCYTE BIOL, V83, P692, DOI 10.1189/jlb.0807586; Franklin TJ, 1999, BIOCHEM PHARMACOL, V58, P867, DOI 10.1016/S0006-2952(99)00170-7; Hajjar AM, 2001, J IMMUNOL, V166, P15, DOI 10.4049/jimmunol.166.1.15; Hamerman JA, 2009, IMMUNOL REV, V232, P42, DOI 10.1111/j.1600-065X.2009.00841.x; Han CF, 2010, NAT IMMUNOL, V11, P734, DOI 10.1038/ni.1908; Harriague J, 2002, NAT IMMUNOL, V3, P1090, DOI 10.1038/ni847; JACKSON RC, 1975, NATURE, V256, P331, DOI 10.1038/256331a0; Jain J, 2004, BIOCHEM PHARMACOL, V67, P767, DOI 10.1016/j.bcp.2003.09.043; Jones ML, 2004, J BIOL CHEM, V279, P40475, DOI 10.1074/jbc.M402970200; Jonsson CA, 2002, CELL IMMUNOL, V216, P93, DOI 10.1016/S0008-8749(02)00502-6; Kawagoe T, 2009, NAT IMMUNOL, V10, P965, DOI 10.1038/ni.1771; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Lee J, 2006, P NATL ACAD SCI USA, V103, P1828, DOI 10.1073/pnas.0510801103; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Lijeroos M, 2007, CELL SIGNAL, V19, P625, DOI 10.1016/j.cellsig.2006.08.013; Mazerolles F, 1997, EUR J IMMUNOL, V27, P2457, DOI 10.1002/eji.1830270946; Mondin M, 2007, BIOCHEM PHARMACOL, V73, P1491, DOI 10.1016/j.bcp.2006.12.025; Olsson S, 2006, MOL IMMUNOL, V43, P607, DOI 10.1016/j.molimm.2005.04.011; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Poole AW, 2005, CELL SIGNAL, V17, P1323, DOI 10.1016/j.cellsig.2005.05.016; Russell JA, 2006, NEW ENGL J MED, V355, P1699, DOI 10.1056/NEJMra043632; Sattler M, 2001, J BIOL CHEM, V276, P2451, DOI 10.1074/jbc.M006250200; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Sierra SS, 2009, EMBO J, V28, P2018, DOI 10.1038/emboj.2009.158; Sintchak MD, 2000, IMMUNOPHARMACOLOGY, V47, P163, DOI 10.1016/S0162-3109(00)00193-4; Slevogt H, 2008, NAT IMMUNOL, V9, P1270, DOI 10.1038/ni.1661; Soong G, 2004, J CLIN INVEST, V113, P1482, DOI 10.1172/JCI200420773; Strassheim D, 2005, J IMMUNOL, V174, P8064, DOI 10.4049/jimmunol.174.12.8064; Strassheim D, 2004, J IMMUNOL, V172, P5727, DOI 10.4049/jimmunol.172.9.5727; Triantafilou M, 2002, TRENDS IMMUNOL, V23, P301, DOI 10.1016/S1471-4906(02)02233-0; Triantafilou M, 2002, J CELL SCI, V115, P2603; Triantafilou M, 2006, J BIOL CHEM, V281, P31002, DOI 10.1074/jbc.M602794200; Wald D, 2003, NAT IMMUNOL, V4, P920, DOI 10.1038/ni968; Weigel G, 2002, MOL PHARMACOL, V62, P453, DOI 10.1124/mol.62.3.453; Yoshida H, 2005, J BIOL CHEM, V280, P41111, DOI 10.1074/jbc.M509526200; Zhou DL, 2010, J LEUKOCYTE BIOL, V87, P845, DOI 10.1189/jlb.0409289	48	10	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23319	23333		10.1074/jbc.M110.201210	http://dx.doi.org/10.1074/jbc.M110.201210			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21460227	Green Published, hybrid			2022-12-25	WOS:000292025000064
J	Chan, P; Gabay, M; Wright, FA; Tall, GG				Chan, PuiYee; Gabay, Meital; Wright, Forrest A.; Tall, Gregory G.			Ric-8B Is a GTP-dependent G Protein alpha(s) Guanine Nucleotide Exchange Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSDUCIN-LIKE PROTEIN; HETEROTRIMERIC G-PROTEINS; FUNCTIONAL EXPRESSION; PLASMA-MEMBRANE; CORTICAL LOCALIZATION; MOLECULAR CHAPERONE; DROSOPHILA RIC-8; GAMMA-SUBUNITS; SF9 CELLS; PURIFICATION	ric-8 (resistance to inhibitors of cholinesterase 8) genes have positive roles in variegated G protein signaling pathways, including G alpha(q) and G alpha(s) regulation of neurotransmission, G alpha(i)-dependent mitotic spindle positioning during (asymmetric) cell division, and G alpha(olf)-dependent odorant receptor signaling. Mammalian Ric-8 activities are partitioned between two genes, ric-8A and ric-8B. Ric-8A is a guanine nucleotide exchange factor (GEF) for G alpha(i)/alpha(q)/alpha(12/13) subunits. Ric-8B potentiated G(s) signaling presumably as a G alpha(s)-class GEF activator, but no demonstration has shown Ric-8B GEF activity. Here, two Ric-8B isoforms were purified and found to be G alpha subunit GDP release factor/GEFs. In HeLa cells, full-length Ric-8B (Ric-8BFL) bound endogenously expressed G alpha s and lesser amounts of G alpha(q) and G alpha(13). Ric-8BFL stimulated guanosine 5 '-3-O-(thio) triphosphate (GTP gamma S) binding to these subunits andG alpha(olf), whereas the Ric-8B Delta 9 isoform stimulated G alpha(s) (short) GTP gamma S binding only. Michaelis-Menten experiments showed that Ric-8BFL elevated the V-max of G alpha(s) steady stateGTPhydrolysis and the apparent K-m values of GTP binding to G alpha(s) from similar to 385 nM to an estimated value of similar to 42 mu M. Directionality of the Ric-8BFL-catalyzed G alpha s exchange reaction was GTP-dependent. At sub-K-m GTP, Ric-BFL was inhibitory to exchange despite being a rapid GDP release accelerator. Ric-8BFL binds nucleotide-free G alpha s tightly, and near-K-m GTP levels were required to dissociate the Ric-8B.G alpha nucleotide-free intermediate to release free Ric-8B and G alpha-GTP. Ric-8BFL-catalyzed nucleotide exchange probably proceeds in the forward direction to produce G alpha-GTP in cells.	[Chan, PuiYee; Gabay, Meital; Wright, Forrest A.; Tall, Gregory G.] Univ Rochester, Med Ctr, Dept Physiol & Pharmacol, Rochester, NY 14642 USA	University of Rochester	Tall, GG (corresponding author), 601 Elmwood Ave,Box 711, Rochester, NY 14642 USA.	gregory_tall@urmc.rochester.edu		Chan, PuiYee/0000-0002-9133-9506	National Institutes of Health [GM088242]; New York State Stem Cell Science (NYSTEM) [C024307]; National Institute on Drug Abuse (NIDA) [T32 DA07232]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088242] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007232] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York State Stem Cell Science (NYSTEM); National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant GM088242 (to G. G. T.). This work was also supported by New York State Stem Cell Science (NYSTEM) Grant C024307 (to G. G. T.) and National Institute on Drug Abuse (NIDA) Grant T32 DA07232 (to P. C.).	Afshar K, 2005, DEVELOPMENT, V132, P4449, DOI 10.1242/dev.02039; Blumer JB, 2002, J BIOL CHEM, V277, P15897, DOI 10.1074/jbc.M112185200; BRANDT DR, 1985, J BIOL CHEM, V260, P266; Chan P, 2011, J BIOL CHEM, V286, P2625, DOI 10.1074/jbc.M110.178897; Chisari M, 2007, J BIOL CHEM, V282, P24092, DOI 10.1074/jbc.M704246200; Cismowski MJ, 2006, SEMIN CELL DEV BIOL, V17, P334, DOI 10.1016/j.semcdb.2006.03.003; David NB, 2005, NAT CELL BIOL, V7, P1083, DOI 10.1038/ncb1319; Dupre DJ, 2007, J BIOL CHEM, V282, P13703, DOI 10.1074/jbc.M608846200; Garcia-Marcos M, 2009, P NATL ACAD SCI USA, V106, P3178, DOI 10.1073/pnas.0900294106; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Hampoelz B, 2005, NAT CELL BIOL, V7, P1099, DOI 10.1038/ncb1318; HEPLER JR, 1993, J BIOL CHEM, V268, P14367; ITOH H, 1991, J BIOL CHEM, V266, P16226; Jameson EE, 2005, J BIOL CHEM, V280, P7712, DOI 10.1074/jbc.M413810200; Kerr DS, 2008, MOL CELL NEUROSCI, V38, P341, DOI 10.1016/j.mcn.2008.03.006; Klattenhoff C, 2003, J CELL PHYSIOL, V195, P151, DOI 10.1002/jcp.10300; KOZASA T, 1995, J BIOL CHEM, V270, P1734, DOI 10.1074/jbc.270.4.1734; KOZASA T, 1999, CRC METH SIG TRANS, P23; LEE E, 1994, METHOD ENZYMOL, V237, P146; LINDER ME, 1993, P NATL ACAD SCI USA, V90, P3675, DOI 10.1073/pnas.90.8.3675; Lukov GL, 2006, J BIOL CHEM, V281, P22261, DOI 10.1074/jbc.M601590200; Lukov GL, 2005, EMBO J, V24, P1965, DOI 10.1038/sj.emboj.7600673; Malnic B, 2009, ANN NY ACAD SCI, V1170, P150, DOI 10.1111/j.1749-6632.2009.03874.x; McLaughlin JN, 2002, P NATL ACAD SCI USA, V99, P7962, DOI 10.1073/pnas.112075699; Miller KG, 2000, NEURON, V27, P289, DOI 10.1016/S0896-6273(00)00037-4; MUMBY SM, 1991, METHOD ENZYMOL, V195, P215; Nagai Y, 2010, J BIOL CHEM, V285, P11114, DOI 10.1074/jbc.M109.063313; Natochin M, 2005, J BIOL CHEM, V280, P30236, DOI 10.1074/jbc.M500722200; PANG IH, 1990, J BIOL CHEM, V265, P18707; Reynolds NK, 2005, GENETICS, V169, P651, DOI 10.1534/genetics.104.031286; Ross EM, 2008, CURR BIOL, V18, pR777, DOI 10.1016/j.cub.2008.07.035; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Ross EM, 2002, METHOD ENZYMOL, V344, P601; Saini DK, 2009, TRENDS PHARMACOL SCI, V30, P278, DOI 10.1016/j.tips.2009.04.001; Sato M, 2006, ANNU REV PHARMACOL, V46, P151, DOI 10.1146/annurev.pharmtox.46.120604.141115; Schade MA, 2005, GENETICS, V169, P631, DOI 10.1534/genetics.104.032334; SINGER WD, 1994, J BIOL CHEM, V269, P19796; STERNWEIS PC, 1984, J BIOL CHEM, V259, P3806; Tall GG, 2003, J BIOL CHEM, V278, P8356, DOI 10.1074/jbc.M211862200; Tall GG, 2005, P NATL ACAD SCI USA, V102, P16584, DOI 10.1073/pnas.0508306102; Tall GG, 2004, METHOD ENZYMOL, V390, P377; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Tsutsumi R, 2009, MOL CELL BIOL, V29, P435, DOI 10.1128/MCB.01144-08; Von Dannecker LEC, 2005, J NEUROSCI, V25, P3793, DOI 10.1523/JNEUROSCI.4595-04.2005; Von Dannecker LEC, 2006, P NATL ACAD SCI USA, V103, P9310, DOI 10.1073/pnas.0600697103; Wang HY, 2005, NAT CELL BIOL, V7, P1091, DOI 10.1038/ncb1317; Wells CA, 2006, J BIOL CHEM, V281, P20221, DOI 10.1074/jbc.M602409200; Willardson BM, 2007, CELL SIGNAL, V19, P2417, DOI 10.1016/j.cellsig.2007.06.013; Yoshikawa K, 2009, CHEM SENSES, V34, P15, DOI 10.1093/chemse/bjn047; Zhuang HY, 2007, J BIOL CHEM, V282, P15284, DOI 10.1074/jbc.M700386200	50	42	42	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19932	19942		10.1074/jbc.M110.163675	http://dx.doi.org/10.1074/jbc.M110.163675			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21467038	hybrid, Green Published			2022-12-25	WOS:000291027700072
J	Naimy, H; Buczek-Thomas, JA; Nugent, MA; Leymarie, N; Zaia, J				Naimy, Hicham; Buczek-Thomas, Jo Ann; Nugent, Matthew A.; Leymarie, Nancy; Zaia, Joseph			Highly Sulfated Nonreducing End-derived Heparan Sulfate Domains Bind Fibroblast Growth Factor-2 with High Affinity and Are Enriched in Biologically Active Fractions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR TYROSINE KINASES; MASS-SPECTROMETRY; CELL-SURFACE; ENDOTHELIAL-CELLS; CRYSTAL-STRUCTURE; TERNARY COMPLEX; FGF; SPECIFICITY; OLIGOSACCHARIDES; PROTEIN	Human fibroblast growth factor-2 (FGF2) regulates cellular processes including proliferation, adhesion, motility, and angiogenesis. FGF2 exerts its biological function by binding and dimerizing its receptor (FGFR), which activates signal transduction cascades. Effective binding of FGF2 to its receptor requires the presence of heparan sulfate (HS), a linear polysaccharide with N-sulfated domains (NS) localized at the cell surface and extracellular matrix. HS acts as a platform facilitating the formation of a functional FGF-FGFR-HS ternary complex. Crystal structures of the signaling ternary complex revealed two conflicting architectures. In the asymmetrical model, two FGFs and two FGFRs bind a single HS chain. In contrast, the symmetrical model postulates that one FGF and one FGFR bind to the free end of the HS chain and dimerization require these ends to join, bringing the two half-complexes together. In this study, we screened a hexasaccharide HS library for compositions that are able to bind FGF2. The library was composed primarily of NS domains internal to the HS chain with minor presence of non-reducing end (NRE) NS. The binders were categorized into low versus high affinity binders. The low affinity fraction contained primarily hexasaccharides with low degree of sulfation that were internal to the HS chains. In contrast, the high affinity bound fraction was enriched in NRE oligosaccharides that were considerably more sulfated and had the ability to promote FGFR-mediated cell proliferation. The results suggest a role of the NRE of HS in FGF2 signaling and favor the formation of the symmetrical architecture on short NS domains.	[Naimy, Hicham; Buczek-Thomas, Jo Ann; Nugent, Matthew A.; Leymarie, Nancy; Zaia, Joseph] Boston Univ, Sch Med, Dept Biochem, Ctr Biomed Mass Spectrometry, Boston, MA 02118 USA	Boston University	Zaia, J (corresponding author), Boston Univ, Sch Med, Dept Biochem, Ctr Biomed Mass Spectrometry, 670 Albany St,Rm 509, Boston, MA 02118 USA.	jzaia@bu.edu	Zaia, Joseph/U-7850-2019	Zaia, Joseph/0000-0001-9497-8701; Buczek-Thomas, JoAnn/0000-0003-2784-9453; Nugent, Matthew/0000-0002-8630-4712	National Institutes of Health [P41RR10888, R01HL098950, R01HL088572, S10RR020946]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR020946, P41RR010888] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088572, R01HL098950] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants P41RR10888, R01HL098950, R01HL088572, and S10RR020946 for funding.	Ai XB, 2003, J CELL BIOL, V162, P341, DOI 10.1083/jcb.200212083; Ashikari-Hada S, 2004, J BIOL CHEM, V279, P12346, DOI 10.1074/jbc.M313523200; Bame KJ, 2001, GLYCOBIOLOGY, V11, p91R, DOI 10.1093/glycob/11.6.91R; Bikfalvi A, 1997, ENDOCR REV, V18, P26, DOI 10.1210/er.18.1.26; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; CASU B, 1986, NATURE, V322, P215, DOI 10.1038/322215b0; Conrad H. E., 1998, HEPARIN BINDING PROT; DESAI UR, 1993, BIOCHEMISTRY-US, V32, P8140, DOI 10.1021/bi00083a012; ERIKSSON AE, 1991, P NATL ACAD SCI USA, V88, P3441, DOI 10.1073/pnas.88.8.3441; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Faham S, 1996, SCIENCE, V271, P1116, DOI 10.1126/science.271.5252.1116; Fannon M, 1996, J BIOL CHEM, V271, P17949, DOI 10.1074/jbc.271.30.17949; FLORKIEWICZ RZ, 1989, P NATL ACAD SCI USA, V86, P3978, DOI 10.1073/pnas.86.11.3978; FOLKMAN J, 1988, AM J PATHOL, V130, P393; Goodger SJ, 2008, J BIOL CHEM, V283, P13001, DOI 10.1074/jbc.M704531200; GUIMOND S, 1993, J BIOL CHEM, V268, P23906; HABUCHI H, 1992, BIOCHEM J, V285, P805, DOI 10.1042/bj2850805; Habuchi O, 2000, BBA-GEN SUBJECTS, V1474, P115, DOI 10.1016/S0304-4165(00)00016-7; Harmer NJ, 2006, BIOCHEM J, V393, P741, DOI 10.1042/BJ20050985; Harmer NJ, 2004, J MOL BIOL, V339, P821, DOI 10.1016/j.jmb.2004.04.031; Inatani M, 2003, SCIENCE, V302, P1044, DOI 10.1126/science.1090497; Jastrebova N, 2006, J BIOL CHEM, V281, P26884, DOI 10.1074/jbc.M600806200; JAYE M, 1992, BIOCHIM BIOPHYS ACTA, V1135, P185, DOI 10.1016/0167-4889(92)90136-Y; Jemth P, 2002, J BIOL CHEM, V277, P30567, DOI 10.1074/jbc.M203404200; KIEFER MC, 1990, P NATL ACAD SCI USA, V87, P6985, DOI 10.1073/pnas.87.18.6985; KLAGSBRUN M, 1987, P NATL ACAD SCI USA, V84, P1839, DOI 10.1073/pnas.84.7.1839; Kreuger J, 2001, J BIOL CHEM, V276, P30744, DOI 10.1074/jbc.M102628200; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; LEE JC, 1982, J IMMUNOL, V128, P2393; Lin XH, 1999, DEVELOPMENT, V126, P3715; Loo JA, 1997, MASS SPECTROM REV, V16, P1; Lundin L, 2000, J BIOL CHEM, V275, P24653, DOI 10.1074/jbc.M908930199; MACCARANA M, 1993, J BIOL CHEM, V268, P23898; MCNEIL PL, 1989, J CELL BIOL, V109, P811, DOI 10.1083/jcb.109.2.811; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; MOSCATELLI D, 1987, J CELL PHYSIOL, V131, P123, DOI 10.1002/jcp.1041310118; Naimy H, 2008, BIOCHEMISTRY-US, V47, P3155, DOI 10.1021/bi702043e; Naimy H, 2010, BIOCHEMISTRY-US, V49, P3743, DOI 10.1021/bi100135d; NUGENT MA, 1992, BIOCHEMISTRY-US, V31, P8876, DOI 10.1021/bi00152a026; OLWIN BB, 1992, J CELL BIOL, V118, P631, DOI 10.1083/jcb.118.3.631; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; ORNITZ DM, 1992, J BIOL CHEM, V267, P16305; ORNITZ DM, 1992, MOL CELL BIOL, V12, P240, DOI 10.1128/MCB.12.1.240; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Pellegrini L, 2001, CURR OPIN STRUC BIOL, V11, P629, DOI 10.1016/S0959-440X(00)00258-X; Pikas DS, 1998, J BIOL CHEM, V273, P18770, DOI 10.1074/jbc.273.30.18770; PRATS H, 1989, P NATL ACAD SCI USA, V86, P1836, DOI 10.1073/pnas.86.6.1836; Pye DA, 1998, J BIOL CHEM, V273, P22936, DOI 10.1074/jbc.273.36.22936; QUARTO N, 1991, J CELL PHYSIOL, V147, P311, DOI 10.1002/jcp.1041470217; RAPRAEGER AC, 1994, METHOD ENZYMOL, V245, P219; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; Robinson CJ, 2005, J BIOL CHEM, V280, P42274, DOI 10.1074/jbc.M505720200; ROGHANI M, 1994, J BIOL CHEM, V269, P3976; RUSNATI M, 1994, BIOCHEM BIOPH RES CO, V203, P450, DOI 10.1006/bbrc.1994.2203; Sasisekharan R, 2000, CURR OPIN CHEM BIOL, V4, P626, DOI 10.1016/S1367-5931(00)00145-9; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Staples GO, 2010, J BIOL CHEM, V285, P18336, DOI 10.1074/jbc.M110.101592; TURNBULL JE, 1992, J BIOL CHEM, V267, P10337; Wu ZLL, 2005, J BIOL CHEM, V280, P33749, DOI 10.1074/jbc.M505677200; Wu ZLL, 2003, J BIOL CHEM, V278, P17121, DOI 10.1074/jbc.M212590200; YARDEN Y, 1988, ANNU REV BIOCHEM, V57, P443, DOI 10.1146/annurev.bi.57.070188.002303; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W; Yu YH, 2006, J AM SOC MASS SPECTR, V17, P524, DOI 10.1016/j.jasms.2005.12.008; ZHU X, 1991, SCIENCE, V251, P90, DOI 10.1126/science.1702556; Ziegler A, 2006, J CHROMATOGR B, V837, P76, DOI 10.1016/j.jchromb.2006.04.013	65	32	33	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19311	19319		10.1074/jbc.M110.204693	http://dx.doi.org/10.1074/jbc.M110.204693			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21471211	Green Published, hybrid			2022-12-25	WOS:000291027700013
J	Sit, RK; Radic, Z; Gerardi, V; Zhang, LM; Garcia, E; Katalinic, M; Amitai, G; Kovarik, Z; Fokin, VV; Sharpless, KB; Taylor, P				Sit, Rakesh K.; Radic, Zoran; Gerardi, Valeria; Zhang, Limin; Garcia, Edzna; Katalinic, Maja; Amitai, Gabriel; Kovarik, Zrinka; Fokin, Valery V.; Sharpless, K. Barry; Taylor, Palmer			New Structural Scaffolds for Centrally Acting Oxime Reactivators of Phosphylated Cholinesterases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-BRAIN-BARRIER; ACETYLCHOLINESTERASE; NANOPARTICLES; AGENTS	We describe here the synthesis and activity of a new series of oxime reactivators of cholinesterases (ChEs) that contain tertiary amine or imidazole protonatable functional groups. Equilibration between the neutral and protonated species at physiological pH enables the reactivators to cross the blood-brain barrier and distribute in the CNS aqueous space as dictated by interstitial and cellular pH values. Our structure-activity analysis of 134 novel compounds considers primarily imidazole aldoximes and N-substituted 2-hydroxyiminoacetamides. Reactivation capacities of novel oximes are rank ordered by their relative reactivation rate constants at 0.67 mM compared with 2-pyridinealdoxime methiodide for reactivation of four organophosphate (sarin, cyclosarin, VX, and paraoxon) conjugates of human acetylcholinesterase (hAChE). Rank order of the rates differs for reactivation of human butyrylcholinesterase (hBChE) conjugates. The 10 best reactivating oximes, predominantly hydroxyimino acetamide derivatives (for hAChE) and imidazole-containing aldoximes (for hBChE) also exhibited reasonable activity in the reactivation of tabun conjugates. Reactivation kinetics of the lead hydroxyimino acetamide reactivator of hAChE, when analyzed in terms of apparent affinity (1/K-ox) and maximum reactivation rate (k(2)), is superior to the reference uncharged reactivators monoisonitrosoacetone and 2,3-butanedione monoxime and shows potential for further refinement. The disparate pH dependences for reactivation of ChE and the general base-catalyzed oximolysis of acetylthiocholine reveal that distinct reactivator ionization states are involved in the reactivation of ChE conjugates and in conferring nucleophilic reactivity of the oxime group.	[Radic, Zoran; Gerardi, Valeria; Zhang, Limin; Garcia, Edzna; Taylor, Palmer] Univ Calif San Diego, SSPPS, La Jolla, CA 92093 USA; [Sit, Rakesh K.; Fokin, Valery V.; Sharpless, K. Barry] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Sit, Rakesh K.; Fokin, Valery V.; Sharpless, K. Barry] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Katalinic, Maja; Kovarik, Zrinka] Inst Med Res & Occupat Hlth, HR-10001 Zagreb, Croatia; [Amitai, Gabriel] Israel Inst Biol Res, Dept Pharmacol, IL-74100 Ness Ziona, Israel	University of California System; University of California San Diego; Scripps Research Institute; Scripps Research Institute; Institute for Medical Research & Occupational Health (IMROH)	Taylor, P (corresponding author), Univ Calif San Diego, SSPPS, 9500 Gilman Dr, La Jolla, CA 92093 USA.	pwtaylor@ucsd.edu		Katalinic, Maja/0000-0001-7043-4291	National Institutes of Health United States Public Health Service through the NINDS [U01 NS 058046]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM018360] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS058046] Funding Source: NIH RePORTER	National Institutes of Health United States Public Health Service through the NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Counter Act Program United States Public Health Service Grant U01 NS 058046 through the NINDS.	Amitai G, 2007, TOXICOLOGY, V233, P187, DOI 10.1016/j.tox.2006.09.020; Asati A, 2009, ANGEW CHEM INT EDIT, V48, P2308, DOI 10.1002/anie.200805279; Beccalli EM, 2008, J ORG CHEM, V73, P4746, DOI 10.1021/jo800621n; BODOR N, 1975, SCIENCE, V190, P155, DOI 10.1126/science.1166305; Cossrow J., 2008, U. S. Patent, Patent No. [20,090,005,359:01, 2009000535901]; Demar JC, 2010, CHEM-BIOL INTERACT, V187, P191, DOI 10.1016/j.cbi.2010.02.015; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Garcia GE, 2010, CHEM-BIOL INTERACT, V187, P199, DOI 10.1016/j.cbi.2010.02.033; HELDMAN E, 1986, CARBOHYD RES, V151, P337, DOI 10.1016/S0008-6215(00)90353-7; Kalisiak J, 2008, ORG LETT, V10, P3171, DOI 10.1021/ol8006748; Kovarik Z, 2004, BIOCHEMISTRY-US, V43, P3222, DOI 10.1021/bi036191a; Kufleitner J, 2010, J MICROENCAPSUL, V27, P594, DOI 10.3109/02652048.2010.501395; Manetsch R, 2004, J AM CHEM SOC, V126, P12809, DOI 10.1021/ja046382g; Nicolaides DN, 2005, SYNTHESIS-STUTTGART, P407, DOI 10.1055/s-20040-837285; Nozaki H, 1995, INTENS CARE MED, V21, P1032, DOI 10.1007/BF01700667; Okumura T, 1996, ANN EMERG MED, V28, P129, DOI 10.1016/S0196-0644(96)70052-5; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Sekijima Y, 1995, Rinsho Shinkeigaku, V35, P1241; Shih TM, 2003, TOXICOL APPL PHARM, V188, P69, DOI 10.1016/S0041-008X(03)00019-X; Shih TM, 2010, J MOL NEUROSCI, V40, P63, DOI 10.1007/s12031-009-9259-7; Skovira JW, 2010, CHEM-BIOL INTERACT, V187, P318, DOI 10.1016/j.cbi.2010.03.010; Stefely JA, 2010, J MED CHEM, V53, P3389, DOI 10.1021/jm1000979; Taylor P., 2011, GOODMAN GILMANS PHAR, V12th ed, P239; Wagner S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014213; Yanagisawa N, 2006, J NEUROL SCI, V249, P76, DOI 10.1016/j.jns.2006.06.007	25	109	115	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19422	19430		10.1074/jbc.M111.230656	http://dx.doi.org/10.1074/jbc.M111.230656			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21464125	Green Published, hybrid			2022-12-25	WOS:000291027700025
J	Jastrzebska, B; Palczewski, K; Golczak, M				Jastrzebska, Beata; Palczewski, Krzysztof; Golczak, Marcin			Role of Bulk Water in Hydrolysis of the Rhodopsin Chromophore	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; HYDROGEN-DEUTERIUM EXCHANGE; RETINAL SCHIFF-BASE; CRYSTAL-STRUCTURE; BOVINE RHODOPSIN; ACTIVATION; RESONANCE; OPSIN; PHOTOACTIVATION; INTERMEDIATE	Rhodopsin (Rho) is a prototypical G protein-coupled receptor that changes from an inactive conformational state to a G protein-activating state as a consequence of its retinal chromophore isomerization, 11-cis-retinal -> all-trans-retinal. The photoisomerized chromophore covalently linked to Lys(296) by a Schiff base is subsequently hydrolyzed, but little is known about this reaction. Recent research indicates a significant role for tightly bound transmembrane water molecules in the Rho activation process. Atomic structures of Rho and hydroxyl radical footprinting reveal ordered waters within Rho transmembrane helices that are located close to highly conserved and functionally important receptor residues, forming a hydrogen bond network. Using O-18-labeled H2O, we now report that water from bulk solvent, but not tightly bound water, is involved in the hydrolytic release of chromophore upon Rho activation by light. Moreover, small molecules (and presumably, water) enter the Rho structure from the cytoplasmic side of the membrane. Thus, this work indicates two distinct origins of water vital for Rho function.	[Jastrzebska, Beata; Palczewski, Krzysztof; Golczak, Marcin] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA	Case Western Reserve University	Palczewski, K (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	kxp65@case.edu; mxg149@case.edu			National Institutes of Health [EY008061, GM079191]; NATIONAL EYE INSTITUTE [R29EY008061, R01EY008061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079191] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants EY008061 and GM079191.	AKHTAR M, 1968, BIOCHEM J, V110, P693, DOI 10.1042/bj1100693; Angel TE, 2009, P NATL ACAD SCI USA, V106, P14367, DOI 10.1073/pnas.0901074106; Angel TE, 2009, P NATL ACAD SCI USA, V106, P8555, DOI 10.1073/pnas.0903545106; Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; BOWNDS D, 1965, NATURE, V205, P254, DOI 10.1038/205254a0; BYRN M, 1966, J AM CHEM SOC, V88, P1916, DOI 10.1021/ja00961a013; COOPER A, 1987, J AM CHEM SOC, V109, P7254, DOI 10.1021/ja00258a002; DENG H, 1994, BIOPHYS J, V66, P1129, DOI 10.1016/S0006-3495(94)80893-8; FAGER RS, 1978, VISION RES, V18, P483, DOI 10.1016/0042-6989(78)90060-3; Filipek S, 2003, ANNU REV PHYSIOL, V65, P851, DOI 10.1146/annurev.physiol.65.092101.142611; GREENZAID P, 1967, J AM CHEM SOC, V89, P756, DOI 10.1021/ja00980a005; Grossfield A, 2008, J MOL BIOL, V381, P478, DOI 10.1016/j.jmb.2008.05.036; Hildebrand PW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004382; Holger S, 2006, J BIOL CHEM, V281, P9845, DOI 10.1074/jbc.M511668200; Janz JM, 2004, J BIOL CHEM, V279, P55886, DOI 10.1074/jbc.M408766200; Jastrzebska B, 2004, J BIOL CHEM, V279, P54663, DOI 10.1074/jbc.M408691200; Lodowski DT, 2010, BIOCHEMISTRY-US, V49, P9425, DOI 10.1021/bi101502v; Ludeke S, 2005, J MOL BIOL, V353, P345, DOI 10.1016/j.jmb.2005.08.039; McBee JK, 2000, BIOCHEMISTRY-US, V39, P11370, DOI 10.1021/bi001061c; Mirzadegan T, 2003, BIOCHEMISTRY-US, V42, P2759, DOI 10.1021/bi027224+; Niu L, 2002, P NATL ACAD SCI USA, V99, P13409, DOI 10.1073/pnas.212518899; Okada T, 2000, J STRUCT BIOL, V130, P73, DOI 10.1006/jsbi.1999.4209; Okada T, 2002, P NATL ACAD SCI USA, V99, P5982, DOI 10.1073/pnas.082666399; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; PALCZEWSKI K, 1991, J BIOL CHEM, V266, P15334; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; PAPERMASTER DS, 1982, METHOD ENZYMOL, V81, P48; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; RAFERTY CN, 1981, PHOTOCHEM PHOTOBIOL, V33, P229, DOI 10.1111/j.1751-1097.1981.tb05329.x; Rath P, 1998, BIOPHYS J, V74, P192, DOI 10.1016/S0006-3495(98)77779-3; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; Sandberg MN, 2011, J AM CHEM SOC, V133, P2808, DOI 10.1021/ja1094183; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P6481, DOI 10.1073/pnas.88.15.6481; Szundi I, 2006, BIOCHEMISTRY-US, V45, P4974, DOI 10.1021/bi0524619; WALD G, 1968, SCIENCE, V162, P230, DOI 10.1126/science.162.3850.230; Wang T, 2007, J AM CHEM SOC, V129, P6970, DOI 10.1021/ja0691977; YOSHIZAWA T, 1963, NATURE, V197, P1279, DOI 10.1038/1971279a0	37	42	42	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18930	18937		10.1074/jbc.M111.234583	http://dx.doi.org/10.1074/jbc.M111.234583			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21460218	Green Published, hybrid			2022-12-25	WOS:000290785700064
J	Shinkyo, R; Guengerich, FP				Shinkyo, Raku; Guengerich, F. Peter			Inhibition of Human Cytochrome P450 3A4 by Cholesterol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECOMBINANT HUMAN CYTOCHROME-P450; DRUG-DRUG INTERACTIONS; HUMAN-LIVER-MICROSOMES; LIGAND-BINDING; ACTIVE-SITE; P450 REDUCTASE; OXIDATION; COOPERATIVITY; METABOLISM; 4-BETA-HYDROXYCHOLESTEROL	Cholesterol has been shown to be hydroxylated at the 4 beta-position by cytochrome P450 3A4, and the reaction occurs in vivo (Bodin, K., Andersson, U., Rystedt, E., Ellis, E., Norlin, M., Pikuleva, I., Eggertsen, G., Bjorkhem, I., and Diczfalusy, U. (2002) J. Biol. Chem. 277, 31534-31540). If cholesterol is a substrate of P450 3A4, then it follows that it should also be an inhibitor, particularly in light of the high concentrations found in liver. Heme perturbation spectra indicated a K-d value of 8 mu M for the P450 3A4-cholesterol complex. Cholesterol inhibited the P450 3A4-catalyzed oxidations of nifedipine and quinidine, two prototypic substrates, in liver microsomes and a reconstituted enzyme system with K-i similar to 10 mu M in an apparently non-competitive manner. The concentration of cholesterol could be elevated 4-6-fold in cultured human hepatocytes by incubation with cholesterol; the level of P450 3A4 and cell viability were not altered under the conditions used. Nifedipine oxidation was inhibited when the cholesterol level was increased. We conclude that cholesterol is both a substrate and an inhibitor of P450 3A4, and a model is presented to explain the kinetic behavior. We propose that the endogenous cholesterol in hepatocytes should be considered in models of prediction of metabolism of drugs and steroids, even in the absence of changes in the concentrations of free cholesterol.	[Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Guengerich, FP (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 638 Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu	Shinkyo, Raku/HIK-2997-2022		National Institutes of Health [R37 CA090426, P30 ES000267]; Eisai Co., Ltd.; NATIONAL CANCER INSTITUTE [R37CA090426] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eisai Co., Ltd.(Eisai Co Ltd); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R37 CA090426 and P30 ES000267 (to F. P. G.). This work was also supported by Eisai Co., Ltd. (to R. S.).	Baas BJ, 2004, ARCH BIOCHEM BIOPHYS, V430, P218, DOI 10.1016/j.abb.2004.07.003; BOCKER RH, 1986, J MED CHEM, V29, P1596; Bodin K, 2001, J BIOL CHEM, V276, P38685, DOI 10.1074/jbc.M105127200; Bodin K, 2002, J BIOL CHEM, V277, P31534, DOI 10.1074/jbc.M201712200; Dabrowski MJ, 2002, J AM CHEM SOC, V124, P11866, DOI 10.1021/ja027552x; Diczfalusy U, 2011, BRIT J CLIN PHARMACO, V71, P183, DOI 10.1111/j.1365-2125.2010.03773.x; Dixon M., 1964, ENZYMES, V2nd; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; Garcia-Calvo M, 2005, P NATL ACAD SCI USA, V102, P8132, DOI 10.1073/pnas.0500269102; GILLAM EMJ, 1993, ARCH BIOCHEM BIOPHYS, V305, P123, DOI 10.1006/abbi.1993.1401; Guengerich F.P., 2005, CYTOCHROME P450 STRU, V3rd ed., P377, DOI [10.1007/0-387-27447-2_10, DOI 10.1007/0-387-27447-2_10]; GUENGERICH FP, 1986, J BIOL CHEM, V261, P5051; Guengerich FP, 2005, ARCH BIOCHEM BIOPHYS, V440, P204, DOI 10.1016/j.abb.2005.06.019; GUENGERICH FP, 1990, CHEM RES TOXICOL, V3, P363, DOI 10.1021/tx00016a015; GUENGERICH FP, 2009, INHIBITION DRUG META, P203; GUENGERICH FP, 1994, P 8 INT C CYT P450 B, P97; Hanna IH, 1998, ARCH BIOCHEM BIOPHYS, V350, P324, DOI 10.1006/abbi.1997.0534; HE YA, 2006, P 16 INT S MICR DRUG; Hosea NA, 2000, BIOCHEMISTRY-US, V39, P5929, DOI 10.1021/bi992765t; Isin EM, 2006, J BIOL CHEM, V281, P9127, DOI 10.1074/jbc.M511375200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Mast N, 2005, J LIPID RES, V46, P1561, DOI 10.1194/jlr.D500008-JLR200; Ohno Y, 2007, CLIN PHARMACOKINET, V46, P681, DOI 10.2165/00003088-200746080-00005; ONEIL MJ, 2001, MERCK INDEX, P2223; Ortiz de Montellano P. R., 2005, CYTOCHROME P450 STRU; SCHENKMAN JB, 1967, MOL PHARMACOL, V3, P113; SEGEL IH, 1975, ENZYME KINETICS, P109; Segel IH, 1975, ENZYME KINETICS BEHA; Shaw PM, 1997, ARCH BIOCHEM BIOPHYS, V348, P107, DOI 10.1006/abbi.1997.0378; SHIMADA T, 1989, P NATL ACAD SCI USA, V86, P462, DOI 10.1073/pnas.86.2.462; Shinkyo R, 2011, J BIOL CHEM, V286, P4632, DOI 10.1074/jbc.M110.193409; SHOU M, 1994, BIOCHEMISTRY-US, V33, P6450, DOI 10.1021/bi00187a009; Shou M, 2001, J BIOL CHEM, V276, P2256, DOI 10.1074/jbc.M008799200; Sligar SG, 2007, DRUG METAB REV, V39, P567, DOI 10.1080/03602530701498521; Sohl CD, 2008, J BIOL CHEM, V283, P7293, DOI 10.1074/jbc.M709783200; Soucek P, 1995, BIOCHEMISTRY-US, V34, P16013, DOI 10.1021/bi00049a015; Tang ZM, 2010, ANAL CHEM, V82, P7706, DOI 10.1021/ac1015497; UENG YF, 1995, CHEM RES TOXICOL, V8, P218, DOI 10.1021/tx00044a006; Ueng YF, 1997, BIOCHEMISTRY-US, V36, P370, DOI 10.1021/bi962359z; WANG RW, 1991, ARCH BIOCHEM BIOPHYS, V290, P355, DOI 10.1016/0003-9861(91)90551-S; WAXMAN DJ, 1988, ARCH BIOCHEM BIOPHYS, V263, P424, DOI 10.1016/0003-9861(88)90655-8; Wienkers LC, 2005, NAT REV DRUG DISCOV, V4, P825, DOI 10.1038/nrd1851; Williams JA, 2004, DRUG METAB DISPOS, V32, P1201, DOI 10.1124/dmd.104.000794; Williams PA, 2004, SCIENCE, V305, P683, DOI 10.1126/science.1099736; Yano JK, 2004, J BIOL CHEM, V279, P38091, DOI 10.1074/jbc.C400293200	45	22	22	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18426	18433		10.1074/jbc.M111.240457	http://dx.doi.org/10.1074/jbc.M111.240457			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21471209	Green Published, hybrid			2022-12-25	WOS:000290785700015
J	Boesler, C; Kruse, J; Soderbom, F; Hammann, C				Boesler, Carsten; Kruse, Janis; Soderbom, Fredrik; Hammann, Christian			Sequence and Generation of Mature Ribosomal RNA Transcripts in Dictyostelium discoideum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLULAR SLIME-MOLD; SMALL NUCLEOLAR RNA; SACCHAROMYCES-CEREVISIAE; NUCLEOTIDE-SEQUENCE; DNA; SUBUNIT; REGIONS; GENES; 5S; POLYADENYLATION	The amoeba Dictyostelium discoideum is a well established model organism for studying numerous aspects of cellular and developmental functions. Its ribosomal RNA (rRNA) is encoded in an extrachromosomal palindrome that exists in similar to 100 copies in the cell. In this study, we have set out to investigate the sequence of the expressed rRNA. For this, we have ligated the rRNA ends and performed RT-PCR on these circular RNAs. Sequencing revealed that the mature 26 S, 17 S, 5.8 S, and 5 S rRNAs have sizes of 3741, 1871, 162, and 112 nucleotides, respectively. Unlike the published data, all mature rRNAs of the same type uniformly display the same start and end nucleotides in the analyzed AX2 strain. We show the existence of a short lived primary transcript covering the rRNA transcription unit of 17 S, 5.8 S, and 26 S rRNA. Northern blots and RT-PCR reveal that from this primary transcript two precursor molecules of the 17 S and two precursors of the 26 S rRNA are generated. We have also determined the sequences of these precursor molecules, and based on these data, we propose a model for the maturation of the rRNAs in Dictyostelium discoideum that we compare with the processing of the rRNA transcription unit of Saccharomyces cerevisiae.	[Boesler, Carsten; Kruse, Janis; Hammann, Christian] Tech Univ Darmstadt, Heisenberg Res Grp Ribogenet, D-64287 Darmstadt, Germany; [Soderbom, Fredrik] Swedish Univ Agr Sci, Uppsala Biomed Ctr, Dept Mol Biol, S-75124 Uppsala, Sweden	Technical University of Darmstadt; Swedish University of Agricultural Sciences	Hammann, C (corresponding author), Schnittspahnstr 10, D-64287 Darmstadt, Germany.	hammann@bio.tu-darmstadt.de	Hammann, Christian/A-3530-2012; Hammann, Christian/AAE-7325-2020		Deutsche Forschungsgemeinschaft [HA 3459/5]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Recipient of Fellowship HA 3459/5 from the Heisenberg Program of the Deutsche Forschungsgemeinschaft.	Ansel KM, 2008, NAT STRUCT MOL BIOL, V15, P523, DOI 10.1038/nsmb.1417; Aspegren A, 2004, NUCLEIC ACIDS RES, V32, P4646, DOI 10.1093/nar/gkh804; BATTSYOUNG B, 1978, P NATL ACAD SCI USA, V75, P740, DOI 10.1073/pnas.75.2.740; BATTSYOUNG B, 1977, J BIOL CHEM, V252, P3952; Bhattacharya S, 1998, PARASITOL TODAY, V14, P181, DOI 10.1016/S0169-4758(98)01222-8; Carneiro T, 2007, MOL CELL BIOL, V27, P4157, DOI 10.1128/MCB.00120-07; Chamberlain JR, 1996, NUCLEIC ACIDS RES, V24, P3158, DOI 10.1093/nar/24.16.3158; Champoux JJ, 2009, FEBS J, V276, P1506, DOI 10.1111/j.1742-4658.2009.06909.x; COCKBURN AF, 1976, CELL, V9, P605, DOI 10.1016/0092-8674(76)90043-X; COCKBURN AF, 1978, CHROMOSOMA, V70, P19, DOI 10.1007/BF00292212; Couttet P, 1997, P NATL ACAD SCI USA, V94, P5628, DOI 10.1073/pnas.94.11.5628; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; ENGBERG J, 1976, J MOL BIOL, V104, P455, DOI 10.1016/0022-2836(76)90281-3; Faber AW, 2002, RNA, V8, P1095, DOI 10.1017/S1355838202021027; FRANKEL G, 1977, J MOL BIOL, V109, P539, DOI 10.1016/S0022-2836(77)80090-9; Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2; Gabel HW, 2008, NAT STRUCT MOL BIOL, V15, P531, DOI 10.1038/nsmb.1411; GRAINGER RM, 1980, CELL, V20, P619, DOI 10.1016/0092-8674(80)90308-6; Granneman S, 2004, MOL CELL BIOL, V24, P8600, DOI 10.1128/MCB.24.19.8600-8610.2004; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; Hinas A, 2006, EUKARYOT CELL, V5, P924, DOI 10.1128/EC.00065-06; HORI H, 1980, NUCLEIC ACIDS RES, V8, P5535, DOI 10.1093/nar/8.23.5535; HOSHIKAWA Y, 1983, NUCLEIC ACIDS RES, V11, P1725, DOI 10.1093/nar/11.6.1725; HUGHES JE, 1988, NUCLEIC ACIDS RES, V16, P2338, DOI 10.1093/nar/16.5.2338; Kiss T, 2001, EMBO J, V20, P3617, DOI 10.1093/emboj/20.14.3617; Kuai L, 2004, P NATL ACAD SCI USA, V101, P8581, DOI 10.1073/pnas.0402888101; Kuhlmann M, 2005, NUCLEIC ACIDS RES, V33, P6405, DOI 10.1093/nar/gki952; MAIZELS N, 1976, CELL, V9, P431, DOI 10.1016/0092-8674(76)90088-X; Millevoi S, 2010, NUCLEIC ACIDS RES, V38, P2757, DOI 10.1093/nar/gkp1176; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; NOLLER HF, 1992, SCIENCE, V256, P1416, DOI 10.1126/science.1604315; OZAKI T, 1984, NUCLEIC ACIDS RES, V12, P4171, DOI 10.1093/nar/12.10.4171; RUBIN GM, 1973, J MOL BIOL, V79, P521, DOI 10.1016/0022-2836(73)90403-8; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; Sharma K, 1999, MOL CELL BIOL, V19, P6012; Slomovic S, 2006, NUCLEIC ACIDS RES, V34, P2966, DOI 10.1093/nar/gkl357; Sucgang R, 2003, NUCLEIC ACIDS RES, V31, P2361, DOI 10.1093/nar/gkg348; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; VOGT VM, 1976, J MOL BIOL, V106, P567, DOI 10.1016/0022-2836(76)90252-7; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Win TZ, 2006, MOL CELL BIOL, V26, P1710, DOI 10.1128/MCB.26.5.1710-1721.2006; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030	42	4	4	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17693	17703		10.1074/jbc.M110.208306	http://dx.doi.org/10.1074/jbc.M110.208306			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454536	Green Published, hybrid			2022-12-25	WOS:000290585200033
J	Motamed, M; Zhang, YX; Wang, ML; Seemann, J; Kwon, HJ; Goldstein, JL; Brown, MS				Motamed, Massoud; Zhang, Yinxin; Wang, Michael L.; Seemann, Joachim; Kwon, Hyock Joo; Goldstein, Joseph L.; Brown, Michael S.			Identification of Luminal Loop 1 of Scap Protein as the Sterol Sensor That Maintains Cholesterol Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLEAVAGE-ACTIVATING PROTEIN; ELEMENT-BINDING PROTEINS; ENDOPLASMIC-RETICULUM; MEMBRANE-PROTEIN; SENSING DOMAIN; COMPETITIVE INHIBITOR; REGULATED TRANSPORT; COPII PROTEINS; ER MEMBRANES; SREBPS	Cellular cholesterol homeostasis is maintained by Scap, an endoplasmic reticulum (ER) protein with eight transmembrane helices. In cholesterol-depleted cells, Scap transports sterol regulatory element-binding proteins (SREBPs) to the Golgi, where the active fragment of SREBP is liberated by proteases so that it can activate genes for cholesterol synthesis. When ER cholesterol increases, Scap binds cholesterol, and this changes the conformation of cytosolic Loop 6, which contains the binding site for COPII proteins. The altered conformation precludes COPII binding, abrogating movement to the Golgi. Consequently, cholesterol synthesis declines. Here, we identify the cholesterol-binding site on Scap as Loop 1, a 245-amino acid sequence that projects into the ER lumen. Recombinant Loop 1 binds sterols with a specificity identical to that of the entire Scap membrane domain. When tyrosine 234 in Loop 1 is mutated to alanine, Loop 6 assumes the cholesterol-bound conformation, even in sterol-depleted cells. As a result, full-length Scap(Y234A) cannot mediate SREBP processing in transfected cells. These results indicate that luminal Loop 1 of Scap controls the conformation of cytosolic Loop 6, thereby determining whether cells produce cholesterol.	[Motamed, Massoud; Zhang, Yinxin; Wang, Michael L.; Goldstein, Joseph L.; Brown, Michael S.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Seemann, Joachim] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Kwon, Hyock Joo] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Goldstein, JL (corresponding author), 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	joe.goldstein@utsouthwestern.edu	zhang, yinxin/D-8896-2013; Zhang, Yinxin/I-9996-2019	Zhang, Yinxin/0000-0001-5909-3676	National Institutes of Healt [HL20948, GM096070, ST32 GM08014]; Ara Parseghian Medical Research Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096070, T32GM008014] Funding Source: NIH RePORTER	National Institutes of Healt(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ara Parseghian Medical Research Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants HL20948 and GM096070.; Supported by the Ara Parseghian Medical Research Foundation.; Supported by National Institutes of Health Medical Scientist Training Program Grant ST32 GM08014.	Brown AJ, 2002, MOL CELL, V10, P237, DOI 10.1016/S1097-2765(02)00591-9; BROWN MS, 1978, J BIOL CHEM, V253, P1121; Feramisco JD, 2005, P NATL ACAD SCI USA, V102, P3242, DOI 10.1073/pnas.0500206102; GIL G, 1985, CELL, V41, P249, DOI 10.1016/0092-8674(85)90078-9; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; Gong Y, 2006, CELL METAB, V3, P15, DOI 10.1016/j.cmet.2005.11.014; Hannah VC, 2001, J BIOL CHEM, V276, P4365, DOI 10.1074/jbc.M007273200; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hua XX, 1996, CELL, V87, P415, DOI 10.1016/S0092-8674(00)81362-8; Ikeda Y, 2009, J BIOL CHEM, V284, P34889, DOI 10.1074/jbc.M109.044875; Infante RE, 2008, J BIOL CHEM, V283, P1052, DOI 10.1074/jbc.M707943200; Kapust RB, 2002, BIOCHEM BIOPH RES CO, V294, P949, DOI 10.1016/S0006-291X(02)00574-0; KITA T, 1980, J CLIN INVEST, V66, P1094, DOI 10.1172/JCI109938; Kwon HJ, 2009, CELL, V137, P1213, DOI 10.1016/j.cell.2009.03.049; Nohturfft A, 2000, CELL, V102, P315, DOI 10.1016/S0092-8674(00)00037-4; Nohturfft A, 1998, P NATL ACAD SCI USA, V95, P12848, DOI 10.1073/pnas.95.22.12848; Nohturfft A, 1998, J BIOL CHEM, V273, P17243, DOI 10.1074/jbc.273.27.17243; Pentchev P. G., 1995, METABOLIC MOL BASIS; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; Radhakrishnan A, 2004, MOL CELL, V15, P259, DOI 10.1016/j.molcel.2004.06.019; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Radhakrishnan A, 2008, CELL METAB, V8, P512, DOI 10.1016/j.cmet.2008.10.008; Rawson RB, 1999, J BIOL CHEM, V274, P28549, DOI 10.1074/jbc.274.40.28549; Sakai J, 1997, J BIOL CHEM, V272, P20213, DOI 10.1074/jbc.272.32.20213; Sever N, 2003, J BIOL CHEM, V278, P52479, DOI 10.1074/jbc.M310053200; SKALNIK DG, 1988, J BIOL CHEM, V263, P6836; Sun LP, 2007, P NATL ACAD SCI USA, V104, P6519, DOI 10.1073/pnas.0700907104; Sun LP, 2005, J BIOL CHEM, V280, P26483, DOI 10.1074/jbc.M504041200; TESSIER DC, 1991, GENE, V98, P177, DOI 10.1016/0378-1119(91)90171-7; Wei JH, 2009, NAT PROTOC, V4, P1653, DOI 10.1038/nprot.2009.160; Yabe D, 2002, P NATL ACAD SCI USA, V99, P16672, DOI 10.1073/pnas.262669399; Yabe D, 2002, P NATL ACAD SCI USA, V99, P12753, DOI 10.1073/pnas.162488899; YAMAMOTO T, 1984, CELL, V39, P27, DOI 10.1016/0092-8674(84)90188-0; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3	35	66	67	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					18002	18012		10.1074/jbc.M111.238311	http://dx.doi.org/10.1074/jbc.M111.238311			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454655	Green Published, hybrid			2022-12-25	WOS:000290585200062
J	Shi, QL; Xu, H; Yu, HQ; Zhang, NW; Ye, YZ; Estevez, AG; Deng, HT; Gibson, GE				Shi, Qingli; Xu, Hui; Yu, Haiqiang; Zhang, Nawei; Ye, Yaozu; Estevez, Alvaro G.; Deng, Haiteng; Gibson, Gary E.			Inactivation and Reactivation of the Mitochondrial alpha-Ketoglutarate Dehydrogenase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE NITRATION; PEROXYNITRITE-TREATED PROTEINS; PROGRESSIVE SUPRANUCLEAR PALSY; DEPENDENT ENZYME CHANGES; LUNG EPITHELIAL-CELLS; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; HYDROGEN-PEROXIDE; GLUTATHIONE METABOLISM; MULTIENZYME COMPLEXES	Reduced brain metabolism is an invariant feature of Alzheimer Disease (AD) that is highly correlated to the decline in brain functions. Decreased activities of key tricarboxylic acid cycle (TCA) cycle enzymes may underlie this abnormality and are highly correlated to the clinical state of the patient. The activity of the alpha-ketoglutarate dehydrogenase complex (KGDHC), an arguably rate-limiting enzyme of the TCA cycle, declines with AD, but the mechanism of inactivation and whether it can be reversed remains unknown. KGDHC consists of multiple copies of three subunits. KGDHC is sensitive to oxidative stress, which is pervasive in AD brain. The present studies tested the mechanism for the peroxynitrite-induced inactivation and subsequent reactivation of purified and cellular KGDHC. Peroxynitrite inhibited purified KGDHC activity in a dose-dependent manner and reduced subunit immunoreactivity and increased nitrotyrosine immunoreactivity. Nano-LC-MS/MS showed that the inactivation was related to nitration of specific tyrosine residues in the three subunits. GSH diminished the nitrotyrosine immunoreactivity of peroxynitrite-treated KGDHC, restored the activity and the immunoreactivity for KGDHC. Nano-LC-MS/MS showed this was related to de-nitration of specific tyrosine residues, suggesting KGDHC may have a denitrase activity. Treatment of N2a cells with peroxynitrite for 5 min followed by recovery of cells for 24 h reduced KGDHC activity and increased nitrotyrosine immunoreactivity. Increasing cellular GSH in peroxynitrite-treated cells rescued KGDHC activity to the control level. The results suggest that restoring KGDHC activity is possible and may be a useful therapeutic approach in neurodegenerative diseases.	[Shi, Qingli; Xu, Hui; Gibson, Gary E.] Weill Cornell Med Coll, Burke Med Res Inst, Dept Neurol & Neurosci, White Plains, NY 10605 USA; [Yu, Haiqiang; Zhang, Nawei; Deng, Haiteng] Rockefeller Univ, Prot Resource Ctr, New York, NY 10065 USA; [Ye, Yaozu] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Estevez, Alvaro G.] Univ Cent Florida, Burnett Sch Biomed Sci, Orlando, FL 32827 USA	Cornell University; Rockefeller University; University of Alabama System; University of Alabama Birmingham; State University System of Florida; University of Central Florida	Gibson, GE (corresponding author), Weill Cornell Med Coll, Burke Med Res Inst, Dept Neurol & Neurosci, 785 Mamaroneck Ave, White Plains, NY 10605 USA.	ggibson@med.cornell.edu		Deng, Haiteng/0000-0001-9496-1280	National Institutes of Health [PPG AG14930]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG014930] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant PPG AG14930.	Abello N, 2009, J PROTEOME RES, V8, P3222, DOI 10.1021/pr900039c; Albers DS, 2000, J NEUROCHEM, V74, P878, DOI 10.1046/j.1471-4159.2000.740878.x; Applegate MAB, 2008, BIOCHEMISTRY-US, V47, P473, DOI 10.1021/bi7017464; Au HC, 1998, EUR J BIOCHEM, V251, P164, DOI 10.1046/j.1432-1327.1998.2510164.x; Bajt ML, 2004, TOXICOL SCI, V80, P343, DOI 10.1093/toxsci/kfh151; BENSON DF, 1983, ARCH NEUROL-CHICAGO, V40, P711, DOI 10.1001/archneur.1983.04050110029003; Berg A, 1997, BIOL CHEM, V378, P617; Bian K, 2001, FREE RADICAL BIO MED, V31, P421, DOI 10.1016/S0891-5849(01)00600-1; Bubber P, 2005, ANN NEUROL, V57, P695, DOI 10.1002/ana.20474; BUTTERWORTH RF, 1990, METAB BRAIN DIS, V5, P179, DOI 10.1007/BF00997071; BUTTERWORTH RF, 1993, ALCOHOL CLIN EXP RES, V17, P1084, DOI 10.1111/j.1530-0277.1993.tb05668.x; Chen HJC, 2002, CHEM-BIOL INTERACT, V140, P199, DOI 10.1016/S0009-2797(02)00019-4; Chinopoulos C, 1999, J NEUROCHEM, V73, P220, DOI 10.1046/j.1471-4159.1999.0730220.x; Chouchani ET, 2010, BIOCHEM J, V430, P49, DOI 10.1042/BJ20100633; Dringen R, 2000, EUR J BIOCHEM, V267, P4903, DOI 10.1046/j.1432-1327.2000.01651.x; Frank RAW, 2007, J MOL BIOL, V368, P639, DOI 10.1016/j.jmb.2007.01.080; GIBSON GE, 1988, ARCH NEUROL-CHICAGO, V45, P836, DOI 10.1001/archneur.1988.00520320022009; Gibson GE, 2004, J BIOENERG BIOMEMBR, V36, P335, DOI 10.1023/B:JOBB.0000041764.45552.f3; Gibson GE, 2003, NEUROCHEM INT, V43, P129, DOI 10.1016/S0197-0186(02)00225-5; Gibson GE, 2002, FREE RADICAL BIO MED, V32, P1061, DOI 10.1016/S0891-5849(02)00802-X; Golladay SA, 1997, ENVIRON HEALTH PERSP, V105, P1273, DOI 10.2307/3433546; Gow AJ, 1996, FEBS LETT, V385, P63, DOI 10.1016/0014-5793(96)00347-X; Ischiropoulos H, 2003, BIOCHEM BIOPH RES CO, V305, P776, DOI 10.1016/S0006-291X(03)00814-3; Ischiropoulos H, 1998, ARCH BIOCHEM BIOPHYS, V356, P1, DOI 10.1006/abbi.1998.0755; Jeitner TM, 2005, J NEUROCHEM, V92, P302, DOI 10.1111/j.1471-4159.2004.02868.x; Jiao KS, 2001, ANAL BIOCHEM, V293, P43, DOI 10.1006/abio.2001.5118; Kamisaki Y, 1998, P NATL ACAD SCI USA, V95, P11584, DOI 10.1073/pnas.95.20.11584; Knapp JE, 2000, PROTEIN SCI, V9, P37; Korotchkina LG, 2001, FREE RADICAL BIO MED, V30, P992, DOI 10.1016/S0891-5849(01)00491-9; Kuo WN, 1999, MOL CELL BIOCHEM, V201, P11, DOI 10.1023/A:1007024126947; Kuo WN, 1999, BIOCHEM MOL BIOL INT, V47, P1061; Markesbery WR, 1999, BRAIN PATHOL, V9, P133; MASTROGIACOMO F, 1993, J NEUROCHEM, V61, P2007, DOI 10.1111/j.1471-4159.1993.tb07436.x; MEISTER A, 1988, J BIOL CHEM, V263, P17205; Miranda S, 1999, BIOCHEM BIOPH RES CO, V258, P44, DOI 10.1006/bbrc.1999.0580; MIZUNO Y, 1994, ANN NEUROL, V35, P204, DOI 10.1002/ana.410350212; Nauser T, 2001, CHEM RES TOXICOL, V14, P348, DOI 10.1021/tx000236g; Nulton-Persson AC, 2001, J BIOL CHEM, V276, P23357, DOI 10.1074/jbc.M100320200; PADMAJA S, 1993, BIOCHEM BIOPH RES CO, V195, P539, DOI 10.1006/bbrc.1993.2079; Park LCH, 1999, J NEUROCHEM, V72, P1948, DOI 10.1046/j.1471-4159.1999.0721948.x; Park LCH, 2000, ANAL BIOCHEM, V277, P86, DOI 10.1006/abio.1999.4359; Park LCH, 2001, J NEUROSCI RES, V66, P1028, DOI 10.1002/jnr.10062; Perham RN, 1998, BIOCHEM SOC T, V26, P299, DOI 10.1042/bst0260299; PERHAM RN, 1991, BIOCHEMISTRY-US, V30, P8501, DOI 10.1021/bi00099a001; Petersen CAH, 2008, P NATL ACAD SCI USA, V105, P13145, DOI 10.1073/pnas.0806192105; PETTIT FH, 1973, J BIOL CHEM, V248, P5282; Piantadosi CA, 2008, CIRC RES, V103, P1232, DOI 10.1161/01.RES.0000338597.71702.ad; RAPOPORT SI, 1991, ADV EXP MED BIOL, V291, P231; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Shi Q, 2007, NEUROCHEM INT, V50, P921, DOI 10.1016/j.neuint.2007.03.010; Smallwood HS, 2007, BIOCHEMISTRY-US, V46, P10498, DOI 10.1021/bi7009713; SMITH GS, 1992, ARCH NEUROL-CHICAGO, V49, P1142, DOI 10.1001/archneur.1992.00530350056020; Smith MA, 2000, BBA-MOL BASIS DIS, V1502, P139, DOI 10.1016/S0925-4439(00)00040-5; Souza JM, 1999, ARCH BIOCHEM BIOPHYS, V371, P169, DOI 10.1006/abbi.1999.1480; Starkov AA, 2004, J NEUROSCI, V24, P7779, DOI 10.1523/JNEUROSCI.1899-04.2004; Torreilles F, 1999, BRAIN RES REV, V30, P153, DOI 10.1016/S0165-0173(99)00014-4; Ye YZ, 2007, J BIOL CHEM, V282, P6324, DOI 10.1074/jbc.M610800200; Yeh STY, 2006, TOXICOLOGY, V223, P181, DOI 10.1016/j.tox.2006.03.019	58	53	56	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17640	17648		10.1074/jbc.M110.203018	http://dx.doi.org/10.1074/jbc.M110.203018			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454586	Green Published, hybrid			2022-12-25	WOS:000290585200027
J	Liu, X; Hein, J; Richardson, SCW; Basse, PH; Toptan, T; Moore, PS; Gjoerup, OV; Chang, Y				Liu, Xi; Hein, Jennifer; Richardson, Simon C. W.; Basse, Per H.; Toptan, Tuna; Moore, Patrick S.; Gjoerup, Ole V.; Chang, Yuan			Merkel Cell Polyomavirus Large T Antigen Disrupts Lysosome Clustering by Translocating Human Vam6p from the Cytoplasm to the Nucleus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIMIAN-VIRUS-40 LARGE T; C-VPS COMPLEX; TUMOR-ANTIGEN; SV40-TRANSFORMED CELLS; CARCINOMA-CELLS; HOST PROTEIN; FUSION; TRANSFORMATION; BINDING; LOCALIZATION	Merkel cell polyomavirus (MCV) has been recently described as the cause for most human Merkel cell carcinomas. MCV is similar to simian virus 40 (SV40) and encodes a nuclear large T (LT) oncoprotein that is usually mutated to eliminate viral replication among tumor-derived MCV. We identified the hVam6p cytoplasmic protein involved in lysosomal processing as a novel interactor with MCV LT but not SV40 LT. hVam6p binds through its clathrin heavy chain homology domain to a unique region of MCV LT adjacent to the retinoblastoma binding site. MCV LT translocates hVam6p to the nucleus, sequestering it from involvement in lysosomal trafficking. A naturally occurring, tumor-derived mutant LT (MCV350) lacking a nuclear localization signal binds hVam6p but fails to inhibit hVam6p-induced lysosomal clustering. MCV has evolved a novel mechanism to target hVam6p that may contribute to viral uncoating or egress through lysosomal processing during virus replication.	[Liu, Xi; Hein, Jennifer; Toptan, Tuna; Moore, Patrick S.; Gjoerup, Ole V.; Chang, Yuan] Univ Pittsburgh, Canc Virol Program, Pittsburgh, PA 15213 USA; [Basse, Per H.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15213 USA; [Richardson, Simon C. W.] Univ Greenwich, Sch Sci, Dept Pharmaceut Chem & Environm Sci, Medway ME4 4TB, Kent, England	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Greenwich	Moore, PS (corresponding author), Univ Pittsburgh, Canc Virol Program, Pittsburgh, PA 15213 USA.	psm9@pitt.edu; ovg27@pitt.edu; yc70@pitt.edu	Richardson, Dr Simon/AAB-9516-2022; Toptan, Tuna/A-6721-2013; Moore, Patrick/GVR-8294-2022; Grabmair, Tuna Toptan/AAN-6129-2021; Toptan, Tuna/F-5503-2011; Moore, Patrick S./F-3960-2011; Richardson, Simon C/C-9049-2009; Chang, Yuan/F-4146-2011	Richardson, Dr Simon/0000-0002-7927-0649; Grabmair, Tuna Toptan/0000-0002-5399-9263; Moore, Patrick S./0000-0002-8132-858X; Richardson, Simon C/0000-0002-7927-0649; Chang, Yuan/0000-0003-1125-4041	National Institutes of Health [CA136363, CA120726, AI078926]; University of Pittsburg Cancer Institute [P30 CA047904]; Al Copeland Foundation for Merkel Cell Carcinoma Research; University of Pittsburgh; American Cancer Society; NATIONAL CANCER INSTITUTE [R01CA136363, R33CA120726, P30CA047904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078926] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pittsburg Cancer Institute; Al Copeland Foundation for Merkel Cell Carcinoma Research; University of Pittsburgh(University of Pittsburgh); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants CA136363, CA120726 (to P. S. M. and Y. C.), and AI078926 (to O. V. G.) and University of Pittsburg Cancer Institute Core Facility Cancer Center Support Grant (CCSG) P30 CA047904, the Al Copeland Foundation for Merkel Cell Carcinoma Research, the University of Pittsburgh EXPLORER program, and American Cancer Society Research Professorships (to P. S. M. and Y. C.).	Ali SH, 2004, J VIROL, V78, P2749, DOI 10.1128/JVI.78.6.2749-2757.2004; Binda M, 2009, MOL CELL, V35, P563, DOI 10.1016/j.molcel.2009.06.033; CAMPBELL KS, 1994, P NATL ACAD SCI USA, V91, P6344, DOI 10.1073/pnas.91.14.6344; Campbell KS, 1997, GENE DEV, V11, P1098, DOI 10.1101/gad.11.9.1098; Caplan S, 2001, J CELL BIOL, V154, P109, DOI 10.1083/jcb.200102142; Cote-Martin A, 2008, J VIROL, V82, P1271, DOI 10.1128/JVI.01405-07; Cotsiki M, 2004, P NATL ACAD SCI USA, V101, P947, DOI 10.1073/pnas.0308006100; DECAPRIO JA, 1988, CELL, V54, P275, DOI 10.1016/0092-8674(88)90559-4; DILWORTH SM, 1994, NATURE, V367, P87, DOI 10.1038/367087a0; Felici A, 2003, EMBO J, V22, P4465, DOI 10.1093/emboj/cdg428; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Flinn RJ, 2010, MOL BIOL CELL, V21, P833, DOI 10.1091/mbc.E09-09-0756; Hakki M, 2006, J VIROL, V80, P11817, DOI 10.1128/JVI.00957-06; Houben R, 2010, J VIROL, V84, P7064, DOI 10.1128/JVI.02400-09; LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0; Laude HC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001076; Li L, 2009, MOL CELL, V35, P543, DOI 10.1016/j.molcel.2009.08.010; Liang CY, 2008, NAT CELL BIOL, V10, P776, DOI 10.1038/ncb1740; LINZER DIH, 1979, CELL, V17, P43, DOI 10.1016/0092-8674(79)90293-9; Mannova P, 2003, J VIROL, V77, P1672, DOI 10.1128/JVI.77.3.1672-1681.2003; Nakamura N, 1997, J BIOL CHEM, V272, P11344; Nakamura T, 2010, VIROLOGY, V398, P273, DOI 10.1016/j.virol.2009.12.024; PALLAS DC, 1990, CELL, V60, P167, DOI 10.1016/0092-8674(90)90726-U; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Peralta ER, 2010, J BIOL CHEM, V285, P16814, DOI 10.1074/jbc.M110.111633; PIPAS JM, 1992, J VIROL, V66, P3979, DOI 10.1128/JVI.66.7.3979-3985.1992; Poupon V, 2003, MOL BIOL CELL, V14, P4015, DOI 10.1091/mbc.E03-01-0040; Price A, 2000, J CELL BIOL, V148, P1231, DOI 10.1083/jcb.148.6.1231; Qian MD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000465; Richardson SCW, 2004, MOL BIOL CELL, V15, P1197, DOI 10.1091/mbc.E03-06-0358; Schowalter RM, 2010, CELL HOST MICROBE, V7, P509, DOI 10.1016/j.chom.2010.05.006; Shuda M, 2008, P NATL ACAD SCI USA, V105, P16272, DOI 10.1073/pnas.0806526105; Shuda M, 2009, INT J CANCER, V125, P1243, DOI 10.1002/ijc.24510; Srinivasan A, 1997, MOL CELL BIOL, V17, P4761, DOI 10.1128/MCB.17.8.4761; Sukarieh R, 2010, J GEN VIROL, V91, P1224, DOI 10.1099/vir.0.018069-0; WHITMAN M, 1985, NATURE, V315, P239, DOI 10.1038/315239a0; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Wurmser AE, 2000, J CELL BIOL, V151, P551, DOI 10.1083/jcb.151.3.551	38	44	44	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17079	17090		10.1074/jbc.M110.192856	http://dx.doi.org/10.1074/jbc.M110.192856			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454559	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000290301900058
J	Winkler, I; Marx, AD; Lariviere, D; Heinze, RJ; Cristovao, M; Reumer, A; Curth, U; Sixma, TK; Friedhoff, P				Winkler, Ines; Marx, Andreas D.; Lariviere, Damien; Heinze, Roger J.; Cristovao, Michele; Reumer, Annet; Curth, Ute; Sixma, Titia K.; Friedhoff, Peter			Chemical Trapping of the Dynamic MutS-MutL Complex Formed in DNA Mismatch Repair in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE MSH2-MSH6; CONFORMATIONAL-CHANGES; CRYSTAL-STRUCTURE; ATPASE ACTIVITY; PROTEIN MUTS; BINDING; RECOGNITION; DOMAIN; HYDROLYSIS; INTERFACE	The ternary complex comprising MutS, MutL, and DNA is a key intermediate in DNA mismatch repair. We used chemical cross-linking and fluorescence resonance energy transfer (FRET) to study the interaction between MutS and MutL and to shed light onto the structure of this complex. Via chemical cross-linking, we could stabilize this dynamic complex and identify the structural features of key events in DNA mismatch repair. We could show that in the complex between MutS and MutL the mismatch-binding and connector domains of MutS are in proximity to the N-terminal ATPase domain of MutL. The DNA- and nucleotide-dependent complex formation could be monitored by FRET using single cysteine variants labeled in the connector domain of MutS and the transducer domain of MutL, respectively. In addition, we could trap MutS after an ATP-induced conformational change by an intramolecular cross-link between Cys-93 of the mismatch-binding domain and Cys-239 of the connector domain.	[Winkler, Ines; Marx, Andreas D.; Heinze, Roger J.; Cristovao, Michele; Friedhoff, Peter] Univ Giessen, Inst Biochem, D-35392 Giessen, Germany; [Lariviere, Damien] Fourmentin Guilbert Sci Fdn, F-93160 Noisy Le Grand, France; [Reumer, Annet; Sixma, Titia K.] Univ Amsterdam, Div Biochem, NL-1066 CX Amsterdam, Netherlands; [Reumer, Annet; Sixma, Titia K.] Univ Amsterdam, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands; [Curth, Ute] Hannover Med Sch, Inst Biophys Chem, D-30625 Hannover, Germany; [Cristovao, Michele] Erasmus MC, Dept Cell Biol & Genet, NL-3000 CA Rotterdam, Netherlands	Justus Liebig University Giessen; University of Amsterdam; University of Amsterdam; Hannover Medical School; Erasmus University Rotterdam; Erasmus MC	Friedhoff, P (corresponding author), Univ Giessen, Inst Biochem, Heinrich Buff Ring 58, D-35392 Giessen, Germany.	peter.friedhoff@chemie.bio.uni-giessen.de	Friedhoff, Peter/G-7905-2012	Friedhoff, Peter/0000-0003-1946-1117; Sixma, Titia K/0000-0001-6180-0632; Lariviere, Damien/0000-0002-0892-5118	European Community [HEALTH-F4-2008-223545]; Deutsche Forschungsgemeinschaft [GRK 1384]; Russian Foundation for Basic Research [RFBR-DFG 08-04-91973]	European Community(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This work was supported by European Community Seventh Framework Program FP7/2007-2013 under Grant HEALTH-F4-2008-223545 (to P. F., I. W., and R. J. H.), Deutsche Forschungsgemeinschaft Grant GRK 1384 "Enzymes and Multienzyme Complexes Acting on Nucleic Acids," and Russian Foundation for Basic Research Grant RFBR-DFG 08-04-91973 (to P. F. and A. D. M.).	Acharya S, 2003, MOL CELL, V12, P233, DOI 10.1016/S1097-2765(03)00219-3; Baitinger C, 2003, J BIOL CHEM, V278, P49505, DOI 10.1074/jbc.M308738200; Ban C, 1998, CELL, V95, P541, DOI 10.1016/S0092-8674(00)81621-9; Ban C, 1999, CELL, V97, P85, DOI 10.1016/S0092-8674(00)80717-5; Blackwell LJ, 2001, J BIOL CHEM, V276, P33233, DOI 10.1074/jbc.M105076200; Constantin N, 2005, J BIOL CHEM, V280, P39752, DOI 10.1074/jbc.M509701200; DRUMMOND JT, 1995, SCIENCE, V268, P1909, DOI 10.1126/science.7604264; DURCHSCHLAG H, 1986, THERMODYNAMIC DATA B, P45; FENG G, 1995, BIOTECHNIQUES, V19, P956; Giron-Monzon L, 2004, J BIOL CHEM, V279, P49338, DOI 10.1074/jbc.M409307200; Gradia S, 2000, J BIOL CHEM, V275, P3922, DOI 10.1074/jbc.275.6.3922; Gradia S, 1999, MOL CELL, V3, P255, DOI 10.1016/S1097-2765(00)80316-0; Green NS, 2001, PROTEIN SCI, V10, P1293, DOI 10.1110/ps.51201; Guarne A, 2004, EMBO J, V23, P4134, DOI 10.1038/sj.emboj.7600412; Hargreaves VV, 2010, J BIOL CHEM, V285, P9301, DOI 10.1074/jbc.M109.096388; Heinze RJ, 2009, NUCLEIC ACIDS RES, V37, P4453, DOI 10.1093/nar/gkp380; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jacobs-Palmer E, 2007, J MOL BIOL, V366, P1087, DOI 10.1016/j.jmb.2006.11.092; Jeong C, 2011, NAT STRUCT MOL BIOL, V18, P379, DOI 10.1038/nsmb.2009; Junop MS, 2003, DNA REPAIR, V2, P387, DOI 10.1016/S1568-7864(02)00245-8; Junop MS, 2001, MOL CELL, V7, P1, DOI 10.1016/S1097-2765(01)00149-6; Kato R, 2001, J MOL BIOL, V309, P227, DOI 10.1006/jmbi.2001.4752; Kirsch RD, 1998, NUCLEIC ACIDS RES, V26, P1848, DOI 10.1093/nar/26.7.1848; Kosinski J, 2005, J MOL BIOL, V351, P895, DOI 10.1016/j.jmb.2005.06.044; LAHUE RS, 1987, P NATL ACAD SCI USA, V84, P1482, DOI 10.1073/pnas.84.6.1482; Lamers MH, 2000, NATURE, V407, P711, DOI 10.1038/35037523; Lamers MH, 2004, J BIOL CHEM, V279, P43879, DOI 10.1074/jbc.M406380200; Lamers MH, 2003, EMBO J, V22, P746, DOI 10.1093/emboj/cdg064; Larrea AA, 2010, CELL, V141, DOI 10.1016/j.cell.2010.05.002; Lebbink JHG, 2006, EMBO J, V25, P409, DOI 10.1038/sj.emboj.7600936; Lebbink JHG, 2010, J BIOL CHEM, V285, P13131, DOI 10.1074/jbc.M109.066001; Lee JY, 2005, MOL CELL, V20, P155, DOI 10.1016/j.molcel.2005.08.019; LI GM, 1995, P NATL ACAD SCI USA, V92, P1950, DOI 10.1073/pnas.92.6.1950; Malkov VA, 1997, J BIOL CHEM, V272, P23811, DOI 10.1074/jbc.272.38.23811; Manelyte L, 2006, NUCLEIC ACIDS RES, V34, P5270, DOI 10.1093/nar/gkl489; Mendillo ML, 2007, J BIOL CHEM, V282, P16345, DOI 10.1074/jbc.M700858200; Mendillo ML, 2010, J BIOL CHEM, V285, P13170, DOI 10.1074/jbc.M110.108894; Mendillo ML, 2009, P NATL ACAD SCI USA, V106, P22223, DOI 10.1073/pnas.0912250106; Mendillo ML, 2005, J BIOL CHEM, V280, P22245, DOI 10.1074/jbc.M407545200; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Mukherjee S, 2009, BIOPHYS J, V96, pL63, DOI 10.1016/j.bpj.2009.04.012; Mukherjee S, 2009, BIOPHYS J, V96, P1707, DOI 10.1016/j.bpj.2008.10.071; Natrajan G, 2003, NUCLEIC ACIDS RES, V31, P4814, DOI 10.1093/nar/gkg677; Obmolova G, 2000, NATURE, V407, P703, DOI 10.1038/35037509; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pillon MC, 2010, MOL CELL, V39, P145, DOI 10.1016/j.molcel.2010.06.027; Plotz G, 2006, NUCLEIC ACIDS RES, V34, P6574, DOI 10.1093/nar/gkl944; Pluciennik A, 2007, P NATL ACAD SCI USA, V104, P12709, DOI 10.1073/pnas.0705129104; Polosina YY, 2010, BIOESSAYS, V32, P51, DOI 10.1002/bies.200900089; Ritchie DW, 2000, PROTEINS, V39, P178, DOI 10.1002/(SICI)1097-0134(20000501)39:2<178::AID-PROT8>3.3.CO;2-Y; Sacho EJ, 2008, MOL CELL, V29, P112, DOI 10.1016/j.molcel.2007.10.030; Schofield MJ, 2001, J BIOL CHEM, V276, P45505, DOI 10.1074/jbc.C100449200; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Stevens N, 2007, PHOTOCH PHOTOBIO SCI, V6, P909, DOI 10.1039/b702631e; Thomas E, 2002, BIOL CHEM, V383, P1459, DOI 10.1515/BC.2002.166; Toedt GH, 2003, NUCLEIC ACIDS RES, V31, P819, DOI 10.1093/nar/gkg191; Wang H, 2003, P NATL ACAD SCI USA, V100, P14822, DOI 10.1073/pnas.2433654100; Warren JJ, 2007, MOL CELL, V26, P579, DOI 10.1016/j.molcel.2007.04.018; Yamamoto A, 2000, NUCLEIC ACIDS RES, V28, P3564, DOI 10.1093/nar/28.18.3564; Zhai J, 2010, P NATL ACAD SCI USA, V107, P680, DOI 10.1073/pnas.0908302107; Zhang YB, 2005, CELL, V122, P693, DOI 10.1016/j.cell.2005.06.027	61	40	41	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17326	17337		10.1074/jbc.M110.187641	http://dx.doi.org/10.1074/jbc.M110.187641			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454657	Green Published, hybrid			2022-12-25	WOS:000290301900080
J	Morris, VK; Ren, Q; Macindoe, I; Kwan, AH; Byrne, N; Sunde, M				Morris, Vanessa K.; Ren, Qin; Macindoe, Ingrid; Kwan, Ann H.; Byrne, Nolene; Sunde, Margaret			Recruitment of Class I Hydrophobins to the Air: Water Interface Initiates a Multi-step Process of Functional Amyloid Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE-TENSION; IONIC LIQUIDS; SALMONELLA-ENTERITIDIS; RECOMBINANT PROTEINS; AGGREGATIVE FIMBRIAE; FUNGAL HYDROPHOBINS; RODLET LAYER; PURIFICATION; HFBI; DENATURATION	Class I fungal hydrophobins form amphipathic monolayers composed of amyloid rodlets. This is a remarkable case of functional amyloid formation in that a hydrophobic: hydrophilic interface is required to trigger the self-assembly of the proteins. The mechanism of rodlet formation and the role of the interface in this process have not been well understood. Here, we have studied the effect of a range of additives, including ionic liquids, alcohols, and detergents, on rodlet formation by two class I hydrophobins, EAS and DewA. Although the conformation of the hydrophobins in these different solutions is not altered, we observe that the rate of rodlet formation is slowed as the surface tension of the solution is decreased, regardless of the nature of the additive. These results suggest that interface properties are of critical importance for the recruitment, alignment, and structural rearrangement of the amphipathic hydrophobin monomers. This work gives insight into the forces that drive macromolecular assembly of this unique family of proteins and allows us to propose a three-stage model for the interface-driven formation of rodlets.	[Morris, Vanessa K.; Ren, Qin; Macindoe, Ingrid; Kwan, Ann H.; Sunde, Margaret] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Byrne, Nolene] Deakin Univ, Ctr Mat & Fibre Innovat, Geelong, Vic 3217, Australia	University of Sydney; Deakin University	Sunde, M (corresponding author), Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia.	margaret.sunde@sydney.edu.au	Morris, Vanessa/AAS-2599-2020; Sunde, Margaret/A-5186-2016; Sunde, Margaret/ABH-2584-2020	Morris, Vanessa/0000-0003-3538-0093; Sunde, Margaret/0000-0002-0150-3203; Sunde, Margaret/0000-0002-0150-3203; Kwan, Ann/0000-0002-1506-2226	Australian Research Council [LP0776672]; Australian Postdoctoral Fellowship; National Health and Medical Research Council	Australian Research Council(Australian Research Council); Australian Postdoctoral Fellowship; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Australian Research Council for Linkage Grant LP0776672 (to M. S. and A. H. K.), the Australian Postdoctoral Fellowship (to N. B.), and the National Health and Medical Research Council RD Wright Career Development Fellowship (to M. S.).	Aimanianda V, 2009, NATURE, V460, P1117, DOI 10.1038/nature08264; Akanbi MHJ, 2010, COLLOID SURFACE B, V75, P526, DOI 10.1016/j.colsurfb.2009.09.030; Arakawa T, 2007, BIOPHYS CHEM, V131, P62, DOI 10.1016/j.bpc.2007.09.004; BEEVER RE, 1979, J BACTERIOL, V140, P1063, DOI 10.1128/JB.140.3.1063-1070.1979; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Butko P, 2001, BIOCHEM BIOPH RES CO, V280, P212, DOI 10.1006/bbrc.2000.4098; Byrne N, 2009, CHEM COMMUN, P1046, DOI 10.1039/b817590j; Catanzariti AM, 2004, PROTEIN SCI, V13, P1331, DOI 10.1110/ps.04618904; Chen F, 2008, J PHYS CHEM B, V112, P8975, DOI 10.1021/jp711062a; COLLINSON SK, 1991, J BACTERIOL, V173, P4773, DOI 10.1128/jb.173.15.4773-4781.1991; Fujita K, 2005, CHEM COMMUN, P4804, DOI 10.1039/b508238b; Gibson DL, 2007, MICROBIOL-SGM, V153, P1131, DOI 10.1099/mic.0.2006/000935-0; Gidalevitz D, 1999, P NATL ACAD SCI USA, V96, P2608, DOI 10.1073/pnas.96.6.2608; Greaves TL, 2008, CHEM SOC REV, V37, P1709, DOI 10.1039/b801395k; Hoernke M, 2010, BIOPHYS CHEM, V150, P64, DOI 10.1016/j.bpc.2010.02.014; Hoshino M, 2007, BBA-BIOMEMBRANES, V1768, P1886, DOI 10.1016/j.bbamem.2007.03.001; Hwang H, 2009, ANAL BIOCHEM, V386, P293, DOI 10.1016/j.ab.2008.12.019; JANCZUK B, 1995, LANGMUIR, V11, P4515, DOI 10.1021/la00011a055; Jean L, 2010, FASEB J, V24, P309, DOI 10.1096/fj.09-137653; Joensuu JJ, 2010, PLANT PHYSIOL, V152, P622, DOI 10.1104/pp.109.149021; Kalhor HR, 2009, BIOMACROMOLECULES, V10, P2468, DOI 10.1021/bm900428q; Kwan AHY, 2006, P NATL ACAD SCI USA, V103, P3621, DOI 10.1073/pnas.0505704103; Kwan AH, 2008, J MOL BIOL, V382, P708, DOI 10.1016/j.jmb.2008.07.034; Lahtinen T, 2008, PROTEIN EXPRES PURIF, V59, P18, DOI 10.1016/j.pep.2007.12.014; Li XX, 2009, COLLOID SURFACE B, V74, P370, DOI 10.1016/j.colsurfb.2009.07.039; Linder M, 2001, BIOMACROMOLECULES, V2, P511, DOI 10.1021/bm0001493; Linder MB, 2005, FEMS MICROBIOL REV, V29, P877, DOI 10.1016/j.femsre.2005.01.004; Mackay JP, 2001, STRUCTURE, V9, P83, DOI 10.1016/S0969-2126(00)00559-1; Martin M, 2006, CHEM ENG SCI, V61, P5196, DOI 10.1016/j.ces.2006.03.027; Morinaga A, 2010, BBA-PROTEINS PROTEOM, V1804, P986, DOI 10.1016/j.bbapap.2010.01.012; Niga P, 2010, LANGMUIR, V26, P8282, DOI 10.1021/la904697g; Pegram LM, 2007, J PHYS CHEM B, V111, P5411, DOI 10.1021/jp070245z; Scholtmeijer K, 2004, BIO-MED MATER ENG, V14, P447; Sen P, 2008, J PHYS CHEM B, V112, P13473, DOI 10.1021/jp8061288; STRINGER MA, 1991, GENE DEV, V5, P1161, DOI 10.1101/gad.5.7.1161; STRINGER MA, 1995, MOL MICROBIOL, V16, P33, DOI 10.1111/j.1365-2958.1995.tb02389.x; Summers CA, 2000, PROTEIN SCI, V9, P2001, DOI 10.1110/ps.9.10.2001; Sunde M, 2008, MICRON, V39, P773, DOI 10.1016/j.micron.2007.08.003; Talbot NJ, 1997, CURR BIOL, V7, pR78, DOI 10.1016/S0960-9822(06)00041-8; Talbot NJ, 2003, CURR BIOL, V13, pR696, DOI 10.1016/j.cub.2003.08.040; Valo HK, 2010, ACS NANO, V4, P1750, DOI 10.1021/nn9017558; VAZQUEZ G, 1995, J CHEM ENG DATA, V40, P611, DOI 10.1021/je00019a016; Wang X, 2005, BIOPHYS J, V88, P3434, DOI 10.1529/biophysj.104.057794; Wang XS, 2010, BIOSENS BIOELECTRON, V26, P1104, DOI 10.1016/j.bios.2010.08.024; Wessels JGH, 1996, TRENDS PLANT SCI, V1, P9, DOI 10.1016/S1360-1385(96)80017-3; Wosten HAB, 2000, BBA-REV BIOMEMBRANES, V1469, P79, DOI 10.1016/S0304-4157(00)00002-2; WOSTEN HAB, 1993, PLANT CELL, V5, P1567; Wosten HAB, 2001, ANNU REV MICROBIOL, V55, P625, DOI 10.1146/annurev.micro.55.1.625; Xiong RQ, 2007, J MICROMECH MICROENG, V17, P1002, DOI 10.1088/0960-1317/17/5/021	49	57	60	0	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18					15955	15963		10.1074/jbc.M110.214197	http://dx.doi.org/10.1074/jbc.M110.214197			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454575	Green Published, hybrid			2022-12-25	WOS:000290022800035
J	Paratkar, S; Deshpande, AP; Tang, GQ; Patel, SS				Paratkar, Swaroopa; Deshpande, Aishwarya P.; Tang, Guo-Qing; Patel, Smita S.			The N-terminal Domain of the Yeast Mitochondrial RNA Polymerase Regulates Multiple Steps of Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROMOTER RECOGNITION; SPECIFICITY FACTOR; SACCHAROMYCES-CEREVISIAE; INITIATION; PURIFICATION; ELONGATION; TRANSITION; EXPRESSION; CLEARANCE; MECHANISM	Transcription of the yeast (Saccharomyces cerevisiae) mitochondrial (mt) genome is catalyzed by nuclear-encoded proteins that include the core RNA polymerase (RNAP) subunit Rpo41 and the transcription factor Mtf1. Rpo41 is homologous to the single-subunit bacteriophage T7/T3 RNAP. Its similar to 80-kDa C-terminal domain is highly conserved among mt RNAPs, but its similar to 50-kDa N-terminal domain (NTD) is less conserved and not present in T7/T3 RNAP. To understand the role of the NTD, we have biochemically characterized a series of NTD deletion mutants of Rpo41. Our studies show that NTD regulates multiple steps of transcription initiation. Interestingly, NTD functions in an autoinhibitory manner during initiation, and its partial deletion increases the efficiency of RNA synthesis. Deletion of 1-270 amino acids (DN270) reduces abortive synthesis and increases full-length to abortive RNA ratio relative to full-length (FL) Rpo41. A larger deletion of 1-380 amino acids (DN380), decreases RNA synthesis on duplex but not on premelted promoter. We show that DN380 is defective in promoter opening near the transcription start site. Most strikingly, both DN270 and DN380 catalyze highly processive RNA synthesis on the premelted promoter, and unlike the FL Rpo41, the mutants are not inhibited by Mtf1. Both mutants show weaker interactions with Mtf1, which explains many of our results, and particularly the ability of the mutants to efficiently transition from initiation to elongation. We propose that in vivo the accessory proteins that bind NTD may modulate interactions of Rpo41 with the promoter/Mtf1 to activate and allow timely release from Mtf1 for transition into elongation.	[Paratkar, Swaroopa; Deshpande, Aishwarya P.; Tang, Guo-Qing; Patel, Smita S.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Patel, SS (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA.	patelss@umdnj.edu			National Institutes of Health [GM51966]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051966, R37GM051966] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM51966.	Bandwar RP, 2006, J MOL BIOL, V360, P466, DOI 10.1016/j.jmb.2006.05.029; Cermakian N, 1996, NUCLEIC ACIDS RES, V24, P648, DOI 10.1093/nar/24.4.648; Cliften PF, 1997, GENE DEV, V11, P2897, DOI 10.1101/gad.11.21.2897; Dvir A, 2002, BBA-GENE STRUCT EXPR, V1577, P208, DOI 10.1016/S0167-4781(02)00453-0; GRALLA JD, 1980, BIOCHEMISTRY-US, V19, P5864, DOI 10.1021/bi00566a031; Guo Q, 2005, J BIOL CHEM, V280, P3474, DOI 10.1074/jbc.M412287200; HALLER I, 1974, P NATL ACAD SCI USA, V71, P2018, DOI 10.1073/pnas.71.5.2018; Hsu LM, 2002, BBA-GENE STRUCT EXPR, V1577, P191, DOI 10.1016/S0167-4781(02)00452-9; JAEHNING JA, 1993, MOL MICROBIOL, V8, P1, DOI 10.1111/j.1365-2958.1993.tb01197.x; JANG SH, 1991, J BIOL CHEM, V266, P22671; Kravchenko JE, 2005, NATURE, V436, P735, DOI 10.1038/nature03848; LEVENS D, 1981, J BIOL CHEM, V256, P1474; Lightowlers Robert N, 2008, Biochem J, V416, pe5, DOI 10.1042/BJ20081942; Lipinski KA, 2010, BBA-BIOENERGETICS, V1797, P1086, DOI 10.1016/j.bbabio.2009.12.019; Liu CH, 2002, J BIOL CHEM, V277, P2725, DOI 10.1074/jbc.M108856200; MANGUS DA, 1994, J BIOL CHEM, V269, P26568; Markov DA, 2009, YEAST, V26, P423, DOI 10.1002/yea.1672; MASTERS BS, 1987, CELL, V51, P89, DOI 10.1016/0092-8674(87)90013-4; Matsunaga M, 2004, J BIOL CHEM, V279, P44239, DOI 10.1074/jbc.C400384200; Matsunaga M, 2004, PROTEIN EXPRES PURIF, V35, P126, DOI 10.1016/j.pep.2003.12.022; Mooney RA, 2005, MOL CELL, V20, P335, DOI 10.1016/j.molcel.2005.10.015; Nayak D, 2009, J BIOL CHEM, V284, P13641, DOI 10.1074/jbc.M900718200; Paratkar S, 2010, J BIOL CHEM, V285, P3949, DOI 10.1074/jbc.M109.050732; Rodeheffer MS, 2003, J BIOL CHEM, V278, P18695, DOI 10.1074/jbc.M301399200; Rodeheffer MS, 2001, J BIOL CHEM, V276, P8616, DOI 10.1074/jbc.M009901200; Savkina M, 2010, J BIOL CHEM, V285, P3957, DOI 10.1074/jbc.M109.051003; SCHINKEL AH, 1987, J BIOL CHEM, V262, P12785; SCHINKEL AH, 1988, EMBO J, V7, P3255, DOI 10.1002/j.1460-2075.1988.tb03192.x; Schubot FD, 2001, PROTEIN SCI, V10, P1980, DOI 10.1110/ps.11201; Shutt TE, 2010, P NATL ACAD SCI USA, V107, P12133, DOI 10.1073/pnas.0910581107; Sologub M, 2009, CELL, V139, P934, DOI 10.1016/j.cell.2009.10.031; Tahirov TH, 2002, NATURE, V420, P43, DOI 10.1038/nature01129; Tang GQ, 2009, P NATL ACAD SCI USA, V106, P22175, DOI 10.1073/pnas.0906979106; Tang GQ, 2009, J BIOL CHEM, V284, P5514, DOI 10.1074/jbc.M807880200; Temiakov D, 2000, P NATL ACAD SCI USA, V97, P14109, DOI 10.1073/pnas.250473197; Wang YH, 1999, P NATL ACAD SCI USA, V96, P8046, DOI 10.1073/pnas.96.14.8046; Xu F, 2008, BIOCHEM J, V416, P15, DOI 10.1042/BJ20080847; Yin YW, 2002, SCIENCE, V298, P1387, DOI 10.1126/science.1077464	38	15	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M111.228023	http://dx.doi.org/10.1074/jbc.M111.228023			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454631	hybrid, Green Published			2022-12-25	WOS:000290022800051
J	Xu, YR; Xia, W; Baker, D; Zhou, J; Cha, HC; Voorhees, JJ; Fisher, GJ				Xu, Yiru; Xia, Wei; Baker, Dustin; Zhou, Jin; Cha, Hyuk Chol; Voorhees, John J.; Fisher, Gary J.			Receptor-type Protein Tyrosine Phosphatase beta (RPTP-beta) Directly Dephosphorylates and Regulates Hepatocyte Growth Factor Receptor (HGFR/Met) Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR SCATTER FACTOR; SMALL-MOLECULE INHIBITOR; HUMAN ENDOTHELIAL-CELLS; C-MET; HUMAN KERATINOCYTES; TPR-MET; FACTOR/SCATTER FACTOR; SIGNAL-TRANSDUCTION; EPITHELIAL-CELLS; MAP KINASES	Protein tyrosine phosphorylation is a ubiquitous, fundamental biochemical mechanism that regulates essential eukaryotic cellular functions. The level of tyrosine phosphorylation of specific proteins is finely tuned by the dynamic balance between protein tyrosine kinase and protein tyrosine phosphatase activities. Hepatocyte growth factor receptor (also known as Met), a receptor protein tyrosine kinase, is a major regulator of proliferation, migration, and survival for many epithelial cell types. Wereport here that receptor-type protein tyrosine phosphatase beta (RPTP-beta) specifically dephosphorylates Met and thereby regulates its function. Expression of RPTP-beta, but not other RPTP family members or catalytically inactive forms of RPTP-beta, reduces hepatocyte growth factor (HGF)-stimulated Met tyrosine phosphorylation in HEK293 cells. Expression of RPTP-beta in primary human keratinocytes reduces both basal and HGF-induced Met phosphorylation at tyrosine 1356 and inhibits downstream MEK1/2 and Erk activation. Furthermore, shRNA-mediated knockdown of endogenous RPTP-beta increases basal and HGF-stimulated Met phosphorylation at tyrosine 1356 in primary human keratinocytes. Purified RPTP-beta intracellular domain preferentially dephosphorylates purified Met at tyrosine 1356 in vitro. In addition, the substrate-trapping mutant of RPTP-beta specifically interacts with Met in intact cells. Expression of RPTP-beta in human primary keratinocytes reduces HGF induction of VEGF expression, proliferation, and motility. Taken together, the above data indicate that RPTP-beta is a key regulator of Met function.	[Xu, Yiru; Fisher, Gary J.] Univ Michigan, Sch Med, Dept Dermatol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Xu, YR (corresponding author), Univ Michigan, Sch Med, Dept Dermatol, Rm 6447,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	xuyiru@umich.edu; dianemch@umich.edu	Voorhees, John/AAM-9966-2020	Voorhees, John/0000-0003-1856-785X; Baker, Dustin/0000-0002-1339-9677	National Institutes of Health [5R01 ES012920]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012920] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health 5R01 ES012920 (to G. J. F.).	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; Bachleitner-Hofmann T, 2008, MOL CANCER THER, V7, P3499, DOI 10.1158/1535-7163.MCT-08-0374; Baumer S, 2006, BLOOD, V107, P4754, DOI 10.1182/blood-2006-01-0141; Berra E, 2000, CANCER METAST REV, V19, P139, DOI 10.1023/A:1026506011458; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Byon JCH, 1997, P SOC EXP BIOL MED, V216, P1; Chmielowiec J, 2007, J CELL BIOL, V177, P151, DOI 10.1083/jcb.200701086; Christensen JG, 2003, CANCER RES, V63, P7345; COOPER CS, 1984, NATURE, V311, P29, DOI 10.1038/311029a0; Dominguez MG, 2007, P NATL ACAD SCI USA, V104, P3243, DOI 10.1073/pnas.0611510104; FERRACINI R, 1991, J BIOL CHEM, V266, P19558; Fischer EH, 1999, ADV ENZYME REGUL, V39, P359, DOI 10.1016/S0065-2571(98)00014-4; FIXMAN ED, 1995, ONCOGENE, V10, P237; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Furge KA, 2000, ONCOGENE, V19, P5582, DOI 10.1038/sj.onc.1203859; Gentile A, 2008, CANCER METAST REV, V27, P85, DOI 10.1007/s10555-007-9107-6; GERARD R, 1995, DNA CLONING PRACTICA, P300; HARDER KW, 1994, BIOCHEM J, V298, P395, DOI 10.1042/bj2980395; HARDER KW, 1992, CYTOGENET CELL GENET, V61, P269, DOI 10.1159/000133419; Heinrich R, 2002, MOL CELL, V9, P957, DOI 10.1016/S1097-2765(02)00528-2; Hornberg JJ, 2005, FEBS J, V272, P244, DOI 10.1111/j.1432-1033.2004.04404.x; Hui B, 2006, J NEUROCHEM, V97, P334, DOI 10.1111/j.1471-4159.2006.03698.x; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Jeffers M, 1996, J MOL MED-JMM, V74, P505, DOI 10.1007/BF00204976; Jo MJ, 2000, J BIOL CHEM, V275, P8806, DOI 10.1074/jbc.275.12.8806; KAPLAN R, 1990, P NATL ACAD SCI USA, V87, P7000, DOI 10.1073/pnas.87.18.7000; KRUEGER NX, 1990, EMBO J, V9, P3241, DOI 10.1002/j.1460-2075.1990.tb07523.x; Li LW, 2000, SEMIN IMMUNOL, V12, P75, DOI 10.1006/smim.2000.0209; Lindner G, 2000, FASEB J, V14, P319, DOI 10.1096/fasebj.14.2.319; LONGATI P, 1994, ONCOGENE, V9, P49; Maalouf S, 2002, MOL CARCINOGEN, V34, P121, DOI 10.1002/mc.10055; Machide M, 2006, J BIOL CHEM, V281, P8765, DOI 10.1074/jbc.M512298200; MATSUMOTO K, 1991, EXP CELL RES, V196, P114, DOI 10.1016/0014-4827(91)90462-4; MAURO LJ, 1994, TRENDS BIOCHEM SCI, V19, P151, DOI 10.1016/0968-0004(94)90274-7; Mazzone M, 2006, FASEB J, V20, P1611, DOI 10.1096/fj.06-5947rev; Michiels C, 2001, IUBMB LIFE, V52, P49, DOI 10.1080/15216540252774766; Moriyama T, 1998, BIOCHEM BIOPH RES CO, V249, P73, DOI 10.1006/bbrc.1998.9078; NAKAMURA T, 1989, NATURE, V342, P440, DOI 10.1038/342440a0; NALDINI L, 1991, MOL CELL BIOL, V11, P1793, DOI 10.1128/MCB.11.4.1793; Nayeri F, 2006, J DERMATOL SCI, V43, P49, DOI 10.1016/j.jdermsci.2006.03.004; Palka HL, 2003, J BIOL CHEM, V278, P5728, DOI 10.1074/jbc.M210656200; PARK M, 1987, P NATL ACAD SCI USA, V84, P6379, DOI 10.1073/pnas.84.18.6379; Peschard P, 2007, ONCOGENE, V26, P1276, DOI 10.1038/sj.onc.1210201; PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2; Puri N, 2007, CANCER RES, V67, P3529, DOI 10.1158/0008-5472.CAN-06-4416; RUBIN JS, 1993, BIOCHIM BIOPHYS ACTA, V1155, P357, DOI 10.1016/0304-419X(93)90015-5; Sangwan V, 2008, J BIOL CHEM, V283, P34374, DOI 10.1074/jbc.M805916200; SATO C, 1995, J INVEST DERMATOL, V104, P958, DOI 10.1111/1523-1747.ep12606221; SHIMAOKA S, 1995, J CELL PHYSIOL, V165, P333, DOI 10.1002/jcp.1041650214; SORIANO JV, 1995, J CELL SCI, V108, P413; Stuart KA, 2000, INT J EXP PATHOL, V81, P17, DOI 10.1046/j.1365-2613.2000.00138.x; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tonks NK, 2001, CURR OPIN CELL BIOL, V13, P182, DOI 10.1016/S0955-0674(00)00196-4; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; WANG Y, 1992, J BIOL CHEM, V267, P16696; WEIDNER KM, 1993, J CELL BIOL, V121, P145, DOI 10.1083/jcb.121.1.145; Wojta J, 1999, LAB INVEST, V79, P427; Xu YR, 2005, J BIOL CHEM, V280, P42694, DOI 10.1074/jbc.M507722200; Yacyshyn OK, 2009, ANGIOGENESIS, V12, P25, DOI 10.1007/s10456-008-9126-0; Yoshida S, 2003, J INVEST DERMATOL, V120, P335, DOI 10.1046/j.1523-1747.2003.12039.x; You WK, 2008, BMB REP, V41, P833, DOI 10.5483/BMBRep.2008.41.12.833; Yu J, 2000, CANCER-AM CANCER SOC, V88, P1801, DOI 10.1002/(SICI)1097-0142(20000415)88:8<1801::AID-CNCR7>3.0.CO;2-U; ZHU H, 1994, J BIOL CHEM, V269, P29943	64	18	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.212597	http://dx.doi.org/10.1074/jbc.M110.212597			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454675	Green Published, hybrid			2022-12-25	WOS:000290022800038
J	Scarisbrick, IA; Epstein, B; Cloud, BA; Yoon, H; Wu, JM; Renner, DN; Blaber, SI; Blaber, M; Vandell, AG; Bryson, AL				Scarisbrick, Isobel A.; Epstein, Benjamin; Cloud, Beth A.; Yoon, Hyesook; Wu, Jianmin; Renner, Danielle N.; Blaber, Sachiko I.; Blaber, Michael; Vandell, Alexander G.; Bryson, Alexandra L.			Functional Role of Kallikrein 6 in Regulating Immune Cell Survival	PLOS ONE			English	Article							PROTEINASE-ACTIVATED RECEPTORS; FAMILY-MEMBER BIM; INDUCED APOPTOSIS; DIFFERENTIAL EXPRESSION; MULTIPLE-SCLEROSIS; TISSUE KALLIKREINS; SERINE-PROTEASE; CANCER CELLS; SPINAL-CORD; DEATH	Background: Kallikrein 6 (KLK6) is a newly identified member of the kallikrein family of secreted serine proteases that prior studies indicate is elevated at sites of central nervous system (CNS) inflammation and which shows regulated expression with T cell activation. Notably, KLK6 is also elevated in the serum of multiple sclerosis (MS) patients however its potential roles in immune function are unknown. Herein we specifically examine whether KLK6 alters immune cell survival and the possible mechanism by which this may occur. Methodology/Principal Findings: Using murine whole splenocyte preparations and the human Jurkat T cell line we demonstrate that KLK6 robustly supports cell survival across a range of cell death paradigms. Recombinant KLK6 was shown to significantly reduce cell death under resting conditions and in response to camptothecin, dexamethasone, staurosporine and Fas-ligand. Moreover, KLK6-over expression in Jurkat T cells was shown to generate parallel pro-survival effects. In mixed splenocyte populations the vigorous immune cell survival promoting effects of KLK6 were shown to include both T and B lymphocytes, to occur with as little as 5 minutes of treatment, and to involve up regulation of the pro-survival protein B-cell lymphoma-extra large (Bcl-XL), and inhibition of the pro-apoptotic protein Bcl-2-interacting mediator of cell death (Bim). The ability of KLK6 to promote survival of splenic T cells was also shown to be absent in cell preparations derived from PAR1 deficient mice. Conclusion/Significance: KLK6 promotes lymphocyte survival by a mechanism that depends in part on activation of PAR1. These findings point to a novel molecular mechanism regulating lymphocyte survival that is likely to have relevance to a range of immunological responses that depend on apoptosis for immune clearance and maintenance of homeostasis.	[Scarisbrick, Isobel A.; Epstein, Benjamin; Yoon, Hyesook; Wu, Jianmin; Renner, Danielle N.; Vandell, Alexander G.; Bryson, Alexandra L.] Mayo Med & Grad Sch, Neurobiol Dis Program, Rochester, MN 55905 USA; [Scarisbrick, Isobel A.; Cloud, Beth A.; Vandell, Alexander G.] Mayo Med & Grad Sch, Dept Phys Med & Rehabil, Rochester, MN USA; [Scarisbrick, Isobel A.] Mayo Med & Grad Sch, Dept Neurol, Rochester, MN USA; [Blaber, Sachiko I.; Blaber, Michael] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; State University System of Florida; Florida State University	Scarisbrick, IA (corresponding author), Mayo Med & Grad Sch, Neurobiol Dis Program, Rochester, MN 55905 USA.	Scarisbrick.Isobel@Mayo.edu	Blaber, Michael/E-7478-2011; Blaber, Michael/ABA-5031-2021; Blaber, Michael/N-1083-2019	Blaber, Michael/0000-0002-6856-1643; Cloud-Biebl, Beth/0000-0001-9121-1820	Mayo Collaborative MS [CA1060A11-02]; Christopher and Dana Reeve Foundation; NCI [P50CA108961]; National Institutes of Health [NS052741, R15NS057771]; National Multiple Sclerosis Society [RG3367]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052741, R15NS057771] Funding Source: NIH RePORTER	Mayo Collaborative MS; Christopher and Dana Reeve Foundation; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Mayo Collaborative MS Research Award CA1060A11-02, the Christopher and Dana Reeve Foundation and NCI P50CA108961, National Institutes of Health Grants NS052741 and R15NS057771 (http://www.nih.gov/) and the National Multiple Sclerosis Society Grants RG3367 (http://www.nationalmssociety.org/index.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTIERI DC, 1994, CELL IMMUNOL, V155, P372, DOI 10.1006/cimm.1994.1130; Angelo PF, 2006, J BIOL CHEM, V281, P3116, DOI 10.1074/jbc.M510096200; Anisowicz A, 1996, MOL MED, V2, P624, DOI 10.1007/BF03401646; ASHWELL JD, 1987, J EXP MED, V165, P173, DOI 10.1084/jem.165.1.173; Bernett MJ, 2002, J BIOL CHEM, V277, P24562, DOI 10.1074/jbc.M202392200; Blaber SI, 2004, FASEB J, V18, P920, DOI 10.1096/fj.03-1212fje; Blaber SI, 2002, BIOCHEMISTRY-US, V41, P1165, DOI 10.1021/bi015781a; Borgono CA, 2004, MOL CANCER RES, V2, P257; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Brenner D, 2009, CURR OPIN CELL BIOL, V21, P871, DOI 10.1016/j.ceb.2009.09.004; BROWN DG, 1993, J BIOL CHEM, V268, P3037; Chae HJ, 2000, PHARMACOL RES, V42, P373, DOI 10.1006/phrs.2000.0700; Chalmers CJ, 2003, BIOCHEM J, V375, P99, DOI 10.1042/BJ20030346; Chen D, 2004, P NATL ACAD SCI USA, V101, P1235, DOI 10.1073/pnas.0308050100; Christophi GP, 2004, J NEUROCHEM, V91, P1439, DOI 10.1111/j.1471-4159.2004.02826.x; Clements J, 2001, BIOL CHEM, V382, P5, DOI 10.1515/BC.2001.002; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Colognato R, 2003, BLOOD, V102, P2645, DOI 10.1182/blood-2002-08-2497; Coughlin SR, 2003, J CLIN INVEST, V111, P25, DOI 10.1172/JCI200317564; Cunningham MA, 2000, J EXP MED, V191, P455, DOI 10.1084/jem.191.3.455; Diamandis EP, 2000, CLIN BIOCHEM, V33, P579, DOI 10.1016/S0009-9120(00)00182-X; Eischen CM, 1997, BLOOD, V90, P935, DOI 10.1182/blood.V90.3.935.935_935_943; Enders A, 2003, J EXP MED, V198, P1119, DOI 10.1084/jem.20030411; Ferraro C, 2000, CELL DEATH DIFFER, V7, P197, DOI 10.1038/sj.cdd.4400595; Ferrell WR, 2003, J CLIN INVEST, V111, P35, DOI 10.1172/JCI200316913; Fields RC, 2003, AM J PATHOL, V162, P1817, DOI 10.1016/S0002-9440(10)64316-7; Han MH, 2008, NATURE, V451, P1076, DOI 10.1038/nature06559; Hildeman DA, 2002, IMMUNITY, V16, P759, DOI 10.1016/S1074-7613(02)00322-9; KAUFMANN SH, 1993, CANCER RES, V53, P3976; Kawagoe J, 2002, JPN J PHARMACOL, V88, P77, DOI 10.1254/jjp.88.77; Kouzaki H, 2009, J IMMUNOL, V183, P1427, DOI 10.4049/jimmunol.0900904; Laxmikanthan G, 2005, PROTEINS, V58, P802, DOI 10.1002/prot.20368; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Li T, 2006, SCAND J IMMUNOL, V64, P10, DOI 10.1111/j.1365-3083.2006.01772.x; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; Malamud V, 2003, J NEUROIMMUNOL, V138, P115, DOI 10.1016/S0165-5728(03)00090-0; Mitsui S, 2002, ANN NY ACAD SCI, V977, P216, DOI 10.1111/j.1749-6632.2002.tb04818.x; Noorbakhsh F, 2006, J EXP MED, V203, P425, DOI 10.1084/jem.20052148; Oikonomopoulou K, 2006, BIOL CHEM, V387, P817, DOI 10.1515/BC.2006.104; Oikonomopoulou K, 2006, J BIOL CHEM, V281, P32095, DOI 10.1074/jbc.M513138200; Pellegrini M, 2003, P NATL ACAD SCI USA, V100, P14175, DOI 10.1073/pnas.2336198100; Ruckert F, 2008, BRIT J CANCER, V99, P1484, DOI 10.1038/sj.bjc.6604717; Scarisbrick IA, 2006, J NEUROIMMUNOL, V178, P167, DOI 10.1016/j.jneuroim.2006.05.022; Scarisbrick IA, 2006, EUR J NEUROSCI, V24, P1457, DOI 10.1111/j.1460-9568.2006.05021.x; Scarisbrick IA, 2002, BRAIN, V125, P1283, DOI 10.1093/brain/awf142; Scarisbrick IA, 1997, J NEUROSCI, V17, P8156; Scarisbrick IA, 2008, BIOL CHEM, V389, P739, DOI 10.1515/BC.2008.085; Shpacovitch V, 2008, J LEUKOCYTE BIOL, V83, P1309, DOI 10.1189/jlb.0108001; Song Q, 1996, CLIN EXP HYPERTENS, V18, P975, DOI 10.3109/10641969609081030; Steinhoff M, 2005, ENDOCR REV, V26, P1, DOI 10.1210/er.2003-0025; Tantivejkul K, 2005, J CELL BIOCHEM, V96, P641, DOI 10.1002/jcb.20533; Vandell AG, 2008, J NEUROCHEM, V107, P855, DOI 10.1111/j.1471-4159.2008.05658.x; Vergnolle N, 2004, J CLIN INVEST, V114, P1444, DOI 10.1172/JCI200421689; Wang YF, 2006, J NEUROCHEM, V98, P1046, DOI 10.1111/j.1471-4159.2006.03950.x; WEE JL, 2009, GASTROENTEROLOGY; White NMA, 2009, BRIT J CANCER, V101, P1107, DOI 10.1038/sj.bjc.6605280; Yang E, 2009, CANCER RES, V69, P6223, DOI 10.1158/0008-5472.CAN-09-0187; Yang YH, 2005, ARTHRITIS RHEUM-US, V52, P1325, DOI 10.1002/art.21001; ZACHARCHUK CM, 1990, J IMMUNOL, V145, P4037; Zarghooni M, 2002, CLIN BIOCHEM, V35, P225, DOI 10.1016/S0009-9120(02)00292-8; Zhang XD, 2004, MOL CANCER THER, V3, P187; Zilman A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012775	63	39	42	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e18376	10.1371/journal.pone.0018376	http://dx.doi.org/10.1371/journal.pone.0018376			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464892	Green Published, gold, Green Submitted			2022-12-25	WOS:000289053800044
J	den Hartog, G; Savelkoul, HFJ; Schoemaker, R; Tijhaar, E; Westphal, AH; de Ruiter, T; van de Weg-Schrijver, E; van Neerven, RJJ				den Hartog, Gerco; Savelkoul, Huub F. J.; Schoemaker, Ruud; Tijhaar, Edwin; Westphal, Adrie H.; de Ruiter, Talitha; van de Weg-Schrijver, Elise; van Neerven, R. J. Joost			Modulation of Human Immune Responses by Bovine Interleukin-10	PLOS ONE			English	Article							T-CELL PROLIFERATION; DENDRITIC CELLS; IFN-GAMMA; NECROTIZING ENTEROCOLITIS; SUBLINGUAL IMMUNOTHERAPY; CYTOKINE PRODUCTION; INTERFERON-GAMMA; AUTOCRINE IL-10; HUMAN-MILK; TGF-BETA	Cytokines can be functionally active across species barriers. Bovine IL-10 has an amino acid sequence identity with human IL-10 of 76.8%. Therefore, the aim of this study was to evaluate whether bovine IL-10 has immunomodulatory activities on human monocytes and dendritic cells. Peripheral blood monocytes were isolated from healthy donors, and used directly or allowed to differentiate to dendritic cells under the influence of IL-4 and GM-CSF. Recombinant bovine IL-10 inhibited TLR induced activation of monocytes, and dose-dependently inhibited LPS-induced activation of monocyte-derived DCs comparable to human IL-10. By using blocking antibodies to either bovine IL-10 or the human IL-10 receptor it was demonstrated that inhibition of monocyte activation by bovine IL-10 was dependent on binding of bovine IL-10 to the human IL-10R. These data demonstrate that bovine IL-10 potently inhibits the activation of human myeloid cells in response to TLR activation. Bovine IL-10 present in dairy products may thus potentially contribute to the prevention of necrotizing enterocolitis and allergy, enhance mucosal tolerance induction and decrease intestinal inflammation and may therefore be applicable in infant foods and in immunomodulatory diets.	[den Hartog, Gerco; Savelkoul, Huub F. J.; Tijhaar, Edwin] Wageningen Univ, Cell Biol & Immunol Grp, Wageningen, Netherlands; [Schoemaker, Ruud; de Ruiter, Talitha; van de Weg-Schrijver, Elise; van Neerven, R. J. Joost] Royal FrieslandCampina Res, Deventer, Netherlands; [Westphal, Adrie H.] Wageningen Univ, Biochem Lab, Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research	den Hartog, G (corresponding author), Wageningen Univ, Cell Biol & Immunol Grp, Wageningen, Netherlands.	joost.vanneerven@frieslandcampina.com	Savelkoul, Huub FJ/F-6026-2012; Westphal, Adrie Herman/L-3517-2019; van Neerven, Joost/GWZ-3214-2022; Hartog, Gerco den/AAB-6329-2019	Westphal, Adrie Herman/0000-0003-4264-6267; Hartog, Gerco den/0000-0002-2103-6315; Schoemaker, Ruud/0000-0003-4651-8406; van Neerven, R.J.Joost/0000-0002-3991-5297				Akdis M, 2009, CURR OPIN IMMUNOL, V21, P700, DOI 10.1016/j.coi.2009.07.012; Ando T, 2007, J ALLERGY CLIN IMMUN, V120, P916, DOI 10.1016/j.jaci.2007.05.023; Berlato C, 2002, J IMMUNOL, V168, P6404, DOI 10.4049/jimmunol.168.12.6404; BERNSTEIN ZP, 1995, BLOOD, V86, P3287, DOI 10.1182/blood.V86.9.3287.bloodjournal8693287; Bohle B, 2007, J ALLERGY CLIN IMMUN, V120, P707, DOI 10.1016/j.jaci.2007.06.013; COLLINS RA, 1994, VET IMMUNOL IMMUNOP, V40, P313, DOI 10.1016/0165-2427(94)90042-6; Corinti S, 2001, J IMMUNOL, V166, P4312, DOI 10.4049/jimmunol.166.7.4312; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; DAUBEROSGUTHORPE P, 1988, PROTEINS, V4, P31, DOI 10.1002/prot.340040106; DELPRETE G, 1993, J IMMUNOL, V150, P353; Demangel C, 2002, EUR J IMMUNOL, V32, P994, DOI 10.1002/1521-4141(200204)32:4<994::AID-IMMU994>3.3.CO;2-Y; Denning TL, 2000, INT IMMUNOL, V12, P133, DOI 10.1093/intimm/12.2.133; DeSmedt T, 1997, EUR J IMMUNOL, V27, P1229, DOI 10.1002/eji.1830270526; Donnelly RP, 1999, J INTERF CYTOK RES, V19, P563, DOI 10.1089/107999099313695; Dvorak B, 2003, PEDIATR RES, V53, P426, DOI 10.1203/01.PDR.0000050657.56817.E0; Enrique E, 2005, J ALLERGY CLIN IMMUN, V116, P1073, DOI 10.1016/j.jaci.2005.08.027; Eswar N, 2003, NUCLEIC ACIDS RES, V31, P3375, DOI 10.1093/nar/gkg543; Fayette J, 1997, J EXP MED, V185, P1909, DOI 10.1084/jem.185.11.1909; Field CJ, 2005, J NUTR, V135, P1; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; FIORENTINO DF, 1991, J IMMUNOL, V146, P3444; Fituch CC, 2004, ACTA PAEDIATR, V93, P1496, DOI 10.1080/08035250410022314; Franke A, 2008, NAT GENET, V40, P1319, DOI 10.1038/ng.221; Frossard CP, 2007, J ALLERGY CLIN IMMUN, V119, P952, DOI 10.1016/j.jaci.2006.12.615; GAROFALO R, 1995, PEDIATR RES, V37, P444, DOI 10.1203/00006450-199504000-00010; Gill HS, 2000, BRIT J NUTR, V84, pS111; Halpern MD, 2006, AM J PHYSIOL-GASTR L, V290, pG757, DOI 10.1152/ajpgi.00408.2005; He B, 2006, J IMMUNOL, V176, P3931, DOI 10.4049/jimmunol.176.7.3931; Hirano T, 2003, IMMUNOL LETT, V89, P251, DOI 10.1016/S0165-2478(03)00156-1; Joetham A, 2007, J IMMUNOL, V178, P1433, DOI 10.4049/jimmunol.178.3.1433; Josephson K, 2001, IMMUNITY, V15, P35, DOI 10.1016/S1074-7613(01)00169-8; Jutel M, 2003, EUR J IMMUNOL, V33, P1205, DOI 10.1002/eji.200322919; Kaiser P, 1998, J INTERF CYTOK RES, V18, P711, DOI 10.1089/jir.1998.18.711; Kalinski P, 1999, J IMMUNOL, V162, P3231; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lawson S, 2001, DEV COMP IMMUNOL, V25, P69, DOI 10.1016/S0145-305X(00)00044-6; Lawson S, 2000, J INTERF CYTOK RES, V20, P161, DOI 10.1089/107999000312568; Li YH, 2006, J IMMUNOL, V177, P1679, DOI 10.4049/jimmunol.177.3.1679; MACATONIA SE, 1993, J IMMUNOL, V150, P3755; MALEFYT RD, 1991, J EXP MED, V174, P1209; MALEFYT RD, 1993, J IMMUNOL, V150, pA180; Morar D, 2007, VET IMMUNOL IMMUNOP, V115, P146, DOI 10.1016/j.vetimm.2006.10.016; Nouri-Aria KT, 2004, J IMMUNOL, V172, P3252, DOI 10.4049/jimmunol.172.5.3252; Ozturk H, 2002, J PEDIATR SURG, V37, P1330, DOI 10.1053/jpsu.2002.35002; Reineke U, 1998, PROTEIN SCI, V7, P951; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Rigotti E, 2006, CLIN EXP ALLERGY, V36, P614, DOI 10.1111/j.1365-2222.2006.02483.x; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Schottelius AJG, 1999, J BIOL CHEM, V274, P31868, DOI 10.1074/jbc.274.45.31868; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Steinbrink K, 1997, J IMMUNOL, V159, P4772; Steinbrink K, 2002, BLOOD, V99, P2468, DOI 10.1182/blood.V99.7.2468; TAGA K, 1992, J IMMUNOL, V148, P1143; TAN JC, 1995, J BIOL CHEM, V270, P12906, DOI 10.1074/jbc.270.21.12906; TAN JC, 1993, J BIOL CHEM, V268, P21053; Untalan PB, 2009, BREASTFEED MED, V4, P138, DOI 10.1089/bfm.2008.0145; van der Aa LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012384; van Odijk J, 2003, ALLERGY, V58, P833, DOI 10.1034/j.1398-9995.2003.00264.x; WANG P, 1995, J BIOL CHEM, V270, P9558, DOI 10.1074/jbc.270.16.9558; YSSEL H, 1984, J IMMUNOL METHODS, V72, P219, DOI 10.1016/0022-1759(84)90450-2	63	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e18188	10.1371/journal.pone.0018188	http://dx.doi.org/10.1371/journal.pone.0018188			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464967	Green Published, Green Submitted, gold			2022-12-25	WOS:000288813900049
J	Huynh, H; Zheng, JK; Umikawa, M; Silvany, R; Xie, XJ; Wu, CJ; Holzenberger, M; Wang, QM; Zhang, CC				Huynh, HoangDinh; Zheng, Junke; Umikawa, Masato; Silvany, Robert; Xie, Xian-Jin; Wu, Catherine J.; Holzenberger, Martin; Wang, Qianming; Zhang, Cheng Cheng			Components of the Hematopoietic Compartments in Tumor Stroma and Tumor-Bearing Mice	PLOS ONE			English	Article							EX-VIVO EXPANSION; STEM-CELLS; GROWTH-FACTOR; PROGENITOR CELLS; NICHE; POPULATION; CANCER; LIVER; IGF-1	Solid tumors are composed of cancerous cells and non-cancerous stroma. A better understanding of the tumor stroma could lead to new therapeutic applications. However, the exact compositions and functions of the tumor stroma are still largely unknown. Here, using a Lewis lung carcinoma implantation mouse model, we examined the hematopoietic compartments in tumor stroma and tumor-bearing mice. Different lineages of differentiated hematopoietic cells existed in tumor stroma with the percentage of myeloid cells increasing and the percentage of lymphoid and erythroid cells decreasing over time. Using bone marrow reconstitution analysis, we showed that the tumor stroma also contained functional hematopoietic stem cells. All hematopoietic cells in the tumor stroma originated from bone marrow. In the bone marrow and peripheral blood of tumor-bearing mice, myeloid populations increased and lymphoid and erythroid populations decreased and numbers of hematopoietic stem cells markedly increased with time. To investigate the function of hematopoietic cells in tumor stroma, we co-implanted various types of hematopoietic cells with cancer cells. We found that total hematopoietic cells in the tumor stroma promoted tumor development. Furthermore, the growth of the primary implanted Lewis lung carcinomas and their metastasis were significantly decreased in mice reconstituted with IGF type I receptor-deficient hematopoietic stem cells, indicating that IGF signaling in the hematopoietic tumor stroma supports tumor outgrowth. These results reveal that hematopoietic cells in the tumor stroma regulate tumor development and that tumor progression significantly alters the host hematopoietic compartment.	[Huynh, HoangDinh; Zheng, Junke; Umikawa, Masato; Silvany, Robert; Zhang, Cheng Cheng] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Huynh, HoangDinh; Zheng, Junke; Umikawa, Masato; Silvany, Robert; Zhang, Cheng Cheng] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA; [Xie, Xian-Jin] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [Wu, Catherine J.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Holzenberger, Martin] Hop St Antoine, INSERM, U515, F-75571 Paris, France; [Wang, Qianming] S China Normal Univ, Sch Chem & Environm, Guangzhou, Guangdong, Peoples R China	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Dana-Farber Cancer Institute; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; South China Normal University	Huynh, H (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA.	Alec.Zhang@UTSouthwestern.edu	Zhang, Cheng/GRS-8698-2022; Holzenberger, Martin/N-9732-2018	Holzenberger, Martin/0000-0003-4869-725X	American Cancer Society [ACS-IRG-02-196]; NIH [K01CA120099]; Welch Foundation [I-1701]; March of Dimes Foundation; DOD [PR093256]; Cancer Prevention and Research Institute of Texas [RP100402]; NATIONAL CANCER INSTITUTE [K01CA120099] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); March of Dimes Foundation(March of Dimes); DOD(United States Department of Defense); Cancer Prevention and Research Institute of Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	American Cancer Society grant ACS-IRG-02-196 (http://www.cancer.org/), NIH grant K01CA120099 (http://grants1.nih.gov/grants/funding/funding.htm), Welch Foundation I-1701 ( http://www.welch1.org/), Basil O'Connor Award from the March of Dimes Foundation (http://www.marchofdimes.com/research/research.html), DOD Peer Reviewed Medical Research Program PR093256 (https://cdmrp.org/), and Cancer Prevention and Research Institute of Texas RP100402 (http://www.cprit.state.tx.us/funding-opportunities/) supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bryder D, 2006, AM J PATHOL, V169, P338, DOI 10.2353/ajpath.2006.060312; Dziadziuszko R, 2008, J THORAC ONCOL, V3, P815, DOI 10.1097/JTO.0b013e31818180f5; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Huynh HD, 2008, STEM CELLS, V26, P1628, DOI 10.1634/stemcells.2008-0064; Jaiswal S, 2009, ANN NY ACAD SCI, V1174, P118, DOI 10.1111/j.1749-6632.2009.04930.x; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kaplan RN, 2007, TRENDS MOL MED, V13, P72, DOI 10.1016/j.molmed.2006.12.003; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kotton DN, 2005, BLOOD, V106, P1574, DOI 10.1182/blood-2005-03-1017; Liao MJ, 2007, CANCER RES, V67, P8131, DOI 10.1158/0008-5472.CAN-06-4493; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; McAllister SS, 2008, CELL, V133, P994, DOI 10.1016/j.cell.2008.04.045; McAllister SS, 2010, J CLIN ONCOL, V28, P4022, DOI 10.1200/JCO.2010.28.4257; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Zhang CC, 2006, NAT MED, V12, P240, DOI 10.1038/nm1342; Zhang CC, 2006, P NATL ACAD SCI USA, V103, P2184, DOI 10.1073/pnas.0510577103; Zhang CC, 2005, BLOOD, V105, P4314, DOI 10.1182/blood-2004-11-4418; Zhang CC, 2004, BLOOD, V103, P2513, DOI 10.1182/blood-2003-08-2955; Zheng J, 2010, BLOOD	21	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e18054	10.1371/journal.pone.0018054	http://dx.doi.org/10.1371/journal.pone.0018054			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464968	Green Published, gold, Green Submitted			2022-12-25	WOS:000288813900030
J	Won, HY; Lee, JA; Park, ZS; Song, JS; Kim, HY; Jang, SM; Yoo, SE; Rhee, Y; Hwang, ES; Bae, MA				Won, Hee Yeon; Lee, Jin-Ah; Park, Zong Sik; Song, Jin Sook; Kim, Hee Yun; Jang, Su-Min; Yoo, Sung-Eun; Rhee, Youmi; Hwang, Eun Sook; Bae, Myung Ae			Prominent Bone Loss Mediated by RANKL and IL-17 Produced by CD4+T Cells in TallyHo/JngJ Mice	PLOS ONE			English	Article							T-CELLS; ESTROGEN DEFICIENCY; ENERGY-METABOLISM; SERUM OSTEOCALCIN; GROWTH-FACTORS; MOUSE MODEL; DUAL ROLE; OSTEOPROTEGERIN; OSTEOPOROSIS; BETA	Increasing evidence that decreased bone density and increased rates of bone fracture are associated with abnormal metabolic states such as hyperglycemia and insulin resistance indicates that diabetes is a risk factor for osteoporosis. In this study, we observed that TallyHo/JngJ (TH) mice, a polygenic model of type II diabetes, spontaneously developed bone deformities with osteoporotic features. Female and male TH mice significantly gained more body weight than control C57BL/6 mice upon aging. Interestingly, bone density was considerably decreased in male TH mice, which displayed hyperglycemia. The osteoblast-specific bone forming markers osteocalcin and osteoprotegerin were decreased in TH mice, whereas osteoclast-driven bone resorption markers such as IL-6 and RANKL were significantly elevated in the bone marrow and blood of TH mice. In addition, RANKL expression was prominently increased in CD4+ T cells of TH mice upon T cell receptor stimulation, which was in accordance with enhanced IL-17 production. IL-17 production in CD4+ T cells was directly promoted by treatment with leptin while IFN-gamma production was not. Moreover, blockade of IFN-gamma further increased RANKL expression and IL-17 production in TH-CD4+ T cells. In addition, the osteoporotic phenotype of TH mice was improved by treatment with alendronate. These results strongly indicate that increased leptin in TH mice may act in conjunction with IL-6 to preferentially stimulate IL-17 production in CD4+ T cells and induce RANKL-mediated osteoclastogenesis. Accordingly, we propose that TH mice could constitute a beneficial model for osteoporosis.	[Won, Hee Yeon; Lee, Jin-Ah; Hwang, Eun Sook] Ewha Womans Univ, Ctr Cell Signaling & Drug Discovery Res, Coll Pharm, Div Life & Pharmaceut Sci, Seoul, South Korea; [Park, Zong Sik; Song, Jin Sook; Kim, Hee Yun; Jang, Su-Min; Yoo, Sung-Eun; Bae, Myung Ae] Korea Res Inst Chem Technol, Korea Bioorgan Sci Div, Taejon 305606, South Korea; [Rhee, Youmi] Yonsei Univ, Sch Med, Seoul 120749, South Korea	Ewha Womans University; Korea Research Institute of Chemical Technology (KRICT); Yonsei University	Won, HY (corresponding author), Ewha Womans Univ, Ctr Cell Signaling & Drug Discovery Res, Coll Pharm, Div Life & Pharmaceut Sci, Seoul, South Korea.	eshwang@ewha.ac.kr; mbae@krict.re.kr	Rhee, Yumie/L-8020-2019	Rhee, Yumie/0000-0003-4227-5638	Ministry of Knowledge Economy [10033674]; Center for Biological Modulators of the 21st Century Frontier RD program; MEST [R15-2006-020]	Ministry of Knowledge Economy(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea); Center for Biological Modulators of the 21st Century Frontier RD program(Ministry of Education, Science & Technology (MEST), Republic of Korea); MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Ministry of Knowledge Economy (10033674) and the Center for Biological Modulators of the 21st Century Frontier R&D program and partly by the NCRC program (R15-2006-020) of KOSEF funded by MEST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanchard F, 2009, CYTOKINE GROWTH F R, V20, P19, DOI 10.1016/j.cytogfr.2008.11.004; Botolin S, 2005, ENDOCRINOLOGY, V146, P3622, DOI 10.1210/en.2004-1677; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Bucay N, 1998, GENE DEV, V12, P1260, DOI 10.1101/gad.12.9.1260; Chilton PM, 2004, DIABETES, V53, P1995, DOI 10.2337/diabetes.53.8.1995; De Rosa V, 2007, IMMUNITY, V26, P241, DOI 10.1016/j.immuni.2007.01.011; Derynck R, 2007, NAT CELL BIOL, V9, P1000, DOI 10.1038/ncb434; Ferron M, 2008, P NATL ACAD SCI USA, V105, P5266, DOI 10.1073/pnas.0711119105; Fukumoto S, 2009, TRENDS ENDOCRIN MET, V20, P230, DOI 10.1016/j.tem.2009.02.001; HAUSCHKA PV, 1986, J BIOL CHEM, V261, P2665; Hofbauer LC, 2007, J BONE MINER RES, V22, P1317, DOI 10.1359/JBMR.070510; Jiang J, 2006, BONE, V39, P494, DOI 10.1016/j.bone.2006.02.068; Jilka RL, 1998, BONE, V23, P75, DOI 10.1016/S8756-3282(98)00077-5; Kim JH, 2005, PHYSIOL GENOMICS, V22, P171, DOI 10.1152/physiolgenomics.00197.2004; Kim JH, 2001, GENOMICS, V74, P273, DOI 10.1006/geno.2001.6569; Kim JH, 2006, J ENDOCRINOL, V191, P437, DOI 10.1677/joe.1.06647; Kindblom JM, 2009, J BONE MINER RES, V24, P785, DOI [10.1359/jbmr.081234, 10.1359/JBMR.081234]; Kobayashi Y, 2000, J BONE MINER RES, V15, P1924, DOI 10.1359/jbmr.2000.15.10.1924; Kong YY, 1999, NATURE, V402, P304, DOI 10.1038/35005552; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lee NK, 2008, TRENDS ENDOCRIN MET, V19, P161, DOI 10.1016/j.tem.2008.02.006; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; LORENTZON R, 1986, Diabetes Research and Clinical Practice, V2, P157, DOI 10.1016/S0168-8227(86)80017-1; MANOLAGAS SC, 1995, NEW ENGL J MED, V332, P305, DOI 10.1056/NEJM199502023320506; Fernandez-Real JM, 2009, J CLIN ENDOCR METAB, V94, P237, DOI 10.1210/jc.2008-0270; MATSUSHITA M, 1986, AM J PATHOL, V125, P276; Matter CM, 2009, CIRC RES, V104, P928, DOI 10.1161/CIRCRESAHA.109.197004; MCSHEEHY PMJ, 1986, ENDOCRINOLOGY, V119, P1654, DOI 10.1210/endo-119-4-1654; Melton LJ, 2008, J BONE MINER RES, V23, P1334, DOI 10.1359/JBMR.080323; MUNDY GR, 1993, J BONE MINER RES, V8, pS505, DOI 10.1002/jbmr.5650081315; Ogata N, 2000, J CLIN INVEST, V105, P935, DOI 10.1172/JCI9017; Page G, 2005, ARTHRITIS RHEUM-US, V52, P2307, DOI 10.1002/art.21211; PFEILSCHIFTER J, 1987, P NATL ACAD SCI USA, V84, P2024, DOI 10.1073/pnas.84.7.2024; Pittas AG, 2009, J CLIN ENDOCR METAB, V94, P827, DOI 10.1210/jc.2008-1422; Qaseem A, 2008, ANN INTERN MED, V148, P680, DOI 10.7326/0003-4819-148-9-200805060-00008; RHEE SD, 2010, EXP CLIN ENDOCRINOL; Schett G, 2010, NAT REV ENDOCRINOL, V6, P698, DOI 10.1038/nrendo.2010.190; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Stein NC, 2008, J BONE MINER RES, V23, P750, DOI 10.1359/JBMR.080203; Steppan CM, 2000, REGUL PEPTIDES, V92, P73, DOI 10.1016/S0167-0115(00)00152-X; Takayanagi H, 2000, NATURE, V408, P600, DOI 10.1038/35046102; THOMSON BM, 1987, J IMMUNOL, V138, P775; Totsuka T, 2009, J IMMUNOL, V182, P6079, DOI 10.4049/jimmunol.0711823; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Weitzmann MN, 2007, ANN NY ACAD SCI, V1116, P360, DOI 10.1196/annals.1402.068	45	60	64	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e18168	10.1371/journal.pone.0018168	http://dx.doi.org/10.1371/journal.pone.0018168			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464945	Green Submitted, Green Published, gold			2022-12-25	WOS:000288813900045
J	Tchou-Wong, KM; Kiok, K; Tang, ZJ; Kluz, T; Arita, A; Smith, PR; Brown, S; Costa, M				Tchou-Wong, Kam-Meng; Kiok, Kathrin; Tang, Zuojian; Kluz, Thomas; Arita, Adriana; Smith, Phillip R.; Brown, Stuart; Costa, Max			Effects of Nickel Treatment on H3K4 Trimethylation and Gene Expression	PLOS ONE			English	Article							HISTONE DEMETHYLASE JMJD1A; LYSINE METHYLATION; ACTIVE GENES; HYPOXIA; TRANSFORMATION; NUCLEOSOME; PARTICLE; COMPASS; GROWTH; CELLS	Occupational exposure to nickel compounds has been associated with lung and nasal cancers. We have previously shown that exposure of the human lung adenocarcinoma A549 cells to NiCl2 for 24 hr significantly increased global levels of trimethylated H3K4 (H3K4me3), a transcriptional activating mark that maps to the promoters of transcribed genes. To further understand the potential epigenetic mechanism(s) underlying nickel carcinogenesis, we performed genome-wide mapping of H3K4me3 by chromatin immunoprecipitation and direct genome sequencing (ChIP-seq) and correlated with transcriptome genome-wide mapping of RNA transcripts by massive parallel sequencing of cDNA (RNA-seq). The effect of NiCl2 treatment on H3K4me3 peaks within 5,000 bp of transcription start sites (TSSs) on a set of genes highly induced by nickel in both A549 cells and human peripheral blood mononuclear cells were analyzed. Nickel exposure increased the level of H3K4 trimethylation in both the promoters and coding regions of several genes including CA9 and NDRG1 that were increased in expression in A549 cells. We have also compared the extent of the H3K4 trimethylation in the absence and presence of formaldehyde crosslinking and observed that crosslinking of chromatin was required to observe H3K4 trimethylation in the coding regions immediately downstream of TSSs of some nickel-induced genes including ADM and IGFBP3. This is the first genome-wide mapping of trimethylated H3K4 in the promoter and coding regions of genes induced after exposure to NiCl2. This study may provide insights into the epigenetic mechanism(s) underlying the carcinogenicity of nickel compounds.	[Tchou-Wong, Kam-Meng; Kiok, Kathrin; Kluz, Thomas; Arita, Adriana; Costa, Max] NYU, Sch Med, Dept Environm Med, Tuxedo Pk, NY USA; [Tang, Zuojian; Smith, Phillip R.; Brown, Stuart] NYU, Sch Med, Dept Cell Biol, Tuxedo Pk, NY USA; [Tang, Zuojian; Smith, Phillip R.; Brown, Stuart] NYU, Sch Med, Ctr Hlth Informat & Bioinformat, Tuxedo Pk, NY USA	New York University; New York University; New York University	Tchou-Wong, KM (corresponding author), NYU, Sch Med, Dept Environm Med, Tuxedo Pk, NY USA.	tchouk02@nyumc.org	Brown, Stuart M./A-9880-2016; costa, max/H-1754-2012	Brown, Stuart M./0000-0002-0906-9907; Smith, Phillip/0000-0002-7850-8440	National Institutes of Environmental Health Sciences [ES000260, ES010344, ES014454, ES005512]; National Cancer Institute [CA16087]; National Center for Research Resources [RR029893]; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000260, P42ES010344, R01ES014454, R01ES005512] Funding Source: NIH RePORTER	National Institutes of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by grant numbers ES000260, ES010344, ES014454, ES005512 from the National Institutes of Environmental Health Sciences, and support from grant number CA16087 from National Cancer Institute and RR029893 from National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacon AL, 2004, ANN MED, V36, P530, DOI 10.1080/07853890410018231; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Becker PB, 2002, EMBO J, V21, P4749, DOI 10.1093/emboj/cdf486; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Cairns BR, 2007, NAT STRUCT MOL BIOL, V14, P989, DOI 10.1038/nsmb1333; Chen HB, 2006, MOL CELL BIOL, V26, P3728, DOI 10.1128/MCB.26.10.3728-3737.2006; Chen HB, 2010, CARCINOGENESIS, V31, P2136, DOI 10.1093/carcin/bgq197; Chen HB, 2010, J BIOL CHEM, V285, P7374, DOI 10.1074/jbc.M109.058503; Chiche J, 2009, CANCER RES, V69, P358, DOI 10.1158/0008-5472.CAN-08-2470; Deville JL, 2010, EXPERT OPIN THER TAR, V14, P1059, DOI 10.1517/14728222.2010.522328; DOLL R, 1970, BRIT J CANCER, V24, P623, DOI 10.1038/bjc.1970.76; Ellen TP, 2008, CARCINOGENESIS, V29, P2, DOI 10.1093/carcin/bgm200; Hung T, 2009, MOL CELL, V33, P248, DOI 10.1016/j.molcel.2008.12.016; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kang J, 2003, TOXICOL SCI, V74, P279, DOI 10.1093/toxsci/kfg137; Ke QD, 2006, CARCINOGENESIS, V27, P1481, DOI 10.1093/carcin/bgl004; Kerckaert GA, 1996, FUND APPL TOXICOL, V34, P67, DOI 10.1006/faat.1996.0176; Kim A, 2007, MOL CELL BIOL, V27, P1271, DOI 10.1128/MCB.01684-06; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; KORNBERG RD, 1974, SCIENCE, V184, P865, DOI 10.1126/science.184.4139.865; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kuper CF, 1997, MUTAT RES-FUND MOL M, V380, P19, DOI 10.1016/S0027-5107(97)00123-1; LEE YW, 1995, MOL CELL BIOL, V15, P2547; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Miller AC, 2001, CARCINOGENESIS, V22, P115, DOI 10.1093/carcin/22.1.115; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schneider J, 2005, MOL CELL, V19, P849, DOI 10.1016/j.molcel.2005.07.024; Sims RJ, 2007, MOL CELL, V28, P665, DOI 10.1016/j.molcel.2007.11.010; Wood A, 2007, MOL CELL BIOL, V27, P709, DOI 10.1128/MCB.01627-06; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou X, 2010, CANCER RES, V70, P4214, DOI 10.1158/0008-5472.CAN-09-2942; Zhou X, 2009, TOXICOL APPL PHARM, V236, P78, DOI 10.1016/j.taap.2009.01.009	36	22	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2011	6	3							e17728	10.1371/journal.pone.0017728	http://dx.doi.org/10.1371/journal.pone.0017728			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740RG	21455298	gold, Green Published, Green Submitted			2022-12-25	WOS:000288811500008
J	Loveless, BC; Mason, JW; Sakurai, T; Inoue, N; Razavi, M; Pearson, TW; Boulanger, MJ				Loveless, Bianca C.; Mason, Jeremy W.; Sakurai, Tatsuya; Inoue, Noboru; Razavi, Morteza; Pearson, Terry W.; Boulanger, Martin J.			Structural Characterization and Epitope Mapping of the Glutamic Acid/Alanine-rich Protein from Trypanosoma congolense DEFINING ASSEMBLY ON THE PARASITE CELL SURFACE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AFRICAN TRYPANOSOMES; PROCYCLIN COAT; GLYCOPROTEIN; IDENTIFICATION; EXPRESSION; FORMS	Trypanosoma congolense is an African trypanosome that causes serious disease in cattle in Sub-Saharan Africa. The four major life cycle stages of T. congolense can be grown in vitro, which has led to the identification of several cell-surface molecules expressed on the parasite during its transit through the tsetse vector. One of these, glutamic acid/alanine-rich protein (GARP), is the first expressed on procyclic forms in the tsetse midgut and is of particular interest because it replaces the major surface coat molecule of bloodstream forms, the variant surface glycoprotein (VSG) that protects the parasite membrane, and is involved in antigenic variation. Unlike VSG, however, the function of GARP is not known, which necessarily limits our understanding of parasite survival in the tsetse. Toward establishing the function of GARP, we report its three-dimensional structure solved by iodide phasing to a resolution of 1.65A. An extended helical bundle structure displays an unexpected and significant degree of homology to the core structure of VSG, the only other major surface molecule of trypanosomes to be structurally characterized. Immunofluorescence microscopy and immunoaffinity-tandem mass spectrometry were used in conjunction with monoclonal antibodies to map both non-surface-disposed and surface epitopes. Collectively, these studies enabled us to derive a model describing the orientation and assembly of GARP on the surface of trypanosomes. The data presented here suggest the possible structure-function relationships involved in replacement of the bloodstream form VSG by GARP as trypanosomes differentiate in the tsetse vector after a blood meal.	[Loveless, Bianca C.; Mason, Jeremy W.; Razavi, Morteza; Pearson, Terry W.; Boulanger, Martin J.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada; [Sakurai, Tatsuya; Inoue, Noboru] Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido 0808555, Japan	University of Victoria; Obihiro University of Agriculture & Veterinary Medicine	Boulanger, MJ (corresponding author), Univ Victoria, Dept Biochem & Microbiol, 3055 STN CSC, Victoria, BC V8W 3P6, Canada.	mboulang@uvic.ca			Natural Sciences and Engineering Research Council of Canada; University of Victoria	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Victoria	This work was supported in part by separate Discovery Grants from the Natural Sciences and Engineering Research Council of Canada (to M.J.B. and T.W.P.).; Supported in part by a University of Victoria graduate award.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAYNE RAL, 1993, MOL BIOCHEM PARASIT, V61, P295, DOI 10.1016/0166-6851(93)90075-9; BEECROFT RP, 1993, MOL BIOCHEM PARASIT, V61, P285, DOI 10.1016/0166-6851(93)90074-8; Butikofer P, 2002, MOL BIOCHEM PARASIT, V119, P7, DOI 10.1016/S0166-6851(01)00382-6; CROSS GAM, 1973, PARASITOLOGY, V67, P315, DOI 10.1017/S0031182000046540; Donelson JE, 2003, ACTA TROP, V85, P391, DOI 10.1016/S0001-706X(02)00237-1; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferguson MAJ, 1999, J CELL SCI, V112, P2799; FISH WR, 1989, BIOCHEMISTRY-US, V28, P5415, DOI 10.1021/bi00439a015; FREYMANN D, 1990, J MOL BIOL, V216, P141, DOI 10.1016/S0022-2836(05)80066-X; Haines LR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000793; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pearson TW, 2000, MOL BIOCHEM PARASIT, V111, P333, DOI 10.1016/S0166-6851(00)00327-3; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; RODITI I, 1989, J CELL BIOL, V108, P737, DOI 10.1083/jcb.108.2.737; Roditi I, 1999, MOL BIOCHEM PARASIT, V103, P99, DOI 10.1016/S0166-6851(99)00124-3; Roditi I, 1998, MOL BIOCHEM PARASIT, V91, P117, DOI 10.1016/S0166-6851(97)00195-3; RODITI I, 1990, PARASITOL TODAY, V6, P79, DOI 10.1016/0169-4758(90)90216-Q; Sakurai T, 2008, MOL BIOCHEM PARASIT, V161, P1, DOI 10.1016/j.molbiopara.2008.05.003; STEBECK CR, 1994, EXP PARASITOL, V78, P432, DOI 10.1006/expr.1994.1050; Swallow B.M, 2000, PAAT TECHNICAL SCI S, V2; TOLSON DL, 1989, MOL BIOCHEM PARASIT, V35, P109, DOI 10.1016/0166-6851(89)90113-8; TOLSON DL, 1990, INFECT IMMUN, V58, P3500, DOI 10.1128/IAI.58.11.3500-3507.1990; Utz S, 2006, EUKARYOT CELL, V5, P1430, DOI 10.1128/EC.00067-06; VICKERMAN K, 1969, J CELL SCI, V5, P163; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; ZWEYGARTH E, 1987, PARASITOL RES, V73, P479, DOI 10.1007/BF00538209	28	9	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20658	20665		10.1074/jbc.M111.218941	http://dx.doi.org/10.1074/jbc.M111.218941			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21471223	Green Published, hybrid			2022-12-25	WOS:000291267600052
J	Dellis, O; Arbabian, A; Papp, B; Rowe, M; Joab, I; Chomienne, C				Dellis, Olivier; Arbabian, Atousa; Papp, Bela; Rowe, Martin; Joab, Irene; Chomienne, Christine			Epstein-Barr Virus Latent Membrane Protein 1 Increases Calcium Influx through Store-operated Channels in B Lymphoid Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-LYMPHOCYTES; IP3 RECEPTORS; CA2+ ENTRY; EXPRESSION; ORAI1; INHIBITION; ACTIVATION; DEFICIENCY; MODULATION; INDUCTION	Ca2+ signaling plays an important role in B cell survival and activation and is dependent on Ca2+ trapped in the endoplasmic reticulum (ER) and on extracellular Ca2+. Epstein-Barr virus (EBV) can immortalize B cells and contributes to lymphomagenesis. Previously, we showed that the ER Ca2+ content of Burkitt lymphoma cell lines was increased following infection with immortalization-competent virus expressing the full set of EBV latency genes (B95-8). In contrast, infection with an immortalization-deficient virus (P3HR-1) not expressing LMP-1 is without effect. LMP-1 protein expression was sufficient to increase the ER Ca2+ content and to increase the cytosolic Ca2+ concentration ([Ca2+](cyt)). In this follow-up study, we showed that the resting [Ca2+](cyt) of P3HR-1-infected cells was decreased, implying that EBV not only modified the ER homeostasis but also affected the cytosolic Ca2+ homeostasis. Furthermore, even if the store-operated calcium entry (SOCE) of these cells was normal, the [Ca2+](cyt) increase after thapsigargin + CaCl2 stimulation was blunted. In contrast, the resting [Ca2+](cyt) of B95-8 infected cells was not changed, even if their SOCE was increased significantly. When expressed alone, LMP-1 induced an increase of the SOCE amplitude and the expression of the protein allowing this influx, Orai1, showing the effect of EBV on SOCE of B cells are mediated by LMP-1. However, other hitherto unidentified EBV processes, unmasked in P3HR-1 infected cells, counteract this LMP-1-dependent increase of SOCE amplitude to impair a general and potentially toxic increase of [Ca2+](i). Thus, EBV infection modifies the cellular Ca2+ homeostasis by acting on the ER and plasma membrane transporters.	[Dellis, Olivier; Arbabian, Atousa; Papp, Bela; Chomienne, Christine] Univ Paris 07, INSERM, UMR S 940, Inst Univ Hematol, Paris, France; [Dellis, Olivier] Univ Paris 11, INSERM, UMR S 757, F-91405 Orsay, France; [Rowe, Martin] Univ Birmingham, Sch Med, Sch Canc Sci, Edgbaston, England; [Joab, Irene] Univ Paris 11, INSERM, UMR S 1014, Villejuif, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of Birmingham; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Dellis, O (corresponding author), Univ Paris 11, INSERM, UMR S 757, Rue Adeles, F-91405 Orsay, France.	olivier.dellis@inserm.fr	Rowe, Martin/B-2880-2009; Dellis, Olivier/E-8501-2011	Rowe, Martin/0000-0003-4139-7326; Dellis, Olivier/0000-0003-0377-9163; CHOMIENNE, Christine/0000-0001-5513-5752; Papp, Bela/0000-0002-5025-3087	INSERM; Association pour la Recherche contre le Cancer; Cancer Research UK, London; Medical Research Council [G9818340B] Funding Source: researchfish	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Cancer Research UK, London(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by INSERM and the Association pour la Recherche contre le Cancer.; Supported by Cancer Research UK, London.	Brouland JP, 2005, AM J PATHOL, V167, P233, DOI 10.1016/S0002-9440(10)62968-9; CALENDER A, 1987, P NATL ACAD SCI USA, V84, P8060, DOI 10.1073/pnas.84.22.8060; CHUNG SC, 1994, BRIT J PHARMACOL, V113, P861, DOI 10.1111/j.1476-5381.1994.tb17072.x; Cloonan SM, 2011, INT J CANCER, V128, P1712, DOI 10.1002/ijc.25477; Dellis O, 2002, J BIOL CHEM, V277, P6044, DOI 10.1074/jbc.M111831200; Dellis O, 2006, SCIENCE, V313, P229, DOI 10.1126/science.1125203; Dellis O, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-59; Eliopoulos AG, 2001, SEMIN CANCER BIOL, V11, P435, DOI 10.1006/scbi.2001.0410; FAGGIONI A, 1986, SCIENCE, V232, P1554, DOI 10.1126/science.3012779; Feske S, 2001, NAT IMMUNOL, V2, P316, DOI 10.1038/86318; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Floettmann JE, 1996, VIROLOGY, V223, P29, DOI 10.1006/viro.1996.0452; Gelebart P, 2002, J BIOL CHEM, V277, P26310, DOI 10.1074/jbc.M201747200; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Harr MW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005579; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; Ji W, 2008, P NATL ACAD SCI USA, V105, P13668, DOI 10.1073/pnas.0806499105; Kawa K, 2000, INT J HEMATOL, V71, P108; Lee DY, 2008, ONCOGENE, V27, P2833, DOI 10.1038/sj.onc.1210946; Li HP, 2003, J BIOMED SCI, V10, P490, DOI 10.1159/000072376; McCarl CA, 2009, J ALLERGY CLIN IMMUN, V124, P1311, DOI 10.1016/j.jaci.2009.10.007; MENEZES J, 1975, BIOMEDICINE, V22, P276; MILLER CL, 1993, J VIROL, V67, P3087, DOI 10.1128/JVI.67.6.3087-3094.1993; Morita T, 2009, J CELL SCI, V122, P1220, DOI 10.1242/jcs.041640; Oh-Hora M, 2008, CURR OPIN IMMUNOL, V20, P250, DOI 10.1016/j.coi.2008.04.004; OWEN CS, 1993, ANAL BIOCHEM, V215, P90, DOI 10.1006/abio.1993.1559; Penna A, 2008, NATURE, V456, P116, DOI 10.1038/nature07338; Prakriya M, 2001, J PHYSIOL-LONDON, V536, P3, DOI 10.1111/j.1469-7793.2001.t01-1-00003.x; Putney J W Jr, 2001, Mol Interv, V1, P84; Robert C, 2006, CANCER RES, V66, P6336, DOI 10.1158/0008-5472.CAN-06-0078; Scrimgeour N, 2009, J PHYSIOL-LONDON, V587, P2903, DOI 10.1113/jphysiol.2009.170662; SINCLAIR AJ, 1992, CELL GROWTH DIFFER, V3, P557; WANG F, 1990, J VIROL, V64, P3407, DOI 10.1128/JVI.64.7.3407-3416.1990; Yang SY, 2009, CANCER CELL, V15, P124, DOI 10.1016/j.ccr.2008.12.019	35	27	28	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18583	18592		10.1074/jbc.M111.222257	http://dx.doi.org/10.1074/jbc.M111.222257			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21454636	Green Published, hybrid			2022-12-25	WOS:000290785700030
J	Hamamura, K; Tsuji, M; Hotta, H; Ohkawa, Y; Takahashi, M; Shibuya, H; Nakashima, H; Yamauchi, Y; Hashimoto, N; Hattori, H; Ueda, M; Furukawa, K; Furukawa, K				Hamamura, Kazunori; Tsuji, Momoko; Hotta, Hiroshi; Ohkawa, Yuki; Takahashi, Masataka; Shibuya, Hidenobu; Nakashima, Hideyuki; Yamauchi, Yoshio; Hashimoto, Noboru; Hattori, Hisashi; Ueda, Minoru; Furukawa, Keiko; Furukawa, Koichi			Functional Activation of Src Family Kinase Yes Protein Is Essential for the Enhanced Malignant Properties of Human Melanoma Cells Expressing Ganglioside GD3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							G(D3) SYNTHASE GENE; C-YES; CARCINOMA CELLS; DOWN-REGULATION; LIPID RAFTS; PC12 CELLS; GROWTH; CANCER; PROLIFERATION; LOCALIZATION	The possible roles of Src family kinases in the enhanced malignant properties of melanomas related to GD3 expression were analyzed. Among Src family kinases only Yes, not Fyn or Src, was functionally involved in the increased cell proliferation and invasion of GD3-expressing transfectant cells (GD3+). Yes was located upstream of p130Cas and paxillin and at an equivalent level to focal adhesion kinase. Yes underwent autophosphorylation even before serum treatment and showed stronger kinase activity in GD3+ cells than in GD3- cells following serum treatment. Coimmunoprecipitation experiments revealed that Yes bound to focal adhesion kinase or p130Cas more strongly in GD3+ cells than in GD3-cells. As a possible mechanism for the enhancing effects of GD3 on cellular phenotypes, it was shown that majority of Yes was localized in glycolipid-enriched microdomain/rafts in GD3+ cells even before serum treatment, whereas it was scarcely detected in glycolipid-enriched microdomain/rafts in GD3- cells. An in vitro kinase assay of Yes revealed that coexistence of GD3 with Yes in membranous environments enhances the kinase activity of GD3- cell-derived Yes toward enolase, p125, and Yes itself. Knock-down of GD3 synthase resulted in the alleviation of tumor phenotypes and reduced activation levels of Yes. Taken together, these results suggest a role of GD3 in the regulation of Src family kinases.	[Hamamura, Kazunori; Tsuji, Momoko; Hotta, Hiroshi; Ohkawa, Yuki; Takahashi, Masataka; Shibuya, Hidenobu; Nakashima, Hideyuki; Yamauchi, Yoshio; Hashimoto, Noboru; Furukawa, Keiko; Furukawa, Koichi] Nagoya Univ, Grad Sch Med, Showa Ku, Dept Biochem 2, Nagoya, Aichi 4660065, Japan; [Hotta, Hiroshi; Shibuya, Hidenobu; Nakashima, Hideyuki; Hattori, Hisashi; Ueda, Minoru] Nagoya Univ, Grad Sch Med, Showa Ku, Dept Oral & Maxillofacial Surg, Nagoya, Aichi 4660065, Japan; [Furukawa, Keiko] Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, Kasugai, Aichi 4878501, Japan	Nagoya University; Nagoya University; Chubu University	Furukawa, K (corresponding author), Nagoya Univ, Grad Sch Med, Showa Ku, Dept Biochem 2, 65 Tsurumai, Nagoya, Aichi 4660065, Japan.	koichi@med.nagoya-u.ac.jp	Yamauchi, Yoshio/I-7539-2014	Yamauchi, Yoshio/0000-0001-5559-4596; Hamamura, Kazunori/0000-0002-8143-338X	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant-in-aid for scientific research on priority areas from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT).	Barraclough J, 2007, NEOPLASIA, V9, P745, DOI 10.1593/neo.07442; Bhunia AK, 2002, J BIOL CHEM, V277, P16396, DOI 10.1074/jbc.M200877200; Birkle S, 2000, J NEUROCHEM, V74, P547, DOI 10.1046/j.1471-4159.2000.740547.x; Daniotti JL, 2002, NEUROCHEM RES, V27, P1421, DOI 10.1023/A:1021684018665; Evans SV, 1999, J MOL RECOGNIT, V12, P155, DOI 10.1002/(SICI)1099-1352(199905/06)12:3<155::AID-JMR456>3.0.CO;2-S; Frame MC, 2002, BBA-REV CANCER, V1602, P114, DOI 10.1016/S0304-419X(02)00040-9; Furukawa K, 2007, COMPREHENSIVE GLYCOS, V4, P149; Hakomori S, 2000, GLYCOCONJUGATE J, V17, P143, DOI 10.1023/A:1026524820177; HAKOMORI SI, 1981, ANNU REV BIOCHEM, V50, P733, DOI 10.1146/annurev.bi.50.070181.003505; Hamamura K, 2005, P NATL ACAD SCI USA, V102, P11041, DOI 10.1073/pnas.0503658102; Hamamura K, 2008, BBA-GEN SUBJECTS, V1780, P513, DOI 10.1016/j.bbagen.2007.11.002; Han NM, 1996, CLIN CANCER RES, V2, P1397; HARAGUCHI M, 1994, P NATL ACAD SCI USA, V91, P10455, DOI 10.1073/pnas.91.22.10455; Kasahara K, 1997, J BIOL CHEM, V272, P29947, DOI 10.1074/jbc.272.47.29947; Kasai A, 2005, GENES CELLS, V10, P1175, DOI 10.1111/j.1365-2443.2005.00909.x; Ko K, 2006, ONCOGENE, V25, P6924, DOI 10.1038/sj.onc.1209683; LEDEEN RW, 1982, METHOD ENZYMOL, V83, P139; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; LOGANZO F, 1993, ONCOGENE, V8, P2637; Marchetti D, 1998, ONCOGENE, V16, P3253, DOI 10.1038/sj.onc.1201877; McCabe JB, 2001, MOL BIOL CELL, V12, P3601, DOI 10.1091/mbc.12.11.3601; Mitsuda T, 2002, J BIOL CHEM, V277, P11239, DOI 10.1074/jbc.M107756200; Moon SK, 2004, J BIOL CHEM, V279, P33063, DOI 10.1074/jbc.M313462200; Nakano J, 1996, J INVEST DERMATOL, V107, P543, DOI 10.1111/1523-1747.ep12582802; Nishio M, 2004, J BIOL CHEM, V279, P33368, DOI 10.1074/jbc.M403816200; Ohkawa Y, 2008, BIOCHEM BIOPH RES CO, V373, P14, DOI 10.1016/j.bbrc.2008.05.149; Okada M, 1996, CANCER RES, V56, P2844; Osenkowski P, 2008, J BIOL CHEM, V283, P22529, DOI 10.1074/jbc.M801925200; PARK J, 1995, MOL CELL BIOL, V15, P2374; SUGAWARA K, 1991, BRIT J CANCER, V63, P508, DOI 10.1038/bjc.1991.121; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Wiegandt H, 1985, GLYCOLIPIDS, V10, P199, DOI DOI 10.1016/S0167-7306(08)60022-8; YAMASHIRO S, 1995, GLYCOCONJUGATE J, V12, P894, DOI 10.1007/BF00731251; Yoshida S, 2001, CANCER RES, V61, P4244; Zeng GC, 2000, INT J CANCER, V88, P53, DOI 10.1002/1097-0215(20001001)88:1<53::AID-IJC8>3.0.CO;2-7; Zhang Q, 2006, J BIOL CHEM, V281, P18145, DOI 10.1074/jbc.M512566200	36	46	48	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18526	18537		10.1074/jbc.M110.164798	http://dx.doi.org/10.1074/jbc.M110.164798			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21454696	Green Published, hybrid			2022-12-25	WOS:000290785700025
J	Jo, C; Cho, SJ; Jo, SA				Jo, Chulman; Cho, Sun-Jung; Jo, Sangmee Ahn			Mitogen-activated Protein Kinase Kinase 1 (MEK1) Stabilizes MyoD through Direct Phosphorylation at Tyrosine 156 During Myogenic Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE ATROPHY; IN-VIVO; REGULATORY FACTORS; UBIQUITIN LIGASE; NUCLEAR EXPORT; DNA-BINDING; MAP KINASE; HUMAN P53; C-MOS; TRANSCRIPTION	Previously, we reported that mitogen-activated protein kinase kinase 1 (MEK1) activated in the mid-stage of skeletal muscle differentiation promotes myogenic differentiation. To elucidate the molecular mechanism, we investigated an activity of MEK1 for MyoD. Activated MEK1 associates with MyoD in the nucleus of differentiating myoblasts. In vitro kinase assay using active MEK1, a P-32-labeled protein band corresponding to GST-MyoD was observed but not to mutant GST-MyoD-Y156F. Tyrosine phosphorylation of endogenous MyoD was detected with a specific anti-pMyoD-Y156 antibody; however, this response was blocked by PD184352, a MEK-specific inhibitor. These results indicate that activated MEK1 phosphorylates the MyoD-Y156 residue directly. Interestingly, the protein level of mutant MyoD-Y156F decreased compared with that of wild type but was recovered in the presence of lactacystin, a proteasome inhibitor. The protein level of MyoD-Y156E, which mimics phosphorylation at Tyr-156, was above that of wild type, indicating that the phosphorylation protects MyoD from the ubiquitin proteasome-mediated degradation. In addition, the low protein level of MyoD-Y156F was recovered over that of wild type by an additional mutation at Leu-164, a critical binding residue of MAFbx/AT-1, a Skp, Cullin, F-box (SCF) E3-ubiquitin ligase. The amount of MyoD co-precipitated with MAFbx/AT-1 also was reduced in the presence of active MEK1. Thus, these results suggested that the phosphorylation probably interrupts the binding of MAFbx/AT-1 to MyoD and thereby increases its stability. Collectively, our results suggest that MEK1 activated in differentiating myoblasts stimulates muscle differentiation by phosphorylating MyoD-Y156, which results in MyoD stabilization.	[Jo, Sangmee Ahn] Dankook Univ, Dept Pharm, Coll Pharm, Cheonan Si 330714, Chungnam, South Korea; [Jo, Chulman; Cho, Sun-Jung; Jo, Sangmee Ahn] Korea Ctr Dis Control & Prevent, Div Brain Dis, Ctr Biomed Sci, Natl Inst Hlth, Gangoe Myeon 363951, Chungcheongbuk, South Korea	Dankook University; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Biomedical Science	Jo, SA (corresponding author), Dankook Univ, Dept Pharm, Coll Pharm, San 29 Anseo Dong, Cheonan Si 330714, Chungnam, South Korea.	smahn@dankook.ac.kr			National Institute of Health (Korea) [4800-4845-300-210]	National Institute of Health (Korea)	This work was supported by an intramural research fund (4800-4845-300-210) from the National Institute of Health (Korea) and conducted by the Research Fund of Dankook University in 2010.	Abu Hatoum O, 1998, MOL CELL BIOL, V18, P5670, DOI 10.1128/MCB.18.10.5670; Bardwell L, 1996, TRENDS BIOCHEM SCI, V21, P373, DOI 10.1016/S0968-0004(96)30032-7; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; BLAIR WS, 1994, MOL CELL BIOL, V14, P7226, DOI 10.1128/MCB.14.11.7226; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Buckingham M, 2001, CURR OPIN GENET DEV, V11, P440, DOI 10.1016/S0959-437X(00)00215-X; Burgermeister E, 2007, MOL CELL BIOL, V27, P803, DOI 10.1128/MCB.00601-06; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chehab NH, 1999, P NATL ACAD SCI USA, V96, P13777, DOI 10.1073/pnas.96.24.13777; Dorman CM, 1999, ONCOGENE, V18, P5167, DOI 10.1038/sj.onc.1202907; Fukuda M, 1997, J BIOL CHEM, V272, P32642, DOI 10.1074/jbc.272.51.32642; Galceran J, 2003, J NEURAL TRANSM-SUPP, P139; Glass DJ, 2003, NAT CELL BIOL, V5, P87, DOI 10.1038/ncb0203-87; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Gredinger E, 1998, J BIOL CHEM, V273, P10436, DOI 10.1074/jbc.273.17.10436; Hughes SM, 1997, MECH DEVELOP, V61, P151, DOI 10.1016/S0925-4773(96)00631-4; Ishido M, 2004, ACTA PHYSIOL SCAND, V180, P281, DOI 10.1046/j.0001-6772.2003.01238.x; Ishido M, 2004, AM J PHYSIOL-CELL PH, V287, pC484, DOI 10.1152/ajpcell.00080.2004; Jaaro H, 1997, P NATL ACAD SCI USA, V94, P3742, DOI 10.1073/pnas.94.8.3742; Jo C, 2005, PROTEIN PEPTIDE LETT, V12, P631, DOI 10.2174/0929866054696064; Jo C, 2005, BBA-MOL CELL RES, V1743, P187, DOI 10.1016/j.bbamcr.2004.11.002; Jo C, 2009, CELL SIGNAL, V21, P1910, DOI 10.1016/j.cellsig.2009.08.008; Kitzmann M, 1999, MOL CELL BIOL, V19, P3167; Lagirand-Cantaloube J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004973; LEIBOVITCH SA, 1991, ONCOGENE, V6, P1617; Lenormand JL, 1997, MOL CELL BIOL, V17, P584, DOI 10.1128/MCB.17.2.584; Lingbeck JM, 2003, J BIOL CHEM, V278, P1817, DOI 10.1074/jbc.M208815200; Liu LN, 1998, CELL GROWTH DIFFER, V9, P699; Maki K, 2008, J IMMUNOL, V181, P494, DOI 10.4049/jimmunol.181.1.494; Megeney LA, 1996, GENE DEV, V10, P1173, DOI 10.1101/gad.10.10.1173; Murton AJ, 2008, BBA-MOL BASIS DIS, V1782, P730, DOI 10.1016/j.bbadis.2008.10.011; Pelpel K, 2000, FEBS LETT, V474, P233, DOI 10.1016/S0014-5793(00)01610-0; Perry RLS, 2001, MOL CELL, V8, P291, DOI 10.1016/S1097-2765(01)00302-1; Puri PL, 2002, NAT GENET, V32, P585, DOI 10.1038/ng1023; Puri PL, 2000, J CELL PHYSIOL, V185, P155, DOI 10.1002/1097-4652(200011)185:2<155::AID-JCP1>3.0.CO;2-Z; Reynaud EG, 1999, MOL CELL BIOL, V19, P7621; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Shaul YD, 2007, BBA-MOL CELL RES, V1773, P1213, DOI 10.1016/j.bbamcr.2006.10.005; Song A, 1998, MOL CELL BIOL, V18, P4994, DOI 10.1128/MCB.18.9.4994; Takahashi-Yanaga F, 2004, BIOCHEM BIOPH RES CO, V316, P411, DOI 10.1016/j.bbrc.2004.02.061; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Tintignac LA, 2005, J BIOL CHEM, V280, P2847, DOI 10.1074/jbc.M411346200; Unger T, 1999, EMBO J, V18, P1805, DOI 10.1093/emboj/18.7.1805; Zetser A, 2001, DEV BIOL, V240, P168, DOI 10.1006/dbio.2001.0465; Zhao WD, 2005, J CELL BIOCHEM, V96, P209, DOI 10.1002/jcb.20468	46	21	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18903	18913		10.1074/jbc.M111.225128	http://dx.doi.org/10.1074/jbc.M111.225128			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21454680	hybrid, Green Published			2022-12-25	WOS:000290785700062
J	Li, LX; Hossain, MA; Sadat, S; Hager, L; Liu, L; Tam, L; Schroer, S; Huogen, L; Fantus, IG; Connelly, PW; Woo, M; Ng, DS				Li, Lixin; Hossain, Mohammad A.; Sadat, Sabreena; Hager, Lauren; Liu, Lu; Tam, Laetitia; Schroer, Stephanie; Huogen, Lu; Fantus, I. George; Connelly, Philip W.; Woo, Minna; Ng, Dominic S.			Lecithin Cholesterol Acyltransferase Null Mice Are Protected from Diet-induced Obesity and Insulin Resistance in a Gender-specific Manner through Multiple Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; SKELETAL-MUSCLE; GENE-EXPRESSION; OXIDATIVE STRESS; ADIPOSE-TISSUE; DEFICIENT MICE; FATTY-ACID; IN-VIVO; METABOLISM; DISEASE	Complete lecithin cholesterol acyltransferase(LCAT) deficiency uniformly results in a profound HDL deficiency. We recently reported unexpected enhanced insulin sensitivity in LCAT knock-out mice in the LDL receptor knock-out background (Ldlr(-/-) x Lcat(-/-); double knock-out (DKO)), when compared with their Ldlr(-/-) x Lcat(+/+) (single knock-out (SKO)) controls. Here, we report that LCAT-deficient mice (DKO and Lcat(-/-)) are protected against high fat high sucrose (HFHS) diet-induced obesity without hypophagia in a gender-specific manner compared with their respective (SKO and WT) controls. The metabolic phenotypes are more pronounced in the females. Changes in endoplasmic reticulum stress were examined as a possible mechanism for the metabolic protection. The female DKO mice developed attenuated HFHS-induced endoplasmic reticulum stress as evidenced by a lack of increase in mRNA levels of the hepatic unfolded protein response (UPR) markers Grp78 and CHOP compared with SKO controls. The DKO female mice were also protected against diet-induced insulin resistance. In white adipose tissue of chow-fed DKO mice, we also observed a reduction in UPR, gene markers for adipogenesis, and markers for activation of Wnt signaling. In skeletal muscles of female DKO mice, we observed an unexpected increase in UCP1 in association with increase in phospho-AMPK alpha, PGC1 alpha, and UCP3 expressions. This increase in UCP1 was associated with ectopic islands of brown adipocytes between skeletal muscle fibers. Our findings suggest that LCAT deficiency confers gender-specific protection against diet-induced obesity and insulin resistance at least in part through regulation in UPR, white adipose tissue adipogenesis, and brown adipocyte partitioning.	[Li, Lixin; Hossain, Mohammad A.; Sadat, Sabreena; Hager, Lauren; Liu, Lu; Tam, Laetitia; Connelly, Philip W.; Woo, Minna; Ng, Dominic S.] St Michaels Hosp, Dept Med, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada; [Huogen, Lu; Fantus, I. George] Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; [Huogen, Lu; Fantus, I. George] Univ Hlth Network, Toronto Gen Res Inst, Banting & Best Diabet Ctr, Toronto, ON M5G 2C4, Canada; [Schroer, Stephanie; Woo, Minna] Univ Toronto, Ontario Canc Inst, Dept Med Biophys, Toronto, ON M5G 2N9, Canada; [Schroer, Stephanie; Woo, Minna] Univ Toronto, Ontario Canc Inst, Inst Med Sci, Toronto, ON M5G 2N9, Canada	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Ng, DS (corresponding author), St Michaels Hosp, Dept Med, Li Ka Shing Knowledge Inst, Keenan Res Ctr, 30 Bond St,Shuter Wing,Rm 3-041, Toronto, ON M5B 1W8, Canada.	ngd@smh.toronto.on.ca	Connelly, Philip W/B-7583-2012; Li, Lixin/F-3034-2014	Connelly, Philip W/0000-0001-7244-6843; Li, Lixin/0000-0003-3016-4228	Heart and Stroke Foundation of Ontario [NA 6331]; Canadian Institutes of Health Research [MOP 77527, MOP-191501, MOP 97979]; Banting and Best Diabetes Center; Department of Laboratory Medicine and Pathobiology at the University of Toronto	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Banting and Best Diabetes Center; Department of Laboratory Medicine and Pathobiology at the University of Toronto	This work was supported in part by Grant-in-aid NA 6331 from the Heart and Stroke Foundation of Ontario; Canadian Institutes of Health Research Operating Grants MOP 77527 (to D.S.N.), MOP-191501 (to M. W.), and MOP 97979 (to I. G. F.); a Banting and Best Diabetes Center summer studentship (to L. T.); and Department of Laboratory Medicine and Pathobiology at the University of Toronto summer studentships (to S. S.).	Almind K, 2007, P NATL ACAD SCI USA, V104, P2366, DOI 10.1073/pnas.0610416104; Azzu V, 2010, TRENDS BIOCHEM SCI, V35, P298, DOI 10.1016/j.tibs.2009.11.001; Basseri S, 2009, J LIPID RES, V50, P2486, DOI 10.1194/jlr.M900216-JLR200; Benton CR, 2008, APPL PHYSIOL NUTR ME, V33, P843, DOI 10.1139/H08-074; Bezaire V, 2005, FASEB J, V19, P977, DOI 10.1096/fj.04-2765fje; Boden G, 2008, DIABETES, V57, P2438, DOI 10.2337/db08-0604; Calabresi L, 2009, CIRCULATION, V120, P628, DOI 10.1161/CIRCULATIONAHA.108.818143; Cinti S, 2009, AM J PHYSIOL-ENDOC M, V297, pE977, DOI 10.1152/ajpendo.00183.2009; Gregor MF, 2009, DIABETES, V58, P693, DOI 10.2337/db08-1220; Guo W, 2007, AM J PHYSIOL-ENDOC M, V293, pE576, DOI 10.1152/ajpendo.00523.2006; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Keipert S, 2010, BBA-BIOENERGETICS, V1797, P324, DOI 10.1016/j.bbabio.2009.11.008; Li LX, 2007, AM J PHYSIOL-ENDOC M, V293, pE587, DOI 10.1152/ajpendo.00278.2007; Michael LF, 2001, P NATL ACAD SCI USA, V98, P3820, DOI 10.1073/pnas.061035098; Moore GBT, 2001, BIOCHEM BIOPH RES CO, V283, P785, DOI 10.1006/bbrc.2001.4848; Neschen S, 2008, PHYSIOL GENOMICS, V33, P333, DOI 10.1152/physiolgenomics.00226.2007; Ng DS, 2008, CARDIOVASC PATHOL, V17, P226, DOI 10.1016/j.carpath.2007.10.001; Ng DS, 2004, J BIOL CHEM, V279, P7636, DOI 10.1074/jbc.M309439200; Ng DS, 2002, J BIOL CHEM, V277, P11715, DOI 10.1074/jbc.M112320200; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Prestwich TC, 2007, CURR OPIN CELL BIOL, V19, P612, DOI 10.1016/j.ceb.2007.09.014; Rong JX, 2007, DIABETES, V56, P1751, DOI 10.2337/db06-1135; Rousset X, 2009, CURR OPIN ENDOCRINOL, V16, P163, DOI 10.1097/MED.0b013e328329233b; Schreyer SA, 2002, AM J PHYSIOL-ENDOC M, V282, pE207, DOI 10.1152/ajpendo.2002.282.1.E207; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Sethi AA, 2010, CLIN CHEM, V56, P1128, DOI 10.1373/clinchem.2009.139931; Sharma NK, 2008, J CLIN ENDOCR METAB, V93, P4532, DOI 10.1210/jc.2008-1001; Song H, 2006, AM J PHYSIOL-ENDOC M, V290, pE17, DOI 10.1152/ajpendo.00597.2004; Sparks LM, 2005, DIABETES, V54, P1926, DOI 10.2337/diabetes.54.7.1926; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104; Wright WS, 2007, DIABETES, V56, P295, DOI 10.2337/db06-1339; Zhu XH, 2004, AM J PATHOL, V165, P1269, DOI 10.1016/S0002-9440(10)63386-X	36	40	43	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17809	17820		10.1074/jbc.M110.180893	http://dx.doi.org/10.1074/jbc.M110.180893			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454561	hybrid, Green Published			2022-12-25	WOS:000290585200044
J	Strube, CP; Homann, A; Gamer, M; Jahn, D; Seibel, J; Heinz, DW				Strube, Christian P.; Homann, Arne; Gamer, Martin; Jahn, Dieter; Seibel, Juergen; Heinz, Dirk W.			Polysaccharide Synthesis of the Levansucrase SacB from Bacillus megaterium Is Controlled by Distinct Surface Motifs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ASPERGILLUS-AWAMORI; SUBSTRATE; SUBTILIS; ENZYMES; INULOSUCRASE; INVERTASE	Despite the widespread biological function of carbohydrates, the polysaccharide synthesis mechanisms of glycosyltransferases remain largely unexplored. Bacterial levansucrases (glycoside hydrolase family 68) synthesize high molecular weight, beta-(2,6)-linked levan from sucrose by transfer of fructosyl units. The kinetic and biochemical characterization of Bacillus megaterium levansucrase SacB variants Y247A, Y247W, N252A, D257A, and K373A reveal novel surface motifs remote from the sucrose binding site with distinct influence on the polysaccharide product spectrum. The wild type activity (k(cat)) and substrate affinity (K-m) are maintained. The structures of the SacB variants reveal clearly distinguishable subsites for polysaccharide synthesis as well as an intact active site architecture. These results lead to a new understanding of polysaccharide synthesis mechanisms. The identified surface motifs are discussed in the context of related glycosyltransferases.	[Homann, Arne; Seibel, Juergen] Univ Wurzburg, Dept Organ Chem, D-97074 Wurzburg, Germany; [Strube, Christian P.; Heinz, Dirk W.] Helmholtz Ctr Infect Res, Dept Mol Struct Biol, D-38124 Braunschweig, Germany; [Gamer, Martin; Jahn, Dieter] Tech Univ Carolo Wilhelmina Braunschweig, Dept Microbiol, D-38106 Braunschweig, Germany	University of Wurzburg; Helmholtz Association; Helmholtz-Center for Infection Research; Braunschweig University of Technology	Seibel, J (corresponding author), Univ Wurzburg, Dept Organ Chem, D-97074 Wurzburg, Germany.	seibel@chemie.uni-wuerzburg.de; dih@helmholtz-hzi.de	Seibel, Juergen/A-6908-2015	Seibel, Juergen/0000-0002-8036-4853; Jahn, Dieter/0000-0002-4064-9205	Deutsche Forschungsgemeinschaft through Collaborative Research Centre [(SFB) 578]; Fonds der Chemischen Industrie	Deutsche Forschungsgemeinschaft through Collaborative Research Centre(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported by the Deutsche Forschungsgemeinschaft through Collaborative Research Centre (SFB) 578.; Supported by the Fonds der Chemischen Industrie.	Alberto F, 2006, BIOCHEM J, V395, P457, DOI [10.1042/BJ20051936, 10.1042/Bj20051936]; Alberto F, 2004, J BIOL CHEM, V279, P18903, DOI 10.1074/jbc.M313911200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beine R, 2008, J BIOTECHNOL, V138, P33, DOI 10.1016/j.jbiotec.2008.07.1998; Beisel HG, 1999, EMBO J, V18, P2313, DOI 10.1093/emboj/18.9.2313; CHAMBERT R, 1974, EUR J BIOCHEM, V41, P285, DOI 10.1111/j.1432-1033.1974.tb03269.x; CHAMBERT R, 1991, BIOCHEM J, V279, P35, DOI 10.1042/bj2790035; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DWEK RA, 1996, GLYCOBIOLOGY, V96, P97; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FEINGOLD DS, 1956, BIOCHEM J, V64, P351, DOI 10.1042/bj0640351; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; HESTRIN S, 1956, BIOCHEM J, V64, P340, DOI 10.1042/bj0640340; Homann A, 2007, BIOCHEM J, V407, P189, DOI 10.1042/BJ20070600; Homann A, 2009, NAT PROD REP, V26, P1555, DOI 10.1039/b909990p; Homann A, 2009, APPL MICROBIOL BIOT, V83, P209, DOI 10.1007/s00253-009-1989-5; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kralj S, 2004, MICROBIOL-SGM, V150, P2099, DOI 10.1099/mic.0.27105-0; Kralj S, 2008, FEBS J, V275, P6002, DOI 10.1111/j.1742-4658.2008.06729.x; Kulminskaya AA, 2003, BBA-PROTEINS PROTEOM, V1650, P22, DOI 10.1016/S1570-9639(03)00187-0; MANTSALA P, 1982, FEMS MICROBIOL LETT, V13, P395, DOI 10.1016/0378-1097(82)90198-7; Martinez-Fleites C, 2005, BIOCHEM J, V390, P19, DOI 10.1042/BJ20050324; Meng G, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-16; Meng GY, 2003, NAT STRUCT BIOL, V10, P935, DOI 10.1038/nsb974; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagem RAP, 2004, J MOL BIOL, V344, P471, DOI 10.1016/j.jmb.2004.09.024; Ozimek LK, 2006, MICROBIOL-SGM, V152, P1187, DOI 10.1099/mic.0.28484-0; van Hijum SAFT, 2006, MICROBIOL MOL BIOL R, V70, P157, DOI 10.1128/MMBR.70.1.157-176.2006; van Hijum SAFT, 2003, FEBS LETT, V534, P207, DOI 10.1016/S0014-5793(02)03841-3; Varki A., 1999, ESSENTIALS GLYCOBIOL; Wong C.-H., 2003, CARBOHYDRATE BASED D	31	76	80	1	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17593	17600		10.1074/jbc.M110.203166	http://dx.doi.org/10.1074/jbc.M110.203166			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21454585	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000290585200022
J	Dar, AA; Majid, S; de Semir, D; Nosrati, M; Bezrookove, V; Kashani-Sabet, M				Dar, Altaf A.; Majid, Shahana; de Semir, David; Nosrati, Mehdi; Bezrookove, Vladimir; Kashani-Sabet, Mohammed			miRNA-205 Suppresses Melanoma Cell Proliferation and Induces Senescence via Regulation of E2F1 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CANCER; TARGET GENES; EXPRESSION; MICRORNAS; APOPTOSIS; FAMILY; DIFFERENTIATION; OVEREXPRESSION; PROGRESSION; METASTASIS	MicroRNAs (miRNAs) regulate gene expression by repressing translation or directing sequence-specific degradation of complementary mRNA. Here, we report that expression of miR-205 is significantly suppressed in melanoma specimens when compared with nevi and is correlated inversely with melanoma progression. miRNA target databases predicted E2F1 and E2F5 as putative targets. The expression levels of E2F1 and E2F5 were correlated inversely with that of miR-205 in melanoma cell lines. miR-205 significantly suppressed the luciferase activity of reporter plasmids containing the 3'-UTR sequences complementary to either E2F1 or E2F5. Overexpression of miR-205 in melanoma cells reduced E2F1 and E2F5 protein levels. The proliferative capacity of melanoma cells was suppressed by miR-205 and mediated by E2F-regulated AKT phosphorylation. miR-205 overexpression resulted in induction of apoptosis, as evidenced by increased cleaved caspase-3, poly-(ADP-ribose) polymerase, and cytochrome c release. Stable overexpression of miR-205 suppressed melanoma cell proliferation, colony formation, and tumor cell growth in vivo and induced a senescence phenotype accompanied by elevated expression of p16INK4A and other markers for senescence. E2F1 overexpression in miR-205-expressing cells partially reversed the effects on melanoma cell growth and senescence. These results demonstrate a novel role for miR-205 as a tumor suppressor in melanoma.	[Kashani-Sabet, Mohammed] Calif Pacific Med Ctr, Ctr Melanoma Res & Treatment, Res Inst, San Francisco, CA 94107 USA; [Majid, Shahana] Vet Affairs Med Ctr, Dept Urol, San Francisco, CA 94121 USA; [Majid, Shahana] Univ Calif San Francisco, San Francisco, CA 94121 USA	California Pacific Medical Center; California Pacific Medical Center Research Institute; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco	Kashani-Sabet, M (corresponding author), Calif Pacific Med Ctr, Ctr Melanoma Res & Treatment, Res Inst, 475 Brannan St,Ste 220, San Francisco, CA 94107 USA.	kashani@cpmcri.org			National Institutes of Health, United States Public Health Service [CA114337, CA122947]; Herschel and Diana Zackheim Endowment Fund; NATIONAL CANCER INSTITUTE [R01CA122947, R01CA114337] Funding Source: NIH RePORTER	National Institutes of Health, United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); Herschel and Diana Zackheim Endowment Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health, United States Public Health Service Grants CA114337 and CA122947 (to M. K.-S.). This work was also supported by the Herschel and Diana Zackheim Endowment Fund.	Alla V, 2010, JNCI-J NATL CANCER I, V102, P127, DOI 10.1093/jnci/djp458; Ambros V, 2007, DEVELOPMENT, V134, P1635, DOI 10.1242/dev.002006; Attwooll C, 2004, EMBO J, V23, P4709, DOI 10.1038/sj.emboj.7600481; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bartels CL, 2009, CLIN CHEM, V55, P623, DOI 10.1373/clinchem.2008.112805; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Dar AA, 2008, CANCER-AM CANCER SOC, V112, P1688, DOI 10.1002/cncr.23371; Dar AA, 2010, J INVEST DERMATOL, V130, P2071, DOI 10.1038/jid.2010.70; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; DeGregori J, 2002, BBA-REV CANCER, V1602, P131, DOI 10.1016/S0304-419X(02)00051-3; Felicetti F, 2008, CANCER RES, V68, P2745, DOI 10.1158/0008-5472.CAN-07-2538; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; Gottardo F, 2007, UROL ONCOL-SEMIN ORI, V25, P387, DOI 10.1016/j.urolonc.2007.01.019; Gregory PA, 2008, CELL CYCLE, V7, P3112, DOI 10.4161/cc.7.20.6851; Guo XM, 2007, CIRC RES, V101, P1113, DOI 10.1161/CIRCRESAHA.107.157644; Haferkamp S, 2008, AGING CELL, V7, P733, DOI 10.1111/j.1474-9726.2008.00422.x; Halaban R, 2000, J EXP MED, V191, P1005, DOI 10.1084/jem.191.6.1005; Harfe BD, 2005, CURR OPIN GENET DEV, V15, P410, DOI 10.1016/j.gde.2005.06.012; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Huang EY, 2001, ONCOGENE, V20, P7051, DOI 10.1038/sj.onc.1204897; Jiang JM, 2005, NUCLEIC ACIDS RES, V33, P5394, DOI 10.1093/nar/gki863; Jiang YY, 2004, J BIOL CHEM, V279, P40511, DOI 10.1074/jbc.M404496200; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kitago M, 2009, CLIN CANCER RES, V15, P2988, DOI 10.1158/1078-0432.CCR-08-3172; Kothandaraman Narasimhan, 2010, BMC Cancer, V10, P64, DOI 10.1186/1471-2407-10-64; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Ladu S, 2008, GASTROENTEROLOGY, V135, P1322, DOI 10.1053/j.gastro.2008.07.012; Lee JH, 1996, JNCI-J NATL CANCER I, V88, P1731, DOI 10.1093/jnci/88.23.1731; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Louie MC, 2004, MOL CELL BIOL, V24, P5157, DOI 10.1128/MCB.24.12.5157-5171.2004; Michael MZ, 2003, MOL CANCER RES, V1, P882; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Nelson MA, 2006, CANCER BIOL THER, V5, P407, DOI 10.4161/cbt.5.4.2512; Nicoloso MS, 2009, NAT REV CANCER, V9, P293, DOI 10.1038/nrc2619; Philippidou D, 2010, CANCER RES, V70, P4163, DOI 10.1158/0008-5472.CAN-09-4512; Pierce AM, 1999, MOL CELL BIOL, V19, P6408; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; SAITO M, 1995, GENOMICS, V25, P130, DOI 10.1016/0888-7543(95)80118-6; Segura MF, 2009, P NATL ACAD SCI USA, V106, P1814, DOI 10.1073/pnas.0808263106; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Sempere LF, 2007, CANCER RES, V67, P11612, DOI 10.1158/0008-5472.CAN-07-5019; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; Thomas GV, 2004, CLIN CANCER RES, V10, P8351, DOI 10.1158/1078-0432.CCR-04-0130; Tong AW, 2008, CANCER GENE THER, V15, P341, DOI 10.1038/cgt.2008.8; Tuve S, 2004, INT J CANCER, V108, P162, DOI 10.1002/ijc.11552; Umemura S, 2009, BRIT J CANCER, V100, P764, DOI 10.1038/sj.bjc.6604900; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yi R, 2010, CELL DEATH DIFFER, V17, P229, DOI 10.1038/cdd.2009.92	51	185	192	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16606	16614		10.1074/jbc.M111.227611	http://dx.doi.org/10.1074/jbc.M111.227611			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454583	Green Published, hybrid			2022-12-25	WOS:000290301900009
J	Larue, K; Ford, RC; Willis, LM; Whitfield, C				Larue, Kane; Ford, Robert C.; Willis, Lisa M.; Whitfield, Chris			Functional and Structural Characterization of Polysaccharide Co-polymerase Proteins Required for Polymer Export in ATP-binding Cassette Transporter-dependent Capsule Biosynthesis Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-WEIGHT SUCCINOGLYCAN; CELL-SURFACE EXPRESSION; GRAM-NEGATIVE BACTERIA; ESCHERICHIA-COLI; OUTER-MEMBRANE; CHAIN-LENGTH; NEISSERIA-MENINGITIDIS; POLYSIALIC ACID; GENE-CLUSTER; TYROSINE AUTOKINASE	Neisseria meningitidis serogroup B and Escherichia coli K1 bacteria produce a capsular polysaccharide (CPS) that is composed of alpha 2,8-linked polysialic acid (PSA). Biosynthesis of PSA in these bacteria occurs via an ABC (ATP-binding cassette) transporter-dependent pathway. In N. meningitidis, export of PSA to the surface of the bacterium requires two proteins that form an ABC transporter (CtrC and CtrD) and two additional proteins, CtrA and CtrB, that are proposed to form a cell envelope-spanning export complex. CtrA is a member of the outer membrane polysaccharide export (OPX) family of proteins, which are proposed to form a pore to mediate export of CPSs across the outer membrane. CtrB is an inner membrane protein belonging to the polysaccharide co-polymerase (PCP) family. PCP proteins involved in other bacterial polysaccharide assembly systems form structures that extend into the periplasm from the inner membrane. There is currently no structural information available for PCP or OPX proteins involved in an ABC transporter-dependent CPS biosynthesis pathway to support their proposed roles in polysaccharide export. Here, we report cryo-EM images of purified CtrB reconstituted into lipid bilayers. These images contained molecular top and side views of CtrB and showed that it formed a conical oligomer that extended similar to 125 angstrom from the membrane. This structure is consistent with CtrB functioning as a component of an envelope-spanning complex. Cross-complementation of CtrA and CtrB in E. coli mutants with defects in genes encoding the corresponding PCP and OPX proteins show that PCP-OPX pairs require interactions with their cognate partners to export polysaccharide. These experiments add further support for the model of an ABC transporter-PCP-OPX multiprotein complex that functions to export CPS across the cell envelope.	[Larue, Kane; Willis, Lisa M.; Whitfield, Chris] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Ford, Robert C.] Univ Manchester, Fac Life Sci, Manchester M60 1QD, Lancs, England	University of Guelph; University of Manchester	Whitfield, C (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	cwhitfie@uoguelph.ca		Willis, Lisa/0000-0001-6204-033X; Ford, Robert/0000-0002-0958-1505	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by operating funding from the Canadian Institutes of Health Research (to C. W.).	AMOS LA, 1983, PROG BIOPHYS MOL BIO, V39, P183, DOI 10.1016/0079-6107(83)90017-2; Arrecubieta C, 2001, J BIOL CHEM, V276, P4245, DOI 10.1074/jbc.M008183200; BASTIN DA, 1993, MOL MICROBIOL, V7, P725, DOI 10.1111/j.1365-2958.1993.tb01163.x; BATCHELOR RA, 1992, J BACTERIOL, V174, P5228, DOI 10.1128/JB.174.16.5228-5236.1992; BATCHELOR RA, 1991, J BACTERIOL, V173, P5699, DOI 10.1128/jb.173.18.5699-5704.1991; Bechet E, 2010, MOL MICROBIOL, V77, P1315, DOI 10.1111/j.1365-2958.2010.07291.x; Becker A, 1998, J BACTERIOL, V180, P395, DOI 10.1128/JB.180.2.395-399.1998; BECKER A, 1995, MOL MICROBIOL, V16, P191, DOI 10.1111/j.1365-2958.1995.tb02292.x; Bliss JM, 1996, MOL MICROBIOL, V21, P221, DOI 10.1046/j.1365-2958.1996.6461357.x; BRONNER D, 1993, J BACTERIOL, V175, P5984, DOI 10.1128/JB.175.18.5984-5992.1993; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; CIESLEWICZ MJ, 1993, J BACTERIOL, V175, P8018, DOI 10.1128/JB.175.24.8018-8023.1993; Clarke BR, 2004, J BIOL CHEM, V279, P35709, DOI 10.1074/jbc.M404738200; Clarke BR, 2009, J BIOL CHEM, V284, P30662, DOI 10.1074/jbc.M109.052878; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Collins RF, 2006, J BIOL CHEM, V281, P2144, DOI 10.1074/jbc.M508078200; Collins RF, 2007, P NATL ACAD SCI USA, V104, P2390, DOI 10.1073/pnas.0607763104; CROSS AS, 1986, J INFECT DIS, V154, P497, DOI 10.1093/infdis/154.3.497; Culham DE, 2003, BIOCHEMISTRY-US, V42, P11815, DOI 10.1021/bi034939j; Cuthbertson L, 2007, P NATL ACAD SCI USA, V104, P19529, DOI 10.1073/pnas.0705709104; Cuthbertson L, 2010, MICROBIOL MOL BIOL R, V74, P341, DOI 10.1128/MMBR.00009-10; Cuthbertson L, 2009, MICROBIOL MOL BIOL R, V73, P155, DOI 10.1128/MMBR.00024-08; Daniels C, 1999, MOL MICROBIOL, V34, P181, DOI 10.1046/j.1365-2958.1999.01591.x; DEVI SJN, 1991, INFECT IMMUN, V59, P732, DOI 10.1128/IAI.59.2.732-736.1991; Dong CJ, 2006, NATURE, V444, P226, DOI 10.1038/nature05267; Doublet P, 2002, J BIOL CHEM, V277, P37339, DOI 10.1074/jbc.M204465200; Drummelsmith J, 2000, EMBO J, V19, P57, DOI 10.1093/emboj/19.1.57; FIGUEROA J, 1993, IMMUNOL RES, V12, P295, DOI 10.1007/BF02918259; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Harvey D, 1999, SEMIN PERINATOL, V23, P218, DOI 10.1016/S0146-0005(99)80066-4; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Klein NJ, 1996, J INFECT DIS, V173, P172, DOI 10.1093/infdis/173.1.172; Kos V, 2009, J BIOL CHEM, V284, P2947, DOI 10.1074/jbc.M807213200; Larue K, 2009, J BIOL CHEM, V284, P7395, DOI 10.1074/jbc.M809068200; Lee DC, 2008, EMBO J, V27, P1758, DOI 10.1038/emboj.2008.97; Lo RYC, 2001, INFECT IMMUN, V69, P4458, DOI 10.1128/IAI.69.7.4458-4464.2001; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; MCNEIL G, 1994, MICROB PATHOGENESIS, V16, P153, DOI 10.1006/mpat.1994.1016; McNulty C, 2006, MOL MICROBIOL, V59, P907, DOI 10.1111/j.1365-2958.2005.05010.x; MORONA R, 1995, J BACTERIOL, V177, P1059, DOI 10.1128/jb.177.4.1059-1068.1995; Morona R, 2000, MICROBIOL-UK, V146, P1, DOI 10.1099/00221287-146-1-1; Morona R, 2009, TRENDS BIOCHEM SCI, V34, P78, DOI 10.1016/j.tibs.2008.11.001; Nesper J, 2003, J BIOL CHEM, V278, P49763, DOI 10.1074/jbc.M308775200; PAZZANI C, 1993, J BACTERIOL, V175, P5978, DOI 10.1128/JB.175.18.5978-5983.1993; Phoenix DA, 2001, BIOCHEM BIOPH RES CO, V285, P976, DOI 10.1006/bbrc.2001.5266; PLATONOV AE, 1995, CLIN EXP IMMUNOL, V100, P32, DOI 10.1111/j.1365-2249.1995.tb03600.x; Silver RP, 2001, RES MICROBIOL, V152, P357, DOI 10.1016/S0923-2508(01)01207-4; Steenbergen SM, 2008, MOL MICROBIOL, V68, P1252, DOI 10.1111/j.1365-2958.2008.06231.x; Tocilj A, 2008, NAT STRUCT MOL BIOL, V15, P130, DOI 10.1038/nsmb.1374; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; VIMR ER, 1985, J BACTERIOL, V164, P845, DOI 10.1128/JB.164.2.845-853.1985; VIMR ER, 1985, J BACTERIOL, V164, P854, DOI 10.1128/JB.164.2.854-860.1985; VIMR ER, 1984, P NATL ACAD SCI-BIOL, V81, P1971, DOI 10.1073/pnas.81.7.1971; VIMR ER, 1989, J BACTERIOL, V171, P1106, DOI 10.1128/jb.171.2.1106-1117.1989; Vimr ER, 2009, MICROBIOL-SGM, V155, P9, DOI 10.1099/mic.0.023564-0; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Woodward R, 2010, NAT CHEM BIOL, V6, P418, DOI 10.1038/nchembio.351; Wugeditsch T, 2001, J BIOL CHEM, V276, P2361, DOI 10.1074/jbc.M009092200; Ye LW, 2001, J BACTERIOL, V183, P2490, DOI 10.1128/JB.183.8.2490-2496.2001	62	26	26	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16658	16668		10.1074/jbc.M111.228221	http://dx.doi.org/10.1074/jbc.M111.228221			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454677	hybrid, Green Published			2022-12-25	WOS:000290301900014
J	Suzuki, T; Wakabayashi, C; Tanaka, K; Feniouk, BA; Yoshida, M				Suzuki, Toshiharu; Wakabayashi, Chiaki; Tanaka, Kazumi; Feniouk, Boris A.; Yoshida, Masasuke			Modulation of Nucleotide Specificity of Thermophilic FoF1-ATP Synthase by epsilon-Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTON MOTIVE FORCE; C-TERMINAL DOMAIN; COLI ATP SYNTHASE; ESCHERICHIA-COLI; ADENOSINE-TRIPHOSPHATASE; F0F1-ATP SYNTHASE; F1F0-ATP SYNTHASE; F-1-ATPASE; ROTATION; MECHANISM	The C-terminal two alpha-helices of the epsilon-subunit of thermophilic Bacillus FoF1-ATP synthase (TFoF1) adopt two conformations: an extended long arm ("up-state") and a retracted hairpin ("down-state"). As ATP becomes poor, changes the conformation from the down-state to the up-state and suppresses further ATP hydrolysis. Using TFoF1 expressed in Escherichia coli, we compared TFoF1 with up-and down-state epsilon in the NTP (ATP, GTP, UTP, and CTP) synthesis reactions. TFoF1 with the up-state epsilon was achieved by inclusion of hexokinase in the assay and TFoF1 with the down-state epsilon was represented by epsilon Delta c-TFoF1, in which epsilon lacks C-terminal helices and hence cannot adopt the up-state under any conditions. The results indicate that TFoF1 with the down-state epsilon synthesizes GTP at the same rate of ATP, whereas TFoF1 with the up-state epsilon synthesizes GTP at a half-rate. Though rates are slow, TFoF1 with the down-state epsilon even catalyzes UTP and CTP synthesis. Authentic TFoF1 from Bacillus cells also synthesizes ATP and GTP at the same rate in the presence of adenosine 5'-(beta,gamma-imino) triphosphate (AMP-PNP), an ATP analogue that has been known to stabilize the downstate. NTP hydrolysis and NTP-driven proton pumping activity of epsilon Delta c-TFoF1 suggests similar modulation of nucleotide specificity in NTP hydrolysis. Thus, depending on its conformation, epsilon-subunit modulates substrate specificity of TFoF1.	[Suzuki, Toshiharu; Wakabayashi, Chiaki; Tanaka, Kazumi; Feniouk, Boris A.; Yoshida, Masasuke] Japan Sci & Technol Corp, Int Res Project ICORP, ATP Synth Regulat Project, Tokyo 1350064, Japan; [Yoshida, Masasuke] Kyoto Sangyo Univ, Dept Mol Biosci, Kyoto 6038555, Japan	Japan Science & Technology Agency (JST); Kyoto Sangyo University	Yoshida, M (corresponding author), Japan Sci & Technol Corp, Int Res Project ICORP, ATP Synth Regulat Project, Aomi 2-41, Tokyo 1350064, Japan.	masasuke.yoshida@cc.kyoto-su.ac.jp	Feniouk, Boris/F-2380-2012	Feniouk, Boris/0000-0003-0474-7411				BAGNARA AS, 1973, EUR J BIOCHEM, V36, P422, DOI 10.1111/j.1432-1033.1973.tb02927.x; Boyer PD, 2002, J BIOL CHEM, V277, P39045, DOI 10.1074/jbc.X200001200; Cipriano DJ, 2006, J BIOL CHEM, V281, P501, DOI 10.1074/jbc.M509986200; Duser MG, 2009, EMBO J, V28, P2689, DOI 10.1038/emboj.2009.213; Feniouk Boris A., 2008, V45, P279, DOI 10.1007/400_2007_043; Feniouk BA, 2007, J BIOL CHEM, V282, P764, DOI 10.1074/jbc.M606321200; Feniouk BA, 2006, BBA-BIOENERGETICS, V1757, P326, DOI 10.1016/j.bbabio.2006.03.022; Feniouk BA, 2010, BIOPHYS J, V98, P434, DOI 10.1016/j.bpj.2009.10.023; Garcia JJ, 2000, J BIOL CHEM, V275, P11075, DOI 10.1074/jbc.275.15.11075; Hong S, 2008, MICROBIOL MOL BIOL R, V72, P590, DOI 10.1128/MMBR.00016-08; Iino R, 2005, J BIOL CHEM, V280, P40130, DOI 10.1074/jbc.M506160200; Junge W, 2009, NATURE, V459, P364, DOI 10.1038/nature08145; Kato Y, 1997, J BIOL CHEM, V272, P24906, DOI 10.1074/jbc.272.40.24906; Kato-Yamada Y, 2003, J BIOL CHEM, V278, P36013, DOI 10.1074/jbc.M306140200; Kato-Yamada Y, 2000, J BIOL CHEM, V275, P35746, DOI 10.1074/jbc.M006575200; Kinosita K, 2004, ANNU REV BIOPH BIOM, V33, P245, DOI 10.1146/annurev.biophys.33.110502.132716; Konno H, 2004, BIOCHEM BIOPH RES CO, V318, P17, DOI 10.1016/j.bbrc.2004.03.179; Masaike T, 2006, BIOCHEM BIOPH RES CO, V342, P800, DOI 10.1016/j.bbrc.2006.02.017; MORIKAWA M, 1980, J BIOCHEM-TOKYO, V87, P441, DOI 10.1093/oxfordjournals.jbchem.a132764; Nakamoto RK, 2008, ARCH BIOCHEM BIOPHYS, V476, P43, DOI 10.1016/j.abb.2008.05.004; Nakanishi-Matsui M, 2010, BBA-BIOENERGETICS, V1797, P1343, DOI 10.1016/j.bbabio.2010.02.014; Neidhardt F. C., 1987, CELLULAR MOL BIOL, P445; Noji H, 2001, J BIOL CHEM, V276, P25480, DOI 10.1074/jbc.M102200200; PENEFSKY HS, 1974, J BIOL CHEM, V249, P3579; Rodgers AJW, 2000, NAT STRUCT BIOL, V7, P1051; Saita E, 2010, J BIOL CHEM, V285, P11411, DOI 10.1074/jbc.M109.099143; Senior AE, 2002, BBA-BIOENERGETICS, V1553, P188, DOI 10.1016/S0005-2728(02)00185-8; SMITH JB, 1977, BIOCHEMISTRY-US, V16, P306, DOI 10.1021/bi00621a023; SONE N, 1975, J BIOL CHEM, V250, P7917; Suzuki T, 2003, J BIOL CHEM, V278, P46840, DOI 10.1074/jbc.M307165200; Suzuki T, 2002, J BIOL CHEM, V277, P13281, DOI 10.1074/jbc.M111210200; Suzuki T, 2007, P NATL ACAD SCI USA, V104, P20776, DOI 10.1073/pnas.0708075105; Tsunoda SP, 2001, P NATL ACAD SCI USA, V98, P6560, DOI 10.1073/pnas.111128098; Uhlin U, 1997, STRUCTURE, V5, P1219, DOI 10.1016/S0969-2126(97)00272-4; von Ballmoos C, 2009, ANNU REV BIOCHEM, V78, P649, DOI 10.1146/annurev.biochem.78.081307.104803; WILKENS S, 1995, NAT STRUCT BIOL, V2, P961, DOI 10.1038/nsb1195-961; Yagi H, 2007, P NATL ACAD SCI USA, V104, P11233, DOI 10.1073/pnas.0701045104; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509	38	4	4	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16807	16813		10.1074/jbc.M110.209965	http://dx.doi.org/10.1074/jbc.M110.209965			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454506	Green Published, hybrid			2022-12-25	WOS:000290301900030
J	Woldt, E; Matz, RL; Terrand, J; Mlih, M; Gracia, C; Foppolo, S; Martin, S; Bruban, V; Ji, J; Velot, E; Herz, J; Boucher, P				Woldt, Estelle; Matz, Rachel L.; Terrand, Jerome; Mlih, Mohamed; Gracia, Celine; Foppolo, Sophie; Martin, Sophie; Bruban, Veronique; Ji, Julie; Velot, Emilie; Herz, Joachim; Boucher, Philippe			Differential Signaling by Adaptor Molecules LRP1 and ShcA Regulates Adipogenesis by the Insulin-like Growth Factor-1 Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESENCHYMAL STEM-CELLS; LIPOPROTEIN RECEPTOR; PHOSPHATIDYLINOSITOL 3-KINASE; IGF-I; PHOSPHOINOSITIDE 3-KINASE; ADIPOCYTE DIFFERENTIATION; TYROSINE PHOSPHORYLATION; CYTOPLASMIC DOMAIN; UROKINASE RECEPTOR; PROTEIN LRP	The low density lipoprotein receptor-related protein (LRP1) is a transmembrane receptor that integrates multiple signaling pathways. Its cytoplasmic domain serves as docking sites for several adaptor proteins such as the Src homology 2/alpha-collagen (ShcA), which also binds to several tyrosine kinase receptors such as the insulin-like growth factor 1 (IGF-1) receptor. However, the physiological significance of the physical interaction between LRP1 and ShcA, and whether this interaction modifies tyrosine kinase receptor signaling, are still unknown. Here we report that LRP1 forms a complex with the IGF-1 receptor, and that LRP1 is required for ShcA to become sensitive to IGF-1 stimulation. Upon IGF-1 treatment, ShcA is tyrosine phosphorylated and translocates to the plasma membrane only in the presence of LRP1. This leads to the recruitment of the growth factor receptor-bound protein 2 (Grb2) to ShcA, and activation of the Ras/MAP kinase pathway. Conversely, in the absence of ShcA, IGF-1 signaling bifurcates toward the Akt/mammalian target of rapamycin pathway and accelerates adipocyte differentiation when cells are stimulated for adipogenesis. These results establish the LRP1-ShcA complex as an essential component in the IGF-1-regulated pathway for MAP kinase and Akt/mammalian target of rapamycin activation, and may help to understand the IGF-1 signaling shift from clonal expansion to growth-arrested cells and differentiation during adipogenesis.	[Woldt, Estelle; Matz, Rachel L.; Terrand, Jerome; Mlih, Mohamed; Gracia, Celine; Foppolo, Sophie; Martin, Sophie; Bruban, Veronique; Ji, Julie; Velot, Emilie; Boucher, Philippe] Univ Strasbourg, CNRS, UMR7213, F-67401 Illkirch Graffenstaden, France; [Herz, Joachim] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Texas System; University of Texas Southwestern Medical Center Dallas	Matz, RL (corresponding author), Univ Strasbourg, CNRS, UMR7213, F-67401 Illkirch Graffenstaden, France.	rachel.matz-westphal@unistra.fr; philippe.boucher@unistra.fr	martin, sophie/AAP-3498-2021; Velot, Emilie/P-6561-2019; Mlih, Mohamed/O-4834-2019	Velot, Emilie/0000-0001-8620-5696; Mlih, Mohamed/0000-0003-3491-9616; Gracia, Celine/0000-0002-3312-6465; Martin, Sophie/0000-0002-2907-7445; MATZ, Rachel/0000-0001-5832-7063; Terrand, jerome/0000-0002-8169-7713; Boucher, Philippe/0000-0002-3928-9812	National Institutes of Health; Centre National Pour la Recherche Scientifique (CNRS); Nouvelle Societe Francaise d'atherosclerose (NSFA); Fondation pour la Recherche Medicale (FRM); Fondation de France; Agence Nationale de la Recherche [ANR-06-Physio-032]; American Health Assistance Foundation; Humboldt Foundation [SFB780]; Consortium for Frontotemporal Dementia; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL063762] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centre National Pour la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Nouvelle Societe Francaise d'atherosclerose (NSFA); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Fondation de France(Fondation de France); Agence Nationale de la Recherche(French National Research Agency (ANR)); American Health Assistance Foundation; Humboldt Foundation(Alexander von Humboldt Foundation); Consortium for Frontotemporal Dementia; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by grants from the National Institutes of Health (to J. H.), the Centre National Pour la Recherche Scientifique (CNRS), Nouvelle Societe Francaise d'atherosclerose (NSFA), Fondation pour la Recherche Medicale (FRM), Fondation de France, and Agence Nationale de la Recherche Grant ANR-06-Physio-032.; Supported by grants from the American Health Assistance Foundation, the Humboldt Foundation, SFB780, and the Consortium for Frontotemporal Dementia.	Barnes H, 2003, ONCOGENE, V22, P3589, DOI 10.1038/sj.onc.1206504; BLAIKIE P, 1994, J BIOL CHEM, V269, P32031; BONEY CM, 1994, ENDOCRINOLOGY, V135, P1863, DOI 10.1210/en.135.5.1863; Boney CM, 1998, ENDOCRINOLOGY, V139, P1638, DOI 10.1210/en.139.4.1638; Boney CM, 2000, MOL ENDOCRINOL, V14, P805, DOI 10.1210/me.14.6.805; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Boucher P, 2002, J BIOL CHEM, V277, P15507, DOI 10.1074/jbc.M200428200; COBB MH, 1995, J BIOL CHEM, V270, P14843, DOI 10.1074/jbc.270.25.14843; CONESE M, 1995, J CELL BIOL, V131, P1609, DOI 10.1083/jcb.131.6.1609; CRAPARO A, 1995, J BIOL CHEM, V270, P15639, DOI 10.1074/jbc.270.26.15639; Dey BR, 1996, MOL ENDOCRINOL, V10, P631, DOI 10.1210/me.10.6.631; HERZ J, 1988, EMBO J, V7, P4119, DOI 10.1002/j.1460-2075.1988.tb03306.x; Herz J, 2009, J LIPID RES, V50, pS287, DOI 10.1194/jlr.R800077-JLR200; Holzenberger M, 2001, ENDOCRINOLOGY, V142, P4469, DOI 10.1210/en.142.10.4469; Hosooka T, 2008, NAT MED, V14, P188, DOI 10.1038/nm1706; Kim JE, 2004, DIABETES, V53, P2748, DOI 10.2337/diabetes.53.11.2748; Kulik G, 1997, MOL CELL BIOL, V17, P1595, DOI 10.1128/MCB.17.3.1595; Laviola L, 2007, CURR PHARM DESIGN, V13, P663, DOI 10.2174/138161207780249146; Levine AJ, 2006, GENE DEV, V20, P267, DOI 10.1101/gad.1363206; Ling Y, 2005, MOL BIOL CELL, V16, P3353, DOI 10.1091/mbc.E04-10-0918; Liu PS, 2002, J BIOL CHEM, V277, P41295, DOI 10.1074/jbc.R200020200; Loukinova E, 2002, J BIOL CHEM, V277, P15499, DOI 10.1074/jbc.M200427200; Mantuano E, 2010, J BIOL CHEM, V285, P14259, DOI 10.1074/jbc.M109.085126; May P, 2007, ANN MED, V39, P219, DOI 10.1080/07853890701214881; Migliaccio E, 1997, EMBO J, V16, P706, DOI 10.1093/emboj/16.4.706; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; PELICCI G, 1992, CELL, V70, P93, DOI 10.1016/0092-8674(92)90536-L; Pessin Jeffrey E., 1999, Endocrine Journal, V46, pS11, DOI 10.1507/endocrj.46.Suppl_S11; Ravichandran KS, 2001, ONCOGENE, V20, P6322, DOI 10.1038/sj.onc.1204776; REICHMAN CT, 1992, CELL GROWTH DIFFER, V3, P451; Sakai J, 1996, CELL, V85, P1037, DOI 10.1016/S0092-8674(00)81304-5; Sakaue H, 1998, J BIOL CHEM, V273, P28945, DOI 10.1074/jbc.273.44.28945; Salani B, 2008, ENDOCRINOLOGY, V149, P461, DOI 10.1210/en.2007-0312; Scavo LM, 2004, J CLIN ENDOCR METAB, V89, P3543, DOI 10.1210/jc.2003-031682; Shao DL, 1998, NATURE, V396, P377, DOI 10.1038/24634; SMITH PJ, 1988, J BIOL CHEM, V263, P9402; STAHL A, 1995, J CELL BIOL, V129, P335, DOI 10.1083/jcb.129.2.335; Takayama Y, 2005, J BIOL CHEM, V280, P18504, DOI 10.1074/jbc.M410265200; Terrand J, 2009, J BIOL CHEM, V284, P381, DOI 10.1074/jbc.M806538200; TOMIYAMA K, 1995, BIOCHEM BIOPH RES CO, V212, P263, DOI 10.1006/bbrc.1995.1965; Webb DJ, 2000, J CELL SCI, V113, P123; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xia XM, 1999, J CELL PHYSIOL, V178, P9, DOI 10.1002/(SICI)1097-4652(199901)178:1<9::AID-JCP2>3.0.CO;2-#; Xu JF, 2004, J BIOL CHEM, V279, P35914, DOI 10.1074/jbc.M402297200; YOKOTE K, 1994, J BIOL CHEM, V269, P15337; Yu WH, 2008, MOL CELL BIOCHEM, V310, P11, DOI 10.1007/s11010-007-9661-9; Zhang JC, 1998, J BIOL CHEM, V273, P32273, DOI 10.1074/jbc.273.48.32273; Zhou L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006922	48	23	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16775	16782		10.1074/jbc.M110.212878	http://dx.doi.org/10.1074/jbc.M110.212878			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21454706	Green Published, hybrid			2022-12-25	WOS:000290301900026
J	Sucic, S; El-Kasaby, A; Kudlacek, O; Sarker, S; Sitte, HH; Marin, P; Freissmuth, M				Sucic, Sonja; El-Kasaby, Ali; Kudlacek, Oliver; Sarker, Subhodeep; Sitte, Harald H.; Marin, Philippe; Freissmuth, Michael			The Serotonin Transporter Is an Exclusive Client of the Coat Protein Complex II (COPII) Component SEC24C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; GABA TRANSPORTER-1; CELL-LINE; FUNCTIONAL EXPRESSION; DOPAMINE TRANSPORTER; OLIGOMER FORMATION; C-TERMINUS; EXPORT; TRAFFICKING; GENE	The transporters for serotonin (SERT), dopamine, and noradrenaline have a conserved hydrophobic core but divergent N and C termini. The C terminus harbors the binding site for the coat protein complex II (COPII) cargo-binding protein SEC24. Here we explored which SEC24 isoform was required for export of SERT from the endoplasmic reticulum (ER). Three lines of evidence argue that SERT can only exit the ER by recruiting SEC24C: (i) Mass spectrometry showed that a peptide corresponding to the C terminus of SERT recruited SEC24C-containing COPII complexes from mouse brain lysates. (ii) Depletion of individual SEC24 isoforms by siRNAs revealed that SERT was trapped in the ER only if SEC24C was down-regulated, in both, cells that expressed SERT endogenously or after transfection. The combination of all siRNAs was not more effective than that directed against SEC24C. ASERT mutant in which the SEC24C-binding motif ((RI608)-R-607) was replaced by alanine was insensitive to down-regulation of SEC24C levels. (iii) Overexpression of a SEC24C variant with a mutation in the candidate cargo-binding motif (SEC24C-D796V/D797N) but not of the corresponding mutant SEC24D-D733V/D734N reduced SERT surface levels. In contrast, noradrenaline and dopamine transporters and the more distantly related GABA transporter 1 relied on SEC24D for ER export. These observations demonstrate that closely related transporters are exclusive client cargo proteins for different SEC24 isoforms. The short promoter polymorphism results in reduced SERT cell surface levels and renders affected individuals more susceptible to depression. By inference, variations in the Sec24C gene may also affect SERT cell surface levels and thus be linked to mood disorders.	[Sucic, Sonja; El-Kasaby, Ali; Kudlacek, Oliver; Sarker, Subhodeep; Sitte, Harald H.; Freissmuth, Michael] Med Univ Vienna, Inst Pharmacol, Ctr Physiol & Pharmacol, A-1090 Vienna, Austria; [El-Kasaby, Ali] Mansoura Univ, Fac Vet Med, Dept Pharmacol, Mansoura, Egypt; [Marin, Philippe] Univ Montpellier 1, INSERM U661, CNRS UMR 5203, Inst Genom Fonct, Montpellier 5, France; [Marin, Philippe] Univ Montpellier 2, INSERM U661, CNRS UMR 5203, Inst Genom Fonct, Montpellier 5, France	Medical University of Vienna; Egyptian Knowledge Bank (EKB); Mansoura University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Freissmuth, M (corresponding author), Med Univ Vienna, Inst Pharmacol, Ctr Physiol & Pharmacol, Waehringer Str 13A, A-1090 Vienna, Austria.	michael.freissmuth@meduniwien.ac.at	Sitte, Harald/N-2681-2013; Sitte, Harald/O-7025-2019	Sitte, Harald/0000-0002-1339-7444; Sitte, Harald/0000-0002-1339-7444; Sucic, Sonja/0000-0001-5136-8022; Freissmuth, Michael/0000-0001-9398-1765; Kudlacek, Oliver/0000-0002-3086-8551; Sarker, Subhodeep/0000-0002-2222-2072	Austrian Science Fund/Fonds zur Forderung der Wissenschaftlichen Forschung [SFB35]; Egyptian Ministry of Higher Education and State for Scientific Research; Austrian Science Fund (FWF) [F 3506] Funding Source: researchfish	Austrian Science Fund/Fonds zur Forderung der Wissenschaftlichen Forschung(Austrian Science Fund (FWF)); Egyptian Ministry of Higher Education and State for Scientific Research(Ministry of Higher Education & Scientific Research (MHESR)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Project Program Grant SFB35 from the Austrian Science Fund/Fonds zur Forderung der Wissenschaftlichen Forschung (to M. F.), and a stipend (to A. E.-K.) from Egyptian Ministry of Higher Education and State for Scientific Research.	Bartolomucci A, 2010, DIS MODEL MECH, V3, P459, DOI 10.1242/dmm.004614; Becamel C, 2004, J BIOL CHEM, V279, P20257, DOI 10.1074/jbc.M312106200; Bjerggaard C, 2004, J NEUROSCI, V24, P7024, DOI 10.1523/JNEUROSCI.1863-04.2004; Bonnon C, 2010, J CELL SCI, V123, P1705, DOI 10.1242/jcs.062950; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; COOL DR, 1991, J BIOL CHEM, V266, P15750; Dancourt J, 2010, ANNU REV BIOCHEM, V79, P777, DOI 10.1146/annurev-biochem-061608-091319; El-Kasaby A, 2010, J BIOL CHEM, V285, P39201, DOI 10.1074/jbc.M110.118000; Farhan H, 2004, J BIOL CHEM, V279, P28553, DOI 10.1074/jbc.M307325200; Farhan H, 2008, J CELL SCI, V121, P753, DOI 10.1242/jcs.017681; Farhan H, 2007, J BIOL CHEM, V282, P7679, DOI 10.1074/jbc.M609720200; Fernandez-Sanchez E, 2008, BIOCHEM J, V409, P669, DOI 10.1042/BJ20070533; Hahn MK, 2003, J NEUROSCI, V23, P4470; Karg K., 2011, ARCH GEN PS IN PRESS; KING SC, 1992, BIOCHEM BIOPH RES CO, V183, P487, DOI 10.1016/0006-291X(92)90508-I; Larsen MB, 2006, BIOCHEMISTRY-US, V45, P1331, DOI 10.1021/bi0508688; Lesch K. P., 2011, CURR TOP BE IN PRESS; Li YL, 2007, J NEUROSCI RES, V85, P2601, DOI 10.1002/jnr.21216; Mancias JD, 2008, EMBO J, V27, P2918, DOI 10.1038/emboj.2008.208; Mancias JD, 2007, MOL CELL, V26, P403, DOI 10.1016/j.molcel.2007.03.017; Merte J, 2010, NAT CELL BIOL, V12, P41, DOI 10.1038/ncb2002; Ohisa S, 2010, DEV BIOL, V342, P85, DOI 10.1016/j.ydbio.2010.03.016; Qi YP, 1997, J NEUROSCI, V17, P1217; Reiterer V, 2008, J NEUROSCI, V28, P12453, DOI 10.1523/JNEUROSCI.3451-08.2008; Russell C, 2010, TRAFFIC, V11, P303, DOI 10.1111/j.1600-0854.2009.01026.x; Sarmah S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010367; Scholze P, 2002, J BIOL CHEM, V277, P43682, DOI 10.1074/jbc.M205602200; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Siddiqi S, 2010, J LIPID RES, V51, P1093, DOI 10.1194/jlr.M002758; Sitte HH, 2003, EUR J PHARMACOL, V479, P229, DOI 10.1016/j.ejphar.2003.08.072; Torres GE, 2003, J BIOL CHEM, V278, P2731, DOI 10.1074/jbc.M201926200; Wansleeben C, 2010, DEVELOPMENT, V137, P1067, DOI 10.1242/dev.041434; Wendeler MW, 2007, EMBO REP, V8, P258, DOI 10.1038/sj.embor.7400893; Yamayoshi S, 2008, CELL HOST MICROBE, V3, P168, DOI 10.1016/j.chom.2008.02.001; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	35	60	60	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M111.230037	http://dx.doi.org/10.1074/jbc.M111.230037			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21454670	hybrid, Green Published			2022-12-25	WOS:000290022800085
J	Vial, F; Johnston, WT; Donnelly, CA				Vial, Flavie; Johnston, W. Thomas; Donnelly, Christl A.			Local Cattle and Badger Populations Affect the Risk of Confirmed Tuberculosis in British Cattle Herds	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS INFECTIONS; REPUBLIC-OF-IRELAND; HUSBANDRY PRACTICES; WILD BOAR; ENGLAND; ASSOCIATION; BREAKDOWNS; FARMS; EPIDEMIOLOGY; STRATEGIES	Background: The control of bovine tuberculosis (bTB) remains a priority on the public health agenda in Great Britain, after launching in 1998 the Randomised Badger Culling Trial (RBCT) to evaluate the effectiveness of badger (Meles meles) culling as a control strategy. Our study complements previous analyses of the RBCT data (focusing on treatment effects) by presenting analyses of herd-level risks factors associated with the probability of a confirmed bTB breakdown in herds within each treatment: repeated widespread proactive culling, localized reactive culling and no culling (survey-only). Methodology/Principal Findings: New cases of bTB breakdowns were monitored inside the RBCT areas from the end of the first proactive badger cull to one year after the last proactive cull. The risk of a herd bTB breakdown was modeled using logistic regression and proportional hazard models adjusting for local farm-level risk factors. Inside survey-only and reactive areas, increased numbers of active badger setts and cattle herds within 1500 m of a farm were associated with an increased bTB risk. Inside proactive areas, the number of M. bovis positive badgers initially culled within 1500 m of a farm was the strongest predictor of the risk of a confirmed bTB breakdown. Conclusions/Significance: The use of herd-based models provide insights into how local cattle and badger populations affect the bTB breakdown risks of individual cattle herds in the absence of and in the presence of badger culling. These measures of local bTB risks could be integrated into a risk-based herd testing programme to improve the targeting of interventions aimed at reducing the risks of bTB transmission.	[Vial, Flavie; Donnelly, Christl A.] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, MRC Ctr Outbreak Anal & Modelling, Dept Infect Dis Epidemiol, London, England; [Johnston, W. Thomas] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England	Imperial College London; University of York - UK	Vial, F (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, MRC Ctr Outbreak Anal & Modelling, Dept Infect Dis Epidemiol, London, England.	f.vial@imperial.ac.uk		Vial, Flavie/0000-0003-3603-4694; Johnston, Tom/0000-0002-5204-0966; Donnelly, Christl/0000-0002-0195-2463	U.K. Department of Environment, Food and Rural Affairs (Defra); U.K. Medical Research Council (MRC); Medical Research Council [G0600719B] Funding Source: researchfish	U.K. Department of Environment, Food and Rural Affairs (Defra)(Department for Environment, Food & Rural Affairs (DEFRA)); U.K. Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors gratefully acknowledge the support of the U.K. Department of Environment, Food and Rural Affairs (Defra; http://www.defra.gov.uk/index.htm) for this work. CAD thanks the U.K. Medical Research Council (MRC; http://www.mrc.ac.uk/index.htm) for Centre funding. The funders had no role in the design of the analyses, data analysis, decision to publish, or preparation (drafting, editing or finalizing) of the manuscript. The Randomised Badger Culling Trial (RBCT) was implemented by the staff of Defra and its associated agencies. Defra funds the ongoing collection and storage of routine surveillance data which were utilized in this study. Defra officials commented on a near-final draft of this manuscript.	Allen AR, 2010, P ROY SOC B-BIOL SCI, V277, P2737, DOI 10.1098/rspb.2010.0830; Ameni G, 2007, CLIN VACCINE IMMUNOL, V14, P1356, DOI 10.1128/CVI.00205-07; Bourne F., 2007, BOVINE TUBERCULOSIS; CHEESEMAN CL, 1989, EPIDEMIOL INFECT, V103, P113, DOI 10.1017/S0950268800030417; COLEMAN J, 2000, BRUSHTAIL POSSUM BIO; Defra, 2010, BOV TUB GOV APPR TAC; *DEFRA, 2009, BOV TB STAT GREAT BR; Denny GO, 1999, VET REC, V144, P305, DOI 10.1136/vr.144.12.305; Donnelly CA, 2006, NATURE, V439, P843, DOI 10.1038/nature04454; Donnelly CA, 2003, NATURE, V426, P834, DOI 10.1038/nature02192; DONNELLY CA, 2010, PLOS ONE COMMENT; Donnelly CA, 2007, INT J INFECT DIS, V11, P300, DOI 10.1016/j.ijid.2007.04.001; Etter E, 2006, ANN NY ACAD SCI, V1081, P61, DOI 10.1196/annals.1373.006; Gilbert M, 2005, NATURE, V435, P491, DOI 10.1038/nature03548; Gopal R, 2006, VET REC, V159, P265, DOI 10.1136/vr.159.9.265; Green LE, 2005, PREV VET MED, V70, P293, DOI 10.1016/j.prevetmed.2005.05.005; Griffin JM, 2005, PREV VET MED, V67, P237, DOI 10.1016/j.prevetmed.2004.10.009; GRIFFIN JM, 1993, PREV VET MED, V17, P145, DOI 10.1016/0167-5877(93)90025-O; Griffin JM, 1996, PREV VET MED, V27, P217, DOI 10.1016/0167-5877(95)00571-4; Hone J, 2008, J APPL ECOL, V45, P1660, DOI 10.1111/j.1365-2664.2008.01556.x; Humblet MF, 2009, VET RES, V40, DOI 10.1051/vetres/2009033; Jenkins HE, 2007, J APPL ECOL, V44, P897, DOI 10.1111/j.1365-2664.2007.01372.x; Jenkins HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009090; Johnston WT, 2005, BIOL LETT-UK, V1, P53, DOI 10.1098/rsbl.2004.0249; Kaneene JB, 2002, J AM VET MED ASSOC, V221, P837, DOI 10.2460/javma.2002.221.837; Krebs J., 1997, PB3423 HMSO; LEFEVRE AM, 2005, IMPACT LOCALISED REA; Marangon S, 1998, PREV VET MED, V34, P87, DOI 10.1016/S0167-5877(97)00087-1; Martin SW, 1997, PREV VET MED, V31, P113, DOI 10.1016/S0167-5877(96)01111-7; Menzies FD, 2000, VET J, V160, P92, DOI 10.1053/tvjl.2000.0482; Michel AL, 2007, BMC VET RES, V3, P23, DOI DOI 10.1186/1746-6148-3-23; Naranjo V, 2008, VET MICROBIOL, V127, P1, DOI 10.1016/j.vetmic.2007.10.002; Nishi JS, 2006, VET MICROBIOL, V112, P325, DOI 10.1016/j.vetmic.2005.11.013; Olea-Popelka FJ, 2004, PREV VET MED, V63, P163, DOI 10.1016/j.prevetmed.2004.03.001; OREILLY LM, 1995, TUBERCLE LUNG DIS, V76, P1, DOI 10.1016/0962-8479(95)90591-X; Payeur JB, 2002, ANN NY ACAD SCI, V969, P259, DOI 10.1111/j.1749-6632.2002.tb04389.x; Porphyre T, 2008, PREV VET MED, V86, P93, DOI 10.1016/j.prevetmed.2008.03.008; PROUD AJ, 2006, GOVT VET J, V16; Ramirez-Villaescusa AM, 2010, PREV VET MED, V95, P224, DOI 10.1016/j.prevetmed.2010.03.009; Reilly LA, 2007, PREV VET MED, V80, P129, DOI 10.1016/j.prevetmed.2007.02.002; Richomme C, 2010, J WILDLIFE DIS, V46, P627, DOI 10.7589/0090-3558-46.2.627; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Thoen C, 2006, VET MICROBIOL, V112, P339, DOI 10.1016/j.vetmic.2005.11.047; White PCL, 2004, PREV VET MED, V63, P1, DOI 10.1016/j.prevetmed.2004.02.003; Woodroffe R, 2008, J ZOOL, V274, P28, DOI 10.1111/j.1469-7998.2007.00353.x; Woodroffe R, 2006, J APPL ECOL, V43, P1, DOI 10.1111/j.1365-2664.2005.01144.x; WOODROFFE R, 2003, CONSERVATION CONFLIC; Woodroffe R, 2006, P NATL ACAD SCI USA, V103, P14713, DOI 10.1073/pnas.0606251103; Woodroffe R, 2009, J WILDLIFE DIS, V45, P128, DOI 10.7589/0090-3558-45.1.128	49	26	26	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e18058	10.1371/journal.pone.0018058	http://dx.doi.org/10.1371/journal.pone.0018058			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21464920	Green Published, Green Submitted, gold			2022-12-25	WOS:000289053800019
J	Fraser, ON; Bugnyar, T				Fraser, Orlaith N.; Bugnyar, Thomas			Ravens Reconcile after Aggressive Conflicts with Valuable Partners	PLOS ONE			English	Article							POSTCONFLICT AFFILIATION; CONVERGENT EVOLUTION; CORVUS-FRUGILEGUS; SCRUB-JAYS; CHIMPANZEES; PRIMATES; RESOLUTION; INTELLIGENCE; CONSOLATION; CORVIDS	Reconciliation, a post-conflict affiliative interaction between former opponents, is an important mechanism for reducing the costs of aggressive conflict in primates and some other mammals as it may repair the opponents' relationship and reduce post-conflict distress. Opponents who share a valuable relationship are expected to be more likely to reconcile as for such partners the benefits of relationship repair should outweigh the risk of renewed aggression. In birds, however, post-conflict behavior has thus far been marked by an apparent absence of reconciliation, suggested to result either from differing avian and mammalian strategies or because birds may not share valuable relationships with partners with whom they engage in aggressive conflict. Here, we demonstrate the occurrence of reconciliation in a group of captive subadult ravens (Corvus corax) and show that it is more likely to occur after conflicts between partners who share a valuable relationship. Furthermore, former opponents were less likely to engage in renewed aggression following reconciliation, suggesting that reconciliation repairs damage caused to their relationship by the preceding conflict. Our findings suggest not only that primate-like valuable relationships exist outside the pair bond in birds, but that such partners may employ the same mechanisms in birds as in primates to ensure that the benefits afforded by their relationships are maintained even when conflicts of interest escalate into aggression. These results provide further support for a convergent evolution of social strategies in avian and mammalian species.	[Fraser, Orlaith N.; Bugnyar, Thomas] Univ Vienna, Dept Cognit Biol, Vienna, Austria; [Bugnyar, Thomas] Konrad Lorenz Forschungstelle, Grunau, Austria	University of Vienna	Fraser, ON (corresponding author), Univ Vienna, Dept Cognit Biol, Vienna, Austria.	orlaith.fraser@univie.ac.at			European Science Fund [ESF-COCOR: I-105-G11]; Austrian Science Fund [FWF-START: Y366-B17]; FWF-Erwin-Schrodinger [J2064, J2225, R31-B03]; Austrian Science Fund (FWF) [Y 366] Funding Source: researchfish	European Science Fund; Austrian Science Fund(Austrian Science Fund (FWF)); FWF-Erwin-Schrodinger(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was supported by grants from the European Science Fund (ESF-COCOR: I-105-G11) and the Austrian Science Fund (FWF-START: Y366-B17; FWF-Erwin-Schrodinger J2064, J2225 and R31-B03) to TB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, LME4 LINEAR MIXED EF; Arnold K., 2010, PRIMATES PERSPECTIVE, V2, P608; Aureli F, 2002, ANIM BEHAV, V64, P325, DOI 10.1006/anbe.2002.3071; Aureli F., 2000, NATURAL CONFLICT RES; Boarman W. I., 1999, BIRDS N AM, V476; Bugnyar T, 2002, ANIM BEHAV, V64, P185, DOI 10.1006/anbe.2002.3056; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Clayton NS, 1998, NATURE, V395, P272, DOI 10.1038/26216; Colmenares F, 2006, INT J PRIMATOL, V27, P1311, DOI 10.1007/s10764-006-9080-x; Cools AKA, 2008, ETHOLOGY, V114, P53, DOI 10.1111/j.1439-0310.2007.01443.x; Cordoni G, 2008, ETHOLOGY, V114, P298, DOI 10.1111/j.1439-0310.2008.01474.x; Cords M., 2000, NATURAL CONFLICT RES, P177; COZZI A, 2010, BEHAV PROCESS; De Waal, 1989, PEACEMAKING PRIMATES; de Waal F.B.M., 1986, P341; de Waal FBM, 2000, SCIENCE, V289, P586, DOI 10.1126/science.289.5479.586; DEWAAL FBM, 1979, BEHAV ECOL SOCIOBIOL, V5, P55, DOI 10.1007/BF00302695; DEWAAL FBM, 1983, BEHAVIOUR, V85, P224, DOI 10.1163/156853983X00237; Dunbar RIM, 2007, SCIENCE, V317, P1344, DOI 10.1126/science.1145463; Dunbar RIM, 2010, BEHAVIOUR, V147, P775, DOI 10.1163/000579510X501151; Emery N. J., 2004, COMP ANAL MINDS, P181, DOI DOI 10.1098/RSTB.2006.1991; Emery NJ, 2007, PHILOS T R SOC B, V362, P489, DOI 10.1098/rstb.2006.1991; Emery NJ, 2004, SCIENCE, V306, P1903, DOI 10.1126/science.1098410; Fraser ON, 2008, AM J PRIMATOL, V70, P1114, DOI 10.1002/ajp.20608; Fraser ON, 2008, ETHOLOGY, V114, P834, DOI 10.1111/j.1439-0310.2008.01527.x; Fraser ON, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010605; Fraser ON, 2010, ANIM BEHAV, V79, P927, DOI 10.1016/j.anbehav.2010.01.008; KAPPELER PM, 1992, ETHOLOGY, V92, P51; Raby CR, 2007, NATURE, V445, P919, DOI 10.1038/nature05575; Ratcliffe DA., 1997, RAVEN; Schino Gabriele, 2000, P225; Seed A, 2009, ETHOLOGY, V115, P401, DOI 10.1111/j.1439-0310.2009.01644.x; Seed AM, 2008, P ROY SOC B-BIOL SCI, V275, P1421, DOI 10.1098/rspb.2008.0111; Seed AM, 2007, CURR BIOL, V17, P152, DOI 10.1016/j.cub.2006.11.025; Silk JB, 2000, NATURAL CONFLICT RES, P179; VEENEMA HC, 1994, BEHAV PROCESS, V31, P29, DOI 10.1016/0376-6357(94)90035-3; VONBLOTZHEIM UNG, 1993, HDB VOGEL MITTELEURO, V13, P600; Wahaj SA, 2001, ETHOLOGY, V107, P1057, DOI 10.1046/j.1439-0310.2001.00717.x; Watts DP, 2006, INT J PRIMATOL, V27, P1337, DOI 10.1007/s10764-006-9081-9; WEIR AAS, 2002, SHAPING HOOKS NEW CA, P981	40	67	68	3	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e18118	10.1371/journal.pone.0018118	http://dx.doi.org/10.1371/journal.pone.0018118			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464962	Green Submitted, Green Published, gold			2022-12-25	WOS:000288813900039
J	Tseng, YC; Chen, RD; Lucassen, M; Schmidt, MM; Dringen, R; Abele, D; Hwang, PP				Tseng, Yung-Che; Chen, Ruo-Dong; Lucassen, Magnus; Schmidt, Maike M.; Dringen, Ralf; Abele, Doris; Hwang, Pung-Pung			Exploring Uncoupling Proteins and Antioxidant Mechanisms under Acute Cold Exposure in Brains of Fish	PLOS ONE			English	Article							OXYGEN SPECIES PRODUCTION; OXIDATIVE STRESS; GENE-EXPRESSION; NONSHIVERING THERMOGENESIS; SUPEROXIDE-DISMUTASE; ENERGY-METABOLISM; SKELETAL-MUSCLE; UP-REGULATION; HYPOXIA; ZEBRAFISH	Exposure to fluctuating temperatures accelerates the mitochondrial respiration and increases the formation of mitochondrial reactive oxygen species (ROS) in ectothermic vertebrates including fish. To date, little is known on potential oxidative damage and on protective antioxidative defense mechanisms in the brain of fish under cold shock. In this study, the concentration of cellular protein carbonyls in brain was significantly increased by 38% within 1 h after cold exposure (from 28 degrees C to 18 degrees C) of zebrafish (Danio rerio). In addition, the specific activity of superoxide dismutase (SOD) and the mRNA level of catalase (CAT) were increased after cold exposure by about 60% (6 h) and by 60%-90% (1 and 24 h), respectively, while the specific glutathione content as well as the ratio of glutathione disulfide to glutathione remained constant and at a very low level. In addition, cold exposure increased the protein level of hypoxia-inducible factor (HIF) by about 50% and the mRNA level of the glucose transporter zglut3 in brain by 50%-100%. To test for an involvement of uncoupling proteins (UCPs) in the cold adaptation of zebrafish, five UCP members were annotated and identified (zucp1-5). With the exception of zucp1, the mRNA levels of the other four zucps were significantly increased after cold exposure. In addition, the mRNA levels of four of the fish homologs (zppar) of the peroxisome proliferator-activated receptor (PPAR) were increased after cold exposure. These data suggest that PPARs and UCPs are involved in the alterations observed in zebrafish brain after exposure to 18 degrees C. The observed stimulation of the PPAR-UCP axis may help to prevent oxidative damage and to maintain metabolic balance and cellular homeostasis in the brains of ectothermic zebrafish upon cold exposure.	[Tseng, Yung-Che; Chen, Ruo-Dong; Hwang, Pung-Pung] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan; [Tseng, Yung-Che] Leibniz Inst Marine Sci, IFM GEOMAR, D-24105 Kiel, Germany; [Chen, Ruo-Dong] Natl Taiwan Univ, Inst Zool, Taipei 10764, Taiwan; [Lucassen, Magnus; Abele, Doris] Alfred Wegener Inst Polar & Marine Res, D-2850 Bremerhaven, Germany; [Schmidt, Maike M.; Dringen, Ralf] Univ Bremen, Ctr Biomol Interact Bremen, Bremen, Germany	Academia Sinica - Taiwan; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Academia Sinica - Taiwan; National Taiwan University; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Bremen	Tseng, YC (corresponding author), Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan.	pphwang@gate.sinica.edu.tw	Hwang, Pung-Pung/AEQ-4633-2022; hwang, pp/A-3641-2011; Tseng, Yung-Che/AAE-7509-2022; Lucassen, Magnus/E-8433-2011; Lucassen, Magnus/ABA-8396-2021; Hwang, Pung-Pung/AAH-1538-2022	Tseng, Yung-Che/0000-0001-7489-0403; Lucassen, Magnus/0000-0003-4276-4781; Lucassen, Magnus/0000-0003-4276-4781; Dringen, Ralf/0000-0001-7869-1305; Abele, Doris/0000-0002-5766-5017	Academia Sinica; Alfred-Wegener Institute for Polar and Marine Research; National Science of Council of Taiwan; International Bureau of the Germany Federal Ministry of Education and Research	Academia Sinica(Academia Sinica - Taiwan); Alfred-Wegener Institute for Polar and Marine Research; National Science of Council of Taiwan(Ministry of Science and Technology, Taiwan); International Bureau of the Germany Federal Ministry of Education and Research	This study was financially supported by Academia Sinica (P. P. Hwang) and Alfred-Wegener Institute for Polar and Marine Research (D. Abele). Y. C. Tseng was awarded the Postdoc Scholarship supported by both the National Science of Council of Taiwan and the Bilateral Cooperation in Science and Technology grant from International Bureau of the Germany Federal Ministry of Education and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele D, 2004, COMP BIOCHEM PHYS A, V138, P405, DOI 10.1016/j.cbpb.2004.05.013; Airaksinen S, 2003, COMP BIOCHEM PHYS B, V136, P275, DOI 10.1016/S1096-4959(03)00205-7; Amo R, 2010, J NEUROSCI, V30, P1566, DOI 10.1523/JNEUROSCI.3690-09.2010; Andrews ZB, 2005, NAT REV NEUROSCI, V6, P829, DOI 10.1038/nrn1767; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Azzu V, 2010, TRENDS BIOCHEM SCI, V35, P298, DOI 10.1016/j.tibs.2009.11.001; Bell EL, 2007, J CELL BIOL, V177, P1029, DOI 10.1083/jcb.200609074; Benarroch EE, 2009, NEUROLOGY, V73, P560, DOI 10.1212/WNL.0b013e3181b2a719; Bermejo-Nogales A, 2010, J COMP PHYSIOL B, V180, P685, DOI 10.1007/s00360-009-0441-6; Blanquart C, 2003, J STEROID BIOCHEM, V85, P267, DOI 10.1016/S0960-0760(03)00214-0; Blomgren K, 2006, FREE RADICAL BIO MED, V40, P388, DOI 10.1016/j.freeradbiomed.2005.08.040; Bordet R, 2006, BIOCHEM SOC T, V34, P1341, DOI 10.1042/BST0341341; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brand MD, 2005, CELL METAB, V2, P85, DOI 10.1016/j.cmet.2005.06.002; Bugge A, 2010, J BIOL CHEM, V285, P17310, DOI 10.1074/jbc.M110.120584; Cannon B, 2006, BBA-BIOENERGETICS, V1757, P449, DOI 10.1016/j.bbabio.2006.05.016; CHAN PH, 1991, ANN NEUROL, V29, P482, DOI 10.1002/ana.410290506; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chavez A, 2008, ANN NY ACAD SCI, V1147, P312, DOI 10.1196/annals.1427.021; Chou MY, 2008, J EXP BIOL, V211, P3077, DOI 10.1242/jeb.019950; Cossins AR, 2002, BIOCHEM SOC T, V30, P1082, DOI 10.1042/bst0301082; CRAWSHAW L, 1985, PHARMACOL THERAPEUT, V30, P19, DOI 10.1016/0163-7258(85)90045-2; Dringen R, 1996, J NEUROCHEM, V67, P1375, DOI 10.1046/j.1471-4159.1996.67041375.x; Echtay KS, 2003, EMBO J, V22, P4103, DOI 10.1093/emboj/cdg412; Fandrey J, 2006, CARDIOVASC RES, V71, P642, DOI 10.1016/j.cardiores.2006.05.005; FRIEDLANDER MJ, 1976, J COMP PHYSIOL, V112, P19, DOI 10.1007/BF00612674; Girnun GD, 2002, MOL ENDOCRINOL, V16, P2793, DOI 10.1210/me.2002-0020; Hansford RG, 1997, J BIOENERG BIOMEMBR, V29, P89, DOI 10.1023/A:1022420007908; HAZEL JR, 1995, ANNU REV PHYSIOL, V57, P19, DOI 10.1146/annurev.ph.57.030195.000315; Heise K, 2007, J COMP PHYSIOL B, V177, P765, DOI 10.1007/s00360-007-0173-4; Heise K, 2006, J EXP BIOL, V209, P353, DOI 10.1242/jeb.01977; Hwang PP, 2010, FISH PHYSIOL, V29, P311, DOI 10.1016/S1546-5098(10)02908-0; JACOB RA, 1995, NUTR RES, V15, P755, DOI 10.1016/0271-5317(95)00041-G; Jastroch M, 2005, PHYSIOL GENOMICS, V22, P150, DOI 10.1152/physiolgenomics.00070.2005; Jastroch M, 2007, J COMP PHYSIOL B, V177, P743, DOI 10.1007/s00360-007-0171-6; Kasai H, 1997, MUTAT RES-REV MUTAT, V387, P147, DOI 10.1016/S1383-5742(97)00035-5; Katz LM, 2004, BRAIN RES, V1017, P85, DOI 10.1016/j.brainres.2004.05.020; Kern B, 2009, COMP BIOCHEM PHYS D, V4, P121, DOI 10.1016/j.cbd.2008.12.006; Krauss S, 2005, NAT REV MOL CELL BIO, V6, P248, DOI 10.1038/nrm1592; Li JF, 2005, CIRC RES, V97, P474, DOI 10.1161/01.RES.0000181132.11393.18; Liu D, 2006, NEUROMOL MED, V8, P389, DOI 10.1385/NMM:8:3:389; Malek RL, 2004, COMP BIOCHEM PHYS C, V138, P363, DOI 10.1016/j.cca.2004.08.014; Mao WG, 1999, FEBS LETT, V443, P326, DOI 10.1016/S0014-5793(98)01713-X; Mark FC, 2006, COMP BIOCHEM PHYS D, V1, P365, DOI 10.1016/j.cbd.2006.08.004; Portner H.-O., 2005, FISH PHYSIOL, V22, P79, DOI DOI 10.1016/S1546-5098(04)22003-9; Rial Eduardo, 2009, Journal of Biology (London), V8, P58, DOI 10.1186/jbiol155; Richardson SM, 2008, HISTOCHEM CELL BIOL, V129, P503, DOI 10.1007/s00418-007-0372-9; Ricquier D, 2000, BIOCHEM J, V345, P161, DOI 10.1042/0264-6021:3450161; Saito S, 2008, GENE, V408, P37, DOI 10.1016/j.gene.2007.10.018; Schwartz TS, 2008, P ROY SOC B-BIOL SCI, V275, P979, DOI 10.1098/rspb.2007.1761; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; SHAKLEE JB, 1977, J EXP ZOOL, V201, P1, DOI 10.1002/jez.1402010102; Soitamo AJ, 2001, J BIOL CHEM, V276, P19699, DOI 10.1074/jbc.M009057200; Sokolova IM, 2005, FEBS LETT, V579, P313, DOI 10.1016/j.febslet.2004.11.103; Tang RY, 2007, ACTA BIOCH BIOPH SIN, V39, P384, DOI 10.1111/j.1745-7270.2007.00283.x; Thisse B, 2004, METHOD CELL BIOL, V77, P505; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Toyama T, 2004, BIOCHEM BIOPH RES CO, V324, P697, DOI 10.1016/j.bbrc.2004.09.110; Tseng YC, 2008, COMP BIOCHEM PHYS C, V148, P419, DOI 10.1016/j.cbpc.2008.04.009; TYLER S, 1984, J EXP ZOOL, V232, P1, DOI 10.1002/jez.1402320102; van den Burg EH, 2005, J NEUROPHYSIOL, V93, P2849, DOI 10.1152/jn.01113.2004; Vannucci SJ, 1997, GLIA, V21, P2, DOI 10.1002/(SICI)1098-1136(199709)21:1<2::AID-GLIA2>3.0.CO;2-C; VidalPuig A, 1997, BIOCHEM BIOPH RES CO, V235, P79, DOI 10.1006/bbrc.1997.6740; Villarroya F, 2007, PPAR RES, V2007, DOI 10.1155/2007/74364; Votyakova TV, 2001, J NEUROCHEM, V79, P266, DOI 10.1046/j.1471-4159.2001.00548.x; Wang PY, 2010, CIRC RES, V106, P911, DOI 10.1161/CIRCRESAHA.109.206185; WULLIMANN M, 1997, PHYSL FISHES, V2007, P245; Yoo HY, 1999, GENE, V234, P87, DOI 10.1016/S0378-1119(99)00176-6; Zhang X, 2007, TOXICOL APPL PHARM, V223, P10, DOI 10.1016/j.taap.2007.05.002	69	76	83	7	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e18180	10.1371/journal.pone.0018180	http://dx.doi.org/10.1371/journal.pone.0018180			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464954	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000288813900047
J	Yang, Z; Cooper, PR; Damera, G; Mukhopadhyay, I; Cho, H; Kehrl, JH; Panettieri, RA; Druey, KM				Yang, Zhao; Cooper, Philip R.; Damera, Gautam; Mukhopadhyay, Indranil; Cho, Hyeseon; Kehrl, John H.; Panettieri, Reynold A., Jr.; Druey, Kirk M.			beta-Agonist-associated Reduction in RGS5 Expression Promotes Airway Smooth Muscle Hyper-responsiveness	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PULMONARY BETA(2)-ADRENOCEPTOR DESENSITIZATION; DOWN-REGULATION; BLOOD-PRESSURE; PROTEIN; RECEPTORS; G(I); REGULATORS; ASTHMA; ENDOTHELIN-1; HYPERTROPHY	Although short-acting and long-acting inhaled beta(2)-adrenergic receptor agonists (SABA and LABA, respectively) relieve asthma symptoms, use of either agent alone without concomitant anti-inflammatory drugs (corticosteroids) may increase the risk of disease exacerbation in some patients. We found previously that pretreatment of human precision-cut lung slices (PCLS) with SABA impaired subsequent beta(2)-agonist-induced bronchodilation, which occurred independently of changes in receptor quantities. Here we provide evidence that prolonged exposure of cultured human airway smooth muscle (HuASM) cells to beta(2)-agonists directly augments procontractile signaling pathways elicited by several compounds including thrombin, bradykinin, and histamine. Such treatment did not increase surface receptor amounts or expression of G proteins and downstream effectors (phospholipase C beta and myosin light chain). In contrast, beta-agonists decreased expression of regulator of G protein signaling 5 (RGS5), which is an inhibitor of G-protein-coupled receptor (GPCR) activity. RGS5 knockdown in HuASM increased agonist-evoked intracellular calcium flux and myosin light chain (MLC) phosphorylation, which are prerequisites for contraction. PCLS from Rgs5(-/-) mice contracted more to carbachol than those from WT mice, indicating that RGS5 negatively regulates bronchial smooth muscle contraction. Repetitive beta(2)-agonist use may not only lead to reduced bronchoprotection but also to sensitization of excitation-contraction signaling pathways as a result of reduced RGS5 expression.	[Yang, Zhao; Mukhopadhyay, Indranil; Druey, Kirk M.] NIAID, Mol Signal Transduct Sect, Lab Allerg Dis, NIH, Bethesda, MD 20892 USA; [Cho, Hyeseon; Kehrl, John H.] NIAID, Cell Mol Immunol Sect B, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; [Cooper, Philip R.; Damera, Gautam; Panettieri, Reynold A., Jr.] Univ Penn, Pulm Allergy & Crit Care Div, Airways Biol Initiat, Philadelphia, PA 19104 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Pennsylvania	Druey, KM (corresponding author), 10 Ctr Dr,Rm 11N242, Bethesda, MD 20892 USA.	kdruey@niaid.nih.gov	panettieri, reynold/AAG-9485-2019; Kehrl, John/AAE-6292-2019; Yang, Zhiyong/E-7834-2013	Seefeldt, Lance/0000-0002-6457-9504; Yang, Zhiyong/0000-0001-8186-9450; Kehrl, John/0000-0002-6526-159X	National Institutes of Health, NIAID [AI000939];  [HL5452235];  [HL543102];  [HL544157]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000939, Z01AI000939] Funding Source: NIH RePORTER	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by the Intramural Research Program of the National Institutes of Health, NIAID (Grant No. AI000939 L. A. D., to K. M. D.) and by Grants HL5452235, HL543102, and HL544157 (to R. A. P.).	Agrawal DK, 2004, J ALLERGY CLIN IMMUN, V113, P503, DOI 10.1016/j.jaci.2003.12.039; Bai Y, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-34; Bansal G, 2008, J IMMUNOL, V181, P7882, DOI 10.4049/jimmunol.181.11.7882; Bansal G, 2007, PHARMACOL THERAPEUT, V116, P473, DOI 10.1016/j.pharmthera.2007.09.005; Bentley J Kelley, 2008, Proc Am Thorac Soc, V5, P89, DOI 10.1513/pats.200705-063VS; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Billington CK, 2003, RESP RES, V4; Black JL, 2009, CHEST, V136, P1095, DOI 10.1378/chest.09-0354; Borchers MT, 2003, AM J PHYSIOL-LUNG C, V285, pL114, DOI 10.1152/ajplung.00322.2002; Broadley KJ, 2006, EUR J PHARMACOL, V533, P15, DOI 10.1016/j.ejphar.2005.12.060; Chen CH, 1997, J BIOL CHEM, V272, P8679, DOI 10.1074/jbc.272.13.8679; Cho H, 2003, FASEB J, V17, P440, DOI 10.1096/fj.02-0340fje; Cho H, 2008, MOL CELL BIOL, V28, P2590, DOI 10.1128/MCB.01889-07; Chowdhury BA, 2010, NEW ENGL J MED, V362, P1169, DOI 10.1056/NEJMp1002074; Cooper PR, 2009, PULM PHARMACOL THER, V22, P398, DOI 10.1016/j.pupt.2008.09.008; Cooper PR, 2008, J ALLERGY CLIN IMMUN, V122, P734, DOI 10.1016/j.jaci.2008.07.040; Cooper PR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010235; Damera G, 2009, BRIT J PHARMACOL, V158, P1429, DOI 10.1111/j.1476-5381.2009.00428.x; Deshpande DA, 2006, CELL SIGNAL, V18, P2105, DOI 10.1016/j.cellsig.2006.04.008; Druey KM, 1996, NATURE, V379, P742, DOI 10.1038/379742a0; Faisy C, 2006, AM J RESP CELL MOL, V34, P410, DOI 10.1165/rcmb.2005-0091OC; Finney PA, 2000, J CLIN INVEST, V106, P125, DOI 10.1172/JCI8374; Finney PA, 2001, BRIT J PHARMACOL, V132, P1261, DOI 10.1038/sj.bjp.0703946; Gu S, 2009, CLIN SCI, V116, P391, DOI 10.1042/CS20080272; Hamzah J, 2008, NATURE, V453, P410, DOI 10.1038/nature06868; Hershenson MB, 2008, ANNU REV PATHOL-MECH, V3, P523, DOI 10.1146/annurev.pathmechdis.1.110304.100213; Hu AH, 2008, AM J PHYSIOL-LUNG C, V294, pL1055, DOI 10.1152/ajplung.00021.2008; Huang CF, 1997, P NATL ACAD SCI USA, V94, P6159, DOI 10.1073/pnas.94.12.6159; Huang XY, 2006, MOL CELL BIOL, V26, P6870, DOI 10.1128/MCB.00314-06; Kehrl JH, 2004, CRIT REV IMMUNOL, V24, P409; Kehrl JH, 2002, INT J BIOCHEM CELL B, V34, P432, DOI 10.1016/S1357-2725(01)00141-8; Krumins AM, 2004, J BIOL CHEM, V279, P2593, DOI 10.1074/jbc.M311600200; Lambert NA, 2010, P NATL ACAD SCI USA, V107, P7066, DOI 10.1073/pnas.0912934107; Li HL, 2010, P NATL ACAD SCI USA, V107, P13818, DOI 10.1073/pnas.1008397107; Mak JCW, 2000, MOL PHARMACOL, V57, P857; McCoy KL, 2009, PROG MOL BIOL TRANSL, V86, P49, DOI 10.1016/S1877-1173(09)86003-1; McGraw DW, 2007, J CLIN INVEST, V117, P1391, DOI 10.1172/JCI30489; McGraw DW, 2006, PHYSIOL GENOMICS, V27, P171, DOI 10.1152/physiolgenomics.00044.2006; McGraw DW, 2003, J CLIN INVEST, V112, P619, DOI 10.1172/JCI200318193; Meurs H, 2008, EUR RESPIR J, V32, P487, DOI 10.1183/09031936.00023608; Misior AM, 2009, AM J RESP CELL MOL, V41, P24, DOI 10.1165/rcmb.2008-0266OC; Munakata Mitsuru, 2006, Allergol Int, V55, P235, DOI 10.2332/allergolint.55.235; Nguyen LP, 2009, P NATL ACAD SCI USA, V106, P2435, DOI 10.1073/pnas.0810902106; Nino G, 2010, J ALLERGY CLIN IMMUN, V125, P1020, DOI 10.1016/j.jaci.2010.02.007; Nino G, 2009, AM J PHYSIOL-LUNG C, V297, pL746, DOI 10.1152/ajplung.00079.2009; Nunn C, 2010, CELL SIGNAL, V22, P1231, DOI 10.1016/j.cellsig.2010.03.015; Penn Raymond B, 2008, Proc Am Thorac Soc, V5, P47, DOI 10.1513/pats.200705-054VS; Penn RB, 2009, P NATL ACAD SCI USA, V106, P2095, DOI 10.1073/pnas.0812935106; Scheschonka A, 2000, MOL PHARMACOL, V58, P719, DOI 10.1124/mol.58.4.719; Seki N, 1998, J HUM GENET, V43, P202, DOI 10.1007/s100380050071; Snabaitis AK, 2005, CELL SIGNAL, V17, P655, DOI 10.1016/j.cellsig.2004.10.008; Song KS, 2009, AM J PHYSIOL-LUNG C, V296, pL684, DOI 10.1152/ajplung.90396.2008; Tovey SC, 2010, J BIOL CHEM, V285, P12979, DOI 10.1074/jbc.M109.096016; Willars GB, 2006, SEMIN CELL DEV BIOL, V17, P363, DOI 10.1016/j.semcdb.2006.03.005	54	30	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11444	11455		10.1074/jbc.M110.212480	http://dx.doi.org/10.1074/jbc.M110.212480			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21454640	Green Published, hybrid			2022-12-25	WOS:000288797100056
